PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Brouwers, L; Iskar, M; Zeller, G; van Noort, V; Bork, P				Brouwers, Lucas; Iskar, Murat; Zeller, Georg; van Noort, Vera; Bork, Peer			Network Neighbors of Drug Targets Contribute to Drug Side-Effect Similarity	PLOS ONE			English	Article							DISULFIRAM; INHIBITION; PREDICTION; PHARMACOLOGY	In pharmacology, it is essential to identify the molecular mechanisms of drug action in order to understand adverse side effects. These adverse side effects have been used to infer whether two drugs share a target protein. However, side-effect similarity of drugs could also be caused by their target proteins being close in a molecular network, which as such could cause similar downstream effects. In this study, we investigated the proportion of side-effect similarities that is due to targets that are close in the network compared to shared drug targets. We found that only a minor fraction of side-effect similarities (5.8%) are caused by drugs targeting proteins close in the network, compared to side-effect similarities caused by overlapping drug targets (64%). Moreover, these targets that cause similar side effects are more often in a linear part of the network, having two or less interactions, than drug targets in general. Based on the examples, we gained novel insight into the molecular mechanisms of side effects associated with several drug targets. Looking forward, such analyses will be extremely useful in the process of drug development to better understand adverse side effects.	[Brouwers, Lucas; Iskar, Murat; Zeller, Georg; van Noort, Vera; Bork, Peer] European Mol Biol Lab, Struct & Computat Biol Unit, Heidelberg, Germany; [Bork, Peer] Max Delbruck Ctr Mol Med, Berlin, Germany	European Molecular Biology Laboratory (EMBL); Helmholtz Association; Max Delbruck Center for Molecular Medicine	Brouwers, L (corresponding author), European Mol Biol Lab, Struct & Computat Biol Unit, Heidelberg, Germany.	bork@embl.de	Bork, Peer/F-1813-2013; Zeller, Georg/M-6484-2013; van Noort, Vera/E-1053-2011; van Noort, Vera/GWZ-9038-2022	Bork, Peer/0000-0002-2627-833X; Zeller, Georg/0000-0003-1429-7485; van Noort, Vera/0000-0002-8436-6602; Iskar, Murat/0000-0001-8603-4313; Iskar, Murat/0000-0001-6448-8779	Bundesministerium fuer Bildung und Forschung (Nationales Genomforschungsnetz Foerderkennzeichen) [01GS08169]; European Commission	Bundesministerium fuer Bildung und Forschung (Nationales Genomforschungsnetz Foerderkennzeichen); European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was supported in part by the Bundesministerium fuer Bildung und Forschung (Nationales Genomforschungsnetz Foerderkennzeichen 01GS08169) and by the European Commission (Erasmus fellowship to LB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Appel S, 1997, J CLIN PHARMACOL, V37, P229, DOI 10.1002/j.1552-4604.1997.tb04785.x; Bender A, 2007, CHEMMEDCHEM, V2, P861, DOI 10.1002/cmdc.200700026; Berthouze M, 2005, FEBS LETT, V579, P2973, DOI 10.1016/j.febslet.2005.04.040; Campillos M, 2008, SCIENCE, V321, P263, DOI 10.1126/science.1158140; Chiang AP, 2009, CLIN PHARMACOL THER, V85, P259, DOI 10.1038/clpt.2008.274; Deane KH., 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD004554.PUB2; Desta Z, 2001, ANTIMICROB AGENTS CH, V45, P382, DOI 10.1128/AAC.45.2.382-392.2001; Fliri AF, 2010, TRENDS PHARMACOL SCI, V31, P547, DOI 10.1016/j.tips.2010.07.005; Fliri AF, 2009, J MED CHEM, V52, P8038, DOI 10.1021/jm901001p; Foti RS, 2010, COMB CHEM HIGH T SCR, V13, P145, DOI 10.2174/138620710790596718; Gunther S, 2008, NUCLEIC ACIDS RES, V36, pD919, DOI 10.1093/nar/gkm862; Hase T, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000550; Hatton RC, 2007, ANN PHARMACOTHER, V41, P381, DOI 10.1345/aph.1H679; Hopkins AL, 2008, NAT CHEM BIOL, V4, P682, DOI 10.1038/nchembio.118; Iskar M, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000925; Keiser MJ, 2009, NATURE, V462, P175, DOI 10.1038/nature08506; KHARASCH ED, 1993, CLIN PHARMACOL THER, V53, P643, DOI 10.1038/clpt.1993.85; Kola I, 2004, NAT REV DRUG DISCOV, V3, P711, DOI 10.1038/nrd1470; Kuhn M, 2008, FEBS LETT, V582, P1283, DOI 10.1016/j.febslet.2008.02.024; Kuhn M, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2009.98; LEMBERGER L, 1980, CLIN PHARMACOL THER, V27, P642, DOI 10.1038/clpt.1980.91; Liebler DC, 2005, NAT REV DRUG DISCOV, V4, P410, DOI 10.1038/nrd1720; Lin SF, 2010, ARTIF INTELL MED, V48, P161, DOI 10.1016/j.artmed.2009.11.002; Loughlin J, 2010, J CARDIOVASC PHARM T, V15, P151, DOI 10.1177/1074248409360357; Martin YC, 2002, J MED CHEM, V45, P4350, DOI 10.1021/jm020155c; Nacher Jose C., 2008, BMC Pharmacology, V8, P5, DOI 10.1186/1471-2210-8-5; Pache RA, 2008, FEBS LETT, V582, P1259, DOI 10.1016/j.febslet.2008.02.014; Paolini GV, 2006, NAT BIOTECHNOL, V24, P805, DOI 10.1038/nbt1228; PETTERSSON H, 1982, J NEUROCHEM, V39, P628, DOI 10.1111/j.1471-4159.1982.tb07939.x; Reeves RR, 2004, PSYCHOSOMATICS, V45, P537, DOI 10.1176/appi.psy.45.6.537; Sanger GJ, 2009, NEUROGASTROENT MOTIL, V21, P1235, DOI 10.1111/j.1365-2982.2009.01425.x; Suthram S, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000662; von Mering C, 2003, P NATL ACAD SCI USA, V100, P15428, DOI 10.1073/pnas.2136809100; von Mering C, 2007, NUCLEIC ACIDS RES, V35, pD358, DOI 10.1093/nar/gkl825; WHITTING.HG, 1969, AM J PSYCHIAT, V125, P1725, DOI 10.1176/ajp.125.12.1725; Willett P, 1998, J CHEM INF COMP SCI, V38, P983, DOI 10.1021/ci9800211; Wishart DS, 2008, NUCLEIC ACIDS RES, V36, pD901, DOI 10.1093/nar/gkm958; Xie L, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000387; Yamanishi Y, 2010, BIOINFORMATICS, V26, pi246, DOI 10.1093/bioinformatics/btq176; Zanzoni A, 2009, FEBS LETT, V583, P1759, DOI 10.1016/j.febslet.2009.03.001; Zhang L, 2009, AAPS J, V11, P300, DOI 10.1208/s12248-009-9106-3; Zhao SW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011764; ZURCHER G, 1990, J NEUR TR S, P375	44	71	71	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2011	6	7							e22187	10.1371/journal.pone.0022187	http://dx.doi.org/10.1371/journal.pone.0022187			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	792WQ	21765950	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000292781500039
J	Rozenberg, I; Sluka, SHM; Mocharla, P; Hallenberg, A; Rotzius, P; Boren, J; Krankel, N; Landmesser, U; Borsig, L; Luscher, TF; Eriksson, EE; Tanner, FC				Rozenberg, Izabela; Sluka, Susanna H. M.; Mocharla, Pavani; Hallenberg, Anders; Rotzius, Pierre; Boren, Jan; Kraenkel, Nicolle; Landmesser, Ulf; Borsig, Lubor; Luescher, Thomas F.; Eriksson, Einar E.; Tanner, Felix C.			Deletion of L-Selectin Increases Atherosclerosis Development in ApoE(-/-) Mice	PLOS ONE			English	Article							P-SELECTIN; CELL-ADHESION; IN-VIVO; INFLAMMATION; ENDOTHELIUM; LIGAND; RECRUITMENT; MONOCYTE; ALPHA	Atherosclerosis is an inflammatory disease characterized by accumulation of leukocytes in the arterial intima. Members of the selectin family of adhesion molecules are important mediators of leukocyte extravasation. However, it is unclear whether L-selectin (L-sel) is involved in the pathogenesis of atherosclerosis. In the present study, mice deficient in L-selectin (L-sel(-/-)) animals were crossed with mice lacking Apolipoprotein E (ApoE(-/-)). The development of atherosclerosis was analyzed in double-knockout ApoE/L-sel (ApoE(-/-) L-sel(-/-)) mice and the corresponding ApoE(-/-) controls fed either a normal or a high cholesterol diet (HCD). After 6 weeks of HCD, aortic lesions were increased two-fold in ApoE(-/-) L-sel(-/-) mice as compared to ApoE(-/-) controls (2.46%+/- 0.54% vs 1.28%+/- 0.24% of total aortic area; p < 0.05). Formation of atherosclerotic lesions was also enhanced in 6-month-old ApoE(-/-) L-sel(-/-) animals fed a normal diet (10.45%+/- 2.58% vs 1.87%+/- 0.37%; p < 0.05). In contrast, after 12 weeks of HCD, there was no difference in atheroma formation between ApoE(-/-) L-sel(-/-) and ApoE(-/-) mice. Serum cholesterol levels remained unchanged by L-sel deletion. Atherosclerotic plaques did not exhibit any differences in cellular composition assessed by immunohistochemistry for CD68, CD3, CD4, and CD8 in ApoE(-/-) L-sel(-/-) as compared to ApoE(-/-) mice. Leukocyte rolling on lesions in the aorta was similar in ApoE(-/-) L-sel(-/-) and ApoE(-/-) animals. ApoE(-/-) L-sel(-/-) mice exhibited reduced size and cellularity of peripheral lymph nodes, increased size of spleen, and increased number of peripheral lymphocytes as compared to ApoE(-/-) controls. These data indicate that L-sel does not promote atherosclerotic lesion formation and suggest that it rather protects from early atherosclerosis.	[Rozenberg, Izabela; Sluka, Susanna H. M.; Mocharla, Pavani; Kraenkel, Nicolle; Landmesser, Ulf; Borsig, Lubor; Luescher, Thomas F.; Tanner, Felix C.] Univ Zurich, Inst Physiol, Zurich, Switzerland; [Rozenberg, Izabela; Sluka, Susanna H. M.; Mocharla, Pavani; Kraenkel, Nicolle; Landmesser, Ulf; Borsig, Lubor; Luescher, Thomas F.; Tanner, Felix C.] Univ Zurich, Ctr Integrat Human Physiol, Zurich, Switzerland; [Hallenberg, Anders; Rotzius, Pierre; Eriksson, Einar E.] Karolinska Inst, Dept Physiol & Pharmacol, Stockholm, Sweden; [Boren, Jan] Univ Gothenburg, Sahlgrenska Acad, Wallenberg Lab, Gothenburg, Sweden; [Landmesser, Ulf; Luescher, Thomas F.; Tanner, Felix C.] Univ Zurich Hosp, Ctr Cardiovasc, CH-8091 Zurich, Switzerland; [Eriksson, Einar E.] Karolinska Inst, Dept Mol Med & Surg, Ctr Mol Med, Karolinska Hosp, Stockholm, Sweden	University of Zurich; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP); Karolinska Institutet; University of Gothenburg; University of Zurich; University Zurich Hospital; Karolinska Institutet; Karolinska University Hospital	Rozenberg, I (corresponding author), Univ Zurich, Inst Physiol, Zurich, Switzerland.	felix.tanner@access.uzh.ch		Sluka, Susanna/0000-0001-9051-8492; Kraenkel, Nicolle/0000-0002-9363-1770; Borsig, Lubor/0000-0003-2263-9545	GEBERT RAceF FOUNDATION; Swiss National Science Foundation [3200B0-113328/1, 3100-068118.02/1]; Novo Nordisk Fonden [NNF11OC1014864] Funding Source: researchfish	GEBERT RAceF FOUNDATION; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Novo Nordisk Fonden(Novo Nordisk Foundation)	This study was made possible by the GEBERT RAceF FOUNDATION (http://www.grstiftung.ch). Further support was obtained from the Swiss National Science Foundation (www.snf.ch) (grant 3200B0-113328/1 to F.C.T. and grant 3100-068118.02/1 to T.F.L.) and the Velux Foundation (http://www.veluxstiftung.ch/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARBONES ML, 1994, IMMUNITY, V1, P247, DOI 10.1016/1074-7613(94)90076-0; BRANDLEY BK, 1990, CELL, V63, P861, DOI 10.1016/0092-8674(90)90487-Y; Dong ZM, 1998, J CLIN INVEST, V102, P145, DOI 10.1172/JCI3001; Eriksson EE, 2001, J EXP MED, V194, P205, DOI 10.1084/jem.194.2.205; Eriksson EE, 2001, FASEB J, V15, P1149, DOI 10.1096/fj.00-0537com; Eriksson EE, 2000, CIRC RES, V86, P526, DOI 10.1161/01.RES.86.5.526; Eriksson EE, 2008, J LEUKOCYTE BIOL, V84, P93, DOI 10.1189/jlb.1107786; Galkina E, 2006, J EXP MED, V203, P1273, DOI 10.1084/jem.20052205; Giuffre L, 1997, J CELL BIOL, V136, P945, DOI 10.1083/jcb.136.4.945; Jung U, 1999, J IMMUNOL, V162, P6755; Kilian K, 2004, J BIOL CHEM, V279, P34472, DOI 10.1074/jbc.M405916200; Kunkel EJ, 1997, AM J PHYSIOL-HEART C, V272, pH1391, DOI 10.1152/ajpheart.1997.272.3.H1391; LEY K, 1991, BLOOD, V77, P2553; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; MAYADAS TN, 1993, CELL, V74, P541, DOI 10.1016/0092-8674(93)80055-J; Mullenix PS, 2005, ANN VASC SURG, V19, P130, DOI 10.1007/s10016-004-0153-z; PHILLIPS ML, 1990, SCIENCE, V250, P1130, DOI 10.1126/science.1701274; Ramos CL, 1999, CIRC RES, V84, P1237, DOI 10.1161/01.RES.84.11.1237; Rigby S, 2000, EUR J IMMUNOL, V30, P98, DOI 10.1002/1521-4141(200001)30:1<98::AID-IMMU98>3.3.CO;2-R; Rivera-Nieves J, 2006, J EXP MED, V203, P907, DOI 10.1084/jem.20052530; Rotzius P, 2010, AM J PATHOL, V177, P493, DOI 10.2353/ajpath.2010.090480; Rotzius P, 2009, ATHEROSCLEROSIS, V202, P111, DOI 10.1016/j.atherosclerosis.2008.04.009; Rozenberg I, 2010, ARTERIOSCL THROM VAS, V30, P923, DOI 10.1161/ATVBAHA.109.201079; Sperandio M, 2003, J EXP MED, V197, P1355, DOI 10.1084/jem.20021854; SPERTINI O, 1991, J IMMUNOL, V147, P2565; Steeber DA, 1996, J IMMUNOL, V157, P4899; TEDDER TF, 1995, FASEB J, V9, P866, DOI 10.1096/fasebj.9.10.7542213; TEDDER TF, 1995, J EXP MED, V181, P2259, DOI 10.1084/jem.181.6.2259; Willerson JT, 2002, PROG CARDIOVASC DIS, V44, P469, DOI 10.1053/pcad.2002.123782	30	18	19	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2011	6	7							e21675	10.1371/journal.pone.0021675	http://dx.doi.org/10.1371/journal.pone.0021675			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791IA	21760899	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000292657200017
J	Sun, X; Tong, LP; Wang, YT; Wu, YX; Sheng, HS; Lu, LJ; Wang, W				Sun, Xin; Tong, Li-Ping; Wang, Yu-Tong; Wu, Yong-Xiang; Sheng, Hong-Shen; Lu, Lian-Jun; Wang, Wen			Can Global Variation of Nasopharynx Cancer Be Retrieved from the Combined Analyses of IARC Cancer Information (CIN) Databases?	PLOS ONE			English	Article							HONG-KONG; CARCINOMA; SINGAPORE; CHINESE; TRENDS; RISK; EPIDEMIOLOGY; MORTALITY	Background: The international nasopharynx cancer (NPC) burdens are masked due to the lack of integrated studies that examine epidemiological data based on up-to-date international disease databases such as the Cancer Information (CIN) databases provided by the International Agency for Research on Cancer (IARC). Methods: By analyzing the most recently updated NPC epidemiological data available from IARC, we tried to retrieve the worldwide NPC burden and patterns from combined analysis with GLOBOCAN2008 and the Cancer Incidence in Five Continents (CI5) databases. We provide age-standardized rates (ASR) for NPC mortality in 20 highest cancer registries from GLOBOCAN2008 and the World Health Organization (WHO) mortality databases, respectively. However, NPC incidence data can not be retrieved since it is not individually listed in CI5 database. The trend of NPC mortality was investigated with Joinpoint analysis in the selected countries/regions with high ASR. Results: GLOBOCAN 2008 revealed that the highest NPC incidence rates in 2008 were in registries from South-Eastern Asia, Micronesia and Southern Africa with Malaysia, Indonesia and Singapore ranking the top 3. WHO mortality database analysis revealed that China Hong Kong, Singapore and Malta ranks the top 3 regions with the highest 5-year mortality rates. Conclusions: NPC mortality rate is about 2-3 times higher in male than that in female, and shows decrease tendency in those selected countries/regions during the analyzed periods. However, the integrated analyses of the current IARC CIN databases may not be suitable to retrieve epidemiological data of NPC. Much effort is required to improve the local cancer entry and regional death-reporting systems so as to aid similar studies.	[Sun, Xin] Fourth Mil Med Univ, Dept Paediat, Xijing Hosp, Xian 710032, Shaanxi, Peoples R China; [Tong, Li-Ping] Fourth Mil Med Univ, Dept Teaching & Training, Xijing Hosp, Xian 710032, Shaanxi, Peoples R China; [Wang, Yu-Tong] Fourth Mil Med Univ, Dept Emergency, Xijing Hosp, Xian 710032, Shaanxi, Peoples R China; [Wu, Yong-Xiang; Lu, Lian-Jun] Fourth Mil Med Univ, Dept Otolaryngol & Head Neck Surg, Xijing Hosp, Xian 710032, Shaanxi, Peoples R China; [Sheng, Hong-Shen] Gen Hosp Chengdu Mil Area, Dept Otolaryngol, Tian Hui Town, Sichuan, Peoples R China; [Wang, Wen] Fourth Mil Med Univ, KK Leung Brain Res Ctr, Unit Evidence Based Med, Xian 710032, Shaanxi, Peoples R China	Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University	Sun, X (corresponding author), Fourth Mil Med Univ, Dept Paediat, Xijing Hosp, Xian 710032, Shaanxi, Peoples R China.	lulianj@fmmu.edu.cn; wangwen@fmmu.edu.cn			Natural Science Foundation of China [30572022, 30700345, 81070790]; Science and Technique Foundation from Shaanxi Province [2010k15-09-01]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technique Foundation from Shaanxi Province	The study was supported by grants from the Natural Science Foundation of China (numbers 30572022, 30700345 and 81070790) and the Science and Technique Foundation from Shaanxi Province (number 2010k15-09-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, GLOBOCAN 2008 CANC I; [Anonymous], 1997, IARC SCI PUBL, Vi-xxxiv, P1; ARMSTRONG RW, 1979, BRIT J CANCER, V40, P557, DOI 10.1038/bjc.1979.221; Center MM, 2009, CA-CANCER J CLIN, V59, P366, DOI 10.3322/caac.20038; Corry J, 2004, Australas Radiol, V48, P509, DOI 10.1111/j.1440-1673.2004.01356.x; Curado M. P., 2008, IARC SCI PUBL, VIX, P1; DETHE G, 1981, YALE J BIOL MED, V54, P33; Devi BCR, 2004, CANCER EPIDEM BIOMAR, V13, P482; HILDESHEIM A, 1993, EPIDEMIOL REV, V15, P466, DOI 10.1093/oxfordjournals.epirev.a036130; JEANNEL D, 1993, INT J CANCER, V54, P536, DOI 10.1002/ijc.2910540403; Jia WH, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-178; Kim HJ, 2000, STAT MED, V19, P335, DOI 10.1002/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.0.CO;2-Z; KIMURA Y, 2011, AURIS NASUS LARYNX; KOPPIKAR SB, 1988, J SURG ONCOL, V39, P179, DOI 10.1002/jso.2930390309; Kumar S, 1996, ANN NATL ACAD MED SC, V32, P199; Lee AWM, 2003, INT J CANCER, V103, P680, DOI 10.1002/ijc.10894; LEE HP, 1994, INT J CANCER, V59, P585, DOI 10.1002/ijc.2910590502; Luo JH, 2007, EUR J EPIDEMIOL, V22, P513, DOI 10.1007/s10654-007-9148-8; MUIR C, 1987, IARC SCI PUBL, V5, P1; Parkin DM, 1997, INT J CANCER, V70, P654, DOI 10.1002/(SICI)1097-0215(19970317)70:6&lt;654::AID-IJC5&gt;3.0.CO;2-U; PARKIN DM, 2002, IARC SCI PUBL, V8, P1; Wang H, 2004, ANN ACAD MED SINGAP, V33, P57; WELLS C, 1964, J Laryngol Otol, V78, P320, DOI 10.1017/S0022215100062137; Yu MC, 2002, SEMIN CANCER BIOL, V12, P421, DOI 10.1016/S1044579X02000858	24	16	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2011	6	7							e22039	10.1371/journal.pone.0022039	http://dx.doi.org/10.1371/journal.pone.0022039			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791HI	21760951	Green Submitted, gold, Green Published			2022-12-27	WOS:000292655400043
J	Wentzensen, N; Black, A; Jacobs, K; Yang, HP; Berg, CD; Caporaso, N; Peters, U; Ragard, L; Buys, SS; Chanock, S; Hartge, P				Wentzensen, Nicolas; Black, Amanda; Jacobs, Kevin; Yang, Hannah P.; Berg, Christine D.; Caporaso, Neil; Peters, Ulrike; Ragard, Lawrence; Buys, Saundra S.; Chanock, Stephen; Hartge, Patricia			Genetic Variation on 9p22 Is Associated with Abnormal Ovarian Ultrasound Results in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; RISK-FACTORS	Background: A recent ovarian cancer genome-wide association study (GWAS) identified a locus on 9p22 associated with reduced ovarian cancer risk. The single nucleotide polymorphism (SNP) markers localize to the BNC2 gene, which has been associated with ovarian development. Methods: We analyzed the association of 9p22 SNPs with transvaginal ultrasound (TVU) screening results and CA-125 blood levels from participants without ovarian cancer in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial (PLCO); 1,106 women with adequate ultrasound screening results and available genotyping information were included in the study. Results: We observed a significantly increased risk of abnormal suspicious TVU results for seven SNPs on 9p22, with odds ratios between 1.68 (95% CI: 1.04-2.72) for rs4961501 and 2.10 (95% CI: 1.31-3.38) for rs12379183. Associations were restricted to abnormal suspicious findings at the first TVU screen. We did not observe an association between 9p22 SNPs and CA-125 levels. Conclusions: Our findings suggest that 9p22 SNPs, which were found to be associated with decreased risk of ovarian cancer in a recent GWAS, are associated with sonographically detectable ovarian abnormalities. Our results corroborate the relevance of the 9p22 locus for ovarian biology. Further studies are required to understand the complex relationship between screening abnormalities and ovarian carcinogenesis and to evaluate whether this locus can influence the risk stratification of ovarian cancer screening.	[Wentzensen, Nicolas; Black, Amanda; Yang, Hannah P.; Caporaso, Neil; Chanock, Stephen; Hartge, Patricia] NCI, Div Canc Epidemiol & Genet, Rockville, MD USA; [Jacobs, Kevin; Chanock, Stephen] NCI, Core Genotyping Facil, Rockville, MD USA; [Berg, Christine D.] NCI, Canc Prevent Div, Bethesda, MD 20892 USA; [Peters, Ulrike] Fred Hutchinson Canc Res Ctr, Canc Prevent Program, Seattle, WA 98104 USA; [Ragard, Lawrence] Westat Corp, Rockville, MD USA; [Buys, Saundra S.] Huntsman Canc Inst, Div Oncol, Salt Lake City, UT USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Fred Hutchinson Cancer Center; Westat; Huntsman Cancer Institute	Wentzensen, N (corresponding author), NCI, Div Canc Epidemiol & Genet, Rockville, MD USA.	wentzenn@mail.nih.gov	Berg, Christine/K-1047-2014; Wentzensen, Nicolas/AAG-8522-2019		Division of Cancer Epidemiology and Genetics; Division of Cancer Prevention, National Cancer Institute, NIH, DHHS; NATIONAL CANCER INSTITUTE [ZIACP010152] Funding Source: NIH RePORTER	Division of Cancer Epidemiology and Genetics(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)NIH National Cancer Institute- Division of Cancer Epidemiology & Genetics); Division of Cancer Prevention, National Cancer Institute, NIH, DHHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by the Intramural Research Program of the Division of Cancer Epidemiology and Genetics and by contracts from the Division of Cancer Prevention, National Cancer Institute, NIH, DHHS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Cancer Society, 2009, CANC FACTS FIG 2009; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Buys SS, 2005, AM J OBSTET GYNECOL, V193, P1630, DOI 10.1016/j.ajog.2005.05.005; Crum CP, 2007, CURR OPIN OBSTET GYN, V19, P3, DOI 10.1097/GCO.0b013e328011a21f; FATHALLA MF, 1971, LANCET, V2, P163; Greenlee RT, 2010, OBSTET GYNECOL SURV, V65, P373, DOI 10.1097/OGX.0b013e3181e5a0d0; Hartge P, 2000, AM J OBSTET GYNECOL, V183, P1232, DOI 10.1067/mob.2000.107401; Loeb S, 2009, J UROLOGY, V182, P101, DOI 10.1016/j.juro.2009.02.126; Menon U, 2009, LANCET ONCOL, V10, P327, DOI 10.1016/S1470-2045(09)70026-9; Nyante SJ, 2011, GYNECOL ONCOL, V120, P474, DOI 10.1016/j.ygyno.2010.11.015; Partridge E, 2009, OBSTET GYNECOL, V113, P775, DOI 10.1097/AOG.0b013e31819cda77; Petersen GM, 2010, NAT GENET, V42, P224, DOI 10.1038/ng.522; Prorok PC, 2000, CONTROL CLIN TRIALS, V21, p273S, DOI 10.1016/S0197-2456(00)00098-2; RIES LAG, 1993, CANCER-AM CANCER SOC, V71, P524; Romano RA, 2004, GENOMICS, V83, P821, DOI 10.1016/j.ygeno.2003.11.009; Rothman N, 2010, NAT GENET, V42, P978, DOI 10.1038/ng.687; Salehi F, 2008, J TOXICOL ENV HEAL B, V11, P301, DOI 10.1080/10937400701876095; Sato S, 2000, CANCER, V89, P582, DOI 10.1002/1097-0142(20000801)89:3<582::AID-CNCR13>3.0.CO;2-#; SONG H, 2009, NATURE GENETICS; VAN NJ, 2000, GYNECOL ONCOL, V77, P350; Vanhoutteghem A, 2006, P NATL ACAD SCI USA, V103, P12423, DOI 10.1073/pnas.0605086103; Wacholder S, 2010, NEW ENGL J MED, V362, P986, DOI 10.1056/NEJMoa0907727	22	8	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2011	6	7							e21731	10.1371/journal.pone.0021731	http://dx.doi.org/10.1371/journal.pone.0021731			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791HI	21750727	Green Submitted, gold, Green Published			2022-12-27	WOS:000292655400014
J	Blaschitz, A; Gauster, M; Fuchs, D; Lang, I; Maschke, P; Ulrich, D; Karpf, E; Takikawa, O; Schimek, MG; Dohr, G; Sedlmayr, P				Blaschitz, Astrid; Gauster, Martin; Fuchs, Dietmar; Lang, Ingrid; Maschke, Petra; Ulrich, Daniela; Karpf, Eva; Takikawa, Osamu; Schimek, Michael G.; Dohr, Gottfried; Sedlmayr, Peter			Vascular Endothelial Expression of Indoleamine 2,3-Dioxygenase 1 Forms a Positive Gradient towards the Feto-Maternal Interface	PLOS ONE			English	Article							TRYPTOPHAN CATABOLISM; HUMAN PLACENTA; INTERFERON-GAMMA; SERUM TRYPTOPHAN; DENDRITIC CELLS; T-CELLS; HLA-G; PREGNANCY; IDO; KYNURENINE	We describe the distribution of indoleamine 2,3-dioxygenase 1 (IDO1) in vascular endothelium of human first-trimester and term placenta. Expression of IDO1 protein on the fetal side of the interface extended from almost exclusively subtrophoblastic capillaries in first-trimester placenta to a nearly general presence on villous vascular endothelia at term, including also most bigger vessels such as villous arteries and veins of stem villi and vessels of the chorionic plate. Umbilical cord vessels were generally negative for IDO1 protein. In the fetal part of the placenta positivity for IDO1 was restricted to vascular endothelium, which did not co-express HLA-DR. This finding paralleled detectability of IDO1 mRNA in first trimester and term tissue and a high increase in the kynurenine to tryptophan ratio in chorionic villous tissue from first trimester to term placenta. Endothelial cells isolated from the chorionic plate of term placenta expressed IDO1 mRNA in contrast to endothelial cells originating from human umbilical vein, iliac vein or aorta. In first trimester decidua we found endothelium of arteries rather than veins expressing IDO1, which was complementory to expression of HLA-DR. An estimation of IDO activity on the basis of the ratio of kynurenine and tryptophan in blood taken from vessels of the chorionic plate of term placenta indicated far higher values than those found in the peripheral blood of adults. Thus, a gradient of vascular endothelial IDO1 expression is present at both sides of the feto-maternal interface.	[Blaschitz, Astrid; Gauster, Martin; Lang, Ingrid; Maschke, Petra; Dohr, Gottfried; Sedlmayr, Peter] Med Univ Graz, Ctr Mol Med, Inst Cell Biol Histol & Embryol, Graz, Austria; [Fuchs, Dietmar] Innsbruck Med Univ, Bioctr, Div Biol Chem, Innsbruck, Austria; [Ulrich, Daniela] Med Univ Graz, Dept Obstet & Gynecol, Graz, Austria; [Karpf, Eva] Med Univ Graz, Ctr Appl Biomed, Inst Pathol, Graz, Austria; [Takikawa, Osamu] Natl Ctr Geriatr & Gerontol, Natl Inst Longev Sci, Lab Radiat Safety, Obu City, Japan; [Schimek, Michael G.] Med Univ Graz, Inst Med Informat Stat & Documentat, Graz, Austria	Medical University of Graz; Medical University of Innsbruck; Medical University of Graz; Medical University of Graz; National Center for Geriatrics & Gerontology; Medical University of Graz	Blaschitz, A (corresponding author), Med Univ Graz, Ctr Mol Med, Inst Cell Biol Histol & Embryol, Graz, Austria.	peter.sedlmayr@medunigraz.at	Gauster, Martin/K-7221-2019; Dohr, Gottfried/E-8070-2010; Fuchs, Dietmar/AAL-8011-2021; Gauster, Martin/M-9659-2019; Gold, Daniela/ABE-4818-2020	Fuchs, Dietmar/0000-0003-1627-9563; Gauster, Martin/0000-0003-0386-6857; Gold, Daniela/0000-0002-7196-454X; Lang-Olip, Ingrid/0000-0003-0403-4884	European Commission (Network of Excellence "The Control of Embryo Implantation (EMBIC)") [FP6-512040]; Medical University of Graz	European Commission (Network of Excellence "The Control of Embryo Implantation (EMBIC)")(European CommissionEuropean Commission Joint Research Centre); Medical University of Graz	This study was supported in part by the European Commission (Network of Excellence "The Control of Embryo Implantation (EMBIC)", FP6-512040, lead researcher involved: P.S.). Martin Gauster has been financially supported by the START funding program of the Medical University of Graz. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Adams O, 2004, MICROBES INFECT, V6, P806, DOI 10.1016/j.micinf.2004.04.007; Ariga H, 2001, TRANSFUSION, V41, P1524, DOI 10.1046/j.1537-2995.2001.41121524.x; BALL HJ, 2008, INT J BIOCH CELL BIO; Batista CEA, 2009, MOL IMAGING BIOL, V11, P460, DOI 10.1007/s11307-009-0225-0; Beutelspacher SC, 2006, AM J TRANSPLANT, V6, P1320, DOI 10.1111/j.1600-6143.2006.01324.x; Blaschitz A, 2005, MOL HUM REPROD, V11, P699, DOI 10.1093/molehr/gah185; Blaschitz A, 2000, HUM IMMUNOL, V61, P1074, DOI 10.1016/S0198-8859(00)00207-X; Blaschitz A, 2008, HISTOCHEM CELL BIOL, V130, P595, DOI 10.1007/s00418-008-0458-z; Cupurdija K, 2004, AM J REPROD IMMUNOL, V51, P117, DOI 10.1046/j.8755-8920.2003.00128.x; Daubener W, 2009, THROMB HAEMOSTASIS, V102, P1110, DOI 10.1160/TH09-04-0250; Dong MY, 2008, CELL PHYSIOL BIOCHEM, V21, P463, DOI 10.1159/000129639; Forouhar F, 2007, P NATL ACAD SCI USA, V104, P473, DOI 10.1073/pnas.0610007104; Hansen AM, 2004, INT J PARASITOL, V34, P1309, DOI 10.1016/j.ijpara.2004.07.008; Holt PG, 2000, ALLERGY, V55, P688, DOI 10.1034/j.1398-9995.2000.00118.x; Honig A, 2004, J REPROD IMMUNOL, V61, P79, DOI 10.1016/j.jri.2003.11.002; Jones BJ, 2007, PLACENTA, V28, P1174, DOI 10.1016/j.placenta.2007.07.001; Knolle Percy A., 2006, V43, P151, DOI 10.1007/018; Koch CA, 2007, CELL IMMUNOL, V248, P12, DOI 10.1016/j.cellimm.2007.05.006; Kositz C, 2008, INT ARCH ALLERGY IMM, V147, P35, DOI 10.1159/000128584; Krabchi K, 2001, CLIN GENET, V60, P145, DOI 10.1034/j.1399-0004.2001.600209.x; Kudo Y, 2004, J REPROD IMMUNOL, V61, P87, DOI 10.1016/j.jri.2003.11.004; Lallemant M, 2000, NEW ENGL J MED, V343, P982, DOI 10.1056/NEJM200010053431401; Lang I, 2008, DIFFERENTIATION, V76, P1031, DOI 10.1111/j.1432-0436.2008.00302.x; Ligam P, 2005, PLACENTA, V26, P498, DOI 10.1016/j.placenta.2004.08.009; Lo YMD, 1998, BRIT J HAEMATOL, V100, P605; Lob S, 2008, BLOOD, V111, P2152, DOI 10.1182/blood-2007-10-116111; Lob S, 2009, CANCER IMMUNOL IMMUN, V58, P153, DOI 10.1007/s00262-008-0513-6; MacKenzie CR, 2007, CURR DRUG METAB, V8, P237, DOI 10.2174/138920007780362518; Metz R, 2007, CANCER RES, V67, P7082, DOI 10.1158/0008-5472.CAN-07-1872; Munn DH, 1998, SCIENCE, V281, P1191, DOI 10.1126/science.281.5380.1191; Munn DH, 2004, J CLIN INVEST, V114, P280, DOI 10.1172/JCI200421583; Munn DH, 1999, J EXP MED, V189, P1363, DOI 10.1084/jem.189.9.1363; Neelson JL, 2008, SCI AM, V298, P72; Nishizawa H, 2008, J OBSTET GYNAECOL RE, V34, P1, DOI 10.1111/j.1447-0756.2007.00679.x; Riesenberg R, 2007, CLIN CANCER RES, V13, P6993, DOI 10.1158/1078-0432.CCR-07-0942; Schrocksnadel H, 1996, OBSTET GYNECOL, V88, P47, DOI 10.1016/0029-7844(96)00084-1; Schrocksnadel K, 2003, LIFE SCI, V72, P785, DOI 10.1016/S0024-3205(02)02304-4; Sedlmayr P, 2002, MOL HUM REPROD, V8, P385, DOI 10.1093/molehr/8.4.385; Suzuki S, 2001, BIOCHEM J, V355, P425, DOI 10.1042/0264-6021:3550425; TAKIKAWA O, 1988, J BIOL CHEM, V263, P2041; Thebault P, 2007, AM J TRANSPLANT, V7, P2472, DOI 10.1111/j.1600-6143.2007.01960.x; Vernochet C, 2007, PLACENTA, V28, P639, DOI 10.1016/j.placenta.2006.10.006; Wang YT, 2010, NAT MED, V16, P279, DOI 10.1038/nm.2092; Widner B, 1997, CLIN CHEM, V43, P2424; Yamashita S, 2007, PROG HISTOCHEM CYTO, V41, P141, DOI 10.1016/j.proghi.2006.09.001; Yuasa HJ, 2007, J MOL EVOL, V65, P705, DOI 10.1007/s00239-007-9049-1	46	52	52	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2011	6	7							e21774	10.1371/journal.pone.0021774	http://dx.doi.org/10.1371/journal.pone.0021774			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791AK	21755000	Green Published, Green Submitted, gold			2022-12-27	WOS:000292632000027
J	Yang, Z; Zhao, JP; Jiang, Y; Li, CB; Wang, JJ; Weng, XC; Northoff, G				Yang, Zhi; Zhao, Jinping; Jiang, Yi; Li, Chunbo; Wang, Jijun; Weng, Xuchu; Northoff, Georg			Altered Negative Unconscious Processing in Major Depressive Disorder: An Exploratory Neuropsychological Study	PLOS ONE			English	Article							CONTINUOUS FLASH SUPPRESSION; EMOTIONAL INFORMATION; FACIAL EXPRESSIONS; ATTENTIONAL BIASES; CORTICAL RESPONSES; AMYGDALA; FACES; PERCEPTION; STIMULI; ANXIETY	Objective: Major depressive disorder (MDD) has been characterized by abnormalities in emotional processing. However, what remains unclear is whether MDD also shows deficits in the unconscious processing of either positive or negative emotions. We conducted a psychological study in healthy and MDD subjects to investigate unconscious emotion processing and its valence-specific alterations in MDD patients. Methods: We combined a well established paradigm for unconscious visual processing, the continuous flash suppression, with positive and negative emotional valences to detect the attentional preference evoked by the invisible emotional facial expressions. Results: Healthy subjects showed an attentional bias for negative emotions in the unconscious condition while this valence bias remained absent in MDD patients. In contrast, this attentional bias diminished in the conscious condition for both healthy subjects and MDD. Conclusion: Our findings demonstrate for the first time valence-specific deficits specifically in the unconscious processing of emotions in MDD; this may have major implications for subsequent neurobiological investigations as well as for clinical diagnosis and therapy.	[Yang, Zhi] Chinese Acad Sci, Inst Psychol, Key Lab Behav Sci, Beijing 100101, Peoples R China; [Zhao, Jinping] Univ Elect Sci & Technol China, Sch Life Sci & Technol, Chengdu 610054, Peoples R China; [Jiang, Yi; Weng, Xuchu] Chinese Acad Sci, Inst Psychol, Key Lab Mental Hlth, Beijing 100101, Peoples R China; [Li, Chunbo; Wang, Jijun] Shanghai Jiao Tong Univ, Sch Med, Shanghai Mental Hlth Ctr, Shanghai 200030, Peoples R China; [Weng, Xuchu; Northoff, Georg] Hangzhou Normal Univ, Ctr Human Brain Res, Hangzhou, Zhejiang, Peoples R China; [Northoff, Georg] Univ Ottawa, Mental Hlth Res Inst, Ottawa, ON, Canada	Chinese Academy of Sciences; Institute of Psychology, CAS; University of Electronic Science & Technology of China; Chinese Academy of Sciences; Institute of Psychology, CAS; Shanghai Jiao Tong University; Hangzhou Normal University; University of Ottawa	Yang, Z (corresponding author), Chinese Acad Sci, Inst Psychol, Key Lab Behav Sci, Beijing 100101, Peoples R China.	yijiang@psych.ac.cn; chunbo_li@163.com	Jiang, Yi/I-1688-2018; Yang, Zhi/W-6459-2019	Jiang, Yi/0000-0002-5746-7301; Yang, Zhi/0000-0002-2222-2312	National Basic Research Program of China (973 Program) [2007CB512306]; NSFC [30900366, 31070903]; Science Foundation from Institute of Psychology, CAS [O9CX012001]; CIHR; EJLB-CIHR; HDRF-ISAN	National Basic Research Program of China (973 Program)(National Basic Research Program of China); NSFC(National Natural Science Foundation of China (NSFC)); Science Foundation from Institute of Psychology, CAS(Chinese Academy of Sciences); CIHR(Canadian Institutes of Health Research (CIHR)); EJLB-CIHR(Canadian Institutes of Health Research (CIHR)); HDRF-ISAN	Support for this work was provided by the National Basic Research Program of China (973 Program, 2007CB512306 to XW), NSFC (30900366 to ZY; 31070903 to YJ), The Science Foundation from Institute of Psychology, CAS (O9CX012001 to ZY), and CIHR, EJLB-CIHR, Michael Smith, and HDRF-ISAN to GN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolphs R, 2002, CURR OPIN NEUROBIOL, V12, P169, DOI 10.1016/S0959-4388(02)00301-X; Alcaro A, 2010, NEUROSCI BIOBEHAV R, V34, P592, DOI 10.1016/j.neubiorev.2009.11.023; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Brascamp JW, 2007, J VISION, V7, DOI 10.1167/7.12.12; Dannlowski U, 2007, J PSYCHIATR NEUROSCI, V32, P423; Davison AC, 1997, BOOTSTRAP METHODS TH; Dimberg U, 2000, PSYCHOL SCI, V11, P86, DOI 10.1111/1467-9280.00221; Efron Bradley, 1993, INTRO BOOTSTRAP, V57; Ekman P., 1976, PICTURES FACIAL AFFE; Fang F, 2005, NAT NEUROSCI, V8, P1380, DOI 10.1038/nn1537; Gotlib IH, 2010, ANNU REV CLIN PSYCHO, V6, P285, DOI 10.1146/annurev.clinpsy.121208.131305; Gotlib IH, 2004, J ABNORM PSYCHOL, V113, P127, DOI 10.1037/0021-843X.113.1.121; Gotlib IH, 2004, J ABNORM PSYCHOL, V113, P386, DOI 10.1037/0021-843x.113.3.386; Grimm S, 2009, HUM BRAIN MAPP, V30, P2617, DOI 10.1002/hbm.20693; HUGDAHL K, 1993, CORTEX, V29, P325, DOI 10.1016/S0010-9452(13)80185-2; Jiang Y, 2006, P NATL ACAD SCI USA, V103, P17048, DOI 10.1073/pnas.0605678103; Jiang Y, 2006, CURR BIOL, V16, P2023, DOI 10.1016/j.cub.2006.08.084; Joormann J, 2010, COGNITION EMOTION, V24, P281, DOI 10.1080/02699930903407948; KIRITA T, 1995, ACTA PSYCHOL, V89, P149, DOI 10.1016/0001-6918(94)00021-8; LeDoux J. E., 1996, EMOTIONAL BRAIN; Leppanen JM, 2004, PSYCHIAT RES, V128, P123, DOI 10.1016/j.psychres.2004.05.020; Leppanen JM, 2006, CURR OPIN PSYCHIATR, V19, P34, DOI 10.1097/01.yco.0000191500.46411.00; Lim SL, 2005, J ABNORM PSYCHOL, V114, P50, DOI 10.1037/0021-843X.114.1.50; Mathews A, 1996, BEHAV RES THER, V34, P695, DOI 10.1016/0005-7967(96)00046-0; McCabe SB, 2000, COGNITIVE THER RES, V24, P427, DOI 10.1023/A:1005579719849; MOGG K, 1995, BRIT J CLIN PSYCHOL, V34, P17, DOI 10.1111/j.2044-8260.1995.tb01434.x; MOGG K, 1993, J ABNORM PSYCHOL, V102, P304, DOI 10.1037/0021-843X.102.2.304; Northoff G, 2011, BIOL PSYCHI IN PRESS; Northoff G, 2011, NEUROSCI BI IN PRESS; Northoff G, 2010, TRENDS NEUROSCI, V33, P277, DOI 10.1016/j.tins.2010.02.006; Panksepp J., 1998, AFFECTIVE NEUROSCIEN; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Phelps EA, 2005, NEURON, V48, P175, DOI 10.1016/j.neuron.2005.09.025; Phillips ML, 2003, BIOL PSYCHIAT, V54, P504, DOI 10.1016/S0006-3223(03)00168-9; Ruys KI, 2008, PSYCHOL SCI, V19, P385, DOI 10.1111/j.1467-9280.2008.02097.x; Sheline YI, 2001, BIOL PSYCHIAT, V50, P651, DOI 10.1016/S0006-3223(01)01263-X; Sterzer P, 2009, TRENDS COGN SCI, V13, P310, DOI 10.1016/j.tics.2009.04.006; Suslow T, 2010, BIOL PSYCHIAT, V67, P155, DOI 10.1016/j.biopsych.2009.07.023; Tsuchiya N, 2005, NAT NEUROSCI, V8, P1096, DOI 10.1038/nn1500; Tsuchiya N, 2006, J VISION, V6, P1068, DOI 10.1167/6.10.6; Tsuchiya N, 2007, TRENDS COGN SCI, V11, P158, DOI 10.1016/j.tics.2007.01.005; Victor TA, 2010, ARCH GEN PSYCHIAT, V67, P1128, DOI 10.1001/archgenpsychiatry.2010.144; Wiens S, 2006, PROG BRAIN RES, V156, P105, DOI 10.1016/S0079-6123(06)56006-6; Yan XD, 2009, ADDICT BIOL, V14, P478, DOI 10.1111/j.1369-1600.2009.00172.x; Yoon KL, 2009, EMOTION, V9, P172, DOI 10.1037/a0014714; Yovel I, 2005, PERS INDIV DIFFER, V38, P785, DOI 10.1016/j.paid.2004.06.003; Zhang M. Y., 1995, HDB PSYCHIAT MEASURE	47	12	15	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2011	6	7							e21881	10.1371/journal.pone.0021881	http://dx.doi.org/10.1371/journal.pone.0021881			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	791AK	21755006	gold, Green Submitted, Green Published			2022-12-27	WOS:000292632000033
J	Christopher, S; Verghis, RM; Antonisamy, B; Sowmyanarayanan, TV; Brahmadathan, KN; Kang, G; Cooper, B				Christopher, Solomon; Verghis, Rejina Mariam; Antonisamy, Belavendra; Sowmyanarayanan, Thuppal Varadachari; Brahmadathan, Kootallur Narayanan; Kang, Gagandeep; Cooper, Ben Symons			Transmission Dynamics of Methicillin-Resistant Staphylococcus aureus in a Medical Intensive Care Unit in India	PLOS ONE			English	Article							INFECTION-CONTROL; COLONIZATION; PATHOGENS; HOSPITALS; ROUTES	Background: Methicillin-resistant Staphylococcus aureus (MRSA) is a global pathogen and an important but seldom investigated cause of morbidity and mortality in lower and middle-income countries where it can place a major burden on limited resources. Quantifying nosocomial transmission in resource-poor settings is difficult because molecular typing methods are prohibitively expensive. Mechanistic statistical models can overcome this problem with minimal cost. We analyse the transmission dynamics of MRSA in a hospital in south India using one such approach and provide conservative estimates of the organism's economic burden. Methods and Findings: Fifty months of MRSA infection data were collected retrospectively from a Medical Intensive Care Unit (MICU) in a tertiary hospital in Vellore, south India. Data were analysed using a previously described structured hidden Markov model. Seventy-two patients developed MRSA infections and, of these, 49 (68%) died in the MICU. We estimated that 4.2% (95% CI 1.0, 19.0) of patients were MRSA-positive when admitted, that there were 0.39 MRSA infections per colonized patient month (0.06, 0.73), and that the ward-level reproduction number for MRSA was 0.42 (0.08, 2.04). Anti-MRSA antibiotic treatment costs alone averaged $124/patient, over three times the monthly income of more than 40% of the Indian population. Conclusions: Our analysis of routine data provides the first estimate of the nosocomial transmission potential of MRSA in India. The high levels of transmission estimated underline the need for cost-effective interventions to reduce MRSA transmission in hospital settings in low and middle income countries.	[Christopher, Solomon; Antonisamy, Belavendra] Christian Med Coll & Hosp, Dept Biostat, Vellore, Tamil Nadu, India; [Verghis, Rejina Mariam] Royal Hosp, NI Clin Res Support Ctr, Belfast, Antrim, North Ireland; [Cooper, Ben Symons] Mahidol Univ, Fac Trop Med, Mahidol Oxford Trop Med Res Unit, Bangkok, Thailand; [Cooper, Ben Symons] Univ Oxford, Nuffield Dept Clin Med, Ctr Clin Vaccinol & Trop Med, Oxford, England; [Sowmyanarayanan, Thuppal Varadachari; Kang, Gagandeep] Christian Med Coll & Hosp, Dept Gastrointestinal Sci, Vellore, Tamil Nadu, India; [Brahmadathan, Kootallur Narayanan] Christian Med Coll & Hosp, Dept Microbiol, Vellore, Tamil Nadu, India	Christian Medical College & Hospital (CMCH) Vellore; Mahidol Oxford Tropical Medicine Research Unit (MORU); Mahidol University; University of Oxford; Christian Medical College & Hospital (CMCH) Vellore; Christian Medical College & Hospital (CMCH) Vellore	Christopher, S (corresponding author), Christian Med Coll & Hosp, Dept Biostat, Vellore, Tamil Nadu, India.	solomon.christopher@gmail.com	Cooper, Ben/HGC-7082-2022; Verghis, Rejina/I-3887-2016	Kang, Gagandeep/0000-0002-3656-564X; Cooper, Ben/0000-0002-9445-7217; Verghis, Rejina/0000-0002-8322-213X				Allegranzi B, 2008, SUMMARY EVIDENCE PAT; Allegranzi B, 2008, LANCET, V372, P1719, DOI 10.1016/S0140-6736(08)61715-8; Archer GL, 1998, CLIN INFECT DIS, V26, P1179, DOI 10.1086/520289; Bonten MJM, 2001, CLIN INFECT DIS, V33, P1739, DOI 10.1086/323761; Bootsma MCJ, 2007, AM J EPIDEMIOL, V166, P841, DOI 10.1093/aje/kwm149; Boyce JM, 2005, LANCET INFECT DIS, V5, P653, DOI 10.1016/S1473-3099(05)70243-7; Chen S.H., 2008, WIDER WORKING PAPER; Cooper B, 2004, BIOSTATISTICS, V5, P223, DOI 10.1093/biostatistics/5.2.223; Cooper BS, 2004, P NATL ACAD SCI USA, V101, P10223, DOI 10.1073/pnas.0401324101; de Sousa MA, 2003, J CLIN MICROBIOL, V41, P159, DOI [10.1128/JCM.41.1.159-163.2002, 10.1128/JCM.41.1.159-163.2003]; Forrester M, 2005, INFECT CONT HOSP EP, V26, P598, DOI 10.1086/502588; Grundmann H, 2006, LANCET INFECT DIS, V6, P39, DOI 10.1016/S1473-3099(05)70325-X; Grundmann H, 2006, LANCET, V368, P874, DOI 10.1016/S0140-6736(06)68853-3; Jain R, 2011, NEW ENGL J MED, V364, P1419, DOI 10.1056/NEJMoa1007474; Ko KS, 2005, J CLIN MICROBIOL, V43, P421, DOI 10.1128/JCM.43.1.421-426.2005; Lynch P, 2007, J HOSP INFECT, V65, P148, DOI 10.1016/S0195-6701(07)60033-4; McBryde ES, 2007, J R SOC INTERFACE, V4, P745, DOI 10.1098/rsif.2007.0224; McBryde ES, 2007, J THEOR BIOL, V245, P470, DOI 10.1016/j.jtbi.2006.11.008; Mehta A, 1996, J Postgrad Med, V42, P1; Nickerson EK, 2006, LANCET INFECT DIS, V6, P70, DOI 10.1016/S1473-3099(06)70363-2; Pelupessy I, 2002, P NATL ACAD SCI USA, V99, P5601, DOI 10.1073/pnas.082412899; Pittet D, 2008, J HOSP INFECT, V68, P285, DOI 10.1016/j.jhin.2007.12.013; R Development Core Team, 2007, R LANG ENV STAT COMP; Rajaduraipandi K, 2006, Indian J Med Microbiol, V24, P34	24	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2011	6	7							e20604	10.1371/journal.pone.0020604	http://dx.doi.org/10.1371/journal.pone.0020604			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	789JO	21750700	Green Submitted, gold, Green Published			2022-12-27	WOS:000292512000006
J	Kaspar, K; Konig, P				Kaspar, Kai; Koenig, Peter			Overt Attention and Context Factors: The Impact of Repeated Presentations, Image Type, and Individual Motivation	PLOS ONE			English	Article							EYE-MOVEMENTS; ACTION ORIENTATION; LUMINANCE CONTRAST; REAL; CONSISTENCY; FIXATION; FEELINGS; DEMANDS; SCENES; BIASES	The present study investigated the dynamic of the attention focus during observation of different categories of complex scenes and simultaneous consideration of individuals' memory and motivational state. We repeatedly presented four types of complex visual scenes in a pseudo-randomized order and recorded eye movements. Subjects were divided into groups according to their motivational disposition in terms of action orientation and individual rating of scene interest. Statistical analysis of eye-tracking data revealed that the attention focus successively became locally expressed by increasing fixation duration; decreasing saccade length, saccade frequency, and single subject's fixation distribution over images; and increasing inter-subject variance of fixation distributions. The validity of these results was supported by verbal reports. This general tendency was weaker for the group of subjects who rated the image set as interesting as compared to the other group. Additionally, effects were partly mediated by subjects' motivational disposition. Finally, we found a generally strong impact of image type on eye movement parameters. We conclude that motivational tendencies linked to personality as well as individual preferences significantly affected viewing behaviour. Hence, it is important and fruitful to consider inter-individual differences on the level of motivation and personality traits within investigations of attention processes. We demonstrate that future studies on memory's impact on overt attention have to deal appropriately with several aspects that had been out of the research focus until now.	[Kaspar, Kai; Koenig, Peter] Univ Osnabruck, Inst Cognit Sci, Osnabruck, Germany	University Osnabruck	Kaspar, K (corresponding author), Univ Osnabruck, Inst Cognit Sci, Osnabruck, Germany.	kkaspar@uos.de	König, Peter/ABB-2380-2020	König, Peter/0000-0003-3654-5267	University of Osnabruck	University of Osnabruck	The authors thank the University of Osnabruck for support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACIK A, 2010, FRONT PERCEPT SCI; Acik A, 2009, VISION RES, V49, P1541, DOI 10.1016/j.visres.2009.03.011; [Anonymous], 2006, MOTIVATION HANDELN; Betz T, 2010, J VISION, V10, DOI 10.1167/10.3.15; Brockmole JR, 2006, Q J EXP PSYCHOL, V59, P1177, DOI 10.1080/17470210600665996; Chun MM, 1998, COGNITIVE PSYCHOL, V36, P28, DOI 10.1006/cogp.1998.0681; Diefendorff JM, 2004, HUM PERFORM, V17, P375, DOI 10.1207/s15327043hup1704_2; Einhauser W, 2006, J VISION, V6, P1148, DOI 10.1167/6.11.1; Einhauser W, 2008, J VISION, V8, DOI 10.1167/8.2.2; Einhauser W, 2010, CURR OPIN NEUROBIOL, V20, P389, DOI 10.1016/j.conb.2010.03.010; Einhauser W, 2003, EUR J NEUROSCI, V17, P1089, DOI 10.1046/j.1460-9568.2003.02508.x; Eizenman M, 2003, PSYCHIAT RES, V118, P117, DOI 10.1016/S0165-1781(03)00068-4; Frey HP, 2008, J VISION, V8, DOI 10.1167/8.14.6; Harding G, 2010, J VISION, V10, DOI 10.1167/10.2.8; Hausser J, 2009, J MACH LEARN RES, V10, P1469; Henderson JM, 1999, J EXP PSYCHOL HUMAN, V25, P210, DOI 10.1037/0096-1523.25.1.210; Hollingworth A, 2000, VIS COGN, V7, P213, DOI 10.1080/135062800394775; Hooge ITC, 1998, VISION RES, V38, P1295, DOI 10.1016/S0042-6989(97)00287-3; Isaacowitz DM, 2006, PSYCHOL AGING, V21, P40, DOI 10.1037/0882-7974.21.1.40; Jostmann NB, 2007, J EXP PSYCHOL GEN, V136, P593, DOI 10.1037/0096-3445.136.4.593; KASPAR K, IMPACT WEB PAG UNPUB; Kaspar K, 2010, Z ARB ORGAN, V54, P29, DOI 10.1026/0932-4089/a000003; Kayser C, 2006, VISION RES, V46, P2535, DOI 10.1016/j.visres.2006.02.003; Koole SL, 2004, J PERS SOC PSYCHOL, V87, P974, DOI 10.1037/0022-3514.87.6.974; KUHL J, 1981, J PERS SOC PSYCHOL, V40, P155, DOI 10.1037/0022-3514.40.1.155; Kuhl J., 1994, VOLITION PERSONALITY, P47; McElroy T, 2007, JUDGM DECIS MAK, V2, P333; MILLER G, 1955, INFORM THEORY PSYC B, V2; Mogg K, 2000, J ABNORM PSYCHOL, V109, P695, DOI 10.1037/0021-843X.109.4.695; NEIDER MB, 2006, COGNITIVE SCI, V26, P207; Olmos A., 2004, MCGILL CALIBRATED CO; Onat S, 2007, J VISION, V7, DOI 10.1167/7.10.11; Parkhurst D, 2002, VISION RES, V42, P107, DOI 10.1016/S0042-6989(01)00250-4; Parkhurst DJ, 2004, EUR J NEUROSCI, V19, P783, DOI 10.1111/j.0953-816X.2003.03183.x; Rayner K, 2007, VISION RES, V47, P2714, DOI 10.1016/j.visres.2007.05.007; Shinoda H, 2001, VISION RES, V41, P3535, DOI 10.1016/S0042-6989(01)00199-7; Smilek D, 2006, BRAIN RES, V1080, P101, DOI 10.1016/j.brainres.2005.12.090; Tatler BW, 2009, VIS COGN, V17, P1029, DOI 10.1080/13506280902764539; Torralba A, 2006, PSYCHOL REV, V113, P766, DOI 10.1037/0033-295X.113.4.766; Underwood G, 2008, CONSCIOUS COGN, V17, P159, DOI 10.1016/j.concog.2006.11.008; WILLMING N, WELL CAN WE MO UNPUB	41	53	53	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2011	6	7							e21719	10.1371/journal.pone.0021719	http://dx.doi.org/10.1371/journal.pone.0021719			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	789JO	21750726	Green Submitted, Green Published, gold			2022-12-27	WOS:000292512000021
J	Mironczuk, AM; Manu, A; Kuipers, OP; Kovacs, AT				Mironczuk, Aleksandra M.; Manu, Amagoia; Kuipers, Oscar P.; Kovacs, Akos T.			Distinct Roles of ComK1 and ComK2 in Gene Regulation in Bacillus cereus	PLOS ONE			English	Article							COMPETENCE TRANSCRIPTION FACTOR; SUBTILIS K-STATE; STREPTOCOCCUS-LACTIS; EXPRESSION DATA; TRANSFORMATION; DNA; PROTEIN; ANTHRACIS; BINDING; OPERON	The B. subtilis transcriptional factor ComK regulates a set of genes coding for DNA uptake from the environment and for its integration into the genome. In previous work we showed that Bacillus cereus expressing the B. subtilis ComK protein is able to take up DNA and integrate it into its own genome. To extend our knowledge on the effect of B. subtilis ComK overexpression in B. cereus we first determined which genes are significantly altered. Transcriptome analysis showed that only part of the competence gene cluster is significantly upregulated. Two ComK homologues can be identified in B. cereus that differ in their respective homologies to other ComK proteins. ComK1 is most similar, while ComK2 lacks the C-terminal region previously shown to be important for transcription activation by B. subtilis ComK. comK1 and comK2 overexpression and deletion studies using transcriptomics techniques showed that ComK1 enhances and ComK2 decreases expression of the comG operon, when B. subtilis ComK was overexpressed simultaneously.	[Mironczuk, Aleksandra M.; Manu, Amagoia; Kuipers, Oscar P.; Kovacs, Akos T.] Univ Groningen, Groningen Biomol Sci & Biotechnol Inst, Mol Genet Grp, Groningen, Netherlands; [Kuipers, Oscar P.] Kluyver Ctr Genom Ind Fermentat, Groningen, Netherlands	University of Groningen	Mironczuk, AM (corresponding author), Univ Groningen, Groningen Biomol Sci & Biotechnol Inst, Mol Genet Grp, Groningen, Netherlands.	o.p.kuipers@rug.nl	Kuipers, Oscar/B-6752-2009; Mironczuk, Aleksandra/A-1823-2017; Kovács, Ákos T/A-9433-2015	Kuipers, Oscar/0000-0001-5596-7735; Mironczuk, Aleksandra/0000-0003-1604-1635; Kovács, Ákos T/0000-0002-4465-1636	ALW-NWO [818.02.004]	ALW-NWO(Netherlands Organization for Scientific Research (NWO))	ATK was financially supported by Grant 818.02.004 from ALW-NWO Open programma. This project was carried out within the research programme of the Kluyver Centre for Genomics of Industrial Fermentation which is part of the Netherlands Genomics Initiative/Netherlands Organization for Scientific Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashikaga S, 2000, J BACTERIOL, V182, P2411, DOI 10.1128/JB.182.9.2411-2415.2000; Baldi P, 2001, BIOINFORMATICS, V17, P509, DOI 10.1093/bioinformatics/17.6.509; Berka RM, 2002, MOL MICROBIOL, V43, P1331, DOI 10.1046/j.1365-2958.2002.02833.x; den Hengst CD, 2005, J BIOL CHEM, V280, P34332, DOI 10.1074/jbc.M502349200; DSOUZA C, 1994, P NATL ACAD SCI USA, V91, P9397, DOI 10.1073/pnas.91.20.9397; Ehling-Schulz M, 2004, MOL NUTR FOOD RES, V48, P479, DOI 10.1002/mnfr.200400055; GASSON MJ, 1983, J BACTERIOL, V154, P1; Burgos MJG, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-227; Granum PE, 1997, FEMS MICROBIOL LETT, V157, P223, DOI 10.1016/S0378-1097(97)00438-2; Hahn J, 2005, CELL, V122, P59, DOI 10.1016/j.cell.2005.04.035; HAHN J, 1993, MOL MICROBIOL, V10, P99, DOI 10.1111/j.1365-2958.1993.tb00907.x; Haijema BJ, 2001, MOL MICROBIOL, V40, P52, DOI 10.1046/j.1365-2958.2001.02363.x; Hamoen LW, 1998, GENE DEV, V12, P1539, DOI 10.1101/gad.12.10.1539; HAMOEN LW, 1995, MOL MICROBIOL, V15, P55, DOI 10.1111/j.1365-2958.1995.tb02220.x; Hamoen LW, 2002, NUCLEIC ACIDS RES, V30, P5517, DOI 10.1093/nar/gkf698; Hamoen LW, 2003, MICROBIOL-SGM, V149, P9, DOI 10.1099/mic.0.26003-0; Helgason E, 2000, APPL ENVIRON MICROB, V66, P2627, DOI 10.1128/AEM.66.6.2627-2630.2000; Hoffmann K, 2010, APPL ENVIRON MICROB, V76, P8211, DOI 10.1128/AEM.01404-10; Holo H, 1995, Methods Mol Biol, V47, P195; INAMINE GS, 1995, J BACTERIOL, V177, P3045, DOI 10.1128/jb.177.11.3045-3051.1995; KONG LY, 1993, MOL MICROBIOL, V9, P365, DOI 10.1111/j.1365-2958.1993.tb01697.x; Koumoutsi A, 2004, J BACTERIOL, V186, P1084, DOI 10.1128/JB.186.4.1084-1096.2004; Kovacs AT, 2009, ENVIRON MICROBIOL, V11, P1911, DOI 10.1111/j.1462-2920.2009.01937.x; Leskela S, 1996, MICROBIOL-SGM, V142, P71, DOI 10.1099/13500872-142-1-71; Lewis PJ, 1999, GENE, V227, P101, DOI 10.1016/S0378-1119(98)00580-0; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LONDONOVALLEJO JA, 1993, MOL MICROBIOL, V9, P119, DOI 10.1111/j.1365-2958.1993.tb01674.x; Maamar H, 2005, MOL MICROBIOL, V56, P615, DOI 10.1111/j.1365-2958.2005.04592.x; Marraffini LA, 2006, MOL MICROBIOL, V62, P1402, DOI 10.1111/j.1365-2958.2006.05469.x; Mironczuk AM, 2008, MICROB BIOTECHNOL, V1, P226, DOI 10.1111/j.1751-7915.2008.00023.x; Mortier-Barriere I, 2007, CELL, V130, P824, DOI 10.1016/j.cell.2007.07.038; Nijland R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009724; Provvedi R, 2001, MOL MICROBIOL, V40, P634, DOI 10.1046/j.1365-2958.2001.02406.x; Rasko DA, 2004, NUCLEIC ACIDS RES, V32, P977, DOI 10.1093/nar/gkh258; Serror P, 1996, J BACTERIOL, V178, P5910, DOI 10.1128/jb.178.20.5910-5915.1996; SIMON D, 1988, BIOCHIMIE, V70, P559, DOI 10.1016/0300-9084(88)90093-4; SPIZIZEN J, 1958, P NATL ACAD SCI USA, V44, P1072, DOI 10.1073/pnas.44.10.1072; Susanna KA, 2006, MICROBIOL-SGM, V152, P473, DOI 10.1099/mic.0.28357-0; Susanna KA, 2004, J BACTERIOL, V186, P1120, DOI 10.1128/JB.186.4.1120-1128.2004; THORNE CB, 1966, J BACTERIOL, V91, P1012, DOI 10.1128/JB.91.3.1012-1020.1966; TRIEUCUOT P, 1991, GENE, V106, P21, DOI 10.1016/0378-1119(91)90561-O; TRIEUCUOT P, 1988, J BACTERIOL, V170, P4388, DOI 10.1128/jb.170.9.4388-4391.1988; Turgay K, 1997, GENE DEV, V11, P119, DOI 10.1101/gad.11.1.119; Turgay K, 1998, EMBO J, V17, P6730; van Hijum SAFT, 2003, BIOINFORMATICS, V19, P1580, DOI 10.1093/bioinformatics/btg203; VANSINDEREN D, 1994, J BACTERIOL, V176, P5762, DOI 10.1128/JB.176.18.5762-5770.1994	46	6	6	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2011	6	7							e21859	10.1371/journal.pone.0021859	http://dx.doi.org/10.1371/journal.pone.0021859			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786HC	21747963	gold, Green Published, Green Submitted			2022-12-27	WOS:000292293400039
J	Belda, E; Pedrola, L; Pereto, J; Martinez-Blanch, JF; Montagud, A; Navarro, E; Urchueguia, J; Ramon, D; Moya, A; Porcar, M				Belda, Eugeni; Pedrola, Laia; Pereto, Juli; Martinez-Blanch, Juan F.; Montagud, Arnau; Navarro, Emilio; Urchueguia, Javier; Ramon, Daniel; Moya, Andres; Porcar, Manuel			Microbial Diversity in the Midguts of Field and Lab-Reared Populations of the European Corn Borer Ostrinia nubilalis	PLOS ONE			English	Article							CELLULOLYTIC BACTERIUM; GLYCOSIDE HYDROLASES; FUNCTIONAL-ANALYSIS; MULTIPLE ALIGNMENT; COMMUNITY; GUT; METAGENOMICS; RECONSTRUCTION; LEPIDOPTERA; ENVIRONMENT	Background: Insects are associated with microorganisms that contribute to the digestion and processing of nutrients. The European Corn Borer (ECB) is a moth present world-wide, causing severe economical damage as a pest on corn and other crops. In the present work, we give a detailed view of the complexity of the microorganisms forming the ECB midgut microbiota with the objective of comparing the biodiversity of the midgut-associated microbiota and explore their potential as a source of genes and enzymes with biotechnological applications. Methodological/Principal Findings: A high-throughput sequencing approach has been used to identify bacterial species, genes and metabolic pathways, particularly those involved in plant-matter degradation, in two different ECB populations (field-collected vs. lab-reared population with artificial diet). Analysis of the resulting sequences revealed the massive presence of Staphylococcus warneri and Weissella paramesenteroides in the lab-reared sample. This enabled us to reconstruct both genomes almost completely. Despite the apparently low diversity, 208 different genera were detected in the sample, although most of them at very low frequency. By contrast, the natural population exhibited an even higher taxonomic diversity along with a wider array of cellulolytic enzyme families. However, in spite of the differences in relative abundance of major taxonomic groups, not only did both metagenomes share a similar functional profile but also a similar distribution of non-redundant genes in different functional categories. Conclusions/Significance: Our results reveal a highly diverse pool of bacterial species in both O. nubilalis populations, with major differences: The lab-reared sample is rich in gram-positive species (two of which have almost fully sequenced genomes) while the field sample harbors mainly gram-negative species and has a larger set of cellulolytic enzymes. We have found a clear relationship between the diet and the midgut microbiota, which reveals the selection pressure of food on the community of intestinal bacteria.	[Belda, Eugeni; Pereto, Juli; Moya, Andres; Porcar, Manuel] Univ Valencia, Inst Cavanilles Biodiversitat & Biol Evolutiva, Valencia, Spain; [Belda, Eugeni; Montagud, Arnau; Urchueguia, Javier] Univ Politecn Valencia, Inst Univ Matemat Pura & Aplicada, E-46071 Valencia, Spain; [Pedrola, Laia; Martinez-Blanch, Juan F.; Ramon, Daniel] Lifesequencing, Valencia, Spain; [Navarro, Emilio] Univ Malaga, Dept Lenguajes & Ciencias Computac, E-29071 Malaga, Spain	University of Valencia; Universitat Politecnica de Valencia; Universidad de Malaga	Belda, E (corresponding author), CEA GENOSCOPE, Lab Anal Bioinformat Genom & Metab, Evry, France.	manuel.porcar@uv.es	Urchueguia, Javier F./AAD-7469-2021; M, Juan/ABB-8388-2021; Navarro, Emilio/A-1420-2013; Montagud, Arnau/B-8001-2008; Moya, Andrés/A-8190-2008; Peretó, Juli/G-5969-2015; Porcar, Manuel/D-2503-2010; Belda, Eugeni/ABI-1349-2020	M, Juan/0000-0002-9340-6207; Navarro, Emilio/0000-0002-0608-2129; Montagud, Arnau/0000-0002-7696-1241; Moya, Andrés/0000-0002-2867-1119; Peretó, Juli/0000-0002-5756-1517; Porcar, Manuel/0000-0002-7916-9479; Belda, Eugeni/0000-0003-4307-5072; Urchueguia, Javier F./0000-0002-3054-3431; Pedrola, Laia/0000-0002-3031-6124	Spanish Ministerio de Ciencia e Innovacion [CIT-010000-2008-5]; MICINN (Ministerio de Ciencia e Innovacion) [TIN2009-12359]; Generalitat Valenciana grant [BFPI/2007/283]	Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); MICINN (Ministerio de Ciencia e Innovacion)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Generalitat Valenciana grant(Center for Forestry Research & Experimentation (CIEF))	The research was funded by the Spanish Ministerio de Ciencia e Innovacion, under grant agreement CIT-010000-2008-5 and by a MICINN (Ministerio de Ciencia e Innovacion) TIN2009-12359 ArtBioCom project. Arnau Montagud acknowledges Generalitat Valenciana grant BFPI/2007/283. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen HK, 2009, DNA CELL BIOL, V28, P109, DOI 10.1089/dna.2008.0812; Allgaier M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008812; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Anand AAP, 2010, J INSECT SCI, V10, DOI 10.1673/031.010.10701; Angly FE, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000593; Broderick NA, 2004, APPL ENVIRON MICROB, V70, P293, DOI 10.1128/AEM.70.1.293-300.2004; Brulc JM, 2009, P NATL ACAD SCI USA, V106, P1948, DOI 10.1073/pnas.0806191105; Burnum KE, 2011, ISME J, V5, P161, DOI 10.1038/ismej.2010.97; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Carver T, 2008, BIOINFORMATICS, V24, P2672, DOI 10.1093/bioinformatics/btn529; Chaves Sandra, 2009, Biotechnology Journal, V4, P1753, DOI 10.1002/biot.200800237; Darling ACE, 2004, GENOME RES, V14, P1394, DOI 10.1101/gr.2289704; Diaz NN, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-56; Diaz-Mendoza M, 2005, INSECT BIOCHEM MOLEC, V35, P1005, DOI 10.1016/j.ibmb.2005.04.003; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Enright AJ, 2003, NUCLEIC ACIDS RES, V31, P4632, DOI 10.1093/nar/gkg495; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; GRINGORTEN JL, 1993, J EXP BIOL, V183, P353; Guan CH, 2007, APPL ENVIRON MICROB, V73, P3669, DOI 10.1128/AEM.02617-06; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hui XA, 2006, CAN J MICROBIOL, V52, P1085, DOI 10.1139/W06-064; Kato S, 2005, APPL ENVIRON MICROB, V71, P7099, DOI 10.1128/AEM.71.11.7099-7106.2005; Kelley ST, 2011, GENETICA, V139, P541, DOI 10.1007/s10709-010-9498-0; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Kurokawa K, 2007, DNA RES, V14, P169, DOI 10.1093/dnares/dsm018; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Moriya Y, 2007, NUCLEIC ACIDS RES, V35, pW182, DOI 10.1093/nar/gkm321; Morrison M, 2009, CURR OPIN BIOTECH, V20, P358, DOI 10.1016/j.copbio.2009.05.004; Noguchi H, 2008, DNA RES, V15, P387, DOI 10.1093/dnares/dsn027; Omenetto FG, 2010, SCIENCE, V329, P528, DOI 10.1126/science.1188936; POITOUT S, 1974, ANN NUTR ALIMENT, V28, P173; Pope PB, 2010, P NATL ACAD SCI USA, V107, P14793, DOI 10.1073/pnas.1005297107; Pytelkova J, 2009, FEBS J, V276, P3531, DOI 10.1111/j.1742-4658.2009.07074.x; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Robert C, 2007, INT J SYST EVOL MICR, V57, P1516, DOI 10.1099/ijs.0.64998-0; Robinson CJ, 2010, MICROB ECOL, V59, P199, DOI 10.1007/s00248-009-9595-8; Suen G, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001129; Tyson GW, 2004, NATURE, V428, P37, DOI 10.1038/nature02340; van der Hoeven R, 2008, FEMS MICROBIOL LETT, V286, P249, DOI 10.1111/j.1574-6968.2008.01277.x; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; Warnecke F, 2007, NATURE, V450, P560, DOI 10.1038/nature06269; Wilm A, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn174; Wilson DB, 2008, ANN NY ACAD SCI, V1125, P289, DOI 10.1196/annals.1419.026; Zhu YT, 2010, BIORESOURCE TECHNOL, V101, P6432, DOI 10.1016/j.biortech.2010.03.041	44	55	57	3	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2011	6	6							e21751	10.1371/journal.pone.0021751	http://dx.doi.org/10.1371/journal.pone.0021751			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786GP	21738787	Green Published, gold			2022-12-27	WOS:000292291800039
J	Bejon, P; Turner, L; Lavstsen, T; Cham, G; Olotu, A; Drakeley, CJ; Lievens, M; Vekemans, J; Savarese, B; Lusingu, J; von Seidlein, L; Bull, PC; Marsh, K; Theander, TG				Bejon, Philip; Turner, Louise; Lavstsen, Thomas; Cham, Gerald; Olotu, Ally; Drakeley, Chris J.; Lievens, Marc; Vekemans, Johan; Savarese, Barbara; Lusingu, John; von Seidlein, Lorenz; Bull, Peter C.; Marsh, Kevin; Theander, Thor G.			Serological Evidence of Discrete Spatial Clusters of Plasmodium falciparum Parasites	PLOS ONE			English	Article							MALARIA TRANSMISSION; CLINICAL MALARIA; TREATED NETS; VAR GENES; DIVERSITY; AREA; EPIDEMIOLOGY; PREVALENCE; MORBIDITY; CHILDREN	Background: Malaria transmission may be considered to be homogenous with well-mixed parasite populations (as in the classic Ross/Macdonald models). Marked fine-scale heterogeneity of transmission has been observed in the field (i.e., over a few kilometres), but there are relatively few data on the degree of mixing. Since the Plasmodium falciparum Erythrocyte Membrane Protein 1 (PfEMP1) is highly polymorphic, the host's serological responses may be used to infer exposure to parasite sub-populations. Methods and Findings: We measured the antibody responses to 46 individual PfEMP1 domains at four time points among 450 children in Kenya, and identified distinct spatial clusters of antibody responses to individual domains. 35 domains showed strongly significant sero-clusters at p = 0.001. Individuals within the high transmission hotspot showed the greatest diversity of anti-PfEMP1 responses. Individuals outside the hotspot had a less diverse range of responses, even if as individuals they were at relatively intense exposure. Conclusions: We infer that antigenically distinct sub-populations of parasites exist on a fine spatial scale in a study area of rural Kenya. Further studies should examine antigenic variation over longer periods of time and in different study areas.	[Bejon, Philip; Olotu, Ally; Bull, Peter C.; Marsh, Kevin] Wellcome Trust Programme, Kenya Med Res Inst, Ctr Geog Med Res, Coast, Kilifi, Kenya; [Bejon, Philip; Marsh, Kevin] Univ Oxford, Nuffield Dept Med, Ctr Clin Vaccinol & Trop Med, Oxford, England; [Turner, Louise; Lavstsen, Thomas; Cham, Gerald; Lusingu, John; Theander, Thor G.] Univ Copenhagen, Ctr Med Parasitol, Copenhagen, Denmark; [Turner, Louise; Lavstsen, Thomas; Cham, Gerald; Lusingu, John; Theander, Thor G.] Rigshosp, Copenhagen Univ Hosp, DK-2100 Copenhagen, Denmark; [Drakeley, Chris J.] London Sch Hyg & Trop Med, Fac Infect & Trop Dis, Dept Immun & Infect, London WC1, England; [Lievens, Marc; Vekemans, Johan] GlaxoSmithKline Biol, Rixensart, Belgium; [Savarese, Barbara] Program Appropriate Technol Hlth PATH Malaria Vac, Bethesda, MD USA; [Lusingu, John] Natl Inst Med Res, Tanga Ctr, Tanga, Tanzania; [von Seidlein, Lorenz] Menzies Sch Hlth Res, Casuarina, Australia	Kenya Medical Research Institute; University of Oxford; University of Copenhagen; Rigshospitalet; University of Copenhagen; University of London; London School of Hygiene & Tropical Medicine; GlaxoSmithKline; National Institute of Medical Research; Charles Darwin University; Menzies School of Health Research	Bejon, P (corresponding author), Wellcome Trust Programme, Kenya Med Res Inst, Ctr Geog Med Res, Coast, Kilifi, Kenya.	pbejon@well.ox.ac.uk	Theander, Thor/F-6714-2015; Lusingu, John P. A./GSJ-3228-2022	Theander, Thor/0000-0002-3509-7514; Lusingu, John P. A./0000-0002-9407-0602; Lavstsen, Thomas/0000-0002-3044-4249; Turner, Louise/0000-0003-4494-2289; Bull, Peter/0000-0002-7674-6752	PATH Malaria Vaccine Initiative (MVI); GlaxoSmithKline Biologicals; Foundation for the National Institutes of Health through the Grand Challenges in Global Health initiative; University of Copenhagen; NIHR Biomedical Research Centre in Oxford	PATH Malaria Vaccine Initiative (MVI); GlaxoSmithKline Biologicals(GlaxoSmithKline); Foundation for the National Institutes of Health through the Grand Challenges in Global Health initiative(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Copenhagen; NIHR Biomedical Research Centre in Oxford	The study received financial support from PATH Malaria Vaccine Initiative (MVI), from GlaxoSmithKline Biologicals, from a grant from the Foundation for the National Institutes of Health through the Grand Challenges in Global Health initiative, and from University of Copenhagen Program of Excellence. PB is funded by the NIHR Biomedical Research Centre in Oxford. GSK Biologicals and PATH MVI employees are co-authors and had a role in study design, preparing the analysis plan and manuscript preparation. The other funders had no role in study design, data collection and analysis, the decision to publish or the preparation of the manuscript.	Abdulla S, 2005, TROP MED INT HEALTH, V10, P11, DOI 10.1111/j.1365-3156.2004.01354.x; Armitage P, 2001, STAT METHODS MED RES, V4th; Bejon P, 2008, NEW ENGL J MED, V359, P2521, DOI 10.1056/NEJMoa0807381; Bejon P, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000304; Bogreau H, 2006, AM J TROP MED HYG, V74, P953; Buckee CO, 2004, P NATL ACAD SCI USA, V101, P10839, DOI 10.1073/pnas.0402000101; Bull PC, 1998, NAT MED, V4, P358, DOI 10.1038/nm0398-358; Cham GKK, 2009, J IMMUNOL, V183, P3356, DOI 10.4049/jimmunol.0901331; Clarke SE, 2002, T ROY SOC TROP MED H, V96, P499, DOI 10.1016/S0035-9203(02)90419-0; Coleman M, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-68; FORSYTH KP, 1989, AM J TROP MED HYG, V40, P344, DOI 10.4269/ajtmh.1989.40.344; Fowler EV, 2006, J INFECT DIS, V194, P939, DOI 10.1086/506619; Jensen ATR, 2004, J EXP MED, V199, P1179, DOI 10.1084/jem.20040274; Joergensen L, 2006, INFECT IMMUN, V74, P6778, DOI 10.1128/IAI.01187-06; Jolliffe I., 2005, SPRINGERLINK PRINCIP, DOI 10.1007/b98835; Kleinschmidt I, 2002, AM J EPIDEMIOL, V155, P257, DOI 10.1093/aje/155.3.257; Kraemer SM, 2003, MOL MICROBIOL, V50, P1527, DOI 10.1046/j.1365-2958.2003.03814.x; Kulldorff, 2010, SATSCAN SOFTWARE SPA; Kulldorff M, 2005, PLOS MED, V2, P216, DOI 10.1371/journal.pmed.0020059; Kyes SA, 2007, EUKARYOT CELL, V6, P1511, DOI 10.1128/EC.00173-07; Langhorne J, 2008, NAT IMMUNOL, V9, P725, DOI 10.1038/ni.f.205; Lavstsen T, 2003, MALARIA J, V2, DOI 10.1186/1475-2875-2-27; Machault V, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-138; Maxwell CA, 2003, MALARIA J, V2, DOI 10.1186/1475-2875-2-28; Mbogo CM, 2003, AM J TROP MED HYG, V68, P734; Midega JT, 2007, J MED ENTOMOL, V44, P923, DOI 10.1603/0022-2585(2007)44[923:EDASOA]2.0.CO;2; MILLER LH, 1994, SCIENCE, V264, P1878, DOI 10.1126/science.8009217; Mmbando BP, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-216; Mwangi TW, 2005, J INFECT DIS, V191, P1932, DOI 10.1086/430006; NAUS JI, 1965, J AM STAT ASSOC, V60, P532, DOI 10.2307/2282688; Noor AM, 2007, PLOS MED, V4, P1341, DOI 10.1371/journal.pmed.0040255; O'Meara WP, 2008, AM J TROP MED HYG, V79, P185, DOI 10.4269/ajtmh.2008.79.185; Okiro EA, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-151; OSIER FH, 2010, INFECT IMMUN; Protopopoff N, 2008, AM J TROP MED HYG, V79, P12, DOI 10.4269/ajtmh.2008.79.12; Rask TS, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000933; Rottmann M, 2006, INFECT IMMUN, V74, P3904, DOI 10.1128/IAI.02073-05; Salanti A, 2004, J EXP MED, V200, P1197, DOI 10.1084/jem.20041579; Saul A, 1997, ACTA TROP, V63, P267, DOI 10.1016/S0001-706X(96)00626-2; Scharlemann JPW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001408; Schultz L, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-336; Shekalaghe SA, 2010, ANTIMICROB AGENTS CH, V54, P1762, DOI 10.1128/AAC.01135-09; Smith DL, 2007, PLOS BIOL, V5, P531, DOI 10.1371/journal.pbio.0050042; Smith JD, 2000, P NATL ACAD SCI USA, V97, P1766, DOI 10.1073/pnas.040545897; Thompson J. N., 2005, INTERSPEC INTERACT; TRAPE JF, 1992, AM J TROP MED HYG, V47, P181, DOI 10.4269/ajtmh.1992.47.181; Woolhouse MEJ, 1997, P NATL ACAD SCI USA, V94, P338, DOI 10.1073/pnas.94.1.338	47	28	28	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2011	6	6							e21711	10.1371/journal.pone.0021711	http://dx.doi.org/10.1371/journal.pone.0021711			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786FZ	21747921	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000292290100059
J	Savard, C; Guerin, A; Drouin, K; Bolduc, M; Laliberte-Gagne, ME; Dumas, MC; Majeau, N; Leclerc, D				Savard, Christian; Guerin, Annie; Drouin, Karine; Bolduc, Marilene; Laliberte-Gagne, Marie-Eve; Dumas, Marie-Christine; Majeau, Nathalie; Leclerc, Denis			Improvement of the Trivalent Inactivated Flu Vaccine Using PapMV Nanoparticles	PLOS ONE			English	Article							INFLUENZA-A VIRUS; CYTOTOXIC T-LYMPHOCYTE; HETEROSUBTYPIC IMMUNITY; NONNEUTRALIZING ANTIBODIES; PROTECTIVE IMMUNITY; MICE; INFECTION; RESPONSES; CELLS; H5N1	Commercial seasonal flu vaccines induce production of antibodies directed mostly towards hemaglutinin (HA). Because HA changes rapidly in the circulating virus, the protection remains partial. Several conserved viral proteins, e. g., nucleocapsid (NP) and matrix proteins (M1), are present in the vaccine, but are not immunogenic. To improve the protection provided by these vaccines, we used nanoparticles made of the coat protein of a plant virus (papaya mosaic virus; PapMV) as an adjuvant. Immunization of mice and ferrets with the adjuvanted formulation increased the magnitude and breadth of the humoral response to NP and to highly conserved regions of HA. They also triggered a cellular mediated immune response to NP and M1, and long-lasting protection in animals challenged with a heterosubtypic influenza strain (WSN/33). Thus, seasonal flu vaccine adjuvanted with PapMV nanoparticles can induce universal protection to influenza, which is a major advancement when facing a pandemic.	[Savard, Christian; Guerin, Annie; Drouin, Karine; Bolduc, Marilene; Laliberte-Gagne, Marie-Eve; Dumas, Marie-Christine; Majeau, Nathalie; Leclerc, Denis] Univ Laval, Infect Dis Res Ctr, Dept Microbiol Infectiol & Immunol, Quebec City, PQ, Canada	Laval University	Savard, C (corresponding author), Univ Laval, Infect Dis Res Ctr, Dept Microbiol Infectiol & Immunol, Quebec City, PQ, Canada.	Denis.Leclerc@crchul.ulaval.ca	Majeau, Nathalie/AAU-1964-2021; Leclerc, Denis/AAG-6112-2019; Leclerc, Denis/P-1604-2019		Canadian Institute of Health Research Canada (CIHR) [185160]	Canadian Institute of Health Research Canada (CIHR)(Canadian Institutes of Health Research (CIHR))	This research project was funded by the Canadian Institute of Health Research Canada (CIHR)(grant number: 185160). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADA GL, 1986, CURR TOP MICROBIOL, V128, P1; Aguilar JC, 2007, VACCINE, V25, P3752, DOI 10.1016/j.vaccine.2007.01.111; Atmar RL, 2009, CURR TOP MICROBIOL, V333, P323, DOI 10.1007/978-3-540-92165-3_16; BEEBE DP, 1983, J IMMUNOL, V130, P1317; Bungener L, 2008, VACCINE, V26, P2350, DOI 10.1016/j.vaccine.2008.02.063; Carragher DM, 2008, J IMMUNOL, V181, P4168, DOI 10.4049/jimmunol.181.6.4168; Chen GL, 2009, NAT MED, V15, P1251, DOI 10.1038/nm1109-1251; COUCH RB, 1983, ANNU REV MICROBIOL, V37, P529, DOI 10.1146/annurev.mi.37.100183.002525; COUTELIER JP, 1987, J EXP MED, V165, P64, DOI 10.1084/jem.165.1.64; Denis J, 2008, VACCINE, V26, P3395, DOI 10.1016/j.vaccine.2008.04.052; Denis J, 2007, VIROLOGY, V363, P59, DOI 10.1016/j.virol.2007.01.011; DONNELLY JJ, 1995, NAT MED, V1, P583, DOI 10.1038/nm0695-583; Ekiert DC, 2009, SCIENCE, V324, P246, DOI 10.1126/science.1171491; Feng JQ, 2002, J VIROL, V76, P1369, DOI 10.1128/JVI.76.3.1369-1378.2002; Gerhard W, 1997, IMMUNOL REV, V159, P95, DOI 10.1111/j.1600-065X.1997.tb01009.x; GORMAN OT, 1992, CURR TOP MICROBIOL, V176, P75; GORMAN OT, 1990, J VIROL, V64, P1487, DOI 10.1128/JVI.64.4.1487-1497.1990; Grebe KM, 2008, MICROBES INFECT, V10, P1024, DOI 10.1016/j.micinf.2008.07.002; Greenbaum JA, 2009, P NATL ACAD SCI USA, V106, P20365, DOI 10.1073/pnas.0911580106; Guillon C, 2007, VACCINE, V25, P7491, DOI 10.1016/j.vaccine.2007.08.060; HOCART MJ, 1989, J GEN VIROL, V70, P2439, DOI 10.1099/0022-1317-70-9-2439; Huber VC, 2006, CLIN VACCINE IMMUNOL, V13, P981, DOI 10.1128/CVI.00156-06; ITO T, 1991, J VIROL, V65, P5491, DOI 10.1128/JVI.65.10.5491-5498.1991; Jegerlehner A, 2004, J IMMUNOL, V172, P5598, DOI 10.4049/jimmunol.172.9.5598; Khurana S, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000624; Kodihalli S, 2000, VACCINE, V18, P2592, DOI 10.1016/S0264-410X(99)00485-5; Kreijtz JHCM, 2008, J VIROL, V82, P5161, DOI 10.1128/JVI.02694-07; Lacasse P, 2008, J VIROL, V82, P785, DOI 10.1128/JVI.01811-07; Leclerc D, 2007, J VIROL, V81, P1319, DOI 10.1128/JVI.01720-06; Lee LYH, 2008, J CLIN INVEST, V118, P3478, DOI 10.1172/JCI32460; LIANG SH, 1994, J IMMUNOL, V152, P1653; Mozdzanowska K, 1999, VIROLOGY, V254, P138, DOI 10.1006/viro.1998.9534; Nguyen HH, 2001, J INFECT DIS, V183, P368, DOI 10.1086/318084; Nichol KL, 2008, VACCINE, V26, pD17, DOI 10.1016/j.vaccine.2008.07.048; O'Hagan DT, 2009, DRUG DISCOV TODAY, V14, P541, DOI 10.1016/j.drudis.2009.02.009; Rangel-Moreno J, 2008, J IMMUNOL, V180, P454, DOI 10.4049/jimmunol.180.1.454; RIMMELZWAAN GF, 1995, VACCINE, V13, P703; Rimmelzwaan GF, 2008, VACCINE, V26, pD41, DOI 10.1016/j.vaccine.2008.07.043; Sambhara S, 2001, CELL IMMUNOL, V211, P143, DOI 10.1006/cimm.2001.1835; Sui JH, 2009, NAT STRUCT MOL BIOL, V16, P265, DOI 10.1038/nsmb.1566; Tao P, 2009, ANTIVIR RES, V81, P253, DOI 10.1016/j.antiviral.2008.12.009; Thomas PG, 2006, EMERG INFECT DIS, V12, P48, DOI 10.3201/eid1201.051237; Tremblay MH, 2006, FEBS J, V273, P14, DOI 10.1111/j.1742-4658.2005.05033.x; Tumpey TM, 2001, J VIROL, V75, P5141, DOI 10.1128/JVI.75.11.5141-5150.2001; Wieseler-Frank J, 2004, NEUROCHEM INT, V45, P389, DOI 10.1016/j.neuint.2003.09.009; Xie H, 2007, VACCINE, V25, P7649, DOI 10.1016/j.vaccine.2007.08.052; Xu JT, 2006, PAIN, V123, P306, DOI 10.1016/j.pain.2006.03.011; YAP KL, 1978, SCAND J IMMUNOL, V7, P389, DOI 10.1111/j.1365-3083.1978.tb00469.x; Zhou ZG, 2010, PAIN, V151, P296, DOI 10.1016/j.pain.2010.06.017; Zuccotti GV, 2011, EXPERT OPIN BIOL TH, V11, P1, DOI 10.1517/14712598.2010.539047	50	42	44	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2011	6	6							e21522	10.1371/journal.pone.0021522	http://dx.doi.org/10.1371/journal.pone.0021522			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786FZ	21747909	Green Published, gold, Green Submitted			2022-12-27	WOS:000292290100031
J	Chhabra, SR; Joachimiak, MP; Petzold, CJ; Zane, GM; Price, MN; Reveco, SA; Fok, V; Johanson, AR; Batth, TS; Singer, M; Chandonia, JM; Joyner, D; Hazen, TC; Arkin, AP; Wall, JD; Singh, AK; Keasling, JD				Chhabra, Swapnil R.; Joachimiak, Marcin P.; Petzold, Christopher J.; Zane, Grant M.; Price, Morgan N.; Reveco, Sonia A.; Fok, Veronica; Johanson, Alyssa R.; Batth, Tanveer S.; Singer, Mary; Chandonia, John-Marc; Joyner, Dominique; Hazen, Terry C.; Arkin, Adam P.; Wall, Judy D.; Singh, Anup K.; Keasling, Jay D.			Towards a Rigorous Network of Protein-Protein Interactions of the Model Sulfate Reducer Desulfovibrio vulgaris Hildenborough	PLOS ONE			English	Article							ESCHERICHIA-COLI; MASS-SPECTROMETRY; GLOBAL ANALYSIS; VULGATIS HILDENBOROUGH; PURIFICATION; METHYLATION; COMPLEXES; ACETYLATION; PEPTIDES; AFFINITY	Protein-protein interactions offer an insight into cellular processes beyond what may be obtained by the quantitative functional genomics tools of proteomics and transcriptomics. The aforementioned tools have been extensively applied to study Escherichia coli and other aerobes and more recently to study the stress response behavior of Desulfovibrio vulgaris Hildenborough, a model obligate anaerobe and sulfate reducer and the subject of this study. Here we carried out affinity purification followed by mass spectrometry to reconstruct an interaction network among 12 chromosomally encoded bait and 90 prey proteins based on 134 bait-prey interactions identified to be of high confidence. Protein-protein interaction data are often plagued by the lack of adequate controls and replication analyses necessary to assess confidence in the results, including identification of potential false positives. We addressed these issues through the use of biological replication, exponentially modified protein abundance indices, results from an experimental negative control, and a statistical test to assign confidence to each putative interacting pair applicable to small interaction data studies. We discuss the biological significance of metabolic features of D. vulgaris revealed by these protein-protein interaction data and the observed protein modifications. These include the distinct role of the putative carbon monoxide-induced hydrogenase, unique electron transfer routes associated with different oxidoreductases, and the possible role of methylation in regulating sulfate reduction.	[Chhabra, Swapnil R.; Joachimiak, Marcin P.; Zane, Grant M.; Price, Morgan N.; Singer, Mary; Chandonia, John-Marc; Joyner, Dominique; Hazen, Terry C.; Arkin, Adam P.; Wall, Judy D.; Singh, Anup K.; Keasling, Jay D.] Univ Calif Berkeley, Lawrence Berkeley Lab, Virtual Inst Microbial Stress & Survival, Berkeley, CA 94720 USA; [Chhabra, Swapnil R.; Joachimiak, Marcin P.; Petzold, Christopher J.; Price, Morgan N.; Reveco, Sonia A.; Fok, Veronica; Johanson, Alyssa R.; Batth, Tanveer S.; Chandonia, John-Marc; Arkin, Adam P.; Keasling, Jay D.] Univ Calif Berkeley, Lawrence Berkeley Lab, Phys Biosci Div, Berkeley, CA 94720 USA; [Singer, Mary; Joyner, Dominique; Hazen, Terry C.] Univ Calif Berkeley, Lawrence Berkeley Lab, Div Earth Sci, Berkeley, CA 94720 USA; [Chandonia, John-Marc] Univ Calif Berkeley, Lawrence Berkeley Lab, Div Life Sci, Berkeley, CA 94720 USA; [Zane, Grant M.; Wall, Judy D.] Univ Missouri, Dept Biochem, Columbia, MO USA; [Zane, Grant M.; Wall, Judy D.] Univ Missouri, Dept Mol Microbiol & Immunol, Columbia, MO USA; [Singh, Anup K.] Sandia Natl Labs, Biosyst Res Dept, Livermore, CA USA; [Arkin, Adam P.; Keasling, Jay D.] Univ Calif Berkeley, Dept Chem Engn, Berkeley, CA 94720 USA; [Arkin, Adam P.; Keasling, Jay D.] Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA; [Chhabra, Swapnil R.; Petzold, Christopher J.; Reveco, Sonia A.; Fok, Veronica; Johanson, Alyssa R.; Batth, Tanveer S.; Hazen, Terry C.; Arkin, Adam P.; Singh, Anup K.; Keasling, Jay D.] Joint BioEnergy Inst, Emeryville, CA USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; United States Department of Energy (DOE); Sandia National Laboratories; University of California System; University of California Berkeley; University of California System; University of California Berkeley; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI	Chhabra, SR (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Lab, Virtual Inst Microbial Stress & Survival, Berkeley, CA 94720 USA.	srchhabra@lbl.gov; mpjoachimiak@lbl.gov	Arkin, Adam P/A-6751-2008; Arkin, Adam/M-9941-2019; Keasling, Jay D/J-9162-2012; Hazen, Terry C/C-1076-2012	Arkin, Adam P/0000-0002-4999-2931; Arkin, Adam/0000-0002-4999-2931; Keasling, Jay D/0000-0003-4170-6088; Hazen, Terry C/0000-0002-2536-9993; Zane, Grant/0000-0002-3357-3097; joachimiak, marcin/0000-0001-8175-045X; Price, Morgan/0000-0002-4251-0362; Petzold, Christopher/0000-0002-8270-5228; Chandonia, John-Marc/0000-0002-5153-9079; Batth, Tanveer Singh/0000-0001-5346-4544	U.S. Department of Energy, Office of Science, Office of Biological and Environmental Research, Genomics [DE-AC02-05CH11231]; Office of Science, Office of Biological and Environmental Research, of the U.S. Department of Energy [DE-AC02-05CH11231]	U.S. Department of Energy, Office of Science, Office of Biological and Environmental Research, Genomics(United States Department of Energy (DOE)); Office of Science, Office of Biological and Environmental Research, of the U.S. Department of Energy(United States Department of Energy (DOE))	This work was part of the U.S. Department of Energy Genomics Sciences program: ENIGMA is a Scientific Focus Area Program supported by the U.S. Department of Energy, Office of Science, Office of Biological and Environmental Research, Genomics: GTL Foundational Science through contract DE-AC02-05CH11231 between Lawrence Berkeley National Laboratory and the U.S. Department of Energy. This work conducted by the Joint BioEnergy Institute was supported by the Office of Science, Office of Biological and Environmental Research, of the U.S. Department of Energy under Contract No. DE-AC02-05CH11231. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alm EJ, 2005, GENOME RES, V15, P1015, DOI 10.1101/gr.3844805; Arifuzzaman M, 2006, GENOME RES, V16, P686, DOI 10.1101/gr.4527806; Arnold Randy J, 2002, Methods Mol Biol, V194, P205; Batagelj V., 1998, CONNECTIONS, V21, P47, DOI DOI 10.1017/CB09780511996368; Berggard T, 2007, PROTEOMICS, V7, P2833, DOI 10.1002/pmic.200700131; Bernstein JA, 2004, P NATL ACAD SCI USA, V101, P2758, DOI 10.1073/pnas.0308747101; BROWN T, 1993, CURRENT PROTOCOLS MO; Bukau B, 1998, CELL, V92, P351, DOI 10.1016/S0092-8674(00)80928-9; Butland G, 2005, NATURE, V433, P531, DOI 10.1038/nature03239; CHEN L, 1994, BIOCHEM BIOPH RES CO, V203, P839, DOI 10.1006/bbrc.1994.2259; Chhabra SR, 2006, J BACTERIOL, V188, P1817, DOI 10.1128/JB.188.5.1817-1828.2006; Chiang T, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r186; Clark ME, 2006, APPL ENVIRON MICROB, V72, P5578, DOI 10.1128/AEM.00284-06; Coburn GA, 1999, GENE DEV, V13, P2594, DOI 10.1101/gad.13.19.2594; CONG Y, P NATL ACAD SCI US, V107, P4967; Davydova MN, 2003, ANAEROBE, V9, P39, DOI 10.1016/S1075-9964(03)00045-3; Dolla A, 2006, J BIOTECHNOL, V126, P87, DOI 10.1016/j.jbiotec.2006.03.041; EFRON B, 1979, ANN STAT, V7, P1, DOI 10.1214/aos/1176344552; ELIAS DA, 2009, NUCL ACIDS RES; Fritz G, 2002, P NATL ACAD SCI USA, V99, P1836, DOI 10.1073/pnas.042664399; GAMER J, 1992, CELL, V69, P833, DOI 10.1016/0092-8674(92)90294-M; Gaucher SP, 2008, J PROTEOME RES, V7, P2320, DOI 10.1021/pr700772s; Gavin AC, 2006, NATURE, V440, P631, DOI 10.1038/nature04532; Gavin AC, 2003, CURR OPIN CHEM BIOL, V7, P21, DOI 10.1016/S1367-5931(02)00007-8; Gentleman R, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-112; Glatter T, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2008.75; Heidelberg JF, 2004, NAT BIOTECHNOL, V22, P554, DOI 10.1038/nbt959; HORTON RM, 1993, METHOD ENZYMOL, V217, P270; Hu PZ, 2009, PLOS BIOL, V7, P929, DOI 10.1371/journal.pbio.1000096; Ishihama Y, 2005, MOL CELL PROTEOMICS, V4, P1265, DOI 10.1074/mcp.M500061-MCP200; Joachimiak MP, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-225; Junttila MR, 2005, PROTEOMICS, V5, P1199, DOI 10.1002/pmic.200400991; Karp PD, 2002, NUCLEIC ACIDS RES, V30, P56, DOI 10.1093/nar/30.1.56; KERBY RL, 1992, J BACTERIOL, V174, P5284, DOI 10.1128/JB.174.16.5284-5294.1992; Kessel M, 1996, FEBS LETT, V398, P274, DOI 10.1016/S0014-5793(96)01261-6; Kim JY, 2002, ANAL CHEM, V74, P5443, DOI 10.1021/ac0256080; Korndorfer IP, 2002, PROTEIN SCI, V11, P883, DOI 10.1110/ps.4150102; Lichty JJ, 2005, PROTEIN EXPRES PURIF, V41, P98, DOI 10.1016/j.pep.2005.01.019; Liou GG, 2001, P NATL ACAD SCI USA, V98, P63, DOI 10.1073/pnas.011535498; Mizutani T, 2009, GENES CELLS, V14, P1405, DOI 10.1111/j.1365-2443.2009.01357.x; Mukhopadhyay A, 2007, J BACTERIOL, V189, P5996, DOI 10.1128/JB.00368-07; Mukhopadhyay A, 2006, J BACTERIOL, V188, P4068, DOI 10.1128/JB.01921-05; Paik WK, 2007, TRENDS BIOCHEM SCI, V32, P146, DOI 10.1016/j.tibs.2007.01.006; PIERIK AJ, 1992, EUR J BIOCHEM, V205, P111, DOI 10.1111/j.1432-1033.1992.tb16757.x; Polevoda B, 2007, MOL MICROBIOL, V65, P590, DOI 10.1111/j.1365-2958.2007.05831.x; Price MN, 2005, GENOME RES, V15, P809, DOI 10.1101/gr.3368805; Price MN, 2005, NUCLEIC ACIDS RES, V33, P880, DOI 10.1093/nar/gki232; Rodionov DA, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-11-r90; Rohrwild M, 1996, P NATL ACAD SCI USA, V93, P5808, DOI 10.1073/pnas.93.12.5808; Rousset M, 1998, PLASMID, V39, P114, DOI 10.1006/plas.1997.1321; Schmidt TGM, 2007, NAT PROTOC, V2, P1528, DOI 10.1038/nprot.2007.209; SCHRODER H, 1993, EMBO J, V12, P4137, DOI 10.1002/j.1460-2075.1993.tb06097.x; Selengut JD, 2007, NUCLEIC ACIDS RES, V35, pD260, DOI 10.1093/nar/gkl1043; Seol JH, 1997, EUR J BIOCHEM, V247, P1143, DOI 10.1111/j.1432-1033.1997.01143.x; Shilov IV, 2007, MOL CELL PROTEOMICS, V6, P1638, DOI 10.1074/mcp.T600050-MCP200; Soboh B, 2002, EUR J BIOCHEM, V269, P5712, DOI 10.1046/j.1432-1033.2002.03282.x; Stolyar S, 2007, J BACTERIOL, V189, P8944, DOI 10.1128/JB.00284-07; Vasilescu J, 2006, CURR OPIN BIOTECH, V17, P394, DOI 10.1016/j.copbio.2006.06.008; WALL J, 2007, GENETICS GENOMICS SU, P1; Wildschut JD, 2006, J BACTERIOL, V188, P6253, DOI 10.1128/JB.00425-06; Zhang KL, 2004, PROTEOMICS, V4, P1, DOI 10.1002/pmic.200300503; ZHOU JZ, 2010, NATURE REV MIC UNPUB; Zhu H, 2001, SCIENCE, V293, P2101, DOI 10.1126/science.1062191	63	10	10	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2011	6	6							e21470	10.1371/journal.pone.0021470	http://dx.doi.org/10.1371/journal.pone.0021470			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	784FW	21738675	Green Submitted, gold, Green Published			2022-12-27	WOS:000292142800026
J	Jiang, Y; Shen, H; Liu, XA; Dai, JC; Jin, GF; Qin, ZZ; Chen, JP; Wang, S; Wang, XR; Hu, ZB; Shen, HB				Jiang, Yue; Shen, Hao; Liu, Xiao'an; Dai, Juncheng; Jin, Guangfu; Qin, Zhenzhen; Chen, Jiaping; Wang, Shui; Wang, Xinru; Hu, Zhibin; Shen, Hongbing			Genetic Variants at 1p11.2 and Breast Cancer Risk: A Two-Stage Study in Chinese Women	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; SUSCEPTIBILITY; LOCI; ALLELES; NOTCH2	Background: Genome-wide association studies (GWAS) have identified several breast cancer susceptibility loci, and one genetic variant, rs11249433, at 1p11.2 was reported to be associated with breast cancer in European populations. To explore the genetic variants in this region associated with breast cancer in Chinese women, we conducted a two-stage fine-mapping study with a total of 1792 breast cancer cases and 1867 controls. Methodology/Principal Findings: Seven single nucleotide polymorphisms (SNPs) including rs11249433 in a 277 kb region at 1p11.2 were selected and genotyping was performed by using TaqMan (R) OpenArray (TM) Genotyping System for stage 1 samples (878 cases and 900 controls). In stage 2 (914 cases and 967 controls), three SNPs (rs2580520, rs4844616 and rs11249433) were further selected and genotyped for validation. The results showed that one SNP (rs2580520) located at a predicted enhancer region of SRGAP2 was consistently associated with a significantly increased risk of breast cancer in a recessive genetic model [Odds Ratio (OR) = 1.66, 95% confidence interval (CI) = 1.16-2.36 for stage 2 samples; OR = 1.51, 95% CI = 1.16-1.97 for combined samples, respectively]. However, no significant association was observed between rs11249433 and breast cancer risk in this Chinese population (dominant genetic model in combined samples: OR = 1.20, 95% CI = 0.92-1.57). Conclusions/Significance: Genotypes of rs2580520 at 1p11.2 suggest that Chinese women may have different breast cancer susceptibility loci, which may contribute to the development of breast cancer in this population.	[Jiang, Yue; Jin, Guangfu; Wang, Xinru; Hu, Zhibin; Shen, Hongbing] Nanjing Med Univ, State Key Lab Reprod Med, Inst Toxicol, Nanjing, Peoples R China; [Jiang, Yue; Shen, Hao; Dai, Juncheng; Jin, Guangfu; Qin, Zhenzhen; Chen, Jiaping; Wang, Xinru; Hu, Zhibin; Shen, Hongbing] Nanjing Med Univ, Sch Publ Hlth, MOE Key Lab Modern Toxicol, Nanjing, Peoples R China; [Jiang, Yue; Jin, Guangfu; Chen, Jiaping; Hu, Zhibin; Shen, Hongbing] Nanjing Med Univ, Clin Epidemiol Sect, Jiangsu Key Lab Canc Biomarkers Prevent & Treatme, Ctr Canc, Nanjing, Peoples R China; [Liu, Xiao'an; Wang, Shui] Nanjing Med Univ, Dept Gen Surg, Affiliated Hosp 1, Nanjing, Peoples R China	Nanjing Medical University; Nanjing Medical University; Nanjing Medical University; Nanjing Medical University	Jiang, Y (corresponding author), Nanjing Med Univ, State Key Lab Reprod Med, Inst Toxicol, Nanjing, Peoples R China.	hongbingshen@gmail.com	Wang, Xin/AAN-8435-2021	Wang, Xin/0000-0002-4457-7376	National Natural Science Foundation of China [81071715]; Natural Science Foundation of Jiangsu Higher Education Institutions [09KJA330001]; Program for Changjiang Scholars and Innovative Research Team in University [IRT0631]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Higher Education Institutions; Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT))	This work was supported by the National Natural Science Foundation of China (grant number 81071715), Key Grant of Natural Science Foundation of Jiangsu Higher Education Institutions (09KJA330001), and the Program for Changjiang Scholars and Innovative Research Team in University (IRT0631). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed S, 2009, NAT GENET, V41, P585, DOI 10.1038/ng.354; Chai L, 2010, J DENT RES, V89, P705, DOI 10.1177/0022034510365444; Coughlin SS, 2009, CANCER EPIDEMIOL, V33, P315, DOI 10.1016/j.canep.2009.10.003; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Grarup N, 2008, DIABETES, V57, P2534, DOI 10.2337/db08-0436; Guerrier S, 2009, CELL, V138, P990, DOI 10.1016/j.cell.2009.06.047; Hirose H, 2010, ONCOL REP, V23, P35, DOI 10.3892/or_00000603; Iwasaki M, 2011, BREAST CANCER RES TR, V126, P497, DOI 10.1007/s10549-010-1109-3; Kuwano Y, 2007, ARCH DERMATOL RES, V298, P493, DOI 10.1007/s00403-006-0717-6; Lee SH, 2007, APMIS, V115, P1357, DOI 10.1111/j.1600-0463.2007.00751.x; Li JM, 2011, BREAST CANCER RES TR, V126, P717, DOI 10.1007/s10549-010-1172-9; Li YN, 2008, J NEUROSCI RES, V86, P3556, DOI 10.1002/jnr.21810; McKinney C, 2010, ANN RHEUM DIS, V69, P1711, DOI 10.1136/ard.2009.123588; Parr C, 2004, INT J MOL MED, V14, P779; Porter P, 2008, NEW ENGL J MED, V358, P213, DOI 10.1056/NEJMp0708307; Stacey SN, 2008, NAT GENET, V40, P703, DOI 10.1038/ng.131; Staiger H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003019; Szamalek JM, 2006, HUM GENET, V120, P126, DOI 10.1007/s00439-006-0209-y; Thomas G, 2009, NAT GENET, V41, P579, DOI 10.1038/ng.353; Wu C, 2009, CANCER RES, V69, P5065, DOI 10.1158/0008-5472.CAN-09-0081; Wu FT, 2007, FRONT BIOSCI-LANDMRK, V12, P4370, DOI 10.2741/2394; Zheng W, 2009, NAT GENET, V41, P324, DOI 10.1038/ng.318	22	19	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2011	6	6							e21563	10.1371/journal.pone.0021563	http://dx.doi.org/10.1371/journal.pone.0021563			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	783OD	21738711	Green Published, Green Submitted, gold			2022-12-27	WOS:000292092600052
J	Kaminitz, A; Yolcu, ES; Askenasy, EM; Stein, J; Yaniv, I; Shirwan, H; Askenasy, N				Kaminitz, Ayelet; Yolcu, Esma S.; Askenasy, Enosh M.; Stein, Jerry; Yaniv, Isaac; Shirwan, Haval; Askenasy, Nadir			Effector and Naturally Occurring Regulatory T Cells Display No Abnormalities in Activation Induced Cell Death in NOD Mice	PLOS ONE			English	Article							NONOBESE DIABETIC MOUSE; FAS-LIGAND; CUTTING EDGE; IN-VIVO; APOPTOSIS; CD4(+)CD25(+); HOMEOSTASIS; MECHANISMS; INTERLEUKIN-2; SUPPRESSION	Background: Disturbed peripheral negative regulation might contribute to evolution of autoimmune insulitis in type 1 diabetes. This study evaluates the sensitivity of naive/effector (Teff) and regulatory T cells (Treg) to activation-induced cell death mediated by Fas cross-linking in NOD and wild-type mice. Principal Findings: Both effector (CD25(-), FoxP3(-)) and suppressor (CD25(+), FoxP3(+)) CD4(+) T cells are negatively regulated by Fas cross-linking in mixed splenocyte populations of NOD, wild type mice and FoxP3-GFP tranegenes. Proliferation rates and sensitivity to Fas cross-linking are dissociated in Treg cells: fast cycling induced by IL-2 and CD3/CD28 stimulation improve Treg resistance to Fas-ligand (FasL) in both strains. The effector and suppressor CD4(+) subsets display balanced sensitivity to negative regulation under baseline conditions, IL-2 and CD3/CD28 stimulation, indicating that stimulation does not perturb immune homeostasis in NOD mice. Effective autocrine apoptosis of diabetogenic cells was evident from delayed onset and reduced incidence of adoptive disease transfer into NOD. SCID by CD4(+) CD25(-) T cells decorated with FasL protein. Treg resistant to Fas-mediated apoptosis retain suppressive activity in vitro. The only detectable differential response was reduced Teff proliferation and upregulation of CD25 following CD3-activation in NOD mice. Conclusion: These data document negative regulation of effector and suppressor cells by Fas cross-linking and dissociation between sensitivity to apoptosis and proliferation in stimulated Treg. There is no evidence that perturbed AICD in NOD mice initiates or promotes autoimmune insulitis.	[Kaminitz, Ayelet; Askenasy, Enosh M.; Askenasy, Nadir] Schneider Childrens Med Ctr Israel, Frankel Lab, Ctr Stem Cell Res, Petah Tiqwa, Israel; [Kaminitz, Ayelet; Yaniv, Isaac] Tel Aviv Univ, Sackler Sch Med, IL-69978 Tel Aviv, Israel; [Yolcu, Esma S.; Shirwan, Haval] Univ Louisville, Inst Cellular Therapeut, Louisville, KY 40292 USA; [Yolcu, Esma S.; Shirwan, Haval] Univ Louisville, Dept Microbiol & Immunol, Louisville, KY 40292 USA; [Stein, Jerry] Schneider Childrens Med Ctr Israel, Bone Marrow Transplant Unit, Petah Tiqwa, Israel; [Shirwan, Haval] Schneider Childrens Med Ctr Israel, Dept Pediat Hematol Oncol, Petah Tiqwa, Israel	Tel Aviv University; Sackler Faculty of Medicine; University of Louisville; University of Louisville	Kaminitz, A (corresponding author), Schneider Childrens Med Ctr Israel, Frankel Lab, Ctr Stem Cell Res, Petah Tiqwa, Israel.	anadir@012.net.il			Frankel Trust for Experimental Bone Marrow Transplantation	Frankel Trust for Experimental Bone Marrow Transplantation	This work was supported by grants from the Frankel Trust for Experimental Bone Marrow Transplantation and a generous donation in memory of Papi and Mordechai Steigman. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arreaza G, 2003, CLIN IMMUNOL, V107, P103, DOI 10.1016/S1521-6616(03)00049-4; Arreaza GA, 1997, J CLIN INVEST, V100, P2243, DOI 10.1172/JCI119762; Askenasy EM, 2010, AUTOIMMUN REV, V9, P687, DOI 10.1016/j.autrev.2010.05.019; Askenasy N, 2005, BLOOD, V105, P1396, DOI 10.1182/blood-2004-06-2364; Askenasy N, 2008, AUTOIMMUN REV, V7, P370, DOI 10.1016/j.autrev.2008.03.001; Banz A, 2002, J IMMUNOL, V169, P750, DOI 10.4049/jimmunol.169.2.750; Beilhack GF, 2003, DIABETES, V52, P59, DOI 10.2337/diabetes.52.1.59; Belghith M, 2003, NAT MED, V9, P1202, DOI 10.1038/nm924; Berzins SP, 2003, DIABETES, V52, P327, DOI 10.2337/diabetes.52.2.327; Christen U, 2004, DIABETES, V53, P591, DOI 10.2337/diabetes.53.3.591; Colucci F, 1996, J AUTOIMMUN, V9, P271, DOI 10.1006/jaut.1996.0034; D'Alise AM, 2008, P NATL ACAD SCI USA, V105, P19857, DOI 10.1073/pnas.0810713105; de la Rosa M, 2004, EUR J IMMUNOL, V34, P2480, DOI 10.1002/eji.200425274; Decallonne B, 2003, J AUTOIMMUN, V20, P219, DOI 10.1016/S0896-8411(03)00025-8; Delovitch TL, 1997, IMMUNITY, V7, P727, DOI 10.1016/S1074-7613(00)80392-1; Feinerman O, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.90; Franke DDH, 2007, MOL IMMUNOL, V44, P2884, DOI 10.1016/j.molimm.2007.01.014; Fritzsching B, 2005, J IMMUNOL, V175, P32, DOI 10.4049/jimmunol.175.1.32; Fritzsching B, 2006, BLOOD, V108, P3371, DOI 10.1182/blood-2006-02-005660; GIORDANO C, 1995, DIABETOLOGIA, V38, P1449, DOI 10.1007/BF00400606; Gregg RK, 2004, J IMMUNOL, V173, P7308, DOI 10.4049/jimmunol.173.12.7308; Gregori S, 2003, J IMMUNOL, V171, P4040, DOI 10.4049/jimmunol.171.8.4040; KAMINITZ A, 2011, J AUTOIMMUN IN PRESS; Kaminitz A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015684; Kaminitz A, 2010, J AUTOIMMUN, V35, P145, DOI 10.1016/j.jaut.2010.06.002; Kaminitz A, 2009, J AUTOIMMUN, V33, P83, DOI 10.1016/j.jaut.2009.07.001; Kishimoto H, 2001, NAT IMMUNOL, V2, P1025, DOI 10.1038/ni726; Klein L, 2003, P NATL ACAD SCI USA, V100, P8886, DOI 10.1073/pnas.1533365100; KNEITZ B, 1995, EUR J IMMUNOL, V25, P2672; Kukreja A, 2002, J CLIN INVEST, V109, P131, DOI 10.1172/JCI13605; Lan RY, 2008, J AUTOIMMUN, V31, P7, DOI 10.1016/j.jaut.2008.03.002; LENARDO MJ, 1991, NATURE, V353, P858, DOI 10.1038/353858a0; Li H, 1996, J IMMUNOL, V156, P380; Lindley S, 2005, DIABETES, V54, P92, DOI 10.2337/diabetes.54.1.92; Miyara M, 2007, TRENDS MOL MED, V13, P108, DOI 10.1016/j.molmed.2007.01.003; Mohamood AS, 2006, INT IMMUNOL, V18, P1265, DOI 10.1093/intimm/dxl057; Pandiyan P, 2008, BIOL DIRECT, V3, DOI 10.1186/1745-6150-3-6; Pandiyan P, 2007, NAT IMMUNOL, V8, P1353, DOI 10.1038/ni1536; Parijs LV, 1997, J IMMUNOL, V158, P3738; Pearl-Yafe M, 2006, BIOESSAYS, V28, P211, DOI 10.1002/bies.20356; Pearl-Yafe M, 2007, STEM CELLS, V25, P1448, DOI 10.1634/stemcells.2007-0013; Pearl-Yafe M, 2007, CURR PHARM DESIGN, V13, P749, DOI 10.2174/138161207780249155; Pop SM, 2005, J EXP MED, V201, P1333, DOI 10.1084/jem.20042398; Putnam AL, 2005, J AUTOIMMUN, V24, P55, DOI 10.1016/j.jaut.2004.11.004; Radosevic K, 1999, J AUTOIMMUN, V13, P373, DOI 10.1006/jaut.1999.0338; Refaeli Y, 1998, IMMUNITY, V8, P615, DOI 10.1016/S1074-7613(00)80566-X; Salomon B, 2000, IMMUNITY, V12, P431, DOI 10.1016/S1074-7613(00)80195-8; Schneider A, 2008, J IMMUNOL, V181, P7350, DOI 10.4049/jimmunol.181.10.7350; SERREZE DV, 1989, J AUTOIMMUN, V2, P759, DOI 10.1016/0896-8411(89)90003-6; Setoguchi R, 2005, J EXP MED, V201, P723, DOI 10.1084/jem.20041982; Shevach EM, 2009, IMMUNITY, V30, P636, DOI 10.1016/j.immuni.2009.04.010; Taams LS, 2001, EUR J IMMUNOL, V31, P1122, DOI 10.1002/1521-4141(200104)31:4<1122::AID-IMMU1122>3.0.CO;2-P; Tang Q, 2008, IMMUNITY, V28, P687, DOI 10.1016/j.immuni.2008.03.016; Tang QZ, 2003, J IMMUNOL, V171, P3348, DOI 10.4049/jimmunol.171.7.3348; Tritt M, 2008, DIABETES, V57, P113, DOI 10.2337/db06-1700; von Boehmer H, 2005, NAT IMMUNOL, V6, P338, DOI 10.1038/ni1180; Waid DM, 2008, J LEUKOCYTE BIOL, V84, P431, DOI 10.1189/jlb.1207857; Wang RD, 1996, EUR J IMMUNOL, V26, P2263, DOI 10.1002/eji.1830260944; Weber SE, 2006, J IMMUNOL, V176, P4730, DOI 10.4049/jimmunol.176.8.4730; Yang W, 2004, J IMMUNOL, V173, P4407, DOI 10.4049/jimmunol.173.7.4407; Yaniv I, 2009, J AUTOIMMUN, V33, P255, DOI 10.1016/j.jaut.2009.09.002; Yarkoni S, 2010, DIABETOLOGIA, V53, P356, DOI 10.1007/s00125-009-1604-4; Yarkoni S, 2008, BIOESSAYS, V30, P875, DOI 10.1002/bies.20812; Yolcu ES, 2002, IMMUNITY, V17, P795, DOI 10.1016/S1074-7613(02)00482-X; Yolcu ES, 2008, IMMUNOL CELL BIOL, V86, P650, DOI 10.1038/icb.2008.62; You S, 2005, DIABETES, V54, P1415, DOI 10.2337/diabetes.54.5.1415	66	15	15	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2011	6	6							e21630	10.1371/journal.pone.0021630	http://dx.doi.org/10.1371/journal.pone.0021630			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	783OD	21738739	Green Published, gold, Green Submitted			2022-12-27	WOS:000292092600064
J	Carcagno, AL; Marazita, MC; Ogara, MF; Ceruti, JM; Sonzogni, SV; Scassa, ME; Giono, LE; Canepa, ET				Carcagno, Abel L.; Marazita, Mariela C.; Ogara, Maria F.; Ceruti, Julieta M.; Sonzogni, Silvina V.; Scassa, Maria E.; Giono, Luciana E.; Canepa, Eduardo T.			E2F1-Mediated Upregulation of p19INK4d Determines Its Periodic Expression during Cell Cycle and Regulates Cellular Proliferation	PLOS ONE			English	Article							DEPENDENT KINASE INHIBITORS; MAMMALIAN CDK INHIBITORS; SYSTEMS-LEVEL FEEDBACK; INK4 PROTEINS; DNA-REPAIR; 5-AMINOLEVULINATE SYNTHASE; TRANSCRIPTION FACTORS; GENOTOXIC STRESS; GENE-EXPRESSION; S-PHASE	Background: A central aspect of development and disease is the control of cell proliferation through regulation of the mitotic cycle. Cell cycle progression and directionality requires an appropriate balance of positive and negative regulators whose expression must fluctuate in a coordinated manner. p19INK4d, a member of the INK4 family of CDK inhibitors, has a unique feature that distinguishes it from the remaining INK4 and makes it a likely candidate for contributing to the directionality of the cell cycle. p19INK4d mRNA and protein levels accumulate periodically during the cell cycle under normal conditions, a feature reminiscent of cyclins. Methodology/Principal Findings: In this paper, we demonstrate that p19INK4d is transcriptionally regulated by E2F1 through two response elements present in the p19INK4d promoter. Ablation of this regulation reduced p19 levels and restricted its expression during the cell cycle, reflecting the contribution of a transcriptional effect of E2F1 on p19 periodicity. The induction of p19INK4d is delayed during the cell cycle compared to that of cyclin E, temporally separating the induction of these proliferative and antiproliferative target genes. Specific inhibition of the E2F1-p19INK4d pathway using triplex-forming oligonucleotides that block E2F1 binding on p19 promoter, stimulated cell proliferation and increased the fraction of cells in S phase. Conclusions/Significance: The results described here support a model of normal cell cycle progression in which, following phosphorylation of pRb, free E2F induces cyclin E, among other target genes. Once cyclinE/CDK2 takes over as the cell cycle driving kinase activity, the induction of p19 mediated by E2F1 leads to inhibition of the CDK4,6-containing complexes, bringing the G1 phase to an end. This regulatory mechanism constitutes a new negative feedback loop that terminates the G1 phase proliferative signal, contributing to the proper coordination of the cell cycle and provides an additional mechanism to limit E2F activity.	[Carcagno, Abel L.; Marazita, Mariela C.; Ogara, Maria F.; Ceruti, Julieta M.; Sonzogni, Silvina V.; Scassa, Maria E.; Giono, Luciana E.; Canepa, Eduardo T.] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Quim Biol, Mol Biol Lab, Buenos Aires, DF, Argentina	University of Buenos Aires	Carcagno, AL (corresponding author), Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Quim Biol, Mol Biol Lab, Buenos Aires, DF, Argentina.	ecanepa@qb.fcen.uba.ar		Sonzogni, Silvina/0000-0002-6237-6594; Canepa, Eduardo T./0000-0002-4322-1650; Giono, Luciana/0000-0001-6958-6044	Agencia Nacional de Promocion Cientifica y Tecnologica [PICT 622]; Consejo Nacional de Investigaciones Cientificas y Tecnicas [PIP 567]; Universidad de Buenos Aires [X-036]	Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT); Consejo Nacional de Investigaciones Cientificas y Tecnicas(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Universidad de Buenos Aires(University of Buenos Aires)	1. Agencia Nacional de Promocion Cientifica y Tecnologica. Grant Number: PICT 622 URL: http://www.agencia.mincyt.gov.ar. 2. Consejo Nacional de Investigaciones Cientificas y Tecnicas. Grant Number: PIP 567. URL: http://www.conicet.gov.ar. 3. Universidad de Buenos Aires. Grant Number: X-036. URL: http://www.uba.ar. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arata Y, 2000, J BIOL CHEM, V275, P6337, DOI 10.1074/jbc.275.9.6337; Attwooll C, 2004, EMBO J, V23, P4709, DOI 10.1038/sj.emboj.7600481; Besson A, 2008, DEV CELL, V14, P159, DOI 10.1016/j.devcel.2008.01.013; Blais A, 2004, CURR OPIN GENET DEV, V14, P527, DOI 10.1016/j.gde.2004.07.003; Blais A, 2002, J BIOL CHEM, V277, P31679, DOI 10.1074/jbc.M204554200; Blais A, 2007, CURR OPIN CELL BIOL, V19, P658, DOI 10.1016/j.ceb.2007.10.003; Canepa ET, 2007, IUBMB LIFE, V59, P419, DOI 10.1080/15216540701488358; Carcagno AL, 2009, IUBMB LIFE, V61, P537, DOI 10.1002/iub.197; Ceruti JM, 2005, ONCOGENE, V24, P4065, DOI 10.1038/sj.onc.1208570; Ceruti JM, 2009, INT J BIOCHEM CELL B, V41, P1344, DOI 10.1016/j.biocel.2008.12.005; Cunningham JJ, 2002, MOL CELL NEUROSCI, V19, P359, DOI 10.1006/mcne.2001.1090; DeGregori J, 1997, P NATL ACAD SCI USA, V94, P7245, DOI 10.1073/pnas.94.14.7245; del Arroyo AG, 2007, CELL CYCLE, V6, P2697; Dimova DK, 2005, ONCOGENE, V24, P2810, DOI 10.1038/sj.onc.1208612; Du W, 2006, ONCOGENE, V25, P5190, DOI 10.1038/sj.onc.1209651; Dyson N, 1998, GENE DEV, V12, P2245, DOI 10.1101/gad.12.15.2245; Forget A, 2008, CELL CYCLE, V7, P3737, DOI 10.4161/cc.7.23.7187; Gilles L, 2008, BLOOD, V111, P4081, DOI 10.1182/blood-2007-09-113266; Giono LE, 2001, BIOCHEM J, V353, P307, DOI 10.1042/0264-6021:3530307; Hallstrom TC, 2008, CANCER CELL, V13, P11, DOI 10.1016/j.ccr.2007.11.031; HIRAI H, 1995, MOL CELL BIOL, V15, P2672; Iaquinta PJ, 2005, COLD SH Q B, V70, P309, DOI 10.1101/sqb.2005.70.050; Iaquinta PJ, 2007, CURR OPIN CELL BIOL, V19, P649, DOI 10.1016/j.ceb.2007.10.006; Kapuy O, 2009, FEBS LETT, V583, P3992, DOI 10.1016/j.febslet.2009.08.023; Katayama K, 2008, ONCOGENE, V27, P1677, DOI 10.1038/sj.onc.1210813; Komori H, 2005, EMBO J, V24, P3724, DOI 10.1038/sj.emboj.7600836; Lammens T, 2009, TRENDS CELL BIOL, V19, P111, DOI 10.1016/j.tcb.2009.01.002; Lopez-Aviles S, 2009, NATURE, V459, P592, DOI 10.1038/nature07984; Matsuzaki Y, 2002, FEBS LETT, V517, P272, DOI 10.1016/S0014-5793(02)02647-9; Muller H, 2001, GENE DEV, V15, P267, DOI 10.1101/gad.864201; Novak B, 2007, NAT CELL BIOL, V9, P724, DOI 10.1038/ncb0707-724; O'Farrell AM, 2000, J IMMUNOL, V164, P4607, DOI 10.4049/jimmunol.164.9.4607; Ohtani K, 1995, P NATL ACAD SCI USA, V92, P12146, DOI 10.1073/pnas.92.26.12146; Ortega S, 2002, BBA-REV CANCER, V1602, P73, DOI 10.1016/S0304-419X(02)00037-9; Ozono E, 2009, GENES CELLS, V14, P89, DOI 10.1111/j.1365-2443.2008.01248.x; Park KK, 2003, BIOCHEM BIOPH RES CO, V308, P689, DOI 10.1016/S0006-291X(03)01455-4; Pei XH, 2005, ONCOGENE, V24, P2787, DOI 10.1038/sj.onc.1208611; Polager S, 2008, TRENDS CELL BIOL, V18, P528, DOI 10.1016/j.tcb.2008.08.003; Radhakrishnan SK, 2004, ONCOGENE, V23, P4173, DOI 10.1038/sj.onc.1207571; Reed SI, 2003, NAT REV MOL CELL BIO, V4, P855, DOI 10.1038/nrm1246; Ren B, 2002, GENE DEV, V16, P245, DOI 10.1101/gad.949802; Roussel MF, 1999, ONCOGENE, V18, P5311, DOI 10.1038/sj.onc.1202998; Ruas M, 1998, BBA-REV CANCER, V1378, pF115, DOI 10.1016/S0304-419X(98)00017-1; Scassa ME, 2007, DNA REPAIR, V6, P626, DOI 10.1016/j.dnarep.2006.12.003; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Taubert S, 2004, MOL CELL BIOL, V24, P4546, DOI 10.1128/MCB.24.10.4546-4556.2004; Thullberg M, 2000, FEBS LETT, V470, P161, DOI 10.1016/S0014-5793(00)01307-7; Thullberg M, 2000, ONCOGENE, V19, P2870, DOI 10.1038/sj.onc.1203579; Varone CL, 1997, ARCH BIOCHEM BIOPHYS, V341, P259, DOI 10.1006/abbi.1997.9978; Varone CL, 1999, ARCH BIOCHEM BIOPHYS, V372, P261, DOI 10.1006/abbi.1999.1470; Virolle T, 2003, J BIOL CHEM, V278, P11802, DOI 10.1074/jbc.M210279200; Wang CG, 2005, J BIOL CHEM, V280, P12339, DOI 10.1074/jbc.C400536200; Yokota T, 2004, ONCOGENE, V23, P5340, DOI 10.1038/sj.onc.1207689; Zindy F, 2006, P NATL ACAD SCI USA, V103, P11579, DOI 10.1073/pnas.0604727103	54	25	25	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2011	6	7							e21938	10.1371/journal.pone.0021938	http://dx.doi.org/10.1371/journal.pone.0021938			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	792WQ	21765927	Green Published, Green Submitted, gold			2022-12-27	WOS:000292781500024
J	Menezes, P; Miller, WC; Wohl, DA; Adimora, AA; Leone, PA; Miller, WC; Eron, JJ				Menezes, Prema; Miller, William C.; Wohl, David A.; Adimora, Adaora A.; Leone, Peter A.; Miller, William C.; Eron, Joseph J., Jr.			Does HAART Efficacy Translate to Effectiveness? Evidence for a Trial Effect	PLOS ONE			English	Article							COMBINATION ANTIRETROVIRAL THERAPY; SEQUENTIAL 3-DRUG REGIMENS; HIV-1 INFECTION; CLINICAL-TRIALS; INITIAL TREATMENT; RANDOMIZED PATIENTS; TENOFOVIR DF; PARTICIPATION; LAMIVUDINE; EFAVIRENZ	Background: Patients who participate in clinical trials may experience better clinical outcomes than patients who initiate similar therapy within clinical care (trial effect), but no published studies have evaluated a trial effect in HIV clinical trials. Methods: To examine a trial effect we compared virologic suppression (VS) among patients who initiated HAART in a clinical trial versus in routine clinical care. VS was defined as a plasma HIV RNA <= 400 copies/ml at six months after HAART initiation and was assessed within strata of early (1996-99) or current (2000-06) HAART periods. Risk ratios (RR) were estimated using binomial models. Results: Of 738 persons initiating HAART, 30.6% were women, 61.7% were black, 30% initiated therapy in a clinical trial and 67% (n = 496) had an evaluable six month HIV RNA result. HAART regimens differed between the early and current periods (p<0.001); unboosted PI regimens (55.6%) were more common in the early and NNRTI regimens (46.4%) were more common in the current period. Overall, 78% (95% CI 74, 82%) of patients achieved VS and trial participants were 16% more likely to achieve VS (unadjusted RR 1.16, 95% CI 1.06, 1.27). Comparing trial to non-trial participants, VS differed by study period. In the early period, trial participants initiating HAART were significantly more likely to achieve VS than non-trial participants (adjusted RR 1.33; 95% CI 1.15, 1.54), but not in the current period (adjusted RR 0.98; 95% CI 0.87, 1.11). Conclusions: A clear clinical trial effect on suppression of HIV replication was observed in the early HAART period but not in the current period.	[Menezes, Prema; Miller, William C.; Wohl, David A.; Adimora, Adaora A.; Leone, Peter A.; Miller, William C.; Eron, Joseph J., Jr.] Univ N Carolina, Sch Med, Div Infect Dis, Chapel Hill, NC 27515 USA; [Menezes, Prema; Miller, William C.; Adimora, Adaora A.; Leone, Peter A.; Miller, William C.; Eron, Joseph J., Jr.] Univ N Carolina, Sch Publ Hlth, Dept Epidemiol, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill	Menezes, P (corresponding author), Univ N Carolina, Sch Med, Div Infect Dis, Chapel Hill, NC 27515 USA.	menez001@med.unc.edu	Miller, William C/H-4800-2014	Miller, William C/0000-0002-1934-7827	University of North Carolina at Chapel Hill, Center for AIDS Research, National Institutes of Health [P30 AI50410]; Eunice Kennedy Shriver National Institute of Child Health & Human Development [K24HD059358-01]; University of North Carolina, General Clinical Research Center, National Institutes of Health [RR00046]; University of North Carolina, AIDS Clinical Trials Group, National Institutes of Health [AI 69423]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K24HD059358] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000046] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI069423, UM1AI069423, P30AI050410] Funding Source: NIH RePORTER	University of North Carolina at Chapel Hill, Center for AIDS Research, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Eunice Kennedy Shriver National Institute of Child Health & Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); University of North Carolina, General Clinical Research Center, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); University of North Carolina, AIDS Clinical Trials Group, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by the University of North Carolina at Chapel Hill, Center for AIDS Research, National Institutes of Health funded program P30 AI50410; Eunice Kennedy Shriver National Institute of Child Health & Human Development K24HD059358-01; the University of North Carolina, General Clinical Research Center, National Institutes of Health funded program RR00046; the University of North Carolina, AIDS Clinical Trials Group, National Institutes of Health funded program AI 69423. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1984, J AM COLL CARDIOL, V3, P114; [Anonymous], EFAVIRENZ ATAZANAVIR; [Anonymous], 2002, ECRI EV REP PAT REAS; [Anonymous], ONCE DAILY PI NNRTI; Barros Aluisio J D, 2003, BMC Med Res Methodol, V3, P21, DOI 10.1186/1471-2288-3-21; Braunholtz DA, 2001, J CLIN EPIDEMIOL, V54, P217, DOI 10.1016/S0895-4356(00)00305-X; Cheung AM, 2008, J OBSTET GYNAECOL CA, V30, P332, DOI 10.1016/S1701-2163(16)32802-X; Corbie-Smith G, 1999, J GEN INTERN MED, V14, P537, DOI 10.1046/j.1525-1497.1999.07048.x; DELUCCHI KL, 1994, J CONSULT CLIN PSYCH, V62, P569, DOI 10.1037/0022-006X.62.3.569; Elting LS, 2006, CANCER, V106, P2452, DOI 10.1002/cncr.21907; Joseph E, 2006, LANCET, V368, P476, DOI 10.1016/S0140-6736(06)69155-1; Fayter D, 2007, J CLIN EPIDEMIOL, V60, P990, DOI 10.1016/j.jclinepi.2006.12.013; Fischl MA, 2003, J INFECT DIS, V188, P625, DOI 10.1086/377311; Flather M, 2006, CLIN TRIALS, V3, P508, DOI 10.1177/1740774506073464; Gallant JE, 2006, NEW ENGL J MED, V354, P251, DOI 10.1056/NEJMoa051871; Gallant JE, 2004, JAMA-J AM MED ASSOC, V292, P191, DOI 10.1001/jama.292.2.191; Gifford AL, 2002, NEW ENGL J MED, V346, P1373, DOI 10.1056/NEJMsa011565; Gulick RM, 2004, NEW ENGL J MED, V350, P1850, DOI 10.1056/NEJMoa031772; Hollis S, 2002, STAT MED, V21, P3823, DOI 10.1002/sim.1276; Kalayjian RC, 2003, J INFECT DIS, V187, P1924, DOI 10.1086/375372; King SB, 1997, AM J CARDIOL, V79, P1453, DOI 10.1016/S0002-9149(97)00170-7; Lampe FC, 2006, ARCH INTERN MED, V166, P521, DOI 10.1001/archinte.166.5.521; Lantos JD, 1999, J PEDIATR-US, V134, P130, DOI 10.1016/S0022-3476(99)70400-2; McKay JR, 1998, J CONSULT CLIN PSYCH, V66, P697, DOI 10.1037/0022-006X.66.4.697; McNutt LA, 2003, AM J EPIDEMIOL, V157, P940, DOI 10.1093/aje/kwg074; Mildvan DTC, 2007, 14 C RETR OPP INF LO; Moore RD, 2005, JAIDS-J ACQ IMM DEF, V39, P195; Murphy RL, 2001, AIDS, V15, pF1, DOI 10.1097/00002030-200101050-00002; Napravnik S, 2005, JAIDS-J ACQ IMM DEF, V40, P34, DOI 10.1097/01.qai.0000174929.87015.d6; Napravnik S, 2006, AIDS CARE, V18, pS45, DOI 10.1080/09540120600838928; Peppercorn JM, 2004, LANCET, V363, P263, DOI 10.1016/S0140-6736(03)15383-4; Phillips AN, 1999, AIDS, V13, P2075, DOI 10.1097/00002030-199910220-00010; Riddler SA, 2008, NEW ENGL J MED, V358, P2095, DOI 10.1056/NEJMoa074609; Robbins GK, 2003, NEW ENGL J MED, V349, P2293, DOI 10.1056/NEJMoa030264; Sabin CA, 2001, J ANTIMICROB CHEMOTH, V47, P371, DOI 10.1093/jac/47.4.371; Shafer RW, 2003, NEW ENGL J MED, V349, P2304, DOI 10.1056/NEJMoa030265; Silverman William A, 2002, J Perinatol, V22, P261, DOI 10.1038/sj.jp.7210700; Staszewski S, 1999, NEW ENGL J MED, V341, P1865, DOI 10.1056/NEJM199912163412501; STILLER CA, 1994, BRIT J CANCER, V70, P352, DOI 10.1038/bjc.1994.306; STRANDBERG TE, 1995, BRIT HEART J, V74, P449; The European Agency for the Evaluation of Medicinal Products, 2001, EV MED HUM US; Vist GE, 2005, BMJ-BRIT MED J, V330, P1175, DOI 10.1136/bmj.330.7501.1175; Walmsley S, 2002, NEW ENGL J MED, V346, P2039, DOI 10.1056/NEJMoa012354; WILLIFORD WO, 1993, J CLIN EPIDEMIOL, V46, P1025, DOI 10.1016/0895-4356(93)90170-6; ZOLOPA A, 2008, 15 C RETR OPP INF BO; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	46	12	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2011	6	7							e21824	10.1371/journal.pone.0021824	http://dx.doi.org/10.1371/journal.pone.0021824			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	792WQ	21765918	Green Published, Green Submitted, gold			2022-12-27	WOS:000292781500019
J	Zhuang, K; Finzi, A; Tasca, S; Shakirzyanova, M; Knight, H; Westmoreland, S; Sodroski, J; Cheng-Mayer, C				Zhuang, Ke; Finzi, Andres; Tasca, Silvana; Shakirzyanova, Madina; Knight, Heather; Westmoreland, Susan; Sodroski, Joseph; Cheng-Mayer, Cecilia			Adoption of an "Open" Envelope Conformation Facilitating CD4 Binding and Structural Remodeling Precedes Coreceptor Switch in R5 SHIV-Infected Macaques	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; T-CELL DEPLETION; INCREASED NEUTRALIZATION SENSITIVITY; SYNCYTIUM-INDUCING PHENOTYPE; SOLUBLE CD4; MACROPHAGE-TROPISM; TYPE-1 INFECTION; HIV-1 INFECTION; IN-VIVO; ENTRY INHIBITORS	A change in coreceptor preference from CCR5 to CXCR4 towards the end stage disease in some HIV-1 infected individuals has been well documented, but the reasons and mechanisms for this tropism switch remain elusive. It has been suggested that envelope structural constraints in accommodating amino acid changes required for CXCR4 usage is an obstacle to tropism switch, limiting the rate and pathways available for HIV-1 coreceptor switching. The present study was initiated in two R5 SHIV(SF162P3N)-infected rapid progressor macaques with coreceptor switch to test the hypothesis that an early step in the evolution of tropism switch is the adoption of a less constrained and more "open" envelope conformation for better CD4 usage, allowing greater structural flexibility to accommodate further mutational changes that confer CXCR4 utilization. We show that, prior to the time of coreceptor switch, R5 viruses in both macaques evolved to become increasingly sCD4-sensitive, suggestive of enhanced exposure of the CD4 binding site and an "open" envelope conformation, and this correlated with better gp120 binding to CD4 and with more efficient infection of CD4(low) cells such as primary macrophages. Moreover, significant changes in neutralization sensitivity to agents and antibodies directed against functional domains of gp120 and gp41 were seen for R5 viruses close to the time of X4 emergence, consistent with global changes in envelope configuration and structural plasticity. These observations in a simian model of R5-to-X4 evolution provide a mechanistic basis for the HIV-1 coreceptor switch.	[Zhuang, Ke; Tasca, Silvana; Shakirzyanova, Madina; Cheng-Mayer, Cecilia] Aaron Diamond AIDS Res Ctr, New York, NY USA; [Finzi, Andres; Sodroski, Joseph] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Canc Immunol & AIDS,Dept Pathol,Div AIDS, Boston, MA 02115 USA; [Knight, Heather; Westmoreland, Susan] Harvard Univ, Sch Med, New England Primate Res Ctr, Div Comparat Pathol, Southborough, MA 01772 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University	Zhuang, K (corresponding author), Aaron Diamond AIDS Res Ctr, New York, NY USA.	cmayer@adarc.org		Finzi, Andres/0000-0002-4992-5288	NIH [RO1AI46980, R37AI41945]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI041945, R37AI024755, R01AI046980] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The work was supported by NIH grants RO1AI46980 and R37AI41945. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander M, 2010, J VIROL, V84, P4100, DOI 10.1128/JVI.02068-09; Bannert N, 2000, J VIROL, V74, P10984, DOI 10.1128/JVI.74.23.10984-10993.2000; Berger EA, 1997, AIDS, V11, pS3; Berkowitz RD, 1998, J VIROL, V72, P10108, DOI 10.1128/JVI.72.12.10108-10117.1998; Blaak H, 2000, P NATL ACAD SCI USA, V97, P1269, DOI 10.1073/pnas.97.3.1269; BOUHABIB DC, 1994, J VIROL, V68, P6006, DOI 10.1128/JVI.68.9.6006-6013.1994; Brenchley JM, 2004, J EXP MED, V200, P749, DOI 10.1084/jem.20040874; Brown CR, 2007, J VIROL, V81, P5594, DOI 10.1128/JVI.00202-07; Brumme ZL, 2005, J INFECT DIS, V192, P466, DOI 10.1086/431519; Bunnik EM, 2007, J VIROL, V81, P525, DOI 10.1128/JVI.01983-06; BURTON DR, 1994, SCIENCE, V266, P1024, DOI 10.1126/science.7973652; Casper C, 2002, AIDS RES HUM RETROV, V18, P343, DOI 10.1089/088922202753519124; Chan DC, 1998, CELL, V93, P681, DOI 10.1016/S0092-8674(00)81430-0; CHOWDHURY IH, 1991, MED MICROBIOL IMMUN, V180, P183, DOI 10.1007/BF00215247; Cocchi F, 1996, NAT MED, V2, P1244, DOI 10.1038/nm1196-1244; Coetzer M, 2008, J VIROL, V82, P11758, DOI 10.1128/JVI.01141-08; COFFIN JM, 1995, SCIENCE, V267, P483, DOI 10.1126/science.7824947; CONNOR RI, 1995, VIROLOGY, V206, P935, DOI 10.1006/viro.1995.1016; DEJONG JJ, 1992, J VIROL, V66, P6777, DOI 10.1128/JVI.66.11.6777-6780.1992; Demarest JF, 2001, AIDS RES HUM RETROV, V17, P1333, DOI 10.1089/08892220152596597; Derdeyn CA, 2001, J VIROL, V75, P8605, DOI 10.1128/JVI.75.18.8605-8614.2001; Etemad B, 2009, J VIROL, V83, P9694, DOI 10.1128/JVI.00925-09; FOUCHIER RAM, 1992, J VIROL, V66, P3183, DOI 10.1128/JVI.66.5.3183-3187.1992; Furuta RA, 1998, NAT STRUCT BIOL, V5, P276, DOI 10.1038/nsb0498-276; Ganeshan S, 1997, J VIROL, V71, P663, DOI 10.1128/JVI.71.1.663-677.1997; GORNY MK, 1993, J IMMUNOL, V150, P635; Gray L, 2005, VIROLOGY, V337, P384, DOI 10.1016/j.virol.2005.04.034; GROENINK M, 1995, J VIROL, V69, P523, DOI 10.1128/JVI.69.1.523-527.1995; Haim H, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000360; HART TK, 1991, P NATL ACAD SCI USA, V88, P2189, DOI 10.1073/pnas.88.6.2189; Ho SH, 2008, J VIROL, V82, P5653, DOI 10.1128/JVI.00145-08; Ho SH, 2007, J VIROL, V81, P8621, DOI 10.1128/JVI.00759-07; Ho SH, 2006, J VIROL, V80, P6487, DOI 10.1128/JVI.02539-05; Husman AMD, 1997, ANN INTERN MED, V127, P882, DOI 10.7326/0003-4819-127-10-199711150-00004; HWANG SS, 1992, SCIENCE, V257, P535, DOI 10.1126/science.1636088; HWANG SS, 1991, SCIENCE, V253, P71, DOI 10.1126/science.1905842; Isaacman-Beck J, 2009, J VIROL, V83, P8208, DOI 10.1128/JVI.00296-09; Jansson M, 1996, P NATL ACAD SCI USA, V93, P15382, DOI 10.1073/pnas.93.26.15382; Jensen Mark A., 2003, AIDS Reviews, V5, P104; JIANG SB, 1993, NATURE, V365, P113, DOI 10.1038/365113a0; KABAT D, 1994, J VIROL, V68, P2570, DOI 10.1128/JVI.68.4.2570-2577.1994; Karlsson I, 2004, J VIROL, V78, P11807, DOI 10.1128/JVI.78.21.11807-11815.2004; Kassaye S, 2009, JAIDS-J ACQ IMM DEF, V50, P9, DOI 10.1097/QAI.0b013e31818ffdff; Kolchinsky P, 2001, J VIROL, V75, P2041, DOI 10.1128/JVI.75.5.2041-2050.2001; Koning FA, 2003, J INFECT DIS, V188, P864, DOI 10.1086/377105; KOOT M, 1993, ANN INTERN MED, V118, P681, DOI 10.7326/0003-4819-118-9-199305010-00004; Koshiba T, 2003, J BIOL CHEM, V278, P7573, DOI 10.1074/jbc.M211154200; Kozak SL, 1997, J VIROL, V71, P873, DOI 10.1128/JVI.71.2.873-882.1997; KUIKEN CL, 1992, J VIROL, V66, P4622, DOI 10.1128/JVI.66.7.4622-4627.1992; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; Li S, 1999, J VIROL, V73, P9741, DOI 10.1128/JVI.73.12.9741-9755.1999; Liu SL, 1997, J VIROL, V71, P4284, DOI 10.1128/JVI.71.6.4284-4295.1997; Low AJ, 2008, AIDS RES HUM RETROV, V24, P219, DOI 10.1089/aid.2007.0140; Lusso P, 2005, J VIROL, V79, P6957, DOI 10.1128/JVI.79.11.6957-6968.2005; Malim MH, 2001, CELL, V104, P469, DOI 10.1016/S0092-8674(01)00234-3; Markovic I, 2004, CURR HIV RES, V2, P223, DOI 10.2174/1570162043351327; MARTINRICO P, 1995, AIDS, V9, P95; Mattapallil JJ, 1998, J VIROL, V72, P6421, DOI 10.1128/JVI.72.8.6421-6429.1998; Means RE, 2001, J VIROL, V75, P3903, DOI 10.1128/JVI.75.8.3903-3915.2001; Michael NL, 1997, J INFECT DIS, V175, P1352, DOI 10.1086/516467; MIEDEMA F, 1990, IMMUNOL TODAY, V11, P293, DOI 10.1016/0167-5699(90)90116-Q; Miller ED, 2001, J VIROL, V75, P8498, DOI 10.1128/JVI.75.18.8498-8506.2001; Montagnier L, 1997, J INFECT DIS, V175, P955, DOI 10.1086/513999; MOORE JP, 1990, SCIENCE, V250, P1139, DOI 10.1126/science.2251501; MOORE JP, 1992, J VIROL, V66, P235, DOI 10.1128/JVI.66.1.235-243.1992; Moore JP, 2004, AIDS RES HUM RETROV, V20, P111, DOI 10.1089/088922204322749567; Mori K, 2000, J VIROL, V74, P10852, DOI 10.1128/JVI.74.22.10852-10859.2000; Moyle GJ, 2005, J INFECT DIS, V191, P866, DOI 10.1086/428096; OBRIEN WA, 1992, J VIROL, V66, P3125, DOI 10.1128/JVI.66.5.3125-3130.1992; OKA S, 1994, AIDS RES HUM RETROV, V10, P271, DOI 10.1089/aid.1994.10.271; Orenstein JM, 1997, SCIENCE, V276, P1857, DOI 10.1126/science.276.5320.1857; ORLOFF SL, 1993, J VIROL, V67, P1461, DOI 10.1128/JVI.67.3.1461-1471.1993; Overbaugh J, 2001, SCIENCE, V292, P1106, DOI 10.1126/science.1059128; Pacheco B, 2008, J VIROL, V82, P346, DOI 10.1128/JVI.01299-07; Pantophlet R, 2006, ANNU REV IMMUNOL, V24, P739, DOI 10.1146/annurev.immunol.24.021605.090557; Pastore C, 2004, J VIROL, V78, P7565, DOI 10.1128/JVI.78.14.7565-7574.2004; Peters PJ, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-5; Peters PJ, 2004, J VIROL, V78, P6915, DOI 10.1128/JVI.78.13.6915-6926.2004; Platt EJ, 1997, J VIROL, V71, P883, DOI 10.1128/JVI.71.2.883-890.1997; Platt EJ, 2005, J VIROL, V79, P4347, DOI 10.1128/JVI.79.7.4347-4356.2005; Platt EJ, 1998, J VIROL, V72, P2855, DOI 10.1128/JVI.72.4.2855-2864.1998; Platt EJ, 2000, AIDS RES HUM RETROV, V16, P871, DOI 10.1089/08892220050042819; Poignard P, 1996, IMMUNOL TODAY, V17, P239, DOI 10.1016/0167-5699(96)10007-4; Puffer BA, 2002, J VIROL, V76, P2595, DOI 10.1128/JVI.76.6.2595-2605.2002; Pugach P, 2004, VIROLOGY, V321, P8, DOI 10.1016/j.virol.2003.12.012; Reeves JD, 2005, J VIROL, V79, P4991, DOI 10.1128/JVI.79.8.4991-4999.2005; Reeves JD, 2002, P NATL ACAD SCI USA, V99, P16249, DOI 10.1073/pnas.252469399; Regoes RR, 2005, TRENDS MICROBIOL, V13, P269, DOI 10.1016/j.tim.2005.04.005; Ren WZ, 2010, J VIROL, V84, P340, DOI 10.1128/JVI.01865-09; Repits J, 2005, J GEN VIROL, V86, P2859, DOI 10.1099/vir.0.81111-0; Rizzuto CD, 1998, SCIENCE, V280, P1949, DOI 10.1126/science.280.5371.1949; Salazar-Gonzalez JF, 2009, J EXP MED, V206, P1273, DOI 10.1084/jem.20090378; SATTENTAU QJ, 1991, J EXP MED, V174, P407, DOI 10.1084/jem.174.2.407; Scarlatti G, 1997, NAT MED, V3, P1259, DOI 10.1038/nm1197-1259; SCHUITEMAKER H, 1992, J VIROL, V66, P1354, DOI 10.1128/JVI.66.3.1354-1360.1992; SCHUITEMAKER H, 1991, J VIROL, V65, P356, DOI 10.1128/JVI.65.1.356-363.1991; Schwartz AJ, 2002, AIDS RES HUM RETROV, V18, P1021, DOI 10.1089/08892220260235380; Scoggins RM, 2000, J VIROL, V74, P3205, DOI 10.1128/JVI.74.7.3205-3216.2000; Shakirzyanova M, 2010, J VIROL, V84, P12862, DOI 10.1128/JVI.01478-10; SHIODA T, 1991, NATURE, V349, P167, DOI 10.1038/349167a0; SULLIVAN N, 1995, J VIROL, V69, P4413, DOI 10.1128/JVI.69.7.4413-4422.1995; TASCA S, 2011, J VIROL, DOI DOI 10.1128/JVI.021510-021510; Tasca S, 2008, J VIROL, V82, P7089, DOI 10.1128/JVI.00570-08; THALI M, 1992, J VIROL, V66, P5516, DOI 10.1128/JVI.66.9.5516-5524.1992; Thomas ER, 2007, VIROLOGY, V360, P105, DOI 10.1016/j.virol.2006.09.036; Trkola A, 1996, NATURE, V384, P184, DOI 10.1038/384184a0; Tuttle DL, 2002, AIDS RES HUM RETROV, V18, P353, DOI 10.1089/088922202753519133; Van Rij RP, 2003, AIDS RES HUM RETROV, V19, P389, DOI 10.1089/088922203765551737; van't Wout AB, 1998, J VIROL, V72, P5099; vantWout AB, 1998, J VIROL, V72, P488; VANTWOUT AB, 1994, J CLIN INVEST, V94, P2060, DOI 10.1172/JCI117560; Veazey RS, 1998, SCIENCE, V280, P427, DOI 10.1126/science.280.5362.427; Walter BL, 2005, J VIROL, V79, P4828, DOI 10.1128/JVI.79.8.4828-4837.2005; Wei XP, 2002, ANTIMICROB AGENTS CH, V46, P1896, DOI 10.1128/AAC.46.6.1896-1905.2002; WILD C, 1993, AIDS RES HUM RETROV, V9, P1051, DOI 10.1089/aid.1993.9.1051; WILD CT, 1994, P NATL ACAD SCI USA, V91, P9770, DOI 10.1073/pnas.91.21.9770; Wu LJ, 1996, NATURE, V384, P179, DOI 10.1038/384179a0; Wyatt R, 1998, NATURE, V393, P705, DOI 10.1038/31514; Yearley JH, 2008, DEV COMP IMMUNOL, V32, P1510, DOI 10.1016/j.dci.2008.06.006	119	18	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2011	6	7							e21350	10.1371/journal.pone.0021350	http://dx.doi.org/10.1371/journal.pone.0021350			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791IA	21760891	Green Published, gold, Green Submitted			2022-12-27	WOS:000292657200010
J	Zhang, JL; Zhang, CY; Chu, TG; Perc, M				Zhang, Jianlei; Zhang, Chunyan; Chu, Tianguang; Perc, Matjaz			Resolution of the Stochastic Strategy Spatial Prisoner's Dilemma by Means of Particle Swarm Optimization	PLOS ONE			English	Article							EVOLUTIONARY GAMES; SOCIAL DILEMMAS; COOPERATION; INDIVIDUALS; SELECTION; RULES	We study the evolution of cooperation among selfish individuals in the stochastic strategy spatial prisoner's dilemma game. We equip players with the particle swarm optimization technique, and find that it may lead to highly cooperative states even if the temptations to defect are strong. The concept of particle swarm optimization was originally introduced within a simple model of social dynamics that can describe the formation of a swarm, i.e., analogous to a swarm of bees searching for a food source. Essentially, particle swarm optimization foresees changes in the velocity profile of each player, such that the best locations are targeted and eventually occupied. In our case, each player keeps track of the highest payoff attained within a local topological neighborhood and its individual highest payoff. Thus, players make use of their own memory that keeps score of the most profitable strategy in previous actions, as well as use of the knowledge gained by the swarm as a whole, to find the best available strategy for themselves and the society. Following extensive simulations of this setup, we find a significant increase in the level of cooperation for a wide range of parameters, and also a full resolution of the prisoner's dilemma. We also demonstrate extreme efficiency of the optimization algorithm when dealing with environments that strongly favor the proliferation of defection, which in turn suggests that swarming could be an important phenomenon by means of which cooperation can be sustained even under highly unfavorable conditions. We thus present an alternative way of understanding the evolution of cooperative behavior and its ubiquitous presence in nature, and we hope that this study will be inspirational for future efforts aimed in this direction.	[Zhang, Jianlei; Zhang, Chunyan; Chu, Tianguang] Peking Univ, State Key Lab Turbulence & Complex Syst, Coll Engn, Beijing 100871, Peoples R China; [Chu, Tianguang] Peking Univ, Key Lab Machine Percept, Minist Educ, Beijing 100871, Peoples R China; [Perc, Matjaz] Univ Maribor, Dept Phys, Fac Nat Sci & Math, SLO-2000 Maribor, Slovenia	Peking University; Peking University; University of Maribor	Zhang, JL (corresponding author), Peking Univ, State Key Lab Turbulence & Complex Syst, Coll Engn, Beijing 100871, Peoples R China.	chutg@pku.edu.cn	Perc, Matjaz/A-5148-2009; Chu, Tianguang/C-3521-2012	Perc, Matjaz/0000-0002-3087-541X; Zhang, Jianlei/0000-0002-9932-9265	National Nature Science Foundation of China [60974064, 60736022]; Specialized Research Fund for the Doctoral Program of Higher Education [20060001013]; Slovenian Research Agency [Z1-2032]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Slovenian Research Agency(Slovenian Research Agency - Slovenia)	This work was supported by the National Nature Science Foundation of China (grant numbers 60974064 and 60736022) and the Specialized Research Fund for the Doctoral Program of Higher Education (grant number 20060001013). MP acknowledges support from the Slovenian Research Agency (grant number Z1-2032). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramson G, 2001, PHYS REV E, V63, DOI 10.1103/PhysRevE.63.030901; Axelrod R., 1984, EVOLUTION COOPERATIO, DOI DOI 10.2307/3323905; Brandt H, 2006, J THEOR BIOL, V239, P183, DOI 10.1016/j.jtbi.2005.08.045; Brandt H, 2005, P NATL ACAD SCI USA, V102, P2666, DOI 10.1073/pnas.0407370102; Cardillo A, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/10/103034; Chen X, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.051120; Doebeli M, 2005, ECOL LETT, V8, P748, DOI 10.1111/j.1461-0248.2005.00773.x; Droz M, 2009, EUR PHYS J B, V71, P579, DOI 10.1140/epjb/e2009-00160-1; Dugatkin LA, 1996, BIOSYSTEMS, V37, P19, DOI 10.1016/0303-2647(95)01542-6; Eberhart R., 1995, P 6 INT S MICR MACH, V43; Eberhart R.C., 1996, COMPUTATIONAL INTELL; Fu F, 2010, J THEOR BIOL, V266, P358, DOI 10.1016/j.jtbi.2010.06.042; Fu F, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.036101; Gomez-Gardenes J, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.108103; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI 10.1016/0022-5193(64)90039-6; HARDIN G, 1968, SCIENCE, V162, P1243, DOI 10.1126/science.162.3859.1243; Hauert C, 2004, NATURE, V428, P643, DOI 10.1038/nature02360; Helbing D, 2009, P NATL ACAD SCI USA, V106, P3680, DOI 10.1073/pnas.0811503106; Hofbauer J, 1998, EVOLUTIONARY GAMES P; Jiang LL, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.036108; Kennedy J, 1995, 1995 IEEE INTERNATIONAL CONFERENCE ON NEURAL NETWORKS PROCEEDINGS, VOLS 1-6, P1942, DOI 10.1109/icnn.1995.488968; Meloni S, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.067101; Nowak MA, 1998, J THEOR BIOL, V194, P561, DOI 10.1006/jtbi.1998.0775; NOWAK MA, 1992, NATURE, V359, P826, DOI 10.1038/359826a0; Nowak MA, 2006, EVOLUTIONARY DYNAMIC; Nowak MA, 2006, SCIENCE, V314, P1560, DOI 10.1126/science.1133755; Pena J, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.016110; Perc M, 2006, NEW J PHYS, V8, DOI 10.1088/1367-2630/8/2/022; Perc M, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.011904; Perc M, 2010, BIOSYSTEMS, V99, P109, DOI 10.1016/j.biosystems.2009.10.003; Perc M, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/3/033027; Pestelacci Enea, 2008, Biological Theory, V3, P139, DOI 10.1162/biot.2008.3.2.139; Poncela J, 2007, NEW J PHYS, V9, DOI 10.1088/1367-2630/9/6/184; Poncela J, 2009, EPL-EUROPHYS LETT, V88, DOI 10.1209/0295-5075/88/38003; Poncela J, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/8/083031; Poncela J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002449; Roca CP, 2009, PHYS LIFE REV, V6, P208, DOI 10.1016/j.plrev.2009.08.001; Rong ZH, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.026101; Santos FC, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.098104; Santos FC, 2006, P NATL ACAD SCI USA, V103, P3490, DOI 10.1073/pnas.0508201103; Sigmund K, 2010, PRINC SER THEOR COMP, P1; Szabo G, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.047107; Szabo G, 2009, EPL-EUROPHYS LETT, V87, DOI 10.1209/0295-5075/87/18007; Szabo G, 1998, PHYS REV E, V58, P69, DOI 10.1103/PhysRevE.58.69; Szabo G, 2007, PHYS REP, V446, P97, DOI 10.1016/j.physrep.2007.04.004; Szabo G, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.016106; Szolnoki A, 2007, EPL-EUROPHYS LETT, V77, DOI 10.1209/0295-5075/77/30004; Szolnoki A, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.036110; Szolnoki A, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/9/093033; Tomassini M, 2007, INT J MOD PHYS C, V18, P1173, DOI 10.1142/S0129183107011212; Traulsen A, 2006, P NATL ACAD SCI USA, V103, P10952, DOI 10.1073/pnas.0602530103; Vainstein MH, 2007, J THEOR BIOL, V244, P722, DOI 10.1016/j.jtbi.2006.09.012; Vainstein MH, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.051905; Van Segbroeck S, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.058105; Wang QY, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0015851, 10.1371/journal.pone.0021006]; Wu B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011187; Wu ZX, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.026108; Zimmermann MG, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.065102	58	46	46	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2011	6	7							e21787	10.1371/journal.pone.0021787	http://dx.doi.org/10.1371/journal.pone.0021787			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791HI	21760906	Green Published, gold, Green Submitted			2022-12-27	WOS:000292655400019
J	Vianna, FSL; Lopez-Camelo, JS; Leite, JCL; Sanseverino, MTV; Dutra, MD; Castilla, EE; Schuler-Faccini, L				Luiz Vianna, Fernanda Sales; Lopez-Camelo, Jorge S.; Louguercio Leite, Julio Cesar; Vieira Sanseverino, Maria Teresa; Dutra, Maria da Graca; Castilla, Eduardo E.; Schueler-Faccini, Lavinia			Epidemiological Surveillance of Birth Defects Compatible with Thalidomide Embryopathy in Brazil	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA	The thalidomide tragedy of the 1960s resulted in thousands of children being born with severe limb reduction defects (LRD), among other malformations. In Brazil, there are still babies born with thalidomide embryopathy (TE) because of leprosy prevalence, availability of thalidomide, and deficiencies in the control of drug dispensation. Our objective was to implement a system of proactive surveillance to identify birth defects compatible with TE. Along one year, newborns with LRD were assessed in the Brazilian hospitals participating in the Latin-American Collaborative Study of Congenital Malformations (ECLAMC). A phenotype of LRD called thalidomide embryopathy phenotype (TEP) was established for surveillance. Children with TEP born between the years 2000-2008 were monitored, and during the 2007-2008 period we clinically investigated in greater detail all cases with TEP (proactive period). The period from 1982 to 1999 was defined as the baseline period for the cumulative sum statistics. The frequency of TEP during the surveillance period, at 3.10/10,000 births (CI 95%: 2.50-3.70), was significantly higher than that observed in the baseline period (1.92/10,000 births; CI 95%: 1.60-2.20), and not uniformly distributed across different Brazilian regions. During the proactive surveillance (2007-2008), two cases of suspected TE were identified, although the two mothers had denied the use of the drug during pregnancy. Our results suggest that TEP has probably increased in recent years, which coincides with the period of greater thalidomide availability. Our proactive surveillance identified two newborns with suspected TE, proving to be a sensitive tool to detect TE. The high frequency of leprosy and the large use of thalidomide reinforce the need for a continuous monitoring of TEP across Brazil.	[Luiz Vianna, Fernanda Sales; Louguercio Leite, Julio Cesar; Vieira Sanseverino, Maria Teresa; Schueler-Faccini, Lavinia] Hosp Clin Porto Alegre, Med Genet Serv, Teratogen Informat Serv, INAGEMP, Porto Alegre, RS, Brazil; [Luiz Vianna, Fernanda Sales; Schueler-Faccini, Lavinia] Univ Fed Rio Grande do Sul, Dept Genet, INAGEMP, Porto Alegre, RS, Brazil; [Lopez-Camelo, Jorge S.] IMBICE, ECLAMC, INAGEMP Latin Amer Collaborat Study Congenital Ma, La Plata, Argentina; [Lopez-Camelo, Jorge S.; Castilla, Eduardo E.] CEMIC, ECLAMC, INAGEMP, Buenos Aires, DF, Argentina; [Dutra, Maria da Graca; Castilla, Eduardo E.] Fiocruz MS, Inst Oswaldo Cruz, Lab Epidemiol Malformacoes Congenitas, INAGEMP,ECLAMC, BR-21045900 Rio De Janeiro, Brazil	Universidade Federal do Rio Grande do Sul; Centro de Educacion Medica e Investigaciones Clinicas (CEMIC); Fundacao Oswaldo Cruz	Vianna, FSL (corresponding author), Hosp Clin Porto Alegre, Med Genet Serv, Teratogen Informat Serv, INAGEMP, Porto Alegre, RS, Brazil.	lavinia.faccini@ufrgs.br	SANSEVERINO, MARIA TERESA V/G-3884-2017; Inagemp, Inct/J-9451-2013; Vianna, Fernanda Sales Luiz/O-4337-2019; SCHULER-FACCINI, LAVINIA/C-8309-2013; SCHULER-FACCINI, LAVINIA/K-2927-2016	SANSEVERINO, MARIA TERESA V/0000-0002-7404-2911; SCHULER-FACCINI, LAVINIA/0000-0002-2428-0460; SCHULER-FACCINI, LAVINIA/0000-0002-2428-0460; Lopez-Camelo, Jorge S./0000-0002-3146-5447; Loguercio Leite, Julio Cesar/0000-0002-3551-6811	INCT (National Institute of Science and Technology); National Council of Research (CNPq) [573993/2008-4]	INCT (National Institute of Science and Technology); National Council of Research (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	Funding was provided by INCT (National Institute of Science and Technology), National Council of Research (CNPq), Process nr 573993/2008-4. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	*ANVISA ANDVS, 2003, DIARIO OFICIAL UNIAO; Babcock GD, 2005, BIRTH DEFECTS RES A, V73, P669, DOI 10.1002/bdra.20209; Castilla EE, 1996, TERATOLOGY, V54, P273, DOI 10.1002/(SICI)1096-9926(199612)54:6<273::AID-TERA1>3.0.CO;2-#; Castilla EE, 2003, AM J MED GENET A, V123A, P123, DOI 10.1002/ajmg.a.20230; Castilla EE, 2004, COMMUNITY GENET, V7, P76, DOI 10.1159/000080776; Magalhaes MDC, 2007, EPIDEMIOL SERV SAUDE, V16, P75; DAMATO RJ, 1994, P NATL ACAD SCI USA, V91, P4082, DOI 10.1073/pnas.91.9.4082; *JML, 1985, TECHNOMETRICS; LENZ W, 1988, TERATOLOGY, V38, P203, DOI 10.1002/tera.1420380303; Lenz W, 1961, FRAGEN PRAXIS KINDLI, P2555; LENZ W, 1961, TAG RHEIN KIND DUSS; MCBRIDE, 1961, LANCET; MOREIRA AL, 1993, J EXP MED, V177, P1675, DOI 10.1084/jem.177.6.1675; NEUHAUS G, 1960, Med Klin, V55, P544; NEWMAN CGH, 1986, CLIN PERINATOL, V13, P555, DOI 10.1016/S0095-5108(18)30810-8; Oliveira M A, 1999, Cad Saude Publica, V15, P99, DOI 10.1590/S0102-311X1999000100011; Rosano A, 2000, AM J MED GENET, V93, P110, DOI 10.1002/1096-8628(20000717)93:2<110::AID-AJMG6>3.0.CO;2-9; SAMPAIO EP, 1991, J EXP MED, V173, P699, DOI 10.1084/jem.173.3.699; *SAUD MD, 2008, VIG SAUD SIT EP HANS; Schuler-Faccini L, 2007, BIRTH DEFECTS RES A, V79, P671, DOI 10.1002/bdra.20384; Sheskin J, 1969, Int J Lepr Other Mycobact Dis, V37, P135; SHESKIN J, 1965, CLIN PHARMACOL THER, V6, P303; SMITHELLS RW, 1992, J MED GENET, V29, P716, DOI 10.1136/jmg.29.10.716; Trent S, 2001, DARK REMEDY IMPACT T; Uhl K, 2006, DRUG SAFETY, V29, P321, DOI 10.2165/00002018-200629040-00003; Yang QH, 1997, AM J MED GENET, V73, P251, DOI 10.1002/(SICI)1096-8628(19971219)73:3<251::AID-AJMG4>3.0.CO;2-V; 2011, DIARIO OFICIAL  0322	27	26	28	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2011	6	7							e21735	10.1371/journal.pone.0021735	http://dx.doi.org/10.1371/journal.pone.0021735			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791AK	21754997	Green Published, gold, Green Submitted			2022-12-27	WOS:000292632000023
J	Malcolm, KC; Kret, JE; Young, RL; Poch, KR; Caceres, SM; Douglas, IS; Coldren, CD; Burnham, EL; Moss, M; Nick, JA				Malcolm, Kenneth C.; Kret, Jennifer E.; Young, Robert L.; Poch, Katie R.; Caceres, Silvia M.; Douglas, Ivor S.; Coldren, Chris D.; Burnham, Ellen L.; Moss, Marc; Nick, Jerry A.			Bacteria-Specific Neutrophil Dysfunction Associated with Interferon-Stimulated Gene Expression in the Acute Respiratory Distress Syndrome	PLOS ONE			English	Article							BRONCHOALVEOLAR LAVAGE FLUID; STAPHYLOCOCCUS-AUREUS; PULMONARY INFLAMMATION; BLOOD NEUTROPHILS; INFLUENZA-VIRUS; PROTEIN-KINASE; I INTERFERONS; LIPOPOLYSACCHARIDE; APOPTOSIS; ACTIVATION	Acute respiratory distress syndrome (ARDS) is a poorly understood condition with greater than 30% mortality. Massive recruitment of neutrophils to the lung occurs in the initial stages of the ARDS. Significant variability in the severity and duration of ARDS-associated pulmonary inflammation could be linked to heterogeneity in the inflammatory capacity of neutrophils. Interferon-stimulated genes (ISGs) are a broad gene family induced by Type I interferons. While ISGs are central to anti-viral immunity, the potential exists for these genes to evoke extensive modification in cellular response in other clinical settings. In this prospective study, we sought to determine if ISG expression in circulating neutrophils from ARDS patients is associated with changes in neutrophil function. Circulating neutrophil RNA was isolated, and hierarchical clustering ranked patients' expression of three ISGs. Neutrophil response to pathogenic bacteria was compared between normal and high ISG-expressing neutrophils. High neutrophil ISG expression was found in 25 of 95 (26%) of ARDS patients and was associated with reduced migration toward interleukin-8, and altered responses to Staphylococcus aureus, but not Pseudomonas aeruginosa, which included decreased p38 MAP kinase phosphorylation, superoxide anion release, interleukin-8 release, and a shift from necrotic to apoptotic cell death. These alterations in response were reflected in a decreased capacity to kill S. aureus, but not P. aeruginosa. Therefore, the ISG expression signature is associated with an altered circulating neutrophil response phenotype in ARDS that may predispose a large subgroup of patients to increased risk of specific bacterial infections.	[Malcolm, Kenneth C.; Kret, Jennifer E.; Young, Robert L.; Poch, Katie R.; Caceres, Silvia M.; Nick, Jerry A.] Natl Jewish Hlth, Dept Med, Denver, CO USA; [Malcolm, Kenneth C.; Young, Robert L.; Douglas, Ivor S.; Coldren, Chris D.; Burnham, Ellen L.; Moss, Marc; Nick, Jerry A.] Univ Colorado Denver, Sch Med, Dept Med, Div Pulm Sci & Crit Care Med, Aurora, CO USA; [Douglas, Ivor S.] Denver Hlth Med Ctr, Dept Med, Denver, CO USA	National Jewish Health; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Denver Health Medical Center	Malcolm, KC (corresponding author), Natl Jewish Hlth, Dept Med, Denver, CO USA.	malcolmk@njhealth.org	Douglas, Ivor S/AAC-6245-2021	Douglas, Ivor S/0000-0002-4541-1431; Malcolm, Kenneth/0000-0002-8097-6059	CF Foundation; Rebecca Runyon Bryan Chair for Cystic Fibrosis; NIH [1R01HL090991]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL090991] Funding Source: NIH RePORTER	CF Foundation; Rebecca Runyon Bryan Chair for Cystic Fibrosis; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funding for this study was provided by the CF Foundation, Rebecca Runyon Bryan Chair for Cystic Fibrosis, and NIH 1R01HL090991 to J.A.N. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham E, 2003, CRIT CARE MED, V31, pS195, DOI 10.1097/01.CCM.0000057843.47705.E8; Accola MA, 2002, J BIOL CHEM, V277, P21829, DOI 10.1074/jbc.M201641200; Aggarwal A, 2000, EUR RESPIR J, V15, P895, DOI 10.1034/j.1399-3003.2000.15e14.x; Arnalich F, 2000, INFECT IMMUN, V68, P1942, DOI 10.1128/IAI.68.4.1942-1945.2000; Bogdan C, 2004, IMMUNOL REV, V202, P33, DOI 10.1111/j.0105-2896.2004.00207.x; Borregaard N, 1997, BLOOD, V89, P3503, DOI 10.1182/blood.V89.10.3503.3503_3503_3521; Buckley JM, 2006, J LEUKOCYTE BIOL, V80, P731, DOI 10.1189/jlb.0506312; Carrero JA, 2004, J EXP MED, V200, P535, DOI 10.1084/jem.20040769; Ely EW, 2002, ANN INTERN MED, V136, P25, DOI 10.7326/0003-4819-136-1-200201010-00007; Erwig LP, 2007, AM J PATHOL, V171, P2, DOI 10.2353/ajpath.2007.070135; Fan HK, 2004, J ENDOTOXIN RES, V10, P71, DOI 10.1179/096805104225003997; Fessler MB, 2002, J BIOL CHEM, V277, P31291, DOI 10.1074/jbc.M200755200; Fialkow L, 2006, CRIT CARE, V10, DOI 10.1186/cc5090; Gong MN, 2007, CRIT CARE MED, V35, P48, DOI 10.1097/01.CCM.0000251132.10689.F3; Gong MN, 2005, CRIT CARE MED, V33, P1191, DOI 10.1097/01.CCM.0000165566.82925.14; Goodman RB, 1996, AM J RESP CRIT CARE, V154, P602, DOI 10.1164/ajrccm.154.3.8810593; Gungor N, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-24; Guo JJ, 2000, EMBO J, V19, P6891, DOI 10.1093/emboj/19.24.6891; GUTHRIE LA, 1984, J EXP MED, V160, P1656, DOI 10.1084/jem.160.6.1656; GYLLENHAMMAR H, 1988, J INTERFERON RES, V8, P441, DOI 10.1089/jir.1988.8.441; Halminen M, 1997, PEDIATR RES, V41, P647, DOI 10.1203/00006450-199705000-00008; Hampton MB, 1996, INFECT IMMUN, V64, P3512, DOI 10.1128/IAI.64.9.3512-3517.1996; HASLETT C, 1985, AM J PATHOL, V119, P101; Kelly-Scumpia KM, 2010, J EXP MED, V207, P319, DOI 10.1084/jem.20091959; Kobayashi SD, 2010, J INNATE IMMUN, V2, P560, DOI 10.1159/000317134; Lamb NJ, 1999, CRIT CARE MED, V27, P1738, DOI 10.1097/00003246-199909000-00007; Landolt-Marticorena C, 2009, ANN RHEUM DIS, V68, P1440, DOI 10.1136/ard.2008.093146; Lee KS, 2008, RESP MED, V102, P464, DOI 10.1016/j.rmed.2007.10.001; Lesur O, 2000, CRIT CARE MED, V28, P3814, DOI 10.1097/00003246-200012000-00010; Limaye AP, 2008, JAMA-J AM MED ASSOC, V300, P413, DOI 10.1001/jama.300.4.413; LITTLE R, 1994, J INFECT DIS, V170, P802, DOI 10.1093/infdis/170.4.802; LOEB KR, 1992, J BIOL CHEM, V267, P7806; Malcolm KC, 2003, J BIOL CHEM, V278, P15693, DOI 10.1074/jbc.M212033200; Malcolm KC, 2003, AM J PHYSIOL-LUNG C, V284, pL663, DOI 10.1152/ajplung.00094.2002; Mancuso G, 2007, J IMMUNOL, V178, P3126, DOI 10.4049/jimmunol.178.5.3126; MARTIN TR, 1991, AM REV RESPIR DIS, V144, P254, DOI 10.1164/ajrccm/144.2.254; Martinelli S, 2004, J BIOL CHEM, V279, P44123, DOI 10.1074/jbc.M405883200; Mascellino MT, 2001, J MED MICROBIOL, V50, P49, DOI 10.1099/0022-2615-50-1-49; McCullers JA, 2006, CLIN MICROBIOL REV, V19, P571, DOI 10.1128/CMR.00058-05; Moss M, 2000, CRIT CARE MED, V28, P2187, DOI 10.1097/00003246-200007000-00001; Nick JA, 2004, BLOOD, V104, P3878, DOI 10.1182/blood-2004-06-2140; Nick JA, 2002, J IMMUNOL, V169, P5260, DOI 10.4049/jimmunol.169.9.5260; Nick JA, 1999, J CLIN INVEST, V103, P851, DOI 10.1172/JCI5257; O'Connell RM, 2004, J EXP MED, V200, P437, DOI 10.1084/jem.20040712; Owhashi M, 2003, BIOCHEM BIOPH RES CO, V309, P533, DOI 10.1016/j.bbrc.2003.08.038; Pichlmair A, 2007, IMMUNITY, V27, P370, DOI 10.1016/j.immuni.2007.08.012; Ramilo O, 2007, BLOOD, V109, P2066, DOI 10.1182/blood-2006-02-002477; RIVKIND AI, 1991, CIRC SHOCK, V33, P48; ROERS A, 1994, J INFECT DIS, V169, P807, DOI 10.1093/infdis/169.4.807; Rothberg MB, 2008, AM J MED, V121, P258, DOI 10.1016/j.amjmed.2007.10.040; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Sakamoto E, 2005, J LEUKOCYTE BIOL, V78, P301, DOI 10.1189/jlb.1104690; SELLERS TF, 1961, J EXP MED, V114, P237, DOI 10.1084/jem.114.2.237; Shiloh MU, 1997, INFECT IMMUN, V65, P3193, DOI 10.1128/IAI.65.8.3193-3198.1997; Stetson DB, 2006, IMMUNITY, V25, P373, DOI 10.1016/j.immuni.2006.08.007; Stockinger S, 2002, J IMMUNOL, V169, P6522, DOI 10.4049/jimmunol.169.11.6522; Tsangaris I, 2009, THROMB RES, V123, P832, DOI 10.1016/j.thromres.2008.07.018; Voyich JA, 2005, J IMMUNOL, V175, P3907, DOI 10.4049/jimmunol.175.6.3907; Wang KQ, 2003, J IMMUNOL, V171, P1035, DOI 10.4049/jimmunol.171.2.1035; Wright HJ, 2008, J IMMUNOL, V181, P5775, DOI 10.4049/jimmunol.181.8.5775; Zaas AK, 2009, CELL HOST MICROBE, V6, P207, DOI 10.1016/j.chom.2009.07.006	61	11	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2011	6	7							e21958	10.1371/journal.pone.0021958	http://dx.doi.org/10.1371/journal.pone.0021958			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791AK	21755013	Green Published, gold, Green Submitted			2022-12-27	WOS:000292632000040
J	Markovets, AM; Fursova, AZ; Kolosova, NG				Markovets, Anton M.; Fursova, Anzhella Z.; Kolosova, Natalia G.			Therapeutic Action of the Mitochondria-Targeted Antioxidant SkQ1 on Retinopathy in OXYS Rats Linked with Improvement of VEGF and PEDF Gene Expression	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; RETINAL-PIGMENT EPITHELIUM; MACULAR DEGENERATION; SENESCENCE; CATARACT; DYNAMICS; VISION; EYE	The incidence of age-related macular degeneration (AMD), the main cause of blindness in older patients in the developed countries, is increasing with the ageing population. At present there is no effective treatment for the prevailing geographic atrophy, dry AMD, whereas antiangiogenic therapies successful used in managing the wet form of AMD. Recently we showed that mitochondria-targeted antioxidant plastoquinonyl-decyl-triphenylphosphonium (SkQ1) is able to prevent the development and moreover caused regression of pre-existing signs of the retinopathy in OXYS rats, an animal model of AMD. Here we examine the effects of SkQ1 on expression of key regulators of angiogenesis vascular endothelial growth factor A (VEGF) and its antagonist pigment epithelium-derived factor (PEDF) genes in the retina of OXYS rats as evidenced by real-time PCR and an ELISA test for VEGF using Wistar rats as control. Ophthalmoscopic examinations confirmed that SkQ1 supplementation (from 1.5 to 3 months of age, 250 nmol/kg) prevented development while eye drops SkQ1 (250 nM, from 9 to 12 months) caused some reduction of retinopathy signs in OXYS rats and did not reveal any negative effects on the control Wistar rat's retina. Prevention of premature retinopathy by SkQ1 was connected with an increase of VEGF mRNA and protein in OXYS rat's retina up to the levels corresponding to the Wistar rats, and did not involve changes in PEDF expression. In contrast the treatment with SkQ1 drops caused a decrease of VEGF mRNA and protein levels and an increase in the PEDF mRNA level in the middle-aged OXYS rats, but in Wistar rats the changes of gene expression were the opposite. Conclusions: The beneficial effects of SkQ1 on retinopathy connected with normalization of expression of VEGF and PEDF in the retina of OXYS rats and depended on age of the animals and the stage of retinopathy.	[Markovets, Anton M.; Fursova, Anzhella Z.; Kolosova, Natalia G.] Russian Acad Sci, Inst Cytol & Genet, Siberian Branch, SB RAS, Novosibirsk 630090, Russia	Russian Academy of Sciences; Institute of Cytology & Genetics ICG SB RAS	Markovets, AM (corresponding author), Russian Acad Sci, Inst Cytol & Genet, Siberian Branch, SB RAS, Novosibirsk 630090, Russia.	kolosova@bionet.nsc.ru	fursova, anzhella/AAE-1495-2022; Kolosova, Nataliya G/P-3178-2015; Kolosova, Nataliya G/AAR-7409-2020	fursova, anzhella/0000-0001-6311-5452; Kolosova, Nataliya G/0000-0003-2398-8544; Kolosova, Nataliya G/0000-0003-2398-8544	Russian Foundation for Basic Research RFBR [11-04-00666]; presidium of Russian Academy of Science (RAS) [5.11]; FASI [14.740.11.0758]	Russian Foundation for Basic Research RFBR(Russian Foundation for Basic Research (RFBR)); presidium of Russian Academy of Science (RAS)(Russian Academy of Sciences); FASI(Federal Agency for Science & Innovations (FASI))	This work was supported by grants of Russian Foundation for Basic Research RFBR (11-04-00666), presidium of Russian Academy of Science (RAS) (5.11) and FASI state contract 14.740.11.0758. The funders had no role in study design, datacollection and analysis, decision to publish, or preparation of the manuscript.	Bhutto IA, 2006, EXP EYE RES, V82, P99, DOI 10.1016/j.exer.2005.05.007; Chong EWT, 2007, BMJ-BRIT MED J, V335, P755, DOI 10.1136/bmj.39350.500428.47; Feher J, 2006, NEUROBIOL AGING, V27, P983, DOI 10.1016/j.neurobiolaging.2005.05.012; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Filleur S, 2009, J CELL BIOCHEM, V106, P769, DOI 10.1002/jcb.22072; GALE C, 2007, INVEST OPHTH VIS SCI, V44, P2461; Grisanti S, 2008, PROG RETIN EYE RES, V27, P372, DOI 10.1016/j.preteyeres.2008.05.002; Kassoff A, 2001, ARCH OPHTHALMOL-CHIC, V119, P1417, DOI 10.1001/archopht.119.10.1417; KLIFFEN H, 1997, M BR J OPHTHALMOL, V81, P154; Kolosova NG, 2001, B EXP BIOL MED+, V132, P814, DOI 10.1023/A:1013014919721; Kolosova NG, 2003, B EXP BIOL MED+, V136, P415, DOI 10.1023/B:BEBM.0000010967.24302.78; Markovets AM, 2011, AGING-US, V3, P44; Marsili S, 2004, EXP EYE RES, V79, P595, DOI 10.1016/j.exer.2004.06.008; Neroev VV, 2008, BIOCHEMISTRY-MOSCOW+, V73, P1317, DOI 10.1134/S0006297908120043; Nolan T, 2006, NAT PROTOC, V1, P1559, DOI 10.1038/nprot.2006.236; Obukhova LA, 2009, AGING-US, V1, P389, DOI 10.18632/aging.100043; Patten DA, 2010, MOL BIOL CELL, V21, P3247, DOI 10.1091/mbc.E10-01-0025; Saprunova VB, 2010, BIOCHEMISTRY-MOSCOW+, V75, P130, DOI 10.1134/S0006297910020021; Severin FF, 2010, P NATL ACAD SCI USA, V107, P663, DOI 10.1073/pnas.0910216107; Shabalina I. G., 1995, Biokhimiya, V60, P441; Skulachev VP, 2007, BIOCHEMISTRY-MOSCOW+, V72, P1385, DOI 10.1134/S0006297907120139; Skulachev VP, 2009, BBA-BIOENERGETICS, V1787, P437, DOI 10.1016/j.bbabio.2008.12.008; SOLOVEVA NA, 1975, GENETIKA+, V11, P63; Spilsbury K, 2000, AM J PATHOL, V157, P135, DOI 10.1016/S0002-9440(10)64525-7; Tan JSL, 2007, OPHTHALMOLOGY, V114, P1143, DOI 10.1016/j.ophtha.2006.09.033; Witmer AN, 2002, J HISTOCHEM CYTOCHEM, V50, P767, DOI 10.1177/002215540205000603; Wolf S, 2008, JPN J OPHTHALMOL, V52, P433, DOI 10.1007/s10384-008-0580-4; Zhdankina AA, 2008, B EXP BIOL MED+, V146, P455, DOI 10.1007/s10517-009-0298-4	28	42	47	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2011	6	7							e21682	10.1371/journal.pone.0021682	http://dx.doi.org/10.1371/journal.pone.0021682			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	789JO	21750722	gold, Green Published, Green Submitted			2022-12-27	WOS:000292512000019
J	Mubi, M; Janson, A; Warsame, M; Martensson, A; Kallander, K; Petzold, MG; Ngasala, B; Maganga, G; Gustafsson, LL; Massele, A; Tomson, G; Premji, Z; Bjorkman, A				Mubi, Marycelina; Janson, Annika; Warsame, Marian; Martensson, Andreas; Kallander, Karin; Petzold, Max G.; Ngasala, Billy; Maganga, Gloria; Gustafsson, Lars L.; Massele, Amos; Tomson, Goran; Premji, Zul; Bjorkman, Anders			Malaria Rapid Testing by Community Health Workers Is Effective and Safe for Targeting Malaria Treatment: Randomised Cross-Over Trial in Tanzania	PLOS ONE			English	Article							HOME-BASED MANAGEMENT; DIAGNOSTIC-TESTS; ARTEMETHER-LUMEFANTRINE; COMBINATION THERAPY; UNCOMPLICATED MALARIA; FEBRILE CHILDREN; MICROSCOPY; IMPACT; IMPLEMENTATION; ACCEPTABILITY	Background: Early diagnosis and prompt, effective treatment of uncomplicated malaria is critical to prevent severe disease, death and malaria transmission. We assessed the impact of rapid malaria diagnostic tests (RDTs) by community health workers (CHWs) on provision of artemisinin-based combination therapy (ACT) and health outcome in fever patients. Methodology/Principal Findings: Twenty-two CHWs from five villages in Kibaha District, a high-malaria transmission area in Coast Region, Tanzania, were trained to manage uncomplicated malaria using RDT aided diagnosis or clinical diagnosis (CD) only. Each CHW was randomly assigned to use either RDT or CD the first week and thereafter alternating weekly. Primary outcome was provision of ACT and main secondary outcomes were referral rates and health status by days 3 and 7. The CHWs enrolled 2930 fever patients during five months of whom 1988 (67.8%) presented within 24 hours of fever onset. ACT was provided to 775 of 1457 (53.2%) patients during RDT weeks and to 1422 of 1473 (96.5%) patients during CD weeks (Odds Ratio (OR) 0.039, 95% CI 0.029-0.053). The CHWs adhered to the RDT results in 1411 of 1457 (96.8%, 95% CI 95.8-97.6) patients. More patients were referred on inclusion day during RDT weeks (10.0%) compared to CD weeks (1.6%). Referral during days 1-7 and perceived non-recovery on days 3 and 7 were also more common after RDT aided diagnosis. However, no fatal or severe malaria occurred among 682 patients in the RDT group who were not treated with ACT, supporting the safety of withholding ACT to RDT negative patients. Conclusions/Significance: RDTs in the hands of CHWs may safely improve early and well-targeted ACT treatment in malaria patients at community level in Africa.	[Mubi, Marycelina; Maganga, Gloria; Premji, Zul] Muhimbili Univ Hlth & Allied Sci, Sch Publ Hlth, Dept Parasitol, Dar Es Salaam, Tanzania; [Mubi, Marycelina; Martensson, Andreas; Ngasala, Billy; Bjorkman, Anders] Karolinska Univ Hosp, Karolinska Inst, Dept Med Solna, Infect Dis Unit, Stockholm, Sweden; [Janson, Annika] Karolinska Inst, Dept Clin Sci Intervent & Technol CLINTEC, Div Pediat, Stockholm, Sweden; [Warsame, Marian; Kallander, Karin; Tomson, Goran] Karolinska Inst, Dept Publ Hlth Sci, Div Global Hlth IHCAR, Stockholm, Sweden; [Petzold, Max G.] Nordic Sch Publ Hlth, Gothenburg, Sweden; [Ngasala, Billy] Natl Inst Med Res, Dar Es Salaam, Tanzania; [Gustafsson, Lars L.] Karolinska Inst, Dept Lab Med, Div Clin Pharmacol, Stockholm, Sweden; [Massele, Amos] Muhimbili Univ Hlth & Allied Sci, Sch Med, Dept Clin Pharmacol, Dar Es Salaam, Tanzania	Muhimbili University of Health & Allied Sciences; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska Institutet; National Institute of Medical Research; Karolinska Institutet; Muhimbili University of Health & Allied Sciences	Mubi, M (corresponding author), Muhimbili Univ Hlth & Allied Sci, Sch Publ Hlth, Dept Parasitol, Dar Es Salaam, Tanzania.	anders.bjorkman@karolinska.se	Janson, Annika/ABC-8489-2020; Gustafsson, Lars/G-3902-2010	Janson, Annika/0000-0001-5106-5670; Gustafsson, Lars Lennart/0000-0002-0063-552X; Tomson, Goran/0000-0001-9222-3604; Massele, Amos/0000-0003-3816-2040; Kallander, Karin/0000-0002-5778-5780	Muhimbili University of Health and Allied Sciences [Bil-T2 16/9875007059]; Karolinska Institutet [Bil-T2 16/9875007059]	Muhimbili University of Health and Allied Sciences; Karolinska Institutet(Karolinska Institutet)	The study was financed by Sida/SAREC in the framework of a collaborative Malaria Project between Muhimbili University of Health and Allied Sciences and Karolinska Institutet (Bil-T2 16/9875007059). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajayi IO, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-6; Ajayi IO, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-24; Al-Taiar A, 2008, TROP MED INT HEALTH, V13, P762, DOI 10.1111/j.1365-3156.2008.02066.x; Ansah EK, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c930; Bell D, 2006, NAT REV MICROBIOL, V4, P682, DOI 10.1038/nrmicro1474; Bhattarai A, 2007, PLOS MED, V4, P1784, DOI 10.1371/journal.pmed.0040309; Binka FN, 2007, TROP MED INT HEALTH, V12, P578, DOI 10.1111/j.1365-3156.2007.01826.x; Bisoffi Z, 2009, TROP MED INT HEALTH, V14, P491, DOI 10.1111/j.1365-3156.2009.02246.x; Bjorkman A, 2010, CLIN INFECT DIS, V51, P512, DOI 10.1086/655689; Chanda Pascalina, 2009, Cost Eff Resour Alloc, V7, P5, DOI 10.1186/1478-7547-7-5; Chinbuah AM, 2006, TROP MED INT HEALTH, V11, P1003, DOI 10.1111/j.1365-3156.2006.01654.x; Cho MN, 2002, ACTA TROP, V81, P13, DOI 10.1016/S0001-706X(01)00189-9; d'Acremont V, 2010, CLIN INFECT DIS, V51, P506, DOI 10.1086/655688; D'Acremont V, 2009, PLOS MED, V6, P4, DOI 10.1371/journal.pmed.0050252; Dondorp AM, 2009, NEW ENGL J MED, V361, P455, DOI 10.1056/NEJMoa0808859; English M, 2009, PLOS MED, V6, P7, DOI 10.1371/journal.pmed.1000015; Gitonga CW, 2008, TROP MED INT HEALTH, V13, P487, DOI 10.1111/j.1365-3156.2008.02026.x; Haines A, 2007, LANCET, V369, P2121, DOI 10.1016/S0140-6736(07)60325-0; Hamer DH, 2007, JAMA-J AM MED ASSOC, V297, P2227, DOI 10.1001/jama.297.20.2227; Hanscheid T, 1999, CLIN LAB HAEMATOL, V21, P235, DOI 10.1046/j.1365-2257.1999.00220.x; Hopkins H, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-134; Hopkins H, 2008, J INFECT DIS, V197, P510, DOI 10.1086/526502; Houze S, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-211; Kerry SM, 1998, BRIT MED J, V316, P1455, DOI 10.1136/bmj.316.7142.1455; Kidane G, 2000, LANCET, V356, P550, DOI 10.1016/S0140-6736(00)02580-0; Kyabayinze DJ, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-221; Lubell Y, 2008, BMJ-BRIT MED J, V336, P202, DOI 10.1136/bmj.39395.696065.47; McMorrow ML, 2008, AM J TROP MED HYG, V79, P385, DOI 10.4269/ajtmh.2008.79.385; Moody A, 2002, CLIN MICROBIOL REV, V15, P66, DOI 10.1128/CMR.15.1.66-78.2002; Msellem MI, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000070; National Bureau of Statistics & MACRO, 2010, TANZ DEM HLTH SURV 2; Nicastri E, 2009, AM J TROP MED HYG, V80, P712, DOI 10.4269/ajtmh.2009.80.712; *NMCP, 2006, NAT GUID MAL DIAGN T; PREMJI Z, 1994, T ROY SOC TROP MED H, V88, P418, DOI 10.1016/0035-9203(94)90409-X; Rafael Maria E, 2006, Nature, V444 Suppl 1, P39, DOI 10.1038/nature05445; Reyburn H, 2007, BRIT MED J, V334, P403, DOI 10.1136/bmj.39073.496829.AE; Sisowath C, 2005, J INFECT DIS, V191, P1014, DOI 10.1086/427997; Skarbinski J, 2009, AM J TROP MED HYG, V80, P919; Swarthout TD, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-58; WHO, 2010, GUID TREATM MAL, V2nd; WHO, 2004, SCAL HOM BAS MAN MAL; Willcox ML, 2009, ANN TROP MED PARASIT, V103, P3, DOI 10.1179/136485909X384983; Wongsrichanalai C, 2007, AM J TROP MED HYG, V77, P119, DOI 10.4269/ajtmh.2007.77.119; World Health Organization, 2008, WORLD MAL REP; Yeboah-Antwi K, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000340	45	92	93	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2011	6	7							e19753	10.1371/journal.pone.0019753	http://dx.doi.org/10.1371/journal.pone.0019753			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	789JO	21750697	Green Published, gold, Green Submitted			2022-12-27	WOS:000292512000004
J	Redman, RS; Kim, YO; Woodward, CJDA; Greer, C; Espino, L; Doty, SL; Rodriguez, RJ				Redman, Regina S.; Kim, Yong Ok; Woodward, Claire J. D. A.; Greer, Chris; Espino, Luis; Doty, Sharon L.; Rodriguez, Rusty J.			Increased Fitness of Rice Plants to Abiotic Stress Via Habitat Adapted Symbiosis: A Strategy for Mitigating Impacts of Climate Change	PLOS ONE			English	Article							MONOCOT-DICOT DIVERGENCE; PHENOTYPIC PLASTICITY; PIRIFORMOSPORA-INDICA; TOLERANCE; GROWTH; CONSTRAINTS; RESISTANCE; DIVERSITY; EVOLUTION; PHENOLOGY	Climate change and catastrophic events have contributed to rice shortages in several regions due to decreased water availability and soil salinization. Although not adapted to salt or drought stress, two commercial rice varieties achieved tolerance to these stresses by colonizing them with Class 2 fungal endophytes isolated from plants growing across moisture and salinity gradients. Plant growth and development, water usage, ROS sensitivity and osmolytes were measured with and without stress under controlled conditions. The endophytes conferred salt, drought and cold tolerance to growth chamber and greenhouse grown plants. Endophytes reduced water consumption by 20-30% and increased growth rate, reproductive yield, and biomass of greenhouse grown plants. In the absence of stress, there was no apparent cost of the endophytes to plants, however, endophyte colonization decreased from 100% at planting to 65% compared to greenhouse plants grown under continual stress (maintained 100% colonization). These findings indicate that rice plants can exhibit enhanced stress tolerance via symbiosis with Class 2 endophytes, and suggest that symbiotic technology may be useful in mitigating impacts of climate change on other crops and expanding agricultural production onto marginal lands.	[Redman, Regina S.; Kim, Yong Ok; Woodward, Claire J. D. A.; Doty, Sharon L.; Rodriguez, Rusty J.] US Geol Survey, Western Fisheries Res Ctr, Seattle, WA USA; [Redman, Regina S.] Univ Washington, Coll Forest Resources, Seattle, WA 98195 USA; [Redman, Regina S.; Kim, Yong Ok; Woodward, Claire J. D. A.; Rodriguez, Rusty J.] Univ Washington, Dept Biol, Seattle, WA 98195 USA; [Greer, Chris] Univ Calif Cooperat Extens, Yuba City, CA USA; [Espino, Luis] Univ Calif Cooperat Extens, Colusa, CA USA	United States Department of the Interior; United States Geological Survey; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of California System; University of California System	Redman, RS (corresponding author), US Geol Survey, Western Fisheries Res Ctr, Seattle, WA USA.	redmanr@u.washington.edu		Doty, Sharon/0000-0002-9546-315X	California Rice Research Board [RM-6]; United States Geological Survey; National Science Foundation [0414463]; United States-Israel Binational Agricultural Research and Development Fund [3260-01C]; Direct For Biological Sciences [0950447] Funding Source: National Science Foundation	California Rice Research Board; United States Geological Survey(United States Geological Survey); National Science Foundation(National Science Foundation (NSF)); United States-Israel Binational Agricultural Research and Development Fund(US-Israel Binational Science Foundation); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This project was made possible by the permission, assistance, and guidelines of Yellowstone National Park and the University of Washington Cedar Rocks Biological Preserve. This work was supported by the California Rice Research Board (RM-6; 2007, 2008, 2009), United States Geological Survey, and support funding from the National Science Foundation (0414463) and United States-Israel Binational Agricultural Research and Development Fund (3260-01C). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2006, MICROBIAL ROOT ENDOP; Apel K, 2004, ANNU REV PLANT BIOL, V55, P373, DOI 10.1146/annurev.arplant.55.031903.141701; Arnold AE, 2003, P NATL ACAD SCI USA, V100, P15649, DOI 10.1073/pnas.2533483100; Bacon C. W., 1996, P155; Bartels D, 2005, CRIT REV PLANT SCI, V24, P23, DOI 10.1080/07352680590910410; Bertin RI, 2008, J TORREY BOT SOC, V135, P126, DOI 10.3159/07-RP-035R.1; BOHNERT HJ, 1995, PLANT CELL, V7, P1099, DOI 10.1105/tpc.7.7.1099; BRADSHAW A. D., 1965, ADVANCE GENET, V13, P115, DOI 10.1016/S0065-2660(08)60048-6; Chaw SM, 2004, J MOL EVOL, V58, P424, DOI 10.1007/s00239-003-2564-9; Clay K, 1999, SCIENCE, V285, P1742, DOI 10.1126/science.285.5434.1742; FAO, 2005, 20 THINGS KNOW IMP S; Givnish TJ, 2002, EVOL ECOL, V16, P213, DOI 10.1023/A:1019676410041; GORDON SA, 1951, PLANT PHYSIOL, V26, P192, DOI 10.1104/pp.26.1.192; Leone A, 2003, ABIOTIC STRESSES IN PLANTS, P1; Luo Q, 2009, AGR ECOSYST ENVIRON, V129, P261, DOI 10.1016/j.agee.2008.09.010; Marquez LM, 2007, SCIENCE, V315, P513, DOI 10.1126/science.1136237; Pan XY, 2006, ACTA OECOL, V30, P333, DOI 10.1016/j.actao.2006.03.003; Peng SB, 2004, P NATL ACAD SCI USA, V101, P9971, DOI 10.1073/pnas.0403720101; Perelman SB, 2007, J ECOL, V95, P662, DOI 10.1111/j.1365-2745.2007.01255.x; Petrini Orlando, 1996, P87; PIANKA ER, 1966, AM NAT, V100, P33, DOI 10.1086/282398; Redman RS, 2002, SCIENCE, V298, P1581, DOI 10.1126/science.1072191; Redman RS, 2002, SYMBIOSIS, V32, P55; Redman RS, 2001, NEW PHYTOL, V151, P705, DOI 10.1046/j.0028-646x.2001.00210.x; Robe WE, 2000, PLANT CELL ENVIRON, V23, P1041, DOI 10.1046/j.1365-3040.2000.00615.x; RODRIGUEZ RJ, 2009, NEW PHYTOLO IN PRESS; RODRIGUEZ RJ, 2009, COMMUNICATIVE INTEGR, V2, P1; Rodriguez RJ, 2008, ISME J, V2, P404, DOI 10.1038/ismej.2007.106; Sahay NS, 1999, FEMS MICROBIOL LETT, V181, P297, DOI 10.1111/j.1574-6968.1999.tb08858.x; *SAS I INC, 2000, SAS STAT GUID PERS C; Schulz B, 1999, MYCOL RES, V103, P1275, DOI 10.1017/S0953756299008540; Schurr U, 2006, PLANT CELL ENVIRON, V29, P340, DOI 10.1111/j.1365-3040.2005.01490.x; Schwaegerle KE, 2005, EVOLUTION, V59, P1259, DOI 10.1111/j.0014-3820.2005.tb01776.x; Smallwood MF, 1999, PLANT RESPONSES ENV; STEVENS GC, 1989, AM NAT, V133, P240, DOI 10.1086/284913; Stout RG, 2002, ANN BOT-LONDON, V90, P259, DOI 10.1093/aob/mcf174; Sultan SE, 2003, EVOL DEV, V5, P25, DOI 10.1046/j.1525-142X.2003.03005.x; Tao FL, 2006, AGR FOREST METEOROL, V138, P82, DOI 10.1016/j.agrformet.2006.03.014; TU JC, 1985, MICROBIOS, V44, P87; van Kleunen M, 2005, NEW PHYTOL, V166, P49, DOI 10.1111/j.1469-8137.2004.01296.x; VAUGHN KC, 1983, PLANT CELL ENVIRON, V6, P13; Waller F, 2005, P NATL ACAD SCI USA, V102, P13386, DOI 10.1073/pnas.0504423102; WOLFE KH, 1989, P NATL ACAD SCI USA, V86, P6201, DOI 10.1073/pnas.86.16.6201; Yang YW, 1999, J MOL EVOL, V48, P597, DOI 10.1007/PL00006502; Yin XY, 2004, TRENDS PLANT SCI, V9, P426, DOI 10.1016/j.tplants.2004.07.007; Zhou L, 2007, FIELD CROP RES, V100, P294, DOI 10.1016/j.fcr.2006.08.003	46	250	273	5	202	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2011	6	7							e14823	10.1371/journal.pone.0014823	http://dx.doi.org/10.1371/journal.pone.0014823			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	789JO	21750695	Green Published, gold, Green Submitted			2022-12-27	WOS:000292512000002
J	Stewart, CR; Karpala, AJ; Lowther, S; Lowenthal, JW; Bean, AG				Stewart, Cameron R.; Karpala, Adam J.; Lowther, Sue; Lowenthal, John W.; Bean, Andrew G.			Immunostimulatory Motifs Enhance Antiviral siRNAs Targeting Highly Pathogenic Avian Influenza H5N1	PLOS ONE			English	Article							PLASMACYTOID DENDRITIC CELLS; RNA-INTERFERENCE; RIG-I; INDUCTION; VIRUS; ACTIVATION; TRANSCRIPTION; THERAPEUTICS; INHIBITION; VECTORS	Highly pathogenic avian influenza (HPAI) H5N1 virus is endemic in many regions around the world and remains a significant pandemic threat. To date H5N1 has claimed almost 300 human lives worldwide, with a mortality rate of 60% and has caused the death or culling of hundreds of millions of poultry since its initial outbreak in 1997. We have designed multi-functional RNA interference (RNAi)-based therapeutics targeting H5N1 that degrade viral mRNA via the RNAi pathway while at the same time augmenting the host antiviral response by inducing host type I interferon (IFN) production. Moreover, we have identified two factors critical for maximising the immunostimulatory properties of short interfering (si) RNAs in chicken cells (i) mode of synthesis and (ii) nucleoside sequence to augment the response to virus. The 5-bp nucleoside sequence 5'-UGUGU-3' is a key determinant in inducing high levels of expression of IFN -alpha, -beta, -lambda and interleukin 1- beta in chicken cells. Positioning of this 5'-UGUGU-3' motif at the 5'- end of the sense strand of siRNAs, but not the 3'- end, resulted in a rapid and enhanced induction of type I IFN. An anti-H5N1 avian influenza siRNA directed against the PB1 gene (PB1-2257) tagged with 5'-UGUGU-3' induced type I IFN earlier and to a greater extent compared to a non-tagged PB1-2257. Tested against H5N1 in vitro, the tagged PB1-2257 was more effective than non-tagged PB1-2257. These data demonstrate the ability of an immunostimulatory motif to improve the performance of an RNAi-based antiviral, a finding that may influence the design of future RNAi-based anti-influenza therapeutics.	[Stewart, Cameron R.; Karpala, Adam J.; Lowther, Sue; Lowenthal, John W.; Bean, Andrew G.] CSIRO, Australian Anim Hlth Lab, Geelong, Vic, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Stewart, CR (corresponding author), CSIRO, Australian Anim Hlth Lab, Geelong, Vic, Australia.	Cameron.stewart@csiro.au	lowenthal, john w/G-4459-2010; karpala, adam/H-9294-2013; Bean, Andrew G/H-8664-2013; Stewart, Cameron R/E-6823-2011	lowenthal, john w/0000-0002-0548-2497; Bean, Andrew G/0000-0002-4585-3811; Stewart, Cameron/0000-0002-3395-7859; Tripp, Ralph/0000-0002-2924-9956	CSIRO (Commonwealth Science and Industrial Research Organisation)	CSIRO (Commonwealth Science and Industrial Research Organisation)(Commonwealth Scientific & Industrial Research Organisation (CSIRO))	This work was funded by CSIRO (Commonwealth Science and Industrial Research Organisation). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott A, 2003, NATURE, V422, P247, DOI 10.1038/422247b; Barber MRW, 2010, P NATL ACAD SCI USA, V107, P5913, DOI 10.1073/pnas.1001755107; Bridge AJ, 2003, NAT GENET, V34, P263, DOI 10.1038/ng1173; Castanotto D, 2009, NATURE, V457, P426, DOI 10.1038/nature07758; Cyranoski D, 2003, NATURE, V422, P6, DOI 10.1038/422006a; de Fougerolles A, 2007, NAT REV DRUG DISCOV, V6, P443, DOI 10.1038/nrd2310; Gantier MP, 2010, MOL THER, V18, P785, DOI 10.1038/mt.2010.4; Ge Q, 2003, P NATL ACAD SCI USA, V100, P2718, DOI 10.1073/pnas.0437841100; Hawkes RA, 1979, DIAGNOSTIC PROCEDURE, V5th, P3; Hefner E, 2008, J Biomol Tech, V19, P231; Hornung V, 2005, NAT MED, V11, P263, DOI 10.1038/nm1191; Judge AD, 2005, NAT BIOTECHNOL, V23, P457, DOI 10.1038/nbt1081; Karpala AJ, 2008, J INTERF CYTOK RES, V28, P341, DOI 10.1089/jir.2007.0117; Karpala AJ, 2008, DEV COMP IMMUNOL, V32, P435, DOI 10.1016/j.dci.2007.08.004; KARPALA AJ, 2011, J IMMUNOL; Kim DH, 2007, NAT REV GENET, V8, P173, DOI 10.1038/nrg2006; Kim DH, 2004, NAT BIOTECHNOL, V22, P321, DOI 10.1038/nbt940; Kim DH, 2005, NAT BIOTECHNOL, V23, P222, DOI 10.1038/nbt1051; Kleinman ME, 2008, NATURE, V452, P591, DOI 10.1038/nature06765; Layne SP, 2009, SCIENCE, V323, P1560, DOI 10.1126/science.323.5921.1560; Mourrain P, 2000, CELL, V101, P533, DOI 10.1016/S0092-8674(00)80863-6; Pebernard S, 2004, DIFFERENTIATION, V72, P103, DOI 10.1111/j.1432-0436.2004.07202001.x; Poeck H, 2008, NAT MED, V14, P1256, DOI 10.1038/nm.1887; Reich S, 2003, MOL VIS, V9, P210; Reynolds A, 2006, RNA, V12, P988, DOI 10.1261/rna.2340906; Schlee M, 2006, MOL THER, V14, P463, DOI 10.1016/j.ymthe.2006.06.001; Schlender J, 2005, J VIROL, V79, P5507, DOI 10.1128/JVI.79.9.5507-5515.2005; Sledz CA, 2003, NAT CELL BIOL, V5, P834, DOI 10.1038/ncb1038; Stram Y, 2006, VIRUS GENES, V32, P299, DOI 10.1007/s11262-005-6914-0; Villanueva AI, 2011, DEV COMP IMMUNOL, V35, P28, DOI 10.1016/j.dci.2010.08.001; Wathelet MG, 1998, MOL CELL, V1, P507, DOI 10.1016/S1097-2765(00)80051-9; *WHO, 2010, SEAS INFL; WHO, 2009, H5N1 AV INFL TIM MAJ; *WHO, 2009, CUM NUMB CONF HUM CA	34	24	25	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2011	6	7							e21552	10.1371/journal.pone.0021552	http://dx.doi.org/10.1371/journal.pone.0021552			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786HC	21747939	Green Submitted, Green Published, gold			2022-12-27	WOS:000292293400015
J	Antoniou, T; Zagorski, B; Loutfy, MR; Strike, C; Glazier, RH				Antoniou, Tony; Zagorski, Brandon; Loutfy, Mona R.; Strike, Carol; Glazier, Richard H.			Validation of Case-Finding Algorithms Derived from Administrative Data for Identifying Adults Living with Human Immunodeficiency Virus Infection	PLOS ONE			English	Article							DISEASE PREVALENCE; PREDICTIVE VALUES; MEDICAID CLAIMS; CARE; ONTARIO; AIDS; SENSITIVITY; ACCURACY; HIV/AIDS; IMPACT	Objective: We sought to validate a case-finding algorithm for human immunodeficiency virus (HIV) infection using administrative health databases in Ontario, Canada. Methods: We constructed 48 case-finding algorithms using combinations of physician billing claims, hospital and emergency room separations and prescription drug claims. We determined the test characteristics of each algorithm over various time frames for identifying HIV infection, using data abstracted from the charts of 2,040 randomly selected patients receiving care at two medical practices in Toronto, Ontario as the reference standard. Results: With the exception of algorithms using only a single physician claim, the specificity of all algorithms exceeded 99%. An algorithm consisting of three physician claims over a three year period had a sensitivity and specificity of 96.2% (95% CI 95.2%-97.9%) and 99.6% (95% CI 99.1%-99.8%), respectively. Application of the algorithm to the province of Ontario identified 12,179 HIV-infected patients in care for the period spanning April 1, 2007 to March 31, 2009. Conclusions: Case-finding algorithms generated from administrative data can accurately identify adults living with HIV. A relatively simple "3 claims in 3 years" definition can be used for assembling a population-based cohort and facilitating future research examining trends in health service use and outcomes among HIV-infected adults in Ontario.	[Antoniou, Tony] Univ Toronto, Leslie Dan Fac Pharm, Toronto, ON, Canada; [Antoniou, Tony; Glazier, Richard H.] St Michaels Hosp, Dept Family & Community Med, Toronto, ON M5B 1W8, Canada; [Zagorski, Brandon; Glazier, Richard H.] Inst Clin Evaluat Sci, Toronto, ON, Canada; [Loutfy, Mona R.; Glazier, Richard H.] Univ Toronto, Dept Hlth Policy Management & Evaluat, Toronto, ON, Canada; [Loutfy, Mona R.] Univ Toronto, Dept Med, Toronto, ON, Canada; [Loutfy, Mona R.] Womens Coll Hosp, Womens Coll Res Inst, Toronto, ON M5S 1B2, Canada; [Strike, Carol; Glazier, Richard H.] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Glazier, Richard H.] St Michaels Hosp, Ctr Res Inner City Hlth, Toronto, ON M5B 1W8, Canada	University of Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Womens College Hospital; University of Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto	Antoniou, T (corresponding author), Univ Toronto, Leslie Dan Fac Pharm, Toronto, ON, Canada.	tantoniou@smh.toronto.on.ca	Glazier, Richard H/E-5255-2012; Strike, Carol/U-8317-2018	Strike, Carol/0000-0002-2716-3681	Ontario Ministry of Health and Long-Term Care (MOHLTC); Department of Family and Community Medicine, St. Michael's Hospital	Ontario Ministry of Health and Long-Term Care (MOHLTC)(Ministry of Health and Long-Term Care, Ontario); Department of Family and Community Medicine, St. Michael's Hospital	This project was supported by the Institute for Clinical Evaluative Sciences (ICES), which is funded by an annual grant from the Ontario Ministry of Health and Long-Term Care (MOHLTC), and by research funds from the Department of Family and Community Medicine, St. Michael's Hospital. The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	ALTMAN DG, 1994, BRIT MED J, V309, P102, DOI 10.1136/bmj.309.6947.102; Austin PC, 2002, AM HEART J, V144, P290, DOI 10.1067/mhj.2002.123839; Benchimol EI, 2011, J CLIN EPIDEMIOL, V64, P821, DOI 10.1016/j.jclinepi.2010.10.006; Brenner H, 1997, STAT MED, V16, P981, DOI 10.1002/(SICI)1097-0258(19970515)16:9<981::AID-SIM510>3.0.CO;2-N; De Coster C, 2006, BMC HEALTH SERV RES, V6, DOI 10.1186/1472-6963-6-77; Fanning TR, 1995, AIDS PUBLIC POLICY J, V10, P39; Fleishman JA, 2003, JAIDS-J ACQ IMM DEF, V34, P102, DOI 10.1097/00126334-200309010-00015; Fultz SL, 2006, MED CARE, V44, pS25, DOI 10.1097/01.mlr.0000223670.00890.74; Gershon AS, 2009, CAN RESPIR J, V16, P183, DOI 10.1155/2009/963098; Hoogenveen R, 2002, STAT MED, V21, P2271, DOI 10.1002/sim.1085; Hux JE, 2002, DIABETES CARE, V25, P512, DOI 10.2337/diacare.25.3.512; KEYES M, 1991, J ACQ IMMUN DEF SYND, V4, P1015; Krentz HB, 2006, HIV MED, V7, P457, DOI 10.1111/j.1468-1293.2006.00408.x; Lot F, 2004, Euro Surveill, V9, P7, DOI 10.2807/esm.09.10.00481-en; Mocroft A, 2003, LANCET, V362, P22, DOI 10.1016/S0140-6736(03)13802-0; Mrus JM, 2005, CRIT CARE, V9, pR623, DOI 10.1186/cc3811; Mrus JM, 2001, AIDS PUBLIC POLICY J, V16, P48; Nikolopoulos G, 2005, EUR J PUBLIC HEALTH, V15, P296, DOI 10.1093/eurpub/cki064; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Payne Susan M. C., 1995, Annals of Epidemiology, V5, P337, DOI 10.1016/1047-2797(94)00102-Y; REMIS RS, 2009, REPORT HIV AIDS ONTA, P1; Rice BD, 2007, EPIDEMIOL INFECT, V135, P151, DOI 10.1017/S0950268806006522; Robinson JR, 1997, MED CARE, V35, P932, DOI 10.1097/00005650-199709000-00006; ROSENBLUM L, 1993, AM J PUBLIC HEALTH, V83, P1457, DOI 10.2105/AJPH.83.10.1457; Steele LS, 2004, MED CARE, V42, P960, DOI 10.1097/00005650-200410000-00004; Tu Karen, 2007, Open Med, V1, pe18; Walkup JT, 2004, MED CARE, V42, P756, DOI 10.1097/01.mlr.0000132749.20897.46; Wang L, 2009, CAN FAM PHYSICIAN, V55, P178	28	105	105	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2011	6	6							e21748	10.1371/journal.pone.0021748	http://dx.doi.org/10.1371/journal.pone.0021748			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	786GP	21738786	Green Published, Green Submitted, gold			2022-12-27	WOS:000292291800038
J	Brufau, G; Kuipers, F; Lin, YG; Trautwein, EA; Groen, AK				Brufau, Gemma; Kuipers, Folkert; Lin, Yuguang; Trautwein, Elke A.; Groen, Albert K.			A Reappraisal of the Mechanism by Which Plant Sterols Promote Neutral Sterol Loss in Mice	PLOS ONE			English	Article							LIVER-X-RECEPTOR; BILIARY CHOLESTEROL SECRETION; BINDING CASSETTE TRANSPORTERS; ACTIVATION; EXCRETION; STANOLS; ABCA1; METABOLISM; ABSORPTION; ABCG8	Dietary plant sterols (PS) reduce serum total and LDL-cholesterol in hyperlipidemic animal models and in humans. This hypocholesterolemic effect is generally ascribed to inhibition of cholesterol absorption. However, whether this effect fully explains the reported strong induction of neutral sterol excretion upon plant sterol feeding is not known. Recent data demonstrate that the intestine directly mediates plasma cholesterol excretion into feces, i.e., without involvement of the hepato-biliary route. Objective: Aim of this study was to determine whether stimulation of fecal neutral sterol loss during PS feeding is (partly) explained by increased intestinal cholesterol excretion and to assess the role of the cholesterol transporter Abcg5/Abcg8 herein. Methods and Results: Wild-type mice were fed a control diet or diets enriched with increasing amounts of PS (1%, 2%, 4% or 8%, wt/wt) for two weeks. In addition, Abcg5(-/-) mice were fed either control or 8% PS diet. PS feeding resulted in a dose-dependent decrease of fractional cholesterol absorption (similar to 2-7-fold reduction) in wild-type mice and similar to 80% reduction in Abcg5(-/-) mice. Furthermore, PS feeding led to a strong, dose-independent induction of neutral sterol excretion (3.4-fold in wild-types and 2.7-fold in Abcg5(-/-) mice) without changes in biliary cholesterol secretion. It was calculated that PS feeding stimulated intestinal cholesterol excretion by similar to 500% in wild-type mice and by similar to 250% in Abcg5(-/-). Conclusions: Our data indicate that in mice the cholesterol-lowering effects of PS are to a large extent attributable to stimulation of intestinal, non-bile derived, cholesterol excretion. The Abcg5/Abcg8 heterodimer is involved in facilitating this PS-induced flux of cholesterol.	[Brufau, Gemma; Kuipers, Folkert; Groen, Albert K.] Univ Groningen, Univ Med Ctr Groningen, Ctr Liver Digest & Metab Dis, Dept Pediat, Groningen, Netherlands; [Kuipers, Folkert; Groen, Albert K.] Univ Groningen, Univ Med Ctr Groningen, Ctr Liver Digest & Metab Dis, Dept Lab Med, Groningen, Netherlands; [Lin, Yuguang; Trautwein, Elke A.] Unilever R&D, Vlaardingen, Netherlands	University of Groningen; University of Groningen; Unilever	Brufau, G (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Ctr Liver Digest & Metab Dis, Dept Pediat, Groningen, Netherlands.	g.brufau.dones@med.umcg.nl		Kuipers, Folkert/0000-0003-2518-737X	The Netherlands Heart Foundation [2008B100]; Unilever R&D (Vlaardingen, The Netherlands); Unilever RD	The Netherlands Heart Foundation(Netherlands Heart Foundation); Unilever R&D (Vlaardingen, The Netherlands)(Netherlands Government); Unilever RD(Unilever)	This study was supported by The Netherlands Heart Foundation (grant 2008B100) and Unilever R&D (Vlaardingen, The Netherlands). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Unilever R&D funded part of this study; however, this does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Brown JM, 2008, J BIOL CHEM, V283, P10522, DOI 10.1074/jbc.M707659200; Calpe-Berdie L, 2007, PROTEOMICS, V7, P2659, DOI 10.1002/pmic.200600792; Calpe-Berdiel L, 2008, J LIPID RES, V49, P1904, DOI 10.1194/jlr.M700470-JLR200; Calpe-Berdiel L, 2009, ATHEROSCLEROSIS, V203, P18, DOI 10.1016/j.atherosclerosis.2008.06.026; Drobnik W, 2001, GASTROENTEROLOGY, V120, P1203, DOI 10.1053/gast.2001.23250; FEREZOU J, 1981, DIGESTION, V21, P232, DOI 10.1159/000198568; Field FJ, 1997, J LIPID RES, V38, P348; Groen AK, 2001, J CLIN INVEST, V108, P843, DOI 10.1172/JCI12473; Jones PJH, 2009, CURR OPIN CLIN NUTR, V12, P147, DOI 10.1097/MCO.0b013e328326770f; Kaneko E, 2003, J BIOL CHEM, V278, P36091, DOI 10.1074/jbc.M304153200; Kruit JK, 2005, GASTROENTEROLOGY, V128, P147, DOI 10.1053/j.gastro.2004.10.006; Langheim S, 2005, J LIPID RES, V46, P1732, DOI 10.1194/jlr.M500115-JLR200; Mensink RP, 2010, AM J CLIN NUTR, V92, P24, DOI 10.3945/ajcn.2009.29143; MURPHY GM, 1970, J CLIN PATHOL, V23, P594, DOI 10.1136/jcp.23.7.594; Plat J, 2005, J LIPID RES, V46, P2468, DOI 10.1194/jlr.M500272-JLR200; Plat J, 2002, FASEB J, V16, DOI 10.1096/fj.01-0718hyp; Plosch T, 2004, GASTROENTEROLOGY, V126, P290, DOI 10.1053/j.gastro.2003.10.074; Plosch T, 2002, J BIOL CHEM, V277, P33870, DOI 10.1074/jbc.M206522200; Plosch T, 2006, J NUTR, V136, P2135, DOI 10.1093/jn/136.8.2135; Stricker D, 2008, COMPUT METH PROG BIO, V92, P135, DOI 10.1016/j.cmpb.2008.06.010; Temel RE, 2003, J BIOL CHEM, V278, P47594, DOI 10.1074/jbc.M308235200; Temel RE, 2007, J CLIN INVEST, V117, P1968, DOI 10.1172/JCI30060; Temel RE, 2010, CELL METAB, V12, P96, DOI 10.1016/j.cmet.2010.05.011; van der Veen JN, 2009, J BIOL CHEM, V284, P19211, DOI 10.1074/jbc.M109.014860; van der Velde AE, 2008, AM J PHYSIOL-GASTR L, V295, pG203, DOI 10.1152/ajpgi.90231.2008; Van der Velde AE, 2007, GASTROENTEROLOGY, V133, P967, DOI 10.1053/j.gastro.2007.06.019; van der Velde AE, 2010, CURR OPIN LIPIDOL, V21, P167, DOI 10.1097/MOL.0b013e3283395e45; Vrins CLJ, 2009, J LIPID RES, V50, P2046, DOI 10.1194/jlr.M800579-JLR200; Wu T, 2009, ASIA PAC J CLIN NUTR, V18, P179; Xie CL, 2009, J LIPID RES, V50, P1316, DOI 10.1194/jlr.M900024-JLR200; Yu LQ, 2002, P NATL ACAD SCI USA, V99, P16237, DOI 10.1073/pnas.252582399; Yu LQ, 2003, J BIOL CHEM, V278, P15565, DOI 10.1074/jbc.M301311200; Yu LQ, 2002, J CLIN INVEST, V110, P671, DOI [10.1172/JCI200216001, 10.1172/JCI0216001]	34	57	59	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2011	6	6							e21576	10.1371/journal.pone.0021576	http://dx.doi.org/10.1371/journal.pone.0021576			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786GP	21738715	Green Published, gold			2022-12-27	WOS:000292291800024
J	Tokarz, R; Firth, C; Street, C; Cox-Foster, DL; Lipkin, WI				Tokarz, Rafal; Firth, Cadhla; Street, Craig; Cox-Foster, Diana L.; Lipkin, W. Ian			Lack of Evidence for an Association between Iridovirus and Colony Collapse Disorder	PLOS ONE			English	Article							HONEY-BEE; IRIDESCENT-VIRUS; GENE	Colony collapse disorder (CCD) is characterized by the unexplained losses of large numbers of adult worker bees (Apis mellifera) from apparently healthy colonies. Although infections, toxins, and other stressors have been associated with the onset of CCD, the pathogenesis of this disorder remains obscure. Recently, a proteomics study implicated a double-stranded DNA virus, invertebrate iridescent virus (Family Iridoviridae) along with a microsporidium (Nosema sp.) as the cause of CCD. We tested the validity of this relationship using two independent methods: (i) we surveyed healthy and CCD colonies from the United States and Israel for the presence of members of the Iridovirus genus and (ii) we reanalyzed metagenomics data previously generated from RNA pools of CCD colonies for the presence of Iridovirus-like sequences. Neither analysis revealed any evidence to suggest the presence of an Iridovirus in healthy or CCD colonies.	[Tokarz, Rafal; Firth, Cadhla; Street, Craig; Lipkin, W. Ian] Columbia Univ, Ctr Infect & Immun, Mailman Sch Publ Hlth, New York, NY 10027 USA; [Cox-Foster, Diana L.] Penn State Univ, Dept Entomol, University Pk, PA 16802 USA	Columbia University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Tokarz, R (corresponding author), Columbia Univ, Ctr Infect & Immun, Mailman Sch Publ Hlth, New York, NY 10027 USA.	wil2001@columbia.edu	Lipkin, W. Ian/ABE-6216-2020	Lipkin, W. Ian/0000-0002-8768-9386; Firth, Cadhla/0000-0002-2040-8973	U. S. Department of Defense; Pennsylvania Department of Agriculture [ME 447514]	U. S. Department of Defense(United States Department of Defense); Pennsylvania Department of Agriculture	Funding was provided by the U. S. Department of Defense, Google.org, and the Pennsylvania Department of Agriculture (ME 447514, "Colony Collapse disorder in Honey Bees: Defining associated pathology and enabling reuse of equipment"). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; BAILEY L, 1976, J GEN VIROL, V31, P459, DOI 10.1099/0022-1317-31-3-459; BAILEY L, 1978, J INVERTEBR PATHOL, V31, P368, DOI 10.1016/0022-2011(78)90231-8; Bromenshenk JJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013181; Cox-Foster D, 2009, SCI AM, V300, P40, DOI 10.1038/scientificamerican0409-40; Cox-Foster DL, 2007, SCIENCE, V318, P283, DOI 10.1126/science.1146498; Foster LJ, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.006387; Ince IA, 2010, VIROLOGY, V405, P253, DOI 10.1016/j.virol.2010.05.038; Kleespies RG, 1999, J INVERTEBR PATHOL, V73, P84, DOI 10.1006/jipa.1998.4821; Lourenco AP, 2008, APIDOLOGIE, V39, P372, DOI 10.1051/apido:2008015; Ratnieks FLW, 2010, SCIENCE, V327, P152, DOI 10.1126/science.1185563; *UN ENV PROGR, 2010, UNEP EM ISS; vanEngelsdorp D, 2011, J APICULT RES, V50, P1, DOI 10.3896/IBRA.1.50.1.01; vanEngelsdorp D, 2010, J ECON ENTOMOL, V103, P1517, DOI 10.1603/EC09429; vanEngelsdorp D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006481; Webby R, 1998, ARCH VIROL, V143, P1949, DOI 10.1007/s007050050432; Williams GR, 2010, BIOESSAYS, V32, P845, DOI 10.1002/bies.201000075; Williams T, 1996, ADV VIRUS RES, V46, P345, DOI 10.1016/S0065-3527(08)60076-7; Williams T, 2008, NEOTROP ENTOMOL, V37, P615, DOI 10.1590/S1519-566X2008000600001	19	17	19	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2011	6	6							e21844	10.1371/journal.pone.0021844	http://dx.doi.org/10.1371/journal.pone.0021844			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786GP	21738798	gold, Green Published			2022-12-27	WOS:000292291800049
J	Tao, KP; Fong, SW; Lu, ZH; Ching, YP; Chan, KW; Chan, SY				Tao, Kin Pong; Fong, Sze Wan; Lu, Zhihong; Ching, Yick Pang; Chan, Kin Wang; Chan, Siu Yuen			TSPYL2 Is Important for G1 Checkpoint Maintenance upon DNA Damage	PLOS ONE			English	Article							NUCLEOSOME ASSEMBLY PROTEIN; Y-CHROMOSOME; TARGET DENTT; CYCLIN B; MOUSE; GENE; P53; TRANSCRIPTION; EXPRESSION; NAP1	Nucleosome assembly proteins play important roles in chromatin remodeling, which determines gene expression, cell proliferation and terminal differentiation. Testis specific protein, Y-encoded-like 2 (TSPYL2) is a nucleosome assembly protein expressed in neuronal precursors and mature neurons. Previous studies have shown that TSPYL2 binds cyclin B and inhibits cell proliferation in cultured cells suggesting a role in cell cycle regulation. To investigate the physiological significance of TSPYL2 in the control of cell cycle, we generated mice with targeted disruption of Tspyl2. These mutant mice appear grossly normal, have normal life span and do not exhibit increased tumor incidence. To define the role of TSPYL2 in DNA repair, checkpoint arrest and apoptosis, primary embryonic fibroblasts and thymocytes from Tspyl2 deficient mice were isolated and examined under unperturbed and stressed conditions. We show that mutant fibroblasts are impaired in G1 arrest under the situation of DNA damage induced by gamma irradiation. This is mainly attributed to the defective activation of p21 transcription despite proper p53 protein accumulation, suggesting that TSPYL2 is additionally required for p21 induction. TSPYL2 serves a biological role in maintaining the G1 checkpoint under stress condition.	[Tao, Kin Pong; Fong, Sze Wan; Lu, Zhihong; Chan, Kin Wang; Chan, Siu Yuen] Univ Hong Kong, Dept Paediat & Adolescent Med, Ctr Reprod Dev & Growth, Li Ka Shing Fac Med, Hong Kong, Hong Kong, Peoples R China; [Ching, Yick Pang] Univ Hong Kong, Dept Anat, Li Ka Shing Fac Med, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong	Tao, KP (corresponding author), Univ Hong Kong, Dept Paediat & Adolescent Med, Ctr Reprod Dev & Growth, Li Ka Shing Fac Med, Hong Kong, Hong Kong, Peoples R China.	sychan@hkucc.hku.hk		CHING, Yick Pang/0000-0002-6461-8358; Chan, Siu Yuen/0000-0001-7262-1293	Research Grants Council of the Hong Kong Special Administrative Region, China [HKU7323/03M, HKU2/02C]; Committee for Research and Conference Grants, The University of Hong Kong	Research Grants Council of the Hong Kong Special Administrative Region, China(Hong Kong Research Grants Council); Committee for Research and Conference Grants, The University of Hong Kong(University of Hong Kong)	The work described in this paper was substantially supported by a grant from the Research Grants Council of the Hong Kong Special Administrative Region, China (Project No. HKU7323/03M and HKU2/02C) and partly by the Committee for Research and Conference Grants, The University of Hong Kong. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aladjem MI, 1998, CURR BIOL, V8, P145, DOI 10.1016/S0960-9822(98)70061-2; Altman R, 1997, J CELL BIOL, V138, P119, DOI 10.1083/jcb.138.1.119; Barlev NA, 2001, MOL CELL, V8, P1243, DOI 10.1016/S1097-2765(01)00414-2; Canela N, 2003, J BIOL CHEM, V278, P1158, DOI 10.1074/jbc.M207497200; Chai ZL, 2001, J BIOL CHEM, V276, P33665, DOI 10.1074/jbc.M007681200; Delbridge ML, 2004, CHROMOSOME RES, V12, P345, DOI 10.1023/B:CHRO.0000034134.91243.1c; DENG CX, 1995, CELL, V82, P675, DOI 10.1016/0092-8674(95)90039-X; HARVEY M, 1993, FASEB J, V7, P938, DOI 10.1096/fasebj.7.10.8344491; Kandalaft LE, 2008, CARCINOGENESIS, V29, P1282, DOI 10.1093/carcin/bgn087; KELLOGG DR, 1995, J CELL BIOL, V130, P661, DOI 10.1083/jcb.130.3.661; KELLOGG DR, 1995, J CELL BIOL, V130, P675, DOI 10.1083/jcb.130.3.675; Kim TY, 2006, CANCER RES, V66, P7490, DOI 10.1158/0008-5472.CAN-05-4552; Kristiansen LV, 2010, SYNAPSE, V64, P495, DOI 10.1002/syn.20754; Lankenau S, 2003, GENETICS, V163, P611; Lau YFC, 2003, CYTOGENET GENOME RES, V101, P250, DOI 10.1159/000074345; Lewandoski M, 1997, CURR BIOL, V7, P148, DOI 10.1016/S0960-9822(06)00059-5; Li Y, 2008, ONCOGENE, V27, P6141, DOI 10.1038/onc.2008.206; Lin CW, 2006, J COMP NEUROL, V494, P606, DOI 10.1002/cne.20825; Ljungman M, 1999, ONCOGENE, V18, P583, DOI 10.1038/sj.onc.1202356; LOWE SW, 1993, NATURE, V362, P847, DOI 10.1038/362847a0; Luebben WR, 2010, P NATL ACAD SCI USA, V107, P19254, DOI 10.1073/pnas.1009650107; Mazeyrat S, 1998, HUM MOL GENET, V7, P557, DOI 10.1093/hmg/7.3.557; Niida H, 2010, EMBO J, V29, P3558, DOI 10.1038/emboj.2010.218; Olsson A, 2007, CELL DEATH DIFFER, V14, P1561, DOI 10.1038/sj.cdd.4402196; Oram SW, 2006, BMC CANCER, V6, P1, DOI 10.1186/1471-2407-6-154; Ozbun LL, 2001, GENOMICS, V73, P179, DOI 10.1006/geno.2001.6505; Pham Y, 2010, DIABETOLOGIA, V53, P170, DOI 10.1007/s00125-009-1555-9; Puffenberger EG, 2004, P NATL ACAD SCI USA, V101, P11689, DOI 10.1073/pnas.0401194101; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Rogner UC, 2000, NAT GENET, V25, P431, DOI 10.1038/78124; Rogner UC, 2002, AM J MED GENET, V110, P208, DOI 10.1002/ajmg.10453; Schnieders F, 1996, HUM MOL GENET, V5, P1801, DOI 10.1093/hmg/5.11.1801; Shikama N, 2000, MOL CELL BIOL, V20, P8933, DOI 10.1128/MCB.20.23.8933-8943.2000; Sun GF, 2002, BBA-MOL BASIS DIS, V1588, P241, DOI 10.1016/S0925-4439(02)00171-0; Tsuchiya KD, 2004, GENOME RES, V14, P1275, DOI 10.1101/gr.2575904; Tu YG, 2007, J BIOL CHEM, V282, P11722, DOI 10.1074/jbc.M609623200; WALTER PP, 1995, MOL CELL BIOL, V15, P6178; Wang GS, 2004, NEURON, V42, P113, DOI 10.1016/S0896-6273(04)00139-4; Wang YA, 1997, P NATL ACAD SCI USA, V94, P14590, DOI 10.1073/pnas.94.26.14590	39	19	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2011	6	6							e21602	10.1371/journal.pone.0021602	http://dx.doi.org/10.1371/journal.pone.0021602			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	783OD	21738728	Green Published, Green Submitted, gold			2022-12-27	WOS:000292092600061
J	Calabrese, F; Smoreda, Z; Blondel, VD; Ratti, C				Calabrese, Francesco; Smoreda, Zbigniew; Blondel, Vincent D.; Ratti, Carlo			Interplay between Telecommunications and Face-to-Face Interactions: A Study Using Mobile Phone Data	PLOS ONE			English	Article							TRAVEL BEHAVIOR	In this study we analyze one year of anonymized telecommunications data for over one million customers from a large European cellphone operator, and we investigate the relationship between people's calls and their physical location. We discover that more than 90% of users who have called each other have also shared the same space (cell tower), even if they live far apart. Moreover, we find that close to 70% of users who call each other frequently (at least once per month on average) have shared the same space at the same time - an instance that we call co-location. Co-locations appear indicative of coordination calls, which occur just before face-to-face meetings. Their number is highly predictable based on the amount of calls between two users and the distance between their home locations - suggesting a new way to quantify the interplay between telecommunications and face-to-face interactions.	[Calabrese, Francesco] IBM Res, Dublin, Ireland; [Calabrese, Francesco; Ratti, Carlo] MIT, Senseable City Lab, Cambridge, MA 02139 USA; [Smoreda, Zbigniew] Orange Labs, Sociol & Econ Networks & Serv Dept, Issy Les Moulineaux, France; [Blondel, Vincent D.] MIT, LIDS, Cambridge, MA 02139 USA; [Blondel, Vincent D.] Catholic Univ Louvain, Dept Engn Math, B-1348 Louvain, Belgium	Massachusetts Institute of Technology (MIT); Orange SA; Massachusetts Institute of Technology (MIT); Universite Catholique Louvain	Calabrese, F (corresponding author), IBM Res, Dublin, Ireland.	fcalabre@ie.ibm.com	blondel, vincent/A-8916-2011; Smoręda, Zbigniew/D-9265-2011	Smoręda, Zbigniew/0000-0002-4047-7597	ATT Foundation; National Science Foundation [0735956]; MIT SMART; GE; Audi Volkswagen; SNCF; ENEL; IBM Research; Orange Labs	ATT Foundation; National Science Foundation(National Science Foundation (NSF)); MIT SMART; GE; Audi Volkswagen; SNCF; ENEL; IBM Research(International Business Machines (IBM)); Orange Labs	The authors were partially funded by the AT&T Foundation, the National Science Foundation (grant number 0735956), the MIT SMART program, GE, Audi Volkswagen, SNCF and ENEL. Francesco Calabrese was partially funded by IBM Research, which had no role in study design, data collection, data analysis, decision to publish, or preparation of the manuscript. Zbigniew Smoreda was funded by Orange Labs, which contributed to data collection and had no role in study design, data analysis, decision to publish, or preparation of the manuscript. The other funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBERTSON LA, 1977, J COMMUN, V27, P32, DOI 10.1111/j.1460-2466.1977.tb01824.x; Arentze T, 2008, ENVIRON PLANN B, V35, P1012, DOI 10.1068/b3319t; Cairncross F., 1997, RSAI NEWSL NEW SER; Calabrese Francesco, 2010, INT C PERV COMP; Carrasco JA, 2008, TRANSP RES RECORD, P114, DOI 10.3141/2076-13; Choo S., 2010, TRANSPORT RES REC, V1, P121; Crandall DJ, 2010, P NATL ACAD SCI USA, V107, P22436, DOI 10.1073/pnas.1006155107; Diminescu D, 2008, RECONSTRUCTION SPACE; Eagle N, 2009, P NATL ACAD SCI USA, V106, P15274, DOI 10.1073/pnas.0900282106; Gonzalez MC, 2008, NATURE, V453, P779, DOI 10.1038/nature06958; Krings G, 2009, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2009/07/L07003; Lambiotte R, 2008, PHYSICA A, V387, P5317, DOI 10.1016/j.physa.2008.05.014; Larsen J., 2006, MOBILITIES NETWORKS; Larsen J., 2006, MOBILITIES-UK, V1, P261, DOI [DOI 10.1080/17450100600726654, 10.1080/17450100600726654]; Licoppe C., 2006, COMPUTERS PHONES INT; Licoppe C, 2000, RESEAUX, V18, P253; Mitchell William, 1996, CITY BITS SPACE PLAC; Mok D, 2010, URBAN STUD, V47, P2747, DOI 10.1177/0042098010377363; Mokhtarian P.L., 2002, J IND ECOL, V6, P43, DOI [DOI 10.1162/108819802763471771, 10.1162/108819802763471771]; Onnela JP, 2007, P NATL ACAD SCI USA, V104, P7332, DOI 10.1073/pnas.0610245104; Paez A, 2007, ENVIRON PLANN A, V39, P647, DOI 10.1068/a37424; Reades J, 2007, IEEE PERVAS COMPUT, V6, P30, DOI 10.1109/MPRV.2007.53; Salomon I, 1998, TRANSPORT RES C-EMER, V6, P17, DOI 10.1016/S0968-090X(98)00006-0; Sasaki K, 2010, TRANSPORT RES C-EMER, V18, P36, DOI 10.1016/j.trc.2009.04.012; Sheller M, 2006, ENVIRON PLANN A, V38, P207, DOI 10.1068/a37268; Urry John, 1999, SOCIOLOGY SOC MOBILI; Wang P, 2009, SCIENCE, V324, P1071, DOI 10.1126/science.1167053; WHEELER JO, 1971, ANN ASSOC AM GEOGR, V61, P371, DOI 10.1111/j.1467-8306.1971.tb00789.x	29	81	83	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2011	6	7							e20814	10.1371/journal.pone.0020814	http://dx.doi.org/10.1371/journal.pone.0020814			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	792WQ	21765888	Green Published, Green Submitted, gold			2022-12-27	WOS:000292781500002
J	Mirandola, L; Yu, YF; Chui, K; Jenkins, MR; Cobos, E; John, CM; Chiriva-Internati, M				Mirandola, Leonardo; Yu, Yuefei; Chui, Kitty; Jenkins, Marjorie R.; Cobos, Everardo; John, Constance M.; Chiriva-Internati, Maurizio			Galectin-3C Inhibits Tumor Growth and Increases the Anticancer Activity of Bortezomib in a Murine Model of Human Multiple Myeloma	PLOS ONE			English	Article							CARBOHYDRATE-BINDING PROTEIN-35; HOMOTYPIC AGGREGATION; ENDOTHELIAL-CELLS; INDUCED APOPTOSIS; IN-VITRO; ANGIOGENESIS; LECTIN; MIGRATION; THERAPY; ANTIGEN	Galectin-3 is a human lectin involved in many cellular processes including differentiation, apoptosis, angiogenesis, neoplastic transformation, and metastasis. We evaluated galectin-3C, an N-terminally truncated form of galectin-3 that is thought to act as a dominant negative inhibitor, as a potential treatment for multiple myeloma (MM). Galectin-3 was expressed at varying levels by all 9 human MM cell lines tested. In vitro galectin-3C exhibited modest anti-proliferative effects on MM cells and inhibited chemotaxis and invasion of U266 MM cells induced by stromal cell-derived factor (SDF)-1a. Galectin-3C facilitated the anticancer activity of bortezomib, a proteasome inhibitor approved by the FDA for MM treatment. Galectin-3C and bortezomib also synergistically inhibited MM-induced angiogenesis activity in vitro. Delivery of galectin-3C intravenously via an osmotic pump in a subcutaneous U266 cell NOD/SCID mouse model of MM significantly inhibited tumor growth. The average tumor volume of bortezomib-treated animals was 19.6% and of galectin-3C treated animals was 13.5% of the average volume of the untreated controls at day 35. The maximal effect was obtained with the combination of galectin-3C with bortezomib that afforded a reduction of 94% in the mean tumor volume compared to the untreated controls at day 35. In conclusion, this is the first study to show that inhibition of galectin-3 is efficacious in a murine model of human MM. Our results demonstrated that galectin-3C alone was efficacious in a xenograft mouse model of human MM, and that it enhanced the anti-tumor activity of bortezomib in vitro and in vivo. These data provide the rationale for continued testing of galectin-3C towards initiation of clinical trials for treatment of MM.	[Mirandola, Leonardo; Yu, Yuefei; Jenkins, Marjorie R.; Cobos, Everardo; Chiriva-Internati, Maurizio] Texas Tech Univ, Hlth Sci Ctr, Div Hematol & Oncol, Lubbock, TX 79430 USA; [Mirandola, Leonardo; Yu, Yuefei; Jenkins, Marjorie R.; Cobos, Everardo; Chiriva-Internati, Maurizio] SW Canc Treatment & Res Ctr, Lubbock, TX USA; [Mirandola, Leonardo; Jenkins, Marjorie R.; Cobos, Everardo; Chiriva-Internati, Maurizio] Texas Tech Univ, Hlth Sci Ctr, Laura W Bush Inst Womens Hlth, Amarillo, TX USA; [Mirandola, Leonardo; Jenkins, Marjorie R.; Cobos, Everardo; Chiriva-Internati, Maurizio] Texas Tech Univ, Hlth Sci Ctr, Ctr Womens Hlth & Gender Based Med, Amarillo, TX USA; [Chui, Kitty; John, Constance M.] MandalMed, San Francisco, CA USA	Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; Texas Tech University Health Sciences Center Amarillo; Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; Texas Tech University Health Sciences Center Amarillo	Mirandola, L (corresponding author), Texas Tech Univ, Hlth Sci Ctr, Div Hematol & Oncol, Lubbock, TX 79430 USA.	maurizio.chiriva@ttuhsc.edu	Mirandola, Leonardo/B-1575-2013	cobos, everardo/0000-0001-5799-0074	National Institutes of Health [CA135862-01]; NATIONAL CANCER INSTITUTE [R43CA135862] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by a National Institutes of Health grant award (CA135862-01 to C.M.J. and M. C.-I. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGRWAL N, 1993, J BIOL CHEM, V268, P14932; Akahani S, 1997, CANCER RES, V57, P5272; ALBINI A, 1987, CANCER RES, V47, P3239; Alsayed Y, 2007, BLOOD, V109, P2708, DOI 10.1182/blood-2006-07-035857; Anargyrou K, 2008, LEUKEMIA LYMPHOMA, V49, P677, DOI 10.1080/10428190701861686; Ansari NA, 2007, ASIAN PAC J CANCER P, V8, P593; BARONDES SH, 1994, J BIOL CHEM, V269, P20807; BELLAMY WT, 1991, CANCER RES, V51, P995; Bleul CC, 1996, J EXP MED, V184, P1101, DOI 10.1084/jem.184.3.1101; Broek IV, 2008, CLIN EXP METASTAS, V25, P325, DOI 10.1007/s10585-007-9108-4; Caers J, 2008, BRIT J CANCER, V98, P1966, DOI 10.1038/sj.bjc.6604388; Delgado VMC, 2011, FASEB J, V25, P242, DOI 10.1096/fj.09-144907; Chauhan D, 2005, ANNU REV PHARMACOL, V45, P465, DOI 10.1146/annurev.pharmtox.45.120403.100037; Chauhan D, 2005, CANCER RES, V65, P8350, DOI 10.1158/0008-5472.CAN-05-0163; Chauhan D, 2004, BLOOD, V103, P3158, DOI 10.1182/blood-2003-08-2873; CHERAYIL BJ, 1990, P NATL ACAD SCI USA, V87, P7324, DOI 10.1073/pnas.87.18.7324; CHERAYIL BJ, 1989, J EXP MED, V170, P1959, DOI 10.1084/jem.170.6.1959; Chiriva-Internati M, 2008, BRIT J HAEMATOL, V140, P465, DOI 10.1111/j.1365-2141.2007.06940.x; Chiriva-Internati M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010471; Ciechanover A, 2005, NAT REV MOL CELL BIO, V6, P79, DOI 10.1038/nrm1552; Desterro JMP, 2000, CELL MOL LIFE SCI, V57, P1207, DOI 10.1007/PL00000760; Eliceiri BP, 2000, CANCER J, V6, pS245; Engelhardt M, 2010, LEUKEMIA LYMPHOMA, V51, P1424, DOI 10.3109/10428194.2010.487959; Fukumori T, 2007, DRUG RESIST UPDATE, V10, P101, DOI 10.1016/j.drup.2007.04.001; Giatromanolaki A, 2010, ANTICANCER RES, V30, P2831; Granovsky M, 2000, NAT MED, V6, P306; Greenstein S, 2003, EXP HEMATOL, V31, P271, DOI 10.1016/S0301-472X(03)00023-7; Haudek KC, 2009, BIOCHIM BIOPHYS ACTA, V1800, P181; HERRMANN J, 1993, J BIOL CHEM, V268, P26704; Hideshima T, 2009, BLOOD, V114, P1046, DOI 10.1182/blood-2009-01-199604; Hirabayashi C, 2002, DENT MATER J, V21, P314, DOI 10.4012/dmj.21.314; HO MK, 1982, J IMMUNOL, V128, P1221; Hsu DK, 2009, J INVEST DERMATOL, V129, P573, DOI 10.1038/jid.2008.276; HSU DK, 1992, J BIOL CHEM, V267, P14167; Jeon SB, 2010, J IMMUNOL, V185, P7037, DOI 10.4049/jimmunol.1000154; John CM, 2003, CLIN CANCER RES, V9, P2374; Kaufman Jonathan, 2009, Curr Hematol Malig Rep, V4, P99, DOI 10.1007/s11899-009-0014-5; Kiziltepe T, 2010, J PHARM PHARMACOL, V62, P145, DOI 10.1211/jpp.62.01.0017; Koomen JM, 2008, MOL CELL PROTEOMICS, V7, P1780, DOI 10.1074/mcp.R800002-MCP200; Kotla V, 2009, J HEMATOL ONCOL, V2, DOI 10.1186/1756-8722-2-36; Kuklinski S, 1998, J NEUROCHEM, V70, P814; Laubach JP, 2009, LEUKEMIA LYMPHOMA, V50, P694, DOI 10.1080/10428190902866732; Li WW, 2008, BRIT J HAEMATOL, V143, P622, DOI 10.1111/j.1365-2141.2008.07372.x; Markowska AI, 2010, J EXP MED, V207, P1981, DOI 10.1084/jem.20090121; Medinger M, 2010, J ONCOL, V2010, DOI 10.1155/2010/729725; MEHUL B, 1995, FEBS LETT, V360, P160, DOI 10.1016/0014-5793(95)00100-N; MEHUL B, 1994, J BIOL CHEM, V269, P18250; Mina-Osorio P, 2007, BIOCHEM BIOPH RES CO, V353, P605, DOI 10.1016/j.bbrc.2006.12.081; Moon BK, 2001, AM J PATHOL, V159, P1055, DOI 10.1016/S0002-9440(10)61780-4; Morabito F, 2010, EUR J HAEMATOL, V85, P181, DOI 10.1111/j.1600-0609.2010.01472.x; Moschetta M, 2010, EUR J CANCER, V46, P420, DOI 10.1016/j.ejca.2009.10.019; Nangia-Makker P, 2007, CANCER RES, V67, P11760, DOI 10.1158/0008-5472.CAN-07-3233; Nangia-Makker P, 2010, INT J CANCER, V127, P2530, DOI 10.1002/ijc.25254; Nieminen J, 2007, J BIOL CHEM, V282, P1374, DOI 10.1074/jbc.M604506200; Ochieng J, 1998, BBA-GEN SUBJECTS, V1379, P97, DOI 10.1016/S0304-4165(97)00086-X; OCHIENG J, 1994, BIOCHEMISTRY-US, V33, P14109, DOI 10.1021/bi00251a020; Orlowski RZ, 2002, J CLIN ONCOL, V20, P4420, DOI 10.1200/JCO.2002.01.133; Rabinovich GA, 2005, BRIT J CANCER, V92, P1188, DOI 10.1038/sj.bjc.6602493; Rajkumar SV, 2003, LEUKEMIA, V17, P775, DOI 10.1038/sj.leu.2402866; Rajkumar SV, 2000, CANCER TREAT REV, V26, P351, DOI 10.1053/ctrv.2000.0188; Rana C, 2010, ANN HEMATOL, V89, P789, DOI 10.1007/s00277-010-0919-z; Richardson PG, 2007, BRIT J HAEMATOL, V137, P429, DOI 10.1111/j.1365-2141.2007.06585.x; Richardson PG, 2005, NEW ENGL J MED, V352, P2487, DOI 10.1056/NEJMoa043445; Saraswati S, 2011, PROSTATE, V71, P197, DOI 10.1002/pros.21236; Shin WS, 2008, BIOCHEM BIOPH RES CO, V371, P793, DOI 10.1016/j.bbrc.2008.04.168; Streetly MJ, 2010, BLOOD, V115, P3939, DOI 10.1182/blood-2009-10-251660; Sugahara T, 2009, BIOSCI BIOTECH BIOCH, V73, P2043, DOI 10.1271/bbb.90245; Swelam WM, 2010, PATHOL RES PRACT, V206, P753, DOI 10.1016/j.prp.2010.07.006; Tchakarska G, 2009, HAEMATOL-HEMATOL J, V94, P1781, DOI 10.3324/haematol.2009.011460; Thijssen VLJL, 2006, P NATL ACAD SCI USA, V103, P15975, DOI 10.1073/pnas.0603883103; VACCA A, 1995, AM J HEMATOL, V50, P9, DOI 10.1002/ajh.2830500103; Van den Brule FA, 1998, CELL ADHES COMMUN, V5, P425, DOI 10.3109/15419069809005601; WOO HJ, 1991, J BIOL CHEM, V266, P18419; Yang RY, 1996, P NATL ACAD SCI USA, V93, P6737, DOI 10.1073/pnas.93.13.6737; Zhao QC, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-154; Zick Y, 2002, GLYCOCONJUGATE J, V19, P517, DOI 10.1023/B:GLYC.0000014081.55445.af	76	48	51	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2011	6	7							e21811	10.1371/journal.pone.0021811	http://dx.doi.org/10.1371/journal.pone.0021811			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	792WQ	21765917	Green Published, gold, Green Submitted			2022-12-27	WOS:000292781500018
J	Zhang, JD; Koerner, C; Bechtel, S; Bender, C; Keklikoglou, I; Schmidt, C; Irsigler, A; Ernst, U; Sahin, O; Wiemann, S; Tschulena, U				Zhang, Jitao David; Koerner, Cindy; Bechtel, Stephanie; Bender, Christian; Keklikoglou, Ioanna; Schmidt, Christian; Irsigler, Anja; Ernst, Ute; Sahin, Oezguer; Wiemann, Stefan; Tschulena, Ulrich			Time-Resolved Human Kinome RNAi Screen Identifies a Network Regulating Mitotic-Events as Early Regulators of Cell Proliferation	PLOS ONE			English	Article							COMBINATORIAL RNAI; BREAST-CANCER; GENOME; BIOINFORMATICS; VALIDATION; PATHWAYS; DIVISION; REACTOME; ASSAY	Analysis of biological processes is frequently performed with the help of phenotypic assays where data is mostly acquired in single end-point analysis. Alternative phenotypic profiling techniques are desired where time-series information is essential to the biological question, for instance to differentiate early and late regulators of cell proliferation in loss-of-function studies. So far there is no study addressing this question despite of high unmet interests, mostly due to the limitation of conventional end-point assaying technologies. We present the first human kinome screen with a real-time cell analysis system (RTCA) to capture dynamic RNAi phenotypes, employing time-resolved monitoring of cell proliferation via electrical impedance. RTCA allowed us to investigate the dynamics of phenotypes of cell proliferation instead of using conventional end-point analysis. By introducing data transformation with first-order derivative, i.e. the cell-index growth rate, we demonstrate this system suitable for high-throughput screenings (HTS). The screen validated previously identified inhibitor genes and, additionally, identified activators of cell proliferation. With the information of time kinetics available, we could establish a network of mitotic-event related genes to be among the first displaying inhibiting effects after RNAi knockdown. The time-resolved screen captured kinetics of cell proliferation caused by RNAi targeting human kinome, serving as a resource for researchers. Our work establishes RTCA technology as a novel robust tool with biological and pharmacological relevance amenable for high-throughput screening.	[Zhang, Jitao David; Koerner, Cindy; Bechtel, Stephanie; Bender, Christian; Keklikoglou, Ioanna; Schmidt, Christian; Irsigler, Anja; Ernst, Ute; Sahin, Oezguer; Wiemann, Stefan; Tschulena, Ulrich] German Canc Res Ctr, Div Mol Genome Anal, D-6900 Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ)	Zhang, JD (corresponding author), German Canc Res Ctr, Div Mol Genome Anal, D-6900 Heidelberg, Germany.	s.wiemann@dkfz-heidelberg.de; u.tschulena@dkfz-heidelberg.de	Sahin, Özgür/F-4403-2014; Wiemann, Stefan/E-4424-2013	Sahin, Özgür/0000-0002-8033-7089; Wiemann, Stefan/0000-0003-4683-3174; Koerner, Cindy/0000-0003-1150-9462; Schmidt, Christian/0000-0002-9605-5959; Keklikoglou, Ioanna/0000-0003-1219-6912	National Genome Research Network of the Federal Ministry of Education and Research (BMBF) [01GS0864, 01GS0816]; German Research Foundation [DIP-WI3499/1-1]; DKFZ	National Genome Research Network of the Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); German Research Foundation(German Research Foundation (DFG)); DKFZ(Helmholtz Association)	This work was supported by the National Genome Research Network (Contracts No. 01GS0864 and 01GS0816) of the Federal Ministry of Education and Research (BMBF), and by the German Research Foundation (DIP-WI3499/1-1). JDZ and CH are supported by the DKFZ International PhD Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexa A, 2006, BIOINFORMATICS, V22, P1600, DOI 10.1093/bioinformatics/btl140; Atienza JM, 2005, J BIOMOL SCREEN, V10, P795, DOI 10.1177/1087057105279635; Bedard J, 1999, ANTIVIR RES, V41, P35, DOI 10.1016/S0166-3542(98)00061-8; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Boutros M, 2004, SCIENCE, V303, P832, DOI 10.1126/science.1091266; Boutros M, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-7-r66; Brummelkamp TR, 2006, NAT CHEM BIOL, V2, P202, DOI 10.1038/nchembio774; Castro A, 2005, ONCOGENE, V24, P314, DOI 10.1038/sj.onc.1207973; *DDCT, DDCT ALG AN QUANT RE; Friedman A, 2006, NATURE, V444, P230, DOI 10.1038/nature05280; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Guo YS, 2008, MOL BIOL CELL, V19, P2830, DOI 10.1091/mbc.E07-12-1236; Han A, 2007, CLIN CANCER RES, V13, P139, DOI 10.1158/1078-0432.CCR-06-1346; HEALD R, 1993, CELL, V74, P463, DOI 10.1016/0092-8674(93)80048-J; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang HC, 2009, CANCER CELL, V16, P347, DOI 10.1016/j.ccr.2009.08.020; Hutchins JRA, 2010, SCIENCE, V328, P593, DOI 10.1126/science.1181348; Jensen LJ, 2009, NUCLEIC ACIDS RES, V37, pD412, DOI 10.1093/nar/gkn760; Juul N, 2010, LANCET ONCOL, V11, P358, DOI 10.1016/S1470-2045(10)70018-8; Kittler R, 2007, NAT CELL BIOL, V9, P1401, DOI 10.1038/ncb1659; Liu XQ, 2006, MOL CELL BIOL, V26, P2093, DOI 10.1128/MCB.26.6.2093-2108.2006; Malo N, 2006, NAT BIOTECHNOL, V24, P167, DOI 10.1038/nbt1186; Matthews L, 2009, NUCLEIC ACIDS RES, V37, pD619, DOI 10.1093/nar/gkn863; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Neumann B, 2006, NAT METHODS, V3, P385, DOI 10.1038/NMETH876; Neumann B, 2010, NATURE, V464, P721, DOI 10.1038/nature08869; NICOLINI C, 1975, J BIOL CHEM, V250, P3381; Nir O, 2010, GENOME RES, V20, P372, DOI 10.1101/gr.100248.109; Quereda JJ, 2010, TRANSPL P, V42, P3239, DOI 10.1016/j.transproceed.2010.05.059; Root DE, 2006, NAT METHODS, V3, P715, DOI 10.1038/NMETH924; *RPSIXML, R INT PSI MI 2 5 FIL; *RTCA, RTCA OP SOURC TOOLK; Sahin O, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-1; Sahin O, 2007, P NATL ACAD SCI USA, V104, P6579, DOI 10.1073/pnas.0606827104; Schlabach MR, 2008, SCIENCE, V319, P620, DOI 10.1126/science.1149200; Sianina H, 2011, J MICROBIOL METH, V84, P101, DOI 10.1016/j.mimet.2010.11.004; Simmer F, 2003, PLOS BIOL, V1, P77, DOI 10.1371/journal.pbio.0000012; Smout MJ, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000885; Vastrik I, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-3-r39; Wang YL, 2004, CANCER BIOL THER, V3, P305, DOI 10.4161/cbt.3.3.697; Yen HCS, 2008, SCIENCE, V322, P918, DOI 10.1126/science.1160489; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206; Zhang JD, 2009, BIOINFORMATICS, V25, P1470, DOI 10.1093/bioinformatics/btp167	43	10	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2011	6	7							e22176	10.1371/journal.pone.0022176	http://dx.doi.org/10.1371/journal.pone.0022176			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	792WQ	21765947	gold, Green Submitted, Green Published			2022-12-27	WOS:000292781500038
J	Abubucker, S; Martin, J; Taylor, CM; Mitreva, M				Abubucker, Sahar; Martin, John; Taylor, Christina M.; Mitreva, Makedonka			HelmCoP: An Online Resource for Helminth Functional Genomics and Drug and Vaccine Targets Prioritization	PLOS ONE			English	Article							NEMATODE MELOIDOGYNE-INCOGNITA; CAENORHABDITIS-ELEGANS; EUKARYOTIC GENOMES; HIGH-THROUGHPUT; BRUGIA-MALAYI; WEB SERVER; PROTEIN; PREDICTION; RNAI; DATABASE	A vast majority of the burden from neglected tropical diseases result from helminth infections (nematodes and platyhelminthes). Parasitic helminthes infect over 2 billion, exerting a high collective burden that rivals high-mortality conditions such as AIDS or malaria, and cause devastation to crops and livestock. The challenges to improve control of parasitic helminth infections are multi-fold and no single category of approaches will meet them all. New information such as helminth genomics, functional genomics and proteomics coupled with innovative bioinformatic approaches provide fundamental molecular information about these parasites, accelerating both basic research as well as development of effective diagnostics, vaccines and new drugs. To facilitate such studies we have developed an online resource, HelmCoP (Helminth Control and Prevention), built by integrating functional, structural and comparative genomic data from plant, animal and human helminthes, to enable researchers to develop strategies for drug, vaccine and pesticide prioritization, while also providing a useful comparative genomics platform. HelmCoP encompasses genomic data from several hosts, including model organisms, along with a comprehensive suite of structural and functional annotations, to assist in comparative analyses and to study host-parasite interactions. The HelmCoP interface, with a sophisticated query engine as a backbone, allows users to search for multi-factorial combinations of properties and serves readily accessible information that will assist in the identification of various genes of interest. HelmCoP is publicly available at: http://www.nematode.net/helmcop.html.	[Abubucker, Sahar; Martin, John; Taylor, Christina M.; Mitreva, Makedonka] Washington Univ, Sch Med, Genome Inst, St Louis, MO 63130 USA; [Mitreva, Makedonka] Washington Univ, Sch Med, Dept Genet, St Louis, MO USA	Washington University (WUSTL); Washington University (WUSTL)	Abubucker, S (corresponding author), Washington Univ, Sch Med, Genome Inst, St Louis, MO 63130 USA.	mmitreva@genome.wustl.edu		Mitreva, Makedonka/0000-0001-9572-3436	NIH/NIAID [AI081803]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI081803] Funding Source: NIH RePORTER	NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by NIH/NIAID grant AI081803 to MM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abad P, 2008, NAT BIOTECHNOL, V26, P909, DOI 10.1038/nbt.1482; AGUERO F, 2008, NAT REV DRUG DISCOV; Aranda B, 2010, NUCLEIC ACIDS RES, V38, pD525, DOI 10.1093/nar/gkp878; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bag S, 2010, ACTA TROP, V113, P48, DOI 10.1016/j.actatropica.2009.09.004; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Berriman M, 2009, NATURE, V460, P352, DOI 10.1038/nature08160; Besier B, 2007, TRENDS PARASITOL, V23, P21, DOI 10.1016/j.pt.2006.11.004; Brindley PJ, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000538; Brooks DR, 2003, J BIOL CHEM, V278, P52340, DOI 10.1074/jbc.M308858200; Chatr-aryamontri A, 2008, METHODS MOL BIOL, V484, P305, DOI 10.1007/978-1-59745-398-1_20; Chen F, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000383; Chen X, 2002, NUCLEIC ACIDS RES, V30, P412, DOI 10.1093/nar/30.1.412; Cheng Y, 2006, TRENDS BIOTECHNOL, V24, P435, DOI 10.1016/j.tibtech.2006.07.005; Corradin Giarnpietro, 2007, Endocrine Metabolic & Immune Disorders-Drug Targets, V7, P259, DOI 10.2174/187153007782794371; Craig H, 2007, TRENDS PARASITOL, V23, P248, DOI 10.1016/j.pt.2007.04.003; Dieterich C, 2008, NAT GENET, V40, P1193, DOI 10.1038/ng.227; Dosztanyi Z, 2005, BIOINFORMATICS, V21, P3433, DOI 10.1093/bioinformatics/bti541; Doyle MA, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-222; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fink AL, 2005, CURR OPIN STRUC BIOL, V15, P35, DOI 10.1016/j.sbi.2005.01.002; Fletcher S, 2006, J R SOC INTERFACE, V3, P215, DOI 10.1098/rsif.2006.0115; Frand AR, 2005, PLOS BIOL, V3, P1719, DOI 10.1371/journal.pbio.0030312; Fraser AG, 2000, NATURE, V408, P325, DOI 10.1038/35042517; Gasbarre LC, 2009, VET PARASITOL, V166, P281, DOI 10.1016/j.vetpar.2009.08.018; Ghedin E, 2007, SCIENCE, V317, P1756, DOI 10.1126/science.1145406; Gonczy P, 2000, NATURE, V408, P331, DOI 10.1038/35042526; HAN ET, 2010, TROP MED INT HLTH; Hillier LW, 2009, GENOME RES, V19, P657, DOI 10.1101/gr.088112.108; Holden-Dye Lindy, 2007, WormBook, P1, DOI 10.1895/wormbook.1.143.1; Hopkins AL, 2002, NAT REV DRUG DISCOV, V1, P727, DOI 10.1038/nrd892; Hotez PJ, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000680; Hotez PJ, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000412; Hunter S, 2009, NUCLEIC ACIDS RES, V37, pD211, DOI 10.1093/nar/gkn785; Kall L, 2007, NUCLEIC ACIDS RES, V35, pW429, DOI 10.1093/nar/gkm256; Kalinna BH, 2007, TRENDS PARASITOL, V23, P197, DOI 10.1016/j.pt.2007.03.007; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Kjetland EF, 2006, AIDS, V20, P593, DOI 10.1097/01.aids.0000210614.45212.0a; Krautz-Peterson G, 2010, PARASITOLOGY, V137, P485, DOI 10.1017/S0031182009991168; Kumar S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001189; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Lipinski CA, 2001, ADV DRUG DELIVER REV, V46, P3, DOI 10.1016/S0169-409X(00)00129-0; Maeda I, 2001, CURR BIOL, V11, P171, DOI 10.1016/S0960-9822(01)00052-5; Mardis ER, 2008, TRENDS GENET, V24, P133, DOI 10.1016/j.tig.2007.12.007; Martin J, 2009, NUCLEIC ACIDS RES, V37, pD571, DOI 10.1093/nar/gkn744; McCarter JP, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-4-r26; McDonnell AV, 2006, BIOINFORMATICS, V22, P356, DOI 10.1093/bioinformatics/bti797; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; Meiler J, 2003, P NATL ACAD SCI USA, V100, P12105, DOI 10.1073/pnas.1831973100; Mitreva M, 2005, TRENDS GENET, V21, P573, DOI 10.1016/j.tig.2005.08.003; Mitreva M, 2004, GENOME RES, V14, P209, DOI 10.1101/gr.1524804; Nandan D, 2007, PROTEINS, V67, P53, DOI 10.1002/prot.21278; Olugbile S, 2009, INFECT IMMUN, V77, P5701, DOI 10.1128/IAI.00652-09; Opperman CH, 2008, P NATL ACAD SCI USA, V105, P14802, DOI 10.1073/pnas.0805946105; Overington JP, 2006, NAT REV DRUG DISCOV, V5, P993, DOI 10.1038/nrd2199; Rost B, 2004, NUCLEIC ACIDS RES, V32, pW321, DOI 10.1093/nar/gkh377; Rual JF, 2004, GENOME RES, V14, P2162, DOI 10.1101/gr.2505604; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shimizu K, 2009, J MOL BIOL, V392, P1253, DOI 10.1016/j.jmb.2009.07.088; Sonnichsen B, 2005, NATURE, V434, P462, DOI 10.1038/nature03353; Tice CM, 2001, PEST MANAG SCI, V57, P3, DOI 10.1002/1526-4998(200101)57:1<3::AID-PS269>3.0.CO;2-6; Urban JF, 2007, VET PARASITOL, V148, P14, DOI 10.1016/j.vetpar.2007.05.006; Villard V, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000645; von Grotthuss M, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-53; Wang ZY, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-23; WEININGER D, 1988, J CHEM INF COMP SCI, V28, P31, DOI 10.1021/ci00057a005; Williamson SM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000517; Wishart DS, 2008, NUCLEIC ACIDS RES, V36, pD901, DOI 10.1093/nar/gkm958; Yang ZR, 2005, BIOINFORMATICS, V21, P3369, DOI 10.1093/bioinformatics/bti534; Zhou Y, 2009, NATURE, V460, P345, DOI 10.1038/nature08140	71	13	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2011	6	7							e21832	10.1371/journal.pone.0021832	http://dx.doi.org/10.1371/journal.pone.0021832			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791IA	21760913	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000292657200025
J	Handel, IG; Willoughby, K; Land, F; Koterwas, B; Morgan, KL; Tanya, VN; Bronsvoort, BMD				Handel, Ian G.; Willoughby, Kim; Land, Fiona; Koterwas, Bronwyn; Morgan, Kenton L.; Tanya, Vincent N.; Bronsvoort, Barend M. deC.			Seroepidemiology of Bovine Viral Diarrhoea Virus (BVDV) in the Adamawa Region of Cameroon and Use of the SPOT Test to Identify Herds with PI Calves	PLOS ONE			English	Article							DAIRY HERDS; CATTLE; PREVALENCE; INFECTION; PESTIVIRUSES; ANTIBODIES; ANIMALS; DISEASE; EPIDEMIOLOGY; ERADICATION	Bovine viral diarrhoea, caused by the bovine viral diarrhoea virus (BVDV) in the Pestivirus genus of the Flaviviridae, is one of the most important diseases of cattle world wide causing poor reproductive performance in adult cattle and mucosal disease in calves. In addition it causes immunosuppression and increased susceptibility to other infections, the impact of which is uncertain, particularly in sub-Saharan Africa where animals are exposed to a much wider range and higher intensity of infections compared to Europe. There are no previous estimates of the seroprevalence of BVDV in cattle in Cameroon. This paper describes the serological screening for antibodies to BVDV and antigen of BVDV in a cattle population in the Adamawa Region of Cameroon in 2000. The estimates of herd-level and within herd seroprevalences adjusted for test imperfections were 92% and 30% respectively and 16.5% of herds were classed as having a persistently infected calf (PI) in the herd within the last year based on the "spot" test approach. There was evidence of clustering of herds with PI calves across the north and west of the Region which corresponds with the higher cattle density areas and of self-clearance of infection from herds. A multivariable model was developed for the risk of having a PI calf in the herd; proximity to antelope, owning a goat, mixing with > 10 other herds at grazing and the catchment area of the veterinary centre the herd was registered at were all significant risk factors. Very little is known about BVDV in sub-Saharan Africa and these high seroprevalences suggest that there is a large problem which may be having both direct impacts on fertility and neonate mortality and morbidity and also indirect effects through immunosuppression and susceptibility to other infections. Understanding and accounting for BVDV should be an important component of epidemiological studies of other diseases in sub-Saharan Africa.	[Handel, Ian G.; Land, Fiona; Koterwas, Bronwyn; Bronsvoort, Barend M. deC.] Univ Edinburgh, Roslin Inst, Royal Dick Sch Vet Studies, Easter Bush, Midlothian, Scotland; [Morgan, Kenton L.] Univ Liverpool, Dept Vet Clin Sci, Leahurst Vet Teaching Hosp, Wirral L64 7TE, Merseyside, England; [Tanya, Vincent N.] Minist Sci Res & Innovat, Yaounde, Cameroon; [Willoughby, Kim] Moredun Res Inst, Penicuik, Midlothian, Scotland	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of Liverpool; Moredun Research Institute	Handel, IG (corresponding author), Univ Edinburgh, Roslin Inst, Royal Dick Sch Vet Studies, Easter Bush, Midlothian, Scotland.	mark.bronsvoort@ed.ac.uk		Bronsvoort, Mark/0000-0002-3271-8485	Wellcome Trust [053840]; BBSRC	Wellcome Trust(Wellcome TrustEuropean Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The original project was funded by Wellcome Trust Grant No. 053840 and the current BVDV analysis was supported from an Institutional Funding Award from the BBSRC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson EC, 1998, EPIDEMIOL INFECT, V121, P441, DOI 10.1017/S0950268898001289; Branscum AJ, 2004, PREV VET MED, V66, P101, DOI 10.1016/j.prevetmed.2004.09.009; Bronsvoort BMD, 2003, TROP ANIM HEALTH PRO, V35, P491, DOI 10.1023/A:1027302525301; Brooks SP, 1998, J COMPUT GRAPH STAT, V7, P434, DOI 10.2307/1390675; Chongsuvivatwong V, 2009, EPICALC EPIDEMIOLOGI; Couacy-Hymann E, 2007, RES VET SCI, V83, P282, DOI 10.1016/j.rvsc.2006.12.010; Ferreira GM, 2000, J S AFR VET ASSOC, V71, P10; GHIROTTI M, 1991, VET RES COMMUN, V15, P25, DOI 10.1007/BF00497787; Gunn GJ, 2005, PREV VET MED, V72, P149, DOI 10.1016/j.prevetmed.2005.08.012; HAMBLIN C, 1990, EPIDEMIOL INFECT, V105, P585, DOI 10.1017/S0950268800048226; Houe H, 2003, BIOLOGICALS, V31, P137, DOI 10.1016/S1045-1056(03)00030-7; HOUE H, 1995, VET CLIN N AM-FOOD A, V11, P521, DOI 10.1016/S0749-0720(15)30465-5; HOUE H, 1992, RES VET SCI, V53, P320, DOI 10.1016/0034-5288(92)90133-M; Innocent G, 1997, EPIDEMIOL INFECT, V119, P91, DOI 10.1017/S0950268897007723; Kabongo N, 2004, J S AFR VET ASSOC, V75, P90; Lindberg A, 2006, REV SCI TECH OIE, V25, P961, DOI 10.20506/rst.25.3.1703; Lindberg A, 2005, PREV VET MED, V72, P55, DOI 10.1016/j.prevetmed.2005.07.018; Lindberg ALE, 1999, VET MICROBIOL, V64, P197, DOI 10.1016/S0378-1135(98)00270-3; Liu LH, 2008, J VIROL METHODS, V154, P82, DOI 10.1016/j.jviromet.2008.09.001; Mishra N, 2009, TROP ANIM HEALTH PRO, V41, P1231, DOI 10.1007/s11250-009-9305-z; Plummer M, 2009, RJAGS BAYESIAN GRAPH; Potgieter L. N. D., 2004, Infectious diseases of livestock. Volume Two, P946; Rufenacht J, 2000, VET REC, V147, P413, DOI 10.1136/vr.147.15.413; Schnute J. T, 2008, PBSMAPPING PBS MAPPI; Scott HM, 2006, CAN VET J, V47, P981; SOINE C, 1992, TROP ANIM HEALTH PRO, V24, P125, DOI 10.1007/BF02356958; Stahl K, 2008, PREV VET MED, V83, P285, DOI 10.1016/j.prevetmed.2007.08.005; Talafha AQ, 2009, TROP ANIM HEALTH PRO, V41, P499, DOI 10.1007/s11250-008-9214-6; TRAVEN M, 1991, J VET MED B, V38, P453, DOI 10.1111/j.1439-0450.1991.tb00895.x; Valle PS, 1999, PREV VET MED, V40, P165, DOI 10.1016/S0167-5877(99)00030-6; Valle PS, 2005, PREV VET MED, V72, P189, DOI 10.1016/j.prevetmed.2005.07.017; Vilcek S, 2006, VET MICROBIOL, V116, P1, DOI 10.1016/j.vetmic.2006.06.003; VILCEK S, 1994, ARCH VIROL, V136, P309, DOI 10.1007/BF01321060	33	21	22	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2011	6	7							e21620	10.1371/journal.pone.0021620	http://dx.doi.org/10.1371/journal.pone.0021620			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791AK	21754993	Green Submitted, Green Published, gold			2022-12-27	WOS:000292632000018
J	Mandelblat-Cerf, Y; Novick, I; Vaadia, E				Mandelblat-Cerf, Yael; Novick, Itai; Vaadia, Eilon			Expressions of Multiple Neuronal Dynamics during Sensorimotor Learning in the Motor Cortex of Behaving Monkeys	PLOS ONE			English	Article							VISUOMOTOR TRANSFORMATIONS; ADAPTATION; CONSOLIDATION; MEMORY; ACQUISITION; ARM; INTERFERENCE; ERROR; COORDINATION; VARIABILITY	Previous studies support the notion that sensorimotor learning involves multiple processes. We investigated the neuronal basis of these processes by recording single-unit activity in motor cortex of non-human primates (Macaca fascicularis), during adaptation to force-field perturbations. Perturbed trials (reaching to one direction) were practiced along with unperturbed trials (to other directions). The number of perturbed trials relative to the unperturbed ones was either low or high, in two separate practice schedules. Unsurprisingly, practice under high-rate resulted in faster learning with more pronounced generalization, as compared to the low-rate practice. However, generalization and retention of behavioral and neuronal effects following practice in high-rate were less stable; namely, the faster learning was forgotten faster. We examined two subgroups of cells and showed that, during learning, the changes in firing-rate in one subgroup depended on the number of practiced trials, but not on time. In contrast, changes in the second subgroup depended on time and practice; the changes in firing-rate, following the same number of perturbed trials, were larger under high-rate than low-rate learning. After learning, the neuronal changes gradually decayed. In the first subgroup, the decay pace did not depend on the practice rate, whereas in the second subgroup, the decay pace was greater following high-rate practice. This group shows neuronal representation that mirrors the behavioral performance, evolving faster but also decaying faster at learning under high-rate, as compared to low-rate. The results suggest that the stability of a new learned skill and its neuronal representation are affected by the acquisition schedule.	[Mandelblat-Cerf, Yael; Novick, Itai; Vaadia, Eilon] Hebrew Univ Jerusalem, Dept Med Neurobiol, Inst Med Res Israel Canada, Fac Med,Edmond & Lily Safra Ctr Brain Sci, Jerusalem, Israel	Hebrew University of Jerusalem	Mandelblat-Cerf, Y (corresponding author), Hebrew Univ Jerusalem, Dept Med Neurobiol, Inst Med Res Israel Canada, Fac Med,Edmond & Lily Safra Ctr Brain Sci, Jerusalem, Israel.	yaelma@mit.edu	Vaadia, Eilon/E-9347-2011		Binational Science Foundation (BSF); Israel Science Foundation; Rosetrees Trust; Ida Baruch fund	Binational Science Foundation (BSF)(US-Israel Binational Science Foundation); Israel Science Foundation(Israel Science Foundation); Rosetrees Trust(Rosetrees Trust); Ida Baruch fund	This work was supported in part by the Binational Science Foundation (BSF), the Israel Science Foundation, special contributions from the Rosetrees Trust, and the Ida Baruch fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Aboukhalil A, 2004, NEUROSCI LETT, V369, P162, DOI 10.1016/j.neulet.2004.07.085; ARCE F, 2005, FACILITATION RATHER; Arce F, 2010, J NEUROSCI, V30, P5415, DOI 10.1523/JNEUROSCI.0076-10.2010; Bays PM, 2005, EXP BRAIN RES, V163, P400, DOI 10.1007/s00221-005-2299-5; Bock O, 2005, EXP BRAIN RES, V163, P258, DOI 10.1007/s00221-005-2231-z; BrashersKrug T, 1996, NATURE, V382, P252, DOI 10.1038/382252a0; BRASHERSKRUG T, 1996, NATURE; Caithness G, 2004, J NEUROSCI, V24, P8662, DOI 10.1523/JNEUROSCI.2214-04.2004; Commins S, 2003, BEHAV BRAIN RES, V139, P215, DOI 10.1016/S0166-4328(02)00270-X; Criscimagna-Hemminger SE, 2003, J NEUROPHYSIOL, V89, P168, DOI 10.1152/jn.00622.2002; CUNNINGHAM HA, 1994, J EXP PSYCHOL HUMAN, V20, P987, DOI 10.1037/0096-1523.20.5.987; Donchin O, 2003, J NEUROSCI, V23, P9032; Donchin O, 2002, J NEUROPHYSIOL, V88, P2114, DOI 10.1152/jn.2002.88.4.2114; Emken JL, 2007, J NEUROPHYSIOL, V97, P3997, DOI 10.1152/jn.01095.2006; Francis JT, 2005, EXP BRAIN RES, V167, P128, DOI 10.1007/s00221-005-0062-6; Fusi S, 2007, NEURON, V54, P319, DOI 10.1016/j.neuron.2007.03.017; Gandolfo F, 1996, P NATL ACAD SCI USA, V93, P3843, DOI 10.1073/pnas.93.9.3843; GEORGOPOULOS AP, 1982, J NEUROSCI, V2, P1527; GHEZ C, 1995, CAN J PHYSIOL PHARM, V73, P273, DOI 10.1139/y95-038; Goedert KM, 2002, LEARN MEMORY, V9, P279, DOI 10.1101/lm.50102; Goodbody SJ, 1998, J NEUROPHYSIOL, V79, P1825, DOI 10.1152/jn.1998.79.4.1825; Huang VS, 2007, J NEUROPHYSIOL, V97, P3976, DOI 10.1152/jn.01281.2006; Hwang EJ, 2003, PLOS BIOL, V1, P209, DOI 10.1371/journal.pbio.0000025; Imamizu H, 2007, EXP BRAIN RES, V181, P395, DOI 10.1007/s00221-007-0940-1; Izawa J, 2008, J NEUROSCI, V28, P2883, DOI 10.1523/JNEUROSCI.5359-07.2008; Karni A, 1998, P NATL ACAD SCI USA, V95, P861, DOI 10.1073/pnas.95.3.861; Krakauer JW, 2000, J NEUROSCI, V20, P8916, DOI 10.1523/jneurosci.20-23-08916.2000; Krakauer JW, 2005, J NEUROSCI, V25, P473, DOI 10.1523/JNEUROSCI.4218-04.2005; LACKNER JR, 1994, J NEUROPHYSIOL, V72, P299, DOI 10.1152/jn.1994.72.1.299; Li CSR, 2001, NEURON, V30, P593, DOI 10.1016/S0896-6273(01)00301-4; Malfait N, 2002, J NEUROSCI, V22, P9656; Mandelblat-Cerf Y, 2011, J NEUROSCI, V31, P300, DOI 10.1523/JNEUROSCI.4055-10.2011; Mattar AAG, 2007, J NEUROPHYSIOL, V98, P3321, DOI 10.1152/jn.00576.2007; Monsell S, 2003, TRENDS COGN SCI, V7, P134, DOI 10.1016/S1364-6613(03)00028-7; Newell KM, 2009, HUM MOVEMENT SCI, V28, P655, DOI 10.1016/j.humov.2009.07.001; Newell KM, 2001, PSYCHOL REV, V108, P57, DOI 10.1037//0033-295X.108.1.57; Nudo RJ, 1996, J NEUROSCI, V16, P785; Pascual Leone A, 1995, J NEUROPHYSIOL, V74, P1037; Paz R, 2005, EXP BRAIN RES, V161, P209, DOI 10.1007/s00221-004-2061-4; Paz R, 2003, NAT NEUROSCI, V6, P882, DOI 10.1038/nn1097; Poggio T, 2004, NATURE, V431, P768, DOI 10.1038/nature03014; Robertson EM, 2004, NAT REV NEUROSCI, V5, P576, DOI 10.1038/nrn1426; Sainburg RL, 1999, J NEUROPHYSIOL, V81, P1045, DOI 10.1152/jn.1999.81.3.1045; Salinas E, 1994, J Comput Neurosci, V1, P89, DOI 10.1007/BF00962720; Savion-Lemieux T, 2005, EXP BRAIN RES, V161, P423, DOI 10.1007/s00221-004-2085-9; Scheidt RA, 2001, J NEUROPHYSIOL, V86, P971, DOI 10.1152/jn.2001.86.2.971; SHADMEHR R, 1994, J NEUROSCI, V14, P3208; Shadmehr R, 1997, J NEUROSCI, V17, P409, DOI 10.1523/JNEUROSCI.17-01-00409.1997; Shadmehr R, 1997, SCIENCE, V277, P821, DOI 10.1126/science.277.5327.821; SHEA CH, 1990, RES Q EXERCISE SPORT, V61, P169, DOI 10.1080/02701367.1990.10608671; Simon DA, 2001, J EXP PSYCHOL LEARN, V27, P907, DOI 10.1037/0278-7393.27.4.907; Smith MA, 2006, PLOS BIOL, V4, P1035, DOI 10.1371/journal.pbio.0040179; TAMASHITA Y, 2008, PLOS COMPUT BIOL, V4; Thoroughman KA, 2005, J NEUROSCI, V25, P8948, DOI 10.1523/JNEUROSCI.1771-05.2005; Thoroughman KA, 2000, NATURE, V407, P742, DOI 10.1038/35037588; Todorov E, 2004, NAT NEUROSCI, V7, P907, DOI 10.1038/nn1309; Todorov E, 2002, NAT NEUROSCI, V5, P1226, DOI 10.1038/nn963; Wulf G, 1997, J EXP PSYCHOL LEARN, V23, P987, DOI 10.1037/0278-7393.23.4.987	58	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2011	6	7							e21626	10.1371/journal.pone.0021626	http://dx.doi.org/10.1371/journal.pone.0021626			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791AK	21754994	gold, Green Published, Green Submitted			2022-12-27	WOS:000292632000019
J	Marzinelli, EM; Underwood, AJ; Coleman, RA				Marzinelli, Ezequiel M.; Underwood, Antony J.; Coleman, Ross A.			Modified Habitats Influence Kelp Epibiota via Direct and Indirect Effects	PLOS ONE			English	Article							BENTHIC MARINE-INVERTEBRATES; SEA-URCHIN; ARTIFICIAL STRUCTURES; ASSEMBLAGES; HOST; RECRUITMENT; ROADS; AUSTRALIA; ECOLOGY; BIODIVERSITY	Addition of man-made structures alters abiotic and biotic characteristics of natural habitats, which can influence abundances of biota directly and/or indirectly, by altering the ecology of competitors or predators. Marine epibiota in modified habitats were used to test hypotheses to distinguish between direct and indirect processes. In Sydney Harbour, kelps on pier-pilings supported greater covers of bryozoans, particularly of the non-indigenous species Membranipora membranacea, than found on natural reefs. Pilings influenced these patterns and processes directly due to the provision of shade and indirectly by altering abundances of sea-urchins which, in turn, affected covers of bryozoans. Indirect effects were more important than direct effects. This indicates that artificial structures affect organisms living on secondary substrata in complex ways, altering the biodiversity and indirectly affecting abundances of epibiota. Understanding how these components of habitats affect ecological processes is necessary to allow sensible prediction of the effects of modifying habitats on the ecology of organisms.	[Marzinelli, Ezequiel M.; Underwood, Antony J.; Coleman, Ross A.] Univ Sydney, Sch Biol Sci, Ctr Res Ecol Impacts Coastal Cities, Sydney, NSW 2006, Australia	University of Sydney	Marzinelli, EM (corresponding author), Univ Sydney, Sch Biol Sci, Ctr Res Ecol Impacts Coastal Cities, Sydney, NSW 2006, Australia.	e.marzinelli@unsw.edu.au	Marzinelli, Ezequiel/AAH-2906-2019; Coleman, Ross A/B-1314-2008; Marzinelli, Ezequiel/I-7726-2012	Marzinelli, Ezequiel/0000-0002-3762-3389; Coleman, Ross A/0000-0003-4136-5914; 	Endeavour International Postgraduate Research Scholarship; Australian Research Council	Endeavour International Postgraduate Research Scholarship(Australian Government); Australian Research Council(Australian Research Council)	This work was supported by funds from an Endeavour International Postgraduate Research Scholarship to EMM. AJU and RAC were supported by grants from the Australian Research Council's Special Research Centres Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blockley DJ, 2006, MAR ECOL PROG SER, V327, P27, DOI 10.3354/meps327027; Blockley DJ, 2007, MAR ENVIRON RES, V63, P409, DOI 10.1016/j.marenvres.2006.10.007; Bruno JF, 2001, MARINE COMMUNITY ECOLOGY, P201; Bulleri F, 2005, ENVIRON CONSERV, V32, P101, DOI 10.1017/S0376892905002183; Cabanes C, 2001, SCIENCE, V294, P840, DOI 10.1126/science.1063556; CANCINO JM, 1987, J EXP MAR BIOL ECOL, V113, P105, DOI 10.1016/0022-0981(87)90158-4; CHAPMAN MG, 1986, J EXP MAR BIOL ECOL, V103, P181, DOI 10.1016/0022-0981(86)90140-1; Clynick BG, 2008, AUSTRAL ECOL, V33, P140, DOI 10.1111/j.1442-9993.2007.01802.x; Coffin AW, 2007, J TRANSP GEOGR, V15, P396, DOI 10.1016/j.jtrangeo.2006.11.006; Connell Sean D., 2007, P556; DANTONIO C, 1985, J EXP MAR BIOL ECOL, V86, P197, DOI 10.1016/0022-0981(85)90103-0; DAYTON PK, 1971, ECOL MONOGR, V41, P351, DOI 10.2307/1948498; de Nys R, 1999, RECENT ADV MARINE BI, V3, P223; Dean WRJ, 2000, J ARID ENVIRON, V45, P305, DOI 10.1006/jare.2000.0652; Didham RK, 2007, TRENDS ECOL EVOL, V22, P489, DOI 10.1016/j.tree.2007.07.001; Easterling DR, 2000, SCIENCE, V289, P2068, DOI 10.1126/science.289.5487.2068; Forman RTT, 1998, ANNU REV ECOL SYST, V29, P207, DOI 10.1146/annurev.ecolsys.29.1.207; Glasby TM, 2007, MAR BIOL, V151, P887, DOI 10.1007/s00227-006-0552-5; Glasby TM, 1999, J EXP MAR BIOL ECOL, V234, P275, DOI 10.1016/S0022-0981(98)00156-7; Hewitt CL, 2004, MAR BIOL, V144, P183, DOI 10.1007/s00227-003-1173-x; Holloway MG, 2002, ECOL APPL, V12, P1803, DOI 10.2307/3099939; Hunt HL, 1997, MAR ECOL PROG SER, V155, P269, DOI 10.3354/meps155269; KEOUGH MJ, 1982, OECOLOGIA, V54, P348, DOI 10.1007/BF00380003; KNIGHT RL, 1995, BIOL CONSERV, V74, P65, DOI 10.1016/0006-3207(94)00003-9; Lidgard S, 2008, MAR ECOL PROG SER, V359, P117, DOI 10.3354/meps07322; Marzinelli EM, 2009, ECOLOGY, V90, P2948, DOI 10.1890/08-1893.1; MARZINELLI EM, 2009, EFFECTS MODIFICATION; MENGE BA, 1995, ECOL MONOGR, V65, P21, DOI 10.2307/2937158; Parendes LA, 2000, CONSERV BIOL, V14, P64, DOI 10.1046/j.1523-1739.2000.99089.x; People J, 2006, AUSTRAL ECOL, V31, P271, DOI 10.1111/j.1442-9993.2006.01585.x; Pressey RL, 2007, TRENDS ECOL EVOL, V22, P583, DOI 10.1016/j.tree.2007.10.001; RODRIGUEZ SR, 1993, MAR ECOL PROG SER, V97, P193, DOI 10.3354/meps097193; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; SOUSA WP, 1984, ANNU REV ECOL SYST, V15, P353, DOI 10.1146/annurev.es.15.110184.002033; STEINBERG PD, 1995, MAR ECOL PROG SER, V127, P169, DOI 10.3354/meps127169; Steneck RS, 2002, ENVIRON CONSERV, V29, P436, DOI 10.1017/S0376892902000322; Trombulak SC, 2000, CONSERV BIOL, V14, P18, DOI 10.1046/j.1523-1739.2000.99084.x; *UN DESA POP DIV, 2007, ESAPWP202 UN DESA PO; UNDERWOOD AJ, 1989, TRENDS ECOL EVOL, V4, P16, DOI 10.1016/0169-5347(89)90008-6; UNDERWOOD AJ, 1989, BIOL J LINN SOC, V37, P51, DOI 10.1111/j.1095-8312.1989.tb02005.x; VANCE RR, 1979, ECOLOGY, V60, P537, DOI 10.2307/1936074; Vitousek PM, 1997, SCIENCE, V277, P494, DOI 10.1126/science.277.5325.494; WAHL M, 1992, MAR ECOL PROG SER, V88, P225, DOI 10.3354/meps088225; WAHL M, 1995, OECOLOGIA, V102, P329, DOI 10.1007/BF00329800; WAHL M, 1989, MAR ECOL PROG SER, V58, P175, DOI 10.3354/meps058175; Wahl M, 2008, BIOFOULING, V24, P427, DOI 10.1080/08927010802339772; Williamson JE, 2004, ECOLOGY, V85, P1355, DOI 10.1890/02-4083; Williamson JE, 2000, BIOL BULL, V198, P332, DOI 10.2307/1542689	48	33	34	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2011	6	7							e21936	10.1371/journal.pone.0021936	http://dx.doi.org/10.1371/journal.pone.0021936			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791AK	21755011	gold, Green Submitted, Green Published			2022-12-27	WOS:000292632000038
J	Lam, CH; Tsontos, VM				Lam, Chi Hin; Tsontos, Vardis M.			Integrated Management and Visualization of Electronic Tag Data with Tagbase	PLOS ONE			English	Article							LIGHT-BASED GEOLOCATION; IMPROVING LIGHT; THUNNUS-OBESUS; TRACKING; HABITAT; OCEAN; MOVEMENTS; TEMPERATURE; SEABIRDS; SYSTEM	Electronic tags have been used widely for more than a decade in studies of diverse marine species. However, despite significant investment in tagging programs and hardware, data management aspects have received insufficient attention, leaving researchers without a comprehensive toolset to manage their data easily. The growing volume of these data holdings, the large diversity of tag types and data formats, and the general lack of data management resources are not only complicating integration and synthesis of electronic tagging data in support of resource management applications but potentially threatening the integrity and longer-term access to these valuable datasets. To address this critical gap, Tagbase has been developed as a well-rounded, yet accessible data management solution for electronic tagging applications. It is based on a unified relational model that accommodates a suite of manufacturer tag data formats in addition to deployment metadata and reprocessed geopositions. Tagbase includes an integrated set of tools for importing tag datasets into the system effortlessly, and provides reporting utilities to interactively view standard outputs in graphical and tabular form. Data from the system can also be easily exported or dynamically coupled to GIS and other analysis packages. Tagbase is scalable and has been ported to a range of database management systems to support the needs of the tagging community, from individual investigators to large scale tagging programs. Tagbase represents a mature initiative with users at several institutions involved in marine electronic tagging research.	[Lam, Chi Hin] Univ So Calif, Dept Biol Sci, Los Angeles, CA 90089 USA; [Tsontos, Vardis M.] NOAA, Fisheries Resources Div, NMFS, SW Fisheries Sci Ctr, La Jolla, CA USA	University of Southern California; National Oceanic Atmospheric Admin (NOAA) - USA	Lam, CH (corresponding author), Univ So Calif, Dept Biol Sci, Los Angeles, CA 90089 USA.	tim@tagbase.org			NASA Headquarters [NNX08AU86H]	NASA Headquarters(National Aeronautics & Space Administration (NASA))	C.H. Lam was supported by the NASA Headquarters under the Earth and Space Science Fellowship Program Grant - NNX08AU86H. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bigelow KA, 2007, CAN J FISH AQUAT SCI, V64, P1581, DOI 10.1139/F07-115; Block BA, 2002, OCEANOL ACTA, V25, P255, DOI 10.1016/S0399-1784(02)01212-4; Boustany AM, 2010, PROG OCEANOGR, V86, P94, DOI 10.1016/j.pocean.2010.04.015; Childers J, 2011, FISH OCEANOGR, V20, P157, DOI 10.1111/j.1365-2419.2011.00575.x; Costello MJ, 2006, MAR ECOL PROG SER, V316, P203, DOI 10.3354/meps316203; Coyne MS, 2005, MAR ECOL PROG SER, V301, P1, DOI 10.3354/meps301001; Evans K, 2009, REV-METHODS TECHNOL, V9, P343, DOI 10.1007/978-1-4020-9640-2_21; Galuardi B, 2010, CAN J FISH AQUAT SCI, V67, P966, DOI 10.1139/F10-033; Halpin PN, 2006, MAR ECOL PROG SER, V316, P239, DOI 10.3354/meps316239; HARTOG, 2009, TAGGING TRACKING MAR, P367; Hays GC, 2009, J EXP MAR BIOL ECOL, V370, P134, DOI 10.1016/j.jembe.2008.12.009; Hobday AJ, 2009, REV-METHODS TECHNOL, V9, P381, DOI 10.1007/978-1-4020-9640-2_23; Hoolihan JP, 2009, B MAR SCI, V84, P257; Howell EA, 2010, PROG OCEANOGR, V86, P81, DOI 10.1016/j.pocean.2010.04.013; Humphries NE, 2010, NATURE, V465, P1066, DOI 10.1038/nature09116; Jones MB, 2006, ANNU REV ECOL EVOL S, V37, P519, DOI 10.1146/annurev.ecolsys.37.091305.110031; Jorgensen SJ, 2010, P ROY SOC B-BIOL SCI, V277, P679, DOI 10.1098/rspb.2009.1155; Kappes MA, 2010, PROG OCEANOGR, V86, P246, DOI 10.1016/j.pocean.2010.04.012; Kelling S, 2009, BIOSCIENCE, V59, P613, DOI 10.1525/bio.2009.59.7.12; Kraus RT, 2011, MAR BIOL, V158, P699, DOI 10.1007/s00227-010-1593-3; Lam CH, 2008, FISH RES, V91, P15, DOI 10.1016/j.fishres.2007.11.002; Lam CH, 2010, MAR ECOL PROG SER, V419, P71, DOI 10.3354/meps08862; Lehodey P, 2010, PROG OCEANOGR, V86, P302, DOI 10.1016/j.pocean.2010.04.021; McIntyre A., 2010, LIFE WORLDS OCEANS D; Nielsen A, 2007, CAN J FISH AQUAT SCI, V64, P1055, DOI 10.1139/F07-064; Nielsen A, 2006, FISH OCEANOGR, V15, P314, DOI 10.1111/j.1365-2419.2005.00401.x; Prince ED, 2010, FISH OCEANOGR, V19, P448, DOI 10.1111/j.1365-2419.2010.00556.x; Righton DA, 2010, MAR ECOL PROG SER, V420, P1, DOI 10.3354/meps08889; Roberts JJ, 2010, ENVIRON MODELL SOFTW, V25, P1197, DOI 10.1016/j.envsoft.2010.03.029; Schaefer KM, 2009, REV-METHODS TECHNOL, V9, P121, DOI 10.1007/978-1-4020-9640-2_8; Schlitzer R, 2002, COMPUT GEOSCI-UK, V28, P1211, DOI 10.1016/S0098-3004(02)00040-7; Shillinger GL, 2008, PLOS BIOL, V6, P1408, DOI 10.1371/journal.pbio.0060171; SIBERT J, 2006, ELECT TAGGING DATABA; Sibert JR, 2003, FISH OCEANOGR, V12, P141, DOI 10.1046/j.1365-2419.2003.00228.x; Speed CW, 2010, MAR ECOL PROG SER, V408, P275, DOI 10.3354/meps08581; TAYLOR N, 2009, SCRS2008097, P513; Tsontos VM, 2002, OCEANOL ACTA, V25, P199, DOI 10.1016/S0399-1784(02)01209-4; TSONTOS VM, 2006, ICES CM Q, V17, P1; Urbano F, 2010, PHILOS T R SOC B, V365, P2177, DOI 10.1098/rstb.2010.0081; Vetter R, 2008, CAL COOP OCEAN FISH, V49, P142; Votier SC, 2010, J APPL ECOL, V47, P487, DOI 10.1111/j.1365-2664.2010.01790.x; Walli A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006151; [No title captured]	43	12	12	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2011	6	7							e21810	10.1371/journal.pone.0021810	http://dx.doi.org/10.1371/journal.pone.0021810			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	789JO	21750734	Green Published, Green Submitted, gold			2022-12-27	WOS:000292512000026
J	Wang, W; Gao, XF; Xiao, L; Xiang, ZH; He, C				Wang, Wei; Gao, Xiao-Fei; Xiao, Lin; Xiang, Zheng-Hua; He, Cheng			K(V)7/KCNQ Channels Are Functionally Expressed in Oligodendrocyte Progenitor Cells	PLOS ONE			English	Article							KCNQ POTASSIUM CHANNELS; OUTER HAIR-CELLS; K+ CHANNELS; NEURONAL EXCITABILITY; SENSORY NEURONS; INHIBITION; BRAIN; SUPPRESSION; MODULATION; CURRENTS	Background: K(V)7/KCNQ channels are widely expressed in neurons and they have multiple important functions, including control of excitability, spike afterpotentials, adaptation, and theta resonance. Mutations in KCNQ genes have been demonstrated to associate with human neurological pathologies. However, little is known about whether K(V)7/KCNQ channels are expressed in oligodendrocyte lineage cells (OLCs) and what their functions in OLCs. Methods and Findings: In this study, we characterized K(V)7/KCNQ channels expression in rat primary cultured OLCs by RT-PCR, immunostaining and electrophysiology. KCNQ2-5 mRNAs existed in all three developmental stages of rat primary cultured OLCs. K(V)7/KCNQ proteins were also detected in oligodendrocyte progenitor cells (OPCs, early developmental stages of OLCs) of rat primary cultures and cortex slices. Voltage-clamp recording revealed that the I-M antagonist XE991 significantly reduced K(V)7/KCNQ channel current ((IK(Q))) in OPCs but not in differentiated oligodendrocytes. In addition, inhibition of K(V)7/KCNQ channels promoted OPCs motility in vitro. Conclusions: These findings showed that K(V)7/KCNQ channels were functionally expressed in rat primary cultured OLCs and might play an important role in OPCs functioning in physiological or pathological conditions.	[Wang, Wei] Second Mil Med Univ, Changzheng Hosp, Neurosci Res Ctr, Minist Educ,Inst Neurosci, Shanghai, Peoples R China; Second Mil Med Univ, Changzheng Hosp, Neurosci Res Ctr, Minist Educ,Key Lab Mol Neurobiol, Shanghai, Peoples R China	Naval Medical University; Naval Medical University	Wang, W (corresponding author), Second Mil Med Univ, Changzheng Hosp, Neurosci Res Ctr, Minist Educ,Inst Neurosci, Shanghai, Peoples R China.	chenghe@smmu.edu.cn	Messier, Claude/A-2322-2008	Messier, Claude/0000-0002-4791-1763	National Natural Science Foundation [30800430]; National Key Basic Research Program [2007CB947100, 2011CB504401]; Ministry of Science and Technology of China [2009ZX09311-001]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); National Key Basic Research Program(National Basic Research Program of China); Ministry of Science and Technology of China(Ministry of Science and Technology, China)	National Natural Science Foundation (30800430), National Key Basic Research Program (2007CB947100, 2011CB504401), and the Ministry of Science and Technology of China (2009ZX09311-001). The funders had no role in study design, date collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS PR, 1982, J PHYSIOL-LONDON, V332, P263, DOI 10.1113/jphysiol.1982.sp014412; Agresti C, 2005, BRAIN RES REV, V48, P157, DOI 10.1016/j.brainresrev.2004.12.005; AIKEN SP, 1995, BRIT J PHARMACOL, V115, P1163, DOI 10.1111/j.1476-5381.1995.tb15019.x; ARMSTRONG RC, 1990, J NEUROSCI RES, V27, P400, DOI 10.1002/jnr.490270319; Attali B, 1997, J NEUROSCI, V17, P8234; Bacia A, 2004, GLIA, V48, P156, DOI 10.1002/glia.20067; Baumann N, 2001, PHYSIOL REV, V81, P871, DOI 10.1152/physrev.2001.81.2.871; Biervert C, 1998, SCIENCE, V279, P403, DOI 10.1126/science.279.5349.403; BJORN CS, 2000, J BIOL CHEM, V275, P24089; Blakemore WF, 1999, J NEUROIMMUNOL, V98, P69, DOI 10.1016/S0165-5728(99)00083-1; Bradl M, 2010, ACTA NEUROPATHOL, V119, P37, DOI 10.1007/s00401-009-0601-5; Brown D A, 1988, Ion Channels, V1, P55; BROWN DA, 1980, NATURE, V283, P673, DOI 10.1038/283673a0; Brown DA, 2000, J AUTONOM NERV SYST, V81, P31, DOI 10.1016/S0165-1838(00)00150-8; Brown DA, 2009, BRIT J PHARMACOL, V156, P1185, DOI 10.1111/j.1476-5381.2009.00111.x; Cao L, 2006, GLIA, V54, P536, DOI 10.1002/glia.20403; Chittajallu R, 2002, P NATL ACAD SCI USA, V99, P2350, DOI 10.1073/pnas.042698399; Cooper EC, 2001, J NEUROSCI, V21, P9529, DOI 10.1523/JNEUROSCI.21-24-09529.2001; Delmas P, 2005, NAT REV NEUROSCI, V6, P850, DOI 10.1038/nrn1785; DUBOISDALCQ M, 1987, EMBO J, V6, P2587, DOI 10.1002/j.1460-2075.1987.tb02549.x; Gallo V, 1996, J NEUROSCI, V16, P2659, DOI 10.1523/jneurosci.16-08-02659.1996; Gamper N, 2003, J GEN PHYSIOL, V122, P17, DOI 10.1085/jgp.200208783; GARD AL, 1989, DEVELOPMENT, V106, P119; Grosse G, 2000, J NEUROSCI, V20, P1869; Gudz TI, 2006, J NEUROSCI, V26, P2458, DOI 10.1523/JNEUROSCI.4054-05.2006; Hadley JK, 2003, J NEUROSCI, V23, P5012; Hadley JK, 2000, BRIT J PHARMACOL, V129, P413, DOI 10.1038/sj.bjp.0703086; Hansen HH, 2008, J PHYSIOL-LONDON, V586, P1823, DOI 10.1113/jphysiol.2007.149450; Ivanova A, 2003, J NEUROSCI RES, V73, P581, DOI 10.1002/jnr.10717; JEFFREY SS, 2001, J NEUROSCI, V21, P1096; Jentsch TJ, 2000, NAT REV NEUROSCI, V1, P21, DOI 10.1038/35036198; Kananura C, 2000, NEUROREPORT, V11, P2063, DOI 10.1097/00001756-200006260-00050; KARSCHIN A, 1995, NEUROSCI LETT, V183, P135, DOI 10.1016/0304-3940(94)11133-4; Kessaris N, 2006, NAT NEUROSCI, V9, P173, DOI 10.1038/nn1620; Kharkovets T, 2006, EMBO J, V25, P642, DOI 10.1038/sj.emboj.7600951; Kharkovets T, 2000, P NATL ACAD SCI USA, V97, P4333, DOI 10.1073/pnas.97.8.4333; KIRK WB, 2005, J NEUROSCI, V2540, P9285; Knutson P, 1997, J NEUROSCI, V17, P2669, DOI 10.1523/jneurosci.17-08-02669.1997; Koyama S, 2006, J NEUROPHYSIOL, V96, P535, DOI 10.1152/jn.00574.2005; Kubisch C, 1999, CELL, V96, P437, DOI 10.1016/S0092-8674(00)80556-5; Lang PM, 2008, NEUROPHARMACOLOGY, V54, P1271, DOI 10.1016/j.neuropharm.2008.04.006; Lastraioli E, 2004, CANCER RES, V64, P606, DOI 10.1158/0008-5472.CAN-03-2360; Liu BY, 2010, J CLIN INVEST, V120, P1240, DOI 10.1172/JCI41084; Luyt K, 2007, J NEUROCHEM, V100, P822, DOI 10.1111/j.1471-4159.2006.04255.x; MALETICSAVATIC M, 1995, J NEUROSCI, V15, P3840; Matheu MP, 2008, IMMUNITY, V29, P602, DOI 10.1016/j.immuni.2008.07.015; MCKINNON RD, 1990, NEURON, V5, P603, DOI 10.1016/0896-6273(90)90215-2; McTigue DM, 2008, J NEUROCHEM, V107, P1, DOI 10.1111/j.1471-4159.2008.05570.x; Morokuma J, 2008, CELL PHYSIOL BIOCHEM, V21, P357, DOI 10.1159/000129628; Neusch C, 2001, J NEUROSCI, V21, P5429, DOI 10.1523/JNEUROSCI.21-15-05429.2001; Nisenbaum ES, 1996, J NEUROPHYSIOL, V76, P1180, DOI 10.1152/jn.1996.76.2.1180; Paez PM, 2010, J NEUROSCI, V30, P6422, DOI 10.1523/JNEUROSCI.5086-09.2010; Paez PM, 2009, J NEUROSCI, V29, P6663, DOI 10.1523/JNEUROSCI.5806-08.2009; Pankratov Y, 2006, PFLUG ARCH EUR J PHY, V452, P589, DOI 10.1007/s00424-006-0061-x; Passmore GM, 2003, J NEUROSCI, V23, P7227, DOI 10.1523/JNEUROSCI.23-18-07227.2003; Peters HC, 2005, NAT NEUROSCI, V8, P51, DOI 10.1038/nn1375; Rao JN, 2002, AM J PHYSIOL-CELL PH, V282, pC885, DOI 10.1152/ajpcell.00361.2001; Richardson WD, 2006, NAT REV NEUROSCI, V7, P11, DOI 10.1038/nrn1826; Robbins J, 2001, PHARMACOL THERAPEUT, V90, P1, DOI 10.1016/S0163-7258(01)00116-4; Saganich MJ, 2001, J NEUROSCI, V21, P4609, DOI 10.1523/JNEUROSCI.21-13-04609.2001; Schipke CG, 2001, FASEB J, V15, P255, DOI 10.1096/fj.01-0514fje; Schroeder BC, 2000, J BIOL CHEM, V275, P24089, DOI 10.1074/jbc.M003245200; Schwarz JR, 2006, J PHYSIOL-LONDON, V573, P17, DOI 10.1113/jphysiol.2006.106815; Schweitzer P, 2000, J NEUROSCI, V20, P51, DOI 10.1523/JNEUROSCI.20-01-00051.2000; Shah MM, 2002, J PHYSIOL-LONDON, V544, P29, DOI 10.1113/jphysiol.2002.028571; Shapiro MS, 2000, J NEUROSCI, V20, P1710; Shen WX, 2004, J NEUROPHYSIOL, V91, P1337, DOI 10.1152/jn.00414.2003; SHRAGER P, 1995, DEV BRAIN RES, V88, P68, DOI 10.1016/0165-3806(95)00081-N; Tinel N, 1998, FEBS LETT, V438, P171, DOI 10.1016/S0014-5793(98)01296-4; Tiwari-Woodruff S, 2006, AM J PHYSIOL-CELL PH, V291, pC687, DOI 10.1152/ajpcell.00510.2005; Tkatch T, 2000, J NEUROSCI, V20, P579, DOI 10.1523/JNEUROSCI.20-02-00579.2000; Toral C, 2007, LIFE SCI, V81, P255, DOI 10.1016/j.lfs.2007.05.014; Wang HS, 1998, SCIENCE, V282, P1890, DOI 10.1126/science.282.5395.1890; Wladyka CL, 2008, J PHYSIOL-LONDON, V586, P795, DOI 10.1113/jphysiol.2007.145284; Wladyka CL, 2006, J PHYSIOL-LONDON, V575, P175, DOI 10.1113/jphysiol.2006.113308; Yue CY, 2004, J NEUROSCI, V24, P4614, DOI 10.1523/JNEUROSCI.0765-04.2004; Yus-Najera E, 2003, NEUROSCIENCE, V120, P353, DOI 10.1016/S0306-4522(03)00321-X; Zaika O, 2006, J PHYSIOL-LONDON, V575, P49, DOI 10.1113/jphysiol.2006.114074; Zhang HL, 2003, NEURON, V37, P963, DOI 10.1016/S0896-6273(03)00125-9	79	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2011	6	7							e21792	10.1371/journal.pone.0021792	http://dx.doi.org/10.1371/journal.pone.0021792			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	789JO	21750731	Green Submitted, Green Published, gold			2022-12-27	WOS:000292512000023
J	Papatsenko, D; Levine, M				Papatsenko, Dmitri; Levine, Michael			The Drosophila Gap Gene Network Is Composed of Two Parallel Toggle Switches	PLOS ONE			English	Article							COOPERATIVE DNA-BINDING; TRANSCRIPTIONAL REGULATION; BICOID PROTEIN; EXPRESSION; HUNCHBACK; ACTIVATION; KRUPPEL; GRADIENT; LAMBDA; STRIPE	Drosophila "gap'' genes provide the first response to maternal gradients in the early fly embryo. Gap genes are expressed in a series of broad bands across the embryo during first hours of development. The gene network controlling the gap gene expression patterns includes inputs from maternal gradients and mutual repression between the gap genes themselves. In this study we propose a modular design for the gap gene network, involving two relatively independent network domains. The core of each network domain includes a toggle switch corresponding to a pair of mutually repressive gap genes, operated in space by maternal inputs. The toggle switches present in the gap network are evocative of the phage lambda switch, but they are operated positionally (in space) by the maternal gradients, so the synthesis rates for the competing components change along the embryo anterior-posterior axis. Dynamic model, constructed based on the proposed principle, with elements of fractional site occupancy, required 5-7 parameters to fit quantitative spatial expression data for gap gradients. The identified model solutions (parameter combinations) reproduced major dynamic features of the gap gradient system and explained gap expression in a variety of segmentation mutants.	[Papatsenko, Dmitri] Mt Sinai Sch Med, Black Family Stem Cell Inst, Dept Gene & Cell Med, New York, NY USA; [Levine, Michael] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	Icahn School of Medicine at Mount Sinai; University of California System; University of California Berkeley	Papatsenko, D (corresponding author), Mt Sinai Sch Med, Black Family Stem Cell Inst, Dept Gene & Cell Med, New York, NY USA.	dimitri.papatsenko@mssm.edu	Papatsenko, Dmitri/G-7375-2016	Papatsenko, Dmitri/0000-0002-4390-5446; Levine, Michael/0000-0001-7629-0081	National Institutes of Health [GM46638]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM046638, R37GM046638] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The work was supported by a grant from the National Institutes of Health GM46638. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACKERS GK, 1982, P NATL ACAD SCI-BIOL, V79, P1129, DOI 10.1073/pnas.79.4.1129; Berezhkovskii AM, 2010, BIOPHYS J, V99, pL59, DOI 10.1016/j.bpj.2010.07.045; Bintu L, 2005, CURR OPIN GENET DEV, V15, P125, DOI 10.1016/j.gde.2005.02.006; Bintu L, 2005, CURR OPIN GENET DEV, V15, P116, DOI 10.1016/j.gde.2005.02.007; Bolouri H, 2002, BIOESSAYS, V24, P1118, DOI 10.1002/bies.10189; Bolouri H, 2008, COMPUTATIONAL MODELI; Burz DS, 1998, EMBO J, V17, P5998, DOI 10.1093/emboj/17.20.5998; BURZ DS, 1994, BIOCHEMISTRY-US, V33, P8406, DOI 10.1021/bi00194a004; Clyde DE, 2003, NATURE, V426, P849, DOI 10.1038/nature02189; Davidson EH, 2002, SCIENCE, V295, P1669, DOI 10.1126/science.1069883; DILAO R, PLOS, V5; DRIEVER W, 1989, NATURE, V337, P138, DOI 10.1038/337138a0; DRIEVER W, 1988, CELL, V54, P95, DOI 10.1016/0092-8674(88)90183-3; Fujimoto K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002772; Gertz J, 2009, NATURE, V457, P215, DOI 10.1038/nature07521; Gregor T, 2007, CELL, V130, P153, DOI 10.1016/j.cell.2007.05.025; Gregor T, 2007, CELL, V130, P141, DOI 10.1016/j.cell.2007.05.026; HASTINGS WK, 1970, BIOMETRIKA, V57, P97, DOI 10.2307/2334940; Holloway DM, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001069; HULSKAMP M, 1990, NATURE, V346, P577, DOI 10.1038/346577a0; Ishihara S, 2008, J THEOR BIOL, V252, P131, DOI 10.1016/j.jtbi.2008.01.027; Jaeger J, 2004, GENETICS, V167, P1721, DOI 10.1534/genetics.104.027334; Jaeger J, 2004, NATURE, V430, P368, DOI 10.1038/nature02678; Janssens H, 2006, NAT GENET, V38, P1159, DOI 10.1038/ng1886; KAZEMIAN M, PLOS, V8; KRAUT R, 1991, DEVELOPMENT, V111, P601; KRAUT R, 1991, DEVELOPMENT, V111, P611; Ladame S, 2006, BIOCHEMISTRY-US, V45, P1393, DOI 10.1021/bi050229x; Lander AD, 2002, DEV CELL, V2, P785, DOI 10.1016/S1534-5807(02)00179-X; LANGELAND JA, 1994, DEVELOPMENT, V120, P2945; Lebrecht D, 2005, P NATL ACAD SCI USA, V102, P13176, DOI 10.1073/pnas.0506462102; Librizzi MD, 1996, J BIOL CHEM, V271, P32695, DOI 10.1074/jbc.271.51.32695; Lifanov AP, 2003, GENOME RES, V13, P579, DOI 10.1101/gr.668403; Lopes FJP, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000184; Manu, 2009, PLOS BIOL, V7, P591, DOI 10.1371/journal.pbio.1000049; MARGOLIS JS, 1995, DEVELOPMENT, V121, P3067; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; MJOLSNESS E, 1991, J THEOR BIOL, V152, P429, DOI 10.1016/S0022-5193(05)80391-1; Owen AB, 2005, P NATL ACAD SCI USA, V102, P8844, DOI 10.1073/pnas.0409596102; Papatsenko D, 2008, P NATL ACAD SCI USA, V105, P2901, DOI 10.1073/pnas.0711941105; Papatsenko D, 2009, NUCLEIC ACIDS RES, V37, P5665, DOI 10.1093/nar/gkp619; Papatsenko D, 2009, BIOESSAYS, V31, P1172, DOI 10.1002/bies.200900096; Perkins TJ, 2006, PLOS COMPUT BIOL, V2, P417, DOI 10.1371/journal.pcbi.0020051; Pisarev A, 2009, NUCLEIC ACIDS RES, V37, pD560, DOI 10.1093/nar/gkn717; Poustelnikova E, 2004, BIOINFORMATICS, V20, P2212, DOI 10.1093/bioinformatics/bth222; Ptashne M, 2005, TRENDS BIOCHEM SCI, V30, P275, DOI 10.1016/j.tibs.2005.04.003; RIVERAPOMAR R, 1995, NATURE, V376, P253, DOI 10.1038/376253a0; Sample C, 2010, P NATL ACAD SCI USA, V107, P10092, DOI 10.1073/pnas.1001139107; SCHULZ C, 1994, DEVELOPMENT, V120, P3043; STANOJEVIC D, 1991, SCIENCE, V254, P1385, DOI 10.1126/science.1683715; STRUHL G, 1992, CELL, V69, P237, DOI 10.1016/0092-8674(92)90405-2; STRUHL G, 1989, CELL, V57, P1259, DOI 10.1016/0092-8674(89)90062-7; WILSON D, 1993, GENE DEV, V7, P2120, DOI 10.1101/gad.7.11.2120; Zinzen RP, 2007, PLOS COMPUT BIOL, V3, P826, DOI 10.1371/journal.pcbi.0030084; Zinzen RP, 2006, CURR BIOL, V16, P1358, DOI 10.1016/j.cub.2006.05.044; ZUO P, 1991, GENE DEV, V5, P254, DOI 10.1101/gad.5.2.254	56	32	32	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2011	6	7							e21145	10.1371/journal.pone.0021145	http://dx.doi.org/10.1371/journal.pone.0021145			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786HC	21747931	Green Published, Green Submitted, gold			2022-12-27	WOS:000292293400006
J	Caron, F; d'Errico, F; Del Moral, P; Santos, F; Zilhao, J				Caron, Francois; d'Errico, Francesco; Del Moral, Pierre; Santos, Frederic; Zilhao, Joao			The Reality of Neandertal Symbolic Behavior at the Grotte du Renne, Arcy-sur-Cure, France	PLOS ONE			English	Article							ORNAMENTS; MODERNITY; EMERGENCE; REMAINS; CONTEXT; MIDDLE	Background: The question of whether symbolically mediated behavior is exclusive to modern humans or shared with anatomically archaic populations such as the Neandertals is hotly debated. At the Grotte du Renne, Arcy-sur-Cure, France, the Chatelperronian levels contain Neandertal remains and large numbers of personal ornaments, decorated bone tools and colorants, but it has been suggested that this association reflects intrusion of the symbolic artifacts from the overlying Protoaurignacian and/or of the Neandertal remains from the underlying Mousterian. Methodology/Principal Findings: We tested these hypotheses against the horizontal and vertical distributions of the various categories of diagnostic finds and statistically assessed the probability that the Chatelperronian levels are of mixed composition. Our results reject that the associations result from large or small scale, localized or generalized post-depositional displacement, and they imply that incomplete sample decontamination is the parsimonious explanation for the stratigraphic anomalies seen in the radiocarbon dating of the sequence. Conclusions/Significance: The symbolic artifacts in the Chatelperronian of the Grotte du Renne are indeed Neandertal material culture.	[Caron, Francois; Del Moral, Pierre] Univ Bordeaux, Inst Math Bordeaux, Inst Natl Rech Informat & Automat Bordeaux Sud Ou, Talence, France; [d'Errico, Francesco; Santos, Frederic] Univ Bordeaux, Unite Mixte Rech Prehist Actuel Culture Environm, Talence, France; [d'Errico, Francesco] Univ Bergen, Inst Archaeol Hist Cultural & Religious Studies, Bergen, Norway; [Zilhao, Joao] Univ Barcelona, Inst Catalana Recerca & Estudis Avancats, Seminari Estudis & Recerques Preistor, Barcelona, Spain	Centre National de la Recherche Scientifique (CNRS); Inria; UDICE-French Research Universities; Universite de Bordeaux; UDICE-French Research Universities; Universite de Bordeaux; University of Bergen; ICREA; University of Barcelona	Caron, F (corresponding author), Univ Bordeaux, Inst Math Bordeaux, Inst Natl Rech Informat & Automat Bordeaux Sud Ou, Talence, France.	f.derrico@pacea.u-bordeaux1.fr	Caron, Francois/G-1312-2010; Zilhão, João/L-5670-2014; Santos, Frédéric/I-3565-2019; Del Moral, Pierre/F-5433-2014	Zilhão, João/0000-0001-5937-3061; Santos, Frédéric/0000-0003-1445-3871; Del Moral, Pierre/0000-0003-1151-6662	European Research Council [249587]; ICREA Funding Source: Custom	European Research Council(European Research Council (ERC)European Commission); ICREA(ICREA)	This work was supported by the European Research Council (FP7/2007/2013/ERC Grant TRACSYMBOLS no249587). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agresti A., 2013, CATEGORICAL DATA ANA, V3rd ed.; Bailey SE, 2006, J HUM EVOL, V50, P485, DOI 10.1016/j.jhevol.2005.11.008; Bar-Yosef O, 2010, J HUM EVOL, V59, P586, DOI 10.1016/j.jhevol.2010.06.009; BARYOSEF O, 2006, NEANDERTHALS MODERN, P467; Bernardo J.M., 2004, BAYESIAN THEORY; Brantingham PJ, 2007, J ANTHROPOL ARCHAEOL, V26, P517, DOI 10.1016/j.jaa.2007.08.003; Conard NJ, 2008, S AFR ARCHAEOL SOC G, V10, P175; Couraud C., 1991, GALLIA PREHISTOIRE, V33, P17, DOI DOI 10.3406/galip.1991.2284; d'Errico F, 1998, CURR ANTHROPOL, V39, pS1, DOI 10.1086/204689; D'Errico F., 2003, CHRONOLOGY AURIGNACI, P247; d'Errico F, 2011, PHILOS T R SOC B, V366, P1060, DOI 10.1098/rstb.2010.0340; David F., 2001, B SOC PREHIST FR, V98, P207; de Beaune S.A., 2002, AURIGNACIEN GROTTE R, P199; DeGiorgio M, 2009, P NATL ACAD SCI USA, V106, P16057, DOI 10.1073/pnas.0903341106; Granger JM, 1997, CR ACAD SCI II A, V325, P537, DOI 10.1016/S1251-8050(97)89874-6; Higham T, 2006, P NATL ACAD SCI USA, V103, P553, DOI 10.1073/pnas.0510005103; Higham T, 2011, ANTIQUITY, V85, P235, DOI 10.1017/S0003598X00067570; Higham T, 2010, P NATL ACAD SCI USA, V107, P20234, DOI 10.1073/pnas.1007963107; Hovers E, 2009, SOURCEBOOK OF PALEOLITHIC TRANSITIONS, P455, DOI 10.1007/978-0-387-76487-0_30; Jacobs Z, 2008, SCIENCE, V322, P733, DOI 10.1126/science.1162219; Julien M., 2002, AURIGNACIEN GROTTE S, P217; Langley MC, 2008, CAMB ARCHAEOL J, V18, P289, DOI 10.1017/S0959774308000371; LEROI-GOURHAN A., 1964, RELIG PREHISTOIRE; Leroi-Gourhan A., 1968, PREHISTOIRE PROBLEME, P275; LEROIGOURHANARL, 1964, GALLIA PREHISTOIRE, V7, P36; Mellars P, 2010, P NATL ACAD SCI USA, V107, P20147, DOI 10.1073/pnas.1014588107; Nowell A, 2010, ANNU REV ANTHROPOL, V39, P437, DOI 10.1146/annurev.anthro.012809.105113; Peresani M, 2011, P NATL ACAD SCI USA, V108, P3888, DOI 10.1073/pnas.1016212108; Ramsey CB, 2009, RADIOCARBON, V51, P337, DOI 10.1017/S0033822200033865; Rightmire GP, 2009, P NATL ACAD SCI USA, V106, P16046, DOI 10.1073/pnas.0903930106; Roussel M, 2010, PREHISTOIRE ENTRE VI, P203; SALOMON H, 2009, THESIS U BORDEAUX; SALVATORE JR, 2009, SOURCEBOOK PALEOLITH, P377; Schmider B., 2002, AURIGNACIEN GROTTE R, P253; SCHMIDER B, 2002, AURIGNACIEN GROTTE R, P15; Wasserman L., 2003, ALL STAT CONCISE COU; White R., 2001, ATHENA REV, V2, P41, DOI DOI 10.1016/J.JHEVOL.2008.08.017; Zilhao J., 2003, PALEO, V15, P69; Zilhao J, 2007, J ARCHAEOL RES, V15, P1, DOI 10.1007/s10814-006-9008-1; Zilhao J, 2006, EVOL ANTHROPOL, V15, P183, DOI 10.1002/evan.20110; Zilhao J, 2006, P NATL ACAD SCI USA, V103, P12643, DOI 10.1073/pnas.0605128103; Zilhao J, 2011, VERTEBR PALEOBIOL PA, P331, DOI 10.1007/978-94-007-0492-3_25; Zilhao J, 2010, P NATL ACAD SCI USA, V107, P1023, DOI 10.1073/pnas.0914088107	43	112	115	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2011	6	6							e21545	10.1371/journal.pone.0021545	http://dx.doi.org/10.1371/journal.pone.0021545			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	786FZ	21738702	Green Published, gold, Green Submitted			2022-12-27	WOS:000292290100034
J	Dullinger, S; Hulber, K				Dullinger, Stefan; Huelber, Karl			Experimental Evaluation of Seed Limitation in Alpine Snowbed Plants	PLOS ONE			English	Article							SPECIES-RICHNESS; CLIMATE-CHANGE; COMMUNITIES; DISPERSAL; DISTRIBUTIONS; RECRUITMENT; DEMOGRAPHY; MICROSITE; HABITAT; ROLES	Background: The distribution and abundance of plants is controlled by the availability of seeds and of sites suitable for establishment. The relative importance of these two constraints is still contentious and possibly varies among species and ecosystems. In alpine landscapes, the role of seed limitation has traditionally been neglected, and the role of abiotic gradients emphasized. Methodology/Principal Findings: We evaluated the importance of seed limitation for the incidence of four alpine snowbed species (Achillea atrata L., Achillea clusiana Tausch, Arabis caerulea L., Gnaphalium hoppeanum W. D. J. Koch) in local plant communities by comparing seedling emergence, seedling, juvenile and adult survival, juvenile and adult growth, flowering frequency as well as population growth rates lambda of experimental plants transplanted into snowbed patches which were either occupied or unoccupied by the focal species. In addition, we accounted for possible effects of competition or facilitation on these rates by including a measure of neighbourhood biomass into the analysis. We found that only A. caerulea had significantly lower seedling and adult survival as well as a lower population growth rate in unoccupied sites whereas the vital rates of the other three species did not differ among occupied and unoccupied sites. By contrast, all species were sensitive to competitive effects of the surrounding vegetation in terms of at least one of the studied rates. Conclusions/Significance: We conclude that seed and site limitation jointly determine the species composition of these snowbed plant communities and that constraining site factors include both abiotic conditions and biotic interactions. The traditional focus on abiotic gradients for explaining alpine plant distribution hence appears lopsided. The influence of seed limitation on the current distribution of these plants casts doubt on their ability to readily track shifting habitats under climate change unless seed production is considerably enhanced under a warmer climate.	[Dullinger, Stefan; Huelber, Karl] Univ Vienna, Fac Ctr Biodivers, Dept Conservat Biol Vegetat & Landscape Ecol, Vienna, Austria; [Dullinger, Stefan; Huelber, Karl] Vienna Inst Nat Conservat & Anal, Vienna, Austria	University of Vienna	Dullinger, S (corresponding author), Univ Vienna, Fac Ctr Biodivers, Dept Conservat Biol Vegetat & Landscape Ecol, Vienna, Austria.	karl.huelber@vinca.at	Hülber, Karl/H-7822-2019	Hülber, Karl/0000-0001-9274-1647; Dullinger, Stefan/0000-0003-3919-0887	Austrian Science Fund FWF [P17632-B03]; European Science Commission [036866:ECOCHANGE]	Austrian Science Fund FWF(Austrian Science Fund (FWF)); European Science Commission	The study was funded by the Austrian Science Fund FWF (P17632-B03). Additional financial support came from the European Science Commission (FP 6 project 036866:ECOCHANGE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BATES D, 2004, DAI B LME4 LINEAR MI; BILLINGS WD, 1968, BIOL REV, V43, P481, DOI 10.1111/j.1469-185X.1968.tb00968.x; Callaway RM, 2002, NATURE, V417, P844, DOI 10.1038/nature00812; CANTY A, 2008, BOOT BOOTSTRAP R S P, P2; Caswell, 2000, MATRIX POPULATION MO; Choler P, 2001, ECOLOGY, V82, P3295, DOI 10.1890/0012-9658(2001)082[3295:FACOGI]2.0.CO;2; Clark CJ, 2007, AM NAT, V170, P128, DOI 10.1086/518565; Dirnbock T, 2003, J BIOGEOGR, V30, P401, DOI 10.1046/j.1365-2699.2003.00839.x; DIRNBOCK T, 1997, LINZER BIOL BEITRAGE, V229, P623; Dirnbock T., 1999, MITTEILUNGEN NATURWI, V129, P111; Dirnboeck T., 1997, Linzer Biologische Beitrage, V29, P299; Dullinger S, 2007, J ECOL, V95, P1284, DOI 10.1111/j.1365-2745.2007.01288.x; Dullinger S, 2011, ECOGRAPHY, V34, P576, DOI 10.1111/j.1600-0587.2010.06601.x; Efron Bradley, 1993, INTRO BOOTSTRAP, V57; Ehrlen J, 2006, J ECOL, V94, P1224, DOI 10.1111/j.1365-2745.2006.01169.x; Ellenberg H., 2010, OKOLOGISCHER DYNAMIS; Emery NC, 2009, NEW PHYTOL, V181, P734, DOI 10.1111/j.1469-8137.2008.02676.x; Engler R, 2011, GLOBAL CHANGE BIOL, V17, P2330, DOI 10.1111/j.1365-2486.2010.02393.x; Engler R, 2009, ECOGRAPHY, V32, P34, DOI 10.1111/j.1600-0587.2009.05789.x; Eskelinen A, 2005, OIKOS, V110, P360, DOI 10.1111/j.0030-1299.2005.13579.x; Forbis TA, 2004, AM J BOT, V91, P1147, DOI 10.3732/ajb.91.7.1147; Forbis TA, 2003, AM J BOT, V90, P1197, DOI 10.3732/ajb.90.8.1197; Foster BL, 2001, ECOL LETT, V4, P530, DOI 10.1046/j.1461-0248.2001.00266.x; Franco M, 2004, ECOLOGY, V85, P531, DOI 10.1890/02-0651; Grabherr G., 1993, PFLANZENGESELLSCHA 2, P276; Greene DF, 2002, DISPERSAL ECOLOGY, P3; Greimler J., 1996, Linzer Biologische Beitraege, V28, P437; GRUBB PJ, 1977, BIOL REV, V52, P107, DOI 10.1111/j.1469-185X.1977.tb01347.x; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Gustafsson C, 2002, J VEG SCI, V13, P719, DOI 10.1111/j.1654-1103.2002.tb02099.x; Heegaard E, 2004, OECOLOGIA, V139, P459, DOI 10.1007/s00442-004-1523-5; Heer C, 2002, BASIC APPL ECOL, V3, P39, DOI 10.1078/1439-1791-00075; HORVITZ CC, 1995, ECOL MONOGR, V65, P155, DOI 10.2307/2937136; Howard TG, 2001, ECOLOGY, V82, P979, DOI 10.1890/0012-9658(2001)082[0979:CRHFGG]2.0.CO;2; Hulber K, 2011, PERSPECT PLANT ECOL, V13, P15, DOI 10.1016/j.ppees.2011.01.001; Kikvidze Z, 2005, ECOLOGY, V86, P1395, DOI 10.1890/04-1926; Klanderud K, 2005, J ECOL, V93, P127, DOI 10.1111/j.1365-2745.2004.00944.x; Klanderud K, 2010, J ECOL, V98, P1128, DOI 10.1111/j.1365-2745.2010.01703.x; Korner C, 2003, ALPINE PLANT LIFE FU, DOI DOI 10.1007/978-3-030-59538-8; LEFKOVITCH LP, 1965, BIOMETRICS, V21, P1, DOI 10.2307/2528348; Moore KA, 2006, ECOL LETT, V9, P797, DOI 10.1111/j.1461-0248.2006.00923.x; Moore KA, 2009, ECOLOGY, V90, P378, DOI 10.1890/07-1753.1; Munzbergova Z, 2005, OECOLOGIA, V145, P1, DOI 10.1007/s00442-005-0052-1; Munzbergova Z, 2004, J ECOL, V92, P854, DOI 10.1111/j.0022-0477.2004.00919.x; Myers JA, 2009, ECOL LETT, V12, P1250, DOI 10.1111/j.1461-0248.2009.01373.x; Ouborg N. J., 2003, ECOLOGY GENETICS EVO, P447; Pearman PB, 2008, ECOL LETT, V11, P357, DOI 10.1111/j.1461-0248.2007.01150.x; R Development Core Team, 2008, LANG ENV STAT COMP; Randin CF, 2009, GLOBAL CHANGE BIOL, V15, P1557, DOI 10.1111/j.1365-2486.2008.01766.x; SILVERTOWN J, 1993, J ECOL, V81, P465, DOI 10.2307/2261525; Turnbull LA, 2000, OIKOS, V88, P225, DOI 10.1034/j.1600-0706.2000.880201.x; Zobel M, 2000, ECOLOGY, V81, P3274, DOI 10.1890/0012-9658(2000)081[3274:ISSSRL]2.0.CO;2	52	19	20	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2011	6	6							e21537	10.1371/journal.pone.0021537	http://dx.doi.org/10.1371/journal.pone.0021537			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786FZ	21738694	Green Published, Green Submitted, gold			2022-12-27	WOS:000292290100033
J	Peng, MS; Zhang, YP				Peng, Min-Sheng; Zhang, Ya-Ping			Inferring the Population Expansions in Peopling of Japan	PLOS ONE			English	Article							HUMAN MITOCHONDRIAL-DNA; BAYESIAN COALESCENT INFERENCE; GENOME VARIATION; MTDNA GENOMES; AMERICA; ORIGINS; SEQUENCES; COLONIZATION; EVOLUTION; HISTORY	Background: Extensive studies in different fields have been performed to reconstruct the prehistory of populations in the Japanese archipelago. Estimates the ancestral population dynamics based on Japanese molecular sequences can extend our understanding about the colonization of Japan and the ethnogenesis of modern Japanese. Methodology/Principal Findings: We applied Bayesian skyline plot (BSP) with a dataset based on 952 Japanese mitochondrial DNA (mtDNA) genomes to depict the female effective population size (N-ef) through time for the total Japanese and each of the major mtDNA haplogroups in Japanese. Our results revealed a rapid N-ef growth since similar to 5 thousand years ago had left similar to 72% Japanese mtDNA lineages with a salient signature. The BSP for the major mtDNA haplogroups indicated some different demographic history. Conclusions/Significance: The results suggested that the rapid population expansion acted as a major force in shaping current maternal pool of Japanese. It supported a model for population dynamics in Japan in which the prehistoric population growth initiated in the Middle Jomon Period experienced a smooth and swift transition from Jomon to Yayoi, and then continued through the Yayoi Period. The confounding demographic backgrounds of different mtDNA haplogroups could also have some implications for some related studies in future.	[Peng, Min-Sheng; Zhang, Ya-Ping] Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Kunming, Yunnan, Peoples R China; [Peng, Min-Sheng; Zhang, Ya-Ping] KIZ CUHK Joint Lab Bioresources & Mol Res Common, Kunming, Yunnan, Peoples R China; [Zhang, Ya-Ping] Yunnan Univ, Lab Conservat & Utilizat Bioresources, Kunming 650091, Yunnan, Peoples R China; [Peng, Min-Sheng] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China	Chinese Academy of Sciences; Kunming Institute of Zoology; Yunnan University; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Peng, MS (corresponding author), Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Kunming, Yunnan, Peoples R China.	zhangyp@mail.kiz.ac.cn			National Natural Science Foundation of China [30621092, 30900797]; Bureau of Science and Technology of Yunnan Province [2009CI119]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Bureau of Science and Technology of Yunnan Province	This study was supported by grants from the National Natural Science Foundation of China (30621092 and 30900797) and the Bureau of Science and Technology of Yunnan Province (2009CI119). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Atkinson QD, 2008, MOL BIOL EVOL, V25, P468, DOI 10.1093/molbev/msm277; Atkinson QD, 2009, P ROY SOC B-BIOL SCI, V276, P367, DOI 10.1098/rspb.2008.0785; Bilal E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002421; Bleed P, 2010, J ARCHAEOL METHOD TH, V17, P356, DOI 10.1007/s10816-010-9094-8; Cavalli-Sforza L. L., 1994, HIST GEOGRAPHY HUMAN; Clark PU, 2009, SCIENCE, V325, P710, DOI 10.1126/science.1172873; Crawford GW, 2006, BLACKW STUD GLOB ARC, P77, DOI 10.1002/9780470774670.ch5; Crawford GW, 2008, WORLD ARCHAEOL, V40, P445, DOI 10.1080/00438240802451181; Crawford GW, 2003, ANTIQUITY, V77, P87, DOI 10.1017/S0003598X00061378; CRAWFORD GW, 2011, CURR ANTHR IN PRESS; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Endicott P, 2008, AM J HUM GENET, V82, P895, DOI 10.1016/j.ajhg.2008.01.019; Endicott P, 2009, TRENDS ECOL EVOL, V24, P515, DOI 10.1016/j.tree.2009.04.006; Fagundes NJR, 2008, AM J HUM GENET, V82, P583, DOI 10.1016/j.ajhg.2007.11.013; Fagundes NJR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003157; Fan L, 2011, MITOCHONDRION, V11, P351, DOI 10.1016/j.mito.2010.09.013; Felsenstein J, 2006, MOL BIOL EVOL, V23, P691, DOI 10.1093/molbev/msj079; Fuller DQ, 2010, ARCHAEOL ANTHROP SCI, V2, P115, DOI 10.1007/s12520-010-0035-y; Fuller DQ, 2009, WORLD ARCHAEOL, V41, P88, DOI 10.1080/00438240802668321; Gunnarsdottir ED, 2011, GENOME RES, V21, P1, DOI 10.1101/gr.107615.110; HABU J., 2004, ANCIENT JOMON JAPAN; Hammer MF, 2006, J HUM GENET, V51, P47, DOI 10.1007/s10038-005-0322-0; HAMMER MF, 1995, AM J HUM GENET, V56, P951; Harpending HC, 1998, P NATL ACAD SCI USA, V95, P1961, DOI 10.1073/pnas.95.4.1961; Hartmann A, 2009, HUM MUTAT, V30, P115, DOI 10.1002/humu.20816; HASTINGS WK, 1970, BIOMETRIKA, V57, P97, DOI 10.2307/2334940; Heled J, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-289; Hey J, 2005, PLOS BIOL, V3, P965, DOI 10.1371/journal.pbio.0030193; Ho SYW, 2008, AM J HUM GENET, V83, P142, DOI 10.1016/j.ajhg.2008.06.014; Horai S, 1996, AM J HUM GENET, V59, P579; Hudson M. J., 1999, RUINS IDENTITY ETHNO; Imamura K, 1996, ORIGINS SPREAD AGR P, P442; Ingman M, 2000, NATURE, V408, P708, DOI 10.1038/35047064; Kazuno AA, 2005, PSYCHIAT CLIN NEUROS, V59, P497, DOI 10.1111/j.1440-1819.2005.01404.x; Kitchen A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001596; Kivisild T, 2006, GENETICS, V172, P373, DOI 10.1534/genetics.105.043901; Kivisild T, 2002, MOL BIOL EVOL, V19, P1737, DOI 10.1093/oxfordjournals.molbev.a003996; Kong QP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003016; Koyama S., 1978, SENRI ETHNOL STUD, V2, P1; Kumar S, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-230; Liu Li, 2004, CHINESE NEOLITHIC TR; METROPOLIS N, 1953, J CHEM PHYS, V21, P1087, DOI 10.1063/1.1699114; Mizoguchi K., 2002, ARCHAEOLOGICAL HIST; Mizoguchi K, 2006, BLACKW STUD GLOB ARC, P55; Mulligan CJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003199; Nohira C, 2010, INT J LEGAL MED, V124, P7, DOI 10.1007/s00414-008-0308-5; Omoto K, 1997, AM J PHYS ANTHROPOL, V102, P437; OOTA H, 1995, AM J PHYS ANTHROPOL, V98, P133, DOI 10.1002/ajpa.1330980204; Pereira L, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-390; Qian YP, 2001, J HUM GENET, V46, P211, DOI 10.1007/s100380170091; Rasteiro R, 2009, J HUM GENET, V54, P349, DOI 10.1038/jhg.2009.39; ROGERS AR, 1995, EVOLUTION, V49, P608, DOI 10.1111/j.1558-5646.1995.tb02297.x; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Shapiro B, 2004, SCIENCE, V306, P1561, DOI 10.1126/science.1101074; SHERRY ST, 1994, HUM BIOL, V66, P761; Tanaka M, 2004, GENOME RES, V14, P1832, DOI 10.1101/gr.2286304; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Ueno H, 2009, MITOCHONDRION, V9, P385, DOI 10.1016/j.mito.2009.06.003; Underhill AP, 2006, BLACKW STUD GLOB ARC, P121, DOI 10.1002/9780470774670.ch7; van Oven M, 2009, HUM MUTAT, V30, pE386, DOI 10.1002/humu.20921; XU PF, 2004, FORMATION CHINESE CI; Yamaguchi-Kabata Y, 2008, AM J HUM GENET, V83, P445, DOI 10.1016/j.ajhg.2008.08.019; Yao YG, 2009, AM J HUM GENET, V85, P929, DOI 10.1016/j.ajhg.2009.10.023; [No title captured]	66	6	8	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2011	6	6							e21509	10.1371/journal.pone.0021509	http://dx.doi.org/10.1371/journal.pone.0021509			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	786FZ	21747908	Green Published, Green Submitted, gold			2022-12-27	WOS:000292290100030
J	Bidard, F; Benkhali, JA; Coppin, E; Imbeaud, S; Grognet, P; Delacroix, H; Debuchy, R				Bidard, Frederique; Benkhali, Jinane Ait; Coppin, Evelyne; Imbeaud, Sandrine; Grognet, Pierre; Delacroix, Herve; Debuchy, Robert			Genome-Wide Gene Expression Profiling of Fertilization Competent Mycelium in Opposite Mating Types in the Heterothallic Fungus Podospora anserina	PLOS ONE			English	Article							REAL-TIME PCR; PHEROMONE PRECURSOR GENES; NEUROSPORA-CRASSA; MITOCHONDRIAL GENOME; SORDARIA-MACROSPORA; GIBBERELLA-ZEAE; DNA-SEQUENCE; CELL-TYPE; PROTEIN; FERTILITY	Background: Mating-type loci in yeasts and ascomycotan filamentous fungi (Pezizomycotina) encode master transcriptional factors that play a critical role in sexual development. Genome-wide analyses of mating-type-specification circuits and mating-type target genes are available in Saccharomyces cerevisiae and Schizosaccharomyces pombe; however, no such analyses have been performed in heterothallic (self-incompatible) Pezizomycotina. The heterothallic fungus Podospora anserina serves as a model for understanding the basic features of mating-type control. Its mat+ and mat- mating types are determined by dissimilar allelic sequences. The mat- sequence contains three genes, designated FMR1, SMR1 and SMR2, while the mat+ sequence contains one gene, FPR1. FMR1 and FPR1 are the major regulators of fertilization, and this study presents a genome-wide view of their target genes and analyzes their target gene regulation. Methodology/Principal Findings: The transcriptomic profiles of the mat+ and mat- strains revealed 157 differentially transcribed genes, and transcriptomic analysis of fmr1(-) and fpr1(-) mutant strains was used to determine the regulatory actions exerted by FMR1 and FPR1 on these differentially transcribed genes. All possible combinations of transcription repression and/or activation by FMR1 and/or FPR1 were observed. Furthermore, 10 additional mating-type target genes were identified that were up-or down-regulated to the same level in mat+ and mat- strains. Of the 167 genes identified, 32 genes were selected for deletion, which resulted in the identification of two genes essential for the sexual cycle. Interspecies comparisons of mating-type target genes revealed significant numbers of orthologous pairs, although transcriptional profiles were not conserved between species. Conclusions/Significance: This study represents the first comprehensive genome-wide analysis of mating-type direct and indirect target genes in a heterothallic filamentous fungus. Mating-type transcription factors have many more target genes than are found in yeasts and exert a much greater diversity of regulatory actions on target genes, most of which are not directly related to mating.	[Bidard, Frederique; Benkhali, Jinane Ait; Coppin, Evelyne; Grognet, Pierre; Debuchy, Robert] Univ Paris 11, Inst Genet & Microbiol, UMR8621, F-91405 Orsay, France; [Bidard, Frederique; Benkhali, Jinane Ait; Coppin, Evelyne; Debuchy, Robert] CNRS, UMR8621, Inst Genet & Microbiol, F-91405 Orsay, France; [Imbeaud, Sandrine; Delacroix, Herve] CNRS, Ctr Genet Mol, FRE3144, GODMAP, Gif Sur Yvette, France; [Grognet, Pierre] Univ Paris 07, UFR Sci Vivant, Paris, France	UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Cite	Bidard, F (corresponding author), Ecole Normale Super, Inst Biol, IBENS, 24 Rue Lhomond, F-75231 Paris, France.	robert.debuchy@igmors.u-psud.fr	Grognet, Pierre/R-9615-2017; Debuchy, Robert/J-3040-2012; Imbeaud, Sandrine/P-8780-2017	Grognet, Pierre/0000-0002-2791-6233; Debuchy, Robert/0000-0003-1206-0361; Imbeaud, Sandrine/0000-0001-8439-6732	French National Research Agency [ANR-05-BLAN-0385];  [IFR115]	French National Research Agency(French National Research Agency (ANR)); 	This study and the salary of FB were funded by the French National Research Agency (http://www.agence-nationale-recherche.fr/) grant number ANR-05-BLAN-0385, project SexDevMycol, coordinator R. Debuchy. The microarray scanner was provided by the Programme Pluri-Formation (PPF) of Univ Paris-Sud 11 "Plate-forme Puces a ADN Gif-Orsay 2005-2008''. The http://podospora.igmors.u-psud.fr/methods.php address was hosted on a server funded by IFR115. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Arnaise S, 2001, GENETICS, V159, P545; ASTELL CR, 1981, CELL, V27, P15, DOI 10.1016/0092-8674(81)90356-1; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bidard Frederique, 2010, BMC Res Notes, V3, P171, DOI 10.1186/1756-0500-3-171; Bobrowicz P, 2002, MOL MICROBIOL, V45, P795, DOI 10.1046/j.1365-2958.2002.03052.x; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Colot HV, 2006, P NATL ACAD SCI USA, V103, P10352, DOI 10.1073/pnas.0601456103; Coppin E, 2000, GENETICS, V155, P657; Coppin E, 2005, EUKARYOT CELL, V4, P407, DOI 10.1128/EC.4.2.407-420.2005; CUMMINGS DJ, 1990, CURR GENET, V17, P375, DOI 10.1007/BF00334517; Davey J, 1998, SEMIN CELL DEV BIOL, V9, P19, DOI 10.1006/scdb.1997.0197; DEBUCHY R, 1993, MOL GEN GENET, V241, P667, DOI 10.1007/BF00279909; DEBUCHY R, 1992, MOL GEN GENET, V233, P113, DOI 10.1007/BF00587568; Debuchy R, 2010, CELLULAR AND MOLECULAR BIOLOGY OF FILAMENTOUS FUNGI, P501; DEQUARDCHABLAT M, 1994, J BIOL CHEM, V269, P14951; DYER P, 1992, CONTROL SEXUAL MORPH, P421; DYER PS, 1993, MYCOL RES, V97, P485, DOI 10.1016/S0953-7562(09)80137-8; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; El-Khoury R, 2008, CURR GENET, V53, P249, DOI 10.1007/s00294-008-0180-3; Espagne E, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-5-r77; Ferreira AVB, 1998, GENETICS, V148, P1069; Ferreira AVB, 1996, MOL GEN GENET, V250, P767, DOI 10.1007/BF02172989; Fleissner A, 2009, GENETICS, V181, P497, DOI 10.1534/genetics.108.096149; Galgoczy DJ, 2004, P NATL ACAD SCI USA, V101, P18069, DOI 10.1073/pnas.0407611102; GLASS NL, 1990, P NATL ACAD SCI USA, V87, P4912, DOI 10.1073/pnas.87.13.4912; GLASS NL, 1992, GENETICS, V132, P125; Goodrich-Tanrikulu M, 1998, MICROBIOL-UK, V144, P1713, DOI 10.1099/00221287-144-7-1713; Grossetete S, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-81; HE B, 1991, P NATL ACAD SCI USA, V88, P11373, DOI 10.1073/pnas.88.24.11373; HERSKOWITZ I, 1989, NATURE, V342, P749, DOI 10.1038/342749a0; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Imbeaud S, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni054; Jamet-Vierny C, 2007, FUNGAL GENET BIOL, V44, P1219, DOI 10.1016/j.fgb.2007.04.005; Kanematsu S, 2007, CURR GENET, V52, P11, DOI 10.1007/s00294-007-0132-3; Keszthelyi A, 2007, ANTON LEEUW INT J G, V91, P373, DOI 10.1007/s10482-006-9123-5; Kim H, 2004, MOL MICROBIOL, V52, P1781, DOI 10.1111/j.1365-2958.2004.04096.x; Kim H, 2002, EUKARYOT CELL, V1, P987, DOI 10.1128/EC.1.6.987-999.2002; Klix V, 2010, EUKARYOT CELL, V9, P894, DOI 10.1128/EC.00019-10; KUCHLER K, 1989, EMBO J, V8, P3973, DOI 10.1002/j.1460-2075.1989.tb08580.x; Lee SH, 2008, CURR GENET, V53, P175, DOI 10.1007/s00294-008-0176-z; Lorin S, 2001, MOL MICROBIOL, V42, P1259, DOI 10.1046/j.1365-2958.2001.02690.x; Malagnac Fabienne, 2008, Commun Integr Biol, V1, P180; Marisa L, 2007, BIOINFORMATICS, V23, P2339, DOI 10.1093/bioinformatics/btm321; Martin T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015199; Mata J, 2006, P NATL ACAD SCI USA, V103, P15517, DOI 10.1073/pnas.0603403103; McCarroll SA, 2004, NAT GENET, V36, P197, DOI 10.1038/ng1291; METZENBERG RL, 1990, BIOESSAYS, V12, P53, DOI 10.1002/bies.950120202; ORBACH MJ, 1994, GENE, V150, P159, DOI 10.1016/0378-1119(94)90877-X; Paoletti M, 2007, CURR BIOL, V17, P1384, DOI 10.1016/j.cub.2007.07.012; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Poggeler S, 2006, MOL GENET GENOMICS, V275, P492, DOI 10.1007/s00438-006-0107-y; Poggeler S, 1997, GENETICS, V147, P567; Qi WH, 2006, MOL GENET GENOMICS, V276, P87, DOI 10.1007/s00438-006-0125-9; RIDDER R, 1992, CURR GENET, V21, P207, DOI 10.1007/BF00336843; RIZET GEORGES, 1949, REV CYTOL ET BIOL VEG, V11, P201; RIZET GEORGES, 1952, REV CYTOL ET BIOL VEG, V13, P51; Rubini A, 2011, NEW PHYTOL, V189, P710, DOI 10.1111/j.1469-8137.2010.03492.x; Ruepp A, 2004, NUCLEIC ACIDS RES, V32, P5539, DOI 10.1093/nar/gkh894; SAMILS N, 2011, FUNGAL GENETICS RE S, V58; Saupe S, 1996, MOL GEN GENET, V250, P115, DOI 10.1007/BF02191831; Schmoll M, 2010, MOL MICROBIOL, V77, P1483, DOI 10.1111/j.1365-2958.2010.07295.x; Shen WC, 1999, FUNGAL GENET BIOL, V27, P253, DOI 10.1006/fgbi.1999.1151; Silar P, 1995, FUNG GENET NEWSLETT, V42, P73, DOI DOI 10.4148/1941-4765.1353; STABEN C, 1990, P NATL ACAD SCI USA, V87, P4917, DOI 10.1073/pnas.87.13.4917; Turgeon B. Gillian, 2007, P93; Turgeon G, 2000, FUNGAL GENET BIOL, V31, P1, DOI 10.1006/fgbi.2000.1227; Vallim MA, 2004, MICROBIOL-SGM, V150, P1925, DOI 10.1099/mic.0.27030-0; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wik L, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-109; Wirsel S, 1998, MOL GEN GENET, V259, P272, DOI 10.1007/s004380050813; Wirsel S, 1996, CURR GENET, V29, P241; WURMBACH E, 2010, PCR REVOLUTION BASIC, P262; Wurmbach Elisa, 2009, P137; Xiang QJ, 2002, GENETICS, V160, P169; Zhang L, 1998, MOL CELL BIOL, V18, P953, DOI 10.1128/MCB.18.2.953; ZICKLER D, 1995, GENETICS, V140, P493; ZICKLER D, 1973, MEIOSE MITOSES COURS	78	45	46	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2011	6	6							e21476	10.1371/journal.pone.0021476	http://dx.doi.org/10.1371/journal.pone.0021476			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	784FW	21738678	Green Submitted, Green Published, gold			2022-12-27	WOS:000292142800028
J	de Vries, LE; Valles, Y; Agerso, Y; Vaishampayan, PA; Garcia-Montaner, A; Kuehl, JV; Christensen, H; Barlow, M; Francino, MP				de Vries, Lisbeth E.; Valles, Yvonne; Agerso, Yvonne; Vaishampayan, Parag A.; Garcia-Montaner, Andrea; Kuehl, Jennifer V.; Christensen, Henrik; Barlow, Miriam; Francino, M. Pilar			The Gut as Reservoir of Antibiotic Resistance: Microbial Diversity of Tetracycline Resistance in Mother and Infant	PLOS ONE			English	Article							STREPTOCOCCUS-GALLOLYTICUS; GENE; SEQUENCE; TET(W); BACTEROIDES; BACTERIA	The microbiota in the human gastrointestinal tract (GIT) is highly exposed to antibiotics, and may be an important reservoir of resistant strains and transferable resistance genes. Maternal GIT strains can be transmitted to the offspring, and resistances could be acquired from birth. This is a case study using a metagenomic approach to determine the diversity of microorganisms conferring tetracycline resistance (Tc-r) in the guts of a healthy mother-infant pair one month after childbirth, and to investigate the potential for horizontal transfer and maternal transmission of Tc-r genes. Fecal fosmid libraries were functionally screened for Tc-r, and further PCR-screened for specific Tc-r genes. Tc-r fosmid inserts were sequenced at both ends to establish bacterial diversity. Mother and infant libraries contained Tc-r, although encoded by different genes and organisms. Tc-r organisms in the mother consisted mainly of Firmicutes and Bacteroidetes, and the main gene detected was tet(O), although tet(W) and tet(X) were also found. Identical Tc-r gene sequences were present in different bacterial families and even phyla, which may indicate horizontal transfer within the maternal GIT. In the infant library, Tc-r was present exclusively in streptococci carrying tet(M), tet(L) and erm(T) within a novel composite transposon, Tn6079. This transposon belongs to a family of broad host range conjugative elements, implying a potential for the joint spread of tetracycline and erythromycin resistance within the infant's gut. In addition, although not found in the infant metagenomic library, tet(O) and tet(W) could be detected in the uncloned DNA purified from the infant fecal sample. This is the first study to reveal the diversity of Tc-r bacteria in the human gut, to detect a likely transmission of antibiotic resistance from mother to infant GITs and to indicate the possible occurrence of gene transfers among distantly related bacteria coinhabiting the GIT of the same individual.	[de Vries, Lisbeth E.; Christensen, Henrik] Univ Copenhagen, Dept Vet Dis Biol, Frederiksberg, Denmark; [de Vries, Lisbeth E.; Agerso, Yvonne] Tech Univ Denmark, Natl Food Inst, DK-2800 Lyngby, Denmark; [Valles, Yvonne; Garcia-Montaner, Andrea; Francino, M. Pilar] Univ Valencia, Inst Cavanilles, Ctr Super Invest Salut Publ, Unitat Mixta Invest Genom & Salut, Valencia, Spain; [Vaishampayan, Parag A.; Kuehl, Jennifer V.; Francino, M. Pilar] Joint Genome Inst, Dept Energy, Evolutionary Genom Program, Walnut Creek, CA USA; [Barlow, Miriam; Francino, M. Pilar] Univ Calif Merced, Sch Nat Sci, Merced, CA USA	University of Copenhagen; Technical University of Denmark; University of Valencia; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI; University of California System; University of California Merced	de Vries, LE (corresponding author), Univ Copenhagen, Dept Vet Dis Biol, Frederiksberg, Denmark.	francino_pil@gva.es	Valles, Yvonne/AAC-9380-2019; Francino, M.Pilar/H-9090-2015	Francino, M.Pilar/0000-0002-4510-5653; , Andrea/0000-0002-1034-1672; Valles, Yvonne/0000-0002-5435-4504; Christensen, Henrik/0000-0003-4238-4658	Danish Research Council for Technology and Production Sciences [274-05-0117]; NIH (National Institutes of Health, USA) [R01 DK66288]; Office of Science of the U.S. Department of Energy [DE-AC02-05CH11231]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK066288] Funding Source: NIH RePORTER	Danish Research Council for Technology and Production Sciences; NIH (National Institutes of Health, USA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office of Science of the U.S. Department of Energy(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was partly funded by a grant from The Danish Research Council for Technology and Production Sciences (274-05-0117) and by a grant R01 DK66288 from NIH (National Institutes of Health, USA) to MPF. Part of this work was performed at the U.S. Department of Energy Joint Genome Institute. The work conducted by the U.S. Department of Energy Joint Genome Institute is supported by the Office of Science of the U.S. Department of Energy under Contract No. DE-AC02-05CH11231. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarestrup FM, 2000, VET MICROBIOL, V74, P353, DOI 10.1016/S0378-1135(00)00197-8; Aarestrup FM, 2000, DIAGN MICR INFEC DIS, V37, P127, DOI 10.1016/S0732-8893(00)00130-9; Alazmi W, 2006, DIGEST DIS SCI, V51, P732, DOI 10.1007/s10620-006-3199-7; *AM AC PED, 2003, ANT AG REL THER TETR; Barbosa TM, 1999, ENVIRON MICROBIOL, V1, P53, DOI 10.1046/j.1462-2920.1999.00004.x; Beck M, 2008, J CLIN MICROBIOL, V46, P2966, DOI 10.1128/JCM.00078-08; Chopra I, 2001, MICROBIOL MOL BIOL R, V65, P232, DOI 10.1128/MMBR.65.2.232-260.2001; Cochetti I, 2008, ANTIMICROB AGENTS CH, V52, P1285, DOI 10.1128/AAC.01457-07; Collado MC, 2009, LETT APPL MICROBIOL, V48, P523, DOI 10.1111/j.1472-765X.2009.02567.x; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Favier CF, 2002, APPL ENVIRON MICROB, V68, P219, DOI 10.1128/AEM.68.1.219-226.2002; Gueimonde M, 2006, FEMS IMMUNOL MED MIC, V48, P21, DOI 10.1111/j.1574-695X.2006.00112.x; Huson DH, 2007, GENOME RES, V17, P377, DOI 10.1101/gr.5969107; Kazimierczak KA, 2006, ANTIMICROB AGENTS CH, V50, P2632, DOI 10.1128/AAC.01587-05; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Manichanh C, 2006, GUT, V55, P205, DOI 10.1136/gut.2005.073817; Manichanh C, 2008, NUCLEIC ACIDS RES, V36, P5180, DOI 10.1093/nar/gkn496; Ng LK, 2001, MOL CELL PROBE, V15, P209, DOI 10.1006/mcpr.2001.0363; O'Mahony C, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000112; Palmer C, 2007, PLOS BIOL, V5, P1556, DOI 10.1371/journal.pbio.0050177; Rice LB, 1998, ANTIMICROB AGENTS CH, V42, P1871, DOI 10.1128/AAC.42.8.1871; Roberts AP, 2008, PLASMID, V60, P167, DOI 10.1016/j.plasmid.2008.08.001; Roberts AP, 2009, TRENDS MICROBIOL, V17, P251, DOI 10.1016/j.tim.2009.03.002; Roberts MC, 2003, ANAEROBE, V9, P63, DOI 10.1016/S1075-9964(03)00058-1; Roberts MC, 2005, FEMS MICROBIOL LETT, V245, P195, DOI 10.1016/j.femsle.2005.02.034; Rusniok C, 2010, J BACTERIOL, V192, P2266, DOI 10.1128/JB.01659-09; Salyers AA, 2004, TRENDS MICROBIOL, V12, P412, DOI 10.1016/j.tim.2004.07.004; Schumann A, 2005, PHYSIOL GENOMICS, V23, P235, DOI 10.1152/physiolgenomics.00057.2005; Scott KP, 2000, ANTIMICROB AGENTS CH, V44, P775, DOI 10.1128/AAC.44.3.775-777.2000; Seville LA, 2009, MICROB DRUG RESIST, V15, P159, DOI 10.1089/mdr.2009.0916; Shoemaker NB, 2001, APPL ENVIRON MICROB, V67, P561, DOI 10.1128/AEM.67.2.561-568.2001; Sommer MOA, 2009, SCIENCE, V325, P1128, DOI 10.1126/science.1176950; SPEER BS, 1990, J BACTERIOL, V172, P292, DOI 10.1128/JB.172.1.292-298.1990; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tsai JC, 2005, ANTIMICROB AGENTS CH, V49, P4347, DOI 10.1128/AAC.49.10.4347-4350.2005; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Turroni F, 2008, ANTON LEEUW INT J G, V94, P35, DOI 10.1007/s10482-008-9232-4; Vaishampayan PA, 2010, GENOME BIOL EVOL, V2, P53, DOI 10.1093/gbe/evp057; Warburton PJ, 2007, J ANTIMICROB CHEMOTH, V60, P973, DOI 10.1093/jac/dkm331	42	87	87	3	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2011	6	6							e21644	10.1371/journal.pone.0021644	http://dx.doi.org/10.1371/journal.pone.0021644			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	784FW	21738748	Green Published, gold, Green Submitted			2022-12-27	WOS:000292142800051
J	Schanzer, DL; Langley, JM; Dummer, T; Aziz, S				Schanzer, Dena L.; Langley, Joanne M.; Dummer, Trevor; Aziz, Samina			The Geographic Synchrony of Seasonal Influenza: A Waves across Canada and the United States	PLOS ONE			English	Article							SPREAD; MORTALITY; EPIDEMIC; PATTERNS	Background: As observed during the 2009 pandemic, a novel influenza virus can spread globally before the epidemic peaks locally. As consistencies in the relative timing and direction of spread could form the basis for an early alert system, the objectives of this study were to use the case-based reporting system for laboratory confirmed influenza from the Canadian FluWatch surveillance program to identify the geographic scale at which spatial synchrony exists and then to describe the geographic patterns of influenza A virus across Canada and in relationship to activity in the United States (US). Methodology/Principal Findings: Weekly laboratory confirmations for influenza A were obtained from the Canadian FluWatch and the US FluView surveillance programs from 1997/98 to 2006/07. For the six seasons where at least 80% of the specimens were antigenically similar, we identified the epidemic midpoint of the local/regional/provincial epidemics and analyzed trends in the direction of spread. In three out of the six seasons, the epidemic appeared first in Canada. Regional epidemics were more closely synchronized across the US (3-5 weeks) compared to Canada (5-13 weeks), with a slight gradient in timing from the southwest regions in the US to northeast regions of Canada and the US. Cities, as well as rural areas within provinces, usually peaked within a couple of weeks of each other. The anticipated delay in peak activity between large cities and rural areas was not observed. In some mixed influenza A seasons, lack of synchronization sub-provincially was evident. Conclusions/Significance: As mixing between regions appears to be too weak to force a consistency in the direction and timing of spread, local laboratory-based surveillance is needed to accurately assess the level of influenza activity in the community. In comparison, mixing between urban communities and adjacent rural areas, and between some communities, may be sufficient to force synchronization.	[Schanzer, Dena L.; Aziz, Samina] Publ Hlth Agcy Canada, Infect Dis Prevent & Control Branch, Ottawa, ON, Canada; [Langley, Joanne M.] Dalhousie Univ, Canadian Ctr Vaccinol, IWK Hlth Ctr, Halifax, NS, Canada; [Langley, Joanne M.] Dalhousie Univ, Fac Med, Halifax, NS, Canada; [Dummer, Trevor] Dalhousie Univ, Dept Pediat, Populat Canc Res Program, Halifax, NS, Canada	Public Health Agency of Canada; Dalhousie University; Dalhousie University; Dalhousie University	Schanzer, DL (corresponding author), Publ Hlth Agcy Canada, Infect Dis Prevent & Control Branch, Ottawa, ON, Canada.	Dena_Schanzer@phac-aspc.gc.ca	Schanzer, Dena/G-1593-2011	Schanzer, Dena/0000-0001-7093-4309; Langley, Joanne/0000-0003-3270-7345	National FluWatch Network	National FluWatch Network	The authors gratefully acknowledge the support of the National FluWatch Network, and all those involved in the collection and compilation of this data, as well as the data provided to FluView. Special thanks to the reviewers for their thoughtful comments.	Alonso WJ, 2007, AM J EPIDEMIOL, V165, P1434, DOI 10.1093/aje/kwm012; Arkema JM, 2008, EURO SURVEILL, V13; Bonabeau E, 1998, P ROY SOC B-BIOL SCI, V265, P2421, DOI 10.1098/rspb.1998.0593; *CDC, 1999, MMWR-MORBID MORTAL W, V48, P374; CDC, 1998, UPDATE, V47, P280; *CDCP, 2009, FLUVIEW WEEKL INFL S; Chowell G, 2008, P ROY SOC B-BIOL SCI, V275, P501, DOI 10.1098/rspb.2007.1477; Finkelman BS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001296; FLAHAULT A, 1988, STAT MED, V7, P1147, DOI 10.1002/sim.4780071107; FLAHAULT A, 1994, EUR J EPIDEMIOL, V10, P471, DOI 10.1007/BF01719679; Hayden FG, 2004, J INFECT DIS, V189, P440, DOI 10.1086/381128; Khan K, 2009, NEW ENGL J MED, V361, P212, DOI 10.1056/NEJMc0904559; Lofgren E, 2007, J VIROL, V81, P5429, DOI 10.1128/JVI.01680-06; McNiven C., 2000, CENSUS METROPOLITAN; Molinari NAM, 2007, VACCINE, V25, P5086, DOI 10.1016/j.vaccine.2007.03.046; Onozuka D, 2008, EPIDEMIOLOGY, V19, P824, DOI 10.1097/EDE.0b013e3181880eda; Paget J, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-141; *PUBL HLTH AG CAN, 2008, FLUWATCH REP; Reyes F, 2007, Can Commun Dis Rep, V33, P21; *ROCH LAB INC, 2004, TAMIFLU COMPL PROD I; SAITO R, 2005, EUROSURVEILLANCE, V10; Sakai T, 2004, EMERG INFECT DIS, V10, P1822, DOI 10.3201/eid1010.040147; Schanzer DL, 2007, EPIDEMIOL INFECT, V135, P1109, DOI 10.1017/S0950268807007923; Schanzer DL, 2008, INFLUENZA OTHER RESP, V2, P1, DOI 10.1111/j.1750-2659.2008.00035.x; Schanzer DL, 2008, VACCINE, V26, P4697, DOI 10.1016/j.vaccine.2008.06.087; Schanzer DL, 2006, PEDIATR INFECT DIS J, V25, P795, DOI 10.1097/01.inf.0000232632.86800.8c; Schanzer DL, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-90; Schanzer DL, 2010, INFLUENZA OTHER RESP, V4, P295, DOI 10.1111/j.1750-2659.2010.00154.x; *STAT CAN, 2008, PLAC WORK COMM WORK; *STAT CAN, 2002, POP DWELL COUNTS ON; Viboud C, 2006, SCIENCE, V312, P447, DOI 10.1126/science.1125237; Wenger JB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010187	32	16	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2011	6	6							e21471	10.1371/journal.pone.0021471	http://dx.doi.org/10.1371/journal.pone.0021471			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	784FW	21738676	Green Published, Green Submitted, gold			2022-12-27	WOS:000292142800027
J	Delobel, P; Saliou, A; Nicot, F; Dubois, M; Trancart, S; Tangre, P; Aboulker, JP; Taburet, AM; Molina, JM; Massip, P; Marchou, B; Izopet, J				Delobel, Pierre; Saliou, Adrien; Nicot, Florence; Dubois, Martine; Trancart, Stephanie; Tangre, Philippe; Aboulker, Jean-Pierre; Taburet, Anne-Marie; Molina, Jean-Michel; Massip, Patrice; Marchou, Bruno; Izopet, Jacques		ANRS 106-Window Study Team	Minor HIV-1 Variants with the K103N Resistance Mutation during Intermittent Efavirenz-Containing Antiretroviral Therapy and Virological Failure	PLOS ONE			English	Article							STRUCTURED TREATMENT INTERRUPTIONS; IMMUNODEFICIENCY-VIRUS TYPE-1; TREATMENT-NAIVE PATIENTS; SINGLE-DOSE NEVIRAPINE; DRUG-RESISTANCE; INITIAL TREATMENT; VIRAL VARIANTS; LOW-FREQUENCY; INFECTION; POPULATIONS	The impact of minor drug-resistant variants of the type 1 immunodeficiency virus (HIV-1) on the failure of antiretroviral therapy remains unclear. We have evaluated the importance of detecting minor populations of viruses resistant to non-nucleoside reverse-transcriptase inhibitors (NNRTI) during intermittent antiretroviral therapy, a high-risk context for the emergence of drug-resistant HIV-1. We carried out a longitudinal study on plasma samples taken from 21 patients given efavirenz and enrolled in the intermittent arm of the ANRS 106 trial. Allele-specific real-time PCR was used to detect and quantify minor K103N mutants during off-therapy periods. The concordance with ultra-deep pyrosequencing was assessed for 11 patients. The pharmacokinetics of efavirenz was assayed to determine whether its variability could influence the emergence of K103N mutants. Allele-specific real-time PCR detected K103N mutants in 15 of the 19 analyzable patients at the end of an off-therapy period while direct sequencing detected mutants in only 6 patients. The frequency of K103N mutants was,0.1% in 7 patients by allele-specific real-time PCR without further selection, and > 0.1% in 8. It was 0.1%-10% in 6 of these 8 patients. The mutated virus populations of 4 of these 6 patients underwent further selection and treatment failed for 2 of them. The K103N mutant frequency was >10% in the remaining 2, treatment failed for one. The copy numbers of K103N variants quantified by allele-specific real-time PCR and ultra-deep pyrosequencing agreed closely (rho = 0.89 P < 0.0001). The half-life of efavirenz was higher (50.5 hours) in the 8 patients in whom K103N emerged (>0.1%) than in the 11 patients in whom it did not (32 hours) (P = 0.04). Thus ultrasensitive methods could prove more useful than direct sequencing for predicting treatment failure in some patients. However the presence of minor NNRTI-resistant viruses need not always result in virological escape.	[Delobel, Pierre; Massip, Patrice; Izopet, Jacques] Hop Purpan, Serv Malad Infect & Trop, Toulouse, France; [Delobel, Pierre; Saliou, Adrien; Nicot, Florence; Dubois, Martine; Izopet, Jacques] Fac Med Toulouse, INSERM, UMR1043, F-31073 Toulouse, France; [Nicot, Florence; Dubois, Martine; Izopet, Jacques] Hop Purpan, Virol Lab, Toulouse, France; [Trancart, Stephanie] Hop Purpan, Lab Pharmacocinet & Toxicol, Toulouse, France; [Tangre, Philippe; Aboulker, Jean-Pierre] INSERM, SC10, Villejuif, France; [Taburet, Anne-Marie] Hop Bicetre, Pharmacol Lab, Le Kremlin Bicetre, France; [Molina, Jean-Michel] Hop St Louis, Serv Malad Infect & Trop, Paris, France; [Molina, Jean-Michel] Univ Paris 07, Paris, France	CHU de Toulouse; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU de Toulouse; CHU de Toulouse; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Delobel, P (corresponding author), Hop Purpan, Serv Malad Infect & Trop, Toulouse, France.	delobel.p@chu-toulouse.fr	IZOPET, Jacques/L-5756-2014; Delobel, Pierre/Q-6028-2019; Delobel, Pierre/K-3166-2014	Delobel, Pierre/0000-0002-2874-3581; Delobel, Pierre/0000-0002-2874-3581	French National Agency for Research; Merck-Sharp and Dohme-Chibret; Bristol-Myers Squibb; Gilead Sciences; Tibotec	French National Agency for Research(French National Research Agency (ANR)); Merck-Sharp and Dohme-Chibret; Bristol-Myers Squibb(Bristol-Myers Squibb); Gilead Sciences(Gilead Sciences); Tibotec	Funded by the French National Agency for Research on AIDS and Viral Hepatitis (http://www.anrs.fr): ANRS 106 trial. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have read the journal's policy and have the following conflicts: Dr Taburet has received travel grants, consultancy fees, and honoraria for presentation at workshops from Merck-Sharp and Dohme-Chibret, Bristol-Myers Squibb, Gilead Sciences and Tibotec. Other authors: none reported. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Bacheler LT, 2000, ANTIMICROB AGENTS CH, V44, P2475, DOI 10.1128/AAC.44.9.2475-2484.2000; Balduin M, 2009, J CLIN VIROL, V45, P34, DOI 10.1016/j.jcv.2009.03.002; Clavel F, 2000, Adv Pharmacol, V49, P41; Coovadia A, 2009, CLIN INFECT DIS, V48, P462, DOI 10.1086/596486; DARMINIO MA, 2005, J ACQ IMMUN DEF SYND, V38, P407; El-Sadr WM, 2006, NEW ENGL J MED, V355, P2283, DOI 10.1056/NEJMoa062360; Fagard C, 2003, ARCH INTERN MED, V163, P1220, DOI 10.1001/archinte.163.10.1220; Gianella S, 2010, J INFECT DIS, V202, P657, DOI 10.1086/655397; Goodman DD, 2009, ANTIVIR THER, V14, pA43; Gulick RM, 2004, NEW ENGL J MED, V350, P1850, DOI 10.1056/NEJMoa031772; Halvas EK, 2006, J CLIN MICROBIOL, V44, P2612, DOI 10.1128/JCM.00449-06; Halvas EK, 2010, J INFECT DIS, V201, P672, DOI 10.1086/650542; Hammer SM, 2002, JAMA-J AM MED ASSOC, V288, P169, DOI 10.1001/jama.288.2.169; Hirsch MS, 2008, CLIN INFECT DIS, V47, P266, DOI 10.1086/589297; Hoffmann C, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm435; Hsiou Y, 2001, J MOL BIOL, V309, P437, DOI 10.1006/jmbi.2001.4648; Izopet J, 2008, ANTIVIR THER, V13, P537; Johnson JA, 2005, J INFECT DIS, V192, P16, DOI 10.1086/430741; Johnson JA, 2008, PLOS MED, V5, P1112, DOI 10.1371/journal.pmed.0050158; Jourdain G, 2004, NEW ENGL J MED, V351, P229, DOI 10.1056/NEJMoa041305; Le T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006079; Lecossier D, 2005, JAIDS-J ACQ IMM DEF, V38, P37, DOI 10.1097/00126334-200501010-00007; Li JZ, 2011, JAMA-J AM MED ASSOC, V305, P1327, DOI 10.1001/jama.2011.375; Lockman S, 2007, NEW ENGL J MED, V356, P135, DOI 10.1056/NEJMoa062876; Marchou B, 2007, AIDS, V21, P457, DOI 10.1097/QAD.0b013e328013d9eb; Martinez-Picado J, 2002, AIDS, V16, P895, DOI 10.1097/00002030-200204120-00009; Metzner KJ, 2007, AIDS, V21, P703, DOI 10.1097/QAD.0b013e3280121ac6; Metzner KJ, 2009, CLIN INFECT DIS, V48, P239, DOI 10.1086/595703; Metzner KJ, 2003, J INFECT DIS, V188, P1433, DOI 10.1086/379215; Metzner KJ, 2005, AIDS, V19, P1819, DOI 10.1097/01.aids.0000189878.97480.ed; O'Meara D, 2001, J CLIN MICROBIOL, V39, P464, DOI 10.1128/JCM.39.2.464-473.2001; Palmer S, 2006, P NATL ACAD SCI USA, V103, P7094, DOI 10.1073/pnas.0602033103; Palmer S, 2006, AIDS, V20, P701, DOI 10.1097/01.aids.0000216370.69066.7f; Paredes R, 2010, J INFECT DIS, V201, P662, DOI 10.1086/650543; Riddler SA, 2008, NEW ENGL J MED, V358, P2095, DOI 10.1056/NEJMoa074609; Simen BB, 2009, J INFECT DIS, V199, P693, DOI 10.1086/596736; Staszewski S, 1999, NEW ENGL J MED, V341, P1865, DOI 10.1056/NEJM199912163412501; Stringer JSA, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000233; Wang CL, 2007, GENOME RES, V17, P1195, DOI 10.1101/gr.6468307; Yerly S, 2003, ANTIVIR THER, V8, P411	40	29	29	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2011	6	6							e21655	10.1371/journal.pone.0021655	http://dx.doi.org/10.1371/journal.pone.0021655			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	783OD	21738752	gold, Green Published, Green Submitted			2022-12-27	WOS:000292092600068
J	Hong, KW; Weiss, A; Morimura, N; Udono, T; Hayasaka, I; Humle, T; Murayama, Y; Ito, S; Inoue-Murayama, M				Hong, Kyung-Won; Weiss, Alexander; Morimura, Naruki; Udono, Toshifumi; Hayasaka, Ikuo; Humle, Tatyana; Murayama, Yuichi; Ito, Shin'ichi; Inoue-Murayama, Miho			Polymorphism of the Tryptophan Hydroxylase 2 (TPH2) Gene Is Associated with Chimpanzee Neuroticism	PLOS ONE			English	Article							SEROTONIN TRANSPORTER GENE; MAJOR DEPRESSION; PAN-TROGLODYTES; REGULATORY REGION; PROMOTER POLYMORPHISM; PERSONALITY STRUCTURE; HAPLOTYPE ANALYSIS; ZOOLOGICAL PARKS; NO ASSOCIATION; HARM AVOIDANCE	In the brain, serotonin production is controlled by tryptophan hydroxylase 2 (TPH2), a genotype. Previous studies found that mutations on the TPH2 locus in humans were associated with depression and studies of mice and studies of rhesus macaques have shown that the TPH2 locus was involved with aggressive behavior. We previously reported a functional single nucleotide polymorphism (SNP) in the form of an amino acid substitution, Q468R, in the chimpanzee TPH2 gene coding region. In the present study we tested whether this SNP was associated with neuroticism in captive and wild-born chimpanzees living in Japan and Guinea, respectively. Even after correcting for multiple tests (Bonferroni p = 0.05/6 = 0.008), Q468R was significantly related to higher neuroticism (b = 0.372, p = 0.005). This study is the first to identify a genotype linked to a personality trait in chimpanzees. In light of the prior studies on humans, mice, and rhesus macaques, these findings suggest that the relationship between neuroticism and TPH2 has deep phylogenetic roots.	[Hong, Kyung-Won] Gifu Univ, United Grad Sch Agr Sci, Gifu, Japan; [Weiss, Alexander] Univ Edinburgh, Dept Psychol, Sch Philosophy Psychol & Language Sci, Scottish Primate Res Grp, Edinburgh, Midlothian, Scotland; [Morimura, Naruki; Inoue-Murayama, Miho] Kyoto Univ, Wildlife Res Ctr, Kyoto, Japan; [Udono, Toshifumi; Hayasaka, Ikuo] Sanwa Kagaku Kenkyusho Co Ltd, Chimpanzee Sanctuary Uto, Kumamoto, Japan; [Humle, Tatyana] Univ Kent, Sch Anthropol & Conservat, Canterbury, Kent, England; [Murayama, Yuichi] Natl Inst Anim Hlth, Tsukuba, Ibaraki 305, Japan; [Ito, Shin'ichi] Gifu Univ, Fac Appl Biol Sci, Gifu, Japan	Gifu University; University of Edinburgh; Kyoto University; Sanwa Kagaku Kenkyusho Co., Ltd.; University of Kent; National Agriculture & Food Research Organization - Japan; National Institute of Animal Health - Japan; Gifu University	Hong, KW (corresponding author), Korea Natl Inst Hlth, Ctr Genome Sci, Chungbuk, South Korea.	mmurayama@wrc.kyoto-u.ac.jp			Ministry of Education, Science, Sports and Culture [18310152, 21310150]; PRI, Kyoto University; University of Edinburgh [2828]; Daiwa Foundation [6515/6818]	Ministry of Education, Science, Sports and Culture(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); PRI, Kyoto University; University of Edinburgh; Daiwa Foundation	This study was financially supported by the Ministry of Education, Science, Sports and Culture, Grant-in-Aid for Scientific Research (B) (#18310152 and #21310150 to MIM) and the Cooperation Research Program of PRI, Kyoto University. Alexander Weiss's work on this project was funded by a University of Edinburgh Development Trust Grant (#2828) and a Daiwa Foundation Small Grant (6515/6818). These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. TU and IH are employed by a commercial company, Sanwa Kagaku Kenkyusho Co., Ltd. and helped perform the experiments.	Alaerts M, 2009, ARCH GEN PSYCHIAT, V66, P828, DOI 10.1001/archgenpsychiatry.2009.82; Ball D, 1997, NEUROREPORT, V8, P1301, DOI 10.1097/00001756-199703240-00048; Chen GL, 2010, HORM BEHAV, V57, P184, DOI 10.1016/j.yhbeh.2009.10.012; Cote F, 2003, P NATL ACAD SCI USA, V100, P13525, DOI 10.1073/pnas.2233056100; Di Fiore A, 2003, YEARB PHYS ANTHROPOL, V46, P62, DOI 10.1002/ajpa.10382; Ebstein RP, 1997, MOL PSYCHIATR, V2, P224, DOI 10.1038/sj.mp.4000275; Frodl T, 2008, AM J MED GENET B, V147B, P1003, DOI 10.1002/ajmg.b.30680; Greenberg BD, 2000, AM J MED GENET, V96, P202, DOI 10.1002/(SICI)1096-8628(20000403)96:2<202::AID-AJMG16>3.0.CO;2-J; Herbst JH, 2000, AM J PSYCHIAT, V157, P1285, DOI 10.1176/appi.ajp.157.8.1285; Hong KW, 2007, NEUROSCI LETT, V412, P195, DOI 10.1016/j.neulet.2006.11.010; Inoue-Murayama M, 2001, CONTEMPORARY NEUROPSYCHIATRY, P425; Jorm AF, 1998, MOL PSYCHIATR, V3, P449, DOI 10.1038/sj.mp.4000424; KAUFMAN S, 1993, ANNU REV NUTR, V13, P261, DOI 10.1146/annurev.nu.13.070193.001401; King JE, 2005, J PERS, V73, P389, DOI 10.1111/j.1467-6494.2005.00313.x; King JE, 1997, J RES PERS, V31, P257, DOI 10.1006/jrpe.1997.2179; Kulikov AV, 2005, GENES BRAIN BEHAV, V4, P482, DOI 10.1111/j.1601-183X.2005.00145.x; Lesch KP, 1996, SCIENCE, V274, P1527, DOI 10.1126/science.274.5292.1527; Lopez VA, 2007, BIOL PSYCHIAT, V61, P181, DOI 10.1016/j.biopsych.2006.03.028; Middeldorp CM, 2007, BEHAV GENET, V37, P294, DOI 10.1007/s10519-006-9139-7; Morimura N, 2011, AM J PRIMATOL, V73, P226, DOI 10.1002/ajp.20887; Munafo MR, 2009, AM J MED GENET B, V150B, P271, DOI 10.1002/ajmg.b.30808; Murakami F, 1999, J HUM GENET, V44, P15, DOI 10.1007/s100380050098; Pederson AK, 2005, J RES PERS, V39, P534, DOI 10.1016/j.jrp.2004.07.002; Ricketts MH, 1998, PSYCHIATR GENET, V8, P41, DOI 10.1097/00041444-199800820-00001; Sen S, 2004, BIOL PSYCHIAT, V55, P244, DOI 10.1016/j.biopsych.2003.08.006; Tadic A, 2009, AM J MED GENET B, V150B, P487, DOI 10.1002/ajmg.b.30843; Walitza S, 2005, MOL PSYCHIATR, V10, P1126, DOI 10.1038/sj.mp.4001734; Walther DJ, 2003, SCIENCE, V299, P76, DOI 10.1126/science.1078197; Weiss A, 2002, J PERS SOC PSYCHOL, V83, P1141, DOI 10.1037//0022-3514.83.5.1141; Weiss A, 2009, AM J PRIMATOL, V71, P283, DOI 10.1002/ajp.20649; Weiss A, 2007, AM J PRIMATOL, V69, P1264, DOI 10.1002/ajp.20428; Weissglas-Volkov D, 2010, J LIPID RES, V51, P2032, DOI 10.1194/jlr.R004739; Willis-Owen SAG, 2005, BIOL PSYCHIAT, V58, P451, DOI 10.1016/j.biopsych.2005.04.050; Xu X, 2008, AM J MED GENET B, V147B, P1306, DOI 10.1002/ajmg.b.30737; Zaboli G, 2008, AM J MED GENET B, V147B, P301, DOI 10.1002/ajmg.b.30597; Zhang XD, 2005, NEURON, V45, P11, DOI 10.1016/j.neuron.2004.12.014; Zill P, 2004, MOL PSYCHIATR, V9, P1030, DOI 10.1038/sj.mp.4001525	37	25	26	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2011	6	7							e22144	10.1371/journal.pone.0022144	http://dx.doi.org/10.1371/journal.pone.0022144			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	792WQ	21765945	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000292781500037
J	Hwang, S; Kwak, SH; Bhak, J; Kang, HS; Lee, YR; Koo, BK; Park, KS; Lee, HK; Cho, YM				Hwang, Seungwoo; Kwak, Soo Heon; Bhak, Jong; Kang, Hae Sun; Lee, You Ri; Koo, Bo Kyung; Park, Kyong Soo; Lee, Hong Kyu; Cho, Young Min			Gene Expression Pattern in Transmitochondrial Cytoplasmic Hybrid Cells Harboring Type 2 Diabetes-Associated Mitochondrial DNA Haplogroups	PLOS ONE			English	Article							SET ENRICHMENT ANALYSIS; KOREAN POPULATION; MTDNA; MELLITUS; POLYMORPHISMS; RESISTANCE; SELECTION; PROFILES; MUTATION; HUMANS	Decreased mitochondrial function plays a pivotal role in the pathogenesis of type 2 diabetes mellitus (T2DM). Recently, it was reported that mitochondrial DNA (mtDNA) haplogroups confer genetic susceptibility to T2DM in Koreans and Japanese. Particularly, mtDNA haplogroup N9a is associated with a decreased risk of T2DM, whereas haplogroups D5 and F are associated with an increased risk. To examine functional consequences of these haplogroups without being confounded by the heterogeneous nuclear genomic backgrounds of different subjects, we constructed transmitochondrial cytoplasmic hybrid (cybrid) cells harboring each of the three haplogroups (N9a, D5, and F) in a background of a shared nuclear genome. We compared the functional consequences of the three haplogroups using cell-based assays and gene expression microarrays. Cell-based assays did not detect differences in mitochondrial functions among the haplogroups in terms of ATP generation, reactive oxygen species production, mitochondrial membrane potential, and cellular dehydrogenase activity. However, differential expression and clustering analyses of microarray data revealed that the three haplogroups exhibit a distinctive nuclear gene expression pattern that correlates with their susceptibility to T2DM. Pathway analysis of microarray data identified several differentially regulated metabolic pathways. Notably, compared to the T2DM-resistant haplogroup N9a, the T2DM-susceptible haplogroup F showed down-regulation of oxidative phosphorylation and up-regulation of glycolysis. These results suggest that variations in mtDNA can affect the expression of nuclear genes regulating mitochondrial functions or cellular energetics. Given that impaired mitochondrial function caused by T2DM-associated mtDNA haplogroups is compensated by the nuclear genome, we speculate that defective nuclear compensation, under certain circumstances, might lead to the development of T2DM.	[Hwang, Seungwoo] Korea Res Inst Biosci & Biotechnol, Korean Bioinformat Ctr, Taejon, South Korea; [Kwak, Soo Heon; Kang, Hae Sun; Lee, You Ri; Koo, Bo Kyung; Park, Kyong Soo; Cho, Young Min] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul 151, South Korea; [Bhak, Jong] Theragen BiO Inst, Suwon, South Korea; [Lee, Hong Kyu] Eulji Univ, Coll Med, Dept Internal Med, Seoul, South Korea	Korea Research Institute of Bioscience & Biotechnology (KRIBB); Seoul National University (SNU); Eulji University	Hwang, S (corresponding author), Korea Res Inst Biosci & Biotechnol, Korean Bioinformat Ctr, Taejon, South Korea.	ymchomd@snu.ac.kr	Koo, Bo Kyung/ABB-7170-2020; Park, Kyong Soo/C-2265-2008; Cho, Young Min/J-5669-2012; Kwak, Soo Heon/H-1463-2011	Park, Kyong Soo/0000-0003-3597-342X; Kwak, Soo Heon/0000-0003-1230-0919	National Research Foundation [M10753020005-07N5302-00500]; Korea Research Institute of Bioscience and Biotechnology (KRIBB); Seoul National University Hospital, South Korea [03-2005-001-0]	National Research Foundation; Korea Research Institute of Bioscience and Biotechnology (KRIBB); Seoul National University Hospital, South Korea	This work was supported by grants from the National Research Foundation (M10753020005-07N5302-00500), the Korea Research Institute of Bioscience and Biotechnology (KRIBB) Research Initiative Program, and Seoul National University Hospital intramural research fund (03-2005-001-0), South Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Amo T, 2008, GENE, V411, P69, DOI 10.1016/j.gene.2008.01.007; Backes C, 2007, NUCLEIC ACIDS RES, V35, pW186, DOI 10.1093/nar/gkm323; Chinnery PF, 2005, LANCET, V366, P1650, DOI 10.1016/S0140-6736(05)67492-2; Cho YM, 2005, DIABETOLOGIA, V48, P2033, DOI 10.1007/s00125-005-1855-7; Chomyn A, 1996, Methods Enzymol, V264, P334, DOI 10.1016/S0076-6879(96)64031-2; Delsite Robert, 2002, Mol Cancer, V1, P6, DOI 10.1186/1476-4598-1-6; Fuku N, 2007, AM J HUM GENET, V80, P407, DOI 10.1086/512202; Gomez-Duran A, 2010, HUM MOL GENET, V19, P3343, DOI 10.1093/hmg/ddq246; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Kim JH, 2005, DIABETOLOGIA, V48, P1323, DOI 10.1007/s00125-005-1793-4; Kim TM, 2008, BIOINFORMATICS, V24, P1957, DOI 10.1093/bioinformatics/btn357; KING MP, 1989, SCIENCE, V246, P500, DOI 10.1126/science.2814477; Lu HF, 2010, DIABETES, V59, P448, DOI 10.2337/db09-0129; Maechler P, 2001, NATURE, V414, P807, DOI 10.1038/414807a; Mishmar D, 2003, P NATL ACAD SCI USA, V100, P171, DOI 10.1073/pnas.0136972100; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Murphy R, 2008, DIABETIC MED, V25, P383, DOI 10.1111/j.1464-5491.2008.02359.x; Park KS, 2008, DIABETOLOGIA, V51, P602, DOI 10.1007/s00125-008-0933-z; Patti ME, 2003, P NATL ACAD SCI USA, V100, P8466, DOI 10.1073/pnas.1032913100; Petersen KF, 2004, NEW ENGL J MED, V350, P664, DOI 10.1056/NEJMoa031314; Pravenec M, 2007, GENOME RES, V17, P1319, DOI 10.1101/gr.6548207; Ruiz-Pesini E, 2004, SCIENCE, V303, P223, DOI 10.1126/science.1088434; Saxena R, 2006, AM J HUM GENET, V79, P54, DOI 10.1086/504926; Saxena V, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl766; Silva JP, 2000, NAT GENET, V26, P336, DOI 10.1038/81649; Sturn A, 2002, BIOINFORMATICS, V18, P207, DOI 10.1093/bioinformatics/18.1.207; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tafrechi RSJ, 2005, MUTAT RES-FUND MOL M, V578, P43, DOI 10.1016/j.mrfmmm.2005.02.002; Trounce I A, 1996, Methods Enzymol, V264, P484, DOI 10.1016/S0076-6879(96)64044-0	30	38	38	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2011	6	7							e22116	10.1371/journal.pone.0022116	http://dx.doi.org/10.1371/journal.pone.0022116			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	792WQ	21765942	gold, Green Published, Green Submitted			2022-12-27	WOS:000292781500034
J	Dai, K; Liao, SH; Zhang, JH; Zhang, XC; Tu, XM				Dai, Kun; Liao, Shanhui; Zhang, Jiahai; Zhang, Xuecheng; Tu, Xiaoming			Solution Structure of Tensin2 SH2 Domain and Its Phosphotyrosine-Independent Interaction with DLC-1	PLOS ONE			English	Article							GTPASE-ACTIVATING PROTEIN; PHOSPHOLIPASE-C-GAMMA; TYROSINE KINASES; CANCER; RECEPTOR; BINDING; ASSOCIATION; SUPPRESSION; MECHANISM; CTEN	Background: Src homology 2 (SH2) domain is a conserved module involved in various biological processes. Tensin family member was reported to be involved in tumor suppression by interacting with DLC-1 (deleted-in-liver-cancer-1) via its SH2 domain. We explore here the important questions that what the structure of tensin2 SH2 domain is, and how it binds to DLC-1, which might reveal a novel binding mode. Principal Findings: Tensin2 SH2 domain adopts a conserved SH2 fold that mainly consists of five beta-strands flanked by two a-helices. Most SH2 domains recognize phosphorylated ligands specifically. However, tensin2 SH2 domain was identified to interact with nonphosphorylated ligand (DLC-1) as well as phosphorylated ligand. Conclusions: We determined the solution structure of tensin2 SH2 domain using NMR spectroscopy, and revealed the interactions between tensin2 SH2 domain and its ligands in a phosphotyrosine-independent manner.	[Dai, Kun; Liao, Shanhui; Zhang, Jiahai; Tu, Xiaoming] Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Sch Life Sci, Hefei, Anhui, Peoples R China; [Zhang, Xuecheng] Anhui Univ, Sch Life Sci, Hefei 230039, Anhui, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Anhui University	Dai, K (corresponding author), Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Sch Life Sci, Hefei, Anhui, Peoples R China.	xmtu@ustc.edu.cn	Tu, Xiaoming/G-5090-2018; Liao, Shanhui/N-1628-2018	Liao, Shanhui/0000-0002-5083-667X	Chinese Academy of Science [KSCX2-EW-Q-4]; National High-Tech RD Program [2006AA02A315]; National Basic Research Program of China (973 Program) [2007CB914503, 2009CB918804]	Chinese Academy of Science(Chinese Academy of Sciences); National High-Tech RD Program; National Basic Research Program of China (973 Program)(National Basic Research Program of China)	This work was supported by the Knowledge Innovation Program of the Chinese Academy of Science, Grant KSCX2-EW-Q-4, the National High-Tech R&D Program, Grant 2006AA02A315 and the National Basic Research Program of China (973 Program), Grants 2007CB914503 and 2009CB918804. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albasri A, 2009, J PATHOL, V218, P57, DOI 10.1002/path.2508; Beattie J, 1996, CELL SIGNAL, V8, P75, DOI 10.1016/0898-6568(95)02033-0; Chan LK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005572; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Durkin ME, 2007, J CELL MOL MED, V11, P1185, DOI 10.1111/j.1582-4934.2007.00098.x; ELLIS C, 1990, NATURE, V343, P377, DOI 10.1038/343377a0; Goddard T. D., SPARKY 3; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Hwang PM, 2002, EMBO J, V21, P314, DOI 10.1093/emboj/21.3.314; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; LADBURY JE, 1995, P NATL ACAD SCI USA, V92, P3199, DOI 10.1073/pnas.92.8.3199; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Liao SH, 2009, BIOCHEM J, V422, P207, DOI 10.1042/BJ20090738; Liao YC, 2007, J CELL BIOL, V176, P43, DOI 10.1083/jcb.200608015; Liao YC, 2009, CANCER RES, V69, P4563, DOI 10.1158/0008-5472.CAN-09-0117; Lo SH, 2004, INT J BIOCHEM CELL B, V36, P31, DOI 10.1016/S1357-2725(03)00171-7; Machida K, 2005, BBA-PROTEINS PROTEOM, V1747, P1, DOI 10.1016/j.bbapap.2004.10.005; Mahajan NP, 2003, J BIOL CHEM, V278, P42596, DOI 10.1074/jbc.M305817200; MARGOLIS B, 1990, MOL CELL BIOL, V10, P435, DOI 10.1128/MCB.10.2.435; Martuszewska D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004350; MORRISON DK, 1990, MOL CELL BIOL, V10, P2359, DOI 10.1128/MCB.10.5.2359; Pero SC, 2002, J BIOL CHEM, V277, P11918, DOI 10.1074/jbc.M111816200; Qian XL, 2007, P NATL ACAD SCI USA, V104, P9012, DOI 10.1073/pnas.0703033104; Qian XL, 2009, CANCER CELL, V16, P246, DOI 10.1016/j.ccr.2009.07.031; SADOWSKI I, 1986, MOL CELL BIOL, V6, P4396, DOI 10.1128/MCB.6.12.4396; Sawyer TK, 1998, BIOPOLYMERS, V47, P243, DOI 10.1002/(SICI)1097-0282(1998)47:3<243::AID-BIP4>3.0.CO;2-P; Sayos J, 1998, NATURE, V395, P462, DOI 10.1038/26683; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; SONGYANG Z, 1994, MOL CELL BIOL, V14, P2777, DOI 10.1128/MCB.14.4.2777; Waksman Gabriel, 2004, Expert Reviews in Molecular Medicine, V6, P1, DOI 10.1017/S1462399404007331; Yam JWP, 2006, CANCER RES, V66, P8367, DOI 10.1158/0008-5472.CAN-05-2850; ZHOU SY, 1993, CELL, V72, P767, DOI 10.1016/0092-8674(93)90404-E	35	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2011	6	7							e21965	10.1371/journal.pone.0021965	http://dx.doi.org/10.1371/journal.pone.0021965			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791WM	21765928	Green Published, Green Submitted, gold			2022-12-27	WOS:000292699000016
J	Huang, JC; Meek, C; Kadie, C; Heckerman, D				Huang, Jim C.; Meek, Christopher; Kadie, Carl; Heckerman, David			Conditional Random Fields for Fast, Large-Scale Genome-Wide Association Studies	PLOS ONE			English	Article							SEQUENCE VARIANTS; GENETIC-ANALYSIS; STRATIFICATION	Understanding the role of genetic variation in human diseases remains an important problem to be solved in genomics. An important component of such variation consist of variations at single sites in DNA, or single nucleotide polymorphisms (SNPs). Typically, the problem of associating particular SNPs to phenotypes has been confounded by hidden factors such as the presence of population structure, family structure or cryptic relatedness in the sample of individuals being analyzed. Such confounding factors lead to a large number of spurious associations and missed associations. Various statistical methods have been proposed to account for such confounding factors such as linear mixed-effect models (LMMs) or methods that adjust data based on a principal components analysis (PCA), but these methods either suffer from low power or cease to be tractable for larger numbers of individuals in the sample. Here we present a statistical model for conducting genome-wide association studies (GWAS) that accounts for such confounding factors. Our method scales in runtime quadratic in the number of individuals being studied with only a modest loss in statistical power as compared to LMM-based and PCA-based methods when testing on synthetic data that was generated from a generalized LMM. Applying our method to both real and synthetic human genotype/phenotype data, we demonstrate the ability of our model to correct for confounding factors while requiring significantly less runtime relative to LMMs. We have implemented methods for fitting these models, which are available at http://www.microsoft.com/science.	[Huang, Jim C.; Meek, Christopher; Kadie, Carl; Heckerman, David] Microsoft Res, Redmond, WA USA	Microsoft	Huang, JC (corresponding author), Microsoft Res, Redmond, WA USA.	heckerma@microsoft.com			Wellcome Trust [076113, 085475]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL072524] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [U10AA008401] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	Funding for the project was provided by the Wellcome Trust under award 076113 and 085475. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARNOLD BC, 1991, SANKHYA SER B, V53, P233; Balding DJ, 2006, NAT REV GENET, V7, P781, DOI 10.1038/nrg1916; BESAG J, 1975, J ROY STAT SOC D-STA, V24, P179, DOI 10.2307/2987782; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; CHAKRABORTHY R, 1994, EXPERIENTIA S, V67, P153; DEMIDENKO E, 2004, MIXED MODELS THEOR A; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Edenberg HJ, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-S1-S2; GOURIEROUX C, 1984, ECONOMETRICA, V52, P681, DOI 10.2307/1913471; Gretarsdottir S, 2010, NAT GENET, V42, P692, DOI 10.1038/ng.622; Huber P. J., 1967, P 5 BERK S MATH STAT, V1, P221; JENSEN JL, 1994, ANN I STAT MATH, V46, P475; Kang HM, 2008, GENETICS, V178, P1709, DOI 10.1534/genetics.107.080101; Lai CQ, 2007, ARTERIOSCL THROM VAS, V27, P1417, DOI 10.1161/ATVBAHA.107.140103; Listgarten J, 2010, P NATL ACAD SCI USA, V107, P16465, DOI 10.1073/pnas.1002425107; Molenberghs G., 2005, MODELS DISCRETE LONG; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Price AL, 2010, NAT REV GENET, V11, P459, DOI 10.1038/nrg2813; Pritchard JK, 2000, AM J HUM GENET, V67, P170, DOI 10.1086/302959; Sulem P, 2009, NAT GENET, V41, P734, DOI 10.1038/ng.383; Thorleifsson G, 2009, NAT GENET, V41, P18, DOI 10.1038/ng.274; Yu JM, 2006, NAT GENET, V38, P203, DOI 10.1038/ng1702; Zhang ZW, 2010, NAT GENET, V42, P355, DOI 10.1038/ng.546	23	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2011	6	7							e21591	10.1371/journal.pone.0021591	http://dx.doi.org/10.1371/journal.pone.0021591			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791WM	21765897	gold, Green Published, Green Submitted			2022-12-27	WOS:000292699000007
J	Rands, SA				Rands, Sean A.			Approximating Optimal Behavioural Strategies Down to Rules-of-Thumb: Energy Reserve Changes in Pairs of Social Foragers	PLOS ONE			English	Article							DECISION-MAKING; SELFISH HERD; COLLECTIVE BEHAVIOR; FISH SCHOOLS; GROUP-SIZE; EMERGENCE; DOMINANCE; ANIMALS; MODEL; RISK	Functional explanations of behaviour often propose optimal strategies for organisms to follow. These 'best' strategies could be difficult to perform given biological constraints such as neural architecture and physiological constraints. Instead, simple heuristics or 'rules-of-thumb' that approximate these optimal strategies may instead be performed. From a modelling perspective, rules-of-thumb are also useful tools for considering how group behaviour is shaped by the behaviours of individuals. Using simple rules-of-thumb reduces the complexity of these models, but care needs to be taken to use rules that are biologically relevant. Here, we investigate the similarity between the outputs of a two-player dynamic foraging game (which generated optimal but complex solutions) and a computational simulation of the behaviours of the two members of a foraging pair, who instead followed a rule-of-thumb approximation of the game's output. The original game generated complex results, and we demonstrate here that the simulations following the much-simplified rules-of-thumb also generate complex results, suggesting that the rule-of-thumb was sufficient to make some of the model outcomes unpredictable. There was some agreement between both modelling techniques, but some differences arose - particularly when pair members were not identical in how they gained and lost energy. We argue that exploring how rules-of-thumb perform in comparison to their optimal counterparts is an important exercise for biologically validating the output of agent-based models of group behaviour.	Univ Bristol, Sch Vet Sci, Ctr Behav Biol, Bristol BS18 7DU, Avon, England	University of Bristol	Rands, SA (corresponding author), Univ Bristol, Sch Vet Sci, Ctr Behav Biol, Bristol BS18 7DU, Avon, England.	sean.rands@bristol.ac.uk	Rands, Sean A/B-2243-2008	Rands, Sean A/0000-0002-7400-005X				Altizer S, 2003, ANNU REV ECOL EVOL S, V34, P517, DOI 10.1146/annurev.ecolsys.34.030102.151725; [Anonymous], 2010, R LANG ENV STAT COMP; Ballerini M, 2008, P NATL ACAD SCI USA, V105, P1232, DOI 10.1073/pnas.0711437105; Ballerini M, 2008, ANIM BEHAV, V76, P201, DOI 10.1016/j.anbehav.2008.02.004; Beauchamp G, 2008, BEHAV ECOL, V19, P1361, DOI 10.1093/beheco/arn096; Brierley AS, 2010, CURR BIOL, V20, P1758, DOI 10.1016/j.cub.2010.08.041; Buchkremer EM, 2008, BEHAV ECOL, V19, P984, DOI 10.1093/beheco/arn057; Buchkremer EM, 2010, BEHAV ECOL, V21, P576, DOI 10.1093/beheco/arq026; Camazine S., 2001, SELF ORG BIOL SYSTEM, DOI DOI 10.1515/9780691212920; Cavagna A, 2010, BEHAV PROCESS, V84, P653, DOI 10.1016/j.beproc.2010.02.026; CLARK CW, 1986, THEOR POPUL BIOL, V30, P45, DOI 10.1016/0040-5809(86)90024-9; Conradt L, 2003, NATURE, V421, P155, DOI 10.1038/nature01294; Conradt L, 2009, PHILOS T R SOC B, V364, P719, DOI 10.1098/rstb.2008.0276; Couzin ID, 2005, NATURE, V433, P513, DOI 10.1038/nature03236; Couzin ID, 2002, J THEOR BIOL, V218, P1, DOI 10.1006/jtbi.2002.3065; Couzin ID, 2003, ADV STUD BEHAV, V32, P1, DOI 10.1016/S0065-3454(03)01001-5; de Vries H, 2009, BEHAVIOUR, V146, P843, DOI 10.1163/156853909X412241; ELGAR MA, 1989, BIOL REV, V64, P13, DOI 10.1111/j.1469-185X.1989.tb00636.x; Fox J, 2005, J BEHAV EDUC, V14, P1, DOI 10.1007/s10864-005-0957-0; Gross R, 2008, J R SOC INTERFACE, V5, P1193, DOI 10.1098/rsif.2007.1348; HAMILTON WD, 1971, J THEOR BIOL, V31, P295, DOI 10.1016/0022-5193(71)90189-5; Hemelrijk CK, 1999, P ROY SOC B-BIOL SCI, V266, P361, DOI 10.1098/rspb.1999.0646; Hemelrijk CK, 2000, ANIM BEHAV, V59, P1035, DOI 10.1006/anbe.2000.1400; Houston AI, 2007, PHILOS T R SOC B, V362, P1531, DOI 10.1098/rstb.2007.2051; Hutchinson JMC, 2005, BEHAV PROCESS, V69, P97, DOI 10.1016/j.beproc.2005.02.019; James R, 2004, J THEOR BIOL, V228, P107, DOI 10.1016/j.jtbi.2003.12.005; Krause J, 2002, LIVING GROUPS; Kunz H, 2003, ARTIF LIFE, V9, P237, DOI 10.1162/106454603322392451; Low C, 2008, BEHAV ECOL, V19, P532, DOI 10.1093/beheco/arm157; Marshall JAR, 2009, J R SOC INTERFACE, V6, P1065, DOI 10.1098/rsif.2008.0511; MCNAMARA JM, 1986, AM NAT, V127, P358, DOI 10.1086/284489; MCNAMARA JM, 1992, ANIM BEHAV, V43, P641, DOI 10.1016/0003-3472(92)90086-O; McNamara JM, 2009, TRENDS ECOL EVOL, V24, P670, DOI 10.1016/j.tree.2009.05.011; MOORING MS, 1992, BEHAVIOUR, V123, P173, DOI 10.1163/156853992X00011; Morrell LJ, 2008, BEHAV ECOL, V19, P909, DOI 10.1093/beheco/arn050; Morrell LJ, 2008, BEHAV ECOL, V19, P193, DOI 10.1093/beheco/arm122; Morrell LJ, 2011, P ROY SOC B-BIOL SCI, V278, P605, DOI 10.1098/rspb.2010.1605; PARKER GA, 1990, NATURE, V348, P27, DOI 10.1038/348027a0; Petit O, 2010, BEHAV PROCESS, V84, P635, DOI 10.1016/j.beproc.2010.04.009; Pulliam HR., 1984, BEHAVIOURAL ECOLOGY, P122; Rands SA, 2004, P ROY SOC B-BIOL SCI, V271, P2613, DOI 10.1098/rspb.2004.2906; Rands SA, 2003, NATURE, V423, P432, DOI 10.1038/nature01630; Rands SA, 2006, BEHAV ECOL SOCIOBIOL, V60, P572, DOI 10.1007/s00265-006-0202-4; Rands SA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011705; Rands SA, 2010, BEHAV PROCESS, V84, P668, DOI 10.1016/j.beproc.2010.03.001; Rands SA, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-51; Rands SA, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-81; Riipi M, 2001, NATURE, V413, P512, DOI 10.1038/35097061; SMITH JM, 1978, ANNU REV ECOL SYST, V9, P31, DOI 10.1146/annurev.es.09.110178.000335; Sumpter D. J., 2010, COLLECTIVE ANIMAL BE, DOI [10.1515/9781400837106, DOI 10.1515/9781400837106]; Trimmer PC, 2008, P ROY SOC B-BIOL SCI, V275, P2353, DOI 10.1098/rspb.2008.0417; Vabo R, 1997, FISH OCEANOGR, V6, P155, DOI 10.1046/j.1365-2419.1997.00037.x; Waksberg A, 2009, BEHAV ECOL SOCIOBIOL, V63, P461, DOI 10.1007/s00265-008-0681-6; Wood AJ, 2010, J THEOR BIOL, V264, P1102, DOI 10.1016/j.jtbi.2010.03.035; Wood AJ, 2007, P R SOC B, V274, P1637, DOI 10.1098/rspb.2007.0306; [No title captured]	56	9	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2011	6	7							e22104	10.1371/journal.pone.0022104	http://dx.doi.org/10.1371/journal.pone.0022104			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791WM	21765938	gold, Green Published, Green Submitted			2022-12-27	WOS:000292699000024
J	Tucker, JD; Chang, H; Brandt, A; Gao, X; Lin, M; Luo, J; Song, P; Sun, K; Zhang, XX				Tucker, Joseph D.; Chang, Helena; Brandt, Allison; Gao, Xing; Lin, Margaret; Luo, Jing; Song, Philip; Sun, Kai; Zhang, Xiaoxi			An Empirical Analysis of Overlap Publication in Chinese Language and English Research Manuscripts	PLOS ONE			English	Article							DUPLICATE PUBLICATION; ERROR MANAGEMENT; CITATIONS; JOURNALS; ICEBERG; TIP	Background: There are a number of sound justifications for publishing nearly identical information in Chinese and English medical journals, assuming several conditions are met. Although overlap publication is perceived as undesirable and ethically questionable in Europe and North America, it may serve an important function in some regions where English is not the native tongue. There is no empirical data on the nature and degree of overlap publication in English and Chinese language journals. Methods/Principal Findings: A random sample of 100 English manuscripts from Chinese institutions was selected from PubMed. Key words and institutions were searched in the China National Knowledge Infrastructure, a comprehensive Chinese language research database. Unacknowledged overlap was a priori defined according to International Committee of Medical Journal Editor (ICMJE) guidelines following examination by two individuals. 19% (95% CI 11-27) of English manuscripts from Chinese institutions were found to have substantial overlap with Chinese published work based on full text examination. None of the manuscripts met all of the criteria established by the ICMJE for an acknowledged overlap publication. Individual-level, journal-level, and institutional factors seem to influence overlap publication. Manuscripts associated with an institution outside of China and with more than one institution were significantly less likely to have substantial overlap (p<0.05). Conclusions/Significance: Overlap publication was common in this context, but instances of standard ICMJE notations to acknowledge this practice were rare. This research did not cite the identified overlap manuscripts with the hope that these empirical data will inform journal policy changes and structural initiatives to promote clearer policies and manuscripts.	[Tucker, Joseph D.] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Tucker, Joseph D.; Chang, Helena] Univ N Carolina, Dept Med, Chapel Hill, NC USA; [Chang, Helena] Univ Wisconsin, Dept Med, Madison, WI USA; [Brandt, Allison] Univ Oxford, Dept Int Dev, Oxford, England; [Gao, Xing] US Ctr Dis Control, Beijing, Peoples R China; [Lin, Margaret; Sun, Kai] Washington Univ, Dept Med, St Louis, MO USA; [Luo, Jing] Univ Illinois, Dept Med, Chicago, IL USA; [Song, Philip] Johns Hopkins Univ, Dept Med, Baltimore, MD USA; [Zhang, Xiaoxi] UCL, Dept Med, London WC1E 6BT, England	Harvard University; Massachusetts General Hospital; University of North Carolina; University of North Carolina Chapel Hill; University of Wisconsin System; University of Wisconsin Madison; University of Oxford; Washington University (WUSTL); University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Johns Hopkins University; University of London; University College London	Tucker, JD (corresponding author), Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA.	jtucker4@partners.org		Tucker, Joseph/0000-0003-2804-1181				ADAMS J, 2010, NEW SCI         0106; [Anonymous], 2010, LANCET, V375, P94, DOI 10.1016/S0140-6736(10)60030-X; [Anonymous], 2010, CHINA DAILY; Bin F, 2005, ELECTRON LIBR, V23, P181, DOI 10.1108/02640470510592870; Doring O, 2003, NAT REV GENET, V4, P233, DOI 10.1038/nrg1022; Durani P, 2006, J PLAST RECONSTR AES, V59, P975, DOI 10.1016/j.bjps.2005.11.039; Errami M, 2008, NATURE, V451, P397, DOI 10.1038/451397a; Errami M, 2009, NUCLEIC ACIDS RES, V37, pD921, DOI 10.1093/nar/gkn546; Fersht A, 2009, P NATL ACAD SCI USA, V106, P6883, DOI 10.1073/pnas.0903307106; Fuyuno I, 2006, NATURE, V441, P792, DOI 10.1038/441792b; Hales BM, 2006, J CRIT CARE, V21, P231, DOI 10.1016/j.jcrc.2006.06.002; HUA X, 2006, HUA X J STOMATOLOGY; Kleinert S, 2011, LANCET, V377, P281, DOI 10.1016/S0140-6736(11)60075-5; Kleinman A, 2010, LANCET, V375, P1074, DOI 10.1016/S0140-6736(10)60466-7; Leape L L, 1997, J Eval Clin Pract, V3, P213; Leape LL, 2002, NEW ENGL J MED, V347, P1633, DOI 10.1056/NEJMNEJMhpr011493; LEAPE LL, 1999, MEDICATION ERRORS CA; Mojon-Azzi SM, 2004, OPHTHALMOLOGY, V111, P863, DOI 10.1016/j.ophtha.2003.09.029; Nie JB, 2007, J BIOETHIC INQ, V4, P163, DOI 10.1007/s11673-007-9061-6; QIAN S, 2005, CHINESE MED J; Rizkallah J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010204; Schein M, 2001, SURGERY, V129, P655, DOI 10.1067/msy.2001.114549; SHI X, CHINESE J PEDI UNPUB; SHI X, 2009, CHINESE J INTE UNPUB; SPATH PL, ERROR REDUCTION HLTH; von Elm E, 2004, JAMA-J AM MED ASSOC, V291, P974, DOI 10.1001/jama.291.8.974; Wen QF, 2007, INT J APPL LINGUIST, V17, P221, DOI 10.1111/j.1473-4192.2007.00147.x; Wu JZ, 2003, J ACAD LIBR, V29, P249, DOI 10.1016/S0099-1333(03)00044-2; Xia J, 2008, HEALTH INFO LIBR J, V25, P55, DOI 10.1111/j.1471-1842.2007.00734.x; Zhang YH, 2010, NATURE, V467, P153, DOI 10.1038/467153d; 2009, CHINESE J OCULAR FUN; 2008, CHINESE J NEUROLOGY; 2006, NATL MED J CHINA CHI	34	9	9	8	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2011	6	7							e22149	10.1371/journal.pone.0022149	http://dx.doi.org/10.1371/journal.pone.0022149			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791WM	21765946	Green Published, gold, Green Submitted			2022-12-27	WOS:000292699000026
J	Kobayashi, M; Sasabe, T; Shigihara, Y; Tanaka, M; Watanabe, Y				Kobayashi, Masayuki; Sasabe, Tetsuya; Shigihara, Yoshihito; Tanaka, Masaaki; Watanabe, Yasuyoshi			Gustatory Imagery Reveals Functional Connectivity from the Prefrontal to Insular Cortices Traced with Magnetoencephalography	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; ORBITOFRONTAL CORTEX; TASTE PERCEPTION; MACAQUE MONKEY; BRAIN; AREAS; REPRESENTATION; STIMULATION; ACTIVATION; NEURONS	Our experience and prejudice concerning food play an important role in modulating gustatory information processing; gustatory memory stored in the central nervous system influences gustatory information arising from the peripheral nervous system. We have elucidated the mechanism of the 'top-down" modulation of taste perception in humans using functional magnetic resonance imaging (fMRI) and demonstrated that gustatory imagery is mediated by the prefrontal (PFC) and insular cortices (IC). However, the temporal order of activation of these brain regions during gustatory imagery is still an open issue. To explore the source of "top-down" signals during gustatory imagery tasks, we analyzed the temporal activation patterns of activated regions in the cerebral cortex using another non-invasive brain imaging technique, magnetoencephalography (MEG). Gustatory imagery tasks were presented by words (Letter G-V) or pictures (Picture G-V) of foods/beverages, and participants were requested to recall their taste. In the Letter G-V session, 7/9 (77.8%) participants showed activation in the IC with a latency of 401.7 +/- 34.7 ms (n = 7) from the onset of word exhibition. In 5/7 (71.4%) participants who exhibited IC activation, the PFC was activated prior to the IC at a latency of 315.2 +/- 56.5 ms (n = 5), which was significantly shorter than the latency to the IC activation. In the Picture G-V session, the IC was activated in 6/9 (66.7%) participants, and only 1/9 (11.1%) participants showed activation in the PFC. There was no significant dominance between the right and left IC or PFC during gustatory imagery. These results support those from our previous fMRI study in that the Letter G-V session rather than the Picture G-V session effectively activates the PFC and IC and strengthen the hypothesis that the PFC mediates "top-down" control of retrieving gustatory information from the storage of long-term memories and in turn activates the IC.	[Kobayashi, Masayuki] Nihon Univ, Sch Dent, Dept Pharmacol, Chiyoda Ku, Tokyo 101, Japan; [Kobayashi, Masayuki] Nihon Univ, Sch Dent, Dent Res Ctr, Div Oral & Craniomaxillofacial Res,Chiyoda Ku, Tokyo 101, Japan; [Kobayashi, Masayuki; Sasabe, Tetsuya; Shigihara, Yoshihito; Tanaka, Masaaki; Watanabe, Yasuyoshi] Osaka City Univ, Grad Sch Med, Dept Physiol, Abeno Ku, Osaka 558, Japan; [Shigihara, Yoshihito; Tanaka, Masaaki; Watanabe, Yasuyoshi] 21st Century COE Program Base Overcome Fatigue, Abeno Ku, Osaka, Japan; [Watanabe, Yasuyoshi] RIKEN, Ctr Mol Imaging Sci, Mol Probe Dynam Lab, Chuo Ku, Kobe, Hyogo, Japan	Nihon University; Nihon University; Osaka Metropolitan University; RIKEN	Kobayashi, M (corresponding author), Nihon Univ, Sch Dent, Dept Pharmacol, Chiyoda Ku, Tokyo 101, Japan.	masayuki@dent.osaka-u.ac.jp	Shigihara, Yoshihito/AFL-8377-2022; Shigihara, Yoshihito/AAG-8442-2022	Shigihara, Yoshihito/0000-0003-0996-110X; Shigihara, Yoshihito/0000-0003-0996-110X	Japanese Ministry of Education, Culture, Sports, Science and Technology; The Promotion and Mutual Aid Corporation for Private School of Japan; Nihon University	Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); The Promotion and Mutual Aid Corporation for Private School of Japan; Nihon University	This work was supported by Grant for the Promotion of Multi-Disciplinary Research Projects entitled "Translational Research Network on Orofacial Neurological Disorders" from the Japanese Ministry of Education, Culture, Sports, Science and Technology to M.K.; The Promotion and Mutual Aid Corporation for Private School of Japan to M.K.; and Nihon University Joint Research Grant to M.K. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Augustine JR, 1996, BRAIN RES REV, V22, P229, DOI 10.1016/S0165-0173(96)00011-2; Barry MA, 2001, CHEM SENSES, V26, P471, DOI 10.1093/chemse/26.5.471; Cerf-Ducastel B, 2001, CHEM SENSES, V26, P371, DOI 10.1093/chemse/26.4.371; Cheng K, 2001, NEURON, V32, P359, DOI 10.1016/S0896-6273(01)00477-9; Damasio A.R., 2000, FEELING WHAT HAPPENS; Darvas F, 2004, NEUROIMAGE, V23, pS289, DOI 10.1016/j.neuroimage.2004.07.014; Duncan J, 2000, TRENDS NEUROSCI, V23, P475, DOI 10.1016/S0166-2236(00)01633-7; Faurion A, 1999, NEUROSCI LETT, V277, P189, DOI 10.1016/S0304-3940(99)00881-2; Francis S, 1999, NEUROREPORT, V10, P453, DOI 10.1097/00001756-199902250-00003; Frey S, 1999, EUR J NEUROSCI, V11, P2985, DOI 10.1046/j.1460-9568.1999.00738.x; Frith C, 1997, PHILOS T R SOC B, V352, P1221, DOI 10.1098/rstb.1997.0104; Fuster JM, 2000, BRAIN RES BULL, V52, P331, DOI 10.1016/S0361-9230(99)00258-0; GoldmanRakic PS, 1996, PHILOS T ROY SOC B, V351, P1445, DOI 10.1098/rstb.1996.0129; Haase L, 2009, NEUROIMAGE, V44, P1008, DOI 10.1016/j.neuroimage.2008.09.044; HAUSSERHAUW C, 1987, BRAIN, V110, P339, DOI 10.1093/brain/110.2.339; Ishai A, 2002, NEUROIMAGE, V17, P1729, DOI 10.1006/nimg.2002.1330; Ishai A, 2000, NEURON, V28, P979, DOI 10.1016/S0896-6273(00)00168-9; Kikuchi S, 2005, NEUROREPORT, V16, P281, DOI 10.1097/00001756-200502280-00016; KINOMURA S, 1994, BRAIN RES, V659, P263, DOI 10.1016/0006-8993(94)90890-7; Kobayashi M, 2004, NEUROIMAGE, V23, P1271, DOI 10.1016/j.neuroimage.2004.08.002; Kobayashi M, 2002, EUR J NEUROSCI, V16, P975, DOI 10.1046/j.1460-9568.2002.02151.x; Kosslyn SM, 2001, NAT REV NEUROSCI, V2, P635, DOI 10.1038/35090055; Miyashita Y, 2000, CURR OPIN NEUROBIOL, V10, P187, DOI 10.1016/S0959-4388(00)00071-4; MOTTA G, 1959, Bull Sci Med (Bologna), V131, P480; Murakami S, 2006, J PHYSIOL-LONDON, V575, P925, DOI 10.1113/jphysiol.2006.105379; Naqvi NH, 2007, SCIENCE, V315, P531, DOI 10.1126/science.1135926; Naqvi NH, 2009, TRENDS NEUROSCI, V32, P56, DOI 10.1016/j.tins.2008.09.009; Okamoto M, 2006, NEUROIMAGE, V31, P796, DOI 10.1016/j.neuroimage.2005.12.021; Okamoto M, 2011, NEUROIMAGE, V54, P1578, DOI 10.1016/j.neuroimage.2010.08.016; Peltz E, 2011, NEUROIMAGE, V54, P1324, DOI 10.1016/j.neuroimage.2010.09.012; Penfield W, 1937, BRAIN, V60, P389, DOI 10.1093/brain/60.4.389; PENFIELD W, 1955, BRAIN, V78, P445, DOI 10.1093/brain/78.4.445; Pritchard TC, 1999, BEHAV NEUROSCI, V113, P663, DOI 10.1037/0735-7044.113.4.663; PRITCHARD TC, 1986, J COMP NEUROL, V244, P213, DOI 10.1002/cne.902440208; ROLLS ET, 1990, J NEUROPHYSIOL, V64, P1055, DOI 10.1152/jn.1990.64.4.1055; ROLLS ET, 1994, J NEUROSCI, V14, P5437; SCOTT TR, 1991, J NEUROPHYSIOL, V65, P76, DOI 10.1152/jn.1991.65.1.76; SCOTT TR, 1993, J NEUROPHYSIOL, V69, P1810, DOI 10.1152/jn.1993.69.6.1810; Scott TR, 1999, PHYSIOL BEHAV, V67, P489, DOI 10.1016/S0031-9384(99)00115-8; Shigihara Y, 2010, NEUROSCIENCE, V166, P482, DOI 10.1016/j.neuroscience.2009.12.077; Simmons WK, 2005, CEREB CORTEX, V15, P1602, DOI 10.1093/cercor/bhi038; Small DM, 1999, NEUROREPORT, V10, P7, DOI 10.1097/00001756-199901180-00002; Small DM, 1997, NEUROREPORT, V8, P3913, DOI 10.1097/00001756-199712220-00014; Small DM, 1997, J NEUROSCI, V17, P5136; Tobimatsu S, 2006, CLIN NEUROPHYSIOL, V117, P1414, DOI 10.1016/j.clinph.2006.01.004; Tomita H, 1999, NATURE, V401, P699, DOI 10.1038/44372; VANESSEN DC, 1992, SCIENCE, V255, P419, DOI 10.1126/science.1734518; Veldhuizen MG, 2007, CHEM SENSES, V32, P569, DOI 10.1093/chemse/bjm025; Zatorre RJ, 1996, J COGNITIVE NEUROSCI, V8, P29, DOI 10.1162/jocn.1996.8.1.29	49	11	11	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2011	6	7							e21736	10.1371/journal.pone.0021736	http://dx.doi.org/10.1371/journal.pone.0021736			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791IA	21760903	Green Published, Green Submitted, gold			2022-12-27	WOS:000292657200020
J	O'Brien, TR; Everhart, JE; Morgan, TR; Lok, AS; Chung, RT; Shao, YW; Shiffman, ML; Dotrang, M; Sninsky, JJ; Bonkovsky, HL; Pfeiffer, RM				O'Brien, Thomas R.; Everhart, James E.; Morgan, Timothy R.; Lok, Anna S.; Chung, Raymond T.; Shao, Yongwu; Shiffman, Mitchell L.; Dotrang, Myhanh; Sninsky, John J.; Bonkovsky, Herbert L.; Pfeiffer, Ruth M.		HALT-C Trial Grp	An IL28B Genotype-Based Clinical Prediction Model for Treatment of Chronic Hepatitis C	PLOS ONE			English	Article							LONG-TERM TREATMENT; GENETIC-VARIATION; INTERFERON-ALPHA; PEGYLATED INTERFERON; VIRUS-INFECTION; RIBAVIRIN; PEGINTERFERON; TELAPREVIR; THERAPY; LAMBDA	Background: Genetic variation in IL28B and other factors are associated with sustained virological response (SVR) after pegylated-interferon/ribavirin treatment for chronic hepatitis C (CHC). Using data from the HALT-C Trial, we developed a model to predict a patient's probability of SVR based on IL28B genotype and clinical variables. Methods: HALT-C enrolled patients with advanced CHC who had failed previous interferon-based treatment. Subjects were re-treated with pegylated-interferon/ribavirin during trial lead-in. We used step-wise logistic regression to calculate adjusted odds ratios (aOR) and create the predictive model. Leave-one-out cross-validation was used to predict a priori probabilities of SVR and determine area under the receiver operator characteristics curve (AUC). Results: Among 646 HCV genotype 1-infected European American patients, 14.2% achieved SVR. IL28B rs12979860-CC genotype was the strongest predictor of SVR (aOR, 7.56; p <.0001); the model also included HCV RNA (log10 IU/ml), AST:ALT ratio, Ishak fibrosis score and prior ribavirin treatment. For this model AUC was 78.5%, compared to 73.0% for a model restricted to the four clinical predictors and 60.0% for a model restricted to IL28B genotype (p < 0.001). Subjects with a predicted probability of SVR < 10% had an observed SVR rate of 3.8%; subjects with a predicted probability > 10% (43.3% of subjects) had an SVR rate of 27.9% and accounted for 84.8% of subjects actually achieving SVR. To verify that consideration of both IL28B genotype and clinical variables is required for treatment decisions, we calculated AUC values from published data for the IDEAL Study. Conclusion: A clinical prediction model based on IL28B genotype and clinical variables can yield useful individualized predictions of the probability of treatment success that could increase SVR rates and decrease the frequency of futile treatment among patients with CHC.	[O'Brien, Thomas R.; Pfeiffer, Ruth M.] NCI, Div Canc Epidemiol & Genet, NIH, Dept Hlth & Human Serv, Bethesda, MD 20892 USA; [Everhart, James E.] NIDDKD, Div Digest Dis & Nutr, NIH, Dept Hlth & Human Serv, Bethesda, MD 20892 USA; [Morgan, Timothy R.] Univ Calif Irvine, Div Gastroenterol, Irvine, CA USA; [Morgan, Timothy R.] VA Long Beach Healthcare Syst, Gastroenterol Serv, Long Beach, CA USA; [Lok, Anna S.] Univ Michigan, Med Ctr, Div Gastroenterol, Ann Arbor, MI USA; [Chung, Raymond T.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Med,Gastrointestinal Unit,Med Serv, Boston, MA USA; [Shao, Yongwu] Informat Management Serv Inc, Silver Spring, MD USA; [Shiffman, Mitchell L.] Bon Secours Hlth Syst, Liver Inst Virginia, Newport News, VA USA; [Dotrang, Myhanh] CSC, Rockville, MD USA; [Sninsky, John J.] Celera Corp, Alameda, CA USA; [Bonkovsky, Herbert L.] Univ Connecticut, Ctr Hlth, Dept Med, Farmington, CT USA; [Bonkovsky, Herbert L.] Univ Connecticut, Ctr Hlth, Dept Mol & Struct Biol, Farmington, CT USA; [Bonkovsky, Herbert L.] Univ Connecticut, Ctr Hlth, Liver Biliary Pancreat Ctr, Farmington, CT USA; [Bonkovsky, Herbert L.] Carolinas Med Ctr, Charlotte, NC 28203 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); University of California System; University of California Irvine; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Long Beach Healthcare System; University of Michigan System; University of Michigan; Harvard University; Harvard Medical School; Massachusetts General Hospital; Information Management Services, Inc.; University of Connecticut; University of Connecticut; University of Connecticut; Carolinas Medical Center	O'Brien, TR (corresponding author), NCI, Div Canc Epidemiol & Genet, NIH, Dept Hlth & Human Serv, Bethesda, MD 20892 USA.	obrient@mail.nih.gov	Bonkovsky, Herbert L./AAH-1892-2021; Pfeiffer, Ruth M/F-4748-2011	Bonkovsky, Herbert L./0000-0001-7387-3230; Dienstag, Jules/0000-0001-7024-0980; Yang, Shuman/0000-0002-9638-0890	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); National Institute of Allergy and Infectious Diseases (NIAID); National Cancer Institute (NCI); National Center for Minority Health and Health Disparities; National Center for Research Resources, National Institutes of Health; Hoffmann-La Roche, Inc.; Celera Corporation through National Institutes of Health; National Institutes of Health, National Cancer Institute, Division of Cancer Epidemiology and Genetics; University of Massachusetts Medical Center, Worcester, MA [N01-DK-9-2326]; University of Connecticut Health Center, Farmington, CT [M01RR-06192]; Saint Louis University School of Medicine, St Louis, MO [N01-DK-w9-2324]; Massachusetts General Hospital, Boston, MA [N01-DK-9-2319, M01RR-01066, 1 UL1 RR025758-01]; University of Colorado Denver, School of Medicine, Aurora, CO [N01-DK-9-2327, M01RR-00051, 1 UL1 RR 025780-01]; University of California Irvine, Irvine, CA [N01-DK-9-2320, M01RR-00827]; University of Texas Southwestern Medical Center, Dallas, TX [N01-DK-9-2321, M01RR-00633, 1 UL1 RR024982-01]; University of Southern California, Los Angeles, CA [N01-DK-9-2325, M01RR-00043]; University of Michigan Medical Center, Ann Arbor, MI [N01-DK-9-2323, M01RR-00042, 1 UL1 RR024986]; Virginia Commonwealth University Health System, Richmond, VA [N01-DK-9-2322, M01RR-00065]; Vertex Pharmaceuticals; Merck; Schering Plough Corporation; WAKO Diagnostics; Bristol-Myers Squibb; Gilead and Eisai Pharmaceuticals; Novartis; Romark; Biolex; Conatus; Glaxo SmithKline; Globeimmune; Human Genome Sciences; Idenix; Roche; Tibotec; Valeant; Wyeth; Zymogenetics; Novartis Pharmaceuticals; NATIONAL CANCER INSTITUTE [ZIACP005782] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000827, M01RR000633, M01RR000042, UL1RR024986, UL1RR025758, UL1RR024982, M01RR000051, M01RR006192, M01RR000065, UL1RR025780, M01RR000043, M01RR001066] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [N01DK092318, N01DK092322, N01DK092319, N01DK092325, N01DK092324, N01DK092328, N01DK092323, N01DK092327, N01DK092321, N01DK092320, N01DK092326] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Center for Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); National Center for Research Resources, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Hoffmann-La Roche, Inc.(Hoffmann-La Roche); Celera Corporation through National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health, National Cancer Institute, Division of Cancer Epidemiology and Genetics(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)NIH National Cancer Institute- Division of Cancer Epidemiology & Genetics); University of Massachusetts Medical Center, Worcester, MA; University of Connecticut Health Center, Farmington, CT; Saint Louis University School of Medicine, St Louis, MO; Massachusetts General Hospital, Boston, MA; University of Colorado Denver, School of Medicine, Aurora, CO; University of California Irvine, Irvine, CA; University of Texas Southwestern Medical Center, Dallas, TX; University of Southern California, Los Angeles, CA; University of Michigan Medical Center, Ann Arbor, MI(University of Michigan System); Virginia Commonwealth University Health System, Richmond, VA; Vertex Pharmaceuticals(Vertex Pharmaceuticals); Merck(Merck & Company); Schering Plough Corporation(Merck & CompanySchering Plough Corporation); WAKO Diagnostics; Bristol-Myers Squibb(Bristol-Myers Squibb); Gilead and Eisai Pharmaceuticals; Novartis(Novartis); Romark; Biolex; Conatus; Glaxo SmithKline(GlaxoSmithKline); Globeimmune; Human Genome Sciences(GlaxoSmithKline); Idenix; Roche(Roche Holding); Tibotec; Valeant; Wyeth(Wyeth); Zymogenetics; Novartis Pharmaceuticals(Novartis); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), the National Institute of Allergy and Infectious Diseases (NIAID), the National Cancer Institute (NCI), the National Center for Minority Health and Health Disparities, General Clinical Research Center and Clinical and Translational Science Center grants from the National Center for Research Resources, National Institutes of Health. Employees of NIDDK and NCI played a role in study design, data collection and analysis, decision to publish, and preparation of the manuscript. Additional funding to conduct this study was supplied by Hoffmann-La Roche, Inc., and Celera Corporation through Cooperative Research and Development Agreements (CRADA) with the National Institutes of Health. The present study was also supported by the Intramural Research Program of the National Institutes of Health, National Cancer Institute, Division of Cancer Epidemiology and Genetics. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the U.S. Government. Yongwu Shao was employed by Information Management Services, Silver Spring; Myhanh Dotrang by CSC, Rockville; and John J. Sninsky by Celera Corporation, Alameda. These authors played a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Contract and grant numbers: University of Massachusetts Medical Center, Worcester, MA: (Contract N01-DK-9-2326); University of Connecticut Health Center, Farmington, CT: (Grant M01RR-06192); Saint Louis University School of Medicine, St Louis, MO: (Contract N01-DK-w9-2324); Massachusetts General Hospital, Boston, MA: (Contract N01-DK-9-2319, Grant M01RR-01066; Grant 1 UL1 RR025758-01, Harvard Clinical and Translational Science Center); University of Colorado Denver, School of Medicine, Aurora, CO: (Contract N01-DK-9-2327, Grant M01RR-00051, Grant 1 UL1 RR 025780-01); University of California Irvine, Irvine, CA: (Contract N01-DK-9-2320, Grant M01RR-00827); University of Texas Southwestern Medical Center, Dallas, TX: (Contract N01-DK-9-2321, Grant M01RR-00633, Grant 1 UL1 RR024982-01, North and Central Texas Clinical and Translational Science Initiative); University of Southern California, Los Angeles, CA: (Contract N01-DK-9-2325, Grant M01RR-00043); University of Michigan Medical Center, Ann Arbor, MI: (Contract N01-DK-9-2323, Grant M01RR-00042, Grant 1 UL1 RR024986, Michigan Center for Clinical and Health Research); Virginia Commonwealth University Health System, Richmond, VA: (Contract N01-DK-9-2322, Grant M01RR-00065).; The authors wish to report the following relationships that might appear to represent a potential conflict: John J. Sninsky is employed by Celera Corporation, Alameda. T. R. Morgan is on the speaker's bureau and receives research support from Hoffmann-La Roche, Inc.; is a consultant, serves on an advisory board, and receives research support from Vertex Pharmaceuticals; serves on an advisory board for Gilead Sciences; and receives research support from Merck, Schering Plough Corporation, and WAKO Diagnostics. A. S. Lok is a consultant for Hoffmann-La Roche, Inc., Abbott and Gilead; and receives research support from Schering-Plough Corporation, Bristol-Myers Squibb, Gilead and Eisai Pharmaceuticals. R. T. Chung receives research support from Hoffmann-La Roche, Inc.; receives research support from Schering-Plough, Novartis, and Romark; and is a consultant for Vertex Pharmaceuticals, Merck, Pfizer, Astellas, Novartis, and Gilead. M. L. Shiffman is a consultant for Celera Corporation, Hoffmann-La Roche, Inc., and National Genome Sciences; has attended advisor meetings with Anadys, Biolex, Bristol-Myers-Squibb, Conatus, Globeimmune, Human Genome Sciences, Novartis, Roche, Romark, Pfizer, Schering-Plough, Valeant, Vertex and Zymogenetics; is a speaker for Roche and Schering-Plough; is on the data safety monitoring boards with Abbott and Anadys; and has received research support from Biolex, Conatus, Glaxo SmithKline, Globeimmune, Human Genome Sciences, Idenix, Roche, Romark, Tibotec, Valeant, Vertex, Wyeth and Zymogenetics. J. J. Sninsky is an employee of Celera Corporation. H. L. Bonkovsky receives research support from Hoffmann-La Roche, Inc.; is a consultant for Boehringer-Ingelheim; is a consultant and on the advisory board for Clinuvel, Inc.; is a consultant, advisory board member and receives research support from Novartis Pharmaceuticals; is a consultant and on the speakers' bureau for Lundbeck Pharmaceuticals; and receives research support from Vertex Pharmaceuticals. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials. Authors with no financial relationships related to this project are: T. R. O'Brien, J. E. Everhart, Y. Shao, M. Dotrang, and R. M. Pfeiffer.	Akuta N, 2010, HEPATOLOGY, V52, P421, DOI 10.1002/hep.23690; [Anonymous], 2002, NIH Consens State Sci Statements, V19, P1; Bowden DS, 2006, FUTURE MICROBIOL, V1, P103, DOI 10.2217/17460913.1.1.103; Di Bisceglie AM, 2008, NEW ENGL J MED, V359, P2429, DOI 10.1056/NEJMoa0707615; Feero WG, 2010, NEW ENGL J MED, V362, P2001, DOI 10.1056/NEJMra0907175; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; Germer S, 2000, GENOME RES, V10, P258, DOI 10.1101/gr.10.2.258; Hezode C, 2009, NEW ENGL J MED, V360, P1839, DOI 10.1056/NEJMoa0807650; Lee WM, 2004, CONTROL CLIN TRIALS, V25, P472, DOI 10.1016/j.cct.2004.08.003; Marcello T, 2006, GASTROENTEROLOGY, V131, P1887, DOI 10.1053/j.gastro.2006.09.052; McHutchison JG, 2010, NEW ENGL J MED, V362, P1292, DOI 10.1056/NEJMoa0908014; McHutchison JG, 2009, NEW ENGL J MED, V360, P1827, DOI 10.1056/NEJMoa0806104; McHutchison JG, 2009, NEW ENGL J MED, V361, P580, DOI 10.1056/NEJMoa0808010; Molinaro AM, 2005, BIOINFORMATICS, V21, P3301, DOI 10.1093/bioinformatics/bti499; Morishima C, 2006, HEPATOLOGY, V44, P360, DOI 10.1002/hep.21265; O'Brien TR, 2009, NAT GENET, V41, P1048, DOI 10.1038/ng.453; Pepe M. S., 2003, STAT EVALUATION MED; Rauch A, 2010, GASTROENTEROLOGY, V138, P1338, DOI 10.1053/j.gastro.2009.12.056; Robek MD, 2005, J VIROL, V79, P3851, DOI 10.1128/JVI.79.6.3851-3854.2005; Sarrazin C, 2010, GASTROENTEROLOGY, V138, P447, DOI 10.1053/j.gastro.2009.11.055; Shepard CW, 2005, LANCET INFECT DIS, V5, P558, DOI 10.1016/S1473-3099(05)70216-4; Siren J, 2005, J IMMUNOL, V174, P1932, DOI 10.4049/jimmunol.174.4.1932; Suppiah V, 2009, NAT GENET, V41, P1100, DOI 10.1038/ng.447; Tanaka Y, 2009, NAT GENET, V41, P1105, DOI 10.1038/ng.449; Thomas DL, 2009, NATURE, V461, P798, DOI 10.1038/nature08463; Thompson AJ, 2010, GASTROENTEROLOGY, V139, P120, DOI 10.1053/j.gastro.2010.04.013; Welzel TM, 2009, HEPATOLOGY, V49, P1847, DOI 10.1002/hep.22877	27	22	24	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2011	6	7							e20904	10.1371/journal.pone.0020904	http://dx.doi.org/10.1371/journal.pone.0020904			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791IA	21760886	Green Submitted, Green Published, gold			2022-12-27	WOS:000292657200005
J	Crespi, S; Biagi, L; d'Avossa, G; Burr, DC; Tosetti, M; Morrone, MC				Crespi, Sofia; Biagi, Laura; d'Avossa, Giovanni; Burr, David C.; Tosetti, Michela; Morrone, Maria Concetta			Spatiotopic Coding of BOLD Signal in Human Visual Cortex Depends on Spatial Attention	PLOS ONE			English	Article							AREA MT; DIRECTED ATTENTION; RECEPTIVE-FIELDS; CORTICAL AREA; PARIETAL; MOTION; NEURONS; REPRESENTATION; RETINOTOPY; RESPONSES	The neural substrate of the phenomenological experience of a stable visual world remains obscure. One possible mechanism would be to construct spatiotopic neural maps where the response is selective to the position of the stimulus in external space, rather than to retinal eccentricities, but evidence for these maps has been inconsistent. Here we show, with fMRI, that when human subjects perform concomitantly a demanding attentive task on stimuli displayed at the fovea, BOLD responses evoked by moving stimuli irrelevant to the task were mostly tuned in retinotopic coordinates. However, under more unconstrained conditions, where subjects could attend easily to the motion stimuli, BOLD responses were tuned not in retinal but in external coordinates (spatiotopic selectivity) in many visual areas, including MT, MST, LO and V6, agreeing with our previous fMRI study. These results indicate that spatial attention may play an important role in mediating spatiotopic selectivity.	[Crespi, Sofia; Burr, David C.] Univ Florence, Dept Psychol, Florence, Italy; [Crespi, Sofia] Univ Vita Salute San Raffaele, Dept Psychol, Milan, Italy; [Biagi, Laura; Tosetti, Michela] Fdn Stella Maris, Pisa, Italy; [d'Avossa, Giovanni] Bangor Univ, Sch Psychol, Bangor, Gwynedd, Wales; [Burr, David C.] CNR, Ist Neurosci, I-56100 Pisa, Italy; [Morrone, Maria Concetta] Univ Pisa, Dept Physiol Sci, Pisa, Italy; [Morrone, Maria Concetta] Ist Italiano Tecnol, Dept Robot Brain & Cognit Sci, Genoa, Italy	University of Florence; Vita-Salute San Raffaele University; IRCCS Fondazione Stella Maris; Bangor University; Consiglio Nazionale delle Ricerche (CNR); Istituto di Neuroscienze (IN-CNR); University of Pisa; Istituto Italiano di Tecnologia - IIT	Crespi, S (corresponding author), Univ Florence, Dept Psychol, Florence, Italy.	dave@in.cnr.it	Tosetti, Michela/K-5749-2016; Morrone, Maria Concetta/C-6756-2014; Biagi, Laura/K-5692-2016	Tosetti, Michela/0000-0002-2515-7560; Morrone, Maria Concetta/0000-0002-1025-0316; Biagi, Laura/0000-0003-2159-439X; CRESPI, Sofia Allegra/0000-0001-7429-0440; Burr, David/0000-0003-1541-8832	EEC [85154, 91070]; Italian Ministry of Universities and Research-MIUR	EEC; Italian Ministry of Universities and Research-MIUR(Ministry of Education, Universities and Research (MIUR))	This work was supported by the following: EEC framework 6 project MEMORY, http://cordis.europa.eu/fetch?CALLER = FP6_PROJ&ACTION = D&DOC = 3&CAT = PROJ&QUERY = 012dbd64851c:9d6e:69ebe69b&RCN = 85154; EEC framework 7 project ERC: STANIB, http://cordis.europa.eu/fetch?CALLER = FP7_PROJ_EN&ACTION = D&DOC = 1&CAT = PROJ&QUERY = 012dbd65f4f3:0989:37bc586e&RCN= 91070; and the Italian Ministry of Universities and Research-MIUR, http://prin.miur.it/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSEN RA, 1985, SCIENCE, V230, P456, DOI 10.1126/science.4048942; ANDERSEN RA, 1983, J NEUROSCI, V3, P532; Bisley JW, 2003, SCIENCE, V299, P81, DOI 10.1126/science.1077395; Boynton GM, 1996, J NEUROSCI, V16, P4207, DOI 10.1523/jneurosci.16-13-04207.1996; Brefczynski JA, 1999, NAT NEUROSCI, V2, P370, DOI 10.1038/7280; Bremmer F, 1997, J NEUROPHYSIOL, V77, P944, DOI 10.1152/jn.1997.77.2.944; Bremmer F, 1998, EUR J NEUROSCI, V10, P153; BREMMER F, 2009, EXP BRAIN RES; BURR DC, 2010, PHIL T ROY IN PRESS; Cavanagh P, 2010, TRENDS COGN SCI, V14, P147, DOI 10.1016/j.tics.2010.01.007; Cohen YE, 2002, NAT REV NEUROSCI, V3, P553, DOI 10.1038/nrn873; Colby CL, 1999, ANNU REV NEUROSCI, V22, P319, DOI 10.1146/annurev.neuro.22.1.319; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; d'Avossa G, 2007, NAT NEUROSCI, V10, P249, DOI 10.1038/nn1824; DeSouza JFX, 2002, CEREB CORTEX, V12, P991, DOI 10.1093/cercor/12.9.991; Duhamel JR, 1997, NATURE, V389, P845, DOI 10.1038/39865; Durand JB, 2010, NEURON, V66, P126, DOI 10.1016/j.neuron.2010.03.014; Fetsch CR, 2010, J NEUROPHYSIOL, V104, P1506, DOI 10.1152/jn.91247.2008; Fischer J, 2009, CURR BIOL, V19, P1356, DOI 10.1016/j.cub.2009.06.059; Fox MD, 2005, NEUROIMAGE, V28, P956, DOI 10.1016/j.neuroimage.2005.06.025; Froehler MT, 2002, SCIENCE, V295, P2462, DOI 10.1126/science.1067426; GALLETTI C, 1993, EXP BRAIN RES, V96, P221; Gandhi SP, 1999, P NATL ACAD SCI USA, V96, P3314, DOI 10.1073/pnas.96.6.3314; Gardner JL, 2008, J NEUROSCI, V28, P3988, DOI 10.1523/JNEUROSCI.5476-07.2008; Golomb JD, 2008, J NEUROSCI, V28, P10654, DOI 10.1523/JNEUROSCI.2525-08.2008; Golomb JD, 2010, J NEUROSCI, V30, P10493, DOI 10.1523/JNEUROSCI.1546-10.2010; Goossens J, 2006, J NEUROSCI, V26, P5616, DOI 10.1523/JNEUROSCI.0730-06.2006; Hansen KA, 2007, J NEUROSCI, V27, P11896, DOI 10.1523/JNEUROSCI.2991-07.2007; Hasnain MK, 1998, HUM BRAIN MAPP, V6, P301, DOI 10.1002/(SICI)1097-0193(1998)6:4<301::AID-HBM8>3.0.CO;2-7; Huk AC, 2002, J NEUROSCI, V22, P7195; Ilg UJ, 2004, NEURON, V43, P145, DOI 10.1016/j.neuron.2004.06.006; Kastner S, 1998, SCIENCE, V282, P108, DOI 10.1126/science.282.5386.108; Kastner S, 1999, NEURON, V22, P751, DOI 10.1016/S0896-6273(00)80734-5; Larsson J, 2006, J NEUROSCI, V26, P13128, DOI 10.1523/JNEUROSCI.1657-06.2006; Lauritzen TZ, 2009, J VISION, V9, DOI 10.1167/9.13.18; MAFFEI L, 1984, DOC OPHTHALMOL, V58, P97, DOI 10.1007/BF00140905; MATHOT S, 2010, PSYCHOL SCI; Mathot S, 2010, EXP BRAIN RES, V200, P117, DOI 10.1007/s00221-009-2055-3; McKyton A, 2007, CEREB CORTEX, V17, P1164, DOI 10.1093/cercor/bhl027; Melcher D, 2005, CURR BIOL, V15, P1745, DOI 10.1016/j.cub.2005.08.044; Melcher D, 2004, VISION RES, V44, P1367, DOI 10.1016/j.visres.2003.11.023; Melcher D, 2003, NAT NEUROSCI, V6, P877, DOI 10.1038/nn1098; Melcher D, 2008, TRENDS COGN SCI, V12, P466, DOI 10.1016/j.tics.2008.09.003; Merriam EP, 2007, J NEUROPHYSIOL, V97, P1738, DOI 10.1152/jn.00189.2006; Merriam EP, 2003, NEURON, V39, P361, DOI 10.1016/S0896-6273(03)00393-3; Mesulam MM, 1999, PHILOS T R SOC B, V354, P1325, DOI 10.1098/rstb.1999.0482; Moore T, 2003, NEURON, V40, P671, DOI 10.1016/S0896-6273(03)00716-5; MORRIS A, 2010, J VIS IN PRESS; Morrone MC, 2000, NAT NEUROSCI, V3, P1322, DOI 10.1038/81860; Mullette-Gillman OA, 2005, J NEUROPHYSIOL, V94, P2331, DOI 10.1152/jn.00021.2005; Ollinger JM, 2001, NEUROIMAGE, V13, P218, DOI 10.1006/nimg.2000.0711; Ong WS, 2009, J NEUROPHYSIOL, V102, P2435, DOI 10.1152/jn.00684.2009; Pertzov Y, 2010, J NEUROSCI, V30, P8882, DOI 10.1523/JNEUROSCI.3986-09.2010; PITZALIS S, 2009, HUMAN, V6; Pouget A, 2002, NAT REV NEUROSCI, V3, P741, DOI 10.1038/nrn914; Rees G, 1997, SCIENCE, V278, P1616, DOI 10.1126/science.278.5343.1616; RIZZOLATTI G, 1987, NEUROPSYCHOLOGIA, V25, P31, DOI 10.1016/0028-3932(87)90041-8; Sapir A, 2004, J COGNITIVE NEUROSCI, V16, P503, DOI 10.1162/089892904323057245; Saygin AP, 2008, CEREB CORTEX, V18, P2158, DOI 10.1093/cercor/bhm242; Schlack A, 2005, J NEUROSCI, V25, P4616, DOI 10.1523/JNEUROSCI.0455-05.2005; Sereno MI, 2006, NAT NEUROSCI, V9, P1337, DOI 10.1038/nn1777; Silver MA, 2005, J NEUROPHYSIOL, V94, P1358, DOI 10.1152/jn.01316.2004; Silver MA, 2009, TRENDS COGN SCI, V13, P488, DOI 10.1016/j.tics.2009.08.005; Tootell RBH, 1998, NEURON, V21, P1409, DOI 10.1016/S0896-6273(00)80659-5; Trotter Y, 1999, NATURE, V398, P239, DOI 10.1038/18444; Wexler M, 2001, NATURE, V409, P85, DOI 10.1038/35051081; Womelsdorf T, 2006, NAT NEUROSCI, V9, P1156, DOI 10.1038/nn1748; Zaksas D, 2005, J NEUROPHYSIOL, V94, P4156, DOI 10.1152/jn.00505.2005; ZIPSER D, 1988, NATURE, V331, P679, DOI 10.1038/331679a0	69	66	68	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2011	6	7							e21661	10.1371/journal.pone.0021661	http://dx.doi.org/10.1371/journal.pone.0021661			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791HI	21750720	Green Published, Green Submitted, gold			2022-12-27	WOS:000292655400009
J	Weisswange, TH; Rothkopf, CA; Rodemann, T; Triesch, J				Weisswange, Thomas H.; Rothkopf, Constantin A.; Rodemann, Tobias; Triesch, Jochen			Bayesian Cue Integration as a Developmental Outcome of Reward Mediated Learning	PLOS ONE			English	Article							SACCADIC EYE-MOVEMENTS; MULTISENSORY INTEGRATION; AUDITORY SPACE; MOTION CUES; VISUAL CUES; PERCEPTION; TEXTURE; SIGNALS; PREDICTION; INFERENCE	Average human behavior in cue combination tasks is well predicted by Bayesian inference models. As this capability is acquired over developmental timescales, the question arises, how it is learned. Here we investigated whether reward dependent learning, that is well established at the computational, behavioral, and neuronal levels, could contribute to this development. It is shown that a model free reinforcement learning algorithm can indeed learn to do cue integration, i.e. weight uncertain cues according to their respective reliabilities and even do so if reliabilities are changing. We also consider the case of causal inference where multimodal signals can originate from one or multiple separate objects and should not always be integrated. In this case, the learner is shown to develop a behavior that is closest to Bayesian model averaging. We conclude that reward mediated learning could be a driving force for the development of cue integration and causal inference.	[Weisswange, Thomas H.; Rothkopf, Constantin A.; Triesch, Jochen] Frankfurt Inst Adv Studies, Frankfurt, Germany; [Rodemann, Tobias] Honda Res Inst Europe GmbH, Offenbach, Germany	Honda Motor Company	Weisswange, TH (corresponding author), Frankfurt Inst Adv Studies, Frankfurt, Germany.	weisswange@fias.uni-frankfurt.de	Weisswange, Thomas H/H-3576-2013	Weisswange, Thomas H/0000-0003-2119-6965; Rothkopf, Constantin/0000-0002-5636-0801	EC MEXT; German Federal Ministry of Education and Research (BMBF) [01GQ0840]; Honda Research Institute Europe GmbH	EC MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Honda Research Institute Europe GmbH	Authors J.T. and C. R. were supported by the EC MEXT project PLICON; J.T., C. R., and T. W. by the German Federal Ministry of Education and Research (BMBF) within the "Bernstein Focus: Neurotechnology" through research grant 01GQ0840. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Author T. W. gratefully acknowledges the financial support from Honda Research Institute Europe GmbH. Author T. R. is an employee of Honda Research Institute Europe GmbH and played a role in design and writing of the paper.	Alais D, 2004, CURR BIOL, V14, P257, DOI 10.1016/j.cub.2004.01.029; Bair WN, 2007, EXP BRAIN RES, V183, P435, DOI 10.1007/s00221-007-1057-2; Battaglia PW, 2003, J OPT SOC AM A, V20, P1391, DOI 10.1364/JOSAA.20.001391; Beck JM, 2008, NEURON, V60, P1142, DOI 10.1016/j.neuron.2008.09.021; Brandwein AB, 2011, CEREB CORTEX, V21, P1042, DOI 10.1093/cercor/bhq170; CRICK F, 1989, NATURE, V337, P129, DOI 10.1038/337129a0; D'Ardenne K, 2008, SCIENCE, V319, P1264, DOI 10.1126/science.1150605; D'Souza P, 2010, P NATL ACAD SCI USA, V107, P4722, DOI 10.1073/pnas.0909394107; Daw ND, 2006, NATURE, V441, P876, DOI 10.1038/nature04766; Daw ND, 2011, NEURON, V69, P1204, DOI 10.1016/j.neuron.2011.02.027; Daw ND, 2005, NAT NEUROSCI, V8, P1704, DOI 10.1038/nn1560; Ernst MO, 2002, NATURE, V415, P429, DOI 10.1038/415429a; Ernst MO, 2004, TRENDS COGN SCI, V8, P162, DOI 10.1016/j.tics.2004.02.002; Fiser J, 2010, TRENDS COGN SCI, V14, P119, DOI 10.1016/j.tics.2010.01.003; Fujisaki W, 2004, NAT NEUROSCI, V7, P773, DOI 10.1038/nn1268; FUZESSERY ZM, 1985, HEARING RES, V20, P85, DOI 10.1016/0378-5955(85)90061-9; Gori M, 2008, CURR BIOL, V18, P694, DOI 10.1016/j.cub.2008.04.036; Gori M, 2010, CURR BIOL, V20, P223, DOI 10.1016/j.cub.2009.11.069; Gottfried JA, 2003, SCIENCE, V301, P1104, DOI 10.1126/science.1087919; GRANT DA, 1951, J EXP PSYCHOL, V42, P1, DOI 10.1037/h0054051; Hairston WD, 2003, J COGNITIVE NEUROSCI, V15, P20, DOI 10.1162/089892903321107792; Haruno M, 2006, J NEUROPHYSIOL, V95, P948, DOI 10.1152/jn.00382.2005; Helbig HB, 2007, PERCEPTION, V36, P1523, DOI 10.1068/p5851; Held R, 2011, NAT NEUROSCI, V14, P551, DOI 10.1038/nn.2795; Hikosaka O, 2006, J NEUROPHYSIOL, V95, P567, DOI 10.1152/jn.00458.2005; Jacobs RA, 1999, VISION RES, V39, P4062, DOI 10.1016/S0042-6989(99)00120-0; Jacobs RA, 1999, VISION RES, V39, P3621, DOI 10.1016/S0042-6989(99)00088-7; Keramati M, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002055; Kersten D, 2004, ANNU REV PSYCHOL, V55, P271, DOI 10.1146/annurev.psych.55.090902.142005; Kersten D, 2003, CURR OPIN NEUROBIOL, V13, P150, DOI 10.1016/S0959-4388(03)00042-4; Knill DC, 2005, J VISION, V5, P103, DOI 10.1167/5.2.2; Knill DC, 2003, VISION RES, V43, P2539, DOI 10.1016/S0042-6989(03)00458-9; Knill DC, 2004, TRENDS NEUROSCI, V27, P712, DOI 10.1016/j.tins.2004.10.007; Knill DC, 1996, PERCEPTION BAYESIAN; KNUDSEN EI, 1991, SCIENCE, V253, P85, DOI 10.1126/science.2063209; Kording KP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000943; Kording KP, 2004, PLOS BIOL, V2, P1652, DOI 10.1371/journal.pbio.0020330; LEE CK, 1988, NATURE, V332, P357, DOI 10.1038/332357a0; Lengyel M., 2008, ADV NEURAL INFORM PR, P889; Lewald J, 2003, COGNITIVE BRAIN RES, V16, P468, DOI 10.1016/S0926-6410(03)00074-0; Ma WJ, 2006, NAT NEUROSCI, V9, P1432, DOI 10.1038/nn1790; Morris G, 2006, NAT NEUROSCI, V9, P1057, DOI 10.1038/nn1743; Nardini M, 2008, CURR BIOL, V18, P689, DOI 10.1016/j.cub.2008.04.021; Nardini M, 2010, P NATL ACAD SCI USA, V107, P17041, DOI 10.1073/pnas.1001699107; Neil PA, 2006, DEVELOPMENTAL SCI, V9, P454, DOI 10.1111/j.1467-7687.2006.00512.x; O'Doherty J, 2004, SCIENCE, V304, P452, DOI 10.1126/science.1094285; Pessiglione M, 2008, NEURON, V59, P561, DOI 10.1016/j.neuron.2008.07.005; Pessiglione M, 2006, NATURE, V442, P1042, DOI 10.1038/nature05051; Putzar L, 2007, NAT NEUROSCI, V10, P1243, DOI 10.1038/nn1978; Rangel A, 2010, CURR OPIN NEUROBIOL, V20, P262, DOI 10.1016/j.conb.2010.03.001; Rao C.R, 1973, LINEAR STAT INFERENC, V2; Roelfsema PR, 2005, NEURAL COMPUT, V17, P2176, DOI 10.1162/0899766054615699; Rothkopf C, 2010, MULTISENSORY OBJECT PERCEPTION IN THE PRIMATE BRAIN, P21, DOI 10.1007/978-1-4419-5615-6_3; RUBINSTEIN I, 1959, J EXP PSYCHOL, V57, P413, DOI 10.1037/h0038962; Rumelhart G.E., 1986, PARALLEL DISTRIBUTED, P318, DOI DOI 10.1016/B978-1-4832-1446-7.50035-2; Samejima K, 2005, SCIENCE, V310, P1337, DOI 10.1126/science.1115270; Sato Y, 2007, NEURAL COMPUT, V19, P3335, DOI 10.1162/neco.2007.19.12.3335; Schonberg T, 2007, J NEUROSCI, V27, P12860, DOI 10.1523/JNEUROSCI.2496-07.2007; Schorr EA, 2005, P NATL ACAD SCI USA, V102, P18748, DOI 10.1073/pnas.0508862102; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Schultz W, 2000, NAT REV NEUROSCI, V1, P199, DOI 10.1038/35044563; Shah A, 2009, BRAIN RES, V1299, P55, DOI 10.1016/j.brainres.2009.07.006; Shams L, 2010, TRENDS COGN SCI, V14, P425, DOI 10.1016/j.tics.2010.07.001; Simoncelli E., 2008, ADV NEURAL INFORM PR, V20, P1409, DOI DOI 10.1037/A0013553; Sloman SA, 1996, PSYCHOL BULL, V119, P3, DOI 10.1037/0033-2909.119.1.3; Strelnikov K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018344; Sutton R.S., 2015, REINFORCEMENT LEARNI, V2nd ed.; Takikawa Y, 2002, EXP BRAIN RES, V142, P284, DOI 10.1007/s00221-001-0928-1; Tao HZW, 2000, J NEUROSCI, V20, P3233, DOI 10.1523/JNEUROSCI.20-09-03233.2000; Thomas GJ, 1941, J EXP PSYCHOL, V28, P163, DOI 10.1037/h0055183; Triesch J, 2002, PERCEPTION, V31, P421, DOI 10.1068/p3314; Wallace MT, 2007, J NEUROPHYSIOL, V97, P921, DOI 10.1152/jn.00497.2006; Wallace MT, 1997, J NEUROSCI, V17, P2429; Wallace MT, 2001, J NEUROSCI, V21, P8886, DOI 10.1523/JNEUROSCI.21-22-08886.2001; WEISSWANGE TH, 2009, 8 INT C DEV LEARN IE, P1, DOI DOI 10.1109/DEVLRN.2009.5175531; Whiteley L, 2008, J VISION, V8, DOI 10.1167/8.3.2; Wozny DR, 2011, J NEUROSCI, V31, P4607, DOI 10.1523/JNEUROSCI.6079-10.2011; Wozny DR, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000871; YOUNG MJ, 1993, VISION RES, V33, P2685, DOI 10.1016/0042-6989(93)90228-O	79	16	16	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2011	6	7							e21575	10.1371/journal.pone.0021575	http://dx.doi.org/10.1371/journal.pone.0021575			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	789JO	21750717	Green Published, gold, Green Submitted			2022-12-27	WOS:000292512000017
J	Sato, SM; Wissman, AM; McCollum, AF; Woolley, CS				Sato, Satoru M.; Wissman, Anne Marie; McCollum, Andrew F.; Woolley, Catherine S.			Quantitative Mapping of Cocaine-Induced Delta FosB Expression in the Striatum of Male and Female Rats	PLOS ONE			English	Article							EARLY GENE-EXPRESSION; SEX-DIFFERENCES; NUCLEUS-ACCUMBENS; BEHAVIORAL SENSITIZATION; VENTRAL STRIATUM; DRUG-ABUSE; COMPARTMENTAL ORGANIZATION; DYNORPHIN EXPRESSION; ROTATIONAL BEHAVIOR; BASAL FOREBRAIN	Delta FosB plays a critical role in drug-induced long-term changes in the brain. In the current study, we evaluated locomotor activity in male and female rats treated with saline or cocaine for 2 weeks and quantitatively mapped Delta FosB expression in the dorsal striatum and nucleus accumbens of each animal by using an anti-FosB antibody that recognizes Delta FosB isoforms preferentially. Behavioral analysis showed that while there was little difference between males and females that sensitized to cocaine, nonsensitizing rats showed a large sex difference. Nonsensitizing males showed low behavioral activation in response to cocaine on the first day of treatment, and their activity remained low. In contrast, nonsensitizing females showed high activation on the first day of treatment and their activity remained high. Western blot and immunohistochemical analyses indicated that basal levels of Delta FosB were higher in the nucleus accumbens than the dorsal striatum, but that the effect of cocaine on Delta FosB was greater in the dorsal striatum. Immunostaining showed that the effect of cocaine in both the dorsal striatum and nucleus accumbens was primarily to increase the intensity of Delta FosB immunoreactivity in individual neurons, rather than to increase the number of cells that express Delta FosB. Detailed mapping of Delta FosB-labeled nuclei showed that basal Delta FosB levels were highest in the medial portion of the dorsal striatum and dorsomedial accumbens, particularly adjacent to the lateral ventricle, whereas the cocaine-induced increase in Delta FosB was most pronounced in the lateral dorsal striatum, where basal Delta FosB expression was lowest. Sex differences in Delta FosB expression were small and independent of cocaine treatment. We discuss implications of the sex difference in locomotor activation and regionally-specific Delta FosB induction by cocaine.	[Sato, Satoru M.; Wissman, Anne Marie; McCollum, Andrew F.; Woolley, Catherine S.] Northwestern Univ, Dept Neurobiol & Physiol, Evanston, IL 60208 USA	Northwestern University	Sato, SM (corresponding author), Northwestern Univ, Dept Neurobiol & Physiol, 2153 Sheridan Rd, Evanston, IL 60208 USA.	cwoolley@northwestern.edu		Woolley, Catherine/0000-0002-8069-2646	National Institute of Health [R01 DA 020492]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA020492] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This research was supported by National Institute of Health (www.nih.gov) R01 DA 020492 to CSW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balleine BW, 2009, BEHAV BRAIN RES, V199, P43, DOI 10.1016/j.bbr.2008.10.034; Becker JB, 1999, PHARMACOL BIOCHEM BE, V64, P803, DOI 10.1016/S0091-3057(99)00168-9; Becker JB, 2008, FRONT NEUROENDOCRIN, V29, P36, DOI 10.1016/j.yfrne.2007.07.003; BERENDSE HW, 1990, J COMP NEUROL, V299, P187, DOI 10.1002/cne.902990206; Boudreau AC, 2005, J NEUROSCI, V25, P9144, DOI 10.1523/JNEUROSCI.2252-05.2005; BROG JS, 1993, J COMP NEUROL, V338, P255, DOI 10.1002/cne.903380209; BRONSTEIN DM, 1994, MOL BRAIN RES, V23, P191, DOI 10.1016/0169-328X(94)90226-7; CAMP DM, 1988, BEHAV BRAIN RES, V30, P55, DOI 10.1016/0166-4328(88)90008-3; CASTNER SA, 1993, BRAIN RES, V610, P127, DOI 10.1016/0006-8993(93)91225-H; Castner SA, 1996, BRAIN RES, V712, P245, DOI 10.1016/0006-8993(95)01429-2; Colby CR, 2003, J NEUROSCI, V23, P2488; DELFS JM, 1990, J NEUROSCI, V10, P303; Di Chiara G, 2002, BEHAV BRAIN RES, V137, P75, DOI 10.1016/S0166-4328(02)00286-3; FALLON JH, 1978, J COMP NEUROL, V180, P545, DOI 10.1002/cne.901800310; Festa ED, 2004, NEUROPHARMACOLOGY, V46, P672, DOI 10.1016/j.neuropharm.2003.11.017; Forlano PM, 2010, J COMP NEUROL, V518, P1330, DOI 10.1002/cne.22279; GERFEN CR, 1990, SCIENCE, V250, P1429, DOI 10.1126/science.2147780; GERFEN CR, 1992, ANNU REV NEUROSCI, V15, P285, DOI 10.1146/annurev.neuro.15.1.285; Girault JA, 2007, CURR OPIN PHARMACOL, V7, P77, DOI 10.1016/j.coph.2006.08.012; Graybiel AM, 2008, ANNU REV NEUROSCI, V31, P359, DOI 10.1146/annurev.neuro.29.051605.112851; Groenewegen HJ, 1999, ANN NY ACAD SCI, V877, P49, DOI 10.1111/j.1749-6632.1999.tb09260.x; GUNDERSEN HJG, 1987, J MICROSC-OXFORD, V147, P229, DOI 10.1111/j.1365-2818.1987.tb02837.x; Gundersen HJG, 1999, J MICROSC-OXFORD, V193, P199, DOI 10.1046/j.1365-2818.1999.00457.x; Harlan RE, 1998, MOL NEUROBIOL, V16, P221, DOI 10.1007/BF02741385; Hart SA, 2001, J COMP NEUROL, V440, P144, DOI 10.1002/cne.1376; HOPE B, 1992, P NATL ACAD SCI USA, V89, P5764, DOI 10.1073/pnas.89.13.5764; Hu M, 2006, SYNAPSE, V59, P122, DOI 10.1002/syn.20221; Hu M, 2003, J NEUROSCI, V23, P693, DOI 10.1523/JNEUROSCI.23-02-00693.2003; Jedynak JP, 2007, EUR J NEUROSCI, V25, P847, DOI 10.1111/j.1460-9568.2007.05316.x; Jiao Y, 1999, J NEUROSCI METH, V93, P149, DOI 10.1016/S0165-0270(99)00142-9; Joel D, 2000, NEUROSCIENCE, V96, P451, DOI 10.1016/S0306-4522(99)00575-8; Kelz MB, 1999, NATURE, V401, P272, DOI 10.1038/45790; KITA H, 1990, J COMP NEUROL, V298, P40, DOI 10.1002/cne.902980104; Larson EB, 2010, J NEUROCHEM, V115, P112, DOI 10.1111/j.1471-4159.2010.06907.x; Lee KW, 2006, P NATL ACAD SCI USA, V103, P3399, DOI 10.1073/pnas.0511244103; LEMOINE C, 1995, J COMP NEUROL, V355, P418, DOI 10.1002/cne.903550308; Lu XY, 1998, NEUROSCIENCE, V82, P767; Lynch WJ, 1999, PSYCHOPHARMACOLOGY, V144, P77, DOI 10.1007/s002130050979; Lynch WJ, 2002, PSYCHOPHARMACOLOGY, V164, P121, DOI 10.1007/s00213-002-1183-2; MCGEORGE AJ, 1989, NEUROSCIENCE, V29, P503, DOI 10.1016/0306-4522(89)90128-0; Mello NK, 1997, PHARMACOL BIOCHEM BE, V57, P571, DOI 10.1016/S0091-3057(96)00433-9; Mermelstein PG, 1996, J NEUROSCI, V16, P595; Moratalla R, 1996, NEURON, V17, P147, DOI 10.1016/S0896-6273(00)80288-3; Nelson A, 2006, J NEUROSCI, V26, P3805, DOI 10.1523/JNEUROSCI.4305-05.2006; Nestler EJ, 2001, P NATL ACAD SCI USA, V98, P11042, DOI 10.1073/pnas.191352698; Nestler EJ, 2008, PHILOS T R SOC B, V363, P3245, DOI 10.1098/rstb.2008.0067; Nye HE, 1995, J PHARMACOL EXP THER, V275, P1671; Paxinos G, 2004, RAT BRAIN STEROTAXIC; PERIS J, 1991, BRAIN RES, V566, P255, DOI 10.1016/0006-8993(91)91706-7; Perrotti LI, 2008, SYNAPSE, V62, P358, DOI 10.1002/syn.20500; Perrotti LI, 2004, J NEUROSCI, V24, P10594, DOI 10.1523/JNEUROSCI.2542-04.2004; Radwanska K, 2006, NEUROSCIENCE, V137, P253, DOI 10.1016/j.neuroscience.2005.09.001; Robbins TW, 2008, ANN NY ACAD SCI, V1141, P1, DOI 10.1196/annals.1441.020; ROBERTS DCS, 1989, PSYCHOPHARMACOLOGY, V98, P408, DOI 10.1007/BF00451696; ROBINSON TE, 1984, PSYCHOPHARMACOLOGY, V84, P466, DOI 10.1007/BF00431451; ROBINSON TE, 1980, BRAIN RES BULL, V5, P539, DOI 10.1016/0361-9230(80)90260-9; Roth ME, 2004, NEUROSCI BIOBEHAV R, V28, P533, DOI 10.1016/j.neubiorev.2004.08.001; Russo SJ, 2010, TRENDS NEUROSCI, V33, P267, DOI 10.1016/j.tins.2010.02.002; Russo SJ, 2003, BRAIN RES, V970, P214, DOI 10.1016/S0006-8993(03)02346-1; STEINER H, 1993, J NEUROSCI, V13, P5066, DOI 10.1523/JNEUROSCI.13-12-05066.1993; Thomas GM, 2004, NAT REV NEUROSCI, V5, P173, DOI 10.1038/nrn1346; Valjent E, 2004, EUR J NEUROSCI, V19, P1826, DOI 10.1111/j.1460-9568.2004.03278.x; Valjent E, 2010, NEUROPSYCHOPHARMACOL, V35, P401, DOI 10.1038/npp.2009.143; Vanderschuren LJMJ, 2000, PSYCHOPHARMACOLOGY, V151, P99, DOI 10.1007/s002130000493; Vezina P, 2004, NEUROSCI BIOBEHAV R, V27, P827, DOI 10.1016/j.neubiorev.2003.11.001; Voorn P, 2004, TRENDS NEUROSCI, V27, P468, DOI 10.1016/j.tins.2004.06.006; Walker QD, 2001, NEUROPSYCHOPHARMACOL, V25, P118, DOI 10.1016/S0893-133X(00)00248-7; WEST MJ, 1991, ANAT RECORD, V231, P482, DOI 10.1002/ar.1092310411; WISSMAN AM, 2011, NEUROPHARMA IN PRESS; Wright CI, 1996, J NEUROSCI, V16, P1877; Zaborszky L, 1999, ANN NY ACAD SCI, V877, P339, DOI 10.1111/j.1749-6632.1999.tb09276.x; Zahm DS, 1999, ANN NY ACAD SCI, V877, P113, DOI 10.1111/j.1749-6632.1999.tb09264.x; Zhang DS, 2002, J NEUROCHEM, V82, P1453, DOI 10.1046/j.1471-4159.2002.01089.x	73	51	53	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2011	6	7							e21783	10.1371/journal.pone.0021783	http://dx.doi.org/10.1371/journal.pone.0021783			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786HC	21747956	gold, Green Published, Green Submitted			2022-12-27	WOS:000292293400032
J	Ahidjo, BA; Kuhnert, D; McKenzie, JL; Machowski, EE; Gordhan, BG; Arcus, V; Abrahams, GL; Mizrahi, V				Ahidjo, Bintou Ahmadou; Kuhnert, Diane; McKenzie, Joanna L.; Machowski, Edith E.; Gordhan, Bhavna G.; Arcus, Vickery; Abrahams, Garth L.; Mizrahi, Valerie			VapC Toxins from Mycobacterium tuberculosis Are Ribonucleases that Differentially Inhibit Growth and Are Neutralized by Cognate VapB Antitoxins	PLOS ONE			English	Article							ESCHERICHIA-COLI; GENE-EXPRESSION; PIN-DOMAIN; ANTIBIOTIC TOLERANCE; PERSISTER CELLS; CRYSTAL-STRUCTURE; HYPOXIC RESPONSE; OXIDATIVE STRESS; MUTANTS; PROTEIN	The chromosome of Mycobacterium tuberculosis (Mtb) encodes forty seven toxin-antitoxin modules belonging to the VapBC family. The role of these modules in the physiology of Mtb and the function(s) served by their expansion are unknown. We investigated ten vapBC modules from Mtb and the single vapBC from M. smegmatis. Of the Mtb vapCs assessed, only Rv0549c, Rv0595c, Rv2549c and Rv2829c were toxic when expressed from a tetracycline-regulated promoter in M. smegmatis. The same genes displayed toxicity when conditionally expressed in Mtb. Toxicity of Rv2549c in M. smegmatis correlated with the level of protein expressed, suggesting that the VapC level must exceed a threshold for toxicity to be observed. In addition, the level of Rv2456 protein induced in M. smegmatis was markedly lower than Rv2549c, which may account for the lack of toxicity of this and other VapCs scored as 'non-toxic'. The growth inhibitory effects of toxic VapCs were neutralized by expression of the cognate VapB as part of a vapBC operon or from a different chromosomal locus, while that of non-cognate antitoxins did not. These results demonstrated a specificity of interaction between VapCs and their cognate VapBs, a finding corroborated by yeast two-hybrid analyses. Deletion of selected vapC or vapBC genes did not affect mycobacterial growth in vitro, but rendered the organisms more susceptible to growth inhibition following toxic VapC expression. However, toxicity of 'non-toxic' VapCs was not unveiled in deletion mutant strains, even when the mutation eliminated the corresponding cognate VapB, presumably due to insufficient levels of VapC protein. Together with the ribonuclease (RNase) activity demonstrated for Rv0065 and Rv0617 - VapC proteins with similarity to Rv0549c and Rv3320c, respectively - these results suggest that the VapBC family potentially provides an abundant source of RNase activity in Mtb, which may profoundly impact the physiology of the organism.	[Ahidjo, Bintou Ahmadou; Kuhnert, Diane; Machowski, Edith E.; Gordhan, Bhavna G.; Abrahams, Garth L.; Mizrahi, Valerie] Univ Witwatersrand, MRC,Dept Sci & Technol,Natl Res Fdn, Natl Hlth Lab Serv,Ctr Excellence Biomed TB Res, Mol Mycobacteriol Res Unit,Fac Hlth Sci, Johannesburg, South Africa; [McKenzie, Joanna L.; Arcus, Vickery] Univ Waikato, Dept Biol Sci, Hamilton, New Zealand	National Health Laboratory Service; National Research Foundation - South Africa; University of Witwatersrand; University of Waikato	Ahidjo, BA (corresponding author), Univ Witwatersrand, MRC,Dept Sci & Technol,Natl Res Fdn, Natl Hlth Lab Serv,Ctr Excellence Biomed TB Res, Mol Mycobacteriol Res Unit,Fac Hlth Sci, Johannesburg, South Africa.	valerie.mizrahi@uct.ac.za		Hicks, Joanna/0000-0002-0307-0923; Ahidjo, Bintou/0000-0002-3782-261X; Abrahams, Garth/0000-0001-7246-0901	Howard Hughes Medical Institute [55005522]; National Research Foundation; South African Medical Research Council	Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Research Foundation; South African Medical Research Council(South African Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by an International Scholars grant from the Howard Hughes Medical Institute to V.M. (grant no. 55005522; www.hhmi.org), and by grants from the National Research Foundation (www.nrf.ac.za) and the South African Medical Research Council (www.mrc.ac.za). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Arcus VL, 2011, PROTEIN ENG DES SEL, V24, P33, DOI 10.1093/protein/gzq081; Arcus VL, 2005, TRENDS MICROBIOL, V13, P360, DOI 10.1016/j.tim.2005.06.008; Arcus VL, 2004, J BIOL CHEM, V279, P16471, DOI 10.1074/jbc.M313833200; Balaban NQ, 2004, SCIENCE, V305, P1622, DOI 10.1126/science.1099390; Barry CE, 2010, NAT REV MICROBIOL, V8, DOI 10.1038/nrmicro2236-c2; Bodogai M, 2006, MOL PLANT MICROBE IN, V19, P811, DOI 10.1094/MPMI-19-0811; Boshoff HIM, 2008, J BIOL CHEM, V283, P19329, DOI 10.1074/jbc.M800694200; Brosch R, 1998, INFECT IMMUN, V66, P2221, DOI 10.1128/IAI.66.5.2221-2229.1998; Bryk R, 2008, CELL HOST MICROBE, V3, P137, DOI 10.1016/j.chom.2008.02.003; Bryk R, 2010, BIOCHEMISTRY-US, V49, P1616, DOI 10.1021/bi9016186; Bunker RD, 2008, PROTEINS, V72, P510, DOI 10.1002/prot.22048; Carroll P, 2007, FEMS MICROBIOL LETT, V274, P73, DOI 10.1111/j.1574-6968.2007.00842.x; Dhar N, 2007, CURR OPIN MICROBIOL, V10, P30, DOI 10.1016/j.mib.2006.12.007; Downing KJ, 2004, TUBERCULOSIS, V84, P167, DOI 10.1016/j.tube.2003.12.004; Dubnau E, 2002, INFECT IMMUN, V70, P2787, DOI 10.1128/IAI.70.6.2787-2795.2002; Ehrt S, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni013; Ehrt S, 2009, CELL MICROBIOL, V11, P1170, DOI 10.1111/j.1462-5822.2009.01335.x; Firmani MA, 2002, J CLIN MICROBIOL, V40, P3162, DOI 10.1128/JCM.40.9.3162-3166.2002; Fisher MA, 2002, J BACTERIOL, V184, P4025, DOI 10.1128/JB.184.14.4025-4032.2002; Gandotra S, 2007, NAT MED, V13, P1515, DOI 10.1038/nm1683; Gerdes K, 2005, NAT REV MICROBIOL, V3, P371, DOI 10.1038/nrmicro1147; Gerdes K, 2000, J BACTERIOL, V182, P561, DOI 10.1128/JB.182.3.561-572.2000; Goldstone RM, 2008, PROTEIN EXPRES PURIF, V57, P81, DOI 10.1016/j.pep.2007.08.015; Gupta A, 2009, FEMS MICROBIOL LETT, V290, P45, DOI 10.1111/j.1574-6968.2008.01400.x; Hansen S, 2008, ANTIMICROB AGENTS CH, V52, P2718, DOI 10.1128/AAC.00144-08; Hopper S, 2000, INFECT IMMUN, V68, P896, DOI 10.1128/IAI.68.2.896-905.2000; Keren I, 2004, J BACTERIOL, V186, P8172, DOI 10.1128/JB.186.24.8172-8180.2004; Keren I, 2004, FEMS MICROBIOL LETT, V230, P13, DOI 10.1016/S0378-1097(03)00856-5; Khoo SK, 2007, J BIOL CHEM, V282, P19606, DOI 10.1074/jbc.M701703200; Korch SB, 2003, MOL MICROBIOL, V50, P1199, DOI 10.1046/j.1365-2958.2003.03779.x; KORCH SB, 2008, J BACTERIOL; Korch SB, 2006, J BACTERIOL, V188, P3826, DOI 10.1128/JB.01740-05; Kumar P, 2008, J MOL BIOL, V383, P482, DOI 10.1016/j.jmb.2008.08.067; Kwan AHY, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng124; LABES M, 1990, GENE, V89, P37, DOI 10.1016/0378-1119(90)90203-4; Levin BR, 2006, NAT REV MICROBIOL, V4, P556, DOI 10.1038/nrmicro1445; Lewis K, 2007, NAT REV MICROBIOL, V5, P48, DOI 10.1038/nrmicro1557; Li GY, 2008, J MOL BIOL, V380, P107, DOI 10.1016/j.jmb.2008.04.039; Ma J, 2002, J BACTERIOL, V184, P5733, DOI 10.1128/JB.184.20.5733-5745.2002; Magnuson RD, 2007, J BACTERIOL, V189, P6089, DOI 10.1128/JB.00958-07; Manganelli R, 2001, MOL MICROBIOL, V41, P423, DOI 10.1046/j.1365-2958.2001.02525.x; Mattison K, 2006, J BIOL CHEM, V281, P37942, DOI 10.1074/jbc.M605198200; Miallau L, 2009, J BIOL CHEM, V284, P276, DOI 10.1074/jbc.M805061200; Mowa MB, 2009, J BACTERIOL, V191, P985, DOI 10.1128/JB.01409-08; Muttucumaru DGN, 2004, TUBERCULOSIS, V84, P239, DOI 10.1016/j.tube.2003.12.006; Pandey DP, 2005, NUCLEIC ACIDS RES, V33, P966, DOI 10.1093/nar/gki201; Parish T, 2000, MICROBIOL-SGM, V146, P1969, DOI 10.1099/00221287-146-8-1969; Parish T, 1997, MICROBIOL-UK, V143, P2267, DOI 10.1099/00221287-143-7-2267; Park HD, 2003, MOL MICROBIOL, V48, P833, DOI 10.1046/j.1365-2958.2003.03474.x; Pham TT, 2007, MICROBIOL-SGM, V153, P2711, DOI 10.1099/mic.0.2007/008904-0; Ramage HR, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000767; Robson J, 2009, J MOL BIOL, V390, P353, DOI 10.1016/j.jmb.2009.05.006; Rodriguez GM, 2002, INFECT IMMUN, V70, P3371, DOI 10.1128/IAI.70.7.3371-3381.2002; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; Sevin EW, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r155; Shah D, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-53; Sherman DR, 2001, P NATL ACAD SCI USA, V98, P7534, DOI 10.1073/pnas.121172498; Singh R, 2008, SCIENCE, V322, P1392, DOI 10.1126/science.1164571; Singh R, 2010, J BACTERIOL, V192, P1279, DOI 10.1128/JB.01285-09; Spoering AL, 2006, J BACTERIOL, V188, P5136, DOI 10.1128/JB.00369-06; Stewart GR, 2003, NAT REV MICROBIOL, V1, P97, DOI 10.1038/nrmicro749; Stewart GR, 2002, MICROBIOL-SGM, V148, P3129, DOI 10.1099/00221287-148-10-3129; Stewart GR, 2005, PLOS PATHOG, V1, P269, DOI 10.1371/journal.ppat.0010033; Talaat AM, 2004, P NATL ACAD SCI USA, V101, P4602, DOI 10.1073/pnas.0306023101; Tsilibaris V, 2007, J BACTERIOL, V189, P6101, DOI 10.1128/JB.00527-07; Vandal OH, 2009, J BACTERIOL, V191, P625, DOI 10.1128/JB.00932-08; Warner DF, 2006, CLIN MICROBIOL REV, V19, P558, DOI 10.1128/CMR.00060-05; Winther KS, 2011, P NATL ACAD SCI USA, V108, P7403, DOI 10.1073/pnas.1019587108; Wiuff C, 2005, ANTIMICROB AGENTS CH, V49, P1483, DOI 10.1128/AAC.49.4.1483-1494.2005; Young DB, 2008, J CLIN INVEST, V118, P1255, DOI 10.1172/JCI34614; Zhao LX, 2008, FEBS LETT, V582, P710, DOI 10.1016/j.febslet.2008.01.045; ZHU L, 2010, J BIOL CHEM; Zhu L, 2006, J BIOL CHEM, V281, P18638, DOI 10.1074/jbc.M512693200	73	63	68	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2011	6	6							e21738	10.1371/journal.pone.0021738	http://dx.doi.org/10.1371/journal.pone.0021738			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786FZ	21738782	Green Submitted, Green Published, gold			2022-12-27	WOS:000292290100066
J	Mor, A; Aizman, E; George, J; Kloog, Y				Mor, Adi; Aizman, Elizabeta; George, Jacob; Kloog, Yoel			Ras Inhibition Induces Insulin Sensitivity and Glucose Uptake	PLOS ONE			English	Article							NF-KAPPA-B; SKELETAL-MUSCLE CELLS; PROTEIN-KINASE-C; NECROSIS-FACTOR-ALPHA; REGULATORY T-CELLS; NUCLEAR-FACTOR; FARNESYLTHIOSALICYLIC ACID; RECEPTOR SUBSTRATE-1; SIGNAL-TRANSDUCTION; DOWN-REGULATION	Background: Reduced glucose uptake due to insulin resistance is a pivotal mechanism in the pathogenesis of type 2 diabetes. It is also associated with increased inflammation. Ras inhibition downregulates inflammation in various experimental models. The aim of this study was to examine the effect of Ras inhibition on insulin sensitivity and glucose uptake, as well as its influence on type 2 diabetes development. Methods and Findings: The effect of Ras inhibition on glucose uptake was examined both in vitro and in vivo. Ras was inhibited in cells transfected with a dominant-negative form of Ras or by 5-fluoro-farnesylthiosalicylic acid (F-FTS), a small-molecule Ras inhibitor. The involvement of I kappa B and NF-kappa B in Ras-inhibited glucose uptake was investigated by immunoblotting. High fat (HF)-induced diabetic mice were treated with F-FTS to test the effect of Ras inhibition on induction of hyperglycemia. Each of the Ras-inhibitory modes resulted in increased glucose uptake, whether in insulin-resistant C2C12 myotubes in vitro or in HF-induced diabetic mice in vivo. Ras inhibition also caused increased IkB expression accompanied by decreased expression of NF-kappa B. In fat-induced diabetic mice treated daily with F-FTS, both the incidence of hyperglycemia and the levels of serum insulin were significantly decreased. Conclusions: Inhibition of Ras apparently induces a state of heightened insulin sensitization both in vitro and in vivo. Ras inhibition should therefore be considered as an approach worth testing for the treatment of type 2 diabetes.	[Mor, Adi; Aizman, Elizabeta; Kloog, Yoel] Tel Aviv Univ, George S Wise Fac Life Sci, Dept Neurobiol, IL-69978 Tel Aviv, Israel; [George, Jacob] Kaplan Med Ctr, Dept Cardiol, Rehovot, Israel; [George, Jacob] Hebrew Univ Jerusalem, Hadassah Med Sch, IL-91010 Jerusalem, Israel	Tel Aviv University; Hebrew University of Jerusalem; Kaplan Medical Center; Hebrew University of Jerusalem	Mor, A (corresponding author), Tel Aviv Univ, George S Wise Fac Life Sci, Dept Neurobiol, IL-69978 Tel Aviv, Israel.	kloog@post.tau.ac.il			Israel Science Foundation [912/06]; Prajs-Drimmer Institute for The Development of Anti-Degenerative Drugs	Israel Science Foundation(Israel Science Foundation); Prajs-Drimmer Institute for The Development of Anti-Degenerative Drugs	This work was supported in part by The Israel Science Foundation 912/06 (Y. Kloog) and by the Prajs-Drimmer Institute for The Development of Anti-Degenerative Drugs (Y. Kloog and E. Aizman). Y. Kloog is the incumbent of the Jack H. Skirball Chair in Applied Neurobiology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aharonson Z, 1998, BBA-MOL BASIS DIS, V1406, P40, DOI 10.1016/S0925-4439(97)00077-X; Aizman E, 2010, EUR J PHARMACOL, V643, P139, DOI 10.1016/j.ejphar.2010.06.029; Arkan MC, 2005, NAT MED, V11, P191, DOI 10.1038/nm1185; Bar-Sagi D, 2000, CELL, V103, P227, DOI 10.1016/S0092-8674(00)00115-X; Bjornholm M, 2005, BIOCHEM SOC T, V33, P354; BOGUSKI MS, 1993, NATURE, V366, P643, DOI 10.1038/366643a0; BOS JL, 1989, CANCER RES, V49, P4682; Cai DS, 2005, NAT MED, V11, P183, DOI 10.1038/nm1166; Louzao MC, 2008, GLYCOCONJUGATE J, V25, P503, DOI 10.1007/s10719-007-9075-7; Cox AD, 2002, CANCER BIOL THER, V1, P599, DOI 10.4161/cbt.306; Das UN, 2002, NUTRITION, V18, P430, DOI 10.1016/S0899-9007(01)00747-X; DEFRONZO RA, 1991, DIABETES CARE, V14, P173, DOI 10.2337/diacare.14.3.173; DeFronzo RA, 2009, DIABETES, V58, P773, DOI 10.2337/db09-9028; Downward J, 1998, CURR OPIN GENET DEV, V8, P49, DOI 10.1016/S0959-437X(98)80061-0; Franckhauser S, 2008, DIABETOLOGIA, V51, P1306, DOI 10.1007/s00125-008-0998-8; Frost JA, 2000, J BIOL CHEM, V275, P19693, DOI 10.1074/jbc.M909860199; Genot E, 2000, CURR OPIN IMMUNOL, V12, P289, DOI 10.1016/S0952-7915(00)00089-3; Genot E, 1996, EMBO J, V15, P3923, DOI 10.1002/j.1460-2075.1996.tb00766.x; George J, 2002, CIRCULATION, V105, P2416, DOI 10.1161/01.CIR.0000016065.90068.96; HOTAMISLIGIL GS, 1995, J CLIN INVEST, V95, P2409, DOI 10.1172/JCI117936; Itani SI, 2002, DIABETES, V51, P2005, DOI 10.2337/diabetes.51.7.2005; Jager J, 2007, ENDOCRINOLOGY, V148, P241, DOI 10.1210/en.2006-0692; Jove M, 2006, ENDOCRINOLOGY, V147, P552, DOI 10.1210/en.2005-0440; Jove M, 2005, ENDOCRINOLOGY, V146, P3087, DOI 10.1210/en.2004-1560; Kane LP, 1999, CURR BIOL, V9, P601, DOI 10.1016/S0960-9822(99)80265-6; Karin M, 2001, BIOFACTORS, V15, P87, DOI 10.1002/biof.5520150207; KARUSIS D, 2001, J NEUROIMMU IN PRESS; Karussis D, 2001, J NEUROIMMUNOL, V120, P1; Katzav A, 2003, IMMUNOBIOLOGY, V207, P47, DOI 10.1078/0171-2985-00208; Katzav A, 2001, CLIN EXP IMMUNOL, V126, P570, DOI 10.1046/j.1365-2249.2001.01674.x; Kloog Y, 2000, MOL MED TODAY, V6, P398, DOI 10.1016/S1357-4310(00)01789-5; McFall A, 2001, MOL CELL BIOL, V21, P5488, DOI 10.1128/MCB.21.16.5488-5499.2001; Mor A, 2008, EUR J IMMUNOL, V38, P1493, DOI 10.1002/eji.200838292; Mora A, 2009, EUR J PHARMACOL, V616, P301, DOI 10.1016/j.ejphar.2009.06.001; Nguyen MTA, 2007, J BIOL CHEM, V282, P35279, DOI 10.1074/jbc.M706762200; Philips MR, 2005, BIOCHEM SOC T, V33, P657, DOI 10.1042/BST0330657; REAVEN GM, 1988, DIABETES, V37, P1595, DOI 10.2337/diabetes.37.12.1595; Rotblat B, 2008, METHOD ENZYMOL, V439, P467, DOI 10.1016/S0076-6879(07)00432-6; Shalom-Feuerstein R, 2008, BBA-MOL CELL RES, V1783, P985, DOI 10.1016/j.bbamcr.2008.03.009; Sinha S, 2004, J BIOL CHEM, V279, P41294, DOI 10.1074/jbc.M406514200; SURWIT RS, 1995, METABOLISM, V44, P645, DOI 10.1016/0026-0495(95)90123-X; Taniguchi CM, 2006, NAT REV MOL CELL BIO, V7, P85, DOI 10.1038/nrm1837; Uysal KT, 1997, NATURE, V389, P610, DOI 10.1038/39335; Wang LY, 2010, DIABETES, V59, P3117, DOI 10.2337/db09-1805; Weigert C, 2006, J BIOL CHEM, V281, P7060, DOI 10.1074/jbc.M509782200	45	17	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2011	6	6							e21712	10.1371/journal.pone.0021712	http://dx.doi.org/10.1371/journal.pone.0021712			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786FZ	21738773	Green Published, gold, Green Submitted			2022-12-27	WOS:000292290100060
J	Santos, MCT; Goldfeder, MB; Zanchin, NIT; Oliveira, CC				Santos, Marcia C. T.; Goldfeder, Mauricio B.; Zanchin, Nilson I. T.; Oliveira, Carla C.			The Essential Nucleolar Yeast Protein Nop8p Controls the Exosome Function during 60S Ribosomal Subunit Maturation	PLOS ONE			English	Article							MESSENGER-RNA DEGRADATION; SACCHAROMYCES-CEREVISIAE; BINDING PROTEIN; QUALITY-CONTROL; BIOGENESIS; INTERACTS; 5.8S; DYNAMICS; COMPLEX; RRP43P	The yeast nucleolar protein Nop8p has previously been shown to interact with Nip7p and to be required for 60S ribosomal subunit formation. Although depletion of Nop8p in yeast cells leads to premature degradation of rRNAs, the biochemical mechanism responsible for this phenotype is still not known. In this work, we show that the Nop8p amino-terminal region mediates interaction with the 5.8S rRNA, while its carboxyl-terminal portion interacts with Nip7p and can partially complement the growth defect of the conditional mutant strain Dnop8/GAL::NOP8. Interestingly, Nop8p mediates association of Nip7p to pre-ribosomal particles. Nop8p also interacts with the exosome subunit Rrp6p and inhibits the complex activity in vitro, suggesting that the decrease in 60S ribosomal subunit levels detected upon depletion of Nop8p may result from degradation of pre-rRNAs by the exosome. These results strongly indicate that Nop8p may control the exosome function during pre-rRNA processing.	[Santos, Marcia C. T.; Goldfeder, Mauricio B.; Oliveira, Carla C.] Univ Sao Paulo, Dept Biochem, Inst Chem, Sao Paulo, Brazil; [Zanchin, Nilson I. T.] Univ Estadual Campinas, Ctr Biol Mol & Engn Genet, Sao Paulo, Brazil; [Zanchin, Nilson I. T.] Univ Estadual Campinas, Fac Ciencias Aplicadas, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade Estadual de Campinas; Universidade Estadual de Campinas	Santos, MCT (corresponding author), Univ Sao Paulo, Dept Biochem, Inst Chem, Sao Paulo, Brazil.	ccoliv@iq.usp.br	Oliveira, Carla C/F-2323-2011; Zanchin, Nilson Ivo Tonin/AAB-4907-2019	Oliveira, Carla C/0000-0002-1098-9241; Zanchin, Nilson Ivo Tonin/0000-0002-1153-0694	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - FAPESP [09/52826-4]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by a grant from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - FAPESP (09/52826-4 to C.C.O.). M. C. T. S. and M. B. G. were recipients of FAPESP fellowships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albanese V, 2010, J CELL BIOL, V189, P69, DOI 10.1083/jcb.201001054; Allmang C, 1999, EMBO J, V18, P5399, DOI 10.1093/emboj/18.19.5399; Allmang C, 2000, NUCLEIC ACIDS RES, V28, P1684, DOI 10.1093/nar/28.8.1684; Araki Y, 2001, EMBO J, V20, P4684, DOI 10.1093/emboj/20.17.4684; Baker KE, 2006, RNA, V12, P1441, DOI 10.1261/rna.92706; BARTEL PL, 1995, METHOD ENZYMOL, V254, P241; Bassler J, 2001, MOL CELL, V8, P517, DOI 10.1016/S1097-2765(01)00342-2; Callahan KP, 2008, NUCLEIC ACIDS RES, V36, P6645, DOI 10.1093/nar/gkn743; CHEN DC, 1992, CURR GENET, V21, P83, DOI 10.1007/BF00318659; Coltri PP, 2007, BIOCHEMISTRY-US, V46, P14177, DOI 10.1021/bi7015876; de la Cruz J, 2004, GENETICS, V166, P1687, DOI 10.1534/genetics.166.4.1687; de la Cruz J, 1998, EMBO J, V17, P1128, DOI 10.1093/emboj/17.4.1128; Dechampesme AM, 1999, J CELL BIOL, V145, P1369, DOI 10.1083/jcb.145.7.1369; Dez C, 2006, EMBO J, V25, P1534, DOI 10.1038/sj.emboj.7601035; Dez C, 2004, MOL CELL BIOL, V24, P6324, DOI 10.1128/MCB.24.14.6324-6337.2004; Fatica A, 2002, MOL CELL, V9, P341, DOI 10.1016/S1097-2765(02)00458-6; Fink AL, 2005, CURR OPIN STRUC BIOL, V15, P35, DOI 10.1016/j.sbi.2005.01.002; Gonzales FA, 2005, J MOL BIOL, V346, P437, DOI 10.1016/j.jmb.2004.11.071; Granato DC, 2008, FEBS J, V275, P4164, DOI 10.1111/j.1742-4658.2008.06565.x; Granato DC, 2005, FEBS J, V272, P4450, DOI 10.1111/j.1742-4658.2005.04861.x; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; Henras AK, 2008, CELL MOL LIFE SCI, V65, P2334, DOI 10.1007/s00018-008-8027-0; Horsey EW, 2004, RNA, V10, P813, DOI 10.1261/rna.5255804; Houseley J, 2006, NAT REV MOL CELL BIO, V7, P529, DOI 10.1038/nrm1964; James P, 1996, GENETICS, V144, P1425; Kuai L, 2004, P NATL ACAD SCI USA, V101, P8581, DOI 10.1073/pnas.0402888101; LaCava J, 2005, CELL, V121, P713, DOI 10.1016/j.cell.2005.04.029; Lebreton A, 2008, NUCLEIC ACIDS RES, V36, P4988, DOI 10.1093/nar/gkn469; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luz JS, 2010, BMC BIOCHEM, V11, DOI 10.1186/1471-2091-11-22; Lykke-Andersen S, 2009, J CELL SCI, V122, P1487, DOI 10.1242/jcs.047399; Midtgaard SF, 2006, P NATL ACAD SCI USA, V103, P11898, DOI 10.1073/pnas.0604731103; Milligan L, 2008, MOL CELL BIOL, V28, P5446, DOI 10.1128/MCB.00463-08; Mitchell P, 2003, MOL CELL BIOL, V23, P6982, DOI 10.1128/MCB.23.19.6982-6992.2003; Nissan TA, 2002, EMBO J, V21, P5539, DOI 10.1093/emboj/cdf547; Oliveira CC, 2002, NUCLEIC ACIDS RES, V30, P4186, DOI 10.1093/nar/gkf545; OLIVEIRA CC, 1995, J BIOL CHEM, V270, P8936, DOI 10.1074/jbc.270.15.8936; Peng WT, 2003, CELL, V113, P919, DOI 10.1016/S0092-8674(03)00466-5; Rodriguez-Mateos M, 2009, NUCLEIC ACIDS RES, V37, P7519, DOI 10.1093/nar/gkp806; Rosado IV, 2004, RNA, V10, P1073, DOI 10.1261/rna.7340404; Rosado IV, 2007, MOL CELL BIOL, V27, P1207, DOI 10.1128/MCB.01523-06; Sambrook J., 2002, MOL CLONING LAB MANU; Schilders G, 2005, NUCLEIC ACIDS RES, V33, P6795, DOI 10.1093/nar/gki982; Sekiguchi T, 2004, J BIOL CHEM, V279, P8343, DOI 10.1074/jbc.M305935200; Sekiguchi T, 2006, NUCLEIC ACIDS RES, V34, P4593, DOI 10.1093/nar/gkl603; Srivastava L, 2010, MOL CELL BIOL, V30, P2947, DOI 10.1128/MCB.00226-10; Stead JA, 2007, NUCLEIC ACIDS RES, V35, P5556, DOI 10.1093/nar/gkm614; Vanacova S, 2007, EMBO REP, V8, P651, DOI 10.1038/sj.embor.7401005; VOJTEK AB, 1995, METHOD ENZYMOL, V255, P331; Zanchin NIT, 1997, MOL CELL BIOL, V17, P5001, DOI 10.1128/MCB.17.9.5001; Zanchin NIT, 1999, NUCLEIC ACIDS RES, V27, P1283, DOI 10.1093/nar/27.5.1283; Zanchin NIT, 1999, MOL CELL BIOL, V19, P1518	52	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2011	6	6							e21686	10.1371/journal.pone.0021686	http://dx.doi.org/10.1371/journal.pone.0021686			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786FZ	21747919	gold, Green Published, Green Submitted			2022-12-27	WOS:000292290100056
J	Andrews-Hanna, JR; Seghete, KLM; Claus, ED; Burgess, GC; Ruzic, L; Banich, MT				Andrews-Hanna, Jessica R.; Seghete, Kristen L. Mackiewicz; Claus, Eric D.; Burgess, Gregory C.; Ruzic, Luka; Banich, Marie T.			Cognitive Control in Adolescence: Neural Underpinnings and Relation to Self-Report Behaviors	PLOS ONE			English	Article							ANTERIOR CINGULATE CORTEX; INFERIOR FRONTAL JUNCTION; MAPPING BRAIN MATURATION; HUMAN CEREBRAL-CORTEX; PREFRONTAL CORTEX; ATTENTIONAL CONTROL; WORKING-MEMORY; NEURODEVELOPMENTAL TRAJECTORIES; RESPONSE-INHIBITION; DEVELOPMENTAL FMRI	Background: Adolescence is commonly characterized by impulsivity, poor decision-making, and lack of foresight. However, the developmental neural underpinnings of these characteristics are not well established. Methodology/Principal Findings: To test the hypothesis that these adolescent behaviors are linked to under-developed proactive control mechanisms, the present study employed a hybrid block/event-related functional Magnetic Resonance Imaging (fMRI) Stroop paradigm combined with self-report questionnaires in a large sample of adolescents and adults, ranging in age from 14 to 25. Compared to adults, adolescents under-activated a set of brain regions implicated in proactive top-down control across task blocks comprised of difficult and easy trials. Moreover, the magnitude of lateral prefrontal activity in adolescents predicted self-report measures of impulse control, foresight, and resistance to peer pressure. Consistent with reactive compensatory mechanisms to reduced proactive control, older adolescents exhibited elevated transient activity in regions implicated in response-related interference resolution. Conclusions/Significance: Collectively, these results suggest that maturation of cognitive control may be partly mediated by earlier development of neural systems supporting reactive control and delayed development of systems supporting proactive control. Importantly, the development of these mechanisms is associated with cognitive control in real-life behaviors.	[Andrews-Hanna, Jessica R.; Seghete, Kristen L. Mackiewicz; Burgess, Gregory C.; Ruzic, Luka; Banich, Marie T.] Univ Colorado, Inst Cognit Sci, Boulder, CO 80309 USA; [Claus, Eric D.] Mind Res Network, Albuquerque, NM USA; [Banich, Marie T.] Univ Colorado, Dept Psychol & Neurosci, Boulder, CO 80309 USA; [Banich, Marie T.] Univ Colorado, Dept Psychiat, Denver, CO 80202 USA	University of Colorado System; University of Colorado Boulder; Lovelace Respiratory Research Institute; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Denver	Andrews-Hanna, JR (corresponding author), Univ Colorado, Inst Cognit Sci, Boulder, CO 80309 USA.	Jessica.Andrews-Hanna@colorado.edu; Marie.Banich@colorado.edu	Seghete, Kristen/AAY-8365-2020; Claus, Eric/AAQ-5035-2021	Seghete, Kristen/0000-0001-9173-3979; BANICH, MARIE/0000-0001-9373-9194	John D. and Catherine T. MacArthur Foundation Research Network on Adolescent Development; Juvenile Justice; NIMH [P50 MH079485]; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH079485] Funding Source: NIH RePORTER	John D. and Catherine T. MacArthur Foundation Research Network on Adolescent Development; Juvenile Justice; NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the John D. and Catherine T. MacArthur Foundation Research Network on Adolescent Development and Juvenile Justice and an NIMH-funded Interdisciplinary Behavioral Science Center grant (P50 MH079485). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adleman NE, 2002, NEUROIMAGE, V16, P61, DOI 10.1006/nimg.2001.1046; ALBERT D, CHILD DEV IN PRESS; Arnett JJ, 2000, AM PSYCHOL, V55, P469, DOI 10.1037/0003-066X.55.5.469; Banich MT, 2009, NEUROPSYCHOLOGIA, V47, P3095, DOI 10.1016/j.neuropsychologia.2009.07.005; Banich MT, 2009, CURR DIR PSYCHOL SCI, V18, P89, DOI 10.1111/j.1467-8721.2009.01615.x; Banich MT, 2009, NEUROSCI BIOBEHAV R, V33, P613, DOI 10.1016/j.neubiorev.2008.09.010; Banich MT, 2000, COGNITIVE BRAIN RES, V10, P1, DOI 10.1016/S0926-6410(00)00015-X; Bennett CM, 2006, HUM BRAIN MAPP, V27, P762, DOI 10.1002/hbm.20218; Brahmbhatt SB, 2010, BRAIN RES, V1354, P140, DOI 10.1016/j.brainres.2010.07.055; Brass M, 2005, TRENDS COGN SCI, V9, P314, DOI 10.1016/j.tics.2005.05.001; Brass M, 2002, CEREB CORTEX, V12, P908, DOI 10.1093/cercor/12.9.908; Braver T. S., 2007, VARIATION WORKING ME, P76, DOI DOI 10.1093/ACPROF:OSO/9780195168648.003.0004; Braver TS, 2009, P NATL ACAD SCI USA, V106, P7351, DOI 10.1073/pnas.0808187106; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Bunge SA, 2003, J NEUROPHYSIOL, V90, P3419, DOI 10.1152/jn.00910.2002; Bunge SA, 2007, CURR OPIN NEUROBIOL, V17, P243, DOI 10.1016/j.conb.2007.02.005; Burgess GC, 2010, BIOL PSYCHIAT, V67, P632, DOI 10.1016/j.biopsych.2009.10.036; Burgund ED, 2006, NEUROIMAGE, V29, P812, DOI 10.1016/j.neuroimage.2005.08.056; Casey BJ, 2008, ANN NY ACAD SCI, V1124, P111, DOI 10.1196/annals.1440.010; Chatham CH, 2009, P NATL ACAD SCI USA, V106, P5529, DOI 10.1073/pnas.0810002106; Chawla D, 1999, NAT NEUROSCI, V2, P671, DOI 10.1038/10230; Christakou A, 2011, NEUROIMAGE, V54, P1344, DOI 10.1016/j.neuroimage.2010.08.067; Christakou A, 2009, NEUROIMAGE, V48, P223, DOI 10.1016/j.neuroimage.2009.06.070; Cohen P, 2003, DEV PSYCHOL, V39, P657, DOI 10.1037/0012-1649.39.4.657; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Crone EA, 2006, CEREB CORTEX, V16, P475, DOI 10.1093/cercor/bhi127; Crone EA, 2006, J NEUROSCI, V26, P11239, DOI 10.1523/JNEUROSCI.2165-06.2006; Crone EA, 2009, DEVELOPMENTAL SCI, V12, P825, DOI 10.1111/j.1467-7687.2009.00918.x; Derrfuss J, 2005, HUM BRAIN MAPP, V25, P22, DOI 10.1002/hbm.20127; Derrfuss J, 2004, NEUROIMAGE, V23, P604, DOI 10.1016/j.neuroimage.2004.06.007; Devlin JT, 2007, NEUROIMAGE, V37, P1033, DOI 10.1016/j.neuroimage.2006.09.055; Donaldson DI, 2001, NEUROIMAGE, V13, P129, DOI 10.1006/nimg.2000.0664; Dosenbach NUF, 2006, NEURON, V50, P799, DOI 10.1016/j.neuron.2006.04.031; Duncan J, 2000, TRENDS NEUROSCI, V23, P475, DOI 10.1016/S0166-2236(00)01633-7; Durston S, 2006, DEVELOPMENTAL SCI, V9, P1, DOI 10.1111/j.1467-7687.2005.00454.x; Durston S, 2006, NEUROPSYCHOLOGIA, V44, P2149, DOI 10.1016/j.neuropsychologia.2005.10.010; Fair DA, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000381; Galvan A, 2007, DEVELOPMENTAL SCI, V10, pF8, DOI 10.1111/j.1467-7687.2006.00579.x; Giedd JN, 2008, J ADOLESCENT HEALTH, V42, P335, DOI 10.1016/j.jadohealth.2008.01.007; Giedd JN, 2004, ANN NY ACAD SCI, V1021, P77, DOI 10.1196/annals.1308.009; Giedd JN, 1999, NAT NEUROSCI, V2, P861, DOI 10.1038/13158; Gogtay N, 2004, P NATL ACAD SCI USA, V101, P8174, DOI 10.1073/pnas.0402680101; Grosbras MH, 2007, J NEUROSCI, V27, P8040, DOI 10.1523/JNEUROSCI.1360-07.2007; Luna B, 2004, ANN NY ACAD SCI, V1021, P296, DOI 10.1196/annals.1308.035; Luna B, 2001, NEUROIMAGE, V13, P786, DOI 10.1006/nimg.2000.0743; Luna B, 2010, BRAIN COGNITION, V72, P101, DOI 10.1016/j.bandc.2009.08.005; MACLEOD CM, 2001, PSYCHOL B, V109; Marsh R, 2006, HUM BRAIN MAPP, V27, P848, DOI 10.1002/hbm.20225; Milham MP, 2001, COGNITIVE BRAIN RES, V12, P467, DOI 10.1016/S0926-6410(01)00076-3; Milham MP, 2005, HUM BRAIN MAPP, V25, P328, DOI 10.1002/hbm.20110; Milham MP, 2003, COGNITIVE BRAIN RES, V17, P212, DOI 10.1016/S0926-6410(03)00108-3; Milham MP, 2003, NEUROIMAGE, V18, P483, DOI 10.1016/S1053-8119(02)00050-2; Miller EK, 2000, NAT REV NEUROSCI, V1, P59, DOI 10.1038/35036228; Monsell S, 2001, MEM COGNITION, V29, P137, DOI 10.3758/BF03195748; Neumann J, 2008, HUM BRAIN MAPP, V29, P177, DOI 10.1002/hbm.20380; Paus T, 2005, TRENDS COGN SCI, V9, P60, DOI 10.1016/j.tics.2004.12.008; Paxton JL, 2008, CEREB CORTEX, V18, P1010, DOI 10.1093/cercor/bhm135; Petrides M., 1994, HDB NEUROPSYCHOLOGY, V9, P17; Power JD, 2010, NEURON, V67, P735, DOI 10.1016/j.neuron.2010.08.017; Rubia K, 2000, NEUROSCI BIOBEHAV R, V24, P13, DOI 10.1016/S0149-7634(99)00055-X; Rubia K, 2007, HUM BRAIN MAPP, V28, P1163, DOI 10.1002/hbm.20347; Rubia K, 2006, HUM BRAIN MAPP, V27, P973, DOI 10.1002/hbm.20237; Rubia K, 2010, NEUROIMAGE, V51, P817, DOI 10.1016/j.neuroimage.2010.02.058; Scherf KS, 2006, J COGNITIVE NEUROSCI, V18, P1045, DOI 10.1162/jocn.2006.18.7.1045; Schubert Carol A, 2004, Youth Violence Juv Justice, V2, P237, DOI 10.1177/1541204004265875; Shaw P, 2008, J NEUROSCI, V28, P3586, DOI 10.1523/JNEUROSCI.5309-07.2008; Silton RL, 2010, NEUROIMAGE, V50, P1292, DOI 10.1016/j.neuroimage.2009.12.061; Sisk CL, 2005, FRONT NEUROENDOCRIN, V26, P163, DOI 10.1016/j.yfrne.2005.10.003; Sowell ER, 2004, J NEUROSCI, V24, P8223, DOI 10.1523/JNEUROSCI.1798-04.2004; Sowell ER, 2003, NAT NEUROSCI, V6, P309, DOI 10.1038/nn1008; Sowell ER, 2001, J NEUROSCI, V21, P8819, DOI 10.1523/JNEUROSCI.21-22-08819.2001; Steinberg L, 2005, TRENDS COGN SCI, V9, P69, DOI 10.1016/j.tics.2004.12.005; Steinberg L, 2007, DEV PSYCHOL, V43, P1531, DOI 10.1037/0012-1649.43.6.1531; Steinberg L, 2009, CHILD DEV, V80, P28, DOI 10.1111/j.1467-8624.2008.01244.x; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Toga AW, 2006, TRENDS NEUROSCI, V29, P148, DOI 10.1016/j.tins.2006.01.007; Van Essen DC, 2005, NEUROIMAGE, V28, P635, DOI 10.1016/j.neuroimage.2005.06.058; Velanova K, 2009, J NEUROSCI, V29, P12558, DOI 10.1523/JNEUROSCI.1579-09.2009; Visscher KM, 2003, NEUROIMAGE, V19, P1694, DOI 10.1016/S1053-8119(03)00178-2; Wager TD, 2004, NEUROIMAGE, V22, P1679, DOI 10.1016/j.neuroimage.2004.03.052; Ward B. D., 2000, SIMULTANEOUS INFEREN, DOI https://afni.nimh.nih.gov/pub/dist/doc/manuals/AlphaSim.pdf; WEINBERGER DA, 1990, J PERS, V58, P381, DOI 10.1111/j.1467-6494.1990.tb00235.x; Woolrich M, 2008, NEUROIMAGE, V41, P286, DOI 10.1016/j.neuroimage.2008.02.042; ZUCKERMAN M, 1978, J CONSULT CLIN PSYCH, V46, P139, DOI 10.1037/0022-006X.46.1.139	84	92	95	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2011	6	6							e21598	10.1371/journal.pone.0021598	http://dx.doi.org/10.1371/journal.pone.0021598			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	784FW	21738725	gold, Green Published, Green Submitted			2022-12-27	WOS:000292142800043
J	Wolny, M; Grzybek, M; Bok, E; Chorzalska, A; Lenoir, M; Czogalla, A; Adamczyk, K; Kolondra, A; Diakowski, W; Overduin, M; Sikorski, AF				Wolny, Marcin; Grzybek, Michal; Bok, Ewa; Chorzalska, Anna; Lenoir, Marc; Czogalla, Aleksander; Adamczyk, Klaudia; Kolondra, Adam; Diakowski, Witold; Overduin, Michael; Sikorski, Aleksander F.			Key Amino Acid Residues of Ankyrin-Sensitive Phosphatidylethanolamine/Phosphatidylcholine-Lipid Binding Site of beta I-Spectrin	PLOS ONE			English	Article							MEMBRANE PHOSPHOLIPIDS; ERYTHROCYTE SPECTRIN; CELL MEMBRANE; HIGH-AFFINITY; ROD DOMAIN; PROTEIN; MONOLAYER; BILAYER; IDENTIFICATION; DYSTROPHIN	It was shown previously that an ankyrin-sensitive, phosphatidylethanolamine/phosphatidylcholine (PE/PC) binding site maps to the N-terminal part of the ankyrin-binding domain of beta-spectrin (ankBDn). Here we have identified the amino acid residues within this domain which are responsible for recognizing monolayers and bilayers composed of PE/PC mixtures. In vitro binding studies revealed that a quadruple mutant with substituted hydrophobic residues W1771, L1775, M1778 and W1779 not only failed to effectively bind PE/PC, but its residual PE/PC-binding activity was insensitive to inhibition with ankyrin. Structure prediction and analysis, supported by in vitro experiments, suggests that "opening'' of the coiled-coil structure underlies the mechanism of this interaction. Experiments on red blood cells and HeLa cells supported the conclusions derived from the model and in vitro lipid-protein interaction results, and showed the potential physiological role of this binding. We postulate that direct interactions between spectrin ankBDn and PE-rich domains play an important role in stabilizing the structure of the spectrin-based membrane skeleton.	[Wolny, Marcin; Chorzalska, Anna; Czogalla, Aleksander; Adamczyk, Klaudia; Kolondra, Adam; Diakowski, Witold; Sikorski, Aleksander F.] Univ Wroclaw, Biotechnol Fac, Lab Cytobiochem, PL-50138 Wroclaw, Poland; [Grzybek, Michal] Max Planck Inst Mol Cell Biol & Genet, Dresden, Germany; [Bok, Ewa] Univ Zielona Gora, Dept Mol Biol, Zielona Gora, Poland; [Lenoir, Marc; Overduin, Michael] Univ Birmingham, Sch Canc Sci, Henry Wellcome Bldg Biomol NMR Spect, Birmingham, W Midlands, England	University of Wroclaw; Max Planck Society; University of Zielona Gora; University of Birmingham	Wolny, M (corresponding author), Univ Wroclaw, Biotechnol Fac, Lab Cytobiochem, PL-50138 Wroclaw, Poland.	afsbc@ibmb.uni.wroc.pl	Sikorski, Aleksander/HGD-5159-2022; Overduin, Michael/AAG-3632-2020; Sikorski, Aleksander F/C-3361-2009; Czogalla, Aleksander/M-8504-2019; Czogalla, Aleksander/A-9752-2014; Grzybek, Michal/D-3802-2017	Overduin, Michael/0000-0002-3114-6585; Czogalla, Aleksander/0000-0003-3035-059X; Kolondra, Adam/0000-0001-5849-7185; Wolny, Marcin/0000-0003-1030-7607; Lenoir, Marc/0000-0001-7410-2323; Grzybek, Michal/0000-0003-2083-0506; Sikorski, Aleksander F./0000-0003-3779-8266	Polish Ministry of Science and University Education [N N301 286037]; EU; University of Wroclaw; Office of the Marshal of the Lubuskie Voivodeship	Polish Ministry of Science and University Education; EU(European Commission); University of Wroclaw; Office of the Marshal of the Lubuskie Voivodeship	This study was supported by grant No. N N301 286037 from the Polish Ministry of Science and University Education, the EU PRISM project, the University of Wroclaw Research Fund, and by The European Social Fund grant from Office of the Marshal of the Lubuskie Voivodeship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An XL, 2005, BIOCHEMISTRY-US, V44, P10681, DOI 10.1021/bi047331z; An XL, 2005, BIOCHEM BIOPH RES CO, V327, P794, DOI 10.1016/j.bbrc.2004.12.063; An XL, 2004, BLOOD CELL MOL DIS, V32, P430, DOI 10.1016/j.bcmd.2004.02.001; Bates PA, 2001, PROTEINS, P39; BENNETT V, 1979, NATURE, V280, P468, DOI 10.1038/280468a0; Bennett V, 2008, TRENDS MOL MED, V14, P28, DOI 10.1016/j.molmed.2007.11.005; BIALKOWSKA K, 1994, BBA-BIOMEMBRANES, V1191, P21, DOI 10.1016/0005-2736(94)90228-3; Bok E, 2007, CELL BIOL INT, V31, P1482, DOI 10.1016/j.cellbi.2007.06.014; CHORZALSKA A, 2010, CELL MOL BIOL LETT; CZOGALLA A, CELL MOL LIFE SCI, V67, P2679; Czogalla A, 2007, MOL MEMBR BIOL, V24, P215, DOI 10.1080/09687860601102427; Czogalla A, 2008, BBA-BIOMEMBRANES, V1778, P2612, DOI 10.1016/j.bbamem.2008.07.020; Das A, 2006, J CELL BIOL, V175, P325, DOI 10.1083/jcb.200602095; Diakowski W, 1999, BIOCHEM J, V338, P83, DOI 10.1042/0264-6021:3380083; Diakowski Witold, 1994, Acta Biochimica Polonica, V41, P153; Fiser A, 2000, PROTEIN SCI, V9, P1753, DOI 10.1110/ps.9.9.1753; GREENFIE.N, 1969, BIOCHEMISTRY-US, V8, P4108, DOI 10.1021/bi00838a031; Grum VL, 1999, CELL, V98, P523, DOI 10.1016/S0092-8674(00)81980-7; Grzybek M, 2006, CHEM PHYS LIPIDS, V141, P133, DOI 10.1016/j.chemphyslip.2006.02.008; Hryniewicz-Jankowska A, 2004, BIOCHEM J, V382, P677, DOI 10.1042/BJ20040358; HU RJ, 1995, J CELL BIOL, V128, P1069, DOI 10.1083/jcb.128.6.1069; Ipsaro JJ, 2010, BLOOD, V115, P4093, DOI 10.1182/blood-2009-11-255604; Ipsaro JJ, 2009, BLOOD, V113, P5385, DOI 10.1182/blood-2008-10-184358; KENNEDY SP, 1991, J CELL BIOL, V115, P267, DOI 10.1083/jcb.115.1.267; Kolondra A, 2008, PROTEIN EXPRES PURIF, V60, P157, DOI 10.1016/j.pep.2008.04.002; Kolondra A, 2010, BBA-BIOMEMBRANES, V1798, P2084, DOI 10.1016/j.bbamem.2010.07.024; La-Borde PJ, 2010, BIOCHEM BIOPH RES CO, V392, P490, DOI 10.1016/j.bbrc.2010.01.046; Le Rumeur E, 2003, J BIOL CHEM, V278, P5993, DOI 10.1074/jbc.M207321200; Legardinier S, 2009, J MOL BIOL, V389, P546, DOI 10.1016/j.jmb.2009.04.025; Maget-Dana R, 1999, BBA-BIOMEMBRANES, V1462, P109, DOI 10.1016/S0005-2736(99)00203-5; Malovrh P, 2000, BIOCHEM J, V346, P223, DOI 10.1042/0264-6021:3460223; Manno S, 2002, P NATL ACAD SCI USA, V99, P1943, DOI 10.1073/pnas.042688399; MICHALAK K, 1993, GEN PHYSIOL BIOPHYS, V12, P163; Nicolas V, 2003, J BIOL CHEM, V278, P25526, DOI 10.1074/jbc.M302816200; Ray S, 2004, MOL MEMBR BIOL, V21, P93, DOI 10.1080/09687680310001625800; Salomao M, 2008, P NATL ACAD SCI USA, V105, P8026, DOI 10.1073/pnas.0803225105; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Shao C, 2008, J BIOL CHEM, V283, P7230, DOI 10.1074/jbc.M705195200; SIKORSKI A, 1996, CELL MOL BIOL LETT, V1, P97; Stabach PR, 2009, BLOOD, V113, P5377, DOI 10.1182/blood-2008-10-184291; THWAY T, J PHARM BIOMED ANAL, V51, P626; VERKLEIJ AJ, 1973, BIOCHIM BIOPHYS ACTA, V323, P178, DOI 10.1016/0005-2736(73)90143-0; Wimley WC, 1996, BIOCHEMISTRY-US, V35, P5109, DOI 10.1021/bi9600153; Yi SJ, 1997, BIOCHEMISTRY-US, V36, P9596, DOI 10.1021/bi9704966; YU J, 1979, P NATL ACAD SCI USA, V76, P2340, DOI 10.1073/pnas.76.5.2340	45	17	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2011	6	6							e21538	10.1371/journal.pone.0021538	http://dx.doi.org/10.1371/journal.pone.0021538			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	784FW	21738695	Green Published, Green Submitted, gold			2022-12-27	WOS:000292142800034
J	Chadwick, W; Boyle, JP; Zhou, Y; Wang, LY; Park, SS; Martin, B; Wang, R; Becker, KG; Wood, WH; Zhang, YQ; Peers, C; Maudsley, S				Chadwick, Wayne; Boyle, John P.; Zhou, Yu; Wang, Liyun; Park, Sung-Soo; Martin, Bronwen; Wang, Rui; Becker, Kevin G.; Wood, William H., III; Zhang, Yongqing; Peers, Chris; Maudsley, Stuart			Multiple Oxygen Tension Environments Reveal Diverse Patterns of Transcriptional Regulation in Primary Astrocytes	PLOS ONE			English	Article							DIETARY ENERGY-INTAKE; EXPRESSION PATTERNS; MOLECULAR-CLONING; OXIDATIVE STRESS; HYPOXIA; RECEPTOR; CELLS; GENE; ACTIVATION; GROWTH	The central nervous system normally functions at O-2 levels which would be regarded as hypoxic by most other tissues. However, most in vitro studies of neurons and astrocytes are conducted under hyperoxic conditions without consideration of O-2-dependent cellular adaptation. We analyzed the reactivity of astrocytes to 1, 4 and 9% O-2 tensions compared to the cell culture standard of 20% O-2, to investigate their ability to sense and translate this O-2 information to transcriptional activity. Variance of ambient O-2 tension for rat astrocytes resulted in profound changes in ribosomal activity, cytoskeletal and energy-regulatory mechanisms and cytokine-related signaling. Clustering of transcriptional regulation patterns revealed four distinct response pattern groups that directionally pivoted around the 4% O-2 tension, or demonstrated coherent ascending/decreasing gene expression patterns in response to diverse oxygen tensions. Immune response and cell cycle/cancer-related signaling pathway transcriptomic subsets were significantly activated with increasing hypoxia, whilst hemostatic and cardiovascular signaling mechanisms were attenuated with increasing hypoxia. Our data indicate that variant O-2 tensions induce specific and physiologically-focused transcript regulation patterns that may underpin important physiological mechanisms that connect higher neurological activity to astrocytic function and ambient oxygen environments. These strongly defined patterns demonstrate a strong bias for physiological transcript programs to pivot around the 4% O-2 tension, while uni-modal programs that do not, appear more related to pathological actions. The functional interaction of these transcriptional 'programs' may serve to regulate the dynamic vascular responsivity of the central nervous system during periods of stress or heightened activity.	[Chadwick, Wayne; Zhou, Yu; Wang, Liyun; Park, Sung-Soo; Maudsley, Stuart] NIA, Receptor Pharmacol Unit, NIH, Baltimore, MD 21224 USA; [Boyle, John P.; Peers, Chris] Univ Leeds, Inst Cardiovasc Res, Leeds Inst Genet Hlth & Therapeut, Leeds, W Yorkshire, England; [Martin, Bronwen; Wang, Rui] NIA, Metab Unit, NIH, Baltimore, MD 21224 USA; [Becker, Kevin G.; Wood, William H., III; Zhang, Yongqing] NIA, Gene Express & Genom Unit, Res Resources Branch, NIH, Baltimore, MD 21224 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of Leeds; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Chadwick, W (corresponding author), NIA, Receptor Pharmacol Unit, NIH, Baltimore, MD 21224 USA.	c.s.peers@leeds.ac.uk; maudsleyst@mail.nih.gov	Boyle, John/N-4868-2016; Wang, Rui/I-5643-2019; Maudsley, Stuart/AAV-9929-2021; Zhou, Yu/M-7975-2014; Maudsley, Stuart/Q-4782-2019	Wang, Rui/0000-0001-7015-0272; Maudsley, Stuart/0000-0002-1868-184X; Becker, Kevin/0000-0002-6794-6656; Peers, Chris/0000-0002-8354-346X; Martin, Bronwen/0000-0002-9185-6925	National Institute on Aging/National Institutes of Health; Alzheimer's Research Trust (ART/PG) [2006/1]; The Alzheimer's Society; Medical Research Council; NATIONAL INSTITUTE ON AGING [ZIAAG000915, ZIAAG000319, ZICAG000616, ZIAAG000917, ZIAAG000916, ZIAAG000318, ZIAAG000325] Funding Source: NIH RePORTER; Alzheimers Research UK [ARUK-PPG2011B-1] Funding Source: researchfish	National Institute on Aging/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Alzheimer's Research Trust (ART/PG); The Alzheimer's Society; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Alzheimers Research UK(Alzheimer&apos;s Research UK (ARUK))	This work was carried out by funding from the Intramural Research Program of the National Institute on Aging/National Institutes of Health, the Alzheimer's Research Trust (ART/PG 2006/1), The Alzheimer's Society and the Medical Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adesida AB, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1929; Alvarez S, 2010, J NEUROCHEM, V113, P772, DOI 10.1111/j.1471-4159.2010.06646.x; Aprelikova O, 2006, CANCER RES, V66, P5641, DOI 10.1158/0008-5472.CAN-05-3345; Bedo G, 2005, INT J DEV BIOL, V49, P431, DOI 10.1387/ijdb.041901gb; Boggs DE, 2006, RESP PHYSIOL NEUROBI, V152, P92, DOI 10.1016/j.resp.2005.06.004; Burton GJ, 2009, PLACENTA, V30, P473, DOI 10.1016/j.placenta.2009.02.009; Candore G, 2010, REJUV RES, V13, P301, DOI 10.1089/rej.2009.0993; Cao X, 2010, BRAIN RES, V1347, P142, DOI 10.1016/j.brainres.2010.05.072; Castaldi PJ, 2009, CHEST, V135, P737, DOI 10.1378/chest.08-1993; CHADWICK W, 2010, INT J ALZHEIMERS DIS, DOI DOI 10.4061/2010/604792; CHADWICK W, 2011, J SIGNAL TRANSUCT; Chadwick W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014352; Clark MA, 2007, REGUL PEPTIDES, V144, P115, DOI 10.1016/j.regpep.2007.07.001; Cummins EP, 2005, PFLUG ARCH EUR J PHY, V450, P363, DOI 10.1007/s00424-005-1413-7; Dallas M, 2007, J NEUROSCI, V27, P3946, DOI 10.1523/JNEUROSCI.5030-06.2007; Do JH, 2008, MOL CELLS, V25, P279; Fujitani M, 2004, J NEUROCHEM, V91, P737, DOI 10.1111/j.1471-4159.2004.02738.x; Gerber SA, 2008, J IMMUNOL, V181, P1052, DOI 10.4049/jimmunol.181.2.1052; Grimpe B, 1999, GLIA, V28, P138, DOI 10.1002/(SICI)1098-1136(199911)28:2<138::AID-GLIA5>3.0.CO;2-8; Haigis MC, 2006, GENE DEV, V20, P2913, DOI 10.1101/gad.1467506; Han MD, 2006, DEV DYNAM, V235, P124, DOI 10.1002/dvdy.20531; Hongo S, 2006, J CELL BIOCHEM, V98, P185, DOI 10.1002/jcb.20763; Iadecola C, 2007, NAT NEUROSCI, V10, P1369, DOI 10.1038/nn2003; Jessberger S, 2008, PSYCHOL AGING, V23, P684, DOI 10.1037/a0014188; Jiang W, 2008, BLOOD CELL MOL DIS, V41, P169, DOI 10.1016/j.bcmd.2008.04.006; Kane R, 2008, MOL VIS, V14, P1138; Keleg S, 2007, INT J CANCER, V121, P21, DOI 10.1002/ijc.22596; Kim SM, 2010, FEBS LETT, V584, P213, DOI 10.1016/j.febslet.2009.11.063; Kim SH, 2010, CANCER RES, V70, P4054, DOI 10.1158/0008-5472.CAN-09-2110; Kim SY, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-144; Koehler RC, 2009, TRENDS NEUROSCI, V32, P160, DOI 10.1016/j.tins.2008.11.005; Lafont JE, 2008, J BIOL CHEM, V283, P4778, DOI 10.1074/jbc.M707729200; LaManna JC, 2007, ESSAYS BIOCHEM, V43, P139; Luo GH, 2008, TRANSPL P, V40, P2800, DOI 10.1016/j.transproceed.2008.08.004; Lynn EG, 2008, FEBS LETT, V582, P2857, DOI 10.1016/j.febslet.2008.07.016; Malthankar-Phatak GH, 2008, BRAIN RES, V1229, P147, DOI 10.1016/j.brainres.2008.06.074; Martin B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004146; Martin B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002398; Martin B, 2009, J BIOL CHEM, V284, P2493, DOI 10.1074/jbc.M804545200; Maudsley S, 2000, MOL CELL BIOL, V20, P8352, DOI 10.1128/MCB.20.22.8352-8363.2000; Maudsley S, 2006, NAT MED, V12, P392, DOI 10.1038/nm0406-392; Maudsley S, 2000, J BIOL CHEM, V275, P9572, DOI 10.1074/jbc.275.13.9572; Morciano M, 2009, J NEUROCHEM, V108, P662, DOI 10.1111/j.1471-4159.2008.05824.x; Myers DA, 2008, AM J PHYSIOL-REG I, V294, pR1312, DOI 10.1152/ajpregu.00004.2008; Nakada N, 2002, DEV BRAIN RES, V135, P45, DOI 10.1016/S0165-3806(02)00303-6; Nguyen AD, 2007, J BIOL CHEM, V282, P27436, DOI 10.1074/jbc.M704976200; Nieminen AL, 2005, J CELL PHYSIOL, V204, P364, DOI 10.1002/jcp.20406; Oliveira CA, 2002, CLIN GENET, V61, P354, DOI 10.1034/j.1399-0004.2002.610506.x; Pallares I, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-75; PARPURA V, 1995, FEBS LETT, V360, P266, DOI 10.1016/0014-5793(95)00121-O; Pastorino L, 2006, NATURE, V440, P528, DOI 10.1038/nature04543; Peers C, 2007, ESSAYS BIOCHEM, V43, P153, DOI 10.1042/bse0430153; Peuchen S, 1997, PROG NEUROBIOL, V52, P261, DOI 10.1016/S0301-0082(97)00010-5; Ray PS, 2009, NATURE, V457, P915, DOI 10.1038/nature07598; Sakuta H, 2001, SCIENCE, V293, P111, DOI 10.1126/science.1058379; Sansone P, 2007, STEM CELLS, V25, P807, DOI 10.1634/stemcells.2006-0442; SATO K, 1994, LEUKEMIA, V8, P1663; Schonemeier B, 2008, J NEUROIMMUNOL, V198, P39, DOI 10.1016/j.jneuroim.2008.04.010; Scragg JL, 2004, FASEB J, V18, P150, DOI 10.1096/fj.04-2659fje; Semenza GL, 2010, CURR OPIN GENET DEV, V20, P51, DOI 10.1016/j.gde.2009.10.009; Shirakura M, 2010, BIOCHEM BIOPH RES CO, V393, P800, DOI 10.1016/j.bbrc.2010.02.086; Shukunami C, 2001, BIOCHEM BIOPH RES CO, V280, P1323, DOI 10.1006/bbrc.2001.4271; SICK TJ, 1982, J APPL PHYSIOL, V53, P1354, DOI 10.1152/jappl.1982.53.6.1354; Takacova M, 2009, BIOCHEM J, V419, P419, DOI 10.1042/BJ20080952; Tanji K, 2003, BRAIN RES, V976, P125, DOI 10.1016/S0006-8993(03)02633-7; Taylor SC, 1999, J BIOL CHEM, V274, P31217, DOI 10.1074/jbc.274.44.31217; Uryu K, 2007, EXP NEUROL, V208, P185, DOI 10.1016/j.expneurol.2007.06.018; Vangeison G, 2009, NEUROSCIENTIST, V15, P579, DOI 10.1177/1073858409332405; Wakasugi K, 2004, BIOCHEM BIOPH RES CO, V318, P453, DOI 10.1016/j.bbrc.2004.04.045; Westberg JA, 2007, AM J PHYSIOL-HEART C, V293, pH1766, DOI 10.1152/ajpheart.00017.2007; Wiedmann MW, 2005, CURR CANCER DRUG TAR, V5, P171, DOI 10.2174/1568009053765771; Willer CJ, 2009, NAT GENET, V41, P25, DOI 10.1038/ng.287; Zhang YF, 2008, BIOCHEM J, V413, P239, DOI 10.1042/BJ20071510; Zhao YH, 2006, MOL NEUROBIOL, V34, P181, DOI 10.1385/MN:34:3:181	74	21	21	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2011	6	6							e21638	10.1371/journal.pone.0021638	http://dx.doi.org/10.1371/journal.pone.0021638			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	783OD	21738745	Green Submitted, gold, Green Published			2022-12-27	WOS:000292092600067
J	Damulewicz, M; Pyza, E				Damulewicz, Milena; Pyza, Elzbieta			The Clock Input to the First Optic Neuropil of Drosophila melanogaster Expressing Neuronal Circadian Plasticity	PLOS ONE			English	Article							PIGMENT-DISPERSING FACTOR; RHYTHMIC SIZE CHANGES; MUSCA-DOMESTICA L; VISUAL-SYSTEM; PHOTORECEPTOR TERMINALS; PACEMAKER NEURONS; LATERAL NEURONS; GLIAL-CELLS; CRYPTOCHROME; LIGHT	In the first optic neuropil (lamina) of the fly's visual system, two interneurons, L1 and L2 monopolar cells, and epithelial glial cells show circadian rhythms in morphological plasticity. These rhythms depend on clock gene period (per) and cryptochrome (cry) expression. In the present study, we found that rhythms in the lamina of Drosophila melanogaster may be regulated by circadian clock neurons in the brain since the lamina is invaded by one neurite extending from ventral lateral neurons; the so-called pacemaker neurons. These neurons and the projection to the lamina were visualized by green fluorescent protein (GFP). GFP reporter gene expression was driven by the cry promotor in cry-GAL4/UAS-GFP transgenic lines. We observed that the neuron projecting to the lamina forms arborizations of varicose fibers in the distal lamina. These varicose fibers do not form synaptic contacts with the lamina cells and are immunoreactive to the antisera raised against a specific region of Schistocerca gregaria ion transport peptide (ITP). ITP released in a paracrine way in the lamina cortex, may regulate the swelling and shrinking rhythms of the lamina monopolar cells and the glia by controlling the transport of ions and fluids across cell membranes at particular times of the day.	[Damulewicz, Milena; Pyza, Elzbieta] Jagiellonian Univ, Inst Zool, Dept Cell Biol & Imaging, PL-30060 Krakow, Poland	Jagiellonian University	Damulewicz, M (corresponding author), Jagiellonian Univ, Inst Zool, Dept Cell Biol & Imaging, PL-30060 Krakow, Poland.	elzbieta.pyza@uj.edu.pl	Damulewicz, Milena/AAK-2606-2020		Jagiellonian University [K/ZDS/000793]	Jagiellonian University	Jagiellonian University grant K/ZDS/000793. The funder had no role in study design, data collection and analysi, decision to publish, or preparation of the manuscript.	AUDSLEY N, 1992, J EXP BIOL, V173, P261; Awasaki T, 2008, J NEUROSCI, V28, P13742, DOI 10.1523/JNEUROSCI.4844-08.2008; Balys M, 2001, J EXP BIOL, V204, P3303; Benito J, 2008, J BIOL RHYTHM, V23, P296, DOI 10.1177/0748730408318588; Ceriani MF, 1999, SCIENCE, V285, P553, DOI 10.1126/science.285.5427.553; Collins B, 2006, CURR BIOL, V16, P441, DOI 10.1016/j.cub.2006.01.034; Cusumano P, 2009, NAT NEUROSCI, V12, P1431, DOI 10.1038/nn.2429; Emery P, 2000, NEURON, V26, P493, DOI 10.1016/S0896-6273(00)81181-2; Emery P, 1998, CELL, V95, P669, DOI 10.1016/S0092-8674(00)81637-2; Fujii S, 2010, P NATL ACAD SCI USA, V107, P10590, DOI 10.1073/pnas.0912457107; Gorska-Andrzejak J, 2005, PHOTOCH PHOTOBIO SCI, V4, P721, DOI 10.1039/b417023g; Gorska-Andrzejak J, 2009, J INSECT PHYSIOL, V55, P459, DOI 10.1016/j.jinsphys.2009.02.003; Grima B, 2004, NATURE, V431, P869, DOI 10.1038/nature02935; Helfrich-Forster C, 2007, J COMP NEUROL, V500, P47, DOI 10.1002/cne.21146; Helfrich-Forster C, 2009, J BIOL RHYTHM, V24, P259, DOI 10.1177/0748730409339614; Helfrich-Forster C, 1998, J COMP PHYSIOL A, V182, P435, DOI 10.1007/s003590050192; HELFRICHFORSTER C, 1995, P NATL ACAD SCI USA, V92, P612, DOI 10.1073/pnas.92.2.612; Im SH, 2010, J COMP NEUROL, V518, P1925, DOI 10.1002/cne.22311; Ivanchenko M, 2001, J BIOL RHYTHM, V16, P205, DOI 10.1177/074873001129001917; Johard HAD, 2009, J COMP NEUROL, V516, P59, DOI 10.1002/cne.22099; Klarsfeld A, 2004, J NEUROSCI, V24, P1468, DOI 10.1523/JNEUROSCI.3661-03.2004; Krishnan B, 2001, NATURE, V411, P313, DOI 10.1038/35077094; Kula E, 2007, DEV NEUROBIOL, V67, P1433, DOI 10.1002/dneu.20518; Lee CG, 1996, SCIENCE, V271, P1740, DOI 10.1126/science.271.5256.1740; Lin Y, 2004, J NEUROSCI, V24, P7951, DOI 10.1523/JNEUROSCI.2370-04.2004; Miskiewicz K, 2004, NEUROSCI LETT, V363, P73, DOI 10.1016/j.neulet.2004.03.051; Miskiewicz K, 2008, J COMP NEUROL, V509, P422, DOI 10.1002/cne.21765; Miyasako Y, 2007, J BIOL RHYTHM, V22, P115, DOI 10.1177/0748730407299344; Myers EM, 2003, CURR BIOL, V13, P526, DOI 10.1016/S0960-9822(03)00167-2; Naidoo N, 1999, SCIENCE, V285, P1737, DOI 10.1126/science.285.5434.1737; Park D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001896; Park JH, 2000, P NATL ACAD SCI USA, V97, P3608, DOI 10.1073/pnas.070036197; Peng Y, 2003, PLOS BIOL, V1, P32, DOI 10.1371/journal.pbio.0000013; Phillips JE, 1996, J EXP ZOOL, V275, P292, DOI 10.1002/(SICI)1097-010X(19960701)275:4&lt;292::AID-JEZ7&gt;3.0.CO;2-K; Pyza E, 2004, J INSECT PHYSIOL, V50, P985, DOI 10.1016/j.jinsphys.2004.08.003; Pyza E, 2004, J NEUROBIOL, V59, P205, DOI 10.1002/neu.10307; Pyza E, 2003, MICROSC RES TECHNIQ, V62, P103, DOI 10.1002/jemt.10365; Pyza E, 1996, J COMP PHYSIOL A, V178, P33, DOI 10.1007/BF00189588; Pyza E, 2002, MICROSC RES TECHNIQ, V58, P335, DOI 10.1002/jemt.10141; Pyza E, 1998, J COMP PHYSIOL A, V183, P719, DOI 10.1007/s003590050294; PYZA E, 1993, P ROY SOC B-BIOL SCI, V254, P97, DOI 10.1098/rspb.1993.0133; Pyza E, 2001, J INSECT PHYSIOL, V47, P897, DOI 10.1016/S0022-1910(01)00062-2; Pyza E, 1997, EUR J NEUROSCI, V9, P1784, DOI 10.1111/j.1460-9568.1997.tb01537.x; Pyza E, 1999, J NEUROBIOL, V40, P77, DOI 10.1002/(SICI)1097-4695(199907)40:1<77::AID-NEU7>3.0.CO;2-0; PYZA E, 1995, J NEUROSCI, V15, P407; Pyza E, 1997, J NEUROBIOL, V32, P517, DOI 10.1002/(SICI)1097-4695(199705)32:5<517::AID-NEU6>3.0.CO;2-8; PYZA E, 1999, COLD SPRING HARB M N, P145; PYZA E, 2010, ENCY EYE, V1, P302; Pyza Elzbieta, 2001, P55, DOI 10.1016/B978-044450608-5/50037-4; Renn SCP, 1999, CELL, V99, P791, DOI 10.1016/S0092-8674(00)81676-1; Rieger D, 2006, J NEUROSCI, V26, P2531, DOI 10.1523/JNEUROSCI.1234-05.2006; Romero-Calderon R, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000245; Shafer OT, 2006, J COMP NEUROL, V498, P180, DOI 10.1002/cne.21021; Shang YH, 2008, P NATL ACAD SCI USA, V105, P19587, DOI 10.1073/pnas.0809577105; Sheeba V, 2008, CURR BIOL, V18, P1537, DOI 10.1016/j.cub.2008.08.033; SIWICKI KK, 1988, NEURON, V1, P141, DOI 10.1016/0896-6273(88)90198-5; Stanewsky R, 1997, J NEUROSCI, V17, P676; Stoleru D, 2004, NATURE, V431, P862, DOI 10.1038/nature02926; Suh J, 2007, NEURON, V55, P435, DOI 10.1016/j.neuron.2007.06.038; Weber P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004290; XIONG WC, 1994, GENE DEV, V8, P981, DOI 10.1101/gad.8.8.981; Yoshii T, 2005, EUR J NEUROSCI, V22, P1176, DOI 10.1111/j.1460-9568.2005.04295.x; Yoshii T, 2008, J COMP NEUROL, V508, P952, DOI 10.1002/cne.21702; ZERR DM, 1990, J NEUROSCI, V10, P2749; Zhang Y, 2010, CURR BIOL, V20, P600, DOI 10.1016/j.cub.2010.02.044; Zhao J, 2003, CELL, V113, P755, DOI 10.1016/S0092-8674(03)00400-8; Zheng H, 2008, J BIOL RHYTHM, V23, P283, DOI 10.1177/0748730408318566	67	20	20	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2011	6	6							e21258	10.1371/journal.pone.0021258	http://dx.doi.org/10.1371/journal.pone.0021258			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	783OD	21760878	Green Published, gold, Green Submitted			2022-12-27	WOS:000292092600024
J	Renzoni, A; Andrey, DO; Jousselin, A; Barras, C; Monod, A; Vaudaux, P; Lew, D; Kelley, WL				Renzoni, Adriana; Andrey, Diego O.; Jousselin, Ambre; Barras, Christine; Monod, Antoinette; Vaudaux, Pierre; Lew, Daniel; Kelley, William L.			Whole Genome Sequencing and Complete Genetic Analysis Reveals Novel Pathways to Glycopeptide Resistance in Staphylococcus aureus	PLOS ONE			English	Article							VANCOMYCIN-INTERMEDIATE RESISTANCE; CELL-WALL BIOSYNTHESIS; SERINE/THREONINE KINASE; BACILLUS-SUBTILIS; ANTIBIOTIC-RESISTANCE; MULTIDRUG-RESISTANCE; FUNCTIONAL-ANALYSIS; 2-COMPONENT SYSTEM; BIOFILM FORMATION; STRESS TOLERANCE	The precise mechanisms leading to the emergence of low-level glycopeptide resistance in Staphylococcus aureus are poorly understood. In this study, we used whole genome deep sequencing to detect differences between two isogenic strains: a parental strain and a stable derivative selected stepwise for survival on 4 mg/ml teicoplanin, but which grows at higher drug concentrations (MIC 8 mg/ml). We uncovered only three single nucleotide changes in the selected strain. Nonsense mutations occurred in stp1, encoding a serine/threonine phosphatase, and in yjbH, encoding a post-transcriptional negative regulator of the redox/thiol stress sensor and global transcriptional regulator, Spx. A missense mutation (G45R) occurred in the histidine kinase sensor of cell wall stress, VraS. Using genetic methods, all single, pairwise combinations, and a fully reconstructed triple mutant were evaluated for their contribution to low-level glycopeptide resistance. We found a synergistic cooperation between dual phospho-signalling systems and a subtle contribution from YjbH, suggesting the activation of oxidative stress defences via Spx. To our knowledge, this is the first genetic demonstration of multiple sensor and stress pathways contributing simultaneously to glycopeptide resistance development. The multifactorial nature of glycopeptide resistance in this strain suggests a complex reprogramming of cell physiology to survive in the face of drug challenge.	[Renzoni, Adriana; Andrey, Diego O.; Jousselin, Ambre; Barras, Christine; Monod, Antoinette; Vaudaux, Pierre; Lew, Daniel; Kelley, William L.] Univ Hosp Geneva, Infect Dis Serv, Geneva, Switzerland	University of Geneva	Renzoni, A (corresponding author), Univ Hosp Geneva, Infect Dis Serv, Geneva, Switzerland.	Adriana.Renzoni@hcuge.ch		jousselin, ambre/0000-0001-7003-5426; ANDREY, Diego/0000-0003-3247-9274; Renzoni, Adriana/0000-0002-4897-5208	Swiss National Science Foundation [3100A0-120428, 310030-125109]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by the Swiss National Science Foundation grant 3100A0-120428 (WLK) and 310030-125109 (DL) and an F. Hoffmann-La Roche MD-PhD training grant (DOA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrey DO, 2010, J BACTERIOL, V192, P6077, DOI 10.1128/JB.00146-10; Beltramini AM, 2009, INFECT IMMUN, V77, P1406, DOI 10.1128/IAI.01499-08; Berger-Bachi B, 2006, INJURY, V37, P20, DOI 10.1016/j.injury.2006.04.005; Boyle-Vavra S, 2001, J ANTIMICROB CHEMOTH, V48, P617, DOI 10.1093/jac/48.5.617; Bruckner R, 1997, FEMS MICROBIOL LETT, V151, P1; Burnside K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011071; Chen PR, 2009, MOL MICROBIOL, V71, P198, DOI 10.1111/j.1365-2958.2008.06518.x; Cui L, 2003, J CLIN MICROBIOL, V41, P5, DOI 10.1128/JCM.41.1.5-14.2003; Cui L, 2009, ANTIMICROB AGENTS CH, V53, P1231, DOI 10.1128/AAC.01173-08; Cui LZ, 2005, ANTIMICROB AGENTS CH, V49, P3404, DOI 10.1128/AAC.49.8.3404-3413.2005; Debarbouille M, 2009, J BACTERIOL, V191, P4070, DOI 10.1128/JB.01813-08; Deleo FR, 2009, J CLIN INVEST, V119, P2464, DOI 10.1172/JCI38226; Donat S, 2009, J BACTERIOL, V191, P4056, DOI 10.1128/JB.00117-09; Dwyer DJ, 2009, CURR OPIN MICROBIOL, V12, P482, DOI 10.1016/j.mib.2009.06.018; Frees D, 2003, MOL MICROBIOL, V48, P1565, DOI 10.1046/j.1365-2958.2003.03524.x; GALBUSERA E, 2010, ANTIMICROB AGENTS CH; Gardete S, 2006, ANTIMICROB AGENTS CH, V50, P3424, DOI 10.1128/AAC.00356-06; Garg SK, 2009, J BACTERIOL, V191, P1268, DOI 10.1128/JB.01289-08; Hiramatsu K, 2001, Lancet Infect Dis, V1, P147, DOI 10.1016/S1473-3099(01)00091-3; Howden BP, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-39; Howden BP, 2006, ANTIMICROB AGENTS CH, V50, P3039, DOI 10.1128/AAC.00422-06; Howden BP, 2010, CLIN MICROBIOL REV, V23, P99, DOI 10.1128/CMR.00042-09; Katayama Y, 2009, ANTIMICROB AGENTS CH, V53, P3190, DOI 10.1128/AAC.00834-08; Kato Y, 2010, J ANTIMICROB CHEMOTH, V65, P37, DOI 10.1093/jac/dkp394; Kohanski MA, 2007, CELL, V130, P797, DOI 10.1016/j.cell.2007.06.049; Kohanski MA, 2010, MOL CELL, V37, P311, DOI 10.1016/j.molcel.2010.01.003; KREISWIRTH BN, 1983, NATURE, V305, P709, DOI 10.1038/305709a0; Kuroda M, 2003, MOL MICROBIOL, V49, P807, DOI 10.1046/j.1365-2958.2003.03599.x; Kuroda M, 2000, BIOCHEM BIOPH RES CO, V269, P485, DOI 10.1006/bbrc.2000.2277; Liebeke M, 2010, CHEM BIOL, V17, P820, DOI 10.1016/j.chembiol.2010.06.012; Lodise TP, 2008, ANTIMICROB AGENTS CH, V52, P3315, DOI 10.1128/AAC.00113-08; Maclayton DO, 2007, ANN PHARMACOTHER, V41, P235, DOI 10.1345/aph.1H414; Maki H, 2004, ANTIMICROB AGENTS CH, V48, P1953, DOI 10.1128/AAC.48.6.1953-1959.2004; McCallum N, 2006, BBA-GEN SUBJECTS, V1760, P1475, DOI 10.1016/j.bbagen.2006.06.008; McCallum N, 2011, ANTIMICROB AGENTS CH, V55, P1391, DOI 10.1128/AAC.01213-10; Meehl M, 2007, ANTIMICROB AGENTS CH, V51, P2679, DOI 10.1128/AAC.00209-07; Mwangi MM, 2007, P NATL ACAD SCI USA, V104, P9451, DOI 10.1073/pnas.0609839104; Nakano S, 2003, P NATL ACAD SCI USA, V100, P4233, DOI 10.1073/pnas.0637648100; Neoh HM, 2008, ANTIMICROB AGENTS CH, V52, P45, DOI 10.1128/AAC.00534-07; Ohlsen K, 2010, INT J MED MICROBIOL, V300, P137, DOI 10.1016/j.ijmm.2009.08.016; Pamp SJ, 2006, J BACTERIOL, V188, P4861, DOI 10.1128/JB.00194-06; Paracuellos P, 2010, J MOL BIOL, V404, P847, DOI 10.1016/j.jmb.2010.10.012; Perichon B, 2009, ANTIMICROB AGENTS CH, V53, P4580, DOI 10.1128/AAC.00346-09; Pfeltz RF, 2000, ANTIMICROB AGENTS CH, V44, P294, DOI 10.1128/AAC.44.2.294-303.2000; Quoc PHT, 2007, INFECT IMMUN, V75, P1079, DOI 10.1128/IAI.01143-06; Renzoni A, 2006, ANTIMICROB AGENTS CH, V50, P3048, DOI 10.1128/AAC.00113-06; Renzoni A, 2009, ANTIMICROB AGENTS CH, V53, P903, DOI 10.1128/AAC.01287-08; Sieradzki K, 2003, J BACTERIOL, V185, P7103, DOI 10.1128/JB.185.24.7103-7110.2003; STAHL ML, 1983, J BACTERIOL, V154, P406, DOI 10.1128/JB.154.1.406-412.1983; SULLIVAN MA, 1984, GENE, V29, P21, DOI 10.1016/0378-1119(84)90161-6; Tamber S, 2010, INFECT IMMUN, V78, P3637, DOI 10.1128/IAI.00296-10; Tenover FC, 2007, CLIN INFECT DIS, V44, P1208, DOI 10.1086/513203; Tenover FC, 2009, INT J ANTIMICROB AG, V33, P564, DOI 10.1016/j.ijantimicag.2008.12.010; Utaida S, 2003, MICROBIOL-SGM, V149, P2719, DOI 10.1099/mic.0.26426-0; Vaudaux P, 2002, INFECT IMMUN, V70, P5428, DOI 10.1128/IAI.70.10.5428-5437.2002; Vaudaux P, 2010, ANTIMICROB AGENTS CH, V54, P3861, DOI 10.1128/AAC.00269-10; Yin SH, 2006, ANTIMICROB AGENTS CH, V50, P336, DOI 10.1128/AAC.50.1.336-343.2006; You CH, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-128; ZHU W, 2010, ANTIMICROB AGENTS CH	59	51	53	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2011	6	6							e21577	10.1371/journal.pone.0021577	http://dx.doi.org/10.1371/journal.pone.0021577			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	783OD	21738716	Green Published, Green Submitted, gold			2022-12-27	WOS:000292092600054
J	Visweswaran, GRR; Dijkstra, BW; Kok, J				Visweswaran, Ganesh Ram R.; Dijkstra, Bauke W.; Kok, Jan			A Minimum of Three Motifs Is Essential for Optimal Binding of Pseudomurein Cell Wall-Binding Domain of Methanothermobacter thermautotrophicus	PLOS ONE			English	Article							METHANOBACTERIUM-THERMOAUTOTROPHICUM; ESCHERICHIA-COLI; LYTIC ENZYME; LYSM; BACTERIA	We have biochemically and functionally characterized the pseudomurein cell wall-binding (PMB) domain that is present at the C-terminus of the Surface (S)-layer protein MTH719 from Methanothermobacter thermautotrophicus. Chemical denaturation of the protein with guanidinium hydrochloride occurred at 3.8 M. A PMB-GFP fusion protein not only binds to intact pseudomurein of methanogenic archaea, but also to spheroplasts of lysozyme-treated bacterial cells. This binding is pH dependent. At least two of the three motifs that are present in the domain are necessary for binding. Limited proteolysis revealed a possible cleavage site in the spacing sequence between motifs 1 and 2 of the PMB domain, indicating that the motif region itself is protected from proteases.	[Visweswaran, Ganesh Ram R.; Kok, Jan] Univ Groningen, Dept Mol Genet, Groningen Biomol Sci & Biotechnol Inst, Groningen, Netherlands; [Visweswaran, Ganesh Ram R.; Dijkstra, Bauke W.] Univ Groningen, Groningen Biomol Sci & Biotechnol Inst, Biophys Chem Lab, Groningen, Netherlands	University of Groningen; University of Groningen	Visweswaran, GRR (corresponding author), Univ Groningen, Dept Mol Genet, Groningen Biomol Sci & Biotechnol Inst, Groningen, Netherlands.	jan.kok@rug.nl	Dijkstra, Bauke W./H-4308-2019; Kok, Jan/C-9972-2012; Visweswaran, Ganesh Ram R/H-7888-2013	Dijkstra, Bauke W./0000-0001-9731-6586; 	University of Groningen	University of Groningen	The study was funded by the University of Groningen, http://www.rug.nl/corporate/index. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bateman A, 2000, J MOL BIOL, V299, P1113, DOI 10.1006/jmbi.2000.3778; Buist G, 2008, MOL MICROBIOL, V68, P838, DOI 10.1111/j.1365-2958.2008.06211.x; Geertsma ER, 2007, NAT METHODS, V4, P705, DOI 10.1038/NMETH1073; KIENER A, 1987, J BACTERIOL, V169, P1010, DOI 10.1128/jb.169.3.1010-1016.1987; KONIG H, 1979, ARCH MICROBIOL, V123, P295, DOI 10.1007/BF00406664; KONIG H, 1983, H-S Z PHYSIOL CHEM, V364, P627, DOI 10.1515/bchm2.1983.364.1.627; Luo YN, 2002, FEMS MICROBIOL LETT, V208, P47; Luo YN, 2001, J BACTERIOL, V183, P5788, DOI 10.1128/JB.183.19.5788-5792.2001; Molle V, 2003, MOL MICROBIOL, V50, P1683, DOI 10.1046/j.1365-2958.2003.03818.x; Ohnuma T, 2008, J BIOL CHEM, V283, P5178, DOI 10.1074/jbc.M707156200; Pfister P, 1998, MOL MICROBIOL, V30, P233, DOI 10.1046/j.1365-2958.1998.01073.x; STAX D, 1992, FEMS MICROBIOL LETT, V100, P433, DOI 10.1111/j.1574-6968.1992.tb05736.x; Steenbakkers PJM, 2006, MOL MICROBIOL, V62, P1618, DOI 10.1111/j.1365-2958.2006.05483.x; van Roosmalen ML, 2006, METHODS, V38, P144, DOI 10.1016/j.ymeth.2005.09.015; VANDIE IM, 1983, J GEN MICROBIOL, V129, P663; Visweswaran GRR, 2010, ARCHAEA, V2010, DOI 10.1155/2010/480492	16	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2011	6	6							e21582	10.1371/journal.pone.0021582	http://dx.doi.org/10.1371/journal.pone.0021582			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	783OD	21738718	Green Published, Green Submitted, gold			2022-12-27	WOS:000292092600056
J	Morina, N; von Lersner, U; Prigerson, HG				Morina, Nexhmedin; von Lersner, Ulrike; Prigerson, Holly G.			War and Bereavement: Consequences for Mental and Physical Distress	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; NEUROPSYCHIATRIC INTERVIEW MINI; COMPLICATED GRIEF; HEALTH OUTCOMES; TRAUMATIC GRIEF; BOSNIAN REFUGEES; PARENTAL DEATH; DEPRESSION; VALIDITY; SURVIVORS	Background: Little is known about the long-term impact of the killing of a parent in childhood or adolescence during war on distress and disability in young adulthood. This study assessed current prevalence rates of mental disorders and levels of dysfunction among young adults who had lost their father due to war-related violence in childhood or adolescence. Methods: 179 bereaved young adults and 175 non-bereaved young adults were interviewed a decade after experiencing the war in Kosovo. Prevalence rates of Major Depressive Episode (MDE), anxiety, and substance use disorders, and current suicide risk were assessed using the Mini-International Neuropsychiatric Interview. The syndrome of Prolonged Grief Disorder (PGD) was assessed with the Prolonged Grief Disorder Interview (PG-13). Somatic symptoms were measured with the Patient Health Questionnaire. General health distress was assessed with the General Health Questionnaire. Findings: Bereaved participants were significantly more likely to suffer from either MDE or any anxiety disorder than non-bereaved participants (58.7% vs. 40%). Among bereaved participants, 39.7% met criteria for Post-Traumatic Stress Disorder, 34.6% for PGD, and 22.3% for MDE. Bereaved participants with PGD were more likely to suffer from MDE, any anxiety disorder, or current suicide risk than bereaved participants without PGD. Furthermore, these participants reported significantly greater physical distress than bereaved participants without PGD. Conclusion: War-related loss during middle childhood and adolescence presents significant risk for adverse mental health and dysfunction in young adulthood in addition to exposure to other war-related traumatic events. Furthermore, the syndrome of PGD can help to identify those with the greatest degree of distress and dysfunction.	[Morina, Nexhmedin] Univ Amsterdam, Dept Clin Psychol, NL-1018 WB Amsterdam, Netherlands; [von Lersner, Ulrike] Humboldt Univ, Dept Psychol, Berlin, Germany; [Prigerson, Holly G.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA	University of Amsterdam; Humboldt University of Berlin; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School	Morina, N (corresponding author), Univ Amsterdam, Dept Clin Psychol, NL-1018 WB Amsterdam, Netherlands.	n.morina@uva.nl	Prigerson, Holly/L-3800-2019; Morina, Nexhmedin/D-4976-2012; Prigerson, Holly/GWV-3283-2022; Morina, Nexhmedin/AAK-7071-2021	Prigerson, Holly/0000-0002-7075-4268; Morina, Nexhmedin/0000-0002-2331-9140; 	Children and War Foundation; German Psychological Society (DGPs), division for Clinical Psychology and Psychotherapy	Children and War Foundation; German Psychological Society (DGPs), division for Clinical Psychology and Psychotherapy	This study was supported by the Children and War Foundation (www.childrenandwar.org). The preparation for the study was also supported by a travel scholarship to the Harvard Medical School in Boston, USA, given to the first author by the German Psychological Society (DGPs), division for Clinical Psychology and Psychotherapy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agovino T, 1999, LANCET, V353, P1701, DOI 10.1016/S0140-6736(99)04433-5; Attanayake Vindya, 2009, Med Confl Surviv, V25, P4, DOI 10.1080/13623690802568913; Bonanno GA, 2007, J ABNORM PSYCHOL, V116, P342, DOI 10.1037/0021-843X.116.2.342; Brent D, 2009, AM J PSYCHIAT, V166, P786, DOI 10.1176/appi.ajp.2009.08081244; Cardozo BL, 2000, JAMA-J AM MED ASSOC, V284, P569, DOI 10.1001/jama.284.5.569; de Jong JTVM, 2001, JAMA-J AM MED ASSOC, V286, P555, DOI 10.1001/jama.286.5.555; Doi Y, 2003, PSYCHIAT CLIN NEUROS, V57, P379, DOI 10.1046/j.1440-1819.2003.01135.x; Eytan A, 2011, SOC PSYCH PSYCH EPID, V46, P953, DOI 10.1007/s00127-010-0269-0; Goldberg D.P., 1988, USERS GUIDE GEN HLTH; Harrison L, 2001, J ADOLESCENCE, V24, P159, DOI 10.1006/jado.2001.0379; Kashdan TB, 2009, J ANXIETY DISORD, V23, P185, DOI 10.1016/j.janxdis.2008.06.006; KRANZLER EM, 1990, J AM ACAD CHILD PSY, V29, P513, DOI 10.1097/00004583-199007000-00002; Kroenke K, 2002, PSYCHOSOM MED, V64, P258, DOI 10.1097/00006842-200203000-00008; Lecrubier Y, 1997, EUR PSYCHIAT, V12, P224, DOI 10.1016/S0924-9338(97)83296-8; Lichtenthal WG, 2004, CLIN PSYCHOL REV, V24, P637, DOI 10.1016/j.cpr.2004.07.002; Lustig SL, 2004, J AM ACAD CHILD PSY, V43, P24, DOI 10.1097/00004583-200401000-00012; Machel G., 2001, IMPACT WAR CHILDREN; Marshall GN, 2005, JAMA-J AM MED ASSOC, V294, P571, DOI 10.1001/jama.294.5.571; Melhem NM, 2008, ARCH PEDIAT ADOL MED, V162, P403, DOI 10.1001/archpedi.162.5.403; Mollica RF, 2007, J NERV MENT DIS, V195, P572, DOI 10.1097/NMD.0b013e318093ed2c; Momartin S, 2004, COMPR PSYCHIAT, V45, P475, DOI 10.1016/j.comppsych.2004.07.013; MORINA N, 2006, COMMUNICATION; Morina N, 2008, INT J SOC PSYCHIATR, V54, P425, DOI 10.1177/0020764008090505; Morina N, 2010, SOC PSYCH PSYCH EPID, V45, P1167, DOI 10.1007/s00127-009-0160-z; Morina N, 2010, INT J SOC PSYCHIATR, V56, P288, DOI 10.1177/0020764008101638; Morina N, 2010, CLIN PSYCHOL PSYCHOT, V17, P79, DOI 10.1002/cpp.673; Priebe S, 2010, ARCH GEN PSYCHIAT, V67, P518, DOI 10.1001/archgenpsychiatry.2010.37; PRIGERSON HG, 1995, AM J PSYCHIAT, V152, P22; Prigerson HG, 1997, AM J PSYCHIAT, V154, P616, DOI 10.1176/ajp.154.5.616; Prigerson HG, 1999, AM J PSYCHIAT, V156, P1994; Prigerson HG, 1999, BRIT J PSYCHIAT, V174, P67, DOI 10.1192/bjp.174.1.67; Prigerson HG, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000121; Reynolds CF, 1999, AM J PSYCHIAT, V156, P202; Shear K, 2005, JAMA-J AM MED ASSOC, V293, P2601, DOI 10.1001/jama.293.21.2601; Sheehan DV, 1997, EUR PSYCHIAT, V12, P232, DOI 10.1016/S0924-9338(97)83297-X; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; Steel Z, 2009, JAMA-J AM MED ASSOC, V302, P537, DOI 10.1001/jama.2009.1132; Stroebe M, 2007, LANCET, V370, P1960, DOI 10.1016/S0140-6736(07)61816-9; Wexler ID, 2006, JAMA-J AM MED ASSOC, V296, P579, DOI 10.1001/jama.296.5.579; Wilcox HC, 2010, J AM ACAD CHILD PSY, V49, P514, DOI 10.1016/j.jaac.2010.01.020; Wu NS, 2010, ADDICT BEHAV, V35, P68, DOI 10.1016/j.addbeh.2009.09.003	41	49	49	4	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2011	6	7							e22140	10.1371/journal.pone.0022140	http://dx.doi.org/10.1371/journal.pone.0022140			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	791WM	21765944	Green Published, gold, Green Submitted			2022-12-27	WOS:000292699000025
J	Koulnis, M; Liu, Y; Hallstrom, K; Socolovsky, M				Koulnis, Miroslav; Liu, Ying; Hallstrom, Kelly; Socolovsky, Merav			Negative Autoregulation by Fas Stabilizes Adult Erythropoiesis and Accelerates Its Stress Response	PLOS ONE			English	Article							INDUCED CELL-DEATH; GLUCOCORTICOID-RECEPTOR; C-KIT; MICE; LIGAND; DEFICIENT; EXPANSION; FETAL; PROGENITORS; EXPRESSION	Erythropoiesis maintains a stable hematocrit and tissue oxygenation in the basal state, while mounting a stress response that accelerates red cell production in anemia, blood loss or high altitude. Thus, tissue hypoxia increases secretion of the hormone erythropoietin (Epo), stimulating an increase in erythroid progenitors and erythropoietic rate. Several cell divisions must elapse, however, before Epo-responsive progenitors mature into red cells. This inherent delay is expected to reduce the stability of erythropoiesis and to slow its response to stress. Here we identify a mechanism that helps to offset these effects. We recently showed that splenic early erythroblasts, 'EryA', negatively regulate their own survival by co-expressing the death receptor Fas, and its ligand, FasL. Here we studied mice mutant for either Fas or FasL, bred onto an immune-deficient background, in order to avoid an autoimmune syndrome associated with Fas deficiency. Mutant mice had a higher hematocrit, lower serum Epo, and an increased number of splenic erythroid progenitors, suggesting that Fas negatively regulates erythropoiesis at the level of the whole animal. In addition, Fas-mediated autoregulation stabilizes the size of the splenic early erythroblast pool, since mutant mice had a significantly more variable EryA pool than matched control mice. Unexpectedly, in spite of the loss of a negative regulator, the expansion of EryA and ProE progenitors in response to high Epo in vivo, as well as the increase in erythropoietic rate in mice injected with Epo or placed in a hypoxic environment, lagged significantly in the mutant mice. This suggests that Fas-mediated autoregulation accelerates the erythropoietic response to stress. Therefore, Fas-mediated negative autoregulation within splenic erythropoietic tissue optimizes key dynamic features in the operation of the erythropoietic network as a whole, helping to maintain erythroid homeostasis in the basal state, while accelerating the stress response.	[Koulnis, Miroslav] Univ Massachusetts, Sch Med, Dept Pediat, Worcester, MA 01605 USA; Univ Massachusetts, Sch Med, Dept Canc Biol, Worcester, MA USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Koulnis, M (corresponding author), Univ Massachusetts, Sch Med, Dept Pediat, Worcester, MA 01605 USA.	merav.socolovsky@umassmed.edu		Socolovsky, Merav/0000-0001-6747-7960	NIH/NHLBI [RO1 HL084168]; American Cancer Society [RSG06-051-01]; Diabetes Endocrinology Research Center [DK32520]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL084168] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK032520] Funding Source: NIH RePORTER	NIH/NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Cancer Society(American Cancer Society); Diabetes Endocrinology Research Center; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was funded by NIH/NHLBI RO1 HL084168 (M.S.), and by the American Cancer Society grant RSG06-051-01 (M. S). Core resources supported by the Diabetes Endocrinology Research Center grant DK32520 were also used. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALDERSON MR, 1995, J EXP MED, V181, P71, DOI 10.1084/jem.181.1.71; Alon U, 2007, NAT REV GENET, V8, P450, DOI 10.1038/nrg2102; Bader-Meunier B, 2000, BRIT J HAEMATOL, V108, P300; Bauer A, 1999, GENE DEV, V13, P2996, DOI 10.1101/gad.13.22.2996; Becskei A, 2000, NATURE, V405, P590, DOI 10.1038/35014651; Bessman J.D., 1990, CLIN METHODS HIST PH; BORSOOK HENRY, 1962, NATURE, V196, P347, DOI 10.1038/196347a0; Bouscary D, 2003, BLOOD, V101, P3436, DOI 10.1182/blood-2002-07-2332; Bratsun D, 2005, P NATL ACAD SCI USA, V102, P14593, DOI 10.1073/pnas.0503858102; Broudy VC, 1996, BLOOD, V88, P75; BRUNNER T, 1995, NATURE, V373, P441, DOI 10.1038/373441a0; Camas FM, 2006, P NATL ACAD SCI USA, V103, P12718, DOI 10.1073/pnas.0602119103; DANDREA AD, 1989, CELL, V57, P277, DOI 10.1016/0092-8674(89)90965-3; De Maria R, 1999, BLOOD, V93, P796, DOI 10.1182/blood.V93.3.796.403k23_796_803; Ebert BL, 1999, BLOOD, V94, P1864; Fawcett DW, 1997, BLOOM FAWCETT CONCIS, P84; GREGORY CJ, 1975, J CELL PHYSIOL, V86, P1, DOI 10.1002/jcp.1040860102; Guihard S, 2010, BLOOD, V115, P3686, DOI 10.1182/blood-2009-09-242487; Haase VH, 2010, AM J PHYSIOL-RENAL, V299, pF1, DOI 10.1152/ajprenal.00174.2010; HARA H, 1976, AM J HEMATOL, V1, P453, DOI 10.1002/ajh.2830010410; Haseyama Y, 1999, BLOOD, V94, P1568, DOI 10.1182/blood.V94.5.1568.417a07_1568_1577; JU ST, 1995, NATURE, V373, P444, DOI 10.1038/373444a0; Kawai T, 1999, IMMUNITY, V11, P115, DOI 10.1016/S1074-7613(00)80086-2; Kline DD, 2002, P NATL ACAD SCI USA, V99, P821, DOI 10.1073/pnas.022634199; Koury MJ, 2002, CURR OPIN HEMATOL, V9, P93, DOI 10.1097/00062752-200203000-00002; KOURY MJ, 1990, SCIENCE, V248, P378, DOI 10.1126/science.2326648; Lenox LE, 2005, BLOOD, V105, P2741, DOI 10.1182/blood-2004-02-0703; Liu Y, 2006, BLOOD, V108, P123, DOI 10.1182/blood-2005-11-4458; Longmore GD, 2006, J CLIN INVEST, V116, P626, DOI 10.1172/JCI27988; McAdams HH, 1999, TRENDS GENET, V15, P65, DOI 10.1016/S0168-9525(98)01659-X; Menon MP, 2006, J CLIN INVEST, V116, P683, DOI 10.1172/JCI25227; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; NAGATA S, 1995, IMMUNOL TODAY, V16, P39, DOI 10.1016/0167-5699(95)80069-7; Nguyen T, 2001, IMMUNOLOGY, V103, P426, DOI 10.1046/j.1365-2567.2001.01264.x; Palis J, 2008, CURR OPIN HEMATOL, V15, P155, DOI 10.1097/MOH.0b013e3282f97ae1; PAPAYANNOPOULOU T, 1972, J CLIN INVEST, V51, P1179, DOI 10.1172/JCI106911; RAMSDELL F, 1994, EUR J IMMUNOL, V24, P928, DOI 10.1002/eji.1830240422; RHODES MM, 2005, BLOOD; Rosenfeld N, 2002, J MOL BIOL, V323, P785, DOI 10.1016/S0022-2836(02)00994-4; RUSSELL ELIZABETH S., 1966, P351; Sathyanarayana P, 2008, BLOOD, V111, P5390, DOI 10.1182/blood-2007-10-119743; SAVAGEAU MA, 1974, NATURE, V252, P546, DOI 10.1038/252546a0; Schmidt W, 2002, HIGH ALT MED BIOL, V3, P167, DOI 10.1089/15270290260131902; Schneider E, 1999, BLOOD, V94, P2613, DOI 10.1182/blood.V94.8.2613.420k33_2613_2621; Semenza GL, 2009, BLOOD, V114, P2015, DOI 10.1182/blood-2009-05-189985; SENO S, 1964, BLOOD, V24, P582, DOI 10.1182/blood.V24.5.582.582; Silva M, 1999, J BIOL CHEM, V274, P22165, DOI 10.1074/jbc.274.32.22165; Socolovsky M, 1999, CELL, V98, P181, DOI 10.1016/S0092-8674(00)81013-2; Socolovsky M, 2007, PLOS BIOL, V5, P2296, DOI 10.1371/journal.pbio.0050252; Socolovsky M, 2007, CURR OPIN HEMATOL, V14, P215, DOI 10.1097/MOH.0b013e3280de2bf1; STAMATOYANNOPOULOS G, 1985, ANN NY ACAD SCI, V445, P188, DOI 10.1111/j.1749-6632.1985.tb17188.x; Stelling J, 2004, CELL, V118, P675, DOI 10.1016/j.cell.2004.09.008; STEPHENSON JR, 1971, P NATL ACAD SCI USA, V68, P1542, DOI 10.1073/pnas.68.7.1542; Thieffry D, 1998, BIOESSAYS, V20, P433, DOI 10.1002/(SICI)1521-1878(199805)20:5<433::AID-BIES10>3.0.CO;2-2; von Lindern M, 2004, CELL CYCLE, V3, P876; von Lindern M, 1999, BLOOD, V94, P550, DOI 10.1182/blood.V94.2.550.414k39_550_559; Wood AD, 2009, BLOOD, V114, P1820, DOI 10.1182/blood-2009-02-206573	57	35	37	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2011	6	7							e21192	10.1371/journal.pone.0021192	http://dx.doi.org/10.1371/journal.pone.0021192			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791IA	21760888	Green Published, gold, Green Submitted			2022-12-27	WOS:000292657200007
J	Meyer, HG; Lindemann, JP; Egelhaaf, M				Meyer, Hanno Gerd; Lindemann, Jens Peter; Egelhaaf, Martin			Pattern-Dependent Response Modulations in Motion-Sensitive Visual Interneurons-A Model Study	PLOS ONE			English	Article							DENDRITIC INTEGRATION; OPTOMOTOR SYSTEM; HORIZONTAL CELLS; GAIN-CONTROL; OPTIC FLOW; FLY; ADAPTATION; DETECTORS; EYE	Even if a stimulus pattern moves at a constant velocity across the receptive field of motion-sensitive neurons, such as lobula plate tangential cells (LPTCs) of flies, the response amplitude modulates over time. The amplitude of these response modulations is related to local pattern properties of the moving retinal image. On the one hand, pattern-dependent response modulations have previously been interpreted as 'pattern-noise', because they deteriorate the neuron's ability to provide unambiguous velocity information. On the other hand, these modulations might also provide the system with valuable information about the textural properties of the environment. We analyzed the influence of the size and shape of receptive fields by simulations of four versions of LPTC models consisting of arrays of elementary motion detectors of the correlation type (EMDs). These models have previously been suggested to account for many aspects of LPTC response properties. Pattern-dependent response modulations decrease with an increasing number of EMDs included in the receptive field of the LPTC models, since spatial changes within the visual field are smoothed out by the summation of spatially displaced EMD responses. This effect depends on the shape of the receptive field, being the more pronounced - for a given total size - the more elongated the receptive field is along the direction of motion. Large elongated receptive fields improve the quality of velocity signals. However, if motion signals need to be localized the velocity coding is only poor but the signal provides - potentially useful - local pattern information. These modelling results suggest that motion vision by correlation type movement detectors is subject to uncertainty: you cannot obtain both an unambiguous and a localized velocity signal from the output of a single cell. Hence, the size and shape of receptive fields of motion sensitive neurons should be matched to their potential computational task.	[Meyer, Hanno Gerd; Lindemann, Jens Peter; Egelhaaf, Martin] Univ Bielefeld, Dept Neurobiol, Bielefeld, Germany; [Lindemann, Jens Peter; Egelhaaf, Martin] Univ Bielefeld, CITEC, Bielefeld, Germany	University of Bielefeld; University of Bielefeld	Meyer, HG (corresponding author), Univ Bielefeld, Dept Neurobiol, Bielefeld, Germany.	hanno.meyer@uni-bielefeld.de	Egelhaaf, Martin/A-9824-2010	Egelhaaf, Martin/0000-0002-9336-4270; Lindemann, Jens Peter/0000-0002-5441-7931; Meyer, Hanno Gerd/0000-0003-2454-3897	Deutsche Forschungsgemeinschaft (DFG); Volkswagen Stiftung	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Volkswagen Stiftung(Volkswagen)	This project was supported by the Deutsche Forschungsgemeinschaft (DFG) and by a grant of the Volkswagen Stiftung to Anne-Kathrin Warzecha. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BORST A, 1995, J COMPUT NEUROSCI, V2, P5, DOI 10.1007/BF00962705; Borst A, 2003, VISION RES, V43, P1309, DOI 10.1016/S0042-6989(03)00092-0; BORST A, 2010, ANNU REV NEUROSCI, P49; Brinkworth RSA, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000555; BUCHNER E, 1976, BIOL CYBERN, V24, P85, DOI 10.1007/BF00360648; Dror RO, 2001, J OPT SOC AM A, V18, P241, DOI 10.1364/JOSAA.18.000241; EGELHAAF M, 1989, J OPT SOC AM A, V6, P116, DOI 10.1364/JOSAA.6.000116; EGELHAAF M, 1989, J OPT SOC AM A, V6, P1070, DOI 10.1364/JOSAA.6.001070; EGELHAAF M, 1993, J NEUROSCI, V13, P4563; Egelhaaf M, 2006, INVERTEBRATE VISION, P399; Egelhaaf Martin, 1993, Reviews of Oculomotor Research, V5, P53; GOTZ KG, 1964, KYBERNETIK, V2, P77, DOI 10.1007/BF00288561; Harris RA, 1999, VISION RES, V39, P2603, DOI 10.1016/S0042-6989(98)00297-1; Harris RA, 2000, NEURON, V28, P595, DOI 10.1016/S0896-6273(00)00136-7; HAUSEN K, 1982, BIOL CYBERN, V46, P67, DOI 10.1007/BF00335352; HAUSEN K, 1982, BIOL CYBERN, V45, P143, DOI 10.1007/BF00335241; Juusola M, 1995, J NEUROPHYSIOL, V74, P2538, DOI 10.1152/jn.1995.74.6.2538; Krapp HG, 2001, J NEUROPHYSIOL, V85, P724, DOI 10.1152/jn.2001.85.2.724; Kurtz R, 2009, P ROY SOC B-BIOL SCI, V276, P3711, DOI 10.1098/rspb.2009.0596; LAPPE M, 1999, NEURONAL PROCESSING, P44; Lindemann JP, 2005, J NEUROSCI, V25, P6435, DOI 10.1523/JNEUROSCI.1132-05.2005; MADDESS T, 1985, PROC R SOC SER B-BIO, V225, P251, DOI 10.1098/rspb.1985.0061; NAKA KI, 1966, J PHYSIOL-LONDON, V185, P536, DOI 10.1113/jphysiol.1966.sp008001; Petrowitz R, 2000, J COMP PHYSIOL A, V186, P737, DOI 10.1007/s003590000127; Rajesh S, 2005, PROC SPIE, V5651, P160, DOI 10.1117/12.582409; Rajesh S, 2007, PROC SPIE, V6414, DOI 10.1117/12.696105; Reichardt W, 1961, SENS COMMUN, P303; Reinhard E., 2005, HIGH DYNAMIC RANGE I; Reisenman C, 2003, VISION RES, V43, P1291, DOI 10.1016/S0042-6989(03)00091-9; Shoemaker PA, 2005, BIOL CYBERN, V93, P275, DOI 10.1007/s00422-005-0007-y; Single S, 1998, SCIENCE, V281, P1848, DOI 10.1126/science.281.5384.1848; SRINIVASAN MV, 1990, J COMP PHYSIOL A, V166, P287, DOI 10.1007/BF00204803; Straw AD, 2008, J VISION, V8, DOI 10.1167/8.3.32; van Hateren JH, 2001, VISION RES, V41, P1851, DOI 10.1016/S0042-6989(01)00052-9	35	23	23	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2011	6	7							e21488	10.1371/journal.pone.0021488	http://dx.doi.org/10.1371/journal.pone.0021488			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791IA	21760894	gold, Green Submitted, Green Published			2022-12-27	WOS:000292657200013
J	Brankatschk, B; Pons, V; Parton, RG; Gruenberg, J				Brankatschk, Ben; Pons, Veronique; Parton, Robert G.; Gruenberg, Jean			Role of SNX16 in the Dynamics of Tubulo-Cisternal Membrane Domains of Late Endosomes	PLOS ONE			English	Article							PHOSPHATIDYLINOSITOL 3-PHOSPHATE 5-KINASE; MULTIVESICULAR ENDOSOMES; SIGNAL-TRANSDUCTION; ENDOCYTIC PATHWAY; PROTEIN RILP; BAR DOMAINS; TRANSPORT; CELLS; CHOLESTEROL; LOCALIZATION	In this paper, we report that the PX domain-containing protein SNX16, a member of the sorting nexin family, is associated with late endosome membranes. We find that SNX16 is selectively enriched on tubulo-cisternal elements of this membrane system, whose highly dynamic properties and formation depend on intact microtubules. By contrast, SNX16 was not found on vacuolar elements that typically contain LBPA, and thus presumably correspond to multivesicular endosomes. We conclude that SNX16, together with its partner phosphoinositide, define a highly dynamic subset of late endosomal membranes, supporting the notion that late endosomes are organized in distinct morphological and functional regions. Our data also indicate that SNX16 is involved in tubule formation and cholesterol transport as well as trafficking of the tetraspanin CD81, suggesting that the protein plays a role in the regulation of late endosome membrane dynamics.	[Brankatschk, Ben; Pons, Veronique; Gruenberg, Jean] Univ Geneva, Dept Biochem, CH-1211 Geneva, Switzerland; [Parton, Robert G.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld, Australia; [Parton, Robert G.] Univ Queensland, Ctr Microscopy & Microanal, Brisbane, Qld, Australia	University of Geneva; University of Queensland; University of Queensland	Brankatschk, B (corresponding author), Univ Geneva, Dept Biochem, CH-1211 Geneva, Switzerland.	jean.gruenberg@unige.ch	Parton, Robert G/C-5673-2009	Parton, Robert G/0000-0002-7494-5248; PONS, Veronique/0000-0001-5821-8481	Swiss National Science Foundation [31003A_124776]; EU; Swiss SystemsX initiative in Systems Biology; Swiss National Science Foundation; National Center for Competence in Research (NCCR); Human Frontier Science Program Organization	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); EU(European Commission); Swiss SystemsX initiative in Systems Biology; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); National Center for Competence in Research (NCCR)(Swiss National Science Foundation (SNSF)); Human Frontier Science Program Organization(Human Frontier Science Program)	Support was from the Swiss National Science Foundation (grant number: 31003A_124776), PRISM from the EU Sixth Framework Programme, LipidX from the Swiss SystemsX initiative in Systems Biology, evaluated by the Swiss National Science Foundation and the National Center for Competence in Research (NCCR) in Chemical Biology (to J.G.), and the Human Frontier Science Program Organization (R.G.P.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANIENTO F, 1993, J CELL BIOL, V123, P1373, DOI 10.1083/jcb.123.6.1373; Bravo J, 2001, MOL CELL, V8, P829, DOI 10.1016/S1097-2765(01)00372-0; Brown MS, 2009, J LIPID RES, V50, pS15, DOI 10.1194/jlr.R800054-JLR200; Cabezas A, 2006, GENE, V371, P34, DOI 10.1016/j.gene.2005.11.009; Cantalupo G, 2001, EMBO J, V20, P683, DOI 10.1093/emboj/20.4.683; Choi JH, 2004, J CELL SCI, V117, P4209, DOI 10.1242/jcs.01233; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Escola JM, 1998, J BIOL CHEM, V273, P20121, DOI 10.1074/jbc.273.32.20121; Ferguson CJ, 2010, AUTOPHAGY, V6, P170, DOI 10.4161/auto.6.1.10626; Frost A, 2008, CELL, V132, P807, DOI 10.1016/j.cell.2007.12.041; Gillooly DJ, 2000, EMBO J, V19, P4577, DOI 10.1093/emboj/19.17.4577; GRIFFITHS G, 1984, J ULTRA MOL STRUCT R, V89, P65, DOI 10.1016/S0022-5320(84)80024-6; GRUENBERG J, 1995, CURR OPIN CELL BIOL, V7, P552, DOI 10.1016/0955-0674(95)80013-1; GRUENBERG J, 1989, J CELL BIOL, V108, P1301, DOI 10.1083/jcb.108.4.1301; Gu F, 1997, J CELL BIOL, V139, P1183, DOI 10.1083/jcb.139.5.1183; Habermann B, 2004, EMBO REP, V5, P250, DOI 10.1038/sj.embor.7400105; Hanson BJ, 2003, J BIOL CHEM, V278, P34617, DOI 10.1074/jbc.M300143200; Hopkins C, 2000, METHOD ENZYMOL, V327, P35, DOI 10.1016/S0076-6879(00)27265-0; Hurley JH, 2006, BBA-MOL CELL BIOL L, V1761, P805, DOI 10.1016/j.bbalip.2006.02.020; Ikonen E, 2004, SEMIN CELL DEV BIOL, V15, P445, DOI 10.1016/j.semcdb.2004.03.001; Ikonomov OC, 2006, AM J PHYSIOL-CELL PH, V291, pC393, DOI 10.1152/ajpcell.00019.2006; Jordens I, 2001, CURR BIOL, V11, P1680, DOI 10.1016/S0960-9822(01)00531-0; Kobayashi T, 2000, MOL BIOL CELL, V11, P1829, DOI 10.1091/mbc.11.5.1829; Kobayashi T, 1999, NAT CELL BIOL, V1, P113, DOI 10.1038/10084; Kobayashi T, 1998, NATURE, V392, P193, DOI 10.1038/32440; Kobayashi T, 2002, J BIOL CHEM, V277, P32157, DOI 10.1074/jbc.M202838200; Le Blanc I, 2005, NAT CELL BIOL, V7, P653, DOI 10.1038/ncb1269; Lebrand C, 2002, EMBO J, V21, P1289, DOI 10.1093/emboj/21.6.1289; Levy S, 1998, ANNU REV IMMUNOL, V16, P89, DOI 10.1146/annurev.immunol.16.1.89; Lindmo K, 2006, J CELL SCI, V119, P605, DOI 10.1242/jcs.02855; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; Luyet PP, 2008, TRAFFIC, V9, P2279, DOI 10.1111/j.1600-0854.2008.00820.x; Mayran N, 2003, EMBO J, V22, P3242, DOI 10.1093/emboj/cdg321; Miaczynska M, 2004, CELL, V116, P445, DOI 10.1016/S0092-8674(04)00117-5; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Nicot AS, 2008, TRAFFIC, V9, P1240, DOI 10.1111/j.1600-0854.2008.00754.x; PARTON RG, 1992, J CELL SCI, V103, P335; Peter BJ, 2004, SCIENCE, V303, P495, DOI 10.1126/science.1092586; Pons V, 2008, PLOS BIOL, V6, P1942, DOI 10.1371/journal.pbio.0060214; Rojo M, 1997, J CELL BIOL, V139, P1119, DOI 10.1083/jcb.139.5.1119; Rutherford AC, 2006, J CELL SCI, V119, P3944, DOI 10.1242/jcs.03153; Schnatwinkel C, 2004, PLOS BIOL, V2, P1363, DOI 10.1371/journal.pbio.0020261; Shin HW, 2005, J CELL BIOL, V170, P607, DOI 10.1083/jcb.200505128; Shisheva A, 2008, CELL BIOL INT, V32, P591, DOI 10.1016/j.cellbi.2008.01.006; Sobo K, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000851; SOKOL J, 1988, J BIOL CHEM, V263, P3411; Stein MP, 2003, TRAFFIC, V4, P754, DOI 10.1034/j.1600-0854.2003.00133.x; Stoorvogel W, 1996, J CELL BIOL, V132, P21, DOI 10.1083/jcb.132.1.21; Storch J, 2009, BBA-MOL CELL BIOL L, V1791, P671, DOI 10.1016/j.bbalip.2009.02.001; Teasdale RD, 2001, BIOCHEM J, V358, P7, DOI 10.1042/0264-6021:3580007; TOOZE J, 1991, J CELL BIOL, V115, P635, DOI 10.1083/jcb.115.3.635; TOOZE J, 1992, J CELL BIOL, V118, P813, DOI 10.1083/jcb.118.4.813; Turcic P, 2009, MOLECULES, V14, P5017, DOI 10.3390/molecules14125017; VAICKUS L, 1985, J IMMUNOL, V135, P1987; van der Goot FG, 2006, TRENDS CELL BIOL, V16, P514, DOI 10.1016/j.tcb.2006.08.003; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055; Zoncu R, 2009, CELL, V136, P1110, DOI 10.1016/j.cell.2009.01.032	57	21	22	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2011	6	7							e21771	10.1371/journal.pone.0021771	http://dx.doi.org/10.1371/journal.pone.0021771			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791AK	21754999	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000292632000026
J	Lachmann, S; Jevons, A; De Rycker, M; Casamassima, A; Radtke, S; Collazos, A; Parker, PJ				Lachmann, Sylvie; Jevons, Amy; De Rycker, Manu; Casamassima, Adele; Radtke, Simone; Collazos, Alejandra; Parker, Peter J.			Regulatory Domain Selectivity in the Cell-Type Specific PKN-Dependence of Cell Migration	PLOS ONE			English	Article							PROTEIN-KINASE-N; RHO EFFECTOR RECOGNITION; C-TERMINUS; POTENTIAL EFFECTOR; SMALL GTPASE; ACTIVATION; PHOSPHORYLATION; EXPRESSION; BINDING; PRK1	The mammalian protein kinase N (PKN) family of Serine/Threonine kinases comprises three isoforms, which are targets for Rho family GTPases. Small GTPases are major regulators of the cellular cytoskeleton, generating interest in the role(s) of specific PKN isoforms in processes such as cell migration and invasion. It has been reported that PKN3 is required for prostate tumour cell invasion but not PKN1 or 2. Here we employ a cell model, the 5637 bladder tumour cell line where PKN2 is relatively highly expressed, to assess the potential redundancy of these isoforms in migratory responses. It is established that PKN2 has a critical role in the migration and invasion of these cells. Furthermore, using a PKN wild-type and chimera rescue strategy, it is shown that PKN isoforms are not simply redundant in supporting migration, but appear to be linked through isoform specific regulatory domain properties to selective upstream signals. It is concluded that intervention in PKNs may need to be directed at multiple isoforms to be effective in different cell types.	[Lachmann, Sylvie; Jevons, Amy; De Rycker, Manu; Casamassima, Adele; Radtke, Simone; Collazos, Alejandra; Parker, Peter J.] London Res Inst, Prot Phosphorylat Lab, London, England; [Parker, Peter J.] Kings Coll London, Div Canc Studies, London WC2R 2LS, England	University of London; King's College London	Lachmann, S (corresponding author), London Res Inst, Prot Phosphorylat Lab, London, England.	peter.parker@cancer.org.uk	Parker, Peter j/D-5192-2013	parker, peter/0000-0002-6218-2933; De Rycker, Manu/0000-0002-3171-3519	Cancer Research United Kingdom	Cancer Research United Kingdom(Cancer Research UK)	The study was funded through Cancer Research United Kingdom's direct support to the London Research Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ammer AG, 2008, CELL MOTIL CYTOSKEL, V65, P687, DOI 10.1002/cm.20296; Betson M, 2007, GENETICS, V176, P2201, DOI 10.1534/genetics.107.072967; Blumenstein L, 2004, J BIOL CHEM, V279, P53419, DOI 10.1074/jbc.M409551200; Bourguignon LYW, 2007, J NEUROCHEM, V101, P1002, DOI 10.1111/j.1471-4159.2007.04485.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Braverman LE, 1999, J BIOL CHEM, V274, P5542, DOI 10.1074/jbc.274.9.5542; Bustelo XR, 2007, BIOESSAYS, V29, P356, DOI 10.1002/bies.20558; Calautti E, 2002, J CELL BIOL, V156, P137, DOI 10.1083/jcb.200105140; Deaton RA, 2005, J BIOL CHEM, V280, P31172, DOI 10.1074/jbc.M504774200; Dong LQ, 2000, P NATL ACAD SCI USA, V97, P5089, DOI 10.1073/pnas.090491897; Flynn P, 1998, J BIOL CHEM, V273, P2698, DOI 10.1074/jbc.273.5.2698; Friedl P, 2000, CELL MOL LIFE SCI, V57, P41, DOI 10.1007/s000180050498; Gotoh Y, 2004, BIOCHEM BIOPH RES CO, V314, P688, DOI 10.1016/j.bbrc.2003.12.148; Hamaguchi T, 2000, BIOCHEM BIOPH RES CO, V274, P825, DOI 10.1006/bbrc.2000.3225; Kato T, 2008, GENES CELLS, V13, P509, DOI 10.1111/j.1365-2443.2008.01182.x; Kim JH, 2006, J BIOL CHEM, V281, P15747, DOI 10.1074/jbc.M509844200; KITAGAWA M, 1995, BIOCHEM J, V310, P657, DOI 10.1042/bj3100657; Leenders F, 2004, EMBO J, V23, P3303, DOI 10.1038/sj.emboj.7600345; Lim MA, 2004, ONCOGENE, V23, P9348, DOI 10.1038/sj.onc.1208147; Lim WG, 2008, ARCH BIOCHEM BIOPHYS, V479, P170, DOI 10.1016/j.abb.2008.09.008; Lim WG, 2006, CELL SIGNAL, V18, P1473, DOI 10.1016/j.cellsig.2005.11.009; Lim WG, 2005, CELL SIGNAL, V17, P1084, DOI 10.1016/j.cellsig.2004.12.003; Lu Y, 1999, GENE DEV, V13, P1168, DOI 10.1101/gad.13.9.1168; Maesaki R, 1999, MOL CELL, V4, P793, DOI 10.1016/S1097-2765(00)80389-5; Marinissen MT, 2001, GENE DEV, V15, P535, DOI 10.1101/gad.855801; Matsuzawa K, 1997, BIOCHEM BIOPH RES CO, V234, P621, DOI 10.1006/bbrc.1997.6669; Mellor H, 1998, J BIOL CHEM, V273, P4811, DOI 10.1074/jbc.273.9.4811; Metzger E, 2003, EMBO J, V22, P270, DOI 10.1093/emboj/cdg023; Metzger E, 2008, NAT CELL BIOL, V10, P53, DOI 10.1038/ncb1668; Monami G, 2006, CANCER RES, V66, P7103, DOI 10.1158/0008-5472.CAN-06-0633; Mukai H, 1996, J BIOL CHEM, V271, P9816, DOI 10.1074/jbc.271.16.9816; MUKAI H, 1994, BIOCHEM BIOPH RES CO, V204, P348, DOI 10.1006/bbrc.1994.2466; Mukai H, 1997, J BIOL CHEM, V272, P4740, DOI 10.1074/jbc.272.8.4740; Naumanen P, 2008, J MICROSC-OXFORD, V231, P446, DOI 10.1111/j.1365-2818.2008.02057.x; Oishi K, 1999, BIOCHEM BIOPH RES CO, V261, P808, DOI 10.1006/bbrc.1999.1116; Owen D, 2003, J BIOL CHEM, V278, P50578, DOI 10.1074/jbc.M304313200; PALMER RH, 1995, EUR J BIOCHEM, V227, P344, DOI 10.1111/j.1432-1033.1995.tb20395.x; PALMER RH, 1995, J BIOL CHEM, V270, P22412, DOI 10.1074/jbc.270.38.22412; Quilliam LA, 1996, J BIOL CHEM, V271, P28772, DOI 10.1074/jbc.271.46.28772; Raftopoulou M, 2004, DEV BIOL, V265, P23, DOI 10.1016/j.ydbio.2003.06.003; Sahai E, 2003, NAT CELL BIOL, V5, P711, DOI 10.1038/ncb1019; Shibata H, 2001, J BIOCHEM, V130, P23, DOI 10.1093/oxfordjournals.jbchem.a002958; Takahashi M, 2003, J BIOCHEM, V133, P181, DOI 10.1093/jb/mvg022; Torbett NE, 2003, J BIOL CHEM, V278, P32344, DOI 10.1074/jbc.M303532200; Turner N, 2010, ONCOGENE, V29, P2013, DOI 10.1038/onc.2009.489; Vega FM, 2008, FEBS LETT, V582, P2093, DOI 10.1016/j.febslet.2008.04.039; Vincent S, 1997, MOL CELL BIOL, V17, P2247, DOI 10.1128/MCB.17.4.2247; Wood W, 2002, NAT CELL BIOL, V4, P907, DOI 10.1038/ncb875; Yu WP, 1997, J BIOL CHEM, V272, P10030	49	57	60	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2011	6	7							e21732	10.1371/journal.pone.0021732	http://dx.doi.org/10.1371/journal.pone.0021732			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791AK	21754995	Green Published, Green Submitted			2022-12-27	WOS:000292632000021
J	Tu, CY; Chen, TJ; Chou, LF				Tu, Chun-Yi; Chen, Tzeng-Ji; Chou, Li-Fang			Application of Frequent Itemsets Mining to Analyze Patterns of One-Stop Visits in Taiwan	PLOS ONE			English	Article							CHINESE HERBAL MEDICINE; CHRONIC DISEASE; PRESCRIPTIONS; PREVALENCE; CARE	Background: The free choice of health care facilities without limitations on frequency of visits within the National Health Insurance in Taiwan gives rise to not only a high number of annual ambulatory visits per capita but also a unique "one-stop shopping'' phenomenon, which refers to a patient' visits to several specialties of the same healthcare facility in one day. The visits to multiple physicians would increase the potential risk of polypharmacy. The aim of this study was to analyze the frequency and patterns of one-stop visits in Taiwan. Methodology/Principal Findings: The claims datasets of 1 million nationally representative people within Taiwan's National Health Insurance in 2005 were used to calculate the number of patients with one-stop visits. The frequent itemsets mining was applied to compute the combination patterns of specialties in the one-stop visits. Among the total 13,682,469 ambulatory care visits in 2005, one-stop visits occurred 144,132 times and involved 296,822 visits (2.2% of all visits) by 66,294 (6.6%) persons. People tended to have this behavior with age and the percentage reached 27.5% (5,662 in 20,579) in the age group >= 80 years. In general, women were more likely to have one-stop visits than men (7.2% vs. 6.0%). Internal medicine plus ophthalmology was the most frequent combination with a visited frequency of 3,552 times (2.5%), followed by cardiology plus neurology with 3,183 times (2.2%). The most frequent three-specialty combination, cardiology plus neurology and gastroenterology, occurred only 111 times. Conclusions/Significance: Without the novel computational technique, it would be hardly possible to analyze the extremely diverse combination patterns of specialties in one-stop visits. The results of the study could provide useful information either for the hospital manager to set up integrated services or for the policymaker to rebuild the health care system.	[Tu, Chun-Yi; Chen, Tzeng-Ji] Natl Yang Ming Univ, Sch Med, Inst Hosp & Hlth Care Adm, Taipei 112, Taiwan; [Tu, Chun-Yi] Taoyuan Vet Hosp, Dept Family Med, Tao Yuan, Taiwan; [Chen, Tzeng-Ji] Taipei Vet Gen Hosp, Dept Family Med, Taipei, Taiwan; [Chou, Li-Fang] Natl Chengchi Univ, Dept Publ Finance, Taipei 11623, Taiwan	National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; National Chengchi University	Tu, CY (corresponding author), Natl Yang Ming Univ, Sch Med, Inst Hosp & Hlth Care Adm, Taipei 112, Taiwan.	tjchen@vghtpe.gov.tw	Chen, TJ/AAH-8430-2021		National Science Council [NSC 96-2416-H-004-007-MY2]; Taipei Veterans General Hospital [V98S2-006]	National Science Council(Ministry of Science and Technology, Taiwan); Taipei Veterans General Hospital(Taipei Veterans General Hospital)	This study was supported by grants from the National Science Council (NSC 96-2416-H-004-007-MY2) and the Taipei Veterans General Hospital (V98S2-006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal R., 1993, ACM SIGMOD RECORD, V22, P207, DOI DOI 10.1145/170035.170072; Berry M, 1997, DATA MINING TECHNIQU; Birns J, 2006, AGE AGEING, V35, P306, DOI 10.1093/ageing/afj057; Chen FP, 2008, J ETHNOPHARMACOL, V117, P84, DOI 10.1016/j.jep.2008.01.018; Chen TJ, 2003, CLIN THER, V25, P2453, DOI 10.1016/S0149-2918(03)80287-4; Chen TJ, 2006, BMC HEALTH SERV RES, V6, DOI 10.1186/1472-6963-6-54; Cheng TM, 2003, HEALTH AFFAIR, V22, P61, DOI 10.1377/hlthaff.22.3.61; Galdas PM, 2005, J ADV NURS, V49, P616, DOI 10.1111/j.1365-2648.2004.03331.x; Han J., 2006, DATA MINING CONCEPTS, DOI 10.1016/C2009-0-61819-5; Jackson Jane, 2009, Nurs Manag (Harrow), V15, P24; Kung YY, 2006, ALLERGY, V61, P1316, DOI 10.1111/j.1398-9995.2006.01152.x; Liu ZR, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-394; Marengoni A, 2009, J AM GERIATR SOC, V57, P225, DOI 10.1111/j.1532-5415.2008.02109.x; Naughton C, 2006, AGE AGEING, V35, P633, DOI 10.1093/ageing/afl106; Nguyen Thach, 2005, J Interv Cardiol, V18, P107, DOI 10.1111/j.1540-8183.2005.4046a.x; Reid MJ, 2009, ANN ROY COLL SURG, V91, P301, DOI 10.1308/003588409X391910; ROMANO M, 2002, MODERN HEALTHCARE, V32, P32; Tamblyn RM, 1996, CAN MED ASSOC J, V154, P1177; 1996, ED MANAG, V8, P40	19	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2011	6	7							e14824	10.1371/journal.pone.0014824	http://dx.doi.org/10.1371/journal.pone.0014824			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	786HC	21747926	gold, Green Submitted, Green Published			2022-12-27	WOS:000292293400001
J	Grant, AJ; Dickens, JC				Grant, Alan J.; Dickens, Joseph C.			Functional Characterization of the Octenol Receptor Neuron on the Maxillary Palps of the Yellow Fever Mosquito, Aedes aegypti	PLOS ONE			English	Article							ODORANT RECEPTOR; CARBON-DIOXIDE; CULEX-QUINQUEFASCIATUS; 1-OCTEN-3-OL; IDENTIFICATION; ATTRACTANT; PHEROMONE; RESPONSES; SENSILLA; DIPTERA	Background: 1-Octen-3-ol (octenol) is a common attractant released by vertebrates which in combination with carbon dioxide (CO2) attracts hematophagous arthropods including mosquitoes. A receptor neuron contained within basiconic sensilla on the maxillary palps of adult mosquitoes responds selectively to 1-octen-3-ol. Recently, an odorant receptor (AaegOR8) known to occur on the maxillary palps was expressed in a heterologous system and demonstrated to be selectively sensitive to (R)-(-)-1-octen-3-ol, one of two enantiomeric forms. Lesser responses were elicited by stimulation with the (S)-enantiomer and various structural analogs. Methodology/Principal Findings: Here we characterize the specificity of the octenol receptor neuron in the yellow fever mosquito, Aedes aegypti (L.), in vivo using single cell recordings. The octenol neuron is exquisitely sensitive to (R)-(-)-1-octen-3-ol; comparable responses to (S)-(+)-1-octen-3-ol were elicited only at stimulus doses over 100x that required for the (R)-enantiomer. An intermediate response closer to that elicited by the (R)-(-)-enantiomer was elicited by racemic 1-octen-3-ol. Small structural changes in (R)-(-)-1-octen-3-ol resulted in large decreases in responses. Increases in spike activity were also elicited in the octenol neuron by 2-undecanone, a known repellent; other repellents (DEET, IR3535 and picaridin) were inactive. Conclusions/Significance: The results of our electrophysiological studies of the octenol receptor neuron in vivo approximates results of a previous study of the octenol receptor (AaegOR8 with its obligate partner Aaeg\ORco) expressed heterologously in Xenopus oocytes. By comparison of our current results with those of the heterologous expression study, we conclude that specificity of the octenol receptor neuron can be explained largely by characteristics of the OR alone without other associated proteins present in vivo. Our findings show that repellents may have specific stimulatory effects on receptor neurons and support the notion of repellents as modulators of mosquito odorant receptor activity.	[Grant, Alan J.; Dickens, Joseph C.] ARS, Invas Insect Biocontrol & Behav Lab, Henry A Wallace Beltsville Agr Res Ctr, Inst Plant Sci,USDA, Beltsville, MD USA	United States Department of Agriculture (USDA)	Grant, AJ (corresponding author), ARS, Invas Insect Biocontrol & Behav Lab, Henry A Wallace Beltsville Agr Res Ctr, Inst Plant Sci,USDA, Beltsville, MD USA.	joseph.dickens@ars.usda.gov	Dickens, Dick/AGY-7295-2022		US Department of Defense through the Armed Forces Pest Management Board (AFPMB)	US Department of Defense through the Armed Forces Pest Management Board (AFPMB)(United States Department of Defense)	This work was supported in part by a grant to JCD from the Deployed War Fighter Protection (DWFP) Research Program, funded by the US Department of Defense through the Armed Forces Pest Management Board (AFPMB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blackwell A, 1996, PHYSIOL ENTOMOL, V21, P15, DOI 10.1111/j.1365-3032.1996.tb00830.x; Bohbot JD, 2011, MED VET ENTOMOL, V25, P436, DOI 10.1111/j.1365-2915.2011.00949.x; Bohbot JD, 2010, ECOL CONT VECTOR-BOR, V2, P17; Bohbot JD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012138; Bohbot JD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007032; Debboun M, 2007, INSECT REPELLENTS PR; DICKENS JC, 1990, CHEM SENSES, V15, P311, DOI 10.1093/chemse/15.3.311; DICKENS JC, 1978, ENTOMOL EXP APPL, V24, P336, DOI 10.1007/BF02385082; Ditzen M, 2008, SCIENCE, V319, P1838, DOI 10.1126/science.1153121; FRENCH FE, 1989, J MED ENTOMOL, V26, P459, DOI 10.1093/jmedent/26.5.459; Grant AJ, 1996, CIBA F SYMP, V200, P233; GRANT AJ, 1995, J COMP PHYSIOL A, V177, P389, DOI 10.1007/BF00187475; Grant AJ, 2010, ECOL CONT VECTOR-BOR, V2, P91; HALL DR, 1984, INSECT SCI APPL, V5, P335, DOI 10.1017/S1742758400008626; Hallem EA, 2006, CELL, V125, P143, DOI 10.1016/j.cell.2006.01.050; Jones WD, 2005, CURR BIOL, V15, pR119, DOI 10.1016/j.cub.2005.02.007; Kline DL, 2007, MED VET ENTOMOL, V21, P323, DOI 10.1111/j.1365-2915.2007.00697.x; KLINE DL, 1994, MED VET ENTOMOL, V8, P25, DOI 10.1111/j.1365-2915.1994.tb00379.x; Kwon JY, 2007, P NATL ACAD SCI USA, V104, P3574, DOI 10.1073/pnas.0700079104; Lu T, 2007, CURR BIOL, V17, P1533, DOI 10.1016/j.cub.2007.07.062; MCIVER SB, 1982, J MED ENTOMOL, V19, P489, DOI 10.1093/jmedent/19.5.489; Sato K, 2008, NATURE, V452, P1002, DOI 10.1038/nature06850; Syed Z, 2007, CHEM SENSES, V32, P727, DOI 10.1093/chemse/bjm040; TAKKEN W, 1989, J AM MOSQUITO CONTR, V5, P311; TUMLINSON JH, 1977, SCIENCE, V197, P789, DOI 10.1126/science.197.4305.789; Vogt RG, 1999, CHEM SENSES, V24, P481, DOI 10.1093/chemse/24.5.481; Xia YF, 2006, INSECT BIOCHEM MOLEC, V36, P169, DOI 10.1016/j.ibmb.2005.12.003; Zhou JJ, 2008, INSECT MOL BIOL, V17, P147, DOI 10.1111/j.1365-2583.2007.00789.x	28	27	28	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2011	6	6							e21785	10.1371/journal.pone.0021785	http://dx.doi.org/10.1371/journal.pone.0021785			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786GP	21738794	gold, Green Published, Green Submitted			2022-12-27	WOS:000292291800045
J	Hsieh, M; Thao, K; Conti, M				Hsieh, Minnie; Kao Thao; Conti, Marco			Genetic Dissection of Epidermal Growth Factor Receptor Signaling during Luteinizing Hormone-Induced Oocyte Maturation	PLOS ONE			English	Article							GRANULOSA-CELLS; MEIOTIC ARREST; MOUSE OOCYTES; DEPENDENT ACTIVATION; FOLLICLE DEVELOPMENT; RODENT OOCYTES; CYCLIC-GMP; G-PROTEIN; CUMULUS; EXPRESSION	Recent evidence that luteinizing hormone (LH) stimulation of ovulatory follicles causes transactivation of the epidermal growth factor receptor (EGFR) has provided insights into the mechanisms of ovulation. However, the complete array of signals that promote oocyte reentry into the meiotic cell cycle in the follicle are still incompletely understood. To elucidate the signaling downstream of EGFR involved in oocyte maturation, we have investigated the LH responses in granulosa cells with targeted ablation of EGFR. Oocyte maturation and ovulation is disrupted when EGFR expression is progressively reduced. In granulosa cells from mice with either global or granulosa cell-specific disruption of EGFR signaling, LH-induced phosphorylation of MAPK3/1, p38MAPK, and connexin-43 is impaired. Although the LH-induced decrease in cGMP is EGFR-dependent in wild type follicles, LH still induces a decrease in cGMP in Egfr(delta/f) Cyp19-Cre follicles. Thus compensatory mechanisms appear activated in the mutant. Spatial propagation of the LH signal in the follicle also is dependent on the EGF network, and likely is important for the control of signaling to the oocyte. Thus, multiple signals and redundant pathways contribute to regulating oocyte reentry into the cell cycle.	[Hsieh, Minnie; Kao Thao; Conti, Marco] Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Hsieh, M (corresponding author), Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, San Francisco, CA 94143 USA.	ContiM@obgyn.ucsf.edu			NIH [1RO1HD052909, RO1GM08527, R01HD052909]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD052909] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	The work done in the authors' laboratory was supported by NIH 1RO1HD052909 and RO1GM08527. This work was also supported by NIH R01HD052909 to MC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMSTERDAM A, 1975, J CELL BIOL, V67, P894, DOI 10.1083/jcb.67.3.894; Andric N, 2008, ENDOCRINOLOGY, V149, P5549, DOI 10.1210/en.2008-0618; Andric N, 2010, MOL ENDOCRINOL, V24, P552, DOI 10.1210/me.2009-0450; Ashkenazi H, 2005, ENDOCRINOLOGY, V146, P77, DOI 10.1210/en.2004-0588; Conti M, 2002, BIOL REPROD, V67, P1653, DOI 10.1095/biolreprod.102.004952; DOWNS SM, 1988, J EXP ZOOL, V245, P86, DOI 10.1002/jez.1402450113; EDWARDS RG, 1965, NATURE, V208, P349, DOI 10.1038/208349a0; Eppig JJ, 2001, REPRODUCTION, V122, P829, DOI 10.1530/rep.0.1220829; Eppig John J., 1993, P185; Fan HY, 2008, DEVELOPMENT, V135, P2127, DOI 10.1242/dev.020560; Fan HY, 2009, SCIENCE, V324, P938, DOI 10.1126/science.1171396; Freudzon L, 2005, J CELL BIOL, V171, P255, DOI 10.1083/jcb.200506194; Hinckley M, 2005, DEV BIOL, V287, P249, DOI 10.1016/j.ydbio.2005.08.019; Holbro T, 2004, ANNU REV PHARMACOL, V44, P195, DOI 10.1146/annurev.pharmtox.44.101802.121440; Horner K, 2003, DEV BIOL, V258, P385, DOI 10.1016/S0012-1606(03)00134-9; Hsieh M, 2007, MOL CELL BIOL, V27, P1914, DOI 10.1128/MCB.01919-06; HUBBARD CJ, 1982, BIOL REPROD, V26, P628, DOI 10.1095/biolreprod26.4.628; Lee TC, 2009, GENESIS, V47, P85, DOI 10.1002/dvg.20464; LEUNG PCK, 1992, ENDOCR REV, V13, P476, DOI 10.1210/er.13.3.476; Masciarelli S, 2004, J CLIN INVEST, V114, P196, DOI 10.1172/JCI2004210804; Mehlmann LM, 2002, SCIENCE, V297, P1343, DOI 10.1126/science.1073978; Mehlmann LM, 2004, SCIENCE, V306, P1947, DOI 10.1126/science.1103974; Norris RP, 2008, DEVELOPMENT, V135, P3229, DOI 10.1242/dev.025494; Norris RP, 2010, REPRODUCTION, V140, P655, DOI 10.1530/REP-10-0288; Norris RP, 2009, DEVELOPMENT, V136, P1869, DOI 10.1242/dev.035238; Panigone S, 2008, MOL ENDOCRINOL, V22, P924, DOI 10.1210/me.2007-0246; Park JY, 2004, SCIENCE, V303, P682, DOI 10.1126/science.1092463; PENG XR, 1991, ENDOCRINOLOGY, V129, P3200, DOI 10.1210/endo-129-6-3200; Pincus G, 1935, J EXP MED, V62, P655; Prevot V, 2005, ENDOCRINOLOGY, V146, P1465, DOI 10.1210/en.2004-1146; Reizel Y, 2010, MOL ENDOCRINOL, V24, P402, DOI 10.1210/me.2009-0267; Richard FJ, 2001, BIOL REPROD, V65, P1444, DOI 10.1095/biolreprod65.5.1444; RICHARDS JS, 1994, ENDOCR REV, V15, P725, DOI 10.1210/er.15.6.725; Richards JS, 2001, MOL ENDOCRINOL, V15, P209, DOI 10.1210/me.15.2.209; Sekiguchi T, 2004, J MOL ENDOCRINOL, V33, P281, DOI 10.1677/jme.0.0330281; Sela-Abramovich S, 2006, ENDOCRINOLOGY, V147, P2280, DOI 10.1210/en.2005-1011; Shimada M, 2006, MOL ENDOCRINOL, V20, P1352, DOI 10.1210/me.2005-0504; Su YQ, 2003, DEV BIOL, V263, P126, DOI 10.1016/S0012-1606(03)00437-8; TORNELL J, 1984, ACTA PHYSIOL SCAND, V122, P507, DOI 10.1111/j.1748-1716.1984.tb07539.x; TORNELL J, 1990, ACTA PHYSIOL SCAND, V139, P511, DOI 10.1111/j.1748-1716.1990.tb08953.x; Tsafriri A, 1996, DEV BIOL, V178, P393, DOI 10.1006/dbio.1996.0226; Tsafriri A., 1994, MOL BIOL FEMALE REPR, P207; Vaccari S, 2009, BIOL REPROD, V81, P595, DOI 10.1095/biolreprod.109.077768; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073	44	75	79	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2011	6	6							e21574	10.1371/journal.pone.0021574	http://dx.doi.org/10.1371/journal.pone.0021574			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786GP	21738714	Green Published, Green Submitted, gold			2022-12-27	WOS:000292291800023
J	Nunn, CL; Thrall, PH; Leendertz, FH; Boesch, C				Nunn, Charles L.; Thrall, Peter H.; Leendertz, Fabian H.; Boesch, Christophe			The Spread of Fecally Transmitted Parasites in Socially-Structured Populations	PLOS ONE			English	Article							EMERGING INFECTIOUS-DISEASES; IMPENETRABLE NATIONAL-PARK; GORILLA-GORILLA; TRANSMISSION; ECOLOGY; CRYPTOSPORIDIUM; CONSERVATION; PATHOGENS; DYNAMICS; PRIMATES	Mammals are infected by a wide array of gastrointestinal parasites, including parasites that also infect humans and domesticated animals. Many of these parasites are acquired through contact with infectious stages present in soil, feces or vegetation, suggesting that ranging behavior will have a major impact on their spread. We developed an individual-based spatial simulation model to investigate how range use intensity, home range overlap, and defecation rate impact the spread of fecally transmitted parasites in a population composed of social groups (i.e., a socially structured population). We also investigated the effects of epidemiological parameters involving host and parasite mortality rates, transmissibility, disease-related mortality, and group size. The model was spatially explicit and involved the spillover of a gastrointestinal parasite from a reservoir population along the edge of a simulated reserve, which was designed to mimic the introduction pathogens into protected areas. Animals ranged randomly within a "core" area, with biased movement toward the range center when outside the core. We systematically varied model parameters using a Latin hypercube sampling design. Analyses of simulation output revealed a strong positive association between range use intensity and the prevalence of infection. Moreover, the effects of range use intensity were similar in magnitude to effects of group size, mortality rates, and the per-contact probability of transmission. Defecation rate covaried positively with gastrointestinal parasite prevalence. Greater home range overlap had no positive effects on prevalence, with a smaller core resulting in less range overlap yet more intensive use of the home range and higher prevalence. Collectively, our results reveal that parasites with fecal-oral transmission spread effectively in socially structured populations. Future application should focus on parameterizing the model with empirically derived ranging behavior for different species or populations and data on transmission characteristics of different infectious organisms.	[Nunn, Charles L.] Harvard Univ, Dept Human Evolutionary Biol, Cambridge, MA 02138 USA; [Thrall, Peter H.] CSIRO Plant Ind, Canberra, ACT, Australia; [Leendertz, Fabian H.] Robert Koch Inst, Res Grp Emerging Zoonoses, D-1000 Berlin, Germany; [Boesch, Christophe] Max Planck Inst Evolutionary Anthropol, Leipzig, Germany	Harvard University; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Robert Koch Institute; Max Planck Society	Nunn, CL (corresponding author), Harvard Univ, Dept Human Evolutionary Biol, Cambridge, MA 02138 USA.	cnunn@oeb.harvard.edu	Leendertz, Fabian Hubertus/H-8902-2019; Thrall, Peter/J-6672-2013		Max Planck Society; Harvard University	Max Planck Society(Max Planck SocietyFoundation CELLEX); Harvard University	This research was supported by the Max Planck Society and Harvard University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALDOORY Y, 1969, MYCOPATH MYCOL APPL, V38, P7, DOI 10.1007/BF02051671; Altizer S, 2003, TRENDS ECOL EVOL, V18, P589, DOI 10.1016/j.tree.2003.08.013; ANDERSON RM, 1982, POPULATION BIOL INFE; [Anonymous], 2009, LANG ENV STAT COMP; Appelbee AJ, 2005, TRENDS PARASITOL, V21, P370, DOI 10.1016/j.pt.2005.06.004; Ashford RW, 1996, J ZOOL, V239, P507, DOI 10.1111/j.1469-7998.1996.tb05939.x; Bermejo M, 2006, SCIENCE, V314, P1564, DOI 10.1126/science.1133105; BLOWER SM, 1994, INT STAT REV, V62, P229, DOI 10.2307/1403510; Bonnell TR, 2010, ECOL MODEL, V221, P2491, DOI 10.1016/j.ecolmodel.2010.07.020; Caillaud D, 2006, CURR BIOL, V16, pR489, DOI 10.1016/j.cub.2006.06.017; Chapman CA, 2005, EVOL ANTHROPOL, V14, P134, DOI 10.1002/evan.20068; CLUTTONBROCK TH, 1977, J ZOOL, V183, P1, DOI 10.1111/j.1469-7998.1977.tb04171.x; Cross PC, 2005, ECOL LETT, V8, P587, DOI 10.1111/j.1461-0248.2005.00760.x; Daszak P, 2000, SCIENCE, V287, P443, DOI 10.1126/science.287.5452.443; Dobson A, 2001, PHILOS T R SOC B, V356, P1001, DOI 10.1098/rstb.2001.0900; DUNBAR RIM, 1980, J ANIM ECOL, V49, P485, DOI 10.2307/4259; Ezenwa VO, 2004, BEHAV ECOL, V15, P446, DOI 10.1093/beheco/arh028; FREELAND W J, 1976, Biotropica, V8, P12, DOI 10.2307/2387816; FREELAND WJ, 1979, ECOLOGY, V60, P719, DOI 10.2307/1936609; Gillespie TR, 2008, YEARB PHYS ANTHROPOL, V51, P53, DOI 10.1002/ajpa.20949; Gillespie TR, 2005, J APPL ECOL, V42, P699, DOI 10.1111/j.1365-2664.2005.01049.x; Goldberg TL, 2008, EMERG INFECT DIS, V14, P1375, DOI [10.3201/eid14.9.071196, 10.3201/eid1409.071196]; Goldberg TL, 2007, BIOL CONSERV, V135, P511, DOI 10.1016/j.biocon.2006.10.048; GULLAND FMD, 1993, P ROY SOC B-BIOL SCI, V254, P7, DOI 10.1098/rspb.1993.0119; HART BL, 1990, NEUROSCI BIOBEHAV R, V14, P273, DOI 10.1016/S0149-7634(05)80038-7; Harvell CD, 2002, SCIENCE, V296, P2158, DOI 10.1126/science.1063699; Hess G, 1996, ECOLOGY, V77, P1617, DOI 10.2307/2265556; HESS GR, 1994, CONSERV BIOL, V8, P256, DOI 10.1046/j.1523-1739.1994.08010256.x; Hugot JP, 1996, INT J PARASITOL, V26, P147, DOI 10.1016/0020-7519(95)00108-5; Kondgen S, 2008, CURR BIOL, V18, P260, DOI 10.1016/j.cub.2008.01.012; Leendertz FH, 2006, BIOL CONSERV, V131, P325, DOI 10.1016/j.biocon.2006.05.002; Leroy EM, 2005, NATURE, V438, P575, DOI 10.1038/438575a; LOEHLE C, 1995, ECOLOGY, V76, P326, DOI 10.2307/1941192; MITANI JC, 1979, BEHAV ECOL SOCIOBIOL, V5, P241, DOI 10.1007/BF00293673; Nizeyi JB, 2002, PARASITOL RES, V88, P380, DOI 10.1007/s00436-001-0543-x; Nizeyi JB, 1999, J PARASITOL, V85, P1084, DOI 10.2307/3285672; Normand E, 2009, ANIM BEHAV, V77, P1195, DOI 10.1016/j.anbehav.2009.01.025; Nunn CL, 2008, EVOL ECOL, V22, P519, DOI 10.1007/s10682-007-9180-x; Nunn CL, 2006, BIOL LETTERS, V2, P351, DOI 10.1098/rsbl.2006.0485; Nunn CL, 2009, ANIM BEHAV, V77, P1515, DOI 10.1016/j.anbehav.2009.02.023; Nunn CL, 2000, AM NAT, V156, P519, DOI 10.1086/303405; Nunn CL, 2006, INFECT DIS PRIMATES; Rushton SP, 2000, J APPL ECOL, V37, P997, DOI 10.1046/j.1365-2664.2000.00553.x; Samuel W.M., 2001, PARASITIC DIS WILD M; SCOTT M E, 1988, Conservation Biology, V2, P40, DOI 10.1111/j.1523-1739.1988.tb00334.x; SEAHOLM SK, 1988, INT J BIOMED COMPUT, V23, P97, DOI 10.1016/0020-7101(88)90067-0; Smith KF, 2009, ANIM CONSERV, V12, P1, DOI 10.1111/j.1469-1795.2008.00228.x; Smouse PE, 2010, PHILOS T R SOC B, V365, P2201, DOI 10.1098/rstb.2010.0078; Stoner KE, 1996, CONSERV BIOL, V10, P539, DOI 10.1046/j.1523-1739.1996.10020539.x; Walsh PD, 2003, NATURE, V422, P611, DOI 10.1038/nature01566; WASER PM, 1976, AM NAT, V110, P911, DOI 10.1086/283117; WEVERS D, VIROLOGY J IN PRESS; WILLIAMS ES, 2001, INFECT DIS WILD MAMM, P558	53	46	47	2	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2011	6	6							e21677	10.1371/journal.pone.0021677	http://dx.doi.org/10.1371/journal.pone.0021677			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786GP	21738763	Green Published, Green Submitted, gold			2022-12-27	WOS:000292291800030
J	Wang, R; Sperry, AO				Wang, Rong; Sperry, Ann O.			PP1 Forms an Active Complex with TLRR (lrrc67), a Putative PP1 Regulatory Subunit, during the Early Stages of Spermiogenesis in Mice	PLOS ONE			English	Article							PROTEIN PHOSPHATASE 1C-GAMMA; EPIDIDYMAL SPERM MATURATION; MANCHETTE DEVELOPMENT; MOUSE TESTIS; MUTANT MICE; GERM-CELLS; PP1-GAMMA-2; SPERMATOGENESIS; IDENTIFICATION; MORPHOGENESIS	Mammalian spermatogenesis is a highly regulated developmental pathway that demands dramatic rearrangement of the cytoskeleton of the male germ cell. We have described previously a leucine rich repeat protein, TLRR (also known as lrrc67), which is associated with the spermatid cytoskeleton in mouse testis and is a binding partner of protein phosphatase-1 (PP1), an extremely well conserved signaling molecule. The activity of PP1 is modulated by numerous specific regulators of which TLRR is a candidate. In this study we measured the phosphatase activity of the TLRR-PP1 complex in the adult and the developing mouse testis, which contains varying populations of developing germ cell types, in order to determine whether TLRR acts as an activator or an inhibitor of PP1 and whether the phosphatase activity of this complex is developmentally regulated during spermatogenesis. Additionally, we assayed the ability of bacterially expressed TLRR to affect the enzymatic activity of PP1. Furthermore, we examined phosphorylation of TLRR, and elements of the spermatid cytoskeleton during the first wave of spermatogenesis in the developing testis. We demonstrate here that the TLRR complex is associated with a phosphatase activity in adult mouse testis. The relative phosphatase activity of this complex appears to reach a peak at about 21 days after birth, when pachytene spermatocytes and round spermatids are abundant in the seminiferous epithelium of the mouse testis. TLRR, in addition to tubulin and kinesin-1B, is phosphorylated during the first wave of spermatogenesis. These findings indicate that the TLRR-PP1 complex is active prior to translocation of TLRR toward the sperm flagella and that TLRR, and constituents of the spermatid cytoskeleton, may be subject to regulation by reversible phosphorylation during spermatogenesis in murine testis.	[Wang, Rong; Sperry, Ann O.] E Carolina Univ, Dept Anat & Cell Biol, Brody Sch Med, Greenville, NC 27858 USA	University of North Carolina; East Carolina University	Wang, R (corresponding author), E Carolina Univ, Dept Anat & Cell Biol, Brody Sch Med, Greenville, NC 27858 USA.	sperrya@ecu.edu			National Institutes of Health, National Institute of Health and Human Development [HD058027]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R03HD058027] Funding Source: NIH RePORTER	National Institutes of Health, National Institute of Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was funded by the National Institutes of Health, National Institute of Health and Human Development grant number HD058027 to AOS http://www.nichd.nih.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BELLVE AR, 1977, J HISTOCHEM CYTOCHEM, V25, P480, DOI 10.1177/25.7.893996; Chakrabarti R, 2007, ASIAN J ANDROL, V9, P445, DOI 10.1111/j.1745-7262.2007.00307.x; Chakrabarti R, 2007, BIOL REPROD, V76, P992, DOI 10.1095/biolreprod.106.058610; Cheng L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004861; CHERRY LM, 1984, CHROMOSOMA, V90, P265, DOI 10.1007/BF00287034; COLE A, 1988, BIOL REPROD, V38, P385, DOI 10.1095/biolreprod38.2.385; DeBoer SR, 2008, BIOCHEMISTRY-US, V47, P4535, DOI 10.1021/bi702445j; Henderson H., 2010, INT J ANDROL, P1; Hrabchak C, 2004, J BIOL CHEM, V279, P37079, DOI 10.1074/jbc.M403710200; Huang ZH, 2004, BIOL REPROD, V70, P439, DOI 10.1095/biolreprod.103.020024; Kierszenbaum AL, 2002, MOL REPROD DEV, V63, P1, DOI 10.1002/mrd.10179; Li JB, 2004, CELL, V117, P541, DOI 10.1016/S0092-8674(04)00450-7; McClintock TS, 2008, PHYSIOL GENOMICS, V32, P198, DOI 10.1152/physiolgenomics.00128.2007; MEISTRICH ML, 1990, AM J ANAT, V188, P74, DOI 10.1002/aja.1001880109; Mishra S, 2003, BIOL REPROD, V69, P1572, DOI 10.1095/biolreprod.103.018739; Moreno RD, 2000, CELL MOTIL CYTOSKEL, V46, P235, DOI 10.1002/1097-0169(200008)46:4<235::AID-CM1>3.0.CO;2-G; Morfini GA, 2009, NAT NEUROSCI, V12, P864, DOI 10.1038/nn.2346; Oppedisano-Wells L, 2003, MOL REPROD DEV, V65, P157, DOI 10.1002/mrd.10284; SHIMA H, 1993, BIOCHEM BIOPH RES CO, V194, P930, DOI 10.1006/bbrc.1993.1910; Su AI, 2002, P NATL ACAD SCI USA, V99, P4465, DOI 10.1073/pnas.012025199; Varmuza S, 1999, DEV BIOL, V205, P98, DOI 10.1006/dbio.1998.9100; Vijayaraghavan S, 1996, BIOL REPROD, V54, P709, DOI 10.1095/biolreprod54.3.709; Wang R, 2010, BIOL CELL, V102, P173, DOI 10.1042/BC20090091; Wang R, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-9; Wang WP, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-62; WOLOSEWICK JJ, 1977, AM J ANAT, V150, P301, DOI 10.1002/aja.1001500206	26	8	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2011	6	6							e21767	10.1371/journal.pone.0021767	http://dx.doi.org/10.1371/journal.pone.0021767			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786GP	21738792	Green Published, gold, Green Submitted			2022-12-27	WOS:000292291800043
J	Gan, PP; McCarroll, JA; Byrne, FL; Garner, J; Kavallaris, M				Gan, Pei Pei; McCarroll, Joshua A.; Byrne, Frances L.; Garner, James; Kavallaris, Maria			Specific beta-Tubulin Isotypes Can Functionally Enhance or Diminish Epothilone B Sensitivity in Non-Small Cell Lung Cancer Cells	PLOS ONE			English	Article							MICROTUBULE-STABILIZING AGENTS; III-TUBULIN; MITOTIC ARREST; INHIBITS GROWTH; BINDING AGENTS; IN-VIVO; PACLITAXEL; PATUPILONE; RESISTANCE; MUTATIONS	Epothilones are a new class of microtubule stabilizing agents with promising preclinical and clinical activity. Their cellular target is beta-tubulin and factors influencing intrinsic sensitivity to epothilones are not well understood. In this study, the functional significance of specific beta-tubulin isotypes in intrinsic sensitivity to epothilone B was investigated using siRNA gene knockdown against beta II-, beta III- or beta IVb-tubulins in two independent non-small cell lung cancer (NSCLC) cell lines, NCI-H460 and Calu-6. Drug-treated clonogenic assays showed that sensitivity to epothilone B was not altered following knockdown of beta II-tubulin in both NSCLC cell lines. In contrast, knockdown of beta III-tubulin significantly increased sensitivity to epothilone B. Interestingly, beta IVb-tubulin knockdowns were significantly less sensitive to epothilone B, compared to mock- and control siRNA cells. Cell cycle analysis of beta III-tubulin knockdown cells showed a higher percentage of cell death with epothilone B concentrations as low as 0.5 nM. In contrast, beta IVb-tubulin knockdown cells displayed a decrease in epothilone B-induced G(2)-M cell cycle accumulation compared to control siRNA cells. Importantly, beta III-tubulin knockdowns displayed a significant dose-dependent increase in the percentage of apoptotic cells upon treatment with epothilone B, as detected using caspase 3/7 activity and Annexin-V staining. Higher concentrations of epothilone B were required to induce apoptosis in the beta IVb-tubulin knockdowns compared to control siRNA, highlighting a potential mechanism underlying decreased sensitivity to this agent. This study demonstrates that specific beta-tubulin isotypes can influence sensitivity to epothilone B and may influence differential sensitivity to this promising new agent.	[Gan, Pei Pei; McCarroll, Joshua A.; Byrne, Frances L.; Kavallaris, Maria] Univ New S Wales, Lowy Canc Res Ctr, Childrens Canc Inst Australia, Randwick, NSW, Australia; [Garner, James] Univ New S Wales, Sch Chem, Sydney, NSW, Australia; [Kavallaris, Maria] Univ New S Wales, Australian Ctr Nanomed, Sydney, NSW, Australia	Children's Cancer Institute; University of New South Wales Sydney; University of New South Wales Sydney; University of New South Wales Sydney	Gan, PP (corresponding author), Univ New S Wales, Lowy Canc Res Ctr, Childrens Canc Inst Australia, Randwick, NSW, Australia.	m.kavallaris@ccia.unsw.edu.au	McCarroll, Joshua/E-8481-2010; Kavallaris, Maria/J-5240-2014; Byrne, Frances/AAW-7748-2020	McCarroll, Joshua/0000-0001-8807-3623; Byrne, Frances/0000-0002-8897-8438; Giannakakou, Paraskevi/0000-0001-7378-262X	Children's Cancer Institute Australia for Medical Research, which is affiliated with the University of New South Wales; Sydney Children's Hospital; New South Wales Cancer Council; Endeavour International Postgraduate Research Scholarship; University of New South Wales Faculty of Medicine; Balnaves Award; Anthony Rothe Postgraduate Award; NHMRC	Children's Cancer Institute Australia for Medical Research, which is affiliated with the University of New South Wales; Sydney Children's Hospital; New South Wales Cancer Council(Cancer Council New South Wales); Endeavour International Postgraduate Research Scholarship(Australian Government); University of New South Wales Faculty of Medicine; Balnaves Award; Anthony Rothe Postgraduate Award; NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	Children's Cancer Institute Australia for Medical Research, which is affiliated with the University of New South Wales and the Sydney Children's Hospital and grants from the New South Wales Cancer Council (MK). Endeavour International Postgraduate Research Scholarship (PPG), University of New South Wales Faculty of Medicine Fellowship (JAM), University of New South Wales Faculty of Medicine Early Career Research Award (JAM), Balnaves Award (JAM), Anthony Rothe Postgraduate Award (JLB), and by a NHMRC Senior Fellowship (MK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blade K, 1999, J CELL SCI, V112, P2213; BOLLAG DM, 1995, CANCER RES, V55, P2325; Dumontet C, 2009, MOL CANCER THER, V8, P17, DOI 10.1158/1535-7163.MCT-08-0986; Freedman H, 2009, J CHEM INF MODEL, V49, P424, DOI 10.1021/ci8003336; Gan PP, 2007, CANCER RES, V67, P9356, DOI 10.1158/0008-5472.CAN-07-0509; Gan PP, 2010, MOL CANCER THER, V9, P1339, DOI 10.1158/1535-7163.MCT-09-0679; Gan PP, 2008, CANCER RES, V68, P9817, DOI 10.1158/0008-5472.CAN-08-1501; Giannakakou P, 2000, P NATL ACAD SCI USA, V97, P2904, DOI 10.1073/pnas.040546297; Giannakakou P, 1997, J BIOL CHEM, V272, P17118, DOI 10.1074/jbc.272.27.17118; Joe PA, 2008, CELL MOTIL CYTOSKEL, V65, P476, DOI 10.1002/cm.20274; Kamath K, 2003, CANCER RES, V63, P6026; Kavallaris M, 2010, NAT REV CANCER, V10, P194, DOI 10.1038/nrc2803; Khawaja NR, 2008, MOL PHARMACOL, V74, P1072, DOI 10.1124/mol.108.048405; Kowalski RJ, 1997, J BIOL CHEM, V272, P2534; Lee JJ, 2008, CLIN CANCER RES, V14, P1618, DOI 10.1158/1078-0432.CCR-07-2201; Lee JJ, 2009, NAT CLIN PRACT ONCOL, V6, P85, DOI 10.1038/ncponc1281; Lin B, 2005, BLOOD, V105, P350, DOI 10.1182/blood-2004-06-2499; Magnani M, 2006, FEBS J, V273, P3301, DOI 10.1111/j.1742-4658.2006.05340.x; McCarroll JA, 2010, CANCER RES, V70, P4995, DOI 10.1158/0008-5472.CAN-09-4487; Milross CG, 1996, JNCI-J NATL CANCER I, V88, P1308, DOI 10.1093/jnci/88.18.1308; Mozzetti S, 2008, CANCER RES, V68, P10197, DOI 10.1158/0008-5472.CAN-08-2091; Nettles JH, 2004, SCIENCE, V305, P866, DOI 10.1126/science.1099190; O'Reilly T, 2005, PROSTATE, V65, P231, DOI 10.1002/pros.20289; Phillips PA, 2007, CANCER RES, V67, P9407, DOI 10.1158/0008-5472.CAN-07-1077; Risinger AL, 2008, CANCER RES, V68, P8881, DOI 10.1158/0008-5472.CAN-08-2037; Rubin EH, 2005, J CLIN ONCOL, V23, P9120, DOI 10.1200/JCO.2005.03.0981; Seve P, 2008, LANCET ONCOL, V9, P168, DOI 10.1016/S1470-2045(08)70029-9; Vansteenkiste J, 2007, J CLIN ONCOL, V25, DOI 10.1200/JCO.2006.09.7097; Verrills NM, 2003, CHEM BIOL, V10, P597, DOI 10.1016/S1074-5521(03)00141-8; Yang CPH, 2005, MOL CANCER THER, V4, P987, DOI 10.1158/1535-7163.MCT-05-0024; Yang HL, 2007, J BIOL CHEM, V282, P27058, DOI 10.1074/jbc.M704101200	31	35	37	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2011	6	6							e21717	10.1371/journal.pone.0021717	http://dx.doi.org/10.1371/journal.pone.0021717			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786FZ	21738778	Green Published, Green Submitted, gold			2022-12-27	WOS:000292290100063
J	Froelich, S; Tai, A; Kennedy, K; Zubair, A; Wang, P				Froelich, Steven; Tai, April; Kennedy, Katie; Zubair, Adnan; Wang, Pin			Virus-Receptor Mediated Transduction of Dendritic Cells by Lentiviruses Enveloped with Glycoproteins Derived from Semliki Forest Virus	PLOS ONE			English	Article							MOLECULE 3-GRABBING NONINTEGRIN; HUMAN-IMMUNODEFICIENCY-VIRUS; DC-SIGN; IN-VIVO; CANCER-IMMUNOTHERAPY; HIV-1 INFECTION; T-LYMPHOCYTES; VECTORS; TRANSMISSION; EXPRESSION	Lentiviruses have recently attracted considerable interest for their potential as a genetic modification tool for dendritic cells (DCs). In this study, we explore the ability of lentiviruses enveloped with alphaviral envelope glycoproteins derived from Semliki Forest virus (SFV) to mediate transduction of DCs. We found that SFV glycoprotein (SFV-G)-pseudotyped lentiviruses use C-type lectins (DC-SIGN and L-SIGN) as attachment factors for transduction of DCs. Importantly, SFV-G pseudotypes appear to have enhanced transduction towards C-type lectin-expressing cells when produced under conditions limiting glycosylation to simple high-mannose, N-linked glycans. These results, in addition to the natural DC tropism of SFV-G, offer evidence to support the use of SFV-G-bearing lentiviruses to genetically modify DCs for the study of DC biology and DC-based immunotherapy.	[Froelich, Steven; Tai, April; Kennedy, Katie; Zubair, Adnan; Wang, Pin] Univ So Calif, Mork Family Dept Chem Engn & Mat Sci, Los Angeles, CA 90089 USA; [Wang, Pin] Univ So Calif, Dept Biomed Engn, Los Angeles, CA 90089 USA; [Wang, Pin] Univ So Calif, Dept Pharmacol & Pharmaceut Sci, Los Angeles, CA USA	University of Southern California; University of Southern California; University of Southern California	Froelich, S (corresponding author), Univ So Calif, Mork Family Dept Chem Engn & Mat Sci, Los Angeles, CA 90089 USA.	pinwang@usc.edu			U.S. National Institute of Health [R01AI68978, P01CA132681]; California HIV/AIDS Research Program [ID09-USC-027]; NATIONAL CANCER INSTITUTE [P01CA132681] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI068978] Funding Source: NIH RePORTER	U.S. National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); California HIV/AIDS Research Program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants from the U.S. National Institute of Health (R01AI68978 and P01CA132681) and California HIV/AIDS Research Program (ID09-USC-027). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baribaud F, 2002, J VIROL, V76, P9135, DOI 10.1128/JVI.76.18.9135-9142.2002; Bashirova AA, 2001, J EXP MED, V193, P671, DOI 10.1084/jem.193.6.671; Braet Filip, 2002, Comp Hepatol, V1, P1, DOI 10.1186/1476-5926-1-1; Breckpot K, 2003, J GENE MED, V5, P654, DOI 10.1002/jgm.400; Cronin J, 2005, CURR GENE THER, V5, P387, DOI 10.2174/1566523054546224; Davis CW, 2006, J VIROL, V80, P1290, DOI 10.1128/JVI.80.3.1290-1301.2006; Dullaers M, 2006, J GENE MED, V8, P3, DOI 10.1002/jgm.846; Dyall J, 2001, BLOOD, V97, P114, DOI 10.1182/blood.V97.1.114; Esslinger C, 2003, J CLIN INVEST, V111, P1673, DOI 10.1172/JCI200317098; Figdor CG, 2002, NAT REV IMMUNOL, V2, P77, DOI 10.1038/nri723; Firat H, 2002, J GENE MED, V4, P38, DOI 10.1002/jgm.243; Froelich S, 2010, IMMUNOPHARM IMMUNOT, V32, P208, DOI 10.3109/08923970903420582; FUHRMANN U, 1984, NATURE, V307, P755, DOI 10.1038/307755a0; Gruber A, 2000, BLOOD, V96, P1327, DOI 10.1182/blood.V96.4.1327.h8001327_1327_1333; Halary F, 2002, IMMUNITY, V17, P653, DOI 10.1016/S1074-7613(02)00447-8; Hu BL, 2011, IMMUNOL REV, V239, P45, DOI 10.1111/j.1600-065X.2010.00967.x; Joo KI, 2008, GENE THER, V15, P1384, DOI 10.1038/gt.2008.87; Kahl CA, 2004, J VIROL, V78, P1421, DOI 10.1128/JVI.78.3.1421-1430.2004; Klimstra WB, 2003, J VIROL, V77, P12022, DOI 10.1128/JVI.77.22.12022-12032.2003; Kwon DS, 2002, IMMUNITY, V16, P135, DOI 10.1016/S1074-7613(02)00259-5; Lin G, 2003, J VIROL, V77, P1337, DOI 10.1128/JVI.77.2.1337-1346.2003; Lizee G, 2004, HUM GENE THER, V15, P393, DOI 10.1089/104303404322959542; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; Lozach Pierre-Yves, 2007, Methods Mol Biol, V379, P51; Lozach PY, 2005, J BIOL CHEM, V280, P23698, DOI 10.1074/jbc.M504337200; Lozach PY, 2003, J BIOL CHEM, V278, P20358, DOI 10.1074/jbc.M301284200; Mancini EJ, 2000, MOL CELL, V5, P255, DOI 10.1016/S1097-2765(00)80421-9; Marzi A, 2007, J INFECT DIS, V196, pS237, DOI 10.1086/520607; Metharom P, 2001, HUM GENE THER, V12, P2203, DOI 10.1089/10430340152710540; Mitchell DA, 2001, J BIOL CHEM, V276, P28939, DOI 10.1074/jbc.M104565200; Morizono K, 2010, J VIROL, V84, P6923, DOI 10.1128/JVI.00435-10; Obermaier Bianca, 2003, Biol Proced Online, V5, P197, DOI 10.1251/bpo62; Oki M, 2001, EXP HEMATOL, V29, P1210, DOI 10.1016/S0301-472X(01)00695-6; Palmowski MJ, 2004, J IMMUNOL, V172, P1582, DOI 10.4049/jimmunol.172.3.1582; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; Ribas Antoni, 2002, Current Gene Therapy, V2, P57, DOI 10.2174/1566523023348129; SCHLEGEL R, 1983, CELL, V32, P639, DOI 10.1016/0092-8674(83)90483-X; Schroder ARW, 2002, CELL, V110, P521, DOI 10.1016/S0092-8674(02)00864-4; Simmons G, 2002, J VIROL, V76, P2518, DOI 10.1128/JVI.76.5.2518-2528.2002; Soilleux EJ, 2003, CLIN SCI, V104, P437, DOI 10.1042/CS20020092; Song W, 1997, J EXP MED, V186, P1247, DOI 10.1084/jem.186.8.1247; Strang BL, 2005, J VIROL, V79, P1765, DOI 10.1128/JVI.79.3.1765-1771.2005; STRAUSS JH, 1994, MICROBIOL REV, V58, P491, DOI 10.1128/MMBR.58.3.491-562.1994; Sumimoto H, 2002, J IMMUNOL METHODS, V271, P153, DOI 10.1016/S0022-1759(02)00342-3; Trumpfheller C, 2003, INT IMMUNOL, V15, P289, DOI 10.1093/intimm/dxg030; Unutmaz D, 1999, J EXP MED, V189, P1735, DOI 10.1084/jem.189.11.1735; Wu L, 2004, VIROLOGY, V318, P17, DOI 10.1016/j.virol.2003.09.028; Yang L, 2008, NAT BIOTECHNOL, V26, P326, DOI 10.1038/nbt1390; Zarei S, 2004, J VIROL, V78, P7843, DOI 10.1128/JVI.78.14.7843-7845.2004; Zarei S, 2002, J ALLERGY CLIN IMMUN, V109, P988, DOI 10.1067/mai.2002.124663	50	8	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2011	6	6							e21491	10.1371/journal.pone.0021491	http://dx.doi.org/10.1371/journal.pone.0021491			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	783OD	21738680	Green Published, gold			2022-12-27	WOS:000292092600046
J	Minard, LV; Lin, LJ; Schultz, MC				Minard, Laura V.; Lin, Ling-ju; Schultz, Michael C.			SWI/SNF and Asf1 Independently Promote Derepression of the DNA Damage Response Genes under Conditions of Replication Stress	PLOS ONE			English	Article							HISTONE CHAPERONE ASF1; CHROMATIN REMODELING COMPLEX; TRANSCRIPTIONAL ACTIVATION; YEAST PHO5; EVICTION; DELETION; GENOME; RECRUITMENT; DISRUPTION; STRAINS	The histone chaperone Asf1 and the chromatin remodeler SWI/SNF have been separately implicated in derepression of the DNA damage response (DDR) genes in yeast cells treated with genotoxins that cause replication interference. Using genetic and biochemical approaches, we have tested if derepression of the DDR genes in budding yeast involves functional interplay between Asf1 and SWI/SNF. We find that Asf1 and SWI/SNF are both recruited to DDR genes under replication stress triggered by hydroxyurea, and have detected a soluble complex that contains Asf1 and the Snf2 subunit of SWI/SNF. SWI/SNF recruitment to DDR genes however does not require Asf1, and deletion of Snf2 does not affect Asf1 occupancy of DDR gene promoters. A checkpoint engagement defect is sufficient to explain the synthetic effect of deletion of ASF1 and SNF2 on derepression of the DDR genes in hydroxyurea-treated cells. Collectively, our results show that the DDR genes fall into a class in which Asf1 and SWI/SNF independently control transcriptional induction.	[Minard, Laura V.; Lin, Ling-ju; Schultz, Michael C.] Univ Alberta, Dept Biochem, Sch Mol & Syst Med, Fac Med & Dent, Edmonton, AB, Canada	University of Alberta	Minard, LV (corresponding author), Univ Alberta, Dept Biochem, Sch Mol & Syst Med, Fac Med & Dent, Edmonton, AB, Canada.	michael.schultz@ualberta.ca			Canadian Institutes of Health Research (CIHR); Alberta Heritage Foundation for Medical Research (AHFMR); QEII; Government of Canada (CIHR); Government of Canada (Natural Science and Engineering Research Council of Canada)	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Alberta Heritage Foundation for Medical Research (AHFMR)(Alberta Heritage Foundation for Medical Research); QEII; Government of Canada (CIHR)(Canadian Institutes of Health Research (CIHR)); Government of Canada (Natural Science and Engineering Research Council of Canada)(Natural Sciences and Engineering Research Council of Canada (NSERC))	Operating support for this work was provided by grants to M. C. S. from the Canadian Institutes of Health Research (CIHR) and the Alberta Heritage Foundation for Medical Research (AHFMR). Personnel support was provided by the Government of Alberta (AHFMR Research Scientist Award to M. C. S.; QEII Scholarships to L. V. M. and L. L.) and the Government of Canada (Master's Award from the CIHR and a scholarship from the Natural Science and Engineering Research Council of Canada to L. V. M.). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adkins MW, 2007, MOL CELL BIOL, V27, P6372, DOI 10.1128/MCB.00981-07; Adkins MW, 2004, MOL CELL, V14, P657, DOI 10.1016/j.molcel.2004.05.016; Basrai MA, 1999, MOL CELL BIOL, V19, P7041; Brachmann CB, 1998, YEAST, V14, P115; Burgess RJ, 2010, MOL CELL, V37, P469, DOI 10.1016/j.molcel.2010.01.020; Chai B, 2005, GENE DEV, V19, P1656, DOI 10.1101/gad.1273105; Collins SR, 2007, NATURE, V446, P806, DOI 10.1038/nature05649; De Koning L, 2007, NAT STRUCT MOL BIOL, V14, P997, DOI 10.1038/nsmb1318; Driscoll R, 2007, SCIENCE, V315, P649, DOI 10.1126/science.1135862; Dror V, 2004, MOL CELL BIOL, V24, P8227, DOI 10.1128/MCB.24.18.8227-8235.2004; Durr H, 2006, NUCLEIC ACIDS RES, V34, P4160, DOI 10.1093/nar/gkl540; Emili A, 2001, MOL CELL, V7, P13, DOI 10.1016/S1097-2765(01)00150-2; Flanagan JF, 1999, NUCLEIC ACIDS RES, V27, P2022, DOI 10.1093/nar/27.9.2022; Friis RMN, 2009, NUCLEIC ACIDS RES, V37, P3969, DOI 10.1093/nar/gkp270; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Goldstein AL, 1999, YEAST, V15, P1541, DOI 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.3.CO;2-B; Gong F, 2006, NAT STRUCT MOL BIOL, V13, P902, DOI 10.1038/nsmb1152; Gray M, 2001, NUCLEIC ACIDS RES, V29, P5156, DOI 10.1093/nar/29.24.5156; Han JH, 2007, SCIENCE, V315, P653, DOI 10.1126/science.1133234; Holstege FCP, 1998, CELL, V95, P717, DOI 10.1016/S0092-8674(00)81641-4; Hu FH, 2001, GENE DEV, V15, P1061, DOI 10.1101/gad.873201; Huang MX, 1997, MOL CELL BIOL, V17, P6105, DOI 10.1128/MCB.17.10.6105; Kobor MS, 2004, PLOS BIOL, V2, P587, DOI 10.1371/journal.pbio.0020131; Korber P, 2006, J BIOL CHEM, V281, P5539, DOI 10.1074/jbc.M513340200; LAURENT BC, 1993, GENE DEV, V7, P583, DOI 10.1101/gad.7.4.583; Lee KK, 2004, BIOCHEM SOC T, V32, P899, DOI 10.1042/BST0320899; Lin LJ, 2010, MOL CELL BIOL, V30, P1116, DOI 10.1128/MCB.01229-09; Logie C, 1997, EMBO J, V16, P6772, DOI 10.1093/emboj/16.22.6772; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Minard LV, 2011, J BIOL CHEM, V286, P7082, DOI 10.1074/jbc.M110.193813; Moshkin YM, 2002, GENE DEV, V16, P2621, DOI 10.1101/gad.231202; OwenHughes T, 1996, EMBO J, V15, P4702, DOI 10.1002/j.1460-2075.1996.tb00847.x; Park YJ, 2008, CURR OPIN STRUC BIOL, V18, P282, DOI 10.1016/j.sbi.2008.04.003; Phelan ML, 1999, MOL CELL, V3, P247, DOI 10.1016/S1097-2765(00)80315-9; Pondugula S, 2009, MOL CELL BIOL, V29, P4891, DOI 10.1128/MCB.00222-09; Ramaswamy V, 2003, MOL CELL BIOL, V23, P9136, DOI 10.1128/MCB.23.24.9136-9149.2003; Rocha W, 2008, FEBS LETT, V582, P1938, DOI 10.1016/j.febslet.2008.03.006; Schermer UJ, 2005, MOL CELL, V19, P279, DOI 10.1016/j.molcel.2005.05.028; Schwabish MA, 2007, MOL CELL BIOL, V27, P6987, DOI 10.1128/MCB.00717-07; Sharma VM, 2003, GENE DEV, V17, P502, DOI 10.1101/gad.1039503; SIKORSKI RS, 1989, GENETICS, V122, P19; Spry M, 2007, FRONT BIOSCI-LANDMRK, V12, P4191, DOI 10.2741/2380; Sudarsanam P, 2000, TRENDS GENET, V16, P345, DOI 10.1016/S0168-9525(00)02060-6; Sudarsanam P, 2000, P NATL ACAD SCI USA, V97, P3364, DOI 10.1073/pnas.050407197; Takahata S, 2009, MOL CELL, V34, P405, DOI 10.1016/j.molcel.2009.04.010; Tercero JA, 2003, MOL CELL, V11, P1323, DOI 10.1016/S1097-2765(03)00169-2; TRECO DA, 1993, CURRENT PROTOCOLS MO; Tyler JK, 1999, NATURE, V402, P555, DOI 10.1038/990147; van Vugt JJFA, 2007, BBA-GENE STRUCT EXPR, V1769, P153, DOI 10.1016/j.bbaexp.2007.01.013; Versteege I, 1998, NATURE, V394, P203, DOI 10.1038/28212; Weissman B, 2009, CANCER RES, V69, P8223, DOI 10.1158/0008-5472.CAN-09-2166; Williams SK, 2007, CURR OPIN GENET DEV, V17, P88, DOI 10.1016/j.gde.2007.02.001; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Yoon S, 2003, MOL CELL BIOL, V23, P8829, DOI 10.1128/MCB.23.23.8829-9945.2003; Zabaronick SR, 2005, MOL CELL BIOL, V25, P652, DOI 10.1128/MCB.25.2.652-660.2005; Zhang Z, 2005, MOL CELL BIOL, V25, P7399, DOI 10.1128/MCB.25.17.7399-7411.2005	56	7	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2011	6	6							e21633	10.1371/journal.pone.0021633	http://dx.doi.org/10.1371/journal.pone.0021633			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	783OD	21738741	Green Published, Green Submitted, gold			2022-12-27	WOS:000292092600066
J	Scheider, L; Grassmann, S; Kaminski, J; Tomasello, M				Scheider, Linda; Grassmann, Susanne; Kaminski, Juliane; Tomasello, Michael			Domestic Dogs Use Contextual Information and Tone of Voice when following a Human Pointing Gesture	PLOS ONE			English	Article							CANIS-FAMILIARIS; HIDDEN FOOD; CUES	Domestic dogs are skillful at using the human pointing gesture. In this study we investigated whether dogs take contextual information into account when following pointing gestures, specifically, whether they follow human pointing gestures more readily in the context in which food has been found previously. Also varied was the human's tone of voice as either imperative or informative. Dogs were more sustained in their searching behavior in the 'context' condition as opposed to the 'no context' condition, suggesting that they do not simply follow a pointing gesture blindly but use previously acquired contextual information to inform their interpretation of that pointing gesture. Dogs also showed more sustained searching behavior when there was pointing than when there was not, suggesting that they expect to find a referent when they see a human point. Finally, dogs searched more in high-pitched informative trials as opposed to the low-pitched imperative trials, whereas in the latter dogs seemed more inclined to respond by sitting. These findings suggest that a dog's response to a pointing gesture is flexible and depends on the context as well as the human's tone of voice.	[Scheider, Linda; Kaminski, Juliane; Tomasello, Michael] Max Planck Inst Evolutionary Anthropol, Dept Dev & Comparat Psychol, Leipzig, Germany; [Grassmann, Susanne] Univ Groningen, Dept Dev Psychol, Groningen, Netherlands	Max Planck Society; University of Groningen	Scheider, L (corresponding author), Max Planck Inst Evolutionary Anthropol, Dept Dev & Comparat Psychol, Leipzig, Germany.	scheider@eva.mpg.de		grassmann, susanne/0000-0003-3421-5600; Kaminski, Juliane/0000-0002-3437-3484	Volkswagenstiftung; Max Planck Gesellschaft	Volkswagenstiftung(Volkswagen); Max Planck Gesellschaft(Max Planck Society)	Juliane Kaminski was funded by a grant from the Volkswagenstiftung (http://www.volkswagen-stiftung.de/), and Linda Scheider was funded by a stipend from the Max Planck Gesellschaft (http://www.mpg.de/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnetta B., 2000, ANIMAL COGNITION, V3, P107, DOI [10.1007/s100710000070, DOI 10.1007/S100710000070, DOI 10.1177/0963721416667718]; Brauer J, 2006, J COMP PSYCHOL, V120, P38, DOI 10.1037/0735-7036.120.1.38; Fukuzawa M, 2005, J COMP PSYCHOL, V119, P117, DOI 10.1037/0735-7036.119.1.117; FUKUZAWA M, 2004, P 38 INT C INT SOC A, P237; Hare B, 1999, J COMP PSYCHOL, V113, P173, DOI 10.1037/0735-7036.113.2.173; Hare B., 1998, EVOL COMMUN, V2, P137; Miklosi A, 2005, J COMP PSYCHOL, V119, P179, DOI 10.1037/0735-7036.119.2.179; Miklosi A, 1998, Anim Cogn, V1, P113, DOI 10.1007/s100710050016; Miklosi A, 2006, ANIM COGN, V9, P81, DOI 10.1007/s10071-005-0008-1; Soproni K, 2002, J COMP PSYCHOL, V116, P27, DOI 10.1037//0735-7036.116.1.27; Soproni K, 2001, J COMP PSYCHOL, V115, P122, DOI 10.1037//0735-7036.115.2.122; Szetei V, 2003, APPL ANIM BEHAV SCI, V83, P141, DOI 10.1016/S0168-1591(03)00114-X; Udell MAR, 2010, ANIM BEHAV, V79, pE9, DOI 10.1016/j.anbehav.2009.11.033; Wynne CDL, 2008, ANIM BEHAV, V76, pE1, DOI 10.1016/j.anbehav.2008.03.010	14	66	67	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2011	6	7							e21676	10.1371/journal.pone.0021676	http://dx.doi.org/10.1371/journal.pone.0021676			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	792WQ	21765904	Green Published, gold, Green Submitted			2022-12-27	WOS:000292781500009
J	Theves, C; Senescau, A; Vanin, S; Keyser, C; Ricaut, FX; Alekseev, AN; Dabernat, H; Ludes, B; Fabre, R; Crubezy, E				Theves, Catherine; Senescau, Alice; Vanin, Stefano; Keyser, Christine; Ricaut, Francois Xavier; Alekseev, Anatoly N.; Dabernat, Henri; Ludes, Bertrand; Fabre, Richard; Crubezy, Eric			Molecular Identification of Bacteria by Total Sequence Screening: Determining the Cause of Death in Ancient Human Subjects	PLOS ONE			English	Article							YERSINIA-PESTIS; DNA; PERMAFROST; EVOLUTION; INSIGHTS; SEARCH	Research of ancient pathogens in ancient human skeletons has been mainly carried out on the basis of one essential historical or archaeological observation, permitting specific pathogens to be targeted. Detection of ancient human pathogens without such evidence is more difficult, since the quantity and quality of ancient DNA, as well as the environmental bacteria potentially present in the sample, limit the analyses possible. Using human lung tissue and/or teeth samples from burials in eastern Siberia, dating from the end of 17(th) to the 19(th) century, we propose a methodology that includes the: 1) amplification of all 16S rDNA gene sequences present in each sample; 2) identification of all bacterial DNA sequences with a degree of identity >= 95%, according to quality criteria; 3) identification and confirmation of bacterial pathogens by the amplification of the rpoB gene; and 4) establishment of authenticity criteria for ancient DNA. This study demonstrates that from teeth samples originating from ancient human subjects, we can realise: 1) the correct identification of bacterial molecular sequence signatures by quality criteria; 2) the separation of environmental and pathogenic bacterial 16S rDNA sequences; 3) the distribution of bacterial species for each subject and for each burial; and 4) the characterisation of bacteria specific to the permafrost. Moreover, we identified three pathogens in different teeth samples by 16S rDNA sequence amplification: Bordetella sp., Streptococcus pneumoniae and Shigella dysenteriae. We tested for the presence of these pathogens by amplifying the rpoB gene. For the first time, we confirmed sequences from Bordetella pertussis in the lungs of an ancient male Siberian subject, whose grave dated from the end of the 17(th) century to the early 18(th) century.	[Theves, Catherine; Keyser, Christine; Ricaut, Francois Xavier; Dabernat, Henri; Ludes, Bertrand; Crubezy, Eric] Univ Strasbourg, CNRS, Univ Toulouse 3, Lab AMIS,UMR 5288, Toulouse, France; [Theves, Catherine; Senescau, Alice; Fabre, Richard] Lab Bio Pole, Toulouse, France; [Vanin, Stefano] Univ Huddersfield, Dept Chem & Biol Sci, Huddersfield HD1 3DH, W Yorkshire, England; [Ludes, Bertrand] Inst Med Legale, F-67085 Strasbourg, France; [Alekseev, Anatoly N.] NE Fed Univ, Yakutsk, Sakha Yakutia R, Russia; [Dabernat, Henri] Fac Med Toulouse, Bacteriol Lab, Toulouse, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; University of Huddersfield; North-Eastern Federal University in Yakutsk	Theves, C (corresponding author), Univ Strasbourg, CNRS, Univ Toulouse 3, Lab AMIS,UMR 5288, Toulouse, France.	ctheves@cict.fr	Ricaut, Francois Xavier/G-1206-2010; LUDES, Bertrand/AAB-6309-2022; Crubézy, Eric/AAB-5165-2022; Alekseev, Anatoliy Nickolaevich/O-1096-2015	Crubézy, Eric/0000-0001-9417-9053; Alekseev, Anatoliy Nickolaevich/0000-0002-9488-573X; /0000-0002-3854-4420; RICAUT, Francois-Xavier/0000-0001-7609-7898; Vanin, Stefano/0000-0003-1676-5916	Bonus Qualite Recherche (BQR) of the University Paul Sabatier, Toulouse, France; Institut Polaire Emile Victor (IPEV); Ministere des Affaires Etrangeres - MAE, France	Bonus Qualite Recherche (BQR) of the University Paul Sabatier, Toulouse, France; Institut Polaire Emile Victor (IPEV); Ministere des Affaires Etrangeres - MAE, France	This project was funded by Bonus Qualite Recherche (BQR) of the University Paul Sabatier, Toulouse, France (www.ups-tlse.fr/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The Institut Polaire Emile Victor (IPEV) and the COSIE program (Ministere des Affaires Etrangeres - MAE, France) permitted and funded the program. The administrative and research aspects of the project were made through the collaboration between the University Paul Sabatier (Toulouse, France) and the North-eastern Federal University (Yakutsk University). We thank Prof. Drancourt for his advice during discussions; Catherine Cannet for her discussions on histological sections and tissue preservation; Lenka Tisseyre, Laure Tonasso and Aurelie Marchet for their technical assistance; Patrice Gerard for producing the maps and charts; Marie Marty (Laboratoire TRACES, Toulouse, CNRS) and Olga Menitchouk (North-eastern Federal University) for the Institutional collaboration, Patricia Balaresque for her for pertinent comments during the redaction of the paper and Becky Coles for the translated manuscript. We thank reviewers for their valuable comments to improve this manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bakermans C, 2006, INT J SYST EVOL MICR, V56, P1285, DOI 10.1099/ijs.0.64043-0; Castillo-Rojas G, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-119; Cooper A, 2000, SCIENCE, V289, P1139; Corless CE, 2000, J CLIN MICROBIOL, V38, P1747, DOI 10.1128/JCM.38.5.1747-1752.2000; Crubezy E, 2007, CHAMANE KYSS JEUNE F; Crubezy E, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-25; Diavatopoulos DA, 2005, PLOS PATHOG, V1, P373, DOI 10.1371/journal.ooat.0010045; Drancourt M, 2005, NAT REV MICROBIOL, V3, P23, DOI 10.1038/nrmicro1063; Drancourt M, 2004, EMERG INFECT DIS, V10, P1585, DOI 10.3201/eid1009.030933; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; Gilbert MTP, 2007, NUCLEIC ACIDS RES, V35, P1, DOI 10.1093/nar/gkl483; Gilbert MTP, 2005, TRENDS ECOL EVOL, V20, P541, DOI 10.1016/j.tree.2005.07.005; Gilbert MTP, 2004, MICROBIOL-SGM, V150, P341, DOI 10.1099/mic.0.26594-0; Gilichinsky DA, 2007, ASTROBIOLOGY, V7, P275, DOI 10.1089/ast.2006.0012; Gross R, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-449; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Haensch S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001134; Hershkovitz I, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003426; Ho SYW, 2010, MITOCHONDRION, V10, P1, DOI 10.1016/j.mito.2009.09.005; Hofreiter M, 2001, NUCLEIC ACIDS RES, V29, P4793, DOI 10.1093/nar/29.23.4793; Hofreiter M, 2008, CR PALEVOL, V7, P113, DOI 10.1016/j.crpv.2007.12.005; JUKES T H, 1969, P21; Keyser C, 2009, HUM GENET, V126, P395, DOI 10.1007/s00439-009-0683-0; Keyser-Tracqui Christine, 2005, V297, P253; Marchler-Bauer A, 2004, NUCLEIC ACIDS RES, V32, pW327, DOI 10.1093/nar/gkh454; Marchler-Bauer A, 2009, NUCLEIC ACIDS RES, V37, pD205, DOI 10.1093/nar/gkn845; Parkhill J, 2003, NAT GENET, V35, P32, DOI 10.1038/ng1227; Petrosino JF, 2009, CLIN CHEM, V55, P856, DOI 10.1373/clinchem.2008.107565; Poinar HN, 2006, SCIENCE, V311, P392, DOI 10.1126/science.1123360; Raoult D, 2000, P NATL ACAD SCI USA, V97, P12800, DOI 10.1073/pnas.220225197; Ricaut FX, 2005, FORENSIC SCI INT, V151, P31, DOI 10.1016/j.forsciint.2004.07.001; Rodrigues DF, 2006, EXTREMOPHILES, V10, P285, DOI 10.1007/s00792-005-0497-5; Rollo F, 1999, PHILOS T R SOC B, V354, P111, DOI 10.1098/rstb.1999.0364; Sampietro ML, 2006, MOL BIOL EVOL, V23, P1801, DOI 10.1093/molbev/msl047; Stiller M, 2006, P NATL ACAD SCI USA, V103, P13578, DOI 10.1073/pnas.0605327103; Stinear TP, 2008, GENOME RES, V18, P729, DOI 10.1101/gr.075069.107; Strimmer K, 1997, MOL BIOL EVOL, V14, P210, DOI 10.1093/oxfordjournals.molbev.a025756; Strimmer K, 1996, MOL BIOL EVOL, V13, P964, DOI 10.1093/oxfordjournals.molbev.a025664; Swanston T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016864; Taylor GM, 2010, INT J OSTEOARCHAEOL, V20, P747, DOI 10.1002/oa.1077; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tran-Hung L, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001062; Vorobyova E.A., 2005, LIFE IN ANCIENT ICE, P277; Wiechmann I, 2005, AM J PHYS ANTHROPOL, V126, P48, DOI 10.1002/ajpa.10276; Willerslev E, 2004, TRENDS ECOL EVOL, V19, P141, DOI 10.1016/j.tree.2003.11.010	46	15	17	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2011	6	7							e21733	10.1371/journal.pone.0021733	http://dx.doi.org/10.1371/journal.pone.0021733			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	792WQ	21765907	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000292781500010
J	Kim, Y; Hollenbaugh, JA; Kim, DH; Kim, B				Kim, Yuri; Hollenbaugh, Joseph A.; Kim, Dong-Hyun; Kim, Baek			Novel PI3K/Akt Inhibitors Screened by the Cytoprotective Function of Human Immunodeficiency Virus Type 1 Tat	PLOS ONE			English	Article							PROTEIN-KINASE; COMPOUND K; CELLS; AKT; MACROPHAGES; CANCER; ACTIVATION; METABOLISM; EXPRESSION; INFECTION	The PI3K/Akt pathway regulates various stress-related cellular responses such as cell survival, cell proliferation, metabolism and protein synthesis. Many cancer cell types display the activation of this pathway, and compounds inhibiting this cell survival pathway have been extensively evaluated as anti-cancer agents. In addition to cancers, several human viruses, such as HTLV, HPV, HCV and HIV-1, also modulate this pathway, presumably in order to extend the life span of the infected target cells for productive viral replication. The expression of HIV-1 Tat protein exhibited the cytoprotective effect in macrophages and a human microglial cell line by inhibiting the negative regulator of this pathway, PTEN. This cytoprotective effect of HIV-1 appears to contribute to the long-term survival and persistent HIV-1 production in human macrophage reservoirs. In this study we exploited the PI3K/Akt dependent cytoprotective effect of Tat-expressing CHME5 cells. We screened a collection of compounds known to modulate inflammation, and identified three novel compounds: Lancemaside A, Compound K and Arctigenin that abolished the cytoprotective phenotype of Tat-expressing CHME5 cells. All three compounds antagonized the kinase activity of Akt. Further detailed signaling studies revealed that each of these three compounds targeted different steps of the PI3K/Akt pathway. Arctigenin regulates the upstream PI3K enzyme from converting PIP2 to PIP3. Lancemaside A1 inhibited the movement of Akt to the plasma membrane, a critical step for Akt activation. Compound K inhibited Akt phosphorylation. This study supports that Tat-expressing CHME5 cells are an effective model system for screening novel PI3K/Akt inhibitors.	[Kim, Yuri; Kim, Dong-Hyun] Kyung Hee Univ, Dept Pharm, Seoul, South Korea; [Hollenbaugh, Joseph A.; Kim, Baek] Univ Rochester, Dept Microbiol & Immunol, Med Ctr Rochester, Rochester, NY USA	Kyung Hee University; University of Rochester	Kim, Y (corresponding author), Kyung Hee Univ, Dept Pharm, Seoul, South Korea.	baek_kim@urmc.rochester.edu; dhkim@khu.ac.kr			NIH [A1077401, T32 DA07232]; Ministry of Education, Science and Technology [R33-2008-000-10018-0]; NATIONAL INSTITUTE ON DRUG ABUSE [T32DA007232] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This study was supported by a grant from NIH A1077401 (BK), NIH grant T32 DA07232 (JAH), and World Class University Program through the National Research Foundation of Korea funded by the Ministry of Education, Science and Technology (R33-2008-000-10018-0). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Awale S, 2006, CANCER RES, V66, P1751, DOI 10.1158/0008-5472.CAN-05-3143; Bae EA, 2001, ARCH PHARM RES, V24, P297, DOI 10.1007/BF02975095; Borgatti P, 1997, EUR J IMMUNOL, V27, P2805, DOI 10.1002/eji.1830271110; Brown A, 2006, J LEUKOCYTE BIOL, V80, P1127, DOI 10.1189/jlb.0206126; Bunney TD, 2010, NAT REV CANCER, V10, P342, DOI 10.1038/nrc2842; Chang SY, 2009, BIOMOL THER, V17, P430, DOI 10.4062/biomolther.2009.17.4.430; Choo MK, 2003, PLANTA MED, V69, P518, DOI 10.1055/s-2003-40653; Chugh P, 2007, J MOL BIOL, V366, P67, DOI 10.1016/j.jmb.2006.11.011; Chugh P, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-11; Cosenza MA, 2004, NEUROPATH APPL NEURO, V30, P478, DOI 10.1111/j.1365-2990.2004.00563.x; Currie RA, 1999, BIOCHEM J, V337, P575, DOI 10.1042/0264-6021:3370575; Danial NN, 2008, ONCOGENE, V27, pS53, DOI 10.1038/onc.2009.44; Deregibus MC, 2002, J BIOL CHEM, V277, P25195, DOI 10.1074/jbc.M200921200; Ferte C, 2010, NAT REV CLIN ONCOL, V7, P367, DOI 10.1038/nrclinonc.2010.84; Gras G, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-30; Hernandez-Campos A, 2010, CHEM BIOL DRUG DES, V76, P269, DOI 10.1111/j.1747-0285.2010.01002.x; HU C, 2011, J CELL MOL MED; Irish BP, 2009, AM J INFECT DIS, V5, P231, DOI 10.3844/ajidsp.2009.231.258; Jeong A, 2010, BIOL PHARM BULL, V33, P945, DOI 10.1248/bpb.33.945; Joh EH, 2010, J CELL BIOCHEM, V111, P865, DOI 10.1002/jcb.22773; Joh EH, 2010, INT J COLORECTAL DIS, V25, P545, DOI 10.1007/s00384-009-0858-0; Kim DH, 1998, BIOL PHARM BULL, V21, P360; KIM DH, 1994, BIOL PHARM BULL, V17, P443, DOI 10.1248/bpb.17.443; Kim DY, 2009, J AGR FOOD CHEM, V57, P1532, DOI 10.1021/jf802867b; Kim D, 2010, J BIOL CHEM, V285, P8383, DOI 10.1074/jbc.M109.094060; Kim N, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001103; KOENIG S, 1986, SCIENCE, V233, P1089, DOI 10.1126/science.3016903; Komoto N, 2010, J NAT MED-TOKYO, V64, P321, DOI 10.1007/s11418-010-0415-8; Liu Y, 2001, ONCOGENE, V20, P2514, DOI 10.1038/sj.onc.1204364; Lucas A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013121; Noh KH, 2009, MOL THER, V17, P439, DOI 10.1038/mt.2008.255; Park SH, 2005, PLANTA MED, V71, P24, DOI 10.1055/s-2005-837746; SCHRIER RD, 1990, J VIROL, V64, P3280, DOI 10.1128/JVI.64.7.3280-3288.1990; Street A, 2004, J BIOL CHEM, V279, P12232, DOI 10.1074/jbc.M312245200; Tsai WJ, 2011, CHIN MED-UK, V6, DOI 10.1186/1749-8546-6-12; Vinciguerra M, 2008, ANN HEPATOL, V7, P192, DOI 10.1016/S1665-2681(19)31848-4; Wolf D, 2001, NAT MED, V7, P1217, DOI 10.1038/nm1101-1217; YAMADA N, 2011, PSYCHOPHARMACOLOGY B; YAO X, 2011, J CELL BIOCH; Zhang SY, 2010, CLIN CANCER RES, V16, P4325, DOI 10.1158/1078-0432.CCR-09-2990; ZHOU H, 2010, CURR PROTEIN PEPT SC	41	30	34	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2011	6	7							e21781	10.1371/journal.pone.0021781	http://dx.doi.org/10.1371/journal.pone.0021781			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791WM	21765914	Green Published, Green Submitted, gold			2022-12-27	WOS:000292699000011
J	Fenhammar, J; Andersson, A; Forestier, J; Weitzberg, E; Sollevi, A; Hjelmqvist, H; Frithiof, R				Fenhammar, Johan; Andersson, Andreas; Forestier, Jakob; Weitzberg, Eddie; Sollevi, Alf; Hjelmqvist, Hans; Frithiof, Robert			Endothelin Receptor A Antagonism Attenuates Renal Medullary Blood Flow Impairment in Endotoxemic Pigs	PLOS ONE			English	Article							PORCINE ENDOTOXEMIA; SEPTIC SHOCK; ETB-RECEPTOR; B RECEPTORS; TEZOSENTAN; RAT; MICROCIRCULATION; DYSFUNCTION; RESPONSES; PIGLETS	Background: Endothelin-1 is a potent endogenous vasoconstrictor that contributes to renal microcirculatory impairment during endotoxemia and sepsis. Here we investigated if the renal circulatory and metabolic effects of endothelin during endotoxemia are mediated through activation of endothelin-A receptors. Methods and Findings: A randomized experimental study was performed with anesthetized and mechanically ventilated pigs subjected to Escherichia coli endotoxin infusion for five hours. After two hours the animals were treated with the selective endothelin receptor type A antagonist TBC 3711 (2 mg.kg(-1), n = 8) or served as endotoxin-treated controls (n = 8). Renal artery blood flow, diuresis and creatinine clearance decreased in response to endotoxemia. Perfusion in the cortex, as measured by laser doppler flowmetry, was reduced in both groups, but TBC 3711 attenuated the decrease in the medulla (p = 0.002). Compared to control, TBC 3711 reduced renal oxygen extraction as well as cortical and medullary lactate/pyruvate ratios (p < 0.05) measured by microdialysis. Furthermore, TBC 3711 attenuated the decline in renal cortical interstitial glucose levels (p = 0.02) and increased medullary pyruvate levels (p = 0.03). Decreased creatinine clearance and oliguria were present in both groups without any significant difference. Conclusions: These results suggest that endothelin released during endotoxemia acts via endothelin A receptors to impair renal medullary blood flow causing ischemia. Reduced renal oxygen extraction and cortical levels of lactate by TBC 3711, without effects on cortical blood flow, further suggest additional metabolic effects of endothelin type A receptor activation in this model of endotoxin induced acute kidney injury.	[Fenhammar, Johan; Andersson, Andreas; Forestier, Jakob; Sollevi, Alf; Hjelmqvist, Hans] Karolinska Univ Hosp Huddinge, Dept Anaesthesiol & Intens Care, Stockholm, Sweden; [Fenhammar, Johan; Andersson, Andreas; Forestier, Jakob; Sollevi, Alf; Hjelmqvist, Hans] Karolinska Inst, Dept Clin Sci Intervent & Technol, Stockholm, Sweden; [Weitzberg, Eddie] Karolinska Inst, Sect Anaesthesiol & Intens Care, Dept Physiol & Pharmacol, Stockholm, Sweden; [Frithiof, Robert] Karolinska Inst, Dept Physiol & Pharmacol, Stockholm, Sweden	Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska Institutet; Karolinska Institutet	Fenhammar, J (corresponding author), Karolinska Univ Hosp Huddinge, Dept Anaesthesiol & Intens Care, Stockholm, Sweden.	johan.fenhammar@karolinska.se	Andersson, Andreas/AAP-6940-2021	Andersson, Andreas/0000-0001-8371-8920	Karolinska Institutet; Karolinska University Hospital; Lars Hierta Memorial Fund; Soderbergska Foundation	Karolinska Institutet(Karolinska Institutet); Karolinska University Hospital(Karolinska Institutet); Lars Hierta Memorial Fund; Soderbergska Foundation	This study has been financially supported by the Karolinska Institutet, Karolinska University Hospital, Lars Hierta Memorial Fund and Soderbergska Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson A, 2006, ACTA ANAESTH SCAND, V50, P1198, DOI 10.1111/j.1399-6576.2006.01140.x; Andersson A, 2010, BRIT J ANAESTH, V105, P640, DOI 10.1093/bja/aeq217; Andersson A, 2008, J SURG RES, V149, P138, DOI 10.1016/j.jss.2007.12.751; Bohr C, 1904, SKAND ARCH PHYSIOL, V16, P402, DOI 10.1111/j.1748-1716.1904.tb01382.x; Bugaj V, 2008, AM J PHYSIOL-RENAL, V295, pF1063, DOI 10.1152/ajprenal.90321.2008; Chen J, 2010, AM J PHYSIOL-RENAL, V298, pF1369, DOI 10.1152/ajprenal.00572.2009; Chin A, 2002, J PEDIATR SURG, V37, P482, DOI 10.1053/jpsu.2002.30871; Chvojka J, 2008, CRIT CARE, V12, DOI 10.1186/cc7164; Evans RG, 2001, J HYPERTENS, V19, P1789, DOI 10.1097/00004872-200110000-00013; EVANS RG, 2010, AM J PHYSL IN PRESS; Fenhammar J, 2008, ACTA ANAESTH SCAND, V52, P1385, DOI 10.1111/j.1399-6576.2008.01768.x; Fenhammar J, 2011, ANESTHESIOLOGY, V114, P1130, DOI 10.1097/ALN.0b013e31820b8b44; Frithiof R, 2011, ACTA ANAESTH SCAND, V55, P401, DOI 10.1111/j.1399-6576.2011.02406.x; FUKURODA T, 1994, BIOCHEM BIOPH RES CO, V199, P1461, DOI 10.1006/bbrc.1994.1395; HEMSEN A, 1991, ACTA PHYSIOL SCAND, V142, P1; KELLEY KW, 1973, J ANIM SCI, V36, P927; Kuklin V, 2005, CRIT CARE, V9, pR211, DOI 10.1186/cc3497; Levy B, 2005, LANCET, V365, P871, DOI 10.1016/S0140-6736(05)71045-X; Nakano D, 2008, AM J PHYSIOL-RENAL, V294, pF1205, DOI 10.1152/ajprenal.00578.2007; Nitescu N, 2008, SHOCK, V29, P402, DOI 10.1097/SHK.0b013e3181454118; Oldner A, 1999, BRIT J PHARMACOL, V127, P1793, DOI 10.1038/sj.bjp.0702736; Oldner A, 1998, GUT, V42, P696, DOI 10.1136/gut.42.5.696; Oldner A, 1996, SHOCK, V6, P188, DOI 10.1097/00024382-199609000-00006; Perreault T, 2001, PEDIATR RES, V50, P374, DOI 10.1203/00006450-200109000-00013; PITTET JF, 1991, ANN SURG, V213, P261, DOI 10.1097/00000658-199103000-00014; Sasser JM, 2007, J AM SOC NEPHROL, V18, P143, DOI 10.1681/ASN.2006030208; Schildroth J, 2011, NEPHROL DIAL TRANSPL, V26, P779, DOI 10.1093/ndt/gfq534; Schrier RW, 2004, NEW ENGL J MED, V351, P159, DOI 10.1056/NEJMra032401; SILLDORFF EP, 1995, J CLIN INVEST, V95, P2734, DOI 10.1172/JCI117976; Wanecek M, 1999, EUR J PHARMACOL, V386, P235, DOI 10.1016/S0014-2999(99)00774-8; Weitzberg E, 1996, BRIT J PHARMACOL, V118, P617, DOI 10.1111/j.1476-5381.1996.tb15446.x; Wu CD, 2004, J MED CHEM, V47, P1969, DOI 10.1021/jm030528p; YANAGISAWA M, 1988, NATURE, V332, P411, DOI 10.1038/332411a0; ZEIDEL ML, 1989, AM J PHYSIOL, V257, pC1101, DOI 10.1152/ajpcell.1989.257.6.C1101	34	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2011	6	7							e21534	10.1371/journal.pone.0021534	http://dx.doi.org/10.1371/journal.pone.0021534			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791IA	21760895	Green Published, Green Submitted, gold			2022-12-27	WOS:000292657200014
J	Chai, Y; Xu, HC; Wang, WX; Liu, B; Yang, DH; Fan, H; Song, FJ; Lu, ZX				Chai, Yun; Xu, Hancheng; Wang, Wenxin; Liu, Bing; Yang, Dehua; Fan, Hong; Song, Fujian; Lu, Zuxun			A Survey of Factors Associated with the Utilization of Community Health Centers for Managing Hypertensive Patients in Chengdu, China	PLOS ONE			English	Article							CHRONIC ILLNESS; SYSTEM REFORM; MANAGEMENT; DISEASES; CARE	Background: For decades the development of community health services has been emphasized in China to cope with the growing burden of chronic diseases by providing basic medical services. This survey aims at investigating factors associated with the use of Community Health Centers (CHCs) for the management of hypertensive patients in Chengdu, China. Methods: We used a systematic sampling method to select 2,030 patients with hypertension or diabetes registered in 29 CHCs in Chengdu in 2007. Researchers interviewed patients who consented to participate at their home. This paper reports findings from the survey of 1,716 hypertensive patients with completed questionnaires. Univariate analyses and multiple logistic regression analyses were conducted to explore factors influencing the use of CHCs for the management of hypertensive patients. Results: 81.4% of hypertensive patients regularly used CHCs for hypertension monitoring and treatment in Chengdu. Univariate analyses indicated that use of CHCs was associated with the education level, occupation, types of medical insurance, Body Mass Index(BMI), patients' knowledge on hypertension, awareness of CHCs functions, satisfaction of the service of CHCs. Multiple regression analyses found that use of CHCs was positively associated with the following factors: the Urban Resident Basic Medical Insurance(URBMI), knowledge on blood pressure, awareness of the sites in CHCs to measure blood pressure, awareness of having to take life-long antihypertensive medicine once the treatment started, awareness of the health records registration in CHCs, regular follow up, improved convenience of seeing doctor. Patients with professional job were less likely to use the services of CHCs. Conclusions: The use of CHCs for hypertension management could be increased by improving residents' knowledge on the monitoring and treatment of hypertension, and the awareness of CHCs functions. The CHCs could play an important role in providing medical care to low-income, unemployed and other disadvantaged patients with hypertension.	[Chai, Yun; Xu, Hancheng; Wang, Wenxin; Fan, Hong; Lu, Zuxun] Huazhong Univ Sci & Technol, Sch Publ Hlth, Tongji Med Coll, Wuhan 430074, Hubei, Peoples R China; [Chai, Yun; Liu, Bing] Hubei Univ Med, Original Yunyang Med Coll, Fac Publ Adm, Shiyan, Hubei, Peoples R China; [Yang, Dehua] Fourth People Hosp Chengdu, Chengdu, Sichuan, Peoples R China; [Song, Fujian] Univ E Anglia, Fac Hlth, Norwich NR4 7TJ, E Anglia, England; [Xu, Hancheng] Wuhan Univ Sci & Technol, Int Exchange & Cooperat Off, Wuhan, Hubei, Peoples R China	Huazhong University of Science & Technology; Hubei University of Medicine; University of East Anglia; Wuhan University of Science & Technology	Chai, Y (corresponding author), Huazhong Univ Sci & Technol, Sch Publ Hlth, Tongji Med Coll, Wuhan 430074, Hubei, Peoples R China.	Fujian.song@uea.ac.uk; luac6@163.com	Song, Fujian/B-3516-2013					Bodenheimer T, 2002, JAMA-J AM MED ASSOC, V288, P1775, DOI 10.1001/jama.288.14.1775; *CCDCP, 2009, REP CHRON DIS RISK F; *CCGMH, 2005, GUID PREV TREATM HIG; Dib HH, 2010, HEALTH PLACE, V16, P477, DOI 10.1016/j.healthplace.2009.12.005; HE J, 2009, LANCET; Jiang HL, 2009, HEALTH ECON, V18, pS107, DOI 10.1002/hec.1517; Li C, 2007, MODERN PREVENT MED, V34, P1242; Liu YL, 2008, LANCET, V372, P1914, DOI 10.1016/S0140-6736(08)61362-8; MENG Q, 2007, CHIN J HOSP ADM, V23, P14; *MIN HLTH PEOPL RE, 2003, AN REP NAT HLTH SERV, V4; *MOH, 2006, REP CHRON DIS CHIN; *MOH, 2008, 3 NAT SURV CAUS DEAT; Pan XL, 2006, BMC HEALTH SERV RES, V6, DOI 10.1186/1472-6963-6-93; Peng j, 2005, CHIN J HOSP ADM, V21, P464; Schmittdiel JA, 2006, ANN FAM MED, V4, P117, DOI 10.1370/afm.520; Wang LD, 2005, LANCET, V366, P1821, DOI 10.1016/S0140-6736(05)67344-8; Weingarten SR, 2002, BRIT MED J, V325, P925, DOI 10.1136/bmj.325.7370.925; Xu JL, 2010, RES ASTRON ASTROPHYS, V10, P151, DOI 10.1088/1674-4527/10/2/006; Xu J, 2010, J HUAZHONG U SCI-MED, V30, P141, DOI 10.1007/s11596-010-0201-6; Yang GH, 2008, LANCET, V372, P1697, DOI 10.1016/S0140-6736(08)61366-5; YE H, 2005, CHIN GEN PRAC, V8, P1990; Zhou JA, 2005, CHIN GEN PRAC, V8, P356; ZHOU X, 2006, CHIN GEN PRAC, V9, P559	23	12	12	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2011	6	7							e21718	10.1371/journal.pone.0021718	http://dx.doi.org/10.1371/journal.pone.0021718			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791HI	21750725	Green Published, Green Submitted, gold			2022-12-27	WOS:000292655400012
J	Feng, JY; Lu, L; Hua, C; Qin, L; Zhao, PW; Wang, J; Wang, Y; Li, WY; Shi, XD; Jiang, YF				Feng, Junyan; Lu, Lu; Hua, Cong; Qin, Ling; Zhao, Pingwei; Wang, Juan; Wang, Ye; Li, Wanyu; Shi, Xiaodong; Jiang, Yanfang			High Frequency of CD4(+)CXCR5(+) TFH Cells in Patients with Immune-Active Chronic Hepatitis B	PLOS ONE			English	Article							CYTOMETRIC BEAD ARRAY; NATURAL-KILLER-CELLS; REGULATORY T-CELLS; VIRUS-INFECTION; TRANSGENIC MICE; LIVER-INJURY; HISTORY; MARKERS; LYMPHOMA; DISEASE	Background: T follicular helper (TFH) cells are a special subpopulation of T helper cells and can regulate humoral immune responses. This study examined whether the frequency of CD4(+)CXCR5(+) TFH cells could be associated with active immunity in chronic hepatitis B (CHB) patients. Methodology and Findings: The frequencies of peripheral blood CD4(+)CXCR5(+) TFH cells, inducible T cell costimulator (ICOS), and/or programmed death 1 (PD-1) positive CD4(+)CXCR5(+) TFH cells in immune-active (IA), immune-tolerant (IT) CHB, and healthy controls (HC) were characterized by flow cytometry analysis. The effect of adevofir dipivoxil treatment on the frequency of CD4(+)CXCR5(+) TFH cells, the concentrations of serum IL-2, IFN-gamma, TNF-alpha, IL-4, IL-6, IL-10, IL-21, ALT, AST, HBsAg, HBsAb, HBeAg, HBeAb and HBV loads in IA patients were determined. The potential association of the frequency of CD4(+)CXCR5(+) TFH cells with clinical measures was analyzed. In addition, the frequency of splenic and liver CD4(+)CXCR5(+) TFH cells in HBV-transgenic mice was examined. We found that the frequency of CD4(+)CXCR5(+) TFH cells in IA patients was significantly higher than that of IT patients and HC, and the percentages of CD4(+)CXCR5(+) TFH in IA patients were positively correlated with AST. Furthermore, the percentages of ICOS+, PD-1(+), and ICOS+PD-1(+) in CD4(+)CXCR5(+) TFH cells in CHB patients were significantly higher than that of HC. Treatment with adefovir dipivoxil reduced the frequency of CD4(+)CXCR5(+) TFH, PD-1(+)CD4(+)CXCR5(+) TFH cells and the concentrations of HBsAg and HBeAg, but increased the concentrations of HBsAb, HBeAb, IL-2 and IFN-gamma in IA patients. Moreover, the frequency of splenic and liver CD4(+)CXCR5(+) TFH cells in HBV-transgenic mice was higher than that of wild-type controls. Conclusions: These data indicate that CD4(+)CXCR5(+) TFH cells may participate in the HBV-related immune responses and that high frequency of CD4(+)CXCR5(+) TFH cells may be a biomarker for the evaluation of active immune stage of CHB patients.	[Feng, Junyan; Lu, Lu; Hua, Cong; Qin, Ling; Zhao, Pingwei; Wang, Juan; Wang, Ye; Li, Wanyu; Shi, Xiaodong; Jiang, Yanfang] Jilin Univ, Dept Cent Lab, Hosp 1, Changchun 130023, Peoples R China	Jilin University	Feng, JY (corresponding author), Jilin Univ, Dept Cent Lab, Hosp 1, Changchun 130023, Peoples R China.	yanfangjiang@hotmail.com	Wang, Ye/GWQ-7482-2022		National Natural Science Foundation of China [30972610]; Jilin Province Science and Technology Agency [200705128]; Administration of Chinese Medicine of Jilin Province [08sys-086]; Health Department Research Projects in Jilin Province [2009Z054]; Jilin University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jilin Province Science and Technology Agency; Administration of Chinese Medicine of Jilin Province; Health Department Research Projects in Jilin Province; Jilin University(Jilin University)	This work supported by grants from the National Natural Science Foundation of China (No. 30972610), Jilin Province Science and Technology Agency (No. 200705128), the Subject of Chinese Medical Science and Technology Projects in Administration of Chinese Medicine of Jilin Province (08sys-086), the Health Department Research Projects in Jilin Province (2009Z054), the Cutting-edge Science and Interdisciplinary Innovation Projects of Jilin University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bandi P, 2010, ANTIMICROB AGENTS CH, V54, P749, DOI 10.1128/AAC.01101-09; Baumert TF, 2007, WORLD J GASTROENTERO, V13, P82, DOI 10.3748/wjg.v13.i1.82; Bertoletti A, 2006, J GEN VIROL, V87, P1439, DOI 10.1099/vir.0.81920-0; Chen YY, 2007, HEPATOLOGY, V46, P706, DOI 10.1002/hep.21872; Franzese O, 2005, J VIROL, V79, P3322, DOI 10.1128/JVI.79.6.3322-3328.2005; Ganem D, 2004, NEW ENGL J MED, V350, P1118, DOI 10.1056/NEJMra031087; Huang XY, 2009, J NEUROIMMUNOL, V211, P3, DOI 10.1016/j.jneuroim.2009.04.006; Jiang YF, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/143026; Jiang YF, 2011, CELL MOL IMMUNOL, V8, P75, DOI 10.1038/cmi.2010.37; Lai CL, 2007, J VIRAL HEPATITIS, V14, P6, DOI 10.1111/j.1365-2893.2007.00909.x; Laurent C, 2010, HAEMATOL-HEMATOL J, V95, P356, DOI 10.3324/haematol.2009.019133; Li A, 2010, CLIN VACCINE IMMUNOL, V17, P464, DOI 10.1128/CVI.00457-09; Linterman MA, 2010, SEMIN IMMUNOPATHOL, V32, P183, DOI 10.1007/s00281-009-0194-z; Rodriguez-Pinilla SM, 2008, AM J SURG PATHOL, V32, P1787, DOI 10.1097/PAS.0b013e31817f123e; Morgan E, 2004, CLIN IMMUNOL, V110, P252, DOI 10.1016/j.clim.2003.11.017; Pan Calvin Q, 2005, Int J Med Sci, V2, P36; Pelletier N, 2010, NAT IMMUNOL, V11, P1110, DOI 10.1038/ni.1954; Pesu Marko, 2010, Duodecim, V126, P2179; Pol S, 2006, PRESSE MED, V35, P308, DOI 10.1016/S0755-4982(06)74576-6; Rehermann B, 2005, NAT REV IMMUNOL, V5, P215, DOI 10.1038/nri1573; Pinilla SMR, 2009, AM J SURG PATHOL, V33, P81, DOI 10.1097/PAS.0b013e31818e52fe; Sallusto F, 2004, ANNU REV IMMUNOL, V22, P745, DOI 10.1146/annurev.immunol.22.012703.104702; Simpson N, 2010, ARTHRITIS RHEUM-US, V62, P234, DOI 10.1002/art.25032; Stoop JN, 2005, HEPATOLOGY, V41, P771, DOI 10.1002/hep.20649; Tarnok A, 2003, CLIN CHEM, V49, P1000, DOI 10.1373/49.6.1000; Wang FS, 2001, WORLD J GASTROENTERO, V7, P537; Ye P, 2008, WORLD J GASTROENTERO, V14, P4551, DOI 10.3748/wjg.14.4551; Yim HJ, 2006, HEPATOLOGY, V43, pS173, DOI 10.1002/hep.20956; Zhang Z, 2011, HEPATOLOGY, V53, P73, DOI 10.1002/hep.23977; 张春梅, 2009, [细胞与分子免疫学杂志, Chinese Journal of Cellular and Molecular Immunology], V25, P1063	30	56	68	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2011	6	7							e21698	10.1371/journal.pone.0021698	http://dx.doi.org/10.1371/journal.pone.0021698			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791HI	21750724	Green Submitted, Green Published, gold			2022-12-27	WOS:000292655400011
J	Fomchenko, EI; Dougherty, JD; Helmy, KY; Katz, AM; Pietras, A; Brennan, C; Huse, JT; Milosevic, A; Holland, EC				Fomchenko, Elena I.; Dougherty, Joseph D.; Helmy, Karim Y.; Katz, Amanda M.; Pietras, Alexander; Brennan, Cameron; Huse, Jason T.; Milosevic, Ana; Holland, Eric C.			Recruited Cells Can Become Transformed and Overtake PDGF-Induced Murine Gliomas In Vivo during Tumor Progression	PLOS ONE			English	Article							TRANSLATIONAL PROFILING APPROACH; GROWTH-FACTOR-RECEPTOR; STEM-CELLS; GLIAL PROGENITORS; CLONAL EVOLUTION; GLIOBLASTOMA; GRADE; PROLIFERATION; IDENTIFICATION; AMPLIFICATION	Background: Gliomas are thought to form by clonal expansion from a single cell-of-origin, and progression-associated mutations to occur in its progeny cells. Glioma progression is associated with elevated growth factor signaling and loss of function of tumor suppressors Ink4a, Arf and Pten. Yet, gliomas are cellularly heterogeneous; they recruit and trap normal cells during infiltration. Methodology/Principal Findings: We performed lineage tracing in a retrovirally mediated, molecularly and histologically accurate mouse model of hPDGFb-driven gliomagenesis. We were able to distinguish cells in the tumor that were derived from the cell-of-origin from those that were not. Phenotypic, tumorigenic and expression analyses were performed on both populations of these cells. Here we show that during progression of hPDGFb-induced murine gliomas, tumor suppressor loss can expand the recruited cell population not derived from the cell-of-origin within glioma microenvironment to dominate regions of the tumor, with essentially no contribution from the progeny of glioma cell-of-origin. Moreover, the recruited cells can give rise to gliomas upon transplantation and passaging, acquire polysomal expression profiles and genetic aberrations typically present in glioma cells rather than normal progenitors, aid progeny cells in glioma initiation upon transplantation, and become independent of PDGFR signaling. Conclusions/Significance: These results indicate that non-cell-of-origin derived cells within glioma environment in the mouse can be corrupted to become bona fide tumor, and deviate from the generally established view of gliomagenesis.	[Fomchenko, Elena I.; Helmy, Karim Y.; Katz, Amanda M.; Pietras, Alexander; Huse, Jason T.; Holland, Eric C.] Mem Sloan Kettering Canc Ctr, Dept Canc Biol & Genet, New York, NY 10021 USA; [Brennan, Cameron; Holland, Eric C.] Mem Sloan Kettering Canc Ctr, Dept Surg Neurosurg, New York, NY 10021 USA; [Brennan, Cameron; Holland, Eric C.] Mem Sloan Kettering Canc Ctr, Dept Neurol, New York, NY 10021 USA; [Dougherty, Joseph D.; Milosevic, Ana] Rockefeller Univ, Dept Mol Biol, New York, NY 10021 USA; [Huse, Jason T.] Mem Sloan Kettering Canc Ctr, Dept Human Oncol, New York, NY 10021 USA; [Huse, Jason T.] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10021 USA; [Huse, Jason T.] Mem Sloan Kettering Canc Ctr, Dept Pathogenesis, New York, NY 10021 USA; [Brennan, Cameron; Holland, Eric C.] Mem Sloan Kettering Canc Ctr, Brain Tumor Ctr, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Rockefeller University; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Fomchenko, EI (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Canc Biol & Genet, 1275 York Ave, New York, NY 10021 USA.	hollande@mskcc.org	Brennan, Cameron/R-7082-2019	Brennan, Cameron/0000-0003-4064-8891; Dougherty, Joseph/0000-0002-6385-3997; Pietras, Alexander/0000-0002-5783-9347	NIH [U54 CA126518, U54 CA143798]; Starr Foundation; Tegger Foundation; Swedish Research Council; NATIONAL CANCER INSTITUTE [U54CA143798, U54CA126518] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R00NS067239] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Starr Foundation; Tegger Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by NIH grants U54 CA126518, U54 CA143798 and the Starr Foundation. AP was supported by the Tegger Foundation and the Swedish Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldape KD, 2004, J NEUROPATH EXP NEUR, V63, P700, DOI 10.1093/jnen/63.7.700; [Anonymous], 2009, 2009 CBTRUS STAT REP; Assanah MC, 2009, GLIA, V57, P1835, DOI 10.1002/glia.20895; Assanah M, 2006, J NEUROSCI, V26, P6781, DOI 10.1523/JNEUROSCI.0514-06.2006; Becher OJ, 2008, CANCER RES, V68, P2241, DOI 10.1158/0008-5472.CAN-07-6350; Brennan C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007752; Calabrese C, 2007, CANCER CELL, V11, P69, DOI 10.1016/j.ccr.2006.11.020; Charles NA, 2010, CELL STEM CELL, V6, P6, DOI 10.1016/j.stem.2009.12.005; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Di Rocco F, 1998, NEUROSURGERY, V42, P341, DOI 10.1097/00006123-199802000-00080; Dong ZQ, 2002, HUM PATHOL, V33, P528, DOI 10.1053/hupa.2002.124784; Doyle JP, 2008, CELL, V135, P749, DOI 10.1016/j.cell.2008.10.029; FLEMING TP, 1992, CANCER RES, V52, P4550; Gagos S, 1996, CANCER GENET CYTOGEN, V90, P157, DOI 10.1016/S0165-4608(96)00049-0; Galli R, 2004, CANCER RES, V64, P7011, DOI 10.1158/0008-5472.CAN-04-1364; Gomori E, 2002, J NEUROPATH EXP NEUR, V61, P396; Heiman M, 2008, CELL, V135, P738, DOI 10.1016/j.cell.2008.10.028; HERMANSON M, 1992, CANCER RES, V52, P3213; Holland EC, 1998, P NATL ACAD SCI USA, V95, P1218, DOI 10.1073/pnas.95.3.1218; Holland EC, 2000, NAT GENET, V25, P55, DOI 10.1038/75596; Hu XY, 2005, NEOPLASIA, V7, P356, DOI 10.1593/neo.04595; Ivanova NB, 2002, SCIENCE, V298, P601, DOI 10.1126/science.1073823; Jackson EL, 2006, NEURON, V51, P187, DOI 10.1016/j.neuron.2006.06.012; Jelsma R K, 1967, Trans Am Neurol Assoc, V92, P90; Kattar MM, 1997, HUM PATHOL, V28, P1166, DOI 10.1016/S0046-8177(97)90255-0; Kleihues P, 1999, Neuro Oncol, V1, P44, DOI 10.1093/neuonc/1.1.44; Kleihues P, 2000, PATHOLOGY GENETICS T; Lee J, 2006, CANCER CELL, V9, P391, DOI 10.1016/j.ccr.2006.03.030; Lokker NA, 2002, CANCER RES, V62, P3729; Louis DN, 2001, AM J PATHOL, V159, P779, DOI 10.1016/S0002-9440(10)61750-6; McLendon R, 2006, RUSSELL RUBINSTEINS, V7th; Mueller W, 2001, BRAIN PATHOL, V11, P39; Nishikawa Ryo, 2004, Brain Tumor Pathol, V21, P53, DOI 10.1007/BF02484510; Park CC, 2000, J NEUROPATH EXP NEUR, V59, P1044, DOI 10.1093/jnen/59.12.1044; Phillips HS, 2006, CANCER CELL, V9, P157, DOI 10.1016/j.ccr.2006.02.019; Piccirillo SGM, 2009, ONCOGENE, V28, P1807, DOI 10.1038/onc.2009.27; Scherer HJ, 1940, BRAIN, V40, P631; Shih AH, 2004, CANCER RES, V64, P4783, DOI 10.1158/0008-5472.CAN-03-3831; Singh SK, 2003, CANCER RES, V63, P5821; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Smith JS, 1999, ONCOGENE, V18, P4144, DOI 10.1038/sj.onc.1202759; Smith JS, 2000, J NEUROPATH EXP NEUR, V59, P495, DOI 10.1093/jnen/59.6.495; Tchougounova E, 2007, ONCOGENE, V26, P6289, DOI 10.1038/sj.onc.1210455; Uhrbom L, 2004, NAT MED, V10, P1257, DOI 10.1038/nm1120; Yuan XP, 2004, ONCOGENE, V23, P9392, DOI 10.1038/sj.onc.1208311; Zhu JJ, 1997, AM J PATHOL, V151, P565	46	60	60	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2011	6	7							e20605	10.1371/journal.pone.0020605	http://dx.doi.org/10.1371/journal.pone.0020605			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791AK	21754979	gold, Green Published, Green Submitted			2022-12-27	WOS:000292632000003
J	Klouwenberg, PK; Sasi, P; Bashraheil, M; Awuondo, K; Bonten, M; Berkley, J; Marsh, K; Borrmann, S				Klouwenberg, Peter Klein; Sasi, Philip; Bashraheil, Mahfudh; Awuondo, Ken; Bonten, Marc; Berkley, James; Marsh, Kevin; Borrmann, Steffen			Temporal Association of Acute Hepatitis A and Plasmodium falciparum Malaria in Children	PLOS ONE			English	Article							CASE DEFINITIONS; B-VIRUS; INFECTION; TRANSMISSION; VIREMIA	Background: In sub-Saharan Africa, Plasmodium falciparum and hepatitis A (HAV) infections are common, especially in children. Co-infections with these two pathogens may therefore occur, but it is unknown if temporal clustering exists. Materials and Methods: We studied the pattern of co-infection of P. falciparum malaria and acute HAV in Kenyan children under the age of 5 years in a cohort of children presenting with uncomplicated P. falciparum malaria. HAV status was determined during a 3-month follow-up period. Discussion: Among 222 cases of uncomplicated malaria, 10 patients were anti-HAV IgM positive. The incidence of HAV infections during P. falciparum malaria was 1.7 (95% CI 0.81-3.1) infections/person-year while the cumulative incidence of HAV over the 3-month follow-up period was 0.27 (95% CI 0.14-0.50) infections/person-year. Children with or without HAV co-infections had similar mean P. falciparum asexual parasite densities at presentation (31,000/mu L vs. 34,000/mu L, respectively), largely exceeding the pyrogenic threshold of 2,500 parasites/mL in this population and minimizing risk of over-diagnosis of malaria as an explanation. Conclusion: The observed temporal association between acute HAV and P. falciparum malaria suggests that co-infections of these two hepatotrophic human pathogens may result from changes in host susceptibility. Testing this hypothesis will require larger prospective studies.	[Klouwenberg, Peter Klein; Bonten, Marc] Univ Med Ctr Utrecht, Utrecht, Netherlands; [Klouwenberg, Peter Klein; Sasi, Philip; Bashraheil, Mahfudh; Awuondo, Ken; Berkley, James; Marsh, Kevin; Borrmann, Steffen] Kenya Govt Med Res Ctr, Ctr Geog Med Res Coast, Wellcome Trust Res Programme, Kilifi, Kenya; [Sasi, Philip] Muhimbili Univ, Dar Es Salaam, Tanzania; [Borrmann, Steffen] Heidelberg Univ, Sch Med, Dept Infect Dis, Heidelberg, Germany	Utrecht University; Utrecht University Medical Center; Kenya Medical Research Institute; Ruprecht Karls University Heidelberg	Klouwenberg, PK (corresponding author), Univ Med Ctr Utrecht, Utrecht, Netherlands.	sborrmann@kilifi.kemri-wellcome.org	Borrmann, Steffen/G-1838-2013	Borrmann, Steffen/0000-0001-9189-4393; Berkley, James/0000-0002-1236-849X	Deutsche Forschungsgemeinschaft (DFG) [SFB 544, A7]; Kenya Medical Research Institute; Wellcome Trust	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Kenya Medical Research Institute; Wellcome Trust(Wellcome TrustEuropean Commission)	SB is funded by a Deutsche Forschungsgemeinschaft (DFG) Junior Group grant (SFB 544, A7). This study was supported by the Kenya Medical Research Institute and the Wellcome Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Raddad LJ, 2006, SCIENCE, V314, P1603, DOI 10.1126/science.1132338; Anand AC, 2005, J GASTROEN HEPATOL, V20, P1322, DOI 10.1111/j.1440-1746.2005.03884.x; Barcus MJ, 2002, AM J TROP MED HYG, V66, P140, DOI 10.4269/ajtmh.2002.66.140; Bassat Q, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007871; Bejon P, 2007, PLOS MED, V4, P1333, DOI 10.1371/journal.pmed.0040251; Bower WA, 2000, J INFECT DIS, V182, P12, DOI 10.1086/315701; BRABIN L, 1989, ANN TROP MED PARASIT, V83, P365, DOI 10.1080/00034983.1989.11812359; Chene A, 2007, PLOS PATHOG, V3, P826, DOI 10.1371/journal.ppat.0030080; Ciocca M, 2000, VACCINE, V18, pS71, DOI 10.1016/S0264-410X(99)00470-3; Jacobsen KH, 2004, EPIDEMIOL INFECT, V132, P1005, DOI 10.1017/S0950268804002857; Jiang XJ, 2000, J VIRAL HEPATITIS, V7, P292; Jimmy EO, 1996, T ROY SOC TROP MED H, V90, P37, DOI 10.1016/S0035-9203(96)90472-1; Mbogo CM, 2003, AM J TROP MED HYG, V68, P734; Moormann AM, 2005, J INFECT DIS, V191, P1233, DOI 10.1086/428910; Mwangi TW, 2005, J INFECT DIS, V191, P1932, DOI 10.1086/430006; Normann A, 2004, J MED VIROL, V72, P10, DOI 10.1002/jmv.10532; Olotu A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015569; Pasquetto V, 2000, J EXP MED, V192, P529, DOI 10.1084/jem.192.4.529; SMITH T, 1994, STAT MED, V13, P2345, DOI 10.1002/sim.4780132206; Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342; STAPLETON JT, 1995, J INFECT DIS, V171, pS9, DOI 10.1093/infdis/171.Supplement_1.S9; THURSZ MR, 1995, NAT MED, V1, P374, DOI 10.1038/nm0495-374	22	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2011	6	7							e21013	10.1371/journal.pone.0021013	http://dx.doi.org/10.1371/journal.pone.0021013			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791AK	21754982	Green Published, Green Submitted, gold			2022-12-27	WOS:000292632000006
J	Liu, Y; Chen, XQ; Liang, HX; Zhang, FX; Zhang, B; Jin, J; Chen, YL; Cheng, YX; Zhou, GB				Liu, Ying; Chen, Xiao-Qin; Liang, Heng-Xing; Zhang, Feng-Xiang; Zhang, Bo; Jin, Jie; Chen, Yong-Long; Cheng, Yong-Xian; Zhou, Guang-Biao			Small Compound 6-O-Angeloylplenolin Induces Mitotic Arrest and Exhibits Therapeutic Potentials in Multiple Myeloma	PLOS ONE			English	Article							NF-KAPPA-B; CELL-CYCLE CONTROL; OVERCOMES DRUG-RESISTANCE; CENTIPEDA-MINIMA; ANTITUMOR-ACTIVITY; KINASE-ACTIVITY; HUMAN CANCER; IN-VITRO; ACTIVATION; EXPRESSION	Background: Multiple myeloma (MM) is a disease of cell cycle dysregulation while cell cycle modulation can be a target for MM therapy. In this study we investigated the effects and mechanisms of action of a sesquiterpene lactone 6-O-angeloylplenolin (6-OAP) on MM cells. Methodology/Principal Findings: MM cells were exposed to 6-OAP and cell cycle distribution were analyzed. The role for cyclin B1 to play in 6-OAP-caused mitotic arrest was tested by specific siRNA analyses in U266 cells. MM.1S cells coincubated with interleukin-6 (IL-6), insulin-like growth factor-I (IGF-I), or bone marrow stromal cells (BMSCs) were treated with 6-OAP. The effects of 6-OAP plus other drugs on MM.1S cells were evaluated. The in vivo therapeutic efficacy and pharmacokinetic features of 6-OAP were tested in nude mice bearing U266 cells and Sprague-Dawley rats, respectively. We found that 6-OAP suppressed the proliferation of dexamethasone-sensitive and dexamethasone-resistant cell lines and primary CD138+ MM cells. 6-OAP caused mitotic arrest, accompanied by activation of spindle assembly checkpoint and blockage of ubiquitiniation and subsequent proteasomal degradation of cyclin B1. Combined use of 6-OAP and bortezomib induced potentiated cytotoxicity with inactivation of ERK1/2 and activation of JNK1/2 and Casp-8/-3. 6-OAP overcame the protective effects of IL-6 and IGF-I on MM cells through inhibition of Jak2/Stat3 and Akt, respectively. 6-OAP inhibited BMSCs-facilitated MM cell expansion and TNF-alpha-induced NF-kappa B signal. Moreover, 6-OAP exhibited potent anti-MM activity in nude mice and favorable pharmacokinetics in rats. Conclusions/Significance: These results indicate that 6-OAP is a new cell cycle inhibitor which shows therapeutic potentials for MM.	[Liu, Ying; Zhang, Feng-Xiang; Zhang, Bo; Chen, Yong-Long; Zhou, Guang-Biao] Chinese Acad Sci, Inst Zool, Guangzhou Inst Biomed & Hlth, Beijing, Peoples R China; [Liu, Ying; Zhang, Feng-Xiang; Zhang, Bo; Chen, Yong-Long; Zhou, Guang-Biao] Chinese Acad Sci, Inst Zool, State Key Lab Biomembrane & Membrane Biotechnol, Beijing, Peoples R China; [Liu, Ying] Univ Sci & Technol China, Sch Life Sci, Hefei 230026, Peoples R China; [Chen, Xiao-Qin] Sun Yat Sen Univ, Canc Hosp, Dept Hematol, Guangzhou 510275, Guangdong, Peoples R China; [Liang, Heng-Xing; Cheng, Yong-Xian] Chinese Acad Sci, Kunming Inst Bot, State Key Lab Phytochem & Plant Resources W China, Kunming, Peoples R China; [Jin, Jie] Zhejiang Univ, Coll Med, Affiliated Hosp 1, Dept Hematol, Hangzhou 310003, Zhejiang, Peoples R China	Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS; Institute of Zoology, CAS; Chinese Academy of Sciences; Institute of Zoology, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Sun Yat Sen University; Chinese Academy of Sciences; Kunming Institute of Botany, CAS; Zhejiang University	Liu, Y (corresponding author), Chinese Acad Sci, Inst Zool, Guangzhou Inst Biomed & Hlth, Beijing, Peoples R China.	yxcheng@mail.kib.ac.cn; gbzhou@ioz.ac.cn	Zhou, Guang-Biao/ABG-5795-2021; Zhou, Guangbiao/J-6575-2017; Liu, Ying/I-2050-2016	Zhou, Guangbiao/0000-0002-6327-2316; Zhou, Guang-Biao/0000-0001-6778-7133	National Key Program for Basic Research (973) [2010CB529201]; CAS [KSCX1-YW-R-26, KSCX2-YW-R-235]; National Natural Science Foundation of China [81071930, 30871110]; National Major Scientific and Technological Program for Drug Discovery [2009ZX09103-101]; Natural Science Foundation of Yunnan [2006B0041Q]; Talent Scholarship for the Youth of Yunnan [2007PY01-48]	National Key Program for Basic Research (973)(National Basic Research Program of China); CAS(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Major Scientific and Technological Program for Drug Discovery; Natural Science Foundation of Yunnan(Natural Science Foundation of Yunnan Province); Talent Scholarship for the Youth of Yunnan	This work is supported in part by the National Key Program for Basic Research (973, 2010CB529201), the Key Project of Knowledge Innovation Program of the CAS (KSCX1-YW-R-26 and KSCX2-YW-R-235), the National Natural Science Foundation of China (81071930, 30871110), the National Major Scientific and Technological Program for Drug Discovery (2009ZX09103-101), the Natural Science Foundation of Yunnan (2006B0041Q), and the Talent Scholarship for the Youth of Yunnan (No. 2007PY01-48). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attal M, 2003, NEW ENGL J MED, V349, P2495, DOI 10.1056/NEJMoa032290; Bergsagel PL, 2003, IMMUNOL REV, V194, P96, DOI 10.1034/j.1600-065X.2003.00052.x; Bjorck E, 2005, BLOOD, V105, P2908, DOI 10.1182/blood-2004-07-2721; Carracedo A, 2008, J CLIN INVEST, V118, P3065, DOI [10.1172/jCI34739, 10.1172/JCI34739]; Catlett-Falcone R, 1999, IMMUNITY, V10, P105, DOI 10.1016/S1074-7613(00)80011-4; CHANGLONG L, 2007, BIOMEDICINE PHARMACO, V62, P401; Chauhan D, 1996, BLOOD, V87, P1104, DOI 10.1182/blood.V87.3.1104.bloodjournal8731104; Chen B, 2006, NEUROSCI LETT, V406, P178, DOI 10.1016/j.neulet.2006.06.074; Chen-Kiang S, 2003, IMMUNOL REV, V194, P39, DOI 10.1034/j.1600-065X.2003.00065.x; Chu S, 2004, BLOOD, V103, P3167, DOI 10.1182/blood-2003-04-1271; Clute P, 1999, NAT CELL BIOL, V1, P82, DOI 10.1038/10049; Corson TW, 2007, CELL, V130, P769, DOI 10.1016/j.cell.2007.08.021; Crosio C, 2002, MOL CELL BIOL, V22, P874, DOI 10.1128/MCB.22.3.874-885.2002; Demoe JH, 2009, CANCER RES, V69, P1509, DOI 10.1158/0008-5472.CAN-08-3133; Dimopoulos M, 2007, NEW ENGL J MED, V357, P2123, DOI 10.1056/NEJMoa070594; Ding LF, 2009, J ASIAN NAT PROD RES, V11, P732, DOI 10.1080/10286020903029231; Ely S, 2005, CANCER RES, V65, P11345, DOI 10.1158/0008-5472.CAN-05-2159; Fang GW, 1998, MOL CELL, V2, P163, DOI 10.1016/S1097-2765(00)80126-4; Fang L, 2008, J CANCER RES CLIN, V134, P1337, DOI 10.1007/s00432-008-0416-0; Faretta M, 1998, CYTOMETRY, V31, P53; Francois G, 1996, PLANTA MED, V62, P126, DOI 10.1055/s-2006-957833; GOLDMANLEIKIN RE, 1989, J LAB CLIN MED, V113, P335; GRANA X, 1995, ONCOGENE, V11, P211; Harikumar KB, 2010, MOL CANCER RES, V8, P751, DOI 10.1158/1541-7786.MCR-09-0565; Hashimoto O, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-292; Hideshima T, 2001, CANCER RES, V61, P3071; Hideshima T, 2004, BLOOD, V104, P607, DOI 10.1182/blood-2004-01-0037; Hideshima T, 2002, J BIOL CHEM, V277, P16639, DOI 10.1074/jbc.M200360200; Hideshima T, 2001, ONCOGENE, V20, P5991, DOI 10.1038/sj.onc.1204833; Hideshima T, 2009, BLOOD, V114, P1046, DOI 10.1182/blood-2009-01-199604; Jordan MA, 2004, NAT REV CANCER, V4, P253, DOI 10.1038/nrc1317; KAWANO M, 1988, NATURE, V332, P83, DOI 10.1038/332083a0; Kirkpatrick DS, 2006, NAT CELL BIOL, V8, P700, DOI 10.1038/ncb1436; Kyle RA, 2004, NEW ENGL J MED, V351, P1860, DOI 10.1056/NEJMra041875; LeBlanc R, 2002, CANCER RES, V62, P4996; Lee TJ, 2006, CANCER LETT, V240, P234, DOI 10.1016/j.canlet.2005.09.013; Lin H, 2002, INT J CANCER, V97, P121, DOI 10.1002/ijc.1570; MANFREDI JJ, 1984, PHARMACOL THERAPEUT, V25, P83, DOI 10.1016/0163-7258(84)90025-1; Menu E, 2008, CANCER RES, V68, P5519, DOI 10.1158/0008-5472.CAN-07-6404; Mitsiades CS, 2004, CANCER CELL, V6, P439, DOI 10.1016/j.ccr.2004.10.020; Mitsiades CS, 2004, CANCER CELL, V5, P221, DOI 10.1016/S1535-6108(04)00050-9; Mitsiades CS, 2002, ONCOGENE, V21, P5673, DOI 10.1038/sj.onc.1205664; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; NILSSON K, 1970, CLIN EXP IMMUNOL, V7, P477; Oh HM, 2006, ARCH PHARM RES, V29, P64, DOI 10.1007/BF02977470; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Piloto O, 2007, BLOOD, V109, P1643, DOI 10.1182/blood-2006-05-023804; Raab MS, 2009, LANCET, V374, P324, DOI 10.1016/S0140-6736(09)60221-X; RESNITZKY D, 1995, MOL CELL BIOL, V15, P3463; Richardson PG, 2005, NEW ENGL J MED, V352, P2487, DOI 10.1056/NEJMoa043445; Richardson PG, 2003, NEW ENGL J MED, V348, P2609, DOI 10.1056/NEJMoa030288; Sanchez I, 2005, SEMIN CELL DEV BIOL, V16, P311, DOI 10.1016/j.semcdb.2005.02.007; Schwikkard S, 2002, NAT PROD REP, V19, P675, DOI 10.1039/b008980j; Shaughnessy JD, 2003, IMMUNOL REV, V194, P140, DOI 10.1034/j.1600-065X.2003.00054.x; Singhal S, 1999, NEW ENGL J MED, V341, P1565, DOI 10.1056/NEJM199911183412102; Swanton C, 2004, LANCET ONCOL, V5, P27, DOI 10.1016/S1470-2045(03)01321-4; Taylor RSL, 1998, PHYTOCHEMISTRY, V47, P631, DOI 10.1016/S0031-9422(97)00534-7; Weaver BAA, 2005, CANCER CELL, V8, P7, DOI 10.1016/j.ccr.2005.06.011; Yamada HY, 2006, MOL CANCER THER, V5, P2963, DOI 10.1158/1535-7163.MCT-06-0319; Yasui H, 2005, CANCER RES, V65, P7478, DOI 10.1158/0008-5472.CAN-05-0850; Zhou GB, 2007, BLOOD, V109, P3441, DOI 10.1182/blood-2006-06-032250	61	35	38	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2011	6	7							e21930	10.1371/journal.pone.0021930	http://dx.doi.org/10.1371/journal.pone.0021930			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791AK	21755010	gold, Green Submitted, Green Published			2022-12-27	WOS:000292632000037
J	Niu, YJ; Wang, J; Shang, ZQ; Huang, SP; Shyr, CR; Yeh, SY; Chang, CS				Niu, Yuanjie; Wang, Juan; Shang, Zhiqun; Huang, Shu-Pin; Shyr, Chih-Rong; Yeh, Shuyuan; Chang, Chawnshang			Increased CK5/CK8-Positive Intermediate Cells with Stromal Smooth Muscle Cell Atrophy in the Mice Lacking Prostate Epithelial Androgen Receptor	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; TGF-BETA; IMMUNOHISTOCHEMICAL LOCALIZATION; STEM-CELLS; EXPRESSION; CANCER; DIFFERENTIATION; PROLIFERATION; INDUCTION; IDENTIFICATION	Results from tissue recombination experiments documented well that stromal androgen receptor (AR) plays essential roles in prostate development, but epithelial AR has little roles in prostate development. Using cell specific knockout AR strategy, we generated pes-ARKO mouse with knock out of AR only in the prostate epithelial cells and demonstrated that epithelial AR might also play important roles in the development of prostate gland. We found mice lacking the prostate epithelial AR have increased apoptosis in epithelial CK8-positive luminal cells and increased proliferation in epithelial CK5-positive basal cells. The consequences of these two contrasting results could then lead to the expansion of CK5/CK8-positive intermediate cells, accompanied by stromal atrophy and impaired ductal morphogenesis. Molecular mechanism dissection found AR target gene, TGF-beta(1), might play important roles in this epithelial AR-to-stromal morphogenesis modulation. Collectively, these results provided novel information relevant to epithelial AR functions in epithelial-stromal interactions during the development of normal prostate, and suggested AR could also function as suppressor in selective cells within prostate.	[Niu, Yuanjie; Wang, Juan; Shang, Zhiqun; Chang, Chawnshang] Tianjin Med Univ, Tianjin Inst Urol, Chawnshang Chang Sex Hormone Res Ctr, Tianjin, Peoples R China; [Niu, Yuanjie; Shang, Zhiqun; Huang, Shu-Pin; Yeh, Shuyuan; Chang, Chawnshang] Univ Rochester, Med Ctr, Dept Pathol, George Whipple Lab Canc Res, Rochester, NY 14642 USA; [Niu, Yuanjie; Shang, Zhiqun; Huang, Shu-Pin; Yeh, Shuyuan; Chang, Chawnshang] Univ Rochester, Med Ctr, Dept Urol, George Whipple Lab Canc Res, Rochester, NY 14642 USA; [Shyr, Chih-Rong; Chang, Chawnshang] China Med Univ & Hosp, Sex Hormone Res Ctr, Taichung, Taiwan	Tianjin Medical University; University of Rochester; University of Rochester; China Medical University Taiwan; China Medical University Hospital - Taiwan	Niu, YJ (corresponding author), Tianjin Med Univ, Tianjin Inst Urol, Chawnshang Chang Sex Hormone Res Ctr, Tianjin, Peoples R China.	niuyuanjie@gmail.com; chang@urmc.rochester.edu	shang, zhiqun/J-6631-2018	Chang, Chawnshang/0000-0001-8510-3516	NSFC [30872587]; TSTC [09ZCZDSF04300]	NSFC(National Natural Science Foundation of China (NSFC)); TSTC	This work was supported by NSFC grant 30872587 and TSTC grant 09ZCZDSF04300. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barron DA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013751; Blanpain C, 2007, CELL, V128, P445, DOI 10.1016/j.cell.2007.01.014; Cardillo MR, 2000, ANAL QUANT CYTOL, V22, P403; CUNHA GR, 1983, RECENT PROG HORM RES, V39, P559; CUNHA GR, 1976, INT REV CYTOL, V47, P137, DOI 10.1016/S0074-7696(08)60088-1; CUNHA GR, 1981, J STEROID BIOCHEM, V14, P1317, DOI 10.1016/0022-4731(81)90338-1; Cunha GR, 2004, J STEROID BIOCHEM, V92, P221, DOI 10.1016/j.jsbmb.2004.10.017; CUNHA GR, 1978, J EXP ZOOL, V205, P343; Danielpour D, 1996, J CELL PHYSIOL, V166, P231, DOI 10.1002/(SICI)1097-4652(199601)166:1<231::AID-JCP24>3.0.CO;2-G; Hartsock A, 2008, BBA-BIOMEMBRANES, V1778, P660, DOI 10.1016/j.bbamem.2007.07.012; Hayward SW, 1998, DIFFERENTIATION, V63, P131, DOI 10.1046/j.1432-0436.1998.6330131.x; Huang XM, 2003, FRONT BIOSCI-LANDMRK, V8, pS740, DOI 10.2741/1093; Kassen A, 1996, PROSTATE, V28, P89, DOI 10.1002/(SICI)1097-0045(199602)28:2<89::AID-PROS3>3.0.CO;2-I; Kim IY, 1996, MOL ENDOCRINOL, V10, P107, DOI 10.1210/me.10.1.107; Kim IY, 1996, CLIN CANCER RES, V2, P1255; Klingler HC, 1999, PROSTATE, V41, P110; Litvinov IV, 2003, J CLIN ENDOCR METAB, V88, P2972, DOI 10.1210/jc.2002-022038; MCNEAL JE, 1983, MONOGR UROL, V4, P1; MORI H, 1990, PROSTATE, V16, P71, DOI 10.1002/pros.2990160108; Nemeth JA, 1997, PROSTATE, V33, P64; Niu Y, 2001, BJU INT, V87, P386, DOI 10.1046/j.1464-410x.2001.00103.x; Niu YJ, 2008, P NATL ACAD SCI USA, V105, P12188, DOI 10.1073/pnas.0804701105; Niu YJ, 2008, P NATL ACAD SCI USA, V105, P12182, DOI 10.1073/pnas.0804700105; Peehl DM, 1997, EXP CELL RES, V232, P208, DOI 10.1006/excr.1997.3525; Perry KT, 1997, PROSTATE, V33, P133, DOI 10.1002/(SICI)1097-0045(19971001)33:2<133::AID-PROS7>3.0.CO;2-L; Raghow S, 1999, J UROLOGY, V162, P509, DOI 10.1016/S0022-5347(05)68617-X; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Robinson EJ, 1998, PROSTATE, V37, P149, DOI 10.1002/(SICI)1097-0045(19981101)37:3<149::AID-PROS4>3.0.CO;2-E; Salm SN, 2000, J CELL PHYSIOL, V184, P70, DOI 10.1002/(SICI)1097-4652(200007)184:1<70::AID-JCP7>3.3.CO;2-L; Story MT, 1996, J CELL PHYSIOL, V169, P97, DOI 10.1002/(SICI)1097-4652(199610)169:1<97::AID-JCP10>3.0.CO;2-L; STORY MT, 1993, PROSTATE, V22, P183, DOI 10.1002/pros.2990220302; Tang DG, 2007, MOL CARCINOGEN, V46, P1, DOI 10.1002/mc.20255; Wang YZ, 2001, DIFFERENTIATION, V68, P270, DOI 10.1046/j.1432-0436.2001.680414.x; Williams RH, 1996, CLIN CANCER RES, V2, P635; Wu CT, 2007, P NATL ACAD SCI USA, V104, P12679, DOI 10.1073/pnas.0704940104; Xue Y, 1998, PROSTATE, V34, P292, DOI 10.1002/(SICI)1097-0045(19980301)34:4<292::AID-PROS7>3.0.CO;2-J; Zhao H, 2002, BIOCHEM BIOPH RES CO, V292, P482, DOI 10.1006/bbrc.2002.6660; Zhu ML, 2008, PROSTATE, V68, P287, DOI 10.1002/pros.20698	38	18	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2011	6	7							e20202	10.1371/journal.pone.0020202	http://dx.doi.org/10.1371/journal.pone.0020202			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791AK	21754978	Green Submitted, Green Published, gold			2022-12-27	WOS:000292632000002
J	von Boehmer, L; Keller, L; Mortezavi, A; Provenzano, M; Sais, G; Hermanns, T; Sulser, T; Jungbluth, AA; Old, LJ; Kristiansen, G; van den Broek, M; Moch, H; Knuth, A; Wild, PJ				von Boehmer, Lotta; Keller, Lukas; Mortezavi, Ashkan; Provenzano, Maurizio; Sais, Giovanni; Hermanns, Thomas; Sulser, Tullio; Jungbluth, Achim A.; Old, Lloyd J.; Kristiansen, Glen; van den Broek, Maries; Moch, Holger; Knuth, Alexander; Wild, Peter J.			MAGE-C2/CT10 Protein Expression Is an Independent Predictor of Recurrence in Prostate Cancer	PLOS ONE			English	Article							CYTOLYTIC T-LYMPHOCYTES; GENE-EXPRESSION; NY-ESO-1 PROTEIN; TESTIS ANTIGENS; HEPATOCELLULAR-CARCINOMA; MELANOMA PATIENTS; IMMUNE-RESPONSES; CELL RESPONSES; TUMOR-ANTIGENS; MAGE FAMILY	The cancer-testis (CT) family of antigens is expressed in a variety of malignant neoplasms. In most cases, no CT antigen is found in normal tissues, except in testis, making them ideal targets for cancer immunotherapy. A comprehensive analysis of CT antigen expression has not yet been reported in prostate cancer. MAGE-C2/CT-10 is a novel CT antigen. The objective of this study was to analyze extent and prognostic significance of MAGE-C2/CT10 protein expression in prostate cancer. 348 prostate carcinomas from consecutive radical prostatectomies, 29 castration-refractory prostate cancer, 46 metastases, and 45 benign hyperplasias were immunohistochemically analyzed for MAGE-C2/CT10 expression using tissue microarrays. Nuclear MAGE-C2/CT10 expression was identified in only 3.3% primary prostate carcinomas. MAGE-C2/CT10 protein expression was significantly more frequent in metastatic (16.3% positivity) and castration-resistant prostate cancer (17% positivity; p < 0.001). Nuclear MAGE-C2/CT10 expression was identified as predictor of biochemical recurrence after radical prostatectomy (p = 0.015), which was independent of preoperative PSA, Gleason score, tumor stage, and surgical margin status in multivariate analysis (p < 0.05). MAGE-C2/CT10 expression in prostate cancer correlates with the degree of malignancy and indicates a higher risk for biochemical recurrence after radical prostatectomy. Further, the results suggest MAGE-C2/CT10 as a potential target for adjuvant and palliative immunotherapy in patients with prostate cancer.	[von Boehmer, Lotta; Keller, Lukas; van den Broek, Maries; Knuth, Alexander] Univ Zurich Hosp, Clin Oncol, CH-8091 Zurich, Switzerland; [Mortezavi, Ashkan; Provenzano, Maurizio; Sais, Giovanni; Hermanns, Thomas; Sulser, Tullio] Univ Zurich Hosp, Urol Clin, CH-8091 Zurich, Switzerland; [Kristiansen, Glen; Moch, Holger; Wild, Peter J.] Univ Zurich Hosp, Inst Surg Pathol, CH-8091 Zurich, Switzerland; [Jungbluth, Achim A.; Old, Lloyd J.] Mem Sloan Kettering Canc Ctr, New York Branch, Ludwig Inst Canc Res, New York, NY 10021 USA	University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital; Ludwig Institute for Cancer Research; Memorial Sloan Kettering Cancer Center	von Boehmer, L (corresponding author), Univ Zurich Hosp, Clin Oncol, CH-8091 Zurich, Switzerland.	Lotta.vonBoehmer@usz.ch	knuth, alexander/H-2608-2014; van den Broek, Maries/G-4128-2016	knuth, alexander/0000-0002-9318-2784; Mortezavi, Ashkan/0000-0001-6307-2659; von Boehmer, Lotta/0000-0001-8018-1814; Wild, Peter Johannes/0000-0002-1017-3744; van den Broek, Maries/0000-0002-9489-3692	Atlantic Philanthropies (New York, USA); Cancer Research Institute; Science Foundation for Oncology; Hanne Liebermann Foundation (Zurich); Hartman Muller Foundation (Zurich); Zurich Cancer League (Zurich); Terry Fox Foundation (Winnipeg, Canada)	Atlantic Philanthropies (New York, USA); Cancer Research Institute; Science Foundation for Oncology; Hanne Liebermann Foundation (Zurich); Hartman Muller Foundation (Zurich); Zurich Cancer League (Zurich); Terry Fox Foundation (Winnipeg, Canada)	This work was supported by Atlantic Philanthropies (New York, USA), Cancer Research Institute, the Science Foundation for Oncology, the Hanne Liebermann Foundation (Zurich), the Hartman Muller Foundation (Zurich), the Zurich Cancer League (Zurich), and the Terry Fox Foundation (Winnipeg, Canada). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akers SN, 2010, FUTURE ONCOL, V6, P717, DOI [10.2217/fon.10.36, 10.2217/FON.10.36]; Andrade Valeria C C, 2008, Cancer Immun, V8, P2; Andriole GL, 2009, NEW ENGL J MED, V360, P1310, DOI 10.1056/NEJMoa0810696; Atanackovic D, 2008, P NATL ACAD SCI USA, V105, P1650, DOI 10.1073/pnas.0707140104; Atanackovic D, 2009, CLIN CANCER RES, V15, P1343, DOI 10.1158/1078-0432.CCR-08-0989; Bachmann IM, 2006, J CLIN ONCOL, V24, P268, DOI 10.1200/JCO.2005.01.5180; Barrow C, 2006, CLIN CANCER RES, V12, P764, DOI 10.1158/1078-0432.CCR-05-1544; Bender Armin, 2007, Cancer Immun, V7, P16; Bill-Axelson A, 2005, NEW ENGL J MED, V352, P1977, DOI 10.1056/NEJMoa043739; Bubendorf L, 1996, J PATHOL, V178, P437, DOI 10.1002/(SICI)1096-9896(199604)178:4<437::AID-PATH484>3.0.CO;2-4; Chen YT, 1997, P NATL ACAD SCI USA, V94, P1914, DOI 10.1073/pnas.94.5.1914; Davis ID, 2004, P NATL ACAD SCI USA, V101, P10697, DOI 10.1073/pnas.0403572101; De Smet C, 1999, MOL CELL BIOL, V19, P7327; Dearnaley DP, 2005, BRIT J CANCER, V92, P488, DOI 10.1038/sj.bjc.6602301; Debes JD, 2004, NEW ENGL J MED, V351, P1488, DOI 10.1056/NEJMp048178; Epstein JI, 2005, SCAND J UROL NEPHROL, V39, P34, DOI 10.1080/03008880510030932; Fleischmann A, 2008, CLIN CANCER RES, V14, P7838, DOI 10.1158/1078-0432.CCR-08-1432; Fossa A, 2004, PROSTATE, V59, P440, DOI 10.1002/pros.20025; Foster CS, 2004, ONCOGENE, V23, P5871, DOI 10.1038/sj.onc.1207800; Furuta J, 2004, CANCER SCI, V95, P962, DOI 10.1111/j.1349-7006.2004.tb03184.x; Germeau C, 2005, J EXP MED, V201, P241, DOI 10.1084/jem.20041379; Gjerstorff MF, 2006, BRIT J CANCER, V94, P1864, DOI 10.1038/sj.bjc.6603163; Godelaine D, 2007, CANCER IMMUNOL IMMUN, V56, P753, DOI 10.1007/s00262-006-0244-5; Gure AO, 2005, CLIN CANCER RES, V11, P8055, DOI 10.1158/1078-0432.CCR-05-1203; Gure AO, 2000, INT J CANCER, V85, P726, DOI 10.1002/(SICI)1097-0215(20000301)85:5<726::AID-IJC21>3.0.CO;2-F; Hudolin T, 2006, PROSTATE, V66, P13, DOI 10.1002/pros.20312; Jager E, 2006, P NATL ACAD SCI USA, V103, P14453, DOI 10.1073/pnas.0606512103; Jager Dirk, 2005, Cancer Immun, V5, P11; Karbach J, 2011, CLIN CANCER RES, V17, P861, DOI 10.1158/1078-0432.CCR-10-1811; Karpf AR, 2009, MOL CANCER RES, V7, P523, DOI 10.1158/1541-7786.MCR-08-0400; Kononen J, 1998, NAT MED, V4, P844, DOI 10.1038/nm0798-844; Kruger T, 2005, CANCER IMMUNOL IMMUN, V54, P826, DOI 10.1007/s00262-004-0650-5; Lapointe J, 2004, P NATL ACAD SCI USA, V101, P811, DOI 10.1073/pnas.0304146101; Lethe B, 1998, INT J CANCER, V76, P903, DOI 10.1002/(SICI)1097-0215(19980610)76:6<903::AID-IJC22>3.0.CO;2-1; Li M, 2005, CLIN CANCER RES, V11, P1809, DOI 10.1158/1078-0432.CCR-04-1365; Lucas S, 2000, INT J CANCER, V87, P55, DOI 10.1002/1097-0215(20000701)87:1<55::AID-IJC8>3.3.CO;2-A; Ma WB, 2004, INT J CANCER, V109, P698, DOI 10.1002/ijc.20038; Meklat F, 2007, BRIT J HAEMATOL, V136, P769, DOI 10.1111/j.1365-2141.2006.06484.x; Nakada Tetsuya, 2003, Cancer Immun, V3, P10; Napoletano C, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2007.05.019; Odunsi K, 2003, CANCER RES, V63, P6076; Odunsi K, 2007, P NATL ACAD SCI USA, V104, P12837, DOI 10.1073/pnas.0703342104; Peng JR, 2005, CANCER LETT, V219, P223, DOI 10.1016/j.canlet.2004.07.028; Prikler L, 2004, AKTUEL UROL, V35, P326, DOI 10.1055/s-2004-818510; Riener MO, 2009, INT J CANCER, V124, P352, DOI 10.1002/ijc.23966; Scanlan MJ, 2002, CANCER RES, V62, P4041; Schroeder FH, 2009, NEW ENGL J MED, V360, P1320, DOI 10.1056/NEJMoa0810084; Sharma P, 2006, CLIN CANCER RES, V12, P5442, DOI 10.1158/1078-0432.CCR-06-0527; Sharma Padmanee, 2003, Cancer Immun, V3, P19; Simpson AJG, 2005, NAT REV CANCER, V5, P615, DOI 10.1038/nrc1669; Tyagi P, 2009, CLIN LUNG CANCER, V10, P371, DOI 10.3816/CLC.2009.n.052; Valmori D, 2007, P NATL ACAD SCI USA, V104, P8947, DOI 10.1073/pnas.0703395104; van Baren N, 2005, J CLIN ONCOL, V23, P9008, DOI 10.1200/JCO.2005.08.375; Velazquez Elsa F, 2007, Cancer Immun, V7, P11; Wang Y, 2002, J IMMUNOL, V169, P1102, DOI 10.4049/jimmunol.169.2.1102; Wischnewski F, 2006, MOL CANCER RES, V4, P339, DOI 10.1158/1541-7786.MCR-05-0229; Yang B, 2007, CANCER RES, V67, P9954, DOI 10.1158/0008-5472.CAN-07-1478; Yang B, 2007, J INVEST DERMATOL, V127, P2123, DOI 10.1038/sj.jid.5700836; Zellweger T, 2009, INT J CANCER, V124, P2116, DOI 10.1002/ijc.24174; Zhuang Ran, 2006, Cancer Immun, V6, P7	60	38	39	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2011	6	7							e21366	10.1371/journal.pone.0021366	http://dx.doi.org/10.1371/journal.pone.0021366			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791AK	21754986	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000292632000010
J	Gourion, B; Delmotte, N; Bonaldi, K; Nouwen, N; Vorholt, JA; Giraud, E				Gourion, Benjamin; Delmotte, Nathanael; Bonaldi, Katia; Nouwen, Nico; Vorholt, Julia A.; Giraud, Eric			Bacterial RuBisCO Is Required for Efficient Bradyrhizobium/Aeschynomene Symbiosis	PLOS ONE			English	Article							TRANSPOSON MUTAGENESIS; EXPRESSION; NODULE; GENES; PHOTOSYNTHESIS; METABOLISM; MECHANISM; FIXATION; SEQUENCE; INSIGHTS	Rhizobia and legume plants establish symbiotic associations resulting in the formation of organs specialized in nitrogen fixation. In such organs, termed nodules, bacteria differentiate into bacteroids which convert atmospheric nitrogen and supply the plant with organic nitrogen. As a counterpart, bacteroids receive carbon substrates from the plant. This rather simple model of metabolite exchange underlies symbiosis but does not describe the complexity of bacteroids' central metabolism. A previous study using the tropical symbiotic model Aeschynomene indica/photosynthetic Bradyrhizobium sp. ORS278 suggested a role of the bacterial Calvin cycle during the symbiotic process. Herein we investigated the role of two RuBisCO gene clusters of Bradyrhizobium sp. ORS278 during symbiosis. Using gene reporter fusion strains, we showed that cbbL1 but not the paralogous cbbL2 is expressed during symbiosis. Congruently, CbbL1 was detected in bacteroids by proteome analysis. The importance of CbbL1 for symbiotic nitrogen fixation was proven by a reverse genetic approach. Interestingly, despite its symbiotic nitrogen fixation defect, the cbbL1 mutant was not affected in nitrogen fixation activity under free living state. This study demonstrates a critical role for bacterial RuBisCO during a rhizobia/legume symbiotic interaction.	[Gourion, Benjamin; Bonaldi, Katia; Nouwen, Nico; Giraud, Eric] Univ Montpellier 2, Ctr Cooperat Int Rech Agron Dev, Inst Natl Rech Agron,Inst Rech Dev, Lab Symbioses Trop & Mediterraneennes,SupAgro, Montpellier, France; [Delmotte, Nathanael; Vorholt, Julia A.] Eidgenoss Tech Hsch Zurich, Inst Microbiol, Zurich, Switzerland	CIRAD; INRAE; Institut Agro; Montpellier SupAgro; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier	Gourion, B (corresponding author), CNRS, Inst Sci Vegetal, Gif Sur Yvette, France.	benjamin.gourion@isv.cnrs-gif.fr	Delmotte, Nathanael/G-7531-2016; Giraud, Eric/GLS-1036-2022; Delmotte, Nathanael/D-1337-2010; Vorholt, Julia/K-3514-2016; Gourion, Benjamin/AAG-9063-2019	Vorholt, Julia/0000-0002-6011-4910; Gourion, Benjamin/0000-0001-5768-6961	French national research agency [ANR-NEWNOD-2006-BLAN-0095, ANR-SESAM-2010-BLAN-170801]; European Molecular Biology Organization	French national research agency(French National Research Agency (ANR)); European Molecular Biology Organization(European Molecular Biology Organization (EMBO))	This work was supported by grants from the French national research agency (ANR-NEWNOD-2006-BLAN-0095 and ANR-SESAM-2010-BLAN-170801); BG was supported by a grant from the European Molecular Biology Organization. This work has benefited from the facilities and expertise of the Functional Genomic Center Zurich. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALAZARD D, 1990, FEMS MICROBIOL LETT, V68, P177, DOI 10.1111/j.1574-6968.1990.tb04145.x; Amadou C, 2008, GENOME RES, V18, P1472, DOI 10.1101/gr.076448.108; Andersson I, 2008, PLANT PHYSIOL BIOCH, V46, P275, DOI 10.1016/j.plaphy.2008.01.001; Andersson I, 2008, J EXP BOT, V59, P1555, DOI 10.1093/jxb/ern091; Badger MR, 2008, J EXP BOT, V59, P1525, DOI 10.1093/jxb/erm297; Berg IA, 2011, APPL ENVIRON MICROB, V77, P1925, DOI 10.1128/AEM.02473-10; Bonaldi K, 2010, MOL PLANT MICROBE IN, V23, P1537, DOI 10.1094/MPMI-06-10-0137; Bonaldi K, 2010, MOL PLANT MICROBE IN, V23, P760, DOI 10.1094/MPMI-23-6-0760; Delmotte N, 2010, PROTEOMICS, V10, P1391, DOI 10.1002/pmic.200900710; Delmotte N, 2009, P NATL ACAD SCI USA, V106, P16428, DOI 10.1073/pnas.0905240106; DREYFUS BL, 1983, APPL ENVIRON MICROB, V45, P711, DOI 10.1128/AEM.45.2.711-713.1983; EHRHARDT DW, 1992, SCIENCE, V256, P998, DOI 10.1126/science.10744524; FALCONE DL, 1991, J BACTERIOL, V173, P2099, DOI 10.1128/jb.173.6.2099-2108.1991; Galibert F, 2001, SCIENCE, V293, P668, DOI 10.1126/science.1060966; Giraud E, 2004, PHOTOSYNTH RES, V82, P115, DOI 10.1007/s11120-004-1768-1; Giraud E, 2000, P NATL ACAD SCI USA, V97, P14795, DOI 10.1073/pnas.250484097; Giraud E, 2007, SCIENCE, V316, P1307, DOI 10.1126/science.1139548; GUTTERIDGE S, 1995, PLANT CELL, V7, P809, DOI 10.1105/tpc.7.7.809; HALLENBECK PL, 1990, J BACTERIOL, V172, P1736, DOI 10.1128/jb.172.4.1736-1748.1990; HILLMER P, 1977, J BACTERIOL, V129, P724, DOI 10.1128/JB.129.2.724-731.1977; HUNGRIA M, 1993, BIOL FERT SOILS, V15, P208, DOI 10.1007/BF00361613; Joshi HM, 1996, P NATL ACAD SCI USA, V93, P14515, DOI 10.1073/pnas.93.25.14515; Koch M, 2010, MOL PLANT MICROBE IN, V23, P784, DOI 10.1094/MPMI-23-6-0784; KOKOTEK W, 1989, GENE, V84, P467, DOI 10.1016/0378-1119(89)90522-2; Lorquin J, 1997, APPL ENVIRON MICROB, V63, P1151, DOI 10.1128/AEM.63.3.1151-1154.1997; MAIER RJ, 1981, J BACTERIOL, V145, P533, DOI 10.1128/JB.145.1.533-540.1981; McKinlay JB, 2010, P NATL ACAD SCI USA, V107, P11669, DOI 10.1073/pnas.1006175107; MULLER F. M., 1933, ARCHIV MIKRO BIOL, V4, P131, DOI 10.1007/BF00407535; Oke V, 1999, MOL MICROBIOL, V32, P837, DOI 10.1046/j.1365-2958.1999.01402.x; Pickering BS, 2008, J BACTERIOL, V190, P6409, DOI 10.1128/JB.00757-08; Prell J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013933; Price GD, 2008, J EXP BOT, V59, P1441, DOI 10.1093/jxb/erm112; QUANDT J, 1993, GENE, V127, P15, DOI 10.1016/0378-1119(93)90611-6; RICHARDSON DJ, 1988, ARCH MICROBIOL, V150, P131, DOI 10.1007/BF00425152; Sarma AD, 2005, PROTEOMICS, V5, P4170, DOI 10.1002/pmic.200401296; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; White J, 2007, PLANT PHYSIOL, V144, P604, DOI 10.1104/pp.107.097741; Yeates TO, 2008, NAT REV MICROBIOL, V6, P681, DOI 10.1038/nrmicro1913	40	30	31	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2011	6	7							e21900	10.1371/journal.pone.0021900	http://dx.doi.org/10.1371/journal.pone.0021900			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	789JO	21750740	Green Published, Green Submitted, gold			2022-12-27	WOS:000292512000032
J	Nams, VO				Nams, Vilis O.			Emergent Properties of Patch Shapes Affect Edge Permeability to Animals	PLOS ONE			English	Article							HABITAT EDGES; SEED DISPERSAL; POPULATION; RESPONSES; SCALE; EMIGRATION; LOCATIONS; MORTALITY; MIGRATION; MOVEMENT	Animal travel between habitat patches affects populations, communities and ecosystems. There are three levels of organization of edge properties, and each of these can affect animals. At the lowest level are the different habitats on each side of an edge, then there is the edge itself, and finally, at the highest level of organization, is the geometry or structure of the edge. This study used computer simulations to (1) find out whether effects of edge shapes on animal behavior can arise as emergent properties solely due to reactions to edges in general, without the animals reacting to the shapes of the edges, and to (2) generate predictions to allow field and experimental studies to test mechanisms of edge shape response. Individual animals were modeled traveling inside a habitat patch that had different kinds of edge shapes (convex, concave and straight). When animals responded edges of patches, this created an emergent property of responding to the shape of the edge. The response was mostly to absolute width of the shapes, and not the narrowness of them. When animals were attracted to edges, then they tended to collect in convexities and disperse from concavities, and the opposite happened when animals avoided edges. Most of the responses occurred within a distance of 40% of the perceptual range from the tip of the shapes. Predictions were produced for directionality at various locations and combinations of treatments, to be used for testing edge behavior mechanisms. These results suggest that edge shapes tend to either concentrate or disperse animals, simply because the animals are either attracted to or avoid edges, with an effect as great as 3 times the normal density. Thus edge shape could affect processes like pollination, seed predation and dispersal and predator abundance.	[Nams, Vilis O.] Nova Scotia Agr Coll, Dept Environm Sci, Truro, NS B2N 5E3, Canada; [Nams, Vilis O.] James Cook Univ, Sch Marine & Trop Biol, Townsville, Qld 4811, Australia	Dalhousie University; James Cook University	Nams, VO (corresponding author), Nova Scotia Agr Coll, Dept Environm Sci, Truro, NS B2N 5E3, Canada.	vnams@nsac.ca			Natural Science and Engineering Research Council of Canada	Natural Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	This study was funded by the Natural Science and Engineering Research Council of Canada (http://www.nserc-crsng.gc.ca/Index_eng.asp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baguette M, 2000, J APPL ECOL, V37, P100, DOI 10.1046/j.1365-2664.2000.00478.x; Beckmann Jon P., 2008, Human-Wildlife Conflicts, V2, P168; Buechner M, 1989, LANDSCAPE ECOL, V2, P191, DOI 10.1007/BF00126018; Cadenasso ML, 2000, J ECOL, V88, P31, DOI 10.1046/j.1365-2745.2000.00423.x; CAIN ML, 1985, ECOLOGY, V66, P876, DOI 10.2307/1940550; Collinge SK, 2002, LANDSCAPE ECOL, V17, P647, DOI 10.1023/A:1021536302195; Debinski DM, 2001, BIOL CONSERV, V98, P179, DOI 10.1016/S0006-3207(00)00153-1; Desrochers A, 2000, OIKOS, V91, P376, DOI 10.1034/j.1600-0706.2000.910218.x; Englund G, 2004, ECOLOGY, V85, P320, DOI 10.1890/03-3039; Ewers RM, 2007, CONSERV BIOL, V21, P926, DOI 10.1111/j.1523-1739.2007.00720.x; Fagan WE, 1999, AM NAT, V153, P165, DOI 10.1086/303162; Finder RA, 1999, LANDSCAPE URBAN PLAN, V44, P77, DOI 10.1016/S0169-2046(99)00006-7; Grez AA, 2000, ENVIRON ENTOMOL, V29, P1244, DOI 10.1603/0046-225X-29.6.1244; GUNSON KE, 2006, P 2005 INT C EC TRAN, P545; Haddad NM, 1999, AM NAT, V153, P215, DOI 10.1086/303163; Haines AM, 2005, J WILDLIFE MANAGE, V69, P255, DOI 10.2193/0022-541X(2005)069<0255:SASOMI>2.0.CO;2; HARDT RA, 1989, ECOLOGY, V70, P1252, DOI 10.2307/1938183; Holl KD, 1997, BIOTROPICA, V29, P459, DOI 10.1111/j.1744-7429.1997.tb00040.x; Holtcamp WN, 1997, ECOLOGY, V78, P308; Hubbard MW, 2000, J WILDLIFE MANAGE, V64, P707, DOI 10.2307/3802740; Kaczensky P, 2003, BIOL CONSERV, V111, P191, DOI 10.1016/S0006-3207(02)00273-2; Levey DJ, 2005, SCIENCE, V309, P146, DOI 10.1126/science.1111479; MORRIS WF, 1994, ECOL APPL, V4, P157, DOI 10.2307/1942125; Pagel M, 1996, OIKOS, V76, P323, DOI 10.2307/3546204; RASMUSSEN IR, 1992, OECOLOGIA, V89, P277, DOI 10.1007/BF00317228; RECIO MR, 2010, NZ J ZOOL, V34; Ries L, 2001, J ANIM ECOL, V70, P840, DOI 10.1046/j.0021-8790.2001.00546.x; Ries L, 2004, ANNU REV ECOL EVOL S, V35, P491, DOI 10.1146/annurev.ecolsys.35.112202.130148; Ross JA, 2005, LANDSCAPE ECOL, V20, P127, DOI 10.1007/s10980-004-1010-8; Schultz CB, 2001, ECOLOGY, V82, P1879, DOI 10.1890/0012-9658(2001)082[1879:EMDBIA]2.0.CO;2; Seiler A, 2005, J APPL ECOL, V42, P371, DOI 10.1111/j.1365-2664.2005.01013.x; SISK T, 2002, HABITAT EDGES AVIAN, P30; STAMPS JA, 1987, AM ZOOL, V27, P307; STAMPS JA, 1987, AM NAT, V129, P533, DOI 10.1086/284656; Taylor SK, 2002, J WILDLIFE DIS, V38, P107, DOI 10.7589/0090-3558-38.1.107; Turchin Peter, 1998; Wahlberg N, 2002, OECOLOGIA, V130, P33, DOI 10.1007/s004420100775; Wolfram Research I, 2008, MATH; Zollner PA, 1999, ECOLOGY, V80, P1019, DOI 10.2307/177035	39	9	10	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2011	6	7							e21886	10.1371/journal.pone.0021886	http://dx.doi.org/10.1371/journal.pone.0021886			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786HC	21747965	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000292293400041
J	Kim, C; Ahmed, JA; Eidex, RB; Nyoka, R; Waiboci, LW; Erdman, D; Tepo, A; Mahamud, AS; Kabura, W; Nguhi, M; Muthoka, P; Burton, W; Breiman, RF; Njenga, MK; Katz, MA				Kim, Curi; Ahmed, Jamal A.; Eidex, Rachel B.; Nyoka, Raymond; Waiboci, Lilian W.; Erdman, Dean; Tepo, Adan; Mahamud, Abdirahman S.; Kabura, Wamburu; Nguhi, Margaret; Muthoka, Philip; Burton, Wagacha; Breiman, Robert F.; Njenga, M. Kariuki; Katz, Mark A.			Comparison of Nasopharyngeal and Oropharyngeal Swabs for the Diagnosis of Eight Respiratory Viruses by Real-Time Reverse Transcription-PCR Assays	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; CHILDREN; INFECTIONS; SPECIMENS; H5N1	Background: Many acute respiratory illness surveillance systems collect and test nasopharyngeal (NP) and/or oropharyngeal (OP) swab specimens, yet there are few studies assessing the relative measures of performance for NP versus OP specimens. Methods: We collected paired NP and OP swabs separately from pediatric and adult patients with influenza-like illness or severe acute respiratory illness at two respiratory surveillance sites in Kenya. The specimens were tested for eight respiratory viruses by real-time reverse transcription-polymerase chain reaction (qRT-PCR). Positivity for a specific virus was defined as detection of viral nucleic acid in either swab. Results: Of 2,331 paired NP/OP specimens, 1,402 (60.1%) were positive for at least one virus, and 393 (16.9%) were positive for more than one virus. Overall, OP swabs were significantly more sensitive than NP swabs for adenovirus (72.4% vs. 57.6%, p < 0.01) and 2009 pandemic influenza A (H1N1) virus (91.2% vs. 70.4%, p < 0.01). NP specimens were more sensitive for influenza B virus (83.3% vs. 61.5%, p = 0.02), parainfluenza virus 2 (85.7%, vs. 39.3%, p < 0.01), and parainfluenza virus 3 (83.9% vs. 67.4%, p < 0.01). The two methods did not differ significantly for human metapneumovirus, influenza A (H3N2) virus, parainfluenza virus 1, or respiratory syncytial virus. Conclusions: The sensitivities were variable among the eight viruses tested; neither specimen was consistently more effective than the other. For respiratory disease surveillance programs using qRT-PCR that aim to maximize sensitivity for a large number of viruses, collecting combined NP and OP specimens would be the most effective approach.	[Kim, Curi; Erdman, Dean] US Ctr Dis Control & Prevent, Atlanta, GA USA; [Ahmed, Jamal A.; Eidex, Rachel B.; Nyoka, Raymond; Waiboci, Lilian W.; Tepo, Adan; Mahamud, Abdirahman S.; Breiman, Robert F.; Njenga, M. Kariuki; Katz, Mark A.] Ctr Dis Control & Prevent Kenya, Nairobi, Kenya; [Kabura, Wamburu] Kenya Govt Med Res Ctr, Nairobi, Kenya; [Nguhi, Margaret] Int Rescue Comm, Nairobi, Kenya; [Muthoka, Philip] Minist Publ Hlth & Sanitat, Nairobi, Kenya; [Burton, Wagacha] United Nations High Commissioner Refugees, Nairobi, Kenya	Centers for Disease Control & Prevention - USA; Kenya Medical Research Institute	Kim, C (corresponding author), US Ctr Dis Control & Prevent, Atlanta, GA USA.	mkatz@ke.cdc.gov						Beigel H, 2005, NEW ENGL J MED, V353, P1374, DOI 10.1056/NEJMra052211; Chan KH, 2008, J CLIN VIROL, V42, P65, DOI 10.1016/j.jcv.2007.12.003; Covalciuc KA, 1999, J CLIN MICROBIOL, V37, P3971, DOI 10.1128/JCM.37.12.3971-3974.1999; Echavarria M., 2009, Principles and practice of clinical virology, P463, DOI 10.1002/9780470741405.ch19; Guarner J, 2009, ARCH MED RES, V40, P655, DOI 10.1016/j.arcmed.2009.10.001; Healing T., 2006, COLL PRES SHIPP SPEC; Henrickson KJ, 2003, CLIN MICROBIOL REV, V16, P242, DOI 10.1128/CMR.16.2.242-264.2003; HERNES S, 2010, EUR J CLIN MICROBIOL; Jennings LC, 2004, PEDIATR INFECT DIS J, V23, P1003, DOI 10.1097/01.inf.0000143648.04673.6c; Kandun IN, 2006, NEW ENGL J MED, V355, P2186, DOI 10.1056/NEJMoa060930; Kodani M, 2011, J CLIN MICROBIOL, V49, P2175, DOI 10.1128/JCM.02270-10; Lambert SB, 2008, PEDIATRICS, V122, pE615, DOI 10.1542/peds.2008-0691; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lieberman D, 2009, J CLIN MICROBIOL, V47, P3439, DOI 10.1128/JCM.00886-09; Loens K, 2009, J CLIN MICROBIOL, V47, P21, DOI 10.1128/JCM.02037-08; Meerhoff TJ, 2010, EUR J CLIN MICROBIOL, V29, P365, DOI 10.1007/s10096-009-0865-7; de la Tabla VO, 2010, J CLIN MICROBIOL, V48, P3492, DOI 10.1128/JCM.01105-10; Robinson JL, 2008, CLIN INFECT DIS, V46, pE61, DOI 10.1086/529386; Sung RYT, 2008, J CLIN MICROBIOL, V46, P3073, DOI 10.1128/JCM.01209-08; *US CDCP, 2009, CDC PROT REALT RTPCR; WHO, 2005, HDB IMCI INT MAN CHI; WHO, 2009, WHO REG OFF EUR GUID; Williams BG, 2002, LANCET INFECT DIS, V2, P25, DOI 10.1016/S1473-3099(01)00170-0; WOLD WSM, 2007, FIELD VIROLOGY, P02395; World Health Organization, 2008, PRACT GUID HARM VIR	25	105	108	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2011	6	6							e21610	10.1371/journal.pone.0021610	http://dx.doi.org/10.1371/journal.pone.0021610			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786GP	21738731	Green Published, gold, Green Submitted			2022-12-27	WOS:000292291800026
J	Lockridge, JL; Chen, XX; Zhou, Y; Rajesh, D; Roenneburg, DA; Hegde, S; Gerdts, S; Cheng, TY; Anderson, RJ; Painter, GF; Moody, DB; Burlingham, WJ; Gumperz, JE				Lockridge, Jennifer L.; Chen, Xiuxu; Zhou, Ying; Rajesh, Deepika; Roenneburg, Drew A.; Hegde, Subramanya; Gerdts, Sarah; Cheng, Tan-Yun; Anderson, Regan J.; Painter, Gavin F.; Moody, D. Branch; Burlingham, William J.; Gumperz, Jenny E.			Analysis of the CD1 Antigen Presenting System in Humanized SCID Mice	PLOS ONE			English	Article							T-CELL RECOGNITION; MYCOBACTERIUM-TUBERCULOSIS INFECTION; NKT CELLS; DISTINCT SUBSETS; LEPROSY LESIONS; DENDRITIC CELLS; ACTIVATION; SELF; EXPRESSION; MOLECULES	CD1 molecules are glycoproteins that present lipids and glycolipids for recognition by T cells. CD1-dependent immune activation has been implicated in a wide range of immune responses, however, our understanding of the role of this pathway in human disease remains limited because of species differences between humans and other mammals: whereas humans express five different CD1 gene products (CD1a, CD1b, CD1c, CD1d, and CD1e), muroid rodents express only one CD1 isoform (CD1d). Here we report that immune deficient mice engrafted with human fetal thymus, liver, and CD34(+) hematopoietic stem cells develop a functional human CD1 compartment. CD1a, b, c, and d isoforms were highly expressed by human thymocytes, and CD1a(+) cells with a dendritic morphology were present in the thymic medulla. CD1(+) cells were also detected in spleen, liver, and lungs. APCs from spleen and liver were capable of presenting bacterial glycolipids to human CD1-restricted T cells. ELISpot analyses of splenocytes demonstrated the presence of CD1-reactive IFN-gamma producing cells. CD1d tetramer staining directly identified human iNKT cells in spleen and liver samples from engrafted mice, and injection of the glycolipid antigen alpha-GalCer resulted in rapid elevation of human IFN-gamma and IL-4 levels in the blood indicating that the human iNKT cells are biologically active in vivo. Together, these results demonstrate that the human CD1 system is present and functionally competent in this humanized mouse model. Thus, this system provides a new opportunity to study the role of CD1-related immune activation in infections to human-specific pathogens.	[Lockridge, Jennifer L.; Chen, Xiuxu; Hegde, Subramanya; Gerdts, Sarah; Gumperz, Jenny E.] Univ Wisconsin, Dept Med Microbiol & Immunol, Sch Med & Publ Hlth, Madison, WI 53706 USA; [Zhou, Ying; Rajesh, Deepika; Roenneburg, Drew A.; Burlingham, William J.] Univ Wisconsin, Dept Surg, Sch Med & Publ Hlth, Madison, WI USA; [Cheng, Tan-Yun; Moody, D. Branch] Brigham & Womens Hosp, Div Rheumatol Immunol & Allergy, Boston, MA 02115 USA; [Anderson, Regan J.; Painter, Gavin F.] Ind Res Ltd, Carbohydrate Chem Team, Lower Hutt, New Zealand	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Harvard University; Brigham & Women's Hospital; Callaghan Innovation	Lockridge, JL (corresponding author), Univ Wisconsin, Dept Med Microbiol & Immunol, Sch Med & Publ Hlth, Madison, WI 53706 USA.	jegumperz@wisc.edu		Rajesh, Deepika/0000-0002-8820-4328; Anderson, Regan/0000-0003-3467-9202	Pew Scholars Program in the Biomedical Sciences; NIH [R01AI060777, R21AI076707]; Medical Education and Research Committee; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI060777, R21AI076707] Funding Source: NIH RePORTER	Pew Scholars Program in the Biomedical Sciences; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Education and Research Committee; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Major funding for this work was from an award to JEG from the Pew Scholars Program in the Biomedical Sciences and from NIH grants R01AI060777 and R21AI076707 to JEG, and by a grant from the Medical Education and Research Committee of the Wisconsin Partnership Program to WJB. GFP and RJA are employees of Industrial Research Ltd., which is a limited liability company fully owned by the government of New Zealand. The role these authors played in this study was to prepare the synthetic glycolipid a-GalCer and to formulate it for injection into mice. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEEKMAN EM, 1994, NATURE, V372, P691, DOI 10.1038/372691a0; Brigl M, 2003, NAT IMMUNOL, V4, P1230, DOI 10.1038/ni1002; Brigl M, 2004, ANNU REV IMMUNOL, V22, P817, DOI 10.1146/annurev.immunol.22.012703.104608; Chen XX, 2007, J IMMUNOL, V178, P6181, DOI 10.4049/jimmunol.178.10.6181; Chiu YH, 2002, NAT IMMUNOL, V3, P55, DOI 10.1038/ni740; Chiu YH, 1999, J EXP MED, V189, P103, DOI 10.1084/jem.189.1.103; Christiansen D, 2008, PLOS BIOL, V6, P1527, DOI 10.1371/journal.pbio.0060172; Chun T, 2003, J EXP MED, V197, P907, DOI 10.1084/jem.20021366; Dascher CC, 2003, TRENDS IMMUNOL, V24, P412, DOI 10.1016/S1471-4906(03)00179-0; de Jong A, 2007, CHEM BIOL, V14, P1232, DOI 10.1016/j.chembiol.2007.09.010; de Jong A, 2010, NAT IMMUNOL, V11, P1102, DOI 10.1038/ni.1956; de Lalla C, 2011, EUR J IMMUNOL, V41, P602, DOI 10.1002/eji.201041211; Durante-Mangoni E, 2004, J IMMUNOL, V173, P2159, DOI 10.4049/jimmunol.173.3.2159; Exley M, 2000, IMMUNOLOGY, V100, P37, DOI 10.1046/j.1365-2567.2000.00001.x; Fox LM, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000228; Gilleron M, 2004, J EXP MED, V199, P649, DOI 10.1084/jem.20031097; Gumperz JE, 2002, J EXP MED, V195, P625, DOI 10.1084/jem.20011786; Gumperz JE, 2006, TRAFFIC, V7, P2, DOI 10.1111/j.1600-0854.2005.00364.x; Kenna T, 2007, CANCER IMMUNOL IMMUN, V56, P563, DOI 10.1007/s00262-006-0215-x; Kita H, 2002, GASTROENTEROLOGY, V123, P1031, DOI 10.1053/gast.2002.36020; Lan P, 2006, BLOOD, V108, P487, DOI 10.1182/blood-2005-11-4388; LOZZIO BB, 1979, LEUKEMIA RES, V3, P363, DOI 10.1016/0145-2126(79)90033-X; MARTIN LH, 1986, P NATL ACAD SCI USA, V83, P9154, DOI 10.1073/pnas.83.23.9154; Matsuda JL, 2000, J EXP MED, V192, P741, DOI 10.1084/jem.192.5.741; Matsunaga I, 2004, J EXP MED, V200, P1559, DOI 10.1084/jem.20041429; Miller MM, 2005, P NATL ACAD SCI USA, V102, P8674, DOI 10.1073/pnas.0500105102; Moody DB, 2000, J EXP MED, V192, P965, DOI 10.1084/jem.192.7.965; Moody DB, 2004, SCIENCE, V303, P527, DOI 10.1126/science.1089353; Moody DB, 2002, NAT IMMUNOL, V3, P435, DOI 10.1038/ni780; Moody DB, 2000, NATURE, V404, P884, DOI 10.1038/35009119; Moody DB, 1997, SCIENCE, V278, P283, DOI 10.1126/science.278.5336.283; Osman Y, 2000, EUR J IMMUNOL, V30, P1919, DOI 10.1002/1521-4141(200007)30:7<1919::AID-IMMU1919>3.0.CO;2-3; PORCELLI S, 1989, NATURE, V341, P447, DOI 10.1038/341447a0; Prigozy TI, 2001, SCIENCE, V291, P664, DOI 10.1126/science.291.5504.664; Rajesh D, 2010, HUM IMMUNOL, V71, P551, DOI 10.1016/j.humimm.2010.02.019; Rosat JP, 1999, J IMMUNOL, V162, P366; Rymarchyk SL, 2008, IMMUNOLOGY, V125, P331, DOI 10.1111/j.1365-2567.2008.02846.x; Shamshiev A, 1999, EUR J IMMUNOL, V29, P1667, DOI 10.1002/(SICI)1521-4141(199905)29:05<1667::AID-IMMU1667>3.0.CO;2-U; Sieling PA, 2000, J IMMUNOL, V165, P5338, DOI 10.4049/jimmunol.165.9.5338; Sieling PA, 1999, J IMMUNOL, V162, P1851; Sieling PA, 2000, J IMMUNOL, V164, P4790, DOI 10.4049/jimmunol.164.9.4790; SIELING PA, 1995, SCIENCE, V269, P227, DOI 10.1126/science.7542404; Spada FM, 2000, J EXP MED, V191, P937, DOI 10.1084/jem.191.6.937; Spinozzi F, 2007, IMMUNOL ALLERGY CLIN, V27, P79, DOI 10.1016/j.iac.2006.11.004; Ulrichs T, 2003, INFECT IMMUN, V71, P3076, DOI 10.1128/IAI.71.6.3076-3087.2003; Van Kaer L, 2007, CURR OPIN IMMUNOL, V19, P354, DOI 10.1016/j.coi.2007.03.001; Vincent MS, 2005, J IMMUNOL, V175, P6344, DOI 10.4049/jimmunol.175.10.6344; Wang XH, 2008, BLOOD, V112, P4128, DOI 10.1182/blood-2008-05-157529; Wei DG, 2005, J EXP MED, V202, P239, DOI 10.1084/jem.20050413; Yu KOA, 2005, IMMUNOL LETT, V100, P42, DOI 10.1016/j.imlet.2005.06.010; Yu KOA, 2005, P NATL ACAD SCI USA, V102, P3383, DOI 10.1073/pnas.0407488102; Zhou DP, 2004, SCIENCE, V306, P1786, DOI 10.1126/science.1103440	52	28	28	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2011	6	6							e21701	10.1371/journal.pone.0021701	http://dx.doi.org/10.1371/journal.pone.0021701			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786GP	21738769	gold, Green Published, Green Submitted			2022-12-27	WOS:000292291800032
J	Knottnerus, ILH; Gielen, M; Lodder, J; Rouhl, RPW; Staals, J; Vlietinck, R; van Oostenbrugge, RJ				Knottnerus, Iris L. H.; Gielen, Marij; Lodder, Jan; Rouhl, Rob P. W.; Staals, Julie; Vlietinck, Robert; van Oostenbrugge, Robert J.			Estimating the Magnitude of Genetic Factors by Calculating the Genetic Relative Risk of Stroke in First-Ever Lacunar Stroke Patients	PLOS ONE			English	Article							MATTER HYPERINTENSITY VOLUME; FAMILY-HISTORY; ISCHEMIC-STROKE; PREVALENCE; POPULATION; SUBTYPES; COMMUNITY; SIBLINGS	Background: Positive family history of stroke is an independent risk factor for lacunar stroke. However, the magnitude of familial aggregation of a certain disease is better evaluated by the genetic relative risk. This is calculated by dividing the prevalence of specific disease in family members of patients by the prevalence of this disease in the general population. In a cohort of lacunar stroke patients, who were subtyped clinically and radiologically, we determined the genetic relative risk of stroke. Methods: By questionnaire and additional interview, we obtained a complete first-degree family history of stroke. The prevalence of stroke in first-degree relatives of these lacunar stroke patients was compared to the self-reported prevalence of stroke in a Dutch community based cohort of elderly volunteers. Secondly, the influence of proband characteristics and family composition on parental and sibling history of stroke were evaluated. Principal Findings: We collected data of 1066 first-degree relatives of 195 lacunar stroke patients. Strokes occurred in 13.5% of first-degree relatives. The genetic relative risk was 2.94 (95% CI 2.45-3.53) for overall first-degree relatives, 4.52 (95% CI 3.61-5.65) for patients' parents and 2.10 (95% CI 1.63-2.69) for patients' siblings. Age of proband and proband status for hypertension influenced the chance of having a parent with a history of stroke whereas the likelihood of having a concordant sibling increased with sibship size. Conclusions: We found an increased genetic relative risk of stroke in first-degree relatives of patients with lacunar stroke. Our data warrant further genomic research in this well-defined high risk population for stroke.	[Knottnerus, Iris L. H.; Lodder, Jan; Rouhl, Rob P. W.; Staals, Julie; van Oostenbrugge, Robert J.] Maastricht Univ, Med Ctr, Dept Neurol, Maastricht, Netherlands; [Knottnerus, Iris L. H.; Lodder, Jan; Staals, Julie; van Oostenbrugge, Robert J.] Maastricht Univ, Med Ctr, Cardiovasc Res Inst Maastricht CARIM, Maastricht, Netherlands; [Knottnerus, Iris L. H.] Med Spectrum Twente, Dept Neurol, Enschede, Netherlands; [Gielen, Marij] Nutr & Toxicol Res Inst Maastricht NUTRIM, Dept Genet & Cell Biol, Sect Complex Genet, Maastricht, Netherlands; [Gielen, Marij] Univ Birmingham, Unit Genet Epidemiol, Dept Publ Hlth Epidemiol & Biostat, Birmingham, W Midlands, England; [Vlietinck, Robert] Catholic Univ Louvain, Dept Human Genet, Fac Med, B-3000 Leuven, Belgium	Maastricht University; Maastricht University; Medical Spectrum Twente; Maastricht University; University of Birmingham	Knottnerus, ILH (corresponding author), Maastricht Univ, Med Ctr, Dept Neurol, Maastricht, Netherlands.	iris.knottnerus@home.nl	gielen, marij/D-8010-2011		Netherlands Thrombosis Foundation [2007-3]	Netherlands Thrombosis Foundation	I.L.H. Knottnerus is supported by a research grant of the Netherlands Thrombosis Foundation (grant number 2007-3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atwood LD, 2004, STROKE, V35, P1609, DOI 10.1161/01.STR.0000129643.77045.10; BAMFORD J, 1987, STROKE, V18, P545, DOI 10.1161/01.STR.18.3.545; Bots ML, 1996, STROKE, V27, P1499, DOI 10.1161/01.STR.27.9.1499; Burton PR, 2005, LANCET, V366, P941, DOI 10.1016/S0140-6736(05)67322-9; Carmelli D, 1998, STROKE, V29, P1177, DOI 10.1161/01.STR.29.6.1177; Flossmann E, 2005, CEREBROVASC DIS, V19, P1, DOI 10.1159/000081905; Geddes JML, 1996, J EPIDEMIOL COMMUN H, V50, P140, DOI 10.1136/jech.50.2.140; Hassan A, 2002, NEUROLOGY, V58, P1483, DOI 10.1212/WNL.58.10.1483; Jackson C, 2005, STROKE, V36, P891, DOI 10.1161/01.STR.0000157949.34986.30; Jerrard-Dunne P, 2003, STROKE, V34, P1364, DOI 10.1161/01.STR.0000069723.17984.FD; Jood K, 2005, STROKE, V36, P1383, DOI 10.1161/01.STR.0000169944.46025.09; Jungehulsing GJ, 2008, NEUROEPIDEMIOLOGY, V30, P51, DOI 10.1159/000115750; Knottnerus ILH, 2010, STROKE, V41, P1617, DOI 10.1161/STROKEAHA.109.576223; Leistner S, 2008, EUR NEUROL, V59, P143, DOI 10.1159/000111877; Lindgren A, 2005, CEREBROVASC DIS, V20, P381, DOI 10.1159/000088668; Lisabeth LD, 2008, NEUROEPIDEMIOLOGY, V31, P33, DOI 10.1159/000136649; Markus HS, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000225; Meschia JF, 2001, STROKE, V32, P2939, DOI 10.1161/hs1201.099795; Mullen SA, 2009, NEUROLOGY, V72, P558, DOI 10.1212/01.wnl.0000341942.29513.bd; Polychronopoulos P, 2002, J NEUROL SCI, V195, P117, DOI 10.1016/S0022-510X(01)00691-8; Rouhl RPW, 2008, J NEUROL, V255, P692, DOI 10.1007/s00415-008-0777-y; Staals J, 2009, STROKE, V40, P3264, DOI 10.1161/STROKEAHA.109.558049	22	3	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2011	6	6							e21439	10.1371/journal.pone.0021439	http://dx.doi.org/10.1371/journal.pone.0021439			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786FZ	21747905	Green Submitted, Green Published, gold			2022-12-27	WOS:000292290100023
J	Nowick, K; Fields, C; Gernat, T; Caetano-Anolles, D; Kholina, N; Stubbs, L				Nowick, Katja; Fields, Christopher; Gernat, Tim; Caetano-Anolles, Derek; Kholina, Nadezda; Stubbs, Lisa			Gain, Loss and Divergence in Primate Zinc-Finger Genes: A Rich Resource for Evolution of Gene Regulatory Differences between Species	PLOS ONE			English	Article							TRANSCRIPTION FACTORS; RECOMBINATION HOTSPOTS; MEIOTIC RECOMBINATION; MOLECULAR EVOLUTION; KRAB; EXPRESSION; PRDM9; EXPANSION; PROTEINS; DOMAINS	The molecular changes underlying major phenotypic differences between humans and other primates are not well understood, but alterations in gene regulation are likely to play a major role. Here we performed a thorough evolutionary analysis of the largest family of primate transcription factors, the Kruppel-type zinc finger (KZNF) gene family. We identified and curated gene and pseudogene models for KZNFs in three primate species, chimpanzee, orangutan and rhesus macaque, to allow for a comparison with the curated set of human KZNFs. We show that the recent evolutionary history of primate KZNFs has been complex, including many lineage-specific duplications and deletions. We found 213 species-specific KZNFs, among them 7 human-specific and 23 chimpanzee-specific genes. Two human-specific genes were validated experimentally. Ten genes have been lost in humans and 13 in chimpanzees, either through deletion or pseudogenization. We also identified 30 KZNF orthologs with human-specific and 42 with chimpanzee-specific sequence changes that are predicted to affect DNA binding properties of the proteins. Eleven of these genes show signatures of accelerated evolution, suggesting positive selection between humans and chimpanzees. During primate evolution the most extensive re-shaping of the KZNF repertoire, including most gene additions, pseudogenizations, and structural changes occurred within the subfamily homininae. Using zinc finger (ZNF) binding predictions, we suggest potential impact these changes have had on human gene regulatory networks. The large species differences in this family of TFs stands in stark contrast to the overall high conservation of primate genomes and potentially represents a potent driver of primate evolution.	[Nowick, Katja; Fields, Christopher; Gernat, Tim; Caetano-Anolles, Derek; Kholina, Nadezda; Stubbs, Lisa] Univ Illinois, Inst Genom Biol, Urbana, IL 61801 USA; [Nowick, Katja; Caetano-Anolles, Derek; Kholina, Nadezda; Stubbs, Lisa] Univ Illinois, Dept Cell & Dev Biol, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Nowick, K (corresponding author), Univ Leipzig, Bioinformat Grp, Paul Flechsig Inst Brain Res, Leipzig, Germany.	ljstubbs@illinois.edu	Caetano-Anoles, Derek/L-7251-2019; Nowick, Katja/J-8270-2014	Caetano-Anoles, Derek/0000-0001-7704-0578; Nowick, Katja/0000-0003-3993-4479; Gernat, Tim/0000-0002-5977-3900; Fields, Christopher/0000-0002-7749-5844; Stubbs, Lisa/0000-0002-9556-1972	U.S. National Institutes of Health, NIGMS [GM078368]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078368] Funding Source: NIH RePORTER	U.S. National Institutes of Health, NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the U.S. National Institutes of Health, NIGMS under grant number GM078368 (awarded to L.S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baudat F, 2010, SCIENCE, V327, P836, DOI 10.1126/science.1183439; BELLEFROID EJ, 1993, EMBO J, V12, P1363, DOI 10.1002/j.1460-2075.1993.tb05781.x; Collins T, 2001, MOL CELL BIOL, V21, P3609, DOI 10.1128/MCB.21.11.3609-3615.2001; Eloy-Trinquet S, 2009, DEV DYNAM, V238, P1195, DOI 10.1002/dvdy.21946; Emerson RO, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000325; Enard W, 2002, NATURE, V418, P869, DOI 10.1038/nature01025; Hamilton AT, 2006, GENOME RES, V16, P584, DOI 10.1101/gr.4843906; Hamilton AT, 2003, COLD SPRING HARB SYM, V68, P131, DOI 10.1101/sqb.2003.68.131; Hecht J, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000025; Huntley S, 2006, GENOME RES, V16, P669, DOI 10.1101/gr.4842106; Kaplan T, 2005, PLOS COMPUT BIOL, V1, P5, DOI 10.1371/journal.pcbi.0010001; Kim Mi Young, 2009, J Calif Dent Assoc, V37, P875; Lewis S.E., 2002, GENOME BIOL, V3, pRESEARCH0082, DOI [10.1186/gb-2002-3-12-research0082, DOI 10.1186/GB-2002-3-12-RESEARCH0082]; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Looman C, 2002, MOL BIOL EVOL, V19, P2118, DOI 10.1093/oxfordjournals.molbev.a004037; MARGOLIN JF, 1994, P NATL ACAD SCI USA, V91, P4509, DOI 10.1073/pnas.91.10.4509; Marques-Bonet T, 2009, NATURE, V457, P877, DOI 10.1038/nature07744; Martin A, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-91; Mason S, 2009, MOL NEUROBIOL, V39, P10, DOI 10.1007/s12035-008-8048-6; McKay Sheldon J, 2010, Curr Protoc Bioinformatics, VChapter 9, DOI 10.1002/0471250953.bi0912s31; Myers S, 2010, SCIENCE, V327, P876, DOI 10.1126/science.1182363; NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4; Nowick K, 2010, MOL BIOL EVOL, V27, P2606, DOI 10.1093/molbev/msq157; Nowick K, 2010, BRIEF FUNCT GENOMICS, V9, P65, DOI 10.1093/bfgp/elp056; Nowick K, 2009, P NATL ACAD SCI USA, V106, P22358, DOI 10.1073/pnas.0911376106; Oliver PL, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000753; Parvanov ED, 2010, SCIENCE, V327, P835, DOI 10.1126/science.1181495; Perry GH, 2006, P NATL ACAD SCI USA, V103, P8006, DOI 10.1073/pnas.0602318103; Prufer K, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-41; Shannon M, 2003, GENOME RES, V13, P1097, DOI 10.1101/gr.963903; Stajich JE, 2002, GENOME RES, V12, P1611, DOI 10.1101/gr.361602; Stein LD, 2002, GENOME RES, V12, P1599, DOI 10.1101/gr.403602; Stubbs L, 2009, FOCUS ZINC FINGER PR, P13; Tadepally HD, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-176; Thomas JH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008505; Thomas JH, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-51; Uittenbogaard M., 2002, Gene Expression Patterns, V1, P115, DOI 10.1016/S1567-133X(01)00022-9; Urrutia R, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-231; Urs S, 2010, FASEB J, V24, P3264, DOI 10.1096/fj.10-155127; Vaquerizas JM, 2009, NAT REV GENET, V10, P252, DOI 10.1038/nrg2538; Wolfe SA, 2001, STRUCTURE, V9, P717, DOI 10.1016/S0969-2126(01)00632-3; Yang XH, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-48; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555	43	39	39	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2011	6	6							e21553	10.1371/journal.pone.0021553	http://dx.doi.org/10.1371/journal.pone.0021553			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786FZ	21738707	Green Submitted, Green Published, gold			2022-12-27	WOS:000292290100037
J	Ma, T; Liaset, B; Hao, Q; Petersen, RK; Fjaere, E; Ngo, HT; Lillefosse, HH; Ringholm, S; Sonne, SB; Treebak, JT; Pilegaard, H; Froyland, L; Kristiansen, K; Madsen, L				Ma, Tao; Liaset, Bjorn; Hao, Qin; Petersen, Rasmus Koefoed; Fjaere, Even; Ha Thi Ngo; Lillefosse, Haldis Haukas; Ringholm, Stine; Sonne, Si Brask; Treebak, Jonas Thue; Pilegaard, Henriette; Froyland, Livar; Kristiansen, Karsten; Madsen, Lise			Sucrose Counteracts the Anti-Inflammatory Effect of Fish Oil in Adipose Tissue and Increases Obesity Development in Mice	PLOS ONE			English	Article							POLYUNSATURATED FATTY-ACIDS; DIET-INDUCED OBESITY; INSULIN-RESISTANCE; HEPATIC GLUCONEOGENESIS; EICOSAPENTAENOIC ACID; ADIPOCYTE DIFFERENTIATION; ENERGY-EXPENDITURE; BROWN ADIPOCYTES; DIABETIC MICE; HIGH-PROTEIN	Background: Polyunsaturated n-3 fatty acids (n-3 PUFAs) are reported to protect against high fat diet-induced obesity and inflammation in adipose tissue. Here we aimed to investigate if the amount of sucrose in the background diet influences the ability of n-3 PUFAs to protect against diet-induced obesity, adipose tissue inflammation and glucose intolerance. Methodology/Principal Findings: We fed C57BL/6J mice a protein-(casein) or sucrose-based high fat diet supplemented with fish oil or corn oil for 9 weeks. Irrespective of the fatty acid source, mice fed diets rich in sucrose became obese whereas mice fed high protein diets remained lean. Inclusion of sucrose in the diet also counteracted the well-known anti-inflammatory effect of fish oil in adipose tissue, but did not impair the ability of fish oil to prevent accumulation of fat in the liver. Calculation of HOMA-IR indicated that mice fed high levels of proteins remained insulin sensitive, whereas insulin sensitivity was reduced in the obese mice fed sucrose irrespectively of the fat source. We show that a high fat diet decreased glucose tolerance in the mice independently of both obesity and dietary levels of n-3 PUFAs and sucrose. Of note, increasing the protein: sucrose ratio in high fat diets decreased energy efficiency irrespective of fat source. This was accompanied by increased expression of Ppargc1a (peroxisome proliferator-activated receptor, gamma, coactivator 1 alpha) and increased gluconeogenesis in the fed state. Conclusions/Significance: The background diet influence the ability of n-3 PUFAs to protect against development of obesity, glucose intolerance and adipose tissue inflammation. High levels of dietary sucrose counteract the anti-inflammatory effect of fish oil in adipose tissue and increases obesity development in mice.	[Ma, Tao; Hao, Qin; Petersen, Rasmus Koefoed; Fjaere, Even; Lillefosse, Haldis Haukas; Ringholm, Stine; Sonne, Si Brask; Pilegaard, Henriette; Kristiansen, Karsten; Madsen, Lise] Univ Copenhagen, Dept Biol, Copenhagen, Denmark; [Liaset, Bjorn; Fjaere, Even; Ha Thi Ngo; Lillefosse, Haldis Haukas; Froyland, Livar; Madsen, Lise] Natl Inst Nutr & Seafood Res NIFES, Bergen, Norway; [Treebak, Jonas Thue] Univ Copenhagen, Dept Exercise & Sport Sci, Copenhagen, Denmark	University of Copenhagen; University of Copenhagen	Ma, T (corresponding author), Univ Copenhagen, Dept Biol, Copenhagen, Denmark.	kk@bio.ku.dk; lise.madsen@nifes.no	Sonne, Si Brask/A-4851-2012; Treebak, Jonas Thue/B-4521-2017; Pilegaard, Henriette/M-2315-2014; Madsen, Lise/C-6246-2012; Kristiansen, Karsten/J-5148-2014	Sonne, Si Brask/0000-0003-3194-3805; Treebak, Jonas Thue/0000-0003-1488-7012; Pilegaard, Henriette/0000-0002-1071-0327; Madsen, Lise/0000-0003-4468-1947; Kristiansen, Karsten/0000-0002-6024-0917; Liaset, Bjorn/0000-0002-8652-7801; Hao, Qin/0000-0002-6775-2181	Danish Natural Science Research Council; Novo Nordisk Foundation; Carlsberg Foundation; National Institute of Nutrition and Seafood Research, Norway; Danish Council for Strategic Research [NO 2101 06 0005]	Danish Natural Science Research Council(Danish Natural Science Research Council); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Carlsberg Foundation(Carlsberg Foundation); National Institute of Nutrition and Seafood Research, Norway; Danish Council for Strategic Research(Danske Strategiske Forskningsrad (DSF))	This work was supported by the Danish Natural Science Research Council, the Novo Nordisk Foundation, the Carlsberg Foundation, and the National Institute of Nutrition and Seafood Research, Norway. Part of the work was carried out as a part of the research program of the Danish Obesity Research Centre (DanORC). DanORC is supported by the Danish Council for Strategic Research (Grant NO 2101 06 0005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ailhaud G, 2007, GENES NUTR, V2, P39, DOI 10.1007/s12263-007-0017-6; Ailhaud G, 2006, PROG LIPID RES, V45, P203, DOI 10.1016/j.plipres.2006.01.003; Arai T, 2009, J ATHEROSCLER THROMB, V16, P674, DOI 10.5551/jat.1313; Arkan MC, 2005, NAT MED, V11, P191, DOI 10.1038/nm1185; Arslan G, 2002, LIPIDS, V37, P935, DOI 10.1007/s11745-006-0983-2; Barbatelli G, 2010, AM J PHYSIOL-ENDOC M, V298, pE1244, DOI 10.1152/ajpendo.00600.2009; BELZUNG F, 1993, AM J PHYSIOL, V264, pR1111, DOI 10.1152/ajpregu.1993.264.6.R1111; Bluher M, 2002, DEV CELL, V3, P25, DOI 10.1016/S1534-5807(02)00199-5; Calder PC, 2009, BIOCHIMIE, V91, P791, DOI 10.1016/j.biochi.2009.01.008; Cani PD, 2007, DIABETES, V56, P1761, DOI 10.2337/db06-1491; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; de Luca C, 2008, FEBS LETT, V582, P97, DOI 10.1016/j.febslet.2007.11.057; Donath MY, 2011, NAT REV IMMUNOL, V11, P98, DOI 10.1038/nri2925; Erkkila A, 2008, PROG LIPID RES, V47, P172, DOI 10.1016/j.plipres.2008.01.004; Flachs P, 2005, DIABETOLOGIA, V48, P2365, DOI 10.1007/s00125-005-1944-7; Froyland L, 1997, J LIPID RES, V38, P1851; Groeger AL, 2010, NAT CHEM BIOL, V6, P433, DOI 10.1038/nchembio.367; Guerra C, 1998, J CLIN INVEST, V102, P412, DOI 10.1172/JCI3155; Halton TL, 2004, J AM COLL NUTR, V23, P373, DOI 10.1080/07315724.2004.10719381; Harris William S, 2010, Curr Cardiol Rep, V12, P503, DOI 10.1007/s11886-010-0141-6; Herzig S, 2001, NATURE, V413, P179, DOI 10.1038/35093131; Hoehn KL, 2010, CELL METAB, V11, P70, DOI 10.1016/j.cmet.2009.11.008; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Huber J, 2007, INT J OBESITY, V31, P1004, DOI 10.1038/sj.ijo.0803511; Itoh M, 2007, ARTERIOSCL THROM VAS, V27, P1918, DOI 10.1161/ATVBAHA.106.136853; Jucker BM, 1999, DIABETES, V48, P134, DOI 10.2337/diabetes.48.1.134; Kalupahana NS, 2010, J NUTR, V140, P1915, DOI 10.3945/jn.110.125732; Kim JK, 2001, J CLIN INVEST, V108, P437, DOI 10.1172/JCI11559; Kopecky J, 1996, AM J PHYSIOL-ENDOC M, V270, pE768, DOI 10.1152/ajpendo.1996.270.5.E768; Liaset B, 2009, BBA-MOL CELL BIOL L, V1791, P254, DOI 10.1016/j.bbalip.2009.01.016; Madsen L, 1999, LIPIDS, V34, P951, DOI 10.1007/s11745-999-0445-x; Madsen L, 2005, BBA-MOL BASIS DIS, V1740, P266, DOI 10.1016/j.bbadis.2005.03.001; Madsen L, 2003, BIOCHEM J, V375, P539, DOI 10.1042/BJ20030503; Madsen L, 2008, J BIOL CHEM, V283, P7196, DOI 10.1074/jbc.M707775200; Madsen L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011391; Madsen L, 2010, ANN NY ACAD SCI, V1190, P1, DOI 10.1111/j.1749-6632.2009.05262.x; Massiera F, 2003, J LIPID RES, V44, P271, DOI 10.1194/jlr.M200346-JLR200; Mikkelsen PB, 2000, AM J CLIN NUTR, V72, P1135; Murata Y, 2007, BIOCHEM BIOPH RES CO, V364, P301, DOI 10.1016/j.bbrc.2007.10.007; Neschen S, 2007, DIABETES, V56, P1034, DOI 10.2337/db06-1206; Oh DY, 2010, CELL, V142, P687, DOI 10.1016/j.cell.2010.07.041; Pandey SK, 2002, ENDOCRINOLOGY, V143, P375, DOI 10.1210/en.143.2.375; Perez-Echarri N, 2008, EUR J NUTR, V47, P380, DOI 10.1007/s00394-008-0738-3; Puigserver P, 2003, NATURE, V423, P550, DOI 10.1038/nature01667; ROBINSON SM, 1990, AM J CLIN NUTR, V52, P72, DOI 10.1093/ajcn/52.1.72; Rokling-Andersen MH, 2009, BRIT J NUTR, V102, P995, DOI 10.1017/S0007114509353210; Ruzickova J, 2005, LIPIDS, V40, P115; Samane S, 2009, METABOLISM, V58, P909, DOI 10.1016/j.metabol.2009.02.013; Sato A, 2010, DIABETES, V59, P2495, DOI 10.2337/db09-1554; Shoelson SE, 2003, INT J OBESITY, V27, pS49, DOI 10.1038/sj.ijo.0802501; Simopoulos AP, 2002, BIOMED PHARMACOTHER, V56, P365, DOI 10.1016/S0753-3322(02)00253-6; STORLIEN LH, 1987, SCIENCE, V237, P885, DOI 10.1126/science.3303333; Todoric J, 2006, DIABETOLOGIA, V49, P2109, DOI 10.1007/s00125-006-0300-x; Wang HQ, 2002, AM J PHYSIOL-ENDOC M, V282, pE1352, DOI 10.1152/ajpendo.00230.2001; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Yoon JC, 2001, NATURE, V413, P131, DOI 10.1038/35093050	57	40	40	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2011	6	6							e21647	10.1371/journal.pone.0021647	http://dx.doi.org/10.1371/journal.pone.0021647			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	784FW	21738749	Green Submitted, Green Published, gold			2022-12-27	WOS:000292142800052
J	Kelber, A; Jonsson, F; Wallen, R; Warrant, E; Kornfeldt, T; Baird, E				Kelber, Almut; Jonsson, Fredrik; Wallen, Rita; Warrant, Eric; Kornfeldt, Torill; Baird, Emily			Hornets Can Fly at Night without Obvious Adaptations of Eyes and Ocelli	PLOS ONE			English	Article							SPECTRAL SENSITIVITY; NOCTURNAL VISION; FACET LENS; SWEAT BEES; LIGHT; PHOTORECEPTORS; HONEYBEES; LIMITS; SIZE	Hornets, the largest social wasps, have a reputation of being facultatively nocturnal. Here we confirm flight activity of hornet workers in dim twilight. We studied the eyes and ocelli of European hornets (Vespa crabro) and common wasps (Vespula vulgaris) with the goal to find the optical and anatomical adaptations that enable them to fly in dim light. Adaptations described for obligately nocturnal hymenoptera such as the bees Xylocopa tranquebarica and Megalopta genalis and the wasp Apoica pallens include large ocelli and compound eyes with wide rhabdoms and large facet lenses. Interestingly, we did not find any such adaptations in hornet eyes or ocelli. On the contrary, their eyes are even less sensitive than those of the obligately diurnal common wasps. Therefore we conclude that hornets, like several facultatively nocturnal bee species such as Apis mellifera adansonii, A. dorsata and X. tenuiscapa are capable of seeing in dim light simply due to the large body and thus eye size. We propose that neural pooling strategies and behavioural adaptations precede anatomical adaptations in the eyes and ocelli when insects with apposition compound eyes turn to dim light activity.	[Kelber, Almut; Jonsson, Fredrik; Wallen, Rita; Warrant, Eric; Kornfeldt, Torill; Baird, Emily] Lund Univ, Lund Vis Grp, Dept Biol, Lund, Sweden	Lund University	Kelber, A (corresponding author), Lund Univ, Lund Vis Grp, Dept Biol, Lund, Sweden.	almut.kelber@biol.lu.se	Baird, Emily/G-8763-2014; Kelber, Almut/H-6216-2014	Baird, Emily/0000-0003-3625-3897; Kelber, Almut/0000-0003-3937-2808; Warrant, Eric/0000-0001-7480-7016	Crafoord Foundation; Swedish Research Council [2003-7165, 2006-4510]	Crafoord Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission)	This study was funded by the Crafoord Foundation and the Swedish Research Council (2003-7165, 2006-4510). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BLACKITH R. E., 1958, INSECTS SOCIAUX, V5, P263, DOI 10.1007/BF02223936; BRUNO MS, 1977, J COMP PHYSIOL, V120, P123, DOI 10.1007/BF00619310; Frederiksen R, 2008, J EXP BIOL, V211, P844, DOI 10.1242/jeb.012179; Greiner B, 2006, J COMP NEUROL, V495, P255, DOI 10.1002/cne.20882; Greiner B, 2007, CURR BIOL, V17, pR879, DOI 10.1016/j.cub.2007.08.015; Greiner B, 2006, INT REV CYTOL, V250, P1, DOI 10.1016/S0074-7696(06)50001-4; Homann H., 1924, Z VGL PHYSL, V1, P541, DOI 10.1007/BF00337911; Kelber A, 2006, BEHAV ECOL, V17, P63, DOI 10.1093/beheco/arj001; Kelber A, 2010, OPHTHAL PHYSL OPT, V30, P454, DOI 10.1111/j.1475-1313.2010.00721.x; KERFOOT WB, 1967, AM NAT, V101, P65, DOI 10.1086/282470; KIRSCHFELD K, 1974, Z NATURFORSCH C, VC 29, P592; Land M.F., 1981, HDB SENSORY PHYSL, P471, DOI DOI 10.1007/978-3-642-66907-14; LAND MF, 1985, J COMP PHYSIOL A, V156, P525, DOI 10.1007/BF00613976; MIZUNAMI M, 1995, VISION RES, V35, P443, DOI 10.1016/0042-6989(94)00192-O; Somanathan H, 2008, J COMP PHYSIOL A, V194, P97, DOI 10.1007/s00359-007-0291-1; Somanathan H, 2009, J EXP BIOL, V212, P2448, DOI 10.1242/jeb.031484; Somanathan H, 2009, J COMP PHYSIOL A, V195, P571, DOI 10.1007/s00359-009-0432-9; Spaethe J, 2001, P NATL ACAD SCI USA, V98, P3898, DOI 10.1073/pnas.071053098; Spiewok S, 2006, PHYSIOL BIOCHEM ZOOL, V79, P188, DOI 10.1086/498181; Stange G, 2002, J COMP PHYSIOL A, V188, P455, DOI 10.1007/s00359-002-0317-7; Stavenga DG, 2003, J COMP PHYSIOL A, V189, P189, DOI 10.1007/s00359-003-0390-6; Stavenga DG, 2003, J COMP PHYSIOL A, V189, P1, DOI 10.1007/s00359-002-0370-2; Theobald JC, 2007, J EXP BIOL, V210, P4034, DOI 10.1242/jeb.003756; Theobald JC, 2006, VISION RES, V46, P2298, DOI 10.1016/j.visres.2006.01.002; Warrant E, 1996, P ROY SOC B-BIOL SCI, V263, P1521, DOI 10.1098/rspb.1996.0222; Warrant EJ, 2004, CURR BIOL, V14, P1309, DOI 10.1016/j.cub.2004.07.057; Warrant EJ, 1998, VISION RES, V38, P195, DOI 10.1016/S0042-6989(97)00151-X; Warrant EJ, 2008, J EXP BIOL, V211, P1737, DOI 10.1242/jeb.015396; Warrant EJ, 2006, ARTHROPOD STRUCT DEV, V35, P293, DOI 10.1016/j.asd.2006.08.012	29	16	16	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2011	6	7							e21892	10.1371/journal.pone.0021892	http://dx.doi.org/10.1371/journal.pone.0021892			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791WM	21765923	Green Published, gold, Green Submitted			2022-12-27	WOS:000292699000015
J	Rivarola, M; Foster, JT; Chan, AP; Williams, AL; Rice, DW; Liu, XY; Melake-Berhan, A; Creasy, HH; Puiu, D; Rosovitz, MJ; Khouri, HM; Beckstrom-Sternberg, SM; Allan, GJ; Keim, P; Ravel, J; Rabinowicz, PD				Rivarola, Maximo; Foster, Jeffrey T.; Chan, Agnes P.; Williams, Amber L.; Rice, Danny W.; Liu, Xinyue; Melake-Berhan, Admasu; Creasy, Heather Huot; Puiu, Daniela; Rosovitz, M. J.; Khouri, Hoda M.; Beckstrom-Sternberg, Stephen M.; Allan, Gerard J.; Keim, Paul; Ravel, Jacques; Rabinowicz, Pablo D.			Castor Bean Organelle Genome Sequencing and Worldwide Genetic Diversity Analysis	PLOS ONE			English	Article							COMPLETE NUCLEOTIDE-SEQUENCE; PLANT MITOCHONDRIAL GENOMES; CHLOROPLAST GENOME; PHYLOGENETIC-RELATIONSHIPS; DNA; EVOLUTION; MAIZE; ORGANIZATION; METHYLATION; MECHANISM	Castor bean is an important oil-producing plant in the Euphorbiaceae family. Its high-quality oil contains up to 90% of the unusual fatty acid ricinoleate, which has many industrial and medical applications. Castor bean seeds also contain ricin, a highly toxic Type 2 ribosome-inactivating protein, which has gained relevance in recent years due to biosafety concerns. In order to gain knowledge on global genetic diversity in castor bean and to ultimately help the development of breeding and forensic tools, we carried out an extensive chloroplast sequence diversity analysis. Taking advantage of the recently published genome sequence of castor bean, we assembled the chloroplast and mitochondrion genomes extracting selected reads from the available whole genome shotgun reads. Using the chloroplast reference genome we used the methylation filtration technique to readily obtain draft genome sequences of 7 geographically and genetically diverse castor bean accessions. These sequence data were used to identify single nucleotide polymorphism markers and phylogenetic analysis resulted in the identification of two major clades that were not apparent in previous population genetic studies using genetic markers derived from nuclear DNA. Two distinct sub-clades could be defined within each major clade and large-scale genotyping of castor bean populations worldwide confirmed previously observed low levels of genetic diversity and showed a broad geographic distribution of each sub-clade.	[Rivarola, Maximo; Liu, Xinyue; Creasy, Heather Huot; Khouri, Hoda M.; Ravel, Jacques; Rabinowicz, Pablo D.] Univ Maryland, Sch Med, Inst Genome Sci, Baltimore, MD 21201 USA; [Foster, Jeffrey T.; Beckstrom-Sternberg, Stephen M.; Keim, Paul] No Arizona Univ, Ctr Microbial Genet & Genom, Flagstaff, AZ 86011 USA; [Chan, Agnes P.; Melake-Berhan, Admasu; Puiu, Daniela; Rosovitz, M. J.; Rabinowicz, Pablo D.] J Craig Venter Inst, Rockville, MD USA; [Williams, Amber L.; Allan, Gerard J.] No Arizona Univ, Dept Biol Sci, Environm Genet & Genom Lab, Flagstaff, AZ 86011 USA; [Rice, Danny W.] Indiana Univ, Dept Biol, Bloomington, IN USA; [Beckstrom-Sternberg, Stephen M.] Translat Genom Res Inst, Pathogen Genom Div, Phoenix, AZ USA; [Ravel, Jacques] Univ Maryland, Sch Med, Dept Microbiol & Immunol, Baltimore, MD 21201 USA; [Rabinowicz, Pablo D.] Univ Maryland, Sch Med, Dept Biochem & Mol Biol, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; Northern Arizona University; J. Craig Venter Institute; Northern Arizona University; Indiana University System; Indiana University Bloomington; Translational Genomics Research Institute; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Rivarola, M (corresponding author), Inst Nacl Tecnol Agr, Inst Biotecnol, Buenos Aires, DF, Argentina.	Paul.Keim@nau.edu; jravel@som.umaryland.edu; prabinowicz@som.umaryland.edu	Rivarola, Maximo L/C-1261-2014; Ravel, Jacques/D-2530-2009; Keim, Paul S/A-2269-2010	Rivarola, Maximo/0000-0003-2818-1037; Ravel, Jacques/0000-0002-0851-2233; Foster, Jeffrey/0000-0001-8235-8564; Chan, Agnes/0000-0003-2373-9580; Rice, Danny/0000-0002-1123-4617	National Institute of Allergy and Infectious Diseases (NIAID); National Institutes of Health, Department of Health and Human Services, under NIAID [N01-AI-30071]; Federal Bureau of Investigation (FBI) [J-FBI-04-186]	National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health, Department of Health and Human Services, under NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Federal Bureau of Investigation (FBI)	This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID; http://www.niaid.nih.gov), National Institutes of Health, Department of Health and Human Services, under NIAID Contract N01-AI-30071 (R. communis subproject), and by the Federal Bureau of Investigation (FBI; http://www.fbi.gov) grant J-FBI-04-186. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams KL, 2002, P NATL ACAD SCI USA, V99, P9905, DOI 10.1073/pnas.042694899; Allan G, 2008, GENET RESOUR CROP EV, V55, P365, DOI 10.1007/s10722-007-9244-3; ANDERSON S, 1981, NUCLEIC ACIDS RES, V9, P3015, DOI 10.1093/nar/9.13.3015; Bausher MG, 2006, BMC PLANT BIOL, V6, DOI 10.1186/1471-2229-6-21; Bedell JA, 2005, PLOS BIOL, V3, P103, DOI 10.1371/journal.pbio.0030013; BIRREN B, 1997, GENOME ANAL LAB MANU; Brigham R.D., 1993, NEW CROPS; Chan AP, 2010, NAT BIOTECHNOL, V28, P951, DOI 10.1038/nbt.1674; Chumley TW, 2006, MOL BIOL EVOL, V23, P2175, DOI 10.1093/molbev/msl089; Chung HJ, 2006, PLANT CELL REP, V25, P1369, DOI 10.1007/s00299-006-0196-4; Da Silva ND, 2006, APPL BIOCHEM BIOTECH, V130, P405, DOI 10.1385/ABAB:130:1:405; Daniell H, 2008, THEOR APPL GENET, V116, P723, DOI 10.1007/s00122-007-0706-y; Davis CC, 2007, SCIENCE, V315, P1812, DOI 10.1126/science.1135260; Dean FB, 2001, GENOME RES, V11, P1095, DOI 10.1101/gr.180501; DeVries J, 2001, SECURING HARVEST BIO; ENDO Y, 1987, J BIOL CHEM, V262, P5908; Fojtova M, 2001, PLANT SCI, V160, P585, DOI 10.1016/S0168-9452(00)00411-8; Foster JT, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-13; Goodrum JW, 2005, BIORESOURCE TECHNOL, V96, P851, DOI 10.1016/j.biortech.2004.07.006; Grant JR, 2008, NUCLEIC ACIDS RES, V36, pW181, DOI 10.1093/nar/gkn179; GUNSTONE FD, 2005, INFORM, V16, P736; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Kim KJ, 2004, DNA RES, V11, P247, DOI 10.1093/dnares/11.4.247; Kubo N, 2010, DNA RES, V17, P1, DOI 10.1093/dnares/dsp024; Lee SB, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-61; MAIER RM, 1995, J MOL BIOL, V251, P614, DOI 10.1006/jmbi.1995.0460; Masood MS, 2004, GENE, V340, P133, DOI 10.1016/j.gene.2004.06.008; MCCULLOUGH AJ, 1992, PLANT PHYSIOL, V100, P958, DOI 10.1104/pp.100.2.958; Moore MJ, 2006, BMC PLANT BIOL, V6, DOI 10.1186/1471-2229-6-17; Mower JP, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-265; Myers EW, 2000, SCIENCE, V287, P2196, DOI 10.1126/science.287.5461.2196; Newton AC, 1999, TRENDS ECOL EVOL, V14, P140, DOI 10.1016/S0169-5347(98)01555-9; PALMER LE, 2003, SCIENCE IN PRESS; PALMER M, 1991, MOL BIOL PLASTIDS, P5; Pop M, 2004, BRIEF BIOINFORM, V5, P237, DOI 10.1093/bib/5.3.237; Provan J, 2001, TRENDS ECOL EVOL, V16, P142, DOI 10.1016/S0169-5347(00)02097-8; Rabinowicz PD, 2007, CHEM REV, V107, P3377, DOI 10.1021/cr0682960; Rabinowicz PD, 1999, NAT GENET, V23, P305, DOI 10.1038/15479; Roetheli J.C., 1991, CASTOR ASSESSING FEA; SANDBRINK JM, 1989, BIOCHEM SYST ECOL, V17, P45, DOI 10.1016/0305-1978(89)90041-0; Saski C, 2005, PLANT MOL BIOL, V59, P309, DOI 10.1007/s11103-005-8882-0; Steane DA, 2005, DNA RES, V12, P215, DOI 10.1093/dnares/dsi006; Sucher NJ, 2008, PLANTA MED, V74, P603, DOI 10.1055/s-2008-1074517; Sugiura M, 1998, ANNU REV GENET, V32, P437, DOI 10.1146/annurev.genet.32.1.437; SUGIURA M, 1992, PLANT MOL BIOL, V19, P149, DOI 10.1007/BF00015612; Whitelaw CA, 2003, SCIENCE, V302, P2118, DOI 10.1126/science.1090047; Woloszynska M, 2010, J EXP BOT, V61, P657, DOI 10.1093/jxb/erp361; Wurdack KJ, 2005, AM J BOT, V92, P1397, DOI 10.3732/ajb.92.8.1397; Wyman SK, 2004, BIOINFORMATICS, V20, P3252, DOI 10.1093/bioinformatics/bth352	49	70	71	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2011	6	7							e21743	10.1371/journal.pone.0021743	http://dx.doi.org/10.1371/journal.pone.0021743			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791HI	21750729	Green Submitted, gold, Green Published			2022-12-27	WOS:000292655400016
J	Briffa, M; Greenaway, J				Briffa, Mark; Greenaway, Julie			High In Situ Repeatability of Behaviour Indicates Animal Personality in the Beadlet Anemone Actinia equina (Cnidaria)	PLOS ONE			English	Article							BRACHYRAPHIS-EPISCOPI; HERMIT-CRABS; BODY-SIZE; BOLDNESS; CONSISTENCY; EVOLUTION; AWARENESS; TRAITS	'Animal personality' means that individuals differ from one another in either single behaviours or suites of related behaviours in a way that is consistent over time. It is usually assumed that such consistent individual differences in behaviour are driven by variation in how individuals respond to information about their environment, rather than by differences in external factors such as variation in microhabitat. Since behavioural variation is ubiquitous in nature we might expect 'animal personality' to be present in diverse taxa, including animals with relatively simple nervous systems. We investigated in situ startle responses in a sea anemone, Actinia equina, to determine whether personalities might be present in this example of an animal with a simple nervous system. We found very high levels of repeatability among individuals that were re-identified in the same locations over a three week sampling period. In a subset of the data, where we used tide-pool temperature measurements to control for a key element of variation in microhabitat, these high levels of repeatability remained. Although a range of other consistent differences in micro-habitat features could have contributed to consistent differences between the behaviour of individuals, these data suggest the presence of animal personality in A. equina. Rather than being restricted to certain groups, personality may be a general feature of animals and may be particularly pronounced in species with simple nervous systems.	[Briffa, Mark; Greenaway, Julie] Univ Plymouth, Marine Biol & Ecol Res Ctr, Plymouth PL4 8AA, Devon, England	University of Plymouth	Briffa, M (corresponding author), Univ Plymouth, Marine Biol & Ecol Res Ctr, Plymouth PL4 8AA, Devon, England.	mark.briffa@plymouth.ac.uk	Briffa, Mark/M-9041-2013	Briffa, Mark/0000-0003-2520-0538				AYRE DJ, 1982, MAR BIOL, V68, P199, DOI 10.1007/BF00397607; Bell AM, 2007, P ROY SOC B-BIOL SCI, V274, P755, DOI 10.1098/rspb.2006.0199; Bell AM, 2009, ANIM BEHAV, V77, P771, DOI 10.1016/j.anbehav.2008.12.022; Biro PA, 2010, P ROY SOC B-BIOL SCI, V277, P71, DOI 10.1098/rspb.2009.1346; Bolund E, 2007, ANIM BEHAV, V74, P715, DOI 10.1016/j.anbehav.2006.10.032; Briffa M, 2008, P R SOC B, V275, P1305, DOI 10.1098/rspb.2008.0025; Briffa M, 2011, BIOL LETTERS, V7, P330, DOI 10.1098/rsbl.2010.0761; Briffa M, 2010, CURR BIOL, V20, pR912, DOI 10.1016/j.cub.2010.09.019; Briffa M, 2009, CAN J ZOOL, V87, P597, DOI 10.1139/Z09-047; Brown C, 2005, ANIM BEHAV, V70, P1003, DOI 10.1016/j.anbehav.2004.12.022; Brown C, 2004, ANIM BEHAV, V68, P1325, DOI 10.1016/j.anbehav.2004.04.004; Brusca R.C., 1990, INVERTEBRATES SINAUE; Clarac F, 2007, BRAIN RES REV, V54, P113, DOI 10.1016/j.brainresrev.2006.12.007; Dall SRX, 2004, ECOL LETT, V7, P734, DOI 10.1111/j.1461-0248.2004.00618.x; Davidson CJ, 2008, ANNU REV GENET, V42, P253, DOI 10.1146/annurev.genet.42.110807.091601; Fish JD, 2011, STUDENTS GUIDE SEASH; Fraser DF, 2001, AM NAT, V158, P124, DOI 10.1086/321307; LESSELLS CM, 1987, AUK, V104, P116, DOI 10.2307/4087240; Levine TR, 2002, HUM COMMUN RES, V28, P612, DOI 10.1093/hcr/28.4.612; Magnhagen C, 2008, ANIM BEHAV, V75, P509, DOI 10.1016/j.anbehav.2007.06.007; McNamara JM, 2009, P ROY SOC B-BIOL SCI, V276, P605, DOI 10.1098/rspb.2008.1182; Nakagawa S, 2010, BIOL REV, V85, P935, DOI 10.1111/j.1469-185X.2010.00141.x; Rands SA, 2003, NATURE, V423, P432, DOI 10.1038/nature01630; Schuett W, 2010, BIOL REV, V85, P217, DOI 10.1111/j.1469-185X.2009.00101.x; Sih A, 2004, Q REV BIOL, V79, P241, DOI 10.1086/422893; Sih A, 2004, TRENDS ECOL EVOL, V19, P372, DOI 10.1016/j.tree.2004.04.009; Sinn DL, 2005, J COMP PSYCHOL, V119, P99, DOI 10.1037/0735-7036.119.1.99; Sokal RR, 1995, BIOMETRY; Speakman JR, 2005, J EXP BIOL, V208, P1717, DOI 10.1242/jeb.01556; Wolf M, 2007, NATURE, V447, P581, DOI 10.1038/nature05835	30	48	48	1	94	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2011	6	7							e21963	10.1371/journal.pone.0021963	http://dx.doi.org/10.1371/journal.pone.0021963			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791AK	21755015	gold, Green Submitted, Green Published			2022-12-27	WOS:000292632000042
J	Hernandez-Lemus, E; Correa-Rodriguez, MD				Hernandez-Lemus, Enrique; Correa-Rodriguez, Maria D.			Non-Equilibrium Hyperbolic Transport in Transcriptional Regulation	PLOS ONE			English	Article							GENE-EXPRESSION; METABOLIC-REGULATION; PULSE; PATTERNS; KINETICS; CELL; THERMODYNAMICS; MOLECULE; SYSTEMS; HYDRODYNAMICS	In this work we studied memory and irreversible transport phenomena in a non-equilibrium thermodynamical model for genomic transcriptional regulation. Transcriptional regulation possess an extremely complex phenomenology, and it is, of course, of foremost importance in organismal cell development and in the pathogenesis of complex diseases. A better understanding of the way in which these processes occur is mandatory to optimize the construction of gene regulatory networks, but also to connect these networks with multi-scale phenomena (e.g. metabolism, signalling pathways, etc.) under an integrative Systems Biology-like vision. In this paper we analyzed three simple mechanisms of genetic stimulation: an instant pulse, a periodic biochemical signal and a saturation process with sigmoidal kinetics and from these we derived the system's thermodynamical response, in the form of, for example, anomalous transcriptional bursts.	[Hernandez-Lemus, Enrique; Correa-Rodriguez, Maria D.] Natl Inst Genom Med, Computat Genom Dept, Mexico City, DF, Mexico; [Hernandez-Lemus, Enrique] Univ Nacl Autonoma Mexico, Ctr Complex Sci, Mexico City, DF, Mexico; [Correa-Rodriguez, Maria D.] Univ Nacl Autonoma Mexico, Sch Sci, Dept Phys, Mexico City, DF, Mexico	Instituto Nacional de Medicina Genomica; Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico	Hernandez-Lemus, E (corresponding author), Natl Inst Genom Med, Computat Genom Dept, Mexico City, DF, Mexico.	ehernandez@inmegen.gob.mx		Hernandez-Lemus, Enrique/0000-0002-1872-1397	National Institute of Genomic Medicine (Mexico)	National Institute of Genomic Medicine (Mexico)	Work funded by the National Institute of Genomic Medicine (Mexico). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basu S, 2004, P NATL ACAD SCI USA, V101, P6355, DOI 10.1073/pnas.0307571101; Berg J, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.188101; Blanchard JL, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001186; Brynildsen MP, 2005, BIOCHEM SOC T, V33, P1423, DOI 10.1042/BST0331423; Chappell PE, 2003, J NEUROSCI, V23, P11202; Chen CF, 1997, MICROBIOL-UK, V143, P2079, DOI 10.1099/00221287-143-6-2079; Chen J, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-286; CHEN M, 1993, J MATH PHYS, V34, P3012, DOI 10.1063/1.530060; Djeridane Y, 2010, J PHYSIOL PHARMACOL, V61, P115; Eyring H, 1935, J CHEM PHYS, V3, P107, DOI 10.1063/1.1749604; Fujiwara T, 2009, DNA RES, V16, P59, DOI 10.1093/dnares/dsn032; Garber K, 2006, SCIENCE, V312, P1158, DOI 10.1126/science.312.5777.1158; Garcia-Colin LS, 1995, INT J MOD PHYS B, V9, P1993; Geschwind Jean-Francois, 2004, Expert Rev Anticancer Ther, V4, P449, DOI 10.1586/14737140.4.3.449; Glynn EF, 2006, BIOINFORMATICS, V22, P310, DOI 10.1093/bioinformatics/bti789; GRABERT H, 1977, Z PHYS B CON MAT, V26, P79, DOI 10.1007/BF01313375; Greive SJ, 2005, NAT REV MOL CELL BIO, V6, P221, DOI 10.1038/nrm1588; Harper CV, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000607; Hatton JP, 2003, J BONE MINER RES, V18, P58, DOI 10.1359/jbmr.2003.18.1.58; Lemus EH, 2009, J NON-EQUIL THERMODY, V34, P371, DOI 10.1515/JNETDY.2009.019; Hernandez-Lemus E, 2006, J NON-EQUIL THERMODY, V31, P397, DOI 10.1515/JNETDY.2006.017; Hernandez-Lemus E, 2010, J NON-NEWTON FLUID, V165, P1029, DOI 10.1016/j.jnnfm.2010.02.016; HERNANDEZLEMUS E, 2010, NEW TRENDS STAT PHYS; Hilioti Z, 2008, CURR BIOL, V18, P1; Hill T. L., 2002, THERMODYNAMICS SMALL; Hill TL, 1998, P NATL ACAD SCI USA, V95, P12779, DOI 10.1073/pnas.95.22.12779; Hill TL, 2004, FREE ENERGY TRANSDUC; Houseley J, 2009, CELL, V136, P763, DOI 10.1016/j.cell.2009.01.019; John S, 2009, ENDOCRINOLOGY, V150, P1766, DOI 10.1210/en.2008-0863; JOU D, 1985, PHYS REV A, V31, P2502, DOI 10.1103/PhysRevA.31.2502; JOU D, 1980, PHYSICA A, V101, P588, DOI 10.1016/0378-4371(80)90197-1; Kanasaki H, 2009, BIOL REPROD, V81, P465, DOI 10.1095/biolreprod.108.074765; KENKRE VM, 2003, P PASI MOD CHALL STA; Kenkre VM, 2007, CONTRIBUTIONS MATH P, P147; Keys DN, 2005, P NATL ACAD SCI USA, V102, P679, DOI 10.1073/pnas.0408952102; Khanin R, 2007, BIOMETRICS, V63, P816, DOI 10.1111/j.1541-0420.2007.00757.x; Kim BR, 2008, GENETICS, V180, P821, DOI 10.1534/genetics.108.093690; Knipper M, 1998, DEVELOPMENT, V125, P3709; Komili S, 2008, NAT REV GENET, V9, P38, DOI 10.1038/nrg2223; Komorowski M, 2010, BIOPHYS J, V98, P2759, DOI 10.1016/j.bpj.2010.03.032; Lee AW, 2011, MOL IMMUNOL, V48, P1160, DOI 10.1016/j.molimm.2011.02.010; Manne KK, 2000, PHYS REV E, V61, P4177, DOI 10.1103/PhysRevE.61.4177; Morse P.M., 1953, METHODS THEORETICAL; Muller D, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000279; Muller I, 1998, SPRINGER TRACTS NATU, V37, P393; Norris AJ, 2003, MOL ENDOCRINOL, V17, P193, DOI 10.1210/me.2002-0201; Pagonabarraga I, 1997, PHYSICA A, V237, P205, DOI 10.1016/S0378-4371(96)00377-9; Perez-Ortin JE, 2007, TRENDS GENET, V23, P250, DOI 10.1016/j.tig.2007.03.006; Piessens R., 1983, QUADPACK SUBROUTINE; Qian H, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.016102; Reguera D, 2005, J PHYS CHEM B, V109, P21502, DOI 10.1021/jp052904i; Resendis-Antonio O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012383; Rietsch A, 2006, MOL MICROBIOL, V59, P807, DOI 10.1111/j.1365-2958.2005.04990.x; Rozhdestvenskii BL, 2001, ENCY MATH; Rubi JM, 2007, J PHYS CHEM B, V111, P9598, DOI 10.1021/jp073413w; Rubi JM, 2007, ENERGY, V32, P297, DOI 10.1016/j.energy.2005.11.013; Rubi JM, 2008, MATEMATICHE NATUR S1, VLXXXVI; Rustici G, 2004, NAT GENET, V36, P809, DOI 10.1038/ng1377; Shaw RJ, 2006, CURR OPIN CELL BIOL, V18, P598, DOI 10.1016/j.ceb.2006.10.005; Shlomi T, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100141; Soranzo N, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-18; Swinburne IA, 2008, GENE DEV, V22, P2342, DOI 10.1101/gad.1696108; Tennant DA, 2010, NAT REV CANCER, V10, P267, DOI 10.1038/nrc2817; Tomi M, 2002, INVEST OPHTH VIS SCI, V43, P774; Wang YF, 2009, BIOPHYS J, V96, P609, DOI 10.1016/j.bpj.2008.09.040; WHITE MRH, 1995, J CELL SCI, V108, P441; Yang HT, 2007, J BIOCHEM, V142, P135, DOI 10.1093/jb/mvm151; YASIN M, 1995, ENDOCRINOLOGY, V136, P1559, DOI 10.1210/en.136.4.1559; Yu J, 2006, SCIENCE, V311, P1600, DOI 10.1126/science.1119623; Zhdanov VP, 2007, JETP LETT+, V86, P492, DOI 10.1134/S0021364007190149	70	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2011	6	7							e21558	10.1371/journal.pone.0021558	http://dx.doi.org/10.1371/journal.pone.0021558			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791AK	21754990	Green Published, Green Submitted, gold			2022-12-27	WOS:000292632000014
J	Leaver-Fay, A; Jacak, R; Stranges, PB; Kuhlman, B				Leaver-Fay, Andrew; Jacak, Ron; Stranges, P. Benjamin; Kuhlman, Brian			A Generic Program for Multistate Protein Design	PLOS ONE			English	Article							COMPUTING PARTITION-FUNCTIONS; END ELIMINATION CRITERION; COMPUTATIONAL DESIGN; SEARCH ALGORITHM; AIDED-DESIGN; RAL GTPASES; SEQUENCE; SPECIFICITY; OPTIMIZATION; STABILITY	Some protein design tasks cannot be modeled by the traditional single state design strategy of finding a sequence that is optimal for a single fixed backbone. Such cases require multistate design, where a single sequence is threaded onto multiple backbones (states) and evaluated for its strengths and weaknesses on each backbone. For example, to design a protein that can switch between two specific conformations, it is necessary to to find a sequence that is compatible with both backbone conformations. We present in this paper a generic implementation of multistate design that is suited for a wide range of protein design tasks and demonstrate in silico its capabilities at two design tasks: one of redesigning an obligate homodimer into an obligate heterodimer such that the new monomers would not homodimerize, and one of redesigning a promiscuous interface to bind to only a single partner and to no longer bind the rest of its partners. Both tasks contained negative design in that multistate design was asked to find sequences that would produce high energies for several of the states being modeled. Success at negative design was assessed by computationally redocking the undesired protein-pair interactions; we found that multistate design's accuracy improved as the diversity of conformations for the undesired protein-pair interactions increased. The paper concludes with a discussion of the pitfalls of negative design, which has proven considerably more challenging than positive design.	[Leaver-Fay, Andrew; Jacak, Ron; Stranges, P. Benjamin; Kuhlman, Brian] Univ N Carolina, Dept Biochem, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill	Leaver-Fay, A (corresponding author), Univ N Carolina, Dept Biochem, Chapel Hill, NC 27599 USA.	aleaverfay@gmail.com		Stranges, Peter Benjamin/0000-0003-1377-7321; Kuhlman, Brian/0000-0003-4907-9699	NIH [GM073960, GM073151]; University of North Carolina at Chapel Hill; Research Computing group; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073151, R01GM073960] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of North Carolina at Chapel Hill; Research Computing group; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH grants GM073960 and GM073151 (http://grants.nih.gov/grants/oer.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank the University of North Carolina at Chapel Hill and the Research Computing group for providing computational resources and support that have contributed to these research results.	Allen BD, 2006, J COMPUT CHEM, V27, P1071, DOI 10.1002/jcc.20420; Allen BD, 2010, J COMPUT CHEM, V31, P904, DOI 10.1002/jcc.21375; Ambroggio XI, 2006, J AM CHEM SOC, V128, P1154, DOI 10.1021/ja054718w; Ashworth J, 2010, NUCLEIC ACIDS RES, V38, P5601, DOI 10.1093/nar/gkq283; Bodemann BO, 2008, NAT REV CANCER, V8, P133, DOI 10.1038/nrc2296; CANTOR SB, 1995, MOL CELL BIOL, V15, P4578; Chica RA, 2010, P NATL ACAD SCI USA, V107, P20257, DOI 10.1073/pnas.1013910107; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Dahiyat BI, 1997, SCIENCE, V278, P82, DOI 10.1126/science.278.5335.82; Dantas G, 2003, J MOL BIOL, V332, P449, DOI 10.1016/S0022-2836(03)00888-X; DESMET J, 1992, NATURE, V356, P539, DOI 10.1038/356539a0; Desmet J, 2002, PROTEINS, V48, P31, DOI 10.1002/prot.10131; Ding F, 2006, PLOS COMPUT BIOL, V2, P725, DOI 10.1371/journal.pcbi.0020085; Dunbrack RL, 2002, CURR OPIN STRUC BIOL, V12, P431, DOI 10.1016/S0959-440X(02)00344-5; Dunbrack RL, 1997, PROTEIN SCI, V6, P1661, DOI 10.1002/pro.5560060807; Fenwick RB, 2010, STRUCTURE, V18, P985, DOI 10.1016/j.str.2010.05.013; Fleishman SJ, 2011, SCIENCE IN PRESS; Fleishman SJ, 2011, PLOS 1 UNPUB, V1; Fromer M, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000627; Fromer M, 2010, PROTEINS, V78, P530, DOI 10.1002/prot.22575; Fukai S, 2003, EMBO J, V22, P3267, DOI 10.1093/emboj/cdg329; Georgiev I, 2008, J COMPUT CHEM, V29, P1527, DOI 10.1002/jcc.20909; Georgiev I, 2006, LECT NOTES COMPUT SC, V3909, P530, DOI 10.1007/11732990_44; Gray JJ, 2003, J MOL BIOL, V331, P281, DOI 10.1016/S0022-2836(03)00670-3; Grigoryan G, 2006, PLOS COMPUT BIOL, V2, P551, DOI 10.1371/journal.pcbi.0020063; Grigoryan G, 2009, NATURE, V458, P859, DOI 10.1038/nature07885; Harbury PB, 1998, SCIENCE, V282, P1462, DOI 10.1126/science.282.5393.1462; Havranek JJ, 2003, NAT STRUCT BIOL, V10, P45, DOI 10.1038/nsb877; Hu XZ, 2006, PROTEINS, V62, P739, DOI 10.1002/prot.20786; Humphris EL, 2007, PLOS COMPUT BIOL, V3, P1591, DOI 10.1371/journal.pcbi.0030164; Inc G, 1999, EXPERT OPINION THERA, V9, P785; Jiang L, 2008, SCIENCE, V319, P1387, DOI 10.1126/science.1152692; Jin RS, 2005, EMBO J, V24, P2064, DOI 10.1038/sj.emboj.7600699; Joachimiak L, 2006, J MOL BIOL; Kamisetty H, 2011, PROTEINS, V79, P444, DOI 10.1002/prot.22894; Karanicolas J, 2009, CURRENT OPINION STRU, V19, P485; Keating AE, 2001, P NATL ACAD SCI USA, V98, P14825, DOI 10.1073/pnas.261563398; Kuhlman B, 2000, P NATL ACAD SCI USA, V97, P10383, DOI 10.1073/pnas.97.19.10383; Kuhlman B, 2003, SCIENCE, V302, P1364, DOI 10.1126/science.1089427; Kuhlman B, 2002, J MOL BIOL, V315, P471, DOI 10.1006/jmbi.2001.5229; Leaver-Fay A, 2005, PACIFIC SYMPOSIUM ON BIOCOMPUTING 2005, P16; Leaver-Fay A, 2008, LECT N BIOINFORMAT, V4983, P343, DOI 10.1007/978-3-540-79450-9_32; Leaver-Fay A, 2011, METHOD ENZYMOL, P545, DOI [10.1016/S0076-6879(11)87019-9, 10.1016/B978-0-12-381270-4.00019-6]; LEAVERFAY A, 2004, 6 WORKSH ALG ENG EXP; Lim KH, 2005, CANCER CELL, V7, P533, DOI 10.1016/j.ccr.2005.04.030; Lippow SM, 2007, CURR OPIN BIOTECH, V18, P305, DOI 10.1016/j.copbio.2007.04.009; Liu LF, 2010, CHEM COMMUN, V46, P8803, DOI 10.1039/c0cc02961k; Lovell SC, 2000, PROTEINS, V40, P389, DOI 10.1002/1097-0134(20000815)40:3<389::AID-PROT50>3.0.CO;2-2; Lum LG, 2006, EXP HEMATOL, V34, P1, DOI 10.1016/j.exphem.2005.07.013; Luo BH, 2009, J BIOL CHEM, V284, P3917, DOI 10.1074/jbc.M806312200; Malakauskas SM, 1998, NAT STRUCT BIOL, V5, P470, DOI 10.1038/nsb0698-470; Mandell DJ, 2009, NAT CHEM BIOL, V5, P797, DOI 10.1038/nchembio.251; METROPOLIS N, 1953, J CHEM PHYS, V21, P1087, DOI 10.1063/1.1699114; Moskalenko S, 2003, J BIOL CHEM, V278, P51743, DOI 10.1074/jbc.M308702200; NAUTIYAL S, 1995, BIOCHEMISTRY-US, V34, P11645, DOI 10.1021/bi00037a001; Pierce NA, 2002, PROTEIN ENG, V15, P779, DOI 10.1093/protein/15.10.779; PONDER JW, 1987, J MOL BIOL, V193, P775, DOI 10.1016/0022-2836(87)90358-5; Reina J, 2002, NAT STRUCT BIOL, V9, P621, DOI 10.1038/nsb815; Rohl CA, 2004, METHOD ENZYMOL, V383, P66; Rothlisberger D, 2008, NATURE, V453, P190, DOI 10.1038/nature06879; Shah PS, 2007, J MOL BIOL, V372, P1, DOI 10.1016/j.jmb.2007.06.032; Shimaoka M, 2000, NAT STRUCT BIOL, V7, P674, DOI 10.1038/77978; Siegel JB, 2010, SCIENCE, V329, P309, DOI 10.1126/science.1190239; Wu Z, 2010, NEOPLASIA, V12, P1003, DOI 10.1593/neo.101080	64	65	65	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2011	6	7							e20937	10.1371/journal.pone.0020937	http://dx.doi.org/10.1371/journal.pone.0020937			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791AK	21754981	Green Published, gold, Green Submitted			2022-12-27	WOS:000292632000005
J	Fang, D; Xu, GR; Hu, YL; Pan, C; Xie, LP; Zhang, RQ				Fang, Dong; Xu, Guangrui; Hu, Yilin; Pan, Cong; Xie, Liping; Zhang, Rongqing			Identification of Genes Directly Involved in Shell Formation and Their Functions in Pearl Oyster, Pinctada fucata	PLOS ONE			English	Article							MATRIX PROTEIN FAMILY; PRISMATIC LAYER FORMATION; CALMODULIN-LIKE PROTEIN; CARBONIC-ANHYDRASE; CALCIUM-BINDING; FRAMEWORK FORMATION; NACRE LAMELLAE; ORGANIC MATRIX; DUAL ROLE; MOLLUSK	Mollusk shell formation is a fascinating aspect of biomineralization research. Shell matrix proteins play crucial roles in the control of calcium carbonate crystallization during shell formation in the pearl oyster, Pinctada fucata. Characterization of biomineralization-related genes during larval development could enhance our understanding of shell formation. Genes involved in shell biomineralization were isolated by constructing three suppression subtractive hybridization (SSH) libraries that represented genes expressed at key points during larval shell formation. A total of 2,923 ESTs from these libraries were sequenced and gave 990 unigenes. Unigenes coding for secreted proteins and proteins with tandem-arranged repeat units were screened in the three SSH libraries. A set of sequences coding for genes involved in shell formation was obtained. RTPCR and in situ hybridization assays were carried out on five genes to investigate their spatial expression in several tissues, especially the mantle tissue. They all showed a different expression pattern from known biomineralization-related genes. Inhibition of the five genes by RNA interference resulted in different defects of the nacreous layer, indicating that they all were involved in aragonite crystallization. Intriguingly, one gene (UD_Cluster94.seq.Singlet1) was restricted to the 'aragonitic line'. The current data has yielded for the first time, to our knowledge, a suite of biomineralization-related genes active during the developmental stages of P. fucata, five of which were responsible for nacreous layer formation. This provides a useful starting point for isolating new genes involved in shell formation. The effects of genes on the formation of the 'aragonitic line', and other areas of the nacreous layer, suggests a different control mechanism for aragonite crystallization initiation from that of mature aragonite growth.	[Fang, Dong; Xu, Guangrui; Hu, Yilin; Pan, Cong; Xie, Liping; Zhang, Rongqing] Tsinghua Univ, Sch Life Sci, Inst Marine Biotechnol, Beijing 100084, Peoples R China; [Xie, Liping; Zhang, Rongqing] Tsinghua Univ, Minist Educ, Prot Sci Lab, Beijing 100084, Peoples R China	Tsinghua University; Tsinghua University	Fang, D (corresponding author), Tsinghua Univ, Sch Life Sci, Inst Marine Biotechnol, Beijing 100084, Peoples R China.	lpxie@mail.tsinghua.edu.cn; rqzhang@mail.tsinghua.edu.cn			National Natural Science Foundation of China [30871911, 20876088, 40876068, U0831001]; National Basic Research Program of China [2010CB126405]; National High Technology Research and Development Program of China [2010AA09Z405]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China)	This work was supported by National Natural Science Foundation of China Grants 30871911, 20876088, 40876068, U0831001 (Joint Fund with Guangdong) http://www.nsfc.gov.cn/Portal0/default124.htm; the National Basic Research Program of China 2010CB126405 http://www.973.gov.cn/English/Index. aspx and the National High Technology Research and Development Program of China 2010AA09Z405 http://www.most.gov.cn/eng/index.htm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addadi L, 2006, CHEM-EUR J, V12, P981, DOI 10.1002/chem.200500980; Areva S, 2002, CHEM MATER, V14, P1614, DOI 10.1021/cm0107272; ARIAS JL, 1991, CONNECT TISSUE RES, V26, P37, DOI 10.3109/03008209109152162; Belcher A.M., 1996, CONTROL CRYSTAL PHAS; Belcher AM, 1996, NATURE, V381, P56, DOI 10.1038/381056a0; BENSON SC, 1986, J CELL BIOL, V102, P1878, DOI 10.1083/jcb.102.5.1878; CARIOLOU MA, 1988, J COMP PHYSIOL B, V157, P717, DOI 10.1007/BF00691002; Christie MR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015715; Clark MS, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-362; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Cuif JP, 1996, AQUAT LIVING RESOUR, V9, P187, DOI 10.1051/alr:1996022; Dauphin Y, 2008, ANAL BIOANAL CHEM, V390, P1659, DOI 10.1007/s00216-008-1860-z; Eisenhaber B, 1999, J MOL BIOL, V292, P741, DOI 10.1006/jmbi.1999.3069; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Falini G, 1996, SCIENCE, V271, P67, DOI 10.1126/science.271.5245.67; Fang Z, 2008, PROG NAT SCI-MATER, V18, P405, DOI 10.1016/j.pnsc.2007.11.011; Fujimura Takuya, 1995, Venus the Japanese Journal of Malacology, V54, P25; Goldstien SJ, 2006, MOL ECOL, V15, P3259, DOI 10.1111/j.1365-294X.2006.02977.x; Gong NP, 2008, J STRUCT BIOL, V164, P33, DOI 10.1016/j.jsb.2008.05.009; Gotliv BA, 2003, CHEMBIOCHEM, V4, P522, DOI 10.1002/cbic.200200548; Hartgerink JD, 2001, SCIENCE, V294, P1684, DOI 10.1126/science.1063187; Hofmann GE, 2008, MAR ECOL PROG SER, V373, P219, DOI 10.3354/meps07775; Illies MR, 2002, DEV GENES EVOL, V212, P419, DOI 10.1007/s00427-002-0261-0; Inoue H, 2004, BIOCHEM BIOPH RES CO, V318, P649, DOI 10.1016/j.bbrc.2004.04.075; Iseli C, 1999, Proc Int Conf Intell Syst Mol Biol, P138; Jackson DJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-160; Jackson DJ, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-40; Jackson DJ, 2010, MOL BIOL EVOL, V27, P591, DOI 10.1093/molbev/msp278; JIAN L, 2009, FUNCTIONAL CHARACTER; KEITH J, 1993, COMP BIOCHEM PHYS B, V105, P487, DOI 10.1016/0305-0491(93)90078-J; Kim YK, 2010, BIOMATERIALS, V31, P6618, DOI 10.1016/j.biomaterials.2010.04.060; Klimley AP, 2001, MAR BIOL, V138, P617, DOI 10.1007/s002270000489; Kong YW, 2009, J BIOL CHEM, V284, P10841, DOI 10.1074/jbc.M808357200; Le TQ, 2006, EUR J ORAL SCI, V114, P320, DOI 10.1111/j.1600-0722.2006.00313.x; Leu JH, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-120; Li S, 2004, COMP BIOCHEM PHYS B, V138, P235, DOI 10.1016/j.cbpc.2004.03.012; LOWENSTAM HA, 1981, SCIENCE, V211, P1126, DOI 10.1126/science.7008198; Ma ZJ, 2007, J BIOL CHEM, V282, P23253, DOI 10.1074/jbc.M700001200; Mann K, 2006, COMP BIOCHEM PHYS B, V143, P160, DOI 10.1016/j.cbpb.2005.11.003; Mann K, 2004, BBA-PROTEINS PROTEOM, V1696, P41, DOI 10.1016/j.bbapap.2003.09.006; Marin F, 2004, CR PALEVOL, V3, P469, DOI 10.1016/j.crpv.2004.07.009; Marin F, 2008, CURR TOP DEV BIOL, V80, P209, DOI 10.1016/S0070-2153(07)80006-8; Matsushiro A, 2004, J BONE MINER METAB, V22, P163, DOI 10.1007/s00774-003-0484-9; Miranda LS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010182; Miyamoto H, 1996, P NATL ACAD SCI USA, V93, P9657, DOI 10.1073/pnas.93.18.9657; Miyashita T, 2002, VELIGER, V45, P250; Miyashita T, 2008, BIOSCI BIOTECH BIOCH, V72, P37, DOI 10.1271/bbb.70302; Miyazaki Y, 2010, COMP BIOCHEM PHYS B, V155, P241, DOI 10.1016/j.cbpb.2009.11.009; MURAMOTO K, 1994, COMP BIOCHEM PHYS B, V107, P401, DOI 10.1016/0305-0491(94)90204-6; Newman AM, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-382; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; Pertea G, 2003, BIOINFORMATICS, V19, P651, DOI 10.1093/bioinformatics/btg034; Politi Y, 2008, P NATL ACAD SCI USA, V105, P17362, DOI 10.1073/pnas.0806604105; ROSE RA, 1994, AQUACULTURE, V126, P35, DOI 10.1016/0044-8486(94)90246-1; Samata T, 1999, FEBS LETT, V462, P225, DOI 10.1016/S0014-5793(99)01387-3; Santambrogio P, 1996, BIOCHEM J, V314, P139, DOI 10.1042/bj3140139; Saruwatari K, 2009, BIOMATERIALS, V30, P3028, DOI 10.1016/j.biomaterials.2009.03.011; Schonitzer V, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-71; Shechter A, 2008, P NATL ACAD SCI USA, V105, P7129, DOI 10.1073/pnas.0800193105; Sudo S, 1997, NATURE, V387, P563, DOI 10.1038/42391; Suzuki M, 2004, BIOCHEM J, V382, P205, DOI 10.1042/BJ20040319; Suzuki M, 2007, BIOSCI BIOTECH BIOCH, V71, P1735, DOI 10.1271/bbb.70140; Suzuki M, 2009, SCIENCE, V325, P1388, DOI 10.1126/science.1173793; TAFT KL, 1994, INORG CHEM, V33, P1510, DOI 10.1021/ic00085a049; Takagi R, 2010, ZOOL SCI, V27, P416, DOI 10.2108/zsj.27.416; Takahashi T, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-240; Tsukamoto D, 2004, BIOCHEM BIOPH RES CO, V320, P1175, DOI 10.1016/j.bbrc.2004.06.072; Uemura T, 1997, MAT SCI ENG C-BIO S, V4, P303, DOI 10.1016/S0928-4931(97)00015-5; Veis A., 1990, SCIENCE, V247, P1129; Vera JC, 2008, MOL ECOL, V17, P1636, DOI 10.1111/j.1365-294X.2008.03666.x; Watanabe J, 2007, BIOMACROMOLECULES, V8, P2288, DOI 10.1021/bm0702915; WEINER S, 1979, CALCIFIED TISSUE INT, V29, P163, DOI 10.1007/BF02408072; WeiQuan Huang, 2001, Life Sciences, V68, P1727, DOI 10.1016/S0024-3205(01)00968-7; Weiss IM, 2006, FEBS LETT, V580, P1846, DOI 10.1016/j.febslet.2006.02.044; Weiss IM, 2006, J STRUCT BIOL, V153, P264, DOI 10.1016/j.jsb.2005.11.006; Weiss IM, 2000, BIOCHEM BIOPH RES CO, V267, P17, DOI 10.1006/bbrc.1999.1907; Wilt FH, 2003, DIFFERENTIATION, V71, P237, DOI 10.1046/j.1432-0436.2003.7104501.x; Wong KKW, 1996, ADV MATER, V8, P928, DOI 10.1002/adma.19960081114; Wynn A, 2005, COMP BIOCHEM PHYS B, V141, P294, DOI 10.1016/j.cbpc.2005.04.002; Yamashita I, 2001, THIN SOLID FILMS, V393, P12, DOI 10.1016/S0040-6090(01)01083-5; Yan ZG, 2007, BBA-GEN SUBJECTS, V1770, P1338, DOI 10.1016/j.bbagen.2007.06.018; Yano M, 2007, BIOCHEM BIOPH RES CO, V362, P158, DOI 10.1016/j.bbrc.2007.07.172; Yano M, 2006, COMP BIOCHEM PHYS B, V144, P254, DOI 10.1016/j.cbpb.2006.03.004; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Yu ZY, 2006, COMP BIOCHEM PHYS B, V143, P190, DOI 10.1016/j.cbpb.2005.11.006; Zhang C, 2006, MAR BIOTECHNOL, V8, P624, DOI 10.1007/s10126-006-6037-1; Zhang C, 2006, BIOCHEM BIOPH RES CO, V344, P735, DOI 10.1016/j.bbrc.2006.03.179; Zhang Y, 2003, COMP BIOCHEM PHYS B, V135, P565, DOI 10.1016/S1096-4959(03)00138-6	89	99	101	0	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2011	6	7							e21860	10.1371/journal.pone.0021860	http://dx.doi.org/10.1371/journal.pone.0021860			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786HC	21747964	Green Published, gold, Green Submitted			2022-12-27	WOS:000292293400040
J	Kachi, Y; Nakao, M; Takeuchi, T; Yano, E				Kachi, Yuko; Nakao, Mutsuhiro; Takeuchi, Takeaki; Yano, Eiji			Association between Insomnia Symptoms and Hemoglobin A(1c) Level in Japanese Men	PLOS ONE			English	Article							DIABETES-MELLITUS; SLEEP DURATION; RISK; METAANALYSIS; DEPRESSION; PREVALENCE; COMMITTEE; QUALITY; SMOKING; HEALTH	Background: The evidence for an association between insomnia symptoms and blood hemoglobin A(1c) (HbA(1c)) level has been limited and inconclusive. The aim of this study was to assess whether each symptom of initial, middle, and terminal insomnia influences HbA(1c) level in Japanese men. Methods: This cross-sectional study examined 1,022 male workers aged 22-69 years with no history of diabetes at a Japanese company's annual health check-up in April 2010. High HbA(1c) was defined as a blood level of HbA(1c) >= 6.0%. Three types of insomnia symptoms (i.e., difficulty in initiating sleep, difficulty in maintaining sleep, and early morning awakening) from the previous month were assessed by 3 responses (i.e., lasting more than 2 weeks, sometimes, and seldom or never [reference group]). Results: The overall prevalence of high HbA(1c) was 5.2%. High HbA(1c) was positively and linearly associated with both difficulty in maintaining sleep (P for trend = .002) and early morning awakening (P for trend = .007). More specifically, after adjusting for potential confounding factors, high HbA(1c) was significantly associated with difficulty in maintaining sleep lasting more than 2 weeks (adjusted odds ratio, 6.79 [95% confidence interval, 1.86-24.85]) or sometimes (2.33 [1.19-4.55]). High HbA(1c) was also significantly associated with early morning awakening lasting more than 2 weeks (3.96 [1.24-12.59]). Conclusion: Insomnia symptoms, particularly difficulty in maintaining sleep and early morning awakening, were found to have a close association with high HbA(1c) in a dose-response relationship.	[Kachi, Yuko; Nakao, Mutsuhiro; Takeuchi, Takeaki; Yano, Eiji] Teikyo Univ, Sch Med, Dept Hyg & Publ Hlth, Tokyo 173, Japan	Teikyo University	Kachi, Y (corresponding author), Teikyo Univ, Sch Med, Dept Hyg & Publ Hlth, Tokyo 173, Japan.	katti@orange.zero.jp			Ministry of Education, Culture, Sports, Science and Technology [22890195]	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by the Ministry of Education, Culture, Sports, Science and Technology, Grant-in-Aid for Research Activity Start-up (No. 22890195). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akerstedt T, 2003, J INTERN MED, V254, P6, DOI 10.1046/j.1365-2796.2003.01195.x; Allen RP, 2005, ARCH INTERN MED, V165, P1286, DOI 10.1001/archinte.165.11.1286; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Benediktsdottir B, 2010, SLEEP MED, V11, P1043, DOI 10.1016/j.sleep.2010.08.006; Beneto A, 2009, SLEEP MED REV, V13, P287, DOI 10.1016/j.smrv.2008.09.006; Cappuccio FP, 2010, DIABETES CARE, V33, P414, DOI 10.2337/dc09-1124; Chan JCN, 2009, JAMA-J AM MED ASSOC, V301, P2129, DOI 10.1001/jama.2009.726; Fisher L, 2007, DIABETES CARE, V30, P542, DOI 10.2337/dc06-1614; Kayukawa Y., 1996, BIOMED THERAP, V30, P179; Knutson KL, 2008, ANN NY ACAD SCI, V1129, P287, DOI 10.1196/annals.1417.033; Knutson KL, 2006, ARCH INTERN MED, V166, P1768, DOI 10.1001/archinte.166.16.1768; Lamond N, 2000, SLEEP, V23, P415; Ministry of Health Labour and Welfare in Japan, 2010, NAT HLTH NUTR SURV J; Nakajima H, 2008, SLEEP MED, V9, P745, DOI 10.1016/j.sleep.2007.07.017; Nathan DM, 2009, DIABETES CARE, V32, P1327, DOI 10.2337/dc09-9033; Neville SE, 2009, DIABETES-METAB RES, V25, P705, DOI 10.1002/dmrr.1012; Nomura K, 2005, SLEEP, V28, P1328, DOI 10.1093/sleep/28.10.1328; Nomura K, 2009, SLEEP MED, V10, P626, DOI 10.1016/j.sleep.2008.06.010; Punjabi NM, 2004, AM J EPIDEMIOL, V160, P521, DOI 10.1093/aje/kwh261; Seino Y., 2010, Journal of the Japan Diabetes Society, V53, P450, DOI 10.1111/j.2040-1124.2010.00074.x; SRIDHAR GR, 1994, DIABETES RES CLIN PR, V23, P183, DOI 10.1016/0168-8227(94)90103-1; Tachibana Naoko, 2003, Neurology, V60, pA38; Takeuchi T, 2004, J OCCUP HEALTH, V46, P489, DOI 10.1539/joh.46.489; Vgontzas AN, 2001, J CLIN ENDOCR METAB, V86, P3787, DOI 10.1210/jc.86.8.3787; Willi C, 2007, JAMA-J AM MED ASSOC, V298, P2654, DOI 10.1001/jama.298.22.2654	25	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2011	6	7							e21420	10.1371/journal.pone.0021420	http://dx.doi.org/10.1371/journal.pone.0021420			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786HC	21747936	gold, Green Published, Green Submitted			2022-12-27	WOS:000292293400012
J	Leshem, O; Madar, S; Kogan-Sakin, I; Kamer, I; Goldstein, I; Brosh, R; Cohen, Y; Jacob-Hirsch, J; Ehrlich, M; Ben-Sasson, S; Goldfinger, N; Loewenthal, R; Gazit, E; Rotter, V; Berger, R				Leshem, Orit; Madar, Shalom; Kogan-Sakin, Ira; Kamer, Iris; Goldstein, Ido; Brosh, Ran; Cohen, Yehudit; Jacob-Hirsch, Jasmine; Ehrlich, Marcelo; Ben-Sasson, Shmuel; Goldfinger, Naomi; Loewenthal, Ron; Gazit, Ephraim; Rotter, Varda; Berger, Raanan			TMPRSS2/ERG Promotes Epithelial to Mesenchymal Transition through the ZEB1/ZEB2 Axis in a Prostate Cancer Model	PLOS ONE			English	Article							TMPRSS2-ERG GENE FUSION; TANDEM REPEAT LOCI; CELL-LINE; EXPRESSION; ERG; RECEPTOR; ZEB1; OVEREXPRESSION; IDENTIFICATION; ACTIVATION	Prostate cancer is the most common non-dermatologic malignancy in men in the Western world. Recently, a frequent chromosomal aberration fusing androgen regulated TMPRSS2 promoter and the ERG gene (TMPRSS2/ERG) was discovered in prostate cancer. Several studies demonstrated cooperation between TMPRSS2/ERG and other defective pathways in cancer progression. However, the unveiling of more specific pathways in which TMPRSS2/ERG takes part, requires further investigation. Using immortalized prostate epithelial cells we were able to show that TMPRSS2/ERG over-expressing cells undergo an Epithelial to Mesenchymal Transition (EMT), manifested by acquisition of mesenchymal morphology and markers as well as migration and invasion capabilities. These findings were corroborated in vivo, where the control cells gave rise to discrete nodules while the TMPRSS2/ERG-expressing cells formed malignant tumors, which expressed EMT markers. To further investigate the general transcription scheme induced by TMPRSS2/ERG, cells were subjected to a microarray analysis that revealed a distinct EMT expression program, including up-regulation of the EMT facilitators, ZEB1 and ZEB2, and down-regulation of the epithelial marker CDH1(E-Cadherin). A chromatin immunoprecipitation assay revealed direct binding of TMPRSS2/ERG to the promoter of ZEB1 but not ZEB2. However, TMPRSS2/ERG was able to bind the promoters of the ZEB2 modulators, IL1R2 and SPINT1. This set of experiments further illuminates the mechanism by which the TMPRSS2/ERG fusion affects prostate cancer progression and might assist in targeting TMPRSS2/ERG and its downstream targets in future drug design efforts.	[Leshem, Orit; Cohen, Yehudit; Jacob-Hirsch, Jasmine; Berger, Raanan] Sheba Med Ctr, Sheba Canc Res Ctr, Ramat Gan, Israel; [Leshem, Orit; Ben-Sasson, Shmuel] Hebrew Univ Jerusalem, Hadassah Med Sch, IMRIC, Dept Dev Biol & Canc Res, IL-91010 Jerusalem, Israel; [Madar, Shalom; Kogan-Sakin, Ira; Kamer, Iris; Goldstein, Ido; Brosh, Ran; Goldfinger, Naomi; Rotter, Varda] Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel; [Ehrlich, Marcelo] Tel Aviv Univ, George S Wise Fac Life Sci, Dept Cell Res & Immunol, IL-69978 Tel Aviv, Israel; [Loewenthal, Ron; Gazit, Ephraim] Sheba Med Ctr, Tissue Typing Unit, Ramat Gan, Israel	Chaim Sheba Medical Center; Hebrew University of Jerusalem; Weizmann Institute of Science; Tel Aviv University; Chaim Sheba Medical Center	Leshem, O (corresponding author), Sheba Med Ctr, Sheba Canc Res Ctr, Ramat Gan, Israel.	raanan.berger@sheba.health.gov.il	Goldstein, Ido/Y-6554-2019; Brosh, Ran/H-7309-2019; Jackson, Benjamin L/C-4297-2012; Brosh, Ran/HDL-9562-2022	Goldstein, Ido/0000-0003-0139-1499; Brosh, Ran/0000-0001-9714-8623; Ehrlich, Marcelo/0000-0002-2352-1808	Flight Attendant Medical Research Institute (FAMRI); EC [LSHC-CT-2004-503576]; Yad Abraham Center for Cancer Diagnosis and Therapy; Ridgefield Foundation	Flight Attendant Medical Research Institute (FAMRI); EC(European CommissionEuropean Commission Joint Research Centre); Yad Abraham Center for Cancer Diagnosis and Therapy; Ridgefield Foundation	This research was supported by a Center of Excellence grant from Flight Attendant Medical Research Institute (FAMRI), EC FP6 Grant LSHC-CT-2004-503576, the Yad Abraham Center for Cancer Diagnosis and Therapy and the Ridgefield Foundation, "Talpiot'' program for medical leadership at the Sheba Medical Center, and the Israeli Cancer Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attard G, 2008, ONCOGENE, V27, P253, DOI 10.1038/sj.onc.1210640; Berger R, 2004, CANCER RES, V64, P8867, DOI 10.1158/0008-5472.CAN-04-2938; Bjorkman M, 2008, INT J CANCER, V123, P2774, DOI 10.1002/ijc.23885; Cai CM, 2009, CANCER RES, V69, P6027, DOI 10.1158/0008-5472.CAN-09-0395; Carver BS, 2009, NATURE, V457, pE1, DOI 10.1038/nature07738; Carver BS, 2009, NAT GENET, V41, P619, DOI 10.1038/ng.370; Cerveira N, 2006, NEOPLASIA, V8, P826, DOI 10.1593/neo.06427; Chang SY, 2009, CYTOKINE, V45, P32, DOI 10.1016/j.cyto.2008.10.013; Cheng HX, 2009, CANCER RES, V69, P1828, DOI 10.1158/0008-5472.CAN-08-3728; Chinnaiyan AM, 2008, NEOPLASIA, V10, P177, DOI 10.1593/neo.07822; Darnel AD, 2009, CANCER BIOL THER, V8, P125, DOI 10.4161/cbt.8.2.7134; Demichelis F, 2007, ONCOGENE, V26, P4596, DOI 10.1038/sj.onc.1210237; Drake JM, 2009, MOL BIOL CELL, V20, P2207, DOI 10.1091/mbc.E08-10-1076; EDWARDS A, 1992, GENOMICS, V12, P241, DOI 10.1016/0888-7543(92)90371-X; EDWARDS A, 1991, AM J HUM GENET, V49, P746; Evett IW, 1996, AM J HUM GENET, V58, P398; Graham TR, 2008, CANCER RES, V68, P2479, DOI 10.1158/0008-5472.CAN-07-2559; GUPTA S, 2010, CANC RES; HAMMOND HA, 1994, AM J HUM GENET, V55, P175; Hermans KG, 2006, CANCER RES, V66, P10658, DOI 10.1158/0008-5472.CAN-06-1871; Ikenouchi J, 2003, J CELL SCI, V116, P1959, DOI 10.1242/jcs.00389; Iljin K, 2006, CANCER RES, V66, P10242, DOI 10.1158/0008-5472.CAN-06-1986; Ke XS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003368; King JC, 2009, NAT GENET, V41, P524, DOI 10.1038/ng.371; Klezovitch O, 2008, P NATL ACAD SCI USA, V105, P2105, DOI 10.1073/pnas.0711711105; Kong DJ, 2009, STEM CELLS, V27, P1712, DOI 10.1002/stem.101; Kumar-Sinha C, 2008, NAT REV CANCER, V8, P497, DOI 10.1038/nrc2402; Ma Y, 2008, BLOOD, V111, P2339, DOI 10.1182/blood-2007-09-112128; Madar S, 2009, CARCINOGENESIS, V30, P20, DOI 10.1093/carcin/bgn232; Mertz KD, 2007, NEOPLASIA, V9, P200, DOI 10.1593/neo.07103; Mosquera JM, 2008, CLIN CANCER RES, V14, P3380, DOI 10.1158/1078-0432.CCR-07-5194; Pena C, 2006, INT J CANCER, V119, P2098, DOI 10.1002/ijc.22083; Perner S, 2007, AM J SURG PATHOL, V31, P882, DOI 10.1097/01.pas.0000213424.38503.aa; Saleem M, 2006, CANCER EPIDEM BIOMAR, V15, P217, DOI 10.1158/1055-9965.EPI-05-0737; Sanders AJ, 2007, INT J MOL MED, V20, P613; Saramaki OR, 2008, CLIN CANCER RES, V14, P3395, DOI 10.1158/1078-0432.CCR-07-2051; Sun C, 2008, ONCOGENE, V27, P5348, DOI 10.1038/onc.2008.183; Teixeira MR, 2008, AM J SURG PATHOL, V32, P642, DOI 10.1097/PAS.0b013e31815b6056; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679; Tomlins SA, 2009, EUR UROL, V56, P275, DOI 10.1016/j.eururo.2009.04.036; Wang JH, 2008, CANCER RES, V68, P8516, DOI 10.1158/0008-5472.CAN-08-1147; Yoshimoto M, 2006, NEOPLASIA, V8, P465, DOI 10.1593/neo.06283; Zhau HE, 2008, CLIN EXP METASTAS, V25, P601, DOI 10.1007/s10585-008-9183-1; Zhu M, 2009, FASEB J, V23; Zong Y, 2009, P NATL ACAD SCI USA, V106, P12465, DOI 10.1073/pnas.0905931106	46	78	85	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2011	6	7							e21650	10.1371/journal.pone.0021650	http://dx.doi.org/10.1371/journal.pone.0021650			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786HC	21747944	Green Published, Green Submitted, gold			2022-12-27	WOS:000292293400020
J	Shi, JQ; Li, RY; Zou, J; Long, Y; Meng, JL				Shi, Jiaqin; Li, Ruiyuan; Zou, Jun; Long, Yan; Meng, Jinling			A Dynamic and Complex Network Regulates the Heterosis of Yield-Correlated Traits in Rapeseed (Brassica napus L.)	PLOS ONE			English	Article							OVERDOMINANT EPISTATIC LOCI; RECOMBINANT INBRED LINES; PRIMARY GENETIC-BASIS; GRAIN-YIELD; INBREEDING DEPRESSION; TESTCROSS PROGENIES; OILSEED RAPE; HEADING DATE; CROP YIELD; RICE	Although much research has been conducted, the genetic architecture of heterosis remains ambiguous. To unravel the genetic architecture of heterosis, a reconstructed F-2 population was produced by random intercross among 202 lines of a double haploid population in rapeseed (Brassica napus L.). Both populations were planted in three environments and 15 yield-correlated traits were measured, and only seed yield and eight yield-correlated traits showed significant mid-parent heterosis, with the mean ranging from 8.7% (branch number) to 31.4% (seed yield). Hundreds of QTL and epistatic interactions were identified for the 15 yield-correlated traits, involving numerous variable loci with moderate effect, genome-wide distribution and obvious hotspots. All kinds of mode-of-inheritance of QTL (additive, A; partial-dominant, PD; full-dominant, D; over-dominant, OD) and epistatic interactions (additive x additive, AA; additive x dominant/dominant x additive, AD/DA; dominant x dominant, DD) were observed and epistasis, especially AA epistasis, seemed to be the major genetic basis of heterosis in rapeseed. Consistent with the low correlation between marker heterozygosity and mid-parent heterosis/hybrid performance, a considerable proportion of dominant and DD epistatic effects were negative, indicating heterozygosity was not always advantageous for heterosis/hybrid performance. The implications of our results on evolution and crop breeding are discussed.	[Shi, Jiaqin; Li, Ruiyuan; Zou, Jun; Long, Yan; Meng, Jinling] Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Wuhan, Hubei, Peoples R China	Huazhong Agricultural University	Shi, JQ (corresponding author), Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Wuhan, Hubei, Peoples R China.	jmeng@mail.hzau.edu.cn			National Basic Research and Development Program [2006CB101600]	National Basic Research and Development Program(National Basic Research Program of China)	Financial support for this work was provided by the National Basic Research and Development Program (2006CB101600). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel S, 2005, EUPHYTICA, V146, P157, DOI 10.1007/s10681-005-3364-7; ALLARD R. W., 1956, HILGARDIA, V24, P235; ALLARD RW, 1988, J HERED, V79, P225, DOI 10.1093/oxfordjournals.jhered.a110503; Arcade A, 2004, BIOINFORMATICS, V20, P2324, DOI 10.1093/bioinformatics/bth230; Basunanda P, 2010, THEOR APPL GENET, V120, P271, DOI 10.1007/s00122-009-1133-z; Birchler JA, 2006, P NATL ACAD SCI USA, V103, P12957, DOI 10.1073/pnas.0605627103; Chan EKF, 2010, GENETICS, V185, P991, DOI 10.1534/genetics.109.108522; CHEN W, 2008, MOL DISSECTION GENET; CHURCHILL GA, 1994, GENETICS, V138, P963; Dubcovsky J, 2007, SCIENCE, V316, P1862, DOI 10.1126/science.1143986; Duvick DN, 2001, NAT REV GENET, V2, P69, DOI 10.1038/35047587; East EM, 1936, GENETICS, V21, P375; Flint-Garcia SA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007433; Ford-Lloyd BV, 2001, HEREDITY, V87, P530, DOI 10.1046/j.1365-2540.2001.00937.x; Garcia AAF, 2008, GENETICS, V180, P1707, DOI 10.1534/genetics.107.082867; Frascaroli E, 2007, GENETICS, V176, P625, DOI 10.1534/genetics.106.064493; Fu J, 2009, NAT GENET, V41, P166, DOI 10.1038/ng.308; Goffinet B, 2000, GENETICS, V155, P463; Guo M, 2010, PLANT CELL, V22, P1057, DOI 10.1105/tpc.109.073676; HUA J, 2003, GENETIC DISSECTION B; Hua JP, 2003, P NATL ACAD SCI USA, V100, P2574, DOI 10.1073/pnas.0437907100; Hua JP, 2002, GENETICS, V162, P1885; Jiang WZ, 2008, THEOR APPL GENET, V116, P1117, DOI 10.1007/s00122-008-0740-4; KONG F, 2005, QUANTITAIVE GENETICS, P224; Krieger U, 2010, NAT GENET, V42, P459, DOI 10.1038/ng.550; Kusterer B, 2007, GENETICS, V175, P2009, DOI 10.1534/genetics.106.069005; Li LZ, 2008, GENETICS, V180, P1725, DOI 10.1534/genetics.108.091942; Li ZK, 1997, GENETICS, V145, P453; Li ZK, 2003, THEOR APPL GENET, V108, P141, DOI 10.1007/s00122-003-1401-2; Li ZK, 2001, GENETICS, V158, P1737; Liao CY, 2001, THEOR APPL GENET, V103, P104, DOI 10.1007/s001220000528; Lippman ZB, 2007, TRENDS GENET, V23, P60, DOI 10.1016/j.tig.2006.12.006; Lisec J, 2009, PLANT J, V59, P777, DOI 10.1111/j.1365-313X.2009.03910.x; Long Y, 2007, GENETICS, V177, P2433, DOI 10.1534/genetics.107.080705; Lu H, 2003, THEOR APPL GENET, V107, P494, DOI 10.1007/s00122-003-1271-7; Luo LJ, 2001, GENETICS, V158, P1755; Lysak MA, 2007, PLANT PHYSIOL, V145, P402, DOI 10.1104/pp.107.104380; Maccaferri M, 2008, GENETICS, V178, P489, DOI 10.1534/genetics.107.077297; Matioli SR, 1999, HEREDITY, V83, P54, DOI 10.1038/sj.hdy.6885320; Mei HW, 2005, THEOR APPL GENET, V110, P649, DOI 10.1007/s00122-004-1890-7; Melchinger AE, 2007, GENETICS, V177, P1815, DOI 10.1534/genetics.107.077537; Melchinger AE, 2007, GENETICS, V177, P1827, DOI [10.1534/genetics.107.080564, 10.1534/genetics.107.084871]; Meyer RC, 2010, THEOR APPL GENET, V120, P227, DOI 10.1007/s00122-009-1074-6; Mika V, 2003, PLANT SOIL ENVIRON, V49, P141, DOI 10.17221/4104-PSE; Ni ZF, 2009, NATURE, V457, P327, DOI 10.1038/nature07523; Peng JH, 2003, P NATL ACAD SCI USA, V100, P2489, DOI 10.1073/pnas.252763199; Qiu D, 2006, THEOR APPL GENET, V114, P67, DOI 10.1007/s00122-006-0411-2; Radoev M, 2008, GENETICS, V179, P1547, DOI 10.1534/genetics.108.089680; Reif JC, 2009, GENETICS, V181, P247, DOI 10.1534/genetics.108.093047; Rhode JM, 2005, AM NAT, V166, pE124, DOI 10.1086/491798; Roff DA, 2006, EVOLUTION, V60, P1981, DOI 10.1111/j.0014-3820.2006.tb01836.x; Sanjuan R, 2006, P NATL ACAD SCI USA, V103, P14402, DOI 10.1073/pnas.0604543103; Schauer N, 2006, NAT BIOTECHNOL, V24, P447, DOI 10.1038/nbt1192; Schauer N, 2008, PLANT CELL, V20, P509, DOI 10.1105/tpc.107.056523; SCHNELL FW, 1992, GENETICS, V131, P461; Semel Y, 2006, P NATL ACAD SCI USA, V103, P12981, DOI 10.1073/pnas.0604635103; Shi JQ, 2009, GENETICS, V182, P851, DOI 10.1534/genetics.109.101642; SHULL G.H., 1908, J HERED, V4, P296; Singh H, 2004, HEREDITAS, V141, P106, DOI 10.1111/j.1601-5223.2004.01728.x; Springer NM, 2007, GENOME RES, V17, P264, DOI 10.1101/gr.5347007; STUBER CW, 1987, CROP SCI, V27, P639, DOI 10.2135/cropsci1987.0011183X002700040006x; STUBER CW, 1992, GENETICS, V132, P823; Tang JH, 2010, THEOR APPL GENET, V120, P333, DOI 10.1007/s00122-009-1213-0; Terao T, 2010, THEOR APPL GENET, V120, P875, DOI 10.1007/s00122-009-1218-8; U. N., 1935, Japanese Journal of Botany, V7, P389; Wang DL, 1999, THEOR APPL GENET, V99, P1255, DOI 10.1007/s001220051331; WILLIAMS W, 1959, NATURE, V184, P527, DOI 10.1038/184527a0; Xing YZ, 2008, THEOR APPL GENET, V116, P789, DOI 10.1007/s00122-008-0711-9; Xu SZ, 2007, GENETICS, V175, P1955, DOI 10.1534/genetics.106.066571; Xue WY, 2008, NAT GENET, V40, P761, DOI 10.1038/ng.143; YAN J, 2003, STUDY GENETIC BASIS; Yan JB, 2006, EUPHYTICA, V149, P121, DOI 10.1007/s10681-005-9060-9; You AQ, 2006, GENETICS, V172, P1287, DOI 10.1534/genetics.105.047209; Yu SB, 1997, P NATL ACAD SCI USA, V94, P9226, DOI 10.1073/pnas.94.17.9226; ZENG ZB, 1994, GENETICS, V136, P1457; Zeng ZB, 2005, GENETICS, V169, P1711, DOI 10.1534/genetics.104.035857; ZHANG QF, 1994, THEOR APPL GENET, V89, P185, DOI 10.1007/BF00225139; Zhang YS, 2009, THEOR APPL GENET, V118, P1035, DOI 10.1007/s00122-008-0960-7	79	48	56	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2011	6	7							e21645	10.1371/journal.pone.0021645	http://dx.doi.org/10.1371/journal.pone.0021645			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786HC	21747942	Green Published, Green Submitted, gold			2022-12-27	WOS:000292293400018
J	Vestergaard-Poulsen, P; Wegener, G; Hansen, B; Bjarkam, CR; Blackband, SJ; Nielsen, NC; Jespersen, SN				Vestergaard-Poulsen, Peter; Wegener, Gregers; Hansen, Brian; Bjarkam, Carsten R.; Blackband, Stephen J.; Nielsen, Niels C.; Jespersen, Sune N.			Diffusion-Weighted MRI and Quantitative Biophysical Modeling of Hippocampal Neurite Loss in Chronic Stress	PLOS ONE			English	Article							CA3 PYRAMIDAL NEURONS; DENDRITIC ATROPHY; ADRENAL-STEROIDS; RESTRAINT STRESS; APICAL DENDRITES; SPATIAL MEMORY; DENTATE GYRUS; PSYCHOSOCIAL STRESS; SEX-DIFFERENCES; TENSOR MRI	Chronic stress has detrimental effects on physiology, learning and memory and is involved in the development of anxiety and depressive disorders. Besides changes in synaptic formation and neurogenesis, chronic stress also induces dendritic remodeling in the hippocampus, amygdala and the prefrontal cortex. Investigations of dendritic remodeling during development and treatment of stress are currently limited by the invasive nature of histological and stereological methods. Here we show that high field diffusion-weighted MRI combined with quantitative biophysical modeling of the hippocampal dendritic loss in 21 day restraint stressed rats highly correlates with former histological findings. Our study strongly indicates that diffusion-weighted MRI is sensitive to regional dendritic loss and thus a promising candidate for non-invasive studies of dendritic plasticity in chronic stress and stress-related disorders.	[Vestergaard-Poulsen, Peter; Hansen, Brian; Jespersen, Sune N.] Aarhus Univ, Ctr Functionally Integrat Neurosci, Aarhus, Denmark; [Wegener, Gregers] Aarhus Psychiat Univ Hosp, Ctr Basic Psychiat Res, Risskov, Denmark; [Nielsen, Niels C.] Aarhus Univ, Dept Chem, Ctr Insoluble Prot Struct, DK-8000 Aarhus, Denmark; [Nielsen, Niels C.] Aarhus Univ, Dept Chem, Interdisplinary Nanosci Ctr, DK-8000 Aarhus, Denmark; [Blackband, Stephen J.] Univ Florida, McKnight Brain Inst, Dept Neurosci, Gainesville, FL USA; [Blackband, Stephen J.] Univ Florida, Natl High Magnet Field Lab, Gainesville, FL USA; [Bjarkam, Carsten R.] Aarhus Univ Hosp, Dept Neurosurg, DK-8000 Aarhus, Denmark	Aarhus University; Aarhus University; Aarhus University; Aarhus University; State University System of Florida; University of Florida; State University System of Florida; University of Florida; Aarhus University	Vestergaard-Poulsen, P (corresponding author), Aarhus Univ, Ctr Functionally Integrat Neurosci, Aarhus, Denmark.	peterv@pet.auh.dk	Wegener, Gregers/Z-3945-2019; Wegener, Gregers/A-1019-2011; Jespersen, Sune Nørhøj/B-1914-2008	Wegener, Gregers/0000-0002-0081-0068; Jespersen, Sune Nørhøj/0000-0003-3146-4329; Bjarkam, Carsten/0000-0002-0164-9595; Nielsen, Niels Chr./0000-0003-2978-4366	Danish National Research Foundation [95093538-2458, 100297]; Danish Biotechnological Instrument Centre	Danish National Research Foundation(Danmarks Grundforskningsfond); Danish Biotechnological Instrument Centre	This research was funded by the Danish National Research Foundation (95093538-2458, project 100297) and The Danish Biotechnological Instrument Centre. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALGER BE, 1984, J NEUROPHYSIOL, V52, P892, DOI 10.1152/jn.1984.52.5.892; Basser PJ, 1996, J MAGN RESON SER B, V111, P209, DOI [10.1006/jmrb.1996.0086, 10.1016/j.jmr.2011.09.022]; Buynitsky T, 2009, NEUROSCI BIOBEHAV R, V33, P1089, DOI 10.1016/j.neubiorev.2009.05.004; CAMERON HA, 1994, NEUROSCIENCE, V61, P203, DOI 10.1016/0306-4522(94)90224-0; Conrad CD, 1999, BEHAV NEUROSCI, V113, P902, DOI 10.1037/0735-7044.113.5.902; Conrad CD, 1996, BEHAV NEUROSCI, V110, P1321, DOI 10.1037/0735-7044.110.6.1321; Coplan JD, 2010, NEUROSCI LETT, V480, P93, DOI 10.1016/j.neulet.2010.06.012; Dyrby TB, 2011, HUM BRAIN MAPP, V32, P544, DOI 10.1002/hbm.21043; Galea LAM, 1997, NEUROSCIENCE, V81, P689, DOI 10.1016/S0306-4522(97)00233-9; GOULD E, 1991, J COMP NEUROL, V313, P486, DOI 10.1002/cne.903130309; Gould E, 1997, J NEUROSCI, V17, P2492; Hardin RH, 1996, DISCRETE COMPUT GEOM, V15, P429, DOI 10.1007/BF02711518; Jackowski AP, 2008, PSYCHIAT RES-NEUROIM, V162, P256, DOI 10.1016/j.pscychresns.2007.08.006; Jespersen SN, 2007, NEUROIMAGE, V34, P1473, DOI 10.1016/j.neuroimage.2006.10.037; Jespersen SN, 2010, NEUROIMAGE, V49, P205, DOI 10.1016/j.neuroimage.2009.08.053; Katz M, 2009, DEV NEUROSCI-BASEL, V31, P293, DOI 10.1159/000216540; KERR DS, 1991, J NEUROSCI, V11, P1316; Kim JJ, 2002, NAT REV NEUROSCI, V3, P453, DOI 10.1038/nrn849; Kroenke CD, 2009, CEREB CORTEX, V19, P2916, DOI 10.1093/cercor/bhp061; Lambert KG, 1998, PHYSIOL BEHAV, V65, P43, DOI 10.1016/S0031-9384(98)00114-0; Le Bihan D, 2003, NAT REV NEUROSCI, V4, P469, DOI 10.1038/nrn1119; Lee T, 2009, NEUROREPORT, V20, P1554, DOI 10.1097/WNR.0b013e328332bb09; LUINE V, 1994, BRAIN RES, V639, P167, DOI 10.1016/0006-8993(94)91778-7; MAGARINOS AM, 1995, NEUROSCIENCE, V69, P89, DOI 10.1016/0306-4522(95)00259-L; Magarinos AM, 1996, J NEUROSCI, V16, P3534; MCEWEN BS, 1995, CURR OPIN NEUROBIOL, V5, P205, DOI 10.1016/0959-4388(95)80028-X; McEwen BS, 1995, VITAM HORM, V51, P371, DOI 10.1016/S0083-6729(08)61045-6; McEwen BS, 1999, ANNU REV NEUROSCI, V22, P105, DOI 10.1146/annurev.neuro.22.1.105; McLaughlin KJ, 2007, BRAIN RES, V1161, P56, DOI 10.1016/j.brainres.2007.05.042; McLaughlin KJ, 2005, NEUROSCIENCE, V135, P1045, DOI 10.1016/j.neuroscience.2005.06.083; MOSELEY ME, 1990, MAGN RESON MED, V14, P330, DOI 10.1002/mrm.1910140218; Ong HH, 2008, NEUROIMAGE, V40, P1619, DOI 10.1016/j.neuroimage.2008.01.017; PASTERNAK JF, 1975, J COMP NEUROL, V160, P307, DOI 10.1002/cne.901600304; Roozendaal B, 2009, NAT REV NEUROSCI, V10, P423, DOI 10.1038/nrn2651; SAPOLSKY RM, 1985, J NEUROSCI, V5, P1222; Shepherd TM, 2009, MAGN RESON MED, V62, P26, DOI 10.1002/mrm.21977; Shors TJ, 2001, J NEUROSCI, V21, P6292, DOI 10.1523/JNEUROSCI.21-16-06292.2001; Sousa N, 2000, NEUROSCIENCE, V97, P253, DOI 10.1016/S0306-4522(00)00050-6; Stanisz GJ, 1997, MAGNET RESON MED, V37, P103, DOI 10.1002/mrm.1910370115; Sunanda Rao MS, 1995, BRAIN RES, V694, P312, DOI DOI 10.1016/0006-8993(95)00822-8.PUBMED:8974660; UNO H, 1989, J NEUROSCI, V9, P1705, DOI 10.1523/jneurosci.09-05-01705.1989; Vestergaard-Poulsen P, 2007, J MAGN RESON IMAGING, V26, P529, DOI 10.1002/jmri.21030; WATANABE Y, 1992, EUR J PHARMACOL, V222, P157, DOI 10.1016/0014-2999(92)90830-W; WATANABE Y, 1992, BRAIN RES, V588, P341, DOI 10.1016/0006-8993(92)91597-8; WATANABE Y, 1992, HIPPOCAMPUS, V2, P431, DOI 10.1002/hipo.450020410; Watson C., 2005, RAT BRAIN STEREOTACT; WOOLLEY CS, 1990, BRAIN RES, V531, P225, DOI 10.1016/0006-8993(90)90778-A; Xu L, 1997, NATURE, V387, P497, DOI 10.1038/387497a0	48	36	36	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2011	6	7							e20653	10.1371/journal.pone.0020653	http://dx.doi.org/10.1371/journal.pone.0020653			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786HC	21747929	gold, Green Submitted, Green Published			2022-12-27	WOS:000292293400004
J	Li, DJ; Shin, JH; Duan, DS				Li, Dejia; Shin, Jin-Hong; Duan, Dongsheng			iNOS Ablation Does Not Improve Specific Force of the Extensor Digitorum Longus Muscle in Dystrophin-Deficient mdx4cv Mice	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; DUCHENNE MUSCULAR-DYSTROPHY; SKELETAL-MUSCLE; GLYCOPROTEIN COMPLEX; RYANODINE RECEPTOR; EXPRESSION; GENE; MOUSE; NNOS; MACROPHAGES	Nitrosative stress compromises force generation in Duchenne muscular dystrophy (DMD). Both inducible nitric oxide synthase (iNOS) and delocalized neuronal NOS (nNOS) have been implicated. We recently demonstrated that genetic elimination of nNOS significantly enhanced specific muscle forces of the extensor digitorum longus (EDL) muscle of dystrophin-null mdx4cv mice (Li D et al J. Path. 223:88-98, 2011). To determine the contribution of iNOS, we generated iNOS deficient mdx4cv mice. Genetic elimination of iNOS did not alter muscle histopathology. Further, the EDL muscle of iNOS/dystrophin DKO mice yielded specific twitch and tetanic forces similar to those of mdx4cv mice. Additional studies suggest iNOS ablation did not augment nNOS expression neither did it result in appreciable change of nitrosative stress markers in muscle. Our results suggest that iNOS may play a minor role in mediating nitrosative stress-associated force reduction in DMD.	[Li, Dejia; Shin, Jin-Hong; Duan, Dongsheng] Univ Missouri, Dept Mol Microbiol & Immunol, Columbia, MO USA	University of Missouri System; University of Missouri Columbia	Li, DJ (corresponding author), Wuhan Univ, Dept Occupat & Environm Hlth, Sch Publ Hlth, Wuhan 430072, Hubei, Peoples R China.	duand@missouri.edu	Shin, Jin-Hong/AAZ-8809-2020	Shin, Jin-Hong/0000-0002-5174-286X; Duan, Dongsheng/0000-0003-4109-1132	National Institutes of Health [AR-49419]; Muscular Dystrophy Association; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR049419] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Muscular Dystrophy Association(Muscular Dystrophy Association); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by the National Institutes of Health (AR-49419, DD) and the Muscular Dystrophy Association (DD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen DG, 2010, CAN J PHYSIOL PHARM, V88, P83, DOI 10.1139/Y09-058; Amthor H, 2004, NEUROMUSCULAR DISORD, V14, P791, DOI 10.1016/j.nmd.2004.08.004; Batchelor CL, 2006, TRENDS CELL BIOL, V16, P198, DOI 10.1016/j.tcb.2006.02.001; Bellinger AM, 2008, J CLIN INVEST, V118, P445, DOI 10.1172/JCI34006; Bellinger AM, 2009, NAT MED, V15, P325, DOI 10.1038/nm.1916; Bia BL, 1999, J MOL CELL CARDIOL, V31, P1857, DOI 10.1006/jmcc.1999.1018; Bostick B, 2009, MOL THER, V17, P253, DOI 10.1038/mt.2008.264; BRENMAN JE, 1995, CELL, V82, P743, DOI 10.1016/0092-8674(95)90471-9; Chao DS, 1996, J EXP MED, V184, P609, DOI 10.1084/jem.184.2.609; CHO HJ, 1992, J EXP MED, V176, P599, DOI 10.1084/jem.176.2.599; Forrester MT, 2009, NAT BIOTECHNOL, V27, P557, DOI 10.1038/nbt.1545; Goldstein JA, 2010, J GEN PHYSIOL, V136, P29, DOI 10.1085/jgp.201010436; Hainsey TA, 2003, NEUROMUSCULAR DISORD, V13, P294, DOI 10.1016/S0960-8966(02)00286-9; Jackson MJ, 2007, J APPL PHYSIOL, V102, P1664, DOI 10.1152/japplphysiol.01102.2006; Kunkel LM, 2005, AM J HUM GENET, V76, P205, DOI 10.1086/428143; Lai Y, 2005, NAT BIOTECHNOL, V23, P1435, DOI 10.1038/nbt1153; Lai Y, 2009, J CLIN INVEST, V119, P624, DOI 10.1172/JCI36612; LAUBACH VE, 1995, P NATL ACAD SCI USA, V92, P10688, DOI 10.1073/pnas.92.23.10688; Li DJ, 2008, AM J PATHOL, V172, P1332, DOI 10.2353/ajpath.2008.071042; Li DJ, 2011, J PATHOL, V223, P88, DOI 10.1002/path.2799; Li DJ, 2010, J CELL SCI, V123, P2007, DOI 10.1242/jcs.064808; Li DJ, 2009, HUM MOL GENET, V18, P1209, DOI 10.1093/hmg/ddp015; Li S, 2006, HUM MOL GENET, V15, P1610, DOI 10.1093/hmg/ddl082; Liu MJ, 2005, MOL THER, V11, P245, DOI 10.1016/j.ymthe.2004.09.013; Louboutin JP, 2001, MOL MED, V7, P355, DOI 10.1007/BF03402218; MACMICKING, 1995, CELL, V81, pU17; MACMICKING JD, 1995, CELL, V81, P641, DOI 10.1016/0092-8674(95)90085-3; MOENS P, 1993, J MUSCLE RES CELL M, V14, P446, DOI 10.1007/BF00121296; NATHAN C, 1994, CELL, V78, P915, DOI 10.1016/0092-8674(94)90266-6; Perreault M, 2001, NAT MED, V7, P1138, DOI 10.1038/nm1001-1138; Petrof BJ, 2002, AM J PHYS MED REHAB, V81, pS162, DOI 10.1097/00002060-200211001-00017; Romitti P., 2009, Morbidity and Mortality Weekly Report, V58, P1119; SAITO A, 1984, J CELL BIOL, V99, P875, DOI 10.1083/jcb.99.3.875; Shin JH, 2011, MUSCLE NERVE, V43, P283, DOI 10.1002/mus.21873; SHMIDT HHHW, 1992, CELL CALCIUM, V13, P427, DOI 10.1016/0143-4160(92)90055-W; Smith BF, 2011, LAB INVEST, V91, P216, DOI 10.1038/labinvest.2010.146; Stamler JS, 2001, PHYSIOL REV, V81, P209, DOI 10.1152/physrev.2001.81.1.209; Thomas GD, 1998, P NATL ACAD SCI USA, V95, P15090, DOI 10.1073/pnas.95.25.15090; Thompson M, 1996, J APPL PHYSIOL, V81, P2415, DOI 10.1152/jappl.1996.81.6.2415; Villalta SA, 2009, HUM MOL GENET, V18, P482, DOI 10.1093/hmg/ddn376; WEBSTER C, 1988, CELL, V52, P503, DOI 10.1016/0092-8674(88)90463-1; XIE QW, 1992, SCIENCE, V256, P225, DOI 10.1126/science.1373522; Yue YP, 2006, MOL THER, V14, P79, DOI 10.1016/j.ymthe.2006.01.007; Yue YP, 2008, MOL THER, V16, P1944, DOI 10.1038/mt.2008.207	44	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2011	6	6							e21618	10.1371/journal.pone.0021618	http://dx.doi.org/10.1371/journal.pone.0021618			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786GP	21738735	Green Published, Green Submitted, gold			2022-12-27	WOS:000292291800028
J	Zhang, Y; Lin, XP; Desrosiers, M; Zhang, W; Meng, N; Zhao, LP; Han, DM; Zhang, L				Zhang, Yuan; Lin, Xiaoping; Desrosiers, Martin; Zhang, Wei; Meng, Na; Zhao, Liping; Han, Demin; Zhang, Luo			Association Pattern of Interleukin-1 Receptor-Associated Kinase-4 Gene Polymorphisms with Allergic Rhinitis in a Han Chinese Population	PLOS ONE			English	Article							TOLL-LIKE-RECEPTORS; MULTIFACTOR DIMENSIONALITY REDUCTION; T-CELLS; ASTHMA; EPISTASIS; INNATE; IRAK-4; EXPRESSION; LIPOPOLYSACCHARIDE; SUSCEPTIBILITY	Objective: Interleukin-1 receptor-associated kinase-4 (IRAK-4) encodes a kinase that is essential for NF-kB activation in Toll-like receptor and T-cell receptor signaling pathways, indicating a possible crosstalk between innate and acquired immunities. We attempted to determine whether the polymorphisms in the Interleukin-1 receptor-associated kinase-4 (IRAK-4) gene are associated with allergic rhinitis (AR) in the Han Chinese population. Methods: A population of 379 patients with AR and 333 healthy controls was studied. Blood was drawn for DNA extraction and total serum immunoglobulin E (IgE). A total of 11 single nucleotide polymorphisms (SNPs) in IRAK-4 were selected and individually genotyped. Results: Significant allelic differences between cases and controls were obtained for the SNP of rs3794262 in the IRAK-4 gene. In the stratified analysis for gender, two SNPs (rs4251431 and rs6582484) in males appeared as significant associations. Subgroup analysis for the presence of different allergen sensitivities displayed associations only in the house dust mite-allergic cohorts (rs3794262, rs4251481). None of the selected SNPs in IRAK-4 was associated with total IgE level. The haplotype analyisis indicated GCCTGCGA was significantly associated with AR. The SNP-SNP interaction information analysis indicated that the selected sets of polymorphisms had no synergistic effect. Conclusions: Our findings did not support the potential contribution of the IRAK-4 gene to serum IgE levels. However, the results demonstrated a gender-and allergen-dependant association pattern between polymorphisms in IRAK-4 and AR in Chinese population.	[Zhang, Yuan; Zhang, Wei; Meng, Na; Zhao, Liping; Han, Demin; Zhang, Luo] Beijing Inst Otorhinolaryngol, Key Lab Otolaryngol Head & Neck Surg, Minist Educ China, Beijing, Peoples R China; [Zhang, Yuan; Han, Demin; Zhang, Luo] Capital Med Univ, Dept Otolaryngol Head & Neck Surg, Beijing TongRen Hosp, Beijing, Peoples R China; [Lin, Xiaoping] Gen Hosp Shenyang Mil Command, Ctr Allergy & Immunotherapy, Shenyang, Liaoning, Peoples R China; [Desrosiers, Martin] Univ Montreal, Dept Otolaryngol, Hotel Dieu Hosp, Montreal, PQ, Canada; [Desrosiers, Martin] McGill Univ, Montreal Gen Hosp, Dept Otolaryngol Head & Neck Surg, Montreal, PQ H3G 1A4, Canada	Ministry of Education, China; Capital Medical University; Laval University; Universite de Montreal; McGill University	Zhang, Y (corresponding author), Beijing Inst Otorhinolaryngol, Key Lab Otolaryngol Head & Neck Surg, Minist Educ China, Beijing, Peoples R China.	handm@trhos.com; dr.luozhang@gmail.com		Zhang, Luo/0000-0002-0910-9884	National Science Fund for Distinguished Young Scholars [81025007]; National Natural Science Foundation of China [30872846, 30973282]; Beijing Science and Technology Program [KZ200910025008]; Beijing Natural Science Foundation [7072017]; Special Fund of Sanitation Elite Reconstruction of Beijing [2009-2-007]	National Science Fund for Distinguished Young Scholars(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Science and Technology Program; Beijing Natural Science Foundation(Beijing Natural Science Foundation); Special Fund of Sanitation Elite Reconstruction of Beijing	This work was supported by grants from the National Science Fund for Distinguished Young Scholars (81025007), National Natural Science Foundation of China (30872846 and 30973282), Beijing Science and Technology Program (KZ200910025008), Beijing Natural Science Foundation (7072017) and the Special Fund of Sanitation Elite Reconstruction of Beijing (2009-2-007) to LZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Bacchetta R, 2007, J ALLERGY CLIN IMMUN, V120, P227, DOI 10.1016/j.jaci.2007.06.023; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bauer S, 2007, IMMUNOBIOLOGY, V212, P521, DOI 10.1016/j.imbio.2007.03.011; Beasley R, 1998, LANCET, V351, P1225, DOI 10.1016/S0140-6736(97)07302-9; Braun-Fahrlander C, 2002, NEW ENGL J MED, V347, P869, DOI 10.1056/NEJMoa020057; Carlborg O, 2004, NAT REV GENET, V5, P618, DOI 10.1038/nrg1407; Caron G, 2005, J IMMUNOL, V175, P1551, DOI 10.4049/jimmunol.175.3.1551; Choudhry S, 2008, HUM GENET, V123, P455, DOI 10.1007/s00439-008-0495-7; Cottalorda A, 2006, EUR J IMMUNOL, V36, P1684, DOI 10.1002/eji.200636181; DREBORG S, 1993, ALLERGY, V48, P49, DOI 10.1111/j.1398-9995.1993.tb04756.x; Eisenbarth SC, 2002, J EXP MED, V196, P1645, DOI 10.1084/jem.20021340; Erdfelder E, 1996, BEHAV RES METH INS C, V28, P1, DOI 10.3758/BF03203630; Hahn LW, 2003, BIOINFORMATICS, V19, P376, DOI 10.1093/bioinformatics/btf869; Hammad H, 2009, NAT MED, V15, P410, DOI 10.1038/nm.1946; Himes BE, 2009, AM J HUM GENET, V84, P581, DOI 10.1016/j.ajhg.2009.04.006; Hornung V, 2002, J IMMUNOL, V168, P4531, DOI 10.4049/jimmunol.168.9.4531; Huebner M, 2008, J ALLERGY CLIN IMMUN, V121, P408, DOI 10.1016/j.jaci.2007.09.020; Kabesch M, 2006, J ALLERGY CLIN IMMUN, V117, P269, DOI 10.1016/j.jaci.2005.10.024; Kay AB, 2001, NEW ENGL J MED, V344, P30, DOI 10.1056/NEJM200101043440106; Ku CL, 2007, J MED GENET, V44, P16, DOI 10.1136/jmg.2006.044446; Medvedev AE, 2003, J EXP MED, V198, P521, DOI 10.1084/jem.20030701; Michel S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013894; Moffatt MF, 2007, NATURE, V448, P470, DOI 10.1038/nature06014; Moore JH, 2007, LECT NOTES COMPUT SC, V4447, P166; Moore JH, 2006, J THEOR BIOL, V241, P252, DOI 10.1016/j.jtbi.2005.11.036; Moore JH, 2003, HUM HERED, V56, P73, DOI 10.1159/000073735; Moore JH, 2005, NAT GENET, V37, P13, DOI 10.1038/ng0105-13; Mullol J, 2008, J INVEST ALLERG CLIN, V18, P327; Netea MG, 2004, J IMMUNOL, V172, P3712, DOI 10.4049/jimmunol.172.6.3712; Okada H, 2010, CLIN EXP IMMUNOL, V160, P1, DOI 10.1111/j.1365-2249.2010.04139.x; Peng GY, 2005, SCIENCE, V309, P1380, DOI 10.1126/science.1113401; Phillips PC, 2008, NAT REV GENET, V9, P855, DOI 10.1038/nrg2452; Picard C, 2003, SCIENCE, V299, P2076, DOI 10.1126/science.1081902; Ritchie MD, 2003, GENET EPIDEMIOL, V24, P150, DOI 10.1002/gepi.10218; STRACHAN DP, 1989, BRIT MED J, V299, P1259, DOI 10.1136/bmj.299.6710.1259; Suzuki N, 2006, SCIENCE, V311, P1927, DOI 10.1126/science.1124256; Suzuki N, 2006, TRENDS IMMUNOL, V27, P566, DOI 10.1016/j.it.2006.10.003; Tabeta K, 2004, P NATL ACAD SCI USA, V101, P3516, DOI 10.1073/pnas.0400525101; Tewfik MA, 2009, ALLERGY, V64, P746, DOI 10.1111/j.1398-9995.2008.01889.x; Trompette A, 2009, NATURE, V457, P585, DOI 10.1038/nature07548; Vercelli D, 2008, NAT REV IMMUNOL, V8, P169, DOI 10.1038/nri2257; von Mutius E, 2001, EUR RESPIR J, V18, P872, DOI 10.1183/09031936.01.00268401; Weidinger S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000166; Ye H, 2002, NATURE, V418, P443, DOI 10.1038/nature00888; Zarember KA, 2002, J IMMUNOL, V168, P554, DOI 10.4049/jimmunol.168.2.554; Zhang L, 2009, INT ARCH ALLERGY IMM, V149, P47, DOI 10.1159/000176306	48	8	8	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2011	6	6							e21769	10.1371/journal.pone.0021769	http://dx.doi.org/10.1371/journal.pone.0021769			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786GP	21738793	Green Published, gold, Green Submitted			2022-12-27	WOS:000292291800044
J	Jiang, YY; Sirinupong, N; Brunzelle, J; Yang, Z				Jiang, Yuanyuan; Sirinupong, Nualpun; Brunzelle, Joseph; Yang, Zhe			Crystal Structures of Histone and p53 Methyltransferase SmyD2 Reveal a Conformational Flexibility of the Autoinhibitory C-Terminal Domain	PLOS ONE			English	Article							FUNCTIONAL-ANALYSIS; HSP90; CHROMATIN; PROTEIN; PROLIFERATION; METHYLATION; SPECIFICITY; DROSOPHILA; ENCODES; COMPLEX	SmyD2 belongs to a new class of chromatin regulators that control gene expression in heart development and tumorigenesis. Besides methylation of histone H3 K4, SmyD2 can methylate non-histone targets including p53 and the retinoblastoma tumor suppressor. The methyltransferase activity of SmyD proteins has been proposed to be regulated by autoinhibition via the intra-and interdomain bending of the conserved C-terminal domain (CTD). However, there has been no direct evidence of a conformational change in the CTD. Here, we report two crystal structures of SmyD2 bound either to the cofactor product S-adenosylhomocysteine or to the inhibitor sinefungin. SmyD2 has a two-lobed structure with the active site located at the bottom of a deep crevice formed between the CTD and the catalytic domain. By extensive engagement with the methyltransferase domain, the CTD stabilizes the autoinhibited conformation of SmyD2 and restricts access to the catalytic site. Unexpectedly, despite that the two SmyD2 structures are highly superimposable, significant differences are observed in the first two helices of the CTDs: the two helices bend outwards and move away from the catalytic domain to generate a less closed conformation in the sinefungin-bound structure. Although the overall fold of the individual domains is structurally conserved among SmyD proteins, SmyD2 appear to be a conformational "intermediate'' between a close form of SmyD3 and an open form of SmyD1. In addition, the structures reveal that the CTD is structurally similar to tetratricopeptide repeats (TPR), a motif through which many cochaperones bind to the heat shock protein Hsp90. Our results thus provide the first evidence for the intradomain flexibility of the TPR-like CTD, which may be important for the activation of SmyD proteins by Hsp90.	[Jiang, Yuanyuan; Sirinupong, Nualpun; Yang, Zhe] Wayne State Univ, Sch Med, Dept Biochem & Mol Biol, Detroit, MI 48202 USA; [Brunzelle, Joseph] Argonne Natl Lab, Adv Photon Source, Argonne, IL 60439 USA	Wayne State University; United States Department of Energy (DOE); Argonne National Laboratory	Jiang, YY (corresponding author), Wayne State Univ, Sch Med, Dept Biochem & Mol Biol, Detroit, MI 48202 USA.	zyang@med.wayne.edu	jiang, anyi/GPT-0379-2022; Sirinupong, Nualpun/AAX-4886-2020	Sirinupong, Nualpun/0000-0002-9986-3011	American Heart Association (AHA)	American Heart Association (AHA)(American Heart Association)	This work was supported, in part, by the American Heart Association (AHA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Farha M, 2008, MOL CELL PROTEOMICS, V7, P560, DOI 10.1074/mcp.M700271-MCP200; Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Berger SL, 2007, NATURE, V447, P407, DOI 10.1038/nature05915; Blanc E, 2004, ACTA CRYSTALLOGR D, V60, P2210, DOI 10.1107/S0907444904016427; Brown MA, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-26; Couture JF, 2006, NAT STRUCT MOL BIOL, V13, P140, DOI 10.1038/nsmb1045; Couture JF, 2005, GENE DEV, V19, P1455, DOI 10.1101/gad.1318405; Diehl F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009748; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gottlieb PD, 2002, NAT GENET, V31, P25, DOI 10.1038/ng866; Hamamoto R, 2004, NAT CELL BIOL, V6, P731, DOI 10.1038/ncb1151; Hayward S, 1998, PROTEINS, V30, P144, DOI 10.1002/(SICI)1097-0134(19980201)30:2<144::AID-PROT4>3.0.CO;2-N; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Huang J, 2006, NATURE, V444, P629, DOI 10.1038/nature05287; Kawamura S, 2008, CYTOTECHNOLOGY, V57, P161, DOI 10.1007/s10616-008-9128-1; Komatsu S, 2009, CARCINOGENESIS, V30, P1139, DOI 10.1093/carcin/bgp116; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Li DL, 2009, NUCLEIC ACIDS RES, V37, P7059, DOI 10.1093/nar/gkp773; Liu YZ, 2007, CANCER CELL, V11, P483, DOI 10.1016/j.ccr.2007.04.010; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pearl LH, 2000, CURR OPIN STRUC BIOL, V10, P46, DOI 10.1016/S0959-440X(99)00047-0; Ruden DM, 2008, CURR GENOMICS, V9, P500, DOI 10.2174/138920208786241207; SADDIC LA, 2010, J BIOL CHEM, V24, P24; Scheufler C, 2000, CELL, V101, P199, DOI 10.1016/S0092-8674(00)80830-2; Sirinupong N, 2011, J MOL BIOL, V406, P149, DOI 10.1016/j.jmb.2010.12.014; Sirinupong N, 2010, J BIOL CHEM, V285, P40635, DOI 10.1074/jbc.M110.168187; Soti C, 2002, J BIOL CHEM, V277, P7066, DOI 10.1074/jbc.M105568200; Tan XG, 2006, P NATL ACAD SCI USA, V103, P2713, DOI 10.1073/pnas.0509503103; Tariq M, 2009, P NATL ACAD SCI USA, V106, P1157, DOI 10.1073/pnas.0809669106; Thompson EC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003008; Wilson JR, 2002, CELL, V111, P105, DOI 10.1016/S0092-8674(02)00964-9; XU S, 2011, NUCLEIC ACIDS RES, V25, P25; Yang J, 2005, EMBO J, V24, P1, DOI 10.1038/sj.emboj.7600496; Young JC, 1998, J BIOL CHEM, V273, P18007, DOI 10.1074/jbc.273.29.18007; Zhang X, 2002, CELL, V111, P117, DOI 10.1016/S0092-8674(02)00999-6; Zhang X, 2003, MOL CELL, V12, P177, DOI 10.1016/S1097-2765(03)00224-7	36	36	37	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2011	6	6							e21640	10.1371/journal.pone.0021640	http://dx.doi.org/10.1371/journal.pone.0021640			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	784FW	21738746	Green Submitted, gold, Green Published			2022-12-27	WOS:000292142800049
J	Rauschecker, AM; Dastjerdi, M; Weiner, KS; Witthoft, N; Chen, J; Selimbeyoglu, A; Parvizi, J				Rauschecker, Andreas M.; Dastjerdi, Mohammad; Weiner, Kevin S.; Witthoft, Nathan; Chen, Janice; Selimbeyoglu, Aslihan; Parvizi, Josef			Illusions of Visual Motion Elicited by Electrical Stimulation of Human MT Complex	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; BRAIN-DAMAGE; AREA MT; MACAQUE MONKEY; DIRECTION DISCRIMINATION; SELECTIVE IMPAIRMENT; CORTICAL STIMULATION; EXTRASTRIATE CORTEX; CEREBRAL-LESIONS; APPARENT MOTION	Human cortical area MT+ (hMT(+)) is known to respond to visual motion stimuli, but its causal role in the conscious experience of motion remains largely unexplored. Studies in non-human primates demonstrate that altering activity in area MT can influence motion perception judgments, but animal studies are inherently limited in assessing subjective conscious experience. In the current study, we use functional magnetic resonance imaging (fMRI), intracranial electrocorticography (ECoG), and electrical brain stimulation (EBS) in three patients implanted with intracranial electrodes to address the role of area hMT(+) in conscious visual motion perception. We show that in conscious human subjects, reproducible illusory motion can be elicited by electrical stimulation of hMT(+). These visual motion percepts only occurred when the site of stimulation overlapped directly with the region of the brain that had increased fMRI and electrophysiological activity during moving compared to static visual stimuli in the same individual subjects. Electrical stimulation in neighboring regions failed to produce illusory motion. Our study provides evidence for the sufficient causal link between the hMT(+) network and the human conscious experience of visual motion. It also suggests a clear spatial relationship between fMRI signal and ECoG activity in the human brain.	[Rauschecker, Andreas M.; Dastjerdi, Mohammad; Selimbeyoglu, Aslihan; Parvizi, Josef] Stanford Univ, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA; [Rauschecker, Andreas M.] Stanford Univ, Med Scientist Training Program, Stanford, CA 94305 USA; [Rauschecker, Andreas M.] Stanford Univ, Neurosci Program, Stanford, CA 94305 USA; [Rauschecker, Andreas M.; Weiner, Kevin S.; Witthoft, Nathan; Chen, Janice] Stanford Univ, Dept Psychol, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Stanford University	Rauschecker, AM (corresponding author), Stanford Univ, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA.	jparvizi@stanford.edu		Dastjerdi, Mohammad/0000-0001-5972-5936; Rauschecker, Andreas/0000-0003-0633-9876; chen, janice/0000-0003-4511-4725	Stanford Institute for Neuro-Innovation and Translational Neuroscience; Milken Family Foundation; Stanford University	Stanford Institute for Neuro-Innovation and Translational Neuroscience; Milken Family Foundation; Stanford University(Stanford University)	This work was supported by the Stanford Institute for Neuro-Innovation and Translational Neuroscience (http://neuroscience.stanford.edu), the Milken Family Foundation (www.mff.org), and a Stanford University Bio-X Fellowship (http://biox.stanford.edu/grant/fellowships.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amano K, 2009, J NEUROPHYSIOL, V102, P2704, DOI 10.1152/jn.00102.2009; BARTON JJS, 1995, ANN NEUROL, V37, P665, DOI 10.1002/ana.410370517; BECKERS G, 1995, BRAIN, V118, P49, DOI 10.1093/brain/118.1.49; BECKERS G, 1992, P ROY SOC B-BIOL SCI, V249, P173, DOI 10.1098/rspb.1992.0100; Blanke O, 2003, EUR J NEUROSCI, V18, P709, DOI 10.1046/j.1460-9568.2003.02771.x; Blanke O, 2002, EUR J NEUROSCI, V15, P2043, DOI 10.1046/j.1460-9568.2002.02038.x; Canolty RT, 2006, SCIENCE, V313, P1626, DOI 10.1126/science.1128115; DeYoe EA, 1996, P NATL ACAD SCI USA, V93, P2382, DOI 10.1073/pnas.93.6.2382; DUBNER R, 1971, BRAIN RES, V35, P528, DOI 10.1016/0006-8993(71)90494-X; DUHAMEL JR, 1992, SCIENCE, V255, P90, DOI 10.1126/science.1553535; Dumoulin SO, 2000, CEREB CORTEX, V10, P454, DOI 10.1093/cercor/10.5.454; Glover GH, 1999, MAGNET RESON MED, V42, P412, DOI 10.1002/(SICI)1522-2594(199908)42:2<412::AID-MRM25>3.0.CO;2-U; Gradinaru V, 2009, SCIENCE, V324, P354, DOI 10.1126/science.1167093; Greenlee MW, 1997, J NEUROSCI, V17, P804; Grill-Spector K, 2004, ANNU REV NEUROSCI, V27, P649, DOI 10.1146/annurev.neuro.27.070203.144220; HAGLUND MM, 1993, J NEUROSURG, V78, P785, DOI 10.3171/jns.1993.78.5.0785; Histed MH, 2009, NEURON, V63, P508, DOI 10.1016/j.neuron.2009.07.016; HOTSON J, 1994, VISION RES, V34, P2115, DOI 10.1016/0042-6989(94)90321-2; Huk AC, 2002, J NEUROSCI, V22, P7195; Jacobs J, 2010, TRENDS COGN SCI, V14, P162, DOI 10.1016/j.tics.2010.01.005; Khawaja FA, 2009, J NEUROSCI, V29, P13702, DOI 10.1523/JNEUROSCI.2844-09.2009; Kreiman G, 2000, NATURE, V408, P357, DOI 10.1038/35042575; Lee HW, 2000, NEUROLOGY, V54, P849, DOI 10.1212/WNL.54.4.849; Logothetis NK, 2010, NAT NEUROSCI, V13, P1283, DOI 10.1038/nn.2631; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; Marcar VL, 1997, NEUROPSYCHOLOGIA, V35, P1459, DOI 10.1016/S0028-3932(97)00057-2; MATIN L, 1982, SCIENCE, V216, P198, DOI 10.1126/science.7063881; Matsumoto R, 2004, CLIN NEUROPHYSIOL, V115, P2056, DOI 10.1016/j.clinph.2004.03.030; MAUNSELL JHR, 1983, J NEUROSCI, V3, P2563; Miller KJ, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000609; Moo LR, 2008, COGN NEUROPSYCHOL, V25, P677, DOI 10.1080/02643290802271599; Moulton ST, 2009, PHILOS T R SOC B, V364, P1273, DOI 10.1098/rstb.2008.0314; Muckli L, 2002, J NEUROSCI, V22; MULLAN S, 1959, ARCH NEURO PSYCHIATR, V81, P269, DOI 10.1001/archneurpsyc.1959.02340150001001; Murakami I, 1998, NATURE, V395, P798, DOI 10.1038/27435; Murphey DK, 2009, P NATL ACAD SCI USA, V106, P5389, DOI 10.1073/pnas.0804998106; Nestares O, 2000, MAGNET RESON MED, V43, P705, DOI 10.1002/(SICI)1522-2594(200005)43:5<705::AID-MRM13>3.0.CO;2-R; NEWSOME WT, 1988, J NEUROSCI, V8, P2201; NEWSOME WT, 1985, J NEUROSCI, V5, P825; OJEMANN GA, 1983, BEHAV BRAIN SCI, V6, P189, DOI 10.1017/S0140525X00015491; Pascual-Leone A, 2001, SCIENCE, V292, P510, DOI 10.1126/science.1057099; PLANT GT, 1993, BRAIN, V116, P1303, DOI 10.1093/brain/116.6.1303; Rubehn B, 2009, J NEURAL ENG, V6, DOI 10.1088/1741-2560/6/3/036003; SALZMAN CD, 1990, NATURE, V346, P174, DOI 10.1038/346174a0; SALZMAN CD, 1992, J NEUROSCI, V12, P2331; Sasaki Y, 2002, NEURON, V35, P1147, DOI 10.1016/S0896-6273(02)00899-1; Schenk T, 1997, NEUROPSYCHOLOGIA, V35, P1289, DOI 10.1016/S0028-3932(97)00004-3; Selimbeyoglu A, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00046; Sestieri C, 2008, FRONT HUM NEUROSCI, V1, DOI 10.3389/neuro.09.001.2007; Sommer MA, 2008, ANNU REV NEUROSCI, V31, P317, DOI 10.1146/annurev.neuro.31.060407.125627; TANAKA K, 1989, J NEUROPHYSIOL, V62, P642, DOI 10.1152/jn.1989.62.3.642; THEILER J, 1992, PHYSICA D, V58, P77, DOI 10.1016/0167-2789(92)90102-S; Tolias AS, 2005, NEURON, V48, P901, DOI 10.1016/j.neuron.2005.11.034; Vaina LM, 2001, BRAIN, V124, P310, DOI 10.1093/brain/124.2.310; VAINA LM, 1989, BIOL CYBERN, V61, P347, DOI 10.1007/BF00200800; Walsh V, 1998, P ROY SOC B-BIOL SCI, V265, P537, DOI 10.1098/rspb.1998.0328; Wibral M, 2009, CEREB CORTEX, V19, P1567, DOI 10.1093/cercor/bhn192; Yushkevich PA, 2006, NEUROIMAGE, V31, P1116, DOI 10.1016/j.neuroimage.2006.01.015; ZEKI S, 1991, J NEUROSCI, V11, P641; ZEKI S, 1991, BRAIN, V114, P811, DOI 10.1093/brain/114.2.811; ZIHL J, 1983, BRAIN, V106, P313, DOI 10.1093/brain/106.2.313	61	18	18	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2011	6	7							e21798	10.1371/journal.pone.0021798	http://dx.doi.org/10.1371/journal.pone.0021798			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	792WQ	21765915	Green Published, gold, Green Submitted			2022-12-27	WOS:000292781500016
J	van Wijk, M; de Bruijn, PJA; Sabelis, MW				van Wijk, Michiel; de Bruijn, Paulien J. A.; Sabelis, Maurice W.			Complex Odor from Plants under Attack: Herbivore's Enemies React to the Whole, Not Its Parts	PLOS ONE			English	Article							PHYTOSEIULUS-PERSIMILIS ACARI; PREDATORY MITES LEARN; LIMA-BEAN LEAVES; TETRANYCHUS-URTICAE; METHYL SALICYLATE; HOST-PLANT; VOLATILES; PREY; ATTRACTION; IDENTIFICATION	Background: Insect herbivory induces plant odors that attract herbivores' natural enemies. Assuming this attraction emerges from individual compounds, genetic control over odor emission of crops may provide a rationale for manipulating the distribution of predators used for pest control. However, studies on odor perception in vertebrates and invertebrates suggest that olfactory information processing of mixtures results in odor percepts that are a synthetic whole and not a set of components that could function as recognizable individual attractants. Here, we ask if predators respond to herbivore-induced attractants in odor mixtures or to odor mixture as a whole. Methodology/Principal Findings: We studied a system consisting of Lima bean, the herbivorous mite Tetranychus urticae and the predatory mite Phytoseiulus persimilis. We found that four herbivore-induced bean volatiles are not attractive in pure form while a fifth, methyl salicylate (MeSA), is. Several reduced mixtures deficient in one component compared to the full spider-mite induced blend were not attractive despite the presence of MeSA indicating that the predators cannot detect this component in these odor mixtures. A mixture of all five HIPV is most attractive, when offered together with the non-induced odor of Lima bean. Odors that elicit no response in their pure form were essential components of the attractive mixture. Conclusions/Significance: We conclude that the predatory mites perceive odors as a synthetic whole and that the hypothesis that predatory mites recognize attractive HIPV in odor mixtures is unsupported.	[van Wijk, Michiel; de Bruijn, Paulien J. A.; Sabelis, Maurice W.] Univ Amsterdam, IBED, Sect Populat Biol, Amsterdam, Netherlands	University of Amsterdam	van Wijk, M (corresponding author), Univ Amsterdam, IBED, Sect Populat Biol, Amsterdam, Netherlands.	M.vanwijk@.uva.nl			department of Population Biology of The University of Amsterdam	department of Population Biology of The University of Amsterdam	This research was funded by the department of Population Biology of The University of Amsterdam. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arimura G, 2001, BIOCHEM SYST ECOL, V29, P1049, DOI 10.1016/S0305-1978(01)00049-7; Bolland HR., 1998, WORLD CATALOGUE SPID; de Boer JG, 2008, J CHEM ECOL, V34, P281, DOI 10.1007/s10886-007-9405-z; De Boer JG, 2005, ANIM BEHAV, V69, P869, DOI 10.1016/j.anbehav.2004.07.010; De Boer JG, 2004, J CHEM ECOL, V30, P2215, DOI 10.1023/B:JOEC.0000048784.79031.5e; De Boer JG, 2004, J CHEM ECOL, V30, P255, DOI 10.1023/B:JOEC.0000017976.60630.8c; de Boer JG, 2004, ENTOMOL EXP APPL, V110, P181, DOI 10.1111/j.0013-8703.2004.00133.x; DICKE M, 1994, J PLANT PHYSIOL, V143, P465, DOI 10.1016/S0176-1617(11)81808-0; DICKE M, 1990, J CHEM ECOL, V16, P381, DOI 10.1007/BF01021772; Drukker B, 2000, EXP APPL ACAROL, V24, P881, DOI 10.1023/A:1010645720829; El-Sayed AM, DATABASE INSECT PHER; Guerrieri F, 2005, PLOS BIOL, V3, P718, DOI 10.1371/journal.pbio.0030060; Horiuchi J, 2003, APPL ENTOMOL ZOOL, V38, P109, DOI 10.1303/aez.2003.109; Kappers IF, 2005, SCIENCE, V309, P2070, DOI 10.1126/science.1116232; Krips OE, 1999, J CHEM ECOL, V25, P2623, DOI 10.1023/A:1020887104771; Laurent G, 2001, ANNU REV NEUROSCI, V24, P263, DOI 10.1146/annurev.neuro.24.1.263; Lledo PM, 2005, PHYSIOL REV, V85, P281, DOI 10.1152/physrev.00008.2004; Mithofer A, 2005, PLANT PHYSIOL, V137, P1160, DOI 10.1104/pp.104.054460; Niessing J, 2010, NATURE, V465, P47, DOI 10.1038/nature08961; Riffell JA, 2009, CURR BIOL, V19, P335, DOI 10.1016/j.cub.2009.01.041; SABELIS MW, 1983, ENTOMOL EXP APPL, V33, P303, DOI 10.1111/j.1570-7458.1983.tb03273.x; Sabelis MW., 1984, ACAROLOGY 6; Semmelhack JL, 2009, NATURE, V459, P218, DOI 10.1038/nature07983; Shiojiri K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012161; Sokal RR, 1995, BIOMETRY; Van Den Boom CEM, 2004, J CHEM ECOL, V30, P69, DOI 10.1023/B:JOEC.0000013183.72915.99; van den Boom CEM, 2002, B ENTOMOL RES, V92, P539, DOI 10.1079/BER2002193; van Wijk M, 2008, J CHEM ECOL, V34, P791, DOI 10.1007/s10886-008-9492-5; van Wijk M, 2006, EXP APPL ACAROL, V40, P205, DOI 10.1007/s10493-006-9039-9; van Wijk M, 2006, EXP APPL ACAROL, V40, P217, DOI 10.1007/s10493-006-9038-x; van Wijk M, 2010, J CHEM ECOL, V36, P1211, DOI 10.1007/s10886-010-9858-3; Webster B, 2010, ANIM BEHAV, V79, P451, DOI 10.1016/j.anbehav.2009.11.028; Zar J. H., 1996, BIOSTATISTICAL ANAL	33	49	49	0	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2011	6	7							e21742	10.1371/journal.pone.0021742	http://dx.doi.org/10.1371/journal.pone.0021742			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	792WQ	21765908	Green Submitted, Green Published, gold			2022-12-27	WOS:000292781500011
J	Skyberg, JA; Thornburg, T; Rollins, M; Huarte, E; Jutila, MA; Pascual, DW				Skyberg, Jerod A.; Thornburg, Theresa; Rollins, MaryClare; Huarte, Eduardo; Jutila, Mark A.; Pascual, David W.			Murine and Bovine gamma delta T Cells Enhance Innate Immunity against Brucella abortus Infections	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; ESCHERICHIA-COLI INFECTION; CLASS I-DEFICIENT; LISTERIA-MONOCYTOGENES; MYCOBACTERIUM-BOVIS; IL-17 PRODUCTION; BALB/C MICE; GM-CSF; MACROPHAGES; VACCINATION	gamma delta T cells have been postulated to act as a first line of defense against infectious agents, particularly intracellular pathogens, representing an important link between the innate and adaptive immune responses. Human gamma delta T cells expand in the blood of brucellosis patients and are active against Brucella in vitro. However, the role of gamma delta T cells in vivo during experimental brucellosis has not been studied. Here we report TCR delta(-/-) mice are more susceptible to B. abortus infection than C57BL/6 mice at one week post-infection as measured by splenic colonization and splenomegaly. An increase in TCR gamma delta cells was observed in the spleens of B. abortus-infected C57BL/6 mice, which peaked at two weeks post-infection and occurred concomitantly with diminished brucellae. gamma delta T cells were the major source of IL-17 following infection and also produced IFN-gamma. Depletion of gamma delta T cells from C57BL/6, IL-17R alpha(-/-), and GMCSF(-/-) mice enhanced susceptibility to B. abortus infection although this susceptibility was unaltered in the mutant mice; however, when gamma delta T cells were depleted from IFN-gamma(-/-) mice, enhanced susceptibility was observed. Neutralization of gamma delta T cells in the absence of TNF-alpha did not further impair immunity. In the absence of TNF-alpha or gamma delta T cells, B. abortus-infected mice showed enhanced IFN-gamma, suggesting that they augmented production to compensate for the loss of gamma delta T cells and/or TNF-alpha. While the protective role of gamma delta T cells was TNF-alpha-dependent, gamma delta T cells were not the major source of TNF-alpha and activation of gamma delta T cells following B. abortus infection was TNF-alpha-independent. Additionally, bovine TCR gamma delta cells were found to respond rapidly to B. abortus infection upon co-culture with autologous macrophages and could impair the intramacrophage replication of B. abortus via IFN-gamma. Collectively, these results demonstrate gamma delta T cells are important for early protection to B. abortus infections.	[Skyberg, Jerod A.; Thornburg, Theresa; Rollins, MaryClare; Huarte, Eduardo; Jutila, Mark A.; Pascual, David W.] Montana State Univ, Dept Immunol & Infect Dis, Bozeman, MT 59717 USA	Montana State University System; Montana State University Bozeman	Skyberg, JA (corresponding author), Montana State Univ, Dept Immunol & Infect Dis, Bozeman, MT 59717 USA.	dpascual@montana.edu	Pascual, David/AAC-2248-2022	Huarte, Eduardo/0000-0001-7498-7547	USDA [2007-01612, 2009-34397-20133]; Montana Agricultural Station; U.S. Department of Agriculture; National Institutes of Health [P20 RR020185, HHSN266200400009N01-AI, P01 AT004986]; M.J. Murdock Charitable Trust; NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE [P01AT004986] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR020185] Funding Source: NIH RePORTER	USDA(United States Department of Agriculture (USDA)); Montana Agricultural Station; U.S. Department of Agriculture(United States Department of Agriculture (USDA)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); M.J. Murdock Charitable Trust; NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work is supported by grants from USDA 2007-01612, USDA 2009-34397-20133, Montana Agricultural Station, U.S. Department of Agriculture Formula Funds, National Institutes of Health Grant P20 RR020185, NIH contract HHSN266200400009N01-AI, P01 AT004986, and an equipment grant from the M.J. Murdock Charitable Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldwin CL, 2002, VET MICROBIOL, V90, P365, DOI 10.1016/S0378-1135(02)00221-3; Belles C, 1996, J IMMUNOL, V156, P4280; BERTOTTO A, 1993, EUR J IMMUNOL, V23, P1177, DOI 10.1002/eji.1830230531; CAMPBELL GA, 1992, VET IMMUNOL IMMUNOP, V34, P291, DOI 10.1016/0165-2427(92)90171-L; Cardoso PCG, 2006, MICROB CELL FACT, V5, DOI 10.1186/1475-2859-5-13; COLMENERO JD, 1991, ANN RHEUM DIS, V50, P23, DOI 10.1136/ard.50.1.23; Denis M, 2005, IMMUNOL CELL BIOL, V83, P643, DOI 10.1111/j.1440-1711.2005.01386.x; Dudal S, 2006, J IMMUNOL, V177, P5533, DOI 10.4049/jimmunol.177.8.5533; Edmonds M, 2000, VET MICROBIOL, V76, P81, DOI 10.1016/S0378-1135(00)00225-X; FERNANDES DM, 1995, INFECT IMMUN, V63, P4029, DOI 10.1128/IAI.63.10.4029-4033.1995; Hamada S, 2008, J IMMUNOL, V181, P3456, DOI 10.4049/jimmunol.181.5.3456; Hedges JF, 2003, J IMMUNOL, V171, P4959, DOI 10.4049/jimmunol.171.10.4959; HEIN WR, 1991, IMMUNOL TODAY, V12, P30, DOI 10.1016/0167-5699(91)90109-7; HIROMATSU K, 1992, J EXP MED, V175, P49, DOI 10.1084/jem.175.1.49; Holderness J, 2007, J IMMUNOL, V179, P6468, DOI 10.4049/jimmunol.179.10.6468; Holtmeier Wolfgang, 2005, V86, P151, DOI 10.1159/000086659; JIANG XS, 1993, INFECT IMMUN, V61, P124, DOI 10.1128/IAI.61.1.124-134.1993; Jutila Mark A., 2008, Animal Health Research Reviews, V9, P47, DOI 10.1017/S1466252307001363; King DP, 1999, J IMMUNOL, V162, P5033; Ko JY, 2003, CLIN MICROBIOL REV, V16, P65, DOI 10.1128/CMR.16.1.65-78.2003; Koenecke C, 2009, EUR J IMMUNOL, V39, P372, DOI 10.1002/eji.200838741; LADEL CH, 1995, EUR J IMMUNOL, V25, P377, DOI 10.1002/eji.1830250211; Lahn M, 1998, J IMMUNOL, V160, P5221; Leite F, 2005, VET IMMUNOL IMMUNOP, V103, P187, DOI 10.1016/j.vetimm.2004.08.015; LeVine AM, 1999, J CLIN INVEST, V103, P563, DOI 10.1172/JCI5212; Lin YY, 2009, IMMUNITY, V31, P799, DOI 10.1016/j.immuni.2009.08.025; Lockhart E, 2006, J IMMUNOL, V177, P4662, DOI 10.4049/jimmunol.177.7.4662; McKenzie BS, 2006, TRENDS IMMUNOL, V27, P17, DOI 10.1016/j.it.2005.10.003; Moore TA, 2000, J IMMUNOL, V165, P2643, DOI 10.4049/jimmunol.165.5.2643; Morris CA, 2007, VET J, V174, P481, DOI 10.1016/j.tvjl.2006.09.006; MULLER D, 1995, INFECT IMMUN, V63, P2361, DOI 10.1128/IAI.63.6.2361-2366.1995; Murphy EA, 2001, FEMS IMMUNOL MED MIC, V32, P85, DOI 10.1111/j.1574-695X.2001.tb00536.x; Murphy EA, 2001, IMMUNOLOGY, V103, P511, DOI 10.1046/j.1365-2567.2001.01258.x; Naessens J, 1997, IMMUNOL TODAY, V18, P365, DOI 10.1016/S0167-5699(97)81055-9; NISHIMURA H, 1995, EUR J IMMUNOL, V25, P1465, DOI 10.1002/eji.1830250551; Ochoa-Reparaz J, 2007, INFECT IMMUN, V75, P5845, DOI 10.1128/IAI.00901-07; Ochoa-Reparaz J, 2007, J IMMUNOL, V178, P1791, DOI 10.4049/jimmunol.178.3.1791; Oliaro J, 2005, J LEUKOCYTE BIOL, V77, P652, DOI 10.1189/jlb.0704433; Ottones F, 2000, J IMMUNOL, V165, P7133, DOI 10.4049/jimmunol.165.12.7133; Palmer MV, 1998, AM J VET RES, V59, P153; Pappas G, 2006, LANCET INFECT DIS, V6, P91, DOI 10.1016/S1473-3099(06)70382-6; Pascual DW, 2002, INFECT IMMUN, V70, P4273, DOI 10.1128/IAI.70.8.4273-4281.2002; Pascual DW, 2001, J IMMUNOL, V167, P407, DOI 10.4049/jimmunol.167.1.407; RANGES GE, 1987, J EXP MED, V166, P991, DOI 10.1084/jem.166.4.991; Shibata K, 2007, J IMMUNOL, V178, P4466, DOI 10.4049/jimmunol.178.7.4466; Smith RA, 1999, J LEUKOCYTE BIOL, V65, P28, DOI 10.1002/jlb.65.1.28; Takano M, 1998, INFECT IMMUN, V66, P3270, DOI 10.1128/IAI.66.7.3270-3278.1998; Tramonti D, 2006, EUR J IMMUNOL, V36, P1729, DOI 10.1002/eji.200635959; Wilson E, 1998, IMMUNOL LETT, V64, P39, DOI 10.1016/S0165-2478(98)00077-7; Yang XH, 2005, INFECT IMMUN, V73, P7297, DOI 10.1128/IAI.73.11.7297-7303.2005; Yang XH, 2007, VACCINE, V25, P2261, DOI 10.1016/j.vaccine.2006.12.004; Yang XH, 2006, INFECT IMMUN, V74, P3874, DOI 10.1128/IAI.01957-05; Zhan YF, 1998, BLOOD, V91, P863, DOI 10.1182/blood.V91.3.863.863_863_869	53	48	51	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2011	6	7							e21978	10.1371/journal.pone.0021978	http://dx.doi.org/10.1371/journal.pone.0021978			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791WM	21765931	Green Submitted, Green Published, gold			2022-12-27	WOS:000292699000019
J	Zhao, YF; Chen, XP; Yang, H; Zhou, LC; Okoro, EU; Guo, ZM				Zhao, Yanfeng; Chen, Xinping; Yang, Hong; Zhou, Lichun; Okoro, Emmanuel U.; Guo, Zhongmao			A Novel Function of Apolipoprotein E: Upregulation of ATP-Binding Cassette Transporter A1 Expression	PLOS ONE			English	Article							LOW-DENSITY-LIPOPROTEIN; CHOLESTEROL EFFLUX; X-RECEPTOR; PLASMA-CONCENTRATION; LDL RECEPTOR; GENE; MACROPHAGES; CELLS; ATHEROSCLEROSIS; RECOGNITION	Despite the well known importance of apolipoprotein (Apo) E in cholesterol efflux, the effect of ApoE on the expression of ATP-binding cassette transporter A1 (ABCA1) has never been investigated. The objective of this study was to determine the effect of ApoE on ApoB-carrying lipoprotein-induced expression of ABCA1, a protein that mediates cholesterol efflux. Our data demonstrate that ApoB-carrying lipoproteins obtained from both wild-type and ApoE knockout mice induced ApoAI-mediated cholesterol efflux in mouse macrophages, which was associated with an enhanced ABCA1 promoter activity, and an increased ABCA1 mRNA and protein expression. In addition, these lipoproteins increased the level of phosphorylated specificity protein 1 (Sp1) and the amount of Sp1 bound to the ABCA1 promoter. However, all these inductions were significantly diminished in cells treated with ApoE-free lipoproteins, when compared to those treated with wild-type lipoproteins. Enrichment with human ApoE3 reversed the reduced inducibility of ApoE-free lipoproteins. Moreover, we observed that inhibition of Sp1 DNA-binding by mithramycin A diminished ABCA1 expression and ApoAI-mediated cholesterol efflux induced by ApoB-carrying lipoproteins, and that mutation of the Sp1-binding motif in the ABCA1 promoter region diminished ApoB-carrying lipoprotein-induced ABCA1 promoter activity. Collectively, these data suggest that ApoE associated with ApoB-carrying lipoproteins has an upregulatory role on ABCA1 expression, and that induction of Sp1 phosphorylation is a mechanism by which ApoE upregulates ABCA1 expression.	[Zhao, Yanfeng] Wuhan Univ, Sch Basic Med Sci, Dept Physiol, Wuhan 430072, Peoples R China; [Chen, Xinping; Yang, Hong; Zhou, Lichun; Okoro, Emmanuel U.; Guo, Zhongmao] Meharry Med Coll, Dept Physiol, Nashville, TN 37208 USA	Wuhan University; Meharry Medical College	Zhao, YF (corresponding author), Wuhan Univ, Sch Basic Med Sci, Dept Physiol, Wuhan 430072, Peoples R China.	zguo@mmc.edu			National Institutes of Health [R01ES014471, R01HL089382, SC1HL101431, U54RR026140]; NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR026140] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL089382, SC1HL101431] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by National Institutes of Health grants R01ES014471 and R01HL089382 (Zhongmao Guo), and SC1HL101431 and U54RR026140 (Hong Yang). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baranova IN, 2008, J IMMUNOL, V181, P7147, DOI 10.4049/jimmunol.181.10.7147; Blacklow SC, 2007, CURR OPIN STRUC BIOL, V17, P419, DOI 10.1016/j.sbi.2007.08.017; BLUME SW, 1991, J CLIN INVEST, V88, P1613, DOI 10.1172/JCI115474; Chawla A, 2001, MOL CELL, V7, P161, DOI 10.1016/S1097-2765(01)00164-2; CLAVEY V, 1995, ARTERIOSCL THROM VAS, V15, P963, DOI 10.1161/01.ATV.15.7.963; Cohn JS, 1996, ARTERIOSCL THROM VAS, V16, P149, DOI 10.1161/01.ATV.16.1.149; Costet P, 2000, J BIOL CHEM, V275, P28240; Dove DE, 2005, AM J PHYSIOL-CELL PH, V288, pC586, DOI 10.1152/ajpcell.00210.2004; Dove DE, 2005, ARTERIOSCL THROM VAS, V25, P128, DOI 10.1161/01.ATV.0000148323.94021.e5; Geeraert B, 2007, J THROMB HAEMOST, V5, P2529, DOI 10.1111/j.1538-7836.2007.02786.x; Haddy N, 2002, EUR J HUM GENET, V10, P841, DOI 10.1038/sj.ejhg.5200864; Hakamata H, 1998, BIOCHEMISTRY-US, V37, P13720, DOI 10.1021/bi980762v; Heeren J, 2006, ARTERIOSCL THROM VAS, V26, P442, DOI 10.1161/01.ATV.0000201282.64751.47; Heeren J, 2004, J BIOL CHEM, V279, P55483, DOI 10.1074/jbc.M409324200; Heeren J, 2003, J BIOL CHEM, V278, P14370, DOI 10.1074/jbc.M209006200; Huang ZH, 2001, ARTERIOSCL THROM VAS, V21, P2019, DOI 10.1161/hq1201.100242; Janowski BA, 1999, P NATL ACAD SCI USA, V96, P266, DOI 10.1073/pnas.96.1.266; Jong MC, 1997, BIOCHEM J, V328, P745; Mahley RW, 2000, ANNU REV GENOM HUM G, V1, P507, DOI 10.1146/annurev.genom.1.1.507; Moore KJ, 2006, ARTERIOSCL THROM VAS, V26, P1702, DOI 10.1161/01.ATV.0000229218.97976.43; Oram JF, 2006, CIRC RES, V99, P1031, DOI 10.1161/01.RES.0000250171.54048.5c; PIEDRAHITA JA, 1992, P NATL ACAD SCI USA, V89, P4471, DOI 10.1073/pnas.89.10.4471; Reamon-Buettner SM, 2008, CANCER RES, V68, P7587, DOI 10.1158/0008-5472.CAN-08-0967; Repa JJ, 2002, NAT MED, V8, P1243, DOI 10.1038/nm1102-1243; Tan NY, 2009, MOL CELL BIOL, V29, P2483, DOI 10.1128/MCB.01828-08; Tang TA, 2010, FREE RADICAL BIO MED, V49, P487, DOI 10.1016/j.freeradbiomed.2010.05.007; Thymiakou E, 2007, BIOCHEMISTRY-US, V46, P11473, DOI 10.1021/bi700994m; van der Geer P, 2002, TRENDS CARDIOVAS MED, V12, P160, DOI 10.1016/S1050-1738(02)00154-8; Vedhachalam C, 2007, BIOCHEMISTRY-US, V46, P2583, DOI 10.1021/bi602407r; Venkateswaran A, 2000, P NATL ACAD SCI USA, V97, P12097, DOI 10.1073/pnas.200367697; Wang N, 2003, ARTERIOSCL THROM VAS, V23, P1178, DOI 10.1161/01.ATV.0000075912.83860.26; Wang ZF, 2009, FREE RADICAL BIO MED, V47, P1221, DOI 10.1016/j.freeradbiomed.2009.08.001; Wu DF, 2007, J LIPID RES, V48, P2571, DOI 10.1194/jlr.M700217-JLR200; Yu JH, 1999, J BIOL CHEM, V274, P34327, DOI 10.1074/jbc.274.48.34327; Zhang GC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000252; Zhang WY, 1996, J BIOL CHEM, V271, P28641, DOI 10.1074/jbc.271.45.28641; Zhao Yanfeng, 2010, J Bioanal Biomed, V2, P113; Zhao ZZ, 2005, ARTERIOSCL THROM VAS, V25, P168, DOI 10.1161/01.ATV.0000149145.00865.d9; Zhu Y, 2005, CARDIOVASC RES, V68, P425, DOI 10.1016/j.cardiores.2005.07.003	39	17	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2011	6	7							e21453	10.1371/journal.pone.0021453	http://dx.doi.org/10.1371/journal.pone.0021453			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791QY	21779326	gold, Green Published, Green Submitted			2022-12-27	WOS:000292680900005
J	Kameda, H; Hirabayashi, K; Wada, K; Fukuyama, K				Kameda, Haruka; Hirabayashi, Kei; Wada, Kei; Fukuyama, Keiichi			Mapping of Protein-Protein Interaction Sites in the Plant-Type [2Fe-2S] Ferredoxin	PLOS ONE			English	Article							MAIN CHAIN FOLD; BLUE-GREEN-ALGA; APHANOTHECE-SACRUM; ELECTRON-TRANSFER; ANGSTROM RESOLUTION; 3-DIMENSIONAL STRUCTURE; SPIRULINA-PLATENSIS; EQUISETUM-ARVENSE; 2.5-A RESOLUTION; STRUCTURAL BASIS	Knowing the manner of protein-protein interactions is vital for understanding biological events. The plant-type [2Fe-2S] ferredoxin (Fd), a well-known small iron-sulfur protein with low redox potential, partitions electrons to a variety of Fd-dependent enzymes via specific protein-protein interactions. Here we have refined the crystal structure of a recombinant plant-type Fd I from the blue green alga Aphanothece sacrum (AsFd-I) at 1.46 angstrom resolution on the basis of the synchrotron radiation data. Incorporating the revised amino-acid sequence, our analysis corrects the 3D structure previously reported; we identified the short alpha-helix (67-71) near the active center, which is conserved in other plant-type [ 2Fe-2S] Fds. Although the 3D structures of the four molecules in the asymmetric unit are similar to each other, detailed comparison of the four structures revealed the segments whose conformations are variable. Structural comparison between the Fds from different sources showed that the distribution of the variable segments in AsFd-I is highly conserved in other Fds, suggesting the presence of intrinsically flexible regions in the plant-type [ 2Fe-2S] Fd. A few structures of the complexes with Fd-dependent enzymes clearly demonstrate that the protein-protein interactions are achieved through these variable regions in Fd. The results described here will provide a guide for interpreting the biochemical and mutational studies that aim at the manner of interactions with Fd-dependent enzymes.	[Kameda, Haruka; Hirabayashi, Kei; Wada, Kei; Fukuyama, Keiichi] Osaka Univ, Grad Sch Sci, Dept Biol Sci, Osaka, Japan	Osaka University	Kameda, H (corresponding author), Osaka Univ, Grad Sch Sci, Dept Biol Sci, Osaka, Japan.	fukuyama@bio.sci.osaka-u.ac.jp		Wada, Kei/0000-0001-7631-4151	Japan Foundation for Applied Enzymology [20370037, 23370052, 21770112]; Kurata Memorial Hitachi Science and Technology Foundation	Japan Foundation for Applied Enzymology; Kurata Memorial Hitachi Science and Technology Foundation	This study was supported in part by Grants-in-Aid for Scientific Research 20370037 and 23370052 (to K. F.) and 21770112 (to K. W.), a grant from the Japan Foundation for Applied Enzymology (to K. W and K. F.) and the Kurata Memorial Hitachi Science and Technology Foundation (to K. W). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akashi T, 1999, J BIOL CHEM, V274, P29399, DOI 10.1074/jbc.274.41.29399; ARNON DI, 1965, SCIENCE, V149, P1460, DOI 10.1126/science.149.3691.1460; Bes MT, 1999, STRUCT FOLD DES, V7, P1201, DOI 10.1016/S0969-2126(00)80054-4; COLMAN PM, 1987, NATURE, V326, P358, DOI 10.1038/326358a0; Dai SD, 2007, NATURE, V448, P92, DOI 10.1038/nature05937; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fish A, 2005, J MOL BIOL, V350, P599, DOI 10.1016/j.jmb.2005.04.071; FOUST GP, 1969, J BIOL CHEM, V244, P964; Fujishiro T, 2004, APPL ENVIRON MICROB, V70, P3338, DOI 10.1128/AEM.70.6.3338-3345.2004; Fukuyama K, 2004, PHOTOSYNTH RES, V81, P289, DOI 10.1023/B:PRES.0000036882.19322.0a; FUKUYAMA K, 1980, NATURE, V286, P522, DOI 10.1038/286522a0; FUKUYAMA K, 1995, J BIOCHEM-TOKYO, V117, P1017, DOI 10.1093/oxfordjournals.jbchem.a124800; Hanke GT, 2004, PHOTOSYNTH RES, V81, P317, DOI 10.1023/B:PRES.0000036885.01534.b8; Hasegawa K, 2009, J APPL CRYSTALLOGR, V42, P1165, DOI 10.1107/S0021889809042277; HOGLE JM, 1985, SCIENCE, V229, P1358, DOI 10.1126/science.2994218; HOLDEN HM, 1994, J BIOENERG BIOMEMBR, V26, P67, DOI 10.1007/BF00763220; IKEMIZU S, 1994, ACTA CRYSTALLOGR D, V50, P167, DOI 10.1107/S0907444993009588; JACOBSON BL, 1993, BIOCHEMISTRY-US, V32, P6788, DOI 10.1021/bi00077a033; KLEYWEGT GJ, 1994, ESF CCP4 NEWSLETTER, V31, P9; KNAFF DB, 1991, BIOCHIM BIOPHYS ACTA, V1056, P93, DOI 10.1016/S0005-2728(05)80277-4; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; KUNITA A, 1978, J BIOCHEM-TOKYO, V84, P989, DOI 10.1093/oxfordjournals.jbchem.a132214; Kurisu G, 2001, NAT STRUCT BIOL, V8, P117, DOI 10.1038/84097; Kurisu G, 2005, J BIOL CHEM, V280, P2275, DOI 10.1074/jbc.M408904200; Lovenberg W., 1973, IRON SULFUR PROTEINS; Morales R, 2000, EMBO REP, V1, P271, DOI 10.1093/embo-reports/kvd057; Nakamura M, 1999, J BIOCHEM, V126, P10, DOI 10.1093/oxfordjournals.jbchem.a022409; ROSSMANN MG, 1985, NATURE, V317, P145, DOI 10.1038/317145a0; RYPNIEWSKI WR, 1991, BIOCHEMISTRY-US, V30, P4126, DOI 10.1021/bi00231a003; TAINER JA, 1984, NATURE, V312, P127, DOI 10.1038/312127a0; TSUKIHARA T, 1990, J MOL BIOL, V216, P399, DOI 10.1016/S0022-2836(05)80330-4; TSUKIHARA T, 1981, J BIOCHEM-TOKYO, V90, P1763, DOI 10.1093/oxfordjournals.jbchem.a133654; TSUTSUI T, 1983, J BIOCHEM-TOKYO, V94, P299, DOI 10.1093/oxfordjournals.jbchem.a134343; WADA K, 1974, J BIOCHEM-TOKYO, V76, P1217, DOI 10.1093/oxfordjournals.jbchem.a130674; WESTHOF E, 1984, NATURE, V311, P123, DOI 10.1038/311123a0; ZANETTI G, 2001, HDB METALLOPROTEINS, P532	37	19	19	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2011	6	7							e21947	10.1371/journal.pone.0021947	http://dx.doi.org/10.1371/journal.pone.0021947			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791IA	21760931	gold, Green Published, Green Submitted			2022-12-27	WOS:000292657200035
J	Nedellec, R; Coetzer, M; Lederman, MM; Offord, RE; Hartley, O; Mosier, DE				Nedellec, Rebecca; Coetzer, Mia; Lederman, Michael M.; Offord, Robin E.; Hartley, Oliver; Mosier, Donald E.			Resistance to the CCR5 Inhibitor 5P12-RANTES Requires a Difficult Evolution from CCR5 to CXCR4 Coreceptor Use	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; SMALL-MOLECULE INHIBITOR; CHEMOKINE RECEPTOR CCR5; VAGINAL SHIV CHALLENGE; HIGHLY POTENT; HIV-1 ESCAPE; SELECTIVE TRANSMISSION; TYPE-1 VARIANTS; SINGLE-CYCLE; IN-VIVO	Viral resistance to small molecule allosteric inhibitors of CCR5 is well documented, and involves either selection of preexisting CXCR4-using HIV-1 variants or envelope sequence evolution to use inhibitor-bound CCR5 for entry. Resistance to macromolecular CCR5 inhibitors has been more difficult to demonstrate, although selection of CXCR4-using variants might be expected. We have compared the in vitro selection of HIV-1 CC1/85 variants resistant to either the small molecule inhibitor maraviroc (MVC) or the macromolecular inhibitor 5P12-RANTES. High level resistance to MVC was conferred by the same envelope mutations as previously reported after 16-18 weeks of selection by increasing levels of MVC. The MVC-resistant mutants were fully sensitive to inhibition by 5P12-RANTES. By contrast, only transient and low level resistance to 5P12-RANTES was achieved in three sequential selection experiments, and each resulted in a subsequent collapse of virus replication. A fourth round of selection by 5P12-RANTES led, after 36 weeks, to a "resistant" variant that had switched from CCR5 to CXCR4 as a coreceptor. Envelope sequences diverged by 3.8% during selection of the 5P12-RANTES resistant, CXCR4-using variants, with unique and critical substitutions in the V3 region. A subset of viruses recovered from control cultures after 44 weeks of passage in the absence of inhibitors also evolved to use CXCR4, although with fewer and different envelope mutations. Control cultures contained both viruses that evolved to use CXCR4 by deleting four amino acids in V3, and others that maintained entry via CCR5. These results suggest that coreceptor switching may be the only route to resistance for compounds like 5P12-RANTES. This pathway requires more mutations and encounters more fitness obstacles than development of resistance to MVC, confirming the clinical observations that resistance to small molecule CCR5 inhibitors very rarely involves coreceptor switching.	[Nedellec, Rebecca; Coetzer, Mia; Mosier, Donald E.] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA; [Lederman, Michael M.] Case Western Reserve Univ, Dept Med, Univ Hosp Case Med Ctr, Cleveland, OH 44106 USA; [Offord, Robin E.] Mintaka Fdn Med Res, Geneva, Switzerland; [Hartley, Oliver] Univ Geneva, Dept Struct Biol & Bioinformat, Geneva, Switzerland	Scripps Research Institute; Case Western Reserve University; Case Western Reserve University Hospital; University of Geneva	Nedellec, R (corresponding author), Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA.	dmosier@scripps.edu			National Institute of Allergy and Infectious Diseases (NIAID) [R01 AI052778, U19 AI076981]; Swiss National Science Foundation; CONRAD; World Health Organization; International Partnership for Microbicides; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI052778, U19AI076981] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); CONRAD(United States Agency for International Development (USAID)); World Health Organization(World Health Organization); International Partnership for Microbicides; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants R01 AI052778 and U19 AI076981 from the National Institute of Allergy and Infectious Diseases (NIAID; http://www.niaid.nih.gov). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIAID or the National Institutes of Health. Additional support was provided by the La Jolla Foundation for Microbicide Research (http://www.clevelandactu.org/lajolla/), The Mintaka Foundation (http://www.mintakafoundation.org/), and the James B. Pendleton Charitable Trust. OH acknowledges support from the Swiss National Science Foundation (http://www.snf.ch/E/funding/Pages/default.aspx). REO acknowledges support from CONRAD (http://www.conrad.org/),the World Health Organization (http://www.who.int/en/), and the International Partnership for Microbicides (http://www.ipmglobal.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abram ME, 2010, J VIROL, V84, P9864, DOI 10.1128/JVI.00915-10; Anastassopoulou CG, 2009, P NATL ACAD SCI USA, V106, P5318, DOI 10.1073/pnas.0811713106; Anonymous, 2005, Antiviral Chemistry & Chemotherapy, V16, P339; Baba M, 1999, P NATL ACAD SCI USA, V96, P5698, DOI 10.1073/pnas.96.10.5698; Berro R, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000548; Chesebro B, 1996, J VIROL, V70, P9055, DOI 10.1128/JVI.70.12.9055-9059.1996; Coetzer M, 2008, J VIROL, V82, P11758, DOI 10.1128/JVI.01141-08; Connor RI, 1997, J EXP MED, V185, P621, DOI 10.1084/jem.185.4.621; CONNOR RI, 1995, VIROLOGY, V206, P935, DOI 10.1006/viro.1995.1016; Dorn CP, 2001, BIOORG MED CHEM LETT, V11, P259, DOI 10.1016/S0960-894X(00)00637-5; Dorr P, 2005, ANTIMICROB AGENTS CH, V49, P4721, DOI 10.1128/AAC.49.11.4721-4732.2005; Dragic T, 2000, P NATL ACAD SCI USA, V97, P5639, DOI 10.1073/pnas.090576697; Dudley DM, 2009, J VIROL, V83, P5067, DOI 10.1128/JVI.00055-09; Fatkenheuer G, 2008, NEW ENGL J MED, V359, P1442, DOI 10.1056/NEJMoa0803154; Fatkenheuer G, 2005, NAT MED, V11, P1170, DOI 10.1038/nm1319; Gaertner H, 2008, P NATL ACAD SCI USA, V105, P17706, DOI 10.1073/pnas.0805098105; Gao F, 1996, J VIROL, V70, P1651, DOI 10.1128/JVI.70.3.1651-1667.1996; Hartley O, 2004, P NATL ACAD SCI USA, V101, P16460, DOI 10.1073/pnas.0404802101; Karlsson I, 2004, J VIROL, V78, P11807, DOI 10.1128/JVI.78.21.11807-11815.2004; Keele BF, 2008, P NATL ACAD SCI USA, V105, P7552, DOI 10.1073/pnas.0802203105; Kiselyeva Y, 2007, J VIROL, V81, P3657, DOI 10.1128/JVI.02310-06; Kondru R, 2008, MOL PHARMACOL, V73, P789, DOI 10.1124/mol.107.042101; Kuhmann SE, 2004, J VIROL, V78, P2790, DOI 10.1128/JVI.78.6.2790-2807.2004; Learn GH, 2002, J VIROL, V76, P11953, DOI 10.1128/JVI.76.23.11953-11959.2002; Lederman MM, 2004, SCIENCE, V306, P485, DOI 10.1126/science.1099288; Li M, 2006, J VIROL, V80, P11776, DOI 10.1128/JVI.01730-06; Liu R, 1996, CELL, V86, P367, DOI 10.1016/S0092-8674(00)80110-5; Long EM, 2002, AIDS RES HUM RETROV, V18, P567, DOI 10.1089/088922202753747914; Mack M, 1998, J EXP MED, V187, P1215, DOI 10.1084/jem.187.8.1215; Maeda K, 2006, J BIOL CHEM, V281, P12688, DOI 10.1074/jbc.M512688200; Margolis L, 2006, NAT REV MICROBIOL, V4, P312, DOI 10.1038/nrmicro1387; Marozsan AJ, 2005, VIROLOGY, V338, P182, DOI 10.1016/j.virol.2005.04.035; McGovern RA, 2010, AIDS, V24, P2512, DOI 10.1097/QAD.0b013e32833e6cfb; Michael NL, 1997, NAT MED, V3, P1160, DOI 10.1038/nm1097-1160; Moncunill G, 2008, AIDS, V22, P23, DOI 10.1097/QAD.0b013e3282f303e6; Moore JP, 2009, CURR OPIN HIV AIDS, V4, P118, DOI 10.1097/COH.0b013e3283223d46; Moore JP, 2004, AIDS RES HUM RETROV, V20, P111, DOI 10.1089/088922204322749567; Mosier DE, 1999, J VIROL, V73, P3544, DOI 10.1128/JVI.73.5.3544-3550.1999; Nedellec R, 2010, J VIROL, V84, P5842, DOI 10.1128/JVI.01907-09; Nolan KM, 2008, J VIROL, V82, P664, DOI 10.1128/JVI.01793-07; Pastore C, 2006, J VIROL, V80, P750, DOI 10.1128/JVI.80.2.750-758.2006; Pastore C, 2003, ANTIMICROB AGENTS CH, V47, P509, DOI 10.1128/AAC.47.2.509-517.2003; Pastore C, 2007, J VIROL, V81, P8165, DOI 10.1128/JVI.02792-06; Paxton WA, 1998, AIDS RES HUM RETROV, V14, pS89; Peters PJ, 2006, J VIROL, V80, P6324, DOI 10.1128/JVI.02328-05; Pugach P, 2004, VIROLOGY, V321, P8, DOI 10.1016/j.virol.2003.12.012; Pugach P, 2007, VIROLOGY, V361, P212, DOI 10.1016/j.virol.2006.11.004; Roos JW, 2000, VIROLOGY, V273, P307, DOI 10.1006/viro.2000.0431; Salazar-Gonzalez JF, 2009, J EXP MED, V206, P1273, DOI 10.1084/jem.20090378; SEIBERT C, 2006, VIROLOGY; Simmons G, 1997, SCIENCE, V276, P276, DOI 10.1126/science.276.5310.276; Strizki JM, 2001, P NATL ACAD SCI USA, V98, P12718, DOI 10.1073/pnas.221375398; Strizki JM, 2005, ANTIMICROB AGENTS CH, V49, P4911, DOI 10.1128/AAC.49.12.4911-4919.2005; Tilton JC, 2010, J VIROL, V84, P10863, DOI 10.1128/JVI.01109-10; Trkola A, 2002, P NATL ACAD SCI USA, V99, P395, DOI 10.1073/pnas.012519099; Tsibris AMN, 2008, J VIROL, V82, P8210, DOI 10.1128/JVI.00444-08; Tsibris AMN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005683; Veazey RS, 2009, J INFECT DIS, V199, P1525, DOI 10.1086/598685; Veazey RS, 2005, NAT MED, V11, P1293, DOI 10.1038/nm1321; Veazey RS, 2003, J EXP MED, V198, P1551, DOI 10.1084/jem.20031266; Veazey RS, 2005, NATURE, V438, P99, DOI 10.1038/nature04055; Watson C, 2005, MOL PHARMACOL, V67, P1268, DOI 10.1124/mol.104.008565; Westby M, 2006, J VIROL, V80, P4909, DOI 10.1128/JVI.80.10.4909-4920.2006; Westby M, 2007, J VIROL, V81, P2359, DOI 10.1128/JVI.02006-06; Wilkinson DA, 1998, J INFECT DIS, V178, P1163, DOI 10.1086/515675; WOLINSKY SM, 1992, SCIENCE, V255, P1134, DOI 10.1126/science.1546316	66	33	34	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2011	6	7							e22020	10.1371/journal.pone.0022020	http://dx.doi.org/10.1371/journal.pone.0022020			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791IA	21760945	Green Submitted, gold, Green Published			2022-12-27	WOS:000292657200040
J	Baguet, A; Everaert, I; Hespel, P; Petrovic, M; Achten, E; Derave, W				Baguet, Audrey; Everaert, Inge; Hespel, Peter; Petrovic, Mirko; Achten, Eric; Derave, Wim			A New Method for Non-Invasive Estimation of Human Muscle Fiber Type Composition	PLOS ONE			English	Article							BETA-ALANINE SUPPLEMENTATION; HUMAN VASTUS LATERALIS; HUMAN SKELETAL-MUSCLE; INTENSITY EXERCISE PERFORMANCE; CARNOSINE CONCENTRATIONS; RELAXATION-TIME; CROSS-SECTIONS; IN-VIVO; SPRINTERS; CAPACITY	Background: It has been established that excellence in sports with short and long exercise duration requires a high proportion of fast-twitch (FT) or type-II fibers and slow-twitch (ST) or type-I fibers, respectively. Until today, the muscle biopsy method is still accepted as gold standard to measure muscle fiber type composition. Because of its invasive nature and high sampling variance, it would be useful to develop a non-invasive alternative. Methodology: Eighty-three control subjects, 15 talented young track-and-field athletes, 51 elite athletes and 14 ex-athletes volunteered to participate in the current study. The carnosine content of all 163 subjects was measured in the gastrocnemius muscle by proton magnetic resonance spectroscopy ((1)H-MRS). Muscle biopsies for fiber typing were taken from 12 untrained males. Principal Findings: A significant positive correlation was found between muscle carnosine, measured by (1)H-MRS, and percentage area occupied by type II fibers. Explosive athletes had similar to 30% higher carnosine levels compared to a reference population, whereas it was similar to 20% lower than normal in typical endurance athletes. Similar results were found in young talents and ex-athletes. When active elite runners were ranked according to their best running distance, a negative sigmoidal curve was found between logarithm of running distance and muscle carnosine. Conclusions: Muscle carnosine content shows a good reflection of the disciplines of elite track-and-field athletes and is able to distinguish between individual track running distances. The differences between endurance and sprint muscle types is also observed in young talents and former athletes, suggesting this characteristic is genetically determined and can be applied in early talent identification. This quick method provides a valid alternative for the muscle biopsy method. In addition, this technique may also contribute to the diagnosis and monitoring of many conditions and diseases that are characterized by an altered muscle fiber type composition.	[Baguet, Audrey; Everaert, Inge; Derave, Wim] Univ Ghent, Dept Movement & Sport Sci, B-9000 Ghent, Belgium; [Hespel, Peter] Katholieke Univ Leuven, Res Ctr Exercise & Hlth, Leuven, Belgium; [Petrovic, Mirko] Univ Ghent, Dept Internal Med, B-9000 Ghent, Belgium; [Achten, Eric] Univ Ghent, Dept Radiol, GIFMI, B-9000 Ghent, Belgium	Ghent University; KU Leuven; Ghent University; Ghent University	Baguet, A (corresponding author), Univ Ghent, Dept Movement & Sport Sci, B-9000 Ghent, Belgium.	wim.derave@ugent.be	Derave, Wim/B-2554-2014	Derave, Wim/0000-0002-2225-5587; Hespel, Peter/0000-0003-1283-2229	Research Foundation - Flanders (FWO) [1.5.149.08, G024311N]; Vlaamse Atletiekliga	Research Foundation - Flanders (FWO)(FWO); Vlaamse Atletiekliga	This study was financially supported by a grant from the Research Foundation - Flanders (FWO 1.5.149.08 and G024311N). A. B. is a recipient of a PhD scholarship from the Research Foundation - Flanders. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors acknowledge the support from the Vlaamse Atletiekliga and their coaches and athletes. The assistance of Hanne Gyselbrecht, Sara Willemijns, Dajo Aertssen and Mattias Ysebie is acknowledged. Correspondence and requests for materials should be addressed to Wim Derave (wim.derave@ugent.be).	Albracht K, 2008, J BIOMECH, V41, P2211, DOI 10.1016/j.jbiomech.2008.04.020; Baguet A, 2011, EUR J APPL PHYSIOL, V111, P2571, DOI 10.1007/s00421-011-1877-4; Baguet A, 2010, J APPL PHYSIOL, V109, P1096, DOI 10.1152/japplphysiol.00141.2010; Baguet A, 2009, J APPL PHYSIOL, V106, P837, DOI 10.1152/japplphysiol.91357.2008; BERNUS G, 1993, MED SCI SPORT EXER, V25, P479; Bonny JM, 1998, MAGN RESON IMAGING, V16, P167, DOI 10.1016/S0730-725X(97)00249-X; COSTILL DL, 1976, J APPL PHYSIOL, V40, P149, DOI 10.1152/jappl.1976.40.2.149; De Bock K, 2007, J APPL PHYSIOL, V102, P183, DOI 10.1152/japplphysiol.00799.2006; De Bock K, 2007, AM J PHYSIOL-ENDOC M, V293, pE428, DOI 10.1152/ajpendo.00112.2007; Derave W, 2007, J APPL PHYSIOL, V103, P1736, DOI 10.1152/japplphysiol.00397.2007; Diffee GM, 2002, AM J PHYSIOL-CELL PH, V283, pC1376, DOI 10.1152/ajpcell.00154.2002; ELDER GCB, 1982, J APPL PHYSIOL, V53, P1473, DOI 10.1152/jappl.1982.53.6.1473; Everaert I, 2011, AMINO ACIDS, V40, P1221, DOI 10.1007/s00726-010-0749-2; Frontera WR, 2000, J APPL PHYSIOL, V88, P1321; GOLLNICK PD, 1972, J APPL PHYSIOL, V33, P312, DOI 10.1152/jappl.1972.33.3.312; GOLLNICK PD, 1984, AM J SPORT MED, V12, P212, DOI 10.1177/036354658401200309; Gosker HR, 2007, THORAX, V62, P944, DOI 10.1136/thx.2007.078980; Harris RC, 1998, J SPORT SCI, V16, P639; Harris RC, 2006, AMINO ACIDS, V30, P279, DOI 10.1007/s00726-006-0299-9; Hill CA, 2007, AMINO ACIDS, V32, P225, DOI 10.1007/s00726-006-0364-4; HOUMARD JA, 1995, J APPL PHYSIOL, V78, P807, DOI 10.1152/jappl.1995.78.3.807; Ingalls CP, 2004, J APPL PHYSIOL, V97, P1591, DOI 10.1152/classicessays.00010.2004; Kendrick IP, 2008, AMINO ACIDS, V34, P547, DOI 10.1007/s00726-007-0008-3; Kendrick IP, 2009, EUR J APPL PHYSIOL, V106, P131, DOI 10.1007/s00421-009-0998-5; KUNO S, 1988, RADIOLOGY, V169, P567, DOI 10.1148/radiology.169.2.3175009; LEXELL J, 1985, J APPL PHYSIOL, V59, P1228, DOI 10.1152/jappl.1985.59.4.1228; LEXELL J, 1983, ACTA PHYSIOL SCAND, V117, P115, DOI 10.1111/j.1748-1716.1983.tb07185.x; Malisoux L, 2007, J APPL PHYSIOL, V102, P340, DOI 10.1152/japplphysiol.00609.2006; MANNION AF, 1994, EUR J APPL PHYSIOL O, V68, P356, DOI 10.1007/BF00571457; MANNION AF, 1995, EXP PHYSIOL, V80, P89, DOI 10.1113/expphysiol.1995.sp003837; MANNION AF, 1992, EUR J APPL PHYSIOL O, V64, P47, DOI 10.1007/BF00376439; Nyholm B, 1997, DIABETES, V46, P1822, DOI 10.2337/diabetes.46.11.1822; PARKHOUSE WS, 1985, J APPL PHYSIOL, V58, P14, DOI 10.1152/jappl.1985.58.1.14; Suzuki Y, 2002, JPN J PHYSIOL, V52, P199, DOI 10.2170/jjphysiol.52.199; Trappe S, 2009, J APPL PHYSIOL, V106, P1159, DOI 10.1152/japplphysiol.91578.2008; Van Damme R, 2002, NATURE, V415, P755, DOI 10.1038/415755b; Zierath JR, 2004, PLOS BIOL, V2, P1523, DOI 10.1371/journal.pbio.0020348	37	63	66	3	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2011	6	7							e21956	10.1371/journal.pone.0021956	http://dx.doi.org/10.1371/journal.pone.0021956			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791HI	21760934	Green Published, gold, Green Submitted			2022-12-27	WOS:000292655400031
J	Boh, B; Herholz, SC; Lappe, C; Pantev, C				Boh, Bastiaan; Herholz, Sibylle C.; Lappe, Claudia; Pantev, Christo			Processing of Complex Auditory Patterns in Musicians and Nonmusicians	PLOS ONE			English	Article							MISMATCH NEGATIVITY MMN; FEATURE CONJUNCTIONS; COMPARING MUSICIANS; SEQUENTIAL SOUNDS; WORKING-MEMORY; PITCH; ATTENTION; CORTEX; ORGANIZATION; MODULATION	In the present study we investigated the capacity of the memory store underlying the mismatch negativity (MMN) response in musicians and nonmusicians for complex tone patterns. While previous studies have focused either on the kind of information that can be encoded or on the decay of the memory trace over time, we studied capacity in terms of the length of tone sequences, i.e., the number of individual tones that can be fully encoded and maintained. By means of magnetoencephalography (MEG) we recorded MMN responses to deviant tones that could occur at any position of standard tone patterns composed of four, six or eight tones during passive, distracted listening. Whereas there was a reliable MMN response to deviant tones in the four-tone pattern in both musicians and nonmusicians, only some individuals showed MMN responses to the longer patterns. This finding of a reliable capacity of the short-term auditory store underlying the MMN response is in line with estimates of a three to five item capacity of the short-term memory trace from behavioural studies, although pitch and contour complexity covaried with sequence length, which might have led to an understatement of the reported capacity. Whereas there was a tendency for an enhancement of the pattern MMN in musicians compared to nonmusicians, a strong advantage for musicians could be shown in an accompanying behavioural task of detecting the deviants while attending to the stimuli for all pattern lengths, indicating that long-term musical training differentially affects the memory capacity of auditory short-term memory for complex tone patterns with and without attention. Also, a left-hemispheric lateralization of MMN responses in the six-tone pattern suggests that additional networks that help structuring the patterns in the temporal domain might be recruited for demanding auditory processing in the pitch domain.	[Boh, Bastiaan] Maastricht Univ, Fac Psychol & Neurosci, Maastricht, Netherlands; [Herholz, Sibylle C.] McGill Univ, Montreal Neurol Inst, Montreal, PQ, Canada; [Herholz, Sibylle C.] Int Lab Brain Mus & Sound Res BRAMS, Montreal, PQ, Canada; [Lappe, Claudia; Pantev, Christo] Inst Biomagnetism & Biosignalanal, Munster, Germany; [Pantev, Christo] Univ Munster, Otto Creutzfeldt Ctr Cognit & Behav Neurosci, Munster, Germany	Maastricht University; McGill University; Universite de Montreal; University of Munster	Boh, B (corresponding author), Maastricht Univ, Fac Psychol & Neurosci, Maastricht, Netherlands.	sibylle.herholz@mail.mcgill.ca			Deutsche Forschungsgemeinschaft (DFG) [PA392/12-2, HE6067/1-1]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This research was supported by the Deutsche Forschungsgemeinschaft (DFG; PA392/12-2 and HE6067/1-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baddeley A, 2003, NAT REV NEUROSCI, V4, P829, DOI 10.1038/nrn1201; Baddeley AD, 2001, AM PSYCHOL, V56, P851, DOI 10.1037/0003-066X.56.11.851; BOTTCHERGANDOR C, 1992, PSYCHOPHYSIOLOGY, V29, P546, DOI 10.1111/j.1469-8986.1992.tb02028.x; Brown S, 1997, PERCEPT PSYCHOPHYS, V59, P442, DOI 10.3758/BF03211910; Carlyon RP, 2004, TRENDS COGN SCI, V8, P465, DOI 10.1016/j.tics.2004.08.008; COWAN N, 1993, J EXP PSYCHOL LEARN, V19, P909, DOI 10.1037/0278-7393.19.4.909; Cowan N, 2001, BEHAV BRAIN SCI, V24; DOWLING WJ, 1978, PSYCHOL REV, V85, P341, DOI 10.1037/0033-295X.85.4.341; Fujioka T, 2004, J COGNITIVE NEUROSCI, V16, P1010, DOI 10.1162/0898929041502706; Garrido MI, 2009, CLIN NEUROPHYSIOL, V120, P453, DOI 10.1016/j.clinph.2008.11.029; Herholz SC, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-42; Imm JH, 2008, NEUROREPORT, V19, P99, DOI 10.1097/WNR.0b013e3282f36f91; Jaaskelainen IP, 2004, P NATL ACAD SCI USA, V101, P6809, DOI 10.1073/pnas.0303760101; Janata P, 2005, ANN NY ACAD SCI, V1060, P111, DOI 10.1196/annals.1360.008; Johnsrude IS, 2000, BRAIN, V123, P155, DOI 10.1093/brain/123.1.155; Koelsch S, 2000, J COGNITIVE NEUROSCI, V12, P520, DOI 10.1162/089892900562183; Koelsch S, 2003, J COGNITIVE NEUROSCI, V15, P1149, DOI 10.1162/089892903322598111; KRUMHANSL CL, 1982, J EXP PSYCHOL HUMAN, V8, P24, DOI 10.1037/0096-1523.8.1.24; Kujala T, 2007, BIOL PSYCHOL, V74, P1, DOI 10.1016/j.biopsycho.2006.06.001; Lappe C, 2008, J NEUROSCI, V28, P9632, DOI 10.1523/JNEUROSCI.2254-08.2008; Naatanen R, 2007, CLIN NEUROPHYSIOL, V118, P2544, DOI 10.1016/j.clinph.2007.04.026; Naatanen R, 2005, PSYCHOPHYSIOLOGY, V42, P25, DOI 10.1111/j.1469-8986.2005.00256.x; NAATANEN R, 1993, NEUROREPORT, V4, P503; Naatanen R, 1999, PSYCHOL BULL, V125, P826, DOI 10.1037/0033-2909.125.6.826; Naatanen R, 2004, CLIN NEUROPHYSIOL, V115, P140, DOI 10.1016/j.clinph.2003.04.001; NAATANEN R, 1993, PSYCHOPHYSIOLOGY, V30, P436, DOI 10.1111/j.1469-8986.1993.tb02067.x; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Paavilainen P, 2001, PSYCHOPHYSIOLOGY, V38, P359, DOI 10.1017/S0048577201000920; Paavilainen P, 2007, NEUROREPORT, V18, P159, DOI 10.1097/WNR.0b013e328010e2ac; Pantev C, 2001, NEUROREPORT, V12, P169, DOI 10.1097/00001756-200101220-00041; Pearce MT, 2006, MUSIC PERCEPT, V23, P377, DOI 10.1525/mp.2006.23.5.377; Pearce MT, 2010, NEUROIMAGE, V50, P302, DOI 10.1016/j.neuroimage.2009.12.019; Pegado F, 2010, NEUROPSYCHOLOGIA, V48, P3145, DOI 10.1016/j.neuropsychologia.2010.06.030; Reiterer SM, 2005, NEUROREPORT, V16, P239, DOI 10.1097/00001756-200502280-00007; SAMS M, 1993, J COGNITIVE NEUROSCI, V5, P363, DOI 10.1162/jocn.1993.5.3.363; Seppanen M, 2007, NEUROBIOL LEARN MEM, V87, P236, DOI 10.1016/j.nlm.2006.08.011; Sussman E, 2003, PSYCHOPHYSIOLOGY, V40, P430, DOI 10.1111/1469-8986.00045; Sussman E, 2001, COGNITIVE BRAIN RES, V12, P431, DOI 10.1016/S0926-6410(01)00067-2; Sussman E, 1998, BRAIN RES, V793, P95, DOI 10.1016/S0006-8993(98)00164-4; Sussman ES, 2005, NEUROREPORT, V16, P1519, DOI 10.1097/01.wnr.0000177002.35193.4c; Takegata R, 2004, NEUROREPORT, V15, P1683, DOI 10.1097/01.wnr.0000134929.04561.64; Tervaniemi M, 2001, LEARN MEMORY, V8, P295, DOI 10.1101/lm.39501; Tervaniemi M, 2009, EUR J NEUROSCI, V30, P1636, DOI 10.1111/j.1460-9568.2009.06955.x; TESCHE CD, 1995, ELECTROEN CLIN NEURO, V95, P189, DOI 10.1016/0013-4694(95)00064-6; van Zuijen TL, 2006, J COGNITIVE NEUROSCI, V18, P1292, DOI 10.1162/jocn.2006.18.8.1292; van Zuijen TL, 2005, COGNITIVE BRAIN RES, V23, P270, DOI 10.1016/j.cogbrainres.2004.10.007; van Zuijen TL, 2004, J COGNITIVE NEUROSCI, V16, P331, DOI 10.1162/089892904322984607; Vuust P, 2005, NEUROIMAGE, V24, P560, DOI 10.1016/j.neuroimage.2004.08.039; Williamson VJ, 2010, MEM COGNITION, V38, P163, DOI 10.3758/MC.38.2.163; Williamson VJ, 2010, MEMORY, V18, P657, DOI 10.1080/09658211.2010.501339; Winkler I, 1996, BRAIN RES, V742, P239, DOI 10.1016/S0006-8993(96)01008-6; WOLDORFF MG, 1991, PSYCHOPHYSIOLOGY, V28, P30, DOI 10.1111/j.1469-8986.1991.tb03384.x; WOLDORFF MG, 1993, P NATL ACAD SCI USA, V90, P8722, DOI 10.1073/pnas.90.18.8722; Zatorre RJ, 2001, CEREB CORTEX, V11, P946, DOI 10.1093/cercor/11.10.946	54	42	44	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2011	6	7							e21458	10.1371/journal.pone.0021458	http://dx.doi.org/10.1371/journal.pone.0021458			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	791HI	21750713	Green Published, gold, Green Submitted			2022-12-27	WOS:000292655400006
J	Chen, EZ; Chiu, RWK; Sun, H; Akolekar, R; Chan, KCA; Leung, TY; Jiang, PY; Zheng, YWL; Lun, FMF; Chan, LYS; Jin, YJ; Go, ATJI; Lau, ET; To, WWK; Leung, WC; Tang, RYK; Au-Yeung, SKC; Lam, H; Kung, YY; Zhang, XQ; van Vugt, JMG; Minekawa, R; Tang, MHY; Wang, J; Oudejans, CBM; Lau, TK; Nicolaides, KH; Lo, YMD				Chen, Eric Z.; Chiu, Rossa W. K.; Sun, Hao; Akolekar, Ranjit; Chan, K. C. Allen; Leung, Tak Y.; Jiang, Peiyong; Zheng, Yama W. L.; Lun, Fiona M. F.; Chan, Lisa Y. S.; Jin, Yongjie; Go, Attie T. J. I.; Lau, Elizabeth T.; To, William W. K.; Leung, Wing C.; Tang, Rebecca Y. K.; Au-Yeung, Sidney K. C.; Lam, Helena; Kung, Yu Y.; Zhang, Xiuqing; van Vugt, John M. G.; Minekawa, Ryoko; Tang, Mary H. Y.; Wang, Jun; Oudejans, Cees B. M.; Lau, Tze K.; Nicolaides, Kypros H.; Lo, Y. M. Dennis			Noninvasive Prenatal Diagnosis of Fetal Trisomy 18 and Trisomy 13 by Maternal Plasma DNA Sequencing	PLOS ONE			English	Article							1ST-TRIMESTER; ANEUPLOIDY	Massively parallel sequencing of DNA molecules in the plasma of pregnant women has been shown to allow accurate and noninvasive prenatal detection of fetal trisomy 21. However, whether the sequencing approach is as accurate for the noninvasive prenatal diagnosis of trisomy 13 and 18 is unclear due to the lack of data from a large sample set. We studied 392 pregnancies, among which 25 involved a trisomy 13 fetus and 37 involved a trisomy 18 fetus, by massively parallel sequencing. By using our previously reported standard z-score approach, we demonstrated that this approach could identify 36.0% and 73.0% of trisomy 13 and 18 at specificities of 92.4% and 97.2%, respectively. We aimed to improve the detection of trisomy 13 and 18 by using a non-repeat-masked reference human genome instead of a repeat-masked one to increase the number of aligned sequence reads for each sample. We then applied a bioinformatics approach to correct GC content bias in the sequencing data. With these measures, we detected all (25 out of 25) trisomy 13 fetuses at a specificity of 98.9% (261 out of 264 non-trisomy 13 cases), and 91.9% (34 out of 37) of the trisomy 18 fetuses at 98.0% specificity (247 out of 252 non-trisomy 18 cases). These data indicate that with appropriate bioinformatics analysis, noninvasive prenatal diagnosis of trisomy 13 and trisomy 18 by maternal plasma DNA sequencing is achievable.	[Chen, Eric Z.; Chiu, Rossa W. K.; Sun, Hao; Chan, K. C. Allen; Jiang, Peiyong; Zheng, Yama W. L.; Lun, Fiona M. F.; Chan, Lisa Y. S.; Jin, Yongjie; Lo, Y. M. Dennis] Chinese Univ Hong Kong, Li Ka Shing Inst Hlth Sci, Ctr Res Circulating Fetal Nucle Acids, Hong Kong, Hong Kong, Peoples R China; [Chen, Eric Z.; Chiu, Rossa W. K.; Sun, Hao; Chan, K. C. Allen; Jiang, Peiyong; Zheng, Yama W. L.; Lun, Fiona M. F.; Chan, Lisa Y. S.; Jin, Yongjie; Lo, Y. M. Dennis] Chinese Univ Hong Kong, Dept Chem Pathol, Hong Kong, Hong Kong, Peoples R China; [Leung, Tak Y.; Lau, Tze K.] Chinese Univ Hong Kong, Dept Obstet & Gynaecol, Hong Kong, Hong Kong, Peoples R China; [Akolekar, Ranjit; Minekawa, Ryoko; Nicolaides, Kypros H.] Kings Coll London, Harris Birthright Res Ctr Fetal Med, London WC2R 2LS, England; [Go, Attie T. J. I.; van Vugt, John M. G.; Oudejans, Cees B. M.] Vrije Univ Amsterdam Med Ctr, Amsterdam, Netherlands; [Lau, Elizabeth T.; Tang, Mary H. Y.] Univ Hong Kong, Dept Obstet & Gynaecol, Tsan Yuk Hosp, Hong Kong, Hong Kong, Peoples R China; [To, William W. K.] United Christian Hosp, Hong Kong, Hong Kong, Peoples R China; [Leung, Wing C.] Kwong Wah Hosp, Hong Kong, Hong Kong, Peoples R China; [Tang, Rebecca Y. K.] Pamela Youde Nethersole Eastern Hosp, Hong Kong, Hong Kong, Peoples R China; [Au-Yeung, Sidney K. C.] Tuen Mun Hosp, Hong Kong, Hong Kong, Peoples R China; [Lam, Helena] Princess Margaret Hosp, Hosp Author, Hong Kong, Hong Kong, Peoples R China; [Kung, Yu Y.] YY Kung Med Ctr, Hong Kong, Hong Kong, Peoples R China; [Zhang, Xiuqing; Wang, Jun; Lo, Y. M. Dennis] Joint Chinese Univ Hong Kong, Beijing Genom Inst Genome Res Ctr, Li Ka Shing Inst Hlth Sci, Hong Kong, Hong Kong, Peoples R China; [Zhang, Xiuqing; Wang, Jun] Beijing Genom Inst Shenzhen, Shenzhen, Peoples R China	Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong; University of London; King's College London; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; University of Hong Kong; United Christian Hospital; Kwong Wah Hospital; Pamela Youde Nethersole Eastern Hospital; Tuen Mun Hospital; Chinese University of Hong Kong; Beijing Genomics Institute (BGI)	Chen, EZ (corresponding author), Chinese Univ Hong Kong, Li Ka Shing Inst Hlth Sci, Ctr Res Circulating Fetal Nucle Acids, Hong Kong, Hong Kong, Peoples R China.	loym@cuhk.edu.hk	Lo, Yuk Ming Dennis/D-4468-2011; Vugt, J.M.G./L-4737-2015; Tang, Mary Hoi Yin/A-7638-2013; sun, hao/GRS-7732-2022; Wang, Jun/A-7261-2013; Chan, K.C. Allen/M-2930-2013; Sun, Hao/T-5576-2019; JIANG, Peiyong/AAZ-9898-2020; Sun, Hao/J-9964-2013; c, c/I-5855-2016; Wang, Jun/B-9503-2016; Wang, Jun/C-8434-2016	Lo, Yuk Ming Dennis/0000-0001-8746-0293; Chan, K.C. Allen/0000-0003-1780-1691; Sun, Hao/0000-0002-5547-9501; Sun, Hao/0000-0002-5547-9501; Oudejans, Cees/0000-0003-0717-4946; Nicolaides, Kypros/0000-0003-1266-0711; Wang, Jun/0000-0002-2113-5874; MINEKAWA, RYOKO/0000-0001-7429-3203; Jiang, Peiyong/0000-0003-4523-3476; Lau, Tze Kin/0000-0002-0242-1410; Wang, Jun/0000-0002-8540-8931	Sequenom and Life Technologies [ITS/054/09]; University Grants Committee of the Government of the Hong Kong Special Administration Region, China [AoE/M-04/06]; Li Ka Shing Foundation; Sequenom	Sequenom and Life Technologies; University Grants Committee of the Government of the Hong Kong Special Administration Region, China; Li Ka Shing Foundation; Sequenom	The study was supported by the Innovation and Technology Fund (ITS/054/09; co-sponsored by Sequenom and Life Technologies), University Grants Committee of the Government of the Hong Kong Special Administration Region, China, under the Areas of Excellence Scheme (AoE/M-04/06) and an additional sponsored research agreement with Sequenom. Y.M.D. Lo was supported by an Endowed Chair from the Li Ka Shing Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkan C, 2009, NAT GENET, V41, P1061, DOI 10.1038/ng.437; Chan KCA, 2004, CLIN CHEM, V50, P88, DOI 10.1373/clinchem.2003.024893; Chiu RWK, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.c7401; Chiu RWK, 2010, CLIN CHEM, V56, P459, DOI 10.1373/clinchem.2009.136507; Chiu RWK, 2009, TRENDS GENET, V25, P324, DOI 10.1016/j.tig.2009.05.004; Chiu RWK, 2008, P NATL ACAD SCI USA, V105, P20458, DOI 10.1073/pnas.0810641105; Chiu RWK, 2001, CLIN CHEM, V47, P1607; Dohm JC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn425; Driscoll DA, 2009, NEW ENGL J MED, V360, P2556, DOI 10.1056/NEJMcp0900134; Ehrich M, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2010.12.060; Fan HC, 2008, P NATL ACAD SCI USA, V105, P16266, DOI 10.1073/pnas.0808319105; Fan HC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010439; Finning K, 2008, BRIT MED J, V336, P816, DOI 10.1136/bmj.39518.463206.25; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Li RQ, 2009, GENOME RES, V19, P1124, DOI 10.1101/gr.088013.108; Lo YMD, 2007, P NATL ACAD SCI USA, V104, P13116, DOI 10.1073/pnas.0705765104; Lo YMD, 2007, NAT MED, V13, P218, DOI 10.1038/nm1530; Lo YMD, 2007, NAT REV GENET, V8, P71, DOI 10.1038/nrg1982; Lo YMD, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001720; Lo YMD, 1997, LANCET, V350, P485, DOI 10.1016/S0140-6736(97)02174-0; Lo YMD, 1998, NEW ENGL J MED, V339, P1734, DOI 10.1056/NEJM199812103392402; Malone FD, 2005, NEW ENGL J MED, V353, P2001, DOI 10.1056/NEJMoa043693; Papageorgiou EA, 2009, AM J PATHOL, V174, P1609, DOI 10.2353/ajpath.2009.081038; Samura O, 2003, CLIN CHEM, V49, P1193, DOI 10.1373/49.7.1193; TABOR A, 1986, LANCET, V1, P1287; Tong YK, 2006, CLIN CHEM, V52, P2194, DOI 10.1373/clinchem.2006.076851; Tong YK, 2010, CLIN CHEM, V56, P90, DOI 10.1373/clinchem.2009.134114; Tsui NBY, 2009, PRENATAL DIAG, V29, P1031, DOI 10.1002/pd.2340; Wapner R, 2003, NEW ENGL J MED, V349, P1405, DOI 10.1056/NEJMoa025273; Wright CF, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b2451	30	216	317	1	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2011	6	7							e21791	10.1371/journal.pone.0021791	http://dx.doi.org/10.1371/journal.pone.0021791			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791AK	21755002	Green Published, gold			2022-12-27	WOS:000292632000029
J	Kissel, JT; Scott, CB; Reyna, SP; Crawford, TO; Simard, LR; Krosschell, KJ; Acsadi, G; Elsheik, B; Schroth, MK; D'Anjou, G; LaSalle, B; Prior, TW; Sorenson, S; Maczulski, JA; Bromberg, MB; Chan, GM; Swoboda, KJ				Kissel, John T.; Scott, Charles B.; Reyna, Sandra P.; Crawford, Thomas O.; Simard, Louise R.; Krosschell, Kristin J.; Acsadi, Gyula; Elsheik, Bakri; Schroth, Mary K.; D'Anjou, Guy; LaSalle, Bernard; Prior, Thomas W.; Sorenson, Susan; Maczulski, Jo Anne; Bromberg, Mark B.; Chan, Gary M.; Swoboda, Kathryn J.		Project Cure Spinal Muscular Atrop	SMA CARNI-VAL TRIAL PART II: A Prospective, Single-Armed Trial of L-Carnitine and Valproic Acid in Ambulatory Children with Spinal Muscular Atrophy	PLOS ONE			English	Article							HAND-HELD DYNAMOMETRY; SMN2 COPY NUMBER; PROTEIN-LEVEL; MODEL MICE; SURVIVAL; GENE; PHENOTYPE; IDENTIFICATION; INCREASES; SEVERITY	Background: Multiple lines of evidence have suggested that valproic acid (VPA) might benefit patients with spinal muscular atrophy (SMA). The SMA CARNIVAL TRIAL was a two part prospective trial to evaluate oral VPA and l-carnitine in SMA children. Part 1 targeted non-ambulatory children ages 2-8 in a 12 month cross over design. We report here Part 2, a twelve month prospective, open-label trial of VPA and L-carnitine in ambulatory SMA children. Methods: This study involved 33 genetically proven type 3 SMA subjects ages 3-17 years. Subjects underwent two baseline assessments over 4-6 weeks and then were placed on VPA and L-carnitine for 12 months. Assessments were performed at baseline, 3, 6 and 12 months. Primary outcomes included safety, adverse events and the change at 6 and 12 months in motor function assessed using the Modified Hammersmith Functional Motor Scale Extend (MHFMS-Extend), timed motor tests and fine motor modules. Secondary outcomes included changes in ulnar compound muscle action potential amplitudes (CMAP), handheld dynamometry, pulmonary function, and Pediatric Quality of Life Inventory scores. Results: Twenty-eight subjects completed the study. VPA and carnitine were generally well tolerated. Although adverse events occurred in 85% of subjects, they were usually mild and transient. Weight gain of 20% above body weight occurred in 17% of subjects. There was no significant change in any primary outcome at six or 12 months. Some pulmonary function measures showed improvement at one year as expected with normal growth. CMAP significantly improved suggesting a modest biologic effect not clinically meaningful. Conclusions: This study, coupled with the CARNIVAL Part 1 study, indicate that VPA is not effective in improving strength or function in SMA children. The outcomes used in this study are feasible and reliable, and can be employed in future trials in SMA.	[Kissel, John T.; Elsheik, Bakri] Ohio State Univ, Dept Neurol, Columbus, OH 43210 USA; [Kissel, John T.; Elsheik, Bakri] Ohio State Univ, Dept Pediat, Columbus, OH 43210 USA; [Scott, Charles B.] CBS Squared Inc, Ft Washington, PA USA; [Reyna, Sandra P.; Bromberg, Mark B.; Swoboda, Kathryn J.] Univ Utah, Sch Med, Dept Neurol, Salt Lake City, UT USA; [Swoboda, Kathryn J.] Univ Utah, Sch Med, Dept Pediat, Salt Lake City, UT USA; [Crawford, Thomas O.] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Crawford, Thomas O.] Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA; [Simard, Louise R.] Univ Manitoba, Dept Biochem & Med Genet, Winnipeg, MB, Canada; [Krosschell, Kristin J.] Northwestern Univ, Dept Phys Therapy & Human Movement Sci, Feinberg Sch Med, Chicago, IL 60611 USA; [Acsadi, Gyula] Wayne State Univ, Sch Med, Dept Neurol, Detroit, MI 48201 USA; [Acsadi, Gyula] Wayne State Univ, Sch Med, Dept Pediat, Detroit, MI 48201 USA; [Schroth, Mary K.] Univ Wisconsin, Sch Med, Dept Pediat, Madison, WI USA; [D'Anjou, Guy] Hop St Justine, Div Pediat Neurol, Montreal, PQ H3T 1C5, Canada; [LaSalle, Bernard] Univ Utah, Sch Med, Dept Biomed Informat, Salt Lake City, UT USA; [Prior, Thomas W.] Ohio State Univ, Dept Mol Pathol, Columbus, OH 43210 USA; [Sorenson, Susan] Primary Childrens Med Ctr, Salt Lake City, UT 84103 USA; [Maczulski, Jo Anne] Pediat Occupat Therapy Serv, Chicago, IL USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Johns Hopkins University; Johns Hopkins University; University of Manitoba; Northwestern University; Feinberg School of Medicine; Wayne State University; Wayne State University; University of Wisconsin System; University of Wisconsin Madison; Universite de Montreal; Utah System of Higher Education; University of Utah; University System of Ohio; Ohio State University	Kissel, JT (corresponding author), Ohio State Univ, Dept Neurol, Columbus, OH 43210 USA.	john.kissel@osumc.edu	Crawford, Thomas/E-6307-2012	Swoboda, Kathryn/0000-0002-4593-6342; Simard, Louise/0000-0003-0391-8821; Krosschell, Kristin/0000-0003-2879-5055	Families of Spinal Muscular Atrophy; University of Utah, Center for Clinical and Translational Sciences [UL1RR025764]; Johns Hopkins University, General Clinical Research Center [UL1RR025005]; University of Wisconsin, Clinical and Translational Research Core [UL1RR025011]; Ohio State University, General Clinical Research Center [UL1RR025755]; Clinical Research Center, Children's Hospital of Michigan; National Center for Research Resources, National Institutes of Health; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD069045] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025764, UL1RR025755, UL1RR025005, UL1RR025011] Funding Source: NIH RePORTER	Families of Spinal Muscular Atrophy; University of Utah, Center for Clinical and Translational Sciences; Johns Hopkins University, General Clinical Research Center(Johns Hopkins UniversityUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); University of Wisconsin, Clinical and Translational Research Core; Ohio State University, General Clinical Research Center(Ohio State UniversityUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Clinical Research Center, Children's Hospital of Michigan; National Center for Research Resources, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was funded by Families of Spinal Muscular Atrophy. The investigation was also supported by grants UL1RR025764 (University of Utah, Center for Clinical and Translational Sciences), UL1RR025005 (Johns Hopkins University, General Clinical Research Center), UL1RR025011 (University of Wisconsin, Clinical and Translational Research Core), UL1RR025755 (Ohio State University, General Clinical Research Center) and the Clinical Research Center, Children's Hospital of Michigan, given by the National Center for Research Resources, National Institutes of Health. The funding sources had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beenakker EAC, 2001, NEUROMUSCULAR DISORD, V11, P441, DOI 10.1016/S0960-8966(01)00193-6; BRAHE C, 2006, J MOL MED, V74, P555; Brichta L, 2003, HUM MOL GENET, V12, P2481, DOI 10.1093/hmg/ddg256; Brichta L, 2006, ANN NEUROL, V59, P970, DOI 10.1002/ana.20836; Burghes AHM, 2009, NAT REV NEUROSCI, V10, P597, DOI 10.1038/nrn2670; CZEIZEL A, 1989, J MED GENET, V26, P761, DOI 10.1136/jmg.26.12.761; Emery A E, 1991, Neuromuscul Disord, V1, P19, DOI 10.1016/0960-8966(91)90039-U; Feldkotter M, 2002, AM J HUM GENET, V70, P358, DOI 10.1086/338627; Kernochan LE, 2005, HUM MOL GENET, V14, P1171, DOI 10.1093/hmg/ddi130; Krosschell KJ, 2006, NEUROMUSCULAR DISORD, V16, P417, DOI 10.1016/j.nmd.2006.03.015; Lefebvre S, 1997, NAT GENET, V16, P265, DOI 10.1038/ng0797-265; LEFEBVRE S, 1995, CELL, V80, P155, DOI 10.1016/0092-8674(95)90460-3; Leng Y, 2006, J NEUROSCI, V26, P7502, DOI 10.1523/JNEUROSCI.0096-06.2006; Lorson CL, 1999, P NATL ACAD SCI USA, V96, P6307, DOI 10.1073/pnas.96.11.6307; Mailman MD, 2002, GENET MED, V4, P20, DOI 10.1097/00125817-200201000-00004; Merlini L, 2002, MUSCLE NERVE, V26, P64, DOI 10.1002/mus.10166; MERLINI L, 1992, NEUROMUSCULAR DISORD, V2, P197, DOI 10.1016/0960-8966(92)90006-R; Oprea GE, 2008, SCIENCE, V320, P524, DOI 10.1126/science.1155085; PEARN J, 1978, J MED GENET, V15, P409, DOI 10.1136/jmg.15.6.409; Prior TW, 2009, AM J HUM GENET, V85, P408, DOI 10.1016/j.ajhg.2009.08.002; Prior TW, 2004, AM J MED GENET A, V130A, P307, DOI 10.1002/ajmg.a.30251; ROBERTS DF, 1970, ARCH DIS CHILD, V45, P33, DOI 10.1136/adc.45.239.33; Sloan Colleen, 2002, Physical and Occupational Therapy in Pediatrics, V22, P79, DOI 10.1300/J006v22n02_05; Sproule DM, 2009, NEUROMUSCULAR DISORD, V19, P391, DOI 10.1016/j.nmd.2009.03.009; SROULE DM, 2010, NEUROMUSCULAR DISORD, V20, P448; Sugai F, 2004, EUR J NEUROSCI, V20, P3179, DOI 10.1111/j.1460-9568.2004.03765.x; Sumner CJ, 2003, ANN NEUROL, V54, P647, DOI 10.1002/ana.10743; Swoboda KJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005268; Swoboda KJ, 2005, ANN NEUROL, V57, P704, DOI 10.1002/ana.20473; SWOBODA KJ, 2010, PLOS ONE IN PRESS; Tsai LK, 2007, EUR J NEUROL, V14, pE8, DOI 10.1111/j.1468-1331.2007.01992.x; Tsai LK, 2008, J MOL MED, V86, P1243, DOI 10.1007/s00109-008-0388-1; Tsai LK, 2006, NEUROBIOL DIS, V24, P286, DOI 10.1016/j.nbd.2006.07.004; van Bergeijk J, 2006, CHEM BIOL DRUG DES, V67, P244, DOI 10.1111/j.1747-0285.2006.00369.x; VARNI JW, 2007, J PEDIAT PSYCHOL MAR, P1; Wan LL, 2005, MOL CELL BIOL, V25, P5543, DOI 10.1128/MCB.25.13.5543-5551.2005; Weihl CC, 2006, NEUROLOGY, V67, P500, DOI 10.1212/01.wnl.0000231139.26253.d0; Wirth B, 2006, HUM GENET, V119, P422, DOI 10.1007/s00439-006-0156-7; Wirth B, 1999, AM J HUM GENET, V64, P1340, DOI 10.1086/302369	39	89	92	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2011	6	7							e21296	10.1371/journal.pone.0021296	http://dx.doi.org/10.1371/journal.pone.0021296			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791AK	21754985	Green Published, Green Submitted, gold			2022-12-27	WOS:000292632000009
J	Moon, S; Gurkan, UA; Blander, J; Fawzi, WW; Aboud, S; Mugusi, F; Kuritzkes, DR; Demirci, U				Moon, SangJun; Gurkan, Umut Atakan; Blander, Jeffrey; Fawzi, Wafaie W.; Aboud, Said; Mugusi, Ferdinand; Kuritzkes, Daniel R.; Demirci, Utkan			Enumeration of CD4(+) T-Cells Using a Portable Microchip Count Platform in Tanzanian HIV-Infected Patients	PLOS ONE			English	Article							DIAGNOSTIC TECHNOLOGIES; LYMPHOCYTE COUNTS; PREVENTION	Background: CD4(+) T-lymphocyte count (CD4 count) is a standard method used to monitor HIV-infected patients during anti-retroviral therapy (ART). The World Health Organization (WHO) has pointed out or recommended that a handheld, point-of-care, reliable, and affordable CD4 count platform is urgently needed in resource-scarce settings. Methods: HIV-infected patient blood samples were tested at the point-of-care using a portable and label-free microchip CD4 count platform that we have developed. A total of 130 HIV-infected patient samples were collected that included 16 de-identified left over blood samples from Brigham and Women's Hospital (BWH), and 114 left over samples from Muhimbili University of Health and Allied Sciences (MUHAS) enrolled in the HIV and AIDS care and treatment centers in the City of Dar es Salaam, Tanzania. The two data groups from BWH and MUHAS were analyzed and compared to the commonly accepted CD4 count reference method (FACSCalibur system). Results: The portable, battery operated and microscope-free microchip platform developed in our laboratory (BWH) showed significant correlation in CD4 counts compared with FACSCalibur system both at BWH (r = 0.94, p < 0.01) and MUHAS (r = 0.49, p < 0.01), which was supported by the Bland-Altman methods comparison analysis. The device rapidly produced CD4 count within 10 minutes using an in-house developed automated cell counting program. Conclusions: We obtained CD4 counts of HIV-infected patients using a portable platform which is an inexpensive (<$1 material cost) and disposable microchip that uses whole blood sample (< 10 mu l) without any pre-processing. The system operates without the need for antibody-based fluorescent labeling and expensive fluorescent illumination and microscope setup. This portable CD4 count platform displays agreement with the FACSCalibur results and has the potential to expand access to HIV and AIDS monitoring using fingerprick volume of whole blood and helping people who suffer from HIV and AIDS in resource-limited settings.	[Moon, SangJun; Gurkan, Umut Atakan; Blander, Jeffrey; Demirci, Utkan] Harvard Univ, Brigham & Womens Hosp, Sch Med, Demirci Bioacoust MEMS Lab,Ctr Biomed Engn, Boston, MA 02115 USA; [Blander, Jeffrey] Harvard Univ, Sch Med, Dept Epidemiol, Boston, MA USA; [Fawzi, Wafaie W.] Harvard Univ, Sch Publ Hlth, Dept Nutr, Dept Epidemiol,Dept Global Hlth & Populat, Boston, MA 02115 USA; [Aboud, Said] Muhimbili Univ Hlth & Allied Sci, Dept Microbiol & Immunol, Dar Es Salaam, Tanzania; [Mugusi, Ferdinand] Muhimbili Univ Hlth & Allied Sci, Dept Internal Med, Dar Es Salaam, Tanzania; [Kuritzkes, Daniel R.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Sect Retroviral Therapeut, Boston, MA 02115 USA; [Demirci, Utkan] Harvard MIT Hlth Sci & Technol, Cambridge, MA USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Muhimbili University of Health & Allied Sciences; Muhimbili University of Health & Allied Sciences; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University	Moon, S (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Demirci Bioacoust MEMS Lab,Ctr Biomed Engn, Boston, MA 02115 USA.	udemirci@rics.bwh.harvard.edu	Gurkan, Umut A./Z-2496-2019	Gurkan, Umut A./0000-0002-0331-9960	Wallace H. Coulter Foundation; National Institutes of Health (NIH) [R01AI081534, R21AI087107, RR016482, AI060354]; NATIONAL CENTER FOR RESEARCH RESOURCES [K24RR016482] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI060354, R21AI087107, R01AI081534] Funding Source: NIH RePORTER	Wallace H. Coulter Foundation; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Dr. Demirci would like to thank the Wallace H. Coulter Foundation for the Young Investigator in Bioengineering Award for supporting all the testing, travel and associated costs in Tanzania. Investigators were also partially supported by the National Institutes of Health (NIH) (R01AI081534), NIH (R21AI087107). Dr. Kuritzkes would like to acknowledge NIH grants RR016482 and AI060354 (Harvard University Center for AIDS Research). Dr. Blander acknowledges the NIH Fogarty Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlford A, 2010, ANALYST, V135, P2377, DOI 10.1039/c0an00321b; Buve A, 2002, LANCET, V359, P2011, DOI 10.1016/S0140-6736(02)08823-2; Chandrasekaran P, 2008, AIDS, V22, pS1, DOI 10.1097/01.aids.0000343760.70078.89; Cheng XH, 2007, JAIDS-J ACQ IMM DEF, V45, P257; Chin CD, 2007, LAB CHIP, V7, P41, DOI 10.1039/b611455e; Gurkan UA, 2011, BIOTECHNOL J, V6, P138, DOI 10.1002/biot.201000427; Hawkins KR, 2010, PROC SPIE, V7593, DOI 10.1117/12.845500; Lee BS, 2011, LAB CHIP, V11, P70, DOI [10.1039/c0lc00205d, 10.1039/c01c00205d]; Lee WG, 2010, ADV DRUG DELIVER REV, V62, P449, DOI 10.1016/j.addr.2009.11.016; Menon S, 2010, J PUBLIC HEALTH POL, V31, P385, DOI 10.1057/jphp.2010.29; Moon S, 2009, BIOSENS BIOELECTRON, V24, P3208, DOI 10.1016/j.bios.2009.03.037; Rodriguez WR, 2005, PLOS MED, V2, P663, DOI 10.1371/journal.pmed.0020182; Sandstrom E, 2003, INT J STD AIDS, V14, P547, DOI 10.1258/095646203767869165; Simon V, 2006, LANCET, V368, P489, DOI 10.1016/S0140-6736(06)69157-5; Spacek LA, 2006, JAIDS-J ACQ IMM DEF, V41, P607, DOI 10.1097/01.qai.0000214807.98465.a2; Wang SQ, 2010, BIOTECHNOL ADV, V28, P770, DOI 10.1016/j.biotechadv.2010.06.004; Wang YN, 2008, LAB CHIP, V8, P309, DOI 10.1039/b713932b; Weigl BH, 2009, EXPERT REV MED DEVIC, V6, P461, DOI [10.1586/erd.09.31, 10.1586/ERD.09.31]; WHO, 2008, CD4 T CELL EN TECHN; [World Health Organization (WHO) UNAIDS UNICEF], 2010, UN ACC SCAL PRIOR HI; Yager P, 2008, ANNU REV BIOMED ENG, V10, P107, DOI 10.1146/annurev.bioeng.10.061807.160524; Yager P, 2006, NATURE, V442, P412, DOI 10.1038/nature05064	22	58	61	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2011	6	7							e21409	10.1371/journal.pone.0021409	http://dx.doi.org/10.1371/journal.pone.0021409			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791AK	21754988	Green Published, gold, Green Submitted			2022-12-27	WOS:000292632000012
J	Larkum, AWD; Salih, A; Kuhl, M				Larkum, Anthony W. D.; Salih, Anya; Kuehl, Michael			Rapid Mass Movement of Chloroplasts during Segment Formation of the Calcifying Siphonalean Green Alga, Halimeda macroloba	PLOS ONE			English	Article							GREAT-BARRIER-REEF; CORAL-REEFS; PHOTOSYNTHESIS; CALCIFICATION; CHLOROPHYTA; BIOHERMS; PROVINCE; ECOLOGY	Background: The calcifying siphonalean green alga, Halimeda macroloba is abundant on coral reefs and is important in the production of calcium carbonate sediments. The process by which new green segments are formed over-night is revealed here for the first time. Methodology/Principal Findings: Growth of new segments was visualised by epifluorescence and confocal microscopy and by pulse amplitude modulation (PAM) fluorimetry. Apical colourless proto-segments were initiated on day 1, and formed a loose network of non-calcified, non-septate filaments, containing no chloroplasts. Rapid greening was initiated at dusk by i) the mass movement of chloroplasts into these filaments from the parent segment and ii) the growth of new filaments containing chloroplasts. Greening was usually complete in 3-5 h and certainly before dawn on day 2 when the first signs of calcification were apparent. Mass chloroplast movement took place at a rate of similar to 0.65 mu m/s. Photosynthetic yield and rate remained low for a period of 1 to several hours, indicating that the chloroplasts were made de novo. Use of the inhibitors colchicine and cytochalasin d indicated that the movement process is dependent on both microtubules and microfilaments. Significance: This unusual process involves the mass movement of chloroplasts at a high rate into new segments during the night and rapid calcification on the following day and may be an adaptation to minimise the impact of herbivorous activity.	[Larkum, Anthony W. D.] Univ Sydney, Sch Biol Sci, Camperdown, NSW, Australia; [Salih, Anya] Univ Western Sydney, Sch Nat Sci, Confocal Bioimaging Facil, Richmond, NSW, Australia; [Kuehl, Michael] Univ Copenhagen, Dept Biol, Marine Biol Sect, Helsingor, Denmark; [Larkum, Anthony W. D.; Kuehl, Michael] Univ Technol, Broadway, NSW, Australia	University of Sydney; Western Sydney University; University of Copenhagen; University of Technology Sydney	Larkum, AWD (corresponding author), Univ Sydney, Sch Biol Sci, Camperdown, NSW, Australia.	a.larkum@sydney.edu.au	Kühl, Michael/A-1977-2009	Kühl, Michael/0000-0002-1792-4790	Australian Research Council; Danish Natural Science Research Council; Carlsberg Foundation	Australian Research Council(Australian Research Council); Danish Natural Science Research Council(Danish Natural Science Research Council); Carlsberg Foundation(Carlsberg Foundation)	The study was financed by the Australian Research Council (AWDL, AS), the Danish Natural Science Research Council (MK) and the Carlsberg Foundation (MK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1980, ADV MAR BIOL; BOROWITZKA MA, 1976, J EXP BOT, V27, P879, DOI 10.1093/jxb/27.5.879; BOROWITZKA MA, 1974, PROTOPLASMA, V81, P131, DOI 10.1007/BF01275808; BOROWITZKA MA, 1977, J PHYCOL, V13, P6, DOI 10.1111/j.1529-8817.1977.tb02879.x; BOROWITZKA MA, 1976, J EXP BOT, V27, P894, DOI 10.1093/jxb/27.5.894; BOROWITZKA MA, 1974, 8 INT C EL MICR CANB, V2, P588; BOROWITZKA MA, 1986, BIOMINERALIZATION LO, P107; BOROWITZKA MA, 1982, BIOMINERALIZATION CH, P63; Braga JC, 1996, GEOLOGY, V24, P35, DOI 10.1130/0091-7613(1996)024<0035:ISOSRH>2.3.CO;2; De Beer D, 2001, PLANT CELL ENVIRON, V24, P1209, DOI 10.1046/j.1365-3040.2001.00772.x; Drew E.A., 1983, CORAL REEFS, V2, P101, DOI DOI 10.1007/BF02395280; DREW EA, 1988, CORAL REEFS, V6, P195, DOI 10.1007/BF00302016; DREW EA, 1990, BOT MAR, V33, P31, DOI 10.1515/botm.1990.33.1.31; DREW EA, 1992, J INTERDISCIPLINARY, V22, P128; FORNOS JJ, 1992, SEDIMENT GEOL, V75, P283, DOI 10.1016/0037-0738(92)90097-B; Hay ME, 1996, J EXP MAR BIOL ECOL, V200, P103, DOI 10.1016/S0022-0981(96)02659-7; Larkum AWD, 2003, MAR BIOL, V142, P1073, DOI 10.1007/s00227-003-1022-y; Luning K, 2008, J PHYCOL, V44, P866, DOI 10.1111/j.1529-8817.2008.00535.x; Mantyka CS, 2007, CORAL REEFS, V26, P435, DOI 10.1007/s00338-007-0214-1; MARSHALL JF, 1988, CORAL REEFS, V6, P139, DOI 10.1007/BF00302010; ORME GR, 1988, CORAL REEFS, V6, P131, DOI 10.1007/BF00302009; PAUL VJ, 1988, CORAL REEFS, V6, P263, DOI 10.1007/BF00302022; PAUL VJ, 1992, J EXP MAR BIOL ECOL, V160, P191, DOI 10.1016/0022-0981(92)90237-5; Ralph PJ, 2005, J PHYCOL, V41, P335, DOI 10.1111/j.1529-8817.2005.04034.x; Rees SA, 2007, CORAL REEFS, V26, P177, DOI 10.1007/s00338-006-0166-x; SABNIS DD, 1967, J CELL SCI, V2, P465; Schreiber U, 2004, ADV PHOTO RESPIRAT, V19, P279; WILBUR K. M., 1969, PHYCOLOGIA, V8, P27, DOI 10.2216/I0031-8884-8-1-27.1; WILLIAMSON RE, 1993, ANNU REV PLANT PHYS, V44, P181, DOI 10.1146/annurev.pp.44.060193.001145; WOLANSKI E, 1988, ESTUAR COAST SHELF S, V26, P169, DOI 10.1016/0272-7714(88)90049-2; [No title captured]	31	15	15	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2011	6	7							e20841	10.1371/journal.pone.0020841	http://dx.doi.org/10.1371/journal.pone.0020841			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	789JO	21750703	Green Published, gold			2022-12-27	WOS:000292512000009
J	Vangestel, C; Mergeay, J; Dawson, DA; Vandomme, V; Lens, L				Vangestel, Carl; Mergeay, Joachim; Dawson, Deborah A.; Vandomme, Viki; Lens, Luc			Developmental Stability Covaries with Genome-Wide and Single-Locus Heterozygosity in House Sparrows	PLOS ONE			English	Article							FLUCTUATING ASYMMETRY; MICROSATELLITE LOCI; LINKAGE DISEQUILIBRIUM; FITNESS CORRELATIONS; PAIRWISE RELATEDNESS; NULL ALLELES; PRIMER SETS; NUMBER; STRESS; COEFFICIENTS	Fluctuating asymmetry (FA), a measure of developmental instability, has been hypothesized to increase with genetic stress. Despite numerous studies providing empirical evidence for associations between FA and genome-wide properties such as multi-locus heterozygosity, support for single-locus effects remains scant. Here we test if, and to what extent, FA co-varies with single-and multilocus markers of genetic diversity in house sparrow (Passer domesticus) populations along an urban gradient. In line with theoretical expectations, FA was inversely correlated with genetic diversity estimated at genome level. However, this relationship was largely driven by variation at a single key locus. Contrary to our expectations, relationships between FA and genetic diversity were not stronger in individuals from urban populations that experience higher nutritional stress. We conclude that loss of genetic diversity adversely affects developmental stability in P. domesticus, and more generally, that the molecular basis of developmental stability may involve complex interactions between local and genome-wide effects. Further study on the relative effects of single-locus and genome-wide effects on the developmental stability of populations with different genetic properties is therefore needed.	[Vangestel, Carl; Vandomme, Viki; Lens, Luc] Univ Ghent, Dept Biol, Terr Ecol Unit, B-9000 Ghent, Belgium; [Mergeay, Joachim] Res Inst Nat & Forest, Res Grp Genet Div, Geraardsbergen, Belgium; [Dawson, Deborah A.] Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England	Ghent University; Research Institute for Nature & Forest; University of Sheffield	Vangestel, C (corresponding author), Univ Ghent, Dept Biol, Terr Ecol Unit, B-9000 Ghent, Belgium.	Carl.Vangestel@UGent.be	Mergeay, Joachim/E-7670-2011	Mergeay, Joachim/0000-0002-6504-0551; Lens, Luc/0000-0002-0241-2215; vangestel, carl/0000-0003-1024-8213	Natural Environment Research Council, UK; Fund for Scientific Research - Flanders [G.0149.09]; Ghent University [01J01808]; NERC [NBAF010001] Funding Source: UKRI; Natural Environment Research Council [NBAF010001] Funding Source: researchfish	Natural Environment Research Council, UK(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Fund for Scientific Research - Flanders(FWO); Ghent University(Ghent University); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	Genotyping was performed at the NERC Biomolecular Analysis Facility funded by the Natural Environment Research Council, UK. Fieldwork and genetic analyses were funded by research grants G.0149.09 of the Fund for Scientific Research - Flanders (to LL) and research grant 01J01808 of Ghent University (to LL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALHO JS, 2010, MOL ECOL RESOUR; Amos W, 2001, P ROY SOC B-BIOL SCI, V268, P2021, DOI 10.1098/rspb.2001.1751; Aparicio JM, 2006, MOL ECOL, V15, P4659, DOI 10.1111/j.1365-294X.2006.03111.x; Badyaev AV, 2000, P ROY SOC B-BIOL SCI, V267, P371, DOI 10.1098/rspb.2000.1011; Balloux F, 2004, MOL ECOL, V13, P3021, DOI 10.1111/j.1365-294X.2004.02318.x; Borrell YJ, 2004, HEREDITY, V92, P585, DOI 10.1038/sj.hdy.6800477; Breuker CJ, 2006, TRENDS ECOL EVOL, V21, P488, DOI 10.1016/j.tree.2006.06.003; Brookfield JFY, 1996, MOL ECOL, V5, P453, DOI 10.1046/j.1365-294X.1996.00098.x; CHAKRABORTY R, 1981, GENETICS, V98, P461; Chapman JR, 2009, MOL ECOL, V18, P2746, DOI 10.1111/j.1365-294X.2009.04247.x; Clarke GM, 2000, P ROY SOC B-BIOL SCI, V267, P1815, DOI 10.1098/rspb.2000.1215; Clarke GM, 1997, TRENDS ECOL EVOL, V12, P89, DOI 10.1016/S0169-5347(97)01029-X; CLARKE GM, 1993, GENETICA, V89, P15, DOI 10.1007/BF02424502; Coltman DW, 2003, EVOLUTION, V57, P971, DOI 10.1111/j.0014-3820.2003.tb00309.x; Coltman DW, 1999, EVOLUTION, V53, P1259, DOI [10.2307/2640828, 10.1111/j.1558-5646.1999.tb04538.x]; Coulson T, 1999, EVOLUTION, V53, P1951, DOI 10.1111/j.1558-5646.1999.tb04575.x; Coulson TN, 1998, P ROY SOC B-BIOL SCI, V265, P489, DOI 10.1098/rspb.1998.0321; Dakin EE, 2004, HEREDITY, V93, P504, DOI 10.1038/sj.hdy.6800545; David P, 1998, HEREDITY, V80, P531, DOI 10.1046/j.1365-2540.1998.00393.x; DAWSON DA, MOL ECOL RESOU UNPUB; Dawson DA, 2010, MOL ECOL RESOUR, V10, P475, DOI 10.1111/j.1755-0998.2009.02775.x; Gebhardt KJ, 2008, J FIELD ORNITHOL, V79, P286, DOI 10.1111/j.1557-9263.2008.00175.x; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Graham JH, 2010, SYMMETRY-BASEL, V2, P466, DOI 10.3390/sym2020466; Griffith SC, 2007, MOL ECOL NOTES, V7, P333, DOI 10.1111/j.1471-8286.2006.01598.x; Hansson B, 2004, EVOLUTION, V58, P870; Hansson B, 2002, MOL ECOL, V11, P2467, DOI 10.1046/j.1365-294X.2002.01644.x; Hansson B, 2010, MOL ECOL, V19, P1082, DOI 10.1111/j.1365-294X.2010.04556.x; Hartl GB, 1995, PHILOS T R SOC B, V350, P313, DOI 10.1098/rstb.1995.0167; Heath DD, 2002, CAN J FISH AQUAT SCI, V59, P77, DOI 10.1139/F01-192; Kark S, 2001, HEREDITY, V86, P119, DOI 10.1038/sj/hdy/6888560; Karvonen E, 2003, OIKOS, V100, P507, DOI 10.1034/j.1600-0706.2003.11851.x; Knierim U, 2007, PHYSIOL BEHAV, V92, P398, DOI 10.1016/j.physbeh.2007.02.014; Kretzmann M, 2006, J HERED, V97, P555, DOI 10.1093/jhered/esl043; Kruuk LEB, 2002, P ROY SOC B-BIOL SCI, V269, P1581, DOI 10.1098/rspb.2002.2049; Lai YL, 2003, MOL BIOL EVOL, V20, P2123, DOI 10.1093/molbev/msg228; LEARY RF, 1993, GENETICA, V89, P3, DOI 10.1007/BF02424501; Lens L, 2002, BIOL REV, V77, P27, DOI 10.1017/S1464793101005796; Lens L, 2000, J EVOLUTION BIOL, V13, P889, DOI 10.1046/j.1420-9101.2000.00232.x; Lerner IM, 1954, GENETIC HOMEOSTASIS; Liker A, 2008, J ANIM ECOL, V77, P789, DOI 10.1111/j.1365-2656.2008.01402.x; Littell R. C., 2006, SAS SYSTEMS MIXED MO, V2nd; Ludwig W., 1932, RECHTS LINKS PROBLEM; MARKOW TA, 1995, ANNU REV ENTOMOL, V40, P105, DOI 10.1146/annurev.en.40.010195.000541; McRae AF, 2002, GENETICS, V160, P1113; MITTON JB, 1993, GENETICA, V89, P47, DOI 10.1007/BF02424505; MITTON JB, 1997, SELECTION NATURAL PO; Moller AP, 2002, OECOLOGIA, V132, P492, DOI 10.1007/s00442-002-0952-2; MULVEY M, 1994, EVOLUTION, V48, P1810, DOI [10.1111/j.1558-5646.1994.tb02216.x, 10.2307/2410510]; NEI M, 1978, GENETICS, V89, P583; Neumann K, 1996, MOL ECOL, V5, P307; PALMER AR, 1986, ANNU REV ECOL SYST, V17, P391, DOI 10.1146/annurev.es.17.110186.002135; PARSONS PA, 1990, BIOL REV, V65, P131, DOI 10.1111/j.1469-185X.1990.tb01186.x; Peach WJ, 2008, ANIM CONSERV, V11, P493, DOI 10.1111/j.1469-1795.2008.00209.x; Pemberton J.M., 1999, MICROSATELLITES EVOL, P151; Pertoldi C, 2006, HEREDITY, V96, P122, DOI 10.1038/sj.hdy.6800777; Polak M., 2003, CAUSES CONSEQUENCES; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Reich DE, 2001, NATURE, V411, P199, DOI 10.1038/35075590; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Ritland K, 1996, GENET RES, V67, P175, DOI 10.1017/S0016672300033620; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Sangster TA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000648; Schlotterer C, 2000, CHROMOSOMA, V109, P365, DOI 10.1007/s004120000089; Siikamaki P, 1998, EVOLUTION, V52, P1285, DOI 10.1111/j.1558-5646.1998.tb02010.x; Slate J, 2002, J EVOLUTION BIOL, V15, P20, DOI 10.1046/j.1420-9101.2002.00373.x; Sweigart A, 1999, HEREDITY, V83, P625, DOI 10.1038/sj.hdy.6886020; Takahashi KH, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-284; Talloen W, 2010, BIOL J LINN SOC, V100, P103, DOI 10.1111/j.1095-8312.2010.01422.x; Tsitrone A, 2001, GENETICS, V159, P1845; Van Dongen S, 1998, ANN ZOOL FENN, V35, P79; van Dongen S, 1999, J EVOLUTION BIOL, V12, P94, DOI 10.1046/j.1420-9101.1999.00012.x; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Vangestel C, 2011, ECOL INDIC, V11, P389, DOI 10.1016/j.ecolind.2010.06.009; Vangestel C, 2010, BIOL J LINN SOC, V101, P41, DOI 10.1111/j.1095-8312.2010.01493.x; Verbeke G, 2000, LINEAR MIXED MODELS; Vollestad LA, 1999, HEREDITY, V83, P206, DOI 10.1046/j.1365-2540.1999.00555.x; WALSH PS, 1991, BIOTECHNIQUES, V10, P506, DOI 10.2144/000114018; Whitlock M, 1998, P ROY SOC B-BIOL SCI, V265, P1429, DOI 10.1098/rspb.1998.0453; Zachos FE, 2007, HEREDITY, V98, P392, DOI 10.1038/sj.hdy.6800954; ZOUROS E, 1993, GENETICA, V89, P35, DOI 10.1007/BF02424504	81	20	20	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2011	6	7							e21569	10.1371/journal.pone.0021569	http://dx.doi.org/10.1371/journal.pone.0021569			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786HC	21747940	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000292293400016
J	Kim, H; Zahir, T; Tator, CH; Shoichet, MS				Kim, Howard; Zahir, Tasneem; Tator, Charles H.; Shoichet, Molly S.			Effects of Dibutyryl Cyclic-AMP on Survival and Neuronal Differentiation of Neural Stem/Progenitor Cells Transplanted into Spinal Cord Injured Rats	PLOS ONE			English	Article							STEM-CELLS; PROGENITOR CELLS; IN-VITRO; AXONAL REGENERATION; CHITOSAN CHANNELS; PRECURSOR CELLS; PROTEIN-KINASE; GROWTH-FACTOR; CAMP; RECOVERY	Neural stem/progenitor cells (NSPCs) have great potential as a cell replacement therapy for spinal cord injury. However, poor control over transplant cell differentiation and survival remain major obstacles. In this study, we asked whether dibutyryl cyclic-AMP (dbcAMP), which was shown to induce up to 85% in vitro differentiation of NSPCs into neurons would enhance survival of transplanted NSPCs through prolonged exposure either in vitro or in vivo through the controlled release of dbcAMP encapsulated within poly(lactic-co-glycolic acid) (PLGA) microspheres and embedded within chitosan guidance channels. NSPCs, seeded in fibrin scaffolds within the channels, differentiated in vitro to betaIII-tubulin positive neurons by immunostaining and mRNA expression, in response to dbcAMP released from PLGA microspheres. After transplantation in spinal cord injured rats, the survival and differentiation of NSPCs was evaluated. Untreated NSPCs, NSPCs transplanted with dbcAMP-releasing microspheres, and NSPCs pre-differentiated with dbcAMP for 4 days in vitro were transplanted after rat spinal cord transection and assessed 2 and 6 weeks later. Interestingly, NSPC survival was highest in the dbcAMP pre-treated group, having approximately 80% survival at both time points, which is remarkable given that stem cell transplantation often results in less than 1% survival at similar times. Importantly, dbcAMP pre-treatment also resulted in the greatest number of in vivo NSPCs differentiated into neurons (37 +/- 4%), followed by dbcAMP-microsphere treated NSPCs (27 +/- 14%) and untreated NSPCs (15 +/- 7%). The reverse trend was observed for NSPC-derived oligodendrocytes and astrocytes, with these populations being highest in untreated NSPCs. This combination strategy of stem cell-loaded chitosan channels implanted in a fully transected spinal cord resulted in extensive axonal regeneration into the injury site, with improved functional recovery after 6 weeks in animals implanted with pre-differentiated stem cells in chitosan channels.	[Kim, Howard; Tator, Charles H.; Shoichet, Molly S.] Univ Toronto, Inst Med Sci, Toronto, ON M5S 1A1, Canada; [Kim, Howard; Shoichet, Molly S.] Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON M5S 1A1, Canada; [Zahir, Tasneem; Shoichet, Molly S.] Univ Toronto, Dept Chem Engn & Appl Chem, Toronto, ON M5S 1A1, Canada; [Tator, Charles H.] Univ Hlth Network, Toronto Western Res Inst, Toronto, ON, Canada; [Tator, Charles H.] Univ Hlth Network, Krembil Neurosci Ctr, Toronto, ON, Canada	University of Toronto; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Krembil Research Institute; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Kim, H (corresponding author), Univ Toronto, Inst Med Sci, Toronto, ON M5S 1A1, Canada.	molly.shoichet@utoronto.ca			Canadian Institutes of Health Research (CIHR) [459627]; Krembil Foundation [481143]; Ontario Neurotrauma Foundation [2009-SCI-PHD-679]; Canadian Paraplegic Association, Ontario Branch	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Krembil Foundation; Ontario Neurotrauma Foundation; Canadian Paraplegic Association, Ontario Branch	Funding was provided by the Canadian Institutes of Health Research (CIHR; fund no. 459627, operating grant; http://www.cihr-irsc.gc.ca), the Krembil Foundation(provided matching funds to CIHR, fund no. 481143, operating grant; http://www.krembilfoundation.ca), the Ontario Neurotrauma Foundation (grant no. 2009-SCI-PHD-679; student scholarship; http://www.onf.org), and the Canadian Paraplegic Association, Ontario Branch, titled Spinal Cord Regeneration. (This is a research grant that has no funding number associated with it; http://www.cpaont.org/.) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abematsu M, 2010, J CLIN INVEST, V120, P3255, DOI 10.1172/JCI42957; Aizawa Y, 2008, BIOMATERIALS, V29, P4676, DOI 10.1016/j.biomaterials.2008.08.018; Aubert-Pouessel A, 2004, J CONTROL RELEASE, V95, P463, DOI 10.1016/j.jconrel.2003.12.012; BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; Bozkurt G, 2010, NEUROSURGERY, V67, P1733, DOI 10.1227/NEU.0b013e3181f9af35; Bretzner F, 2010, J NEUROSCI RES, V88, P2833, DOI 10.1002/jnr.22440; Cai DM, 2002, NEURON, V35, P711, DOI 10.1016/S0896-6273(02)00826-7; Cao QL, 2002, EXP NEUROL, V177, P349, DOI 10.1006/exnr.2002.7981; COOKE MJ, J BIOMED MAT RES A, V93, P824; Davies Jeannette E, 2008, J Biol, V7, P24, DOI 10.1186/jbiol85; Davies Jeannette E, 2006, J Biol, V5, P7, DOI 10.1186/jbiol35; de Boer R, 2010, J BIOMED MATER RES A, V95A, P1067, DOI 10.1002/jbm.a.32900; Dworkin S, 2010, EXPERT OPIN THER TAR, V14, P869, DOI 10.1517/14728222.2010.501332; Dyke HJ, 2002, EXPERT OPIN INV DRUG, V11, P1; Fouad K, 2009, J NEUROTRAUM, V26, P733, DOI 10.1089/neu.2008.0730; Freier T, 2005, BIOMATERIALS, V26, P4624, DOI 10.1016/j.biomaterials.2004.11.040; Gao Y, 2003, J NEUROSCI, V23, P11770; Hakamata Y, 2001, BIOCHEM BIOPH RES CO, V286, P779, DOI 10.1006/bbrc.2001.5452; Hannila SS, 2008, EXP NEUROL, V209, P321, DOI 10.1016/j.expneurol.2007.06.020; Hofstetter CP, 2005, NAT NEUROSCI, V8, P346, DOI 10.1038/nn1405; Jagasia R, 2009, J NEUROSCI, V29, P7966, DOI 10.1523/JNEUROSCI.1054-09.2009; JOHNSON PJ, 2009, CELL TRANSPLANT; Karimi-Abdolrezaee S, 2006, J NEUROSCI, V26, P3377, DOI 10.1523/JNEUROSCI.4184-05.2006; Kim G, 2002, MOL BRAIN RES, V109, P134, DOI 10.1016/S0169-328X(02)00550-8; Kim H, 2008, BIOTECHNOL PROGR, V24, P932, DOI 10.1021/bp070352a; Kim H, 2011, J BIOMED MATER RES A, V97A, P395, DOI 10.1002/jbm.a.33070; King VR, 2010, BIOMATERIALS, V31, P4447, DOI 10.1016/j.biomaterials.2010.02.018; Kume T, 2008, NEUROSCI LETT, V443, P199, DOI 10.1016/j.neulet.2008.07.079; Lavertu M, 2003, J PHARMACEUT BIOMED, V32, P1149, DOI 10.1016/S0731-7085(03)00155-9; Le Belle JE, 2004, J NEUROSCI RES, V76, P174, DOI 10.1002/jnr.20035; Leipzig ND, 2009, BIOMATERIALS, V30, P6867, DOI 10.1016/j.biomaterials.2009.09.002; Martens DJ, 2002, EUR J NEUROSCI, V16, P1045, DOI 10.1046/j.1460-9568.2002.02181.x; MENA MA, 1995, J NEUROCHEM, V65, P2612; Mothe AJ, 2005, J HISTOCHEM CYTOCHEM, V53, P1215, DOI 10.1369/jhc.5A6639.2005; Mothe AJ, 2005, NEUROSCIENCE, V131, P177, DOI 10.1016/j.neuroscience.2004.10.011; Nakao N, 1998, NEUROSCIENCE, V82, P1009; Nakashima K, 2001, P NATL ACAD SCI USA, V98, P5868, DOI 10.1073/pnas.101109698; Nomura H, 2008, TISSUE ENG PT A, V14, P649, DOI 10.1089/tea.2007.0180; Nout YS, 2011, EXP NEUROL, V227, P159, DOI 10.1016/j.expneurol.2010.10.011; Olstorn H, 2011, NEUROSURGERY, V68, P213, DOI 10.1227/NEU.0b013e3181fd2c11; Parr AM, 2007, J NEUROTRAUM, V24, P835, DOI 10.1089/neu.2006.3771; Pearse DD, 2004, NAT MED, V10, P610, DOI 10.1038/nm1056; Qiu J, 2002, NEURON, V34, P895, DOI 10.1016/S0896-6273(02)00730-4; Rossi SL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011852; Saha K, 2008, BIOPHYS J, V95, P4426, DOI 10.1529/biophysj.108.132217; Smith PM, 2000, EUR J NEUROSCI, V12, P2414, DOI 10.1046/j.1460-9568.2000.00137.x; Tang BL, 2007, CELL MOL NEUROBIOL, V27, P75, DOI 10.1007/s10571-006-9119-8; Tarasenko YI, 2007, J NEUROSCI RES, V85, P47, DOI 10.1002/jnr.21098; Taylor SJ, 2006, J CONTROL RELEASE, V113, P226, DOI 10.1016/j.jconrel.2006.05.005; Tojima T, 2003, J NEUROSCI RES, V74, P829, DOI 10.1002/jnr.10754; Tsai EC, 2006, BIOMATERIALS, V27, P519, DOI 10.1016/j.biomaterials.2005.07.025; Tsai EC, 2004, J NEUROTRAUM, V21, P789, DOI 10.1089/0897715041269687; Whitaker CM, 2008, NEUROSCI LETT, V438, P200, DOI 10.1016/j.neulet.2008.03.087; Willerth SM, 2006, BIOMATERIALS, V27, P5990, DOI 10.1016/j.biomaterials.2006.07.036; Yang M, 2004, CELL TRANSPLANT, V13, P535, DOI 10.3727/000000004783983729; Zahir T, 2008, CELL TRANSPLANT, V17, P245, DOI 10.3727/096368908784153887; Zahir T, 2009, STEM CELLS DEV, V18, P1423, DOI 10.1089/scd.2008.0412	57	56	57	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2011	6	6							e21744	10.1371/journal.pone.0021744	http://dx.doi.org/10.1371/journal.pone.0021744			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786GP	21738784	gold, Green Published, Green Submitted			2022-12-27	WOS:000292291800036
J	Demirkan, G; Yu, KB; Boylan, JM; Salomon, AR; Gruppuso, PA				Demirkan, Gokhan; Yu, Kebing; Boylan, Joan M.; Salomon, Arthur R.; Gruppuso, Philip A.			Phosphoproteomic Profiling of In Vivo Signaling in Liver by the Mammalian Target of Rapamycin Complex 1 (mTORC1)	PLOS ONE			English	Article							HIGHLY SELECTIVE ENRICHMENT; ACID-SOLUBLE PROTEIN; PHOSPHORYLATED PEPTIDES; MASS-SPECTROMETRY; CELL-GROWTH; QUANTITATIVE-ANALYSIS; RAT-LIVER; KINASE; IDENTIFICATION; TRANSLATION	Background: Our understanding of signal transduction networks in the physiological context of an organism remains limited, partly due to the technical challenge of identifying serine/threonine phosphorylated peptides from complex tissue samples. In the present study, we focused on signaling through the mammalian target of rapamycin ( mTOR) complex 1 (mTORC1), which is at the center of a nutrient-and growth factor-responsive cell signaling network. Though studied extensively, the mechanisms involved in many mTORC1 biological functions remain poorly understood. Methodology/Principal Findings: We developed a phosphoproteomic strategy to purify, enrich and identify phosphopeptides from rat liver homogenates. Using the anticancer drug rapamycin, the only known target of which is mTORC1, we characterized signaling in liver from rats in which the complex was maximally activated by refeeding following 48 hr of starvation. Using protein and peptide fractionation methods, TiO2 affinity purification of phosphopeptides and mass spectrometry, we reproducibly identified and quantified over four thousand phosphopeptides. Along with 5 known rapamycin-sensitive phosphorylation events, we identified 62 new rapamycin-responsive candidate phosphorylation sites. Among these were PRAS40, gephyrin, and AMP kinase 2. We observed similar proportions of increased and reduced phosphorylation in response to rapamycin. Gene ontology analysis revealed over-representation of mTOR pathway components among rapamycin-sensitive phosphopeptide candidates. Conclusions/Significance: In addition to identifying potential new mTORC1-mediated phosphorylation events, and providing information relevant to the biology of this signaling network, our experimental and analytical approaches indicate the feasibility of large-scale phosphoproteomic profiling of tissue samples to study physiological signaling events in vivo.	[Demirkan, Gokhan; Boylan, Joan M.; Gruppuso, Philip A.] Brown Univ, Dept Pediat, Providence, RI 02912 USA; [Demirkan, Gokhan; Boylan, Joan M.; Gruppuso, Philip A.] Rhode Isl Hosp, Providence, RI USA; [Demirkan, Gokhan; Yu, Kebing; Salomon, Arthur R.; Gruppuso, Philip A.] Brown Univ, Dept Mol Biol Cell Biol & Biochem, Providence, RI 02912 USA; [Yu, Kebing; Salomon, Arthur R.] Brown Univ, Dept Chem, Providence, RI 02912 USA	Brown University; Lifespan Health Rhode Island; Rhode Island Hospital; Brown University; Brown University	Demirkan, G (corresponding author), Brown Univ, Dept Pediat, Providence, RI 02912 USA.	Philip_Gruppuso@brown.edu	Yu, Kebing/D-4585-2014		USPHS [R01HD024455, 1R01AI083636, 2P20RR015578, R21AI083908]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD024455] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR015578] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI083636, R21AI083908] Funding Source: NIH RePORTER	USPHS(United States Department of Health & Human ServicesUnited States Public Health Service); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by USPHS grants R01HD024455 (to P.A.G.), and 1R01AI083636, 2P20RR015578 and R21AI083908 (to A.R.S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham RT, 2002, CELL, V111, P9, DOI 10.1016/S0092-8674(02)01009-7; Alcolea MP, 2009, J PROTEOME RES, V8, P3808, DOI 10.1021/pr800955n; Alessi DR, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.267pe27; Anand P, 2006, J NUTR, V136, P27, DOI 10.1093/jn/136.1.27; Anand P, 2005, J BIOL CHEM, V280, P16427, DOI 10.1074/jbc.M410576200; Beausoleil SA, 2004, P NATL ACAD SCI USA, V101, P12130, DOI 10.1073/pnas.0404720101; Beausoleil SA, 2006, NAT BIOTECHNOL, V24, P1285, DOI 10.1038/nbt1240; BRONSHTEIN IN, 2004, HDB MATH; Cao L, 2007, J IMMUNOL, V179, P5864, DOI 10.4049/jimmunol.179.9.5864; Cao LL, 2006, ADV EXP MED BIOL, V584, P277; Chen RQ, 2009, CANCER RES, V69, P2663, DOI 10.1158/0008-5472.CAN-08-3222; Cheng SWY, 2004, J BIOL CHEM, V279, P15719, DOI 10.1074/jbc.C300534200; Choo AY, 2008, P NATL ACAD SCI USA, V105, P17414, DOI 10.1073/pnas.0809136105; Choo AY, 2009, CELL CYCLE, V8, P567, DOI 10.4161/cc.8.4.7659; Dalby KN, 1998, J BIOL CHEM, V273, P1496, DOI 10.1074/jbc.273.3.1496; Dowling RJO, 2010, SCIENCE, V328, P1172, DOI 10.1126/science.1187532; Dunlop EA, 2009, CELL SIGNAL, V21, P827, DOI 10.1016/j.cellsig.2009.01.012; Efeyan A, 2010, CURR OPIN CELL BIOL, V22, P169, DOI 10.1016/j.ceb.2009.10.007; Elias JE, 2010, METHODS MOL BIOL, V604, P55, DOI 10.1007/978-1-60761-444-9_5; Ficarro SB, 2005, RAPID COMMUN MASS SP, V19, P57, DOI 10.1002/rcm.1746; Foster KG, 2010, J BIOL CHEM, V285, P14071, DOI 10.1074/jbc.R109.094003; Foster KG, 2010, J BIOL CHEM, V285, P80, DOI 10.1074/jbc.M109.029637; Gingras AC, 2003, CURR TOP MICROBIOL, V279, P169; Gronborg M, 2002, MOL CELL PROTEOMICS, V1, P517, DOI 10.1074/mcp.M200010-MCP200; Gruppuso PA, 2008, AM J PHYSIOL-REG I, V295, pR558, DOI 10.1152/ajpregu.00091.2008; Guertin DA, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.267pe24; Hall M N, 2008, Transplant Proc, V40, pS5, DOI 10.1016/j.transproceed.2008.10.009; Han GH, 2008, PROTEOMICS, V8, P1346, DOI 10.1002/pmic.200700884; Han GH, 2010, ELECTROPHORESIS, V31, P1080, DOI 10.1002/elps.200900493; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Hidalgo M, 2000, ONCOGENE, V19, P6680, DOI 10.1038/sj.onc.1204091; Holz MK, 2005, CELL, V123, P569, DOI 10.1016/j.cell.2005.10.024; HUBBARD MJ, 1993, TRENDS BIOCHEM SCI, V18, P172, DOI 10.1016/0968-0004(93)90109-Z; Huber A, 2009, GENE DEV, V23, P1929, DOI 10.1101/gad.532109; HUNTER T, 1980, P NATL ACAD SCI-BIOL, V77, P1311, DOI 10.1073/pnas.77.3.1311; Jin WH, 2004, RAPID COMMUN MASS SP, V18, P2169, DOI 10.1002/rcm.1604; Keranen LM, 1995, CURR BIOL, V5, P1394, DOI 10.1016/S0960-9822(95)00277-6; Kimura N, 2003, GENES CELLS, V8, P65, DOI 10.1046/j.1365-2443.2003.00615.x; Knebel A, 2001, EMBO J, V20, P4360, DOI 10.1093/emboj/20.16.4360; Kweon HK, 2006, ANAL CHEM, V78, P1743, DOI 10.1021/ac0522355; Kyono Y, 2008, J PROTEOME RES, V7, P4585, DOI 10.1021/pr800305y; Larsen MR, 2005, MOL CELL PROTEOMICS, V4, P873, DOI 10.1074/mcp.T500007-MCP200; Lemeer S, 2009, CURR OPIN CHEM BIOL, V13, P414, DOI 10.1016/j.cbpa.2009.06.022; Liao LJ, 2008, J PROTEOME RES, V7, P4743, DOI 10.1021/pr8003198; Loewith R, 2002, MOL CELL, V10, P457, DOI 10.1016/S1097-2765(02)00636-6; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; Mayeur GL, 2003, EUR J BIOCHEM, V270, P4133, DOI 10.1046/j.1432-1033.2003.03807.x; Morishita R, 1999, J BIOL CHEM, V274, P20688, DOI 10.1074/jbc.274.29.20688; Moser K, 2006, J PROTEOME RES, V5, P98, DOI 10.1021/pr0503073; Nguyen V, 2009, MOL CELL PROTEOMICS, V8, P2418, DOI 10.1074/mcp.M800307-MCP200; Nojima H, 2003, J BIOL CHEM, V278, P15461, DOI 10.1074/jbc.C200665200; OKA T, 1995, J BIOL CHEM, V270, P30060, DOI 10.1074/jbc.270.50.30060; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Polak P, 2009, CURR OPIN CELL BIOL, V21, P209, DOI 10.1016/j.ceb.2009.01.024; Prasad TSK, 2009, METHODS MOL BIOL, V577, P67, DOI 10.1007/978-1-60761-232-2_6; Sabatini DM, 1999, SCIENCE, V284, P1161, DOI 10.1126/science.284.5417.1161; Salomon AR, 2003, P NATL ACAD SCI USA, V100, P443, DOI 10.1073/pnas.2436191100; Shor B, 2010, J BIOL CHEM, V285, P15380, DOI 10.1074/jbc.M109.071639; Sugiyama N, 2007, MOL CELL PROTEOMICS, V6, P1103, DOI 10.1074/mcp.T600060-MCP200; Thingholm TE, 2006, NAT PROTOC, V1, P1929, DOI 10.1038/nprot.2006.185; Thingholm TE, 2009, PROTEOMICS, V9, P1451, DOI 10.1002/pmic.200800454; Vander Haar E, 2007, NAT CELL BIOL, V9, P316, DOI 10.1038/ncb1547; Villen J, 2007, P NATL ACAD SCI USA, V104, P1488, DOI 10.1073/pnas.0609836104; Villen J, 2008, NAT PROTOC, V3, P1630, DOI 10.1038/nprot.2008.150; Wang L, 2008, J BIOL CHEM, V283, P15619, DOI 10.1074/jbc.M800723200; Wolschin F, 2005, PROTEOMICS, V5, P4389, DOI 10.1002/pmic.200402049; WOOL IG, 1979, ANNU REV BIOCHEM, V48, P719, DOI 10.1146/annurev.bi.48.070179.003443; Wu JA, 2010, PROTEOMICS, V10, P2224, DOI 10.1002/pmic.200900788; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Xia QW, 2008, J PROTEOME RES, V7, P2845, DOI 10.1021/pr8000496; Yu KB, 2010, PROTEOMICS, V10, P2113, DOI 10.1002/pmic.200900159; Yu KB, 2009, PROTEOMICS, V9, P5350, DOI 10.1002/pmic.200900119; Yu KB, 2009, PROTEOMICS, V9, P3115, DOI 10.1002/pmic.200800899; Zanivan S, 2008, J PROTEOME RES, V7, P5314, DOI 10.1021/pr800599n; Zhang Y, 2005, MOL CELL PROTEOMICS, V4, P1240, DOI 10.1074/mcp.M500089-MCP200	75	50	52	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2011	6	6							e21729	10.1371/journal.pone.0021729	http://dx.doi.org/10.1371/journal.pone.0021729			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	784FW	21738781	gold, Green Submitted, Green Published			2022-12-27	WOS:000292142800064
J	Castrillo, G; Turck, F; Leveugle, M; Lecharny, A; Carbonero, P; Coupland, G; Paz-Ares, J; Onate-Sanchez, L				Castrillo, Gabriel; Turck, Franziska; Leveugle, Magalie; Lecharny, Alain; Carbonero, Pilar; Coupland, George; Paz-Ares, Javier; Onate-Sanchez, Luis			Speeding Cis-Trans Regulation Discovery by Phylogenomic Analyses Coupled with Screenings of an Arrayed Library of Arabidopsis Transcription Factors	PLOS ONE			English	Article							WIDE COMPARATIVE-ANALYSIS; FUNCTIONAL GENOMICS; SEED-GERMINATION; GENE-EXPRESSION; PROTEIN; SEQUENCE; FAMILY; DNA; PROMOTER; ELEMENTS	Transcriptional regulation is an important mechanism underlying gene expression and has played a crucial role in evolution. The number, position and interactions between cis-elements and transcription factors (TFs) determine the expression pattern of a gene. To identify functionally relevant cis-elements in gene promoters, a phylogenetic shadowing approach with a lipase gene (LIP1) was used. As a proof of concept, in silico analyses of several Brassicaceae LIP1 promoters identified a highly conserved sequence (LIP1 element) that is sufficient to drive strong expression of a reporter gene in planta. A collection of ca. 1,200 Arabidopsis thaliana TF open reading frames (ORFs) was arrayed in a 96-well format (RR library) and a convenient mating based yeast one hybrid (Y1H) screening procedure was established. We constructed an episomal plasmid (pTUY1H) to clone the LIP1 element and used it as bait for Y1H screenings. A novel interaction with an HD-ZIP (AtML1) TF was identified and abolished by a 2 bp mutation in the LIP1 element. A role of this interaction in transcriptional regulation was confirmed in planta. In addition, we validated our strategy by reproducing the previously reported interaction between a MYB-CC (PHR1) TF, a central regulator of phosphate starvation responses, with a conserved promoter fragment (IPS1 element) containing its cognate binding sequence. Finally, we established that the LIP1 and IPS1 elements were differentially bound by HD-ZIP and MYB-CC family members in agreement with their genetic redundancy in planta. In conclusion, combining in silico analyses of orthologous gene promoters with Y1H screening of the RR library represents a powerful approach to decipher cis- and trans-regulatory codes.	[Castrillo, Gabriel; Paz-Ares, Javier] CSIC, Ctr Nacl Biotecnol, Dept Plant Mol Genet, Madrid, Spain; [Turck, Franziska; Coupland, George] Max Planck Inst Plant Breeding Res, Dept Plant Dev Biol, Cologne, Germany; [Leveugle, Magalie; Lecharny, Alain] INRA, Unite Rech Genom Vegetale, Evry, France; [Leveugle, Magalie; Lecharny, Alain] CNRS, Evry, France; [Carbonero, Pilar; Onate-Sanchez, Luis] Univ Politecn Madrid, Dept Biotechnol, Madrid, Spain; [Carbonero, Pilar; Onate-Sanchez, Luis] Univ Politecn Madrid, Ctr Biotecnol & Genom Plantas, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); Max Planck Society; INRAE; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); Universidad Politecnica de Madrid; Universidad Politecnica de Madrid	Castrillo, G (corresponding author), CSIC, Ctr Nacl Biotecnol, Dept Plant Mol Genet, Madrid, Spain.	luis.onate@upm.es	Oñate-Sánchez, Luis J/C-6274-2017; Turck, Franziska/G-1240-2013; Coupland, George/AAP-8609-2020; Castrillo, Gabriel/Z-6321-2019	Oñate-Sánchez, Luis J/0000-0001-7047-5739; Turck, Franziska/0000-0002-4982-5949; Coupland, George/0000-0001-6988-4172; Castrillo, Gabriel/0000-0002-1557-6614; Paz-Ares, Javier/0000-0003-0553-9745	Knowledge Based Bio-Economy (KBBE); Spanish Ministry of Science and Innovation (MICINN) [CONSOLIDER CSD2007-00057, BIO2008-04715, BFU2009-11809, BIO2010-17334]; Marie Curie IRG [036524]	Knowledge Based Bio-Economy (KBBE); Spanish Ministry of Science and Innovation (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Marie Curie IRG(European Commission)	This research was supported by two Knowledge Based Bio-Economy (KBBE) projects (REGULATORS and TRANSNET; French-German-Spanish trilateral program on plant Genomics), grants from the Spanish Ministry of Science and Innovation (MICINN; CONSOLIDER CSD2007-00057, BIO2008-04715, BFU2009-11809; BIO2010-17334) and a Marie Curie IRG grant to LO-S (036524). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe M, 2001, PLANT J, V26, P487, DOI 10.1046/j.1365-313x.2001.01047.x; Adrian J, 2010, PLANT CELL, V22, P1425, DOI 10.1105/tpc.110.074682; Akoh CC, 2004, PROG LIPID RES, V43, P534, DOI 10.1016/j.plipres.2004.09.002; Alonso R, 2009, PLANT CELL, V21, P1747, DOI 10.1105/tpc.108.062968; Boffelli D, 2003, SCIENCE, V299, P1391, DOI 10.1126/science.1081331; Brady SM, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2010.114; Bustos R, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001102; Cao DN, 2006, PLANT PHYSIOL, V142, P509, DOI 10.1104/pp.106.082289; Carroll SB, 2005, PLOS BIOL, V3, P1159, DOI 10.1371/journal.pbio.0030245; Chen WQ, 1999, PLANT J, V19, P667, DOI 10.1046/j.1365-313x.1999.00560.x; Chini A, 2007, NATURE, V448, P666, DOI 10.1038/nature06006; Cliften PF, 2001, GENOME RES, V11, P1175, DOI 10.1101/gr.182901; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; De Bodt S, 2006, MOL BIOL EVOL, V23, P1293, DOI 10.1093/molbev/msk016; Deplancke B, 2006, CELL, V125, P1193, DOI 10.1016/j.cell.2006.04.038; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Dobi KC, 2007, MOL CELL BIOL, V27, P5575, DOI 10.1128/MCB.00459-07; Earley KW, 2006, PLANT J, V45, P616, DOI 10.1111/j.1365-313X.2005.02617.x; Fernandez-Calvo P, 2011, PLANT CELL, V23, P701, DOI 10.1105/tpc.110.080788; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; Franco-Zorrilla JM, 2004, J EXP BOT, V55, P285, DOI 10.1093/jxb/erh009; Franzke A, 2011, TRENDS PLANT SCI, V16, P108, DOI 10.1016/j.tplants.2010.11.005; Gagnot S, 2008, NUCLEIC ACIDS RES, V36, pD986, DOI 10.1093/nar/gkm757; Gong W, 2004, PLANT PHYSIOL, V135, P773, DOI 10.1104/pp.104.042176; Gong W, 2008, MOL PLANT, V1, P27, DOI 10.1093/mp/ssm009; Guo AY, 2005, BIOINFORMATICS, V21, P2568, DOI 10.1093/bioinformatics/bti334; Haberer G, 2006, PLANT PHYSIOL, V142, P1589, DOI 10.1104/pp.106.085639; Hilson P, 2006, TRENDS PLANT SCI, V11, P133, DOI 10.1016/j.tplants.2006.01.006; Hong RL, 2003, PLANT CELL, V15, P1296, DOI 10.1105/tpc.009548; Hruz Tomas, 2008, Advances in Bioinformatics, V2008, P420747, DOI 10.1155/2008/420747; Iida K, 2005, DNA RES, V12, P247, DOI 10.1093/dnares/dsi011; Isabel-LaMoneda I, 2003, PLANT J, V33, P329, DOI 10.1046/j.1365-313X.2003.01628.x; Kellis M, 2003, NATURE, V423, P241, DOI 10.1038/nature01644; Lee JY, 2006, P NATL ACAD SCI USA, V103, P6055, DOI 10.1073/pnas.0510607103; Lee JY, 2005, DEVELOPMENT, V132, P5021, DOI 10.1242/dev.02067; Ludwig MZ, 1998, DEVELOPMENT, V125, P949; Ludwig MZ, 2000, NATURE, V403, P564, DOI 10.1038/35000615; LUDWIG MZ, 1995, MOL BIOL EVOL, V12, P1002; Martin AC, 2000, PLANT J, V24, P559, DOI 10.1046/j.1365-313x.2000.00893.x; McGregor AP, 2001, EVOL DEV, V3, P397, DOI 10.1046/j.1525-142X.2001.01043.x; McGregor AP, 2001, DEV GENES EVOL, V211, P315, DOI 10.1007/s004270100148; MISTUDA N, 2010, PLANT CELL PHYSL, V51, P2145; Moreno-Risueno MA, 2007, MOL GENET GENOMICS, V277, P379, DOI 10.1007/s00438-006-0186-9; Morgenstern B, 1996, P NATL ACAD SCI USA, V93, P12098, DOI 10.1073/pnas.93.22.12098; Nakabayashi K, 2005, PLANT J, V41, P697, DOI 10.1111/j.1365-313X.2005.02337.x; Nakamura M, 2006, PLANT PHYSIOL, V141, P1363, DOI 10.1104/pp.106.077388; OU B, 2011, MOL PLANT       0222; Paz-Ares J, 2002, COMP FUNCT GENOM, V3, P102, DOI 10.1002/cfg.146; Penfield S, 2006, PLANT CELL, V18, P1887, DOI 10.1105/tpc.106.041277; Pruneda-Paz JL, 2009, SCIENCE, V323, P1481, DOI 10.1126/science.1167206; Qu LJ, 2006, CURR OPIN PLANT BIOL, V9, P544, DOI 10.1016/j.pbi.2006.07.005; Riechmann JL, 2000, SCIENCE, V290, P2105, DOI 10.1126/science.290.5499.2105; Rubio V, 2001, GENE DEV, V15, P2122, DOI 10.1101/gad.204401; Samson F, 2004, NUCLEIC ACIDS RES, V32, pD347, DOI 10.1093/nar/gkh134; Singh KB, 2002, CURR OPIN PLANT BIOL, V5, P430, DOI 10.1016/S1369-5266(02)00289-3; Spensley M, 2009, PLANT CELL, V21, P2606, DOI 10.1105/tpc.109.069898; Thatcher LF, 2007, J BIOL CHEM, V282, P28915, DOI 10.1074/jbc.M702207200; Tominaga-Wada R, 2009, PLANT J, V60, P564, DOI 10.1111/j.1365-313X.2009.03976.x; Town CD, 2006, PLANT CELL, V18, P1348, DOI 10.1105/tpc.106.041665; Weigel R., 2002, ARABIDOPSIS LAB MANU; Weiste C, 2007, PLANT J, V52, P382, DOI 10.1111/j.1365-313X.2007.03229.x; Xiong YQ, 2005, PLANT MOL BIOL, V59, P191, DOI 10.1007/s11103-005-6503-6	62	64	71	3	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2011	6	6							e21524	10.1371/journal.pone.0021524	http://dx.doi.org/10.1371/journal.pone.0021524			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	783OD	21738689	Green Published, gold			2022-12-27	WOS:000292092600049
J	Lackner, DH; Durocher, D; Karlseder, J				Lackner, Daniel H.; Durocher, Daniel; Karlseder, Jan			A siRNA-Based Screen for Genes Involved in Chromosome End Protection	PLOS ONE			English	Article							DNA-DAMAGE RESPONSE; HUMAN TELOMERES; MEDIATED TRANSCRIPTION; MAMMALIAN TELOMERES; INTERACTING PROTEIN; SKIP INTERACTS; CELL-CYCLE; HIV-1 TAT; TRF2; RNA	Telomeres are nucleoprotein complexes which protect the ends of linear chromosomes from detection as DNA damage and provide a sequence buffer against replication-associated shortening. In mammals, telomeres consist of repetitive DNA sequence (TTAGGG) and associated proteins. The telomeric core complex is called shelterin and is comprised of the proteins TRF1, TRF2, POT1, TIN2, TPP1 and RAP1. Excessive telomere shortening or de-protection of telomeres through the loss of shelterin subunits allows the detection of telomeres as DNA damage, which can be visualized as DNA damage protein foci at chromosome ends called TIF (Telomere Dysfunction-Induced Foci). We sought to exploit the TIF phenotype as marker for telomere dysfunction to identify novel genes involved in telomere protection by siRNA-mediatedknock-down of a set of 386 candidates. Here we report the establishment, specificity and feasibility of such a screen and the results of the genes tested. Only one of the candidate genes showed a unique TIF phenotype comparable to the suppression of the main shelterin components TRF2 or TRF1 and that gene was identified as a TRF1-like pseudogene. We also identified a weak TIF phenotype for SKIIP (SNW1), a splicing factor and transcriptional co-activator. However, the knock-down of SKIIP also induced a general, not telomere-specific DNA damage response, which complicates conclusions about a telomeric role. In summary, this report is a technical demonstration of the feasibility of a cell-based screen for telomere deprotection with the potential of scaling it to a high-throughput approach.	[Lackner, Daniel H.; Karlseder, Jan] Salk Inst Biol Studies, Mol & Cellular Biol Dept, La Jolla, CA 92037 USA; [Durocher, Daniel] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada	Salk Institute; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute	Lackner, DH (corresponding author), Salk Inst Biol Studies, Mol & Cellular Biol Dept, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	Karlseder@salk.edu	Durocher, Daniel/A-7733-2010	Durocher, Daniel/0000-0003-3863-8635	NIH [RO1 AG025837, RO1 GM087476]; Salk Institute for Biological Studies; European Molecular Biology Organization; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM087476] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG025837] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Salk Institute for Biological Studies; European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was funded by grants from the NIH (RO1 AG025837, RO1 GM087476) and by an innovation grant from the Salk Institute for Biological Studies (http://www.salk.edu/). DHL is the recipient of a European Molecular Biology Organization long-term postdoctoral fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azzalin CM, 2007, SCIENCE, V318, P798, DOI 10.1126/science.1147182; Baudino TA, 1998, J BIOL CHEM, V273, P16434, DOI 10.1074/jbc.273.26.16434; Bres V, 2005, GENE DEV, V19, P1211, DOI 10.1101/gad.1291705; Bres V, 2009, MOL CELL, V36, P75, DOI 10.1016/j.molcel.2009.08.015; Celli GB, 2005, NAT CELL BIOL, V7, P712, DOI 10.1038/ncb1275; CELLI GB, 2006, NAT CELL BIOL, V8, P855; Cesare AJ, 2009, NAT STRUCT MOL BIOL, V16, P1244, DOI 10.1038/nsmb.1725; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; Dejardin J, 2009, CELL, V136, P175, DOI 10.1016/j.cell.2008.11.045; Denchi EL, 2007, NATURE, V448, P1068, DOI 10.1038/nature06065; Denchi EL, 2006, GENE DEV, V20, P2648, DOI 10.1101/gad.1453606; Figueroa JD, 2004, BIOCHEM BIOPH RES CO, V319, P1105, DOI 10.1016/j.bbrc.2004.05.096; Folk P, 2004, CELL MOL LIFE SCI, V61, P629, DOI 10.1007/s00018-003-3215-4; Kolas NK, 2007, SCIENCE, V318, P1637, DOI 10.1126/science.1150034; Li BB, 2000, CELL, V101, P471, DOI 10.1016/S0092-8674(00)80858-2; MARTINEZ P, 2010, NAT CELL BI IN PRESS; Maser RS, 1997, MOL CELL BIOL, V17, P6087, DOI 10.1128/MCB.17.10.6087; Nagai K, 2004, BIOCHEM BIOPH RES CO, V316, P512, DOI 10.1016/j.bbrc.2004.02.077; O'Sullivan RJ, 2010, NAT REV MOL CELL BIO, V11, P171, DOI 10.1038/nrm2848; Paulsen RD, 2009, MOL CELL, V35, P228, DOI 10.1016/j.molcel.2009.06.021; Prathapam T, 2002, NUCLEIC ACIDS RES, V30, P5261, DOI 10.1093/nar/gkf658; Schoeftner S, 2008, NAT CELL BIOL, V10, P228, DOI 10.1038/ncb1685; Sfeir A, 2010, SCIENCE, V327, P1657, DOI 10.1126/science.1185100; Smogorzewska A, 2002, CURR BIOL, V12, P1635, DOI 10.1016/S0960-9822(02)01179-X; Takai H, 2003, CURR BIOL, V13, P1549, DOI 10.1016/S0960-9822(03)00542-6; TEO H, 2010, NAT CELL BI IN PRESS; van Steensel B, 1998, CELL, V92, P401, DOI 10.1016/S0092-8674(00)80932-0; Verdun RE, 2007, NATURE, V447, P924, DOI 10.1038/nature05976; Verdun RE, 2005, MOL CELL, V20, P551, DOI 10.1016/j.molcel.2005.09.024; Ye JZS, 2004, J BIOL CHEM, V279, P47264, DOI 10.1074/jbc.M409047200; Zhang C, 2003, J BIOL CHEM, V278, P35325, DOI 10.1074/jbc.M305191200; Zhou SF, 2000, J VIROL, V74, P1939, DOI 10.1128/JVI.74.4.1939-1947.2000; Zhu XD, 2000, NAT GENET, V25, P347, DOI 10.1038/77139	33	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2011	6	6							e21407	10.1371/journal.pone.0021407	http://dx.doi.org/10.1371/journal.pone.0021407			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TT	21760879	gold, Green Submitted, Green Published			2022-12-27	WOS:000292035400033
J	Gao, K; Miller, J				Gao, Kun; Miller, Jonathan			Algebraic Distribution of Segmental Duplication Lengths in Whole-Genome Sequence Self-Alignments	PLOS ONE			English	Article							LONG-RANGE CORRELATIONS; DNA; MODEL; EVOLUTION; EXPANSION; ELEMENTS; RECOMBINATION; INSERTIONS; DELETIONS; PATTERNS	Distributions of duplicated sequences from genome self-alignment are characterized, including forward and backward alignments in bacteria and eukaryotes. A Markovian process without auto-correlation should generate an exponential distribution expected from local effects of point mutation and selection on localised function; however, the observed distributions show substantial deviation from exponential form - they are roughly algebraic instead - suggesting a novel kind of long-distance correlation that must be non-local in origin.	[Gao, Kun; Miller, Jonathan] Okinawa Inst Sci & Technol, Phys & Biol Unit, Okinawa, Japan	Okinawa Institute of Science & Technology Graduate University	Gao, K (corresponding author), Okinawa Inst Sci & Technol, Phys & Biol Unit, Okinawa, Japan.	jm@oist.jp	Gao, Kun/G-2881-2015; Miller, Jonathan/M-4389-2014	Miller, Jonathan/0000-0003-2190-6824				APARICIO S, 1995, P NATL ACAD SCI USA, V92, P1684, DOI 10.1073/pnas.92.5.1684; Bailey JA, 2003, AM J HUM GENET, V73, P823, DOI 10.1086/378594; Bailey JA, 2002, SCIENCE, V297, P1003, DOI 10.1126/science.1072047; Bailey JA, 2006, NAT REV GENET, V7, P552, DOI 10.1038/nrg1895; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Bejerano G, 2004, SCIENCE, V304, P1321, DOI 10.1126/science.1098119; Bodmer W. F., 1962, ADV GENETICS; BULDYREV SV, 1993, BIOPHYS J, V65, P2673, DOI 10.1016/S0006-3495(93)81290-6; Buldyrev SV, 1999, PHYSICA A, V273, P19, DOI 10.1016/S0378-4371(99)00338-6; BULDYREV SV, 1993, PHYS REV E, V47, P4514, DOI 10.1103/PhysRevE.47.4514; Csuros M, 2007, TRENDS GENET, V23, P543, DOI 10.1016/j.tig.2007.07.008; DESCLOIZEAUX J, 1980, J PHYS-PARIS, V41, P223, DOI 10.1051/jphys:01980004103022300; DOVER GA, 1986, TRENDS GENET, V2, P159, DOI 10.1016/0168-9525(86)90211-8; Garcia-Fernandez J, 2005, NAT REV GENET, V6, P881, DOI 10.1038/nrg1723; GROSBERG A, 1993, EUROPHYS LETT, V23, P373, DOI 10.1209/0295-5075/23/5/012; GU X, 1995, J MOL EVOL, V40, P464, DOI 10.1007/BF00164032; Hedrick P.W., 2011, GENETICS POPULATIONS; Kammandel B, 1999, DEV BIOL, V205, P79, DOI 10.1006/dbio.1998.9128; KARLIN S, 1985, MOL BIOL EVOL, V2, P35; Kent WJ, 2003, P NATL ACAD SCI USA, V100, P11484, DOI 10.1073/pnas.1932072100; Knoch TA, 2009, EUR BIOPHYS J BIOPHY, V38, P757, DOI 10.1007/s00249-009-0489-y; Laherrere J, 1998, EUR PHYS J B, V2, P525, DOI 10.1007/s100510050276; LI W, 1992, EUROPHYS LETT, V17, P655, DOI 10.1209/0295-5075/17/7/014; LI WT, 1992, IEEE T INFORM THEORY, V38, P1842, DOI 10.1109/18.165464; Li WT, 1997, COMPUT CHEM, V21, P257, DOI 10.1016/S0097-8485(97)00022-3; LI WT, 1991, PHYS REV A, V43, P5240, DOI 10.1103/PhysRevA.43.5240; Luscombe NM, 2002, GENOME BIOL, V3; Mandelbrot B, 1977, FRACTAL GEOMETRY NAT; Mani A, 2010, NUCLEIC ACIDS RES, V38, P2036, DOI 10.1093/nar/gkp1177; Messer PW, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.138103; Miller J, 2009, IEICE TECHNICAL REPO, V109; Ohno S., 1970, EVOLUTION GENE DUPLI; PENG CK, 1992, NATURE, V356, P168, DOI 10.1038/356168a0; Redner S, 1998, EUR PHYS J B, V4, P131, DOI 10.1007/s100510050359; Sagi D, 2006, NUCLEIC ACIDS RES, V34, P5021, DOI 10.1093/nar/gkl586; Salerno W, 2006, P NATL ACAD SCI USA, V103, P13121, DOI 10.1073/pnas.0605735103; Santoyo G, 2005, FEMS MICROBIOL REV, V29, P169, DOI 10.1016/j.femsre.2004.10.004; Shibata T, 2001, P NATL ACAD SCI USA, V98, P8425, DOI 10.1073/pnas.111005198; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Sindi SS, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.061912; Stephan W, 2010, PHILOS T R SOC B, V365, P1245, DOI 10.1098/rstb.2009.0278; Stone EA, 2005, ANNU REV GENOM HUM G, V6, P143, DOI 10.1146/annurev.genom.6.080604.162146; Stringer MJ, 2010, J AM SOC INF SCI TEC, V61, P1377, DOI 10.1002/asi.21335; Zhang J, 2010, APPL BIOCHEM BIOTECH, V162, P321, DOI 10.1007/s12010-009-8793-7; Zhang LQ, 2005, MOL BIOL EVOL, V22, P135, DOI 10.1093/molbev/msh262; Zhang ZL, 2003, NUCLEIC ACIDS RES, V31, P5338, DOI 10.1093/nar/gkg745	47	18	18	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2011	6	7							e18464	10.1371/journal.pone.0018464	http://dx.doi.org/10.1371/journal.pone.0018464			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	793HP	21779315	Green Submitted, Green Published, gold			2022-12-27	WOS:000292811300001
J	Sugiura, D; Tateno, M				Sugiura, Daisuke; Tateno, Masaki			Optimal Leaf-to-Root Ratio and Leaf Nitrogen Content Determined by Light and Nitrogen Availabilities	PLOS ONE			English	Article							BIOMASS ALLOCATION; SHADE TOLERANCE; SEEDLING GROWTH; TREE SEEDLINGS; PHOTOSYNTHESIS; SURVIVAL; OPTIMIZATION; ACCLIMATION; MORPHOLOGY; PLANTS	Plants exhibit higher leaf-to-root ratios (L/R) and lower leaf nitrogen content (N-area) in low-light than in high-light environments, but an ecological significance of this trait has not been explained from a whole-plant perspective. This study aimed to theoretically and experimentally demonstrate whether these observed L/R and N-area are explained as optimal biomass allocation that maximize whole-plant relative growth rate (RGR). We developed a model which predicts optimal L/R and N-area in response to nitrogen and light availability. In the model, net assimilation rate (NAR) was determined by light-photosynthesis curve, light availability measured during experiments, and leaf temperature affecting the photosynthesis and leaf dark respiration rate in high and low-light environments. Two pioneer trees, Morus bombycis and Acer buergerianum, were grown in various light and nitrogen availabilities in an experimental garden and used for parameterizing and testing the model predictions. They were grouped into four treatment groups (relative photosynthetic photon flux density, RPPFD 100% or 10% x nitrogen-rich or nitrogen-poor conditions) and grown in an experimental garden for 60 to 100 days. The model predicted that optimal L/R is higher and N-area is lower in low-light than high-light environments when compared in the same soil nitrogen availability. Observed L/R and N-area of the two pioneer trees were close to the predicted optimums. From the model predictions and pot experiments, we conclude that the pioneer trees, M. bombycis and A. buergerianum, regulated L/R and N-area to maximize RGR in response to nitrogen and light availability.	[Sugiura, Daisuke; Tateno, Masaki] Univ Tokyo, Grad Sch Sci, Nikko Bot Garden, Nikko, Tochigi, Japan	University of Tokyo	Sugiura, D (corresponding author), Univ Tokyo, Grad Sch Sci, Nikko Bot Garden, Nikko, Tochigi, Japan.	dsugiura@biol.s.u-tokyo.ac.jp			MEXT, Japan	MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Global COE Program (Integrative Life Science Based on the Study of Biosignaling Mechanisms), MEXT, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGREN GI, 1987, PLANT CELL ENVIRON, V10, P579, DOI 10.1111/j.1365-3040.1987.tb01838.x; Atkin OK, 2000, PLANT PHYSIOL, V122, P915, DOI 10.1104/pp.122.3.915; CHAPIN FS, 1980, ANNU REV ECOL SYST, V11, P233, DOI 10.1146/annurev.es.11.110180.001313; ELLSWORTH DS, 1992, FUNCT ECOL, V6, P423, DOI 10.2307/2389280; FARQUHAR GD, 1980, PLANTA, V149, P78, DOI 10.1007/BF00386231; FIELD C, 1986, EC PLANT FORM FUNCTI, P28; GARNIER E, 1991, TRENDS ECOL EVOL, V6, P126, DOI 10.1016/0169-5347(91)90091-B; GIVNISH TJ, 1988, AUST J PLANT PHYSIOL, V15, P63, DOI 10.1071/PP9880063; GIVNISH TJ, 1982, AM NAT, V120, P353, DOI 10.1086/283995; GLEESON SK, 1993, ANN BOT-LONDON, V71, P23, DOI 10.1006/anbo.1993.1003; Hikosaka K, 2006, J EXP BOT, V57, P291, DOI 10.1093/jxb/erj049; HIKOSAKA K, 1995, PLANT CELL ENVIRON, V18, P605, DOI 10.1111/j.1365-3040.1995.tb00562.x; Hikosaka K, 1999, OECOLOGIA, V118, P388, DOI 10.1007/s004420050740; HILBERT DW, 1990, ANN BOT-LONDON, V66, P91, DOI 10.1093/oxfordjournals.aob.a088005; HILBERT DW, 1991, ANN BOT-LONDON, V68, P417, DOI 10.1093/oxfordjournals.aob.a088273; HIROSE T, 1987, OECOLOGIA, V72, P520, DOI 10.1007/BF00378977; HIROSE T, 1986, ANN BOT-LONDON, V58, P479, DOI 10.1093/annbot/58.4.479; Ida TY, 2008, ANN BOT-LONDON, V101, P435, DOI 10.1093/aob/mcm296; IWASA Y, 1984, THEOR POPUL BIOL, V25, P78, DOI 10.1016/0040-5809(84)90007-8; KITAJIMA K, 1994, OECOLOGIA, V98, P419, DOI 10.1007/BF00324232; McCarthy MC, 2007, FUNCT ECOL, V21, P713, DOI 10.1111/j.1365-2435.2007.01276.x; MURAKAMI T, 1983, Bulletin of the Sericultural Experiment Station (Tokyo), V29, P1; Myers JA, 2007, J ECOL, V95, P383, DOI 10.1111/j.1365-2745.2006.01207.x; Niinemets U, 1997, FUNCT ECOL, V11, P518, DOI 10.1046/j.1365-2435.1997.00109.x; Oguchi R, 2008, OECOLOGIA, V155, P665, DOI 10.1007/s00442-007-0951-4; Osone Y, 2005, FUNCT ECOL, V19, P460, DOI 10.1111/j.1365-2435.2005.00970.x; Osone Y, 2003, FUNCT ECOL, V17, P627, DOI 10.1046/j.1365-2435.2003.00763.x; Poorter H, 2000, AUST J PLANT PHYSIOL, V27, P595, DOI 10.1071/PP99173; Poorter L, 1999, FUNCT ECOL, V13, P396, DOI 10.1046/j.1365-2435.1999.00332.x; Reich PB, 1998, FUNCT ECOL, V12, P327, DOI 10.1046/j.1365-2435.1998.00208.x; Reich PB, 1998, FUNCT ECOL, V12, P395, DOI 10.1046/j.1365-2435.1998.00209.x; Sack L, 2002, OECOLOGIA, V131, P175, DOI 10.1007/s00442-002-0873-0; SATOH M, 1976, P CROP SCI SOC JPN, V45, P51; Schreeg LA, 2005, CAN J FOREST RES, V35, P263, DOI [10.1139/x04-168, 10.1139/X04-168]; Seiwa K, 2007, ANN BOT-LONDON, V99, P537, DOI 10.1093/aob/mcl283; Shipley B, 2002, FUNCT ECOL, V16, P326, DOI 10.1046/j.1365-2435.2002.00626.x; TATENO M, 1990, PLANT PHYSIOL, V92, P12, DOI 10.1104/pp.92.1.12; Tsutsumi T, 1989, FOREST ECOLOGY; Valladares F, 2000, ECOLOGY, V81, P1925, DOI 10.1890/0012-9658(2000)081[1925:PPRTLO]2.0.CO;2; WALTERS MB, 1993, OECOLOGIA, V96, P219, DOI 10.1007/BF00317735; Walters MB, 2000, ECOLOGY, V81, P1887, DOI 10.1890/0012-9658(2000)081[1887:SSNSAG]2.0.CO;2; WALTERS MB, 1993, OECOLOGIA, V94, P7, DOI 10.1007/BF00317294; Walters MB, 1996, ECOLOGY, V77, P841, DOI 10.2307/2265505	43	37	41	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2011	6	7							e22236	10.1371/journal.pone.0022236	http://dx.doi.org/10.1371/journal.pone.0022236			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791WM	21765957	Green Published, Green Submitted, gold			2022-12-27	WOS:000292699000033
J	Karnauskas, M; Cherubin, LM; Paris, CB				Karnauskas, Mandy; Cherubin, Laurent M.; Paris, Claire B.			Adaptive Significance of the Formation of Multi-Species Fish Spawning Aggregations near Submerged Capes	PLOS ONE			English	Article							GROUPER EPINEPHELUS-STRIATUS; NASSAU GROUPER; LOCAL RETENTION; BARRIER-REEF; FLOW; VARIABILITY; POPULATIONS; MECHANISMS; DISPERSAL; TRANSPORT	Background: Many fishes are known to spawn at distinct geomorphological features such as submerged capes or "promontories," and the widespread use of these sites for spawning must imply some evolutionary advantage. Spawning at these capes is thought to result in rapid offshore transport of eggs, thereby reducing predation levels and facilitating dispersal to areas of suitable habitat. Methodology/Principal Findings: To test this "off-reef transport" hypothesis, we use a hydrodynamic model and explore the effects of topography on currents at submerged capes where spawning occurs and at similar capes where spawning does not occur, along the Mesoamerican Barrier Reef. All capes modeled in this study produced eddy-shedding regimes, but specific eddy attributes differed between spawning and non-spawning sites. Eddies at spawning sites were significantly stronger than those at non-spawning sites, and upwelling and fronts were the products of the eddy formation process. Frontal zones, present particularly at the edges of eddies near the shelf, may serve to retain larvae and nutrients. Spawning site eddies were also more predictable in terms of diameter and longevity. Passive particles released at spawning and control sites were dispersed from the release site at similar rates, but particles from spawning sites were more highly aggregated in their distributions than those from control sites, and remained closer to shore at all times. Conclusions/Significance: Our findings contradict previous hypotheses that cape spawning leads to high egg dispersion due to offshore transport, and that they are attractive for spawning due to high, variable currents. Rather, we show that current regimes at spawning sites are more predictable, concentrate the eggs, and keep larvae closer to shore. These attributes would confer evolutionary advantages by maintaining relatively similar recruitment patterns year after year.	[Karnauskas, Mandy] Univ Miami, Rosenstiel Sch Marine & Atmospher Sci, Div Marine Biol & Fisheries, Miami, FL 33149 USA; [Cherubin, Laurent M.] Univ Miami, Rosenstiel Sch Marine & Atmospher Sci, Div Meteorol & Phys Oceanog, Miami, FL 33149 USA; [Paris, Claire B.] Univ Miami, Rosenstiel Sch Marine & Atmospher Sci, Div Appl Marine Phys, Miami, FL 33149 USA	University of Miami; University of Miami; University of Miami	Karnauskas, M (corresponding author), Univ Miami, Rosenstiel Sch Marine & Atmospher Sci, Div Marine Biol & Fisheries, Miami, FL 33149 USA.	mkarnauskas@rsmas.miami.edu		Paris-Limouzy, Claire Beatrix/0000-0002-0637-1334; Karnauskas, Mandy/0000-0002-6631-0592	University of Miami; Conservation International Marine Management Area Science Program (MMASP); NSF [OCE0825625, OCE0550732, OCE0928423]	University of Miami; Conservation International Marine Management Area Science Program (MMASP); NSF(National Science Foundation (NSF))	M. Karnauskas was supported by a University of Miami Fellowship while completing this work. The study was in part supported by a Conservation International Marine Management Area Science Program (MMASP) award to C. B. Paris and L. M. Cherubin to model larval dispersal at spawning aggregation sites in Belize. C. B. Paris and L. M. Cherubin are also funded by NSF OCE0825625; C. B. Paris is funded by NSF OCE0550732, OCE0928423. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agostini VN, 2002, FISH OCEANOGR, V11, P129, DOI 10.1046/j.1365-2419.2002.00201.x; Aguilar-Perera A, 2006, MAR ECOL PROG SER, V327, P289, DOI 10.3354/meps327289; Almany GR, 2007, SCIENCE, V316, P742, DOI 10.1126/science.1140597; Bakun A., 1996, OCEAN PROCESSES MARI; BARLOW GW, 1981, ENVIRON BIOL FISH, V6, P65, DOI 10.1007/BF00001801; Bez N, 2000, FISH OCEANOGR, V9, P372, DOI 10.1046/j.1365-2419.2000.00148.x; Bolden SK, 2000, FISH B-NOAA, V98, P642; BOYER DL, 1987, J FLUID MECH, V180, P429, DOI 10.1017/S0022112087001885; Cherubin LM, 2008, CORAL REEFS, V27, P503, DOI 10.1007/s00338-007-0348-1; Cherubin LM, 2006, J PHYS OCEANOGR, V36, P569, DOI 10.1175/JPO2871.1; Claro Rodolfo, 2003, Gulf and Caribbean Research, V14, P91; DAVIES PA, 1990, DYNAM ATMOS OCEANS, V14, P497; De Mitcheson YS, 2008, CONSERV BIOL, V22, P1233, DOI 10.1111/j.1523-1739.2008.01020.x; Doglioli AM, 2004, J GEOPHYS RES-OCEANS, V109, DOI 10.1029/2004JC002422; DOHERTY PJ, 1985, ENVIRON BIOL FISH, V12, P81, DOI 10.1007/BF00002761; Domeier ML, 1997, B MAR SCI, V60, P698; Dong CM, 2007, J PHYS OCEANOGR, V37, P962, DOI 10.1175/JPO3047.1; Ertel H., 1942, METEOROL Z, V59, P271; Ezer T, 2005, OCEAN DYNAM, V55, P458, DOI 10.1007/s10236-005-0033-2; Gladstone W, 2007, MAR ECOL PROG SER, V351, P235, DOI 10.3354/meps07108; Graham RT, 2007, FISH RES, V84, P71, DOI 10.1016/j.fishres.2006.11.026; Graham RT, 2005, FISH B-NOAA, V103, P426; Hansen C, 2010, DEEP-SEA RES PT I, V57, P1079, DOI 10.1016/j.dsr.2010.05.013; HEPPELL SA, 2008, P 61 ANN GULF CAR FI, P325; Heyman W, 2002, STATUS MULTISPECIES; Heyman WD, 2005, J FISH BIOL, V67, P83, DOI 10.1111/j.0022-1112.2005.00714.x; Heyman WD, 2008, B MAR SCI, V83, P531; JOHANNES R E, 1978, Environmental Biology of Fishes, V3, P65, DOI 10.1007/BF00006309; Jones GP, 2005, CURR BIOL, V15, P1314, DOI 10.1016/j.cub.2005.06.061; Kobara S, 2010, MAR ECOL PROG SER, V405, P243, DOI 10.3354/meps08512; Kobara S, 2008, MAR GEOD, V31, P231, DOI 10.1080/01490410802466397; Levy M, 2003, J GEOPHYS RES-OCEANS, V108, DOI 10.1029/2002JC001577; MacCready P, 2001, J PHYS OCEANOGR, V31, P2824, DOI 10.1175/1520-0485(2001)031<2824:SFAACS>2.0.CO;2; Mace AJ, 2006, MAR ECOL PROG SER, V318, P19, DOI 10.3354/meps318019; Magaldi MG, 2008, OCEAN MODEL, V25, P65, DOI 10.1016/j.ocemod.2008.06.006; McGillicuddy DJ, 2007, SCIENCE, V316, P1021, DOI 10.1126/science.1136256; MURDOCH RC, 1989, ESTUAR COAST SHELF S, V29, P361, DOI 10.1016/0272-7714(89)90034-6; OKUBO A, 1971, DEEP-SEA RES, V18, P789, DOI 10.1016/0011-7471(71)90046-5; PAGE MA, 1985, J FLUID MECH, V156, P205, DOI 10.1017/S0022112085002051; Paris CB, 2004, LIMNOL OCEANOGR, V49, P1964, DOI 10.4319/lo.2004.49.6.1964; Paris CB, 2007, MAR ECOL PROG SER, V347, P285, DOI 10.3354/meps06985; Pedlosky J, 1987, GEOPHYS FLUID DYN, DOI [10.1007/978-1-4612-4650-3, DOI 10.1007/978-1-4612-4650-3]; RICHARDS WJ, 2005, EARLY STAGES ATLANTI, P1225; Richardson DE, 2009, PROG OCEANOGR, V82, P252, DOI 10.1016/j.pocean.2009.07.003; Sadovy Y, 2005, FISH FISH, V6, P167, DOI 10.1111/j.1467-2979.2005.00186.x; Sadovy Y., 1999, NOAA TECHNICAL REPOR, V146, P1; Sala E, 2001, FISHERIES, V26, P23, DOI 10.1577/1548-8446(2001)026<0023:RDONGS>2.0.CO;2; Salas E, 2010, MAR BIOL, V157, P437, DOI 10.1007/s00227-009-1330-y; Santos AMP, 2007, PROG OCEANOGR, V74, P192, DOI 10.1016/j.pocean.2007.04.008; SCHULTZ ET, 1994, MAR ECOL PROG SER, V109, P15, DOI 10.3354/meps109015; Shchepetkin AF, 2005, OCEAN MODEL, V9, P347, DOI 10.1016/j.ocemod.2004.08.002; Starr RM, 2007, MAR ECOL PROG SER, V343, P239, DOI 10.3354/meps06897; Warner RR, 2002, B MAR SCI, V70, P245; Whaylen L, 2004, ENVIRON BIOL FISH, V70, P305, DOI 10.1023/B:EBFI.0000033341.57920.a8; WING SR, 1995, LIMNOL OCEANOGR, V40, P316, DOI 10.4319/lo.1995.40.2.0316	55	44	45	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2011	6	7							e22067	10.1371/journal.pone.0022067	http://dx.doi.org/10.1371/journal.pone.0022067			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791IA	21760954	Green Submitted, gold, Green Published			2022-12-27	WOS:000292657200044
J	Li, C; Huang, LM; Xu, CG; Zhao, Y; Zhou, DX				Li, Chen; Huang, Limin; Xu, Caiguo; Zhao, Yu; Zhou, Dao-Xiu			Altered Levels of Histone Deacetylase OsHDT1 Affect Differential Gene Expression Patterns in Hybrid Rice	PLOS ONE			English	Article							CHROMATIN MODIFICATION; NUCLEOLAR DOMINANCE; ALLELIC VARIATION; MOLECULAR-BASIS; ARABIDOPSIS; MAIZE; REGULATOR; HETEROSIS; ACETYLTRANSFERASE; IDENTIFICATION	Hybrids between different inbred varieties display novel patterns of gene expression resulted from parental variation in allelic nucleotide sequences. To study the function of chromatin regulators in hybrid gene expression, the histone deacetylase gene OsHDT1 whose expression displayed a circadian rhythm was over-expressed or inactivated by RNAi in an elite rice parent. Increased OsHDT1 expression did not affect plant growth in the parent but led to early flowering in the hybrid. Nonadditive up-regulation of key flowering time genes was found to be related to flowering time of the hybrid. Over-expression of OsHDT1 repressed the nonadditive expression of the key flowering repressors in the hybrid (i.e. OsGI and Hd1) inducing early flowering. Analysis of histone acetylation suggested that OsHDT1 over-expression might promote deacetylation on OsGI and Hd1 chromatin during the peak expression phase. High throughput differential gene expression analysis revealed that altered OsHDT1 levels affected nonadditive expression of many genes in the hybrid. These data demonstrate that nonadditive gene expression was involved in flowering time control in the hybrid rice and that OsHDT1 level was important for nonadditive or differential expression of many genes including the flowering time genes, suggesting that OsHDT1 may be involved in epigenetic control of parental genome interaction for differential gene expression.	[Li, Chen; Huang, Limin; Xu, Caiguo; Zhao, Yu; Zhou, Dao-Xiu] Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Wuhan, Peoples R China; [Zhou, Dao-Xiu] Univ Paris 11, CNRS, UMR8618, Inst Biol Plantes, F-91405 Orsay, France	Huazhong Agricultural University; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Li, C (corresponding author), Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Wuhan, Peoples R China.	dao-xiu.zhou@u-psud.fr		Zhou, Dao-Xiu/0000-0002-1540-0598	Chinese Ministry of Agriculture Transgenic Programs; National Natural Science Foundation	Chinese Ministry of Agriculture Transgenic Programs; National Natural Science Foundation(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the Chinese Ministry of Agriculture Transgenic Programs and the National Natural Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Berger SL, 2007, NATURE, V447, P407, DOI 10.1038/nature05915; Birchler JA, 2003, PLANT CELL, V15, P2236, DOI 10.1105/tpc.151030; Chen ZJ, 2007, BBA-GENE STRUCT EXPR, V1769, P295, DOI 10.1016/j.bbaexp.2007.04.007; Chu ZH, 2006, GENE DEV, V20, P1250, DOI 10.1101/gad.1416306; Crane YM, 2007, P NATL ACAD SCI USA, V104, P15156, DOI 10.1073/pnas.0706986104; Doi K, 2004, GENE DEV, V18, P926, DOI 10.1101/gad.1189604; Green RM, 2002, PLANT PHYSIOL, V129, P576, DOI 10.1104/pp.004374; Guo M, 2003, PLANT J, V36, P30, DOI 10.1046/j.1365-313X.2003.01852.x; Hayama R, 2004, PLANT PHYSIOL, V135, P677, DOI 10.1104/pp.104.042614; He GM, 2010, PLANT CELL, V22, P17, DOI 10.1105/tpc.109.072041; Huang LM, 2007, PLANT PHYSIOL, V144, P1508, DOI 10.1104/pp.107.099473; Hubner N, 2005, NAT GENET, V37, P243, DOI 10.1038/ng1522; Ishikawa R, 2009, MOL PLANT, V2, P589, DOI 10.1093/mp/ssp028; Itoh H, 2010, NAT GENET, V42, P635, DOI 10.1038/ng.606; Izawa T, 2011, PLANT CELL, V23, P1741, DOI 10.1105/tpc.111.083238; Komiya R, 2009, DEVELOPMENT, V136, P3443, DOI 10.1242/dev.040170; Krieger U, 2010, NAT GENET, V42, P459, DOI 10.1038/ng.550; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Lawrence RJ, 2004, MOL CELL, V13, P599, DOI 10.1016/S1097-2765(04)00064-4; Lin YJ, 2005, PLANT CELL REP, V23, P540, DOI 10.1007/s00299-004-0843-6; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lusser A, 1997, SCIENCE, V277, P88, DOI 10.1126/science.277.5322.88; Millar CB, 2006, NAT REV MOL CELL BIO, V7, P657, DOI 10.1038/nrm1986; Morrissy AS, 2009, GENOME RES, V19, P1825, DOI 10.1101/gr.094482.109; Ni ZF, 2009, NATURE, V457, P327, DOI 10.1038/nature07523; Pandey R, 2002, NUCLEIC ACIDS RES, V30, P5036, DOI 10.1093/nar/gkf660; Pontes O, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001157; Qin FJ, 2010, MOL PLANT, V3, P773, DOI 10.1093/mp/ssq030; Reiner A, 2003, BIOINFORMATICS, V19, P368, DOI 10.1093/bioinformatics/btf877; Rubio V, 2005, PLANT J, V41, P767, DOI 10.1111/j.1365-313X.2004.02328.x; Servet C, 2010, MOL PLANT, V3, P670, DOI 10.1093/mp/ssq018; Song RT, 2003, P NATL ACAD SCI USA, V100, P9055, DOI 10.1073/pnas.1032999100; Springer NM, 2007, GENOME RES, V17, P264, DOI 10.1101/gr.5347007; Sun QW, 2008, P NATL ACAD SCI USA, V105, P13679, DOI 10.1073/pnas.0805901105; Swanson-Wagner RA, 2006, P NATL ACAD SCI USA, V103, P6805, DOI 10.1073/pnas.0510430103; t Hoen PAC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn705; Ueno Y, 2007, PLANT CELL, V19, P445, DOI 10.1105/tpc.106.042325; Wei G, 2009, P NATL ACAD SCI USA, V106, P7695, DOI 10.1073/pnas.0902340106; Xue WY, 2008, NAT GENET, V40, P761, DOI 10.1038/ng.143; Yano M, 2000, PLANT CELL, V12, P2473, DOI 10.1105/tpc.12.12.2473; Zhao Y, 2009, PLANT CELL, V21, P736, DOI 10.1105/tpc.108.061655; Zhou CH, 2004, PLANT J, V38, P715, DOI 10.1111/j.1365-313X.2004.02083.x	43	39	49	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2011	6	7							e21789	10.1371/journal.pone.0021789	http://dx.doi.org/10.1371/journal.pone.0021789			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791IA	21760907	Green Published, gold, Green Submitted			2022-12-27	WOS:000292657200021
J	Murphy, K; O'Sullivan, O; Rea, MC; Cotter, PD; Ross, RP; Hill, C				Murphy, Kiera; O'Sullivan, Orla; Rea, Mary C.; Cotter, Paul D.; Ross, R. Paul; Hill, Colin			Genome Mining for Radical SAM Protein Determinants Reveals Multiple Sactibiotic-Like Gene Clusters	PLOS ONE			English	Article							CLOSTRIDIUM-DIFFICILE; BACILLUS-SUBTILIS; NARROW-SPECTRUM; BACTERIOCIN; IDENTIFICATION; BIOSYNTHESIS; SEQUENCE; METHYLTRANSFERASE; VISUALIZATION; LANTIBIOTICS	Thuricin CD is a two-component bacteriocin produced by Bacillus thuringiensis that kills a wide range of clinically significant Clostridium difficile. This bacteriocin has recently been characterized and consists of two distinct peptides, Trn beta and Trn alpha, which both possess 3 intrapeptide sulphur to alpha-carbon bridges and act synergistically. Indeed, thuricin CD and subtilosin A are the only antimicrobials known to possess these unusual structures and are known as the sactibiotics (sulplur to alpha carbon-containing antibiotics). Analysis of the thuricin CD-associated gene cluster revealed the presence of genes encoding two highly unusual SAM proteins (TrnC and TrnD) which are proposed to be responsible for these unusual post-translational modifications. On the basis of the frequently high conservation among enzymes responsible for the post-translational modification of specific antimicrobials, we performed an in silico screen for novel thuricin CD-like gene clusters using the TrnC and TrnD radical SAM proteins as driver sequences to perform an initial homology search against the complete non-redundant database. Fifteen novel thuricin CD-like gene clusters were identified, based on the presence of TrnC and TrnD homologues in the context of neighbouring genes encoding potential bacteriocin structural peptides. Moreover, metagenomic analysis revealed that TrnC or TrnD homologs are present in a variety of metagenomic environments, suggesting a widespread distribution of thuricin-like operons in a variety of environments. In-silico analysis of radical SAM proteins is sufficient to identify novel putative sactibiotic clusters.	[Murphy, Kiera; Hill, Colin] Natl Univ Ireland Univ Coll Cork, Dept Microbiol, Cork, Ireland; [Murphy, Kiera; O'Sullivan, Orla; Rea, Mary C.; Cotter, Paul D.; Ross, R. Paul] TEAGASC, Food Res Ctr, Fermoy, Cork, Ireland; [Rea, Mary C.; Cotter, Paul D.; Ross, R. Paul; Hill, Colin] Alimentary Pharmabiot Ctr, Cork, Ireland	University College Cork; Teagasc; University College Cork	Murphy, K (corresponding author), Natl Univ Ireland Univ Coll Cork, Dept Microbiol, Cork, Ireland.		O'Sullivan, Orla/ABE-5980-2020; Ross, Paul/A-7584-2015; Cotter, Paul/AAX-5449-2021; Cotter, Paul/B-7781-2008; Hill, Colin/A-5611-2012; STANTON, CATHERINE/A-9549-2015	O'Sullivan, Orla/0000-0002-4332-1109; Ross, Paul/0000-0003-4876-8839; Cotter, Paul/0000-0002-5465-9068; Cotter, Paul/0000-0002-5465-9068; Hill, Colin/0000-0002-8527-1445; Rea, Mary/0000-0003-3782-0232; STANTON, CATHERINE/0000-0002-6724-7011	Science Foundation of Ireland-funded Centre for Science, Engineering and Technology (SFI-CSET); Alimentary Pharmabiotic Centre (APC)	Science Foundation of Ireland-funded Centre for Science, Engineering and Technology (SFI-CSET)(Science Foundation Ireland); Alimentary Pharmabiotic Centre (APC)(Science Foundation Ireland)	This work was supported by the Science Foundation of Ireland-funded Centre for Science, Engineering and Technology (SFI-CSET): the Alimentary Pharmabiotic Centre (APC), http://www.sfi.ie. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Begley M, 2009, APPL ENVIRON MICROB, V75, P5451, DOI 10.1128/AEM.00730-09; Brede DA, 2004, APPL ENVIRON MICROB, V70, P7303, DOI 10.1128/AEM.70.12.7303-7310.2004; Bredholt S, 1999, INT J SYST BACTERIOL, V49, P991, DOI 10.1099/00207713-49-3-991; Cotter PD, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000144; Dabard J, 2001, APPL ENVIRON MICROB, V67, P4111, DOI 10.1128/AEM.67.9.4111-4118.2001; Diep DB, 2007, P NATL ACAD SCI USA, V104, P2384, DOI 10.1073/pnas.0608775104; Dineen SS, 2000, APPL ENVIRON MICROB, V66, P5480, DOI 10.1128/AEM.66.12.5480-5483.2000; Dischinger J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006788; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; GIALLO J, 1983, APPL ENVIRON MICROB, V45, P843, DOI 10.1128/AEM.45.3.843-849.1983; Gonzalez DJ, 2010, J BIOL CHEM, V285, P28220, DOI 10.1074/jbc.M110.118554; Granum PE, 1997, FEMS MICROBIOL LETT, V157, P223, DOI 10.1016/S0378-1097(97)00438-2; Guedon E, 1999, J BACTERIOL, V181, P3262, DOI 10.1128/JB.181.10.3262-3269.1999; Haft DH, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-70; Hamahata A, 1996, BIOCHEM J, V317, P141, DOI 10.1042/bj3170141; Huson DH, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-460; Hyink O, 2007, APPL ENVIRON MICROB, V73, P1107, DOI 10.1128/AEM.02265-06; Jernberg C, 2010, MICROBIOL-SGM, V156, P3216, DOI 10.1099/mic.0.040618-0; Kaminska KH, 2010, NUCLEIC ACIDS RES, V38, P1652, DOI 10.1093/nar/gkp1142; Kawulka KE, 2004, BIOCHEMISTRY-US, V43, P3385, DOI 10.1021/bi0359527; LaButti K, 2009, STAND GENOMIC SCI, V1, P159, DOI 10.4056/sigs.24194; Larsen L, 1997, ARCH MICROBIOL, V168, P114, DOI 10.1007/s002030050476; Lawton EM, 2007, MINI-REV MED CHEM, V7, P1236, DOI 10.2174/138955707782795638; Lawton EM, 2007, FEMS MICROBIOL LETT, V267, P64, DOI 10.1111/j.1574-6968.2006.00539.x; Lee SW, 2008, P NATL ACAD SCI USA, V105, P5879, DOI 10.1073/pnas.0801338105; LI AW, 1982, CAN J MICROBIOL, V28, P860, DOI 10.1139/m82-128; Li SY, 2009, CHEMBIOCHEM, V10, P1297, DOI 10.1002/cbic.200900088; Lien T, 1998, INT J SYST BACTERIOL, V48, P1007, DOI 10.1099/00207713-48-3-1007; Loo VG, 2005, NEW ENGL J MED, V353, P2442, DOI 10.1056/NEJMoa051639; MADDEN RH, 1982, INT J SYST BACTERIOL, V32, P87, DOI 10.1099/00207713-32-1-87; Marsh AJ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-679; McClerren AL, 2006, P NATL ACAD SCI USA, V103, P17243, DOI 10.1073/pnas.0606088103; Nes IF, 1996, ANTON LEEUW INT J G, V70, P113, DOI 10.1007/BF00395929; Niewmierzycka A, 1999, J BIOL CHEM, V274, P814, DOI 10.1074/jbc.274.2.814; NISHIO C, 1983, BIOCHEM BIOPH RES CO, V116, P751, DOI 10.1016/0006-291X(83)90588-0; O'Sullivan L, 2002, BIOCHIMIE, V84, P593, DOI 10.1016/S0300-9084(02)01457-8; Pag U, 2002, CURR PHARM DESIGN, V8, P815, DOI 10.2174/1381612023395439; Rea MC, 2011, P NATL ACAD SCI USA, V108, P4639, DOI 10.1073/pnas.1001224107; Rea MC, 2011, PROKARYOTIC ANTIMICROBIAL PEPTIDES: FROM GENES TO APPLICATIONS, P29, DOI 10.1007/978-1-4419-7692-5_3; Rea MC, 2010, P NATL ACAD SCI USA, V107, P9352, DOI 10.1073/pnas.0913554107; Redelings MD, 2007, EMERG INFECT DIS, V13, P1417, DOI 10.3201/eid1309.061116; Rusch DB, 2007, PLOS BIOL, V5, P398, DOI 10.1371/journal.pbio.0050077; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; Schnepf E, 1998, MICROBIOL MOL BIOL R, V62, P775, DOI 10.1128/MMBR.62.3.775-806.1998; Scholz R, 2011, J BACTERIOL, V193, P215, DOI 10.1128/JB.00784-10; Sebaihia M, 2006, NAT GENET, V38, P779, DOI 10.1038/ng1830; Seshadri R, 2007, PLOS BIOL, V5, P394, DOI 10.1371/journal.pbio.0050075; Sofia HJ, 2001, NUCLEIC ACIDS RES, V29, P1097, DOI 10.1093/nar/29.5.1097; Stein T, 2002, J BACTERIOL, V184, P1703, DOI 10.1128/JB.184.6.1703-1711.2002; Tringe SG, 2005, SCIENCE, V308, P554, DOI 10.1126/science.1107851; WALK ST, 2008, INTERDISCIPLINARY PE, P12508; Wexler HM, 2007, CLIN MICROBIOL REV, V20, P593, DOI 10.1128/CMR.00008-07; Yutin N, 2007, ENVIRON MICROBIOL, V9, P1464, DOI 10.1111/j.1462-2920.2007.01265.x; Zheng GL, 2000, J BACTERIOL, V182, P3266, DOI 10.1128/JB.182.11.3266-3273.2000	55	63	63	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2011	6	7							e20852	10.1371/journal.pone.0020852	http://dx.doi.org/10.1371/journal.pone.0020852			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791IA	21760885	gold, Green Published, Green Submitted			2022-12-27	WOS:000292657200004
J	Nakerakanti, SS; Bujor, AM; Trojanowska, M				Nakerakanti, Sashidhar S.; Bujor, Andreea M.; Trojanowska, Maria			CCN2 Is Required for the TGF-beta Induced Activation of Smad1-Erk1/2 Signaling Network	PLOS ONE			English	Article							TISSUE GROWTH-FACTOR; COLLAGEN-SYNTHESIS; FACTOR EXPRESSION; RECEPTOR; SMAD1; PHOSPHORYLATION; FIBROSIS; PATHWAY; GENE; SRC	Connective tissue growth factor (CCN2) is a multifunctional matricellular protein, which is frequently overexpressed during organ fibrosis. CCN2 is a mediator of the pro-fibrotic effects of TGF-beta in cultured cells, but the specific function of CCN2 in the fibrotic process has not been elucidated. In this study we characterized the CCN2-dependent signaling pathways that are required for the TGF-beta induced fibrogenic response. By depleting endogenous CCN2 we show that CCN2 is indispensable for the TGF-beta-induced phosphorylation of Smad1 and Erk1/2, but it is unnecessary for the activation of Smad3. TGF-beta stimulation triggered formation of the CCN2/beta(3) integrin protein complexes and activation of Src signaling. Furthermore, we demonstrated that signaling through the alpha(v)beta(3) integrin receptor and Src was required for the TGF-beta induced Smad1 phosphorylation. Recombinant CCN2 activated Src and Erk1/2 signaling, and induced phosphorylation of Fli1, but was unable to stimulate Smad1 or Smad3 phosphorylation. Additional experiments were performed to investigate the role of CCN2 in collagen production. Consistent with the previous studies, blockade of CCN2 abrogated TGF-beta-induced collagen mRNA and protein levels. Recombinant CCN2 potently stimulated collagen mRNA levels and upregulated activity of the COL1A2 promoter, however CCN2 was a weak inducer of collagen protein levels. CCN2 stimulation of collagen was dose-dependent with the lower doses (<50 ng/ml) having a stimulatory effect and higher doses having an inhibitory effect on collagen gene expression. In conclusion, our study defines a novel CCN2/alpha(v)beta(3) integrin/Src/Smad1 axis that contributes to the pro-fibrotic TGF-beta signaling and suggests that blockade of this pathway may be beneficial for the treatment of fibrosis.	[Nakerakanti, Sashidhar S.; Bujor, Andreea M.; Trojanowska, Maria] Boston Univ, Sch Med, Arthrit Ctr, Boston, MA 02118 USA	Boston University	Nakerakanti, SS (corresponding author), Boston Univ, Sch Med, Arthrit Ctr, Boston, MA 02118 USA.	trojanme@bu.edu	Bujor, Andreea/AAN-8621-2021	Bujor, Andreea/0000-0002-8840-8937; Trojanowska, Maria/0000-0001-9550-7178	National Institutes of Health [AR44883, AR42334]; Scleroderma Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR044883, R56AR044883, R01AR042334] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Scleroderma Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This study was supported by the National Institutes of Health grants AR44883 and AR42334 (MT) and by the Scleroderma Foundation New Investigator grant (AB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe H, 2004, J BIOL CHEM, V279, P14201, DOI 10.1074/jbc.M310427200; Abraham D, 2008, RHEUMATOLOGY, V47, pV8, DOI 10.1093/rheumatology/ken278; Abreu JG, 2002, NAT CELL BIOL, V4, P599, DOI 10.1038/ncb826; Asano Y, 2005, J IMMUNOL, V175, P7708, DOI 10.4049/jimmunol.175.11.7708; Asano Y, 2009, MOL CELL BIOL, V29, P1882, DOI 10.1128/MCB.01320-08; Babic AM, 1999, MOL CELL BIOL, V19, P2958; Bhattacharyya S, 2008, AM J PATHOL, V173, P1085, DOI 10.2353/ajpath.2008.080382; Bleau AM, 2005, FRONT BIOSCI-LANDMRK, V10, P998, DOI 10.2741/1594; Bujor AM, 2010, EXP DERMATOL, V19, P347, DOI 10.1111/j.1600-0625.2010.01065.x; Chen CC, 2001, J BIOL CHEM, V276, P10443, DOI 10.1074/jbc.M008087200; Crean JKG, 2002, J BIOL CHEM, V277, P44187, DOI 10.1074/jbc.M203715200; Duncan MR, 1999, FASEB J, V13, P1774, DOI 10.1096/fasebj.13.13.1774; Fonseca C, 2007, NEW ENGL J MED, V357, P1210, DOI 10.1056/NEJMoa067655; Gautschi O, 2008, CANCER RES, V68, P2250, DOI 10.1158/0008-5472.CAN-07-6403; Gore-Hyer E, 2003, ARTHRITIS RHEUM-US, V48, P798, DOI 10.1002/art.10953; Goumans MJ, 2003, MOL CELL, V12, P817, DOI 10.1016/S1097-2765(03)00386-1; Grotendorst Gary R., 1997, Cytokine and Growth Factor Reviews, V8, P171, DOI 10.1016/S1359-6101(97)00010-5; KAPANADZE B, 2009, J CELL MOL MED; Kucich U, 2001, ARCH BIOCHEM BIOPHYS, V395, P103, DOI 10.1006/abbi.2001.2571; Lasky JA, 1998, AM J PHYSIOL-LUNG C, V275, pL365, DOI 10.1152/ajplung.1998.275.2.L365; Lebrin F, 2005, CARDIOVASC RES, V65, P599, DOI 10.1016/j.cardiores.2004.10.036; Leivonen SK, 2005, J INVEST DERMATOL, V124, P1162, DOI 10.1111/j.0022-202X.2005.23750.x; Liu IM, 2009, EMBO J, V28, P88, DOI 10.1038/emboj.2008.266; Liu SX, 2011, ARTHRITIS RHEUM-US, V63, P239, DOI 10.1002/art.30074; Luchetti MM, 2003, J BIOL CHEM, V278, P1533, DOI 10.1074/jbc.M204392200; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; Mima A, 2006, LAB INVEST, V86, P927, DOI 10.1038/labinvest.3700445; Mitra SK, 2006, CURR OPIN CELL BIOL, V18, P516, DOI 10.1016/j.ceb.2006.08.011; Mori T, 1999, J CELL PHYSIOL, V181, P153, DOI 10.1002/(SICI)1097-4652(199910)181:1<153::AID-JCP16>3.0.CO;2-K; Morris E, 2011, J CELL PHYSL; Moussad EEDA, 2000, MOL GENET METAB, V71, P276, DOI 10.1006/mgme.2000.3059; Moustakas A, 2008, FEBS LETT, V582, P2051, DOI 10.1016/j.febslet.2008.03.027; Nakerakanti SS, 2006, J BIOL CHEM, V281, P25259, DOI 10.1074/jbc.M600466200; Pannu J, 2008, ARTHRITIS RHEUM-US, V58, P2528, DOI 10.1002/art.23698; Pannu J, 2007, J BIOL CHEM, V282, P10405, DOI 10.1074/jbc.M611742200; Quan TH, 2010, J INVEST DERMATOL, V130, P415, DOI 10.1038/jid.2009.224; Rachfal AW, 2005, VITAM HORM, V70, P69, DOI 10.1016/S0083-6729(05)70003-0; Ricupero DA, 1999, AM J PHYSIOL-LUNG C, V277, pL1165, DOI 10.1152/ajplung.1999.277.6.L1165; Scaffidi AK, 2004, J BIOL CHEM, V279, P37726, DOI 10.1074/jbc.M403010200; Shi-Wen X, 2000, EXP CELL RES, V259, P213, DOI 10.1006/excr.2000.4972; Shi-Wen X, 2008, CYTOKINE GROWTH F R, V19, P133, DOI 10.1016/j.cytogfr.2008.01.002; Skhirtladze C, 2008, ARTHRITIS RHEUM, V58, P1475, DOI 10.1002/art.23436; Smith HW, 2008, J CELL BIOL, V182, P777, DOI 10.1083/jcb.200712050; SONNYLAL S, ARTHRITIS RHEUM, V62, P1523; Tan NY, 2009, MOL CELL BIOL, V29, P2483, DOI 10.1128/MCB.01828-08; ten Dijke P, 2008, ANGIOGENESIS, V11, P79, DOI 10.1007/s10456-008-9101-9; Wahab NA, 2005, J AM SOC NEPHROL, V16, P340, DOI 10.1681/ASN.2003100905; Wang B, 2010, J MED GENET, V47, P391, DOI 10.1136/jmg.2009.073098; Wenger C, 1999, ONCOGENE, V18, P1073, DOI 10.1038/sj.onc.1202395; Wiercinska E, 2006, HEPATOLOGY, V43, P1032, DOI 10.1002/hep.21135; Wrighton KH, 2009, J BIOL CHEM, V284, P9755, DOI 10.1074/jbc.M809223200; Yokoi H, 2001, AM J KIDNEY DIS, V38, pS134, DOI 10.1053/ajkd.2001.27422; Zhang C, 2004, LIFE SCI, V75, P367, DOI 10.1016/j.lfs.2004.02.005; Zhang YE, 2009, CELL RES, V19, P128, DOI 10.1038/cr.2008.328	54	67	69	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2011	6	7							e21911	10.1371/journal.pone.0021911	http://dx.doi.org/10.1371/journal.pone.0021911			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791IA	21760921	gold, Green Published, Green Submitted			2022-12-27	WOS:000292657200028
J	Renoir, T; Zajac, MS; Du, X; Pang, TY; Leang, L; Chevarin, C; Lanfumey, L; Hannan, AJ				Renoir, Thibault; Zajac, Michelle S.; Du, Xin; Pang, Terence Y.; Leang, Leah; Chevarin, Caroline; Lanfumey, Laurence; Hannan, Anthony J.			Sexually Dimorphic Serotonergic Dysfunction in a Mouse Model of Huntington's Disease and Depression	PLOS ONE			English	Article							DORSAL RAPHE NUCLEUS; SEROTONIN(1A) RECEPTOR-BINDING; POSITRON-EMISSION-TOMOGRAPHY; 5-HT1A RECEPTOR; SEX-DIFFERENCES; MAJOR DEPRESSION; HUMAN BRAIN; MICE; GENDER; GENE	Depression is the most common psychiatric disorder in Huntington's disease (HD) patients. In the general population, women are more prone to develop depression and such susceptibility might be related to serotonergic dysregulation. There is yet to be a study of sexual dimorphism in the development and presentation of depression in HD patients. We investigated whether 8-week-old male and female R6/1 transgenic HD mice display depressive-like endophenotypes associated with serotonergic impairments. We also studied the behavioral effects of acute treatment with sertraline. We found that only female HD mice exhibited a decreased preference for saccharin as well as impaired emotionality-related behaviors when assessed on the novelty-suppressed feeding test (NSFT) and the forced-swimming test (FST). The exaggerated immobility time displayed by female HD in the FST was reduced by acute administration of sertraline. We also report an increased response to the 5-HT1A receptor agonist 8-OH-DPAT in inducing hypothermia and a decreased 5-HT2A receptor function in HD animals. While tissue levels of serotonin were reduced in both male and female HD mice, we found that serotonin concentration and hydroxylase-2 (TPH2) mRNA levels were higher in the hippocampus of males compared to female animals. Finally, the antidepressant-like effects of sertraline in the FST were blunted in male HD animals. This study reveals sex-specific depressive-related behaviors during an early stage of HD prior to any cognitive and motor deficits. Our data suggest a crucial role for disrupted serotonin signaling in mediating the sexually dimorphic depression-like phenotype in HD mice.	[Renoir, Thibault; Zajac, Michelle S.; Du, Xin; Pang, Terence Y.; Leang, Leah; Hannan, Anthony J.] Univ Melbourne, Florey Neurosci Inst, Howard Florey Inst, Parkville, Vic 3052, Australia; [Zajac, Michelle S.; Du, Xin; Hannan, Anthony J.] Univ Melbourne, Dept Anat & Cell Biol, Parkville, Vic 3052, Australia; [Chevarin, Caroline; Lanfumey, Laurence] Univ Paris 06, UMR S894, UPMC, Paris, France; [Chevarin, Caroline; Lanfumey, Laurence] INSERM, UMR S894, Paris, France	Florey Institute of Neuroscience & Mental Health; University of Melbourne; University of Melbourne; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm)	Renoir, T (corresponding author), Univ Melbourne, Florey Neurosci Inst, Howard Florey Inst, Parkville, Vic 3052, Australia.	thibault.renoir@florey.edu.au	Pang, Terence Y/D-2826-2012; Lanfumey, Laurence/P-3037-2017; Du, Xin/L-9412-2019; Chevarin, Caroline/M-1438-2015; Pang, Terence Y/L-6444-2019; Lanfumey, Laurence/F-7695-2013	Du, Xin/0000-0003-3960-5317; Pang, Terence Y/0000-0002-7000-5304; Hannan, Anthony/0000-0001-7532-8922	National Health and Medical Research Council (NHMRC); Pfizer; NHMRC-INSERM; University of Melbourne	National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Pfizer(Pfizer); NHMRC-INSERM(National Health and Medical Research Council (NHMRC) of Australia); University of Melbourne(University of Melbourne)	This work was supported by National Health and Medical Research Council (NHMRC) Project Grants (AJH), philanthropic support from a Pfizer Australia Research Fellowship (AJH), NHMRC-INSERM Exchange Fellowship (TR) and University of Melbourne Research Scholarships (MSZ and XD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armbruster D, 2010, BIOL PSYCHOL, V83, P214, DOI 10.1016/j.biopsycho.2009.12.010; Bai F, 2001, PHARMACOL BIOCHEM BE, V70, P187, DOI 10.1016/S0091-3057(01)00599-8; Bauer A, 2005, J NEUROCHEM, V94, P639, DOI 10.1111/j.1471-4159.2005.03169.x; Bert B, 2006, BEHAV BRAIN RES, V167, P328, DOI 10.1016/j.bbr.2005.09.020; Bhagwagar Z, 2004, MOL PSYCHIATR, V9, P386, DOI 10.1038/sj.mp.4001401; BILL DJ, 1991, BRIT J PHARMACOL, V103, P1857, DOI 10.1111/j.1476-5381.1991.tb12342.x; Bjorkqvist M, 2006, HUM MOL GENET, V15, P1713, DOI 10.1093/hmg/ddl094; Bode FJ, 2008, HUM MOL GENET, V17, P2595, DOI 10.1093/hmg/ddn159; Bouali S, 2003, EUR J NEUROSCI, V18, P2203, DOI 10.1046/j.1460-9568.2003.02960.x; Brummett BH, 2008, BEHAV GENET, V38, P34, DOI 10.1007/s10519-007-9172-1; Celada P, 2004, J PSYCHIATR NEUROSCI, V29, P252; Chopra KK, 2009, PSYCHONEUROENDOCRINO, V34, P1235, DOI 10.1016/j.psyneuen.2009.03.014; DALLA C, 2009, BASIC CLIN PHARM TOX; Dawson LA, 2002, J PSYCHOPHARMACOL, V16, P145, DOI 10.1177/026988110201600205; Dorner JL, 2007, BEHAV BRAIN RES, V178, P90, DOI 10.1016/j.bbr.2006.12.004; Drevets WC, 2007, NUCL MED BIOL, V34, P865, DOI 10.1016/j.nucmedbio.2007.06.008; Duff K, 2007, BIOL PSYCHIAT, V62, P1341, DOI 10.1016/j.biopsych.2006.11.034; Dulawa SC, 2005, NEUROSCI BIOBEHAV R, V29, P771, DOI 10.1016/j.neubiorev.2005.03.017; El Yacoubi M, 2003, P NATL ACAD SCI USA, V100, P6227, DOI 10.1073/pnas.1034823100; Fava M, 2000, NEURON, V28, P335, DOI 10.1016/S0896-6273(00)00112-4; Frey BN, 2008, NEUROIMAGE, V42, P850, DOI 10.1016/j.neuroimage.2008.05.009; Frey BN, 2010, PSYCHIAT RES-NEUROIM, V183, P157, DOI 10.1016/j.pscychresns.2010.05.005; Goswami DB, 2010, J NEUROCHEM, V112, P397, DOI 10.1111/j.1471-4159.2009.06462.x; Grabe HJ, 2005, MOL PSYCHIATR, V10, P220, DOI 10.1038/sj.mp.4001555; Harkin A, 2002, J PSYCHOPHARMACOL, V16, P115, DOI 10.1177/026988110201600201; Hedlund PB, 2004, EUR J PHARMACOL, V487, P125, DOI 10.1016/j.ejphar.2004.01.031; Jans LAW, 2007, MOL PSYCHIATR, V12, P522, DOI 10.1038/sj.mp.4001920; Jennings KA, 2008, NEUROPHARMACOLOGY, V54, P776, DOI 10.1016/j.neuropharm.2007.12.001; Julien CL, 2007, J NEUROL NEUROSUR PS, V78, P939, DOI 10.1136/jnnp.2006.103309; Kinney GG, 1997, BRAIN RES, V756, P68, DOI 10.1016/S0006-8993(97)00119-4; Kornstein SG, 2000, AM J PSYCHIAT, V157, P1445, DOI 10.1176/appi.ajp.157.9.1445; Li Q, 2000, J NEUROSCI, V20, P7888; Lira A, 2003, BIOL PSYCHIAT, V54, P960, DOI 10.1016/S0006-3223(03)00696-6; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; Marcus SM, 2008, COMPR PSYCHIAT, V49, P238, DOI 10.1016/j.comppsych.2007.06.012; Marshall J, 2007, ARCH NEUROL-CHICAGO, V64, P116, DOI 10.1001/archneur.64.1.116; Mato S, 2007, J NEUROCHEM, V103, P2111, DOI 10.1111/j.1471-4159.2007.04961.x; Matuszewich L, 2003, PSYCHOPHARMACOLOGY, V169, P169, DOI 10.1007/s00213-003-1498-7; Messa C, 2003, PSYCHOPHARMACOLOGY, V167, P72, DOI 10.1007/s00213-002-1379-5; Miller JM, 2009, NEUROPSYCHOPHARMACOL, V34, P2275, DOI 10.1038/npp.2009.54; Mizuno T, 2006, J PSYCHOSOM RES, V60, P91, DOI 10.1016/j.jpsychores.2005.06.068; Mnie-Filali O, 2007, DRUG NEWS PERSPECT, V20, P613, DOI 10.1358/dnp.2007.20.10.1181354; NAKANO Y, 1992, EUR J PHARMACOL, V219, P339; Nishizawa S, 1997, P NATL ACAD SCI USA, V94, P5308, DOI 10.1073/pnas.94.10.5308; Nithianantharajah J, 2008, NEUROBIOL DIS, V29, P490, DOI 10.1016/j.nbd.2007.11.006; Olivier JDA, 2008, NEUROSCIENCE, V152, P573, DOI 10.1016/j.neuroscience.2007.12.032; Overstreet DH, 2003, STRESS, V6, P101, DOI 10.1080/1025389031000111311; Overstreet DH, 2002, BEHAV GENET, V32, P335, DOI 10.1023/A:1020262205227; Pang TYC, 2006, NEUROSCIENCE, V141, P569, DOI 10.1016/j.neuroscience.2006.04.013; Pang TYC, 2009, HUM MOL GENET, V18, P753, DOI 10.1093/hmg/ddn385; Paulsen JS, 2005, J NEUROPSYCH CLIN N, V17, P496, DOI 10.1176/appi.neuropsych.17.4.496; Pouladi MA, 2009, BRAIN, V132, P919, DOI 10.1093/brain/awp006; Preece P, 2003, MOL BRAIN RES, V118, P60, DOI 10.1016/S0169-328X(03)00337-1; Renard CE, 2001, PSYCHOPHARMACOLOGY, V159, P42, DOI 10.1007/s002130100836; Renoir T, 2008, INT J NEUROPSYCHOPH, V11, P1149, DOI 10.1017/S1461145708009048; Reynolds GP, 1999, J NEUROCHEM, V72, P1773, DOI 10.1046/j.1471-4159.1999.721773.x; Richardson-Jones JW, 2010, NEURON, V65, P40, DOI 10.1016/j.neuron.2009.12.003; Rogoz Z, 2006, PHARMACOL REP, V58, P493; Rossi DV, 2008, J NEUROCHEM, V105, P1091, DOI 10.1111/j.1471-4159.2007.05201.x; Sargent PA, 2000, ARCH GEN PSYCHIAT, V57, P174, DOI 10.1001/archpsyc.57.2.174; Sarkisyan G, 2010, BEHAV BRAIN RES, V209, P99, DOI 10.1016/j.bbr.2010.01.022; Sjoberg RL, 2006, INT J NEUROPSYCHOPH, V9, P443, DOI 10.1017/S1461145705005936; Stockmeier CA, 1998, J NEUROSCI, V18, P7394; Sun YH, 2009, NEUROPSYCHOPHARMACOL, V34, P1601, DOI 10.1038/npp.2008.217; Szewczyk B, 2009, INT J NEUROPSYCHOPH, V12, P155, DOI 10.1017/S1461145708009012; van Gaalen MM, 2002, GENES BRAIN BEHAV, V1, P174, DOI 10.1034/j.1601-183X.2002.10305.x; Wood NI, 2008, BRAIN RES BULL, V76, P70, DOI 10.1016/j.brainresbull.2007.12.007; Wood NI, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009077; Yatham LN, 2000, ARCH GEN PSYCHIAT, V57, P850, DOI 10.1001/archpsyc.57.9.850; Yohrling GJ, 2002, J NEUROCHEM, V82, P1416, DOI 10.1046/j.1471-4159.2002.01084.x; ZAJAC MS, 2009, HIPPOCAMPUS	71	74	75	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2011	6	7							e22133	10.1371/journal.pone.0022133	http://dx.doi.org/10.1371/journal.pone.0022133			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791IA	21760962	Green Published, gold			2022-12-27	WOS:000292657200051
J	Burri, A; Cherkas, L; Spector, T; Rahman, Q				Burri, Andrea; Cherkas, Lynn; Spector, Timothy; Rahman, Qazi			Genetic and Environmental Influences on Female Sexual Orientation, Childhood Gender Typicality and Adult Gender Identity	PLOS ONE			English	Article							CONGENITAL ADRENAL-HYPERPLASIA; TYPED BEHAVIOR; MALE HOMOSEXUALITY; PSYCHOSEXUAL DEVELOPMENT; UNITED-STATES; TWIN SAMPLE; WOMEN; POPULATION; ANDROGEN; LINKAGE	Background: Human sexual orientation is influenced by genetic and non-shared environmental factors as are two important psychological correlates - childhood gender typicality (CGT) and adult gender identity (AGI). However, researchers have been unable to resolve the genetic and non-genetic components that contribute to the covariation between these traits, particularly in women. Methodology/Principal Findings: Here we performed a multivariate genetic analysis in a large sample of British female twins (N = 4,426) who completed a questionnaire assessing sexual attraction, CGT and AGI. Univariate genetic models indicated modest genetic influences on sexual attraction (25%), AGI (11%) and CGT (31%). For the multivariate analyses, a common pathway model best fitted the data. Conclusions/Significance: This indicated that a single latent variable influenced by a genetic component and common non-shared environmental component explained the association between the three traits but there was substantial measurement error. These findings highlight common developmental factors affecting differences in sexual orientation.	[Burri, Andrea; Rahman, Qazi] Queen Mary Univ London, Biol & Expt Psychol Grp, Sch Biol & Chem Sci, London, England; [Burri, Andrea; Cherkas, Lynn; Spector, Timothy] Kings Coll London, Dept Twin Res & Genet Epidemiol, London WC2R 2LS, England	University of London; Queen Mary University London; University of London; King's College London	Burri, A (corresponding author), Queen Mary Univ London, Biol & Expt Psychol Grp, Sch Biol & Chem Sci, London, England.	a.burri@qmul.ac.uk; q.rahman@qmul.ac.uk		Rahman, Qazi/0000-0001-8346-4529; Burri, Andrea/0000-0002-4705-3551				Andrew T, 2001, Twin Res, V4, P464, DOI 10.1375/1369052012803; Auyeung B, 2009, PSYCHOL SCI, V20, P144, DOI 10.1111/j.1467-9280.2009.02279.x; Bailey JM, 2009, NEBR SYM MOTIV, V54, P43; Bailey JM, 2000, J PERS SOC PSYCHOL, V78, P524, DOI 10.1037//0022-3514.78.3.524; BAILEY JM, 1995, DEV PSYCHOL, V31, P43, DOI 10.1037/0012-1649.31.1.43; Bailey JM, 1999, BEHAV GENET, V29, P79, DOI 10.1023/A:1021652204405; BAILEY JM, 1993, ARCH GEN PSYCHIAT, V50, P217; BAILEY JM, 1991, ARCH GEN PSYCHIAT, V48, P1089; Bartlett NH, 2006, ARCH SEX BEHAV, V35, P659, DOI 10.1007/s10508-006-9055-1; Baumeister RF, 2000, PSYCHOL BULL, V126, P347, DOI 10.1037/0033-2909.126.3.347; Baumgartner H, 2001, J MARKETING RES, V38, P143, DOI 10.1509/jmkr.38.2.143.18840; Bem DJ, 1996, PSYCHOL REV, V103, P320, DOI 10.1037/0033-295X.103.2.320; Berenbaum SA, 1999, HORM BEHAV, V35, P102, DOI 10.1006/hbeh.1998.1503; Camperio-Ciani A, 2004, P ROY SOC B-BIOL SCI, V271, P2217, DOI 10.1098/rspb.2004.2872; Cardoso FL, 2009, ARCH SEX BEHAV, V38, P726, DOI 10.1007/s10508-008-9312-6; Cohen-Bendahan CCC, 2005, NEUROSCI BIOBEHAV R, V29, P353, DOI 10.1016/j.neubiorev.2004.11.004; Dunne MP, 2000, ARCH SEX BEHAV, V29, P549, DOI 10.1023/A:1002002420159; DuPree MG, 2004, BEHAV GENET, V34, P243, DOI 10.1023/B:BEGE.0000017870.77610.52; ELLIS E, 1987, PSYCHOL BULL, V101, P233; Grimbos T, 2010, BEHAV NEUROSCI, V124, P278, DOI 10.1037/a0018764; HAMER DH, 1993, SCIENCE, V261, P321, DOI 10.1126/science.8332896; Hayes RD, 2008, J SEX MED, V5, P1681, DOI 10.1111/j.1743-6109.2008.00838.x; Heath AC, 1998, BEHAV GENET, V28, P415, DOI 10.1023/A:1021633127604; Hines M, 2004, J SEX RES, V41, P75, DOI 10.1080/00224490409552215; Hines M, 2002, CHILD DEV, V73, P1678, DOI 10.1111/1467-8624.00498; HU S, 1995, NAT GENET, V11, P248, DOI 10.1038/ng1195-248; Iervolino AC, 2005, CHILD DEV, V76, P826, DOI 10.1111/j.1467-8624.2005.00880.x; Johnson AM, 2001, LANCET, V358, P1835, DOI 10.1016/S0140-6736(01)06883-0; Kendler KS, 2000, AM J PSYCHIAT, V157, P1843, DOI 10.1176/appi.ajp.157.11.1843; Kirk KM, 2000, BEHAV GENET, V30, P345, DOI 10.1023/A:1026557719181; Knafo A, 2005, J PERS SOC PSYCHOL, V88, P400, DOI 10.1037/0022-3514.88.2.400; Langstrom N, 2010, ARCH SEX BEHAV, V39, P75, DOI 10.1007/s10508-008-9386-1; Lippa R, 1999, J PERS, V67, P127, DOI 10.1111/1467-6494.00050; Lippa RA, 2002, ARCH SEX BEHAV, V31, P83, DOI 10.1023/A:1014035302843; Lippa RA, 2001, CROSS-CULT RES, V35, P65, DOI 10.1177/106939710103500104; MACKE JP, 1993, AM J HUM GENET, V53, P844; MARTIN NG, 1978, HEREDITY, V40, P97, DOI 10.1038/hdy.1978.10; Meyer-Bahlburg HFL, 2008, ARCH SEX BEHAV, V37, P85, DOI 10.1007/s10508-007-9265-1; Meyer-Bahlburg HFL, 2006, J SEX RES, V43, P364, DOI 10.1080/00224490609552335; Mustanski BS, 2005, HUM GENET, V116, P272, DOI 10.1007/s00439-004-1241-4; Neale M. C., 2006, MX STAT MODELING, V7th; Neale MC, 1992, METHODOLOGY GENETIC; OOKI S, 1990, ACTA GENET MED GEMEL, V39, P109, DOI 10.1017/S0001566000005626; PATTATUCCI AML, 1995, BEHAV GENET, V25, P407, DOI 10.1007/BF02253370; Posthuma D, 2003, TWIN RES, V6, P361, DOI 10.1375/twin.6.5.361; Rahman Q, 2005, NEUROSCI BIOBEHAV R, V29, P1057, DOI 10.1016/j.neubiorev.2005.03.002; Rahman Q, 2008, ARCH SEX BEHAV, V37, P962, DOI 10.1007/s10508-007-9191-2; Rice G, 1999, SCIENCE, V284, P665, DOI 10.1126/science.284.5414.665; Rieger G, 2008, DEV PSYCHOL, V44, P46, DOI 10.1037/0012-1649.44.1.46; SANDERS AR, 1998, M AM PSYCH ASS TOR C; Sandfort TGM, 2006, AM J PUBLIC HEALTH, V96, P1119, DOI 10.2105/AJPH.2004.058891; SELL RL, 1995, ARCH SEX BEHAV, V24, P235, DOI 10.1007/BF01541598; Servin A, 2003, DEV PSYCHOL, V39, P440, DOI 10.1037/0012-1649.39.3.440; Spector TD, 2006, TWIN RES HUM GENET, V9, P899, DOI 10.1375/twin.9.6.899; van Beijsterveldt CEM, 2006, ARCH SEX BEHAV, V35, P647, DOI 10.1007/s10508-006-9072-0; WHITAM FL, 1991, ARCH SEX BEHAV, V20, P151, DOI 10.1007/BF01541941; WILLIAMS MK, 2004, BMC CARDIOVASC DISOR, V4, P20; Wilson G., 2005, BORN GAY PSYCHOBIOLO; Witting K, 2008, J SEX MED, V5, P2587, DOI 10.1111/j.1743-6109.2008.00984.x; Zucker KJ, 1996, HORM BEHAV, V30, P300, DOI 10.1006/hbeh.1996.0038	60	31	32	1	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2011	6	7							e21982	10.1371/journal.pone.0021982	http://dx.doi.org/10.1371/journal.pone.0021982			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	791HI	21760939	Green Published, gold, Green Submitted			2022-12-27	WOS:000292655400034
J	Behura, SK; Haugen, M; Flannery, E; Sarro, J; Tessier, CR; Severson, DW; Duman-Scheel, M				Behura, Susanta K.; Haugen, Morgan; Flannery, Ellen; Sarro, Joseph; Tessier, Charles R.; Severson, David W.; Duman-Scheel, Molly			Comparative Genomic Analysis of Drosophila melanogaster and Vector Mosquito Developmental Genes	PLOS ONE			English	Article							YELLOW-FEVER MOSQUITO; ANOPHELES-GAMBIAE; SEXUAL-DIFFERENTIATION; SALIVARY-GLAND; AEDES-AEGYPTI; MALARIA MOSQUITO; EXPRESSION ANALYSIS; AXON GUIDANCE; CNS MIDLINE; CELL-DEATH	Genome sequencing projects have presented the opportunity for analysis of developmental genes in three vector mosquito species: Aedes aegypti, Culex quinquefasciatus, and Anopheles gambiae. A comparative genomic analysis of developmental genes in Drosophila melanogaster and these three important vectors of human disease was performed in this investigation. While the study was comprehensive, special emphasis centered on genes that 1) are components of developmental signaling pathways, 2) regulate fundamental developmental processes, 3) are critical for the development of tissues of vector importance, 4) function in developmental processes known to have diverged within insects, and 5) encode microRNAs (miRNAs) that regulate developmental transcripts in Drosophila. While most fruit fly developmental genes are conserved in the three vector mosquito species, several genes known to be critical for Drosophila development were not identified in one or more mosquito genomes. In other cases, mosquito lineage-specific gene gains with respect to D. melanogaster were noted. Sequence analyses also revealed that numerous repetitive sequences are a common structural feature of Drosophila and mosquito developmental genes. Finally, analysis of predicted miRNA binding sites in fruit fly and mosquito developmental genes suggests that the repertoire of developmental genes targeted by miRNAs is species-specific. The results of this study provide insight into the evolution of developmental genes and processes in dipterans and other arthropods, serve as a resource for those pursuing analysis of mosquito development, and will promote the design and refinement of functional analysis experiments.	[Behura, Susanta K.; Flannery, Ellen; Sarro, Joseph; Severson, David W.; Duman-Scheel, Molly] Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA; [Behura, Susanta K.; Flannery, Ellen; Sarro, Joseph; Severson, David W.; Duman-Scheel, Molly] Univ Notre Dame, Eck Inst Global Hlth, Notre Dame, IN 46556 USA; [Haugen, Morgan; Tessier, Charles R.; Severson, David W.; Duman-Scheel, Molly] Indiana Univ Sch Med, Dept Med & Mol Genet, South Bend, IN USA	University of Notre Dame; University of Notre Dame; Indiana University System; Indiana University South Bend	Behura, SK (corresponding author), Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA.	mscheel@nd.edu	Flannery, Ellen/D-3941-2014	behura, Susanta/0000-0003-1057-2435; BEHURA, SUSANTA/0000-0002-0654-6288	NIH/NIAID [R01-AI081795-02, RO1-AI059342, RO1-AI079125]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI079125, R01AI059342, R01AI081795] Funding Source: NIH RePORTER	NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIH/NIAID Awards R01-AI081795-02 to MDS, and RO1-AI059342 and RO1-AI079125 to DWS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABBOTT MK, 1991, GENETICS, V129, P783; Abrams EW, 2003, TRENDS CELL BIOL, V13, P247, DOI 10.1016/S0962-8924(03)00055-2; Adelman ZN, 2007, P NATL ACAD SCI USA, V104, P9970, DOI 10.1073/pnas.0701515104; Aguilar R, 2005, INSECT BIOCHEM MOLEC, V35, P709, DOI 10.1016/j.ibmb.2005.02.019; Almeras L, 2010, VECTOR-BORNE ZOONOT, V10, P391, DOI 10.1089/vbz.2009.0042; ALONSO MC, 1988, EMBO J, V7, P2585, DOI 10.1002/j.1460-2075.1988.tb03108.x; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Andrew DJ, 2000, MECH DEVELOP, V92, P5, DOI 10.1016/S0925-4773(99)00321-4; Arensburger P, 2010, SCIENCE, V330, P86, DOI 10.1126/science.1191864; Artayanis-Tsakonas S, 2010, CURR TOP DEV BIOL, V92, P1, DOI 10.1016/S0070-2153(10)92001-2; BAKER BS, 1988, GENE DEV, V2, P477, DOI 10.1101/gad.2.4.477; Bashaw GJ, 2007, NEURON, V53, P157, DOI 10.1016/j.neuron.2007.01.002; Behura SK, 2007, INSECT BIOCHEM MOLEC, V37, P3, DOI 10.1016/j.ibmb.2006.10.006; Beye M, 2003, CELL, V114, P419, DOI 10.1016/S0092-8674(03)00606-8; BOGGS RT, 1987, CELL, V50, P739, DOI 10.1016/0092-8674(87)90332-1; Brody T, 1999, TRENDS GENET, V15, P333, DOI 10.1016/S0168-9525(99)01775-8; Bryant B, 2008, INSECT BIOCHEM MOLEC, V38, P331, DOI 10.1016/j.ibmb.2007.11.012; Bryant B, 2010, P NATL ACAD SCI USA, V107, P22391, DOI 10.1073/pnas.1016230107; BURTIS KC, 1989, CELL, V56, P997, DOI 10.1016/0092-8674(89)90633-8; Calvo E, 2006, J BIOL CHEM, V281, P1935, DOI 10.1074/jbc.M510359200; Calvo E, 2005, INSECT BIOCHEM MOLEC, V35, P789, DOI 10.1016/j.ibmb.2005.02.007; Campbell CL, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-425; Catteruccia F, 2007, PEST MANAG SCI, V63, P634, DOI 10.1002/ps.1324; Chen MS, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-296; CLEMONS A, 2010, COLD SPRING HARB PRO; CLEMONS A, 2010, COLD SPRING HARB PRO; CLEMONS A, 2010, COLD SPRING HARB PRO; CLEMONS A, 2010, COLD SPRING HARB PRO; CLEMONS A, 2010, COLD SPRING HARB PRO; Clemons A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016730; Cline TW, 1996, ANNU REV GENET, V30, P637, DOI 10.1146/annurev.genet.30.1.637; COHEN SM, 1990, NATURE, V346, P482, DOI 10.1038/346482a0; Cooper DM, 2007, INSECT MOL BIOL, V16, P563, DOI 10.1111/j.1365-2583.2007.00758.x; Cooper DM, 2007, INSECT BIOCHEM MOLEC, V37, P559, DOI 10.1016/j.ibmb.2007.03.005; CRAIG GB, 1967, B WORLD HEALTH ORGAN, V36, P559; CURTISS J, 1995, DEVELOPMENT, V121, P3819; DasGupta R, 2009, CURR DRUG TARGETS, V10, P620, DOI 10.2174/138945009788680455; DAVIS CATHERINE W. C., 1967, AUST J ZOOL, V15, P547, DOI 10.1071/ZO9670547; Davis GK, 2002, ANNU REV ENTOMOL, V47, P669, DOI 10.1146/annurev.ento.47.091201.145251; Davis GK, 2001, DEVELOPMENT, V128, P3445; Dearden PK, 2006, GENOME RES, V16, P1376, DOI 10.1101/gr.5108606; Emerald BS, 2003, DEVELOPMENT, V130, P1171, DOI 10.1242/dev.00323; Feiguin F, 2001, DEV CELL, V1, P93, DOI 10.1016/S1534-5807(01)00010-7; FUSE N, 1994, GENE DEV, V8, P2270, DOI 10.1101/gad.8.19.2270; Gempe T, 2011, BIOESSAYS, V33, P52, DOI 10.1002/bies.201000043; Goltsev Y, 2004, DEV BIOL, V275, P435, DOI 10.1016/j.ydbio.2004.08.021; Goltsev Y, 2007, DEVELOPMENT, V134, P2415, DOI 10.1242/dev.02863; Goltsev Y, 2009, DEV BIOL, V330, P462, DOI 10.1016/j.ydbio.2009.02.038; Goulding SE, 2000, NEURON, V25, P69, DOI 10.1016/S0896-6273(00)80872-7; Griffiths-Jones Sam, 2006, V342, P129, DOI 10.1385/1-59745-123-1:129; Grossman G.L., 1993, Insect Molecular Biology, V1, P223, DOI 10.1111/j.1365-2583.1993.tb00095.x; Harris R, 1996, NEURON, V17, P217, DOI 10.1016/S0896-6273(00)80154-3; HAUGEN M, 2010, COLD SPRING HARBOR P; Hing H, 1999, CELL, V97, P853, DOI 10.1016/S0092-8674(00)80798-9; HINZ U, 1994, CELL, V76, P77, DOI 10.1016/0092-8674(94)90174-0; HIRTH F, 1995, NEURON, V15, P769, DOI 10.1016/0896-6273(95)90169-8; Holt RA, 2002, SCIENCE, V298, P129, DOI 10.1126/science.1076181; Hornstein E, 2006, NAT GENET, V38, pS20, DOI 10.1038/ng1803; HORSFALL WR, 1973, EMBRYOLOGY AEDES VEX, P137; HOSHIJIMA K, 1991, SCIENCE, V252, P833, DOI 10.1126/science.1902987; Huang P, 2005, CYTOKINE GROWTH F R, V16, P151, DOI 10.1016/j.cytogfr.2005.03.002; Huntley MA, 2004, GENETICS, V166, P1141, DOI 10.1534/genetics.166.3.1141; Huntley MA, 2007, MOL BIOL EVOL, V24, P2598, DOI 10.1093/molbev/msm129; Iwai S, 2008, COMP BIOCHEM PHYS B, V149, P38, DOI 10.1016/j.cbpb.2007.08.004; Jhaveri D, 2000, DEV BIOL, V226, P73, DOI 10.1006/dbio.2000.9855; Jiang J, 2006, CELL CYCLE, V5, P2457, DOI 10.4161/cc.5.21.3406; Jin ZG, 2006, CURR BIOL, V16, pR966, DOI 10.1016/j.cub.2006.10.018; Jones CI, 2010, BIOCHEM SOC T, V38, P1137, DOI 10.1042/BST0381137; Jones NA, 1998, DEVELOPMENT, V125, P4163; Juhn J, 2008, INSECT MOL BIOL, V17, P545, DOI 10.1111/j.1365-2583.2008.00823.x; Juhn J, 2006, INSECT MOL BIOL, V15, P363, DOI 10.1111/j.1365-2583.2006.00655.x; Kaprielian Z, 2001, DEV DYNAM, V221, P154, DOI 10.1002/dvdy.1143; Karlin S, 1996, P NATL ACAD SCI USA, V93, P1560, DOI 10.1073/pnas.93.4.1560; Karlin S, 2002, P NATL ACAD SCI USA, V99, P333, DOI 10.1073/pnas.012608599; Kim SN, 2008, DEV BIOL, V319, P121, DOI 10.1016/j.ydbio.2008.04.017; Klein DE, 2004, NATURE, V430, P1040, DOI 10.1038/nature02840; Kofler R, 2007, BIOINFORMATICS, V23, P1683, DOI 10.1093/bioinformatics/btm157; Komiyama T, 2007, CURR BIOL, V17, P278, DOI 10.1016/j.cub.2006.11.067; Koutsos AC, 2007, P NATL ACAD SCI USA, V104, P11304, DOI 10.1073/pnas.0703988104; Kriventseva EV, 2008, NUCLEIC ACIDS RES, V36, pD271, DOI 10.1093/nar/gkm845; Kusserow A, 2005, NATURE, V433, P156, DOI 10.1038/nature03158; Lammel U, 2000, MECH DEVELOP, V92, P179, DOI 10.1016/S0925-4773(99)00337-8; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lawson D, 2009, NUCLEIC ACIDS RES, V37, pD583, DOI 10.1093/nar/gkn857; LEHMANN R, 1986, CELL, V47, P141, DOI 10.1016/0092-8674(86)90375-2; Li H, 1998, DEVELOPMENT, V125, P2641; Li S, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-581; Lilly B, 1999, MECH DEVELOP, V88, P195, DOI 10.1016/S0925-4773(99)00189-6; Liu QZ, 2011, APOPTOSIS, V16, P105, DOI 10.1007/s10495-010-0558-9; Lynch JA, 2006, NATURE, V439, P728, DOI 10.1038/nature04445; McGregor AP, 2005, BIOESSAYS, V27, P904, DOI 10.1002/bies.20285; MCHAFFEY DG, 1972, J MED ENTOMOL, V9, P564, DOI 10.1093/jmedent/9.6.564; McNeill H, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003376; Mead EA, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-244; Mitchell KJ, 1996, NEURON, V17, P203, DOI 10.1016/S0896-6273(00)80153-1; MOHLER J, 1995, DEVELOPMENT, V121, P237; Mueller AK, 2010, INT J PARASITOL, V40, P1229, DOI 10.1016/j.ijpara.2010.05.005; Nassif C, 1998, DEV BIOL, V197, P170, DOI 10.1006/dbio.1998.8875; Nei M., 2000, MOL EVOLUTION PHYLOG; Nene V, 2007, SCIENCE, V316, P1718, DOI 10.1126/science.1138878; Noguchi H, 2001, EUR J BIOCHEM, V268, P774, DOI 10.1046/j.1432-1327.2001.01933.x; NOLL M, 1993, CURR OPIN GENET DEV, V3, P595, DOI 10.1016/0959-437X(93)90095-7; NUSSLEINVOLHARD C, 1980, NATURE, V287, P795, DOI 10.1038/287795a0; O'Brien KP, 2005, NUCLEIC ACIDS RES, V33, pD476, DOI 10.1093/nar/gki107; Orme M, 2009, APOPTOSIS, V14, P950, DOI 10.1007/s10495-009-0358-2; Patel NH, 2000, GENOME BIOL, V1; Pires-daSilva A, 2003, NAT REV GENET, V4, P39, DOI 10.1038/nrg977; PIRROTTA V, 1988, GENE DEV, V2, P1839, DOI 10.1101/gad.2.12b.1839; Podos SD, 1999, TRENDS GENET, V15, P396, DOI 10.1016/S0168-9525(99)01854-5; Posnien N, 2010, ARTHROPOD STRUCT DEV, V39, P399, DOI 10.1016/j.asd.2010.08.002; RAMINANI L N, 1975, International Journal of Insect Morphology and Embryology, V4, P517, DOI 10.1016/0020-7322(75)90028-8; RAMINANI LN, 1978, INT J INSECT MORPHOL, V7, P273, DOI 10.1016/0020-7322(78)90009-0; Rao Y, 2000, Sheng Li Ke Xue Jin Zhan, V31, P198; Romoser WS, 2004, J MED ENTOMOL, V41, P467, DOI 10.1603/0022-2585-41.3.467; ROSSIGNOL PA, 1986, COMP BIOCHEM PHYS B, V83, P819, DOI 10.1016/0305-0491(86)90153-7; Salazar MI, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-9; Scali C, 2005, J EXP BIOL, V208, P3701, DOI 10.1242/jeb.01819; Schroder R, 2000, P NATL ACAD SCI USA, V97, P6591, DOI 10.1073/pnas.100005497; Schwank G, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001669; Schweitzer R, 1997, TRENDS GENET, V13, P191, DOI 10.1016/S0168-9525(97)01091-3; Senti KA, 2000, DEVELOPMENT, V127, P2291; Shigenobu S, 2010, INSECT MOL BIOL, V19, P47, DOI 10.1111/j.1365-2583.2009.00944.x; Simanton W, 2009, EVOL DEV, V11, P260, DOI 10.1111/j.1525-142X.2009.00328.x; Smedley D, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-22; Somel M, 2010, GENOME RES, V20, P1207, DOI 10.1101/gr.106849.110; Song ZW, 1997, SCIENCE, V275, P536, DOI 10.1126/science.275.5299.536; Sonnenfeld MJ, 2004, MECH DEVELOP, V121, P1531, DOI 10.1016/j.mod.2004.07.006; Spletter ML, 2007, NEURAL DEV, V2, DOI 10.1186/1749-8104-2-14; Stathopoulos A, 2004, GENE DEV, V18, P687, DOI 10.1101/gad.1166404; Steller H, 2008, CELL DEATH DIFFER, V15, P1132, DOI 10.1038/cdd.2008.50; Stocker RE, 2009, ANN NY ACAD SCI, V1170, P482, DOI 10.1111/j.1749-6632.2009.03896.x; TAJIMA F, 1993, JPN J GENET, V68, P567, DOI 10.1266/jjg.68.567; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Terman JR, 2004, SCIENCE, V303, P1204, DOI 10.1126/science.1092121; Thomson T, 2009, ANNU REV CELL DEV BI, V25, P355, DOI 10.1146/annurev.cellbio.24.110707.175327; Tweedie S, 2009, NUCLEIC ACIDS RES, V37, pD555, DOI 10.1093/nar/gkn788; Van der Zee M, 2008, DEV GENES EVOL, V218, P203, DOI 10.1007/s00427-007-0179-7; Volk T, 2010, ADV EXP MED BIOL, V693, P93; WASSARMAN DA, 1995, CURR OPIN GENET DEV, V5, P44, DOI 10.1016/S0959-437X(95)90052-7; WHARTON KA, 1985, CELL, V40, P55, DOI 10.1016/0092-8674(85)90308-3; Wienholds E, 2005, FEBS LETT, V579, P5911, DOI 10.1016/j.febslet.2005.07.070; Wienholds E, 2005, SCIENCE, V309, P310, DOI 10.1126/science.1114519; Xu WH, 1996, ACTA BIOCH BIOPH SIN, V28, P214; Zdobnov EM, 2002, SCIENCE, V298, P149, DOI 10.1126/science.1077061; Zhou L, 2005, EMBO REP, V6, P769, DOI 10.1038/sj.embor.7400473; Zuckerkandl E, 1965, EVOL GENES PROTEINS, P97, DOI DOI 10.1016/B978-1-4832-2734-4.50017-6	147	42	44	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2011	6	7							e21504	10.1371/journal.pone.0021504	http://dx.doi.org/10.1371/journal.pone.0021504			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791AK	21754989	gold, Green Submitted, Green Published			2022-12-27	WOS:000292632000013
J	Lehmann, L				Lehmann, Laurent			The Demographic Benefits of Belligerence and Bravery: Defeated Group Repopulation or Victorious Group Size Expansion?	PLOS ONE			English	Article							SUBDIVIDED POPULATIONS; KIN SELECTION; EVOLUTIONARY-THEORY; INCLUSIVE FITNESS; COMPETITION; DISPERSAL; ALTRUISM; DYNAMICS; WARFARE; WAR	Intraspecific coalitional aggression between groups of individuals is a widespread trait in the animal world. It occurs in invertebrates and vertebrates, and is prevalent in humans. What are the conditions under which coalitional aggression evolves in natural populations? In this article, I develop a mathematical model delineating conditions where natural selection can favor the coevolution of belligerence and bravery between small-scale societies. Belligerence increases an actor's group probability of trying to conquer another group and bravery increase the actors's group probability of defeating an attacked group. The model takes into account two different types of demographic scenarios that may lead to the coevolution of belligerence and bravery. Under the first, the fitness benefits driving the coevolution of belligerence and bravery come through the repopulation of defeated groups by fission of victorious ones. Under the second demographic scenario, the fitness benefits come through a temporary increase in the local carrying capacity of victorious groups, after transfer of resources from defeated groups to victorious ones. The analysis of the model suggests that the selective pressures on belligerence and bravery are stronger when defeated groups can be repopulated by victorious ones. The analysis also suggests that, depending on the shape of the contest success function, costly bravery can evolve in groups of any size.	Univ Lausanne, Dept Ecol & Evolut, Lausanne, Switzerland	University of Lausanne	Lehmann, L (corresponding author), Univ Lausanne, Dept Ecol & Evolut, Lausanne, Switzerland.	laurent.lehmann@unil.ch	lehmann, laurent/B-6875-2012		Swiss National Science Foundation (SNSF) [PP00P3-123344]	Swiss National Science Foundation (SNSF)(Swiss National Science Foundation (SNSF))	This work has been supported by grant PP00P3-123344 from the Swiss National Science Foundation (SNSF, http://www.snf.ch/E/Pages/default.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajar E, 2003, BMC EVOL BIOL, V3, DOI 10.1186/1471-2148-3-22; ALEXANDER RD, 1990, ETHOL SOCIOBIOL, V11, P241, DOI 10.1016/0162-3095(90)90012-U; [Anonymous], 2018, HIST DYNAMICS WHY ST, DOI DOI 10.23943/PRINCETON/9780691180779.001.0001; Bowles S, 2006, SCIENCE, V314, P1569, DOI 10.1126/science.1134829; Bowles S, 2009, SCIENCE, V324, P1293, DOI 10.1126/science.1168112; CHAGNON NA, 1988, SCIENCE, V239, P985, DOI 10.1126/science.239.4843.985; Choi JK, 2007, SCIENCE, V318, P636, DOI 10.1126/science.1144237; Crofoot MC, 2010, MIND THE GAP: TRACING THE ORIGINS OF HUMAN UNIVERSALS, P171, DOI 10.1007/978-3-642-02725-3_8; DURHAM WH, 1976, Q REV BIOL, V51, P385, DOI 10.1086/409471; Eshel I, 1996, J MATH BIOL, V34, P485; Gandon S, 1999, J THEOR BIOL, V200, P345, DOI 10.1006/jtbi.1999.0994; Garfinkel M.R., 2007, HDB DEFENSE EC, V2, P649; Gat A, 2000, ANTHROPOL QUART, V73, P20; Gat A, 1999, J ANTHROPOL RES, V55, P563, DOI 10.1086/jar.55.4.3631615; Gat A, 2009, EUR J INT RELAT, V15, P571, DOI 10.1177/1354066109344661; Gat Azar, 2006, WAR HUMAN CIVILIZATI; Geritz SAH, 1998, EVOL ECOL, V12, P35, DOI 10.1023/A:1006554906681; Gillespie J. H., 2004, POPULATION GENETICS; Goodall J., 1986, CHIMPANZEES GOMBE PA; Grinstead C. M., 1997, INTRO PROBABILITY; Guillaume F, 2006, GENETICS, V173, P497, DOI 10.1534/genetics.105.046847; Hamilton W. D., 1975, BIOSOCIAL ANTHR, P133; HAUSKEN K, 1995, J MATH ECON, V24, P655, DOI 10.1016/0304-4068(94)00709-J; Hausken K, 2004, ECON INQ, V42, P572, DOI 10.1093/ei/cbh082; HIRSHLEIFER J, 1991, AM ECON REV, V81, P130; HIRSHLEIFER J, 1989, PUBLIC CHOICE, V63, P101, DOI 10.1007/BF00153394; Hirshleifer J, 2001, DARK SIDE FORCE EC F; Holldobler B., 1990, pi; Horiuchi S, 2002, J THEOR BIOL, V218, P195, DOI 10.1006/jtbi.2002.3068; Johnstone RA, 2008, AM NAT, V172, P318, DOI 10.1086/589899; KARLIN S, 1968, J APPL PROBAB, V5, P487, DOI 10.2307/3211920; Keeley L. H., 1997, WAR CIVILIZATION MYT; Keller L, 1999, LEVELS SELECTION EVO; Kelly RC, 2005, P NATL ACAD SCI USA, V102, P15294, DOI 10.1073/pnas.0505955102; Lehmann L, 2008, P ROY SOC B-BIOL SCI, V275, P2877, DOI 10.1098/rspb.2008.0842; Lehmann L, 2009, EVOLUTION, V63, P2896, DOI 10.1111/j.1558-5646.2009.00778.x; Lehmann L, 2009, P R SOC B, V276, P4083, DOI 10.1098/rspb.2009.1465; Lehmann L, 2006, EVOLUTION, V60, P1137; Leturque H, 2002, THEOR POPUL BIOL, V62, P169, DOI 10.1006/tpbi.2002.1600; LEVIN BR, 1974, EVOLUTION, V28, P527, DOI 10.1111/j.1558-5646.1974.tb00787.x; Lion S, 2009, J EVOLUTION BIOL, V22, P1487, DOI 10.1111/j.1420-9101.2009.01769.x; Maynard Smith J., 1982, pi; Michod RE, 1999, DARWINIAN DYNAMICS; Pen I, 2000, EVOLUTION, V54, P293, DOI 10.1111/j.0014-3820.2000.tb00030.x; Rousset F, 2000, J EVOLUTION BIOL, V13, P814, DOI 10.1046/j.1420-9101.2000.00219.x; Rousset F, 2004, THEOR POPUL BIOL, V65, P127, DOI 10.1016/j.tpb.2003.09.003; Rousset F, 2002, HEREDITY, V88, P371, DOI 10.1038/sj.hdy.6800065; Rousset F., 2004, GENETIC STRUCTURE SE; Roze D, 2003, GENETICS, V165, P2153; Skaperdas S, 1996, ECON THEORY, V7, P283, DOI 10.1007/s001990050053; Smirnov O, 2007, J POLIT, V69, P927, DOI 10.1111/j.1468-2508.2007.00599.x; Szathmary E, 1995, MAJOR TRANSITIONS EV; Taylor PD, 1996, J THEOR BIOL, V180, P27, DOI 10.1006/jtbi.1996.0075; TAYLOR PD, 1992, EVOL ECOL, V6, P352, DOI 10.1007/BF02270971; TAYLOR PD, 1990, AM NAT, V135, P95, DOI 10.1086/285034; Tooby J., 1988, 881 I EV STUD; Vincent T. L., 2005, EVOLUTIONARY GAME TH; WADE MJ, 1985, AM NAT, V125, P61, DOI 10.1086/284328; West SA, 2007, CURR BIOL, V17, pR661, DOI 10.1016/j.cub.2007.06.004; Whitlock MC, 2002, GENETICS, V160, P1191; Wright S, 1931, GENETICS, V16, P0097	62	12	12	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2011	6	7							e21437	10.1371/journal.pone.0021437	http://dx.doi.org/10.1371/journal.pone.0021437			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	789JO	21750712	Green Submitted, Green Published, gold			2022-12-27	WOS:000292512000014
J	Cao, SH; Kumimoto, RW; Siriwardana, CL; Risinger, JR; Holt, BF				Cao, Shuanghe; Kumimoto, Roderick W.; Siriwardana, Chamindika L.; Risinger, Jan R.; Holt, Ben F., III			Identification and Characterization of NF-Y Transcription Factor Families in the Monocot Model Plant Brachypodium distachyon	PLOS ONE			English	Article							CCAAT-BINDING-FACTOR; AGROBACTERIUM-MEDIATED TRANSFORMATION; ARABIDOPSIS LEAFY COTYLEDON1; FACTOR CBF; B-SUBUNIT; FUNCTIONAL DOMAINS; FLOWERING-TIME; DNA-BINDING; COMPLEX; CONSTANS	Background: Nuclear Factor Y (NF-Y) is a heterotrimeric transcription factor composed of NF-YA, NF-YB and NF-YC proteins. Using the dicot plant model system Arabidopsis thaliana (Arabidopsis), NF-Y were previously shown to control a variety of agronomically important traits, including drought tolerance, flowering time, and seed development. The aim of the current research was to identify and characterize NF-Y families in the emerging monocot model plant Brachypodium distachyon (Brachypodium) with the long term goal of assisting in the translation of known dicot NF-Y functions to the grasses. Methodology/Principal Findings: We identified, annotated, and further characterized 7 NF-YA, 17 NF-YB, and 12 NF-YC proteins in Brachypodium (BdNF-Y). By examining phylogenetic relationships, orthology predictions, and tissue-specific expression patterns for all 36 BdNF-Y, we proposed numerous examples of likely functional conservation between dicots and monocots. To test one of these orthology predictions, we demonstrated that a BdNF-YB with predicted orthology to Arabidopsis floral-promoting NF-Y proteins can rescue a late flowering Arabidopsis mutant. Conclusions/Significance: The Brachypodium genome encodes a similar complement of NF-Y to other sequenced angiosperms. Information regarding NF-Y phylogenetic relationships, predicted orthologies, and expression patterns can facilitate their study in the grasses. The current data serves as an entry point for translating many NF-Y functions from dicots to the genetically tractable monocot model system Brachypodium. In turn, studies of NF-Y function in Brachypodium promise to be more readily translatable to the agriculturally important grasses.	[Cao, Shuanghe; Kumimoto, Roderick W.; Siriwardana, Chamindika L.; Risinger, Jan R.; Holt, Ben F., III] Univ Oklahoma, Dept Bot & Microbiol, Norman, OK 73019 USA	University of Oklahoma System; University of Oklahoma - Norman	Cao, SH (corresponding author), Univ Oklahoma, Dept Bot & Microbiol, Norman, OK 73019 USA.	benholt@ou.edu	Holt, Ben F/D-1513-2011	CAO, SHUANGHE/0000-0002-2905-0728; Siriwardana, Chamindika/0000-0002-7746-9427	Oklahoma Center for the Advancement of Science and Technology (OCAST) [PSB10-013]; National Science Foundation (NSF) [IOS-0920258]	Oklahoma Center for the Advancement of Science and Technology (OCAST); National Science Foundation (NSF)(National Science Foundation (NSF)National Research Foundation of Korea)	Funding support for this project came from the Oklahoma Center for the Advancement of Science and Technology (OCAST, PSB10-013) and the National Science Foundation (NSF, IOS-0920258). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; An HL, 2004, DEVELOPMENT, V131, P3615, DOI 10.1242/dev.01231; Aoki K, 2007, PLANT CELL PHYSIOL, V48, P381, DOI 10.1093/pcp/pcm013; BALLIF J, 2011, PLANT PHYSL IN PRESS; Ballif J, 2011, PLANT PHYSIOL BIOCH, V49, P579, DOI 10.1016/j.plaphy.2011.01.013; Barker D, 2005, PLOS COMPUT BIOL, V1, P24, DOI 10.1371/journal.pcbi.0010003; BECHTOLD N, 1993, CR ACAD SCI III-VIE, V316, P1194; Ben-Naim O, 2006, PLANT J, V46, P462, DOI 10.1111/j.1365-313X.2006.02706.x; Bevan MW, 2010, CURR OPIN BIOTECH, V21, P211, DOI 10.1016/j.copbio.2010.03.006; Bhattacharya A, 2003, CANCER RES, V63, P8167; Braybrook SA, 2008, TRENDS PLANT SCI, V13, P624, DOI 10.1016/j.tplants.2008.09.008; BUCHER P, 1990, J MOL BIOL, V212, P563, DOI 10.1016/0022-2836(90)90223-9; Cai XN, 2007, PLANT PHYSIOL, V145, P98, DOI 10.1104/pp.107.102079; Chen NZ, 2007, J BIOCHEM MOL BIOL, V40, P1083; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Combier JP, 2008, GENE DEV, V22, P1549, DOI 10.1101/gad.461808; Combier JP, 2006, GENE DEV, V20, P3084, DOI 10.1101/gad.402806; Coustry F, 1996, J BIOL CHEM, V271, P14485, DOI 10.1074/jbc.271.24.14485; di Silvio A, 1999, NUCLEIC ACIDS RES, V27, P2578; Draper J, 2001, PLANT PHYSIOL, V127, P1539, DOI 10.1104/pp.010196; Zanetti ME, 2010, PLANT CELL, V22, P4142, DOI 10.1105/tpc.110.079137; Finkelstein R, 2008, ANNU REV PLANT BIOL, V59, P387, DOI 10.1146/annurev.arplant.59.032607.092740; FitzGerald PC, 2004, GENOME RES, V14, P1562, DOI 10.1101/gr.1953904; Frontini M, 2004, CELL CYCLE, V3, P217; Gabaldon T, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-10-235; Gatta R, 2008, NUCLEIC ACIDS RES, V36, P6592, DOI 10.1093/nar/gkn699; Gray J, 2009, PLANT PHYSIOL, V149, P4, DOI 10.1104/pp.108.128504; Gusmaroli G, 2001, GENE, V264, P173, DOI 10.1016/S0378-1119(01)00323-7; Hall B. G., 2008, PHYLOGENETIC TREES M; Hong SY, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-112; Jones-Rhoades MW, 2004, MOL CELL, V14, P787, DOI 10.1016/j.molcel.2004.05.027; Kagiya G, 2010, J BIOSCI BIOENG, V110, P118, DOI 10.1016/j.jbiosc.2009.12.013; Kellogg EA, 2001, PLANT PHYSIOL, V125, P1198, DOI 10.1104/pp.125.3.1198; Kim IS, 1996, MOL CELL BIOL, V16, P4003; Klimaszewska K, 2010, PLANT CELL REP, V29, P723, DOI 10.1007/s00299-010-0859-z; KOZIEL M G, 1984, Journal of Molecular and Applied Genetics, V2, P549; Kumar Sachin, 2009, BMC Res Notes, V2, P93, DOI 10.1186/1756-0500-2-93; Kumimoto RW, 2008, PLANTA, V228, P709, DOI 10.1007/s00425-008-0773-6; Kumimoto RW, 2010, PLANT J, V63, P379, DOI 10.1111/j.1365-313X.2010.04247.x; Kusnetsov V, 1999, J BIOL CHEM, V274, P36009, DOI 10.1074/jbc.274.50.36009; Kwong RW, 2003, PLANT CELL, V15, P5, DOI 10.1105/tpc.006973; Larionov A, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-62; Lee HS, 2003, P NATL ACAD SCI USA, V100, P2152, DOI 10.1073/pnas.0437909100; Li WX, 2008, PLANT CELL, V20, P2238, DOI 10.1105/tpc.108.059444; Liu JX, 2010, PLANT CELL, V22, P782, DOI 10.1105/tpc.109.072173; Lotan T, 1998, CELL, V93, P1195, DOI 10.1016/S0092-8674(00)81463-4; MAITY SN, 1992, J BIOL CHEM, V267, P8286; Maity SN, 1998, TRENDS BIOCHEM SCI, V23, P174, DOI 10.1016/S0968-0004(98)01201-8; Mantovani R, 1999, GENE, V239, P15, DOI 10.1016/S0378-1119(99)00368-6; Mantovani R, 1998, NUCLEIC ACIDS RES, V26, P1135, DOI 10.1093/nar/26.5.1135; Matuoka K, 2002, AGEING RES REV, V1, P639, DOI 10.1016/S1568-1637(02)00026-0; Matuoka K, 1999, EXP CELL RES, V253, P365, DOI 10.1006/excr.1999.4605; McNabb DS, 1997, MOL CELL BIOL, V17, P7008, DOI 10.1128/MCB.17.12.7008; Nelson DE, 2007, P NATL ACAD SCI USA, V104, P16450, DOI 10.1073/pnas.0707193104; Ogawal R, 2007, BIOTECHNIQUES, V42, P628, DOI 10.2144/000112436; OLESEN JT, 1990, GENE DEV, V4, P1714, DOI 10.1101/gad.4.10.1714; Onouchi H, 2000, PLANT CELL, V12, P885, DOI 10.1105/tpc.12.6.885; Opanowicz M, 2008, TRENDS PLANT SCI, V13, P172, DOI 10.1016/j.tplants.2008.01.007; Ostlund G, 2010, NUCLEIC ACIDS RES, V38, pD196, DOI 10.1093/nar/gkp931; PUTTERILL J, 1995, CELL, V80, P847, DOI 10.1016/0092-8674(95)90288-0; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Remm M, 2001, J MOL BIOL, V314, P1041, DOI 10.1006/jmbi.2000.5197; Riechmann JL, 2000, SCIENCE, V290, P2105, DOI 10.1126/science.290.5499.2105; Romier C, 2003, J BIOL CHEM, V278, P1336, DOI 10.1074/jbc.M209635200; Rouard M, 2011, NUCLEIC ACIDS RES, V39, pD1095, DOI 10.1093/nar/gkq811; Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045; Siefers N, 2009, PLANT PHYSIOL, V149, P625, DOI 10.1104/pp.108.130591; Sinha S, 1996, MOL CELL BIOL, V16, P328; Steidl S, 2004, J MOL BIOL, V342, P515, DOI 10.1016/j.jmb.2004.07.011; STEPHENSON TJ, 2011, FUNCT INTEG IN PRESS; Stephenson TJ, 2007, PLANT MOL BIOL, V65, P77, DOI 10.1007/s11103-007-9200-9; Stephenson TJ, 2010, FUNCT INTEGR GENOMIC, V10, P265, DOI 10.1007/s10142-010-0158-3; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Testa A, 2005, J BIOL CHEM, V280, P13606, DOI 10.1074/jbc.M414039200; Thirumurugan T, 2008, MOL GENET GENOMICS, V279, P279, DOI 10.1007/s00438-007-0312-3; Thole V, 2010, PLANT BIOTECHNOL J, V8, P734, DOI 10.1111/j.1467-7652.2010.00518.x; Thompson JD, 2002, CURR PROTOC BIOINFOR, V2, P23, DOI 10.1002/0471250953.bi0203s00; Vogel JP, 2010, NATURE, V463, P763, DOI 10.1038/nature08747; Vogel JP, 2006, PLANT CELL TISS ORG, V84, P199, DOI 10.1007/s11240-005-9023-9; Warpeha KM, 2007, PLANT PHYSIOL, V143, P1590, DOI 10.1104/pp.106.089904; Wenkel S, 2006, PLANT CELL, V18, P2971, DOI 10.1105/tpc.106.043299; WEST MAL, 1994, PLANT CELL, V6, P1731, DOI 10.1105/tpc.6.12.1731; XING YY, 1993, EMBO J, V12, P4647, DOI 10.1002/j.1460-2075.1993.tb06153.x; XING YY, 1994, P NATL ACAD SCI USA, V91, P3009, DOI 10.1073/pnas.91.8.3009; Yamamoto A, 2009, PLANT J, V58, P843, DOI 10.1111/j.1365-313X.2009.03817.x; Yang J, 2005, NEW PHYTOL, V165, P623, DOI 10.1111/j.1469-8137.2004.01260.x; Yoshioka Y, 2007, GENESIS, V45, P21, DOI 10.1002/dvg.20260; Yun JJ, 2006, NUCLEIC ACIDS RES, V34, P6718, DOI 10.1093/nar/gkl1020; Zhang JY, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-449; Zhao M, 2011, NEW PHYTOL, V190, P906, DOI 10.1111/j.1469-8137.2011.03647.x	91	67	77	6	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2011	6	6							e21805	10.1371/journal.pone.0021805	http://dx.doi.org/10.1371/journal.pone.0021805			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786GP	21738795	Green Published, Green Submitted, gold			2022-12-27	WOS:000292291800046
J	Muller-Sienerth, N; Dietz, L; Holtz, P; Kapp, M; Grigoleit, GU; Schmuck, C; Wajant, H; Siegmund, D				Mueller-Sienerth, Nicole; Dietz, Lena; Holtz, Philipp; Kapp, Markus; Grigoleit, Gotz Ulrich; Schmuck, Carsten; Wajant, Harald; Siegmund, Daniela			SMAC Mimetic BV6 Induces Cell Death in Monocytes and Maturation of Monocyte-Derived Dendritic Cells	PLOS ONE			English	Article							KAPPA-B ACTIVATION; ALPHA-DEPENDENT APOPTOSIS; CASPASE-8 ACTIVATION; CANCER; TRAF2; CIAP1; NECROSIS; COMPLEX; C-IAP1; RIP1	Background: Compounds mimicking the inhibitory effect of SMAC / DIABLO on X-linked inhibitor of apoptosis (XIAP) have been developed with the aim to achieve sensitization for apoptosis of tumor cells resistant due to deregulated XIAP expression. It turned out that SMAC mimetics also have complex effects on the NF kappa B system and TNF signaling. In view of the overwhelming importance of the NF kappa B transcription factors in the immune system, we analyzed here the effects of the SMAC mimetic BV6 on immune cells. Principal Findings: BV6 induced apoptotic and necrotic cell death in monocytes while T-cells, dendritic cells and macrophages were largely protected against BV6-induced cell death. In immature dendritic cells BV6 treatment resulted in moderate activation of the classical NF kappa B pathway, but it also diminished the stronger NF kappa B-inducing effect of TNF and CD40L. Despite its inhibitory effect on TNF- and CD40L signaling, BV6 was able to trigger maturation of immature DCs as indicated by upregulation of CD83, CD86 and IL12. Significance: The demonstrated effects of SMAC mimetics on immune cells may complicate the development of tumor therapeutic concepts based on these compounds but also arise the possibility to exploit them for the development of immune stimulatory therapies.	[Mueller-Sienerth, Nicole; Dietz, Lena; Kapp, Markus; Grigoleit, Gotz Ulrich; Wajant, Harald; Siegmund, Daniela] Univ Hosp Wurzburg, Dept Internal Med 2, Wurzburg, Germany; [Holtz, Philipp; Schmuck, Carsten] Univ Duisburg Essen, Dept Organ Chem 2, Essen, Germany	University of Wurzburg; University of Duisburg Essen	Muller-Sienerth, N (corresponding author), Univ Hosp Wurzburg, Dept Internal Med 2, Wurzburg, Germany.	harald.wajant@mail.uni-wuerzburg.de	Wajant, Harald/A-3020-2017; Grigoleit, Goetz U/K-4555-2016	Wajant, Harald/0000-0002-2005-3949; Muller-Sienerth, Nicole/0000-0002-7527-5127	Deutsche Forschungsgemeinschaft [DFG Wa 1025/18-1, Wa 1025/21-1]; Wilhelm Sander-Stiftung [2009.052.1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Wilhelm Sander-Stiftung	This work was supported by Deutsche Forschungsgemeinschaft (DFG Wa 1025/18-1 and Wa 1025/21-1) and Wilhelm Sander-Stiftung (project 2009.052.1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bertrand MJM, 2008, MOL CELL, V30, P689, DOI 10.1016/j.molcel.2008.05.014; BURKLY L, 1995, NATURE, V373, P531, DOI 10.1038/373531a0; Chen DJ, 2009, ANTI-CANCER DRUG, V20, P646, DOI 10.1097/CAD.0b013e32832ced78; Degterev A, 2008, NAT CHEM BIOL, V4, P313, DOI 10.1038/nchembio.83; Didelot C, 2008, CELL DEATH DIFFER, V15, P859, DOI 10.1038/sj.cdd.4402320; Dougan M, 2010, J EXP MED, V207, P2195, DOI 10.1084/jem.20101123; Dupoux A, 2009, BLOOD, V113, P175, DOI 10.1182/blood-2008-02-137919; Gaither A, 2007, CANCER RES, V67, P11493, DOI 10.1158/0008-5472.CAN-07-5173; Haas TL, 2009, MOL CELL, V36, P831, DOI 10.1016/j.molcel.2009.10.013; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Jost PJ, 2009, NATURE, V460, P1035, DOI 10.1038/nature08229; Karin M, 2009, IMMUNOL REV, V228, P225, DOI 10.1111/j.1600-065X.2008.00755.x; LaCasse EC, 2008, ONCOGENE, V27, P6252, DOI 10.1038/onc.2008.302; Li L, 2004, SCIENCE, V305, P1471, DOI 10.1126/science.1098231; Lu JF, 2008, CANCER RES, V68, P9384, DOI 10.1158/0008-5472.CAN-08-2655; Mahoney DJ, 2008, P NATL ACAD SCI USA, V105, P11778, DOI 10.1073/pnas.0711122105; Petersen SL, 2007, CANCER CELL, V12, P445, DOI 10.1016/j.ccr.2007.08.029; Rajalingam K, 2006, PLOS PATHOG, V2, P1013, DOI 10.1371/journal.ppat.0020114; Speirs K, 2004, J IMMUNOL, V172, P752, DOI 10.4049/jimmunol.172.2.752; Vallabhapurapu S, 2008, NAT IMMUNOL, V9, P1364, DOI 10.1038/ni.1678; Vandenabeele P, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3115re4; Varfolomeev E, 2008, J BIOL CHEM, V283, P24295, DOI 10.1074/jbc.C800128200; Varfolomeev E, 2007, CELL, V131, P669, DOI 10.1016/j.cell.2007.10.030; Vince JE, 2007, CELL, V131, P682, DOI 10.1016/j.cell.2007.10.037; Wang CY, 1998, SCIENCE, V281, P1680, DOI 10.1126/science.281.5383.1680; Wang L, 2008, CELL, V133, P693, DOI 10.1016/j.cell.2008.03.036; Wertz IE, 2010, CELL DEATH DIFFER, V17, P14, DOI 10.1038/cdd.2009.168; Wyzgol A, 2009, J IMMUNOL, V183, P1851, DOI 10.4049/jimmunol.0802597; Zarnegar B, 2008, P NATL ACAD SCI USA, V105, P3503, DOI 10.1073/pnas.0707959105; Zarnegar BJ, 2008, NAT IMMUNOL, V9, P1371, DOI 10.1038/ni.1676	30	44	45	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2011	6	6							e21556	10.1371/journal.pone.0021556	http://dx.doi.org/10.1371/journal.pone.0021556			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786GP	21738708	gold, Green Published, Green Submitted			2022-12-27	WOS:000292291800021
J	Huso, DL; Edie, S; Levine, MA; Schwindinger, W; Wang, YL; Juppner, H; Germain-Lee, EL				Huso, David L.; Edie, Sarah; Levine, Michael A.; Schwindinger, William; Wang, Yingli; Jueppner, Harald; Germain-Lee, Emily L.			Heterotopic Ossifications in a Mouse Model of Albright Hereditary Osteodystrophy	PLOS ONE			English	Article							STIMULATORY G-PROTEIN; GS-ALPHA GENE; PROGRESSIVE OSSEOUS HETEROPLASIA; TOTAL HIP-ARTHROPLASTY; ECTOPIC BONE-FORMATION; PSEUDOHYPOPARATHYROIDISM TYPE-1A; INACTIVATING MUTATIONS; TARGETED DISRUPTION; HORMONE RESISTANCE; SUBUNIT G(S)ALPHA	Albright hereditary osteodystrophy (AHO) is characterized by short stature, brachydactyly, and often heterotopic ossifications that are typically subcutaneous. Subcutaneous ossifications (SCO) cause considerable morbidity in AHO with no effective treatment. AHO is caused by heterozygous inactivating mutations in those GNAS exons encoding the alpha-subunit of the stimulatory G protein (G alpha(s)). When inherited maternally, these mutations are associated with obesity, cognitive impairment, and resistance to certain hormones that mediate their actions through G protein-coupled receptors, a condition termed pseudohypoparathyroidism type 1a (PHP1a). When inherited paternally, GNAS mutations cause only AHO but not hormonal resistance, termed pseudopseudohypoparathyroidism (PPHP). Mice with targeted disruption of exon 1 of Gnas (Gnas(E1-/+)) replicate human PHP1a or PPHP phenotypically and hormonally. However, SCO have not yet been reported in Gnas(E1+/-) mice, at least not those that had been analyzed by us up to 3 months of age. Here we now show that Gnas(E1-/+) animals develop SCO over time. The ossified lesions increase in number and size and are uniformly detected in adult mice by one year of age. They are located in both the dermis, often in perifollicular areas, and the subcutis. These lesions are particularly prominent in skin prone to injury or pressure. The SCO comprise mature bone with evidence of mineral deposition and bone marrow elements. Superficial localization was confirmed by radiographic and computerized tomographic imaging. In situ hybridization of SCO lesions were positive for both osteonectin and osteopontin. Notably, the ossifications were much more extensive in males than females. Because Gnas(E1-/+) mice develop SCO features that are similar to those observed in AHO patients, these animals provide a model system suitable for investigating pathogenic mechanisms involved in SCO formation and for developing novel therapeutics for heterotopic bone formation. Moreover, these mice provide a model with which to investigate the regulatory mechanisms of bone formation.	[Huso, David L.] Johns Hopkins Univ, Sch Med, Dept Mol & Comparat Pathobiol, Baltimore, MD 21218 USA; [Edie, Sarah] Johns Hopkins Univ, Sch Med, Inst Med Genet, Baltimore, MD USA; [Levine, Michael A.] Childrens Hosp Philadelphia, Div Endocrinol & Diabet, Philadelphia, PA 19104 USA; [Levine, Michael A.] Univ Penn, Sch Med, Dept Pediat, Philadelphia, PA 19104 USA; [Schwindinger, William] Weis Ctr Res, Geisinger Clin, Danville, PA 17822 USA; [Wang, Yingli] Mt Sinai Sch Med, Dept Genet & Genom Sci, New York, NY USA; [Jueppner, Harald] Massachusetts Gen Hosp, Endocrine Unit, Boston, MA 02114 USA; [Jueppner, Harald] Massachusetts Gen Hosp, Pediat Nephrol Unit, Boston, MA 02114 USA; [Jueppner, Harald] Harvard Univ, Sch Med, Boston, MA USA; [Germain-Lee, Emily L.] Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA; [Germain-Lee, Emily L.] Kennedy Krieger Inst, Albright Clin, Baltimore, MD USA; [Germain-Lee, Emily L.] Hugo W Moser Res Inst Kennedy Krieger, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins University; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Icahn School of Medicine at Mount Sinai; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Johns Hopkins University; Kennedy Krieger Institute	Huso, DL (corresponding author), Johns Hopkins Univ, Sch Med, Dept Mol & Comparat Pathobiol, Baltimore, MD 21218 USA.	germainlee@kennedykrieger.org		Edie, Sarah/0000-0003-2823-7571; Germain-Lee, Emily/0000-0002-5727-610X; Levine, Michael/0000-0003-0036-7809	Bosworth Family; Friedman Family	Bosworth Family; Friedman Family	This work was supported by generous donations to the research of E.L.G.-L. by the Bosworth Family, the Friedman Family, and the families/friends of patients with Albright hereditary osteodystrophy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adegbite NS, 2008, AM J MED GENET A, V146A, P1788, DOI 10.1002/ajmg.a.32346; Bastepe M, 2004, P NATL ACAD SCI USA, V101, P14794, DOI 10.1073/pnas.0405091101; Bastepe M, 2010, ENDOCRINOLOGY, P1223; Botchkarev VA, 2003, J INVEST DERMATOL, V120, P36, DOI 10.1046/j.1523-1747.2003.12002.x; Chen M, 2005, P NATL ACAD SCI USA, V102, P7386, DOI 10.1073/pnas.0408268102; Cortes W, 2006, J CRANIOFAC SURG, V17, P21, DOI 10.1097/01.scs.0000188906.42225.39; Davies AJ, 1993, J MED GENET, V30, P101; DEBEUR SMJ, 2001, PARATHYROIDS BASIC C, P807; DELEE J, 1976, CLIN ORTHOP RELAT R, P53; Eddy MC, 2000, J BONE MINER RES, V15, P2074, DOI 10.1359/jbmr.2000.15.11.2074; Fuchs E, 2007, NATURE, V445, P834, DOI 10.1038/nature05659; Germain-Lee EL, 2005, ENDOCRINOLOGY, V146, P4697, DOI 10.1210/en.2005-0681; Germain-Lee EL, 2003, J CLIN ENDOCR METAB, V88, P4059, DOI 10.1210/jc.2003-030028; Germain-Lee EL, 2002, BIOCHEM BIOPH RES CO, V296, P67, DOI 10.1016/S0006-291X(02)00833-1; Germain-Lee Emily L, 2006, Pediatr Endocrinol Rev, V3 Suppl 2, P318; Hayward BE, 2001, J CLIN INVEST, V107, pR31, DOI 10.1172/JCI11887; HSU S, 2006, PEDIAT RES, V59; Hu H P, 1991, Acta Orthop Belg, V57, P169; HUSO D, 2007, END SOC 89 ANN M TOR; Jahoda CAB, 2003, EXP DERMATOL, V12, P849, DOI 10.1111/j.0906-6705.2003.00161.x; LAZANSKY MG, 1973, CLIN ORTHOP RELAT R, P96; Lebrun M, 2010, J CLIN ENDOCR METAB, V95, P3028, DOI 10.1210/jc.2009-1451; LEVINE MA, 1983, J CLIN INVEST, V72, P316, DOI 10.1172/JCI110971; Levine MA, 2000, ENDOCRINOLOGY, P1133; Lietman SA, 2005, CLIN ORTHOP RELAT R, P231, DOI 10.1097/01.blo.0000153279.90512.38; Liu J, 2003, J CLIN ENDOCR METAB, V88, P4336, DOI 10.1210/jc.2003-030393; Mantovani G, 2004, J CLIN ENDOCR METAB, V89, P6316, DOI 10.1210/jc.2004-0558; Mantovani G, 2003, J CLIN ENDOCR METAB, V88, P4070, DOI 10.1210/jc.2002-022028; Mantovani G, 2002, J CLIN ENDOCR METAB, V87, P4736, DOI 10.1210/jc.2002-020183; Medici D, 2010, NAT MED, V16, P1400, DOI 10.1038/nm.2252; MORREY BF, 1984, CLIN ORTHOP RELAT R, P160; Perez-Moreno M, 2006, DEV CELL, V11, P601, DOI 10.1016/j.devcel.2006.10.010; Plagge A, 2008, J ENDOCRINOL, V196, P193, DOI 10.1677/JOE-07-0544; RITTER MA, 1977, J BONE JOINT SURG AM, V59, P345, DOI 10.2106/00004623-197759030-00009; Safer JD, 2007, ENDOCRINOLOGY, V148, P1167, DOI 10.1210/en.2006-1442; Sakamoto A, 2005, J BIOL CHEM, V280, P21369, DOI 10.1074/jbc.M500346200; Sakamoto A, 2005, J BONE MINER RES, V20, P663, DOI 10.1359/JBMR.041210; Sakamoto A, 2009, ENDOCR RES, V34, P1, DOI 10.1080/07435800902841280; Schwindinger WF, 1997, ENDOCRINOLOGY, V138, P4058, DOI 10.1210/en.138.10.4058; Shore EM, 2002, NEW ENGL J MED, V346, P99, DOI 10.1056/NEJMoa011262; SOBALLE K, 1988, CLIN ORTHOP RELAT R, P57; Thomson M, 2003, EXP DERMATOL, V12, P389, DOI 10.1034/j.1600-0625.2003.00068.x; Wang Y, 2002, J DERMATOL SCI, V30, P136, DOI 10.1016/S0923-1811(02)00074-9; Wang YL, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-22; Weinstein LS, 2001, ENDOCR REV, V22, P675, DOI 10.1210/er.22.5.675; Wilkinson DG, 1992, SITU HYBRIDIZATION P; Yeh GL, 2000, J BONE MINER RES, V15, P2063, DOI 10.1359/jbmr.2000.15.11.2063; Yu SH, 1998, P NATL ACAD SCI USA, V95, P8715, DOI 10.1073/pnas.95.15.8715	48	28	29	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2011	6	6							e21755	10.1371/journal.pone.0021755	http://dx.doi.org/10.1371/journal.pone.0021755			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786FZ	21747923	Green Submitted, Green Published, gold			2022-12-27	WOS:000292290100067
J	Bai, M; McCullough, E; Song, KQ; Liu, WG; Yang, XK				Bai, Ming; McCullough, Erin; Song, Ke-Qing; Liu, Wan-Gang; Yang, Xing-Ke			Evolutionary Constraints in Hind Wing Shape in Chinese Dung Beetles (Coleoptera: Scarabaeinae)	PLOS ONE			English	Article							PHYLOGENETIC ANALYSIS; STATISTICAL SIGNIFICANCE; FLIGHT; ARTICULATION; MORPHOLOGY; DISTANCE; BEHAVIOR; BASE	This study examines the evolution hindwing shape in Chinese dung beetle species using morphometric and phylogenetic analyses. Previous studies have analyzed the evolution of wing shape within a single or very few species, or by comparing only a few wing traits. No study has analyzed wing shape evolution of a large number of species, or quantitatively compared morphological variation of wings with proposed phylogenetic relationships. This study examines the morphological variation of hindwings based on 19 landmarks, 119 morphological characters, and 81 beetle species. Only one most parsimonious tree (MPT) was found based on 119 wing and body characters. To better understand the possible role of the hindwing in the evolution of Scarabaeinae, additional phylogenetic analyses were proposed based on the only body features (106 characters, wing characters excluded). Two MPT were found based on 106 body characters, and five nodes were collapsed in a strict consensus. There was a strong correlation between the morphometric tree and all phylogenetic trees (r > 0.5). Reconstructions of the ancestral wing forms suggest that Scarabaeinae hindwing morphology has not changed substantially over time, but the morphological changes that do occur are focused at the base of the wing. These results suggest that flight has been important since the origin of Scarabaeinae, and that variation in hindwing morphology has been limited by functional constraints. Comparison of metric disparity values and relative evolutionary sequences among Scarabaeinae tribes suggest that the primitive dung beetles had relatively diverse hindwing morphologies, while advanced dung beetles have relatively similar wing morphologies. The strong correlation between the morphometric tree and phylogenetic trees suggest that hindwing features reflect the evolution of whole body morphology and that wing characters are suitable for the phylogenetic analyses. By integrating morphometric and cladistic approaches, this paper sheds new light on the evolution of dung beetle hind wings.	[Bai, Ming; Song, Ke-Qing; Liu, Wan-Gang; Yang, Xing-Ke] Chinese Acad Sci, Inst Zool, Key Lab Zool Systemat & Evolut, Beijing, Peoples R China; [McCullough, Erin] Univ Montana, Div Biol Sci, Missoula, MT 59812 USA	Chinese Academy of Sciences; Institute of Zoology, CAS; University of Montana System; University of Montana	Bai, M (corresponding author), Chinese Acad Sci, Inst Zool, Key Lab Zool Systemat & Evolut, Beijing, Peoples R China.	yangxk@ioz.ac.cn			Chinese Academy of Sciences [KSCX3-IOZ-1004, KSCX2-EW-G-4, KSCX2-EW-Z-8]; National Natural Science Foundation of China [30900144, 31010103913]; National Basic Research Program of China (973 Program) [2011CB302102]	Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 Program)(National Basic Research Program of China)	This research was supported by the Knowledge Innovation Program of Chinese Academy of Sciences (Nos. KSCX3-IOZ-1004, KSCX2-EW-G-4 and KSCX2-EW-Z-8), the National Natural Science Foundation of China (Nos. 30900144 and 31010103913), the National Basic Research Program of China (973 Program) (No. 2011CB302102). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012850; Balthasar V., 1963, MONOGRAPHIE SCARABAE, V2; Beldade P, 2002, NATURE, V416, P844, DOI 10.1038/416844a; Bookstein F.L., 1991, MORPHOMETRIC TOOLS L; Bos FM, 2008, J FLUID MECH, V594, P341, DOI 10.1017/S0022112007009172; BREUKER CJ, 2007, J EXP ZOOLOG B, V308; BROWNE DJ, 1995, SYST ENTOMOL, V20, P145, DOI 10.1111/j.1365-3113.1995.tb00089.x; BROWNE DJ, 1994, SYST ENTOMOL, V19, P133, DOI 10.1111/j.1365-3113.1994.tb00583.x; BROWNE DJ, 1996, BONN ZOOL MONOGR, P1; Browne J, 1998, SYST ENTOMOL, V23, P307, DOI 10.1046/j.1365-3113.1998.00059.x; Bullen RD, 2007, AUST J ZOOL, V55, P237, DOI 10.1071/ZO07010; Chapman R.E., 1990, P MICHIGAN MORPHOMET, P251; [程暮林 CHENG Mulin], 2006, [应用数学和力学, Applied Mathematics and Mechanics], V27, P533; Crowson R. A., 1961, Entomologist's Monthly Magazine, V96, P158; CROWSON RA, 1973, J NAT HIST, V7, P225, DOI 10.1080/00222937300770181; CROWSON RA, 1955, NATURAL CLASSIFICATI; DOLIN V G, 1975, Zoologicheskii Zhurnal, V54, P1618; DUJARDIN JP, 2006, COV SOFTWARE VERSION; Emlen DJ, 2006, COLEOPTS BULL, V60, P47, DOI 10.1649/0010-065X(2006)60[47:PEFAAB]2.0.CO;2; Evans MR, 2004, AM NAT, V163, P341, DOI 10.1086/381770; Forbes W. T. M., 1922, Annals of the Entomological Society of America, V15, P328; Forgie SA, 2006, MOL PHYLOGENET EVOL, V40, P662, DOI 10.1016/j.ympev.2006.04.018; GOLOBOFF P, 1995, NONA VERSION 2 0; Goodall C., 1987, Computer Science and Statistics: Proceedings of the 19th Symposium on the Interface, P86; GOODALL C, 1991, J ROY STAT SOC B MET, V53, P285, DOI 10.1111/j.2517-6161.1991.tb01825.x; Halffter G., 1982, Publicaciones Instituto de Ecologia Mexico, P1; HALFFTER GONZALO, 1966, FOLIA ENTOMOL MEX, V12/14, P1; Hanski I., 1991, pi; HEDENSTROM A, 1992, P ROY SOC B-BIOL SCI, V247, P183, DOI 10.1098/rspb.1992.0026; Hunt T, 2007, SCIENCE, V318, P1913, DOI 10.1126/science.1146954; IABLOKOFF-KHNZORIAN S M, 1977, Entomologische Abhandlungen (Dresden), V41, P135; Johansson F, 2009, BIOL J LINN SOC, V97, P362, DOI 10.1111/j.1095-8312.2009.01211.x; Kaboli M, 2007, IBIS, V149, P792, DOI 10.1111/j.1474-919X.2007.00714.x; KRELL FT, 2006, COLEOPTERISTS SOC MO, V5, P120; KUKALOVAPECK J, 1993, CAN ENTOMOL, V125, P181, DOI 10.4039/Ent125181-2; LAPOINTE FJ, 1992, SYST BIOL, V41, P378, DOI 10.2307/2992574; LOMMEN ST, 2009, EVOL DEV, V11; LUZZATTO M, 1994, THESIS U STUDI PAVIA; Maddison W.P., MESQUITE MODULAR SYS; MANTEL N, 1967, CANCER RES, V27, P209; MARCHETTI K, 1995, J AVIAN BIOL, V26, P177, DOI 10.2307/3677316; MARCUS LF, 1993, CONTRIHUTIONS TOMORP; Miller LA, 2001, AM ZOOL, V41, P1648; Monaghan MT, 2007, MOL PHYLOGENET EVOL, V45, P674, DOI 10.1016/j.ympev.2007.06.009; Montreuil O, 1998, ANN SOC ENTOMOL FR, V34, P135; Nixon K. C., 1999, WINCLADA VERSION 1 0; Oliver JC, 2009, P ROY SOC B-BIOL SCI, V276, P2369, DOI 10.1098/rspb.2009.0182; Philips TK, 2004, INVERTEBR SYST, V18, P53, DOI 10.1071/IS03030; Pretorius E, 2001, BIOL J LINN SOC, V74, P35, DOI 10.1111/j.1095-8312.2001.tb01375.x; Rohlf, 2007, NTSYS PC NUMERICAL T; Rohlf F.J., 1993, CONTRIBUTIONS MORPHO, P131; Rohlf F.J., 2003, TPS SMALL VERSION 1; Rohlf F. J., 2018, TPSUTIL VERSION 1 76; Rohlf F. J., 2006, TPS DIG DIGITIZE LAN; Rohlf FJ, 2006, TPS RELW RELATIVE WA; ROHLF FJ, 1990, ORDINATIONS STUDY MO; Rohlf FJ, 2004, TPS SPLIN THIN PLATE; *SCARABNET, 2009, SCARABNET GLOB TAX D; SCHOLTZ CH, 1990, J NAT HIST, V24, P1027, DOI 10.1080/00222939000770631; SOKAL RR, 1979, SYST ZOOL, V28, P227, DOI 10.2307/2412528; Stiles FG, 2005, AUK, V122, P872, DOI 10.1642/0004-8038(2005)122[0872:WMAFBO]2.0.CO;2; Toomey J, 2008, PHYS FLUIDS, V20, DOI 10.1063/1.2956372; Villalba S, 2002, J MOL EVOL, V55, P116, DOI 10.1007/s00239-002-2314-4; Voelker G, 2001, BIOL J LINN SOC, V73, P425, DOI 10.1111/j.1095-8312.2001.tb01371.x; Yang Xing-ke, 1994, P102; Zelditch M. L., 2004, GEOMETRIC MORPHOMETR; Zunino M., 1984, Bulletin de la Societe Entomologique de France, V88, P531; ZUNINO M, 1985, Folia Entomologica Mexicana, P101; ZUNINO M, 1984, B MUSEO REGIONALE SC, V2, P445	69	37	50	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2011	6	6							e21600	10.1371/journal.pone.0021600	http://dx.doi.org/10.1371/journal.pone.0021600			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	783OD	21738727	Green Submitted, gold, Green Published			2022-12-27	WOS:000292092600060
J	Willis, EL; Kersey, DC; Durrant, BS; Kouba, AJ				Willis, Erin L.; Kersey, David C.; Durrant, Barbara S.; Kouba, Andrew J.			The Acute Phase Protein Ceruloplasmin as a Non-Invasive Marker of Pseudopregnancy, Pregnancy, and Pregnancy Loss in the Giant Panda	PLOS ONE			English	Article							AILUROPODA-MELANOLEUCA; OXIDASE ACTIVITY; STEROID METABOLITES; ENZYME-IMMUNOASSAY; PRE-ECLAMPSIA; HUMAN SERUM; COPPER; IMMUNOPOTENTIATION; HETEROGENEITY; HYPERTENSION	After ovulation, non-pregnant female giant pandas experience pseudopregnancy. During pseudopregnancy, non-pregnant females exhibit physiological and behavioral changes similar to pregnancy. Monitoring hormonal patterns that are usually different in pregnant mammals are not effective at determining pregnancy status in many animals that undergo pseudopregnancy, including the giant panda. Therefore, a physiological test to distinguish between pregnancy and pseudopregnancy in pandas has eluded scientists for decades. We examined other potential markers of pregnancy and found that activity of the acute phase protein ceruloplasmin increases in urine of giant pandas in response to pregnancy. Results indicate that in term pregnancies, levels of active urinary ceruloplasmin were elevated the first week of pregnancy and remain elevated until 20-24 days prior to parturition, while no increase was observed during the luteal phase in known pseudopregnancies. Active ceruloplasmin also increased during ultrasound-confirmed lost pregnancies; however, the pattern was different compared to term pregnancies, particularly during the late luteal phase. In four out of the five additional reproductive cycles included in the current study where females were bred but no birth occurred, active ceruloplasmin in urine increased during the luteal phase. Similar to the known lost pregnancies, the temporal pattern of change in urinary ceruloplasmin during the luteal phase deviated from the term pregnancies suggesting that these cycles may have also been lost pregnancies. Among giant pandas in captivity, it has been presumed that there is a high rate of pregnancy loss and our results are the first to provide evidence supporting this notion.	[Willis, Erin L.; Kouba, Andrew J.] Memphis Zool Soc, Dept Conservat & Res, Memphis, TN USA; [Kersey, David C.] Natl Zool Pk, Smithsonian Conservat Biol Inst, Dept Reprod Sci, Ctr Species Survival, Front Royal, VA USA; [Durrant, Barbara S.] San Diego Zoo Global, Inst Conservat Res, Reprod Physiol Div, Escondido, CA USA	Smithsonian Institution; Smithsonian National Zoological Park & Conservation Biology Institute	Willis, EL (corresponding author), Memphis Zool Soc, Dept Conservat & Res, Memphis, TN USA.	ewillis@memphiszoo.org	Durrant, Barbara/AAF-7451-2021		Memphis Zoo Department of Conservation and Research	Memphis Zoo Department of Conservation and Research	Support for this work was provided by the Memphis Zoo Department of Conservation and Research's TM Giant Panda Physiology and Nutrition Research Program. The director of the Memphis Zoo's Department of Conservation and Research partipated in the decision to fund the project, and in the preparation of and decision to publish the manuscript.	Anagnostopoulos AK, 2010, J PROTEOMICS, V73, P943, DOI 10.1016/j.jprot.2009.12.009; Boivin S, 2001, BIOCHEM BIOPH RES CO, V288, P1006, DOI 10.1006/bbrc.2001.5881; BURROWS S, 1971, AM J OBSTET GYNECOL, V109, P907, DOI 10.1016/0002-9378(71)90805-2; CHAUDHURI M, 1988, J REPROD FERTIL, V84, P23; CURZON G, 1960, BIOCHEM J, V74, P279, DOI 10.1042/bj0740279; Czekala N, 2003, ZOO BIOL, V22, P389, DOI 10.1002/zoo.10108; Dehnhard M, 2006, THERIOGENOLOGY, V66, P1755, DOI 10.1016/j.theriogenology.2006.01.012; DENKO CW, 1979, AGENTS ACTIONS, V9, P333, DOI 10.1007/BF01970657; Durrant BS, 2006, THERIOGENOLOGY, V66, P1729, DOI 10.1016/j.theriogenology.2006.02.046; Edmondson RD, 1996, J AM SOC MASS SPECTR, V7, P995, DOI 10.1016/1044-0305(96)00027-X; Ellis S, 2006, GIANT PANDAS: BIOLOGY, VETERINARY MEDICINE AND MANAGEMENT, P1, DOI 10.1017/CBO9780511542244.002; FATTAH MMA, 1976, ACTA OBSTET GYN SCAN, V55, P383, DOI 10.3109/00016347609158520; Goldstein I M, 1979, Trans Assoc Am Physicians, V92, P360; Goritz F, 1997, J REPROD FERTIL, P303; Graham L, 2001, ZOO BIOL, V20, P227, DOI 10.1002/zoo.1022; GRIFFIN JFT, 1983, AUST NZ J OBSTET GYN, V23, P11, DOI 10.1111/j.1479-828X.1983.tb00150.x; HARTLEY HO, 1950, BIOMETRIKA, V37, P308, DOI 10.2307/2332383; Hildebrandt TB, 2006, BIOL GIANT PANDA, P410; HODGES JK, 1984, J ZOOL, V203, P253; HOLMBERG CG, 1948, ACTA CHEM SCAND, V2, P550, DOI 10.3891/acta.chem.scand.02-0550; IUCN/ SSC, 2010, 2010 BREED STRAT REC; Jenkins C, 2000, ANTIOXID REDOX SIGN, V2, P623, DOI 10.1089/15230860050192369; Kersey DC, 2010, REPROD FERT DEVELOP, V22, P901, DOI 10.1071/RD09178; Kersey DC, 2010, REPRODUCTION, V140, P183, DOI 10.1530/REP-10-0003; KINGSTON IB, 1977, P NATL ACAD SCI USA, V74, P5377, DOI 10.1073/pnas.74.12.5377; Komlos L, 2007, INT J IMMUNOGENET, V34, P241, DOI 10.1111/j.1744-313X.2007.00682.x; KOMLOS L, 1977, CLIN IMMUNOL IMMUNOP, V7, P330, DOI 10.1016/0090-1229(77)90066-6; LOWENSTEIN H, 1975, INT J PEPT PROT RES, V7, P1; MARKOWITZ H, 1955, J CLIN INVEST, V34, P1498, DOI 10.1172/JCI103201; McGeehan L, 2002, ZOO BIOL, V21, P449, DOI 10.1002/zoo.10047; MEDDA R, 1987, PREP BIOCHEM, V17, P447, DOI 10.1080/00327488708062507; MONFORT SL, 1989, J REPROD FERTIL, V85, P203; MUNRO CJ, 1991, CLIN CHEM, V37, P838; Neter J, 1985, APPL LINEAR REGRESSI; OSAKI S, 1966, J BIOL CHEM, V241, P2746; Robertson SA, 1997, AM J REPROD IMMUNOL, V37, P438; RYAN TP, 1992, ARCH BIOCHEM BIOPHYS, V293, P1, DOI 10.1016/0003-9861(92)90357-3; Savion S, 2002, REPRODUCTION, V123, P399, DOI 10.1530/reprod/123.3.399; Serdar Z, 2006, CELL BIOCHEM FUNCT, V24, P209, DOI 10.1002/cbf.1235; Steinetz BG, 2005, ANN NY ACAD SCI, V1041, P367, DOI 10.1196/annals.1282.057; Steinman KJ, 2006, GIANT PANDAS: BIOLOGY, VETERINARY MEDICINE AND MANAGEMENT, P198, DOI 10.1017/CBO9780511542244.009; SUNDERMAN FW, 1970, CLIN CHEM, V16, P903; Sutherland-Smith M, 2004, ZOO BIOL, V23, P449, DOI 10.1002/zoo.20022; TANGRI S, 1993, BIOL REPROD, V49, P850, DOI 10.1095/biolreprod49.4.850; TAUSSKY HH, 1954, J BIOL CHEM, V208, P853; Toder V, 1989, J Reprod Fertil Suppl, V37, P79; TSUBOTA T, 1990, INT C BEAR, V8, P125; Ulutas PA, 2009, RES VET SCI, V86, P373, DOI 10.1016/j.rvsc.2008.09.001; Vannucchi CI, 2002, ANIM REPROD SCI, V74, P87, DOI 10.1016/S0378-4320(02)00160-4; WISDOM SJ, 1991, AM J OBSTET GYNECOL, V165, P1701, DOI 10.1016/0002-9378(91)90018-M; Zhang HM, 2009, REPRODUCTION, V138, P979, DOI 10.1530/REP-09-0241; ZIGRIL M, 1991, FERTIL STERIL, V56, P653	52	28	28	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2011	6	7							e21159	10.1371/journal.pone.0021159	http://dx.doi.org/10.1371/journal.pone.0021159			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	792WQ	21765892	gold, Green Submitted, Green Published			2022-12-27	WOS:000292781500003
J	Stone, N; Pangilinan, F; Molloy, AM; Shane, B; Scott, JM; Ueland, PM; Mills, JL; Kirke, PN; Sethupathy, P; Brody, LC				Stone, Nicole; Pangilinan, Faith; Molloy, Anne M.; Shane, Barry; Scott, John M.; Ueland, Per Magne; Mills, James L.; Kirke, Peader N.; Sethupathy, Praveen; Brody, Lawrence C.			Bioinformatic and Genetic Association Analysis of MicroRNA Target Sites in One-Carbon Metabolism Genes	PLOS ONE			English	Article							MICROBIOLOGICAL ASSAY; METHIONINE SYNTHASE; FOLATE-DEFICIENCY; CELLULAR UPTAKE; MITOCHONDRIAL; REDUCTASE; RECEPTOR; MUTATION; BIOSYNTHESIS; PURIFICATION	One-carbon metabolism (OCM) is linked to DNA synthesis and methylation, amino acid metabolism and cell proliferation. OCM dysfunction has been associated with increased risk for various diseases, including cancer and neural tube defects. MicroRNAs (miRNAs) are similar to 22 nt RNA regulators that have been implicated in a wide array of basic cellular processes, such as differentiation and metabolism. Accordingly, mis-regulation of miRNA expression and/or activity can underlie complex disease etiology. We examined the possibility of OCM regulation by miRNAs. Using computational miRNA target prediction methods and Monte-Carlo based statistical analyses, we identified two candidate miRNA "master regulators" (miR-22 and miR-125) and one candidate pair of "master co-regulators" (miR-344-5p/484 and miR-488) that may influence the expression of a significant number of genes involved in OCM. Interestingly, miR-22 and miR-125 are significantly up-regulated in cells grown under low-folate conditions. In a complementary analysis, we identified 15 single nucleotide polymorphisms (SNPs) that are located within predicted miRNA target sites in OCM genes. We genotyped these 15 SNPs in a population of healthy individuals (age 18-28, n = 2,506) that was previously phenotyped for various serum metabolites related to OCM. Prior to correction for multiple testing, we detected significant associations between TCblR rs9426 and methylmalonic acid (p = 0.045), total homocysteine levels (tHcy) (p = 0.033), serum B12 (p < 0.0001), holo transcobalamin (p < 0.0001) and total transcobalamin (p < 0.0001); and between MTHFR rs1537514 and red blood cell folate (p < 0.0001). However, upon further genetic analysis, we determined that in each case, a linked missense SNP is the more likely causative variant. Nonetheless, our Monte-Carlo based in silico simulations suggest that miRNAs could play an important role in the regulation of OCM.	[Stone, Nicole; Pangilinan, Faith; Sethupathy, Praveen; Brody, Lawrence C.] NHGRI, Genome Technol Branch, NIH, Bethesda, MD 20892 USA; [Molloy, Anne M.; Scott, John M.] Trinity Coll Dublin, Sch Immunol & Biochem, Dublin, Ireland; [Shane, Barry] Univ Calif Berkeley, Dept Nutr Sci & Toxicol, Berkeley, CA 94720 USA; [Ueland, Per Magne] Univ Bergen, Pharmacol Sect, Inst Med, Bergen, Norway; [Ueland, Per Magne] Univ Bergen, Haukeland Univ Hosp, Bergen, Norway; [Mills, James L.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Div Epidemiol Stat & Prevent Res, NIH, Bethesda, MD USA; [Kirke, Peader N.] Hlth Res Board Ireland, Child Hlth Epidemiol Unit, Dublin, Ireland	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Trinity College Dublin; University of California System; University of California Berkeley; University of Bergen; University of Bergen; Haukeland University Hospital; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Health Research Board - Ireland	Stone, N (corresponding author), Univ Calif San Francisco, Biomed Sci Grad Program, San Francisco, CA 94143 USA.	sethupathyp@mail.nih.gov; lbrody@mail.nih.gov	Ueland, Per M/C-7340-2013	Mills, James/0000-0003-4496-332X; Molloy, Anne/0000-0002-1688-9049; Ueland, Per Magne/0000-0002-1903-0571	National Institutes of Health, Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Human Genome Research Institute; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD002502] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG000167] Funding Source: NIH RePORTER	National Institutes of Health, Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This study was supported by the Intramural Research Programs of the National Institutes of Health, Eunice Kennedy Shriver National Institute of Child Health and Human Development, and the National Human Genome Research Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Blount BC, 1997, P NATL ACAD SCI USA, V94, P3290, DOI 10.1073/pnas.94.7.3290; Bolusani S, 2011, J BIOL CHEM, V286, P5166, DOI 10.1074/jbc.M110.196840; Brody LC, 1999, MOL GENET METAB, V67, P324, DOI 10.1006/mgme.1999.2881; Bulock KG, 2002, J BIOL CHEM, V277, P22168, DOI 10.1074/jbc.M111964200; Chekulaeva M, 2009, CURR OPIN CELL BIOL, V21, P452, DOI 10.1016/j.ceb.2009.04.009; Couzin J, 2008, SCIENCE, V319, P1782, DOI 10.1126/science.319.5871.1782; Crott JW, 2008, J NUTR BIOCHEM, V19, P328, DOI 10.1016/j.jnutbio.2007.05.003; Czech MP, 2006, NEW ENGL J MED, V354, P1194, DOI 10.1056/NEJMcibr060065; Ebert MS, 2010, RNA, V16, P2043, DOI 10.1261/rna.2414110; Esau C, 2006, CELL METAB, V3, P87, DOI 10.1016/j.cmet.2006.01.005; Field MS, 2006, J BIOL CHEM, V281, P4215, DOI 10.1074/jbc.M510624200; Foote M, 1999, SCIENCE, V283, P1310, DOI 10.1126/science.283.5406.1310; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; FROSST P, 1995, NAT GENET, V10, P111, DOI 10.1038/ng0595-111; Galivan J, 2000, PHARMACOL THERAPEUT, V85, P207, DOI 10.1016/S0163-7258(99)00063-7; Garrow TA, 1996, J BIOL CHEM, V271, P22831, DOI 10.1074/jbc.271.37.22831; GARROW TA, 1993, ADV EXP MED BIOL, V338, P659; GARROW TA, 1993, J BIOL CHEM, V268, P11910; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Griffiths-Jones Sam, 2010, Curr Protoc Bioinformatics, VChapter 12, DOI 10.1002/0471250953.bi1209s29; Gu Shuo, 2010, Silence, V1, P11, DOI 10.1186/1758-907X-1-11; Halsted CH, 2000, J BIOL CHEM, V275, P30746; KELLEHER BP, 1991, J CLIN PATHOL, V44, P592, DOI 10.1136/jcp.44.7.592; Kohls D, 1999, ACTA CRYSTALLOGR D, V55, P1206, DOI 10.1107/S0907444999003601; Kozyraki R, 1998, BLOOD, V91, P3593; KREMER JM, 1986, ARTHRITIS RHEUM, V29, P832, DOI 10.1002/art.1780290703; Krupenko NI, 2010, J BIOL CHEM, V285, P23054, DOI 10.1074/jbc.M110.128843; Kulis M, 2010, ADV GENET, V70, P27, DOI [10.1016/S0065-2660(10)70002-X, 10.1016/B978-0-12-380866-0.60002-2]; Lee JE, 2011, AM J CLIN NUTR; Li GR, 2009, MECH AGEING DEV, V130, P731, DOI 10.1016/j.mad.2009.09.002; Luka Z, 2002, HUM GENET, V110, P68, DOI 10.1007/s00439-001-0648-4; MacFarlane AJ, 2009, J BIOL CHEM, V284, P1533, DOI 10.1074/jbc.M808281200; Marsit CJ, 2006, CANCER RES, V66, P10843, DOI 10.1158/0008-5472.CAN-06-1894; McCarty EA, 2004, J BIOL CHEM, V279, P33829, DOI 10.1074/jbc.M403677200; MILLS JL, 1995, LANCET, V345, P149, DOI 10.1016/S0140-6736(95)90165-5; Moestrup SK, 1996, P NATL ACAD SCI USA, V93, P8612, DOI 10.1073/pnas.93.16.8612; Molloy AM, 1997, METHOD ENZYMOL, V281, P43; Molloy AM, 2009, BIRTH DEFECTS RES A, V85, P285, DOI 10.1002/bdra.20566; Mudd SH, 2011, AM J MED GENET C, V157C, P3, DOI 10.1002/ajmg.c.30293; NANAO K, 1994, GENOMICS, V19, P27, DOI 10.1006/geno.1994.1007; Neely LA, 2006, NAT METHODS, V3, P41, DOI 10.1038/NMETH825; PANGILINAN F, 2010, J MED GENET; Pike ST, 2010, J BIOL CHEM, V285, P4612, DOI 10.1074/jbc.M109.079855; PORTER DH, 1985, ARCH BIOCHEM BIOPHYS, V243, P396, DOI 10.1016/0003-9861(85)90516-8; Quadros EV, 2010, HUM MUTAT, V31, P924, DOI 10.1002/humu.21297; Quadros EV, 2009, BLOOD, V113, P186, DOI 10.1182/blood-2008-05-158949; Ramani K, 2010, HEPATOLOGY, V51, P986, DOI 10.1002/hep.23411; Rosa A, 2009, CELL CYCLE, V8, P3513, DOI 10.4161/cc.8.21.9847; SCHWEITZER BI, 1990, FASEB J, V4, P2441, DOI 10.1096/fasebj.4.8.2185970; Sethupathy P, 2006, NAT METHODS, V3, P881, DOI 10.1038/NMETH954; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; SHEVELL MI, 1993, AM J MED GENET, V45, P619, DOI 10.1002/ajmg.1320450521; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Takeuchi N, 1998, J BIOL CHEM, V273, P15085, DOI 10.1074/jbc.273.24.15085; Welin M, 2010, NUCLEIC ACIDS RES, V38, P7308, DOI 10.1093/nar/gkq595; Woeller CF, 2007, J BIOL CHEM, V282, P17623, DOI 10.1074/jbc.M702526200; XIONG J, 2010, ONCOGENE; Yamada K, 2005, P NATL ACAD SCI USA, V102, P10454, DOI 10.1073/pnas.0504786102; Yamada K, 2006, P NATL ACAD SCI USA, V103, P9476, DOI 10.1073/pnas.0603694103; ZHAO R, 2010, ANN REV NUTR; Zittoun J, 1993, Rev Prat, V43, P1358	63	35	39	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2011	6	7							e21851	10.1371/journal.pone.0021851	http://dx.doi.org/10.1371/journal.pone.0021851			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791WM	21765920	Green Accepted, gold, Green Published			2022-12-27	WOS:000292699000013
J	Tikhmyanova, N; Golemis, EA				Tikhmyanova, Nadezhda; Golemis, Erica A.			NEDD9 and BCAR1 Negatively Regulate E-Cadherin Membrane Localization, and Promote E-Cadherin Degradation	PLOS ONE			English	Article							FOCAL ADHESION KINASE; CELL-CELL-ADHESION; TYROSINE PHOSPHORYLATION; ANTIGEN RECEPTOR; DOCKING PROTEIN; BREAST-CANCER; C-SRC; V-SRC; P130CAS; CAS	The Cas scaffolding proteins (NEDD9/HEF1/CAS-L, BCAR1/p130Cas, EFSSIN, and HEPL/CASS4) regulate cell migration, division and survival, and are often deregulated in cancer. High BCAR1 expression is linked to poor prognosis in breast cancer patients, while upregulation of NEDD9 contributes to the metastatic behavior of melanoma and glioblastoma cells. Our recent work knocking out the single Drosophila Cas protein, Dcas, identified a genetic interaction with E-cadherin. As E-cadherin is often downregulated during epithelial-mesenchymal transition (EMT) prior to metastasis, if such an activity was conserved in mammals it might partially explain how Cas proteins promote aggressive tumor behavior. We here establish that Cas proteins negatively regulate E-cadherin expression in human mammary cells. Cas proteins do not affect E-cadherin transcription, but rather, BCAR1 and NEDD9 signal through SRC to promote E-cadherin removal from the cell membrane and lysosomal degradation. We also find mammary tumors arising in MMTV-polyoma virus T-antigen mice have enhanced junctional E-cadherin in a Nedd9(-/-) background. Cumulatively, these results suggest a new role for Cas proteins in cell-cell adhesion signaling in cancer.	[Tikhmyanova, Nadezhda; Golemis, Erica A.] Fox Chase Canc Ctr, Philadelphia, PA 19111 USA; [Tikhmyanova, Nadezhda] Drexel Univ, Sch Med, Dept Biochem, Philadelphia, PA 19104 USA	Fox Chase Cancer Center; Drexel University	Tikhmyanova, N (corresponding author), Fox Chase Canc Ctr, 7701 Burholme Ave, Philadelphia, PA 19111 USA.	ea_golemis@fccc.edu		Golemis, Erica/0000-0003-3618-3673	NIH [CA63366, CA113342, CA06927]; Pennsylvania Tobacco Settlement Funds; Commonwealth of Pennsylvania; NATIONAL CANCER INSTITUTE [P30CA006927, R29CA063366, R01CA113342, R01CA063366] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pennsylvania Tobacco Settlement Funds; Commonwealth of Pennsylvania; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by NIH R01s CA63366 and CA113342, and by Pennsylvania Tobacco Settlement Funds (to EAG); and by an appropriation from the Commonwealth of Pennsylvania, and NIH core grant CA06927 (to Fox Chase Cancer Center). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ando Y, 2007, MOL BIOL CELL, V18, P3752, DOI 10.1091/mbc.E07-03-0281; Astier A, 1997, LEUKEMIA LYMPHOMA, V28, P65, DOI 10.3109/10428199709058332; Birukova AA, 2007, AM J PHYSIOL-LUNG C, V293, pL199, DOI 10.1152/ajplung.00020.2007; Brabek J, 2005, MOL CANCER RES, V3, P307, DOI 10.1158/1541-7786.MCR-05-0015; Braga VMM, 1997, J CELL BIOL, V137, P1421, DOI 10.1083/jcb.137.6.1421; BRIKNAROVA K, 2005, J BIOL CHEM; Brinkman A, 2000, JNCI-J NATL CANCER I, V92, P112, DOI 10.1093/jnci/92.2.112; Bui LC, 2009, ONCOGENE, V28, P3642, DOI 10.1038/onc.2009.224; Cabodi S, 2006, CANCER RES, V66, P4672, DOI 10.1158/0008-5472.CAN-05-2909; Cabodi S, 2010, FASEB J, V24, P3796, DOI 10.1096/fj.10-157347; Dadke D, 2006, MOL BIOL CELL, V17, P1204, DOI 10.1091/mbc.E05-03-0237; Defilippi P, 2006, TRENDS CELL BIOL, V16, P257, DOI 10.1016/j.tcb.2006.03.003; Enan E, 1996, BIOCHEM PHARMACOL, V52, P1599, DOI 10.1016/S0006-2952(96)00566-7; Fashena SJ, 2002, J CELL SCI, V115, P99; Fujita Y, 2002, NAT CELL BIOL, V4, P222, DOI 10.1038/ncb758; Giehl K, 2008, FRONT BIOSCI-LANDMRK, V13, P3975, DOI 10.2741/2985; Guo C, 2008, HEPATOB PANCREAT DIS, V7, P490; Huber MA, 2005, CURR OPIN CELL BIOL, V17, P548, DOI 10.1016/j.ceb.2005.08.001; Ishino M, 1995, ONCOGENE, V11, P2331; Izumchenko E, 2009, CANCER RES, V69, P7198, DOI 10.1158/0008-5472.CAN-09-0795; JANDA E, 2006, ONCOGENE; Ji HB, 2007, NATURE, V448, P807, DOI 10.1038/nature06030; Kim M, 2006, CELL, V125, P1269, DOI 10.1016/j.cell.2006.06.008; Law SF, 1996, MOL CELL BIOL, V16, P3327; Le TL, 1999, J CELL BIOL, V146, P219, DOI 10.1083/jcb.146.1.219; Manie SN, 1997, J BIOL CHEM, V272, P4230, DOI 10.1074/jbc.272.7.4230; MATSUYOSHI N, 1992, J CELL BIOL, V118, P703, DOI 10.1083/jcb.118.3.703; Minegishi M, 1996, J EXP MED, V184, P1365, DOI 10.1084/jem.184.4.1365; Natarajan M, 2006, ONCOGENE, V25, P1721, DOI 10.1038/sj.onc.1209199; O'Neill GM, 2007, CANCER RES, V67, P8975, DOI 10.1158/0008-5472.CAN-07-1328; Palacios F, 2005, MOL CELL BIOL, V25, P389, DOI 10.1128/MCB.25.1.389-402.2005; Peifer M, 2003, J CELL BIOL, V163, P437, DOI 10.1083/jcb.200310090; SAKAI R, 1994, EMBO J, V13, P3748, DOI 10.1002/j.1460-2075.1994.tb06684.x; Sanz-Moreno V, 2008, CELL, V135, P510, DOI 10.1016/j.cell.2008.09.043; Sattler M, 1997, J BIOL CHEM, V272, P14320, DOI 10.1074/jbc.272.22.14320; Shewan AM, 2005, MOL BIOL CELL, V16, P4531, DOI 10.1091/mbc.E05-04-0330; Singh MK, 2008, MOL BIOL CELL, V19, P1627, DOI 10.1091/mbc.E07-09-0953; Singh MK, 2007, CELL BIOCHEM BIOPHYS, V48, P54, DOI 10.1007/s12013-007-0036-3; Singh MK, 2010, CANCER RES, V70, P8907, DOI 10.1158/0008-5472.CAN-10-0353; Tikhmyanova N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012369; Tikhmyanova N, 2010, CELL MOL LIFE SCI, V67, P1025, DOI 10.1007/s00018-009-0213-1; TORNILLO G, 2010, EUR J CELL BIOL; van der Flier S, 2000, JNCI-J NATL CANCER I, V92, P120, DOI 10.1093/jnci/92.2.120; van Seventer GA, 2001, EUR J IMMUNOL, V31, P1417, DOI 10.1002/1521-4141(200105)31:5<1417::AID-IMMU1417>3.0.CO;2-C; Xing LZ, 2000, MOL CELL BIOL, V20, P7363, DOI 10.1128/MCB.20.19.7363-7377.2000	45	62	62	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2011	6	7							e22102	10.1371/journal.pone.0022102	http://dx.doi.org/10.1371/journal.pone.0022102			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791WM	21765937	Green Published, Green Submitted, gold			2022-12-27	WOS:000292699000023
J	Baatz, F; Nijhuis, M; Lemaire, M; Riedijk, M; Wensing, AMJ; Servais, JY; van Ham, PM; Hoepelman, AIM; Koopmans, PP; Sprenger, HG; Devaux, C; Schmit, JC; Bercoff, DP				Baatz, Franky; Nijhuis, Monique; Lemaire, Morgane; Riedijk, Martiene; Wensing, Annemarie M. J.; Servais, Jean-Yves; van Ham, Petra M.; Hoepelman, Andy I. M.; Koopmans, Peter P.; Sprenger, Herman G.; Devaux, Carole; Schmit, Jean-Claude; Bercoff, Danielle Perez			Impact of the HIV-1 env Genetic Context outside HR1-HR2 on Resistance to the Fusion Inhibitor Enfuvirtide and Viral Infectivity in Clinical Isolates	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; BASE-LINE SUSCEPTIBILITY; TYPE-1 GP41; PHENOTYPIC RESISTANCE; ENTRY INHIBITORS; ENVELOPE GLYCOPROTEIN; MEMBRANE-FUSION; HEPTAD REPEAT; MAXIMUM-LIKELIHOOD; FUNCTIONAL-ROLE	Resistance mutations to the HIV-1 fusion inhibitor enfuvirtide emerge mainly within the drug's target region, HR1, and compensatory mutations have been described within HR2. The surrounding envelope (env) genetic context might also contribute to resistance, although to what extent and through which determinants remains elusive. To quantify the direct role of the env context in resistance to enfuvirtide and in viral infectivity, we compared enfuvirtide susceptibility and infectivity of recombinant viral pairs harboring the HR1-HR2 region or the full Env ectodomain of longitudinal env clones from 5 heavily treated patients failing enfuvirtide therapy. Prior to enfuvirtide treatment onset, no env carried known resistance mutations and full Env viruses were on average less susceptible than HR1-HR2 recombinants. All escape clones carried at least one of G36D, V38A, N42D and/or N43D/S in HR1, and accordingly, resistance increased 11- to 2800-fold relative to baseline. Resistance of full Env recombinant viruses was similar to resistance of their HR1-HR2 counterpart, indicating that HR1 and HR2 are the main contributors to resistance. Strictly X4 viruses were more resistant than strictly R5 viruses, while dual-tropic Envs featured similar resistance levels irrespective of the coreceptor expressed by the cell line used. Full Env recombinants from all patients gained infectivity under prolonged drug pressure; for HR1-HR2 viruses, infectivity remained steady for 3/5 patients, while for 2/5 patients, gains in infectivity paralleled those of the corresponding full Env recombinants, indicating that the env genetic context accounts mainly for infectivity adjustments. Phylogenetic analyses revealed that quasispecies selection is a step-wise process where selection of enfuvirtide resistance is a dominant factor early during therapy, while increased infectivity is the prominent driver under prolonged therapy.	[Baatz, Franky; Lemaire, Morgane; Servais, Jean-Yves; Devaux, Carole; Schmit, Jean-Claude; Bercoff, Danielle Perez] CRP Sante, Lab Retrovirol, Luxembourg, Luxembourg; [Nijhuis, Monique; Riedijk, Martiene; Wensing, Annemarie M. J.; van Ham, Petra M.] UMC Utrecht, Dept Virol, Utrecht, Netherlands; [Riedijk, Martiene; Hoepelman, Andy I. M.] UMC Utrecht, Dept Internal Med & Infect Dis, Utrecht, Netherlands; [Koopmans, Peter P.] Radboud Univ Nijmegen, Med Ctr, Dept Gen Internal Med, Div Infect Dis, NL-6525 ED Nijmegen, Netherlands; [Sprenger, Herman G.] Univ Groningen, Univ Med Ctr Groningen, Dept Internal Med, Div Infect Dis, NL-9713 AV Groningen, Netherlands	Luxembourg Institute of Health; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Radboud University Nijmegen; University of Groningen	Baatz, F (corresponding author), CRP Sante, Lab Retrovirol, Luxembourg, Luxembourg.	danielle.perezbercoff@crp-sante.lu	wensing, a.m.j./F-3005-2011	Seguin-Devaux, Carole/0000-0003-0636-5222; Perez Bercoff, Danielle/0000-0003-4415-0150	Fonds National de Recherche, Luxembourg [TR-PHD BFR06-033]; Netherlands Organisation for Scientific Research (NWO) [91796349]; Dutch Ministry of Health	Fonds National de Recherche, Luxembourg; Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Dutch Ministry of Health	FB was supported by a fellowship from the Fonds National de Recherche, Luxembourg [TR-PHD BFR06-033]. MN and PvH were supported by The Netherlands Organisation for Scientific Research (NWO) VIDI (91796349). The ATHENA database is supported by a grant from the Dutch Ministry of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAI X, 2008, BIOCHEMISTRY; Baldwin CE, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-84; Bjorndal A, 1997, J VIROL, V71, P7478; BOOM R, 1990, J CLIN MICROBIOL, V28, P495, DOI 10.1128/JCM.28.3.495-503.1990; Chan DC, 1998, P NATL ACAD SCI USA, V95, P15613, DOI 10.1073/pnas.95.26.15613; CHEN SSL, 1994, J VIROL, V68, P2002, DOI 10.1128/JVI.68.3.2002-2010.1994; Chen SSL, 1998, J VIROL, V72, P4765, DOI 10.1128/JVI.72.6.4765-4774.1998; Derdeyn CA, 2001, J VIROL, V75, P8605, DOI 10.1128/JVI.75.18.8605-8614.2001; Derdeyn CA, 2000, J VIROL, V74, P8358, DOI 10.1128/JVI.74.18.8358-8367.2000; Doms RW, 2000, GENE DEV, V14, P2677, DOI 10.1101/gad.833300; Doms RW, 2000, J CELL BIOL, V151, pF9, DOI 10.1083/jcb.151.2.F9; Eckert DM, 2001, ANNU REV BIOCHEM, V70, P777, DOI 10.1146/annurev.biochem.70.1.777; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Goubard A, 2009, ANTIVIR THER, V14, P597; Greenberg ML, 2004, J ANTIMICROB CHEMOTH, V54, P333, DOI 10.1093/jac/dkh330; GROENINK M, 1993, SCIENCE, V260, P1513, DOI 10.1126/science.8502996; GU X, 1995, MOL BIOL EVOL, V12, P546; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hanna GJ, 2002, CLIN LAB MED, V22, P637, DOI 10.1016/S0272-2712(02)00007-0; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Heil ML, 2004, J VIROL, V78, P7582, DOI 10.1128/JVI.78.14.7582-7589.2004; Jenwitheesuk E, 2005, ANTIVIR THER, V10, P893; Kilby JM, 1998, NAT MED, V4, P1302, DOI 10.1038/3293; KOITO A, 1994, J VIROL, V68, P2253, DOI 10.1128/JVI.68.4.2253-2259.1994; Labrosse B, 2003, J VIROL, V77, P1610, DOI 10.1128/JVI.77.2.1610-1613.2003; Labrosse B, 2006, J VIROL, V80, P8807, DOI 10.1128/JVI.02706-05; Lohrengel S, 2005, J VIROL, V79, P10237, DOI 10.1128/JVI.79.16.10237-10246.2005; Lu J, 2004, J VIROL, V78, P4628, DOI 10.1128/JVI.78.9.4628-4637.2004; Lu J, 2006, JAIDS-J ACQ IMM DEF, V43, P60, DOI 10.1097/01.qai.0000234083.34161.55; Markosyan RM, 2003, MOL BIOL CELL, V14, P926, DOI 10.1091/mbc.E02-09-0573; Melby T, 2007, AIDS RES HUM RETROV, V23, P1366, DOI 10.1089/aid.2006.0277; Melby T, 2006, AIDS RES HUM RETROV, V22, P375, DOI 10.1089/aid.2006.22.375; Melikyan GB, 2000, J CELL BIOL, V151, P413, DOI 10.1083/jcb.151.2.413; Menzo S, 2004, ANTIMICROB AGENTS CH, V48, P3253, DOI 10.1128/AAC.48.9.3253-3259.2004; Mink M, 2005, J VIROL, V79, P12447, DOI 10.1128/JVI.79.19.12447-12454.2005; Moyle G, 2003, J ANTIMICROB CHEMOTH, V51, P213, DOI 10.1093/jac/dkg066; Nameki D, 2005, J VIROL, V79, P764, DOI 10.1128/JVI.79.2.764-770.2005; PAGE KA, 1990, J VIROL, V64, P5270, DOI 10.1128/JVI.64.11.5270-5276.1990; Perez-Alvarez L, 2006, J MED VIROL, V78, P141, DOI 10.1002/jmv.20520; Perez-Bercoff D, 2007, J VIROL, V81, P4540, DOI 10.1128/JVI.01620-06; Platt EJ, 2005, J VIROL, V79, P4347, DOI 10.1128/JVI.79.7.4347-4356.2005; Ray N, 2007, J VIROL, V81, P3240, DOI 10.1128/JVI.02413-06; Ray N, 2009, J VIROL, V83, P2989, DOI 10.1128/JVI.02496-08; Reeves JD, 2004, J VIROL, V78, P5476, DOI 10.1128/JVI.78.10.5476-5485.2004; Reeves JD, 2005, J VIROL, V79, P4991, DOI 10.1128/JVI.79.8.4991-4999.2005; Reeves JD, 2002, P NATL ACAD SCI USA, V99, P16249, DOI 10.1073/pnas.252469399; Rimsky LT, 1998, J VIROL, V72, P986, DOI 10.1128/JVI.72.2.986-993.1998; Roman F, 2006, J VIROL METHODS, V131, P99, DOI 10.1016/j.jviromet.2005.07.005; Sista PR, 2004, AIDS, V18, P1787, DOI 10.1097/00002030-200409030-00007; Su C, 2006, J CLIN VIROL, V36, P249, DOI 10.1016/j.jcv.2006.03.007; SULLIVAN N, 1993, J VIROL, V67, P3674, DOI 10.1128/JVI.67.6.3674-3679.1993; Wei XP, 2002, ANTIMICROB AGENTS CH, V46, P1896, DOI 10.1128/AAC.46.6.1896-1905.2002; WILD CT, 1994, P NATL ACAD SCI USA, V91, P9770, DOI 10.1073/pnas.91.21.9770; Xu L, 2005, ANTIMICROB AGENTS CH, V49, P1113, DOI 10.1128/AAC.49.3.1113-1119.2005	54	14	14	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2011	6	7							e21535	10.1371/journal.pone.0021535	http://dx.doi.org/10.1371/journal.pone.0021535			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791IA	21760896	gold, Green Published, Green Submitted			2022-12-27	WOS:000292657200015
J	Khalafalla, RE				Khalafalla, Reda E.			A Survey Study on Gastrointestinal Parasites of Stray Cats in Northern Region of Nile Delta, Egypt	PLOS ONE			English	Article							INTESTINAL HELMINTHS; DOMESTIC CATS; TOXOCARA-CATI; PREVALENCE; URBAN; DOGS	A survey study on gastrointestinal parasites in 113 faecal samples from stray cats collected randomly from Kafrelsheikh province, northern region of Nile delta of Egypt; was conducted in the period between January and May 2010. The overall prevalence was 91%. The results of this study reported seven helminth species: Toxocara cati (9%), Ancylostoma tubaeforme (4%), Toxascaris leonina (5%), Dipylidium caninum (5%), Capillaria spp. (3%), Taenia taeniformis (22%) and Heterophyes heterophyes (3%), four protozoal species: Toxoplasma gondii (9%), Sarcocyst spp. (1%), Isospora spp. (2%) and Giardia spp. (2%) and two arthropod species; Linguatula serrata (2%) and mites eggs (13%). The overall prevalence of intestinal parasites may continue to rise due to lack of functional veterinary clinics for cat care in Egypt. Therefore, there is a need to plan adequate control programs to diagnose, treat and control gastrointestinal parasites of companion as well as stray cats in the region.	Kafrelsheikh Univ, Fac Vet Med, Dept Parasitol, Kafrelsheikh, Egypt	Egyptian Knowledge Bank (EKB); Kafrelsheikh University	Khalafalla, RE (corresponding author), Kafrelsheikh Univ, Fac Vet Med, Dept Parasitol, Kafrelsheikh, Egypt.	Redabast@hotmail.de	Khalafalla, Reda/Q-7880-2019	khalafalla, Reda/0000-0002-1810-9501	Faculty of Veterinary Medicine and the Department of Parasitology at the University of Kafrelsheikh, Egypt	Faculty of Veterinary Medicine and the Department of Parasitology at the University of Kafrelsheikh, Egypt(Kafrelsheikh University)	The funders are the Faculty of Veterinary Medicine and the Department of Parasitology at the University of Kafrelsheikh, Egypt; these funds are part of a general institutional research fund offered by the faculty council to the Department of Parasitology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Madi MA, 2010, VET PARASITOL, V168, P284, DOI 10.1016/j.vetpar.2009.11.027; Abu-Madi MA, 2008, PARASITE VECTOR, V1, DOI 10.1186/1756-3305-1-39; ABU-ZAKHAM A A, 1989, Journal of the Egyptian Society of Parasitology, V19, P225; BAKER MK, 1989, J S AFR VET ASSOC, V60, P139; Calvete C, 1998, VET PARASITOL, V75, P235, DOI 10.1016/S0304-4017(97)00182-9; Dryden MW, 2005, VET THER, V6, P15; El-Shabrawy M.N., 1978, Journal of the Egyptian Veterinary Medical Association, V38, P19; Faust E. C., 1938, American Journal of Tropical Medicine, V18, P169; HARALAMPIDIS ST, 1977, THESIS ARISTOTLE U T; HENDRIX CM, 1983, VET CLIN N AM-SMALL, V13, P627, DOI 10.1016/S0195-5616(83)50063-6; HOSSAIN A, 1986, TROP GEOGR MED, V38, P244; HUTCHISON WM, 1957, J PARASITOL, V43, P318, DOI 10.2307/3274356; Labarthe N, 2004, VET PARASITOL, V123, P133, DOI 10.1016/j.vetpar.2004.06.002; LENGY J, 1969, J PARASITOL, V55, P1239, DOI 10.2307/3277266; MCCOLM AA, 1980, J HELMINTHOL, V54, P255, DOI 10.1017/S0022149X00006714; McGlade TR, 2003, VET PARASITOL, V117, P251, DOI 10.1016/j.vetpar.2003.08.010; Morsy T.A., 1980, Journal of the Egyptian Society of Parasitology, V10, P5; NIAK A, 1972, VET REC, V91, P534, DOI 10.1136/vr.91.22.534; NICHOL S, 1981, VET PARASITOL, V9, P107, DOI 10.1016/0304-4017(81)90028-5; Serra Cathia Maria Barrientos, 2003, Rev. Soc. Bras. Med. Trop., V36, P331, DOI 10.1590/S0037-86822003000300003; Sharif M., 2010, Comparative Clinical Pathology, V19, P257, DOI 10.1007/s00580-009-0866-z; SOULSBY EJL, 1982, HELMINTHS ARTHROPODA; THIENPONT D, 1981, RECL MED VET, V157, P591; Zibaei M, 2007, TROP BIOMED, V24, P39; LOOKLEX ENCY ORIENT	25	31	35	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2011	6	7							e20283	10.1371/journal.pone.0020283	http://dx.doi.org/10.1371/journal.pone.0020283			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791IA	21760884	Green Published, gold, Green Submitted			2022-12-27	WOS:000292657200003
J	Wesley, CS; Guo, H; Chaudhry, KA; Thali, MJ; Yin, JC; Clason, T; Wesley, UV				Wesley, Cedric S.; Guo, Heng; Chaudhry, Kanita A.; Thali, Markus J.; Yin, Jerry C.; Clason, Todd; Wesley, Umadevi V.			Loss of PTB or Negative Regulation of Notch mRNA Reveals Distinct Zones of Notch and Actin Protein Accumulation in Drosophila Embryo	PLOS ONE			English	Article							TRACT-BINDING-PROTEIN; CELL FATE; LIGAND ENDOCYTOSIS; DORSAL ECTODERM; DOWN-REGULATION; DELTA; ACTIVATION; MASTERMIND; RECEPTOR; ENCODES	Polypyrimidine Tract Binding (PTB) protein is a regulator of mRNA processing and translation. Genetic screens and studies of wing and bristle development during the post-embryonic stages of Drosophila suggest that it is a negative regulator of the Notch pathway. How PTB regulates the Notch pathway is unknown. Our studies of Drosophila embryogenesis indicate that (1) the Notch mRNA is a potential target of PTB, (2) PTB and Notch functions in the dorso-lateral regions of the Drosophila embryo are linked to actin regulation but not their functions in the ventral region, and (3) the actin-related Notch activity in the dorsolateral regions might require a Notch activity at or near the cell surface that is different from the nuclear Notch activity involved in cell fate specification in the ventral region. These data raise the possibility that the Drosophila embryo is divided into zones of different PTB and Notch activities based on whether or not they are linked to actin regulation. They also provide clues to the almost forgotten role of Notch in cell adhesion and reveal a role for the Notch pathway in cell fusions.	[Wesley, Cedric S.; Yin, Jerry C.] Univ Wisconsin, Dept Genet, Madison, WI 53706 USA; [Wesley, Cedric S.; Yin, Jerry C.] Univ Wisconsin, Dept Med Genet, Madison, WI 53706 USA; [Guo, Heng] Boston Univ, Dept Biochem, Boston, MA 02215 USA; [Chaudhry, Kanita A.] Univ Vermont, Dept Biochem, Burlington, VT 05405 USA; [Thali, Markus J.] Univ Vermont, Dept Microbiol & Mol Genet, Burlington, VT 05405 USA; [Clason, Todd] Univ Vermont, Dept Anat & Neurobiol, Burlington, VT 05405 USA; [Wesley, Umadevi V.] Univ Wisconsin, Dept Neurol Surg, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Boston University; University of Vermont; University of Vermont; University of Vermont; University of Wisconsin System; University of Wisconsin Madison	Wesley, CS (corresponding author), Univ Wisconsin, Dept Genet, Madison, WI 53706 USA.	cswesley@wisc.edu		Thali, Markus/0000-0001-8621-2095	NIH [1 R21 HD062928-01]; University of Vermont Neuroscience NIH/NCRR COBRE [P20 RR16435]; University of Vermont-College of Medicine;  [R01 NS063245-01]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016435] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI080302] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS063245] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Vermont Neuroscience NIH/NCRR COBRE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); University of Vermont-College of Medicine; ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	NIH 1 R21 HD062928-01 (to CSW), University of Vermont Neuroscience NIH/NCRR COBRE (P20 RR16435), University of Vermont-College of Medicine Bridge Fund, and R01 NS063245-01 (to JCY) provided financial support for the study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAMS JM, 1993, DEVELOPMENT, V117, P29; Ahimou F, 2004, J CELL BIOL, V167, P1217, DOI 10.1083/jcb.200407100; Albrecht S, 2006, MECH DEVELOP, V123, P372, DOI 10.1016/j.mod.2006.03.005; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; ASHBURNER M, 2004, DROSOPHHILA LAB HDB; Baker R, 1996, DEVELOPMENT, V122, P617; Bardot B, 2005, EXP CELL RES, V304, P202, DOI 10.1016/j.yexcr.2004.10.030; Ben-Yaacov S, 2001, J CELL BIOL, V152, P1, DOI 10.1083/jcb.152.1.1; Bentley DL, 2005, CURR OPIN CELL BIOL, V17, P251, DOI 10.1016/j.ceb.2005.04.006; Berechid BE, 2002, J BIOL CHEM, V277, P8154, DOI 10.1074/jbc.M108238200; Besse F, 2009, GENE DEV, V23, P195, DOI 10.1101/gad.505709; Bier E, 2004, GENE, V342, P1, DOI 10.1016/j.gene.2004.07.018; Bruckner K, 2000, NATURE, V406, P411, DOI 10.1038/35019075; Castelo-Branco P, 2004, MOL CELL BIOL, V24, P4174, DOI 10.1128/MCB.24.10.4174-4183.2004; Chartier A, 2002, DEVELOPMENT, V129, P3241; CROSS DP, 1978, J EMBRYOL EXP MORPH, V45, P173; Dansereau DA, 2002, DEVELOPMENT, V129, P5553, DOI 10.1242/dev.00153; Davis MB, 2002, MECH DEVELOP, V111, P143, DOI 10.1016/S0925-4773(01)00595-0; Delon I, 2003, MECH DEVELOP, V120, P747, DOI 10.1016/S0925-4773(03)00081-9; Emery G, 2005, CELL, V122, P763, DOI 10.1016/j.cell.2005.08.017; FEHON RG, 1990, CELL, V61, P523, DOI 10.1016/0092-8674(90)90534-L; Fiuza UM, 2007, J ENDOCRINOL, V194, P459, DOI 10.1677/JOE-07-0242; Fryer CJ, 2004, MOL CELL, V16, P509, DOI 10.1016/j.molcel.2004.10.014; Fryer CJ, 2002, GENE DEV, V16, P1397, DOI 10.1101/gad.991602; Garneau NL, 2007, NAT REV MOL CELL BIO, V8, P113, DOI 10.1038/nrm2104; Harden N, 2002, DIFFERENTIATION, V70, P181, DOI 10.1046/j.1432-0436.2002.700408.x; Hayward P, 2005, DEVELOPMENT, V132, P1819, DOI 10.1242/dev.01724; Herranz H, 2006, BIOESSAYS, V28, P113, DOI 10.1002/bies.20366; High FA, 2008, NAT REV GENET, V9, P49, DOI 10.1038/nrg2279; Hori K, 2004, DEVELOPMENT, V131, P5527, DOI 10.1242/dev.01448; IRVINE KD, 1994, CELL, V79, P595, DOI 10.1016/0092-8674(94)90545-2; Kankel MW, 2007, GENETICS, V177, P2493, DOI 10.1534/genetics.107.080994; Kidd S, 1998, GENE DEV, V12, P3728, DOI 10.1101/gad.12.23.3728; Krecic AM, 1999, CURR OPIN CELL BIOL, V11, P363, DOI 10.1016/S0955-0674(99)80051-9; Lai EC, 2001, DEV CELL, V1, P783, DOI 10.1016/S1534-5807(01)00092-2; Langdon T, 2006, DEV DYNAM, V235, P998, DOI 10.1002/dvdy.20735; Le Borgne R, 2005, DEVELOPMENT, V132, P1751, DOI 10.1242/dev.01789; Le Sommer C, 2005, MOL CELL BIOL, V25, P9595, DOI 10.1128/MCB.25.21.9595-9607.2005; LeComte M, 2006, DEV DYNAM, V235, P411, DOI 10.1002/dvdy.20650; LIEBER T, 1993, GENE DEV, V7, P1949, DOI 10.1101/gad.7.10.1949; LYMAN D, 1993, P NATL ACAD SCI USA, V90, P10395, DOI 10.1073/pnas.90.21.10395; Major RJ, 2005, DEVELOPMENT, V132, P3823, DOI 10.1242/dev.01957; Martin D, 1999, J CELL BIOL, V145, P191, DOI 10.1083/jcb.145.1.191; Mishra-Gorur K, 2002, J CELL BIOL, V159, P313, DOI 10.1083/jcb.200203117; Mok LP, 2005, BMC DEV BIOL, V5, DOI 10.1186/1471-213X-5-6; Moloney DJ, 2000, NATURE, V406, P369, DOI 10.1038/35019000; Noll E, 2000, DEV BIOL, V227, P450, DOI 10.1006/dbio.2000.9925; Norga KK, 2003, CURR BIOL, V13, P1388, DOI 10.1016/S0960-9822(03)00546-3; Oren-Suissa M, 2007, TRENDS CELL BIOL, V17, P537, DOI 10.1016/j.tcb.2007.09.004; Panin VM, 2002, J BIOL CHEM, V277, P29945, DOI 10.1074/jbc.M204445200; Parks AL, 2000, DEVELOPMENT, V127, P1373; Pavlopoulos E, 2001, DEV CELL, V1, P807, DOI 10.1016/S1534-5807(01)00093-4; Pazdera TM, 1998, DEVELOPMENT, V125, P3427; Poulson DF, 1937, P NATL ACAD SCI USA, V23, P133, DOI 10.1073/pnas.23.3.133; RICHARD ML, 1997, DEVELOPMENT, V124, P2129; Robida M, 2010, P NATL ACAD SCI USA, V107, P12570, DOI 10.1073/pnas.1007935107; Robida MD, 2003, EMBO J, V22, P2924, DOI 10.1093/emboj/cdg301; Sakata T, 2004, CURR BIOL, V14, P2228, DOI 10.1016/j.cub.2004.12.028; Sapir A, 2005, DEVELOPMENT, V132, P123, DOI 10.1242/dev.01546; Shepherd A, 2010, DEV DYNAM, V239, P1220, DOI 10.1002/dvdy.22262; Shepherd AK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008063; Stronach BE, 2001, DEVELOPMENT, V128, P2905; STRUHL G, 1993, CELL, V74, P331, DOI 10.1016/0092-8674(93)90424-O; Sullivan W., 2000, DROSOPHILA PROTOCOLS; Tao Y, 2007, SEMIN CELL DEV BIOL, V18, P3, DOI 10.1016/j.semcdb.2006.12.001; Tien AC, 2009, J CELL BIOL, V184, P621, DOI 10.1083/jcb.200811141; Valcarcel J, 1997, CURR BIOL, V7, pR705, DOI 10.1016/S0960-9822(06)00361-7; Wang WD, 2005, DEVELOPMENT, V132, P2883, DOI 10.1242/dev.01860; Wang WD, 2004, DEVELOPMENT, V131, P5367, DOI 10.1242/dev.01413; Wesley CS, 2003, MOL CELL BIOL, V23, P5581, DOI 10.1128/MCB.23.16.5581-5593.2003; Wesley CS, 2000, J BIOL CHEM, V275, P9099, DOI 10.1074/jbc.275.13.9099; Wesley CS, 2000, J CELL BIOL, V149, P683, DOI 10.1083/jcb.149.3.683; Wickens M, 2002, TRENDS GENET, V18, P150, DOI 10.1016/S0168-9525(01)02616-6; Wilkin MB, 2005, MOL MEMBR BIOL, V22, P279, DOI 10.1080/09687860500129778; Wilkin MB, 2004, CURR BIOL, V14, P2237, DOI 10.1016/j.cub.2004.11.030; Wilusz CJ, 2001, NAT REV MOL CELL BIO, V2, P237, DOI 10.1038/35067025; Wilusz CJ, 2001, RNA, V7, P1416; Zhao J, 1999, MICROBIOL MOL BIOL R, V63, P405, DOI 10.1128/MMBR.63.2.405-445.1999	78	11	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2011	6	7							e21876	10.1371/journal.pone.0021876	http://dx.doi.org/10.1371/journal.pone.0021876			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	789JO	21750738	Green Published, gold, Green Submitted			2022-12-27	WOS:000292512000030
J	Kuwae, A; Sjolinder, H; Eriksson, J; Eriksson, S; Chen, Y; Jonsson, AB				Kuwae, Asaomi; Sjolinder, Hong; Eriksson, Jens; Eriksson, Sara; Chen, Yao; Jonsson, Ann-Beth			NafA Negatively Controls Neisseria meningitidis Piliation	PLOS ONE			English	Article							HUMAN ENDOTHELIAL-CELLS; HUMAN EPITHELIAL-CELLS; IV PILI; MENINGOCOCCAL DISEASE; PATHOGENIC NEISSERIA; TWITCHING MOTILITY; OPA PROTEINS; SIALIC-ACID; GONORRHOEAE; ATTACHMENT	Bacterial auto-aggregation is a critical step during adhesion of N. meningitidis to host cells. The precise mechanisms and functions of bacterial auto-aggregation still remain to be fully elucidated. In this work, we characterize the role of a meningococcal hypothetical protein, NMB0995/NMC0982, and show that this protein, here denoted NafA, acts as an anti-aggregation factor. NafA was confirmed to be surface exposed and was found to be induced at a late stage of bacterial adherence to epithelial cells. A NafA deficient mutant was hyperpiliated and formed bundles of pili. Further, the mutant displayed increased adherence to epithelial cells when compared to the wild-type strain. In the absence of host cells, the NafA deficient mutant was more aggregative than the wild-type strain. The in vivo role of NafA in sepsis was studied in a murine model of meningococcal disease. Challenge with the NafA deficient mutant resulted in lower bacteremia levels and mortality when compared to the wild-type strain. The present study reveals that meningococcal NafA is an anti-aggregation factor with strong impact on the disease outcome. These data also suggest that appropriate bacterial auto-aggregation is controlled by both aggregation and anti-aggregation factors during Neisseria infection in vivo.	[Kuwae, Asaomi; Sjolinder, Hong; Eriksson, Jens; Eriksson, Sara; Chen, Yao; Jonsson, Ann-Beth] Stockholm Univ, Dept Genet Microbiol & Toxicol, S-10691 Stockholm, Sweden	Stockholm University	Kuwae, A (corresponding author), Kitasato Univ, Grad Sch Infect Control Sci, Lab Bacterial Infect, Minato Ku, Tokyo, Japan.	kuwae@lisci.kitasato-u.ac.jp		Eriksson, Jens/0000-0002-8945-2665	Swedish Research Council [Dnr 2006-4112, 2007-3369, 2008-2572, 2009-5679]; Swedish Cancer Society; JSPS (Japan Society for the Promotion of Science); Torsten and Ragnar Soderbergs Stiftelse; Stiftelsen Anna Brita och Bo Castegrens Minne; Tore Nilsons stiftelse for Medicinsk Forskning; Harald Jeanssons Stiftelser; Ake Wiberg stiftelse; Stiftelsen Lars Hiertas Minne; Magnus Bergvalls Stiftelse; Knut and Alice Wallenbergs Stiftelse	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Society(Swedish Cancer Society); JSPS (Japan Society for the Promotion of Science)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Torsten and Ragnar Soderbergs Stiftelse; Stiftelsen Anna Brita och Bo Castegrens Minne; Tore Nilsons stiftelse for Medicinsk Forskning; Harald Jeanssons Stiftelser; Ake Wiberg stiftelse; Stiftelsen Lars Hiertas Minne; Magnus Bergvalls Stiftelse; Knut and Alice Wallenbergs Stiftelse	This work was supported by the Swedish Research Council (Dnr 2006-4112, 2007-3369, 2008-2572, 2009-5679, www.vr.se) the Swedish Cancer Society (www.cancerfonden.se), Torsten and Ragnar Soderbergs Stiftelse (www.soderbergsstiftelser.se), Stiftelsen Anna Brita och Bo Castegrens Minne, Tore Nilsons stiftelse for Medicinsk Forskning (http://www.torenilsonsstiftelse.nu), Harald Jeanssons Stiftelser (http://www.jeanssonsstiftelser.se/index.html), Ake Wiberg stiftelse (http://www.ake-wiberg.com), Stiftelsen Lars Hiertas Minne (http://www.larshiertasminne.se), Magnus Bergvalls Stiftelse (http://www.magnbergvallsstiftelse.nu) and Knut and Alice Wallenbergs Stiftelse (http://www.wallenberg.com/kaw). A. K. is the recipient of the JSPS (Japan Society for the Promotion of Science: http://www.jsps.go.jp/english/index.html) Postdoctoral Fellowships for Research Abroad 2007-2008. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambur OH, 2007, J BACTERIOL, V189, P2077, DOI 10.1128/JB.01408-06; Bieber D, 1998, SCIENCE, V280, P2114, DOI 10.1126/science.280.5372.2114; BRANDTZAEG P, 1992, J INFECT DIS, V166, P650, DOI 10.1093/infdis/166.3.650; BRANDTZAEG P, 1989, J INFECT DIS, V159, P195, DOI 10.1093/infdis/159.2.195; Casey R, 2008, INFECT IMMUN, V76, P1298, DOI 10.1128/IAI.00741-07; Cattaneo R, 2004, J VIROL, V78, P4385, DOI 10.1128/JVI.78.9.4385-4388.2004; Claus H, 2005, J INFECT DIS, V191, P1263, DOI 10.1086/428590; de Jonge MI, 2003, MOL MICROBIOL, V50, P1005, DOI 10.1046/j.1365-2958.2003.03749.x; de Vries FP, 1998, MOL MICROBIOL, V27, P1203, DOI 10.1046/j.1365-2958.1998.00763.x; Deghmane AE, 2002, MOL MICROBIOL, V43, P1555, DOI 10.1046/j.1365-2958.2002.02838.x; deVries FP, 1996, INFECT IMMUN, V64, P2998, DOI 10.1128/IAI.64.8.2998-3006.1996; Dietrich M, 2009, FEMS MICROBIOL LETT, V296, P248, DOI 10.1111/j.1574-6968.2009.01647.x; ELKINS C, 1991, J BACTERIOL, V173, P3911, DOI 10.1128/JB.173.12.3911-3913.1991; FRASCH CE, 1978, J BACTERIOL, V136, P1127, DOI 10.1128/JB.136.3.1127-1134.1978; Grifantini R, 2002, NAT BIOTECHNOL, V20, P914, DOI 10.1038/nbt728; Hammerschmidt S, 1996, EMBO J, V15, P192, DOI 10.1002/j.1460-2075.1996.tb00347.x; Helaine S, 2005, MOL MICROBIOL, V55, P65, DOI 10.1111/j.1365-2958.2004.04372.x; Helaine S, 2007, P NATL ACAD SCI USA, V104, P15888, DOI 10.1073/pnas.0707581104; JARVIS GA, 1987, INFECT IMMUN, V55, P174, DOI 10.1128/IAI.55.1.174-180.1987; Johansson L, 2005, J IMMUNOL, V175, P433, DOI 10.4049/jimmunol.175.1.433; Johansson L, 2003, SCIENCE, V301, P373, DOI 10.1126/science.1086476; Jones A, 2009, J BACTERIOL, V191, P3861, DOI 10.1128/JB.01313-08; Uria MJ, 2008, J EXP MED, V205, P1423, DOI 10.1084/jem.20072577; KELLOGG DS, 1963, J BACTERIOL, V85, P1274, DOI 10.1128/JB.85.6.1274-1279.1963; KELLOGG DS, 1968, J BACTERIOL, V96, P596, DOI 10.1128/JB.96.3.596-605.1968; Kirchner M, 2005, MOL MICROBIOL, V56, P945, DOI 10.1111/j.1365-2958.2005.04600.x; Kirchner M, 2005, INFECT IMMUN, V73, P3072, DOI 10.1128/IAI.73.5.3072-3082.2005; MARCEAU M, 1995, MOL MICROBIOL, V17, P855, DOI 10.1111/j.1365-2958.1995.mmi_17050855.x; Mattick JS, 2002, ANNU REV MICROBIOL, V56, P289, DOI 10.1146/annurev.micro.56.012302.160938; NASSIF X, 1993, MOL MICROBIOL, V8, P719, DOI 10.1111/j.1365-2958.1993.tb01615.x; Pelicic V, 2008, MOL MICROBIOL, V68, P827, DOI 10.1111/j.1365-2958.2008.06197.x; Pujol C, 1999, P NATL ACAD SCI USA, V96, P4017, DOI 10.1073/pnas.96.7.4017; Pujol C, 1997, INFECT IMMUN, V65, P4836, DOI 10.1128/IAI.65.11.4836-4842.1997; Rahman M, 1997, MOL MICROBIOL, V25, P11, DOI 10.1046/j.1365-2958.1997.4601823.x; Renauld-Mongenie G, 2004, INFECT IMMUN, V72, P3461, DOI 10.1128/IAI.72.6.3461-3470.2004; Schubert-Unkmeir A, 2007, INFECT IMMUN, V75, P899, DOI 10.1128/IAI.01508-06; Sjolinder H, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000241; Soto GE, 1999, J BACTERIOL, V181, P1059, DOI 10.1128/JB.181.4.1059-1071.1999; Spinosa MR, 2007, INFECT IMMUN, V75, P3594, DOI 10.1128/IAI.01945-06; SWANSON J, 1973, J EXP MED, V137, P571, DOI 10.1084/jem.137.3.571; Tonjum T, 1998, MOL MICROBIOL, V29, P111, DOI 10.1046/j.1365-2958.1998.00910.x; Unkmeir A, 2002, MOL MICROBIOL, V46, P933, DOI 10.1046/j.1365-2958.2002.03222.x; VIRJI M, 1994, MOL MICROBIOL, V14, P173, DOI 10.1111/j.1365-2958.1994.tb01277.x; Virji M, 1999, MOL MICROBIOL, V34, P538, DOI 10.1046/j.1365-2958.1999.01620.x; VIRJI M, 1991, MOL MICROBIOL, V5, P1831, DOI 10.1111/j.1365-2958.1991.tb00807.x; Virji M, 1996, MOL MICROBIOL, V22, P941, DOI 10.1046/j.1365-2958.1996.01551.x; Wolfgang M, 1998, MOL MICROBIOL, V29, P321, DOI 10.1046/j.1365-2958.1998.00935.x	47	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2011	6	7							e21749	10.1371/journal.pone.0021749	http://dx.doi.org/10.1371/journal.pone.0021749			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786HC	21747953	Green Submitted, gold, Green Published			2022-12-27	WOS:000292293400029
J	Song, SX; Chen, DK; Lu, JC; Liao, JW; Luo, YX; Yang, ZL; Fu, XH; Fan, XJ; Wei, YS; Yang, L; Wang, L; Wang, JP				Song, Shunxin; Chen, Dianke; Lu, Jiachun; Liao, Jiawei; Luo, Yanxin; Yang, Zuli; Fu, Xinhui; Fan, Xinjuan; Wei, Yisheng; Yang, Lei; Wang, Lei; Wang, Jianping			NF kappa B1 and NF kappa BIA Polymorphisms Are Associated with Increased Risk for Sporadic Colorectal Cancer in a Southern Chinese Population	PLOS ONE			English	Article							TRANSCRIPTION FACTORS; B ACTIVATION; INSERTION/DELETION POLYMORPHISM; CHROMOSOMAL LOCALIZATION; PROMOTER POLYMORPHISM; UNTRANSLATED REGION; APOPTOSIS; NFKB1; GENE; PROGRESSION	Background: Nuclear factor kappa B (NF kappa B) plays a key role in the regulation of apoptosis. The function of NF kappa B is inhibited by binding to NF kappa B inhibitor (I kappa B), and disruption of the balance of NFkB and IkB is related to the development of many diseases, including tumors. Therefore, we hypothesized that the NF kappa B1 (-94del/insATTG) and NF kappa BIA (2758 A>G) polymorphisms were associated with colorectal cancer (CRC) susceptibility. Methods: In a hospital-based case-control study of 1001 CRC patients and 1005 cancer-free controls frequency matched by age and sex, we genotyped polymorphisms using polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) method and performed luciferase assays and Western blotting analysis to identify whether genetic variants in NF kappa BIA alter its gene expressions and functions and thus cancer risk. Results: We found that both NF kappa B1-94 ins/delATTG and NF kappa BIA 2758 A>G polymorphisms were correlated with CRC risk (OR = 1.47; 95% CI = 1.14-1.86, and OR = 1.38; 95% CI = 1.14-1.66, respectively). Furthermore, when evaluated these two polymorphisms together, the combined genotypes with 2 variant (risk) alleles (2758GG and -94ins/ins+del/ins) were associated with an increased risk of CRC (OR = 1.71; 95% CI = 1.23-2.38) compared to 0 variant, and the significant trend for 2 variant (risk) alleles were more pronounced among subgroups of aged,60 years, women, never drinkers, never smokers, persons with a normal BMI and those with a family history of cancer(P-trend < 0.01). Moreover, luciferase assays showed that the G allele in the 3'UTR significantly decreased NF kappa BIA mRNA stability and the A allele regulation by miRNA449a in vitro and that the NF kappa BIA protein expression levels of the AA+AG variant carriers were significantly higher in peritumoral tissues than those of the 2758GG genotype. Conclusion: NF kappa B1 and NF kappa BIA polymorphisms appear to jointly contribute to risk of CRC. These two variants may be a genetic modifier for CRC susceptibility in this southern Chinese population.	[Song, Shunxin; Chen, Dianke; Liao, Jiawei; Luo, Yanxin; Yang, Zuli; Fu, Xinhui; Fan, Xinjuan; Wang, Lei; Wang, Jianping] Sun Yat Sen Univ, Gastrointestinal Inst, Affiliated Hosp 6, Guangzhou 510275, Guangdong, Peoples R China; [Song, Shunxin; Luo, Yanxin; Yang, Zuli; Wang, Lei; Wang, Jianping] Sun Yat Sen Univ, Dept Colorectal Surg, Affiliated Hosp 6, Guangzhou 510275, Guangdong, Peoples R China; [Wei, Yisheng] Guangzhou Med Univ, Dept Gastrointestinal Surg, Affiliated Hosp 2, Guangzhou, Guangdong, Peoples R China; [Lu, Jiachun; Yang, Lei] Guangzhou Med Univ, Inst Chem Carcinogenesis, State Key Lab Resp Dis, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Guangzhou Medical University; Guangzhou Medical University; State Key Laboratory of Respiratory Disease	Song, SX (corresponding author), Sun Yat Sen Univ, Gastrointestinal Inst, Affiliated Hosp 6, Guangzhou 510275, Guangdong, Peoples R China.	leiwangyinghu@yahoo.com.cn; wangjply@yahoo.com.cn	Chen, Dianke/E-2248-2011		National Natural Scientific Foundation of China [81072042, 81072366, 81001108]; Guangdong Provincial Scientific Research Grants [8151008901000059, 10251008901000008]; Gongdong province government; Education Department of Chinese Government; Science and Technology Department of Chinese Government [00590101220610034]; Research Fund for the Doctoral Program of Higher Education of China [200805580074]; Yat-Sen Innovative Talents Cultivation Program for Excellent Tutors [88000-3126201]; Fundamental Research Funds for the Central Universities	National Natural Scientific Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Provincial Scientific Research Grants; Gongdong province government; Education Department of Chinese Government; Science and Technology Department of Chinese Government; Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Yat-Sen Innovative Talents Cultivation Program for Excellent Tutors; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by the National Natural Scientific Foundation of China grants [81072042 to Lei Wang, 81072366 to Jiachun Lu and 81001108 to Yisheng Wei], the Guangdong Provincial Scientific Research Grants [8151008901000059, 10251008901000008 to Lei Wang], the Gongdong province government, Education Department of Chinese Government, Science and Technology Department of Chinese Government [00590101220610034 to Jianping Wang], and the Research Fund for the Doctoral Program of Higher Education of China [200805580074 to Jianping Wang] and Yat-Sen Innovative Talents Cultivation Program for Excellent Tutors [88000-3126201 to Dianke Chen and Lei Wang] and supported by the Fundamental Research Funds for the Central Universities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amiri KI, 2005, CANCER METAST REV, V24, P301, DOI 10.1007/s10555-005-1579-7; Andersen V, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-484; Baldwin AS, 2001, J CLIN INVEST, V107, P3, DOI 10.1172/JCI11891; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Biswas DK, 2000, P NATL ACAD SCI USA, V97, P8542, DOI 10.1073/pnas.97.15.8542; BLANK V, 1992, TRENDS BIOCHEM SCI, V17, P135, DOI 10.1016/0968-0004(92)90321-Y; Borset M, 1999, EUR J HAEMATOL, V63, P345; Bu H, 2007, J CANCER RES CLIN, V133, P859, DOI 10.1007/s00432-007-0228-7; Campbell KJ, 2006, BIOCHEM SOC SYMP, V73, P165, DOI 10.1042/bss0730165; Cao Ka-Jia, 2008, Ai Zheng, V27, P225; Cheah PY, 2009, CRIT REV ONCOL HEMAT, V69, P45, DOI 10.1016/j.critrevonc.2008.08.001; Conne B, 2000, NAT MED, V6, P637, DOI 10.1038/76211; Curran JE, 2002, CANCER LETT, V188, P103, DOI 10.1016/S0304-3835(02)00460-3; Dajee M, 2003, NATURE, V421, P639, DOI 10.1038/nature01283; Dolcet X, 2005, VIRCHOWS ARCH, V446, P475, DOI 10.1007/s00428-005-1264-9; Duerr RH, 2000, AM J HUM GENET, V66, P1857, DOI 10.1086/302947; Eaden JA, 2001, GUT, V48, P526, DOI 10.1136/gut.48.4.526; Gao JF, 2007, SCAND J GASTROENTERO, V42, P345, DOI 10.1080/00365520600880856; Gilmore Thomas D, 2003, Cancer Treat Res, V115, P241; GLAVAC D, 1994, HUM GENET, V93, P694, DOI 10.1007/BF00201573; Hayden Matthew S, 2006, Cell, V127, P1286; Heron E, 1995, GENOMICS, V30, P493, DOI 10.1006/geno.1995.1270; HOSHIYAMA Y, 1993, TOHOKU J EXP MED, V171, P153, DOI 10.1620/tjem.171.153; Huxley RR, 2009, INT J CANCER, V125, P171, DOI 10.1002/ijc.24343; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Karban AS, 2004, HUM MOL GENET, V13, P35, DOI 10.1093/hmg/ddh008; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; Kim LH, 2003, HUM MUTAT, V21, DOI 10.1002/humu.9130; Klein W, 2004, INT J COLORECTAL DIS, V19, P153, DOI 10.1007/s00384-003-0531-y; Kurylowicz A, 2009, THYROID RES, V2, DOI 10.1186/1756-6614-2-10; LEBEAU MM, 1992, GENOMICS, V14, P529, DOI 10.1016/S0888-7543(05)80261-7; Lichtenstein P, 2000, NEW ENGL J MED, V343, P78, DOI 10.1056/NEJM200007133430201; Lind DS, 2001, SURGERY, V130, P363, DOI 10.1067/msy.2001.116672; Maldonado V, 1997, MUTAT RES-FUND MOL M, V381, P67, DOI 10.1016/S0027-5107(97)00150-4; MATHEW S, 1993, ONCOGENE, V8, P191; Mayo MW, 1997, SCIENCE, V278, P1812, DOI 10.1126/science.278.5344.1812; Miller MR, 2010, OBESITY, V18, P555, DOI 10.1038/oby.2009.303; Ota N, 1999, J HUM GENET, V44, P129, DOI 10.1007/s100380050125; Richmond A, 2002, NAT REV IMMUNOL, V2, P664, DOI 10.1038/nri887; Riemann K, 2007, INT J CLIN PHARM TH, V45, P423; Riemann K, 2006, PHARMACOGENET GENOM, V16, P783, DOI 10.1097/01.fpc.0000230414.74726.f6; Shibata W, 2010, GASTROENTEROLOGY, V138, P1022, DOI 10.1053/j.gastro.2009.11.054; Sonenshein GE, 1997, SEMIN CANCER BIOL, V8, P113, DOI 10.1006/scbi.1997.0062; Sun XF, 2007, HISTOL HISTOPATHOL, V22, P1387, DOI 10.14670/HH-22.1387; Tanaka H, 2009, MOL CANCER RES, V7, P557, DOI 10.1158/1541-7786.MCR-08-0197; THOMPSON CB, 1995, SCIENCE, V267, P1456, DOI 10.1126/science.7878464; THOMPSON HJ, 1992, CANCER EPIDEM BIOMAR, V1, P597; Tsong WH, 2007, BRIT J CANCER, V96, P821, DOI 10.1038/sj.bjc.6603623; von Roon AC, 2007, DIS COLON RECTUM, V50, P839, DOI 10.1007/s10350-006-0848-z; Wei YS, 2009, INT J CANCER, V125, P1876, DOI 10.1002/ijc.24575; Yu HG, 2003, ONCOLOGY-BASEL, V65, P37, DOI 10.1159/000071203; Yu ZB, 2007, NUCLEIC ACIDS RES, V35, P4535, DOI 10.1093/nar/gkm480; Zhou BF, 2002, BIOMED ENVIRON SCI, V15, P83; Zhou B, 2009, CANCER LETT, V275, P72, DOI 10.1016/j.canlet.2008.10.002	54	59	62	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2011	6	6							e21726	10.1371/journal.pone.0021726	http://dx.doi.org/10.1371/journal.pone.0021726			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786GP	21738780	Green Submitted, Green Published, gold			2022-12-27	WOS:000292291800034
J	Fernandez, C; Schuhmann, K; Herzog, R; Fielding, B; Frayn, K; Shevchenko, A; James, P; Holm, C; Strom, K				Fernandez, Celine; Schuhmann, Kai; Herzog, Ronny; Fielding, Barbara; Frayn, Keith; Shevchenko, Andrej; James, Peter; Holm, Cecilia; Strom, Kristoffer			Altered Desaturation and Elongation of Fatty Acids in Hormone-Sensitive Lipase Null Mice	PLOS ONE			English	Article							STEAROYL-COA DESATURASE-1; ADIPOSE-TISSUE; PROTECTS MICE; OBESITY; DEFICIENCY; EXPRESSION; IDENTIFICATION; ADIPOGENESIS; METABOLISM; RESISTANCE	Background: Hormone-sensitive lipase (HSL) is expressed predominantly in adipose tissue, where it plays an important role in catecholamine-stimulated hydrolysis of stored lipids, thus mobilizing fatty acids. HSL exhibits broad substrate specificity and besides acylglycerides it hydrolyzes cholesteryl esters, retinyl esters and lipoidal esters. Despite its role in fatty acid mobilization, HSL null mice have been shown to be resistant to diet-induced obesity. The aim of this study was to define lipid profiles in plasma, white adipose tissue (WAT) and liver of HSL null mice, in order to better understand the role of this multifunctional enzyme. Methodology/ Principal Findings: This study used global and targeted lipidomics and expression profiling to reveal changed lipid profiles in WAT, liver and plasma as well as altered expression of desaturases and elongases in WAT and liver of HSL null mice on high fat diet. Decreased mRNA levels of stearoyl-CoA desaturase 1 and 2 in WAT were consistent with a lowered ratio of 16:1n7/16:0 and 18:1n9/18:0 in WAT and plasma. In WAT, increased ratio of 18:0/16:0 could be linked to elevated mRNA levels of the Elovl1 elongase. Conclusions: This study illustrates the importance of HSL for normal lipid metabolism in response to a high fat diet. HSL deficiency greatly influences the expression of elongases and desaturases, resulting in altered lipid profiles in WAT, liver and plasma. Finally, altered proportions of palmitoleate, a recently-suggested lipokine, in tissue and plasma of HSL null mice, could be an important factor mediating and contributing to the changed lipid profile, and possibly also to the decreased insulin sensitivity seen in HSL null mice.	[Fernandez, Celine; Holm, Cecilia; Strom, Kristoffer] Lund Univ, Dept Expt Med Sci, Lund, Sweden; [Schuhmann, Kai; Herzog, Ronny; Shevchenko, Andrej] Max Planck Inst Mol Cell Biol & Genet, Dresden, Germany; [Fielding, Barbara; Frayn, Keith] Univ Oxford, Oxford Ctr Diabet Endocrinol & Metab, Oxford, England; [James, Peter] Lund Univ, Dept Immunotechnol, Lund, Sweden	Lund University; Max Planck Society; University of Oxford; Lund University	Fernandez, C (corresponding author), Lund Univ, Malmo Univ Hosp, Dept Clin Sci, Malmo, Sweden.	kristoffer.strom@med.lu.se	Fernandez, Celine/ABH-9332-2020	Fernandez, Celine/0000-0003-1290-4982	Foundation of Tage Blucher for Medical Research; Novo Nordisk foundation; Royal Physiographic Society in Lund; Swedish Research Council [11284]; Swedish Diabetes Association; Bundesministerium f. Bildung u. Forschung (BMBF) [/0315757]; A. Pahlsson, Ahlen; Lars Hiertas Minne; Diabetesforeningen i Malmo med omnejd	Foundation of Tage Blucher for Medical Research; Novo Nordisk foundation(Novo Nordisk FoundationNovocure Limited); Royal Physiographic Society in Lund; Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Diabetes Association; Bundesministerium f. Bildung u. Forschung (BMBF)(Federal Ministry of Education & Research (BMBF)); A. Pahlsson, Ahlen; Lars Hiertas Minne; Diabetesforeningen i Malmo med omnejd	Financial support was provided by the Foundation of Tage Blucher for Medical Research (K.S.); the Novo Nordisk foundation and the Royal Physiographic Society in Lund (C.F.); the Swedish Research Council (project no 11284) and the Swedish Diabetes Association (C.H.); TRR 83 grant from Deutsche Forschungsgemeinschaft (DFG) and Virtual Liver (Code/0315757) grant from Bundesministerium f. Bildung u. Forschung (BMBF) (A.S.), and the following foundations: Novo Nordisk, A. Pahlsson, Ahlen, Lars Hiertas Minne, Diabetesforeningen i Malmo med omnejd. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Burdge GC, 2000, BRIT J NUTR, V84, P781; Cao HM, 2008, CELL, V134, P933, DOI 10.1016/j.cell.2008.07.048; Christianson JL, 2008, J BIOL CHEM, V283, P2906, DOI 10.1074/jbc.M705656200; Cohen P, 2002, SCIENCE, V297, P240, DOI 10.1126/science.1071527; Evans K, 2002, DIABETES, V51, P2684, DOI 10.2337/diabetes.51.9.2684; Fernandez C, 2008, AM J PHYSIOL-ENDOC M, V295, pE820, DOI 10.1152/ajpendo.90206.2008; FOLCH J, 1957, J BIOL CHEM, V226, P497; Graessler J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006261; Grober J, 2003, J BIOL CHEM, V278, P6510, DOI 10.1074/jbc.M208513200; Guillou H, 2010, PROG LIPID RES, V49, P186, DOI 10.1016/j.plipres.2009.12.002; Haemmerle G, 2002, J BIOL CHEM, V277, P4806, DOI 10.1074/jbc.M110355200; Hansson O, 2005, J LIPID RES, V46, P2614, DOI 10.1194/jlr.M500028-JLR200; Harada K, 2003, AM J PHYSIOL-ENDOC M, V285, pE1182, DOI 10.1152/ajpendo.00259.2003; Hodson L, 2008, PROG LIPID RES, V47, P348, DOI 10.1016/j.plipres.2008.03.003; Hotamisligil GS, 1996, SCIENCE, V274, P1377, DOI 10.1126/science.274.5291.1377; Kim YC, 2000, J LIPID RES, V41, P1310; Maeda K, 2005, CELL METAB, V1, P107, DOI 10.1016/j.cmet.2004.12.008; Maeda K, 2003, DIABETES, V52, P300, DOI 10.2337/diabetes.52.2.300; Matsuzaka T, 2007, NAT MED, V13, P1193, DOI 10.1038/nm1662; Matyash V, 2008, J LIPID RES, V49, P1137, DOI 10.1194/jlr.D700041-JLR200; Miyazaki M, 2006, J LIPID RES, V47, P700, DOI 10.1194/jlr.C500025-JLR200; Miyazaki M, 2007, CELL METAB, V6, P484, DOI 10.1016/j.cmet.2007.10.014; Mulder H, 2003, J BIOL CHEM, V278, P36380, DOI 10.1074/jbc.M213032200; Ntambi JM, 2002, P NATL ACAD SCI USA, V99, P11482, DOI 10.1073/pnas.132384699; Paton CM, 2009, AM J PHYSIOL-ENDOC M, V297, pE28, DOI 10.1152/ajpendo.90897.2008; Raclot T, 2001, J LIPID RES, V42, P2049; RODBELL M, 1964, J BIOL CHEM, V239, P375; Sampath H, 2007, J BIOL CHEM, V282, P2483, DOI 10.1074/jbc.M610158200; Shen WJ, 2011, BBA-MOL CELL BIOL L, V1811, P9, DOI 10.1016/j.bbalip.2010.10.001; Stewart WC, 2004, BIOCHEM BIOPH RES CO, V324, P355, DOI 10.1016/j.bbrc.2004.09.053; Strom K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001793; Strom K, 2009, FASEB J, V23, P2307, DOI 10.1096/fj.08-120923; Tzameli I, 2004, J BIOL CHEM, V279, P36093, DOI 10.1074/jbc.M405346200; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wang Y, 2006, J LIPID RES, V47, P2028, DOI 10.1194/jlr.M600177-JLR200; Yeaman SJ, 2004, BIOCHEM J, V379, P11, DOI 10.1042/BJ20031811	36	13	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2011	6	6							e21603	10.1371/journal.pone.0021603	http://dx.doi.org/10.1371/journal.pone.0021603			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786FZ	21738729	Green Published, Green Submitted, gold			2022-12-27	WOS:000292290100044
J	Malcom, JW				Malcom, Jacob W.			Gene Networks and Metacommunities: Dispersal Differences Can Override Adaptive Advantage	PLOS ONE			English	Article							RAPID EVOLUTION; DYNAMICS; PRODUCTIVITY; ECOLOGY; FLOW; MONOPOLIZATION; BIODIVERSITY; POPULATION; DIVERSITY; SELECTION	Dispersal is an important mechanism contributing to both ecological and evolutionary dynamics. In metapopulation and metacommunity ecology, dispersal enables new patches to be colonized; in evolution, dispersal counter-acts local selection, leading to regional homogenization. Here, I consider a three-patch metacommunity in which two species, each with a limiting quantitative trait underlain by gene networks of 16 to 256 genes, compete with one another and disperse among patches. Incorporating dispersal among heterogeneous patches introduces a tradeoff not observed in single-patch simulations: if the difference between gene network size of the two species is greater than the difference in dispersal ability (e. g., if the ratio of network sizes is larger than the ratio of dispersal abilities), then genetic architecture drives community outcome. However, if the difference in dispersal abilities is greater than gene network differences, then any adaptive advantages afforded by genetic architecture are over-ridden by dispersal. Thus, in addition to the selective pressures imposed by competition that shape the genetic architecture of quantitative traits, dispersal among patches creates an escape that may further alter the effects of different genetic architectures. These results provide a theoretical expectation for what we may observe as the field of ecological genomics develops.	Univ Texas Austin, Dept Integrat Biol, Austin, TX 78712 USA	University of Texas System; University of Texas Austin	Malcom, JW (corresponding author), Univ Texas Austin, Dept Integrat Biol, Austin, TX 78712 USA.	jmalcom@mail.utexas.edu	/AAD-1873-2020	/0000-0002-4904-8369	University of Texas at Austin	University of Texas at Austin	This work was supported in part by a start-up grant from the University of Texas at Austin. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; [Anonymous], 1963, ANIMAL SPECIES EVOLU; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Bohonak AJ, 2003, ECOL LETT, V6, P783, DOI 10.1046/j.1461-0248.2003.00486.x; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Carter AJR, 2005, THEOR POPUL BIOL, V68, P179, DOI 10.1016/j.tpb.2005.05.002; Chase J.M., 2009, ECOLOGICAL NICHES LI; Chase JM, 2002, NATURE, V416, P427, DOI 10.1038/416427a; CHEVERUD JM, 1995, GENETICS, V139, P1455; Cork JM, 2004, BIOESSAYS, V26, P479, DOI 10.1002/bies.20026; De Meester L, 2002, ACTA OECOL, V23, P121, DOI 10.1016/S1146-609X(02)01145-1; DOBZHANSKY T, 1947, GENETICS, V32, P303; Etienne R, 2002, ECOL MODEL, V148, P153, DOI 10.1016/S0304-3800(01)00417-3; France KE, 2006, NATURE, V441, P1139, DOI 10.1038/nature04729; Frank SA, 1999, J THEOR BIOL, V197, P281, DOI 10.1006/jtbi.1998.0872; Fukami T, 2007, NATURE, V446, P436, DOI 10.1038/nature05629; Garant D, 2007, FUNCT ECOL, V21, P434, DOI 10.1111/j.1365-2435.2006.01228.x; GOMULKIEWICZ R, 1995, EVOLUTION, V49, P201, DOI 10.1111/j.1558-5646.1995.tb05971.x; Gravel D, 2006, ECOL LETT, V9, P399, DOI 10.1111/j.1461-0248.2006.00884.x; Gravel D, 2010, AM NAT, V176, P289, DOI 10.1086/655426; Gravel D, 2010, ECOLOGY, V91, P2172, DOI 10.1890/09-0843.1; Haag CR, 2005, P ROY SOC B-BIOL SCI, V272, P2449, DOI 10.1098/rspb.2005.3235; Hairston NG, 2005, ECOL LETT, V8, P1114, DOI 10.1111/j.1461-0248.2005.00812.x; Hansen TF, 2006, AM NAT, V168, P168, DOI 10.1086/505768; Hanski I., 1999, METAPOPULATION ECOLO; HANSKI I, 1997, METAPOPULATION BIOL; Holt RD, 1997, AM NAT, V149, P563, DOI 10.1086/286005; Holyoak M, 2006, ECOLOGY, V87, P1370, DOI 10.1890/0012-9658(2006)87[1370:REEWNC]2.0.CO;2; Hubbell Stephen P., 2001, V32, pi; Johnson KH, 1996, TRENDS ECOL EVOL, V11, P372, DOI 10.1016/0169-5347(96)10040-9; Johnson MTJ, 2007, TRENDS ECOL EVOL, V22, P250, DOI 10.1016/j.tree.2007.01.014; JOHNSTON JS, 1982, DISPERSAL CLINES OPU, P241; KIMBRELL T, 2009, EVOL ECOL; Kimbrell T, 2007, AM NAT, V169, P370, DOI 10.1086/511314; Leibold M.A, 2009, PRINCETON GUIDE ECOL, P312; Leibold MA, 2004, ECOL LETT, V7, P601, DOI 10.1111/j.1461-0248.2004.00608.x; Lenormand T, 2002, TRENDS ECOL EVOL, V17, P183, DOI 10.1016/S0169-5347(02)02497-7; Loeuille N, 2008, AM NAT, V171, P788, DOI 10.1086/587745; Loreau M., 2010, POPULATIONS ECOSYSTE; Malcom J, PLOS ONE IN PRESS; Malcom JW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014645; MCPEEK MA, 1992, AM NAT, V140, P1010, DOI 10.1086/285453; Mouquet N., 2005, METACOMMUNITIES SPAT, P237; Neter J, 1985, APPL LINEAR REGRESSI; Nichols J., 2001, DISPERSAL; Nuismer SL, 2004, EVOLUTION, V58, P1165, DOI 10.1111/j.0014-3820.2004.tb01697.x; Parris KM, 2004, ECOGRAPHY, V27, P392, DOI 10.1111/j.0906-7590.2004.03711.x; R Core Team, 2020, R LANG ENV STAT COMP; Repsilber D, 2009, EURASIP J BIOINFO SY, V2009; Terhorst CP, 2010, ECOLOGY, V91, P629, DOI 10.1890/09-1481.1; Urban MC, 2008, TRENDS ECOL EVOL, V23, P311, DOI 10.1016/j.tree.2008.02.007; Urban MC, 2006, ECOLOGY, V87, P1616, DOI 10.1890/0012-9658(2006)87[1616:EMTAEP]2.0.CO;2; URBAN MC, 2009, P BIOL SCI; Venail PA, 2008, NATURE, V452, P210, DOI 10.1038/nature06554; Wilenski U., 1999, NETLOGO; Yoshida T, 2003, NATURE, V424, P303, DOI 10.1038/nature01767; Yoshida T, 2007, PLOS BIOL, V5, P1868, DOI 10.1371/journal.pbio.0050235	57	4	4	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2011	6	6							e21541	10.1371/journal.pone.0021541	http://dx.doi.org/10.1371/journal.pone.0021541			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	784FW	21738698	Green Submitted, Green Published, gold			2022-12-27	WOS:000292142800036
J	Lee, ST; Chu, K; Jung, KH; Song, YM; Jeon, D; Kim, SU; Kim, M; Lee, SK; Roh, JK				Lee, Soon-Tae; Chu, Kon; Jung, Keun-Hwa; Song, Young-Mi; Jeon, Daejong; Kim, Seung U.; Kim, Manho; Lee, Sang Kun; Roh, Jae-Kyu			Direct Generation of Neurosphere-Like Cells from Human Dermal Fibroblasts	PLOS ONE			English	Article							NEURAL STEM-CELLS; PROGENITOR CELLS; SOMATIC-CELLS; TRANSPLANTATION; NEURONS; INDUCTION; MOUSE; DIFFERENTIATION; ENGRAFTMENT; MECHANISM	Neural stem cell (NSC) transplantation replaces damaged brain cells and provides disease-modifying effects in many neurological disorders. However, there has been no efficient way to obtain autologous NSCs in patients. Given that ectopic factors can reprogram somatic cells to be pluripotent, we attempted to generate human NSC-like cells by reprograming human fibroblasts. Fibroblasts were transfected with NSC line-derived cellular extracts and grown in neurosphere culture conditions. The cells were then analyzed for NSC characteristics, including neurosphere formation, gene expression patterns, and ability to differentiate. The obtained induced neurosphere-like cells (iNS), which formed daughter neurospheres after serial passaging, expressed neural stem cell markers, and had demethylated SOX2 regulatory regions, all characteristics of human NSCs. The iNS had gene expression patterns that were a combination of the patterns of NSCs and fibroblasts, but they could be differentiated to express neuroglial markers and neuronal sodium channels. These results show for the first time that iNS can be directly generated from human fibroblasts. Further studies on their application in neurological diseases are warranted.	[Lee, Soon-Tae; Chu, Kon; Jung, Keun-Hwa; Song, Young-Mi; Kim, Manho; Lee, Sang Kun; Roh, Jae-Kyu] Seoul Natl Univ Hosp, Clin Res Inst, Dept Neurol, Seoul 110744, South Korea; [Lee, Soon-Tae; Chu, Kon; Jung, Keun-Hwa; Kim, Manho; Lee, Sang Kun; Roh, Jae-Kyu] Seoul Natl Univ, Program Neurosci, Neurosci Res Inst SNUMRC, Seoul, South Korea; [Jeon, Daejong] Korea Adv Inst Sci & Technol, Dept Bio & Brain Engn, Taejon 305701, South Korea; [Kim, Seung U.] Univ British Columbia, Dept Med, Div Neurol, UBC Hosp, Vancouver, BC V6T 1W5, Canada; [Kim, Seung U.] Chung Ang Univ, Sch Med, Med Res Inst, Seoul, South Korea	Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Korea Advanced Institute of Science & Technology (KAIST); University of British Columbia; Chung Ang University; Chung Ang University Hospital	Lee, ST (corresponding author), Seoul Natl Univ Hosp, Clin Res Inst, Dept Neurol, Seoul 110744, South Korea.	rohjk@snu.ac.kr	Lee, Sang Kun/J-5578-2012; Jeon, Daejong/C-1814-2011; Kim, Manho/J-2738-2012; Roh, Jae Kyu/J-5459-2012; Lee, Soon-Tae/C-4663-2013	Lee, Soon-Tae/0000-0003-4767-7564; Jeon, Daejong/0000-0002-6998-7603; Chu, Kon/0000-0001-5863-0302	Ministry for Health, Welfare & Family Affairs, Republic of Korea [A100548]; Seoul National University Hospital [0320090200, 0420080160, 0320090160, 0320110160, 0420100200, 0420080620, 0320110360, 0420090280]	Ministry for Health, Welfare & Family Affairs, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea); Seoul National University Hospital	This study was supported by Research Grants from the Korea Healthcare Technology R&D Project, Ministry for Health, Welfare & Family Affairs, Republic of Korea (A100548). JKR was supported by Seoul National University Hospital Research Funds (0320090200, 0420080160). SKL was supported by Seoul National University Hospital Research Funds (0320090160, 0320110160, 0420100200, 0420080620). KC was supported by Seoul National University Hospital Research Funds (0320110360, 0420090280). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnhold S, 2004, INVEST OPHTH VIS SCI, V45, P4251, DOI 10.1167/iovs.03-1108; Chan EM, 2009, NAT BIOTECHNOL, V27, P1033, DOI 10.1038/nbt.1580; Cho HJ, 2010, BLOOD, V116, P386, DOI 10.1182/blood-2010-02-269589; Chu K, 2004, BRAIN RES, V1023, P213, DOI 10.1016/j.brainres.2004.07.045; Chu K, 2008, BRAIN RES, V1207, P182, DOI 10.1016/j.brainres.2008.02.043; Donato R, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-36; Episkopou V, 2005, TRENDS NEUROSCI, V28, P219, DOI 10.1016/j.tins.2005.03.003; Flax JD, 1998, NAT BIOTECHNOL, V16, P1033, DOI 10.1038/3473; Hakelien AM, 2002, NAT BIOTECHNOL, V20, P460, DOI 10.1038/nbt0502-460; Ieda M, 2010, CELL, V142, P375, DOI 10.1016/j.cell.2010.07.002; Jeon D, 2003, NEURON, V38, P965, DOI 10.1016/S0896-6273(03)00334-9; Kaech S, 2006, NAT PROTOC, V1, P2406, DOI 10.1038/nprot.2006.356; Kaneko Y, 2000, DEV NEUROSCI-BASEL, V22, P139, DOI 10.1159/000017435; Kim K, 2010, NATURE, V467, P285, DOI 10.1038/nature09342; Kim Seung U., 2008, V438, P103, DOI 10.1007/978-1-59745-133-8_10; Kim YT, 2006, EXP NEUROL, V199, P222, DOI 10.1016/j.expneurol.2006.03.015; Koch P, 2009, LANCET NEUROL, V8, P819, DOI 10.1016/S1474-4422(09)70202-9; Lee HJ, 2007, STEM CELLS, V25, P1204, DOI 10.1634/stemcells.2006-0409; Lee ST, 2008, BRAIN, V131, P616, DOI 10.1093/brain/awm306; Martino G, 2006, NAT REV NEUROSCI, V7, P395, DOI 10.1038/nrn1908; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Nunes MC, 2003, NAT MED, V9, P439, DOI 10.1038/nm837; Okita K, 2008, SCIENCE, V322, P949, DOI 10.1126/science.1164270; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Ourednik J, 2002, NAT BIOTECHNOL, V20, P1103, DOI 10.1038/nbt750; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Qin M, 2005, STEM CELLS, V23, P712, DOI 10.1634/stemcells.2004-0195; Rajasingh J, 2008, CIRC RES, V102, pE107, DOI 10.1161/CIRCRESAHA.108.176115; Roy NS, 2006, NAT MED, V12, P1259, DOI 10.1038/nm1495; Sanai N, 2004, NATURE, V427, P740, DOI 10.1038/nature02301; Seminatore C, 2010, STROKE, V41, P153, DOI 10.1161/STROKEAHA.109.563015; Sikorska M, 2008, J NEUROSCI RES, V86, P1680, DOI 10.1002/jnr.21635; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Taranger CK, 2005, MOL BIOL CELL, V16, P5719, DOI 10.1091/mbc.e05-06-0572; Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797; Wernig M, 2004, J NEUROSCI, V24, P5258, DOI 10.1523/JNEUROSCI.0428-04.200; Woltjen K, 2009, NATURE, V458, P766, DOI 10.1038/nature07863; Yamanaka S, 2010, NATURE, V465, P704, DOI 10.1038/nature09229; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	41	11	11	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2011	6	7							e21801	10.1371/journal.pone.0021801	http://dx.doi.org/10.1371/journal.pone.0021801			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	792WQ	21765916	gold, Green Published, Green Submitted			2022-12-27	WOS:000292781500017
J	Navarro, JA; Llorens, JV; Soriano, S; Botella, JA; Schneuwly, S; Martinez-Sebastian, MJ; Molto, MD				Navarro, Juan A.; Llorens, Jose V.; Soriano, Sirena; Botella, Jose A.; Schneuwly, Stephan; Martinez-Sebastian, Maria J.; Molto, Maria D.			Overexpression of Human and Fly Frataxins in Drosophila Provokes Deleterious Effects at Biochemical, Physiological and Developmental Levels	PLOS ONE			English	Article							FRIEDREICH ATAXIA; OXIDATIVE STRESS; PARKINSONS-DISEASE; IRON CHAPERONE; IN-VIVO; SACCHAROMYCES-CEREVISIAE; ENERGY-METABOLISM; ESCHERICHIA-COLI; SCAFFOLD PROTEIN; UP-REGULATION	Background: Friedreich's ataxia (FA), the most frequent form of inherited ataxias in the Caucasian population, is caused by a reduced expression of frataxin, a highly conserved protein. Model organisms have contributed greatly in the efforts to decipher the function of frataxin; however, the precise function of this protein remains elusive. Overexpression studies are a useful approach to investigate the mechanistic actions of frataxin; however, the existing literature reports contradictory results. To further investigate the effect of frataxin overexpression, we analyzed the consequences of overexpressing human (FXN) and fly (FH) frataxins in Drosophila. Methodology/Principal Findings: We obtained transgenic flies that overexpressed human or fly frataxins in a general pattern and in different tissues using the UAS-GAL4 system. For both frataxins, we observed deleterious effects at the biochemical, histological and behavioral levels. Oxidative stress is a relevant factor in the frataxin overexpression phenotypes. Systemic frataxin overexpression reduces Drosophila viability and impairs the normal embryonic development of muscle and the peripheral nervous system. A reduction in the level of aconitase activity and a decrease in the level of NDUF3 were also observed in the transgenic flies that overexpressed frataxin. Frataxin overexpression in the nervous system reduces life span, impairs locomotor ability and causes brain degeneration. Frataxin aggregation and a misfolding of this protein have been shown not to be the mechanism that is responsible for the phenotypes that have been observed. Nevertheless, the expression of human frataxin rescues the aconitase activity in the fh knockdown mutant. Conclusion/Significance: Our results provide in vivo evidence of a functional equivalence for human and fly frataxins and indicate that the control of frataxin expression is important for treatments that aim to increase frataxin levels.	[Navarro, Juan A.; Botella, Jose A.; Schneuwly, Stephan] Univ Regensburg, Inst Zool, D-8400 Regensburg, Germany; [Llorens, Jose V.; Soriano, Sirena; Martinez-Sebastian, Maria J.; Molto, Maria D.] Univ Valencia, Dept Genet, Valencia, Spain; [Llorens, Jose V.] CSIC, Inst Biomed, Valencia, Spain; [Molto, Maria D.] CIBERSAM Ctr Invest Biomed & Red Salud Mental, Madrid, Spain	University of Regensburg; University of Valencia; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biomedicina de Valencia (IBV); CIBER - Centro de Investigacion Biomedica en Red; CIBERSAM	Navarro, JA (corresponding author), Univ Regensburg, Inst Zool, Univ Str 31, D-8400 Regensburg, Germany.	jose.vicente.llorens@uv.es	Langa, Juan Antonio Navarro/AAA-8013-2020	Langa, Juan Antonio Navarro/0000-0003-2266-728X; Martinez-Sebastian, Maria-Jose/0000-0001-5549-7921; Molto, Maria Dolores/0000-0001-5219-2022; Soriano, Sirena/0000-0001-9967-7262; Schneuwly, Stephan/0000-0001-7711-8902; Llorens, Jose V./0000-0001-9823-6246	Fondo Investigaciones Sanitarias [ISCIII06- PI0677]; La Fundacio la Marato TV3 of Spain [exp 101932]; European Friedreich's Ataxia Consortium for Translational Studies; Ministerio de Ciencia e Innovacion of Spain; NICHD	Fondo Investigaciones Sanitarias(Instituto de Salud Carlos III); La Fundacio la Marato TV3 of Spain; European Friedreich's Ataxia Consortium for Translational Studies; Ministerio de Ciencia e Innovacion of Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by grants from Fondo Investigaciones Sanitarias (ISCIII06- PI0677) and La Fundacio la Marato TV3 (exp 101932) of Spain. JVL is supported by the European Friedreich's Ataxia Consortium for Translational Studies. SS is a recipient of a fellowship from Ministerio de Ciencia e Innovacion of Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank Dr. Dan Kiehart and Dr. Francesc Palau for the generous gifts of the anti-MHC and anti-Frataxin, respectively. The hybridoma antibodies 22C10 and BP102, which were developed by S. Benzer and C. Goodman, respectively, were obtained from the Developmental Studies Hybridoma Bank, developed under the auspices of the NICHD, and maintained by the University of Iowa, Department of Biological Sciences, IA 52242. We also thank the Bloomington Stock Center for the fly stocks. The authors would like to thank Uschi Roth for their technical assistance, and Dr. Juan Ferre and Dr. Emmanuel Lesuisse for their technical assistance and protocol for the gel filtration experiment. We also thank the Servicio Central de Soporte a la Investigacion Experimental de la Universitat de Valencia for access to the DNA analysis resources and databases.	Adinolfi S, 2009, NAT STRUCT MOL BIOL, V16, P390, DOI 10.1038/nsmb.1579; Aloria K, 2004, EMBO REP, V5, P1096, DOI 10.1038/sj.embor.7400272; Anderson PR, 2008, P NATL ACAD SCI USA, V105, P611, DOI 10.1073/pnas.0709691105; Anderson PR, 2005, HUM MOL GENET, V14, P3397, DOI 10.1093/hmg/ddi367; Auluck PK, 2002, SCIENCE, V295, P865, DOI 10.1126/science.1067389; Babcock M, 1997, SCIENCE, V276, P1709, DOI 10.1126/science.276.5319.1709; Botella JA, 2004, CURR BIOL, V14, P782, DOI 10.1016/j.cub.2004.04.036; Bou-Abdallah F, 2004, J MOL BIOL, V341, P605, DOI 10.1016/j.jmb.2004.05.072; Bulteau AL, 2004, SCIENCE, V305, P242, DOI 10.1126/science.1098991; Bulteau AL, 2007, FREE RADICAL BIO MED, V42, P1561, DOI 10.1016/j.freeradbiomed.2007.02.014; Campuzano V, 1996, SCIENCE, V271, P1423, DOI 10.1126/science.271.5254.1423; Campuzano V, 1997, HUM MOL GENET, V6, P1771, DOI 10.1093/hmg/6.11.1771; Canizares J, 2000, GENE, V256, P35, DOI 10.1016/S0378-1119(00)00343-7; Cavadini P, 2000, HUM MOL GENET, V9, P2523, DOI 10.1093/hmg/9.17.2523; Das N, 2001, BIOCHEM J, V360, P209, DOI 10.1042/0264-6021:3600209; Delaval E, 2004, EUR J BIOCHEM, V271, P4559, DOI 10.1111/j.1432-1033.2004.04422.x; Emond M, 2000, NEUROLOGY, V55, P1752, DOI 10.1212/WNL.55.11.1752; Feany MB, 2000, NATURE, V404, P394, DOI 10.1038/35006074; Fernandez-Funez P, 2000, NATURE, V408, P101, DOI 10.1038/35040584; Fernandez-Funez P, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000507; Finelli A, 2004, MOL CELL NEUROSCI, V26, P365, DOI 10.1016/j.mcn.2004.03.001; Gibson TJ, 1996, TRENDS NEUROSCI, V19, P465, DOI 10.1016/S0166-2236(96)20054-2; Gonzalez-Cabo P, 2005, HUM MOL GENET, V14, P2091, DOI 10.1093/hmg/ddi214; Guillon B, 2009, FEBS J, V276, P1036, DOI 10.1111/j.1742-4658.2008.06847.x; HARDING AE, 1981, BRAIN, V104, P589, DOI 10.1093/brain/104.3.589; HARDING AE, 1993, ADV NEUROL, V61, P1; HARDING AE, 1983, Q J MED, V52, P489; Kirby K, 2002, P NATL ACAD SCI USA, V99, P16162, DOI 10.1073/pnas.252342899; Kondapalli KC, 2008, BIOCHEMISTRY-US, V47, P6917, DOI 10.1021/bi800366d; Layer G, 2006, J BIOL CHEM, V281, P16256, DOI 10.1074/jbc.M513569200; Li KY, 2008, HUM MOL GENET, V17, P2265, DOI 10.1093/hmg/ddn127; Li KY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012286; Llorens JV, 2007, FASEB J, V21, P333, DOI 10.1096/fj.05-5709com; Marsh JL, 2003, HUM MOL GENET, V12, pR187, DOI 10.1093/hmg/ddg271; Miranda CJ, 2004, FEBS LETT, V572, P281, DOI 10.1016/j.febslet.2004.07.022; Moreno-Cermeno A, 2010, J BIOL CHEM, V285, P41653, DOI 10.1074/jbc.M110.149443; Muhlenhoff U, 2003, EMBO J, V22, P4815, DOI 10.1093/emboj/cdg446; Mutsuddi M, 2004, CURR BIOL, V14, P302, DOI 10.1016/j.cub.2004.01.034; Navarro JA, 2010, HUM MOL GENET, V19, P2828, DOI 10.1093/hmg/ddq183; Ohshima K, 1998, J BIOL CHEM, V273, P14588, DOI 10.1074/jbc.273.23.14588; Oktay Y, 2007, J BIOL CHEM, V282, P11750, DOI 10.1074/jbc.M611133200; ORR WC, 1992, ARCH BIOCHEM BIOPHYS, V297, P35, DOI 10.1016/0003-9861(92)90637-C; Palau F, 2006, ORPHANET J RARE DIS, V1, DOI 10.1186/1750-1172-1-47; Park S, 2003, J BIOL CHEM, V278, P31340, DOI 10.1074/jbc.M303158200; PATEL NH, 1994, METHOD CELL BIOL, V44, P445, DOI 10.1016/S0091-679X(08)60927-9; Puccio H, 2001, NAT GENET, V27, P181, DOI 10.1038/84818; Ramazzotti A, 2004, FEBS LETT, V557, P215, DOI 10.1016/S0014-5793(03)01498-4; Ristow M, 2000, P NATL ACAD SCI USA, V97, P12239, DOI 10.1073/pnas.220403797; Ristow M, 2003, J CLIN INVEST, V112, P527, DOI 10.1172/JCI200318107; Rotig A, 1997, NAT GENET, V17, P215, DOI 10.1038/ng1097-215; RUBIN GM, 1982, SCIENCE, V218, P348, DOI 10.1126/science.6289436; Runkoa AP, 2008, FEBS LETT, V582, P715, DOI 10.1016/j.febslet.2008.01.046; Sakamoto N, 1999, MOL CELL, V3, P465, DOI 10.1016/S1097-2765(00)80474-8; Schmucker S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016199; Schulz JB, 2000, NEUROLOGY, V55, P1719, DOI 10.1212/WNL.55.11.1719; Schulz TJ, 2010, AGING-US, V2, P843, DOI 10.18632/aging.100234; Schulz TJ, 2006, J BIOL CHEM, V281, P977, DOI 10.1074/jbc.M511064200; Seguin A, 2009, MITOCHONDRION, V9, P130, DOI 10.1016/j.mito.2009.01.007; Shidara Y, 2010, J NEUROSCI, V30, P11369, DOI 10.1523/JNEUROSCI.0529-10.2010; Shoichet SA, 2002, HUM MOL GENET, V11, P815, DOI 10.1093/hmg/11.7.815; Stemmler TL, 2010, J BIOL CHEM, V285, P26737, DOI 10.1074/jbc.R110.118679; Sutak R, 2008, PROTEOMICS, V8, P1731, DOI 10.1002/pmic.200701049; Vazquez-Manrique RP, 2005, FASEB J, V19, P172, DOI 10.1096/fj.05-4212fje; Venderova K, 2009, HUM MOL GENET, V18, P4390, DOI 10.1093/hmg/ddp394; Vivas E, 2006, J BACTERIOL, V188, P1175, DOI 10.1128/JB.188.3.1175-1179.2006; Warrick JM, 1999, NAT GENET, V23, P425, DOI 10.1038/70532	66	26	26	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2011	6	7							e21017	10.1371/journal.pone.0021017	http://dx.doi.org/10.1371/journal.pone.0021017			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791QY	21779322	Green Submitted, gold, Green Published			2022-12-27	WOS:000292680900003
J	Eronina, T; Borzova, V; Maloletkina, O; Kleymenov, S; Asryants, R; Markossian, K; Kurganov, B				Eronina, Tatyana; Borzova, Vera; Maloletkina, Olga; Kleymenov, Sergey; Asryants, Regina; Markossian, Kira; Kurganov, Boris			A Protein Aggregation Based Test for Screening of the Agents Affecting Thermostability of Proteins	PLOS ONE			English	Article							GLYCOGEN-PHOSPHORYLASE-B; RABBIT SKELETAL-MUSCLE; THERMAL AGGREGATION; ALPHA-CRYSTALLIN; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; GLOBULAR-PROTEINS; LIGHT-SCATTERING; BETA-LACTOGLOBULIN; MECHANISM; KINETICS	To search for agents affecting thermal stability of proteins, a test based on the registration of protein aggregation in the regime of heating with a constant rate was used. The initial parts of the dependences of the light scattering intensity (I) on temperature (T) were analyzed using the following empiric equation: I = K-agg(T-T-0)(2), where K-agg is the parameter characterizing the initial rate of aggregation and T-0 is a temperature at which the initial increase in the light scattering intensity is registered. The aggregation data are interpreted in the frame of the model assuming the formation of the start aggregates at the initial stages of the aggregation process. Parameter T-0 corresponds to the moment of the origination of the start aggregates. The applicability of the proposed approach was demonstrated on the examples of thermal aggregation of glycogen phosphorylase b from rabbit skeletal muscles and bovine liver glutamate dehydrogenase studied in the presence of agents of different chemical nature. The elaborated approach to the study of protein aggregation may be used for rapid identification of small molecules that interact with protein targets.	[Eronina, Tatyana; Borzova, Vera; Maloletkina, Olga; Markossian, Kira; Kurganov, Boris] Russian Acad Sci, Bach Inst Biochem, Moscow, Russia; [Kleymenov, Sergey] Russian Acad Sci, Koltsov Inst Dev Biol, Moscow, Russia; [Asryants, Regina] Moscow MV Lomonosov State Univ, Belozersky Inst Physicochem Biol, Moscow, Russia	Research Center of Biotechnology RAS; Russian Academy of Sciences; Russian Academy of Sciences; Koltzov Institute of Developmental Biology of the Russian Academy of Sciences; Lomonosov Moscow State University	Eronina, T (corresponding author), Russian Acad Sci, Bach Inst Biochem, Moscow, Russia.	eronina@inbi.ras.ru; kurganov@inbi.ras.ru	Kurganov, Boris/M-1286-2019; Borzova, Vera/F-4021-2017; Asryants, Regina/E-1348-2013; Kleymenov, Sergey/R-1195-2018	Borzova, Vera/0000-0003-1544-8804; Kurganov, Boris/0000-0002-2930-2286; Kleymenov, Sergey/0000-0001-5085-0327	Russian Foundation for Basic Research [11-04-00932-?, 11-04-01271-a, 11-04-01350-?]; Presidium of the Russian Academy of Sciences; Dmitry Zimin Dynasty Foundation; Federal Target Program "Scientific and Scientific-Pedagogical Personnel of Innovative Russia" [P1356]	Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Presidium of the Russian Academy of Sciences(Russian Academy of Sciences); Dmitry Zimin Dynasty Foundation; Federal Target Program "Scientific and Scientific-Pedagogical Personnel of Innovative Russia"	This study was funded by the Russian Foundation for Basic Research (grants 11-04-00932-?, 11-04-01271-a and 11-04-01350-?), the Program "Molecular and Cell Biology" of the Presidium of the Russian Academy of Sciences and Dmitry Zimin Dynasty Foundation, the Federal Target Program "Scientific and Scientific-Pedagogical Personnel of Innovative Russia" in 2009-2013 (the state contract No. P1356). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aymard P, 1996, J CHIM PHYS PCB, V93, P987, DOI 10.1051/jcp/1996930987; Baussay K, 2004, INT J BIOL MACROMOL, V34, P21, DOI 10.1016/j.ijbiomac.2003.11.003; Bolen D W, 2001, Methods Mol Biol, V168, P17; Bumagina Z, 2010, INT J MOL SCI, V11, P4556, DOI 10.3390/ijms11114556; Bumagina ZM, 2010, BIOPHYS CHEM, V146, P108, DOI 10.1016/j.bpc.2009.11.002; Cellmer T, 2007, BIOPHYS CHEM, V125, P350, DOI 10.1016/j.bpc.2006.09.010; Chaitankar V, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S6-S19; Chebotareva NA, 2004, BIOCHEMISTRY-MOSCOW+, V69, P1239, DOI 10.1007/s10541-005-0070-y; Chen SM, 2002, P NATL ACAD SCI USA, V99, P11884, DOI 10.1073/pnas.182276099; CHRUNYK BA, 1993, PROTEIN ENG, V6, P733, DOI 10.1093/protein/6.7.733; CHRUNYK BA, 1993, J BIOL CHEM, V268, P18053; DEYOUNG LR, 1993, ACCOUNTS CHEM RES, V26, P614, DOI 10.1021/ar00036a002; Durand D, 2002, PHYSICA A, V304, P253, DOI 10.1016/S0378-4371(01)00514-3; Duy C, 2005, J BIOL CHEM, V280, P37360, DOI 10.1074/jbc.M507530200; Eronina TB, 2010, BIOPOLYMERS, V93, P986, DOI 10.1002/bip.21508; Eronina TB, 2010, MACROMOL BIOSCI, V10, P768, DOI 10.1002/mabi.200900396; Eronina TB, 2009, BIOPHYS CHEM, V141, P66, DOI 10.1016/j.bpc.2008.12.007; Ferrone F, 1999, METHOD ENZYMOL, V309, P256; Golub N, 2007, FEBS LETT, V581, P4223, DOI 10.1016/j.febslet.2007.07.066; Golub NV, 2009, EUR BIOPHYS J BIOPHY, V38, P547, DOI 10.1007/s00249-009-0403-7; Ignatova Z, 2005, BIOCHEMISTRY-US, V44, P7266, DOI 10.1021/bi047404e; KASTENSCHMIDT LL, 1968, BIOCHEMISTRY-US, V7, P3590, DOI 10.1021/bi00850a037; Khanova HA, 2005, BIOCHEMISTRY-US, V44, P15480, DOI 10.1021/bi051175u; Khanova HA, 2007, BIOPHYS CHEM, V125, P521, DOI 10.1016/j.bpc.2006.11.002; KIRSCHENBAUM DM, 1972, INT J PROT RES, V4, P63; Kornilaev BA, 1996, BIOCHEM MOL BIOL INT, V38, P921; Kornilaev BA, 1996, BIOCHEMISTRY-MOSCOW+, V61, P628; Kornilaev BA, 1997, MOL BIOL+, V31, P82; KORNILAEV BA, 1997, DOKLADY BIOCH, V1352, P1; Kurganov BI, 2000, BIOCHEMISTRY-US, V39, P13144, DOI 10.1021/bi000975w; Kurganov BI, 1998, BIOCHEMISTRY-MOSCOW+, V63, P364; Le Bon C, 1999, MACROMOLECULES, V32, P6120, DOI 10.1021/ma9905775; Li Y, 2009, J PHYS CHEM B, V113, P7020, DOI 10.1021/jp8083088; Maloletkina OI, 2010, INT J BIOL MACROMOL, V46, P487, DOI 10.1016/j.ijbiomac.2010.03.008; Maloletkina OI, 2010, BIOPHYS CHEM, V148, P121, DOI 10.1016/j.bpc.2010.03.005; Markossian K. A., 2006, P89; Markossian KA, 2008, BBA-PROTEINS PROTEOM, V1784, P1286, DOI 10.1016/j.bbapap.2008.04.030; Markossian KA, 2006, BIOCHEMISTRY-US, V45, P13375, DOI 10.1021/bi0610707; Markossian KA, 2010, PROTEIN J, V29, P11, DOI 10.1007/s10930-009-9217-9; Markossian KA, 2009, INT J MOL SCI, V10, P1314, DOI 10.3390/ijms10031314; Mauro M, 2007, J MOL BIOL, V366, P258, DOI 10.1016/j.jmb.2006.11.008; Meremyanin AV, 2007, BIOCHEMISTRY-MOSCOW+, V72, P518, DOI 10.1134/S0006297907050082; Meremyanin AV, 2008, BIOPOLYMERS, V89, P124, DOI 10.1002/bip.20872; *MICR INC, 1995, SCI EXP DAT FITT MIC; Morris AM, 2009, BBA-PROTEINS PROTEOM, V1794, P375, DOI 10.1016/j.bbapap.2008.10.016; Muranov KO, 2011, EXP EYE RES, V92, P76, DOI 10.1016/j.exer.2010.11.005; NODA L, 1955, METHOD ENZYMOL, V2, P605, DOI 10.1016/S0076-6879(55)02264-7; Panyukov Y, 2007, BIOPHYS CHEM, V127, P9, DOI 10.1016/j.bpc.2006.11.006; Philo JS, 2009, CURR PHARM BIOTECHNO, V10, P348, DOI 10.2174/138920109788488932; Pouzot M, 2004, MACROMOLECULES, V37, P614, DOI 10.1021/ma035117x; Privalov P L, 1986, Methods Enzymol, V131, P4; Putilina T, 2003, J BIOL CHEM, V278, P13747, DOI 10.1074/jbc.M208157200; Raibekas AA, 2008, ANAL BIOCHEM, V380, P331, DOI 10.1016/j.ab.2008.05.023; ROBERTS CJ, 2006, MISBEHAVING PROTEINS, P17; Sabbaghian M, 2009, INT J BIOL MACROMOL, V44, P156, DOI 10.1016/j.ijbiomac.2008.11.011; SCOPES RK, 1982, METHOD ENZYMOL, V90, P479; Senisterra GA, 2010, J BIOMOL SCREEN, V15, P314, DOI 10.1177/1087057109357117; Senisterra GA, 2006, J BIOMOL SCREEN, V11, P940, DOI 10.1177/1087057106294699; Speed MA, 1997, BIOTECHNOL BIOENG, V54, P333; Street TO, 2006, P NATL ACAD SCI USA, V103, P13997, DOI 10.1073/pnas.0606236103; SUGUNAKAR YP, 1996, BIOPHYS J, V70, P2888; Tomita S, 2011, BIOPOLYMERS, V95, P695, DOI 10.1002/bip.21637; Wang KY, 2003, BIOPHYS CHEM, V106, P97, DOI 10.1016/S0301-4622(03)00134-0; Weiss WF, 2009, J PHARM SCI-US, V98, P1246, DOI 10.1002/jps.21521	64	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2011	6	7							e22154	10.1371/journal.pone.0022154	http://dx.doi.org/10.1371/journal.pone.0022154			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791IA	21760963	Green Published, gold, Green Submitted			2022-12-27	WOS:000292657200052
J	Trottier, J; Bialek, A; Caron, P; Straka, RJ; Milkiewicz, P; Barbier, O				Trottier, Jocelyn; Bialek, Andrzej; Caron, Patrick; Straka, Robert J.; Milkiewicz, Piotr; Barbier, Olivier			Profiling Circulating and Urinary Bile Acids in Patients with Biliary Obstruction before and after Biliary Stenting	PLOS ONE			English	Article							INTRAHEPATIC CHOLESTASIS; LITHOCHOLIC ACID; RAT-LIVER; FENOFIBRATE; EXPRESSION; GOLDN; TRIGLYCERIDE; ASSOCIATION; METABOLISM; PREGNANCY	Bile acids are considered as extremely toxic at the high concentrations reached during bile duct obstruction, but each acid displays variable cytotoxic properties. This study investigates how biliary obstruction and restoration of bile flow interferes with urinary and circulating levels of 17 common bile acids. Bile acids (conjugated and unconjugated) were quantified by liquid chromatography coupled with tandem mass spectrometry in serum and urine samples from 17 patients (8 men and 9 women) with biliary obstruction, before and after biliary stenting. Results were compared with serum concentrations measured in 40 age-and sex-paired control donors (20 men and 20 women). The total circulating bile acid concentration increases from 2.7 mu M in control donors to 156.9 mu M in untreated patients with biliary stenosis. Serum taurocholic and glycocholic acids exhibit 304- and 241-fold accumulations in patients with biliary obstruction compared to controls. The enrichment in chenodeoxycholic acid species reached a maximum of only 39-fold, while all secondary and 6 alpha-hydroxylated species -except taurolithocholic acids - were either unchanged or significantly reduced. Stenting was efficient in restoring an almost normal circulating profile and in reducing urinary bile acids. Conclusion: These results demonstrate that biliary obstruction affects differentially the circulating and/or urinary levels of the various bile acids. The observation that the most drastically affected acids correspond to the less toxic species supports the activation of self-protecting mechanisms aimed at limiting the inherent toxicity of bile acids in face of biliary obstruction.	[Trottier, Jocelyn; Caron, Patrick; Barbier, Olivier] CHUQ, Res Ctr, Mol Pharmacol Lab, Quebec City, PQ, Canada; [Trottier, Jocelyn; Caron, Patrick; Barbier, Olivier] Univ Laval, Fac Pharm, Quebec City, PQ, Canada; [Bialek, Andrzej] Pomeranian Med Univ, Dept Gastroenterol, Szczecin, Poland; [Straka, Robert J.] Univ Minnesota, Coll Pharm, Dept Expt & Clin Pharmacol, Minneapolis, MN 55455 USA; [Milkiewicz, Piotr] Pomeranian Med Univ, Liver Unit, Szczecin, Poland; [Milkiewicz, Piotr] Pomeranian Med Univ, Liver Res Labs, Szczecin, Poland	Laval University; Laval University; Pomeranian Medical University; University of Minnesota System; University of Minnesota Twin Cities; Pomeranian Medical University; Pomeranian Medical University	Trottier, J (corresponding author), CHUQ, Res Ctr, Mol Pharmacol Lab, Quebec City, PQ, Canada.	olivier.barbier@crchul.ulaval.ca	Bialek, Andrzej/A-8135-2015	Milkiewicz, Piotr/0000-0002-1817-0724; Straka, Robert/0000-0002-9541-7823; Barbier, Olivier/0000-0002-3067-1134	Canadian Institutes of Health Research (CIHR) [MOP-84338, MSH95330]; Canadian Foundation for Innovation (CFI) [10469]; Fonds pour la Recherche en Sante du Quebec, FRSQ; NIH Heart, Lung and Blood Institute [U 01 HL72524]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL072524] Funding Source: NIH RePORTER	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canadian Foundation for Innovation (CFI)(Canada Foundation for Innovation); Fonds pour la Recherche en Sante du Quebec, FRSQ(Fonds de la Recherche en Sante du Quebec); NIH Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by grants from the Canadian Institutes of Health Research (CIHR; grant #MOP-84338) and the Canadian Foundation for Innovation (CFI, grant #10469). J. Trottier is holder of a CIHR Scholarship. O. Barbier is holder of a salary grant from the CIHR (New investigator award #MSH95330) and the "Fonds pour la Recherche en Sante du Quebec, FRSQ" (Junior 2 Scholarship). The GOLDN study was supported by the NIH Heart, Lung and Blood Institute Grant U 01 HL72524 Genetic and Environmental Determinants of Triglycerides. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araya Z, 1999, BBA-MOL CELL BIOL L, V1438, P47, DOI 10.1016/S1388-1981(99)00031-1; Baiocchi L, 2008, TRANSPL INT, V21, P792, DOI 10.1111/j.1432-2277.2008.00682.x; Bairaktari E, 2001, HEPATOLOGY, V33, P1365, DOI 10.1053/jhep.2001.25089; Basiglio CL, 2010, CHEM-BIOL INTERACT, V188, P386, DOI 10.1016/j.cbi.2010.08.004; Bodin K, 2005, BBA-MOL CELL BIOL L, V1687, P84, DOI 10.1016/j.bbalip.2004.11.003; Chijiiwa K, 2002, WORLD J SURG, V26, P457; Hirano F, 2006, J GASTROEN HEPATOL, V21, P1807, DOI 10.1111/j.1440-1746.2006.04363.x; Hofmann AF, 2004, DRUG METAB REV, V36, P703, DOI 10.1081/DMR-200033475; Hofmann AF, 1999, NEWS PHYSIOL SCI, V14, P24, DOI 10.1152/physiologyonline.1999.14.1.24; Hunt MC, 2000, J BIOL CHEM, V275, P28947, DOI 10.1074/jbc.M002782200; KRAHENBUHL S, 1994, HEPATOLOGY, V20, P1595, DOI 10.1002/hep.1840200632; Lai CQ, 2007, ARTERIOSCL THROM VAS, V27, P1417, DOI 10.1161/ATVBAHA.107.140103; Mann DV, 2002, GUT, V50, P118, DOI 10.1136/gut.50.1.118; Monte MJ, 2009, WORLD J GASTROENTERO, V15, P804, DOI 10.3748/wjg.15.804; Perez MJ, 2009, WORLD J GASTROENTERO, V15, P1677, DOI 10.3748/wjg.15.1677; Pusl T, 2008, BIOCHEM BIOPH RES CO, V367, P208, DOI 10.1016/j.bbrc.2007.12.122; Rust C, 2000, J BIOL CHEM, V275, P20210, DOI 10.1074/jbc.M909992199; Schaap FG, 2009, HEPATOLOGY, V49, P1228, DOI 10.1002/hep.22771; Sharma R, 2010, BIOORGAN MED CHEM, V18, P6886, DOI 10.1016/j.bmc.2010.07.030; Shen J, 2008, DIABETES CARE, V31, P910, DOI 10.2337/dc07-1687; Shoda J, 2001, AM J GASTROENTEROL, V96, P3368; Smith JA, 2008, EUR J HUM GENET, V16, P603, DOI 10.1038/sj.ejhg.5202003; Torchia EC, 1997, EUR J CELL BIOL, V74, P190; Torchia EC, 2001, BMC BIOCHEM, V2, DOI 10.1186/1471-2091-2-11; Tribe RM, 2010, AM J GASTROENTEROL, V105, P585, DOI 10.1038/ajg.2009.633; TROTTIER J, CLIN PHARM IN PRESS; Trottier J, 2006, MOL PHARMACEUT, V3, P212, DOI 10.1021/mp060020t; VYVODA OS, 1977, BIOCHIM BIOPHYS ACTA, V465, P68, DOI 10.1016/0005-2736(77)90356-X; Wimmer R, 2008, GUT, V57, P1448, DOI 10.1136/gut.2007.140871; Wojczynski MK, 2010, J LIPID RES, V51, P3316, DOI 10.1194/jlr.P001834; YANAGISAWA J, 1989, Gastroenterologia Japonica, V24, P156; Ye L, 2007, J CHROMATOGR B, V860, P10, DOI 10.1016/j.jchromb.2007.09.031	32	65	66	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2011	6	7							e22094	10.1371/journal.pone.0022094	http://dx.doi.org/10.1371/journal.pone.0022094			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791IA	21760958	gold, Green Published, Green Submitted			2022-12-27	WOS:000292657200047
J	Bralten, LB; Nouwens, S; Kockx, C; Erdem, L; Hoogenraad, CC; Kros, JM; Moorhouse, MJ; Smitt, PAS; van der Spek, P; van Ijcken, W; Stubbs, A; French, PJ				Bralten, Linda B.; Nouwens, Stephan; Kockx, Christel; Erdem, Lale; Hoogenraad, Casper C.; Kros, Johan M.; Moorhouse, Michael J.; Smitt, Peter A. Sillevis; van der Spek, Peter; van Ijcken, Wilfred; Stubbs, Andrew; French, Pim J.			Absence of Common Somatic Alterations in Genes on 1p and 19q in Oligodendrogliomas	PLOS ONE			English	Article							CANDIDATE TUMOR-SUPPRESSOR; CANCER; MUTATIONS; IDH1; IDENTIFICATION; RESTORATION; SURVIVAL; REGION; GLIOMA; 10Q	A common and histologically well defined subtype of glioma are the oligodendroglial brain tumors. Approximately 70% of all oligodendrogliomas have a combined loss of the entire 1p and 19q chromosomal arms. This remarkably high frequency suggests that the remaining arms harbor yet to be identified tumor suppressor genes. Identification of these causal genetic changes in oligodendrogliomas is important because they form direct targets for treatment. In this study we therefore performed targeted resequencing of all exons, microRNAs, splice sites and promoter regions residing on 1p and 19q on 7 oligodendrogliomas and 4 matched controls. Only one missense mutation was identified in a single sample in the ARHGEF16 gene. This mutation lies within-and disrupts the conserved PDZ binding domain. No similar ARHGEF16 mutations or deletions were found in a larger set of oligodendrogliomas. The absence of common somatic changes within genes located on 1p and 19q in three out of four samples indicates that no additional "second hit'' is required to drive oncogenic transformation on either chromosomal arm.	[Bralten, Linda B.; Erdem, Lale; Smitt, Peter A. Sillevis; French, Pim J.] Erasmus MC, Dept Neurol, Rotterdam, Netherlands; [Nouwens, Stephan; Moorhouse, Michael J.; van der Spek, Peter; Stubbs, Andrew] Erasmus MC, Dept Bioinformat, Rotterdam, Netherlands; [Kockx, Christel; van Ijcken, Wilfred] Erasmus MC, Ctr Biom, Rotterdam, Netherlands; [Hoogenraad, Casper C.] Erasmus MC, Dept Neurosci, Rotterdam, Netherlands; [Kros, Johan M.] Erasmus MC, Dept Pathol, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	Bralten, LB (corresponding author), Erasmus MC, Dept Neurol, Rotterdam, Netherlands.	p.french@erasmusmc.nl	van ijcken, willem/N-9805-2018	van ijcken, willem/0000-0002-0421-8301; Hoogenraad, Casper/0000-0002-2666-0758; French, Pim/0000-0002-0668-9529; Kockx, Christel/0000-0002-8871-3659	Erasmus MC [2006, 2008]	Erasmus MC	This work was supported by Erasmus MC grants 2006 and 2008. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alaminos M, 2005, CANCER RES, V65, P2565, DOI 10.1158/0008-5472.CAN-04-4283; Bagchi A, 2008, CANCER RES, V68, P2551, DOI 10.1158/0008-5472.CAN-07-2095; Bagchi A, 2007, CELL, V128, P459, DOI 10.1016/j.cell.2006.11.052; Barbashina V, 2005, CLIN CANCER RES, V11, P1119; Bralten LBC, 2011, ANN NEUROL, V69, P455, DOI 10.1002/ana.22390; Bralten LBC, 2010, GENE CHROMOSOME CANC, V49, P509, DOI 10.1002/gcc.20760; Broderick DK, 2004, CANCER RES, V64, P5048, DOI 10.1158/0008-5472.CAN-04-1170; Bykov VJN, 2002, NAT MED, V8, P282, DOI 10.1038/nm0302-282; Cairncross JG, 1998, J NATL CANCER I, V90, P1473, DOI 10.1093/jnci/90.19.1473; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Choi M, 2011, SCIENCE, V331, P768, DOI 10.1126/science.1198785; Cooper GM, 2005, GENOME RES, V15, P901, DOI 10.1101/gr.3577405; Esteller M, 2008, NEW ENGL J MED, V358, P1148, DOI 10.1056/NEJMra072067; FIGUEROA ME, CANC CELL, V18, P553; French PJ, 2007, CANCER RES, V67, P5635, DOI 10.1158/0008-5472.CAN-06-2869; French PJ, 2005, CANCER RES, V65, P11335, DOI 10.1158/0008-5472.CAN-05-1886; Gravendeel LAM, 2010, HUM MUTAT, V31, pE1186, DOI 10.1002/humu.21201; Gravendeel LAM, 2009, CANCER RES, V69, P9065, DOI 10.1158/0008-5472.CAN-09-2307; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Hampson L, 2009, BRIT J CANCER, V101, P829, DOI 10.1038/sj.bjc.6605208; Hartmann C, 2009, ACTA NEUROPATHOL, V118, P469, DOI 10.1007/s00401-009-0561-9; Kloosterhof NK, 2011, LANCET ONCOL, V12, P83, DOI 10.1016/S1470-2045(10)70053-X; KNUDSON AG, 1971, P NATL ACAD SCI USA, V68, P820, DOI 10.1073/pnas.68.4.820; Ohgaki H, 2005, J NEUROPATH EXP NEUR, V64, P479, DOI 10.1093/jnen/64.6.479; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Parsons DW, 2011, SCIENCE, V331, P435, DOI 10.1126/science.1198056; Riemenschneider MJ, 2008, INT J CANCER, V122, P2503, DOI 10.1002/ijc.23409; Taby R, 2010, CA-CANCER J CLIN, V60, P376, DOI 10.3322/caac.20085; Tews B, 2006, INT J CANCER, V119, P792, DOI 10.1002/ijc.21901; Thiessen B, 2003, J NEURO-ONCOL, V64, P271, DOI 10.1023/A:1025689004046; Ueki K, 2002, CLIN CANCER RES, V8, P196; van den Bent MJ, 2003, J CLIN ONCOL, V21, P2525, DOI 10.1200/JCO.2003.12.015; van den Bent MJ, 2003, CANCER-AM CANCER SOC, V97, P1276, DOI 10.1002/cncr.11187; Ventura A, 2007, NATURE, V445, P661, DOI 10.1038/nature05541; Weinstein IB, 2008, CANCER RES, V68, P3077, DOI 10.1158/0008-5472.CAN-07-3293; Weinstein IB, 2008, CANCER RES, V68, P3086; Xu W, 2011, CANCER CELL, V19, P17, DOI 10.1016/j.ccr.2010.12.014	37	10	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2011	6	7							e22000	10.1371/journal.pone.0022000	http://dx.doi.org/10.1371/journal.pone.0022000			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791HI	21760942	Green Published, gold, Green Submitted			2022-12-27	WOS:000292655400037
J	Gaudin, F; Nasreddine, S; Donnadieu, AC; Emilie, D; Combadiere, C; Prevot, S; Machelon, V; Balabanian, K				Gaudin, Francoise; Nasreddine, Salam; Donnadieu, Anne-Claire; Emilie, Dominique; Combadiere, Christophe; Prevot, Sophie; Machelon, Veronique; Balabanian, Karl			Identification of the Chemokine CX(3)CL1 as a New Regulator of Malignant Cell Proliferation in Epithelial Ovarian Cancer	PLOS ONE			English	Article							INDUCED LEUCINE-ZIPPER; PROTECTS T-LYMPHOCYTES; ANTITUMOR RESPONSES; GENE-EXPRESSION; FALLOPIAN-TUBE; CLEAR-CELL; FRACTALKINE; RECEPTOR; ADHESION; MODEL	Background: Little is known about the molecules that contribute to the growth of epithelial ovarian carcinomas (EOC), which remain the most lethal gynecological cancer in women. The chemokine Fractalkine/CX(3)CL1 has been widely reported to play a biologically relevant role in tumor growth and spread. We report here the first investigation of the expression and role of CX(3)CL1 in EOC. Results: Epithelial cells from the surface of the ovary and the Fallopian tubes and from benign, borderline and malignant tumors all stained positive for CX(3)CL1. In tumor specimens from 54 women who underwent surgical treatment for EOC diagnosis, CX(3)CL1 immunoreactivity was unevenly distributed in epithelial tumor cells, and ranged from strong (33%) to absent (17%). This uneven distribution of CX(3)CL1 did not reflect the morphological heterogeneity of EOC. It was positively correlated with the proliferation index Ki-67 and with GILZ (glucocorticoid-induced leucine zipper), previously identified as an activator of the proliferation of malignant EOC cells. Hierarchical clustering analysis, including age at diagnosis, tumor grade, FIGO stage, Ki-67 index, CX(3)CL1, SDF-1/CXCL12 and GILZ immunostaining scores, distinguished two major clusters corresponding to low and high levels of proliferation and differing in terms of GILZ and CX(3)CL1 expression. GILZ overexpression in the carcinoma-derived BG1 cell line resulted in parallel changes in CX(3)CL1 products. Conversely, CX(3)CL1 promoted through its binding to CX(3)CR1 AKT activation and proliferation in BG1 cells. In a mouse subcutaneous xenograft model, the overexpression of GILZ was associated with higher expression of CX(3)CL1 and faster tumor growth. Conclusion: Our findings highlight the previously unappreciated constitutive expression of CX(3)CL1 preceding tumorigenesis in ovarian epithelial cells. Together with GILZ, this chemokine emerges as a regulator of cell proliferation, which may be of potential clinical relevance for the selection of the most appropriate treatment for EOC patients.	[Gaudin, Francoise; Nasreddine, Salam; Donnadieu, Anne-Claire; Emilie, Dominique; Machelon, Veronique; Balabanian, Karl] Univ Paris 11, INSERM, UMR S996, Clamart, France; [Emilie, Dominique] Hop Antoine Beclere, AP HP, Serv Microbiol Immunol Biol, Clamart, France; [Combadiere, Christophe] Univ Paris 06, Hop La Pitie Salpetriere, AP HP, INSERM,UMR S945, Paris, France; [Prevot, Sophie] Hop Antoine Beclere, AP HP, Serv Anat & Cytol Pathol, Clamart, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Antoine-Beclere - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Antoine-Beclere - APHP	Gaudin, F (corresponding author), Univ Paris 11, INSERM, UMR S996, Clamart, France.	veronique.machelon@u-psud.fr	Balabanian, Karl/I-2990-2016; Combadiere, Christophe/I-5639-2013; Balabanian, Karl/S-6250-2019	Balabanian, Karl/0000-0002-0534-3198; Combadiere, Christophe/0000-0002-1755-4531; Balabanian, Karl/0000-0002-0534-3198	Ligue contre le cancer (Comite Val d'Oise); Institut National de la Sante et de la Recherche Medicale (INSERM); Universite Paris-Sud; European Union [LSHB-CT-2005-518167]	Ligue contre le cancer (Comite Val d'Oise); Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Universite Paris-Sud; European Union(European Commission)	This work was supported by the Ligue contre le cancer (Comite Val d'Oise), the Institut National de la Sante et de la Recherche Medicale (INSERM), the Universite Paris-Sud, and the European Union FP6 (INNOCHEM, grant number LSHB-CT-2005-518167). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altomare DA, 2004, ONCOGENE, V23, P5853, DOI 10.1038/sj.onc.1207721; Altomare DA, 2005, ONCOGENE, V24, P7455, DOI 10.1038/sj.onc.1209085; Asselin-Labat ML, 2004, BLOOD, V104, P215, DOI 10.1182/blood-2003-12-4295; Ayroldi E, 2002, MOL CELL BIOL, V22, P7929, DOI 10.1128/MCB.22.22.7929-7941.2002; Balkwill F, 2004, NAT REV CANCER, V4, P540, DOI 10.1038/nrc1388; Barbieri F, 2010, J ONCOL, V2010, DOI 10.1155/2010/426956; Bazan JF, 1997, NATURE, V385, P640, DOI 10.1038/385640a0; Belot MP, 2007, J CELL BIOCHEM, V102, P1271, DOI 10.1002/jcb.21357; Brand S, 2002, GASTROENTEROLOGY, V122, P166, DOI 10.1053/gast.2002.30329; Chandrasekar B, 2003, BIOCHEM J, V373, P547, DOI 10.1042/BJ20030207; Cook A, 2010, J BIOL CHEM, V285, P10563, DOI 10.1074/jbc.M109.035477; D'Adamio F, 1997, IMMUNITY, V7, P803, DOI 10.1016/S1074-7613(00)80398-2; D'Haese JG, 2010, EXPERT OPIN THER TAR, V14, P207, DOI 10.1517/14728220903540265; Dorgham K, 2009, J LEUKOCYTE BIOL, V86, P903, DOI 10.1189/jlb.0308158; Fong AM, 1998, J EXP MED, V188, P1413, DOI 10.1084/jem.188.8.1413; Gao N, 2004, AM J PHYSIOL-CELL PH, V287, pC281, DOI 10.1152/ajpcell.00422.2003; Garton KJ, 2001, J BIOL CHEM, V276, P37993; Goda S, 2000, J IMMUNOL, V164, P4313, DOI 10.4049/jimmunol.164.8.4313; Guo J, 2003, IMMUNOL LETT, V89, P1, DOI 10.1016/S0165-2478(03)00101-9; Guo J, 2003, INT J CANCER, V103, P212, DOI 10.1002/ijc.10816; Hannan NJ, 2004, J CLIN ENDOCR METAB, V89, P6119, DOI 10.1210/jc.2003-031379; Jamieson WL, 2008, CANCER RES, V68, P1715, DOI 10.1158/0008-5472.CAN-07-1315; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Karst AM, 2010, J ONCOL, V2010, DOI 10.1155/2010/932371; Khouja MH, 2007, INT J GYNECOL PATHOL, V26, P418, DOI 10.1097/pgp.0b013e31804216a0; Kobel M, 2008, PLOS MED, V5, P1749, DOI 10.1371/journal.pmed.0050232; Kryczek I, 2005, CANCER RES, V65, P465; Lavergne E, 2003, CANCER RES, V63, P7468; Lazennec G, 2010, TRENDS MOL MED, V16, P133, DOI 10.1016/j.molmed.2010.01.003; Levanon K, 2010, ONCOGENE, V29, P1103, DOI 10.1038/onc.2009.402; Lucas AD, 2001, AM J PATHOL, V158, P855, DOI 10.1016/S0002-9440(10)64034-5; Machelon V, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-97; Marchesi F, 2008, CANCER RES, V68, P9060, DOI 10.1158/0008-5472.CAN-08-1810; Marchesi F, 2010, J NEUROIMMUNOL, V224, P39, DOI 10.1016/j.jneuroim.2010.05.007; Naora H, 2005, NAT REV CANCER, V5, P355, DOI 10.1038/nrc1611; Ohta M, 2005, INT J ONCOL, V26, P41; Permuth-Wey Jennifer, 2009, V472, P413, DOI 10.1007/978-1-60327-492-0_20; Perros F, 2007, EUR RESPIR J, V29, P937, DOI 10.1183/09031936.00104706; Porcile C, 2005, EXP CELL RES, V308, P241, DOI 10.1016/j.yexcr.2005.04.024; Redjimi N, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-83; Runz S, 2007, GYNECOL ONCOL, V107, P563, DOI 10.1016/j.ygyno.2007.08.064; Schwartz DR, 2002, CANCER RES, V62, P4722; Shayesteh L, 1999, NAT GENET, V21, P99, DOI 10.1038/5042; Shih IM, 2004, AM J PATHOL, V164, P1511, DOI 10.1016/S0002-9440(10)63708-X; Shimizu Y, 1998, CANCER-AM CANCER SOC, V82, P893, DOI 10.1002/(SICI)1097-0142(19980301)82:5<893::AID-CNCR14>3.0.CO;2-W; Shulby SA, 2004, CANCER RES, V64, P4693, DOI 10.1158/0008-5472.CAN-03-3437; Vitale S, 2007, GUT, V56, P365, DOI 10.1136/gut.2005.088989; Yu YRA, 2007, INT J CANCER, V121, P316, DOI 10.1002/ijc.22660; Zhang Q, 2004, HUM REPROD, V19, P409, DOI 10.1093/humrep/deh085; Zhang WX, 2008, J BIOL CHEM, V283, P4723, DOI 10.1074/jbc.M704147200; Zorn KK, 2005, CLIN CANCER RES, V11, P6422, DOI 10.1158/1078-0432.CCR-05-0508; Zou WP, 2001, NAT MED, V7, P1339, DOI 10.1038/nm1201-1339	52	41	44	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2011	6	7							e21546	10.1371/journal.pone.0021546	http://dx.doi.org/10.1371/journal.pone.0021546			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791HI	21750716	Green Published, gold, Green Submitted			2022-12-27	WOS:000292655400007
J	Bardaweel, S; Ghosh, B; Chou, TF; Sadowsky, MJ; Wagner, CR				Bardaweel, Sanaa; Ghosh, Brahma; Chou, Tsui-Fen; Sadowsky, Michael J.; Wagner, Carston R.			E. coli Histidine Triad Nucleotide Binding Protein 1 (ecHinT) Is a Catalytic Regulator of D-Alanine Dehydrogenase (DadA) Activity In Vivo	PLOS ONE			English	Article							AMINO-ACID DEHYDROGENASE; ESCHERICHIA-COLI; PHENOTYPE MICROARRAYS; SUBSTRATE-SPECIFICITY; MYCOPLASMA-HOMINIS; HINT; PHOSPHORAMIDASE; SUPERFAMILY; EXPRESSION; INDUCTION	Histidine triad nucleotide binding proteins (Hints) are highly conserved members of the histidine triad (HIT) protein superfamily. Hints comprise the most ancient branch of this superfamily and can be found in Archaea, Bacteria, and Eukaryota. Prokaryotic genomes, including a wide diversity of both Gram-negative and Gram-positive bacteria, typically have one Hint gene encoded by hinT (ycfF in E. coli). Despite their ubiquity, the foundational reason for the wide-spread conservation of Hints across all kingdoms of life remains a mystery. In this study, we used a combination of phenotypic screening and complementation analyses with wild-type and hinT knock-out Escherichia coli strains to show that catalytically active ecHinT is required in E. coli for growth on D-alanine as a sole carbon source. We demonstrate that the expression of catalytically active ecHinT is essential for the activity of the enzyme D-alanine dehydrogenase (DadA) (equivalent to D-amino acid oxidase in eukaryotes), a necessary component of the D-alanine catabolic pathway. Site-directed mutagenesis studies revealed that catalytically active C-terminal mutants of ecHinT are unable to activate DadA activity. In addition, we have designed and synthesized the first cell-permeable inhibitor of ecHinT and demonstrated that the wild-type E. coli treated with the inhibitor exhibited the same phenotype observed for the hinT knock-out strain. These results reveal that the catalytic activity and structure of ecHinT is essential for DadA function and therefore alanine metabolism in E. coli. Moreover, they provide the first biochemical evidence linking the catalytic activity of this ubiquitous protein to the biological function of Hints in Escherichia coli.	[Bardaweel, Sanaa; Ghosh, Brahma; Chou, Tsui-Fen; Wagner, Carston R.] Univ Minnesota, Dept Med Chem, Minneapolis, MN 55455 USA; [Sadowsky, Michael J.] Univ Minnesota, Dept Soil Water & Climate, St Paul, MN 55108 USA; [Sadowsky, Michael J.] Univ Minnesota, Inst Biotechnol, St Paul, MN 55108 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Bardaweel, S (corresponding author), Univ Minnesota, Dept Med Chem, Minneapolis, MN 55455 USA.	sadowsky@umn.edu; wagne003@umn.edu	Sadowsky, Michael/J-2507-2016; Bardaweel, Sanaa/C-2556-2015	Sadowsky, Michael/0000-0001-8779-2781; Ghosh, Brahma/0000-0003-2288-8293	University of Minnesota	University of Minnesota(University of Minnesota System)	Funding was provided by the University of Minnesota. No external funding sources for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAHAMSON JLA, 1983, EUR J BIOCHEM, V134, P77, DOI 10.1111/j.1432-1033.1983.tb07533.x; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Bardaweel S, 2010, J MOL BIOL, V404, P627, DOI 10.1016/j.jmb.2010.09.066; Bieganowski P, 2002, J BIOL CHEM, V277, P10852, DOI 10.1074/jbc.M111480200; Bochner BR, 2001, GENOME RES, V11, P1246, DOI 10.1101/gr.186501; Brenner C, 2002, BIOCHEMISTRY-US, V41, P9003, DOI 10.1021/bi025942q; Brenner C, 1999, J CELL PHYSIOL, V181, P179, DOI 10.1002/(SICI)1097-4652(199911)181:2<179::AID-JCP1>3.0.CO;2-8; Butland G, 2005, NATURE, V433, P531, DOI 10.1038/nature03239; Chou TF, 2005, J BIOL CHEM, V280, P15356, DOI 10.1074/jbc.M500434200; Chou TF, 2007, BIOCHEMISTRY-US, V46, P13074, DOI 10.1021/bi701244h; Chou TF, 2007, MOL PHARMACEUT, V4, P208, DOI 10.1021/mp060070y; Chou TF, 2007, J BIOL CHEM, V282, P4719, DOI 10.1074/jbc.M610530200; Deutch CE, 2004, FEMS MICROBIOL LETT, V238, P383, DOI 10.1016/j.femsle.2004.08.001; FRANKLIN FCH, 1976, MOL GEN GENET, V149, P229, DOI 10.1007/BF00332894; Hopfe M, 2004, BMC MICROBIOL, V4, DOI 10.1186/1471-2180-4-46; Hsieh SY, 2009, J PROTEOME RES, V8, P3977, DOI 10.1021/pr900289g; Ito M, 2005, METAB ENG, V7, P318, DOI 10.1016/j.ymben.2005.06.004; Kitzerow A, 2001, MOL MICROBIOL, V41, P279, DOI 10.1046/j.1365-2958.2001.02524.x; Kolodkin-Gal I, 2010, SCIENCE, V328, P627, DOI 10.1126/science.1188628; Korsisaari N, 2000, J BIOL CHEM, V275, P34837, DOI 10.1074/jbc.C000505200; Korsisaari N, 2003, MOL CELL BIOL, V23, P3929, DOI 10.1128/MCB.23.11.3929-3935.2003; Li H, 2006, ONCOGENE, V25, P713, DOI 10.1038/sj.onc.1209111; Lima CD, 1996, P NATL ACAD SCI USA, V93, P5357, DOI 10.1073/pnas.93.11.5357; LOBOCKA M, 1994, J BACTERIOL, V176, P1500, DOI 10.1128/jb.176.5.1500-1510.1994; Martin J, 2011, HEPATOLOGY, V53, P243, DOI 10.1002/hep.23978; OLSIEWSKI PJ, 1980, J BIOL CHEM, V255, P4487; Pollegioni L, 2007, CELL MOL LIFE SCI, V64, P1373, DOI 10.1007/s00018-007-6558-4; RAUNIO RP, 1973, J BACTERIOL, V115, P560, DOI 10.1128/JB.115.2.560-566.1973; Sambrook J.E.F., 1989, MOL CLONING LAB MANU, P1659; Su T, 2003, P NATL ACAD SCI USA, V100, P7824, DOI 10.1073/pnas.1332160100; WALSH CT, 1989, J BIOL CHEM, V264, P2393; Weiske J, 2005, J CELL SCI, V118, P3117, DOI 10.1242/jcs.02437; YASUDA Y, 1985, MICROBIOL IMMUNOL, V29, P229, DOI 10.1111/j.1348-0421.1985.tb00822.x; Yuan BZ, 2004, NEOPLASIA, V6, P412, DOI 10.1593/neo.03490	34	13	15	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2011	6	7							e20897	10.1371/journal.pone.0020897	http://dx.doi.org/10.1371/journal.pone.0020897			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791AK	21754980	Green Accepted, gold, Green Published, Green Submitted			2022-12-27	WOS:000292632000004
J	Lu, SX; Kappel, LW; Charbonneau-Allard, AM; Atallah, R; Holland, AM; Turbide, C; Hubbard, VM; Rotolo, JA; Smith, M; Suh, D; King, C; Rao, UK; Yim, N; Bautista, JL; Jenq, RR; Penack, O; Na, IK; Liu, C; Murphy, G; Alpdogan, O; Blumberg, RS; Macian, F; Holmes, KV; Beauchemin, N; van den Brink, MRM				Lu, Sydney X.; Kappel, Lucy W.; Charbonneau-Allard, Anne-Marie; Atallah, Renee; Holland, Amanda M.; Turbide, Claire; Hubbard, Vanessa M.; Rotolo, Jimmy A.; Smith, Marsinay; Suh, David; King, Christopher; Rao, Uttam K.; Yim, Nury; Bautista, Johanne L.; Jenq, Robert R.; Penack, Olaf; Na, Il-Kang; Liu, Chen; Murphy, George; Alpdogan, Onder; Blumberg, Richard S.; Macian, Fernando; Holmes, Kathryn V.; Beauchemin, Nicole; van den Brink, Marcel R. M.			Ceacam1 Separates Graft-versus-Host-Disease from Graft-versus-Tumor Activity after Experimental Allogeneic Bone Marrow Transplantation	PLOS ONE			English	Article							CELL-ADHESION MOLECULE-1; CARCINOEMBRYONIC ANTIGEN FAMILY; ALLOREACTIVE T-CELLS; BILIARY GLYCOPROTEIN; C-CAM; TAP2-DEFICIENT PATIENTS; SUPPRESSOR GENES; HUMAN-MELANOMA; GROWTH-FACTOR; NK CELLS	Background: Allogeneic bone marrow transplantation (allo-BMT) is a potentially curative therapy for a variety of hematologic diseases, but benefits, including graft-versus-tumor (GVT) activity are limited by graft-versus-host-disease (GVHD). Carcinoembryonic antigen related cell adhesion molecule 1 (Ceacam1) is a transmembrane glycoprotein found on epithelium, T cells, and many tumors. It regulates a variety of physiologic and pathological processes such as tumor biology, leukocyte activation, and energy homeostasis. Previous studies suggest that Ceacam1 negatively regulates inflammation in inflammatory bowel disease models. Methods: We studied Ceacam1 as a regulator of GVHD and GVT after allogeneic bone marrow transplantation (allo-BMT) in mouse models. In vivo, Ceacam1(-/-) T cells caused increased GVHD mortality and GVHD of the colon, and greater numbers of donor T cells were positive for activation markers (CD25(hi), CD62L(lo)). Additionally, Ceacam1(-/-) CD8 T cells had greater expression of the gut-trafficking integrin alpha(4)beta(7), though both CD4 and CD8 T cells were found increased numbers in the gut post-transplant. Ceacam1(-/-) recipients also experienced increased GVHD mortality and GVHD of the colon, and alloreactive T cells displayed increased activation. Additionally, Ceacam1(-/-) mice had increased mortality and decreased numbers of regenerating small intestinal crypts upon radiation exposure. Conversely, Ceacam1-overexpressing T cells caused attenuated target-organ and systemic GVHD, which correlated with decreased donor T cell numbers in target tissues, and mortality. Finally, graft-versus-tumor survival in a Ceacam1(+) lymphoma model was improved in animals receiving Ceacam1(-/-) vs. control T cells. Conclusions: We conclude that Ceacam1 regulates T cell activation, GVHD target organ damage, and numbers of donor T cells in lymphoid organs and GVHD target tissues. In recipients of allo-BMT, Ceacam1 may also regulate tissue radiosensitivity. Because of its expression on both the donor graft and host tissues, this suggests that targeting Ceacam1 may represent a potent strategy for the regulation of GVHD and GVT after allogeneic transplantation.	[Lu, Sydney X.; Kappel, Lucy W.; Holland, Amanda M.; Hubbard, Vanessa M.; Smith, Marsinay; Suh, David; King, Christopher; Rao, Uttam K.; Yim, Nury; Bautista, Johanne L.; Jenq, Robert R.; Penack, Olaf; Na, Il-Kang; Alpdogan, Onder; van den Brink, Marcel R. M.] Mem Sloan Kettering Canc Ctr, Dept Immunol & Med, New York, NY 10021 USA; [Kappel, Lucy W.; Holland, Amanda M.] Weill Cornell Grad Sch Med Sci, Dept Immunol, New York, NY USA; [Charbonneau-Allard, Anne-Marie; Atallah, Renee; Turbide, Claire; Beauchemin, Nicole] McGill Canc Ctr, Goodman Canc Ctr, Montreal, PQ, Canada; [Charbonneau-Allard, Anne-Marie; Atallah, Renee; Turbide, Claire; Beauchemin, Nicole] McGill Canc Ctr, Dept Biochem, Montreal, PQ, Canada; [Charbonneau-Allard, Anne-Marie; Atallah, Renee; Turbide, Claire; Beauchemin, Nicole] McGill Canc Ctr, Dept Med, Montreal, PQ, Canada; [Charbonneau-Allard, Anne-Marie; Atallah, Renee; Beauchemin, Nicole] McGill Canc Ctr, Dept Oncol, Montreal, PQ, Canada; [Hubbard, Vanessa M.; Macian, Fernando] Albert Einstein Coll Med, Dept Pathol, Bronx, NY 10467 USA; [Rotolo, Jimmy A.] Mem Sloan Kettering Canc Ctr, Dept Mol Pharmacol & Chem, New York, NY 10021 USA; [Penack, Olaf; Na, Il-Kang] Charite CBF Univ Med Berlin, Dept Hematol & Oncol, Berlin, Germany; [Liu, Chen] Univ Florida, Coll Med, Dept Pathol, Gainesville, FL USA; [Murphy, George] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Alpdogan, Onder] Yale Univ, Sch Med, Dept Med, New Haven, CT 06510 USA; [Blumberg, Richard S.] Brigham & Womens Hosp, Dept Gastroenterol, Boston, MA 02115 USA; [Holmes, Kathryn V.] Univ Colorado, Dept Microbiol, Sch Med, Aurora, CO USA	Memorial Sloan Kettering Cancer Center; Cornell University; Qatar Foundation (QF); Weill Cornell Medical College Qatar; McGill University; McGill University; McGill University; McGill University; Yeshiva University; Albert Einstein College of Medicine; Memorial Sloan Kettering Cancer Center; State University System of Florida; University of Florida; Harvard University; Brigham & Women's Hospital; Yale University; Harvard University; Brigham & Women's Hospital; University of Colorado System; University of Colorado Anschutz Medical Campus	Lu, SX (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Immunol & Med, 1275 York Ave, New York, NY 10021 USA.	vandenbm@mskcc.org	van den Brink, Marcel R. M./HGB-9434-2022; Penack, Olaf/L-1068-2016	Penack, Olaf/0000-0003-4876-802X; Rotolo, Jim/0000-0003-4195-6167; Na, Il-Kang/0000-0001-9902-5424; Macian, Fernando/0000-0003-2666-035X; Lu, Sydney/0000-0002-2217-1674	National Institutes of Health [RO1-HL069929, RO1-CA107096, RO1-AI080455, PO1-CA33049, R01-HL095075, P20-CA103694]; US Department of Defense [W81XWH-09-1-0294]; Radiation Effects Research Foundation (RERF-NIAID); Ryan Gibson Foundation (Dallas, TX); Elsa U. Pardee Foundation (Midland, MI); Byrne Foundation (Etna, NH); Emerald Foundation (New York, NY); Mr. William H. Goodwin and Mrs. Alice Goodwin, Alex's Lemonade Stand; Commonwealth Foundation for Cancer Research (Richmond, VA); Bobby Zucker Memorial Fund (Phoenixville, PA); Lymphoma Foundation (New York, NY); Canadian Institutes of Health Reseach; National Marrow Donor Program (NMDP); Marrow Foundation; Deutsche Krebshilfe, Mildred-Scheel-Stiftung; Deutsche Forschungsgemeinschaft; NATIONAL CANCER INSTITUTE [R01CA107096, P01CA033049, P20CA103694, P30CA008748] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL069929, R01HL095075] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI080455, R01AI059738] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK051362] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Department of Defense(United States Department of Defense); Radiation Effects Research Foundation (RERF-NIAID); Ryan Gibson Foundation (Dallas, TX); Elsa U. Pardee Foundation (Midland, MI); Byrne Foundation (Etna, NH); Emerald Foundation (New York, NY); Mr. William H. Goodwin and Mrs. Alice Goodwin, Alex's Lemonade Stand; Commonwealth Foundation for Cancer Research (Richmond, VA); Bobby Zucker Memorial Fund (Phoenixville, PA); Lymphoma Foundation (New York, NY); Canadian Institutes of Health Reseach; National Marrow Donor Program (NMDP); Marrow Foundation; Deutsche Krebshilfe, Mildred-Scheel-Stiftung(Deutsche Krebshilfe); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported by National Institutes of Health grants RO1-HL069929 (MvdB), RO1-CA107096 (MvdB), RO1-AI080455 (MvdB), PO1-CA33049 (MvdB) and R01-HL095075 (MvdB). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. Support was also received from the US Department of Defense: USAMRAA Award W81XWH-09-1-0294 (MvdB), the Radiation Effects Research Foundation (RERF-NIAID) (MvdB). Support was also received from the Ryan Gibson Foundation (Dallas, TX), the Elsa U. Pardee Foundation (Midland, MI), the Byrne Foundation (Etna, NH), the Emerald Foundation (New York, NY), and The Experimental Therapeutics Center of Memorial Sloan-Kettering Cancer Center funded by Mr. William H. Goodwin and Mrs. Alice Goodwin, Alex's Lemonade Stand, and The Peter Solomon Fund the Commonwealth Foundation for Cancer Research (Richmond, VA), The Bobby Zucker Memorial Fund (Phoenixville, PA) and The Lymphoma Foundation (New York, NY). NB is supported by the Canadian Institutes of Health Reseach. OA is the recipient of an Amy Strelzer Manasevit Scholar Award from The National Marrow Donor Program (NMDP) and The Marrow Foundation and is supported by grant P20-CA103694 from the National Institutes of Health. IKN is supported by the Deutsche Krebshilfe, Mildred-Scheel-Stiftung. OP is supported by the Deutsche Forschungsgemeinschaft. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou-Rjaily GA, 2004, J CLIN INVEST, V114, P944, DOI 10.1172/JCI200421786; Bamberger AM, 2002, VIRCHOWS ARCH, V440, P139, DOI 10.1007/s00428-001-0554-0; Beauchemin N, 1999, EXP CELL RES, V252, P243; Beilhack A, 2005, BLOOD, V106, P1113, DOI 10.1182/blood-2005-02-0509; CANMAN CE, 1995, SEMIN CANCER BIOL, V6, P17, DOI 10.1006/scbi.1995.0003; Carrasco M, 2000, ANN HEMATOL, V79, P299, DOI 10.1007/s002779900146; Donda A, 2000, EUR J IMMUNOL, V30, P2593, DOI 10.1002/1521-4141(200009)30:9<2593::AID-IMMU2593>3.0.CO;2-0; Dutt S, 2005, BLOOD, V106, P4009, DOI 10.1182/blood-2005-06-2339; Ergun S, 2000, MOL CELL, V5, P311, DOI 10.1016/S1097-2765(00)80426-8; Ferrara J L, 1999, Biol Blood Marrow Transplant, V5, P347, DOI 10.1016/S1083-8791(99)70011-X; Ferrara JLM, 2006, SEMIN HEMATOL, V43, P3, DOI 10.1053/j.seminhematol.2005.09.001; GAGNETEN S, 1995, J VIROL, V69, P889, DOI 10.1128/JVI.69.2.889-895.1995; Gray-Owen SD, 2006, NAT REV IMMUNOL, V6, P433, DOI 10.1038/nri1864; Gray-Owen SD, 1997, MOL MICROBIOL, V26, P971, DOI 10.1046/j.1365-2958.1997.6342006.x; Hemmila E, 2004, J VIROL, V78, P10156, DOI 10.1128/JVI.78.18.10156-10165.2004; Hill GR, 2000, BLOOD, V95, P2754, DOI 10.1182/blood.V95.9.2754.009k25_2754_2759; HSIEH JT, 1995, CANCER RES, V55, P190; Huber M, 1999, J BIOL CHEM, V274, P335, DOI 10.1074/jbc.274.1.335; Hunter I, 1998, FEBS LETT, V425, P141, DOI 10.1016/S0014-5793(98)00223-3; Iijima H, 2004, J EXP MED, V199, P471, DOI 10.1084/jem.20030437; Kammerer R, 2004, J PATHOL, V204, P258, DOI 10.1002/path.1657; KUIJPERS TW, 1992, J CELL BIOL, V118, P457, DOI 10.1083/jcb.118.2.457; Laack E, 2002, J CLIN ONCOL, V20, P4279, DOI 10.1200/JCO.2002.08.067; Leung N, 2008, ONCOGENE, V27, P4943, DOI 10.1038/onc.2008.136; LEUSCH HG, 1991, ZBL BAKT-INT J MED M, V275, P118; Markel G, 2004, BLOOD, V103, P1770, DOI 10.1182/blood-2003-06-2114; Markel G, 2004, EUR J IMMUNOL, V34, P2138, DOI 10.1002/eji.200425021; Markel G, 2004, J IMMUNOL, V173, P3732, DOI 10.4049/jimmunol.173.6.3732; Markel G, 2002, J IMMUNOL, V168, P2803, DOI 10.4049/jimmunol.168.6.2803; Markel G, 2002, J CLIN INVEST, V110, P943, DOI 10.1172/JCI200215643; Morales VM, 1999, J IMMUNOL, V163, P1363; Nagaishi T, 2006, IMMUNITY, V25, P769, DOI 10.1016/j.immuni.2006.08.026; Nakajima A, 2002, J IMMUNOL, V168, P1028, DOI 10.4049/jimmunol.168.3.1028; Nittka S, 2004, ONCOGENE, V23, P9306, DOI 10.1038/sj.onc.1208259; Obrink B, 1997, CURR OPIN CELL BIOL, V9, P616, DOI 10.1016/S0955-0674(97)80114-7; OCKLIND C, 1982, J BIOL CHEM, V257, P6788; Park SY, 2006, AM J PHYSIOL-ENDOC M, V291, pE517, DOI 10.1152/ajpendo.00077.2006; Petrovic A, 2004, BLOOD, V103, P1542, DOI 10.1182/blood-2003-03-0957; Pomp J, 1996, RADIAT RES, V146, P374, DOI 10.2307/3579299; Prall F, 1996, J HISTOCHEM CYTOCHEM, V44, P35, DOI 10.1177/44.1.8543780; Reddy P, 2003, HEMATOL ONCOL, V21, P149, DOI 10.1002/hon.716; Reddy P, 2003, BLOOD REV, V17, P187, DOI 10.1016/S0268-960X(03)00009-2; ROJAS M, 1990, CELL GROWTH DIFFER, V1, P527; Singer BB, 2002, J IMMUNOL, V168, P5139, DOI 10.4049/jimmunol.168.10.5139; Waldman E, 2006, BLOOD, V107, P1703, DOI 10.1182/blood-2005-08-3445	45	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2011	6	7							e21611	10.1371/journal.pone.0021611	http://dx.doi.org/10.1371/journal.pone.0021611			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791AK	21760897	Green Submitted, gold, Green Published, Green Accepted			2022-12-27	WOS:000292632000017
J	Arikawa, M; Kakinuma, Y; Handa, T; Yamasaki, F; Sato, T				Arikawa, Mikihiko; Kakinuma, Yoshihiko; Handa, Takemi; Yamasaki, Fumiyasu; Sato, Takayuki			Donepezil, Anti-Alzheimer's Disease Drug, Prevents Cardiac Rupture during Acute Phase of Myocardial Infarction in Mice	PLOS ONE			English	Article							MATRIX-METALLOPROTEINASE INHIBITION; VENTRICULAR FREE-WALL; TARGETED DELETION; HEART-FAILURE; INFLAMMATORY RESPONSE; VAGAL-STIMULATION; NEUROPROTECTION; ACETYLCHOLINE; MATRIX-METALLOPROTEINASE-9; ANGIOGENESIS	Background: We have previously demonstrated that the chronic intervention in the cholinergic system by donepezil, an acetylcholinesterase inhibitor, plays a beneficial role in suppressing long-term cardiac remodeling after myocardial infarction (MI). In comparison with such a chronic effect, however, the acute effect of donepezil during an acute phase of MI remains unclear. Noticing recent findings of a cholinergic mechanism for anti-inflammatory actions, we tested the hypothesis that donepezil attenuates an acute inflammatory tissue injury following MI. Methods and Results: In isolated and activated macrophages, donepezil significantly reduced intra-and extracellular matrix metalloproteinase-9 (MMP-9). In mice with MI, despite the comparable values of heart rate and blood pressure, the donepezil-treated group showed a significantly lower incidence of cardiac rupture than the untreated group during the acute phase of MI. Immunohistochemistry revealed that MMP-9 was localized at the infarct area where a large number of inflammatory cells including macrophages infiltrated, and the expression and the enzymatic activity of MMP-9 at the left ventricular infarct area was significantly reduced in the donepezil-treated group. Conclusion: The present study suggests that donepezil inhibits the MMP-9-related acute inflammatory tissue injury in the infarcted myocardium, thereby reduces the risk of left ventricular free wall rupture during the acute phase of MI.	[Arikawa, Mikihiko; Kakinuma, Yoshihiko; Handa, Takemi; Sato, Takayuki] Kochi Med Sch, Dept Cardiovasc Control, Nanko Ku, Kochi, Japan; [Yamasaki, Fumiyasu] Kochi Med Sch, Dept Clin Lab, Nanko Ku, Kochi, Japan	Kochi University; Kochi University	Arikawa, M (corresponding author), Kochi Med Sch, Dept Cardiovasc Control, Nanko Ku, Kochi, Japan.	marikawa@kochi-u.ac.jp		Kakinuma, Yoshihiko/0000-0001-5470-9128	Japan Society for the Promotion of Science [21790729]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by a Grant-in-Aid for Young Scientists (21790729) from Japan Society for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaike A, 2010, J MOL NEUROSCI, V40, P211, DOI 10.1007/s12031-009-9236-1; Akasofu S, 2008, CHEM-BIOL INTERACT, V175, P222, DOI 10.1016/j.cbi.2008.04.045; Ando M, 2005, CIRCULATION, V112, P164, DOI 10.1161/CIRCULATIONAHA.104.525493; Arikawa M, 2007, CIRCULATION, V116, P291; BATTS KP, 1990, HUM PATHOL, V21, P530, DOI 10.1016/0046-8177(90)90010-3; Borovikova LV, 2000, NATURE, V405, P458, DOI 10.1038/35013070; Creemers EEJM, 2001, CIRC RES, V89, P201, DOI 10.1161/hh1501.094396; Davis N, 2002, PERFUSION-UK, V17, P63, DOI 10.1191/0267659102pf521oa; De Ferrari GM, 2009, IEEE ENG MED BIO, P2037, DOI 10.1109/IEMBS.2009.5334414; Dewald O, 2004, AM J PATHOL, V164, P665, DOI 10.1016/S0002-9440(10)63154-9; DonnellyRoberts DL, 1996, BRAIN RES, V719, P36, DOI 10.1016/0006-8993(96)00063-7; Ducharme A, 2000, J CLIN INVEST, V106, P55, DOI 10.1172/JCI8768; Fang L, 2008, CLIN SCI, V115, P99, DOI 10.1042/CS20070365; Figueras J, 1997, J AM COLL CARDIOL, V29, P512, DOI 10.1016/S0735-1097(96)00542-6; Gao XM, 2010, INT J CARDIOL, V143, P20, DOI 10.1016/j.ijcard.2009.01.019; Gao XM, 2005, CARDIOVASC RES, V65, P469, DOI 10.1016/j.cardiores.2004.10.014; Handa T, 2009, J CARD FAIL, V15, P805, DOI 10.1016/j.cardfail.2009.05.008; Hayashidani S, 2003, AM J PHYSIOL-HEART C, V285, pH1229, DOI 10.1152/ajpheart.00207.2003; Heymans S, 1999, NAT MED, V5, P1135, DOI 10.1038/13459; Kakinuma Y, 2005, FEBS LETT, V579, P2111, DOI 10.1016/j.febslet.2005.02.065; Kakinuma Y, 2010, J MOL CELL CARDIOL, V48, P680, DOI 10.1016/j.yjmcc.2009.11.010; Katare RG, 2009, J THORAC CARDIOV SUR, V137, P223, DOI 10.1016/j.jtcvs.2008.08.020; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lambert JM, 2008, INT J CARDIOL, V130, P147, DOI 10.1016/j.ijcard.2008.04.059; Leva Cristian, 2006, Interact Cardiovasc Thorac Surg, V5, P408, DOI 10.1510/icvts.2006.131037; Li M, 2004, CIRCULATION, V109, P120, DOI 10.1161/01.CIR.0000105721.71640.DA; LI MH, 2009, CIRCULATION S2, V120, pS1178; Lindsey ML, 2004, HEART FAIL REV, V9, P7, DOI 10.1023/B:HREV.0000011390.44039.b7; Lindsey ML, 2002, CIRCULATION, V105, P753, DOI 10.1161/hc0602.103674; Lu F, 2007, J MOL CELL CARDIOL, V43, P535, DOI 10.1016/j.yjmcc.2007.06.011; Matsumura S, 2005, J CLIN INVEST, V115, P599, DOI 10.1172/JCI200522304; McMullan MH, 2001, ANN THORAC SURG, V71, P1894, DOI 10.1016/S0003-4975(01)02625-X; Nagaoka I, 2000, INFLAMM RES, V49, P55, DOI 10.1007/s000110050559; Okazaki Y, 2010, J PHYSIOL SCI, V60, P67, DOI 10.1007/s12576-009-0071-5; Pavlov VA, 2006, BIOCHEM SOC T, V34, P1037, DOI 10.1042/BST0341037; Peterson JT, 2001, CIRCULATION, V103, P2303; PFEFFER J, 1979, AM J CARDIOL, V44, P994, DOI 10.1016/0002-9149(79)90234-0; PFEFFER JM, 1985, CIRC RES, V57, P84, DOI 10.1161/01.RES.57.1.84; Purcaro A, 1997, AM J CARDIOL, V80, P397, DOI 10.1016/S0002-9149(97)00385-8; Rohde LE, 1999, CIRCULATION, V99, P3063, DOI 10.1161/01.CIR.99.23.3063; Ryan RE, 2001, BRIT J PHARMACOL, V132, P1650, DOI 10.1038/sj.bjp.0703989; Sakaguchi G, 2008, ANN THORAC SURG, V85, P1344, DOI 10.1016/j.athoracsur.2007.12.073; Sato K, 2010, CLIN PHARMACOL THER, V88, P335, DOI 10.1038/clpt.2010.98; Schwartz PJ, 2008, EUR J HEART FAIL, V10, P884, DOI 10.1016/j.ejheart.2008.07.016; Schwartz PJ, 2009, HEART RHYTHM, V6, pS76, DOI 10.1016/j.hrthm.2009.08.012; Shepherd G, 1999, ANN PHARMACOTHER, V33, P812, DOI 10.1345/aph.18273; Spinale FG, 1999, CIRC RES, V85, P364, DOI 10.1161/01.RES.85.4.364; Takada Y, 2003, J PHARMACOL EXP THER, V306, P772, DOI 10.1124/jpet.103.050104; Takada-Takatori Y, 2008, J NEUROSCI RES, V86, P3575, DOI 10.1002/jnr.21798; WHITEHOUSE PJ, 1982, ANN NEUROL, V12, P494, DOI 10.1002/ana.410120517; Yang YN, 2008, AM J PHYSIOL-HEART C, V294, pH1815, DOI 10.1152/ajpheart.00831.2007; Zhang Y, 2006, J PHARMACOL SCI, V101, P214, DOI 10.1254/jphs.FP0051023	52	23	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2011	6	7							e20629	10.1371/journal.pone.0020629	http://dx.doi.org/10.1371/journal.pone.0020629			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	789JO	21750701	gold, Green Submitted, Green Published			2022-12-27	WOS:000292512000007
J	Yu, J; Yaba, A; Kasiman, C; Thomson, T; Johnson, J				Yu, James; Yaba, Aylin; Kasiman, Corinna; Thomson, Travis; Johnson, Joshua			mTOR Controls Ovarian Follicle Growth by Regulating Granulosa Cell Proliferation	PLOS ONE			English	Article							CHROMOSOME SEGREGATION; TRANSLATION INITIATION; RAPAMYCIN MTOR; FACTOR-I; PATHWAY; PROGRESSION; INHIBITION; TARGET; ACTIVATION; ANEUPLOIDY	We have shown that inhibition of mTOR in granulosa cells and ovarian follicles results in compromised granulosa proliferation and reduced follicle growth. Further analysis here using spontaneously immortalized rat granulosa cells has revealed that mTOR pathway activity is enhanced during M-phase of the cell cycle. mTOR specific phosphorylation of p70S6 kinase and 4E-BP, and expression of Raptor are all enhanced during M-phase. The predominant effect of mTOR inhibition by the specific inhibitor Rapamycin (RAP) was a dose-responsive arrest in the G1 cell cycle stage. The fraction of granulosa cells that continued to divide in the presence of RAP exhibited a dose-dependent increase in aberrant mitotic figures known as anaphase bridges. Strikingly, estradiol consistently decreased the incidence of aberrant mitotic figures. In mice treated with RAP, the mitotic index was reduced compared to controls, and a similar increase in aberrant mitotic events was noted. RAP injected during a superovulation regime resulted in a dose-dependent reduction in the numbers of eggs ovulated. Implications for the real-time regulation of follicle growth and dominance, including the consequences of increased numbers of aneuploid granulosa cells, are discussed.	[Yu, James; Johnson, Joshua] Yale Univ, Sch Med, Dept Obstet Gynecol & Reprod Sci, New Haven, CT 06520 USA; [Yaba, Aylin] Akdeniz Univ, Dept Histol & Embryol, TR-07058 Antalya, Turkey; [Kasiman, Corinna] Smith Coll, Northampton, MA 01063 USA; [Thomson, Travis] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA USA; [Thomson, Travis] Univ Massachusetts, Sch Med, Program Cell & Dev Dynam, Worcester, MA USA	Yale University; Akdeniz University; Smith College; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Yu, J (corresponding author), Yale Univ, Sch Med, Dept Obstet Gynecol & Reprod Sci, New Haven, CT 06520 USA.	josh.johnson@yale.edu	Yaba, Aylin/K-3414-2014; Johnson, Johnson/HDL-9124-2022	Johnson, Joshua/0000-0002-6016-8089	Yale Department of Obstetrics, Gynecology, and Reproductive Sciences; Donaghue Yale Women's Health Research Program	Yale Department of Obstetrics, Gynecology, and Reproductive Sciences; Donaghue Yale Women's Health Research Program	JJ is supported by Yale Department of Obstetrics, Gynecology, and Reproductive Sciences Research Funds and the Donaghue Yale Women's Health Research Program (http://medicine.yale.edu/whr/faculty/funding.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahams VM, 2004, J IMMUNOL, V173, P4286, DOI 10.4049/jimmunol.173.7.4286; Akcakanat A, 2007, BIOCHEM BIOPH RES CO, V362, P330, DOI 10.1016/j.bbrc.2007.07.151; Alam H, 2004, J BIOL CHEM, V279, P19431, DOI 10.1074/jbc.M401235200; Baerwald AR, 2003, BIOL REPROD, V69, P1023, DOI 10.1095/biolreprod.103.017772; Banu SK, 2008, TOXICOL APPL PHARM, V232, P180, DOI 10.1016/j.taap.2008.06.002; Barilli A, 2008, CARDIOVASC RES, V78, P563, DOI 10.1093/cvr/cvn024; Berga SL, 2006, ANN NY ACAD SCI, V1092, P114, DOI 10.1196/annals.1365.010; Berga SL, 2003, FERTIL STERIL, V80, P976, DOI 10.1016/S0015-0282(03)01124-5; Bonatti S, 1998, CHROMOSOMA, V107, P498, DOI 10.1007/s004120050335; Bonatti S, 2005, ENVIRON MOL MUTAGEN, V46, P164, DOI 10.1002/em.20145; Chan KL, 2007, EMBO J, V26, P3397, DOI 10.1038/sj.emboj.7601777; Chavarro JE, 2008, FERTIL STERIL, V89, P668, DOI 10.1016/j.fertnstert.2007.03.089; Chavarro JE, 2007, OBSTET GYNECOL, V110, P1050, DOI 10.1097/01.AOG.0000287293.25465.e1; Chavarro JE, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2007.06.057; Choe G, 2003, CANCER RES, V63, P2742; Dmitriev SE, 2003, MOL CELL BIOL, V23, P8925, DOI 10.1128/MCB.23.24.8925-8933.2003; Eskelinen EL, 2002, TRAFFIC, V3, P878, DOI 10.1034/j.1600-0854.2002.31204.x; Gersak K, 2000, FERTIL STERIL, V74, P158, DOI 10.1016/S0015-0282(00)00578-1; Gingras AC, 2001, GENE DEV, V15, P807, DOI 10.1101/gad.887201; Ginther OJ, 2003, ANIM REPROD SCI, V78, P239, DOI 10.1016/S0378-4320(03)00093-9; Ginther OJ, 2002, BIOL REPROD, V67, P14, DOI 10.1095/biolreprod67.1.14; Ginther OJ, 2001, BIOL REPROD, V65, P638, DOI 10.1095/biolreprod65.3.638; Gisselsson D, 2008, CHROMOSOMA, V117, P511, DOI 10.1007/s00412-008-0169-1; Gonzalez-Bulnes A, 2004, ANIM REPROD SCI, V84, P107, DOI 10.1016/j.anireprosci.2003.11.004; Grunwald K, 1998, HUM REPROD, V13, P2679, DOI 10.1093/humrep/13.10.2679; Gwinn DM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009197; HEITMAN J, 1991, SCIENCE, V253, P905, DOI 10.1126/science.1715094; Jacinto E, 2004, NAT CELL BIOL, V6, P1122, DOI 10.1038/ncb1183; Johnson J, 2004, NATURE, V428, P145, DOI 10.1038/nature02316; Kaleli S, 2005, FERTIL STERIL, V84, P802, DOI 10.1016/j.fertnstert.2005.02.040; Kim DH, 2003, CURR TOP MICROBIOL, V279, P259; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Lujan ME, 2006, ENDOCRINOLOGY, V147, P483, DOI 10.1210/en.2005-0821; Matzuk MM, 2000, MOL CELL ENDOCRINOL, V163, P61, DOI 10.1016/S0303-7207(99)00241-5; Neale D, 2003, J Matern Fetal Neonatal Med, V13, P39, DOI 10.1080/713605755; Ponticelli C, 2004, J NEPHROL, V17, P762; QUIRK SM, 2004, J ANIM SCI E S, V82; Rousseau D, 1996, ONCOGENE, V13, P2415; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Song JX, 2007, NAT IMMUNOL, V8, P64, DOI 10.1038/ni1413; STEIN LS, 1991, CANCER RES, V51, P696; Stewenius Y, 2005, P NATL ACAD SCI USA, V102, P5541, DOI 10.1073/pnas.0408454102; Straszewski-Chavez SL, 2004, MOL HUM REPROD, V10, P33, DOI 10.1093/molehr/gah001; Szoltys M, 2001, Reprod Biol, V1, P42; Temime-Smaali N, 2008, EMBO J, V27, P1513, DOI 10.1038/emboj.2008.74; Thomson TC, 2010, CELL DEATH DIFFER, V17, P1717, DOI 10.1038/cdd.2010.49; Thomson TC, 2010, MOL HUM REPROD, V16, P916, DOI 10.1093/molehr/gaq066; Tilly Jonathan L, 2003, Reprod Biol Endocrinol, V1, P11, DOI 10.1186/1477-7827-1-11; Vazquez-Martin A, 2009, BIOCHEM BIOPH RES CO, V380, P638, DOI 10.1016/j.bbrc.2009.01.153; Wiederrecht G J, 1995, Prog Cell Cycle Res, V1, P53; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; WULLSCHLEGER S, 2005, J BIOL CHEM; Yaba A, 2008, REPROD SCI, V15, P128, DOI 10.1177/1933719107312037; Zhou XY, 2004, CLIN CANCER RES, V10, P6779, DOI 10.1158/1078-0432.CCR-04-0112; Zielak AE, 2008, MOL REPROD DEV, V75, P904, DOI 10.1002/mrd.20819	55	62	68	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2011	6	7							e21415	10.1371/journal.pone.0021415	http://dx.doi.org/10.1371/journal.pone.0021415			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	789JO	21750711	Green Published, gold, Green Submitted			2022-12-27	WOS:000292512000013
J	Prosdocimi, F; Bittencourt, D; da Silva, FR; Kirst, M; Motta, PC; Rech, EL				Prosdocimi, Francisco; Bittencourt, Daniela; da Silva, Felipe Rodrigues; Kirst, Matias; Motta, Paulo C.; Rech, Elibio L.			Spinning Gland Transcriptomics from Two Main Clades of Spiders (Order: Araneae) - Insights on Their Molecular, Anatomical and Behavioral Evolution	PLOS ONE			English	Article							GENOME SEQUENCE; TARANTULA SPIDER; SILK FIBROIN; BETA-SUBUNIT; MEPRIN; GENES; PROTEINS; DATABASE; IDENTIFICATION; GENERATION	Characterized by distinctive evolutionary adaptations, spiders provide a comprehensive system for evolutionary and developmental studies of anatomical organs, including silk and venom production. Here we performed cDNA sequencing using massively parallel sequencers (454 GS-FLX Titanium) to generate similar to 80,000 reads from the spinning gland of Actinopus spp. (infraorder: Mygalomorphae) and Gasteracantha cancriformis (infraorder: Araneomorphae, Orbiculariae clade). Actinopus spp. retains primitive characteristics on web usage and presents a single undifferentiated spinning gland while the orbiculariae spiders have seven differentiated spinning glands and complex patterns of web usage. MIRA, Celera Assembler and CAP3 software were used to cluster NGS reads for each spider. CAP3 unigenes passed through a pipeline for automatic annotation, classification by biological function, and comparative transcriptomics. Genes related to spider silks were manually curated and analyzed. Although a single spidroin gene family was found in Actinopus spp., a vast repertoire of specialized spider silk proteins was encountered in orbiculariae. Astacin-like metalloproteases (meprin subfamily) were shown to be some of the most sampled unigenes and duplicated gene families in G. cancriformis since its evolutionary split from mygalomorphs. Our results confirm that the evolution of the molecular repertoire of silk proteins was accompanied by the (i) anatomical differentiation of spinning glands and (ii) behavioral complexification in the web usage. Finally, a phylogenetic tree was constructed to cluster most of the known spidroins in gene clades. This is the first large-scale, multi-organism transcriptome for spider spinning glands and a first step into a broad understanding of spider web systems biology and evolution.	[Prosdocimi, Francisco] Univ Fed Rio de Janeiro, Inst Bioquim Med, Rio de Janeiro, Brazil; [Bittencourt, Daniela] EMBRAPA Amazonia Ocidental, Manaus, Amazonas, Brazil; [Prosdocimi, Francisco] Univ Catolica Brasilia, Brasilia, DF, Brazil; [da Silva, Felipe Rodrigues] EMBRAPA Informat Agr, Sao Paulo, Brazil; [Kirst, Matias] Univ Florida, IFAS, Gainesville, FL 32611 USA; [Motta, Paulo C.] Dept Zool UnB, Brasilia, DF, Brazil; [Rech, Elibio L.] EMBRAPA CeNaRGen, Brasilia, DF, Brazil	Universidade Federal do Rio de Janeiro; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Universidade Catolica de Brasilia; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); State University System of Florida; University of Florida; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA)	Prosdocimi, F (corresponding author), Univ Fed Rio de Janeiro, Inst Bioquim Med, Rio de Janeiro, Brazil.	prosdocimi@bioqmed.ufrj.br; rech@cenargen.embrapa.br	da Silva, Felipe Rodrigues/A-5627-2008; Prosdocimi, Francisco/F-6847-2012; Bittencourt, Daniela/D-9483-2013; Prosdocimi, Francisco/V-5252-2019	da Silva, Felipe Rodrigues/0000-0002-3527-6870; Prosdocimi, Francisco/0000-0002-6761-3069; Prosdocimi, Francisco/0000-0002-6761-3069; Matias de Carvalho Bittencourt, Daniela/0000-0002-3137-6567	CNPq; FAPDF	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPDF(Fundacao de Apoio a Pesquisa do Distrito Federal (FAPDF))	This work was supported by the Brazilian government funding agencies CNPq and FAPDF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ashburner M, 2001, GENOME RES, V11, P1425; Becker-Pauly C, 2007, J INVEST DERMATOL, V127, P1115, DOI 10.1038/sj.jid.5700675; Becker-Pauly C, 2009, J MOL BIOL, V385, P236, DOI 10.1016/j.jmb.2008.10.062; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; Bini E, 2004, J MOL BIOL, V335, P27, DOI 10.1016/j.jmb.2003.10.043; Bittencourt D, 2007, COMP BIOCHEM PHYS B, V147, P597, DOI 10.1016/j.cbpb.2007.03.013; Bittencourt D, 2010, COMP BIOCHEM PHYS B, V155, P419, DOI 10.1016/j.cbpb.2010.01.005; BOGUSKI MS, 1993, NAT GENET, V4, P332, DOI 10.1038/ng0893-332; BOND JS, 1986, CURR TOP CELL REGUL, V28, P263; BOND JS, 1995, PROTEIN SCI, V4, P1247, DOI 10.1002/pro.5560040701; *CEL, CEL WGS ASS MAN; Chevreux B, 2004, GENOME RES, V14, P1147, DOI 10.1101/gr.1917404; CHEVREUX B, SEQUENCE ASSEMBLY MI; CODDINGTON JA, 1991, ANNU REV ECOL SYST, V22, P565, DOI 10.1146/annurev.es.22.110191.003025; Colgin MA, 1998, PROTEIN SCI, V7, P667, DOI 10.1002/pro.5560070315; Crisman JM, 2004, J IMMUNOL, V172, P4510, DOI 10.4049/jimmunol.172.7.4510; Da Silveira RB, 2007, BIOCHEM J, V406, P355, DOI 10.1042/BJ20070363; Feitosa L, 1998, TOXICON, V36, P1039, DOI 10.1016/S0041-0101(97)00083-4; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Foelix RF, 1996, BIOL SPIDERS; Foo CWP, 2002, ADV DRUG DELIVER REV, V54, P1131; Garb JE, 2005, P NATL ACAD SCI USA, V102, P11379, DOI 10.1073/pnas.0502473102; Garb JE, 2007, MOL BIOL EVOL, V24, P2454, DOI 10.1093/molbev/msm179; Gatesy J, 2001, SCIENCE, V291, P2603, DOI 10.1126/science.1057561; Gosline J, 2002, PHILOS T R SOC B, V357, P121, DOI 10.1098/rstb.2001.1022; Hayashi CY, 1999, INT J BIOL MACROMOL, V24, P271, DOI 10.1016/S0141-8130(98)00089-0; Herzog C, 2005, CYTOKINE, V31, P394, DOI 10.1016/j.cyto.2005.06.012; HINMAN MB, 1992, J BIOL CHEM, V267, P19320; Holt RA, 2002, SCIENCE, V298, P129, DOI 10.1126/science.1076181; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; JIANG WP, 1992, FEBS LETT, V312, P110, DOI 10.1016/0014-5793(92)80916-5; Katayama S, 2005, SCIENCE, V309, P1564, DOI 10.1126/science.1112009; Kluge JA, 2008, TRENDS BIOTECHNOL, V26, P244, DOI 10.1016/j.tibtech.2008.02.006; Kronenberg D, 2010, J INVEST DERMATOL, V130, P2727, DOI 10.1038/jid.2010.202; Lorenzini DM, 2006, DEV COMP IMMUNOL, V30, P545, DOI 10.1016/j.dci.2005.09.001; Loytynoja A, 2005, P NATL ACAD SCI USA, V102, P10557, DOI 10.1073/pnas.0409137102; Loytynoja A, 2008, SCIENCE, V320, P1632, DOI 10.1126/science.1158395; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; MARPLES B. J., 1967, J LINN SOC LONDON ZOOL, V46, P209; Mattick JS, 2009, ANN NY ACAD SCI, V1178, P29, DOI 10.1111/j.1749-6632.2009.04991.x; Mattick JS, 2001, EMBO REP, V2, P986, DOI 10.1093/embo-reports/kve230; Meisel RP, 2009, J MOL EVOL, V69, P81, DOI 10.1007/s00239-009-9254-1; Miller JR, 2008, BIOINFORMATICS, V24, P2818, DOI 10.1093/bioinformatics/btn548; Mohrlen F, 2006, EVOL DEV, V8, P223, DOI 10.1111/j.1525-142X.2006.00092.x; MUMA M H, 1971, Florida Entomologist, V54, P345, DOI 10.2307/3493600; Nei M., 2000, MOL EVOLUTION PHYLOG; Nene V, 2007, SCIENCE, V316, P1718, DOI 10.1126/science.1138878; Novaes E, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-312; PALMER JM, 1985, J MORPHOL, V186, P195, DOI 10.1002/jmor.1051860205; PALMER JM, 1982, J MORPHOL, V174, P269, DOI 10.1002/jmor.1051740303; PEAKALL DB, 1964, J EXP ZOOL, V156, P345, DOI 10.1002/jez.1401560310; PEAKALL DB, 1965, NATURE, V207, P102, DOI 10.1038/207102a0; Pertea G, 2003, BIOINFORMATICS, V19, P651, DOI 10.1093/bioinformatics/btg034; Platnick N.I., 1976, American Museum Novitates, VNo. 2607, P1; Pontius J., 2003, NCBI HDB, P1; Prosdocimi F, 2002, MEM I OSWALDO CRUZ, V97, P61, DOI 10.1590/S0074-02762002000900014; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; RAVEN RJ, 1985, B AM MUS NAT HIST, V182, P1; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; RZHETSKY A, 1992, MOL BIOL EVOL, V9, P945; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schutte A, 2007, BIOL CHEM, V388, P523, DOI 10.1515/BC.2007.060; Shakhnovich BE, 2006, GENOME RES, V16, P1529, DOI 10.1101/gr.5346206; Shumway M, 2010, NUCLEIC ACIDS RES, V38, pD870, DOI 10.1093/nar/gkp1078; Soskine M, 2010, NAT REV GENET, V11, P572, DOI 10.1038/nrg2808; STRADLING DJ, 1994, BIOTROPICA, V26, P84, DOI 10.2307/2389113; Tai PL, 2004, INT J BIOL MACROMOL, V34, P295, DOI 10.1016/j.ijbiomac.2004.08.002; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Telles GP, 2001, GENET MOL BIOL, V24, P17, DOI 10.1590/S1415-47572001000100004; Teule F, 2009, NAT PROTOC, V4, P341, DOI 10.1038/nprot.2008.250; Trevisan-Silva D, 2010, BIOCHIMIE, V92, P21, DOI 10.1016/j.biochi.2009.10.003; Vendrely C, 2007, MACROMOL BIOSCI, V7, P401, DOI 10.1002/mabi.200600255; Vettore AL, 2003, GENOME RES, V13, P2725, DOI 10.1101/gr.1532103; VOLLRATH F, 1992, SCI AM, V266, P70, DOI 10.1038/scientificamerican0392-70; Vollrath F, 2007, ANNU REV ECOL EVOL S, V38, P819, DOI 10.1146/annurev.ecolsys.37.091305.110221; Weiss B, 1999, CELL MOL LIFE SCI, V55, P334, DOI 10.1007/s000180050296; Wittenborn T, 2010, J INNATE IMMUN, V2, P167, DOI 10.1159/000218324; WOLZ RL, 1991, BIOCHEMISTRY-US, V30, P8488, DOI 10.1021/bi00098a029; Xia XX, 2010, P NATL ACAD SCI USA, V107, P14059, DOI 10.1073/pnas.1003366107; XU M, 1990, P NATL ACAD SCI USA, V87, P7120, DOI 10.1073/pnas.87.18.7120; Yan L, 2000, DEVELOPMENT, V127, P129; Zhang XL, 2008, ADV EXP MED BIOL, V632, P105, DOI 10.1007/978-0-387-78952-1_9; Zhu JG, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-117; Zuckerkandl E, 1965, EVOL GENES PROTEINS, P97, DOI DOI 10.1016/B978-1-4832-2734-4.50017-6; NUCL ACIDS RES, V38, pD142	89	31	31	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2011	6	6							e21634	10.1371/journal.pone.0021634	http://dx.doi.org/10.1371/journal.pone.0021634			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786FZ	21738742	gold, Green Published			2022-12-27	WOS:000292290100049
J	Varthaman, A; Clement, M; Khallou-Laschet, J; Fornasa, G; Gaston, AT; Dussiot, M; Caligiuri, G; Cantor, H; Kaveri, S; Nicoletti, A				Varthaman, Aditi; Clement, Marc; Khallou-Laschet, Jamila; Fornasa, Giulia; Gaston, Anh-Thu; Dussiot, Michael; Caligiuri, Giuseppina; Cantor, Harvey; Kaveri, Srinivas; Nicoletti, Antonino			Physiological Induction of Regulatory Qa-1-Restricted CD8+T Cells Triggered by Endogenous CD4+T Cell Responses	PLOS ONE			English	Article							CD8-ALPHA-ALPHA+TCR-ALPHA-BETA(+) T-CELLS; EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; HLA-E; AUTOIMMUNE ENCEPHALOMYELITIS; DENDRITIC CELLS; VACCINATION; MOLECULE; RECEPTOR; MICE; SPECIFICITY	T cell-dependent autoimmune diseases are characterized by the expansion of T cell clones that recognize immunodominant epitopes on the target antigen. As a consequence, for a given autoimmune disorder, pathogenic T cell clones express T cell receptors with a limited number of variable regions that define antigenic specificity. Qa-1, a MHC class I-like molecule, presents peptides from the variable region of TCRs to Qa-1-restricted CD8+ T cells. The induction of V beta-specific CD8+ T cells has been harnessed in an immunotherapeutic strategy known as the "T cell vaccination'' (TCV) that comprises the injection of activated and attenuated CD4+ T cell clones so as to induce protective CD8+ T cells. We hypothesized that Qa-1-restricted CD8+ regulatory T cells could also constitute a physiologic regulatory arm of lymphocyte responses upon expansion of endogenous CD4+ T cells, in the absence of deliberate exogenous T cell vaccination. We immunized mice with two types of antigenic challenges in order to sequentially expand antigen-specific endogenous CD4+ T cells with distinct antigenic specificities but characterized by a common V beta chain in their TCR. The first immunization was performed with a non-self antigen while the second challenge was performed with a myelin-derived peptide known to drive experimental autoimmune encephalomyelitis (EAE), a mouse model of multiple sclerosis. We show that regulatory V beta-specific Qa-1-restricted CD8+ T cells induced during the first endogenous CD4+ T cell responses are able to control the expansion of subsequently mobilized pathogenic autoreactive CD4+ T cells. In conclusion, apart from the immunotherapeutic TCV, Qa-1-restricted specialized CD8+ regulatory T cells can also be induced during endogenous CD4+ T cell responses. At variance with other regulatory T cell subsets, the action of these Qa-1-restricted T cells seems to be restricted to the immediate reactivation of CD4+ T cells.	[Varthaman, Aditi; Clement, Marc; Khallou-Laschet, Jamila; Fornasa, Giulia; Gaston, Anh-Thu; Dussiot, Michael; Caligiuri, Giuseppina; Nicoletti, Antonino] Univ Paris 07, INSERM, UMRS698, Paris, France; [Varthaman, Aditi; Clement, Marc; Khallou-Laschet, Jamila; Fornasa, Giulia; Gaston, Anh-Thu; Dussiot, Michael; Caligiuri, Giuseppina; Kaveri, Srinivas; Nicoletti, Antonino] Univ Paris 06, INSERM, UMRS872, Ctr Rech Cordeliers,Equipe 16, Paris, France; [Cantor, Harvey] Dana Farber Canc Inst, Dept Canc Immunol & AIDS, Boston, MA 02115 USA; [Cantor, Harvey] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School	Varthaman, A (corresponding author), Univ Paris 07, INSERM, UMRS698, Paris, France.	antonino.nicoletti@inserm.fr	Fornasa, Giulia/AAB-8912-2019; Caligiuri, Giuseppina/G-4810-2015; Nicoletti, Antonino/A-9460-2015; CLEMENT, Marc/GVS-8052-2022	Fornasa, Giulia/0000-0002-2250-7983; Caligiuri, Giuseppina/0000-0003-4973-2205; Nicoletti, Antonino/0000-0002-2623-0897; CLEMENT, Marc/0000-0002-6479-8360; Varthaman, Aditi/0000-0002-8703-5534; Laschet, Jamila/0000-0002-5090-4417; Kaveri, Srini/0000-0002-0837-4053	INSERM	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission)	This study was funded by INSERM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENNUN A, 1981, NATURE, V292, P60, DOI 10.1038/292060a0; Bousso P, 2008, NAT REV IMMUNOL, V8, P675, DOI 10.1038/nri2379; Chun T, 1998, IMMUNOLOGY, V94, P64; DeCloux A, 1997, J IMMUNOL, V158, P2183; Hu D, 2004, NAT IMMUNOL, V5, P516, DOI 10.1038/ni1063; Itoh Y, 1997, P NATL ACAD SCI USA, V94, P12047, DOI 10.1073/pnas.94.22.12047; Jiang H, 1998, P NATL ACAD SCI USA, V95, P4533, DOI 10.1073/pnas.95.8.4533; Jiang H, 2001, P NATL ACAD SCI USA, V98, P6301, DOI 10.1073/pnas.101123098; Kariyone A, 2003, INT IMMUNOL, V15, P1183, DOI 10.1093/intimm/dxg115; KIM HJ, NATURE, V467, P328; KOH DR, 1992, SCIENCE, V256, P1210, DOI 10.1126/science.256.5060.1210; Li JF, 2001, J IMMUNOL, V167, P3800, DOI 10.4049/jimmunol.167.7.3800; LIDER O, 1988, SCIENCE, V239, P181, DOI 10.1126/science.2447648; Michaelsson J, 2002, J EXP MED, V196, P1403, DOI 10.1084/jem.20020797; O'Callaghan CA, 1998, MOL CELL, V1, P531, DOI 10.1016/S1097-2765(00)80053-2; Panoutsakopoulou V, 2004, J CLIN INVEST, V113, P1218, DOI 10.1172/JCI200420772; Reboldi A, 2009, NAT IMMUNOL, V10, P514, DOI 10.1038/ni.1716; Stromnes IM, 2006, NAT PROTOC, V1, P1810, DOI 10.1038/nprot.2006.285; Sullivan BA, 2002, IMMUNITY, V17, P95, DOI 10.1016/S1074-7613(02)00343-6; Tang X, 2006, J IMMUNOL, V177, P7645, DOI 10.4049/jimmunol.177.11.7645; VARTHAMAN A, J IMMUNOL, V184, P6585	22	15	15	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2011	6	6							e21628	10.1371/journal.pone.0021628	http://dx.doi.org/10.1371/journal.pone.0021628			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	783OD	21738737	Green Submitted, Green Published, gold			2022-12-27	WOS:000292092600063
J	Montefeltro, FC; Larsson, HCE; Langer, MC				Montefeltro, Felipe C.; Larsson, Hans C. E.; Langer, Max C.			A New Baurusuchid (Crocodyliformes, Mesoeucrocodylia) from the Late Cretaceous of Brazil and the Phylogeny of Baurusuchidae	PLOS ONE			English	Article							BAURU BASIN; ADAMANTINA FORMATION; SP-NOV.; CROCODYLOMORPHA; EVOLUTION; PATAGONIA; ANATOMY; THALATTOSUCHIA; ARCHOSAURIA; NOTOSUCHIA	Background: Baurusuchidae is a group of extinct Crocodyliformes with peculiar, dog-faced skulls, hypertrophied canines, and terrestrial, cursorial limb morphologies. Their importance for crocodyliform evolution and biogeography is widely recognized, and many new taxa have been recently described. In most phylogenetic analyses of Mesoeucrocodylia, the entire clade is represented only by Baurusuchus pachecoi, and no work has attempted to study the internal relationships of the group or diagnose the clade and its members. Methodology/Principal Findings: Based on a nearly complete skull and a referred partial skull and lower jaw, we describe a new baurusuchid from the Vale do Rio do Peixe Formation (Bauru Group), Late Cretaceous of Brazil. The taxon is diagnosed by a suite of characters that include: four maxillary teeth, supratemporal fenestra with equally developed medial and anterior rims, four laterally visible quadrate fenestrae, lateral Eustachian foramina larger than medial Eustachian foramen, deep depression on the dorsal surface of pterygoid wing. The new taxon was compared to all other baurusuchids and their internal relationships were examined based on the maximum parsimony analysis of a discrete morphological data matrix. Conclusion: The monophyly of Baurusuchidae is supported by a large number of unique characters implying an equally large morphological gap between the clade and its immediate outgroups. A complex phylogeny of baurusuchids was recovered. The internal branch pattern suggests two main lineages, one with a relatively broad geographical range between Argentina and Brazil (Pissarrachampsinae), which includes the new taxon, and an endemic clade of the Bauru Group in Brazil (Baurusuchinae).	[Montefeltro, Felipe C.; Langer, Max C.] Univ Sao Paulo, Dept Biol, Fac Filosofia Ciencias & Letras Ribeirao Preto, BR-14049 Ribeirao Preto, Brazil; [Larsson, Hans C. E.] McGill Univ, Redpath Museum, Montreal, PQ H3A 2K6, Canada	Universidade de Sao Paulo; McGill University	Montefeltro, FC (corresponding author), Univ Sao Paulo, Dept Biol, Fac Filosofia Ciencias & Letras Ribeirao Preto, BR-14049 Ribeirao Preto, Brazil.	felipecm@pg.ffclrp.usp.br	Larsson, Hans/AAD-4579-2019; Montefeltro, Felipe Chinaglia/AAQ-4003-2020; Langer, Max C/F-7483-2012; Montefeltro, Felipe C/L-5780-2015; Langer, Max/Y-1753-2019	Larsson, Hans/0000-0002-6377-4770; Montefeltro, Felipe Chinaglia/0000-0001-6519-8546; Langer, Max C/0000-0003-1009-4605; 	FAPESP [2008/57642-6]; Programa de Pos-Graduacao em Biologia Comparada; FFCLRP-USP; Programa Doutorando com Estagio no Exterior; CAPES [1275/10-0]; CNPQ; CRC; NSERC	FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Programa de Pos-Graduacao em Biologia Comparada; FFCLRP-USP; Programa Doutorando com Estagio no Exterior; CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPQ(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CRC(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	FAPESP (grant number: 2008/57642-6), Programa de Pos-Graduacao em Biologia Comparada, FFCLRP-USP, and Programa Doutorando com Estagio no Exterior, CAPES (grant number 1275/10-0) to FCM, CNPQ and FAPESP to MCL, CRC and NSERC to HCEL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnarsson I, 2008, CLADISTICS, V24, P51, DOI [10.1111/j.1096-0031.2007.00168.x, 10.1111/j.1096-0031.2008.00229.x]; Antunes M.T., 1975, COMUNICACOES SERVICO, V59, P285; BAEZ A M, 1989, Anais da Academia Brasileira de Ciencias, V61, P447; Barcelos JH, 1984, RECONSTRUCAO PALEOGE; BARRY T. H., 1957, PALAEONTOL AFRICANA, V5, P57; Benton M.J., 1988, Systematics Association Special Volume Series, P295; Bonaparte JF., 1991, REV MUSEO ARGENTINO, V4, P17; BREMER K, 1988, EVOLUTION, V42, P795, DOI 10.1111/j.1558-5646.1988.tb02497.x; Brochu CA, 2002, J PALEONTOL, V76, P1060, DOI 10.1666/0022-3360(2002)076<1060:ADCBFM>2.0.CO;2; Brochu CA, 1999, J VERTEBR PALEONTOL, V19, P9, DOI 10.1080/02724634.1999.10011201; Buckley GA, 1999, SPEC PAP PALAEONTOL, P149; Buckley GA, 2000, NATURE, V405, P941, DOI 10.1038/35016061; BUFFETAUT E, 1989, Palaeontographica Abteilung A Palaeozoologie-Stratigraphie, V208, P1; BUFFETAUT E, 1980, Annales de Paleontologie Vertebres, V66, P1; BUSBEY AB, 1995, FUNCTIONAL MORPHOLOGY IN VERTEBRATE PALEONTOLOGY, P173; Buscalioni A.D., 1988, Historical Biology, V1, P233; Campos DA, 1988, ANAIS ACAD BRASILEIR, V60, P492; Campos Diogenes de Almeida, 2001, Boletim do Museu Nacional Nova Serie Geologia, V57, P1; Candeiro CRA, 2006, J S AM EARTH SCI, V22, P116, DOI 10.1016/j.jsames.2006.08.001; Candeiro CRA, 2004, J S AM EARTH SCI, V18, P1, DOI 10.1016/j.jsames.2004.08.004; Carvalho I.S., 1999, GEOLOGIA COLOMBIANA, V24, P83, DOI DOI 10.15446/GC; Carvalho ID, 2004, GONDWANA RES, V7, P975, DOI 10.1016/S1342-937X(05)71079-0; Carvalho ID, 2005, GONDWANA RES, V8, P11, DOI 10.1016/S1342-937X(05)70259-8; Carvalho ID, 2010, PALAEOGEOGR PALAEOCL, V297, P252, DOI 10.1016/j.palaeo.2010.08.003; CLARK JM, 1994, IN THE SHADOW OF THE DINOSAURS, P84; Coimbra, 2003, 18 C BRAS PAL BRAS B, P152; COLBERT EH, 1946, B AM MUS NAT HIST, V87, P223; Company J, 2005, J VERTEBR PALEONTOL, V25, P343, DOI 10.1671/0272-4634(2005)025[0343:ANSODC]2.0.CO;2; de Andrade MB, 2008, HIST BIOL, V20, P101, DOI 10.1080/08912960701642949; De Andrade Marco Brandalise, 2008, Arquivos do Museu Nacional Rio de Janeiro, V66, P7; De Andrade Marco Brandalise, 2006, REVISTA BRASILEIRA DE PALEONTOLOGIA, V9, P323; de Gasparini Z.B., 1972, Ameghiniana, V9, P23; DEBUFFRENIL V, 1982, ZOOMORPHOLOGY, V99, P155, DOI 10.1007/BF00310307; Dias-Brito Dimas, 2001, Revue de Paleobiologie, V20, P245; ESTES R, 1973, SCIENCE, V180, P748, DOI 10.1126/science.180.4087.748; FARRIS JS, 1970, SYST ZOOL, V19, P83, DOI 10.2307/2412028; Fernandes L.A., 2000, REV BRASILEIRA GEOCI, V30, P717, DOI DOI 10.25249/0375-7536.2000304717728; Fernandes LA., 1996, ANAIS ACAD BRASILEIR, V68, P105; Fiorelli Lucas, 2008, Arquivos do Museu Nacional Rio de Janeiro, V66, P83; Fiorelli Lucas E., 2007, Arquivos do Museu Nacional (Rio de Janeiro), V65, P417; FRANCA MAG, 2005, GEODIVERSITAS, V27, P391; Gasparini Z, 2006, SCIENCE, V311, P70, DOI 10.1126/science.1120803; Gasparini Z., 1991, Journal of Vertebrate Paleontology, V11, P316; GASPARINI Z, 1981, Ameghiniana, V18, P177; Gasparini Zulma, 1993, Historical Biology, V7, P1; Goloboff PA, 2008, CLADISTICS, V24, P774, DOI 10.1111/j.1096-0031.2008.00217.x; Hill RV, 2003, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2003)395<0001:ANSOPG>2.0.CO;2; Holliday CM, 2007, J MORPHOL, V268, P457, DOI 10.1002/jmor.10524; Holliday CM, 2009, J VERTEBR PALEONTOL, V29, P715, DOI 10.1671/039.029.0330; Horner JR, 2006, P ROY SOC B-BIOL SCI, V273, P2757, DOI 10.1098/rspb.2006.3643; Horner JR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007626; IORDANSKY N. N., 1964, ANAT ANZ, V115, P256; Iordansky N.N., 1973, P201; Kuhn, 1968, VORZEITLICHEN KROKOD; Larsson H.C.E., 1998, NEUES JB GEOLOGIE PA, V210, P345; Larsson HCE, 2007, ZOOL J LINN SOC-LOND, V149, P533, DOI 10.1111/j.1096-3642.2007.00271.x; Lauprasert K, 2009, GEOL SOC SPEC PUBL, V315, P175, DOI 10.1144/SP315.13; Laurenti J. N, 1768, SPECIMEN MEDICUM EXH; Lecuona A, 2008, CR PALEVOL, V7, P407, DOI 10.1016/j.crpv.2008.07.001; Marinho TS, 2009, J S AM EARTH SCI, V27, P36, DOI 10.1016/j.jsames.2008.11.005; Martill DM, 2006, PALAEONTOLOGY, V49, P925, DOI 10.1111/j.1475-4983.2006.00575.x; Leardi JM, 2009, CRETACEOUS RES, V30, P1376, DOI 10.1016/j.cretres.2009.08.002; Martinelli AG, 2008, CR PALEVOL, V7, P371, DOI 10.1016/j.crpv.2008.05.002; Mook CC, 1921, B AM MUS NAT HIST, V44, P51; Nascimento Paulo Miranda, 2010, Pap. Avulsos Zool. (São Paulo), V50, P323, DOI 10.1590/S0031-10492010002100001; Nascimento PM, 2008, DESCRICAO MORFOLOGIC; Nascimento PM, 2010, ZOOLOGICAL IN PRESS; O'Connor PM, 2010, NATURE, V466, P748, DOI 10.1038/nature09061; Ortega F, 1996, GEOBIOS-LYON, V29, P353, DOI 10.1016/S0016-6995(96)80037-4; Ortega F, 2000, J VERTEBR PALEONTOL, V20, P57, DOI 10.1671/0272-4634(2000)020[0057:ANSOAC]2.0.CO;2; Piacentini Pinheiro Andre Eduardo, 2008, Revista Brasileira de Paleontologia, V11, P37; Pol D, 2004, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2004)458<0001:ANGCTF>2.0.CO;2; Pol D, 2004, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2004)445<0001:ANCFCM>2.0.CO;2; Pol D, 2004, CRETACEOUS RES, V25, P603, DOI 10.1016/j.cretres.2004.05.002; Pol D, 2005, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2005)490[0001:NARFTE]2.0.CO;2; Pol D, ZOOLOGICAL IN PRESS; Pol D, 1999, ESQUELETO POSTCRANEA; Pol Diego, 2007, P116; Pol D, 2009, B AM MUS NAT HIST, P1; Pol D, 2009, J SYST PALAEONTOL, V7, P163, DOI 10.1017/S1477201908002605; Prasad Guntupalli V.R., 2002, Annales de Paleontologie, V88, P19, DOI 10.1016/S0753-3969(02)01036-4; Price L.I., 1945, NOTAS PRELIMINARES E, V25, P1; PRICE LI, 1959, B DGM RJ, V118, P1; Price LI, 1955, D F, V27, P487; Riff D, ZOOLOGICAL IN PRESS; Riff Douglas, 2001, Boletim do Museu Nacional Nova Serie Geologia, V59, P1; Romer A, 1956, OSTEOLOGY REPTILES; Rossmann Torsten, 2000, Palaeontologische Zeitschrift, V74, P379; Santucci R.M., 2001, BRAZ J GENET, V31, P307; Sereno PC, 2009, ZOOKEYS, P1, DOI 10.3897/zookeys.28.325; Sereno PC, 2003, J VERTEBR PALEONTOL, V23, P477, DOI 10.1671/0272-4634(2003)023[0477:ANNFTE]2.0.CO;2; Sereno PC, 2001, SCIENCE, V294, P1516, DOI 10.1126/science.1066521; SHUTE C. C. D., 1955, PROC ZOOL SOC LONDON, V124, P741; Simpson G. G., 1937, American Museum Novitates, P1; Smith JB, 2003, J VERTEBR PALEONTOL, V23, P1, DOI 10.1671/0272-4634(2003)23[1:APFAST]2.0.CO;2; Soares P.C., 1980, REV BRASILEIRA GEOCI, V10, P177, DOI DOI 10.25249/0375-7536.1980177185; Steyer JS, 2000, ZOOL J LINN SOC-LOND, V130, P449, DOI 10.1006/zjls.1999.0220; SWOFFORD DL, 1987, MATH BIOSCI, V87, P199, DOI 10.1016/0025-5564(87)90074-5; TARSITANO SF, 1989, AM ZOOL, V29, P843; Tsuihiji T, 2007, J MORPHOL, V268, P986, DOI 10.1002/jmor.10565; Turner AH, 2004, P ROY SOC B-BIOL SCI, V271, P2003, DOI 10.1098/rspb.2004.2840; Turner AH, 2005, J VERTEBR PALEONTOL, V25, P87, DOI 10.1671/0272-4634(2005)025[0087:ANSCFT]2.0.CO;2; Turner AH, 2008, J VERTEBR PALEONTOL, V28, P382, DOI 10.1671/0272-4634(2008)28[382:MICMCA]2.0.CO;2; Turner AH, 2010, J VERTEBR PALEONTOL, V30, P177, DOI 10.1080/02724634.2010.532348; Tykoski RS, 2002, J VERTEBR PALEONTOL, V22, P593, DOI 10.1671/0272-4634(2002)022[0593:CVANCF]2.0.CO;2; Vasc F. M., 2005, ANU INST GEOCIENC, V28, P49; Vasconcellos FM., 2010, B NEW MEXICO MUSEUM, V51, P227; WALKER AD, 1970, PHILOS T ROY SOC B, V257, P323, DOI 10.1098/rstb.1970.0028; WALKER AD, 1968, GEOL MAG, V105, P1, DOI 10.1017/S0016756800046434; Whetstone K.N., 1983, OCCASIONAL PAPERS MU, V106, P1, DOI DOI 10.1017/CBO9781107415324.004; Wilson Jeffrey A., 2001, Contributions from the Museum of Paleontology University of Michigan, V30, P321; Witmer LM, 1997, J VERTEBR PALEONTOL, V17, P1, DOI 10.1080/02724634.1997.10011027; Woodward A.S., 1896, ANALES MUSEO PLATA P, V4, P1; Wu XC, 1996, J VERTEBR PALEONTOL, V16, P688, DOI 10.1080/02724634.1996.10011358; Young MT, 2009, ZOOL J LINN SOC-LOND, V157, P551, DOI 10.1111/j.1096-3642.2009.00536.x; Zaher H, 2006, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2006)3512[1:ROTCMO]2.0.CO;2	116	62	63	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2011	6	7							e21916	10.1371/journal.pone.0021916	http://dx.doi.org/10.1371/journal.pone.0021916			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	792WQ	21765925	Green Submitted, Green Published, gold			2022-12-27	WOS:000292781500022
J	Gaveau, J; Papaxanthis, C				Gaveau, Jeremie; Papaxanthis, Charalambos			The Temporal Structure of Vertical Arm Movements	PLOS ONE			English	Article							MOTOR CORTICAL REPRESENTATION; DIRECTIONAL ISOMETRIC FORCE; SIGNAL-DEPENDENT NOISE; POINTING MOVEMENTS; SAGITTAL PLANE; CORTEX; INTEGRATION; GRAVITY; SENSORIMOTOR; MODEL	The present study investigates how the CNS deals with the omnipresent force of gravity during arm motor planning. Previous studies have reported direction-dependent kinematic differences in the vertical plane; notably, acceleration duration was greater during a downward than an upward arm movement. Although the analysis of acceleration and deceleration phases has permitted to explore the integration of gravity force, further investigation is necessary to conclude whether feedforward or feedback control processes are at the origin of this incorporation. We considered that a more detailed analysis of the temporal features of vertical arm movements could provide additional information about gravity force integration into the motor planning. Eight subjects performed single joint vertical arm movements (45 degrees rotation around the shoulder joint) in two opposite directions (upwards and downwards) and at three different speeds (slow, natural and fast). We calculated different parameters of hand acceleration profiles: movement duration (MD), duration to peak acceleration (D PA), duration from peak acceleration to peak velocity (D PA-PV), duration from peak velocity to peak deceleration (D PV-PD), duration from peak deceleration to the movement end (D PD-End), acceleration duration (AD), deceleration duration (DD), peak acceleration (PA), peak velocity (PV), and peak deceleration (PD). While movement durations and amplitudes were similar for upward and downward movements, the temporal structure of acceleration profiles differed between the two directions. More specifically, subjects performed upward movements faster than downward movements; these direction-dependent asymmetries appeared early in the movement (i.e., before PA) and lasted until the moment of PD. Additionally, PA and PV were greater for upward than downward movements. Movement speed also changed the temporal structure of acceleration profiles. The effect of speed and direction on the form of acceleration profiles is consistent with the premise that the CNS optimises motor commands with respect to both gravitational and inertial constraints.	[Gaveau, Jeremie; Papaxanthis, Charalambos] INSERM, U Motr Plast 887, Dijon, France; [Gaveau, Jeremie; Papaxanthis, Charalambos] Univ Bourgogne, UFR STAPS, Dijon, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bourgogne	Gaveau, J (corresponding author), INSERM, U Motr Plast 887, Dijon, France.	charalambos.Papaxanthis@u-bourgogne.fr	Gaveau, Jeremie/AAJ-7822-2020	Gaveau, Jeremie/0000-0001-8827-1486	INSERM; Ministere de l'Education Nationale, de l'Enseignement et de la Recherche	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Ministere de l'Education Nationale, de l'Enseignement et de la Recherche	This work was supported by INSERM. Jeremie Gaveau was supported by grants from the 'Ministere de l'Education Nationale, de l'Enseignement et de la Recherche'. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashe J, 1997, BEHAV BRAIN RES, V87, P255; ATKESON CG, 1985, J NEUROSCI, V5, P2318; Berret B, 2009, J NEUROSCI, V29, P191, DOI 10.1523/JNEUROSCI.3426-08.2009; Berret B, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000194; Biess A, 2007, J NEUROSCI, V27, P13045, DOI 10.1523/JNEUROSCI.4334-06.2007; CAMINITI R, 1991, J NEUROSCI, V11, P1182; Cheron G, 1997, ELECTROMYOGR MOTOR C, V105, P58, DOI 10.1016/S0924-980X(96)96544-3; Courtine G, 2002, NEUROSCI LETT, V332, P70, DOI 10.1016/S0304-3940(02)00909-6; Crevecoeur F, 2009, NEUROSCIENCE, V161, P589, DOI 10.1016/j.neuroscience.2009.03.025; Crevecoeur F, 2009, J NEUROPHYSIOL, V102, P786, DOI 10.1152/jn.00113.2009; Fautrelle L, 2010, NEUROSCIENCE, V169, P697, DOI 10.1016/j.neuroscience.2010.05.014; FLASH T, 1985, J NEUROSCI, V5, P1688, DOI 10.1523/jneurosci.05-07-01688.1985; Furuya S, 2009, NEUROSCIENCE, V164, P822, DOI 10.1016/j.neuroscience.2009.08.024; GAVEAU J, 2011, KINEMATIC ELECTROMYO; Gaveau J., 2011, J NEUROPHYSIOL; Gentili R, 2007, NEUROSCIENCE, V145, P20, DOI 10.1016/j.neuroscience.2006.11.035; Gentili RJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005176; GEORGOPOULOS A, 1990, ATTENTION PERFORM, P227; GORDON J, 1994, EXP BRAIN RES, V99, P112, DOI 10.1007/BF00241416; Harris CM, 1998, NATURE, V394, P780, DOI 10.1038/29528; Indovina I, 2005, SCIENCE, V308, P416, DOI 10.1126/science.1107961; Izawa J, 2008, J NEUROSCI, V28, P2883, DOI 10.1523/JNEUROSCI.5359-07.2008; Jones KE, 2002, J NEUROPHYSIOL, V88, P1533, DOI 10.1152/jn.2002.88.3.1533; Kakei S, 2003, NEUROSCI RES, V46, P1, DOI 10.1016/S0168-0102(03)00031-2; KALASKA JF, 1989, J NEUROSCI, V9, P2080; Lackner JR, 2000, EXP BRAIN RES, V130, P2, DOI 10.1007/s002210050002; Le Seac'h AB, 2007, NEUROSCI LETT, V423, P211, DOI 10.1016/j.neulet.2007.07.034; McIntyre J, 2001, NAT NEUROSCI, V4, P693, DOI 10.1038/89477; Moran DW, 1999, J NEUROPHYSIOL, V82, P2676, DOI 10.1152/jn.1999.82.5.2676; MORASSO P, 1981, EXP BRAIN RES, V42, P223; Nishikawa KC, 1999, J NEUROPHYSIOL, V81, P2582, DOI 10.1152/jn.1999.81.5.2582; Paillard J, 1996, CAN J PHYSIOL PHARM, V74, P401, DOI 10.1139/cjpp-74-4-401; Papaxanthis C, 2005, NEUROSCIENCE, V135, P371, DOI 10.1016/j.neuroscience.2005.06.063; Papaxanthis C, 2003, NEUROSCIENCE, V117, P779, DOI 10.1016/S0306-4522(02)00964-8; Papaxanthis C, 2003, EXP BRAIN RES, V148, P498, DOI 10.1007/s00221-002-1327-y; Papaxanthis C, 1998, NEUROSCI LETT, V253, P103, DOI 10.1016/S0304-3940(98)00604-1; Papaxanthis C, 1998, EXP BRAIN RES, V120, P233, DOI 10.1007/s002210050397; Pozzo T, 1998, BRAIN RES REV, V28, P92, DOI 10.1016/S0165-0173(98)00030-7; PRABLANC C, 1992, J NEUROPHYSIOL, V67, P455, DOI 10.1152/jn.1992.67.2.455; Saijo N, 2005, J NEUROSCI, V25, P4941, DOI 10.1523/JNEUROSCI.4143-04.2005; Sergio LE, 1998, J NEUROPHYSIOL, V80, P1577, DOI 10.1152/jn.1998.80.3.1577; Sergio LE, 2003, J NEUROPHYSIOL, V89, P212, DOI 10.1152/jn.00016.2002; SOECHTING JF, 1983, J NEUROPHYSIOL, V49, P548, DOI 10.1152/jn.1983.49.2.548; Todorov E, 2002, NAT NEUROSCI, V5, P1226, DOI 10.1038/nn963; Torres E, 2006, J NEUROPHYSIOL, V96, P2613, DOI 10.1152/jn.00188.2006; van Beers RJ, 2002, PHILOS T R SOC B, V357, P1137, DOI 10.1098/rstb.2002.1101; Winter D., 1990, BIOMECHANICS MOTOR C, V2nd	47	34	34	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2011	6	7							e22045	10.1371/journal.pone.0022045	http://dx.doi.org/10.1371/journal.pone.0022045			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791WM	21765935	gold, Green Submitted, Green Published			2022-12-27	WOS:000292699000021
J	Page, SH; Wright, EK; Gama, L; Clements, JE				Page, Stephen H.; Wright, Edward K., Jr.; Gama, Lucio; Clements, Janice E.			Regulation of CCL2 Expression by an Upstream TALE Homeodomain Protein-Binding Site That Synergizes with the Site Created by the A-2578G SNP	PLOS ONE			English	Article							MONOCYTE CHEMOATTRACTANT PROTEIN-1; NF-KAPPA-B; MCP-1 GENE-TRANSCRIPTION; CEREBROSPINAL-FLUID; INCREASED SUSCEPTIBILITY; PULMONARY TUBERCULOSIS; ASTROCYTOMA-CELLS; IFN-GAMMA; POLYMORPHISM; PROMOTER	CC Chemokine Ligand 2 (CCL2) is a potent chemoattractant produced by macrophages and activated astrocytes during periods of inflammation within the central nervous system. Increased CCL2 expression is correlated with disease progression and severity, as observed in pulmonary tuberculosis, HCV-related liver disease, and HIV-associated dementia. The CCL2 distal promoter contains an A/G polymorphism at position -2578 and the homozygous -2578 G/G genotype is associated with increased CCL2 production and inflammation. However, the mechanisms that contribute to the phenotypic differences in CCL2 expression are poorly understood. We previously demonstrated that the -2578 G polymorphism creates a TALE homeodomain protein binding site (TALE binding site) for PREP1/PBX2 transcription factors. In this study, we identified the presence of an additional TALE binding site 22 bp upstream of the site created by the -2578 G polymorphism and demonstrated the synergistic effects of the two sites on the activation of the CCL2 promoter. Using chromatin immunoprecipitation (ChIP) assays, we demonstrated increased binding of the TALE proteins PREP1 and PBX2 to the -2578 G allele, and binding of IRF1 to both the A and G alleles. The presence of TALE binding sites that form inverted repeats within the -2578 G allele results in increased transcriptional activation of the CCL2 distal promoter while the presence of only the upstream TALE binding site within the -2578 A allele exerts repression of promoter activity.	[Page, Stephen H.] Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD 21218 USA; [Page, Stephen H.; Gama, Lucio; Clements, Janice E.] Johns Hopkins Univ, Sch Med, Dept Mol & Comparat Pathobiol, Baltimore, MD USA; [Clements, Janice E.] Johns Hopkins Univ, Sch Med, Dept Neurol Pathol & Mol Biol & Genet, Baltimore, MD USA; [Wright, Edward K., Jr.] Henry M Jackson Fdn Adv Mil Med, Washington, DC USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc	Page, SH (corresponding author), Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD 21218 USA.	jclements@jhmi.edu		Gama, Lucio/0000-0001-9511-012X	NIH [NS050028, NS47984, MH70306]; NATIONAL INSTITUTE OF MENTAL HEALTH [P01MH070306] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS050028, R01NS047984] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was supported by NIH grants to J.E.C. (NS050028, NS47984, and MH70306). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham S, 2005, J NEUROIMMUNOL, V160, P219, DOI 10.1016/j.jneuroim.2004.11.009; Abraham S, 2003, VIROLOGY, V309, P196, DOI 10.1016/S0042-6822(03)00112-0; Bernasconi S, 1996, J INFECT DIS, V174, P1098, DOI 10.1093/infdis/174.5.1098; Berthelsen J, 1999, GENE DEV, V13, P946, DOI 10.1101/gad.13.8.946; Boekhoudt GH, 2003, J IMMUNOL, V170, P4139, DOI 10.4049/jimmunol.170.8.4139; Charo IF, 2004, CIRC RES, V95, P858, DOI 10.1161/01.RES.0000146672.10582.17; Cho ML, 2004, AUTOIMMUNITY, V37, P77, DOI 10.1080/08916930310001609446; Christopherson K, 2001, STEM CELLS, V19, P388, DOI 10.1634/stemcells.19-5-388; Dickson ME, 2008, CIRC RES, V103, P940, DOI 10.1161/CIRCRESAHA.108.180653; Fenoglio C, 2004, NEUROBIOL AGING, V25, P1169, DOI 10.1016/j.neurobiolaging.2003.11.008; Ferretti E, 2006, MOL CELL BIOL, V26, P5650, DOI 10.1128/MCB.00313-06; Flores-Villanueva PO, 2005, J EXP MED, V202, P1649, DOI 10.1084/jem.20050126; Froberg MK, 2001, CIRC RES, V89, P1224, DOI 10.1161/hh2401.100601; Gonzalez E, 2002, P NATL ACAD SCI USA, V99, P13795, DOI 10.1073/pnas.202357499; Goudet G, 1999, J BIOL CHEM, V274, P4067, DOI 10.1074/jbc.274.7.4067; Kim HL, 2002, AM J KIDNEY DIS, V40, P1146, DOI 10.1053/ajkd.2002.36858; Kumar SN, 2000, MOL IMMUNOL, V37, P623, DOI 10.1016/S0161-5890(00)00097-3; Lim SP, 2000, J VIROL, V74, P1632, DOI 10.1128/JVI.74.4.1632-1640.2000; Majumder S, 1996, J NEUROSCI RES, V45, P758, DOI 10.1002/(SICI)1097-4547(19960915)45:6<758::AID-JNR12>3.0.CO;2-S; Mankowski JL, 2004, J NEUROIMMUNOL, V157, P66, DOI 10.1016/j.jneuroim.2004.08.031; Mori Honami, 2005, Clin Exp Nephrol, V9, P297, DOI 10.1007/s10157-005-0375-6; Muhlbauer M, 2003, GASTROENTEROLOGY, V125, P1085, DOI 10.1016/S0016-5085(03)01213-7; Okada Y, 2003, BIOCHEM BIOPH RES CO, V305, P155, DOI 10.1016/S0006-291X(03)00718-6; Ping DS, 1999, J IMMUNOL, V162, P727; Ping DS, 2000, J BIOL CHEM, V275, P1708, DOI 10.1074/jbc.275.3.1708; Ping DS, 1996, IMMUNITY, V4, P455, DOI 10.1016/S1074-7613(00)80412-4; Rose CE, 2003, MICROCIRCULATION, V10, P273, DOI 10.1038/sj.mn.7800193; Rovin BH, 1999, BIOCHEM BIOPH RES CO, V259, P344, DOI 10.1006/bbrc.1999.0796; Saura M, 1999, J MOL BIOL, V289, P459, DOI 10.1006/jmbi.1999.2752; Shen WF, 1999, MOL CELL BIOL, V19, P3051; Shen WF, 1997, MOL CELL BIOL, V17, P6448, DOI 10.1128/MCB.17.11.6448; SHYY YJ, 1993, BIOCHEM BIOPH RES CO, V192, P693, DOI 10.1006/bbrc.1993.1470; Simeoni E, 2004, DIABETOLOGIA, V47, P1574, DOI 10.1007/s00125-004-1494-4; Sui YJ, 2005, AM J PATHOL, V166, P355, DOI 10.1016/S0002-9440(10)62259-6; Szalai C, 2001, J ALLERGY CLIN IMMUN, V108, P375, DOI 10.1067/mai.2001.117930; Tabara Y, 2003, HYPERTENS RES, V26, P677, DOI 10.1291/hypres.26.677; Tamouza R, 2006, M S-MED SCI, V22, P571, DOI 10.1051/medsci/20062267571; Teferedegne B, 2006, MOL CELL BIOL, V26, P5759, DOI 10.1128/MCB.00271-06; ter Veld F, 2009, J ENDOCRINOL INVEST, V32, P123, DOI 10.1007/BF03345700; Tucci M, 2004, ARTHRITIS RHEUM-US, V50, P1842, DOI 10.1002/art.20266; UEDA A, 1994, J IMMUNOL, V153, P2052; Ueda A, 1997, J BIOL CHEM, V272, P31092, DOI 10.1074/jbc.272.49.31092; Winter C, 2009, J IMMUNOL, V182, P4931, DOI 10.4049/jimmunol.0804096; Wright EK, 2008, GENES IMMUN, V9, P419, DOI 10.1038/gene.2008.33; YADAV A, CLIN CHIM ACTA, V411, P1570; Zhou ZHL, 1998, J IMMUNOL, V160, P3908; Zhou ZHL, 2001, FASEB J, V15, P383, DOI 10.1096/fj.00-0373com; Zink MC, 2001, J INFECT DIS, V184, P1015, DOI 10.1086/323478	48	17	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2011	6	7							e22052	10.1371/journal.pone.0022052	http://dx.doi.org/10.1371/journal.pone.0022052			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791IA	21760952	Green Published, gold, Green Submitted			2022-12-27	WOS:000292657200042
J	Facente, SN; Pilcher, CD; Hartogensis, WE; Klausner, JD; Philip, SS; Louie, B; Christopoulos, KA; Dowling, T; Colfax, GN				Facente, Shelley N.; Pilcher, Christopher D.; Hartogensis, Wendy E.; Klausner, Jeffrey D.; Philip, Susan S.; Louie, Brian; Christopoulos, Katerina A.; Dowling, Teri; Colfax, Grant N.			Performance of Risk-Based Criteria for Targeting Acute HIV Screening in San Francisco	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; INFECTION; TRANSMISSION; ADULTS; SURVEILLANCE; ADOLESCENTS	Background: Federal guidelines now recommend supplemental HIV RNA testing for persons at high risk for acute HIV infection. However, many rapid HIV testing sites do not include HIV RNA or p24 antigen testing due to concerns about cost, the need for results follow-up, and the impact of expanded venipuncture on clinic flow. We developed criteria to identify patients in a municipal STD clinic in San Francisco who are asymptomatic but may still be likely to have acute infection. Methods: Data were from patients tested with serial HIV antibody and HIV RNA tests to identify acute HIV infection. BED-CEIA results were used to classify non-acute cases as recent or longstanding. Demographics and self-reported risk behaviors were collected at time of testing. Multivariate models were developed and preliminarily evaluated using predictors associated with recent infection in bivariate analyses as a proxy for acute HIV infection. Multivariate models demonstrating >= 70% sensitivity for recent infection while testing <= 60% of patients in this development dataset were then validated by determining their performance in identifying acute infections. Results: From 2004-2007, 137 of 12,622 testers had recent and 36 had acute infections. A model limiting acute HIV screening to MSM plus any one of a series of other predictors resulted in a sensitivity of 83.3% and only 47.6% of patients requiring testing. A single-factor model testing only patients reporting any receptive anal intercourse resulted in 88.9% sensitivity with only 55.2% of patients requiring testing. Conclusions: In similar high risk HIV testing sites, acute screening using "supplemental" HIV p24 antigen or RNA tests can be rationally targeted to testers who report particular HIV risk behaviors. By improving the efficiency of acute HIV testing, such criteria could facilitate expanded acute case identification.	[Facente, Shelley N.] Facente Consulting, San Francisco, CA USA; [Facente, Shelley N.; Pilcher, Christopher D.; Hartogensis, Wendy E.; Christopoulos, Katerina A.] Univ Calif San Francisco, San Francisco Gen Hosp, Div HIV AIDS, San Francisco, CA USA; [Klausner, Jeffrey D.; Philip, Susan S.] San Francisco Dept Publ Hlth STD Prevent & Contro, San Francisco, CA USA; [Louie, Brian] San Francisco Dept Publ Hlth, Microbiol Lab, San Francisco, CA USA; [Dowling, Teri; Colfax, Grant N.] San Francisco Dept Publ Hlth, HIV Prevent Sect, San Francisco, CA USA	San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; San Francisco Department of Public Health; San Francisco Department of Public Health; San Francisco Department of Public Health	Facente, SN (corresponding author), Facente Consulting, San Francisco, CA USA.	shelley@facenteconsulting.com	Facente, Shelley/M-1147-2019	Facente, Shelley N./0000-0002-7266-352X	NIAID NIH HHS [P30 AI027763] Funding Source: Medline; NIMH NIH HHS [K23 MH092220] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027763] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K23MH092220] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Abbott Laboratories, 2009, ARCHITECT HIV AG AB; Abbott Molecular, 2009, ABB REALTIME HIV 1 A; [Association of Public Health Laboratories (APHL) Centers for Disease Control and Prevention], 2009, HIV TEST ALG STAT RE; Bayer Healthcare, 2004, VERS HIV 1 RNA 3 0 A; Branson Bernard M., 2006, Morbidity and Mortality Weekly Report, V55, P1; Braunstein SL, 2009, AIDS REV, V11, P140; Brooks JT, 2006, AIDS, V20, P923, DOI 10.1097/01.aids.0000218558.82402.59; Centers for Disease Control and Prevention, 1989, MMWR; Karita E, 2007, AIDS, V21, P403, DOI 10.1097/QAD.0b013e32801481b7; McWalter TA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007368; Miller WC, 2009, AIDS, V23, P835, DOI 10.1097/QAD.0b013e328326f55e; Patel P, 2006, JAIDS-J ACQ IMM DEF, V42, P75, DOI 10.1097/01.qai.0000218363.21088.ad; Pilcher CD, 2005, NEW ENGL J MED, V352, P1873, DOI 10.1056/NEJMoa042291; Pilcher CD, 2004, J INFECT DIS, V189, P1785, DOI 10.1086/386333; Pilcher CD, 2007, AIDS, V21, P1723, DOI 10.1097/QAD.0b013e3281532c82; Plant AJ, 1998, SOC SCI MED, V47, P1147, DOI 10.1016/S0277-9536(98)00186-5; Powers KA, 2007, AIDS, V21, P2237, DOI 10.1097/QAD.0b013e3282f08b4d; Rynn L., 2008, Morbidity and Mortality Weekly Report, V57, P1; San Francisco Department of Public Health, 2009, HIV AIDS EP ANN REP; San Francisco Department of Public Health, 2010, SAN FRANC HIV PREV P; Sherlock M, 2007, SEX TRANSM DIS, V34, P314, DOI 10.1097/01.olq.0000263262.00273.9c; Stein CR, 2008, ANN EPIDEMIOL, V18, P560, DOI 10.1016/j.annepidem.2008.03.002; Stekler J, 2005, AIDS, V19, P1323, DOI 10.1097/01.aids.0000180105.73264.81; Wawer MJ, 2005, J INFECT DIS, V191, P1403, DOI 10.1086/429411; Westreich DJ, 2008, J CLIN MICROBIOL, V46, P1785, DOI 10.1128/JCM.00787-07	25	20	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2011	6	7							e21813	10.1371/journal.pone.0021813	http://dx.doi.org/10.1371/journal.pone.0021813			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791AK	21755003	gold, Green Published			2022-12-27	WOS:000292632000030
J	Adatto, I; Lawrence, C; Thompson, M; Zon, LI				Adatto, Isaac; Lawrence, Christian; Thompson, Michael; Zon, Leonard I.			A New System for the Rapid Collection of Large Numbers of Developmentally Staged Zebrafish Embryos	PLOS ONE			English	Article							DANIO-RERIO; VERTEBRATE; BEHAVIOR	The zebrafish is an excellent genetic and developmental model system used to study biology and disease. While the zebrafish model is associated with high fecundity, its reproductive potential has not been completely realized by scientists. One major issue is that embryo collection is inefficient. Here, we have developed an innovative breeding vessel designed to stimulate the natural reproductive behavior of the fish. This novel apparatus allows us to collect large numbers of developmentally synchronized embryos in brief and defined windows of time, and with minimal investments in labor and space. To demonstrate the efficacy of this approach, we placed three separate groups (n = 180) of fish in the vessel and allowed them to spawn for 10-minute intervals. During these trials, which were repeated three times, the fish produced 8600 +/- 917, 8400 +/- 794, and 6800 +/- 1997 embryos, respectively. This level of embryo production is nearly twice what we were able to achieve when using conventional crossing equipment with some of the same fish, and it required significantly less room and time to set up and break down. This system overcomes major space and labor restrictions inherent in spawning equipment currently used in the field, and will greatly accelerate efforts to improve the scale and throughput of experiments.	[Adatto, Isaac; Zon, Leonard I.] Childrens Hosp, Stem Cell Program, Boston, MA 02115 USA; [Adatto, Isaac; Zon, Leonard I.] Childrens Hosp, Div Hematol Oncol, Boston, MA 02115 USA; [Adatto, Isaac; Zon, Leonard I.] Dana Farber Canc Inst, Boston, MA 02115 USA; [Adatto, Isaac; Zon, Leonard I.] Harvard Stem Cell Inst, Boston, MA USA; [Zon, Leonard I.] Harvard Univ, Sch Med, Boston, MA USA; [Zon, Leonard I.] Howard Hughes Med Inst, Boston, MA 02115 USA; [Lawrence, Christian] Childrens Hosp, Aquat Resources Program, Boston, MA 02115 USA; [Thompson, Michael] Plast Concepts Inc, Billerica, MA USA	Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Boston Children's Hospital	Adatto, I (corresponding author), Childrens Hosp, Stem Cell Program, 300 Longwood Ave, Boston, MA 02115 USA.	zon@enders.tch.harvard.edu			National Institutes of Health (NIH) [2P30DK049216-17]; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK049216] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	I.A. is supported by the National Institutes of Health (NIH) grant # 2P30DK049216-17. L.I.Z. is supported by the Howard Hughes Medical Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. M. T. is the owner and president of Plastics Concepts, Inc. and supervised fabrication of the breeding vessel prototype.	Engeszer RE, 2007, ZEBRAFISH, V4, P21, DOI 10.1089/zeb.2006.9997; Gerlach G, 2006, ANIM BEHAV, V72, P1119, DOI 10.1016/j.anbehav.2006.03.009; Kaufman CK, 2009, NAT PROTOC, V4, P1422, DOI 10.1038/nprot.2009.144; Lawrence C, 2007, AQUACULTURE, V269, P1, DOI 10.1016/j.aquaculture.2007.04.077; MULLINS MC, 1994, CURR BIOL, V4, P189, DOI 10.1016/S0960-9822(00)00048-8; Pardo-Martin C, 2010, NAT METHODS, V7, P634, DOI [10.1038/NMETH.1481, 10.1038/nmeth.1481]; Sessa AK, 2008, ZEBRAFISH, V5, P335, DOI 10.1089/zeb.2008.0535; Spence R, 2008, BIOL REV, V83, P13, DOI 10.1111/j.1469-185X.2007.00030.x; Spence R, 2007, BEHAVIOUR, V144, P953, DOI 10.1163/156853907781492726; Stern HM, 2005, NAT CHEM BIOL, V1, P366, DOI 10.1038/nchembio749	11	40	41	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2011	6	6							e21715	10.1371/journal.pone.0021715	http://dx.doi.org/10.1371/journal.pone.0021715			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786FZ	21738776	Green Published, gold, Green Submitted			2022-12-27	WOS:000292290100062
J	Pierron, D; Chang, I; Arachiche, A; Heiske, M; Thomas, O; Borlin, M; Pennarun, E; Murail, P; Thoraval, D; Rocher, C; Letellier, T				Pierron, Denis; Chang, Ivan; Arachiche, Amal; Heiske, Margit; Thomas, Olivier; Borlin, Marine; Pennarun, Erwan; Murail, Pacal; Thoraval, Didier; Rocher, Christophe; Letellier, Thierry			Mutation Rate Switch inside Eurasian Mitochondrial Haplogroups: Impact of Selection and Consequences for Dating Settlement in Europe	PLOS ONE			English	Article							TIME DEPENDENCY; MTDNA VARIATION; AFRICAN POPULATIONS; SUBSTITUTION RATES; RELATIVE RATES; DNA; EVOLUTION; REVEALS; PERSPECTIVE; GENE	R-lineage mitochondrial DNA represents over 90% of the European population and is significantly present all around the planet (North Africa, Asia, Oceania, and America). This lineage played a major role in migration "out of Africa'' and colonization in Europe. In order to determine an accurate dating of the R lineage and its sublineages, we analyzed 1173 individuals and complete mtDNA sequences from Mitomap. This analysis revealed a new coalescence age for R at 54.500 years, as well as several limitations of standard dating methods, likely to lead to false interpretations. These findings highlight the association of a striking under-accumulation of synonymous mutations, an over-accumulation of non-synonymous mutations, and the phenotypic effect on haplogroup J. Consequently, haplogroup J is apparently not a Neolithic group but an older haplogroup (Paleolithic) that was subjected to an underestimated selective force. These findings also indicated an under-accumulation of synonymous and non-synonymous mutations localized on coding and non-coding (HVS1) sequences for haplogroup R0, which contains the major haplogroups H and V. These new dates are likely to impact the present colonization model for Europe and confirm the late glacial resettlement scenario.	[Pierron, Denis; Arachiche, Amal; Heiske, Margit; Thomas, Olivier; Borlin, Marine; Rocher, Christophe; Letellier, Thierry] Univ Bordeaux 2, INSERM, U688, Lab Physiopathol Mitochondriale, F-33076 Bordeaux, France; [Thoraval, Didier] Univ Bordeaux 2, CNRS, UMR 5095, Inst Biochim & Genet Cellulaires, F-33076 Bordeaux, France; [Murail, Pacal] Univ Bordeaux 1, CNRS, UMR 5199, Lab Anthropol Populat Passe PACEA, F-33405 Talence, France; [Chang, Ivan] Univ Calif Irvine, Inst Genom Biol, Irvine, CA USA; [Pennarun, Erwan] Univ Tartu, Inst Mol & Cell Biol, Dept Evolutionary Biol, EE-50090 Tartu, Estonia; [Pennarun, Erwan] Estonian Bioctr, Tartu, Estonia	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite de Bordeaux; University of California System; University of California Irvine; University of Tartu; Estonian Biocentre	Pierron, D (corresponding author), Univ Bordeaux 2, INSERM, U688, Lab Physiopathol Mitochondriale, F-33076 Bordeaux, France.	thierry.letellier@u-bordeaux2.fr	Pennarun, Erwan/AAW-7041-2020	Pennarun, Erwan/0000-0002-8267-883X; Rocher, Christophe/0000-0003-1859-9704	Association Francaise contre les Myopathies; INSERM; Universite Victor Segalen Bordeaux-2; Aquitaine; Association contre les Maladies Mitochondriales; CNRS	Association Francaise contre les Myopathies(Association Francaise contre les Myopathies); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Universite Victor Segalen Bordeaux-2; Aquitaine; Association contre les Maladies Mitochondriales; CNRS(Centre National de la Recherche Scientifique (CNRS))	The authors specially thank the Association Francaise contre les Myopathies, INSERM, Universite Victor Segalen Bordeaux-2, Aquitaine for financial support. D. Pierron was supported by a grant from the Association contre les Maladies Mitochondriales and a grant from the CNRS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achilli A, 2004, AM J HUM GENET, V75, P910, DOI 10.1086/425590; Arenas M, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-458; Bandelt HJ, 2008, HEREDITY, V100, P1, DOI 10.1038/sj.hdy.6801054; Bandelt HJ, 2002, AM J HUM GENET, V71, P1150, DOI 10.1086/344397; Brown MD, 2002, HUM GENET, V110, P130, DOI 10.1007/s00439-001-0660-8; CHEN YS, 1995, AM J HUM GENET, V57, P133; Endicott P, 2008, AM J HUM GENET, V82, P895, DOI 10.1016/j.ajhg.2008.01.019; Forster P, 1996, AM J HUM GENET, V59, P935; Henn BM, 2009, MOL BIOL EVOL, V26, P217, DOI 10.1093/molbev/msn244; Heyer E, 2001, AM J HUM GENET, V69, P1113, DOI 10.1086/324024; Ho SYW, 2007, SYST BIOL, V56, P515, DOI 10.1080/10635150701435401; Howell N, 2008, HEREDITY, V101, P107, DOI 10.1038/hdy.2008.52; Howell N, 2004, MOL BIOL EVOL, V21, P1843, DOI 10.1093/molbev/msh184; Howell N, 2007, MOL BIOL EVOL, V24, P2213, DOI 10.1093/molbev/msm147; Hudson G, 2007, AM J HUM GENET, V81, P228, DOI 10.1086/519394; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Ingman M, 2007, HUM MOL GENET, V16, P2281, DOI 10.1093/hmg/ddm180; KIMURA M, 1968, GENET RES, V11, P247, DOI 10.1017/S0016672300011459; Kivisild T, 2006, GENETICS, V172, P373, DOI 10.1534/genetics.105.043901; Kumar S, 2001, BIOINFORMATICS, V17, P1244, DOI 10.1093/bioinformatics/17.12.1244; Mellars P, 2006, P NATL ACAD SCI USA, V103, P9381, DOI 10.1073/pnas.0510792103; Mishmar D, 2003, P NATL ACAD SCI USA, V100, P171, DOI 10.1073/pnas.0136972100; Moilanen JS, 2003, MOL BIOL EVOL, V20, P2132, DOI 10.1093/molbev/msg230; Palanichamy MG, 2004, AM J HUM GENET, V75, P966, DOI 10.1086/425871; Pereira L, 2005, GENOME RES, V15, P19, DOI 10.1101/gr.3182305; Pierron D, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-70; Pierron D, 2008, BMC MED GENET, V9, DOI 10.1186/1471-2350-9-41; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; Richard C, 2007, ANN HUM BIOL, V34, P68, DOI 10.1080/03014460601076098; Roostalu U, 2007, MOL BIOL EVOL, V24, P436, DOI 10.1093/molbev/msl173; Rootsi S, 2004, AM J HUM GENET, V75, P128, DOI 10.1086/422196; Ruiz-Pesini E, 2004, SCIENCE, V303, P223, DOI 10.1126/science.1088434; Ruiz-Pesini E, 2007, NUCLEIC ACIDS RES, V35, pD823, DOI 10.1093/nar/gkl927; Semino O, 2000, SCIENCE, V290, P1155, DOI 10.1126/science.290.5494.1155; Tambets K, 2004, AM J HUM GENET, V74, P661, DOI 10.1086/383203; Tishkoff SA, 2002, NAT REV GENET, V3, P611, DOI 10.1038/nrg865; Torroni A, 1998, AM J HUM GENET, V62, P1137, DOI 10.1086/301822; Torroni A, 2001, AM J HUM GENET, V69, P844, DOI 10.1086/323485; TORRONI A, 1993, AM J HUM GENET, V53, P591; TORRONI A, 1993, AM J HUM GENET, V53, P563; Torroni A, 2006, TRENDS GENET, V22, P339, DOI 10.1016/j.tig.2006.04.001; Wilcox TP, 2004, MOL PHYLOGENET EVOL, V31, P1101, DOI 10.1016/j.ympev.2003.11.006	42	16	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2011	6	6							e21543	10.1371/journal.pone.0021543	http://dx.doi.org/10.1371/journal.pone.0021543			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	784FW	21738700	Green Submitted, Green Published, gold			2022-12-27	WOS:000292142800037
J	Alves, LR; Costa, ES; Sorgine, MHF; Nascimento-Silva, MCL; Teodosio, C; Barcena, P; Castro-Faria-Neto, HC; Bozza, PT; Orfao, A; Oliveira, PL; Maya-Monteiro, CM				Alves, Liliane R.; Costa, Elaine S.; Sorgine, Marcos H. F.; Nascimento-Silva, Maria Clara L.; Teodosio, Cristina; Barcena, Paloma; Castro-Faria-Neto, Hugo C.; Bozza, Patricia T.; Orfao, Alberto; Oliveira, Pedro L.; Maya-Monteiro, Clarissa M.			Heme-Oxygenases during Erythropoiesis in K562 and Human Bone Marrow Cells	PLOS ONE			English	Article							MESSENGER-RNA EXPRESSION; ERYTHROID-DIFFERENTIATION; TRANSCRIPTION FACTORS; HEMATOPOIETIC CYTOKINES; ERYTHROLEUKEMIC CELLS; DEGRADATIVE ENZYMES; IRON-METABOLISM; GENE-EXPRESSION; POTENT INDUCER; RAT-LIVER	In mammalian cells, heme can be degraded by heme-oxygenases (HO). Heme-oxygenase 1 (HO-1) is known to be the heme inducible isoform, whereas heme-oxygenase 2 (HO-2) is the constitutive enzyme. Here we investigated the presence of HO during erythroid differentiation in human bone marrow erythroid precursors and K562 cells. HO-1 mRNA and protein expression levels were below limits of detection in K562 cells. Moreover, heme was unable to induce HO-1, at the protein and mRNA profiles. Surprisingly, HO-2 expression was inhibited upon incubation with heme. To evaluate the physiological relevance of these findings, we analyzed HO expression during normal erythropoiesis in human bone marrow. Erythroid precursors were characterized by lack of significant expression of HO-1 and by progressive reduction of HO-2 during differentiation. FLVCR expression, a recently described heme exporter found in erythroid precursors, was also analyzed. Interestingly, the disruption in the HO detoxification system was accompanied by a transient induction of FLVCR. It will be interesting to verify if the inhibition of HO expression, that we found, is preventing a futile cycle of concomitant heme synthesis and catabolism. We believe that a significant feature of erythropoiesis could be the replacement of heme breakdown by heme exportation, as a mechanism to prevent heme toxicity.	[Alves, Liliane R.; Sorgine, Marcos H. F.; Nascimento-Silva, Maria Clara L.; Oliveira, Pedro L.] Univ Fed Rio de Janeiro, Inst Bioquim Med, Rio De Janeiro, Brazil; [Costa, Elaine S.] Univ Fed Rio de Janeiro, Inst Pediat & Puericultura Martagao Gesteira, Rio De Janeiro, Brazil; [Teodosio, Cristina; Barcena, Paloma; Orfao, Alberto] Univ Salamanca, Ctr Invest Canc, Dept Med, E-37008 Salamanca, Spain; [Teodosio, Cristina; Barcena, Paloma; Orfao, Alberto] Univ Salamanca, Serv Citometria, E-37008 Salamanca, Spain; [Castro-Faria-Neto, Hugo C.; Bozza, Patricia T.; Maya-Monteiro, Clarissa M.] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Imunofarmacol, Rio De Janeiro, Brazil; [Oliveira, Pedro L.] Inst Nacl Ciencia & Tecnol Entomol Mol, Rio De Janeiro, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigacion del Cancer (CIC); CSIC-USAL - Instituto de Biologia Molecular y Celular del Cancer de Salamanca (IBMCC); University of Salamanca; University of Salamanca; Fundacao Oswaldo Cruz	Alves, LR (corresponding author), Univ Fed Rio de Janeiro, Inst Bioquim Med, Rio De Janeiro, Brazil.	pedro@bioqmed.ufrj.br; clarissa@ioc.fiocruz.br	Bozza, Patricia T./AAM-4537-2021; COSTA, ELAINE SOBRAL/AAE-9574-2021; Orfao, Alberto/B-5801-2017; Bozza, Patricia T./AAE-2933-2021; L. Oliveira, Pedro/A-9438-2010; Sobral da Costa, Elaine/O-6523-2014	Bozza, Patricia T./0000-0001-8349-9529; L. Oliveira, Pedro/0000-0003-0307-354X; Sobral da Costa, Elaine/0000-0002-5340-5816; Teodosio, Cristina/0000-0002-2097-7199	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Fundacao Oswaldo Cruz (FIOCRUZ); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ); Howard Hughes Medical Institute (HHMI) [55005952]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao Oswaldo Cruz (FIOCRUZ); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Howard Hughes Medical Institute (HHMI)(Howard Hughes Medical Institute)	This work was supported by grants from the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), the Fundacao Oswaldo Cruz (FIOCRUZ), the Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ), and the Howard Hughes Medical Institute (HHMI) number 55005952 to Pedro Lagerblad de Oliveira. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CRAIK CS, 1980, P NATL ACAD SCI-BIOL, V77, P1384, DOI 10.1073/pnas.77.3.1384; Della Porta MG, 2006, LEUKEMIA, V20, P549, DOI 10.1038/sj.leu.2404142; FUJITA H, 1989, BRIT J HAEMATOL, V73, P557, DOI 10.1111/j.1365-2141.1989.tb00297.x; Furuyama K, 2007, TOHOKU J EXP MED, V213, P1, DOI 10.1620/tjem.213.1; Gozzelino R, 2010, ANNU REV PHARMACOL, V50, P323, DOI 10.1146/annurev.pharmtox.010909.105600; HAMILTON JW, 1991, ARCH BIOCHEM BIOPHYS, V289, P387, DOI 10.1016/0003-9861(91)90428-L; Han AP, 2001, EMBO J, V20, P6909, DOI 10.1093/emboj/20.23.6909; HOFFMAN R, 1980, BLOOD, V56, P567; IBRAHIM NG, 1982, BRIT J HAEMATOL, V50, P17, DOI 10.1111/j.1365-2141.1982.tb01886.x; Keel SB, 2008, SCIENCE, V319, P825, DOI 10.1126/science.1151133; Kumar S, 2005, TOXICOL LETT, V157, P175, DOI 10.1016/j.toxlet.2005.03.004; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lammers R, 2002, EXP HEMATOL, V30, P537, DOI 10.1016/S0301-472X(02)00798-1; LAVROVSKY Y, 1994, P NATL ACAD SCI USA, V91, P5987, DOI 10.1073/pnas.91.13.5987; LEDER A, 1975, CELL, V5, P319, DOI 10.1016/0092-8674(75)90107-5; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LOZZIO CB, 1975, BLOOD, V45, P321, DOI 10.1182/blood.V45.3.321.321; MAINES MD, 1988, FASEB J, V2, P2557, DOI 10.1096/fasebj.2.10.3290025; MAINES MD, 1986, J BIOL CHEM, V261, P411; Mayerhofer M, 2004, CANCER RES, V64, P3148, DOI 10.1158/0008-5472.CAN-03-1200; MELEFORS O, 1993, J BIOL CHEM, V268, P5974; Mense SM, 2006, CELL RES, V16, P681, DOI 10.1038/sj.cr.7310086; Metcalf D, 2008, BLOOD, V111, P485, DOI 10.1182/blood-2007-03-079681; Ogawa K, 2001, EMBO J, V20, P2835, DOI 10.1093/emboj/20.11.2835; Pamplona A, 2007, NAT MED, V13, P703, DOI 10.1038/nm1586; Ponka P, 1999, AM J MED SCI, V318, P241, DOI 10.1097/00000441-199910000-00004; Ponka P, 1997, BLOOD, V89, P1; Quigley JG, 2004, CELL, V118, P757, DOI 10.1016/j.cell.2004.08.014; Rey MA, 2008, HAEMATOL-HEMATOL J, V93, P1617, DOI 10.3324/haematol.13359; RUTHERFORD TR, 1979, NATURE, V280, P164, DOI 10.1038/280164a0; Ryter SW, 2000, FREE RADICAL BIO MED, V28, P289, DOI 10.1016/S0891-5849(99)00223-3; Sadlon TJ, 1999, INT J BIOCHEM CELL B, V31, P1153, DOI 10.1016/S1357-2725(99)00073-4; SASSA S, 1970, P NATL ACAD SCI USA, V67, P517, DOI 10.1073/pnas.67.2.517; SASSA S, 1976, J EXP MED, V143, P305, DOI 10.1084/jem.143.2.305; Schaer DJ, 2006, EUR J HAEMATOL, V77, P432, DOI 10.1111/j.1600-0609.2006.00730.x; Schranzhofer M, 2006, BLOOD, V107, P4159, DOI 10.1182/blood-2005-05-1809; Sharma HS, 2000, ACTA NEUROCHIR SUPPL, V76, P153; Shokawa T, 2006, J PHARMACOL SCI, V100, P162, DOI 10.1254/jphs.SC0040188; Soe-Lin S, 2009, P NATL ACAD SCI USA, V106, P5960, DOI 10.1073/pnas.0900808106; Sutherland BA, 2009, NEUROSCI RES, V65, P326, DOI 10.1016/j.neures.2009.08.007; Suzuki H, 2004, EMBO J, V23, P2544, DOI 10.1038/sj.emboj.7600248; Tahara T, 2004, J BIOL CHEM, V279, P5480, DOI 10.1074/jbc.M302733200; TENHUNEN R, 1968, P NATL ACAD SCI USA, V61, P748, DOI 10.1073/pnas.61.2.748; TRAKSHEL GM, 1987, EXP HEMATOL, V15, P859; Wagener FADTG, 2001, BLOOD, V98, P1802, DOI 10.1182/blood.V98.6.1802; YAMAMOTO M, 1982, BIOCHEM BIOPH RES CO, V105, P985, DOI 10.1016/0006-291X(82)91067-1; YOSHIDA T, 1988, EUR J BIOCHEM, V171, P457, DOI 10.1111/j.1432-1033.1988.tb13811.x; Zhu J, 2002, ONCOGENE, V21, P3295, DOI 10.1038/sj.onc.1205318	48	18	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2011	6	7							e21358	10.1371/journal.pone.0021358	http://dx.doi.org/10.1371/journal.pone.0021358			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	792WQ	21765894	Green Published, Green Submitted, gold			2022-12-27	WOS:000292781500004
J	Wang, JG; Li, Y; Shi, JH; Han, J; Xu, CL; Ma, CS; Meng, X				Wang, Jiangang; Li, Yan; Shi, Jiahai; Han, Jie; Xu, Chunlei; Ma, Changsheng; Meng, Xu			Minimally Invasive Surgical Versus Catheter Ablation for the Long-Lasting Persistent Atrial Fibrillation	PLOS ONE			English	Article							PULMONARY VEIN ISOLATION; EFFICACY; IMPACT	Objective: To assess the efficacy of video-assisted minimally invasive surgical vs. catheter ablation for the long-standing persistent AF. Methods: We performed a retrospective comparative analysis in a series of 166 long-standing persistent AF patients treated between 2006 and 2009 with either video-assisted minimally invasive ablation (83 patients), or catheter ablations (83 patients). The catheter group was screened using a 'pair-matched case-control' methodology in order to select appropriate statistical comparison candidates out of 169 long-standing persistent AF patients which were potentially suitable for surgery, but have been treated with catheter approaches in order to balance major prognostic factors between the two groups. Follow-up for all patients ranged from 1 to 3.6 years. Results: No patient died postoperatively. One patient suffered from stroke in the surgical group but recovered before discharge. Freedom from AF was obtained in 59.0% and 74.7% during follow-up in the catheter group and the surgical group respectively (P = 0.047). Patients in the catheter group had a significantly higher rate of recurrent arrhythmia (P = 0.011, hazard ratio: 0.555, 95% CI: 0.354 to 0.872) compared with the surgically treated group. The freedom from antiarrhythmic drugs was 44.6% in the catheter group and 61.4% in the surgical group (P = 0.043). Conclusions: The video-assisted minimally invasive ablation was safe and effective, and had an optimistic success rate for patients with long-standing persistent AF in our retrospective comparative study. Thus, further randomized studies addressing this issue seem to be justified.	[Wang, Jiangang; Li, Yan; Han, Jie; Xu, Chunlei; Ma, Changsheng; Meng, Xu] Capital Med Univ, Beijing Anzhen Hosp, Dept Atrial Fibrillat Ctr, Beijing, Peoples R China; [Shi, Jiahai] Nantong Univ, Affiliated Hosp, Dept Cardiothorac Surg, Nantong, Peoples R China	Capital Medical University; Nantong University	Wang, JG (corresponding author), Capital Med Univ, Beijing Anzhen Hosp, Dept Atrial Fibrillat Ctr, Beijing, Peoples R China.	mxu@263.net	wang, jian/GVS-0711-2022		National Natural Science Foundation of China [30900629]; Beijing Novo Program [2010B047]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Novo Program	This work was supported by National Natural Science Foundation of China (Grant No. 30900629), and the Beijing Novo Program, (Grant No. 2010B047). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cappato R, 2010, CIRC-ARRHYTHMIA ELEC, V3, P32, DOI 10.1161/CIRCEP.109.859116; Elayi CS, 2008, HEART RHYTHM, V5, P1658, DOI 10.1016/j.hrthm.2008.09.016; Fuster V, 2006, CIRCULATION, V114, pE257, DOI 10.1161/CIRCULATIONAHA.106.177292; Haissaguerre M, 1998, NEW ENGL J MED, V339, P659, DOI 10.1056/NEJM199809033391003; Hunter RJ, 2010, HEART, V96, P1372, DOI 10.1136/hrt.2009.188128; Li H, 2008, ANN THORAC SURG, V86, P1219, DOI 10.1016/j.athoracsur.2008.04.081; Mehall JR, 2007, ANN THORAC SURG, V83, P538, DOI 10.1016/j.athoracsur.2006.09.022; Mikhaylov E, 2010, ACTA CARDIOL, V65, P153, DOI 10.2143/AC.65.2.2047048; Oral H, 2002, CIRCULATION, V105, P1077, DOI 10.1161/hc0902.104712; Oral H, 2007, CIRCULATION, V115, P2606, DOI 10.1161/CIRCULATIONAHA.107.691386; Pappone C, 2004, CIRCULATION, V109, P327, DOI 10.1161/01.CIR.0000112641.16340.C7; Pokushalov E, 2010, EUROPACE, V12, P342, DOI 10.1093/europace/euq014; Scanavacca MI, 2004, J CARDIOVASC ELECTR, V15, P960, DOI 10.1046/j.1540-8167.2004.04083.x; Scharf C, 2009, J AM COLL CARDIOL, V54, P1450, DOI 10.1016/j.jacc.2009.07.009; Scherlag BJ, 2005, J AM COLL CARDIOL, V45, P1878, DOI 10.1016/j.jacc.2005.01.057; Scherlag BJ, 2005, J INTERV CARD ELECTR, V13, P37, DOI 10.1007/s10840-005-2492-2; Tilz RR, 2010, J CARDIOVASC ELECTR, V21, P1085, DOI 10.1111/j.1540-8167.2010.01799.x; Tzou WS, 2010, CIRC-ARRHYTHMIA ELEC, V3, P237, DOI 10.1161/CIRCEP.109.923771; Willems S, 2006, EUR HEART J, V27, P2871, DOI 10.1093/eurheartj/ehl093; Wokhlu A, 2010, J CARDIOVASC ELECTR, V21, P1071, DOI 10.1111/j.1540-8167.2010.01786.x; Wolf RK, 2005, J THORAC CARDIOV SUR, V130, P797, DOI 10.1016/j.jtcvs.2005.03.041; Yilmaz A, 2010, EUR J CARDIO-THORAC, V38, P356, DOI 10.1016/j.ejcts.2010.01.058; Zeng YP, 2010, ANN THORAC SURG, V90, P510, DOI 10.1016/j.athoracsur.2010.04.063; Zhou Zi-qiang, 2004, Zhonghua Nei Ke Za Zhi, V43, P491	24	15	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2011	6	7							e22122	10.1371/journal.pone.0022122	http://dx.doi.org/10.1371/journal.pone.0022122			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	792WQ	21765943	Green Submitted, Green Published, gold			2022-12-27	WOS:000292781500035
J	Esselstyn, JA; Maher, SP; Brown, RM				Esselstyn, Jacob A.; Maher, Sean P.; Brown, Rafe M.			Species Interactions during Diversification and Community Assembly in an Island Radiation of Shrews	PLOS ONE			English	Article							COMPETITIVE-EXCLUSION PRINCIPLE; BODY-SIZE EVOLUTION; GEOGRAPHIC DISTRIBUTIONS; NICHE CONSERVATISM; PHYLOGENETIC OVERDISPERSION; PHILIPPINE ARCHIPELAGO; CHARACTER DISPLACEMENT; HUXLEYS MODIFICATION; SORICIDAE CROCIDURA; ADAPTIVE RADIATION	Background: Closely related, ecologically similar species often have adjacent distributions, suggesting competitive exclusion may contribute to the structure of some natural communities. In systems such as island archipelagos, where speciation is often tightly associated with dispersal over oceanic barriers, competitive exclusion may prevent population establishment following inter-island dispersal and subsequent cladogenesis. Methodology/Principal Findings: Using a combination of tools, we test the hypothesis that the distributions of shrew (Crocidura) species in the Philippines are the result of competitive exclusion preventing secondary invasion of occupied islands. We first compare ecological niche models between two widespread, allopatric species and find statistical support for their ecological similarity, implying that competition for habitat between these species is possible. We then examine dispersion patterns among sympatric species and find some signal for overdispersion of body size, but not for phylogenetic branch length. Finally, we simulate the process of inter-island colonization under a stochastic model of dispersal lacking ecological forces. Results are dependent on the geographic scope and colonization probability employed. However, some combinations suggest that the number of inter-island dispersal events necessary to populate the archipelago may be much higher than the minimum number of colonization events necessary to explain current estimates of species richness and phylogenetic relationships. If our model is appropriate, these results imply that alternative factors, such as competitive exclusion, may have influenced the process of inter-island colonization and subsequent cladogenesis. Conclusions/Significance: We interpret the combined results as providing tenuous evidence that similarity in body size may prevent co-occurrence in Philippine shrews and that competitive exclusion among ecologically similar species, rather than an inability to disperse among islands, may have limited diversification in this group, and, possibly other clades endemic to island archipelagos.	[Esselstyn, Jacob A.] McMaster Univ, Dept Biol, Hamilton, ON, Canada; [Maher, Sean P.] Univ Georgia, Odum Sch Ecol, Athens, GA 30602 USA; [Brown, Rafe M.] Univ Kansas, Biodivers Inst, Lawrence, KS 66045 USA; [Brown, Rafe M.] Univ Kansas, Dept Ecol & Evolutionary Biol, Lawrence, KS 66045 USA	McMaster University; University System of Georgia; University of Georgia; University of Kansas; University of Kansas	Esselstyn, JA (corresponding author), McMaster Univ, Dept Biol, Hamilton, ON, Canada.	jessel@mcmaster.ca	Maher, Sean/V-7553-2017	Maher, Sean/0000-0002-3430-0410; Esselstyn, Jacob/0000-0002-1823-4062	The United States National Science Foundation [DEB 0743491, 0640737, OISE 0965856]; American Society of Mammalogists; University of Kansas; Direct For Biological Sciences [0743491] Funding Source: National Science Foundation	The United States National Science Foundation; American Society of Mammalogists; University of Kansas; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	The United States National Science Foundation (http://www.nsf.gov/) provided financial support through DEB 0743491 and 0640737 to RMB and Graduate Research and International Postdoctoral (OISE 0965856) fellowships to JAE. Additional financial support was provided by the American Society of Mammalogists and E. Raymond Hall Fund of the University of Kansas. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson RP, 2010, J BIOGEOGR, V37, P1378, DOI 10.1111/j.1365-2699.2010.02290.x; Anderson RP, 2002, OIKOS, V98, P3, DOI 10.1034/j.1600-0706.2002.t01-1-980116.x; [Anonymous], 2014, TRACER V1 6; [Anonymous], 1963, ANIMAL SPECIES EVOLU; [Anonymous], 2009, ENCY ISLANDS; Barve N, 2011, ECOL MODEL, V222, P1810, DOI 10.1016/j.ecolmodel.2011.02.011; Bintanja R, 2005, NATURE, V437, P125, DOI 10.1038/nature03975; Blackburn DC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012090; Brown RM, 2002, BIOL J LINN SOC, V76, P393, DOI 10.1111/j.1095-8312.2002.tb01704.x; BROWN RM, 2002, SILLIMAN J, V42, P133; BROWN RM, 2009, ENCY ISLANDS, P723; Cardillo M, 2010, GLOBAL ECOL BIOGEOGR, V19, P465, DOI 10.1111/j.1466-8238.2010.00537.x; Case T., 1986, COMMUNITY ECOL, P98; Cavender-Bares J, 2004, AM NAT, V163, P823, DOI 10.1086/386375; CHAN RCY, 1985, INFECT IMMUN, V47, P84, DOI 10.1128/IAI.47.1.84-89.1985; CONNELL JH, 1980, OIKOS, V35, P131, DOI 10.2307/3544421; Cooper N, 2008, P ROY SOC B-BIOL SCI, V275, P2031, DOI 10.1098/rspb.2008.0420; Darwin C, 1859, ORIGIN SPECIES MEANS; DENBOER PJ, 1986, TRENDS ECOL EVOL, V1, P25, DOI 10.1016/0169-5347(86)90064-9; DIAMOND J, 1989, AM NAT, V134, P675, DOI 10.1086/285006; Diamond J.M., 1975, P342; DIAMOND JM, 1983, OIKOS, V41, P307, DOI 10.2307/3544090; Dib L, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040007; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Esselstyn JA, 2010, J MAMMAL, V91, P1467, DOI 10.1644/10-MAMM-A-002.1; Esselstyn JA, 2010, J BIOGEOGR, V37, P2054, DOI 10.1111/j.1365-2699.2010.02378.x; Esselstyn JA, 2010, J BIOGEOGR, V37, P1504, DOI 10.1111/j.1365-2699.2010.02295.x; Esselstyn JA, 2009, EVOLUTION, V63, P2595, DOI 10.1111/j.1558-5646.2009.00743.x; Esselstyn JA, 2009, MOL PHYLOGENET EVOL, V53, P171, DOI 10.1016/j.ympev.2009.05.034; Evans BJ, 2003, SYST BIOL, V52, P794, DOI 10.1080/10635150390251063; Gause G. F., 1934, STRUGGLE EXISTENCE; GOULD SJ, 1979, PROC R SOC SER B-BIO, V205, P581, DOI 10.1098/rspb.1979.0086; Grant P., 1986, COMMUNITY ECOLOGY, P173; Grinnell J., 1904, AUK, V21, P364, DOI DOI 10.2307/4070199; GUREVITCH J, 1992, AM NAT, V140, P539, DOI 10.1086/285428; Hall R, 2002, J ASIAN EARTH SCI, V20, P353, DOI 10.1016/S1367-9120(01)00069-4; Hall Robert, 1998, P99; HARDIN G, 1960, SCIENCE, V131, P1292, DOI 10.1126/science.131.3409.1292; Harmon LJ, 2008, BIOINFORMATICS, V24, P129, DOI 10.1093/bioinformatics/btm538; Heaney L.R., 1985, Modern Quaternary Research in Southeast Asia, V9, P127; Heaney L. R., 1998, FIELDIANA ZOOL, V88, P1, DOI DOI 10.5962/BHL.TITLE.3419; Heaney L. R., 2010, SYNOPSIS PHILIPPINE; Heaney Lawrence R., 2006, Fieldiana Zoology, P1; Heaney LR, 2005, J BIOGEOGR, V32, P229, DOI 10.1111/j.1365-2699.2004.01120.x; HEANEY LR, 1994, SPECIAL PUBLICATION, V18, P357; HEANEY LR, 2002, SYLVATROP, V10, P6; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; HUTCHINSON GE, 1959, AM NAT, V93, P145, DOI 10.1086/282070; Hutterer Rainer, 2007, Lynx (Prague), P5; Inger R. F., 1954, Fieldiana Zoology, V33, P181; Jimenez-Valverde Alberto, 2009, Biodiversity Informatics, V6, P28; Jordan DS, 1908, AM NAT, V42, P73, DOI 10.1086/278905; Kirkland Jr G. L., 1991, SPEC PUBL MUS SW BIO, P15; Lack D., 1947, DARWINS FINCHES; Lomolino MV, 2005, J BIOGEOGR, V32, P1683, DOI 10.1111/j.1365-2699.2005.01314.x; Losos JB, 2010, EVOLUTION DARWIN 1 1, V150, P381; Losos JB, 2010, AM NAT, V175, P623, DOI 10.1086/652433; Mahler DL, 2010, EVOLUTION, V64, P2731, DOI 10.1111/j.1558-5646.2010.01026.x; Mayfield MM, 2010, ECOL LETT, V13, P1085, DOI 10.1111/j.1461-0248.2010.01509.x; McPeek MA, 2008, AM NAT, V172, pE270, DOI 10.1086/593137; Miller G. S., 1910, Proceedings of the United States National Museum Smithsonian Institution Washington, V38; Miller KG, 2005, SCIENCE, V310, P1293, DOI 10.1126/science.1116412; Moen DS, 2009, EVOLUTION, V63, P195, DOI 10.1111/j.1558-5646.2008.00538.x; Neill C, 2009, OIKOS, V118, P1570, DOI 10.1111/j.1600-0706.2009.17522.x; Olson ME, 2009, BIOESSAYS, V31, P1337, DOI 10.1002/bies.200900102; Otto-Bliesner BL, 2006, SCIENCE, V311, P1751, DOI 10.1126/science.1120808; Pagel M, 1999, NATURE, V401, P877, DOI 10.1038/44766; Passarge J, 2006, ECOL MONOGR, V76, P57, DOI 10.1890/04-1824; Pearson RG, 2007, J BIOGEOGR, V34, P102, DOI 10.1111/j.1365-2699.2006.01594.x; Peterson AT, 2011, J BIOGEOGR, V38, P817, DOI 10.1111/j.1365-2699.2010.02456.x; Peterson AT, 2002, PREDICTING SPECIES OCCURRENCES: ISSUES OF ACCURACY AND SCALE, P617; Peterson AT, 1999, SCIENCE, V285, P1265, DOI 10.1126/science.285.5431.1265; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; Pritchard JR, 2001, EVOL ECOL RES, V3, P209; R Core Team, 2020, R LANG ENV STAT COMP; Rabosky DL, 2007, OECOLOGIA, V154, P561, DOI 10.1007/s00442-007-0849-1; Roberts TE, 2006, BIOL J LINN SOC, V88, P329, DOI 10.1111/j.1095-8312.2006.00616.x; Roberts TE, 2006, MOL ECOL, V15, P2183, DOI 10.1111/j.1365-294X.2006.02928.x; Schluter D., 2000, ECOLOGY ADAPTIVE RAD; SCHOENER TW, 1983, NATURE, V302, P332, DOI 10.1038/302332a0; SETIADI MI, 2011, AM NAT IN PRESS; Siler CD, 2010, MOL PHYLOGENET EVOL, V55, P699, DOI 10.1016/j.ympev.2010.01.027; SIMBERLOFF D, 1978, AM NAT, V112, P713, DOI 10.1086/283313; Soberon J, 2007, ECOL LETT, V10, P1115, DOI 10.1111/j.1461-0248.2007.01107.x; Soberon Jorge, 2005, Biodiversity Informatics, V2, P1; Stanley WT, 2010, BIOL J LINN SOC, V100, P669, DOI 10.1111/j.1095-8312.2010.01448.x; Sukumaran J, 2010, BIOINFORMATICS, V26, P1569, DOI 10.1093/bioinformatics/btq228; Taylor EH, 1928, DISTRIBUTION LIFE PH, V21, P214; Vitt LJ, 2005, P NATL ACAD SCI USA, V102, P7877, DOI 10.1073/pnas.0501104102; Voris HK, 2000, J BIOGEOGR, V27, P1153, DOI 10.1046/j.1365-2699.2000.00489.x; Warren DL, 2008, EVOLUTION, V62, P2868, DOI 10.1111/j.1558-5646.2008.00482.x; Webb CO, 2002, ANNU REV ECOL SYST, V33, P475, DOI 10.1146/annurev.ecolsys.33.010802.150448; Webb CO, 2000, AM NAT, V156, P145, DOI 10.1086/303378; Wiens JJ, 2004, EVOLUTION, V58, P193, DOI 10.1111/j.0014-3820.2004.tb01586.x; Wiens JJ, 2010, ECOL LETT, V13, P1310, DOI 10.1111/j.1461-0248.2010.01515.x; WILEY EO, 1978, SYST ZOOL, V27, P17, DOI 10.2307/2412809; WILSON DS, 1975, AM NAT, V109, P769, DOI 10.1086/283042	99	26	26	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2011	6	7							e21885	10.1371/journal.pone.0021885	http://dx.doi.org/10.1371/journal.pone.0021885			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791HI	21760918	Green Published, Green Submitted, gold			2022-12-27	WOS:000292655400024
J	Grainger, SJ; Putnam, AJ				Grainger, Stephanie J.; Putnam, Andrew J.			Assessing the Permeability of Engineered Capillary Networks in a 3D Culture	PLOS ONE			English	Article							BLOOD-VESSELS; IN-VITRO; ENDOTHELIAL-CELLS; PROGENITOR CELLS; TISSUE; ANGIOGENESIS; MORPHOGENESIS; ABNORMALITIES; MICROVESSELS; VASCULATURE	Many pathologies are characterized by poor blood vessel growth and reduced nutrient delivery to the surrounding tissue, introducing a need for tissue engineered blood vessels. Our lab has developed a 3D co-culture method to grow interconnected networks of pericyte-invested capillaries, which can anastamose with host vasculature following implantation to restore blood flow to ischemic tissues. However, if the engineered vessels contain endothelial cells (ECs) that are misaligned or contain wide junctional gaps, they may function improperly and behave more like the pathologic vessels that nourish tumors. The purpose of this study was to test the resistance to permeability of these networks in vitro, grown with different stromal cell types, as a metric of vessel functionality. A fluorescent dextran tracer was used to visualize transport across the endothelium and the pixel intensity was quantified using a customized MATLAB algorithm. In fibroblast-EC co-cultures, the dextran tracer easily penetrated through the vessel wall and permeability was high through the first 5 days of culture, indicative of vessel immaturity. Beyond day 5, dextran accumulated at the periphery of the vessel, with very little transported across the endothelium. Quantitatively, permeability dropped from initial levels of 61% to 39% after 7 days, and to 7% after 2 weeks. When ECs were co-cultured with bone marrow-derived mesenchymal stem cells (MSCs) or adipose-derived stem cells (AdSCs), much tighter control of permeability was achieved. Relative to the EC-fibroblast co-cultures, permeabilities were reduced 41% for the EC-MSC co-cultures and 50% for the EC-AdSC co-cultures after 3 days of culture. By day 14, these permeabilities decreased by 68% and 77% over the EC-fibroblast cultures. Co-cultures containing stem cells exhibit elevated VE-cadherin levels and more prominent EC-EC junctional complexes when compared to cultures containing fibroblasts. These data suggest the stromal cell identity influences the functionality and physiologic relevance of engineered capillary networks.	[Grainger, Stephanie J.; Putnam, Andrew J.] Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Grainger, SJ (corresponding author), Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA.	putnam@umich.edu	Putnam, Andrew J./E-8643-2010	Putnam, Andrew J./0000-0002-1262-4377	National Heart, Lung, and Blood Institute [R01-HL-085339]; American Recovery and Reinvestment Act supplement [R01-HL-085339-03S1]; NIH [T32-GM-008353]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085339] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008353] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Recovery and Reinvestment Act supplement; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was partially supported by Award Number R01-HL-085339 from the National Heart, Lung, and Blood Institute, and an American Recovery and Reinvestment Act supplement to that grant (R01-HL-085339-03S1). S.J.G. was supported by a predoctoral fellowship from NIH Cellular Biotechnology Training Grant (T32-GM-008353). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Au P, 2008, BLOOD, V111, P4551, DOI 10.1182/blood-2007-10-118273; Baluk P, 2005, CURR OPIN GENET DEV, V15, P102, DOI 10.1016/j.gde.2004.12.005; Blau HM, 2001, NAT MED, V7, P532, DOI 10.1038/87850; Brey EM, 2005, TISSUE ENG, V11, P567, DOI 10.1089/ten.2005.11.567; Carmeliet P, 2000, NAT MED, V6, P389, DOI 10.1038/74651; Chen XF, 2009, TISSUE ENG PT A, V15, P1363, DOI 10.1089/ten.tea.2008.0314; Chrobak KM, 2006, MICROVASC RES, V71, P185, DOI 10.1016/j.mvr.2006.02.005; CURRY FE, 1983, AM J PHYSIOL, V245, pH495, DOI 10.1152/ajpheart.1983.245.3.H495; Ghajar CM, 2008, CRIT REV EUKAR GENE, V18, P251, DOI 10.1615/CritRevEukarGeneExpr.v18.i3.30; Ghajar CM, 2008, BIOPHYS J, V94, P1930, DOI 10.1529/biophysj.107.120774; Ghajar CM, 2006, TISSUE ENG, V12, P2875, DOI 10.1089/ten.2006.12.2875; Ghajar CM, 2010, EXP CELL RES, V316, P813, DOI 10.1016/j.yexcr.2010.01.013; Griffith CK, 2005, TISSUE ENG, V11, P257, DOI 10.1089/ten.2005.11.257; Hashizume H, 2000, AM J PATHOL, V156, P1363, DOI 10.1016/S0002-9440(10)65006-7; Jain RK, 2005, NAT BIOTECHNOL, V23, P821, DOI 10.1038/nbt0705-821; Jain RK, 2003, NAT MED, V9, P685, DOI 10.1038/nm0603-685; KACHGAL S, 2010, ANGIOGENESIS; Koike N, 2004, NATURE, V428, P138, DOI 10.1038/428138a; LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529; Levenberg S, 2005, NAT BIOTECHNOL, V23, P879, DOI 10.1038/nbt1109; McDonald DM, 2002, CANCER RES, V62, P5381; Melero-Martin JM, 2008, CIRC RES, V103, P194, DOI 10.1161/CIRCRESAHA.108.178590; Melero-Martin JM, 2007, BLOOD, V109, P4761, DOI 10.1182/blood-2006-12-062471; Merfeld-Clauss S, 2010, TISSUE ENG PT A, V16, P2953, DOI [10.1089/ten.tea.2009.0635, 10.1089/ten.TEA.2009.0635]; Midwood KS, 2004, INT J BIOCHEM CELL B, V36, P1031, DOI 10.1016/j.biocel.2003.12.003; MONTESANO R, 1993, J CELL SCI, V105, P1013; Morikawa S, 2002, AM J PATHOL, V160, P985, DOI 10.1016/S0002-9440(10)64920-6; Neumann T, 2003, MICROVASC RES, V66, P59, DOI 10.1016/S0026-2862(03)00040-2; Nor JE, 2001, LAB INVEST, V81, P453, DOI 10.1038/labinvest.3780253; PAKWAI A, 2008, ENG FUNCTIONAL BLOOD; Price GM, 2010, BIOMATERIALS, V31, P6182, DOI 10.1016/j.biomaterials.2010.04.041; Richardson TP, 2001, NAT BIOTECHNOL, V19, P1029, DOI 10.1038/nbt1101-1029; Sandoval R, 2001, AM J PHYSIOL-LUNG C, V280, pL239, DOI 10.1152/ajplung.2001.280.2.L239; Shaterian A, 2009, BURNS, V35, P811, DOI 10.1016/j.burns.2008.12.012; Shepherd BR, 2009, TISSUE ENG PT A, V15, P165, DOI 10.1089/ten.tea.2008.0010; Traktuev DO, 2008, CIRC RES, V102, P77, DOI 10.1161/CIRCRESAHA.107.159475	36	47	47	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2011	6	7							e22086	10.1371/journal.pone.0022086	http://dx.doi.org/10.1371/journal.pone.0022086			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791HI	21760956	Green Published, Green Submitted, gold			2022-12-27	WOS:000292655400044
J	Yamada, H; Ueda, T; Yano, A				Yamada, Hidetoshi; Ueda, Tomohiro; Yano, Akira			Water-Soluble Extract of Pacific Krill Prevents Triglyceride Accumulation in Adipocytes by Suppressing PPAR gamma and C/EBP alpha Expression	PLOS ONE			English	Article							ACTIVATED-RECEPTOR-GAMMA; GENE-EXPRESSION; PROMOTES ADIPOGENESIS; 3T3-L1 PREADIPOCYTES; INSULIN-RESISTANCE; ADIPOSE-TISSUE; KEY REGULATOR; SERUM-LIPIDS; OBESE GENE; DIFFERENTIATION	Background: Pacific Krill (Euphausia pacifica) are small, red crustaceans, similar to shrimp, that flourish in the North Pacific and are eaten in Japan. Methods and Findings: We investigated the effect of a water-soluble extract of Pacific Krill on adipocytes and discovered that this extract suppressed triglyceride accumulation in adipocytes. Furthermore, the water-soluble extract of Pacific Krill suppressed the expression of two master regulators of adipocyte differentiation, peroxisome proliferator-activated receptor gamma (PPAR gamma) and CCAAT enhancer binding protein alpha (C/EBP alpha). C/EBP beta promotes PPAR gamma and C/EBP alpha expression, but the water-soluble extract of Pacific Krill did not inhibit the expression of C/EBP beta or C/EBP beta-mediated transcriptional activation. The Pacific Krill extract was more effective than a PPAR gamma antagonist in suppressing PPAR gamma and C/EBP alpha expression. Conclusions: These results indicated that the water-soluble extract of Pacific Krill was not simply a PPAR gamma antagonist, but that it prevented triglyceride accumulation in adipocytes by suppression of PPAR gamma and C/EBP alpha via a pathway that is independent of C/EBP beta.	[Yamada, Hidetoshi; Yano, Akira] Iwate Biotechnol Res Ctr, Kitakami, Iwate, Japan; [Ueda, Tomohiro] Iwate Fisheries Technol Ctr, Kamaishi, Iwate 0260001, Japan	Iwate Biotechnology Research Center	Yamada, H (corresponding author), Iwate Biotechnol Res Ctr, Kitakami, Iwate, Japan.	hyamada@ibrc.or.jp	Yano, Akira/AAL-3544-2020		Basic Biotechnology Project of Iwate Prefecture, Japan; Sanriku Foundation	Basic Biotechnology Project of Iwate Prefecture, Japan; Sanriku Foundation	This work was supported by a fund from the Basic Biotechnology Project of Iwate Prefecture, Japan, and Grants-in-Aid from the Sanriku Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Batetta B, 2009, J NUTR, V139, P1495, DOI 10.3945/jn.109.104844; Bridges KM, 2010, J AGR FOOD CHEM, V58, P2830, DOI 10.1021/jf9036408; Bunea Ruxandra, 2004, Altern Med Rev, V9, P420; CAMPFIELD LA, 1995, SCIENCE, V269, P546, DOI 10.1126/science.7624778; CHRISTY RJ, 1991, P NATL ACAD SCI USA, V88, P2593, DOI 10.1073/pnas.88.6.2593; Deutsch L, 2007, J AM COLL NUTR, V26, P39, DOI 10.1080/07315724.2007.10719584; FERRAMOSCA A, 2011, J ANIMAL PHYSL ANIMA; Gesta S, 2007, CELL, V131, P242, DOI 10.1016/j.cell.2007.10.004; Gigliotti JC, 2011, UROL RES, V39, P59, DOI 10.1007/s00240-010-0261-x; Guo W, 2009, CELL RES, V19, P216, DOI 10.1038/cr.2008.319; HALAAS JL, 1995, SCIENCE, V269, P543, DOI 10.1126/science.7624777; Han LK, 1999, INT J OBESITY, V23, P98, DOI 10.1038/sj.ijo.0800766; Hong KM, 2007, J BIOL CHEM, V282, P22910, DOI 10.1074/jbc.M703597200; Hutley L, 2004, DIABETES, V53, P3097, DOI 10.2337/diabetes.53.12.3097; Ierna M, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-136; Kao YH, 2006, MOL NUTR FOOD RES, V50, P188, DOI 10.1002/mnfr.200500109; Kidd PM, 2007, ALTERN MED REV, V12, P207; Kubota N, 1999, MOL CELL, V4, P597, DOI 10.1016/S1097-2765(00)80210-5; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Lee G, 2002, J BIOL CHEM, V277, P19649, DOI 10.1074/jbc.M200743200; Lowell BB, 1999, CELL, V99, P239, DOI 10.1016/S0092-8674(00)81654-2; Maeda H, 2005, BIOCHEM BIOPH RES CO, V332, P392, DOI 10.1016/j.bbrc.2005.05.002; Matsumura H, 2005, CELL MICROBIOL, V7, P11, DOI 10.1111/j.1462-5822.2004.00478.x; Matsumura H, 2003, P NATL ACAD SCI USA, V100, P15718, DOI 10.1073/pnas.2536670100; Matsumura H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012010; Mori TA, 1999, AM J CLIN NUTR, V70, P817; Okamura M, 2009, P NATL ACAD SCI USA, V106, P5819, DOI 10.1073/pnas.0901676106; PELLEYMOUNTER MA, 1995, SCIENCE, V269, P540, DOI 10.1126/science.7624776; Prusty D, 2002, J BIOL CHEM, V277, P46226, DOI 10.1074/jbc.M207776200; Rochford JJ, 2004, MOL CELL BIOL, V24, P9863, DOI 10.1128/MCB.24.22.9863-9872.2004; Sakaue H, 2002, GENE DEV, V16, P908, DOI 10.1101/gad.983202; Sarruf DA, 2005, MOL CELL BIOL, V25, P9985, DOI 10.1128/MCB.25.22.9985-9995.2005; Tanaka T, 1997, EMBO J, V16, P7432, DOI 10.1093/emboj/16.24.7432; Tandy S, 2009, J AGR FOOD CHEM, V57, P9339, DOI 10.1021/jf9016042; Tang QQ, 1999, MOL CELL BIOL, V19, P4855; Tchoukalova YD, 2010, P NATL ACAD SCI USA, V107, P18226, DOI 10.1073/pnas.1005259107; Tong Q, 2005, MOL CELL BIOL, V25, P706, DOI 10.1128/MCB.25.2.706-715.2005; Tou JC, 2007, NUTR REV, V65, P63, DOI [10.1111/j.1753-4887.2007.tb00283.x, 10.1301/nr.2007.feb.63-77]; Ulven SM, 2011, LIPIDS, V46, P37, DOI 10.1007/s11745-010-3490-4; WAKABAYASHI S, 1995, J ENDOCRINOL, V144, P533, DOI 10.1677/joe.0.1440533; Widberg CH, 2009, AM J PHYSIOL-ENDOC M, V296, pE121, DOI 10.1152/ajpendo.90602.2008; Yamauchi T, 2001, NAT MED, V7, P941, DOI 10.1038/90984; Zandbergen F, 2005, BIOCHEM J, V392, P313, DOI 10.1042/BJ20050636; Zhu JJ, 2008, LIPIDS HEALTH DIS, V7, DOI 10.1186/1476-511X-7-30; ZHU YJ, 1995, P NATL ACAD SCI USA, V92, P7921, DOI 10.1073/pnas.92.17.7921	45	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2011	6	7							e21952	10.1371/journal.pone.0021952	http://dx.doi.org/10.1371/journal.pone.0021952			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791HI	21760932	Green Submitted, gold, Green Published			2022-12-27	WOS:000292655400030
J	Rodgers, GM; Ward, JR; Askwith, B; Morrell, LJ				Rodgers, Gwendolen M.; Ward, Jonathan R.; Askwith, Beth; Morrell, Lesley J.			Balancing the Dilution and Oddity Effects: Decisions Depend on Body Size	PLOS ONE			English	Article							GUPPY POECILIA-RETICULATA; SHOALING BEHAVIOR; PREDATION RISK; SCHOOLING BEHAVIOR; KIN RECOGNITION; FISH; PREFERENCES; CHOICE; SEGREGATION; POPULATIONS	Background: Grouping behaviour, common across the animal kingdom, is known to reduce an individual's risk of predation; particularly through dilution of individual risk and predator confusion (predator inability to single out an individual for attack). Theory predicts greater risk of predation to individuals more conspicuous to predators by difference in appearance from the group (the 'oddity' effect). Thus, animals should choose group mates close in appearance to themselves (eg. similar size), whilst also choosing a large group. Methodology and Principal Findings: We used the Trinidadian guppy (Poecilia reticulata), a well known model species of group-living freshwater fish, in a series of binary choice trials investigating the outcome of conflict between preferences for large and phenotypically matched groups along a predation risk gradient. We found body-size dependent differences in the resultant social decisions. Large fish preferred shoaling with size-matched individuals, while small fish demonstrated no preference. There was a trend towards reduced preferences for the matched shoal under increased predation risk. Small fish were more active than large fish, moving between shoals more frequently. Activity levels increased as predation risk decreased. We found no effect of unmatched shoal size on preferences or activity. Conclusions and Significance: Our results suggest that predation risk and individual body size act together to influence shoaling decisions. Oddity was more important for large than small fish, reducing in importance at higher predation risks. Dilution was potentially of limited importance at these shoal sizes. Activity levels may relate to how much sampling of each shoal was needed by the test fish during decision making. Predation pressure may select for better decision makers to survive to larger size, or that older, larger fish have learned to make shoaling decisions more efficiently, and this, combined with their size relative to shoal-mates, and attractiveness as prey items influences shoaling decisions.	[Rodgers, Gwendolen M.; Ward, Jonathan R.; Askwith, Beth; Morrell, Lesley J.] Univ Leeds, Inst Integrat & Comparat Biol, Leeds, W Yorkshire, England; [Morrell, Lesley J.] Univ Hull, Dept Biol Sci, Kingston Upon Hull HU6 7RX, N Humberside, England	University of Leeds; University of Hull	Rodgers, GM (corresponding author), Univ Leeds, Inst Integrat & Comparat Biol, Leeds, W Yorkshire, England.	bsgmr@leeds.ac.uk	Morrell, Lesley J/A-4311-2008	Morrell, Lesley J/0000-0003-0256-7871	Biotechnology and Biological Sciences Research Council (BBSRC); Natural Environment Research Council (NERC) [NE/D008921/1]; Natural Environment Research Council [NE/D008921/1] Funding Source: researchfish; NERC [NE/D008921/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Natural Environment Research Council (NERC)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was funded by a Biotechnology and Biological Sciences Research Council (BBSRC) studentship to GMR and a Natural Environment Research Council (NERC) postdoctoral fellowship (NE/D008921/1) to LJM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARBER I, 1995, J FISH BIOL, V47, P524, DOI 10.1006/jfbi.1995.0156; Binoy VV, 2004, CURR SCI INDIA, V86, P207; Boland CRJ, 2003, ETHOLOGY, V109, P209, DOI 10.1046/j.1439-0310.2003.00860.x; BOTHAM MS, 2008, ECOLOGY IN PRESS; Bradner J, 2001, J FISH BIOL, V59, P960, DOI 10.1006/jfbi.2001.1712; Caro Tim, 2005, pXIII; Croft DP, 2006, AM NAT, V167, P867, DOI 10.1086/504853; Croft DP, 2003, OIKOS, V100, P429, DOI 10.1034/j.1600-0706.2003.12023.x; ELGAR MA, 1989, BIOL REV, V64, P13, DOI 10.1111/j.1469-185X.1989.tb00636.x; FITZGERALD GJ, 1992, ETHOL ECOL EVOL, V4, P273, DOI 10.1080/08927014.1992.9523138; FOSTER WA, 1981, NATURE, V293, P466, DOI 10.1038/293466a0; Frommen JG, 2007, ZOOLOGY, V110, P369, DOI 10.1016/j.zool.2007.06.002; Gomez-Laplaza LM, 2005, BEHAVIOUR, V142, P827, DOI 10.1163/1568539054729141; Griffiths SW, 1999, BEHAV ECOL SOCIOBIOL, V45, P437, DOI 10.1007/s002650050582; Griffiths SW, 1998, ANIM BEHAV, V56, P689, DOI 10.1006/anbe.1998.0767; Griffiths SW, 1997, P ROY SOC B-BIOL SCI, V264, P547, DOI 10.1098/rspb.1997.0078; Hoare DJ, 2000, J FISH BIOL, V57, P1351, DOI 10.1006/jfbi.2000.1446; Hoare DJ, 2000, OIKOS, V89, P546, DOI 10.1034/j.1600-0706.2000.890314.x; Hoare DJ, 2004, ANIM BEHAV, V67, P155, DOI 10.1016/j.anbehav.2003.04.004; Houston AI, 2003, EVOL ECOL RES, V5, P195; Jones KA, 2010, ETHOLOGY, V116, P147, DOI 10.1111/j.1439-0310.2009.01727.x; Kelley JL, 2003, BEHAV ECOL SOCIOBIOL, V54, P225, DOI 10.1007/s00265-003-0621-4; KRAKAUER DC, 1995, BEHAV ECOL SOCIOBIOL, V36, P421, DOI 10.1007/s002650050165; KRAUSE J, 1994, ETHOLOGY, V98, P128; KRAUSE J, 1995, ANIM BEHAV, V50, P465, DOI 10.1006/anbe.1995.0260; LANDEAU L, 1986, ANIM BEHAV, V34, P1372, DOI 10.1016/S0003-3472(86)80208-1; Ledesma JM, 2008, BEHAV PROCESS, V77, P384, DOI 10.1016/j.beproc.2007.10.006; MAGURRAN AE, 1995, ADV STUD BEHAV, V24, P155, DOI 10.1016/S0065-3454(08)60394-0; MAGURRAN AE, 1993, MAR BEHAV PHYSIOL, V23, P29, DOI 10.1080/10236249309378855; MAGURRAN AE, 1991, BEHAVIOUR, V118, P214, DOI 10.1163/156853991X00292; MAGURRAN AE, 2005, EVOLUTIONARY ECOLOGY; Mathis A, 2003, BEHAV ECOL, V14, P334, DOI 10.1093/beheco/14.3.334; McRobert SP, 1998, ANIM BEHAV, V56, P611, DOI 10.1006/anbe.1998.0846; METCALFE NB, 1995, P ROY SOC B-BIOL SCI, V259, P207, DOI 10.1098/rspb.1995.0030; Miller RC, 1922, ECOLOGY, V3, P122, DOI 10.2307/1929145; Morrell LJ, 2007, ANIM BEHAV, V74, P311, DOI 10.1016/j.anbehav.2006.10.021; Morrell LJ, 2004, BEHAV ECOL SOCIOBIOL, V56, P539, DOI 10.1007/s00265-004-0821-6; Peuhkuri N, 1999, BEHAV ECOL SOCIOBIOL, V46, P307, DOI 10.1007/s002650050624; Pitcher T. J, 1993, BEHAV TELEOST FISHES; Ranta Esa, 1994, Ecoscience, V1, P99; RODGERS GM, ANIMAL BEHAV, V79, P1025; Ruhl N, 2005, J FISH BIOL, V67, P1318, DOI 10.1111/j.0022-1112.2005.00826.x; SEGHERS BH, 1974, EVOLUTION, V28, P486, DOI 10.1111/j.1558-5646.1974.tb00774.x; Svensson PA, 2000, J FISH BIOL, V56, P1477, DOI 10.1111/j.1095-8649.2000.tb02158.x; Tegeder RW, 1995, PHILOS T R SOC B, V350, P381, DOI 10.1098/rstb.1995.0172; THEODORAKIS CW, 1989, ANIM BEHAV, V38, P496, DOI 10.1016/S0003-3472(89)80042-9; TURNER GF, 1986, AM NAT, V128, P228, DOI 10.1086/284556; Ward AJW, 2005, ENVIRON BIOL FISH, V72, P155, DOI 10.1007/s10641-004-9078-1; Ward AJW, 2004, BEHAV ECOL SOCIOBIOL, V55, P561, DOI 10.1007/s00265-003-0751-8; Ward AJW, 2002, BEHAV ECOL SOCIOBIOL, V52, P182, DOI 10.1007/s00265-002-0505-z; Wong BBM, 2005, ETHOLOGY, V111, P179, DOI 10.1111/j.1439-0310.2004.01044.x; Wright D, 2006, NAT PROTOC, V1, P1828, DOI 10.1038/nprot.2006.287	52	27	27	2	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2011	6	7							e14819	10.1371/journal.pone.0014819	http://dx.doi.org/10.1371/journal.pone.0014819			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	789JO	21750694	Green Published, gold, Green Submitted			2022-12-27	WOS:000292512000001
J	Lin, R; Rosahl, TW; Whiting, PJ; Fawcett, JW; Kwok, JCF				Lin, Rachel; Rosahl, Thomas W.; Whiting, Paul J.; Fawcett, James W.; Kwok, Jessica C. F.			6-Sulphated Chondroitins Have a Positive Influence on Axonal Regeneration	PLOS ONE			English	Article							SPINAL-CORD-INJURY; REACTIVE ASTROCYTES; NEURITE OUTGROWTH; FUNCTIONAL RECOVERY; GLIAL SCAR; SULFATE PROTEOGLYCANS; EXTRACELLULAR-MATRIX; CELL-MIGRATION; STAIRCASE TEST; RAT-BRAIN	Chondroitin sulphate proteoglycans (CSPGs) upregulated in the glial scar inhibit axon regeneration via their sulphated glycosaminoglycans (GAGs). Chondroitin 6-sulphotransferase-1 (C6ST-1) is upregulated after injury leading to an increase in 6-sulphated GAG. In this study, we ask if this increase in 6-sulphated GAG is responsible for the increased inhibition within the glial scar, or whether it represents a partial reversion to the permissive embryonic state dominated by 6-sulphated glycosaminoglycans (GAGs). Using C6ST-1 knockout mice (KO), we studied post-injury changes in chondroitin sulphotransferase (CSST) expression and the effect of chondroitin 6-sulphates on both central and peripheral axon regeneration. After CNS injury, wild-type animals (WT) showed an increase in mRNA for C6ST-1, C6ST-2 and C4ST-1, but KO did not upregulate any CSSTs. After PNS injury, while WT upregulated C6ST-1, KO showed an upregulation of C6ST-2. We examined regeneration of nigrostriatal axons, which demonstrate mild spontaneous axon regeneration in the WT. KO showed many fewer regenerating axons and more axonal retraction than WT. However, in the PNS, repair of the median and ulnar nerves led to similar and normal levels of axon regeneration in both WT and KO. Functional tests on plasticity after the repair also showed no evidence of enhanced plasticity in the KO. Our results suggest that the upregulation of 6-sulphated GAG after injury makes the extracellular matrix more permissive for axon regeneration, and that the balance of different CSs in the microenvironment around the lesion site is an important factor in determining the outcome of nervous system injury.	[Lin, Rachel; Fawcett, James W.; Kwok, Jessica C. F.] Univ Cambridge, Cambridge Ctr Brain Repair, Dept Clin Neurosci, Cambridge, England; [Rosahl, Thomas W.; Whiting, Paul J.] Merck Sharp & Dohme Ltd, Neurosci Res Ctr, Harlow CM20 2QR, Essex, England	University of Cambridge; Merck & Company	Lin, R (corresponding author), Univ Cambridge, Cambridge Ctr Brain Repair, Dept Clin Neurosci, Cambridge, England.	jcfk2@cam.ac.uk	Kwok, Jessica/A-6740-2013	Whiting, Paul/0000-0002-4121-1379; Fawcett, James/0000-0002-7990-4568; Kwok, Jessica/0000-0002-9798-9083	Medical Research Council; Wellcome Trust; Christopher and Dana Reeve foundation; European Union; Framework 7 project Plasticise	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); Christopher and Dana Reeve foundation; European Union(European Commission); Framework 7 project Plasticise	This research was funded by grants from the Medical Research Council, the Wellcome Trust, the Christopher and Dana Reeve foundation, the European Union Framework 6 network of excellence NeuroNE, the Framework 7 project Plasticise. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asher R A, 2001, Prog Brain Res, V132, P611; Baird AL, 2001, BRAIN RES BULL, V54, P243, DOI 10.1016/S0361-9230(00)00457-3; Bush TG, 1999, NEURON, V23, P297, DOI 10.1016/S0896-6273(00)80781-3; Calabro A, 2000, GLYCOBIOLOGY, V10, P273, DOI 10.1093/glycob/10.3.273; Calabro A, 2000, GLYCOBIOLOGY, V10, P283, DOI 10.1093/glycob/10.3.283; Carulli D, 2010, BRAIN, V133, P2331, DOI 10.1093/brain/awq145; Chau CH, 2004, FASEB J, V18, P194, DOI 10.1096/fj.03-0196fje; Chung KY, 2000, DEVELOPMENT, V127, P2673; Clement AM, 1999, NEUROSCI LETT, V269, P125, DOI 10.1016/S0304-3940(99)00432-2; Clement AM, 1998, J BIOL CHEM, V273, P28444, DOI 10.1074/jbc.273.43.28444; Deepa SS, 2006, J BIOL CHEM, V281, P17789, DOI 10.1074/jbc.M600544200; Faulkner JR, 2004, J NEUROSCI, V24, P2143, DOI 10.1523/JNEUROSCI.3547-03.2004; Fawcett JW, 2006, ADV EXP MED BIOL, V557, P11; FAWCETT JW, 1990, ANNU REV NEUROSCI, V13, P43, DOI 10.1146/annurev.neuro.13.1.43; Galtrey CM, 2007, BRAIN, V130, P926, DOI 10.1093/brain/awl372; Galtrey CM, 2007, J PERIPHER NERV SYST, V12, P11, DOI 10.1111/j.1529-8027.2007.00113.x; Gilbert RJ, 2005, MOL CELL NEUROSCI, V29, P545, DOI 10.1016/j.mcn.2005.04.006; Golding JP, 1999, DEV BIOL, V216, P85, DOI 10.1006/dbio.1999.9497; Habuchi O, 2000, BBA-GEN SUBJECTS, V1474, P115, DOI 10.1016/S0304-4165(00)00016-7; Kinoshita A, 2001, BIOCHEMISTRY-US, V40, P12654, DOI 10.1021/bi015577n; Kitagawa H, 1997, J BIOL CHEM, V272, P31377, DOI 10.1074/jbc.272.50.31377; Kubota Y, 1999, DEV DYNAM, V214, P55, DOI 10.1002/(SICI)1097-0177(199901)214:1<55::AID-DVDY6>3.0.CO;2-E; Kwok JCF, 2008, RESTOR NEUROL NEUROS, V26, P131; Kwok JCF, 2010, J NEUROCHEM, V114, P1447, DOI 10.1111/j.1471-4159.2010.06878.x; Liu J, 2006, J CELL SCI, V119, P933, DOI 10.1242/jcs.02796; McKeon RJ, 1999, J NEUROSCI, V19, P10778, DOI 10.1523/JNEUROSCI.19-24-10778.1999; Mitsumoto Y, 1998, BIOCHEM BIOPH RES CO, V248, P660, DOI 10.1006/bbrc.1998.8986; MONTOYA CP, 1991, J NEUROSCI METH, V36, P219, DOI 10.1016/0165-0270(91)90048-5; Moon LDF, 2003, J NEUROSCI RES, V71, P23, DOI 10.1002/jnr.10449; Perris R, 2000, MECH DEVELOP, V95, P3, DOI 10.1016/S0925-4773(00)00365-8; Pizzorusso T, 2002, SCIENCE, V298, P1248, DOI 10.1126/science.1072699; Pizzorusso T, 2006, P NATL ACAD SCI USA, V103, P8517, DOI 10.1073/pnas.0602657103; Properzi F, 2005, EUR J NEUROSCI, V21, P378, DOI 10.1111/j.1460-9568.2005.03876.x; Rhodes KE, 2004, J ANAT, V204, P33, DOI 10.1111/j.1469-7580.2004.00261.x; Schwab JM, 2001, J NEUROIMMUNOL, V119, P214, DOI 10.1016/S0165-5728(01)00375-7; Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326; SNOW DM, 1990, EXP NEUROL, V109, P111, DOI 10.1016/S0014-4886(05)80013-5; Sofroniew MV, 2005, NEUROSCIENTIST, V11, P400, DOI 10.1177/1073858405278321; Uchimura K, 2002, J BIOL CHEM, V277, P1443, DOI 10.1074/jbc.M104719200; Wang H, 2008, J CELL SCI, V121, P3083, DOI 10.1242/jcs.032649	40	26	27	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2011	6	7							e21499	10.1371/journal.pone.0021499	http://dx.doi.org/10.1371/journal.pone.0021499			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786HC	21747937	Green Published, gold, Green Submitted			2022-12-27	WOS:000292293400013
J	Paul, J; Maiti, K; Read, M; Hure, A; Smith, J; Chan, EC; Smith, R				Paul, Jonathan; Maiti, Kaushik; Read, Mark; Hure, Alexis; Smith, Julia; Chan, Eng-Cheng; Smith, Roger			Phasic Phosphorylation of Caldesmon and ERK 1/2 during Contractions in Human Myometrium	PLOS ONE			English	Article							SMOOTH-MUSCLE; CHICKEN GIZZARD; TROPOMYOSIN; ACTIN; CALMODULIN; PROTEIN; BINDING	Human myometrium develops phasic contractions during labor. Phosphorylation of caldesmon (h-CaD) and extracellular signal-regulated kinase 1/2 (ERK 1/2) has been implicated in development of these contractions, however the phospho-regulation of these proteins is yet to be examined during periods of both contraction and relaxation. We hypothesized that protein phosphorylation events are implicated in the phasic nature of myometrial contractions, and aimed to examine h-CaD and ERK 1/2 phosphorylation in myometrium snap frozen at specific stages, including; (1) prior to onset of contractions, (2) at peak contraction and (3) during relaxation. We aimed to compare h-CaD and ERK 1/2 phosphorylation in vitro against results from in vivo studies that compared not-in-labor (NIL) and laboring (L) myometrium. Comparison of NIL (n = 8) and L (n = 8) myometrium revealed a 2-fold increase in h-CaD phosphorylation (ser-789; P = 0.012) during onset of labor in vivo, and was associated with significantly up-regulated ERK2 expression (P = 0.022), however no change in ERK2 phosphorylation was observed (P = 0.475). During in vitro studies (n = 5), transition from non-contracting tissue to tissue at peak contraction was associated with increased phosphorylation of both h-CaD and ERK 1/2. Furthermore, tissue preserved at relaxation phase exhibited diminished levels of h-CaD and ERK 1/2 phosphorylation compared to tissue preserved at peak contraction, thereby producing a phasic phosphorylation profile for h-CaD and ERK 1/2. h-CaD and ERK 1/2 are phosphorylated during myometrial contractions, however their phospho-regulation is dynamic, in that h-CaD and ERK 1/2 are phosphorylated and dephosphorylated in phase with contraction and relaxation respectively. Comparisons of NIL and L tissue are at risk of failing to detect these changes, as L samples are not necessarily preserved in the midst of an active contraction.	[Paul, Jonathan; Maiti, Kaushik; Read, Mark; Hure, Alexis; Smith, Julia; Chan, Eng-Cheng; Smith, Roger] Univ Newcastle, Fac Hlth, Mothers & Babies Res Ctr, Callaghan, NSW 2308, Australia; [Paul, Jonathan; Maiti, Kaushik; Read, Mark; Hure, Alexis; Smith, Julia; Chan, Eng-Cheng; Smith, Roger] John Hunter Hosp, Hunter Med Res Inst, New Lambton, Australia	University of Newcastle; Hunter Medical Research Institute; John Hunter Hospital; University of Newcastle	Paul, J (corresponding author), Univ Newcastle, Fac Hlth, Mothers & Babies Res Ctr, Callaghan, NSW 2308, Australia.	Jonathan.Paul@newcastle.edu.au	Hure, Alexis/D-6790-2011	Paul, Jonathan/0000-0003-3064-6358; Hure, Alexis/0000-0003-2225-0986; Smith, Roger/0000-0003-4720-0280	Australian Government National Health and Medical Research Council [455556]	Australian Government National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This research was funded by the Australian Government National Health and Medical Research Council (grant number: 455556). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	D'Angelo G, 1999, J BIOL CHEM, V274, P30115, DOI 10.1074/jbc.274.42.30115; EWOANE C, 1990, BIOCH LIFE SCI ADV, V9, P71; FUJII T, 1988, J BIOCHEM-TOKYO, V104, P734, DOI 10.1093/oxfordjournals.jbchem.a122542; GRACEFFA P, 1987, FEBS LETT, V218, P139, DOI 10.1016/0014-5793(87)81034-7; HORIUCHI KY, 1988, BIOCHEMISTRY-US, V27, P8388, DOI 10.1021/bi00422a014; Huang RJ, 2003, BIOCHEMISTRY-US, V42, P2513, DOI 10.1021/bi0268605; Li YP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007489; MARSTON SB, 1991, BIOCHEM J, V279, P1; Morgan KG, 2001, J APPL PHYSIOL, V91, P953, DOI 10.1152/jappl.2001.91.2.953; SADOVSKY Y, 1992, NEW ENGL J MED, V326, P709; SOBUE K, 1991, J BIOL CHEM, V266, P12115; SOBUE K, 1981, P NATL ACAD SCI-BIOL, V78, P5652, DOI 10.1073/pnas.78.9.5652; SZPACENKO A, 1986, FEBS LETT, V202, P182, DOI 10.1016/0014-5793(86)80683-4	13	23	23	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2011	6	6							e21542	10.1371/journal.pone.0021542	http://dx.doi.org/10.1371/journal.pone.0021542			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786GP	21738699	Green Published, gold			2022-12-27	WOS:000292291800019
J	Lee, H; Park, MT; Choi, BH; Oh, ET; Song, MJ; Lee, J; Kim, C; Lim, BU; Park, HJ				Lee, Hyemi; Park, Moon-Taek; Choi, Bo-Hwa; Oh, Eun-Taex; Song, Min-Jeong; Lee, Jeonghun; Kim, Chulhee; Lim, Byung Uk; Park, Heon Joo			Endoplasmic Reticulum Stress-Induced JNK Activation Is a Critical Event Leading to Mitochondria-Mediated Cell Death Caused by beta-Lapachone Treatment	PLOS ONE			English	Article							UNFOLDED PROTEIN RESPONSE; BREAST-CANCER CELLS; INDUCED APOPTOSIS; IONIZING-RADIATION; CYTOCHROME-C; MAP KINASES; CLEAVAGE; BAX; BCL-2; ERK	Background: beta-lapachone (beta-lap) is a bioreductive agent that is activated by the two-electron reductase NAD(P)H quinone oxidoreductase 1 (NQO1). Although beta-lap has been reported to induce apoptosis in various cancer types in an NQO1-dependent manner, the signaling pathways by which beta-lap causes apoptosis are poorly understood. Methodology/Principal Findings: beta-lap-induced apoptosis and related molecular signaling pathways in NQO1-negative and NQO1-overexpressing MDA-MB-231 cells were investigated. Pharmacological inhibitors or siRNAs against factors involved in beta-lap-induced apoptosis were used to clarify the roles played by such factors in beta-lap-activated apoptotic signaling pathways. beta-lap leads to clonogenic cell death and apoptosis in an NQO1-dependent manner. Treatment of NQO1-overexpressing MDA-MB-231 cells with beta-lap causes rapid disruption of mitochondrial membrane potential, nuclear translocation of AIF and Endo G from mitochondria, and subsequent caspase-independent apoptotic cell death. siRNAs targeting AIF and Endo G effectively attenuate beta-lap-induced clonogenic and apoptotic cell death. Moreover, beta-lap induces cleavage of Bax, which accumulates in mitochondria, coinciding with the observed changes in mitochondria membrane potential. Pretreatment with Salubrinal (Sal), an endoplasmic reticulum (ER) stress inhibitor, efficiently attenuates JNK activation caused by beta-lap, and subsequent mitochondria-mediated cell death. In addition, beta-lap-induced generation and mitochondrial translocation of cleaved Bax are efficiently blocked by JNK inhibition. Conclusions/Significance: Our results indicate that b-lap triggers induction of endoplasmic reticulum (ER) stress, thereby leading to JNK activation and mitochondria-mediated apoptosis. The signaling pathways that we revealed in this study may significantly contribute to an improvement of NQO1-directed tumor therapies.	[Lee, Hyemi; Park, Moon-Taek; Choi, Bo-Hwa; Oh, Eun-Taex; Song, Min-Jeong; Lim, Byung Uk; Park, Heon Joo] Inha Univ, Ctr Adv Med Educ Project BK21, Coll Med, Dept Microbiol, Inchon, South Korea; [Lee, Jeonghun; Kim, Chulhee] Inha Univ, Dept Polymer Sci & Engn, Inchon, South Korea	Inha University; Inha University	Lee, H (corresponding author), Inha Univ, Ctr Adv Med Educ Project BK21, Coll Med, Dept Microbiol, Inchon, South Korea.	park001@inha.ac.kr			Korea Health 21 RD Project [A062254]; KOSEF [2009-0093747]	Korea Health 21 RD Project; KOSEF(Korea Science and Engineering Foundation)	This work was supported by grants from the Korea Health 21 R&D Project (A062254), and the Nuclear R&D Program of KOSEF (2009-0093747). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarti I, 2010, APOPTOSIS, V15, P679, DOI 10.1007/s10495-010-0474-z; Ariyama H, 2006, J CELL BIOCHEM, V97, P724, DOI 10.1002/jcb.20678; Belgardt BF, 2010, AGING-US, V2, P621, DOI 10.18632/aging.100192; Bey EA, 2007, P NATL ACAD SCI USA, V104, P11832, DOI 10.1073/pnas.0702176104; Bhattacharya S, 2005, BIOCHEM J, V392, P335, DOI 10.1042/BJ20050465; BOOTHMAN DA, 1989, CANCER RES, V49, P605; Cao XF, 2003, BLOOD, V102, P2605, DOI 10.1182/blood-2003-01-0211; Choi HJ, 2009, EXP MOL MED, V41, P94, DOI 10.3858/emm.2009.41.2.012; Dadakhujaev S, 2009, AUTOPHAGY, V5, P103, DOI 10.4161/auto.5.1.7276; Daugas E, 2000, FEBS LETT, V476, P118, DOI 10.1016/S0014-5793(00)01731-2; DEMARIA M, 2010, AGING ALBANY NY, V11, P823; DONG Y, 2011, CLIN CANCER RES, V15, P131; Dudekula S, 2010, AGING-US, V2, P1023, DOI 10.18632/aging.100263; GUIRAUD P, 1994, PLANTA MED, V60, P373, DOI 10.1055/s-2006-959504; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Huang DCS, 2000, CELL, V103, P839, DOI 10.1016/S0092-8674(00)00187-2; Johnson GL, 2002, SCIENCE, V298, P1911, DOI 10.1126/science.1072682; Joza N, 2001, NATURE, V410, P549, DOI 10.1038/35069004; Kadowaki H, 2004, J CHEM NEUROANAT, V28, P93, DOI 10.1016/j.jchemneu.2004.05.004; Katagiri C, 2005, J BIOL CHEM, V280, P14716, DOI 10.1074/jbc.M500200200; Kaufmann SH, 2000, EXP CELL RES, V256, P42, DOI 10.1006/excr.2000.4838; Klekotka PA, 2001, J BIOL CHEM, V276, P32353, DOI 10.1074/jbc.M101921200; Lai CC, 1998, HISTOL HISTOPATHOL, V13, P89, DOI 10.14670/HH-13.89; Lee J. I., 2006, Experimental Oncology, V28, P30; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; Lien YC, 2008, HISTOL HISTOPATHOL, V23, P1299, DOI 10.14670/HH-23.1299; Malhotra JD, 2007, SEMIN CELL DEV BIOL, V18, P716, DOI 10.1016/j.semcdb.2007.09.003; Masuda K, 2003, J BIOL CHEM, V278, P32448, DOI 10.1074/jbc.M213254200; Pardee AB, 2002, CURR CANCER DRUG TAR, V2, P227, DOI 10.2174/1568009023333854; Park HJ, 2005, INT J RADIAT ONCOL, V61, P212, DOI 10.1016/j.ijrobp.2004.09.018; Park MT, 2005, BLOOD, V105, P1724, DOI 10.1182/blood-2004-07-2938; Park MT, 2003, J BIOL CHEM, V278, P50624, DOI 10.1074/jbc.M309011200; Paumelle R, 2000, MOL BIOL CELL, V11, P3751, DOI 10.1091/mbc.11.11.3751; Pink JJ, 2000, J BIOL CHEM, V275, P5416, DOI 10.1074/jbc.275.8.5416; Pink JJ, 2000, EXP CELL RES, V255, P144, DOI 10.1006/excr.1999.4790; Planchon SM, 1999, ONCOL REP, V6, P485; Preston TJ, 2001, ADV DRUG DELIVER REV, V49, P45, DOI 10.1016/S0169-409X(01)00127-2; Pu YS, 2004, PROSTATE, V60, P120, DOI 10.1002/pros.20057; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Sakahira H, 1998, NATURE, V391, P96, DOI 10.1038/34214; SEGER R, 1995, FASEB J, V9, P726, DOI 10.1096/fasebj.9.9.7601337; Shiah SG, 1999, CANCER RES, V59, P391; Su LT, 2010, J MOL BIOL, V396, P858, DOI 10.1016/j.jmb.2010.01.014; Sun XG, 2006, CELL CYCLE, V5, P2029, DOI 10.4161/cc.5.17.3312; Szegezdi E, 2006, EMBO REP, V7, P880, DOI 10.1038/sj.embor.7400779; Tagliarino C, 2001, J BIOL CHEM, V276, P19150, DOI 10.1074/jbc.M100730200; Theruvath TP, 2008, TRANSPLANTATION, V85, P1500, DOI 10.1097/TP.0b013e31816fefb5; Toyota H, 2003, CANCER LETT, V189, P221, DOI 10.1016/S0304-3835(02)00552-9; Wada T, 2004, ONCOGENE, V23, P2838, DOI 10.1038/sj.onc.1207556; Wang XZ, 1998, EMBO J, V17, P3619, DOI 10.1093/emboj/17.13.3619; Wuerzberger SM, 1998, CANCER RES, V58, P1876; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326; Yanase N, 2000, J INTERF CYTOK RES, V20, P1121, DOI 10.1089/107999000750053799; Yeo JK, 2002, CANCER LETT, V182, P83, DOI 10.1016/S0304-3835(02)00075-7	54	38	39	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2011	6	6							e21533	10.1371/journal.pone.0021533	http://dx.doi.org/10.1371/journal.pone.0021533			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786FZ	21738692	Green Published, Green Submitted, gold			2022-12-27	WOS:000292290100032
J	Oikonomou, E; Koc, M; Sourkova, V; Andera, L; Pintzas, A				Oikonomou, Eftychia; Koc, Michal; Sourkova, Vladimira; Andera, Ladislav; Pintzas, Alexander			Selective BRAFV600E Inhibitor PLX4720, Requires TRAIL Assistance to Overcome Oncogenic PIK3CA Resistance	PLOS ONE			English	Article							COLON-CANCER CELLS; INDUCED APOPTOSIS; PATHWAY ACTIVATION; MAPK PATHWAY; RECEPTOR; RAF; TRANSFORMATION; MUTATION; KINASE; HSP90	Documented sensitivity of melanoma cells to PLX4720, a selective BRAFV600E inhibitor, is based on the presence of mutant BRAF(V600E) alone, while wt-BRAF or mutated KRAS result in cell proliferation. In colon cancer appearance of oncogenic alterations is complex, since BRAF, like KRAS mutations, tend to co-exist with those in PIK3CA and mutated PI3K has been shown to interfere with the successful application of MEK inhibitors. When PLX4720 was used to treat colon tumours, results were not encouraging and herein we attempt to understand the cause of this recorded resistance and discover rational therapeutic combinations to resensitize oncogene driven tumours to apoptosis. Treatment of two genetically different BRAF(V600E) mutant colon cancer cell lines with PLX4720 conferred complete resistance to cell death. Even though p-MAPK/ERK kinase (MEK) suppression was achieved, TRAIL, an apoptosis inducing agent, was used synergistically in order to achieve cell death by apoptosis in RKOBRAFV600E/PIK3CAH1047 cells. In contrast, for the same level of apoptosis in HT29(BRAFV600E/PIK3CAP449T) cells, TRAIL was combined with 17-AAG, an Hsp90 inhibitor. For cells where PLX4720 was completely ineffective, 17-AAG was alternatively used to target mutant BRAF(V600E). TRAIL dependence on the constitutive activation of BRAF(V600E) is emphasised through the overexpression of BRAF(V600E) in the permissive genetic background of colon adenocarcinoma Caco-2 cells. Pharmacological suppression of the PI3K pathway further enhances the synergistic effect between TRAIL and PLX4720 in RKO cells, indicating the presence of PIK3CA(MT) as the inhibitory factor. Another rational combination includes 17-AAG synergism with TRAIL in a BRAF(V600E) mutant dependent manner to commit cells to apoptosis, through DR5 and the amplification of the apoptotic pathway. We have successfully utilised combinations of two chemically unrelated BRAF(V600E) inhibitors in combination with TRAIL in a BRAF(V600E) mutated background and provided insight for new anti-cancer strategies where the activated PI3KCA mutation oncogene should be suppressed.	[Oikonomou, Eftychia; Pintzas, Alexander] Natl Hellen Res Fdn, Lab Signal Mediated Gene Express, Inst Biol Res & Biotechnol, Athens, Greece; [Koc, Michal; Sourkova, Vladimira; Andera, Ladislav] Czech Acad Sci, Lab Cell Signaling & Apoptosis, Inst Mol Genet, Prague, Czech Republic	National Hellenic Research Foundation; Czech Academy of Sciences; Institute of Molecular Genetics of the Czech Academy of Sciences	Oikonomou, E (corresponding author), Natl Hellen Res Fdn, Lab Signal Mediated Gene Express, Inst Biol Res & Biotechnol, Athens, Greece.	apint@eie.gr	Andera, Ladislav/A-4536-2011; Andera, Ladislav/ABA-3403-2020; Koc, Michal/D-1234-2014	Koc, Michal/0000-0003-0928-4196; Horova, Vladimira/0000-0002-3969-2329	EU [LSHC-CT-2006-037278]	EU(European Commission)	This work was supported by EU grant LSHC-CT-2006-037278 "ONCODEATH'' to AP and LA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JM, 2007, ONCOGENE, V26, P1324, DOI 10.1038/sj.onc.1210220; Basso AD, 2002, J BIOL CHEM, V277, P39858, DOI 10.1074/jbc.M206322200; Dias SD, 2005, CANCER RES, V65, P10686, DOI 10.1158/0008-5472.CAN-05-2632; Drosopoulos KG, 2005, J BIOL CHEM, V280, P22856, DOI 10.1074/jbc.M412483200; Fang JY, 2005, LANCET ONCOL, V6, P322, DOI 10.1016/S1470-2045(05)70168-6; Grbovic OM, 2006, P NATL ACAD SCI USA, V103, P57, DOI 10.1073/pnas.0609973103; Hague A, 2005, BRIT J CANCER, V92, P736, DOI 10.1038/sj.bjc.6602387; Halilovic E, 2010, CANCER RES, V70, P6804, DOI 10.1158/0008-5472.CAN-10-0409; Hatzivassiliou G, 2010, NATURE, V464, P431, DOI 10.1038/nature08833; Heidorn SJ, 2010, CELL, V140, P209, DOI 10.1016/j.cell.2009.12.040; Jin ZY, 2004, J BIOL CHEM, V279, P35829, DOI 10.1074/jbc.M405538200; Kamal A, 2003, NATURE, V425, P407, DOI 10.1038/nature01913; Kischkel FC, 2001, J BIOL CHEM, V276, P46639, DOI 10.1074/jbc.M105102200; Kopetz S, 2010, J CLIN ONCOL S, V28, p15s; Li WQ, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-2; LoPiccolo J, 2008, DRUG RESIST UPDATE, V11, P32, DOI 10.1016/j.drup.2007.11.003; Lowe SW, 2004, NATURE, V432, P307, DOI 10.1038/nature03098; MacFarlane M, 2003, TOXICOL LETT, V139, P89, DOI 10.1016/S0378-4274(02)00422-8; Michl P, 2005, Z GASTROENTEROL, V43, P1133, DOI 10.1055/s-2005-858638; Oikonomou E, 2007, BRIT J CANCER, V97, P73, DOI 10.1038/sj.bjc.6603835; Oikonomou E, 2009, NEOPLASIA, V11, P1116, DOI 10.1593/neo.09514; Opel D, 2011, CLIN CANCER RES, V17, P3233, DOI 10.1158/1078-0432.CCR-10-2530; Park WS, 2001, GASTROENTEROLOGY, V121, P1219, DOI 10.1053/gast.2001.28663; Poulikakos PI, 2010, NATURE, V464, P427, DOI 10.1038/nature08902; Qiao L, 2001, MOL BIOL CELL, V12, P2629, DOI 10.1091/mbc.12.9.2629; Roberts ML, 2006, INT J CANCER, V118, P616, DOI 10.1002/ijc.21386; Roninson IB, 2001, DRUG RESIST UPDATE, V4, P303, DOI 10.1054/drup.2001.0213; Rychahou PG, 2005, SURGERY, V138, P391, DOI 10.1016/j.surg.2005.05.012; Schwartsmann G, 2005, LANCET ONCOL, V6, P444, DOI 10.1016/S1470-2045(05)70226-6; She QB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003065; Siegelin MD, 2009, NEUROBIOL DIS, V33, P243, DOI 10.1016/j.nbd.2008.10.005; Solit DB, 2006, NATURE, V439, P358, DOI 10.1038/nature04304; Suliman A, 2001, ONCOGENE, V20, P2122, DOI 10.1038/sj.onc.1204282; Tominaga K, 2004, ALIMENT PHARM THER, V20, P143, DOI 10.1111/j.1365-2036.2004.01986.x; Tran SEF, 2001, J BIOL CHEM, V276, P16484, DOI 10.1074/jbc.M010384200; Tsai J, 2008, P NATL ACAD SCI USA, V105, P3041, DOI 10.1073/pnas.0711741105; Vaculova A, 2006, FEBS LETT, V580, P6565, DOI 10.1016/j.febslet.2006.11.004; Vasilevskaya IA, 2005, BIOCHEM PHARMACOL, V70, P580, DOI 10.1016/j.bcp.2005.05.018; Walczak H, 1999, NAT MED, V5, P157, DOI 10.1038/5517; Wee S, 2009, CANCER RES, V69, P4286, DOI 10.1158/0008-5472.CAN-08-4765; Wertz IE, 2010, CELL DEATH DIFFER, V17, P14, DOI 10.1038/cdd.2009.168; Ziegler U, 2004, NEWS PHYSIOL SCI, V19, P124, DOI 10.1152/nips.01519.2004	42	33	35	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2011	6	6							e21632	10.1371/journal.pone.0021632	http://dx.doi.org/10.1371/journal.pone.0021632			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	783OD	21738740	Green Published, Green Submitted, gold			2022-12-27	WOS:000292092600065
J	Murillo-Rodriguez, E; Palomero-Rivero, M; Millan-Aldaco, D; Arias-Carrion, O; Drucker-Colin, R				Murillo-Rodriguez, Eric; Palomero-Rivero, Marcela; Millan-Aldaco, Diana; Arias-Carrion, Oscar; Drucker-Colin, Rene			Administration of URB597, Oleoylethanolamide or Palmitoylethanolamide Increases Waking and Dopamine in Rats	PLOS ONE			English	Article							SLEEP-WAKE CYCLE; RECEPTOR ANTAGONIST; ANANDAMIDE; MODULATION; PROJECTIONS; NUCLEUS	Background: Oleoylethanolamide (OEA) and palmitoylethanolamide (PEA) are amides of fatty acids and ethanolamine named N-acylethanolamines or acylethanolamides. The hydrolysis of OEA and PEA is catalyzed by the fatty acid amide hydrolase (FAAH). A number of FAAH inhibitors that increase the levels of OEA and PEA in the brain have been developed, including URB597. In the present report, we examined whether URB597, OEA or PEA injected into wake-related brain areas, such as lateral hypothalamus (LH) or dorsal raphe nuclei (DRN) would promote wakefulness (W) in rats. Methodology and Principal Findings: Male Wistar rats (250-300 g) were implanted for sleep studies with electrodes to record the electroencephalogram and electromyogram as well as a cannulae aimed either into LH or into DRN. Sleep stages were scored to determine W, slow wave sleep (SWS) and rapid eye movement sleep (REMS). Power spectra bands underly neurophysiological mechanisms of the sleep-wake cycle and provide information about quality rather than quantity of sleep, thus fast Fourier transformation analysis was collected after the pharmacological trials for alpha (for W; alpha = 8-12 Hz), delta (for SWS; delta = 0.5-4.0 Hz) and theta (for REMS; theta = 6.0-12.0 Hz). Finally, microdialysis samples were collected from a cannula placed into the nucleus accumbens (AcbC) and the levels of dopamine (DA) were determined by HPLC means after the injection of URB597, OEA or PEA. We found that microinjection of compounds (10, 20, 30 mu g/1 mu L; each) into LH or DRN during the lights-on period increased W and decreased SWS as well as REMS and enhanced DA extracellular levels. Conclusions: URB597, OEA or PEA promoted waking and enhanced DA if injected into LH or DRN. The wake-promoting effects of these compounds could be linked with the enhancement in levels of DA and indirectly mediated by anandamide.	[Murillo-Rodriguez, Eric] Univ Anahuac Mayab, Div Ciencias Salud, Escuela Med, Lab Neurociencias Mol & Integrat, Merida, Yucatan, Mexico; [Palomero-Rivero, Marcela; Millan-Aldaco, Diana; Drucker-Colin, Rene] Univ Nacl Autonoma Mexico, Inst Fisiol Celular, Div Neurociencias, Mexico City 04510, DF, Mexico; [Arias-Carrion, Oscar] Univ Marburg, Dept Neurol, Marburg, Germany	Universidad Nacional Autonoma de Mexico; Philipps University Marburg	Murillo-Rodriguez, E (corresponding author), Univ Anahuac Mayab, Div Ciencias Salud, Escuela Med, Lab Neurociencias Mol & Integrat, Merida, Yucatan, Mexico.	eric.murillo@anahuac.mx	Arias-Carrion, Oscar/J-2801-2012; Arias-Carrion, Oscar/A-4248-2018	Arias-Carrion, Oscar/0000-0002-9982-7571	UNAM/DGAPA/PAPIIT [IN208206-2]; FIDEICOMISO UNAM; CONACyT [79009]	UNAM/DGAPA/PAPIIT(Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT)Universidad Nacional Autonoma de Mexico); FIDEICOMISO UNAM; CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	Supported by UNAM/DGAPA/PAPIIT (IN208206-2) and FIDEICOMISO UNAM (R. D.-C.) and CONACyT (79009; E.M.-R.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn K, 2008, CHEM REV, V108, P1687, DOI 10.1021/cr0782067; Calignano A, 2001, EUR J PHARMACOL, V419, P191, DOI 10.1016/S0014-2999(01)00988-8; Capasso R, 2001, BRIT J PHARMACOL, V134, P945, DOI 10.1038/sj.bjp.0704339; Corsi-Cabrera M, 2001, SLEEP, V24, P374, DOI 10.1093/sleep/24.4.374; de Fonseca FR, 2001, NATURE, V414, P209, DOI 10.1038/35102582; Dzirasa K, 2006, J NEUROSCI, V26, P10577, DOI 10.1523/JNEUROSCI.1767-06.2006; Fegley D, 2005, J PHARMACOL EXP THER, V313, P352, DOI 10.1124/jpet.104.078980; Fu J, 2003, NATURE, V425, P90, DOI 10.1038/nature01921; Gaetani S, 2003, NEUROPSYCHOPHARMACOL, V28, P1311, DOI 10.1038/sj.npp.1300166; HABER SN, 1985, J COMP NEUROL, V235, P322, DOI 10.1002/cne.902350304; Hansen HS, 2010, EXP NEUROL, V224, P48, DOI 10.1016/j.expneurol.2010.03.022; Jones BE, 2005, TRENDS PHARMACOL SCI, V26, P578, DOI 10.1016/j.tips.2005.09.009; Kathuria S, 2003, NAT MED, V9, P76, DOI 10.1038/nm803; Llinas RR, 2006, J NEUROPHYSIOL, V95, P3297, DOI 10.1152/jn.00166.2006; Lo Verme J, 2005, MOL PHARMACOL, V67, P15, DOI 10.1124/mol.104.006353; Monti JM, 2007, SLEEP MED REV, V11, P113, DOI 10.1016/j.smrv.2006.08.003; Monti JM, 2008, PROG BRAIN RES, V172, P625, DOI 10.1016/S0079-6123(08)00929-1; Mor M, 2004, J MED CHEM, V47, P4998, DOI 10.1021/jm031140x; Murillo-Rodniguez E, 2006, LIFE SCI, V79, P30, DOI 10.1016/j.lfs.2005.12.028; Murillo-Rodriguez E, 2008, NEUROSCIENCE, V157, P1, DOI 10.1016/j.neuroscience.2008.08.056; Murillo-Rodriguez E, 2003, SLEEP, V26, P943, DOI 10.1093/sleep/26.8.943; Murillo-Rodriguez E, 2001, NEUROREPORT, V12, P2131, DOI 10.1097/00001756-200107200-00018; Murillo-Rodriguez E, 1998, BRAIN RES, V812, P270, DOI 10.1016/S0006-8993(98)00969-X; Murillo-Rodriguez E, 2008, BEHAV NEUROSCI, V122, P1378, DOI 10.1037/a0013278; Murillo-Rodriguez E, 2007, EUR J PHARMACOL, V562, P82, DOI 10.1016/j.ejphar.2007.01.076; Murillo-Rodriguez E, 2009, CNS NEUROL DISORD-DR, V8, P245, DOI 10.2174/187152709788921654; Paxinos G., 2005, RAT BRAIN STEREOTAXI, V5th Edn, DOI 10.1016/c2009-0-63235-9; Piomelli D, 2006, CNS DRUG REV, V12, P21, DOI 10.1111/j.1527-3458.2006.00021.x; Santucci V, 1996, LIFE SCI, V58, pPL103, DOI 10.1016/0024-3205(95)02319-4; Schmid HHO, 1996, CHEM PHYS LIPIDS, V80, P133, DOI 10.1016/0009-3084(96)02554-6; Schwartz GJ, 2008, CELL METAB, V8, P281, DOI 10.1016/j.cmet.2008.08.005; Steriade M, 2006, NEUROSCIENCE, V137, P1087, DOI 10.1016/j.neuroscience.2005.10.029; STRATFORD TR, 1990, BRAIN RES, V511, P173, DOI 10.1016/0006-8993(90)90239-8; Tarzia G, 2003, J MED CHEM, V46, P2352, DOI 10.1021/jm021119g; ZAHM DS, 1993, J COMP NEUROL, V327, P220, DOI 10.1002/cne.903270205	35	34	37	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2011	6	7							e20766	10.1371/journal.pone.0020766	http://dx.doi.org/10.1371/journal.pone.0020766			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	793HP	21779318	gold, Green Submitted, Green Published			2022-12-27	WOS:000292811300003
J	Garred, MM; Wang, MM; Guo, X; Harrington, CA; Lein, PJ				Garred, Michelle M.; Wang, Michael M.; Guo, Xin; Harrington, Christina A.; Lein, Pamela J.			Transcriptional Responses of Cultured Rat Sympathetic Neurons during BMP-7-Induced Dendritic Growth	PLOS ONE			English	Article							CYCLASE-ACTIVATING POLYPEPTIDE; CEREBRAL CORTICAL-NEURONS; PROTEIN-KINASE-A; B-CELL FACTOR; OSTEOGENIC PROTEIN-1; NEURITE OUTGROWTH; MORPHOLOGICAL-DIFFERENTIATION; SYNAPTOTAGMIN-IV; NEWBORN NEURONS; DOWN-REGULATION	Background: Dendrites are the primary site of synapse formation in the vertebrate nervous system; however, relatively little is known about the molecular mechanisms that regulate the initial formation of primary dendrites. Embryonic rat sympathetic neurons cultured under defined conditions extend a single functional axon, but fail to form dendrites. Addition of bone morphogenetic proteins (BMPs) triggers these neurons to extend multiple dendrites without altering axonal growth or cell survival. We used this culture system to examine differential gene expression patterns in naive vs. BMP-treated sympathetic neurons in order to identify candidate genes involved in regulation of primary dendritogenesis. Methodology/Principal Findings: To determine the critical transcriptional window during BMP-induced dendritic growth, morphometric analysis of microtubule-associated protein (MAP-2)-immunopositive processes was used to quantify dendritic growth in cultures exposed to the transcription inhibitor actinomycin-D added at varying times after addition of BMP-7. BMP-7-induced dendritic growth was blocked when transcription was inhibited within the first 24 hr after adding exogenous BMP-7. Thus, total RNA was isolated from sympathetic neurons exposed to three different experimental conditions: (1) no BMP-7 treatment; (2) treatment with BMP-7 for 6 hr; and (3) treatment with BMP-7 for 24 hr. Affymetrix oligonucleotide microarrays were used to identify differential gene expression under these three culture conditions. BMP-7 significantly regulated 56 unique genes at 6 hr and 185 unique genes at 24 hr. Bioinformatic analyses implicate both established and novel genes and signaling pathways in primary dendritogenesis. Conclusions/Significance: This study provides a unique dataset that will be useful in generating testable hypotheses regarding transcriptional control of the initial stages of dendritic growth. Since BMPs selectively promote dendritic growth in central neurons as well, these findings may be generally applicable to dendritic growth in other neuronal cell types.	[Garred, Michelle M.; Harrington, Christina A.] Oregon Hlth & Sci Univ, Portland, OR 97201 USA; [Wang, Michael M.] Univ Michigan, Dept Neurol, VA Ann Arbor Healthcare Syst, Ann Arbor, MI USA; [Wang, Michael M.] Univ Michigan, Dept Mol & Integrat Physiol, VA Ann Arbor Healthcare Syst, Ann Arbor, MI 48109 USA; [Guo, Xin] Johns Hopkins Univ, Dept Environm Hlth Sci, Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA; [Lein, Pamela J.] Univ Calif Davis, Sch Vet Med, Dept Mol Biosci, Davis, CA 95616 USA	Oregon Health & Science University; University of Michigan System; University of Michigan; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System; University of Michigan System; University of Michigan; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of California System; University of California Davis	Garred, MM (corresponding author), Millennium Sci, Melbourne, Vic, Australia.	pjlein@ucdavis.edu		Lein, Pamela/0000-0001-7665-7584	National Institutes of Health [R21 NS45037, R01 ES014901, K02 NS054724]; Burroughs Wellcome Fund; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES014901] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS045037, K02NS054724] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund(Burroughs Wellcome Fund); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by funding from the National Institutes of Health (grants R21 NS45037 to PJL and MMW; R01 ES014901 to PJL; and K02 NS054724 to MMW) and the Burroughs Wellcome Fund (Career Award in Biomedical Sciences to MMW). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Abe E, 2000, J BONE MINER RES, V15, P663, DOI 10.1359/jbmr.2000.15.4.663; Aglah C, 2008, NEUROPHARMACOLOGY, V55, P8, DOI 10.1016/j.neuropharm.2008.04.005; [Anonymous], [No title captured]; Appaiah H, 2010, CANCER BIOL THER, V10, P600, DOI 10.4161/cbt.10.6.12586; Banisadr G, 2002, EUR J NEUROSCI, V16, P1661, DOI 10.1046/j.1460-9568.2002.02237.x; Beck HN, 2001, BMC NEUROSCI, V2, DOI 10.1186/1471-2202-2-12; Benson DL, 1996, J NEUROCYTOL, V25, P181, DOI 10.1007/BF02284795; BergerSweeney J, 1997, BEHAV BRAIN RES, V86, P121, DOI 10.1016/S0166-4328(96)02251-6; Bernstein HG, 1999, J NEUROCYTOL, V28, P655, DOI 10.1023/A:1007056731551; Bianchi LM, 2005, JARO-J ASSOC RES OTO, V6, P355, DOI 10.1007/s10162-005-0013-8; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Brann AB, 1999, J NEUROSCI, V19, P8199; Breunig JJ, 2007, P NATL ACAD SCI USA, V104, P20558, DOI 10.1073/pnas.0710156104; BRUCKENSTEIN DA, 1988, DEV BIOL, V128, P324, DOI 10.1016/0012-1606(88)90295-3; Chang CB, 2003, DEV BIOL, V255, P1, DOI 10.1016/S0012-1606(02)00075-1; CHIARAMELLO A, 1995, MOL CELL BIOL, V15, P6036; Choi WS, 2001, BIOCHEM BIOPH RES CO, V287, P656, DOI 10.1006/bbrc.2001.5649; CLEVELAND DW, 1981, CELL, V25, P537, DOI 10.1016/0092-8674(81)90072-6; Connors SL, 2008, PEDIATR NEUROL, V38, P163, DOI 10.1016/j.pediatrneurol.2007.10.009; Corty MM, 2009, DEVELOPMENT, V136, P1049, DOI 10.1242/dev.014423; CRAIG AM, 1994, ANNU REV NEUROSCI, V17, P267, DOI 10.1146/annurev.ne.17.030194.001411; DEBERNARDO AP, 1995, DEV BIOL, V169, P65, DOI 10.1006/dbio.1995.1127; DERUITER JP, 1987, BRAIN RES, V402, P217, DOI 10.1016/0006-8993(87)90028-X; Deuel TAS, 2006, NEURON, V49, P41, DOI 10.1016/j.neuron.2005.10.038; Dijkmans TF, 2009, BRAIN RES, V1249, P19, DOI 10.1016/j.brainres.2008.10.050; Drahushuk K, 2002, J NEUROSCI, V22, P6560; Esquenazi S, 2002, EXP NEUROL, V176, P41, DOI 10.1006/exnr.2002.7906; Flood D.G., 1990, PROG BRAIN RES, P435; Gao FB, 2003, TRENDS NEUROSCI, V26, P262, DOI 10.1016/S0166-2236(03)00078-X; Gazzerro E, 1998, J CLIN INVEST, V102, P2106, DOI 10.1172/JCI3459; Gehler S, 2004, J NEUROSCI, V24, P4363, DOI 10.1523/JNEUROSCI.0404-04.2004; Gisler R, 2002, J IMMUNOL, V168, P5130, DOI 10.4049/jimmunol.168.10.5130; Gratacos E, 2002, J NEUROSCI RES, V70, P638, DOI 10.1002/jnr.10438; Guo X, 1998, NEUROSCI LETT, V245, P131, DOI 10.1016/S0304-3940(98)00192-X; Guo X, 2001, J NEUROBIOL, V48, P120, DOI 10.1002/neu.1046; Harada A, 2002, J CELL BIOL, V158, P541, DOI 10.1083/jcb.200110134; Hartmann M, 2004, J CELL SCI, V117, P5803, DOI 10.1242/jcs.01511; Hay E, 2000, J CELL PHYSIOL, V183, P117, DOI 10.1002/(SICI)1097-4652(200004)183:1<117::AID-JCP14>3.0.CO;2-#; Higgins D, 1997, CURR OPIN NEUROBIOL, V7, P599, DOI 10.1016/S0959-4388(97)80078-5; Higgins D., 1991, CULTURING NERVE CELL, P177; Hocking JC, 2008, MOL CELL NEUROSCI, V37, P247, DOI 10.1016/j.mcn.2007.09.011; Ibata K, 2000, J NEUROCHEM, V74, P518, DOI 10.1046/j.1471-4159.2000.740518.x; Ibata K, 2002, NEUROSCI RES, V43, P401, DOI 10.1016/S0168-0102(02)00066-4; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; IWASAKI Y, 1994, J NEUROL SCI, V125, P11, DOI 10.1016/0022-510X(94)90235-6; JAGADHA V, 1989, CAN J NEUROL SCI, V16, P41, DOI 10.1017/S0317167100028493; Jin KL, 2006, J NEUROBIOL, V66, P236, DOI 10.1002/neu.20215; Kameda T, 1999, GENES CELLS, V4, P175, DOI 10.1046/j.1365-2443.1999.00250.x; Kang YB, 2003, MOL CELL, V11, P915, DOI 10.1016/S1097-2765(03)00109-6; Kim JH, 2005, FASEB J, V19, P109, DOI 10.1096/fj.05-4826fje; Kim WY, 2009, J NEUROCHEM, V108, P1057, DOI 10.1111/j.1471-4159.2008.05854.x; KIMURA H, 1992, J CELL BIOL, V116, P777, DOI 10.1083/jcb.116.3.777; Knofler M, 2002, BIOCHEM J, V361, P641, DOI 10.1042/0264-6021:3610641; KNUTSEN R, 1995, ENDOCRINOLOGY, V136, P857, DOI 10.1210/en.136.3.857; Lakshmana MK, 1998, BRAIN RES, V796, P38, DOI 10.1016/S0006-8993(98)00312-6; Lee MJ, 2003, J IMMUNOL, V170, P2557, DOI 10.4049/jimmunol.170.5.2557; Lein P, 1996, INT J DEV NEUROSCI, V14, P203, DOI 10.1016/0736-5748(96)00008-1; LEIN P, 1995, NEURON, V15, P597, DOI 10.1016/0896-6273(95)90148-5; Lein PJ, 2007, J NEUROSCI, V27, P4725, DOI 10.1523/JNEUROSCI.5633-06.2007; Levkovitz Y, 2001, J NEUROSCI, V21, P45, DOI 10.1523/JNEUROSCI.21-01-00045.2001; Licht T, 2010, DEVELOPMENT, V137, P261, DOI 10.1242/dev.039636; Lonn P, 2005, NEUROCHEM RES, V30, P753, DOI 10.1007/s11064-005-6868-6; Lopez-Coviella I, 2005, P NATL ACAD SCI USA, V102, P6984, DOI 10.1073/pnas.0502097102; Maussion G, 2008, HUM MOL GENET, V17, P2541, DOI 10.1093/hmg/ddn154; McAvoy T, 2009, P NATL ACAD SCI USA, V106, P3531, DOI 10.1073/pnas.0813263106; Metzger F, 2010, Curr Mol Pharmacol, V3, P1; MILLER JP, 1984, J EXP BIOL, V112, P129; Miyashita M, 2004, MOL BIOL CELL, V15, P3950, DOI 10.1091/mbc.E04-01-0019; Miyazono Kohei, 2002, Sci STKE, V2002, ppe40, DOI 10.1126/stke.2002.151.pe40; Moon JI, 2008, DEV BIOL, V315, P404, DOI 10.1016/j.ydbio.2007.12.041; Ohno K, 2009, J NEUROCHEM, V111, P790, DOI 10.1111/j.1471-4159.2009.06370.x; Opatz J, 2009, MOL CELL NEUROSCI, V40, P293, DOI 10.1016/j.mcn.2008.11.002; Ou YM, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-16; Pardo CA, 2007, BRAIN PATHOL, V17, P434, DOI 10.1111/j.1750-3639.2007.00102.x; Pavelock KA, 2007, J NEUROCHEM, V100, P603, DOI 10.1111/j.1471-4159.2006.04293.x; Prieto AL, 2007, NEUROSCIENCE, V150, P319, DOI 10.1016/j.neuroscience.2007.09.047; Purpura DP., 1967, NEUROSCIENCES A STUD, P372; PURVES D, 1975, J PHYSIOL-LONDON, V252, P429, DOI 10.1113/jphysiol.1975.sp011151; Quartu M, 2007, BRAIN RES, V1173, P36, DOI 10.1016/j.brainres.2007.07.064; Rao BSS, 1999, BRAIN RES, V821, P218, DOI 10.1016/S0006-8993(98)01362-6; Read DE, 2008, BRAIN RES, V1221, P14, DOI 10.1016/j.brainres.2008.05.028; Redmond L, 2001, CURR OPIN NEUROBIOL, V11, P111, DOI 10.1016/S0959-4388(00)00181-1; Salama-Cohen P, 2006, J NEUROCHEM, V97, P1269, DOI 10.1111/j.1471-4159.2006.03783.x; Schiller MR, 1996, J HISTOCHEM CYTOCHEM, V44, P1489, DOI 10.1177/44.12.8985141; Schuman EM, 1997, NEURON, V18, P339, DOI 10.1016/S0896-6273(00)81234-9; Scott EK, 2001, NAT NEUROSCI, V4, P359, DOI 10.1038/86006; Scott IC, 2000, MOL CELL BIOL, V20, P530, DOI 10.1128/MCB.20.2.530-541.2000; Seijffers R, 2006, MOL CELL NEUROSCI, V32, P143, DOI 10.1016/j.mcn.2006.03.005; Sejnowski T, 1997, SCIENCE, V275, P178, DOI 10.1126/science.275.5297.178; SHARMA E, 1995, J BIOL CHEM, V270, P49, DOI 10.1074/jbc.270.1.49; Sikder H, 2003, CANCER CELL, V4, P291, DOI 10.1016/S1535-6108(03)00245-9; Sivertsen EA, 2007, EUR J IMMUNOL, V37, P2937, DOI 10.1002/eji.200636759; Smith DL, 2009, P NATL ACAD SCI USA, V106, P16877, DOI 10.1073/pnas.0908706106; Smith EMK, 2002, J IMMUNOL, V169, P261, DOI 10.4049/jimmunol.169.1.261; Smith KE, 2006, J NEUROSCI, V26, P2391, DOI 10.1523/JNEUROSCI.3092-05.2006; Sparrow DB, 1998, MECH DEVELOP, V71, P151, DOI 10.1016/S0925-4773(98)00010-0; Spilker C, 2003, MOL CELL NEUROSCI, V24, P766, DOI 10.1016/S1044-7431(03)00242-2; Svitkina T, 2010, J NEUROSCI, V30, P14937, DOI 10.1523/JNEUROSCI.4276-10.2010; Tan ZJ, 2010, P NATL ACAD SCI USA, V107, P9873, DOI 10.1073/pnas.1003480107; Thal MA, 2009, P NATL ACAD SCI USA, V106, P552, DOI 10.1073/pnas.0802550106; TROPEA M, 1988, GLIA, V1, P380, DOI 10.1002/glia.440010605; Urbanska M, 2008, ACTA NEUROBIOL EXP, V68, P264; Van Aelst L, 2004, CURR OPIN NEUROBIOL, V14, P297, DOI 10.1016/j.conb.2004.05.012; VYAS S, 1994, FEBS LETT, V351, P53, DOI 10.1016/0014-5793(94)00821-3; Wang YQ, 2009, NEUROCHEM INT, V55, P629, DOI 10.1016/j.neuint.2009.06.007; Wei QZ, 1997, J NEUROSCI RES, V50, P618; Williams ME, 2010, NEURON, V68, P9, DOI 10.1016/j.neuron.2010.09.007; Withers GS, 2000, EUR J NEUROSCI, V12, P106, DOI 10.1046/j.1460-9568.2000.00889.x; Wu XD, 2002, GENE EXPRESSION, V10, P279, DOI 10.3727/000000002783992361; Yabe T, 2002, J NEUROSCI RES, V68, P161, DOI 10.1002/jnr.10210; Yeh LCC, 1997, ENDOCRINOLOGY, V138, P4181, DOI 10.1210/en.138.10.4181; Yeh LCC, 1999, MOL CELL ENDOCRINOL, V153, P113, DOI 10.1016/S0303-7207(99)00076-3; Zheng Y, 2009, BIOCHEM BIOPH RES CO, V378, P371, DOI 10.1016/j.bbrc.2008.11.049; Zoghbi HY, 2003, SCIENCE, V302, P826, DOI 10.1126/science.1089071	114	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2011	6	7							e21754	10.1371/journal.pone.0021754	http://dx.doi.org/10.1371/journal.pone.0021754			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	792WQ	21765909	Green Published, gold			2022-12-27	WOS:000292781500012
J	Mahowald, GK; Mahowald, MA; Moon, C; Khor, B; Sleckman, BP				Mahowald, Grace K.; Mahowald, Michael A.; Moon, Clara; Khor, Bernard; Sleckman, Barry P.			Out-of-Frame T Cell Receptor Beta Transcripts Are Eliminated by Multiple Pathways In Vivo	PLOS ONE			English	Article							NONSENSE-MEDIATED DECAY; CHROMOSOMAL V(D)J RECOMBINATION; EXON JUNCTION COMPLEX; MESSENGER-RNA DECAY; CYTOPLASMIC TRANSLATION; REGULATORY MECHANISM; PROTEIN-SYNTHESIS; CODONS; INTRON; GENES	Non-productive antigen receptor genes with frame shifts generated during the assembly of these genes are found in many mature lymphocytes. Transcripts from these genes have premature termination codons (PTCs) and could encode truncated proteins if they are not either inactivated or destroyed by nonsense-mediated decay (NMD). In mammalian cells, NMD can be activated by pathways that rely on the presence of an intron downstream of the PTC; however, NMD can also be activated by pathways that do not rely on these downstream introns, and pathways independent of NMD can inactivate PTC-containing transcripts. Here, through the generation and analysis of mice with gene-targeted modifications of the endogenous T cell receptor beta (Tcrb) locus, we demonstrate that in T cells in vivo, optimal clearance of PTC-containing Tcrb transcripts depends on the presence of an intron downstream of the PTC.	[Mahowald, Grace K.; Mahowald, Michael A.; Moon, Clara; Khor, Bernard; Sleckman, Barry P.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63130 USA	Washington University (WUSTL)	Mahowald, GK (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63130 USA.	Sleckman@immunology.wustl.edu		Mahowald, Grace/0000-0003-4541-4920; Khor, Bernard/0000-0003-4689-5092; Moon, Clara/0000-0003-2076-9282	National Institutes of Health (NIH) [AI47829]; National Center for Research Resources (NCRR) [RR012466]; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR012466] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI047829] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR048335] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work is supported by National Institutes of Health (NIH) grant AI47829 (B. P. S.). Mice were produced by a transgenic core facility supported by the Rheumatic Diseases Core Center at Washington University (NIH P30-AR48335) and housed in a facility supported by National Center for Research Resources (NCRR) grant RR012466. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoufouchi S, 1996, CELL, V85, P415, DOI 10.1016/S0092-8674(00)81119-8; Bassing CH, 2000, NATURE, V405, P583, DOI 10.1038/35014635; Bassing CH, 2002, CELL, V109, pS45, DOI 10.1016/S0092-8674(02)00675-X; Brady BL, 2010, J IMMUNOL, V185, P3801, DOI 10.4049/jimmunol.1001158; Brocke KS, 2002, HUM MOL GENET, V11, P331, DOI 10.1093/hmg/11.3.331; Brogna S, 2009, NAT STRUCT MOL BIOL, V16, P107, DOI 10.1038/nsmb.1550; Buhler M, 2006, NAT STRUCT MOL BIOL, V13, P462, DOI 10.1038/nsmb1081; Carter MS, 1996, EMBO J, V15, P5965, DOI 10.1002/j.1460-2075.1996.tb00983.x; CARTER MS, 1995, J BIOL CHEM, V270, P28995, DOI 10.1074/jbc.270.48.28995; Chang YF, 2007, J BIOL CHEM, V282, P29738, DOI 10.1074/jbc.M704372200; Chemin G, 2010, J IMMUNOL, V184, P5009, DOI 10.4049/jimmunol.0902949; CHENG J, 1994, MOL CELL BIOL, V14, P6317, DOI 10.1128/MCB.14.9.6317; Delpy L, 2004, P NATL ACAD SCI USA, V101, P7375, DOI 10.1073/pnas.0305586101; Fugmann SD, 2000, ANNU REV IMMUNOL, V18, P495, DOI 10.1146/annurev.immunol.18.1.495; Glusman G, 2001, IMMUNITY, V15, P337, DOI 10.1016/S1074-7613(01)00200-X; Imam JS, 2010, NUCLEIC ACIDS RES, V38, P1559, DOI 10.1093/nar/gkp1115; Khor B, 2005, EUR J IMMUNOL, V35, P964, DOI 10.1002/eji.200425806; Khor B, 2009, MOL IMMUNOL, V46, P321, DOI 10.1016/j.molimm.2008.10.030; Le Hir H, 2001, EMBO J, V20, P4987, DOI 10.1093/emboj/20.17.4987; LOZANO F, 1994, EMBO J, V13, P4617, DOI 10.1002/j.1460-2075.1994.tb06783.x; Mahowald GK, 2009, P NATL ACAD SCI USA, V106, P18339, DOI 10.1073/pnas.0902545106; Maquat LE, 2002, GENE DEV, V16, P1743, DOI 10.1101/gad.1014502; Maquat LE, 2001, RNA, V7, P445, DOI 10.1017/S1355838201002229; Matsuda D, 2007, NAT STRUCT MOL BIOL, V14, P974, DOI 10.1038/nsmb1297; Nagy E, 1998, TRENDS BIOCHEM SCI, V23, P198, DOI 10.1016/S0968-0004(98)01208-0; Neu-Yilik G, 2001, EMBO J, V20, P532, DOI 10.1093/emboj/20.3.532; Tange TO, 2004, CURR OPIN CELL BIOL, V16, P279, DOI 10.1016/j.ceb.2004.03.012; Thermann R, 1998, EMBO J, V17, P3484, DOI 10.1093/emboj/17.12.3484; Valentine CR, 1998, MUTAT RES-REV MUTAT, V411, P87, DOI 10.1016/S1383-5742(98)00010-6; Wang J, 2002, MOL CELL, V10, P951, DOI 10.1016/S1097-2765(02)00635-4; Wang J, 2002, EMBO REP, V3, P274, DOI 10.1093/embo-reports/kvf036; Weischenfeldt J, 2008, GENE DEV, V22, P1381, DOI 10.1101/gad.468808; Zhang J, 1998, MOL CELL BIOL, V18, P5272, DOI 10.1128/MCB.18.9.5272; Zhang J, 1998, RNA, V4, P801, DOI 10.1017/S1355838298971849	34	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2011	6	7							e21627	10.1371/journal.pone.0021627	http://dx.doi.org/10.1371/journal.pone.0021627			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	792WQ	21765899	Green Published, Green Submitted, gold			2022-12-27	WOS:000292781500005
J	Seregin, SS; Aldhamen, YA; Appledorn, DM; Aylsworth, CF; Godbehere, S; Liu, CJJ; Quiroga, D; Amalfitano, A				Seregin, Sergey S.; Aldhamen, Yasser A.; Appledorn, Daniel M.; Aylsworth, Charles F.; Godbehere, Sarah; Liu, Chyong-Jy Joyce; Quiroga, Dionisia; Amalfitano, Andrea			TRIF Is a Critical Negative Regulator of TLR Agonist Mediated Activation of Dendritic Cells In Vivo	PLOS ONE			English	Article							ADAPTIVE IMMUNE-RESPONSES; ALUMINUM-CONTAINING ADJUVANTS; TOLL-LIKE RECEPTORS; EIMERIA-ACERVULINA; VACCINE ADJUVANTS; LIPOPOLYSACCHARIDE; MACROPHAGES; INFECTION; PATHWAYS; PROTEIN	Despite recent advances in developing and licensing adjuvants, there is a great need for more potent formulations to enhance immunogenicity of vaccines. An Eimeria tenella derived antigen (rEA) augments immune responses against several pathogens in animal models and recently was confirmed to be safe for human use. In this study, we have analyzed the molecular mechanisms underlying rEA activity in mice, and confirmed that rEA activates multiple immune cell types, including DCs, macrophages, NK, B, and T cells. The rEA adjuvant also elicits the induction of pleiotropic pro-inflammatory cytokines, responses that completely depend upon the presence of the TLR adaptor protein MyD88. Surprisingly, we also found that the TRIF adaptor protein acts as a potent negative regulator of TLR agonist-triggered immune responses. For example, IL12 production and the induction of co-stimulatory molecule expression by DCs and IFN gamma production by NK cells in vivo were significantly increased in rEA-treated TRIF-KO mice. Importantly, however, TRIF suppressive effects were not restricted to rEA-mediated responses, but were apparent in LPS- or ODN2006-activated DCs as well. Taken together, our findings confirm that rEA is a potent adjuvant, triggering robust activation of the innate immune system, in a manner that is augmented by MyD88 and inhibited by TRIF; thereby unveiling the potential complexities of modulating TLR activity to augment vaccine efficacy.	[Seregin, Sergey S.; Aldhamen, Yasser A.; Appledorn, Daniel M.; Aylsworth, Charles F.; Godbehere, Sarah; Liu, Chyong-Jy Joyce; Quiroga, Dionisia; Amalfitano, Andrea] Michigan State Univ, Coll Osteopath Med, Dept Pediat, Dept Microbiol & Mol Genet, E Lansing, MI 48824 USA	Michigan State University; Michigan State University College of Osteopathic Medicine	Seregin, SS (corresponding author), Michigan State Univ, Coll Osteopath Med, Dept Pediat, Dept Microbiol & Mol Genet, E Lansing, MI 48824 USA.	amalfit1@msu.edu	Quiroga, Dionisia/ABH-7893-2020	Quiroga, Dionisia/0000-0003-3388-7069; Aldhamen, Yasser/0000-0002-9560-8013	National Institutes of Health [RO1DK-069884, P01 CA078673]; MSU Foundation; Osteopathic Heritage Foundation; NATIONAL CANCER INSTITUTE [P01CA078673] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK069884] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MSU Foundation; Osteopathic Heritage Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	National Institutes of Health grants RO1DK-069884, P01 CA078673, the MSU Foundation (http://www.msufoundation.msu.edu/) as well the Osteopathic Heritage Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appledorn DM, 2009, J INNATE IMMUN, V1, P376, DOI 10.1159/000207194; Appledorn DM, 2008, J IMMUNOL, V181, P2134, DOI 10.4049/jimmunol.181.3.2134; Appledorn DM, 2010, PLOS ONE, V5, pA130, DOI 10.1371/journal.pone.0009579; APPLEDORN DM, 2010, CLIN VACCINE IMMUNOL; Biswas SK, 2007, J IMMUNOL, V179, P4083, DOI 10.4049/jimmunol.179.6.4083; Blanco P, 2008, CYTOKINE GROWTH F R, V19, P41, DOI 10.1016/j.cytogfr.2007.10.004; Boonstra A, 2006, J IMMUNOL, V177, P7551, DOI 10.4049/jimmunol.177.11.7551; Choi YJ, 2010, J BIOL CHEM, V285, P21382, DOI 10.1074/jbc.M110.115022; Coffman RL, 2010, IMMUNITY, V33, P492, DOI 10.1016/j.immuni.2010.10.002; Conroy H, 2008, ONCOGENE, V27, P168, DOI 10.1038/sj.onc.1210910; Gowen BB, 2006, ANTIMICROB AGENTS CH, V50, P2023, DOI 10.1128/AAC.01473-05; Hartman ZC, 2007, J VIROL, V81, P1796, DOI 10.1128/JVI.01936-06; Hawlisch H, 2006, MOL IMMUNOL, V43, P13, DOI 10.1016/j.molimm.2005.06.028; Hedhli D, 2009, VACCINE, V27, P2274, DOI 10.1016/j.vaccine.2009.01.100; Hem SL, 2007, EXPERT REV VACCINES, V6, P685, DOI 10.1586/14760584.6.5.685; Hoebe K, 2003, NAT IMMUNOL, V4, P1223, DOI 10.1038/ni1010; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; JENKINS MC, 1988, EXP PARASITOL, V66, P96, DOI 10.1016/0014-4894(88)90054-9; Juckett DA, 2008, MED HYPOTHESES, V71, P104, DOI 10.1016/j.mehy.2008.01.024; Kantoff PW, 2010, NEW ENGL J MED, V363, P411, DOI 10.1056/NEJMoa1001294; Kawai T, 2007, SEMIN IMMUNOL, V19, P24, DOI 10.1016/j.smim.2006.12.004; Kenny EF, 2008, CYTOKINE, V43, P342, DOI 10.1016/j.cyto.2008.07.010; Kumar H, 2008, J IMMUNOL, V180, P683, DOI 10.4049/jimmunol.180.2.683; Kumar H, 2009, BIOCHEM BIOPH RES CO, V388, P621, DOI 10.1016/j.bbrc.2009.08.062; Lambrecht BN, 2009, CURR OPIN IMMUNOL, V21, P23, DOI 10.1016/j.coi.2009.01.004; LAURENT F, 1994, MOL BIOCHEM PARASIT, V63, P79, DOI 10.1016/0166-6851(94)90010-8; Lee MS, 2007, ANNU REV BIOCHEM, V76, P447, DOI 10.1146/annurev.biochem.76.060605.122847; Liu MA, 2010, IMMUNITY, V33, P504, DOI 10.1016/j.immuni.2010.10.004; Loniewski KJ, 2007, MOL IMMUNOL, V44, P3715, DOI 10.1016/j.molimm.2007.04.002; Mbow ML, 2010, CURR OPIN IMMUNOL, V22, P411, DOI 10.1016/j.coi.2010.04.004; McAleer JP, 2009, J IMMUNOL, V182, P5322, DOI 10.4049/jimmunol.0803616; Morefield GL, 2005, VACCINE, V23, P1588, DOI 10.1016/j.vaccine.2004.07.050; Parameswaran N, 2006, J BIOL CHEM, V281, P34159, DOI 10.1074/jbc.M605376200; Power MR, 2007, J IMMUNOL, V178, P3170, DOI 10.4049/jimmunol.178.5.3170; Rader JS, 2008, CLIN CANCER RES, V14, P3089, DOI 10.1158/1078-0432.CCR-07-4250; Rosenberg B, 2005, INT J CANCER, V114, P756, DOI 10.1002/ijc.20801; Seregin SS, 2010, BLOOD, V116, P1669, DOI 10.1182/blood-2010-03-276949; Seregin SS, 2009, MOL THER, V17, P685, DOI 10.1038/mt.2008.297; Tritto E, 2009, VACCINE, V27, P3331, DOI 10.1016/j.vaccine.2009.01.084; Williamson ED, 2002, BRIT MED BULL, V62, P163, DOI 10.1093/bmb/62.1.163; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Yarovinsky F, 2005, SCIENCE, V308, P1626, DOI 10.1126/science.1109893	42	11	12	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2011	6	7							e22064	10.1371/journal.pone.0022064	http://dx.doi.org/10.1371/journal.pone.0022064			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791IA	21760953	Green Published, Green Submitted, gold			2022-12-27	WOS:000292657200043
J	Takeda, K; Mori, A; Yanagida, M				Takeda, Kojiro; Mori, Ayaka; Yanagida, Mitsuhiro			Identification of Genes Affecting the Toxicity of Anti-Cancer Drug Bortezomib by Genome-Wide Screening in S. pombe	PLOS ONE			English	Article							PHASE-PROMOTING FACTOR; FISSION YEAST; SCHIZOSACCHAROMYCES-POMBE; UBIQUITIN LIGASE; PROTEASE SUBUNIT; PATHWAY; HETEROCHROMATIN; DESTRUCTION; MAINTENANCE; TRANSITION	Bortezomib/PS-341/Velcade, a proteasome inhibitor, is widely used to treat multiple myeloma. While several mechanisms of the cytotoxicity of the drug were proposed, the actual mechanism remains elusive. We aimed to identify genes affecting the cytotoxicity of Bortezomib in the fission yeast S. pombe as the drug inhibits this organism's cell division cycle like proteasome mutants. Among the 2815 genes screened (covering 56% of total ORFs), 19 genes, whose deletions induce strong synthetic lethality with Bortezomib, were identified. The products of the 19 genes included four ubiquitin enzymes and one nuclear proteasome factor, and 13 of them are conserved in humans. Our results will provide useful information for understanding the actions of Bortezomib within cells.	[Takeda, Kojiro; Mori, Ayaka; Yanagida, Mitsuhiro] Okinawa Inst Sci & Technol, Cell Unit G0, Okinawa, Japan	Okinawa Institute of Science & Technology Graduate University	Takeda, K (corresponding author), Okinawa Inst Sci & Technol, Cell Unit G0, Okinawa, Japan.	takeda@oist.jp			Astellas Foundation for Research on Metabolic Disorders	Astellas Foundation for Research on Metabolic Disorders	KT was financially supported by the research grant of Astellas Foundation for Research on Metabolic Disorders (http://www.astellas.com/jp/byoutai/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams J, 1999, CANCER RES, V59, P2615; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Chang HJ, 2004, GENETICS, V168, P1899, DOI 10.1534/genetics.104.032961; Chen SQ, 2010, CANCER RES, V70, P4318, DOI 10.1158/0008-5472.CAN-09-4428; D'Angiolella V, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000247; Elliott PJ, 2001, AM J CLIN PATHOL, V116, P637; GOLDBERG AL, 1995, CHEM BIOL, V2, P503, DOI 10.1016/1074-5521(95)90182-5; GORDON C, 1993, NATURE, V366, P355, DOI 10.1038/366355a0; Gordon C, 1996, J BIOL CHEM, V271, P5704, DOI 10.1074/jbc.271.10.5704; Grieco D, 1996, SCIENCE, V271, P1718, DOI 10.1126/science.271.5256.1718; Han TX, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-6-r60; Harada H, 2001, J HUM GENET, V46, P90, DOI 10.1007/s100380170115; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Horn PJ, 2005, GENE DEV, V19, P1705, DOI 10.1101/gad.1328005; Jia ST, 2005, NAT CELL BIOL, V7, P1007, DOI 10.1038/ncb1300; Kennedy PJ, 2008, TOXICOL SCI, V106, P124, DOI 10.1093/toxsci/kfn153; Kim DU, 2010, NAT BIOTECHNOL, V28, P617, DOI 10.1038/nbt.1628; Kominami K, 1997, GENE DEV, V11, P1548, DOI 10.1101/gad.11.12.1548; Kouranti I, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000471; Krogan NJ, 2004, MOL CELL, V16, P1027, DOI 10.1016/j.molcel.2004.11.033; McConkey DJ, 2008, DRUG RESIST UPDATE, V11, P164, DOI 10.1016/j.drup.2008.08.002; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Ogiso Y, 2004, MOL CELL BIOL, V24, P2324, DOI 10.1128/MCB.24.6.2324-2331.2004; Takeda K, 2005, CELL, V122, P393, DOI 10.1016/j.cell.2005.05.023; Takeda K, 2010, P NATL ACAD SCI USA, V107, P3540, DOI 10.1073/pnas.0911055107; Tatebe H, 2000, CURR BIOL, V10, P1329, DOI 10.1016/S0960-9822(00)00773-9; Tatebe H, 2010, CURR BIOL, V20, P1975, DOI 10.1016/j.cub.2010.10.026; Uzunova K, 2007, J BIOL CHEM, V282, P34167, DOI 10.1074/jbc.M706505200; Verma R, 2011, MOL CELL, V41, P82, DOI 10.1016/j.molcel.2010.12.017; Yamashita YM, 1996, NATURE, V384, P276, DOI 10.1038/384276a0	30	24	24	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2011	6	7							e22021	10.1371/journal.pone.0022021	http://dx.doi.org/10.1371/journal.pone.0022021			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791IA	21760946	gold, Green Published, Green Submitted			2022-12-27	WOS:000292657200041
J	Katsouri, L; Georgopoulos, S				Katsouri, Loukia; Georgopoulos, Spiros			Lack of LDL Receptor Enhances Amyloid Deposition and Decreases Glial Response in an Alzheimer's Disease Mouse Model	PLOS ONE			English	Article							DENSITY-LIPOPROTEIN RECEPTOR; APOLIPOPROTEIN-E; BETA DEPOSITION; TRANSGENIC MICE; BRAIN; PATHOLOGY; APOE; CHOLESTEROL; PATHWAYS; PEPTIDE	Background: Apolipoprotein E (ApoE), a cholesterol carrier associated with atherosclerosis, is a major risk factor for Alzheimer's disease (AD). The low-density lipoprotein receptor (LDLR) regulates ApoE levels in the periphery and in the central nervous system. LDLR has been identified on astrocytes and a number of studies show that it modulates amyloid deposition in AD transgenic mice. However these findings are controversial on whether LDLR deletion is beneficial or detrimental on the AD-like phenotype of the transgenic mice. Methodology/Principal Findings: To investigate the role of LDLR in the development of the amyloid related phenotype we used an APP/PS1 transgenic mouse (5XFAD) that develops an AD-like pathology with amyloid plaques, astrocytosis and microgliosis. We found that 4 months old 5XFAD transgenic mice on the LDLR deficient background (LDLR-/-) have increased amyloid plaque deposition. This increase is associated with a significant decrease in astrocytosis and microgliosis in the 5XFAD/LDLR-/- mice. To further elucidate the role of LDLR in relation with ApoE we have generated 5XFAD transgenic mice on the ApoE deficient (ApoE-/-) or the ApoE/LDLR double deficient background (ApoE-/-/LDLR -/-). We have found that ApoE deletion in the 4 months old 5XFAD/ApoE-/- mice decreases amyloid plaque formation as expected, but has no effect on astrocytosis or microgliosis. By comparison 5XFAD/ApoE-/- LDLR -/- double deficient mice of the same age have increased amyloid deposition with decreased astrocytosis and microgliosis. Conclusions: Our analysis shows that LDL deficiency regulates astrocytosis and microgliosis in an AD mouse model. This effect is independent of ApoE, as both 5XFAD/LDLR -/- and 5XFAD/ApoE-/- LDLR -/- mice show reduction in inflammatory response and increase in amyloid deposition compared to control mice. These results demonstrate that LDLR regulates glial response in this mouse model independently of ApoE and modifies amyloid deposition.	[Katsouri, Loukia; Georgopoulos, Spiros] Acad Athens, Biomed Res Fdn, Dept Cell Biol, Athens, Greece	Academy of Athens	Katsouri, L (corresponding author), Acad Athens, Biomed Res Fdn, Dept Cell Biol, Athens, Greece.	sgeorgopoulos@rics.bwh.harvard.edu		Katsouri, Loukia/0000-0003-0186-6116	Ministry of Development of Greece; Pfizer Hellas [PENED 03ED/464]	Ministry of Development of Greece; Pfizer Hellas	This work was supported by a Ministry of Development of Greece Grant and Pfizer Hellas to SG (PENED 03ED/464). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abazov VM, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.051601; ANDERSON JP, 1989, EMBO J, V8, P3627, DOI 10.1002/j.1460-2075.1989.tb08536.x; Bales KR, 1999, P NATL ACAD SCI USA, V96, P15233, DOI 10.1073/pnas.96.26.15233; Bales KR, 1997, NAT GENET, V17, P263, DOI 10.1038/ng1197-263; Bell RD, 2007, J CEREBR BLOOD F MET, V27, P909, DOI 10.1038/sj.jcbfm.9600419; BENJAMIN R, 1994, LANCET, V344, P473, DOI 10.1016/S0140-6736(94)91804-X; Bu GJ, 2009, NAT REV NEUROSCI, V10, P333, DOI 10.1038/nrn2620; Buttini M, 2002, J NEUROSCI, V22, P10539; Callahan MJ, 2001, AM J PATHOL, V158, P1173, DOI 10.1016/S0002-9440(10)64064-3; Cao DF, 2006, NEUROBIOL AGING, V27, P1632, DOI 10.1016/j.neurobiolaging.2005.09.011; Coon KD, 2007, J CLIN PSYCHIAT, V68, P613, DOI 10.4088/JCP.v68n0419; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Fagan AM, 2004, AM J PATHOL, V165, P1413, DOI 10.1016/S0002-9440(10)63399-8; Fryer JD, 2005, J BIOL CHEM, V280, P25754, DOI 10.1074/jbc.M502143200; Herz J, 2000, NAT REV NEUROSCI, V1, P51, DOI 10.1038/35036221; Herz Joachim, 1993, Current Opinion in Lipidology, V4, P107, DOI 10.1097/00041433-199304000-00006; Hirsch-Reinshagen V, 2005, J BIOL CHEM, V280, P43243, DOI 10.1074/jbc.M508781200; HOBBS HH, 1990, ANNU REV GENET, V24, P133, DOI 10.1146/annurev.ge.24.120190.001025; Holtzman DM, 2000, ANN NEUROL, V47, P739, DOI 10.1002/1531-8249(200006)47:6<739::AID-ANA6>3.0.CO;2-8; Holtzman DM, 1999, J CLIN INVEST, V103, pR15, DOI 10.1172/JCI6179; ISHIBASHI S, 1993, J CLIN INVEST, V92, P883, DOI 10.1172/JCI116663; Kashon ML, 2004, J ALZHEIMERS DIS, V6, P595; Kim J, 2009, NEURON, V64, P632, DOI 10.1016/j.neuron.2009.11.013; Kim J, 2009, NEURON, V63, P287, DOI 10.1016/j.neuron.2009.06.026; Lamsa R, 2008, NEUROBIOL AGING, V29, P848, DOI 10.1016/j.neurobiolaging.2006.12.009; Leduc V, 2010, TRENDS MOL MED, V16, P469, DOI 10.1016/j.molmed.2010.07.008; Linton MF, 1999, J BIOL CHEM, V274, P19204, DOI 10.1074/jbc.274.27.19204; Mahley RW, 1999, J LIPID RES, V40, P1; MAHLEY RW, 1988, SCIENCE, V240, P622, DOI 10.1126/science.3283935; Nagele RG, 2004, NEUROBIOL AGING, V25, P663, DOI 10.1016/j.neurobiolaging.2004.01.007; Oakley H, 2006, J NEUROSCI, V26, P10129, DOI 10.1523/JNEUROSCI.1202-06.2006; SELKOE DJ, 1991, NEURON, V6, P487, DOI 10.1016/0896-6273(91)90052-2; Shibata M, 2000, J CLIN INVEST, V106, P1489, DOI 10.1172/JCI10498; Thanopoulou K, 2010, P NATL ACAD SCI USA, V107, P20816, DOI 10.1073/pnas.1005888107; Vina J, 2010, J ALZHEIMERS DIS, V20, pS527, DOI 10.3233/JAD-2010-100501; Wahrle SE, 2005, J BIOL CHEM, V280, P43236, DOI 10.1074/jbc.M508780200; Wang J, 2003, NEUROBIOL DIS, V14, P318, DOI 10.1016/j.nbd.2003.08.009; Yancey PG, 2007, J LIPID RES, V48, P1140, DOI 10.1194/jlr.M600539-JLR200; Zlokovic BV, 2004, J NEUROCHEM, V89, P807, DOI 10.1111/j.1471-4159.2004.02385.x; Zou FG, 2008, HUM MOL GENET, V17, P929, DOI 10.1093/hmg/ddm365	40	43	44	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2011	6	7							e21880	10.1371/journal.pone.0021880	http://dx.doi.org/10.1371/journal.pone.0021880			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791AK	21755005	gold, Green Published, Green Submitted			2022-12-27	WOS:000292632000032
J	Pyenson, ND; Lindberg, DR				Pyenson, Nicholas D.; Lindberg, David R.			What Happened to Gray Whales during the Pleistocene? The Ecological Impact of Sea-Level Change on Benthic Feeding Areas in the North Pacific Ocean	PLOS ONE			English	Article							SHIFTING BASE-LINE; ESCHRICHTIUS-ROBUSTUS; MARINE MAMMALS; CHUKCHI SEAS; BERING-SEA; SHELF; RECORD; ISLAND; EXTINCTIONS; COMMUNITIES	Background: Gray whales (Eschrichtius robustus) undertake long migrations, from Baja California to Alaska, to feed on seasonally productive benthos of the Bering and Chukchi seas. The invertebrates that form their primary prey are restricted to shallow water environments, but global sea-level changes during the Pleistocene eliminated or reduced this critical habitat multiple times. Because the fossil record of gray whales is coincident with the onset of Northern Hemisphere glaciation, gray whales survived these massive changes to their feeding habitat, but it is unclear how. Methodology/Principal Findings: We reconstructed gray whale carrying capacity fluctuations during the past 120,000 years by quantifying gray whale feeding habitat availability using bathymetric data for the North Pacific Ocean, constrained by their maximum diving depth. We calculated carrying capacity based on modern estimates of metabolic demand, prey availability, and feeding duration; we also constrained our estimates to reflect current population size and account for glaciated and non-glaciated areas in the North Pacific. Our results show that key feeding areas eliminated by sea-level lowstands were not replaced by commensurate areas. Our reconstructions show that such reductions affected carrying capacity, and harmonic means of these fluctuations do not differ dramatically from genetic estimates of carrying capacity. Conclusions/Significance: Assuming current carrying capacity estimates, Pleistocene glacial maxima may have created multiple, weak genetic bottlenecks, although the current temporal resolution of genetic datasets does not test for such signals. Our results do not, however, falsify molecular estimates of pre-whaling population size because those abundances would have been sufficient to survive the loss of major benthic feeding areas (i.e., the majority of the Bering Shelf) during glacial maxima. We propose that gray whales survived the disappearance of their primary feeding ground by employing generalist filter-feeding modes, similar to the resident gray whales found between northern Washington State and Vancouver Island.	[Pyenson, Nicholas D.] Smithsonian Inst, Natl Museum Nat Hist, Dept Paleobiol, Washington, DC 20560 USA; [Pyenson, Nicholas D.] Univ Washington, Dept Mammal, Burke Museum Nat Hist & Culture, Seattle, WA 98195 USA; [Pyenson, Nicholas D.] Univ Washington, Dept Paleontol, Burke Museum Nat Hist & Culture, Seattle, WA 98195 USA; [Lindberg, David R.] Univ Calif Berkeley, Dept Integrat Biol, Ctr Computat Biol, Berkeley, CA 94720 USA; [Lindberg, David R.] Univ Calif Berkeley, Museum Paleontol, Berkeley, CA 94720 USA	Smithsonian Institution; Smithsonian National Museum of Natural History; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Pyenson, ND (corresponding author), Smithsonian Inst, Natl Museum Nat Hist, Dept Paleobiol, Washington, DC 20560 USA.	pyensonn@si.edu	Lindberg, David R/D-8138-2011	Pyenson, Nicholas/0000-0003-4678-5782	Department of Integrative Biology; University of California Museum of Paleontology at the University of California, Berkeley; National Science Foundation; Natural Sciences and Engineering Research Council of Canada; Smithsonian Institution; Biodiversity Synthesis Center at the Field Museum, Chicago	Department of Integrative Biology; University of California Museum of Paleontology at the University of California, Berkeley; National Science Foundation(National Science Foundation (NSF)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Smithsonian Institution(Smithsonian Institution); Biodiversity Synthesis Center at the Field Museum, Chicago	This research was supported with funding from the Department of Integrative Biology and the University of California Museum of Paleontology at the University of California, Berkeley, to DRL. Funding from a National Science Foundation Graduate Research Fellowship, a Natural Sciences and Engineering Research Council of Canada postdoctoral research fellowship and from the Smithsonian Institution supported NDP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; For discussion and constructive comments at various manuscript stages, we thank S. E. Alter, P. K. Dayton, J. A. Estes, T. A. Demere, D. Jacobs, B. J. Le Boeuf, S. R. Palumbi, M. Slatkin, and D. Strong. We sincerely appreciate the perceptive and thorough comments from two anonymous reviewers, who greatly improved the quality of this paper. We also thank B. Eakins for assistance with the calculation of benthos area and E. B. Davis for help with pilot analyses in the early stages of this project. This study also benefited from valuable discussion at an Encyclopedia of Life synthesis meeting on the evolution and diversity of marine tetrapods, funded by the Biodiversity Synthesis Center at the Field Museum, Chicago, in 2009. We also thank the conveners and participants of a symposium at the Society of Vertebrate Paleontology's annual meeting on the physical drivers and the evolution of marine tetrapods, in 2010. This paper is University of California Museum of Paleontology contribution number 1982.	Addicott WO, 1966, US GEOL SURV PROF C, V523C, pC1; Allendorf FW, 2008, TRENDS ECOL EVOL, V23, P327, DOI 10.1016/j.tree.2008.02.008; Alter SE, 2007, P NATL ACAD SCI USA, V104, P15162, DOI 10.1073/pnas.0706056104; Alter SE, 2009, INT MAR CONS C G MAS; Amante C., 2009, NGDC24 NOAA NESDIS; Anderson PK, 2001, J MAMMAL, V82, P623, DOI 10.1644/1545-1542(2001)082<0623:MMITNO>2.0.CO;2; Barnes LG, 1984, GRAY WHALE ESCHRICHT, P3; Barnosky AD, 2004, SCIENCE, V306, P70, DOI 10.1126/science.1101476; Barrett-Lennard LG, 2011, MAR ECOL PROG SER, V421, P229, DOI 10.3354/meps08906; Berzin A.A., 1984, P409; Bigg GR, 2008, EARTH PLANET SC LETT, V265, P559, DOI 10.1016/j.epsl.2007.10.052; Bisconti M, 2008, ZOOL J LINN SOC-LOND, V153, P161, DOI 10.1111/j.1096-3642.2008.00374.x; Bisconti M, 2006, RIV ITAL PALEONTOL S, V112, P447, DOI 10.13130/2039-4942/6352; Bolger DT, 2008, ECOL LETT, V11, P63; Bradford AL, 2006, MAR ECOL PROG SER, V315, P293, DOI 10.3354/meps315293; Bradford Amanda L., 2008, Endangered Species Research, V6, P1, DOI 10.3354/esr00106; Brigham-Grette J, 2001, QUATERNARY SCI REV, V20, P15, DOI 10.1016/S0277-3791(00)00134-7; BRYANT PJ, 1995, J MAMMAL, V76, P857, DOI 10.2307/1382754; Burton RK, 2001, OECOLOGIA, V128, P107, DOI 10.1007/s004420100631; CACCHIONE DA, 1987, CONT SHELF RES, V7, P553, DOI 10.1016/0278-4343(87)90021-5; Calambokidis John, 2002, Journal of Cetacean Research and Management, V4, P267; Cheng H, 2009, SCIENCE, V326, P248, DOI 10.1126/science.1177840; Clapham PJ, 1999, MAMMAL REV, V29, P35; Darling J.D., 1984, P267; DAYTON PK, 1969, SCIENCE, V163, P273, DOI 10.1126/science.163.3864.273; DAYTON PK, 1974, ECOL MONOGR, V44, P105, DOI 10.2307/1942321; Dayton PK, 1998, ECOL APPL, V8, P309, DOI 10.1890/1051-0761(1998)008[0309:SBGARE]2.0.CO;2; Dearborn JH, 1963, B ECOL SOC AM, V44, P41; Demere Thomas A., 2005, Journal of Mammalian Evolution, V12, P99, DOI 10.1007/s10914-005-6944-3; Denton GH, 2010, SCIENCE, V328, P1652, DOI 10.1126/science.1184119; Domning DP., 1978, U CALIFORNIA PUBLICA, V118, P1; Dunham JS, 2002, MAR MAMMAL SCI, V18, P419, DOI 10.1111/j.1748-7692.2002.tb01046.x; Eakins B. W., 2010, VOLUMES WORLDS OCEAN; Erlandson JM, 1999, J FIELD ARCHAEOL, V26, P255, DOI 10.1179/jfa.1999.26.3.255; Erlandson JM, 2008, HUMAN IMPACTS ON ANCIENT MARINE ECOSYSTEMS: A GLOBAL PERSPECTIVE, P1; Erlandson JM, 2010, ANNU REV MAR SCI, V2, P231, DOI 10.1146/annurev.marine.010908.163749; Gardner SC, 2000, MAR MAMMAL SCI, V16, P728, DOI 10.1111/j.1748-7692.2000.tb00968.x; Gill JL, 2009, SCIENCE, V326, P1100, DOI 10.1126/science.1179504; Goebel T, 2008, SCIENCE, V319, P1497, DOI 10.1126/science.1153569; GREBMEIER JM, 1989, MAR ECOL PROG SER, V51, P253, DOI 10.3354/meps051253; Grebmeier JM, 2006, SCIENCE, V311, P1461, DOI 10.1126/science.1121365; GREBMEIER JM, 1988, MAR ECOL PROG SER, V48, P57, DOI 10.3354/meps048057; GREBMEIER JM, 1989, MAR ECOL PROG SER, V53, P79, DOI 10.3354/meps053079; HAQ BU, 1987, SCIENCE, V235, P1156, DOI 10.1126/science.235.4793.1156; Henderson D.A., 1984, P159; Highsmith RC, 2006, WHALES, WHALING, AND OCEAN ECOSYSTEMS, P303; Ichishima H, 2006, J PALEONTOL, V80, P367, DOI 10.1666/0022-3360(2006)080[0367:TOROEC]2.0.CO;2; ICUN, 2011, W GRAY WHAL MAK UN J; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Jackson JBC, 2006, WHALES, WHALING, AND OCEAN ECOSYSTEMS, P27; Jacobs SE, 2005, PROFESSIONAL SURVEY, P101; JOHNSON KR, 1984, SCIENCE, V225, P1150, DOI 10.1126/science.225.4667.1150; Johnston C, 2010, MAR MAMMAL SCI, V26, P186, DOI 10.1111/j.1748-7692.2009.00305.x; Jones M. L., 1984, GRAY WHALE ESCHRICHT, P309; KAUFFMAN TA, 1974, ANTARCT J US, V9, P307; Kaufman DS, 2004, DEV QUA SCI, V2, P9; KIM SL, 1989, CAN J ZOOL, V67, P1531, DOI 10.1139/z89-218; Koch PL, 2006, ANNU REV ECOL EVOL S, V37, P215, DOI 10.1146/annurev.ecolsys.34.011802.132415; Krupnik I.I., 1984, P103; LEBOEUF BJ, 1986, MAR MAMMAL SCI, V2, P70, DOI 10.1111/j.1748-7692.1986.tb00028.x; Liljeborg W, 1867, NOVA ACTA ROY SOC 3, VVI; Lindquist O, 2000, OCCASIONAL PAPERS U; Martin PS, 1984, QUATERNARY EXTINCTIO; Mead J.G., 1984, P33; Michel C, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-49; Miller KG, 2005, SCIENCE, V310, P1293, DOI 10.1126/science.1116412; Mitchell E., 1979, REPORT INT WHALING C, V29, P307; Mitchell ED, 1990, ABORIGINAL WHALING G; Moore SE, 2003, CAN J ZOOL, V81, P734, DOI 10.1139/Z03-043; Moore SE, 2001, MAR MAMMAL SCI, V17, P954, DOI 10.1111/j.1748-7692.2001.tb01310.x; Moore SE, 2008, ECOL APPL, V18, pS157, DOI 10.1890/06-0571.1; MOORE TC, 1981, PALAEOGEOGR PALAEOCL, V35, P357, DOI 10.1016/0031-0182(81)90102-4; Muller RD, 2008, SCIENCE, V319, P1357, DOI 10.1126/science.1151540; National Research Council, 1996, BER SEA EC; Nerini M., 1984, P423; Newsome SD, 2007, P NATL ACAD SCI USA, V104, P9709, DOI 10.1073/pnas.0610986104; NOAA National Geophysical Data Center, 2011, BATH GLOB REL WEBP; Noakes SE, 2009, DIVING SCI 2009; O'Leary B.L., 1984, P79; Palsboll Per J, 2007, Proc Natl Acad Sci U S A, V104, pE3, DOI 10.1073/pnas.0710072105; PAULY D, 1995, TRENDS ECOL EVOL, V10, P430, DOI 10.1016/S0169-5347(00)89171-5; PIKE GC, 1962, J FISH RES BOARD CAN, V19, P815, DOI 10.1139/f62-051; Reilly SB, 2010, IUCN 2010 IUCN RED L; Rettie WJ, 2000, ECOGRAPHY, V23, P466, DOI 10.1034/j.1600-0587.2000.230409.x; Rice D. W, 1971, Spec Publ Am Soc Mammal, VNo. 3, P1; Rick TC, 2005, J WORLD PREHIST, V19, P169, DOI 10.1007/s10963-006-9004-x; Rohling EJ, 2009, NAT GEOSCI, V2, P500, DOI 10.1038/ngeo557; Roman J, 2003, SCIENCE, V301, P508, DOI 10.1126/science.1084524; Rugh David J., 2005, Journal of Cetacean Research and Management, V7, P1; Russell D, 2001, EYE WHALE EPIC PASSA; SANCETTA C, 1984, MAR GEOL, V62, P55, DOI 10.1016/0025-3227(84)90054-9; SANCETTA C, 1992, NATURE, V360, P249, DOI 10.1038/360249a0; SANCETTA C, 1983, DEEP-SEA RES, V30, P851, DOI 10.1016/0198-0149(83)90004-3; Sayers H., 1984, P121; Scammon C.M., 1874, MARINE MAMMALS N W C; Scheinin Aviad P., 2011, Marine Biodiversity Records, V4; Schipper J, 2008, SCIENCE, V322, P225, DOI 10.1126/science.1165115; Shelden KEW, 2004, ECOL APPL, V14, P1789, DOI 10.1890/03-5349; SIMENSTAD CA, 1978, SCIENCE, V200, P403, DOI 10.1126/science.200.4340.403; Stafford KM, 2007, ARCTIC, V60, P167; Stelle LL, 2008, MAR MAMMAL SCI, V24, P462, DOI 10.1111/j.1748-7692.2008.00205.x; Stewart Brent S., 1994, P29; Stringer CB, 2008, P NATL ACAD SCI USA, V105, P14319, DOI 10.1073/pnas.0805474105; Swartz SL, 2006, MAMMAL REV, V36, P66, DOI 10.1111/j.1365-2907.2006.00082.x; Takahashi K, 2005, DEEP-SEA RES PT II, V52, P2080, DOI 10.1016/j.dsr2.2005.08.003; Thomas AL, 2009, SCIENCE, V324, P1186, DOI 10.1126/science.1168754; Turvey ST, 2007, BIOL LETTERS, V3, P537, DOI 10.1098/rsbl.2007.0292; Tynan CT, 2004, MAR ECOL PROG SER, V272, P281, DOI 10.3354/meps272281; Uhen MD, 2007, PALAEONTOL ELECTRON, V10; Wade Paul R., 2002, Journal of Cetacean Research and Management, V4, P85; Weber DS, 2004, J HERED, V95, P144, DOI 10.1093/jhered/esh018; Werth Alexander, 2000, P487, DOI 10.1016/B978-012632590-4/50017-4; Whitmore Frank C. Jr, 2008, Virginia Museum of Natural History Special Publication, V14, P181; Williams M., 1998, EVIDENCE DESERTS QUA, V2nd	114	55	55	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2011	6	7							e21295	10.1371/journal.pone.0021295	http://dx.doi.org/10.1371/journal.pone.0021295			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791AK	21754984	Green Submitted, Green Published, gold			2022-12-27	WOS:000292632000008
J	Balgi, AD; Diering, GH; Donohue, E; Lam, KKY; Fonseca, BD; Zimmerman, C; Numata, M; Roberge, M				Balgi, Aruna D.; Diering, Graham H.; Donohue, Elizabeth; Lam, Karen K. Y.; Fonseca, Bruno D.; Zimmerman, Carla; Numata, Masayuki; Roberge, Michel			Regulation of mTORC1 Signaling by pH	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; CELL-GROWTH; PHOSPHATIDIC-ACID; INTRACELLULAR PH; TUBEROUS SCLEROSIS; EXTRACELLULAR PH; CYTOPLASMIC PH; CARDIAC-ARREST; HUMAN CANCER; TUMOR PH	Background: Acidification of the cytoplasm and the extracellular environment is associated with many physiological and pathological conditions, such as intense exercise, hypoxia and tumourigenesis. Acidification affects important cellular functions including protein synthesis, growth, and proliferation. Many of these vital functions are controlled by mTORC1, a master regulator protein kinase that is activated by various growth-stimulating signals and inactivated by starvation conditions. Whether mTORC1 can also respond to changes in extracellular or cytoplasmic pH and play a role in limiting anabolic processes in acidic conditions is not known. Methodology/Findings: We examined the effects of acidifying the extracellular medium from pH 7.4 to 6.4 on human breast carcinoma MCF-7 cells and immortalized mouse embryo fibroblasts. Decreasing the extracellular pH caused intracellular acidification and rapid, graded and reversible inhibition of mTORC1, assessed by measuring the phosphorylation of the mTORC1 substrate S6K. Fibroblasts deleted of the tuberous sclerosis complex TSC2 gene, a major negative regulator of mTORC1, were unable to inhibit mTORC1 in acidic extracellular conditions, showing that the TSC1-TSC2 complex is required for this response. Examination of the major upstream pathways converging on the TSC1-TSC2 complex showed that Akt signaling was unaffected by pH but that the Raf/MEK/ERK pathway was inhibited. Inhibition of MEK with drugs caused only modest mTORC1 inhibition, implying that other unidentified pathways also play major roles. Conclusions: This study reveals a novel role for the TSC1/TSC2 complex and mTORC1 in sensing variations in ambient pH. As a common feature of low tissue perfusion, low glucose availability and high energy expenditure, acidic pH may serve as a signal for mTORC1 to downregulate energy-consuming anabolic processes such as protein synthesis as an adaptive response to metabolically stressful conditions.	[Balgi, Aruna D.; Diering, Graham H.; Donohue, Elizabeth; Lam, Karen K. Y.; Fonseca, Bruno D.; Zimmerman, Carla; Numata, Masayuki; Roberge, Michel] Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V5Z 1M9, Canada; [Roberge, Michel] Ctr Drug Res & Dev, Vancouver, BC, Canada	University of British Columbia	Balgi, AD (corresponding author), Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V5Z 1M9, Canada.	michelr@mail.ubc.ca		Lam, Karen/0000-0002-7881-3883; Zimmerman, Carla/0000-0002-5132-2101	Canadian Breast Cancer Foundation	Canadian Breast Cancer Foundation(Canadian Cancer Society (CCS))	Financial support for this study was obtained from the Canadian Breast Cancer Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andresen BT, 2002, FEBS LETT, V531, P65, DOI 10.1016/S0014-5793(02)03483-X; Avruch J, 2006, ONCOGENE, V25, P6361, DOI 10.1038/sj.onc.1209882; Balgi AD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007124; Baxter KA, 1996, J PHYSIOL-LONDON, V493, P457, DOI 10.1113/jphysiol.1996.sp021396; Becelli R, 2007, J CRANIOFAC SURG, V18, P1051, DOI 10.1097/scs.0b013e3180de63eb; BRAVO R, 1986, FEBS LETT, V195, P309, DOI 10.1016/0014-5793(86)80183-1; Brugarolas J, 2004, GENE DEV, V18, P2893, DOI 10.1101/gad.1256804; Carling D, 2008, INT J OBESITY, V32, pS55, DOI 10.1038/ijo.2008.124; Carracedo A, 2008, J CLIN INVEST, V118, P3065, DOI [10.1172/jCI34739, 10.1172/JCI34739]; CHAILLET JR, 1985, J GEN PHYSIOL, V86, P765, DOI 10.1085/jgp.86.6.765; CHAMBARD JC, 1986, EXP CELL RES, V164, P282, DOI 10.1016/0014-4827(86)90029-7; Chiche J, 2009, CANCER RES, V69, P358, DOI 10.1158/0008-5472.CAN-08-2470; Corradetti MN, 2006, ONCOGENE, V25, P6347, DOI 10.1038/sj.onc.1209885; DeYoung MP, 2008, GENE DEV, V22, P239, DOI 10.1101/gad.1617608; DIERING GH, 2011, MOL BIOL CELL; ENGLAND BK, 1991, AM J PHYSIOL, V260, pC277, DOI 10.1152/ajpcell.1991.260.2.C277; Fischer B, 2000, J IMMUNOTHER, V23, P196, DOI 10.1097/00002371-200003000-00004; FITTS RH, 1994, PHYSIOL REV, V74, P49, DOI 10.1152/physrev.1994.74.1.49; Fukumura D, 2001, CANCER RES, V61, P6020; Garcia-Martinez JM, 2008, BIOCHEM J, V416, P375, DOI 10.1042/BJ20081668; Gau CL, 2005, MOL CANCER THER, V4, P918, DOI 10.1158/1535-7163.MCT-04-0347; Hall M N, 2008, Transplant Proc, V40, pS5, DOI 10.1016/j.transproceed.2008.10.009; Hardie DG, 2003, FEBS LETT, V546, P113, DOI 10.1016/S0014-5793(03)00560-X; Hresko RC, 2005, J BIOL CHEM, V280, P40406, DOI 10.1074/jbc.M508361200; Huang J, 2008, BIOCHEM J, V412, P179, DOI 10.1042/BJ20080281; Inoki K, 2005, NAT GENET, V37, P19, DOI 10.1038/ng1494; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; JOHNSON BA, 1995, J APPL PHYSIOL, V78, P1579, DOI 10.1152/jappl.1995.78.4.1579; KARURI AR, 1993, BRIT J CANCER, V68, P1080, DOI 10.1038/bjc.1993.485; Kerkhoff E, 2001, ADV ENZYME REGUL, V41, P261, DOI 10.1016/S0065-2571(00)00023-6; Korolchuk VI, 2011, NAT CELL BIOL, V13, P453, DOI 10.1038/ncb2204; Kraft CA, 2008, J BIOL CHEM, V283, P36636, DOI 10.1074/jbc.M804633200; Kraut JA, 2010, NAT REV NEPHROL, V6, P274, DOI 10.1038/nrneph.2010.33; LAMANNA JC, 1995, BRAIN RES, V687, P175, DOI 10.1016/0006-8993(95)00516-S; Levraut Jacques, 2003, Curr Opin Crit Care, V9, P260, DOI 10.1097/00075198-200308000-00002; Ma L, 2005, CELL, V121, P179, DOI 10.1016/j.cell.2005.02.031; Ma L, 2007, CANCER RES, V67, P7106, DOI 10.1158/0008-5472.CAN-06-4798; Menon S, 2008, Oncogene, V27 Suppl 2, pS43, DOI 10.1038/onc.2009.352; MUSGROVE E, 1987, EXP CELL RES, V172, P65, DOI 10.1016/0014-4827(87)90093-0; POUYSSEGUR J, 1985, FEBS LETT, V190, P115, DOI 10.1016/0014-5793(85)80439-7; Reiling JH, 2006, ONCOGENE, V25, P6373, DOI 10.1038/sj.onc.1209889; Robert F, 2006, RNA, V12, P717, DOI 10.1261/rna.2346806; Rubinsztein DC, 2007, NAT REV DRUG DISCOV, V6, P304, DOI 10.1038/nrd2272; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Sancak Y, 2010, CELL, V141, P290, DOI 10.1016/j.cell.2010.02.024; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Smallbone K, 2007, J THEOR BIOL, V244, P703, DOI 10.1016/j.jtbi.2006.09.010; Sofer A, 2005, MOL CELL BIOL, V25, P5834, DOI 10.1128/MCB.25.14.5834-5845.2005; Udell CM, 2011, CELL MOL LIFE SCI, V68, P553, DOI 10.1007/s00018-010-0520-6; van Sluis R, 1999, MAGN RESON MED, V41, P743, DOI 10.1002/(SICI)1522-2594(199904)41:4<743::AID-MRM13>3.0.CO;2-Z; VAUPEL P, 1989, CANCER RES, V49, P6449; Wakabayashi I, 2006, PLATELETS, V17, P454, DOI 10.1080/09537100600757489; Wellbrock C, 2004, NAT REV MOL CELL BIO, V5, P875, DOI 10.1038/nrm1498; Yao H, 2004, CELL CALCIUM, V36, P247, DOI 10.1016/j.ceca.2004.02.013; Young BP, 2010, SCIENCE, V329, P1085, DOI 10.1126/science.1191026; Zang MW, 2008, J BIOL CHEM, V283, P31429, DOI 10.1074/jbc.M802855200; Zhang HB, 2003, J CLIN INVEST, V112, P1223, DOI 10.1172/JCI200317222; Zhang XM, 2010, J NUCL MED, V51, P1167, DOI 10.2967/jnumed.109.068981; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	59	86	87	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2011	6	6							e21549	10.1371/journal.pone.0021549	http://dx.doi.org/10.1371/journal.pone.0021549			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786FZ	21738705	Green Published, gold, Green Submitted			2022-12-27	WOS:000292290100036
J	Lee, KM; Yu, J; Son, M; Lee, YW; Kim, KH				Lee, Kyung-Mi; Yu, Jisuk; Son, Moonil; Lee, Yin-Won; Kim, Kook-Hyung			Transmission of Fusarium boothii Mycovirus via Protoplast Fusion Causes Hypovirulence in Other Phytopathogenic Fungi	PLOS ONE			English	Article							NIVALENOL-PRODUCING CHEMOTYPES; GIBBERELLA-ZEAE; CRYPHONECTRIA-PARASITICA; CHESTNUT BLIGHT; GENETIC-RECOMBINATION; ENDOTHIA-PARASITICA; ROSELLINIA-NECATRIX; DSRNA MYCOVIRUS; GRAMINEARUM; PATHOGEN	There is increasing concern regarding the use of fungicides to control plant diseases, whereby interest has increased in the biological control of phytopathogenic fungi by the application of hypovirulent mycoviruses as a possible alternative to fungicides. Transmission of hypovirulence-associated double-stranded RNA (dsRNA) viruses between mycelia, however, is prevented by the vegetative incompatibility barrier that often exists between different species or strains of filamentous fungi. We determined whether protoplast fusion could be used to transmit FgV1-DK21 virus, which is associated with hypovirulence on F. boothii (formerly F. graminearum strain DK21), to F. graminearum, F. asiaticum, F. oxysporum f. sp. lycopersici, and Cryphonectria parasitica. Relative to virus-free strains, the FgV1-DK21 recipient strains had reduced growth rates, altered pigmentation, and reduced virulence. These results indicate that protoplast fusion can be used to introduce FgV1-DK21 dsRNA into other Fusarium species and into C. parasitica and that FgV1-DK21 can be used as a hypovirulence factor and thus as a biological control agent.	[Lee, Kyung-Mi] Seoul Natl Univ, Dept Agr Biotechnol, Seoul, South Korea; Seoul Natl Univ, Ctr Fungal Pathogenesis, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU)	Lee, KM (corresponding author), Seoul Natl Univ, Dept Agr Biotechnol, Seoul, South Korea.	kookkim@snu.ac.kr		Son, Moonil/0000-0002-1325-2085	Ministry of Education, Science, and Technology (MEST) [20110000959]	Ministry of Education, Science, and Technology (MEST)(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This research was supported by a grant from the Center for Fungal Pathogenesis (No. 20110000959) funded by the Ministry of Education, Science, and Technology (MEST). K-ML, JY, and MS were supported by graduate research fellowships from the MEST through the Brain Korea 21 Project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS G, 1987, EXP MYCOL, V11, P339, DOI 10.1016/0147-5975(87)90022-3; Aoki N, 2009, VIRUS RES, V140, P179, DOI 10.1016/j.virusres.2008.12.003; Baltz RH, 1999, J IND MICROBIOL BIOT, V22, P460, DOI 10.1038/sj.jim.2900659; Chen BS, 1996, PHYTOPATHOLOGY, V86, P301, DOI 10.1094/Phyto-86-301; Chiba S, 2009, J VIROL, V83, P12801, DOI 10.1128/JVI.01830-09; Chu YM, 2004, VIRUS GENES, V28, P135, DOI 10.1023/B:VIRU.0000012270.67302.35; Chu YM, 2002, APPL ENVIRON MICROB, V68, P2529, DOI 10.1128/AEM.68.5.2529-2534.2002; CHURCHILL ACL, 1990, CURR GENET, V17, P25, DOI 10.1007/BF00313245; DAS A, 1989, ENZYME MICROB TECH, V11, P2, DOI 10.1016/0141-0229(89)90104-X; Di Pietro A, 1998, MOL PLANT MICROBE IN, V11, P91, DOI 10.1094/MPMI.1998.11.2.91; FULBRIGHT DW, 1984, PHYTOPATHOLOGY, V74, P722, DOI 10.1094/Phyto-74-722; Geiser DM, 2004, EUR J PLANT PATHOL, V110, P473, DOI 10.1023/B:EJPP.0000032386.75915.a0; GOKHALE DV, 1992, J SCI IND RES INDIA, V51, P497; HERRING AJ, 1974, J GEN VIROL, V22, P387, DOI 10.1099/0022-1317-22-3-387; Hong SY, 2010, PLANT PATHOLOGY J, V26, P409, DOI 10.5423/PPJ.2010.26.4.409; Kanematsu S, 2004, PHYTOPATHOLOGY, V94, P561, DOI 10.1094/PHYTO.2004.94.6.561; Kanematsu S, 2010, PHYTOPATHOLOGY, V100, P922, DOI 10.1094/PHYTO-100-9-0922; Kim C, 1997, ARCH PHARM RES, V20, P448, DOI 10.1007/BF02973938; Kim JE, 2005, APPL ENVIRON MICROB, V71, P1701, DOI 10.1128/AEM.71.4.1701-1708.2005; Kwon SJ, 2007, MOL CELLS, V23, P304, DOI 10.1007/s10059-009-0112-1; Lee T, 2002, APPL ENVIRON MICROB, V68, P2148, DOI 10.1128/AEM.68.5.2148-2154.2002; Lee T, 2001, APPL ENVIRON MICROB, V67, P2966, DOI 10.1128/AEM.67.7.2966-2972.2001; LESLIE JF, 1993, ANNU REV PHYTOPATHOL, V31, P127, DOI 10.1146/annurev.py.31.090193.001015; MADHOSINGH C, 1994, J PHYTOPATHOL, V142, P301, DOI 10.1111/j.1439-0434.1994.tb04543.x; NUSS DL, 1992, MICROBIOL REV, V56, P561, DOI 10.1128/MMBR.56.4.561-576.1992; Nuss DL, 2005, NAT REV MICROBIOL, V3, P632, DOI 10.1038/nrmicro1206; O'Donnell K, 2004, FUNGAL GENET BIOL, V41, P600, DOI 10.1016/j.fgb.2004.03.003; O'Donnell K, 2008, FUNGAL GENET BIOL, V45, P1514, DOI 10.1016/j.fgb.2008.09.002; Pearson MN, 2009, MOL PLANT PATHOL, V10, P115, DOI 10.1111/j.1364-3703.2008.00503.x; PEBERDY JF, 1980, ENZYME MICROB TECH, V2, P23, DOI 10.1016/0141-0229(80)90004-6; PUHALLA JE, 1971, PHYTOPATHOLOGY, V61, P169, DOI 10.1094/Phyto-61-169; Rubinder K, 2000, CAN J MICROBIOL, V46, P669, DOI 10.1139/cjm-46-7-669; Seong K, 2005, PHYTOPATHOLOGY, V95, P744, DOI 10.1094/PHYTO-95-0744; SHAIN L, 1992, CAN J BOT, V70, P557, DOI 10.1139/b92-070; Sun QH, 2009, EUKARYOT CELL, V8, P262, DOI 10.1128/EC.00338-08; Suzuki N, 2002, J VIROL, V76, P7747, DOI 10.1128/JVI.76.15.7747-7759.2002; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; TURGEON BG, 1987, MOL CELL BIOL, V7, P3297, DOI 10.1128/MCB.7.9.3297; van Diepeningen A. D., 2000, FUNGAL GENET NEWSLET, V47, P99, DOI DOI 10.4148/1941-4765.1216; van Diepeningen AD, 1998, FUNGAL GENET BIOL, V25, P171, DOI 10.1006/fgbi.1998.1096; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; Wang C, 2009, CAN J MICROBIOL, V55, P1070, DOI [10.1139/W09-064, 10.1139/w09-064]	42	37	39	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2011	6	6							e21629	10.1371/journal.pone.0021629	http://dx.doi.org/10.1371/journal.pone.0021629			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786FZ	21738738	Green Submitted, Green Published, gold			2022-12-27	WOS:000292290100048
J	Toomey, MB; McGraw, KJ				Toomey, Matthew B.; McGraw, Kevin J.			The Effects of Dietary Carotenoid Supplementation and Retinal Carotenoid Accumulation on Vision-Mediated Foraging in the House Finch	PLOS ONE			English	Article							AVIAN COLOR-VISION; OIL DROPLETS; CARPODACUS-MEXICANUS; VISUAL PIGMENTS; FOOD COLOR; BIRDS; AVAILABILITY; LIGHT; DISCRIMINATION; TETRACHROMACY	Background: For many bird species, vision is the primary sensory modality used to locate and assess food items. The health and spectral sensitivities of the avian visual system are influenced by diet-derived carotenoid pigments that accumulate in the retina. Among wild House Finches (Carpodacus mexicanus), we have found that retinal carotenoid accumulation varies significantly among individuals and is related to dietary carotenoid intake. If diet-induced changes in retinal carotenoid accumulation alter spectral sensitivity, then they have the potential to affect visually mediated foraging performance. Methodology/Principal Findings: In two experiments, we measured foraging performance of house finches with dietarily manipulated retinal carotenoid levels. We tested each bird's ability to extract visually contrasting food items from a matrix of inedible distracters under high-contrast (full) and dimmer low-contrast (red-filtered) lighting conditions. In experiment one, zeaxanthin-supplemented birds had significantly increased retinal carotenoid levels, but declined in foraging performance in the high-contrast condition relative to astaxanthin-supplemented birds that showed no change in retinal carotenoid accumulation. In experiments one and two combined, we found that retinal carotenoid concentrations predicted relative foraging performance in the low-vs. high-contrast light conditions in a curvilinear pattern. Performance was positively correlated with retinal carotenoid accumulation among birds with low to medium levels of accumulation (similar to 0.5-1.5 mu g/retina), but declined among birds with very high levels (>2.0 mu g/retina). Conclusion/Significance: Our results suggest that carotenoid-mediated spectral filtering enhances color discrimination, but that this improvement is traded off against a reduction in sensitivity that can compromise visual discrimination. Thus, retinal carotenoid levels may be optimized to meet the visual demands of specific behavioral tasks and light environments.	[Toomey, Matthew B.; McGraw, Kevin J.] Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA	Arizona State University; Arizona State University-Tempe	Toomey, MB (corresponding author), Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA.	matthew.toomey@asu.edu	Toomey, Matthew/AAJ-9133-2020	Toomey, Matthew/0000-0001-9184-197X	National Science Foundation [IOS-0910357, 0923694]; American Ornithologists' Union; Animal Behavior Society	National Science Foundation(National Science Foundation (NSF)); American Ornithologists' Union; Animal Behavior Society	This work was funded by grants from the National Science Foundation (IOS-0910357 to KJM and 0923694 to MBT and KJM), the American Ornithologists' Union to MBT, and the Animal Behavior Society to MBT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aviles JM, 2008, AM NAT, V171, P327, DOI 10.1086/527493; Bascunan AL, 2009, ETHOLOGY, V115, P1066, DOI 10.1111/j.1439-0310.2009.01697.x; Bennett ATD, 2007, AM NAT, V169, pS1, DOI 10.1086/510163; Blount JD, 2004, ARCH BIOCHEM BIOPHYS, V430, P10, DOI 10.1016/j.abb.2004.03.039; Caine NG, 2000, P ROY SOC B-BIOL SCI, V267, P439, DOI 10.1098/rspb.2000.1019; Cummings ME, 2004, VISION RES, V44, P1127, DOI 10.1016/j.visres.2003.12.013; Das D, 1999, VISION RES, V39, P2801, DOI 10.1016/S0042-6989(99)00023-1; Douglas R.H., 1999, P95; Eaton MD, 2005, P NATL ACAD SCI USA, V102, P10942, DOI 10.1073/pnas.0501891102; Endler J. A., 1992, AM NAT, V139, pS125; ENDLER JA, 1993, ECOL MONOGR, V63, P1, DOI 10.2307/2937121; Goldsmith TH, 2005, J COMP PHYSIOL A, V191, P933, DOI 10.1007/s00359-005-0024-2; GOLDSMITH TH, 1984, VISION RES, V24, P1661, DOI 10.1016/0042-6989(84)90324-9; Grether GF, 2005, P ROY SOC B-BIOL SCI, V272, P2181, DOI 10.1098/rspb.2005.3197; Hart NS, 2006, J EXP BIOL, V209, P4776, DOI 10.1242/jeb.02568; Hart NS, 2001, J COMP PHYSIOL A, V187, P685, DOI 10.1007/s00359-001-0240-3; Hill G. E., 2002, RED BIRD BROWN BAG F; Knott B, 2010, P ROY SOC B-BIOL SCI, V277, P953, DOI 10.1098/rspb.2009.1805; LESSELLS CM, 1987, AUK, V104, P116, DOI 10.2307/4087240; Lind O, 2009, VISION RES, V49, P1939, DOI 10.1016/j.visres.2009.05.003; Lythgoe J.N., 1979, ECOLOGY VISION; LYTHGOE JN, 1991, VISION RES, V31, P361, DOI 10.1016/0042-6989(91)90089-N; Maddocks SA, 2001, J EXP BIOL, V204, P2509; McGraw KJ, 2006, PHYSIOL BEHAV, V87, P103, DOI 10.1016/j.physbeh.2005.09.001; Osorio D, 2008, VISION RES, V48, P2042, DOI 10.1016/j.visres.2008.06.018; Osorio D, 2004, AM NAT, V164, P696, DOI 10.1086/425332; Osorio D, 1996, P ROY SOC B-BIOL SCI, V263, P593, DOI 10.1098/rspb.1996.0089; Partridge J.C., 1999, P251; Perez C, 2008, BEHAV ECOL, V19, P967, DOI 10.1093/beheco/arn053; Pike TW, 2007, BIOL LETTERS, V3, P353, DOI 10.1098/rsbl.2007.0072; Rovamo JM, 2001, VISION RES, V41, P1659, DOI 10.1016/S0042-6989(01)00036-0; SALT GW, 1952, ECOL MONOGR, V22, P121, DOI 10.2307/1943514; Schaefer HM, 2008, FUNCT ECOL, V22, P303, DOI 10.1111/j.1365-2435.2007.01363.x; Seehausen O, 2008, NATURE, V455, P620, DOI 10.1038/nature07285; Siddiqi A, 2004, J EXP BIOL, V207, P2471, DOI 10.1242/jeb.01047; Stockton-Shields C., 1997, THESIS AUBURN U AUBU; Toomey MB, 2010, ARCH BIOCHEM BIOPHYS, V504, P161, DOI 10.1016/j.abb.2010.06.033; Toomey MB, 2010, J EXP BIOL, V213, P1709, DOI 10.1242/jeb.041004; Toomey MB, 2009, FUNCT ECOL, V23, P321, DOI 10.1111/j.1365-2435.2008.01498.x; Vorobyev M, 2003, P ROY SOC B-BIOL SCI, V270, P1255, DOI 10.1098/rspb.2003.2381; Vorobyev M, 1998, J COMP PHYSIOL A, V183, P621, DOI 10.1007/s003590050286	42	19	20	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2011	6	6							e21653	10.1371/journal.pone.0021653	http://dx.doi.org/10.1371/journal.pone.0021653			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786FZ	21747917	gold, Green Published, Green Submitted			2022-12-27	WOS:000292290100052
J	Yang, TL; Guo, Y; Shen, H; Lei, SF; Liu, YJ; Li, J; Liu, YZ; Yu, N; Chen, J; Xu, T; Cheng, Y; Tian, Q; Yu, P; Papasian, CJ; Deng, HW				Yang, Tie-Lin; Guo, Yan; Shen, Hui; Lei, Shu-Feng; Liu, Yong-Jun; Li, Jian; Liu, Yao-Zhong; Yu, Na; Chen, Jia; Xu, Ting; Cheng, Yu; Tian, Qing; Yu, Ping; Papasian, Christopher J.; Deng, Hong-Wen			Genetic Association Study of Common Mitochondrial Variants on Body Fat Mass	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; HUMAN OBESITY; ATP-SYNTHASE; DISEASE; POPULATION; OVERWEIGHT; MUTATION; MTDNA	Mitochondria play a central role in ATP production and energy metabolism. Previous studies suggest that common variants in mtDNA are associated with several common complex diseases, including obesity. To test the hypothesis that common mtDNA variants influence obesity-related phenotypes, including BMI and body fat mass, we genotyped a total of 445 mtSNPs across the whole mitochondrial genome in a large sample of 2,286 unrelated Caucasian subjects. 72 of these 445 mtSNPs passed quality control criteria, and were used for subsequent analyses. We also classified all subjects into nine common European haplogroups. Association analyses were conducted for both BMI and body fat mass with single mtSNPs and mtDNA haplogroups. Two mtSNPs, mt4823 and mt8873 were detected to be significantly associated with body fat mass, with adjusted P values of 4.94610(-3) and 4.58610(-2), respectively. The minor alleles mt4823 C and mt8873 A were associated with reduced fat mass values and the effect size (beta) was estimated to be 3.52 and 3.18, respectively. These two mtSNPs also achieved nominally significant levels for association with BMI. For haplogroup analyses, we found that haplogroup X was strongly associated with both BMI (adjusted P = 8.31610(-3)) and body fat mass (adjusted P = 5.67610(-4)) Subjects classified as haplogroup X had lower BMI and fat mass values, with the beta estimated to be 2.86 and 6.03, respectively. Our findings suggest that common variants in mitochondria might play a role in variations of body fat mass. Further molecular and functional studies will be needed to clarify the potential mechanism.	[Yang, Tie-Lin; Guo, Yan] Xi An Jiao Tong Univ, Sch Life Sci & Technol, Key Lab Biomed Informat Engn, Minist Educ, Xian 710049, Shaanxi, Peoples R China; [Yang, Tie-Lin; Guo, Yan] Xi An Jiao Tong Univ, Sch Life Sci & Technol, Inst Mol Genet, Xian 710049, Shaanxi, Peoples R China; [Shen, Hui; Lei, Shu-Feng; Liu, Yong-Jun; Li, Jian; Liu, Yao-Zhong; Yu, Na; Chen, Jia; Xu, Ting; Cheng, Yu; Tian, Qing; Yu, Ping; Papasian, Christopher J.; Deng, Hong-Wen] Tulane Univ, Sch Publ Hlth & Trop Med, New Orleans, LA USA; [Deng, Hong-Wen] Beijing Jiaotong Univ, Sch Sci, Inst Biosci & Biotechnol, Beijing, Peoples R China	Xi'an Jiaotong University; Xi'an Jiaotong University; Tulane University; Beijing Jiaotong University	Guo, Y (corresponding author), Xi An Jiao Tong Univ, Sch Life Sci & Technol, Key Lab Biomed Informat Engn, Minist Educ, Xian 710049, Shaanxi, Peoples R China.	guoyan253@xjtu.edu.cn; hdeng2@tulane.edu	Liu, Yong/GWQ-6163-2022; Liu, Yaozhong/ABD-5544-2020; Li, Jian/G-4445-2015; Yang, Tie-Lin/G-8365-2014; Guo, Yan/G-8742-2014	Yang, Tie-Lin/0000-0001-7062-3025; Guo, Yan/0000-0002-7364-2392; Deng, Hong-Wen/0000-0002-0387-8818	National Institutes of Health [R01 AR050496, R21 AG027110, R01 AG026564, R01 AR057049-01A1, R21 AA015973]; Specialized Center of Research grant [P50 AR055081]; National Science Foundation of China [81000363, 31000554]; Fundamental Research Funds for the Central Universities; Shanghai Leading Academic Discipline Project [S30501]; Ministry of Education; University of Shanghai for Science and Technology; Xi'an Jiaotong University; Ministry of Education of China; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR050496, P50AR055081, R01AR057049] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG026564, R21AG027110] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R21AA015973] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Specialized Center of Research grant; National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Shanghai Leading Academic Discipline Project(Shanghai Leading Academic Discipline Project); Ministry of Education; University of Shanghai for Science and Technology; Xi'an Jiaotong University(Xi'an Jiaotong University); Ministry of Education of China(Ministry of Education, China); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	Investigators of this work were supported by grants from the National Institutes of Health (R01 AR050496, R21 AG027110, R01 AG026564, R01 AR057049-01A1 and R21 AA015973) and a Specialized Center of Research grant (P50 AR055081). The study was also supported by grants from the National Science Foundation of China (81000363, 31000554), the Fundamental Research Funds for the Central Universities, Shanghai Leading Academic Discipline Project (S30501), a grant from Ministry of Education to Shanghai University of Science and Technology, and startup funds from University of Shanghai for Science and Technology and Xi'an Jiaotong University, and the Ministry of Education of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Bell CG, 2005, NAT REV GENET, V6, P221, DOI 10.1038/nrg1556; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Chagnon P, 1999, AM J MED GENET, V85, P20, DOI 10.1002/(SICI)1096-8628(19990702)85:1<20::AID-AJMG6>3.0.CO;2-K; Chinnery PF, 2005, LANCET, V366, P1650, DOI 10.1016/S0140-6736(05)67492-2; Deng HW, 2002, AM J HUM GENET, V70, P1138, DOI 10.1086/339934; DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567; Herrnstadt C, 2002, AM J HUM GENET, V70, P1152, DOI 10.1086/339933; HOLT IJ, 1990, AM J HUM GENET, V46, P428; HOUSTEK J, 1995, BBA-MOL BASIS DIS, V1271, P349, DOI 10.1016/0925-4439(95)00063-A; Liu YJ, 2008, HUM MOL GENET, V17, P1803, DOI 10.1093/hmg/ddn072; Morava E, 2003, J INHERIT METAB DIS, V26, P720, DOI 10.1023/B:BOLI.0000005647.71704.25; Ogilvie I, 1999, FEBS LETT, V453, P179, DOI 10.1016/S0014-5793(99)00605-5; Pietilainen KH, 2008, PLOS MED, V5, DOI 10.1371/journal.pmed.0050051; Poulton J, 2002, HUM MOL GENET, V11, P1581, DOI 10.1093/hmg/11.13.1581; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Saxena R, 2006, AM J HUM GENET, V79, P54, DOI 10.1086/504926; TATUCH Y, 1992, AM J HUM GENET, V50, P852; Torroni A, 1996, GENETICS, V144, P1835; van der Walt JM, 2003, AM J HUM GENET, V72, P804, DOI 10.1086/373937; Walley AJ, 2009, NAT REV GENET, V10, P431, DOI 10.1038/nrg2594; Wang YF, 2008, OBESITY, V16, P2323, DOI 10.1038/oby.2008.351; Wortmann SB, 2009, PEDIATR RES, V65, P103, DOI 10.1203/PDR.0b013e31818d1c8a	23	24	25	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2011	6	6							e21595	10.1371/journal.pone.0021595	http://dx.doi.org/10.1371/journal.pone.0021595			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786FZ	21747914	Green Published, Green Submitted, gold			2022-12-27	WOS:000292290100043
J	Lesting, J; Narayanan, RT; Kluge, C; Sangha, S; Seidenbecher, T; Pape, HC				Lesting, Joerg; Narayanan, Rajeevan T.; Kluge, Christian; Sangha, Susan; Seidenbecher, Thomas; Pape, Hans-Christian			Patterns of Coupled Theta Activity in Amygdala-Hippocampal-Prefrontal Cortical Circuits during Fear Extinction	PLOS ONE			English	Article							LATERAL AMYGDALA; SYNAPTIC PLASTICITY; PHASE PRECESSION; CONSCIOUS CATS; MEMORY; NEURONS; OSCILLATIONS; MECHANISMS; RETRIEVAL; SEQUENCES	Signals related to fear memory and extinction are processed within brain pathways involving the lateral amygdala (LA) for formation of aversive stimulus associations, the CA1 area of the hippocampus for context-dependent modulation of these associations, and the infralimbic region of the medial prefrontal cortex (mPFC) for extinction processes. While many studies have addressed the contribution of each of these modules individually, little is known about their interactions and how they function as an integrated system. Here we show, by combining multiple site local field potential (LFP) and unit recordings in freely behaving mice in a fear conditioning paradigm, that theta oscillations may provide a means for temporally and functionally connecting these modules. Theta oscillations occurred with high specificity in the CA1-LA-mPFC network. Theta coupling increased between all areas during retrieval of conditioned fear, and declined during extinction learning. During extinction recall, theta coupling partly rebounded in LA-mPFC and CA1-mPFC, and remained at a low level in CA1-LA. Interfering with theta coupling through local electrical microstimulation in CA1-LA affected conditioned fear and extinction recall depending on theta phase. These results support the hypothesis that theta coupling provides a means for inter-areal coordination in conditioned behavioral responsiveness. More specifically, theta oscillations seem to contribute to a population code indicating conditioned stimuli during recall of fear memory before and after extinction.	[Lesting, Joerg; Narayanan, Rajeevan T.; Kluge, Christian; Sangha, Susan; Seidenbecher, Thomas; Pape, Hans-Christian] Univ Munster, Inst Physiol 1, Munster, Germany; [Kluge, Christian] Otto Von Guericke Univ, Dept Neurol, Magdeburg, Germany; [Kluge, Christian] UCL, Inst Cognit Neurosci, London, England; [Kluge, Christian] UCL, Wellcome Trust Ctr Neuroimaging, London, England; [Pape, Hans-Christian] Univ Munster, Inst Expt Epilepsy Res, Munster, Germany	University of Munster; Otto von Guericke University; University of London; University College London; University of London; University College London; University of Munster	Lesting, J (corresponding author), Univ Munster, Inst Physiol 1, Munster, Germany.	papechris@ukmuenster.de		Sangha, Susan/0000-0002-6461-4146	Deutsche Forschungsgemeinschaft [SFB-TRR58, A02]; Max-Planck Society; Humboldt Foundation; International Human Frontier Science Program Organization	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Max-Planck Society(Max Planck Society); Humboldt Foundation(Alexander von Humboldt Foundation); International Human Frontier Science Program Organization(Human Frontier Science Program)	This study was sponsored with funding from the Deutsche Forschungsgemeinschaft (SFB-TRR58, A02 to TS and HCP; http://sfbtrr58.uni-muenster.de/), the Max-Planck Society and Humboldt Foundation (Research Award 2007 to HCP; http://www.mpg.de/mpForschungspreis?page = 2), as well as the International Human Frontier Science Program Organization (SS; http://www.hfsp.org/funding/postdoctoral-fellowships). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikari A, 2010, NEURON, V65, P257, DOI 10.1016/j.neuron.2009.12.002; Buzsaki G, 2005, HIPPOCAMPUS, V15, P827, DOI 10.1002/hipo.20113; Buzsaki G, 2002, NEURON, V33, P325, DOI 10.1016/S0896-6273(02)00586-X; Corcoran KA, 2001, J NEUROSCI, V21, P1720, DOI 10.1523/JNEUROSCI.21-05-01720.2001; Dragoi G, 2006, NEURON, V50, P145, DOI 10.1016/j.neuron.2006.02.023; Farinelli M, 2006, LEARN MEMORY, V13, P329, DOI 10.1101/lm.204806; Fink AE, 2009, J NEUROSCI, V29, P11203, DOI 10.1523/JNEUROSCI.1450-09.2009; Franklin K. B. J., 2008, PAXINOS FRANKLINS MO; Herry C, 2008, NATURE, V454, P600, DOI 10.1038/nature07166; Hugues S, 2007, LEARN MEMORY, V14, P520, DOI 10.1101/lm.625407; Jensen O, 1996, LEARN MEMORY, V3, P279, DOI 10.1101/lm.3.2-3.279; Ji JZ, 2007, HIPPOCAMPUS, V17, P749, DOI 10.1002/hipo.20331; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Lesting J, 2011, EPILEPSIA, V52, P337, DOI 10.1111/j.1528-1167.2010.02758.x; MAGEE JC, 1995, SCIENCE, V268, P301, DOI 10.1126/science.7716525; Malenka RC, 2003, NAT REV NEUROSCI, V4, P923, DOI 10.1038/nrn1258; Maren S, 2004, NAT REV NEUROSCI, V5, P844, DOI 10.1038/nrn1535; Maren S, 2007, LEARN MEMORY, V14, P318, DOI 10.1101/lm.477007; Mizuseki K, 2009, NEURON, V64, P267, DOI 10.1016/j.neuron.2009.08.037; Myers KM, 2007, MOL PSYCHIATR, V12, P120, DOI 10.1038/sj.mp.4001939; Narayanan RT, 2007, EUR J NEUROSCI, V25, P1823, DOI 10.1111/j.1460-9568.2007.05437.x; Narayanan RT, 2007, NEUROREPORT, V18, P1107, DOI 10.1097/WNR.0b013e3282004992; Pape HC, 2010, PHYSIOL REV, V90, P419, DOI 10.1152/physrev.00037.2009; Pape HC, 2005, HIPPOCAMPUS, V15, P874, DOI 10.1002/hipo.20120; Pare D, 1996, J NEUROSCI, V16, P3334; Pare D, 2000, J NEUROSCI, V20, P2701; Paz R, 2008, LEARN MEMORY, V15, P524, DOI 10.1101/lm.932408; PHILLIPS RG, 1992, BEHAV NEUROSCI, V106, P274, DOI 10.1037/0735-7044.106.2.274; Popa D, 2010, P NATL ACAD SCI USA, V107, P6516, DOI 10.1073/pnas.0913016107; QUIRK GJ, 1995, NEURON, V15, P1029, DOI 10.1016/0896-6273(95)90092-6; Quirk GJ, 2008, NEUROPSYCHOPHARMACOL, V33, P56, DOI 10.1038/sj.npp.1301555; Repa JC, 2001, NAT NEUROSCI, V4, P724, DOI 10.1038/89512; Rodrigues SM, 2004, NEURON, V44, P75, DOI 10.1016/j.neuron.2004.09.014; Sangha S, 2009, J NEUROSCI, V29, P15713, DOI 10.1523/JNEUROSCI.2620-09.2009; Sehlmeyer C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005865; Seidenbecher T, 2003, SCIENCE, V301, P846, DOI 10.1126/science.1085818; Siapas AG, 2005, NEURON, V46, P141, DOI 10.1016/j.neuron.2005.02.028; Sirota A, 2008, NEURON, V60, P683, DOI 10.1016/j.neuron.2008.09.014; Skaggs WE, 1996, HIPPOCAMPUS, V6, P149, DOI 10.1002/(SICI)1098-1063(1996)6:2<149::AID-HIPO6>3.0.CO;2-K	39	164	166	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2011	6	6							e21714	10.1371/journal.pone.0021714	http://dx.doi.org/10.1371/journal.pone.0021714			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	784FW	21738775	Green Submitted, Green Published, gold			2022-12-27	WOS:000292142800063
J	McFarland, JM; Hahn, TTG; Mehta, MR				McFarland, James M.; Hahn, Thomas T. G.; Mehta, Mayank R.			Explicit-Duration Hidden Markov Model Inference of UP-DOWN States from Continuous Signals	PLOS ONE			English	Article							FORWARD-BACKWARD ALGORITHM; NEOCORTICAL NEURONS; SLOW OSCILLATIONS; IN-VIVO; PROBABILISTIC FUNCTIONS; SENSORY RESPONSES; DEPENDENCE; BURSTS; PHASE	Neocortical neurons show UP-DOWN state (UDS) oscillations under a variety of conditions. These UDS have been extensively studied because of the insight they can yield into the functioning of cortical networks, and their proposed role in putative memory formation. A key element in these studies is determining the precise duration and timing of the UDS. These states are typically determined from the membrane potential of one or a small number of cells, which is often not sufficient to reliably estimate the state of an ensemble of neocortical neurons. The local field potential (LFP) provides an attractive method for determining the state of a patch of cortex with high spatio-temporal resolution; however current methods for inferring UDS from LFP signals lack the robustness and flexibility to be applicable when UDS properties may vary substantially within and across experiments. Here we present an explicit-duration hidden Markov model (EDHMM) framework that is sufficiently general to allow statistically principled inference of UDS from different types of signals (membrane potential, LFP, EEG), combinations of signals (e. g., multichannel LFP recordings) and signal features over long recordings where substantial non-stationarities are present. Using cortical LFPs recorded from urethane-anesthetized mice, we demonstrate that the proposed method allows robust inference of UDS. To illustrate the flexibility of the algorithm we show that it performs well on EEG recordings as well. We then validate these results using simultaneous recordings of the LFP and membrane potential (MP) of nearby cortical neurons, showing that our method offers significant improvements over standard methods. These results could be useful for determining functional connectivity of different brain regions, as well as understanding network dynamics.	[McFarland, James M.] Brown Univ, Dept Phys, Providence, RI 02912 USA; [McFarland, James M.; Mehta, Mayank R.] Univ Calif Los Angeles, Dept Phys & Astron, Los Angeles, CA USA; [McFarland, James M.; Mehta, Mayank R.] Univ Calif Los Angeles, Integrat Ctr Learning & Memory, Los Angeles, CA USA; [Hahn, Thomas T. G.] Cent Inst Mental Hlth, Dept Psychiat, D-6800 Mannheim, Germany; [Hahn, Thomas T. G.] Max Planck Inst Med Res, Heidelberg, Germany; [Mehta, Mayank R.] Univ Calif Los Angeles, Dept Neurol, Los Angeles, CA 90024 USA; [Mehta, Mayank R.] Univ Calif Los Angeles, Dept Neurobiol, Los Angeles, CA 90024 USA	Brown University; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Central Institute of Mental Health; Max Planck Society; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	McFarland, JM (corresponding author), Brown Univ, Dept Phys, Providence, RI 02912 USA.	james_mcfarland@brown.edu; MayankMehta@ucla.edu		Mehta, Mayank/0000-0003-2005-2468	Whitehall Foundation [2009-0594]; NSF [IIS-0969034]; NIH-CRCNS-BMBF [1-R01-MH-092925-01]; W.M. Keck Foundation; Max-Planck Society; BMBF [01GQ1003B, 01GQ1007]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH092925] Funding Source: NIH RePORTER	Whitehall Foundation; NSF(National Science Foundation (NSF)); NIH-CRCNS-BMBF; W.M. Keck Foundation(W.M. Keck Foundation); Max-Planck Society(Max Planck SocietyFoundation CELLEX); BMBF(Federal Ministry of Education & Research (BMBF)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the Whitehall Foundation (www.whitehall.org) grant #2009-0594, an NSF career award (grant #IIS-0969034), an NIH-CRCNS-BMBF grant #1-R01-MH-092925-01, the W.M. Keck Foundation, the Max-Planck Society and BMBF grants 01GQ1003B and 01GQ1007. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson J, 2000, NAT NEUROSCI, V3, P617, DOI 10.1038/75797; Battaglia FP, 2004, LEARN MEMORY, V11, P697, DOI 10.1101/lm.73504; BAUM LE, 1966, ANN MATH STAT, V37, P1554, DOI 10.1214/aoms/1177699147; BAUM LE, 1970, ANN MATH STAT, V41, P164, DOI 10.1214/aoms/1177697196; Bhattacharyya A., 1943, B CALCUTTA MATH SOC, V35, P99; Bishop C. M, 2006, PATTERN RECOGNITION; Bokil H, 2010, J NEUROSCI METH, V192, P146, DOI 10.1016/j.jneumeth.2010.06.020; Chen Z, 2009, NEURAL COMPUT, V21, P1797, DOI 10.1162/neco.2009.06-08-799; CHOI SC, 1969, TECHNOMETRICS, V11, P683, DOI 10.2307/1266892; Clement EA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002004; CONTRERAS D, 1995, J NEUROSCI, V15, P604; COWAN RL, 1994, J NEUROPHYSIOL, V71, P17, DOI 10.1152/jn.1994.71.1.17; Curto C, 2009, J NEUROSCI, V29, P10600, DOI 10.1523/JNEUROSCI.2053-09.2009; Datta R, 2008, INT C PATT RECOG, P2593; EPHRAIM Y, 1989, IEEE T ACOUST SPEECH, V37, P1846, DOI 10.1109/29.45532; Ferguson JD, 1980, P S APPL HIDD MARK M, P143; Gerkin RC, 2010, J CLIN NEUROPHYSIOL, V27, P425, DOI 10.1097/WNP.0b013e3181fdf8bd; Hahn TTG, 2007, P NATL ACAD SCI USA, V104, P5169, DOI 10.1073/pnas.0700222104; Hahn TTG, 2006, NAT NEUROSCI, V9, P1359, DOI 10.1038/nn1788; Haider B, 2006, J NEUROSCI, V26, P4535, DOI 10.1523/JNEUROSCI.5297-05.2006; Haider B, 2007, J NEUROPHYSIOL, V97, P4186, DOI 10.1152/jn.01114.2006; Isomura Y, 2006, NEURON, V52, P871, DOI 10.1016/j.neuron.2006.10.023; Ji DY, 2007, NAT NEUROSCI, V10, P100, DOI 10.1038/nn1825; KAILATH T, 1967, IEEE T COMMUN TECHN, VCO15, P52, DOI 10.1109/TCOM.1967.1089532; Kasanetz F, 2002, J PHYSIOL-LONDON, V543, P577, DOI 10.1113/jphysiol.2002.0024786; Levinson S. E., 1986, Computer Speech and Language, V1, P29, DOI 10.1016/S0885-2308(86)80009-2; Luczak A, 2007, P NATL ACAD SCI USA, V104, P347, DOI 10.1073/pnas.0605643104; Margrie TW, 2002, PFLUG ARCH EUR J PHY, V444, P491, DOI 10.1007/s00424-002-0831-z; Marshall L, 2006, NATURE, V444, P610, DOI 10.1038/nature05278; MITCHELL C, 1995, IEEE T SPEECH AUDI P, V3, P213, DOI 10.1109/89.388149; MITCHELL C, 1993, IEEE INT C AC SPEECH, P11331; Molle M, 2006, J NEUROPHYSIOL, V96, P62, DOI 10.1152/jn.00014.2006; Molle M, 2002, J NEUROSCI, V22, P10941; Mukovski M, 2007, CEREB CORTEX, V17, P400, DOI 10.1093/cercor/bhj157; Petersen CCH, 2003, P NATL ACAD SCI USA, V100, P13638, DOI 10.1073/pnas.2235811100; RABINER LR, 1989, P IEEE, V77, P257, DOI 10.1109/5.18626; Saleem AB, 2010, J COMPUT NEUROSCI, V29, P49, DOI 10.1007/s10827-010-0228-5; Sanchez-Vives MV, 2010, J NEUROPHYSIOL, V104, P1314, DOI 10.1152/jn.00178.2010; Sanchez-Vives MV, 2000, NAT NEUROSCI, V3, P1027, DOI 10.1038/79848; Seamari Y, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000888; Shu YS, 2003, NATURE, V423, P288, DOI 10.1038/nature01616; Steriade M, 2000, NEUROSCIENCE, V101, P243, DOI 10.1016/S0306-4522(00)00353-5; STERIADE M, 1993, J NEUROSCI, V13, P3252, DOI 10.1523/jneurosci.13-08-03252.1993; Stickgold R, 2005, NATURE, V437, P1272, DOI 10.1038/nature04286; TERRELL GR, 1990, J AM STAT ASSOC, V85, P470, DOI 10.2307/2289786; THOMSON DJ, 1982, P IEEE, V70, P1055, DOI 10.1109/PROC.1982.12433; Tokdar S, 2010, J COMPUT NEUROSCI, V29, P203, DOI 10.1007/s10827-009-0182-2; Volgushev M, 2006, J NEUROSCI, V26, P5665, DOI 10.1523/JNEUROSCI.0279-06.2006; Wolansky T, 2006, J NEUROSCI, V26, P6213, DOI 10.1523/JNEUROSCI.5594-05.2006; Yu SZ, 2010, ARTIF INTELL, V174, P215, DOI 10.1016/j.artint.2009.11.011; Yu SZ, 2006, IEEE T SIGNAL PROCES, V54, P1947, DOI 10.1109/TSP.2006.872540; Yu SZ, 2003, IEEE SIGNAL PROC LET, V10, P11, DOI 10.1109/LSP.2002.806705	52	11	12	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2011	6	6							e21606	10.1371/journal.pone.0021606	http://dx.doi.org/10.1371/journal.pone.0021606			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	784FW	21738730	Green Published, gold			2022-12-27	WOS:000292142800045
J	Rohde, M; Di Luca, M; Ernst, MO				Rohde, Marieke; Di Luca, Massimiliano; Ernst, Marc O.			The Rubber Hand Illusion: Feeling of Ownership and Proprioceptive Drift Do Not Go Hand in Hand	PLOS ONE			English	Article							VISUAL CAPTURE; BODY OWNERSHIP; TOUCH; EXPERIENCE; AMPUTEES; PHANTOM; MIRROR; BRAIN; ARM	In the Rubber Hand Illusion, the feeling of ownership of a rubber hand displaced from a participant's real occluded hand is evoked by synchronously stroking both hands with paintbrushes. A change of perceived finger location towards the rubber hand (proprioceptive drift) has been reported to correlate with this illusion. To measure the time course of proprioceptive drift during the Rubber Hand Illusion, we regularly interrupted stroking (performed by robot arms) to measure perceived finger location. Measurements were made by projecting a probe dot into the field of view (using a semi-transparent mirror) and asking participants if the dot is to the left or to the right of their invisible hand (Experiment 1) or to adjust the position of the dot to that of their invisible hand (Experiment 2). We varied both the measurement frequency (every 10 s, 40 s, 120 s) and the mode of stroking (synchronous, asynchronous, just vision). Surprisingly, with frequent measurements, proprioceptive drift occurs not only in the synchronous stroking condition but also in the two control conditions (asynchronous stroking, just vision). Proprioceptive drift in the synchronous stroking condition is never higher than in the just vision condition. Only continuous exposure to asynchronous stroking prevents proprioceptive drift and thus replicates the differences in drift reported in the literature. By contrast, complementary subjective ratings (questionnaire) show that the feeling of ownership requires synchronous stroking and is not present in the asynchronous stroking condition. Thus, subjective ratings and drift are dissociated. We conclude that different mechanisms of multisensory integration are responsible for proprioceptive drift and the feeling of ownership. Proprioceptive drift relies on visuoproprioceptive integration alone, a process that is inhibited by asynchronous stroking, the most common control condition in Rubber Hand Illusion experiments. This dissociation implies that conclusions about feelings of ownership cannot be drawn from measuring proprioceptive drift alone.	[Rohde, Marieke; Ernst, Marc O.] Univ Bielefeld, Dept Cognit Neurosci, Bielefeld, Germany; [Rohde, Marieke; Di Luca, Massimiliano; Ernst, Marc O.] Max Planck Inst Biol Cybernet, Multisensory Percept & Act Grp, Tubingen, Germany; [Di Luca, Massimiliano] Max Planck Inst Biol Cybernet, Dept Human Percept Cognit & Act, Tubingen, Germany	University of Bielefeld; Max Planck Society; Max Planck Society	Rohde, M (corresponding author), Univ Bielefeld, Dept Cognit Neurosci, Bielefeld, Germany.	marieke.rohde@tuebingen.mpg.de	Di Luca, Massimiliano/A-7850-2012	Di Luca, Massimiliano/0000-0003-3085-7251; Rohde, Marieke/0000-0002-8354-8850; Ernst, Marc/0000-0003-4197-8569	EU [IST-2006-027141, IST-2009-248587]; HFSP; Max Planck Society	EU(European Commission); HFSP(Human Frontier Science Program); Max Planck Society(Max Planck SocietyFoundation CELLEX)	This research was supported by the EU Grants ImmerSence (IST-2006-027141) and THE (IST-2009-248587), the HFSP Research Grant (2006) on "Mechanisms of associative learning in human perception" and the Max Planck Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Armel KC, 2003, P ROY SOC B-BIOL SCI, V270, P1499, DOI 10.1098/rspb.2003.2364; Botvinick M, 1998, NATURE, V391, P756, DOI 10.1038/35784; Costantini M, 2007, CONSCIOUS COGN, V16, P229, DOI 10.1016/j.concog.2007.01.001; Davies AMA, 2010, PERCEPTION, V39, P830, DOI 10.1068/p6610; Durgin FH, 2007, PSYCHOL SCI, V18, P152, DOI 10.1111/j.1467-9280.2007.01865.x; Ehrsson HH, 2007, SCIENCE, V317, P1048, DOI 10.1126/science.1142175; Ehrsson HH, 2007, P NATL ACAD SCI USA, V104, P9828, DOI 10.1073/pnas.0610011104; Ehrsson HH, 2008, BRAIN, V131, P3443, DOI 10.1093/brain/awn297; Ehrsson HH, 2005, J NEUROSCI, V25, P10564, DOI 10.1523/JNEUROSCI.0800-05.2005; Ehrsson HH, 2004, SCIENCE, V305, P875, DOI 10.1126/science.1097011; Farne A, 2000, BRAIN, V123, P2350, DOI 10.1093/brain/123.11.2350; Gallagher S., 2005, BODY SHAPES MIND; Giummarra MJ, 2010, PERCEPTION, V39, P103, DOI 10.1068/p6519; Graziano MSA, 1999, P NATL ACAD SCI USA, V96, P10418, DOI 10.1073/pnas.96.18.10418; Holmes NP, 2006, PERCEPT PSYCHOPHYS, V68, P685, DOI 10.3758/BF03208768; Holmes NP, 2004, COGN AFFECT BEHAV NE, V4, P193, DOI 10.3758/CABN.4.2.193; IJsselsteijn WA, 2006, PRESENCE-TELEOP VIRT, V15, P455, DOI 10.1162/pres.15.4.455; Kammers MPM, 2009, NEUROPSYCHOLOGIA, V47, P204, DOI 10.1016/j.neuropsychologia.2008.07.028; Kammers MPM, 2009, J COGNITIVE NEUROSCI, V21, P1311, DOI 10.1162/jocn.2009.21095; Kanayama N, 2007, PSYCHOPHYSIOLOGY, V44, P392, DOI 10.1111/j.1469-8986.2007.00511.x; Lenggenhager B, 2007, SCIENCE, V317, P1096, DOI 10.1126/science.1143439; Longo MR, 2008, COGNITION, V107, P978, DOI 10.1016/j.cognition.2007.12.004; Longo MR, 2008, CONSCIOUS COGN, V17, P1181, DOI 10.1016/j.concog.2008.01.001; Lopez C, 2010, CONSCIOUS COGN, V19, P33, DOI 10.1016/j.concog.2009.12.003; Makin TR, 2008, BEHAV BRAIN RES, V191, P1, DOI 10.1016/j.bbr.2008.02.041; Moseley GL, 2008, P NATL ACAD SCI USA, V105, P13169, DOI 10.1073/pnas.0803768105; Mussap AJ, 2006, J HEALTH PSYCHOL, V11, P627, DOI 10.1177/1359105306065022; Pavani F, 2000, PSYCHOL SCI, V11, P353, DOI 10.1111/1467-9280.00270; Peled A, 2003, SCHIZOPHR RES, V64, P157, DOI 10.1016/S0920-9964(03)00057-4; Peled A, 2000, BIOL PSYCHIAT, V48, P1105, DOI 10.1016/S0006-3223(00)00947-1; Petkova VI, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006933; Petkova VI, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003832; RAMACHANDRAN VS, 1995, NATURE, V377, P489, DOI 10.1038/377489a0; Schutz-Bosbach S, 2009, BRAIN COGNITION, V70, P136, DOI 10.1016/j.bandc.2009.01.006; Shimada S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006185; Slater M, 2008, FRONT HUM NEUROSCI, V2, DOI 10.3389/neuro.09.006.2008; TREUTWEIN B, 1995, VISION RES, V35, P2503, DOI 10.1016/0042-6989(95)00016-X; Tsakiris M, 2005, J EXP PSYCHOL HUMAN, V31, P80, DOI 10.1037/0096-1523.31.1.80; Tsakiris M, 2008, NEUROPSYCHOLOGIA, V46, P3014, DOI 10.1016/j.neuropsychologia.2008.06.004; Tsakiris M, 2007, CEREB CORTEX, V17, P2235, DOI 10.1093/cercor/bhl131; Tsakiris M, 2006, CONSCIOUS COGN, V15, P423, DOI 10.1016/j.concog.2005.09.004; Tsakiris M, 2010, NEUROPSYCHOLOGIA, V48, P703, DOI 10.1016/j.neuropsychologia.2009.09.034; Tsakiris M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004040; van Beers RJ, 1998, EXP BRAIN RES, V122, P367, DOI 10.1007/s002210050525; WANN JP, 1992, EXP BRAIN RES, V91, P162; WELCH RB, 1980, PSYCHOL BULL, V88, P638, DOI 10.1037/0033-2909.88.3.638; White RC, 2010, CONSCIOUS COGN, V19, P505, DOI 10.1016/j.concog.2009.08.003; Wichmann FA, 2001, PERCEPT PSYCHOPHYS, V63, P1293, DOI 10.3758/BF03194544; Zopf R, 2010, NEUROPSYCHOLOGIA, V48, P713, DOI 10.1016/j.neuropsychologia.2009.10.028	49	329	330	4	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2011	6	6							e21659	10.1371/journal.pone.0021659	http://dx.doi.org/10.1371/journal.pone.0021659			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	784FW	21738756	Green Submitted, gold, Green Published			2022-12-27	WOS:000292142800055
J	Bell, L; Chowdhary, R; Liu, JS; Niu, XF; Zhang, JF				Bell, Lindsey; Chowdhary, Rajesh; Liu, Jun S.; Niu, Xufeng; Zhang, Jinfeng			Integrated Bio-Entity Network: A System for Biological Knowledge Discovery	PLOS ONE			English	Article							PROTEIN-INTERACTION DATABASE; GENE-CENTERED INFORMATION; AUTOMATIC EXTRACTION; ONTOLOGY ANNOTATION; EVENT EXTRACTION; ENTREZ GENE; DISEASE; TEXT; ACTIVATION; ASSOCIATION	A significant part of our biological knowledge is centered on relationships between biological entities (bio-entities) such as proteins, genes, small molecules, pathways, gene ontology (GO) terms and diseases. Accumulated at an increasing speed, the information on bio-entity relationships is archived in different forms at scattered places. Most of such information is buried in scientific literature as unstructured text. Organizing heterogeneous information in a structured form not only facilitates study of biological systems using integrative approaches, but also allows discovery of new knowledge in an automatic and systematic way. In this study, we performed a large scale integration of bio-entity relationship information from both databases containing manually annotated, structured information and automatic information extraction of unstructured text in scientific literature. The relationship information we integrated in this study includes protein-protein interactions, protein/gene regulations, protein-small molecule interactions, protein-GO relationships, protein-pathway relationships, and pathway-disease relationships. The relationship information is organized in a graph data structure, named integrated bio-entity network (IBN), where the vertices are the bio-entities and edges represent their relationships. Under this framework, graph theoretic algorithms can be designed to perform various knowledge discovery tasks. We designed breadth-first search with pruning (BFSP) and most probable path (MPP) algorithms to automatically generate hypotheses-the indirect relationships with high probabilities in the network. We show that IBN can be used to generate plausible hypotheses, which not only help to better understand the complex interactions in biological systems, but also provide guidance for experimental designs.	[Bell, Lindsey; Niu, Xufeng; Zhang, Jinfeng] Florida State Univ, Dept Stat, Tallahassee, FL 32306 USA; [Chowdhary, Rajesh] MCRF BIRC, Marshfield Ctr, Marshfield Clin, Marshfield, WI USA; [Liu, Jun S.] Harvard Univ, Dept Stat, Cambridge, MA 02138 USA	State University System of Florida; Florida State University; Marshfield Clinic; Harvard University	Bell, L (corresponding author), Florida State Univ, Dept Stat, Tallahassee, FL 32306 USA.	jinfeng@stat.fsu.edu	Chowdhary, Rajesh/D-5865-2012		NIH [R01-HG02518-02]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002518] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	JSL was supported in part by the NIH Grant R01-HG02518-02. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfarano C, 2005, NUCLEIC ACIDS RES, V33, pD418, DOI 10.1093/nar/gki051; Apweiler R, 2004, NUCLEIC ACIDS RES, V32, pD115, DOI 10.1093/nar/gkh131; Aranda B, 2010, NUCLEIC ACIDS RES, V38, pD525, DOI 10.1093/nar/gkp878; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Barrell D, 2009, NUCLEIC ACIDS RES, V37, pD396, DOI 10.1093/nar/gkn803; Beuming T, 2005, BIOINFORMATICS, V21, P827, DOI 10.1093/bioinformatics/bti098; Bjorne J, 2010, BIOINFORMATICS, V26, pi382, DOI 10.1093/bioinformatics/btq180; Blaschke C, 2001, COMP FUNCT GENOM, V2, P310, DOI 10.1002/cfg.102; BUI QC, 2010, HYBRID APPROACH EXTR; Bui QC, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-101; CASTAGNA M, 1982, J BIOL CHEM, V257, P7847; Ceol A, 2008, FEBS LETT, V582, P1171, DOI 10.1016/j.febslet.2008.02.071; Chatr-Aryamontri A, 2007, NUCLEIC ACIDS RES, V35, pD572, DOI 10.1093/nar/gkl950; Chowdhary R, 2009, BIOINFORMATICS, V25, P1536, DOI 10.1093/bioinformatics/btp245; CORMEN TH, 2009, INTROCUTION ALGORITH; Coulet A, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S4-S3; Crnich R, 2010, AM J PHYSIOL-CELL PH, V299, pC682, DOI 10.1152/ajpcell.00101.2010; Daraselia N, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-243; Devignes Marie-Dominique, 2010, International Journal of Metadata, Semantics and Ontologies, V5, P184; Dijkstra E. W., 1959, NUMERISCHE MATH, V1, P269, DOI [DOI 10.1007/BF01386390, 10.1007/BF01386390]; Du KY, 2003, SCIENCE, V300, P1574, DOI 10.1126/science.1079817; Friedman C., 2001, BIOINFORMATICS S1, V17, P74; Frijters R, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000943; Gama-Castro S, 2008, NUCLEIC ACIDS RES, V36, pD120, DOI 10.1093/nar/gkm994; Gao ZG, 2002, J BIOL CHEM, V277, P48115, DOI 10.1074/jbc.M209459200; Giles CB, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S9-S11; Gong L., 2008, CURR PROTOC BIOINFOR; Gonzalez G, 2007, PACIFIC SYMPOSIUM ON BIOCOMPUTING 2007, P28; Griffith OL, 2008, NUCLEIC ACIDS RES, V36, pD107, DOI 10.1093/nar/gkm967; Grote A, 2009, NUCLEIC ACIDS RES, V37, pD61, DOI 10.1093/nar/gkn837; Han K, 2004, BIOINFORMATICS, V20, P2466, DOI 10.1093/bioinformatics/bth253; Hoffmann R, 2004, NAT GENET, V36, P664, DOI 10.1038/ng0704-664; Hoffmann R, 2005, SCI STKE, V2005, P21; Hristovski Dimitar, 2006, AMIA Annu Symp Proc, P349; Huang ML, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-S2-S12; Huang ZQ, 2008, BIOCHEM BIOPH RES CO, V374, P517, DOI 10.1016/j.bbrc.2008.07.058; Iossifov I, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000559; Jensen LJ, 2006, NAT REV GENET, V7, P119, DOI 10.1038/nrg1768; Kanehisa M, 2002, NOVART FDN SYMP, V247, P91; Kann MG, 2007, BRIEF BIOINFORM, V8, P333, DOI 10.1093/bib/bbm031; Koike A, 2005, BIOINFORMATICS, V21, P1227, DOI 10.1093/bioinformatics/bti084; Korbel JO, 2005, PLOS BIOL, V3, P815, DOI 10.1371/journal.pbio.0030134; Krallinger M., 2007, P 2 BIOCREATIVE CHAL, P41; Krallinger M, 2008, GENOME BIOL, V9, DOI [10.1186/gb-2008-9-s2-s1, 10.1186/gb-2008-9-S2-S4, 10.1186/gb-2008-9-s2-s4, 10.1186/gb-2008-9-S2-S1]; KUHN M, NUCL ACIDS RES, V38, pD552; Kuhn M, 2008, NUCLEIC ACIDS RES, V36, pD684, DOI 10.1093/nar/gkm795; Leitner F, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-S2-S6; Li Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004346; Liu HF, 2006, BIOINFORMATICS, V22, P103, DOI 10.1093/bioinformatics/bti749; Maglott D, 2005, NUCLEIC ACIDS RES, V33, pD54, DOI 10.1093/nar/gki031; Maglott D, 2007, NUCLEIC ACIDS RES, V35, pD26, DOI 10.1093/nar/gkl993; Mathivanan S, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S5-S19; Matys V, 2003, NUCLEIC ACIDS RES, V31, P374, DOI 10.1093/nar/gkg108; Mishra GR, 2006, NUCLEIC ACIDS RES, V34, pD411, DOI 10.1093/nar/gkj141; Mottaz A, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S5-S3; Naidu S, 2008, J IMMUNOL, V181, P4113, DOI 10.4049/jimmunol.181.6.4113; Pagel P, 2005, BIOINFORMATICS, V21, P832, DOI 10.1093/bioinformatics/bti115; Prasad TSK, 2009, NUCLEIC ACIDS RES, V37, pD767, DOI 10.1093/nar/gkn892; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; Rzhetsky A, 2008, CELL, V134, P9, DOI 10.1016/j.cell.2008.06.029; Saetre R, 2010, IEEE ACM T COMPUT BI, V7, P442, DOI 10.1109/TCBB.2010.46; Salwinski L, 2004, NUCLEIC ACIDS RES, V32, pD449, DOI 10.1093/nar/gkh086; Schaefer CF, 2009, NUCLEIC ACIDS RES, V37, pD674, DOI 10.1093/nar/gkn653; Shahi P, 2006, NUCLEIC ACIDS RES, V34, pD115, DOI 10.1093/nar/gkj093; Sierro N, 2006, NUCLEIC ACIDS RES, V34, pD552, DOI 10.1093/nar/gkj064; Srinivasan P, 2004, J AM SOC INF SCI TEC, V55, P396, DOI 10.1002/asi.10389; Stark C, 2006, NUCLEIC ACIDS RES, V34, pD535, DOI 10.1093/nar/gkj109; SWANSON DR, 1986, LIBR QUART, V56, P103, DOI 10.1086/601720; Tikk D, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000837; Vastrik I, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-3-r39; Wang YL, 2009, NUCLEIC ACIDS RES, V37, pW623, DOI 10.1093/nar/gkp456; Wong LS, 2010, J COMPUT SCI TECH-CH, V25, P124, DOI 10.1007/s11390-010-9310-8; Wren JD, 2004, BIOINFORMATICS, V20, P389, DOI 10.1093/bioinformatics/btg421; Yetisgen-Yildiz M, 2006, J BIOMED INFORM, V39, P600, DOI 10.1016/j.jbi.2005.11.010; Yilmaz S, 2009, BIOINFORMATICS, V25, P230, DOI 10.1093/bioinformatics/btn612; Yuryev A, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-171	76	23	24	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2011	6	6							e21474	10.1371/journal.pone.0021474	http://dx.doi.org/10.1371/journal.pone.0021474			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	783OD	21738677	gold, Green Published, Green Submitted			2022-12-27	WOS:000292092600044
J	Li, RS; Xia, W; Zhang, ZH; Wu, K				Li, Ruisong; Xia, Wei; Zhang, Zhihong; Wu, Kun			S100B Protein, Brain-Derived Neurotrophic Factor, and Glial Cell Line-Derived Neurotrophic Factor in Human Milk	PLOS ONE			English	Article							FACTOR MESSENGER-RNA; NEURITE EXTENSION; NEURON SURVIVAL; NERVOUS-SYSTEM; NITRIC-OXIDE; RAT; GDNF; DIFFERENTIATION; PURIFICATION; INFLAMMATION	Background: Human milk contains a wide variety of nutrients that contribute to the fulfillment of its functions, which include the regulation of newborn development. However, few studies have investigated the concentrations of S100B protein, brain-derived neurotrophic factor (BDNF), and glial cell line-derived neurotrophic factor (GDNF) in human milk. The associations of the concentrations of S100B protein, BDNF, and GDNF with maternal factors are not well explored. Methodology/Principal Findings: To investigate the concentrations of S100B protein, BDNF, and GDNF in human milk and characterize the maternal factors associated with their levels in human milk, human milk samples were collected at days 3, 10, 30, and 90 after parturition. Levels of S100B protein, BDNF, and GDNF, and their mRNAs in the samples were detected. Then, these concentrations were compared with lactation and other maternal factors. S100B protein levels in human milk samples collected at 3, 10, 30, and 90 d after parturition were 1249.79 +/- 398.10, 1345.05 +/- 539.16, 1481.83 +/- 573.30, and 1414.39 +/- 621.31 ng/L, respectively. On the other hand, the BDNF concentrations in human milk samples were 10.99 +/- 4.55, 13.01 +/- 5.88, 13.35 +/- 6.43, and 2.83 +/- 5.47 mu g/L, while those of GDNF were 10.90 +/- 1.65, 11.38 +/- 1., 11.29 +/- 3.10, and 11.40 +/- 2.21 g/L for the same time periods. Maternal post-pregnancy body mass index was positively associated with S100B levels in human milk (r = 0.335, P = 0.030 < 0.05). In addition, there was a significant correlation between the levels of S100B protein and BDNF (z = 2.09, P = 0.037 < 0.05). Delivery modes were negatively associated with the concentration of GDNF in human milk. Conclusions: S100B protein, BDNF, and GDNF are present in all samples of human milk, and they may be responsible for the long term effects of breast feeding.	[Li, Ruisong; Zhang, Zhihong; Wu, Kun] Harbin Med Coll, Sch Publ Hlth, Dept Nutr & Food Hyg, Harbin, Peoples R China; [Xia, Wei] Harbin Med Coll, Sch Publ Hlth, Dept Children Hlth & Hyg, Harbin, Peoples R China	Harbin Medical University; Harbin Medical University	Li, RS (corresponding author), Harbin Med Coll, Sch Publ Hlth, Dept Nutr & Food Hyg, Harbin, Peoples R China.	wukun_15000@163.com	zhang, zh/GWV-4677-2022					Alexanian AR, 1999, FASEB J, V13, P1611, DOI 10.1096/fasebj.13.12.1611; Barnabe-Heider F, 2003, J NEUROSCI, V23, P5149; Bhandari N, 2003, LANCET, V361, P1418, DOI 10.1016/S0140-6736(03)13134-0; BHATTACHARYYA A, 1992, J NEUROBIOL, V23, P451, DOI 10.1002/neu.480230410; Boesmans W, 2008, GUT, V57, DOI 10.1136/gut.2007.131839; Cheng AW, 2003, DEV BIOL, V258, P319, DOI 10.1016/S0012-1606(03)00120-9; Chirico G, 2008, J NUTR, V138, p1801S, DOI 10.1093/jn/138.9.1801S; Cunha ABM, 2006, NEUROSCI LETT, V398, P215, DOI 10.1016/j.neulet.2005.12.085; de Amici D, 2001, EUR J EPIDEMIOL, V17, P357, DOI 10.1023/A:1012731713393; Delafoy L, 2006, GUT, V55, P940, DOI 10.1136/gut.2005.064063; Enstrom Amanda, 2008, Am J Biochem Biotechnol, V4, P121; Ernfors P, 2003, TRENDS NEUROSCI, V26, P171, DOI 10.1016/S0166-2236(03)00064-X; Gazzolo D, 2004, CLIN NUTR, V23, P23, DOI 10.1016/S0261-5614(03)00084-0; Gazzolo D, 2003, BBA-GEN SUBJECTS, V1619, P209, DOI 10.1016/S0304-4165(02)00499-3; Gerlai R, 2001, EUR J NEUROSCI, V14, P1153, DOI 10.1046/j.0953-816x.2001.01724.x; Gromov L A, 1992, Neurosci Behav Physiol, V22, P25, DOI 10.1007/BF01186664; Haglid KG, 1997, BRAIN RES, V753, P196, DOI 10.1016/S0006-8993(96)01463-1; HAIMOTO H, 1985, AM J PATHOL, V121, P185; Hamosh M, 2001, PEDIATR CLIN N AM, V48, P69, DOI 10.1016/S0031-3955(05)70286-8; Hashimoto M, 2005, BIOMED RES-TOKYO, V26, P223, DOI 10.2220/biomedres.26.223; Heizmann CW, 2002, FRONT BIOSCI-LANDMRK, V7, pD1356, DOI 10.2741/heizmann; HOFER M, 1990, EMBO J, V9, P2459, DOI 10.1002/j.1460-2075.1990.tb07423.x; Horwood LJ, 2001, ARCH DIS CHILD-FETAL, V84, pF23, DOI 10.1136/fn.84.1.F23; Kerschensteiner M, 1999, J EXP MED, V189, P865, DOI 10.1084/jem.189.5.865; KLIGMAN D, 1985, P NATL ACAD SCI USA, V82, P7136, DOI 10.1073/pnas.82.20.7136; Ledda F, 2007, NAT NEUROSCI, V10, P293, DOI 10.1038/nn1855; LEWIS D, 1986, BRAIN RES, V383, P159, DOI 10.1016/0006-8993(86)90016-8; LIN LFH, 1993, SCIENCE, V260, P1130, DOI 10.1126/science.8493557; LIN LFH, 1994, J NEUROCHEM, V63, P758; Lonnerdal B, 2003, AM J CLIN NUTR, V77, p1537S; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lucas A, 1998, BRIT MED J, V317, P1481, DOI 10.1136/bmj.317.7171.1481; MacDorman MF, 2008, BIRTH-ISS PERINAT C, V35, P3, DOI 10.1111/j.1523-536X.2007.00205.x; Mattson MP, 2004, TRENDS NEUROSCI, V27, P589, DOI 10.1016/j.tins.2004.08.001; Moore MW, 1996, NATURE, V382, P76, DOI 10.1038/382076a0; Murer MG, 2001, PROG NEUROBIOL, V63, P71, DOI 10.1016/S0301-0082(00)00014-9; MUSUMECI M, 2008, NUTR METAB, V22, P5; Netto CBO, 2006, ARCH MED RES, V37, P683, DOI 10.1016/j.arcmed.2005.11.005; Nishi M, 1996, SYNAPSE, V23, P1, DOI 10.1002/(SICI)1098-2396(199605)23:1<1::AID-SYN1>3.0.CO;2-E; ODowd BS, 1997, NEUROBIOL LEARN MEM, V67, P197, DOI 10.1006/nlme.1997.3766; Pascual A, 2008, NAT NEUROSCI, V11, P755, DOI 10.1038/nn.2136; Portela LVC, 2002, CLIN CHEM, V48, P950; Riol H, 1997, J NEUROSCI RES, V48, P53; Schanler RJ, 1999, PEDIATRICS, V103, P1150, DOI 10.1542/peds.103.6.1150; Steiner J, 2010, PSYCHONEUROENDOCRINO, V35, P321, DOI 10.1016/j.psyneuen.2009.07.012; UEDA S, 1995, MOL BRAIN RES, V29, P365, DOI 10.1016/0169-328X(94)00269-K; VANELDIK LJ, 1991, BRAIN RES, V542, P280, DOI 10.1016/0006-8993(91)91579-P; Wartiovaara K, 1998, J PEDIATR SURG, V33, P1501, DOI 10.1016/S0022-3468(98)90485-7; WINNINGHAMMAJOR F, 1989, J CELL BIOL, V109, P3063, DOI 10.1083/jcb.109.6.3063; Zanardo V, 2010, BIRTH-ISS PERINAT C, V37, P275, DOI 10.1111/j.1523-536X.2010.00421.x; Zhang DK, 2010, J PATHOL, V222, P213, DOI 10.1002/path.2749; Zhang XB, 2008, PROG NEURO-PSYCHOPH, V32, P886, DOI 10.1016/j.pnpbp.2008.01.004	52	19	24	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2011	6	6							e21663	10.1371/journal.pone.0021663	http://dx.doi.org/10.1371/journal.pone.0021663			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	783OD	21738758	Green Published, gold, Green Submitted			2022-12-27	WOS:000292092600070
J	Hamai, A; Duperrier-Amouriaux, K; Pignon, P; Raimbaud, I; Memeo, L; Colarossi, C; Canzonieri, V; Perin, T; Classe, JM; Campone, M; Jezequel, P; Campion, L; Ayyoub, M; Valmori, D				Hamai, Ahmed; Duperrier-Amouriaux, Karine; Pignon, Pascale; Raimbaud, Isabelle; Memeo, Lorenzo; Colarossi, Cristina; Canzonieri, Vincenzo; Perin, Tiziana; Classe, Jean-Marc; Campone, Mario; Jezequel, Pascal; Campion, Loic; Ayyoub, Maha; Valmori, Danila			Antibody Responses to NY-ESO-1 in Primary Breast Cancer Identify a Subtype Target for Immunotherapy	PLOS ONE			English	Article							TESTIS ANTIGEN NY-ESO-1; IMMUNE-RESPONSES; EXPRESSION; MELANOMA; EPITOPES; CELLS	The highly immunogenic human tumor antigen NY-ESO-1 (ESO) is a target of choice for anti-cancer immune therapy. In this study, we assessed spontaneous antibody (Ab) responses to ESO in a large cohort of patients with primary breast cancer (BC) and addressed the correlation between the presence of anti-ESO Ab, the expression of ESO in the tumors and their characteristics. We found detectable Ab responses to ESO in 1% of the patients. Tumors from patients with circulating Ab to ESO exhibited common characteristics, being mainly hormone receptor (HR)(-) invasive ductal carcinomas of high grade, including both HER2(-) and HER2(+) tumors. In line with these results, we detected ESO expression in 20% of primary HR(-) BC, including both ESO Ab(+) and Ab(-) patients, but not in HR(+) BC. Interestingly, whereas expression levels in ESO(+) BC were not significantly different between ESO Ab(+) and Ab(-) patients, the former had, in average, significantly higher numbers of tumor-infiltrated lymph nodes, indicating that lymph node invasion may be required for the development of spontaneous anti-tumor immune responses. Thus, the presence of ESO Ab identifies a tumor subtype of HR(-) (HER2(-) or HER2(+)) primary BC with frequent ESO expression and, together with the assessment of antigen expression in the tumor, may be instrumental for the selection of patients for whom ESO-based immunotherapy may complement standard therapy.	[Hamai, Ahmed; Duperrier-Amouriaux, Karine; Pignon, Pascale; Raimbaud, Isabelle; Ayyoub, Maha; Valmori, Danila] CLCC Rene Gauducheau, INSERM, U892, St Herblain, France; [Memeo, Lorenzo; Colarossi, Cristina] Mediterranean Inst Oncol, Pathol Unit, Catania, Italy; [Canzonieri, Vincenzo; Perin, Tiziana] IRCCS, Ctr Riferimento Oncol, Aviano, Pordenone, Italy; [Classe, Jean-Marc] CLCC Rene Gauducheau, Dept Surg, St Herblain, France; [Campone, Mario] CLCC Rene Gauducheau, Dept Med Oncol, St Herblain, France; [Jezequel, Pascal] CLCC Rene Gauducheau, Dept Oncobiol, St Herblain, France; [Campion, Loic] CLCC Rene Gauducheau, Dept Biostat, St Herblain, France; [Campone, Mario] IRT UN, INSERM, U892, Nantes, France; [Valmori, Danila] Univ Nantes, Fac Med, Nantes, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Institut de Cancerologie de l'Ouest (ICO); Mediterranean Institute of Oncology; IRCCS Aviano (CRO); UNICANCER; Institut de Cancerologie de l'Ouest (ICO); UNICANCER; Institut de Cancerologie de l'Ouest (ICO); UNICANCER; Institut de Cancerologie de l'Ouest (ICO); UNICANCER; Institut de Cancerologie de l'Ouest (ICO); Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite	Hamai, A (corresponding author), CLCC Rene Gauducheau, INSERM, U892, St Herblain, France.	Maha.Ayyoub@univ-nantes.fr; Danila.Valmori@univ-nantes.fr	Ayyoub, Maha/A-2074-2017; Valmori, Danila/AAL-9766-2021; Canzonieri, Vincenzo/Z-5933-2019; Ayyoub, Maha/G-2778-2013; Canzonieri, Vincenzo/AAA-7951-2019; Perin, Tiziana/AAC-2403-2020; Campion, Loic/K-4726-2015; Jézéquel, Pascal/K-8206-2015; Ansquer, Catherine/M-1519-2015; Valmori, Danila/K-2439-2015	Ayyoub, Maha/0000-0003-2022-0898; Canzonieri, Vincenzo/0000-0001-6010-0976; Perin, Tiziana/0000-0002-9823-0167; Campion, Loic/0000-0003-4903-0908; Colarossi, Cristina/0000-0001-5395-8608; Memeo, Lorenzo/0000-0003-4251-7203	Cancer Research Institute; Ludwig Institute for Cancer Research; Institut National du Cancer; Canceropole Grand Ouest	Cancer Research Institute; Ludwig Institute for Cancer Research; Institut National du Cancer(Institut National du Cancer (INCA) France); Canceropole Grand Ouest	This study was supported by the Cancer Research Institute (http://www.cancerresearch.org) and the Ludwig Institute for Cancer Research (http://www.licr.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Sera and surgical tumor specimens from breast cancer patients were obtained from the tumor bank of the Institut Regional du Cancer Nantes-Atlantique, supported by the Institut National du Cancer and the Canceropole Grand Ouest. We are grateful to Drs. G. Ritter and L.J. Old for providing the recombinant proteins and for helpful advice, and to Dr. Maryam Mehrpour for providing the BC lines. We would like to thank Mrs. Nicole Andrieux for assistance with clinical data analysis, and Mr. Sandro Barbuscia for IHC staining.	Ayyoub M, 2009, P NATL ACAD SCI USA, V106, P8635, DOI 10.1073/pnas.0900621106; Burstein HJ, 2005, NEW ENGL J MED, V353, P1652, DOI 10.1056/NEJMp058197; Cheever MA, 2009, CLIN CANCER RES, V15, P5323, DOI 10.1158/1078-0432.CCR-09-0737; Hortobagyi GN, 2005, NEW ENGL J MED, V353, P1734, DOI 10.1056/NEJMe058196; Hunder NN, 2008, NEW ENGL J MED, V358, P2698, DOI 10.1056/NEJMoa0800251; Jager E, 1998, J EXP MED, V187, P265, DOI 10.1084/jem.187.2.265; Jager E, 1999, INT J CANCER, V84, P506, DOI 10.1002/(SICI)1097-0215(19991022)84:5<506::AID-IJC10>3.0.CO;2-6; Jungbluth AA, 2001, INT J CANCER, V92, P856, DOI 10.1002/ijc.1282; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Odunsi K, 2003, CANCER RES, V63, P6076; Pageau GJ, 2007, NAT REV CANCER, V7, P628, DOI 10.1038/nrc2172; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Ross MT, 2005, NATURE, V434, P325, DOI 10.1038/nature03440; Rouzier R, 2005, CLIN CANCER RES, V11, P5678, DOI 10.1158/1078-0432.CCR-04-2421; Simpson AJG, 2005, NAT REV CANCER, V5, P615, DOI 10.1038/nrc1669; Smith IE, 2003, NEW ENGL J MED, V348, P2431, DOI 10.1056/NEJMra023246; Sotiriou C, 2009, NEW ENGL J MED, V360, P790, DOI 10.1056/NEJMra0801289; Stockert E, 1998, J EXP MED, V187, P1349, DOI 10.1084/jem.187.8.1349; Valmori D, 2005, CLIN IMMUNOL, V117, P24, DOI 10.1016/j.clim.2005.05.003; Valmori D, 2000, CANCER RES, V60, P4499; Valmori D, 2007, P NATL ACAD SCI USA, V104, P8947, DOI 10.1073/pnas.0703395104	21	19	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2011	6	6							e21129	10.1371/journal.pone.0021129	http://dx.doi.org/10.1371/journal.pone.0021129			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778VR	21747904	Green Published, gold, Green Submitted			2022-12-27	WOS:000291737600045
J	Chen, CH; Chen, CS; Moyzis, R; Stern, H; He, QH; Li, H; Li, J; Zhu, B; Dong, Q				Chen, Chunhui; Chen, Chuansheng; Moyzis, Robert; Stern, Hal; He, Qinghua; Li, He; Li, Jin; Zhu, Bi; Dong, Qi			Contributions of Dopamine-Related Genes and Environmental Factors to Highly Sensitive Personality: A Multi-Step Neuronal System-Level Approach	PLOS ONE			English	Article							CATECHOL-O-METHYLTRANSFERASE; DEFICIT HYPERACTIVITY DISORDER; SENSORY-PROCESSING SENSITIVITY; WHOLE-GENOME ASSOCIATION; VAL158MET POLYMORPHISM; MONOAMINE-OXIDASE; CANDIDATE GENES; NOVELTY SEEKING; HARM AVOIDANCE; LIFE EVENTS	Traditional behavioral genetic studies (e. g., twin, adoption studies) have shown that human personality has moderate to high heritability, but recent molecular behavioral genetic studies have failed to identify quantitative trait loci (QTL) with consistent effects. The current study adopted a multi-step approach (ANOVA followed by multiple regression and permutation) to assess the cumulative effects of multiple QTLs. Using a system-level (dopamine system) genetic approach, we investigated a personality trait deeply rooted in the nervous system (the Highly Sensitive Personality, HSP). 480 healthy Chinese college students were given the HSP scale and genotyped for 98 representative polymorphisms in all major dopamine neurotransmitter genes. In addition, two environment factors (stressful life events and parental warmth) that have been implicated for their contributions to personality development were included to investigate their relative contributions as compared to genetic factors. In Step 1, using ANOVA, we identified 10 polymorphisms that made statistically significant contributions to HSP. In Step 2, these polymorphism's main effects and interactions were assessed using multiple regression. This model accounted for 15% of the variance of HSP (p < 0.001). Recent stressful life events accounted for an additional 2% of the variance. Finally, permutation analyses ascertained the probability of obtaining these findings by chance to be very low, p ranging from 0.001 to 0.006. Dividing these loci by the subsystems of dopamine synthesis, degradation/transport, receptor and modulation, we found that the modulation and receptor subsystems made the most significant contribution to HSP. The results of this study demonstrate the utility of a multi-step neuronal system-level approach in assessing genetic contributions to individual differences in human behavior. It can potentially bridge the gap between the high heritability estimates based on traditional behavioral genetics and the lack of reproducible genetic effects observed currently from molecular genetic studies.	[Chen, Chunhui; Li, Jin; Zhu, Bi; Dong, Qi] Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China; [Chen, Chuansheng] Univ Calif Irvine, Dept Psychol & Social Behav, Irvine, CA USA; [Moyzis, Robert] Univ Calif Irvine, Dept Biol Chem, Irvine, CA 92717 USA; [Moyzis, Robert] Univ Calif Irvine, Inst Genom & Bioinformat, Irvine, CA USA; [Stern, Hal] Univ Calif Irvine, Dept Stat, Irvine, CA USA; [He, Qinghua] Univ So Calif, Brain & Creat Inst, Los Angeles, CA USA; [Li, He] China Acad Chinese Med Sci, Inst Basic Res Clin Med, Beijing, Peoples R China	Beijing Normal University; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; University of Southern California; China Academy of Chinese Medical Sciences; Institute of Basic Research In Clinical Medicine, CACMS	Chen, CH (corresponding author), Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China.	dongqi@bnu.edu.cn	He, Qinghua/B-2573-2008	He, Qinghua/0000-0001-6396-6273; Chen, Chuansheng/0000-0002-8224-1005	111 Project [B07008]; Ministry of Education of China [10YJCXLX032]	111 Project(Ministry of Education, China - 111 Project); Ministry of Education of China(Ministry of Education, China)	This study was supported by the 111 Project (B07008) and the project for young people who are devoted to the researches of humanities and social sciences (10YJCXLX032) of the Ministry of Education of China. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson CA, 2010, NAT PROTOC, V5, P1564, DOI 10.1038/nprot.2010.116; Aron A, 2010, SOC COGN AFFECT NEUR, V5, P219, DOI 10.1093/scan/nsq028; Aron EN, 1997, J PERS SOC PSYCHOL, V73, P345, DOI 10.1037/0022-3514.73.2.345; Aron EN, 2005, PERS SOC PSYCHOL B, V31, P181, DOI 10.1177/0146167204271419; Austin J, 2000, MOL PSYCHIATR, V5, P552, DOI 10.1038/sj.mp.4000761; Benham G, 2006, PERS INDIV DIFFER, V40, P1433, DOI 10.1016/j.paid.2005.11.021; BOUCHARD TJ, 1994, SCIENCE, V264, P1700, DOI 10.1126/science.8209250; Boules M, 2007, CNS DRUGS, V21, P13, DOI 10.2165/00023210-200721010-00002; Caceda R, 2006, PEPTIDES, V27, P2385, DOI 10.1016/j.peptides.2006.04.024; Caspi A, 2003, SCIENCE, V301, P386, DOI 10.1126/science.1083968; Caspi A, 2006, NAT REV NEUROSCI, V7, P583, DOI 10.1038/nrn1925; Chen C, ADDICTION B IN PRESS; Collins FS, 2004, NATURE, V431, P931, DOI 10.1038/nature03001; COMPAS BE, 1987, CLIN PSYCHOL REV, V7, P275, DOI 10.1016/0272-7358(87)90037-7; Depue RA, 1999, BEHAV BRAIN SCI, V22, P491; Derringer J, 2010, PSYCHOL SCI, V21, P1282, DOI 10.1177/0956797610380699; Ding YC, 2002, P NATL ACAD SCI USA, V99, P309, DOI 10.1073/pnas.012464099; Distel MA, 2008, PSYCHOL MED, V38, P1219, DOI 10.1017/S0033291707002024; Distel MA, 2008, PSYCHIAT GENET, V18, P302, DOI 10.1097/YPG.0b013e3283118468; Ebstein RP, 1996, NAT GENET, V12, P78, DOI 10.1038/ng0196-78; Enoch MA, 2003, PSYCHIAT GENET, V13, P33, DOI 10.1097/00041444-200303000-00006; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Gillespie NA, 2008, J PERS, V76, P1415, DOI 10.1111/j.1467-6494.2008.00527.x; Gonda X, 2009, EUR ARCH PSY CLIN N, V259, P106, DOI 10.1007/s00406-008-0842-7; Greenberger E, 2000, J CONSULT CLIN PSYCH, V68, P209, DOI 10.1037//0022-006X.68.2.209; Gregory AM, 2009, DEVELOPMENTAL SCI, V12, P165, DOI 10.1111/j.1467-7687.2008.00739.x; Gu DF, 2006, HYPERTENSION, V47, P1147, DOI 10.1161/01.HYP.0000219041.66702.45; Guan L, 2009, MOL PSYCHIATR, V14, P546, DOI 10.1038/sj.mp.4002139; Ham BJ, 2004, NEUROSCI LETT, V354, P2, DOI 10.1016/S0304-3940(03)00753-5; Hashimoto R, 2007, NEUROSCI LETT, V428, P17, DOI 10.1016/j.neulet.2007.09.036; Hawks J, 2007, P NATL ACAD SCI USA, V104, P20753, DOI 10.1073/pnas.0707650104; Hong XM, 2009, CURR OPIN PEDIATR, V21, P770, DOI 10.1097/MOP.0b013e32833252dc; Hosak L, 2006, NEUROENDOCRINOL LETT, V27, P799; Isen J, 2009, BEHAV GENET, V39, P36, DOI 10.1007/s10519-008-9244-x; Ishii G, 2007, EUR PSYCHIAT, V22, P462, DOI 10.1016/j.eurpsy.2007.05.005; Ivorra-Martinez J, 2007, REV NEUROLOGIA, V45, P418, DOI 10.33588/rn.4507.2007247; Jomphe C, 2006, EUR J NEUROSCI, V24, P2789, DOI 10.1111/j.1460-9568.2006.05151.x; Kim SJ, 2006, NEUROSCI LETT, V401, P154, DOI 10.1016/j.neulet.2006.03.006; Krueger RF, 2008, J PERS, V76, P1485, DOI 10.1111/j.1467-6494.2008.00529.x; Lee HJ, 2003, AM J MED GENET B, V121B, P44, DOI 10.1002/ajmg.b.20054; Light KJ, 2007, BEHAV BRAIN FUNCT, V3, DOI 10.1186/1744-9081-3-3; Manolio TA, 2008, J CLIN INVEST, V118, P1590, DOI 10.1172/JCI34772; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; McCaffery JM, 2009, AM J CLIN NUTR, V89, P1011, DOI 10.3945/ajcn.2008.27170; McGuffin P, 2001, SCIENCE, V291, P1232, DOI 10.1126/science.1057264; Moore JH, 2010, BIOINFORMATICS, V26, P445, DOI 10.1093/bioinformatics/btp713; Murcray CE, 2009, AM J EPIDEMIOL, V169, P219, DOI 10.1093/aje/kwn353; Nilsson KW, 2009, UPSALA J MED SCI, V114, P100, DOI 10.1080/03009730902833406; Ohinata K, 2007, PEPTIDES, V28, P1470, DOI 10.1016/j.peptides.2007.06.002; Plomin R, 2009, J CHILD PSYCHOL PSYC, V50, P63, DOI 10.1111/j.1469-7610.2008.01978.x; Plomp E, 2009, NEUROSCIENCE, V164, P230, DOI 10.1016/j.neuroscience.2009.07.024; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Qian Q, 2004, AM J MED GENET B, V128B, P84, DOI 10.1002/ajmg.b.30079; Qian QJ, 2003, AM J MED GENET B, V118B, P103, DOI 10.1002/ajmg.b.10064; Ruchkin VV, 1998, COMPR PSYCHIAT, V39, P225, DOI 10.1016/S0010-440X(98)90065-7; Sabol SZ, 1998, HUM GENET, V103, P273, DOI 10.1007/s004390050816; Samochowiec J, 2000, Psychiatr Pol, V34, P99; Shifman S, 2008, MOL PSYCHIATR, V13, P302, DOI 10.1038/sj.mp.4002048; Smillie LD, 2010, NEUROSCI LETT, V468, P234, DOI 10.1016/j.neulet.2009.10.095; St-Gelais F, 2006, J PSYCHIATR NEUROSCI, V31, P229; Torgersen S, 2008, PSYCHOL MED, V38, P1617, DOI 10.1017/S0033291708002924; Wang E, 2004, AM J HUM GENET, V74, P931, DOI 10.1086/420854; Wang ET, 2006, P NATL ACAD SCI USA, V103, P135, DOI 10.1073/pnas.0509691102; Wang LY, 2008, CLIN SCI, V115, P151, DOI 10.1042/CS20070335; Wermter AK, 2010, EUR CHILD ADOLES PSY, V19, P199, DOI 10.1007/s00787-009-0082-z; WILLS TA, 1992, AM J COMMUN PSYCHOL, V20, P349, DOI 10.1007/BF00937914; Wu J, 2010, GENET EPIDEMIOL, V34, P275, DOI 10.1002/gepi.20459; Wu XS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004578; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608	70	27	29	2	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2011	6	7							e21636	10.1371/journal.pone.0021636	http://dx.doi.org/10.1371/journal.pone.0021636			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	792WQ	21765900	Green Published, gold			2022-12-27	WOS:000292781500006
J	de Jong, PW; Hemerik, L; Gort, G; van Alphen, JJM				de Jong, Peter W.; Hemerik, Lia; Gort, Gerrit; van Alphen, Jacques J. M.			Rapid Establishment of a Regular Distribution of Adult Tropical Drosophila Parasitoids in a Multi-Patch Environment by Patch Defence Behaviour	PLOS ONE			English	Article							INTERSPECIFIC HOST DISCRIMINATION; ASOBARA-TABIDA NEES; TIME ALLOCATION; ADAPTIVE SUPERPARASITISM; SOLITARY PARASITOIDS; INSECT PARASITOIDS; WASPS; INTERFERENCE; STRATEGIES; EFFICIENCY	Females of the larval parasitoid of Drosophila, Asobara citri, from sub-Saharan Africa, defend patches with hosts by fighting and chasing conspecific females upon encounter. Females of the closely related, palearctic species Asobara tabida do not defend patches and often search simultaneously in the same patch. The effect of patch defence by A. citri females on their distribution in a multi-patch environment was investigated, and their distributions were compared with those of A. tabida. For both species 20 females were released from two release-points in replicate experiments. Females of A. citri quickly reached a regular distribution across 16 patches, with a small variance/mean ratio per patch. Conversely, A. tabida females initially showed a clumped distribution, and after gradual dispersion, a more Poisson-like distribution across patches resulted (variance/mean ratio was closer to 1 and higher than for A. citri). The dispersion of A. tabida was most probably an effect of exploitation: these parasitoids increasingly made shorter visits to already exploited patches. We briefly discuss hypotheses on the adaptive significance of patch defence behaviour or its absence in the light of differences in the natural history of both parasitoid species, notably the spatial distribution of their hosts.	[de Jong, Peter W.] Wageningen Univ, Entomol Lab, Wageningen, Netherlands; [Hemerik, Lia; Gort, Gerrit] Wageningen Univ, Dept Math & Stat Methods, Wageningen, Netherlands; [van Alphen, Jacques J. M.] Univ Amsterdam, Inst Biodivers & Ecosyst Dynam, Amsterdam, Netherlands	Wageningen University & Research; Wageningen University & Research; University of Amsterdam	de Jong, PW (corresponding author), Wageningen Univ, Entomol Lab, Wageningen, Netherlands.	lia.hemerik@wur.nl		Hemerik, Lia/0000-0002-6892-2840				Ardeh MJ, 2005, BIOL CONTROL, V33, P74, DOI 10.1016/j.biocontrol.2005.01.006; Bakker K., 1961, Archives Neerlandaises de Zoologie Leiden, V14, P200; BAKKER K, 1985, OECOLOGIA, V67, P572, DOI 10.1007/BF00790029; Bolker B, 2008, ECOLOGICAL MODELS DA; Field SA, 1997, ECOL ENTOMOL, V22, P142, DOI 10.1046/j.1365-2311.1997.t01-1-00057.x; Goubault M, 2005, BEHAV ECOL, V16, P693, DOI 10.1093/beheco/ari043; Hemerik L, 2002, ACTA BIOTHEOR, V50, P167, DOI 10.1023/A:1016543310896; HEMERIK L, 1993, J ANIM ECOL, V62, P33, DOI 10.2307/5480; JANSSEN A, 1989, FUNCT ECOL, V3, P469, DOI 10.2307/2389621; JANSSEN A, 1988, NETH J ZOOL, V38, P61, DOI 10.1163/156854288X00049; Pinheiro JC, 2000, STAT COMPUTING MIXED; SEVENSTER JG, 1992, THESIS LEIDEN U NETH; van der Hoeven N, 2002, ENVIRON ECOL STAT, V9, P201, DOI 10.1023/A:1015126322223; VANALPHEN JJM, 1992, FUNCT ECOL, V6, P528, DOI 10.2307/2390049; VANALPHEN JJM, 1982, NETH J ZOOL, V32, P232, DOI 10.1163/002829682X00157; VANALPHEN JJM, 1983, J ANIM ECOL, V52, P937, DOI 10.2307/4465; VANALPHEN JJM, 1990, ANNU REV ENTOMOL, V35, P59, DOI 10.1146/annurev.en.35.010190.000423; VANDERHOEVEN N, 1990, J THEOR BIOL, V146, P467, DOI 10.1016/S0022-5193(05)80373-X; VANSTRIENVANLIEMPT WTFH, 1981, NETH J ZOOL, V31, P701; VET LEM, 1983, PHYSIOL ENTOMOL, V8, P97, DOI 10.1111/j.1365-3032.1983.tb00338.x; VISSER ME, 1993, BEHAV ECOL, V4, P22, DOI 10.1093/beheco/4.1.22; VISSER ME, 1990, BEHAVIOUR, V114, P21, DOI 10.1163/156853990X00031; Visser ME, 1999, J ANIM ECOL, V68, P108, DOI 10.1046/j.1365-2656.1999.00269.x; VISSER ME, 1992, J ANIM ECOL, V61, P93, DOI 10.2307/5512; WAAGE JK, 1982, ECOL ENTOMOL, V7, P103, DOI 10.1111/j.1365-2311.1982.tb00648.x; Wajnberg E, 2004, J ANIM ECOL, V73, P1179, DOI 10.1111/j.0021-8790.2004.00892.x; WEISSER WW, 1993, FUNCT ECOL, V7, P27, DOI 10.2307/2389864	27	6	6	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2011	6	7							e20870	10.1371/journal.pone.0020870	http://dx.doi.org/10.1371/journal.pone.0020870			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791WM	21765889	Green Submitted, Green Published, gold			2022-12-27	WOS:000292699000002
J	Kaur, J; Mencl, S; Sahaboglu, A; Farinelli, P; van Veen, T; Zrenner, E; Ekstrom, P; Paquet-Durand, F; Arango-Gonzalez, B				Kaur, Jasvir; Mencl, Stine; Sahaboglu, Ayse; Farinelli, Pietro; van Veen, Theo; Zrenner, Eberhart; Ekstrom, Per; Paquet-Durand, Francois; Arango-Gonzalez, Blanca			Calpain and PARP Activation during Photoreceptor Cell Death in P23H and S334ter Rhodopsin Mutant Rats	PLOS ONE			English	Article							RETINITIS-PIGMENTOSA; POLY(ADP-RIBOSE) POLYMERASE; CLINICAL EXPRESSION; PROTEASE CALPAIN; TRANSGENIC RAT; APOPTOSIS; CALPASTATIN; MUTATION; MODEL; DEGENERATION	Retinitis pigmentosa (RP) is a heterogeneous group of inherited neurodegenerative diseases affecting photoreceptors and causing blindness. Many human cases are caused by mutations in the rhodopsin gene. An important question regarding RP pathology is whether different genetic defects trigger the same or different cell death mechanisms. To answer this question, we analysed photoreceptor degeneration in P23H and S334ter transgenic rats carrying rhodopsin mutations that affect protein folding and sorting respectively. We found strong activation of calpain and poly(ADP-ribose) polymerase (PARP) in both mutants, concomitant with calpastatin down-regulation, increased oxidative DNA damage and accumulation of PAR polymers. These parameters were strictly correlated with the temporal progression of photoreceptor degeneration, mirroring earlier findings in the phosphodiesterase-6 mutant rd1 mouse, and suggesting execution of non-apoptotic cell death mechanisms. Interestingly, activation of caspases-3 and -9 and cytochrome c leakage-key events in apoptotic cell death-were observed only in the S334ter mutant, which also showed increased expression of PARP-1. The identification of the same metabolic markers triggered by different mutations in two different species suggests the existence of common cell death mechanisms, which is a major consideration for any mutation independent treatment.	[Kaur, Jasvir; Mencl, Stine; Sahaboglu, Ayse; Farinelli, Pietro; van Veen, Theo; Zrenner, Eberhart; Paquet-Durand, Francois; Arango-Gonzalez, Blanca] Univ Tubingen, Ctr Ophthalmol, Inst Ophthalm Res, Tubingen, Germany; [Farinelli, Pietro; van Veen, Theo; Ekstrom, Per] Lund Univ, Dept Ophthalmol, Lund, Sweden	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Lund University	Arango-Gonzalez, B (corresponding author), Univ Tubingen, Ctr Ophthalmol, Inst Ophthalm Res, Tubingen, Germany.	blanca.arango-gonzalez@klinikum.uni-tuebingen.de	Paquet-Durand, Francois/G-6709-2015; Farinelli, Pietro/G-8000-2017; Arango-Gonzalez, Blanca/AAR-7427-2021	Paquet-Durand, Francois/0000-0001-7355-5742; Farinelli, Pietro/0000-0002-4242-3090; Arango-Gonzalez, Blanca/0000-0002-9045-182X; Sahaboglu, Ayse/0000-0003-3241-0672	Tistou and Charlotte Kerstan Foundation; medical faculty of Lund University; German Research Council (DFG) [PA1751/1-1]; Centre for Integrative Neuroscience (CIN) [2009-20]	Tistou and Charlotte Kerstan Foundation; medical faculty of Lund University; German Research Council (DFG)(German Research Foundation (DFG)); Centre for Integrative Neuroscience (CIN)	This work was supported by the Tistou and Charlotte Kerstan Foundation, the medical faculty of Lund University, the German Research Council (DFG; PA1751/1-1), and the Centre for Integrative Neuroscience (CIN; pool project 2009-20). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azuma M, 2008, SURV OPHTHALMOL, V53, P150, DOI 10.1016/j.survophthal.2007.12.006; BERSON EL, 1993, INVEST OPHTH VIS SCI, V34, P1659; CHANG GQ, 1993, NEURON, V11, P595, DOI 10.1016/0896-6273(93)90072-Y; CROALL DE, 1991, PHYSIOL REV, V71, P813, DOI 10.1152/physrev.1991.71.3.813; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; DRYJA TP, 1990, NATURE, V343, P364, DOI 10.1038/343364a0; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; Gomez-Vicente V, 2005, CELL DEATH DIFFER, V12, P796, DOI 10.1038/sj.cdd.4401621; GRASLKRAUPP B, 1995, HEPATOLOGY, V21, P1465, DOI 10.1016/0270-9139(95)90071-3; Green ES, 2000, INVEST OPHTH VIS SCI, V41, P1546; Griciuc A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001075; Halliwell B, 2006, J NEUROCHEM, V97, P1634, DOI 10.1111/j.1471-4159.2006.03907.x; Hartong DT, 2006, LANCET, V368, P1795, DOI 10.1016/S0140-6736(06)69740-7; Hurley JB, 1998, VISION RES, V38, P1341, DOI 10.1016/S0042-6989(97)00459-8; Jellinger Kurt A., 2006, Current Alzheimer Research, V3, P377, DOI 10.2174/156720506778249434; KOMEIMA K, 2008, FREE RADIC BIOL MED; Komeima K, 2006, P NATL ACAD SCI USA, V103, P11300, DOI 10.1073/pnas.0604056103; Liu CD, 1999, J NEUROSCI, V19, P4778; Lockshin RA, 2004, ONCOGENE, V23, P2766, DOI 10.1038/sj.onc.1207514; Machida S, 2000, INVEST OPHTH VIS SCI, V41, P3200; MAKI M, 1989, J BIOL CHEM, V264, P18866; MAKI M, 1987, BIOCHEM BIOPH RES CO, V143, P300, DOI 10.1016/0006-291X(87)90665-6; Mantamadiotis T, 2002, NAT GENET, V31, P47, DOI 10.1038/ng882; MENDOZAALVAREZ H, 1993, J BIOL CHEM, V268, P22575; Oh KT, 2003, AM J OPHTHALMOL, V136, P306, DOI 10.1016/S0002-9394(03)00206-X; Oka S, 2008, EMBO J, V27, P421, DOI 10.1038/sj.emboj.7601975; Palczewski K, 2006, ANNU REV BIOCHEM, V75, P743, DOI 10.1146/annurev.biochem.75.103004.142743; Paquet-Durand F, 2006, J NEUROCHEM, V96, P802, DOI 10.1111/j.1471-4159.2005.03628.x; Paquet-Durand F, 2007, J NEUROSCI, V27, P10311, DOI 10.1523/JNEUROSCI.1514-07.2007; Paquet-Durand F, 2010, J NEUROCHEM, V115, P930, DOI 10.1111/j.1471-4159.2010.06983.x; Paquet-Durand F, 2009, J NEUROCHEM, V108, P796, DOI 10.1111/j.1471-4159.2008.05822.x; Phelan JK, 2000, MOL VIS, V6, P116; Rao MV, 2008, J NEUROSCI, V28, P12241, DOI 10.1523/JNEUROSCI.4119-08.2008; Sahaboglu A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015495; Sancho-Pelluz J, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.4; Sancho-Pelluz J, 2008, MOL NEUROBIOL, V38, P253, DOI 10.1007/s12035-008-8045-9; SANDBERG MA, 1995, INVEST OPHTH VIS SCI, V36, P1934; Sanz MM, 2007, NEUROSCIENCE, V145, P1120, DOI 10.1016/j.neuroscience.2006.12.034; Schreiber V, 2006, NAT REV MOL CELL BIO, V7, P517, DOI 10.1038/nrm1963; Struthers L, 1998, ANAL BIOCHEM, V255, P20, DOI 10.1006/abio.1997.2354; SUNG CH, 1991, P NATL ACAD SCI USA, V88, P8840, DOI 10.1073/pnas.88.19.8840; Vosler PS, 2009, EXP NEUROL, V218, P213, DOI 10.1016/j.expneurol.2009.04.032; Wang YF, 2009, EXP NEUROL, V218, P193, DOI 10.1016/j.expneurol.2009.03.020; Yoshizawa K, 2002, GRAEF ARCH CLIN EXP, V240, P214, DOI 10.1007/s00417-002-0427-5; YOUNG RW, 1984, J COMP NEUROL, V229, P362, DOI 10.1002/cne.902290307; Yu SW, 2006, P NATL ACAD SCI USA, V103, P18314, DOI 10.1073/pnas.0606528103	46	70	70	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2011	6	7							e22181	10.1371/journal.pone.0022181	http://dx.doi.org/10.1371/journal.pone.0022181			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791WM	21765948	Green Published, gold, Green Submitted			2022-12-27	WOS:000292699000027
J	Takeuchi, T; Puntous, T; Tuladhar, A; Yoshimoto, S; Shirama, A				Takeuchi, Tatsuto; Puntous, Theodore; Tuladhar, Anup; Yoshimoto, Sanae; Shirama, Aya			Estimation of Mental Effort in Learning Visual Search by Measuring Pupil Response	PLOS ONE			English	Article							PERFORMANCE; LOAD	Perceptual learning refers to the improvement of perceptual sensitivity and performance with training. In this study, we examined whether learning is accompanied by a release from mental effort on the task, leading to automatization of the learned task. For this purpose, we had subjects conduct a visual search for a target, defined by a combination of orientation and spatial frequency, while we monitored their pupil size. It is well known that pupil size reflects the strength of mental effort invested in a task. We found that pupil size increased rapidly as the learning proceeded in the early phase of training and decreased at the later phase to a level half of its maximum value. This result does not support the simple automatization hypothesis. Instead, it suggests that the mental effort and behavioral performance reflect different aspects of perceptual learning. Further, mental effort would be continued to be invested to maintain good performance at a later stage of training.	[Takeuchi, Tatsuto; Yoshimoto, Sanae] Japan Womens Univ, Dept Psychol, Kawasaki, Kanagawa, Japan; [Puntous, Theodore] Univ Lyon, ENISE, LTDS, CNRS UMR 5513, St Etienne, France; [Tuladhar, Anup] Univ Waterloo, Dept Chem Engn, Waterloo, ON N2L 3G1, Canada; [Yoshimoto, Sanae; Shirama, Aya] NTT Commun Sci Labs, Percept & Emot Res Grp, Atsugi, Kanagawa, Japan; [Shirama, Aya] Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol JST CREST, Tokyo, Japan	Japan Womens University; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); University of Waterloo; Nippon Telegraph & Telephone Corporation; Japan Science & Technology Agency (JST)	Takeuchi, T (corresponding author), Japan Womens Univ, Dept Psychol, Kawasaki, Kanagawa, Japan.	tatsutot@gmail.com	Tuladhar, Anup/AAL-7139-2020	Shirama, Aya/0000-0003-4174-5175; Tuladhar, Anup/0000-0002-3942-2732	Japan Science and Technology Agency	Japan Science and Technology Agency(Japan Science & Technology Agency (JST))	This study was supported by Japan Science and Technology Agency (http://www.jst.go.jp/EN/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baluchg F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009127; BARBUR JL, 2004, VISUAL NEUROSCIENCES, V1, P641; BEATTY J, 1982, PSYCHOL BULL, V91, P276, DOI 10.1037/0033-2909.91.2.276; Boucsein W., 1992, ELECTRODERMAL ACTIVI; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; DAWSON ME, 2000, HDB PSYCHOPHYSIOLOGY, P200; Hampson RE, 2010, BEHAV BRAIN RES, V212, P1, DOI 10.1016/j.bbr.2010.03.011; Hugdahl K., 1995, PSYCHOPHYSIOLOGY MIN; KAHNEMAN D, 1969, J EXP PSYCHOL, V79, P312, DOI 10.1037/h0026912; KAHNEMAN D, 1966, SCIENCE, V154, P1583, DOI 10.1126/science.154.3756.1583; KARNI A, 1991, P NATL ACAD SCI USA, V88, P4966, DOI 10.1073/pnas.88.11.4966; Karni A, 1996, COGNITIVE BRAIN RES, V5, P39, DOI 10.1016/S0926-6410(96)00039-0; Leonards U, 2002, VISION RES, V42, P2193, DOI 10.1016/S0042-6989(02)00134-7; Leonards U, 1998, COGNITIVE BRAIN RES, V7, P207, DOI 10.1016/S0926-6410(98)00026-3; Partala T, 2003, INT J HUM-COMPUT ST, V59, P185, DOI 10.1016/S1071-5819(03)00017-X; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Porter G, 2007, Q J EXP PSYCHOL, V60, P211, DOI 10.1080/17470210600673818; Rosenzweig M. R., 2002, BIOL PSYCHOL; Seitz A, 2005, TRENDS COGN SCI, V9, P329, DOI 10.1016/j.tics.2005.05.010; SHIFFRIN RM, 1977, PSYCHOL REV, V84, P127, DOI 10.1037/0033-295X.84.2.127; Sigman M, 2005, NEURON, V46, P823, DOI 10.1016/j.neuron.2005.05.014; Sireteanu R, 2000, VISION RES, V40, P2925, DOI 10.1016/S0042-6989(00)00145-0; TREISMAN AM, 1980, COGNITIVE PSYCHOL, V12, P97, DOI 10.1016/0010-0285(80)90005-5; Tsodyks M, 2004, NATURE, V431, P775, DOI 10.1038/nature03013; Van Orden KF, 2000, BIOL PSYCHOL, V52, P221, DOI 10.1016/S0301-0511(99)00043-5; Van Orden KF, 2001, HUM FACTORS, V43, P111, DOI 10.1518/001872001775992570; Wolfe JM, 2004, NAT REV NEUROSCI, V5, P495, DOI 10.1038/nrn1411; Yotsumoto Y, 2008, NEURON, V57, P827, DOI 10.1016/j.neuron.2008.02.034	29	11	11	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2011	6	7							e21973	10.1371/journal.pone.0021973	http://dx.doi.org/10.1371/journal.pone.0021973			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	791IA	21760936	Green Submitted, gold, Green Published			2022-12-27	WOS:000292657200038
J	Li, J; Lau, GKK; Chen, LL; Dong, SS; Lan, HY; Huang, XR; Li, Y; Luk, JM; Yuan, YF; Guan, XY				Li, Jian; Lau, George Ka-Kit; Chen, Leilei; Dong, Sui-sui; Lan, Hui-Yao; Huang, Xiao-Ru; Li, Yan; Luk, John M.; Yuan, Yun-Fei; Guan, Xin-yuan			Interleukin 17A Promotes Hepatocellular Carcinoma Metastasis via NF-kB Induced Matrix Metalloproteinases 2 and 9 Expression	PLOS ONE			English	Article							T-CELLS; KAPPA-B; RHEUMATOID-ARTHRITIS; ACTIVATED MONOCYTES; TUMOR-GROWTH; TH17 CELLS; IL-17; CANCER; PROGRESSION; EXPANSION	Background: IL-17A is a pro-inflammatory cytokine that plays important role in inflammatory disease pathology and tumor microenvironment. The aim of this study is to investigate the effect of IL-17A on the progression of hepatocellular carcinoma (HCC). Methodology and Principal Finding: Expression pattern of IL-17A in clinical HCC samples (n = 43) was determined by immunohistochemistry staining. Transcript levels of MMP2, MMP9 and IL-17A were measured in another 50 pairs (including tumor and related non-tumor tissues) HCC samples. Cell growth, focus formation, cell migration, invasion and western blot assays were used to characterize the functional and signaling mechanisms in IL-17A-treated HCC. Association study was used to identify clinical significance of IL-17A in HCC. Compared with paired non-tumor tissue, higher frequency of IL-17A-positive cells was detected in tumor tissues in HCCs with metastasis, and the frequency of IL-17A-positive cells was also significantly associated with poor prognosis of HCC (P = 0.01). Functional study found that IL-17A could promote HCC cell migration and invasion. Further molecular analysis also showed that IL-17A could upregulate MMP2 and MMP9 expression via NF-kappa B signaling activation. Conclusions: IL-17A could promote HCC metastasis by the upregulation of MMP2 and MMP9 expression via activating NF-kB signaling pathway.	[Li, Jian; Chen, Leilei; Dong, Sui-sui; Li, Yan; Guan, Xin-yuan] Univ Hong Kong, Dept Clin Oncol, Li Ka Shing Fac Med, Hong Kong, Hong Kong, Peoples R China; [Lau, George Ka-Kit] Univ Hong Kong, Dept Med, Li Ka Shing Fac Med, Hong Kong, Hong Kong, Peoples R China; [Chen, Leilei; Dong, Sui-sui; Li, Yan; Guan, Xin-yuan] Univ Hong Kong, State Key Lab Liver Res, Li Ka Shing Fac Med, Hong Kong, Hong Kong, Peoples R China; [Lan, Hui-Yao; Huang, Xiao-Ru] Univ Hong Kong, Dept Med & Therapeut, Hong Kong, Hong Kong, Peoples R China; [Lan, Hui-Yao; Huang, Xiao-Ru] Univ Hong Kong, Li Ka Shing Inst Hlth Sci, Hong Kong, Hong Kong, Peoples R China; [Luk, John M.] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Pharmacol, Canc Sci Inst, Singapore 117595, Singapore; [Luk, John M.] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Surg, Canc Sci Inst, Singapore 117595, Singapore; [Yuan, Yun-Fei; Guan, Xin-yuan] Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol So China, Guangzhou 510275, Guangdong, Peoples R China	University of Hong Kong; University of Hong Kong; University of Hong Kong; University of Hong Kong; University of Hong Kong; National University of Singapore; National University of Singapore; Sun Yat Sen University	Li, J (corresponding author), Univ Hong Kong, Dept Clin Oncol, Li Ka Shing Fac Med, Hong Kong, Hong Kong, Peoples R China.	xyguan@hkucc.hku.hk	Lan, Hui Yao/C-9734-2015; Luk, John/A-4085-2008; Lau, George/AAQ-2085-2021; Chen, Leilei/F-7668-2011; Guan, Xin-Yuan/A-3639-2009; /A-3639-2009	Lan, Hui Yao/0000-0003-4283-9755; Luk, John/0000-0002-6323-7940; Guan, Xin-Yuan/0000-0002-4485-6017; /0000-0003-1874-9805; Yuan, Yunfei/0000-0003-2467-3683; Chen, Polly Leilei/0000-0002-1987-3878	Hong Kong Research Grant Council [HKU 7656/07M]; Hong Kong RGC [HKU5/CRF/08, HKU7/CRG09]; Sun Yat-sen University [85000-3171311]	Hong Kong Research Grant Council(Hong Kong Research Grants Council); Hong Kong RGC(Hong Kong Research Grants Council); Sun Yat-sen University	This work was supported by a Hong Kong Research Grant Council Grant (HKU 7656/07M), Hong Kong RGC Collaborative Research Grants (HKU5/CRF/08 and HKU7/CRG09) and the "Hundred Talents Program'' at Sun Yat-sen University (85000-3171311). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Axtell RC, 2010, NAT MED, V16, P406, DOI 10.1038/nm.2110; Bond M, 1998, FEBS LETT, V435, P29, DOI 10.1016/S0014-5793(98)01034-5; Bu W, 1997, Zhonghua Yi Xue Za Zhi, V77, P661; Budhu A, 2006, CANCER CELL, V10, P99, DOI 10.1016/j.ccr.2006.06.016; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Condeelis J, 2006, CELL, V124, P263, DOI 10.1016/j.cell.2006.01.007; Cortez DM, 2007, AM J PHYSIOL-HEART C, V293, pH3356, DOI 10.1152/ajpheart.00928.2007; Cupedo T, 2009, NAT IMMUNOL, V10, P66, DOI 10.1038/ni.1668; Ding T, 2009, HUM PATHOL, V40, P381, DOI 10.1016/j.humpath.2008.08.011; Doreau A, 2009, NAT IMMUNOL, V10, P778, DOI 10.1038/ni.1741; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Ferretti S, 2003, J IMMUNOL, V170, P2106, DOI 10.4049/jimmunol.170.4.2106; Fu JL, 2007, GASTROENTEROLOGY, V132, P2328, DOI 10.1053/j.gastro.2007.03.102; Fujino S, 2003, GUT, V52, P65, DOI 10.1136/gut.52.1.65; Gao C, 2009, CELL MOL NEUROBIOL, V29, P1161, DOI 10.1007/s10571-009-9409-z; He DG, 2006, J IMMUNOL, V177, P6852, DOI 10.4049/jimmunol.177.10.6852; He DG, 2010, J IMMUNOL, V184, P2281, DOI 10.4049/jimmunol.0902574; Ikeguchi M, 2004, EJSO-EUR J SURG ONC, V30, P53, DOI 10.1016/j.ejso.2003.10.001; Inozume T, 2009, J IMMUNOTHER, V32, P109, DOI 10.1097/CJI.0b013e31819302da; Ito Y, 2009, ARTHRITIS RHEUM-US, V60, P2294, DOI 10.1002/art.24687; Kehlen A, 1999, J NEUROIMMUNOL, V101, P1, DOI 10.1016/S0165-5728(99)00111-3; Kessenbrock K, 2010, CELL, V141, P52, DOI 10.1016/j.cell.2010.03.015; Kobayashi N, 2007, CLIN CANCER RES, V13, P902, DOI 10.1158/1078-0432.CCR-06-2363; Kotake S, 1999, J CLIN INVEST, V103, P1345, DOI 10.1172/JCI5703; Kryczek I, 2009, BLOOD, V114, P357, DOI 10.1182/blood-2008-09-177360; Kuang DM, 2010, J IMMUNOL, V185, P1544, DOI 10.4049/jimmunol.0904094; Kuang DM, 2010, HEPATOLOGY, V51, P154, DOI 10.1002/hep.23291; Li Y, 2001, WORLD J GASTROENTERO, V7, P630; LIFSCHITZMERCER B, 1987, CANCER, V59, P1494, DOI 10.1002/1097-0142(19870415)59:8<1494::AID-CNCR2820590817>3.0.CO;2-V; Littlepage LE, 2010, CANCER RES, V70, P2224, DOI 10.1158/0008-5472.CAN-09-3515; Ma S, 2008, MOL CANCER RES, V6, P1146, DOI 10.1158/1541-7786.MCR-08-0035; Martin-Orozco N, 2009, IMMUNITY, V31, P787, DOI 10.1016/j.immuni.2009.09.014; RAZ A, 1987, CANCER METAST REV, V6, P3, DOI 10.1007/BF00047606; Semela D, 2004, J HEPATOL, V41, P864, DOI 10.1016/j.jhep.2004.09.006; Shalom-Barak T, 1998, J BIOL CHEM, V273, P27467, DOI 10.1074/jbc.273.42.27467; Solinas G, 2010, CANCER METAST REV, V29, P243, DOI 10.1007/s10555-010-9227-2; Su XM, 2010, J IMMUNOL, V184, P1630, DOI 10.4049/jimmunol.0902813; Sun S, 2007, LIVER INT, V27, P1021, DOI 10.1111/j.1478-3231.2007.01533.x; Wang J B, 1981, Zhonghua Zhong Liu Za Zhi, V3, P241; Wang L, 2009, J EXP MED, V206, P1457, DOI 10.1084/jem.20090207; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Yang P, 2009, HEPATOL RES, V39, P1169, DOI 10.1111/j.1872-034X.2009.00563.x; Zhang B, 2008, BIOCHEM BIOPH RES CO, V374, P533, DOI 10.1016/j.bbrc.2008.07.060; Zhang JP, 2009, J HEPATOL, V50, P980, DOI 10.1016/j.jhep.2008.12.033; Zhu XW, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2195	45	133	148	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2011	6	7							e21816	10.1371/journal.pone.0021816	http://dx.doi.org/10.1371/journal.pone.0021816			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791HI	21760911	Green Submitted, Green Published, gold			2022-12-27	WOS:000292655400021
J	Qi, ZT; He, J; Su, YH; He, Q; Liu, JX; Yu, L; Al-Attas, O; Hussain, T; Ding, SZ; Ji, L; Qian, M				Qi, Zhengtang; He, Jie; Su, Yuhui; He, Qiang; Liu, Jingxia; Yu, Lu; Al-Attas, Omar; Hussain, Tajamul; Ding, Shuzhe; Ji, Liu; Qian, Min			Physical Exercise Regulates p53 Activity Targeting SCO2 and Increases Mitochondrial COX Biogenesis in Cardiac Muscle with Age	PLOS ONE			English	Article							MANGANESE SUPEROXIDE-DISMUTASE; C-OXIDASE ACTIVITY; SKELETAL-MUSCLE; GENE-EXPRESSION; OXIDATIVE STRESS; TRANSLOCATION; DYSFUNCTION; TRANSCRIPTION; DEFICIENCY; APOPTOSIS	The purpose of this study was to outline the timelines of mitochondrial function, oxidative stress and cytochrome c oxidase complex (COX) biogenesis in cardiac muscle with age, and to evaluate whether and how these age-related changes were attenuated by exercise. ICR/CD-1 mice were treated with pifithrin-m (PFT mu), sacrificed and studied at different ages; ICR/CD-1 mice at younger or older ages were randomized to endurance treadmill running and sedentary conditions. The results showed that mRNA expression of p53 and its protein levels in mitochondria increased with age in cardiac muscle, accompanied by increased mitochondrial oxidative stress, reduced expression of COX subunits and assembly proteins, and decreased expression of most markers in mitochondrial biogenesis. Most of these age-related changes including p53 activity targeting cytochrome oxidase deficient homolog 2 (SCO2), p53 translocation to mitochondria and COX biogenesis were attenuated by exercise in older mice. PFTm, an inhibitor blocking p53 translocation to mitochondria, increased COX biogenesis in older mice, but not in young mice. Our data suggest that physical exercise attenuates age-related changes in mitochondrial COX biogenesis and p53 activity targeting SCO2 and mitochondria, and thereby induces antisenescent and protective effects in cardiac muscle.	[Qi, Zhengtang; He, Jie; Su, Yuhui; He, Qiang; Liu, Jingxia; Yu, Lu; Ding, Shuzhe; Ji, Liu] Minist Educ, Key Lab Adolescent Hlth Assessment & Exercise Int, Shanghai, Peoples R China; [Qi, Zhengtang; Ding, Shuzhe; Ji, Liu] E China Normal Univ, Coll Phys Educ & Hlth, Shanghai 200062, Peoples R China; [Qi, Zhengtang; Qian, Min] E China Normal Univ, Inst Biomed Sci, Shanghai 200062, Peoples R China; [Al-Attas, Omar; Hussain, Tajamul] King Saud Univ, Ctr Excellence Biotechnol Res, Riyadh, Saudi Arabia	East China Normal University; East China Normal University; King Saud University	Qi, ZT (corresponding author), Minist Educ, Key Lab Adolescent Hlth Assessment & Exercise Int, Shanghai, Peoples R China.	szding@tyxx.ecnu.edu.cn	Hussain, Tajamul/E-8151-2014	Hussain, Tajamul/0000-0001-7601-1417	National Natural Science Foundation of China [30871212]; Program for New Century Excellent Talents in University [790013P8]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET))	This work was supported by grants from the National Natural Science Foundation of China (Grant No. 30871212) and the Program for New Century Excellent Talents in University (Grant No. 790013P8). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achanta G, 2005, EMBO J, V24, P3482, DOI 10.1038/sj.emboj.7600819; Arima Y, 2005, J BIOL CHEM, V280, P19166, DOI 10.1074/jbc.M410691200; Barazzoni R, 2000, J BIOL CHEM, V275, P3343, DOI 10.1074/jbc.275.5.3343; Bertoni-Freddari C, 2004, ANN NY ACAD SCI, V1019, P33, DOI 10.1196/annals.1297.007; Boveris A, 2008, FREE RADICAL BIO MED, V44, P224, DOI 10.1016/j.freeradbiomed.2007.08.015; Charlot JF, 2004, APOPTOSIS, V9, P333, DOI 10.1023/B:APPT.0000025810.58981.4c; Chen JQ, 2009, BBA-MOL CELL RES, V1793, P1540, DOI 10.1016/j.bbamcr.2009.06.001; Chen K, 2009, BRAIN RES, V1279, P131, DOI 10.1016/j.brainres.2009.04.054; Corcoran CA, 2006, CANCER BIOL THER, V5, P1610, DOI 10.4161/cbt.5.12.3617; Dai DF, 2009, TRENDS CARDIOVAS MED, V19, P213, DOI 10.1016/j.tcm.2009.12.004; Dai DF, 2009, CIRCULATION, V119, P2789, DOI 10.1161/CIRCULATIONAHA.108.822403; Daosukho C, 2005, FREE RADICAL BIO MED, V39, pS150; Ding H, 2010, BBA-GEN SUBJECTS, V1800, P250, DOI 10.1016/j.bbagen.2009.08.007; Donahue RJ, 2001, FASEB J, V15, P635, DOI 10.1096/fj.00-0262com; Dyachenko V, 2006, EXP GERONTOL, V41, P489, DOI 10.1016/j.exger.2006.03.003; Edwards MG, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-80; Falkenberg M, 2002, NAT GENET, V31, P289, DOI 10.1038/ng909; Fattoretti P, 2004, ANN NY ACAD SCI, V1030, P303, DOI 10.1196/annals.1329.038; Fernandez-Vizarra E, 2010, MITOCHONDRION, V10, P253, DOI 10.1016/j.mito.2009.12.148; Freisinger P, 2004, J INHERIT METAB DIS, V27, P67, DOI 10.1023/B:BOLI.0000016614.47380.2f; Garcia-Roves PM, 2006, AM J PHYSIOL-ENDOC M, V290, pE1172, DOI 10.1152/ajpendo.00633.2005; Gleyzer N, 2005, MOL CELL BIOL, V25, P1354, DOI 10.1128/MCB.25.4.1354-1366.2005; Gomez-Cabrera MC, 2008, AM J CLIN NUTR, V87, P142, DOI 10.1093/ajcn/87.1.142; Hao JJ, 2009, J CELL MOL MED, V13, P701, DOI 10.1111/j.1582-4934.2008.00342.x; Holley AK, 2010, ANN NY ACAD SCI, V1201, P72, DOI 10.1111/j.1749-6632.2010.05612.x; Holloszy JO, 2008, J PHYSIOL PHARMACOL, V59, P5; HOLLOSZY JO, 1967, J BIOL CHEM, V242, P2278; Hood DA, 2010, BBA-BIOENERGETICS, V1797, P106, DOI 10.1016/j.bbabio.2010.04.321; Hood DA, 2009, APPL PHYSIOL NUTR ME, V34, P465, DOI 10.1139/H09-045; Jezek P, 2009, INT J BIOCHEM CELL B, V41, P1790, DOI 10.1016/j.biocel.2009.02.014; Johnson WT, 2008, J NUTR, V138, P1269, DOI 10.1093/jn/138.7.1269; Johnson WT, 2007, J NUTR BIOCHEM, V18, P97, DOI 10.1016/j.jnutbio.2006.03.005; Judge S, 2005, FASEB J, V19, P419, DOI 10.1096/fj.04-2622fje; Judge S, 2007, AM J PHYSIOL-CELL PH, V292, pC1983, DOI 10.1152/ajpcell.00285.2006; Koopman R, 2006, AM J PHYSIOL-ENDOC M, V290, pE1245, DOI 10.1152/ajpendo.00530.2005; Kuo WW, 2005, J BIOMED SCI, V12, P601, DOI 10.1007/s11373-005-7373-2; Leary SC, 2007, CELL METAB, V5, P9, DOI 10.1016/j.cmet.2006.12.001; Lebedeva MA, 2009, BBA-BIOENERGETICS, V1787, P328, DOI 10.1016/j.bbabio.2009.01.004; Lesnefsky EJ, 2001, J MOL CELL CARDIOL, V33, P1065, DOI 10.1006/jmcc.2001.1378; Litonin D, 2010, J BIOL CHEM, V285, P18129, DOI 10.1074/jbc.C110.128918; Liu B, 2008, FREE RADICAL BIO MED, V44, P1529, DOI 10.1016/j.freeradbiomed.2008.01.011; Liu JF, 2008, FEBS LETT, V582, P1319, DOI 10.1016/j.febslet.2008.03.013; Liu JK, 2009, ADV DRUG DELIVER REV, V61, P1343, DOI 10.1016/j.addr.2009.06.007; Liu JK, 2005, NUTR NEUROSCI, V8, P67, DOI 10.1080/10284150500047161; Ljubicic V, 2010, MECH AGEING DEV, V131, P79, DOI 10.1016/j.mad.2009.12.004; Ljubicic V, 2010, BBA-GEN SUBJECTS, V1800, P223, DOI 10.1016/j.bbagen.2009.07.031; Loh K, 2009, CELL METAB, V10, P260, DOI 10.1016/j.cmet.2009.08.009; MARINGARCIA J, 1994, J MOL CELL CARDIOL, V26, P1029, DOI 10.1006/jmcc.1994.1123; Matoba S, 2006, SCIENCE, V312, P1650, DOI 10.1126/science.1126863; Nemajerova A, 2005, FEBS LETT, V579, P6079, DOI 10.1016/j.febslet.2005.09.074; Ojaimi J, 1999, ANN NEUROL, V46, P656, DOI 10.1002/1531-8249(199910)46:4<656::AID-ANA16>3.3.CO;2-H; Park JY, 2009, CIRC RES, V105, P705, DOI 10.1161/CIRCRESAHA.109.205310; Ren JC, 2010, BIOCHEM BIOPH RES CO, V401, P64, DOI 10.1016/j.bbrc.2010.09.009; Saleem A, 2009, PHYSIOL GENOMICS, V37, P58, DOI 10.1152/physiolgenomics.90346.2008; Scarpulla RC, 2008, PHYSIOL REV, V88, P611, DOI 10.1152/physrev.00025.2007; Smith JAH, 2007, AM J PHYSIOL-ENDOC M, V292, pE413, DOI 10.1152/ajpendo.00142.2006; Tasdemir E, 2008, AUTOPHAGY, V4, P810, DOI 10.4161/auto.6486; Terman A, 2004, ANN NY ACAD SCI, V1019, P70, DOI 10.1196/annals.1297.015; Vesela K, 2008, APMIS, V116, P41, DOI 10.1111/j.1600-0463.2008.00772.x; Vina J, 2009, ADV DRUG DELIVER REV, V61, P1369, DOI 10.1016/j.addr.2009.06.006; Wadley GD, 2010, J APPL PHYSIOL, V108, P1719, DOI 10.1152/japplphysiol.00127.2010; Wright DC, 2007, J BIOL CHEM, V282, P194, DOI 10.1074/jbc.M606116200; Zhang XD, 2010, ACTA PHARMACOL SIN, V31, P1208, DOI 10.1038/aps.2010.151; Zhao YF, 2005, CANCER RES, V65, P3745, DOI 10.1158/0008-5472.CAN-04-3835; Zuo XA, 2010, CARDIOVASC TOXICOL, V10, P208, DOI 10.1007/s12012-010-9080-0	65	23	27	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2011	6	7							e21140	10.1371/journal.pone.0021140	http://dx.doi.org/10.1371/journal.pone.0021140			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791HI	21750704	Green Published, Green Submitted, gold			2022-12-27	WOS:000292655400002
J	Truong, T; Altiok, E; Yuen, D; Ecoiffier, T; Chen, L				Truong, Tan; Altiok, Eda; Yuen, Don; Ecoiffier, Tatiana; Chen, Lu			Novel Characterization of Lymphatic Valve Formation during Corneal Inflammation	PLOS ONE			English	Article							MURINE CORNEA; LYMPHANGIOGENESIS; BLOOD; ANGIOGENESIS; MECHANISMS; INTEGRINS; BLOCKADE; VESSELS; SYSTEM	Lymphatic research has progressed rapidly in recent years. Though lymphatic dysfunction has been found in a wide array of disorders from transplant rejection to cancer metastasis, to date, there is still little effective treatment for lymphatic diseases. The cornea offers an optimal site for lymphatic research due to its accessible location, transparent nature, and lymphatic-free but inducible features. However, it still remains unknown whether lymphatic valves exist in newly formed lymphatic vessels in the cornea, and how this relates to an inflammatory response. In this study, we provide the first evidence showing that lymphatic valves were formed in mouse cornea during suture-induced inflammation with the up-regulation of integrin alpha 9. The number of corneal valves increased with the progression of inflammatory lymphangiogenesis. Moreover, we have detected lymphatic valves at various developmental stages, from incomplete to more developed ones. In addition to defining the average diameter of lymphatic vessels equipped with lymphatic valves, we also report that lymphatic valves were more often located near the branching points. Taken together, these novel findings not only provide new insights into corneal lymphatic formation and maturation, but also identify a new model for future investigation on lymphatic valve formation and possibly therapeutic intervention.	[Truong, Tan; Altiok, Eda; Yuen, Don; Ecoiffier, Tatiana; Chen, Lu] Univ Calif Berkeley, Ctr Eye Dis & Dev, Program Vis Sci, Sch Optometry, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Truong, T (corresponding author), Univ Calif Berkeley, Ctr Eye Dis & Dev, Program Vis Sci, Sch Optometry, Berkeley, CA 94720 USA.	chenlu@berkeley.edu			National Institutes of Health; University of California at Berkeley; NATIONAL EYE INSTITUTE [R01EY017392] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California at Berkeley; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work is supported by research grants from National Institutes of Health and the University of California at Berkeley. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bazigou E, 2009, DEV CELL, V17, P175, DOI 10.1016/j.devcel.2009.06.017; Berman AE, 2003, BIOCHEMISTRY-MOSCOW+, V68, P1284, DOI 10.1023/B:BIRY.0000011649.03634.74; Brown P, 2005, NATURE, V436, P456, DOI 10.1038/436456a; Chen L, 2009, LYMPHOLOGY, V42, P66; Chen L, 2007, ARCH OPHTHALMOL-CHIC, V125, P783, DOI 10.1001/archopht.125.6.783; Chen L, 2011, J SURG ONCOL, V103, P475, DOI 10.1002/jso.21794; Cursiefen C, 2006, CORNEA, V25, P443, DOI 10.1097/01.ico.0000183485.85636.ff; Cursiefen C, 2003, CORNEA, V22, P273, DOI 10.1097/00003226-200304000-00021; Dietrich T, 2007, AM J PATHOL, V171, P361, DOI 10.2353/ajpath.2007.060896; Dietrich T, 2010, J IMMUNOL, V184, P535, DOI 10.4049/jimmunol.0903180; Ecoiffier T, 2010, INVEST OPHTH VIS SCI, V51, P2436, DOI 10.1167/iovs.09-4505; Folkman J, 2004, NAT IMMUNOL, V5, P11, DOI 10.1038/ni0104-11; GIMBRONE MA, 1974, J NATL CANCER I, V52, P413, DOI 10.1093/jnci/52.2.413; Gonzalo P, 2010, BIOFACTORS, V36, P248, DOI 10.1002/biof.99; GRIMALDO S, 2011, INVEST OPHTHALM 0302; Huang XZ, 2000, MOL CELL BIOL, V20, P5208, DOI 10.1128/MCB.20.14.5208-5215.2000; Oliver G, 2002, GENE DEV, V16, P773, DOI 10.1101/gad.975002; Rogers MS, 2007, NAT PROTOC, V2, P2545, DOI 10.1038/nprot.2007.368; Singh D, 2003, J CATARACT REFR SURG, V29, P632, DOI 10.1016/S0886-3350(03)00161-5; Stepp MA, 2006, EXP EYE RES, V83, P3, DOI 10.1016/j.exer.2006.01.010; Tammela T, 2010, CELL, V140, P460, DOI 10.1016/j.cell.2010.01.045; Yuen D, 2011, INVEST OPHTH VIS SCI, V52, P2593, DOI 10.1167/iovs.10-6408; Zawieja David C., 2009, Lymphatic Research and Biology, V7, P87, DOI 10.1089/lrb.2009.0007; Zhang H, 2011, INVEST OPHTH VIS SCI, V52, P334, DOI 10.1167/iovs.10-5404	24	17	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2011	6	7							e21918	10.1371/journal.pone.0021918	http://dx.doi.org/10.1371/journal.pone.0021918			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791HI	21760922	Green Submitted, Green Published, gold			2022-12-27	WOS:000292655400027
J	Yeakel, JD; Novak, M; Guimaraes, PR; Dominy, NJ; Koch, PL; Ward, EJ; Moore, JW; Semmens, BX				Yeakel, Justin D.; Novak, Mark; Guimaraes, Paulo R., Jr.; Dominy, Nathaniel J.; Koch, Paul L.; Ward, Eric J.; Moore, Jonathan W.; Semmens, Brice X.			Merging Resource Availability with Isotope Mixing Models: The Role of Neutral Interaction Assumptions	PLOS ONE			English	Article							INTERACTION STRENGTHS; STABLE-ISOTOPES; NICHE; TOO	Background: Bayesian mixing models have allowed for the inclusion of uncertainty and prior information in the analysis of trophic interactions using stable isotopes. Formulating prior distributions is relatively straightforward when incorporating dietary data. However, the use of data that are related, but not directly proportional, to diet (such as prey availability data) is often problematic because such information is not necessarily predictive of diet, and the information required to build a reliable prior distribution for all prey species is often unavailable. Omitting prey availability data impacts the estimation of a predator's diet and introduces the strong assumption of consumer ultrageneralism (where all prey are consumed in equal proportions), particularly when multiple prey have similar isotope values. Methodology: We develop a procedure to incorporate prey availability data into Bayesian mixing models conditional on the similarity of isotope values between two prey. If a pair of prey have similar isotope values (resulting in highly uncertain mixing model results), our model increases the weight of availability data in estimating the contribution of prey to a predator's diet. We test the utility of this method in an intertidal community against independently measured feeding rates. Conclusions: Our results indicate that our weighting procedure increases the accuracy by which consumer diets can be inferred in situations where multiple prey have similar isotope values. This suggests that the exchange of formalism for predictive power is merited, particularly when the relationship between prey availability and a predator's diet cannot be assumed for all species in a system.	[Yeakel, Justin D.; Novak, Mark] Univ Calif Santa Cruz, Dept Ecol & Evolutionary Biol, Santa Cruz, CA 95064 USA; [Guimaraes, Paulo R., Jr.] Univ Sao Paulo, Inst Biociencias, Dept Ecol, Sao Paulo, Brazil; [Dominy, Nathaniel J.] Dartmouth Coll, Dept Anthropol, Hanover, NH 03755 USA; [Dominy, Nathaniel J.] Dartmouth Coll, Dept Biol Sci, Hanover, NH 03755 USA; [Koch, Paul L.] Univ Calif Santa Cruz, Dept Earth & Planetary Sci, Santa Cruz, CA 95064 USA; [Ward, Eric J.; Semmens, Brice X.] NOAA, Natl Marine Fisheries Serv, NW Fisheries Sci Ctr, Seattle, WA 98112 USA; [Moore, Jonathan W.] Simon Fraser Univ, Dept Biol Sci, Burnaby, BC V5A 1S6, Canada	University of California System; University of California Santa Cruz; Universidade de Sao Paulo; Dartmouth College; Dartmouth College; University of California System; University of California Santa Cruz; National Oceanic Atmospheric Admin (NOAA) - USA; Simon Fraser University	Yeakel, JD (corresponding author), Univ Calif Santa Cruz, Dept Ecol & Evolutionary Biol, Santa Cruz, CA 95064 USA.	jdyeakel@gmail.com	Guimaraes, Paulo R./E-1915-2016; Novak, Mark/E-2194-2012; Dominy, Nathaniel Jay/A-6151-2013; Guimaraes, Paulo/B-1099-2008; Guimarães-Junior, Paulo R/M-1298-2016	Guimaraes, Paulo R./0000-0001-9161-8305; Novak, Mark/0000-0002-7881-4253; Dominy, Nathaniel Jay/0000-0001-5916-418X; Yeakel, Justin/0000-0002-6597-3511	National Science Foundation [DEB-0608178]; U.S. Environmental Protection Agency; Department of Education; Sigma Xi; University of Chicago; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superioris	National Science Foundation(National Science Foundation (NSF)); U.S. Environmental Protection Agency(United States Environmental Protection Agency); Department of Education(US Department of Education); Sigma Xi; University of Chicago(University of Chicago); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superioris	Field work was supported by a National Science Foundation Doctoral Dissertation Improvement Grant (DEB-0608178), a U.S. Environmental Protection Agency Science To Achieve Results fellowship, a Department of Education Graduate Assistance in Areas of National Need training grant, Sigma Xi, and the University of Chicago Hinds Fund. Additional funding for this work was provided by a National Science Foundation Graduate Research Fellowship, a Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, and a Coordenacao de Aperfeicoamento de Pessoal de Nivel Superioris research grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams PA, 2000, TRENDS ECOL EVOL, V15, P337, DOI 10.1016/S0169-5347(00)01908-X; BOND A, 2011, ECOLOGICAL APPL; Chen Y, 2008, MAR FRESHWATER RES, V59, P145, DOI 10.1071/MF07126; Darimont CT, 2009, J ANIM ECOL, V78, P126, DOI 10.1111/j.1365-2656.2008.01473.x; Fry B., 2006, STABLE ISOTOPE ECOLO; Gelman A., 2004, BAYESIAN DATA ANAL; Gotelli NJ, 2001, ECOL LETT, V4, P379, DOI 10.1046/j.1461-0248.2001.00230.x; Hilborn Ray, 1997, V28; Hubbell Stephen P., 2001, V32, pi; Jeschke JM, 2004, BIOL REV, V79, P337, DOI 10.1017/S1464793103006286; Koch PL, 2007, ECOL METHOD CONCEPT, P99, DOI 10.1002/9780470691854.ch5; Koch PL, 1998, ANNU REV EARTH PL SC, V26, P573, DOI 10.1146/annurev.earth.26.1.573; Krishna A, 2008, OIKOS, V117, P1609, DOI 10.1111/j.1600-0706.2008.16540.x; LU RP, 1989, THEOR POPUL BIOL, V35, P1, DOI 10.1016/0040-5809(89)90007-5; Lubetkin SC, 2004, J APPL ECOL, V41, P996, DOI 10.1111/j.0021-8901.2004.00957.x; Moore JW, 2008, ECOL LETT, V11, P470, DOI 10.1111/j.1461-0248.2008.01163.x; Morisita M., 1959, MEM FS KYUSHU U    E, V3, P65, DOI DOI 10.18960/SEITAI.11.6_252_4; MURDOCH WW, 1973, J APPL ECOL, V10, P335; Newsome SD, 2007, FRONT ECOL ENVIRON, V5, P429, DOI 10.1890/060150.1; NOVAK M, 2008, TROPHIC OMNIVORY STR; Novak M, 2008, ECOLOGY, V89, P2083, DOI 10.1890/08-0033.1; Novak M, 2010, ECOLOGY, V91, P2394, DOI 10.1890/09-0275.1; PAINE RT, 1988, ECOLOGY, V69, P1648, DOI 10.2307/1941141; Parnell AC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009672; Phillips DL, 2005, OECOLOGIA, V144, P520, DOI [10.1007/s00442-004-1816-8, 10.1007/s000442-004-1816-8]; Phillips DL, 2002, OECOLOGIA, V130, P114, DOI 10.1007/s004420100786; Phillips DL, 2003, OECOLOGIA, V136, P261, DOI 10.1007/s00442-003-1218-3; PIANKA ER, 1974, P NATL ACAD SCI USA, V71, P2141, DOI 10.1073/pnas.71.5.2141; Semmens BX, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006187; Slade NA, 2000, J MAMMAL, V81, P1035, DOI 10.1644/1545-1542(2000)081<1035:AETOUC>2.0.CO;2; SOLE RV, 2006, SELF ORG COMPLEX ECO; Vander Zanden MJ, 2001, LIMNOL OCEANOGR, V46, P2061; Williams RJ, 2002, P NATL ACAD SCI USA, V99, P12913, DOI 10.1073/pnas.192448799; Yeakel JD, 2009, P NATL ACAD SCI USA, V106, P19040, DOI 10.1073/pnas.0905309106	34	28	28	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2011	6	7							e22015	10.1371/journal.pone.0022015	http://dx.doi.org/10.1371/journal.pone.0022015			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791HI	21760944	Green Published, Green Submitted, gold			2022-12-27	WOS:000292655400038
J	Blom, L; Poulsen, BC; Jensen, BM; Hansen, A; Poulsen, LK				Blom, Lars; Poulsen, Britta C.; Jensen, Bettina M.; Hansen, Anker; Poulsen, Lars K.			IL-33 Induces IL-9 Production in Human CD4(+) T Cells and Basophils	PLOS ONE			English	Article							ACTIVATED MAST-CELLS; TGF-BETA; TH2 CELLS; DIFFERENTIATION; EXPRESSION; CYTOKINES; PU.1; ST2; INFLAMMATION; RESPONSES	IL-33, an IL-1 family member and ligand for the IL-1 receptor-related protein ST2, has been associated with induction of Th2 cytokines such as IL-4, IL-5, and IL-13. Here, we report that IL-33 can initiate IL-9 protein secretion in vitro in human CD4+ T cells and basophils isolated from peripheral blood. TGF-beta has been described as a critical factor for IL-9 induction in Th2 cells; however, we found that TGF-beta also induces co-production of IL-9 in purified, naive (> 99%) CD4(+)CD45RA(+)CD45RO(-)CD25(-) T cells differentiated towards a Th1 profile. Subsequently, it was demonstrated that TGF-beta is important, although not an absolute requirement, for IL-9 production in CD4+ T cells. IL-9 production by purified (> 95%) human basophils, cultured for 24 h with IL-3 or IL-33, was found, with a strong synergy between the two, likely to be explained by the IL-3 upregulated ST2 expression. Collectively, these data indicate that barrier functioning cells are important for the regulation of IL-9 production by immune cells in inflamed tissue.	[Blom, Lars; Poulsen, Britta C.; Jensen, Bettina M.; Hansen, Anker; Poulsen, Lars K.] Copenhagen Univ Hosp, Dermato Allergol Dept K, Gentofte, Denmark; [Poulsen, Britta C.] Univ Copenhagen, Dept Vet Dis Biol, Fac Life Sci, Copenhagen, Denmark	University of Copenhagen; University of Copenhagen	Blom, L (corresponding author), Copenhagen Univ Hosp, Dermato Allergol Dept K, Gentofte, Denmark.	LBLO0015@geh.regionh.dk	Poulsen, Lars K/J-3065-2019	Poulsen, Lars K/0000-0002-1730-847X	allergy clinic at Gentofte Hospital Denmark as a part of the national public health care systems	allergy clinic at Gentofte Hospital Denmark as a part of the national public health care systems	This work was funded by the allergy clinic at Gentofte Hospital Denmark as a part of the national public health care systems. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allakhverdi Z, 2007, J IMMUNOL, V179, P2051, DOI 10.4049/jimmunol.179.4.2051; Angkasekwinai P, 2010, NAT IMMUNOL, V11, P250, DOI 10.1038/ni.1846; Beriou G, 2010, J IMMUNOL, V185, P46, DOI 10.4049/jimmunol.1000356; Chang HC, 2005, IMMUNITY, V22, P693, DOI 10.1016/j.immuni.2005.03.016; Chang HC, 2010, NAT IMMUNOL, V11, P527, DOI 10.1038/ni.1867; Gorelik L, 2002, J EXP MED, V195, P1499, DOI 10.1084/jem.20012076; HAAKFRENDSCHO M, 1988, J ALLERGY CLIN IMMUN, V81, P224, DOI 10.1016/0091-6749(88)90460-5; Haraldsen G, 2009, TRENDS IMMUNOL, V30, P227, DOI 10.1016/j.it.2009.03.003; Hultner L, 2000, J IMMUNOL, V164, P5556, DOI 10.4049/jimmunol.164.11.5556; Humphreys NE, 2008, J IMMUNOL, V180, P2443, DOI 10.4049/jimmunol.180.4.2443; Kearley J, 2011, AM J RESP CRIT CARE, V183, P865, DOI 10.1164/rccm.200909-1462OC; Kurowska-Stolarska M, 2008, J IMMUNOL, V181, P4780, DOI 10.4049/jimmunol.181.7.4780; Lamkanfi M, 2009, IMMUNITY, V31, P5, DOI 10.1016/j.immuni.2009.06.011; Lecart S, 2002, EUR J IMMUNOL, V32, P2979, DOI 10.1002/1521-4141(2002010)32:10<2979::AID-IMMU2979>3.0.CO;2-5; Li HM, 2010, J NEUROIMMUNE PHARM, V5, P198, DOI 10.1007/s11481-009-9186-y; Liew FY, 2010, NAT REV IMMUNOL, V10, P103, DOI 10.1038/nri2692; McMillan SJ, 2005, J IMMUNOL, V174, P5774, DOI 10.4049/jimmunol.174.9.5774; Noelle RJ, 2010, NAT REV IMMUNOL, V10, P683, DOI 10.1038/nri2848; Pecaric-Petkovic T, 2009, BLOOD, V113, P1526, DOI 10.1182/blood-2008-05-157818; Putheti P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008706; Rekhtman N, 1999, GENE DEV, V13, P1398, DOI 10.1101/gad.13.11.1398; Saenz SA, 2008, IMMUNOL REV, V226, P172, DOI 10.1111/j.1600-065X.2008.00713.x; SCHMITT E, 1994, J IMMUNOL, V153, P3989; Schmitz J, 2005, IMMUNITY, V23, P479, DOI 10.1016/j.immuni.2005.09.015; Slack JL, 2001, J MOL DIAGN, V3, P141, DOI 10.1016/S1525-1578(10)60665-4; Smithgall MD, 2008, INT IMMUNOL, V20, P1019, DOI 10.1093/intimm/dxn060; Suzukawa M, 2008, J IMMUNOL, V181, P5981, DOI 10.4049/jimmunol.181.9.5981; Tan CY, 2010, J IMMUNOL, V185, P6795, DOI 10.4049/jimmunol.1001676; Veldhoen M, 2008, NAT IMMUNOL, V9, P1341, DOI 10.1038/ni.1659; Veldhoen M, 2010, IMMUNITY, V33, P141, DOI 10.1016/j.immuni.2010.08.007; Wiener Z, 2004, CYTOKINE, V26, P122, DOI 10.1016/j.cyto.2004.01.006; Wong MT, 2010, IMMUNOL CELL BIOL, V88, P624, DOI 10.1038/icb.2010.53; Xu D, 1998, J EXP MED, V187, P787, DOI 10.1084/jem.187.5.787; YAMAGUCHI M, 1992, INT ARCH ALLERGY IMM, V97, P322, DOI 10.1159/000236140; Zhang P, 1999, P NATL ACAD SCI USA, V96, P8705, DOI 10.1073/pnas.96.15.8705; Zhu JF, 2010, ANNU REV IMMUNOL, V28, P445, DOI 10.1146/annurev-immunol-030409-101212	36	68	71	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2011	6	7							e21695	10.1371/journal.pone.0021695	http://dx.doi.org/10.1371/journal.pone.0021695			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791AK	21765905	Green Published, Green Submitted, gold			2022-12-27	WOS:000292632000020
J	Margam, VM; Coates, BS; Bayles, DO; Hellmich, RL; Agunbiade, T; Seufferheld, MJ; Sun, WL; Kroemer, JA; Ba, MN; Binso-Dabire, CL; Baoua, I; Ishiyaku, MF; Covas, FG; Srinivasan, R; Armstrong, J; Murdock, LL; Pittendrigh, BR				Margam, Venu M.; Coates, Brad S.; Bayles, Darrell O.; Hellmich, Richard L.; Agunbiade, Tolulope; Seufferheld, Manfredo J.; Sun, Weilin; Kroemer, Jeremy A.; Ba, Malick N.; Binso-Dabire, Clementine L.; Baoua, Ibrahim; Ishiyaku, Mohammad F.; Covas, Fernando G.; Srinivasan, Ramasamy; Armstrong, Joel; Murdock, Larry L.; Pittendrigh, Barry R.			Transcriptome Sequencing, and Rapid Development and Application of SNP Markers for the Legume Pod Borer Maruca vitrata (Lepidoptera: Crambidae)	PLOS ONE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; EUROPEAN CORN-BORER; OSTRINIA-NUBILALIS; POPULATION-STRUCTURE; FLANKING REGIONS; CANDIDATE GENES; GENOME; TAGS; DNA; MICROSATELLITES	The legume pod borer, Maruca vitrata (Lepidoptera: Crambidae), is an insect pest species of crops grown by subsistence farmers in tropical regions of Africa. We present the de novo assembly of 3729 contigs from 454- and Sanger-derived sequencing reads for midgut, salivary, and whole adult tissues of this non-model species. Functional annotation predicted that 1320 M. vitrata protein coding genes are present, of which 631 have orthologs within the Bombyx mori gene model. A homology-based analysis assigned M. vitrata genes into a group of paralogs, but these were subsequently partitioned into putative orthologs following phylogenetic analyses. Following sequence quality filtering, a total of 1542 putative single nucleotide polymorphisms (SNPs) were predicted within M. vitrata contig assemblies. Seventy one of 1078 designed molecular genetic markers were used to screen M. vitrata samples from five collection sites in West Africa. Population substructure may be present with significant implications in the insect resistance management recommendations pertaining to the release of biological control agents or transgenic cowpea that express Bacillus thuringiensis crystal toxins. Mutation data derived from transcriptome sequencing is an expeditious and economical source for genetic markers that allow evaluation of ecological differentiation.	[Margam, Venu M.; Murdock, Larry L.] Purdue Univ, Dept Entomol, W Lafayette, IN 47907 USA; [Coates, Brad S.; Bayles, Darrell O.; Hellmich, Richard L.; Kroemer, Jeremy A.] Iowa State Univ, USDA ARS, Corn Insect & Crop Genet Res Unit, Genet Lab, Ames, IA USA; [Agunbiade, Tolulope; Sun, Weilin; Pittendrigh, Barry R.] Univ Illinois, Dept Entomol, Champaign, IL USA; [Seufferheld, Manfredo J.] Univ Illinois, Dept Crop Sci, Champaign, IL USA; [Ba, Malick N.; Binso-Dabire, Clementine L.] Inst Environm & Rech Agr INERA, Stn Kamboinse, Ouagadougou, Burkina Faso; [Baoua, Ibrahim] Inst Natl Rech Agron Niger, Maradi, Niger; [Ishiyaku, Mohammad F.] Ahmadu Bello Univ, Dept Plant Sci, Inst Agr Res, Zaria, Nigeria; [Covas, Fernando G.] Univ Puerto Rico, Mayaguez, PR USA; [Srinivasan, Ramasamy] AVRDC World Vegetable Ctr, Tainan, Taiwan; [Armstrong, Joel] Commonwealth Sci & Ind Res Org, Black Mt, ACT, Australia	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Iowa State University; United States Department of Agriculture (USDA); University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; Ahmadu Bello University; Institute for Agricultural Research, Samaru, Zaria; University of Puerto Rico; University of Puerto Rico Mayaguez; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Margam, VM (corresponding author), Purdue Univ, Dept Entomol, W Lafayette, IN 47907 USA.	pittendr@illinois.edu	Armstrong, Joel/E-6873-2011; Margam, Venu M/E-5876-2010; Ba, Malick Niango/I-8557-2012; Ramasamy, Srinivasan/N-1686-2019	Ba, Malick Niango/0000-0001-7323-8739; Ramasamy, Srinivasan/0000-0002-8454-7331; Coates, Brad/0000-0001-8908-1529; Margam, Venu/0000-0001-6510-4618	Bureau for Economic Growth, Agriculture, and Trade, U.S. Agency for International Development [EDH-A-00-07-00005]	Bureau for Economic Growth, Agriculture, and Trade, U.S. Agency for International Development(United States Agency for International Development (USAID))	This research has been made possible through support provided to the Dry Grains Pulses Collaborative Research Support Program (CRSP) by the Bureau for Economic Growth, Agriculture, and Trade, U.S. Agency for International Development, under the terms of Grant No. EDH-A-00-07-00005. The opinions expressed herein are those of the authors and do not necessarily reflect the views of the U.S. Agency for International Development or the U.S. government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS MD, 1991, SCIENCE, V252, P1651, DOI 10.1126/science.2047873; ALGHALI AM, 1991, TROP PEST MANAGE, V37, P71, DOI 10.1080/09670879109371540; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Anderson K., 2006, International Journal of Technology and Globalisation, V2, P65, DOI 10.1504/IJTG.2006.009127; ATACHI P, 1994, ANN SOC ENTOMOL FR, V30, P169; Bai XD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011370; Bailie DA, 2010, J CRUSTACEAN BIOL, V30, P664, DOI 10.1651/09-3252.1; Barbazuk WB, 2007, PLANT J, V51, P910, DOI 10.1111/j.1365-313X.2007.03193.x; Beldade P, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000366; Bennett S, 2004, PHARMACOGENOMICS, V5, P433, DOI 10.1517/14622416.5.4.433; Bergeron A, 2002, BIOINFORMATICS, V18, pS54, DOI 10.1093/bioinformatics/18.suppl_2.S54; BINDRA OS, 1968, 2 ANN WORKSH PULS CR; Chaisson MJ, 2009, GENOME RES, V19, P336, DOI 10.1101/gr.079053.108; Chen SH, 2004, WORLD BANK RES OBSER, V19, P141, DOI 10.1093/wbro/lkh020; CHINH NT, 2000, LEGUMES RICE BASED C, P111; Coates BS, 2008, INSECT MOL BIOL, V17, P607, DOI 10.1111/j.1365-2583.2008.00833.x; Coates BS, 2011, INSECT MOL BIOL, V20, P15, DOI 10.1111/j.1365-2583.2010.01046.x; Coates BS, 2010, J MOL EVOL, V70, P275, DOI 10.1007/s00239-010-9330-6; Coates BS, 2009, GENOME, V52, P57, DOI 10.1139/G08-104; COCKERHAM CC, 1984, BIOMETRICS, V40, P157, DOI 10.2307/2530754; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Falush D, 2007, MOL ECOL NOTES, V7, P574, DOI 10.1111/j.1471-8286.2007.01758.x; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Gabriel Stacey, 2009, Curr Protoc Hum Genet, VChapter 2, DOI 10.1002/0471142905.hg0212s60; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Hawken RJ, 2004, MAMM GENOME, V15, P819, DOI 10.1007/s00335-004-2382-4; Hayes BJ, 2007, BIOINFORMATICS, V23, P1692, DOI 10.1093/bioinformatics/btm154; Heidel-Fischer HM, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-506; Hoskeri H, 2010, J COMP SCI SYSTEMATI, V3, P5052; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; Hunter S, 2009, NUCLEIC ACIDS RES, V37, pD211, DOI 10.1093/nar/gkn785; Huntley D, 2006, BIOINFORMATICS, V22, P495, DOI 10.1093/bioinformatics/btk006; Jackai L.E.N., 1988, TROPICAL GRAIN LEGUM, V35, P2; Jensen JL, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-13; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Keane OM, 2009, GENET MOL RES, V8, P1013, DOI 10.4238/vol8-3gmr594; Kennedy GC, 2003, NAT BIOTECHNOL, V21, P1233, DOI 10.1038/nbt869; Khajuria C, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-286; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; MCCOMBIE WR, 1992, NAT GENET, V1, P124, DOI 10.1038/ng0592-124; McInerney CE, 2011, HEREDITY, V106, P78, DOI 10.1038/hdy.2010.36; Meglecz E, 2004, MOL ECOL, V13, P1693, DOI 10.1111/j.1365-294X.2004.02163.x; Nagaraj SH, 2007, BRIEF BIOINFORM, V8, P6, DOI 10.1093/bib/bbl015; Noda H, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-117; Novaes E, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-312; Oparaeke, 2006, Journal of Plant Sciences, V1, P132; OTA T, 1994, J MOL EVOL, V38, P642; Patnaik H. P., 1986, Legume Research, V9, P7; Pauchet Y, 2010, INSECT MOL BIOL, V19, P61, DOI 10.1111/j.1365-2583.2009.00936.x; Pavy N, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-174; Picoult-Newberg L, 1999, GENOME RES, V9, P167; Rafalski A, 2002, CURR OPIN PLANT BIOL, V5, P94, DOI 10.1016/S1369-5266(02)00240-6; RAHEJA AJ, 1974, P 1 IITA GRAIN LEG I, P295; RAHMAN MM, 1989, BANG J SCI RES, V7, P27; Ronaghi M, 2001, GENOME RES, V11, P3, DOI 10.1101/gr.11.1.3; Ronaghi M, 1998, SCIENCE, V281, P363, DOI 10.1126/science.281.5375.363; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sharma HC, 1998, CROP PROT, V17, P373, DOI 10.1016/S0261-2194(98)00045-3; Siegfried BD, 2005, INSECT MOL BIOL, V14, P137, DOI 10.1111/j.1365-2583.2005.00538.x; Sobrino B, 2005, FORENSIC SCI INT, V154, P181, DOI 10.1016/j.forsciint.2004.10.020; Soeun M., 2001, Legumes in rice-based cropping systems in tropical Asia: constraints and opportunities, P4; Tamura K, 2011, MOL BIOL EV IN PRESS; Tang K, 1999, P NATL ACAD SCI USA, V96, P10016, DOI 10.1073/pnas.96.18.10016; Tay WT, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-144; Taylor T. A., 1967, Journal of the West African Science Association, V12, P111; Ulrichs Ch., 2001, Mitteilungen der Deutschen Gesellschaft fuer Allgemeine und Angewandte Entomologie, V13, P283; Useche F J, 2001, Genome Inform, V12, P194; Van't Hof AE, 2007, HEREDITY, V98, P320, DOI 10.1038/sj.hdy.6800944; Vera JC, 2008, MOL ECOL, V17, P1636, DOI 10.1111/j.1365-294X.2008.03666.x; Vignal A, 2002, GENET SEL EVOL, V34, P275, DOI [10.1186/1297-9686-34-3-275, 10.1051/gse:2002009]; Wang P, 1997, P NATL ACAD SCI USA, V94, P6977, DOI 10.1073/pnas.94.13.6977; Wang SL, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-1-r8; WEIR BS, 1992, GENETICS, V130, P873; Wernersson R, 2006, NUCLEIC ACIDS RES, V34, pW385, DOI 10.1093/nar/gkl252; Wiedmann RT, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-81; Williams Larissa M, 2010, BMC Genet, V11, P32, DOI 10.1186/1471-2156-11-32; Xing C, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-S1-S29; Yamamoto K, 2006, GENETICS, V173, P151, DOI 10.1534/genetics.105.053801; Zhang DX, 2004, TRENDS ECOL EVOL, V19, P507, DOI 10.1016/j.tree.2004.07.020	83	24	27	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2011	6	7							e21388	10.1371/journal.pone.0021388	http://dx.doi.org/10.1371/journal.pone.0021388			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791AK	21754987	gold, Green Published, Green Submitted			2022-12-27	WOS:000292632000011
J	Metzner, KJ; Leemann, C; Di Giallonardo, F; Grube, C; Scherrer, AU; Braun, D; Kuster, H; Weber, R; Guenthard, HF				Metzner, Karin J.; Leemann, Christine; Di Giallonardo, Francesca; Grube, Christina; Scherrer, Alexandra U.; Braun, Dominique; Kuster, Herbert; Weber, Rainer; Guenthard, Huldrych F.			Reappearance of Minority K103N HIV-1 Variants after Interruption of ART Initiated during Primary HIV-1 Infection	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; DRUG-RESISTANCE MUTATIONS; TREATMENT-NAIVE PATIENTS; ACTIVE ANTIRETROVIRAL THERAPY; SOCIETY-USA PANEL; REVERSE-TRANSCRIPTASE; PLASMA VIREMIA; IN-VIVO; TRANSMISSION; POPULATIONS	Background: In the Zurich Primary HIV infection study (ZPHI), minority drug-resistant HIV-1 variants were detected in some acutely HIV-1-infected patients prior to initiation of early antiretroviral therapy (ART). Here, we investigated the reappearance of minority K103N and M184V HIV-1 variants in these patients who interrupted efficient early ART after 8-27 months according to the study protocol. These mutations are key mutations conferring drug resistance to reverse transcriptase inhibitors and they belong to the most commonly transmitted drug resistance mutations. Methodology/Principal Findings: Early ART was offered to acutely HIV-1-infected patients enrolled in the longitudinal prospective ZPHI study. Six patients harboring and eleven patients not harboring drug-resistant viruses at low frequencies prior to ART were included in this substudy. Minority K103N and M184V HIV-1 variants were quantified in longitudinal plasma samples after treatment interruption by allele-specific real-time PCR. All 17 patients were infected with HIV-1 subtype B between 04/2003 and 09/2005 and received LPV/r+AZT+3TC during primary HIV-1 infection (PHI). Minority K103N HIV-1 variants reappeared after cessation of ART in two of four patients harboring this variant during PHI and even persisted in one of those patients at frequencies similar to the frequency observed prior to ART (< 1%). The K103N mutation did not appear during treatment interruption in any other patient. Minority M184V HIV-1 variants were detected in two patients after ART interruption, one harboring and one not harboring these variants prior to ART. Conclusion: Minority K103N HIV-1 variants, present in acutely HIV-1 infected patients prior to early ART, can reappear and persist after interruption of suppressive ART containing two nucleoside/nucleotide analogue reverse transcriptase inhibitors and a ritonavir-boosted protease inhibitor.	[Metzner, Karin J.; Leemann, Christine; Di Giallonardo, Francesca; Grube, Christina; Scherrer, Alexandra U.; Braun, Dominique; Kuster, Herbert; Weber, Rainer; Guenthard, Huldrych F.] Univ Zurich, Div Infect Dis & Hosp Epidemiol, Univ Zurich Hosp, Zurich, Switzerland	University of Zurich; University Zurich Hospital	Metzner, KJ (corresponding author), Univ Zurich, Div Infect Dis & Hosp Epidemiol, Univ Zurich Hosp, Zurich, Switzerland.	Karin.Metzner@usz.ch	Kuster, Herbert/A-3912-2013; Weber, Rainer/D-5175-2012; gunthard, huldrych f/F-1724-2011; Metzner, Karin J/G-5319-2011	gunthard, huldrych f/0000-0002-1142-6723; Metzner, Karin J/0000-0003-4862-1503; Braun, Dominique Laurent/0000-0003-4036-1030; Kuster, Herbert/0000-0001-6873-0091; Di Giallonardo, Francesca/0000-0002-8749-4095	Swiss National Science Foundation (SNF) [324700-120793, 324730-130865]; Gilead Sciences Switzerland; European Community [FP7/2007-2013, 223131]; Gilead; Roche Diagnostics; GlaxoSmithKline; Bristol-Myers Squibb; Tibotec; Abbott; Gilead Sciences; Merck Sharp Dome; Pfizer; LaRoche; TRB Chemedica; Astra-Zeneca; Boehringer Ingelheim; Roche	Swiss National Science Foundation (SNF)(Swiss National Science Foundation (SNSF)); Gilead Sciences Switzerland(Gilead Sciences); European Community(European Commission); Gilead(Gilead Sciences); Roche Diagnostics; GlaxoSmithKline(GlaxoSmithKline); Bristol-Myers Squibb(Bristol-Myers Squibb); Tibotec; Abbott(Abbott Laboratories); Gilead Sciences(Gilead Sciences); Merck Sharp Dome; Pfizer(Pfizer); LaRoche; TRB Chemedica; Astra-Zeneca(AstraZeneca); Boehringer Ingelheim(Boehringer Ingelheim); Roche(Roche Holding)	This study was financed by Swiss National Science Foundation (SNF) grant 324700-120793 (to H.F.G. and K.J.M.), SNF grants 324730-130865 (to H.F.G.), and an unrestricted research grant from Gilead Sciences Switzerland. The research leading to these results has received further funding from the European Community's Seventh Framework Programme (FP7/2007-2013) under the project "Collaborative HIV and Anti-HIV Drug Resistance Network (CHAIN)" - grant agreement no 223131. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; K.J.M. has received travel grants and honoraria from Gilead, Roche Diagnostics, GlaxoSmithKline, Bristol-Myers Squibb, Tibotec, and Abbott, and has received a research grant from Gilead. R.W. has received travel grants or speakers honoraria from Abbott, Boehringer Ingelheim, Bristol-Myers Squibb, Gilead Sciences, GlaxoSmithKline, Merck Sharp & Dome, Pfizer, LaRoche, TRB Chemedica, and Tibotec. H.F.G. has been an adviser and/or consultant for the following companies: GlaxoSmithKline, Abbott, Gilead, Novartis, Boehringer Ingelheim, Roche, Tibotec, Pfizer, ViiV Healthcare, and Bristol-Myers Squibb, and has received unrestricted research and educational grants from Roche, Abbott, Bristol-Myers Squibb, Gilead, Astra-Zeneca, GlaxoSmithKline, and Merck Sharp & Dohme. All other authors declare no conflict of interest.	Allers K, 2007, JAIDS-J ACQ IMM DEF, V44, P377, DOI 10.1097/QAI.0b013e31803104c0; Bailey JR, 2006, J VIROL, V80, P6441, DOI 10.1128/JVI.00591-06; Balduin M, 2009, J CLIN VIROL, V45, P34, DOI 10.1016/j.jcv.2009.03.002; Bennett DE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004724; Bergroth T, 2009, J MED VIROL, V81, P1, DOI 10.1002/jmv.21363; Carr JM, 2009, J MED VIROL, V81, P1983, DOI 10.1002/jmv.21628; Chun TW, 2008, J INFECT DIS, V197, P714, DOI 10.1086/527324; Chun TW, 2000, NAT MED, V6, P757, DOI 10.1038/77481; COFFIN JM, 1995, SCIENCE, V267, P483, DOI 10.1126/science.7824947; Cozzi-Lepri A, 2010, CLIN INFECT DIS, V50, P1275, DOI 10.1086/651684; Finzi D, 1997, SCIENCE, V278, P1295, DOI 10.1126/science.278.5341.1295; Gianella S, 2010, J INFECT DIS, V202, P657, DOI 10.1086/655397; Gunthard HF, 1999, J VIROL, V73, P9404; Gunthard HF, 1998, AIDS RES HUM RETROV, V14, P869, DOI 10.1089/aid.1998.14.869; Hance AJ, 2001, J VIROL, V75, P6410, DOI 10.1128/JVI.75.14.6410-6417.2001; Heneine W, 2010, J INFECT DIS, V201, P647, DOI 10.1086/650545; Hirsch MS, 2008, CLIN INFECT DIS, V47, P266, DOI 10.1086/589297; Jakobsen MR, 2010, CLIN INFECT DIS, V50, P566, DOI 10.1086/650001; Johnson JA, 2008, PLOS MED, V5, P1112, DOI 10.1371/journal.pmed.0050158; Johnson Victoria A, 2008, Top HIV Med, V16, P138; Joos B, 2008, P NATL ACAD SCI USA, V105, P16725, DOI 10.1073/pnas.0804192105; Lataillade M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010952; Masquelier BND, 2005, JAIDS-J ACQ IMM DEF, V40, P505, DOI 10.1097/01.qai.0000186361.42834.61; Metzner Karin J, 2006, J HIV Ther, V11, P74; Metzner KJ, 2006, FUTURE VIROL, V1, P377, DOI 10.2217/17460794.1.3.377; Metzner KJ, 2007, AIDS, V21, P703, DOI 10.1097/QAD.0b013e3280121ac6; Metzner KJ, 2010, J INFECT DIS, V201, P1063, DOI 10.1086/651136; Metzner KJ, 2009, CLIN INFECT DIS, V48, P239, DOI 10.1086/595703; Metzner KJ, 2003, J INFECT DIS, V188, P1433, DOI 10.1086/379215; Nicastri E, 2003, J MED VIROL, V69, P1, DOI 10.1002/jmv.10269; Paredes R, 2010, J INFECT DIS, V201, P662, DOI 10.1086/650543; Peuchant O, 2008, AIDS, V22, P1417, DOI 10.1097/QAD.0b013e3283034953; Rieder P, 2010, AIDS, V24, P1177, DOI 10.1097/QAD.0b013e328338e4de; Schuurman R, 1999, J CLIN MICROBIOL, V37, P2291, DOI 10.1128/JCM.37.7.2291-2296.1999; Simen BB, 2009, J INFECT DIS, V199, P693, DOI 10.1086/596736; Sterne JAC, 2005, LANCET, V366, P378, DOI 10.1016/S0140-6736(05)67022-5; Thompson MA, 2010, JAMA-J AM MED ASSOC, V304, P321, DOI 10.1001/jama.2010.1004; Van Laethem K, 2007, J CLIN VIROL, V39, P43, DOI 10.1016/j.jcv.2007.02.003; Vignoles M, 2009, ANTIVIR THER, V14, P1175, DOI 10.3851/IMP1461; Wainberg Mark A, 2004, Expert Rev Anti Infect Ther, V2, P147, DOI 10.1586/14787210.2.1.147; Wang JO, 2010, J VIROL, V84, P9377, DOI 10.1128/JVI.00618-10; Wong JK, 1997, SCIENCE, V278, P1291, DOI 10.1126/science.278.5341.1291; Yerly S, 2007, AIDS, V21, P2223, DOI 10.1097/QAD.0b013e3282f0b685; Zaccarelli M, 2003, ANTIVIR THER, V8, P51; Zhang LQ, 2000, J CLIN INVEST, V106, P839, DOI 10.1172/JCI10565	45	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2011	6	7							e21734	10.1371/journal.pone.0021734	http://dx.doi.org/10.1371/journal.pone.0021734			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791AK	21754996	Green Accepted, gold, Green Published, Green Submitted			2022-12-27	WOS:000292632000022
J	Yao, J; Chen, SH; Mao, ZS; Cadenas, E; Brinton, RD				Yao, Jia; Chen, Shuhua; Mao, Zisu; Cadenas, Enrique; Brinton, Roberta Diaz			2-Deoxy-D-Glucose Treatment Induces Ketogenesis, Sustains Mitochondrial Function, and Reduces Pathology in Female Mouse Model of Alzheimer's Disease	PLOS ONE			English	Article							A-BETA-DEPOSITION; CALORIC RESTRICTION; DIETARY RESTRICTION; GLUCOSE-METABOLISM; AMYLOID-BETA; AEROBIC GLYCOLYSIS; ENERGY-METABOLISM; COGNITIVE DECLINE; BRAIN; 2-DEOXYGLUCOSE	Previously, we demonstrated that mitochondrial bioenergetic deficits preceded Alzheimer's disease (AD) pathology in the female triple-transgenic AD (3xTgAD) mouse model. In parallel, 3xTgAD mice exhibited elevated expression of ketogenic markers, indicating a compensatory mechanism for energy production in brain. This compensatory response to generate an alternative fuel source was temporary and diminished with disease progression. To determine whether this compensatory alternative fuel system could be sustained, we investigated the impact of 2-deoxy-D-glucose (2-DG), a compound known to induce ketogenesis, on bioenergetic function and AD pathology burden in brain. 6-month-old female 3xTgAD mice were fed either a regular diet (AIN-93G) or a diet containing 0.04% 2-DG for 7 weeks. 2-DG diet significantly increased serum ketone body level and brain expression of enzymes required for ketone body metabolism. The 2-DG-induced maintenance of mitochondrial bioenergetics was paralleled by simultaneous reduction in oxidative stress. Further, 2-DG treated mice exhibited a significant reduction of both amyloid precursor protein (APP) and amyloid beta (A beta) oligomers, which was paralleled by significantly increased alpha-secretase and decreased gamma-secretase expression, indicating that 2-DG induced a shift towards a non-amyloidogenic pathway. In addition, 2-DG increased expression of genes involved in A beta clearance pathways, degradation, sequestering, and transport. Concomitant with increased bioenergetic capacity and reduced beta-amyloid burden, 2-DG significantly increased expression of neurotrophic growth factors, BDNF and NGF. Results of these analyses demonstrate that dietary 2-DG treatment increased ketogenesis and ketone metabolism, enhanced mitochondrial bioenergetic capacity, reduced beta-amyloid generation and increased mechanisms of beta-amyloid clearance. Further, these data link bioenergetic capacity with beta-amyloid generation and demonstrate that beta-amyloid burden was dynamic and reversible, as 2-DG reduced activation of the amyloidogenic pathway and increased mechanisms of beta-amyloid clearance. Collectively, these data provide preclinical evidence for dietary 2-DG as a disease-modifying intervention to delay progression of bioenergetic deficits in brain and associated b-amyloid burden.	[Yao, Jia; Chen, Shuhua; Mao, Zisu; Cadenas, Enrique; Brinton, Roberta Diaz] Univ So Calif, Sch Pharm, Dept Pharmacol & Pharmaceut Sci, Los Angeles, CA 90089 USA; [Brinton, Roberta Diaz] Univ So Calif, Keck Sch Med, Dept Neurol, Los Angeles, CA 90033 USA	University of Southern California; University of Southern California	Yao, J (corresponding author), Univ So Calif, Sch Pharm, Dept Pharmacol & Pharmaceut Sci, Los Angeles, CA 90089 USA.	rbrinton@usc.edu		Brinton, Roberta/0000-0001-8450-772X	National Institute on Aging [2R01AG032236, 5P01AG026572]; Eileen L. Norris Foundation; NATIONAL INSTITUTE ON AGING [R01AG032236, P01AG026572] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Eileen L. Norris Foundation; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Research reported herein was supported by National Institute on Aging Grant 2R01AG032236 (to RDB), National Institute on Aging Grant 5P01AG026572 (Project 1 to EC and RDB) and Eileen L. Norris Foundation (to RDB). The funders had no role in study design, data collection or analysis, decision to publish, or preparation of the manuscript.	AUESTAD N, 1991, J NEUROCHEM, V56, P1376, DOI 10.1111/j.1471-4159.1991.tb11435.x; Beal MF, 2005, ANN NEUROL, V58, P495, DOI 10.1002/ana.20624; Blalock EM, 2004, P NATL ACAD SCI USA, V101, P2173, DOI 10.1073/pnas.0308512100; Blass JP, 2000, ANN NY ACAD SCI, V903, P204, DOI 10.1111/j.1749-6632.2000.tb06370.x; Brinton RD, 2008, TRENDS NEUROSCI, V31, P529, DOI 10.1016/j.tins.2008.07.003; Brinton RD, 2008, ADV DRUG DELIVER REV, V60, P1504, DOI 10.1016/j.addr.2008.06.003; Cadenas Enrique, 2004, Molecular Aspects of Medicine, V25, P17, DOI 10.1016/j.mam.2004.02.005; CHEN K, 2011, NEUROIMAGE; Corona C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017971; Costantini LC, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-S2-S16; Duan WZ, 1999, J NEUROSCI RES, V57, P195, DOI 10.1002/(SICI)1097-4547(19990715)57:2&lt;195::AID-JNR5&gt;3.0.CO;2-P; Duan WZ, 2003, P NATL ACAD SCI USA, V100, P2911, DOI 10.1073/pnas.0536856100; Duan WZ, 2001, J MOL NEUROSCI, V16, P1, DOI 10.1385/JMN:16:1:1; Dwarakanath BS, 2009, J CANCER RES THER, V5, P21, DOI 10.4103/0973-1482.55136; Fischer PM, 2008, NAT CHEM BIOL, V4, P448, DOI 10.1038/nchembio0808-448; Frier B, 2005, EXP GERONTOL, V40, P615, DOI 10.1016/j.exger.2005.04.011; Gasior M, 2006, BEHAV PHARMACOL, V17, P431, DOI 10.1097/00008877-200609000-00009; Guzman M, 2004, PROSTAG LEUKOTR ESS, V70, P287, DOI 10.1016/j.plefa.2003.05.001; Halagappa VKM, 2007, NEUROBIOL DIS, V26, P212, DOI 10.1016/j.nbd.2006.12.019; HOYER S, 1991, ANN NY ACAD SCI, V640, P53, DOI 10.1111/j.1749-6632.1991.tb00190.x; Irwin RW, 2008, ENDOCRINOLOGY, V149, P3167, DOI 10.1210/en.2007-1227; Ishii K, 1997, J NUCL MED, V38, P925; KERN KA, 1987, SURGERY, V102, P380; LaFerla FM, 2007, NAT REV NEUROSCI, V8, P499, DOI 10.1038/nrn2168; Lee J, 2000, J MOL NEUROSCI, V15, P99, DOI 10.1385/JMN:15:2:99; Lustbader JW, 2004, SCIENCE, V304, P448, DOI 10.1126/science.1091230; Maalouf M, 2009, BRAIN RES REV, V59, P293, DOI 10.1016/j.brainresrev.2008.09.002; Magistretti PJ, 2006, J EXP BIOL, V209, P2304, DOI 10.1242/jeb.02208; Marsh J, 2008, NUTR METAB, V5, DOI 10.1186/1743-7075-5-33; Meilandt WJ, 2009, J NEUROSCI, V29, P1977, DOI 10.1523/JNEUROSCI.2984-08.2009; Miller JA, 2008, J NEUROSCI, V28, P1410, DOI 10.1523/JNEUROSCI.4098-07.2008; Minor RK, 2010, TOXICOL APPL PHARM, V243, P332, DOI 10.1016/j.taap.2009.11.025; Mohanti BK, 1996, INT J RADIAT ONCOL, V35, P103, DOI 10.1016/S0360-3016(96)85017-6; Moreira PI, 2010, BBA-MOL BASIS DIS, V1802, P212, DOI 10.1016/j.bbadis.2009.10.007; Morris AAM, 2005, J INHERIT METAB DIS, V28, P109, DOI 10.1007/s10545-005-5518-0; Mosconi L, 2005, EUR J NUCL MED MOL I, V32, P486, DOI [10.1007/s00259-008-1039-z, 10.1007/s00259-005-1762-7]; Mosconi L, 2008, NEUROBIOL AGING, V29, P676, DOI 10.1016/j.neurobiolaging.2006.12.008; Oddo S, 2003, NEURON, V39, P409, DOI 10.1016/S0896-6273(03)00434-3; Patel NV, 2005, NEUROBIOL AGING, V26, P995, DOI 10.1016/j.neurobiolaging.2004.09.014; Ralser M, 2008, P NATL ACAD SCI USA, V105, P17807, DOI 10.1073/pnas.0803090105; Ramirez-Amaya V, 2005, J NEUROSCI, V25, P1761, DOI 10.1523/JNEUROSCI.4342-04.2005; Reddy PH, 2010, J ALZHEIMERS DIS, V20, pS499, DOI 10.3233/JAD-2010-100504; Santos RX, 2010, INT J CLIN EXP PATHO, V3, P570; Shepherd JD, 2011, NAT NEUROSCI, V14, P279, DOI 10.1038/nn.2708; Soane L, 2007, J NEUROSCI RES, V85, P3407, DOI 10.1002/jnr.21498; Sreekumar R, 2002, AM J PHYSIOL-ENDOC M, V283, pE38, DOI 10.1152/ajpendo.00387.2001; Stein M, 2010, PROSTATE, V70, P1388, DOI 10.1002/pros.21172; Swerdlow RH, 2009, J ALZHEIMERS DIS, V17, P737, DOI 10.3233/JAD-2009-1095; Takuma K, 2005, FASEB J, V19, P597, DOI 10.1096/fj.04-2582fje; Vaishnavi SN, 2010, P NATL ACAD SCI USA, V107, P17757, DOI 10.1073/pnas.1010459107; Vlassenko AG, 2010, P NATL ACAD SCI USA, V107, P17763, DOI 10.1073/pnas.1010461107; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; Wan RQ, 2004, AM J PHYSIOL-HEART C, V287, pH1186, DOI 10.1152/ajpheart.00932.2003; Wang J, 2005, FASEB J, V19, P659, DOI 10.1096/fj.04-3182fje; Wang J, 2006, FASEB J, V20, P2313, DOI 10.1096/fj.06-6281com; Yan SD, 2005, INT J EXP PATHOL, V86, P161, DOI 10.1111/j.0959-9673.2005.00427.x; Yao J, 2010, BBA-GEN SUBJECTS, V1800, P1121, DOI 10.1016/j.bbagen.2010.06.002; Yao J, 2009, P NATL ACAD SCI USA, V106, P14670, DOI 10.1073/pnas.0903563106; Yu ZF, 1999, J NEUROSCI RES, V57, P830, DOI 10.1002/(SICI)1097-4547(19990915)57:6&lt;830::AID-JNR8&gt;3.0.CO;2-2	59	104	108	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2011	6	7							e21788	10.1371/journal.pone.0021788	http://dx.doi.org/10.1371/journal.pone.0021788			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786HC	21747957	Green Submitted, Green Published, gold			2022-12-27	WOS:000292293400033
J	Williams, JL; Ellers-Kirk, C; Orth, RG; Gassmann, AJ; Head, G; Tabashnik, BE; Carriere, Y				Williams, Jennifer L.; Ellers-Kirk, Christa; Orth, Robert G.; Gassmann, Aaron J.; Head, Graham; Tabashnik, Bruce E.; Carriere, Yves			Fitness Cost of Resistance to Bt Cotton Linked with Increased Gossypol Content in Pink Bollworm Larvae	PLOS ONE			English	Article							BACILLUS-THURINGIENSIS; INSECT RESISTANCE; HOST-PLANT; HELICOVERPA-ARMIGERA; HELIOTHIS-VIRESCENS; TOXIN CRY1AC; CADHERIN; LEPIDOPTERA; CROPS; GELECHIIDAE	Fitness costs of resistance to Bacillus thuringiensis (Bt) crops occur in the absence of Bt toxins, when individuals with resistance alleles are less fit than individuals without resistance alleles. As costs of Bt resistance are common, refuges of non-Bt host plants can delay resistance not only by providing susceptible individuals to mate with resistant individuals, but also by selecting against resistance. Because costs typically vary across host plants, refuges with host plants that magnify costs or make them less recessive could enhance resistance management. Limited understanding of the physiological mechanisms causing fitness costs, however, hampers attempts to increase costs. In several major cotton pests including pink bollworm (Pectinophora gossypiella), resistance to Cry1Ac cotton is associated with mutations altering cadherin proteins that bind this toxin in susceptible larvae. Here we report that the concentration of gossypol, a cotton defensive chemical, was higher in pink bollworm larvae with cadherin resistance alleles than in larvae lacking such alleles. Adding gossypol to the larval diet decreased larval weight and survival, and increased the fitness cost affecting larval growth, but not survival. Across cadherin genotypes, the cost affecting larval growth increased as the gossypol concentration of larvae increased. These results suggest that increased accumulation of plant defensive chemicals may contribute to fitness costs associated with resistance to Bt toxins.	[Williams, Jennifer L.; Ellers-Kirk, Christa; Gassmann, Aaron J.; Tabashnik, Bruce E.; Carriere, Yves] Univ Arizona, Dept Entomol, Tucson, AZ 85721 USA; [Orth, Robert G.; Head, Graham] Monsanto LLC, St Louis, MO USA; [Gassmann, Aaron J.] Iowa State Univ, Dept Entomol, Ames, IA USA	University of Arizona; Monsanto; Iowa State University	Williams, JL (corresponding author), Univ Arizona, Dept Entomol, Tucson, AZ 85721 USA.	ycarrier@ag.arizona.edu		Head, Graham/0000-0003-0521-0616	USDA [2003-04371]; Cotton Foundation; Cotton Inc.; National Cotton Council; Monsanto; Dow AgroSciences	USDA(United States Department of Agriculture (USDA)); Cotton Foundation; Cotton Inc.; National Cotton Council; Monsanto; Dow AgroSciences	This research was partly funded by USDA Biotechnology Risk Assessment Research Grant 2003-04371 (http://www.csrees.usda.gov/fo/biotechnologyriskassessment.cfm). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; BE Tabashnik received support for research that is not related to this publication from the following sources: Cotton Foundation, Cotton Inc., National Cotton Council, Monsanto, and Dow AgroSciences. Tabashnik is also co-author of a patent application on engineering modified Bt toxins to counter pest resistance, which is related to research described by Soberon et al. (2007, Science 318: 1640-1642). Robert G. Orth and Graham Head are employed by a commercial company, Monsanto LLC, which provides transgenic crops for the control of pests. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	ADKISSON PL, 1960, J ECON ENTOMOL, V53, P759, DOI 10.1093/jee/53.5.759; Bagla P, 2010, SCIENCE, V327, P1439, DOI 10.1126/science.327.5972.1439; Bird LJ, 2007, BIOL CONTROL, V40, P196, DOI 10.1016/j.biocontrol.2006.11.004; Bravo A, 2008, TRENDS BIOTECHNOL, V26, P573, DOI 10.1016/j.tibtech.2008.06.005; Carriere Y, 2005, J ECON ENTOMOL, V98, P947, DOI 10.1603/0022-0493-98.3.947; Carriere Y, 2004, J ECON ENTOMOL, V97, P1710, DOI 10.1603/0022-0493-97.5.1710; Carriere Y, 2001, P ROY SOC B-BIOL SCI, V268, P1475, DOI 10.1098/rspb.2001.1689; Carriere Y, 2006, J ECON ENTOMOL, V99, P1925, DOI 10.1603/0022-0493-99.6.1925; Carriere Y, 2010, EVOL APPL, V3, P561, DOI 10.1111/j.1752-4571.2010.00129.x; Carriere Y, 2009, J INSECT PHYSIOL, V55, P1058, DOI 10.1016/j.jinsphys.2009.07.013; Committee on the Impact of Biotechnology on Farm-Level Economics and Sustainability and The National Research Council T, 2010, IMP GEN ENG CROPS FA; Crowder DW, 2009, J THEOR BIOL, V261, P423, DOI 10.1016/j.jtbi.2009.08.017; Downes S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012567; Fabrick JA, 2007, INSECT BIOCHEM MOLEC, V37, P97, DOI 10.1016/j.ibmb.2006.10.010; Falconer D. S., 1981, INTRO QUANTITATIVE G; Gahan LJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001248; Gahan LJ, 2001, SCIENCE, V293, P857, DOI 10.1126/science.1060949; Gassmann AJ, 2006, J ECON ENTOMOL, V99, P920, DOI 10.1603/0022-0493-99.3.920; Gassmann AJ, 2009, ANNU REV ENTOMOL, V54, P147, DOI 10.1146/annurev.ento.54.110807.090518; Gould F, 2006, J ECON ENTOMOL, V99, P2091, DOI 10.1603/0022-0493-99.6.2091; GRAHAM HM, 1971, J ECON ENTOMOL, V64, P376, DOI 10.1093/jee/64.2.376; Higginson DM, 2005, EVOLUTION, V59, P915, DOI 10.1111/j.0014-3820.2005.tb01765.x; Hill E, 2001, J MOL BIOL, V305, P1011, DOI 10.1006/jmbi.2000.4361; Hron RJ, 1999, J AM OIL CHEM SOC, V76, P1351, DOI 10.1007/s11746-999-0149-5; Hutchison WD, 2010, SCIENCE, V330, P222, DOI 10.1126/science.1190242; Janmaat AF, 2005, P ROY SOC B-BIOL SCI, V272, P1031, DOI 10.1098/rspb.2004.3040; Mao YB, 2007, NAT BIOTECHNOL, V25, P1307, DOI 10.1038/nbt1352; Midboe EG, 2003, COMP BIOCHEM PHYS B, V135, P125, DOI 10.1016/S1096-4959(03)00054-X; Morin S, 2004, INSECT BIOCHEM MOLEC, V34, P1225, DOI 10.1016/j.ibmb.2004.08.003; Morin S, 2003, P NATL ACAD SCI USA, V100, P5004, DOI 10.1073/pnas.0831036100; Onstad D. W., 2008, INSECT RESISTANCE MA; Orth RG, 2007, J CHEM ECOL, V33, P1131, DOI 10.1007/s10886-007-9284-3; Ramsey F. L., 2002, STAT SLEUTH COURSE M; Raymond B, 2007, BIOL LETT-UK, V3, P82, DOI 10.1098/rsbl.2006.0560; SAS, 2008, JMP 8 0; Schlichting K, 2006, J CELL SCI, V119, P1184, DOI 10.1242/jcs.02831; SHAVER T N, 1970, Journal of Economic Entomology, V63, P1802; Stipanovic RD, 2008, ENVIRON ENTOMOL, V37, P1081, DOI 10.1603/0046-225X(2008)37[1081:EORAGO]2.0.CO;2; Storer NP, 2010, J ECON ENTOMOL, V103, P1031, DOI 10.1603/EC10040; Sunilkumar G, 2006, P NATL ACAD SCI USA, V103, P18054, DOI 10.1073/pnas.0605389103; Tabashnik BE, 2000, P NATL ACAD SCI USA, V97, P12980, DOI 10.1073/pnas.97.24.12980; Tabashnik BE, 2005, J ECON ENTOMOL, V98, P635, DOI 10.1603/0022-0493-98.3.635; Tabashnik BE, 2005, P NATL ACAD SCI USA, V102, P15389, DOI 10.1073/pnas.0507857102; Tabashnik BE, 2008, NAT BIOTECHNOL, V26, P199, DOI 10.1038/nbt1382; Tabashnik BE, 2009, J ECON ENTOMOL, V102, P2011, DOI 10.1603/029.102.0601; Xu XJ, 2005, APPL ENVIRON MICROB, V71, P948, DOI 10.1128/AEM.71.2.948-954.2005	46	38	38	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2011	6	6							e21863	10.1371/journal.pone.0021863	http://dx.doi.org/10.1371/journal.pone.0021863			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786GP	21738799	Green Published, gold, Green Submitted			2022-12-27	WOS:000292291800050
J	Zhang, R; Jongejans, E; Shea, K				Zhang, Rui; Jongejans, Eelke; Shea, Katriona			Warming Increases the Spread of an Invasive Thistle	PLOS ONE			English	Article							SPECIES SUCCESS; CLIMATE-CHANGE; ELEVATED CO2; DISPERSAL; DISTANCE; CONSEQUENCES; DEMOGRAPHY; VELOCITY; GROWTH	Background: Global warming and shifted precipitation regimes increasingly affect species abundances and distributions worldwide. Despite a large literature on species' physiological, phenological, growth, and reproductive responses to such climate change, dispersal is rarely examined. Our study aims to test whether the dispersal ability of a non-native, wind-dispersed plant species is affected by climate change, and to quantify the ramifications for future invasion spread rates. Methodology/Principal Findings: We experimentally increased temperature and precipitation in a two-cohort, factorial field study (n = 80). We found an overwhelming warming effect on plant life history: warming not only improved emergence, survival, and reproduction of the thistle Carduus nutans, but also elevated plant height, which increased seed dispersal distances. Using spatial population models, we demonstrate that these empirical warming effects on demographic vital rates, and dispersal parameters, greatly exacerbate spatial spread. Predicted levels of elevated winter precipitation decreased seed production per capitulum, but this only slightly offset the warming effect on spread. Using a spread rate decomposition technique (c*-LTRE), we also found that plant height-mediated changes in dispersal contribute most to increased spread rate under climate change. Conclusions/Significance: We found that both dispersal and spread of this wind-dispersed plant species were strongly impacted by climate change. Dispersal responses to climate change can improve, or diminish, a species' ability to track climate change spatially, and should not be overlooked. Methods that combine both demographic and dispersal responses thus will be an invaluable complement to projections of suitable habitat under climate change.	[Zhang, Rui; Shea, Katriona] Penn State Univ, Dept Biol, University Pk, PA 16802 USA; [Jongejans, Eelke] Radboud Univ Nijmegen, Dept Expt Plant Ecol, Inst Water & Wetland Res, NL-6525 ED Nijmegen, Netherlands	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Radboud University Nijmegen	Zhang, R (corresponding author), Penn State Univ, Dept Biol, University Pk, PA 16802 USA.	ruz104@psu.edu	Jongejans, Eelke/B-4832-2008; Shea, Katriona/B-7954-2008	Jongejans, Eelke/0000-0003-1148-7419; Shea, Katriona/0000-0002-7607-8248	National Science Foundation [DEB-0815373]; Netherlands Organisation for Scientific Research [863.08.006]; Direct For Biological Sciences [0815373] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Netherlands Organisation for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by a National Science Foundation grant (DEB-0815373) to KS and a Netherlands Organisation for Scientific Research veni-grant (863.08.006) to EJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsos IG, 2007, SCIENCE, V316, P1606, DOI 10.1126/science.1139178; Berg MP, 2010, GLOBAL CHANGE BIOL, V16, P587, DOI 10.1111/j.1365-2486.2009.02014.x; Brooker RW, 2007, J THEOR BIOL, V245, P59, DOI 10.1016/j.jtbi.2006.09.033; Chen M, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL024535; Doak DF, 2010, NATURE, V467, P959, DOI 10.1038/nature09439; Dukes JS, 2002, PLANT ECOL, V160, P225, DOI 10.1023/A:1015813919850; Engler R, 2009, DIVERS DISTRIB, V15, P590, DOI 10.1111/j.1472-4642.2009.00566.x; Frumhoff PC, 2007, CONFRONTING CLIMATE; Hayhoe K, 2007, CLIM DYNAM, V28, P381, DOI 10.1007/s00382-006-0187-8; Hellmann JJ, 2008, CONSERV BIOL, V22, P534, DOI 10.1111/j.1523-1739.2008.00951.x; Jablonski LM, 2002, NEW PHYTOL, V156, P9, DOI 10.1046/j.1469-8137.2002.00494.x; Jeltsch F, 2008, PERSPECT PLANT ECOL, V9, P171, DOI 10.1016/j.ppees.2007.11.004; Jongejans E, 2008, J ECOL, V96, P687, DOI 10.1111/j.1365-2745.2008.01367.x; Jump AS, 2005, ECOL LETT, V8, P1010, DOI 10.1111/j.1461-0248.2005.00796.x; Katul GG, 2005, AM NAT, V166, P368, DOI 10.1086/432589; Kokko H, 2006, SCIENCE, V313, P789, DOI 10.1126/science.1128566; Kuparinen A, 2009, P ROY SOC B-BIOL SCI, V276, P3081, DOI 10.1098/rspb.2009.0693; Loarie SR, 2009, NATURE, V462, P1052, DOI 10.1038/nature08649; Marchetto KM, 2010, ECOL RES, V25, P83, DOI 10.1007/s11284-009-0634-1; Matlack GR, 2004, J ECOL, V92, P1025, DOI 10.1111/j.0022-0477.2004.00908.x; MCCARTY MK, 1985, WEED SCI, V33, P664, DOI 10.1017/S0043174500083053; Molgaard, 1996, INT TUNDRA EXPT MANU; Nagel JM, 2004, ECOLOGY, V85, P100, DOI 10.1890/02-3005; Nathan R, 2011, ECOL LETT, V14, P211, DOI 10.1111/j.1461-0248.2010.01573.x; Neubert MG, 2000, ECOLOGY, V81, P1613, DOI 10.1890/0012-9658(2000)081[1613:DADCAS]2.0.CO;2; Polley HW, 2003, PLANT ECOL, V164, P85, DOI 10.1023/A:1021271226866; R Core Team, 2020, R LANG ENV STAT COMP; Shea K, 2010, ECOL APPL, V20, P1148, DOI 10.1890/09-0316.1; Skarpaas O, 2007, AM NAT, V170, P421, DOI 10.1086/519854; Smith SD, 2000, NATURE, V408, P79, DOI 10.1038/35040544; Soons MB, 2008, J ECOL, V96, P581, DOI 10.1111/j.1365-2745.2008.01370.x; Theoharides KA, 2007, NEW PHYTOL, V176, P256, DOI 10.1111/j.1469-8137.2007.02207.x; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Thuiller W, 2005, P NATL ACAD SCI USA, V102, P8245, DOI 10.1073/pnas.0409902102; Willis CG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008878; Wilson JRU, 2009, TRENDS ECOL EVOL, V24, P136, DOI 10.1016/j.tree.2008.10.007; Ziska LH, 2003, J EXP BOT, V54, P395, DOI 10.1093/jxb/erg027	37	25	25	2	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2011	6	6							e21725	10.1371/journal.pone.0021725	http://dx.doi.org/10.1371/journal.pone.0021725			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786FZ	21738779	gold, Green Published, Green Submitted			2022-12-27	WOS:000292290100065
J	Fussbroich, B; Wagener, N; Macher-Goeppinger, S; Benner, A; Falth, M; Sultmann, H; Holzer, A; Hoppe-Seyler, K; Hoppe-Seyler, F				Fussbroich, Bettina; Wagener, Nina; Macher-Goeppinger, Stephan; Benner, Axel; Faelth, Maria; Sueltmann, Holger; Holzer, Angela; Hoppe-Seyler, Karin; Hoppe-Seyler, Felix			EZH2 Depletion Blocks the Proliferation of Colon Cancer Cells	PLOS ONE			English	Article							METHYLTRANSFERASE GENE EZH2; HISTONE METHYLTRANSFERASE; COLORECTAL-CANCER; ENHANCER-OF-ZESTE-HOMOLOG-2 GENE; SOMATIC MUTATIONS; BREAST-CANCER; EXPRESSION; INVASION; DIFFERENTIATION; METHYLATION	The Enhancer of Zeste 2 (EZH2) protein has been reported to stimulate cell growth in some cancers and is therefore considered to represent an interesting new target for therapeutic intervention. Here, we investigated a possible role of EZH2 for the growth control of colon cancer cells. RNA interference (RNAi) mediated intracellular EZH2 depletion led to cell cycle arrest of colon carcinoma cells at the G1/S transition. This was associated with a reduction of cell numbers upon transient transfection of synthetic EZH2-targeting siRNAs and with inhibition of their colony formation capacity upon stable expression of vector-borne siRNAs. We furthermore tested whether EZH2 may repress the growth-inhibitory p27 gene, as reported for pancreatic cancer. However, expression analyses of colon cancer cell lines and colon cancer biopsies did not reveal a consistent correlation between EZH2 and p27 levels. Moreover, EZH2 depletion did not re-induce p27 expression in colon cancer cells, indicating that p27 repression by EZH2 may be cell- or tissue-specific. Whole genome transcriptome analyses identified cellular genes affected by EZH2 depletion in colon cancer cell lines. They included several cancer-associated genes linked to cellular proliferation or invasion, such as Dag1, MageD1, SDC1, Timp2, and Tob1. In conclusion, our results demonstrate that EZH2 depletion blocks the growth of colon cancer cells. These findings might provide benefits for the treatment of colon cancer.	[Fussbroich, Bettina; Wagener, Nina; Holzer, Angela; Hoppe-Seyler, Karin; Hoppe-Seyler, Felix] German Canc Res Ctr, Heidelberg, Germany; [Wagener, Nina] Heidelberg Univ, Dept Urol, D-6900 Heidelberg, Germany; [Macher-Goeppinger, Stephan] Heidelberg Univ, Inst Pathol, D-6900 Heidelberg, Germany; [Benner, Axel] German Canc Res Ctr, Div Biostat, D-6900 Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ)	Fussbroich, B (corresponding author), German Canc Res Ctr, Heidelberg, Germany.	hoppe-seyler@dkfz.de	Sültmann, Holger/E-4534-2013	Sültmann, Holger/0000-0002-5257-8600; Hoppe-Seyler, Felix/0000-0002-1864-300X				[Anonymous], 2010, GLOBOCAN 2008 CANC I; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bracken AP, 2003, EMBO J, V22, P5323, DOI 10.1093/emboj/cdg542; Butz K, 2003, ONCOGENE, V22, P5938, DOI 10.1038/sj.onc.1206894; BUTZ K, 1995, ONCOGENE, V10, P927; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Chu IM, 2008, NAT REV CANCER, V8, P253, DOI 10.1038/nrc2347; Crnkovic-Mertens I, 2006, LUNG CANCER, V54, P135, DOI 10.1016/j.lungcan.2006.07.018; Cullmann C, 2009, INT J CANCER, V125, P2014, DOI 10.1002/ijc.24671; Du Q, 2009, ONCOL REP, V22, P659, DOI 10.3892/or_00000486; Dukers DF, 2004, AM J PATHOL, V164, P873, DOI 10.1016/S0002-9440(10)63175-6; Ernst T, 2010, NAT GENET, V42, P722, DOI 10.1038/ng.621; Ezhkova E, 2009, CELL, V136, P1122, DOI 10.1016/j.cell.2008.12.043; Fiskus W, 2009, BLOOD, V114, P2733, DOI 10.1182/blood-2009-03-213496; Fluge O, 2009, BRIT J CANCER, V101, P1282, DOI 10.1038/sj.bjc.6605333; FOX MH, 1980, CYTOMETRY, V1, P71, DOI 10.1002/cyto.990010114; Fujita T, 2008, AM J PATHOL, V173, P217, DOI 10.2353/ajpath.2008.070957; Holland D, 2008, CANCER RES, V68, P9964, DOI 10.1158/0008-5472.CAN-08-1134; JABBAR SAB, 1989, BRIT J CANCER, V60, P523, DOI 10.1038/bjc.1989.306; Jackson AL, 2010, NAT REV DRUG DISCOV, V9, P57, DOI 10.1038/nrd3010; Kamminga LM, 2006, BLOOD, V107, P2170, DOI 10.1182/blood-2005-09-3585; Kleer CG, 2003, P NATL ACAD SCI USA, V100, P11606, DOI 10.1073/pnas.1933744100; Kodach LL, 2010, CARCINOGENESIS, V31, P1567, DOI 10.1093/carcin/bgq147; LIEBERSBACH BF, 1994, J BIOL CHEM, V269, P20013; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu CH, 2010, CANCER CELL, V18, P185, DOI 10.1016/j.ccr.2010.06.016; Martinez-Garcia E, 2010, NAT GENET, V42, P100, DOI 10.1038/ng0210-100; Mimori K, 2005, EJSO-EUR J SURG ONC, V31, P376, DOI 10.1016/j.ejso.2004.11.001; Morin RD, 2010, NAT GENET, V42, P181, DOI 10.1038/ng.518; Nikoloski G, 2010, NAT GENET, V42, P665, DOI 10.1038/ng.620; Ougolkov AV, 2008, CLIN CANCER RES, V14, P6790, DOI 10.1158/1078-0432.CCR-08-1013; Palmqvist R, 1999, J PATHOL, V188, P18, DOI 10.1002/(SICI)1096-9896(199905)188:1<18::AID-PATH311>3.0.CO;2-T; Parsons BD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008471; Peng LR, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-110; Pereira JD, 2010, P NATL ACAD SCI USA, V107, P15957, DOI 10.1073/pnas.1002530107; PETTY RD, 1995, J BIOLUM CHEMILUM, V10, P29, DOI 10.1002/bio.1170100105; R Development Core Team, 2011, LANG ENV STAT COMP, DOI 10.1007/978-3-540-74686-7; Rao ZY, 2010, CARCINOGENESIS, V31, P1576, DOI 10.1093/carcin/bgq150; Schneider G, 2006, EMBO J, V25, P3801, DOI 10.1038/sj.emboj.7601259; Sgambato A, 2003, AM J PATHOL, V162, P849, DOI 10.1016/S0002-9440(10)63881-3; Simon JA, 2008, MUTAT RES-FUND MOL M, V647, P21, DOI 10.1016/j.mrfmmm.2008.07.010; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Sneeringer CJ, 2010, P NATL ACAD SCI USA, V107, P20980, DOI 10.1073/pnas.1012525107; Sparmann A, 2006, NAT REV CANCER, V6, P846, DOI 10.1038/nrc1991; Sudo T, 2005, BRIT J CANCER, V92, P1754, DOI 10.1038/sj.bjc.6602531; Takeshita F, 2005, P NATL ACAD SCI USA, V102, P12177, DOI 10.1073/pnas.0501753102; Tan J, 2007, GENE DEV, V21, P1050, DOI 10.1101/gad.1524107; Tukey JW, 1977, EXPLORATORY DATA ANA; Tuma RS, 2009, J NATL CANCER I, V101, P1300, DOI 10.1093/jnci/djp342; Varambally S, 2002, NATURE, V419, P624, DOI 10.1038/nature01075; Wagener N, 2008, INT J CANCER, V123, P1545, DOI 10.1002/ijc.23683; Wang CG, 2010, WORLD J GASTROENTERO, V16, P2421, DOI 10.3748/wjg.v16.i19.2421; Wang PW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010202; Wei YK, 2011, NAT CELL BIOL, V13, P87, DOI 10.1038/ncb2139; Winkler GS, 2010, J CELL PHYSIOL, V222, P66, DOI 10.1002/jcp.21919; Wu ZL, 2010, CELL DEATH DIFFER, V17, P801, DOI 10.1038/cdd.2009.162	57	88	95	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2011	6	7							e21651	10.1371/journal.pone.0021651	http://dx.doi.org/10.1371/journal.pone.0021651			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	792WQ	21765901	Green Published, gold, Green Submitted			2022-12-27	WOS:000292781500007
J	Shiao, YH; Leighty, RM; Wang, CJ; Ge, X; Crawford, EB; Spurrier, JM; McCann, SD; Fields, JR; Fornwald, L; Riffle, L; Driver, C; Quinones, OA; Wilson, RE; Kasprzak, KS; Travlos, GS; Alvord, WG; Anderson, LM				Shiao, Yih-Horng; Leighty, Robert M.; Wang, Cuiju; Ge, Xin; Crawford, Erik B.; Spurrier, Joshua M.; McCann, Sean D.; Fields, Janet R.; Fornwald, Laura; Riffle, Lisa; Driver, Craig; Quinones, Octavio A.; Wilson, Ralph E.; Kasprzak, Kazimierz S.; Travlos, Gregory S.; Alvord, W. Gregory; Anderson, Lucy M.			Ontogeny-Driven rDNA Rearrangement, Methylation, and Transcription, and Paternal Influence	PLOS ONE			English	Article							RNA-POLYMERASE-I; RIBOSOMAL-RNA; EPIGENETIC INHERITANCE; GENE-EXPRESSION; EVOLUTION; MICE; MECHANISMS; COMPONENT; PROMOTER; DISEASE	Gene rearrangement occurs during development in some cell types and this genome dynamics is modulated by intrinsic and extrinsic factors, including growth stimulants and nutrients. This raises a possibility that such structural change in the genome and its subsequent epigenetic modifications may also take place during mammalian ontogeny, a process undergoing finely orchestrated cell division and differentiation. We tested this hypothesis by comparing single nucleotide polymorphism-defined haplotype frequencies and DNA methylation of the rDNA multicopy gene between two mouse ontogenic stages and among three adult tissues of individual mice. Possible influences to the genetic and epigenetic dynamics by paternal exposures were also examined for Cr(III) and acid saline extrinsic factors. Variables derived from litters, individuals, and duplicate assays in large mouse populations were examined using linear mixed-effects model. We report here that active rDNA rearrangement, represented by changes of haplotype frequencies, arises during ontogenic progression from day 8 embryos to 6-week adult mice as well as in different tissue lineages and is modifiable by paternal exposures. The rDNA methylation levels were also altered in concordance with this ontogenic progression and were associated with rDNA haplotypes. Sperm showed highest level of methylation, followed by lungs and livers, and preferentially selected haplotypes that are positively associated with methylation. Livers, maintaining lower levels of rDNA methylation compared with lungs, expressed more rRNA transcript. In vitro transcription demonstrated haplotype-dependent rRNA expression. Thus, the genome is also dynamic during mammalian ontogeny and its rearrangement may trigger epigenetic changes and subsequent transcriptional controls, that are further influenced by paternal exposures.	[Shiao, Yih-Horng; Wang, Cuiju; Crawford, Erik B.; Spurrier, Joshua M.; McCann, Sean D.; Fields, Janet R.; Kasprzak, Kazimierz S.; Anderson, Lucy M.] NCI, Comparat Carcinogenesis Lab, Frederick, MD 21701 USA; [Leighty, Robert M.; Quinones, Octavio A.; Alvord, W. Gregory] Data Management Serv Inc, Frederick, MD USA; [Ge, Xin; Fornwald, Laura; Riffle, Lisa; Driver, Craig] Sci Applicat Int Corp Frederick, Frederick, MD USA; [Wilson, Ralph E.; Travlos, Gregory S.] NIEHS, Natl Toxicol Program, Res Triangle Pk, NC 27709 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Shiao, YH (corresponding author), NCI, Comparat Carcinogenesis Lab, Frederick, MD 21701 USA.	shiaoy@mail.nih.gov	Shiao, Yih-Horng/ABC-7262-2021	Spurrier, Joshua/0000-0002-6267-7231; Shiao, Yih-Horng/0000-0001-9841-7784	NIH, National Cancer Institute, Center for Cancer Research; National Cancer Institute, National Institutes of Health [HHSN261200800001E]	NIH, National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported in part by the Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research. This project was also funded in part with Federal funds from the National Cancer Institute, National Institutes of Health, under Contract No. HHSN261200800001E. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Ahmadian A, 2006, CLIN CHIM ACTA, V363, P83, DOI 10.1016/j.cccn.2005.04.038; Badyaev AV, 2005, P ROY SOC B-BIOL SCI, V272, P877, DOI 10.1098/rspb.2004.3045; BORST P, 1987, SCIENCE, V235, P658, DOI 10.1126/science.3544215; BOSTOCK C J, 1984, Journal of Embryology and Experimental Morphology, V83, P7; CATTANACH BM, 1995, INT J RADIAT BIOL, V67, P607, DOI 10.1080/09553009514550721; Cheng RYS, 2004, MOL CARCINOGEN, V40, P1, DOI 10.1002/mc.20022; Eickbush TH, 2007, GENETICS, V175, P477, DOI 10.1534/genetics.107.071399; Feinberg AP, 2010, P NATL ACAD SCI USA, V107, P1757, DOI 10.1073/pnas.0906183107; Fichelson P, 2009, NAT CELL BIOL, V11, P685, DOI 10.1038/ncb1874; Gagnon-Kugler T, 2009, MOL CELL, V35, P414, DOI 10.1016/j.molcel.2009.07.008; Grummt I, 2003, NAT REV MOL CELL BIO, V4, P641, DOI 10.1038/nrm1171; Honda K, 2005, J BIOL CHEM, V280, P20978, DOI 10.1074/jbc.M500526200; Jablonka E, 2009, Q REV BIOL, V84, P131, DOI 10.1086/598822; Kobayashi T, 2005, SCIENCE, V309, P1581, DOI 10.1126/science.1116102; KUHN A, 1990, P NATL ACAD SCI USA, V87, P7527, DOI 10.1073/pnas.87.19.7527; Laferte A, 2006, GENE DEV, V20, P2030, DOI 10.1101/gad.386106; Littell R. C., 2006, SAS SYSTEMS MIXED MO, V2nd; LONG EO, 1980, ANNU REV BIOCHEM, V49, P727, DOI 10.1146/annurev.bi.49.070180.003455; McGowan PO, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002085; MERTZ W, 1993, J NUTR, V123, P626, DOI 10.1093/jn/123.4.626; Milliken GA, 1992, ANAL MESSY DATA, V1; Paredes S, 2009, P NATL ACAD SCI USA, V106, P17829, DOI 10.1073/pnas.0906811106; Parlato R, 2008, J NEUROSCI, V28, P12759, DOI 10.1523/JNEUROSCI.2439-08.2008; Pinheiro J, 2001, MIXED EFFECTS MODELS; Rando OJ, 2007, CELL, V128, P655, DOI 10.1016/j.cell.2007.01.023; Santoro R, 2001, MOL CELL, V8, P719, DOI 10.1016/S1097-2765(01)00317-3; Shiao YH, 2005, TOXICOL APPL PHARM, V205, P290, DOI 10.1016/j.taap.2004.10.017; SHIAO YH, 2010, MINGCHUAN HLTH TECH, V1, pE2; Shiao YH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007505; Shiratori M, 2002, ONCOGENE, V21, P2447, DOI 10.1038/sj.onc.1205334; Stults DM, 2008, GENOME RES, V18, P13, DOI 10.1101/gr.6858507; Tjiong HL, 2009, PERITON DIALYSIS INT, V29, P384; White RJ, 2008, TRENDS GENET, V24, P622, DOI 10.1016/j.tig.2008.10.003; Young DW, 2007, NATURE, V445, P442, DOI 10.1038/nature05473; Yu W, 1999, TOXICOL APPL PHARM, V158, P161, DOI 10.1006/taap.1999.8692	35	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2011	6	7							e22266	10.1371/journal.pone.0022266	http://dx.doi.org/10.1371/journal.pone.0022266			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791WM	21765958	gold, Green Submitted, Green Published			2022-12-27	WOS:000292699000034
J	Hoffmann, M; Kuska, JP; Zscharnack, M; Loeffler, M; Galle, J				Hoffmann, Martin; Kuska, Jens-Peer; Zscharnack, Matthias; Loeffler, Markus; Galle, Joerg			Spatial Organization of Mesenchymal Stem Cells In Vitro-Results from a New Individual Cell-Based Model with Podia	PLOS ONE			English	Article							HUMAN BONE-MARROW; MULTICELLULAR SYSTEMS; DIRECTIONAL CONTROL; OXYGEN-TENSION; STROMAL CELLS; MIAMI CELLS; DYNAMICS; GROWTH; DIFFERENTIATION; MIGRATION	Therapeutic application of mesenchymal stem cells (MSC) requires their extensive in vitro expansion. MSC in culture typically grow to confluence within a few weeks. They show spindle-shaped fibroblastoid morphology and align to each other in characteristic spatial patterns at high cell density. We present an individual cell-based model (IBM) that is able to quantitatively describe the spatio-temporal organization of MSC in culture. Our model substantially improves on previous models by explicitly representing cell podia and their dynamics. It employs podia-generated forces for cell movement and adjusts cell behavior in response to cell density. At the same time, it is simple enough to simulate thousands of cells with reasonable computational effort. Experimental sheep MSC cultures were monitored under standard conditions. Automated image analysis was used to determine the location and orientation of individual cells. Our simulations quantitatively reproduced the observed growth dynamics and cell-cell alignment assuming cell density-dependent proliferation, migration, and morphology. In addition to cell growth on plain substrates our model captured cell alignment on micro-structured surfaces. We propose a specific surface micro-structure that according to our simulations can substantially enlarge cell culture harvest. The 'tool box' of cell migratory behavior newly introduced in this study significantly enhances the bandwidth of IBM. Our approach is capable of accommodating individual cell behavior and collective cell dynamics of a variety of cell types and tissues in computational systems biology.	[Hoffmann, Martin] Maastricht Univ, Dept Knowledge Engn, Biomath & Bioinformat Grp, Maastricht, Netherlands; [Hoffmann, Martin; Kuska, Jens-Peer; Galle, Joerg] Univ Leipzig, Interdisciplinary Ctr Bioinformat, Leipzig, Germany; [Zscharnack, Matthias] Univ Leipzig, Ctr Biotechnol & Biomed, Leipzig, Germany; [Loeffler, Markus] Univ Leipzig, Inst Med Informat Stat & Epidemiol, Leipzig, Germany	Maastricht University; Leipzig University; Leipzig University; Leipzig University	Hoffmann, M (corresponding author), Maastricht Univ, Dept Knowledge Engn, Biomath & Bioinformat Grp, Maastricht, Netherlands.	martin.hoffmann@maastrichtuniversity.nl			German Research Foundation (DFG), IZBI [AU 132/3-1]; Federal Ministry of Education and Research of Germany [0313836]; DFG [BIZ-6 1/1]	German Research Foundation (DFG), IZBI(German Research Foundation (DFG)); Federal Ministry of Education and Research of Germany(Federal Ministry of Education & Research (BMBF)); DFG(German Research Foundation (DFG))	This study was supported by a joint grant from the German Research Foundation (DFG, http://www.dfg.de/en/index.jsp; AU 132/3-1, IZBI). MH, JPK and MZ were supported by the Federal Ministry of Education and Research of Germany (http://www.bmbf.de/en/index.php) through grant 0313836 (MS CartPro). JG was supported by DFG-grant BIZ-6 1/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alakel N, 2009, EXP HEMATOL, V37, P504, DOI 10.1016/j.exphem.2008.12.005; Andrew N, 2007, NAT CELL BIOL, V9, P193, DOI 10.1038/ncb1536; Ball SG, 2007, J CELL MOL MED, V11, P1012, DOI 10.1111/j.1582-4934.2007.00120.x; Barry FP, 2004, INT J BIOCHEM CELL B, V36, P568, DOI 10.1016/j.biocel.2003.11.001; Benoit M, 2002, CELLS TISSUES ORGANS, V172, P174, DOI 10.1159/000066964; Beysens DA, 2000, P NATL ACAD SCI USA, V97, P9467, DOI 10.1073/pnas.97.17.9467; Block M, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.248101; Byrne H, 2009, J MATH BIOL, V58, P657, DOI 10.1007/s00285-008-0212-0; Cai AQ, 2007, J THEOR BIOL, V245, P576, DOI 10.1016/j.jtbi.2006.10.024; Caplan A, 2009, J PATHOL, V217, P318, DOI 10.1002/path.2469; Chan CE, 2008, SCIENCE, V322, P1687, DOI 10.1126/science.1163595; Chen CW, 2009, CYTOKINE GROWTH F R, V20, P429, DOI 10.1016/j.cytogfr.2009.10.014; Chen FH, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2514; Cho HJ, 2007, PLOS BIOL, V5, P2614, DOI 10.1371/journal.pbio.0050302; Colter DC, 2000, P NATL ACAD SCI USA, V97, P3213, DOI 10.1073/pnas.070034097; Colter DC, 2001, P NATL ACAD SCI USA, V98, P7841, DOI 10.1073/pnas.141221698; Curran JM, 2006, BIOMATERIALS, V27, P4783, DOI 10.1016/j.biomaterials.2006.05.001; D'Ippolito G, 2004, J CELL SCI, V117, P2971, DOI 10.1242/jcs.01103; D'Ippolito G, 2006, BONE, V39, P513, DOI 10.1016/j.bone.2006.02.061; Dailey ME, 1996, J NEUROSCI, V16, P2983; Dalby MJ, 2007, NAT MATER, V6, P997, DOI 10.1038/nmat2013; Dieterich P, 2008, P NATL ACAD SCI USA, V105, P459, DOI 10.1073/pnas.0707603105; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Engler AJ, 2009, SCIENCE, V324, P208, DOI 10.1126/science.1170107; Freyman TM, 2002, EXP CELL RES, V272, P153, DOI 10.1006/excr.2001.5408; Fu JP, 2010, NAT METHODS, V7, P733, DOI 10.1038/nmeth.1487; Galle J, 2005, BIOPHYS J, V88, P62, DOI 10.1529/biophysj.104.041459; Galle J, 2009, J MATH BIOL, V58, P261, DOI 10.1007/s00285-008-0172-4; Galle J, 2006, CYTOM PART A, V69A, P704, DOI 10.1002/cyto.a.20287; Guck J, 2001, BIOPHYS J, V81, P767, DOI 10.1016/S0006-3495(01)75740-2; Hastings A, 2011, BIOL LETTERS, V7, P163, DOI 10.1098/rsbl.2010.0948; Heng BC, 2004, STEM CELLS, V22, P1152, DOI 10.1634/stemcells.2004-0062; Hoehme S, 2010, BIOINFORMATICS, V26, P2641, DOI 10.1093/bioinformatics/btq437; Hoffmann M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002922; Huang NF, 2008, REGEN MED, V3, P877, DOI 10.2217/17460751.3.6.877; Insall RH, 2010, NAT REV MOL CELL BIO, V11, P453, DOI 10.1038/nrm2905; Jiang YH, 2002, NATURE, V418, P41, DOI 10.1038/nature00870; Jontes JD, 2000, NAT NEUROSCI, V3, P231, DOI 10.1038/72936; Kipper MJ, 2007, BIOPHYS J, V93, P1797, DOI 10.1529/biophysj.106.096800; Krinner A, 2009, CELL PROLIFERAT, V42, P471, DOI 10.1111/j.1365-2184.2009.00621.x; Krinner A, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-73; Lan YH, 2008, BIOPHYS J, V94, P3839, DOI 10.1529/biophysj.107.123778; LANGE S, 2010, CELLULAR THERAPY TRA, V1, DOI DOI 10.3205/CTT-2010-EN-000051.000001; Lennon DP, 2001, J CELL PHYSIOL, V187, P345, DOI 10.1002/jcp.1081; Levine H, 2001, PHYS REV E, V63, DOI 10.1103/PhysRevE.63.017101; Li L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002093; Mahaffy RE, 2000, PHYS REV LETT, V85, P880, DOI 10.1103/PhysRevLett.85.880; Mammoto T, 2010, DEVELOPMENT, V137, P1407, DOI 10.1242/dev.024166; Mancuso L, 2009, CELL PROLIFERAT, V42, P602, DOI 10.1111/j.1365-2184.2009.00626.x; Maree AFM, 2006, B MATH BIOL, V68, P1169, DOI 10.1007/s11538-006-9131-7; Mata A, 2007, INT J NANOMED, V2, P389; MERCURIEVA AA, 1992, MAKROMOL CHEM-THEOR, V1, P205; Merks RMH, 2006, NONLINEARITY, V19, pC1, DOI 10.1088/0951-7715/19/1/000; Merks RMH, 2006, DEV BIOL, V289, P44, DOI 10.1016/j.ydbio.2005.10.003; Merks RMH, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000163; Meyer-Hermann M, 2009, TRENDS IMMUNOL, V30, P157, DOI 10.1016/j.it.2009.01.005; Mogilner A, 2005, BIOPHYS J, V89, P782, DOI 10.1529/biophysj.104.056515; Narayan V, 2007, SCIENCE, V317, P105, DOI 10.1126/science.1140414; Nathan R, 2008, P NATL ACAD SCI USA, V105, P19052, DOI 10.1073/pnas.0800375105; Newman TJ, 2008, CURR TOP DEV BIOL, V81, P157, DOI 10.1016/S0070-2153(07)81005-2; ODELL GM, 1981, DEV BIOL, V85, P446, DOI 10.1016/0012-1606(81)90276-1; Oh S, 2009, P NATL ACAD SCI USA, V106, P2130, DOI 10.1073/pnas.0813200106; Palomo LF, 1996, CELL IMMUNOL, V172, P43, DOI 10.1006/cimm.1996.0213; Palsson E, 2000, P NATL ACAD SCI USA, V97, P10448, DOI 10.1073/pnas.97.19.10448; Parker KK, 2002, FASEB J, V16, DOI 10.1096/fj.02-0038com; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Portera-Cailliau C, 2003, J NEUROSCI, V23, P7129, DOI 10.1523/JNEUROSCI.23-18-07129.2003; Prass M, 2006, J CELL BIOL, V174, P767, DOI 10.1083/jcb.200601159; Rappel WJ, 1999, PHYS REV LETT, V83, P1247, DOI 10.1103/PhysRevLett.83.1247; Ricci JL, 2008, J BIOMED MATER RES A, V85A, P313, DOI 10.1002/jbm.a.31379; Rosland GV, 2009, CANCER RES, V69, P5331, DOI 10.1158/0008-5472.CAN-08-4630; Rubio D, 2005, CANCER RES, V65, P3035, DOI 10.1158/0008-5472.CAN-04-4194; SANDERSIUS SA, 2011, EMERGENT CELL TISSUE; Sandersius SA, 2008, PHYS BIOL, V5, DOI 10.1088/1478-3975/5/1/015002; Sarugaser R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006498; Schaller G, 2007, J THEOR BIOL, V247, P554, DOI 10.1016/j.jtbi.2007.03.023; Simha RA, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.058101; Sorrentino A, 2008, EXP HEMATOL, V36, P1035, DOI 10.1016/j.exphem.2008.03.004; Starruss J, 2007, J STAT PHYS, V128, P269, DOI 10.1007/s10955-007-9298-9; Stephanou A, 2008, J THEOR BIOL, V253, P701, DOI 10.1016/j.jtbi.2008.04.035; Stockholm D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014441; Suva D, 2004, J CELL PHYSIOL, V198, P110, DOI 10.1002/jcp.10396; Szabo B, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.061908; Tamulonis C, 2011, DEV BIOL, V351, P217, DOI 10.1016/j.ydbio.2010.10.017; Toner J, 2005, ANN PHYS-NEW YORK, V318, P170, DOI 10.1016/j.aop.2005.04.011; Tosin A, 2006, B MATH BIOL, V68, P1819, DOI 10.1007/s11538-006-9071-2; VICSEK T, 2010, ARXIV10105017V1CONDM; Volfson D, 2008, P NATL ACAD SCI USA, V105, P15346, DOI 10.1073/pnas.0706805105; Wu YL, 2007, PLOS COMPUT BIOL, V3, P2546, DOI 10.1371/journal.pcbi.0030253; Xia N, 2008, FASEB J, V22, P1649, DOI 10.1096/fj.07-090571; Xu CY, 1997, LECT NOTES COMPUT SC, V1230, P399; Zhang HP, 2010, P NATL ACAD SCI USA, V107, P13626, DOI 10.1073/pnas.1001651107; Zhuravlev PI, 2009, P NATL ACAD SCI USA, V106, P11570, DOI 10.1073/pnas.0812746106; Zscharnack M, 2009, CELLS TISSUES ORGANS, V190, P81, DOI 10.1159/000178024; Zscharnack M, 2010, AM J SPORT MED, V38, P1857, DOI 10.1177/0363546510365296	95	15	16	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2011	6	7							e21960	10.1371/journal.pone.0021960	http://dx.doi.org/10.1371/journal.pone.0021960			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791IA	21760935	Green Published, gold, Green Submitted			2022-12-27	WOS:000292657200037
J	Pendt, LK; Reuter, I; Muller, H				Pendt, Lisa Katharina; Reuter, Iris; Mueller, Hermann			Motor Skill Learning, Retention, and Control Deficits in Parkinson's Disease	PLOS ONE			English	Article							BASAL GANGLIA; PRISM ADAPTATION; STRIATUM; CORTEX; TASK; VARIABILITY; MEMORY; DEGENERATION; PERFORMANCE; REFINEMENT	Parkinson's disease, which affects the basal ganglia, is known to lead to various impairments of motor control. Since the basal ganglia have also been shown to be involved in learning processes, motor learning has frequently been investigated in this group of patients. However, results are still inconsistent, mainly due to skill levels and time scales of testing. To bridge across the time scale problem, the present study examined de novo skill learning over a long series of practice sessions that comprised early and late learning stages as well as retention. 19 non-demented, medicated, mild to moderate patients with Parkinson's disease and 19 healthy age and gender matched participants practiced a novel throwing task over five days in a virtual environment where timing of release was a critical element. Six patients and seven control participants came to an additional long-term retention testing after seven to nine months. Changes in task performance were analyzed by a method that differentiates between three components of motor learning prominent in different stages of learning: Tolerance, Noise and Covariation. In addition, kinematic analysis related the influence of skill levels as affected by the specific motor control deficits in Parkinson patients to the process of learning. As a result, patients showed similar learning in early and late stages compared to the control subjects. Differences occurred in short-term retention tests; patients' performance constantly decreased after breaks arising from poorer release timing. However, patients were able to overcome the initial timing problems within the course of each practice session and could further improve their throwing performance. Thus, results demonstrate the intact ability to learn a novel motor skill in non-demented, medicated patients with Parkinson's disease and indicate confounding effects of motor control deficits on retention performance.	[Pendt, Lisa Katharina; Mueller, Hermann] Univ Giessen, Dept Psychol & Sport Sci, Giessen, Germany; [Reuter, Iris] Univ Giessen, Dept Neurol, Giessen, Germany	Justus Liebig University Giessen; Justus Liebig University Giessen	Pendt, LK (corresponding author), Univ Giessen, Dept Psychol & Sport Sci, Giessen, Germany.	lisa.k.pendt@sport.uni-giessen.de			German Research Foundation (DFG) [MU 1374/3-1]; German National Academic Foundation	German Research Foundation (DFG)(German Research Foundation (DFG)); German National Academic Foundation	This work was supported by grants from the German Research Foundation (DFG, http://www.dfg.de/en/index.jsp) [MU 1374/3-1] and the German National Academic Foundation (Studienstiftung des deutschen Volkes, http://www.studienstiftung.de/en/start.html) [to L.K.P.]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agostino R, 1996, J NEUROL SCI, V139, P218; Agostino R, 2004, MOVEMENT DISORD, V19, P1285, DOI 10.1002/mds.20247; Behrman AL, 2000, J NEUROL SCI, V174, P127, DOI 10.1016/S0022-510X(00)00267-7; Brasted PJ, 2004, EUR J NEUROSCI, V19, P721, DOI 10.1111/j.0953-816X.2003.03181.x; CANAVAN AGM, 1990, NEUROPSYCHOLOGIA, V28, P969, DOI 10.1016/0028-3932(90)90112-2; Cohen RG, 2009, EXP BRAIN RES, V193, P69, DOI 10.1007/s00221-008-1596-1; Contreras-Vidal JL, 2003, EXP BRAIN RES, V150, P25, DOI 10.1007/s00221-003-1403-y; Doyon J, 2002, P NATL ACAD SCI USA, V99, P1017, DOI 10.1073/pnas.022615199; Doyon J, 2009, BEHAV BRAIN RES, V199, P61, DOI 10.1016/j.bbr.2008.11.012; Fernandez-Ruiz J, 2003, EUR J NEUROSCI, V18, P689, DOI 10.1046/j.1460-9568.2003.02785.x; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fujii N, 2005, P NATL ACAD SCI USA, V102, P9032, DOI 10.1073/pnas.0503541102; Graybiel AM, 2005, CURR OPIN NEUROBIOL, V15, P638, DOI 10.1016/j.conb.2005.10.006; Graybiel AM, 1995, CURR OPIN NEUROBIOL, V5, P733, DOI 10.1016/0959-4388(95)80100-6; HARRINGTON DL, 1990, J CLIN EXP NEUROPSYC, V12, P323, DOI 10.1080/01688639008400978; HEINDEL WC, 1989, J NEUROSCI, V9, P582; HUFSCHMIDT A, 1995, MOVEMENT DISORD, V10, P267, DOI 10.1002/mds.870100306; JENKINS IH, 1994, J NEUROSCI, V14, P3775; Jessop RT, 2006, NEUROREHAB NEURAL RE, V20, P459, DOI 10.1177/1545968306287107; JORDAN N, 1994, INT J NEUROSCI, V77, P153, DOI 10.3109/00207459408986027; Jueptner M, 1997, J NEUROPHYSIOL, V77, P1325, DOI 10.1152/jn.1997.77.3.1325; Krebs HI, 2001, EXP BRAIN RES, V141, P425, DOI 10.1007/s002210100871; Mentis MJ, 2003, NEUROLOGY, V60, P612, DOI 10.1212/01.WNL.0000044154.92143.DC; Mochizuki-Kawai H, 2004, NEUROPSYCHOLOGIA, V42, P1858, DOI 10.1016/j.neuropsychologia.2004.03.012; Muller H, 2004, J EXP PSYCHOL HUMAN, V30, P212, DOI 10.1037/0096-1523.30.1.212; MULLER H, 2008, PROGR MOTOR CONTROL, P439; Muller H., 2004, J HUM KINET, V12, P31; Muslimovic D, 2007, BRAIN, V130, P2887, DOI 10.1093/brain/awm211; Nambu A, 2008, CURR OPIN NEUROBIOL, V18, P595, DOI 10.1016/j.conb.2008.11.001; PASCUALLEONE A, 1993, ANN NEUROL, V34, P594, DOI 10.1002/ana.410340414; Pasupathy A, 2005, NATURE, V433, P873, DOI 10.1038/nature03287; Platz T, 1998, BRAIN, V121, P505, DOI 10.1093/brain/121.3.505; Rauch SL, 1997, HUM BRAIN MAPP, V5, P124, DOI 10.1002/(SICI)1097-0193(1997)5:2<124::AID-HBM6>3.3.CO;2-P; Reed CL, 1998, COGNITIVE NEUROPSYCH, V15, P723, DOI 10.1080/026432998381078; Seitz R J, 1990, Neuroreport, V1, P57, DOI 10.1097/00001756-199009000-00016; SEITZ RJ, 1994, NEUROREPORT, V5, P2541, DOI 10.1097/00001756-199412000-00034; SHERIDAN MR, 1990, BRAIN, V113, P1149, DOI 10.1093/brain/113.4.1149; Smiley-Oyen AL, 2003, EXP BRAIN RES, V152, P453, DOI 10.1007/s00221-003-1570-x; Smiley-Oyen AL, 2002, MOVEMENT DISORD, V17, P1196, DOI 10.1002/mds.10278; Smiley-Oyen AL, 2006, MOVEMENT DISORD, V21, P1078, DOI 10.1002/mds.20906; Soliveri P, 1997, BRAIN, V120, P1325, DOI 10.1093/brain/120.8.1325; Swinnen SP, 2000, BEHAV BRAIN RES, V111, P45, DOI 10.1016/S0166-4328(00)00144-3; Wolpert DM, 2001, TRENDS COGN SCI, V5, P487, DOI 10.1016/S1364-6613(00)01773-3; Yu H, 2007, NEUROIMAGE, V35, P222, DOI 10.1016/j.neuroimage.2006.11.047	44	25	27	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2011	6	7							e21669	10.1371/journal.pone.0021669	http://dx.doi.org/10.1371/journal.pone.0021669			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	791IA	21760898	gold, Green Published, Green Submitted			2022-12-27	WOS:000292657200016
J	Le Bihan-Duval, E; Nadaf, J; Berri, C; Pitel, F; Graulet, B; Godet, E; Leroux, SY; Demeure, O; Lagarrigue, S; Duby, C; Cogburn, LA; Beaumont, CM; Duclos, MJ				Le Bihan-Duval, Elisabeth; Nadaf, Javad; Berri, Cecile; Pitel, Frederique; Graulet, Benoit; Godet, Estelle; Leroux, Sophie Y.; Demeure, Olivier; Lagarrigue, Sandrine; Duby, Cecile; Cogburn, Larry A.; Beaumont, Catherine M.; Duclos, Michel J.			Detection of a Cis eQTL Controlling BMCO1 Gene Expression Leads to the Identification of a QTG for Chicken Breast Meat Color	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; BETA-CAROTENE; BODY-COMPOSITION; MUSCLE GLYCOGEN; GROWTH CURVE; VITAMIN-A; SELECTION; QUALITY; ASTAXANTHIN; CONVERSION	Classical quantitative trait loci (QTL) analysis and gene expression QTL (eQTL) were combined to identify the causal gene (or QTG) underlying a highly significant QTL controlling the variation of breast meat color in a F2 cross between divergent high-growth (HG) and low-growth (LG) chicken lines. Within this meat quality QTL, BCMO1 (Accession number GenBank: AJ271386), encoding the beta-carotene 15, 15'-monooxygenase, a key enzyme in the conversion of beta-carotene into colorless retinal, was a good functional candidate. Analysis of the abundance of BCMO1 mRNA in breast muscle of the HG x LG F2 population allowed for the identification of a strong cis eQTL. Moreover, reevaluation of the color QTL taking BCMO1 mRNA levels as a covariate indicated that BCMO1 mRNA levels entirely explained the variations in meat color. Two fully-linked single nucleotide polymorphisms (SNP) located within the proximal promoter of BCMO1 gene were identified. Haplotype substitution resulted in a marked difference in BCMO1 promoter activity in vitro. The association study in the F2 population revealed a three-fold difference in BCMO1 expression leading to a difference of 1 standard deviation in yellow color between the homozygous birds at this haplotype. This difference in meat yellow color was fully consistent with the difference in carotenoid content (i.e. lutein and zeaxanthin) evidenced between the two alternative haplotypes. A significant association between the haplotype, the level of BCMO1 expression and the yellow color of the meat was also recovered in an unrelated commercial broiler population. The mutation could be of economic importance for poultry production by making possible a gene-assisted selection for color, a determining aspect of meat quality. Moreover, this natural genetic diversity constitutes a new model for the study of beta-carotene metabolism which may act upon diverse biological processes as precursor of the vitamin A.	[Le Bihan-Duval, Elisabeth; Nadaf, Javad; Berri, Cecile; Godet, Estelle; Beaumont, Catherine M.; Duclos, Michel J.] INRA, UR83, F-37380 Nouzilly, France; [Pitel, Frederique; Leroux, Sophie Y.] INRA, ENVT, Genet Cellulaire UMR444, F-31326 Castanet Tolosan, France; [Graulet, Benoit] INRA, Herbivores UR1213, Ctr Clermont Ferrand Theix, F-63122 St Genes Champanelle, France; [Demeure, Olivier; Lagarrigue, Sandrine; Duby, Cecile] INRA, UMR Genet Anim 598, F-35042 Rennes, France; [Demeure, Olivier; Lagarrigue, Sandrine; Duby, Cecile] Agrocampus Ouest, UMR Genet Anim 598, Rennes, France; [Cogburn, Larry A.] Univ Delaware, Dept Anim & Food Sci, Newark, DE USA	INRAE; INRAE; Universite de Toulouse; Ecole Nationale Veterinaire de Toulouse; INRAE; INRAE; Institut Agro; Agrocampus Ouest; University of Delaware	Le Bihan-Duval, E (corresponding author), INRA, UR83, F-37380 Nouzilly, France.	lebihan@tours.inra.fr	Berri, Cécile/H-6409-2016; DUCLOS, Michel/AAQ-3957-2021; Pitel, Frédérique/C-2847-2009; , AGROCAMPUS OUEST/O-6651-2016	Berri, Cécile/0000-0002-3613-1825; DUCLOS, Michel/0000-0002-9305-3982; Pitel, Frédérique/0000-0002-1477-7633; Cogburn, Larry/0000-0003-0977-7580; Lagarrigue, Sandrine/0000-0002-4887-7245; , AGROCAMPUS OUEST/0000-0002-1800-4558	United States Department of Agriculture - Initiative for Future Agriculture and Food Systems [00-52100-9614]; AGENAE (France); INRA Departments of Animal Genetics and Animal Physiology (France); ANR [0426]	United States Department of Agriculture - Initiative for Future Agriculture and Food Systems(United States Department of Agriculture (USDA)); AGENAE (France); INRA Departments of Animal Genetics and Animal Physiology (France); ANR(French National Research Agency (ANR))	The creation of the original F2 resource population from the HG x LG intercross and the subsequent quantitative trait loci (QTL) analysis were funded by grants from the United States Department of Agriculture - Initiative for Future Agriculture and Food Systems Animal Genome Program [Grant # 00-52100-9614 to LAC], AGENAE (France) and INRA Departments of Animal Genetics and Animal Physiology (France). The expression QTL study was funded by a grant from the ANR Genanimal Program 2004 [Grant # 0426 to MD and SL]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarado CZ, 2007, POULTRY SCI, V86, P156, DOI 10.1093/ps/86.1.156; Beccavin C, 2001, J ENDOCRINOL, V168, P297, DOI 10.1677/joe.0.1680297; Berri C, 2005, BRIT POULTRY SCI, V46, P572, DOI 10.1080/00071660500303099; Berri C, 2001, POULTRY SCI, V80, P833, DOI 10.1093/ps/80.7.833; Biesalski HK, 2007, VITAM HORM, V75, P117, DOI 10.1016/S0083-6729(06)75005-1; Chauveau-Duriot B, 2010, ANAL BIOANAL CHEM, V397, P777, DOI 10.1007/s00216-010-3594-y; CHURCHILL GA, 1994, GENETICS, V138, P963; Duclos MJ, 1996, GROWTH REGULAT, V6, P176; Eriksson J, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000010; Fletcher D., 1999, POULTRY MEAT SCI, P159; Georges M, 2007, ANNU REV GENOM HUM G, V8, P131, DOI 10.1146/annurev.genom.8.080706.092408; Groenen MAM, 2000, GENOME RES, V10, P137; Groeneveld E., 1990, PEST USERS MANUAL; Hessel S, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M706763200; Leung WC, 2009, FASEB J, V23, P1041, DOI 10.1096/fj.08-121962; Lietz G, 2010, ARCH BIOCHEM BIOPHYS, V502, P8, DOI 10.1016/j.abb.2010.06.032; Lindqvist A, 2007, J NUTR, V137, P2346, DOI 10.1093/jn/137.11.2346; Mangin B, 1997, HEREDITY, V78, P345, DOI 10.1038/hdy.1997.57; Mignon-Grasteau S, 2001, POULTRY SCI, V80, P849, DOI 10.1093/ps/80.7.849; Mignon-Grasteu S, 1999, BRIT POULTRY SCI, V40, P44, DOI 10.1080/00071669987827; Moren M, 2002, FISH PHYSIOL BIOCHEM, V27, P71, DOI 10.1023/B:FISH.0000021819.46235.12; Nadaf J, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-155; Nadaf J, 2009, PHYSIOL GENOMICS, V38, P241, DOI 10.1152/physiolgenomics.90384.2008; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; REMIGNON H, 1995, J MUSCLE RES CELL M, V16, P95, DOI 10.1007/BF00122527; RICARD F H, 1975, Annales de Genetique et de Selection Animale, V7, P427, DOI 10.1186/1297-9686-7-4-427; Ron M, 2007, ANIM GENET, V38, P429, DOI 10.1111/j.1365-2052.2007.01640.x; Sangeetha RK, 2010, CAN J PHYSIOL PHARM, V88, P977, DOI [10.1139/Y10-074, 10.1139/y10-074]; Seaton G, 2002, BIOINFORMATICS, V18, P339, DOI 10.1093/bioinformatics/18.2.339; Sibut V, 2008, J ANIM SCI, V86, P2888, DOI 10.2527/jas.2008-1062	30	33	35	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2011	6	7							e14825	10.1371/journal.pone.0014825	http://dx.doi.org/10.1371/journal.pone.0014825			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	789JO	21750696	Green Published, Green Submitted, gold			2022-12-27	WOS:000292512000003
J	Hollenbach, JP; Resch, AM; Palakodeti, D; Graveley, BR; Heinen, CD				Hollenbach, Jessica P.; Resch, Alissa M.; Palakodeti, Dasaradhi; Graveley, Brenton R.; Heinen, Christopher D.			Loss of DNA Mismatch Repair Imparts a Selective Advantage in Planarian Adult Stem Cells	PLOS ONE			English	Article							METHYLATING AGENTS; GENE-EXPRESSION; CANCER; CHECKPOINT; MUTATION; IDENTIFICATION; REGENERATION; APOPTOSIS; BIOLOGY; MODELS	Lynch syndrome (LS) leads to an increased risk of early-onset colorectal and other types of cancer and is caused by germline mutations in DNA mismatch repair (MMR) genes. Loss of MMR function results in a mutator phenotype that likely underlies its role in tumorigenesis. However, loss of MMR also results in the elimination of a DNA damage-induced checkpoint/apoptosis activation barrier that may allow damaged cells to grow unchecked. A fundamental question is whether loss of MMR provides pre-cancerous stem cells an immediate selective advantage in addition to establishing a mutator phenotype. To test this hypothesis in an in vivo system, we utilized the planarian Schmidtea mediterranea which contains a significant population of identifiable adult stem cells. We identified a planarian homolog of human MSH2, a MMR gene which is mutated in 38% of LS cases. The planarian Smed-msh2 is expressed in stem cells and some progeny. We depleted Smed-msh2 mRNA levels by RNA-interference and found a striking survival advantage in these animals treated with a cytotoxic DNA alkylating agent compared to control animals. We demonstrated that this tolerance to DNA damage is due to the survival of mitotically active, MMR-deficient stem cells. Our results suggest that loss of MMR provides an in vivo survival advantage to the stem cell population in the presence of DNA damage that may have implications for tumorigenesis.	[Hollenbach, Jessica P.; Heinen, Christopher D.] Univ Connecticut, Ctr Hlth, Neag Comprehens Canc Ctr, Farmington, CT 06030 USA; [Hollenbach, Jessica P.; Heinen, Christopher D.] Univ Connecticut, Ctr Hlth, Ctr Mol Med, Farmington, CT USA; [Resch, Alissa M.; Palakodeti, Dasaradhi; Graveley, Brenton R.] Univ Connecticut, Ctr Hlth, Stem Cell Inst, Dept Genet & Dev Biol, Farmington, CT USA	University of Connecticut; University of Connecticut; University of Connecticut	Hollenbach, JP (corresponding author), Univ Connecticut, Ctr Hlth, Neag Comprehens Canc Ctr, Farmington, CT 06030 USA.	cheinen@uchc.edu	Graveley, Brenton R/C-3108-2013	Graveley, Brenton/0000-0001-5777-5892	State of Connecticut Department of Public Health [2010-0088]; Raymond and Beverly Sackler Fund for the Arts and Sciences	State of Connecticut Department of Public Health; Raymond and Beverly Sackler Fund for the Arts and Sciences	This work was supported by the State of Connecticut Department of Public Health #2010-0088 (to CDH) and the Raymond and Beverly Sackler Fund for the Arts and Sciences (to BRG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarado AS, 1999, P NATL ACAD SCI USA, V96, P5049, DOI 10.1073/pnas.96.9.5049; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bartkova J, 2005, NATURE, V434, P864, DOI 10.1038/nature03482; de Wind N, 1998, CANCER RES, V58, P248; Edelmann L, 2004, AM J MED GENET C, V129C, P91, DOI 10.1002/ajmg.c.30021; Eisenhoffer GT, 2008, CELL STEM CELL, V3, P327, DOI 10.1016/j.stem.2008.07.002; FISHEL R, 1995, CURR OPIN GENET DEV, V5, P382, DOI 10.1016/0959-437X(95)80055-7; FOSTER JA, 1963, CANCER RES, V23, P300; Gertz EM, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-41; Gorgoulis VG, 2005, NATURE, V434, P907, DOI 10.1038/nature03485; HANDBERGTHORSAG.EF, 2008, BIOSCIENCE, V13, P6374; Hayashi T, 2006, DEV GROWTH DIFFER, V48, P371, DOI 10.1111/j.1440-169x.2006.00876.x; Heinen CD, 2002, CANCER BIOL THER, V1, P477, DOI 10.4161/cbt.1.5.160; Hendzel MJ, 1997, CHROMOSOMA, V106, P348, DOI 10.1007/s004120050256; Hsieh P, 2008, MECH AGEING DEV, V129, P391, DOI 10.1016/j.mad.2008.02.012; Jiricny J, 2006, NAT REV MOL CELL BIO, V7, P335, DOI 10.1038/nrm1907; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lin DP, 2004, CANCER RES, V64, P517, DOI 10.1158/0008-5472.CAN-03-2957; Lobo NA, 2007, ANNU REV CELL DEV BI, V23, P675, DOI 10.1146/annurev.cellbio.22.010305.104154; Lu YC, 2009, RNA, V15, P1483, DOI 10.1261/rna.1702009; Lynch H. T., 2003, HERED CANCER CLIN PR, V1, P7, DOI DOI 10.1186/1897-4287-1-1-7; Mastrocola AS, 2010, HUM MUTAT, V31, pE1699, DOI 10.1002/humu.21333; Newmark PA, 2003, P NATL ACAD SCI USA, V100, P11861, DOI 10.1073/pnas.1834205100; Newmark PA, 2002, NAT REV GENET, V3, P210, DOI 10.1038/nrg759; Orii H, 2005, DEV GENES EVOL, V215, P143, DOI 10.1007/s00427-004-0460-y; Oviedo N. J., 2008, COLD SPRING HARBOR P; Pardal R, 2003, NAT REV CANCER, V3, P895, DOI 10.1038/nrc1232; Pearson BJ, 2009, DEV DYNAM, V238, P443, DOI 10.1002/dvdy.21849; Peltomaki P, 1997, GASTROENTEROLOGY, V113, P1146, DOI 10.1053/gast.1997.v113.pm9322509; Reddien PW, 2005, SCIENCE, V310, P1327, DOI 10.1126/science.1116110; Reddien PW, 2005, DEV CELL, V8, P635, DOI 10.1016/j.devcel.2005.02.014; Reddien PW, 2004, ANNU REV CELL DEV BI, V20, P725, DOI 10.1146/annurev.cellbio.20.010403.095114; Robb SMC, 2008, NUCLEIC ACIDS RES, V36, pD599, DOI 10.1093/nar/Gkm684; Stojic L, 2005, CELL CYCLE, V4, P473, DOI 10.4161/cc.4.3.1528; Stojic L, 2004, DNA REPAIR, V3, P1091, DOI 10.1016/j.dnarep.2004.06.006; Stojic L, 2004, GENE DEV, V18, P1331, DOI 10.1101/gad.294404; Toft NJ, 1999, P NATL ACAD SCI USA, V96, P3911, DOI 10.1073/pnas.96.7.3911; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Wyatt MD, 2006, CHEM RES TOXICOL, V19, P1580, DOI 10.1021/tx060164e; Yang GZ, 2004, CANCER CELL, V6, P139, DOI 10.1016/j.ccr.2004.06.024; Zayas RM, 2005, P NATL ACAD SCI USA, V102, P18491, DOI 10.1073/pnas.0509507102; Zhang H, 1999, CANCER RES, V59, P3021	42	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2011	6	7							e21808	10.1371/journal.pone.0021808	http://dx.doi.org/10.1371/journal.pone.0021808			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786HC	21747960	Green Published, gold, Green Submitted			2022-12-27	WOS:000292293400036
J	Izzotti, A; Longobardi, M; Cartiglia, C; Rathschuler, F; Sacca, SC				Izzotti, Alberto; Longobardi, Mariagrazia; Cartiglia, Cristina; Rathschuler, Federico; Sacca, Sergio Claudio			Trabecular Meshwork Gene Expression after Selective Laser Trabeculoplasty	PLOS ONE			English	Article							OPEN-ANGLE GLAUCOMA; OPTIC-NERVE HEAD; RANDOMIZED CLINICAL-TRIAL; AQUEOUS-HUMOR OUTFLOW; LAMINA-CRIBROSA CELLS; INTRAOCULAR-PRESSURE; EXTRACELLULAR-MATRIX; OXIDATIVE STRESS; IN-VITRO; DAMAGE	Background: Trabecular meshwork and Schlemm's canal are the tissues appointed to modulate the aqueous humour outflow from the anterior chamber. The impairment of their functions drives to an intraocular pressure increase. The selective laser trabeculoplasty is a laser therapy of the trabecular meshwork able to decrease intraocular pressure. The exact response mechanism to this treatment has not been clearly delineated yet. The herein presented study is aimed at studying the gene expression changes induced in trabecular meshwork cells by selective laser trabeculoplasty (SLT) in order to better understand the mechanisms subtending its efficacy. Methodology/Principal Findings: Primary human trabecular meshwork cells cultured in fibroblast medium underwent selective laser trabeculoplasty treatment. RNA was extracted from a pool of cells 30 minutes after treatment while the remaining cells were further cultured and RNA was extracted respectively 2 and 6 hours after treatment. Control cells stored in incubator in absence of SLT treatment were used as reference samples. Gene expression was evaluated by hybridization on miRNA-microarray and laser scanner analysis. Scanning electron microscopic examination was performed on 2 Trabecular meshwork samples after SLT at 4(th) and 6(th) hour from treatment. On the whole, selective laser trabeculoplasty modulates in trabecular meshwork the expression of genes involved in cell motility, intercellular connections, extracellular matrix production, protein repair, DNA repair, membrane repair, reactive oxygen species production, glutamate toxicity, antioxidant activities, and inflammation. Conclusions/Significance: SLT did not induce any phenotypic alteration in TM samples. TM is a complex tissue possessing a great variety of function pivotal for the active regulation of aqueous humour outflow from the anterior chamber. SLT is able to modulate these functions at the postgenomic molecular level without inducing damage either at molecular or phenotypic levels.	[Izzotti, Alberto; Longobardi, Mariagrazia; Cartiglia, Cristina] Univ Genoa, Fac Med, Dept Hlth Sci, Genoa, Italy; [Rathschuler, Federico; Sacca, Sergio Claudio] St Martino Hosp, Dept Head Neck Pathol, Ophthalmol Unit, Genoa, Italy	University of Genoa	Izzotti, A (corresponding author), Univ Genoa, Fac Med, Dept Hlth Sci, Genoa, Italy.	sergio.sacca@hsanmartino.it	Sacca, Sergio/D-5118-2018; Saccà, Sergio/AAG-3335-2019	Sacca, Sergio/0000-0001-6973-5978; Saccà, Sergio/0000-0001-6973-5978; izzotti, alberto/0000-0002-8588-0347	Glaucoma Foundation (New York, United States of America)	Glaucoma Foundation (New York, United States of America)	This study was supported by The Glaucoma Foundation (New York, United States of America). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acott TS, 2008, EXP EYE RES, V86, P543, DOI 10.1016/j.exer.2008.01.013; ALVARADO J, 1984, OPHTHALMOLOGY, V91, P564; Alvarado J, 1984, RECENT ADV GLAUCOMA, P3; Alvarado JA, 2005, BRIT J OPHTHALMOL, V89, P1500, DOI 10.1136/bjo.2005.081307; Alvarado Jorge A, 2005, Trans Am Ophthalmol Soc, V103, P148; Alvarado JA, 2010, ARCH OPHTHALMOL-CHIC, V128, P731, DOI 10.1001/archophthalmol.2010.85; Balaratnasingam C, 2007, INVEST OPHTH VIS SCI, V48, P3632, DOI 10.1167/iovs.06-1002; Balaratnasingam C, 2008, BRAIN RES, V1244, P142, DOI 10.1016/j.brainres.2008.09.044; Borras T, 2003, PROG RETIN EYE RES, V22, P435, DOI 10.1016/S1350-9462(03)00018-1; BYLSMA SS, 1988, ARCH OPHTHALMOL-CHIC, V106, P544; Coca-Prados M, 2007, PROG RETIN EYE RES, V26, P239, DOI 10.1016/j.preteyeres.2007.01.002; Cvekl A, 2004, BIOESSAYS, V26, P374, DOI 10.1002/bies.20009; Cvenkel B, 2004, OPHTHALMOLOGICA, V218, P20, DOI 10.1159/000074562; Damji KF, 2006, BRIT J OPHTHALMOL, V90, P1490, DOI 10.1136/bjo.2006.098855; DEKATER AW, 1990, INVEST OPHTH VIS SCI, V31, P347; DUEKER DK, 1990, INVEST OPHTH VIS SCI, V31, P115; Epstein DL, 1997, INVEST OPHTH VIS SCI, V38, P1526; GAASTERLAND D, 1978, INVEST OPHTH VIS SCI, V17, P838; Goyal S, 2010, BRIT J OPHTHALMOL, V94, P1443, DOI 10.1136/bjo.2009.176024; Gupta N, 2009, BRIT J OPHTHALMOL, V93, P56, DOI 10.1136/bjo.2008.138172; Guzey M, 2001, EUR J OPHTHALMOL, V11, P47, DOI 10.1177/112067210101100109; He Y, 2008, INVEST OPHTH VIS SCI, V49, P4912, DOI 10.1167/iovs.08-2192; Hof PR, 1998, EXP NEUROL, V153, P234, DOI 10.1006/exnr.1998.6881; Izzotti A, 2006, MUTAT RES-REV MUTAT, V612, P105, DOI 10.1016/j.mrrev.2005.11.001; Izzotti A, 2004, FASEB J, V18, P1559, DOI 10.1096/fj.04-1877fje; Izzotti A, 2003, AM J MED, V114, P638, DOI 10.1016/S0002-9343(03)00114-1; Izzotti A, 2010, J PROTEOME RES, V9, P4831, DOI 10.1021/pr1005372; Izzotti A, 1999, MUTAT RES-GEN TOX EN, V446, P215, DOI 10.1016/S1383-5718(99)00189-8; Izzotti A, 2010, ARCH OPHTHALMOL-CHIC, V128, P724, DOI 10.1001/archophthalmol.2010.87; Izzotti A, 2009, INVEST OPHTH VIS SCI, V50, P5251, DOI 10.1167/iovs.09-3871; Izzotti A, 2009, BRAIN PATHOL, V19, P650, DOI 10.1111/j.1750-3639.2008.00229.x; Kaufman PL, 2008, EXP EYE RES, V86, P3, DOI 10.1016/j.exer.2007.10.007; Keller KE, 2007, INVEST OPHTH VIS SCI, V48, P1164, DOI 10.1167/iovs.06-0875; Kirwan RP, 2005, MOL VIS, V11, P798; Kompass KS, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-93; Kroemer G, 2000, NAT MED, V6, P513, DOI 10.1038/74994; Lanzetta P, 1999, BRIT J OPHTHALMOL, V83, P29, DOI 10.1136/bjo.83.1.29; Latina MA, 1998, OPHTHALMOLOGY, V105, P2082, DOI 10.1016/S0161-6420(98)91129-0; Li GR, 2007, MOL VIS, V13, P2282; Luna C, 2009, MOL VIS, V15, P2488; Luna C, 2009, MOL VIS, V15, P534; Lutjen-Drecoll E, 2005, EXP EYE RES, V81, P1, DOI 10.1016/j.exer.2005.02.008; Okuno T, 2006, EXP EYE RES, V82, P465, DOI 10.1016/j.exer.2005.08.004; Osborne NN, 2010, EXP EYE RES, V90, P750, DOI 10.1016/j.exer.2010.03.008; PARSHLEY DE, 1995, CURR EYE RES, V14, P537, DOI 10.3109/02713689508998400; Parshley DE, 1996, INVEST OPHTH VIS SCI, V37, P795; Read AT, 2007, EXP EYE RES, V84, P213, DOI 10.1016/j.exer.2006.10.001; Roedl JB, 2007, J NEURAL TRANSM, V114, P445, DOI 10.1007/s00702-006-0556-9; SACCA S, 1991, ALTERNATIVE LASER TR; Sacca SC, 2008, PROG BRAIN RES, V173, P385, DOI 10.1016/S0079-6123(08)01127-8; SACCA SC, 2009, MUTAT RES, V667, P698; SACCA SC, 1991, B OCUL S5, V70, P323; Shifera AS, 2010, EXP EYE RES, V91, P42, DOI 10.1016/j.exer.2010.04.001; Singh K, 2009, CURR OPIN OPHTHALMOL, V20, P84, DOI 10.1097/ICU.0b013e328324e6c4; SMITH PJ, 1986, AM J VET RES, V47, P2445; Steely HT, 2000, EXP EYE RES, V70, P17, DOI 10.1006/exer.1999.0764; Vittal V, 2005, INVEST OPHTH VIS SCI, V46, P2857, DOI 10.1167/iovs.05-0075; Wiederholt M, 1998, Curr Opin Ophthalmol, V9, P46, DOI 10.1097/00055735-199804000-00009; Wiederholt M, 2000, PROG RETIN EYE RES, V19, P271, DOI 10.1016/S1350-9462(99)00015-4; WISE JB, 1979, ARCH OPHTHALMOL-CHIC, V97, P319, DOI 10.1001/archopht.1979.01020010165017; Wood JPM, 2010, LASER SURG MED, V42, P326, DOI 10.1002/lsm.20907; Wordinger R, 2002, MOL VIS, V8, P241; Wordinger RJ, 2007, INVEST OPHTH VIS SCI, V48, P1191, DOI 10.1167/iovs.06-0296; Zhang SD, 2009, BRAIN RES, V1303, P131, DOI 10.1016/j.brainres.2009.09.029; Zode GS, 2007, INVEST OPHTH VIS SCI, V48, P5058, DOI 10.1167/iovs.07-0127	65	33	34	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2011	6	7							e20110	10.1371/journal.pone.0020110	http://dx.doi.org/10.1371/journal.pone.0020110			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786HC	21747927	Green Published, Green Submitted, gold			2022-12-27	WOS:000292293400002
J	Kyme, AZ; Zhou, VW; Meikle, SR; Baldock, C; Fulton, RR				Kyme, Andre Z.; Zhou, Victor W.; Meikle, Steven R.; Baldock, Clive; Fulton, Roger R.			Optimised Motion Tracking for Positron Emission Tomography Studies of Brain Function in Awake Rats	PLOS ONE			English	Article							PET; ANESTHESIA; ISOFLURANE; SCANNER; SCHEME	Positron emission tomography (PET) is a non-invasive molecular imaging technique using positron-emitting radioisotopes to study functional processes within the body. High resolution PET scanners designed for imaging rodents and non-human primates are now commonplace in preclinical research. Brain imaging in this context, with motion compensation, can potentially enhance the usefulness of PET by avoiding confounds due to anaesthetic drugs and enabling freely moving animals to be imaged during normal and evoked behaviours. Due to the frequent and rapid motion exhibited by alert, awake animals, optimal motion correction requires frequently sampled pose information and precise synchronisation of these data with events in the PET coincidence data stream. Motion measurements should also be as accurate as possible to avoid degrading the excellent spatial resolution provided by state-of-the-art scanners. Here we describe and validate methods for optimised motion tracking suited to the correction of motion in awake rats. A hardware based synchronisation approach is used to achieve temporal alignment of tracker and scanner data to within 10 ms. We explored the impact of motion tracker synchronisation error, pose sampling rate, rate of motion, and marker size on motion correction accuracy. With accurate synchronisation (<100 ms error), a sampling rate of >20 Hz, and a small head marker suitable for awake animal studies, excellent motion correction results were obtained in phantom studies with a variety of continuous motion patterns, including realistic rat motion (<5% bias in mean concentration). Feasibility of the approach was also demonstrated in an awake rat study. We conclude that motion tracking parameters needed for effective motion correction in preclinical brain imaging of awake rats are achievable in the laboratory setting. This could broaden the scope of animal experiments currently possible with PET.	[Kyme, Andre Z.; Baldock, Clive; Fulton, Roger R.] Univ Sydney, Sch Phys, Sydney, NSW 2006, Australia; [Kyme, Andre Z.; Zhou, Victor W.; Meikle, Steven R.; Fulton, Roger R.] Univ Sydney, Brain & Mind Res Inst, Sydney, NSW 2006, Australia; [Meikle, Steven R.; Fulton, Roger R.] Univ Sydney, Fac Hlth Sci, Sydney, NSW 2006, Australia; [Fulton, Roger R.] Westmead Hosp, Dept Med Phys, Sydney, NSW, Australia; [Zhou, Victor W.] Cent Queensland Univ, Sch Engn & Built Environm, Mackay, Australia	University of Sydney; University of Sydney; University of Sydney; University of Sydney; Central Queensland University	Kyme, AZ (corresponding author), Univ Sydney, Sch Phys, Sydney, NSW 2006, Australia.	a.kyme@physics.usyd.edu.au	Baldock, Clive/B-2893-2008; Meikle, Steven/AAH-4973-2020; Meikle, Steven R/A-5470-2009	Baldock, Clive/0000-0001-7559-3769; Meikle, Steven/0000-0001-7397-0364; Meikle, Steven R/0000-0001-7397-0364; Kyme, Andre/0000-0003-3297-5390; Fulton, Roger/0000-0003-2536-2190	Australian Research Council [DP 0663519, DP0988166]	Australian Research Council(Australian Research Council)	The work was supported by the Australian Research Council Discovery Projects (DP 0663519 and DP0988166, www.arc.gov.au). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARCLAY RJ, 1988, 2 UFAW; Bloomfield PM, 2003, PHYS MED BIOL, V48, P959, DOI 10.1088/0031-9155/48/8/301; Buhler P, 2004, IEEE T MED IMAGING, V23, P1176, DOI 10.1109/TMI.2004.831214; Cherry S., 2012, PHYS NUCL MED; Cherry SR, 2011, NAT METHODS, V8, P301, DOI 10.1038/nmeth0411-301; DEFRISE M, 1995, INVERSE PROBL, V11, P983, DOI 10.1088/0266-5611/11/5/003; Dong HL, 2006, ANESTHESIOLOGY, V104, P122, DOI 10.1097/00000542-200601000-00018; Fitzpatrick JM, 1998, IEEE T MED IMAGING, V17, P694, DOI 10.1109/42.736021; Fulton R, 2004, IEEE NUCL SCI CONF R, P4226; Fulton R, 2004, IEEE NUCL SCI CONF R, P3286, DOI 10.1109/NSSMIC.2003.1352598; Hosoi R, 2005, BRAIN RES, V1039, P199, DOI 10.1016/j.brainres.2005.01.064; HUDSON HM, 1994, IEEE T MED IMAGING, V13, P601, DOI 10.1109/42.363108; Kilbourn MR, 2007, NUCL MED BIOL, V34, P479, DOI 10.1016/j.nucmedbio.2007.04.008; KINAHAN PE, 1989, IEEE T NUCL SCI, V36, P964, DOI 10.1109/23.34585; Kreuter JD, 2004, NEUROSCIENCE, V127, P233, DOI 10.1016/j.neuroscience.2004.04.047; Kyme AZ, 2008, PHYS MED BIOL, V53, P2651, DOI 10.1088/0031-9155/53/10/014; Lancelot S, 2010, TRENDS PHARMACOL SCI, V31, P411, DOI 10.1016/j.tips.2010.06.002; Luo F, 2007, J MAGN RESON IMAGING, V26, P557, DOI 10.1002/jmri.21083; Maclaren J, 2011, MAGN RESON MED, V65, P1724, DOI 10.1002/mrm.22754; Martin C, 2002, J NEUROSCI METH, V120, P25, DOI 10.1016/S0165-0270(02)00185-1; Martin C, 2006, NEUROIMAGE, V32, P33, DOI 10.1016/j.neuroimage.2006.02.021; OHATA M, 1981, J CEREBR BLOOD F MET, V1, P187, DOI 10.1038/jcbfm.1981.19; Oria M, 2008, J NEUROTRAUM, V25, P266, DOI 10.1089/neu.2007.0393; PARRY TJ, 1993, PHYSIOL BEHAV, V53, P1011, DOI 10.1016/0031-9384(93)90283-L; Santarelli R, 2003, ACTA OTO-LARYNGOL, V123, P176, DOI 10.1080/0036554021000028108; Schulz D, 2011, NAT METHODS, V8, P347, DOI [10.1038/nmeth.1582, 10.1038/NMETH.1582]; Shimoji K, 2004, J NUCL MED, V45, P665; Stavdahl O, 2005, ROBOTICA, V23, P283, DOI 10.1017/S0263574704001304; Tai YC, 2005, J NUCL MED, V46, P455; WEISENBERGER AG, 2008, P 2008 IEEE NUCL SCI; Zhou VW, 2008, MOL IMAGING BIOL, V10, P315, DOI 10.1007/s11307-008-0157-0; Zhou VW, 2009, PHYS MED BIOL, V54, P5321, DOI 10.1088/0031-9155/54/17/016	32	56	57	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2011	6	7							e21727	10.1371/journal.pone.0021727	http://dx.doi.org/10.1371/journal.pone.0021727			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786HC	21747951	Green Submitted, Green Published, gold			2022-12-27	WOS:000292293400027
J	Luzardo, R; Silva, PA; Einicker-Lamas, M; Ortiz-Costa, S; do Carmo, MDT; Vieira-Filho, LD; Paixao, ADO; Lara, LS; Vieyra, A				Luzardo, Ricardo; Silva, Paulo A.; Einicker-Lamas, Marcelo; Ortiz-Costa, Susana; Tavares do Carmo, Maria da Graca; Vieira-Filho, Leucio D.; Paixao, Ana D. O.; Lara, Lucienne S.; Vieyra, Adalberto			Metabolic Programming during Lactation Stimulates Renal Na+ Transport in the Adult Offspring Due to an Early Impact on Local Angiotensin II Pathways	PLOS ONE			English	Article							ATPASE ACTIVITY; PHOSPHORYLATED INTERMEDIATE; PROTEIN RESTRICTION; GLOMERULAR NUMBER; SODIUM-TRANSPORT; NEPHRON NUMBER; BLOOD-PRESSURE; KIDNEY CORTEX; FOOD-INTAKE; LEPTIN	Background: Several studies have correlated perinatal malnutrition with diseases in adulthood, giving support to the programming hypothesis. In this study, the effects of maternal undernutrition during lactation on renal Na+-transporters and on the local angiotensin II (Ang II) signaling cascade in rats were investigated. Methodology/Principal Findings: Female rats received a hypoproteic diet (8% protein) throughout lactation. Control and programmed offspring consumed a diet containing 20% protein after weaning. Programming caused a decrease in the number of nephrons (35%), in the area of the Bowman's capsule (30%) and the capillary tuft (30%), and increased collagen deposition in the cortex and medulla (by 175% and 700%, respectively). In programmed rats the expression of (Na++K+) ATPase in proximal tubules increased by 40%, but its activity was doubled owing to a threefold increase in affinity for K+. Programming doubled the ouabain-insensitive Na+-ATPase activity with loss of its physiological response to Ang II, increased the expression of AT(1) and decreased the expression of AT(2) receptors), and caused a pronounced inhibition (90%) of protein kinase C activity with decrease in the expression of the alpha (24%) and epsilon (13%) isoforms. Activity and expression of cyclic AMP-dependent protein kinase decreased in the same proportion as the AT2 receptors (30%). In vivo studies at 60 days revealed an increased glomerular filtration rate (GFR) (70%), increased Na+ excretion (80%) and intense proteinuria (increase of 400% in protein excretion). Programmed rats, which had normal arterial pressure at 60 days, became hypertensive by 150 days. Conclusions/Significance: Maternal protein restriction during lactation results in alterations in GFR, renal Na+ handling and in components of the Ang II-linked regulatory pathway of renal Na+ reabsorption. At the molecular level, they provide a framework for understanding how metabolic programming of renal mechanisms contributes to the onset of hypertension in adulthood.	[Luzardo, Ricardo; Silva, Paulo A.; Einicker-Lamas, Marcelo; Vieyra, Adalberto] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, BR-21941 Rio De Janeiro, Brazil; [Luzardo, Ricardo; Silva, Paulo A.; Einicker-Lamas, Marcelo; Vieira-Filho, Leucio D.; Paixao, Ana D. O.; Lara, Lucienne S.; Vieyra, Adalberto] Univ Fed Rio de Janeiro, Natl Inst Struct Biol & Bioimaging, Rio De Janeiro, Brazil; [Ortiz-Costa, Susana; Tavares do Carmo, Maria da Graca] Univ Fed Rio de Janeiro, Inst Nutr Josue de Castro, Rio De Janeiro, Brazil; [Vieira-Filho, Leucio D.; Paixao, Ana D. O.] Univ Fed Pernambuco, Dept Physiol & Pharmacol, Recife, PE, Brazil; [Lara, Lucienne S.] Univ Fed Rio de Janeiro, Inst Biomed Sci, Rio De Janeiro, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade Federal de Pernambuco; Universidade Federal do Rio de Janeiro	Luzardo, R (corresponding author), Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, BR-21941 Rio De Janeiro, Brazil.	avieyra@biof.ufrj.br	Morcillo, Lucienne/F-5771-2017; Fisiologia, Ciencias Biologicas/C-2407-2012	Morcillo, Lucienne/0000-0002-2204-8799; Vieira, Leucio/0000-0002-6041-1720	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Ministerio da Saude/Departamento de Ciencia e Tecnologia (MS/DECIT); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ); Fundacao de Amparo a Ciencia e Tecnologia do Estado de Pernambuco (FACEPE); National Institutes of Science and Technology (Brazil)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Ministerio da Saude/Departamento de Ciencia e Tecnologia (MS/DECIT); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Fundacao de Amparo a Ciencia e Tecnologia do Estado de Pernambuco (FACEPE)(Fundacao de Amparo a Ciencia e Tecnologia do Estado de Pernambuco (FACEPE)); National Institutes of Science and Technology (Brazil)	This work has been funded by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Ministerio da Saude/Departamento de Ciencia e Tecnologia (MS/DECIT), Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ), Fundacao de Amparo a Ciencia e Tecnologia do Estado de Pernambuco (FACEPE) and National Institutes of Science and Technology (Brazil). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript,	Alwasel SH, 2009, CLIN SCI, V117, P75, DOI 10.1042/CS20080294; ANDERSON S, 1986, J HYPERTENS, V4, pS236; APERIA A, 1994, FASEB J, V8, P436, DOI 10.1096/fasebj.8.6.8168694; Axelband F, 2009, REGUL PEPTIDES, V155, P81, DOI 10.1016/j.regpep.2009.03.014; Barker D. J. P., 1993, Nutrition and Health (Bicester), V9, P99; Barker D. J. P., 1994, MOTHERS BABIES DIS L; Barker DJP, 1997, BRIT MED BULL, V53, P96; Barker DJP, 2002, TRENDS ENDOCRIN MET, V13, P364, DOI 10.1016/S1043-2760(02)00689-6; Barreira AL, 2009, CELL PHYSIOL BIOCHEM, V24, P585, DOI 10.1159/000257514; Beltowski J, 2004, ACTA BIOCHIM POL, V51, P1003; Beltowski J, 2007, CLIN EXP HYPERTENS, V29, P189, DOI 10.1080/10641960701361585; Bertram C, 2001, ENDOCRINOLOGY, V142, P2841, DOI 10.1210/en.142.7.2841; BIOLLAZ J, 1986, HYPERTENSION, V8, P117, DOI 10.1161/01.HYP.8.2.117; Bonomo IT, 2005, HORM METAB RES, V37, P220, DOI 10.1055/s-2005-861381; Brenner B.M., 1997, KIDNEY INT S, P124; Brenner BM, 1996, KIDNEY INT, V49, P1774, DOI 10.1038/ki.1996.265; BURNIER M, 1994, HYPERTENSION, V23, P496, DOI 10.1161/01.HYP.23.4.496; Cabral LMP, 2007, J BIOL CHEM, V282, P24599, DOI 10.1074/jbc.M701669200; Caruso-Neves C, 2000, BBA-BIOMEMBRANES, V1468, P107, DOI 10.1016/S0005-2736(00)00248-0; Casabiell X, 1997, J CLIN ENDOCR METAB, V82, P4270, DOI 10.1210/jc.82.12.4270; CHAKRAVARTHY BR, 1994, BIOCHEM J, V304, P809, DOI 10.1042/bj3040809; CORMAN B, 1992, PRESSE MED, V21, P1238; Dagan A, 2007, AM J PHYSIOL-REG I, V292, pR1230, DOI 10.1152/ajpregu.00669.2006; Dagan A, 2009, AM J PHYSIOL-REG I, V297, pR93, DOI 10.1152/ajpregu.91006.2008; De Souza AM, 2007, BIOCHIMIE, V89, P1425, DOI 10.1016/j.biochi.2007.05.010; De Souza AM, 2004, REGUL PEPTIDES, V120, P167, DOI 10.1016/j.regpep.2004.03.005; Du ZP, 2003, AM J PHYSIOL-RENAL, V284, pF688, DOI 10.1152/ajprenal.00261.2002; EISEN EJ, 1976, J ANIM SCI, V42, P1008; Fowden AL, 2009, EXP PHYSIOL, V94, P607, DOI 10.1113/expphysiol.2008.046359; Fowden AL, 2006, PHYSIOLOGY, V21, P29, DOI 10.1152/physiol.00050.2005; HARRIS PJ, 1977, PFLUG ARCH EUR J PHY, V367, P295, DOI 10.1007/BF00581370; Hoy WE, 2005, J AM SOC NEPHROL, V16, P2557, DOI 10.1681/ASN.2005020172; Hughson M, 2003, KIDNEY INT, V63, P2113, DOI 10.1046/j.1523-1755.2003.00018.x; LANGLEY SC, 1994, CLIN SCI, V86, P217, DOI 10.1042/cs0860217; Lara LD, 2006, BIOCHEM J, V395, P183, DOI 10.1042/BJ20051455; LARSSON L, 1980, KIDNEY INT, V18, P29, DOI 10.1038/ki.1980.107; Louzada RAN, 2010, CARDIOVASC DRUG THER, V24, P121, DOI 10.1007/s10557-010-6215-2; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Manning J, 2002, AM J PHYSIOL-RENAL, V283, pF202, DOI 10.1152/ajprenal.00358.2001; McDonough AA, 2010, AM J PHYSIOL-REG I, V298, pR851, DOI 10.1152/ajpregu.00002.2010; Mesquita FF, 2010, BRAZ J MED BIOL RES, V43, P1010, DOI [10.1590/S0100-879X2010007500113, 10.1590/S0100-879X2010001100001]; Mesquita FF, 2010, NEPHROL DIAL TRANSPL, V25, P380, DOI 10.1093/ndt/gfp505; MITCHELL KD, 2007, PHARMACOL REV, V59, P251; Mukherjea R, 1999, LIFE SCI, V65, P1183, DOI 10.1016/S0024-3205(99)00352-5; NEJAD KZ, 2006, HYPERTENSION, V47, P502; NOEL MB, 1993, PHYSIOL BEHAV, V54, P151, DOI 10.1016/0031-9384(93)90057-M; Pickavance L, 1998, BIOCHEM BIOPH RES CO, V248, P196, DOI 10.1006/bbrc.1998.8934; POST RL, 1965, J BIOL CHEM, V240, P1437; PROVERBIO F, 1981, BIOCHIM BIOPHYS ACTA, V646, P99, DOI 10.1016/0005-2736(81)90276-5; PROVERBIO F, 1989, CURR TOP MEMBR TRANS, V34, P105; QUEIROZMADEIRA EP, 2009, BIOCHIM BIOPHYS ACTA, V1798, P360; Rangel LBA, 2005, REGUL PEPTIDES, V127, P177, DOI 10.1016/j.regpep.2004.12.007; Rangel LBA, 2002, BBA-BIOMEMBRANES, V1564, P310, DOI 10.1016/S0005-2736(02)00472-8; REEVES PG, 1993, J NUTR, V123, P1939, DOI 10.1093/jn/123.11.1939; Rocafull MA, 2011, BBA-BIOMEMBRANES, V1808, P1684, DOI 10.1016/j.bbamem.2011.02.010; SOLOMON S, 1977, J PHYSIOL-LONDON, V272, P573, DOI 10.1113/jphysiol.1977.sp012061; TAUSSKY HH, 1953, J BIOL CHEM, V202, P675; Teixeira CV, 2002, J NUTR BIOCHEM, V13, P493, DOI 10.1016/S0955-2863(02)00197-3; Vehaskari VM, 2004, AM J PHYSIOL-RENAL, V287, pF262, DOI 10.1152/ajprenal.00055.2004; Ventrella V, 2010, BIOCHIMIE, V92, P128, DOI 10.1016/j.biochi.2009.10.010; Vieira LD, 2011, ARCH BIOCHEM BIOPHYS, V505, P91, DOI 10.1016/j.abb.2010.09.025; Vieira LD, 2009, CLIN EXP PHARMACOL P, V36, P1157, DOI 10.1111/j.1440-1681.2009.05212.x; VIEYRA A, 1986, J BIOL CHEM, V261, P4247; Welham SJM, 2002, KIDNEY INT, V61, P1231, DOI 10.1046/j.1523-1755.2002.00264.x; WHITTEMB.G, 1970, PFLUG ARCH EUR J PHY, V316, P1, DOI 10.1007/BF00587893; Woods LL, 1998, AM J PHYSIOL-REG I, V275, pR1593, DOI 10.1152/ajpregu.1998.275.5.R1593; Woods LL, 2001, PEDIATR RES, V49, P460, DOI 10.1203/00006450-200104000-00005; Zallocchi Marisa, 2003, Med Sci Monit, V9, pBR85	68	31	31	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2011	6	7							e21232	10.1371/journal.pone.0021232	http://dx.doi.org/10.1371/journal.pone.0021232			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786HC	21747933	Green Published, gold, Green Submitted			2022-12-27	WOS:000292293400008
J	Meng, T; Kolpe, AB; Kiener, TK; Chow, VTK; Kwang, J				Meng, Tao; Kolpe, Annasaheb B.; Kiener, Tanja K.; Chow, Vincent T. K.; Kwang, Jimmy			Display of VP1 on the Surface of Baculovirus and Its Immunogenicity against Heterologous Human Enterovirus 71 Strains in Mice	PLOS ONE			English	Article							MOUTH-DISEASE; LETHAL ENTEROVIRUS-71; INFLUENZA-VIRUS; NEUTRALIZING ANTIBODIES; MAMMALIAN-CELLS; PROTECTS MICE; NEWBORN MICE; IE1 PROMOTER; INFECTION; OUTBREAK	Background: Human Enterovirus 71 (EV71) is a common cause of hand, foot and mouth disease (HFMD) in young children. It is often associated with severe neurological diseases and has caused high mortalities in recent outbreaks across the Asia Pacific region. Currently, there is no effective vaccine and antiviral agents available against EV71 infections. VP1 is one of the major immunogenic capsid protein of EV71 and plays a crucial role in viral infection. Antibodies against VP1 are important for virus neutralization. Methodology/Principal Finding: In the present study, infectious EV71 viruses were generated from their synthetic complementary DNA using the human RNA polymerase I reverse genetics system. Secondly, the major immunogenic capsid protein (VP1) of EV71-Fuyang (subgenogroup C4) was displayed on the surface of recombinant baculovirus Bac-Pie1-gp64-VP1 as gp64 fusion protein under a novel White Spot Syndrome Virus (WSSV) immediate early ie1 promoter. Baculovirus expressed VP1 was able to maintain its structural and antigenic conformity as indicated by immunofluorescence assay and western blot analysis. Interestingly, our results with confocal microscopy revealed that VP1 was able to localize on the plasma membrane of insect cells infected with recombinant baculovirus. In addition, we demonstrated with transmission electron microscopy that baculovirus successfully acquired VP1 from the insect cell membrane via the budding process. After two immunizations in mice, Bac-Pie1-gp64-VP1 elicited neutralization antibody titer of 1: 64 against EV71 (subgenogroup C4) in an in vitro neutralization assay. Furthermore, the antisera showed high cross-neutralization activities against all 11 subgenogroup EV71 strains. Conclusion: Our results illustrated that Bac-Pie1-gp64-VP1 retained native epitopes of VP1 and acted as an effective EV71 vaccine candidate which would enable rapid production without any biosafety concerns.	[Meng, Tao; Kolpe, Annasaheb B.; Kiener, Tanja K.; Kwang, Jimmy] Temasek Life Sci Lab, Singapore, Singapore; [Chow, Vincent T. K.; Kwang, Jimmy] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Microbiol, Singapore, Singapore	National University of Singapore	Meng, T (corresponding author), Temasek Life Sci Lab, Singapore, Singapore.	kwang@tll.org.sg		Kolpe, Annasaheb/0000-0002-1255-1593; Chow, Vincent/0000-0003-2634-6213	Temasek Life Sciences Laboratory	Temasek Life Sciences Laboratory(National University of Singapore)	The authors are grateful for the financial support received from Temasek Life Sciences Laboratory (http://www.tll.org.sg/), Singapore. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AbuBakar S, 2009, EMERG INFECT DIS, V15, P79, DOI 10.3201/eid1501.080264; Arita M, 2005, J GEN VIROL, V86, P1391, DOI 10.1099/vir.0.80784-0; Arita M, 2007, J VIROL, V81, P9386, DOI 10.1128/JVI.02856-06; Bible JM, 2007, REV MED VIROL, V17, P371, DOI 10.1002/rmv.538; Cello J, 2002, SCIENCE, V297, P1016, DOI 10.1126/science.1072266; Chan LG, 2000, CLIN INFECT DIS, V31, P678, DOI 10.1086/314032; Chang Luan-Yin, 2008, Pediatrics and Neonatology, V49, P103, DOI 10.1016/S1875-9572(08)60023-6; Chang YY, 2009, ACTA BIOCH BIOPH SIN, V41, P998, DOI 10.1093/abbs/gmp093; Chen CW, 2011, VACCINE, V29, P2772, DOI 10.1016/j.vaccine.2011.01.094; Chiu CH, 2006, MICROBES INFECT, V8, P1671, DOI 10.1016/j.micinf.2006.01.021; Chung YC, 2008, VACCINE, V26, P1855, DOI 10.1016/j.vaccine.2008.01.058; Foo DGW, 2007, MICROBES INFECT, V9, P1299, DOI 10.1016/j.micinf.2007.06.002; Gao H, 2007, J BIOTECHNOL, V131, P138, DOI 10.1016/j.jbiotec.2007.06.002; Grabherr R, 2010, CURR GENE THER, V10, P195, DOI 10.2174/156652310791321297; He F, 2009, EXPERT REV VACCINES, V8, P455, DOI 10.1586/ERV.09.2; He F, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-238; Heymann DL, 2004, B WORLD HEALTH ORGAN, V82, P1; Ho HT, 2009, CLIN VACCINE IMMUNOL, V16, P726, DOI 10.1128/CVI.00465-08; Ho Monto, 2000, Journal of Microbiology Immunology and Infection, V33, P205; Hoffmann E, 2000, P NATL ACAD SCI USA, V97, P6108, DOI 10.1073/pnas.100133697; Kitagawa Y, 2005, J VIROL, V79, P3639, DOI 10.1128/JVI.79.6.3639-3652.2005; Kung SH, 2007, CLIN MICROBIOL INFEC, V13, P782, DOI 10.1111/j.1469-0691.2007.01745.x; LaBarre DD, 2001, J VIROL METHODS, V96, P107, DOI 10.1016/S0166-0934(01)00316-0; Li XL, 2009, BIOCHEM BIOPH RES CO, V390, P1126, DOI 10.1016/j.bbrc.2009.09.103; Lin YH, 2008, VACCINE, V26, P6361, DOI 10.1016/j.vaccine.2008.09.008; Liu CC, 2000, J CLIN VIROL, V17, P23, DOI 10.1016/S1386-6532(00)00068-8; Liu JN, 2010, VACCINE, V28, P7444, DOI 10.1016/j.vaccine.2010.08.080; McMinn PC, 2002, FEMS MICROBIOL REV, V26, P91, DOI 10.1111/j.1574-6976.2002.tb00601.x; Miller L K, 1988, Biotechnology, V10, P457; Mizuta K, 2009, VACCINE, V27, P3153, DOI 10.1016/j.vaccine.2009.03.060; Monsma SA, 1996, J VIROL, V70, P4607, DOI 10.1128/JVI.70.7.4607-4616.1996; Musthaq SS, 2009, VIROLOGY, V391, P315, DOI 10.1016/j.virol.2009.06.017; Ong KC, 2010, J VIROL, V84, P661, DOI 10.1128/JVI.00999-09; OReilly D.R., 1992, BACULOVIRUS EXPRESSI; Prabakaran M, 2008, VIROLOGY, V380, P412, DOI 10.1016/j.virol.2008.08.002; Prabakaran M, 2010, J VIROL, V84, P11822, DOI 10.1128/JVI.00891-10; Prabakaran M, 2010, J VIROL, V84, P3201, DOI 10.1128/JVI.02175-09; Qiu J, 2008, LANCET NEUROL, V7, P868, DOI 10.1016/S1474-4422(08)70207-2; Ranganathan Shoba, 2002, Appl Bioinformatics, V1, P43; Singh S, 2002, J CLIN MICROBIOL, V40, P2823, DOI 10.1128/JCM.40.8.2823-2827.2002; Sivasamugham LA, 2006, J MED VIROL, V78, P1096, DOI 10.1002/jmv.20668; Solomon T, 2010, LANCET INFECT DIS, V10, P778, DOI 10.1016/S1473-3099(10)70194-8; TAKEDA N, 1994, J VIROL, V68, P854, DOI 10.1128/JVI.68.2.854-862.1994; Tami C, 2004, VACCINE, V23, P840, DOI 10.1016/j.vaccine.2004.03.070; Tan CS, 2007, ARCH VIROL, V152, P1069, DOI 10.1007/s00705-007-0941-1; Tee KK, 2010, J VIROL, V84, P3339, DOI 10.1128/JVI.01019-09; Tung Wong Siew, 2007, Genet Vaccines Ther, V5, P6, DOI 10.1186/1479-0556-5-6; van der Sanden S, 2010, J GEN VIROL, V91, P1949, DOI 10.1099/vir.0.019695-0; van der Sanden S, 2009, J CLIN MICROBIOL, V47, P2826, DOI 10.1128/JCM.00507-09; WHITFORD M, 1989, J VIROL, V63, P1393, DOI 10.1128/JVI.63.3.1393-1399.1989; Wu CN, 2001, VACCINE, V20, P895, DOI 10.1016/S0264-410X(01)00385-1; Wu TC, 2007, J VIROL, V81, P10310, DOI 10.1128/JVI.00372-07; Wu Y, 2010, INT J INFECT DIS, V14, pE1076, DOI 10.1016/j.ijid.2010.07.006; Yang F, 2009, J CLIN MICROBIOL, V47, P2351, DOI 10.1128/JCM.00563-09	54	45	53	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2011	6	7							e21757	10.1371/journal.pone.0021757	http://dx.doi.org/10.1371/journal.pone.0021757			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786HC	21747954	gold, Green Submitted, Green Published			2022-12-27	WOS:000292293400030
J	Spilde, M; Lanzirotti, A; Qualls, C; Phillips, G; Ali, AM; Agenbroad, L; Appenzeller, O				Spilde, Mike; Lanzirotti, Antonio; Qualls, Clifford; Phillips, Genevieve; Ali, Abdul-Mehdi; Agenbroad, Larry; Appenzeller, Otto			Biologic Rhythms Derived from Siberian Mammoths' Hairs	PLOS ONE			English	Article							LIFE	Hair is preserved for millennia in permafrost; it enshrines a record of biologic rhythms and offers a glimpse at chronobiology as it was in extinct animals. Here we compare biologic rhythms gleaned from mammoth's hairs with those of modern human hair. Four mammoths' hairs came from varying locations in Siberia 4600 km, four time zones, apart ranging in age between 18,000 and 20,000 years before present. We used two contemporaneous human hairs for comparison. Power spectra derived from hydrogen isotope ratios along the length of the hairs gave insight into biologic rhythms, which were different in the mammoths depending on location and differed from humans. Hair growth for mammoths was,31 cms/year and,16 cms/year for humans. Recurrent annual rhythms of slow and fast growth varying from 3.4 weeks/cycles to 8.7 weeks/cycles for slow periods and 1.2 weeks/cycles to 2.2 weeks/cycles for fast periods were identified in mammoth's hairs. The mineral content of mammoth's hairs was measured by electron microprobe analysis (k-ratios), which showed no differences in sulfur amongst the mammoth hairs but significantly more iron then in human hair. The fractal nature of the data derived from the hairs became evident in Mandelbrot sets derived from hydrogen isotope ratios, mineral content and geographic location. Confocal microscopy and scanning electron microscopy showed varied degrees of preservation of the cuticle largely independent of age but not location of the specimens. X-ray fluorescence microprobe and fluorescence computed micro-tomography analyses allowed evaluation of metal distribution and visualization of hollow tubes in the mammoth's hairs. Seasonal variations in iron and copper content combined with spectral analyses gave insights into variation in food intake of the animals. Biologic rhythms gleaned from power spectral plots obtained by modern methods revealed life style and behavior of extinct mega-fauna.	[Spilde, Mike] Univ New Mexico, Inst Meteorit, Dept Earth & Planetary Sci, Albuquerque, NM 87131 USA; [Lanzirotti, Antonio] Brookhaven Natl Lab, Natl Synchrotron Light Source, Upton, NY 11973 USA; [Qualls, Clifford] Univ New Mexico, Dept Math, Albuquerque, NM 87131 USA; [Qualls, Clifford] Univ New Mexico, Dept Stat, Albuquerque, NM 87131 USA; [Phillips, Genevieve] Univ New Mexico, Canc Res & Treatment Ctr, Fluorescence Microscopy Facil, Albuquerque, NM 87131 USA; [Ali, Abdul-Mehdi] Univ New Mexico, Analyt Chem Lab, Dept Earth & Planetary Sci, Albuquerque, NM 87131 USA; [Agenbroad, Larry] Mammoth Site, Hot Springs, SD USA; [Appenzeller, Otto] New Mexico Hlth Enhancement & Marathon Clin Res F, Albuquerque, NM USA	University of New Mexico; State University of New York (SUNY) System; United States Department of Energy (DOE); Brookhaven National Laboratory; University of New Mexico; University of New Mexico; University of New Mexico; University of New Mexico	Spilde, M (corresponding author), Univ New Mexico, Inst Meteorit, Dept Earth & Planetary Sci, Albuquerque, NM 87131 USA.	oarun@unm.edu		Lanzirotti, Antonio/0000-0002-7597-5924	New Mexico Health Enhancement and Marathon Clinics (NMHEMC) Research Foundation	New Mexico Health Enhancement and Marathon Clinics (NMHEMC) Research Foundation	This work was supported by the New Mexico Health Enhancement and Marathon Clinics (NMHEMC) Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akashi M, 2010, P NATL ACAD SCI USA, V107, P15643, DOI 10.1073/pnas.1003878107; Allen M, 2010, NATURE, V466, P31, DOI 10.1038/466031a; Appenzeller O, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000636; Bernard A, 2010, SCIENCE, V328, P1379, DOI 10.1126/science.1187443; Bromage TG, 2009, CALCIFIED TISSUE INT, V84, P388, DOI 10.1007/s00223-009-9221-2; Brown JH, 2002, PHILOS T R SOC B, V357, P619, DOI 10.1098/rstb.2001.0993; Campbell KL, 2010, NAT GENET, V42, P536, DOI 10.1038/ng.574; Gibbons A, 2010, SCIENCE, V330, P1616, DOI 10.1126/science.330.6011.1616; MALLIANI A, 1991, CIRCULATION, V84, P482, DOI 10.1161/01.CIR.84.2.482; Mandelbrot B.B, 1982, FRACTAL GEOMETRY NAT; Marcheva B, 2010, NATURE, V466, P627, DOI 10.1038/nature09253; Sharp ZD, 2003, J ARCHAEOL SCI, V30, P1709, DOI 10.1016/S0305-4403(03)00071-2; WEST BG, 1997, SCIENCE, V276, P122	13	5	5	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2011	6	6							e21705	10.1371/journal.pone.0021705	http://dx.doi.org/10.1371/journal.pone.0021705			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786FZ	21747920	Green Published, Green Submitted, gold			2022-12-27	WOS:000292290100057
J	Widdershoven, JCC; Spruijt, NE; Spliet, WGM; Breugem, CC; Kon, M; van der Molen, ABM				Widdershoven, Josine C. C.; Spruijt, Nicole E.; Spliet, Wim G. M.; Breugem, Corstiaan C.; Kon, Moshe; van der Molen, Aebele B. Mink			Histology of the Pharyngeal Constrictor Muscle in 22q11.2 Deletion Syndrome and Non-Syndromic Children with Velopharyngeal Insufficiency	PLOS ONE			English	Article							CARDIO-FACIAL SYNDROME; LEVATOR VELI PALATINI; VELOCARDIOFACIAL-SYNDROME; DIGEORGE-SYNDROME; SPHINCTER PHARYNGOPLASTY; SPEECH CHARACTERISTICS; ISOLATED STIMULATION; PRESCHOOL-CHILDREN; CANDIDATE GENE; NEURAL CREST	Plastic surgeons aim to correct velopharyngeal insufficiency manifest by hypernasal speech with a velopharyngoplasty. The functional outcome has been reported to be worse in patients with 22q11.2 deletion syndrome than in patients without the syndrome. A possible explanation is the hypotonia that is often present as part of the syndrome. To confirm a myogenic component of the etiology of velopharyngeal insufficiency in children with 22q11.2 deletion syndrome, specimens of the pharyngeal constrictor muscle were taken from children with and without the syndrome. Histologic properties were compared between the groups. Specimens from the two groups did not differ regarding the presence of increased perimysial or endomysial space, fiber grouping by size or type, internalized nuclei, the percentage type I fibers, or the diameters of type I and type II fibers. In conclusion, a myogenic component of the etiology of velopharyngeal insufficiency in children with 22q11.2 deletion syndrome could not be confirmed.	[Widdershoven, Josine C. C.] Maastricht Univ Med Ctr, Dept Otolaryngol Head & Neck Surg, Maastricht, Netherlands; [Spruijt, Nicole E.; Breugem, Corstiaan C.; Kon, Moshe; van der Molen, Aebele B. Mink] Univ Med Ctr Utrecht, Dept Plast Surg, Maastricht, Netherlands; [Spliet, Wim G. M.] Univ Med Ctr Utrecht, Dept Pathol, Utrecht, Netherlands	Maastricht University; Maastricht University Medical Centre (MUMC); Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center	Widdershoven, JCC (corresponding author), Maastricht Univ Med Ctr, Dept Otolaryngol Head & Neck Surg, Maastricht, Netherlands.	josine.widdershoven@mumc.nl						Abu-Issa R, 2002, DEVELOPMENT, V129, P4613; Adachi T, 1997, J DENT RES, V76, P1745, DOI 10.1177/00220345970760110501; Arneja JS, 2008, PLAST RECONSTR SURG, V122, P845, DOI 10.1097/PRS.0b013e3181811a83; Arnold JS, 2006, DEVELOPMENT, V133, P977, DOI 10.1242/dev.02264; Bolland E, 2000, Eur J Paediatr Neurol, V4, P73, DOI 10.1053/ejpn.2000.0266; BROOKE MH, 1969, NEUROLOGY, V19, P591, DOI 10.1212/WNL.19.6.591; D'Antonio LL, 2001, CLEFT PALATE-CRAN J, V38, P455, DOI 10.1597/1545-1569(2001)038<0455:AOSCIC>2.0.CO;2; Devriendt K, 1998, J MED GENET, V35, P789, DOI 10.1136/jmg.35.9.789-a; Dworkin JP, 2004, LANG SPEECH HEAR SER, V35, P333, DOI 10.1044/0161-1461(2004/033); Farzaneh F, 2008, SCAND J PLAST RECONS, V42, P7, DOI 10.1080/02844310701694522; Garg V, 2001, DEV BIOL, V235, P62, DOI 10.1006/dbio.2001.0283; Gerdes M, 1999, AM J MED GENET, V85, P127, DOI 10.1002/(SICI)1096-8628(19990716)85:2<127::AID-AJMG6>3.0.CO;2-F; Gerdes M, 2001, GENET MED, V3, P40, DOI 10.1097/00125817-200101000-00009; Grifone R, 2008, DEV DYNAM, V237, P3071, DOI 10.1002/dvdy.21718; Havkin N, 2000, INT J PEDIATR OTORHI, V54, P103, DOI 10.1016/S0165-5876(00)00350-5; Hultman CS, 2000, PLAST RECONSTR SURG, V106, P16, DOI 10.1097/00006534-200007000-00004; Inman DS, 2005, BRIT J PLAST SURG, V58, P1051, DOI 10.1016/j.bjps.2005.05.019; Kelly RG, 2004, HUM MOL GENET, V13, P2829, DOI 10.1093/hmg/ddh304; Kitsiou-Tzeli S, 2004, IN VIVO, V18, P603; Kobrynski LJ, 2007, LANCET, V370, P1443, DOI 10.1016/S0140-6736(07)61601-8; Kogo M, 1996, CLEFT PALATE-CRAN J, V33, P273, DOI 10.1597/1545-1569(1996)033<0273:OOVCPF>2.3.CO;2; LEESE G, 1986, ACTA ANAT, V127, P77; Losken A, 2006, PLAST RECONSTR SURG, V117, P1493, DOI 10.1097/01.prs.0000206377.14083.ce; Losken A, 2003, PLAST RECONSTR SURG, V112, P1755, DOI 10.1097/01.PRS.0000090720.33554.8B; Mongini T, 2001, NEUROPEDIATRICS, V32, P107, DOI 10.1055/s-2001-13877; Okiyama N, 2005, BRIT J DERMATOL, V152, P1370, DOI 10.1111/j.1365-2133.2005.06622.x; Oskarsdottir S, 2005, DEV MED CHILD NEUROL, V47, P177, DOI 10.1017/S0012162205000320; Phua YS, 2008, CLEFT PALATE-CRAN J, V45, P172, DOI 10.1597/06-205.1; Robin NH, 2005, J PEDIATR-US, V147, P90, DOI 10.1016/j.jpeds.2005.03.007; Roubertie A, 2001, BRAIN DEV-JPN, V23, P810, DOI 10.1016/S0387-7604(01)00258-3; Saitta SC, 2004, HUM MOL GENET, V13, P417, DOI 10.1093/hmg/ddh041; Sell D, 2001, CLEFT PALATE-CRAN J, V38, P30, DOI 10.1597/1545-1569(2001)038<0030:CLAPCI>2.0.CO;2; Shprintzen RJ, 2008, DEV DISABIL RES REV, V14, P3, DOI 10.1002/ddrr.2; Sie KCY, 2001, PLAST RECONSTR SURG, V108, P17, DOI 10.1097/00006534-200107000-00004; Sie KCY, 1998, LARYNGOSCOPE, V108, P1211, DOI 10.1097/00005537-199808000-00021; SMIRNE S, 1991, LANCET, V337, P597; Stal PS, 2000, J ANAT, V197, P275, DOI 10.1017/S0021878299006627; Sundman E, 2004, ACTA ANAESTH SCAND, V48, P423, DOI 10.1111/j.1399-6576.2004.00364.x; Van Aken K, 2007, DEV MED CHILD NEUROL, V49, P210, DOI 10.1111/j.1469-8749.2007.00210.x; Van Lierde KM, 2004, INT J PEDIATR OTORHI, V68, P865, DOI 10.1016/j.ijporl.2004.01.020; Vitelli F, 2002, HUM MOL GENET, V11, P915, DOI 10.1093/hmg/11.8.915; Walker MB, 2006, CLIN GENET, V69, P471, DOI 10.1111/j.0009-9163.2006.00615.x; Widdershoven JCC, 2008, J PLAST RECONSTR AES, V61, P1016, DOI 10.1016/j.bjps.2008.02.007; Widdershoven JCC, 2008, ARCH OTOLARYNGOL, V134, P1159, DOI 10.1001/archotol.134.11.1159; Wurdak H, 2006, BIOESSAYS, V28, P1078, DOI 10.1002/bies.20484; Xu HS, 2005, DEVELOPMENT, V132, P4387, DOI 10.1242/dev.02018; Zim Shane, 2003, Arch Facial Plast Surg, V5, P503, DOI 10.1001/archfaci.5.6.503	47	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2011	6	6							e21672	10.1371/journal.pone.0021672	http://dx.doi.org/10.1371/journal.pone.0021672			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	784FW	21738760	Green Published, Green Submitted, gold			2022-12-27	WOS:000292142800056
J	Zajac, M; Law, J; Cvetkovic, DD; Pampillo, M; McColl, L; Pape, C; Di Guglielmo, GM; Postovit, LM; Babwah, AV; Bhattacharya, M				Zajac, Mateusz; Law, Jeffrey; Cvetkovic, Dragana Donna; Pampillo, Macarena; McColl, Lindsay; Pape, Cynthia; Di Guglielmo, Gianni M.; Postovit, Lynne M.; Babwah, Andy V.; Bhattacharya, Moshmi			GPR54 (KISS1R) Transactivates EGFR to Promote Breast Cancer Cell Invasiveness	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; METASTASIS-SUPPRESSOR GENE; PROTEIN-COUPLED RECEPTOR; FOCAL ADHESION KINASE; BETA-ARRESTIN; BETA(2)-ADRENERGIC RECEPTOR; SIGNAL TRANSACTIVATION; CARCINOMA CELLS; MIGRATION; INVASION	Kisspeptins (Kp), peptide products of the Kisspeptin-1 (KISS1) gene are endogenous ligands for a G protein-coupled receptor 54 (GPR54). Previous findings have shown that KISS1 acts as a metastasis suppressor in numerous cancers in humans. However, recent studies have demonstrated that an increase in KISS1 and GPR54 expression in human breast tumors correlates with higher tumor grade and metastatic potential. At present, whether or not Kp signaling promotes breast cancer cell invasiveness, required for metastasis and the underlying mechanisms, is unknown. We have found that kisspeptin-10 (Kp-10), the most potent Kp, stimulates the invasion of human breast cancer MDA-MB-231 and Hs578T cells using Matrigel-coated Transwell chamber assays and induces the formation of invasive stellate structures in three-dimensional invasion assays. Furthermore, Kp-10 stimulated an increase in matrix metalloprotease (MMP)-9 activity. We also found that Kp-10 induced the transactivation of epidermal growth factor receptor (EGFR). Knockdown of the GPCR scaffolding protein, beta-arrestin 2, inhibited Kp-10-induced EGFR transactivation as well as Kp-10 induced invasion of breast cancer cells via modulation of MMP-9 secretion and activity. Finally, we found that the two receptors associate with each other under basal conditions, and FRET analysis revealed that GPR54 interacts directly with EGFR. The stability of the receptor complex formation was increased upon treatment of cells by Kp-10. Taken together, our findings suggest a novel mechanism by which Kp signaling via GPR54 stimulates breast cancer cell invasiveness.	[Zajac, Mateusz; Law, Jeffrey; Cvetkovic, Dragana Donna; McColl, Lindsay; Pape, Cynthia; Di Guglielmo, Gianni M.; Babwah, Andy V.; Bhattacharya, Moshmi] Univ Western Ontario, Dept Physiol & Pharmacol, London, ON, Canada; [Pampillo, Macarena; Babwah, Andy V.] Univ Western Ontario, Childrens Hlth Res Inst, London, ON, Canada; [Pampillo, Macarena; Babwah, Andy V.] Univ Western Ontario, Lawson Hlth Res Inst, London, ON, Canada; [Pampillo, Macarena; Babwah, Andy V.] Univ Western Ontario, Dept Obstet & Gynaecol, London, ON, Canada; [Postovit, Lynne M.] Univ Western Ontario, Dept Anat & Cell Biol, London, ON, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario)	Zajac, M (corresponding author), Univ Western Ontario, Dept Physiol & Pharmacol, London, ON, Canada.	Moshmi.Bhattacharya@schulich.uwo.ca		Postovit, Lynne-Marie/0000-0002-8088-4197	Canadian Institutes of Health Research/Canadian Breast Cancer Research Alliance (CIHR) [MOP 107972]; NSERC; Translational Breast Cancer Research Unit (TBCRU)	Canadian Institutes of Health Research/Canadian Breast Cancer Research Alliance (CIHR)(Canadian Institutes of Health Research (CIHR)); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Translational Breast Cancer Research Unit (TBCRU)	This study was funded by grants awarded to M. Bhattacharya by the Canadian Institutes of Health Research/Canadian Breast Cancer Research Alliance (CIHR) MOP 107972. The following are recipients of a salary award and studentships: M. Bhattacharya, A. V. Babwah, and L. M Postovit, CIHR New Investigator Awards, M. Zajac, Ontario Graduate Studentship, Jeff Law, NSERC studentships, Donna Cvetkovic, Translational Breast Cancer Research Unit (TBCRU) Studentship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS LS, CANC RES, V70, P3594; Aziziyeh AI, 2009, CELL SIGNAL, V21, P1207, DOI 10.1016/j.cellsig.2009.03.011; Bhattacharya M, 2002, NAT CELL BIOL, V4, P547, DOI 10.1038/ncb821; Buchanan FG, 2006, P NATL ACAD SCI USA, V103, P1492, DOI 10.1073/pnas.0510562103; Caceres M, 2005, EXP CELL RES, V309, P229, DOI 10.1016/j.yexcr.2005.05.020; Campos SM, 2008, CANCER INVEST, V26, P757, DOI 10.1080/07357900801971040; Chen M, 2007, AM J PHYSIOL-CELL PH, V292, pC1927, DOI 10.1152/ajpcell.00400.2006; Clarke RB, 2004, TRENDS ENDOCRIN MET, V15, P316, DOI 10.1016/j.tem.2004.07.004; Cortes-Reynosa P, 2008, MATRIX BIOL, V27, P220, DOI 10.1016/j.matbio.2007.11.003; Crisp S J, 1994, Methods Mol Biol, V32, P233; Darmoul D, 2004, MOL CANCER RES, V2, P514; Elangovan M, 2003, METHODS, V29, P58, DOI 10.1016/S1046-2023(02)00283-9; Franceschini I, 2006, NEUROSCI LETT, V401, P225, DOI 10.1016/j.neulet.2006.03.039; Fuentes LQ, 2008, CELL SIGNAL, V20, P1642, DOI 10.1016/j.cellsig.2008.05.009; Graham CH, 1996, AM J OBSTET GYNECOL, V175, P555; Gschwind A, 2002, CANCER RES, V62, P6329; Guerrero J, 2004, EXP CELL RES, V292, P201, DOI 10.1016/j.yexcr.2003.08.011; Hart S, 2005, BIOL CHEM, V386, P845, DOI 10.1515/BC.2005.099; Hatakeyama M, 2007, MOL BIOSYST, V3, P111, DOI 10.1039/b612800a; Hori A, 2001, BIOCHEM BIOPH RES CO, V286, P958, DOI 10.1006/bbrc.2001.5470; Huang J, 2007, CANCER RES, V67, P5906, DOI 10.1158/0008-5472.CAN-07-0691; Kim J, 2003, BIOCHEMISTRY-US, V42, P2887, DOI 10.1021/bi026942t; Kim J, 2009, J BIOL CHEM, V284, P11953, DOI 10.1074/jbc.M808176200; Kotani M, 2001, J BIOL CHEM, V276, P34631, DOI 10.1074/jbc.M104847200; Lee JH, 1997, CANCER RES, V57, P2384; Lee JH, 1996, JNCI-J NATL CANCER I, V88, P1731, DOI 10.1093/jnci/88.23.1731; Li TT, 2009, MOL CANCER RES, V7, P1064, DOI 10.1158/1541-7786.MCR-08-0578; Lu ZM, 2001, MOL CELL BIOL, V21, P4016, DOI 10.1128/MCB.21.12.4016-4031.2001; Makri A, 2008, CANCER TREAT REV, V34, P682, DOI 10.1016/j.ctrv.2008.05.007; Marot D, 2007, ENDOCR-RELAT CANCER, V14, P691, DOI 10.1677/ERC-07-0012; Martin TA, 2005, CLIN EXP METASTAS, V22, P503, DOI 10.1007/s10585-005-4180-0; Masui T, 2004, BIOCHEM BIOPH RES CO, V315, P85, DOI 10.1016/j.bbrc.2004.01.021; Maudsley S, 2000, J BIOL CHEM, V275, P9572, DOI 10.1074/jbc.275.13.9572; Navenot JM, 2005, CANCER RES, V65, P10450, DOI 10.1158/0008-5472.CAN-05-1757; Nicholson KM, 2003, BREAST CANCER RES TR, V81, P117, DOI 10.1023/A:1025765215765; Ohtaki T, 2001, NATURE, V411, P613, DOI 10.1038/35079135; Ohtsu H, 2006, AM J PHYSIOL-CELL PH, V291, pC1, DOI 10.1152/ajpcell.00620.2005; Pampillo M, 2009, MOL ENDOCRINOL, V23, P2060, DOI 10.1210/me.2009-0013; Parsons M, 2008, J CELL SCI, V121, P265, DOI 10.1242/jcs.018440; Price JT, 1999, CANCER RES, V59, P5475; Raghuwanshi SK, 2008, J IMMUNOL, V180, P5699, DOI 10.4049/jimmunol.180.8.5699; Rosano L, 2009, P NATL ACAD SCI USA, V106, P2806, DOI 10.1073/pnas.0807158106; Roseweir AK, 2009, J NEUROSCI, V29, P3920, DOI 10.1523/JNEUROSCI.5740-08.2009; Santen RJ, 2002, J STEROID BIOCHEM, V80, P239, DOI 10.1016/S0960-0760(01)00189-3; Schafer B, 2004, ONCOGENE, V23, P991, DOI 10.1038/sj.onc.1207278; Shenoy SK, 2001, SCIENCE, V294, P1307, DOI 10.1126/science.1063866; Shida D, 2008, CANCER RES, V68, P6569, DOI 10.1158/0008-5472.CAN-08-0411; Shoji S, 2009, EUR UROL, V55, P441, DOI 10.1016/j.eururo.2008.02.048; Tilley DG, 2009, J BIOL CHEM, V284, P20375, DOI 10.1074/jbc.M109.005793; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; Watt HL, 2009, CELL SIGNAL, V21, P428, DOI 10.1016/j.cellsig.2008.11.012; WOUTERS FS, 2006, CURR PROTOC NEUROSCI, pCH5; Yan CH, 2001, J BIOL CHEM, V276, P1164, DOI 10.1074/jbc.M008681200; Zou L, 2008, FASEB J, V22, P355, DOI 10.1096/fj.07-9046com; Zuo YF, 2006, BIOCHEM BIOPH RES CO, V351, P361, DOI 10.1016/j.bbrc.2006.10.043	55	76	79	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2011	6	6							e21599	10.1371/journal.pone.0021599	http://dx.doi.org/10.1371/journal.pone.0021599			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	784FW	21738726	Green Published, gold, Green Submitted			2022-12-27	WOS:000292142800044
J	Mukhopadhya, I; Thomson, JM; Hansen, R; Berry, SH; El-Omar, EM; Hold, GL				Mukhopadhya, Indrani; Thomson, John M.; Hansen, Richard; Berry, Susan H.; El-Omar, Emad M.; Hold, Georgina L.			Detection of Campylobacter concisus and Other Campylobacter Species in Colonic Biopsies from Adults with Ulcerative Colitis	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; LENGTH POLYMORPHISM ANALYSIS; BACTEROIDES-UREOLYTICUS; RAPID IDENTIFICATION; HELICOBACTER; PREVALENCE; EPIDEMIOLOGY; ARCOBACTER; DIVERSITY; SAMPLES	Introduction: The critical role of bacteria in the pathogenesis of ulcerative colitis (UC) is well recognized, but an individual causative microorganism has not been singled out so far. Campylobacter concisus and other non-jejuni species of Campylobacter have been implicated as putative aetiological agents in inflammatory bowel disease in children, but such studies have not been addressed in adults. This study investigated the prevalence of Campylobacter species in colonic biopsy samples from adults with UC and healthy controls. Methods: Adult patients who were undergoing diagnostic colonoscopy were recruited for the study, which included 69 patients with histologically proven UC and 65 healthy controls. DNA was extracted from the biopsy samples and subjected to Campylobacter genus specific and Campylobacter concisus specific polymerase chain reaction and sequencing. Results: Detection of all Campylobacter DNA utilising genus specific primers was significantly higher in cases of UC, with a prevalence of 73.9% (51/69) compared to 23.1% (15/65) in controls (p = 0.0001). Nested PCR for C. concisus DNA was positive in 33.3% (23/69) of biopsy samples fromsubjects with UC, which was significantly higher than the prevalence rate of 10.8% (7/65) from controls (p = 0.0019). Sequencing of the remaining Campylobacter positive samples revealed that Campylobacter ureolyticus was positive in 21.7% (15/69) of samples from UC subjects as opposed to 3.1% (2/65) in controls (p = 0.0013). Mixed Campylobacter species were more common in UC patients, 20.3% (14/69) as compared to controls 4.6% (3/65) (p = 0.0084). Conclusion: The higher prevalence of Campylobacter genus and more specifically C. concisus and C. ureolyticus in biopsy samples from adults with UC suggests these genera of bacteria may be involved in the chronic inflammation that is characteristically seen in UC. To the best of our knowledge this is the first report of this association of C. concisus and C. ureolyticus with UC in adults.	[Mukhopadhya, Indrani; Thomson, John M.; Hansen, Richard; Berry, Susan H.; El-Omar, Emad M.; Hold, Georgina L.] Univ Aberdeen, Div Appl Med, Gastrointestinal Res Grp, Aberdeen, Scotland	University of Aberdeen	Mukhopadhya, I (corresponding author), Univ Aberdeen, Div Appl Med, Gastrointestinal Res Grp, Foresterhill, Aberdeen, Scotland.	g.l.hold@abdn.ac.uk	Mukhopadhya, Indrani/K-1113-2019; El-Omar, Emad/AAT-7780-2021; Hold, Georgina Louise/AAG-9923-2020; Hansen, Richard/G-3871-2011	Mukhopadhya, Indrani/0000-0003-2577-518X; Hold, Georgina Louise/0000-0001-7573-3397; Hansen, Richard/0000-0002-3944-6646; El-Omar, Emad/0000-0002-0011-3924	Broad Medical Research Program [IBD-0178]; GI Research Unit, Aberdeen Royal Infirmary	Broad Medical Research Program; GI Research Unit, Aberdeen Royal Infirmary	This work was funded by the Broad Medical Research Program (Grant number IBD-0178). JMT was supported by grants from the GI Research Unit, Aberdeen Royal Infirmary. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aabenhus R, 2005, J CLIN MICROBIOL, V43, P5091, DOI 10.1128/JCM.43.10.5091-5096.2005; Aabenhus R, 2002, SCAND J INFECT DIS, V34, P248, DOI 10.1080/00365540110080566; Armitage E, 2001, EUR J GASTROEN HEPAT, V13, P1439, DOI 10.1097/00042737-200112000-00007; Baumgart DC, 2011, INFLAMM BOWEL DIS, V17, P639, DOI 10.1002/ibd.21409; Benchimol EI, 2011, INFLAMM BOWEL DIS, V17, P423, DOI 10.1002/ibd.21349; Bohr URM, 2004, J CLIN MICROBIOL, V42, P2766, DOI 10.1128/JCM.42.6.2766-2768.2004; Bullman S, 2011, FEMS IMMUNOL MED MIC, V61, P228, DOI 10.1111/j.1574-695X.2010.00760.x; Carter MJ, 2004, GUT, V53, DOI 10.1136/gut.2004.043372; DUERDEN BI, 1989, J MED MICROBIOL, V29, P63, DOI 10.1099/00222615-29-1-63; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Engberg J, 2005, CLIN MICROBIOL INFEC, V11, P288, DOI 10.1111/j.1469-0691.2005.01111.x; Engberg J, 2000, J CLIN MICROBIOL, V38, P286; Gillespie IA, 2009, EMERG INFECT DIS, V15, P2046, DOI 10.3201/eid1512.090280; Gradel KO, 2009, GASTROENTEROLOGY, V137, P495, DOI 10.1053/j.gastro.2009.04.001; Hansen R, 2010, J GASTROENTEROL, V45, P266, DOI 10.1007/s00535-009-0191-y; HENDERSON P, 2011, INFLAMM BOWEL DIS; HILL AB, 1965, P ROY SOC MED, V58, P295, DOI 10.1177/003591576505800503; Hold GL, 2002, FEMS MICROBIOL ECOL, V39, P33, DOI 10.1111/j.1574-6941.2002.tb00904.x; Istivan TS, 2008, FEMS IMMUNOL MED MIC, V54, P224, DOI 10.1111/j.1574-695X.2008.00467.x; Jess T, 2011, GUT, V60, P318, DOI 10.1136/gut.2010.223396; Kalischuk LD, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-53; Lastovica AJ, 2009, J CLIN MICROBIOL, V47, P2360, DOI 10.1128/JCM.00568-09; Linton D, 1996, RES MICROBIOL, V147, P707, DOI 10.1016/S0923-2508(97)85118-2; Loftus EV, 2004, GASTROENTEROLOGY, V126, P1504, DOI 10.1053/j.gastro.2004.01.063; Macuch PJ, 2000, J DENT RES, V79, P785, DOI 10.1177/00220345000790021301; Man SM, 2010, J INFECT DIS, V202, P1855, DOI 10.1086/657316; Man SM, 2010, INFLAMM BOWEL DIS, V16, P1008, DOI 10.1002/ibd.21157; Marshall SM, 1999, J CLIN MICROBIOL, V37, P4158, DOI 10.1128/JCM.37.12.4158-4160.1999; Momozawa Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016952; Saitoh S, 2002, CLIN DIAGN LAB IMMUN, V9, P54, DOI 10.1128/CDLI.9.1.54-59.2002; Silverberg MS, 2005, CAN J GASTROENTEROL, V19, p5A, DOI 10.1155/2005/269076; Sonnenberg A, 2010, EUR J GASTROEN HEPAT, V22, P95, DOI 10.1097/MEG.0b013e32832e9d54; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tannock GW, 2010, INT J INFLAMM, V2010, DOI 10.4061/2010/954051; Thomson JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017184; Vandamme P, 2010, INT J SYST EVOL MICR, V60, P2016, DOI 10.1099/ijs.0.017152-0; Woolley PD, 2000, INT J STD AIDS, V11, P347, DOI 10.1258/0956462001915976; Zhang L, 2010, J CLIN MICROBIOL, V48, P2965, DOI 10.1128/JCM.02391-09; Zhang L, 2009, J CLIN MICROBIOL, V47, P453, DOI 10.1128/JCM.01949-08	39	100	104	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2011	6	6							e21490	10.1371/journal.pone.0021490	http://dx.doi.org/10.1371/journal.pone.0021490			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	783OD	21738679	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000292092600045
J	Zheng, L; Xie, GF; Duan, GJ; Yan, XC; Li, QW				Zheng, Lei; Xie, Ganfeng; Duan, Guangjie; Yan, Xiaochu; Li, Qianwei			High Expression of Testes-Specific Protease 50 Is Associated with Poor Prognosis in Colorectal Carcinoma	PLOS ONE			English	Article							COLON-CANCER PATIENTS; CARCINOEMBRYONIC ANTIGEN; TUMOR-MARKERS; MICROSATELLITE INSTABILITY; HEPATOCELLULAR-CARCINOMA; CANCER/TESTIS ANTIGENS; ADJUVANT CHEMOTHERAPY; PREDICTING SURVIVAL; TISSUE MICROARRAY; PANCREATIC-CANCER	Background: Testes-specific protease 50 (TSP50) is normally expressed in testes and abnormally expressed in breast cancer, but whether TSP50 is expressed in colorectal carcinoma (CRC) and its clinical significance is unclear. We aimed to detect TSP50 expression in CRC, correlate it with clinicopathological factors, and assess its potential diagnostic and prognostic value. Methodology/Principal Findings: TSP50 mRNAs and proteins were detected in 7 CRC cell lines and 8 CRC specimens via RTPCR and Western blot analysis. Immunohistochemical analysis of TSP50, p53 and carcinoembryonic antigen (CEA) with tissue microarrays composed of 95 CRCs, 20 colorectal adenomas and 20 normal colorectal tissues were carried out and correlated with clinicopathological characteristics and disease-specific survival for CRC patients. There was no significant correlation between the expression levels of TSP50 and p53 (P = 0.751) or CEA (P = 0.663). Abundant expression of TSP50 protein was found in CRCs (68.4%) while it was poorly expressed in colorectal adenomas and normal tissues (P<0.0001). Thus, CRCs can be distinguished from them with high specificity (92.5%) and positive predictive value (PPV, 95.6%). The survival of CRC patients with high TSP50 expression was significantly shorter than that of the patients with low TSP50 expression (P = 0.010), specifically in patients who had early-stage tumors (stage I and II; P = 0.004). Multivariate Cox regression analysis indicated that high TSP50 expression was a statistically significant independent risk factor (hazard ratio = 2.205, 95% CI = 1.214-4.004, P = 0.009). Conclusion: Our data demonstrate that TSP50 is a potential effective indicator of poor survival for CRC patients, especially for those with early-stage tumors.	[Zheng, Lei; Li, Qianwei] Third Mil Med Univ, Southwest Hosp, Dept Nucl Med, Chongqing, Peoples R China; [Xie, Ganfeng] Third Mil Med Univ, Southwest Hosp, Dept Oncol, Chongqing, Peoples R China; [Xie, Ganfeng; Duan, Guangjie; Yan, Xiaochu] Third Mil Med Univ, Southwest Hosp, SW Canc Ctr, Chongqing, Peoples R China; [Duan, Guangjie; Yan, Xiaochu] Third Mil Med Univ, Southwest Hosp, Dept Pathol, Chongqing, Peoples R China	Army Medical University; Army Medical University; Army Medical University; Army Medical University	Li, QW (corresponding author), Third Mil Med Univ, Southwest Hosp, Dept Nucl Med, Chongqing, Peoples R China.	lqw_swhospital@163.com	Ganfeng, Xie/C-8218-2012	Zheng, Lei/0000-0002-5343-5249; Duan, Guang-jie/0000-0002-5564-4394	National Natural Science Foundation of China [30870726]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by the National Natural Science Foundation of China (Grant No. 30870726; URL: http://www.nsfc.gov.cn/PortalO/default124.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhatnagar J, 1999, ANTICANCER RES, V19, P2181; Bourdon JC, 2007, BRIT J CANCER, V97, P277, DOI 10.1038/sj.bjc.6603886; Bouzourene H, 2000, EUR J CANCER, V36, P1008, DOI 10.1016/S0959-8049(00)00036-8; Caballero OL, 2009, CANCER SCI, V100, P2014, DOI 10.1111/j.1349-7006.2009.01303.x; Chang SC, 2006, INT J CANCER, V118, P1721, DOI 10.1002/ijc.21563; Chen MF, 2010, INT J RADIAT ONCOL, V78, P868, DOI 10.1016/j.ijrobp.2010.05.025; Chen YT, 1997, P NATL ACAD SCI USA, V94, P1914, DOI 10.1073/pnas.94.5.1914; Chen ZG, 2010, DIS COLON RECTUM, V53, P31, DOI 10.1007/DCR.0b013e3181bdca3a; Compton CC, 2000, ARCH PATHOL LAB MED, V124, P979; Conlin A, 2005, GUT, V54, P1283, DOI 10.1136/gut.2005.066514; Cui HM, 2003, SCIENCE, V299, P1753, DOI 10.1126/science.1080902; Cunningham D, 2010, LANCET, V375, P1030, DOI 10.1016/S0140-6736(10)60353-4; de Jong KP, 2005, CLIN CANCER RES, V11, P4067, DOI 10.1158/1078-0432.CCR-04-2389; Duan Guang-Jie, 2004, Zhonghua Bing Li Xue Za Zhi, V33, P518; Duffy MJ, 2007, EUR J CANCER, V43, P1348, DOI 10.1016/j.ejca.2007.03.021; El-Serafi MM, 2010, CANCER-AM CANCER SOC, V116, P4954, DOI 10.1002/cncr.25417; Elsaleh H, 2000, ONCOLOGY-BASEL, V58, P52, DOI 10.1159/000012079; FEINBERG AP, 1983, NATURE, V301, P89, DOI 10.1038/301089a0; Gaber A, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-498; Galizia G, 2004, DIS COLON RECTUM, V47, P1904, DOI 10.1007/s10350-004-0695-8; Gallego MG, 2000, DIS COLON RECTUM, V43, P971; Hilska M, 2005, DIS COLON RECTUM, V48, P2197, DOI 10.1007/s10350-005-0202-x; Houet L, 2006, EUR J CANCER, V42, P1653, DOI 10.1016/j.ejca.2006.03.008; Huang Y, 2008, BIOCHEM BIOPH RES CO, V374, P658, DOI 10.1016/j.bbrc.2008.07.087; Kalejs M, 2005, CANCER CELL INT, V5, DOI 10.1186/1475-2867-5-4; Katkoori VR, 2009, CLIN CANCER RES, V15, P2406, DOI 10.1158/1078-0432.CCR-08-1719; Kato K, 2009, INT J ONCOL, V35, P467, DOI 10.3892/ijo_00000358; Kim J, 2006, INT J CANCER, V118, P2269, DOI 10.1002/ijc.21656; Kwak JM, 2010, WORLD J GASTROENTERO, V16, P3897, DOI 10.3748/wjg.v16.i31.3897; Lagerstedt KK, 2005, INT J ONCOL, V27, P1707; Lan YT, 2007, INT J COLORECTAL DIS, V22, P499, DOI 10.1007/s00384-006-0194-6; Li M, 2009, COLORECTAL DIS, V11, P276, DOI 10.1111/j.1463-1318.2008.01591.x; Locker GY, 2006, J CLIN ONCOL, V24, P5313, DOI 10.1200/JCO.2006.08.2644; Loriot A, 2003, INT J CANCER, V105, P371, DOI 10.1002/ijc.11104; Lyall MS, 2006, CLIN CANCER RES, V12, P1184, DOI 10.1158/1078-0432.CCR-05-1864; Machado-Silva A, 2010, SEMIN CANCER BIOL, V20, P57, DOI 10.1016/j.semcancer.2010.02.005; Marcel V, 2010, FEBS LETT, V584, P4463, DOI 10.1016/j.febslet.2010.10.005; Martelange V, 2000, CANCER RES, V60, P3848; Matta A, 2008, J PROTEOME RES, V7, P2078, DOI 10.1021/pr7007797; Matta A, 2009, INT J CANCER, V125, P1398, DOI 10.1002/ijc.24517; Mollevi DG, 2007, CARCINOGENESIS, V28, P1241, DOI 10.1093/carcin/bgm012; Noske A, 2009, ONCOL REP, V22, P3, DOI 10.3892/or_00000398; Ogino S, 2008, CLIN CANCER RES, V14, P8221, DOI 10.1158/1078-0432.CCR-08-1841; Pancione M, 2010, HUM PATHOL, V41, P867, DOI 10.1016/j.humpath.2009.09.019; Peng JR, 2005, CANCER LETT, V219, P223, DOI 10.1016/j.canlet.2004.07.028; Pereira H, 1997, WORLD J SURG, V21, P210, DOI 10.1007/s002689900218; Resnick MB, 2004, CLIN CANCER RES, V10, P3069, DOI 10.1158/1078-0432.CCR-03-0462; Riener MO, 2009, INT J CANCER, V124, P352, DOI 10.1002/ijc.23966; Russo A, 2005, J CLIN ONCOL, V23, P7518, DOI 10.1200/JCO.2005.00.471; Samowitz WS, 2002, INT J CANCER, V99, P597, DOI 10.1002/ijc.10405; Scanlan MJ, 2000, CANCER LETT, V150, P155, DOI 10.1016/S0304-3835(99)00385-7; Shan JD, 2002, CANCER RES, V62, P290; Smyth EF, 2004, DIS COLON RECTUM, V47, P2086, DOI 10.1007/s10350-004-0710-0; SONG Z, 2011, BIOCH J; Starzynska T, 1997, EUR J GASTROEN HEPAT, V9, P183, DOI 10.1097/00042737-199702000-00014; Sun LC, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-288; Takikita M, 2009, CANCER RES, V69, P2950, DOI 10.1158/0008-5472.CAN-08-3879; Tamada S, 2006, CLIN CANCER RES, V12, P4257, DOI 10.1158/1078-0432.CCR-05-2814; Tureci O, 2002, ONCOGENE, V21, P3879, DOI 10.1038/sj.onc.1205481; Tureci O, 1998, P NATL ACAD SCI USA, V95, P5211, DOI 10.1073/pnas.95.9.5211; VandenEynde BJ, 1997, CURR OPIN IMMUNOL, V9, P684, DOI 10.1016/S0952-7915(97)80050-7; Velazquez Elsa F, 2007, Cancer Immun, V7, P11; Vidaurreta M, 2008, INT J COLORECTAL DIS, V23, P581, DOI 10.1007/s00384-008-0454-8; Wang M, 2008, DNA CELL BIOL, V27, P307, DOI 10.1089/dna.2007.0692; Wang M, 2010, J CELL BIOCHEM, V111, P75, DOI 10.1002/jcb.22664; Watanabe T, 2001, NEW ENGL J MED, V344, P1196, DOI 10.1056/NEJM200104193441603; Westra JL, 2005, J CLIN ONCOL, V23, P5635, DOI 10.1200/JCO.2005.04.096; Xu HP, 2007, CANCER RES, V67, P1239, DOI 10.1158/0008-5472.CAN-06-3688; Xu HP, 2004, UROLOGY, V64, P826, DOI 10.1016/j.urology.2004.05.012; Yokoe T, 2008, CANCER RES, V68, P1074, DOI 10.1158/0008-5472.CAN-07-0964; Yuan LM, 1999, CANCER RES, V59, P3215; Zhou LA, 2010, IUBMB LIFE, V62, P825, DOI 10.1002/iub.390	72	24	28	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2011	6	7							e22203	10.1371/journal.pone.0022203	http://dx.doi.org/10.1371/journal.pone.0022203			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791WM	21765952	Green Published, gold, Green Submitted			2022-12-27	WOS:000292699000029
J	Holliday, KL; Pye, SR; Thomson, W; Boonen, S; Borghs, H; Vanderschueren, D; Gielen, E; Huhtaniemi, IT; Adams, JE; Ward, KA; Bartfai, G; Casanueva, F; Finn, JD; Forti, G; Giwercman, A; Han, TS; Kula, K; Labrie, F; Lean, MEJ; Pendleton, N; Punab, M; Wu, FCW; O'Neill, TW				Holliday, Kate L.; Pye, Stephen R.; Thomson, Wendy; Boonen, Steven; Borghs, Herman; Vanderschueren, Dirk; Gielen, Evelien; Huhtaniemi, Ilpo T.; Adams, Judith E.; Ward, Kate A.; Bartfai, Gyorgy; Casanueva, Felipe; Finn, Joseph D.; Forti, Gianni; Giwercman, Aleksander; Han, Thang S.; Kula, Krzysztof; Labrie, Fernand; Lean, Michael E. J.; Pendleton, Neil; Punab, Margus; Wu, Frederick C. W.; O'Neill, Terence W.		EMAS Study Grp	The ESR1 (6q25) Locus Is Associated with Calcaneal Ultrasound Parameters and Radial Volumetric Bone Mineral Density in European Men	PLOS ONE			English	Article							AUTOMATED SERUM ASSAY; QUANTITATIVE ULTRASOUND; GENE POLYMORPHISMS; I COLLAGEN; OLDER MEN; TURNOVER; OSTEOPOROSIS; ESTROGEN; RISK; TESTOSTERONE	Purpose: Genome-wide association studies (GWAS) have identified 6q25, which incorporates the oestrogen receptor alpha gene (ESR1), as a quantitative trait locus for areal bone mineral density (BMDa) of the hip and lumbar spine. The aim of this study was to determine the influence of this locus on other bone health outcomes; calcaneal ultrasound (QUS) parameters, radial peripheral quantitative computed tomography (pQCT) parameters and markers of bone turnover in a population sample of European men. Methods: Eight single nucleotide polymorphisms (SNP) in the 6q25 locus were genotyped in men aged 40-79 years from 7 European countries, participating in the European Male Ageing Study (EMAS). The associations between SNPs and measured bone parameters were tested under an additive genetic model adjusting for centre using linear regression. Results: 2468 men, mean (SD) aged 59.9 (11.1) years had QUS measurements performed and bone turnover marker levels measured. A subset of 628 men had DXA and pQCT measurements. Multiple independent SNPs showed significant associations with BMD using all three measurement techniques. Most notably, rs1999805 was associated with a 0.10 SD (95%CI 0.05, 0.16; p = 0.0001) lower estimated BMD at the calcaneus, a 0.14 SD (95%CI 0.05, 0.24; p = 0.004) lower total hip BMDa, a 0.12 SD (95%CI 0.02, 0.23; p = 0.026) lower lumbar spine BMDa and a 0.18 SD (95%CI 0.06, 0.29; p = 0.003) lower trabecular BMD at the distal radius for each copy of the minor allele. There was no association with serum levels of bone turnover markers and a single SNP which was associated with cortical density was also associated with cortical BMC and thickness. Conclusions: Our data replicate previous associations found between SNPs in the 6q25 locus and BMDa at the hip and extend these data to include associations with calcaneal ultrasound parameters and radial volumetric BMD.	[Boonen, Steven] Katholieke Univ Leuven, Leuven Univ, Div Geriatr Med, Louvain, Belgium; [Boonen, Steven; Borghs, Herman; Vanderschueren, Dirk; Gielen, Evelien] Katholieke Univ Leuven, Leuven Univ, Ctr Metab Bone Dis, Louvain, Belgium; [Vanderschueren, Dirk] Katholieke Univ Leuven, Dept Androl & Endocrinol, Louvain, Belgium; [Huhtaniemi, Ilpo T.] Univ London Imperial Coll Sci Technol & Med, Dept Surg & Canc, London, England; [Adams, Judith E.] Manchester Royal Infirm, Manchester Acad Hlth Sci Ctr, Manchester M13 9WL, Lancs, England; [Ward, Kate A.] Elsie Widdowson Lab, MRC Human Nutr Res, Cambridge, England; [Bartfai, Gyorgy] Albert Szent Gyorgy Med Univ, Dept Obstet Gynaecol & Androl, Szeged, Hungary; [Casanueva, Felipe] Univ Santiago de Compostela, Dept Med, CHUS, Inst Salud Carlos III,CIBER Fisiopatol Obesidad &, Santiago De Compostela, Spain; [Finn, Joseph D.; Wu, Frederick C. W.] Univ Manchester, Manchester Royal Infirm, Manchester Acad Hlth Sci Ctr, Androl Res Unit,Dev & Regenerat Biomed Res Grp, Manchester M13 9WL, Lancs, England; [Forti, Gianni] Univ Florence, Endocrinol Unit, Dept Clin Physiopathol, Florence, Italy; [Giwercman, Aleksander] Lund Univ, Reprod Med Ctr, Skane Univ Hosp, Malmo, Sweden; [Han, Thang S.] UCL, Dept Endocrinol, London, England; [Kula, Krzysztof] Med Univ Lodz, Dept Androl & Reprod Endocrinol, Lodz, Poland; [Labrie, Fernand] Univ Laval, Lab Mol Endocrinol & Oncol, Quebec City, PQ, Canada; [Lean, Michael E. J.] Univ Glasgow, Dept Human Nutr, Glasgow, Lanark, Scotland; [Pendleton, Neil] Univ Manchester, Salford Royal NHS Trust, Sch Community Based Med, Salford, Lancs, England; [Punab, Margus] Tartu Univ Clin, United Labs, Androl Unit, Tartu, Estonia; [Holliday, Kate L.; Pye, Stephen R.; Thomson, Wendy; O'Neill, Terence W.] Univ Manchester, Manchester Acad Hlth Sci Ctr, Arthrit Res UK Epidemiol Unit, Manchester, Lancs, England	KU Leuven; KU Leuven; KU Leuven; Imperial College London; University of Manchester; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); MRC Human Nutrition Research; Szeged University; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Complexo Hospitalario Universitario de Santiago de Compostela; Instituto de Salud Carlos III; Universidade de Santiago de Compostela; University of Manchester; University of Florence; Lund University; Skane University Hospital; University of London; University College London; Medical University Lodz; Laval University; University of Glasgow; Salford Royal NHS Foundation Trust; University of Manchester; University of Tartu; University of Manchester	Holliday, KL (corresponding author), Univ Manchester, Manchester Acad Hlth Sci Ctr, Arthrit Res UK Epidemiol Unit, Manchester, Lancs, England.	kata.holliday@manchester.ac.uk	Pendleton, Neil/F-2333-2015; Pye, Stephen R/D-9236-2011	Pendleton, Neil/0000-0003-0794-2386; Pye, Stephen R/0000-0002-7263-2897; Ward, Kate/0000-0001-7034-6750; Han, Thang/0000-0003-2570-0938; vanderschueren, dirk/0000-0003-1395-0104; Thomson, Wendy/0000-0002-9022-5179; Punab, Margus/0000-0001-9601-6311; O'Neill, Terence/0000-0002-8896-4677	Commission of the European Communities [QLK6-CT-2001-00258]; Arthritis Research UK; University Hospitals Leuven, Belgium; Scientific Research-Flanders, Belgium, (F.W.O.-Vlaanderen); Medical Research Council [MC_U105960371] Funding Source: researchfish; MRC [MC_U105960371] Funding Source: UKRI	Commission of the European Communities(European Commission); Arthritis Research UK(Versus Arthritis); University Hospitals Leuven, Belgium; Scientific Research-Flanders, Belgium, (F.W.O.-Vlaanderen)(FWO); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The European Male Ageing Study (EMAS) is funded by the Commission of the European Communities Fifth Framework Programme "Quality of Life and Management of Living Resources'' Grant QLK6-CT-2001-00258 and supported by funding from the Arthritis Research UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The EMAS principal investigator is Professor Frederick Wu, MD; Dept of Endocrinology, Manchester Royal Infirmary, UK. The authors wish to thank the men who participated in the eight countries, the research/nursing staff in the eight centres: C Pott, Manchester, E Wouters, Leuven, M Nilsson, Malmo, M del Mar Fernandez, Santiago de Compostela, M Jedrzejowska, Lodz, H-M Tabo, Tartu, A Heredi, Szeged, for their data collection and C Moseley, Manchester, for data entry and project coordination. Dr Vanderschueren is a senior clinical investigator supported by the Clinical Research Fund of the University Hospitals Leuven, Belgium. Dr. Boonen is a senior clinical investigator of the Fund for Scientific Research-Flanders, Belgium, (F.W.O.-Vlaanderen). Dr. Boonen is holder of the Leuven University Chair in Metabolic Bone Diseases.	Bachrach LK, 2001, TRENDS ENDOCRIN MET, V12, P22, DOI 10.1016/S1043-2760(00)00336-2; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bauer DC, 2007, OSTEOPOROSIS INT, V18, P771, DOI 10.1007/s00198-006-0317-5; Bauer DC, 2009, J BONE MINER RES, V24, P2032, DOI [10.1359/JBMR.090526, 10.1359/jbmr.090526]; Bland R, 2000, CLIN SCI, V98, P217, DOI 10.1042/CS19990252; Chaitou A, 2010, J BONE MINER RES, V25, P2313, DOI 10.1002/jbmr.124; Compston JE, 2001, PHYSIOL REV, V81, P419, DOI 10.1152/physrev.2001.81.1.419; Dennison E, 1999, OSTEOPOROSIS INT, V10, P384, DOI 10.1007/s001980050244; Falahati-Nini A, 2000, J CLIN INVEST, V106, P1553, DOI 10.1172/JCI10942; Garnero P, 2001, CLIN CHEM, V47, P694; Garnero P, 2008, CLIN CHEM, V54, P188, DOI 10.1373/clinchem.2007.094953; Gauderman W, QUANTO 1 1 COMPUTER; Gennari L, 2005, AM J EPIDEMIOL, V161, P307, DOI 10.1093/aje/kwi055; Ichikawa S, 2010, J BONE MINER RES, V25, P1821, DOI 10.1002/jbmr.62; Ioannidis JPA, 2004, JAMA-J AM MED ASSOC, V292, P2105, DOI 10.1001/jama.292.17.2105; Kenny AM, 1998, J GERONTOL A-BIOL, V53, pM419, DOI 10.1093/gerona/53A.6.M419; Khosla S, 2002, J CLIN ENDOCR METAB, V87, P1443, DOI 10.1210/jc.87.4.1443; Khosla S, 1998, J CLIN ENDOCR METAB, V83, P2266, DOI 10.1210/jc.83.7.2266; Labrie F, 2007, J STEROID BIOCHEM, V103, P178, DOI 10.1016/j.jsbmb.2006.09.034; Leder Benjamin, 2007, Curr Opin Endocrinol Diabetes Obes, V14, P241, DOI 10.1097/MED.0b013e32814db87b; Leder BZ, 2003, J CLIN ENDOCR METAB, V88, P204, DOI 10.1210/jc.2002-021036; Lee DM, 2009, INT J ANDROL, V32, P11, DOI 10.1111/j.1365-2605.2008.00879.x; Limer KL, 2009, J BONE MINER RES, V24, P314, DOI 10.1359/JBMR.080912; Liu JM, 2010, J CLIN ENDOCR METAB, V95, pE112, DOI 10.1210/jc.2009-2768; Marin F, 2006, J BONE MINER RES, V21, P1126, DOI 10.1359/JBMR.060417; Mellstrom D, 2008, J BONE MINER RES, V23, P1552, DOI 10.1359/JBMR.080518; Meszaros S, 2007, JOINT BONE SPINE, V74, P79, DOI 10.1016/j.jbspin.2006.04.008; Moayyeri A, 2009, J BONE MINER RES, V24, P1319, DOI [10.1359/jbmr.090212, 10.1359/JBMR.090212]; Ongphiphadhanakul B, 1998, CLIN ENDOCRINOL, V49, P803, DOI 10.1046/j.1365-2265.1998.00631.x; Paternoster L, 2010, J CLIN ENDOCR METAB, V95, P3940, DOI 10.1210/jc.2010-0025; Rivadeneira F, 2009, NAT GENET, V41, P1199, DOI 10.1038/ng.446; Seeman E, 2006, NEW ENGL J MED, V354, P2250, DOI 10.1056/NEJMra053077; Styrkarsdottir U, 2008, NEW ENGL J MED, V358, P2355, DOI 10.1056/NEJMoa0801197; Styrkarsdottir U, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013217; Szulc P, 2008, ANN RHEUM DIS, V67, P1249, DOI 10.1136/ard.2007.077941; Van Pottelbergh I, 2003, J CLIN ENDOCR METAB, V88, P3075, DOI 10.1210/jc.2002-021691; Vanderschueren D, 2010, OSTEOPOROSIS INT, V21, P1331, DOI 10.1007/s00198-009-1144-2; Vanderschueren D, 2004, ENDOCR REV, V25, P389, DOI 10.1210/er.2003-0003; Vermeulen A, 1999, J CLIN ENDOCR METAB, V84, P3666, DOI 10.1210/jc.84.10.3666; Ward KA, 2011, OSTEOPOROSIS INT, V22, P1513, DOI 10.1007/s00198-010-1437-5; Wu FCW, 2008, J CLIN ENDOCR METAB, V93, P2737, DOI 10.1210/jc.2007-1972	41	8	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2011	6	7							e22037	10.1371/journal.pone.0022037	http://dx.doi.org/10.1371/journal.pone.0022037			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791HI	21760950	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000292655400042
J	Itzhaki, Z				Itzhaki, Zohar			Domain-Domain Interactions Underlying Herpesvirus-Human Protein-Protein Interaction Networks	PLOS ONE			English	Article							MOLECULAR INTERACTION DATABASE; EPSTEIN-BARR-VIRUS; CODON USAGE; PATHOGENS; IL-10; HOST	Protein-domains play an important role in mediating protein-protein interactions. Furthermore, the same domain-pairs mediate different interactions in different contexts and in various organisms, and therefore domain-pairs are considered as the building blocks of interactome networks. Here we extend these principles to the host-virus interface and find the domain-pairs that potentially mediate human-herpesvirus interactions. Notably, we find that the same domain-pairs used by other organisms for mediating their interactions underlie statistically significant fractions of human-virus protein inter-interaction networks. Our analysis shows that viral domains tend to interact with human domains that are hubs in the human domain-domain interaction network. This may enable the virus to easily interfere with a variety of mechanisms and processes involving various and different human proteins carrying the relevant hub domain. Comparative genomics analysis provides hints at a molecular mechanism by which the virus acquired some of its interacting domains from its human host.	Hebrew Univ Jerusalem, Dept Microbiol & Mol Genet, IMRIC, Fac Med, Jerusalem, Israel	Hebrew University of Jerusalem	Itzhaki, Z (corresponding author), Hebrew Univ Jerusalem, Dept Microbiol & Mol Genet, IMRIC, Fac Med, Jerusalem, Israel.	zohari@ekmd.huji.ac.il	Barnett-Itzhaki, Zohar/AAA-4029-2021	Barnett-Itzhaki, Zohar/0000-0001-9891-9397	Israel Science Foundation [1171/09]	Israel Science Foundation(Israel Science Foundation)	This study was supported by grant 1171/09 from the Israel Science Foundation administered by the Israeli Academy for Sciences and Humanities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Apweiler R, 2010, NUCLEIC ACIDS RES, V38, pD142, DOI 10.1093/nar/gkp846; Aranda B, 2010, NUCLEIC ACIDS RES, V38, pD525, DOI 10.1093/nar/gkp878; Bahir I, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.71; Calderwood MA, 2007, P NATL ACAD SCI USA, V104, P7606, DOI 10.1073/pnas.0702332104; Chatr-Aryamontri A, 2007, NUCLEIC ACIDS RES, V35, pD572, DOI 10.1093/nar/gkl950; Chatr-aryamontri A, 2009, NUCLEIC ACIDS RES, V37, pD669, DOI 10.1093/nar/gkn739; Costa S., 2008, V186, P383, DOI 10.1007/978-3-540-72843-6_16; Driscoll T, 2009, NUCLEIC ACIDS RES, V37, pD647, DOI 10.1093/nar/gkn799; Dyer MD, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040032; Finn RD, 2005, BIOINFORMATICS, V21, P410, DOI 10.1093/bioinformatics/bti011; Finn RD, 2006, NUCLEIC ACIDS RES, V34, pD247, DOI 10.1093/nar/gkj149; Fossum E, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000570; Greenbaum BD, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000079; Itzhaki Z, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-12-r125; Iyer LA, 2006, VIRUS RES, V117, P156, DOI 10.1016/j.virusres.2006.01.009; Koonin EV, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-29; Maglott D, 2007, NUCLEIC ACIDS RES, V35, pD26, DOI 10.1093/nar/gkl993; Nakamura Y, 2000, NUCLEIC ACIDS RES, V28, P292, DOI 10.1093/nar/28.1.292; Navratil V, 2009, NUCLEIC ACIDS RES, V37, pD661, DOI 10.1093/nar/gkn794; Nye TMW, 2005, BIOINFORMATICS, V21, P993, DOI 10.1093/bioinformatics/bti086; Pawson T, 2002, FEBS LETT, V513, P2, DOI 10.1016/S0014-5793(01)03292-6; PITMAN E. J. G., 1937, J. Roy. Statist. Soc. 1937., (Suppl.), V4, P119; Redpath S, 2001, TRENDS MICROBIOL, V9, P86, DOI 10.1016/S0966-842X(00)01919-3; Schlicker A, 2007, BIOINFORMATICS, V23, P859, DOI 10.1093/bioinformatics/btm012; Schuster-Bockler B, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-259; Stein A, 2009, NUCLEIC ACIDS RES, V37, pD300, DOI 10.1093/nar/gkn690; Verschuren EW, 2004, J GEN VIROL, V85, P1347, DOI 10.1099/vir.0.79812-0; Yoon SI, 2005, STRUCTURE, V13, P551, DOI 10.1016/j.str.2005.01.016	29	15	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2011	6	7							e21724	10.1371/journal.pone.0021724	http://dx.doi.org/10.1371/journal.pone.0021724			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791HI	21760902	Green Submitted, Green Published, gold			2022-12-27	WOS:000292655400013
J	McMillin, DW; Delmore, J; Negri, J; Ooi, M; Klippel, S; Miduturu, CV; Gray, NS; Richardson, PG; Anderson, KC; Kung, AL; Mitsiades, CS				McMillin, Douglas W.; Delmore, Jake; Negri, Joseph; Ooi, Melissa; Klippel, Steffen; Miduturu, Chandrasekhar V.; Gray, Nathanael S.; Richardson, Paul G.; Anderson, Kenneth C.; Kung, Andrew L.; Mitsiades, Constantine S.			Microenvironmental Influence on Pre-Clinical Activity of Polo-Like Kinase Inhibition in Multiple Myeloma: Implications for Clinical Translation	PLOS ONE			English	Article							ADVANCED SOLID TUMORS; GENE-EXPRESSION; BI 2536; MOLECULAR CLASSIFICATION; CHROMOSOMAL INSTABILITY; DRUG-RESISTANCE; CANCER-CELLS; PHASE-I; SURVIVAL; APOPTOSIS	Polo-like kinases (PLKs) play an important role in cell cycle progression, checkpoint control and mitosis. The high mitotic index and chromosomal instability of advanced cancers suggest that PLK inhibitors may be an attractive therapeutic option for presently incurable advanced neoplasias with systemic involvement, such as multiple myeloma (MM). We studied the PLK 1, 2, 3 inhibitor BI 2536 and observed potent (IC50,40 nM) and rapid (commitment to cell death,24 hrs) in vitro activity against MM cells in isolation, as well as in vivo activity against a traditional subcutaneous xenograft mousemodel. Tumor cells in MM patients, however, don't exist in isolation, but reside in and interact with the bone microenvironment. Therefore conventional in vitro and in vivo preclinical assays don't take into account how interactions between MM cells and the bone microenvironment can potentially confer drug resistance. To probe this question, we performed tumor cell compartment-specific bioluminescence imaging assays to compare the preclinical anti-MM activity of BI 2536 in vitro in the presence vs. absence of stromal cells or osteoclasts. We observed that the presence of these bone marrow non-malignant cells led to decreased anti-MM activity of BI 2536. We further validated these results in an orthotopic in vivo mouse model of diffuse MM bone lesions where tumor cells interact with non-malignant cells of the bone microenvironment. We again observed that BI 2536 had decreased activity in this in vivo model of tumor-bone microenvironment interactions highlighting that, despite BI 2536's promising activity in conventional assays, its lack of activity in microenvironmental models raises concerns for its clinical development for MM. More broadly, preclinical drug testing in the absence of relevant tumor microenvironment interactions may overestimate potential clinical activity, thus explaining at least in part the gap between preclinical vs. clinical efficacy in MM and other cancers.	[McMillin, Douglas W.; Delmore, Jake; Negri, Joseph; Ooi, Melissa; Klippel, Steffen; Richardson, Paul G.; Anderson, Kenneth C.; Mitsiades, Constantine S.] Dana Farber Canc Inst, Jerome Lipper Multiple Myeloma Ctr, Dept Med Oncol, Boston, MA 02115 USA; [McMillin, Douglas W.; Delmore, Jake; Negri, Joseph; Ooi, Melissa; Klippel, Steffen; Richardson, Paul G.; Anderson, Kenneth C.; Mitsiades, Constantine S.] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Miduturu, Chandrasekhar V.; Gray, Nathanael S.] Dana Farber Canc Inst, Dept Biol Chem & Mol Pharmacol, Dept Canc Biol, Boston, MA 02115 USA; [Kung, Andrew L.] Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; [Kung, Andrew L.] Childrens Hosp Boston, Boston, MA USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Boston Children's Hospital	McMillin, DW (corresponding author), Dana Farber Canc Inst, Jerome Lipper Multiple Myeloma Ctr, Dept Med Oncol, Boston, MA 02115 USA.	Constantine_Mitsiades@dfci.harvard.edu	Kung, Andrew L/AEU-0826-2022; Kung, Andrew/AAL-2384-2020	Kung, Andrew L/0000-0002-9091-488X; Ooi, Melissa/0000-0002-7392-0655	Dana-Farber Cancer Institute; Chambers Medical Foundation; Stepanian Fund for Myeloma Research; Cobb Family Fellowship; NIH [R01CA050947]; Millennium; Celgene; Amgen Pharmaceuticals; AVEO Pharma; EMD Serono; Sunesis; Gloucester Pharmaceuticals; Johnson Johnson; NATIONAL CANCER INSTITUTE [R01CA050947] Funding Source: NIH RePORTER	Dana-Farber Cancer Institute; Chambers Medical Foundation; Stepanian Fund for Myeloma Research; Cobb Family Fellowship; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Millennium(Takeda Pharmaceutical Company Ltd); Celgene(Bristol-Myers SquibbCelgene Corporation); Amgen Pharmaceuticals(Amgen); AVEO Pharma(Dexcel Pharma); EMD Serono; Sunesis; Gloucester Pharmaceuticals; Johnson Johnson(Johnson & JohnsonJohnson & Johnson USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Supported in part by the "Dunkin Donuts Rising Stars" Program at the Dana-Farber Cancer Institute (C. S. M.), the Chambers Medical Foundation (P. G. R. and C. S. M.), the Stepanian Fund for Myeloma Research (P. G. R. and C. S. M.), the Cobb Family Fellowship (D. W. M.), and NIH grant R01CA050947 (C. S. M. and K. C. A.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; D. W. M. is an equity holder in Axios Biosciences. J.D., J.N., M.O., S. K., C. V. M., N.S.G., and A. L. K. have nothing to disclose. P. G. R. has received honoraria from Millennium and Celgene. K. C. A. has received research grants and honoraria from Millennium and Celgene. C. S. M. has received in the past Consultant honoraria from Millennium Pharmaceuticals, Novartis Pharmaceuticals, Bristol-Myers Squibb, Merck & Co., Kosan Pharmaceuticals, Celgene and Pharmion, licensing royalties from PharmaMar, and research funding from Amgen Pharmaceuticals, AVEO Pharma, EMD Serono, Sunesis, Gloucester Pharmaceuticals, and Johnson & Johnson.	Barlogie B, 2001, BLOOD, V98, P492, DOI 10.1182/blood.V98.2.492; BREITKREUTZ I, 2008, LEUKEMIA; Broyl A, 2010, BLOOD, V116, P2543, DOI 10.1182/blood-2009-12-261032; Burington B, 2008, CLIN CANCER RES, V14, P4821, DOI 10.1158/1078-0432.CCR-07-4568; Decaux O, 2008, J CLIN ONCOL, V26, P4798, DOI 10.1200/JCO.2007.13.8545; Food and Drug Administration, 2004, INN STAGN CHALL OPP; HOFFMANN MG, 2004, DIHYDROPTERIDINONES; Hofheinz RD, 2010, CLIN CANCER RES, V16, P4666, DOI 10.1158/1078-0432.CCR-10-0318; HOLTRICH U, 1994, P NATL ACAD SCI USA, V91, P1736, DOI 10.1073/pnas.91.5.1736; Liu XQ, 2006, MOL CELL BIOL, V26, P2093, DOI 10.1128/MCB.26.6.2093-2108.2006; Mattioli M, 2005, ONCOGENE, V24, P2461, DOI 10.1038/sj.onc.1208447; McMillin DW, 2010, NAT MED, V16, P483, DOI 10.1038/nm.2112; McMillin DW, 2009, CANCER RES, V69, P5835, DOI 10.1158/0008-5472.CAN-08-4285; Mitsiades CS, 2001, BLOOD, V98, P795, DOI 10.1182/blood.V98.3.795; Mitsiades CS, 2004, CANCER CELL, V5, P221, DOI 10.1016/S1535-6108(04)00050-9; Mross K, 2008, J CLIN ONCOL, V26, P5511, DOI 10.1200/JCO.2008.16.1547; Ng SS, 2006, CURR GENET, V50, P73, DOI 10.1007/s00294-006-0077-y; Olmos D, 2011, CLIN CANC RES; Schoffski P, 2010, EUR J CANCER, V46, P2206, DOI 10.1016/j.ejca.2010.03.039; Sebastian M, 2010, J THORAC ONCOL, V5, P1060, DOI 10.1097/JTO.0b013e3181d95dd4; Sethi T, 1999, NAT MED, V5, P662, DOI 10.1038/9511; Shaughnessy JD, 2007, BLOOD, V109, P2276, DOI 10.1182/blood-2006-07-038430; STEWART HJ, 2010, EXP HEMATOL; Strebhardt K, 2006, NAT REV CANCER, V6, P321, DOI 10.1038/nrc1841; Yamamoto Y, 2006, ONCOLOGY-BASEL, V70, P231, DOI 10.1159/000094416; Zhan F, 2006, BLOOD, V108, P2020, DOI 10.1182/blood-2005-11-013458	26	29	30	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2011	6	7							e20226	10.1371/journal.pone.0020226	http://dx.doi.org/10.1371/journal.pone.0020226			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791HI	21750699	Green Published, Green Submitted, gold			2022-12-27	WOS:000292655400001
J	Sarrion-Perdigones, A; Falconi, EE; Zandalinas, SI; Juarez, P; Fernandez-del-Carmen, A; Granell, A; Orzaez, D				Sarrion-Perdigones, Alejandro; Elvira Falconi, Erica; Zandalinas, Sara I.; Juarez, Paloma; Fernandez-del-Carmen, Asun; Granell, Antonio; Orzaez, Diego			GoldenBraid: An Iterative Cloning System for Standardized Assembly of Reusable Genetic Modules	PLOS ONE			English	Article							PLANT TRANSFORMATION; EXPRESSION; VECTORS	Synthetic Biology requires efficient and versatile DNA assembly systems to facilitate the building of new genetic modules/pathways from basic DNA parts in a standardized way. Here we present GoldenBraid (GB), a standardized assembly system based on type IIS restriction enzymes that allows the indefinite growth of reusable gene modules made of standardized DNA pieces. The GB system consists of a set of four destination plasmids (pDGBs) designed to incorporate multipartite assemblies made of standard DNA parts and to combine them binarily to build increasingly complex multigene constructs. The relative position of type IIS restriction sites inside pDGB vectors introduces a double loop ("braid'') topology in the cloning strategy that allows the indefinite growth of composite parts through the succession of iterative assembling steps, while the overall simplicity of the system is maintained. We propose the use of GoldenBraid as an assembly standard for Plant Synthetic Biology. For this purpose we have GB-adapted a set of binary plasmids for A. tumefaciens-mediated plant transformation. Fast GB-engineering of several multigene T-DNAs, including two alternative modules made of five reusable devices each, and comprising a total of 19 basic parts are also described.	[Sarrion-Perdigones, Alejandro; Elvira Falconi, Erica; Zandalinas, Sara I.; Juarez, Paloma; Fernandez-del-Carmen, Asun; Granell, Antonio; Orzaez, Diego] Univ Politecn Valencia, IBMCP, CSIC, Valencia, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Universitat Politecnica de Valencia; CSIC-UPV - Instituto de Biologia Molecular y Celular de Plantas (IBMCP)	Sarrion-Perdigones, A (corresponding author), Univ Politecn Valencia, IBMCP, CSIC, Valencia, Spain.	dorzaez@ibmcp.upv.es	Sarrion-Perdigones, Alejandro/H-6750-2019; Granell, Antonio/G-3664-2010; ORZAEZ, DIEGO/X-2915-2019; Zandalinas, Sara I/AAH-1075-2019; Orzaez, Diego/H-3457-2012	Sarrion-Perdigones, Alejandro/0000-0002-4584-4827; ORZAEZ, DIEGO/0000-0003-1662-5403; Zandalinas, Sara I/0000-0002-1256-9371; Orzaez, Diego/0000-0003-1662-5403; Fernandez-del-Carmen, Maria Asuncion/0000-0002-9202-4960	Spanish Ministry of Science and Innovation [BIO2008-03434, BIO2010-15384]; Spanish Ministry of Education	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Spanish Ministry of Education(Spanish Government)	This work was supported by the Spanish Ministry of Science and Innovation grants BIO2008-03434 and BIO2010-15384. A. Sarrion-Perdigones is a recipient of a FPI fellowship of the Spanish Ministry of Science and Innovation and P. Juarez is a recipient of a FPU fellowship from the Spanish Ministry of Education. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson J Christopher, 2010, J Biol Eng, V4, P1, DOI 10.1186/1754-1611-4-1; Butelli E, 2008, NAT BIOTECHNOL, V26, P1301, DOI 10.1038/nbt.1506; Carter GW, 2010, CHAOS, V20, DOI 10.1063/1.3455183; Castilho A, 2010, J BIOL CHEM, V285, P15923, DOI 10.1074/jbc.M109.088401; Cermak T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr218; Check E, 2005, NATURE, V438, P417, DOI 10.1038/438417a; Chen QJ, 2006, PLANT MOL BIOL, V62, P927, DOI 10.1007/s11103-006-9065-3; Chen QJ, 2010, PLANT PHYSIOL, V153, P41, DOI 10.1104/pp.109.152249; Dafny-Yelin M, 2007, PLANT PHYSIOL, V145, P1118, DOI 10.1104/pp.107.106104; Ellis T, 2011, INTEGR BIOL-UK, V3, P109, DOI 10.1039/c0ib00070a; Engler C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003647; Engler C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005553; Fujisawa M, 2009, J EXP BOT, V60, P1319, DOI 10.1093/jxb/erp006; Gibson DG, 2010, SCIENCE, V329, P52, DOI 10.1126/science.1190719; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Goderis IJWM, 2002, PLANT MOL BIOL, V50, P17, DOI 10.1023/A:1016052416053; Hamilton CM, 1997, GENE, V200, P107, DOI 10.1016/S0378-1119(97)00388-0; Haseloff J, 2009, J R SOC INTERFACE, V6, DOI 10.1098/rsif.2009.0176.focus; Hellens RP, 2000, PLANT MOL BIOL, V42, P819, DOI 10.1023/A:1006496308160; Estornell LH, 2009, PLANT BIOTECHNOL J, V7, P298, DOI 10.1111/j.1467-7652.2009.00402.x; Karimi M, 2002, TRENDS PLANT SCI, V7, P193, DOI 10.1016/S1360-1385(02)02251-3; Knight T., 2003, IDEMPOTENT VECTOR DE; Kobayashi K, 2006, PLANT CELL REP, V25, P1347, DOI 10.1007/s00299-006-0206-6; KOLTUNOW AM, 1990, PLANT CELL, V2, P1201, DOI 10.1105/tpc.2.12.1201; Kosuri S, 2010, NAT BIOTECHNOL, V28, P1295, DOI 10.1038/nbt.1716; Li T, 2011, NUCLEIC ACIDS RES, V39, P6315, DOI 10.1093/nar/gkr188; Lin L, 2003, P NATL ACAD SCI USA, V100, P5962, DOI 10.1073/pnas.0931425100; Matzas M, 2010, NAT BIOTECHNOL, V28, P1291, DOI 10.1038/nbt.1710; MORBITZER R, 2011, NUCL ACIDS IN PRESS, DOI DOI 10.1093/NAR/GKR15; NAQVI S, 2009, TRENDS PLANT SCI; WEBER E, PLOS ONE, V6; Wieland WH, 2006, J BIOTECHNOL, V122, P382, DOI 10.1016/j.jbiotec.2005.12.020; Zhang F, 2011, NAT BIOTECHNOL, V29, P149, DOI 10.1038/nbt.1775	33	188	204	2	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2011	6	7							e21622	10.1371/journal.pone.0021622	http://dx.doi.org/10.1371/journal.pone.0021622			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791HI	21750718	Green Published, gold, Green Submitted			2022-12-27	WOS:000292655400008
J	Schluter, A; Ruiz-Trillo, I; Pujol, A				Schlueter, Agatha; Ruiz-Trillo, Inaki; Pujol, Aurora			Phylogenomic Evidence for a Myxococcal Contribution to the Mitochondrial Fatty Acid Beta-Oxidation	PLOS ONE			English	Article							GENE-TRANSFER; SYNTROPHUS-ACIDITROPHICUS; BACTERIAL GENOMES; EVOLUTION; PROTEIN; ORIGIN; BIOLOGY; PROTEOBACTERIA; MICROORGANISMS; VISUALIZATION	Background: The origin of eukaryotes remains a fundamental question in evolutionary biology. Although it is clear that eukaryotic genomes are a chimeric combination of genes of eubacterial and archaebacterial ancestry, the specific ancestry of most eubacterial genes is still unknown. The growing availability of microbial genomes offers the possibility of analyzing the ancestry of eukaryotic genomes and testing previous hypotheses on their origins. Methodology/Principal Findings: Here, we have applied a phylogenomic analysis to investigate a possible contribution of the Myxococcales to the first eukaryotes. We conducted a conservative pipeline with homologous sequence searches against a genomic sampling of 40 eukaryotic and 357 prokaryotic genomes. The phylogenetic reconstruction showed that several eukaryotic proteins traced to Myxococcales. Most of these proteins were associated with mitochondrial lipid intermediate pathways, particularly enzymes generating reducing equivalents with pivotal roles in fatty acid beta-oxidation metabolism. Our data suggest that myxococcal species with the ability to oxidize fatty acids transferred several genes to eubacteria that eventually gave rise to the mitochondrial ancestor. Later, the eukaryotic nucleocytoplasmic lineage acquired those metabolic genes through endosymbiotic gene transfer. Conclusions/Significance: Our results support a prokaryotic origin, different from alpha-proteobacteria, for several mitochondrial genes. Our data reinforce a fluid prokaryotic chromosome model in which the mitochondrion appears to be an important entry point for myxococcal genes to enter eukaryotes.	[Schlueter, Agatha; Pujol, Aurora] Inst Invest Biomed Bellvitge IDIBELL, Neurometabol Dis Lab, Barcelona, Spain; [Schlueter, Agatha; Pujol, Aurora] Univ Barcelona, Hosp Univ Bellvitge, Inst Neuropathol, Barcelona, Spain; [Schlueter, Agatha; Pujol, Aurora] Ctr Invest Red Enfermedades Raras CIBERER, Valencia, Spain; [Ruiz-Trillo, Inaki] Univ Barcelona, Dept Genet, Barcelona, Spain; [Ruiz-Trillo, Inaki] Univ Barcelona, Inst Recerca Biodiversitat Irbio, Barcelona, Spain; [Ruiz-Trillo, Inaki; Pujol, Aurora] ICREA, Barcelona, Spain	Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; University of Barcelona; University of Barcelona; ICREA	Schluter, A (corresponding author), Inst Invest Biomed Bellvitge IDIBELL, Neurometabol Dis Lab, Barcelona, Spain.	apujol@idibell.cat	Ruiz-Trillo, Iñaki/H-3217-2019; Pujol, Aurora/N-4990-2014; Ruiz-Trillo, Iñaki/C-1360-2008; Schlüter, Agatha/N-4097-2014; Schluter, Agatha/AAA-9665-2021	Ruiz-Trillo, Iñaki/0000-0001-6547-5304; Pujol, Aurora/0000-0002-9606-0600; Ruiz-Trillo, Iñaki/0000-0001-6547-5304; Schlüter, Agatha/0000-0001-6732-1528; 	Ministerio de Ciencia e Innovacion (MICINN) [BFU2008-02839/BMC]; Fondo de Investigacion Sanitaria (FIS) [ECA07/055]; ICREA Funding Source: Custom	Ministerio de Ciencia e Innovacion (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Fondo de Investigacion Sanitaria (FIS)(Instituto de Salud Carlos III); ICREA(ICREA)	A. Schluter is a recipient of Fondo de Investigacion Sanitaria (FIS) (ECA07/055). Centro de Investigacion en Red sobre Enfermedades Raras (CIBERER) is an initiative of the Instituto de Salud Carlos III. IR-T's contribution was supported by a Ministerio de Ciencia e Innovacion (MICINN) grant awarded to IR-T (BFU2008-02839/BMC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen JF, 2003, PHILOS T R SOC B, V358, P19, DOI 10.1098/rstb.2002.1191; Alvarez HM, 2002, APPL MICROBIOL BIOT, V60, P367, DOI 10.1007/s00253-002-1135-0; Azad RK, 2007, NUCLEIC ACIDS RES, V35, P4629, DOI 10.1093/nar/gkm204; Boussau B, 2004, P NATL ACAD SCI USA, V101, P9722, DOI 10.1073/pnas.0400975101; Capella-Gutierrez S, 2009, BIOINFORMATICS, V25, P1972, DOI 10.1093/bioinformatics/btp348; Dworkin M, 1996, MICROBIOL REV, V60, P70, DOI 10.1128/MMBR.60.1.70-102.1996; Eaton S, 2002, PROG LIPID RES, V41, P197, DOI 10.1016/S0163-7827(01)00024-8; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; El Bawab S, 2000, J BIOL CHEM, V275, P21508, DOI 10.1074/jbc.M002522200; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Embley TM, 2006, NATURE, V440, P623, DOI 10.1038/nature04546; Ensenauer R, 2005, J BIOL CHEM, V280, P32309, DOI 10.1074/jbc.M504460200; Esser C, 2004, MOL BIOL EVOL, V21, P1643, DOI 10.1093/molbev/msh160; Esser C, 2007, BIOL LETT-UK, V3, P180, DOI 10.1098/rsbl.2006.0582; Gabaldon T, 2003, SCIENCE, V301, P609, DOI 10.1126/science.1085463; Garcia-Vallve S, 2000, GENOME RES, V10, P1719, DOI 10.1101/gr.130000; Goldman BS, 2006, P NATL ACAD SCI USA, V103, P15200, DOI 10.1073/pnas.0607335103; Gray MW, 1999, SCIENCE, V283, P1476, DOI 10.1126/science.283.5407.1476; Heath RJ, 2002, NAT PROD REP, V19, P581, DOI 10.1039/b110221b; Jackson BE, 1999, ARCH MICROBIOL, V171, P107, DOI 10.1007/s002030050685; Javaux Emmanuelle, 2011, P414, DOI 10.1017/CBO9780511933875.028; Karlin S, 2000, J BACTERIOL, V182, P5238, DOI 10.1128/JB.182.18.5238-5250.2000; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Kumar S, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-357; LANE N, NATURE, V467, P929; Langille MGI, 2009, BIOINFORMATICS, V25, P664, DOI 10.1093/bioinformatics/btp030; Lawrence JG, 1997, J MOL EVOL, V44, P383, DOI 10.1007/PL00006158; Leonardy S, 2010, EMBO J, V29, P2276, DOI 10.1038/emboj.2010.114; Lopez-Garcia P, 2006, BIOESSAYS, V28, P525, DOI 10.1002/bies.20413; Margulis L, 2006, P NATL ACAD SCI USA, V103, P13080, DOI 10.1073/pnas.0604985103; Martin W, 1999, BIOESSAYS, V21, P99, DOI 10.1002/(SICI)1521-1878(199902)21:2<99::AID-BIES3>3.3.CO;2-2; Martin W, 1998, NATURE, V392, P37, DOI 10.1038/32096; MCDANIEL LD, SCIENCE, V330, P50; McInerney MJ, 2007, P NATL ACAD SCI USA, V104, P7600, DOI 10.1073/pnas.0610456104; McInerney MJ, 2009, CURR OPIN BIOTECH, V20, P623, DOI 10.1016/j.copbio.2009.10.001; Miller M. A., 2010, CIPRES PORTALS; Moreira D, 1998, J MOL EVOL, V47, P517, DOI 10.1007/PL00006408; Mrazek J, 1999, ANN NY ACAD SCI, V870, P314, DOI 10.1111/j.1749-6632.1999.tb08893.x; Ochman H, 2000, NATURE, V405, P299, DOI 10.1038/35012500; Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016; Pereto J, 2005, J MOL EVOL, V61, P65, DOI 10.1007/s00239-004-0280-8; Perez J, 2008, P NATL ACAD SCI USA, V105, P15950, DOI 10.1073/pnas.0806851105; RICHARDS TA, CURR BIOL, V21, pR112; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Searcy DG, 2003, CELL RES, V13, P229, DOI 10.1038/sj.cr.7290168; Shen YQ, 2009, NUCLEIC ACIDS RES, V37, P5619, DOI 10.1093/nar/gkp566; Sousa DZ, 2009, FEMS MICROBIOL ECOL, V68, P257, DOI 10.1111/j.1574-6941.2009.00680.x; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stothard P, 2005, BIOINFORMATICS, V21, P537, DOI 10.1093/bioinformatics/bti054; Timmis JN, 2004, NAT REV GENET, V5, P123, DOI 10.1038/nrg1271; Watkins PA, 1997, PROG LIPID RES, V36, P55, DOI 10.1016/S0163-7827(97)00004-0; Winkler U, 2003, PLANT PHYSIOL, V131, P753, DOI 10.1104/pp.013151	52	5	5	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2011	6	7							e21989	10.1371/journal.pone.0021989	http://dx.doi.org/10.1371/journal.pone.0021989			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791HI	21760940	Green Published, Green Submitted, gold			2022-12-27	WOS:000292655400035
J	Perrot-Applanat, M; Vacher, S; Toullec, A; Pelaez, I; Velasco, G; Cormier, F; Saad, HE; Lidereau, R; Baud, V; Bieche, I				Perrot-Applanat, Martine; Vacher, Sophie; Toullec, Aurore; Pelaez, Irma; Velasco, Guillaume; Cormier, Francoise; Saad, Hanan El Sheikh; Lidereau, Rosette; Baud, Veronique; Bieche, Ivan			Similar NF-kappa B Gene Signatures in TNF-alpha Treated Human Endothelial Cells and Breast Tumor Biopsies	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; INFLAMMATORY CYTOKINES; SIGNAL-TRANSDUCTION; GM-CSF; EXPRESSION; CANCER; ACTIVATION; TRANSCRIPTION; TARGET; ROLES	Background: Endothelial dysfunction has been implicated in the pathogenesis of diverse pathologies ranging from vascular and immune diseases to cancer. TNF-alpha is one of the mediators of endothelial dysfunction through the activation of transcription factors, including NF-kappa B. While HUVEC (macrovascular cells) have been largely used in the past, here, we documented an NF-kappa B gene signature in TNF alpha-stimulated microvascular endothelial cells HMEC often used in tumor angiogenesis studies. Methodology/Principal Findings: We measured mRNA expression of 55 NF-kappa B related genes using quantitative RT-PCR in HUVEC and HMEC. Our study identified twenty genes markedly up-regulated in response to TNF alpha, including adhesion molecules, cytokines, chemokines, and apoptosis regulators, some of them being identified as TNF-alpha-inducible genes for the first time in endothelial cells (two apoptosis regulators, TNFAIP3 and TNFRSF10B/Trail R2 (DR5), the chemokines GM-CSF/CSF2 and MCF/CSF1, and CD40 and TNF-alpha itself, as well as NF-kappa B components (RELB, NFKB1or 50/p105 and NFKB2 or p52/p100). For eight genes, the fold induction was much higher in HMEC, as compared to HUVEC. Most importantly, our study described for the first time a connection between NF-kappa B activation and the induction of most, if not all, of these genes in HMEC as evaluated by pharmacological inhibition and RelA expression knock-down by RNA interference. Moreover, since TNF-alpha is highly expressed in tumors, we further applied the NF-kappa B gene signature documented in TNF alpha-stimulated endothelial cells to human breast tumors. We found a significant positive correlation between TNF and the majority (85 %) of the identified endothelial TNF-induced genes in a well-defined series of 96 (48 ER alpha positive and 48 ER alpha negative) breast tumors. Conclusion/Significance: Taken together these data suggest the potential use of this NF-kappa B gene signature in analyzing the role of TNF-alpha in the endothelial dysfunction, as well as in breast tumors independently of the presence of ER alpha.	[Perrot-Applanat, Martine; Toullec, Aurore; Pelaez, Irma; Velasco, Guillaume; Saad, Hanan El Sheikh] INSERM, U965, Paris, France; [Perrot-Applanat, Martine; Toullec, Aurore; Pelaez, Irma; Velasco, Guillaume; Saad, Hanan El Sheikh] Univ Paris Diderot, Paris, France; [Vacher, Sophie; Lidereau, Rosette; Bieche, Ivan] Hop Rene Huguenin, FNCLCC, Inst Curie, INSERM,U735, St Cloud, France; [Cormier, Francoise; Baud, Veronique] Inst Cochin, INSERM, U1016, Paris, France; [Cormier, Francoise; Baud, Veronique] CNRS, UMR8104, Paris, France; [Cormier, Francoise; Baud, Veronique; Bieche, Ivan] Univ Paris 05, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Rene Huguenin Hospital; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Perrot-Applanat, M (corresponding author), INSERM, U965, Paris, France.	martine.applanat@inserm.fr	Velasco, Guillaume/AAM-2447-2020; Baud, Veronique/F-7699-2013; Baud, Veronique/AAL-3950-2020; Bièche, Ivan/O-7399-2017	Baud, Veronique/0000-0002-4090-718X; Baud, Veronique/0000-0002-4090-718X; Bièche, Ivan/0000-0002-2430-5429; Cormier, Francoise/0000-0002-6904-5122	Institut National de la Sante et de la Recherche Medicale (INSERM); Centre National de la Recherche Scientifique (CNRS); Centre Rene Huguenin (Saint-Cloud, France); Universite Paris Diderot, France; Region Ile de France; Agence Nationale pour la Recherche; Association pour la Recherche sur le Cancer; Belgian InterUniversity Attraction Pole; Canceropole Ile-de-France; Institut National du Cancer; Universite Paris Descartes, France	Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Centre Rene Huguenin (Saint-Cloud, France); Universite Paris Diderot, France; Region Ile de France(Region Ile-de-France); Agence Nationale pour la Recherche(French National Research Agency (ANR)); Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Belgian InterUniversity Attraction Pole(Belgian Federal Science Policy Office); Canceropole Ile-de-France(Region Ile-de-France); Institut National du Cancer(Institut National du Cancer (INCA) France); Universite Paris Descartes, France	This work was supported by the Institut National de la Sante et de la Recherche Medicale (INSERM), the Centre National de la Recherche Scientifique (CNRS), the Centre Rene Huguenin (Saint-Cloud, France) and Universite Paris Diderot, France. A. Toullec is supported by a grant from Region Ile de France. V. Baud is supported by grants from Agence Nationale pour la Recherche, Association pour la Recherche sur le Cancer, Belgian InterUniversity Attraction Pole, Canceropole Ile-de-France, Institut National du Cancer and Universite Paris Descartes, France. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation in the manuscript.	Aggarwal BB, 2004, CANCER CELL, V6, P203, DOI 10.1016/j.ccr.2004.09.003; Baldwin AS, 2001, J CLIN INVEST, V107, P241, DOI 10.1172/JCI11991; Baud V, 2001, TRENDS CELL BIOL, V11, P372, DOI 10.1016/S0962-8924(01)02064-5; Baud V, 2009, NAT REV DRUG DISCOV, V8, P33, DOI 10.1038/nrd2781; Bernardini G, 2003, J IMMUNOL METHODS, V273, P83, DOI 10.1016/S0022-1759(02)00420-9; Bieche I, 2001, ONCOGENE, V20, P8109, DOI 10.1038/sj.onc.1204917; Bieche I, 2004, CLIN CANCER RES, V10, P6789, DOI 10.1158/1078-0432.CCR-04-0306; Bieche I, 2007, ENDOCR-RELAT CANCER, V14, P1039, DOI 10.1677/erc.1.01301; BLOOM HJG, 1957, BRIT J CANCER, V11, P359, DOI 10.1038/bjc.1957.43; Cao YX, 2003, J MAMMARY GLAND BIOL, V8, P215, DOI 10.1023/A:1025905008934; Claudio E, 2002, NAT IMMUNOL, V3, P958, DOI 10.1038/ni842; Cogswell PC, 2000, ONCOGENE, V19, P1123, DOI 10.1038/sj.onc.1203412; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Dejardin E, 2002, IMMUNITY, V17, P525, DOI 10.1016/S1074-7613(02)00423-5; Derudder E, 2003, J BIOL CHEM, V278, P23278, DOI 10.1074/jbc.M300106200; FOLKMAN J, 1995, NAT MED, V1, P27, DOI 10.1038/nm0195-27; Gasparini C, 2009, EUR J IMMUNOL, V39, P2215, DOI 10.1002/eji.200939209; Goebeler M, 2001, BLOOD, V97, P46, DOI 10.1182/blood.V97.1.46; Hamilton JA, 2002, TRENDS IMMUNOL, V23, P403, DOI 10.1016/S1471-4906(02)02260-3; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; HOU JZ, 1994, P NATL ACAD SCI USA, V91, P11641, DOI 10.1073/pnas.91.24.11641; Jacque E, 2005, P NATL ACAD SCI USA, V102, P14635, DOI 10.1073/pnas.0507342102; JAFFE EA, 1973, J CLIN INVEST, V52, P2745, DOI 10.1172/JCI107470; Karin M, 2002, NAT REV CANCER, V2, P301, DOI 10.1038/nrc780; Karin M, 2002, NAT IMMUNOL, V3, P221, DOI 10.1038/ni0302-221; Karl E, 2005, CANCER RES, V65, P5063, DOI 10.1158/0008-5472.CAN-05-0140; Karsan A, 1996, J BIOL CHEM, V271, P27201, DOI 10.1074/jbc.271.44.27201; Karsan A, 1996, BLOOD, V87, P3089, DOI 10.1182/blood.V87.8.3089.bloodjournal8783089; Kieusseian A, 2006, BLOOD, V107, P492, DOI 10.1182/blood-2005-02-0529; Kim DW, 2000, CARCINOGENESIS, V21, P871, DOI 10.1093/carcin/21.5.871; Krishnaswamy G, 1998, MICROVASC RES, V55, P189, DOI 10.1006/mvre.1998.2079; Kuldo JM, 2005, AM J PHYSIOL-CELL PH, V289, pC1229, DOI 10.1152/ajpcell.00620.2004; LEDEBUR HC, 1995, J BIOL CHEM, V270, P933, DOI 10.1074/jbc.270.2.933; Lenhoff S, 1996, CYTOKINE, V8, P702, DOI 10.1006/cyto.1996.0093; Levkau B, 1999, NAT CELL BIOL, V1, P227, DOI 10.1038/12050; Locksley RM, 2001, CELL, V104, P487, DOI 10.1016/S0092-8674(01)00237-9; Marui N, 2005, BIOCHEM J, V390, P317, DOI 10.1042/BJ20041659; Mocellin S, 2005, CYTOKINE GROWTH F R, V16, P35, DOI 10.1016/j.cytogfr.2004.11.001; Pahl HL, 1999, ONCOGENE, V18, P6853, DOI 10.1038/sj.onc.1203239; Park BK, 2007, NAT MED, V13, P62, DOI 10.1038/nm1519; Pierce JW, 1997, J BIOL CHEM, V272, P21096, DOI 10.1074/jbc.272.34.21096; QUESENBERRY PJ, 1980, BLOOD, V56, P1060, DOI 10.1182/blood.V56.6.1060.1060; Rossol M, 2007, J IMMUNOL, V179, P4239, DOI 10.4049/jimmunol.179.6.4239; Saji H, 2001, CANCER, V92, P1085, DOI 10.1002/1097-0142(20010901)92:5<1085::AID-CNCR1424>3.0.CO;2-K; Schumm K, 2006, EMBO J, V25, P4820, DOI 10.1038/sj.emboj.7601343; Shishodia Shishir, 2004, Cancer Treat Res, V119, P139; Sors A, 2008, CLIN CANCER RES, V14, P901, DOI 10.1158/1078-0432.CCR-07-1419; Sovak MA, 1997, J CLIN INVEST, V100, P2952, DOI 10.1172/JCI119848; Stroka DM, 1999, BLOOD, V93, P3803, DOI 10.1182/blood.V93.11.3803.411a27_3803_3810; ten Hagen TLM, 2008, IMMUNOL REV, V222, P299, DOI 10.1111/j.1600-065X.2008.00619.x; TRACEY KJ, 1993, ANNU REV CELL BIOL, V9, P317, DOI 10.1146/annurev.cb.09.110193.001533; Vanden Berghe W, 2000, BIOCHEM PHARMACOL, V60, P1185, DOI 10.1016/S0006-2952(00)00412-3; Viemann D, 2006, J LEUKOCYTE BIOL, V80, P174, DOI 10.1189/jlb.0905530; Wosik K, 2007, J NEUROL SCI, V259, P53, DOI 10.1016/j.jns.2006.08.018; Yoshida S, 1997, MOL CELL BIOL, V17, P4015, DOI 10.1128/MCB.17.7.4015; Zha R, 2005, BIOCHEM BIOPH RES CO, V327, P985, DOI 10.1016/j.bbrc.2004.12.109; Zhou J, 2002, INFLAMM RES, V51, P332, DOI 10.1007/PL00000312	57	34	36	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2011	6	7							e21589	10.1371/journal.pone.0021589	http://dx.doi.org/10.1371/journal.pone.0021589			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791AK	21754991	gold, Green Published, Green Submitted			2022-12-27	WOS:000292632000015
J	van Abel, D; Holzel, DR; Jain, S; Lun, FMF; Zheng, YMWL; Chen, EZ; Sun, H; Chiu, RWK; Lo, YMD; van Dijk, M; Oudejans, CBM				van Abel, Daan; Holzel, Dennis R.; Jain, Shushant; Lun, Fiona M. F.; Zheng, Yama W. L.; Chen, Eric Z.; Sun, Hao; Chiu, Rossa W. K.; Lo, Y. M. Dennis; van Dijk, Marie; Oudejans, Cees B. M.			SFRS7-Mediated Splicing of Tau Exon 10 Is Directly Regulated by STOX1A in Glial Cells	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; DIFFERENTIAL EXPRESSION; 9G8; PREECLAMPSIA; ENHANCER; BIOLOGY; INTRON; GROWTH; BRAIN; DNA	Background: In this study, we performed a genome-wide search for effector genes bound by STOX1A, a winged helix transcription factor recently demonstrated to be involved in late onset Alzheimer's disease and affecting the amyloid processing pathway. Methodology/Principal Findings: Our results show that out of 218 genes bound by STOX1A as identified by chromatin-immunoprecipitation followed by sequencing (ChIP-Seq), the serine/arginine-rich splicing factor 7 (SFRS7) was found to be induced, both at the mRNA and protein levels, by STOX1A after stable transfection in glial cells. The increase in SFRS7 was followed by an increase in the 4R/3R ratios of the microtubule-associated protein tau (MAPT) by differential exon 10 splicing. Secondly, STOX1A also induced expression of total tau both at the mRNA and protein levels. Upregulation of total tau expression (SFRS7-independent) and tau exon 10 splicing (SFRS7-independent), as shown in this study to be both affected by STOX1A, is known to have implications in neurodegeneration. Conclusions: Our data further supports the functional importance and central role of STOX1A in neurodegeneration.	[van Abel, Daan; van Dijk, Marie; Oudejans, Cees B. M.] Vrije Univ Amsterdam Med Ctr, Dept Clin Chem, Amsterdam, Netherlands; [Holzel, Dennis R.; Jain, Shushant] Vrije Univ Amsterdam Med Ctr, Sect Med Genom, Dept Clin Genet, Amsterdam, Netherlands; [Lun, Fiona M. F.; Zheng, Yama W. L.; Chen, Eric Z.; Sun, Hao; Chiu, Rossa W. K.; Lo, Y. M. Dennis] Prince Wales Hosp, Dept Chem Pathol, Shatin, Hong Kong, Peoples R China	Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Chinese University of Hong Kong; Prince of Wales Hospital	van Abel, D (corresponding author), Vrije Univ Amsterdam Med Ctr, Dept Clin Chem, Amsterdam, Netherlands.	cbm.oudejans@vumc.nl	Sun, Hao/J-9964-2013; c, c/I-5855-2016; van Dijk, Marie/L-1901-2014; sun, hao/GRS-7732-2022; Lo, Yuk Ming Dennis/D-4468-2011; Sun, Hao/T-5576-2019	Sun, Hao/0000-0002-5547-9501; Lo, Yuk Ming Dennis/0000-0001-8746-0293; Sun, Hao/0000-0002-5547-9501; Oudejans, Cees/0000-0003-0717-4946; van Dijk, Marie/0000-0003-1461-3441	University Grants Committee of the Government of the Hong Kong Special Administrative Region, China [AoE/M-04/06]	University Grants Committee of the Government of the Hong Kong Special Administrative Region, China	This study was partially supported by the University Grants Committee of the Government of the Hong Kong Special Administrative Region, China, under the Areas of Excellence Scheme (AoE/M-04/06). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta S, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-12; Arai T, 2001, ACTA NEUROPATHOL, V101, P167; Armstrong RA, 2009, FOLIA NEUROPATHOL, V47, P289; BARNES EN, 1981, IN VITRO CELL DEV B, V17, P619, DOI 10.1007/BF02618461; BIEDLER JL, 1973, CANCER RES, V33, P2643; BRENNAN RG, 1993, CELL, V74, P773, DOI 10.1016/0092-8674(93)90456-Z; Cramer P, 1999, MOL CELL, V4, P251, DOI 10.1016/S1097-2765(00)80372-X; Ding S, 2011, NEUROBIOL AGING; Duley L, 2009, SEMIN PERINATOL, V33, P130, DOI 10.1053/j.semperi.2009.02.010; Galiana-Arnoux D, 2003, J BIOL CHEM, V278, P32943, DOI 10.1074/jbc.M301090200; Gao L, 2007, MOL CELL NEUROSCI, V34, P48, DOI 10.1016/j.mcn.2006.10.004; GOEDERT M, 1989, EMBO J, V8, P393, DOI 10.1002/j.1460-2075.1989.tb03390.x; HARDY J, 1991, TRENDS PHARMACOL SCI, V12, P383, DOI 10.1016/0165-6147(91)90609-V; KSIEZAKREDING H, 1995, J NEUROSCI RES, V41, P583, DOI 10.1002/jnr.490410504; Li XL, 2000, RNA, V6, P1847, DOI 10.1017/S1355838200000674; Newman M, 2007, BBA-MOL BASIS DIS, V1772, P285, DOI 10.1016/j.bbadis.2006.12.001; ROSS RA, 1983, J NATL CANCER I, V71, P741; Schuster SC, 2008, NAT METHODS, V5, P16, DOI [10.1038/nmeth1156, 10.1038/NMETH1156]; Shin HJ, 2009, BIOINFORMATICS, V25, P2605, DOI 10.1093/bioinformatics/btp479; SONG WH, 1995, NUCLEIC ACIDS RES, V23, P3609, DOI 10.1093/nar/23.17.3609; van Dijk M, 2005, NAT GENET, V37, P514, DOI 10.1038/ng1541; van Dijk M, 2010, J ALZHEIMERS DIS, V19, P673, DOI 10.3233/JAD-2010-1265	22	8	8	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2011	6	7							e21994	10.1371/journal.pone.0021994	http://dx.doi.org/10.1371/journal.pone.0021994			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791AK	21755018	Green Published, gold			2022-12-27	WOS:000292632000045
J	Lamb, JR; Zhang, CS; Xie, T; Wang, K; Zhang, B; Hao, K; Chudin, E; Fraser, HB; Millstein, J; Ferguson, M; Suver, C; Ivanovska, I; Scott, M; Philippar, U; Bansal, D; Zhang, Z; Burchard, J; Smith, R; Greenawalt, D; Cleary, M; Derry, J; Loboda, A; Watters, J; Poon, RTP; Fan, ST; Yeung, C; Lee, NPY; Guinney, J; Molony, C; Emilsson, V; Buser-Doepner, C; Zhu, J; Friend, S; Mao, M; Shaw, PM; Dai, HY; Luk, JM; Schadt, EE				Lamb, John R.; Zhang, Chunsheng; Xie, Tao; Wang, Kai; Zhang, Bin; Hao, Ke; Chudin, Eugene; Fraser, Hunter B.; Millstein, Joshua; Ferguson, Mark; Suver, Christine; Ivanovska, Irena; Scott, Martin; Philippar, Ulrike; Bansal, Dimple; Zhang, Zhan; Burchard, Julja; Smith, Ryan; Greenawalt, Danielle; Cleary, Michele; Derry, Jonathan; Loboda, Andrey; Watters, James; Poon, Ronnie T. P.; Fan, Sheung T.; Yeung, Chun; Lee, Nikki P. Y.; Guinney, Justin; Molony, Cliona; Emilsson, Valur; Buser-Doepner, Carolyn; Zhu, Jun; Friend, Stephen; Mao, Mao; Shaw, Peter M.; Dai, Hongyue; Luk, John M.; Schadt, Eric E.			Predictive Genes in Adjacent Normal Tissue Are Preferentially Altered by sCNV during Tumorigenesis in Liver Cancer and May Rate Limiting	PLOS ONE			English	Article							COPY-NUMBER ALTERATION; HEPATOCELLULAR-CARCINOMA; SEGREGATION ERRORS; GENOMIC ANALYSIS; EXPRESSION; MICE; TUMORS; CLASSIFICATION; EVOLUTION; DISEASE	Background: In hepatocellular carcinoma (HCC) genes predictive of survival have been found in both adjacent normal (AN) and tumor (TU) tissues. The relationships between these two sets of predictive genes and the general process of tumorigenesis and disease progression remains unclear. Methodology/Principal Findings: Here we have investigated HCC tumorigenesis by comparing gene expression, DNA copy number variation and survival using similar to 250 AN and TU samples representing, respectively, the pre-cancer state, and the result of tumorigenesis. Genes that participate in tumorigenesis were defined using a gene-gene correlation meta-analysis procedure that compared AN versus TU tissues. Genes predictive of survival in AN (AN-survival genes) were found to be enriched in the differential gene-gene correlation gene set indicating that they directly participate in the process of tumorigenesis. Additionally the AN-survival genes were mostly not predictive after tumorigenesis in TU tissue and this transition was associated with and could largely be explained by the effect of somatic DNA copy number variation (sCNV) in cis and in trans. The data was consistent with the variance of AN-survival genes being rate-limiting steps in tumorigenesis and this was confirmed using a treatment that promotes HCC tumorigenesis that selectively altered AN-survival genes and genes differentially correlated between AN and TU. Conclusions/Significance: This suggests that the process of tumor evolution involves rate-limiting steps related to the background from which the tumor evolved where these were frequently predictive of clinical outcome. Additionally treatments that alter the likelihood of tumorigenesis occurring may act by altering AN-survival genes, suggesting that the process can be manipulated. Further sCNV explains a substantial fraction of tumor specific expression and may therefore be a causal driver of tumor evolution in HCC and perhaps many solid tumor types.	[Lamb, John R.; Zhang, Chunsheng; Xie, Tao; Wang, Kai; Zhang, Bin; Hao, Ke; Chudin, Eugene; Fraser, Hunter B.; Millstein, Joshua; Ferguson, Mark; Suver, Christine; Ivanovska, Irena; Zhang, Zhan; Burchard, Julja; Smith, Ryan; Greenawalt, Danielle; Derry, Jonathan; Molony, Cliona; Emilsson, Valur; Zhu, Jun; Mao, Mao; Dai, Hongyue; Schadt, Eric E.] Rosetta Inpharmat LLC, Seattle, WA USA; [Cleary, Michele; Loboda, Andrey; Watters, James; Buser-Doepner, Carolyn; Friend, Stephen; Shaw, Peter M.] Merck & Co Inc, Upper Gwynedd, PA USA; [Scott, Martin; Philippar, Ulrike; Bansal, Dimple] Merck & Co Inc, Boston, MA USA; [Poon, Ronnie T. P.; Fan, Sheung T.; Yeung, Chun; Lee, Nikki P. Y.; Luk, John M.] Univ Hong Kong, Queen Mary Hosp, Dept Surg, Hong Kong, Hong Kong, Peoples R China; [Guinney, Justin] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA	Merck & Company; Merck & Company; Merck & Company; University of Hong Kong; Fred Hutchinson Cancer Center	Lamb, JR (corresponding author), Rosetta Inpharmat LLC, Seattle, WA USA.	john.lamb@pfizer.com; jmluk@nus.edu.sg; eschadt@pacificbiosciences.com	Luk, John/A-4085-2008	Luk, John/0000-0002-6323-7940; Suver, Christine/0000-0002-2986-385X; Wang, Kai/0000-0003-0567-3004; Emilsson, Valur/0000-0001-9982-0524	Merck Co	Merck Co(Merck & Company)	This work was entirely funded by Merck & Co and its wholly owned subsidiary Rosetta Inpharmatics, Inc. Many of the authors were or are Merck employees. The manuscript was reviewed by Merck and approved for release into the public domain without alteration. Other than this Rosetta Inpharmatics and Merck had no role in study design, data collection and analysis, or preparation of the manuscript.	Albertson DG, 2003, NAT GENET, V34, P369, DOI 10.1038/ng1215; Artandi SE, 2000, NATURE, V406, P641, DOI 10.1038/35020592; ATKIN NB, 1989, CANCER GENET CYTOGEN, V40, P3, DOI 10.1016/0165-4608(89)90140-4; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Calle EE, 2003, NEW ENGL J MED, V348, P1625, DOI 10.1056/NEJMoa021423; Chen YQ, 2008, NATURE, V452, P429, DOI 10.1038/nature06757; Costa JL, 2008, SEMIN RADIAT ONCOL, V18, P98, DOI 10.1016/j.semradonc.2007.10.005; Dai MS, 2008, J CELL BIOCHEM, V105, P670, DOI 10.1002/jcb.21895; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Ghazalpour A, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-7-r59; Ghazalpour A, 2006, PLOS GENET, V2, P1182, DOI 10.1371/journal.pgen.0020130; Gisselsson D, 2008, CHROMOSOMA, V117, P511, DOI 10.1007/s00412-008-0169-1; Gunderson KL, 2005, NAT GENET, V37, P549, DOI 10.1038/ng1547; HANSEMANN D, 1891, ARCH PATHOL ANAT PHY, V119, P299; Hao K, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-389; Hill-Baskin AE, 2009, HUM MOL GENET, V18, P2975, DOI 10.1093/hmg/ddp236; Hoshida Y, 2008, NEW ENGL J MED, V359, P1995, DOI 10.1056/NEJMoa0804525; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Jin YS, 2007, CLIN CANCER RES, V13, P1703, DOI 10.1158/1078-0432.CCR-06-2705; Kumar S, 1998, NATURE, V392, P917, DOI 10.1038/31927; LEQUESNE JP, 2009, J PATHOL; Loeb LA, 2001, CANCER RES, V61, P3230; Moffatt MF, 2007, NATURE, V448, P470, DOI 10.1038/nature06014; Nilsson B, 2009, BIOINFORMATICS, V25, P1078, DOI 10.1093/bioinformatics/btp091; NOWELL PC, 1976, SCIENCE, V194, P23, DOI 10.1126/science.959840; Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016; Park CC, 2008, NAT GENET, V40, P421, DOI 10.1038/ng.113; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Picard F, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-27; Pollack JR, 2002, P NATL ACAD SCI USA, V99, P12963, DOI 10.1073/pnas.162471999; Rajagopalan H, 2004, NATURE, V432, P338, DOI 10.1038/nature03099; SOBIN LH, 1988, CANCER, V61, P2310, DOI 10.1002/1097-0142(19880601)61:11<2310::AID-CNCR2820611127>3.0.CO;2-X; Thorgeirsson SS, 2002, NAT GENET, V31, P339, DOI 10.1038/ng0802-339; Trevisani F, 2008, CARCINOGENESIS, V29, P1299, DOI 10.1093/carcin/bgn113; Wang R, 2001, J CELL BIOL, V153, P1023, DOI 10.1083/jcb.153.5.1023; Wang YK, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni177; Weidensdorfer D, 2009, RNA, V15, P104, DOI 10.1261/rna.1175909; Wurmbach E, 2007, HEPATOLOGY, V45, P938, DOI 10.1002/hep.21622; XIE T, OMICS, V14, P91; Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128	40	56	56	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2011	6	7							e20090	10.1371/journal.pone.0020090	http://dx.doi.org/10.1371/journal.pone.0020090			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	789JO	21750698	Green Submitted, Green Published, gold			2022-12-27	WOS:000292512000005
J	Schosser, A; Butler, AW; Ising, M; Perroud, N; Uher, R; Ng, MY; Cohen-Woods, S; Craddock, N; Owen, MJ; Korszun, A; Jones, L; Jones, I; Gill, M; Rice, JP; Maier, W; Mors, O; Rietschel, M; Lucae, S; Binder, EB; Preisig, M; Perry, J; Tozzi, F; Muglia, P; Aitchison, KJ; Breen, G; Craig, IW; Farmer, AE; Muller-Myhsok, B; McGuffin, P; Lewis, CM				Schosser, Alexandra; Butler, Amy W.; Ising, Marcus; Perroud, Nader; Uher, Rudolf; Ng, Mandy Y.; Cohen-Woods, Sarah; Craddock, Nick; Owen, Michael J.; Korszun, Ania; Jones, Lisa; Jones, Ian; Gill, Michael; Rice, John P.; Maier, Wolfgang; Mors, Ole; Rietschel, Marcella; Lucae, Susanne; Binder, Elisabeth B.; Preisig, Martin; Perry, Julia; Tozzi, Federica; Muglia, Pierandrea; Aitchison, Katherine J.; Breen, Gerome; Craig, Ian W.; Farmer, Anne E.; Mueller-Myhsok, Bertram; McGuffin, Peter; Lewis, Cathryn M.			Genomewide Association Scan of Suicidal Thoughts and Behaviour in Major Depression	PLOS ONE			English	Article							NEUROTROPHIC FACTOR; WIDE ASSOCIATION; POSTMORTEM BRAIN; GENE; LINKAGE; POLYMORPHISMS; DISORDER; EXPRESSION; PHENOTYPE; EPISODES	Background: Suicidal behaviour can be conceptualised as a continuum from suicidal ideation, to suicidal attempts to completed suicide. In this study we identify genes contributing to suicidal behaviour in the depression study RADIANT. Methodology/Principal Findings: A quantitative suicidality score was composed of two items from the SCAN interview. In addition, the 251 depression cases with a history of serious suicide attempts were classified to form a discrete trait. The quantitative trait was correlated with younger onset of depression and number of episodes of depression, but not with gender. A genome-wide association study of 2,023 depression cases was performed to identify genes that may contribute to suicidal behaviour. Two Munich depression studies were used as replication cohorts to test the most strongly associated SNPs. No SNP was associated at genome-wide significance level. For the quantitative trait, evidence of association was detected at GFRA1, a receptor for the neurotrophin GDRA (p = 2e-06). For the discrete trait of suicide attempt, SNPs in KIAA1244 and RGS18 attained p-values of <5e-6. None of these SNPs showed evidence for replication in the additional cohorts tested. Candidate gene analysis provided some support for a polymorphism in NTRK2, which was previously associated with suicidality. Conclusions/Significance: This study provides a genome-wide assessment of possible genetic contribution to suicidal behaviour in depression but indicates a genetic architecture of multiple genes with small effects. Large cohorts will be required to dissect this further.	[Schosser, Alexandra; Butler, Amy W.; Perroud, Nader; Uher, Rudolf; Ng, Mandy Y.; Cohen-Woods, Sarah; Aitchison, Katherine J.; Breen, Gerome; Craig, Ian W.; Farmer, Anne E.; McGuffin, Peter; Lewis, Cathryn M.] Kings Coll London, Inst Psychiat, MRC Social Genet & Dev Psychiat Ctr, London WC2R 2LS, England; [Schosser, Alexandra] Med Univ Vienna, Dept Psychiat & Psychotherapy, Vienna, Austria; [Butler, Amy W.] Univ Hong Kong, Dept Psychiat, Hong Kong, Hong Kong, Peoples R China; [Ising, Marcus; Lucae, Susanne; Binder, Elisabeth B.; Mueller-Myhsok, Bertram] Max Planck Inst Psychiat, D-80804 Munich, Germany; [Perroud, Nader] Univ Geneva, Dept Psychiat, Geneva, Switzerland; [Craddock, Nick; Owen, Michael J.; Jones, Ian] Cardiff Univ, MRC Ctr Neuropsychiat Genet & Genom, Neurosci & Mental Hlth Res Inst, Cardiff, S Glam, Wales; [Korszun, Ania] Queen Mary Univ London, Barts & London Med Sch, London, England; [Jones, Lisa] Univ Birmingham, Dept Psychiat, Neuropharmacol & Neurobiol Sect, Birmingham, W Midlands, England; [Gill, Michael] Trinity Ctr Hlth Sci, Dept Psychiat, Dublin, Ireland; [Rice, John P.] Washington Univ, Dept Psychiat, St Louis, MO USA; [Maier, Wolfgang] Univ Bonn, Dept Psychiat, D-5300 Bonn, Germany; [Mors, Ole] Aarhus Univ Hosp, Ctr Psychiat Res, Risskov, Denmark; [Rietschel, Marcella] Cent Inst Mental Hlth, Div Genet Epidemiol Psychiat, D-6800 Mannheim, Germany; [Preisig, Martin] Univ Lausanne, Lausanne, Switzerland; [Preisig, Martin] Univ Hosp Ctr, Lausanne, Switzerland; [Perry, Julia] GlaxoSmithKline Res & Dev Ltd, Stockley Pk, Middx, England; [Tozzi, Federica; Muglia, Pierandrea] GlaxoSmithKline Res & Dev Ltd, Verona, Italy; [Muglia, Pierandrea] Univ Toronto, Dept Psychiat, Toronto, ON, Canada; [Muglia, Pierandrea] NeuroSearch AS, Ballerup, Denmark; [Breen, Gerome] Kings Coll London, NIHR Biomed Res Ctr Mental Hlth, S London & Maudsley NHS Fdn Trust, London WC2R 2LS, England	University of London; King's College London; Medical University of Vienna; University of Hong Kong; Max Planck Society; University of Geneva; Cardiff University; University of London; Queen Mary University London; University of Birmingham; Trinity College Dublin; Washington University (WUSTL); University of Bonn; Aarhus University; Central Institute of Mental Health; University of Lausanne; GlaxoSmithKline; GlaxoSmithKline; University of Toronto; South London & Maudsley NHS Trust; University of London; King's College London	Schosser, A (corresponding author), Kings Coll London, Inst Psychiat, MRC Social Genet & Dev Psychiat Ctr, London WC2R 2LS, England.	Cathryn.lewis@kcl.ac.uk	McGuffin, Peter/A-1565-2012; Jones, Ian R/B-4925-2009; Lewis, Cathryn M/A-5225-2010; Cohen-Woods, Sarah/F-8674-2014; Muglia, Pierandrea/ABD-9235-2020; Lewis, Cathryn/M-8766-2019; Breen, Gerome/Y-2706-2019; Binder, Elisabeth B/K-8905-2014; Müller-Myhsok, Bertram/A-3289-2013; Breen, Gerome D/A-5540-2010; Ng, Mandy/D-8661-2012; Preisig, Martin/H-3441-2016; Aitchison, Katherine J/G-4476-2013; Cohen-Woods, Sarah/ABF-3768-2021; Tozzi, Federica/AAP-5462-2021; Uher, Rudolf/A-5477-2008; Craig, Ian/AAF-9167-2019	McGuffin, Peter/0000-0002-9888-2907; Jones, Ian R/0000-0001-5821-5889; Lewis, Cathryn M/0000-0002-8249-8476; Muglia, Pierandrea/0000-0002-3973-8606; Lewis, Cathryn/0000-0002-8249-8476; Breen, Gerome/0000-0003-2053-1792; Breen, Gerome D/0000-0003-2053-1792; Aitchison, Katherine J/0000-0002-1107-3024; Tozzi, Federica/0000-0002-3536-2920; Uher, Rudolf/0000-0002-2998-0546; Cohen-Woods, Sarah/0000-0003-2199-6129; Jones, Lisa/0000-0002-5122-8334; Preisig, Martin/0000-0001-5689-4259; Gill, Michael/0000-0003-0206-5337; Craig, Ian/0000-0002-4063-1005; Mors, Ole/0000-0002-5660-0393	Medical Research Council, UK; GlaxoSmithKline [G0701420]; Austrian Science Funds [J2647]; NIHR Biomedical Research Centre for Mental Health at the South London; Maudsley NHS Foundation Trust; Institute of Psychiatry, King's College London; European Commission [LSHB-CT-2003-503428]; German Federal Ministry of Education and Research (BMBF) [01ES0811, 01KG0709]; Bavarian Ministry of Commerce; Excellence Foundation for the Advancement of the Max Planck Society; German Federal Ministry of Education and Research within German National Genome Research Network; Johnson & Johnson Pharmaceutical Research Development; Bristol-Myers Squibb Pharmaceuticals Limited; E Merck Pharmaceuticals; PharmaNeuroboost; Medical Research Council [G0701003, G0801418B, G9817803B] Funding Source: researchfish; MRC [G0701003] Funding Source: UKRI	Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); GlaxoSmithKline(GlaxoSmithKline); Austrian Science Funds(Austrian Science Fund (FWF)); NIHR Biomedical Research Centre for Mental Health at the South London(National Institute for Health Research (NIHR)); Maudsley NHS Foundation Trust; Institute of Psychiatry, King's College London; European Commission(European CommissionEuropean Commission Joint Research Centre); German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Bavarian Ministry of Commerce; Excellence Foundation for the Advancement of the Max Planck Society; German Federal Ministry of Education and Research within German National Genome Research Network; Johnson & Johnson Pharmaceutical Research Development(Johnson & JohnsonJohnson & Johnson USA); Bristol-Myers Squibb Pharmaceuticals Limited(Bristol-Myers Squibb); E Merck Pharmaceuticals; PharmaNeuroboost; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by a joint grant from the Medical Research Council, UK and GlaxoSmithKline [G0701420]; by Erwin-Schroedinger Fellowship [J2647] of the Austrian Science Funds (to AS), by financial support from the NIHR Biomedical Research Centre for Mental Health at the South London and Maudsley NHS Foundation Trust and Institute of Psychiatry, King's College London. The GENDEP study was funded by a European Commission Framework 6 grant, EC Contract Ref.: LSHB-CT-2003-503428. The MARS project is funded by the German Federal Ministry of Education and Research (BMBF, project no. 01ES0811 and 01KG0709), and genomewide genotyping was supported by the Bavarian Ministry of Commerce and by the Excellence Foundation for the Advancement of the Max Planck Society. This work was also supported by the German Federal Ministry of Education and Research within the context of the German National Genome Research Network (NGFN-2 and NGFN-plus). These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. GlaxoSmithKline funded the collection of the DeNt cohort of depression cases, the genotyping of all RADIANT cases (with the MRC), and both the collection and genotyping of the GSK-Munich cohort of depression cases. Authors JP, PM and FT are, or were, employees of GlaxoSmithKline when that research was performed, and helped with analysis.; Aitchison, Farmer and McGuffin have received consultancy fees and honoraria for participating in expert panels for pharmaceutical companies, including GlaxoSmithKline. Aitchison declares interests through Advisory Boards for Johnson & Johnson, Lundbeck, Roche Diagnostics, and Bristol-Myers Squibb; membership of Bristol-Myers Squibb UK Steering group 2003 to present; consultancy work for Roche Diagnostics, Johnson & Johnson Pharmaceutical Research and Development, Lundbeck, and Bristol-Myers Squibb Pharmaceuticals Limited; grants awarded by Johnson & Johnson Pharmaceutical Research & Development, Bristol-Myers Squibb Pharmaceuticals Limited, and E Merck Pharmaceuticals. Souery is involved in advisory boards for Astra Zeneca, Eli Lilly, BMS, Janssen-Cilag and Lundbeck. Perry is an employee of GlaxoSmithKline; Muglia and Tozzi were employees of GlaxoSmithKline when the research was performed. Henigsberg has participated in clinical trials sponsored by pharmaceutical companies including GlaxoSmithKline, and Lundbeck and has received honoraria for participating in expert panels for pharmaceutical companies including Lundbeck. Ising has received consultancy honoraria from MSD Merck. Binder has received grant support from PharmaNeuroboost. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials, as detailed online in the guide for authors. All other authors (Schosser, Butler, Perroud, Uher, Ng, Cohen-Woods, Craddock, Owen Korszun, Jones I, Jones L, Gill, Rice, Hauser, Maier, Zobel, Mors, Placentino, Rietschel, Souery, Kozel, Lucae, Preisig, Breen, Craig, Muller-Myhsok, and Lewis) declare no conflicts of interest.	Arsenault-Lapierre G, 2004, BMC PSYCHIATRY, V4, DOI 10.1186/1471-244X-4-37; Binder EB, 2004, NAT GENET, V36, P1319, DOI 10.1038/ng1479; Bondy B, 2006, MOL PSYCHIATR, V11, P336, DOI 10.1038/sj.mp.4001803; Brent DA, 2005, AM J MED GENET C, V133C, P13, DOI 10.1002/ajmg.c.30042; Brezo J, 2008, PSYCHIAT CLIN N AM, V31, P179, DOI 10.1016/j.psc.2008.01.008; Chen PS, 2006, MOL PSYCHIATR, V11, P1116, DOI 10.1038/sj.mp.4001893; Cohen-Woods S, 2009, HUM MOL GENET, V18, P1504, DOI 10.1093/hmg/ddp051; Courtet P, 2005, AM J MED GENET C, V133C, P25, DOI 10.1002/ajmg.c.30043; Cui H, 2008, NEUROPSYCHOPHARMACOL, V33, P1537, DOI 10.1038/sj.npp.1301557; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Dudbridge F, 2008, GENET EPIDEMIOL, V32, P227, DOI 10.1002/gepi.20297; Dwivedi Y, 2003, ARCH GEN PSYCHIAT, V60, P804, DOI 10.1001/archpsyc.60.8.804; Farmer A, 2004, BMC PSYCHIATRY, V4, DOI 10.1186/1471-244X-4-42; Fu Q, 2002, PSYCHOL MED, V32, P11, DOI 10.1017/S0033291701004846; Kim B, 2008, NEUROPSYCHOBIOLOGY, V58, P97, DOI 10.1159/000162356; Kohli MA, 2010, ARCH GEN PSYCHIAT, V67, P348, DOI 10.1001/archgenpsychiatry.2009.201; Kunzel HE, 2003, NEUROPSYCHOPHARMACOL, V28, P2169, DOI 10.1038/sj.npp.1300280; Laje G, 2009, PHARMACOGENET GENOM, V19, P666, DOI 10.1097/FPC.0b013e32832e4bcd; Lavedan C, 2009, MOL PSYCHIATR, V14, P804, DOI 10.1038/mp.2008.56; Lewis CM, 2010, AM J PSYCHIAT, V167, P949, DOI 10.1176/appi.ajp.2010.09091380; Li J, 2005, HEREDITY, V95, P221, DOI 10.1038/sj.hdy.6800717; Mann JJ, 2002, ANN INTERN MED, V136, P302, DOI 10.7326/0003-4819-136-4-200202190-00010; McGuffin P, 2005, HUM MOL GENET, V14, P3337, DOI 10.1093/hmg/ddi363; McGuffin P, 2001, Crisis, V22, P61, DOI 10.1027//0227-5910.22.2.61; Michel TM, 2008, EUR PSYCHIAT, V23, P413, DOI 10.1016/j.eurpsy.2008.06.001; Muglia P, 2010, MOL PSYCHIATR, V15, P589, DOI 10.1038/mp.2008.131; Nyholt DR, 2004, AM J HUM GENET, V74, P765, DOI 10.1086/383251; Otsuki K, 2008, J PSYCHIATR RES, V42, P1145, DOI 10.1016/j.jpsychires.2008.01.010; Perlis RH, 2010, AM J PSYCHIAT, V167, P1499, DOI 10.1176/appi.ajp.2010.10040541; Perroud N., 2010, PHARMACOGENOMICS J; Perroud N, 2010, J AFFECT DISORDERS, V123, P131, DOI 10.1016/j.jad.2009.09.001; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2003, BIOINFORMATICS, V19, P149, DOI 10.1093/bioinformatics/19.1.149; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rosa AR, 2006, NEUROSCI LETT, V407, P146, DOI 10.1016/j.neulet.2006.08.026; ROY A, 1991, ARCH GEN PSYCHIAT, V48, P29; Rush AJ, 2004, CONTROL CLIN TRIALS, V25, P119, DOI 10.1016/S0197-2456(03)00112-0; Shindo S, 2005, FORENSIC SCI INT, V150, P85, DOI 10.1016/j.forsciint.2004.10.001; Suominen K, 2004, AM J PSYCHIAT, V161, P562, DOI 10.1176/appi.ajp.161.3.562; Turecki G, 2005, J PSYCHIATR NEUROSCI, V30, P398; Uher R, 2010, AM J PSYCHIAT, V167, P1425, DOI 10.1176/appi.ajp.2010.10081227; Wasserman Danuta, 2006, Behav Brain Funct, V2, P14, DOI 10.1186/1744-9081-2-14; WING JK, 1990, ARCH GEN PSYCHIAT, V47, P589	43	81	83	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2011	6	7							e20690	10.1371/journal.pone.0020690	http://dx.doi.org/10.1371/journal.pone.0020690			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	789JO	21750702	Green Accepted, Green Published			2022-12-27	WOS:000292512000008
J	Follo, C; Ozzano, M; Mugoni, V; Castino, R; Santoro, M; Isidoro, C				Follo, Carlo; Ozzano, Matteo; Mugoni, Vera; Castino, Roberta; Santoro, Massimo; Isidoro, Ciro			Knock-Down of Cathepsin D Affects the Retinal Pigment Epithelium, Impairs Swim-Bladder Ontogenesis and Causes Premature Death in Zebrafish	PLOS ONE			English	Article							D-DEFICIENT MICE; GENE-EXPRESSION; CELL-DEATH; EMBRYONIC-DEVELOPMENT; PROTEOMIC ANALYSIS; LYSOSOMAL STORAGE; OVARIAN-FOLLICLE; YOLK FORMATION; PROCATHEPSIN-D; TNF-ALPHA	The lysosomal aspartic protease Cathepsin D (CD) is ubiquitously expressed in eukaryotic organisms. CD activity is essential to accomplish the acid-dependent extensive or partial proteolysis of protein substrates within endosomal and lysosomal compartments therein delivered via endocytosis, phagocytosis or autophagocytosis. CD may also act at physiological pH on small-size substrates in the cytosol and in the extracellular milieu. Mouse and fruit fly CD knock-out models have highlighted the multi-pathophysiological roles of CD in tissue homeostasis and organ development. Here we report the first phenotypic description of the lack of CD expression during zebrafish (Danio rerio) development obtained by morpholino-mediated knock-down of CD mRNA. Since the un-fertilized eggs were shown to be supplied with maternal CD mRNA, only a morpholino targeting a sequence containing the starting ATG codon was effective. The main phenotypic alterations produced by CD knock-down in zebrafish were: 1. abnormal development of the eye and of retinal pigment epithelium; 2. absence of the swim-bladder; 3. skin hyper-pigmentation; 4. reduced growth and premature death. Rescue experiments confirmed the involvement of CD in the developmental processes leading to these phenotypic alterations. Our findings add to the list of CD functions in organ development and patho-physiology in vertebrates.	[Follo, Carlo; Ozzano, Matteo; Castino, Roberta; Isidoro, Ciro] Univ Piemonte Orientale, Dipartimento Sci Med, Lab Patol Mol, Novara, Italy; [Follo, Carlo; Ozzano, Matteo; Castino, Roberta; Isidoro, Ciro] Univ Piemonte Orientale, Ctr Biotecnol Ric Med Applicata, Novara, Italy; [Mugoni, Vera; Santoro, Massimo] Univ Turin, Ctr Mol Biotechnol, Turin, Italy	University of Eastern Piedmont Amedeo Avogadro; University of Eastern Piedmont Amedeo Avogadro; University of Turin	Follo, C (corresponding author), Univ Piemonte Orientale, Dipartimento Sci Med, Lab Patol Mol, Novara, Italy.	isidoro@med.unipmn.it	Isidoro, Ciro/J-6063-2016	Isidoro, Ciro/0000-0002-5494-3034; SANTORO, Massimo Mattia/0000-0003-4605-5085; Follo, Carlo/0000-0001-9711-2655				Abbott DE, 2010, CANCER BIOL THER, V9, P23, DOI 10.4161/cbt.9.1.10378; ADLER AJ, 1989, EXP EYE RES, V49, P1067, DOI 10.1016/S0014-4835(89)80027-2; Awano T, 2006, MOL GENET METAB, V87, P341, DOI 10.1016/j.ymgme.2005.11.005; BALDWIN ET, 1993, P NATL ACAD SCI USA, V90, P6796, DOI 10.1073/pnas.90.14.6796; Barrett A.J., 2008, CIBA F SYMP, V15, P37, DOI [10.1002/9780470720585.ch3, DOI 10.1002/9780470720585.CH3]; Bidere N, 2003, J BIOL CHEM, V278, P31401, DOI 10.1074/jbc.M301911200; Capasso C, 1999, BBA-PROTEIN STRUCT M, V1431, P64, DOI 10.1016/S0167-4838(99)00039-4; Carnevali O, 2006, GEN COMP ENDOCR, V146, P195, DOI 10.1016/j.ygcen.2005.12.007; Carnevali O, 1999, BIOL REPROD, V60, P140, DOI 10.1095/biolreprod60.1.140; Castino R, 2008, ENDOCRINOLOGY, V149, P4095, DOI 10.1210/en.2008-0249; Castino R, 2007, FREE RADICAL BIO MED, V42, P1305, DOI 10.1016/j.freeradbiomed.2006.12.030; Chen H, 2009, INVEST OPHTH VIS SCI, V50, P1895, DOI 10.1167/iovs.08-2850; Cheng AL, 2008, J PROTEOME RES, V7, P2415, DOI 10.1021/pr7008548; Deiss LP, 1996, EMBO J, V15, P3861, DOI 10.1002/j.1460-2075.1996.tb00760.x; Demoz M, 2006, PROTEIN EXPRES PURIF, V45, P157, DOI 10.1016/j.pep.2005.07.024; Demoz M, 2002, BIOL CHEM, V383, P1237, DOI 10.1515/BC.2002.137; Erdmann S, 2007, AM J PHYSIOL-ENDOC M, V293, pE1365, DOI 10.1152/ajpendo.00280.2007; Follo C, 2008, BIOTECHNOL APPL BIOC, V49, P175, DOI 10.1042/BA20070045; Follo C, 2007, INT J BIOCHEM CELL B, V39, P638, DOI 10.1016/j.biocel.2006.11.010; GEISLER R, 2008, DEVELOPMENT, V135, P387; GIESELMANN V, 1983, J CELL BIOL, V97, P1, DOI 10.1083/jcb.97.1.1; Handley CJ, 2001, MATRIX BIOL, V20, P543, DOI 10.1016/S0945-053X(01)00168-8; Hiramatsu N, 2002, J EXP ZOOL, V292, P11, DOI 10.1002/jez.1138; Hu L, 2008, CANCER RES, V68, P4666, DOI 10.1158/0008-5472.CAN-07-6276; Isidoro C, 1995, INT J CANCER, V63, P866, DOI 10.1002/ijc.2910630619; ISIDORO C, 1991, BIOCHEM J, V273, P363, DOI 10.1042/bj2730363; Jensen AM, 2004, CURR BIOL, V14, P711, DOI 10.1016/j.cub.2004.04.006; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Knoll-Gellida A, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-46; Kociok N, 2007, GRAEF ARCH CLIN EXP, V245, P101, DOI 10.1007/s00417-006-0266-x; Koike M, 2003, MOL CELL NEUROSCI, V22, P146, DOI 10.1016/S1044-7431(03)00035-6; Koike M, 2000, J NEUROSCI, V20, P6898, DOI 10.1523/JNEUROSCI.20-18-06898.2000; Krohne TU, 2010, EXP EYE RES, V90, P261, DOI 10.1016/j.exer.2009.10.014; Kwon JY, 2001, BIOL REPROD, V65, P1701, DOI 10.1095/biolreprod65.6.1701; Lee AY, 1998, NAT STRUCT BIOL, V5, P866, DOI 10.1038/2306; Li G, 2009, PROTEOMICS, V9, P20, DOI 10.1002/pmic.200701195; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lkhider M, 2004, J CELL SCI, V117, P5155, DOI 10.1242/jcs.01396; Maldonado E, 2006, PIGM CELL RES, V19, P315, DOI 10.1111/j.1600-0749.2006.00320.x; Margaryan NV, 2010, CANCER BIOL THER, V10, DOI 10.4161/cbt.10.5.12534; Minazaki CK, 2008, RES VET SCI, V84, P326, DOI 10.1016/j.rvsc.2007.06.013; MORRISON RL, 1991, J MORPHOL, V209, P229, DOI 10.1002/jmor.1052090209; Myllykangas L, 2005, NEUROBIOL DIS, V19, P194, DOI 10.1016/j.nbd.2004.12.019; Nakamura K, 1996, COMP BIOCHEM PHYS B, V113, P835, DOI 10.1016/0305-0491(95)02102-7; Nakanishi H, 2001, J NEUROSCI, V21, P7526, DOI 10.1523/JNEUROSCI.21-19-07526.2001; Nicotra G, 2010, CANCER BIOMARK, V7, P47, DOI 10.3233/CBM-2010-0143; Nielsen LB, 2001, COMP BIOCHEM PHYS B, V128, P351, DOI 10.1016/S1096-4959(00)00332-8; Nixon SJ, 2005, HUM MOL GENET, V14, P1727, DOI 10.1093/hmg/ddi179; Nuckels RJ, 2009, INVEST OPHTH VIS SCI, V50, P893, DOI 10.1167/iovs.08-2743; Parichy DM, 2009, DEV DYNAM, V238, P2975, DOI 10.1002/dvdy.22113; Rakoczy PE, 2002, AM J PATHOL, V161, P1515, DOI 10.1016/S0002-9440(10)64427-6; RAYMOND SM, 1995, CURR BIOL, V5, P1286, DOI 10.1016/S0960-9822(95)00255-7; RETZEK H, 1992, DNA CELL BIOL, V11, P661, DOI 10.1089/dna.1992.11.661; ROUGHLEY PJ, 1977, BIOCHEM J, V167, P639, DOI 10.1042/bj1670639; Rubinstein AL, 2003, CURR OPIN DRUG DI DE, V6, P218; Sabaliauskas NA, 2006, METHODS, V39, P246, DOI 10.1016/j.ymeth.2006.03.001; Sadler KC, 2005, DEVELOPMENT, V132, P3561, DOI 10.1242/dev.01918; SAFTIG P, 1995, EMBO J, V14, P3599, DOI 10.1002/j.1460-2075.1995.tb00029.x; Santoro MM, 2007, NAT GENET, V39, P1397, DOI 10.1038/ng.2007.8; Schonthaler HB, 2008, DEVELOPMENT, V135, P387, DOI 10.1242/dev.006098; SCOTT PG, 1981, EUR J BIOCHEM, V114, P59; Stalmans I, 2003, NAT MED, V9, P173, DOI 10.1038/nm819; Strauss O, 2005, PHYSIOL REV, V85, P845, DOI 10.1152/physrev.00021.2004; TANG J, 1987, J CELL BIOCHEM, V33, P53, DOI 10.1002/jcb.240330106; Tyynela J, 2000, EMBO J, V19, P2786, DOI 10.1093/emboj/19.12.2786; Tyynela J, 2001, Eur J Paediatr Neurol, V5 Suppl A, P43, DOI 10.1053/ejpn.2000.0433; Vashishta Aruna, 2009, Endocrine Metabolic & Immune Disorders-Drug Targets, V9, P385; Wallace R A, 1985, Dev Biol (N Y 1985), V1, P127; Workman P, 1998, BRIT J CANCER, V77, P1; Yoshizaki N, 2004, DEV GROWTH DIFFER, V46, P229, DOI 10.1111/j.1440-169X.2004.00740.x; Zhong TP, 2000, SCIENCE, V287, P1820, DOI 10.1126/science.287.5459.1820; Zuzarte-Luis V, 2007, DEV DYNAM, V236, P880, DOI 10.1002/dvdy.21076	72	31	38	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2011	6	7							e21908	10.1371/journal.pone.0021908	http://dx.doi.org/10.1371/journal.pone.0021908			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786HC	21747967	Green Published, gold, Green Submitted			2022-12-27	WOS:000292293400043
J	Prunetti, L; Brugna, M; Lebrun, R; Giudici-Orticoni, MT; Guiral, M				Prunetti, Laurence; Brugna, Myriam; Lebrun, Regine; Giudici-Orticoni, Marie-Therese; Guiral, Marianne			The Elusive Third Subunit IIa of the Bacterial B-Type Oxidases: The Enzyme from the Hyperthermophile Aquifex aeolicus	PLOS ONE			English	Article							CYTOCHROME B(6)F COMPLEX; OPEN READING FRAME; THERMUS-THERMOPHILUS; C-OXIDASE; BACILLUS-STEAROTHERMOPHILUS; NATRONOBACTERIUM-PHARAONIS; RESPIRATORY-CHAIN; TERMINAL OXIDASES; OXYGEN REDUCTASE; BA(3) OXIDASE	The reduction of molecular oxygen to water is catalyzed by complicated membrane-bound metallo-enzymes containing variable numbers of subunits, called cytochrome c oxidases or quinol oxidases. We previously described the cytochrome c oxidase II from the hyperthermophilic bacterium Aquifex aeolicus as a ba(3)-type two-subunit (subunits I and II) enzyme and showed that it is included in a supercomplex involved in the sulfide-oxygen respiration pathway. It belongs to the B-family of the heme-copper oxidases, enzymes that are far less studied than the ones from family A. Here, we describe the presence in this enzyme of an additional transmembrane helix "subunit IIa", which is composed of 41 amino acid residues with a measured molecular mass of 5105 Da. Moreover, we show that subunit II, as expected, is in fact longer than the originally annotated protein (from the genome) and contains a transmembrane domain. Using Aquifex aeolicus genomic sequence analyses, N-terminal sequencing, peptide mass fingerprinting and mass spectrometry analysis on entire subunits, we conclude that the B-type enzyme from this bacterium is a three-subunit complex. It is composed of subunit I (encoded by coxA(2)) of 59000 Da, subunit II (encoded by coxB(2)) of 16700 Da and subunit IIa which contain 12, 1 and 1 transmembrane helices respectively. A structural model indicates that the structural organization of the complex strongly resembles that of the ba(3) cytochrome c oxidase from the bacterium Thermus thermophilus, the IIa helical subunit being structurally the lacking N-terminal transmembrane helix of subunit II present in the A-type oxidases. Analysis of the genomic context of genes encoding oxidases indicates that this third subunit is present in many of the bacterial oxidases from B-family, enzymes that have been described as two-subunit complexes.	[Prunetti, Laurence; Brugna, Myriam; Giudici-Orticoni, Marie-Therese; Guiral, Marianne] CNRS, Lab Bioenerget & Ingn Prot, UPR 9036, Inst Microbiol Mediterranee IFR88, Marseille, France; [Brugna, Myriam] Univ Aix Marseille 1, Marseille, France; [Lebrun, Regine] CNRS, Plate Forme Prot IFR88, Marseille, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS)	Prunetti, L (corresponding author), CNRS, Lab Bioenerget & Ingn Prot, UPR 9036, Inst Microbiol Mediterranee IFR88, Marseille, France.	guiral@ifr88.cnrs-mrs.fr		BRUGNA, Myriam/0000-0002-4017-3294	CNRS; Region-Provence-Alpes Cote d'Azur; French Ministry of Research (Ministere de l'Enseignement Superieur et de la Recherche)	CNRS(Centre National de la Recherche Scientifique (CNRS)); Region-Provence-Alpes Cote d'Azur(Region Provence-Alpes-Cote d'Azur); French Ministry of Research (Ministere de l'Enseignement Superieur et de la Recherche)(Ministry of Research, France)	This work was financially supported by the CNRS and the Region-Provence-Alpes Cote d'Azur. L. Prunetti had a fellowship of the French Ministry of Research (Ministere de l'Enseignement Superieur et de la Recherche). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; BERTHOLD DA, 1995, J BIOL CHEM, V270, P29293, DOI 10.1074/jbc.270.49.29293; Brochier-Armanet C, 2009, MOL BIOL EVOL, V26, P285, DOI 10.1093/molbev/msn246; Deckert G, 1998, NATURE, V392, P353, DOI 10.1038/32831; Ducluzeau A. L., 2009, THESIS U PROVENCE MA; Ducluzeau AL, 2009, TRENDS BIOCHEM SCI, V34, P9, DOI 10.1016/j.tibs.2008.10.005; Falb M, 2005, GENOME RES, V15, P1336, DOI 10.1101/gr.3952905; GARCIAHORSMAN JA, 1994, J BACTERIOL, V176, P5587, DOI 10.1128/JB.176.18.5587-5600.1994; Giuffre A, 1999, BIOCHEMISTRY-US, V38, P1057, DOI 10.1021/bi9815389; Guiral M, 2009, J PROTEOME RES, V8, P1717, DOI 10.1021/pr8007946; Hager M, 1999, EMBO J, V18, P5834, DOI 10.1093/emboj/18.21.5834; Hemp James, 2008, V45, P1, DOI 10.1007/400_2007_046; Hunsicker-Wang LM, 2005, ACTA CRYSTALLOGR D, V61, P340, DOI 10.1107/S0907444904033906; Ishikawa R, 2002, ARCH MICROBIOL, V179, P42, DOI 10.1007/s00203-002-0496-1; Janzon J, 2007, IUBMB LIFE, V59, P563, DOI 10.1080/15216540701242482; KEIGHTLEY JA, 1995, J BIOL CHEM, V270, P20345, DOI 10.1074/jbc.270.35.20345; LUBBEN M, 1994, MOL MICROBIOL, V13, P327, DOI 10.1111/j.1365-2958.1994.tb00426.x; LUBBEN M, 1994, J BIOL CHEM, V269, P21473; Mattar S, 1997, EUR J BIOCHEM, V250, P332, DOI 10.1111/j.1432-1033.1997.0332a.x; Nikaido K, 2000, BBA-BIOENERGETICS, V1456, P35, DOI 10.1016/S0005-2728(99)00102-4; Nikaido K, 1998, BBA-GENE STRUCT EXPR, V1397, P262, DOI 10.1016/S0167-4781(98)00043-8; Nowaczyk MM, 2011, BIOCHEMISTRY-US, V50, P1121, DOI 10.1021/bi102044b; Nunoura T, 2003, MICROBIOL-SGM, V149, P673, DOI 10.1099/mic.0.26000-0; Otten MF, 2001, EUR J BIOCHEM, V268, P2486, DOI 10.1046/j.1432-1327.2001.02131.x; Pereira MM, 2001, BBA-BIOENERGETICS, V1505, P185, DOI 10.1016/S0005-2728(01)00169-4; Prunetti L, 2010, J BIOL CHEM, V285, P41815, DOI 10.1074/jbc.M110.167841; Rodgers S, 2000, EUR J BIOCHEM, V267, P3753, DOI 10.1046/j.1432-1327.2000.01411.x; Schagger H, 2006, NAT PROTOC, V1, P16, DOI 10.1038/nprot.2006.4; Scharf B, 1997, BIOCHEMISTRY-US, V36, P4471, DOI 10.1021/bi962312d; Schutz M, 2000, J MOL BIOL, V300, P663, DOI 10.1006/jmbi.2000.3915; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Shi LX, 2004, BBA-BIOENERGETICS, V1608, P75, DOI 10.1016/j.bbabio.2003.12.004; Snel B, 2000, TRENDS GENET, V16, P9, DOI 10.1016/S0168-9525(99)01924-1; Soulimane T, 2000, EMBO J, V19, P1766, DOI 10.1093/emboj/19.8.1766; Soulimane T, 1997, BIOCHEM BIOPH RES CO, V237, P572, DOI 10.1006/bbrc.1997.7041; Soulimane T, 2000, PROTEIN SCI, V9, P2068, DOI 10.1110/ps.9.11.2068; Takahashi Y, 1996, EMBO J, V15, P3498, DOI 10.1002/j.1460-2075.1996.tb00718.x; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Verissimo AF, 2007, FEMS MICROBIOL LETT, V269, P41, DOI 10.1111/j.1574-6968.2006.00598.x; Zickermann V, 2010, FEBS LETT, V584, P2516, DOI 10.1016/j.febslet.2010.04.021; ZIMMERMANN BH, 1988, P NATL ACAD SCI USA, V85, P5779, DOI 10.1073/pnas.85.16.5779	41	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2011	6	6							e21616	10.1371/journal.pone.0021616	http://dx.doi.org/10.1371/journal.pone.0021616			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786GP	21738733	gold, Green Published, Green Submitted			2022-12-27	WOS:000292291800027
J	Han, WH; Takamatsu, Y; Yamamoto, H; Kasai, S; Endo, S; Shirao, T; Kojima, N; Ikeda, K				Han, Wenhua; Takamatsu, Yukio; Yamamoto, Hideko; Kasai, Shinya; Endo, Shogo; Shirao, Tomoaki; Kojima, Nobuhiko; Ikeda, Kazutaka			Inhibitory Role of Inducible cAMP Early Repressor (ICER) in Methamphetamine-Induced Locomotor Sensitization	PLOS ONE			English	Article							AMPHETAMINE-REGULATED TRANSCRIPT; ELEMENT-BINDING PROTEIN; CART MESSENGER-RNA; NUCLEUS-ACCUMBENS; BEHAVIORAL SENSITIZATION; GENE-EXPRESSION; COCAINE REWARD; CREB ACTIVITY; PEPTIDE; DOPAMINE	Background: The inducible cyclic adenosine monophosphate (cAMP) early repressor (ICER) is highly expressed in the central nervous system and functions as a repressor of cAMP response element-binding protein (CREB) transcription. The present study sought to clarify the role of ICER in the effects of methamphetamine (METH). Methods and Findings: We tested METH-induced locomotor sensitization in wildtype mice, ICER knockout mice, and ICER I-overexpressing mice. Both ICER wildtype mice and knockout mice displayed increased locomotor activity after continuous injections of METH. However, ICER knockout mice displayed a tendency toward higher locomotor activity compared with wildtype mice, although no significant difference was observed between the two genotypes. Moreover, compared with wildtype mice, ICER I-overexpressing mice displayed a significant decrease in METH-induced locomotor sensitization. Furthermore, Western blot analysis and quantitative real-time reverse transcription polymerase chain reaction demonstrated that ICER overexpression abolished the METH-induced increase in CREB expression and repressed cocaine- and amphetamine-regulated transcript (CART) and prodynorphin (Pdyn) expression in mice. The decreased CART and Pdyn mRNA expression levels in vivo may underlie the inhibitory role of ICER in METH-induced locomotor sensitization. Conclusions: Our data suggest that ICER plays an inhibitory role in METH-induced locomotor sensitization.	[Han, Wenhua; Takamatsu, Yukio; Yamamoto, Hideko; Kasai, Shinya; Ikeda, Kazutaka] Tokyo Metropolitan Inst Med Sci, Res Project Addict Subst, Tokyo 113, Japan; [Endo, Shogo; Kojima, Nobuhiko] Tokyo Metropolitan Inst Gerontol, Tokyo, Japan; [Shirao, Tomoaki; Kojima, Nobuhiko] Gunma Univ, Dept Neurobiol & Behav, Grad Sch Med, Maebashi, Gunma 371, Japan; [Kojima, Nobuhiko] RIKEN, Brain Sci Inst, Lab Neurobiol Emot, Wako, Saitama, Japan	Tokyo Metropolitan Institute of Medical Science; Tokyo Metropolitan Institute of Gerontology; Gunma University; RIKEN	Han, WH (corresponding author), Tokyo Metropolitan Inst Med Sci, Res Project Addict Subst, Bunkyo Ku, Tokyo 113, Japan.	nkojima@med.gunma-u.ac.jp	Ikeda, Kazutaka/I-4694-2013; Shirao, Tomoaki/I-9257-2016	Ikeda, Kazutaka/0000-0001-8342-0278; Shirao, Tomoaki/0000-0003-4323-028X	Ministry of Education, Science, Sports and Culture of Japan [17025054, 19659405, 20390162]; Ministry of Health, Labour and Welfare of Japan [H17-pharmaco-001, H19-iyaku-023, 19A-8]; Naito Foundation	Ministry of Education, Science, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Naito Foundation(Naito Memorial Foundation)	This work was supported by research grants from the Ministry of Education, Science, Sports and Culture of Japan (17025054, 19659405, 20390162), the Ministry of Health, Labour and Welfare of Japan (H17-pharmaco-001, H19-iyaku-023, 19A-8 for Nervous and Mental Disorders), and the Naito Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrot M, 2002, P NATL ACAD SCI USA, V99, P11435, DOI 10.1073/pnas.172091899; Bilbao A, 2008, P NATL ACAD SCI USA, V105, P17549, DOI 10.1073/pnas.0803959105; Carlezon WA, 1998, SCIENCE, V282, P2272, DOI 10.1126/science.282.5397.2272; Carlezon WA, 2005, TRENDS NEUROSCI, V28, P436, DOI 10.1016/j.tins.2005.06.005; Chefer VI, 2006, EUR J NEUROSCI, V23, P229, DOI 10.1111/j.1460-9568.2005.04525.x; COLE RL, 1995, NEURON, V14, P813, DOI 10.1016/0896-6273(95)90225-2; Couceyro PR, 2005, J PHARMACOL EXP THER, V315, P1091, DOI 10.1124/jpet.105.091678; Dallvechia-Adams S, 2002, J COMP NEUROL, V448, P360, DOI 10.1002/cne.10268; DiRocco DP, 2009, J NEUROSCI, V29, P2393, DOI 10.1523/JNEUROSCI.4356-08.2009; Dominguez G, 2004, MOL BRAIN RES, V126, P22, DOI 10.1016/j.molbrainres.2004.02.027; Dominguez G, 2002, J NEUROCHEM, V80, P885, DOI 10.1046/j.0022-3042.2002.00775.x; DOUGLASS J, 1995, J NEUROSCI, V15, P2471; Fagergren P, 1999, NEUROREPORT, V10, P3449, DOI 10.1097/00001756-199911080-00034; Fasano S, 2009, FRONT BEHAV NEUROSCI, V3, DOI 10.3389/neuro.08.029.2009; Fukushima S, 2007, PSYCHOPHARMACOLOGY, V193, P55, DOI 10.1007/s00213-007-0749-4; Green TA, 2006, J NEUROSCI, V26, P8235, DOI 10.1523/JNEUROSCI.0880-06.2006; Hubert GW, 2006, NEUROPEPTIDES, V40, P409, DOI 10.1016/j.npep.2006.09.001; Hunter RG, 2005, BRAIN RES, V1048, P12, DOI 10.1016/j.brainres.2005.04.032; Jaworski J, 2003, J NEUROSCI, V23, P4519; Jaworski JN, 2008, BEHAV BRAIN RES, V191, P266, DOI 10.1016/j.bbr.2008.03.039; Kim S, 2007, REGUL PEPTIDES, V144, P6, DOI 10.1016/j.regpep.2007.07.003; Kojima N, 2008, J NEUROSCI, V28, P6459, DOI 10.1523/JNEUROSCI.0412-08.2008; Kreibich AS, 2004, J NEUROSCI, V24, P6686, DOI 10.1523/JNEUROSCI.1706-04.2004; Maiya R, 2009, P NATL ACAD SCI USA, V106, P1983, DOI 10.1073/pnas.0812491106; Maldonado R, 1996, SCIENCE, V273, P657, DOI 10.1126/science.273.5275.657; Marie-Claire C, 2003, NEUROSCI LETT, V345, P77, DOI 10.1016/S0304-3940(03)00307-0; McClung CA, 2003, NAT NEUROSCI, V6, P1208, DOI 10.1038/nn1143; Mioduszewska B, 2003, J NEUROCHEM, V87, P1313, DOI 10.1046/j.1471-4159.2003.02116.x; MOLINA CA, 1993, CELL, V75, P875, DOI 10.1016/0092-8674(93)90532-U; Pierce RC, 1997, BRAIN RES REV, V25, P192, DOI 10.1016/S0165-0173(97)00021-0; Pliakas AM, 2001, J NEUROSCI, V21, P7397, DOI 10.1523/JNEUROSCI.21-18-07397.2001; ROBINSON TE, 1986, BRAIN RES REV, V11, P157, DOI 10.1016/0165-0173(86)90002-0; Rogge GA, 2009, BRAIN RES, V1251, P42, DOI 10.1016/j.brainres.2008.11.011; Sakai N, 2002, MOL PHARMACOL, V61, P1453, DOI 10.1124/mol.61.6.1453; Shippenberg TS, 2007, PHARMACOL THERAPEUT, V116, P306, DOI 10.1016/j.pharmthera.2007.06.011; SPANAGEL R, 1992, P NATL ACAD SCI USA, V89, P2046, DOI 10.1073/pnas.89.6.2046; SPANGLER R, 1993, MOL BRAIN RES, V19, P323, DOI 10.1016/0169-328X(93)90133-A; SPIESS J, 1980, BIOCHEMISTRY-US, V19, P2861, DOI 10.1021/bi00554a007; STEWART J, 1993, BEHAV PHARMACOL, V4, P289; Tinti C, 1996, J BIOL CHEM, V271, P25375, DOI 10.1074/jbc.271.41.25375; Turgeon SM, 1997, BRAIN RES, V749, P120, DOI 10.1016/S0006-8993(96)01316-9; Valverde O, 2004, NEUROPSYCHOPHARMACOL, V29, P1122, DOI 10.1038/sj.npp.1300416; Vicentic A, 2007, J PHARMACOL EXP THER, V320, P499, DOI 10.1124/jpet.105.091512; Vrang N, 2002, NEUROREPORT, V13, P1215, DOI 10.1097/00001756-200207020-00029; Walters CL, 2001, J NEUROSCI, V21, P9438, DOI 10.1523/JNEUROSCI.21-23-09438.2001; WIDNELL KL, 1994, P NATL ACAD SCI USA, V91, P10947, DOI 10.1073/pnas.91.23.10947; Yoon HS, 2007, NEUROPHARMACOLOGY, V53, P344, DOI 10.1016/j.neuropharm.2007.05.014; Zhang Y, 2004, PSYCHOPHARMACOLOGY, V172, P422, DOI 10.1007/s00213-003-1688-3	48	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2011	6	6							e21637	10.1371/journal.pone.0021637	http://dx.doi.org/10.1371/journal.pone.0021637			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	784FW	21738744	Green Published, Green Submitted, gold			2022-12-27	WOS:000292142800048
J	Liu, F; He, KM; Yang, XX; Xu, N; Liang, ZY; Xu, M; Zhao, XS; Han, QD; Zhang, YY				Liu, Fei; He, Kangmin; Yang, Xinxing; Xu, Ning; Liang, Zhangyi; Xu, Ming; Zhao, Xinsheng; Han, Qide; Zhang, Youyi			alpha(1A)-Adrenergic Receptor Induces Activation of Extracellular Signal-Regulated Kinase 1/2 through Endocytic Pathway	PLOS ONE			English	Article							PROTEIN-KINASE; MYOSIN-V; ALPHA(1)-ADRENOCEPTOR SUBTYPES; PHOSPHATIDYLINOSITOL 3-KINASE; DEPENDENT ENDOCYTOSIS; MEDIATED ENDOCYTOSIS; CARDIAC-HYPERTROPHY; TRANSGENIC MICE; BETA-ARRESTINS; CELLS	G protein-coupled receptors (GPCRs) activate mitogen-activated protein kinases through a number of distinct pathways in cells. Increasing evidence has suggested that endosomal signaling has an important role in receptor signal transduction. Here we investigated the involvement of endocytosis in alpha(1A)-adrenergic receptor (alpha(1A)-AR)-induced activation of extracellular signal-regulated kinase 1/2 (ERK1/2). Agonist-mediated endocytic traffic of alpha(1A)-AR was assessed by real-time imaging of living, stably transfected human embryonic kidney 293A cells (HEK-293A). alpha(1A)-AR was internalized dynamically in cells with agonist stimulation, and actin filaments regulated the initial trafficking of alpha(1A)-AR. alpha(1A)-AR-induced activation of ERK1/2 but not p38 MAPK was sensitive to disruption of endocytosis, as demonstrated by 4 degrees C chilling, dynamin mutation and treatment with cytochalasin D (actin depolymerizing agent). Activation of protein kinase C (PKC) and C-Raf by alpha(1A)-AR was not affected by 4 degrees C chilling or cytochalasin D treatment. U73122 (a phospholipase C [PLC] inhibitor) and Ro 31-8220 (a PKC inhibitor) inhibited alpha(1B)-AR-but not alpha(1A)-AR-induced ERK1/2 activation. These data suggest that the endocytic pathway is involved in a1A-AR-induced ERK1/2 activation, which is independent of G(q)/PLC/PKC signaling.	[Liu, Fei; He, Kangmin; Xu, Ning; Xu, Ming; Han, Qide; Zhang, Youyi] Peking Univ, Inst Vasc Med, Hosp 3, Beijing 100871, Peoples R China; [Liu, Fei; He, Kangmin; Xu, Ning; Xu, Ming; Han, Qide; Zhang, Youyi] Minist Educ, Key Lab Mol Cardiovasc Sci, Beijing, Peoples R China; [Yang, Xinxing; Liang, Zhangyi; Zhao, Xinsheng] Peking Univ, Beijing Natl Lab Mol Sci,Biodynam Opt Imaging Ctr, State Key Lab Struct Chem Unstable & Stable Speci, Dept Biol Chem,Coll Chem & Mol Engn, Beijing 100871, Peoples R China	Peking University; Chinese Academy of Sciences; Peking University	Liu, F (corresponding author), Peking Univ, Inst Vasc Med, Hosp 3, Beijing 100871, Peoples R China.	zhangyy@bjmu.edu.cn	He, Kangmin/F-8235-2012; Liang, Zhangyi/G-5372-2011		National Key Basic Research Program of People's Republic of China [2007CB935601, 2006CB910300]; Natural Science Foundation of China [81030001, 30821001, 20733001]	National Key Basic Research Program of People's Republic of China(National Basic Research Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Key Basic Research Program of People's Republic of China (2007CB935601, 2006CB910300) and the Natural Science Foundation of China (81030001, 30821001, 20733001) (http://www.most.gov.cn/eng/programmes1/200610/t20061009_36223.htm and http://www.nsfc.gov.cn/Portal0/default106.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007306; Agrawal R, 2010, PHARMACOL RES, V61, P269, DOI 10.1016/j.phrs.2009.11.012; Bayer N, 2001, J BIOL CHEM, V276, P3952, DOI 10.1074/jbc.M004722200; Berts A, 1999, MOL PHARMACOL, V55, P296, DOI 10.1124/mol.55.2.296; Bliss SP, 2007, MOL ENDOCRINOL, V21, P538, DOI 10.1210/me.2006-0289; Bueno OF, 2000, EMBO J, V19, P6341, DOI 10.1093/emboj/19.23.6341; Calebiro D, 2010, TRENDS PHARMACOL SCI, V31, P221, DOI 10.1016/j.tips.2010.02.002; Copik AJ, 2009, MOL PHARMACOL, V75, P713, DOI 10.1124/mol.108.050765; Daaka Y, 1998, J BIOL CHEM, V273, P685, DOI 10.1074/jbc.273.2.685; DAMKE H, 1994, J CELL BIOL, V127, P915, DOI 10.1083/jcb.127.4.915; DeFea KA, 2000, J CELL BIOL, V148, P1267, DOI 10.1083/jcb.148.6.1267; DeFea KA, 2000, P NATL ACAD SCI USA, V97, P11086, DOI 10.1073/pnas.190276697; DeWire SM, 2007, ANNU REV PHYSIOL, V69, P483, DOI 10.1146/annurev.physiol.69.022405.154749; Docherty JR, 2010, CELL MOL LIFE SCI, V67, P405, DOI 10.1007/s00018-009-0174-4; Du XJ, 2006, CARDIOVASC RES, V71, P735, DOI 10.1016/j.cardiores.2006.06.015; Flechtner-Mors M, 2004, OBES RES, V12, P612, DOI 10.1038/oby.2004.70; Flesch M, 2001, CIRCULATION, V104, P2273, DOI 10.1161/hc4401.099449; Gong KZ, 2008, J BIOL CHEM, V283, P29028, DOI 10.1074/jbc.M801313200; HAWES BE, 1995, J BIOL CHEM, V270, P17148, DOI 10.1074/jbc.270.29.17148; Hu ZW, 1999, MOL ENDOCRINOL, V13, P3, DOI 10.1210/me.13.1.3; Huang Y, 2007, CIRCULATION, V115, P763, DOI 10.1161/CIRCULATIONAHA.106.664862; Iaccarino G, 2001, J AM COLL CARDIOL, V38, P534, DOI 10.1016/S0735-1097(01)01396-1; Kohlhaas SL, 2007, J BIOL CHEM, V282, P12831, DOI 10.1074/jbc.M700438200; Koshimizu T, 2003, PHARMACOL THERAPEUT, V98, P235, DOI 10.1016/S0163-7258(03)00033-0; Liang ZY, 2007, BIOCHEM BIOPH RES CO, V353, P231, DOI 10.1016/j.bbrc.2006.11.116; Lin G, 2001, CIRC RES, V89, P343, DOI 10.1161/hh1601.095912; Luttrell LM, 2001, P NATL ACAD SCI USA, V98, P2449, DOI 10.1073/pnas.041604898; Mallik R, 2004, NATURE, V427, P649, DOI 10.1038/nature02293; Mehta AD, 1999, NATURE, V400, P590, DOI 10.1038/23072; Michelotti GA, 2000, PHARMACOL THERAPEUT, V88, P281, DOI 10.1016/S0163-7258(00)00092-9; Muratoglu SC, 2010, J BIOL CHEM, V285, P14308, DOI 10.1074/jbc.M109.046672; O-Uchi J, 2008, CIRC RES, V102, P1378, DOI 10.1161/CIRCRESAHA.107.167734; Pelkmans L, 2002, SCIENCE, V296, P535, DOI 10.1126/science.1069784; Puthenveedu MA, 2006, CELL, V127, P113, DOI 10.1016/j.cell.2006.08.035; Rief M, 2000, P NATL ACAD SCI USA, V97, P9482, DOI 10.1073/pnas.97.17.9482; Slessareva JE, 2006, CELL, V126, P191, DOI 10.1016/j.cell.2006.04.045; Stanasila L, 2008, MOL PHARMACOL, V74, P562, DOI 10.1124/mol.107.043422; TERZIC A, 1993, PHARMACOL REV, V45, P147; Toews ML, 2003, LIFE SCI, V74, P379, DOI 10.1016/j.lfs.2003.09.024; Tohgo A, 2003, J BIOL CHEM, V278, P6258, DOI 10.1074/jbc.M212231200; Vieira AV, 1996, SCIENCE, V274, P2086, DOI 10.1126/science.274.5295.2086; WU DQ, 1992, J BIOL CHEM, V267, P25798; Xiao L, 2001, J MOL CELL CARDIOL, V33, P779, DOI 10.1006/jmcc.2001.1348; Xiao RP, 2006, TRENDS PHARMACOL SCI, V27, P330, DOI 10.1016/j.tips.2006.04.009; Xu N, 2007, ACTA PHARMACOL SIN, V28, P796, DOI 10.1111/j.1745-7254.2007.00545.x; Yamada H, 2009, J BIOL CHEM, V284, P34244, DOI 10.1074/jbc.M109.064204; Yildiz A, 2003, SCIENCE, V300, P2061, DOI 10.1126/science.1084398; Yue TL, 2000, CIRC RES, V86, P692, DOI 10.1161/01.RES.86.6.692; Zhang YY, 1999, J PHARMACOL EXP THER, V291, P829	49	12	13	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2011	6	6							e21520	10.1371/journal.pone.0021520	http://dx.doi.org/10.1371/journal.pone.0021520			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	784FW	21738688	Green Published, gold, Green Submitted			2022-12-27	WOS:000292142800031
J	Miller, DL; Dou, CY; Sorenson, D; Liu, M				Miller, Douglas L.; Dou, Chunyan; Sorenson, Dorothy; Liu, Ming			Histological Observation of Islet Hemorrhage Induced by Diagnostic Ultrasound with Contrast Agent in Rat Pancreas	PLOS ONE			English	Article							IN-VIVO; BLOOD-FLOW; MODEL	Contrast enhanced diagnostic ultrasound CEDUS has been shown to induce capillary hemorrhage in heart and kidney. This study characterized the capillary hemorrhage induced in rat pancreas. The pancreata of anesthetized hairless rats were accessed by laparotomy. A 1.5 MHz diagnostic ultrasound probe with 2.3 MPa peak rarefactional pressure amplitude and 1 s intermittent trigger was used to scan the pancreas, located at the focus (3.8 cm), through saline coupling. The probe was swept to expose the entire organ in 5 min during infusion of Definity (R) contrast agent at 10 mu L/kg/min, and this was repeated in a reverse sweep. The entire pancreas was removed, spread flat for fixation and histological slides were prepared from the mid-plane. Slides were scored blind for islet hemorrhage over the entire area of the organ. Intra-islet microlesions were evident and hemorrhage surrounded many islets. The hemorrhage often impacted nearby acini, and expanded into inter-lobular septa. In CEDUS pancreata removed soon after scanning, 76.2+/-11.8% (n=6) of islets had evidence of hemorrhage and/or islet microlesions compared to 1.1+/-2.5% (n=5) for sham CEDUS (P<0.001). In pancreata removed after 4 hr, fibrin formation was detected by immunohistology in the hemorrhage and intra-islet microlesions. Diagnostic ultrasound with contrast agent induced substantial capillary hemorrhage in rat pancreas, concentrated particularly in the islets.	[Miller, Douglas L.; Dou, Chunyan; Sorenson, Dorothy; Liu, Ming] Univ Michigan Hlth Syst, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Miller, DL (corresponding author), Univ Michigan Hlth Syst, Ann Arbor, MI 48109 USA.	douglm@umich.edu			National Institutes of Health, DHHS, USA [EB00338]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB000338] Funding Source: NIH RePORTER	National Institutes of Health, DHHS, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported by PHS grant EB00338 awarded by the National Institutes of Health, DHHS, USA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badea R, 2009, J GASTROINTEST LIVER, V18, P237; CANAS X, 1995, ENDOCRINOLOGY, V136, P3871, DOI 10.1210/en.136.9.3871; Chen S, 2010, GENE THER, V17, P1411, DOI 10.1038/gt.2010.85; D'Onofrio M, 2007, ABDOM IMAGING, V32, P171, DOI 10.1007/s00261-006-9010-6; Imaoka M, 2007, TOXICOL PATHOL, V35, P388, DOI 10.1080/01926230701230304; Iwase M, 2001, AM J PHYSIOL-REG I, V280, pR1601, DOI 10.1152/ajpregu.2001.280.6.R1601; Li XQ, 2006, DIABETES, V55, P2965, DOI 10.2337/db06-0733; Martinez-Noguera A, 2001, EUR RADIOL, V11, P1594, DOI 10.1007/s003300101003; Masuyama T, 2004, BIOCHEM BIOPH RES CO, V314, P870, DOI 10.1016/j.bbrc.2003.12.180; MENGER MD, 1995, CLIN APPIED MICROCIR, pCH22; Miller DL, 2008, J ULTRAS MED, V27, P611, DOI 10.7863/jum.2008.27.4.611; Miller DL, 2007, ULTRASOUND MED BIOL, V33, P129, DOI 10.1016/j.ultrasmedbio.2006.07.033; Miller DL, 2010, IEEE T BIO-MED ENG, V57, P167, DOI 10.1109/TBME.2009.2030960; Miller DL, 2009, ULTRASOUND MED BIOL, V35, P869, DOI 10.1016/j.ultrasmedbio.2008.10.015; Muller Michael W, 2007, Pancreas, V35, pe30; Nyman LR, 2008, J CLIN INVEST, V118, P3790, DOI 10.1172/JCI36209; Sakamoto H, 2008, ULTRASOUND MED BIOL, V34, P525, DOI 10.1016/j.ultrasmedbio.2007.09.018	17	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2011	6	6							e21617	10.1371/journal.pone.0021617	http://dx.doi.org/10.1371/journal.pone.0021617			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	784FW	21738734	Green Submitted, Green Published, gold			2022-12-27	WOS:000292142800047
J	Emery, M; Schorderet, DF; Roduit, R				Emery, Martine; Schorderet, Daniel F.; Roduit, Raphael			Acute Hypoglycemia Induces Retinal Cell Death in Mouse	PLOS ONE			English	Article							INDUCED OXIDATIVE STRESS; NEURONAL DEATH; GLUTATHIONE-PEROXIDASE; DIABETIC-RETINOPATHY; IN-VITRO; ACTIVATION; APOPTOSIS; INSULIN; DAMAGE; BRAIN	Background: Glucose is the most important metabolic substrate of the retina and maintenance of normoglycemia is an essential challenge for diabetic patients. Glycemic excursions could lead to cardiovascular disease, nephropathy, neuropathy and retinopathy. A vast body of literature exists on hyperglycemia namely in the field of diabetic retinopathy, but very little is known about the deleterious effect of hypoglycemia. Therefore, we decided to study the role of acute hypoglycemia in mouse retina. Methodology/Principal Findings: To test effects of hypoglycemia, we performed a 5-hour hyperinsulinemic/hypoglycemic clamp; to exclude an effect of insulin, we made a hyperinsulinemic/euglycemic clamp as control. We then isolated retinas from each group at different time-points after the clamp to analyze cells apoptosis and genes regulation. In parallel, we used 661W photoreceptor cells to confirm in vivo results. We showed herein that hypoglycemia induced retinal cell death in mouse via caspase 3 activation. We then tested the mRNA expression of glutathione transferase omega 1 (Gsto1) and glutathione peroxidase 3 (Gpx3), two genes involved in glutathione (GSH) homeostasis. The expression of both genes was up-regulated by low glucose, leading to a decrease of reduced glutathione (GSH). In vitro experiments confirmed the low-glucose induction of 661W cell death via superoxide production and activation of caspase 3, which was concomitant with a decrease of GSH content. Moreover, decrease of GSH content by inhibition with buthionine sulphoximine (BSO) at high glucose induced apoptosis, while complementation with extracellular glutathione ethyl ester (GSHee) at low glucose restored GSH level and reduced apoptosis. Conclusions/Significance: We showed, for the first time, that acute insulin-induced hypoglycemia leads to caspase 3-dependant retinal cell death with a predominant role of GSH content.	[Emery, Martine; Schorderet, Daniel F.; Roduit, Raphael] Inst Res Ophthalmol, Sion, Switzerland; [Emery, Martine; Schorderet, Daniel F.; Roduit, Raphael] Univ Lausanne, Dept Ophthalmol, Lausanne, Switzerland; [Schorderet, Daniel F.] Ecole Polytech Fed Lausanne, Lausanne, Switzerland	University of Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Emery, M (corresponding author), Inst Res Ophthalmol, Sion, Switzerland.	raphael.roduit@irovision.ch	Roduit, Raphael/AAC-3890-2021	Roduit, Raphael/0000-0001-7440-2799; Schorderet, Daniel/0000-0002-1331-504X				Ahuja-Jensen P, 2007, NEUROREPORT, V18, P797, DOI 10.1097/WNR.0b013e3280c1e344; Baird L, 2011, ARCH TOXICOL, V85, P241, DOI 10.1007/s00204-011-0674-5; Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a; Choi IY, 2001, J CEREBR BLOOD F MET, V21, P653, DOI 10.1097/00004647-200106000-00003; Cook S, 2004, DIABETES, V53, P2067, DOI 10.2337/diabetes.53.8.2067; Crawford TN, 2009, CURR DIABETES REV, V5, P8, DOI 10.2174/157339909787314149; Cryer PE, 2008, DIABETES, V57, P3169, DOI 10.2337/db08-1084; Dalle-Donne I, 2007, FREE RADICAL BIO MED, V43, P883, DOI 10.1016/j.freeradbiomed.2007.06.014; DENEKE SM, 1989, AM J PHYSIOL, V257, pL163, DOI 10.1152/ajplung.1989.257.4.L163; Dunn KC, 1996, EXP EYE RES, V62, P155, DOI 10.1006/exer.1996.0020; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Ganea E, 2006, CURR EYE RES, V31, P1, DOI 10.1080/02713680500477347; Geraldes P, 2009, NAT MED, V15, P1298, DOI 10.1038/nm.2052; Groeger G, 2009, J NEUROCHEM, V109, P1544, DOI 10.1111/j.1471-4159.2009.06081.x; Hamann S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006616; Heidbreder M, 2007, BIOCHEM BIOPH RES CO, V352, P437, DOI 10.1016/j.bbrc.2006.11.027; Hernandez-Fonseca K, 2008, J NEUROSCI RES, V86, P1768, DOI 10.1002/jnr.21634; Hirata C, 1997, BIOCHEM BIOPH RES CO, V236, P712, DOI 10.1006/bbrc.1997.7036; KERN TS, 1994, INVEST OPHTH VIS SCI, V35, P2962; Kowluru RA, 2006, FREE RADICAL BIO MED, V41, P1191, DOI 10.1016/j.freeradbiomed.2006.01.012; Lewerenz J, 2011, ANTIOXID REDOX SIGN, V14, P1449, DOI 10.1089/ars.2010.3600; Limb GA, 2002, INVEST OPHTH VIS SCI, V43, P864; Luo XM, 2001, INVEST OPHTH VIS SCI, V42, P2695; Mackey AM, 2008, CELL DEATH DIFFER, V15, P1291, DOI 10.1038/cdd.2008.43; McGowan JE, 2006, NEUROSCI LETT, V399, P111, DOI 10.1016/j.neulet.2006.01.034; Miranda M, 2007, FREE RADICAL BIO MED, V43, P1494, DOI 10.1016/j.freeradbiomed.2007.08.001; Nematollahi LR, 2009, METABOLISM, V58, P443, DOI 10.1016/j.metabol.2008.10.018; Nguyen TT, 2009, CURR DIABETES REP, V9, P277, DOI 10.1007/s11892-009-0043-4; Paramo B, 2010, NEUROSCIENCE, V167, P1057, DOI 10.1016/j.neuroscience.2010.02.074; Piaggi S, 2010, CARCINOGENESIS, V31, P804, DOI 10.1093/carcin/bgq031; Punzo C, 2009, NAT NEUROSCI, V12, P44, DOI 10.1038/nn.2234; Rahman I, 2001, BIOCHEM PHARMACOL, V62, P787, DOI 10.1016/S0006-2952(01)00702-X; Reliene R, 2006, CARCINOGENESIS, V27, P240, DOI 10.1093/carcin/bgi222; Ristoff E, 2007, J INHERIT METAB DIS, V30, P102, DOI 10.1007/s10545-006-0412-y; Ristoff E, 2001, J PEDIATR-US, V139, P79, DOI 10.1067/mpd.2001.114480; Russell JW, 2002, FASEB J, V16, P1738, DOI 10.1096/fj.01-1027com; Suh SW, 2007, GLIA, V55, P1280, DOI 10.1002/glia.20440; Suh SW, 2007, J CLIN INVEST, V117, P910, DOI 10.1172/JCI30077; Tan E, 2004, INVEST OPHTH VIS SCI, V45, P764, DOI 10.1167/iovs.03-1114; Tanito M, 2002, INVEST OPHTH VIS SCI, V43, P2392; Umino Y, 2006, P NATL ACAD SCI USA, V103, P19541, DOI 10.1073/pnas.0604478104; WINKLER BS, 1986, EXP EYE RES, V43, P829, DOI 10.1016/S0014-4835(86)80013-6; Zeevalk GD, 2000, J NEUROCHEM, V75, P1027, DOI 10.1046/j.1471-4159.2000.0751027.x	43	26	27	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2011	6	6							e21586	10.1371/journal.pone.0021586	http://dx.doi.org/10.1371/journal.pone.0021586			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	783OD	21738719	Green Published, Green Submitted, gold			2022-12-27	WOS:000292092600057
J	Jelinek, J; Gharibyan, V; Estecio, MRH; Kondo, K; He, R; Chung, W; Lu, Y; Zhang, NX; Liang, SD; Kantarjian, HM; Cortes, JE; Issa, JPJ				Jelinek, Jaroslav; Gharibyan, Vazganush; Estecio, Marcos R. H.; Kondo, Kimie; He, Rong; Chung, Woonbok; Lu, Yue; Zhang, Nianxiang; Liang, Shoudan; Kantarjian, Hagop M.; Cortes, Jorge E.; Issa, Jean-Pierre J.			Aberrant DNA Methylation Is Associated with Disease Progression, Resistance to Imatinib and Shortened Survival in Chronic Myelogenous Leukemia	PLOS ONE			English	Article							CHRONIC MYELOID-LEUKEMIA; CHRONIC LYMPHOCYTIC-LEUKEMIA; CPG ISLAND METHYLATION; LOW-DOSE DECITABINE; GENOME-WIDE SCREEN; CELL-LINE; HEMATOPOIETIC NEOPLASMS; PHILADELPHIA-CHROMOSOME; PROMOTER METHYLATION; COLORECTAL-CANCER	The epigenetic impact of DNA methylation in chronic myelogenous leukemia (CML) is not completely understood. To elucidate its role we analyzed 120 patients with CML for methylation of promoter-associated CpG islands of 10 genes. Five genes were identified by DNA methylation screening in the K562 cell line and 3 genes in patients with myeloproliferative neoplasms. The CDKN2B gene was selected for its frequent methylation in myeloid malignancies and ABL1 as the target of BCR-ABL translocation. Thirty patients were imatinib-naive (mostly treated by interferon-alpha before the imatinib era), 30 were imatinib-responsive, 50 were imatinib-resistant, and 10 were imatinib-intolerant. We quantified DNA methylation by bisulfite pyrosequencing. The average number of methylated genes was 4.5 per patient in the chronic phase, increasing significantly to 6.2 in the accelerated and 6.4 in the blastic phase. Higher numbers of methylated genes were also observed in patients resistant or intolerant to imatinib. These patients also showed almost exclusive methylation of a putative transporter OSCP1. Abnormal methylation of a Src suppressor gene PDLIM4 was associated with shortened survival independently of CML stage and imatinib responsiveness. We conclude that aberrant DNA methylation is associated with CML progression and that DNA methylation could be a marker associated with imatinib resistance. Finally, DNA methylation of PDLIM4 may help identify a subset of CML patients that would benefit from treatment with Src/Abl inhibitors.	[Jelinek, Jaroslav; Gharibyan, Vazganush; Estecio, Marcos R. H.; Kondo, Kimie; He, Rong; Chung, Woonbok; Lu, Yue; Kantarjian, Hagop M.; Cortes, Jorge E.; Issa, Jean-Pierre J.] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA; [Zhang, Nianxiang; Liang, Shoudan] Univ Texas MD Anderson Canc Ctr, Dept Bioinformat & Computat Biol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Jelinek, J (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA.	jjelinek@mdanderson.org	Jelinek, Jaroslav/D-2282-2012; Jelinek, Jaroslav/O-6876-2019	Jelinek, Jaroslav/0000-0002-2533-0220; Issa, Jean-Pierre/0000-0003-2258-5030; Lu, Yue/0000-0002-5479-9095; Estecio, Marcos/0000-0002-6874-7413; Cortes, Jorge/0000-0002-8636-1071	National Institutes of Health [CA046939, CA100632]; National Cancer Institute [2P01CA049639-20A2]; NATIONAL CANCER INSTITUTE [P01CA049639, K25CA123344, P50CA100632] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by CA046939 and CA100632 grants from the National Institutes of Health. J-P.J.I. is an American Cancer Society Clinical Research Professor supported by a generous gift from the F. M. Kirby Foundation. This work was also supported by the grant 2P01CA049639-20A2 from the National Cancer Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avramouli A, 2009, LEUKEMIA RES, V33, P1130, DOI 10.1016/j.leukres.2009.01.003; Baylin SB, 1998, ADV CANCER RES, V72, P141; Boumber YA, 2007, CANCER RES, V67, P1997, DOI 10.1158/0008-5472.CAN-06-3093; Chung W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002079; DALEY GQ, 1988, P NATL ACAD SCI USA, V85, P9312, DOI 10.1073/pnas.85.23.9312; Dunwell T, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-44; Eckhardt F, 2006, NAT GENET, V38, P1378, DOI 10.1038/ng1909; Estecio MRH, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000399; Estecio MRH, 2007, GENOME RES, V17, P1529, DOI 10.1101/gr.6417007; Feng W, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1762; Herman JG, 1996, CANCER RES, V56, P722; Herman JG, 1997, CANCER RES, V57, P837; Inoue A, 2010, FASEB J, V24, P485, DOI 10.1096/fj.09-143370; Issa JPJ, 2005, J CLIN ONCOL, V23, P3948, DOI 10.1200/JCO.2005.11.981; Issa JPJ, 1996, CANCER RES, V56, P973; Issa JPJ, 1997, CANCER RES, V57, P1678; Jabbour E, 2009, TARGET ONCOL, V4, P3, DOI 10.1007/s11523-008-0100-y; Jelinek J, 2004, BLOOD, V104, p319A; Jelinek J, 2003, BLOOD, V102, p660A; Jiang Y, 2009, BLOOD, V113, P1315, DOI 10.1182/blood-2008-06-163246; Kanduri M, 2010, BLOOD, V115, P296, DOI 10.1182/blood-2009-07-232868; Kobayashi Y, 2005, J BIOL CHEM, V280, P32332, DOI 10.1074/jbc.M504246200; Koga Y, 2009, GENOME RES, V19, P1462, DOI 10.1101/gr.091447.109; Kondo Y, 2007, HEPATOL RES, V37, P974, DOI 10.1111/j.1872-034X.2007.00141.x; Kroeger H, 2008, BLOOD, V112, P1366, DOI 10.1182/blood-2007-11-126227; Kuang SQ, 2008, LEUKEMIA, V22, P1529, DOI 10.1038/leu.2008.130; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Liu TH, 2006, CANCER RES, V66, P653, DOI 10.1158/0008-5472.CAN-05-3712; LOZZIO CB, 1975, BLOOD, V45, P321, DOI 10.1182/blood.V45.3.321.321; NELKIN BD, 1991, BLOOD, V77, P2431; Nguyen TT, 2000, BLOOD, V95, P2990, DOI 10.1182/blood.V95.9.2990.009k08_2990_2992; Nie XM, 2003, J CANCER RES CLIN, V129, P410, DOI 10.1007/s00432-003-0451-9; Oki Y, 2007, CANCER, V109, P899, DOI 10.1002/cncr.22470; Pehlivan M, 2009, LEUKEMIA RES, V33, P1062, DOI 10.1016/j.leukres.2008.11.013; Quintas-Cardama A, 2009, NAT REV CLIN ONCOL, V6, P535, DOI 10.1038/nrclinonc.2009.112; Roman-Gomez J, 2005, ONCOGENE, V24, P7213, DOI 10.1038/sj.onc.1208866; Roman-Gomez J, 2003, J CLIN ONCOL, V21, P1472, DOI 10.1200/JCO.2003.08.166; Roman-Gomez J, 2008, LEUKEMIA RES, V32, P487, DOI 10.1016/j.leukres.2007.07.021; Rush LJ, 2004, CANCER RES, V64, P2424, DOI 10.1158/0008-5472.CAN-03-2870; Shen LL, 2010, J CLIN ONCOL, V28, P605, DOI 10.1200/JCO.2009.23.4781; Strathdee G, 2007, CLIN CANCER RES, V13, P5048, DOI 10.1158/1078-0432.CCR-07-0919; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Tellez CS, 2009, MELANOMA RES, V19, P146, DOI 10.1097/CMR.0b013e32832b274e; Toyota M, 1999, CANCER RES, V59, P2307; Toyota M, 2005, SEMIN ONCOL, V32, P521, DOI 10.1053/j.seminoncol.2005.07.003; Toyota M, 1999, P NATL ACAD SCI USA, V96, P8681, DOI 10.1073/pnas.96.15.8681; Vanaja DK, 2009, CANCER INVEST, V27, P264, DOI 10.1080/07357900802406319; Widschwendter A, 2004, CLIN CANCER RES, V10, P565, DOI 10.1158/1078-0432.CCR-0825-03; Yang AS, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh032; Zhang YJ, 2009, J CELL BIOL, V184, P785, DOI 10.1083/jcb.200810155; ZION M, 1994, P NATL ACAD SCI USA, V91, P10722, DOI 10.1073/pnas.91.22.10722	51	85	95	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2011	6	7							e22110	10.1371/journal.pone.0022110	http://dx.doi.org/10.1371/journal.pone.0022110			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791IA	21760961	Green Published, Green Submitted, gold			2022-12-27	WOS:000292657200050
J	Puspasari, N; Rowley, SM; Gordon, L; Lockhart, PJ; Ioannou, PA; Delatycki, MB; Sarsero, JP				Puspasari, Novita; Rowley, Simone M.; Gordon, Lavinia; Lockhart, Paul J.; Ioannou, Panos A.; Delatycki, Martin B.; Sarsero, Joseph P.			Long Range Regulation of Human FXN Gene Expression	PLOS ONE			English	Article							OCT-1 TRANSCRIPTION FACTOR; FRIEDREICH ATAXIA; EPIGENETIC CHANGES; GENOME BROWSER; FRATAXIN GENE; BINDING-SITE; DNA; PROMOTER; PROTEIN; MOUSE	Background: Friedreich ataxia (FRDA) is the most common form of hereditary ataxia characterized by the presence of a GAA trinucleotide repeat expansion within the first intron of the FXN gene. The expansion inhibits FXN gene expression resulting in an insufficiency of frataxin protein. Methodology/Principal Finding: In this study, computational analyses were performed on the 21.3 kb region upstream of exon 1 of the human FXN gene and orthologs from other species in order to identify conserved non-coding DNA sequences with potential regulatory functions. The conserved non-coding regions identified were individually analyzed in two complementing assay systems, a conventional luciferase reporter system and a novel Bacterial Artificial Chromosome (BAC)-based genomic reporter. The BAC system allows the evaluation of gene expression to be made in the context of its entire genomic locus and preserves the normal location and spacing of many regulatory elements which may be positioned over large distances from the initiation codon of the gene. Conclusions/Significance: The two approaches were used to identify a region of 17 bp located approximately 4.9 kb upstream of the first exon of the FXN gene that plays an important role in FXN gene expression. Modulation of FXN gene expression was found to be mediated by the action of the Oct-1 transcription factor at this site. A better understanding of cis-acting regulatory elements that control FXN gene expression has the potential to develop new strategies for the upregulation of the FXN gene as a therapy for FRDA.	[Puspasari, Novita; Rowley, Simone M.; Lockhart, Paul J.; Delatycki, Martin B.; Sarsero, Joseph P.] Royal Childrens Hosp, Murdoch Childrens Res Inst, Bruce Lefroy Ctr Genet Hlth Res, Parkville, Vic 3052, Australia; [Gordon, Lavinia] Royal Childrens Hosp, Murdoch Childrens Res Inst, Bioinformat Unit, Parkville, Vic 3052, Australia; [Puspasari, Novita; Lockhart, Paul J.; Ioannou, Panos A.; Delatycki, Martin B.; Sarsero, Joseph P.] Univ Melbourne, Dept Paediat, Royal Childrens Hosp, Parkville, Vic 3052, Australia; [Delatycki, Martin B.] Austin Hlth, Dept Clin Genet, Heidelberg, Vic, Australia	Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; Royal Children's Hospital Melbourne; University of Melbourne; Austin Research Institute; Florey Institute of Neuroscience & Mental Health	Puspasari, N (corresponding author), Royal Childrens Hosp, Murdoch Childrens Res Inst, Bruce Lefroy Ctr Genet Hlth Res, Flemington Rd, Parkville, Vic 3052, Australia.	joe@sarsero.com	Lockhart, Paul J/E-7753-2011; Gordon, Lavinia C/L-1310-2016; Delatycki, Martin B/A-5409-2013	Lockhart, Paul J/0000-0003-2531-8413; Gordon, Lavinia C/0000-0003-3469-8489; Rowley, Simone/0000-0002-5897-7979; Puspasari, Novita/0000-0002-1398-805X	Friedreich Ataxia Research Association (Australasia); Friedreich's Ataxia Research Alliance (USA); National Ataxia Foundation (USA); Victorian Government	Friedreich Ataxia Research Association (Australasia); Friedreich's Ataxia Research Alliance (USA); National Ataxia Foundation (USA); Victorian Government	This work was supported by the Friedreich Ataxia Research Association (Australasia), the Friedreich's Ataxia Research Alliance (USA), the National Ataxia Foundation (USA) and the Victorian Government's Operational Infrastructure Support Program. NP was the recipient of a Ph.D. stipend from the Friedreich Ataxia Research Association (Australasia). MBD is a National Health and Medical Research Council Practitioner Fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Mahdawi S, 2008, HUM MOL GENET, V17, P735, DOI 10.1093/hmg/ddm346; Blanchette M, 2004, GENOME RES, V14, P708, DOI 10.1101/gr.1933104; Castaldo I, 2008, J MED GENET, V45, P808, DOI 10.1136/jmg.2008.058594; Cheng CK, 2002, ENDOCRINOLOGY, V143, P4693, DOI 10.1210/en.2002-220576; Chiaromonte F, 2002, Pac Symp Biocomput, P115; De Biase I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007914; Dong B, 2007, BIOCHEM J, V401, P57, DOI 10.1042/BJ20060570; Filla A, 1992, Acta Neurol (Napoli), V14, P420; Frengen E, 1999, GENOMICS, V58, P250, DOI 10.1006/geno.1998.5693; Fujita PA, 2011, NUCLEIC ACIDS RES, V39, pD876, DOI 10.1093/nar/gkq963; Gambari R, 2004, CURR DRUG TARGETS, V5, P419, DOI 10.2174/1389450043345416; Gottesfeld JM, 2007, PHARMACOL THERAPEUT, V116, P236, DOI 10.1016/j.pharmthera.2007.06.014; Greene E, 2005, GENOMICS, V85, P221, DOI 10.1016/j.ygeno.2004.10.013; Greene E, 2007, NUCLEIC ACIDS RES, V35, P3383, DOI 10.1093/nar/gkm271; HARDING AE, 1981, J MED GENET, V18, P285, DOI 10.1136/jmg.18.4.285; Herman D, 2006, NAT CHEM BIOL, V2, P551, DOI 10.1038/nchembio815; Hobert O, 2002, BIOTECHNIQUES, V32, P728, DOI 10.2144/02324bm01; Jegga AG, 2007, NUCLEIC ACIDS RES, V35, pD116, DOI 10.1093/nar/gkl1011; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; King DC, 2005, GENOME RES, V15, P1051, DOI 10.1101/gr.3642605; Kolbe D, 2004, GENOME RES, V14, P700, DOI 10.1101/gr.1976004; Leclerc GM, 2005, MOL CELL ENDOCRINOL, V245, P86, DOI 10.1016/j.mce.2005.10.026; Lee EC, 2001, GENOMICS, V73, P56, DOI 10.1006/geno.2000.6451; Li KY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012286; Lins K, 2003, EMBO J, V22, P2188, DOI 10.1093/emboj/cdg199; Matheos DD, 1998, J CELL BIOCHEM, V68, P309, DOI 10.1002/(SICI)1097-4644(19980301)68:3<309::AID-JCB3>3.0.CO;2-Y; NAKSHATRI H, 1995, J BIOL CHEM, V270, P19613, DOI 10.1074/jbc.270.33.19613; Oktay Y, 2007, J BIOL CHEM, V282, P11750, DOI 10.1074/jbc.M611133200; Pandolfo M, 2006, METH MOLEC MED, V126, P197; Rai M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001958; Ramazzotti A, 2004, FEBS LETT, V557, P215, DOI 10.1016/S0014-5793(03)01498-4; ROMEO G, 1983, AM J HUM GENET, V35, P523; Sarsero JP, 2004, MAMM GENOME, V15, P370, DOI 10.1007/s00335-004-3019-3; Sarsero JP, 2003, J GENE MED, V5, P72, DOI 10.1002/jgm.320; Saveliev A, 2003, NATURE, V422, P909, DOI 10.1038/nature01596; Schwartz S, 2003, GENOME RES, V13, P103, DOI 10.1101/gr.809403; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; STURM RA, 1988, GENE DEV, V2, P1582, DOI 10.1101/gad.2.12a.1582; Tantin D, 2005, CANCER RES, V65, P10750, DOI 10.1158/0008-5472.CAN-05-2399; Taylor J, 2006, GENOME RES, V16, P1596, DOI 10.1101/gr.4537706; USHEVA A, 1994, CELL, V76, P1115, DOI 10.1016/0092-8674(94)90387-5; Wang VEH, 2004, MOL CELL BIOL, V24, P1022, DOI 10.1128/MCB.24.3.1022-1032.2004; Wu GD, 1997, J BIOL CHEM, V272, P2396; Xu XXS, 2009, J HEMATOL ONCOL, V2, DOI 10.1186/1756-8722-2-15; Yoon T, 2004, J BIOL CHEM, V279, P25943, DOI 10.1074/jbc.C400107200	45	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2011	6	7							e22001	10.1371/journal.pone.0022001	http://dx.doi.org/10.1371/journal.pone.0022001			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791IA	21760943	gold, Green Published			2022-12-27	WOS:000292657200039
J	Toombs, JA; Liss, NM; Cobble, KR; Ben-Musa, Z; Ross, ED				Toombs, James A.; Liss, Nathan M.; Cobble, Kacy R.; Ben-Musa, Zobaida; Ross, Eric D.			[PSI+] Maintenance Is Dependent on the Composition, Not Primary Sequence, of the Oligopeptide Repeat Domain	PLOS ONE			English	Article							YEAST SACCHAROMYCES-CEREVISIAE; CHAPERONE PROTEIN HSP104; INHERITED PRION DISEASE; PAIR GENE INSERTION; GUANIDINE-HYDROCHLORIDE; STRAIN VARIANTS; PROPAGATION; AGGREGATION; PSI(+); REGION	[PSI+], the prion form of the yeast Sup35 protein, results from the structural conversion of Sup35 from a soluble form into an infectious amyloid form. The infectivity of prions is thought to result from chaperone-dependent fiber cleavage that breaks large prion fibers into smaller, inheritable propagons. Like the mammalian prion protein PrP, Sup35 contains an oligopeptide repeat domain. Deletion analysis indicates that the oligopeptide repeat domain is critical for [PSI+] propagation, while a distinct region of the prion domain is responsible for prion nucleation. The PrP oligopeptide repeat domain can substitute for the Sup35 oligopeptide repeat domain in supporting [PSI+] propagation, suggesting a common role for repeats in supporting prion maintenance. However, randomizing the order of the amino acids in the Sup35 prion domain does not block prion formation or propagation, suggesting that amino acid composition is the primary determinant of Sup35's prion propensity. Thus, it is unclear what role the oligopeptide repeats play in [PSI+] propagation: the repeats could simply act as a non-specific spacer separating the prion nucleation domain from the rest of the protein; the repeats could contain specific compositional elements that promote prion propagation; or the repeats, while not essential for prion propagation, might explain some unique features of [PSI+]. Here, we test these three hypotheses and show that the ability of the Sup35 and PrP repeats to support [PSI+] propagation stems from their amino acid composition, not their primary sequences. Furthermore, we demonstrate that compositional requirements for the repeat domain are distinct from those of the nucleation domain, indicating that prion nucleation and propagation are driven by distinct compositional features.	[Toombs, James A.; Liss, Nathan M.; Cobble, Kacy R.; Ross, Eric D.] Colorado State Univ, Dept Biochem & Mol Biol, Ft Collins, CO 80523 USA; [Ben-Musa, Zobaida; Ross, Eric D.] Colorado State Univ, Grad Program Cell & Mol Biol, Ft Collins, CO 80523 USA	Colorado State University; Colorado State University	Toombs, JA (corresponding author), Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA.	eric.ross@colostate.edu		Ross, Eric/0000-0002-6473-9977; Toombs, James/0000-0002-1601-5675	National Sciences Foundation [MCB-1023771]; March of Dimes Basil O'Connor Award [5-FY07-104]	National Sciences Foundation(National Science Foundation (NSF)); March of Dimes Basil O'Connor Award(March of Dimes)	This work was supported by National Sciences Foundation grant MCB-1023771 to EDR and a March of Dimes Basil O'Connor Award (#5-FY07-104) to EDR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandrov IM, 2008, J BIOL CHEM, V283, P15185, DOI 10.1074/jbc.M802071200; Antzutkin ON, 2002, BIOCHEMISTRY-US, V41, P15436, DOI 10.1021/bi0204185; CHERNOFF YO, 1995, SCIENCE, V268, P880, DOI 10.1126/science.7754373; COLLINGE J, 1992, BRAIN, V115, P687, DOI 10.1093/brain/115.3.687; COX BS, 1971, HEREDITY, V26, P211, DOI 10.1038/hdy.1971.28; Crist CG, 2003, GENES CELLS, V8, P603, DOI 10.1046/j.1365-2443.2003.00661.x; DePace AH, 1998, CELL, V93, P1241, DOI 10.1016/S0092-8674(00)81467-1; Derdowski A, 2010, SCIENCE, V330, P680, DOI 10.1126/science.1197785; Dong JJ, 2007, J BIOL CHEM, V282, P34204, DOI 10.1074/jbc.M704952200; Douglas PM, 2008, P NATL ACAD SCI USA, V105, P7206, DOI 10.1073/pnas.0802593105; Esteras-Chopo A, 2005, P NATL ACAD SCI USA, V102, P16672, DOI 10.1073/pnas.0505905102; Ferreira PC, 2001, MOL MICROBIOL, V40, P1357, DOI 10.1046/j.1365-2958.2001.02478.x; Flechsig E, 2000, NEURON, V27, P399, DOI 10.1016/S0896-6273(00)00046-5; Jung GM, 2002, P NATL ACAD SCI USA, V99, P9936, DOI 10.1073/pnas.152333299; Jung GM, 2001, CURR MICROBIOL, V43, P7, DOI 10.1007/s002840010251; Kalastavadi Tejas, 2008, BMC Biochemistry, V9, P7, DOI 10.1186/1471-2091-9-7; Liu JJ, 2002, P NATL ACAD SCI USA, V99, P16446, DOI 10.1073/pnas.252652099; Liu JJ, 1999, NATURE, V400, P573, DOI 10.1038/23048; Nakayashiki T, 2001, MOL CELL, V7, P1121, DOI 10.1016/S1097-2765(01)00259-3; Nemecek J, 2009, P NATL ACAD SCI USA, V106, P1892, DOI 10.1073/pnas.0812470106; Ness F, 2002, MOL CELL BIOL, V22, P5593, DOI 10.1128/MCB.22.15.5593-5605.2002; Ohhashi Y, 2010, NAT CHEM BIOL, V6, P225, DOI 10.1038/NCHEMBIO.306; Osherovich LZ, 2004, PLOS BIOL, V2, P442, DOI 10.1371/journal.pbio.0020086; Parham SN, 2001, EMBO J, V20, P2111, DOI 10.1093/emboj/20.9.2111; Paushkin SV, 1996, EMBO J, V15, P3127, DOI 10.1002/j.1460-2075.1996.tb00675.x; POULTER M, 1992, BRAIN, V115, P675, DOI 10.1093/brain/115.3.675; Prusiner SB, 1998, CELL, V93, P337, DOI 10.1016/S0092-8674(00)81163-0; Romanova NV, 2009, PROTEIN PEPTIDE LETT, V16, P598, DOI 10.2174/092986609788490078; Ross CD, 2009, GENETICS, V183, P929, DOI 10.1534/genetics.109.109322; Ross ED, 2005, P NATL ACAD SCI USA, V102, P12825, DOI 10.1073/pnas.0506136102; Ross ED, 2010, PRION, V4, DOI 10.4161/pri.4.2.12190; Schlumpberger M, 2001, MOL CELL BIOL, V21, P7035, DOI 10.1128/MCB.21.20.7035-7046.2001; SHERMAN F, 1991, METHOD ENZYMOL, V194, P3; Shkundina IS, 2006, GENETICS, V172, P827, DOI 10.1534/genetics.105.048660; Shorter J, 2004, SCIENCE, V304, P1793, DOI 10.1126/science.1098007; Shorter J, 2008, NEUROSIGNALS, V16, P63, DOI 10.1159/000109760; Sondheimer N, 2000, MOL CELL, V5, P163, DOI 10.1016/S1097-2765(00)80412-8; Song YT, 2005, EUKARYOT CELL, V4, P289, DOI 10.1128/EC.4.2.289-297.2005; STANSFIELD I, 1995, EMBO J, V14, P4365, DOI 10.1002/j.1460-2075.1995.tb00111.x; Street AG, 1999, P NATL ACAD SCI USA, V96, P9074, DOI 10.1073/pnas.96.16.9074; Tank EMH, 2007, MOL CELL BIOL, V27, P5445, DOI 10.1128/MCB.02127-06; TERAVANESYAN MD, 1994, GENETICS, V137, P671; TERAVANESYAN MD, 1993, MOL MICROBIOL, V7, P683, DOI 10.1111/j.1365-2958.1993.tb01159.x; Tessier PM, 2009, NAT STRUCT MOL BIOL, V16, P598, DOI 10.1038/nsmb.1617; Toombs JA, 2010, MOL CELL BIOL, V30, P319, DOI 10.1128/MCB.01140-09; Toyama BH, 2007, NATURE, V449, P233, DOI 10.1038/nature06108; TUITE MF, 1981, GENETICS, V98, P691; Vitrenko YA, 2007, CURR GENET, V51, P309, DOI 10.1007/s00294-007-0127-0; Wadsworth JD, 2003, BRIT MED BULL, V66, P241, DOI 10.1093/bmb/66.1.241; Wegrzyn RD, 2001, MOL CELL BIOL, V21, P4656, DOI 10.1128/MCB.21.14.4656-4669.2001; WICKNER RB, 1994, SCIENCE, V264, P566, DOI 10.1126/science.7909170; Wickner RB, 2010, FEMS YEAST RES, V10, P980, DOI 10.1111/j.1567-1364.2010.00666.x; Yuan C, 2007, FEBS LETT, V581, P241, DOI 10.1016/j.febslet.2006.12.019; ZHOURAVLEVA G, 1995, EMBO J, V14, P4065, DOI 10.1002/j.1460-2075.1995.tb00078.x	54	25	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2011	6	7							e21953	10.1371/journal.pone.0021953	http://dx.doi.org/10.1371/journal.pone.0021953			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791IA	21760933	Green Submitted, Green Published, gold			2022-12-27	WOS:000292657200036
J	Phillips, JE; Huang, EY; Shaulsky, G; Gomer, RH				Phillips, Jonathan E.; Huang, Eryong; Shaulsky, Gad; Gomer, Richard H.			The Putative bZIP Transcripton Factor BzpN Slows Proliferation and Functions in the Regulation of Cell Density by Autocrine Signals in Dictyostelium	PLOS ONE			English	Article							GENE-EXPRESSION; PRIMARY TUMOR; DISCOIDEUM; CHALONE; SIZE; PROTEINS; DORMANCY; GROWTH; DIFFERENTIATION; DISEASE	The secreted proteins AprA and CfaD function as autocrine signals that inhibit cell proliferation in Dictyostelium discoideum, thereby regulating cell numbers by a negative feedback mechanism. We report here that the putative basic leucine zipper transcription factor BzpN plays a role in the inhibition of proliferation by AprA and CfaD. Cells lacking BzpN proliferate more rapidly than wild-type cells but do not reach a higher stationary density. Recombinant AprA inhibits wild-type cell proliferation but does not inhibit the proliferation of cells lacking BzpN. Recombinant CfaD also inhibits wild-type cell proliferation, but promotes the proliferation of cells lacking BzpN. Overexpression of BzpN results in a reduced cell density at stationary phase, and this phenotype requires AprA, CfaD, and the kinase QkgA. Conditioned media from high-density cells stops the proliferation of wild-type but not bzpN(-) cells and induces a nuclear localization of a BzpN-GFP fusion protein, though this localization does not require AprA or CfaD. Together, the data suggest that BzpN is necessary for some but not all of the effects of AprA and CfaD, and that BzpN may function downstream of AprA and CfaD in a signal transduction	[Phillips, Jonathan E.] Rice Univ, Dept Biochem & Cell Biol, Houston, TX 77251 USA; [Huang, Eryong; Shaulsky, Gad] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Gomer, Richard H.] Texas A&M Univ, Dept Biol, College Stn, TX 77843 USA	Rice University; Baylor College of Medicine; Texas A&M University System; Texas A&M University College Station	Phillips, JE (corresponding author), Rice Univ, Dept Biochem & Cell Biol, POB 1892, Houston, TX 77251 USA.	rgomer@bio.tamu.edu		Gomer, Richard/0000-0003-2361-4307; Phillips, Jonathan/0000-0001-9896-5895; Shaulsky, Gad/0000-0002-0532-0551	NIH [GM074990]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074990] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH grant GM074990. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHERN KG, 1988, NUCLEIC ACIDS RES, V16, P6825; Aubry L, 1999, ANNU REV CELL DEV BI, V15, P469, DOI 10.1146/annurev.cellbio.15.1.469; Bakthavatsalam D, 2008, J CELL SCI, V121, P2473, DOI 10.1242/jcs.026682; Bakthavatsalam D, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-44; Bokko PB, 2007, MOL BIOL CELL, V18, P1874, DOI 10.1091/mbc.E06-09-0881; Brock DA, 2005, DEVELOPMENT, V132, P4553, DOI 10.1242/dev.02032; Brock DA, 1999, GENE DEV, V13, P1960, DOI 10.1101/gad.13.15.1960; BULLOUGH WS, 1964, EXP CELL RES, V36, P192, DOI 10.1016/0014-4827(64)90172-7; BUSCH SJ, 1990, TRENDS GENET, V6, P36, DOI 10.1016/0168-9525(90)90071-D; Chen GK, 2004, DEVELOPMENT, V131, P2619, DOI 10.1242/dev.01151; Choe JM, 2009, BMC BIOCHEM, V10, DOI 10.1186/1471-2091-10-4; Demicheli R, 2001, SEMIN CANCER BIOL, V11, P297, DOI 10.1006/scbi.2001.0385; Faix J, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh136; GARCIAGIRALT E, 1970, EUR J CLIN BIOL RES, V15, P1012; GOMER RH, 1991, DEVELOPMENT, V112, P269; Gomer RH, 2001, NAT REV MOL CELL BIO, V2, P48, DOI 10.1038/35048058; Guba M, 2001, CANCER RES, V61, P5575; HOUCK JC, 1972, NATURE-NEW BIOL, V240, P210, DOI 10.1038/newbio240210a0; Huang EY, 2006, DEVELOPMENT, V133, P449, DOI 10.1242/dev.02240; JAIN R, 1992, GENE DEV, V6, P390, DOI 10.1101/gad.6.3.390; Jakoby M, 2002, TRENDS PLANT SCI, V7, P106, DOI 10.1016/S1360-1385(01)02223-3; Kagaya Y, 2002, PLANT CELL, V14, P3177, DOI 10.1105/tpc.005272; Kango-Singh M, 2009, DEV DYNAM, V238, P1627, DOI 10.1002/dvdy.21996; KERR L D, 1992, Current Opinion in Cell Biology, V4, P496, DOI 10.1016/0955-0674(92)90017-7; Kessin R.H., 2001, DICTYOSTELIUM EVOLUT; LANDSCHULZ WH, 1988, SCIENCE, V240, P1759, DOI 10.1126/science.3289117; Manahan CL, 2004, ANNU REV CELL DEV BI, V20, P223, DOI 10.1146/annurev.cellbio.20.011303.132633; MANSTEIN DJ, 1995, GENE, V162, P129, DOI 10.1016/0378-1119(95)00351-6; McPherron AC, 1997, NATURE, V387, P83, DOI 10.1038/387083a0; Peeters CFJM, 2008, ANN SURG ONCOL, V15, P3308, DOI 10.1245/s10434-008-0029-5; Phillips JE, 2010, EUKARYOT CELL, V9, P1557, DOI 10.1128/EC.00121-10; Rot G, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-265; Souza GM, 1998, DEVELOPMENT, V125, P2291; Su TT, 1998, CURR BIOL, V8, pR687, DOI 10.1016/S0960-9822(98)70436-1; Sykiotis GP, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3112re3; Thompson CRL, 2004, DEVELOPMENT, V131, P513, DOI 10.1242/dev.00939; Veltman DM, 2009, PLASMID, V61, P110, DOI 10.1016/j.plasmid.2008.11.003; VOADEN MJ, 1968, EXP EYE RES, V7, P326, DOI 10.1016/S0014-4835(68)80045-4; YARGER J, 1974, J CELL SCI, V14, P681; Zhukovskaya NV, 2006, DEVELOPMENT, V133, P439, DOI 10.1242/dev.02190	41	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2011	6	7							e21765	10.1371/journal.pone.0021765	http://dx.doi.org/10.1371/journal.pone.0021765			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791HI	21760904	Green Submitted, Green Published, gold			2022-12-27	WOS:000292655400017
J	Proverbio, AM; Riva, F; Paganelli, L; Cappa, SF; Canessa, N; Perani, D; Zani, A				Proverbio, Alice Mado; Riva, Federica; Paganelli, Laura; Cappa, Stefano F.; Canessa, Nicola; Perani, Daniela; Zani, Alberto			Neural Coding of Cooperative vs. Affective Human Interactions: 150 ms to Code the Action's Purpose	PLOS ONE			English	Article							EXTRASTRIATE BODY AREA; SEX-DIFFERENCES; MIRROR-NEURON; GENDER-DIFFERENCES; CORTICAL RESPONSE; FACE PERCEPTION; PARIETAL AREAS; BRAIN; HAND; RECOGNITION	The timing and neural processing of the understanding of social interactions was investigated by presenting scenes in which 2 people performed cooperative or affective actions. While the role of the human mirror neuron system (MNS) in understanding actions and intentions is widely accepted, little is known about the time course within which these aspects of visual information are automatically extracted. Event-Related Potentials were recorded in 35 university students perceiving 260 pictures of cooperative (e. g., 2 people dragging a box) or affective (e. g., 2 people smiling and holding hands) interactions. The action's goal was automatically discriminated at about 150-170 ms, as reflected by occipito/temporal N170 response. The swLORETA inverse solution revealed the strongest sources in the right posterior cingulate cortex (CC) for affective actions and in the right pSTS for cooperative actions. It was found a right hemispheric asymmetry that involved the fusiform gyrus (BA37), the posterior CC, and the medial frontal gyrus (BA10/11) for the processing of affective interactions, particularly in the 155-175 ms time window. In a later time window (200-250 ms) the processing of cooperative interactions activated the left post-central gyrus (BA3), the left parahippocampal gyrus, the left superior frontal gyrus (BA10), as well as the right premotor cortex (BA6). Women showed a greater response discriminative of the action's goal compared to men at P300 and anterior negativity level (220-500 ms). These findings might be related to a greater responsiveness of the female vs. male MNS. In addition, the discriminative effect was bilateral in women and was smaller and left-sided in men. Evidence was provided that perceptually similar social interactions are discriminated on the basis of the agents' intentions quite early in neural processing, differentially activating regions devoted to face/body/action coding, the limbic system and the MNS.	[Proverbio, Alice Mado; Riva, Federica; Paganelli, Laura] Univ Milano Bicocca, Dept Psychol, Milan, Italy; [Zani, Alberto] CNR, Inst Mol Bioimaging & Physiol, I-20133 Milan, Italy; [Cappa, Stefano F.; Canessa, Nicola; Perani, Daniela] Univ Vita Salute San Raffaele, Milan, Italy; [Cappa, Stefano F.; Canessa, Nicola; Perani, Daniela] Ist Sci San Raffaele, Div Neurosci, I-20132 Milan, Italy	University of Milano-Bicocca; Consiglio Nazionale delle Ricerche (CNR); Istituto di Bioimmagini e Fisiologia Molecolare (IBFM-CNR); Vita-Salute San Raffaele University; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele	Proverbio, AM (corresponding author), Univ Milano Bicocca, Dept Psychol, Milan, Italy.	mado.proverbio@unimib.it	Zani, Alberto/ABG-8894-2020; Cappa, Stefano/B-1874-2014; Perani, Daniela/AAN-3221-2020; Canessa, Nicola/K-3223-2016; Zani, Alberto/ABI-3498-2020	Cappa, Stefano/0000-0003-1003-3925; Canessa, Nicola/0000-0002-0179-6384; Zani, Alberto/0000-0002-3906-7988; Proverbio, Alice Mado/0000-0002-5138-1523	University of Milano-Bicocca; CNR	University of Milano-Bicocca; CNR(Consiglio Nazionale delle Ricerche (CNR))	This work was funded by FAR 2008 grants from the University of Milano-Bicocca to AMP and CNR grants to AZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abell F, 2000, COGNITIVE DEV, V15, P1, DOI 10.1016/S0885-2014(00)00014-9; Adolphs R, 2003, NAT REV NEUROSCI, V4, P165, DOI 10.1038/nrn1056; Avikainen S, 2002, NEUROIMAGE, V15, P640, DOI 10.1006/nimg.2001.1029; Bach P, 2009, SOC NEUROSCI-UK, V4, P212, DOI 10.1080/17470910802362546; Baron-Cohen S, 2003, J AUTISM DEV DISORD, V33, P509, DOI 10.1023/A:1025879411971; Baron-Cohen S, 2005, SCIENCE, V310, P819, DOI 10.1126/science.1115455; Bentin S, 1996, J COGNITIVE NEUROSCI, V8, P551, DOI 10.1162/jocn.1996.8.6.551; Bourne VJ, 2005, NEUROPSYCHOLOGIA, V43, P953, DOI 10.1016/j.neuropsychologia.2004.08.007; Buccino G, 2001, EUR J NEUROSCI, V13, P400, DOI 10.1046/j.1460-9568.2001.01385.x; Buccino G, 2004, NEURON, V42, P323, DOI 10.1016/S0896-6273(04)00181-3; Caldara R, 2004, NEUROREPORT, V15, P905, DOI 10.1097/00001756-200404090-00034; CAPPA S, I SEE WHAT YOU UNPUB; Carter EJ, 2011, NEUROIMAGE, V54, P1634, DOI 10.1016/j.neuroimage.2010.08.077; Centelles L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015749; Cheng Y, 2009, NEUROSCIENCE, V158, P713, DOI 10.1016/j.neuroscience.2008.10.026; Cheng YW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002113; DECETY J, 1994, NATURE, V371, P600, DOI 10.1038/371600a0; Domes G, 2007, BIOL PSYCHIAT, V61, P731, DOI 10.1016/j.biopsych.2006.07.015; Downing PE, 2006, SOC NEUROSCI, V1, P52, DOI 10.1080/17470910600668854; Fecteau S, 2004, NEUROREPORT, V15, P2625, DOI 10.1097/00001756-200412030-00013; Freeman JB, 2010, NEUROREPORT, V21, P24, DOI 10.1097/WNR.0b013e3283320d54; George N, 2005, COGNITIVE BRAIN RES, V24, P663, DOI 10.1016/j.cogbrainres.2005.03.017; Gliga T, 2005, J COGNITIVE NEUROSCI, V17, P1328, DOI 10.1162/0898929055002481; Grezes J, 2001, HUM BRAIN MAPP, V12, P1, DOI 10.1002/1097-0193(200101)12:1<1::AID-HBM10>3.0.CO;2-V; Gunter TC, 2004, NEUROSCI LETT, V372, P52, DOI 10.1016/j.neulet.2004.09.011; Hamilton AFD, 2006, J NEUROSCI, V26, P1133, DOI 10.1523/JNEUROSCI.4551-05.2006; Hamilton AFD, 2008, CEREB CORTEX, V18, P1160, DOI 10.1093/cercor/bhm150; Hari R, 1998, NEUROSCI LETT, V240, P131, DOI 10.1016/S0304-3940(97)00945-2; Haxby JV, 2000, TRENDS COGN SCI, V4, P223, DOI 10.1016/S1364-6613(00)01482-0; Heider F, 1944, AM J PSYCHOL, V57, P243, DOI 10.2307/1416950; Henson RN, 2003, CEREB CORTEX, V13, P793, DOI 10.1093/cercor/13.7.793; Iacoboni M, 2005, PLOS BIOL, V3, P529, DOI 10.1371/journal.pbio.0030079; Iacoboni M, 2004, NEUROIMAGE, V21, P1167, DOI 10.1016/j.neuroimage.2003.11.013; Johnson BW, 2002, NEUROREPORT, V13, P1929, DOI 10.1097/00001756-200210280-00020; Junghofer M, 2001, PSYCHOPHYSIOLOGY, V38, P175, DOI 10.1017/S0048577201000762; Kanwisher N, 2006, PHILOS T R SOC B, V361, P2109, DOI 10.1098/rstb.2006.1934; Kaplan JT, 2006, SOC NEUROSCI-UK, V1, P175, DOI 10.1080/17470910600985605; Kemp AH, 2004, NEUROIMAGE, V21, P632, DOI 10.1016/j.neuroimage.2003.09.055; Kokal I, 2009, NEUROIMAGE, V47, P2046, DOI 10.1016/j.neuroimage.2009.06.010; Kovalev VA, 2003, NEUROIMAGE, V19, P895, DOI 10.1016/S1053-8119(03)00140-X; McCabe K, 2001, P NATL ACAD SCI USA, V98, P11832, DOI 10.1073/pnas.211415698; Molnar-Szakacs I, 2006, NEUROIMAGE, V33, P923, DOI 10.1016/j.neuroimage.2006.07.035; Mottonen R, 2005, NEUROIMAGE, V24, P731, DOI 10.1016/j.neuroimage.2004.10.011; Newman-Norlund R, 2010, BRAIN RES, V1315, P63, DOI 10.1016/j.brainres.2009.11.065; O Scalaidhe SP, 1999, CEREB CORTEX, V9, P459, DOI 10.1093/cercor/9.5.459; Ortigue S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012160; Palmero-Soler E, 2007, PHYS MED BIOL, V52, P1783, DOI 10.1088/0031-9155/52/7/002; PASCUALMARQUI RD, 1994, INT J PSYCHOPHYSIOL, V18, P49, DOI 10.1016/0167-8760(84)90014-X; PAVLOVA M, 2010, CEREB CORTEX; Pavlova M, 2010, NEUROIMAGE, V50, P1327, DOI 10.1016/j.neuroimage.2009.12.096; Pelphrey KA, 2004, J COGNITIVE NEUROSCI, V16, P1706, DOI 10.1162/0898929042947900; Pelphrey KA, 2003, J NEUROSCI, V23, P6819; Perry A, 2009, BRAIN RES, V1282, P126, DOI 10.1016/j.brainres.2009.05.059; Phillips ML, 1998, PSYCHIAT RES-NEUROIM, V83, P127, DOI 10.1016/S0925-4927(98)00036-5; Pineda JA, 2008, BEHAV BRAIN FUNCT, V4, DOI 10.1186/1744-9081-4-47; Pizzagalli DA, 2002, NEUROIMAGE, V16, P663, DOI 10.1006/nimg.2002.1126; Proverbio AM, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-44; Proverbio AM, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-56; Proverbio AM, 2007, SCAND J PSYCHOL, V48, P477, DOI 10.1111/j.1467-9450.2007.00616.x; Proverbio AM, 2006, NEUROPSYCHOLOGIA, V44, P2987, DOI 10.1016/j.neuropsychologia.2006.06.015; Proverbio AM, 2010, NEUROPSYCHOLOGIA, V48, P1454, DOI 10.1016/j.neuropsychologia.2010.01.015; Proverbio AM, 2009, NEUROPSYCHOLOGIA, V47, P2374, DOI 10.1016/j.neuropsychologia.2008.10.030; Proverbio AM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005389; Puce A, 1998, J NEUROSCI, V18, P2188; Rilea SL, 2004, BRAIN COGNITION, V56, P332, DOI 10.1016/j.bandc.2004.09.002; Rilling JK, 2002, NEURON, V35, P395, DOI 10.1016/S0896-6273(02)00755-9; Rizzolatti G, 2004, ANNU REV NEUROSCI, V27, P169, DOI 10.1146/annurev.neuro.27.070203.144230; Rizzolatti G, 2010, NAT REV NEUROSCI, V11, P264, DOI 10.1038/nrn2805; Rossion B, 2003, NEUROIMAGE, V20, P1609, DOI 10.1016/j.neuroimage.2003.07.010; Schneider F, 2000, HUM BRAIN MAPP, V9, P226, DOI 10.1002/(SICI)1097-0193(200004)9:4<226::AID-HBM4>3.0.CO;2-K; Schubotz RI, 2004, J NEUROSCI, V24, P5467, DOI 10.1523/JNEUROSCI.1169-04.2004; Schulte-Ruther M, 2008, NEUROIMAGE, V42, P393, DOI 10.1016/j.neuroimage.2008.04.180; Schulte-Ruther M, 2007, J COGNITIVE NEUROSCI, V19, P1354, DOI 10.1162/jocn.2007.19.8.1354; SHAYWITZ BA, 1995, NATURE, V373, P607, DOI 10.1038/373607a0; Shibata H, 2009, NEUROSCI LETT, V452, P189, DOI 10.1016/j.neulet.2009.01.042; Shmuelof L, 2007, NEUROSCIENTIST, V13, P667, DOI 10.1177/1073858407302457; Singer T, 2006, NATURE, V439, P466, DOI 10.1038/nature04271; Takahashi H, 2008, PSYCHIAT CLIN NEUROS, V62, P214, DOI 10.1111/j.1440-1819.2008.01757.x; Taylor MJ, 2011, BRAIN RES, V1381, P167, DOI 10.1016/j.brainres.2010.12.083; Tremoulet PD, 2006, PERCEPT PSYCHOPHYS, V68, P1047, DOI 10.3758/BF03193364; Ulloa ER, 2007, BEHAV BRAIN RES, V183, P188, DOI 10.1016/j.bbr.2007.06.007; Vogt BA, 2006, NEUROIMAGE, V29, P452, DOI 10.1016/j.neuroimage.2005.07.048; Yang CY, 2009, BRAIN RES, V1251, P176, DOI 10.1016/j.brainres.2008.11.062; Zanow F, 2004, BRAIN TOPOGR, V16, P287	84	25	27	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2011	6	7							e22026	10.1371/journal.pone.0022026	http://dx.doi.org/10.1371/journal.pone.0022026			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791HI	21760948	Green Published, gold, Green Submitted			2022-12-27	WOS:000292655400040
J	Barber, LJ; Rosa, JMR; Kozarewa, I; Fenwick, K; Assiotis, I; Mitsopoulos, C; Sims, D; Hakas, J; Zvelebil, M; Lord, CJ; Ashworth, A				Barber, Louise J.; Rosa, Juan M. Rosa; Kozarewa, Iwanka; Fenwick, Kerry; Assiotis, Ioannis; Mitsopoulos, Costas; Sims, David; Hakas, Jarle; Zvelebil, Marketa; Lord, Christopher J.; Ashworth, Alan			Comprehensive Genomic Analysis of a BRCA2 Deficient Human Pancreatic Cancer	PLOS ONE			English	Article							HOMOLOGY-DIRECTED REPAIR; COLORECTAL-CANCER; HUMAN BREAST; CELL-LINES; GENE; MUTATIONS; PROTEIN; DCC; DNA; SEQUENCE	Capan-1 is a well-characterised BRCA2-deficient human cell line isolated from a liver metastasis of a pancreatic adenocarcinoma. Here we report a genome-wide assessment of structural variations and high-depth exome characterization of single nucleotide variants and small insertion/deletions in Capan-1. To identify potential somatic and tumour-associated variations in the absence of a matched-normal cell line, we devised a novel method based on the analysis of HapMap samples. We demonstrate that Capan-1 has one of the most rearranged genomes sequenced to date. Furthermore, small insertions and deletions are detected more frequently in the context of short sequence repeats than in other genomes. We also identify a number of novel mutations that may represent genetic changes that have contributed to tumour progression. These data provide insight into the genomic effects of loss of BRCA2 function.	[Barber, Louise J.; Rosa, Juan M. Rosa; Kozarewa, Iwanka; Fenwick, Kerry; Assiotis, Ioannis; Mitsopoulos, Costas; Sims, David; Hakas, Jarle; Zvelebil, Marketa; Lord, Christopher J.; Ashworth, Alan] Inst Canc Res, Breakthrough Breast Canc Res Ctr, London SW3 6JB, England	Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK	Barber, LJ (corresponding author), Inst Canc Res, Breakthrough Breast Canc Res Ctr, London SW3 6JB, England.	Chris.Lord@icr.ac.uk; Alan.Ashworth@icr.ac.uk	Lord, Christopher J/B-3295-2012; Lord, Christopher/AAX-7130-2021; Barber, Louise J./L-8579-2019	Lord, Christopher J/0000-0002-3226-0515; Barber, Louise J./0000-0001-9265-3516; Mitsopoulos, Costas/0000-0002-9116-5921; Zvelebil, Marketa/0000-0001-8018-5591	Breakthrough Breast Cancer, Cancer Research UK; American Association for Cancer Research/Stand Up to Cancer	Breakthrough Breast Cancer, Cancer Research UK(Cancer Research UK); American Association for Cancer Research/Stand Up to Cancer	The authors thank Breakthrough Breast Cancer, Cancer Research UK, and the American Association for Cancer Research/Stand Up to Cancer for funding this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn SM, 2009, GENOME RES, V19, P1622, DOI 10.1101/gr.092197.109; Antoniou A, 2003, AM J HUM GENET, V72, P1117, DOI 10.1086/375033; Bartsch D, 1999, CANCER LETT, V139, P43, DOI 10.1016/S0304-3835(98)00380-2; Campbell PJ, 2008, NAT GENET, V40, P722, DOI 10.1038/ng.128; Chen K, 2009, NAT METHODS, V6, P677, DOI [10.1038/NMETH.1363, 10.1038/nmeth.1363]; Chen ZH, 1996, CANCER RES, V56, P1083; Clark MJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000832; Dann CE, 2001, NATURE, V412, P86, DOI 10.1038/35083601; Davies OR, 2007, NAT STRUCT MOL BIOL, V14, P475, DOI 10.1038/nsmb1251; Ding L, 2010, NATURE, V464, P999, DOI 10.1038/nature08989; Edwards SL, 2008, NATURE, V451, P1111, DOI 10.1038/nature06548; Esashi F, 2007, NAT STRUCT MOL BIOL, V14, P468, DOI 10.1038/nsmb1245; FOGH J, 1977, JNCI-J NATL CANCER I, V59, P221, DOI 10.1093/jnci/59.1.221; FOGH J, 1977, J NATL CANCER I, V58, P209, DOI 10.1093/jnci/58.2.209; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Ghadimi BM, 1999, AM J PATHOL, V154, P525, DOI 10.1016/S0002-9440(10)65298-4; Goggins M, 1996, CANCER RES, V56, P5360; Gudmundsdottir K, 2006, ONCOGENE, V25, P5864, DOI 10.1038/sj.onc.1209874; Herath NI, 2010, INT J CANCER, V126, P2003, DOI 10.1002/ijc.25147; Hilgers W, 2000, GENE CHROMOSOME CANC, V27, P353, DOI 10.1002/(SICI)1098-2264(200004)27:4<353::AID-GCC3>3.3.CO;2-X; Hoeijmakers JHJ, 2001, NATURE, V411, P366, DOI 10.1038/35077232; Hsiang D, 1997, AM J SURG, V174, P242, DOI 10.1016/S0002-9610(97)00133-5; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; KALTHOFF H, 1993, ONCOGENE, V8, P289; KeinoMasu K, 1996, CELL, V87, P175, DOI 10.1016/S0092-8674(00)81336-7; Koike J, 1999, BIOCHEM BIOPH RES CO, V262, P39, DOI 10.1006/bbrc.1999.1161; Kozarewa I, 2009, NAT METHODS, V6, P291, DOI [10.1038/nmeth.1311, 10.1038/NMETH.1311]; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; Lord CJ, 2008, CURR OPIN PHARMACOL, V8, P363, DOI 10.1016/j.coph.2008.06.016; Mackay A, 2009, BREAST CANCER RES TR, V118, P481, DOI 10.1007/s10549-008-0296-7; Mehlen P, 1998, NATURE, V395, P801, DOI 10.1038/27441; Meriane M, 2004, J CELL BIOL, V167, P687, DOI 10.1083/jcb.200405053; Moynahan ME, 2001, MOL CELL, V7, P263, DOI 10.1016/S1097-2765(01)00174-5; Moynahan ME, 1999, MOL CELL, V4, P511, DOI 10.1016/S1097-2765(00)80202-6; Namkoong J, 2007, CANCER RES, V67, P2298, DOI 10.1158/0008-5472.CAN-06-3665; Natrajan R, 2010, BREAST CANCER RES TR, V121, P575, DOI 10.1007/s10549-009-0501-3; Natsume W, 2006, MOL BIOL CELL, V17, P2592, DOI 10.1091/mbc.E05-10-0909; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Pleasance ED, 2010, NATURE, V463, P191, DOI 10.1038/nature08658; Pleasance ED, 2010, NATURE, V463, P184, DOI 10.1038/nature08629; Rehn M, 1998, TRENDS BIOCHEM SCI, V23, P415, DOI 10.1016/S0968-0004(98)01290-0; Schwarz JM, 2010, NAT METHODS, V7, P575, DOI 10.1038/nmeth0810-575; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Spain BH, 1999, P NATL ACAD SCI USA, V96, P13920, DOI 10.1073/pnas.96.24.13920; Stephens PJ, 2011, CELL, V144, P27, DOI 10.1016/j.cell.2010.11.055; Stephens PJ, 2009, NATURE, V462, P1005, DOI 10.1038/nature08645; Tai YC, 2007, J NATL CANCER I, V99, P1811, DOI 10.1093/jnci/djm203; Teng DHF, 1997, CANCER RES, V57, P4177; Terasaki H, 2002, INT J MOL MED, V9, P107; Turnbull C, 2005, CLIN MED, V5, P491, DOI 10.7861/clinmedicine.5-5-491; Tutt A, 2001, EMBO J, V20, P4704, DOI 10.1093/emboj/20.17.4704; Weinstock DM, 2006, BLOOD, V107, P777, DOI 10.1182/blood-2005-06-2437; Wong HH, 2009, NAT REV GASTRO HEPAT, V6, P412, DOI 10.1038/nrgastro.2009.89; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Yachida S, 2010, NATURE, V467, P1114, DOI 10.1038/nature09515; Yamasaki N, 2010, ONCOGENE, V29, P1963, DOI 10.1038/onc.2009.475; Yang HJ, 2002, SCIENCE, V297, P1837, DOI 10.1126/science.297.5588.1837; Ye K, 2009, BIOINFORMATICS, V25, P2865, DOI 10.1093/bioinformatics/btp394; Yuan SSF, 1999, CANCER RES, V59, P3547; Zeng G, 2006, NEOPLASIA, V8, P279, DOI 10.1593/neo.05607	64	15	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2011	6	7							e21639	10.1371/journal.pone.0021639	http://dx.doi.org/10.1371/journal.pone.0021639			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	789JO	21750719	Green Submitted, gold, Green Published			2022-12-27	WOS:000292512000018
J	Campbell, JL; Arora, J; Cowell, SF; Garg, A; Eu, P; Bhargava, SK; Bansal, V				Campbell, Jos L.; Arora, Jyoti; Cowell, Simon F.; Garg, Ashish; Eu, Peter; Bhargava, Suresh K.; Bansal, Vipul			Quasi-Cubic Magnetite/Silica Core-Shell Nanoparticles as Enhanced MRI Contrast Agents for Cancer Imaging	PLOS ONE			English	Article							IRON-OXIDE NANOPARTICLES; MAGNETIC NANOPARTICLES; COLLOIDAL PARTICLES; SIZE; RELAXIVITY; GADOLINIUM; DIAGNOSIS; SILICA	Development of magnetic resonance imaging (MRI) contrast agents that can be readily applied for imaging of biological tissues under clinical settings is a challenging task. This is predominantly due to the expectation of an ideal MR agent being able to be synthesized in large quantities, possessing longer shelf life, reasonable biocompatibility, tolerance against its aggregation in biological fluids, and high relaxivity, resulting in better contrast during biological imaging. Although a repertoire of reports address various aforementioned issues, the previously reported results are far from optimal, which necessitates further efforts in this area. In this study, we demonstrate facile large-scale synthesis of sub-100 nm quasi-cubic magnetite and magnetite/ silica core-shell (Mag@SiO2) nanoparticles and their applicability as a biocompatible T2 contrast agent for MRI of biological tissues. Our study suggests that silica-coated magnetite nanoparticles reported in this study can potentially act as improved MR contrast agents by addressing a number of aforementioned issues, including longer shelf life and stability in biological fluids. Additionally, our in vitro and in vivo studies clearly demonstrate the importance of silica coating towards improved applicability of T2 contrast agents for cancer imaging.	[Campbell, Jos L.; Bhargava, Suresh K.; Bansal, Vipul] RMIT Univ, Sch Appl Sci, Melbourne, Vic, Australia; [Arora, Jyoti; Cowell, Simon F.] RMIT Univ, Sch Med Sci, Melbourne, Vic, Australia; [Arora, Jyoti] Cell Therapies & Peter MacCallum Canc Ctr, Melbourne, Vic, Australia; [Garg, Ashish] Indian Inst Technol, Dept Mat Sci & Engn, Kanpur 208016, Uttar Pradesh, India; [Eu, Peter] Peter MacCallum Canc Ctr, Melbourne, Vic, Australia	Royal Melbourne Institute of Technology (RMIT); Royal Melbourne Institute of Technology (RMIT); Peter Maccallum Cancer Center; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Kanpur; Peter Maccallum Cancer Center	Campbell, JL (corresponding author), RMIT Univ, Sch Appl Sci, Melbourne, Vic, Australia.	peter.eu@petermac.org; suresh.bhargava@rmit.edu.au; vipul.bansal@rmit.edu.au	Bhargava, Suresh K./AAQ-2675-2020; Bansal, Vipul/B-2485-2008; Garg, Ashish/F-9843-2010; Bhargava, Suresh K./C-5783-2011	Bhargava, Suresh K./0000-0002-3127-8166; Bansal, Vipul/0000-0002-3354-4317; Bhargava, Suresh K./0000-0002-3127-8166; Garg, Ashish/0000-0003-4163-5355				Alberola AP, 2009, BIOMATERIALS, V30, P3766, DOI 10.1016/j.biomaterials.2009.03.031; Babes L, 1999, J COLLOID INTERF SCI, V212, P474, DOI 10.1006/jcis.1998.6053; Bansal V, 2011, AUST J CHEM, V64, P279, DOI 10.1071/CH10343; Bardhan R, 2009, ADV FUNCT MATER, V19, P3901, DOI 10.1002/adfm.200901235; Bharde A, 2006, SMALL, V2, P135, DOI 10.1002/smll.200500180; Chen TJ, 2009, J BIOL INORG CHEM, V14, P253, DOI 10.1007/s00775-008-0445-9; CHIKAZUMI S, 1987, J MAGN MAGN MATER, V65, P245, DOI 10.1016/0304-8853(87)90043-6; Fang CL, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/12/125601; Goloverda G, 2009, J MAGN MAGN MATER, V321, P1372, DOI 10.1016/j.jmmm.2009.02.041; Gupta AK, 2005, BIOMATERIALS, V26, P3995, DOI 10.1016/j.biomaterials.2004.10.012; High WA, 2007, J AM ACAD DERMATOL, V56, P21, DOI 10.1016/j.jaad.2006.10.047; Hilger I, 2007, NANOTECHNOLOGY, V18, DOI 10.1088/0957-4484/18/13/135103; Jun YW, 2005, J AM CHEM SOC, V127, P5732, DOI 10.1021/ja0422155; JUN YW, 2007, NANOBIOTECHNOLOGY, V2, P321; Kanal E, 2008, RADIOLOGY, V246, P11, DOI 10.1148/radiol.2461071267; Kobayashi H, 2005, ADV DRUG DELIVER REV, V57, P2271, DOI 10.1016/j.addr.2005.09.016; KOENIG SH, 1995, MAGNET RESON MED, V34, P227, DOI 10.1002/mrm.1910340214; Kuo PH, 2007, RADIOLOGY, V242, P647, DOI 10.1148/radiol.2423061640; Lee JH, 2007, NAT MED, V13, P95, DOI [10.1038/nm1467, 10.20659/jfp.13.1_95]; Losic D, 2010, CHEM COMMUN, V46, P6323, DOI 10.1039/c0cc01305f; Lu AH, 2007, ANGEW CHEM INT EDIT, V46, P1222, DOI 10.1002/anie.200602866; Lu J, 2009, BIOMATERIALS, V30, P2919, DOI 10.1016/j.biomaterials.2009.02.001; MANSOOR A, 2007, NANOTECHNOLOGY CANC, P201; Martina MS, 2005, J AM CHEM SOC, V127, P10676, DOI 10.1021/ja0516460; Morel AL, 2008, ACS NANO, V2, P847, DOI 10.1021/nn800091q; Mulder WJM, 2006, NMR BIOMED, V19, P142, DOI 10.1002/nbm.1011; Muller K, 2007, BIOMATERIALS, V28, P1629, DOI 10.1016/j.biomaterials.2006.12.002; Murakami Y, 2004, THIN SOLID FILMS, V461, P68, DOI 10.1016/j.tsf.2004.02.065; Nel A, 2006, SCIENCE, V311, P622, DOI 10.1126/science.1114397; OHMORI M, 1992, J COLLOID INTERF SCI, V150, P594, DOI 10.1016/0021-9797(92)90229-F; OHMORI M, 1993, J COLLOID INTERF SCI, V160, P288, DOI 10.1006/jcis.1993.1398; Park J, 2004, NAT MATER, V3, P891, DOI 10.1038/nmat1251; Paul KG, 2004, BIOCONJUGATE CHEM, V15, P394, DOI 10.1021/bc034194u; RAI K, 1990, J MAGN MAGN MATER, V85, P233; Saini A, 2004, CLIN RADIOL, V59, P1079, DOI 10.1016/j.crad.2004.04.014; Shukla R, 2005, LANGMUIR, V21, P10644, DOI 10.1021/la0513712; Sivakumar S, 2009, ADV MATER, V21, P1820, DOI 10.1002/adma.200802475; Sun SH, 2004, J AM CHEM SOC, V126, P273, DOI 10.1021/ja0380852; Suzuki K, 2004, LUNG CANCER, V46, P357, DOI 10.1016/j.lungcan.2004.05.011; Taboada E, 2009, ADV FUNCT MATER, V19, P2319, DOI 10.1002/adfm.200801681; Talelli M, 2009, LANGMUIR, V25, P2060, DOI 10.1021/la8036499; Tanaka K, 2010, LANGMUIR, V26, P11759, DOI 10.1021/la1015077; Tromsdorf UI, 2007, NANO LETT, V7, P2422, DOI 10.1021/nl071099b; Tsang SC, 2004, ANGEW CHEM INT EDIT, V43, P5645, DOI 10.1002/anie.200460552; van Straaten ECW, 2004, J NEUROL SCI, V226, P9, DOI 10.1016/j.jns.2004.09.003; Vogl TJ, 2003, EUR RADIOL, V13, P262, DOI 10.1007/s00330-002-1677-7; Wan JQ, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/23/235104; Wang YJ, 2008, NANO LETT, V8, P1741, DOI 10.1021/nl080877c; Wang YXJ, 2001, EUR RADIOL, V11, P2319, DOI 10.1007/s003300100908; WEISSLEDER R, 1989, AM J ROENTGENOL, V152, P167, DOI 10.2214/ajr.152.1.167; Wuang SC, 2008, BIOMATERIALS, V29, P2270, DOI 10.1016/j.biomaterials.2008.01.028; Yoon TJ, 2006, SMALL, V2, P209, DOI [10.1002/smll.200500360, 10.1002/511111.200500360]; Yu X, 2000, MAGNET RESON MED, V44, P867, DOI 10.1002/1522-2594(200012)44:6<867::AID-MRM7>3.0.CO;2-P; YUAN F, 1995, CANCER RES, V55, P3752	54	38	38	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2011	6	7							e21857	10.1371/journal.pone.0021857	http://dx.doi.org/10.1371/journal.pone.0021857			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786HC	21747962	Green Published, Green Submitted, gold			2022-12-27	WOS:000292293400038
J	Greco, D; Kivi, N; Qian, K; Leivonen, SK; Auvinen, P; Auvinen, E				Greco, Dario; Kivi, Niina; Qian, Kui; Leivonen, Suvi-Katri; Auvinen, Petri; Auvinen, Eeva			Human Papillomavirus 16 E5 Modulates the Expression of Host MicroRNAs	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; TUMOR-SUPPRESSIVE MICRORNAS; PROMOTES CELL-PROLIFERATION; MHC CLASS-I; DOWN-REGULATION; MATRIX METALLOPROTEINASE-12; TARGET PREDICTION; CERVICAL-CANCER; TYPE-16 E7; E-CADHERIN	Human papillomavirus (HPV) infection is a prerequisite of developing cervical cancer, approximately half of which are associated with HPV type 16. HPV 16 encodes three oncogenes, E5, E6, and E7, of which E5 is the least studied so far. Its roles in regulating replication and pathogenesis of HPV are not fully understood. Here we utilize high-throughput screening to coordinately investigate the effect of E5 on the expression of host protein-coding and microRNA genes. MicroRNAs form a class of 22nt long noncoding RNAs with regulatory activity. Among the altered cellular microRNAs we focus on the alteration in the expression of miR-146a, miR-203 and miR-324-5p and their target genes in a time interval of 96 hours of E5 induction. Our results indicate that HPV infection and subsequent transformation take place through complex regulatory patterns of gene expression in the host cells, part of which are regulated by the E5 protein.	[Greco, Dario; Qian, Kui; Auvinen, Petri] Univ Helsinki, Inst Biotechnol, DNA Sequencing & Genom Lab, Helsinki, Finland; [Greco, Dario] Karolinska Inst, Dept Biosci & Nutr, Stockholm, Sweden; [Kivi, Niina; Auvinen, Eeva] Univ Helsinki, Haartman Inst, Dept Virol, Helsinki, Finland; [Leivonen, Suvi-Katri] VTT Tech Res Ctr Finland, Turku, Finland; [Auvinen, Eeva] Univ Helsinki, Hosp Lab, Dept Virol & Immunol, Helsinki, Finland	University of Helsinki; Karolinska Institutet; University of Helsinki; VTT Technical Research Center Finland; University of Helsinki	Greco, D (corresponding author), Univ Helsinki, Inst Biotechnol, DNA Sequencing & Genom Lab, Helsinki, Finland.	eeva.auvinen@helsinki.fi	Leivonen, Suvi-Katri/AAK-3096-2021; Auvinen, Petri/D-5044-2009; Auvinen, Petri/AAP-8117-2021; Qian, Kui/J-1942-2014; Greco, Dario/T-7113-2019	Auvinen, Petri/0000-0002-3947-4778; Qian, Kui/0000-0001-7170-533X; Greco, Dario/0000-0001-9195-9003; Leivonen, Suvi-Katri/0000-0003-3224-0757; Auvinen, Eeva/0000-0002-2094-985X	Finnish Cultural Foundation [12256]; Maud Kuistila Foundation; K. Albin Johansson Foundation; Sukupuolitautien Vastustamisyhdistys Foundation; Academy of Finland; Helsinki University	Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); Maud Kuistila Foundation; K. Albin Johansson Foundation; Sukupuolitautien Vastustamisyhdistys Foundation; Academy of Finland(Academy of Finland); Helsinki University	The work was supported by the Finnish Cultural Foundation (http://www.skr.fi/default.asp?docId=12256), Maud Kuistila Foundation (http://www.maudkuistilanmuistosaatio.fi/index.php?lang=en), K. Albin Johansson Foundation (http://www.foundationweb.net/johansson/), Sukupuolitautien Vastustamisyhdistys Foundation (http://sukupuolitaudit.info/yhdistys.htm), the Academy of Finland (http://www.aka.fi/fi/A/), and the Helsinki University Research Funds (http://www.helsinki.fi/rahastot/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashrafi GH, 2006, VIRUS RES, V120, P208, DOI 10.1016/j.virusres.2006.02.005; Ashrafi GH, 2005, INT J CANCER, V113, P276, DOI 10.1002/ijc.20558; Auvinen E, 2004, ARCH VIROL, V149, P1745, DOI 10.1007/s00705-004-0325-8; Auvinen E, 2007, EXP CELL RES, V313, P824, DOI 10.1016/j.yexcr.2006.12.002; Balsitis S, 2006, CANCER RES, V66, P9393, DOI 10.1158/0008-5472.CAN-06-0984; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Berezikov E, 2007, MOL CELL, V28, P328, DOI 10.1016/j.molcel.2007.09.028; Betel D, 2008, NUCLEIC ACIDS RES, V36, pD149, DOI 10.1093/nar/gkm995; Bohling T, 1996, AM J PATHOL, V148, P367; BOSCH FX, 1995, JNCI-J NATL CANCER I, V87, P796, DOI 10.1093/jnci/87.11.796; Bottley G, 2008, ONCOGENE, V27, P1794, DOI 10.1038/sj.onc.1210798; Cai XZ, 2006, J VIROL, V80, P10890, DOI 10.1128/JVI.01175-06; Cai XZ, 2004, RNA, V10, P1957, DOI 10.1261/rna.7135204; Campo MS, 2002, VIRUS RES, V89, P249, DOI 10.1016/S0168-1702(02)00193-4; CONRAD M, 1993, J VIROL, V67, P6170, DOI 10.1128/JVI.67.10.6170-6178.1993; Crusius K, 1998, EXP CELL RES, V241, P76, DOI 10.1006/excr.1998.4024; Crusius K, 1997, ONCOGENE, V15, P1437, DOI 10.1038/sj.onc.1201312; Curtale G, 2010, BLOOD, V115, P265, DOI 10.1182/blood-2009-06-225987; Davidson LA, 2009, CARCINOGENESIS, V30, P2077, DOI 10.1093/carcin/bgp245; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Dweep H, 2011, J BIOMED INFORM, V44, P839, DOI 10.1016/j.jbi.2011.05.002; DYSON N, 1989, SCIENCE, V243, P934, DOI 10.1126/science.2537532; Fehrmann F, 2003, J VIROL, V77, P2819, DOI 10.1128/JVI.77.5.2819-2831.2003; Ferretti E, 2008, EMBO J, V27, P2616, DOI 10.1038/emboj.2008.172; Furuta M, 2010, CARCINOGENESIS, V31, P766, DOI 10.1093/carcin/bgp250; Genther SM, 2003, J VIROL, V77, P2832, DOI 10.1128/JVI.77.5.2832-2842.2003; Gottardo F, 2007, UROL ONCOL-SEMIN ORI, V25, P387, DOI 10.1016/j.urolonc.2007.01.019; Greither T, 2010, INT J CANCER, V126, P73, DOI 10.1002/ijc.24687; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; HECK DV, 1992, P NATL ACAD SCI USA, V89, P4442, DOI 10.1073/pnas.89.10.4442; Hirohashi S, 2003, CANCER SCI, V94, P575, DOI 10.1111/j.1349-7006.2003.tb01485.x; Hiscox S, 1999, J CELL SCI, V112, P3081; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Iorio MV, 2007, CANCER RES, V67, P8699, DOI 10.1158/0008-5472.CAN-07-1936; Ireton RC, 2002, J CELL BIOL, V159, P465, DOI 10.1083/jcb.200205115; JOCHMUSKUDIELKA I, 1989, J NATL CANCER I, V81, P1698, DOI 10.1093/jnci/81.22.1698; Kertesz M, 2007, NAT GENET, V39, P1278, DOI 10.1038/ng2135; Kim YK, 2007, EMBO J, V26, P775, DOI 10.1038/sj.emboj.7601512; Kivi N, 2008, ONCOGENE, V27, P2532, DOI 10.1038/sj.onc.1210916; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Lambert PF, 2005, METH MOLEC MED, V119, P141; Lee Y, 2004, EMBO J, V23, P4051, DOI 10.1038/sj.emboj.7600385; LEECHANACHAI P, 1992, ONCOGENE, V7, P19; Lena AM, 2008, CELL DEATH DIFFER, V15, P1187, DOI 10.1038/cdd.2008.69; Lewis C, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-30; Li W, 2010, INT J GYNECOL CANCER, V20, P227, DOI 10.1111/IGC.0b013e3181cceec5; Lin SL, 2008, RNA, V14, P417, DOI 10.1261/rna.874808; Lozano E, 1998, MOL CARCINOGEN, V21, P273, DOI 10.1002/(SICI)1098-2744(199804)21:4<273::AID-MC6>3.0.CO;2-L; Lu LF, 2010, CELL, V142, P914, DOI 10.1016/j.cell.2010.08.012; Lui WO, 2007, CANCER RES, V67, P6031, DOI 10.1158/0008-5472.CAN-06-0561; Lyu J, 2005, J BIOL CHEM, V280, P21653, DOI 10.1074/jbc.m500374200; Maes OC, 2009, CURR GENOMICS, V10, P154, DOI 10.2174/138920209788185252; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Maragkakis M, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-295; Martinez I, 2008, ONCOGENE, V27, P2575, DOI 10.1038/sj.onc.1210919; Matsumoto S, 1998, AM J PATHOL, V153, P109, DOI 10.1016/S0002-9440(10)65551-4; Maufort JP, 2007, CANCER RES, V67, P6106, DOI 10.1158/0008-5472.CAN-07-0921; Maufort JP, 2010, CANCER RES, V70, P2924, DOI 10.1158/0008-5472.CAN-09-3436; Melar-New M, 2010, J VIROL, V84, P5212, DOI 10.1128/JVI.00078-10; Miranda KC, 2006, CELL, V126, P1203, DOI 10.1016/j.cell.2006.07.031; Murchison EP, 2004, CURR OPIN CELL BIOL, V16, P223, DOI 10.1016/j.ceb.2004.04.003; Nguyen M, 2002, J VIROL, V76, P13039, DOI 10.1128/JVI.76.24.13039-13048.2002; OELZE I, 1995, J VIROL, V69, P4489, DOI 10.1128/JVI.69.7.4489-4494.1995; Oetke C, 2000, ARCH VIROL, V145, P2183, DOI 10.1007/s007050070048; PIM D, 1992, ONCOGENE, V7, P27; Roberts APE, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-1-201; SCHEFFNER M, 1990, CELL, V63, P1129, DOI 10.1016/0092-8674(90)90409-8; SCHEFFNER M, 1993, CELL, V75, P495, DOI 10.1016/0092-8674(93)90384-3; Schetter AJ, 2008, JAMA-J AM MED ASSOC, V299, P425, DOI 10.1001/jama.299.4.425; Schiffman M, 2007, LANCET, V370, P890, DOI [10.1016/S0140-6736(07)61416-0, 10.1016/S0140-6736(13)60022-7]; Shai A, 2007, CANCER RES, V67, P1626, DOI 10.1158/0008-5472.CAN-06-3344; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Sonkoly E, 2008, CLIN EXP DERMATOL, V33, P312, DOI 10.1111/j.1365-2230.2008.02804.x; Sonkoly E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000610; Stanley M, 2006, VACCINE, V24, P16, DOI 10.1016/j.vaccine.2005.09.002; Stoppler MC, 1996, VIROLOGY, V223, P251, DOI 10.1006/viro.1996.0475; STRAIGHT SW, 1993, J VIROL, V67, P4521, DOI 10.1128/JVI.67.8.4521-4532.1993; Suprynowicz FA, 2008, ONCOGENE, V27, P1071, DOI 10.1038/sj.onc.1210725; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Tomakidi P, 2000, EUR J CELL BIOL, V79, P407, DOI 10.1078/0171-9335-00060; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Wang XH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002557; Wang XW, 2008, RNA, V14, P1012, DOI 10.1261/rna.965408; WERNESS BA, 1990, SCIENCE, V248, P76, DOI 10.1126/science.2157286; Williams SMG, 2005, CANCER RES, V65, P6534, DOI 10.1158/0008-5472.CAN-05-0083; Woodman CBJ, 2007, NAT REV CANCER, V7, P11, DOI 10.1038/nrc2050; Yao Q, 2009, BIOCHEM BIOPH RES CO, V388, P539, DOI 10.1016/j.bbrc.2009.08.044; Zhang BY, 2003, VIROLOGY, V310, P100, DOI 10.1016/S0042-6822(03)00103-X; zur Hausen H, 2002, NAT REV CANCER, V2, P342, DOI 10.1038/nrc798	90	75	82	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2011	6	7							e21646	10.1371/journal.pone.0021646	http://dx.doi.org/10.1371/journal.pone.0021646			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786HC	21747943	gold, Green Submitted, Green Published			2022-12-27	WOS:000292293400019
J	Alen, MMF; De Burghgraeve, T; Kaptein, SJF; Balzarini, J; Neyts, J; Schols, D				Alen, Marijke M. F.; De Burghgraeve, Tine; Kaptein, Suzanne J. F.; Balzarini, Jan; Neyts, Johan; Schols, Dominique			Broad Antiviral Activity of Carbohydrate-Binding Agents against the Four Serotypes of Dengue Virus in Monocyte-Derived Dendritic Cells	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; MOLECULE 3-GRABBING NONINTEGRIN; HEPATITIS-C VIRUS; DC-SIGN; MANNOSE RECEPTOR; T-CELLS; DISEASE PATHOGENESIS; HEMORRHAGIC-FEVER; HIV-1 INFECTION; TRANS-INFECTION	Background: Dendritic cells (DC), present in the skin, are the first target cells of dengue virus (DENV). Dendritic cell-specific intercellular adhesion molecule 3-grabbing non-integrin (DC-SIGN) is present on DC and recognizes N-glycosylation sites on the E-glycoprotein of DENV. Thus, the DC-SIGN/E-glycoprotein interaction can be considered as an important target for inhibitors of viral replication. We evaluated various carbohydrate-binding agents (CBAs) against all four described serotypes of DENV replication in Raji/DC-SIGN(+) cells and in monocyte-derived DC (MDDC). Methodology/Principal Findings: A dose-dependent anti-DENV activity of the CBAs Hippeastrum hybrid (HHA), Galanthus nivalis (GNA) and Urtica dioica (UDA), but not actinohivin (AH) was observed against all four DENV serotypes as analyzed by flow cytometry making use of anti-DENV antibodies. Remarkably, the potency of the CBAs against DENV in MDDC cultures was significantly higher (up to 100-fold) than in Raji/DC-SIGN(+) cells. Pradimicin-S (PRM-S), a small-size non-peptidic CBA, exerted antiviral activity in MDDC but not in Raji/DC-SIGN(+) cells. The CBAs act at an early step of DENV infection as they bind to the viral envelope of DENV and subsequently prevent virus attachment. Only weak antiviral activity of the CBAs was detected when administered after the virus attachment step. The CBAs were also able to completely prevent the cellular activation and differentiation process of MDDC induced upon DENV infection. Conclusions/Significance: The CBAs exerted broad spectrum antiviral activity against the four DENV serotypes, laboratory-adapted viruses and low passage clinical isolates, evaluated in Raji/DC-SIGN+ cells and in primary MDDC.	[Alen, Marijke M. F.; De Burghgraeve, Tine; Kaptein, Suzanne J. F.; Balzarini, Jan; Neyts, Johan; Schols, Dominique] Katholieke Univ Leuven, Dept Microbiol & Immunol, Rega Inst Med Res, Louvain, Belgium	KU Leuven	Alen, MMF (corresponding author), Katholieke Univ Leuven, Dept Microbiol & Immunol, Rega Inst Med Res, Louvain, Belgium.	Dominique.Schols@rega.kuleuven.be	Kaptein, Suzanne JF/O-8855-2018; Schols, Dominique/S-9057-2017; Kaptein, Suzanne JF/O-4714-2019; Neyts, Johan/U-8267-2017; Schols, Dominique/AAC-1309-2021	Kaptein, Suzanne JF/0000-0002-7935-0219; Schols, Dominique/0000-0003-3256-5850; Kaptein, Suzanne JF/0000-0002-7935-0219; Neyts, Johan/0000-0002-0033-7514; Schols, Dominique/0000-0003-3256-5850	European Commission EMPRO [503558, FP6-2003-INCO-DEV2 DENFRAME, 517711]; Fonds voor Wetenschappelijk Onderzoek (FWO) Krediet [G-485-08]; K. U. Leuven (Krediet) [EF/05/015, PF/10/018]; Dormeur Investment Service	European Commission EMPRO(European CommissionEuropean Commission Joint Research Centre); Fonds voor Wetenschappelijk Onderzoek (FWO) Krediet(FWO); K. U. Leuven (Krediet)(KU Leuven); Dormeur Investment Service	This work was supported by the European Commission EMPRO No. 503558 of the 6th Frame Work Programme, FP6-2003-INCO-DEV2 DENFRAME "Innovative Diagnostic Tools and Therapeutic Approaches for Dengue Disease" (Contract No.: 517711), the Fonds voor Wetenschappelijk Onderzoek (FWO) Krediet nr. G-485-08, the Centers of Excellence and Program Financing of the K. U. Leuven (Krediet nr. EF/05/015 and PF/10/018), and the Dormeur Investment Service. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alen MMF, 2009, VIROLOGY, V387, P67, DOI 10.1016/j.virol.2009.01.043; BALZARINI J, 1991, ANTIMICROB AGENTS CH, V35, P410, DOI 10.1128/AAC.35.3.410; BALZARINI J, 1992, ANTIVIR RES, V18, P191, DOI 10.1016/0166-3542(92)90038-7; Balzarini J, 2007, LANCET, V369, P787, DOI 10.1016/S0140-6736(07)60202-5; Balzarini J, 2007, MOL PHARMACOL, V71, P3, DOI 10.1124/mol.106.030155; Balzarini J, 2010, ANTIMICROB AGENTS CH, V54, P1425, DOI 10.1128/AAC.01347-09; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Bayry J, 2003, BLOOD, V101, P758, DOI 10.1182/blood-2002-05-1447; Bertaux C, 2007, VIROLOGY, V366, P40, DOI 10.1016/j.virol.2007.04.008; Chen YC, 1999, J VIROL, V73, P2650, DOI 10.1128/JVI.73.4.2650-2657.1999; Chen YP, 1997, NAT MED, V3, P866, DOI 10.1038/nm0897-866; Chiba H, 2001, BIOCHEM BIOPH RES CO, V282, P595, DOI 10.1006/bbrc.2001.4495; de Witte L, 2007, P NATL ACAD SCI USA, V104, P19464, DOI 10.1073/pnas.0703747104; Dejnirattisai W, 2008, J IMMUNOL, V181, P5865, DOI 10.4049/jimmunol.181.9.5865; Dejnirattisai W, 2010, SCIENCE, V328, P745, DOI 10.1126/science.1185181; Francois KO, 2008, MOL PHARMACOL, V74, P330, DOI 10.1124/mol.108.047621; Geijtenbeek TBH, 2000, CELL, V100, P587, DOI 10.1016/S0092-8674(00)80694-7; Granelli-Piperno A, 2005, J IMMUNOL, V175, P4265, DOI 10.4049/jimmunol.175.7.4265; Gubler DJ, 2004, COMP IMMUNOL MICROB, V27, P319, DOI 10.1016/j.cimid.2004.03.013; Guy B, 2009, J CLIN VIROL, V46, pS16, DOI 10.1016/S1386-6532(09)70290-2; Hacker K, 2009, J GEN VIROL, V90, P2097, DOI 10.1099/vir.0.012120-0; HALSTEAD SB, 1988, SCIENCE, V239, P476, DOI 10.1126/science.3277268; Halstead SB, 2007, LANCET, V370, P1644, DOI 10.1016/S0140-6736(07)61687-0; Ho LJ, 2001, J IMMUNOL, V166, P1499, DOI 10.4049/jimmunol.166.3.1499; Hong PWP, 2007, J VIROL, V81, P8325, DOI 10.1128/JVI.01765-06; Hoorelbeke B, 2010, ANTIMICROB AGENTS CH, V54, P3287, DOI 10.1128/AAC.00254-10; IRIE K, 1989, GENE, V75, P197, DOI 10.1016/0378-1119(89)90266-7; Jindadamrongwech S, 2004, ARCH VIROL, V149, P915, DOI 10.1007/s00705-003-0263-x; Kou Z, 2008, J MED VIROL, V80, P134, DOI 10.1002/jmv.21051; Kwan WH, 2005, J VIROL, V79, P7291, DOI 10.1128/JVI.79.12.7291-7299.2005; Kyle JL, 2006, AM J TROP MED HYG, V75, P316; Lambert AA, 2008, BLOOD, V112, P1299, DOI 10.1182/blood-2008-01-136473; Libraty DH, 2001, J VIROL, V75, P3501, DOI 10.1128/JVI.75.8.3501-3508.2001; Lozach PY, 2005, J BIOL CHEM, V280, P23698, DOI 10.1074/jbc.M504337200; Luallen RJ, 2009, J VIROL, V83, P4861, DOI 10.1128/JVI.02537-08; Luplerdlop N, 2006, EMBO REP, V7, P1176, DOI 10.1038/sj.embor.7400814; Mairuhu ATA, 2004, EUR J CLIN MICROBIOL, V23, P425, DOI 10.1007/s10096-004-1145-1; Marovich M, 2001, J INVEST DERM SYMP P, V6, P219, DOI 10.1046/j.0022-202x.2001.00037.x; Marzi A, 2007, J INFECT DIS, V196, pS237, DOI 10.1086/520607; Mathew A, 2008, IMMUNOL REV, V225, P300, DOI 10.1111/j.1600-065X.2008.00678.x; Miller JL, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040017; Navarro-Sanchez E, 2003, EMBO REP, V4, P723, DOI 10.1038/sj.embor.embor866; Palmer DR, 2005, J VIROL, V79, P2432, DOI 10.1128/JVI.79.4.2432-2439.2005; Palucka AK, 2000, NAT MED, V6, P748, DOI 10.1038/77470; Pohlmann S, 2003, J VIROL, V77, P4070, DOI 10.1128/JVI.77.7.4070-4080.2003; Pokidysheva E, 2006, CELL, V124, P485, DOI 10.1016/j.cell.2005.11.042; Pollielta M, 2008, VIROLOGY, V370, P382, DOI 10.1016/j.virol.2007.08.033; Relloso M, 2002, J IMMUNOL, V168, P2634, DOI 10.4049/jimmunol.168.6.2634; Rigau-Perez JG, 1998, LANCET, V352, P971, DOI 10.1016/S0140-6736(97)12483-7; Rogers KM, 2009, J INNATE IMMUN, V1, P405, DOI 10.1159/000226422; Rothman AL, 1999, VIROLOGY, V257, P1, DOI 10.1006/viro.1999.9656; SAITOH K, 1993, J ANTIBIOT, V46, P406, DOI 10.7164/antibiotics.46.406; Simmons M, 2010, VIROLOGY, V396, P280, DOI 10.1016/j.virol.2009.10.023; Stahl PD, 1998, CURR OPIN IMMUNOL, V10, P50, DOI 10.1016/S0952-7915(98)80031-9; Sun PF, 2009, VIROLOGY, V383, P207, DOI 10.1016/j.virol.2008.10.022; Tacken PJ, 2007, NAT REV IMMUNOL, V7, P790, DOI 10.1038/nri2173; Takada A, 2003, REV MED VIROL, V13, P387, DOI 10.1002/rmv.405; Tanaka H, 2009, P NATL ACAD SCI USA, V106, P15633, DOI 10.1073/pnas.0907572106; Tassaneetrithep B, 2003, J EXP MED, V197, P823, DOI 10.1084/jem.20021840; Taylor PR, 2005, TRENDS IMMUNOL, V26, P104, DOI 10.1016/j.it.2004.12.001; Trkola A, 1996, J VIROL, V70, P1100, DOI 10.1128/JVI.70.2.1100-1108.1996; Valle JRD, 2005, J VIROL, V79, P4557, DOI 10.1128/JVI.79.8.4557-4567.2005; van Kooyk Y, 2003, NAT REV IMMUNOL, V3, P697, DOI 10.1038/nri1182; VANDAMME EJM, 1991, EUR J BIOCHEM, V202, P23, DOI 10.1111/j.1432-1033.1991.tb16339.x; VANDAMME EJM, 1987, FEBS LETT, V215, P140, DOI 10.1016/0014-5793(87)80129-1; Whitehead SS, 2007, NAT REV MICROBIOL, V5, P518, DOI 10.1038/nrmicro1690; Wu SJL, 2000, NAT MED, V6, P816, DOI 10.1038/77553	67	51	51	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2011	6	6							e21658	10.1371/journal.pone.0021658	http://dx.doi.org/10.1371/journal.pone.0021658			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786GP	21738755	Green Published, gold, Green Submitted			2022-12-27	WOS:000292291800029
J	Ogata, Y; Horaguchi, T; Watanabe, N; Yamamoto, M				Ogata, Yousuke; Horaguchi, Takahiro; Watanabe, Noriya; Yamamoto, Miyuki			Comparison of the Choice Effect and the Distance Effect in a Number-Comparison Task by fMRI	PLOS ONE			English	Article							EVENT-RELATED FMRI; HUMAN INTRAPARIETAL CORTEX; ANTERIOR CINGULATE CORTEX; HUMAN PARIETAL CORTEX; ATTENTIONAL CONTROL; HUMAN BRAIN; CORTICAL MECHANISMS; RESPONSE-SELECTION; SUBANGULAR LESION; INFERIOR PARIETAL	Behavioral and neurophysiological studies of numerical comparisons have shown a "distance effect," whereby smaller numerical distances between two digits are associated with longer response times and higher activity in the parietal region. In this experiment, we introduced a two-choice condition (between either the smaller/lower or the larger/higher of two digits) and examined its effect on brain activity by fMRI. We observed longer response times and greater activity with the choice of smaller numbers ("choice effect") in several brain regions including the right temporo-parietal region, (pre)cuneus, superior temporal sulcus, precentral gyrus, superior frontal gyrus, bilateral insula, and anterior cingulate cortex. These regions correspond to areas that have been suggested to play a role in attentional shift and response conflict. However, brain activity associated with the distance effect disappeared even though the behavioral distance effect remained. Despite the absence of the distance effect on brain activity, several areas changed activity in relation to response time, including regions that were reported to change activity in both a distance effect and a reaction-time-related manner. The result suggested that the level of task load may change the activity of regions that are responsible for magnitude detection.	[Ogata, Yousuke; Yamamoto, Miyuki] Univ Tsukuba, Tsukuba, Ibaraki, Japan; [Horaguchi, Takahiro] Ibaraki Prefectural Univ Hlth Sci, Ctr Med Sci, Inashiki, Ibaraki, Japan; [Watanabe, Noriya] Tamagawa Univ, Grad Sch Engn, Tokyo, Japan	University of Tsukuba	Ogata, Y (corresponding author), Univ Tsukuba, Tsukuba, Ibaraki, Japan.	ogata-y@mike.md.tsukuba.ac.jp		Ogata, Yousuke/0000-0003-4613-7435; Watanabe, Noriya/0000-0002-7847-6338	Ministry of Education, Culture, Sports, Science and Technology of the Japanese government; Grants-in-Aid for Scientific Research [23300082] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of the Japanese government(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Funding was provided by the COE program from the Ministry of Education, Culture, Sports, Science and Technology of the Japanese government (http://www.jsps.go.jp/j-21coe/08_jigo/kekka_j.html). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andres M, 2005, COGNITIVE BRAIN RES, V25, P283, DOI 10.1016/j.cogbrainres.2005.06.002; BALLAN M, 2010, SOC 40 ANN M SAN DIE; Behrmann M, 2004, CURR OPIN NEUROBIOL, V14, P212, DOI 10.1016/j.conb.2004.03.012; Botvinick M, 1999, NATURE, V402, P179, DOI 10.1038/46035; Braver TS, 2001, CEREB CORTEX, V11, P825, DOI 10.1093/cercor/11.9.825; Cantlon JF, 2006, PLOS BIOL, V4, P844, DOI 10.1371/journal.pbio.0040125; Cantlon JF, 2005, P NATL ACAD SCI USA, V102, P16507, DOI 10.1073/pnas.0506463102; Chambers CD, 2004, NAT NEUROSCI, V7, P217, DOI 10.1038/nn1203; Chochon F, 1999, J COGNITIVE NEUROSCI, V11, P617, DOI 10.1162/089892999563689; Corbetta M, 1998, NEURON, V21, P761, DOI 10.1016/S0896-6273(00)80593-0; Corbetta M, 2000, NAT NEUROSCI, V3, P292, DOI 10.1038/73009; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Corbetta M, 2008, NEURON, V58, P306, DOI 10.1016/j.neuron.2008.04.017; DEHAENE S, 1989, PERCEPT PSYCHOPHYS, V45, P557, DOI 10.3758/BF03208063; Dehaene S, 1997, CORTEX, V33, P219, DOI 10.1016/S0010-9452(08)70002-9; Dehaene S, 1999, SCIENCE, V284, P970, DOI 10.1126/science.284.5416.970; DEHAENE S, 1993, J EXP PSYCHOL GEN, V122, P371, DOI 10.1037/0278-7393.21.2.314; Dehaene S, 1998, TRENDS NEUROSCI, V21, P355, DOI 10.1016/S0166-2236(98)01263-6; Delazer M, 1997, CORTEX, V33, P697, DOI 10.1016/S0010-9452(08)70727-5; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; Downar J, 2001, NEUROIMAGE, V14, P1256, DOI 10.1006/nimg.2001.0946; Eger E, 2003, NEURON, V37, P719, DOI 10.1016/S0896-6273(03)00036-9; Fias W, 2003, J COGNITIVE NEUROSCI, V15, P47, DOI 10.1162/089892903321107819; Fulbright RK, 2003, AM J NEURORADIOL, V24, P193; Garavan H, 2003, NEUROIMAGE, V20, P1132, DOI 10.1016/S1053-8119(03)00334-3; Giesbrecht B, 2003, NEUROIMAGE, V19, P496, DOI 10.1016/S1053-8119(03)00162-9; Gobel SM, 2004, J COGNITIVE NEUROSCI, V16, P1536, DOI 10.1162/0898929042568442; GRAFMAN J, 1982, CORTEX, V18, P37, DOI 10.1016/S0010-9452(82)80017-8; Horaguchi T, 2008, NEUROSCI RES, V61, P294, DOI 10.1016/j.neures.2008.03.011; Jiang YH, 2003, J COGNITIVE NEUROSCI, V15, P1080, DOI 10.1162/089892903322598067; Jones AD, 2002, COGN AFFECT BEHAV NE, V2, P300, DOI 10.3758/CABN.2.4.300; Kadosh RC, 2005, NEUROPSYCHOLOGIA, V43, P1238, DOI 10.1016/j.neuropsychologia.2004.12.017; Kadosh RC, 2008, CEREB CORTEX, V18, P337, DOI 10.1093/cercor/bhm058; Kadosh RC, 2007, NEURON, V53, P307, DOI 10.1016/j.neuron.2006.12.025; Kaufmann L, 2005, NEUROIMAGE, V25, P888, DOI 10.1016/j.neuroimage.2004.12.041; Kowatari Y, 2009, HUM BRAIN MAPP, V30, P1678, DOI 10.1002/hbm.20633; Le TH, 1998, J NEUROPHYSIOL, V79, P1535, DOI 10.1152/jn.1998.79.3.1535; Liu TS, 2003, CEREB CORTEX, V13, P1334, DOI 10.1093/cercor/bhg080; Livesey AC, 2007, NEUROPSYCHOLOGIA, V45, P321, DOI 10.1016/j.neuropsychologia.2006.06.033; Martory MD, 2003, NEUROCASE, V9, P319, DOI 10.1076/neur.9.4.319.15549; Mayer E, 1999, BRAIN, V122, P1107, DOI 10.1093/brain/122.6.1107; Merkley R, 2010, EXP BRAIN RES, V206, P455, DOI 10.1007/s00221-010-2419-8; MOYER RS, 1967, NATURE, V215, P1519, DOI 10.1038/2151519a0; Nieder A, 2005, NAT REV NEUROSCI, V6, P177, DOI 10.1038/nrn1626; Nieder A, 2004, P NATL ACAD SCI USA, V101, P7457, DOI 10.1073/pnas.0402239101; Piazza M, 2007, NEURON, V53, P293, DOI 10.1016/j.neuron.2006.11.022; Pinel P, 1999, NEUROREPORT, V10, P1473, DOI 10.1097/00001756-199905140-00015; Pinel P, 2004, NEURON, V41, P983, DOI 10.1016/S0896-6273(04)00107-2; Pinel P, 2001, NEUROIMAGE, V14, P1013, DOI 10.1006/nimg.2001.0913; Rao SM, 2001, NAT NEUROSCI, V4, P317, DOI 10.1038/85191; Rickard TC, 2000, NEUROPSYCHOLOGIA, V38, P325, DOI 10.1016/S0028-3932(99)00068-8; Roberts KL, 2008, J COGNITIVE NEUROSCI, V20, P1063, DOI 10.1162/jocn.2008.20074; Rushworth MFS, 2001, J NEUROSCI, V21, P5262, DOI 10.1523/JNEUROSCI.21-14-05262.2001; Sawamura H, 2002, NATURE, V415, P918, DOI 10.1038/415918a; Serences JT, 2005, PSYCHOL SCI, V16, P114, DOI 10.1111/j.0956-7976.2005.00791.x; Shapiro K, 2002, CURR BIOL, V12, P1320, DOI 10.1016/S0960-9822(02)01040-0; Shulman GL, 2002, CEREB CORTEX, V12, P1124, DOI 10.1093/cercor/12.11.1124; Ullsperger M, 2001, NEUROIMAGE, V14, P1387, DOI 10.1006/nimg.2001.0935; Walsh V, 2003, TRENDS COGN SCI, V7, P483, DOI 10.1016/j.tics.2003.09.002; Yantis S, 2003, CURR OPIN NEUROBIOL, V13, P187, DOI 10.1016/S0959-4388(03)00033-3; Yantis S, 2002, NAT NEUROSCI, V5, P995, DOI 10.1038/nn921	61	2	2	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2011	6	6							e21716	10.1371/journal.pone.0021716	http://dx.doi.org/10.1371/journal.pone.0021716			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786GP	21738777	Green Published, gold, Green Submitted			2022-12-27	WOS:000292291800033
J	Pirozzi, G; Tirino, V; Camerlingo, R; Franco, R; La Rocca, A; Liguori, E; Martucci, N; Paino, F; Normanno, N; Rocco, G				Pirozzi, Giuseppe; Tirino, Virginia; Camerlingo, Rosa; Franco, Renato; La Rocca, Aantonello; Liguori, Eleonora; Martucci, Nicola; Paino, Francesca; Normanno, Nicola; Rocco, Gaetano			Epithelial to Mesenchymal Transition by TGF beta-1 Induction Increases Stemness Characteristics in Primary Non Small Cell Lung Cancer Cell Line	PLOS ONE			English	Article							IN-VITRO; SELF-RENEWAL; BETA-CATENIN; E-CADHERIN; IDENTIFICATION; LEUKEMIA; CD133; MECHANISMS; EXPRESSION; BIOLOGY	Background: Cancer Stem Cells (CSCs) hypothesis asserts that only a small subset of cells within a tumour is capable of both tumour initiation and sustainment. The Epithelial-Mesenchymal Transition (EMT) is an embryonic developmental program that is often activated during cancer invasion and metastasis. The aim of this study is to shed light on the relationship between EMT and CSCs by using LC31 lung cancer primary cell line. Materials and Methods: A549 and LC31 cell lines were treated with 2 ng/ml TGF beta-1 for 30 days, and 80 days, respectively. To evaluate EMT, morphological changes were assessed by light microscopy, immunofluorescence and cytometry for following markers: cytokeratins, e-cadherin, CD326 (epithelial markers) and CD90, and vimentin (mesenchymal markers). Moreover, RT-PCR for Slug, Twist and beta-catenin genes were performed. On TGF beta-1 treated and untreated LC31 cell lines, we performed stemness tests such as pneumospheres growth and stem markers expression such as Oct4, Nanog, Sox2, c-kit and CD133. Western Blot for CD133 and tumorigenicity assays using NOD/SCID mice were performed. Results: TGF beta-1 treated LC31 cell line lost its epithelial morphology assuming a fibroblast-like appearance. The same results were obtained for the A549 cell line (as control). Immunofluorescence and cytometry showed up-regulation of vimentin and CD90 and down-regulation of cytocheratin, e-cadherin and CD326 in TGF beta-1 treated LC31 and A549 cell lines. Slug, Twist and beta-catenin m-RNA transcripts were up-regulated in TGF beta-1 treated LC31 cell line confirming EMT. This cell line showed also over-expression of Oct4, Nanog, Sox2 and CD133, all genes of stemness. In addition, in TGF beta-1 treated LC31 cell line, an increased pneumosphere-forming capacity and tumours-forming ability in NOD/SCID mice were detectable. Conclusions: The induction of EMT by TGF beta-1 exposure, in primary lung cancer cell line results in the acquisition of mesenchymal profile and in the expression of stem cell markers.	[Pirozzi, Giuseppe; Camerlingo, Rosa; Liguori, Eleonora; Normanno, Nicola] NCI, Dept Expt Oncol, Naples, Italy; [Tirino, Virginia; Paino, Francesca] Univ Naples 2, Dept Expt Med, Naples, Italy; [Franco, Renato] NCI, Dept Pathol, Naples, Italy; [La Rocca, Aantonello; Martucci, Nicola; Rocco, Gaetano] NCI, Dept Thorac Surg & Oncol, Naples, Italy	IRCCS Fondazione Pascale; Universita della Campania Vanvitelli; IRCCS Fondazione Pascale; IRCCS Fondazione Pascale	Pirozzi, G (corresponding author), NCI, Dept Expt Oncol, Naples, Italy.	pinopiro@tin.it	Camerlingo, Rosa/AAB-8349-2022; Rocco, Gaetano/K-4801-2016; paino, francesca/AAC-8150-2019; Normanno, Nicola/AAT-1107-2021	Rocco, Gaetano/0000-0003-4150-8604; paino, francesca/0000-0002-3186-1888; Franco, Renato/0000-0002-8340-3184; Normanno, Nicola/0000-0002-7158-2605; Camerlingo, Rosa/0000-0001-6488-9740; Tirino, Virginia/0000-0003-2731-5718				Angelo RCD, 2010, PROG MOL BIOL TRANSL, V95, P113, DOI 10.1016/B978-0-12-385071-3.00006-X; Aoi T, 2008, SCIENCE, V321, P699, DOI 10.1126/science.1154884; Bidlingmaier S, 2008, J MOL MED, V86, P1025, DOI 10.1007/s00109-008-0357-8; Casas E, 2011, CANCER RES, V71, P245, DOI 10.1158/0008-5472.CAN-10-2330; Chaffer CL, 2011, SCIENCE, V331, P1559, DOI 10.1126/science.1203543; Chuthapisith S, 2010, SURG ONCOL, V19, P27, DOI 10.1016/j.suronc.2009.01.004; Clarke MF, 2006, CELL, V124, P1111, DOI 10.1016/j.cell.2006.03.011; Cufi S, 2010, CELL CYCLE, V9, P4461, DOI 10.4161/cc.9.22.14048; Dean M, 2005, NAT REV CANCER, V5, P275, DOI 10.1038/nrc1590; Eramo A, 2008, CELL DEATH DIFFER, V15, P504, DOI 10.1038/sj.cdd.4402283; Ferrandina G, 2009, EXPERT OPIN THER TAR, V13, P823, DOI 10.1517/14728220903005616; Hay ED, 2005, DEV DYNAM, V233, P706, DOI 10.1002/dvdy.20345; Hayashida T, 2011, J ONCOL, V2011, DOI 10.1155/2011/591427; HIDA T, 1994, INT J CANCER, P108; Hong KO, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-28; Immervoll H, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-48; Jordan CT, 2006, NEW ENGL J MED, V355, P1253, DOI 10.1056/NEJMra061808; Jordan CT, 2004, CURR OPIN CELL BIOL, V16, P708, DOI 10.1016/j.ceb.2004.09.002; JU HK, 2007, J KOREAN MED SCI, V22, P898; Kasai H, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-56; Kondo M, 2003, ANNU REV IMMUNOL, V21, P759, DOI 10.1146/annurev.immunol.21.120601.141007; Larue L, 2005, ONCOGENE, V24, P7443, DOI 10.1038/sj.onc.1209091; Levina V, 2010, CANCER RES, V70, P338, DOI 10.1158/0008-5472.CAN-09-1102; Levina V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003077; Liu SL, 2006, CANCER RES, V66, P6063, DOI 10.1158/0008-5472.CAN-06-0054; LO JF, 2010, CANCER RES, V17, DOI DOI 10.1158/0008-5472; Locke M, 2005, CANCER RES, V65, P8944, DOI 10.1158/0008-5472.CAN-05-0931; Lu ZM, 2003, CANCER CELL, V4, P499, DOI 10.1016/S1535-6108(03)00304-0; Maitah MY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016068; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Morali OG, 2001, ONCOGENE, V20, P4942, DOI 10.1038/sj.onc.1204660; Ponti D, 2005, CANCER RES, V65, P5506, DOI 10.1158/0008-5472.CAN-05-0626; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Sansone P, 2007, STEM CELLS, V25, P807, DOI 10.1634/stemcells.2006-0442; Sarry JE, 2011, J CLIN INVEST, V121, P384, DOI 10.1172/JCI41495; Singh SK, 2003, CANCER RES, V63, P5821; Steinbach D, 2007, LEUKEMIA, V21, P1172, DOI 10.1038/sj.leu.2404692; Thiery JP, 2010, B CANCER, V97, P1285, DOI 10.1684/bdc.2010.1206; Thiery JP, 2001, B ACAD NAT MED PARIS, V185, P1279, DOI 10.1016/S0001-4079(19)34450-4; Thiery JP, 2003, CURR OPIN CELL BIOL, V15, P740, DOI 10.1016/j.ceb.2003.10.006; Tirino V, 2009, EUR J CARDIO-THORAC, V36, P446, DOI 10.1016/j.ejcts.2009.03.063; Tong M, 2006, CARCINOGENESIS, V27, P2170, DOI 10.1093/carcin/bgl053; Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499; Wheelock MJ, 2003, ANNU REV CELL DEV BI, V19, P207, DOI 10.1146/annurev.cellbio.19.011102.111135; Yauch RL, 2005, CLIN CANCER RES, V11, P8686, DOI 10.1158/1078-0432.CCR-05-1492; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	46	140	145	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2011	6	6							e21548	10.1371/journal.pone.0021548	http://dx.doi.org/10.1371/journal.pone.0021548			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786GP	21738704	Green Submitted, Green Published, gold			2022-12-27	WOS:000292291800020
J	Rodriguez-Paris, J; Tamayo, ML; Gelvez, N; Schrijver, I				Rodriguez-Paris, Juan; Tamayo, Marta L.; Gelvez, Nancy; Schrijver, Iris			Allele-Specific Impairment of GJB2 Expression by GJB6 Deletion del(GJB6-D13S1854)	PLOS ONE			English	Article							NONSYNDROMIC HEARING IMPAIRMENT; CONNEXIN 26 GENE; GAP-JUNCTIONS; MUTATION; MULTICENTER; PCR	Mutations in the GJB2 gene, which encodes connexin 26, are a frequent cause of congenital non-syndromic sensorineural hearing loss. Two large deletions, del(GJB6-D13S1830) and del(GJB6-D13S1854), which truncate GJB6 (connexin 30), cause hearing loss in individuals homozygous, or compound heterozygous for these deletions or one such deletion and a mutation in GJB2. Recently, we have demonstrated that the del(GJB6-D13S1830) deletion contributes to hearing loss due to an allele-specific lack of GJB2 mRNA expression and not as a result of digenic inheritance, as was postulated earlier. In the current study we investigated the smaller del(GJB6-D13S1854) deletion, which disrupts the expression of GJB2 at the transcriptional level in a manner similar to the more common del(GJB6-D13S1830) deletion. Interestingly, in the presence of this deletion, GJB2 expression remains minimally but reproducibly present. The relative allele-specific expression of GJB2 was assessed by reverse-transcriptase PCR and restriction digestions in three probands who were compound heterozygous for a GJB2 mutation and del(GJB6-D13S1854). Each individual carried a different sequence variant in GJB2. All three individuals expressed the mutated GJB2 allele in trans with del(GJB6-D13S1854), but expression of the GJB2 allele in cis with the deletion was almost absent. Our study clearly corroborates the hypothesis that the del(GJB6-D13S1854), similar to the larger and more common del(GJB6-D13S1830), removes (a) putative cis-regulatory element(s) upstream of GJB6 and narrows down the region of location.	[Rodriguez-Paris, Juan; Schrijver, Iris] Stanford Univ, Dept Pathol, Sch Med, Stanford, CA 94305 USA; [Tamayo, Marta L.; Gelvez, Nancy] Univ Javeriana, Inst Genet Humana, Bogota, Colombia; [Tamayo, Marta L.] Fdn Oftalmol Nacl, Bogota, Colombia; [Schrijver, Iris] Stanford Univ, Dept Pediat, Sch Med, Stanford, CA 94305 USA	Stanford University; Pontificia Universidad Javeriana; Stanford University	Rodriguez-Paris, J (corresponding author), Stanford Univ, Dept Pathol, Sch Med, Stanford, CA 94305 USA.	ischrijver@stanfordmed.org		Gelvez, Nancy/0000-0002-3925-1451; Tamayo, Martha Lucia/0000-0001-8297-3970	Arline and Pete Harman Faculty; Instituto de Genetica Humana-Universidad Javeriana [6207-12-16739]; Colciencias [120334319246]	Arline and Pete Harman Faculty; Instituto de Genetica Humana-Universidad Javeriana; Colciencias(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias)	This work was generously supported by the Arline and Pete Harman Faculty Scholar Endowed Fund, by the Instituto de Genetica Humana-Universidad Javeriana-Grant # 6207-12-16739; and, by Colciencias-Grant # 120334319246. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad S, 2003, BIOCHEM BIOPH RES CO, V307, P362, DOI 10.1016/S0006-291X(03)01166-5; Common JEA, 2005, CLIN EXP DERMATOL, V30, P688, DOI 10.1111/j.1365-2230.2005.01878.x; del Castillo FJ, 2005, J MED GENET, V42, P588, DOI 10.1136/jmg.2004.028324; del Castillo I, 2002, NEW ENGL J MED, V346, P243, DOI 10.1056/NEJMoa012052; del Castillo I, 2003, AM J HUM GENET, V73, P1452, DOI 10.1086/380205; Feldmann D, 2009, EUR J MED GENET, V52, P195, DOI 10.1016/j.ejmg.2008.11.006; Hilgert N, 2009, MUTAT RES-REV MUTAT, V681, P189, DOI 10.1016/j.mrrev.2008.08.002; Kenneson A, 2002, GENET MED, V4, P258, DOI 10.1097/00125817-200207000-00004; Lerer I, 2001, Hum Mutat, V18, P460, DOI 10.1002/humu.1222; Matos TD, 2007, J MED GENET, V44, P721, DOI 10.1136/jmg.2007.050682; Mueller RF, 1999, INT J PEDIATR OTORHI, V50, P3, DOI 10.1016/S0165-5876(99)00242-6; Ortolano S, 2008, P NATL ACAD SCI USA, V105, P18776, DOI 10.1073/pnas.0800831105; Pallares-Ruiz N, 2002, EUR J HUM GENET, V10, P72, DOI 10.1038/sj.ejhg.5200762; Putcha GV, 2007, GENET MED, V9, P413, DOI 10.1097/GIM.0b013e3180a03276; Raff T, 1997, BIOTECHNIQUES, V23, P456, DOI 10.2144/97233st02; Rodriguez-Paris J, 2009, BIOCHEM BIOPH RES CO, V389, P354, DOI 10.1016/j.bbrc.2009.08.152; Vinken M, 2009, BBA-REV CANCER, V1795, P53, DOI 10.1016/j.bbcan.2008.08.002; Wilch E, 2010, CLIN GENET, V78, P267, DOI 10.1111/j.1399-0004.2010.01387.x; Wilch E, 2006, AM J HUM GENET, V79, P174, DOI 10.1086/505333; Wilcox SA, 2000, MOL DIAGN, V5, P75, DOI 10.2165/00066982-200005010-00015; Zhao HB, 2006, J MEMBRANE BIOL, V209, P177, DOI 10.1007/s00232-005-0832-x	21	33	35	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2011	6	6							e21665	10.1371/journal.pone.0021665	http://dx.doi.org/10.1371/journal.pone.0021665			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786FZ	21738759	gold, Green Submitted, Green Published			2022-12-27	WOS:000292290100054
J	Broen, K; Levenga, H; Vos, J; van Bergen, K; Fredrix, H; Greupink-Draaisma, A; Kester, M; Falkenburg, JHF; de Mulder, P; de Witte, T; Griffioen, M; Dolstra, H				Broen, Kelly; Levenga, Henriette; Vos, Johanna; van Bergen, Kees; Fredrix, Hanny; Greupink-Draaisma, Annelies; Kester, Michel; Falkenburg, J. H. Frederik; de Mulder, Pieter; de Witte, Theo; Griffioen, Marieke; Dolstra, Harry			A Polymorphism in the Splice Donor Site of ZNF419 Results in the Novel Renal Cell Carcinoma-Associated Minor Histocompatibility Antigen ZAPHIR	PLOS ONE			English	Article							CYTOTOXIC T-CELLS; ABERRANT EXPRESSION; TRANSPLANTATION; LEUKEMIA; IMMUNOTHERAPY; FEASIBILITY; REGRESSION; CANCER; GENE	Nonmyeloablative allogeneic stem cell transplantation (SCT) can induce remission in patients with renal cell carcinoma (RCC), but this graft-versus-tumor (GVT) effect is often accompanied by graft-versus-host disease (GVHD). Here, we evaluated minor histocompatibility antigen (MiHA)-specific T cell responses in two patients with metastatic RCC who were treated with reduced-intensity conditioning SCT followed by donor lymphocyte infusion (DLI). One patient had stable disease and emergence of SMCY.A2-specific CD8+ T cells was observed after DLI with the potential of targeting SMCY-expressing RCC tumor cells. The second patient experienced partial regression of lung metastases from whom we isolated a MiHA-specific CTL clone with the capability of targeting RCC cell lines. Whole genome association scanning revealed that this CTL recognizes a novel HLA-B7-restricted MiHA, designated ZAPHIR, resulting from a polymorphism in the splice donor site of the ZNF419 gene. Tetramer analysis showed that emergence of ZAPHIR-specific CD8+ T cells in peripheral blood occurred in the absence of GVHD. Furthermore, the expression of ZAPHIR in solid tumor cell lines indicates the involvement of ZAPHIR-specific CD8+ T cell responses in selective GVT immunity. These findings illustrate that the ZNF419-encoded MiHA ZAPHIR is an attractive target for specific immunotherapy after allogeneic SCT.	[Broen, Kelly; Vos, Johanna; Fredrix, Hanny; Greupink-Draaisma, Annelies; Dolstra, Harry] Radboud Univ Nijmegen, Med Ctr, Dept Lab Med, Hematol Lab, NL-6525 ED Nijmegen, Netherlands; [Levenga, Henriette] Radboud Univ Nijmegen, Med Ctr, Dept Hematol, NL-6525 ED Nijmegen, Netherlands; [van Bergen, Kees; Kester, Michel; Falkenburg, J. H. Frederik; Griffioen, Marieke] Leiden Univ, Med Ctr, Dept Hematol, Leiden, Netherlands; [de Mulder, Pieter] Radboud Univ Nijmegen, Med Ctr, Dept Med Oncol, NL-6525 ED Nijmegen, Netherlands; [de Witte, Theo] Radboud Univ Nijmegen, Med Ctr, Nijmegen Ctr Mol Life Sci, Dept Tumor Immunol, NL-6525 ED Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Radboud University Nijmegen; Radboud University Nijmegen	Broen, K (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Lab Med, Hematol Lab, NL-6525 ED Nijmegen, Netherlands.	h.dolstra@labgk.umcn.nl	Griffioen, Marieke/ABA-1561-2021; Van Bergen, Cornelis A.M./P-5782-2016	Griffioen, Marieke/0000-0002-3001-4441; Van Bergen, Cornelis A.M./0000-0001-6386-4517	NATIONAL CANCER INSTITUTE [R01CA118880] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA118880, R01CA118880] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Akatsuka Y, 2003, J EXP MED, V197, P1489, DOI 10.1084/jem.20021925; Bleakley M, 2004, NAT REV CANCER, V4, P371, DOI 10.1038/nrc1365; Burrows SR, 2000, J IMMUNOL, V165, P6229, DOI 10.4049/jimmunol.165.11.6229; Chao NJ, 2004, BIOL BLOOD MARROW TR, V10, P215, DOI 10.1016/j.bbmt.2003.10.003; Childs R, 2000, NEW ENGL J MED, V343, P750, DOI 10.1056/NEJM200009143431101; den Haan JMM, 1998, SCIENCE, V279, P1054, DOI 10.1126/science.279.5353.1054; Dolstra H, 1999, J EXP MED, V189, P301, DOI 10.1084/jem.189.2.301; Ferrara JLM, 2009, LANCET, V373, P1550, DOI 10.1016/S0140-6736(09)60237-3; Fujii S, 2001, LEUKEMIA LYMPHOMA, V42, P357, DOI 10.3109/10428190109064592; Goulmy E, 1997, IMMUNOL REV, V157, P125, DOI 10.1111/j.1600-065X.1997.tb00978.x; Hambach L, 2008, BLOOD, V112, P1844, DOI 10.1182/blood-2007-11-125492; Hobo W, 2010, BLOOD, V116, P4501, DOI 10.1182/blood-2010-04-278739; HOROWITZ MM, 1990, BLOOD, V75, P555; Jedema I, 2004, BLOOD, V103, P2677, DOI 10.1182/blood-2003-06-2070; Kawase T, 2007, BLOOD, V110, P1055, DOI 10.1182/blood-2007-02-075911; Kircher B, 2002, BRIT J HAEMATOL, V117, P935, DOI 10.1046/j.1365-2141.2002.03536.x; Marijt WAE, 2003, P NATL ACAD SCI USA, V100, P2742, DOI 10.1073/pnas.0530192100; Mutis T, 1999, BLOOD, V93, P2336, DOI 10.1182/blood.V93.7.2336.407k26_2336_2341; Overes IM, 2009, J IMMUNOTHER, V32, P539, DOI 10.1097/CJI.0b013e3181987c22; Overes IM, 2009, CANCER IMMUNOL IMMUN, V58, P429, DOI 10.1007/s00262-008-0569-3; Pedrazzoli P, 2002, CANCER, V94, P2409, DOI 10.1002/cncr.10491.abs; Rijke BC, 2005, J CLIN INVEST, V115, P3506, DOI 10.1172/JCI24832; Rini BI, 2002, J CLIN ONCOL, V20, P2017, DOI 10.1200/JCO.2002.08.068; Takahashi Y, 2008, J CLIN INVEST, V118, P1099, DOI 10.1172/JCI34409; Torikai H, 2008, INT J HEMATOL, V87, P467, DOI 10.1007/s12185-008-0076-5; Tykodi SS, 2008, CLIN CANCER RES, V14, P5260, DOI 10.1158/1078-0432.CCR-08-0028; Tykodi SS, 2004, CLIN CANCER RES, V10, P7799, DOI 10.1158/1078-0432.CCR-04-0072; Ueno NT, 1998, J CLIN ONCOL, V16, P986, DOI 10.1200/JCO.1998.16.3.986; Van Bergen CAM, 2010, CANCER RES, V70, P9073, DOI 10.1158/0008-5472.CAN-10-1832; VANBERGEN CAM, 2010, CANC RES, V70; Yang JC, 2006, J CLIN ONCOL, V24, P5576, DOI 10.1200/JCO.2006.08.3774	31	20	20	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2011	6	6							e21699	10.1371/journal.pone.0021699	http://dx.doi.org/10.1371/journal.pone.0021699			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	784FW	21738768	Green Submitted, Green Published, gold			2022-12-27	WOS:000292142800060
J	Duraffour, S; Matthys, P; van den Oord, JJ; De Schutter, T; Mitera, T; Snoeck, R; Andrei, G				Duraffour, Sophie; Matthys, Patrick; van den Oord, Joost J.; De Schutter, Tim; Mitera, Tania; Snoeck, Robert; Andrei, Graciela			Study of Camelpox Virus Pathogenesis in Athymic Nude Mice	PLOS ONE			English	Article							ACYCLIC NUCLEOSIDE PHOSPHONATES; VACCINIA VIRUS; COMPOUND ST-246; MONKEYPOX VIRUS; VARIOLA VIRUS; PET RATS; COWPOX; INFECTION; CIDOFOVIR; IDENTIFICATION	Camelpox virus (CMLV) is the closest known orthopoxvirus genetically related to variola virus. So far, CMLV was restricted to camelids but, recently, three human cases of camelpox have been described in India, highlighting the need to pursue research on its pathogenesis, which has been hampered by the lack of small animal models. Here, we confirm that NMRI immunocompetent mice are resistant to intranasal (i.n.) CMLV infection. However, we demonstrate that CMLV induced a severe disease following i.n. challenge of athymic nude mice, which was accompanied with a failure in gaining weight, leading to euthanasia of the animals. On the other hand, intracutaneous (i.c.) infection resulted in disease development without impacting the body weight evolution. CMLV replication in tissues and body fluids was confirmed in the two models. We further analyzed innate immune and B cell responses induced in the spleen and draining lymph nodes after exposure to CMLV. In both models, strong increases in CD11b(+)F4/80(+) macrophages were seen in the spleen, while neutrophils, NK and B cell responses varied between the routes of infection. In the lymph nodes, the magnitude of CD11c(+)CD8 alpha(+) lymphoid and CD11c(+)CD11b(+) myeloid dendritic cell responses increased in i.n. challenged animals. Analysis of cytokine profiles revealed significant increases of interleukin (IL)-6 and IL-18 in the sera of infected animals, while those of other cytokines were similar to uninfected controls. The efficacy of two antivirals (cidofovir or HPMPC, and its 2, 6-diaminopurine analog) was evaluated in both models. HPMPC was the most effective molecule affording 100% protection from morbidity. It appeared that both treatments did not affect immune cell responses or cytokine expression. In conclusion, we demonstrated that immunodeficient mice are permissive for CMLV propagation. These results provide a basis for studying the pathogenesis of CMLV, as well as for evaluating potential antiviral therapies in an immunodeficiency context.	[Duraffour, Sophie; De Schutter, Tim; Snoeck, Robert; Andrei, Graciela] Katholieke Univ Leuven, Rega Inst, Lab Virol & Chemotherapy, Louvain, Belgium; [Matthys, Patrick; Mitera, Tania] Katholieke Univ Leuven, Rega Inst, Immunobiol Lab, Louvain, Belgium; [van den Oord, Joost J.] UZ Sint Raphael, Lab Morphol & Mol Pathol, Louvain, Belgium	KU Leuven; KU Leuven	Duraffour, S (corresponding author), Katholieke Univ Leuven, Rega Inst, Lab Virol & Chemotherapy, Louvain, Belgium.	sophie.duraffour@rega.kuleuven.be	Matthys, Patrick/B-4813-2018; Andrei, Graciela/V-7721-2017; Snoeck, Robert/V-3867-2017	Matthys, Patrick/0000-0002-9685-6836; Andrei, Graciela/0000-0003-2609-4896; Snoeck, Robert/0000-0002-7586-5434	FWO (Fund for Scientific Research-Flanders, Belgium) [G.0680.08, G.0555.08]; GOA (Geconcerteerd Onderzoek Actie) [10/014, 12/017]	FWO (Fund for Scientific Research-Flanders, Belgium)(FWO); GOA (Geconcerteerd Onderzoek Actie)	This research was supported by FWO (Fund for Scientific Research-Flanders, Belgium, Grants G.0680.08 and G.0555.08) and by GOA (Geconcerteerd Onderzoek Actie, Grants 10/014 and 12/017). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abadie V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008159; Abrahao JS, 2010, EMERG INFECT DIS, V16, P976, DOI 10.3201/eid1606.091187; Abu Elzein EME, 1999, REV SCI TECH OIE, V18, P749, DOI 10.20506/rst.18.3.1194; Afonso CL, 2002, VIROLOGY, V295, P1, DOI 10.1006/viro.2001.1343; Al-Zi'abi O, 2007, J VET MED SCI, V69, P541, DOI 10.1292/jvms.69.541; ALCAMI A, 1995, J VIROL, V69, P4633; ALFALLUJI MM, 1979, J HYG-CAMBRIDGE, V83, P267, DOI 10.1017/S002217240002605X; Americo JL, 2010, J VIROL, V84, P8172, DOI 10.1128/JVI.00621-10; Anonymous, 2007, Morbidity and Mortality Weekly Report, V56, P478; BAXBY D, 1972, LANCET, V2, P1063; Bayer-Garner IB, 2005, J CUTAN PATHOL, V32, P28, DOI 10.1111/j.0303-6987.2005.00254.x; BERA BC, 2011, VET MICROBI IN PRESS; Bhanuprakash V, 2010, ZOONOSES PUBLIC HLTH, V57, pE149, DOI 10.1111/j.1863-2378.2009.01314.x; Bhanuprakash V, 2010, TROP ANIM HEALTH PRO, V42, P1271, DOI 10.1007/s11250-010-9560-z; Bristol N, 2007, DISASTER MED PUBLIC, V1, P11, DOI 10.1097/DMP.0b013e3180690d58; BULLER RML, 1991, MICROBIOL REV, V55, P80, DOI 10.1128/MMBR.55.1.80-122.1991; Campe H, 2009, EMERG INFECT DIS, V15, P777, DOI 10.3201/eid1505.090159; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P532; Chapman JL, 2010, VET PATHOL, V47, P852, DOI 10.1177/0300985810378649; Chaudhri G, 2004, P NATL ACAD SCI USA, V101, P9057, DOI 10.1073/pnas.0402949101; DAMON IK, 2007, FIELDS VIROLOGY, P2947; Dato V., 2009, Morbidity and Mortality Weekly Report, V58, P1204; DAVIES FG, 1975, J HYG-CAMBRIDGE, V75, P381, DOI 10.1017/S002217240002444X; Duraffour S, 2007, ANTIVIR THER, V12, P1205; Duraffour S, 2007, ANTIMICROB AGENTS CH, V51, P4410, DOI 10.1128/AAC.00838-07; Duraffour S, 2010, IDRUGS, V13, P181; Duroffour S, 2008, ANTIVIR THER, V13, P977; Gammon DB, 2008, J VIROL, V82, P12520, DOI 10.1128/JVI.01528-08; Glatz M, 2010, LANCET INFECT DIS, V10, P288, DOI 10.1016/S1473-3099(10)70054-2; Grosenbach DW, 2010, P NATL ACAD SCI USA, V107, P838, DOI 10.1073/pnas.0912134107; Gubser C, 2002, J GEN VIROL, V83, P855, DOI 10.1099/0022-1317-83-4-855; Gubser C, 2007, PLOS PATHOG, V3, P246, DOI 10.1371/journal.ppat.0030017; Gubser C, 2007, J GEN VIROL, V88, P1667, DOI 10.1099/vir.0.82748-0; HAFEZ SM, 1992, VACCINE, V10, P533, DOI 10.1016/0264-410X(92)90353-L; Hostetler KY, 2009, ANTIVIR RES, V82, pA84, DOI 10.1016/j.antiviral.2009.01.005; Jezek Z, 1983, J Hyg Epidemiol Microbiol Immunol, V27, P29; Kaiser J, 2007, SCIENCE, V316, P1418, DOI 10.1126/science.316.5830.1418; Karupiah G, 1996, J VIROL, V70, P8301, DOI 10.1128/JVI.70.12.8301-8309.1996; Kinne J, 1998, J COMP PATHOL, V118, P257, DOI 10.1016/S0021-9975(07)80002-8; Knorr CW, 2006, ANTIVIR RES, V72, P125, DOI 10.1016/j.antiviral.2006.05.005; KRIZ B, 1982, J COMP PATHOL, V92, P1, DOI 10.1016/0021-9975(82)90037-8; Kurth A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006883; Liu G, 2004, FEMS IMMUNOL MED MIC, V40, P201, DOI 10.1016/S0928-8244(03)00358-4; Marris E, 2007, NAT MED, V13, P517, DOI 10.1038/nm0507-517; Medeiros-Silva DC, 2010, BRAZ J INFECT DIS, V14, P129, DOI 10.1590/S1413-86702010000200003; Najarro P, 2001, J VIROL, V75, P3185, DOI 10.1128/JVI.75.7.3185-3196.2001; Nakanishi K, 2001, CYTOKINE GROWTH F R, V12, P53, DOI 10.1016/S1359-6101(00)00015-0; Neyts J, 2004, ANTIMICROB AGENTS CH, V48, P2267, DOI 10.1128/AAC.48.6.2267-2273.2004; Ninove L, 2009, EMERG INFECT DIS, V15, P781, DOI 10.3201/eid1505.090235; O'Gorman WE, 2010, CELL HOST MICROBE, V8, P174, DOI 10.1016/j.chom.2010.07.008; Osorio JE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006592; Otterbein C K, 1996, Rev Elev Med Vet Pays Trop, V49, P114; Pfeffer M, 1996, VET MICROBIOL, V49, P135, DOI 10.1016/0378-1135(95)00181-6; Quenelle DC, 2004, ANTIVIR RES, V63, P33, DOI 10.1016/j.antiviral.2004.02.003; Ramshaw IA, 1997, IMMUNOL REV, V159, P119, DOI 10.1111/j.1600-065X.1997.tb01011.x; RAMYAR H, 1972, ZENTRALB VET RIEHE B, V19, P182; Reading PC, 2003, J VIROL, V77, P9960, DOI 10.1128/JVI.77.18.9960-9968.2003; Reading PC, 2003, J GEN VIROL, V84, P1973, DOI 10.1099/vir.0.19285-0; Rimoin AW, 2010, P NATL ACAD SCI USA, V107, P16262, DOI 10.1073/pnas.1005769107; Schoepp RJ, 2004, LAB INVEST, V84, P41, DOI 10.1038/labinvest.3700008; Sehgal C L, 1980, J Commun Dis, V12, P177; Smee DF, 2004, J INFECT DIS, V190, P1132, DOI 10.1086/422696; Smee DF, 2008, INT J ANTIMICROB AG, V31, P352, DOI 10.1016/j.ijantimicag.2007.11.013; Smee Donald F., 2008, Antiviral Chemistry & Chemotherapy, V19, P115; Stabenow J, 2010, J VIROL, V84, P3909, DOI 10.1128/JVI.02012-09; TANTAWI HH, 1978, ACTA VIROL, V22, P451; Thin G, 1882, J Anat Physiol, V16, P202; Tscharke DC, 2006, J VIROL, V80, P6318, DOI 10.1128/JVI.00427-06; Tscharke DC, 2002, J GEN VIROL, V83, P1977, DOI 10.1099/0022-1317-83-8-1977; von Bomhard W, 2011, VET DERMATOL, V22, P111, DOI 10.1111/j.1365-3164.2010.00923.x; Vora S, 2008, CLIN INFECT DIS, V46, P1555, DOI 10.1086/587668; Wernery U, 1999, J VET MED B, V46, P131, DOI 10.1111/j.0931-1793.1999.00250.x; Yang G, 2005, J VIROL, V79, P13139, DOI 10.1128/JVI.79.20.13139-13149.2005	73	14	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2011	6	6							e21561	10.1371/journal.pone.0021561	http://dx.doi.org/10.1371/journal.pone.0021561			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	784FW	21738709	Green Published, Green Submitted, gold			2022-12-27	WOS:000292142800040
J	Wang, CY; Li, H; Hao, XD; Liu, J; Wang, JX; Wang, WZ; Kong, QP; Zhang, YP				Wang, Cheng-Ye; Li, Hui; Hao, Xiao-Dan; Liu, Jia; Wang, Jia-Xin; Wang, Wen-Zhi; Kong, Qing-Peng; Zhang, Ya-Ping			Uncovering the Profile of Somatic mtDNA Mutations in Chinese Colorectal Cancer Patients	PLOS ONE			English	Article							MITOCHONDRIAL-DNA MUTATIONS; SPERMINE OXIDASE; POINT MUTATIONS; PROSTATE-CANCER; SEQUENCE; TUMORS; PHYLOGENY; GENOME; ERRORS; DAMAGE	In the past decade, a high incidence of somatic mitochondrial DNA (mtDNA) mutations has been observed, mostly based on a fraction of the molecule, in various cancerous tissues; nevertheless, some of them were queried due to problems in data quality. Obviously, without a comprehensive understanding of mtDNA mutational profile in the cancerous tissue of a specific patient, it is unlikely to disclose the genuine relationship between somatic mtDNA mutations and tumorigenesis. To achieve this objective, the most straightforward way is to directly compare the whole mtDNA genome variation among three tissues (namely, cancerous tissue, para-cancerous tissue, and distant normal tissue) from the same patient. Considering the fact that most of the previous studies on the role of mtDNA in colorectal tumor focused merely on the D-loop or partial segment of the molecule, in the current study we have collected three tissues (cancerous, para-cancerous and normal tissues) respectively recruited from 20 patients with colorectal tumor and completely sequenced the mitochondrial genome of each tissue. Our results reveal a relatively lower incidence of somatic mutations in these patients; intriguingly, all somatic mutations are in heteroplasmic status. Surprisingly, the observed somatic mutations are not restricted to cancer tissues, for the para-cancer tissues and distant normal tissues also harbor somatic mtDNA mutations with a lower frequency than cancerous tissues but higher than that observed in the general population. Our results suggest that somatic mtDNA mutations in cancerous tissues could not be simply explained as a consequence of tumorigenesis; meanwhile, the somatic mtDNA mutations in normal tissues might reflect an altered physiological environment in cancer patients.	[Wang, Cheng-Ye; Li, Hui; Hao, Xiao-Dan; Wang, Wen-Zhi; Kong, Qing-Peng; Zhang, Ya-Ping] Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Kunming, Peoples R China; [Liu, Jia; Wang, Jia-Xin; Zhang, Ya-Ping] Yunnan Univ, Lab Conservat & Utilizat Bioresource, Kunming 650091, Peoples R China; [Kong, Qing-Peng; Zhang, Ya-Ping] KIZ CUHK Joint Lab Bioresources & Mol Res Common, Kunming, Peoples R China; [Hao, Xiao-Dan; Wang, Wen-Zhi] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China	Chinese Academy of Sciences; Kunming Institute of Zoology; Yunnan University; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Wang, CY (corresponding author), Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Kunming, Peoples R China.	kongqp@yahoo.com.cn; zhangyp1@263.net.cn	hao, xiaodan/ABD-7161-2021	Hao, Xiao-dan/0000-0002-4611-8325	Science and Technology Committee of Yunnan Province [2007C103M]; National Natural Science Foundation of China	Science and Technology Committee of Yunnan Province; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from Science and Technology Committee of Yunnan Province (2007C103M), and the National Natural Science Foundation of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akouchekian M, 2009, DIS COLON RECTUM, V52, P526, DOI 10.1007/DCR.0b013e31819acb99; Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Babbar N, 2006, CANCER RES, V66, P11125, DOI 10.1158/0008-5472.CAN-06-3174; Bandelt HJ, 2007, BIOCHEM BIOPH RES CO, V352, P283, DOI 10.1016/j.bbrc.2006.10.131; Bandelt HJ, 2001, INT J LEGAL MED, V115, P64, DOI 10.1007/s004140100228; Beckman KB, 1997, J BIOL CHEM, V272, P19633, DOI 10.1074/jbc.272.32.19633; Bendall KE, 1996, AM J HUM GENET, V59, P1276; Brandon M, 2006, ONCOGENE, V25, P4647, DOI 10.1038/sj.onc.1209607; Cadet J, 2003, MUTAT RES-FUND MOL M, V531, P5, DOI 10.1016/j.mrfmmm.2003.09.001; Carew Jennifer S, 2002, Mol Cancer, V1, P9, DOI 10.1186/1476-4598-1-9; Chatterjee A, 2006, ONCOGENE, V25, P4663, DOI 10.1038/sj.onc.1209604; Chen JJZ, 2003, CARCINOGENESIS, V24, P1481, DOI 10.1093/carcin/bgg102; Chinnery PF, 2002, LANCET, V360, P1323, DOI 10.1016/S0140-6736(02)11310-9; Coller HA, 2001, NAT GENET, V28, P147, DOI 10.1038/88859; Copeland WC, 2002, CANCER INVEST, V20, P557, DOI 10.1081/CNV-120002155; Goodwin AC, 2008, PROSTATE, V68, P766, DOI 10.1002/pros.20735; Greaves LC, 2006, P NATL ACAD SCI USA, V103, P714, DOI 10.1073/pnas.0505903103; Grzybowski T, 2000, ELECTROPHORESIS, V21, P548, DOI 10.1002/(SICI)1522-2683(20000201)21:3<548::AID-ELPS548>3.0.CO;2-U; He YP, 2010, NATURE, V464, P610, DOI 10.1038/nature08802; Hibi K, 2001, INT J CANCER, V94, P429, DOI 10.1002/ijc.1480; Ishikawa K, 2008, SCIENCE, V320, P661, DOI 10.1126/science.1156906; Kong QP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003016; Kong QP, 2006, HUM MOL GENET, V15, P2076, DOI 10.1093/hmg/ddl130; Kong QP, 2003, AM J HUM GENET, V73, P671, DOI 10.1086/377718; Lievre A, 2005, J CLIN ONCOL, V23, P3517, DOI 10.1200/JCO.2005.07.044; Lim SD, 2005, PROSTATE, V62, P200, DOI 10.1002/pros.20137; Mehrabi S, 2010, DIAGN PATHOL, V5, DOI 10.1186/1746-1596-5-66; Ohta S, 2006, ONCOGENE, V25, P4768, DOI 10.1038/sj.onc.1209602; Osborne A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005636; Palanichamy MG, 2004, AM J HUM GENET, V75, P966, DOI 10.1086/425871; Parr RL, 2006, J MOL DIAGN, V8, P312, DOI 10.2353/jmoldx.2006.050112; Petros JA, 2005, P NATL ACAD SCI USA, V102, P719, DOI 10.1073/pnas.0408894102; Polyak K, 1998, NAT GENET, V20, P291, DOI 10.1038/3108; Salas A, 2005, PLOS MED, V2, P1158, DOI 10.1371/journal.pmed.0020296; Santos C, 2005, MOL BIOL EVOL, V22, P1490, DOI 10.1093/molbev/msi141; Santos C, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-167; Sobin, 2009, UICC TNM CLASSIFICAT; Sternberg D, 2001, BRAIN, V124, P984, DOI 10.1093/brain/124.5.984; Suissa S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000474; Sun C, 2006, MOL BIOL EVOL, V23, P683, DOI 10.1093/molbev/msj078; Tan DJ, 2002, CANCER RES, V62, P972; Taylor RW, 2003, J CLIN INVEST, V112, P1351, DOI 10.1172/JCI200319435; Vega A, 2004, ONCOGENE, V23, P1314, DOI 10.1038/sj.onc.1207214; von Kleist-Retzow JC, 2003, EXP PHYSIOL, V88, P155, DOI 10.1113/eph8802509; Wang CY, 2007, INT J CANCER, V121, P1253, DOI 10.1002/ijc.22822; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; White HE, 2005, GENET TEST, V9, P190, DOI 10.1089/gte.2005.9.190; Xu HX, 2004, CANCER RES, V64, P8521, DOI 10.1158/0008-5472.CAN-04-3511; Yao YG, 2004, FORENSIC SCI INT, V141, P1, DOI 10.1016/j.forsciint.2003.12.004; Zhu WZ, 2005, CARCINOGENESIS, V26, P145, DOI 10.1093/carcin/bgh282	50	20	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2011	6	6							e21613	10.1371/journal.pone.0021613	http://dx.doi.org/10.1371/journal.pone.0021613			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	784FW	21738732	gold, Green Published, Green Submitted			2022-12-27	WOS:000292142800046
J	Engelen, K; Fu, Q; Meysman, P; Sanchez-Rodriguez, A; De Smet, R; Lemmens, K; Fierro, AC; Marchal, K				Engelen, Kristof; Fu, Qiang; Meysman, Pieter; Sanchez-Rodriguez, Aminael; De Smet, Riet; Lemmens, Karen; Fierro, Ana Carolina; Marchal, Kathleen			COLOMBOS: Access Port for Cross-Platform Bacterial Expression Compendia	PLOS ONE			English	Article							MICROARRAY EXPERIMENT MIAME; ESCHERICHIA-COLI; MINIMUM INFORMATION; GENE-REGULATION; DATABASE; FUR; NORMALIZATION; TRANSCRIPTION; TRANSPORTER; COLLECTION	Background: Microarrays are the main technology for large-scale transcriptional gene expression profiling, but the large bodies of data available in public databases are not useful due to the large heterogeneity. There are several initiatives that attempt to bundle these data into expression compendia, but such resources for bacterial organisms are scarce and limited to integration of experiments from the same platform or to indirect integration of per experiment analysis results. Methodology/Principal Findings: We have constructed comprehensive organism-specific cross-platform expression compendia for three bacterial model organisms (Escherichia coli, Bacillus subtilis, and Salmonella enterica serovar Typhimurium) together with an access portal, dubbed COLOMBOS, that not only provides easy access to the compendia, but also includes a suite of tools for exploring, analyzing, and visualizing the data within these compendia. It is freely available at http://bioi.biw.kuleuven.be/colombos. The compendia are unique in directly combining expression information from different microarray platforms and experiments, and we illustrate the potential benefits of this direct integration with a case study: extending the known regulon of the Fur transcription factor of E. coli. The compendia also incorporate extensive annotations for both genes and experimental conditions; these heterogeneous data are functionally integrated in the COLOMBOS analysis tools to interactively browse and query the compendia not only for specific genes or experiments, but also metabolic pathways, transcriptional regulation mechanisms, experimental conditions, biological processes, etc. Conclusions/Significance: We have created cross-platform expression compendia for several bacterial organisms and developed a complementary access port COLOMBOS, that also serves as a convenient expression analysis tool to extract useful biological information. This work is relevant to a large community of microbiologists by facilitating the use of publicly available microarray experiments to support their research.	[Engelen, Kristof; Fu, Qiang; Meysman, Pieter; Sanchez-Rodriguez, Aminael; De Smet, Riet; Lemmens, Karen; Fierro, Ana Carolina; Marchal, Kathleen] Katholieke Univ Leuven, Dept Microbial & Mol Syst, B-3001 Heverlee, Belgium	KU Leuven	Engelen, K (corresponding author), Katholieke Univ Leuven, Dept Microbial & Mol Syst, B-3001 Heverlee, Belgium.	kristof.engelen@biw.kuleuven.be; kathleen.marchal@biw.kuleuven.be	Marchal, Kathleen/B-5001-2013; Marchal, Kathleen/O-7936-2017; Meysman, Pieter/I-1891-2019	Marchal, Kathleen/0000-0002-2169-4588; Marchal, Kathleen/0000-0002-2169-4588; Meysman, Pieter/0000-0001-5903-633X; Sanchez-Rodriguez, Aminael/0000-0002-9269-0621; Engelen, Kristof/0000-0001-6215-1689	KULeuven Research Council [PF/10/010 - NATAR, GOA/08/011, CoE EF/05/007 - SymBioSys, CREA/08/023, OT 05-33, OT09/022]; agency for Innovation by Science and Technology (SBO-BioFrame) [SB-81297]; Interuniversity Attraction Poles [P6/25 - BioMaGNet]; Research Foundation - Flanders [IOK-B9725-G.0329.09]; Human Frontier Science Program [RGY0079/2007C]	KULeuven Research Council(KU Leuven); agency for Innovation by Science and Technology (SBO-BioFrame); Interuniversity Attraction Poles(Belgian Federal Science Policy Office); Research Foundation - Flanders(FWO); Human Frontier Science Program(Human Frontier Science Program)	This work is supported by the KULeuven Research Council (PF/10/010 - NATAR, GOA/08/011, CoE EF/05/007 - SymBioSys, CREA/08/023, OT 05-33, OT09/022); the agency for Innovation by Science and Technology (SBO-BioFrame, SB-81297); Interuniversity Attraction Poles (P6/25 - BioMaGNet); Research Foundation - Flanders (IOK-B9725-G.0329.09); and the Human Frontier Science Program (RGY0079/2007C). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bammler T, 2005, NAT METHODS, V2, P351, DOI 10.1038/nmeth0605-477a; Barrett T, 2009, NUCLEIC ACIDS RES, V37, pD885, DOI 10.1093/nar/gkn764; Berardini TZ, 2010, NUCLEIC ACIDS RES, V38, pD331, DOI 10.1093/nar/gkp1018; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Brazma A, 2001, NAT GENET, V29, P365, DOI 10.1038/ng1201-365; Brazma A, 2009, THESCIENTIFICWORLDJO, V9, P420, DOI 10.1100/tsw.2009.57; Camon E, 2004, NUCLEIC ACIDS RES, V32, pD262, DOI 10.1093/nar/gkh021; Caspi R, 2010, NUCLEIC ACIDS RES, V38, pD473, DOI 10.1093/nar/gkp875; Chen Z, 2007, NUCLEIC ACIDS RES, V35, P6762, DOI 10.1093/nar/gkm631; Elfilali A, 2006, NUCLEIC ACIDS RES, V34, pD613, DOI 10.1093/nar/gkj022; Engelen K, 2006, BIOINFORMATICS, V22, P1251, DOI 10.1093/bioinformatics/btl068; Fadda A, 2009, MOL BIOSYST, V5, P1840, DOI 10.1039/b907310h; Faith JJ, 2008, NUCLEIC ACIDS RES, V36, pD866, DOI 10.1093/nar/gkm815; Fierro AC, 2008, CURR GENOMICS, V9, P525, DOI 10.2174/138920208786847935; Gama-Castro S, 2008, NUCLEIC ACIDS RES, V36, pD120, DOI 10.1093/nar/gkm994; Grosse C, 2006, MOL MICROBIOL, V62, P120, DOI 10.1111/j.1365-2958.2006.05326.x; Hruz Tomas, 2008, Advances in Bioinformatics, V2008, P420747, DOI 10.1155/2008/420747; Irizarry RA, 2005, NAT METHODS, V2, P345, DOI 10.1038/nmeth756; Keseler IM, 2009, NUCLEIC ACIDS RES, V37, pD464, DOI 10.1093/nar/gkn751; Kuo WP, 2006, NAT BIOTECHNOL, V24, P832, DOI 10.1038/nbt1217; Lemmens K, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r27; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Lukk M, 2010, NAT BIOTECHNOL, V28, P322, DOI 10.1038/nbt0410-322; Masse E, 2002, P NATL ACAD SCI USA, V99, P4620, DOI 10.1073/pnas.032066599; McHugh JP, 2003, J BIOL CHEM, V278, P29478, DOI 10.1074/jbc.M303381200; Meysman P, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkq1071; Nandal A, 2010, MOL MICROBIOL, V75, P637, DOI 10.1111/j.1365-2958.2009.06977.x; Pan F, 2007, NUCLEIC ACIDS RES, V35, pD756, DOI 10.1093/nar/gkl798; Panina EM, 2001, NUCLEIC ACIDS RES, V29, P5195, DOI 10.1093/nar/29.24.5195; Parkinson H, 2009, NUCLEIC ACIDS RES, V37, pD868, DOI 10.1093/nar/gkn889; Patzer SI, 2001, J BACTERIOL, V183, P4806, DOI 10.1128/JB.183.16.4806-4813.2001; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; Rhodes DR, 2007, NEOPLASIA, V9, P166, DOI 10.1593/neo.07112; Ritchie ME, 2007, BIOINFORMATICS, V23, P2700, DOI 10.1093/bioinformatics/btm412; Shi LM, 2006, NAT BIOTECHNOL, V24, P1151, DOI 10.1038/nbt1239; Shi LM, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-S2-S12; Sierro N, 2008, NUCLEIC ACIDS RES, V36, pD93, DOI 10.1093/nar/gkm910; Tan PK, 2003, NUCLEIC ACIDS RES, V31, P5676, DOI 10.1093/nar/gkg763; Yang YH, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.4.e15; Zarrineh P, 2010, NUCL ACIDS IN PRESS; Zhang ZG, 2005, J BACTERIOL, V187, P980, DOI 10.1128/JB.187.3.980-990.2005	43	22	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2011	6	7							e20938	10.1371/journal.pone.0020938	http://dx.doi.org/10.1371/journal.pone.0020938			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	793HP	21779320	Green Submitted, Green Published, gold			2022-12-27	WOS:000292811300005
J	Penna-Coutinho, J; Cortopassi, WA; Oliveira, AA; Franca, TCC; Krettli, AU				Penna-Coutinho, Julia; Cortopassi, Wilian Augusto; Oliveira, Aline Alves; Costa Franca, Tanos Celmar; Krettli, Antoniana Ursine			Antimalarial Activity of Potential Inhibitors of Plasmodium falciparum Lactate Dehydrogenase Enzyme Selected by Docking Studies	PLOS ONE			English	Article							IN-VITRO; QUINOLINE ANTIMALARIALS; MOLECULAR DOCKING; DRUG-SENSITIVITY; NATURAL-PRODUCTS; CHLOROQUINE; RESISTANCE; MALARIA; CULTURE; PARASITES	The Plasmodium falciparum lactate dehydrogenase enzyme (PfLDH) has been considered as a potential molecular target for antimalarials due to this parasite's dependence on glycolysis for energy production. Because the LDH enzymes found in P. vivax, P. malariae and P. ovale (pLDH) all exhibit similar to 90% identity to PfLDH, it would be desirable to have new anti-pLDH drugs, particularly ones that are effective against P. falciparum, the most virulent species of human malaria. Our present work used docking studies to select potential inhibitors of pLDH, which were then tested for antimalarial activity against P. falciparum in vitro and P. berghei malaria in mice. A virtual screening in DrugBank for analogs of NADH (an essential cofactor to pLDH) and computational studies were undertaken, and the potential binding of the selected compounds to the PfLDH active site was analyzed using Molegro Virtual Docker software. Fifty compounds were selected based on their similarity to NADH. The compounds with the best binding energies (itraconazole, atorvastatin and posaconazole) were tested against P. falciparum chloroquine-resistant blood parasites. All three compounds proved to be active in two immunoenzymatic assays performed in parallel using monoclonals specific to PfLDH or a histidine rich protein (HRP2). The IC(50) values for each drug in both tests were similar, were lowest for posaconazole (< 5 mu M) and were 40- and 100-fold less active than chloroquine. The compounds reduced P. berghei parasitemia in treated mice, in comparison to untreated controls; itraconazole was the least active compound. The results of these activity trials confirmed that molecular docking studies are an important strategy for discovering new antimalarial drugs. This approach is more practical and less expensive than discovering novel compounds that require studies on human toxicology, since these compounds are already commercially available and thus approved for human use.	[Penna-Coutinho, Julia; Krettli, Antoniana Ursine] Univ Fed Minas Gerais, Fac Med, Belo Horizonte, MG, Brazil; [Penna-Coutinho, Julia; Krettli, Antoniana Ursine] Fiocruz MS, Ctr Pesquisas Rene Rachou, Lab Malaria, Belo Horizonte, MG, Brazil; [Cortopassi, Wilian Augusto; Oliveira, Aline Alves; Costa Franca, Tanos Celmar] Mil Inst Engn, Lab Mol Modeling Appl Chem & Biol Def LMCBD, Rio De Janeiro, Brazil	Universidade Federal de Minas Gerais; Fundacao Oswaldo Cruz	Penna-Coutinho, J (corresponding author), Univ Fed Minas Gerais, Fac Med, Belo Horizonte, MG, Brazil.	tanos@ime.eb.br; akrettli@cpqrr.fiocruz.br	Cortopassi, Wilian/P-3136-2014; Oliveira, Aline/O-1698-2013; França, Tanos Celmar Costa/I-9519-2012	Cortopassi, Wilian/0000-0001-8038-7847; Oliveira, Aline/0000-0001-9605-6276; França, Tanos Celmar Costa/0000-0002-6048-8103	MCT/CNPq/CT-Saude/MS/SCTIE/DECIT; FIOCRUZ-PAPES; FAPEMIG; FAPERJ; CNPq	MCT/CNPq/CT-Saude/MS/SCTIE/DECIT(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FIOCRUZ-PAPES; FAPEMIG(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by the Brazilian funding agencies MCT/CNPq/CT-Saude/MS/SCTIE/DECIT, FIOCRUZ-PAPES, FAPEMIG and FAPERJ, and by CNPq fellowships to AUK, JPC, AAO and WAC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Badr AA, 2009, PROF DRUG SUB EXCIP, V34, P193, DOI [10.1016/S1871-5125(09)34005-4, 10.1016/S0099-5428(08)00005-1]; [Anonymous], GUID TREATM MAL; Berman HM, 2002, ACTA CRYSTALLOGR D, V58, P899, DOI 10.1107/S0907444902003451; Brown WM, 2004, BIOCHEMISTRY-US, V43, P6219, DOI 10.1021/bi049892w; CARVALHO LH, 1991, MEM I OSWALDO CRUZ, V86, P181, DOI 10.1590/S0074-02761991000600041; CARVALHO LH, 1991, BRAZ J MED BIOL RES, V24, P1113; de Andrade-Neto VF, 2004, BIOORG MED CHEM LETT, V14, P1145, DOI 10.1016/j.bmcl.2003.12.069; Druilhe P, 2001, AM J TROP MED HYG, V64, P233, DOI 10.4269/ajtmh.2001.64.233; Egan TJ, 2005, J INORG BIOCHEM, V99, P1532, DOI 10.1016/j.jinorgbio.2005.04.013; Ferraz ML, 2009, ANTIMICROB AGENTS CH, V53, P174, DOI 10.1128/AAC.00779-08; Foley M, 1998, PHARMACOL THERAPEUT, V79, P55, DOI 10.1016/S0163-7258(98)00012-6; Krettli AU, 2009, CURR DRUG TARGETS, V10, P261, DOI 10.2174/138945009787581203; Krettli AU, 2009, EXPERT OPIN DRUG DIS, V4, P95, DOI 10.1517/17530050802678127; LAMBROS C, 1979, J PARASITOL, V65, P418, DOI 10.2307/3280287; *MAL SVS MIN SAUD, 2009, MAL DOENC A Z; Menting JG, 1997, MOL BIOCHEM PARASIT, V88, P215, DOI 10.1016/S0166-6851(97)00095-9; Ncokazi KK, 2005, ANAL BIOCHEM, V338, P306, DOI 10.1016/j.ab.2004.11.022; Noedl H, 2002, EXP PARASITOL, V102, P157, DOI 10.1016/S0014-4894(03)00051-1; Oliveira-Ferreira J, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-115; Parquet V, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-139; PETERS W, 1965, EXP PARASITOL, V17, P80, DOI 10.1016/0014-4894(65)90012-3; Read JA, 1999, J BIOL CHEM, V274, P10213, DOI 10.1074/jbc.274.15.10213; RIECKMANN KH, 1978, LANCET, V1, P22; Taoufiq Z, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-52; Thomsen R, 2006, J MED CHEM, V49, P3315, DOI 10.1021/jm051197e; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Urbina JA, 2009, MEM I OSWALDO CRUZ, V104, P311, DOI 10.1590/S0074-02762009000900041; Vennerstrom JL, 1999, ANTIMICROB AGENTS CH, V43, P598, DOI 10.1128/AAC.43.3.598; WHO, 2010, WORLD MALARIA REPORT 2010, P1; Wishart DS, 2008, NUCLEIC ACIDS RES, V36, pD901, DOI 10.1093/nar/gkm958; Yang JM, 2004, PROTEINS, V55, P288, DOI 10.1002/prot.20035; Yohannes AM, 2011, AM J TROP MED HYG, V84, P137, DOI 10.4269/ajtmh.2011.09-0723	32	85	86	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2011	6	7							e21237	10.1371/journal.pone.0021237	http://dx.doi.org/10.1371/journal.pone.0021237			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	793HP	21779323	Green Published, Green Submitted, gold			2022-12-27	WOS:000292811300007
J	Qu, J; Myhr, KL				Qu, Juan; Myhr, Karen L.			The Morphology and Intrinsic Excitability of Developing Mouse Retinal Ganglion Cells	PLOS ONE			English	Article							MUDPUPPY NECTURUS MACULOSUS; CATS RETINA; VISUAL EXPERIENCE; CLASSIFICATION; ORGANIZATION; DIVERSITY; PATHWAYS; PATTERNS; MUTANT; BRISK	The retinal ganglion cells (RGCs) have diverse morphology and physiology. Although some studies show that correlations between morphological properties and physiological properties exist in cat RGCs, these properties are much less distinct and their correlations are unknown in mouse RGCs. In this study, using three-dimensional digital neuron reconstruction, we systematically analyzed twelve morphological parameters of mouse RGCs as they developed in the first four postnatal weeks. The development of these parameters fell into three different patterns and suggested that contact from bipolar cells and eye opening might play important roles in RGC morphological development. Although there has been a general impression that the morphological parameters are not independent, such as RGCs with larger dendritic fields usually have longer but sparser dendrites, there was not systematic study and statistical analysis proving it. We used Pearson's correlation coefficients to determine the relationship among these morphological parameters and demonstrated that many morphological parameters showed high statistical correlation. In the same cells we also measured seven physiological parameters using whole-cell patch-clamp recording, focusing on intrinsic excitability. We previously reported the increase in intrinsic excitability in mouse RGCs during early postnatal development. Here we showed that strong correlations also existed among many physiological parameters that measure the intrinsic excitability. However, Pearson's correlation coefficient revealed very limited correlation across morphological and physiological parameters. In addition, principle component analysis failed to separate RGCs into clusters using combined morphological and physiological parameters. Therefore, despite strong correlations within the morphological parameters and within the physiological parameters, postnatal mouse RGCs had only limited correlation between morphology and physiology. This may be due to developmental immaturity, or to selection of parameters.	[Qu, Juan; Myhr, Karen L.] Wayne State Univ, Dept Biol Sci, Detroit, MI 48202 USA; [Myhr, Karen L.] Wayne State Univ, Dept Anat & Cell Biol, Detroit, MI USA	Wayne State University; Wayne State University	Qu, J (corresponding author), Harvard Univ, Sch Med, Howe Lab Ophthalmol, Massachusetts Eye & Ear Infirm, Boston, MA 02115 USA.	kmyhr@wayne.edu			Wayne State University	Wayne State University	This work was supported by Wayne State University Startup funds to Dr. Karen Myhr. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott LF, 2002, NAT NEUROSCI, V5, P391, DOI 10.1038/nn0502-391; Anishchenko A, 2010, J NEUROPHYSIOL, V103, P1856, DOI 10.1152/jn.00896.2009; Badea TC, 2004, J COMP NEUROL, V480, P331, DOI 10.1002/cne.20304; BALKEMA GW, 1982, J NEUROPHYSIOL, V48, P968, DOI 10.1152/jn.1982.48.4.968; BOYCOTT BB, 1974, J PHYSIOL-LONDON, V240, P397, DOI 10.1113/jphysiol.1974.sp010616; CALDWELL JH, 1978, J PHYSIOL-LONDON, V276, P257, DOI 10.1113/jphysiol.1978.sp012232; Carcieri SM, 2003, J NEUROPHYSIOL, V90, P1704, DOI 10.1152/jn.00127.2003; Chichilnisky EJ, 2002, J NEUROSCI, V22, P2737, DOI 10.1523/JNEUROSCI.22-07-02737.2002; CLELAND BG, 1974, J PHYSIOL-LONDON, V240, P421, DOI 10.1113/jphysiol.1974.sp010617; CLELAND BG, 1974, J PHYSIOL-LONDON, V240, P457, DOI 10.1113/jphysiol.1974.sp010618; Coombs J, 2006, NEUROSCIENCE, V140, P123, DOI 10.1016/j.neuroscience.2006.02.079; Coombs JL, 2007, J COMP NEUROL, V503, P803, DOI 10.1002/cne.21429; Demas J, 2003, J NEUROSCI, V23, P2851; Diao L, 2004, J NEUROBIOL, V61, P236, DOI 10.1002/neu.20041; DOI M, 1995, J COMP NEUROL, V356, P368, DOI 10.1002/cne.903560305; DOWLING JE, 1969, J NEUROPHYSIOL, V32, P315, DOI 10.1152/jn.1969.32.3.315; ENROTHCUGELL C, 1966, J PHYSIOL-LONDON, V187, P517, DOI 10.1113/jphysiol.1966.sp008107; Farrow K, 2011, J NEUROPHYSIOL, V105, P1516, DOI 10.1152/jn.00331.2010; FUKUDA Y, 1984, J NEUROPHYSIOL, V52, P999, DOI 10.1152/jn.1984.52.6.999; Kong JH, 2005, J COMP NEUROL, V489, P293, DOI 10.1002/cne.20631; LEVICK WR, 1967, J PHYSIOL-LONDON, V188, P285, DOI 10.1113/jphysiol.1967.sp008140; Margolis DJ, 2007, J NEUROSCI, V27, P5994, DOI 10.1523/JNEUROSCI.0130-07.2007; Margolis DJ, 2010, J NEUROSCI, V30, P7127, DOI 10.1523/JNEUROSCI.5694-09.2010; Masland RH, 2001, NAT NEUROSCI, V4, P877, DOI 10.1038/nn0901-877; Myhr KL, 2001, J NEUROSCI, V21, P8664, DOI 10.1523/JNEUROSCI.21-21-08664.2001; O'Brien BJ, 2002, J PHYSIOL-LONDON, V538, P787, DOI 10.1113/jphysiol.2001.013009; Pandarinath C, 2010, J NEUROSCI, V30, P10006, DOI 10.1523/JNEUROSCI.5616-09.2010; Qu J, 2008, DEV NEUROBIOL, V68, P1196, DOI 10.1002/dneu.20653; Robinson DW, 1997, CURR BIOL, V7, P366, DOI 10.1016/S0960-9822(06)00184-9; RODIECK RW, 1983, BRAIN BEHAV EVOLUT, V23, P121, DOI 10.1159/000121492; SAITO HA, 1983, J COMP NEUROL, V221, P279, DOI 10.1002/cne.902210304; STONE C, 1992, J PHYSIOL-LONDON, V456, P125, DOI 10.1113/jphysiol.1992.sp019330; STONE C, 1993, VISUAL NEUROSCI, V10, P31, DOI 10.1017/S0952523800003205; Sun WZ, 2002, J COMP NEUROL, V451, P115, DOI 10.1002/cne.10323; THIBOS LN, 1983, EXP BRAIN RES, V51, P16; Van Wyk M, 2009, VISUAL NEUROSCI, V26, P297, DOI 10.1017/S0952523809990137; WASSLE H, 1991, PHYSIOL REV, V71, P447, DOI 10.1152/physrev.1991.71.2.447; WERBLIN FS, 1969, J NEUROPHYSIOL, V32, P339, DOI 10.1152/jn.1969.32.3.339; Wong RC, 2011, INVEST OPHTHALMOL VI, V43; Wong ROL, 1996, NEURON, V16, P1087, DOI 10.1016/S0896-6273(00)80135-X; Zeck GM, 2007, EUR J NEUROSCI, V26, P367, DOI 10.1111/j.1460-9568.2007.05670.x	41	6	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2011	6	7							e21777	10.1371/journal.pone.0021777	http://dx.doi.org/10.1371/journal.pone.0021777			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	792WQ	21765913	Green Published, gold, Green Submitted			2022-12-27	WOS:000292781500015
J	Ragon, M; Restoux, G; Moreira, D; Moller, AP; Lopez-Garcia, P				Ragon, Marie; Restoux, Gwendal; Moreira, David; Moller, Anders Pape; Lopez-Garcia, Purificacion			Sunlight-Exposed Biofilm Microbial Communities Are Naturally Resistant to Chernobyl Ionizing-Radiation Levels	PLOS ONE			English	Article							GRADIENT GEL-ELECTROPHORESIS; ANCIENT WALL PAINTINGS; SEA HYDROTHERMAL VENTS; RUBROBACTER-RADIOTOLERANS; DEINOCOCCUS-RADIODURANS; SP-NOV.; MOLECULAR PHYLOGENETICS; ULTRAVIOLET-RADIATION; EXTREME ENVIRONMENT; RADIOACTIVE IMPACT	Background: The Chernobyl accident represents a long-term experiment on the effects of exposure to ionizing radiation at the ecosystem level. Though studies of these effects on plants and animals are abundant, the study of how Chernobyl radiation levels affect prokaryotic and eukaryotic microbial communities is practically non-existent, except for a few reports on human pathogens or soil microorganisms. Environments enduring extreme desiccation and UV radiation, such as sunlight exposed biofilms could in principle select for organisms highly resistant to ionizing radiation as well. Methodology/Principal Findings: To test this hypothesis, we explored the diversity of microorganisms belonging to the three domains of life by cultivation-independent approaches in biofilms developing on concrete walls or pillars in the Chernobyl area exposed to different levels of radiation, and we compared them with a similar biofilm from a non-irradiated site in Northern Ireland. Actinobacteria, Alphaproteobacteria, Bacteroidetes, Acidobacteria and Deinococcales were the most consistently detected bacterial groups, whereas green algae (Chlorophyta) and ascomycete fungi (Ascomycota) dominated within the eukaryotes. Close relatives to the most radio-resistant organisms known, including Rubrobacter species, Deinococcales and melanized ascomycete fungi were always detected. The diversity of bacteria and eukaryotes found in the most highly irradiated samples was comparable to that of less irradiated Chernobyl sites and Northern Ireland. However, the study of mutation frequencies in non-coding ITS regions versus SSU rRNA genes in members of a same actinobacterial operational taxonomic unit (OTU) present in Chernobyl samples and Northern Ireland showed a positive correlation between increased radiation and mutation rates. Conclusions/Significance: Our results show that biofilm microbial communities in the most irradiated samples are comparable to non-irradiated samples in terms of general diversity patterns, despite increased mutation levels at the single-OTU level. Therefore, biofilm communities growing in sunlight exposed substrates are capable of coping with increased mutation rates and appear pre-adapted to levels of ionizing radiation in Chernobyl due to their natural adaptation to periodical desiccation and ambient UV radiation.	[Ragon, Marie; Restoux, Gwendal; Moreira, David; Moller, Anders Pape; Lopez-Garcia, Purificacion] Univ Paris 11, CNRS, UMR8079, Unite Ecol Systemat & Evolut, F-91405 Orsay, France	AgroParisTech; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite Paris Saclay	Ragon, M (corresponding author), Univ Paris 11, CNRS, UMR8079, Unite Ecol Systemat & Evolut, F-91405 Orsay, France.	puri.lopez@u-psud.fr	Lopez-Garcia, Purificacion/B-6775-2012; Moller, Anders/O-6665-2016; Moreira, David/F-7445-2012	Lopez-Garcia, Purificacion/0000-0002-0927-0651; Moller, Anders/0000-0003-3739-4675; Moreira, David/0000-0002-2064-5354	"Convention Industrielle de Formation par la REcherche" (CIFRE)	"Convention Industrielle de Formation par la REcherche" (CIFRE)	M. R. and this work were financed by a "Convention Industrielle de Formation par la REcherche" (CIFRE) fellowship and its accompanying research contract. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; AMANN RI, 1995, MICROBIOL REV, V59, P143, DOI 10.1128/MMBR.59.1.143-169.1995; Asgarani E, 2000, J RADIAT RES, V41, P19, DOI 10.1269/jrr.41.19; Backor M, 2008, SYMBIOSIS, V46, P1; BARR DJS, 1978, BIOSYSTEMS, V10, P153, DOI 10.1016/0303-2647(78)90037-0; Berry D, 2006, CURR OPIN BIOTECH, V17, P297, DOI 10.1016/j.copbio.2006.05.007; BROOKS BW, 1981, INT J SYST BACTERIOL, V31, P353, DOI 10.1099/00207713-31-3-353; BUBRICK P, 1984, NEW PHYTOL, V97, P455, DOI 10.1111/j.1469-8137.1984.tb03611.x; Cadet J, 2005, MUTAT RES-FUND MOL M, V571, P3, DOI 10.1016/j.mrfmmm.2004.09.012; Cadet J, 2010, FREE RADICAL BIO MED, V49, P9, DOI 10.1016/j.freeradbiomed.2010.03.025; Cappitelli F, 2007, SCI TOTAL ENVIRON, V385, P172, DOI 10.1016/j.scitotenv.2007.06.022; Chanal A, 2006, ENVIRON MICROBIOL, V8, P514, DOI 10.1111/j.1462-2920.2005.00921.x; Charmasson S, 2009, J ENVIRON RADIOACTIV, V100, P522, DOI 10.1016/j.jenvrad.2009.02.002; Czirjak GA, 2010, MICROB ECOL, V60, P373, DOI 10.1007/s00248-010-9716-4; Dadachova E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000457; Dadachova E, 2008, CURR OPIN MICROBIOL, V11, P525, DOI 10.1016/j.mib.2008.09.013; Daly MJ, 2007, PLOS BIOL, V5, P769, DOI 10.1371/journal.pbio.0050092; Daly MJ, 2009, NAT REV MICROBIOL, V7, P237, DOI 10.1038/nrmicro2073; de Groot A, 2005, INT J SYST EVOL MICR, V55, P2441, DOI 10.1099/ijs.0.63717-0; de la Torre JR, 2003, APPL ENVIRON MICROB, V69, P3858, DOI 10.1128/AEM.69.7.3858-3867.2003; Dighton J, 2008, FEMS MICROBIOL LETT, V281, P109, DOI 10.1111/j.1574-6968.2008.01076.x; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Ettenauer J, 2010, INT J ASTROBIOL, V9, P59, DOI 10.1017/S1473550409990383; Ferreira AC, 1999, EXTREMOPHILES, V3, P235, DOI 10.1007/s007920050121; Fow J, 2003, J STAT SOFTW, V8, P1; Fredrickson JK, 2008, ISME J, V2, P393, DOI 10.1038/ismej.2007.116; FREDRICKSON JK, 1995, APPL ENVIRON MICROB, V61, P1917, DOI 10.1128/AEM.61.5.1917-1922.1995; Gadd GM, 2007, MYCOL RES, V111, P3, DOI 10.1016/j.mycres.2006.12.001; Gallego V, 2006, INT J SYST EVOL MICR, V56, P2291, DOI 10.1099/ijs.0.64379-0; Garvie LAJ, 2008, NATURWISSENSCHAFTEN, V95, P705, DOI 10.1007/s00114-008-0373-0; Geras'kin SA, 2008, ENVIRON INT, V34, P880, DOI 10.1016/j.envint.2007.12.012; Gremion F, 2003, ENVIRON MICROBIOL, V5, P896, DOI 10.1046/j.1462-2920.2003.00484.x; Harutyunyan S, 2008, STUD MYCOL, P83, DOI 10.3114/sim.2008.61.08; Horn M, 2004, J EUKARYOT MICROBIOL, V51, P509, DOI 10.1111/j.1550-7408.2004.tb00278.x; Hughes KA, 2003, ENVIRON MICROBIOL, V5, P555, DOI 10.1046/j.1462-2920.2003.00439.x; Imperi F, 2007, ENVIRON MICROBIOL, V9, P2894, DOI 10.1111/j.1462-2920.2007.01393.x; Jaccard P., 1901, B SOC VAUD SCI NAT, V37, P241, DOI DOI 10.5169/SEALS-266440; Janse I, 2004, J MICROBIOL METH, V57, P279, DOI 10.1016/j.mimet.2003.12.006; Jobb G, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-18; Jolivet E, 2004, EXTREMOPHILES, V8, P219, DOI 10.1007/s00792-004-0380-9; Jolivet E, 2003, INT J SYST EVOL MICR, V53, P847, DOI 10.1099/ijs.0.02503-0; Karsten U, 2007, PLANTA, V225, P991, DOI 10.1007/s00425-006-0406-x; Karsten U, 2005, J PHYCOL, V41, P557, DOI 10.1111/j.1529-8817.2005.00081.x; Kausar J, 1997, INT J SYST BACTERIOL, V47, P684, DOI 10.1099/00207713-47-3-684; Kimura S, 2006, BIOCHEM BIOPH RES CO, V346, P51, DOI 10.1016/j.bbrc.2006.05.126; Liu YQ, 2003, P NATL ACAD SCI USA, V100, P4191, DOI 10.1073/pnas.0630387100; Lopez-Garcia P, 2008, RES MICROBIOL, V159, P67, DOI 10.1016/j.resmic.2007.11.019; MADIGAN MT, 2002, BROCK BIOL MICROORGA; MCAULAY I R, 1989, Journal of Radiological Protection, V9, P29, DOI 10.1088/0952-4746/9/1/004; McCullagh P, 1989, GEN LINEAR MODELS; Moller AP, 2006, TRENDS ECOL EVOL, V21, P200, DOI 10.1016/j.tree.2006.01.008; Nascimbene J, 2009, SCI TOTAL ENVIRON, V407, P5001, DOI 10.1016/j.scitotenv.2009.06.012; Nercessian O, 2005, APPL ENVIRON MICROB, V71, P6885, DOI 10.1128/AEM.71.11.6885-6899.2005; Pellerin A, 2009, ASTROBIOLOGY, V9, P807, DOI 10.1089/ast.2008.0302; Perez-Pantoja D, 2008, FEMS MICROBIOL REV, V32, P736, DOI 10.1111/j.1574-6976.2008.00122.x; PHILIPPE H, 1993, NUCLEIC ACIDS RES, V21, P5264, DOI 10.1093/nar/21.22.5264; Pinar G, 2001, FEMS MICROBIOL ECOL, V37, P45, DOI 10.1016/S0168-6496(01)00144-1; Pinar G, 2009, INT BIODETER BIODEGR, V63, P851, DOI 10.1016/j.ibiod.2009.02.004; Pinto FL, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-79; Pointing SB, 2007, ENVIRON MICROBIOL, V9, P414, DOI 10.1111/j.1462-2920.2006.01153.x; Rainey FA, 2005, APPL ENVIRON MICROB, V71, P5225, DOI 10.1128/AEM.71.9.5225-5235.2005; Romanovskaia V A, 2000, Mikrobiol Z, V62, P40; Romanovskaya V. A., 1999, Mikrobiologiya, V68, P534; Romanovskaya VA, 1998, MICROBIOLOGY+, V67, P226; RPII, 2008, RAD MON IR ENV; Sait M, 2002, ENVIRON MICROBIOL, V4, P654, DOI 10.1046/j.1462-2920.2002.00352.x; SAITO T, 1994, ARCH MICROBIOL, V162, P414, DOI 10.1007/s002030050159; Schabereiter-Gurtner C, 2001, J MICROBIOL METH, V47, P345, DOI 10.1016/S0167-7012(01)00344-X; Schloss PD, 2005, APPL ENVIRON MICROB, V71, P1501, DOI 10.1128/AEM.71.3.1501-1506.2005; Sert H, 2007, MYCOL RES, V111, P1235, DOI 10.1016/j.mycres.2007.06.011; Sette LD, 2010, FUNGAL DIVERS, V44, P53, DOI 10.1007/s13225-010-0048-y; Sghaier H, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-297; Shestopalov V. M., 1996, ATLAS CHERNOBYL EXCL; Shi T, 2001, J IND MICROBIOL BIOT, V26, P283, DOI 10.1038/sj.jim.7000130; Shravage BV, 2007, MICROBIOL RES, V162, P15, DOI 10.1016/j.micres.2006.01.005; Slade D, 2011, MICROBIOL MOL BIOL R, V75, P133, DOI 10.1128/MMBR.00015-10; SOKAL ROBERT R., 1958, UNIV KANSAS SCI BULL, V38, P1409; SUZUKI K, 1988, FEMS MICROBIOL LETT, V52, P33, DOI 10.1111/j.1574-6968.1988.tb02568.x; Tanabe Y, 2005, J GEN APPL MICROBIOL, V51, P267, DOI 10.2323/jgam.51.267; Team R. D. C, 2011, R LANG ENV STAT COMP; Tian B, 2010, TRENDS MICROBIOL, V18, P512, DOI 10.1016/j.tim.2010.07.007; Trefault N, 2004, ENVIRON MICROBIOL, V6, P655, DOI 10.1111/j.1462-2920.2004.00596.x; Tugay T, 2006, MYCOLOGIA, V98, P521, DOI 10.3852/mycologia.98.4.521; White O, 1999, SCIENCE, V286, P1571, DOI 10.1126/science.286.5444.1571; Wong FKY, 2010, MICROB ECOL, V60, P730, DOI 10.1007/s00248-010-9653-2; Wornik S, 2010, MICROB ECOL, V59, P150, DOI 10.1007/s00248-009-9584-y; Yablokov AV, 2009, ANN NY ACAD SCI, V1181, P223, DOI [10.1111/j.1749-6632.2009.04831.x, 10.1111/j.1749-6632.2009.04830.x]; Yablokov AV, 2009, ANN NY ACAD SCI, V1181, P237, DOI [10.1111/j.1749-6632.2009.04832.x, 10.1111/j.1749-6632.2009.04830.x]; Yablokov AV, 2009, ANN NY ACAD SCI, V1181, P281, DOI 10.1111/j.1749-6632.2009.04830.x; Zavilgelsky GB, 1998, J PHOTOCH PHOTOBIO B, V43, P152, DOI 10.1016/S1011-1344(98)00099-2; Zhdanova NN, 2004, MYCOL RES, V108, P1089, DOI 10.1017/S0953756204000966; Zhdanova NN, 2003, J ENVIRON RADIOACTIV, V67, P119, DOI 10.1016/S0265-931X(02)00164-9; ZHDANOVA NN, 1994, MYCOL RES, V98, P789, DOI 10.1016/S0953-7562(09)81057-5; Zhdanova NN, 2000, MYCOL RES, V104, P1421, DOI 10.1017/S0953756200002756	94	49	49	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2011	6	7							e21764	10.1371/journal.pone.0021764	http://dx.doi.org/10.1371/journal.pone.0021764			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	792WQ	21765911	Green Submitted, Green Published, gold			2022-12-27	WOS:000292781500013
J	Oshima, M; Mizuno, M; Imamura, A; Ogawa, M; Yasukawa, M; Yamazaki, H; Morita, R; Ikeda, E; Nakao, K; Takano-Yamamoto, T; Kasugai, S; Saito, M; Tsuji, T				Oshima, Masamitsu; Mizuno, Mitsumasa; Imamura, Aya; Ogawa, Miho; Yasukawa, Masato; Yamazaki, Hiromichi; Morita, Ritsuko; Ikeda, Etsuko; Nakao, Kazuhisa; Takano-Yamamoto, Teruko; Kasugai, Shohei; Saito, Masahiro; Tsuji, Takashi			Functional Tooth Regeneration Using a Bioengineered Tooth Unit as a Mature Organ Replacement Regenerative Therapy	PLOS ONE			English	Article							STEM-CELLS; IN-VIVO; TRANSPLANTATION; GENERATION; REPAIR; LIVER; TEETH; ORGANOGENESIS; PERIODONTIUM; PROMISE	Donor organ transplantation is currently an essential therapeutic approach to the replacement of a dysfunctional organ as a result of disease, injury or aging in vivo. Recent progress in the area of regenerative therapy has the potential to lead to bioengineered mature organ replacement in the future. In this proof of concept study, we here report a further development in this regard in which a bioengineered tooth unit comprising mature tooth, periodontal ligament and alveolar bone, was successfully transplanted into a properly-sized bony hole in the alveolar bone through bone integration by recipient bone remodeling in a murine transplantation model system. The bioengineered tooth unit restored enough the alveolar bone in a vertical direction into an extensive bone defect of murine lower jaw. Engrafted bioengineered tooth displayed physiological tooth functions such as mastication, periodontal ligament function for bone remodeling and responsiveness to noxious stimulations. This study thus represents a substantial advance and demonstrates the real potential for bioengineered mature organ replacement as a next generation regenerative therapy.	[Oshima, Masamitsu; Mizuno, Mitsumasa; Ogawa, Miho; Morita, Ritsuko; Nakao, Kazuhisa; Saito, Masahiro; Tsuji, Takashi] Tokyo Univ Sci, Res Inst Sci & Technol, Chiba, Japan; [Mizuno, Mitsumasa; Ikeda, Etsuko; Takano-Yamamoto, Teruko] Tohoku Univ, Div Orthodont & Dentofacial Orthoped, Grad Sch Dent, Sendai, Miyagi, Japan; [Imamura, Aya; Yasukawa, Masato; Yamazaki, Hiromichi; Saito, Masahiro; Tsuji, Takashi] Tokyo Univ Sci, Dept Biol Sci & Technol, Grad Sch Ind Sci & Technol, Chiba, Japan; [Ogawa, Miho; Tsuji, Takashi] Organ Technol Inc, Tokyo, Japan; [Kasugai, Shohei] Tokyo Med & Dent Univ, Oral Implantol & Regenerat Dent Med Grad Sch, Bunkyo Ku, Tokyo, Japan	Tokyo University of Science; Tohoku University; Tokyo University of Science; Tokyo Medical & Dental University (TMDU)	Oshima, M (corresponding author), Tokyo Univ Sci, Res Inst Sci & Technol, Chiba, Japan.	t-tsuji@rs.noda.tus.ac.jp	Tsuji, Takashi/N-6086-2015; Morita, Ritsuko/AAY-6642-2021	Morita, Ritsuko/0000-0001-6550-8778	Ministry of Health, Labour, and Welfare [21040101]; Ministry of Education, Culture, Sports and Technology, Japan [50339131]; Grants-in-Aid for Scientific Research [21390509, 23249085] Funding Source: KAKEN	Ministry of Health, Labour, and Welfare(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was partially supported by Health and Labour Sciences Research Grants from the Ministry of Health, Labour, and Welfare (No. 21040101) to T.T., a Grant-in Aid for Scientific Research in Priority Areas (No. 50339131) to T.T., a Grant-in-Aid for Scientific Research (A) to T.T. and a Grant-in-Aid for Young Scientists (B) to M. Oshima from Ministry of Education, Culture, Sports and Technology, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atala A, 2005, EXPERT OPIN BIOL TH, V5, P879, DOI 10.1517/14712598.5.7.879; Bueno EM, 2009, NAT REV RHEUMATOL, V5, P685, DOI 10.1038/nrrheum.2009.228; Byers MR, 1999, CRIT REV ORAL BIOL M, V10, P4, DOI 10.1177/10454411990100010101; Cai JL, 2007, DEV BIOL, V304, P499, DOI 10.1016/j.ydbio.2007.01.002; Cho MI, 2000, PERIODONTOL 2000, V24, P9, DOI 10.1034/j.1600-0757.2000.2240102.x; Copelan EA, 2006, NEW ENGL J MED, V354, P1813, DOI 10.1056/NEJMra052638; GEERTMAN ME, 1994, J DENT RES, V73, P1858, DOI 10.1177/00220345940730121101; Gridelli B, 2000, NEW ENGL J MED, V343, P404, DOI 10.1056/NEJM200008103430606; Hu B, 2006, TISSUE ENG, V12, P2069, DOI 10.1089/ten.2006.12.2069; Ikeda E, 2008, EXPERT OPIN BIOL TH, V8, P735, DOI [10.1517/14712598.8.6.735, 10.1517/14712598.8.6.735 ]; Ikeda E, 2009, P NATL ACAD SCI USA, V106, P13475, DOI 10.1073/pnas.0902944106; Ishida K, 2011, BIOCHEM BIOPH RES CO, V405, P455, DOI 10.1016/j.bbrc.2011.01.052; Jernvall J, 2000, MECH DEVELOP, V92, P19, DOI 10.1016/S0925-4773(99)00322-6; Kallu R, 2005, INT J ORAL MAX SURG, V34, P745, DOI 10.1016/j.ijom.2005.03.009; Khademhosseini A, 2006, P NATL ACAD SCI USA, V103, P2480, DOI 10.1073/pnas.0507681102; Kinoshita M, 2010, INT J DEV BIOL, V54, P851, DOI 10.1387/ijdb.093036mk; Korbling M, 2003, NEW ENGL J MED, V349, P570, DOI 10.1056/NEJMra022361; Layer PG, 2002, TRENDS NEUROSCI, V25, P131, DOI 10.1016/S0166-2236(00)02036-1; Lechler RI, 2005, NAT MED, V11, P605, DOI 10.1038/nm1251; Miyahara Y, 2006, NAT MED, V12, P459, DOI 10.1038/nm1391; Moers C, 2009, NEW ENGL J MED, V360, P7, DOI 10.1056/NEJMoa0802289; Nakao K, 2007, NAT METHODS, V4, P227, DOI 10.1038/nmeth1012; Nickel JC, 2003, J DENT RES, V82, P212, DOI 10.1177/154405910308200312; Nishikawa S, 2008, NAT REV MOL CELL BIO, V9, P725, DOI 10.1038/nrm2466; Ohashi K, 2007, NAT MED, V13, P880, DOI 10.1038/nm1576; Purnell B, 2008, SCIENCE, V322, P1489, DOI 10.1126/science.322.5907.1489; Sedohara A, 2003, DEV GROWTH DIFFER, V45, P463; Shackleton M, 2006, NATURE, V439, P84, DOI 10.1038/nature04372; Sharpe PT, 2005, SCI AM, V293, P34, DOI 10.1038/scientificamerican0805-34; Slack JMW, 2008, SCIENCE, V322, P1498, DOI 10.1126/science.1162782; Tyler D, 2003, BIOESSAYS, V25, P5, DOI 10.1002/bies.10211; Uygun BE, 2010, NAT MED, V16, P814, DOI 10.1038/nm.2170; Van der Weijden F, 2009, J CLIN PERIODONTOL, V36, P1048, DOI 10.1111/j.1600-051X.2009.01482.x; Wang XH, 2010, TISSUE ENG PART B-RE, V16, P189, DOI [10.1089/ten.teb.2009.0576, 10.1089/ten.TEB.2009.0576]; Yelick P.C., 2006, DENT CLIN N AM, V50, pviii; Yelick Pamela C, 2006, Dent Clin North Am, V50, P191, DOI 10.1016/j.cden.2005.11.005; Yen AHH, 2006, EXPERT OPIN BIOL TH, V6, P9, DOI 10.1517/14712598.6.1.9; Zaret KS, 2008, SCIENCE, V322, P1490, DOI 10.1126/science.1161431; Zheng Y, 2005, J INVEST DERMATOL, V124, P867, DOI 10.1111/j.0022-202X.2005.23716.x	39	127	135	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2011	6	7							e21531	10.1371/journal.pone.0021531	http://dx.doi.org/10.1371/journal.pone.0021531			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791WM	21765896	Green Published, Green Submitted, gold			2022-12-27	WOS:000292699000006
J	Bouchami, O; Ben Hassen, A; de Lencastre, H; Miragaia, M				Bouchami, Ons; Ben Hassen, Assia; de Lencastre, Herminia; Miragaia, Maria			Molecular Epidemiology of Methicillin-Resistant Staphylococcus hominis (MRSHo): Low Clonality and Reservoirs of SCCmec Structural Elements	PLOS ONE			English	Article							CASSETTE CHROMOSOME MEC; COAGULASE-NEGATIVE STAPHYLOCOCCI; FIELD GEL-ELECTROPHORESIS; PANDEMIC CLONES; AUREUS STRAINS; EPIDERMIDIS; SEQUENCE; IDENTIFICATION; EVOLUTION; GENOME	Background: Methicillin resistant Staphylococcus hominis (MRSHo) are important human pathogens in immunocompromised patients. However, little is known regarding its population structure and staphylococcal chromosomal cassette mec (SCCmec) content. Methodology/Principal Findings: To assess the population structure and the SCCmec content of S. hominis, 34 MRSHo and 11 methicillin-susceptible S. hominis (MSSHo) from neutropenic patients collected over a 3-year period were studied. The genetic backgrounds of S. hominis isolates were analyzed by pulsed-field gel electrophoresis (PFGE) and SCCmec types were determined by PCR. Cassette chromosome recombinases (ccr) were characterized by PCR and ccrB sequencing. The 34 S. hominis isolates were classified into as many as 28 types and 32 subtypes (SID = 99.82%); clonal dissemination was occasionally observed. The main SCCmec structures identified were SCCmec type VI (4B) (20%), SCCmec VIII (4A) (15%), and a new SCCmec composed of mec complex A in association with ccrAB1 (38%); 27% of the isolates harbored non-typeable SCCmec. Overall, a high prevalence of mec complex A (73.5%), ccrAB1 (50%) and ccrAB4 (44%) were found. Importantly, ccrB1 and ccrB4 from both MRSHo and MSSHo showed a high nucleotide sequence homology with those found in S. aureus SCCmec I, VI and VIII respectively (>95%). Conclusions/Significance: The S. hominis population showed a limited clonality and a low genetic diversity in the allotypes of ccr and classes of mec complex. Moreover, our data suggest that S. hominis might have been a privileged source of mec complex A, ccrB1 and ccrB4, for the assembly of primordial SCCmec types.	[Bouchami, Ons; de Lencastre, Herminia; Miragaia, Maria] Univ Nova Lisboa, Inst Tecnol Quim & Biol, Mol Genet Lab, P-2780156 Oeiras, Portugal; [Bouchami, Ons; Ben Hassen, Assia] Bone Marrow Transplant Ctr Tunisia, Tunis, Tunisia; [de Lencastre, Herminia] Rockefeller Univ, Microbiol Lab, New York, NY 10021 USA	Universidade Nova de Lisboa; Universite de Tunis-El-Manar; Centre Nationale de Greffe de la Moelle Osseuse; Rockefeller University	Bouchami, O (corresponding author), Univ Nova Lisboa, Inst Tecnol Quim & Biol, Mol Genet Lab, P-2780156 Oeiras, Portugal.	miragaia@itqb.unl.pt	Miragaia, Maria/J-2704-2015	Miragaia, Maria/0000-0002-1323-7184; /0000-0001-6816-8932; Bouchami, Ons/0000-0002-9425-3513	European Community [F3-2008-222718, 053/BI-BTI/2009]; Tunisia-Portugal MESRST/GRICES [Proc<SUP>o</SUP>4. 1. 5]	European Community(European Commission); Tunisia-Portugal MESRST/GRICES	This work was partially supported by Project CONCORD (Ref. FP7-Health-F3-2008-222718) from the European Community to HL and by grant Ref: 053/BI-BTI/2009 from the same Project to OB. Additional funding was provided by project Tunisia-Portugal MESRST/GRICES ref. Proc<SUP>o</SUP>4. 1. 5. The funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Boyle-Vavra S, 2005, J CLIN MICROBIOL, V43, P4719, DOI 10.1128/JCM.43.9.4719-4730.2005; Chongtrakool P, 2006, ANTIMICROB AGENTS CH, V50, P1001, DOI 10.1128/AAC.50.3.1001-1012.2006; Chung M, 2000, MICROB DRUG RESIST, V6, P189, DOI 10.1089/mdr.2000.6.189; Couto I, 1996, MICROB DRUG RESIST, V2, P377, DOI 10.1089/mdr.1996.2.377; Couto I, 2001, J CLIN MICROBIOL, V39, P3099, DOI 10.1128/JCM.39.9.3099-3103.2001; DELENCASTRE H, 1994, EUR J CLIN MICROBIOL, V13, P64, DOI 10.1007/BF02026129; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Frebourg NB, 2000, J CLIN MICROBIOL, V38, P877, DOI 10.1128/JCM.38.2.877-880.2000; Garza-Gonzalez E, 2010, EPIDEMIOL INFECT, V138, P645, DOI 10.1017/S0950268809991361; Gill SR, 2005, J BACTERIOL, V187, P2426, DOI 10.1128/JB.187.7.2426-2438.2005; GILL VJ, 1983, J CLIN MICROBIOL, V18, P1314, DOI 10.1128/JCM.18.6.1314-1319.1983; Ham JS, 2010, MOL CELLS, V30, P71, DOI 10.1007/s10059-010-0090-3; Hanssen AM, 2004, ANTIMICROB AGENTS CH, V48, P285, DOI 10.1128/AAC.48.1.285-296.2004; Hanssen AM, 2007, ANTIMICROB AGENTS CH, V51, P1671, DOI 10.1128/AAC.00978-06; HARTMAN BJ, 1984, J BACTERIOL, V158, P513, DOI 10.1128/JB.158.2.513-516.1984; Ibrahem S, 2009, J CLIN MICROBIOL, V47, P32, DOI 10.1128/JCM.01085-08; Ito T, 2004, ANTIMICROB AGENTS CH, V48, P2637, DOI 10.1128/AAC.48.7.2637-2651.2004; Ito T, 2001, ANTIMICROB AGENTS CH, V45, P1323, DOI 10.1128/AAC.45.5.1323-1336.2001; Ito T, 1999, ANTIMICROB AGENTS CH, V43, P1449, DOI 10.1128/AAC.43.6.1449; Ito T, 2009, ANTIMICROB AGENTS CH, V53, P4961, DOI 10.1128/AAC.00579-09; Katayama Y, 2003, J BACTERIOL, V185, P2711, DOI 10.1128/JB.185.9.2711-2722.2003; Katayama Y, 2001, ANTIMICROB AGENTS CH, V45, P1955, DOI 10.1128/AAC.45.7.1955-1963.2001; Kennedy HF, 2000, J MED MICROBIOL, V49, P367, DOI 10.1099/0022-1317-49-4-367; Kloos WE., 1997, STAPHYLOCOCCI HUMAN, P113; Kuroda M, 2005, P NATL ACAD SCI USA, V102, P13272, DOI 10.1073/pnas.0502950102; Li SS, 2011, ANTIMICROB AGENTS CH, V55, P3046, DOI 10.1128/AAC.01475-10; Liakopoulos V, 2008, NEPHROL DIAL TRANSPL, V23, P2599, DOI 10.1093/ndt/gfn101; Miragaia M, 2007, J BACTERIOL, V189, P2540, DOI 10.1128/JB.01484-06; Miragaia M, 2005, MICROB DRUG RESIST, V11, P83, DOI 10.1089/mdr.2005.11.83; Miragaia M, 2002, J CLIN MICROBIOL, V40, P430, DOI 10.1128/JCM.40.2.430-438.2002; Machado ABP, 2007, J MED MICROBIOL, V56, P1328, DOI 10.1099/jmm.0.47294-0; Murchan S, 2003, J CLIN MICROBIOL, V41, P1574, DOI 10.1128/JCM.41.4.1574-1585.2003; MUSSER JM, 1992, J CLIN MICROBIOL, V30, P2058, DOI 10.1128/JCM.30.8.2058-2063.1992; Okuma K, 2002, J CLIN MICROBIOL, V40, P4289, DOI 10.1128/JCM.40.11.4289-4294.2002; Oliveira DC, 2002, LANCET INFECT DIS, V2, P180, DOI 10.1016/S1473-3099(02)00227-X; Oliveira DC, 2001, MICROB DRUG RESIST, V7, P349, DOI 10.1089/10766290152773365; Oliveira DC, 2008, J ANTIMICROB CHEMOTH, V61, P959, DOI 10.1093/jac/dkn021; Oliveira DC, 2006, ANTIMICROB AGENTS CH, V50, P3457, DOI 10.1128/AAC.00629-06; Oliveira DC, 2006, J ANTIMICROB CHEMOTH, V58, P23, DOI 10.1093/jac/dkl208; Ruppe E, 2009, ANTIMICROB AGENTS CH, V53, P442, DOI 10.1128/AAC.00724-08; SIMPSON EH, 1949, NATURE, V163, P688, DOI 10.1038/163688a0; Takeuchi F, 2005, J BACTERIOL, V187, P7292, DOI 10.1128/JB.187.21.7292-7308.2005; TENOVER FC, 1995, J CLIN MICROBIOL, V33, P2233, DOI 10.1128/JCM.33.9.2233-2239.1995; Wisplinghoff H, 2003, ANTIMICROB AGENTS CH, V47, P3574, DOI 10.1128/AAC.47.11.3574-3579.2003; Wu SW, 1996, MICROB DRUG RESIST, V2, P435, DOI 10.1089/mdr.1996.2.435; Zhang YQ, 2003, MOL MICROBIOL, V49, P1577, DOI 10.1046/j.1365-2958.2003.03671.x	46	36	39	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2011	6	7							e21940	10.1371/journal.pone.0021940	http://dx.doi.org/10.1371/journal.pone.0021940			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791IA	21760926	Green Published, gold, Green Submitted			2022-12-27	WOS:000292657200030
J	Boutros, PC; Moffat, ID; Okey, AB; Pohjanvirta, R				Boutros, Paul C.; Moffat, Ivy D.; Okey, Allan B.; Pohjanvirta, Raimo			mRNA Levels in Control Rat Liver Display Strain-Specific, Hereditary, and AHR-Dependent Components	PLOS ONE			English	Article							ARYL-HYDROCARBON RECEPTOR; HUMAN GENE-EXPRESSION; CELL LUNG-CANCER; PROBE LEVEL; NULL MICE; GENOME; MOUSE; RESISTANT; TCDD; TOXICOGENOMICS	Rat is a major model organism in toxicogenomics and pharmacogenomics. Hepatic mRNA profiles after treatment with xenobiotic chemicals are used to predict and understand drug toxicity and mechanisms. Surprisingly, neither inter- and intra-strain variability of mRNA abundances in control rats nor the heritability of rat mRNA abundances yet been established. We address these issues by studying five populations: the popular Sprague-Dawley strain, sub-strains of Long-Evans and Wistar rats, and two lines derived from crosses between the Long-Evans and Wistar sub-strains. Using three independent techniques - variance analysis, linear modelling, and unsupervised pattern recognition - we characterize extensive intra- and inter- strain variability in mRNA levels. We find that both sources of variability are non-random and are enriched for specific functional groups. Specific transcription-factor binding-sites are enriched in their promoter regions and these genes occur in "islands" scattered throughout the rat genome. Using the two lines generated by crossbreeding we tested heritability of hepatic mRNA levels: the majority of rat genes appear to exhibit directional genetics, with only a few interacting loci. Finally, a comparison of inter- strain heterogeneity between mouse and rat orthologs shows more heterogeneity in rats than mice; thus rat and mouse heterogeneity are uncorrelated. Our results establish that control hepatic mRNA levels are relatively homogeneous within rat strains but highly variable between strains. This variability may be related to increased activity of specific transcription-factors and has clear functional consequences. Future studies may take advantage of this phenomenon by surveying panels of rat strains.	[Boutros, Paul C.; Moffat, Ivy D.; Okey, Allan B.] Univ Toronto, Dept Pharmacol & Toxicol, Toronto, ON, Canada; [Boutros, Paul C.] Ontario Inst Canc Res, Toronto, ON, Canada; [Pohjanvirta, Raimo] Univ Helsinki, Dept Food & Environm Hyg, Helsinki, Finland; [Pohjanvirta, Raimo] Natl Inst Hlth & Welf, Toxicol Lab, Kuopio, Finland	University of Toronto; Ontario Institute for Cancer Research; University of Toronto; University Toronto Affiliates; University of Helsinki; Finland National Institute for Health & Welfare	Boutros, PC (corresponding author), Univ Toronto, Dept Pharmacol & Toxicol, Toronto, ON, Canada.	Paul.Boutros@utoronto.ca	Pohjanvirta, Raimo/I-4509-2019	Pohjanvirta, Raimo/0000-0003-0952-5746; Boutros, Paul/0000-0003-0553-7520	Canadian Institutes of Health Research [FRN-57903, MOP-57903]; Academy of Finland [211120, 123345]; Government of Ontario	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Academy of Finland(Academy of Finland); Government of Ontario	This work was financially supported by the Canadian Institutes of Health Research (Grants number FRN-57903 to ABO and MOP-57903 to ABO and PCB) and the Academy of Finland (Grant numbers 211120 and 123345 to RP). This study was conducted with the support of the Ontario Institute for Cancer Research to PCB through funding provided by the Government of Ontario. The funding agencies had no role in study design, data collection, analysis or interpretation, nor the writing of or decision to submit the manuscript for publication.	Amin RP, 2002, TOXICOLOGY, V181, P555, DOI 10.1016/S0300-483X(02)00481-X; Bachtiary B, 2006, CLIN CANCER RES, V12, P5632, DOI 10.1158/1078-0432.CCR-06-0357; Boedigheimer MJ, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-285; Boorman GA, 2005, TOXICOL SCI, V86, P185, DOI 10.1093/toxsci/kfi166; Boorman GA, 2005, TOXICOL PATHOL, V33, P102, DOI 10.1080/01926230590522211; Boutros PC, 2009, TOXICOL SCI, V112, P245, DOI 10.1093/toxsci/kfp191; Boutros PC, 2009, P NATL ACAD SCI USA, V106, P2824, DOI 10.1073/pnas.0809444106; Boutros PC, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-419; Boutros PC, 2005, BRIEF BIOINFORM, V6, P331, DOI 10.1093/bib/6.4.331; Boverhof DR, 2006, TOXICOL SCI, V94, P398, DOI 10.1093/toxsci/kfl100; Burgoon LD, 2006, TOXICOL SCI, V90, P558, DOI 10.1093/toxsci/kfj097; Cerutti C, 2006, PHYSIOL GENOMICS, V27, P295, DOI 10.1152/physiolgenomics.00318.2005; Chen HY, 2007, NEW ENGL J MED, V356, P11, DOI 10.1056/NEJMoa060096; Cheung VG, 2005, NATURE, V437, P1365, DOI 10.1038/nature04244; Cheung VG, 2003, NAT GENET, V33, P422, DOI 10.1038/ng1094; Cutler G, 2007, GENOME RES, V17, P1743, DOI 10.1101/gr.6754607; Daniels GM, 2002, GENES BRAIN BEHAV, V1, P35, DOI 10.1046/j.1601-1848.2001.00008.x; Efron B, 2002, GENET EPIDEMIOL, V23, P70, DOI 10.1002/gepi.1124; Fernandes C, 2004, EUR J NEUROSCI, V19, P2576, DOI 10.1111/j.0953-816X.2004.03358.x; Franc MA, 2008, ARCH TOXICOL, V82, P809, DOI 10.1007/s00204-008-0303-0; Frijters R, 2007, PHARMACOGENOMICS, V8, P1521, DOI 10.2217/14622416.8.11.1521; Frith MC, 2004, NUCLEIC ACIDS RES, V32, P1372, DOI 10.1093/nar/gkh299; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Gibbs RA, 2004, NATURE, V428, P493, DOI 10.1038/nature02426; Gu YZ, 2000, ANNU REV PHARMACOL, V40, P519, DOI 10.1146/annurev.pharmtox.40.1.519; Guo L, 2006, NAT BIOTECHNOL, V24, P1162, DOI 10.1038/nbt1238; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Jacob HJ, 2002, NAT REV GENET, V3, P33, DOI 10.1038/nrg702; Jin W, 2001, NAT GENET, V29, P389, DOI 10.1038/ng766; Karolchik D, 2003, NUCLEIC ACIDS RES, V31, P51, DOI 10.1093/nar/gkg129; Lazar J, 2005, GENOME RES, V15, P1717, DOI 10.1101/gr.3744005; Lund AK, 2003, TOXICOL APPL PHARM, V193, P177, DOI 10.1016/j.taap.2003.08.008; Martin R, 2006, PHARMACOGENOMICS, V7, P1003, DOI 10.2217/14622416.7.7.1003; McMillan BJ, 2007, MOL PHARMACOL, V72, P487, DOI 10.1124/mol.107.037259; Moffat ID, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-263; Monks SA, 2004, AM J HUM GENET, V75, P1094, DOI 10.1086/426461; Morley M, 2004, NATURE, V430, P743, DOI 10.1038/nature02797; OKEY AB, 1994, TRENDS PHARMACOL SCI, V15, P226, DOI 10.1016/0165-6147(94)90316-6; Okey AB, 2007, TOXICOL SCI, V98, P5, DOI 10.1093/toxsci/kfm096; Pohjanvirta R, 1998, MOL PHARMACOL, V54, P86, DOI 10.1124/mol.54.1.86; Pohjanvirta R, 1990, Toxicol Appl Pharmacol, V105, P508, DOI 10.1016/0041-008X(90)90154-M; Pohjanvirta R, 1999, TOXICOL APPL PHARM, V155, P82, DOI 10.1006/taap.1998.8565; Pohjanvirta R, 2008, TOXICOL APPL PHARM, V230, P41, DOI 10.1016/j.taap.2008.02.002; Pritchard C, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-3-r26; Pritchard CC, 2001, P NATL ACAD SCI USA, V98, P13266, DOI 10.1073/pnas.221465998; Ranz JM, 2003, SCIENCE, V300, P1742, DOI 10.1126/science.1085881; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Rockman MV, 2006, NAT REV GENET, V7, P862, DOI 10.1038/nrg1964; Sandelin A, 2004, NUCLEIC ACIDS RES, V32, pD91, DOI 10.1093/nar/gkh012; Schadt EE, 2003, NATURE, V422, P297, DOI 10.1038/nature01434; Seidel SD, 2006, TOXICOL SCI, V94, P226, DOI 10.1093/toxsci/kfl082; SMYTH GK, 2003, STAT APPL GENET MOL, V3, P1; Tijet N, 2006, MOL PHARMACOL, V69, P140, DOI 10.1124/mol.105.018705; Tuomisto JT, 1999, TOXICOL APPL PHARM, V155, P71, DOI 10.1006/taap.1998.8564; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; Wasserman WW, 2004, NAT REV GENET, V5, P276, DOI 10.1038/nrg1315; Woon PY, 2007, P NATL ACAD SCI USA, V104, P14412, DOI 10.1073/pnas.0703247104; Zeeberg BR, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-4-r28	58	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2011	6	7							e18337	10.1371/journal.pone.0018337	http://dx.doi.org/10.1371/journal.pone.0018337			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791IA	21760882	Green Published, Green Submitted, gold			2022-12-27	WOS:000292657200001
J	Carbajo, V; den Braber, B; van der Putten, WH; De Deyn, GB				Carbajo, Vanesa; den Braber, Bowy; van der Putten, Wim H.; De Deyn, Gerlinde B.			Enhancement of Late Successional Plants on Ex-Arable Land by Soil Inoculations	PLOS ONE			English	Article							SPECIES-RICH GRASSLAND; RESTORATION; COMMUNITIES; FERTILITY; CHRONOSEQUENCE; MICROBES; FEEDBACK; NEMATODE	Restoration of species-rich grasslands on ex-arable land can help the conservation of biodiversity but faces three big challenges: absence of target plant propagules, high residual soil fertility and restoration of soil communities. Seed additions and top soil removal can solve some of these constraints, but restoring beneficial biotic soil conditions remains a challenge. Here we test the hypotheses that inoculation of soil from late secondary succession grasslands in arable receptor soil enhances performance of late successional plants, especially after top soil removal but pending on the added dose. To test this we grew mixtures of late successional plants in arable top (organic) soil or in underlying mineral soil mixed with donor soil in small or large proportions. Donor soils were collected from different grasslands that had been under restoration for 5 to 41 years, or from semi-natural grassland that has not been used intensively. Donor soil addition, especially when collected from older restoration sites, increased plant community biomass without altering its evenness. In contrast, addition of soil from semi-natural grassland promoted plant community evenness, and hence its diversity, but reduced community biomass. Effects of donor soil additions were stronger in mineral than in organic soil and larger with bigger proportions added. The variation in plant community composition was explained best by the abundances of nematodes, ergosterol concentration and soil pH. We show that in controlled conditions inoculation of soil from secondary succession grassland into ex-arable land can strongly promote target plant species, and that the role of soil biota in promoting target plant species is greatest when added after top soil removal. Together our results point out that transplantation of later secondary succession soil can promote grassland restoration on ex-arable land.	[Carbajo, Vanesa; den Braber, Bowy; van der Putten, Wim H.; De Deyn, Gerlinde B.] Netherlands Inst Ecol, Dept Terr Ecol, Wageningen, Netherlands; [Carbajo, Vanesa] Alcala Univ, Dept Ecol, Madrid, Spain; [den Braber, Bowy] Univ Wageningen & Res Ctr, Nat Conservat & Plant Ecol Grp, Wageningen, Netherlands; [van der Putten, Wim H.] Univ Wageningen & Res Ctr, Nematol Lab, Wageningen, Netherlands	Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW); Universidad de Alcala; Wageningen University & Research; Wageningen University & Research	Carbajo, V (corresponding author), Netherlands Inst Ecol, Dept Terr Ecol, Wageningen, Netherlands.	g.dedeyn@nioo.knaw.nl	van der Putten, Wim H/C-3707-2011; De Deyn, Gerlinde B/C-1593-2009; De Deyn, Gerlinde/AFI-8702-2022; De Deyn, Gerlinde/F-7080-2017	van der Putten, Wim H/0000-0002-9341-4442; De Deyn, Gerlinde B/0000-0003-4823-6912; De Deyn, Gerlinde/0000-0003-4823-6912; De Deyn, Gerlinde/0000-0003-4823-6912	ALW-Vici [865.05.002]	ALW-Vici	This study was funded by ALW-Vici, project number 865.05.002, to WHvdP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baath E, 2001, SOIL BIOL BIOCHEM, V33, P2011, DOI 10.1016/S0038-0717(01)00137-7; Bakker JP, 1999, TRENDS ECOL EVOL, V14, P63, DOI 10.1016/S0169-5347(98)01544-4; Bever JD, 2003, NEW PHYTOL, V157, P465, DOI 10.1046/j.1469-8137.2003.00714.x; Blumenthal DM, 2003, ECOL APPL, V13, P605, DOI 10.1890/1051-0761(2003)013[0605:SCACWA]2.0.CO;2; Collins CD, 2009, ECOLOGY, V90, P2567, DOI 10.1890/08-1560.1; de Bello F, 2010, BIOL CONSERV, V143, P9, DOI 10.1016/j.biocon.2009.04.022; De Deyn GB, 2004, J ECOL, V92, P824, DOI 10.1111/j.0022-0477.2004.00924.x; De Deyn GB, 2003, NATURE, V422, P711, DOI 10.1038/nature01548; Eschen R, 2007, J APPL ECOL, V44, P95, DOI 10.1111/j.1365-2664.2006.01240.x; Eviner VT, 2008, RESTOR ECOL, V16, P713, DOI 10.1111/j.1526-100X.2008.00482.x; Fagan KC, 2008, J APPL ECOL, V45, P1293, DOI 10.1111/j.1365-2664.2008.01492.x; Frouz J, 2009, BIODIVERS CONSERV, V18, P3963, DOI 10.1007/s10531-009-9692-5; GRIME JP, 1977, AM NAT, V111, P1169, DOI 10.1086/283244; Harris J, 2009, SCIENCE, V325, P573, DOI 10.1126/science.1172975; Hoeksema JD, 2010, ECOL LETT, V13, P394, DOI 10.1111/j.1461-0248.2009.01430.x; Hol WHG, 2010, ECOL LETT, V13, P292, DOI 10.1111/j.1461-0248.2009.01424.x; HOUBA VJG, 1985, SOIL ANAL 2; Johnson NC, 2003, ECOLOGY, V84, P1895, DOI 10.1890/0012-9658(2003)084[1895:NEAMAA]2.0.CO;2; Kardol P, 2005, BIOL CONSERV, V126, P317, DOI 10.1016/j.biocon.2005.06.005; Kardol P, 2008, BIOL CONSERV, V141, P2208, DOI 10.1016/j.biocon.2008.06.011; Kardol P, 2006, ECOL LETT, V9, P1080, DOI 10.1111/j.1461-0248.2006.00953.x; Kardol P, 2010, TRENDS ECOL EVOL, V25, P670, DOI 10.1016/j.tree.2010.09.001; Kardol P, 2009, RESTOR ECOL, V17, P258, DOI 10.1111/j.1526-100X.2007.00351.x; Kiehl K, 2010, BASIC APPL ECOL, V11, P285, DOI 10.1016/j.baae.2009.12.004; Lindborg R, 2004, ECOLOGY, V85, P1840, DOI 10.1890/04-0367; MARRS RH, 1993, ADV ECOL RES, V24, P241, DOI 10.1016/S0065-2504(08)60044-6; MIDDLETON EL, 2011, RESTORATION IN PRESS, DOI DOI 10.1111/J.1526-100X.2010.00752.X; NOVOZAMSKY I, 1984, NETH J AGR SCI, V32, P322; Olff H, 1998, TRENDS ECOL EVOL, V13, P261, DOI 10.1016/S0169-5347(98)01364-0; Olsen S. R., 1982, Methods of soil analysis. Part 2. Chemical and microbiological properties, P403; Oostenbrink I.C., 1960, NEMATOLOGY, P439; Ozinga WA, 2009, ECOL LETT, V12, P66, DOI 10.1111/j.1461-0248.2008.01261.x; Piotrowski JS, 2008, ADV AGRON, V97, P111, DOI 10.1016/S0065-2113(07)00003-X; Pywell RF, 2002, J APPL ECOL, V39, P294, DOI 10.1046/j.1365-2664.2002.00718.x; Pywell RF, 2007, J APPL ECOL, V44, P81, DOI 10.1111/j.1365-2664.2006.01260.x; Reynolds HL, 2009, APPL VEG SCI, V12, P33, DOI 10.1111/j.1654-109X.2009.01020.x; Schaminû«e J., 1996, VEGETATIE NEDERLAND; SIMPSON EH, 1949, NATURE, V163, P688, DOI 10.1038/163688a0; Stevens CJ, 2004, SCIENCE, V303, P1876, DOI 10.1126/science.1094678; Suding KN, 2004, TRENDS ECOL EVOL, V19, P46, DOI 10.1016/j.tree.2003.10.005; TERBRAAK CJF, 1998, CANOCO WINDOWS 4 5 B; van der Wal A, 2006, SOIL BIOL BIOCHEM, V38, P51, DOI 10.1016/j.soilbio.2005.04.017; Walker KJ, 2004, BIOL CONSERV, V119, P1, DOI 10.1016/j.biocon.2003.10.020; Walters DR, 2007, ANN APPL BIOL, V151, P307, DOI 10.1111/j.1744-7348.2007.00176.x; Wardle DA, 2004, SCIENCE, V304, P1629, DOI 10.1126/science.1094875; YEATES GW, 1993, J NEMATOL, V25, P315	46	30	31	4	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2011	6	7							e21943	10.1371/journal.pone.0021943	http://dx.doi.org/10.1371/journal.pone.0021943			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791IA	21760929	Green Published, gold, Green Submitted			2022-12-27	WOS:000292657200033
J	Ferraris, J; Radl, DB; Zarate, S; Jaita, G; Eijo, G; Zaldivar, V; Clapp, C; Seilicovich, A; Pisera, D				Ferraris, Jimena; Betiana Radl, Daniela; Zarate, Sandra; Jaita, Gabriela; Eijo, Guadalupe; Zaldivar, Veronica; Clapp, Carmen; Seilicovich, Adriana; Pisera, Daniel			N-Terminal Prolactin-Derived Fragments, Vasoinhibins, Are Proapoptoptic and Antiproliferative in the Anterior Pituitary	PLOS ONE			English	Article							CATHEPSIN-D; ANTIANGIOGENIC FACTOR; APOPTOSIS; ESTROGENS; CELLS; PROLIFERATION; ANGIOGENESIS; LACTOTROPHS; EXPRESSION; INHIBITOR	The anterior pituitary is under a constant cell turnover modulated by gonadal steroids. In the rat, an increase in the rate of apoptosis occurs at proestrus whereas a peak of proliferation takes place at estrus. At proestrus, concomitant with the maximum rate of apoptosis, a peak in circulating levels of prolactin is observed. Prolactin can be cleaved to different N-terminal fragments, vasoinhibins, which are proapoptotic and antiproliferative factors for endothelial cells. It was reported that a 16 kDa vasoinhibin is produced in the rat anterior pituitary by cathepsin D. In the present study we investigated the anterior pituitary production of N-terminal prolactin-derived fragments along the estrous cycle and the involvement of estrogens in this process. In addition, we studied the effects of a recombinant vasoinhibin, 16 kDa prolactin, on anterior pituitary apoptosis and proliferation. We observed by Western Blot that N-terminal prolactin-derived fragments production in the anterior pituitary was higher at proestrus with respect to diestrus and that the content and release of these prolactin forms from anterior pituitary cells in culture were increased by estradiol. A recombinant preparation of 16 kDa prolactin induced apoptosis (determined by TUNEL assay and flow cytometry) of cultured anterior pituitary cells and lactotropes from ovariectomized rats only in the presence of estradiol, as previously reported for other proapoptotic factors in the anterior pituitary. In addition, 16 kDa prolactin decreased forskolin-induced proliferation (evaluated by BrdU incorporation) of rat total anterior pituitary cells and lactotropes in culture and decreased the proportion of cells in S-phase of the cell cycle (determined by flow cytometry). In conclusion, our study indicates that the anterior pituitary production of 16 kDa prolactin is variable along the estrous cycle and increased by estrogens. The antiproliferative and estradiol-dependent proapoptotic actions of this vasoinhibin may be involved in the control of anterior pituitary cell renewal.	[Ferraris, Jimena; Betiana Radl, Daniela; Zarate, Sandra; Jaita, Gabriela; Eijo, Guadalupe; Zaldivar, Veronica; Seilicovich, Adriana; Pisera, Daniel] Univ Buenos Aires, Fac Med, Inst Invest Reprod, Buenos Aires, DF, Argentina; [Clapp, Carmen] Univ Nacl Autonoma Mexico, Inst Neurobiol, Juriquilla, Mexico	University of Buenos Aires; Universidad Nacional Autonoma de Mexico	Ferraris, J (corresponding author), Univ Buenos Aires, Fac Med, Inst Invest Reprod, Buenos Aires, DF, Argentina.	dpisera@fmed.uba.ar		JAITA, GABRIELA/0000-0002-6513-0514; Ferraris, Jimena/0000-0001-7472-0439; Pisera, Daniel/0000-0001-8795-1551	Agencia Nacional de Promocion Cientifica Tecnologica-ANPCYT (National Agency for Scientific and Technologic Promotion) [2005- PICT 38223, PICT 2006-92]; Consejo Nacional de investigaciones Cientificas y Tecnologicas-CONICET (National Council for Scientific and Technologic Research) [PIP 5368]; Universidad de Buenos Aires-UBA (University of Buenos Aires) [UBACyT 2008-2010 M057]	Agencia Nacional de Promocion Cientifica Tecnologica-ANPCYT (National Agency for Scientific and Technologic Promotion); Consejo Nacional de investigaciones Cientificas y Tecnologicas-CONICET (National Council for Scientific and Technologic Research)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Universidad de Buenos Aires-UBA (University of Buenos Aires)(University of Buenos Aires)	This study was supported by Agencia Nacional de Promocion Cientifica Tecnologica-ANPCYT (National Agency for Scientific and Technologic Promotion)(2005- PICT 38223), Agencia Nacional de Promocion Cientifica Tecnologica-ANPCYT (National Agency for Scientific and Technologic Promotion)(PICT 2006-92), Consejo Nacional de investigaciones Cientificas y Tecnologicas-CONICET (National Council for Scientific and Technologic Research) (PIP 5368) and Universidad de Buenos Aires-UBA (University of Buenos Aires)(UBACyT 2008-2010 M057). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDRIES M, 1992, BIOCHEM J, V281, P393, DOI 10.1038/355393a0; Candolfi M, 2002, ENDOCRINOLOGY, V143, P3611, DOI 10.1210/en.2002-220377; Castino R, 2008, ENDOCRINOLOGY, V149, P4095, DOI 10.1210/en.2008-0249; CLAPP C, 1993, ENDOCRINOLOGY, V133, P1292, DOI 10.1210/en.133.3.1292; Clapp C, 2006, TRENDS ENDOCRIN MET, V17, P301, DOI 10.1016/j.tem.2006.08.002; Cruz-Soto ME, 2009, ENDOCRINOLOGY, V150, P5446, DOI 10.1210/en.2009-0390; ELANGOVAN S, 1980, J BIOL CHEM, V255, P7474; Erdmann S, 2007, AM J PHYSIOL-ENDOC M, V293, pE1365, DOI 10.1152/ajpendo.00280.2007; Freeman ME, 2000, PHYSIOL REV, V80, P1523, DOI 10.1152/physrev.2000.80.4.1523; Galfione M, 2003, PROTEIN EXPRES PURIF, V28, P252, DOI 10.1016/S1046-5928(02)00639-3; Ge GX, 2007, P NATL ACAD SCI USA, V104, P10010, DOI 10.1073/pnas.0704179104; HASHI A, 1995, ENDOCRINOLOGY, V136, P4665, DOI 10.1210/en.136.10.4665; Jaita G, 2005, ENDOCRINOLOGY, V146, P4737, DOI 10.1210/en.2005-0279; Liaudet-Coopman E, 2006, CANCER LETT, V237, P167, DOI 10.1016/j.canlet.2005.06.007; Lkhider M, 2004, J CELL SCI, V117, P5155, DOI 10.1242/jcs.01396; Martini JF, 2000, MOL ENDOCRINOL, V14, P1536, DOI 10.1210/me.14.10.1536; Mendez I, 2010, FRONT HORM RES, V38, P184, DOI 10.1159/000318509; Pisera D, 2004, AM J PHYSIOL-ENDOC M, V287, pE767, DOI 10.1152/ajpendo.00052.2004; Piwnica D, 2004, MOL ENDOCRINOL, V18, P2522, DOI 10.1210/me.2004-0200; Piwnica D, 2006, MOL ENDOCRINOL, V20, P3263, DOI 10.1210/me.2006-0044; Radl DB, 2008, NEUROENDOCRINOLOGY, V88, P43, DOI 10.1159/000116117; Rochefort H, 2001, J STEROID BIOCHEM, V76, P119, DOI 10.1016/S0960-0760(00)00142-4; SINHA YN, 1995, ENDOCR REV, V16, P354, DOI 10.1210/er.16.3.354; Suzuki S, 1999, ENDOCRINOLOGY, V140, P2850, DOI 10.1210/en.140.6.2850; Tabruyn SP, 2005, MOL ENDOCRINOL, V19, P1932, DOI 10.1210/me.2004-0515; Tabruyn SP, 2003, MOL ENDOCRINOL, V17, P1815, DOI 10.1210/me.2003-0132; TURNER HE, 2000, J CLIN ENDOCR METAB, V85, P131; Yin P, 2002, NEUROENDOCRINOLOGY, V76, P272, DOI 10.1159/000066626; Zaldivar V, 2009, NEUROENDOCRINOLOGY, V90, P292, DOI 10.1159/000235618; Zarate S, 2010, FRONT HORM RES, V38, P25, DOI 10.1159/000318491; Zarate S, 2009, AM J PHYSIOL-ENDOC M, V296, pE664, DOI 10.1152/ajpendo.90785.2008	31	10	10	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2011	6	7							e21806	10.1371/journal.pone.0021806	http://dx.doi.org/10.1371/journal.pone.0021806			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791HI	21760910	Green Published, gold, Green Submitted			2022-12-27	WOS:000292655400020
J	Kraeussling, M; Wagner, TU; Schartl, M				Kraeussling, Michael; Wagner, Toni Ulrich; Schartl, Manfred			Highly Asynchronous and Asymmetric Cleavage Divisions Accompany Early Transcriptional Activity in Pre-Blastula Medaka Embryos	PLOS ONE			English	Article							RNA-POLYMERASE-II; MAJOR DEVELOPMENTAL TRANSITION; EARLY DROSOPHILA DEVELOPMENT; EARLY XENOPUS-EMBRYOS; MIDBLASTULA TRANSITION; CELL-CYCLE; TERMINAL DOMAIN; ZEBRAFISH; PHOSPHORYLATION; EMBRYOGENESIS	In the initial phase of development of fish embryos, a prominent and critical event is the midblastula transition (MBT). Before MBT cell cycle is rapid, highly synchronous and zygotic gene transcription is turned off. Only during MBT the cell cycle desynchronizes and transcription is activated. Multiple mechanisms, primarily the nucleocytoplasmic ratio, are supposed to control MBT activation. Unexpectedly, we find in the small teleost fish medaka (Oryzias latipes) that at very early stages, well before midblastula, cell division becomes asynchronous and cell volumes diverge. Furthermore, zygotic transcription is extensively activated already after the 64-cell stage. Thus, at least in medaka, the transition from maternal to zygotic transcription is uncoupled from the midblastula stage and not solely controlled by the nucleocytoplasmic ratio.				toni.wagner@biozentrum.uni-wuerzburg.de		Schartl, Manfred/0000-0001-9882-5948	German Research Foundation (DFG); EU through Plurigenes [018673]; University of Wuerzburg	German Research Foundation (DFG)(German Research Foundation (DFG)); EU through Plurigenes; University of Wuerzburg	This study was supported by German Research Foundation (DFG) via the "pecial research group 1048''(http://www.gk-1048.uni-wuerzburg.de/) and by the EU through Plurigenes (FP6 project 018673)(http://www.plurigenes.org/). This publication was funded by the German Research Foundation (DFG) and the University of Wuerzburg in the funding program Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizawa K, 2003, GENE EXPR PATTERNS, V3, P43, DOI 10.1016/S1567-133X(02)00075-3; ANDERSON KV, 1980, CELL, V21, P717, DOI 10.1016/0092-8674(80)90435-3; Aoki F, 1997, DEV BIOL, V181, P296, DOI 10.1006/dbio.1996.8466; Ashworth R, 2007, J BIOL CHEM, V282, P13984, DOI 10.1074/jbc.M700940200; BISSEN ST, 1989, DEVELOPMENT, V106, P105; CADENA DL, 1987, J BIOL CHEM, V262, P12468; CLUTE P, 1995, DEV BIOL, V171, P273, DOI 10.1006/dbio.1995.1280; Dirks RW, 1999, HISTOCHEM CELL BIOL, V111, P405, DOI 10.1007/s004180050374; EDGAR BA, 1986, CELL, V44, P871, DOI 10.1016/0092-8674(86)90009-7; EDGAR BA, 1986, CELL, V44, P365, DOI 10.1016/0092-8674(86)90771-3; GRAHAM CF, 1966, DEV BIOL, V14, P439, DOI 10.1016/0012-1606(66)90024-8; HARTL P, 1993, J CELL BIOL, V120, P613, DOI 10.1083/jcb.120.3.613; HOWE JA, 1995, GENE DEV, V9, P1164, DOI 10.1101/gad.9.10.1164; Howe JA, 1996, P NATL ACAD SCI USA, V93, P2060, DOI 10.1073/pnas.93.5.2060; Iwamatsu T, 2004, MECH DEVELOP, V121, P605, DOI 10.1016/j.mod.2004.03.012; KANE DA, 1993, DEVELOPMENT, V119, P447; KIMELMAN D, 1987, CELL, V48, P399, DOI 10.1016/0092-8674(87)90191-7; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; KOBAYAKAWA Y, 1981, J EMBRYOL EXP MORPH, V62, P83; LIEDTKE D, 2010, SNAIL GENE EXPRESSIO; Mathavan S, 2005, PLOS GENET, V1, P260, DOI 10.1371/journal.pgen.0010029; MITA I, 1984, J EXP ZOOL, V229, P215, DOI 10.1002/jez.1402290206; NEWPORT J, 1982, CELL, V30, P675, DOI 10.1016/0092-8674(82)90272-0; NEWPORT J, 1982, CELL, V30, P687, DOI 10.1016/0092-8674(82)90273-2; NONCHEV S, 1990, MOL REPROD DEV, V25, P72, DOI 10.1002/mrd.1080250113; OBRIEN T, 1994, NATURE, V370, P75, DOI 10.1038/370075a0; Okazaki K., 1975, P177; PAYNE JM, 1989, J BIOL CHEM, V264, P19621; SULSTON JE, 1983, DEV BIOL, V100, P64, DOI 10.1016/0012-1606(83)90201-4; VALAY JG, 1995, J MOL BIOL, V249, P535, DOI 10.1006/jmbi.1995.0316; Wittbrodt J, 2002, NAT REV GENET, V3, P53, DOI 10.1038/nrg704	31	17	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2011	6	7							e21741	10.1371/journal.pone.0021741	http://dx.doi.org/10.1371/journal.pone.0021741			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791HI	21750728	Green Published, gold, Green Submitted			2022-12-27	WOS:000292655400015
J	Li, TN; Chin, KH; Fung, KM; Yang, MT; Wang, AHJ; Chou, SH				Li, Tso-Ning; Chin, Ko-Hsin; Fung, Kit-Man; Yang, Ming-Te; Wang, Andrew H. -J.; Chou, Shan-Ho			A Novel Tetrameric PilZ Domain Structure from Xanthomonads	PLOS ONE			English	Article							C-DI-GMP; COILED-COIL TETRAMER; PSEUDOMONAS-AERUGINOSA; CRYSTAL-STRUCTURE; ANALYTICAL ULTRACENTRIFUGATION; PROTEIN INTERACTIONS; TWITCHING MOTILITY; BINDING-PROTEIN; CAMPESTRIS; RECEPTOR	PilZ domain is one of the key receptors for the newly discovered secondary messenger molecule cyclic di-GMP (c-di-GMP). To date, several monomeric PilZ domain proteins have been identified. Some exhibit strong c-di-GMP binding activity, while others have barely detectable c-di-GMP binding activity and require an accessory protein such as FimX to indirectly respond to the c-di-GMP signal. We now report a novel tetrameric PilZ domain structure of XCC6012 from the plant pathogen Xanthomonas campestris pv. campestris (Xcc). It is one of the four PilZ domain proteins essential for Xcc pathogenicity. Although the monomer adopts a structure similar to those of the PilZ domains with very weak c-di-GMP binding activity, it is nevertheless interrupted in the middle by two extra long helices. Four XCC6012 proteins are thus self-assembled into a tetramer via the extra heptad repeat alpha 3 helices to form a parallel four-stranded coiled-coil, which is further enclosed by two sets of inclined alpha 2 and alpha 4 helices. We further generated a series of XCC6012 variants and measured the unfolding temperatures and oligomeric states in order to investigate the nature of this novel tetramer. Discovery of this new PilZ domain architecture increases the complexity of c-di-GMP-mediated regulation.	[Li, Tso-Ning; Chou, Shan-Ho] Natl Chung Hsing Univ, Inst Biochem, Taichung 40227, Taiwan; [Chin, Ko-Hsin] Natl Chung Hsing Univ, Ctr Biotechnol, Taichung 40227, Taiwan; [Fung, Kit-Man; Yang, Ming-Te] Natl Chung Hsing Univ, Inst Mol Biol, Taichung 40227, Taiwan; [Wang, Andrew H. -J.] Acad Sinica, Inst Biol Chem, Taipei, Taiwan; [Chou, Shan-Ho] China Med Univ, Grad Inst Basic Med Sci, Taichung, Taiwan	National Chung Hsing University; National Chung Hsing University; National Chung Hsing University; Academia Sinica - Taiwan; China Medical University Taiwan	Li, TN (corresponding author), Natl Chung Hsing Univ, Inst Biochem, Taichung 40227, Taiwan.	shchou@nchu.edu.tw	Yang, Ming-Te/B-5626-2017	Yang, Ming-Te/0000-0002-7644-0964; CHOU, Shan-Ho/0000-0002-5202-8238	National Science Council, Taiwan [97-2113-M005-005-MY3]; Ministry of Education, Taiwan; National Science Council, Taiwan, ROC; National Research Program for Genomic Medicine, Taiwan, ROC	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); Ministry of Education, Taiwan(Ministry of Education, Taiwan); National Science Council, Taiwan, ROC(Ministry of Science and Technology, Taiwan); National Research Program for Genomic Medicine, Taiwan, ROC(Ministry of Science and Technology, Taiwan)	National Science Council, Taiwan (97-2113-M005-005-MY3), and Ministry of Education, Taiwan. The funders had no role in study desing, data collection and analysis, decision to publish, or preparation of the manuscript.r We appreciate the services of the Structural Genomics Databases provided by the GMBD Bioinformatics Core (http//www.tbi.org.tw), NRPGM, Taiwan. We would like to thank the Core Facilities for Protein X-ray Crystallography in the Academia Sinica, Taiwan for their assistance in crystal screening, the National Synchrotron Radiation Research Center (NSRRC) in Taiwan for their assistance in X-ray data collection. The National Synchrotron Radiation Research Center is a user facility supported by the National Science Council, Taiwan, ROC, and the Protein Crystallography Facility is supported by the National Research Program for Genomic Medicine, Taiwan, ROC. We also thank Bonnie Levitt for her help in reviewing this manuscript.	Alm RA, 1996, J BACTERIOL, V178, P46, DOI 10.1128/jb.178.1.46-53.1996; Amikam D, 2006, BIOINFORMATICS, V22, P3, DOI 10.1093/bioinformatics/bti739; Apostolovic B, 2010, CHEM SOC REV, V39, P3541, DOI 10.1039/b914339b; ASLANIDIS C, 1990, NUCLEIC ACIDS RES, V18, P6069, DOI 10.1093/nar/18.20.6069; Benach J, 2007, EMBO J, V26, P5153, DOI 10.1038/sj.emboj.7601918; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Bruylants G, 2005, CURR MED CHEM, V12, P2011, DOI 10.2174/0929867054546564; Burkhard P, 2001, TRENDS CELL BIOL, V11, P82, DOI 10.1016/S0962-8924(00)01898-5; Chin KH, 2010, J MOL BIOL, V396, P646, DOI 10.1016/j.jmb.2009.11.076; Christen B, 2006, J BIOL CHEM, V281, P32015, DOI 10.1074/jbc.M603589200; Christen M, 2005, J BIOL CHEM, V280, P30829, DOI 10.1074/jbc.M504429200; CRICK FHC, 1953, ACTA CRYSTALLOGR, V6, P685, DOI 10.1107/S0365110X53001952; DALAHAY RM, 2002, MOL MICROBIOL, V45; FRIEDMAN AM, 1995, SCIENCE, V268, P1721, DOI 10.1126/science.7792597; Grigoryan G, 2008, CURR OPIN STRUC BIOL, V18, P477, DOI 10.1016/j.sbi.2008.04.008; Gruber M, 2003, TRENDS BIOCHEM SCI, V28, P679, DOI 10.1016/j.tibs.2003.10.008; Guzzo CR, 2009, J MOL BIOL, V393, P848, DOI 10.1016/j.jmb.2009.07.065; HARBURY PB, 1993, SCIENCE, V262, P1401, DOI 10.1126/science.8248779; He YW, 2007, MOL MICROBIOL, V64, P281, DOI 10.1111/j.1365-2958.2007.05670.x; Hickman JW, 2008, MOL MICROBIOL, V69, P376, DOI 10.1111/j.1365-2958.2008.06281.x; HOLM L, 1995, TRENDS BIOCHEM SCI, V20, P478, DOI 10.1016/S0968-0004(00)89105-7; Huang BX, 2003, J BACTERIOL, V185, P7068, DOI 10.1128/JB.185.24.7068-7076.2003; Huguet E, 1998, MOL MICROBIOL, V29, P1379, DOI 10.1046/j.1365-2958.1998.01019.x; Jenal U, 2006, ANNU REV GENET, V40, P385, DOI 10.1146/annurev.genet.40.110405.090423; Jones S, 1996, P NATL ACAD SCI USA, V93, P13, DOI 10.1073/pnas.93.1.13; Kazmierczak BI, 2006, MOL MICROBIOL, V60, P1026, DOI 10.1111/j.1365-2958.2006.05156.x; Kohn WD, 1998, J MOL BIOL, V283, P993, DOI 10.1006/jmbi.1998.2125; Laue T.M., 1992, ANAL ULTRACENTRIFUGA; Leduc JL, 2009, J BACTERIOL, V191, P7121, DOI 10.1128/JB.00845-09; Lee VT, 2007, MOL MICROBIOL, V65, P1474, DOI 10.1111/j.1365-2958.2007.05879.x; Lewis M, 1996, SCIENCE, V271, P1247, DOI 10.1126/science.271.5253.1247; Li TN, 2009, ACTA CRYSTALLOGR F, V65, P1056, DOI 10.1107/S1744309109036239; Li TN, 2009, PROTEINS, V75, P282, DOI 10.1002/prot.22330; Liu J, 2007, BIOCHEMISTRY-US, V46, P14951, DOI 10.1021/bi701930d; Liu J, 2006, BIOCHEMISTRY-US, V45, P15224, DOI 10.1021/bi061914m; Lu J, 2006, EMBO J, V25, P2930, DOI 10.1038/sj.emboj.7601151; Lupas A, 1996, TRENDS BIOCHEM SCI, V21, P375, DOI 10.1016/0968-0004(96)10052-9; Lupas AN, 2005, ADV PROTEIN CHEM, V70, P37, DOI 10.1016/S0065-3233(04)70003-0; Mason JM, 2004, CHEMBIOCHEM, V5, P170, DOI 10.1002/cbic.200300781; Mccarthy Y, 2008, MOL PLANT PATHOL, V9, P819, DOI [10.1111/j.1364-3703.2008.00495.x, 10.1111/J.1364-3703.2008.00495.X]; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; Merighi M, 2007, MOL MICROBIOL, V65, P876, DOI 10.1111/j.1365-2958.2007.05817.x; Mittl PRE, 2000, P NATL ACAD SCI USA, V97, P2562, DOI 10.1073/pnas.97.6.2562; Moutevelis E, 2009, J MOL BIOL, V385, P726, DOI 10.1016/j.jmb.2008.11.028; Navarro MVAS, 2009, STRUCTURE, V17, P1104, DOI 10.1016/j.str.2009.06.010; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Parry DAD, 2008, J STRUCT BIOL, V163, P258, DOI 10.1016/j.jsb.2008.01.016; Pratt JT, 2007, J BIOL CHEM, V282, P12860, DOI 10.1074/jbc.M611593200; Ramelot TA, 2007, PROTEINS, V66, P266, DOI 10.1002/prot.21199; Romling U, 2005, MOL MICROBIOL, V57, P629, DOI 10.1111/j.1365-2958.2005.04697.x; Rose A, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-66; Rose A, 2004, CELL MOL LIFE SCI, V61, P1996, DOI 10.1007/s00018-004-4039-6; Ryan RP, 2006, P NATL ACAD SCI USA, V103, P6712, DOI 10.1073/pnas.0600345103; Ryjenkov DA, 2006, J BIOL CHEM, V281, P30310, DOI 10.1074/jbc.C600179200; Schirmer T, 2009, NAT REV MICROBIOL, V7, P724, DOI 10.1038/nrmicro2203; Schuck P, 2002, BIOPHYS J, V82, P1096, DOI 10.1016/S0006-3495(02)75469-6; SCHWEIZER HP, 1993, BIOTECHNIQUES, V15, P831; Stafford Walter F. III, 2009, V490, P83, DOI 10.1007/978-1-59745-367-7_4; Stetefeld J, 2000, NAT STRUCT BIOL, V7, P772, DOI 10.1038/79006; Tao F, 2010, J BACTERIOL, V192, P1020, DOI 10.1128/JB.01253-09; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; TERWILLIGER TC, 2002, ACTA CRYSTALLOGR D, V59, P3444; VANDEYAR MA, 1988, GENE, V65, P129, DOI 10.1016/0378-1119(88)90425-8; Wu YY, 2005, ACTA CRYSTALLOGR F, V61, P902, DOI 10.1107/S1744309105027132	64	17	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2011	6	7							e22036	10.1371/journal.pone.0022036	http://dx.doi.org/10.1371/journal.pone.0022036			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791HI	21760949	Green Published, Green Submitted, gold			2022-12-27	WOS:000292655400041
J	Wheeler, HE; Gorsic, LK; Welsh, M; Stark, AL; Gamazon, ER; Cox, NJ; Dolan, ME				Wheeler, Heather E.; Gorsic, Lidija K.; Welsh, Marleen; Stark, Amy L.; Gamazon, Eric R.; Cox, Nancy J.; Dolan, M. Eileen			Genome-Wide Local Ancestry Approach Identifies Genes and Variants Associated with Chemotherapeutic Susceptibility in African Americans	PLOS ONE			English	Article							INDUCED CYTOTOXICITY; JAB1 EXPRESSION; MOLECULAR-BASIS; PHASE-II; CARBOPLATIN; CYTARABINE; RESISTANCE; CISPLATIN; PROLIFERATION; MECHANISMS	Chemotherapeutic agents are used in the treatment of many cancers, yet variable resistance and toxicities among individuals limit successful outcomes. Several studies have indicated outcome differences associated with ancestry among patients with various cancer types. Using both traditional SNP-based and newly developed gene-based genome-wide approaches, we investigated the genetics of chemotherapeutic susceptibility in lymphoblastoid cell lines derived from 83 African Americans, a population for which there is a disparity in the number of genome-wide studies performed. To account for population structure in this admixed population, we incorporated local ancestry information into our association model. We tested over 2 million SNPs and identified 325, 176, 240, and 190 SNPs that were suggestively associated with cytarabine-, 5'-deoxyfluorouridine (5'-DFUR)-, carboplatin-, and cisplatin-induced cytotoxicity, respectively (p <= 10(-4)). Importantly, some of these variants are found only in populations of African descent. We also show that cisplatin-susceptibility SNPs are enriched for carboplatin- susceptibility SNPs. Using a gene-based genome-wide association approach, we identified 26, 11, 20, and 41 suggestive candidate genes for association with cytarabine-, 5'-DFUR-, carboplatin-, and cisplatin-induced cytotoxicity, respectively (p <= 10(-3)). Fourteen of these genes showed evidence of association with their respective chemotherapeutic phenotypes in the Yoruba from Ibadan, Nigeria (p < 0.05), including TP53/11, COPS5 and GAS8, which are known to be involved in tumorigenesis. Although our results require further study, we have identified variants and genes associated with chemotherapeutic susceptibility in African Americans by using an approach that incorporates local ancestry information.	[Wheeler, Heather E.; Gorsic, Lidija K.; Welsh, Marleen; Dolan, M. Eileen] Univ Chicago, Dept Med, Hematol Oncol Sect, Chicago, IL 60637 USA; [Stark, Amy L.] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; [Gamazon, Eric R.; Cox, Nancy J.] Univ Chicago, Dept Med, Med Genet Sect, Chicago, IL 60637 USA	University of Chicago; University of Chicago; University of Chicago	Wheeler, HE (corresponding author), Univ Chicago, Dept Med, Hematol Oncol Sect, Chicago, IL 60637 USA.	edolan@medicine.bsd.uchicago.edu	Gamazon, Eric/I-6873-2018; Wheeler, Heather/I-9279-2019	Gamazon, Eric/0000-0003-4204-8734; Wheeler, Heather/0000-0003-1365-9667	NIH/NIGMS [U01GM61393]; University of Chicago Breast Cancer SPORE [P50 CA125183]; Department of Defense [BC087674]; Leukemia and Lymphoma Society; NATIONAL CANCER INSTITUTE [P50CA125183] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM061393] Funding Source: NIH RePORTER	NIH/NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); University of Chicago Breast Cancer SPORE(University of Chicago); Department of Defense(United States Department of Defense); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study is supported by NIH/NIGMS Pharmacogenomics of Anticancer grant U01GM61393 (MED, NJC), by the University of Chicago Breast Cancer SPORE grant P50 CA125183 (MED, NJC), by the Department of Defense Breast Cancer Research Program grant BC087674 (MW), and by a Specialized Center of Research Grant from the Leukemia and Lymphoma Society (MED). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abecasis GR, 2000, EUR J HUM GENET, V8, P545, DOI 10.1038/sj.ejhg.5200494; ACS, 2005, CANC FACTS FIG AFR A; Adeyemo A, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000564; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Aplenc R, 2006, BLOOD, V108, P74, DOI 10.1182/blood-2005-10-4004; BAKER WJ, 1991, J CLIN ONCOL, V9, P679, DOI 10.1200/JCO.1991.9.4.679; Bonilla C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016044; Borghaei H, 2008, J THORAC ONCOL, V3, P1286, DOI 10.1097/JTO.0b013e318189f50e; Briasoulis E, 2001, ONCOLOGIST, V6, P153, DOI 10.1634/theoncologist.6-2-153; Browning BL, 2009, AM J HUM GENET, V84, P210, DOI 10.1016/j.ajhg.2009.01.005; Bryc K, 2010, P NATL ACAD SCI USA, V107, P786, DOI 10.1073/pnas.0909559107; Celik I, 1996, J CLIN ONCOL, V14, P1043, DOI 10.1200/JCO.1996.14.3.1043; Choy E, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000287; Deo RC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000342; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Dong YY, 2005, CLIN CANCER RES, V11, P259; Duan S, 2008, AM J HUM GENET, V82, P1101, DOI 10.1016/j.ajhg.2008.03.006; Galmarini CM, 2002, BRIT J HAEMATOL, V117, P860, DOI 10.1046/j.1365-2141.2002.03538.x; Gamazon ER, 2010, P NATL ACAD SCI USA, V107, P9287, DOI 10.1073/pnas.1001827107; Hao K, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-27; Harada K, 2006, ANTICANCER RES, V26, P1615; Hartford CM, 2009, BLOOD, V113, P2145, DOI 10.1182/blood-2008-05-154302; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Huang RS, 2008, MOL CANCER THER, V7, P3038, DOI 10.1158/1535-7163.MCT-08-0248; Huang RS, 2007, AM J HUM GENET, V81, P427, DOI 10.1086/519850; Jallow M, 2009, NAT GENET, V41, P657, DOI 10.1038/ng.388; Kaiser J, 2008, SCIENCE, V319, P395, DOI 10.1126/science.319.5862.395; Kang SJ, 2010, HUM MOL GENET, V19, P2725, DOI 10.1093/hmg/ddq154; Kouvaraki MA, 2003, CANCER RES, V63, P2977; Li L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007765; Liu JZ, 2010, AM J HUM GENET, V87, P139, DOI 10.1016/j.ajhg.2010.06.009; McMurrough J, 1996, BRIT J CLIN PHARMACO, V41, P425, DOI 10.1046/j.1365-2125.1996.34212.x; McWhinney SR, 2009, MOL CANCER THER, V8, P10, DOI 10.1158/1535-7163.MCT-08-0840; Micheletti E, 1997, AM J CLIN ONCOL-CANC, V20, P613, DOI 10.1097/00000421-199712000-00017; Need AC, 2009, TRENDS GENET, V25, P489, DOI 10.1016/j.tig.2009.09.012; Niu N, 2011, CLIN PHARMACOL THER, V89, pS66; Pasaniuc B, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001371; Patterson N, 2004, AM J HUM GENET, V74, P979, DOI 10.1086/420871; Polite BN, 2006, J CLIN ONCOL, V24, P2179, DOI 10.1200/JCO.2005.05.4775; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Price AL, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000519; Pruim RJ, 2010, BIOINFORMATICS, V26, P2336, DOI 10.1093/bioinformatics/btq419; Rabik CA, 2007, CANCER TREAT REV, V33, P9, DOI 10.1016/j.ctrv.2006.09.006; Rassidakis GZ, 2003, CLIN CANCER RES, V9, P1121; REYKDAL S, 1995, LEUKEMIA RES, V19, P141, DOI 10.1016/0145-2126(94)00123-R; Rotimi CN, 2010, NEW ENGL J MED, V363, P1551, DOI 10.1056/NEJMra0911564; Sankararaman S, 2008, AM J HUM GENET, V82, P290, DOI 10.1016/j.ajhg.2007.09.022; Schadt EE, 2008, PLOS BIOL, V6, P1020, DOI 10.1371/journal.pbio.0060107; Shain SA, 2004, MOL CANCER RES, V2, P653; Siddik ZH, 2003, ONCOGENE, V22, P7265, DOI 10.1038/sj.onc.1206933; Stark A, 2010, CANCER; STARK AL, 2010, PHARMACOGENOMICS J; Stark AL, 2010, AM J HUM GENET, V87, P829, DOI 10.1016/j.ajhg.2010.10.018; Stranger BE, 2007, NAT GENET, V39, P1217, DOI 10.1038/ng2142; Styczynski J, 2007, CURR PHARM BIOTECHNO, V8, P59, DOI 10.2174/138920107780487465; Sui L, 2001, CLIN CANCER RES, V7, P4130; Sundquist A, 2008, GENOME RES, V18, P676, DOI 10.1101/gr.072850.107; Tian L, 2010, ONCOGENE, V29, P6125, DOI 10.1038/onc.2010.345; VANGLABBEKE M, 1988, EUR J CANCER CLIN ON, V24, P255, DOI 10.1016/0277-5379(88)90262-3; Wang D, 2005, NAT REV DRUG DISCOV, V4, P307, DOI 10.1038/nrd1691; Watters JW, 2004, P NATL ACAD SCI USA, V101, P11809, DOI 10.1073/pnas.0404580101; Wei XX, 1996, J CLIN INVEST, V98, P610, DOI 10.1172/JCI118830; Welsh M, 2009, PHARMACOL REV, V61, P413, DOI 10.1124/pr.109.001461; Whitmore SA, 1998, GENOMICS, V52, P325, DOI 10.1006/geno.1998.5457; Wu Y, 2009, PATHOL ONCOL RES, V15, P411, DOI 10.1007/s12253-008-9138-5; Ziliak D, 2011, TRANSL RES, V157, P265, DOI 10.1016/j.trsl.2011.01.005	67	20	21	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2011	6	7							e21920	10.1371/journal.pone.0021920	http://dx.doi.org/10.1371/journal.pone.0021920			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791AK	21755009	Green Published, gold, Green Submitted			2022-12-27	WOS:000292632000036
J	Sinha, S; Miller, LM; Subramanian, S; Burrows, GG; Vandenbark, AA; Offner, H				Sinha, Sushmita; Miller, Lisa M.; Subramanian, Sandhya; Burrows, Gregory G.; Vandenbark, Arthur A.; Offner, Halina			RTL551 Treatment of EAE Reduces CD226 and T-bet+CD4 T Cells in Periphery and Prevents Infiltration of T-bet+ IL-17, IFN-gamma Producing T Cells into CNS	PLOS ONE			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; MULTIPLE-SCLEROSIS; RECEPTOR LIGANDS; ADHESION MOLECULE; CYTOKINE SWITCH; TH1 CELLS; SJL MICE; DIFFERENTIATION; EXPRESSION; DISEASE	Recombinant T cell receptor ligands (RTLs) that target encephalitogenic T-cells can reverse clinical and histological signs of EAE, and are currently in clinical trials for treatment of multiple sclerosis. To evaluate possible regulatory mechanisms, we tested effects of RTL therapy on expression of pathogenic and effector T-cell maturation markers, CD226, T-bet and CD44, by CD4+ Th1 cells early after treatment of MOG-35-55 peptide-induced EAE in C57BL/6 mice. We showed that 1-5 daily injections of RTL551 (two-domain I-A(b) covalently linked to MOG-35-55 peptide), but not the control RTL550 ("empty'' two-domain I-A(b) without a bound peptide) or Vehicle, reduced clinical signs of EAE, prevented trafficking of cells outside the spleen, significantly reduced the frequency of CD226 and T-bet expressing CD4+ T-cells in blood and inhibited expansion of CD44 expressing CD4+ T-cells in blood and spleen. Concomitantly, RTL551 selectively reduced CNS inflammatory lesions, absolute numbers of CNS infiltrating T-bet expressing CD4+ T-cells and IL-17 and IFN-gamma secretion by CNS derived MOG-35-55 reactive cells cultured ex vivo. These novel results demonstrate that a major effect of RTL therapy is to attenuate Th1 specific changes in CD4+ T-cells during EAE and prevent expansion of effector T-cells that mediate clinical signs and CNS inflammation in EAE.	[Sinha, Sushmita; Miller, Lisa M.; Subramanian, Sandhya; Vandenbark, Arthur A.; Offner, Halina] Oregon Hlth & Sci Univ, Vet Affairs Med Ctr, Portland, OR 97201 USA; [Sinha, Sushmita; Miller, Lisa M.; Burrows, Gregory G.; Vandenbark, Arthur A.; Offner, Halina] Oregon Hlth & Sci Univ, Dept Neurol, Portland, OR 97201 USA; [Burrows, Gregory G.] Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97201 USA; [Vandenbark, Arthur A.] Dept Vet Affairs Med Ctr, Res Serv, Portland, OR USA; [Vandenbark, Arthur A.] Oregon Hlth & Sci Univ, Dept Mol Microbiol & Immunol, Portland, OR 97201 USA; [Offner, Halina] Oregon Hlth & Sci Univ, Dept Anesthesiol & Perioperat Med, Portland, OR 97201 USA	Oregon Health & Science University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Oregon Health & Science University; Oregon Health & Science University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Portland Health Care System; Oregon Health & Science University; Oregon Health & Science University	Sinha, S (corresponding author), Oregon Hlth & Sci Univ, Vet Affairs Med Ctr, Portland, OR 97201 USA.	offnerva@ohsu.edu		sinha, sushmita/0000-0003-3385-1023	National Multiple Sclerosis Society [FG1749-A-1, RG3794-A-4, RG3794-B-6]; NIH [NS47661]; Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Biomedical Laboratory Research and Development; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS047661] Funding Source: NIH RePORTER	National Multiple Sclerosis Society(National Multiple Sclerosis Society); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Biomedical Laboratory Research and Development(US Department of Veterans Affairs); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Dr. Sinha is a Postdoctoral Fellow of the National Multiple Sclerosis Society and this work was supported in part by the National Multiple Sclerosis Society Postdoctoral Fellowship FG1749-A-1, grants RG3794-A-4 and RG3794-B-6; NIH Grant NS47661. This material is based upon work supported in part by the Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Biomedical Laboratory Research and Development. The contents do not represent the views of the Department of Veterans Affairs or the United States Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bebo BF, 1996, J NEUROSCI RES, V45, P680, DOI 10.1002/(SICI)1097-4547(19960915)45:6<680::AID-JNR4>3.0.CO;2-4; Bettelli E, 2004, J EXP MED, V200, P79, DOI 10.1084/jem.20031819; Burrows GG, 2001, J IMMUNOL, V167, P4386, DOI 10.4049/jimmunol.167.8.4386; Burrows GG, 1999, PROTEIN ENG, V12, P771, DOI 10.1093/protein/12.9.771; Chu CQ, 2000, J EXP MED, V192, P123, DOI 10.1084/jem.192.1.123; Dardalhon V, 2005, J IMMUNOL, V175, P1558, DOI 10.4049/jimmunol.175.3.1558; Fontenot AP, 2006, J IMMUNOL, V177, P3874, DOI 10.4049/jimmunol.177.6.3874; Frisullo G, 2006, J NEUROSCI RES, V84, P1027, DOI 10.1002/jnr.20995; GOCKE AR, 2007, T BET REGULATES FATE, P1341; Hafler JP, 2009, GENES IMMUN, V10, P5, DOI 10.1038/gene.2008.82; Huan JY, 2004, J IMMUNOL, V172, P4556, DOI 10.4049/jimmunol.172.7.4556; Lovett-Racke AE, 2004, IMMUNITY, V21, P719, DOI 10.1016/j.immuni.2004.09.010; Nath N, 2006, IMMUNOLOGY, V118, P384, DOI 10.1111/j.1365-2567.2006.02385.x; Offner H, 2005, J IMMUNOL, V175, P4103, DOI 10.4049/jimmunol.175.6.4103; OFFNER H, 1993, J IMMUNOL, V151, P506; Offner H, 2008, REV NEUROSCIENCE, V19, P327; Pure E, 2001, TRENDS MOL MED, V7, P213, DOI 10.1016/S1471-4914(01)01963-3; Shibuya A, 1996, IMMUNITY, V4, P573, DOI 10.1016/S1074-7613(00)70060-4; Shibuya K, 1999, IMMUNITY, V11, P615, DOI 10.1016/S1074-7613(00)80136-3; Shibuya K, 2003, J EXP MED, V198, P1829, DOI 10.1084/jem.20030958; Siffrin V, 2010, IMMUNITY, V33, P424, DOI 10.1016/j.immuni.2010.08.018; Sinha S, 2007, J NEUROSCI, V27, P12531, DOI 10.1523/JNEUROSCI.3599-07.2007; Sinha S, 2010, J NEUROIMMUNOL, V225, P52, DOI 10.1016/j.jneuroim.2010.04.013; Sinha S, 2010, J NEUROIMMUNE PHARM, V5, P231, DOI 10.1007/s11481-009-9175-1; Sinha S, 2009, J NEUROSCI, V29, P3816, DOI 10.1523/JNEUROSCI.5812-08.2009; SWANBORG RH, 1995, CLIN IMMUNOL IMMUNOP, V77, P4, DOI 10.1016/0090-1229(95)90130-2; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; TAMURA T, 1995, J IMMUNOL, V155, P4692; Tamura T, 2001, J IMMUNOL, V167, P1962, DOI 10.4049/jimmunol.167.4.1962; Vandenbark AA, 2003, J IMMUNOL, V171, P127, DOI 10.4049/jimmunol.171.1.127; Wang CH, 2003, J IMMUNOL, V171, P1934, DOI 10.4049/jimmunol.171.4.1934; Yang YH, 2009, J EXP MED, V206, P1549, DOI 10.1084/jem.20082584	32	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2011	6	7							e21868	10.1371/journal.pone.0021868	http://dx.doi.org/10.1371/journal.pone.0021868			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	789JO	21750737	gold, Green Published, Green Submitted			2022-12-27	WOS:000292512000029
J	Wanyenze, RK; Kamya, MR; Fatch, R; Mayanja-Kizza, H; Baveewo, S; Sawires, S; Bangsberg, DR; Coates, T; Hahn, JA				Wanyenze, Rhoda K.; Kamya, Moses R.; Fatch, Robin; Mayanja-Kizza, Harriet; Baveewo, Steven; Sawires, Sharif; Bangsberg, David R.; Coates, Thomas; Hahn, Judith A.			Missed Opportunities for HIV Testing and Late-Stage Diagnosis among HIV-Infected Patients in Uganda	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; SEXUAL-BEHAVIOR; TRANSMISSION; PREVENTION; STRATEGIES; DISCLOSURE; COUNTRIES; PROGRAMS; OUTCOMES; RISK	Background: Late diagnosis of HIV infection is a major challenge to the scale-up of HIV prevention and treatment. In 2005 Uganda adopted provider-initiated HIV testing in the health care setting to ensure earlier HIV diagnosis and linkage to care. We provided HIV testing to patients at Mulago hospital in Uganda, and performed CD4 tests to assess disease stage at diagnosis. Methods: Patients who had never tested for HIV or tested negative over one year prior to recruitment were enrolled between May 2008 and March 2010. Participants who tested HIV positive had a blood draw for CD4. Late HIV diagnosis was defined as CD4 <= 250 cells/mm. Predictors of late HIV diagnosis were analyzed using multi-variable logistic regression. Results: Of 1966 participants, 616 (31.3%) were HIV infected; 47.6% of these (291) had CD4 counts <= 250. Overall, 66.7% (408) of the HIV infected participants had never received care in a medical clinic. Receiving care in a non-medical setting (home, traditional healer and drug stores) had a threefold increase in the odds of late diagnosis (OR = 3.2; 95% CI: 2.1-4.9) compared to receiving no health care. Conclusions: Late HIV diagnosis remains prevalent five years after introducing provider-initiated HIV testing in Uganda. Many individuals diagnosed with advanced HIV did not have prior exposure to medical clinics and could not have benefitted from the expansion of provider initiated HIV testing within health facilities. In addition to provider-initiated testing, approaches that reach individuals using non-hospital based encounters should be expanded to ensure early HIV diagnosis.	[Wanyenze, Rhoda K.] Makerere Univ, Sch Publ Hlth, Dept Dis Control & Environm Hlth, Kampala, Uganda; [Kamya, Moses R.; Mayanja-Kizza, Harriet; Baveewo, Steven] Makerere Univ, Sch Med, Dept Med, Kampala, Uganda; [Fatch, Robin; Baveewo, Steven; Hahn, Judith A.] Univ Calif San Francisco, San Francisco Gen Hosp, Dept Med, San Francisco, CA USA; [Sawires, Sharif; Coates, Thomas] Univ Calif Los Angeles, David Geffen Sch Med, Div Infect Dis, Los Angeles, CA 90095 USA; [Bangsberg, David R.] Harvard Univ, Sch Med, Boston, MA USA; [Bangsberg, David R.] Massachusetts Gen Hosp, Ctr Global Hlth, Boston, MA 02114 USA	Makerere University; Makerere University; San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital	Wanyenze, RK (corresponding author), Makerere Univ, Sch Publ Hlth, Dept Dis Control & Environm Hlth, Kampala, Uganda.	rwanyenze@hotmail.com	Mayanja-Kizza, Harriet/AAM-5372-2020; Hahn, Judith/J-5813-2014	Mayanja-Kizza, Harriet/0000-0002-9297-6208; Hahn, Judith/0000-0002-2697-8264	National Institute of Mental Health, Division of AIDS and Health and Behavior Research, Center for Mental Health Research on AIDS [1 R01 MH077512]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH077512, K24MH087227, R01MH054907] Funding Source: NIH RePORTER	National Institute of Mental Health, Division of AIDS and Health and Behavior Research, Center for Mental Health Research on AIDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This study was funded by National Institute of Mental Health (1 R01 MH077512), Division of AIDS and Health and Behavior Research, Center for Mental Health Research on AIDS. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brinkhof MWG, 2008, B WORLD HEALTH ORGAN, V86, P559, DOI 10.2471/BLT.07.044248; Bunnell R, 2006, AIDS, V20, P85, DOI 10.1097/01.aids.0000196566.40702.28; Donnell D, 2010, LANCET, V375, P2092, DOI 10.1016/S0140-6736(10)60705-2; Girardi E, 2007, JAIDS-J ACQ IMM DEF, V46, pS3, DOI 10.1097/01.qai.0000286597.57066.2b; Government of Malawi Office of the President and Cabinet NAC, 2003, NAT HIV AIDS POL CAL; Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9; Hladik W, 2008, AIDS, V22, P503, DOI 10.1097/QAD.0b013e3282f470be; Joint United Nations Programme on HIV/AIDS, 2009, AIDS EP; Kiene SM, 2010, AIDS PATIENT CARE ST, V24, P117, DOI 10.1089/apc.2009.0269; Kigozi IM, 2009, JAIDS-J ACQ IMM DEF, V52, P280, DOI 10.1097/QAI.0b013e3181ab6eab; Krentz HB, 2004, HIV MED, V5, P93, DOI 10.1111/j.1468-1293.2004.00193.x; Medley A, 2004, B WORLD HEALTH ORGAN, V82, P299; Menzies N, 2009, AIDS, V23, P395, DOI 10.1097/QAD.0b013e328321e40b; Montaner JSG, 2010, LANCET, V376, P532, DOI 10.1016/S0140-6736(10)60936-1; Nakanjako Damalie, 2007, Afr Health Sci, V7, P124; Obermeyer CM, 2007, AM J PUBLIC HEALTH, V97, P1762, DOI 10.2105/AJPH.2006.096263; Okwero P, 2010, WOR BANK WORK PAPER, P1, DOI 10.1596/978-0-8213-8290-5; *REP KEN MIN HLTH, 2006, GUID HIV TEST CLIN S; *REP S AFR, 2010, CLIN GUID MAN HIV AI; *REP UG MIN HLTH, 2005, UGAND NAT POL HIV CO; *REP UG MIN HLTH, 2008, PERF REP STD AIDS CO; Sobrino-Vegas P, 2009, CURR HIV RES, V7, P224, DOI 10.2174/157016209787581535; *UG BUR STAT MAC I, 2001, UG DEM HLTH SURV 200; *UG BUR STAT MAC I, 2006, UG DEM HLTH SURV 200; UN, MILL DEV GOALS; Wanyenze RK, 2008, B WORLD HEALTH ORGAN, V86, P302, DOI 10.2471/BLT.07.042580; WANYENZE RK, 2010, LINKAGE HIV CARE SUR, P31933; World Health Organization, 2009, RAP ADV ANT THER HIV; Zolopa AR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005575	29	45	45	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2011	6	7							e21794	10.1371/journal.pone.0021794	http://dx.doi.org/10.1371/journal.pone.0021794			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	789JO	21750732	Green Submitted, gold, Green Published			2022-12-27	WOS:000292512000024
J	Ismail, F; Ikram, M; Purdie, K; Harwood, C; Leigh, I; Storey, A				Ismail, Ferina; Ikram, Mohamed; Purdie, Karin; Harwood, Catherine; Leigh, Irene; Storey, Alan			Cutaneous Squamous Cell Carcinoma (SCC) and the DNA Damage Response: pATM Expression Patterns in Pre-Malignant and Malignant Keratinocyte Skin Lesions	PLOS ONE			English	Article							GENE-PRODUCT; ATM; PROTEIN; LOCALIZATION; TUMOR	Recent evidence suggests that an initial barrier to the emergence of tumours is a DNA damage response that evokes a counter-response which arrests the growth of, or eliminates, damaged cells. Early precursor lesions express markers of an activated DNA damage response in several types of tumour, with a diminishing response in more advanced cancers. An important marker of DNA damage is ATM which becomes phosphorylated (pATM) upon activation. We have investigated pATM expression patterns in cultured keratinocytes, skin explants and a spectrum of pre-malignant to malignant keratinocyte skin lesions by immunohistochemistry. We found that pATM was mainly localised to the Golgi apparatus, which contrasts with its nuclear localisation in other tissues. Upon UV irradiation there is transient formation of pATM in nuclear foci, consistent with recruitment to the sites of DNA damage. By immunohistochemistry we show pATM expression in precancerous keratinocyte lesions is greater and predominantly nuclear when compared to the invasive lesions where pATM is weaker and predominantly cytoplasmic. Our results are consistent with the hypothesis that the DNA damage response acts as a barrier to cutaneous tumour formation, but also suggests that ATM expression in skin is different compared to other tissues. This may be a consequence of the constant exposure of skin to UVR, and has implications for skin carcinogenesis.	[Ismail, Ferina; Purdie, Karin; Harwood, Catherine] Queen Mary Univ London, Barts & London Sch Med & Dent, Blizard Inst Cell & Mol Sci, Ctr Cutaneous Res, London, England; [Ikram, Mohamed] Queen Mary Univ London, Barts & London Sch Med & Dent, Inst Canc, London, England; [Leigh, Irene] Univ Dundee, Coll Med Dent & Nursing, Dundee, Scotland; [Storey, Alan] Univ Oxford, John Radcliffe Hosp, Dept Mol Oncol, Oxford OX3 9DU, England	University of London; Queen Mary University London; University of London; Queen Mary University London; University of Dundee; University of Oxford	Ismail, F (corresponding author), Queen Mary Univ London, Barts & London Sch Med & Dent, Blizard Inst Cell & Mol Sci, Ctr Cutaneous Res, London, England.	f.ismail@qmul.ac.uk		Harwood, Catherine/0000-0002-1375-0965; Storey, Alan/0000-0003-2001-9772	Medical Research Council; MRC [G84/6471] Funding Source: UKRI; Cancer Research UK [13044] Funding Source: researchfish; Medical Research Council [G84/6471] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	FI was supported by funding from the Medical Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong BK, 2001, J PHOTOCH PHOTOBIO B, V63, P8, DOI 10.1016/S1011-1344(01)00198-1; Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Barlow C, 2000, P NATL ACAD SCI USA, V97, P871, DOI 10.1073/pnas.97.2.871; Bartek J, 2007, ONCOGENE, V26, P7773, DOI 10.1038/sj.onc.1210881; Bartkova J, 2005, NATURE, V434, P864, DOI 10.1038/nature03482; Brown KD, 1997, P NATL ACAD SCI USA, V94, P1840, DOI 10.1073/pnas.94.5.1840; CLEAVER JE, 1975, ANNU REV GENET, V9, P19, DOI 10.1146/annurev.ge.09.120175.000315; Dahle Jostein, 2005, J Carcinog, V4, P11, DOI 10.1186/1477-3163-4-11; Durham SE, 2003, BRIT J CANCER, V88, P90, DOI 10.1038/sj.bjc.6600773; Garinis GA, 2005, EMBO J, V24, P3952, DOI 10.1038/sj.emboj.7600849; Gorgoulis VG, 2005, NATURE, V434, P907, DOI 10.1038/nature03485; Guzman E, 2003, APOPTOSIS, V8, P315, DOI 10.1023/A:1024112231953; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Jans J, 2006, MOL CELL BIOL, V26, P8515, DOI 10.1128/MCB.00807-06; Lakin ND, 1996, ONCOGENE, V13, P2707; Lim DS, 1998, P NATL ACAD SCI USA, V95, P10146, DOI 10.1073/pnas.95.17.10146; MARKS R, 1986, BRIT J DERMATOL, V115, P649, DOI 10.1111/j.1365-2133.1986.tb06644.x; Muller H, 2001, GENE DEV, V15, P267, DOI 10.1101/gad.864201; Norbury CJ, 2001, ANNU REV PHARMACOL, V41, P367, DOI 10.1146/annurev.pharmtox.41.1.367; Oka A, 1998, NEUROSCI LETT, V252, P195, DOI 10.1016/S0304-3940(98)00576-X; Popp S, 2000, J INVEST DERMATOL, V115, P1095, DOI 10.1046/j.1523-1747.2000.00173.x; RESNITZKY D, 1994, MOL CELL BIOL, V14, P1669, DOI 10.1128/MCB.14.3.1669; Roewert-Huber J, 2007, BRIT J DERMATOL, V157, P18, DOI 10.1111/j.1365-2133.2007.08267.x; Rowert-Huber J, 2007, BRIT J DERMATOL, V156, P8, DOI 10.1111/j.1365-2133.2007.07860.x; ROWE DE, 1992, J AM ACAD DERMATOL, V26, P976, DOI 10.1016/0190-9622(92)70144-5; Sander CS, 2003, BRIT J DERMATOL, V148, P913, DOI 10.1046/j.1365-2133.2003.05303.x; Watters D, 1999, J BIOL CHEM, V274, P34277, DOI 10.1074/jbc.274.48.34277; Watters D, 1997, ONCOGENE, V14, P1911, DOI 10.1038/sj.onc.1201037; Wu ZH, 2006, SCIENCE, V311, P1141, DOI 10.1126/science.1121513; Yang DQ, 2000, NAT CELL BIOL, V2, P893, DOI 10.1038/35046542; Zhang LQ, 2006, CELL SIGNAL, V18, P1386, DOI 10.1016/j.cellsig.2005.10.017	31	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2011	6	7							e21271	10.1371/journal.pone.0021271	http://dx.doi.org/10.1371/journal.pone.0021271			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786HC	21747934	Green Published, gold, Green Submitted			2022-12-27	WOS:000292293400009
J	Hornblad, A; Eriksson, AU; Sock, E; Hill, RE; Ahlgren, U				Hornblad, Andreas; Eriksson, Anna U.; Sock, Elisabeth; Hill, Robert E.; Ahlgren, Ulf			Impaired Spleen Formation Perturbs Morphogenesis of the Gastric Lobe of the Pancreas	PLOS ONE			English	Article							GENE; ORGANOGENESIS; MOUSE; MICE; SPECIFICATION; MESENCHYME; DYNAMICS; NETWORK; SIGNALS; LIVER	Despite the extensive use of the mouse as a model for studies of pancreas development and disease, the development of the gastric pancreatic lobe has been largely overlooked. In this study we use optical projection tomography to provide a detailed three-dimensional and quantitative description of pancreatic growth dynamics in the mouse. Hereby, we describe the epithelial and mesenchymal events leading to the formation of the gastric lobe of the pancreas. We show that this structure forms by perpendicular growth from the dorsal pancreatic epithelium into a distinct lateral domain of the dorsal pancreatic mesenchyme. Our data support a role for spleen organogenesis in the establishment of this mesenchymal domain and in mice displaying perturbed spleen development, including Dh +/-, Bapx1-/- and Sox11-/-, gastric lobe development is disturbed. We further show that the expression profile of markers for multipotent progenitors is delayed in the gastric lobe as compared to the splenic and duodenal pancreatic lobes. Altogether, this study provides new information regarding the developmental dynamics underlying the formation of the gastric lobe of the pancreas and recognizes lobular heterogeneities regarding the time course of pancreatic cellular differentiation. Collectively, these data are likely to constitute important elements in future interpretations of the developing and/or diseased pancreas.	[Hornblad, Andreas; Eriksson, Anna U.; Ahlgren, Ulf] Umea Univ, Umea Ctr Mol Med, Umea, Sweden; [Sock, Elisabeth] Univ Erlangen Nurnberg, Inst Biochem, Emil Fischer Zentrum, Erlangen, Germany; [Hill, Robert E.] Western Gen Hosp, MRC, Human Genet Unit, Edinburgh EH4 2XU, Midlothian, Scotland	Umea University; University of Erlangen Nuremberg; University of Edinburgh	Hornblad, A (corresponding author), Umea Univ, Umea Ctr Mol Med, Umea, Sweden.	Ulf.Ahlgren@ucmm.umu.se		Sock, Elisabeth/0000-0001-9925-3136; Hornblad, Andreas/0000-0003-1283-0784; Ahlgren, Ulf/0000-0001-5923-8572	Medical Research Council; Deutsche Forschungsgemeinschaft [So251/3-1]; Swedish Research Council; Kempe Foundations; Umea University; MRC [MC_U127584494, MC_PC_U127584494] Funding Source: UKRI; Medical Research Council [MC_U127584494, MC_PC_U127584494] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Swedish Research Council(Swedish Research CouncilEuropean Commission); Kempe Foundations; Umea University; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by a Medical Research Council core grant to REH, the Deutsche Forschungsgemeinschaft (So251/3-1) to ES, the Swedish Research Council, the Kempe Foundations and Umea University to UA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlgren U, 1996, DEVELOPMENT, V122, P1409; Ahlgren U, 1997, NATURE, V385, P257, DOI 10.1038/385257a0; Alanentalo T, 2007, NAT METHODS, V4, P31, DOI 10.1038/NMETH985; Asayesh A, 2006, GENE DEV, V20, P2208, DOI 10.1101/gad.381906; Bock P, 1997, MICROSC RES TECHNIQ, V37, P374; Bort R, 2004, DEVELOPMENT, V131, P797, DOI 10.1242/dev.00965; Brendolan A, 2005, DEVELOPMENT, V132, P3113, DOI 10.1242/dev.01884; Brendolan A, 2007, BIOESSAYS, V29, P166, DOI 10.1002/bies.20528; Burn SF, 2008, DEV BIOL, V318, P303, DOI 10.1016/j.ydbio.2008.03.031; DEAR TN, 1995, DEVELOPMENT, V121, P2909; Deutsch G, 2001, DEVELOPMENT, V128, P871; Gittes GK, 2009, DEV BIOL, V326, P4, DOI 10.1016/j.ydbio.2008.10.024; GOLOSOW N, 1962, DEV BIOL, V4, P242, DOI 10.1016/0012-1606(62)90042-8; GREEN MC, 1967, DEV BIOL, V15, P62, DOI 10.1016/0012-1606(67)90006-1; Hagai Hideo, 2003, J Hepatobiliary Pancreat Surg, V10, P48; Hecksher-Sorensen J, 2004, DEVELOPMENT, V131, P4665, DOI 10.1242/dev.01364; Herzer U, 1999, CURR BIOL, V9, P837, DOI 10.1016/S0960-9822(99)80369-8; Kesavan G, 2009, CELL, V139, P791, DOI 10.1016/j.cell.2009.08.049; Kim BM, 2007, DEVELOPMENT, V134, P3603, DOI 10.1242/dev.009308; Kim SK, 2001, GENE DEV, V15, P111, DOI 10.1101/gad.859401; Lammert E, 2001, SCIENCE, V294, P564, DOI 10.1126/science.1064344; Lettice LA, 1999, P NATL ACAD SCI USA, V96, P9695, DOI 10.1073/pnas.96.17.9695; Lu JR, 2000, P NATL ACAD SCI USA, V97, P9525, DOI 10.1073/pnas.97.17.9525; Pabst O, 1999, DEVELOPMENT, V126, P2215; Pan FC, 2011, DEV DYNAM, V240, P530, DOI 10.1002/dvdy.22584; ROBERTS CWM, 1994, NATURE, V368, P747, DOI 10.1038/368747a0; SAND FW, 2011, DEV BIOL; Sharpe J, 2002, SCIENCE, V296, P541, DOI 10.1126/science.1068206; SLACK JMW, 1995, DEVELOPMENT, V121, P1569; Sock E, 2004, MOL CELL BIOL, V24, P6635, DOI 10.1128/mcb.24.15.6635-6644.2004; Villasenor A, 2010, DEVELOPMENT, V137, P4295, DOI 10.1242/dev.052993; Wandzioch E, 2009, SCIENCE, V324, P1707, DOI 10.1126/science.1174497; WESSELLS NK, 1967, DEV BIOL, V15, P237, DOI 10.1016/0012-1606(67)90042-5; Yoshitomi H, 2004, DEVELOPMENT, V131, P807, DOI 10.1242/dev.00960; Zhou Q, 2007, DEV CELL, V13, P103, DOI 10.1016/j.devcel.2007.06.001	35	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2011	6	6							e21753	10.1371/journal.pone.0021753	http://dx.doi.org/10.1371/journal.pone.0021753			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786GP	21738788	Green Published, gold, Green Submitted			2022-12-27	WOS:000292291800040
J	Kammerer, R; Buchner, A; Palluch, P; Pongratz, T; Oboukhovskij, K; Beyer, W; Johansson, A; Stepp, H; Baumgartner, R; Zimmermann, W				Kammerer, Robert; Buchner, Alexander; Palluch, Patrick; Pongratz, Thomas; Oboukhovskij, Konstantin; Beyer, Wolfgang; Johansson, Ann; Stepp, Herbert; Baumgartner, Reinhold; Zimmermann, Wolfgang			Induction of Immune Mediators in Glioma and Prostate Cancer Cells by Non-Lethal Photodynamic Therapy	PLOS ONE			English	Article							INDUCED PROTOPORPHYRIN-IX; NF-KAPPA-B; ANTITUMOR IMMUNITY; GLIOBLASTOMA-MULTIFORME; MALIGNANT GLIOMA; CARCINOMA-CELLS; STRESS-RESPONSE; EXPRESSION; ACTIVATION; DEATH	Background: Photodynamic therapy (PDT) uses the combination of photosensitizing drugs and harmless light to cause selective damage to tumor cells. PDT is therefore an option for focal therapy of localized disease or for otherwise unresectable tumors. In addition, there is increasing evidence that PDT can induce systemic anti-tumor immunity, supporting control of tumor cells, which were not eliminated by the primary treatment. However, the effect of non-lethal PDT on the behavior and malignant potential of tumor cells surviving PDT is molecularly not well defined. Methodology/Principal Findings: Here we have evaluated changes in the transcriptome of human glioblastoma (U87, U373) and human (PC-3, DU145) and murine prostate cancer cells (TRAMP-C1, TRAMP-C2) after non-lethal PDT in vitro and in vivo using oligonucleotide microarray analyses. We found that the overall response was similar between the different cell lines and photosensitizers both in vitro and in vivo. The most prominently upregulated genes encoded proteins that belong to pathways activated by cellular stress or are involved in cell cycle arrest. This response was similar to the rescue response of tumor cells following high-dose PDT. In contrast, tumor cells dealing with non-lethal PDT were found to significantly upregulate a number of immune genes, which included the chemokine genes CXCL2, CXCL3 and IL8/CXCL8 as well as the genes for IL6 and its receptor IL6R, which can stimulate proinflammatory reactions, while IL6 and IL6R can also enhance tumor growth. Conclusions: Our results indicate that PDT can support anti-tumor immune responses and is, therefore, a rational therapy even if tumor cells cannot be completely eliminated by primary phototoxic mechanisms alone. However, non-lethal PDT can also stimulate tumor growth-promoting autocrine loops, as seen by the upregulation of IL6 and its receptor. Thus the efficacy of PDT to treat tumors may be improved by controlling unwanted and potentially deleterious growth-stimulatory pathways.	[Kammerer, Robert] Friedrich Loeffler Inst, Inst Immunol, Tubingen, Germany; [Buchner, Alexander] Univ Hosp Munich, Dept Urol, Munich, Germany; [Buchner, Alexander; Palluch, Patrick; Oboukhovskij, Konstantin; Zimmermann, Wolfgang] Univ Hosp Munich, Tumor Immunol Lab, LIFE Ctr, Munich, Germany; [Pongratz, Thomas; Beyer, Wolfgang; Johansson, Ann; Stepp, Herbert; Baumgartner, Reinhold] Univ Hosp Munich, Laser Res Lab, LIFE Ctr, Munich, Germany	Friedrich Loeffler Institute; University of Munich; University of Munich; University of Munich	Kammerer, R (corresponding author), Friedrich Loeffler Inst, Inst Immunol, Tubingen, Germany.	wolfgang.zimmermann@med.uni-muenchen.de	Zimmermann, Wolfgang/L-9277-2013; Stepp, Herbert/E-1990-2013; Kammerer, Robert/AAQ-1338-2021	Kammerer, Robert/0000-0003-3038-8205; Buchner, Alexander/0000-0001-7895-7070	Deutsche Krebshilfe [107320]	Deutsche Krebshilfe(Deutsche Krebshilfe)	This work was supported by a grant from the Deutsche Krebshilfe (107320; http://www.krebshilfe.de/deutsche-krebshilfe.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed HU, 2009, SURG ONCOL, V18, P219, DOI 10.1016/j.suronc.2009.02.002; Beck TJ, 2007, LASER SURG MED, V39, P386, DOI 10.1002/lsm.20507; Bento C, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-89; Buytaert E, 2008, ONCOGENE, V27, P1916, DOI 10.1038/sj.onc.1210825; Castano AP, 2006, NAT REV CANCER, V6, P535, DOI 10.1038/nrc1894; Cecic I, 2006, INT IMMUNOPHARMACOL, V6, P1259, DOI 10.1016/j.intimp.2006.03.008; Cekaite L, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-273; Chun JY, 2009, CLIN CANCER RES, V15, P4815, DOI 10.1158/1078-0432.CCR-09-0640; COHEN S, 1990, BIOCHEM J, V270, P325, DOI 10.1042/bj2700325; Decarvalho AC, 2007, GLIA, V55, P1053, DOI 10.1002/glia.20525; DESUZINGESMANDO.E, 2010, J BIOL CHEM; Dolmans DEJGJ, 2003, NAT REV CANCER, V3, P380, DOI 10.1038/nrc1071; Duan ZF, 2009, CANCER CHEMOTH PHARM, V63, P681, DOI 10.1007/s00280-008-0785-8; Eleouet S, 2000, NEUROL RES, V22, P361, DOI 10.1080/01616412.2000.11740685; Eljamel MS, 2008, LASER MED SCI, V23, P361, DOI 10.1007/s10103-007-0494-2; Eljamel S, 2010, PHOTODIAGN PHOTODYN, V7, P76, DOI 10.1016/j.pdpdt.2010.02.002; Foster BA, 1997, CANCER RES, V57, P3325; Gao SP, 2007, J CLIN INVEST, V117, P3846, DOI 10.1172/JCI31871; Garg AD, 2010, APOPTOSIS, V15, P1050, DOI 10.1007/s10495-010-0479-7; Gingrich JR, 1996, CANCER RES, V56, P4096; Gollnick SO, 2010, IMMUNOL RES, V46, P216, DOI 10.1007/s12026-009-8119-4; Hsieh YJ, 2003, J CELL PHYSIOL, V194, P363, DOI 10.1002/jcp.10273; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Johansson A, 2010, PHOTOCHEM PHOTOBIOL, V86, P1373, DOI 10.1111/j.1751-1097.2010.00799.x; Joo JH, 2007, CANCER RES, V67, P7929, DOI 10.1158/0008-5472.CAN-07-0931; Kabingu E, 2009, CLIN CANCER RES, V15, P4460, DOI 10.1158/1078-0432.CCR-09-0400; KAMMERER R, 2009, MED LASER APPL, V24, P237; KICK G, 1995, CANCER RES, V55, P2373; Kousis PC, 2007, CANCER RES, V67, P10501, DOI 10.1158/0008-5472.CAN-07-1778; Lee SY, 2010, BRIT J CANCER, V103, P362, DOI 10.1038/sj.bjc.6605797; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Lindner U, 2010, NAT REV UROL, V7, P562, DOI 10.1038/nrurol.2010.142; Liu B, 2009, CANCER SCI, V100, P2126, DOI 10.1111/j.1349-7006.2009.01290.x; Matroule JY, 2006, PHOTOCHEM PHOTOBIOL, V82, P1241, DOI 10.1562/2006-03-30-IR-862; Moore CM, 2009, NAT CLIN PRACT UROL, V6, P18, DOI 10.1038/ncpuro1274; Naderi A, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-111; Nilsson CL, 2010, J PROTEOME RES, V9, P430, DOI 10.1021/pr9007927; Nowis D, 2005, ACTA BIOCHIM POL, V52, P339; Nozaki I, 2005, LAB INVEST, V85, P109, DOI 10.1038/labinvest.3700213; Prasmickaite L, 2006, FEBS LETT, V580, P5739, DOI 10.1016/j.febslet.2006.09.028; Sanovic R, 2009, INT J ONCOL, V35, P921, DOI 10.3892/ijo_00000407; Schroeder A, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-3; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shedden K, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-26; Stummer W, 2008, J NEURO-ONCOL, V87, P103, DOI 10.1007/s11060-007-9497-x; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Stylli SS, 2005, J CLIN NEUROSCI, V12, P389, DOI 10.1016/j.jocn.2005.01.006; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Susanto J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004023; Theilgaard-Monch K, 2004, J IMMUNOL, V172, P7684, DOI 10.4049/jimmunol.172.12.7684; Van Meir EG, 2010, CA-CANCER J CLIN, V60, P166, DOI 10.3322/caac.20069; Verwanger T, 2002, INT J ONCOL, V21, P1353; Wild PJ, 2005, MOL CANCER THER, V4, P516, DOI 10.1158/1535-7163.MCT-04-0141; Yang H, 2010, CARCINOGENESIS, V31, P703, DOI 10.1093/carcin/bgq008; Zheng XG, 2008, CANCER LETT, V265, P177, DOI 10.1016/j.canlet.2008.02.023	55	39	39	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2011	6	6							e21834	10.1371/journal.pone.0021834	http://dx.doi.org/10.1371/journal.pone.0021834			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786GP	21738796	Green Published, gold			2022-12-27	WOS:000292291800047
J	Fischer, A; Prufer, K; Good, JM; Halbwax, M; Wiebe, V; Andre, C; Atencia, R; Mugisha, L; Ptak, SE; Paabo, S				Fischer, Anne; Pruefer, Kay; Good, Jeffrey M.; Halbwax, Michel; Wiebe, Victor; Andre, Claudine; Atencia, Rebeca; Mugisha, Lawrence; Ptak, Susan E.; Paeaebo, Svante			Bonobos Fall within the Genomic Variation of Chimpanzees	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; GENETIC-STRUCTURE; NUCLEOTIDE DIVERSITY; DEMOGRAPHIC HISTORY; DNA POLYMORPHISM; SPECIES TREES; MIXED MODELS; POPULATIONS; PATTERNS; HUMANS	To gain insight into the patterns of genetic variation and evolutionary relationships within and between bonobos and chimpanzees, we sequenced 150,000 base pairs of nuclear DNA divided among 15 autosomal regions as well as the complete mitochondrial genomes from 20 bonobos and 58 chimpanzees. Except for western chimpanzees, we found poor genetic separation of chimpanzees based on sample locality. In contrast, bonobos consistently cluster together but fall as a group within the variation of chimpanzees for many of the regions. Thus, while chimpanzees retain genomic variation that predates bonobo-chimpanzee speciation, extensive lineage sorting has occurred within bonobos such that much of their genome traces its ancestry back to a single common ancestor that postdates their origin as a group separate from chimpanzees.	[Fischer, Anne; Pruefer, Kay; Good, Jeffrey M.; Halbwax, Michel; Wiebe, Victor; Ptak, Susan E.; Paeaebo, Svante] Max Plank Inst Evolutionary Anthropol, Leipzig, Germany; [Andre, Claudine] Lola Ya Bonobo Bonobo Sanctuary, Kinshasa, DEM REP CONGO; [Atencia, Rebeca] Jane Goodall Inst, Pointe Noire, Rep Congo; [Mugisha, Lawrence] CSWCT, Entebbe, Uganda	Max Planck Society	Fischer, A (corresponding author), Int Ctr Insect Physiol & Ecol, POB 30772, Nairobi, Kenya.	afischer@icipe.org	Mugisha, Lawrence/N-4916-2017	Mugisha, Lawrence/0000-0003-4932-3356	Max-Planck Gesellschaft; ERC [233297, TWOPAN]; TWOPAN; NSF [OISE-0754461]	Max-Planck Gesellschaft(Max Planck Society); ERC(European Research Council (ERC)European Commission); TWOPAN; NSF(National Science Foundation (NSF))	This work was financially supported by the Max-Planck Gesellschaft and the ERC grant 233297, TWOPAN. JMG was supported by an NSF international postdoctoral fellowship (OISE-0754461) during a portion of this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becquet C, 2007, GENOME RES, V17, P1505, DOI 10.1101/gr.6409707; Becquet C, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030066; BJORK A, 2010, MOL BIOL EVOL; BRAGA J, 1995, CR ACAD SCI II, V320, P1025; Brockman W, 2008, GENOME RES, V18, P763, DOI 10.1101/gr.070227.107; Caswell JL, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000057; Deinard AS, 2000, AM J PHYS ANTHROPOL, V111, P25, DOI 10.1002/(SICI)1096-8644(200001)111:1<25::AID-AJPA3>3.0.CO;2-R; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Eriksson J, 2004, MOL ECOL, V13, P3425, DOI 10.1111/j.1365-294X.2004.02332.x; Fischer A, 2004, MOL BIOL EVOL, V21, P799, DOI 10.1093/molbev/msh083; Fischer A, 2006, CURR BIOL, V16, P1133, DOI 10.1016/j.cub.2006.04.033; Gagneux P, 1999, P NATL ACAD SCI USA, V96, P5077, DOI 10.1073/pnas.96.9.5077; Geraldes A, 2008, MOL ECOL, V17, P5349, DOI 10.1111/j.1365-294X.2008.04005.x; Gonder MK, 2011, P NATL ACAD SCI USA, V108, P4766, DOI 10.1073/pnas.1015422108; Gonder MK, 1997, NATURE, V388, P337, DOI 10.1038/41005; Green RE, 2006, NATURE, V444, P330, DOI 10.1038/nature05336; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Heckman KL, 2007, MOL PHYLOGENET EVOL, V43, P353, DOI 10.1016/j.ympev.2007.03.005; Hinds DA, 2005, SCIENCE, V307, P1072, DOI 10.1126/science.1105436; Hobolth A, 2007, PLOS GENET, V3, P294, DOI 10.1371/journal.pgen.0030007; HUDSON RR, 1992, GENETICS, V131, P509; Hudson RR, 2002, BIOINFORMATICS, V18, P337, DOI 10.1093/bioinformatics/18.2.337; Jensen-Seaman MI, 2001, J HERED, V92, P475, DOI 10.1093/jhered/92.6.475; Kaessmann H, 1999, SCIENCE, V286, P1159, DOI 10.1126/science.286.5442.1159; Kano T., 1992, LAST APE PYGMY CHIMP; Kimura M, 1983, NEUTRAL THEORY MOL E, P384; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; McGuire JA, 2007, EVOLUTION, V61, P2879, DOI 10.1111/j.1558-5646.2007.00239.x; Meyer M, 2008, NAT PROTOC, V3, P267, DOI 10.1038/nprot.2007.520; Minin V, 2003, SYST BIOL, V52, P674, DOI 10.1080/10635150390235494; Napier JR, 1967, HDB LIVING PRIMATES; PAMILO P, 1988, MOL BIOL EVOL, V5, P568; Patterson N., 2006, NATURE; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Pritchard JK, 2000, GENETICS, V155, P945; Ptak SE, 2005, NAT GENET, V37, P429, DOI 10.1038/ng1529; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; SHEA BT, 1993, MULTIVARIATE CRANIOM; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stone AC, 2002, P NATL ACAD SCI USA, V99, P43, DOI 10.1073/pnas.012364999; Swofford DL, 2002, PAUP PHYLOGENETIC AN; TAJIMA F, 1989, GENETICS, V123, P585; TAKAHATA N, 1993, MOL BIOL EVOL, V10, P2; Thornton K, 2003, BIOINFORMATICS, V19, P2325, DOI 10.1093/bioinformatics/btg316; Uchida A, 1996, TRENDS ECOL EVOL, V11, P163, DOI 10.1016/0169-5347(96)10007-0; Voight BF, 2005, P NATL ACAD SCI USA, V102, P18508, DOI 10.1073/pnas.0507325102; WEGMANN D, 2010, BAYESIAN INFERENCE D; Winckler W, 2005, SCIENCE, V308, P107, DOI 10.1126/science.1105322; Won YJ, 2005, MOL BIOL EVOL, V22, P297, DOI 10.1093/molbev/msi017; Wrangham R. W., 2001, ALL APES GREAT SMALL, V1; WU CI, 1991, GENETICS, V127, P429; Xu XW, 2010, MOL PHYLOGENET EVOL, V55, P1008, DOI 10.1016/j.ympev.2009.11.018; Yu N, 2003, GENETICS, V164, P1511; Zihlman A., 1996, GREAT APE SOC	56	44	45	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2011	6	6							e21605	10.1371/journal.pone.0021605	http://dx.doi.org/10.1371/journal.pone.0021605			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786FZ	21747915	Green Published, gold, Green Submitted			2022-12-27	WOS:000292290100045
J	Indriati, E; Swisher, CC; Lepre, C; Quinn, RL; Suriyanto, RA; Hascaryo, AT; Grun, R; Feibel, CS; Pobiner, BL; Aubert, M; Lees, W; Anton, SC				Indriati, Etty; Swisher, Carl C., III; Lepre, Christopher; Quinn, Rhonda L.; Suriyanto, Rusyad A.; Hascaryo, Agus T.; Gruen, Rainer; Feibel, Craig S.; Pobiner, Briana L.; Aubert, Maxime; Lees, Wendy; Anton, Susan C.			The Age of the 20 Meter Solo River Terrace, Java, Indonesia and the Survival of Homo erectus in Asia	PLOS ONE			English	Article							TOOTH ENAMEL; COSMIC-RAY; U-UPTAKE; NGANDONG; PLEISTOCENE; HOMININ; SAPIENS; FLORES	Homo erectus was the first human lineage to disperse widely throughout the Old World, the only hominin in Asia through much of the Pleistocene, and was likely ancestral to H. sapiens. The demise of this taxon remains obscure because of uncertainties regarding the geological age of its youngest populations. In 1996, some of us co-published electron spin resonance (ESR) and uranium series (U-series) results indicating an age as young as 35-50 ka for the late H. erectus sites of Ngandong and Sambungmacan and the faunal site of Jigar (Indonesia). If correct, these ages favor an African origin for recent humans who would overlap with H. erectus in time and space. Here, we report Ar-40/Ar-39 incremental heating analyses and new ESR/U-series age estimates from the "20 m terrace'' at Ngandong and Jigar. Both data sets are internally consistent and provide no evidence for reworking, yet they are inconsistent with one another. The Ar-40/Ar-39 analyses give an average age of 546 +/- 12 ka (sd +/- 5 se) for both sites, the first reliable radiometric indications of a middle Pleistocene component for the terrace. Given the technical accuracy and consistency of the analyses, the argon ages represent either the actual age or the maximum age for the terrace and are significantly older than previous estimates. Most of the ESR/U-series results are older as well, but the oldest that meets all modeling criteria is 143 ka+20/-17. Most samples indicated leaching of uranium and likely represent either the actual or the minimum age of the terrace. Given known sources of error, the U-series results could be consistent with a middle Pleistocene age. However, the ESR and Ar-40/Ar-39 ages preclude one another. Regardless, the age of the sites and hominins is at least bracketed between these estimates and is older than currently accepted.	[Indriati, Etty; Suriyanto, Rusyad A.; Hascaryo, Agus T.] Gadjah Mada Univ, Fac Med, Lab Bio & Paleoanthropol, Yogyakarta, Indonesia; [Swisher, Carl C., III; Lepre, Christopher; Quinn, Rhonda L.; Feibel, Craig S.] Rutgers State Univ, Dept Earth & Planetary Sci, Piscataway, NJ USA; [Lepre, Christopher] Columbia Univ, Lamont Doherty Earth Observ Palisades, New York, NY USA; [Quinn, Rhonda L.] Loyola Univ Chicago, Dept Anthropol, Chicago, IL USA; [Gruen, Rainer; Aubert, Maxime; Lees, Wendy] Australian Natl Univ, Res Sch Earth Sci, Canberra, ACT, Australia; [Pobiner, Briana L.] Smithsonian Inst, Natl Museum Nat Hist, Human Origins Program, Washington, DC 20560 USA; [Anton, Susan C.] NYU, Dept Anthropol, Ctr Study Human Origins, New York, NY 10003 USA	Gadjah Mada University; Rutgers State University New Brunswick; Columbia University; Loyola University Chicago; Australian National University; Smithsonian Institution; Smithsonian National Museum of Natural History; New York University	Indriati, E (corresponding author), Gadjah Mada Univ, Fac Med, Lab Bio & Paleoanthropol, Yogyakarta, Indonesia.	cswish@rci.rutgers.edu; susan.anton@nyu.edu	Aubert, Maxime/AAT-6198-2020; Grun, Rainer/A-1437-2012	Aubert, Maxime/0000-0002-4189-531X; Grun, Rainer/0000-0003-1366-3674; Quinn, Rhonda/0000-0003-2580-864X; Lepre, Christopher/0000-0001-9930-9339	U.S. NSF [BCS 0317292]; AAAS WISC program; UGM	U.S. NSF(National Science Foundation (NSF)); AAAS WISC program; UGM	The project was funded by the U.S. NSF BCS 0317292 to SCA, an AAAS WISC program grant to EI and SCA, and a UGM sabbatical grant to EI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamiec G., 1998, ANCIENT TL, V16, P37, DOI DOI 10.1016/S0277-3791(03)00021-0; Anton SC, 2004, ANNU REV ANTHROPOL, V33, P271, DOI 10.1146/annurev.anthro.33.070203.144024; Anton SC, 2003, YEARB PHYS ANTHROPOL, V46, P126, DOI 10.1002/ajpa.10399; Anton SC, 1999, AM J PHYS ANTHROPOL, V108, P223; Anton SC, 2002, AM J PHYS ANTHROPOL, V118, P301, DOI 10.1002/ajpa.10091; BARSTRA GJ, 1987, PALEAEOHIST GRONINGE, V29, P1; BARTSTRA GJ, 1988, J HUM EVOL, V17, P325, DOI 10.1016/0047-2484(88)90074-7; Brown P, 2004, NATURE, V431, P1055, DOI 10.1038/nature02999; Carr MJ, 2007, GEOCHEM GEOPHY GEOSY, V8, DOI 10.1029/2006GC001396; CARTMILL M, 2009, HUMAN LINEAGE; Deino AL, 2002, J HUM EVOL, V42, P185, DOI 10.1006/jhev.2001.0517; Eggins S, 2003, QUATERNARY SCI REV, V22, P1373, DOI 10.1016/S0277-3791(03)00064-7; Eggins SM, 2005, QUATERNARY SCI REV, V24, P2523, DOI 10.1016/j.quascirev.2005.07.006; Gibbons A, 1996, SCIENCE, V274, P1841, DOI 10.1126/science.274.5294.1841; Gordon AD, 2008, P NATL ACAD SCI USA, V105, P4650, DOI 10.1073/pnas.0710041105; Grun R, 1997, SCIENCE, V276, P1575, DOI 10.1126/science.276.5318.1575; Grun R, 1997, J HUM EVOL, V32, P83; Grun R, 2002, RADIAT MEAS, V35, P87, DOI 10.1016/S1350-4487(01)00255-4; GRUN R, 1988, NUCL TRACKS RAD MEAS, V14, P237; Grun R., 1994, ANCIENT TL, V12, P35; Grun R, 2008, QUAT GEOCHRONOL, V3, P150, DOI 10.1016/j.quageo.2007.09.004; Grun R, 2009, RADIAT MEAS, V44, P472, DOI 10.1016/j.radmeas.2009.02.011; Grun R, 2009, QUAT GEOCHRONOL, V4, P231, DOI 10.1016/j.quageo.2008.12.005; HUFFMAN OF, 2010, PALEOANTHROPOLOGY, P1, DOI DOI 10.4207/PA.2010.ART34; Jacob T, 2006, P NATL ACAD SCI USA, V103, P13421, DOI 10.1073/pnas.0605563103; JACOB T, 1975, CATALOGUE FOSSIL H 3, P103; JOANNESBOYAU R, QUATERNARY GEO UNPUB; KLEIN RG, 1989, HUMAN CAREER; Larick R, 2001, P NATL ACAD SCI USA, V98, P4866, DOI 10.1073/pnas.081077298; LUCA AP, 1980, YALE U PUB ANTHR, V78, P1; MARSH R, 1999, THESIS MCMASTER U HA; MOELYADI I, 1980, PROY PEN PALEOANTHRO; Oppenoorth W. F.. F., 1932, Wetens Meded Mijnb Batavia, Vno. 20, P49; Potts R, 2004, SCIENCE, V305, P75, DOI 10.1126/science.1097661; PRESCOTT JR, 1988, NUCL TRACKS RAD MEAS, V14, P223; PRESCOTT JR, 1994, RADIAT MEAS, V23, P497, DOI 10.1016/1350-4487(94)90086-8; Renne PR, 1998, CHEM GEOL, V145, P117, DOI 10.1016/S0009-2541(97)00159-9; RIGHTMIRE GP, 1993, EVOLUTION HOMO ERECT; Shen GJ, 2009, NATURE, V458, P198, DOI 10.1038/nature07741; Sondaar P, 1996, GEOL RES DEV CENT PA, V8, P1; STEIGER RH, 1977, EARTH PLANET SC LETT, V36, P359, DOI 10.1016/0012-821X(77)90060-7; Swisher CC, 1996, SCIENCE, V274, P1870, DOI 10.1126/science.274.5294.1870; SWISHER CC, 1994, SCIENCE, V263, P1118, DOI 10.1126/science.8108729; Turrin BD, 2008, J VOLCANOL GEOTH RES, V177, P848, DOI 10.1016/j.jvolgeores.2008.01.049; van den Bergh GD, 2001, PALAEOGEOGR PALAEOCL, V171, P385, DOI 10.1016/S0031-0182(01)00255-3; VANDERPLICHT J, 1989, APPL GEOCHEM, V4, P339; VONKOENIGSWALD GHR, 1934, DE ING NED INDIE, V11, P185; Westaway KE, 2007, J HUM EVOL, V53, P709, DOI 10.1016/j.jhevol.2007.06.002; WIDIASMORO, 1976, PROY PEN PENG PURB D; Wolpoff M. H., 1999, PALEOANTHROPOLOGY; Yokoyama Y, 2008, J HUM EVOL, V55, P274, DOI 10.1016/j.jhevol.2008.01.006	51	73	74	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2011	6	6							e21562	10.1371/journal.pone.0021562	http://dx.doi.org/10.1371/journal.pone.0021562			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	786FZ	21738710	Green Published, gold			2022-12-27	WOS:000292290100039
J	Lappe, C; Trainor, LJ; Herholz, SC; Pantev, C				Lappe, Claudia; Trainor, Laurel J.; Herholz, Sibylle C.; Pantev, Christo			Cortical Plasticity Induced by Short-Term Multimodal Musical Rhythm Training	PLOS ONE			English	Article							AUDITORY-EVOKED POTENTIALS; MISMATCH NEGATIVITY; NON-MUSICIANS; PROFESSIONAL PIANISTS; CEREBRAL HEMODYNAMICS; BEAT PERCEPTION; BRAIN; NONMUSICIANS; CORTEX; MOVEMENT	Performing music is a multimodal experience involving the visual, auditory, and somatosensory modalities as well as the motor system. Therefore, musical training is an excellent model to study multimodal brain plasticity. Indeed, we have previously shown that short-term piano practice increase the magnetoencephalographic (MEG) response to melodic material in novice players. Here we investigate the impact of piano training using a rhythmic-focused exercise on responses to rhythmic musical material. Musical training with non musicians was conducted over a period of two weeks. One group (sensorimotor-auditory, SA) learned to play a piano sequence with a distinct musical rhythm, another group (auditory, A) listened to, and evaluated the rhythmic accuracy of the performances of the SA-group. Training-induced cortical plasticity was evaluated using MEG, comparing the mismatch negativity (MMN) in response to occasional rhythmic deviants in a repeating rhythm pattern before and after training. The SA-group showed a significantly greater enlargement of MMN and P2 to deviants after training compared to the A-group. The training-induced increase of the rhythm MMN was bilaterally expressed in contrast to our previous finding where the MMN for deviants in the pitch domain showed a larger right than left increase. The results indicate that when auditory experience is strictly controlled during training, involvement of the sensorimotor system and perhaps increased attentional recources that are needed in producing rhythms lead to more robust plastic changes in the auditory cortex compared to when rhythms are simply attended to in the auditory domain in the absence of motor production.	[Lappe, Claudia; Herholz, Sibylle C.; Pantev, Christo] Univ Munster, Inst Biomagnetism & Biosignalanal, Munster, Germany; [Trainor, Laurel J.] McMaster Univ, Dept Psychol Neurosci & Behav, Hamilton, ON, Canada; [Trainor, Laurel J.] McMaster Univ, McMaster Inst Music & Mind, Hamilton, ON, Canada; [Herholz, Sibylle C.] McGill Univ, Montreal Neurol Inst, Montreal, PQ, Canada	University of Munster; McMaster University; McMaster University; McGill University	Lappe, C (corresponding author), Univ Munster, Inst Biomagnetism & Biosignalanal, Munster, Germany.	pantev@uni-muenster.de		Trainor, Laurel/0000-0003-3397-2079	DFG	DFG(German Research Foundation (DFG))	The study was funded by the DFG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atienza M, 2002, LEARN MEMORY, V9, P138, DOI 10.1101/lm.46502; Bangert M, 2006, NEUROIMAGE, V30, P917, DOI 10.1016/j.neuroimage.2005.10.044; Bangert M, 2006, EUR J NEUROSCI, V24, P1832, DOI 10.1111/j.1460-9568.2006.05031.x; Baumann S, 2005, ANN NY ACAD SCI, V1060, P186, DOI 10.1196/annals.1360.038; Bermudez P, 2009, CEREB CORTEX, V19, P1583, DOI 10.1093/cercor/bhn196; Bosnyak D.J., 2007, INT C SER, V1300, P25, DOI DOI 10.1016/J.ICS.2006.12.040; Brattico E, 2003, NEUROREPORT, V14, P2489, DOI 10.1097/00001756-200312190-00039; BROWN S, 2003, B PSYCHOL ARTS, V4, P15; Brown S, 2007, BRAIN COGNITION, V63, P59, DOI 10.1016/j.bandc.2006.08.006; Chen JL, 2008, J COGNITIVE NEUROSCI, V20, P226, DOI 10.1162/jocn.2008.20018; Cross I, 2003, COGNITIVE NEUROSCIEN, P42, DOI [10.1093/acprof:oso/9780198525202.003.0004, DOI 10.1093/ACPROF:OSO/9780198525202.003.0004]; ELBERT T, 1995, SCIENCE, V270, P305, DOI 10.1126/science.270.5234.305; Evers S, 1999, BRAIN, V122, P75, DOI 10.1093/brain/122.1.75; Fritz JB, 2007, HEARING RES, V229, P186, DOI 10.1016/j.heares.2007.01.009; Fujioka T, 2005, J COGNITIVE NEUROSCI, V17, P1578, DOI 10.1162/089892905774597263; Fujioka T, 2004, J COGNITIVE NEUROSCI, V16, P1010, DOI 10.1162/0898929041502706; Gaser C, 2003, J NEUROSCI, V23, P9240; Geiser E, 2010, EUR J NEUROSCI, V32, P1979, DOI 10.1111/j.1460-9568.2010.07462.x; Grahn JA, 2007, J COGNITIVE NEUROSCI, V19, P893, DOI 10.1162/jocn.2007.19.5.893; Grahn JA, 2009, J NEUROSCI, V29, P7540, DOI 10.1523/JNEUROSCI.2018-08.2009; Haslinger B, 2005, J COGNITIVE NEUROSCI, V17, P282, DOI 10.1162/0898929053124893; Herholz SC, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-42; Herholz SC, 2008, EUR J NEUROSCI, V28, P2352, DOI 10.1111/j.1460-9568.2008.06515.x; Hirata Y, 1999, NEUROREPORT, V10, P999, DOI 10.1097/00001756-199904060-00019; Hutchinson S, 2003, CEREB CORTEX, V13, P943, DOI 10.1093/cercor/13.9.943; Hyde KL, 2009, J NEUROSCI, V29, P3019, DOI 10.1523/JNEUROSCI.5118-08.2009; Janata P, 2003, NAT NEUROSCI, V6, P682, DOI 10.1038/nn1081; Jongsma MLA, 2005, PSYCHOPHYSIOLOGY, V42, P191, DOI 10.1111/j.1469-8986.2005.00269.x; Jongsma MLA, 2004, BIOL PSYCHOL, V66, P129, DOI 10.1016/j.biopsycho.2003.10.002; KASIA M, 2008, NEUROBIOL LEARN MEM, V89, P153; Koesch S, 2002, CLIN NEUROPHYSIOL, V113, P862, DOI 10.1016/S1388-2457(02)00050-0; Kujala T, 2007, BIOL PSYCHOL, V74, P1, DOI 10.1016/j.biopsycho.2006.06.001; Lappe C, 2008, J NEUROSCI, V28, P9632, DOI 10.1523/JNEUROSCI.2254-08.2008; Limb CJ, 2006, ANAT REC PART A, V288A, P382, DOI 10.1002/ar.a.20298; Marinoni M, 2000, J CLIN NEUROSCI, V7, P425, DOI 10.1054/jocn.1999.0683; Naatanen R, 1995, Int J Neurosci, V80, P317, DOI 10.3109/00207459508986107; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Pantev C, 2001, NEUROREPORT, V12, P169, DOI 10.1097/00001756-200101220-00041; Pantev C, 1998, NATURE, V392, P811, DOI 10.1038/33918; Patel AD, 2005, EXP BRAIN RES, V163, P226, DOI 10.1007/s00221-004-2159-8; Petacchi A, 2005, HUM BRAIN MAPP, V25, P118, DOI 10.1002/hbm.20137; Pfordresher PQ, 2006, PERCEPT PSYCHOPHYS, V68, P362, DOI 10.3758/BF03193683; Phillips-Silver J, 2005, SCIENCE, V308, P1430, DOI 10.1126/science.1110922; Phillips-Silver J, 2007, COGNITION, V105, P533, DOI 10.1016/j.cognition.2006.11.006; Picton TW, 2000, AUDIOL NEURO-OTOL, V5, P111, DOI 10.1159/000013875; Platel H, 1997, BRAIN, V120, P229, DOI 10.1093/brain/120.2.229; Polley DB, 2006, J NEUROSCI, V26, P4970, DOI 10.1523/JNEUROSCI.3771-05.2006; PROKSCH M, FURKLEINE KLAVIERK 2; PROKSCH M, FURKLEINE KLAVIERK 1; Repp BH, 2004, PSYCHOL RES-PSYCH FO, V68, P252, DOI 10.1007/s00426-003-0143-8; Russeler J, 2001, NEUROSCI LETT, V308, P33, DOI 10.1016/S0304-3940(01)01977-2; SCHLAUG G, 1995, NEUROPSYCHOLOGIA, V33, P1047, DOI 10.1016/0028-3932(95)00045-5; Schlaug G, 2001, ANN NY ACAD SCI, V930, P281, DOI 10.1111/j.1749-6632.2001.tb05739.x; Schneider P, 2002, NAT NEUROSCI, V5, P688, DOI 10.1038/nn871; Schonwiesner M, 2005, EUR J NEUROSCI, V22, P1521, DOI 10.1111/j.1460-9568.2005.04315.x; Schulz M, 2003, NEUROREPORT, V14, P157, DOI 10.1097/00001756-200301200-00029; Shahin A, 2003, J NEUROSCI, V23, P5545; Shahin AJ, 2008, NEUROIMAGE, V41, P113, DOI 10.1016/j.neuroimage.2008.01.067; TESCHE CD, 1995, ELECTROEN CLIN NEURO, V95, P189, DOI 10.1016/0013-4694(95)00064-6; Trainor L.J., 2009, HDB MUSIC PSYCHOL, P171; Trainor LJ, 2009, CORTEX, V45, P35, DOI 10.1016/j.cortex.2007.10.014; Vuust P, 2005, NEUROIMAGE, V24, P560, DOI 10.1016/j.neuroimage.2004.08.039; ZATORRE RJ, 1991, BRAIN, V114, P2403, DOI 10.1093/brain/114.6.2403; Zatorre RJ, 2001, CEREB CORTEX, V11, P946, DOI 10.1093/cercor/11.10.946; Zatorre RJ, 2007, NAT REV NEUROSCI, V8, P547, DOI 10.1038/nrn2152; Zentner M, 2010, P NATL ACAD SCI USA, V107, P5768, DOI 10.1073/pnas.1000121107	66	64	65	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2011	6	6							e21493	10.1371/journal.pone.0021493	http://dx.doi.org/10.1371/journal.pone.0021493			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	786FZ	21747907	Green Published, gold			2022-12-27	WOS:000292290100028
J	Laurson, J; Raj, K				Laurson, Joanna; Raj, Kenneth			Localisation of Human Papillomavirus 16 E7 Oncoprotein Changes with Cell Confluence	PLOS ONE			English	Article							HPV16 E7; E6 ONCOPROTEIN; GENE-PRODUCT; TYPE-16; PROTEIN; CARCINOMA; LINE; E7-ONCOPROTEIN; TRANSFORMATION; KERATINOCYTES	E7 is one of the best studied proteins of human papillomavirus type 16, largely because of its oncogenic potential linked to cervical cancer. Yet the sub-cellular location of E7 remains confounding, even though it has been shown to be able to shuttle between the nucleus and the cytoplasm. Here we show with immunocytochemistry that E7 proteins are located in the nucleus and cytoplasm in sub-confluent cells, but becomes cytoplasmic in confluent cells. The change in E7's location is independent of time in culture, cell division, cell cycle phase or cellular differentiation. Levels of E7 are also increased in confluent cells as determined by Western blotting. Our investigations have also uncovered how different analytical techniques influence the observation of where E7 is localised, highlighting the importance of technical choice in such analysis. Understanding the localisation of E7 will help us to better comprehend the function of E7 on its target proteins.	[Laurson, Joanna; Raj, Kenneth] Natl Inst Med Res, Div Virol, Med Res Council, London NW7 1AA, England	MRC National Institute for Medical Research; UK Research & Innovation (UKRI); Medical Research Council UK (MRC)	Laurson, J (corresponding author), Natl Inst Med Res, Div Virol, Med Res Council, London NW7 1AA, England.	Joanna.Laurson@doube.net		Laurson-Doube, Joanna/0000-0001-9619-9170	Medical Research Council	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded by the Medical Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen-Hoffmann BL, 2000, J INVEST DERMATOL, V114, P444, DOI 10.1046/j.1523-1747.2000.00869.x; Angeline M, 2003, VIROLOGY, V317, P13, DOI 10.1016/j.virol.2003.08.024; Baldwin A, 2006, J VIROL, V80, P6669, DOI 10.1128/JVI.02497-05; Barrow-Laing L, 2010, VIROLOGY, V400, P233, DOI 10.1016/j.virol.2010.01.034; Dantur K, 2009, INT J CANCER, V125, P1902, DOI 10.1002/ijc.24579; Dreier K, 2011, VIROLOGY, V409, P54, DOI 10.1016/j.virol.2010.09.024; DURST M, 1983, P NATL ACAD SCI-BIOL, V80, P3812, DOI 10.1073/pnas.80.12.3812; DYSON N, 1989, SCIENCE, V243, P934, DOI 10.1126/science.2537532; FRIEDL F, 1970, P SOC EXP BIOL MED, V135, P543; GISSMANN L, 1984, J INVEST DERMATOL, V83, pS26, DOI 10.1111/1523-1747.ep12281143; GREENFIELD I, 1991, P NATL ACAD SCI USA, V88, P11217, DOI 10.1073/pnas.88.24.11217; HAWLEYNELSON P, 1989, EMBO J, V8, P3905, DOI 10.1002/j.1460-2075.1989.tb08570.x; Hoffmann R, 2006, J VIROL, V80, P4431, DOI 10.1128/JVI.80.9.4431-4439.2006; HUBBERT NL, 1992, J VIROL, V66, P6237, DOI 10.1128/JVI.66.10.6237-6241.1992; Huh KW, 2005, P NATL ACAD SCI USA, V102, P11492, DOI 10.1073/pnas.0505337102; Jeon JH, 2007, EXP MOL MED, V39, P621, DOI 10.1038/emm.2007.68; Klingelhutz AJ, 1996, NATURE, V380, P79, DOI 10.1038/380079a0; Knapp AA, 2009, VIROLOGY, V383, P60, DOI 10.1016/j.virol.2008.09.037; Nguyen CL, 2007, J VIROL, V81, P13533, DOI 10.1128/JVI.01669-07; PATTILLO R A, 1977, Science (Washington D C), V196, P1456, DOI 10.1126/science.867042; Ressler S, 2007, CLIN CANCER RES, V13, P7067, DOI 10.1158/1078-0432.CCR-07-1222; SATO H, 1989, VIROLOGY, V170, P311, DOI 10.1016/0042-6822(89)90386-3; SCHEFFNER M, 1990, CELL, V63, P1129, DOI 10.1016/0092-8674(90)90409-8; Smith-McCune K, 1999, P NATL ACAD SCI USA, V96, P6999, DOI 10.1073/pnas.96.12.6999; SMOTKIN D, 1987, J VIROL, V61, P1686, DOI 10.1128/JVI.61.5.1686-1689.1987; STANLEY MA, 1989, INT J CANCER, V43, P672, DOI 10.1002/ijc.2910430422; TODARO GJ, 1963, J CELL BIOL, V17, P299, DOI 10.1083/jcb.17.2.299; Veldman T, 2001, J VIROL, V75, P4467, DOI 10.1128/JVI.75.9.4467-4472.2001; Wolff B, 1997, CHEM BIOL, V4, P139, DOI 10.1016/S1074-5521(97)90257-X; Zatsepina O, 1997, ONCOGENE, V14, P1137, DOI 10.1038/sj.onc.1200946	30	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2011	6	6							e21501	10.1371/journal.pone.0021501	http://dx.doi.org/10.1371/journal.pone.0021501			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786FZ	21738683	Green Published, gold, Green Submitted			2022-12-27	WOS:000292290100029
J	Gao, F; Zhang, RR				Gao, Feng; Zhang, Randy Ren			Enzymes Are Enriched in Bacterial Essential Genes	PLOS ONE			English	Article							TRANSPOSON MUTAGENESIS; STAPHYLOCOCCUS-AUREUS; BRUGIA-MALAYI; IDENTIFICATION; PREDICTION; PHENOTYPES; NETWORKS; DATABASE; MUTANTS; LIBRARY	Essential genes, those indispensable for the survival of an organism, play a key role in the emerging field, synthetic biology. Characterization of functions encoded by essential genes not only has important practical implications, such as in identifying antibiotic drug targets, but can also enhance our understanding of basic biology, such as functions needed to support cellular life. Enzymes are critical for almost all cellular activities. However, essential genes have not been systematically examined from the aspect of enzymes and the chemical reactions that they catalyze. Here, by comprehensively analyzing essential genes in 14 bacterial genomes in which large-scale gene essentiality screens have been performed, we found that enzymes are enriched in essential genes. Essential enzymes have overrepresented ligases ( especially those forming carbon-oxygen bonds and carbon-nitrogen bonds), nucleotidyltransferases and phosphotransferases, while have underrepresented oxidoreductases. Furthermore, essential enzymes tend to associate with more gene ontology domains. These results, from the aspect of chemical reactions, provide further insights into the understanding of functions needed to support natural cellular life, as well as synthetic cells, and provide additional parameters that can be integrated into gene essentiality prediction algorithms.	[Gao, Feng] Tianjin Univ, Dept Phys, Tianjin 300072, Peoples R China; [Zhang, Randy Ren] Wayne State Univ, Sch Med, Ctr Mol Med & Genet, Detroit, MI USA	Tianjin University; Wayne State University	Gao, F (corresponding author), Tianjin Univ, Dept Phys, Tianjin 300072, Peoples R China.	rzhang@med.wayne.edu	Gao, Feng/C-9913-2009	Gao, Feng/0000-0002-9563-3841	Wayne State University [176412]; National Natural Science Foundation of China [90408028, 30800642, 10747150]	Wayne State University; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The present work was supported in part by a fund (176412) from Wayne State University to RRZ, and by the National Natural Science Foundation of China (Grant Nos. 90408028, 30800642 and 10747150). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akerley BJ, 2002, P NATL ACAD SCI USA, V99, P966, DOI 10.1073/pnas.012602299; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Cameron NMD, 2009, NAT BIOTECHNOL, V27, P1103, DOI 10.1038/nbt1209-1103; Chaudhuri RR, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-291; Chen Y, 2005, BIOINFORMATICS, V21, P575, DOI 10.1093/bioinformatics/bti058; de Berardinis V, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.10; DENG J, 2010, NUCL ACIDS RES; Forsyth RA, 2002, MOL MICROBIOL, V43, P1387, DOI 10.1046/j.1365-2958.2002.02832.x; French CT, 2008, MOL MICROBIOL, V69, P67, DOI 10.1111/j.1365-2958.2008.06262.x; Gallagher LA, 2007, P NATL ACAD SCI USA, V104, P1009, DOI 10.1073/pnas.0606713104; Gerdes S, 2006, CURR OPIN BIOTECH, V17, P448, DOI 10.1016/j.copbio.2006.08.006; Gerdes SY, 2003, J BACTERIOL, V185, P5673, DOI 10.1128/JB.185.19.5673-5684.2003; Glass JI, 2006, P NATL ACAD SCI USA, V103, P425, DOI 10.1073/pnas.0510013103; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Gustafson AM, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-265; Henkel J, 2009, NAT BIOTECHNOL, V27, P1095, DOI 10.1038/nbt1209-1095; Holman AG, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-243; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Ji YD, 2001, SCIENCE, V293, P2266, DOI 10.1126/science.1063566; Jordan IK, 2002, GENOME RES, V12, P962, DOI 10.1101/gr.87702; Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896; Keseler IM, 2011, NUCLEIC ACIDS RES, V39, pD583, DOI 10.1093/nar/gkq1143; Knuth K, 2004, MOL MICROBIOL, V51, P1729, DOI 10.1046/j.1365-2958.2003.03944.x; Kobayashi K, 2003, P NATL ACAD SCI USA, V100, P4678, DOI 10.1073/pnas.0730515100; Koonin EV, 2000, ANNU REV GENOM HUM G, V1, P99, DOI 10.1146/annurev.genom.1.1.99; Kumar S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001189; Langridge GC, 2009, GENOME RES, V19, P2308, DOI 10.1101/gr.097097.109; Lartigue C, 2007, SCIENCE, V317, P632, DOI 10.1126/science.1144622; Liberati NT, 2006, P NATL ACAD SCI USA, V103, P2833, DOI 10.1073/pnas.0511100103; May M, 2009, NAT BIOTECHNOL, V27, P1112, DOI 10.1038/nbt1209-1112; Mushegian AR, 1996, P NATL ACAD SCI USA, V93, P10268, DOI 10.1073/pnas.93.19.10268; Pennisi E, 2010, SCIENCE, V328, P958, DOI 10.1126/science.328.5981.958; Rocha EPC, 2003, NAT GENET, V34, P377, DOI 10.1038/ng1209; Saha S, 2006, GENET MOL RES, V5, P224; Salama NR, 2004, J BACTERIOL, V186, P7926, DOI 10.1128/JB.186.23.7926-7935.2004; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; Seringhaus M, 2006, GENOME RES, V16, P1126, DOI 10.1101/gr.5144106; Soo K, 2006, J MICROBIOL BIOTECHN, V16, P623; Webb E. C., 1992, ENZYME NOMENCLATURE; Zhang R, 2004, NUCLEIC ACIDS RES, V32, pD271, DOI 10.1093/nar/gkh024; Zhang R, 2009, NUCLEIC ACIDS RES, V37, pD455, DOI 10.1093/nar/gkn858	43	13	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2011	6	6							e21683	10.1371/journal.pone.0021683	http://dx.doi.org/10.1371/journal.pone.0021683			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	784FW	21738765	gold, Green Submitted, Green Published			2022-12-27	WOS:000292142800059
J	Crooks, KR; Allingham, RR; Qin, XJ; Liu, YT; Gibson, JR; Santiago-Turla, C; Larocque-Abramson, KR; Del Bono, E; Challa, P; Herndon, LW; Akafo, S; Wiggs, JL; Schmidt, S; Hauser, MA				Crooks, Kristy R.; Allingham, R. Rand; Qin, Xuejun; Liu, Yutao; Gibson, Jason R.; Santiago-Turla, Cecilia; Larocque-Abramson, Karen R.; Del Bono, Elizabeth; Challa, Pratap; Herndon, Leon W.; Akafo, Stephen; Wiggs, Janey L.; Schmidt, Silke; Hauser, Michael A.			Genome-Wide Linkage Scan for Primary Open Angle Glaucoma: Influences of Ancestry and Age at Diagnosis	PLOS ONE			English	Article							ORDERED SUBSET ANALYSIS; GENETIC-LINKAGE; LOCUS; MAPS; REGION; IDENTIFICATION; DISEQUILIBRIUM; LOCALIZATION; MUTATIONS	Primary open-angle glaucoma (POAG) is the most common form of glaucoma and one of the leading causes of vision loss worldwide. The genetic etiology of POAG is complex and poorly understood. The purpose of this work is to identify genomic regions of interest linked to POAG. This study is the largest genetic linkage study of POAG performed to date: genomic DNA samples from 786 subjects (538 Caucasian ancestry, 248 African ancestry) were genotyped using either the Illumina GoldenGate Linkage 4 Panel or the Illumina Infinium Human Linkage-12 Panel. A total of 5233 SNPs was analyzed in 134 multiplex POAG families (89 Caucasian ancestry, 45 African ancestry). Parametric and non-parametric linkage analyses were performed on the overall dataset and within race-specific datasets (Caucasian ancestry and African ancestry). Ordered subset analysis was used to stratify the data on the basis of age of glaucoma diagnosis. Novel linkage regions were identified on chromosomes 1 and 20, and two previously described loci-GLC1D on chromosome 8 and GLC1I on chromosome 15-were replicated. These data will prove valuable in the context of interpreting results from genome-wide association studies for POAG.	[Crooks, Kristy R.; Allingham, R. Rand; Qin, Xuejun; Liu, Yutao; Gibson, Jason R.; Larocque-Abramson, Karen R.; Schmidt, Silke; Hauser, Michael A.] Duke Univ, Med Ctr, Ctr Human Genet, Durham, NC 27710 USA; [Allingham, R. Rand; Santiago-Turla, Cecilia; Challa, Pratap; Herndon, Leon W.; Hauser, Michael A.] Duke Univ, Med Ctr, Dept Ophthalmol, Ctr Eye, Durham, NC 27710 USA; [Del Bono, Elizabeth; Wiggs, Janey L.] Harvard Univ, Sch Med, Dept Ophthalmol, Boston, MA USA; [Del Bono, Elizabeth; Wiggs, Janey L.] Massachusetts Eye & Ear Infirm, Boston, MA 02114 USA; [Akafo, Stephen] Univ Ghana, Sch Med, Dept Surg, Unit Ophthalmol, Accra, Ghana	Duke University; Duke University; Harvard University; Harvard Medical School; Harvard University; Massachusetts Eye & Ear Infirmary; University of Ghana	Crooks, KR (corresponding author), Duke Univ, Med Ctr, Ctr Human Genet, Durham, NC 27710 USA.	mike.hauser@duke.edu			NCRR/NIH [1 UL1 RR024128-01]; NIH [R01EY013315, R01EY019126, RO1EY015543, R01EY015872, P30EY014104]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024128] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY013315, R01EY015872, R01EY015543, P30EY014104, R01EY019126] Funding Source: NIH RePORTER	NCRR/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This work was supported in part by a generous donation by Roger Milliken, Spartanburg, South Carolina and by the research infrastructure of the Duke Center for Human Genetics. This work was also supported by CTSA grant 1 UL1 RR024128-01 from NCRR/NIH, NIH grants R01EY013315 (MAH), R01EY019126 (MAH), RO1EY015543 (RRA), R01EY015872 (JLW), and P30EY014104 (Core support at the Massachusetts Eye and Ear Infirmary).	Abecasis GR, 2005, AM J HUM GENET, V77, P754, DOI 10.1086/497345; Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Allingham RR, 2009, EXP EYE RES, V88, P837, DOI 10.1016/j.exer.2008.11.003; Allingham RR, 2005, INVEST OPHTH VIS SCI, V46, P2002, DOI 10.1167/iovs.04-1477; Alward WLM, 1998, NEW ENGL J MED, V338, P1022, DOI 10.1056/NEJM199804093381503; Baird PN, 2005, HUM GENET, V117, P249, DOI 10.1007/s00439-005-1296-x; Boyles AL, 2005, HUM HERED, V59, P220, DOI 10.1159/000087122; Broman KW, 2001, GENET EPIDEMIOL, V20, P307, DOI 10.1002/gepi.2; Epstein MP, 2000, AM J HUM GENET, V67, P1219, DOI 10.1016/S0002-9297(07)62952-8; Friedman DS, 2004, ARCH OPHTHALMOL-CHIC, V122, P532; Hauser ER, 2004, GENET EPIDEMIOL, V27, P53, DOI 10.1002/gepi.20000; Kong A, 1997, AM J HUM GENET, V61, P1179, DOI 10.1086/301592; Kong X, 2004, AM J HUM GENET, V75, P1143, DOI 10.1086/426405; Lin Y, 2008, MOL VIS, V14, P739; Monemi S, 2005, HUM MOL GENET, V14, P725, DOI 10.1093/hmg/ddi068; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; Pang CP, 2006, MOL VIS, V12, P85; Quigley HA, 1996, BRIT J OPHTHALMOL, V80, P389, DOI 10.1136/bjo.80.5.389; Rezaie T, 2002, SCIENCE, V295, P1077, DOI 10.1126/science.1066901; Sarfarazi M, 1998, AM J HUM GENET, V62, P641, DOI 10.1086/301767; SHEFFIELD VC, 1993, NAT GENET, V4, P47, DOI 10.1038/ng0593-47; Stoilova D, 1996, GENOMICS, V36, P142, DOI 10.1006/geno.1996.0434; Stone EM, 1997, SCIENCE, V275, P668, DOI 10.1126/science.275.5300.668; Sud A, 2008, MOL VIS, V14, P1319; Suriyapperuma SP, 2007, ARCH OPHTHALMOL-CHIC, V125, P86, DOI 10.1001/archopht.125.1.86; Trifan OC, 1998, AM J OPHTHALMOL, V126, P17, DOI 10.1016/S0002-9394(98)00073-7; Wang DY, 2006, INVEST OPHTH VIS SCI, V47, P5315, DOI 10.1167/iovs.06-0179; Wiggs JL, 2004, AM J HUM GENET, V74, P1314, DOI 10.1086/421533; Wirtz MK, 1997, AM J HUM GENET, V60, P296; Wirtz MK, 1999, ARCH OPHTHALMOL-CHIC, V117, P237; Woodroffe A, 2006, EXP EYE RES, V82, P1068, DOI 10.1016/j.exer.2005.10.008	31	16	16	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2011	6	7							e21967	10.1371/journal.pone.0021967	http://dx.doi.org/10.1371/journal.pone.0021967			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791WM	21765929	Green Published, gold, Green Submitted			2022-12-27	WOS:000292699000017
J	Azevedo, AS; Yamamura, AMY; Freire, MS; Trindade, GF; Bonaldo, M; Galler, R; Alves, AMB				Azevedo, Adriana S.; Yamamura, Anna M. Y.; Freire, Marcos S.; Trindade, Gisela F.; Bonaldo, Myrna; Galler, Ricardo; Alves, Ada M. B.			DNA Vaccines against Dengue Virus Type 2 Based on Truncate Envelope Protein or Its Domain III	PLOS ONE			English	Article							NEUTRALIZING ANTIBODY-RESPONSE; JAPANESE ENCEPHALITIS; PROTECTIVE IMMUNITY; SIGNAL SEQUENCES; NS1 GENE; T-CELLS; MICE; CHALLENGE; IMMUNIZATION; FLAVIVIRUS	Two DNA vaccines were constructed encoding the ectodomain (domains I, II and III) of the DENV2 envelope protein (pE1D2) or only its domain III (pE2D2), fused to the human tissue plasminogen activator signal peptide (t-PA). The expression and secretion of recombinant proteins was confirmed in vitro in BHK cells transfected with the two plasmids, detected by immunofluorescence or immunoprecipitation of metabolically labeled gene products, using polyclonal and monoclonal antibodies against DENV2. Besides, results reveal that the ectodomain of the E protein can be efficiently expressed in vivo, in a mammalian system, without the prM protein that is hypothesized to act as a chaperonin during dengue infection. Balb/c mice were immunized with the DNA vaccines and challenged with a lethal dose of DENV2. All pE1D2-vaccinated mice survived challenge, while 45% of animals immunized with the pE2D2 died after infection. Furthermore, only 10% of pE1D2-immunized mice presented some clinical signs of infection after challenge, whereas most of animals inoculated with the pE2D2 showed effects of the disease with high morbidity degrees. Levels of neutralizing antibodies were significantly higher in pE1D2-vaccinated mice than in pE2D2-immunized animals, also suggesting that the pE1D2 vaccine was more protective than the pE2D2.	[Azevedo, Adriana S.; Alves, Ada M. B.] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Biotecnol & Fisiol Infeccoes Virais, Rio De Janeiro, Brazil; [Yamamura, Anna M. Y.; Freire, Marcos S.; Galler, Ricardo] Fundacao Oswaldo Cruz, Inst Tecnol Imunobiol, Lab Tecnol Virol, Rio De Janeiro, Brazil; [Trindade, Gisela F.; Bonaldo, Myrna] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Biol Mol Flavivirus, Rio De Janeiro, Brazil	Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz	Alves, AMB (corresponding author), Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Biotecnol & Fisiol Infeccoes Virais, Rio De Janeiro, Brazil.	ada@ioc.fiocruz.br	Bonaldo, Myrna/AAE-2799-2021; Bonaldo, Myrna C/D-9494-2013; Galler, Ricardo/B-3280-2014	Souza Azevedo, Adriana/0000-0001-7401-5107; Trindade, Gisela/0000-0002-1630-4143	PDTIS-FIOCRUZ; IOC-FIOCRUZ; FAPERJ; CNPq; CNPq-PRONEX	PDTIS-FIOCRUZ; IOC-FIOCRUZ; FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CNPq-PRONEX(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by PDTIS-FIOCRUZ, IOC-FIOCRUZ, FAPERJ, CNPq and CNPq-PRONEX grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison SL, 1999, J VIROL, V73, P5605, DOI 10.1128/JVI.73.7.5605-5612.1999; Ashok MS, 2002, VACCINE, V20, P1563, DOI 10.1016/S0264-410X(01)00492-3; BONALDO MC, 2007, J VIROL, V30, P115; Boyle JS, 1997, INT IMMUNOL, V9, P1897, DOI 10.1093/intimm/9.12.1897; Caufour PS, 2001, VIRUS RES, V79, P1, DOI 10.1016/S0168-1702(01)00273-8; Chambers TJ, 2003, J VIROL, V77, P3655, DOI 10.1128/JVI.77.6.3655-3668.2003; Chang GJJ, 2000, J VIROL, V74, P4244, DOI 10.1128/JVI.74.9.4244-4252.2000; Chang GJJ, 2001, ANN NY ACAD SCI, V951, P272; Chen L, 2007, J VIROL, V81, P11634, DOI 10.1128/JVI.00996-07; Clements DE, 2010, VACCINE, V28, P2705, DOI 10.1016/j.vaccine.2010.01.022; COELHO GE, 2010, SECRETARIA VIGILANCI; Colombage G, 1998, VIROLOGY, V250, P151, DOI 10.1006/viro.1998.9357; Costa SM, 2007, VIROLOGY, V358, P413, DOI 10.1016/j.virol.2006.08.052; Costa SM, 2006, VACCINE, V24, P4562, DOI 10.1016/j.vaccine.2005.08.022; Costa SM, 2006, VACCINE, V24, P195, DOI 10.1016/j.vaccine.2005.07.059; Davis BS, 2001, J VIROL, V75, P4040, DOI 10.1128/JVI.75.9.4040-4047.2001; De Paula SO, 2008, ARCH VIROL, V153, P2215, DOI 10.1007/s00705-008-0250-3; Dejnirattisai W, 2010, SCIENCE, V328, P745, DOI 10.1126/science.1185181; Edelman R, 2005, J INFECT DIS, V191, P650, DOI 10.1086/427784; Edelman R, 2007, CLIN INFECT DIS, V45, pS56, DOI 10.1086/518148; ERHARDT W, 1984, RES EXP MED, V184, P159, DOI 10.1007/BF01852390; Gubler DJ, 2002, ARCH MED RES, V33, P330, DOI 10.1016/S0188-4409(02)00378-8; Guzman MG, 2002, LANCET INFECT DIS, V2, P33, DOI 10.1016/S1473-3099(01)00171-2; HENCHAL EA, 1985, AM J TROP MED HYG, V34, P162, DOI 10.4269/ajtmh.1985.34.162; HENCHAL EA, 1982, AM J TROP MED HYG, V31, P830, DOI 10.4269/ajtmh.1982.31.830; Inchauspe G, 1997, DNA CELL BIOL, V16, P185, DOI 10.1089/dna.1997.16.185; IRIE K, 1989, GENE, V75, P197, DOI 10.1016/0378-1119(89)90266-7; Jaiswal S, 2004, PROTEIN EXPRES PURIF, V33, P80, DOI 10.1016/j.pep.2003.09.009; Jimenez RO, 2000, VACCINE, V19, P648, DOI 10.1016/S0264-410X(00)00247-4; Kinney RM, 2001, INTERVIROLOGY, V44, P176, DOI 10.1159/000050045; Kochel T, 1997, VACCINE, V15, P547, DOI 10.1016/S0264-410X(97)00215-6; Kochel TJ, 2000, VACCINE, V18, P3166, DOI 10.1016/S0264-410X(00)00105-5; Konishi E, 1999, J VIROL, V73, P5527, DOI 10.1128/JVI.73.7.5527-5534.1999; Konishi E, 2000, VACCINE, V18, P1133, DOI 10.1016/S0264-410X(99)00376-X; Kuhn RJ, 2002, CELL, V108, P717, DOI 10.1016/S0092-8674(02)00660-8; KURANE I, 1990, ARCH VIROL, V110, P91, DOI 10.1007/BF01310705; LINDENBACH BD, 2001, FIELDS VIROLOGY, P991; Lu Y, 2003, VACCINE, V21, P2178, DOI 10.1016/S0264-410X(03)00009-4; Miller N, 2010, CURR OPIN MOL THER, V12, P31; Modis Y, 2003, P NATL ACAD SCI USA, V100, P6986, DOI 10.1073/pnas.0832193100; MONATH TP, 1997, CLIN VIROLOGY, P1133; Mota J, 2005, VACCINE, V23, P3469, DOI 10.1016/j.vaccine.2004.12.028; Phillpotts RJ, 1996, ARCH VIROL, V141, P743, DOI 10.1007/BF01718332; Porter KR, 1998, ARCH VIROL, V143, P997, DOI 10.1007/s007050050348; Putnak R, 2003, AM J TROP MED HYG, V68, P469, DOI 10.4269/ajtmh.2003.68.469; Ramanathan MP, 2009, VACCINE, V27, P6444, DOI 10.1016/j.vaccine.2009.06.061; Raviprakash K, 2000, VACCINE, V18, P2426, DOI 10.1016/S0264-410X(99)00570-8; Raviprakash K, 2000, J GEN VIROL, V81, P1659, DOI 10.1099/0022-1317-81-7-1659; Raviprakash K, 2001, VIROLOGY, V290, P74, DOI 10.1006/viro.2001.1136; Nogueira RMR, 2007, REV PANAM SALUD PUBL, V22, P358, DOI 10.1590/S1020-49892007001000009; Roehrig JT, 1998, VIROLOGY, V246, P317, DOI 10.1006/viro.1998.9200; Shrestha B, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000823; Simmons M, 2001, AM J TROP MED HYG, V65, P420, DOI 10.4269/ajtmh.2001.65.420; Stefano I, 1999, VACCINE, V17, P1042, DOI 10.1016/S0264-410X(98)00320-X; Suksanpaisan L, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-17; Teixeira MG, 2009, CAD SAUDE PUBLICA, V25, pS7, DOI 10.1590/S0102-311X2009001300002; Valdes I, 2009, VIROLOGY, V394, P249, DOI 10.1016/j.virol.2009.08.029; Van Der Most RG, 2000, J VIROL, V74, P8094, DOI 10.1128/JVI.74.17.8094-8101.2000; van der Most RG, 2003, INT IMMUNOL, V15, P119, DOI 10.1093/intimm/dxg009; Wahala WMPB, 2009, VIROLOGY, V392, P103, DOI 10.1016/j.virol.2009.06.037; Whitehead SS, 2007, NAT REV MICROBIOL, V5, P518, DOI 10.1038/nrmicro1690; Yauch LE, 2010, J IMMUNOL, V185, P5405, DOI 10.4049/jimmunol.1001709	62	35	38	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2011	6	7							e20528	10.1371/journal.pone.0020528	http://dx.doi.org/10.1371/journal.pone.0020528			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791QY	21779317	Green Submitted, Green Published, gold			2022-12-27	WOS:000292680900001
J	Lumsden, JM; Schwenk, RJ; Rein, LE; Moris, P; Janssens, M; Ofori-Anyinam, O; Cohen, J; Kester, KE; Heppner, DG; Krzych, U				Lumsden, Joanne M.; Schwenk, Robert J.; Rein, Lisa E.; Moris, Philippe; Janssens, Michel; Ofori-Anyinam, Opokua; Cohen, Joe; Kester, Kent E.; Heppner, D. Gray; Krzych, Urszula			Protective Immunity Induced with the RTS,S/AS Vaccine Is Associated with IL-2 and TNF-alpha Producing Effector and Central Memory CD4(+) T Cells	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM; MALARIA VACCINE; DOUBLE-BLIND; IFN-GAMMA; LYMPHOCYTES; PROTEIN; EFFICACY; SAFETY; PHASE; TRIAL	A phase 2a RTS,S/AS malaria vaccine trial, conducted previously at the Walter Reed Army Institute of Research, conferred sterile immunity against a primary challenge with infectious sporozoites in 40% of the 80 subjects enrolled in the study. The frequency of Plasmodium falciparum circumsporozoite protein (CSP)-specific CD4(+) T cells was significantly higher in protected subjects as compared to non-protected subjects. Intrigued by these unique vaccine-related correlates of protection, in the present study we asked whether RTS,S also induced effector/effector memory (T-E/EM) and/or central memory (T-CM) CD4(+) T cells and whether one or both of these sub-populations is the primary source of cytokine production. We showed for the first time that PBMC from malaria-non-exposed RTS,S-immunized subjects contain both T-E/EM and T-CM cells that generate strong IL-2 responses following re-stimulation in vitro with CSP peptides. Moreover, both the frequencies and the total numbers of IL-2-producing CD4(+) T-E/EM cells and of CD4(+) T-CM cells from protected subjects were significantly higher than those from non-protected subjects. We also demonstrated for the first time that there is a strong association between the frequency of CSP peptide-reactive CD4(+) T cells producing IL-2 and the titers of CSP-specific antibodies in the same individual, suggesting that IL-2 may be acting as a growth factor for follicular Th cells and/or B cells. The frequencies of CSP peptide-reactive, TNF-alpha-producing CD4(+) T-E/EM cells and of CD4(+) T-E/EM cells secreting both IL-2 and TNF-alpha were also shown to be higher in protected vs. non-protected individuals. We have, therefore, demonstrated that in addition to TNF-alpha, IL-2 is also a significant contributing factor to RTS,S/AS vaccine induced immunity and that both T-E/EM and T-CM cells are major producers of IL-2.	[Lumsden, Joanne M.; Schwenk, Robert J.; Rein, Lisa E.; Kester, Kent E.; Heppner, D. Gray; Krzych, Urszula] Walter Reed Army Inst Res, Div Malaria Vaccine Dev, Silver Spring, MD 20910 USA; [Moris, Philippe; Janssens, Michel; Ofori-Anyinam, Opokua; Cohen, Joe] GlaxoSmithKline Biol, Rixensart, Belgium	United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); GlaxoSmithKline	Lumsden, JM (corresponding author), Walter Reed Army Inst Res, Div Malaria Vaccine Dev, Silver Spring, MD 20910 USA.	Urszula.Krzych@amedd.army.mil	Kester, Kent/AAF-8235-2020	Kester, Kent/0000-0002-5056-0802; Lumsden, Joanne/0000-0002-0730-9946	United States Army Medical Materiel Development Activity; Military Infectious Diseases Research Program (Fort Detrick, Maryland; GlaxoSmithKline Biologicals (Rixensart, Belgium)	United States Army Medical Materiel Development Activity; Military Infectious Diseases Research Program (Fort Detrick, Maryland; GlaxoSmithKline Biologicals (Rixensart, Belgium)(GlaxoSmithKline)	The project was funded by the United States Army Medical Materiel Development Activity, the Military Infectious Diseases Research Program (Fort Detrick, Maryland) and GlaxoSmithKline Biologicals (Rixensart, Belgium). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso PL, 2004, LANCET, V364, P1411, DOI 10.1016/S0140-6736(04)17223-1; Aponte JJ, 2007, LANCET, V370, P1543, DOI 10.1016/S0140-6736(07)61542-6; BALLOU WR, 1987, LANCET, V1, P1277; Batista FD, 2009, NAT REV IMMUNOL, V9, P15, DOI 10.1038/nri2454; Darrah PA, 2007, NAT MED, V13, P843, DOI 10.1038/nm1592; DEPINAY N, PLOS ONE, V6; Divekar AA, 2006, J IMMUNOL, V176, P1465, DOI 10.4049/jimmunol.176.3.1465; Doolan DL, 2006, CURR MOL MED, V6, P169, DOI 10.2174/156652406776055249; FOLENAWASSERMAN G, 1987, J CHROMATOGR, V411, P345, DOI 10.1016/S0021-9673(00)93985-2; Galli G, 2009, P NATL ACAD SCI USA, V106, P3877, DOI 10.1073/pnas.0813390106; Garcon Nathalie, 2003, Expert Rev Vaccines, V2, P231, DOI 10.1586/14760584.2.2.231; Harari A, 2005, J IMMUNOL, V174, P1037, DOI 10.4049/jimmunol.174.2.1037; Huaman MC, 2009, VACCINE, V27, P5239, DOI 10.1016/j.vaccine.2009.06.066; Kannanganat S, 2007, J VIROL, V81, P8468, DOI 10.1128/JVI.00228-07; Keating SM, 2005, J IMMUNOL, V175, P5675, DOI 10.4049/jimmunol.175.9.5675; Kester KE, 2009, J INFECT DIS, V200, P337, DOI 10.1086/600120; Korten S, 2005, INFECT IMMUN, V73, P849, DOI 10.1128/IAI.73.2.849-858.2005; Litjens NHR, 2008, J IMMUNOL, V181, P3665, DOI 10.4049/jimmunol.181.5.3665; MacLeod MKL, 2009, SEMIN IMMUNOL, V21, P53, DOI 10.1016/j.smim.2009.02.006; MAZIER D, 1990, IMMUNOL LETT, V25, P65, DOI 10.1016/0165-2478(90)90093-6; Miller JD, 2008, IMMUNITY, V28, P710, DOI 10.1016/j.immuni.2008.02.020; PARKER DC, 1993, ANNU REV IMMUNOL, V11, P331, DOI 10.1146/annurev.iy.11.040193.001555; Romero P, 2007, J IMMUNOL, V178, P4112, DOI 10.4049/jimmunol.178.7.4112; Sacarlal J, 2009, J INFECT DIS, V200, P329, DOI 10.1086/600119; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Seder RA, 2008, NAT REV IMMUNOL, V8, P247, DOI 10.1038/nri2274; Stubbe M, 2006, J IMMUNOL, V177, P8185, DOI 10.4049/jimmunol.177.11.8185; Sun PF, 2003, J IMMUNOL, V171, P6961, DOI 10.4049/jimmunol.171.12.6961; Sun Y, 2005, J IMMUNOL, V174, P4753, DOI 10.4049/jimmunol.174.8.4753; van Leeuwen EMM, 2009, CURR OPIN IMMUNOL, V21, P167, DOI 10.1016/j.coi.2009.02.005; WIRTZ RA, 1987, EXP PARASITOL, V63, P166, DOI 10.1016/0014-4894(87)90158-5	31	69	71	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2011	6	7							e20775	10.1371/journal.pone.0020775	http://dx.doi.org/10.1371/journal.pone.0020775			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791QY	21779319	gold, Green Submitted, Green Published			2022-12-27	WOS:000292680900002
J	Sparks, LM; Moro, C; Ukropcova, B; Bajpeyi, S; Civitarese, AE; Hulver, MW; Thoresen, GH; Rustan, AC; Smith, SR				Sparks, Lauren M.; Moro, Cedric; Ukropcova, Barbara; Bajpeyi, Sudip; Civitarese, Anthony E.; Hulver, Matthew W.; Thoresen, G. Hege; Rustan, Arild C.; Smith, Steven R.			Remodeling Lipid Metabolism and Improving Insulin Responsiveness in Human Primary Myotubes	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; HORMONE-SENSITIVE LIPASE; INDUCED MITOCHONDRIAL BIOGENESIS; ADIPOSE TRIGLYCERIDE LIPASE; MUSCLE GLYCOGEN-SYNTHESIS; HUMAN SKELETAL-MUSCLE; FATTY-ACID OXIDATION; GENE-EXPRESSION; EXERCISE; RESISTANCE	Objective: Disturbances in lipid metabolism are strongly associated with insulin resistance and type 2 diabetes (T2D). We hypothesized that activation of cAMP/PKA and calcium signaling pathways in cultured human myotubes would provide further insight into regulation of lipid storage, lipolysis, lipid oxidation and insulin responsiveness. Methods: Human myoblasts were isolated from vastus lateralis, purified, cultured and differentiated into myotubes. All cells were incubated with palmitate during differentiation. Treatment cells were pulsed 1 hour each day with forskolin and ionomycin (PFI) during the final 3 days of differentiation to activate the cAMP/PKA and calcium signaling pathways. Control cells were not pulsed (control). Mitochondrial content, C-14 lipid oxidation and storage were measured, as well as lipolysis and insulin-stimulated glycogen storage. Myotubes were stained for lipids and gene expression measured. Results: PFI increased oxidation of oleate and palmitate to CO2 (p < 0.001), isoproterenol-stimulated lipolysis (p = 0.01), triacylglycerol (TAG) storage (p < 0.05) and mitochondrial DNA copy number (p = 0.01) and related enzyme activities. Candidate gene and microarray analysis revealed increased expression of genes involved in lipolysis, TAG synthesis and mitochondrial biogenesis. PFI increased the organization of lipid droplets along the myofibrillar apparatus. These changes in lipid metabolism were associated with an increase in insulin-mediated glycogen storage (p < 0.001). Conclusions: Activation of cAMP/PKA and calcium signaling pathways in myotubes induces a remodeling of lipid droplets and functional changes in lipid metabolism. These results provide a novel pharmacological approach to promote lipid metabolism and improve insulin responsiveness in myotubes, which may be of therapeutic importance for obesity and type 2 diabetes.	[Sparks, Lauren M.; Moro, Cedric; Bajpeyi, Sudip; Smith, Steven R.] Pennington Biomed Res Ctr, Mol & Expt Endocrinol Lab, Baton Rouge, LA USA; [Ukropcova, Barbara] Slovak Acad Sci, Inst Expt Endocrinol, Diabet Lab, Bratislava, Slovakia; [Civitarese, Anthony E.] Arizona State Univ, Dept Metab Physiol, Phoenix, AZ USA; [Hulver, Matthew W.] Virginia Polytech Inst & State Univ, Dept Human Nutr Food & Exercise, Blacksburg, VA 24061 USA; [Thoresen, G. Hege; Rustan, Arild C.] Univ Oslo, Sch Pharm, Dept Pharmaceut Biosci, Oslo, Norway	Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center; Slovak Academy of Sciences; Arizona State University; Arizona State University-Downtown Phoenix; Virginia Polytechnic Institute & State University; University of Oslo	Sparks, LM (corresponding author), Maastricht Univ, Dept Human Biol, Nutr & Toxicol Res Inst Maastricht NUTRIM, Maastricht, Netherlands.	steven.r.smith.md@flhosp.org	Smith, Steven/HDM-9496-2022; Ukropcova, Barbara/ABE-6186-2020; Moro, Cedric/N-5754-2017; Ukropcova, Barbara/E-7644-2018	Ukropcova, Barbara/0000-0002-3309-7713; Bajpeyi, Sudip/0000-0002-5336-8330; Moro, Cedric/0000-0003-4294-0597; Smith, Steven/0000-0002-5098-8147; Sparks, Lauren/0000-0002-9257-5666	Health and Performance Enhancement Division of the Pennington Biomedical Research Center PBRC [011-61-0114]; PBRC CNRU [P30-DK072476]; USDA [2003-34323-14010];  [R01AG030226]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK072476] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG030226] Funding Source: NIH RePORTER	Health and Performance Enhancement Division of the Pennington Biomedical Research Center PBRC; PBRC CNRU; USDA(United States Department of Agriculture (USDA)); ; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The study was supported in part by a pilot and feasibility grant (BU) from the Health and Performance Enhancement Division of the Pennington Biomedical Research Center PBRC 011-61-0114, and by grants from PBRC CNRU P30-DK072476, USDA 2003-34323-14010 and R01AG030226 (SRS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsted TJ, 2009, AM J PHYSIOL-ENDOC M, V296, pE445, DOI 10.1152/ajpendo.90912.2008; Baar K, 2004, P NUTR SOC, V63, P269, DOI 10.1079/PNS2004334; Baar K, 2002, FASEB J, V16, P1879, DOI 10.1096/fj.02-0367com; Belfort R, 2005, DIABETES, V54, P1640, DOI 10.2337/diabetes.54.6.1640; Bogacka I, 2005, DIABETES, V54, P1392, DOI 10.2337/diabetes.54.5.1392; Boschmann M, 2010, J CLIN ENDOCR METAB, V95, P1634, DOI 10.1210/jc.2009-1293; Civitarese AE, 2006, CELL METAB, V4, P75, DOI 10.1016/j.cmet.2006.05.002; Cline GW, 1999, NEW ENGL J MED, V341, P240, DOI 10.1056/NEJM199907223410404; COSTFORD SR, 2009, AM J PHYSL ENDOCRINO; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Fediuc S, 2006, J LIPID RES, V47, P412, DOI 10.1194/jlr.M500438-JLR200; Gaster M, 2005, DIABETES, V54, P648, DOI 10.2337/diabetes.54.3.648; Goodpaster BH, 2001, J CLIN ENDOCR METAB, V86, P5755, DOI 10.1210/jc.86.12.5755; Goodpaster Bret H, 2002, Curr Diab Rep, V2, P216, DOI 10.1007/s11892-002-0086-2; Hebert TL, 2009, J TISSUE ENG REGEN M, V3, P553, DOI 10.1002/term.198; Hood DA, 2001, J APPL PHYSIOL, V90, P1137, DOI 10.1152/jappl.2001.90.3.1137; Hsieh K, 2004, PLANT PHYSIOL, V136, P3427, DOI 10.1104/pp.104.051060; Hulver MW, 2005, CELL METAB, V2, P251, DOI 10.1016/j.cmet.2005.09.002; Ikeo K, 2003, CR BIOL, V326, P1079, DOI 10.1016/j.crvi.2003.09.034; Itani SI, 2002, DIABETES, V51, P2005, DOI 10.2337/diabetes.51.7.2005; Kelley DE, 2001, DIABETES CARE, V24, P933, DOI 10.2337/diacare.24.5.933; Kelley DE, 2002, ANNU REV NUTR, V22, P325, DOI 10.1146/annurev.nutr.22.010402.102912; Kiens B, 2006, PHYSIOL REV, V86, P205, DOI 10.1152/physrev.00023.2004; Koves TR, 2008, CELL METAB, V7, P45, DOI 10.1016/j.cmet.2007.10.013; Langfort J, 2000, BIOCHEM J, V351, P207, DOI 10.1042/0264-6021:3510207; Langfort J, 1999, BIOCHEM J, V340, P459, DOI 10.1042/0264-6021:3400459; Lass A, 2006, CELL METAB, V3, P309, DOI 10.1016/j.cmet.2006.03.005; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; Liu L, 2007, J CLIN INVEST, V117, P1679, DOI 10.1172/JCI30565; Mairal A, 2006, DIABETOLOGIA, V49, P1629, DOI 10.1007/s00125-006-0272-x; Ohsaki Y, 2005, HISTOCHEM CELL BIOL, V124, P445, DOI 10.1007/s00418-005-0061-5; Perseghin G, 1999, DIABETES, V48, P1600, DOI 10.2337/diabetes.48.8.1600; Petersen KF, 2002, AM J CARDIOL, V90, p11G; Petersen KF, 2007, P NATL ACAD SCI USA, V104, P12587, DOI 10.1073/pnas.0705408104; Prats C, 2006, J LIPID RES, V47, P2392, DOI 10.1194/jlr.M600247-JLR200; Roden M, 2005, INT J OBESITY, V29, pS111, DOI 10.1038/sj.ijo.0803102; Savage DB, 2005, HYPERTENSION, V45, P828, DOI 10.1161/01.HYP.0000163475.04421.e4; Schenk S, 2007, J CLIN INVEST, V117, P1690, DOI 10.1172/JCI30566; Shulman GI, 2000, J CLIN INVEST, V106, P171, DOI 10.1172/JCI10583; SHULMAN GI, 1990, NEW ENGL J MED, V322, P223, DOI 10.1056/NEJM199001253220403; Sparks LM, 2005, DIABETES, V54, P1926, DOI 10.2337/diabetes.54.7.1926; Tarnopolsky MA, 2007, AM J PHYSIOL-REG I, V292, pR1271, DOI 10.1152/ajpregu.00472.2006; Ukropcova B, 2005, J CLIN INVEST, V115, P1934, DOI 10.1172/JCI24332; Votruba SB, 2003, OBES RES, V11, P1509, DOI 10.1038/oby.2003.202; Wang YX, 2004, PLOS BIOL, V2, P1532, DOI 10.1371/journal.pbio.0020294; Watt MJ, 2006, J PHYSIOL-LONDON, V574, P139, DOI 10.1113/jphysiol.2006.107318; Watt MJ, 2003, J PHYSIOL-LONDON, V547, P301, DOI 10.1113/jphysiol.2002.034595; Wright DC, 2007, J BIOL CHEM, V282, P18793, DOI 10.1074/jbc.M611252200; Wright DC, 2007, J BIOL CHEM, V282, P194, DOI 10.1074/jbc.M606116200; Zimmermann R, 2004, SCIENCE, V306, P1383, DOI 10.1126/science.1100747	50	42	42	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2011	6	7							e21068	10.1371/journal.pone.0021068	http://dx.doi.org/10.1371/journal.pone.0021068			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791IA	21760887	Green Published, gold, Green Submitted			2022-12-27	WOS:000292657200006
J	Schiff, M; Benoist, JF; Aissaoui, S; Boepsflug-Tanguy, O; Mouren, MC; de Baulny, HO; Delorme, R				Schiff, Manuel; Benoist, Jean-Francois; Aissaoui, Sofiane; Boepsflug-Tanguy, Odile; Mouren, Marie-Christine; de Baulny, Helene Ogier; Delorme, Richard			Should Metabolic Diseases Be Systematically Screened in Nonsyndromic Autism Spectrum Disorders?	PLOS ONE			English	Article							SANFILIPPO-SYNDROME; MENTAL-RETARDATION; CLINICAL SPECTRUM; NATURAL-HISTORY; DEFICIENCY; CHILDREN; PHENYLKETONURIA; DYSFUNCTION; PREVALENCE; GENETICS	Background: In the investigation of autism spectrum disorders (ASD), a genetic cause is found in approximately 10-20%. Among these cases, the prevalence of the rare inherited metabolic disorders (IMD) is unknown and poorly evaluated. An IMD responsible for ASD is usually identified by the associated clinical phenotype such as dysmorphic features, ataxia, microcephaly, epilepsy, and severe intellectual disability (ID). In rare cases, however, ASD may be considered as nonsyndromic at the onset of a related IMD. Objectives: To evaluate the utility of routine metabolic investigations in nonsyndromic ASD. Patients and Methods: We retrospectively analyzed the results of a metabolic workup (urinary mucopolysaccharides, urinary purines and pyrimidines, urinary creatine and guanidinoacetate, urinary organic acids, plasma and urinary amino acids) routinely performed in 274 nonsyndromic ASD children. Results: The metabolic parameters were in the normal range for all but 2 patients: one with unspecific creatine urinary excretion and the other with persistent 3-methylglutaconic aciduria. Conclusions: These data provide the largest ever reported cohort of ASD patients for whom a systematic metabolic workup has been performed; they suggest that such a routine metabolic screening does not contribute to the causative diagnosis of nonsyndromic ASD. They also emphasize that the prevalence of screened IMD in nonsyndromic ASD is probably not higher than in the general population (<0.5%). A careful clinical evaluation is probably more reasonable and of better medical practice than a costly systematic workup.	[Schiff, Manuel; Benoist, Jean-Francois; de Baulny, Helene Ogier] Hop Robert Debre, Reference Ctr Inherited Metab Dis, APHP, F-75019 Paris, France; [Schiff, Manuel; Boepsflug-Tanguy, Odile; de Baulny, Helene Ogier] Hop Robert Debre, Child Neurol & Metab Dis Dept, APHP, F-75019 Paris, France; [Schiff, Manuel; Benoist, Jean-Francois; Boepsflug-Tanguy, Odile] INSERM, U676, Paris, France; [Delorme, Richard] Inst Pasteur, Paris, France; [Aissaoui, Sofiane; Mouren, Marie-Christine; Delorme, Richard] Hop Robert Debre, Child Psychiat Dept, APHP, F-75019 Paris, France; [Schiff, Manuel; Boepsflug-Tanguy, Odile; Mouren, Marie-Christine; de Baulny, Helene Ogier; Delorme, Richard] Univ Paris 07, IFR02, Fac Med Denis Diderot, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Schiff, M (corresponding author), Hop Robert Debre, Reference Ctr Inherited Metab Dis, APHP, F-75019 Paris, France.	manuel.schiff@rdb.aphp.fr	Schiff, Manuel/G-3596-2017	Schiff, Manuel/0000-0001-8272-232X; benoist, jean-francois/0000-0002-5389-8585; Delorme, Richard/0000-0002-5614-3663				Abrahams BS, 2008, NAT REV GENET, V9, P341, DOI 10.1038/nrg2346; Arias A, 2007, CLIN BIOCHEM, V40, P1328, DOI 10.1016/j.clinbiochem.2007.07.010; Baieli S, 2003, J AUTISM DEV DISORD, V33, P201, DOI 10.1023/A:1022999712639; Brockmann K, 2003, NEURORADIOLOGY, V45, P137, DOI 10.1007/s00234-002-0931-7; Casari G, 1998, CELL, V93, P973, DOI 10.1016/S0092-8674(00)81203-9; Cohen D, 2005, J AUTISM DEV DISORD, V35, P103, DOI 10.1007/s10803-004-1038-2; Damiano M, 2010, BBA-MOL BASIS DIS, V1802, P52, DOI 10.1016/j.bbadis.2009.07.012; Debray FG, 2007, PEDIATRICS, V119, P722, DOI 10.1542/peds.2006-1866; Filipek PA, 2000, NEUROLOGY, V55, P468, DOI 10.1212/WNL.55.4.468; Gorker I, 2005, J PSYCHIATR NEUROSCI, V30, P133; Haas RH, 2010, DEV DISABIL RES REV, V16, P144, DOI 10.1002/ddrr.112; HACKNEY IM, 1968, J PEDIATR-US, V72, P646, DOI 10.1016/S0022-3476(68)80007-1; Heron B, 2011, AM J MED GENET A, V155A, P58, DOI 10.1002/ajmg.a.33779; Jabourian A, 2011, ANN MED-PSYCHOL, V160, P421; Jurecka A, 2009, J INHERIT METAB DIS, V32, P247, DOI 10.1007/s10545-009-1094-z; Kayser MA, 2008, SEMIN PEDIATR NEUROL, V15, P127, DOI 10.1016/j.spen.2008.05.006; Kosinovsky B, 2005, J NEURAL TRANSM, V112, P587, DOI 10.1007/s00702-004-0198-8; Levy SE, 2009, LANCET, V374, P1627, DOI 10.1016/S0140-6736(09)61376-3; LONGO N, 2011, AM J MED GENET C; Manzi B, 2008, J CHILD NEUROL, V23, P307, DOI 10.1177/0883073807308698; Mochel F, 2011, J CLIN INVEST, V121, P493, DOI 10.1172/JCI45691; Moreira PI, 2010, BBA-MOL BASIS DIS, V1802, P212, DOI 10.1016/j.bbadis.2009.10.007; MUDD SH, 1985, AM J HUM GENET, V37, P1; NIDIFFER FD, 1983, J MENT DEFIC RES, V27, P185; Oliveira G, 2005, DEV MED CHILD NEUROL, V47, P185, DOI 10.1017/S0012162205000332; Pearl PL, 2003, NEUROLOGY, V60, P1413, DOI 10.1212/01.WNL.0000059549.70717.80; Rosenberg EH, 2007, HUM MUTAT, V28, P890, DOI 10.1002/humu.20532; Rosenberg EH, 2004, AM J HUM GENET, V75, P97, DOI 10.1086/422102; Rossignol D.A., 2011, MOL PSYCHIAT; Salomons GS, 2003, J INHERIT METAB DIS, V26, P309, DOI 10.1023/A:1024405821638; Sanderson S, 2006, ARCH DIS CHILD, V91, P896, DOI 10.1136/adc.2005.091637; Schaefer GB, 2006, GENET MED, V8, P549, DOI 10.1097/01.gim.0000237789.98842.f1; Schiff M, 2010, ARCH PEDIATRIE, V17, P802, DOI 10.1016/S0929-693X(10)70119-6; Skuse DH, 2007, TRENDS GENET, V23, P387, DOI 10.1016/j.tig.2007.06.003; Smith W, 2005, CRIT CARE CLIN, V21, pS9, DOI 10.1016/j.ccc.2005.05.007; Spiegel EK, 2006, MOL GENET METAB, V89, P19, DOI 10.1016/j.ymgme.2006.04.018; State MW, 2010, NEURON, V68, P254, DOI 10.1016/j.neuron.2010.10.004; Steerneman P, 1997, J AUTISM DEV DISORD, V27, P177, DOI 10.1023/A:1025843908339; Stockler Sylvia, 2007, V46, P149; Touati G, 1997, ARCH DIS CHILD, V76, P16, DOI 10.1136/adc.76.1.16; Wang L, 2010, AUTISM RES, V3, P268, DOI 10.1002/aur.145; Weissman JR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003815; Wortmann S.B., 2010, J INHERIT METAB DIS; Zecavati N, 2009, CURR NEUROL NEUROSCI, V9, P129, DOI 10.1007/s11910-009-0021-x	44	32	32	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2011	6	7							e21932	10.1371/journal.pone.0021932	http://dx.doi.org/10.1371/journal.pone.0021932			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791HI	21760924	Green Submitted, gold, Green Published			2022-12-27	WOS:000292655400028
J	Stranneheim, H; Werne, B; Sherwood, E; Lundeberg, J				Stranneheim, Henrik; Werne, Beata; Sherwood, Ellen; Lundeberg, Joakim			Scalable Transcriptome Preparation for Massive Parallel Sequencing	PLOS ONE			English	Article								Background: The tremendous output of massive parallel sequencing technologies requires automated robust and scalable sample preparation methods to fully exploit the new sequence capacity. Methodology: In this study, a method for automated library preparation of RNA prior to massively parallel sequencing is presented. The automated protocol uses precipitation onto carboxylic acid paramagnetic beads for purification and size selection of both RNA and DNA. The automated sample preparation was compared to the standard manual sample preparation. Conclusion/Significance: The automated procedure was used to generate libraries for gene expression profiling on the Illumina HiSeq 2000 platform with the capacity of 12 samples per preparation with a significantly improved throughput compared to the standard manual preparation. The data analysis shows consistent gene expression profiles in terms of sensitivity and quantification of gene expression between the two library preparation methods.	[Stranneheim, Henrik; Werne, Beata; Lundeberg, Joakim] Royal Inst Technol KTH, Sch Biotechnol, Sci Life Lab, Div Gene Technol, Solna, Sweden; [Sherwood, Ellen] Stockholm Univ, Dept Biochem & Biophys, Sci Life Lab, Solna, Sweden	Royal Institute of Technology; Stockholm University	Stranneheim, H (corresponding author), Royal Inst Technol KTH, Sch Biotechnol, Sci Life Lab, Div Gene Technol, Solna, Sweden.	joakim.lundeberg@scilifelab.se			Swedish Research Council; SNISS; SciLifeLab; Knut & Alice Wallenberg Foundation; European Community [222913]	Swedish Research Council(Swedish Research CouncilEuropean Commission); SNISS; SciLifeLab; Knut & Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); European Community(European Commission)	This work was financially supported by the Swedish Research Council, SNISS, SciLifeLab, Knut & Alice Wallenberg Foundation, and European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement no. 222913. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auer PL, 2010, GENETICS, V185, P405, DOI 10.1534/genetics.110.114983; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Farias-Hesson E, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/617469; Fuller CW, 2009, NAT BIOTECHNOL, V27, P1013, DOI 10.1038/nbt.1585; Klevebring D, 2009, J BIOMED BIOTECHNOL, DOI 10.1155/2009/396808; Leek JT, 2010, NAT REV GENET, V11, P733, DOI 10.1038/nrg2825; Lennon NJ, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r15; Lundin S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010029; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Pettersson E, 2009, GENOMICS, V93, P105, DOI 10.1016/j.ygeno.2008.10.003; Ramskold D, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000598; Shendure J, 2008, NAT METHODS, V5, P585, DOI 10.1038/nmeth0708-585	13	17	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2011	6	7							e21910	10.1371/journal.pone.0021910	http://dx.doi.org/10.1371/journal.pone.0021910			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791HI	21760920	Green Published, gold, Green Submitted			2022-12-27	WOS:000292655400026
J	Wu, LJ; Xu, LR; Liao, JM; Chen, J; Liang, Y				Wu, Ling-Jia; Xu, Li-Rong; Liao, Jun-Ming; Chen, Jie; Liang, Yi			Both the C-Terminal Polylysine Region and the Farnesylation of K-RasB Are Important for Its Specific Interaction with Calmodulin	PLOS ONE			English	Article							GTP-BINDING; H-RAS; TARGET RECOGNITION; IDENTIFICATION; ACTIVATION; PROTEINS; PURIFICATION; CANCER; DOMAIN; RAB3A	Background: Ras protein, as one of intracellular signal switches, plays various roles in several cell activities such as differentiation and proliferation. There is considerable evidence showing that calmodulin (CaM) binds to K-RasB and dissociates K-RasB from membrane and that the inactivation of CaM is able to induce K-RasB activation. However, the mechanism for the interaction of CaM with K-RasB is not well understood. Methodology/Principal Findings: Here, by applying fluorescence spectroscopy and isothermal titration calorimetry, we have obtained thermodynamic parameters for the interaction between these two proteins and identified the important elements of K-RasB for its interaction with Ca2+/CaM. One K-RasB molecule interacts with one CaM molecule in a GTP dependent manner with moderate, micromolar affinity at physiological pH and physiologic ionic strength. Mutation in the polybasic domain of K-Ras decreases the binding affinity. By using a chimera in which the C-terminal polylysine region of K-RasB has been replaced with that of H-Ras and vice versa, we find that at physiological pH, H-Ras-(KKKKKK) and Ca2+/CaM formed a 1:1 complex with an equilibrium association constant around 10(5) M-1, whereas no binding reaction of K-RasB( DESGPC) with Ca2+/CaM is detected. Furthermore, the interaction of K-RasB with Ca2+/CaM is found to be enhanced by the farnesylation of K-RasB. Conclusions/Significance: We demonstrate that the polylysine region of K-RasB not only contributes importantly to the interaction of K-RasB with Ca2+/CaM, but also defines its isoform specific interaction with Ca2+/CaM. The farnesylation of K-RasB is also important for its specific interaction with Ca2+/CaM. Information obtained here can enhance our understanding of how CaM interacts with K-RasB in physiological environments.	[Wu, Ling-Jia; Xu, Li-Rong; Liao, Jun-Ming; Chen, Jie; Liang, Yi] Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan, Hubei, Peoples R China	Wuhan University	Wu, LJ (corresponding author), Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan, Hubei, Peoples R China.	liangyi@whu.edu.cn	Liang, Yi/V-1396-2017; Liao, Jun-Ming/G-3788-2012	Liang, Yi/0000-0002-7349-8300; 	National Key Basic Research Foundation of China [2006CB910301]; National Natural Science Foundation of China [30970599, 30770421]; Fundamental Research Funds for the Central Universities [1104006]	National Key Basic Research Foundation of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This study was supported by National Key Basic Research Foundation of China (http://www.most.gov.cn/, Grant no. 2006CB910301, YL), National Natural Science Foundation of China (http://www.nsfc.gov.cn/, Grant nos. 30970599 and 30770421, YL), and Fundamental Research Funds for the Central Universities (http://www.moe.edu.cn/, Grant no. 1104006, YL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham SJ, 2009, BIOCHEMISTRY-US, V48, P7575, DOI 10.1021/bi900769j; Alvarez-Moya B, 2010, ONCOGENE, V29, P5911, DOI 10.1038/onc.2010.298; Ashery U, 2006, TRAFFIC, V7, P1119, DOI 10.1111/j.1600-0854.2006.00459.x; BARBACID M, 1987, ANNU REV BIOCHEM, V56, P779, DOI 10.1146/annurev.bi.56.070187.004023; Beguin P, 2006, J MOL BIOL, V355, P34, DOI 10.1016/j.jmb.2005.10.013; Beguin P, 2005, BIOCHEM J, V390, P67, DOI 10.1042/BJ20050414; Beguin P, 2001, NATURE, V411, P701, DOI 10.1038/35079621; Bofill-Cardona E, 2000, J BIOL CHEM, V275, P32672, DOI 10.1074/jbc.M002780200; BORDIER C, 1981, J BIOL CHEM, V256, P1604; BOS JL, 1989, CANCER RES, V49, P4682; CRIVICI A, 1995, ANNU REV BIOPH BIOM, V24, P85, DOI 10.1146/annurev.bb.24.060195.000505; Downward J, 2003, NAT REV CANCER, V3, P11, DOI 10.1038/nrc969; Fancy DA, 1999, P NATL ACAD SCI USA, V96, P6020, DOI 10.1073/pnas.96.11.6020; Fischer R, 1996, J BIOL CHEM, V271, P25067, DOI 10.1074/jbc.271.41.25067; Fivaz M, 2005, J CELL BIOL, V170, P429, DOI 10.1083/jcb.200409157; GOPALAKRISHNA R, 1982, BIOCHEM BIOPH RES CO, V104, P830, DOI 10.1016/0006-291X(82)90712-4; Hancock JF, 2003, NAT REV MOL CELL BIO, V4, P373, DOI 10.1038/nrm1105; Hileman RE, 1998, BIOCHEMISTRY-US, V37, P15231, DOI 10.1021/bi980212x; Hoeflich KP, 2002, CELL, V108, P739, DOI 10.1016/S0092-8674(02)00682-7; Hoshino M, 2003, J CELL BIOL, V163, P1067, DOI 10.1083/jcb.200308070; Ikura M, 1996, TRENDS BIOCHEM SCI, V21, P14, DOI 10.1016/0968-0004(96)80879-6; JOHN J, 1990, BIOCHEMISTRY-US, V29, P6058, DOI 10.1021/bi00477a025; JOHNSON JD, 1983, BIOCHEM J, V211, P473, DOI 10.1042/bj2110473; KLEE CB, 1980, ANNU REV BIOCHEM, V49, P489, DOI 10.1146/annurev.bi.49.070180.002421; KUBONIWA H, 1995, NAT STRUCT BIOL, V2, P768, DOI 10.1038/nsb0995-768; Liang Y, 2003, J BIOL CHEM, V278, P30098, DOI 10.1074/jbc.M304050200; Liao JM, 2008, BBA-PROTEINS PROTEOM, V1784, P1560, DOI 10.1016/j.bbapap.2008.08.009; Lopez-Alcala C, 2008, J BIOL CHEM, V283, P10621, DOI 10.1074/jbc.M706238200; MAYER MP, 1993, GENE, V132, P41, DOI 10.1016/0378-1119(93)90512-2; Mo ZY, 2009, J BIOL CHEM, V284, P34648, DOI 10.1074/jbc.M109.058883; Moyers JS, 1997, J BIOL CHEM, V272, P11832, DOI 10.1074/jbc.272.18.11832; Omerovic J, 2007, CELL MOL LIFE SCI, V64, P2575, DOI 10.1007/s00018-007-7133-8; Park JB, 1997, J BIOL CHEM, V272, P20857, DOI 10.1074/jbc.272.33.20857; Park JB, 2002, BIOCHEM J, V362, P651, DOI 10.1042/0264-6021:3620651; Park JB, 1999, BIOCHEM BIOPH RES CO, V263, P765, DOI 10.1006/bbrc.1999.1463; Potenza N, 2005, EMBO REP, V6, P432, DOI 10.1038/sj.embor.7400397; Sidhu RS, 2005, BIOCHEM BIOPH RES CO, V336, P105, DOI 10.1016/j.bbrc.2005.08.053; Sidhu RS, 2003, BIOCHEM BIOPH RES CO, V304, P655, DOI 10.1016/S0006-291X(03)00635-1; van Holde K.E., 2006, PRINCIPLES PHYS BIOC, P91; Villalonga P, 2002, J BIOL CHEM, V277, P37929, DOI 10.1074/jbc.M202245200; Villalonga P, 2001, MOL CELL BIOL, V21, P7345, DOI 10.1128/MCB.21.21.7345-7354.2001; Wang KL, 1999, J BIOL CHEM, V274, P14525, DOI 10.1074/jbc.274.21.14525; Wang KL, 1997, J BIOL CHEM, V272, P16002, DOI 10.1074/jbc.272.25.16002; WEINSTEIN H, 1994, ANNU REV PHYSIOL, V56, P213, DOI 10.1146/annurev.ph.56.030194.001241; Wes PD, 1996, EMBO J, V15, P5839, DOI 10.1002/j.1460-2075.1996.tb00971.x; Wu N, 2006, J MOL BIOL, V364, P955, DOI 10.1016/j.jmb.2006.09.075; ZHANG M, 1995, NAT STRUCT BIOL, V2, P758, DOI 10.1038/nsb0995-758; Zhou YB, 2007, J BIOL CHEM, V282, P35005, DOI 10.1074/jbc.M707728200; Zhou YB, 2009, BIOPHYS J, V96, P2832, DOI 10.1016/j.bpj.2008.12.3941; Zhu HL, 2010, J BIOL CHEM, V285, P3592, DOI 10.1074/jbc.M109.035691	50	25	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2011	6	7							e21929	10.1371/journal.pone.0021929	http://dx.doi.org/10.1371/journal.pone.0021929			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	789JO	21750741	Green Published, gold, Green Submitted			2022-12-27	WOS:000292512000033
J	Coluzza, I				Coluzza, Ivan			A Coarse-Grained Approach to Protein Design: Learning from Design to Understand Folding	PLOS ONE			English	Article							MONTE-CARLO; STATE	Computational studies have given a great contribution in building our current understanding of the complex behavior of protein molecules; nevertheless, a complete characterization of their free energy landscape still represents a major challenge. Here, we introduce a new coarse-grained approach that allows for an extensive sampling of the conformational space of a large number of sequences. We explicitly discuss its application in protein design, and by studying four representative proteins, we show that the method generates sequences with a relatively smooth free energy surface directed towards the target structures.	Univ Vienna, Dept Phys, Vienna, Austria	University of Vienna	Coluzza, I (corresponding author), Univ Vienna, Dept Phys, Vienna, Austria.	ivan.coluzza@univie.ac.at	Coluzza, Ivan/I-4170-2015	Coluzza, Ivan/0000-0001-7728-6033	Austrian Science Foundation (FWF) within the SFB ViCoM [F 41]; Intra-European mobility grant [24496]	Austrian Science Foundation (FWF) within the SFB ViCoM(Austrian Science Fund (FWF)); Intra-European mobility grant	The author acknowledges financial supported by the Austrian Science Foundation (FWF) within the SFB ViCoM (F 41), and Intra-European mobility grant FP6 Project No.: 24496. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeln S, 2011, BIOPHYS J, V100, P693, DOI 10.1016/j.bpj.2010.11.088; ANFINSEN CB, 1973, SCIENCE, V181, P223, DOI 10.1126/science.181.4096.223; Banavar JR, 2009, P NATL ACAD SCI USA, V106, P6900, DOI 10.1073/pnas.0901429106; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Betancourt MR, 1999, PROTEIN SCI, V8, P361; BRYNGELSON JD, 1987, P NATL ACAD SCI USA, V84, P7524, DOI 10.1073/pnas.84.21.7524; Coluzza I, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.051917; Coluzza I, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.046703; Coluzza I, 2005, CHEMPHYSCHEM, V6, P1779, DOI 10.1002/cphc.200400629; Coluzza I, 2007, BIOPHYS J, V92, P1150, DOI 10.1529/biophysj.106.084236; CREIGHTON, 1992, PROTEINS; Das R, 2008, ANNU REV BIOCHEM, V77, P363, DOI 10.1146/annurev.biochem.77.062906.171838; Deutsch JM, 1996, PHYS REV LETT, V76, P323, DOI 10.1103/PhysRevLett.76.323; Dobson CM, 1998, ANGEW CHEM INT EDIT, V37, P868, DOI 10.1002/(SICI)1521-3773(19980420)37:7<868::AID-ANIE868>3.0.CO;2-H; Dolittle RF, 1989, PREDICTION PROTEIN S, P599; Dunker AK, 2002, ADV PROTEIN CHEM, V62, P25; Fersht A., 1999, STRUCTURE MECH PROTE, DOI 10.1142/10574; Fersht AR, 2002, CELL, V108, P573, DOI 10.1016/S0092-8674(02)00620-7; Frenkel D, 2004, P NATL ACAD SCI USA, V101, P17571, DOI 10.1073/pnas.0407950101; Frenkel D., 2000, UNDERSTANDING MOL SI; GO N, 1978, P NATL ACAD SCI USA, V75, P559, DOI 10.1073/pnas.75.2.559; GUTIN AM, 1993, J CHEM PHYS, V98, P8174, DOI 10.1063/1.464522; Hoang TX, 2006, P NATL ACAD SCI USA, V103, P6883, DOI 10.1073/pnas.0601824103; Hoang TX, 2004, P NATL ACAD SCI USA, V101, P7960, DOI 10.1073/pnas.0402525101; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Irback A, 2000, P NATL ACAD SCI USA, V97, P13614, DOI 10.1073/pnas.240245297; Karplus M, 2005, P NATL ACAD SCI USA, V102, P6679, DOI 10.1073/pnas.0408930102; Magee JE, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.207802; Maritan A, 2000, NATURE, V406, P287, DOI 10.1038/35018538; Mirny L, 2001, J MOL BIOL, V308, P123, DOI 10.1006/jmbi.2001.4602; Onuchic JN, 2004, CURR OPIN STRUC BIOL, V14, P70, DOI 10.1016/j.sbi.2004.01.009; Rothlisberger D, 2008, NATURE, V453, P190, DOI 10.1038/nature06879; Seno F, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.078102; SHAKHNOVICH EI, 1993, P NATL ACAD SCI USA, V90, P7195, DOI 10.1073/pnas.90.15.7195; Tozzini V, 2005, CURR OPIN STRUC BIOL, V15, P144, DOI 10.1016/j.sbi.2005.02.005; Vendruscolo M, 1997, J CHEM PHYS, V106, P2970, DOI 10.1063/1.473356; Wilke CO, 2005, BIOPHYS J, V89, P3714, DOI 10.1529/biophysj.105.062125	37	38	38	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2011	6	7							e20853	10.1371/journal.pone.0020853	http://dx.doi.org/10.1371/journal.pone.0020853			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786HC	21747930	Green Published, Green Submitted, gold			2022-12-27	WOS:000292293400005
J	O'Dwyer, L; Lamberton, F; Bokde, ALW; Ewers, M; Faluyi, YO; Tanner, C; Mazoyer, B; O'Neill, D; Bartley, M; Collins, DR; Coughlan, T; Prvulovic, D; Hampel, H				O'Dwyer, Laurence; Lamberton, Franck; Bokde, Arun L. W.; Ewers, Michael; Faluyi, Yetunde O.; Tanner, Colby; Mazoyer, Bernard; O'Neill, Des; Bartley, Mairead; Collins, D. Ronan; Coughlan, Tara; Prvulovic, David; Hampel, Harald			Multiple Indices of Diffusion Identifies White Matter Damage in Mild Cognitive Impairment and Alzheimer's Disease	PLOS ONE			English	Article							WALLERIAN DEGENERATION; VOXELWISE ANALYSIS; MYELIN BREAKDOWN; TRACT INTEGRITY; FIBER TRACTS; TENSOR; BRAIN; AGE; ABNORMALITIES; DEMENTIA	The study of multiple indices of diffusion, including axial (DA), radial (DR) and mean diffusion (MD), as well as fractional anisotropy (FA), enables WM damage in Alzheimer's disease (AD) to be assessed in detail. Here, tract-based spatial statistics (TBSS) were performed on scans of 40 healthy elders, 19 non-amnestic MCI (MCIna) subjects, 14 amnestic MCI (MCIa) subjects and 9 AD patients. Significantly higher DA was found in MCIna subjects compared to healthy elders in the right posterior cingulum/precuneus. Significantly higher DA was also found in MCIa subjects compared to healthy elders in the left prefrontal cortex, particularly in the forceps minor and uncinate fasciculus. In the MCIa versus MCIna comparison, significantly higher DA was found in large areas of the left prefrontal cortex. For AD patients, the overlap of FA and DR changes and the overlap of FA and MD changes were seen in temporal, parietal and frontal lobes, as well as the corpus callosum and fornix. Analysis of differences between the AD versus MCIna, and AD versus MCIa contrasts, highlighted regions that are increasingly compromised in more severe disease stages. Microstructural damage independent of gross tissue loss was widespread in later disease stages. Our findings suggest a scheme where WM damage begins in the core memory network of the temporal lobe, cingulum and prefrontal regions, and spreads beyond these regions in later stages. DA and MD indices were most sensitive at detecting early changes in MCIa.	[O'Dwyer, Laurence; Prvulovic, David; Hampel, Harald] Goethe Univ Frankfurt, Dept Psychiat Psychosomat Med & Psychotherapy, Frankfurt, Germany; [Lamberton, Franck; Mazoyer, Bernard] Univ Caen & Paris Descartes, Ctr Imaging Neurosci & Applicat Pathol, UMR 6232, CNRS,CEA, Paris, France; [Bokde, Arun L. W.] Trinity Coll Dublin, Cognit Syst Grp, Discipline Psychiat, Sch Med, Dublin, Ireland; [Bokde, Arun L. W.] Trinity Coll Dublin, Trinity Coll Inst Neurosci TCIN, Dublin, Ireland; [Ewers, Michael] Univ Calif San Francisco, Dept Radiol, VA Med Ctr, San Francisco, CA USA; [Faluyi, Yetunde O.] Addenbrookes Hosp, Liaison Psychiat Serv, Cambridge, England; [Faluyi, Yetunde O.] Cambridgeshire & Peterborough NHS Fdn Trust, Cambridge, England; [Tanner, Colby] Trinity Coll Dublin, Dept Zool, Dublin, Ireland; [Mazoyer, Bernard] Ctr Hosp Univ, Caen, France; [Mazoyer, Bernard] Inst Univ France, Paris, France; [O'Neill, Des; Bartley, Mairead; Collins, D. Ronan; Coughlan, Tara] Trinity Coll Dublin, Dept Med Gerontol, Dublin, Ireland	Goethe University Frankfurt; CEA; Centre National de la Recherche Scientifique (CNRS); Trinity College Dublin; Trinity College Dublin; University of California System; University of California San Francisco; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Trinity College Dublin; CHU de Caen NORMANDIE; Institut Universitaire de France; Trinity College Dublin	O'Dwyer, L (corresponding author), Goethe Univ Frankfurt, Dept Psychiat Psychosomat Med & Psychotherapy, Frankfurt, Germany.	larodwyer@gmail.com	Mazoyer, Bernard M/B-6303-2012; mazoyer, bernard m/A-5369-2009; Tanner, Colby/H-4653-2012; Lamberton, Franck/GRO-7517-2022; O'Dwyer, Laurence/J-1699-2012; O'Neill, Desmond/D-1486-2013	Mazoyer, Bernard M/0000-0003-0970-2837; mazoyer, bernard m/0000-0003-0970-2837; Bokde, Arun/0000-0003-0114-4914; collins, Ronan/0000-0003-0404-8266; Hampel, Harald/0000-0003-0894-8982; Lamberton, Franck/0000-0002-4655-4397; O'Neill, Desmond/0000-0002-5542-9897	Science Foundation Ireland (SFI) [08/IN.1/B1846]; School of Medicine, Goethe University, Frankfurt, Germany; LOEWE; Irish Research Council for Science Engineering and Technology (IRCSET)	Science Foundation Ireland (SFI)(Science Foundation Ireland); School of Medicine, Goethe University, Frankfurt, Germany; LOEWE; Irish Research Council for Science Engineering and Technology (IRCSET)(Irish Research Council for Science, Engineering and Technology)	This work was supported by the Science Foundation Ireland (SFI) investigator neuroimaging program award 08/IN.1/B1846 to H.H. and institutional research funds of the School of Medicine, Goethe University, Frankfurt, Germany to H.H. This work was also supported by the Neurodegeneration & Alzheimer's disease research grant of the LOEWE program "Neuronal Coordination Research Focus Frankfurt" (NeFF) to H.H. and D.P. C.J.T. was supported by a fellowship from the Irish Research Council for Science Engineering and Technology (IRCSET). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Cabronero J, 2010, BRAIN, V133, P529, DOI 10.1093/brain/awp257; AGOSTA F, 2010, WHITE MATTER DAMAGE; Assaf Y, 2008, J MOL NEUROSCI, V34, P51, DOI 10.1007/s12031-007-0029-0; Assal F, 2002, CURR OPIN NEUROL, V15, P445, DOI 10.1097/00019052-200208000-00007; Bartzokis G, 2004, J ALZHEIMERS DIS, V6, pS53; Bartzokis G, 2004, NEUROBIOL AGING, V25, P5, DOI 10.1016/j.neurobiolaging.2003.03.001; Bartzokis G., 2009, NEUROBIOL AGING; BASSER PJ, 1994, J MAGN RESON SER B, V103, P247, DOI 10.1006/jmrb.1994.1037; BEACH TG, 1989, GLIA, V2, P420, DOI 10.1002/glia.440020605; Beaulieu C, 1996, MAGNET RESON MED, V36, P627, DOI 10.1002/mrm.1910360419; Beaulieu C, 2009, DIFFUSION MRI: FROM QUANTITATIVE MEASUREMENT TO IN VIVO NEUROANATOMY, P105, DOI 10.1016/B978-0-12-374709-9.00006-7; Bosch B, 2010, NEUROBIOL AGING; BRAAK H, 1995, NEUROBIOL AGING, V16, P271, DOI 10.1016/0197-4580(95)00021-6; Braak H, 1996, ACTA NEUROPATHOL, V92, P197, DOI 10.1007/s004010050508; Braak H, 1997, NEUROBIOL AGING, V18, P351, DOI 10.1016/S0197-4580(97)00056-0; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Braak H, 2011, ACTA NEUROPATHOL, V121, P171, DOI 10.1007/s00401-010-0789-4; BRUN A, 1986, ANN NEUROL, V19, P253, DOI 10.1002/ana.410190306; Buckner RL, 2005, J NEUROSCI, V25, P7709, DOI 10.1523/JNEUROSCI.2177-05.2005; Burzynska AZ, 2010, NEUROIMAGE, V49, P2104, DOI 10.1016/j.neuroimage.2009.09.041; Cabeza R, 2004, J COGNITIVE NEUROSCI, V16, P1583, DOI 10.1162/0898929042568578; Ciccarelli O, 2006, BRAIN, V129, P1859, DOI 10.1093/brain/awl100; Damoiseaux JS, 2009, HUM BRAIN MAPP, V30, P1051, DOI 10.1002/hbm.20563; Davis SW, 2009, NEUROIMAGE, V46, P530, DOI 10.1016/j.neuroimage.2009.01.068; Douaud G, NEUROIMAGE IN PRESS; ENGLUND E, 1990, HISTOPATHOLOGY, V16, P433; Englund E, 1998, DEMENT GERIATR COGN, V9, P6, DOI 10.1159/000051183; FAZEKAS F, 1987, AM J ROENTGENOL, V149, P351, DOI 10.2214/ajr.149.2.351; Fellgiebel A, 2005, NEUROBIOL AGING, V26, P1193, DOI 10.1016/j.neurobiolaging.2004.11.006; Fellgiebel A, 2008, NEUROPSYCHOLOGIA, V46, P1698, DOI 10.1016/j.neuropsychologia.2007.12.010; Filippi M, 2001, NEUROLOGY, V56, P304, DOI 10.1212/WNL.56.3.304; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fouquet M, 2009, BRAIN, V132, P2058, DOI 10.1093/brain/awp132; Gold BT, 2010, NEUROIMAGE, V52, P1487, DOI 10.1016/j.neuroimage.2010.05.036; Hampel H, 2010, NAT REV DRUG DISCOV, V9, P560, DOI 10.1038/nrd3115; Huang J, 2007, AM J NEURORADIOL, V28, P1943, DOI 10.3174/ajnr.A0700; HYMAN BT, 1986, ANN NEUROL, V20, P472, DOI 10.1002/ana.410200406; Kantarci K, 2005, NEUROLOGY, V64, P902, DOI 10.1212/01.WNL.0000153076.46126.E9; Le Bihan D, 2003, NAT REV NEUROSCI, V4, P469, DOI 10.1038/nrn1119; Liu Y, 2009, NEUROBIOL AGING; Madden DJ, 2009, NEUROPSYCHOL REV, V19, P415, DOI 10.1007/s11065-009-9113-2; Maguire EA, 2001, PHILOS T R SOC B, V356, P1441, DOI 10.1098/rstb.2001.0944; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Medina D, 2006, NEUROBIOL AGING, V27, P663, DOI 10.1016/j.neurobiolaging.2005.03.026; MIRRA SS, 1991, NEUROLOGY, V41, P479, DOI 10.1212/WNL.41.4.479; MUFSON EJ, 1984, J COMP NEUROL, V225, P31, DOI 10.1002/cne.902250105; Nestor PJ, 2003, ANN NEUROL, V54, P343, DOI 10.1002/ana.10669; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Petersen RC, 2001, ARCH NEUROL-CHICAGO, V58, P1985, DOI 10.1001/archneur.58.12.1985; Petersen RC, 2004, J INTERN MED, V256, P183, DOI 10.1111/j.1365-2796.2004.01388.x; Pierpaoli C, 1996, RADIOLOGY, V201, P637, DOI 10.1148/radiology.201.3.8939209; Pruessmann KP, 1999, MAGNET RESON MED, V42, P952, DOI 10.1002/(SICI)1522-2594(199911)42:5<952::AID-MRM16>3.0.CO;2-S; Rovaris M, 2005, NEUROLOGY, V65, P1526, DOI 10.1212/01.wnl.0000184471.83948.e0; Salat DH, 2010, NEUROBIOL AGING, V31, P244, DOI 10.1016/j.neurobiolaging.2008.03.013; Seeley WW, 2009, NEURON, V62, P42, DOI 10.1016/j.neuron.2009.03.024; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; Sen PN, 2005, BIOPHYS J, V89, P2927, DOI 10.1529/biophysj.105.063016; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2007, NAT PROTOC, V2, P499, DOI 10.1038/nprot.2007.45; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Song SK, 2002, NEUROIMAGE, V17, P1429, DOI 10.1006/nimg.2002.1267; Song SK, 2005, NEUROIMAGE, V26, P132, DOI 10.1016/j.neuroimage.2005.01.028; Song SK, 2003, NEUROIMAGE, V20, P1714, DOI 10.1016/j.neuroimage.2003.07.005; Sotak CH, 2002, NMR BIOMED, V15, P561, DOI 10.1002/nbm.786; Stenset V, 2011, NEUROBIOL AGING, V32, P581, DOI 10.1016/j.neurobiolaging.2009.04.014; Stricker NH, 2009, NEUROIMAGE, V45, P10, DOI 10.1016/j.neuroimage.2008.11.027; Sun SW, 2006, MAGN RESON MED, V55, P302, DOI 10.1002/mrm.20774; Taoka T, 2006, AM J NEURORADIOL, V27, P1040; Teipel SJ, 2007, NEUROIMAGE, V34, P985, DOI 10.1016/j.neuroimage.2006.07.047; Thomalla G, 2005, J NEUROL NEUROSUR PS, V76, P266, DOI 10.1136/jnnp.2004.046375; Thomas B, 2005, BRAIN, V128, P2562, DOI 10.1093/brain/awh600; Vincent JL, 2006, J NEUROPHYSIOL, V96, P3517, DOI 10.1152/jn.00048.2006; Werring DJ, 1999, NEUROLOGY, V52, P1626, DOI 10.1212/WNL.52.8.1626; Xie S, 2006, NEUROLOGY, V66, P1845, DOI 10.1212/01.wnl.0000219625.77625.aa; Yasmin H, 2008, NEURORADIOLOGY, V50, P293, DOI 10.1007/s00234-007-0353-7; Zhang Y, 2007, NEUROLOGY, V68, P13, DOI 10.1212/01.wnl.0000250326.77323.01; ZHANG Y, 2008, NEUROBIOL AGING; Zhuang L, 2010, NEUROIMAGE, V53, P16, DOI 10.1016/j.neuroimage.2010.05.068; Zollinger LV, 2011, J MAGN RESON IMAGING, V33, P557, DOI 10.1002/jmri.22502	81	92	94	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2011	6	6							e21745	10.1371/journal.pone.0021745	http://dx.doi.org/10.1371/journal.pone.0021745			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786GP	21738785	gold, Green Published, Green Submitted			2022-12-27	WOS:000292291800037
J	Wu, DM; Qiu, YF; Gao, X; Yuan, XB; Zhai, QW				Wu, Dongmei; Qiu, Yifu; Gao, Xiang; Yuan, Xiao-Bing; Zhai, Qiwei			Overexpression of SIRT1 in Mouse Forebrain Impairs Lipid/Glucose Metabolism and Motor Function	PLOS ONE			English	Article							MITOCHONDRIAL-FUNCTION; INSULIN SENSITIVITY; ENERGY-METABOLISM; THYROID-HORMONE; MICE SHOW; DISEASE; PROTECTS; FAT; RESTRICTION; ACTIVATION	SIRT1 plays crucial roles in glucose and lipid metabolism, and has various functions in different tissues including brain. The brain-specific SIRT1 knockout mice display defects in somatotropic signaling, memory and synaptic plasticity. And the female mice without SIRT1 in POMC neuron are more sensitive to diet-induced obesity. Here we created transgenic mice overexpressing SIRT1 in striatum and hippocampus under the control of CaMKII alpha promoter. These mice, especially females, exhibited increased fat accumulation accompanied by significant upregulation of adipogenic genes in white adipose tissue. Glucose tolerance of the mice was also impaired with decreased Glut4 mRNA levels in muscle. Moreover, the SIRT1 overexpressing mice showed decreased energy expenditure, and concomitantly mitochondria-related genes were decreased in muscle. In addition, these mice showed unusual spontaneous physical activity pattern, decreased activity in open field and rotarod performance. Further studies demonstrated that SIRT1 deacetylated IRS-2, and upregulated phosphorylation level of IRS-2 and ERK1/2 in striatum. Meanwhile, the neurotransmitter signaling in striatum and the expression of endocrine hormones in hypothalamus and serum T3, T4 levels were altered. Taken together, our findings demonstrate that SIRT1 in forebrain regulates lipid/glucose metabolism and motor function.	[Wu, Dongmei; Qiu, Yifu; Zhai, Qiwei] Chinese Acad Sci, Key Lab Nutr & Metab, Inst Nutr Sci, Shanghai Inst Biol Sci,Grad Sch, Shanghai, Peoples R China; [Gao, Xiang] Nanjing Univ, Model Anim Res Ctr, Nanjing 210008, Peoples R China; [Yuan, Xiao-Bing] Chinese Acad Sci, Inst Neurosci, Shanghai, Peoples R China; [Yuan, Xiao-Bing] Chinese Acad Sci, State Key Lab Neurobiol, Shanghai Inst Biol Sci, Shanghai, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Nanjing University; Chinese Academy of Sciences; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Wu, DM (corresponding author), Chinese Acad Sci, Key Lab Nutr & Metab, Inst Nutr Sci, Shanghai Inst Biol Sci,Grad Sch, Shanghai, Peoples R China.	qwzhai@sibs.ac.cn		Yuan, Xiaobing/0000-0002-1632-8460; Zhai, Qiwei/0000-0002-9617-7403; Qiu, Yifu/0000-0001-5645-3189	National Natural Science Foundation of China [30825009, 30970619, 31030022, 81021002]; National Basic Research Program of China (973 Program) [2009CB918403, 2007CB914501, 2006CB503900]; Chinese Academy of Sciences [KSCX1-YW-02]; Director Foundation of Institute for Nutritional Sciences [20090101]; SA-SIBS	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 Program)(National Basic Research Program of China); Chinese Academy of Sciences(Chinese Academy of Sciences); Director Foundation of Institute for Nutritional Sciences; SA-SIBS	This study was supported by grants from the National Natural Science Foundation of China (30825009, 30970619, 31030022 and 81021002), the National Basic Research Program of China (973 Program, 2009CB918403, 2007CB914501 and 2006CB503900), the Chinese Academy of Sciences (KSCX1-YW-02), the Director Foundation of Institute for Nutritional Sciences (20090101), and the SA-SIBS Scholarship Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baile CA, 2000, ANNU REV NUTR, V20, P105, DOI 10.1146/annurev.nutr.20.1.105; Banks AS, 2008, CELL METAB, V8, P333, DOI 10.1016/j.cmet.2008.08.014; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Bence KK, 2006, NAT MED, V12, P917, DOI 10.1038/nm1435; BLOOM SR, 1987, BRIT MED J, V295, P288, DOI 10.1136/bmj.295.6593.288; Boily G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001759; Bordone L, 2006, PLOS BIOL, V4, P210, DOI 10.1371/journal.pbio.0040031; Bordone L, 2005, NAT REV MOL CELL BIO, V6, P298, DOI 10.1038/nrm1616; Bordone L, 2007, AGING CELL, V6, P759, DOI 10.1111/j.1474-9726.2007.00335.x; Chen D, 2008, GENE DEV, V22, P1753, DOI 10.1101/gad.1650608; Chen G, 2007, GLIA, V55, P1509, DOI 10.1002/glia.20563; Choksi NY, 2003, BIRTH DEFECTS RES B, V68, P479, DOI 10.1002/bdrb.10045; Cohen DE, 2009, GENE DEV, V23, P2812, DOI 10.1101/gad.1839209; da Costa VMC, 2001, J ENDOCRINOL, V171, P193, DOI 10.1677/joe.0.1710193; Dietrich MO, 2010, J NEUROSCI, V30, P11815, DOI 10.1523/JNEUROSCI.2234-10.2010; Donmez G, 2010, CELL, V142, P320, DOI 10.1016/j.cell.2010.06.020; Engel SR, 2009, MOL PSYCHIATR, V14, P448, DOI 10.1038/sj.mp.4002135; Freund TF, 2003, PHYSIOL REV, V83, P1017, DOI 10.1152/physrev.00004.2003; Fujita S, 2010, BRAIN RES, V1322, P30, DOI 10.1016/j.brainres.2010.01.068; Gan L, 2008, NEURON, V58, P10, DOI 10.1016/j.neuron.2008.03.015; Gao J, 2010, NATURE, V466, P1105, DOI 10.1038/nature09271; Gerfen CR, 2008, J NEUROSCI, V28, P7113, DOI 10.1523/JNEUROSCI.3952-07.2008; Gerhart-Hines Z, 2007, EMBO J, V26, P1913, DOI 10.1038/sj.emboj.7601633; Grillner S, 2005, TRENDS NEUROSCI, V28, P364, DOI 10.1016/j.tins.2005.05.004; Haigis MC, 2010, ANNU REV PATHOL-MECH, V5, P253, DOI 10.1146/annurev.pathol.4.110807.092250; Jin QH, 2010, CELL RES, V20, P470, DOI 10.1038/cr.2010.24; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; Kakefuda K, 2009, BIOCHEM BIOPH RES CO, V387, P784, DOI 10.1016/j.bbrc.2009.07.119; Kelley AE, 2005, PHYSIOL BEHAV, V86, P773, DOI 10.1016/j.physbeh.2005.08.066; Kim D, 2007, EMBO J, V26, P3169, DOI 10.1038/sj.emboj.7601758; Kreitzer AC, 2007, NATURE, V445, P643, DOI 10.1038/nature05506; LAFFAN EW, 1989, BEHAV NEURAL BIOL, V52, P411, DOI 10.1016/S0163-1047(89)90532-3; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Lanni A, 2003, FEBS LETT, V543, P5, DOI 10.1016/S0014-5793(03)00320-X; Li Y, 2008, CELL METAB, V8, P38, DOI 10.1016/j.cmet.2008.05.004; Liang FX, 2009, NAT REV ENDOCRINOL, V5, P367, DOI 10.1038/nrendo.2009.101; Lin JD, 2004, CELL, V119, P121, DOI 10.1016/j.cell.2004.09.013; Macotela Y, 2009, DIABETES, V58, P803, DOI 10.2337/db08-1054; Mayford M, 1996, SCIENCE, V274, P1678, DOI 10.1126/science.274.5293.1678; Michan S, 2010, J NEUROSCI, V30, P9695, DOI 10.1523/JNEUROSCI.0027-10.2010; Milne JC, 2007, NATURE, V450, P712, DOI 10.1038/nature06261; Moynihan KA, 2005, CELL METAB, V2, P105, DOI 10.1016/j.cmet.2005.07.001; Munzberg H, 2005, NAT NEUROSCI, V8, P566, DOI 10.1038/nn1454; Obregon MJ, 2008, THYROID, V18, P185, DOI 10.1089/thy.2007.0254; Pfluger PT, 2008, P NATL ACAD SCI USA, V105, P9793, DOI 10.1073/pnas.0802917105; Picard F, 2004, NATURE, V429, P771, DOI 10.1038/nature02583; PRESS M, 1988, DIABETES METAB REV, V4, P391, DOI 10.1002/dmr.5610040406; Purushotham A, 2009, CELL METAB, V9, P327, DOI 10.1016/j.cmet.2009.02.006; Qiu YF, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000514; Ramadori G, 2010, CELL METAB, V12, P78, DOI 10.1016/j.cmet.2010.05.010; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Rueda D, 2002, J BIOL CHEM, V277, P46645, DOI 10.1074/jbc.M206590200; Satoh A, 2010, J NEUROSCI, V30, P10220, DOI 10.1523/JNEUROSCI.1385-10.2010; Selcher JC, 2001, LEARN MEMORY, V8, P11, DOI 10.1101/lm.37001; Silva JE, 2006, PHYSIOL REV, V86, P435, DOI 10.1152/physrev.00009.2005; Sun C, 2007, CELL METAB, V6, P307, DOI 10.1016/j.cmet.2007.08.014; Thomas GM, 2004, NAT REV NEUROSCI, V5, P173, DOI 10.1038/nrn1346; Tontonoz P, 2008, ANNU REV BIOCHEM, V77, P289, DOI 10.1146/annurev.biochem.77.061307.091829; Yan TT, 2010, NEUROCHEM INT, V56, P101, DOI 10.1016/j.neuint.2009.09.007	59	19	21	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2011	6	6							e21759	10.1371/journal.pone.0021759	http://dx.doi.org/10.1371/journal.pone.0021759			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786GP	21738790	Green Submitted, Green Published, gold			2022-12-27	WOS:000292291800041
J	Kim, SH; Kim, UK; Lee, WS; Bok, J; Song, JW; Seong, JK; Choi, JY				Kim, Sung Huhn; Kim, Un-Kyoung; Lee, Won-Sang; Bok, Jinwoong; Song, Jung-Whan; Seong, Je Kyung; Choi, Jae Young			Albumin-Like Protein is the Major Protein Constituent of Luminal Fluid in the Human Endolymphatic Sac	PLOS ONE			English	Article							VESTIBULAR AQUEDUCT SYNDROME; INNER-EAR; SERUM-ALBUMIN; HUMAN PLASMA; DUCT; SUBSTANCES; HYDROPS; COCHLEA	The endolymphatic sac (ES) is an inner ear organ that is connected to the cochleo-vestibular system through the endolymphatic duct. The luminal fluid of the ES contains a much higher concentration of proteins than any other compartment of the inner ear. This high protein concentration likely contributes to inner ear fluid volume regulation by creating an osmotic gradient between the ES lumen and the interstitial fluid. We characterized the protein profile of the ES luminal fluid of patients (n = 11) with enlarged vestibular aqueducts (EVA) by proteomics. In addition, we investigated differences in the protein profiles between patients with recent hearing deterioration and patients without hearing deterioration. The mean total protein concentration of the luminal fluid was 554.7 +/- 94.6 mg/dl. A total of 58 out of 517 spots detected by 2-DE were analyzed by MALDI-TOF MS. The protein profile of the luminal fluid was different from the profile of plasma. Proteins identified from 29 of the spots were also present in the MARC-filtered human plasma; however, the proteins identified from the other 25 spots were not detected in the MARC-filtered human plasma. The most abundant protein in the luminal fluid was albumin-like proteins, but most of them were not detected in MARC-filtered human plasma. The concentration of albumin-like proteins was higher in samples from patients without recent hearing deterioration than in patients with recent hearing deterioration. Consequently, the protein of ES luminal fluid is likely to be originated from both the plasma and the inner ear and considering that inner ear fluid volumes increase abnormally in patients with EVA following recent hearing deterioration, it is tempting to speculate that albumin-like proteins may be involved in the regulation of inner ear fluid volume through creation of an osmotic gradient during pathological conditions such as endolymphatic hydrops.	[Kim, Sung Huhn; Lee, Won-Sang; Choi, Jae Young] Yonsei Univ, Coll Med, Dept Otorhinolaryngol, Seoul, South Korea; [Kim, Un-Kyoung] Kyungpook Natl Univ, Dept Biol, Taegu, South Korea; [Bok, Jinwoong] Yonsei Univ, Coll Med, Dept Anat, Seoul, South Korea; [Song, Jung-Whan] Ajou Univ, Coll Med, Dept Otorhinolaryngol, Suwon 441749, South Korea; [Seong, Je Kyung] Seoul Natl Univ, Lab Dev Biol & Genom, Program Vet Sci BK21,Interdisciplinary Program Bi, Res Inst Vet Sci,Coll Vet Sci, Seoul, South Korea; [Seong, Je Kyung] Seoul Natl Univ, Program Canc Biol, Seoul, South Korea	Yonsei University; Yonsei University Health System; Kyungpook National University; Yonsei University; Yonsei University Health System; Ajou University; Seoul National University (SNU); Seoul National University (SNU)	Kim, SH (corresponding author), Yonsei Univ, Coll Med, Dept Otorhinolaryngol, Seoul, South Korea.	jychoi@yuhs.ac	Bok, Jinwoong/M-2834-2019	Bok, Jinwoong/0000-0003-1958-1872; Seong, Je Kyung/0000-0003-1177-6958; choi, jae young/0000-0001-9493-3458; Kim, Sung Huhn/0000-0003-4408-3066	Ministry for Health, Welfare & Family Affairs, Republic of Korea [A090200]; Ministry of Education, Science and Technology [2010-0011806]	Ministry for Health, Welfare & Family Affairs, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This study was supported by a grant from the Korea Healthcare Technology R&D Project, Ministry for Health, Welfare & Family Affairs, Republic of Korea (http://www.khidi.or.kr/index.do) (A090200) to JYC and a grant from the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (http://www.nrf.go.kr/html/kr/) (2010-0011806) to SHK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cho Sang Yun, 2008, V428, P57; Cho SY, 2005, PROTEOMICS, V5, P3386, DOI 10.1002/pmic.200401310; ERWALL C, 1988, HEARING RES, V35, P109, DOI 10.1016/0378-5955(88)90045-7; ERWALL C, 1988, ACTA OTO-LARYNGOL, V105, P209, DOI 10.3109/00016488809097000; ERWALL C, 1989, ACTA OTO-LARYNGOL, V107, P63, DOI 10.3109/00016488909127480; FRAYSSE BG, 1980, ANN OTO RHINOL LARYN, V89, P2, DOI 10.1177/00034894800896S201; FRIBERG U, 1986, ACTA OTO-LARYNGOL, V101, P172, DOI 10.3109/00016488609132825; FRIBERG U, 1988, ARCH OTOLARYNGOL, V114, P389; FRIBERG U, 1984, ARCH OTOLARYNGOL, V110, P421; FUKAZAWA K, 1991, ANAT REC, V230, P425, DOI 10.1002/ar.1092300315; GALEY FR, 1988, ACTA OTO-LARYNGOL, P1; GULCICEK EE, 2005, CURR PROTOC BIOINFOR, pCH13; HE XM, 1992, NATURE, V358, P209, DOI 10.1038/358209a0; Hirai S, 2006, LARYNGOSCOPE, V116, P2007, DOI 10.1097/01.mlg.0000237673.94781.0a; Koesling S, 2006, EUR J RADIOL, V57, P54, DOI 10.1016/j.ejrad.2005.09.005; Lang F, 2007, AM J PHYSIOL-CELL PH, V293, pC1187, DOI 10.1152/ajpcell.00024.2007; MAROVITZ WF, 1972, ANN OTO RHINOL LARYN, V81, P76, DOI 10.1177/000348947208100108; Okamoto K, 1998, NEURORADIOLOGY, V40, P167, DOI 10.1007/s002340050561; Park HJ, 2003, J MED GENET, V40, P242, DOI 10.1136/jmg.40.4.242; Rask-Andersen H, 1999, HEARING RES, V138, P81, DOI 10.1016/S0378-5955(99)00153-7; ROTHSCHILD MA, 1988, HEPATOLOGY, V8, P385, DOI 10.1002/hep.1840080234; Salt AN, 2001, ANN NY ACAD SCI, V942, P306; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Spiegel JH, 2009, J LARYNGOL OTOL, V123, P919, DOI 10.1017/S0022215108004088; Sugiura M, 2006, J LARYNGOL OTOL, V120, P1084, DOI 10.1017/S0022215106003331; TEICHMANN I, 1964, ACTA BIOL ACAD SCI H, V14, P293; Thalmann I, 2006, ELECTROPHORESIS, V27, P1598, DOI 10.1002/elps.200500768	27	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2011	6	6							e21656	10.1371/journal.pone.0021656	http://dx.doi.org/10.1371/journal.pone.0021656			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786FZ	21738753	gold, Green Published, Green Submitted			2022-12-27	WOS:000292290100053
J	Li, YQ; Wang, GY; Long, JY; Yu, ZL; Huang, BA; Li, XJ; Yu, TY; Liang, CH; Li, Z; Sun, P				Li, Yuanqing; Wang, Guangyi; Long, Jinyi; Yu, Zhuliang; Huang, Biao; Li, Xiaojian; Yu, Tianyou; Liang, Changhong; Li, Zheng; Sun, Pei			Reproducibility and Discriminability of Brain Patterns of Semantic Categories Enhanced by Congruent Audiovisual Stimuli	PLOS ONE			English	Article							MULTISENSORY INTEGRATION; LANGUAGE; BINDING; IMAGES	One of the central questions in cognitive neuroscience is the precise neural representation, or brain pattern, associated with a semantic category. In this study, we explored the influence of audiovisual stimuli on the brain patterns of concepts or semantic categories through a functional magnetic resonance imaging (fMRI) experiment. We used a pattern search method to extract brain patterns corresponding to two semantic categories: "old people" and "young people." These brain patterns were elicited by semantically congruent audiovisual, semantically incongruent audiovisual, unimodal visual, and unimodal auditory stimuli belonging to the two semantic categories. We calculated the reproducibility index, which measures the similarity of the patterns within the same category. We also decoded the semantic categories from these brain patterns. The decoding accuracy reflects the discriminability of the brain patterns between two categories. The results showed that both the reproducibility index of brain patterns and the decoding accuracy were significantly higher for semantically congruent audiovisual stimuli than for unimodal visual and unimodal auditory stimuli, while the semantically incongruent stimuli did not elicit brain patterns with significantly higher reproducibility index or decoding accuracy. Thus, the semantically congruent audiovisual stimuli enhanced the within-class reproducibility of brain patterns and the between-class discriminability of brain patterns, and facilitate neural representations of semantic categories or concepts. Furthermore, we analyzed the brain activity in superior temporal sulcus and middle temporal gyrus (STS/MTG). The strength of the fMRI signal and the reproducibility index were enhanced by the semantically congruent audiovisual stimuli. Our results support the use of the reproducibility index as a potential tool to supplement the fMRI signal amplitude for evaluating multimodal integration.	[Li, Yuanqing; Long, Jinyi; Yu, Zhuliang; Yu, Tianyou] S China Univ Technol, Ctr Brain Comp Interfaces & Brain Informat Proc, Guangzhou, Guangdong, Peoples R China; [Wang, Guangyi] So Med Univ, Grad Sch, Guangzhou, Guangdong, Peoples R China; [Wang, Guangyi; Huang, Biao; Liang, Changhong] Guangdong Gen Hosp, Dept Radiol, Guangzhou, Guangdong, Peoples R China; [Li, Xiaojian] S China Normal Univ, Res Ctr Psychol Applicat, Guangzhou, Guangdong, Peoples R China; [Li, Zheng] Duke Univ, Dept Neurobiol, Durham, NC USA; [Sun, Pei] RIKEN Brain Sci Inst, Lab Cognit Brain Mapping, Saitama, Japan	South China University of Technology; Southern Medical University - China; Guangdong Academy of Medical Sciences & Guangdong General Hospital; South China Normal University; Duke University; RIKEN	Li, YQ (corresponding author), S China Univ Technol, Ctr Brain Comp Interfaces & Brain Informat Proc, Guangzhou, Guangdong, Peoples R China.	auyqli@scut.edu.cn; psun@brain.riken.jp	Sun, Pei/B-5191-2013; Liang, Chang Hong/L-1885-2016	Sun, Pei/0000-0003-4184-1079; 	National Natural Science Foundation of China [60825306, 60802068]; Natural Science Foundation of Guangdong Province, China [9251064101000012]; Science and Technology Programme Foundation of Guangdong Province, China [2009B080701053]; National 973 Program of China [2007CB311001]; SCUT [2009ZZ0055, 2009ZZ0059]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong Province, China(National Natural Science Foundation of Guangdong Province); Science and Technology Programme Foundation of Guangdong Province, China; National 973 Program of China(National Basic Research Program of China); SCUT	This work was supported by National Natural Science Foundation of China under grants 60825306 and 60802068, Natural Science Foundation of Guangdong Province, China under grant 9251064101000012, Science and Technology Programme Foundation of Guangdong Province, China under grant 2009B080701053, National 973 Program of China under grant 2007CB311001), and Fundamental Research Funds for the Central Universities, SCUT under grants 2009ZZ0055 and 2009ZZ0059. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beauchamp MS, 2004, NAT NEUROSCI, V7, P1190, DOI 10.1038/nn1333; Beauchamp MS, 2004, NEURON, V41, P809, DOI 10.1016/S0896-6273(04)00070-4; BOGOUSSLAVSKY J, 1987, J NEUROL NEUROSUR PS, V50, P607, DOI 10.1136/jnnp.50.5.607; Bushara KO, 2003, NAT NEUROSCI, V6, P190, DOI 10.1038/nn993; Bushara KO, 2001, J NEUROSCI, V21, P300, DOI 10.1523/JNEUROSCI.21-01-00300.2001; Calvert GA, 2000, CURR BIOL, V10, P649, DOI 10.1016/S0960-9822(00)00513-3; Calvert GA, 2004, J PHYSIOL-PARIS, V98, P191, DOI 10.1016/j.jphysparis.2004.03.018; Calvert GA, 2001, CEREB CORTEX, V11, P1110, DOI 10.1093/cercor/11.12.1110; Cox DD, 2003, NEUROIMAGE, V19, P261, DOI 10.1016/S1053-8119(03)00049-1; De Martino F, 2008, NEUROIMAGE, V43, P44, DOI 10.1016/j.neuroimage.2008.06.037; Desmond JE, 1998, TRENDS COGN SCI, V2, P355, DOI 10.1016/S1364-6613(98)01211-X; Doehrmann O, 2008, BRAIN RES, V1242, P136, DOI 10.1016/j.brainres.2008.03.071; Fernandez G, 2003, NEUROLOGY, V60, P969, DOI 10.1212/01.WNL.0000049934.34209.2E; Formisano E, 2008, SCIENCE, V322, P970, DOI 10.1126/science.1164318; Frassinetti F, 2002, EXP BRAIN RES, V147, P332, DOI 10.1007/s00221-002-1262-y; Friston KJ, 1994, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; Fuster J. M., 2005, CORTEX MIND UNIFYING; Harrison SA, 2009, NATURE, V458, P632, DOI 10.1038/nature07832; Haxby JV, 2000, TRENDS COGN SCI, V4, P223, DOI 10.1016/S1364-6613(00)01482-0; Ishai A, 2003, J COGNITIVE NEUROSCI, V15, P946, DOI 10.1162/089892903770007335; Kay KN, 2008, NATURE, V452, P352, DOI 10.1038/nature06713; Lavenex P, 2000, HIPPOCAMPUS, V10, P420, DOI 10.1002/1098-1063(2000)10:4<420::AID-HIPO8>3.3.CO;2-X; Li YQ, 2009, IEEE T BIO-MED ENG, V56, P2439, DOI 10.1109/TBME.2009.2025866; Liou M, 2003, J COGNITIVE NEUROSCI, V15, P935, DOI 10.1162/089892903770007326; Macaluso E, 2005, NEUROIMAGE, V26, P414, DOI 10.1016/j.neuroimage.2005.02.002; Macaluso E, 2004, NEUROIMAGE, V21, P725, DOI 10.1016/j.neuroimage.2003.09.049; McGonigle DJ, 2000, NEUROIMAGE, V11, P708, DOI 10.1006/nimg.2000.0562; Mitchell TM, 2008, SCIENCE, V320, P1191, DOI 10.1126/science.1152876; Pereira F, 2009, NEUROIMAGE, V45, pS199, DOI 10.1016/j.neuroimage.2008.11.007; Schurger A, 2010, SCIENCE, V327, P97, DOI 10.1126/science.1180029; Smith AT, 2011, NEUROIMAGE, V56, P525, DOI 10.1016/j.neuroimage.2010.05.079; Taylor KI, 2006, P NATL ACAD SCI USA, V103, P8239, DOI 10.1073/pnas.0509704103; Thirion B, 2006, NEUROIMAGE, V33, P1104, DOI 10.1016/j.neuroimage.2006.06.062; Werner S, 2010, J NEUROSCI, V30, P2662, DOI 10.1523/JNEUROSCI.5091-09.2010; Xue G, 2010, SCIENCE, V330, P97, DOI 10.1126/science.1193125; Yoo SS, 2005, INT J NEUROSCI, V115, P55, DOI 10.1080/00207450490512650	36	12	12	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2011	6	6							e20801	10.1371/journal.pone.0020801	http://dx.doi.org/10.1371/journal.pone.0020801			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	786FZ	21750692	Green Submitted, Green Published, gold			2022-12-27	WOS:000292290100006
J	Haugen, M; Flannery, E; Tomchaney, M; Mori, A; Behura, SK; Severson, DW; Duman-Scheel, M				Haugen, Morgan; Flannery, Ellen; Tomchaney, Michael; Mori, Akio; Behura, Susanta K.; Severson, David W.; Duman-Scheel, Molly			Semaphorin-1a Is Required for Aedes aegypti Embryonic Nerve Cord Development	PLOS ONE			English	Article							GENE-EXPRESSION; AXON GUIDANCE; ANOPHELES-GAMBIAE; PROVIDES EVIDENCE; VECTOR MOSQUITOS; GENOME SEQUENCE; NANOS NOS; DROSOPHILA; NETRIN; CNS	Although mosquito genome projects have uncovered orthologues of many known developmental regulatory genes, extremely little is known about mosquito development. In this study, the role of semaphorin-1a (sema1a) was investigated during vector mosquito embryonic ventral nerve cord development. Expression of sema1a and the plexin A (plexA) receptor are detected in the embryonic ventral nerve cords of Aedes aegypti (dengue vector) and Anopheles gambiae (malaria vector), suggesting that Sema1a signaling may regulate mosquito nervous system development. Analysis of sema1a function was investigated through siRNA-mediated knockdown in A. aegypti embryos. Knockdown of sema1a during A. aegypti development results in a number of nerve cord phenotypes, including thinning, breakage, and occasional fusion of the longitudinal connectives, thin or absent commissures, and general distortion of the nerve cord. Although analysis of Drosophila melanogaster sema1a loss-of-function mutants uncovered many similar phenotypes, aspects of the longitudinal phenotypes differed between D. melanogaster and A. aegypti. The results of this investigation suggest that Sema1a is required for development of the insect ventral nerve cord, but that the developmental roles of this guidance molecule have diverged in dipteran insects.	[Haugen, Morgan; Tomchaney, Michael; Severson, David W.; Duman-Scheel, Molly] Indiana Univ Sch Med, Dept Med & Mol Genet, South Bend, IN 46634 USA; [Flannery, Ellen; Tomchaney, Michael; Mori, Akio; Behura, Susanta K.; Severson, David W.; Duman-Scheel, Molly] Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA; [Flannery, Ellen; Tomchaney, Michael; Mori, Akio; Behura, Susanta K.; Severson, David W.; Duman-Scheel, Molly] Univ Notre Dame, Eck Inst Global Hlth, Notre Dame, IN 46556 USA	Indiana University System; Indiana University South Bend; University of Notre Dame; University of Notre Dame	Haugen, M (corresponding author), Indiana Univ Sch Med, Dept Med & Mol Genet, South Bend, IN 46634 USA.	mscheel@nd.edu	Flannery, Ellen/D-3941-2014	BEHURA, SUSANTA/0000-0002-0654-6288; behura, Susanta/0000-0003-1057-2435; Severson, David/0000-0002-5798-3365	University of Notre Dame College of Science; National Institutes of Health/National Institute of Allergy and Infectious Diseases [R01AI081795-01]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI081795] Funding Source: NIH RePORTER	University of Notre Dame College of Science; National Institutes of Health/National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	MT was supported by the University of Notre Dame College of Science Summer Undergraduate Research Fellowship program. This work was supported by National Institutes of Health/National Institute of Allergy and Infectious Diseases Award R01AI081795-01 to MD-S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adelman ZN, 2007, P NATL ACAD SCI USA, V104, P9970, DOI 10.1073/pnas.0701515104; Arensburger P, 2010, SCIENCE, V330, P86, DOI 10.1126/science.1191864; Ayoob JC, 2006, DEVELOPMENT, V133, P2125, DOI 10.1242/dev.02380; Calvo E, 2005, INSECT BIOCHEM MOLEC, V35, P789, DOI 10.1016/j.ibmb.2005.02.007; Chen XG, 2008, ADV GENET, V64, P19, DOI 10.1016/S0065-2660(08)00802-X; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; CLEMONS A, 2010, COLD SPRING HARB PRO; CLEMONS A, 2010, COLD SPRING HARB PRO; CLEMONS A, 2010, COLD SPRING HARB PRO; CLEMONS A, 2010, COLD SPRING HARB PRO; CLEMONS A, 2010, COLD SPRING HARB PRO; Clemons A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016730; Duman-Scheel M, 1999, DEVELOPMENT, V126, P2327; Duman-Scheel M, 2007, EVOL DEV, V9, P131, DOI 10.1111/j.1525-142X.2007.00144.x; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Flannery E, 2009, CURR DRUG TARGETS, V10, P611, DOI 10.2174/138945009788680383; Flannery E, 2010, DEV NEUROBIOL, V70, P473, DOI 10.1002/dneu.20788; Goltsev Y, 2004, DEV BIOL, V275, P435, DOI 10.1016/j.ydbio.2004.08.021; Goltsev Y, 2007, DEVELOPMENT, V134, P2415, DOI 10.1242/dev.02863; Goltsev Y, 2009, DEV BIOL, V330, P462, DOI 10.1016/j.ydbio.2009.02.038; Harris R, 1996, NEURON, V17, P217, DOI 10.1016/S0896-6273(00)80154-3; HAUGEN M, 2010, COLD SPRING HARBOR P; Holt RA, 2002, SCIENCE, V298, P129, DOI 10.1126/science.1076181; Juhn J, 2008, INSECT MOL BIOL, V17, P545, DOI 10.1111/j.1365-2583.2008.00823.x; Juhn J, 2006, INSECT MOL BIOL, V15, P363, DOI 10.1111/j.1365-2583.2006.00655.x; Kaprielian Z, 2001, DEV DYNAM, V221, P154, DOI 10.1002/dvdy.1143; KOLODKIN AL, 1993, CELL, V75, P1389, DOI 10.1016/0092-8674(93)90625-Z; Kolodziej PA, 1996, CELL, V87, P197, DOI 10.1016/S0092-8674(00)81338-0; Komiyama T, 2007, CELL, V128, P399, DOI 10.1016/j.cell.2006.12.028; Kriventseva EV, 2008, NUCLEIC ACIDS RES, V36, pD271, DOI 10.1093/nar/gkm845; Lawson D, 2009, NUCLEIC ACIDS RES, V37, pD583, DOI 10.1093/nar/gkn857; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mitchell KJ, 1996, NEURON, V17, P203, DOI 10.1016/S0896-6273(00)80153-1; Morlais I, 2003, MOL GENET GENOMICS, V269, P753, DOI 10.1007/s00438-003-0882-7; Nene V, 2007, SCIENCE, V316, P1718, DOI 10.1126/science.1138878; PATEL NH, 1994, METHOD CELL BIOL, V44, P445, DOI 10.1016/S0091-679X(08)60927-9; RAMINANI L N, 1975, International Journal of Insect Morphology and Embryology, V4, P517, DOI 10.1016/0020-7322(75)90028-8; RAMINANI LN, 1978, INT J INSECT MORPHOL, V7, P273, DOI 10.1016/0020-7322(78)90009-0; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Severson DW, 2004, J HERED, V95, P103, DOI 10.1093/jhered/esh023; Simanton W, 2009, EVOL DEV, V11, P260, DOI 10.1111/j.1525-142X.2009.00328.x; Smedley D, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-22; Sweeney LB, 2007, NEURON, V53, P185, DOI 10.1016/j.neuron.2006.12.022; TAKEZAKI N, 1995, MOL BIOL EVOL, V12, P823; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; THOMAS JB, 1984, NATURE, V310, P203, DOI 10.1038/310203a0; Tweedie S, 2009, NUCLEIC ACIDS RES, V37, pD555, DOI 10.1093/nar/gkn788; Winberg ML, 1998, CELL, V95, P903, DOI 10.1016/S0092-8674(00)81715-8; Yu HH, 1998, NEURON, V20, P207, DOI 10.1016/S0896-6273(00)80450-X; Yu HH, 2000, GENETICS, V156, P723; Yu L, 2010, J NEUROSCI, V30, P12151, DOI 10.1523/JNEUROSCI.1494-10.2010; Zlatic M, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000135	53	20	20	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2011	6	6							e21694	10.1371/journal.pone.0021694	http://dx.doi.org/10.1371/journal.pone.0021694			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	783OD	21738767	Green Published, gold, Green Submitted			2022-12-27	WOS:000292092600072
J	Limpert, E; Stahel, WA				Limpert, Eckhard; Stahel, Werner A.			Problems with Using the Normal Distribution - and Ways to Improve Quality and Efficiency of Data Analysis	PLOS ONE			English	Article							SELECTION; INFLAMMATION; VARIABILITY; PHEROMONE; HEALTH; CELLS; MAP	Background: The Gaussian or normal distribution is the most established model to characterize quantitative variation of original data. Accordingly, data are summarized using the arithmetic mean and the standard deviation, by (x) over bar +/- SD, or with the standard error of the mean, (x) over bar +/- 6 SEM. This, together with corresponding bars in graphical displays has become the standard to characterize variation. Methodology/Principal Findings: Here we question the adequacy of this characterization, and of the model. The published literature provides numerous examples for which such descriptions appear inappropriate because, based on the "95% range check", their distributions are obviously skewed. In these cases, the symmetric characterization is a poor description and may trigger wrong Conclusions. To solve the problem, it is enlightening to regard causes of variation. Multiplicative causes are by far more important than additive ones, in general, and benefit from a multiplicative (or log-) normal approach. Fortunately, quite similar to the normal, the log-normal distribution can now be handled easily and characterized at the level of the original data with the help of both, a new sign, (x)/, times-divide, and notation. Analogous to (x) over bar +/- SD, it connects the multiplicative (or geometric) mean (x) over bar +/- * and the multiplicative standard deviation s* in the form (x) over bar +/-(*) (x)/s*, that is advantageous and recommended. Conclusions/Significance: The corresponding shift from the symmetric to the asymmetric view will substantially increase both, recognition of data distributions, and interpretation quality. It will allow for savings in sample size that can be considerable. Moreover, this is in line with ethical responsibility. Adequate models will improve concepts and theories, and provide deeper insight into science and life.	[Limpert, Eckhard] ELI O Res, Life Sci, Zurich, Switzerland; [Stahel, Werner A.] ETH, Swiss Fed Inst Technol, Seminar Stat, Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Limpert, E (corresponding author), ELI O Res, Life Sci, Zurich, Switzerland.	stahel@stat.math.ethz.ch						Aitchison J, 1996, LOG NORMAL DISTRIBUT; [Anonymous], 2007, MATH STAT METASTATIS; [Anonymous], 2011, HDB CHEM PHYS, V91, P2; Auffray C, 2007, SCIENCE, V317, P666, DOI 10.1126/science.1142883; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Baur P, 1997, PLANT CELL ENVIRON, V20, P167, DOI 10.1046/j.1365-3040.1997.d01-66.x; Bendel M, 2006, EUR J PLANT PATHOL, V116, P85, DOI 10.1007/s10658-006-9028-1; BLACK F, 1973, J POLIT ECON, V81, P637, DOI 10.1086/260062; Boilard E, 2010, SCIENCE, V327, P580, DOI 10.1126/science.1181928; Carlton JG, 2007, SCIENCE, V316, P1908, DOI 10.1126/science.1143422; Cumming G, 2007, J CELL BIOL, V177, P7, DOI 10.1083/jcb.200611141; Durand C, 2007, P NATL ACAD SCI USA, V104, P20838, DOI 10.1073/pnas.0706923105; Escobar-Restrepo JM, 2007, SCIENCE, V317, P656, DOI 10.1126/science.1143562; Factor VM, 2000, P NATL ACAD SCI USA, V97, P2196, DOI 10.1073/pnas.040428797; Fisher R.A., 1958, STAT METHODS RES WOR; Fisher RA, 1923, J AGR SCI, V13, P311, DOI 10.1017/S0021859600003592; Galton F, 1889, NATURAL INHERITANCE, P1; Godet F, 1998, PESTIC SCI, V54, P244, DOI 10.1002/(SICI)1096-9063(1998110)54:3&lt;244::AID-PS818&gt;3.0.CO;2-8; Griffin BM, 2007, SCIENCE, V316, P1870, DOI 10.1126/science.1139478; Hattis D, 1999, RISK ANAL, V19, P711, DOI 10.1111/j.1539-6924.1999.tb00441.x; HEATH DF, 1967, NATURE, V213, P1159, DOI 10.1038/2131159a0; Ji HT, 2006, NATURE, V444, P343, DOI 10.1038/nature05323; Johnson N, 1994, CONTINUOUS UNIVARIAT, V1, P761; Kelly BC, 2007, SCIENCE, V317, P236, DOI 10.1126/science.1138275; Lawrence D, 2007, P NATL ACAD SCI USA, V104, P20696, DOI 10.1073/pnas.0705005104; Le Naour F, 2000, SCIENCE, V287, P319, DOI 10.1126/science.287.5451.319; Limpert E, 2001, BIOSCIENCE, V51, P341, DOI 10.1641/0006-3568(2001)051[0341:LNDATS]2.0.CO;2; Limpert E, 1999, MODERN FUNGICIDES AND ANTIFUNGAL COMPOUNDS II, P187; Limpert E, 2003, INT BREED C AUSTR GU, P15; Machi G, 2006, PLANT PATHOL, V55, P614; Maeder CI, 2007, NAT CELL BIOL, V9, P1319, DOI 10.1038/ncb1652; McHugh TJ, 2007, SCIENCE, V317, P94, DOI 10.1126/science.1140263; Merkle FT, 2007, SCIENCE, V317, P381, DOI 10.1126/science.1144914; MERTON RC, 1973, BELL J ECON, V4, P141, DOI 10.2307/3003143; MERTON RC, 1971, J ECON THEORY, V3, P373, DOI 10.1016/0022-0531(71)90038-X; MERTON RC, 1969, REV ECON STAT, V51, P247, DOI 10.2307/1926560; Morrison DA, 2004, PARASITOL RES, V94, P361, DOI 10.1007/s00436-004-1225-2; Mosteller F., 1968, HDB SOC PSYCHOL, V2, P80; Nagamune K, 2008, NATURE, V451, P207, DOI 10.1038/nature06478; Pina-Ochoa E, 2010, P NATL ACAD SCI USA, V107, P1148, DOI 10.1073/pnas.0908440107; Raizen DM, 2008, NATURE, V451, P569, DOI 10.1038/nature06535; Rakoff-Nahoum S, 2007, SCIENCE, V317, P124, DOI 10.1126/science.1140488; RENNER E, 1970, MATH STAT METHODEN P; Rinsoz T, 2006, 8 INT C AER, P253; Rohatgi R, 2007, SCIENCE, V317, P372, DOI 10.1126/science.1139740; Romani L, 2008, NATURE, V451, P211, DOI 10.1038/nature06471; Rowe HM, 2010, NATURE, V463, P237, DOI 10.1038/nature08674; Sales KU, 2010, NAT GENET, V42, P676, DOI 10.1038/ng.629; SAMUELSON PA, 1965, IMR-IND MANAG REV, V6, P13; Schaper M, 2010, BAUTECHNIK, V87, P541, DOI 10.1002/bate.201010036; Smith KL, 2007, SCIENCE, V317, P478, DOI 10.1126/science.1142834; Snedecor G.W., 1989, AMES IOWA STATE U PR; Sorrentino RP, 2007, DEV BIOL, V311, P311, DOI 10.1016/j.ydbio.2007.08.011; Sorrentino RP, 2010, FLY, V4, P327, DOI 10.4161/fly.4.4.13260; Sorrentino RP, 2004, GENETICS, V166, P1343, DOI 10.1534/genetics.166.3.1343; Stehmann C, 1996, EUR J PLANT PATHOL, V102, P171, DOI 10.1007/BF01877104; Tjamos EC, 2004, EUR J PLANT PATHOL, V110, P35, DOI 10.1023/B:EJPP.0000010132.91241.cb; Tondeur S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008990; Wang LM, 2010, NATURE, V463, P227, DOI 10.1038/nature08678; Wilson CG, 2010, SCIENCE, V327, P574, DOI 10.1126/science.1179252; Wisloff U, 2005, SCIENCE, V307, P418, DOI 10.1126/science.1108177	61	109	109	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2011	6	7							e21403	10.1371/journal.pone.0021403	http://dx.doi.org/10.1371/journal.pone.0021403			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	793HP	21779325	Green Published, Green Submitted, gold			2022-12-27	WOS:000292811300008
J	Hasgall, PA; Hoogewijs, D; Faza, MB; Panse, VG; Wenger, RH; Camenisch, G				Hasgall, Philippe A.; Hoogewijs, David; Faza, Marius B.; Panse, Vikram G.; Wenger, Roland H.; Camenisch, Gieri			The Putative RNA Helicase HELZ Promotes Cell Proliferation, Translation Initiation and Ribosomal Protein S6 Phosphorylation	PLOS ONE			English	Article							HYPOXIA-INDUCIBLE FACTOR; POLY(A) BINDING-PROTEIN; TUMOR-SUPPRESSOR PROTEIN; PROLYL 4-HYDROXYLASES; MOLECULAR-MECHANISMS; GENE-EXPRESSION; POLY(A)-BINDING PROTEIN; SHUTTLING PROTEIN; HYDROXYLATION; HIF	The hypoxia-inducible transcription factor (HIF) is a key component of the cellular adaptation mechanisms to hypoxic conditions. HIF alpha subunits are degraded by prolyl-4-hydroxylase domain (PHD) enzyme-dependent prolyl-4-hydroxylation of LxxLAP motifs that confer oxygen-dependent proteolytic degradation. Interestingly, only three non-HIF alpha proteins contain two conserved LxxLAP motifs, including the putative RNA helicase with a zinc finger domain HELZ. However, HELZ proteolytic regulation was found to be oxygen-independent, supporting the notion that a LxxLAP sequence motif alone is not sufficient for oxygen-dependent protein destruction. Since biochemical pathways involving RNA often require RNA helicases to modulate RNA structure and activity, we used luciferase reporter gene constructs and metabolic labeling to demonstrate that HELZ overexpression activates global protein translation whereas RNA-interference mediated HELZ suppression had the opposite effect. Although HELZ interacted with the poly(A)-binding protein (PABP) via its PAM2 motif, PABP was dispensable for HELZ function in protein translation. Importantly, downregulation of HELZ reduced translational initiation, resulting in the disassembly of polysomes, in a reduction of cell proliferation and hypophosphorylation of ribosomal protein S6.	[Hasgall, Philippe A.; Hoogewijs, David; Wenger, Roland H.; Camenisch, Gieri] Univ Zurich UZH, Inst Physiol, Zurich, Switzerland; [Hasgall, Philippe A.; Hoogewijs, David; Wenger, Roland H.; Camenisch, Gieri] Univ Zurich UZH, Zurich Ctr Integrat Human Physiol ZIHP, Zurich, Switzerland; [Faza, Marius B.; Panse, Vikram G.] ETH, Inst Biochem, Zurich, Switzerland	University of Zurich; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP); Swiss Federal Institutes of Technology Domain; ETH Zurich	Hasgall, PA (corresponding author), ITIS Fdn, Zurich, Switzerland.	roland.wenger@access.uzh.ch	Hoogewijs, David/L-5144-2016; Wenger, Roland H./B-7953-2009	Wenger, Roland H./0000-0001-7592-4839; Panse, Vikram/0000-0001-7950-5746	Swiss National Science Foundation [31003A_129962/1]; European Commission [PIEF-GA-2009-236157-HYDRELZ]; ETH Zurich; European Research Council [EURIBIO-260676]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); European Commission(European CommissionEuropean Commission Joint Research Centre); ETH Zurich(ETH Zurich); European Research Council(European Research Council (ERC)European Commission)	This work was supported by the Swiss National Science Foundation (31003A_129962/1). D. Hoogewijs is a recipient of a Marie Curie Intra-European Fellowship from the European Commission (PIEF-GA-2009-236157-HYDRELZ). V. G. Panse is supported by the Swiss National Science Foundation, the ETH Zurich and the European Research Council (EURIBIO-260676). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht M, 2004, BIOCHEM BIOPH RES CO, V316, P129, DOI 10.1016/j.bbrc.2004.02.024; Atayar C, 2006, HUM PATHOL, V37, P675, DOI 10.1016/j.humpath.2006.01.018; Balamurugan K, 2009, ONCOGENE, V28, P3274, DOI 10.1038/onc.2009.186; Barth S, 2007, MOL CELL BIOL, V27, P3758, DOI 10.1128/MCB.01324-06; Blanchette M, 2004, GENOME RES, V14, P708, DOI 10.1101/gr.1933104; Bruick RK, 2001, SCIENCE, V294, P1337, DOI 10.1126/science.1066373; Camenisch G, 1999, FASEB J, V13, P81, DOI 10.1096/fasebj.13.1.81; Collart MA, 2004, PROG NUCLEIC ACID RE, V77, P289, DOI 10.1016/S0079-6603(04)77008-7; Craig AWB, 1998, NATURE, V392, P520, DOI 10.1038/33198; Cummins EP, 2006, P NATL ACAD SCI USA, V103, P18154, DOI 10.1073/pnas.0602235103; Czaplinski K, 2000, RNA, V6, P730, DOI 10.1017/S1355838200992392; Dalmay T, 2001, EMBO J, V20, P2069, DOI 10.1093/emboj/20.8.2069; Diehl F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009748; Dufner A, 1999, EXP CELL RES, V253, P100, DOI 10.1006/excr.1999.4683; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Estrada L, 2001, HUM MOL GENET, V10, P485, DOI 10.1093/hmg/10.5.485; Fairman-Williams ME, 2010, CURR OPIN STRUC BIOL, V20, P313, DOI 10.1016/j.sbi.2010.03.011; Gebauer F, 2004, NAT REV MOL CELL BIO, V5, P827, DOI 10.1038/nrm1488; Gingras AC, 1999, ANNU REV BIOCHEM, V68, P913, DOI 10.1146/annurev.biochem.68.1.913; Hamamoto R, 2004, NAT CELL BIOL, V6, P731, DOI 10.1038/ncb1151; Hirsila M, 2003, J BIOL CHEM, V278, P30772, DOI 10.1074/jbc.M304982200; Huang JH, 2002, J BIOL CHEM, V277, P39792, DOI 10.1074/jbc.M206955200; Ivan M, 2002, P NATL ACAD SCI USA, V99, P13459, DOI 10.1073/pnas.192342099; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Jankowsky E, 2007, CURR OPIN STRUC BIOL, V17, P316, DOI 10.1016/j.sbi.2007.05.007; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; Khaleghpour K, 2001, MOL CELL BIOL, V21, P5200, DOI 10.1128/MCB.21.15.5200-5213.2001; Khaleghpour K, 2001, MOL CELL, V7, P205, DOI 10.1016/S1097-2765(01)00168-X; Koivunen P, 2006, J BIOL CHEM, V281, P28712, DOI 10.1074/jbc.M604628200; Kozlov G, 2004, EMBO J, V23, P272, DOI 10.1038/sj.emboj.7600048; Li DX, 2004, J BIOL CHEM, V279, P55051, DOI 10.1074/jbc.M410287200; Luking A, 1998, CRIT REV BIOCHEM MOL, V33, P259, DOI 10.1080/10409239891204233; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; MADER S, 1995, MOL CELL BIOL, V15, P4990; Mangus DA, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-7-223; Marti HH, 1996, EUR J NEUROSCI, V8, P666, DOI 10.1111/j.1460-9568.1996.tb01252.x; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; MCDONALD WJ, J CELL BIOCH, V110, P1123; McDonough MA, 2006, P NATL ACAD SCI USA, V103, P9814, DOI 10.1073/pnas.0601283103; Mikhaylova O, 2008, MOL CELL BIOL, V28, P2701, DOI 10.1128/MCB.01231-07; Nagai H, 2003, CANCER LETT, V193, P41, DOI 10.1016/S0304383502006882; Okochi K, 2005, GENES CELLS, V10, P151, DOI 10.1111/j.1365-2443.2005.00826.x; PAUSE A, 1992, EMBO J, V11, P2643, DOI 10.1002/j.1460-2075.1992.tb05330.x; Pestova TV, 2001, P NATL ACAD SCI USA, V98, P7029, DOI 10.1073/pnas.111145798; Popowski K, 2005, MOL PHARMACOL, V67, P1629, DOI 10.1124/mol.104.010223; Rhead B, 2010, NUCLEIC ACIDS RES, V38, pD613, DOI 10.1093/nar/gkp939; Roy G, 2002, MOL CELL BIOL, V22, P3769, DOI 10.1128/MCB.22.11.3769-3782.2002; Sachs AB, 1997, CELL, V89, P831, DOI 10.1016/S0092-8674(00)80268-8; Sanchez-Puig N, 2005, MOL CELL, V17, P11, DOI 10.1016/j.molcel.2004.11.019; Sigrist CJA, 2010, NUCLEIC ACIDS RES, V38, pD161, DOI 10.1093/nar/gkp885; Singleton MR, 2007, ANNU REV BIOCHEM, V76, P23, DOI 10.1146/annurev.biochem.76.052305.115300; Smillie DA, 2002, J CELL SCI, V115, P395; Stiehl DP, 2006, J BIOL CHEM, V281, P23482, DOI 10.1074/jbc.M601719200; Wang HZ, 2009, CELL RES, V19, P1388, DOI 10.1038/cr.2009.113; Wenger RH, 2002, FASEB J, V16, DOI 10.1096/fj.01-0944rev	55	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2011	6	7							e22107	10.1371/journal.pone.0022107	http://dx.doi.org/10.1371/journal.pone.0022107			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	792WQ	21765940	Green Published, gold, Green Submitted			2022-12-27	WOS:000292781500032
J	Chatterjee, A; Drews, L; Mehra, S; Takano, E; Kaznessis, YN; Hu, WS				Chatterjee, Anushree; Drews, Laurie; Mehra, Sarika; Takano, Eriko; Kaznessis, Yiannis N.; Hu, Wei-Shou			Convergent Transcription in the Butyrolactone Regulon in Streptomyces coelicolor Confers a Bistable Genetic Switch for Antibiotic Biosynthesis	PLOS ONE			English	Article							AUTOREGULATOR RECEPTOR PROTEIN; ANTISENSE-RNA; GAMMA-BUTYROLACTONE; SECONDARY METABOLISM; SIGNALING MOLECULES; MATHEMATICAL-MODEL; ESCHERICHIA-COLI; REGULATORY GENE; A-FACTOR; INTERFERENCE	cis-encoded antisense RNAs (cis asRNA) have been reported to participate in gene expression regulation in both eukaryotic and prokaryotic organisms. Its presence in Streptomyces coelicolor has also been reported recently; however, its role has yet to be fully investigated. Using mathematical modeling we explore the role of cis asRNA produced as a result of convergent transcription in scbA-scbR genetic switch. scbA and scbR gene pair, encoding repressor-amplifier proteins respectively, mediates the synthesis of a signaling molecule, the gamma-butyrolactone SCB1 and controls the onset of antibiotic production. Our model considers that transcriptional interference caused by convergent transcription of two opposing RNA polymerases results in fatal collision and transcriptional termination, which suppresses transcription efficiency. Additionally, convergent transcription causes sense and antisense interactions between complementary sequences from opposing strands, rendering the full length transcript inaccessible for translation. We evaluated the role of transcriptional interference and the antisense effect conferred by convergent transcription on the behavior of scbA-scbR system. Stability analysis showed that while transcriptional interference affects the system, it is asRNA that confers scbA-scbR system the characteristics of a bistable switch in response to the signaling molecule SCB1. With its critical role of regulating the onset of antibiotic synthesis the bistable behavior offers this two gene system the needed robustness to be a genetic switch. The convergent two gene system with potential of transcriptional interference is a frequent feature in various genomes. The possibility of asRNA regulation in other such gene-pairs is yet to be examined.	[Chatterjee, Anushree; Drews, Laurie; Kaznessis, Yiannis N.; Hu, Wei-Shou] Univ Minnesota, Dept Chem Engn & Mat Sci, Minneapolis, MN 55455 USA; [Mehra, Sarika] Indian Inst Technol, Dept Chem Engn, Bombay 400076, Maharashtra, India; [Takano, Eriko] Univ Groningen, Dept Microbial Physiol, Groningen, Netherlands	University of Minnesota System; University of Minnesota Twin Cities; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Bombay; University of Groningen	Chatterjee, A (corresponding author), Univ Minnesota, Dept Chem Engn & Mat Sci, 421 Washington Ave SE, Minneapolis, MN 55455 USA.	acre@umn.edu	Kaznessis, Yiannis N/H-1795-2015	Mehra, Sarika/0000-0003-3844-4726; Takano, Eriko/0000-0002-6791-3256; Kaznessis, Yiannis/0000-0002-5088-1104	National Institutes of Health [GM081888]; Graduate School at University of Minnesota; University of Groningen	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Graduate School at University of Minnesota; University of Groningen	This work was supported in part by a grant from the National Institutes of Health (GM081888) to WSH. AC was supported by Doctoral Dissertation fellowship from Graduate School at University of Minnesota. ET was supported by a Rosalind Franklin Fellowship, University of Groningen. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andre G, 2008, NUCLEIC ACIDS RES, V36, P5955, DOI 10.1093/nar/gkn601; Arnvig KB, 2009, MOL MICROBIOL, V73, P397, DOI 10.1111/j.1365-2958.2009.06777.x; Bernstein JA, 2002, P NATL ACAD SCI USA, V99, P9697, DOI 10.1073/pnas.112318199; Brantl S, 2002, PLASMID, V48, P165, DOI 10.1016/S0147-619X(02)00108-7; Brantl S, 2002, BBA-GENE STRUCT EXPR, V1575, P15, DOI 10.1016/S0167-4781(02)00280-4; Brantl S, 2007, CURR OPIN MICROBIOL, V10, P102, DOI 10.1016/j.mib.2007.03.012; Callen BP, 2004, MOL CELL, V14, P647, DOI 10.1016/j.molcel.2004.05.010; Chatterjee A, 2008, CURR OPIN BIOTECH, V19, P475, DOI 10.1016/j.copbio.2008.08.010; Chatterjee A, 2011, P NATL ACAD SCI USA, V108, P9721, DOI 10.1073/pnas.1101569108; Chen J, 2010, P NATL ACAD SCI USA, V107, P12523, DOI 10.1073/pnas.1003533107; Chickarmane V, 2006, PLOS COMPUT BIOL, V2, P1080, DOI 10.1371/journal.pcbi.0020123; COXRA, 2004, MICROBIOLOGY, V150, P1413; D'Alia D, 2010, J BACTERIOL, V192, P1160, DOI 10.1128/JB.01374-09; David L, 2006, P NATL ACAD SCI USA, V103, P5320, DOI 10.1073/pnas.0601091103; Ding Y, 2003, NUCLEIC ACIDS RES, V31, P7280, DOI 10.1093/nar/gkg938; Dodd IB, 2007, J MOL BIOL, V369, P1200, DOI 10.1016/j.jmb.2007.04.041; Dornenburg JE, 2010, MBIO, V1; EGUCHI Y, 1991, ANNU REV BIOCHEM, V60, P631, DOI 10.1146/annurev.bi.60.070191.003215; Georg J, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.63; Goryachev AB, 2005, PLOS COMPUT BIOL, V1, P265, DOI 10.1371/journal.pcbi.0010037; Gottelt M, 2010, MICROBIOL-SGM, V156, P2343, DOI 10.1099/mic.0.038281-0; Hernandez JA, 2006, J MOL BIOL, V355, P325, DOI 10.1016/j.jmb.2005.10.079; Hongay CF, 2006, CELL, V127, P735, DOI 10.1016/j.cell.2006.09.038; Horinouchi S, 2002, FRONT BIOSCI-LANDMRK, V7, pD2045, DOI 10.2741/horinouc; Hsiao NH, 2007, MICROBIOL-SGM, V153, P1394, DOI 10.1099/mic.0.2006/004432-0; Hsiao NH, 2009, CHEM BIOL, V16, P951, DOI 10.1016/j.chembiol.2009.08.010; Hughes DT, 2008, NAT REV MICROBIOL, V6, P111, DOI 10.1038/nrmicro1836; Katayama S, 2005, SCIENCE, V309, P1564, DOI 10.1126/science.1112009; Kato JY, 2007, P NATL ACAD SCI USA, V104, P2378, DOI 10.1073/pnas.0607472104; Kim HS, 2004, ARCH MICROBIOL, V182, P44, DOI 10.1007/s00203-004-0697-x; Kinoshita H, 1997, J BACTERIOL, V179, P6986, DOI 10.1128/jb.179.22.6986-6993.1997; Kitani S, 2001, J BACTERIOL, V183, P4357, DOI 10.1128/JB.183.14.4357-4363.2001; Kiyosawa H, 2005, GENOME RES, V15, P463, DOI 10.1101/gr.3155905; KRINKE L, 1987, GENE DEV, V1, P1005, DOI 10.1101/gad.1.9.1005; Lee EJ, 2010, MOL MICROBIOL, V76, P1020, DOI 10.1111/j.1365-2958.2010.07161.x; LIAO SM, 1987, GENE DEV, V1, P197, DOI 10.1101/gad.1.2.197; Maamar H, 2005, MOL MICROBIOL, V56, P615, DOI 10.1111/j.1365-2958.2005.04592.x; Mehra S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002724; MISRA S, 2002, GENOME BIOL, V3, P83, DOI [DOI 10.1186/GB-2002-3-12-RESEARCH0083, 10.1186/gb-2002-3-12-research0083]; Morohashi M, 2002, J THEOR BIOL, V216, P19, DOI 10.1006/jtbi.2002.2537; Natsume R, 2004, J MOL BIOL, V336, P409, DOI 10.1016/j.jmb.2003.12.040; Neuman KC, 2003, CELL, V115, P437, DOI 10.1016/S0092-8674(03)00845-6; Onaka H, 1997, J BACTERIOL, V179, P2748, DOI 10.1128/jb.179.8.2748-2752.1997; Palmer AC, 2009, MOL CELL, V34, P545, DOI 10.1016/j.molcel.2009.04.018; Panek J, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-217; Parsek MR, 1999, P NATL ACAD SCI USA, V96, P4360, DOI 10.1073/pnas.96.8.4360; Prasanth KV, 2007, GENE DEV, V21, P11, DOI 10.1101/gad.1484207; Rasmussen S, 2009, MOL MICROBIOL, V73, P1043, DOI 10.1111/j.1365-2958.2009.06830.x; RUENGJITCHATCHAWALYA M, 1995, J BACTERIOL, V177, P551, DOI 10.1128/jb.177.3.551-557.1995; Santillan M, 2001, P NATL ACAD SCI USA, V98, P1364, DOI 10.1073/pnas.98.4.1364; Shearwin KE, 2005, TRENDS GENET, V21, P339, DOI 10.1016/j.tig.2005.04.009; Shokeen S, 2010, PLASMID, V64, P26, DOI 10.1016/j.plasmid.2010.03.002; Sneppen K, 2005, J MOL BIOL, V346, P399, DOI 10.1016/j.jmb.2004.11.075; Stelling J, 2004, CELL, V118, P675, DOI 10.1016/j.cell.2004.09.008; Swiercz JP, 2008, NUCLEIC ACIDS RES, V36, P7240, DOI 10.1093/nar/gkn898; Takano E, 2000, J BIOL CHEM, V275, P11010, DOI 10.1074/jbc.275.15.11010; Takano E, 2001, MOL MICROBIOL, V41, P1015, DOI 10.1046/j.1365-2958.2001.02562.x; Takano E, 2005, MOL MICROBIOL, V56, P465, DOI 10.1111/j.1365-2958.2005.04543.x; Takano E, 2006, CURR OPIN MICROBIOL, V9, P287, DOI 10.1016/j.mib.2006.04.003; Tang GQ, 2009, P NATL ACAD SCI USA, V106, P22175, DOI 10.1073/pnas.0906979106; THISTED T, 1992, J MOL BIOL, V223, P41, DOI 10.1016/0022-2836(92)90714-U; Thomason MK, 2010, ANNU REV GENET, V44, P167, DOI 10.1146/annurev-genet-102209-163523; Tian TH, 2004, J THEOR BIOL, V227, P229, DOI 10.1016/j.jtbi.2003.11.003; TOMIZAWA JI, 1981, P NATL ACAD SCI-BIOL, V78, P6096, DOI 10.1073/pnas.78.10.6096; Vo NV, 2003, BIOCHEMISTRY-US, V42, P3798, DOI 10.1021/bi026962v; Voigt CA, 2005, GENETICS, V169, P1187, DOI 10.1534/genetics.104.031955; Wang L, 2009, P NATL ACAD SCI USA, V106, P6638, DOI 10.1073/pnas.0806137106; Wang MD, 1998, SCIENCE, V282, P902, DOI 10.1126/science.282.5390.902; Wang XJ, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-4-r30; WARD DF, 1979, J MOL BIOL, V133, P249, DOI 10.1016/0022-2836(79)90533-3; Waters LS, 2009, CELL, V136, P615, DOI 10.1016/j.cell.2009.01.043; Wong P, 1997, BIOTECHNOL PROGR, V13, P132, DOI 10.1021/bp970003o; Yelin R, 2003, NAT BIOTECHNOL, V21, P379, DOI 10.1038/nbt808	73	18	18	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2011	6	7							e21974	10.1371/journal.pone.0021974	http://dx.doi.org/10.1371/journal.pone.0021974			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791WM	21765930	gold, Green Published, Green Submitted			2022-12-27	WOS:000292699000018
J	Houben, R; Hesbacher, S; Schmid, CP; Kauczok, CS; Flohr, U; Haferkamp, S; Muller, CSL; Schrama, D; Wischhusen, J; Becker, JC				Houben, Roland; Hesbacher, Sonja; Schmid, Corinna P.; Kauczok, Claudia S.; Flohr, Ulrike; Haferkamp, Sebastian; Mueller, Cornelia S. L.; Schrama, David; Wischhusen, Joerg; Becker, Juergen C.			High-Level Expression of Wild-Type p53 in Melanoma Cells is Frequently Associated with Inactivity in p53 Reporter Gene Assays	PLOS ONE			English	Article							HUMAN-MALIGNANT MELANOMA; NECROSIS-FACTOR-ALPHA; MUTATIONS; CANCER; ACTIVATION; GAIN; STABILIZATION; PROGRESSION; MOLECULES; MUTANTS	Background: Inactivation of the p53 pathway that controls cell cycle progression, apoptosis and senescence, has been proposed to occur in virtually all human tumors and p53 is the protein most frequently mutated in human cancer. However, the mutational status of p53 in melanoma is still controversial; to clarify this notion we analysed the largest series of melanoma samples reported to date. Methodology/Principal Findings: Immunohistochemical analysis of more than 180 melanoma specimens demonstrated that high levels of p53 are expressed in the vast majority of cases. Subsequent sequencing of the p53 exons 5-8, however, revealed only in one case the presence of a mutation. Nevertheless, by means of two different p53 reporter constructs we demonstrate transcriptional inactivity of wild type p53 in 6 out of 10 melanoma cell lines; the 4 other p53 wild type melanoma cell lines exhibit p53 reporter gene activity, which can be blocked by shRNA knock down of p53. Conclusions/Significance: In melanomas expressing high levels of wild type p53 this tumor suppressor is frequently inactivated at transcriptional level.	[Houben, Roland; Hesbacher, Sonja; Schmid, Corinna P.; Kauczok, Claudia S.; Flohr, Ulrike; Haferkamp, Sebastian; Schrama, David] Univ Hosp Wurzburg, Dept Dermatol, Wurzburg, Germany; [Wischhusen, Joerg] Univ Wurzburg, Dept Obstet & Gynecol, Wurzburg, Germany; [Mueller, Cornelia S. L.] Univ Saarland, Dept Dermatol, D-6650 Homburg, Germany; [Schrama, David; Becker, Juergen C.] Med Univ Graz, Dept Gen Dermatol, Graz, Austria	University of Wurzburg; University of Wurzburg; Saarland University; Medical University of Graz	Houben, R (corresponding author), Univ Hosp Wurzburg, Dept Dermatol, Wurzburg, Germany.	juergen.becker@medunigraz.at	Haferkamp, Sebastian/AAN-3649-2021; Haferkamp, Sebastian/ABD-7390-2021	Haferkamp, Sebastian/0000-0002-3894-8345; Houben, Roland/0000-0003-4538-2324; Schrama, David/0000-0002-6931-8194	Deutsche Krebshilfe [108551]; German Research Foundation (DFG); University of Wuerzburg	Deutsche Krebshilfe(Deutsche Krebshilfe); German Research Foundation (DFG)(German Research Foundation (DFG)); University of Wuerzburg	This work was supported by the Deutsche Krebshilfe (grant 108551 project 11) and also funded by the German Research Foundation (DFG) and the University of Wuerzburg in the funding programme Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBINO AP, 1994, MELANOMA RES, V4, P35, DOI 10.1097/00008390-199402000-00006; Aylon Y, 2007, CELL, V130, P597, DOI 10.1016/j.cell.2007.08.005; Bakker ABH, 1998, J IMMUNOL, V160, P5239; BECKER JC, 1991, J IMMUNOL, V147, P4398; Bergamaschi D, 2003, NAT GENET, V33, P162, DOI 10.1038/ng1070; Blagosklonny MV, 1997, ONCOGENE, V15, P1889, DOI 10.1038/sj.onc.1201374; Box NF, 2008, PIGM CELL MELANOMA R, V21, P525, DOI 10.1111/j.1755-148X.2008.00495.x; CASTRESANA JS, 1993, INT J CANCER, V55, P562, DOI 10.1002/ijc.2910550407; CROOK T, 1991, CELL, V67, P547, DOI 10.1016/0092-8674(91)90529-8; Daniotti M, 2004, ONCOGENE, V23, P5968, DOI 10.1038/sj.onc.1207780; Dickopp A, 2000, CANCER GENE THER, V7, P1043, DOI 10.1038/sj.cgt.7700206; Green DR, 2006, CELL, V126, P30, DOI 10.1016/j.cell.2006.06.032; Grob TJ, 2001, CELL DEATH DIFFER, V8, P1213, DOI 10.1038/sj.cdd.4400962; Haapajarvi T, 1999, CELL GROWTH DIFFER, V10, P163; Haferkamp S, 2009, J INVEST DERMATOL, V129, P1983, DOI 10.1038/jid.2009.5; Homer C, 2005, ONCOGENE, V24, P8314, DOI 10.1038/sj.onc.1208998; Kastan MB, 2007, NAT CELL BIOL, V9, P489, DOI 10.1038/ncb0507-489; Kern SE, 2006, CANCER BIOL THER, V5, P349, DOI 10.4161/cbt.5.4.2551; Kruse JP, 2009, CELL, V137, P609, DOI 10.1016/j.cell.2009.04.050; Lavin MF, 2006, CELL DEATH DIFFER, V13, P941, DOI 10.1038/sj.cdd.4401925; LEHMANN JM, 1989, P NATL ACAD SCI USA, V86, P9891, DOI 10.1073/pnas.86.24.9891; Michael D, 2002, CURR OPIN GENET DEV, V12, P53, DOI 10.1016/S0959-437X(01)00264-7; Nikolaev AY, 2003, CELL, V112, P29, DOI 10.1016/S0092-8674(02)01255-2; Papp T, 1996, J CANCER RES CLIN, V122, P541, DOI 10.1007/BF01213550; Ragnarsson-Olding BK, 2002, MELANOMA RES, V12, P453, DOI 10.1097/00008390-200209000-00007; Riebeling C, 2003, MELANOMA RES, V13, P555, DOI 10.1097/00008390-200312000-00003; Roemer K, 1999, BIOL CHEM, V380, P879, DOI 10.1515/BC.1999.108; Satyamoorthy K, 2000, CELL GROWTH DIFFER, V11, P467; Sherr CJ, 2006, NAT REV CANCER, V6, P663, DOI 10.1038/nrc1954; Smith SL, 2009, J VIROL METHODS, V157, P47, DOI 10.1016/j.jviromet.2008.12.002; Solit DB, 2006, NATURE, V439, P358, DOI 10.1038/nature04304; Song H, 2007, CELL CYCLE, V6, P1570, DOI 10.4161/cc.6.13.4456; Tang Y, 2006, MOL CELL, V24, P827, DOI 10.1016/j.molcel.2006.11.021; Terzian T, 2010, PIGM CELL MELANOMA R, V23, P781, DOI 10.1111/j.1755-148X.2010.00773.x; van Oijen MGCT, 2000, CLIN CANCER RES, V6, P2138; VANMUIJEN GNP, 1991, CLIN EXP METASTAS, V9, P259, DOI 10.1007/BF01753729; Verhaegen M, 2006, CANCER RES, V66, P11348, DOI 10.1158/0008-5472.CAN-06-1748; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; Weisz L, 2007, CANCER RES, V67, P2396, DOI 10.1158/0008-5472.CAN-06-2425; Wischhusen J, 2003, ONCOGENE, V22, P8233, DOI 10.1038/sj.onc.1207198; Yang RC, 1999, J IMMUNOL, V163, P1037; YU H, 2009, AM J PATHOL; Zerp SF, 1999, BRIT J CANCER, V79, P921, DOI 10.1038/sj.bjc.6690147	43	42	45	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2011	6	7							e22096	10.1371/journal.pone.0022096	http://dx.doi.org/10.1371/journal.pone.0022096			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791IA	21760960	Green Published, gold, Green Submitted			2022-12-27	WOS:000292657200049
J	Larroque, B; Ancel, PY; Marchand-Martin, L; Cambonie, G; Fresson, J; Pierrat, V; Roze, JC; Marpeau, L; Thiriez, G; Alberge, C; Breart, G; Kaminski, M; Marret, S				Larroque, Beatrice; Ancel, Pierre-Yves; Marchand-Martin, Laetitia; Cambonie, Gilles; Fresson, Jeanne; Pierrat, Veronique; Roze, Jean-Christophe; Marpeau, Loic; Thiriez, Gerard; Alberge, Corinne; Breart, Gerard; Kaminski, Monique; Marret, Stephane		Epipage Study Grp	Special Care and School Difficulties in 8-Year-Old Very Preterm Children: The Epipage Cohort Study	PLOS ONE			English	Article							LOW-BIRTH-WEIGHT; YOUNG ADULTHOOD; GESTATIONAL-AGE; FOLLOW-UP; BORN; OUTCOMES; INFANTS; DISABILITIES; ADOLESCENCE; HEALTH	Objectives: To investigate school difficulties, special care and behavioral problems in 8 year-old very preterm (VPT) children. Patient and Methods: Longitudinal population-based cohort in nine regions of France of VPT children and a reference group born at 39-40 weeks of gestation (WG). The main outcome measures were information about school, special care and behavioral problems using Strengths and Difficulties Questionnaire from a questionnaire to parents. Results: Among the 1439 VPT children, 5% (75/1439) were in a specialised school or class, 18% (259/1439) had repeated a grade in a mainstream class and 77% (1105/1439) were in the appropriate grade-level in mainstream class; these figures were 1% (3/327), 5% (16/327) and 94% (308/327), respectively, for the reference group. Also, 15% (221/1435) of VPT children in a mainstream class received support at school versus 5% (16/326) of reference group. More VPT children between the ages of five and eight years received special care (55% (794/1436)) than children born at term (38% (124/325)); more VPT children (21% (292/1387)) had behavioral difficulties than the reference group (11% (35/319)). School difficulties, support at school, special care and behavioral difficulties in VPT children without neuromotor or sensory deficits varied with gestational age, socioeconomic status, and cognitive score at the age of five. Conclusions: Most 8-year-old VPT children are in mainstream schools. However, they have a high risk of difficulty in school, with more than half requiring additional support at school and/or special care. Referral to special services has increased between the ages of 5 and 8 years, but remained insufficient for those with borderline cognitive scores.	[Larroque, Beatrice; Ancel, Pierre-Yves; Marchand-Martin, Laetitia; Breart, Gerard; Kaminski, Monique] INSERM, UMR S953, IFR 69, Paris, France; [Larroque, Beatrice; Ancel, Pierre-Yves; Marchand-Martin, Laetitia; Breart, Gerard; Kaminski, Monique] Univ Paris 06, UPMC, UMR S953, Paris, France; [Cambonie, Gilles] Arnaud de Villeneuve Hosp, Dept Neonatol, Montpellier, France; [Fresson, Jeanne] Reg Matern Univ Hosp, Nancy, France; [Pierrat, Veronique] Jeanne de Flandres Hosp, Dept Neonatol, Lille, France; [Roze, Jean-Christophe] Childrens Hosp, Dept Neonatol, Nantes, France; [Marpeau, Loic] Rouen Univ Hosp, Dept Obstet & Gynaecol, Rouen, France; [Marpeau, Loic; Marret, Stephane] Univ Rouen, Inst Biomed Res & Innovat, EA Perinatal Neurol Handicap 4309, Rouen, France; [Thiriez, Gerard] St Jacques Hosp, Paediat Intens Care Unit, Besancon, France; [Alberge, Corinne] Childrens Hosp, Toulouse, France; [Marret, Stephane] Rouen Univ Hosp, Dept Neonatal Med, Rouen, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite de Montpellier; CHU de Montpellier; CHU de Nancy; Universite de Lille - ISITE; CHU Lille; Nantes Universite; CHU de Nantes; CHU de Rouen; Universite de Rouen Normandie; Universite de Franche-Comte; CHU Besancon; CHU de Toulouse; CHU de Rouen	Larroque, B (corresponding author), INSERM, UMR S953, IFR 69, Paris, France.	beatrice.larroque@bjn.aphp.fr	roze, jean christophe/B-5433-2012; Blondel, Beatrice/G-5011-2017; Rozé, Jean-Christophe/AAS-1314-2021; ARNAUD, Catherine/AAC-5646-2019; EGO, Anne/G-7071-2011	ARNAUD, Catherine/0000-0002-4002-802X; EGO, Anne/0000-0002-1025-910X; ANCEL, pierre-yves/0000-0001-9632-7494; burguet, antoine/0000-0001-5140-2884; breart, gerard/0000-0003-3142-9128; pierrat, veronique/0000-0001-7435-5144; Roze, Jean-Christophe/0000-0003-3367-512X; CAMBONIE, GILLES/0000-0002-1360-7915; Marchand-Martin, Laetitia/0000-0002-8036-8387; Marret, Stephane/0000-0002-2858-148X	INSERM (National Institute of Health and Medical Research); Directorate General for Health at the Ministry for Social Affairs; Merck-Sharp and Dohme-Chibret; Medical Research Foundation; French Department of Health; Wyeth Foundation for Children and Adolescents	INSERM (National Institute of Health and Medical Research)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Directorate General for Health at the Ministry for Social Affairs; Merck-Sharp and Dohme-Chibret; Medical Research Foundation(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); French Department of Health; Wyeth Foundation for Children and Adolescents	This study was supported by grants from INSERM (National Institute of Health and Medical Research)(http://www.inserm.fr/), the Directorate General for Health at the Ministry for Social Affairs (http://www.sante.gouv.fr/), Merck-Sharp and Dohme-Chibret (http://www.msd-france.com/content/corporate/index.html), Medical Research Foundation (http://www.frm.org/), and "Hospital Program for Clinical Research 2001 n<SUP>o</SUP>AOM01117" of the French Department of Health (http://www.sante.gouv.fr/ le-programme-hospitalier-de-recherche-clinique-phrc.html). The eight year follow-up was supported by the "Hospital Program for Clinical Research 2004/054/HP" at the French Department of Health and the Wyeth Foundation for Children and Adolescents (http://www.fondation-pfizer.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarnoudse-Moens CSH, 2009, PEDIATRICS, V124, P717, DOI 10.1542/peds.2008-2816; Anderson PJ, 2008, SEMIN PERINATOL, V32, P51, DOI 10.1053/j.semperi.2007.12.009; Aylward GP, 2005, J DEV BEHAV PEDIATR, V26, P427, DOI 10.1097/00004703-200512000-00008; Bhutta AT, 2002, JAMA-J AM MED ASSOC, V288, P728, DOI 10.1001/jama.288.6.728; Cooke RWI, 2004, ARCH DIS CHILD, V89, P201, DOI 10.1136/adc.2003.030197; D'Angio CT, 2002, PEDIATRICS, V110, P1094, DOI 10.1542/peds.110.6.1094; Goodman R, 2001, J AM ACAD CHILD PSY, V40, P1337, DOI 10.1097/00004583-200111000-00015; Gross SJ, 2001, J PEDIATR-US, V138, P169, DOI 10.1067/mpd.2001.111945; Hack M, 2002, NEW ENGL J MED, V346, P149, DOI 10.1056/NEJMoa010856; Hackman DA, 2009, TRENDS COGN SCI, V13, P65, DOI 10.1016/j.tics.2008.11.003; Hille ETM, 2007, PEDIATRICS, V120, pE587, DOI 10.1542/peds.2006-2407; Hille ETM, 2005, PEDIATRICS, V116, pE662, DOI 10.1542/peds.2005-0682; Hintz SR, 2008, ARCH PEDIAT ADOL MED, V162, P748, DOI 10.1001/archpedi.162.8.748; Johnson A, 2003, ARCH DIS CHILD-FETAL, V88, P190; Johnson S, 2009, ARCH DIS CHILD-FETAL, V94, pF283, DOI 10.1136/adc.2008.152793; Landry SH, 2001, DEV PSYCHOL, V37, P387, DOI 10.1037//0012-1649.37.3.387; Larroque B, 2004, ARCH DIS CHILD-FETAL, V89, P139, DOI 10.1136/adc.2002.020396; Larroque B, 2008, LANCET, V371, P813, DOI 10.1016/S0140-6736(08)60380-3; Laucht M, 2001, DEV MED CHILD NEUROL, V43, P292, DOI 10.1017/S0012162201000561; Litt J, 2005, J LEARN DISABIL-US, V38, P130, DOI 10.1177/00222194050380020301; Miceli PJ, 2000, J PEDIATR PSYCHOL, V25, P353, DOI 10.1093/jpepsy/25.5.353; Peterson BS, 2002, PEDIATRICS, V110, P1153, DOI 10.1542/peds.110.6.1153; Roberts G, 2010, ARCH DIS CHILD-FETAL, V95, pF90, DOI 10.1136/adc.2009.165480; Saigal S, 2000, PEDIATRICS, V105, P325, DOI 10.1542/peds.105.2.325; Saigal S, 2006, JAMA-J AM MED ASSOC, V295, P667, DOI 10.1001/jama.295.6.667; Saigal S, 2003, PEDIATRICS, V112, P943, DOI 10.1542/peds.112.4.943; Saigal S, 2008, LANCET, V371, P261, DOI 10.1016/S0140-6736(08)60136-1; Wood NS, 2000, NEW ENGL J MED, V343, P378, DOI 10.1056/NEJM200008103430601	28	66	67	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2011	6	7							e21361	10.1371/journal.pone.0021361	http://dx.doi.org/10.1371/journal.pone.0021361			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	791IA	21760892	Green Published, Green Submitted, gold			2022-12-27	WOS:000292657200011
J	Sontrop, HMJ; Verhaegh, WFJ; Reinders, MJT; Moerland, PD				Sontrop, Herman M. J.; Verhaegh, Wim F. J.; Reinders, Marcel J. T.; Moerland, Perry D.			An Evaluation Protocol for Subtype-Specific Breast Cancer Event Prediction	PLOS ONE			English	Article							GENE-EXPRESSION DATA; CLASSIFICATION; METASTASIS; VALIDATION; SIGNATURE; ACCURACY	In recent years increasing evidence appeared that breast cancer may not constitute a single disease at the molecular level, but comprises a heterogeneous set of subtypes. This suggests that instead of building a single monolithic predictor, better predictors might be constructed that solely target samples of a designated subtype, which are believed to represent more homogeneous sets of samples. An unavoidable drawback of developing subtype-specific predictors, however, is that a stratification by subtype drastically reduces the number of samples available for their construction. As numerous studies have indicated sample size to be an important factor in predictor construction, it is therefore questionable whether the potential benefit of subtyping can outweigh the drawback of a severe loss in sample size. Factors like unequal class distributions and differences in the number of samples per subtype, further complicate comparisons. We present a novel experimental protocol that facilitates a comprehensive comparison between subtype-specific predictors and predictors that do not take subtype information into account. Emphasis lies on careful control of sample size as well as class and subtype distributions. The methodology is applied to a large breast cancer compendium involving over 1500 arrays, using a state-of-the-art subtyping scheme. We show that the resulting subtype-specific predictors outperform those that do not take subtype information into account, especially when taking sample size considerations into account.	[Sontrop, Herman M. J.; Verhaegh, Wim F. J.] Philips Res, Mol Diagnost Dept, Eindhoven, Netherlands; [Reinders, Marcel J. T.] Delft Univ Technol, Delft Bioinformat Lab, Delft, Netherlands; [Moerland, Perry D.] Univ Amsterdam, Acad Med Ctr, Dept Clin Epidemiol Biostat & Bioinformat, Bioinformat Lab, NL-1105 AZ Amsterdam, Netherlands; [Reinders, Marcel J. T.; Moerland, Perry D.] Netherlands Bioinformat Ctr, Nijmegen, Netherlands	Philips; Philips Research; Delft University of Technology; University of Amsterdam; Academic Medical Center Amsterdam	Sontrop, HMJ (corresponding author), Philips Res, Mol Diagnost Dept, Eindhoven, Netherlands.	p.d.moerland@amc.uva.nl	Moerland, Perry/AAG-1425-2020	Moerland, Perry/0000-0002-2357-3659	Philips Research; Delft University of Technology; Academic Medical Center, The Netherlands	Philips Research; Delft University of Technology; Academic Medical Center, The Netherlands(Netherlands Government)	This research was supported by Philips Research, Delft University of Technology, and the Academic Medical Center, The Netherlands. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldi P, 2000, BIOINFORMATICS, V16, P412, DOI 10.1093/bioinformatics/16.5.412; Blagus R, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-523; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Chin K, 2006, CANCER CELL, V10, P529, DOI 10.1016/j.ccr.2006.10.009; Desmedt C, 2008, CLIN CANCER RES, V14, P5158, DOI 10.1158/1078-0432.CCR-07-4756; Desmedt C, 2007, CLIN CANCER RES, V13, P3207, DOI 10.1158/1078-0432.CCR-06-2765; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Haibe-Kains B, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r18; HAIBEKAINS B, 2009, THESIS U LIBRE BRUXE; He HB, 2009, IEEE T KNOWL DATA EN, V21, P1263, DOI 10.1109/TKDE.2008.239; Ihaka R., 1996, J COMPUT GRAPH STAT, V5, P299, DOI [DOI 10.1080/10618600.1996.10474713, 10.2307/1390807]; Kapp AV, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-231; Kauffmann Audrey, 2009, Bioinformatics, V25, P415, DOI 10.1093/bioinformatics/btn647; Kim SY, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-147; Loi S, 2007, J CLIN ONCOL, V25, P1239, DOI 10.1200/JCO.2006.07.1522; McClintick JN, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-49; Michiels S, 2005, LANCET, V365, P488, DOI 10.1016/S0140-6736(05)17866-0; Miller LD, 2005, P NATL ACAD SCI USA, V102, P13550, DOI 10.1073/pnas.0506230102; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Parker BJ, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-326; Parker JS, 2009, J CLIN ONCOL, V27, P1160, DOI 10.1200/JCO.2008.18.1370; Parkinson H, 2005, NUCLEIC ACIDS RES, V33, pD553; Pawitan Y, 2005, BREAST CANCER RES, V7, pR953, DOI 10.1186/bcr1325; Perou CM, 2010, LANCET ONCOL, V11, P718, DOI 10.1016/S1470-2045(10)70176-5; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Pusztai L, 2006, ONCOLOGIST, V11, P868, DOI 10.1634/theoncologist.11-8-868; ROTA GC, 1964, AM MATH MON, V71, P498, DOI 10.2307/2312585; Schmidt M, 2008, CANCER RES, V68, P5405, DOI 10.1158/0008-5472.CAN-07-5206; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Sontrop HMJ, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-389; Sotiriou C, 2006, JNCI-J NATL CANCER I, V98, P262, DOI 10.1093/jnci/djj052; van Vliet MH, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-375; van 't Veer LJ, 2008, NATURE, V452, P564, DOI 10.1038/nature06915; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1; Weigelt B, 2010, LANCET ONCOL, V11, P339, DOI 10.1016/S1470-2045(10)70008-5; Weigelt B, 2010, J PATHOL, V220, P263, DOI 10.1002/path.2648; Wessels LFA, 2005, BIOINFORMATICS, V21, P3755, DOI 10.1093/bioinformatics/bti429; Yasrebi H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007431; Yu JX, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-182	42	8	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2011	6	7							e21681	10.1371/journal.pone.0021681	http://dx.doi.org/10.1371/journal.pone.0021681			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791IA	21760900	Green Published, gold, Green Submitted			2022-12-27	WOS:000292657200018
J	Zeitzer, JM; Ruby, NF; Fisicaro, RA; Heller, HC				Zeitzer, Jamie M.; Ruby, Norman F.; Fisicaro, Ryan A.; Heller, H. Craig			Response of the Human Circadian System to Millisecond Flashes of Light	PLOS ONE			English	Article							RETINAL GANGLION-CELLS; BRIGHT LIGHT; PHASE; MELATONIN; RHYTHMS; PULSES; SLEEP; PHOTORECEPTORS; TEMPERATURE; SENSITIVITY	Ocular light sensitivity is the primary mechanism by which the central circadian clock, located in the suprachiasmatic nucleus (SCN), remains synchronized with the external geophysical day. This process is dependent on both the intensity and timing of the light exposure. Little is known about the impact of the duration of light exposure on the synchronization process in humans. In vitro and behavioral data, however, indicate the circadian clock in rodents can respond to sequences of millisecond light flashes. In a cross-over design, we tested the capacity of humans (n = 7) to respond to a sequence of 60 2-msec pulses of moderately bright light (473 lux) given over an hour during the night. Compared to a control dark exposure, after which there was a 3.5 +/- 7.3 min circadian phase delay, the millisecond light flashes delayed the circadian clock by 45 +/- 13 min (p<0.01). These light flashes also concomitantly increased subjective and objective alertness while suppressing delta and sigma activity (p<0.05) in the electroencephalogram (EEG). Our data indicate that phase shifting of the human circadian clock and immediate alerting effects can be observed in response to brief flashes of light. These data are consistent with the hypothesis that the circadian system can temporally integrate extraordinarily brief light exposures.	[Zeitzer, Jamie M.] Stanford Univ, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA; [Zeitzer, Jamie M.] VA Palo Alto Hlth Care Syst, Mental Illness Res Educ & Clin Ctr, Palo Alto, CA USA; [Ruby, Norman F.; Heller, H. Craig] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Fisicaro, Ryan A.] Stanford Univ, Sch Humanities & Sci, Stanford, CA 94305 USA	Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Stanford University; Stanford University	Zeitzer, JM (corresponding author), Stanford Univ, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA.	jzeitzer@stanford.edu	Zeitzer, Jamie M/A-1168-2007; Zeitzer, Jamie/AAO-2103-2020	Zeitzer, Jamie M/0000-0001-6174-5282; Zeitzer, Jamie/0000-0001-6174-5282; Heller, H Craig/0000-0003-4479-5880	Air Force Office of Scientific Research [F2-4506]	Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR))	Work described in this manuscript was supported by the Air Force Office of Scientific Research (F2-4506). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ancoli-Israel S, 2003, SLEEP, V26, P342, DOI 10.1093/sleep/26.3.342; Arvanitogiannis A, 1999, NEUROSCI LETT, V261, P159, DOI 10.1016/S0304-3940(99)00021-X; Berson DM, 2002, SCIENCE, V295, P1070, DOI 10.1126/science.1067262; Borbely A. A., 2005, PRINCIPLES PRACTICE, P405; Brown TM, 2011, J PHYSIOL-LONDON, V589, P1173, DOI 10.1113/jphysiol.2010.199877; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Cajochen C, 2000, BEHAV BRAIN RES, V115, P75, DOI 10.1016/S0166-4328(00)00236-9; Chang A, 2011, SLEEP, V34, pA162; DINGES DF, 1985, BEHAV RES METH INSTR, V17, P652, DOI 10.3758/BF03200977; Duffy JE, 2002, J BIOL RHYTHM, V17, P4, DOI 10.1177/074873002129002294; Duffy JF, 2009, SLEEP MED CLIN, V4, P165, DOI 10.1016/j.jsmc.2009.01.004; Duffy JF, 1999, J INVEST MED, V47, P141; Gronfier C, 2004, AM J PHYSIOL-ENDOC M, V287, pE174, DOI 10.1152/ajpendo.00385.2003; GROOS GA, 1985, ANN NY ACAD SCI, V453, P134, DOI 10.1111/j.1749-6632.1985.tb11806.x; HODDES E, 1973, PSYCHOPHYSIOLOGY, V10, P431, DOI 10.1111/j.1469-8986.1973.tb00801.x; HORNE J A, 1976, International Journal of Chronobiology, V4, P97; JEWETT ME, 1994, J BIOL RHYTHM, V9, P295, DOI 10.1177/074873049400900310; JUNG CM, 2010, J SLEEP RES IN PRESS; Khalsa SBS, 2003, J PHYSIOL-LONDON, V549, P945, DOI 10.1113/jphysiol.2003.040477; MEIJER JH, 1991, SUPRACHIASMATIC NUCL, P107; MIFFLIN MD, 1990, AM J CLIN NUTR, V51, P241, DOI 10.1093/ajcn/51.2.241; Morin LP, 2009, J BIOL RHYTHM, V24, P497, DOI 10.1177/0748730409349059; Murphy Patricia J., 1996, Physiology and Behavior, V59, P133, DOI 10.1016/0031-9384(95)02036-5; NELSON DE, 1991, J PHYSIOL-LONDON, V439, P115, DOI 10.1113/jphysiol.1991.sp018660; Paul KN, 2009, REV ENDOCR METAB DIS, V10, P271, DOI 10.1007/s11154-009-9120-x; Rechtschaffen A., 1968, BRAIN INFORM SERVICE; Van den Pol AN, 1998, AM J PHYSIOL-REG I, V275, pR654, DOI 10.1152/ajpregu.1998.275.2.R654; Vidal L, 2007, J NEUROSCI, V27, P3375, DOI 10.1523/JNEUROSCI.5496-06.2007; Voultsios A, 1997, J BIOL RHYTHM, V12, P457, DOI 10.1177/074873049701200507; Wong KY, 2007, J PHYSIOL-LONDON, V582, P279, DOI 10.1113/jphysiol.2007.133751; Wong KY, 2005, NEURON, V48, P1001, DOI 10.1016/j.neuron.2005.11.016; Zeitzer JM, 2000, J PHYSIOL-LONDON, V526, P695, DOI 10.1111/j.1469-7793.2000.00695.x	32	59	60	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2011	6	7							e22078	10.1371/journal.pone.0022078	http://dx.doi.org/10.1371/journal.pone.0022078			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791IA	21760955	Green Published, gold, Green Submitted			2022-12-27	WOS:000292657200045
J	Oliveira, R; de Morais, ZM; Goncales, AP; Romero, EC; Vasconcellos, SA; Nascimento, ALTO				Oliveira, Rosane; de Morais, Zenaide Maria; Goncales, Amane Paldes; Romero, Eliete Calo; Vasconcellos, Silvio Arruda; Nascimento, Ana L. T. O.			Characterization of Novel OmpA-Like Protein of Leptospira interrogans That Binds Extracellular Matrix Molecules and Plasminogen	PLOS ONE			English	Article							GRAM-NEGATIVE BACTERIA; IMMUNOGLOBULIN-LIKE PROTEINS; OUTER-MEMBRANE PROTEINS; ESCHERICHIA-COLI; VIRULENCE DETERMINANTS; PATHOGENIC LEPTOSPIRA; FLAGELLAR MOTOR; SURFACE; IDENTIFICATION; LIPOPROTEIN	Leptospira interrogans is the etiological agent of leptospirosis, a zoonotic disease of human and veterinary concern. The identification of novel proteins that mediate host-pathogen interactions is important for understanding the bacterial pathogenesis as well as to identify protective antigens that would help fight the disease. We describe in this work the cloning, expression, purification and characterization of three predicted leptospiral membrane proteins, LIC10258, LIC12880 (Lp30) and LIC12238. We have employed Escherichia coli BL21 (SI) strain as a host expression system. Recently, we have identified LIC12238 as a plasminogen (PLG)-binding receptor. We show now that Lp30 and rLIC10258 are also PLG-receptors of Leptospira, both exhibiting dose-dependent and saturating binding (K(D), 68.8 +/- 25.2 nM and 167.39 +/- 60.1 nM, for rLIC10258 and rLIC12880, respectively). In addition, LIC10258, which is a novel OmpA-like protein, binds laminin and plasma fibronectin ECM molecules and hence, it was named Lsa66 (Leptospiral surface adhesin of 66 kDa). Binding of Lsa66 to ECM components was determined to be specific, dose-dependent and saturable, with a KD of 55.4 +/- 15.9 nM to laminin and of 290.8 +/- 11.8 nM to plasma fibronectin. Binding of the recombinant proteins to PLG or ECM components was assessed by using antibodies against each of the recombinant proteins obtained in mice and confirmed by monoclonal anti-polyhistidine antibodies. Lsa66 caused partial inhibition on leptospiral adherence to immobilized ECM and PLG. Moreover, this adhesin and rLIC12238 are recognized by antibodies in serum samples of confirmed leptospirosis cases. Thus, Lsa66 is a novel OmpA-like protein with dual activity that may promote the attachment of Leptospira to host tissues and may contribute to the leptospiral invasion. To our knowledge, this is the first leptospiral protein with ECM and PLG binding properties reported to date.	[Oliveira, Rosane; Nascimento, Ana L. T. O.] Inst Butantan, Ctr Biotecnol, Sao Paulo, Brazil; [Oliveira, Rosane; Nascimento, Ana L. T. O.] Univ Sao Paulo, Inst Ciencias Biomed, Interunidades Biotecnol, BR-05508 Sao Paulo, Brazil; [de Morais, Zenaide Maria; Goncales, Amane Paldes; Vasconcellos, Silvio Arruda] Univ Sao Paulo, Fac Med Vet & Zootecnia, Lab Zoonoses Bacterianas VPS, Sao Paulo, Brazil; [Romero, Eliete Calo] Inst Adolfo Lutz Registro, Ctr Bacteriol, Sao Paulo, Brazil	Instituto Butantan; Universidade de Sao Paulo; Universidade de Sao Paulo; Instituto Adolfo Lutz	Oliveira, R (corresponding author), Inst Butantan, Ctr Biotecnol, Sao Paulo, Brazil.	tabet@butantan.gov.br	GONÇALES, AMANE P/D-9409-2015; Nascimento, Ana L. T. O./E-8488-2012; Romero, Eliete C/H-6976-2012	Nascimento, Ana L. T. O./0000-0003-4851-0870; Romero, Eliete C/0000-0002-8635-439X	FAPESP; CNPq; Fundacao Butantan, Brazil	FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao Butantan, Brazil	This work was supported by FAPESP, CNPq and Fundacao Butantan, Brazil. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Atzingen MV, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-70; ATZINGEN MV, 2009, J INFECT; Barbosa AS, 2006, INFECT IMMUN, V74, P6356, DOI 10.1128/IAI.00460-06; BOLIN CA, 1989, AM J VET RES, V50, P161; Bulach DM, 2006, P NATL ACAD SCI USA, V103, P14560, DOI 10.1073/pnas.0603979103; Carvalho E, 2009, FEBS LETT; Cascales E, 2002, J BACTERIOL, V184, P754, DOI 10.1128/JB.184.3.754-759.2002; Choy HA, 2007, INFECT IMMUN, V75, P2441, DOI 10.1128/IAI.01635-06; Coleman JL, 1999, J LAB CLIN MED, V134, P567, DOI 10.1016/S0022-2143(99)90095-1; Croda J, 2007, J CLIN MICROBIOL, V45, P1528, DOI 10.1128/JCM.02344-06; DELEAGE G, 1993, COMPUT APPL BIOSCI, V9, P197; Faine S, 1999, LEPTOSPIRA LEPTOSPIR, V2nd; Fenno JC, 2000, INFECT IMMUN, V68, P1884, DOI 10.1128/IAI.68.4.1884-1892.2000; Finn RD, 2006, NUCLEIC ACIDS RES, V34, pD247, DOI 10.1093/nar/gkj149; Flannery B, 2001, J CLIN MICROBIOL, V39, P3303, DOI 10.1128/JCM.39.9.3303-3310.2001; Fraga TR, 2010, J BIOTECHNOL, V148, P156, DOI 10.1016/j.jbiotec.2010.04.007; GALAN JE, 1991, INFECT IMMUN, V59, P2901; Grizot S, 2004, MOL MICROBIOL, V51, P1027, DOI 10.1111/j.1365-2958.2003.03903.x; Haake DA, 2000, INFECT IMMUN, V68, P2276, DOI 10.1128/IAI.68.4.2276-2285.2000; Haake DA, 2002, INFECT IMMUN, V70, P4936, DOI 10.1128/IAI.70.9.4936-4945.2002; Hoke DE, 2008, INFECT IMMUN, V76, P2063, DOI 10.1128/IAI.01643-07; Hsieh WJ, 2005, FEMS MICROBIOL LETT, V243, P339, DOI 10.1016/j.femsle.2004.12.021; Juncker AS, 2003, PROTEIN SCI, V12, P1652, DOI 10.1110/ps.0303703; Klempner MS, 1996, J INFECT DIS, V174, P97, DOI 10.1093/infdis/174.1.97; Kojima S, 2004, INT REV CYTOL, V233, P93, DOI 10.1016/S0074-7696(04)33003-2; Kojima S, 2008, P NATL ACAD SCI USA, V105, P7696, DOI 10.1073/pnas.0800308105; LeBouder F, 2008, J VIROL, V82, P6820, DOI 10.1128/JVI.00246-08; Letunic I, 2006, NUCLEIC ACIDS RES, V34, pD257, DOI 10.1093/nar/gkj079; Levett PN, 2001, CLIN MICROBIOL REV, V14, P296, DOI 10.1128/CMR.14.2.296-326.2001; Lin YP, 2009, J BIOL CHEM, V284, P19380, DOI 10.1074/jbc.M109.004531; Ljungh A, 1996, FEMS IMMUNOL MED MIC, V16, P117, DOI 10.1016/S0928-8244(96)00073-9; Longhi MT, 2009, J MED MICROBIOL, V58, P1275, DOI 10.1099/jmm.0.011916-0; Malmstrom J, 2009, NATURE, V460, P762, DOI 10.1038/nature08184; Marchler-Bauer A, 2009, NUCLEIC ACIDS RES, V37, pD205, DOI 10.1093/nar/gkn845; Matsunaga J, 2003, MOL MICROBIOL, V49, P929, DOI 10.1046/j.1365-2958.2003.03619.x; Matsunaga J, 2007, INFECT IMMUN, V75, P2864, DOI 10.1128/IAI.01619-06; MEKALANOS JJ, 1992, J BACTERIOL, V174, P1; Merien F, 2000, FEMS MICROBIOL LETT, V185, P17, DOI 10.1111/j.1574-6968.2000.tb09034.x; MILLER VL, 1988, J BACTERIOL, V170, P2575, DOI 10.1128/JB.170.6.2575-2583.1988; NAKAI K, 1991, PROTEINS, V11, P95, DOI 10.1002/prot.340110203; Nascimento ALTO, 2004, BRAZ J MED BIOL RES, V37, P459, DOI 10.1590/S0100-879X2004000400003; Neves FO, 2007, ARCH MICROBIOL, V188, P523, DOI 10.1007/s00203-007-0273-2; Oliveira TR, 2010, MICROBES INFECT, V12, P207, DOI 10.1016/j.micinf.2009.12.004; Parsons LM, 2006, BIOCHEMISTRY-US, V45, P2122, DOI 10.1021/bi052227i; Picardeau M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001607; Pinne M, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000815; Ramos CRR, 2004, BRAZ J MED BIOL RES, V37, P1103, DOI 10.1590/S0100-879X2004000800001; Ren SX, 2003, NATURE, V422, P888, DOI 10.1038/nature01597; Ristow P, 2007, PLOS PATHOG, V3, P894, DOI 10.1371/journal.ppat.0030097; Rojas M, 2008, ACTA TROP, V107, P54, DOI 10.1016/j.actatropica.2008.04.013; Smith SGJ, 2007, FEMS MICROBIOL LETT, V273, P1, DOI 10.1111/j.1574-6968.2007.00778.x; Stevenson B, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001188; Sun HM, 2006, PHYSIOLOGY, V21, P281, DOI 10.1152/physiol.00059.2005; TURNER LH, 1970, T ROY SOC TROP MED H, V64, P623, DOI 10.1016/0035-9203(70)90087-8; Verma A, 2006, INFECT IMMUN, V74, P2659, DOI 10.1128/IAI.74.5.2659-2666.2006; Verma A, 2010, INFECT IMMUN, V78, P2053, DOI 10.1128/IAI.01282-09; Vieira ML, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011259; Vieira ML, 2010, J INFECTION, V60, P52, DOI 10.1016/j.jinf.2009.10.047; Vieira ML, 2009, INFECT IMMUN, V77, P4092, DOI 10.1128/IAI.00353-09; Wang Y, 2002, BIOCHEM BIOPH RES CO, V292, P396, DOI 10.1006/bbrc.2002.6657; Yan WW, 2010, VACCINE, V28, P2277, DOI 10.1016/j.vaccine.2009.12.071; Yu CS, 2004, PROTEIN SCI, V13, P1402, DOI 10.1110/ps.03479604; Zhang Y, 2010, ACTA BIOCH BIOPH SIN, V42, P70, DOI 10.1093/abbs/gmp109	64	50	51	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2011	6	7							e21962	10.1371/journal.pone.0021962	http://dx.doi.org/10.1371/journal.pone.0021962			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791AK	21755014	Green Published, gold, Green Submitted			2022-12-27	WOS:000292632000041
J	Herrmann, A; Haake, A; Ammerpohl, O; Martin-Guerrero, I; Szafranski, K; Stemshorn, K; Nothnagel, M; Kotsopoulos, SK; Richter, J; Warner, J; Olson, J; Link, DR; Schreiber, S; Krawczak, M; Platzer, M; Nurnberg, P; Siebert, R; Hampe, J				Herrmann, Alexander; Haake, Andrea; Ammerpohl, Ole; Martin-Guerrero, Idoia; Szafranski, Karol; Stemshorn, Kathryn; Nothnagel, Michael; Kotsopoulos, Steve K.; Richter, Julia; Warner, Jason; Olson, Jeff; Link, Darren R.; Schreiber, Stefan; Krawczak, Michael; Platzer, Matthias; Nuernberg, Peter; Siebert, Reiner; Hampe, Jochen			Pipeline for Large-Scale Microdroplet Bisulfite PCR-Based Sequencing Allows the Tracking of Hepitype Evolution in Tumors	PLOS ONE			English	Article							DNA METHYLATION PATTERNS; ELECTRONIC PCR; CANCER; GENE; GENOME; REVEALS; SIGNATURES; PROMOTERS; LYMPHOMA; DISEASE	Cytosine methylation provides an epigenetic level of cellular plasticity that is important for development, differentiation and cancerogenesis. We adopted microdroplet PCR to bisulfite treated target DNA in combination with second generation sequencing to simultaneously assess DNA sequence and methylation. We show measurement of methylation status in a wide range of target sequences (total 34 kb) with an average coverage of 95% (median 100%) and good correlation to the opposite strand (rho = 0.96) and to pyrosequencing (rho = 0.87). Data from lymphoma and colorectal cancer samples for SNRPN (imprinted gene), FGF6 (demethylated in the cancer samples) and HS3ST2 (methylated in the cancer samples) serve as a proof of principle showing the integration of SNP data and phased DNA-methylation information into "hepitypes" and thus the analysis of DNA methylation phylogeny in the somatic evolution of cancer.	[Herrmann, Alexander; Schreiber, Stefan; Hampe, Jochen] Univ Kiel, Inst Internal Med 1, Kiel, Germany; [Haake, Andrea; Ammerpohl, Ole; Martin-Guerrero, Idoia; Richter, Julia; Siebert, Reiner] Univ Kiel, Inst Human Genet, Kiel, Germany; [Szafranski, Karol; Platzer, Matthias] Fritz Lipman Inst Ageing Res, Genome Anal Grp, Jena, Germany; [Stemshorn, Kathryn; Nuernberg, Peter] Univ Cologne, Cologne Ctr Genom, Cologne, Germany; [Nothnagel, Michael; Link, Darren R.; Krawczak, Michael] Univ Kiel, Inst Med Informat & Stat, Kiel, Germany; [Kotsopoulos, Steve K.; Warner, Jason; Olson, Jeff] RainDance Technol, Lexington, MA USA	University of Kiel; University of Kiel; University of Cologne; University of Kiel	Herrmann, A (corresponding author), Univ Kiel, Inst Internal Med 1, Kiel, Germany.	jhampe@1med.uni-kiel.de	Nothnagel, Michael/G-6545-2014; Krawczak, Michael/A-8964-2010; Nothnagel, Michael/H-6887-2012; Hampe, Jochen/A-2555-2010; Siebert, Reiner/A-8049-2010; Ammerpohl, Ole/G-2691-2010; Martin-Guerrero, Idoia/AAF-3446-2020; Nothnagel, Michael/L-7187-2019	Krawczak, Michael/0000-0003-2603-1502; Hampe, Jochen/0000-0002-2421-6127; Nothnagel, Michael/0000-0001-8305-7114; Martin-Guerrero, Idoia/0000-0002-0098-1908	German Ministry for Education and Research through German National Genome Research Network (NGFNplus); German Ministry for Education and Research through Systems Biology Networks; German Ministry for Education and Research; Government of the Basque Country	German Ministry for Education and Research through German National Genome Research Network (NGFNplus); German Ministry for Education and Research through Systems Biology Networks; German Ministry for Education and Research(Federal Ministry of Education & Research (BMBF)); Government of the Basque Country	This study was supported by the German Ministry for Education and Research through the German National Genome Research Network (NGFNplus) projects Colon Cancer Network "Oncogene", and "EMINet", through the Systems Biology Networks "HamatoSys" and "Virtual Liver" and through "Services@MediGrid". I. M-G. receives a stipend from the Government of the Basque Country. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ball MP, 2009, NAT BIOTECHNOL, V27, P361, DOI 10.1038/nbt.1533; Beck S, 2010, METHODS, V52, P201, DOI 10.1016/j.ymeth.2010.10.003; Bell CG, 2009, GENOME MED, V1, DOI 10.1186/gm56; Bignell GR, 2010, NATURE, V463, P893, DOI 10.1038/nature08768; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Bock C, 2010, NAT BIOTECHNOL, V28, P1106, DOI 10.1038/nbt.1681; Bracken AP, 2009, NAT REV CANCER, V9, P773, DOI 10.1038/nrc2736; Campbell PJ, 2008, P NATL ACAD SCI USA, V105, P13081, DOI 10.1073/pnas.0801523105; Cokus SJ, 2008, NATURE, V452, P215, DOI 10.1038/nature06745; Costello J F, 2000, Brain Tumor Pathol, V17, P49, DOI 10.1007/BF02482735; Costello JF, 2000, NAT GENET, V24, P132, DOI 10.1038/72785; Dittrich B, 1996, NAT GENET, V14, P163, DOI 10.1038/ng1096-163; Eckhardt F, 2006, NAT GENET, V38, P1378, DOI 10.1038/ng1909; Faust C, 1998, DEVELOPMENT, V125, P4495; Gal-Yam EN, 2008, P NATL ACAD SCI USA, V105, P12979, DOI 10.1073/pnas.0806437105; Gal-Yam EN, 2008, ANNU REV MED, V59, P267, DOI 10.1146/annurev.med.59.061606.095816; Harris RA, 2010, NAT BIOTECHNOL, V28, P1097, DOI 10.1038/nbt.1682; HOULSTON RS, 2008, NAT GENET; Hummel M, 2006, NEW ENGL J MED, V354, P2419, DOI 10.1056/NEJMoa055351; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Kanber D, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000790; Kerkel K, 2008, NAT GENET, V40, P904, DOI 10.1038/ng.174; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Martin-Subero JI, 2009, BLOOD, V113, P2488, DOI 10.1182/blood-2008-04-152900; Maunakea AK, 2010, NATURE, V466, P253, DOI 10.1038/nature09165; Murrell A, 2005, HUM MOL GENET, V14, pR3, DOI 10.1093/hmg/ddi110; O'Carroll D, 2001, MOL CELL BIOL, V21, P4330, DOI 10.1128/MCB.21.13.4330-4336.2001; Peng JC, 2009, CELL, V139, P1290, DOI 10.1016/j.cell.2009.12.002; Robertson KD, 2000, NAT REV GENET, V1, P11, DOI 10.1038/35049533; Robertson KD, 2005, NAT REV GENET, V6, P597, DOI 10.1038/nrg1655; Rotmistrovsky K, 2004, NUCLEIC ACIDS RES, V32, pW108, DOI 10.1093/nar/gkh450; Rozen S, 2000, Methods Mol Biol, V132, P365; Schlesinger Y, 2007, NAT GENET, V39, P232, DOI 10.1038/ng1950; Schuler GD, 1997, GENOME RES, V7, P541, DOI 10.1101/gr.7.5.541; Schwindt H, 2009, LEUKEMIA, V23, P1875, DOI 10.1038/leu.2009.120; Taylor KH, 2007, CANCER RES, V67, P8511, DOI 10.1158/0008-5472.CAN-07-1016; Taylor KH, 2007, CANCER RES, V67, P2617, DOI 10.1158/0008-5472.CAN-06-3993; Tewhey R, 2009, NAT BIOTECHNOL, V27, P1025, DOI 10.1038/nbt.1583; UKKONEN E, 1985, INFORM CONTROL, V64, P100, DOI 10.1016/S0019-9958(85)80046-2; Zeschnigk M, 2009, HUM MOL GENET, V18, P1439, DOI 10.1093/hmg/ddp054	41	7	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2011	6	7							e21332	10.1371/journal.pone.0021332	http://dx.doi.org/10.1371/journal.pone.0021332			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	789JO	21750708	gold, Green Published, Green Submitted			2022-12-27	WOS:000292512000012
J	Nazmi, A; Dutta, K; Basu, A				Nazmi, Arshed; Dutta, Kallol; Basu, Anirban			RIG-I Mediates Innate Immune Response in Mouse Neurons Following Japanese Encephalitis Virus Infection	PLOS ONE			English	Article							MICROGLIAL ACTIVATION; DEATH; CELLS; MINOCYCLINE; INTERFERON; EXPRESSION; INDUCTION; ALPHA; MDA5	Background: Neuroinflammation associated with Japanese encephalitis (JE) is mainly due to the activation of glial cells with subsequent release of proinflammatory mediators from them. The recognition of viral RNA, in part, by the pattern recognition receptor retinoic acid-inducible gene I (RIG-I) has been indicated to have a role in such processes. Even though neurons are also known to express this receptor, its role after JE virus (JEV) infections is yet to be elucidated. Methodology/Principal Findings: Upon infecting murine neuroblastoma cells and primary cortical neurons with JEV the expression profile of key proinflammatory cyto/chemokines were analyzed by qRT-PCR and bead array, both before and after ablation of RIG-I. Immunoblotting was performed to evaluate the levels of key molecules downstream to RIG-I leading to production of proinflammatory mediators. Changes in the intracellular viral antigen expression were confirmed by intracellular staining and immunoblotting. JEV infection induced neuronal expression of IL-6, IL-12p70, MCP-1, IP-10 and TNF-alpha in a time-dependent manner, which showed significant reduction upon RIG-I ablation. Molecules downstream to RIG-I showed significant changes upon JEV-infection, that were modulated following RIG-I ablation. Ablation of RIG-I in neurons also increased their susceptibility to JEV. Conclusions/Significance: In this study we propose that neurons are one of the potential sources of proinflammatory cyto/chemokines in JEV-infected brain that are produced via RIG-I dependent pathways. Ablation of RIG-I in neurons leads to increased viral load and reduced release of the cyto/chemokines.	[Nazmi, Arshed; Dutta, Kallol; Basu, Anirban] Natl Brain Res Ctr, Manesar, Haryana, India	Department of Biotechnology (DBT) India; National Brain Research Centre (NBRC)	Nazmi, A (corresponding author), Natl Brain Res Ctr, Manesar, Haryana, India.	anirban@nbrc.ac.in	Dutta, Kallol/J-5827-2019; Nazmi, Arshed/I-2645-2015	Dutta, Kallol/0000-0001-6402-1300; Basu, Anirban/0000-0002-5200-2054; Nazmi, Arshed/0000-0002-5073-2061	Council of Scientific and Industrial Research (CSIR), Government of India [27(1638)/10]; CSIR; Department of Biotechnology, Government of India	Council of Scientific and Industrial Research (CSIR), Government of India(Council of Scientific & Industrial Research (CSIR) - India); CSIR(Council of Scientific & Industrial Research (CSIR) - India); Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	The work is funded by a grant from the Council of Scientific and Industrial Research (CSIR), Government of India [27(1638)/10] to A.B. A.N. is a recipient of a Senior Research Fellowship from CSIR; K.D. is a recipient of a Research Associateship in Biotechnology and Life Sciences, from the Department of Biotechnology, Government of India; A.B. is a recipient of a National Bioscience Award for Career Development-2010 from Department of Biotechnology, Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chakraborty S, 2010, NEUROCHEM INT, V56, P727, DOI 10.1016/j.neuint.2010.02.016; Chang TH, 2006, MICROBES INFECT, V8, P157, DOI 10.1016/j.micinf.2005.06.014; Chen CJ, 2010, J GEN VIROL, V91, P1028, DOI 10.1099/vir.0.013565-0; Das S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008134; Dutta K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009984; Fredericksen BL, 2008, J VIROL, V82, P609, DOI 10.1128/JVI.01305-07; Ghosh D, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000437; Ghoshal A, 2007, GLIA, V55, P483, DOI 10.1002/glia.20474; Janelsins MC, 2008, AM J PATHOL, V173, P1768, DOI 10.2353/ajpath.2008.080528; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kaushik DK, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-68; Monique L, 2006, J MOL NEUROSCI, V29, P185, DOI 10.1385/JMN/29:03:185; Melchjorsen J, 2005, J VIROL, V79, P12944, DOI 10.1128/JVI.79.20.12944-12951.2005; Mikkelsen SS, 2009, J BIOL CHEM, V284, P10774, DOI 10.1074/jbc.M807272200; Mishra MK, 2008, J NEUROCHEM, V105, P1582, DOI 10.1111/j.1471-4159.2008.05238.x; Mishra MK, 2009, NEUROCHEM INT, V54, P464, DOI 10.1016/j.neuint.2009.01.022; Nazmi A, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000892; Ohtori S, 2004, SPINE, V29, P1082, DOI 10.1097/00007632-200405150-00006; Peltier DC, 2010, J IMMUNOL, V184, P7010, DOI 10.4049/jimmunol.0904133; Savarin C, 2008, CURR OPIN PHARMACOL, V8, P472, DOI 10.1016/j.coph.2008.05.002; Suthar MS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000757; Swarup V, 2007, J NEUROCHEM, V103, P771, DOI 10.1111/j.1471-4159.2007.04790.x; Takeuchi O, 2008, CURR OPIN IMMUNOL, V20, P17, DOI 10.1016/j.coi.2008.01.002; Yoneyama M, 2007, J BIOL CHEM, V282, P15315, DOI 10.1074/jbc.R700007200	24	75	76	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2011	6	6							e21761	10.1371/journal.pone.0021761	http://dx.doi.org/10.1371/journal.pone.0021761			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786GP	21738791	Green Published, gold, Green Submitted			2022-12-27	WOS:000292291800042
J	Klais, R; Tamminen, T; Kremp, A; Spilling, K; Olli, K				Klais, Riina; Tamminen, Timo; Kremp, Anke; Spilling, Kristian; Olli, Kalle			Decadal-Scale Changes of Dinoflagellates and Diatoms in the Anomalous Baltic Sea Spring Bloom	PLOS ONE			English	Article							ALEXANDRIUM-FUNDYENSE; SCRIPPSIELLA-HANGOEI; GROWTH STRATEGIES; GULF; GERMINATION; PATTERNS; CYSTS; LIFE; SEDIMENTATION; EVOLUTIONARY	The algal spring bloom in the Baltic Sea represents an anomaly from the winter-spring bloom patterns worldwide in terms of frequent and recurring dominance of dinoflagellates over diatoms. Analysis of approximately 3500 spring bloom samples from the Baltic Sea monitoring programs revealed (i) that within the major basins the proportion of dinoflagellates varied from 0.1 (Kattegat) to.0.8 (central Baltic Proper), and (ii) substantial shifts (e. g. from 0.2 to 0.6 in the Gulf of Finland) in the dinoflagellate proportion over four decades. During a recent decade (1995-2004) the proportion of dinoflagellates increased relative to diatoms mostly in the northernmost basins (Gulf of Bothnia, from 0.1 to 0.4) and in the Gulf of Finland, (0.4 to 0.6) which are typically ice-covered areas. We hypothesize that in coastal areas a specific sequence of seasonal events, involving wintertime mixing and resuspension of benthic cysts, followed by proliferation in stratified thin layers under melting ice, favors successful seeding and accumulation of dense dinoflagellate populations over diatoms. This head-start of dinoflagellates by the onset of the spring bloom is decisive for successful competition with the faster growing diatoms. Massive cyst formation and spreading of cyst beds fuel the expanding and ever larger dinoflagellate blooms in the relatively shallow coastal waters. Shifts in the dominant spring bloom algal groups can have significant effects on major elemental fluxes and functioning of the Baltic Sea ecosystem, but also in the vast shelves and estuaries at high latitudes, where ice-associated cold-water dinoflagellates successfully compete with diatoms.	[Klais, Riina; Olli, Kalle] Univ Tartu, Inst Ecol & Earth Sci, EE-50090 Tartu, Estonia; [Tamminen, Timo; Kremp, Anke; Spilling, Kristian] Ctr Marine Res, Finnish Environm Inst, Helsinki, Finland	University of Tartu; Tartu University Institute of Ecology & Earth Sciences; Finnish Environment Institute	Klais, R (corresponding author), Univ Tartu, Inst Ecol & Earth Sci, Ulikooli 18, EE-50090 Tartu, Estonia.	riina.klais@ut.ee	Klais, Riina/G-6123-2010; Olli, Kalle/G-5389-2010; Spilling, Kristian/L-7932-2014; Kremp, Anke/I-8139-2013	Olli, Kalle/0000-0002-7943-5714; Spilling, Kristian/0000-0002-8390-8270; Klais-Peets, Riina/0000-0003-2895-1273	Estonian Science Foundation [7787]; Academy of Finland [128987]; 6th FP project THRESHOLDS [GOCE-003900]	Estonian Science Foundation; Academy of Finland(Academy of Finland); 6th FP project THRESHOLDS	This study was supported by the Estonian Science Foundation (grant 7787), the Academy of Finland (grant 128987), and the 6th FP project THRESHOLDS (GOCE-003900). The Estonian Science Foundation (http://www.etf.ee/index.php?page=3&) supported Riina Klais with a personal stipend supplement. The Academy of Finland (http://www.aka.fi/eng)supported financially Anke Kremp and Kristian Spilling. The large-scale phytoplankton dataset collection and harmonization was conducted within the EU 6th FP project THRESHOLDS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alheit J, 2005, ICES J MAR SCI, V62, P1205, DOI 10.1016/j.icesjms.2005.04.024; ANDERSON JT, 1981, CAN J BOT, V59, P1793, DOI 10.1139/b81-240; Armbrust EV, 2009, NATURE, V459, P185, DOI 10.1038/nature08057; B.A.C.C. Author Team, 2008, ASS CLIM CHANG BALT; CHARLSON RJ, 1987, NATURE, V326, P655, DOI 10.1038/326655a0; Cloern JE, 2008, ECOL LETT, V11, P1294, DOI 10.1111/j.1461-0248.2008.01244.x; Cloern JE, 2001, MAR ECOL PROG SER, V210, P223, DOI 10.3354/meps210223; Diaz RJ, 2008, SCIENCE, V321, P926, DOI 10.1126/science.1156401; Edler L., 1979, BALTIC MARINE BIOL P, V5, P38; Falkowski P.G., 2007, AQUATIC PHOTOSYNTHES; Fotheringham A. S., 2002, GEOGRAPHICALLY WEIGH; Gallegos CL, 2002, ESTUARIES, V25, P508, DOI 10.1007/BF02804886; GUILLARD RRL, 1977, ECOLOGY MARINE PLANK; HEISKANEN AS, 1993, MAR BIOL, V116, P161, DOI 10.1007/BF00350743; HEISKANEN AS, 1998, FACTORS GOVERNING SE; Humborg C, 2006, BIOGEOCHEMISTRY, V77, P265, DOI 10.1007/s10533-005-1533-3; Ishikawa A, 1997, J PLANKTON RES, V19, P1783, DOI 10.1093/plankt/19.11.1783; Jaanus A, 2006, HYDROBIOLOGIA, V554, P137, DOI 10.1007/s10750-005-1014-7; KONONEN K, 1984, OPHELIA, P101; Kremp A, 2000, J PLANKTON RES, V22, P2155, DOI 10.1093/plankt/22.11.2155; Kremp A, 2000, J PLANKTON RES, V22, P1311, DOI 10.1093/plankt/22.7.1311; Kremp A, 2001, MAR ECOL PROG SER, V216, P57, DOI 10.3354/meps216057; Kremp A, 2008, AQUAT MICROB ECOL, V50, P181, DOI 10.3354/ame01163; Li WKW, 2006, P ROY SOC B-BIOL SCI, V273, P1953, DOI 10.1098/rspb.2006.3529; LIGNELL R, 1993, MAR ECOL PROG SER, V94, P239, DOI 10.3354/meps094239; Logares R, 2008, ENVIRON MICROBIOL, V10, P1231, DOI 10.1111/j.1462-2920.2007.01538.x; Margalef R., 1979, P89; McGillicuddy DJ, 2005, DEEP-SEA RES PT II, V52, P2698, DOI 10.1016/j.dsr2.2005.06.021; McQuoid MR, 2004, LIMNOL OCEANOGR, V49, P1123, DOI 10.4319/lo.2004.49.4.1123; McQuoid MR, 1996, J PHYCOL, V32, P889, DOI 10.1111/j.0022-3646.1996.00889.x; Okolodkov YB, 1999, BOT MAR, V42, P333, DOI 10.1515/BOT.1999.038; Olli K, 2008, J MARINE SYST, V73, P284, DOI 10.1016/j.jmarsys.2007.04.009; Olli K, 2010, DEEP-SEA RES PT II, V57, P235, DOI 10.1016/j.dsr2.2009.09.009; Papush L, 2006, ESTUAR COAST SHELF S, V67, P53, DOI 10.1016/j.ecss.2005.09.017; PINCKNEY JL, 1997, CANADIAN J FISHERIES, V54; Pitkanen H, 2001, AMBIO, V30, P195, DOI 10.1639/0044-7447(2001)030[0195:INFCDI]2.0.CO;2; R Core Team, 2020, R LANG ENV STAT COMP; Rahm L, 1996, MAR ECOL PROG SER, V130, P221, DOI 10.3354/meps130221; Rengefors K, 1998, J PHYCOL, V34, P568, DOI 10.1046/j.1529-8817.1998.340568.x; Reynolds C.S., 2006, PHYTOPLANKTON ECOLOG; Ribeiro P.J, 2001, R NEWS, V1, P14, DOI DOI 10.1159/000323281; Smayda TJ, 2010, PROG OCEANOGR, V85, P92, DOI 10.1016/j.pocean.2010.02.006; Smayda T.J., 1980, SPECIES SUCCESSION; Smayda TJ, 2003, J SEA RES, V49, P95, DOI 10.1016/S1385-1101(02)00219-8; Smayda TJ, 2002, J OCEANOGR, V58, P281, DOI 10.1023/A:1015861725470; SMETACEK VS, 1985, MAR BIOL, V84, P239, DOI 10.1007/BF00392493; Spilling K, 2008, J MARINE SYST, V73, P323, DOI 10.1016/j.jmarsys.2006.10.012; Spilling K, 2008, CONT SHELF RES, V28, P2488, DOI 10.1016/j.csr.2008.07.004; Spilling K, 2007, J PLANKTON RES, V29, P895, DOI 10.1093/plankt/fbm067; Spilling K, 2010, MAR BIOL, V157, P427, DOI 10.1007/s00227-009-1329-4; Stipa T, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL014532; Stock CA, 2007, CONT SHELF RES, V27, P2486, DOI 10.1016/j.csr.2007.06.008; Stoecker DK, 1997, J PHYCOL, V33, P585, DOI 10.1111/j.0022-3646.1997.00585.x; Sundstrom AM, 2009, J PHYCOL, V45, P938, DOI 10.1111/j.1529-8817.2009.00712.x; Tamminen T, 2007, MAR ECOL PROG SER, V340, P121, DOI 10.3354/meps340121; Trigueros JM, 2001, HYDROBIOLOGIA, V444, P119, DOI 10.1023/A:1017563031810; Tuomi P, 1999, J MARINE SYST, V23, P185, DOI 10.1016/S0924-7963(99)00057-3; Vahtera E, 2007, AMBIO, V36, P186, DOI 10.1579/0044-7447(2007)36[186:IEFENC]2.0.CO;2; Wasmund N, 2003, ICES J MAR SCI, V60, P177, DOI 10.1016/S1054-3139(02)00280-1; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279; Zuur Alain F., 2009, P1	61	110	112	2	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2011	6	6							e21567	10.1371/journal.pone.0021567	http://dx.doi.org/10.1371/journal.pone.0021567			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786FZ	21747911	gold, Green Published, Green Submitted			2022-12-27	WOS:000292290100040
J	Paron, I; Berchtold, S; Voros, J; Shamarla, M; Erkan, M; Hofler, H; Esposito, I				Paron, Igor; Berchtold, Sonja; Voeroes, Julia; Shamarla, Madhavi; Erkan, Mert; Hoefler, Heinz; Esposito, Irene			Tenascin-C Enhances Pancreatic Cancer Cell Growth and Motility and Affects Cell Adhesion through Activation of the Integrin Pathway	PLOS ONE			English	Article							STELLATE CELLS; EXPRESSION; PROLIFERATION; GLYCOPROTEINS; ASTROCYTOMA; INHIBITION; SURVIVAL; BINDING; TISSUES; TUMORS	Background: Pancreatic cancer (PDAC) is characterized by an abundant fibrous tissue rich in Tenascin-C (TNC), a large ECM glycoprotein mainly synthesized by pancreatic stellate cells (PSCs). In human pancreatic tissues, TNC expression increases in the progression from low-grade precursor lesions to invasive cancer. Aim of this study was the functional characterization of the effects of TNC on biologic relevant properties of pancreatic cancer cells. Methods: Proliferation, migration and adhesion assays were performed on pancreatic cancer cell lines treated with TNC or grown on a TNC-rich matrix. Stable transfectants expressing the large TNC splice variant were generated to test the effects of endogenous TNC. TNC-dependent integrin signaling was investigated by immunoblotting, immunofluorescence and pharmacological inhibition. Results: Endogenous TNC promoted pancreatic cancer cell growth and migration. A TNC-rich matrix also enhanced migration as well as the adhesion to the uncoated growth surface of poorly differentiated cell lines. In contrast, adhesion to fibronectin was significantly decreased in the presence of TNC. The effects of TNC on cell adhesion were paralleled by changes in the activation state of paxillin and Akt. Conclusion: TNC affects proliferation, migration and adhesion of poorly differentiated pancreatic cancer cell lines and might therefore play a role in PDAC spreading and metastasis in vivo.	[Paron, Igor; Berchtold, Sonja; Voeroes, Julia; Shamarla, Madhavi; Hoefler, Heinz; Esposito, Irene] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Pathol, Neuherberg, Germany; [Paron, Igor; Berchtold, Sonja; Hoefler, Heinz; Esposito, Irene] Tech Univ Munich, Inst Pathol, Munich, Germany; [Erkan, Mert] Tech Univ Munich, Klinikum Rechts Isar, Dept Gen Surg, D-8000 Munich, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; Technical University of Munich	Paron, I (corresponding author), German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Pathol, Neuherberg, Germany.	esposito@lrz.tum.de	P, I/D-8000-2011		Deutsche Krebshilfe [108038]	Deutsche Krebshilfe(Deutsche Krebshilfe)	This study was supported by the Deutsche Krebshilfe (Grant number: 108038). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachem MG, 2005, GASTROENTEROLOGY, V128, P907, DOI 10.1053/j.gastro.2004.12.036; Baxter NN, 2007, ANN SURG ONCOL, V14, P1320, DOI 10.1245/s10434-006-9249-8; Chiquet-Ehrismann R, 2003, J PATHOL, V200, P488, DOI 10.1002/path.1415; CHIQUETEHRISMANN R, 1988, CELL, V53, P383, DOI 10.1016/0092-8674(88)90158-4; CROSSIN KL, 1991, P NATL ACAD SCI USA, V88, P11403, DOI 10.1073/pnas.88.24.11403; DRUCKER BJ, 1988, IN VITRO CELL DEV B, V24, P1179, DOI 10.1007/BF02624187; END P, 1992, EUR J BIOCHEM, V209, P1041, DOI 10.1111/j.1432-1033.1992.tb17380.x; Erickson HP, 1993, CURR OPIN CELL BIOL, V5, P869, DOI 10.1016/0955-0674(93)90037-Q; ERICKSON HP, 1989, ANNU REV CELL BIOL, V5, P71, DOI 10.1146/annurev.cb.05.110189.000443; Esposito I, 2006, J PATHOL, V208, P673, DOI 10.1002/path.1935; Esposito I, 2007, NEOPLASIA, V9, P8, DOI 10.1593/neo.06646; Fischer D, 1997, MOL BIOL CELL, V8, P2055, DOI 10.1091/mbc.8.10.2055; Geback T, 2009, BIOTECHNIQUES, V46, P265, DOI 10.2144/000113083; GIANCOTTI FG, 1990, CELL, V60, P849, DOI 10.1016/0092-8674(90)90098-Y; Giese A, 1996, J CELL SCI, V109, P2161; Hancox RA, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2251; Huang WT, 2001, CANCER RES, V61, P8586; Ishiwata T, 2005, ANTICANCER RES, V25, P489; Jang JH, 2005, CANCER LETT, V229, P101, DOI 10.1016/j.canlet.2004.12.012; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Jones FS, 2000, DEV DYNAM, V218, P235, DOI 10.1002/(SICI)1097-0177(200006)218:2<235::AID-DVDY2>3.3.CO;2-7; Juuti A, 2004, J CLIN PATHOL, V57, P1151, DOI 10.1136/jcp.2003.015818; Kaarteenaho-Wiik R, 2003, HISTOPATHOLOGY, V42, P280, DOI 10.1046/j.1365-2559.2003.01568.x; KOUKOULIS GK, 1991, HUM PATHOL, V22, P636, DOI 10.1016/0046-8177(91)90285-W; Leins A, 2003, CANCER-AM CANCER SOC, V98, P2430, DOI 10.1002/cncr.11796; MIDWOOD KS, 2009, J CELL COMMUN SIGNAL; Moore PS, 2001, VIRCHOWS ARCH, V439, P798, DOI 10.1007/s004280100474; Olive KP, 2009, SCIENCE, V324, P1457, DOI 10.1126/science.1171362; Omary MB, 2007, J CLIN INVEST, V117, P50, DOI 10.1172/JCI30082; Orend G, 2005, INT J BIOCHEM CELL B, V37, P1066, DOI 10.1016/j.biocel.2004.12.002; Pas J, 2006, INT J BIOCHEM CELL B, V38, P1594, DOI 10.1016/j.biocel.2006.03.017; Rivera F, 2009, CANCER TREAT REV, V35, P335, DOI 10.1016/j.ctrv.2008.11.007; Sipos B, 2003, VIRCHOWS ARCH, V442, P444, DOI 10.1007/s00428-003-0784-4; SRIRAMARAO P, 1993, J CELL SCI, V105, P1001; Vonlaufen A, 2008, CANCER RES, V68, P2085, DOI 10.1158/0008-5472.CAN-07-2477; Zamecnik J, 2004, NEOPLASMA, V51, P214	36	53	57	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2011	6	6							e21684	10.1371/journal.pone.0021684	http://dx.doi.org/10.1371/journal.pone.0021684			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786FZ	21747918	gold, Green Published, Green Submitted			2022-12-27	WOS:000292290100055
J	Montero-Pau, J; Ramos-Rodriguez, E; Serra, M; Gomez, A				Montero-Pau, Javier; Ramos-Rodriguez, Eloisa; Serra, Manuel; Gomez, Africa			Long-Term Coexistence of Rotifer Cryptic Species	PLOS ONE			English	Article							DIAPAUSING EGG BANKS; BRACHIONUS-PLICATILIS; MORPHOLOGICAL STASIS; RESOURCE COMPETITION; PATTERNS; SPECIATION; COMPLEX; DNA; ZOOPLANKTON; PREDATION	Despite their high morphological similarity, cryptic species often coexist in aquatic habitats presenting a challenge in the framework of niche differentiation theory and coexistence mechanisms. Here we use a rotifer species complex inhabiting highly unpredictable and fluctuating salt lakes to gain insights into the mechanisms involved in stable coexistence in cryptic species. We combined molecular barcoding surveys of planktonic populations and paleogenetic analysis of diapausing eggs to reconstruct the current and historical coexistence dynamics of two highly morphologically similar rotifer species, B. plicatilis and B. manjavacas. In addition, we carried out laboratory experiments using clones isolated from eight lakes where both species coexist to explore their clonal growth responses to salinity, a challenging, highly variable and unpredictable condition in Mediterranean salt lakes. We show that both species have co-occurred in a stable way in one lake, with population fluctuations in which no species was permanently excluded. The seasonal occurrence patterns of the plankton in two lakes agree with laboratory experiments showing that both species differ in their optimal salinity. These results suggest that stable species coexistence is mediated by differential responses to salinity and its fluctuating regime. We discuss the role of fluctuating salinity and a persistent diapausing egg banks as a mechanism for species coexistence in accordance with the 'storage effect'.	[Montero-Pau, Javier; Ramos-Rodriguez, Eloisa; Serra, Manuel] Univ Valencia, Inst Cavanilles Biodiversitat & Biol Evolut, Valencia, Spain; [Montero-Pau, Javier; Gomez, Africa] Univ Hull, Dept Biol Sci, Kingston Upon Hull HU6 7RX, N Humberside, England	University of Valencia; University of Hull	Montero-Pau, J (corresponding author), Univ Valencia, Inst Cavanilles Biodiversitat & Biol Evolut, Valencia, Spain.	javier.montero@uv.es	Gomez, A/L-6505-2014; Montero-Pau, Javier/H-6711-2015; Ramos-Rodríguez, Eloísa/ABI-6376-2020; Ramos-Rodriguez, Eloisa/K-2819-2014; Serra, Manuel/H-7817-2015	Gomez, A/0000-0002-1297-4502; Montero-Pau, Javier/0000-0002-0864-8157; Ramos-Rodríguez, Eloísa/0000-0003-2440-0765; Ramos-Rodriguez, Eloisa/0000-0003-2440-0765; Serra, Manuel/0000-0003-1731-1529	Spanish Ministerio de Ciencia e Innovacion [CGL2009-07364]; National Environment Research Council (NERC) [NE/B501298/1]; Secretaria General de Universidades e Investigacion; Spanish Ministerio de Ciencia y Tecnologia [BES2004-5248]; Natural Environment Research Council [NE/B501298/1] Funding Source: researchfish	Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); National Environment Research Council (NERC)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Secretaria General de Universidades e Investigacion; Spanish Ministerio de Ciencia y Tecnologia(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was funded by a grant from the Spanish Ministerio de Ciencia e Innovacion (CGL2009-07364) to MS. AG was supported by a National Environment Research Council (NERC) Advanced Fellowship (NE/B501298/1). ER-R was supported by a fellowship by the Secretaria General de Universidades e Investigacion (Consejeria de Educacion y Ciencia, Junta de Andalucia), and JM-P by a fellowship by the Spanish Ministerio de Ciencia y Tecnologia (BES2004-5248). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alizon S, 2008, P NATL ACAD SCI USA, V105, P12382, DOI 10.1073/pnas.0805039105; ALONSO M, 1990, HYDROBIOLOGIA, V197, P221, DOI 10.1007/BF00026952; Bickford D, 2007, TRENDS ECOL EVOL, V22, P148, DOI 10.1016/j.tree.2006.11.004; Blair CP, 2005, EVOLUTION, V59, P304; Boronat L, 2001, HYDROBIOLOGIA, V442, P75, DOI 10.1023/A:1017522004975; Braune P, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-19; Brendonck L, 2003, HYDROBIOLOGIA, V491, P65, DOI 10.1023/A:1024454905119; BROWN MB, 1974, J AM STAT ASSOC, V69, P364, DOI 10.2307/2285659; Caceres CE, 1997, P NATL ACAD SCI USA, V94, P9171, DOI 10.1073/pnas.94.17.9171; Campillo S, 2005, HYDROBIOLOGIA, V546, P181, DOI 10.1007/s10750-005-4120-7; Campillo S, 2009, J EVOLUTION BIOL, V22, P2542, DOI 10.1111/j.1420-9101.2009.01871.x; Carmona MJ, 2009, J EVOLUTION BIOL, V22, P1975, DOI 10.1111/j.1420-9101.2009.01811.x; Carmona MJ, 1995, HYDROBIOLOGIA, V313, P365, DOI 10.1007/BF00025971; Chesson P, 2000, ANNU REV ECOL SYST, V31, P343, DOI 10.1146/annurev.ecolsys.31.1.343; Chesson P, 2003, THEOR POPUL BIOL, V64, P354; Ciros-Perez J, 2004, LIMNOL OCEANOGR, V49, P40, DOI 10.4319/lo.2004.49.1.0040; Ciros-Perez J, 2001, LIMNOL OCEANOGR, V46, P1511, DOI 10.4319/lo.2001.46.6.1511; Comin F.A., 1992, Limnetica, V8, P79; Cordova SE, 2001, FRESHWATER BIOL, V46, P1519, DOI 10.1046/j.1365-2427.2001.00768.x; Cousyn C, 2001, P NATL ACAD SCI USA, V98, P6256, DOI 10.1073/pnas.111606798; Decaestecker E, 2007, NATURE, V450, P870, DOI 10.1038/nature06291; Dominguez-Castro F, 2008, GLOBAL PLANET CHANGE, V63, P230, DOI 10.1016/j.gloplacha.2008.06.002; Fontaneto D, 2007, HYDROBIOLOGIA, V583, P297, DOI 10.1007/s10750-007-0573-1; Garcia-Ferrer I, 2003, HYDROBIOLOGIA, V506, P101, DOI 10.1023/B:HYDR.0000008593.32525.1d; Garcia-Roger EM, 2006, J EXP MAR BIOL ECOL, V336, P198, DOI 10.1016/j.jembe.2006.05.009; Garcia-Roger EM, 2005, J EXP MAR BIOL ECOL, V314, P149, DOI 10.1016/j.jembe.2004.08.023; Geller JB, 1999, CONSERV BIOL, V13, P661, DOI 10.1046/j.1523-1739.1999.97470.x; Gomez A, 2000, MOL ECOL, V9, P203, DOI 10.1046/j.1365-294x.2000.00849.x; Gomez A, 2002, EVOLUTION, V56, P1431; Gomez A, 1996, J EVOLUTION BIOL, V9, P953, DOI 10.1046/j.1420-9101.1996.9060953.x; Gomez A, 2000, P ROY SOC B-BIOL SCI, V267, P2189, DOI 10.1098/rspb.2000.1268; Gomez A, 1997, OECOLOGIA, V111, P350, DOI 10.1007/s004420050245; GOMEZ A, 1995, J EVOLUTION BIOL, V8, P601, DOI 10.1046/j.1420-9101.1995.8050601.x; Gomez A, 2007, MOL ECOL, V16, P3228, DOI 10.1111/j.1365-294X.2007.03372.x; GUILLARD RR, 1962, CAN J MICROBIOL, V8, P229, DOI 10.1139/m62-029; Hairston NG, 1996, LIMNOL OCEANOGR, V41, P1087, DOI 10.4319/lo.1996.41.5.1087; HUTCHINSON GE, 1961, AM NAT, V95, P137, DOI 10.1086/282171; Jankowski T, 2003, LIMNOL OCEANOGR, V48, P1948, DOI 10.4319/lo.2003.48.5.1948; King CE, 1980, EVOLUTION ECOLOGY ZO, P315; KNOWLTON N, 1993, ANNU REV ECOL SYST, V24, P189, DOI 10.1146/annurev.es.24.110193.001201; KNOWLTON N, 1994, TRENDS ECOL EVOL, V9, P7, DOI 10.1016/0169-5347(94)90224-0; Lapesa S, 2004, FRESHWATER BIOL, V49, P1053, DOI 10.1111/j.1365-2427.2004.01249.x; Lapesa S., 2004, THESIS U VALENCIA; Leibold MA, 2006, ECOLOGY, V87, P1399, DOI 10.1890/0012-9658(2006)87[1399:COTNAN]2.0.CO;2; Lowe CD, 2005, MAR BIOL, V146, P923, DOI 10.1007/s00227-004-1501-9; McCullagh P, 1989, GEN LINEAR MODELS; Mergeay J, 2005, LIMNOL OCEANOGR, V50, P1278, DOI 10.4319/lo.2005.50.4.1278; MIRACLE MR, 1989, HYDROBIOLOGIA, V186, P81, DOI 10.1007/BF00048900; Molbo D, 2003, P NATL ACAD SCI USA, V100, P5867, DOI 10.1073/pnas.0930903100; Montero-Pau J, 2008, LIMNOL OCEANOGR-METH, V6, P218, DOI 10.4319/lom.2008.6.218; Montero-Pau J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020314; Nicholls B, 2006, ECOGRAPHY, V29, P697, DOI 10.1111/j.2006.0906-7590.04575.x; Nykanen M, 2009, J PALEOLIMNOL, V42, P551, DOI 10.1007/s10933-008-9304-5; ORITA M, 1989, P NATL ACAD SCI USA, V86, P2766, DOI 10.1073/pnas.86.8.2766; Ortells R, 2003, FRESHWATER BIOL, V48, P2194, DOI 10.1046/j.1365-2427.2003.01159.x; Ortells R, 2000, ARCH HYDROBIOL, V149, P529; Papakostas S, 2005, MAR BIOL, V147, P1129, DOI 10.1007/s00227-005-0012-7; Pfenninger M, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-121; Rodo X, 1997, CLIM DYNAM, V13, P275, DOI 10.1007/s003820050165; Rodriguez-Puebla C, 1998, INT J CLIMATOL, V18, P299, DOI 10.1002/(SICI)1097-0088(19980315)18:3&lt;299::AID-JOC247&gt;3.0.CO;2-L; RODRIGUEZRODRIG.M, 2005, GEOGACETA, V37, P87; Sears ALW, 2007, ECOLOGY, V88, P2240, DOI 10.1890/06-0645.1; Smith MA, 2006, P NATL ACAD SCI USA, V103, P3657, DOI 10.1073/pnas.0511318103; Suatoni E, 2006, MOL PHYLOGENET EVOL, V41, P86, DOI 10.1016/j.ympev.2006.04.025; Wellborn GA, 2007, OECOLOGIA, V154, P175, DOI 10.1007/s00442-007-0816-x	65	47	51	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2011	6	6							e21530	10.1371/journal.pone.0021530	http://dx.doi.org/10.1371/journal.pone.0021530			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	784FW	21738691	Green Published, gold			2022-12-27	WOS:000292142800032
J	Osborne, SE; Coombes, BK				Osborne, Suzanne E.; Coombes, Brian K.			Transcriptional Priming of Salmonella Pathogenicity Island-2 Precedes Cellular Invasion	PLOS ONE			English	Article							ENTERICA SEROVAR TYPHIMURIUM; III SECRETION SYSTEM; INFECTIOUS ENTEROCOLITIS; INTRACELLULAR SALMONELLA; NADPH OXIDASE; HOST-CELLS; IN-VIVO; H-NS; VIRULENCE; EXPRESSION	Invasive salmonellosis caused by Salmonella enterica involves an enteric stage of infection where the bacteria colonize mucosal epithelial cells, followed by systemic infection with intracellular replication in immune cells. The type III secretion system encoded in Salmonella Pathogenicity Island (SPI)-2 is essential for intracellular replication and the regulators governing high-level expression of SPI-2 genes within the macrophage phagosome and in inducing media thought to mimic this environment have been well characterized. However, low-level expression of SPI-2 genes is detectable in media thought to mimic the extracellular environment suggesting that additional regulatory pathways are involved in SPI-2 gene expression prior to cellular invasion. The regulators involved in this activity are not known and the extracellular transcriptional activity of the entire SPI-2 island in vivo has not been studied. We show that low-level, SsrB-independent promoter activity for the ssrA-ssrB two-component regulatory system and the ssaG structural operon encoded in SPI-2 is dependent on transcriptional input by OmpR and Fis under non-inducing conditions. Monitoring the activity of all SPI-2 promoters in real-time following oral infection of mice revealed invasion-independent transcriptional activity of the SPI2 T3SS in the lumen of the gut, which we suggest is a priming activity with functional relevance for the subsequent intracellular host-pathogen interaction.	[Osborne, Suzanne E.; Coombes, Brian K.] McMaster Univ, Dept Biochem & Biomed Sci, Michael G DeGroote Inst Infect Dis Res, Hamilton, ON, Canada	McMaster University	Osborne, SE (corresponding author), McMaster Univ, Dept Biochem & Biomed Sci, Michael G DeGroote Inst Infect Dis Res, Hamilton, ON, Canada.	coombes@mcmaster.ca	Coombes, Brian K/A-1727-2009	Coombes, Brian/0000-0001-9883-1010	Canadian Institutes of Health Research (CIHR) [MOP-82704]; Canada Foundation for Innovation Leaders Opportunity Fund	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canada Foundation for Innovation Leaders Opportunity Fund(Canada Foundation for Innovation)	This research was funded through an operating grant from the Canadian Institutes of Health Research (CIHR; MOP-82704) and an infrastructure grant from Canada Foundation for Innovation Leaders Opportunity Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahams GL, 2006, CELL MICROBIOL, V8, P728, DOI 10.1111/j.1462-5822.2006.00706.x; Bijlsma JJE, 2005, MOL MICROBIOL, V57, P85, DOI 10.1111/j.1365-2958.2005.04668.x; Bispham J, 2001, INFECT IMMUN, V69, P367, DOI 10.1128/IAI.69.1.367-377.2001; Brown NF, 2005, PLOS PATHOG, V1, P252, DOI 10.1371/journal.ppat.0010032; Bustamante VH, 2008, P NATL ACAD SCI USA, V105, P14591, DOI 10.1073/pnas.0801205105; Chakravortty D, 2002, J EXP MED, V195, P1155, DOI 10.1084/jem.20011547; Cirillo DM, 1998, MOL MICROBIOL, V30, P175, DOI 10.1046/j.1365-2958.1998.01048.x; Coburn B, 2005, INFECT IMMUN, V73, P3219, DOI 10.1128/IAI.73.6.3219-3227.2005; Coombes BK, 2005, P NATL ACAD SCI USA, V102, P17460, DOI 10.1073/pnas.0505401102; Coombes BK, 2005, INFECT IMMUN, V73, P7161, DOI 10.1128/IAI.73.11.7161-7169.2005; Coombes BK, 2004, J BIOL CHEM, V279, P49804, DOI 10.1074/jbc.M404299200; Cornelis GR, 2006, NAT REV MICROBIOL, V4, P811, DOI 10.1038/nrmicro1526; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Deiwick J, 1999, MOL MICROBIOL, V31, P1759, DOI 10.1046/j.1365-2958.1999.01312.x; Duong N, 2007, J BIOL CHEM, V282, P34077, DOI 10.1074/jbc.M707352200; Feng XH, 2004, MOL MICROBIOL, V54, P823, DOI 10.1111/j.1365-2958.2004.04317.x; GALAN JE, 1991, INFECT IMMUN, V59, P2901; Galan JE, 2006, NATURE, V444, P567, DOI 10.1038/nature05272; Gallois A, 2001, J IMMUNOL, V166, P5741, DOI 10.4049/jimmunol.166.9.5741; Hapfelmeier S, 2005, J IMMUNOL, V174, P1675, DOI 10.4049/jimmunol.174.3.1675; JONES BD, 1994, J EXP MED, V180, P15, DOI 10.1084/jem.180.1.15; Lane MC, 2007, P NATL ACAD SCI USA, V104, P16669, DOI 10.1073/pnas.0607898104; Lim S, 2006, MICROB PATHOGENESIS, V41, P33, DOI 10.1016/j.micpath.2006.03.005; Miao EA, 2002, J BACTERIOL, V184, P1493, DOI 10.1128/JB.184.5.1493-1497.2002; Navarre WW, 2006, SCIENCE, V313, P236, DOI 10.1126/science.1128794; Navarre WW, 2005, MOL MICROBIOL, V56, P492, DOI 10.1111/j.1365-2958.2005.04553.x; Ochman H, 1996, P NATL ACAD SCI USA, V93, P7800, DOI 10.1073/pnas.93.15.7800; RichterDahlfors A, 1997, J EXP MED, V186, P569, DOI 10.1084/jem.186.4.569; Salcedo SP, 2001, CELL MICROBIOL, V3, P587, DOI 10.1046/j.1462-5822.2001.00137.x; Shea JE, 1996, P NATL ACAD SCI USA, V93, P2593, DOI 10.1073/pnas.93.6.2593; Silphaduang U, 2007, J BACTERIOL, V189, P3669, DOI 10.1128/JB.00002-07; Stapleton MR, 2002, J BIOL CHEM, V277, P17630, DOI 10.1074/jbc.M110178200; Tlili A, 2011, FREE RADICAL BIO MED, V50, P438, DOI 10.1016/j.freeradbiomed.2010.11.024; Tomljenovic-Berube AM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000875; VanderVen BC, 2009, TRAFFIC, V10, P372, DOI [10.1111/j.1600-0854.2008.00877.x, 10.1111/j.1600-0854.2009.00877.x]; Vazquez-Torres A, 2000, SCIENCE, V287, P1655, DOI 10.1126/science.287.5458.1655; Vivero A, 2008, J BACTERIOL, V190, P1152, DOI 10.1128/JB.01206-07; Walthers D, 2007, MOL MICROBIOL, V65, P477, DOI 10.1111/j.1365-2958.2007.05800.x; Waterman SR, 2003, CELL MICROBIOL, V5, P501, DOI 10.1046/j.1462-5822.2003.00294.x; Xu X, 2010, INFECT IMMUN, V78, P49, DOI 10.1128/IAI.00931-09; Yoon HJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000306	41	24	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2011	6	6							e21648	10.1371/journal.pone.0021648	http://dx.doi.org/10.1371/journal.pone.0021648			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	784FW	21738750	Green Submitted, gold, Green Published			2022-12-27	WOS:000292142800053
J	Wen, HX; Lu, YM; Yao, HH; Buch, S				Wen, Hongxiu; Lu, Yaman; Yao, Honghong; Buch, Shilpa			Morphine Induces Expression of Platelet-Derived Growth Factor in Human Brain Microvascular Endothelial Cells: Implication for Vascular Permeability	PLOS ONE			English	Article							RAPID DISEASE PROGRESSION; PROTEASE-ACTIVATED LIGAND; HIV-1 TAT; PDGF; RECEPTOR; METHYLNALTREXONE; TRANSACTIVATION; TRANSCRIPTION; ANGIOGENESIS; INVOLVEMENT	Despite the advent of antiretroviral therapy, complications of HIV-1 infection with concurrent drug abuse are an emerging problem. Morphine, often abused by HIV-infected patients, is known to accelerate neuroinflammation associated with HIV-1 infection. Detailed molecular mechanisms of morphine action however, remain poorly understood. Platelet-derived growth factor (PDGF) has been implicated in a number of pathological conditions, primarily due to its potent mitogenic and permeability effects. Whether morphine exposure results in enhanced vascular permeability in brain endothelial cells, likely via induction of PDGF, remains to be established. In the present study, we demonstrated morphine-mediated induction of PDGF-BB in human brain microvascular endothelial cells, an effect that was abrogated by the opioid receptor antagonistnaltrexone. Pharmacological blockade (cell signaling) and loss-of-function (Egr-1) approaches demonstrated the role of mitogen-activated protein kinases (MAPKs), PI3K/Akt and the downstream transcription factor Egr-1 respectively, in morphine-mediated induction of PDGF-BB. Functional significance of increased PDGF-BB manifested as increased breach of the endothelial barrier as evidenced by decreased expression of the tight junction protein ZO-1 in an in vitro model system. Understanding the regulation of PDGF expression may provide insights into the development of potential therapeutic targets for intervention of morphine-mediated neuroinflammation.	[Wen, Hongxiu; Lu, Yaman; Yao, Honghong; Buch, Shilpa] Univ Nebraska Med Ctr, Dept Pharmacol & Expt Neurosci, Omaha, NE 68198 USA	University of Nebraska System; University of Nebraska Medical Center	Wen, HX (corresponding author), Univ Nebraska Med Ctr, Dept Pharmacol & Expt Neurosci, Omaha, NE 68198 USA.	hyao@unmc.edu; sbuch@unmc.edu		Buch, Shilpa/0000-0002-3103-6685	National Institutes of Health [MH-068212, DA020392, DA023397, DA024442, DA030285]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH068212, P30MH062261] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA023397, R01DA024442, R01DA020392, R21DA030285] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by grants MH-068212, DA020392, DA023397, DA024442 (SB) and DA030285 (HY) from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balasubramanian S, 2001, J MOL CELL CARDIOL, V33, P2179, DOI 10.1006/jmcc.2001.1480; Bell JE, 2006, J NEUROIMMUNE PHARM, V1, P182, DOI 10.1007/s11481-006-9018-2; Bergsten E, 2001, NAT CELL BIOL, V3, P512, DOI 10.1038/35074588; Bokhari SM, 2009, J NEUROVIROL, V15, P219, DOI 10.1080/13550280902913628; Bruce-Keller AJ, 2008, GLIA, V56, P1414, DOI 10.1002/glia.20708; Cabral GA, 2006, J NEUROIMMUNE PHARM, V1, P280, DOI 10.1007/s11481-006-9023-5; Chen C, 2006, CURR NEUROVASC RES, V3, P171, DOI 10.2174/156720206778018767; Chen Y, 2008, J NEUROSCI, V28, P5836, DOI 10.1523/JNEUROSCI.4170-07.2008; Chen Y, 2009, MOL NEUROBIOL, V40, P101, DOI 10.1007/s12035-009-8074-z; DEUEL TF, 1987, ANNU REV CELL BIOL, V3, P443, DOI 10.1146/annurev.cb.03.110187.002303; El-Hage N, 2005, GLIA, V50, P91, DOI 10.1002/glia.20148; Gupta K, 2002, CANCER RES, V62, P4491; HANNINK M, 1989, BIOCHIM BIOPHYS ACTA, V989, P1, DOI 10.1016/0304-419X(89)90031-0; HELDIN CH, 1992, EMBO J, V11, P4251, DOI 10.1002/j.1460-2075.1992.tb05523.x; James AB, 2005, J NEUROCHEM, V95, P796, DOI 10.1111/j.1471-4159.2005.03400.x; Khachigian LM, 1996, SCIENCE, V271, P1427, DOI 10.1126/science.271.5254.1427; Li XR, 2000, NAT CELL BIOL, V2, P302, DOI 10.1038/35010579; Mahajan SD, 2008, J CLIN IMMUNOL, V28, P528, DOI 10.1007/s10875-008-9208-1; Perez-Casanova A, 2007, AIDS RES HUM RETROV, V23, P1004, DOI 10.1089/aid.2006.0286; Potula R, 2004, AM J PATHOL, V165, P815, DOI 10.1016/S0002-9440(10)63344-5; Rivera-Amill V, 2010, VIROLOGY, V398, P201, DOI 10.1016/j.virol.2009.11.046; Roy S, 2003, SURGERY, V134, P336, DOI 10.1067/msy.2003.247; Shin HJ, 2009, CLIN IMMUNOL, V131, P385, DOI 10.1016/j.clim.2009.02.009; Silverman ES, 1999, AM J PATHOL, V154, P665, DOI 10.1016/S0002-9440(10)65312-6; Singleton PA, 2006, MICROVASC RES, V72, P3, DOI 10.1016/j.mvr.2006.04.004; Singleton PA, 2007, AM J RESP CELL MOL, V37, P222, DOI 10.1165/rcmb.2006-0327OC; Su EJ, 2008, NAT MED, V14, P731, DOI 10.1038/nm1787; Turchan-Cholewo J, 2009, J NEUROCHEM, V108, P202, DOI 10.1111/j.1471-4159.2008.05756.x; WINKLES JA, 1991, BIOCHEM BIOPH RES CO, V180, P519, DOI 10.1016/S0006-291X(05)81095-2; YAO H, 2010, BLOOD; Yao HH, 2011, J NEUROSCI, V31, P5942, DOI 10.1523/JNEUROSCI.5618-10.2011; Yao HH, 2009, J NEUROVIROL, V15, P164, DOI 10.1080/13550280902755375; Yao HH, 2009, J NEUROSCI, V29, P1657, DOI 10.1523/JNEUROSCI.2781-08.2009; Yousif S, 2008, J NEUROCHEM, V107, P647, DOI 10.1111/j.1471-4159.2008.05647.x	34	37	37	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2011	6	6							e21707	10.1371/journal.pone.0021707	http://dx.doi.org/10.1371/journal.pone.0021707			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	784FW	21738771	Green Submitted, Green Published, gold			2022-12-27	WOS:000292142800062
J	Liang, LH; Woodward, OM; Chen, ZH; Cotter, R; Guggino, WB				Liang, Lihua; Woodward, Owen M.; Chen, Zhaohui; Cotter, Robert; Guggino, William B.			A Novel Role of Protein Tyrosine Kinase2 in Mediating Chloride Secretion in Human Airway Epithelial Cells	PLOS ONE			English	Article							FOCAL ADHESION KINASE; PYK2; RECEPTORS; SPIPERONE; CALCIUM; PHOSPHORYLATION; CHANNEL; INVASION; BINDING; LIGAND	Ca2+ activated Cl- channels (CaCC) are up-regulated in cystic fibrosis (CF) airway surface epithelia. The presence and functional properties of CaCC make it a possible therapeutic target to compensate for the deficiency of Cl- secretion in CF epithelia. CaCC is activated by an increase in cytosolic Ca2+, which not only activates epithelial CaCCs, but also inhibits epithelial Na+ hyperabsorption, which may also be beneficial in CF. Our previous study has shown that spiperone, a known antipsychotic drug, activates CaCCs and stimulates Cl- secretion in polarized human non-CF and CF airway epithelial cell monolayers in vitro, and in Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) knockout mice in vivo. Spiperone activates CaCC not by acting in its well-known role as an antagonist of either 5-HT2 or D2 receptors, but through a protein tyrosine kinase-coupled phospholipase C-dependent pathway. Moreover, spiperone independently activates CFTR through a novel mechanism. Herein, we performed a mass spectrometry analysis and identified the signaling molecule that mediates the spiperone effect in activating chloride secretion through CaCC and CFTR. Proline-rich tyrosine kinase 2 (PYK2) is a nonreceptor protein tyrosine kinase, which belongs to the focal adhesion kinase family. The inhibition of PYK2 notably reduced the ability of spiperone to increase intracellular Ca2+ and Cl- secretion. In conclusion, we have identified the tyrosine kinase, PYK2, as the modulator, which plays a crucial role in the activation of CaCC and CFTR by spiperone. The identification of this novel role of PYK2 reveals a new signaling pathway in human airway epithelial cells.	[Liang, Lihua; Woodward, Owen M.; Guggino, William B.] Johns Hopkins Univ, Sch Med, Dept Physiol, Baltimore, MD 21205 USA; [Chen, Zhaohui; Cotter, Robert] Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University	Liang, LH (corresponding author), Johns Hopkins Univ, Sch Med, Dept Physiol, Baltimore, MD 21205 USA.	wguggino@jhmi.edu		Woodward, Owen M./0000-0001-9514-2180	National Institutes of Health [P01 DK72074]; Cystic Fibrosis Foundation [R025-CR07]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation)	Funding was provided by the National Institutes of Health (P01 DK72074) and Cystic Fibrosis Foundation Grant R025-CR07. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON MP, 1991, P NATL ACAD SCI USA, V88, P6003, DOI 10.1073/pnas.88.14.6003; Anitei M, 2010, NAT CELL BIOL, V12, P330, DOI 10.1038/ncb2034; Avraham H, 2000, CELL SIGNAL, V12, P123, DOI 10.1016/S0898-6568(99)00076-5; Chien LT, 2006, J GEN PHYSIOL, V128, P247, DOI 10.1085/jgp.200609581; CREESE I, 1978, EUR J PHARMACOL, V49, P201, DOI 10.1016/0014-2999(78)90080-8; Dahan D, 2001, PFLUG ARCH EUR J PHY, V443, pS92, DOI 10.1007/s004240100652; Defilippi P, 2006, TRENDS CELL BIOL, V16, P257, DOI 10.1016/j.tcb.2006.03.003; Esen M, 2001, INFECT IMMUN, V69, P281, DOI 10.1128/IAI.69.1.281-287.2001; Giachini FRC, 2008, J AM SOC HYPERTENS, V2, P431, DOI 10.1016/j.jash.2008.05.001; Glennon Richard A., 2002, Current Topics in Medicinal Chemistry, V2, P539, DOI 10.2174/1568026023393787; GUNDLACH AL, 1984, LIFE SCI, V35, P1981, DOI 10.1016/0024-3205(84)90479-X; Kohno T, 2008, BIOCHEM J, V410, P513, DOI 10.1042/BJ20070665; LEV S, 1995, NATURE, V376, P737, DOI 10.1038/376737a0; LEYSEN JE, 1978, BIOCHEM PHARMACOL, V27, P307, DOI 10.1016/0006-2952(78)90233-2; Li W, 2001, ONCOGENE, V20, P6403, DOI 10.1038/sj.onc.1204782; Liang L, 2009, AM J PHYSIOL-CELL PH, V296, pC131, DOI 10.1152/ajpcell.00346.2008; Lu Desheng, 2009, BMC Pharmacology, V9, P13, DOI 10.1186/1471-2210-9-13; Marshall WS, 2009, J EXP BIOL, V212, P2365, DOI 10.1242/jeb.030015; Matsui A, 2007, CIRCULATION, V116, P1041, DOI 10.1161/CIRCULATIONAHA.106.645416; Mohler PJ, 1999, J CELL BIOL, V147, P879, DOI 10.1083/jcb.147.4.879; Okigaki M, 2003, P NATL ACAD SCI USA, V100, P10740, DOI 10.1073/pnas.1834348100; Rufanova VA, 2009, J CELL PHYSIOL, V219, P45, DOI 10.1002/jcp.21649; Schaller MD, 2010, J CELL SCI, V123, P1007, DOI 10.1242/jcs.045112; Schlaepfer DD, 1999, PROG BIOPHYS MOL BIO, V71, P435, DOI 10.1016/S0079-6107(98)00052-2; Selvaraj NG, 2000, MOL ENDOCRINOL, V14, P2054, DOI 10.1210/me.14.12.2054; Sheppard David N., 1999, Physiological Reviews, V79, pS23; Silva JM, 2009, CELL, V137, P1047, DOI 10.1016/j.cell.2009.04.013; ZEITLIN PL, 1991, AM J RESP CELL MOL, V4, P313, DOI 10.1165/ajrcmb/4.4.313; Zheng LT, 2008, J NEUROCHEM, V107, P1225, DOI 10.1111/j.1471-4159.2008.05675.x	29	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2011	6	7							e21991	10.1371/journal.pone.0021991	http://dx.doi.org/10.1371/journal.pone.0021991			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	792WQ	21765932	gold, Green Published, Green Submitted			2022-12-27	WOS:000292781500025
J	Ho, JY; Lin, TL; Li, CY; Lee, A; Cheng, AN; Chen, MC; Wu, SH; Wang, JT; Li, TL; Tsai, MD				Ho, Jin-Yuan; Lin, Tzu-Lung; Li, Chun-Yen; Lee, Arwen; Cheng, An-Ning; Chen, Ming-Chuan; Wu, Shih-Hsiung; Wang, Jin-Town; Li, Tsung-Lin; Tsai, Ming-Daw			Functions of Some Capsular Polysaccharide Biosynthetic Genes in Klebsiella pneumoniae NTUH K-2044	PLOS ONE			English	Article							PYOGENIC LIVER-ABSCESS; GROUP-B STREPTOCOCCUS; ESCHERICHIA-COLI; O-ACETYLATION; VIRULENCE; BACTERIA; SEROTYPE; TRANSDUCTION; RESISTANCE; PATHWAY	The growing number of Klebsiella pneumoniae infections, commonly acquired in hospitals, has drawn great concern. It has been shown that the K1 and K2 capsular serotypes are the most detrimental strains, particularly to those with diabetes. The K1 cps (capsular polysaccharide) locus in the NTUH-2044 strain of the pyogenic liver abscess (PLA) K. pneumoniae has been identified recently, but little is known about the functions of the genes therein. Here we report characterization of a group of cps genes and their roles in the pathogenesis of K1 K. pneumoniae. By sequential gene deletion, the cps gene cluster was first re-delimited between genes galF and ugd, which serve as up- and down-stream ends, respectively. Eight gene products were characterized in vitro and in vivo to be involved in the syntheses of UDP-glucose, UDP-glucuronic acid and GDP-fucose building units. Twelve genes were identified as virulence factors based on the observation that their deletion mutants became avirulent or lost K1 antigenicity. Furthermore, deletion of kp3706, kp3709 or kp3712 (Delta wcal, Delta wcaG or Delta atf, respectively), which are all involved in fucose biosynthesis, led to a broad range of transcriptional suppression for 52 upstream genes. The genes suppressed include those coding for unknown regulatory membrane proteins and six multidrug efflux system proteins, as well as proteins required for the K1 CPS biosynthesis. In support of the suppression of multidrug efflux genes, we showed that these three mutants became more sensitive to antibiotics. Taken together, the results suggest that kp3706, kp3709 or kp3712 genes are strongly related to the pathogenesis of K. pneumoniae K1.	[Ho, Jin-Yuan; Lee, Arwen; Cheng, An-Ning; Chen, Ming-Chuan; Wu, Shih-Hsiung; Tsai, Ming-Daw] Acad Sinica, Inst Biol Chem, Taipei, Taiwan; [Ho, Jin-Yuan; Li, Chun-Yen; Lee, Arwen; Chen, Ming-Chuan; Li, Tsung-Lin; Tsai, Ming-Daw] Acad Sinica, Genom Res Ctr, Taipei, Taiwan; [Ho, Jin-Yuan; Li, Tsung-Lin; Tsai, Ming-Daw] Acad Sinica, Chem Biol & Mol Biophys Program, Taiwan Int Grad Program, Inst Biochem, Taipei, Taiwan; [Ho, Jin-Yuan; Tsai, Ming-Daw] Natl Taiwan Univ, Inst Biochem Sci, Taipei 10764, Taiwan; [Lin, Tzu-Lung; Wang, Jin-Town] Natl Taiwan Univ, Coll Med, Dept Microbiol, Taipei 10764, Taiwan; [Cheng, An-Ning] Natl Tsing Hua Univ, Inst Bioinformat & Struct Biol, Hsinchu, Taiwan; [Wang, Jin-Town] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan	Academia Sinica - Taiwan; Academia Sinica - Taiwan; Academia Sinica - Taiwan; National Taiwan University; National Taiwan University; National Tsing Hua University; National Taiwan University; National Taiwan University Hospital	Ho, JY (corresponding author), Acad Sinica, Inst Biol Chem, Taipei, Taiwan.	wangjt@ccms.ntu.edu.tw; tlli@gate.sinica.edu.tw; mdtsai@gate.sinica.edu.tw	Tsai, Ming-Daw/G-4689-2019	Tsai, Ming-Daw/0000-0003-1374-0414	National Science Council of Taiwan [94-3112-B-002-024, 97-3112-B-001-003]; Academia Sinica	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); Academia Sinica(Academia Sinica - Taiwan)	National Science Council of Taiwan (Grants 94-3112-B-002-024 to JW, and 97-3112-B-001-003 to SW, MT, and JTW) and Academia Sinica intramural funding. The work has also benefited from Biophysics Core and Mass Core of Academia Sinica. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARKER SA, 1963, NATURE, V197, P899, DOI 10.1038/197899a0; Bergfeld AK, 2009, J BIOL CHEM, V284, P6, DOI 10.1074/jbc.M807518200; Bina XR, 2008, INFECT IMMUN, V76, P3595, DOI 10.1128/IAI.01620-07; Brisse S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004982; Chang KC, 1997, BIOCHEM BIOPH RES CO, V236, P785, DOI 10.1006/bbrc.1997.7050; Chou HC, 2004, INFECT IMMUN, V72, P3783, DOI 10.1128/IAI.72.7.3783-3792.2004; Chuang YP, 2006, J INFECT DIS, V193, P645, DOI 10.1086/499968; Chung DR, 2007, J INFECTION, V54, P578, DOI 10.1016/j.jinf.2006.11.008; Coyne MJ, 2005, SCIENCE, V307, P1778, DOI 10.1126/science.1106469; Dambach MD, 2009, CURR OPIN MICROBIOL, V12, P161, DOI 10.1016/j.mib.2009.01.012; FRANKLIN NC, 1961, VIROLOGY, V15, P299, DOI 10.1016/0042-6822(61)90362-2; Fung CP, 2000, J INFECT DIS, V181, P2075, DOI 10.1086/315488; Hsieh PF, 2008, J INFECT DIS, V197, P1717, DOI 10.1086/588383; Ko WC, 2002, EMERG INFECT DIS, V8, P160, DOI 10.3201/eid0802.010025; Lederman ER, 2005, AM J GASTROENTEROL, V100, P322, DOI 10.1111/j.1572-0241.2005.40310.x; Lewis AL, 2004, P NATL ACAD SCI USA, V101, P11123, DOI 10.1073/pnas.0403010101; Lewis AL, 2007, J BIOL CHEM, V282, P27562, DOI 10.1074/jbc.M700340200; Link AJ, 1997, J BACTERIOL, V179, P6228, DOI 10.1128/jb.179.20.6228-6237.1997; LIU TW, 2009, P NATL ACAD SCI US; Majdalani N, 2005, ANNU REV MICROBIOL, V59, P379, DOI 10.1146/annurev.micro.59.050405.101230; MIZUTA K, 1983, INFECT IMMUN, V40, P56, DOI 10.1128/IAI.40.1.56-61.1983; Morona JK, 1997, MOL MICROBIOL, V23, P751, DOI 10.1046/j.1365-2958.1997.2551624.x; Narberhaus F, 2006, FEMS MICROBIOL REV, V30, P3, DOI 10.1111/j.1574-6976.2005.004.x; Nikaido H, 1996, J BACTERIOL, V178, P5853, DOI 10.1128/jb.178.20.5853-5859.1996; Nordmann P, 2009, LANCET INFECT DIS, V9, P228, DOI 10.1016/S1473-3099(09)70054-4; Pan YJ, 2008, J CLIN MICROBIOL, V46, P2231, DOI 10.1128/JCM.01716-07; Podschun R, 1998, CLIN MICROBIOL REV, V11, P589, DOI 10.1128/CMR.11.4.589; Rahn A, 2003, MOL MICROBIOL, V47, P1045, DOI 10.1046/j.1365-2958.2003.03354.x; REED L. J., 1938, AMER JOUR HYG, V27, P493; Vogel J, 2003, NUCLEIC ACIDS RES, V31, P6435, DOI 10.1093/nar/gkg867; West NP, 2005, SCIENCE, V307, P1313, DOI 10.1126/science.1108472; Whitfield C, 2006, ANNU REV BIOCHEM, V75, P39, DOI 10.1146/annurev.biochem.75.103004.142545; Woodford N, 2004, ANTIMICROB AGENTS CH, V48, P4793, DOI 10.1128/AAC.48.12.4793-4799.2004; Wu JH, 2008, EXP BIOL MED, V233, P64, DOI 10.3181/0706-RM-170; Wu KM, 2009, J BACTERIOL, V191, P4492, DOI 10.1128/JB.00315-09; Yamamoto M, 2002, NATURE, V420, P324, DOI 10.1038/nature01182; Yang Ching-Cheng, 2004, Journal of Microbiology Immunology and Infection, V37, P176; Zamze S, 2002, J BIOL CHEM, V277, P41613, DOI 10.1074/jbc.M207057200	38	23	25	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2011	6	7							e21664	10.1371/journal.pone.0021664	http://dx.doi.org/10.1371/journal.pone.0021664			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791WM	21765903	Green Published, gold, Green Submitted			2022-12-27	WOS:000292699000009
J	Moore, RD; Bartlett, JG; Gallant, JE				Moore, Richard D.; Bartlett, John G.; Gallant, Joel E.			Association between Use of HMG CoA Reductase Inhibitors and Mortality in HIV-Infected Patients	PLOS ONE			English	Article							IMMUNE ACTIVATION; ANTIRETROVIRAL THERAPY; STATINS; INFLAMMATION; IMMUNOSENESCENCE; OUTCOMES; MARKERS; SEPSIS; ANEMIA; AIDS	Introduction: HIV infection is a disease associated with chronic inflammation and immune activation. Antiretroviral therapy reduces inflammation, but not to levels in comparable HIV-negative individuals. The HMG-coenzyme A reductase inhibitors (statins) inhibit several pro-inflammatory processes and suppress immune activation, and are a logical therapy to assess for a possible salutary effect on HIV disease progression and outcomes. Methods: Eligible patients were patients enrolled in the Johns Hopkins HIV Clinical Cohort who achieved virologic suppression within 180 days of starting a new highly active antiretroviral therapy (HAART) regimen after January 1, 1998. Assessment was continued until death in patients who maintained a virologic suppression, with right-censoring of their follow-up time if they had an HIV RNA > 500 copies/ml. Cox proportional hazards regression was used to assess statin use as a time-varying covariate, as well as other demographic and clinical factors. Results: A total of 1538 HIV-infected patients fulfilled eligibility criteria, of whom 238 (15.5%) received a statin while taking HAART. There were 85 deaths (7 in statin users, 78 in non-users). By multivariate Cox regression, statin use was associated with a relative hazard of 0.33 (95% CI: 0.14, 0.76; P = 0.009) after adjusting for CD4, HIV-1 RNA, hemoglobin and cholesterol levels at the start of HAART, age, race, HIV risk group, prior use of ART, year of HAART start, NNRTI vs. PI-based ART, prior AIDS-defining illness, and viral hepatitis coinfection. Malignancy, non-AIDS-defining infection and liver failure were particularly prominent causes of death. Discussion: Statin use was associated with significantly lower hazard of dying in these HIV-infected patients who were being effectively treated with HAART as determined by virologic suppression. Our results suggest the need for confirmation in other observational cohorts, and if confirmed, the need for a clinical trial of statin use in HIV infection.	[Moore, Richard D.; Bartlett, John G.; Gallant, Joel E.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA	Johns Hopkins University	Moore, RD (corresponding author), Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA.	rdmoore@jhmi.edu			National Institutes of Health [R01 DA11602, K24DA00432, R01A16893]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI069918] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K24DA000432, R01DA011602] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by National Institutes of Health grants (R01 DA11602, K24DA00432, R01A16893). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amet T, 2008, MICROBES INFECT, V10, P471, DOI 10.1016/j.micinf.2008.01.009; Appay V, 2008, J PATHOL, V214, P231, DOI 10.1002/path.2276; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Deeks SG, 2011, ANNU REV MED, V62, P141, DOI 10.1146/annurev-med-042909-093756; Deeks Steven G, 2009, Top HIV Med, V17, P118; Dulak J, 2005, CURR CANCER DRUG TAR, V5, P579, DOI 10.2174/156800905774932824; Fedson DS, 2008, LANCET INFECT DIS, V8, P571, DOI 10.1016/S1473-3099(08)70070-7; Ganesan A, 2011, J INFECT DIS, V203, P756, DOI 10.1093/infdis/jiq115; Grunfeld C, 2009, AIDS, V23, P1841, DOI 10.1097/QAD.0b013e32832d3b85; Harris RJ, 2008, ANTIVIR THER, V13, P959; Hunt Peter W, 2007, Curr HIV/AIDS Rep, V4, P42, DOI 10.1007/s11904-007-0007-8; Jadhav SB, 2006, J PHARM PHARMACOL, V58, P3, DOI 10.1211/jpp.58.1.0002; Jain MK, 2005, NAT REV DRUG DISCOV, V4, P977, DOI 10.1038/nrd1901; Janda S, 2010, J CRIT CARE, V25; Jiang W, 2009, J INFECT DIS, V199, P1177, DOI 10.1086/597476; Kopterides P, 2009, CLIN MICROBIOL INFEC, V15, P325, DOI 10.1111/j.1469-0691.2009.02750.x; Kuller LH, 2008, PLOS MED, V5, P1496, DOI 10.1371/journal.pmed.0050203; Kwak B, 2000, NAT MED, V6, P1399, DOI 10.1038/82219; Longenecker CT, 2009, AIDS, V23, P1089, DOI 10.1097/QAD.0b013e32832a3f24; *MD DEP HLTH MENT, 2010, MAR HIV AIDS EP PROF; Mira Emilia, 2009, Endocrine Metabolic & Immune Disorders-Drug Targets, V9, P237; Mocroft A, 1999, AIDS, V13, P943, DOI 10.1097/00002030-199905280-00010; Molina-Pinelo S, 2009, J ANTIMICROB CHEMOTH, V64, P579, DOI 10.1093/jac/dkp248; Moncunill G, 2005, AIDS, V19, P1697, DOI 10.1097/01.aids.0000183517.60384.db; Monforte AD, 2008, AIDS, V22, P2143, DOI 10.1097/QAD.0b013e3283112b77; Moore RD, 1998, J ACQ IMMUN DEF SYND, V17, pS38, DOI 10.1097/00042560-199801001-00011; Moore RD, 2008, CLIN INFECT DIS, V47, P1102, DOI 10.1086/592115; Negredo E, 2006, AIDS, V20, P619, DOI 10.1097/01.aids.0000210617.90954.0e; Neuhaus J, 2010, J INFECT DIS, V201, P1788, DOI 10.1086/652749; PRICE EA, 2010, ADV HEMATOL, P8739; Ridker PM, 2009, LANCET, V373, P1175, DOI 10.1016/S0140-6736(09)60447-5; Thomsen RW, 2008, ARCH INTERN MED, V168, P2081, DOI 10.1001/archinte.168.19.2081; Tleyjeh IM, 2009, ARCH INTERN MED, V169, P1658, DOI 10.1001/archinternmed.2009.286; Yasuda H, 2006, KIDNEY INT, V69, P1535, DOI 10.1038/sj.ki.5000300; Yokota N, 2003, AM J NEPHROL, V23, P13, DOI 10.1159/000066301	35	63	63	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2011	6	7							e21843	10.1371/journal.pone.0021843	http://dx.doi.org/10.1371/journal.pone.0021843			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791WM	21765919	Green Published, Green Submitted, gold			2022-12-27	WOS:000292699000012
J	China, A; Mishra, S; Nagaraja, V				China, Arnab; Mishra, Sonakshi; Nagaraja, Valakunja			A Transcript Cleavage Factor of Mycobacterium tuberculosis Important for Its Survival	PLOS ONE			English	Article							RNA-POLYMERASE-II; ESCHERICHIA-COLI; FACTORS GREA; ELONGATION-FACTOR; THERMUS-THERMOPHILUS; CRYSTAL-STRUCTURE; IN-VIVO; INITIATION; GENES; MECHANISMS	After initiation of transcription, a number of proteins participate during elongation and termination modifying the properties of the RNA polymerase (RNAP). Gre factors are one such group conserved across bacteria. They regulate transcription by projecting their N-terminal coiled-coil domain into the active center of RNAP through the secondary channel and stimulating hydrolysis of the newly synthesized RNA in backtracked elongation complexes. Rv1080c is a putative gre factor (MtbGre) in the genome of Mycobacterium tuberculosis. The protein enhanced the efficiency of promoter clearance by lowering abortive transcription and also rescued arrested and paused elongation complexes on the GC rich mycobacterial template. Although MtbGre is similar in domain organization and shares key residues for catalysis and RNAP interaction with the Gre factors of Escherichia coli, it could not complement an E. coli gre deficient strain. Moreover, MtbGre failed to rescue E. coli RNAP stalled elongation complexes, indicating the importance of specific protein-protein interactions for transcript cleavage. Decrease in the level of MtbGre reduced the bacterial survival by several fold indicating its essential role in mycobacteria. Another Gre homolog, Rv3788 was not functional in transcript cleavage activity indicating that a single Gre is sufficient for efficient transcription of the M. tuberculosis genome.	[China, Arnab; Mishra, Sonakshi; Nagaraja, Valakunja] Indian Inst Sci, Dept Microbiol & Cell Biol, Bangalore 560012, Karnataka, India; [Nagaraja, Valakunja] Indian Inst Sci, Jawaharlal Nehru Ctr Adv Sci Res, Bangalore 560012, Karnataka, India	Indian Institute of Science (IISC) - Bangalore; Department of Science & Technology (India); Jawaharlal Nehru Center for Advanced Scientific Research (JNCASR); Indian Institute of Science (IISC) - Bangalore	China, A (corresponding author), Indian Inst Sci, Dept Microbiol & Cell Biol, Bangalore 560012, Karnataka, India.	vraj@mcbl.iisc.ernet.in		China, Arnab/0000-0003-2832-2338	Department of Biotechnology, Government of India; Council of Scientific and Industrial Research, Government of India; Department of Science and Technology	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); Council of Scientific and Industrial Research, Government of India(Council of Scientific & Industrial Research (CSIR) - India); Department of Science and Technology(Department of Science & Technology (India))	The Phosphorimager Facility of IISc is supported by the Department of Biotechnology, Government of India, and is acknowledged. AC was a recipient of Senior Research Fellowship from Council of Scientific and Industrial Research, Government of India. VN is a recipient of J.C. Bose Fellowship from the Department of Science and Technology and a Center for Excellence in Tuberculosis Research grant from Department of Biotechnology, Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belotserkovskii BP, 2010, P NATL ACAD SCI USA, V107, P12816, DOI 10.1073/pnas.1007580107; Borukhov S, 2005, MOL MICROBIOL, V55, P1315, DOI 10.1111/j.1365-2958.2004.04481.x; BORUKHOV S, 1992, P NATL ACAD SCI USA, V89, P8899, DOI 10.1073/pnas.89.19.8899; BORUKHOV S, 1993, CELL, V72, P459, DOI 10.1016/0092-8674(93)90121-6; Borukhov S, 2001, METHOD ENZYMOL, V342, P64, DOI 10.1016/S0076-6879(01)42536-5; Campbell GRO, 2003, J BACTERIOL, V185, P3853, DOI 10.1128/JB.185.13.3853-3862.2003; China A, 2010, MICROBIOL-SGM, V156, P1942, DOI 10.1099/mic.0.038620-0; China A, 2010, PROTEIN EXPRES PURIF, V69, P235, DOI 10.1016/j.pep.2009.09.022; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Deutscher MP, 2006, NUCLEIC ACIDS RES, V34, P659, DOI 10.1093/nar/gkj472; HARSHEY RM, 1977, J BACTERIOL, V129, P616, DOI 10.1128/JB.129.2.616-622.1977; Haugen SP, 2008, NAT REV MICROBIOL, V6, P507, DOI 10.1038/nrmicro1912; Hogan BP, 2002, J BIOL CHEM, V277, P967, DOI 10.1074/jbc.M108737200; Hsu LM, 2009, METHODS, V47, P25, DOI 10.1016/j.ymeth.2008.10.010; HSU LM, 1995, P NATL ACAD SCI USA, V92, P11588, DOI 10.1073/pnas.92.25.11588; Garcia MJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011575; Kireeva ML, 2005, MOL CELL, V18, P97, DOI 10.1016/j.molcel.2005.02.027; Komissarova N, 1997, J BIOL CHEM, V272, P15329, DOI 10.1074/jbc.272.24.15329; Koulich D, 1998, J MOL BIOL, V276, P379, DOI 10.1006/jmbi.1997.1545; Koulich D, 1997, J BIOL CHEM, V272, P7201, DOI 10.1074/jbc.272.11.7201; Kulish D, 2000, J BIOL CHEM, V275, P12789, DOI 10.1074/jbc.275.17.12789; Lamour V, 2006, J MOL BIOL, V356, P179, DOI 10.1016/j.jmb.2005.10.083; Laptenko O, 2003, METHOD ENZYMOL, V371, P219; Laptenko O, 2003, EMBO J, V22, P6322, DOI 10.1093/emboj/cdg610; Laptenko O, 2006, EMBO J, V25, P2131, DOI 10.1038/sj.emboj.7601094; Len ACL, 2004, MICROBIOL-SGM, V150, P1339, DOI 10.1099/mic.0.27008-0; Loizos N, 1999, J BIOL CHEM, V274, P23378, DOI 10.1074/jbc.274.33.23378; Manganelli R, 1999, MOL MICROBIOL, V31, P715, DOI 10.1046/j.1365-2958.1999.01212.x; Marr MT, 2000, MOL CELL, V6, P1275, DOI 10.1016/S1097-2765(00)00126-X; Mukherjee R, 2008, BIOCHEM BIOPH RES CO, V369, P899, DOI 10.1016/j.bbrc.2008.02.118; Nogales J, 2002, MOL PLANT MICROBE IN, V15, P225, DOI 10.1094/MPMI.2002.15.3.225; Opalka N, 2003, CELL, V114, P335, DOI 10.1016/S0092-8674(03)00600-7; ORLOVA M, 1995, P NATL ACAD SCI USA, V92, P4596, DOI 10.1073/pnas.92.10.4596; REINES D, 1989, J BIOL CHEM, V264, P10799; Roberts JW, 2008, ANNU REV MICROBIOL, V62, P211, DOI 10.1146/annurev.micro.61.080706.093422; Rodrigue S, 2006, FEMS MICROBIOL REV, V30, P926, DOI 10.1111/j.1574-6976.2006.00040.x; Rutherford ST, 2007, J MOL BIOL, V366, P1243, DOI 10.1016/j.jmb.2006.12.013; Sen R, 2001, GENES CELLS, V6, P389, DOI 10.1046/j.1365-2443.2001.00436.x; Sharbati S, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-31; Sigurdsson S, 2010, MOL CELL, V38, P202, DOI 10.1016/j.molcel.2010.02.026; Singh VK, 2001, FEMS MICROBIOL LETT, V199, P79, DOI 10.1016/S0378-1097(01)00163-X; Smith I, 2005, TUBERCULOSIS AND THE TUBERCLE BACILLUS, P219; SNAPPER SB, 1990, MOL MICROBIOL, V4, P1911, DOI 10.1111/j.1365-2958.1990.tb02040.x; STEBBINS CE, 1995, NATURE, V373, P636, DOI 10.1038/373636a0; STOVER CK, 1991, NATURE, V351, P456, DOI 10.1038/351456a0; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; Sun J, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0008769, 10.1371/journal.pone.0011351]; Susa M, 2006, MOL MICROBIOL, V59, P1807, DOI 10.1111/j.1365-2958.2006.05058.x; Vassylyev DG, 2009, CURR OPIN STRUC BIOL, V19, P691, DOI 10.1016/j.sbi.2009.10.004; Vassylyeva MN, 2007, EMBO REP, V8, P1038, DOI 10.1038/sj.embor.7401079; Wu SP, 2004, MOL MICROBIOL, V51, P1551, DOI 10.1111/j.1365-2958.2003.03922.x; Zheng HJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002375	52	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2011	6	7							e21941	10.1371/journal.pone.0021941	http://dx.doi.org/10.1371/journal.pone.0021941			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791IA	21760927	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000292657200031
J	Han, XL; Yu, RT; Zhen, DY; Tao, S; Schmidt, M; Han, L				Han, Xuelin; Yu, Rentao; Zhen, Dongyu; Tao, Sha; Schmidt, Martina; Han, Li			beta-1,3-Glucan-Induced Host Phospholipase D Activation Is Involved in Aspergillus fumigatus Internalization into Type II Human Pneumocyte A549 Cells	PLOS ONE			English	Article							AIRWAY EPITHELIAL-CELLS; BETA-GLUCAN RECEPTOR; BINDING LECTIN SITE; MOUSE PERITONEAL-MACROPHAGES; STRESS FIBER FORMATION; TOLL-LIKE RECEPTORS; PHOSPHATIDIC-ACID; MAST-CELLS; LYSOPHOSPHATIDIC ACID; MURINE MACROPHAGES	The internalization of Aspergillus fumigatus into lung epithelial cells is a process that depends on host cell actin dynamics. The host membrane phosphatidylcholine cleavage driven by phospholipase D (PLD) is closely related to cellular actin dynamics. However, little is known about the impact of PLD on A. fumigatus internalization into lung epithelial cells. Here, we report that once germinated, A. fumigatus conidia were able to stimulate host PLD activity and internalize more efficiently in A549 cells without altering PLD expression. The internalization of A. fumigatus in A549 cells was suppressed by the downregulation of host cell PLD using chemical inhibitors or siRNA interference. The heat-killed swollen conidia, but not the resting conidia, were able to activate host PLD. Further, beta-1,3-glucan, the core component of the conidial cell wall, stimulated host PLD activity. This PLD activation and conidia internalization were inhibited by anti-dectin-1 antibody. Indeed, dectin-1, a beta-1,3-glucan receptor, was expressed in A549 cells, and its expression profile was not altered by conidial stimulation. Finally, host cell PLD1 and PLD2 accompanied A. fumigatus conidia during internalization. Our data indicate that host cell PLD activity induced by beta-1,3-glucan on the surface of germinated conidia is important for the efficient internalization of A. fumigatus into A549 lung epithelial cells.	[Han, Xuelin; Yu, Rentao; Zhen, Dongyu; Tao, Sha; Han, Li] Acad Mil Med Sci, Inst Dis Control & Prevent PLA, Dept Hosp Infect Control & Res, Beijing, Peoples R China; [Schmidt, Martina] Univ Groningen, Dept Mol Pharmacol, Groningen, Netherlands	Academy of Military Medical Sciences - China; University of Groningen	Han, XL (corresponding author), Acad Mil Med Sci, Inst Dis Control & Prevent PLA, Dept Hosp Infect Control & Res, Beijing, Peoples R China.	hanli@bmi.ac.cn	Hu, Mandong/AAH-1140-2019; Schmidt, Martina/C-5339-2018	Schmidt, Martina/0000-0003-3075-0630	Chinese National Scientific Foundation Committee [30772029]; University of Groningen	Chinese National Scientific Foundation Committee; University of Groningen	This work was supported by grant No. 30772029 from Chinese National Scientific Foundation Committee and a Rosalind Franklin Fellowship from the University of Groningen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alekseeva L, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-33; Ariizumi K, 2000, J BIOL CHEM, V275, P20157, DOI 10.1074/jbc.M909512199; Bernard M, 2001, MED MYCOL, V39, P9, DOI 10.1080/mmy.39.1.9.17; Brandenburg LO, 2009, MOL MEMBR BIOL, V26, P371, DOI 10.1080/09687680903188340; Brown FD, 1998, CURR BIOL, V8, P835, DOI 10.1016/S0960-9822(98)70326-4; Brown GD, 2002, J EXP MED, V196, P407, DOI 10.1084/jem.20020470; Brown GD, 2006, NAT REV IMMUNOL, V6, P33, DOI 10.1038/nri1745; Corrotte M, 2006, TRAFFIC, V7, P365, DOI 10.1111/j.1600-0854.2006.00389.x; Cross MJ, 1996, CURR BIOL, V6, P588, DOI 10.1016/S0960-9822(02)00545-6; DeHart DJ, 1997, J INFECT DIS, V175, P146, DOI 10.1093/infdis/175.1.146; Denmat-Ouisse LA, 2001, J BIOL CHEM, V276, P48840, DOI 10.1074/jbc.M104276200; DUBYAK GR, 1993, BIOCHEM J, V292, P121, DOI 10.1042/bj2920121; Exton JH, 2002, FEBS LETT, V531, P58, DOI 10.1016/S0014-5793(02)03405-1; Filler SG, 2006, PLOS PATHOG, V2, P1099, DOI 10.1371/journal.ppat.0020129; Fontaine T, 2000, J BIOL CHEM, V275, P41528; Freyberg Z, 2001, MOL BIOL CELL, V12, P943, DOI 10.1091/mbc.12.4.943; Garrido JL, 2009, MOL ENDOCRINOL, V23, P2048, DOI 10.1210/me.2008-0436; Gastebois A, 2009, FUTURE MICROBIOL, V4, P583, DOI 10.2217/FMB.09.29; Gersuk GM, 2006, J IMMUNOL, V176, P3717, DOI 10.4049/jimmunol.176.6.3717; GIAIMIS J, 1993, J LEUKOCYTE BIOL, V54, P564, DOI 10.1002/jlb.54.6.564; Goldfine H, 2000, INFECT IMMUN, V68, P5735, DOI 10.1128/IAI.68.10.5735-5741.2000; Gomez-Cambronero J, 2007, J LEUKOCYTE BIOL, V82, P272, DOI 10.1189/jlb.0107033; Gomez-Munoz A, 1999, J LIPID RES, V40, P988; HA KS, 1993, J CELL BIOL, V123, P1789, DOI 10.1083/jcb.123.6.1789; Han L, 2007, EMBO J, V26, P4189, DOI 10.1038/sj.emboj.7601852; Herre J, 2004, BLOOD, V104, P4038, DOI 10.1182/blood-2004-03-1140; Hohl TM, 2005, PLOS PATHOG, V1, P232, DOI 10.1371/journal.ppat.0010030; Huang P, 2007, EXPERT OPIN THER TAR, V11, P707, DOI 10.1517/14728222.11.5.707; Iyer SS, 2006, J IMMUNOL, V176, P3686, DOI 10.4049/jimmunol.176.6.3686; Iyer SS, 2004, J IMMUNOL, V173, P2615, DOI 10.4049/jimmunol.173.4.2615; Iyer SS, 1999, J BIOL CHEM, V274, P2350, DOI 10.1074/jbc.274.4.2350; Jenkins GM, 2005, CELL MOL LIFE SCI, V62, P2305, DOI 10.1007/s00018-005-5195-z; Kam Y, 2001, MOL CELL BIOL, V21, P4055, DOI 10.1128/MCB.21.12.4055-4066.2001; Komati H, 2005, MOL BIOL CELL, V16, P1232, DOI 10.1091/mbc.E04-06-0459; Kooijman EE, 2003, TRAFFIC, V4, P162, DOI 10.1034/j.1600-0854.2003.00086.x; Kusner DJ, 1999, J IMMUNOL, V162, P2266; Kusner DJ, 1996, J EXP MED, V184, P585, DOI 10.1084/jem.184.2.585; Lee HY, 2004, EXP MOL MED, V36, P135, DOI 10.1038/emm.2004.20; Lee HM, 2009, J CLIN IMMUNOL, V29, P795, DOI 10.1007/s10875-009-9319-3; Lee HM, 2009, CELL MICROBIOL, V11, P678, DOI 10.1111/j.1462-5822.2009.01285.x; Lee S, 2001, J BIOL CHEM, V276, P28252, DOI 10.1074/jbc.M008521200; Lisboa FA, 2009, J IMMUNOL, V183, P5104, DOI 10.4049/jimmunol.0802728; Loegering DJ, 2004, INFLAMMATION, V28, P23, DOI 10.1023/B:IFLA.0000014708.87440.45; Luther K, 2007, CELL MICROBIOL, V9, P368, DOI 10.1111/j.1462-5822.2006.00796.x; Mambula SS, 2002, J BIOL CHEM, V277, P39320, DOI 10.1074/jbc.M201683200; Melkamu T, 2009, J MEMBRANE BIOL, V229, P101, DOI 10.1007/s00232-009-9175-3; O'Luanaigh N, 2002, MOL BIOL CELL, V13, P3730, DOI 10.1091/mbc.E02-04-0213; Olynych TJ, 2006, J ALLERGY CLIN IMMUN, V118, P837, DOI 10.1016/j.jaci.2006.06.008; Osherov N, 2001, FEMS MICROBIOL LETT, V199, P153, DOI 10.1111/j.1574-6968.2001.tb10667.x; Paris S, 2003, APPL ENVIRON MICROB, V69, P1581, DOI 10.1128/AEM.69.3.1581-1588.2003; Paris S, 1997, INFECT IMMUN, V65, P1510, DOI 10.1128/IAI.65.4.1510-1514.1997; Park JB, 2000, J BIOL CHEM, V275, P21295, DOI 10.1074/jbc.M002463200; Pizarro-Cerda J, 2006, CELL, V124, P715, DOI 10.1016/j.cell.2006.02.012; Porcelli AM, 2002, CELL SIGNAL, V14, P75, DOI 10.1016/S0898-6568(01)00222-4; Rand TG, 2010, ARCH TOXICOL, V84, P205, DOI 10.1007/s00204-009-0481-4; Ross GD, 1999, IMMUNOPHARMACOLOGY, V42, P61, DOI 10.1016/S0162-3109(99)00013-2; Schmidt M, 1999, J BIOL CHEM, V274, P14648, DOI 10.1074/jbc.274.21.14648; Segal BH, 2009, NEW ENGL J MED, V360, P1870, DOI 10.1056/NEJMra0808853; Serrander L, 1996, INFLAMMATION, V20, P439, DOI 10.1007/BF01486745; Steele C, 2005, PLOS PATHOG, V1, P323, DOI 10.1371/journal.ppat.0010042; SUNG SSJ, 1983, J CELL BIOL, V96, P160, DOI 10.1083/jcb.96.1.160; Thornton BP, 1996, J IMMUNOL, V156, P1235; Torosantucci A, 2005, J EXP MED, V202, P597, DOI 10.1084/jem.20050749; VAN BR, 2009, MOL IMMUNOL, V47, P575, DOI DOI 10.1016/J.MOLIMM.2009.09.018; Wang JE, 2001, INFECT IMMUN, V69, P2402, DOI 10.1128/IAI.69.4.2402-2406.2001; Wasylnka JA, 2003, J CELL SCI, V116, P1579, DOI 10.1242/jcs.00329; Wasylnka JA, 2002, INFECT IMMUN, V70, P3156, DOI 10.1128/IAI.70.6.3156-3163.2002; Weernink PAO, 2000, J BIOL CHEM, V275, P10168, DOI 10.1074/jbc.275.14.10168; Weernink PAO, 2004, EUR J PHARMACOL, V500, P87, DOI 10.1016/j.ejphar.2004.07.014; Weernink PAO, 2007, BBA-BIOMEMBRANES, V1768, P888, DOI 10.1016/j.bbamem.2006.09.012; Weernink PAO, 2007, N-S ARCH PHARMACOL, V374, P399, DOI 10.1007/s00210-007-0131-4; Weigert R, 1999, NATURE, V402, P429, DOI 10.1038/46587; Willment JA, 2005, EUR J IMMUNOL, V35, P1539, DOI 10.1002/eji.200425725; Xia Y, 1999, J IMMUNOL, V162, P7285; Xia Y, 1999, J IMMUNOL, V162, P2281; Yeung T, 2007, IMMUNOL REV, V219, P17, DOI 10.1111/j.1600-065X.2007.00546.x; Yeung T, 2006, SCIENCE, V313, P347, DOI 10.1126/science.1129551; Zhang ZH, 2005, J INFECTION, V51, P375, DOI 10.1016/j.jinf.2004.12.012	78	33	39	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2011	6	7							e21468	10.1371/journal.pone.0021468	http://dx.doi.org/10.1371/journal.pone.0021468			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791IA	21760893	Green Published, gold, Green Submitted			2022-12-27	WOS:000292657200012
J	Paterson, NG; Baker, EN				Paterson, Neil G.; Baker, Edward N.			Structure of the Full-Length Major Pilin from Streptococcus pneumoniae: Implications for Isopeptide Bond Formation in Gram-Positive Bacterial Pili	PLOS ONE			English	Article							STABILIZING ISOPEPTIDE; VIRULENCE FACTORS; SURFACE; PROTEIN; ADHESIN; SORTASES	The surface of the pneumococcal cell is adorned with virulence factors including pili. The major pilin RrgB, which forms the pilus shaft on pathogenic Streptococcus pneumoniae, comprises four immunoglobulin (Ig)-like domains, each with a common CnaB topology. The three C-terminal domains are each stabilized by internal Lys-Asn isopeptide bonds, formed autocatalytically with the aid of an essential Glu residue. The structure and orientation of the crucial N-terminal domain, which provides the covalent linkage to the next pilin subunit in the shaft, however, remain incompletely characterised. We report the crystal structure of full length RrgB, solved by X-ray crystallography at 2.8 angstrom resolution. The N-terminal (D1) domain makes few contacts with the rest of the RrgB structure, and has higher B-factors. This may explain why D1 is readily lost by proteolysis, as are the N-terminal domains of many major pilins. D1 is also found to have a triad of Lys, Asn and Glu residues in the same topological positions as in the other domains, yet mass spectrometry and the crystal structure show that no internal isopeptide bond is formed. We show that this is because beta-strand G of D1, which carries the Asn residue, diverges from beta-strand A, carrying the Lys residue, such that these residues are too far apart for bond formation. Strand G also carries the YPKN motif that provides the essential Lys residue for the sortase-mediated intermolecular linkages along the pilus shaft. Interaction with the sortase and formation of the intermolecular linkage could result in a change in the orientation of this strand, explaining why isopeptide bond formation in the N-terminal domains of some major pilins appears to take place only upon assembly of the pili.	[Paterson, Neil G.] Univ Auckland, Maurice Wilkins Ctr Mol Biodiscovery, Auckland 1, New Zealand; Univ Auckland, Sch Biol Sci, Auckland 1, New Zealand	University of Auckland; University of Auckland	Paterson, NG (corresponding author), Univ Auckland, Maurice Wilkins Ctr Mol Biodiscovery, Auckland 1, New Zealand.	ted.baker@auckland.ac.nz		Paterson, Neil/0000-0003-4292-6971; Baker, Edward/0000-0003-2456-7661	Marsden Fund of New Zealand; Health Research Council of New Zealand; Tertiary Education Commission through Maurice Wilkins Centre for Molecular Biodiscovery	Marsden Fund of New Zealand(Royal Society of New ZealandMarsden Fund (NZ)); Health Research Council of New Zealand(Health Research Council of New Zealand); Tertiary Education Commission through Maurice Wilkins Centre for Molecular Biodiscovery	This research was supported by the Marsden Fund of New Zealand, the Health Research Council of New Zealand and the Tertiary Education Commission through its funding of the Maurice Wilkins Centre for Molecular Biodiscovery. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alegre-Cebollada J, 2010, J BIOL CHEM, V285, P11235, DOI 10.1074/jbc.M110.102962; ALONSODEVELASCO E, 1995, MICROBIOL REV, V59, P591, DOI 10.1128/MMBR.59.4.591-603.1995; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barocchi MA, 2006, P NATL ACAD SCI USA, V103, P2857, DOI 10.1073/pnas.0511017103; Blanc E, 2004, ACTA CRYSTALLOGR D, V60, P2210, DOI 10.1107/S0907444904016427; Budzik JM, 2008, P NATL ACAD SCI USA, V105, P10215, DOI 10.1073/pnas.0803565105; Budzik JM, 2009, P NATL ACAD SCI USA, V106, P19992, DOI 10.1073/pnas.0910887106; Budzik JM, 2009, J BIOL CHEM, V284, P12989, DOI 10.1074/jbc.M900927200; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Deivanayagam CCS, 2000, STRUCTURE, V8, P67, DOI 10.1016/S0969-2126(00)00081-2; El Mortaji L, 2010, J BIOL CHEM, V285, P12405, DOI 10.1074/jbc.M109.082776; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Gentile MA, 2011, J BIOL CHEM, V286, P14588, DOI 10.1074/jbc.M110.202739; Hava D, 2002, MOL MICROBIOL, V45, P1389, DOI 10.1046/j.1365-2958.2002.03106.x; Hava DL, 2003, J BACTERIOL, V185, P413, DOI 10.1128/JB.185.2.413-421.2003; Hendrickx APA, 2011, NAT REV MICROBIOL, V9, P166, DOI 10.1038/nrmicro2520; Hilleringmann M, 2009, EMBO J, V28, P3921, DOI 10.1038/emboj.2009.360; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Hung TT, 2004, MOL MICROBIOL, V53, P251, DOI 10.1111/j.1365-2958.2004.04117.x; Izore T, 2010, STRUCTURE, V18, P106, DOI 10.1016/j.str.2009.10.019; KABSCH W, 1988, J APPL CRYSTALLOGR, V21, P916, DOI 10.1107/S0021889888007903; KABSCH W, 1988, J APPL CRYSTALLOGR, V21, P67, DOI 10.1107/S0021889887009737; Kadioglu A, 2008, NAT REV MICROBIOL, V6, P288, DOI 10.1038/nrmicro1871; Kang HJ, 2007, SCIENCE, V318, P1625, DOI 10.1126/science.1145806; Kang HJ, 2011, TRENDS BIOCHEM SCI, V36, P227, DOI 10.1016/j.tibs.2010.09.007; Kang HJ, 2009, P NATL ACAD SCI USA, V106, P16967, DOI 10.1073/pnas.0906826106; Kang HJ, 2009, BIOPOLYMERS, V91, P1126, DOI 10.1002/bip.21170; Kang HJ, 2009, J BIOL CHEM, V284, P20729, DOI 10.1074/jbc.M109.014514; Krishnan V, 2007, STRUCTURE, V15, P893, DOI 10.1016/j.str.2007.06.015; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Li HB, 2000, NAT STRUCT BIOL, V7, P1117; Linke C, 2010, J BIOL CHEM, V285, P20381, DOI 10.1074/jbc.M109.089680; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Moreland N, 2005, ACTA CRYSTALLOGR D, V61, P1378, DOI 10.1107/S090744905023590; Nelson AL, 2007, MOL MICROBIOL, V66, P329, DOI 10.1111/j.1365-2958.2007.05908.x; O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6; Obaro SK, 1996, BMJ-BRIT MED J, V312, P1521, DOI 10.1136/bmj.312.7045.1521; Oh SY, 2008, P NATL ACAD SCI USA, V105, P13703, DOI 10.1073/pnas.0807334105; Pointon JA, 2010, J BIOL CHEM, V285, P33858, DOI 10.1074/jbc.M110.149385; Proft T, 2009, CELL MOL LIFE SCI, V66, P613, DOI 10.1007/s00018-008-8477-4; Riboldi-Tunnicliffe A, 1999, J APPL CRYSTALLOGR, V32, P1003, DOI 10.1107/S0021889899008584; Spraggon G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010919; Telford JL, 2006, NAT REV MICROBIOL, V4, P509, DOI 10.1038/nrmicro1443; Tettelin H, 2001, SCIENCE, V293, P498, DOI 10.1126/science.1061217; Ton-That H, 2003, MOL MICROBIOL, V50, P1429, DOI 10.1046/j.1365-2958.2003.03782.x; Vengadesan K, 2011, J MOL BIOL, V407, P731, DOI 10.1016/j.jmb.2011.02.024; Yeates TO, 2007, SCIENCE, V318, P1558, DOI 10.1126/science.1151398	49	36	36	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2011	6	7							e22095	10.1371/journal.pone.0022095	http://dx.doi.org/10.1371/journal.pone.0022095			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791IA	21760959	Green Submitted, Green Published, gold			2022-12-27	WOS:000292657200048
J	Sehgal, L; Thorat, R; Khapare, N; Mukhopadhaya, A; Sawant, M; Dalal, SN				Sehgal, Lalit; Thorat, Rahul; Khapare, Nileema; Mukhopadhaya, Amitabha; Sawant, Mugdha; Dalal, Sorab N.			Lentiviral Mediated Transgenesis by In Vivo Manipulation of Spermatogonial Stem Cells	PLOS ONE			English	Article							RNA-INTERFERENCE; RETROVIRAL TRANSDUCTION; CRE RECOMBINASE; MICE; VECTOR; INTEGRATION; SPERMATOGENESIS; EXPRESSION; DELIVERY; EMBRYOS	This report describes a technique for the generation of transgenic mice by in vivo manipulation of spermatogonial stem cells with a high rate of success. Spermatogonial stem cells (SSCs) in pre-pubescent animals were infected in vivo with recombinant lentiviruses expressing EGFP-f and mated with normal females. All male pre-founder mice produced transgenic pups with an overall success rate of over 60%. The transgene was heritable and the pre-founder mice could be used in multiple mating experiments. This technology could be used to perform overexpression/knockdown screens in vivo using bar-coded lentiviruses, thus permitting the design of genetic screens in the mouse. Further, this technology could be adapted to other laboratory animals resulting in the generation of model systems that closely approximate human development and disease.	[Sehgal, Lalit; Thorat, Rahul; Khapare, Nileema; Mukhopadhaya, Amitabha; Sawant, Mugdha; Dalal, Sorab N.] Tata Mem Hosp, Adv Ctr Treatment Res Educ & Canc, Kharghar Node, Navi Mumbai, India	Tata Memorial Centre (TMC); Advance Centre for Treatment, Research & Education in Cancer (ACTREC); Tata Memorial Hospital	Sehgal, L (corresponding author), Tata Mem Hosp, Adv Ctr Treatment Res Educ & Canc, KS-215, Kharghar Node, Navi Mumbai, India.	sdalal@actrec.gov.in		Sehgal, lalit/0000-0002-1151-5427	Department of Biotechnology [BT/PR6521/Med/14/828/2005, BT/PR12578/MED/31/75/2009]; Advanced Centre for Treatment Research and Education in Cancer (ACTREC); UGC	Department of Biotechnology; Advanced Centre for Treatment Research and Education in Cancer (ACTREC); UGC(University Grants Commission, India)	Funding was provided by the Department of Biotechnology grants BT/PR6521/Med/14/828/2005 and BT/PR12578/MED/31/75/2009, Advanced Centre for Treatment Research and Education in Cancer (ACTREC) core funds to SND, and a UGC fellowship for AM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berns K, 2004, NATURE, V428, P431, DOI 10.1038/nature02371; De Rooij DG, 2000, J ANDROL, V21, P776; Dhup S, 2008, NAT METHODS, V5, P601, DOI 10.1038/nmeth.1225; GORDON JW, 1980, P NATL ACAD SCI-BIOL, V77, P7380, DOI 10.1073/pnas.77.12.7380; GOSSLER A, 1986, P NATL ACAD SCI USA, V83, P9065, DOI 10.1073/pnas.83.23.9065; Hamra FK, 2002, P NATL ACAD SCI USA, V99, P14931, DOI 10.1073/pnas.222561399; Kanatsu-Shinohara M, 2004, BIOL REPROD, V71, P1202, DOI 10.1095/biolreprod.104.031294; Kanatsu-Shinohara M, 2002, P NATL ACAD SCI USA, V99, P1383, DOI 10.1073/pnas.022646399; Miyoshi H, 1997, P NATL ACAD SCI USA, V94, P10319, DOI 10.1073/pnas.94.19.10319; Nagano M, 1998, APMIS, V106, P47, DOI 10.1111/j.1699-0463.1998.tb01318.x; Nagano M, 2002, FEBS LETT, V524, P111, DOI 10.1016/S0014-5793(02)03010-7; Nagano M, 2001, P NATL ACAD SCI USA, V98, P13090, DOI 10.1073/pnas.231473498; Paddison PJ, 2004, NATURE, V428, P427, DOI 10.1038/nature02370; Pfeifer A, 2001, P NATL ACAD SCI USA, V98, P11450, DOI 10.1073/pnas.201415498; Pfeifer A, 2002, P NATL ACAD SCI USA, V99, P2140, DOI 10.1073/pnas.251682798; Rao MK, 2006, GENE DEV, V20, P147, DOI 10.1101/gad1367806; RONEN K, 2011, MOL THER; Sato T, 2011, NATURE, V471, P504, DOI 10.1038/nature09850; Schroder ARW, 2002, CELL, V110, P521, DOI 10.1016/S0092-8674(02)00864-4; Stewart SA, 2003, RNA, V9, P493, DOI 10.1261/rna.2192803; Tiscornia G, 2004, P NATL ACAD SCI USA, V101, P7347, DOI 10.1073/pnas.0402107101; Tiscornia G, 2003, P NATL ACAD SCI USA, V100, P1844, DOI 10.1073/pnas.0437912100; Ventura A, 2004, P NATL ACAD SCI USA, V101, P10380, DOI 10.1073/pnas.0403954101	24	21	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2011	6	7							e21975	10.1371/journal.pone.0021975	http://dx.doi.org/10.1371/journal.pone.0021975			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791HI	21760937	gold, Green Published, Green Submitted			2022-12-27	WOS:000292655400032
J	Antignano, F; Hamilton, M; Patterson, S; Ho, V; Cohen, C; Levings, MK; Krystal, G				Antignano, Frann; Hamilton, Melisa; Patterson, Scott; Ho, Victor; Cohen, Carla; Levings, Megan K.; Krystal, Gerald			SHIP-Deficient Dendritic Cells, Unlike Wild Type Dendritic Cells, Suppress T Cell Proliferation via a Nitric Oxide-Independent Mechanism	PLOS ONE			English	Article							BONE-MARROW; INDOLEAMINE 2,3-DIOXYGENASE; GM-CSF; MACROPHAGES; INHIBITION; GENERATION; INDUCTION; TOLERANCE; CANCER; ACTIVATION	Background: Dendritic cells (DCs) not only play a crucial role in activating immune cells but also suppressing them. We recently investigated SHIP's role in murine DCs in terms of immune cell activation and found that TLR agonist-stimulated SHIP-/- GM-CSF-derived DCs (GM-DCs) were far less capable than wild type (WT, SHIP+/+) GM-DCs at activating T cell proliferation. This was most likely because SHIP-/- GM-DCs could not up-regulate MHCII and/or co-stimulatory receptors following TLR stimulation. However, the role of SHIP in DC-induced T cell suppression was not investigated. Methodology/Principal Findings: In this study we examined SHIP's role in DC-induced T cell suppression by co-culturing WT and SHIP-/- murine DCs, derived under different conditions or isolated from spleens, with alpha CD3+ alpha CD28 activated WT T cells and determined the relative suppressive abilities of the different DC subsets. We found that, in contrast to SHIP+/+ and -/- splenic or Flt3L-derived DCs, which do not suppress T cell proliferation in vitro, both SHIP+/+ and -/- GM-DCs were capable of potently suppressing T cell proliferation. However, WT GM-DC suppression appeared to be mediated, at least in part, by nitric oxide (NO) production while SHIP-/- GM-DCs expressed high levels of arginase 1 and did not produce NO. Following exhaustive studies to ascertain the mechanism of SHIP-/- DC-mediated suppression, we could conclude that cell-cell contact was required and the mechanism may be related to their relative immaturity, compared to SHIP+/+ GM-DCs. Conclusions: These findings suggest that although both SHIP+/+ and -/- GM-DCs suppress T cell proliferation, the mechanism(s) employed are different. WT GM-DCs suppress, at least in part, via IFN gamma-induced NO production while SHIP-/- GM-DCs do not produce NO and suppression can only be alleviated when contact is prevented.	[Antignano, Frann; Hamilton, Melisa; Ho, Victor; Cohen, Carla; Krystal, Gerald] British Columbia Canc Agcy, Terry Fox Lab, Vancouver, BC V5Z 1L3, Canada; [Antignano, Frann] Univ British Columbia, Biomed Res Ctr, Vancouver, BC, Canada; [Patterson, Scott; Levings, Megan K.] Univ British Columbia, Dept Surg, Vancouver, BC V6T 1W5, Canada; [Patterson, Scott; Levings, Megan K.] BC Childrens Hosp, Immun Hlth & Dis Child & Family Res Inst, Vancouver, BC, Canada	British Columbia Cancer Agency; University of British Columbia; University of British Columbia; BC Childrens Hospital; Child & Family Research Institute; University of British Columbia	Antignano, F (corresponding author), British Columbia Canc Agcy, Terry Fox Lab, 601 W 10th Ave, Vancouver, BC V5Z 1L3, Canada.	gkrystal@bccrc.ca		Cohen, Carla/0000-0002-8398-0010; Levings, Megan/0000-0002-0305-5790; Krystal, Gerald/0000-0002-1961-6281; Antignano, Frann/0000-0003-0502-5330	Terry Fox Foundation; Canadian Institute of Health Research [MOP 57834]; Natural Science and Engineering Research Council; Michael Smith Foundation for Health Research; Canadian Cancer Society Research Institute	Terry Fox Foundation; Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Science and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); Canadian Cancer Society Research Institute(Canadian Cancer Society (CCS))	This work was supported by the Canadian Cancer Society Research Institute with funds from the Terry Fox Foundation and core support by the BC Cancer Foundation and the BC Cancer Agency (GK). It was also supported by the Canadian Institute of Health Research (MOP 57834 to MKL). MKL holds a Canada Research Chair in Transplantation. FA was supported by Natural Science and Engineering Research Council and Michael Smith Foundation for Health Research. MH was supported by Canadian Institute of Health Research and Michael Smith Foundation for Health Research. VH was supported by Natural Sciences and Engineering Research Council. SP holds a CIHR Training Program in Transplantation award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antignano F, 2010, J IMMUNOL, V184, P2805, DOI 10.4049/jimmunol.0903170; Bonham CA, 1996, TRANSPLANTATION, V62, P1871, DOI 10.1097/00007890-199612270-00033; Bronte V, 2005, NAT REV IMMUNOL, V5, P641, DOI 10.1038/nri1668; Bronte V, 2003, J IMMUNOL, V170, P270, DOI 10.4049/jimmunol.170.1.270; Carr G, 2008, J MED CHEM, V51, P2634, DOI 10.1021/jm800143h; Fallarino F, 2002, INT IMMUNOL, V14, P65, DOI 10.1093/intimm/14.1.65; Fontenot JD, 2003, NAT IMMUNOL, V4, P330, DOI 10.1038/ni904; Gondek DC, 2005, J IMMUNOL, V174, P1783, DOI 10.4049/jimmunol.174.4.1783; Griess P, 1879, CHEM BER, V12, P428; Griess P., 1879, BER DTSCH CHEM GES, V12, P426, DOI DOI 10.1002/CBER.187901201117; Hamad ARA, 2003, J IMMUNOL, V171, P2421, DOI 10.4049/jimmunol.171.5.2421; Hawiger D, 2001, J EXP MED, V194, P769, DOI 10.1084/jem.194.6.769; Helgason CD, 1998, GENE DEV, V12, P1610, DOI 10.1101/gad.12.11.1610; Hoffman R A, 1994, Transpl Immunol, V2, P313, DOI 10.1016/0966-3274(94)90008-6; Huber S, 2010, BLOOD, V116, P3311, DOI 10.1182/blood-2010-02-271981; Kraaij MD, 2010, P NATL ACAD SCI USA, V107, P17686, DOI 10.1073/pnas.1012016107; Kuang DM, 2008, J IMMUNOL, V181, P3089, DOI 10.4049/jimmunol.181.5.3089; Kuroda E, 2009, J IMMUNOL, V183, P3652, DOI 10.4049/jimmunol.0900864; Kusmartsev S, 2004, J IMMUNOL, V172, P989, DOI 10.4049/jimmunol.172.2.989; Lange C, 2007, IMMUNOL CELL BIOL, V85, P575, DOI 10.1038/sj.icb.7100088; Lu LN, 1996, J IMMUNOL, V157, P3577; Lutz MB, 2007, IMMUNOBIOLOGY, V212, P855, DOI 10.1016/j.imbio.2007.09.001; Lutz MB, 2000, EUR J IMMUNOL, V30, P1048, DOI 10.1002/(SICI)1521-4141(200004)30:4<1048::AID-IMMU1048>3.0.CO;2-W; Lutz MB, 2000, EUR J IMMUNOL, V30, P1813, DOI 10.1002/1521-4141(200007)30:7<1813::AID-IMMU1813>3.0.CO;2-8; Mellor AL, 1999, IMMUNOL TODAY, V20, P469, DOI 10.1016/S0167-5699(99)01520-0; Miyara M, 2007, TRENDS MOL MED, V13, P108, DOI 10.1016/j.molmed.2007.01.003; Movahedi K, 2008, BLOOD, V111, P4233, DOI 10.1182/blood-2007-07-099226; Pandiyan P, 2007, NAT IMMUNOL, V8, P1353, DOI 10.1038/ni1536; Powell TJ, 2003, IMMUNOLOGY, V109, P197, DOI 10.1046/j.1365-2567.2003.01639.x; Rauh MJ, 2005, IMMUNITY, V23, P361, DOI 10.1016/j.immuni.2005.09.003; Rodriguez PC, 2008, IMMUNOL REV, V222, P180, DOI 10.1111/j.1600-065X.2008.00608.x; Rossner S, 2005, EUR J IMMUNOL, V35, P3533, DOI 10.1002/eji.200526172; Saharinen J, 1999, CYTOKINE GROWTH F R, V10, P99, DOI 10.1016/S1359-6101(99)00010-6; Sato K, 2003, BLOOD, V101, P3581, DOI 10.1182/blood-2002-09-2712; Savage NDL, 2008, J IMMUNOL, V181, P2220, DOI 10.4049/jimmunol.181.3.2220; SCHULER G, 1985, J EXP MED, V161, P526, DOI 10.1084/jem.161.3.526; Serafini P, 2006, SEMIN CANCER BIOL, V16, P53, DOI 10.1016/j.semcancer.2005.07.005; STEINMAN RM, 1978, P NATL ACAD SCI USA, V75, P5132, DOI 10.1073/pnas.75.10.5132; Steinman RM, 2003, ANNU REV IMMUNOL, V21, P685, DOI 10.1146/annurev.immunol.21.120601.141040; STUEHR DJ, 1989, J EXP MED, V169, P1543, DOI 10.1084/jem.169.5.1543; Taieb A, 2007, CLIN IMMUNOL, V123, P176, DOI 10.1016/j.clim.2006.12.007; Terness P, 2002, J EXP MED, V196, P447, DOI 10.1084/jem.20020052; Thornton AM, 1998, J EXP MED, V188, P287, DOI 10.1084/jem.188.2.287; Villadangos JA, 2007, NAT REV IMMUNOL, V7, P543, DOI 10.1038/nri2103; Yamazaki S, 2006, IMMUNOL REV, V212, P314, DOI 10.1111/j.0105-2896.2006.00422.x; ZAL T, 1994, J EXP MED, V180, P2089, DOI 10.1084/jem.180.6.2089; Zea AH, 2005, CANCER RES, V65, P3044, DOI 10.1158/0008-5472.CAN-04-4505; Zou T, 2010, J IMMUNOL, V185, P2790, DOI 10.4049/jimmunol.0903740	48	8	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2011	6	7							e21893	10.1371/journal.pone.0021893	http://dx.doi.org/10.1371/journal.pone.0021893			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791AK	21755007	Green Submitted, Green Published, gold			2022-12-27	WOS:000292632000034
J	Xiao, L; Fu, ZR; Liu, F; Zhang, LD; Shi, XM; Shen, XY; Ni, ZJ; Fu, H; Li, RD; Cao, XT; Ding, GS; Wang, QX				Xiao, Liang; Fu, Zhi-ren; Liu, Fang; Zhang, Lu-ding; Shi, Xiao-min; Shen, Xiao-yun; Ni, Zhi-jia; Fu, Hong; Li, Rui-dong; Cao, Xue-tao; Ding, Guo-shan; Wang, Quan-xing			Suppression of Allograft Rejection by Tim-1-Fc through Cross-Linking with a Novel Tim-1 Binding Partner on T Cells	PLOS ONE			English	Article							ISCHEMIA/REPERFUSION INJURY; ACTIVATING RECEPTOR; GENE FAMILY; CLASS-II; DOMAIN; MOUSE; TOLERANCE; RESPONSES; LIGAND; MODEL	Engagement of T-cell immunoglobulin mucin (Tim)-1 on T cells with its ligand, Tim-4, on antigen presenting cells delivers positive costimulatory signals to T cells. However, the molecular mechanisms for Tim-1-mediated regulation of T-cell activation and differentiation are relatively poorly understood. Here we investigated the role of Tim-1 in T-cell responses and allograft rejection using recombinant human Tim-1 extracellular domain and IgG1-Fc fusion proteins (Tim-1-Fc). In vitro assays confirmed that Tim-1-Fc selectively binds to CD4(+) effector T cells, but not dendritic cells or natural regulatory T cells (nTregs). Tim-1-Fc was able to inhibit the responses of purified CD4(+) T cells that do not express Tim-4 to stimulation by anti-CD3/CD28 mAbs, and this inhibition was associated with reduced AKT and ERK1/2 phosphorylation, but it had no influence on nTregs. Moreover, Tim-1-Fc inhibited the proliferation of CD4(+) T cells stimulated by allogeneic dendritic cells. Treatment of recipient mice with Tim-1-Fc significantly prolonged cardiac allograft survival in a fully MHC-mismatched strain combination, which was associated with impaired Th1 response and preserved Th2 and nTregs function. Importantly, the frequency of Foxp3(+) cells in splenic CD4(+) T cells was increased, thus shifting the balance toward regulators, even though Tim-1-Fc did not induce Foxp3 expression in CD4(+)CD25(-) T cells directly. These results indicate that Tim-1-Fc can inhibit T-cell responses through an unknown Tim-1 binding partner on T cells, and it is a promising immunosuppressive agent for preventing allograft rejection.	[Xiao, Liang; Fu, Zhi-ren; Liu, Fang; Zhang, Lu-ding; Shi, Xiao-min; Ni, Zhi-jia; Fu, Hong; Li, Rui-dong; Ding, Guo-shan] Second Mil Med Univ, Shanghai Changzheng Hosp, Dept Organ Transplantat, Shanghai, Peoples R China; [Shen, Xiao-yun; Cao, Xue-tao; Wang, Quan-xing] Second Mil Med Univ, Natl Key Lab Med Immunol, Shanghai, Peoples R China	Naval Medical University; Naval Medical University	Xiao, L (corresponding author), Second Mil Med Univ, Shanghai Changzheng Hosp, Dept Organ Transplantat, Shanghai, Peoples R China.	dingguoshanmail@163.com; wangqx64@yahoo.com.cn		shen, xiaoyun/0000-0003-2098-9728	National Key Basic Research Program of China [2009CB522402]; National Nature Science Foundation of China [30772056, 30772046, 81072444, U0832009]; Science and Technology Foundation of Shanghai, China [09411951900]	National Key Basic Research Program of China(National Basic Research Program of China); National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Foundation of Shanghai, China	This work was supported by grants from the National Key Basic Research Program of China (2009CB522402, http://www.973.gov.cn), the National Nature Science Foundation of China (30772056, 30772046, 81072444, U0832009, http://www.nsfc.gov.cn) and the Science and Technology Foundation of Shanghai, China (09411951900, http://www.stcsm.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An HZ, 2008, NAT IMMUNOL, V9, P542, DOI 10.1038/ni.1604; Bayer AL, 2009, BLOOD, V113, P733, DOI 10.1182/blood-2008-08-173179; Binne LL, 2007, J IMMUNOL, V178, P4342, DOI 10.4049/jimmunol.178.7.4342; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Degauque N, 2008, J CLIN INVEST, V118, P735, DOI 10.1172/JCI32562; Delgado P, 2000, NATURE, V406, P426, DOI 10.1038/35019102; Encinas JA, 2005, J ALLERGY CLIN IMMUN, V116, P1343, DOI 10.1016/j.jaci.2005.08.031; Grazia TJ, 2004, J IMMUNOL, V172, P7451, DOI 10.4049/jimmunol.172.12.7451; Ichimura T, 1998, J BIOL CHEM, V273, P4135, DOI 10.1074/jbc.273.7.4135; Izawa K, 2007, J BIOL CHEM, V282, P17997, DOI 10.1074/jbc.M701100200; Jacobs SR, 2008, J IMMUNOL, V180, P4476, DOI 10.4049/jimmunol.180.7.4476; Kim HS, 2010, J IMMUNOL, V184, P4095, DOI 10.4049/jimmunol.0901991; Kobayashi N, 2007, IMMUNITY, V27, P927, DOI 10.1016/j.immuni.2007.11.011; Kramer JM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000569; Kuchroo VK, 2003, NAT REV IMMUNOL, V3, P454, DOI 10.1038/nri1111; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mariat C, 2009, TRANSPLANTATION, V87, pS84, DOI 10.1097/TP.0b013e3181a2ba83; Mariat C, 2009, J IMMUNOL, V182, P1379, DOI 10.4049/jimmunol.182.3.1379; Mesri M, 2006, INT IMMUNOL, V18, P473, DOI 10.1093/intimm/dxh388; Meyers JH, 2005, TRENDS MOL MED, V11, P362, DOI 10.1016/j.molmed.2005.06.008; Meyers JH, 2005, NAT IMMUNOL, V6, P455, DOI 10.1038/ni1185; Mizui M, 2008, INT IMMUNOL, V20, P695, DOI 10.1093/intimm/dxn029; Pietra BA, 2000, J CLIN INVEST, V106, P1003, DOI 10.1172/JCI10467; RACIOPPI L, 1993, J EXP MED, V177, P1047, DOI 10.1084/jem.177.4.1047; Rathmell JC, 2003, EUR J IMMUNOL, V33, P2223, DOI 10.1002/eji.200324048; Reynolds LF, 2004, J BIOL CHEM, V279, P18239, DOI 10.1074/jbc.M400257200; Rodriguez-Manzanet R, 2008, J IMMUNOL, V180, P4706, DOI 10.4049/jimmunol.180.7.4706; Song SH, 2010, INT IMMUNOPHARMACOL, V10, P679, DOI 10.1016/j.intimp.2010.03.011; Su EW, 2008, CYTOKINE, V44, P9, DOI 10.1016/j.cyto.2008.06.013; THORBORN G, PLOS ONE, V5, pE9254; Ueno T, 2008, J CLIN INVEST, V118, P742, DOI 10.1172/JCI32451; Umetsu SE, 2005, NAT IMMUNOL, V6, P447, DOI 10.1038/ni1186; Wang QX, 2006, J IMMUNOL, V177, P2175, DOI 10.4049/jimmunol.177.4.2175; Wang QX, 2005, MICROSURG, V25, P76, DOI 10.1002/micr.20082; Xiao S, 2007, J EXP MED, V204, P1691, DOI 10.1084/jem.20062498; Xie AN, 2011, TRANSPLANTATION, V91, P27, DOI 10.1097/TP.0b013e3181fdd948; Yamanishi Y, 2008, BLOOD, V111, P688, DOI 10.1182/blood-2007-04-085787; Yamanishi Y, 2010, J EXP MED, V207, P1501, DOI 10.1084/jem.20090581; Yang PC, 2007, GASTROENTEROLOGY, V133, P1522, DOI 10.1053/j.gastro.2007.08.006	39	8	8	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2011	6	7							e21697	10.1371/journal.pone.0021697	http://dx.doi.org/10.1371/journal.pone.0021697			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	789JO	21750723	Green Published, gold, Green Submitted			2022-12-27	WOS:000292512000020
J	Grandclement, C; Pallandre, JR; Degano, SV; Viel, E; Bouard, A; Balland, J; Remy-Martin, JP; Simon, B; Rouleau, A; Boireau, W; Klagsbrun, M; Ferrand, C; Borg, C				Grandclement, Camille; Pallandre, Jean Rene; Degano, Severine Valmary; Viel, Erika; Bouard, Adeline; Balland, Jeremy; Remy-Martin, Jean-Paul; Simon, Benoit; Rouleau, Alain; Boireau, Wilfrid; Klagsbrun, Michael; Ferrand, Christophe; Borg, Christophe			Neuropilin-2 Expression Promotes TGF-beta 1-Mediated Epithelial to Mesenchymal Transition in Colorectal Cancer Cells	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; PROGNOSTIC-FACTOR; TUMOR-GROWTH; RECEPTOR; SEMAPHORIN; INHIBITOR; VEGF; IDENTIFICATION; COEXPRESSION; METASTASIS	Neuropilins, initially characterized as neuronal receptors, act as co-receptors for cancer related growth factors and were recently involved in several signaling pathways leading to cytoskeletal organization, angiogenesis and cancer progression. Then, we sought to investigate the ability of neuropilin-2 to orchestrate epithelial-mesenchymal transition in colorectal cancer cells. Using specific siRNA to target neuropilin-2 expression, or gene transfer, we first observed that neuropilin-2 expression endows HT29 and Colo320 for xenograft formation. Moreover, neuropilin-2 conferred a fibroblastic-like shape to cancer cells, suggesting an involvement of neuropilin-2 in epithelial-mesenchymal transition. Indeed, the presence of neuropilin-2 in colorectal carcinoma cell lines was correlated with loss of epithelial markers such as cytokeratin-20 and E-cadherin and with acquisition of mesenchymal molecules such as vimentin. Furthermore, we showed by surface plasmon resonance experiments that neuropilin-2 is a receptor for transforming-growth factor-beta 1. The expression of neuropilin-2 on colon cancer cell lines was indeed shown to promote transforming-growth factor-beta 1 signaling, leading to a constitutive phosphorylation of the Smad2/3 complex. Treatment with specific TGF beta-type1 receptor kinase inhibitors restored E-cadherin levels and inhibited in part neuropilin-2-induced vimentin expression, suggesting that neuropilin-2 cooperates with TGF beta-type1 receptor to promote epithelial-mesenchymal transition in colorectal cancer cells. Our results suggest a direct role of NRP2 in epithelial-mesenchymal transition and highlight a cross-talk between neuropilin-2 and TGF-beta 1 signaling to promote cancer progression. These results suggest that neuropilin-2 fulfills all the criteria of a therapeutic target to disrupt multiple oncogenic functions in solid tumors.	[Grandclement, Camille; Pallandre, Jean Rene; Bouard, Adeline; Balland, Jeremy; Remy-Martin, Jean-Paul; Ferrand, Christophe; Borg, Christophe] INSERM, UMR 645, Besancon, France; [Grandclement, Camille; Pallandre, Jean Rene; Bouard, Adeline; Balland, Jeremy; Remy-Martin, Jean-Paul; Ferrand, Christophe; Borg, Christophe] EFS Bourgogne Franche Comte, Besancon, France; [Degano, Severine Valmary] CHU Besancon, Dept Pathol, F-25030 Besancon, France; [Viel, Erika; Borg, Christophe] CHU Besancon, Dept Med Oncol, F-25030 Besancon, France; [Simon, Benoit; Rouleau, Alain; Boireau, Wilfrid] Univ Franche Comte, FEMTO ST Inst, F-25030 Besancon, France; [Klagsbrun, Michael] Childrens Hosp, Dept Surg & Pathol, Boston, MA 02115 USA	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Franche-Comte; CHU Besancon; Universite de Franche-Comte; CHU Besancon; Centre National de la Recherche Scientifique (CNRS); Universite de Franche-Comte; Universite de Technologie de Belfort-Montbeliard (UTBM); Harvard University; Boston Children's Hospital	Grandclement, C (corresponding author), INSERM, UMR 645, Besancon, France.	christophe.borg@efs.sante.fr	ROULEAU, Alain/AAC-4933-2019		University Hospital of Besancon [API-CHU]; French "agence nationale pour la recherche technologique"; regional council of Franche Comte; ligue contre le cancer du doubs	University Hospital of Besancon; French "agence nationale pour la recherche technologique"(French National Research Agency (ANR)); regional council of Franche Comte(Region Bourgogne-Franche-Comte); ligue contre le cancer du doubs	Grant API-CHU 2008 of the University Hospital of Besancon; CG received a fellowship from the French "agence nationale pour la recherche technologique"; JRP received a fellowship from the regional council of Franche Comte; a grant from the "ligue contre le cancer du doubs" supported this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beiter K, 2005, ONCOGENE, V24, P8200, DOI 10.1038/sj.onc.1208960; Boireau W, 2009, BIOSENS BIOELECTRON, V24, P1121, DOI 10.1016/j.bios.2008.06.030; Brabletz T, 2001, P NATL ACAD SCI USA, V98, P10356, DOI 10.1073/pnas.171610498; Brabletz T, 2005, CELLS TISSUES ORGANS, V179, P56, DOI 10.1159/000084509; Cai HB, 1999, J NEUROSCI, V19, P6519; CAI Y, 2010, PATHOL RES PRACT; Calicchio ML, 2009, AM J PATHOL, V174, P1638, DOI 10.2353/ajpath.2009.080517; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; CAO Y, 2010, J BIOL CHEM; Caunt M, 2008, CANCER CELL, V13, P331, DOI 10.1016/j.ccr.2008.01.029; Chalmin F, 2010, J CLIN INVEST, V120, P457, DOI 10.1172/JCI40483; Cohen T, 2002, J PATHOL, V198, P77, DOI 10.1002/path.1179; Costa R, 2009, J CELL BIOCHEM, V108, P1410, DOI 10.1002/jcb.22378; Dallas NA, 2008, CLIN CANCER RES, V14, P8052, DOI 10.1158/1078-0432.CCR-08-1520; Ellis LM, 2006, MOL CANCER THER, V5, P1099, DOI 10.1158/1535-7163.MCT-05-0538; Fakhari M, 2002, CANCER-AM CANCER SOC, V94, P258, DOI 10.1002/cncr.10177; Favier B, 2006, BLOOD, V108, P1243, DOI 10.1182/blood-2005-11-4447; Fukahi K, 2004, CLIN CANCER RES, V10, P581, DOI 10.1158/1078-0432.CCR-0930-03; FUTAMURA MKH, 2007, CANCER RES, V15, P1451; Geretti E, 2008, ANGIOGENESIS, V11, P31, DOI 10.1007/s10456-008-9097-1; GLINKA Y, 2010, CARCINOGENESIS; Glinka Y, 2008, J LEUKOCYTE BIOL, V84, P302, DOI 10.1189/jlb.0208090; Gray MJ, 2008, J NATL CANCER I, V100, P109, DOI 10.1093/jnci/djm279; Guarino M, 2007, INT J BIOCHEM CELL B, V39, P2153, DOI 10.1016/j.biocel.2007.07.011; Handa A, 2000, INT J ONCOL, V17, P291; He ZG, 1997, CELL, V90, P739, DOI 10.1016/S0092-8674(00)80534-6; Hendrix MJC, 1997, AM J PATHOL, V150, P483; Inman GJ, 2002, MOL PHARMACOL, V62, P65, DOI 10.1124/mol.62.1.65; Kawakami T, 2002, CANCER, V95, P2196, DOI 10.1002/cncr.10936; Lacal PM, 2000, J INVEST DERMATOL, V115, P1000, DOI 10.1046/j.1523-1747.2000.00199.x; Laping NJ, 2002, MOL PHARMACOL, V62, P58, DOI 10.1124/mol.62.1.58; Lee JM, 2006, J CELL BIOL, V172, P973, DOI 10.1083/jcb.200601018; Liu BP, 2001, CURR OPIN CELL BIOL, V13, P619, DOI 10.1016/S0955-0674(00)00260-X; Mak P, 2010, CANCER CELL, V17, P319, DOI 10.1016/j.ccr.2010.02.030; Osada R, 2006, HUM PATHOL, V37, P1414, DOI 10.1016/j.humpath.2006.04.031; Piek E, 1999, J CELL SCI, V112, P4557; Pino MS, 2009, GASTROENTEROLOGY; Portella G, 1998, CELL GROWTH DIFFER, V9, P393; Rieger J, 2003, GLIA, V42, P379, DOI 10.1002/glia.10210; Sanchez-Carbayo M, 2003, AM J PATHOL, V163, P505, DOI 10.1016/S0002-9440(10)63679-6; Soker S, 2002, J CELL BIOCHEM, V85, P357, DOI 10.1002/jcb.10140; Takashima S, 2002, P NATL ACAD SCI USA, V99, P3657, DOI 10.1073/pnas.022017899; Tomizawa Y, 2001, P NATL ACAD SCI USA, V98, P13954, DOI 10.1073/pnas.231490898; Uhl M, 2004, CANCER RES, V64, P7954, DOI 10.1158/0008-5472.CAN-04-1013; Valcourt U, 2005, MOL BIOL CELL, V16, P1987, DOI 10.1091/mbc.e04-08-0658; Vales A, 2007, LEUKEMIA LYMPHOMA, V48, P1997, DOI 10.1080/10428190701534424; Varnat F, 2009, EMBO MOL MED, V1, P338, DOI 10.1002/emmm.200900039; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Yasuoka H, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-220	49	67	70	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2011	6	7							e20444	10.1371/journal.pone.0020444	http://dx.doi.org/10.1371/journal.pone.0020444			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786HC	21747928	Green Submitted, Green Published, gold			2022-12-27	WOS:000292293400003
J	Huttunen, R; Kuparinen, T; Jylhava, J; Aittoniemi, J; Vuento, R; Huhtala, H; Laine, J; Syrjanen, J; Hurme, M				Huttunen, Reetta; Kuparinen, Taru; Jylhava, Juulia; Aittoniemi, Janne; Vuento, Risto; Huhtala, Heini; Laine, Janne; Syrjanen, Jaana; Hurme, Mikko			Fatal Outcome in Bacteremia is Characterized by High Plasma Cell Free DNA Concentration and Apoptotic DNA Fragmentation: A Prospective Cohort Study	PLOS ONE			English	Article							ORGAN DYSFUNCTION; SEPSIS; DEATH; INFLAMMATION; PREDICTOR; MORTALITY; SHOCK	Introduction: Recent studies have shown that apoptosis plays a critical role in the pathogenesis of sepsis. High plasma cell free DNA (cf-DNA) concentrations have been shown to be associated with sepsis outcome. The origin of cf-DNA is unclear. Methods: Total plasma cf-DNA was quantified directly in plasma and the amplifiable cf-DNA assessed using quantitative PCR in 132 patients with bacteremia caused by Staphylococcus aureus, Streptococcus pneumoniae, beta-hemolytic streptococcae or Escherichia coli. The quality of cf-DNA was analyzed with a DNA Chip assay performed on 8 survivors and 8 nonsurvivors. Values were measured on days 1-4 after positive blood culture, on day 5-17 and on recovery. Results: The maximum cf-DNA values on days 1-4 (n = 132) were markedly higher in nonsurvivors compared to survivors (2.03 vs 1.26 ug/ml, p < 0.001) and the AUCROC in the prediction of case fatality was 0.81 (95% CI 0.69-0.94). cf-DNA at a cutoff level of 1.52 ug/ml showed 83% sensitivity and 79% specificity for fatal disease. High cf-DNA (> 1.52 ug/ml) remained an independent risk factor for case fatality in a logistic regression model. Qualitative analysis of cf-DNA showed that cf-DNA displayed a predominating low-molecular-weight cf-DNA band (150-200 bp) in nonsurvivors, corresponding to the size of the apoptotic nucleosomal DNA. cf-DNA concentration showed a significant positive correlation with visually graded apoptotic band intensity (R = 0.822, p < 0.001). Conclusions: Plasma cf-DNA concentration proved to be a specific independent prognostic biomarker in bacteremia. cf-DNA displayed a predominating low-molecular-weight cf-DNA band in nonsurvivors corresponding to the size of apoptotic nucleosomal DNA.	[Huttunen, Reetta; Laine, Janne; Syrjanen, Jaana] Tampere Univ Hosp, Dept Internal Med, Tampere, Finland; [Huttunen, Reetta; Syrjanen, Jaana] Univ Tampere, Sch Med, FIN-33101 Tampere, Finland; [Kuparinen, Taru; Jylhava, Juulia; Hurme, Mikko] Univ Tampere, Sch Med, Dept Microbiol & Immunol, FIN-33101 Tampere, Finland; [Aittoniemi, Janne; Vuento, Risto; Hurme, Mikko] Pirkanmaa Hosp Dist, Ctr Lab Med, Tampere, Finland; [Huhtala, Heini] Univ Tampere, Sch Hlth Sci, FIN-33101 Tampere, Finland	Tampere University; Tampere University Hospital; Tampere University; Tampere University; Pirkanmaa Hospital District; Tampere University	Huttunen, R (corresponding author), Tampere Univ Hosp, Dept Internal Med, Tampere, Finland.	reetta.huttunen@uta.fi		Hurme, Mikko/0000-0002-8614-1044; Jylhava, Juulia/0000-0003-0250-4491; Syrjanen, Jaana/0000-0002-7335-573X	Tampere University Hospital; Finnish Medical Foundation; Orion-Farmos Research Foundation	Tampere University Hospital; Finnish Medical Foundation; Orion-Farmos Research Foundation	This study was financially supported by the Competitive Research Funding of Tampere University Hospital, the Finnish Medical Foundation, and the Orion-Farmos Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boyd JC, 1997, SCAND J CLIN LAB INV, V57, P46, DOI 10.1080/00365519709168308; Deligezer U, 2006, EXP MOL PATHOL, V80, P72, DOI 10.1016/j.yexmp.2005.05.001; Moreira VG, 2010, ANN CLIN BIOCHEM, V47, P253, DOI 10.1258/acb.2010.009173; Hotchkiss RS, 2006, NAT REV IMMUNOL, V6, P813, DOI 10.1038/nri1943; Hotchkiss RS, 1999, CRIT CARE MED, V27, P1230, DOI 10.1097/00003246-199907000-00002; Hotchkiss RS, 2003, NEW ENGL J MED, V348, P138, DOI 10.1056/NEJMra021333; Huttunen R, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-13; Huttunen R, 2010, SHOCK, V33, P149, DOI 10.1097/SHK.0b013e3181ad3195; Jahr S, 2001, CANCER RES, V61, P1659; Jylhava J, 2011, MECH AGEING DEV, V132, P20, DOI 10.1016/j.mad.2010.11.001; Legrand M, 2010, J MOL MED, V88, P127, DOI 10.1007/s00109-009-0585-6; MCCABE WR, 1962, ARCH INTERN MED, V110, P856, DOI 10.1001/archinte.1962.03620240038007; Mellor AL, 2004, NAT REV IMMUNOL, V4, P762, DOI 10.1038/nri1457; Papathanassoglou EDE, 2000, CRIT CARE MED, V28, P537, DOI 10.1097/00003246-200002000-00042; Rhodes A, 2006, CRIT CARE, V10, DOI 10.1186/cc4894; Saukkonen K, 2008, CLIN CHEM, V54, P1000, DOI 10.1373/clinchem.2007.101030; Saukkonen K, 2007, INTENS CARE MED, V33, P1624, DOI 10.1007/s00134-007-0686-z; Swarup V, 2007, FEBS LETT, V581, P795, DOI 10.1016/j.febslet.2007.01.051; Turrel-Davin F, 2010, CRIT CARE, V14, DOI 10.1186/cc9181; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751; Wang YT, 2010, NAT MED, V16, P279, DOI 10.1038/nm.2092; Zeerleder S, 2003, CRIT CARE MED, V31, P1947, DOI 10.1097/01.CCM.0000074719.40109.95; Zhong XY, 2007, CLIN CHEM, V53, P1609, DOI 10.1373/clinchem.2006.084509	23	59	69	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2011	6	7							e21700	10.1371/journal.pone.0021700	http://dx.doi.org/10.1371/journal.pone.0021700			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786HC	21747948	Green Published, Green Submitted, gold			2022-12-27	WOS:000292293400024
J	Mei, F; Nagappan, G; Ke, Y; Sacktor, TC; Lu, B				Mei, Fan; Nagappan, Guhan; Ke, Yang; Sacktor, Todd C.; Lu, Bai			BDNF Facilitates L-LTP Maintenance in the Absence of Protein Synthesis through PKM zeta	PLOS ONE			English	Article							LONG-TERM POTENTIATION; KINASE-M-ZETA; SYNAPTIC PLASTICITY; MEMORY; HIPPOCAMPUS; TRAFFICKING; EXPRESSION; INCREASES	Late-phase long term potentiation (L-LTP) is thought to be the cellular basis for long-term memory (LTM). While LTM as well as L-LTP is known to depend on transcription and translation, it is unclear why brain-derived neurotrophic factor (BDNF) could sustain L-LTP when protein synthesis is inhibited. The persistently active protein kinase zeta (PKM zeta) is the only molecule implicated in perpetuating L-LTP maintenance. Here, in mouse acute brain slices, we show that inhibition of PKM zeta reversed BDNF-dependent form of L-LTP. While BDNF did not alter the steady-state level of PKM zeta, BDNF together with the L-LTP inducing theta-burst stimulation (TBS) increased PKM zeta level even without protein synthesis. Finally, in the absence of de novo protein synthesis, BDNF maintained TBS-induced PKM zeta at a sufficient level. These results suggest that BDNF sustains L-LTP through PKM zeta in a protein synthesis-independent manner, revealing an unexpected link between BDNF and PKM zeta.	[Mei, Fan; Ke, Yang] Peking Univ, Hlth Sci Ctr, Sch Basic Med Sci, Beijing 100871, Peoples R China; [Mei, Fan; Nagappan, Guhan; Lu, Bai] NICHHD, Program Dev Neurobiol, Bethesda, MD 20892 USA; [Nagappan, Guhan; Lu, Bai] GlaxoSmithKline, R&D China, Shanghai, Peoples R China; [Sacktor, Todd C.] Suny Downstate Med Ctr, Dept Physiol & Pharmacol, Robert F Furchgott Ctr Neural & Behav Sci, Brooklyn, NY 11203 USA; [Sacktor, Todd C.] Suny Downstate Med Ctr, Dept Neurol, Brooklyn, NY 11203 USA	Peking University; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); GlaxoSmithKline; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center	Mei, F (corresponding author), Peking Univ, Hlth Sci Ctr, Sch Basic Med Sci, Beijing 100871, Peoples R China.	bai.b.lu@gsk.com	Mei, Fan/H-2665-2012; Lu, Bai/A-4018-2012	Lu, Bai/0000-0001-5418-9759	National Institutes of Child Health and Human Development; National Institutes of Mental Health	National Institutes of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institutes of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported in part by the Intramural Research Program of the National Institutes of Child Health and Human Development and the National Institutes of Mental Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; DAVIS HP, 1984, PSYCHOL BULL, V96, P518, DOI 10.1037/0033-2909.96.3.518; DRAGUNOW M, 1993, NEUROSCI LETT, V160, P232, DOI 10.1016/0304-3940(93)90420-P; ERNFORS P, 1994, NATURE, V368, P147, DOI 10.1038/368147a0; Finkbeiner S, 1997, NEURON, V19, P1031, DOI 10.1016/S0896-6273(00)80395-5; Hernandez PJ, 2008, NEUROBIOL LEARN MEM, V89, P293, DOI 10.1016/j.nlm.2007.09.010; Huang YY, 2005, LEARN MEMORY, V12, P587, DOI 10.1101/lm.98905; Ji YY, 2010, NAT NEUROSCI, V13, P302, DOI 10.1038/nn.2505; Jia JM, 2008, J BIOL CHEM, V283, P21242, DOI 10.1074/jbc.M800282200; Kang HJ, 1997, NEURON, V19, P653, DOI 10.1016/S0896-6273(00)80378-5; Kelly MT, 2007, J NEUROSCI, V27, P3439, DOI 10.1523/JNEUROSCI.5612-06.2007; Ling DSF, 2002, NAT NEUROSCI, V5, P295, DOI 10.1038/nn829; Lu B, 2003, LEARN MEMORY, V10, P86, DOI 10.1101/lm.54603; Lu B, 2005, NAT REV NEUROSCI, V6, P603, DOI 10.1038/nrn1726; Lu Y, 2008, NEUROBIOL LEARN MEM, V89, P312, DOI 10.1016/j.nlm.2007.08.018; Mabb AM, 2010, ANNU REV CELL DEV BI, V26, P179, DOI 10.1146/annurev-cellbio-100109-104129; Martin SJ, 2000, ANNU REV NEUROSCI, V23, P649, DOI 10.1146/annurev.neuro.23.1.649; Migues PV, 2010, NAT NEUROSCI, V13, P630, DOI 10.1038/nn.2531; Neves G, 2008, NAT REV NEUROSCI, V9, P65, DOI 10.1038/nrn2303; Osten P, 1996, J NEUROSCI, V16, P2444; Pang PT, 2004, SCIENCE, V306, P487, DOI 10.1126/science.1100135; Patterson SL, 2001, NEURON, V32, P123, DOI 10.1016/S0896-6273(01)00443-3; PATTERSON SL, 1992, NEURON, V9, P1081, DOI 10.1016/0896-6273(92)90067-N; SACKTOR TC, 1993, P NATL ACAD SCI USA, V90, P8342, DOI 10.1073/pnas.90.18.8342; Sacktor TC, 2011, NAT REV NEUROSCI, V12, P9, DOI 10.1038/nrn2949; Sacktor TC, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3112pe9; Sajikumar S, 2005, J NEUROSCI, V25, P5750, DOI 10.1523/JNEUROSCI.1104-05.2005; Sajikumar S, 2011, P NATL ACAD SCI USA, V108, P2551, DOI 10.1073/pnas.1016849108; Segal RA, 2003, ANNU REV NEUROSCI, V26, P299, DOI 10.1146/annurev.neuro.26.041002.131421; Serrano P, 2005, J NEUROSCI, V25, P1979, DOI 10.1523/JNEUROSCI.5132-04.2005; SHAO CY, 2008, PKMZETA MAINTAINS DE; Yao YD, 2008, J NEUROSCI, V28, P7820, DOI 10.1523/JNEUROSCI.0223-08.2008	32	53	55	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2011	6	6							e21568	10.1371/journal.pone.0021568	http://dx.doi.org/10.1371/journal.pone.0021568			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786FZ	21747912	Green Published, gold, Green Submitted			2022-12-27	WOS:000292290100041
J	Vaid, M; Singh, T; Katiyar, SK				Vaid, Mudit; Singh, Tripti; Katiyar, Santosh K.			Grape Seed Proanthocyanidins Inhibit Melanoma Cell Invasiveness by Reduction of PGE(2) Synthesis and Reversal of Epithelial-to-Mesenchymal Transition	PLOS ONE			English	Article							NF-KAPPA-B; LUNG-CANCER; MOUSE SKIN; INFLAMMATORY RESPONSES; GUANYLATE-CYCLASE; PROSTAGLANDIN E-2; CARCINOMA-CELLS; NITRIC-OXIDE; CYCLOOXYGENASE-2; MIGRATION	Melanoma is the leading cause of death from skin disease due, in large part, to its propensity to metastasize. We have examined the effect of grape seed proanthocyanidins (GSPs) on melanoma cancer cell migration and the molecular mechanisms underlying these effects using highly metastasis-specific human melanoma cell lines, A375 and Hs294t. Using in vitro cell invasion assays, we observed that treatment of A375 and Hs294t cells with GSPs resulted in a concentration-dependent inhibition of invasion or cell migration of these cells, which was associated with a reduction in the levels of cyclooxygenase (COX)-2 expression and prostaglandin (PG) E-2 production. Treatment of cells with celecoxib, a COX-2 inhibitor, or transient transfection of melanoma cells with COX-2 small interfering RNA, also inhibited melanoma cell migration. Treatment of cells with 12-O-tetradecanoylphorbol-13-acetate, an inducer of COX-2, enhanced the phosphorylation of ERK1/2, a protein of mitogen-activated protein kinase family, and subsequently cell migration whereas both GSPs and celecoxib significantly inhibited 12-O-tetradecanoylphorbol-13-acetate - promoted cell migration as well as phosphorylation of ERK1/2. Treatment of cells with UO126, an inhibitor of MEK, also inhibited the migration of melanoma cells. Further, GSPs inhibited the activation of NF-kappa B/p65, an upstream regulator of COX-2, in melanoma cells, and treatment of cells with caffeic acid phenethyl ester, an inhibitor of NF-kappa B, also inhibited cell migration. Additionally, inhibition of melanoma cell migration by GSPs was associated with reversal of epithelial-mesenchymal transition process, which resulted in an increase in the levels of epithelial biomarkers (E-cadherin and cytokeratins) while loss of mesenchymal biomarkers (vimentin, fibronectin and N-cadherin) in melanoma cells. Together, these results indicate that GSPs have the ability to inhibit melanoma cell invasion/migration by targeting the endogenous expression of COX-2 and reversing the process of epithelial-to-mesenchymal transition.	[Vaid, Mudit; Singh, Tripti; Katiyar, Santosh K.] Univ Alabama, Dept Dermatol, Birmingham, AL 35294 USA; [Katiyar, Santosh K.] Univ Alabama, Ctr Comprehens Canc, Birmingham, AL 35294 USA; [Katiyar, Santosh K.] Birmingham VA Med Ctr, Birmingham, AL USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; US Department of Veterans Affairs; Veterans Health Administration (VHA); Veterans Affairs Medical Center - Birmingham	Vaid, M (corresponding author), Univ Alabama, Dept Dermatol, Birmingham, AL 35294 USA.	skatiyar@uab.edu			Veterans Administration	Veterans Administration(US Department of Veterans Affairs)	This work was supported by funds from the Veterans Administration Merit Review Award (SKK). There is no grant number. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	*AM FAM PHYS, 2010, EARL DET TREATM SKIN; America Cancer Society, 2011, CANC FACTS FIG; Chua HL, 2007, ONCOGENE, V26, P711, DOI 10.1038/sj.onc.1209808; Dannenberg AJ, 2003, CANCER CELL, V4, P431, DOI 10.1016/S1535-6108(03)00310-6; Dohadwala M, 2002, J BIOL CHEM, V277, P50828, DOI 10.1074/jbc.M210707200; Hall HI, 1999, J AM ACAD DERMATOL, V40, P35, DOI 10.1016/S0190-9622(99)70562-1; Huber MA, 2004, CELL CYCLE, V3, P1477, DOI 10.4161/cc.3.12.1280; Huber MA, 2004, J CLIN INVEST, V114, P569, DOI 10.1172/JCI200421358; Maddodi N, 2008, PHOTOCHEM PHOTOBIOL, V84, P528, DOI 10.1111/j.1751-1097.2007.00283.x; Maier Harald J, 2010, Cancers (Basel), V2, P2058, DOI 10.3390/cancers2042058; Mantena SK, 2006, MOL CANCER THER, V5, P296, DOI 10.1158/1535-7163.MCT-05-0448; Meeran SM, 2008, J INVEST DERMATOL, V128, P2716, DOI 10.1038/jid.2008.140; Meeran SM, 2009, NEOPLASIA, V11, P846, DOI 10.1593/neo.09528; Meeran SM, 2009, CARCINOGENESIS, V30, P520, DOI 10.1093/carcin/bgp019; Min CY, 2008, J CELL BIOCHEM, V104, P733, DOI 10.1002/jcb.21695; Mittal A, 2003, CARCINOGENESIS, V24, P1379, DOI 10.1093/carcin/bgg095; Mukhtar H, 1996, PHOTOCHEM PHOTOBIOL, V63, P355, DOI 10.1111/j.1751-1097.1996.tb03040.x; Nandakumar V, 2008, CANCER LETT, V269, P378, DOI 10.1016/j.canlet.2008.03.049; Punathil T, 2008, BIOCHEM BIOPH RES CO, V375, P162, DOI 10.1016/j.bbrc.2008.07.157; Punathil T, 2009, MOL CARCINOGEN, V48, P232, DOI 10.1002/mc.20473; Riedl K, 2004, DRUG RESIST UPDATE, V7, P169, DOI 10.1016/j.drup.2004.04.003; Sharma SD, 2010, PHARM RES-DORDR, V27, P1092, DOI 10.1007/s11095-010-0050-9; Sharma SD, 2009, CARCINOGENESIS, V30, P1970, DOI 10.1093/carcin/bgp228; Sheng HM, 2001, J BIOL CHEM, V276, P18075, DOI 10.1074/jbc.M009689200; Singh T, 2011, CARCINOGENESIS, V32, P86, DOI 10.1093/carcin/bgq215; Strouse JJ, 2005, J CLIN ONCOL, V23, P4735, DOI 10.1200/JCO.2005.02.899; TSUJII M, 1995, CELL, V83, P493, DOI 10.1016/0092-8674(95)90127-2	27	39	40	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2011	6	6							e21539	10.1371/journal.pone.0021539	http://dx.doi.org/10.1371/journal.pone.0021539			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	783OD	21738696	gold, Green Published, Green Submitted			2022-12-27	WOS:000292092600051
J	Zhou, LH; Too, HP				Zhou, Lihan; Too, Heng-Phon			Mitochondrial Localized STAT3 Is Involved in NGF Induced Neurite Outgrowth	PLOS ONE			English	Article							NERVE GROWTH-FACTOR; PROTEIN-KINASE; SERINE PHOSPHORYLATION; SIGNALING PATHWAYS; PC12 CELLS; ACTIVATION; DIFFERENTIATION; RECEPTOR; TRK; NEURITOGENESIS	Background: Signal transducer and activator of transcription 3 (STAT3) plays critical roles in neural development and is increasingly recognized as a major mediator of injury response in the nervous system. Cytokines and growth factors are known to phosphorylate STAT3 at tyrosine(705) with or without the concomitant phosphorylation at serine(727), resulting in the nuclear localization of STAT3 and subsequent transcriptional activation of genes. Recent evidence suggests that STAT3 may control cell function via alternative mechanisms independent of its transcriptional activity. Currently, the involvement of STAT3 mono-phosphorylated at residue serine(727) (P-Ser-STAT3) in neurite outgrowth and the underlying mechanism is largely unknown. Principal Findings: In this study, we investigated the role of nerve growth factor (NGF) induced P-Ser-STAT3 in mediating neurite outgrowth. NGF induced the phosphorylation of residue serine(727) but not tyrosine(705) of STAT3 in PC12 and primary cortical neuronal cells. In PC12 cells, serine but not tyrosine dominant negative mutant of STAT3 was found to impair NGF induced neurite outgrowth. Unexpectedly, NGF induced P-Ser-STAT3 was localized to the mitochondria but not in the nucleus. Mitochondrial STAT3 was further found to be intimately involved in NGF induced neurite outgrowth and the production of reactive oxygen species (ROS). Conclusion: Taken together, the findings herein demonstrated a hitherto unrecognized novel transcription independent mechanism whereby the mitochondria localized P-Ser-STAT3 is involved in NGF induced neurite outgrowth.	[Zhou, Lihan; Too, Heng-Phon] Natl Univ Singapore, Dept Biochem, Singapore 117548, Singapore; [Zhou, Lihan; Too, Heng-Phon] Singapore Massachusetts Inst Technol Alliance, Singapore, Singapore	National University of Singapore; Massachusetts Institute of Technology (MIT); Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; National University of Singapore	Zhou, LH (corresponding author), Natl Univ Singapore, Dept Biochem, Singapore 117548, Singapore.	heng-phon_too@nuhs.edu.sg			Singapore MIT-Alliance [C-382-651-001-091]; Singapore-Massachusetts Institute of Technology Alliance	Singapore MIT-Alliance; Singapore-Massachusetts Institute of Technology Alliance	This study is funded by the Singapore MIT-Alliance (grant number C-382-651-001-091). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to acknowledge the following colleagues from the NUS Department of Biochemistry for their invaluable advice and generous technical support: Professor SIT Kim Ping and Lab, A/P TANG Bor Luen and Lab, A/P CLEMENT Marie-Veronique and Lab, and A/P CAO Xinmin and Lab. The authors would also like to acknowledge the Singapore-Massachusetts Institute of Technology Alliance for providing the necessary funding, and the Department of Biochemistry for the laboratory equipment.	Alonzi T, 2001, MOL CELL NEUROSCI, V18, P270, DOI 10.1006/mcne.2001.1018; Brodie C, 1999, CELL GROWTH DIFFER, V10, P183; Cassano S, 2010, J BIOL CHEM, V285, P24141, DOI 10.1074/jbc.M109.098525; Cattaneo E, 1999, TRENDS NEUROSCI, V22, P365, DOI 10.1016/S0166-2236(98)01378-2; Chung JK, 1997, MOL CELL BIOL, V17, P6508, DOI 10.1128/MCB.17.11.6508; Dagda RK, 2008, AUTOPHAGY, V4, P770, DOI 10.4161/auto.6458; Decker T, 2000, ONCOGENE, V19, P2628, DOI 10.1038/sj.onc.1203481; Devarajan E, 2009, CURR MOL MED, V9, P626, DOI 10.2174/156652409788488720; Dziennis S, 2008, REV NEUROSCIENCE, V19, P341; Fricker AD, 2005, MOL BRAIN RES, V138, P228, DOI 10.1016/j.molbrainres.2005.04.016; Galli S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007541; Gao Q, 2004, P NATL ACAD SCI USA, V101, P4661, DOI 10.1073/pnas.0303992101; Gopalakrishna R, 2008, J BIOL CHEM, V283, P14430, DOI 10.1074/jbc.M801519200; Gough DJ, 2009, SCIENCE, V324, P1713, DOI 10.1126/science.1171721; He JCJ, 2005, J BIOL CHEM, V280, P33426, DOI 10.1074/jbc.M502812200; Hollenbeck PJ, 2005, J CELL SCI, V118, P5411, DOI 10.1242/jcs.053850; Jain N, 1999, J BIOL CHEM, V274, P24392, DOI 10.1074/jbc.274.34.24392; Johansson J, 2009, NEUROREPORT, V20, P828, DOI 10.1097/WNR.0b013e32832b7324; Kotake-Nara E, 2007, NEUROSCI LETT, V422, P223, DOI 10.1016/j.neulet.2007.06.026; Kuroki M, 1999, BIOCHEM J, V341, P691, DOI 10.1042/0264-6021:3410691; Lee J, 2008, J NEUROSCI RES, V86, P961, DOI 10.1002/jnr.21564; Lim CP, 1999, J BIOL CHEM, V274, P31055, DOI 10.1074/jbc.274.43.31055; Lin WF, 2009, CELL SIGNAL, V21, P1060, DOI 10.1016/j.cellsig.2009.02.009; Liu RY, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-17-j0003.2001; Lufei CC, 2003, EMBO J, V22, P1325, DOI 10.1093/emboj/cdg135; McBride HM, 2006, CURR BIOL, V16, pR551, DOI 10.1016/j.cub.2006.06.054; Miller MW, 2000, BRAIN RES, V852, P355, DOI 10.1016/S0006-8993(99)02176-9; Min JY, 2006, J NEURAL TRANSM, V113, P1821, DOI 10.1007/s00702-006-0500-z; Miranda C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009446; Munnamalai V, 2009, J NEUROCHEM, V108, P644, DOI 10.1111/j.1471-4159.2008.05787.x; Ng YP, 2006, J BIOL CHEM, V281, P15636, DOI 10.1074/jbc.M601863200; Poderoso C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001443; Quesnelle KM, 2007, J CELL BIOCHEM, V102, P311, DOI 10.1002/jcb.21475; Reich NC, 2006, NAT REV IMMUNOL, V6, P602, DOI 10.1038/nri1885; RIZZUTO R, 1992, NATURE, V358, P325, DOI 10.1038/358325a0; Ruthel G, 2003, J NEUROSCI, V23, P8618; Salvi M, 2005, FREE RADICAL BIO MED, V38, P1267, DOI 10.1016/j.freeradbiomed.2005.02.006; Sasagawa S, 2005, NAT CELL BIOL, V7, P365, DOI 10.1038/ncb1233; Shi CS, 2004, J BIOL CHEM, V279, P17224, DOI 10.1074/jbc.M311875200; Suzukawa K, 2000, J BIOL CHEM, V275, P13175, DOI 10.1074/jbc.275.18.13175; Tso PH, 2009, NEUROCHEM RES, V34, P1101, DOI 10.1007/s11064-008-9880-9; Vaudry D, 2002, SCIENCE, V296, P1648, DOI 10.1126/science.1071552; Verburg J, 2008, J NEUROSCI, V28, P8306, DOI 10.1523/JNEUROSCI.2614-08.2008; von Kriegsheim A, 2009, NAT CELL BIOL, V11, P1458, DOI 10.1038/ncb1994; Wegrzyn J, 2009, SCIENCE, V323, P793, DOI 10.1126/science.1164551; Wu HT, 2009, BBA-MOL CELL BIOL L, V1791, P8, DOI 10.1016/j.bbalip.2008.10.004; Wu YY, 2000, J BIOL CHEM, V275, P2147, DOI 10.1074/jbc.275.3.2147; Wu YY, 1996, J BIOL CHEM, V271, P13023, DOI 10.1074/jbc.271.22.13023; Yokogami K, 2000, CURR BIOL, V10, P47, DOI 10.1016/S0960-9822(99)00268-7; Yu H, 2009, NAT REV CANCER, V9, P798, DOI 10.1038/nrc2734; Yung LY, 2008, CELL SIGNAL, V20, P1538, DOI 10.1016/j.cellsig.2008.04.007; Zorina Y, 2010, J BIOL CHEM, V285, P1358, DOI 10.1074/jbc.M109.049841	52	59	63	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2011	6	6							e21680	10.1371/journal.pone.0021680	http://dx.doi.org/10.1371/journal.pone.0021680			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	783OD	21738764	gold, Green Published, Green Submitted			2022-12-27	WOS:000292092600071
J	Fan, D; Rich, D; Holtzman, T; Ruther, P; Dalley, JW; Lopez, A; Rossi, MA; Barter, JW; Salas-Meza, D; Herwik, S; Holzhammer, T; Morizio, J; Yin, HH				Fan, David; Rich, Dylan; Holtzman, Tahl; Ruther, Patrick; Dalley, Jeffrey W.; Lopez, Alberto; Rossi, Mark A.; Barter, Joseph W.; Salas-Meza, Daniel; Herwik, Stanislav; Holzhammer, Tobias; Morizio, James; Yin, Henry H.			A Wireless Multi-Channel Recording System for Freely Behaving Mice and Rats	PLOS ONE			English	Article							NUCLEUS-ACCUMBENS CORE; OSCILLATIONS; LESIONS; CHOICE; CORTEX; STRIATUM; NEURONS	To understand the neural basis of behavior, it is necessary to record brain activity in freely moving animals. Advances in implantable multi-electrode array technology have enabled researchers to record the activity of neuronal ensembles from multiple brain regions. The full potential of this approach is currently limited by reliance on cable tethers, with bundles of wires connecting the implanted electrodes to the data acquisition system while impeding the natural behavior of the animal. To overcome these limitations, here we introduce a multi-channel wireless headstage system designed for small animals such as rats and mice. A variety of single unit and local field potential signals were recorded from the dorsal striatum and substantia nigra in mice and the ventral striatum and prefrontal cortex simultaneously in rats. This wireless system could be interfaced with commercially available data acquisition systems, and the signals obtained were comparable in quality to those acquired using cable tethers. On account of its small size, light weight, and rechargeable battery, this wireless headstage system is suitable for studying the neural basis of natural behavior, eliminating the need for wires, commutators, and other limitations associated with traditional tethered recording systems.	[Fan, David; Lopez, Alberto; Rossi, Mark A.; Barter, Joseph W.; Salas-Meza, Daniel; Yin, Henry H.] Duke Univ, Dept Psychol & Neurosci, Dept Neurobiol, Ctr Cognit Neurosci, Durham, NC 27710 USA; [Rich, Dylan; Holtzman, Tahl; Dalley, Jeffrey W.] Univ Cambridge, Behav & Clin Neurosci Inst, Cambridge, England; [Rich, Dylan; Holtzman, Tahl; Dalley, Jeffrey W.] Univ Cambridge, Dept Expt Psychol, Cambridge CB2 3EB, England; [Ruther, Patrick; Herwik, Stanislav; Holzhammer, Tobias] Univ Freiburg, Dept Microsyst Engn IMTEK, Freiburg, Germany; [Rich, Dylan] Howard Hughes Med Inst Janelia Farm Res Campus, Ashburn, VA USA; [Dalley, Jeffrey W.] Univ Cambridge, Addenbrookes Hosp, Dept Psychiat, Cambridge CB2 2QQ, England; [Morizio, James] Triangle BioSyst Intl, Durham, NC USA	Duke University; University of Cambridge; University of Cambridge; University of Freiburg; Howard Hughes Medical Institute; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Fan, D (corresponding author), Duke Univ, Dept Psychol & Neurosci, Dept Neurobiol, Ctr Cognit Neurosci, Durham, NC 27710 USA.	jmorizio@trianglebiosystems.com; hy43@duke.edu		Dalley, Jeffrey/0000-0002-2282-3660; Rossi, Mark/0000-0002-5724-3615	Duke University; UK Medical Research Council; Wellcome Trust; EU [IST-027017]; Howard Hughes Medical Institute; Medical Research Council [G0001354, G0001354B, G1000183B] Funding Source: researchfish	Duke University; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); EU(European Commission); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This research was supported by Duke University, the UK Medical Research Council, the Wellcome Trust, European Integrated Project NeuroProbes (EU IP IST-027017) and Howard Hughes Medical Institute Janelia Farm Research Campus. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berke JD, 2009, EUR J NEUROSCI, V30, P848, DOI 10.1111/j.1460-9568.2009.06843.x; Berke JD, 2004, NEURON, V43, P883, DOI 10.1016/j.neuron.2004.08.035; Bezzina G, 2007, PSYCHOPHARMACOLOGY, V195, P71, DOI 10.1007/s00213-007-0882-0; BORNA A, 2009, C P IEEE ENG MED BIO, P5413; Brainard MS, 2000, NAT REV NEUROSCI, V1, P31, DOI 10.1038/35036205; Cardinal RN, 2001, SCIENCE, V292, P2499, DOI 10.1126/science.1060818; Chapin JK, 1999, NAT NEUROSCI, V2, P664, DOI 10.1038/10223; Chestek CA, 2009, IEEE T NEUR SYS REH, V17, P330, DOI 10.1109/TNSRE.2009.2023293; Costa RM, 2004, CURR BIOL, V14, P1124, DOI 10.1016/j.cub.2004.06.053; Costa RM, 2006, NEURON, V52, P359, DOI 10.1016/j.neuron.2006.07.030; de Araujo IE, 2006, NEURON, V51, P483, DOI 10.1016/j.neuron.2006.07.009; Dzirasa K, 2011, J NEUROSCI METH, V195, P36, DOI 10.1016/j.jneumeth.2010.11.014; Gilja Vikash, 2006, Conf Proc IEEE Eng Med Biol Soc, V2006, P5643; Gray CM, 1995, J NEUROSCI METH, V63, P43, DOI 10.1016/0165-0270(95)00085-2; GREGORY JA, 2009, C P IEEE ENG MED BIO, P3833; Hampson RE, 2009, J NEUROSCI METH, V182, P195, DOI 10.1016/j.jneumeth.2009.06.007; Harrison RR, 2009, IEEE T NEUR SYS REH, V17, P322, DOI 10.1109/TNSRE.2009.2023298; HIKOSAKA O, 1983, J NEUROPHYSIOL, V49, P1230; Kalenscher T, 2010, J NEUROPHYSIOL, V103, P1658, DOI 10.1152/jn.00432.2009; Kravitz AV, 2010, NATURE, V466, P622, DOI 10.1038/nature09159; Mitra P., 2007, OBSERVED BRAIN DYNAM; Palmiter RD, 2008, ANN NY ACAD SCI, V1129, P35, DOI 10.1196/annals.1417.003; Pasupathy A, 2005, NATURE, V433, P873, DOI 10.1038/nature03287; Paxinos G, 1998, RAT BRAIN STEROTAXIC; Pothuizen HHJ, 2005, EUR J NEUROSCI, V22, P2605, DOI 10.1111/j.1460-9568.2005.04388.x; Reynolds JNJ, 2004, J NEUROSCI, V24, P9870, DOI 10.1523/JNEUROSCI.3225-04.2004; Robbins TW, 2002, PSYCHOPHARMACOLOGY, V163, P362, DOI 10.1007/s00213-002-1154-7; Ruther P, 2010, IEEJ T ELECTR ELECTR, V5, P505, DOI 10.1002/tee.20566; Shadlen MN, 2001, J NEUROPHYSIOL, V86, P1916, DOI 10.1152/jn.2001.86.4.1916; STERIADE M, 1993, SCIENCE, V262, P679, DOI 10.1126/science.8235588; Szuts TA, 2011, NAT NEUROSCI, V14, P263, DOI 10.1038/nn.2730; UNGERSTEDT U, 1968, EUR J PHARMACOL, V5, P107, DOI 10.1016/0014-2999(68)90164-7; van der Meer MAA, 2009, FRONT INTEGR NEUROSC, V3, DOI [10.3389/neuro.07.009.2009, 10.3389/neuro.07.001.2009]; Vargas-Irwin CE, 2010, J NEUROSCI, V30, P9659, DOI 10.1523/JNEUROSCI.5443-09.2010; WEI P, 2009, C P IEEE ENG MED BIO, P5522; Yin HH, 2009, NAT NEUROSCI, V12, P333, DOI 10.1038/nn.2261; YIN M, 2009, C P IEEE ENG MED BIO, P1608	38	85	89	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2011	6	7							e22033	10.1371/journal.pone.0022033	http://dx.doi.org/10.1371/journal.pone.0022033			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791WM	21765934	Green Published, gold, Green Submitted			2022-12-27	WOS:000292699000020
J	Sperandeo, MP; Tosco, A; Izzo, V; Tucci, F; Troncone, R; Auricchio, R; Romanos, J; Trynka, G; Auricchio, S; Jabri, B; Greco, L				Sperandeo, Maria Pia; Tosco, Antonella; Izzo, Valentina; Tucci, Francesca; Troncone, Riccardo; Auricchio, Renata; Romanos, Jihane; Trynka, Gosia; Auricchio, Salvatore; Jabri, Bana; Greco, Luigi			Potential Celiac Patients: A Model of Celiac Disease Pathogenesis	PLOS ONE			English	Article							NF-KAPPA-B; GENE-EXPRESSION; RISK VARIANTS; HLA; INFLAMMATION; CONTRIBUTES; ACTIVATION; MUCOSA; CELLS; IL-21	Background and Aim: Potential celiacs have the 'celiactype' HLA, positive anti-transglutaminase antibodies but no damage at small intestinal mucosa. Only a minority of them develops mucosal lesion. More than 40 genes were associated to Celiac Disease (CD) but we still do not know how those pathways transform a genetically predisposed individual into an affected person. The aim of the study is to explore the genetic features of Potential CD individuals. Methods: 127 'potential' CD patients entered the study because of positive anti-tissue transglutaminase and no mucosal lesions; about 30% of those followed for four years become frankly celiac. They were genotyped for 13 polymorphisms of 'candidate genes' and compared to controls and celiacs. Moreover, 60 biopsy specimens were used for expression studies. Results: Potential CD bear a lighter HLA-related risk, compared to celiac (chi(2) = 48.42; p value = 1x10(-8)). They share most of the polymorphisms of the celiacs, but the frequency of c-REL* G allele was suggestive for a difference compared to celiac (chi(2) = 5.42; p value = 0.02). One marker of the KIAA1109/IL-2/IL-21 candidate region differentiated potentials from celiac (rs4374642: chi(2) = 7.17, p value = 0.01). The expression of IL-21 was completely suppressed in potentials compared to celiacs (p value = 0.02) and to controls (p value = 0.02), in contrast IL-2, KIAA1109 and c-REL expression were over-expressed. Conclusions: Potential CD show genetic features slightly different from celiacs. Genetic and expression markers help to differentiate this condition. Potential CD is a precious biological model of the pathways leading to the small intestinal mucosal damage in genetically predisposed individuals.	[Sperandeo, Maria Pia; Tosco, Antonella; Izzo, Valentina; Tucci, Francesca; Troncone, Riccardo; Auricchio, Renata; Auricchio, Salvatore] Univ Naples Federico 2, European Lab Food Induced Dis, Naples, Italy; [Romanos, Jihane] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, Groningen, Netherlands; [Jabri, Bana] Univ Chicago, Dept Med, Dept Pathol, Chicago, IL 60637 USA; [Jabri, Bana] Univ Chicago, Dept Paediat, Chicago, IL 60637 USA; [Greco, Luigi] Univ Naples Federico 2, Dept Pediat, Naples, Italy	University of Naples Federico II; University of Groningen; University of Chicago; University of Chicago; University of Naples Federico II	Sperandeo, MP (corresponding author), Univ Naples Federico 2, European Lab Food Induced Dis, Naples, Italy.	ydongre@unina.it	Tucci, Francesca/AAB-2184-2022; Romanos, Jihane/F-7372-2012; AURICCHIO, RENATA/AAC-7718-2022; TOSCO, Antonella/U-7052-2017	Tucci, Francesca/0000-0001-8798-8987; TOSCO, Antonella/0000-0003-0470-6839; Trynka, Gosia/0000-0002-6955-9529	PREVENT CD [036383]	PREVENT CD	This work was supported by PREVENT CD (project: EU-FP6-2005-FOOD4B-contract no. 036383). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonizzi G, 2004, TRENDS IMMUNOL, V25, P280, DOI 10.1016/j.it.2004.03.008; Bourgey M, 2007, GUT, V56, P1054, DOI 10.1136/gut.2006.108530; Caruso R, 2007, J IMMUNOL, V178, P5957, DOI 10.4049/jimmunol.178.9.5957; Dubois PCA, 2010, NAT GENET, V42, P295, DOI 10.1038/ng.543; Fina D, 2008, GUT, V57, P887, DOI 10.1136/gut.2007.129882; Greco L, 1998, J PEDIATR GASTR NUTR, V26, P286, DOI 10.1097/00005176-199803000-00009; Hunt KA, 2008, NAT GENET, V40, P395, DOI 10.1038/ng.102; Jabri B, 2009, NAT REV IMMUNOL, V9, P858, DOI 10.1038/nri2670; Karell K, 2003, HUM IMMUNOL, V64, P469, DOI 10.1016/S0198-8859(03)00027-2; Koskinen O, 2008, J PEDIATR GASTR NUTR, V47, P436, DOI 10.1097/MPG.0b013e31817b6dec; Kurppa K, 2010, J PEDIATR-US, V157, P373, DOI 10.1016/j.jpeds.2010.02.070; Lawrence T, 2005, NATURE, V434, P1138, DOI 10.1038/nature03491; Maiuri MC, 2003, N-S ARCH PHARMACOL, V368, P63, DOI 10.1007/s00210-003-0771-y; Maiuri MC, 2003, J MOL MED-JMM, V81, P373, DOI 10.1007/s00109-003-0440-0; Meresse B, 2009, MUCOSAL IMMUNOL, V2, P8, DOI 10.1038/mi.2008.75; Romanos J, 2009, GASTROENTEROLOGY, V137, P834, DOI 10.1053/j.gastro.2009.05.040; Strengell M, 2004, J LEUKOCYTE BIOL, V76, P416, DOI 10.1189/jlb.1003488; TOSCO A, 2010, CLIN GASTROENTE 0917; Trynka G, 2009, GUT, V58, P1078, DOI 10.1136/gut.2008.169052; van Heel DA, 2007, NAT GENET, V39, P827, DOI 10.1038/ng2058; WALKERSMITH JA, 1990, ARCH DIS CHILD, V65, P909, DOI 10.1136/adc.65.8.909	21	40	41	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2011	6	7							e21281	10.1371/journal.pone.0021281	http://dx.doi.org/10.1371/journal.pone.0021281			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791IA	21760890	Green Published, gold, Green Submitted			2022-12-27	WOS:000292657200009
J	Saha, R; Suthers, PF; Maranas, CD				Saha, Rajib; Suthers, Patrick F.; Maranas, Costas D.			Zea mays iRS1563: A Comprehensive Genome-Scale Metabolic Reconstruction of Maize Metabolism	PLOS ONE			English	Article							BROWN-MIDRIB MUTANTS; BIOFUEL PRODUCTION; ESCHERICHIA-COLI; SYSTEMS BIOLOGY; DRAFT SEQUENCE; PLANT; ARABIDOPSIS; PHOTOSYNTHESIS; BIOSYNTHESIS; DATABASE	The scope and breadth of genome-scale metabolic reconstructions have continued to expand over the last decade. Herein, we introduce a genome-scale model for a plant with direct applications to food and bioenergy production (i.e., maize). Maize annotation is still underway, which introduces significant challenges in the association of metabolic functions to genes. The developed model is designed to meet rigorous standards on gene-protein-reaction (GPR) associations, elementally and charged balanced reactions and a biomass reaction abstracting the relative contribution of all biomass constituents. The metabolic network contains 1,563 genes and 1,825 metabolites involved in 1,985 reactions from primary and secondary maize metabolism. For approximately 42% of the reactions direct literature evidence for the participation of the reaction in maize was found. As many as 445 reactions and 369 metabolites are unique to the maize model compared to the AraGEM model for A. thaliana. 674 metabolites and 893 reactions are present in Zea mays iRS1563 that are not accounted for in maize C4GEM. All reactions are elementally and charged balanced and localized into six different compartments (i.e., cytoplasm, mitochondrion, plastid, peroxisome, vacuole and extracellular). GPR associations are also established based on the functional annotation information and homology prediction accounting for monofunctional, multifunctional and multimeric proteins, isozymes and protein complexes. We describe results from performing flux balance analysis under different physiological conditions, (i.e., photosynthesis, photorespiration and respiration) of a C4 plant and also explore model predictions against experimental observations for two naturally occurring mutants (i.e., bm1 and bm3). The developed model corresponds to the largest and more complete to-date effort at cataloguing metabolism for a plant species.	[Saha, Rajib; Suthers, Patrick F.; Maranas, Costas D.] Penn State Univ, Dept Chem Engn, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Saha, R (corresponding author), Penn State Univ, Dept Chem Engn, University Pk, PA 16802 USA.	costas@psu.edu	Maranas, Costas D/A-4774-2011	Maranas, Costas D/0000-0002-1508-1398; Saha, Rajib/0000-0002-2974-0243; Suthers, Patrick/0000-0002-5560-9986	United States Department of Energy (DOE) [DE-FG02-05ER25684]	United States Department of Energy (DOE)(United States Department of Energy (DOE))	This work was supported by United States Department of Energy (DOE) Grant DE-FG02-05ER25684. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramson M, 2010, PLANT SCI, V178, P61, DOI 10.1016/j.plantsci.2009.11.003; Allen JF, 2002, CELL, V110, P273, DOI 10.1016/S0092-8674(02)00870-X; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bennett MD, 2003, ANN BOT-LONDON, V91, P547, DOI 10.1093/aob/mcg057; BENNETZEN J, 2009, HDB MAIZE GENETICS G; DAI ZY, 1995, PLANT PHYSIOL, V107, P815, DOI 10.1104/pp.107.3.815; Dal'Molin CGD, 2010, PLANT PHYSIOL, V154, P1871, DOI 10.1104/pp.110.166488; Dal'Molin CGD, 2010, PLANT PHYSIOL, V152, P579, DOI 10.1104/pp.109.148817; Dennis C, 2000, NATURE, V408, P791; DENNIS DT, 1982, ANNU REV PLANT PHYS, V33, P27, DOI 10.1146/annurev.pp.33.060182.000331; Duarte NC, 2007, P NATL ACAD SCI USA, V104, P1777, DOI 10.1073/pnas.0610772104; Farrell AE, 2006, SCIENCE, V311, P506, DOI 10.1126/science.1121416; Feist AM, 2008, NAT BIOTECHNOL, V26, P659, DOI 10.1038/nbt1401; Feist AM, 2009, NAT REV MICROBIOL, V7, P129, DOI 10.1038/nrmicro1949; Goff SA, 2002, SCIENCE, V296, P92, DOI 10.1126/science.1068275; Grabber JH, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-114; Grafahrend-Belau E, 2009, PLANT PHYSIOL, V149, P585, DOI 10.1104/pp.108.129635; Gregory R. P. F., 1989, BIOCH PHOTOSYNTHESIS; Guillaumie S, 2007, PLANTA, V226, P235, DOI 10.1007/s00425-006-0468-9; Gutierrez RA, 2005, PLANT PHYSIOL, V138, P550, DOI 10.1104/pp.104.900150; Heazlewood JL, 2007, NUCLEIC ACIDS RES, V35, pD213, DOI 10.1093/nar/gkl863; Hervas M, 2003, ACCOUNTS CHEM RES, V36, P798, DOI 10.1021/ar020084b; Hisano H, 2009, IN VITRO CELL DEV-PL, V45, P306, DOI 10.1007/s11627-009-9219-5; Hong SJ, 2007, BIOTECHNOL BIOPROC E, V12, P165, DOI 10.1007/BF03028644; Jerby L, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.56; JOLIVETTOURNIER P, 1984, PLANT PHYSIOL, V74, P108, DOI 10.1104/pp.74.1.108; Kim J, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-53; KUC J, 1964, ARCH BIOCHEM BIOPHYS, V105, P103, DOI 10.1016/0003-9861(64)90240-1; Kumar VS, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-212; Li X, 2008, PLANT J, V54, P569, DOI 10.1111/j.1365-313X.2008.03457.x; Liang CZ, 2009, GENOME RES, V19, P1912, DOI 10.1101/gr.088997.108; Marita JM, 2003, J AGR FOOD CHEM, V51, P1313, DOI 10.1021/jf0260592; Mechin V, 2005, J AGR FOOD CHEM, V53, P5872, DOI 10.1021/jf050722f; Milne Caroline B., 2009, Biotechnology Journal, V4, P1653, DOI 10.1002/biot.200900234; Muller F., 1970, AGR RES REPORT, V736, P1; Notebaart RA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-296; Ouzounis CA, 2000, GENOME RES, V10, P568, DOI 10.1101/gr.10.4.568; Park JM, 2009, BIOTECHNOL ADV, V27, P979, DOI 10.1016/j.biotechadv.2009.05.019; Paterson AH, 2009, NATURE, V457, P551, DOI 10.1038/nature07723; PENNINGDEVRIES FW, 1974, J THEOR BIOL, V45, P339; Pilalis E, 2011, BIOTECHNOL BIOENG, V108, P1673, DOI 10.1002/bit.23107; Poolman MG, 2009, PLANT PHYSIOL, V151, P1570, DOI 10.1104/pp.109.141267; Ranganathan S, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000744; Salamov AA, 2000, GENOME RES, V10, P516, DOI 10.1101/gr.10.4.516; Sanchez OJ, 2008, BIORESOURCE TECHNOL, V99, P5270, DOI 10.1016/j.biortech.2007.11.013; Sattler SE, 2010, PLANT SCI, V178, P229, DOI 10.1016/j.plantsci.2010.01.001; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; Shlomi T, 2008, NAT BIOTECHNOL, V26, P1003, DOI 10.1038/nbt.1487; Smidansky ED, 2003, PLANTA, V216, P656, DOI 10.1007/s00425-002-0897-z; Spector WS, 1956, HDB BIOL DATA, pxxxvi; Stewart CN, 2007, NAT BIOTECHNOL, V25, P283, DOI 10.1038/nbt0307-283; Sticklen MB, 2008, NAT REV GENET, V9, P433, DOI 10.1038/nrg2336; Sticklen MB, 2009, BIOFUEL BIOPROD BIOR, V3, P448, DOI 10.1002/bbb.157; STYLES ED, 1975, PHYTOCHEMISTRY, V14, P413, DOI 10.1016/0031-9422(75)85101-6; Sun Q, 2009, NUCLEIC ACIDS RES, V37, pD969, DOI 10.1093/nar/gkn654; Suthers PF, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000285; Sweetlove LJ, 2003, PLANT PHYSIOL, V132, P420, DOI 10.1104/pp.103.022004; Taiz L., 2002, PLANT PHYSIOL; Thiele I, 2010, NAT PROTOC, V5, P93, DOI 10.1038/nprot.2009.203; Torney F, 2007, CURR OPIN BIOTECH, V18, P193, DOI 10.1016/j.copbio.2007.03.006; TSAFTARIS AS, 1983, P NATL ACAD SCI-BIOL, V80, P4455, DOI 10.1073/pnas.80.14.4455; Vanholme R, 2008, CURR OPIN PLANT BIOL, V11, P278, DOI 10.1016/j.pbi.2008.03.005; VARMA A, 1994, BIO-TECHNOL, V12, P994, DOI 10.1038/nbt1094-994; Vega-Sanchez ME, 2010, CURR OPIN BIOTECH, V21, P218, DOI 10.1016/j.copbio.2010.02.002; VOLK RJ, 1972, PLANT PHYSIOL, V49, P218, DOI 10.1104/pp.49.2.218; Wedig C, 1987, J AGR FOOD CHEM, V35, P23; Wei YL, 2009, BMC BIOCHEM, V10, DOI 10.1186/1471-2091-10-7; WEIDEMANN C, 1991, PLANT CELL REP, V10, P371, DOI 10.1007/BF00193162; Winkel-Shirley B, 2001, PLANT PHYSIOL, V126, P485, DOI 10.1104/pp.126.2.485; WISE RR, 2007, STRUCTURE FUNCTION P, V23, P274; Xavier A, 2010, NATURE P, DOI [10.1038/npre.2010.4908.1, DOI 10.1038/NPRE.2010.4908.1]; Yu J, 2002, SCIENCE, V296, P79, DOI 10.1126/science.1068037	72	139	139	4	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2011	6	7							e21784	10.1371/journal.pone.0021784	http://dx.doi.org/10.1371/journal.pone.0021784			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791AK	21755001	Green Published, Green Submitted, gold			2022-12-27	WOS:000292632000028
J	Karageorgopoulos, DE; Vouloumanou, EK; Korbila, IP; Kapaskelis, A; Falagas, ME				Karageorgopoulos, Drosos E.; Vouloumanou, Evridiki K.; Korbila, Ioanna P.; Kapaskelis, Anastasios; Falagas, Matthew E.			Age Distribution of Cases of 2009 (H1N1) Pandemic Influenza in Comparison with Seasonal Influenza	PLOS ONE			English	Article							A H1N1; INFECTION; MORTALITY; RESPONSES; ANTIBODY	Introduction: Several aspects of the epidemiology of 2009 (H1N1) pandemic influenza have not been accurately determined. We sought to study whether the age distribution of cases differs in comparison with seasonal influenza. Methods: We searched for official, publicly available data through the internet from different countries worldwide on the age distribution of cases of influenza during the 2009 (H1N1) pandemic influenza period and most recent seasonal influenza periods. Data had to be recorded through the same surveillance system for both compared periods. Results: For 2009 pandemic influenza versus recent influenza seasons, in USA, visits for influenza-like illness to sentinel providers were more likely to involve the age groups of 5-24, 25-64 and 0-4 years compared with the reference group of > 64 years [odds ratio (OR) (95% confidence interval (CI)): 2.43 (2.39-2.47), 1.66 (1.64-1.69), and 1.51 (1.48-1.54), respectively]. Pediatric deaths were less likely in the age groups of 2-4 and < 2 years than the reference group of 5-17 years [OR (95% CI): 0.46 (0.25-0.85) and 0.49 (0.30-0.81), respectively]. In Australia, notifications for laboratory-confirmed influenza were more likely in the age groups of 10-19, 5-9, 20-44, 45-64 and 0-4 years than the reference group of > 65 years [OR (95% CI): 7.19 (6.67-7.75), 5.33 (4.90-5.79), 5.04 (4.70-5.41), 3.12 (2.89-3.36) and 1.89 (1.75-2.05), respectively]. In New Zealand, consultations for influenza-like illness by sentinel providers were more likely in the age groups of < 1, 1-4, 35-49, 5-19, 20-34 and 50-64 years than the reference group of > 65 years [OR (95% CI): 2.38 (1.74-3.26), 1.99 (1.62-2.45), 1.57 (1.30-1.89), 1.57 (1.30-1.88), 1.40 (1.17-1.69) and 1.39 (1.14-1.70), respectively]. Conclusions: The greatest increase in influenza cases during 2009 (H1N1) pandemic influenza period, in comparison with most recent seasonal influenza periods, was seen for school-aged children, adolescents, and younger adults.	[Karageorgopoulos, Drosos E.; Vouloumanou, Evridiki K.; Korbila, Ioanna P.; Kapaskelis, Anastasios; Falagas, Matthew E.] Alfa Inst Biomed Sci, Athens, Greece; [Kapaskelis, Anastasios; Falagas, Matthew E.] Henry Dunant Hosp, Dept Med, Athens, Greece; [Falagas, Matthew E.] Tufts Univ, Sch Med, Dept Med, Boston, MA 02111 USA	Alfa Institute Of Biomedical Sciences; Henry Dunant Hospital; Tufts University	Karageorgopoulos, DE (corresponding author), Alfa Inst Biomed Sci, Athens, Greece.	m.falagas@aibs.gr	Karageorgopoulos, Drosos/K-9241-2018	Karageorgopoulos, Drosos/0000-0002-9959-9978				Armstrong GL, 2011, CLIN INFECT DIS, V52, pS83, DOI 10.1093/cid/ciq013; Baguelin M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017074; Bandaranayake D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013211; Bansal S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009360; Bone A, 2010, VACCINE, V28, P8157, DOI 10.1016/j.vaccine.2010.09.096; Epstein SL, 2006, J INFECT DIS, V193, P49, DOI 10.1086/498980; Falagas ME, 2011, EPIDEMIOL INFECT, V139, P27, DOI 10.1017/S0950268810002037; Greenbaum JA, 2009, P NATL ACAD SCI USA, V106, P20365, DOI 10.1073/pnas.0911580106; Napolitano L. M., 2009, Morbidity and Mortality Weekly Report, V58, P749; Hancock K, 2009, NEW ENGL J MED, V361, P1945, DOI 10.1056/NEJMoa0906453; Jamieson DJ, 2009, LANCET, V374, P451, DOI 10.1016/S0140-6736(09)61304-0; Khiabanian H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006832; Lemaitre M, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-162; Louie JK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018221; Louie JK, 2009, JAMA-J AM MED ASSOC, V302, P1896, DOI 10.1001/jama.2009.1583; Miller E, 2010, LANCET, V375, P1100, DOI 10.1016/S0140-6736(09)62126-7; Perez-Padilla R, 2009, NEW ENGL J MED, V361, P680, DOI 10.1056/NEJMoa0904252; Reed C, 2009, EMERG INFECT DIS, V15, P2004, DOI 10.3201/eid1512.091413; Scalera NM, 2009, POSTGRAD MED, V121, P43, DOI 10.3810/pgm.2009.09.2051; Simonsen L, 1998, J INFECT DIS, V178, P53, DOI 10.1086/515616; Skowronski DM, 2011, J INFECT DIS, V203, P158, DOI 10.1093/infdis/jiq039; Tang JWT, 2010, ARCH INTERN MED, V170, P861, DOI 10.1001/archinternmed.2010.108; Tu WW, 2010, J VIROL, V84, P6527, DOI 10.1128/JVI.00519-10; Viboud C, 2010, PLOS CURR	24	9	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2011	6	7							e21690	10.1371/journal.pone.0021690	http://dx.doi.org/10.1371/journal.pone.0021690			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786HC	21747947	Green Published, gold, Green Submitted			2022-12-27	WOS:000292293400023
J	Shan, D; Ge, Z; Ming, SA; Wang, L; Sante, M; He, WS; Zhou, JP; Liu, SL; Wang, L				Shan, Duo; Ge, Zeng; Ming, Shuai; Wang, Lan; Sante, Michael; He, Wensheng; Zhou, Jianping; Liu, Shanglong; Wang, Lu			Quality of Life and Related Factors among HIV-Positive Spouses from Serodiscordant Couples under Antiretroviral Therapy in Henan Province, China	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS-INFECTION; WHOQOL-BREF; PSYCHOMETRIC PROPERTIES; MEDICAL OUTCOMES; HIV/AIDS; INSTRUMENT; VALIDITY; TRANSMISSION; IMPACT; AIDS	Objective: To describe the quality of life and related factors in HIV-positive spouses undergoing ART from discordant couples. Methods: A cross-sectional study was conducted among 1,009 HIV-positive spouses from serodiscordant couples in Zhumadian, Henan Province, between October 1, 2008 and March 31, 2009. HIV-positive spouses were interviewed by local health professionals. Quality of life was evaluated by WHOQOL (Chinese Version). A multiple linear regression model was used to analyze the related factors. Results: The majority of subjects were female (56.39%), had received a high school education (44%), were of Han ethnicity (98.41%), and were farmers (90.09%); the median time period of receiving ART was 3.92 years. The physical, psychological, social, and environmental QOL scores of the subjects were 12.91 +/- 1.95, 12.35 +/- 1.80, 13.96 +/- 2.43, and 12.45 +/- 1.91 respectively. The multiple linear regression model identified the physical domain related factors to be CD4 count, educational level, and occupation; psychological domain related factors include age, educational level, and reported STD symptom; social domain related factors included education level; and environmental domain related factors included education level, reported STD symptoms, and occupation. Conclusion: Being younger, a farmer, having a lower level of education, a reported STD symptom, or lower CD4 count, could decrease one's quality of life, suggesting that the use of blanket ART programs alone may not necessarily improve quality of life. Subjects received lower scores in the psychological domain, suggesting that psychological intervention may also need to be strengthened.	[Shan, Duo; Ming, Shuai; Wang, Lan; Sante, Michael; Wang, Lu] Chinese Ctr Dis Control & Prevent, Natl Ctr AIDS STD Control & Prevent, Beijing, Peoples R China; [Ge, Zeng] Chinese Acad Med Sci, Fuwai Hosp, Beijing 100730, Peoples R China; [Ge, Zeng] Chinese Acad Med Sci, Cardiovasc Inst, Beijing 100730, Peoples R China; [Ge, Zeng] Peking Union Med Coll, Beijing 100021, Peoples R China; [He, Wensheng; Zhou, Jianping] Zhumadian Ctr Dis Control & Prevent, Zhumadian City, Henan Province, Peoples R China; [Liu, Shanglong] Huazhong Univ Sci & Technol, Tongji Med Coll, Wuhan 430074, Peoples R China	Chinese Center for Disease Control & Prevention; National Center for AIDS/STD Control & Prevention, Chinese Center for Disease Control & Prevention; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Huazhong University of Science & Technology	Shan, D (corresponding author), Chinese Ctr Dis Control & Prevent, Natl Ctr AIDS STD Control & Prevent, Beijing, Peoples R China.	wanglu64@chinaaids.cn						Ammassari A, 2001, J ACQ IMMUN DEF SYND, V28, P445, DOI 10.1097/00042560-200112150-00006; Attia S, 2009, AIDS, V23, P1397, DOI 10.1097/QAD.0b013e32832b7dca; Beard J, 2009, AIDS CARE, V21, P1343, DOI 10.1080/09540120902889926; Brooks JT, 2009, CLIN INFECT DIS, V48, P609, DOI 10.1086/596756; Burgoyne RW, 2008, J ANTIMICROB CHEMOTH, V61, P469, DOI 10.1093/jac/dkm499; Carpenter LM, 1999, AIDS, V13, P1083, DOI 10.1097/00002030-199906180-00012; DeBoer JB, 1996, QUAL LIFE RES, V5, P339, DOI 10.1007/BF00433918; Dube MP, 2010, J INFECT DIS, V201, P1783, DOI 10.1086/652751; Fang CT, 2002, QUAL LIFE RES, V11, P753, DOI 10.1023/A:1020870402019; Fauci AS, 1999, NEW ENGL J MED, V341, P1046, DOI 10.1056/NEJM199909303411406; Hsiung PC, 2005, QUAL LIFE RES, V14, P141, DOI 10.1007/s11136-004-6252-z; HYMES KB, 1981, LANCET, V2, P598; Kalichman SC, 2002, INT J STD AIDS, V13, P677, DOI 10.1258/095646202760326426; KAPLAN RM, 1995, PSYCHOSOM MED, V57, P138, DOI 10.1097/00006842-199503000-00006; Lee GM, 2006, PEDIATRICS, V117, P273, DOI 10.1542/peds.2005-0323; Leplege A, 1997, QUAL LIFE RES, V6, P585, DOI 10.1023/A:1018468301617; Liu ZY, 2009, CHINESE MED J-PEKING, V122, P2497, DOI 10.3760/cma.j.issn.0366-6999.2009.20.018; Lurie MN, 2003, AIDS, V17, P2245, DOI 10.1097/00002030-200310170-00013; Mrus JM, 2005, QUAL LIFE RES, V14, P479, DOI 10.1007/s11136-004-4693-z; *NASTAD, 2005, TURN POINT CONFR HIV; Nojomi Marzieh, 2008, Arch Iran Med, V11, P608; O'Carroll RE, 2000, QUAL LIFE RES, V9, P121, DOI 10.1023/A:1008901320492; O'Connell K, 2003, SOC SCI MED, V57, P1259, DOI 10.1016/S0277-9536(02)00506-3; Peterman AH, 1997, QUAL LIFE RES, V6, P572, DOI 10.1023/A:1018416317546; Rao D, 2009, AIDS CARE, V21, P64, DOI 10.1080/09540120802068795; Sakthong Phantipa, 2007, Journal of the Medical Association of Thailand, V90, P2449; Santos Elisabete Cristina Morandi dos, 2007, Rev. Saúde Pública, V41, P64; Skevington SM, 2004, QUAL LIFE RES, V13, P299, DOI 10.1023/B:QURE.0000018486.91360.00; Subramanian T, 2009, AIDS CARE, V21, P473, DOI 10.1080/09540120802283469; WACHTEL T, 1992, ANN INTERN MED, V116, P129, DOI 10.7326/0003-4819-116-2-129; *WHO, 2009, 2009 UPD HIV AIDS EP; *WHO, 2004, WHO QUAL LIFE WHOQOL; Wu AW, 2002, QUAL LIFE RES, V11, P273, DOI 10.1023/A:1015240103565; Wu AW, 1997, QUAL LIFE RES, V6, P481, DOI 10.1023/A:1018451930750; Yang Meei-Horng, 2003, J Nurs Res, V11, P217; Yen CF, 2004, PSYCHIAT CLIN NEUROS, V58, P501, DOI 10.1111/j.1440-1819.2004.01292.x; Zhang FJ, 2005, CELL RES, V15, P877, DOI 10.1038/sj.cr.7290362; Zhang Heng, 2009, Zhonghua Liu Xing Bing Xue Za Zhi, V30, P206	38	19	22	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2011	6	6							e21839	10.1371/journal.pone.0021839	http://dx.doi.org/10.1371/journal.pone.0021839			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	786GP	21738797	Green Submitted, Green Published, gold			2022-12-27	WOS:000292291800048
J	Tanasijevic, B; Rasmussen, TP				Tanasijevic, Borko; Rasmussen, Theodore P.			X Chromosome Inactivation and Differentiation Occur Readily in ES Cells Doubly-Deficient for MacroH2A1 and MacroH2A2	PLOS ONE			English	Article							HISTONE VARIANT MACROH2A; CORE HISTONE; TRANSCRIPTION; EXPRESSION; METHYLATION; INTERFERES; DELETION; SUBTYPES; SWI/SNF; GENOME	Macrohistones (mH2As) are unusual histone variants found exclusively in vertebrate chromatin. In mice, the H2afy gene encodes two splice variants, mH2A1.1 and mH2A1.2 and a second gene, H2afy2, encodes an additional mH2A2 protein. Both mH2A isoforms have been found enriched on the inactive X chromosome (Xi) in differentiated mammalian female cells, and are incorporated into the chromatin of developmentally-regulated genes. To investigate the functional significance of mH2A isoforms for X chromosome inactivation (XCI), we produced male and female embryonic stem cell (ESC) lines with stably-integrated shRNA constructs that simultaneously target both mH2A1 and mH2A2. Surprisingly, we find that female ESCs deficient for both mH2A1 and mH2A2 readily execute and maintain XCI upon differentiation. Furthermore, male and female mH2A-deficient ESCs proliferate normally under pluripotency culture conditions, and respond to several standard differentiation procedures efficiently. Our results show that XCI can readily proceed with substantially reduced total mH2A content.	[Tanasijevic, Borko; Rasmussen, Theodore P.] Univ Connecticut, Ctr Regenerat Biol, Storrs, CT 06269 USA; [Tanasijevic, Borko; Rasmussen, Theodore P.] Univ Connecticut, Dept Mol & Cell Biol, Storrs, CT 06269 USA; [Rasmussen, Theodore P.] Univ Connecticut, Dept Pharmaceut Sci, Storrs, CT 06269 USA	University of Connecticut; University of Connecticut; University of Connecticut	Tanasijevic, B (corresponding author), Univ Connecticut, Ctr Regenerat Biol, Storrs, CT 06269 USA.	theodore.rasmussen@uconn.edu		Rasmussen, Theodore/0000-0001-9450-3394	National Institutes of Health [RO1AG23687]; NATIONAL INSTITUTE ON AGING [R01AG023687] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported by a grant from the National Institutes of Health (RO1AG23687), http://www.nih.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agelopoulos M, 2006, EMBO J, V25, P4843, DOI 10.1038/sj.emboj.7601364; Ambrosi DJ, 2007, STEM CELLS, V25, P1104, DOI 10.1634/stemcells.2006-0532; Angelov D, 2003, MOL CELL, V11, P1033, DOI 10.1016/S1097-2765(03)00100-X; Araya I, 2010, EPIGENET CHROMATIN, V3, DOI 10.1186/1756-8935-3-14; Barzily-Rokni M, 2011, NUCLEIC ACIDS RES, V39, P1326, DOI 10.1093/nar/gkq994; Boulard M, 2010, EPIGENET CHROMATIN, V3, DOI 10.1186/1756-8935-3-8; Buschbeck M, 2009, NAT STRUCT MOL BIOL, V16, P1074, DOI 10.1038/nsmb.1665; Chadwick BP, 2001, HUM MOL GENET, V10, P1101, DOI 10.1093/hmg/10.10.1101; Chang EY, 2008, BIOCHEMISTRY-US, V47, P13726, DOI 10.1021/bi8016944; Changolkar LN, 2007, MOL CELL BIOL, V27, P2758, DOI 10.1128/MCB.02334-06; Changolkar LN, 2006, MOL CELL BIOL, V26, P4410, DOI 10.1128/MCB.02258-05; Changolkar LN, 2010, MOL CELL BIOL; Choo JH, 2006, HUM MOL GENET, V15, P717, DOI 10.1093/hmg/ddi485; Costanzi C, 2000, DEVELOPMENT, V127, P2283; Costanzi C, 1998, NATURE, V393, P599, DOI 10.1038/31275; Costanzi C, 2001, J BIOL CHEM, V276, P21776, DOI 10.1074/jbc.M010919200; Csankovszki G, 1999, NAT GENET, V22, P323, DOI 10.1038/11887; Doyen CM, 2006, MOL CELL BIOL, V26, P1156, DOI 10.1128/MCB.26.3.1156-1164.2006; Gamble MJ, 2010, GENE DEV, V24, P21, DOI 10.1101/gad.1876110; Hernadez-Munoz I, 2005, P NATL ACAD SCI USA, V102, P7635, DOI 10.1073/pnas.0408918102; Hoyer-Fender S, 2000, EXP CELL RES, V258, P254, DOI 10.1006/excr.2000.4951; Kawai J, 2001, NATURE, V409, P685, DOI 10.1038/35055500; Kwiatkowski DL, 2009, J VIROL, V83, P8173, DOI 10.1128/JVI.00686-09; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma YH, 2005, J CELL SCI, V118, P1607, DOI 10.1242/jcs.02291; Mermoud JE, 1999, J CELL BIOL, V147, P1399, DOI 10.1083/jcb.147.7.1399; Mietton F, 2009, MOL CELL BIOL, V29, P150, DOI 10.1128/MCB.00997-08; Ng RK, 2008, NAT CELL BIOL, V10, P1280, DOI 10.1038/ncb1786; Ouararhni K, 2006, GENE DEV, V20, P3324, DOI 10.1101/gad.396106; PEHRSON JR, 1992, SCIENCE, V257, P1398; Pehrson JR, 1998, NUCLEIC ACIDS RES, V26, P2837, DOI 10.1093/nar/26.12.2837; Rasmussen TP, 1999, NUCLEIC ACIDS RES, V27, P3685, DOI 10.1093/nar/27.18.3685; Rasmussen TP, 2000, J CELL BIOL, V150, P1189, DOI 10.1083/jcb.150.5.1189; Rasmussen TP, 2001, CHROMOSOMA, V110, P411, DOI 10.1007/s004120100158; Tanasijevic B, 2009, EPIGENETICS-US, V4, P330, DOI 10.4161/epi.4.5.9275; Zhang RG, 2005, DEV CELL, V8, P19, DOI 10.1016/j.devcel.2004.10.019	36	35	35	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2011	6	6							e21512	10.1371/journal.pone.0021512	http://dx.doi.org/10.1371/journal.pone.0021512			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786GP	21738686	Green Submitted, gold, Green Published			2022-12-27	WOS:000292291800018
J	Lai, CY; Yu, SL; Hsieh, MH; Chen, CH; Chen, HY; Wen, CC; Huang, YH; Hsiao, PC; Hsiao, CK; Liu, CM; Yang, PC; Hwu, HG; Chen, WJ				Lai, Chi-Yu; Yu, Sung-Liang; Hsieh, Ming H.; Chen, Chun-Houh; Chen, Hsuan-Yu; Wen, Chun-Chiang; Huang, Yung-Hsiang; Hsiao, Po-Chang; Hsiao, Chuhsing Kate; Liu, Chih-Min; Yang, Pan-Chyr; Hwu, Hai-Gwo; Chen, Wei J.			MicroRNA Expression Aberration as Potential Peripheral Blood Biomarkers for Schizophrenia	PLOS ONE			English	Article							CONTINUOUS PERFORMANCE-TEST; GENE-EXPRESSION; PREFRONTAL CORTEX; MONONUCLEAR-CELLS; BRAIN; IDENTIFICATION; INDIVIDUALS; DEFICITS; CLASSIFICATION; DYSREGULATION	Since brain tissue is not readily accessible, a new focus in search of biomarkers for schizophrenia is blood-based expression profiling of non-protein coding genes such as microRNAs (miRNAs), which regulate gene expression by inhibiting the translation of messenger RNAs. This study aimed to identify potential miRNA signature for schizophrenia by comparing genome-wide miRNA expression profiles in patients with schizophrenia vs. healthy controls. A genome-wide miRNA expression profiling was performed using a Taqman array of 365 human miRNAs in the mononuclear leukocytes of a learning set of 30 cases and 30 controls. The discriminating performance of potential biomarkers was validated in an independent testing set of 60 cases and 30 controls. The expression levels of the miRNA signature were then evaluated for their correlation with the patients' clinical symptoms, neurocognitive performances, and neurophysiological functions. A seven-miRNA signature (hsa-miR-34a, miR-449a, miR-564, miR-432, miR-548d, miR-572 and miR-652) was derived from a supervised classification with internal cross-validation, with an area under the curve (AUC) of receiver operating characteristics of 93%. The putative signature was then validated in the testing set, with an AUC of 85%. Among these miRNAs, miR-34a was differentially expressed between cases and controls in both the learning (P = 0.005) and the testing set (P = 0.002). These miRNAs were differentially correlated with patients' negative symptoms, neurocognitive performance scores, and event-related potentials. The results indicated that the mononuclear leukocyte-based miRNA profiling is a feasible way to identify biomarkers for schizophrenia, and the seven-miRNA signature warrants further investigation.	[Lai, Chi-Yu; Huang, Yung-Hsiang; Hsiao, Chuhsing Kate; Hwu, Hai-Gwo; Chen, Wei J.] Natl Taiwan Univ, Coll Publ Hlth, Inst Epidemiol & Prevent Med, Taipei 10764, Taiwan; [Yu, Sung-Liang; Chen, Hsuan-Yu; Hsiao, Po-Chang; Hsiao, Chuhsing Kate; Yang, Pan-Chyr; Chen, Wei J.] Natl Taiwan Univ, Ctr Genom Med, Taipei 10764, Taiwan; [Yu, Sung-Liang] Natl Taiwan Univ, Coll Med, Dept Clin Lab Sci & Med Biotechnol, Taipei 10764, Taiwan; [Hsieh, Ming H.; Wen, Chun-Chiang; Liu, Chih-Min; Hwu, Hai-Gwo; Chen, Wei J.] Natl Taiwan Univ, Coll Med, Dept Psychiat, Taipei 10764, Taiwan; [Hsieh, Ming H.; Wen, Chun-Chiang; Liu, Chih-Min; Yang, Pan-Chyr; Hwu, Hai-Gwo; Chen, Wei J.] Natl Taiwan Univ, Natl Taiwan Univ Hosp, Taipei 10764, Taiwan; [Chen, Chun-Houh; Chen, Hsuan-Yu] Acad Sinica, Inst Stat Sci, Taipei 11529, Taiwan; [Yang, Pan-Chyr] Natl Taiwan Univ, Coll Med, Dept Internal Med, Taipei, Taiwan; [Hwu, Hai-Gwo; Chen, Wei J.] Natl Taiwan Univ, Neurobiol & Cognit Ctr, Taipei 10764, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University Hospital; Academia Sinica - Taiwan; National Taiwan University; National Taiwan University	Lai, CY (corresponding author), Natl Taiwan Univ, Coll Publ Hlth, Inst Epidemiol & Prevent Med, Taipei 10764, Taiwan.	wjchen@ntu.edu.tw	Chen, Hsuan-Yu/AAE-8428-2019; Chen, Chun-houh/AAP-2640-2021; Hsieh, Ming H./B-2970-2010	Chen, Chun-houh/0000-0003-0899-7477; HWU, HAI-GWO/0000-0002-2582-2807; Hsiao, Po-Chang/0000-0002-5813-3389; Chen, Wei Jen/0000-0001-5899-5870; LIU, CHIH-MIN/0000-0001-7016-8990; YANG, PAN-CHYR/0000-0001-6330-6048; Hsieh, Ming H./0000-0002-3585-7843; YU, SUNG-LIANG/0000-0003-4535-9036; hsiao, chuhsing kate/0000-0003-4905-8484	National Taiwan University [97R0337, 97HP0023, 97HP0071]; National Science Council, Taiwan [NSC98-2314-B-002-125-MY3]; National Health Research Institutes, Taiwan [NHRI-EX99-9511PP]	National Taiwan University(National Taiwan University); National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); National Health Research Institutes, Taiwan(National Health Research Institutes - Taiwan)	This study was supported by grants from National Taiwan University (97R0337, 97HP0023 and 97HP0071), the National Science Council, Taiwan (NSC98-2314-B-002-125-MY3), and the National Health Research Institutes, Taiwan (NHRI-EX99-9511PP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Elneel K, 2008, NEUROGENETICS, V9, P153, DOI 10.1007/s10048-008-0133-5; Allen NC, 2008, NAT GENET, V40, P827, DOI 10.1038/ng.171; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Betel D, 2008, NUCLEIC ACIDS RES, V36, pD149, DOI 10.1093/nar/gkm995; Beveridge NJ, 2010, MOL PSYCHIATR, V15, P1176, DOI 10.1038/mp.2009.84; Beveridge NJ, 2008, HUM MOL GENET, V17, P1156, DOI 10.1093/hmg/ddn005; Chang CJ, 2002, SCHIZOPHRENIA BULL, V28, P379, DOI 10.1093/oxfordjournals.schbul.a006947; Chen WJ, 1998, SCHIZOPHRENIA BULL, V24, P163, DOI 10.1093/oxfordjournals.schbul.a033308; Chen WJ, 1998, AM J PSYCHIAT, V155, P1214, DOI 10.1176/ajp.155.9.1214; Cheng HYM, 2007, NEURON, V54, P813, DOI 10.1016/j.neuron.2007.05.017; Cheng J. J., 1996, CHINESE PSYCHIAT, V10, P251; Cheung ZH, 2006, NEURON, V50, P13, DOI 10.1016/j.neuron.2006.02.024; Cogswell JP, 2008, J ALZHEIMERS DIS, V14, P27, DOI 10.3233/jad-2008-14103; Conde-Agudelo A, 2010, AM J OBSTET GYNECOL, V203, DOI 10.1016/j.ajog.2010.02.064; Coyle JT, 2009, P NATL ACAD SCI USA, V106, P2975, DOI 10.1073/pnas.0813321106; Dwivedi Y, 2009, INT J NEUROPSYCHOPH, V12, P1337, DOI 10.1017/S1461145709990575; Freedman R, 1996, ARCH GEN PSYCHIAT, V53, P1114; Gladkevich A, 2004, PROG NEURO-PSYCHOPH, V28, P559, DOI 10.1016/j.pnpbp.2004.01.009; Glatt SJ, 2009, MOL PSYCHIATR, V14, P885, DOI 10.1038/mp.2008.30; Glatt SJ, 2005, P NATL ACAD SCI USA, V102, P15533, DOI 10.1073/pnas.0507666102; Gottesman II, 2003, AM J PSYCHIAT, V160, P636, DOI 10.1176/appi.ajp.160.4.636; Guyon I, 2002, MACH LEARN, V46, P389, DOI 10.1023/A:1012487302797; Harrison PJ, 2005, MOL PSYCHIATR, V10, P40, DOI 10.1038/sj.mp.4001558; Hassan SS, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2009.08.016; HEATON RK, WISCONSIN CARD SORTI; Hoh NZ, 2010, J NEUROTRAUM, V27, P1413, DOI 10.1089/neu.2009.1256; Hsu SD, 2008, NUCLEIC ACIDS RES, V36, pD165, DOI 10.1093/nar/gkm1012; Hunter MP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003694; Jasinska AJ, 2009, HUM MOL GENET, V18, P4415, DOI 10.1093/hmg/ddp397; Joyce EM, 2007, CURR OPIN PSYCHIATR, V20, P268; Kay S.R., 1991, POSITIVE NEGATIVE SY; Kerns D, 2010, SCHIZOPHR RES, V120, P150, DOI 10.1016/j.schres.2010.04.012; Keshavan MS, 2008, SCHIZOPHR RES, V106, P89, DOI 10.1016/j.schres.2008.07.020; Kim AH, 2010, SCHIZOPHR RES, V124, P183, DOI 10.1016/j.schres.2010.07.002; Kiriakidou M, 2004, GENE DEV, V18, P1165, DOI 10.1101/gad.1184704; Kocerha J, 2009, P NATL ACAD SCI USA, V106, P3507, DOI 10.1073/pnas.0805854106; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Kuzman MR, 2009, J PSYCHIATR RES, V43, P1073, DOI 10.1016/j.jpsychires.2009.03.005; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Light GA, 2005, ARCH GEN PSYCHIAT, V62, P127, DOI 10.1001/archpsyc.62.2.127; Lin CCH, 2000, J CLIN EXP NEUROPSYC, V22, P69, DOI 10.1076/1380-3395(200002)22:1;1-8;FT069; Liu L, 2010, PSYCHIAT RES, V176, P1, DOI 10.1016/j.psychres.2008.10.024; Liu SK, 1997, SCHIZOPHR RES, V25, P211, DOI 10.1016/S0920-9964(97)00026-1; Lize M, 2010, CELL DEATH DIFFER, V17, P452, DOI 10.1038/cdd.2009.188; *MAMI, MAMI MET PRED MICROR; Marazziti D, 2010, PSYCHIAT RES, V175, P54, DOI 10.1016/j.psychres.2009.03.009; Marques-Deak A, 2005, MOL PSYCHIATR, V10, P239, DOI 10.1038/sj.mp.4001643; MIETTINEN OS, 1976, AM J EPIDEMIOL, V104, P609, DOI 10.1093/oxfordjournals.aje.a112339; Miller BH, 2010, BRAIN RES, V1338, P89, DOI 10.1016/j.brainres.2010.03.035; NURNBERGER JI, 1994, ARCH GEN PSYCHIAT, V51, P849, DOI 10.1001/archpsyc.1994.03950110009002; Ozdemir V, 2006, NAT BIOTECHNOL, V24, P942, DOI 10.1038/nbt0806-942; Perkins DO, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r27; Perkins DO, 2005, MOL PSYCHIATR, V10, P69, DOI 10.1038/sj.mp.4001577; Schipper HM, 2007, GENE REGUL SYST BIO, V1, P263; Schmittgen TD, 2008, METHODS, V44, P31, DOI 10.1016/j.ymeth.2007.09.006; Schwarz E, 2008, BRIT J PHARMACOL, V153, pS133, DOI 10.1038/sj.bjp.0707658; Sethupathy P, 2006, NAT METHODS, V3, P881, DOI 10.1038/NMETH954; Shibata H, 2009, PSYCHIAT RES, V167, P88, DOI 10.1016/j.psychres.2007.12.002; Sullivan PF, 2006, AM J MED GENET B, V141B, P261, DOI 10.1002/ajmg.b.30272; Tamminga CA, 2005, MOL PSYCHIATR, V10, P27, DOI 10.1038/sj.mp.4001563; Tsuang MT, 2005, AM J MED GENET B, V133B, P1, DOI 10.1002/ajmg.b.30161; Turetsky BI, 2007, SCHIZOPHRENIA BULL, V33, P69, DOI 10.1093/schbul/sbl060; van Heerden Johan H, 2009, BMC Res Notes, V2, P195, DOI 10.1186/1756-0500-2-195; van Os J, 2010, NATURE, V468, P203, DOI 10.1038/nature09563; Vawter MP, 2004, SCHIZOPHR RES, V67, P41, DOI 10.1016/S0920-9964(03)00151-8; Wang XW, 2006, NUCLEIC ACIDS RES, V34, P1646, DOI 10.1093/nar/gkl068; Wheeler G, 2006, FEBS LETT, V580, P2195, DOI 10.1016/j.febslet.2006.03.019; Wu HM, 2010, COMPUT STAT DATA AN, V54, P767, DOI 10.1016/j.csda.2008.09.029; Xiao FF, 2009, NUCLEIC ACIDS RES, V37, pD105, DOI 10.1093/nar/gkn851; Yao YR, 2008, J PSYCHIATR RES, V42, P639, DOI 10.1016/j.jpsychires.2007.07.011; Zhou R, 2009, NEUROPSYCHOPHARMACOL, V34, P1395, DOI 10.1038/npp.2008.131	74	174	190	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2011	6	6							e21635	10.1371/journal.pone.0021635	http://dx.doi.org/10.1371/journal.pone.0021635			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786FZ	21738743	Green Submitted, gold, Green Published			2022-12-27	WOS:000292290100050
J	Amaral, EP; Kipnis, TL; de Carvalho, ECQ; da Silva, WD; Leao, SC; Lasunskaia, EB				Amaral, Eduardo Pinheiro; Kipnis, Thereza Liberman; Queiroz de Carvalho, Eulogio Carlos; da Silva, Wilmar Dias; Leao, Sylvia Cardoso; Lasunskaia, Elena B.			Difference in Virulence of Mycobacterium avium Isolates Sharing Indistinguishable DNA Fingerprint Determined in Murine Model of Lung Infection	PLOS ONE			English	Article							FRAGMENT-LENGTH-POLYMORPHISM; NUMBER TANDEM-REPEAT; SUBSP HOMINISSUIS; INDUCTION; COMPLEX; IS1245; IDENTIFICATION; MACROPHAGES; RESISTANCE; DIVERSITY	Background: Opportunistic Mycobacterium avium typically causes disease in immunocompromised patients and in some groups of apparently healthy individuals. The high virulence of some bacterial lineages increases the disease risk. High-resolution molecular genotyping studies of M. avium clinical isolates demonstrated that some genotype patterns were more prevalent than others, suggesting that close genetic relatedness of these successful isolates sharing a similar genotype could determine similar biological properties associated with high virulence. Methods and Findings: In this study, we aimed to compare the virulence and pathogenic properties of two epidemiologically unrelated M. avium isolates sharing an indistinguishable DNA fingerprint in a well-characterized model of pulmonary infection in mice, resistant or susceptible to mycobacteria. The mice, C57BL/6 wild-type or IFN-gamma gene disrupted (GKO), respectively, were intratracheally infected with two isolates, H27 (human blood isolate) and P104 (pig lymph node isolate), and the lungs were examined for bacterial loads, histopathology and cytokine gene expression. The obtained data demonstrated significant differences in the virulence properties of these strains. Although the H27 strain grew significantly faster than P104 in the early stage of infection, this bacterium induced protective immunity that started to reduce bacterial numbers in the wild-type mice, whereas the P104 strain established a chronic infection. In the GKO mice, both strains were capable of causing a chronic infection, associated with higher bacterial burdens and severe lung pathology, in a similar manner. Conclusions/Significance: The results demonstrated that the studied isolates differed in the pathogenic properties although were indistinguishable by actually widely used genotyping techniques demonstrating that the genotype similarity does not predict similarity in virulence of M. avium isolates.	[Amaral, Eduardo Pinheiro; Kipnis, Thereza Liberman; Lasunskaia, Elena B.] Univ Estadual Norte Fluminense, Lab Biol Recognit, Rio De Janeiro, Brazil; [Queiroz de Carvalho, Eulogio Carlos] Univ Estadual Norte Fluminense, Lab Anim Morphol & Pathol, Rio De Janeiro, Brazil; [da Silva, Wilmar Dias] Inst Butantan, Lab Immunochem, Sao Paulo, Brazil; [Leao, Sylvia Cardoso] Univ Fed Sao Paulo, Dept Microbiol Immunol & Parasitol, Sao Paulo, Brazil	Universidade Estadual do Norte Fluminense; Universidade Estadual do Norte Fluminense; Instituto Butantan; Universidade Federal de Sao Paulo (UNIFESP)	Amaral, EP (corresponding author), Univ Estadual Norte Fluminense, Lab Biol Recognit, Rio De Janeiro, Brazil.	elena@uenf.br	Amaral, Eduardo EP/M-2456-2014; Lasunskaia, Elena/M-6259-2019; Leao, Sylvia/F-4431-2012; Dias da Silva, Wilmar/I-6549-2015; Lasunskaia, Elena B/J-6691-2014; Leao, Sylvia/O-9637-2016	Amaral, Eduardo EP/0000-0001-5465-8113; Lasunskaia, Elena/0000-0002-6726-273X; Leao, Sylvia/0000-0003-2083-0119; Lasunskaia, Elena B/0000-0002-6726-273X; Leao, Sylvia/0000-0003-2083-0119; Dias da Silva, Wilmar/0000-0001-5109-3081	Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro, FAPERJ [E-26/111.6111]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico CNPq/MCT/DECIT [410555]; CNPq	Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro, FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico CNPq/MCT/DECIT(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported in part by grants to EL from Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro, FAPERJ (E-26/111.6111, www.faperj.br) and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico CNPq/MCT/DECIT (410555, www.mct.gov.br). EPA was supported by an award from CNPq. WDS was supported by an award from FAPERJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aly S, 2007, J PATHOL, V212, P295, DOI 10.1002/path.2185; Bartos M, 2006, J MICROBIOL METH, V64, P333, DOI 10.1016/j.mimet.2005.05.009; BENSON C, 1994, AIDS RES HUM RETROV, V10, P913, DOI 10.1089/aid.1994.10.913; Blumenthal A, 2005, INFECT IMMUN, V73, P3330, DOI 10.1128/IAI.73.6.3330-3341.2005; Cruz A, 2006, J IMMUNOL, V177, P1416, DOI 10.4049/jimmunol.177.3.1416; Curtis MM, 2009, IMMUNOLOGY, V126, P177, DOI 10.1111/j.1365-2567.2008.03017.x; Dhillon SS, 2000, CLIN INFECT DIS, V30, P572, DOI 10.1086/313726; Field SK, 2006, CHEST, V129, P1653, DOI 10.1378/chest.129.6.1653; Florido M, 2006, IMMUNOLOGY, V118, P122, DOI 10.1111/j.1365-2567.2006.02350.x; Florido M, 2004, IMMUNOLOGY, V111, P323, DOI 10.1111/j.1365-2567.2004.01812.x; Florido M, 1999, INFECT IMMUN, V67, P3610; Florido M, 2005, INFECT IMMUN, V73, P3577, DOI 10.1128/IAI.73.6.3577-3586.2005; Horan KL, 2006, J CLIN MICROBIOL, V44, P783, DOI 10.1128/JCM.44.3.783-789.2006; Hussain S, 1999, J IMMUNOL, V163, P2041; Khader SA, 2008, CYTOKINE, V41, P79, DOI 10.1016/j.cyto.2007.11.022; Krzywinska E, 2004, MICROBIOL-SGM, V150, P1707, DOI 10.1099/mic.0.27088-0; Mijs W, 2002, INT J SYST EVOL MICR, V52, P1505, DOI [10.1099/ijs.0.02037-0, 10.1099/00207713-52-5-1505]; Niemann S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007407; Oliveira RS, 2003, J CLIN MICROBIOL, V41, P44, DOI 10.1128/JCM.41.1.44-49.2003; Ordway D, 2008, CLIN VACCINE IMMUNOL, V15, P1248, DOI 10.1128/CVI.00019-08; Pearl JE, 2001, CELL IMMUNOL, V211, P43, DOI 10.1006/cimm.2001.1819; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Porter JDH, 1996, J ANTIMICROB CHEMOTH, V37, P113, DOI 10.1093/jac/37.suppl_B.113; PRINCE DS, 1989, NEW ENGL J MED, V321, P863, DOI 10.1056/NEJM198909283211304; RACOOSIN EL, 1989, J EXP MED, V170, P1635, DOI 10.1084/jem.170.5.1635; Radomski N, 2010, J CLIN MICROBIOL, V48, P1026, DOI 10.1128/JCM.01869-09; Remus N, 2001, PEDIATR RES, V50, P8, DOI 10.1203/00006450-200107000-00005; Ritacco V, 1998, INT J TUBERC LUNG D, V2, P242; Sambrook J., 2001, MOL CLONING LAB MANU; Tateishi Y, 2009, MICROB PATHOGENESIS, V46, P6, DOI 10.1016/j.micpath.2008.10.007; Tirkkonen T, 2010, ACTA VET SCAND, V52, DOI 10.1186/1751-0147-52-21; Turenne CY, 2008, J BACTERIOL, V190, P2479, DOI 10.1128/JB.01691-07; Turenne CY, 2007, CLIN MICROBIOL REV, V20, P205, DOI 10.1128/CMR.00036-06; Van Soolingen D, 1998, J CLIN MICROBIOL, V36, P3051, DOI 10.1128/JCM.36.10.3051-3054.1998; Vazquez N, 2006, J LEUKOCYTE BIOL, V80, P1136, DOI 10.1189/jlb.0306206	35	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2011	6	6							e21673	10.1371/journal.pone.0021673	http://dx.doi.org/10.1371/journal.pone.0021673			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	784FW	21738761	Green Published, gold, Green Submitted			2022-12-27	WOS:000292142800057
J	Lichten, LA; Ryu, MS; Guo, L; Embury, J; Cousins, RJ				Lichten, Louis A.; Ryu, Moon-Suhn; Guo, Liang; Embury, Jennifer; Cousins, Robert J.			MTF-1-Mediated Repression of the Zinc Transporter Zip10 Is Alleviated by Zinc Restriction	PLOS ONE			English	Article							TRANSCRIPTIONAL ACTIVATOR; TRACE-ELEMENTS; MAMMALIAN ZINC; MOUSE; GENE; EXPRESSION; BRAIN; PROMOTER; REGIONS; CANCER	The regulation of cellular zinc uptake is a key process in the overall mechanism governing mammalian zinc homeostasis and how zinc participates in cellular functions. We analyzed the zinc transporters of the Zip family in both the brain and liver of zinc-deficient animals and found a large, significant increase in Zip10 expression. Additionally, Zip10 expression decreased in response to zinc repletion. Moreover, isolated mouse hepatocytes, AML12 hepatocytes, and Neuro 2A cells also respond differentially to zinc availability in vitro. Measurement of Zip10 hnRNA and actinomycin D inhibition studies indicate that Zip10 was transcriptionally regulated by zinc deficiency. Through luciferase promoter constructs and ChIP analysis, binding of MTF-1 to a metal response element located 17 bp downstream of the transcription start site was shown to be necessary for zinc-induced repression of Zip10. Furthermore, zinc-activated MTF-1 causes down-regulation of Zip10 transcription by physically blocking Pol II movement through the gene. Lastly, ZIP10 is localized to the plasma membrane of hepatocytes and neuro 2A cells. Collectively, these results reveal a novel repressive role for MTF-1 in the regulation of the Zip10 zinc transporter expression by pausing Pol II transcription. ZIP10 may have roles in control of zinc homeostasis in specific sites particularly those of the brain and liver. Within that context ZIP10 may act as an important survival mechanism during periods of zinc inadequacy.	[Lichten, Louis A.; Ryu, Moon-Suhn; Guo, Liang; Cousins, Robert J.] Univ Florida, Dept Food Sci & Human Nutr, Coll Agr & Life Sci, Ctr Nutr Sci, Gainesville, FL 32611 USA; [Embury, Jennifer; Cousins, Robert J.] Univ Florida, Coll Med, Dept Biochem & Mol Biol, Gainesville, FL 32610 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida	Lichten, LA (corresponding author), Univ Florida, Dept Food Sci & Human Nutr, Coll Agr & Life Sci, Ctr Nutr Sci, Gainesville, FL 32611 USA.	cousins@ufl.edu		Ryu, Moon-Suhn/0000-0002-9533-9263; Guo, Liang/0000-0003-1633-1544	National Institute of Health [DK31127]; CALS Alumni Fellowships; University of Florida; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [Z01DK031127, R01DK031127, R37DK031127, R56DK031127] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CALS Alumni Fellowships; University of Florida(University of Florida); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Research described in this report was funded by National Institute of Health Grant DK31127 (RJC), CALS Alumni Fellowships (LAL and M-SR) and limited support from Boston Family Endowment Funds of the University of Florida. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar V, 2010, EMBO MOL MED, V2, P338, DOI 10.1002/emmm.201000089; Andreini C, 2006, J PROTEOME RES, V5, P196, DOI 10.1021/pr050361j; Bird AJ, 2004, EMBO J, V23, P1123, DOI 10.1038/sj.emboj.7600122; Chen H, 2004, J BIOL CHEM, V279, P50829, DOI 10.1074/jbc.M409173200; Chen HZ, 2009, NAT REV CANCER, V9, P785, DOI 10.1038/nrc2696; Chen L, 2006, NEUROSCI LETT, V409, P163, DOI 10.1016/j.neulet.2006.09.033; Choi DW, 1998, ANNU REV NEUROSCI, V21, P347, DOI 10.1146/annurev.neuro.21.1.347; Dufner-Beattie J, 2003, J BIOL CHEM, V278, P33474, DOI 10.1074/jbc.M305000200; Ehsani S, 2011, PROG NEUROBIOL, V93, P405, DOI 10.1016/j.pneurobio.2010.12.001; EIDE, 2006, BIOCHIM BIOPHYS ACTA, P711; Embury JE, 2005, PEDIATR RES, V58, P283, DOI 10.1203/01.PDR.0000170000.78670.44; Frederickson CJ, 2005, NAT REV NEUROSCI, V6, P449, DOI 10.1038/nrn1671; Gunes C, 1998, EMBO J, V17, P2846, DOI 10.1093/emboj/17.10.2846; Guo L, 2010, P NATL ACAD SCI USA, V107, P2818, DOI 10.1073/pnas.0914941107; Hogstrand C, 2008, BIOCHEM SOC T, V36, P1252, DOI 10.1042/BST0361252; Kagara N, 2007, CANCER SCI, V98, P692, DOI 10.1111/j.1349-7006.2007.00446.x; KING JC, 2005, MODERN NUTR HLTH DIS, P271; Langmade SJ, 2000, J BIOL CHEM, V275, P34803, DOI 10.1074/jbc.M007339200; Lichten LA, 2007, FASEB J, V21, pA170; Lichten LA, 2009, ANNU REV NUTR, V29, P153, DOI 10.1146/annurev-nutr-033009-083312; Lichten LA, 2009, AM J PHYSIOL-GASTR L, V296, pG860, DOI 10.1152/ajpgi.90676.2008; Lichtlen P, 2001, NUCLEIC ACIDS RES, V29, P1514, DOI 10.1093/nar/29.7.1514; LIPSON KE, 1989, P NATL ACAD SCI USA, V86, P9774, DOI 10.1073/pnas.86.24.9774; Lis J, 1998, COLD SPRING HARB SYM, V63, P347, DOI 10.1101/sqb.1998.63.347; Liuzzi JP, 2004, P NATL ACAD SCI USA, V101, P14355, DOI 10.1073/pnas.0406216101; Liuzzi JP, 2009, AM J PHYSIOL-GASTR L, V296, pG517, DOI 10.1152/ajpgi.90568.2008; MARGALIOTH EJ, 1983, CANCER, V52, P868, DOI 10.1002/1097-0142(19830901)52:5<868::AID-CNCR2820520521>3.0.CO;2-K; MCCABE MJ, 1993, LAB INVEST, V69, P101; McMahon RJ, 1998, P NATL ACAD SCI USA, V95, P4841, DOI 10.1073/pnas.95.9.4841; OLIN KL, 1995, AM J CLIN NUTR, V61, P1263, DOI 10.1093/ajcn/61.6.1263; PALMITER RD, 1995, EMBO J, V14, P639, DOI 10.1002/j.1460-2075.1995.tb07042.x; PROHASKA JR, 1987, PHYSIOL REV, V67, P858, DOI 10.1152/physrev.1987.67.3.858; RADTKE F, 1993, EMBO J, V12, P1355, DOI 10.1002/j.1460-2075.1993.tb05780.x; Ryu MS, 2008, J NUTR, V138, P2076, DOI 10.3945/jn.108.093575; Saunders A, 2006, NAT REV MOL CELL BIO, V7, P557, DOI 10.1038/nrm1981; Schmitt-Ulms G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007208; SCHWARTZ AE, 1974, SURGERY, V76, P325; Searle P F, 1987, Experientia Suppl, V52, P407; Shagal D I, 1980, Med Tekh, P32; Stoytcheva ZR, 2010, BBA-GEN SUBJECTS, V1800, P416, DOI 10.1016/j.bbagen.2009.11.003; STUART GW, 1985, NATURE, V317, P828, DOI 10.1038/317828a0; Takeda A, 2000, BRAIN RES, V859, P352, DOI 10.1016/S0006-8993(00)02027-8; Tarohda T, 2004, ANAL BIOANAL CHEM, V380, P240, DOI 10.1007/s00216-004-2697-8; Taylor KM, 2004, TRENDS ENDOCRIN MET, V15, P461, DOI 10.1016/j.tem.2004.10.003; Waldron KJ, 2009, NATURE, V460, P823, DOI 10.1038/nature08300; WALLWORK JC, 1983, J NUTR, V113, P1895, DOI 10.1093/jn/113.10.1895; Wang MH, 2010, MAMM GENOME, V21, P287, DOI 10.1007/s00335-010-9257-7; Watt NT, 2003, TRENDS BIOCHEM SCI, V28, P406, DOI 10.1016/S0968-0004(03)00166-X; Wimmer U, 2005, NUCLEIC ACIDS RES, V33, P5715, DOI 10.1093/nar/gki881; Wu C, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r130; XIAO H, 1989, MOL CELL BIOL, V9, P1746, DOI 10.1128/MCB.9.4.1746; Zeitlinger J, 2007, NAT GENET, V39, P1512, DOI 10.1038/ng.2007.26; Zheng DL, 2008, PHYSIOL GENOMICS, V34, P205, DOI 10.1152/physiolgenomics.90206.2008	53	83	85	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2011	6	6							e21526	10.1371/journal.pone.0021526	http://dx.doi.org/10.1371/journal.pone.0021526			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	783OD	21738690	gold, Green Published, Green Submitted			2022-12-27	WOS:000292092600050
J	Proulx-Bonneau, S; Guezguez, A; Annabi, B				Proulx-Bonneau, Sebastien; Guezguez, Amel; Annabi, Borhane			A Concerted HIF-1 alpha/MT1-MMP Signalling Axis Regulates the Expression of the 3BP2 Adaptor Protein in Hypoxic Mesenchymal Stromal Cells	PLOS ONE			English	Article							MEMBRANE-TYPE-1 MATRIX-METALLOPROTEINASE; ENDOTHELIAL GROWTH-FACTOR; STEM-CELLS; GLIOBLASTOMA CELLS; GLUCOSE-6-PHOSPHATE TRANSPORTER; INDUCIBLE FACTOR; GENE-EXPRESSION; UP-REGULATION; GLIOMA-CELLS; TUMOR-GROWTH	Increased plasticity, migratory and immunosuppressive abilities characterize mesenchymal stromal cells (MSC) which enable them to be active participants in the development of hypoxic solid tumours. Our understanding of the oncogenic adaptation of MSC to hypoxia however lacks the identification and characterization of specific biomarkers. In this study, we assessed the hypoxic regulation of 3BP2/SH3BP2 (Abl SH3-binding protein 2), an immune response adaptor/scaffold protein which regulates leukocyte differentiation and motility. Gene silencing of 3BP2 abrogated MSC migration in response to hypoxic cues and generation of MSC stably expressing the transcription factor hypoxia inducible factor 1alpha (HIF-1 alpha) resulted in increased endogenous 3BP2 expression as well as cell migration. Analysis of the 3BP2 promoter sequence revealed only one potential HIF-1 alpha binding site within the human but none in the murine sequence. An alternate early signalling cascade that regulated 3BP2 expression was found to involve membrane type-1 matrix metalloproteinase (MT1-MMP) transcriptional regulation which gene silencing abrogated 3BP2 expression in response to hypoxia. Collectively, we provide evidence for a concerted HIF-1 alpha/MT1-MMP signalling axis that explains the induction of adaptor protein 3BP2 and which may link protein binding partners together and stimulate oncogenic MSC migration. These mechanistic observations support the potential for malignant transformation of MSC within hypoxic tumour stroma and may contribute to evasion of the immune system by a tumour.	[Proulx-Bonneau, Sebastien; Guezguez, Amel; Annabi, Borhane] Univ Quebec, Dept Chim, Ctr Rech BIOMED, Oncol Mol Lab, Montreal, PQ H3C 3P8, Canada	University of Quebec; University of Quebec Montreal	Proulx-Bonneau, S (corresponding author), Univ Quebec, Dept Chim, Ctr Rech BIOMED, Oncol Mol Lab, Montreal, PQ H3C 3P8, Canada.	annabi.borhane@uqam.ca			Natural Sciences and Engineering Research Council of Canada (NSERC) [288249-2010]	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This study was funded by grants from the Natural Sciences and Engineering Research Council of Canada (NSERC; #288249-2010). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annabi B, 2005, J NEUROCHEM, V94, P906, DOI 10.1111/j.1471-4159.2005.03256.x; Annabi B, 2004, J BIOL CHEM, V279, P21888, DOI 10.1074/jbc.M313694200; Annabi B, 2003, EXP HEMATOL, V31, P640, DOI 10.1016/S0301-472X(03)00090-0; Annabi B, 2003, STEM CELLS, V21, P337, DOI 10.1634/stemcells.21-3-337; Annabi B, 2004, J CELL BIOCHEM, V91, P1146, DOI 10.1002/jcb.10763; Annabi B, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-8; Batten P, 2007, PHILOS T R SOC B, V362, P1343, DOI 10.1098/rstb.2007.2120; BelAiba RS, 2007, MOL BIOL CELL, V18, P4691, DOI 10.1091/mbc.E07-04-0391; Belkaid A, 2007, NEOPLASIA, V9, P332, DOI 10.1593/neo.07142; Belkaid A, 2006, CANCER CELL INT, V6, DOI 10.1186/1475-2867-6-7; Birnbaum T, 2007, J NEURO-ONCOL, V83, P241, DOI 10.1007/s11060-007-9332-4; Ceradini DJ, 2005, TRENDS CARDIOVAS MED, V15, P57, DOI 10.1016/j.tcm.2005.02.002; Chen G, 2007, MOL CELL BIOL, V27, P3109, DOI 10.1128/MCB.01014-06; Chi JT, 2006, PLOS MED, V3, P395, DOI 10.1371/journal.pmed.0030047; Currie JC, 2007, J BIOL CHEM, V282, P8142, DOI 10.1074/jbc.M610894200; Deckert M, 1998, IMMUNITY, V9, P595, DOI 10.1016/S1074-7613(00)80657-3; Deryugina EI, 2002, CANCER RES, V62, P580; Djouad F, 2003, BLOOD, V102, P3837, DOI 10.1182/blood-2003-04-1193; Du R, 2008, CANCER CELL, V13, P206, DOI 10.1016/j.ccr.2008.01.034; Dwyer RM, 2007, CLIN CANCER RES, V13, P5020, DOI 10.1158/1078-0432.CCR-07-0731; Eliasson P, 2010, J CELL PHYSIOL, V222, P17, DOI 10.1002/jcp.21908; Finger EC, 2010, CANCER METAST REV, V29, P285, DOI 10.1007/s10555-010-9224-5; Fortier S, 2008, FEBS LETT, V582, P799, DOI 10.1016/j.febslet.2008.01.061; Fortier S, 2008, GLYCOBIOLOGY, V18, P195, DOI 10.1093/glycob/cwm133; Gingras D, 2008, FEBS LETT, V582, P399, DOI 10.1016/j.febslet.2007.12.029; GRIGORIADIS N, 2011, EXP NEUROL IN PRESS; GuezGuez A, 2010, J BIOL CHEM, V285, P20952, DOI 10.1074/jbc.M109.091124; Haas TL, 1999, J BIOL CHEM, V274, P22679, DOI 10.1074/jbc.274.32.22679; Horwitz EM, 2005, CYTOTHERAPY, V7, P393, DOI 10.1080/14653240500319234; Joyce N, 2010, REGEN MED, V5, P933, DOI 10.2217/RME.10.72; Kajita M, 2001, J CELL BIOL, V153, P893, DOI 10.1083/jcb.153.5.893; Kanazawa H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019195; Karow M, 2009, J CELL MOL MED, V13, P2506, DOI 10.1111/j.1582-4934.2008.00619.x; Kaufman DS, 2010, NAT CELL BIOL, V12, P926, DOI 10.1038/ncb1010-926; Klyushnenkova E, 2005, J BIOMED SCI, V12, P47, DOI 10.1007/s11373-004-8183-7; Koh MY, 2010, RECENT RESULTS CANC, V180, P15, DOI 10.1007/978-3-540-78281-0_3; Koong AC, 2000, CANCER RES, V60, P883; Krampera M, 2003, BLOOD, V101, P3722, DOI 10.1182/blood-2002-07-2104; Langlois S, 2005, EXP CELL RES, V307, P452, DOI 10.1016/j.yexcr.2005.04.007; Le Bras S, 2007, FEBS LETT, V581, P967, DOI 10.1016/j.febslet.2007.01.084; Liu G, 2010, J IMMUNOL, V184, P3346, DOI 10.4049/jimmunol.0903789; Liu L, 2011, STEM CELLS IN PRESS; Lord-Dufour S, 2009, STEM CELLS, V27, P489, DOI 10.1634/stemcells.2008-0855; Mylotte LA, 2008, STEM CELLS, V26, P1325, DOI 10.1634/stemcells.2007-1072; Nakamizo A, 2005, CANCER RES, V65, P3307, DOI 10.1158/0008-5472.CAN-04-1874; Nyalendo C, 2007, J BIOL CHEM, V282, P15690, DOI 10.1074/jbc.M608045200; Oliver L, 2009, Curr Mol Pharmacol, V2, P263; Perasso L, 2010, NEURAL PLAST, V2010, DOI 10.1155/2010/534925; Potier E, 2007, BONE, V40, P1078, DOI 10.1016/j.bone.2006.11.024; Prockop DJ, 1997, SCIENCE, V276, P71, DOI 10.1126/science.276.5309.71; Ramirez-Bergeron DL, 2001, STEM CELLS, V19, P279, DOI 10.1634/stemcells.19-4-279; Rattigan Y, 2010, EXP CELL RES, V316, P3417, DOI 10.1016/j.yexcr.2010.07.002; REN RB, 1993, SCIENCE, V259, P1157, DOI 10.1126/science.8438166; Rosova I, 2008, STEM CELLS, V26, P2173, DOI 10.1634/stemcells.2007-1104; Sakamoto T, 2010, J BIOL CHEM, V285, P29951, DOI 10.1074/jbc.M110.132704; Schichor C, 2006, EXP NEUROL, V199, P301, DOI 10.1016/j.expneurol.2005.11.027; Shukla U, 2009, J BIOL CHEM, V284, P33719, DOI 10.1074/jbc.M109.049999; Sina A, 2010, J CELL COMMUN SIGNAL, V4, P31, DOI 10.1007/s12079-009-0084-0; SNYDER EY, 2011, EXP NEUROL IN PRESS; Sounni NE, 2002, FASEB J, V16, P555, DOI 10.1096/fj.01-0790com; Sperandio S, 2009, MOL CARCINOGEN, V48, P38, DOI 10.1002/mc.20454; Strongin AY, 2010, BBA-MOL CELL RES, V1803, P133, DOI 10.1016/j.bbamcr.2009.04.009; Studeny M, 2002, CANCER RES, V62, P3603; Tso CL, 2006, MOL CANCER RES, V4, P607, DOI 10.1158/1541-7786.MCR-06-0005; Uccelli A, 2011, BEST PRACT RES CL HA, V24, P59, DOI 10.1016/j.beha.2011.01.004; Van Meir EG, 2010, CA-CANCER J CLIN, V60, P166, DOI 10.3322/caac.20069; Yan SF, 1999, J BIOL CHEM, V274, P15030, DOI 10.1074/jbc.274.21.15030; Yen BL, 2008, J CANC MOL, V4, P5; Zhang Y, 2011, MOL BIOL RE IN PRESS	69	23	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2011	6	6							e21511	10.1371/journal.pone.0021511	http://dx.doi.org/10.1371/journal.pone.0021511			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	783OD	21738685	gold, Green Submitted, Green Published			2022-12-27	WOS:000292092600047
J	Sanchez-Partida, LG; Kelly, RDW; Sumer, H; Lo, CY; Aharon, R; Holland, MK; O'Bryan, MK; St John, JC				Sanchez-Partida, L. Gabriel; Kelly, Richard D. W.; Sumer, Huseyin; Lo, Camden Y.; Aharon, Rotem; Holland, Michael K.; O'Bryan, Moira K.; St John, Justin C.			The Generation of Live Offspring from Vitrified Oocytes	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; INTRACYTOPLASMIC SPERM INJECTION; MITOCHONDRIAL-DNA REPLICATION; MOUSE OOCYTES; LIQUID-NITROGEN; VIABLE BLASTOCYSTS; NUCLEAR TRANSFER; BOVINE OOCYTES; CRYOPRESERVATION; TREHALOSE	Oocyte cryopreservation is extremely beneficial for assisted reproductive technologies, the treatment of infertility and biotechnology and offers a viable alternative to embryo freezing and ovarian grafting approaches for the generation of embryonic stem cells and live offspring. It also offers the potential to store oocytes to rescue endangered species by somatic cell nuclear transfer and for the generation of embryonic stem cells to study development in these species. We vitrified mouse oocytes using a range of concentrations of trehalose (0 to 0.3 M) and demonstrated that 0.1 and 0.3 M trehalose had similar developmental rates, which were significantly different to the 0.2 M cohort (P < 0.05). As mitochondria are important for fertilisation outcome, we observed that the clustering and distribution of mitochondria of the 0.2 M cohort were more affected by vitifrication than the other groups. Nevertheless, all 3 cohorts were able to develop to blastocyst, following in vitro fertilisation, although developmental rates were better for the 0.1 and 0.3 M cohorts than the 0.2 M cohort (P < 0.05). Whilst blastocysts gave rise to embryonic stem-like cells, it was apparent from immunocytochemistry and RT-PCR that these cells did not demonstrate true pluripotency and exhibited abnormal karyotypes. However, they gave rise to teratomas following injection into SCID mice and differentiated into cells of each of the germinal layers following in vitro differentiation. The transfer of 2-cell embryos from the 0.1 and 0.3 M cohorts resulted in the birth of live offspring that had normal karyotypes (9/10). When 2-cell embryos from vitrified oocytes underwent vitrification, and were thawed and transferred, live offspring were obtained that exhibited normal karyotypes, with the exception of one offspring who was larger and died at 7 months. We conclude that these studies highlight the importance of the endometrial environment for the maintenance of genetic stability and thus the propagation of specific genetic traits.	[Sanchez-Partida, L. Gabriel; Kelly, Richard D. W.; Sumer, Huseyin; St John, Justin C.] Monash Univ, Ctr Reprod & Dev, Monash Inst Med Res, Clayton, Vic 3800, Australia; [Sanchez-Partida, L. Gabriel] Monash Univ, Australian Phen Network, Clayton, Vic 3800, Australia; [Kelly, Richard D. W.; St John, Justin C.] Univ Warwick, Mitochondrial & Reprod Genet Grp, Clin Sci Res Inst, Warwick Med Sch, Coventry CV4 7AL, W Midlands, England; [Lo, Camden Y.] Monash Univ, Sch Math Sci, Clayton, Vic 3800, Australia; [Aharon, Rotem] Monash Inst Med Res, Monash Micro Imaging MHTP, Clayton, Vic, Australia; [Holland, Michael K.] Univ Queensland, Sch Vet Sci, Brisbane, Qld, Australia; [O'Bryan, Moira K.] Monash Univ, Dept Anat & Dev Biol, Clayton, Vic 3800, Australia	Monash University; Monash University; University of Warwick; Monash University; Monash University; University of Queensland; Monash University	Sanchez-Partida, LG (corresponding author), Monash Univ, Ctr Reprod & Dev, Monash Inst Med Res, Clayton, Vic 3800, Australia.	justin.stjohn@monash.edu	Holland, Michael/AAS-5529-2021; Holland, Michael K/D-6911-2013; O'Bryan, Moira K/F-8256-2012; St. John, Justin C/A-2942-2010	Holland, Michael/0000-0003-0360-0098; Holland, Michael K/0000-0003-0360-0098; O'Bryan, Moira K/0000-0001-7298-4940; St. John, Jus/0000-0002-3993-1449; Lo, Camden/0000-0002-6215-2363; Sumer, Huseyin/0000-0001-9413-5579	Medical Research Council (UK); Australian Phenomics Network (an initiative of the Australian Government National Collaborative Research Infrastructure Strategy); Department of Education, Science and Technology, Australia; National Health and Medical Research Council	Medical Research Council (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Australian Phenomics Network (an initiative of the Australian Government National Collaborative Research Infrastructure Strategy)(Australian GovernmentDepartment of Industry, Innovation and Science); Department of Education, Science and Technology, Australia; National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This research was partially funded by the Medical Research Council (UK) and the Australian Phenomics Network (an initiative of the Australian Government National Collaborative Research Infrastructure Strategy). JCSJ received an Endeavour Award (Department of Education, Science and Technology, Australia) to undertake this work. MKOB is the recipient of a National Health and Medical Research Council Fellowship. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe Y, 2005, BIOL REPROD, V72, P1416, DOI 10.1095/biolreprod.104.037051; Ambrosini G, 2006, REPROD TOXICOL, V22, P250, DOI 10.1016/j.reprotox.2006.04.024; Ashworth CJ, 2009, PHILOS T R SOC B, V364, P3351, DOI 10.1098/rstb.2009.0184; BARRITT JA, 2001, REPROD BIOMED ONLINE, V3, P47; Bielanski A, 2000, CRYOBIOLOGY, V40, P110, DOI 10.1006/cryo.1999.2227; Biggers JD, 2000, BIOL REPROD, V63, P281, DOI 10.1095/biolreprod63.1.281; BOLTON VN, 1984, J EMBRYOL EXP MORPH, V79, P139; BOUQUET M, 1993, BIOL REPROD, V49, P764, DOI 10.1095/biolreprod49.4.764; Bowles EJ, 2007, CURR TOP DEV BIOL, V77, P251, DOI 10.1016/S0070-2153(06)77010-7; Campbell KHS, 1996, NATURE, V380, P64, DOI 10.1038/380064a0; Cobo A, 2010, FERTIL STERIL, V94, P1903, DOI 10.1016/j.fertnstert.2009.10.042; Cohen J, 1997, LANCET, V350, P186, DOI 10.1016/S0140-6736(05)62353-7; Coticchio G, 2004, EUR J OBSTET GYN R B, V115, pS2, DOI 10.1016/j.ejogrb.2004.01.006; CROWE LM, 1984, BIOCHIM BIOPHYS ACTA, V769, P141, DOI 10.1016/0005-2736(84)90017-8; Dinnyes A., 1995, Theriogenology, V43, P197, DOI 10.1016/0093-691X(95)92351-9; Doherty AS, 2000, BIOL REPROD, V62, P1526, DOI 10.1095/biolreprod62.6.1526; El Shourbagy SH, 2006, REPRODUCTION, V131, P233, DOI 10.1530/rep.1.00551; Eroglu A, 2009, BIOL REPROD, V80, P70, DOI 10.1095/biolreprod.108.070383; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Facucho-Oliveira JM, 2007, J CELL SCI, V120, P4025, DOI 10.1242/jcs.016972; FOOTE RH, 1993, J DAIRY SCI, V76, P1908, DOI 10.3168/jds.S0022-0302(93)77524-4; Fountain D, 1997, TRANSFUSION, V37, P585, DOI 10.1046/j.1537-2995.1997.37697335152.x; FRASER LR, 1984, J REPROD FERTIL, V72, P373, DOI 10.1530/jrf.0.0720373; Gardner DK, 1997, HUM REPROD UPDATE, V3, P367, DOI 10.1093/humupd/3.4.367; Gutierrez-Perez O, 2009, CRYOBIOLOGY, V58, P287, DOI 10.1016/j.cryobiol.2009.02.003; HONADEL TE, 1988, CRYOBIOLOGY, V25, P331, DOI 10.1016/0011-2240(88)90041-7; Jain JK, 2006, FERTIL STERIL, V86, P1037, DOI 10.1016/j.fertnstert.2006.07.1478; KASAI M, 1980, J REPROD FERTIL, V59, P51, DOI 10.1530/jrf.0.0590051; KAZEM R, 1995, HUM REPROD, V10, P2650, DOI 10.1093/oxfordjournals.humrep.a135761; KELLER GM, 1995, CURR OPIN CELL BIOL, V7, P862, DOI 10.1016/0955-0674(95)80071-9; Lacham-Kaplan O, 2003, BIOL REPROD, V69, P1683, DOI 10.1095/biolreprod.103.018184; Lane M, 2001, MOL REPROD DEV, V58, P342, DOI 10.1002/1098-2795(200103)58:3&lt;342::AID-MRD13&gt;3.0.CO;2-X; Martino A, 1996, BIOL REPROD, V54, P1059, DOI 10.1095/biolreprod54.5.1059; Mavrides A, 2005, EUR J OBSTET GYN R B, V118, P66, DOI 10.1016/j.ejogrb.2004.06.025; McGinnis LK, 2005, BIOL REPROD, V73, P627, DOI 10.1095/biolreprod.105.042291; Mullen SF, 2004, HUM REPROD, V19, P1148, DOI 10.1093/humrep/deh201; NICOLSON GL, 1975, J CELL BIOL, V66, P263, DOI 10.1083/jcb.66.2.263; Parmegiani L, 2010, FERTIL STERIL, V94, P1525, DOI 10.1016/j.fertnstert.2009.05.089; Ramalho-Santos J, 2009, HUM REPROD UPDATE, V15, P553, DOI 10.1093/humupd/dmp016; Sanchez-Partida LG, 1998, REPROD FERT DEVELOP, V10, P347, DOI 10.1071/R98053; Sanchez-Partida LG, 2008, FERTIL STERIL, V89, P742, DOI 10.1016/j.fertnstert.2007.02.066; Santos TA, 2006, FERTIL STERIL, V85, P584, DOI 10.1016/j.fertnstert.2005.09.017; SATHANANTHAN AH, 1988, GAMETE RES, V21, P385, DOI 10.1002/mrd.1120210407; Spikings EC, 2007, BIOL REPROD, V76, P327, DOI 10.1095/biolreprod.106.054536; Stachecki JJ, 2002, CRYOBIOLOGY, V44, P5, DOI 10.1016/S0011-2240(02)00007-X; Tao T, 2008, J ASSIST REPROD GEN, V25, P287, DOI 10.1007/s10815-008-9236-z; Thouas GA, 2006, BIOL REPROD, V74, P969, DOI 10.1095/biolreprod.105.048611; Vajta G, 1998, MOL REPROD DEV, V51, P53, DOI 10.1002/(SICI)1098-2795(199809)51:1&lt;53::AID-MRD6&gt;3.0.CO;2-V; VANDERELST J, 1992, CRYOBIOLOGY, V29, P549, DOI 10.1016/0011-2240(92)90060-F; VINCENT C, 1990, J REPROD FERTIL, V89, P253, DOI 10.1530/jrf.0.0890253; Wilding M, 2001, HUM REPROD, V16, P909, DOI 10.1093/humrep/16.5.909; Wilmut I, 1997, NATURE, V385, P810, DOI 10.1038/385810a0; Zhang XB, 2003, TRANSFUSION, V43, P265, DOI 10.1046/j.1537-2995.2003.00301.x	53	14	19	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2011	6	6							e21597	10.1371/journal.pone.0021597	http://dx.doi.org/10.1371/journal.pone.0021597			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	783OD	21738724	gold, Green Published, Green Submitted			2022-12-27	WOS:000292092600059
J	Atsak, P; Orre, M; Bakker, P; Cerliani, L; Roozendaal, B; Gazzola, V; Moita, M; Keysers, C				Atsak, Piray; Orre, Marie; Bakker, Petra; Cerliani, Leonardo; Roozendaal, Benno; Gazzola, Valeria; Moita, Marta; Keysers, Christian			Experience Modulates Vicarious Freezing in Rats: A Model for Empathy	PLOS ONE			English	Article							SEX-DIFFERENCES; ACTION REPRESENTATION; SOCIAL TRANSMISSION; ULTRASONIC CALLS; MIRROR NEURONS; ESTROUS-CYCLE; FEMALE RATS; PAIN; FEAR; RESPONSES	The study of the neural basis of emotional empathy has received a surge of interest in recent years but mostly employing human neuroimaging. A simpler animal model would pave the way for systematic single cell recordings and invasive manipulations of the brain regions implicated in empathy. Recent evidence has been put forward for the existence of empathy in rodents. In this study, we describe a potential model of empathy in female rats, in which we studied interactions between two rats: a witness observes a demonstrator experiencing a series of footshocks. By comparing the reaction of witnesses with or without previous footshock experience, we examine the role of prior experience as a modulator of empathy. We show that witnesses having previously experienced footshocks, but not naive ones, display vicarious freezing behavior upon witnessing a cage-mate experiencing footshocks. Strikingly, the demonstrator's behavior was in turn modulated by the behavior of the witness: demonstrators froze more following footshocks if their witness froze more. Previous experiments have shown that rats emit ultrasonic vocalizations (USVs) when receiving footshocks. Thus, the role of USV in triggering vicarious freezing in our paradigm is examined. We found that experienced witness-demonstrator pairs emitted more USVs than naive witness-demonstrator pairs, but the number of USVs was correlated with freezing in demonstrators, not in witnesses. Furthermore, playing back the USVs, recorded from witness-demonstrator pairs during the empathy test, did not induce vicarious freezing behavior in experienced witnesses. Thus, our findings confirm that vicarious freezing can be triggered in rats, and moreover it can be modulated by prior experience. Additionally, our result suggests that vicarious freezing is not triggered by USVs per se and it influences back onto the behavior of the demonstrator that had elicited the vicarious freezing in witnesses, introducing a paradigm to study empathy as a social loop.	[Atsak, Piray; Orre, Marie; Bakker, Petra; Cerliani, Leonardo; Roozendaal, Benno; Gazzola, Valeria; Keysers, Christian] Univ Groningen, Univ Med Ctr Groningen, Dept Neurosci, NL-9713 AV Groningen, Netherlands; [Orre, Marie; Cerliani, Leonardo; Gazzola, Valeria; Keysers, Christian] Netherlands Inst Neurosci, Amsterdam, Netherlands; [Moita, Marta] Inst Gulbenkian Ciencias, Champalimaud Neurosci Programme, Oeiras, Portugal	University of Groningen; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW); Fundacao Champalimaud; Instituto Gulbenkian de Ciencia	Atsak, P (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Neurosci, NL-9713 AV Groningen, Netherlands.	c.keysers@nin.knaw.nl	Roozendaal, Benno/B-8403-2013; Atsak, Piray/GPX-9702-2022; Atsak, piray/I-5880-2013; Atsak, Piray/AAB-1451-2019; Keysers, Christian/H-6251-2013	Atsak, Piray/0000-0003-1828-2061; Keysers, Christian/0000-0002-2845-5467; Moita, Marta/0000-0002-5144-6905; cerliani, leonardo/0000-0002-2655-6133; Gazzola, Valeria/0000-0003-0324-0619; Bakker, Petra/0000-0001-7019-0258	NWO VIDI [452-04-305]; European Marie Curie Excellence grant [MEXT-CT-2005-023253]	NWO VIDI(Netherlands Organization for Scientific Research (NWO)); European Marie Curie Excellence grant	This work was supported by the NWO VIDI grant (452-04-305) and European Marie Curie Excellence grant (MEXT-CT-2005-023253) to CK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander GM, 2002, EVOL HUM BEHAV, V23, P467, DOI 10.1016/S1090-5138(02)00107-1; Allen TA, 2007, BEHAV BRAIN RES, V182, P327, DOI 10.1016/j.bbr.2007.03.009; Avenanti A, 2006, NEUROIMAGE, V32, P316, DOI 10.1016/j.neuroimage.2006.03.010; Bang SJ, 2008, NEUROBIOL LEARN MEM, V90, P200, DOI 10.1016/j.nlm.2008.02.009; Baron-Cohen S, 2004, J AUTISM DEV DISORD, V34, P163, DOI 10.1023/B:JADD.0000022607.19833.00; Baron-Cohen S, 2005, SCIENCE, V310, P819, DOI 10.1126/science.1115455; Bastiaansen JACJ, 2009, PHILOS T R SOC B, V364, P2391, DOI 10.1098/rstb.2009.0058; BLANCHARD RJ, 1991, PHYSIOL BEHAV, V50, P967, DOI 10.1016/0031-9384(91)90423-L; Brechbuhl J, 2008, SCIENCE, V321, P1092, DOI 10.1126/science.1160770; Bredy TW, 2009, LEARN MEMORY, V16, P12, DOI 10.1101/lm.1226009; Bruchey AK, 2010, BEHAV BRAIN RES, V214, P80, DOI 10.1016/j.bbr.2010.04.047; Brudzynski S, 1995, PHYSL BEHAV; Brudzynski SM, 2005, BEHAV GENET, V35, P85, DOI 10.1007/s10519-004-0858-3; Brudzynski SM, 2007, BEHAV BRAIN RES, V182, P261, DOI 10.1016/j.bbr.2007.03.004; Burgdorf J, 2005, BEHAV GENET, V35, P67, DOI 10.1007/s10519-004-0856-5; Caggiano V, 2009, SCIENCE, V324, P403, DOI 10.1126/science.1166818; Carr L, 2003, P NATL ACAD SCI USA, V100, P5497, DOI 10.1073/pnas.0935845100; Chen QL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004387; Chen W, 2009, BEHAV BRAIN RES, V201, P8, DOI 10.1016/j.bbr.2009.01.019; Cheng Y, 2009, NEUROSCIENCE, V158, P713, DOI 10.1016/j.neuroscience.2008.10.026; Cheng YW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002113; CHURCH RM, 1959, J COMP PHYSIOL PSYCH, V52, P132, DOI 10.1037/h0043531; Connellan J, 2000, INFANT BEHAV DEV; de Vignemont F, 2006, TRENDS COGN SCI, V10, P435, DOI 10.1016/j.tics.2006.08.008; de Waal FBM, 2008, ANNU REV PSYCHOL, V59, P279, DOI 10.1146/annurev.psych.59.103006.093625; Decety J, 2006, THESCIENTIFICWORLDJO, V6, P1146, DOI 10.1100/tsw.2006.221; Decety J, 2006, CURR DIR PSYCHOL SCI, V15, P54, DOI 10.1111/j.0963-7214.2006.00406.x; Ehret G, 2005, BEHAV GENET, V35, P19, DOI 10.1007/s10519-004-0853-8; EISENBERG N, 1983, PSYCHOL BULL, V94, P100, DOI 10.1037/0033-2909.94.1.100; Etzel JA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003690; Fogassi L, 2005, SCIENCE, V308, P662, DOI 10.1126/science.1106138; Frye CA, 2000, PHARMACOL BIOCHEM BE, V67, P587, DOI 10.1016/S0091-3057(00)00392-0; Fujii N, 2008, SOC NEUROSCI-UK, V3, P250, DOI 10.1080/17470910701434610; GALEF BG, 1985, BEHAV NEURAL BIOL, V43, P298, DOI 10.1016/S0163-1047(85)91645-0; GALEF BG, 1985, ANN NY ACAD SCI, V443, P203, DOI 10.1111/j.1749-6632.1985.tb27074.x; Gallese V, 1996, BRAIN, V119, P593, DOI 10.1093/brain/119.2.593; Gazzola V, 2006, CURR BIOL, V16, P1824, DOI 10.1016/j.cub.2006.07.072; Hiroi R, 2006, BEHAV BRAIN RES, V166, P93, DOI 10.1016/j.bbr.2005.07.021; HOFFMAN ML, 1977, PSYCHOL BULL, V84, P712, DOI 10.1037/0033-2909.84.4.712; Hutchison WD, 1999, NAT NEUROSCI, V2, P403, DOI 10.1038/8065; Jabbi M, 2007, NEUROIMAGE, V34, P1744, DOI 10.1016/j.neuroimage.2006.10.032; Jabbi M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002939; Jabbi M, 2008, EMOTION, V8, P775, DOI 10.1037/a0014194; Jackson PL, 2005, NEUROIMAGE, V24, P771, DOI 10.1016/j.neuroimage.2004.09.006; Jeon D, 2010, NAT NEUROSCI, V13, P482, DOI 10.1038/nn.2504; Keysers C, 2004, NEURON, V42, P335, DOI 10.1016/S0896-6273(04)00156-4; Keysers C, 2004, TRENDS COGN SCI, V8, P501, DOI 10.1016/j.tics.2004.09.005; Keysers C, 2003, EXP BRAIN RES, V153, P628, DOI 10.1007/s00221-003-1603-5; Keysers C, 2006, PROG BRAIN RES, V156, P379, DOI 10.1016/S0079-6123(06)56021-2; Keysers C, 2010, NAT REV NEUROSCI, V11, P417, DOI 10.1038/nrn2833; Keysers C, 2009, CURR OPIN NEUROBIOL, V19, P666, DOI 10.1016/j.conb.2009.10.006; Kim EJ, 2010, PLOS ONE, V5; Kiyokawa Y, 2004, BEHAV NEUROSCI, V118, P798, DOI 10.1037/0735-7044.118.4.798; Knapska E, 2006, P NATL ACAD SCI USA, V103, P3858, DOI 10.1073/pnas.0511302103; Knapska E, 2010, LEARN MEMORY, V17, P824, DOI 10.1101/lm.1670910; Kohler E, 2002, SCIENCE, V297, P846, DOI 10.1126/science.1070311; KOHN B, 1972, J COMP PHYSIOL PSYCH, V78, P292, DOI 10.1037/h0032298; Lahav A, 2007, J NEUROSCI, V27, P308, DOI 10.1523/JNEUROSCI.4822-06.2007; Langford DJ, 2006, SCIENCE, V312, P1967, DOI 10.1126/science.1128322; Li W, 2008, SCIENCE, V319, P1842, DOI 10.1126/science.1152837; Marcondes FK, 2001, PHYSIOL BEHAV, V74, P435, DOI 10.1016/S0031-9384(01)00593-5; Masuda A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006794; Mongeau R, 2003, J NEUROSCI, V23, P3855; Morrison I, 2004, COGN AFFECT BEHAV NE, V4, P270, DOI 10.3758/CABN.4.2.270; Mukamel R, 2010, CURR BIOL, V20, P750, DOI 10.1016/j.cub.2010.02.045; Panksepp J, 2000, BEHAV BRAIN RES, V115, P25, DOI 10.1016/S0166-4328(00)00238-2; Preston SD, 2002, BEHAV BRAIN SCI, V25, P1, DOI 10.1017/S0140525X02000018; Rozzi S, 2008, EUR J NEUROSCI, V28, P1569, DOI 10.1111/j.1460-9568.2008.06395.x; Singer T, 2004, SCIENCE, V303, P1157, DOI 10.1126/science.1093535; Singer T, 2006, NATURE, V439, P466, DOI 10.1038/nature04271; Singer T, 2009, ANN NY ACAD SCI, V1156, P81, DOI 10.1111/j.1749-6632.2009.04418.x; Stack A, 2010, NEUROPSYCHOPHARMACOL, V35, P570, DOI 10.1038/npp.2009.163; Umilta MA, 2001, NEURON, V31, P155, DOI 10.1016/S0896-6273(01)00337-3; WATANABE S, 1986, BEHAV PROCESS, V13, P269, DOI 10.1016/0376-6357(86)90089-6; Westenbroek C, 2005, HORM BEHAV, V47, P620, DOI 10.1016/j.yhbeh.2005.01.004; Westenbroek C, 2003, PROG NEURO-PSYCHOPH, V27, P21, DOI 10.1016/S0278-5846(02)00310-X; Wicker B, 2003, NEURON, V40, P655, DOI 10.1016/S0896-6273(03)00679-2; Wohr M, 2005, NEUROBIOL LEARN MEM, V84, P228, DOI 10.1016/j.nlm.2005.07.004; Yee JR, 2010, BRAIN BEHAV IMMUN, V24, P942, DOI 10.1016/j.bbi.2010.03.006; ZENTALL TR, 1972, SCIENCE, V178, P1220, DOI 10.1126/science.178.4066.1220	80	110	110	0	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2011	6	7							e21855	10.1371/journal.pone.0021855	http://dx.doi.org/10.1371/journal.pone.0021855			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	792WQ	21765921	Green Published, Green Submitted, gold			2022-12-27	WOS:000292781500020
J	Rassouli, O; Liapakis, G; Lazaridis, I; Sakellaris, G; Gkountelias, K; Gravanis, A; Margioris, AN; Karalis, KP; Venihaki, M				Rassouli, Olga; Liapakis, George; Lazaridis, Iakovos; Sakellaris, George; Gkountelias, Kostas; Gravanis, Achille; Margioris, Andrew N.; Karalis, Katia P.; Venihaki, Maria			A Novel Role of Peripheral Corticotropin-Releasing Hormone (CRH) on Dermal Fibroblasts	PLOS ONE			English	Article							HUMAN LUNG FIBROBLASTS; IL-6-DEFICIENT MICE; KNOCKOUT MICE; MOUSE SKIN; EXPRESSION; INTERLEUKIN-6; RECEPTOR; SYSTEM; CELLS; PROLIFERATION	Corticotropin-releasing hormone, or factor, (CRH or CRF) exerts important biological effects in multiple peripheral tissues via paracrine/autocrine actions. The aim of our study was to assess the effects of endogenous CRH in the biology of mouse and human skin fibroblasts, the primary cell type involved in wound healing. We show expression of CRH and its receptors in primary fibroblasts, and we demonstrate the functionality of fibroblast CRH receptors by induction of cAMP. Fibroblasts genetically deficient in Crh (Crh-/-) had higher proliferation and migration rates and compromised production of IL-6 and TGF-b1 compared to the wildtype (Crh+/+) cells. Human primary cultures of foreskin fibroblasts exposed to the CRF(1) antagonist antalarmin recapitulated the findings in the Crh-/- cells, exhibiting altered proliferative and migratory behavior and suppressed production of IL-6. In conclusion, our findings show an important role of fibroblast-expressed CRH in the proliferation, migration, and cytokine production of these cells, processes associated with the skin response to injury. Our data suggest that the immunomodulatory effects of CRH may include an important, albeit not explored yet, role in epidermal tissue remodeling and regeneration and maintenance of tissue homeostasis.	[Rassouli, Olga; Margioris, Andrew N.; Venihaki, Maria] Univ Crete, Sch Med, Dept Clin Chem, Iraklion, Crete, Greece; [Liapakis, George; Lazaridis, Iakovos; Gkountelias, Kostas; Gravanis, Achille] Univ Crete, Sch Med, Dept Pharmacol, Iraklion, Crete, Greece; [Sakellaris, George] Univ Hosp Herakl, Dept Pediat Surg, Iraklion, Greece; [Karalis, Katia P.] Acad Athens, Dev Biol Sect, Biomed Res Fdn, Athens, Greece; [Karalis, Katia P.] Childrens Hosp, Div Endocrinol, Boston, MA 02115 USA	University of Crete; University of Crete; University Hospital of Heraklion; Academy of Athens; Harvard University; Boston Children's Hospital	Rassouli, O (corresponding author), Univ Crete, Sch Med, Dept Clin Chem, Iraklion, Crete, Greece.	venihaki@med.uoc.gr		Lazaridis, Iakovos/0000-0002-4578-2347	PENED; E.U.; Greek Ministry of Development-GSRT; Manasaki Fellowship	PENED(Greek Ministry of Development-GSRT); E.U.(European Commission); Greek Ministry of Development-GSRT(Greek Ministry of Development-GSRT); Manasaki Fellowship	This work was supported in part by PENED [grant cofinanced by E.U.-European Social Fund (75%) and the Greek Ministry of Development-GSRT (25%)] to KK and a Manasaki Fellowship to OR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANGIONI S, 1993, LIFE SCI, V53, P1735, DOI 10.1016/0024-3205(93)90160-5; Arck PC, 2006, J INVEST DERMATOL, V126, P1697, DOI 10.1038/sj.jid.5700104; Ashcroft GS, 1999, NAT CELL BIOL, V1, P260, DOI 10.1038/12971; Berthier F, 1999, CLIN CHEM LAB MED, V37, P593, DOI 10.1515/CCLM.1999.092; CHROUSOS GP, 1995, NEW ENGL J MED, V332, P1351, DOI 10.1056/NEJM199505183322008; Crofford LJ, 1995, ANN NY ACAD SCI, V771, P459, DOI 10.1111/j.1749-6632.1995.tb44702.x; Crowe MJ, 2000, J INVEST DERMATOL, V115, P3, DOI 10.1046/j.1523-1747.2000.00010.x; Eickelberg O, 1999, J BIOL CHEM, V274, P12933, DOI 10.1074/jbc.274.18.12933; Gabbiani G, 2003, J PATHOL, V200, P500, DOI 10.1002/path.1427; Gallelli L, 2008, CELL PROLIFERAT, V41, P393, DOI 10.1111/j.1365-2184.2008.00538.x; Gallucci RM, 2006, J INVEST DERMATOL, V126, P561, DOI 10.1038/sj.jid.5700109; Gallucci RM, 2000, FASEB J, V14, P2525, DOI 10.1096/fj.00-0073com; Ganceviciene R, 2009, BRIT J DERMATOL, V160, P345, DOI 10.1111/j.1365-2133.2008.08959.x; Gkountelias K, 2009, MOL PHARMACOL, V75, P793, DOI 10.1124/mol.108.052423; Itoi K, 2004, J NEUROENDOCRINOL, V16, P348, DOI 10.1111/j.0953-8194.2004.01172.x; Karalis K, 1997, J NEUROIMMUNOL, V72, P131, DOI 10.1016/S0165-5728(96)00178-6; KARALIS K, 1991, SCIENCE, V254, P421, DOI 10.1126/science.1925600; Karalis KP, 1999, P NATL ACAD SCI USA, V96, P7093, DOI 10.1073/pnas.96.12.7093; Kondo T, 1996, INT J LEGAL MED, V108, P231, DOI 10.1007/BF01369816; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Luckett-Chastain LR, 2009, BRIT J DERMATOL, V161, P237, DOI 10.1111/j.1365-2133.2009.09215.x; Martin P, 1997, SCIENCE, V276, P75, DOI 10.1126/science.276.5309.75; MUGLIA L, 1995, NATURE, V373, P427, DOI 10.1038/373427a0; Papakonstanti EA, 1998, J CELL BIOCHEM, V70, P60, DOI 10.1002/(SICI)1097-4644(19980701)70:1<60::AID-JCB7>3.0.CO;2-1; Paquet P, 1996, INT ARCH ALLERGY IMM, V109, P308, DOI 10.1159/000237257; Pisarchik A, 2001, FASEB J, V15, P2754, DOI 10.1096/fj.01-0487fje; Roloff B, 1998, FASEB J, V12, P287, DOI 10.1096/fasebj.12.3.287; SEHGAL PB, 1990, J INVEST DERMATOL, V94, pS2, DOI 10.1111/1523-1747.ep12874963; SINGH VK, 1989, J NEUROIMMUNOL, V23, P257, DOI 10.1016/0165-5728(89)90058-1; SINGH VK, 1990, NEUROSCI LETT, V120, P151, DOI 10.1016/0304-3940(90)90025-5; Slominski A, 2000, PHYSIOL REV, V80, P979, DOI 10.1152/physrev.2000.80.3.979; Slominski A, 2005, J NEUROIMMUNOL, V162, P97, DOI 10.1016/j.jneuroim.2005.01.014; Slominski A, 2001, FASEB J, V15, P1678, DOI 10.1096/fj.00-0850rev; Slominski A, 2006, J CELL PHYSIOL, V206, P780, DOI 10.1002/jcp.20530; Sugawara T, 2001, CYTOKINE, V15, P328, DOI 10.1006/cyto.2001.0946; Venihaki M, 2001, J CLIN INVEST, V108, P1159, DOI 10.1172/JCI12869; Venihaki M, 2003, J NEUROIMMUNOL, V141, P3, DOI 10.1016/S0165-5728(03)00183-8; Venihaki M, 2002, NEUROPEPTIDES, V36, P96, DOI 10.1054/npep.2002.0906; Venihaki M, 1996, PEPTIDES, V17, P413, DOI 10.1016/0196-9781(96)00023-X; Werner S, 2007, J INVEST DERMATOL, V127, P998, DOI 10.1038/sj.jid.5700786; Yates CC, 2007, AM J PATHOL, V171, P484, DOI 10.2353/ajpath.2007.061092; Zbytek B, 2002, LIFE SCI, V70, P1013, DOI 10.1016/S0024-3205(01)01476-X	42	16	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2011	6	7							e21654	10.1371/journal.pone.0021654	http://dx.doi.org/10.1371/journal.pone.0021654			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	792WQ	21765902	Green Published, gold, Green Submitted			2022-12-27	WOS:000292781500008
J	Vinatier, F; Lescourret, F; Duyck, PF; Martin, O; Senoussi, R; Tixier, P				Vinatier, Fabrice; Lescourret, Francoise; Duyck, Pierre-Francois; Martin, Olivier; Senoussi, Rachid; Tixier, Philippe			Should I Stay or Should I Go? A Habitat-Dependent Dispersal Kernel Improves Prediction of Movement	PLOS ONE			English	Article							LEVEL PERCEPTUAL ABILITIES; FORAGING BEHAVIOR; SPACE USE; LANDSCAPE; RANGE; AVAILABILITY; SELECTION; INSECT; MODEL	The analysis of animal movement within different landscapes may increase our understanding of how landscape features affect the perceptual range of animals. Perceptual range is linked to movement probability of an animal via a dispersal kernel, the latter being generally considered as spatially invariant but could be spatially affected. We hypothesize that spatial plasticity of an animal's dispersal kernel could greatly modify its distribution in time and space. After radio tracking the movements of walking insects (Cosmopolites sordidus) in banana plantations, we considered the movements of individuals as states of a Markov chain whose transition probabilities depended on the habitat characteristics of current and target locations. Combining a likelihood procedure and pattern-oriented modelling, we tested the hypothesis that dispersal kernel depended on habitat features. Our results were consistent with the concept that animal dispersal kernel depends on habitat features. Recognizing the plasticity of animal movement probabilities will provide insight into landscape-level ecological processes.	[Vinatier, Fabrice; Duyck, Pierre-Francois; Tixier, Philippe] CIRAD, UPR26, Le Lamentin, Martinique, France; [Lescourret, Francoise] INRA, UR 1115, Avignon, France; [Martin, Olivier; Senoussi, Rachid] INRA, UR 546, Avignon, France	CIRAD; INRAE; INRAE	Vinatier, F (corresponding author), CIRAD, UPR26, Le Lamentin, Martinique, France.	fabrice.vinatier@grignon.inra.fr	Duyck, Pierre-François/C-2416-2008; Vinatier, Fabrice/AAF-7014-2020; Tixier, Philippe/C-2119-2008; Vinatier, Fabrice/B-4532-2011	Duyck, Pierre-François/0000-0001-5484-1970; Tixier, Philippe/0000-0001-5147-9777; Lescourret, Francoise/0000-0002-6576-8067; Vinatier, Fabrice/0000-0003-3693-4422	CIRAD [07-259/NH]; French Ministry of Ecology, Sustainable Development [CV070000779]; E.U. FEFER [30411]	CIRAD; French Ministry of Ecology, Sustainable Development; E.U. FEFER	This work is part of a Ph.D study funded by the CIRAD (http://www.cirad.fr) with the contract number: 07-259/NH. Project SYBAN from the French Ministry of Ecology, Sustainable Development (grant noCV070000779) and Project "sustainable cropping systems design" from E.U. FEFER (grant PRESAGE no30411) have also funded the work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arthur SM, 1996, ECOLOGY, V77, P215, DOI 10.2307/2265671; Bianchi FJJA, 2009, OIKOS, V118, P1363, DOI 10.1111/j.1600-0706.2009.17319.x; Brouwers NC, 2009, LANDSCAPE ECOL, V24, P199, DOI 10.1007/s10980-008-9298-4; Chapman DS, 2007, OECOLOGIA, V154, P55, DOI 10.1007/s00442-007-0806-z; Flaherty EA, 2008, CAN J ZOOL, V86, P1050, DOI 10.1139/Z08-084; Fortin D, 2005, ECOLOGY, V86, P1320, DOI 10.1890/04-0953; Gold Clifford S., 2002, Integrated Pest Management Reviews, V6, P79, DOI 10.1023/A:1023330900707; Grimm V, 2005, SCIENCE, V310, P987, DOI 10.1126/science.1116681; Huffaker CB, 1999, ECOLOGICAL ENTOMOLOG; JANDER R, 1975, ANNU REV ECOL SYST, V6, P171, DOI 10.1146/annurev.es.06.110175.001131; Kot M, 1996, ECOLOGY, V77, P2027, DOI 10.2307/2265698; Lenth R., 2019, Journal of Statistical Software, V60, P1; Lima SL, 1996, TRENDS ECOL EVOL, V11, P131, DOI 10.1016/0169-5347(96)81094-9; Lindstrom T, 2008, ECOLOGY, V89, P1784, DOI 10.1890/07-1363.1; Lindstrom T, 2011, P ROY SOC B-BIOL SCI, V278, P1564, DOI 10.1098/rspb.2010.1902; Marzluff JM, 2004, ECOLOGY, V85, P1411, DOI 10.1890/03-0114; Matthiopoulos J, 2004, J APPL ECOL, V41, P476, DOI 10.1111/j.0021-8901.2004.00911.x; NELDER JA, 1965, COMPUT J, V7, P308, DOI 10.1093/comjnl/7.4.308; Olden JD, 2004, J ANIM ECOL, V73, P1190, DOI 10.1111/j.0021-8790.2004.00889.x; Patterson TA, 2008, TRENDS ECOL EVOL, V23, P87, DOI 10.1016/j.tree.2007.10.009; Phillips BL, 2008, AM NAT, V172, pS34, DOI 10.1086/588255; Pinaud D, 2007, J ANIM ECOL, V76, P9, DOI 10.1111/j.1365-2656.2006.01186.x; Prevedello JA, 2010, J ANIM ECOL, V79, P1315, DOI 10.1111/j.1365-2656.2010.01736.x; Rabasa SG, 2005, ECOGRAPHY, V28, P629, DOI 10.1111/j.2005.0906-7590.04229.x; Rhodes JR, 2005, ECOLOGY, V86, P1199, DOI 10.1890/04-0912; Schick RS, 2008, ECOL LETT, V11, P1338, DOI 10.1111/j.1461-0248.2008.01249.x; Schooley RL, 2003, OIKOS, V102, P559, DOI 10.1034/j.1600-0706.2003.12490.x; Searle KR, 2005, OIKOS, V111, P417, DOI 10.1111/j.0030-1299.2005.13918.x; STEPHENS MA, 1970, J ROY STAT SOC B, V32, P115; Vinatier F, 2011, METHODS ECOL EVOL, V2, P11, DOI 10.1111/j.2041-210X.2010.00059.x; Vinatier F, 2010, ANIM BEHAV, V80, P221, DOI 10.1016/j.anbehav.2010.04.022; Vinatier F, 2009, ECOL MODEL, V220, P2244, DOI 10.1016/j.ecolmodel.2009.06.023; Walters RJ, 2006, P ROY SOC B-BIOL SCI, V273, P2017, DOI 10.1098/rspb.2006.3542; Zollner PA, 2005, OIKOS, V108, P219, DOI 10.1111/j.0030-1299.2005.13711.x; Zollner PA, 1997, OIKOS, V80, P51, DOI 10.2307/3546515; Zollner PA, 2000, LANDSCAPE ECOL, V15, P523, DOI 10.1023/A:1008154532512	36	23	23	1	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2011	6	7							e21115	10.1371/journal.pone.0021115	http://dx.doi.org/10.1371/journal.pone.0021115			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791WM	21765890	Green Published, gold			2022-12-27	WOS:000292699000003
J	Kiliszek, M; Franaszczyk, M; Kozluk, E; Lodzinski, P; Piatkowska, A; Broda, G; Ploski, R; Opolski, G				Kiliszek, Marek; Franaszczyk, Maria; Kozluk, Edward; Lodzinski, Piotr; Piatkowska, Agnieszka; Broda, Grazyna; Ploski, Rafal; Opolski, Grzegorz			Association between Variants on Chromosome 4q25, 16q22 and 1q21 and Atrial Fibrillation in the Polish Population	PLOS ONE			English	Article							ABLATION; HEART; RISK	Background: Genome-wide studies have shown that polymorphisms on chromosome 4q25, 16q22 and 1q21 correlate with atrial fibrillation (AF). However, the distribution of these polymorphisms differs significantly among populations. Objective: To test the polymorphisms on chromosome 4q25, 16q22 and 1q21 in a group of patients (pts) that underwent catheter ablation of AF. Methods: Four hundred and ten patients with AF that underwent pulmonary vein isolation were included in the study. Control group (n = 550) was taken from healthy population, matched for age, sex and presence of hypertension. All participants were genotyped for the presence of the rs2200733, rs10033464, rs17570669, rs3853445, rs6838973 (4q25), rs7193343 (16q22) and rs13376333 (1q21) polymorphisms. Results: All the polymorphisms tested (except rs17570669) correlated significantly with AF in univariate analysis (p values between 0.039 for rs7193343 and 2.7e-27 for rs2200733), with the odds ratio (OR) 0.572 and 0.617 for rs3853445 and rs6838973, respectively (protective role) and OR 1.268 to 3.52 for the other polymorphisms. All 4q25 SNPs tested but rs3853445 were independently linked with AF in multivariate logistic regression analysis. In haplotype analysis six out of nine 4q25 haplotypes were significantly linked with AF. The T allele of rs2200733 favoured increased number of episodes of AF per month (p = 0.045) and larger pulmonary vein diameter (recessive model, p = 0.032). Conclusions: Patients qualified for catheter ablation of AF have a significantly higher frequency of 4q25, 16q22 and 1q21 variants than the control group. The T allele of rs2200733 favours larger pulmonary veins and increased number of episodes of AF.	[Kiliszek, Marek; Kozluk, Edward; Lodzinski, Piotr; Piatkowska, Agnieszka; Opolski, Grzegorz] Med Univ Warsaw, Dept Cardiol 1, Warsaw, Poland; [Franaszczyk, Maria; Ploski, Rafal] Med Univ Warsaw, Dept Med Genet, Warsaw, Poland; [Broda, Grazyna] Natl Inst Cardiol, Warsaw, Poland	Medical University of Warsaw; Medical University of Warsaw; Institute of Cardiology - Poland	Kiliszek, M (corresponding author), Med Univ Warsaw, Dept Cardiol 1, Warsaw, Poland.	kiliszek@mp.pl	; Kozluk, Edward/B-6950-2019	Opolski, Grzegorz/0000-0003-4744-2554; Kozluk, Edward/0000-0002-7829-653X; Lodzinski, Piotr/0000-0002-1747-5999; Ploski, Rafal/0000-0001-6286-5526	Medical University of Warsaw [1WY/N/10, 1WY/N/11]	Medical University of Warsaw	Medical University of Warsaw, grants 1WY/N/10 and 1WY/N/11. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berry FB, 2001, J BIOL CHEM, V276, P25057, DOI 10.1074/jbc.M010378200; Calkins H, 2007, HEART RHYTHM, V4, P816, DOI 10.1016/j.hrthm.2007.04.005; Calkins H, 2009, CIRC-ARRHYTHMIA ELEC, V2, P349, DOI 10.1161/CIRCEP.108.824789; Darbar D, 2008, CIRCULATION, V117, P1927, DOI 10.1161/CIRCULATIONAHA.107.757955; den Uijl DW, 2011, AM J CARDIOL, V107, P243, DOI 10.1016/j.amjcard.2010.08.069; Effinor PT, 2008, HEART RHYTHM, V5, P99, DOI [10.1016/j.hrthm.2007.09.015, 10.1016/j.hrthm.2008.01.014]; Ellinor PT, 2010, NAT GENET, V42, P240, DOI 10.1038/ng.537; Gudbjartsson DF, 2007, NATURE, V448, P353, DOI 10.1038/nature06007; Gudbjartsson DF, 2009, NAT GENET, V41, P876, DOI 10.1038/ng.417; Haissaguerre M, 1998, NEW ENGL J MED, V339, P659, DOI 10.1056/NEJM199809033391003; Husser D, 2010, J AM COLL CARDIOL, V55, P747, DOI 10.1016/j.jacc.2009.11.041; Kaab S, 2009, EUR HEART J, V30, P813, DOI 10.1093/eurheartj/ehn578; Kitamura K, 1999, DEVELOPMENT, V126, P5749; Lubitz SA, 2010, CIRCULATION, V122, P976, DOI 10.1161/CIRCULATIONAHA.109.886440; Mommersteeg MTM, 2007, CIRC RES, V101, P902, DOI 10.1161/CIRCRESAHA.107.161182; Ozgen N, 2007, CARDIOVASC RES, V75, P758, DOI 10.1016/j.cardiores.2007.05.008; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ringborg A, 2008, EUROPACE, V10, P403, DOI 10.1093/europace/eun048; Rywik S., 2005, KARDIOLOGIA POLSKA, V63, pS1; WOLF PA, 1991, STROKE, V22, P983, DOI 10.1161/01.STR.22.8.983; Yang YQ, 2004, AM J HUM GENET, V75, P899, DOI 10.1086/425342	21	24	28	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2011	6	7							e21790	10.1371/journal.pone.0021790	http://dx.doi.org/10.1371/journal.pone.0021790			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791IA	21760908	gold, Green Published, Green Submitted			2022-12-27	WOS:000292657200022
J	Moriscot, C; Gribaldo, S; Jault, JM; Krupovic, M; Arnaud, J; Jamin, M; Schoehn, G; Forterre, P; Weissenhorn, W; Renesto, P				Moriscot, Christine; Gribaldo, Simonetta; Jault, Jean-Michel; Krupovic, Mart; Arnaud, Julie; Jamin, Marc; Schoehn, Guy; Forterre, Patrick; Weissenhorn, Winfried; Renesto, Patricia			Crenarchaeal CdvA Forms Double-Helical Filaments Containing DNA and Interacts with ESCRT-III-Like CdvB	PLOS ONE			English	Article							ACTIN-LIKE FILAMENTS; AAA ATPASE VPS4; STRUCTURAL BASIS; CELL-DIVISION; PLASMID SEGREGATION; PROTEIN; ARCHAEA; EVOLUTION; MACHINERY; HOMOLOG	Background: The phylum Crenarchaeota lacks the FtsZ cell division hallmark of bacteria and employs instead Cdv proteins. While CdvB and CdvC are homologues of the eukaryotic ESCRT-III and Vps4 proteins, implicated in membrane fission processes during multivesicular body biogenesis, cytokinesis and budding of some enveloped viruses, little is known about the structure and function of CdvA. Here, we report the biochemical and biophysical characterization of the three Cdv proteins from the hyperthermophilic archaeon Metallospherae sedula. Methodology/ Principal Findings: Using sucrose density gradient ultracentrifugation and negative staining electron microscopy, we evidenced for the first time that CdvA forms polymers in association with DNA, similar to known bacterial DNA partitioning proteins. We also observed that, in contrast to full-lengh CdvB that was purified as a monodisperse protein, the C-terminally deleted CdvB construct forms filamentous polymers, a phenomenon previously observed with eukaryotic ESCRT-III proteins. Based on size exclusion chromatography data combined with detection by multi-angle laser light scattering analysis, we demonstrated that CdvC assembles, in a nucleotide-independent way, as homopolymers resembling dodecamers and endowed with ATPase activity in vitro. The interactions between these putative cell division partners were further explored. Thus, besides confirming the previous observations that CdvB interacts with both CdvA and CdvC, our data demonstrate that CdvA/CdvB and CdvC/CdvB interactions are not mutually exclusive. Conclusions/Significance: Our data reinforce the concept that Cdv proteins are closely related to the eukaryotic ESCRT-III counterparts and suggest that the organization of the ESCRT-III machinery at the Crenarchaeal cell division septum is organized by CdvA an ancient cytoskeleton protein that might help to coordinate genome segregation.	[Moriscot, Christine; Arnaud, Julie; Jamin, Marc; Schoehn, Guy; Weissenhorn, Winfried; Renesto, Patricia] CNRS EMBL UJF, UVHCI UMI 3265, Grenoble, France; [Moriscot, Christine; Jault, Jean-Michel; Schoehn, Guy] CEA CNRS UJF, Inst Biol Struct Jean Pierre Ebel, UMR 5075, Grenoble, France; [Gribaldo, Simonetta; Krupovic, Mart; Forterre, Patrick] Inst Pasteur, Biol Mol Gene Chez Extremophiles BMGE, Paris, France; [Forterre, Patrick] Univ Paris 11, CNRS, UMR 8621, Inst Genet & Microbiol, F-91405 Orsay, France	European Molecular Biology Laboratory (EMBL); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Moriscot, C (corresponding author), CNRS EMBL UJF, UVHCI UMI 3265, Grenoble, France.	prenesto@embl.fr	Krupovic, Mart/I-4209-2012; renesto, patricia/T-6446-2019; gribaldo, simonetta/AAW-4377-2020; Krupovic, Mart/ABD-6255-2021; Renesto, patricia/M-6105-2014; jault, jean-michel/G-2086-2012	Krupovic, Mart/0000-0001-5486-0098; renesto, patricia/0000-0002-6749-7862; gribaldo, simonetta/0000-0002-7662-021X; Krupovic, Mart/0000-0001-5486-0098; jault, jean-michel/0000-0003-1743-2777; Schoehn, Guy/0000-0002-1459-3201; Jamin, Marc/0000-0002-8677-2110; MORISCOT, Christine/0000-0001-5707-0999	University Joseph Fourier; CNRS; ANR (Agence Nationale pour la Recherche) [ANR-08-blan-0271]; DGCIS	University Joseph Fourier; CNRS(Centre National de la Recherche Scientifique (CNRS)); ANR (Agence Nationale pour la Recherche)(French National Research Agency (ANR)); DGCIS	This work was funded in part by the University Joseph Fourier, the CNRS and the ANR (Agence Nationale pour la Recherche, ANR-08-blan-0271). C. M. was supported by a DGCIS grant. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhmedov AT, 1999, J BIOL CHEM, V274, P38216, DOI 10.1074/jbc.274.53.38216; Anantharaman V, 2002, GENOME BIOL, P3, DOI [DOI 10.1186/GB-2002-3-5-RESEARCH0023, 10.1186/gb-2002-3-11-research0061, 10.1186/gb-2002-3-5-research0023]; Aylett CHS, 2010, P NATL ACAD SCI USA, V107, P19766, DOI 10.1073/pnas.1010176107; Babst M, 1998, EMBO J, V17, P2982, DOI 10.1093/emboj/17.11.2982; Bajorek M, 2009, NAT STRUCT MOL BIOL, V16, P754, DOI 10.1038/nsmb.1621; Baumann P, 1996, P NATL ACAD SCI USA, V93, P6726, DOI 10.1073/pnas.93.13.6726; Bernander R, 2010, CURR OPIN MICROBIOL, V13, P747, DOI 10.1016/j.mib.2010.10.005; Brochier-Armanet C, 2008, NAT REV MICROBIOL, V6, P245, DOI 10.1038/nrmicro1852; Brugger Kim, 2007, Archaea, V2, P127, DOI 10.1155/2007/745987; Carlton JG, 2007, SCIENCE, V316, P1908, DOI 10.1126/science.1143422; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Elkins JG, 2008, P NATL ACAD SCI USA, V105, P8102, DOI 10.1073/pnas.0801980105; Fabrikant G, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000575; GARRETT R, 2007, ARCHAEA EVOLUTION PH; Gerard E, 1998, GENE, V222, P99, DOI 10.1016/S0378-1119(98)00471-5; Gerard FCA, 2007, BIOCHEMISTRY-US, V46, P10328, DOI 10.1021/bi7007799; Ghazi-Tabatabai S, 2008, STRUCTURE, V16, P1345, DOI 10.1016/j.str.2008.06.010; Ghazi-Tabatabai S, 2009, BIOCHEM SOC T, V37, P151, DOI 10.1042/BST0370151; Gibrat JF, 1996, CURR OPIN STRUC BIOL, V6, P377, DOI 10.1016/S0959-440X(96)80058-3; Golovanov AP, 2004, J AM CHEM SOC, V126, P8933, DOI 10.1021/ja049297h; Gribaldo S, 2010, NAT REV MICROBIOL, V8, P743, DOI 10.1038/nrmicro2426; Hanson PI, 2008, J CELL BIOL, V180, P389, DOI 10.1083/jcb.200707031; Hartmann C, 2008, J MOL BIOL, V377, P352, DOI 10.1016/j.jmb.2008.01.010; Hobel CFV, 2008, BIOCHEM SOC T, V36, P94, DOI 10.1042/BST0360094; Hong Y, 2004, J STRUCT BIOL, V148, P251, DOI 10.1016/j.jsb.2004.06.004; Hui MP, 2010, P NATL ACAD SCI USA, V107, P4590, DOI 10.1073/pnas.0913060107; Hurley JH, 2010, NAT REV MOL CELL BIO, V11, P556, DOI 10.1038/nrm2937; Hutchins JRA, 2010, SCIENCE, V328, P593, DOI 10.1126/science.1181348; JAULT JM, 1991, J BIOL CHEM, V266, P8073; Jobb G, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-18; Kieffer C, 2008, DEV CELL, V15, P62, DOI 10.1016/j.devcel.2008.05.014; Landsberg MJ, 2009, STRUCTURE, V17, P427, DOI 10.1016/j.str.2008.12.020; Lata S, 2008, SCIENCE, V321, P1354, DOI 10.1126/science.1161070; Lata S, 2008, J MOL BIOL, V378, P818, DOI 10.1016/j.jmb.2008.03.030; Le SQ, 2008, MOL BIOL EVOL, V25, P1307, DOI 10.1093/molbev/msn067; Lindas AC, 2008, P NATL ACAD SCI USA, V105, P18942, DOI 10.1073/pnas.0809467105; Lowe J, 2009, INT J BIOCHEM CELL B, V41, P323, DOI 10.1016/j.biocel.2008.08.010; Lundgren M, 2005, CURR OPIN MICROBIOL, V8, P662, DOI 10.1016/j.mib.2005.10.008; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Makarova Kira S, 2003, Genome Biol, V4, P115, DOI 10.1186/gb-2003-4-8-115; Makarova KS, 2010, NAT REV MICROBIOL, V8, P731, DOI 10.1038/nrmicro2406; Margolin W, 1996, J BACTERIOL, V178, P1320, DOI 10.1128/jb.178.5.1320-1327.1996; Morita E, 2004, ANNU REV CELL DEV BI, V20, P395, DOI 10.1146/annurev.cellbio.20.010403.102350; Morita E, 2007, EMBO J, V26, P4215, DOI 10.1038/sj.emboj.7601850; Morita E, 2010, P NATL ACAD SCI USA, V107, P12889, DOI 10.1073/pnas.1005938107; Muziol T, 2006, DEV CELL, V10, P821, DOI 10.1016/j.devcel.2006.03.013; Nunoura T, 2011, NUCLEIC ACIDS RES, V39, P3204, DOI 10.1093/nar/gkq1228; Obita T, 2007, NATURE, V449, P735, DOI 10.1038/nature06171; Peel S, 2011, TRENDS BIOCHEM SCI, V36, P199, DOI 10.1016/j.tibs.2010.09.004; Pires R, 2009, STRUCTURE, V17, P843, DOI 10.1016/j.str.2009.04.007; Raiborg C, 2009, NATURE, V458, P445, DOI 10.1038/nature07961; Saksena S, 2007, TRENDS BIOCHEM SCI, V32, P561, DOI 10.1016/j.tibs.2007.09.010; Saksena S, 2009, CELL, V136, P97, DOI 10.1016/j.cell.2008.11.013; Salje J, 2010, NAT REV MICROBIOL, V8, P683, DOI 10.1038/nrmicro2425; Samson RY, 2011, MOL CELL, V41, P186, DOI 10.1016/j.molcel.2010.12.018; Samson RY, 2009, TRENDS MICROBIOL, V17, P507, DOI 10.1016/j.tim.2009.08.003; Samson RY, 2008, SCIENCE, V322, P1710, DOI 10.1126/science.1165322; Scott A, 2005, EMBO J, V24, P3658, DOI 10.1038/sj.emboj.7600818; Shim S, 2007, TRAFFIC, V8, P1068, DOI 10.1111/j.1600-0854.2007.00584.x; van den Ent F, 2002, EMBO J, V21, P6935, DOI 10.1093/emboj/cdf672; Wiederstein M, 2007, NUCLEIC ACIDS RES, V35, pW407, DOI 10.1093/nar/gkm290; Williams RL, 2007, NAT REV MOL CELL BIO, V8, P355, DOI 10.1038/nrm2162; WOESE CR, 1990, P NATL ACAD SCI USA, V87, P4576, DOI 10.1073/pnas.87.12.4576; Wyatt PJ, 1998, J COLLOID INTERF SCI, V197, P9, DOI 10.1006/jcis.1997.5215; Yu ZH, 2008, J MOL BIOL, V377, P364, DOI 10.1016/j.jmb.2008.01.009; Zamborlini A, 2006, P NATL ACAD SCI USA, V103, P19140, DOI 10.1073/pnas.0603788103; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40	67	30	31	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2011	6	7							e21921	10.1371/journal.pone.0021921	http://dx.doi.org/10.1371/journal.pone.0021921			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791IA	21760923	Green Published, Green Submitted, gold			2022-12-27	WOS:000292657200029
J	Delgado, O; Kaisani, AA; Spinola, M; Xie, XJ; Batten, KG; Minna, JD; Wright, WE; Shay, JW				Delgado, Oliver; Kaisani, Aadil A.; Spinola, Monica; Xie, Xian-Jin; Batten, Kimberly G.; Minna, John D.; Wright, Woodring E.; Shay, Jerry W.			Multipotent Capacity of Immortalized Human Bronchial Epithelial Cells	PLOS ONE			English	Article							HUMAN AIRWAY EPITHELIUM; STEM-CELLS; PROGENITOR CELLS; CLARA CELLS; BASAL-CELLS; EPIGENETIC REGULATION; HUMAN TISSUES; MOUSE LUNG; BETA-CELLS; II CELLS	While the adult murine lung utilizes multiple compartmentally restricted progenitor cells during homeostasis and repair, much less is known about the progenitor cells from the human lung. Translating the murine stem cell model to humans is hindered by anatomical differences between species. Here we show that human bronchial epithelial cells (HBECs) display characteristics of multipotent stem cells of the lung. These HBECs express markers indicative of several epithelial types of the adult lung when experimentally tested in cell culture. When cultured in three different three-dimensional (3D) systems, subtle changes in the microenvironment result in unique responses including the ability of HBECs to differentiate into multiple central and peripheral lung cell types. These new findings indicate that the adult human lung contains a multipotent progenitor cell whose differentiation potential is primarily dictated by the microenvironment. The HBEC system is not only important in understanding mechanisms for specific cell lineage differentiation, but also for examining changes that correlate with human lung diseases including lung cancer.	[Delgado, Oliver; Kaisani, Aadil A.; Batten, Kimberly G.; Wright, Woodring E.; Shay, Jerry W.] Univ Texas SW Med Ctr Dallas, Dept Cell Biol, Dallas, TX 75390 USA; [Spinola, Monica; Minna, John D.] Univ Texas SW Med Ctr Dallas, Hamon Ctr Therapeut Oncol Res, Dallas, TX 75390 USA; [Xie, Xian-Jin] Univ Texas SW Med Ctr Dallas, Dept Clin Sci, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Delgado, O (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Cell Biol, Dallas, TX 75390 USA.	jerry.shay@utsouthwestern.edu	Shay, Jerry W/F-7878-2011	Delgado, Oliver/0000-0003-2547-5857	National Cancer Institute (NCI) [SPORE P50CA70907]; National Aeronautics and Space Administration (NASA) [NSCOR NNJ05HD36GD]; NATIONAL CANCER INSTITUTE [P50CA070907] Funding Source: NIH RePORTER	National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Aeronautics and Space Administration (NASA)(National Aeronautics & Space Administration (NASA)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work is supported by National Cancer Institute (NCI) (www.cancer.gov) SPORE P50CA70907 and National Aeronautics and Space Administration (NASA) (www.nasa.gov) NSCOR NNJ05HD36GD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blanpain C, 2007, CELL, V128, P445, DOI 10.1016/j.cell.2007.01.014; Blatt EN, 1999, AM J RESP CELL MOL, V21, P168, DOI 10.1165/ajrcmb.21.2.3691; Boers JE, 1998, AM J RESP CRIT CARE, V157, P2000, DOI 10.1164/ajrccm.157.6.9707011; Boers JE, 1999, AM J RESP CRIT CARE, V159, P1585, DOI 10.1164/ajrccm.159.5.9806044; BOHINSKI RJ, 1994, MOL CELL BIOL, V14, P5671, DOI 10.1128/MCB.14.9.5671; Daniely Y, 2004, AM J PHYSIOL-CELL PH, V287, pC171, DOI 10.1152/ajpcell.00226.2003; Dor Y, 2004, NATURE, V429, P41, DOI 10.1038/nature02520; EVANS MJ, 1975, EXP MOL PATHOL, V22, P142, DOI 10.1016/0014-4800(75)90059-3; Evans MJ, 2001, EXP LUNG RES, V27, P401, DOI 10.1080/019021401300317125; Fehrenbach H, 2001, RESP RES, V2, P33, DOI 10.1186/rr36; Fulcher M Leslie, 2005, Methods Mol Med, V107, P183; Giangreco A, 2002, AM J PATHOL, V161, P173, DOI 10.1016/S0002-9440(10)64169-7; Giangreco A, 2009, P NATL ACAD SCI USA, V106, P9286, DOI 10.1073/pnas.0900668106; Gontan C, 2008, DEV BIOL, V317, P296, DOI 10.1016/j.ydbio.2008.02.035; Hong KU, 2004, AM J PHYSIOL-LUNG C, V286, pL643, DOI 10.1152/ajplung.00155.2003; Hong KU, 2001, AM J RESP CELL MOL, V24, P671, DOI 10.1165/ajrcmb.24.6.4498; Hovenberg HW, 1996, BIOCHEM J, V318, P319, DOI 10.1042/bj3180319; KALINA M, 1992, AM J RESP CELL MOL, V6, P594, DOI 10.1165/ajrcmb/6.6.594; Kohyama J, 2008, P NATL ACAD SCI USA, V105, P18012, DOI 10.1073/pnas.0808417105; Krane CM, 2001, P NATL ACAD SCI USA, V98, P14114, DOI 10.1073/pnas.231273398; Lee GY, 2007, NAT METHODS, V4, P359, DOI 10.1038/NMETH1015; Liu Yuru, 2002, Gene Expression Patterns, V2, P229, DOI 10.1016/S1567-133X(02)00057-1; Lunyak VV, 2008, HUM MOL GENET, V17, pR28, DOI 10.1093/hmg/ddn149; MADRI JA, 1983, J CELL BIOL, V97, P153, DOI 10.1083/jcb.97.1.153; Madsen J, 2003, AM J RESP CELL MOL, V29, P591, DOI 10.1165/rcmb.2002-0274OC; Madsen J, 2000, J IMMUNOL, V164, P5866, DOI 10.4049/jimmunol.164.11.5866; McQualter JL, 2010, P NATL ACAD SCI USA, V107, P1414, DOI 10.1073/pnas.0909207107; ODOM MJ, 1987, ENDOCRINOLOGY, V121, P1155, DOI 10.1210/endo-121-3-1155; Park KS, 2006, AM J RESP CELL MOL, V34, P151, DOI 10.1165/rcmb.2005-0332OC; POLAK JM, 1993, ANAT REC, V236, P169, DOI 10.1002/ar.1092360120; Ramirez RD, 2004, CANCER RES, V64, P9027, DOI 10.1158/0008-5472.CAN-04-3703; Rawlins EL, 2009, DEVELOPMENT, V136, P3741, DOI 10.1242/dev.037317; Rawlins Emma L, 2008, Proc Am Thorac Soc, V5, P675, DOI 10.1513/pats.200801-006AW; Rawlins EL, 2009, CELL STEM CELL, V4, P525, DOI 10.1016/j.stem.2009.04.002; Rock JR, 2009, P NATL ACAD SCI USA, V106, P12771, DOI 10.1073/pnas.0906850106; Sato M, 2006, CANCER RES, V66, P2116, DOI 10.1158/0008-5472.CAN-05-2521; Shi W, 2009, RESPIROLOGY, V14, P656, DOI 10.1111/j.1440-1843.2009.01565.x; Snyder JC, 2009, J PATHOL, V217, P254, DOI 10.1002/path.2473; TOMPKINS DH, 2010, AM J RESP C IN PRESS; Vaughan MB, 2006, DIFFERENTIATION, V74, P141, DOI 10.1111/j.1432-0436.2006.00069.x; Wuenschell CW, 1996, J HISTOCHEM CYTOCHEM, V44, P113, DOI 10.1177/44.2.8609367; Xu XB, 2008, CELL, V132, P197, DOI 10.1016/j.cell.2007.12.015; Yin T, 2006, J CLIN INVEST, V116, P1195, DOI 10.1172/JCI28568; Yu W, 2007, MOL BIOL CELL, V18, P1693, DOI 10.1091/mbc.E06-11-1052	44	50	53	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2011	6	7							e22023	10.1371/journal.pone.0022023	http://dx.doi.org/10.1371/journal.pone.0022023			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791HI	21760947	gold, Green Published, Green Submitted			2022-12-27	WOS:000292655400039
J	Takayama, K; Inamura, M; Kawabata, K; Tashiro, K; Katayama, K; Sakurai, F; Hayakawa, T; Furue, MK; Mizuguchi, H				Takayama, Kazuo; Inamura, Mitsuru; Kawabata, Kenji; Tashiro, Katsuhisa; Katayama, Kazufumi; Sakurai, Fuminori; Hayakawa, Takao; Furue, Miho Kusuda; Mizuguchi, Hiroyuki			Efficient and Directive Generation of Two Distinct Endoderm Lineages from Human ESCs and iPSCs by Differentiation Stage-Specific SOX17 Transduction	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; DEFINITIVE ENDODERM; ADENOVIRUS VECTOR; VISCERAL ENDODERM; GENE-EXPRESSION; MOUSE; INDUCTION; PROMOTES; GASTRULATION; MAINTENANCE	The establishment of methods for directive differentiation from human embryonic stem cells (ESCs) and induced pluripotent stem cells (iPSCs) is important for regenerative medicine. Although Sry-related HMG box 17 (SOX17) overexpression in ESCs leads to differentiation of either extraembryonic or definitive endoderm cells, respectively, the mechanism of these distinct results remains unknown. Therefore, we utilized a transient adenovirus vector-mediated overexpression system to mimic the SOX17 expression pattern of embryogenesis. The number of alpha-fetoprotein-positive extraembryonic endoderm (ExEn) cells was increased by transient SOX17 transduction in human ESC- and iPSC-derived primitive endoderm cells. In contrast, the number of hematopoietically expressed homeobox (HEX)-positive definitive endoderm (DE) cells, which correspond to the anterior DE in vivo, was increased by transient adenovirus vector-mediated SOX17 expression in human ESC- and iPSC-derived mesendoderm cells. Moreover, hepatocyte-like cells were efficiently generated by sequential transduction of SOX17 and HEX. Our findings show that a stage-specific transduction of SOX17 in the primitive endoderm or mesendoderm promotes directive ExEn or DE differentiation by SOX17 transduction, respectively.	[Takayama, Kazuo; Inamura, Mitsuru; Katayama, Kazufumi; Sakurai, Fuminori; Mizuguchi, Hiroyuki] Osaka Univ, Lab Biochem & Mol Biol, Grad Sch Pharmaceut Sci, Osaka, Japan; [Takayama, Kazuo; Inamura, Mitsuru; Kawabata, Kenji; Tashiro, Katsuhisa; Mizuguchi, Hiroyuki] Natl Inst Biomed Innovat, Lab Stem Cell Regulat, Osaka, Japan; [Kawabata, Kenji] Osaka Univ, Lab Biomed Innovat, Grad Sch Pharmaceut Sci, Osaka, Japan; [Hayakawa, Takao] Pharmaceut & Med Devices Agcy, Chiyoda Ku, Tokyo, Japan; [Hayakawa, Takao] Kinki Univ, Pharmaceut Res & Technol Inst, Osaka, Japan; [Furue, Miho Kusuda] Natl Inst Biomed Innovat, JCRB Cell Bank, Div Bioresources, Osaka, Japan; [Furue, Miho Kusuda] Kyoto Univ, Lab Cell Proc, Inst Frontier Med Sci, Sakyo Ku, Kyoto, Japan; [Mizuguchi, Hiroyuki] Osaka Univ, Ctr Adv Med Engn & Informat, Osaka, Japan	Osaka University; National Institute of Health Sciences - Japan; Osaka University; Kindai University (Kinki University); National Institute of Health Sciences - Japan; Kyoto University; Osaka University	Takayama, K (corresponding author), Osaka Univ, Lab Biochem & Mol Biol, Grad Sch Pharmaceut Sci, Osaka, Japan.	mizuguch@phs.osaka-u.ac.jp	Takayama, Kazuo/U-2360-2019	Mizuguchi, Hiroyuki/0000-0003-0594-8178; Takayama, Kazuo/0000-0002-1132-2457; Furue, Miho/0000-0001-5032-9953	Ministry of Health, Labor, and Welfare of Japan; Ministry of Education, Sports, Science and Technology of Japan [20200076]; National Institute of Biomedical Innovation (NIBIO)	Ministry of Health, Labor, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Sports, Science and Technology of Japan(Core Research for Evolutional Science and Technology (CREST)Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National Institute of Biomedical Innovation (NIBIO)(National Institute of Biomedical Innovation)	HM, MKF, and TH were supported by grants from the Ministry of Health, Labor, and Welfare of Japan. K. Kawabata was supported by grants from the Ministry of Education, Sports, Science and Technology of Japan (20200076) and the Ministry of Health, Labor, and Welfare of Japan. K. Katayama was supported by the Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (NIBIO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BLUM M, 1992, CELL, V69, P1097, DOI 10.1016/0092-8674(92)90632-M; D'Amour KA, 2005, NAT BIOTECHNOL, V23, P1534, DOI 10.1038/nbt1163; ENDERS AC, 1978, ANAT REC, V190, P65, DOI 10.1002/ar.1091900107; Fujikura J, 2002, GENE DEV, V16, P784, DOI 10.1101/gad.968802; Furue MK, 2008, P NATL ACAD SCI USA, V105, P13409, DOI 10.1073/pnas.0806136105; Gadue P, 2006, P NATL ACAD SCI USA, V103, P16806, DOI 10.1073/pnas.0603916103; GARDNER RL, 1983, INT REV EXP PATHOL, V24, P63; Gouon-Evans V, 2006, NAT BIOTECHNOL, V24, P1402, DOI 10.1038/nbt1258; Grapin-Botton A, 2007, MECH DEVELOP, V124, P253, DOI 10.1016/j.mod.2007.01.001; Inamura M, 2011, MOL THER, V19, P400, DOI 10.1038/mt.2010.241; Ingelman-Sundberg M, 1999, TRENDS PHARMACOL SCI, V20, P342, DOI 10.1016/S0165-6147(99)01363-2; Kanai-Azuma M, 2002, DEVELOPMENT, V129, P2367; Kawabata K, 2005, MOL THER, V12, P547, DOI 10.1016/j.ymthe.2005.04.015; Koizumi N, 2003, J GENE MED, V5, P267, DOI 10.1002/jgm.348; Koutsourakis M, 1999, DEVELOPMENT, V126, P723; Kunath T, 2004, PLACENTA, V25, pS32, DOI 10.1016/j.placenta.2004.01.015; LevinsonDushnik M, 1997, MOL CELL BIOL, V17, P3817, DOI 10.1128/MCB.17.7.3817; MAIZEL JV, 1968, VIROLOGY, V36, P115, DOI 10.1016/0042-6822(68)90121-9; Makino H, 2009, EXP CELL RES, V315, P2727, DOI 10.1016/j.yexcr.2009.06.016; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Mizuguchi H, 1999, HUM GENE THER, V10, P2013, DOI 10.1089/10430349950017374; Mizuguchi H, 1998, HUM GENE THER, V9, P2577, DOI 10.1089/hum.1998.9.17-2577; Mizuguchi H, 2004, HUM GENE THER, V15, P1034, DOI 10.1089/hum.2004.15.1034; Morrisey EE, 1998, GENE DEV, V12, P3579, DOI 10.1101/gad.12.22.3579; Morrison GM, 2008, CELL STEM CELL, V3, P402, DOI 10.1016/j.stem.2008.07.021; Murry CE, 2008, CELL, V132, P661, DOI 10.1016/j.cell.2008.02.008; Nagata S, 2009, GENES CELLS, V14, P1395, DOI 10.1111/j.1365-2443.2009.01356.x; Niakan KK, 2010, GENE DEV, V24, P312, DOI 10.1101/gad.1833510; Pera MF, 2004, J CELL SCI, V117, P1269, DOI 10.1242/jcs.00970; Qu XB, 2008, DEV GROWTH DIFFER, V50, P585, DOI 10.1111/j.1440-169X.2008.01056.x; SASAKI H, 1993, DEVELOPMENT, V118, P47; Seguin CA, 2008, CELL STEM CELL, V3, P182, DOI 10.1016/j.stem.2008.06.018; SHALABY F, 1995, NATURE, V376, P62, DOI 10.1038/376062a0; Sherwood RI, 2007, DEV BIOL, V304, P541, DOI 10.1016/j.ydbio.2007.01.011; Shimoda M, 2007, J CELL SCI, V120, P3859, DOI 10.1242/jcs.007856; SHIOJIRI N, 1984, J EMBRYOL EXP MORPH, V79, P25; Spence JR, 2009, DEV CELL, V17, P62, DOI 10.1016/j.devcel.2009.05.012; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Tam PPL, 2003, CURR OPIN GENET DEV, V13, P393, DOI 10.1016/S0959-437X(03)00085-6; Tashiro K, 2008, J GENE MED, V10, P498, DOI 10.1002/jgm.1171; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; WILKINSON DG, 1990, NATURE, V343, P657, DOI 10.1038/343657a0; Xu RH, 2002, NAT BIOTECHNOL, V20, P1261, DOI 10.1038/nbt761; Yasunaga M, 2005, NAT BIOTECHNOL, V23, P1542, DOI 10.1038/nbt1167; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	45	39	44	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2011	6	7							e21780	10.1371/journal.pone.0021780	http://dx.doi.org/10.1371/journal.pone.0021780			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791HI	21760905	Green Published, gold			2022-12-27	WOS:000292655400018
J	Shang, PH; Xia, YY; Liu, FY; Wang, XM; Yuan, YL; Hu, DY; Tu, DH; Chen, YX; Deng, PY; Cheng, SM; Zhou, L; Ma, Y; Zhu, LZ; Gao, WW; Wang, HY; Chen, DF; Yang, L; He, PP; Wu, SS; Tang, SW; Lv, XZ; Shu, Z; Zhang, Y; Yang, ZR; Chen, Y; Li, N; Sun, F; Li, XT; He, YJ; Garner, P; Zhan, SY				Shang, Penghui; Xia, Yinyin; Liu, Feiying; Wang, Xiaomeng; Yuan, Yanli; Hu, Daiyu; Tu, Dehua; Chen, Yixin; Deng, Peiyuan; Cheng, Shiming; Zhou, Lin; Ma, Yu; Zhu, Lizhen; Gao, Weiwei; Wang, Hongyuan; Chen, Dafang; Yang, Li; He, Pingping; Wu, Shanshan; Tang, Shaowen; Lv, Xiaozhen; Shu, Zheng; Zhang, Yuan; Yang, Zhirong; Chen, Yan; Li, Na; Sun, Feng; Li, Xiaoting; He, Yingjian; Garner, Paul; Zhan, Siyan			Incidence, Clinical Features and Impact on Anti-Tuberculosis Treatment of Anti-Tuberculosis Drug Induced Liver Injury (ATLI) in China	PLOS ONE			English	Article							INDUCED HEPATOTOXICITY; SUSCEPTIBILITY; PYRAZINAMIDE; HEPATITIS	Background: Anti-tuberculosis drug induced liver injury (ATLI) is emerging as a significant threat to tuberculosis control in China, though limited data is available about the burden of ATLI at population level. This study aimed to estimate the incidence of ATLI, to better understand its clinical features, and to evaluate its impact on anti-tuberculosis (TB) treatment in China. Methodology/Principal Findings: In a population-based prospective study, we monitored 4,304 TB patients receiving directly observed treatment strategy (DOTS) treatment, and found that 106 patients developed ATLI with a cumulative incidence of 2.55% (95% Confidence Interval [CI], 2.04%-3.06%). Nausea, vomiting and anorexia were the top three most frequently observed symptoms. There were 35 (33.02%) ATLI patients with no symptoms, including 8 with severe hepatotoxicity. Regarding the prognosis of ATLI, 84 cases (79.25%) recovered, 18 (16.98%) improved, 2 (1.89%) failed to respond to the treatment with continued elevation of serum alanine aminotransferase, and 2 (1.89%) died as result of ATLI. Of all the ATLI cases, 74 (69.81%) cases changed their anti-TB treatment, including 4 (3.77%) cases with medication administration change, 21 (19.81%) cases with drugs replacement, 54 (50.94%) cases with therapy interruption, and 12 (11.32%) cases who discontinued therapy. In terms of treatment outcomes, 53 (51.46%) cases had TB cured in time, 48 (46.60%) cases had therapy prolonged, and 2 (1.94%) cases died. Compared with non-ATLI patients, ATLI patients had a 9.25-fold (95% CI, 5.69-15.05) risk of unsuccessful anti-TB treatment outcomes and a 2.11-fold (95% CI, 1.23-3.60) risk of prolonged intensive treatment phase. Conclusions/Significance: ATLI could considerably impact the outcomes of anti-TB treatment. Given the incidence of ATLI and the size of TB population in China, the negative impact is substantial. Therefore, more research and efforts are warranted in order to enhance the diagnosis and the prevention of ATLI.	[Shang, Penghui; Wang, Hongyuan; Chen, Dafang; Yang, Li; He, Pingping; Wu, Shanshan; Tang, Shaowen; Lv, Xiaozhen; Shu, Zheng; Zhang, Yuan; Yang, Zhirong; Sun, Feng; Zhan, Siyan] Peking Univ, Hlth Sci Ctr, Sch Publ Hlth, Dept Epidemiol & Biostat, Beijing 100871, Peoples R China; [Xia, Yinyin; Cheng, Shiming; Zhou, Lin] Chinese Ctr Dis Control & Prevent, Ctr TB Control & Prevent, Beijing, Peoples R China; [Liu, Feiying] Ctr Dis Control & Prevent Guangxi Zhuang Autonomo, Nanning, Peoples R China; [Wang, Xiaomeng] Ctr Dis Control & Prevent Zhejiang Prov, Hangzhou, Zhejiang, Peoples R China; [Yuan, Yanli] Ctr Dis Control & Prevent Jilin Prov, Changchun, Peoples R China; [Hu, Daiyu] Ctr Dis Control & Prevent Chongqing Municipal, Chongqing, Peoples R China; [Tu, Dehua] Beijing Inst TB Control, Beijing, Peoples R China; [Chen, Yixin; Deng, Peiyuan] State Food & Drug Adm, Ctr Drug Reassessment, Beijing, Peoples R China; [Ma, Yu; Zhu, Lizhen; Gao, Weiwei] Beijing TB & Thorac Tumor Res Inst, Beijing, Peoples R China; [Chen, Yan] Indiana Univ, Sch Med, Dept Publ Hlth, Indianapolis, IN USA; [Li, Na] Ctr Dis Control & Prevent Fangshan Dist, Beijing, Peoples R China; [Li, Xiaoting; He, Yingjian] Beijing Inst Canc Res, Beijing, Peoples R China; [Garner, Paul] Univ Liverpool, Liverpool Sch Trop Med, Int Hlth Grp, Liverpool L3 5QA, Merseyside, England	Peking University; Chinese Center for Disease Control & Prevention; Indiana University System; Indiana University-Purdue University Indianapolis; Liverpool School of Tropical Medicine; University of Liverpool	Shang, PH (corresponding author), Peking Univ, Hlth Sci Ctr, Sch Publ Hlth, Dept Epidemiol & Biostat, Beijing 100871, Peoples R China.	siyan-zhan@bjmu.edu.cn	Garner, Paul/HII-5856-2022; Garner, Paul/Y-8385-2019; Sun, Feng/AGF-7912-2022; Sun, Feng/E-8859-2010	Garner, Paul/0000-0002-0607-6941; Sun, Feng/0000-0003-4334-6805; Sun, Feng/0000-0001-9212-0496; Zhang, Yuan/0000-0002-4174-0641	China Program for the Global Fund [NO:TB07-030]	China Program for the Global Fund	This study was funded by the China Program for the Global Fund to Fight TB (NO:TB07-030). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2003, AM J RESP CRIT CARE, V167, P603; Baghaei P, 2010, AM J THER, V17, P17, DOI 10.1097/MJT.0b013e31818f9eae; BENICHOU C, 1990, J HEPATOL, V11, P272; *BRIT THOR SOC JOI, 1998, CHEM MAN TUB UK REC, P536; Burman WJ, 2001, AM J RESP CRIT CARE, V164, P1112, DOI 10.1164/ajrccm.164.7.2109052; Chang KC, 2008, AM J RESP CRIT CARE, V177, P1391, DOI 10.1164/rccm.200802-355OC; Chen XY, 2004, LANCET, V364, P417; CHITTURI S, 2002, SCHIFFS DIS LIVER, P1059; GIRLING DJ, 1978, TUBERCLE, V59, P13; Gulbay BE, 2006, RESP MED, V100, P1834, DOI 10.1016/j.rmed.2006.01.014; Huang YS, 2003, HEPATOLOGY, V37, P924, DOI 10.1053/jhep.2003.50144; Kaona FAD, 2004, BMC PUBLIC HEALTH, V4, DOI 10.1186/1471-2458-4-68; Khalili H, 2009, DARU, V17, P163; Larrey D, 2002, SEMIN LIVER DIS, V22, P145, DOI 10.1055/s-2002-30101; Migliori GB, 1999, EUR RESPIR J, V14, P978, DOI 10.1183/09031936.99.14497899; Ormerod LP, 1996, TUBERCLE LUNG DIS, V77, P37, DOI 10.1016/S0962-8479(96)90073-8; Saukkonen JJ, 2006, AM J RESP CRIT CARE, V174, P935, DOI 10.1164/rccm.200510-1666ST; Sharifzadeh M, 2005, PHARMACOL RES, V51, P353, DOI 10.1016/j.phrs.2004.10.009; Sun F, 2008, INT J TUBERC LUNG D, V12, P994; Teleman MD, 2002, INT J TUBERC LUNG D, V6, P699; Tostmann A, 2008, J GASTROEN HEPATOL, V23, P192, DOI 10.1111/j.1440-1746.2007.05207.x; Ungo JR, 1998, AM J RESP CRIT CARE, V157, P1871, DOI 10.1164/ajrccm.157.6.9711039; Wares DF, 2003, INT J TUBERC LUNG D, V7, P327; WHO, 2009, TREATM TUB GUID; WHO, 2002, EX SUMM NAT CANC CON, P1; World Health Organization, 2010, GLOB TUB CONTR WHO R; Xia YY, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-267; Yee D, 2003, AM J RESP CRIT CARE, V167, P1472, DOI 10.1164/rccm.200206-626OC	28	63	78	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2011	6	7							e21836	10.1371/journal.pone.0021836	http://dx.doi.org/10.1371/journal.pone.0021836			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	789JO	21750735	Green Published, Green Accepted, gold			2022-12-27	WOS:000292512000027
J	Grover, VK; Valadez, JG; Bowman, AB; Cooper, MK				Grover, Vandana K.; Valadez, J. Gerardo; Bowman, Aaron B.; Cooper, Michael K.			Lipid Modifications of Sonic Hedgehog Ligand Dictate Cellular Reception and Signal Response	PLOS ONE			English	Article							CHOLESTEROL MODIFICATION; CRYSTAL-STRUCTURE; HUMAN HOMOLOG; FLOOR PLATE; SHH; PALMITOYLATION; REGION; DOMAIN; SITE; FORM	Background: Sonic hedgehog (Shh) signaling regulates cell growth during embryonic development, tissue homeostasis and tumorigenesis. Concentration-dependent cellular responses to secreted Shh protein are essential for tissue patterning. Shh ligand is covalently modified by two lipid moieties, cholesterol and palmitate, and their hydrophobic properties are known to govern the cellular release and formation of soluble multimeric Shh complexes. However, the influences of the lipid moieties on cellular reception and signal response are not well understood. Methodology/Principal Findings: We analyzed fully lipidated Shh and mutant forms to eliminate one or both adducts in NIH3T3 mouse embryonic fibroblasts. Quantitative measurements of recombinant Shh protein concentration, cellular localization, and signaling potency were integrated to determine the contributions of each lipid adduct on ligand cellular localization and signaling potency. We demonstrate that lipid modification is required for cell reception, that either adduct is sufficient to confer cellular association, that the cholesterol adduct anchors ligand to the plasma membrane and that the palmitate adduct augments ligand internalization. We further show that signaling potency correlates directly with cellular concentration of Shh ligand. Conclusions/Significance: The findings of this study demonstrate that lipid modification of Shh determines cell concentration and potency, revealing complementary functions of hydrophobic modification in morphogen signaling by attenuating cellular release and augmenting reception of Shh protein in target tissues.	[Grover, Vandana K.; Valadez, J. Gerardo; Bowman, Aaron B.; Cooper, Michael K.] Vanderbilt Univ, Med Ctr, Dept Neurol, Nashville, TN 37235 USA; [Grover, Vandana K.; Bowman, Aaron B.; Cooper, Michael K.] Vanderbilt Univ, Med Ctr, Vanderbilt Brain Inst, Nashville, TN USA; [Bowman, Aaron B.; Cooper, Michael K.] Vanderbilt Univ, Med Ctr, Vanderbilt Kennedy Ctr, Nashville, TN USA; [Cooper, Michael K.] Vanderbilt Univ, Med Ctr, Vanderbilt Ingram Canc Ctr, Nashville, TN USA; [Cooper, Michael K.] Vet Affairs Tennessee Valley Healthcare Syst, Nashville, TN USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System	Grover, VK (corresponding author), Vanderbilt Univ, Med Ctr, Dept Neurol, Nashville, TN 37235 USA.	michael.cooper@vanderbilt.edu		Bowman, Aaron/0000-0001-8728-3346	NINDS [K02 NS053614]; March of Dimes Foundation; Vanderbilt Brain Institute; Vanderbilt Ingram Cancer Center [P30 CA68485]; Vanderbilt Digestive Disease Research Center [DK058404]; NATIONAL CANCER INSTITUTE [P30CA068485] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK058404] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES016931] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K02NS053614] Funding Source: NIH RePORTER	NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); March of Dimes Foundation(March of Dimes); Vanderbilt Brain Institute; Vanderbilt Ingram Cancer Center; Vanderbilt Digestive Disease Research Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported in part by grants from NINDS (K02 NS053614), the March of Dimes Foundation, and the Vanderbilt Brain Institute Scholar's Program. Flow cytometry experiments were performed in the Vanderbilt Medical Center Flow Cytometry Shared Resource (supported by the Vanderbilt Ingram Cancer Center, P30 CA68485, and the Vanderbilt Digestive Disease Research Center, DK058404). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe Y, 2008, FEBS J, V275, P318, DOI 10.1111/j.1742-4658.2007.06202.x; Bosanac I, 2009, NAT STRUCT MOL BIOL, V16, P691, DOI 10.1038/nsmb.1632; Briscoe J, 2001, MOL CELL, V7, P1279, DOI 10.1016/S1097-2765(01)00271-4; Burke R, 1999, CELL, V99, P803, DOI 10.1016/S0092-8674(00)81677-3; Chamoun Z, 2001, SCIENCE, V293, P2080, DOI 10.1126/science.1064437; Chen MH, 2004, GENE DEV, V18, P641, DOI 10.1101/gad.1185804; Chen W, 2004, SCIENCE, V306, P2257, DOI 10.1126/science.1104135; Cohen MM, 2002, AM J MED GENET, V115, P245, DOI 10.1002/ajmg.10982; Cooper MK, 2003, NAT GENET, V33, P508, DOI 10.1038/ng1134; Dessaud E, 2007, NATURE, V450, P717, DOI 10.1038/nature06347; Eaton S, 2008, NAT REV MOL CELL BIO, V9, P437, DOI 10.1038/nrm2414; Ericson J, 1997, CELL, V90, P169, DOI 10.1016/S0092-8674(00)80323-2; Ericson J, 1996, CELL, V87, P661, DOI 10.1016/S0092-8674(00)81386-0; Feng J, 2004, DEVELOPMENT, V131, P4357, DOI 10.1242/dev.01301; Fuse N, 1999, P NATL ACAD SCI USA, V96, P10992, DOI 10.1073/pnas.96.20.10992; Goetz JA, 2006, J BIOL CHEM, V281, P4087, DOI 10.1074/jbc.M511427200; Goodrich LV, 1997, SCIENCE, V277, P1109, DOI 10.1126/science.277.5329.1109; Hahn H, 1996, CELL, V85, P841, DOI 10.1016/S0092-8674(00)81268-4; HALL TMT, 1995, NATURE, V378, P212, DOI 10.1038/378212a0; Hall TMT, 1997, CELL, V91, P85, DOI 10.1016/S0092-8674(01)80011-8; Harfe BD, 2004, CELL, V118, P517, DOI 10.1016/j.cell.2004.07.024; Huang X, 2007, DEVELOPMENT, V134, P2095, DOI 10.1242/dev.000729; Huangfu DW, 2003, NATURE, V426, P83, DOI 10.1038/nature02061; Ingham PW, 2001, GENE DEV, V15, P3059, DOI 10.1101/gad.938601; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; Jiang J, 2008, DEV CELL, V15, P801, DOI 10.1016/j.devcel.2008.11.010; Johnson RL, 1996, SCIENCE, V272, P1668, DOI 10.1126/science.272.5268.1668; Lee JD, 2001, CURR BIOL, V11, P1147, DOI 10.1016/S0960-9822(01)00323-2; LEE JJ, 1994, SCIENCE, V266, P1528, DOI 10.1126/science.7985023; Lewis PM, 2001, CELL, V105, P599, DOI 10.1016/S0092-8674(01)00369-5; Li YN, 2006, P NATL ACAD SCI USA, V103, P6548, DOI 10.1073/pnas.0600124103; Ma Y, 2002, CELL, V111, P63, DOI 10.1016/S0092-8674(02)00977-7; Marigo V, 1996, NATURE, V384, P176, DOI 10.1038/384176a0; Maun HR, 2010, J BIOL CHEM, V285, P26570, DOI 10.1074/jbc.M110.112284; McLellan JS, 2008, NATURE, V455, P979, DOI 10.1038/nature07358; Milenkovic L, 2009, J CELL BIOL, V187, P365, DOI 10.1083/jcb.200907126; Muenke M, 2000, CURR OPIN GENET DEV, V10, P262, DOI 10.1016/S0959-437X(00)00084-8; Panakova D, 2005, NATURE, V435, P58, DOI 10.1038/nature03504; Pepinsky RB, 2000, J BIOL CHEM, V275, P10995, DOI 10.1074/jbc.275.15.10995; Pepinsky RB, 1998, J BIOL CHEM, V273, P14037, DOI 10.1074/jbc.273.22.14037; PORTER JA, 1995, NATURE, V374, P363, DOI 10.1038/374363a0; Porter JA, 1996, SCIENCE, V274, P255, DOI 10.1126/science.274.5285.255; Porter JA, 1996, CELL, V86, P21, DOI 10.1016/S0092-8674(00)80074-4; ROELINK H, 1995, CELL, V81, P445, DOI 10.1016/0092-8674(95)90397-6; Rohatgi R, 2007, NAT CELL BIOL, V9, P1005, DOI 10.1038/ncb435; Rohatgi R, 2007, SCIENCE, V317, P372, DOI 10.1126/science.1139740; Saha K, 2006, DEVELOPMENT, V133, P889, DOI 10.1242/dev.02254; Sambrook J., 2001, MOL CLONING LAB MANU; Sasaki H, 1997, DEVELOPMENT, V124, P1313; Steinhauer J, 2009, CURR OPIN GENET DEV, V19, P308, DOI 10.1016/j.gde.2009.04.006; Stone DM, 1996, NATURE, V384, P129, DOI 10.1038/384129a0; Taipale J, 2000, NATURE, V406, P1005, DOI 10.1038/35023008; Taipale J, 2002, NATURE, V418, P892, DOI 10.1038/nature00989; Taylor FR, 2001, BIOCHEMISTRY-US, V40, P4359, DOI 10.1021/bi002487u; Williams KP, 1999, J CELL SCI, V112, P4405; Zeng X, 2001, NATURE, V411, P716, DOI 10.1038/35079648; Zheng XY, 2010, GENE DEV, V24, P57, DOI 10.1101/gad.1870310	57	23	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2011	6	7							e21353	10.1371/journal.pone.0021353	http://dx.doi.org/10.1371/journal.pone.0021353			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786HC	21747935	Green Published, Green Submitted, gold			2022-12-27	WOS:000292293400011
J	Ashe, KM; Bangari, D; Li, LY; Cabrera-Salazar, MA; Bercury, SD; Nietupski, JB; Cooper, CGF; Aerts, JMFG; Lee, ER; Copeland, DP; Cheng, SH; Scheule, RK; Marshall, J				Ashe, Karen M.; Bangari, Dinesh; Li, Lingyun; Cabrera-Salazar, Mario A.; Bercury, Scott D.; Nietupski, Jennifer B.; Cooper, Christopher G. F.; Aerts, Johannes M. F. G.; Lee, Edward R.; Copeland, Diane P.; Cheng, Seng H.; Scheule, Ronald K.; Marshall, John			Iminosugar-Based Inhibitors of Glucosylceramide Synthase Increase Brain Glycosphingolipids and Survival in a Mouse Model of Sandhoff Disease	PLOS ONE			English	Article							SUBSTRATE REDUCTION THERAPY; ENZYME REPLACEMENT THERAPY; SYNUCLEIN ACTIVATES MICROGLIA; GAUCHER-DISEASE; TAY-SACHS; ALPHA-SYNUCLEIN; DEPRIVATION THERAPY; CONTROLLED-TRIAL; MICE; GANGLIOSIDOSIS	The neuropathic glycosphingolipidoses are a subgroup of lysosomal storage disorders for which there are no effective therapies. A potential approach is substrate reduction therapy using inhibitors of glucosylceramide synthase (GCS) to decrease the synthesis of glucosylceramide and related glycosphingolipids that accumulate in the lysosomes. Genz-529468, a blood-brain barrier-permeant iminosugar-based GCS inhibitor, was used to evaluate this concept in a mouse model of Sandhoff disease, which accumulates the glycosphingolipid GM2 in the visceral organs and CNS. As expected, oral administration of the drug inhibited hepatic GM2 accumulation. Paradoxically, in the brain, treatment resulted in a slight increase in GM2 levels and a 20-fold increase in glucosylceramide levels. The increase in brain glucosylceramide levels might be due to concurrent inhibition of the non-lysosomal glucosylceramidase, Gba2. Similar results were observed with NB-DNJ, another iminosugar-based GCS inhibitor. Despite these unanticipated increases in glycosphingolipids in the CNS, treatment nevertheless delayed the loss of motor function and coordination and extended the lifespan of the Sandhoff mice. These results suggest that the CNS benefits observed in the Sandhoff mice might not necessarily be due to substrate reduction therapy but rather to off-target effects.	[Ashe, Karen M.; Bangari, Dinesh; Li, Lingyun; Cabrera-Salazar, Mario A.; Bercury, Scott D.; Nietupski, Jennifer B.; Cooper, Christopher G. F.; Lee, Edward R.; Copeland, Diane P.; Cheng, Seng H.; Scheule, Ronald K.; Marshall, John] Genzyme Corp, Framingham, MA 01701 USA; [Aerts, Johannes M. F. G.] Univ Amsterdam, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands	Sanofi-Aventis; Genzyme Corporation; University of Amsterdam; Academic Medical Center Amsterdam	Ashe, KM (corresponding author), Genzyme Corp, Framingham, MA 01701 USA.	john.marshall@genzyme.com	Cheng, Seng H/AAC-6564-2022; Aerts, Johannes/A-1028-2009	Aerts, Johannes/0000-0001-8168-2565; Marshall, John/0000-0003-1361-2869	Genzyme Corporation	Genzyme Corporation(Sanofi-AventisGenzyme Corporation)	All support for these studies was provided by Genzyme Corporation, through the employment of Karen M. Ashe, Dinesh Bangari, Lingyun Li, Mario A. Cabrera-Salazar, Scott D. Bercury, Jennifer B. Nietupski, Christopher G. F. Cooper, Edward R. Lee, Diane P. Copeland, Seng H. Cheng, Ronald K. Scheule and John Marshall, who contributed to all aspects of the study. The described studies were part of the drug development program at Genzyme Corporation. The internal publication review committee approved the manuscript for publication.	Aerts JM, 2007, DIABETES, V56, P1341, DOI 10.2337/db06-1619; Andersson U, 2004, NEUROBIOL DIS, V16, P506, DOI 10.1016/j.nbd.2004.04.012; Ashe KM, 2010, MOL GENET METAB, V100, P309, DOI 10.1016/j.ymgme.2010.05.001; Bellettato CM, 2010, J INHERIT METAB DIS, V33, P347, DOI 10.1007/s10545-010-9075-9; Bodennec J, 2002, FASEB J, V16, P1814, DOI 10.1096/fj.02-0149fje; Boot RG, 2007, J BIOL CHEM, V282, P1305, DOI 10.1074/jbc.M610544200; Davies EH, 2007, J INHERIT METAB DIS, V30, P935, DOI 10.1007/s10545-007-0577-z; GEISLER FH, 1991, NEW ENGL J MED, V324, P1829, DOI 10.1056/NEJM199106273242601; Gravel R. A., 2001, METABOLIC MOL BASES, V3, P3827; Huang JQ, 1997, HUM MOL GENET, V6, P1879, DOI 10.1093/hmg/6.11.1879; Jennemann R, 2005, P NATL ACAD SCI USA, V102, P12459, DOI 10.1073/pnas.0500893102; Jeyakumar M, 2004, ANN NEUROL, V56, P642, DOI 10.1002/ana.20242; Jeyakumar M, 2003, BRAIN, V126, P974, DOI 10.1093/brain/awg089; Jeyakumar M, 1999, P NATL ACAD SCI USA, V96, P6388, DOI 10.1073/pnas.96.11.6388; Jeyakumar M, 2001, BLOOD, V97, P327, DOI 10.1182/blood.V97.1.327; Kasperzyk JL, 2005, J LIPID RES, V46, P744, DOI 10.1194/jlr.M400411-JLR200; Lachmann RH, 2001, EXPERT OPIN INV DRUG, V10, P455, DOI 10.1517/13543784.10.3.455; Lachmann Robin H, 2009, Expert Rev Endocrinol Metab, V4, P217, DOI 10.1586/eem.09.8; Lee EJ, 2010, J IMMUNOL, V185, P615, DOI 10.4049/jimmunol.0903480; Liu YJ, 1999, J CLIN INVEST, V103, P497, DOI 10.1172/JCI5542; Lukina E, 2010, BLOOD, V116, P893, DOI 10.1182/blood-2010-03-273151; Maegawa GHB, 2009, MOL GENET METAB, V98, P215, DOI 10.1016/j.ymgme.2009.06.005; Marshall J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015033; Masciullo M, 2010, J INHERIT METAB DIS, V33, pS355, DOI 10.1007/s10545-010-9186-3; McNally MA, 2007, J NEGAT RESULTS BIOM, V6, DOI 10.1186/1477-5751-6-8; Merrill AH, 2005, METHODS, V36, P207, DOI 10.1016/j.ymeth.2005.01.009; Myerowitz R, 2002, HUM MOL GENET, V11, P1343, DOI 10.1093/hmg/11.11.1343; Norflus F, 1998, J CLIN INVEST, V101, P1881, DOI 10.1172/JCI2127; Overkleeft HS, 1998, J BIOL CHEM, V273, P26522, DOI 10.1074/jbc.273.41.26522; Pelled D, 2003, J BIOL CHEM, V278, P29496, DOI 10.1074/jbc.M302964200; Platt FM, 2003, PHILOS T R SOC B, V358, P947, DOI 10.1098/rstb.2003.1279; SANGO K, 1995, NAT GENET, V11, P170, DOI 10.1038/ng1095-170; Schiffmann R, 2010, J INHERIT METAB DIS, V33, P373, DOI 10.1007/s10545-010-9047-0; Schiffmann R, 2008, ANN NEUROL, V64, P514, DOI 10.1002/ana.21491; Shapiro BE, 2009, GENET MED, V11, P425, DOI 10.1097/GIM.0b013e3181a1b5c5; Shen C, 2004, INT IMMUNOPHARMACOL, V4, P939, DOI 10.1016/j.intimp.2004.04.008; Suzuki K, 2003, NEUROREPORT, V14, P551, DOI 10.1097/00001756-200303240-00004; van Eijk M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004723; Wada R, 2000, P NATL ACAD SCI USA, V97, P10954, DOI 10.1073/pnas.97.20.10954; Walden CM, 2007, J BIOL CHEM, V282, P32655, DOI 10.1074/jbc.M702387200; Weinreb NJ, 2002, AM J MED, V113, P112, DOI 10.1016/S0002-9343(02)01150-6; Wennekes T, 2010, J MED CHEM, V53, P689, DOI 10.1021/jm901281m; Wilcox WR, 2004, AM J HUM GENET, V75, P65, DOI 10.1086/422366; Wraith JE, 2010, MOL GENET METAB, V99, P351, DOI 10.1016/j.ymgme.2009.12.006; Wu YP, 2004, P NATL ACAD SCI USA, V101, P8425, DOI 10.1073/pnas.0400625101; Wu YP, 2008, HUM MOL GENET, V17, P2257, DOI 10.1093/hmg/ddn126; Yamashita T, 2005, GENESIS, V43, P175, DOI 10.1002/gene.20167; Yamashita T, 2005, P NATL ACAD SCI USA, V102, P2725, DOI 10.1073/pnas.0407785102; Yildiz Y, 2006, J CLIN INVEST, V116, P2985, DOI 10.1172/JCI29224; Zhang W, 2005, FASEB J, V19, P533, DOI 10.1096/fj.04-2751com; Zimran A, 2007, J INHERIT METAB DIS, V30, P843, DOI 10.1007/s10545-007-0783-8	51	48	54	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2011	6	6							e21758	10.1371/journal.pone.0021758	http://dx.doi.org/10.1371/journal.pone.0021758			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786FZ	21738789	Green Published, gold			2022-12-27	WOS:000292290100069
J	Bukhari, T; Takken, W; Githeko, AK; Koenraadt, CJM				Bukhari, Tullu; Takken, Willem; Githeko, Andrew K.; Koenraadt, Constantianus J. M.			Efficacy of Aquatain, a Monomolecular Film, for the Control of Malaria Vectors in Rice Paddies	PLOS ONE			English	Article							ORGANIC-SURFACE FILM; DAR-ES-SALAAM; AROSURF MSF; ANOPHELES-GAMBIAE; MOSQUITO-CONTROL; LECITHIN MONOLAYERS; CULEX-QUINQUEFASCIATUS; BACILLUS-SPHAERICUS; IRRIGATION SCHEME; FIELD EVALUATIONS	Background: Rice paddies harbour a large variety of organisms including larvae of malaria mosquitoes. These paddies are challenging for mosquito control because their large size, slurry and vegetation make it difficult to effectively apply a control agent. Aquatain, a monomolecular surface film, can be considered a suitable mosquito control agent for such breeding habitats due to its physical properties. The properties allow Aquatain to self-spread over a water surface and affect multiple stages of the mosquito life cycle. Methodology/Principal Findings: A trial based on a pre-test/post-test control group design evaluated the potential of Aquatain as a mosquito control agent at Ahero rice irrigation scheme in Kenya. After Aquatain application at a dose of 2 ml/m(2) on rice paddies, early stage anopheline larvae were reduced by 36%, and late stage anopheline larvae by 16%. However, even at a lower dose of 1 ml/m(2) there was a 93.2% reduction in emergence of anopheline adults and 69.5% reduction in emergence of culicine adults. No pupation was observed in treated buckets that were part of a field bio-assay carried out parallel to the trial. Aquatain application saved nearly 1.7 L of water in six days from a water surface of 0.2 m(2) under field conditions. Aquatain had no negative effect on rice plants as well as on a variety of non-target organisms, except backswimmers. Conclusions/Significance: We demonstrated that Aquatain is an effective agent for the control of anopheline and culicine mosquitoes in irrigated rice paddies. The agent reduced densities of aquatic larval stages and, more importantly, strongly impacted the emergence of adult mosquitoes. Aquatain also reduced water loss due to evaporation. No negative impacts were found on either abundance of non-target organisms, or growth and development of rice plants. Aquatain, therefore, appears a suitable mosquito control tool for use in rice agro-ecosystems.	[Bukhari, Tullu; Takken, Willem; Koenraadt, Constantianus J. M.] Univ Wageningen & Res Ctr, Entomol Lab, Wageningen, Netherlands; [Githeko, Andrew K.] Kenya Govt Med Res Ctr, Kisumu, Kenya	Wageningen University & Research; Kenya Medical Research Institute	Bukhari, T (corresponding author), Univ Wageningen & Res Ctr, Entomol Lab, Wageningen, Netherlands.	tullu.bukhari@wur.nl		Koenraadt, Constantianus/0000-0001-7861-8781; Bukhari, Syeda/0000-0002-4291-9619	Higher Education Commission, Pakistan through Netherlands Organization for International Cooperation in Higher Education (NUFFIC), The Netherlands	Higher Education Commission, Pakistan through Netherlands Organization for International Cooperation in Higher Education (NUFFIC), The Netherlands(Netherlands Government)	Tullu Bukhari is funded by Higher Education Commission, Pakistan through Netherlands Organization for International Cooperation in Higher Education (NUFFIC), The Netherlands. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali A, 2000, J AM MOSQUITO CONTR, V16, P313; [Anonymous], 1992, BIOL MOSQUITOES DEV; Atieli H, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-108; Bashir A. L., 2008, Southeast Asian Journal of Tropical Medicine and Public Health, V39, P222; Batra CP, 2006, J AM MOSQUITO CONTR, V22, P426, DOI 10.2987/8756-971X(2006)22[426:EOAMMS]2.0.CO;2; Bukhari T, 2009, AM J TROP MED HYG, V80, P758, DOI 10.4269/ajtmh.2009.80.758; BURGESS JH, 1985, J AM MOSQUITO CONTR, V1, P245; Corbet SA, 2000, ENTOMOL EXP APPL, V94, P295, DOI 10.1023/A:1003920817649; Djouaka RF, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-56; Dolo G, 2004, ACTA TROP, V89, P147, DOI 10.1016/j.actatropica.2003.10.014; Fillinger U, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-20; Fillinger U, 2009, B WORLD HEALTH ORGAN, V87, P655, DOI 10.2471/BLT.08.055632; Fillinger U, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-62; GARRETT WD, 1977, MOSQ NEWS, V37, P344; Geissbuhler Y, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-126; Githeko A. K., 1996, Parassitologia (Rome), V38, P481; HERTLEIN B, 1985, J AM MOSQUITO CONTR, V1, P255; HESTER PG, 1989, J AM MOSQUITO CONTR, V5, P272; HESTER PG, 1991, J AM MOSQUITO CONTR, V7, P48; Ijumba JN, 2001, MED VET ENTOMOL, V15, P1, DOI 10.1046/j.1365-2915.2001.00279.x; Jarju LBS, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-170; Kamau L, 2006, J MED ENTOMOL, V43, P774, DOI 10.1603/0022-2585(2006)43[774:EOPROA]2.0.CO;2; KARANJA DMS, 1994, ACTA TROP, V56, P365, DOI 10.1016/0001-706X(94)90107-4; KARCH S, 1991, J AM MOSQUITO CONTR, V7, P176; Keiser J, 2005, AM J TROP MED HYG, V72, P392, DOI 10.4269/ajtmh.2005.72.392; KENNY EA, 1992, J AM MOSQUITO CONTR, V8, P325; KENNY EA, 1993, J AM MOSQUITO CONTR, V9, P361; Killeen GF, 2000, AM J TROP MED HYG, V62, P535, DOI 10.4269/ajtmh.2000.62.535; Klinkenberg E, 2003, ACTA TROP, V85, P71, DOI 10.1016/S0001-706X(02)00254-1; Koenraadt CJM, 2004, ACTA TROP, V90, P141, DOI 10.1016/j.actatropica.2003.11.007; LANG HH, 1980, BEHAV ECOL SOCIOBIOL, V6, P233, DOI 10.1007/BF00569205; LEVY R, 1982, MOSQ NEWS, V42, P1; Levy R., 1984, Journal of the Florida Anti-Mosquito Association, V55, P31; LEVY R, 1984, MOSQ NEWS, V44, P592; LEVY R, 1981, MOSQ NEWS, V41, P291; LEVY R, 1980, MOSQ NEWS, V40, P27; LEVY R, 1986, J AM MOSQUITO CONTR, V2, P233; LEVY R, 1984, MOSQ NEWS, V44; LEVY R, 1982, MOSQ NEWS, V42; MORGAN JC, PLOS ONE, V5; Mulla MS, 2003, J AM MOSQUITO CONTR, V19, P39; Muturi EJ, 2006, J VECTOR ECOL, V31, P129, DOI 10.3376/1081-1710(2006)31[129:MSDAAI]2.0.CO;2; Mwangangi JM, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-228; Nayar JK, 2003, J VECTOR ECOL, V28, P190; Nelder M, 2010, AM J TROP MED HYG, V82, P831, DOI 10.4269/ajtmh.2010.09-0546; Ng'ang'a PN, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-146; Paaijmans KP, 2008, INT J BIOMETEOROL, V52, P747, DOI 10.1007/s00484-008-0167-2; Paaijmans KP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001146; Paaijmans KP, 2009, ACTA TROP, V109, P124, DOI 10.1016/j.actatropica.2008.07.010; RANSON H, TRENDS PARASITOL; REITER P, 1978, MOSQ NEWS, V38, P334; REITER P, 1978, ANN TROP MED PARASIT, V72, P163, DOI 10.1080/00034983.1978.11719299; REITER P, 1978, ANN TROP MED PARASIT, V72, P169, DOI 10.1080/00034983.1978.11719300; REITER P, 1980, ANN TROP MED PARASIT, V74, P541, DOI 10.1080/00034983.1980.11687382; SCOTT JA, 1993, AM J TROP MED HYG, V49, P520, DOI 10.4269/ajtmh.1993.49.520; SERVICE MW, 1989, PARASITOL TODAY, V5, P162, DOI 10.1016/0169-4758(89)90083-5; Stresman GH, 2010, ACTA TROP, V116, P167, DOI 10.1016/j.actatropica.2010.08.005; TAKAHASHI RM, 1984, MOSQ NEWS, V44, P363; Webb CE, 2009, J AM MOSQUITO CONTR, V25, P106, DOI 10.2987/08-5750.1; WEBB CE, 2010, FIELD ASSESSMENT AQU; WEBBER LA, 1984, MOSQ NEWS, V44, P68; WHITE SA, 1977, MOSQ NEWS, V37, P349; Yadouleton A, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-118; YADOULETON AW, MALAR J, V9; 2008, ROLL BACK MALARIA GL	65	29	30	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2011	6	6							e21713	10.1371/journal.pone.0021713	http://dx.doi.org/10.1371/journal.pone.0021713			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786FZ	21738774	gold, Green Published, Green Submitted			2022-12-27	WOS:000292290100061
J	Evans, O; Paulk, AC; van Swinderen, B				Evans, Oliver; Paulk, Angelique C.; van Swinderen, Bruno			An Automated Paradigm for Drosophila Visual Psychophysics	PLOS ONE			English	Article							OPTOKINETIC NYSTAGMUS; MOTION PERCEPTION; ATTENTION; MEMORY; MELANOGASTER; BRAIN; FLY; INTERNEURONS; SUPPRESSION; STIMULI	Background: Mutations that cause learning and memory defects in Drosophila melanogaster have been found to also compromise visual responsiveness and attention. A better understanding of attention-like defects in such Drosophila mutants therefore requires a more detailed characterization of visual responsiveness across a range of visual parameters. Methodology/Principal Findings: We designed an automated behavioral paradigm for efficiently dissecting visual responsiveness in Drosophila. Populations of flies walk through multiplexed serial choice mazes while being exposed to moving visuals displayed on computer monitors, and infra-red fly counters at the end of each maze automatically score the responsiveness of a strain. To test our new design, we performed a detailed comparison between wild-type flies and a learning and memory mutant, dunce(1). We first confirmed that the learning mutant dunce(1) displays increased responsiveness to a black/green moving grating compared to wild type in this new design. We then extended this result to explore responses to a wide range of psychophysical parameters for moving gratings (e.g., luminosity, contrast, spatial frequency, velocity) as well as to a different stimulus, moving dots. Finally, we combined these visuals (gratings versus dots) in competition to investigate how dunce(1) and wild-type flies respond to more complex and conflicting motion effects. Conclusions/Significance: We found that dunce(1) responds more strongly than wild type to high contrast and highly structured motion. This effect was found for simple gratings, dots, and combinations of both stimuli presented in competition.	[Evans, Oliver; Paulk, Angelique C.; van Swinderen, Bruno] Univ Queensland, Queensland Brain Inst, Brisbane, Qld, Australia	University of Queensland	Evans, O (corresponding author), Univ Queensland, Queensland Brain Inst, Brisbane, Qld, Australia.	vanswinderen@uq.edu		van Swinderen, Bruno/0000-0001-6552-7418	Australian Research Council [FT100100725]	Australian Research Council(Australian Research Council)	This research was funded by the Australian Research Council Future Fellowship FT100100725 to BVS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen SK, 2010, P NATL ACAD SCI USA, V107, P13878, DOI 10.1073/pnas.1002436107; BAKER CL, 1991, J NEUROSCI, V11, P454; Bolzon DM, 2009, J NEUROSCI, V29, P14143, DOI 10.1523/JNEUROSCI.2857-09.2009; BORST A, 2010, ANN REV NEUROSCI; Borst A, 2009, CURR BIOL, V19, pR36, DOI 10.1016/j.cub.2008.11.001; GOTZ KG, 1970, J EXP BIOL, V52, P419; GOTZ KG, 1973, J COMP PHYSIOL, V85, P235, DOI 10.1007/BF00694232; Haag J, 2010, P NATL ACAD SCI USA, V107, P20104, DOI 10.1073/pnas.1009381107; Heisenberg M., 1984, Vision in Drosophila.Genetics of microbehaviour.; Joesch M, 2008, CURR BIOL, V18, P368, DOI 10.1016/j.cub.2008.02.022; KALMUS H, 1964, NATURE, V202, P1156, DOI 10.1038/2021156a0; Katsov AY, 2008, NEURON, V59, P322, DOI 10.1016/j.neuron.2008.05.022; Liu G, 2006, NATURE, V439, P551, DOI 10.1038/nature04381; Masseck OA, 2009, ANN NY ACAD SCI, V1164, P430, DOI 10.1111/j.1749-6632.2009.03854.x; NEWSOME WT, 1988, J NEUROSCI, V8, P2201; Nordstrom K, 2009, TRENDS NEUROSCI, V32, P383, DOI 10.1016/j.tins.2009.03.004; Pan YF, 2009, LEARN MEMORY, V16, P289, DOI 10.1101/lm.1331809; PFLUGFELDER GO, 1995, COMP BIOCHEM PHYS A, V110, P185, DOI 10.1016/0300-9629(94)00159-Q; Rister J, 2007, NEURON, V56, P155, DOI 10.1016/j.neuron.2007.09.014; Rubinstein NJ, 2011, INVEST OPHTH VIS SCI, V52, P462, DOI 10.1167/iovs.10-6016; Sareen P, 2011, P NATL ACAD SCI USA, V108, P7230, DOI 10.1073/pnas.1102522108; Schnell B, 2010, J NEUROPHYSIOL, V103, P1646, DOI 10.1152/jn.00950.2009; Srinivasan MV, 1999, VISION RES, V39, P2749, DOI 10.1016/S0042-6989(99)00002-4; Strauss R, 1997, J EXP BIOL, V200, P1281; STRAW AD, 2008, FRONT NEUROINFORM, DOI DOI 10.3389/NEURO.11.0044.2008; Tang SM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014455; van Swinderen B, 2007, DEV NEUROBIOL, V67, P129, DOI 10.1002/dneu.20334; van Swinderen B, 2007, SCIENCE, V315, P1590, DOI 10.1126/science.1137931; van Swinderen B, 2010, J NEUROSCI, V30, P1003, DOI 10.1523/JNEUROSCI.4516-09.2010; van Swinderen B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005989; WILLIAMS DW, 1984, VISION RES, V24, P55, DOI 10.1016/0042-6989(84)90144-5; Williams IM, 2006, J CLIN NEUROSCI, V13, P828, DOI 10.1016/j.jocn.2005.10.010; Yamaguchi S, 2008, P NATL ACAD SCI USA, V105, P4910, DOI 10.1073/pnas.0711484105; Zhu Y, 2009, CURR BIOL, V19, P613, DOI 10.1016/j.cub.2009.02.053	34	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2011	6	6							e21619	10.1371/journal.pone.0021619	http://dx.doi.org/10.1371/journal.pone.0021619			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786FZ	21738736	Green Published, gold, Green Submitted			2022-12-27	WOS:000292290100046
J	Phillips, SP; Hammarstrom, A				Phillips, Susan P.; Hammarstrom, Anne			Relative Health Effects of Education, Socioeconomic Status and Domestic Gender Inequity in Sweden: A Cohort Study	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; SOCIAL-CLASS; WOMEN; MEN; INEQUALITIES; EQUALITY; DEATH; RISK	Introduction: Limited existing research on gender inequities suggests that for men workplace atmosphere shapes wellbeing while women are less susceptible to socioeconomic or work status but vulnerable to home inequities. Methods: Using the 2007 Northern Swedish Cohort (n = 773) we identified relative contributions of perceived gender inequities in relationships, financial strain, and education to self-reported health to determine whether controlling for sex, examining interactions between sex and other social variables, or sex-disaggregating data yielded most information about sex differences. Results and Discussion: Men had lower education but also less financial strain, and experienced less gender inequity. Overall, low education and financial strain detracted from health. However, sex-disaggregated data showed this to be true for women, whereas for men only gender inequity at home affected health. In the relatively egalitarian Swedish environment where women more readily enter all work arenas and men often provide parenting, traditional primacy of the home environment (for women) and the work environment (for men) in shaping health is reversing such that perceived domestic gender inequity has a significant health impact on men, while for women only education and financial strain are contributory. These outcomes were identified only when data were sex-disaggregated.	[Phillips, Susan P.] Queens Univ, Sch Med, Kingston, ON, Canada; [Hammarstrom, Anne] Umea Univ, Dept Publ Hlth & Clin Med, Umea Ctr Gender Studies Med, Umea, Sweden	Queens University - Canada; Umea University	Phillips, SP (corresponding author), Queens Univ, Sch Med, Kingston, ON, Canada.	phillip@post.queensu.ca	Bertorelli, Christina/H-1964-2011	Hammarstrom, Anne/0000-0002-4095-7961; Phillips, Susan/0000-0003-4798-1742	Swedish Council for Social Research, Box 2220, 103 15 Stockholm, Sweden; National Graduate School for Gender Studies at Umea University	Swedish Council for Social Research, Box 2220, 103 15 Stockholm, Sweden; National Graduate School for Gender Studies at Umea University	Financial support for A. Hammarstrom was provided by the Swedish Council for Social Research, Box 2220, 103 15 Stockholm, Sweden, and the National Graduate School for Gender Studies at Umea University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arber S, 1997, SOC SCI MED, V44, P773, DOI 10.1016/S0277-9536(96)00185-2; Backhans MC, 2007, SOC SCI MED, V64, P1892, DOI 10.1016/j.socscimed.2007.01.016; Bartley M, 2004, SOC SCI MED, V59, P1925, DOI 10.1016/j.socscimed.2004.03.002; Borrell C, 2004, SOC SCI MED, V58, P1869, DOI 10.1016/S0277-9536(03)00408-8; Chandola T, 2004, SOC SCI MED, V58, P1501, DOI 10.1016/S0277-9536(03)00352-6; COOPER H, 2008, SOC SCI MED, V54, P693; Hammarstrom A, 2005, SOC SCI MED, V61, P2221, DOI 10.1016/j.socscimed.2005.04.020; Harryson L, 2012, J EPIDEMIOL COMMUN H, V66, P271, DOI 10.1136/jech.2010.109231; Hausmann Ricardo, 2007, GLOBAL GENDER GAP RE; Hunt K, 2007, INT J EPIDEMIOL, V36, P612, DOI 10.1093/ije/dym022; Iyer A, 2008, Glob Public Health, V3 Suppl 1, P13, DOI 10.1080/17441690801892174; Johansson S, 1970, ADULT POPULATIONS ST; Julkunen I, 2002, SOC POLICY ADMIN, V36, P235, DOI 10.1111/1467-9515.00249; KOSKINEN S, 1994, SOC SCI MED, V38, P1385, DOI 10.1016/0277-9536(94)90276-3; Krieger N, 1999, J EPIDEMIOL COMMUN H, V53, P612, DOI 10.1136/jech.53.10.612; Manderbacka K, 1999, SOC SCI MED, V48, P1713, DOI 10.1016/S0277-9536(99)00068-4; Mansdotter A, 2006, J EPIDEMIOL COMMUN H, V60, P616, DOI 10.1136/jech.2005.041327; MARMOT MG, 1978, J EPIDEMIOL COMMUN H, V32, P244, DOI 10.1136/jech.32.4.244; Nordenmark M, 2003, EUR J WOMENS STUD, V10, P181, DOI 10.1177/1350506803010002004; Novo M, 2000, THESIS UMEA U UMEA; Rothstein B, 2012, GENDER WORK ORGAN, V19, P324, DOI 10.1111/j.1468-0432.2010.00517.x; Sacker A, 2001, SOC SCI MED, V52, P763, DOI 10.1016/S0277-9536(00)00176-3; *STATISTICSSWEDEN, 1979, WORK COND SICK LIST; Wilkinson RG, 2006, SOC SCI MED, V62, P1768, DOI 10.1016/j.socscimed.2005.08.036; YUEN P, 1994, PUBLIC HLTH, V104, P65	25	6	6	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2011	6	6							e21722	10.1371/journal.pone.0021722	http://dx.doi.org/10.1371/journal.pone.0021722			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	786FZ	21747922	Green Submitted, Green Published, gold			2022-12-27	WOS:000292290100064
J	Gupta, V; Bassi, DE; Simons, JD; Devarajan, K; Al-Saleem, T; Uzzo, RG; Cukierman, E				Gupta, Vivekanand; Bassi, Daniel E.; Simons, Jeffrey D.; Devarajan, Karthik; Al-Saleem, Tahseen; Uzzo, Robert G.; Cukierman, Edna			Elevated Expression of Stromal Palladin Predicts Poor Clinical Outcome in Renal Cell Carcinoma	PLOS ONE			English	Article							TUMOR-ASSOCIATED FIBROBLASTS; EXTRACELLULAR-MATRIX; MYOFIBROBLASTS; STROMAGENESIS; UTILITY; MARKER	The role that stromal renal cell carcinoma (RCC) plays in support of tumor progression is unclear. Here we sought to determine the predictive value on patient survival of several markers of stromal activation and the feasibility of a fibroblast-derived extracellular matrix (ECM) based three-dimensional (3D) culture stemming from clinical specimens to recapitulate stromal behavior in vitro. The clinical relevance of selected stromal markers was assessed using a well annotated tumor microarray where stromal-marker levels of expression were evaluated and compared to patient outcomes. Also, an in vitro 3D system derived from fibroblasts harvested from patient matched normal kidney, primary RCC and metastatic tumors was employed to evaluate levels and localizations of known stromal markers such as the actin binding proteins palladin, alpha-smooth muscle actin (alpha-SMA), fibronectin and its spliced form EDA. Results suggested that RCCs exhibiting high levels of stromal palladin correlate with a poor prognosis, as demonstrated by overall survival time. Conversely, cases of RCCs where stroma presents low levels of palladin expression indicate increased survival times and, hence, better outcomes. Fibroblast-derived 3D cultures, which facilitate the categorization of stromal RCCs into discrete progressive stromal stages, also show increased levels of expression and stress fiber localization of alpha-SMA and palladin, as well as topographical organization of fibronectin and its splice variant EDA. These observations are concordant with expression levels of these markers in vivo. The study proposes that palladin constitutes a useful marker of poor prognosis in non-metastatic RCCs, while in vitro 3D cultures accurately represent the specific patient's tumor-associated stromal compartment. Our observations support the belief that stromal palladin assessments have clinical relevance thus validating the use of these 3D cultures to study both progressive RCC-associated stroma and stroma-dependent mechanisms affecting tumorigenesis. The clinical value of assessing RCC stromal activation merits further study.	[Gupta, Vivekanand; Bassi, Daniel E.; Simons, Jeffrey D.; Cukierman, Edna] Fox Chase Canc Ctr, Canc Biol Program, Philadelphia, PA 19111 USA; [Bassi, Daniel E.; Al-Saleem, Tahseen] Fox Chase Canc Ctr, Dept Pathol, Philadelphia, PA 19111 USA; [Uzzo, Robert G.] Fox Chase Canc Ctr, Dept Surg Oncol, Philadelphia, PA 19111 USA; [Devarajan, Karthik] Fox Chase Canc Ctr, Dept Biostat, Philadelphia, PA 19111 USA	Fox Chase Cancer Center; Fox Chase Cancer Center; Fox Chase Cancer Center; Fox Chase Cancer Center	Gupta, V (corresponding author), Fox Chase Canc Ctr, Canc Biol Program, 7701 Burholme Ave, Philadelphia, PA 19111 USA.	Edna.Cukierman@fccc.edu	Uzzo, Robert G./U-5238-2019; Cukierman, Edna/A-3951-2013; cukierman, edna/AAU-8932-2020; Gupta, Vivekanand/F-3530-2012	cukierman, edna/0000-0002-1452-9576; 	Fox Chase Cancer Center; American Urological Association Foundation; NCI/NIH [CA113451, CA06927]; NATIONAL CANCER INSTITUTE [R01CA113451, P30CA006927] Funding Source: NIH RePORTER	Fox Chase Cancer Center; American Urological Association Foundation; NCI/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The Keystone Program in Personalized Kidney Cancer Therapy at Fox Chase Cancer Center (Institutional Funds) to EC, VG, TAS and RGU, an American Urological Association Foundation Research Scholar Program Award to VG (http://www.urologyhealth.org/research/grantprograms.cfm), as well as NCI/NIH CA113451 to EC and CA06927 to all authors. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amatangelo MD, 2005, AM J PATHOL, V167, P475, DOI 10.1016/S0002-9440(10)62991-4; Beacham DA, 2005, SEMIN CANCER BIOL, V15, P329, DOI 10.1016/j.semcancer.2005.05.003; BEACHAM DA, 2006, CURR PROTOCOLS CELL; Castello-Cros R, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-94; Castello-Cros Remedios, 2009, V522, P275, DOI 10.1007/978-1-59745-413-1_19; Chometon G, 2009, CLIN TRANSL ONCOL, V11, P75, DOI 10.1007/s12094-009-0317-y; Council L, 2009, MODERN PATHOL, V22, P639, DOI 10.1038/modpathol.2009.9; Cukierman E, 2001, SCIENCE, V294, P1708, DOI 10.1126/science.1064829; Curino AC, 2005, J CELL BIOL, V169, P977, DOI 10.1083/jcb.200411153; De Wever O, 2008, INT J CANCER, V123, P2229, DOI 10.1002/ijc.23925; Desmouliere A, 2005, WOUND REPAIR REGEN, V13, P7, DOI 10.1111/j.1067-1927.2005.130102.x; Desmouliere A, 2004, INT J DEV BIOL, V48, P509, DOI 10.1387/ijdb.041802ad; Engelholm LH, 2009, FRONT BIOSCI-LANDMRK, V14, P2103, DOI 10.2741/3365; Erkan M, 2008, CLIN GASTROENTEROL H, V6, P1155, DOI 10.1016/j.cgh.2008.05.006; GOETZ JG, 2011, CELL IN PRESS   0708; Goicoechea SM, 2009, ONCOGENE, V28, P587, DOI 10.1038/onc.2008.408; Goicoechea SM, 2008, EUR J CELL BIOL, V87, P517, DOI 10.1016/j.ejcb.2008.01.010; Goicoechea SM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010347; Gupta K, 2008, CANCER TREAT REV, V34, P193, DOI 10.1016/j.ctrv.2007.12.001; Hothorn T, 2006, J COMPUT GRAPH STAT, V15, P651, DOI 10.1198/106186006X133933; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; Kaplan RN, 2005, NATURE, V438, P820, DOI 10.1038/nature04186; KOVACS G, 1989, AM J PATHOL, V134, P27; Kwon Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018872; Liu J, 2009, NATURE, V459, P387, DOI 10.1038/nature08040; Lohi J, 1998, HISTOL HISTOPATHOL, V13, P785, DOI 10.14670/HH-13.785; Messaritou G, 2009, J CELL SCI, V122, P4042, DOI 10.1242/jcs.044305; Nelson CM, 2006, ANNU REV CELL DEV BI, V22, P287, DOI 10.1146/annurev.cellbio.22.010305.104315; Pan CC, 2004, HISTOPATHOLOGY, V45, P452, DOI 10.1111/j.1365-2559.2004.01962.x; Pan JD, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-56; Parast MM, 2000, J CELL BIOL, V150, P643, DOI 10.1083/jcb.150.3.643; Provenzano PP, 2006, BMC MED, V4, DOI 10.1186/1741-7015-4-38; Quiros RM, 2008, GYNECOL ONCOL, V110, P99, DOI 10.1016/j.ygyno.2008.03.006; Ronty MJ, 2006, J INVEST DERMATOL, V126, P2387, DOI 10.1038/sj.jid.5700427; Salaria SN, 2007, CANCER BIOL THER, V6, P324, DOI 10.4161/cbt.6.3.3904; Salmon P, 2000, MOL THER, V2, P404, DOI 10.1006/mthe.2000.0141; Sund M, 2009, CANCER METAST REV, V28, P177, DOI 10.1007/s10555-008-9175-2; *TEAM RDC, 2005, R PROJ STAT COMP; Trimboli AJ, 2009, NATURE, V461, P1084, DOI 10.1038/nature08486; Witkiewicz AK, 2008, CELL CYCLE, V7, P3021, DOI 10.4161/cc.7.19.6719	41	31	32	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2011	6	6							e21494	10.1371/journal.pone.0021494	http://dx.doi.org/10.1371/journal.pone.0021494			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	784FW	21738681	Green Published, Green Submitted, gold			2022-12-27	WOS:000292142800029
J	Vidau, C; Diogon, M; Aufauvre, J; Fontbonne, R; Vigues, B; Brunet, JL; Texier, C; Biron, DG; Blot, N; El Alaoui, H; Belzunces, LP; Delbac, F				Vidau, Cyril; Diogon, Marie; Aufauvre, Julie; Fontbonne, Regis; Vigues, Bernard; Brunet, Jean-Luc; Texier, Catherine; Biron, David G.; Blot, Nicolas; El Alaoui, Hicham; Belzunces, Luc P.; Delbac, Frederic			Exposure to Sublethal Doses of Fipronil and Thiacloprid Highly Increases Mortality of Honeybees Previously Infected by Nosema ceranae	PLOS ONE			English	Article							METARHIZIUM-ANISOPLIAE DEUTEROMYCOTINA; APIS-MELLIFERA; DROSOPHILA-MELANOGASTER; SYSTEMIC INSECTICIDES; BEAUVERIA-BASSIANA; BEE; PESTICIDES; RESISTANCE; TOXICITY; CHLORPYRIFOS	Background: The honeybee, Apis mellifera, is undergoing a worldwide decline whose origin is still in debate. Studies performed for twenty years suggest that this decline may involve both infectious diseases and exposure to pesticides. Joint action of pathogens and chemicals are known to threaten several organisms but the combined effects of these stressors were poorly investigated in honeybees. Our study was designed to explore the effect of Nosema ceranae infection on honeybee sensitivity to sublethal doses of the insecticides fipronil and thiacloprid. Methodology/Finding: Five days after their emergence, honeybees were divided in 6 experimental groups: (i) uninfected controls, (ii) infected with N. ceranae, (iii) uninfected and exposed to fipronil, (iv) uninfected and exposed to thiacloprid, (v) infected with N. ceranae and exposed 10 days post-infection (p. i.) to fipronil, and (vi) infected with N. ceranae and exposed 10 days p. i. to thiacloprid. Honeybee mortality and insecticide consumption were analyzed daily and the intestinal spore content was evaluated 20 days after infection. A significant increase in honeybee mortality was observed when N. ceranae-infected honeybees were exposed to sublethal doses of insecticides. Surprisingly, exposures to fipronil and thiacloprid had opposite effects on microsporidian spore production. Analysis of the honeybee detoxification system 10 days p. i. showed that N. ceranae infection induced an increase in glutathione-S-transferase activity in midgut and fat body but not in 7-ethoxycoumarin-O-deethylase activity. Conclusions/Significance: After exposure to sublethal doses of fipronil or thiacloprid a higher mortality was observed in N. ceranae-infected honeybees than in uninfected ones. The synergistic effect of N. ceranae and insecticide on honeybee mortality, however, did not appear strongly linked to a decrease of the insect detoxification system. These data support the hypothesis that the combination of the increasing prevalence of N. ceranae with high pesticide content in beehives may contribute to colony depopulation.	[Vidau, Cyril; Diogon, Marie; Aufauvre, Julie; Fontbonne, Regis; Vigues, Bernard; Biron, David G.; Blot, Nicolas; El Alaoui, Hicham; Delbac, Frederic] Clermont Univ, Univ Blaise Pascal, Lab Microorganismes Genome & Environm, Clermont Ferrand, France; [Vidau, Cyril; Diogon, Marie; Aufauvre, Julie; Fontbonne, Regis; Vigues, Bernard; Texier, Catherine; Biron, David G.; Blot, Nicolas; El Alaoui, Hicham; Delbac, Frederic] CNRS, UMR 6023, LMGE, Aubiere, France; [Brunet, Jean-Luc; Belzunces, Luc P.] INRA, UMR Abeilles & Environm 406, Lab Toxicol Environm, Avignon, France	Centre National de la Recherche Scientifique (CNRS); Universite Clermont Auvergne (UCA); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite Clermont Auvergne (UCA); INRAE	Vidau, C (corresponding author), Clermont Univ, Univ Blaise Pascal, Lab Microorganismes Genome & Environm, BP 10448, Clermont Ferrand, France.	frederic.delbac@univ-bpclermont.fr	, Belzunces/P-7061-2019; BRUNET, Jean-Luc/ABE-9178-2021	, Belzunces/0000-0003-1798-9962; BRUNET, Jean-Luc/0000-0002-3827-1135; El Alaoui, Hicham/0000-0003-1926-0905; TOTTEY, Julie/0000-0001-6500-1117; Vidau, Cyril/0000-0002-1972-5648	Centre National de la Recherche Scientifique (CNRS); Ministere de l'Education Nationale de l'Enseignement Superieur et de la Recherche''	Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Ministere de l'Education Nationale de l'Enseignement Superieur et de la Recherche''	This work was funded by a grant from the Centre National de la Recherche Scientifique (CNRS, MIE: Maladies Infectieuses et Environnement). C. V. acknowledges the support of a Fellowship from the CNRS. J.A. and R. F. were supported by grants from the "Ministere de l'Education Nationale de l'Enseignement Superieur et de la Recherche''. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Mazraawi Mohammad S, 2007, Commun Agric Appl Biol Sci, V72, P549; Alaux C, 2011, J INVERTEBR PATHOL, V106, P380, DOI 10.1016/j.jip.2010.12.005; Alaux C, 2010, ENVIRON MICROBIOL, V12, P774, DOI 10.1111/j.1462-2920.2009.02123.x; Aliouane Y, 2009, ENVIRON TOXICOL CHEM, V28, P113, DOI 10.1897/08-110.1; Alizadeh A, 2007, Commun Agric Appl Biol Sci, V72, P1011; Antunez K, 2009, ENVIRON MICROBIOL, V11, P2284, DOI 10.1111/j.1462-2920.2009.01953.x; Bride JM, 1997, J ECON ENTOMOL, V90, P1514, DOI 10.1093/jee/90.6.1514; Cameron PJ, 2009, CROP PROT, V28, P421, DOI 10.1016/j.cropro.2009.01.002; Claudianos C, 2006, INSECT MOL BIOL, V15, P615, DOI 10.1111/j.1365-2583.2006.00672.x; Cox-Foster DL, 2007, SCIENCE, V318, P283, DOI 10.1126/science.1146498; Cruz AD, 2010, CELL BIOL TOXICOL, V26, P165, DOI 10.1007/s10565-009-9126-x; Desneux N, 2007, ANNU REV ENTOMOL, V52, P81, DOI 10.1146/annurev.ento.52.110405.091440; DESOUSA G, 1995, ANAL BIOCHEM, V229, P86, DOI 10.1006/abio.1995.1382; Dussaubat C, 2010, J CHEM ECOL, V36, P522, DOI 10.1007/s10886-010-9786-2; Enayati AA, 2005, INSECT MOL BIOL, V14, P3, DOI 10.1111/j.1365-2583.2004.00529.x; Ericsson JD, 2007, J ECON ENTOMOL, V100, P31, DOI 10.1603/0022-0493(2007)100[31:SISWTI]2.0.CO;2; Farenhorst M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012081; Farenhorst M, 2009, P NATL ACAD SCI USA, V106, P17443, DOI 10.1073/pnas.0908530106; Felix RC, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-312; Furlong MJ, 2001, J ECON ENTOMOL, V94, P344, DOI 10.1603/0022-0493-94.2.344; Gallai N, 2009, ECOL ECON, V68, P810, DOI 10.1016/j.ecolecon.2008.06.014; Gui ZZ, 2009, J ECON ENTOMOL, V102, P1591, DOI 10.1603/029.102.0425; HABIG WH, 1974, J BIOL CHEM, V249, P7130; Halm MP, 2006, ENVIRON SCI TECHNOL, V40, P2448, DOI 10.1021/es051392i; Hardstone MC, 2010, PEST MANAG SCI, V66, P1171, DOI 10.1002/ps.2001; Higes M, 2006, J INVERTEBR PATHOL, V92, P93, DOI 10.1016/j.jip.2006.02.005; Higes M, 2008, ENVIRON MICROBIOL, V10, P2659, DOI 10.1111/j.1462-2920.2008.01687.x; Higes M, 2010, APIDOLOGIE, V41, P375, DOI 10.1051/apido/2010019; Holmstrup M, 2010, SCI TOTAL ENVIRON, V408, P3746, DOI 10.1016/j.scitotenv.2009.10.067; Johnson RM, 2006, J ECON ENTOMOL, V99, P1046, DOI 10.1603/0022-0493-99.4.1046; KIEVITS JB, 2009, NEUROTOXIQUES SYSTEM, P10187; LADAS A, 1972, Apidologie, V3, P55, DOI 10.1051/apido:19720103; Lassiter TL, 2009, BRAIN RES BULL, V78, P313, DOI 10.1016/j.brainresbull.2008.09.020; Le Goff G, 2006, INSECT BIOCHEM MOLEC, V36, P674, DOI 10.1016/j.ibmb.2006.05.009; LI DP, 1994, J INVERTEBR PATHOL, V63, P209, DOI 10.1006/jipa.1994.1038; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Mariyono J, 2008, PEST MANAG SCI, V64, P1069, DOI 10.1002/ps.1602; Maxim L, 2007, SCI TOTAL ENVIRON, V376, P1, DOI 10.1016/j.scitotenv.2006.12.052; Mayack C, 2010, J INSECT PHYSIOL, V56, P1572, DOI 10.1016/j.jinsphys.2010.05.016; Mayack C, 2009, J INVERTEBR PATHOL, V100, P185, DOI 10.1016/j.jip.2008.12.001; MOHAMED AKA, 1987, MYCOPATHOLOGIA, V99, P99, DOI 10.1007/BF00436913; Mullin CA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009754; OEPP/EPPO, 2003, B OEPP EPPO, V33, P141; Pachamuthu P, 2000, J ECON ENTOMOL, V93, P60, DOI 10.1603/0022-0493-93.1.60; Paxton RJ, 2007, APIDOLOGIE, V38, P558, DOI 10.1051/apido:2007037; Purwar JP, 2006, MICROBIOL RES, V161, P38, DOI 10.1016/j.micres.2005.04.006; Ratnieks FLW, 2010, SCIENCE, V327, P152, DOI 10.1126/science.1185563; Rortais A, 2005, APIDOLOGIE, V36, P71, DOI 10.1051/apido:2004071; Serebrov V V, 2006, Izv Akad Nauk Ser Biol, P712; Shiotsuki T, 1999, INSECT BIOCHEM MOLEC, V29, P731, DOI 10.1016/S0965-1748(99)00054-5; Suchail S, 2001, ENVIRON TOXICOL CHEM, V20, P2482, DOI [10.1002/etc.5620201113, 10.1897/1551-5028(2001)020&lt;2482:DBAACT&gt;2.0.CO;2]; Tchankouo-Nguetcheu S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013149; TERRIERE LC, 1984, ANNU REV ENTOMOL, V29, P71, DOI 10.1146/annurev.en.29.010184.000443; Vidau C, 2009, TOXICOL IN VITRO, V23, P589, DOI 10.1016/j.tiv.2009.01.017; Weddle PW, 2009, PEST MANAG SCI, V65, P1287, DOI 10.1002/ps.1865; YU SJ, 1984, PESTIC BIOCHEM PHYS, V22, P360, DOI 10.1016/0048-3575(84)90029-4; Zibaee A, 2009, BIOCONTROL SCI TECHN, V19, P485, DOI 10.1080/09583150902847127	57	279	287	7	197	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2011	6	6							e21550	10.1371/journal.pone.0021550	http://dx.doi.org/10.1371/journal.pone.0021550			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	784FW	21738706	Green Published, gold			2022-12-27	WOS:000292142800039
J	Kwan, SW; Fidelman, N; Durack, JC; Roberts, JP; Kerlan, RK				Kwan, Sharon W.; Fidelman, Nicholas; Durack, Jeremy C.; Roberts, John P.; Kerlan, Robert K., Jr.			Rex Shunt Preoperative Imaging: Diagnostic Capability of Imaging Modalities	PLOS ONE			English	Article							PORTAL-VEIN THROMBOSIS; CHILDREN; BYPASS; LIVER; FLOW	The purpose of this study was to evaluate the diagnostic capability of imaging modalities used for preoperative mesenteric-left portal bypass ("Rex shunt'') planning. Twenty patients with extrahepatic portal vein thrombosis underwent 57 preoperative planning abdominal imaging studies. Two readers retrospectively reviewed these studies for an ability to confidently determine left portal vein (PV) patency, superior mesenteric vein (SMV) patency, and intrahepatic left and right PV contiguity. In this study, computed tomographic arterial portography allowed for confident characterization of left PV patency, SMV patency and left and right PV continuity in 100% of the examinations. Single phase contrast-enhanced CT, multi-phase contrast-enhanced CT, multiphase contrast-enhanced MRI, and transarterial portography answered all key diagnostic questions in 33%, 30%, 0% and 8% of the examinations, respectively. In conclusion, of the variety of imaging modalities that have been employed for Rex shunt preoperative planning, computed tomographic arterial portography most reliably allows for assessment of left PV patency, SMV patency, and left and right PV contiguity in a single study.	[Kwan, Sharon W.; Fidelman, Nicholas; Durack, Jeremy C.; Kerlan, Robert K., Jr.] Univ Calif San Francisco, Dept Radiol & Biomed Imaging, Div Intervent Radiol, San Francisco, CA 94143 USA; [Roberts, John P.] Univ Calif San Francisco, Dept Surg, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Kwan, SW (corresponding author), Univ Calif San Francisco, Dept Radiol & Biomed Imaging, Div Intervent Radiol, San Francisco, CA 94143 USA.	sharon.kwan@ucsf.edu			NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [T32EB001631] Funding Source: NIH RePORTER; NIBIB NIH HHS [T32 EB001631] Funding Source: Medline	NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NIBIB NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))		Ates O, 2006, J PEDIATR SURG, V41, P1259, DOI 10.1016/j.jpedsurg.2006.03.043; Bambini DA, 2000, J PEDIATR SURG, V35, P13, DOI 10.1016/S0022-3468(00)80068-8; deGoyet JD, 1996, TRANSPLANTATION, V62, P71, DOI 10.1097/00007890-199607150-00015; Lin PH, 2001, J VASC SURG, V34, P1071, DOI 10.1067/mva.2001.119043; Mack CL, 2006, PEDIATRICS, V117, pE405, DOI 10.1542/peds.2005-1177; Mack CL, 2003, J PEDIATR-US, V142, P197, DOI 10.1067/mpd.2003.93; Superina R, 2006, PEDIATR TRANSPLANT, V10, P908, DOI 10.1111/j.1399-3046.2006.00598.x; Vanderlan WB, 2009, J TRAUMA, V66, P260, DOI 10.1097/TA.0b013e3181825b87	8	14	16	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2011	6	7							e22222	10.1371/journal.pone.0022222	http://dx.doi.org/10.1371/journal.pone.0022222			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791WM	21765956	Green Published, gold			2022-12-27	WOS:000292699000032
J	Takao, T; Asanoma, K; Kato, K; Fukushima, K; Tsunematsu, R; Hirakawa, T; Matsumura, S; Seki, H; Takeda, S; Wake, N				Takao, Tomoka; Asanoma, Kazuo; Kato, Kiyoko; Fukushima, Kotaro; Tsunematsu, Ryosuke; Hirakawa, Toshio; Matsumura, Sueo; Seki, Hiroyuki; Takeda, Satoru; Wake, Norio			Isolation and Characterization of Human Trophoblast Side-Population (SP) Cells in Primary Villous Cytotrophoblasts and HTR-8/SVneo Cell Line	PLOS ONE			English	Article							HEMATOPOIETIC STEM-CELLS; GROWTH-FACTOR-I; EXTRAVILLOUS TROPHOBLAST; HUMAN PLACENTA; DIFFERENTIATION; EXPRESSION; RECEPTOR; GENE; ANTIBODY; PATHWAY	Recently, numerous studies have identified that immature cell populations including stem cells and progenitor cells can be found among "side-population'' (SP) cells. Although SP cells isolated from some adult tissues have been reported elsewhere, isolation and characterization of human trophoblast SP remained to be reported. In this study, HTR-8/SVneo cells and human primary villous cytotrophoblasts (vCTBs) were stained with Hoechst 33342 and SP and non-SP (NSP) fractions were isolated using a cell sorter. A small population of SP cells was identified in HTR-8/SVneo cells and in vCTBs. SP cells expressed several vCTB-specific markers and failed to express syncytiotrophoblast (STB) or extravillous cytotrophopblast (EVT)-specific differentiation markers. SP cells formed colonies and proliferated on mouse embryonic fibroblast (MEF) feeder cells or in MEF conditioned medium supplemented with heparin/FGF2, and they also showed long-term repopulating property. SP cells could differentiate into both STB and EVT cell lineages and expressed several differentiation markers. Microarray analysis revealed that IL7R and IL1R2 were exclusively expressed in SP cells and not in NSP cells. vCTB cells sorted as positive for both IL7R and IL1R2 failed to express trophoblast differentiation markers and spontaneously differentiated into both STB and EVT in basal medium. These features shown by the SP cells suggested that IL7R and IL1R2 are available as markers to detect the SP cells and that vCTB progenitor cells and trophoblast stem cells were involved in the SP cell population.	[Takao, Tomoka; Asanoma, Kazuo; Fukushima, Kotaro; Tsunematsu, Ryosuke; Wake, Norio] Kyushu Univ, Grad Sch Med Sci, Dept Obstet & Gynecol, Higashi Ku, Fukuoka 812, Japan; [Kato, Kiyoko; Takeda, Satoru] Juntendo Univ, Dept Obstet & Gynecol, Bunkyo Ku, Tokyo, Japan; [Hirakawa, Toshio] Sanada Womens Clin, Higashi Ku, Fukuoka, Japan; [Matsumura, Sueo] Univ Hyogo, Fac Hlth Sci, Dept Nutr Management, Kakogawa, Hyogo, Japan; [Seki, Hiroyuki] Saitama Med Univ, Saitama Med Ctr, Dept Obstet & Gynecol, Kawagoe, Saitama, Japan	Kyushu University; Juntendo University; University of Hyogo; Saitama Medical University	Takao, T (corresponding author), Kyushu Univ, Grad Sch Med Sci, Dept Obstet & Gynecol, Higashi Ku, Fukuoka 812, Japan.	asanoma@med.kyushu-u.ac.jp	Takao, Tomoka/K-1568-2015	Takeda, Satoru/0000-0001-9547-1435; Takao, Tomoka/0000-0002-6519-2301	Japanese Ministry of Education, Culture, Sports, Science and Technology (Japan) [20390435, 21659385]	Japanese Ministry of Education, Culture, Sports, Science and Technology (Japan)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Grant-in-aid 20390435 and 21659385 from the Japanese Ministry of Education, Culture, Sports, Science and Technology (Japan). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adjaye J, 2005, STEM CELLS, V23, P1514, DOI 10.1634/stemcells.2005-0113; Alvi AJ, 2003, BREAST CANCER RES, V5, DOI 10.1186/bcr563; Aplin JD, 1999, BIOL REPROD, V60, P828, DOI 10.1095/biolreprod60.4.828; Baczyk D, 2006, PLACENTA, V27, P367, DOI 10.1016/j.placenta.2005.03.006; Bilban M, 2010, PLACENTA, V31, P989, DOI 10.1016/j.placenta.2010.08.011; Bjerknes M, 1999, GASTROENTEROLOGY, V116, P7, DOI 10.1016/S0016-5085(99)70222-2; Blaschitz A, 2000, PLACENTA, V21, P733, DOI 10.1053/plac.2000.0559; Castrechini NM, 2010, PLACENTA, V31, P203, DOI 10.1016/j.placenta.2009.12.006; CAULFIELD JJ, 1992, J REPROD IMMUNOL, V21, P71, DOI 10.1016/0165-0378(92)90041-2; Chai N, 1998, DEV BIOL, V198, P105, DOI 10.1016/S0012-1606(98)80031-6; Challen GA, 2006, STEM CELLS, V24, P3, DOI 10.1634/stemcells.2005-0116; Chamberlain G, 2007, STEM CELLS, V25, P2739, DOI 10.1634/stemcells.2007-0197; COLOTTA F, 1993, SCIENCE, V261, P472, DOI 10.1126/science.8332913; DAMSKY CH, 1992, J CLIN INVEST, V89, P210, DOI 10.1172/JCI115565; Das P, 2007, STEM CELL RES, V1, P61, DOI 10.1016/j.scr.2007.09.004; Ding XW, 2010, LIFE SCI, V86, P631, DOI 10.1016/j.lfs.2010.02.012; ELLIS SA, 1990, J IMMUNOL, V144, P731; Ezashi T, 2005, P NATL ACAD SCI USA, V102, P4783, DOI 10.1073/pnas.0501283102; FILLA MS, 1993, CELL GROWTH DIFFER, V4, P387; Forbes K, 2008, AM J PHYSIOL-CELL PH, V294, pC1313, DOI 10.1152/ajpcell.00035.2008; Goodell MA, 1997, NAT MED, V3, P1337, DOI 10.1038/nm1297-1337; Goodell MA, 1996, J EXP MED, V183, P1797, DOI 10.1084/jem.183.4.1797; GRAHAM CH, 1992, BIOL REPROD, V46, P561, DOI 10.1095/biolreprod46.4.561; GRAHAM CH, 1993, EXP CELL RES, V206, P204, DOI 10.1006/excr.1993.1139; Harun R, 2006, HUM REPROD, V21, P1349, DOI 10.1093/humrep/del017; Hemberger M, 2010, HUM MOL GENET, V19, P2456, DOI 10.1093/hmg/ddq128; Hirano T, 1999, MOL HUM REPROD, V5, P162, DOI 10.1093/molehr/5.2.162; IRVING JA, 1995, PLACENTA, V16, P413, DOI 10.1016/0143-4004(95)90100-0; Jackson KA, 2001, J CLIN INVEST, V107, P1395, DOI 10.1172/JCI12150; James JL, 2007, HUM REPROD, V22, P2111, DOI 10.1093/humrep/dem144; Janatpour MJ, 2000, DEVELOPMENT, V127, P549; JONES CJP, 1991, ELECTRON MICROSC REV, V4, P129, DOI 10.1016/0892-0354(91)90019-9; Kabir-Salmani M, 2003, ENDOCRINOLOGY, V144, P1620, DOI 10.1210/en.2002-220886; Kato H, 2006, J REPROD MED, V51, P861; Kato K, 2007, HUM REPROD, V22, P1214, DOI 10.1093/humrep/del514; Kishino M, 1996, KIDNEY INT, V49, P1350, DOI 10.1038/ki.1996.191; KLIMAN HJ, 1986, ENDOCRINOLOGY, V118, P1567, DOI 10.1210/endo-118-4-1567; KOVATS S, 1990, SCIENCE, V248, P220, DOI 10.1126/science.2326636; Larderet G, 2006, STEM CELLS, V24, P965, DOI 10.1634/stemcells.2005-0196; Lassalle B, 2004, DEVELOPMENT, V131, P479, DOI 10.1242/dev.00918; Lewis MP, 1996, PLACENTA, V17, P137, DOI 10.1016/S0143-4004(96)80006-3; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maldonado-Estrada J, 2004, J IMMUNOL METHODS, V286, P21, DOI 10.1016/j.jim.2003.03.001; Manyonda IT, 2001, PLACENTA, V22, P262, DOI 10.1053/plac.2000.0600; MARUO T, 1992, J CLIN ENDOCR METAB, V75, P1362, DOI 10.1210/jcem.75.5.1430098; Maruo T, 1995, Early Pregnancy, V1, P54; Mayhew TM, 2001, HISTOL HISTOPATHOL, V16, P1213, DOI 10.14670/HH-16.1213; Mazzucchelli R, 2007, NAT REV IMMUNOL, V7, P144, DOI 10.1038/nri2023; MOORE KL, 1993, PLACENTA FETAL MEMBR, P94; Morrish DW, 1997, PLACENTA, V18, P577, DOI 10.1016/0143-4004(77)90013-3; Muhlhauser J, 1996, CELL TISSUE RES, V285, P101, DOI 10.1007/s004410050625; Ono M, 2007, P NATL ACAD SCI USA, V104, P18700, DOI 10.1073/pnas.0704472104; Palmer MJ, 2008, CELL MOL IMMUNOL, V5, P79, DOI 10.1038/cmi.2008.10; Petroff MG, 2006, METH MOLEC MED, V121, P203; Rossant J, 2001, STEM CELLS, V19, P477, DOI 10.1634/stemcells.19-6-477; Russ AP, 2000, NATURE, V404, P95, DOI 10.1038/35003601; Sacks GP, 2001, PLACENTA, V22, P550, DOI 10.1053/plac.2001.0686; Saito S, 1997, BIOCHEM BIOPH RES CO, V231, P429, DOI 10.1006/bbrc.1997.6121; SASAGAWA M, 1987, PLACENTA, V8, P515, DOI 10.1016/0143-4004(87)90080-4; Saxena A, 2003, PLACENTA, V24, P835, DOI 10.1016/S0143-4004(03)00130-9; Schugar RC, 2009, J BIOMED BIOTECHNOL, DOI 10.1155/2009/789526; SCHULZ LC, 2008, PLACENTA SA, V29; Shimano K, 2003, AM J PATHOL, V163, P3, DOI 10.1016/S0002-9440(10)63624-3; SHORTER SC, 1993, PLACENTA, V14, P571, DOI 10.1016/S0143-4004(05)80210-3; Summer R, 2003, AM J PHYSIOL-LUNG C, V285, pL97, DOI 10.1152/ajplung.00009.2003; Tanaka S, 1998, SCIENCE, V282, P2072, DOI 10.1126/science.282.5396.2072; Tripathi V, 2009, J CLIN IMMUNOL, V29, P379, DOI 10.1007/s10875-008-9258-4; Xu RH, 2002, NAT BIOTECHNOL, V20, P1261, DOI 10.1038/nbt761; Zhou S, 2001, NAT MED, V7, P1028, DOI 10.1038/nm0901-1028	69	57	60	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2011	6	7							e21990	10.1371/journal.pone.0021990	http://dx.doi.org/10.1371/journal.pone.0021990			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791HI	21760941	gold, Green Published, Green Submitted			2022-12-27	WOS:000292655400036
J	Alameda, JP; Moreno-Maldonado, R; Fernandez-Acenero, MJ; Navarro, M; Page, A; Jorcano, JL; Bravo, A; Ramirez, A; Casanova, ML				Alameda, Josefa P.; Moreno-Maldonado, Rodolfo; Jesus Fernandez-Acenero, M.; Navarro, Manuel; Page, Angustias; Jorcano, Jose L.; Bravo, Ana; Ramirez, Angel; Llanos Casanova, M.			Increased IKK alpha Expression in the Basal Layer of the Epidermis of Transgenic Mice Enhances the Malignant Potential of Skin Tumors	PLOS ONE			English	Article							KAPPA-B-KINASE; TISSUE MICROARRAY ANALYSIS; DEPENDENT GENE-EXPRESSION; NUCLEAR MASPIN EXPRESSION; SQUAMOUS-CELL CARCINOMAS; BREAST-CANCER; ALPHA-6-BETA-4 INTEGRIN; COLORECTAL-CANCER; TWIST EXPRESSION; METASTASIS	Non-melanoma skin cancer is the most frequent type of cancer in humans. In this study we demonstrate that elevated IKK alpha expression in murine epidermis increases the malignancy potential of skin tumors. We describe the generation of transgenic mice overexpressing IKK alpha in the basal, proliferative layer of the epidermis and in the outer root sheath of hair follicles. The epidermis of K5-IKK alpha transgenic animals shows several alterations such as hyperproliferation, mislocalized expression of integrin-alpha 6 and downregulation of the tumor suppressor maspin. Treatment of the back skin of mice with the mitogenic agent 12-O-tetradecanoylphorbol-13-acetate causes in transgenic mice the appearance of different preneoplastic changes such as epidermal atypia with loss of cell polarity and altered epidermal tissue architecture, while in wild type littermates this treatment only leads to the development of benign epidermal hyperplasia. Moreover, in skin carcinogenesis assays, transgenic mice carrying active Ha-ras (K5-IKK alpha-Tg.AC mice) develop invasive tumors, instead of the benign papillomas arising in wild type-Tg-AC mice also bearing an active Ha-ras. Therefore we provide evidence for a tumor promoter role of IKK alpha in skin cancer, similarly to what occurs in other neoplasias, including hepatocarcinomas and breast, prostate and colorectal cancer. The altered expression of cyclin D1, maspin and integrin-alpha 6 in skin of transgenic mice provides, at least in part, the molecular bases for the increased malignant potential found in the K5-IKK alpha skin tumors.	[Alameda, Josefa P.; Moreno-Maldonado, Rodolfo; Navarro, Manuel; Page, Angustias; Jorcano, Jose L.; Ramirez, Angel; Llanos Casanova, M.] CIEMAT, Div Epithelial Biomed, E-28040 Madrid, Spain; [Jesus Fernandez-Acenero, M.] Fdn Jimenez Diaz, Dept Pathol, E-28040 Madrid, Spain; [Bravo, Ana] Univ Santiago de Compostela, Fac Vet, Dept Vet Clin Sci, Lugo, Spain	Centro de Investigaciones Energeticas, Medioambientales Tecnologicas; Universidade de Santiago de Compostela	Alameda, JP (corresponding author), CIEMAT, Div Epithelial Biomed, E-28040 Madrid, Spain.	llanos.casanova@ciemat.es	Moral, Ana María Bravo/AAD-3339-2021; Ramirez, Angel/A-4800-2018; Navarro, Manuel/S-1496-2019; Aceñero, M Jesús Fernández/ABC-5904-2020	Moral, Ana María Bravo/0000-0002-5282-8921; Ramirez, Angel/0000-0001-7745-5108; Navarro, Manuel/0000-0003-1118-8531; Aceñero, M Jesús Fernández/0000-0002-2439-3553; Page, Angustias/0000-0002-0231-8536; Casanova, M. Llanos/0000-0001-7742-8265	Ministerio de Ciencia e Innovacion [PI10/01480, SAF2010-22156]	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government)	This work was funded by grants from the Ministerio de Ciencia e Innovacion (PI10/01480, SAF2010-22156) to MLC and AR respectively. The funders had no roles in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham S, 2003, J UROLOGY, V169, P1157, DOI 10.1097/01.ju.0000040245.70349.37; Alameda JP, 2010, ONCOGENE, V29, P6522, DOI 10.1038/onc.2010.378; Albanese C, 2003, MOL BIOL CELL, V14, P585, DOI 10.1091/mbc.02-06-0101; Anest V, 2003, NATURE, V423, P659, DOI 10.1038/nature01648; Ansieau S, 2008, CANCER CELL, V14, P79, DOI 10.1016/j.ccr.2008.06.005; Bailey CM, 2006, J CELL PHYSIOL, V209, P617, DOI 10.1002/jcp.20782; BALMAIN A, 1983, NATURE, V303, P72, DOI 10.1038/303072a0; Boltze C, 2005, PATHOL RES PRACT, V200, P783, DOI 10.1016/j.prp.2004.10.004; Brown K, 1998, CURR BIOL, V8, P516, DOI 10.1016/S0960-9822(98)70203-9; Cao DF, 2007, MODERN PATHOL, V20, P570, DOI 10.1038/modpathol.3800772; Casanova ML, 2004, FASEB J, V18, P1556, DOI 10.1096/fj.04-1683fje; Casanova ML, 2002, CANCER RES, V62, P3402; Charalambous MP, 2009, BRIT J CANCER, V101, P106, DOI 10.1038/sj.bjc.6605120; Chua I, 2009, J AM ACAD DERMATOL, V60, P758, DOI 10.1016/j.jaad.2009.01.018; DeBusk LM, 2008, CANCER RES, V68, P10223, DOI 10.1158/0008-5472.CAN-08-1833; Dietmaier W, 2006, INT J CANCER, V118, P2247, DOI 10.1002/ijc.21620; Fernandez-Majada V, 2007, P NATL ACAD SCI USA, V104, P276, DOI 10.1073/pnas.0606476104; Futscher BW, 2004, NEOPLASIA, V6, P380, DOI 10.1593/neo.04115; Gareus R, 2007, NAT CELL BIOL, V9, P461, DOI 10.1038/ncb1560; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Hu YL, 2001, NATURE, V410, P710, DOI 10.1038/35070605; Hu YL, 1999, SCIENCE, V284, P316, DOI 10.1126/science.284.5412.316; Huang WC, 2007, MOL CELL, V26, P75, DOI 10.1016/j.molcel.2007.02.019; Jiang RQ, 2010, INT J CANCER, V126, P1263, DOI 10.1002/ijc.24854; Jost M, 2000, EUR J DERMATOL, V10, P505; Karin M, 2008, CELL RES, V18, P334, DOI 10.1038/cr.2008.30; Khalkhali-Ellis Z, 2006, CLIN CANCER RES, V12, P7279, DOI 10.1158/1078-0432.CCR-06-1589; Lamberti C, 2001, J BIOL CHEM, V276, P42276, DOI 10.1074/jbc.M104227200; LEDER A, 1990, P NATL ACAD SCI USA, V87, P9178, DOI 10.1073/pnas.87.23.9178; Lee TK, 2006, CLIN CANCER RES, V12, P5369, DOI 10.1158/1078-0432.CCR-05-2722; Li QT, 1999, GENE DEV, V13, P1322, DOI 10.1101/gad.13.10.1322; Liu BG, 2008, CANCER CELL, V14, P212, DOI 10.1016/j.ccr.2008.07.017; Liu BG, 2006, P NATL ACAD SCI USA, V103, P17202, DOI 10.1073/pnas.0604481103; Luo JL, 2007, NATURE, V446, P690, DOI 10.1038/nature05656; MAHATO R, 2010, PHARM RES; Marinari B, 2008, P NATL ACAD SCI USA, V105, P17091, DOI 10.1073/pnas.0809288105; Marioni G, 2005, HISTOPATHOLOGY, V46, P576, DOI 10.1111/j.1365-2559.2005.02141.x; Merkhofer EC, 2010, ONCOGENE, V29, P1238, DOI 10.1038/onc.2009.410; Moreno-Maldonado R, 2008, CELL CYCLE, V7, P2021, DOI 10.4161/cc.7.13.6147; O'Donnell JD, 2010, GYNECOL ONCOL, V116, P262, DOI 10.1016/j.ygyno.2009.10.052; Ohuchida K, 2007, INT J CANCER, V120, P1634, DOI 10.1002/ijc.22295; Owens DM, 2003, J CELL SCI, V116, P3783, DOI 10.1242/jcs.00725; Park E, 2007, CANCER RES, V67, P9158, DOI 10.1158/0008-5472.CAN-07-0590; Park KJ, 2005, MOL CELL, V18, P71, DOI 10.1016/j.molcel.2005.03.006; Puisieux A, 2006, BRIT J CANCER, V94, P13, DOI 10.1038/sj.bjc.6602876; RAMIREZ A, 1994, DIFFERENTIATION, V58, P53, DOI 10.1007/s002580050065; Rikimaru K, 1997, EXP DERMATOL, V6, P214, DOI 10.1111/j.1600-0625.1997.tb00165.x; Shi HY, 2001, CANCER RES, V61, P6945; Shih VFS, 2011, CELL RES, V21, P86, DOI 10.1038/cr.2010.161; Sil AK, 2004, NATURE, V428, P660, DOI 10.1038/nature02421; Stark AM, 2010, NEUROL RES, V32, P303, DOI 10.1179/016164109X12518779082192; Takeda K, 1999, SCIENCE, V284, P313, DOI 10.1126/science.284.5412.313; TENNENBAUM T, 1993, CANCER RES, V53, P4803; Trimboli AJ, 2009, NATURE, V461, P1084, DOI 10.1038/nature08486; WINTER H, 1990, DIFFERENTIATION, V43, P105, DOI 10.1111/j.1432-0436.1990.tb00436.x; Wu RC, 2002, MOL CELL BIOL, V22, P3549, DOI 10.1128/MCB.22.10.3549-3561.2002; Yamamoto Y, 2003, NATURE, V423, P655, DOI 10.1038/nature01576; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Yoshizawa K, 2009, J ORAL PATHOL MED, V38, P535, DOI 10.1111/j.1600-0714.2009.00762.x; Zhang M, 2000, NAT MED, V6, P196, DOI 10.1038/72303; Zhang Z, 2007, HUM PATHOL, V38, P598, DOI 10.1016/j.humpath.2006.10.004; Zheng HC, 2008, APPL IMMUNOHISTO M M, V16, P459, DOI 10.1097/PAI.0b013e3181640bb1	63	16	16	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2011	6	7							e21984	10.1371/journal.pone.0021984	http://dx.doi.org/10.1371/journal.pone.0021984			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791AK	21755017	Green Published, Green Submitted, gold			2022-12-27	WOS:000292632000044
J	Xu, Y; Seven, A; Su, LJ; Jiang, QX; Rizo, J				Xu, Yi; Seven, Alpay; Su, Lijing; Jiang, Qiu-Xing; Rizo, Josep			Membrane Bridging and Hemifusion by Denaturated Munc18	PLOS ONE			English	Article							SNARE COMPLEX; 3-DIMENSIONAL STRUCTURE; CONFORMATIONAL SWITCH; PHOSPHOLIPID-VESICLES; CRYSTAL-STRUCTURE; FUSION ASSAY; BINDING; PROTEIN; SYNTAXIN; DOMAIN	Neuronal Munc18-1 and members of the Sec1/Munc18 (SM) protein family play a critical function(s) in intracellular membrane fusion together with SNARE proteins, but the mechanism of action of SM proteins remains highly enigmatic. During experiments designed to address this question employing a 7-nitrobenz-2-oxa-1,3-diazole (NBD) fluorescence dequenching assay that is widely used to study lipid mixing between reconstituted proteoliposomes, we observed that Munc18-1 from squid (sMunc18-1) was able to increase the apparent NBD fluorescence emission intensity even in the absence of SNARE proteins. Fluorescence emission scans and dynamic light scattering experiments show that this phenomenon arises at least in part from increased light scattering due to sMunc18-1-induced liposome clustering. Nuclear magnetic resonance and circular dichroism data suggest that, although native sMunc18-1 does not bind significantly to lipids, sMunc18-1 denaturation at 37 degrees C leads to insertion into membranes. The liposome clustering activity of sMunc18-1 can thus be attributed to its ability to bridge two membranes upon (perhaps partial) denaturation; correspondingly, this activity is hindered by addition of glycerol. Cryo-electron microscopy shows that liposome clusters induced by sMunc18-1 include extended interfaces where the bilayers of two liposomes come into very close proximity, and clear hemifusion diaphragms. Although the physiological relevance of our results is uncertain, they emphasize the necessity of complementing fluorescence de-quenching assays with alternative experiments in studies of membrane fusion, as well as the importance of considering the potential effects of protein denaturation. In addition, our data suggest a novel mechanism of membrane hemifusion induced by amphipathic macromolecules that does not involve formation of a stalk intermediate.	[Xu, Yi; Seven, Alpay; Su, Lijing; Rizo, Josep] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Xu, Yi; Seven, Alpay; Su, Lijing; Rizo, Josep] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA; [Jiang, Qiu-Xing] Univ Texas SW Med Ctr Dallas, Dept Cell Biol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Xu, Y (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA.	jose@arnie.swmed.edu	Jiang, Qiu-Xing/ABF-1143-2021; Jiang, Qiu-Xing/AAI-8579-2020		Human Frontiers Science Program [RGP0035/2007-C]; Welch Foundation [I-1304]; National Institutes of Health [NS37200]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS037200] Funding Source: NIH RePORTER	Human Frontiers Science Program(Human Frontier Science Program); Welch Foundation(The Welch Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grants from the Human Frontiers Science Program (RGP0035/2007-C), Welch Foundation (I-1304), and the National Institutes of Health (NS37200) (to JR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arac D, 2003, BIOCHEMISTRY-US, V42, P2774, DOI 10.1021/bi0272050; Arac D, 2006, NAT STRUCT MOL BIOL, V13, P209, DOI 10.1038/nsmb1056; Bowen ME, 2004, BIOPHYS J, V87, P3569, DOI 10.1529/biophysj.104.048637; Bracher A, 2000, STRUCTURE, V8, P685, DOI 10.1016/S0969-2126(00)00156-8; Burkhardt P, 2008, EMBO J, V27, P923, DOI 10.1038/emboj.2008.37; Cai HQ, 2007, DEV CELL, V12, P671, DOI 10.1016/j.devcel.2007.04.005; Carr CM, 2010, CURR OPIN CELL BIOL, V22, P488, DOI 10.1016/j.ceb.2010.04.006; Carr CM, 1999, J CELL BIOL, V146, P333, DOI 10.1083/jcb.146.2.333; Chan YHM, 2009, P NATL ACAD SCI USA, V106, P979, DOI 10.1073/pnas.0812356106; Chen XC, 2006, BIOPHYS J, V90, P2062, DOI 10.1529/biophysj.105.071415; Chen XC, 2008, J BIOMOL NMR, V41, P43, DOI 10.1007/s10858-008-9239-1; Chernomordik LV, 2008, NAT STRUCT MOL BIOL, V15, P675, DOI 10.1038/nsmb.1455; Cohen FS, 2004, J MEMBRANE BIOL, V199, P1, DOI 10.1007/s00232-004-0669-8; Deak F, 2009, J CELL BIOL, V184, P751, DOI 10.1083/jcb.200812026; Dennison SM, 2006, BIOPHYS J, V90, P1661, DOI 10.1529/biophysj.105.069617; Diao JJ, 2010, ACS CHEM NEUROSCI, V1, P168, DOI 10.1021/cn900034p; Dulubova I, 1999, EMBO J, V18, P4372, DOI 10.1093/emboj/18.16.4372; Dulubova I, 2007, P NATL ACAD SCI USA, V104, P2697, DOI 10.1073/pnas.0611318104; Fernandez I, 1998, CELL, V94, P841, DOI 10.1016/S0092-8674(00)81742-0; Fernandez-Chacon R, 2001, NATURE, V410, P41, DOI 10.1038/35065004; Gerber SH, 2008, SCIENCE, V321, P1507, DOI 10.1126/science.1163174; Grote E, 2000, J CELL BIOL, V151, P439, DOI 10.1083/jcb.151.2.439; Guan R, 2008, BIOCHEMISTRY-US, V47, P1474, DOI 10.1021/bi702345m; Hanson PI, 1997, CELL, V90, P523, DOI 10.1016/S0092-8674(00)80512-7; Harrison SC, 2008, NAT STRUCT MOL BIOL, V15, P690, DOI 10.1038/nsmb.1456; Hu K, 2002, NATURE, V415, P646, DOI 10.1038/415646a; Hughson FM, 2009, ANNU REV CELL DEV BI; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Ji H, 2010, BIOPHYS J, V99, P553, DOI 10.1016/j.bpj.2010.04.060; Khvotchev M, 2007, J NEUROSCI, V27, P12147, DOI 10.1523/JNEUROSCI.3655-07.2007; KIM J, 1986, BIOCHEMISTRY-US, V25, P7867, DOI 10.1021/bi00372a012; Kweon DH, 2003, NAT STRUCT BIOL, V10, P440, DOI 10.1038/nsb928; Li LY, 2006, J BIOL CHEM, V281, P15845, DOI 10.1074/jbc.M600888200; Liu TT, 2005, BIOPHYS J, V89, P2458, DOI 10.1529/biophysj.105.062539; Misura KMS, 2000, NATURE, V404, P355, DOI 10.1038/35006120; Parlati F, 1999, P NATL ACAD SCI USA, V96, P12565, DOI 10.1073/pnas.96.22.12565; Pei JM, 2009, J MOL BIOL, V391, P509, DOI 10.1016/j.jmb.2009.06.054; Poirier MA, 1998, NAT STRUCT BIOL, V5, P765, DOI 10.1038/1799; Rathore SS, 2010, P NATL ACAD SCI USA, V107, P22399, DOI 10.1073/pnas.1012997108; Rizo J, 2008, NAT STRUCT MOL BIOL, V15, P665, DOI 10.1038/nsmb.1450; Rizo J, 2006, TRENDS CELL BIOL, V16, P339, DOI 10.1016/j.tcb.2006.04.006; Rodkey TL, 2008, MOL BIOL CELL, V19, P5422, DOI 10.1091/mbc.E08-05-0538; Scott BL, 2003, METHOD ENZYMOL, V372, P274; Shen JS, 2007, CELL, V128, P183, DOI 10.1016/j.cell.2006.12.016; Sudhof TC, 2009, SCIENCE, V323, P474, DOI 10.1126/science.1161748; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; Tareste David, 2008, Proc Natl Acad Sci U S A, V105, P2380, DOI 10.1073/pnas.0712125105; Toonen RFG, 2007, TRENDS NEUROSCI, V30, P564, DOI 10.1016/j.tins.2007.08.008; van den Bogaart G, 2010, NAT STRUCT MOL BIOL, V17, P358, DOI 10.1038/nsmb.1748; Wang L, 2002, CELL, V108, P357, DOI 10.1016/S0092-8674(02)00632-3; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; Wickner W, 2008, NAT STRUCT MOL BIOL, V15, P658, DOI 10.1038/nsmb.1451; Xu Y, 2010, BIOCHEMISTRY-US, V49, P1568, DOI 10.1021/bi9021878; Xue MS, 2008, NAT STRUCT MOL BIOL, V15, P1160, DOI 10.1038/nsmb.1508; ZIMMERBERG J, 1993, ANNU REV BIOPH BIOM, V22, P433, DOI 10.1146/annurev.bb.22.060193.002245	55	13	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2011	6	7							e22012	10.1371/journal.pone.0022012	http://dx.doi.org/10.1371/journal.pone.0022012			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791AK	21765933	Green Submitted, gold, Green Published			2022-12-27	WOS:000292632000046
J	Liu, DW; Hsu, CH; Tsai, SM; Hsiao, CD; Wang, WP				Liu, Da-Wei; Hsu, Chia-Hao; Tsai, Su-Mei; Hsiao, Chung-Der; Wang, Wen-Pin			A Variant of Fibroblast Growth Factor Receptor 2 (Fgfr2) Regulates Left-Right Asymmetry in Zebrafish	PLOS ONE			English	Article							LEFT-RIGHT AXIS; KUPFFERS VESICLE; STRUCTURAL BASIS; VISCERAL ORGANS; NODAL FLOW; EMBRYOS; BRAIN; HEART; SPECIFICATION; ESTABLISHMENT	Many organs in vertebrates are left-right asymmetrical located. For example, liver is at the right side and stomach is at the left side in human. Fibroblast growth factor (Fgf) signaling is important for left-right asymmetry. To investigate the roles of Fgfr2 signaling in zebrafish left-right asymmetry, we used splicing blocking morpholinos to specifically block the splicing of fgfr2b and fgfr2c variants, respectively. We found that the relative position of the liver and the pancreas were disrupted in fgfr2c morphants. Furthermore, the left-right asymmetry of the heart became random. Expression pattern of the laterality controlling genes, spaw and pitx2c, also became random in the morphants. Furthermore, lefty1 was not expressed in the posterior notochord, indicating that the molecular midline barrier had been disrupted. It was also not expressed in the brain diencephalon. Kupffer's vesicle (KV) size became smaller in fgfr2c morphants. Furthermore, KV cilia were shorter in fgfr2c morphants. We conclude that the fgfr2c isoform plays an important role in the left-right asymmetry during zebrafish development.	[Liu, Da-Wei; Tsai, Su-Mei; Wang, Wen-Pin] Tzu Chi Univ, Inst Med Sci, Hualien, Taiwan; [Hsu, Chia-Hao; Wang, Wen-Pin] Tzu Chi Univ, Dept Mol Biol & Human Genet, Hualien, Taiwan; [Hsiao, Chung-Der] Chung Yuan Christian Univ, Dept Biosci Technol, Chungli, Taiwan; [Hsiao, Chung-Der] Chung Yuan Christian Univ, Ctr Nanotechnol, Chungli, Taiwan	Tzu Chi University; Tzu Chi University; Chung Yuan Christian University; Chung Yuan Christian University	Liu, DW (corresponding author), Tzu Chi Univ, Inst Med Sci, Hualien, Taiwan.	wpwang@mail.tcu.edu.tw	Hsiao, Chung-Der/W-4535-2019	Hsiao, Chung-Der/0000-0002-6398-8672; HSU, CHIA-HAO/0000-0001-6920-0316	National Science Council [NSC96-2311-B-320-002-MY2]; Tzu Chi University [TCMRC-P-99013-01]	National Science Council(Ministry of Science and Technology, Taiwan); Tzu Chi University	This work was supported by grants from National Science Council (NSC96-2311-B-320-002-MY2) and Tzu Chi University (TCMRC-P-99013-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albertson RC, 2005, DEV BIOL, V283, P310, DOI 10.1016/j.ydbio.2005.04.025; Amack JD, 2004, CURR BIOL, V14, P685, DOI 10.1016/j.cub.2004.04.002; Amack JD, 2007, DEV BIOL, V310, P196, DOI 10.1016/j.ydbio.2007.05.039; Biemar F, 2001, DEV BIOL, V230, P189, DOI 10.1006/dbio.2000.0103; Bisgrove BW, 2003, ANNU REV GENOM HUM G, V4, P1, DOI 10.1146/annurev.genom.4.070802.110428; Boettger T, 1999, CURR BIOL, V9, P277, DOI 10.1016/S0960-9822(99)80119-5; Capdevila J, 2000, CELL, V101, P9, DOI 10.1016/S0092-8674(00)80619-4; Cheng PY, 2008, DEVELOPMENT, V135, P941, DOI 10.1242/dev.010595; Draper BW, 2003, DEVELOPMENT, V130, P4639, DOI 10.1242/dev.00671; Essner JJ, 2005, DEVELOPMENT, V132, P1247, DOI 10.1242/dev.01663; Essner JJ, 2000, DEVELOPMENT, V127, P1081; Fischer A, 2002, CURR BIOL, V12, P1807, DOI 10.1016/S0960-9822(02)01222-8; Hamada H, 2002, NAT REV GENET, V3, P103, DOI 10.1038/nrg732; Hirokawa N, 2006, CELL, V125, P33, DOI 10.1016/j.cell.2006.03.002; Hong SK, 2009, P NATL ACAD SCI USA, V106, P2230, DOI 10.1073/pnas.0812880106; Itoh N, 2004, TRENDS GENET, V20, P563, DOI 10.1016/j.tig.2004.08.007; Itoh N, 2007, ZEBRAFISH, V4, P179, DOI 10.1089/zeb.2007.0509; Kreiling JA, 2007, DEV DYNAM, V236, P1963, DOI 10.1002/dvdy.21191; Meno C, 1998, CELL, V94, P287, DOI 10.1016/S0092-8674(00)81472-5; Meyers EN, 1999, SCIENCE, V285, P403, DOI 10.1126/science.285.5426.403; Mohammadi M, 2005, CYTOKINE GROWTH F R, V16, P107, DOI 10.1016/j.cytogfr.2005.01.008; Nakayama Y, 2008, DEV BIOL, V313, P752, DOI 10.1016/j.ydbio.2007.11.013; Neugebauer JM, 2009, NATURE, V458, P651, DOI 10.1038/nature07753; Nonaka S, 1998, CELL, V95, P829, DOI 10.1016/S0092-8674(00)81705-5; Olsen SK, 2006, GENE DEV, V20, P185, DOI 10.1101/gad.1365406; Oteiza P, 2008, DEVELOPMENT, V135, P2807, DOI 10.1242/dev.022228; Oviedo NJ, 2007, CELL, V129, P645, DOI 10.1016/j.cell.2007.05.005; Powers CJ, 2000, ENDOCR-RELAT CANCER, V7, P165, DOI 10.1677/erc.0.0070165; Raible F, 2001, MECH DEVELOP, V107, P105, DOI 10.1016/S0925-4773(01)00456-7; Raya A, 2006, NAT REV GENET, V7, P283, DOI 10.1038/nrg1830; Scholpp S, 2004, DEV GENES EVOL, V214, P285, DOI 10.1007/s00427-004-0409-1; Shin D, 2007, DEVELOPMENT, V134, P2041, DOI 10.1242/dev.000281; Supatto W, 2008, BIOPHYS J, V95, pL29, DOI 10.1529/biophysj.108.137786; Tanaka Y, 2005, NATURE, V435, P172, DOI 10.1038/nature03494; Tian T, 2009, BIOCHEM BIOPH RES CO, V380, P537, DOI 10.1016/j.bbrc.2009.01.111; Tonou-Fujimori Noriko, 2002, Gene Expression Patterns, V2, P183, DOI 10.1016/S0925-4773(02)00422-7; Wang WD, 2006, BIOCHEM BIOPH RES CO, V347, P979, DOI 10.1016/j.bbrc.2006.06.174; Westerfield M, 2000, ZEBRAFISH BOOK GUIDE; Yamauchi H, 2009, DEV BIOL, V332, P177, DOI 10.1016/j.ydbio.2009.05.568; Yu XW, 2008, NAT GENET, V40, P1445, DOI 10.1038/ng.263	40	26	26	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2011	6	7							e21793	10.1371/journal.pone.0021793	http://dx.doi.org/10.1371/journal.pone.0021793			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786HC	21747958	Green Submitted, gold, Green Published			2022-12-27	WOS:000292293400034
J	Schubert, G; Stoneking, CJ; Arandjelovic, M; Boesch, C; Eckhardt, N; Hohmann, G; Langergraber, K; Lukas, D; Vigilant, L				Schubert, Grit; Stoneking, Colin J.; Arandjelovic, Mimi; Boesch, Christophe; Eckhardt, Nadin; Hohmann, Gottfried; Langergraber, Kevin; Lukas, Dieter; Vigilant, Linda			Male-Mediated Gene Flow in Patrilocal Primates	PLOS ONE			English	Article							SEX-BIASED DISPERSAL; CHIMPANZEES PAN-TROGLODYTES; EXTRA-GROUP PATERNITY; WILD CHIMPANZEES; SPIDER MONKEYS; PAIR PATERNITY; MOUSE LEMUR; POPULATION; DNA; BONOBOS	Background: Many group-living species display strong sex biases in dispersal tendencies. However, gene flow mediated by apparently philopatric sex may still occur and potentially alters population structure. In our closest living evolutionary relatives, dispersal of adult males seems to be precluded by high levels of territoriality between males of different groups in chimpanzees, and has only been observed once in bonobos. Still, male-mediated gene flow might occur through rare events such as extra-group matings leading to extra-group paternity (EGP) and female secondary dispersal with offspring, but the extent of this gene flow has not yet been assessed. Methodology/Principal Findings: Using autosomal microsatellite genotyping of samples from multiple groups of wild western chimpanzees (Pan troglodytes verus) and bonobos (Pan paniscus), we found low genetic differentiation among groups for both males and females. Characterization of Y-chromosome microsatellites revealed levels of genetic differentiation between groups in bonobos almost as high as those reported previously in eastern chimpanzees, but lower levels of differentiation in western chimpanzees. By using simulations to evaluate the patterns of Y-chromosomal variation expected under realistic assumptions of group size, mutation rate and reproductive skew, we demonstrate that the observed presence of multiple and highly divergent Y-haplotypes within western chimpanzee and bonobo groups is best explained by successful male-mediated gene flow. Conclusions/Significance: The similarity of inferred rates of male-mediated gene flow and published rates of EGP in western chimpanzees suggests this is the most likely mechanism of male-mediated gene flow in this subspecies. In bonobos more data are needed to refine the estimated rate of gene flow. Our findings suggest that dispersal patterns in these closely related species, and particularly for the chimpanzee subspecies, are more variable than previously appreciated. This is consistent with growing recognition of extensive behavioral variation in chimpanzees and bonobos.	[Schubert, Grit; Arandjelovic, Mimi; Boesch, Christophe; Eckhardt, Nadin; Hohmann, Gottfried; Langergraber, Kevin; Vigilant, Linda] Max Planck Inst Evolutionary Anthropol, Dept Primatol, Leipzig, Germany; [Schubert, Grit] Robert Koch Inst, Jr Res Grp Novel Zoonoses, D-1000 Berlin, Germany; [Stoneking, Colin J.] Univ Cambridge Emmanuel Coll, Cambridge CB2 3AP, England; [Langergraber, Kevin] Boston Univ, Dept Anthropol, Boston, MA 02215 USA; [Lukas, Dieter] Univ Cambridge, Dept Zool, Large Anim Res Grp, Cambridge, England	Max Planck Society; Robert Koch Institute; University of Cambridge; Boston University; University of Cambridge	Schubert, G (corresponding author), Max Planck Inst Evolutionary Anthropol, Dept Primatol, Leipzig, Germany.	vigilant@eva.mpg.de		Arandjelovic, Mimi/0000-0001-8920-9684; Lukas, Dieter/0000-0002-7141-3545	Max Planck Society; L.S.B. Leakey Foundation	Max Planck Society(Max Planck SocietyFoundation CELLEX); L.S.B. Leakey Foundation	This study was financed by the Max Planck Society and supported by a grant from the L.S.B. Leakey Foundation to GS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altmann J, 1996, P NATL ACAD SCI USA, V93, P5797, DOI 10.1073/pnas.93.12.5797; Arandjelovic M, 2009, MOL ECOL RESOUR, V9, P28, DOI 10.1111/j.1755-0998.2008.02387.x; Arandjelovic M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014761; Boesch C, 2006, AM J PHYS ANTHROPOL, V130, P103, DOI 10.1002/ajpa.20341; Boesch C, 2009, REAL CHIMPANZEE: SEX STRATEGIES IN THE FOREST, P1; Boesch C, 2000, CHIMPANZEES TAI FORE; Boesch C, 2008, AM J PRIMATOL, V70, P519, DOI 10.1002/ajp.20524; Bradley BJ, 2001, CONSERV GENET, V2, P179, DOI 10.1023/A:1011847528045; Cant MA, 2001, J ZOOL, V254, P155, DOI 10.1017/S0952836901000668; Clutton-Brock TH, 2006, BIOL LETTERS, V2, P513, DOI 10.1098/rsbl.2006.0531; Clutton-Brock T. H., 1988, REPROD SUCCESS; Coulon A, 2006, P ROY SOC B-BIOL SCI, V273, P341, DOI 10.1098/rspb.2005.3329; DeYoung RW, 2005, J WILDLIFE MANAGE, V69, P1362, DOI 10.2193/0022-541X(2005)69[1362:TMTGTI]2.0.CO;2; Di Fiore A, 2003, YEARB PHYS ANTHROPOL, V46, P62, DOI 10.1002/ajpa.10382; Di Fiore A, 2009, BEHAVIOUR, V146, P437, DOI 10.1163/156853909X426345; Douadi MI, 2007, MOL ECOL, V16, P2247, DOI 10.1111/j.1365-294X.2007.03286.x; Eriksson J, 2006, MOL ECOL, V15, P939, DOI 10.1111/j.1365-294X.2006.02845.x; Eriksson J, 2004, MOL ECOL, V13, P3425, DOI 10.1111/j.1365-294X.2004.02332.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Favre L, 1997, P ROY SOC B-BIOL SCI, V264, P127, DOI 10.1098/rspb.1997.0019; FEDIGAN L M, 1984, Primates, V25, P279, DOI 10.1007/BF02382267; Fietz J, 2000, BEHAV ECOL SOCIOBIOL, V49, P8, DOI 10.1007/s002650000269; FOLEY RA, 1989, COMP SOCIOECOLOGY BE, P473; Gauffre B, 2009, P R SOC B, V276, P3487, DOI 10.1098/rspb.2009.0881; Gerloff U, 1999, P ROY SOC B-BIOL SCI, V266, P1189, DOI 10.1098/rspb.1999.0762; Goodall J, 1986, CHIMPANZEES GOMBE, DOI DOI 10.1002/AJPA.1330730313; Goodall J., 1979, GREAT APES, P13; Goossens B, 1998, BEHAV ECOL SOCIOBIOL, V43, P281, DOI 10.1007/s002650050492; GREENWOOD PJ, 1980, ANIM BEHAV, V28, P1140, DOI 10.1016/S0003-3472(80)80103-5; Guschanski K, 2008, CURR BIOL, V18, P1809, DOI 10.1016/j.cub.2008.10.031; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI 10.1016/0022-5193(64)90039-6; Hammond RL, 2006, P ROY SOC B-BIOL SCI, V273, P479, DOI 10.1098/rspb.2005.3257; Handley LJL, 2007, MOL ECOL, V16, P1559, DOI 10.1111/j.1365-294X.2006.03152.x; Harris TR, 2009, MOL ECOL, V18, P1777, DOI 10.1111/j.1365-294X.2009.04139.x; Hedrick PW, 2005, EVOLUTION, V59, P1633, DOI 10.1111/j.0014-3820.2005.tb01814.x; Hey J, 2010, MOL BIOL EVOL, V27, P921, DOI 10.1093/molbev/msp298; Hill K., 1996, ACHE LIFE HIST ECOLO, DOI 10.4324/9781351329248; Hohmann G, 2002, BEHAVIOURAL DIVERSITY IN CHIMPANZEES AND BONOBOS, P138, DOI 10.1017/CBO9780511606397.014; Hohmann G, 2003, CURR ANTHROPOL, V44, P563, DOI 10.1086/377649; Hohmann G, 2001, PRIMATES, V42, P91, DOI 10.1007/BF02640692; Hohmann G., 2003, PAN AFR NEWS, V10, P25, DOI DOI 10.5134/143430; HOLEKAMP KE, 1984, BEHAV ECOL SOCIOBIOL, V16, P21, DOI 10.1007/BF00293100; Idani G., 1990, African Study Monographs, V11, P153; Isvaran K, 2007, P ROY SOC B-BIOL SCI, V274, P219, DOI 10.1098/rspb.2006.3723; Jack KM, 2009, BEHAVIOUR, V146, P471, DOI 10.1163/156853909X404420; Kalinowski ST, 2007, MOL ECOL, V16, P1099, DOI 10.1111/j.1365-294X.2007.03089.x; KANO T, 1982, Primates, V23, P171, DOI 10.1007/BF02381159; Kano T., 1992, LAST APE PYGMY CHIMP; Kayser M, 2006, GENETICS, V173, P2179, DOI 10.1534/genetics.106.055632; LANGERGRABER KE, 2010, P ROYAL SOC B; Langergraber KE, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000973; Lukas D, 2005, MOL ECOL, V14, P2181, DOI 10.1111/j.1365-294X.2005.02560.x; Marlowe FW, 2004, CURR ANTHROPOL, V45, P277, DOI 10.1086/382256; MCCRACKEN GF, 1981, BEHAV ECOL SOCIOBIOL, V8, P11, DOI 10.1007/BF00302840; Meirmans PG, 2006, EVOLUTION, V60, P2399, DOI 10.1111/j.0014-3820.2006.tb01874.x; MELNICK DJ, 1993, MOL BIOL EVOL, V10, P282; Moller LM, 2004, MOL ECOL, V13, P1607, DOI 10.1111/j.1365-294X.2004.02137.x; MORIN PA, 1994, SCIENCE, V265, P1193, DOI 10.1126/science.7915048; Morin PA, 2001, MOL ECOL, V10, P1835, DOI 10.1046/j.0962-1083.2001.01308.x; Muller MN, 2002, BEHAVIOURAL DIVERSITY IN CHIMPANZEES AND BONOBOS, P112, DOI 10.1017/CBO9780511606397.012; Munshi-South J, 2007, BEHAV ECOL SOCIOBIOL, V62, P201, DOI 10.1007/s00265-007-0454-7; Murdock G. P., 1981, ATLAS WORLD CULTURES; Nagy M, 2007, P ROY SOC B-BIOL SCI, V274, P3019, DOI 10.1098/rspb.2007.1008; Natoli A, 2005, P ROY SOC B-BIOL SCI, V272, P1217, DOI 10.1098/rspb.2005.3076; Newton-Fisher NE, 1999, FOLIA PRIMATOL, V70, P167, DOI 10.1159/000021690; Newton-Fisher NE, 2010, AM J PHYS ANTHROPOL, V142, P417, DOI 10.1002/ajpa.21241; Nichols J., 2001, DISPERSAL; NISHIDA T, 1985, Z TIERPSYCHOL, V67, P284; Nishida T., 1990, CHIMPANZEES MAHALE M; Nishimura A, 2003, INT J PRIMATOL, V24, P707, DOI 10.1023/A:1024681703616; Nsubuga AM, 2004, MOL ECOL, V13, P2089, DOI 10.1111/j.1365-294X.2004.02207.x; Ostner J, 2008, BEHAV ECOL, V19, P1150, DOI 10.1093/beheco/arn093; Packer C, 2005, SCIENCE, V307, P390, DOI 10.1126/science.1105122; Pilot M, 2006, MOL ECOL, V15, P4533, DOI 10.1111/j.1365-294X.2006.03110.x; Pusey A, 1996, TRENDS ECOL EVOL, V11, P201, DOI 10.1016/0169-5347(96)10028-8; Pusey A, 1979, GREAT APES, P465; Radespiel U, 2008, AM J PRIMATOL, V70, P860, DOI 10.1002/ajp.20574; RODSETH L, 1991, CURR ANTHROPOL, V32, P221, DOI 10.1086/203952; Segurel L, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000200; Silk JB, 2003, SCIENCE, V302, P1231, DOI 10.1126/science.1088580; SOULSBURY CD, 2010, PLOS ONE, V5, P1; STRIER KB, 1990, INT J PRIMATOL, V11, P7, DOI 10.1007/BF02193693; Struhsaker T.T., 1975, RED COLOBUS MONKEY; Sweitzer RA, 1998, J ZOOL, V244, P159; SYMINGTON MM, 1987, BEHAV ECOL SOCIOBIOL, V20, P421, DOI 10.1007/BF00302985; Thompson ME, 2006, INT J PRIMATOL, V27, P1601, DOI 10.1007/s10764-006-9098-0; Townsend SW, 2007, CURR BIOL, V17, pR355, DOI 10.1016/j.cub.2007.03.020; Van Horn RC, 2007, BEHAV ECOL SOCIOBIOL, V61, P1823, DOI 10.1007/s00265-007-0415-1; Vigilant L, 2001, P NATL ACAD SCI USA, V98, P12890, DOI 10.1073/pnas.231320498; Watts DP, 2001, BEHAVIOUR, V138, P299, DOI 10.1163/15685390152032488; Wegmann D, 2010, MOL BIOL EVOL, V27, P1425, DOI 10.1093/molbev/msq028; Whiten A, 1999, NATURE, V399, P682, DOI 10.1038/21415; Wilkins JF, 2006, BIOESSAYS, V28, P290, DOI 10.1002/bies.20378; Wilson IJ, 2003, J R STAT SOC A STAT, V166, P155, DOI 10.1111/1467-985X.00264; Wilson ML, 2003, ANNU REV ANTHROPOL, V32, P363, DOI 10.1146/annurev.anthro.32.061002.120046; Wimmer B, 2002, BEHAV ECOL SOCIOBIOL, V52, P166, DOI 10.1007/s00265-002-0497-8; Wright S, 1943, GENETICS, V28, P114; Wroblewski EE, 2009, ANIM BEHAV, V77, P873, DOI 10.1016/j.anbehav.2008.12.014; Young AJ, 2007, P ROY SOC B-BIOL SCI, V274, P1603, DOI 10.1098/rspb.2007.0316	99	34	34	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2011	6	7							e21514	10.1371/journal.pone.0021514	http://dx.doi.org/10.1371/journal.pone.0021514			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786HC	21747938	gold, Green Published, Green Submitted			2022-12-27	WOS:000292293400014
J	Magnusson, K; Mendes, AM; Windbichler, N; Papathanos, PA; Nolan, T; Dottorini, T; Rizzi, E; Christophides, GK; Crisanti, A				Magnusson, Kalle; Mendes, Antonio M.; Windbichler, Nikolai; Papathanos, Philippos-Aris; Nolan, Tony; Dottorini, Tania; Rizzi, Ermanno; Christophides, George K.; Crisanti, Andrea			Transcription Regulation of Sex-Biased Genes during Ontogeny in the Malaria Vector Anopheles gambiae	PLOS ONE			English	Article							GENOME-WIDE ANALYSIS; MOLECULAR-CLONING; AEDES-AEGYPTI; EXPRESSION; DROSOPHILA; PROTEIN; MOSQUITOS; EVOLUTION; SPERM; IDENTIFICATION	In Anopheles gambiae, sex-regulated genes are responsible for controlling gender dimorphism and are therefore crucial in determining the ability of female mosquitoes to transmit human malaria. The identification and functional characterization of these genes will shed light on the sexual development and maturation of mosquitoes and provide useful targets for genetic control measures aimed at reducing mosquito fertility and/or distorting the sex ratio. We conducted a genome wide transcriptional analysis of sex-regulated genes from early developmental stages through adulthood combined with functional screening of novel gonadal genes. Our results demonstrate that the male-biased genes undergo a major transcription turnover starting from larval stages to adulthood. The male biased genes at the adult stage include a significant high number of unique sequences compared to the rest of the genome. This is in contrast to female-biased genes that are much more conserved and are mainly activated during late developmental stages. The high frequency of unique sequences would indicate that male-biased genes evolve more rapidly than the rest of the genome. This finding is particularly intriguing because A. gambiae is a strictly female monogamous species suggesting that driving forces in addition to sperm competition must account for the rapid evolution of male-biased genes. We have also identified and functionally characterized a number of previously unknown A. gambiae testis-and ovary-specific genes. Two of these genes, zero population growth and a suppressor of defective silencing 3 domain of the histone deacetylase co-repressor complex, were shown to play a key role in gonad development.	[Magnusson, Kalle; Mendes, Antonio M.; Windbichler, Nikolai; Papathanos, Philippos-Aris; Nolan, Tony; Christophides, George K.; Crisanti, Andrea] Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, London, England; [Dottorini, Tania] Univ Perugia, Dept Expt Med, I-06100 Perugia, Italy; [Rizzi, Ermanno] CNR, Ist Tecnol Biomed, Milan, Italy	Imperial College London; University of Perugia; Consiglio Nazionale delle Ricerche (CNR); Istituto di Tecnologie Biomediche (ITB-CNR)	Magnusson, K (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, London, England.	acrs@imperial.ac.uk	rizzi, ermanno/Q-3399-2016; Rizzi, Ermanno/J-7448-2012; Papathanos, Philippos/ABE-4869-2021; Nolan, Tony/I-4925-2012	rizzi, ermanno/0000-0002-9898-2326; Nolan, Tony/0000-0002-2982-8333; Papathanos, Philippos Aris/0000-0001-8508-4554; M. Mendes, Antonio/0000-0001-6562-5325; Christophides, George/0000-0002-3323-1687; Dottorini, Tania/0000-0001-7733-906X; Crisanti, Andrea/0000-0002-2406-4426; Windbichler, Nikolai/0000-0001-9896-1165	Foundation for the National Institutes of Health through the Grand Challenges in Global Health initiative; BBSRC; Biotechnology and Biological Sciences Research Council [BB/E021794/1] Funding Source: researchfish; BBSRC [BB/E021794/1] Funding Source: UKRI	Foundation for the National Institutes of Health through the Grand Challenges in Global Health initiative(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by a Grant of the Foundation for the National Institutes of Health through the Grand Challenges in Global Health initiative (www.grandchallenges.org/) as well as by a Grant of the BBSRC (www.bbsrc.ac.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alland L, 2002, MOL CELL BIOL, V22, P2743, DOI 10.1128/MCB.22.8.2743-2750.2002; Andres JA, 2006, MOL BIOL EVOL, V23, P1574, DOI 10.1093/molbev/msl020; Barillas-Mury C, 2005, CELL MICROBIOL, V7, P1539, DOI 10.1111/j.1462-5822.2005.00615.x; Blandin S, 2004, CELL, V116, P661, DOI 10.1016/S0092-8674(04)00173-4; Calvo E, 2005, INSECT BIOCHEM MOLEC, V35, P789, DOI 10.1016/j.ibmb.2005.02.007; Carlini DB, 2004, J EVOLUTION BIOL, V17, P779, DOI 10.1111/j.1420-9101.2004.00725.x; Catteruccia F, 2005, NAT BIOTECHNOL, V23, P1414, DOI 10.1038/nbt1152; Dimopoulos G, 2002, P NATL ACAD SCI USA, V99, P8814, DOI 10.1073/pnas.092274999; Dottorini T, 2007, P NATL ACAD SCI USA, V104, P16215, DOI 10.1073/pnas.0703904104; Ellegren H, 2007, NAT REV GENET, V8, P689, DOI 10.1038/nrg2167; Findlay GD, 2009, GENOME RES, V19, P886, DOI 10.1101/gr.089391.108; Haerty W, 2007, GENETICS, V177, P1321, DOI 10.1534/genetics.107.078865; Hahn MW, 2005, CURR BIOL, V15, pR192, DOI 10.1016/j.cub.2005.03.005; Hambuch TM, 2005, GENETICS, V170, P1691, DOI 10.1534/genetics.104.038109; Horn C, 2000, DEV GENES EVOL, V210, P630, DOI 10.1007/s004270000110; Howell PI, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-S2-S8; Huh JR, 2004, PLOS BIOL, V2, P43, DOI 10.1371/journal.pbio.0020015; Iguchi N, 1999, FEBS LETT, V456, P315, DOI 10.1016/S0014-5793(99)00967-9; IKEMURA T, 1981, J MOL BIOL, V151, P389, DOI 10.1016/0022-2836(81)90003-6; Inaba K, 2003, ZOOL SCI, V20, P1043, DOI 10.2108/zsj.20.1043; Juhn J, 2006, INSECT MOL BIOL, V15, P363, DOI 10.1111/j.1365-2583.2006.00655.x; Krzywinski J, 2004, GENETICS, V166, P1291, DOI 10.1534/genetics.166.3.1291; Lebo MS, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-80; Lobo NF, 2006, NAT PROTOC, V1, P1312, DOI 10.1038/nprot.2006.221; Marinotti O, 2006, INSECT MOL BIOL, V15, P1, DOI 10.1111/j.1365-2583.2006.00610.x; Parisi M, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-6-r40; Rogers DW, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000272; Schwed G, 2002, MOL BIOL CELL, V13, P607, DOI 10.1091/mbc.01-08-0400; Sinden RE, 2004, INSECT BIOCHEM MOLEC, V34, P625, DOI 10.1016/j.ibmb.2004.03.015; Spiridonov NA, 2005, MOL CELL BIOL, V25, P4250, DOI 10.1128/MCB.25.10.4250-4261.2005; Swanson WJ, 2002, NAT REV GENET, V3, P137, DOI 10.1038/nrg733; Tai CT, 2001, CIRCULATION, V104, P1501, DOI 10.1161/hc3801.078813; Tazuke SI, 2002, DEVELOPMENT, V129, P2529; Thoemke K, 2005, DEV BIOL, V284, P500, DOI 10.1016/j.ydbio.2005.05.017; Tripet F, 2003, AM J TROP MED HYG, V68, P1; TRYSELIUS Y, 1992, EUR J BIOCHEM, V204, P395, DOI 10.1111/j.1432-1033.1992.tb16648.x; Tsuchida J, 1998, DEV BIOL, V197, P67, DOI 10.1006/dbio.1998.8885; Vilain E, 1998, MOL GENET METAB, V65, P74, DOI 10.1006/mgme.1998.2749; Vlachou D, 2005, CURR BIOL, V15, P1185, DOI 10.1016/j.cub.2005.06.044; Windbichler N, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000291; Wolkowicz MJ, 2002, BIOL REPROD, V66, P241, DOI 10.1095/biolreprod66.1.241; WRIGHT F, 1990, GENE, V87, P23, DOI 10.1016/0378-1119(90)90491-9; Yeh SD, 2002, J BIOL CHEM, V277, P6311, DOI 10.1074/jbc.M106941200	44	54	56	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2011	6	6							e21572	10.1371/journal.pone.0021572	http://dx.doi.org/10.1371/journal.pone.0021572			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786GP	21738713	Green Published, Green Submitted, gold			2022-12-27	WOS:000292291800022
J	Carroll, TD; Matzinger, SR; Fritts, L; McChesney, MB; Miller, CJ				Carroll, Timothy D.; Matzinger, Shannon R.; Fritts, Linda; McChesney, Michael B.; Miller, Christopher J.			Memory B Cells and CD8+Lymphocytes Do Not Control Seasonal Influenza A Virus Replication after Homologous Re-Challenge of Rhesus Macaques	PLOS ONE			English	Article							SIMIAN-IMMUNODEFICIENCY-VIRUS; HUMORAL IMMUNE-RESPONSES; CD8(+) T-CELLS; VAGINAL CHALLENGE; SERUM ANTIBODY; PRIMATE MODEL; INFECTION; TRANSMISSION; LYMPHOCYTES; INTERFERON	This study sought to define the role of memory lymphocytes in the protection from homologous influenza A virus re-challenge in rhesus macaques. Depleting monoclonal antibodies (mAb) were administered to the animals prior to their second experimental inoculation with a human seasonal influenza A virus strain. Treatment with either anti-CD8 alpha or anti-CD20 mAbs prior to re-challenge had minimal effect on influenza A virus replication. Thus, in non-human primates with preexisting anti-influenza A antibodies, memory B cells and CD8 alpha(+) T cells do not contribute to the control of virus replication after re-challenge with a homologous strain of influenza A virus.	[Carroll, Timothy D.; Matzinger, Shannon R.; Fritts, Linda; McChesney, Michael B.; Miller, Christopher J.] Univ Calif Davis, Ctr Comparat Med, Davis, CA 95616 USA; [Carroll, Timothy D.; Matzinger, Shannon R.; Fritts, Linda; McChesney, Michael B.; Miller, Christopher J.] Univ Calif Davis, Calif Natl Primate Res Ctr, Davis, CA 95616 USA; [Miller, Christopher J.] Univ Calif Davis, Dept Pathol Microbiol & Immunol, Sch Vet Med, Davis, CA 95616 USA; [McChesney, Michael B.] Univ Calif Davis, Dept Pathol & Lab Med, Sch Med, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Carroll, TD (corresponding author), Univ Calif Davis, Ctr Comparat Med, Davis, CA 95616 USA.	cjmiller@ucdavis.edu	Carroll, Timothy D/A-4605-2013	Carroll, Timothy D/0000-0002-3459-3364	National Center for Research Resources [P51RR00169]; National Institute of Allergy and Infectious Disease [U01AI57624, U01AI5726]; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000169] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI057264] Funding Source: NIH RePORTER	National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute of Allergy and Infectious Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by Public Health Service grant P51RR00169 from the National Center for Research Resources and grants U01AI57624 and U01AI5726 from the National Institute of Allergy and Infectious Disease. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel K, 2005, J VIROL, V79, P12164, DOI 10.1128/JVI.79.19.12164-12172.2005; Baskin CR, 2007, J VIROL, V81, P11817, DOI 10.1128/JVI.00590-07; BERENDT RF, 1974, INFECT IMMUN, V9, P101, DOI 10.1128/IAI.9.1.101-105.1974; Carroll TD, 2010, VACCINE; Carroll TD, 2008, J IMMUNOL, V180, P2385, DOI 10.4049/jimmunol.180.4.2385; Couch R B, 2003, Dev Biol (Basel), V115, P25; COUCH RB, 1983, ANNU REV MICROBIOL, V37, P529, DOI 10.1146/annurev.mi.37.100183.002525; DELEM A, 1978, J INFECT DIS, V137, P194, DOI 10.1093/infdis/137.2.194; FOX JP, 1982, AM J EPIDEMIOL, V116, P228, DOI 10.1093/oxfordjournals.aje.a113408; Gaufin T, 2009, BLOOD, V113, P4250, DOI 10.1182/blood-2008-09-177741; Genesca M, 2009, J INTERN MED, V265, P67, DOI 10.1111/j.1365-2796.2008.02051.x; Genesca M, 2008, J VIROL, V82, P11181, DOI 10.1128/JVI.01433-08; Gianfrani C, 2000, HUM IMMUNOL, V61, P438, DOI 10.1016/S0198-8859(00)00105-1; GLEZEN WP, 1982, AM J EPIDEMIOL, V116, P589, DOI 10.1093/oxfordjournals.aje.a113441; GREENBERG SB, 1974, AM J EPIDEMIOL, V100, P209, DOI 10.1093/oxfordjournals.aje.a112029; Hartley CA, 1997, ARCH VIROL, V142, P75, DOI 10.1007/s007050050060; Hayden FG, 1998, J CLIN INVEST, V101, P643, DOI 10.1172/JCI1355; HOBSON D, 1972, J HYG-CAMBRIDGE, V70, P767, DOI 10.1017/S0022172400022610; Kobasa D, 2007, NATURE, V445, P319, DOI 10.1038/nature05495; Kugel D, 2009, J VIROL, V83, P3843, DOI 10.1128/JVI.02453-08; Lowen AC, 2007, PLOS PATHOG, V3, P1470, DOI 10.1371/journal.ppat.0030151; Maines TR, 2009, SCIENCE, V325, P484, DOI 10.1126/science.1177238; Manz RA, 2005, ANNU REV IMMUNOL, V23, P367, DOI 10.1146/annurev.immunol.23.021704.115723; Miller CJ, 2007, J VIROL, V81, P5024, DOI 10.1128/JVI.02444-06; Miller CJ, 1997, J VIROL, V71, P1911, DOI 10.1128/JVI.71.3.1911-1921.1997; MILLER DL, 1973, J HYG-CAMBRIDGE, V71, P535, DOI 10.1017/S0022172400046520; PYHALA R, 1975, INT J EPIDEMIOL, V4, P127, DOI 10.1093/ije/4.2.127; REED L. J., 1938, AMER JOUR HYG, V27, P493; Rimmelzwaan GF, 1997, J GEN VIROL, V78, P757, DOI 10.1099/0022-1317-78-4-757; Rimmelzwaan GF, 2001, J VIROL, V75, P6687, DOI 10.1128/JVI.75.14.6687-6691.2001; Salk JE, 1944, J IMMUNOL, V49, P87; Schmitz JE, 2005, J VIROL, V79, P8131, DOI 10.1128/JVI.79.13.8131-8141.2005; Schmitz JE, 2003, J VIROL, V77, P2165, DOI 10.1128/JVI.77.3.2165-2173.2003; Schmitz JE, 1999, SCIENCE, V283, P857, DOI 10.1126/science.283.5403.857; Schmitz JE, 1999, AM J PATHOL, V154, P1923, DOI 10.1016/S0002-9440(10)65450-8; Svitek N, 2008, VIROLOGY, V376, P53, DOI 10.1016/j.virol.2008.02.035; TEDDER TE, 1994, IMMUNOL TODAY, V15, P450, DOI 10.1016/0167-5699(94)90276-3; TEDDER TE, 1994, IMMUNOL TODAY, V15, P437, DOI 10.1016/0167-5699(94)90274-7; Wang YC, 2005, J VIROL, V79, P14355, DOI 10.1128/JVI.79.22.14355-14370.2005; Wright PF, 2007, FIELDS VIROLOGY, V2, P1691	40	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2011	6	6							e21756	10.1371/journal.pone.0021756	http://dx.doi.org/10.1371/journal.pone.0021756			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786FZ	21747924	Green Published, Green Submitted, gold			2022-12-27	WOS:000292290100068
J	Pan, WQ; Issaq, S; Zhang, YP				Pan, Wenqi; Issaq, Sameer; Zhang, Yanping			The In Vivo Role of the RP-Mdm2-p53 Pathway in Signaling Oncogenic Stress Induced by pRb Inactivation and Ras Overexpression	PLOS ONE			English	Article							CELL-CYCLE PROGRESSION; RIBOSOMAL-PROTEIN L23; ARF TUMOR-SUPPRESSOR; C-MYC; PROSTATE-CANCER; STABILIZES P53; FEEDBACK LOOP; MDM2; INHIBITION; GROWTH	The Mdm2-p53 tumor suppression pathway plays a vital role in regulating cellular homeostasis by integrating a variety of stressors and eliciting effects on cell growth and proliferation. Recent studies have demonstrated an in vivo signaling pathway mediated by ribosomal protein (RP)-Mdm2 interaction that responds to ribosome biogenesis stress and evokes a protective p53 reaction. It has been shown that mice harboring a Cys-to-Phe mutation in the zinc finger of Mdm2 that specifically disrupts RP L11-Mdm2 binding are prone to accelerated lymphomagenesis in an oncogenic c-Myc driven mouse model of Burkitt's lymphoma. Because most oncogenes when upregulated simultaneously promote both cellular growth and proliferation, it therefore stands to reason that the RP-Mdm2-p53 pathway might also be essential in response to oncogenes other than c-Myc. Using genetically engineered mice, we now show that disruption of the RP-Mdm2-p53 pathway by an Mdm2(C305F) mutation does not accelerate prostatic tumorigenesis induced by inactivation of the pRb family proteins (pRb/p107/p130). In contrast, loss of p19Arf greatly accelerates the progression of prostate cancer induced by inhibition of pRb family proteins. Moreover, using ectopically expressed oncogenic H-Ras we demonstrate that p53 response remains intact in the Mdm2(C305F) mutant MEF cells. Thus, unlike the p19Arf-Mdm2-p53 pathway, which is considered a general oncogenic response pathway, the RP-Mdm2-p53 pathway appears to specifically suppress tumorigenesis induced by oncogenic c-Myc.	[Pan, Wenqi; Issaq, Sameer; Zhang, Yanping] Univ N Carolina, Dept Radiat Oncol, Chapel Hill, NC 27515 USA; [Pan, Wenqi; Issaq, Sameer; Zhang, Yanping] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Zhang, Yanping] Univ N Carolina, Dept Pharmacol, Chapel Hill, NC USA; [Pan, Wenqi] Univ N Carolina, Sch Med, Curriculum Genet & Mol Biol, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Pan, WQ (corresponding author), Univ N Carolina, Dept Radiat Oncol, Chapel Hill, NC 27515 USA.	ypzhang@med.unc.edu			Leukemia and Lymphoma Society [1416-08]; American Cancer Society [MGO-114790]; National Institute of Health [CA100302, CA127770, CA87580]; NATIONAL CANCER INSTITUTE [R01CA100302, R01CA127770, K01CA087580] Funding Source: NIH RePORTER	Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); American Cancer Society(American Cancer Society); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The study was supported by grants from the Leukemia and Lymphoma Society (No. 1416-08), American Cancer Society (No. MGO-114790), and National Institute of Health (No. CA100302, CA127770, CA87580). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS JM, 1985, NATURE, V318, P533, DOI 10.1038/318533a0; Arabi A, 2005, NAT CELL BIOL, V7, P303, DOI 10.1038/ncb1225; Ayrault O, 2006, EXP CELL RES, V312, P1185, DOI 10.1016/j.yexcr.2006.01.027; Bassi DE, 2010, NEOPLASIA, V12, P516, DOI 10.1593/neo.92030; Bates S, 1998, NATURE, V395, P124, DOI 10.1038/25867; Bensaad K, 2006, CELL, V126, P107, DOI 10.1016/j.cell.2006.05.036; BOOKSTEIN R, 1993, CANCER RES, V53, P3369; Boon K, 2001, EMBO J, V20, P1383, DOI 10.1093/emboj/20.6.1383; Coller HA, 2000, P NATL ACAD SCI USA, V97, P3260, DOI 10.1073/pnas.97.7.3260; CONTI CJ, 1988, CANCER RES, V48, P435; Dai MS, 2004, J BIOL CHEM, V279, P44475, DOI 10.1074/jbc.M403722200; Dai MS, 2004, MOL CELL BIOL, V24, P7654, DOI 10.1128/MCB.24.17.7654-7668.2004; Deisenroth C, 2010, MOL CELL BIOL, V30, P3981, DOI 10.1128/MCB.01284-09; Downward J, 2003, NAT REV CANCER, V3, P11, DOI 10.1038/nrc969; DYSON N, 1994, J CELL SCI, P81; Eischen CM, 1999, GENE DEV, V13, P2658, DOI 10.1101/gad.13.20.2658; Fingar DC, 2004, MOL CELL BIOL, V24, P200, DOI 10.1128/MCB.24.1.200-216.2004; Fingar DC, 2004, ONCOGENE, V23, P3151, DOI 10.1038/sj.onc.1207542; Gomez-Roman N, 2003, NATURE, V421, P290, DOI 10.1038/nature01327; Grewal SS, 2005, NAT CELL BIOL, V7, P295, DOI 10.1038/ncb1223; Guo QM, 2000, CANCER RES, V60, P5922; HEIDENBERG HB, 1995, J UROLOGY, V154, P414, DOI 10.1016/S0022-5347(01)67065-4; Hill R, 2005, CELL, V123, P1001, DOI 10.1016/j.cell.2005.09.030; Hill R, 2005, CANCER RES, V65, P10243, DOI 10.1158/0008-5472.CAN-05-1579; HOLLSTEIN M, 1991, SCIENCE, V253, P49, DOI 10.1126/science.1905840; Jin A, 2004, MOL CELL BIOL, V24, P7669, DOI 10.1128/MCB.24.17.7669-7680.2004; Jorgensen P, 2004, GENE DEV, V18, P2491, DOI 10.1101/gad.1228804; Kamijo T, 1998, P NATL ACAD SCI USA, V95, P8292, DOI 10.1073/pnas.95.14.8292; Kamijo T, 1997, CELL, V91, P649, DOI 10.1016/S0092-8674(00)80452-3; Lin AW, 2001, P NATL ACAD SCI USA, V98, P5025, DOI 10.1073/pnas.091100298; Lindstrom MS, 2007, MOL CELL BIOL, V27, P1056, DOI 10.1128/MCB.01307-06; Lohrum MAE, 2003, CANCER CELL, V3, P577, DOI 10.1016/S1535-6108(03)00134-X; Macias E, 2010, CANCER CELL, V18, P231, DOI 10.1016/j.ccr.2010.08.007; Menssen A, 2002, P NATL ACAD SCI USA, V99, P6274, DOI 10.1073/pnas.082005599; Palmero I, 1998, NATURE, V395, P125, DOI 10.1038/25870; Perry RP, 2007, GENE, V401, P1, DOI 10.1016/j.gene.2007.07.007; PICKSLEY SM, 1993, BIOESSAYS, V15, P689, DOI 10.1002/bies.950151008; Pomerantz J, 1998, CELL, V92, P713, DOI 10.1016/S0092-8674(00)81400-2; Roper E, 2001, EMBO REP, V2, P145, DOI 10.1093/embo-reports/kve020; Stott FJ, 1998, EMBO J, V17, P5001, DOI 10.1093/emboj/17.17.5001; Tolbert D, 2002, MOL CELL BIOL, V22, P370, DOI 10.1128/MCB.22.1.370-377.2002; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; YUSPA SH, 1983, J INVEST DERMATOL, V81, pS162, DOI 10.1111/1523-1747.ep12540999; Zhang YP, 2009, CANCER CELL, V16, P369, DOI 10.1016/j.ccr.2009.09.024; Zhang YP, 1998, CELL, V92, P725, DOI 10.1016/S0092-8674(00)81401-4; Zhou ZX, 2006, CANCER RES, V66, P7889, DOI 10.1158/0008-5472.CAN-06-0486; Zindy F, 1998, GENE DEV, V12, P2424, DOI 10.1101/gad.12.15.2424	47	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2011	6	6							e21625	10.1371/journal.pone.0021625	http://dx.doi.org/10.1371/journal.pone.0021625			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786FZ	21747916	Green Submitted, Green Published, gold			2022-12-27	WOS:000292290100047
J	Super, H; Romeo, A				Super, Hans; Romeo, August			Feedback Enhances Feedforward Figure-Ground Segmentation by Changing Firing Mode	PLOS ONE			English	Article							PRIMARY VISUAL-CORTEX; NEURAL MODEL; THALAMIC NEURONS; DISTINCT MODES; MONKEY; V1; SEGREGATION; MECHANISMS; ATTENTION; DISCRIMINATION	In the visual cortex, feedback projections are conjectured to be crucial in figure-ground segregation. However, the precise function of feedback herein is unclear. Here we tested a hypothetical model of reentrant feedback. We used a previous developed 2-layered feedforwardspiking network that is able to segregate figure from ground and included feedback connections. Our computer model data show that without feedback, neurons respond with regular low-frequency (similar to 9 Hz) bursting to a figure-ground stimulus. After including feedback the firing pattern changed into a regular (tonic) spiking pattern. In this state, we found an extra enhancement of figure responses and a further suppression of background responses resulting in a stronger figure-ground signal. Such push-pull effect was confirmed by comparing the figure-ground responses withthe responses to a homogenous texture. We propose that feedback controlsfigure-ground segregation by influencing the neural firing patterns of feedforward projecting neurons.	[Super, Hans] Inst Brain Cognit & Behav IR3C, Barcelona, Spain; [Super, Hans; Romeo, August] Univ Barcelona, Fac Psychol, Dept Basic Psychol, Barcelona, Spain; [Super, Hans] Catalan Inst Res & Adv Studies ICREA, Barcelona, Spain	University of Barcelona; University of Barcelona; ICREA	Super, H (corresponding author), Inst Brain Cognit & Behav IR3C, Barcelona, Spain.	hans.super@icrea.es		Super, Hans/0000-0001-9328-0096	Spanish Ministry of Education and Science (MICINN) [PSI2010-18139, SAF2009-10367]; Catalan government (AGAUR) [2009-SGR-308]; ICREA Funding Source: Custom	Spanish Ministry of Education and Science (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Catalan government (AGAUR)(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR)); ICREA(ICREA)	This work was supported by grants to HS (PSI2010-18139 & SAF2009-10367) from the Spanish Ministry of Education and Science (MICINN) and (2009-SGR-308) from Catalan government (AGAUR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen HA, 2009, J VISION, V9, DOI 10.1167/9.9.2; Andolina IM, 2007, P NATL ACAD SCI USA, V104, P1685, DOI 10.1073/pnas.0609318104; Angelucci A, 2002, J NEUROSCI, V22, P8633; Arnott SR, 2001, COGNITIVE BRAIN RES, V12, P383, DOI 10.1016/S0926-6410(01)00066-0; Baek K, 2005, IEEE T NEUR SYS REH, V13, P125, DOI 10.1109/TNSRE.2005.847388; Bastiaansen MCM, 2001, INT J PSYCHOPHYSIOL, V43, P91, DOI 10.1016/S0167-8760(01)00181-7; Bhatt R, 2007, VISION RES, V47, P3173, DOI 10.1016/j.visres.2007.07.013; Budd JML, 1998, P ROY SOC B-BIOL SCI, V265, P1037, DOI 10.1098/rspb.1998.0396; Corthout E, 1999, NEUROPSYCHOLOGIA, V37, P137; Craft E, 2007, J NEUROPHYSIOL, V97, P4310, DOI 10.1152/jn.00203.2007; De Weerd P, 1999, NAT NEUROSCI, V2, P753, DOI 10.1038/11234; Deco G, 2004, EUR J NEUROSCI, V20, P1089, DOI 10.1111/j.1460-9568.2004.03528.x; Destexhe A, 2002, PHILOS T ROY SOC B, V357, P1649, DOI 10.1098/rstb.2002.1154; Domijan D, 2008, J VISION, V8, DOI 10.1167/8.7.10; Grossberg S, 2001, CEREB CORTEX, V11, P37, DOI 10.1093/cercor/11.1.37; Grossberg S, 2007, PROG BRAIN RES, V165, P79, DOI 10.1016/S0079-6123(06)65006-1; Hayes RD, 2007, CEREB CORTEX, V17, P1117, DOI 10.1093/cercor/bhl021; Huang JY, 2007, BRAIN RES, V1138, P111, DOI 10.1016/j.brainres.2006.12.081; Hupe JM, 2001, J NEUROPHYSIOL, V85, P146, DOI 10.1152/jn.2001.85.1.146; Hupe JM, 2001, J NEUROPHYSIOL, V85, P134, DOI 10.1152/jn.2001.85.1.134; Hupe JM, 1998, NATURE, V394, P784, DOI 10.1038/29537; Izhikevich EM, 2003, IEEE T NEURAL NETWOR, V14, P1569, DOI 10.1109/TNN.2003.820440; Jehee JFM, 2007, VISION RES, V47, P1153, DOI 10.1016/j.visres.2006.12.018; Jones HE, 2001, J NEUROPHYSIOL, V86, P2011, DOI 10.1152/jn.2001.86.4.2011; Lamme VAF, 2000, TRENDS NEUROSCI, V23, P571, DOI 10.1016/S0166-2236(00)01657-X; Lamme VAF, 2002, J COGNITIVE NEUROSCI, V14, P1044, DOI 10.1162/089892902320474490; Landman R, 2003, J COGNITIVE NEUROSCI, V15, P873, DOI 10.1162/089892903322370799; Le Masson G, 2002, NATURE, V417, P854, DOI 10.1038/nature00825; Llinas RR, 2006, J NEUROPHYSIOL, V95, P3297, DOI 10.1152/jn.00166.2006; McAlonan K, 2008, NATURE, V456, P391, DOI 10.1038/nature07382; Olveczky BP, 2003, NATURE, V423, P401, DOI 10.1038/nature01652; Parkes LM, 2004, NEUROIMAGE, V21, P236, DOI 10.1016/j.neuroimage.2003.08.025; Pascual-Leone A, 2001, SCIENCE, V292, P510, DOI 10.1126/science.1057099; Qiu FTT, 2007, NAT NEUROSCI, V10, P1492, DOI 10.1038/nn1989; Roelfsema PR, 2007, NEURON, V56, P785, DOI 10.1016/j.neuron.2007.10.006; Roelfsema PR, 2002, J COGNITIVE NEUROSCI, V14, P525, DOI 10.1162/08989290260045756; Rossi AF, 1999, J NEUROSCI, V19, P6145, DOI 10.1523/JNEUROSCI.19-14-06145.1999; Scholte HS, 2008, J COGNITIVE NEUROSCI, V20, P2097, DOI 10.1162/jocn.2008.20142; Scholte HS, 2006, BRAIN RES, V1076, P106, DOI 10.1016/j.brainres.2005.10.051; Sherman SM, 2001, TRENDS NEUROSCI, V24, P122, DOI 10.1016/S0166-2236(00)01714-8; Sillito AM, 2006, TRENDS NEUROSCI, V29, P307, DOI 10.1016/j.tins.2006.05.001; Silvanto J, 2005, NAT NEUROSCI, V8, P143, DOI 10.1038/nn1379; Sincich LC, 2001, J NEUROSCI, V21, P4416, DOI 10.1523/JNEUROSCI.21-12-04416.2001; Smith FW, 2010, P NATL ACAD SCI USA, V107, P20099, DOI 10.1073/pnas.1000233107; SPORNS O, 1991, P NATL ACAD SCI USA, V88, P129, DOI 10.1073/pnas.88.1.129; STERIADE M, 1993, SCIENCE, V262, P679, DOI 10.1126/science.8235588; Sun HJ, 1999, IEEE T NEURAL NETWOR, V10, P860, DOI 10.1109/72.774238; Super H, 2003, NEUROSCI LETT, V344, P75, DOI 10.1016/S0304-3940(03)00360-4; Super H, 2003, J NEUROSCI, V23, P3407; Super H, 2001, NAT NEUROSCI, V4, P304, DOI 10.1038/85170; Super H, 2007, NEUROPSYCHOLOGIA, V45, P3329, DOI 10.1016/j.neuropsychologia.2007.07.001; Super H, 2011, J COGNITIVE NEUROSCI, V23, P491, DOI 10.1162/jocn.2010.21512; Super H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010705; Thielscher A, 2003, NEUROSCIENCE, V122, P921, DOI 10.1016/j.neuroscience.2003.08.050; van der Togt C, 2006, CEREB CORTEX, V16, P136, DOI 10.1093/cercor/bhi093; van der Velde F, 2001, J COGNITIVE NEUROSCI, V13, P479, DOI 10.1162/08989290152001907; Vogel EK, 2000, PSYCHOPHYSIOLOGY, V37, P190, DOI 10.1111/1469-8986.3720190; Wagatsuma N, 2008, J VISION, V8, DOI 10.1167/8.7.22; Wersing H, 2001, NEURAL COMPUT, V13, P357, DOI 10.1162/089976601300014574; WEYLAND TG, 2001, J NEUROPHYSIOL, V85, P1107; Zhang NR, 2010, J NEUROSCI, V30, P6482, DOI 10.1523/JNEUROSCI.5168-09.2010; Zhaoping L, 2005, NEURON, V47, P143, DOI 10.1016/j.neuron.2005.04.005; Zwickel T, 2007, BIOSYSTEMS, V89, P216, DOI 10.1016/j.biosystems.2006.04.019	63	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2011	6	6							e21641	10.1371/journal.pone.0021641	http://dx.doi.org/10.1371/journal.pone.0021641			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	784FW	21738747	Green Published, gold, Green Submitted			2022-12-27	WOS:000292142800050
J	Huang, WD; Zhang, YHP				Huang, Wei-Dong; Zhang, Y-H Percival			Energy Efficiency Analysis: Biomass-to-Wheel Efficiency Related with Biofuels Production, Fuel Distribution, and Powertrain Systems	PLOS ONE			English	Article							ESCHERICHIA-COLI; THERMOPHILIC BACTERIUM; HYDROGEN-PRODUCTION; LIFE-CYCLE; ETHANOL; CELL; GASIFICATION; ELECTRICITY; EMISSIONS; ECONOMY	Background: Energy efficiency analysis for different biomass-utilization scenarios would help make more informed decisions for developing future biomass-based transportation systems. Diverse biofuels produced from biomass include cellulosic ethanol, butanol, fatty acid ethyl esters, methane, hydrogen, methanol, dimethyether, Fischer-Tropsch diesel, and bioelectricity; the respective powertrain systems include internal combustion engine (ICE) vehicles, hybrid electric vehicles based on gasoline or diesel ICEs, hydrogen fuel cell vehicles, sugar fuel cell vehicles (SFCV), and battery electric vehicles (BEV). Methodology/Principal Findings: We conducted a simple, straightforward, and transparent biomass-to-wheel (BTW) analysis including three separate conversion elements - biomass-to-fuel conversion, fuel transport and distribution, and respective powertrain systems. BTW efficiency is a ratio of the kinetic energy of an automobile's wheels to the chemical energy of delivered biomass just before entering biorefineries. Up to 13 scenarios were analyzed and compared to a base line case - corn ethanol/ICE. This analysis suggests that BEV, whose electricity is generated from stationary fuel cells, and SFCV, based on a hydrogen fuel cell vehicle with an on-board sugar-to-hydrogen bioreformer, would have the highest BTW efficiencies, nearly four times that of ethanol-ICE. Significance: In the long term, a small fraction of the annual US biomass (e. g., 7.1%, or 700 million tons of biomass) would be sufficient to meet 100% of light-duty passenger vehicle fuel needs (i.e., 150 billion gallons of gasoline/ethanol per year), through up to four-fold enhanced BTW efficiencies by using SFCV or BEV. SFCV would have several advantages over BEV: much higher energy storage densities, faster refilling rates, better safety, and less environmental burdens.	[Huang, Wei-Dong; Zhang, Y-H Percival] Virginia Tech, Dept Biol Syst Engn, Blacksburg, VA 24061 USA; [Huang, Wei-Dong] Univ Sci & Technol China, Environm Div, Coll Earth & Space Sci, Hefei 230026, Peoples R China; [Zhang, Y-H Percival] Virginia Tech, ICTAS, Blacksburg, VA USA; [Zhang, Y-H Percival] DOE BioEnergy Sci Ctr BESC, Oak Ridge, TN USA; [Zhang, Y-H Percival] Gate Fuels Inc, Blacksburg, VA USA	Virginia Polytechnic Institute & State University; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Virginia Polytechnic Institute & State University; United States Department of Energy (DOE); Oak Ridge National Laboratory; BioEnergy Science Center (BESC)	Huang, WD (corresponding author), Virginia Tech, Dept Biol Syst Engn, Blacksburg, VA 24061 USA.	ypzhang@vt.edu			Air Force Office of Scientific Research; MURI [FA9550-08-1-0145]; USDA Biodesign and Bioprocess Center; DOE BESC; China Scholarship Council	Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); MURI(MURI); USDA Biodesign and Bioprocess Center; DOE BESC(United States Department of Energy (DOE)); China Scholarship Council(China Scholarship Council)	This work was supported mainly by the Air Force Office of Scientific Research and MURI (FA9550-08-1-0145), partially by the USDA Biodesign and Bioprocess Center and DOE BESC to YPZ. WH as a visiting scholar was partially supported by the China Scholarship Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahluwalia RK, 2005, J POWER SOURCES, V152, P233, DOI 10.1016/j.jpowsour.2005.01.052; Ahman M, 2001, ENERGY, V26, P973, DOI 10.1016/S0360-5442(01)00049-4; Albertazzi S, 2005, CATAL TODAY, V106, P297, DOI 10.1016/j.cattod.2005.07.160; Amon T, 2007, BIORESOURCE TECHNOL, V98, P3204, DOI 10.1016/j.biortech.2006.07.007; Armand M, 2008, NATURE, V451, P652, DOI 10.1038/451652a; Atsumi S, 2008, NATURE, V451, P86, DOI 10.1038/nature06450; BANDIVADEKAR A, 2008, 200805 LFEE RE MIT; Berglund M, 2006, BIOMASS BIOENERG, V30, P254, DOI 10.1016/j.biombioe.2005.11.011; Borjesson P, 2009, APPL ENERG, V86, P589, DOI 10.1016/j.apenergy.2008.11.025; Campbell E, 2010, BIOTECHNOL BIOENG, V107, P763, DOI 10.1002/bit.22869; Campbell JE, 2009, SCIENCE, V324, P1055, DOI 10.1126/science.1168885; Caputo AC, 2005, BIOMASS BIOENERG, V28, P35, DOI 10.1016/j.biombioe.2004.04.009; Serrano-Ruiz JC, 2011, ENERG ENVIRON SCI, V4, P83, DOI 10.1039/c0ee00436g; Chou CJ, 2008, METAB ENG, V10, P394, DOI 10.1016/j.ymben.2008.06.007; Cleveland CJ, 2005, ENERGY, V30, P769, DOI 10.1016/j.energy.2004.05.023; Cooney MJ, 2008, ENERG ENVIRON SCI, V1, P320, DOI 10.1039/b809009b; Cortright RD, 2002, NATURE, V418, P964, DOI 10.1038/nature01009; Dale BE, 2007, BIOFUEL BIOPROD BIOR, V1, P1, DOI 10.1002/bbb.1; De Oliveira MED, 2005, BIOSCIENCE, V55, P593, DOI 10.1641/0006-3568(2005)055[0593:EAFECD]2.0.CO;2; Demirdoven N, 2004, SCIENCE, V305, P974, DOI 10.1126/science.1093965; Dominguez-Faus R, 2009, ENVIRON SCI TECHNOL, V43, P3005, DOI 10.1021/es802162x; Donolo G, 2006, J POWER SOURCES, V158, P1282, DOI 10.1016/j.jpowsour.2005.10.045; Eaves S, 2004, J POWER SOURCES, V130, P208, DOI 10.1016/j.jpowsour.2003.12.016; Eberhard M., 2006, 21 CENTURY ELECT CAR; EUCAR CONCAWE and JTC, 2007, WELL TO WHEELS AN FU; Evans A, 2010, RENEW SUST ENERG REV, V14, P1419, DOI 10.1016/j.rser.2010.01.010; Farrell AE, 2006, SCIENCE, V311, P506, DOI 10.1126/science.1121416; Hamelinck CN, 2006, ENERG POLICY, V34, P3268, DOI 10.1016/j.enpol.2005.06.012; Hamelinck CN, 2005, BIOMASS BIOENERG, V28, P384, DOI 10.1016/j.biombioe.2004.09.002; Hamelinck CN, 2002, J POWER SOURCES, V111, P1, DOI 10.1016/S0378-7753(02)00220-3; Hermann WA, 2006, ENERGY, V31, P1685, DOI 10.1016/j.energy.2005.09.006; Hicke JA, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL013578; Higo M, 2010, APPL ENERG, V87, P58, DOI 10.1016/j.apenergy.2009.08.030; Hill J, 2009, P NATL ACAD SCI USA, V106, P2077, DOI 10.1073/pnas.0812835106; Hillman Karl M., 2008, International Journal of Alternative Propulsion, V2, P1, DOI 10.1504/IJAP.2008.019689; Huang WD, 2011, ENERG ENVIRON SCI, V4, P784, DOI 10.1039/c0ee00069h; Jacobson MZ, 2009, ENERG ENVIRON SCI, V2, P148, DOI 10.1039/b809990c; Jacobson MZ, 2005, SCIENCE, V308, P1901, DOI 10.1126/science.1109157; JONES DT, 1986, MICROBIOL REV, V50, P484, DOI 10.1128/MMBR.50.4.484-524.1986; Kalscheuer R, 2006, MICROBIOL-SGM, V152, P2529, DOI 10.1099/mic.0.29028-0; Kobayashi S, 2009, ENERG EFFIC, V2, P125, DOI 10.1007/s12053-008-9037-3; Kumabe K, 2008, FUEL, V87, P1422, DOI 10.1016/j.fuel.2007.06.008; Larson ED, 2006, ENERGY SUSTAIN DEV, V10, P109, DOI [10.1016/S0973-0826(08)60536-0, DOI 10.1016/S0973-0826(08)60536-0]; Logan BE, 2009, NAT REV MICROBIOL, V7, P375, DOI 10.1038/nrmicro2113; Lynd LR, 2008, NAT BIOTECHNOL, V26, P169, DOI 10.1038/nbt0208-169; Lynd LR, 2010, ENERG ENVIRON SCI, V3, P1150, DOI 10.1039/c002335n; LYND LR, 1991, SCIENCE, V251, P1318, DOI 10.1126/science.251.4999.1318; MacKay David J.C., 2009, SUSTAINABLE ENERGY H; Maclean HL, 2003, ENVIRON SCI TECHNOL, V37, P5445, DOI 10.1021/es034574q; Melamu R, 2009, INT J HYDROGEN ENERG, V34, P1126, DOI 10.1016/j.ijhydene.2008.11.020; Morey RV, 2006, APPL ENG AGRIC, V22, P723; Moxley G, 2007, ENERG FUEL, V21, P3684, DOI 10.1021/ef7003893; MYUNG S, 2011, BIOTECHNOL PROGR, DOI DOI 10.1002/BTPR.1606; Myung S, 2010, PROCESS BIOCHEM, V45, P1882, DOI 10.1016/j.procbio.2010.03.017; Norby RJ, 2005, P NATL ACAD SCI USA, V102, P18052, DOI 10.1073/pnas.0509478102; Pimentel D., 2005, NAT RESOUR RES, V14, P65, DOI [DOI 10.1007/S11053-005-4679-8, 10.1007/s11053-005-4679-8]; Ptasinski KJ, 2008, BIOFUEL BIOPROD BIOR, V2, P239, DOI 10.1002/bbb.65; Ryan JD, 2008, CHEMBIOCHEM, V9, P2579, DOI 10.1002/cbic.200800246; Schirmer A, 2010, SCIENCE, V329, P559, DOI 10.1126/science.1187936; SCHWEIGER A, 2007, P 15 EUR BIOM C EXH; Searchinger T, 2008, SCIENCE, V319, P1238, DOI 10.1126/science.1151861; Service RF, 2009, SCIENCE, V326, P516, DOI 10.1126/science.326_516; Shaw AJ, 2008, P NATL ACAD SCI USA, V105, P13769, DOI 10.1073/pnas.0801266105; Sheehan John, 2003, Journal of Industrial Ecology, V7, P117; Silko Leslie Marmon, 1998, OIL BEGINNERS GUIDE, P2; Smil V., 2010, ENERGY TRANSITIONS H; Smil Vaclav, 2008, ENERGY NATURE SOC; Smil Vaclav, 1999, ENERGIES ILLUSTRATED; Steen EJ, 2010, NATURE, V463, P559, DOI 10.1038/nature08721; Sun JS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010526; Tarascon JM, 2001, NATURE, V414, P359, DOI 10.1038/35104644; Thomas CE, 2009, INT J HYDROGEN ENERG, V34, P6005, DOI 10.1016/j.ijhydene.2009.06.003; Tijmensen MJA, 2002, BIOMASS BIOENERG, V23, P129, DOI 10.1016/S0961-9534(02)00037-5; van Vliet OPR, 2009, ENERG CONVERS MANAGE, V50, P855, DOI 10.1016/j.enconman.2009.01.008; Wang Y, 2010, J APPL MICROBIOL, V108, P39, DOI 10.1111/j.1365-2672.2009.04396.x; Wang YR, 2011, CHEM BIOL, V18, P372, DOI 10.1016/j.chembiol.2010.12.019; Wang YR, 2009, MICROB CELL FACT, V8, DOI 10.1186/1475-2859-8-30; Wetterlund E, 2010, INT J ENERG RES, V34, P1136, DOI 10.1002/er.1633; Williamson SS, 2005, IEEE T VEH TECHNOL, V54, P856, DOI 10.1109/TVT.2005.847444; Wyman CE, 2007, TRENDS BIOTECHNOL, V25, P153, DOI 10.1016/j.tibtech.2007.02.009; Ye XH, 2009, CHEMSUSCHEM, V2, P149, DOI 10.1002/cssc.200900017; Yoshida A, 2005, APPL ENVIRON MICROB, V71, P6762, DOI 10.1128/AEM.71.11.6762-6768.2005; Zhang KC, 2008, P NATL ACAD SCI USA, V105, P20653, DOI 10.1073/pnas.0807157106; Zhang YHP, 2008, J IND MICROBIOL BIOT, V35, P367, DOI 10.1007/s10295-007-0293-6; Zhang YHP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000456; Zhang YHP, 2011, ENERGIES, V4, P254, DOI 10.3390/en4020254; Zhang YHP, 2010, INT J HYDROGEN ENERG, V35, P10334, DOI 10.1016/j.ijhydene.2010.07.132; Zhang YHP, 2010, BIOTECHNOL BIOENG, V105, P663, DOI 10.1002/bit.22630; Zhang YHP, 2009, ENERG ENVIRON SCI, V2, P272, DOI 10.1039/b818694d; Zhang YHP, 2010, CURR OPIN BIOTECH, V21, P663, DOI 10.1016/j.copbio.2010.05.005; ZHANG YHP, 2011, BIOTECHNOL ADV, DOI DOI 10.1016/J.BIOTECHADV.2011.1005.1020; ZHANG YHP, 2011, J MATER CHEM, DOI DOI 10.1039/C1031JM12078F; Zhu XG, 2008, CURR OPIN BIOTECH, V19, P153, DOI 10.1016/j.copbio.2008.02.004	93	46	46	5	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2011	6	7							e22113	10.1371/journal.pone.0022113	http://dx.doi.org/10.1371/journal.pone.0022113			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	792WQ	21765941	Green Published, Green Submitted, gold			2022-12-27	WOS:000292781500033
J	Hunt, PR; Son, TG; Wilson, MA; Yu, QS; Wood, WH; Zhang, YQ; Becker, KG; Greig, NH; Mattson, MP; Camandola, S; Wolkow, CA				Hunt, Piper R.; Son, Tae Gen; Wilson, Mark A.; Yu, Quian-Sheng; Wood, William H.; Zhang, Yongqing; Becker, Kevin G.; Greig, Nigel H.; Mattson, Mark P.; Camandola, Simonetta; Wolkow, Catherine A.			Extension of Lifespan in C. elegans by Naphthoquinones That Act through Stress Hormesis Mechanisms	PLOS ONE			English	Article							NEMATODE CAENORHABDITIS-ELEGANS; HEAT-SHOCK PROTEINS; OXIDATIVE-STRESS; SACCHAROMYCES-CEREVISIAE; ADAPTIVE RESPONSE; GENE-EXPRESSION; FACTOR SKN-1; LONGEVITY; RESISTANCE; DAF-16	Hormesis occurs when a low level stress elicits adaptive beneficial responses that protect against subsequent exposure to severe stress. Recent findings suggest that mild oxidative and thermal stress can extend lifespan by hormetic mechanisms. Here we show that the botanical pesticide plumbagin, while toxic to C. elegans nematodes at high doses, extends lifespan at low doses. Because plumbagin is a naphthoquinone that can generate free radicals in vivo, we investigated whether it extends lifespan by activating an adaptive cellular stress response pathway. The C. elegans cap'n'collar (CNC) transcription factor, SKN-1, mediates protective responses to oxidative stress. Genetic analysis showed that skn-1 activity is required for lifespan extension by low-dose plumbagin in C. elegans. Further screening of a series of plumbagin analogs identified three additional naphthoquinones that could induce SKN-1 targets in C. elegans. Naphthazarin showed skn-1dependent lifespan extension, over an extended dose range compared to plumbagin, while the other naphthoquinones, oxoline and menadione, had differing effects on C. elegans survival and failed to activate ARE reporter expression in cultured mammalian cells. Our findings reveal the potential for low doses of naturally occurring naphthoquinones to extend lifespan by engaging a specific adaptive cellular stress response pathway.	[Hunt, Piper R.; Son, Tae Gen; Wilson, Mark A.; Mattson, Mark P.; Camandola, Simonetta; Wolkow, Catherine A.] NIA, Neurosci Lab, Intramural Res Program, NIH, Baltimore, MD 21224 USA; [Yu, Quian-Sheng; Greig, Nigel H.] NIA, Drug Design & Dev Sect, Intramural Res Program, NIH, Baltimore, MD 21224 USA; [Wood, William H.; Zhang, Yongqing; Becker, Kevin G.] NIA, Gene Express & Genom Unit, Intramural Res Program, NIH, Baltimore, MD 21224 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Hunt, PR (corresponding author), NIA, Neurosci Lab, Intramural Res Program, NIH, Baltimore, MD 21224 USA.	camandolasi@grc.nia.nih.gov; wolkowca@gmail.com	Hunt, Piper Reid/G-1555-2012; Mattson, Mark P/F-6038-2012	Hunt, Piper Reid/0000-0003-0538-7606; Becker, Kevin/0000-0002-6794-6656	National Institute of Aging [Z01 AG000320]; NATIONAL INSTITUTE ON AGING [ZICAG000616, ZIAAG000311, Z01AG000320] Funding Source: NIH RePORTER	National Institute of Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was funded by the National Institute of Aging Intramural Research Program, Z01 AG000320. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMES BN, 1989, FREE RADICAL RES COM, V7, P121, DOI 10.3109/10715768909087933; An JH, 2003, GENE DEV, V17, P1882, DOI 10.1101/gad.1107803; Balogun E, 2003, BIOCHEM J, V371, P887, DOI 10.1042/BJ20021619; Bejarano Eloy, 2010, Proc Am Thorac Soc, V7, P29, DOI 10.1513/pats.200909-102JS; BLUM J, 1983, ARCH BIOCHEM BIOPHYS, V222, P35, DOI 10.1016/0003-9861(83)90499-X; Bonda DJ, 2010, NEUROPHARMACOLOGY, V59, P290, DOI 10.1016/j.neuropharm.2010.04.005; BRENNER S, 1974, GENETICS, V77, P71; BURTON V, 1988, MOL CELL BIOL, V8, P3550, DOI 10.1128/MCB.8.8.3550; Calabrese EJ, 2007, TOXICOL APPL PHARM, V222, P122, DOI 10.1016/j.taap.2007.02.015; Calabrese V, 2010, ANTIOXID REDOX SIGN, V13, P1763, DOI 10.1089/ars.2009.3074; Cheadle C, 2003, J MOL DIAGN, V5, P73, DOI 10.1016/S1525-1578(10)60455-2; Choksi KB, 2007, FREE RADICAL BIO MED, V43, P1423, DOI 10.1016/j.freeradbiomed.2007.07.027; COHEN SS, 1958, P NATL ACAD SCI USA, V44, P1004, DOI 10.1073/pnas.44.10.1004; Cypser JR, 2003, BIOGERONTOLOGY, V4, P203, DOI 10.1023/A:1025138800672; Cypser JR, 2002, J GERONTOL A-BIOL, V57, pB109, DOI 10.1093/gerona/57.3.B109; Dinkova-Kostova AT, 2002, P NATL ACAD SCI USA, V99, P11908, DOI 10.1073/pnas.172398899; DONIACH T, 1984, DEV BIOL, V106, P223, DOI 10.1016/0012-1606(84)90077-0; Dudas Istvan, 2006, Congenital Anomalies, V46, P39, DOI 10.1111/j.1741-4520.2006.00100.x; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; Furuyama T, 2000, BIOCHEM J, V349, P629, DOI 10.1042/0264-6021:3490629; Garg R, 2008, CARCINOGENESIS, V29, P1022, DOI 10.1093/carcin/bgn064; Garigan D, 2002, GENETICS, V161, P1101; Gems D, 2000, GENETICS, V154, P1597; Gilley J, 2003, J CELL BIOL, V162, P613, DOI 10.1083/jcb.200303026; Head E, 2002, J NEUROCHEM, V82, P375, DOI 10.1046/j.1471-4159.2002.00969.x; Heidler T, 2010, BIOGERONTOLOGY, V11, P183, DOI 10.1007/s10522-009-9239-x; Henderson ST, 2001, CURR BIOL, V11, P1975, DOI 10.1016/S0960-9822(01)00594-2; Higgins LG, 2009, TOXICOL APPL PHARM, V237, P267, DOI 10.1016/j.taap.2009.03.005; Honda Y, 1999, FASEB J, V13, P1385, DOI 10.1096/fasebj.13.11.1385; HOSONO R, 1978, EXP GERONTOL, V13, P369, DOI 10.1016/0531-5565(78)90047-5; Kahn NW, 2008, BIOCHEM J, V409, P205, DOI 10.1042/BJ20070521; Keaney M, 2004, FREE RADICAL BIO MED, V37, P239, DOI 10.1016/j.freeradbiomed.2004.04.005; Kregel KC, 2007, AM J PHYSIOL-REG I, V292, pR18, DOI 10.1152/ajpregu.00327.2006; Le Bourg E, 2009, BBA-GEN SUBJECTS, V1790, P1030, DOI 10.1016/j.bbagen.2009.01.004; Leiers BR, 2003, FREE RADICAL BIO MED, V34, P1405, DOI 10.1016/S0891-5849(03)00102-3; Link CD, 2002, METHOD ENZYMOL, V353, P497; LITHGOW GJ, 1995, P NATL ACAD SCI USA, V92, P7540, DOI 10.1073/pnas.92.16.7540; MCALISTER L, 1980, BIOCHEM BIOPH RES CO, V93, P819, DOI 10.1016/0006-291X(80)91150-X; MESSIER AA, 1990, UNDERSEA BIOMED RES, V17, P305; Munoz MJ, 2003, GENETICS, V163, P171; Murphy CT, 2003, NATURE, V424, P277, DOI 10.1038/nature01789; Newton LAA, 2010, NEW J CHEM, V34, P395, DOI 10.1039/b9nj00534j; Oliveira RP, 2009, AGING CELL, V8, P524, DOI 10.1111/j.1474-9726.2009.00501.x; Park SK, 2009, AGING CELL, V8, P258, DOI 10.1111/j.1474-9726.2009.00473.x; PLESSET J, 1982, BIOCHEM BIOPH RES CO, V108, P1340, DOI 10.1016/0006-291X(82)92147-7; Przybysz AJ, 2009, MECH AGEING DEV, V130, P357, DOI 10.1016/j.mad.2009.02.004; Rattan SIS, 2008, HUM EXP TOXICOL, V27, P151, DOI 10.1177/0960327107083409; Son TG, 2010, J NEUROCHEM, V112, P1316, DOI 10.1111/j.1471-4159.2009.06552.x; SUMMERS WC, 1993, J BACTERIOL, V175, P6049, DOI 10.1128/JB.175.18.6049-6051.1993; Timmons L, 1998, NATURE, V395, P854, DOI 10.1038/27579; Tullet JMA, 2008, CELL, V132, P1025, DOI 10.1016/j.cell.2008.01.030; Ungvari Z, 2008, FRONT BIOSCI-LANDMRK, V13, P5056, DOI 10.2741/3064; Castro FAV, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003999; Wakabayashi N, 2010, ANTIOXID REDOX SIGN, V13, P1649, DOI 10.1089/ars.2010.3216; Yashin AI, 2001, MECH AGEING DEV, V122, P1477, DOI 10.1016/S0047-6374(01)00273-1; Zenkova E, 2000, PHARM CHEM J, V34, P91	56	64	67	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2011	6	7							e21922	10.1371/journal.pone.0021922	http://dx.doi.org/10.1371/journal.pone.0021922			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	792WQ	21765926	Green Published, gold, Green Submitted			2022-12-27	WOS:000292781500023
J	Piwowar, HA				Piwowar, Heather A.			Who Shares? Who Doesn't? Factors Associated with Openly Archiving Raw Research Data	PLOS ONE			English	Article							MICROARRAY DATA; INFORMATION; MOTIVATION; SUBMISSION; GENETICS	Many initiatives encourage investigators to share their raw datasets in hopes of increasing research efficiency and quality. Despite these investments of time and money, we do not have a firm grasp of who openly shares raw research data, who doesn't, and which initiatives are correlated with high rates of data sharing. In this analysis I use bibliometric methods to identify patterns in the frequency with which investigators openly archive their raw gene expression microarray datasets after study publication. Automated methods identified 11,603 articles published between 2000 and 2009 that describe the creation of gene expression microarray data. Associated datasets in best-practice repositories were found for 25% of these articles, increasing from less than 5% in 2001 to 30%-35% in 2007-2009. Accounting for sensitivity of the automated methods, approximately 45% of recent gene expression studies made their data publicly available. First-order factor analysis on 124 diverse bibliometric attributes of the data creation articles revealed 15 factors describing authorship, funding, institution, publication, and domain environments. In multivariate regression, authors were most likely to share data if they had prior experience sharing or reusing data, if their study was published in an open access journal or a journal with a relatively strong data sharing policy, or if the study was funded by a large number of NIH grants. Authors of studies on cancer and human subjects were least likely to make their datasets available. These results suggest research data sharing levels are still low and increasing only slowly, and data is least available in areas where it could make the biggest impact. Let's learn from those with high rates of sharing to embrace the full potential of our research output.	[Piwowar, Heather A.] Univ Pittsburgh, Dept Biomed Informat, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Piwowar, HA (corresponding author), Natl Evolutionary Synth Ctr, Durham, NC USA.	hpiwowar@gmail.com	Piwowar, Heather A/A-4680-2009	Piwowar, Heather/0000-0003-1613-5981	NIH National Library of Medicine [5 T15 LM007059]; NATIONAL LIBRARY OF MEDICINE [T15LM007059] Funding Source: NIH RePORTER	NIH National Library of Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This work was completed in the Department of Biomedical Informatics at the University of Pittsburgh and partially funded by an NIH National Library of Medicine training grant 5 T15 LM007059. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2002, NATURE, V419, P323, DOI 10.1038/419323a; [Anonymous], 2007, NAT BIOTECHNOL, V25, P821, DOI 10.1038/nbt0807-821; [Anonymous], 2007, NAT NEUROSCI, V10, P931; Ball CA, 2004, PLOS BIOL, V2, P1276, DOI 10.1371/journal.pbio.0020317; Barrett T, 2007, NUCL ACIDS RES, V35; Bird S, 2006, NATURAL LANGUAGE TOO; Bitzer J, 2007, J COMP ECON, V35, P160, DOI 10.1016/j.jce.2006.10.001; Blumenthal D, 2006, ACAD MED, V81, P137, DOI 10.1097/00001888-200602000-00008; Blumenthal D, 1997, JAMA-J AM MED ASSOC, V277, P1224, DOI 10.1001/jama.277.15.1224; Bornmann L, 2009, J AM SOC INF SCI TEC, V60, P1286, DOI 10.1002/asi.21016; Brazma A, 2001, NAT GENET, V29, P365, DOI 10.1038/ng1201-365; Brown C, 2003, J AM SOC INF SCI TEC, V54, P926, DOI 10.1002/asi.10289; Campbell EG, 2002, JAMA-J AM MED ASSOC, V287, P473, DOI 10.1001/jama.287.4.473; Cech TR, 2003, PLANT PHYSIOL, V132, P19, DOI 10.1104/pp.900068; CONSTANT D, 1994, INFORM SYST RES, V5, P400, DOI 10.1287/isre.5.4.400; Fienberg S.E., 1985, SHARING RES DATA; Foster MW, 2007, NAT REV GENET, V8, P633, DOI 10.1038/nrg2124; Giordano R, 2007, E SOCIAL SCI; Gorsuch R., 1983, FACTOR ANAL; Harrell FE, 2001, REGRESSION MODELING; Hedstrom M, 2006, IASSIST C 2006 PRES; Hedstrom M, 2008, DAT IMPL ARCH REC MA; Hosek S.D., 2005, GENDER DIFFERENCES M; Hrynaszkiewicz I, 2009, TRIALS, V10, DOI 10.1186/1745-6215-10-17; Kakazu Kerry K, 2004, Hawaii Med J, V63, P273; Kim J, 2007, J DIGITAL INFORM, V8, P2; Kim S, 2008, LIBR INFORM SCI RES, V30, P282, DOI 10.1016/j.lisr.2008.04.003; Kuo FY, 2008, J AM SOC INF SCI TEC, V59, P1224, DOI 10.1002/asi.20816; Kyzas PA, 2005, JNCI-J NATL CANCER I, V97, P1043, DOI 10.1093/jnci/dji184; Lee CP., 2006, HUMAN INFRASTRUCTURE; Lowrance W, ACCESS COLLECTIONS D; Malin B, 2010, J INVEST MED, V58, P11, DOI 10.2310/JIM.0b013e3181c9b2ea; Manolio TA, 2007, NAT GENET, V39, P1045, DOI 10.1038/ng2127; Matzler K, 2008, J ECON PSYCHOL, V29, P301, DOI 10.1016/j.joep.2007.06.004; MCCAIN KW, 1995, SCI COMMUN, V16, P403, DOI 10.1177/1075547095016004003; McCullough BD, 2008, CAN J ECON, V41, P1406, DOI 10.1111/j.1540-5982.2008.00509.x; National Institutes of Health (NIH), 2003, FIN NIH STAT SHAR RE; Navarro Robert, 2008, Inform Prim Care, V16, P257; NIH, 2007, NOTOD08013 NIH; Niu J, 2006, INCENTIVE STUDY RES; Noor MAF, 2006, PLOS BIOL, V4, P1113, DOI 10.1371/journal.pbio.0040228; NSF, 2011, GRANT PROP GUID; Ochsner SA, 2008, NAT METHODS, V5, P991, DOI 10.1038/nmeth1208-991; Parkinson H, 2007, NUCLEIC ACIDS RES, V35, pD747, DOI 10.1093/nar/gkl995; Piwowar H. A., 2008, REV J POLICIES SHARI; Piwowar HA, 2010, THESIS U PITTSBURGH; Piwowar HA, 2011, DATA WHO SHARES WHO, DOI [10.5061/dryad.mflsd, DOI 10.5061/DRYAD.MFLSD]; Piwowar HA, 2010, J BIOMED DISCOV COLL, V5, P7; Piwowar HA, 2010, J INFORMETR, V4, P148, DOI 10.1016/j.joi.2009.11.010; R Core Team, 2018, R LANG ENV STAT COMP; Reidpath DD, 2001, BIOETHICS, V15, P125, DOI 10.1111/1467-8519.00220; Rhodes DR, 2004, P NATL ACAD SCI USA, V101, P9309, DOI 10.1073/pnas.0401994101; Ryu S, 2003, EXPERT SYST APPL, V25, P113, DOI 10.1016/S0957-4174(03)00011-3; Siemsen E, 2008, J OPER MANAG, V26, P426, DOI 10.1016/j.jom.2007.09.001; Theus M., 2008, INTERACTIVE GRAPHICS; Torvik VI, 2009, ACM T KNOWL DISCOV D, V3, DOI 10.1145/1552303.1552304; Tucker J, 2009, THESIS VIRGINIA POLY; University of Nottingham, RES FUND OP ACC POL; Ventura B, 2005, PHYSIOL GENOMICS, V20, P153, DOI 10.1152/physiolgenomics.00264.2004; Vickers AJ, 2008, CANC DATA SORRY CANT; Vogeli C, 2006, ACAD MED, V81, P128, DOI 10.1097/00001888-200602000-00007; Warlick Stefanie E, 2007, Biomed Digit Libr, V4, P1, DOI 10.1186/1742-5581-4-1; Wellcome Trust, 2010, SHAR RES DAT IMPR PU; Yu W, 2007, BMC MED INFORM DECIS, V7, DOI 10.1186/1472-6947-7-17	64	111	115	1	81	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2011	6	7							e18657	10.1371/journal.pone.0018657	http://dx.doi.org/10.1371/journal.pone.0018657			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	792WQ	21765886	Green Submitted, Green Accepted, Green Published, gold			2022-12-27	WOS:000292781500001
J	Mak, MC; Lam, KM; Chan, PK; Lau, YB; Tang, WH; Yeung, PKK; Ko, BCB; Chung, SMS; Chung, SK				Mak, Man Chi; Lam, Ka Man; Chan, Ping Kei; Lau, Yu Bond; Tang, Wai Ho; Yeung, Patrick Ka Kit; Ko, Ben Chi Bun; Chung, Stephen Man Sum; Chung, Sookja Kim			Embryonic Lethality in Mice Lacking the Nuclear Factor of Activated T Cells 5 Protein Due to Impaired Cardiac Development and Function	PLOS ONE			English	Article							TRANSCRIPTION FACTOR; STIMULATES TRANSCRIPTION; BINDING PROTEIN; NFAT5; EXPRESSION; HSP70; HYPERTONICITY; FAMILY; TONEBP/NFAT5; OSMOLALITY	Nuclear factor of activated T cells 5 protein (NFAT5) is thought to be important for cellular adaptation to osmotic stress by regulating the transcription of genes responsible for the synthesis or transport of organic osmolytes. It is also thought to play a role in immune function, myogenesis and cancer invasion. To better understand the function of NFAT5, we developed NFAT5 gene knockout mice. Homozygous NFAT5 null (NFAT5(-/-)) mouse embryos failed to develop normally and died after 14.5 days of embryonic development (E14.5). The embryos showed peripheral edema, and abnormal heart development as indicated by thinner ventricular wall and reduced cell density at the compact and trabecular areas of myocardium. This is associated with reduced level of proliferating cell nuclear antigen and increased caspase-3 in these tissues. Cardiomyocytes from E14.5 NFAT5(-/-) embryos showed a significant reduction of beating rate and abnormal Ca(2+) signaling profile as a consequence of reduced sarco(endo) plasmic reticulum Ca(2+)-ATPase (SERCA) and ryanodine receptor (RyR) expressions. Expression of NFAT5 target genes, such as HSP 70 and SMIT were reduced in NFAT5(-/-) cardiomyocytes. Our findings demonstrated an essential role of NFAT5 in cardiac development and Ca(2+) signaling. Cardiac failure is most likely responsible for the peripheral edema and death of NFAT5(-/-) embryos at E14.5 days.	[Mak, Man Chi; Lam, Ka Man; Chan, Ping Kei; Lau, Yu Bond; Yeung, Patrick Ka Kit; Chung, Sookja Kim] Univ Hong Kong, Li Ka Shing Fac Med, Dept Anat, Hong Kong, Hong Kong, Peoples R China; [Tang, Wai Ho; Chung, Stephen Man Sum] United Int Coll, Div Sci & Technol, Zhuhai, Guandong, Peoples R China; [Ko, Ben Chi Bun] Chinese Univ Hong Kong, Dept Anat & Cellular Pathol, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; Beijing Normal University - Hong Kong Baptist University United International College; Chinese University of Hong Kong	Mak, MC (corresponding author), Univ Hong Kong, Li Ka Shing Fac Med, Dept Anat, Hong Kong, Hong Kong, Peoples R China.	skchung@hkucc.hku.hk	Ko, Chi-bun/ACH-7514-2022	Ko, Ben Chi Bun/0000-0003-2027-5899	University of Hong Kong [7504/06M]	University of Hong Kong(University of Hong Kong)	This work was supported by the Research Grant Council Grants The University of Hong Kong 7504/06M. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERRIDGE MJ, 1989, NATURE, V341, P197, DOI 10.1038/341197a0; Cai Q, 2005, AM J PHYSIOL-RENAL, V289, pF803, DOI 10.1152/ajprenal.00448.2004; Cai Q, 2004, AM J PHYSIOL-RENAL, V286, pF58, DOI 10.1152/ajprenal.00037.2003; Chao DT, 1998, ANNU REV IMMUNOL, V16, P395, DOI 10.1146/annurev.immunol.16.1.395; COPP AJ, 1995, TRENDS GENET, V11, P87, DOI 10.1016/S0168-9525(00)89008-3; Dahl SC, 2001, AM J PHYSIOL-CELL PH, V280, pC248, DOI 10.1152/ajpcell.2001.280.2.C248; Drews-Elger K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005245; Evans HJ, 2003, AM J PHYSIOL-HEART C, V285, pH570, DOI 10.1152/ajpheart.01027.2002; Go WY, 2004, P NATL ACAD SCI USA, V101, P10673, DOI 10.1073/pnas.0403139101; Ho HTB, 2000, MOL CELL BIOL, V20, P5840, DOI 10.1128/MCB.20.16.5840-5846.2000; Jauliac S, 2002, NAT CELL BIOL, V4, P540, DOI 10.1038/ncb816; Kim K, 2000, P NATL ACAD SCI USA, V97, P1731, DOI 10.1073/pnas.040550097; Kim YK, 2006, CIRCULATION, V113, P2589, DOI 10.1161/CIRCULATIONAHA.105.598409; Liu J, 2006, AM J PHYSIOL-CELL PH, V290, pC583, DOI 10.1152/ajpcell.00145.2005; Lopez-Rodriguez C, 1999, P NATL ACAD SCI USA, V96, P7214, DOI 10.1073/pnas.96.13.7214; Lopez-Rodriguez C, 2004, P NATL ACAD SCI USA, V101, P2392, DOI 10.1073/pnas.0308703100; Maouyo D, 2002, AM J PHYSIOL-RENAL, V282, pF802, DOI 10.1152/ajprenal.00123.2001; Miyakawa H, 1999, P NATL ACAD SCI USA, V96, P2538, DOI 10.1073/pnas.96.5.2538; O'Connor RS, 2007, J CELL SCI, V120, P149, DOI 10.1242/jcs.03307; PURI MC, 1995, EMBO J, V14, P5884, DOI 10.1002/j.1460-2075.1995.tb00276.x; Rao A, 1997, ANNU REV IMMUNOL, V15, P707, DOI 10.1146/annurev.immunol.15.1.707; RUSHLOW C, 1992, BIOESSAYS, V14, P89, DOI 10.1002/bies.950140204; Sconzo G, 1999, BIOCHEM BIOPH RES CO, V260, P143, DOI 10.1006/bbrc.1999.0782; Tong EHY, 2006, J BIOL CHEM, V281, P23870, DOI 10.1074/jbc.M602556200; Trama J, 2000, J IMMUNOL, V165, P4884, DOI 10.4049/jimmunol.165.9.4884; Trama J, 2002, J IMMUNOL, V169, P5477, DOI 10.4049/jimmunol.169.10.5477; Wang Y, 2005, J BIOL CHEM, V280, P19986, DOI 10.1074/jbc.M501689200; WILLIAMSON JR, 1985, AM J PHYSIOL, V248, pC203, DOI 10.1152/ajpcell.1985.248.3.C203; Woo SK, 2002, PFLUG ARCH EUR J PHY, V444, P579, DOI 10.1007/s00424-002-0849-2; Woo SK, 2002, MOL CELL BIOL, V22, P5753, DOI 10.1128/MCB.22.16.5753-5760.2002	30	32	32	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2011	6	7							e19186	10.1371/journal.pone.0019186	http://dx.doi.org/10.1371/journal.pone.0019186			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791WM	21765887	gold, Green Submitted, Green Published			2022-12-27	WOS:000292699000001
J	Shilling, V; Williamson, PR; Hickey, H; Sowden, E; Beresford, MW; Smyth, RL; Young, B				Shilling, Valerie; Williamson, Paula R.; Hickey, Helen; Sowden, Emma; Beresford, Michael W.; Smyth, Rosalind L.; Young, Bridget			Communication about Children's Clinical Trials as Observed and Experienced: Qualitative Study of Parents and Practitioners	PLOS ONE			English	Article							RANDOMIZED CONTROLLED TRIALS; OBTAINING INFORMED-CONSENT; DECISION-MAKING; PRIMARY-CARE; PATIENT; CONSULTATIONS; SATISFACTION; INFORMATION; HEALTH; PARTICIPATION	Background: Recruiting children to clinical trials is perceived to be challenging. To identify ways to optimise recruitment and its conduct, we compared how parents and practitioners described their experiences of recruitment to clinical trials. Methods and Findings: This qualitative study ran alongside four children's clinical trials in 11 UK research sites. It compared analyses of semi-structured interviews with analyses of audio-recordings of practitioner-family dialogue during trial recruitment discussions. Parents from 59 families were interviewed; 41 had participated in audio-recorded recruitment discussions. 31 practitioners were interviewed. Parents said little in the recruitment discussions contributing a median 16% of the total dialogue and asking a median of one question. Despite this, parents reported a positive experience of the trial approach describing a sense of comfort and safety. Even if they declined or if the discussion took place at a difficult time, parents understood the need to approach them and spoke of the value of research. Some parents viewed participation as an 'exciting' opportunity. By contrast, practitioners often worried that approaching families about research burdened families. Some practitioners implied that recruiting to clinical trials was something which they found aversive. Many were also concerned about the amount of information they had to provide and believed this overwhelmed families. Whilst some practitioners thought the trial information leaflets were of little use to families, parents reported that they used and valued the leaflets. However, both parties agreed that the leaflets were too long and wanted them to be more reader-friendly. Conclusions: Parents were more positive about being approached to enter their child into a clinical trial than practitioners anticipated. The concerns of some practitioners, that parents would be overburdened, were unfounded. Educating practitioners about how families perceive clinical trials and providing them with 'moral' support in approaching families may benefit paediatric research and, ultimately, patients.	[Shilling, Valerie; Sowden, Emma; Young, Bridget] Univ Liverpool, Inst Psychol Hlth & Soc, Liverpool L69 3BX, Merseyside, England; [Williamson, Paula R.] Univ Liverpool, Dept Biostat, Inst Translat Med, Liverpool L69 3BX, Merseyside, England; [Hickey, Helen] Alder Hey Childrens NHS Fdn Trust, Med Children Res Network Clin Trials Unit, Liverpool, Merseyside, England; [Beresford, Michael W.] Univ Liverpool, Dept Womens & Childrens Med, Inst Translat Med, Alder Hey Childrens NHS Fdn Trust, Liverpool L69 3BX, Merseyside, England	University of Liverpool; University of Liverpool; Alder Hey Children's NHS Foundation Trust; Alder Hey Children's NHS Foundation Trust; University of Liverpool	Shilling, V (corresponding author), Univ Exeter, Peninsula Med Sch, Child Hlth Grp, Exeter EX4 4QJ, Devon, England.	val.shilling@pcmd.ac.uk	Young, Bridget/A-2184-2014; Williamson, Paula R/B-6425-2016; Beresford, Michael William/AAB-5261-2021	Williamson, Paula R/0000-0001-9802-6636; Beresford, Michael William/0000-0002-5400-9911; Sowden, Emma/0000-0002-3538-8725; Young, Bridget/0000-0001-6041-9901	UK National Institute for Health Research [05/516/08]; Medical Research Council [G0800792] Funding Source: researchfish; National Institute for Health Research [05/516/08] Funding Source: researchfish; MRC [G0800792] Funding Source: UKRI	UK National Institute for Health Research(National Institute for Health Research (NIHR)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was supported by a grant from the UK National Institute for Health Research: Health Technology Assessment programme (project number 05/516/08). The funder had no role in the conduct of the study, the decision to publish, or the preparation of the manuscript. The views and opinions expressed are those of the authors and do not necessarily reflect those of the UK Department of Health.	Albrecht TL, 1999, J CLIN ONCOL, V17, P3324, DOI 10.1200/JCO.1999.17.10.3324; Albrecht TL, 2003, PATIENT EDUC COUNS, V50, P39, DOI 10.1016/S0738-3991(03)00078-8; Amiel P, 2007, ARCH PEDIAT ADOL MED, V161, P446, DOI 10.1001/archpedi.161.5.446; Austin JK, 2006, CHRONIC ILLN, V2, P181, DOI 10.1177/17423953060020031101; Ballard Hubert O, 2004, J Perinatol, V24, P409, DOI 10.1038/sj.jp.7211142; Barbour RS, 2001, BMJ-BRIT MED J, V322, P1115, DOI 10.1136/bmj.322.7294.1115; Barry CA, 2000, BRIT MED J, V320, P1246, DOI 10.1136/bmj.320.7244.1246; Brown JB, 1999, ANN INTERN MED, V131, P822, DOI 10.7326/0003-4819-131-11-199912070-00004; Brown RF, 2007, PSYCHO-ONCOLOGY, V16, P507, DOI 10.1002/pon.1095; Brown RF, 2004, SOC SCI MED, V58, P2445, DOI 10.1016/j.socscimed.2003.09.007; Burgess E, 2003, ARCH DIS CHILD-FETAL, V88, P280; BYRNE PS, 1984, DOCTORS TALKING PATI; Caldwell PHY, 2004, LANCET, V364, P803, DOI 10.1016/S0140-6736(04)16942-0; Caldwell PHY, 2002, J PEDIATR-US, V141, P798, DOI 10.1067/mpd.2002.129173; Campbell FA, 2004, PATIENT EDUC COUNS, V53, P205, DOI 10.1016/S0738-3991(03)00162-9; Campbell M K, 2007, Health Technol Assess, V11, pix; Campbell MK, 2007, HEALTH TECHNOL ASSES, V11; Chamberlain JM, 2009, ACAD EMERG MED, V16, P763, DOI 10.1111/j.1553-2712.2009.00455.x; Chamberlain K, 2000, J Health Psychol, V5, P285, DOI 10.1177/135910530000500306; Coleman T, 2000, FAM PRACT, V17, P422, DOI 10.1093/fampra/17.5.422; Collins S., 2007, PATIENT PARTICIPATIO, P3; Davis Ruth E, 2003, Health Expect, V6, P198, DOI 10.1046/j.1369-6513.2003.00235.x; Denzin N.K., 1970, RES ACT; Department for Communities and Local Government, 2007, ENGL IND DEPR 2007; Dixon-Woods M, 2007, SOC SCI MED, V65, P2212, DOI 10.1016/j.socscimed.2007.08.010; Entwistle VA, 2004, PATIENT EDUC COUNS, V55, P105, DOI 10.1016/j.pec.2003.08.005; Freer Y, 2009, PEDIATRICS, V123, P1301, DOI 10.1542/peds.2007-3860; Glaser B.G., 1968, DISCOV GROUNDED THEO; GMC, 2011, ACCESSED, P6; *GMC, 2010, GOOD PRACT RES; Goldsmith DJ, 1997, HUM COMMUN RES, V23, P454, DOI 10.1111/j.1468-2958.1997.tb00406.x; Griffin SJ, 2004, ANN FAM MED, V2, P595, DOI 10.1370/afm.142; Groger L, 1999, QUAL HEALTH RES, V9, P829, DOI 10.1177/104973299129122180; Jefford MH, 2007, J CLIN ONCOL, V25, DOI 10.1200/JCO.2006.10.3341; Jenkins V, 2005, BMJ-BRIT MED J, V330, P400, DOI 10.1136/bmj.38366.562685.8F; Kendall M, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4122; Kipnis K, 2003, THEOR MED BIOETH, V24, P107, DOI 10.1023/A:1024646912928; Klassen TP, 2009, LANCET, V374, P1310, DOI 10.1016/S0140-6736(09)61803-1; Klassen TP, 2008, PLOS MED, V5, P1180, DOI 10.1371/journal.pmed.0050172; Kodish E, 2004, JAMA-J AM MED ASSOC, V291, P470, DOI 10.1001/jama.291.4.470; Kodish ED, 1998, CANCER-AM CANCER SOC, V82, P2467; Macrae D, 2009, CRIT CARE MED, V37, pS136, DOI 10.1097/CCM.0b013e318192101f; Marvel MK, 1999, JAMA-J AM MED ASSOC, V281, P283, DOI 10.1001/jama.281.3.283; Mason SA, 2000, LANCET, V356, P2045, DOI 10.1016/S0140-6736(00)03401-2; Mead N, 2002, SOC SCI MED, V55, P283, DOI 10.1016/S0277-9536(01)00171-X; Mead N, 2002, PATIENT EDUC COUNS, V48, P51, DOI 10.1016/S0738-3991(02)00099-X; Mendick N, 2010, SOC SCI MED, V70, P1904, DOI 10.1016/j.socscimed.2009.12.039; Murphy E, 1998, Health Technol Assess, V2, piii; Murphy E., 1998, HLTH TECHNOLOGY ASSE, V2, P1, DOI DOI 10.3310/HTA2160; *OFF NAT STAT, 2001, CENS DIG BOUND DAT E; ONWUEGBUZIE AJ, 2003, MIXED METHODS SOCIAL, P351; Paterniti DA, 2010, ARCH INTERN MED, V170, P381, DOI 10.1001/archinternmed.2009.533; Saba GW, 2006, ANN FAM MED, V4, P54, DOI 10.1370/afm.393; SALMON P, COMMUNICATIO IN PRES; Seale C, 1997, EUR J PUBLIC HEALTH, V7, P379, DOI 10.1093/eurpub/7.4.379; SEALE C, 1988, QUALITY QUALITATIVE; Shaddy RE, 2010, PEDIATRICS, V125, P850, DOI 10.1542/peds.2010-0082; Shilling V, 2011, HEALTH TECHNOL ASSES, V15, P1, DOI 10.3310/hta15150; Shilling V, 2003, PSYCHO-ONCOL, V12, P599, DOI 10.1002/pon.731; Siminoff LA, 2008, J CLIN ONCOL, V26, P2614, DOI 10.1200/JCO.2008.16.2610; Simon CM, 2004, J CLIN ONCOL, V22, P2708, DOI 10.1200/JCO.2004.10.034; Smyth RL, 2006, ARCH DIS CHILD, V91, P212, DOI 10.1136/adc.2005.077073; SMYTH RL, 1999, LANCET S2, V354, P21; Smyth RL, 2007, ARCH DIS CHILD, V92, P835, DOI 10.1136/adc.2006.113357; Steinbrook R, 2002, NEW ENGL J MED, V347, P1462, DOI 10.1056/NEJMhpr021646; Strauss A., 1998, BASICS QUALITATIVE R; Thompson AGH, 2007, SOC SCI MED, V64, P1297, DOI 10.1016/j.socscimed.2006.11.002; Wade J, 2009, SOC SCI MED, V68, P2018, DOI 10.1016/j.socscimed.2009.02.023; WALTERSPIEL JN, 1990, PEDIATRICS, V85, P119; Yap TY, 2009, ACAD MED, V84, P1036, DOI 10.1097/ACM.0b013e3181acfbcd	70	55	55	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2011	6	7							e21604	10.1371/journal.pone.0021604	http://dx.doi.org/10.1371/journal.pone.0021604			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	791WM	21765898	Green Published, Green Accepted, gold			2022-12-27	WOS:000292699000008
J	Ito, S; Umehara, M; Hanada, A; Kitahata, N; Hayase, H; Yamaguchi, S; Asami, T				Ito, Shinsaku; Umehara, Mikihisa; Hanada, Atsushi; Kitahata, Nobutaka; Hayase, Hiroki; Yamaguchi, Shinjiro; Asami, Tadao			Effects of Triazole Derivatives on Strigolactone Levels and Growth Retardation in Rice	PLOS ONE			English	Article							ARBUSCULAR MYCORRHIZAL FUNGI; BIOSYNTHESIS INHIBITORS; ANALOG GR24; BRASSINOSTEROIDS	We previously discovered a lead compound for strigolactone (SL) biosynthesis inhibitors, TIS13 (2,2-dimethyl-7-phenoxy-4(1H-1,2,4-triazol-1-yl)heptan-3-ol). Here, we carried out a structure-activity relationship study of TIS13 to discover more potent and specific SL biosynthesis inhibitor because TIS13 has a severe side effect at high concentrations, including retardation of the growth of rice seedlings. TIS108, a new TIS13 derivative, was found to be a more specific SL biosynthesis inhibitor than TIS13. Treatment of rice seedlings with TIS108 reduced SL levels in both roots and root exudates in a concentration-dependent manner and did not reduce plant height. In addition, root exudates of TIS108-treated rice seedlings stimulated Striga germination less than those of control plants. These results suggest that TIS108 has a potential to be applied in the control of root parasitic weeds germination.	[Ito, Shinsaku; Kitahata, Nobutaka; Hayase, Hiroki; Asami, Tadao] Univ Tokyo, Dept Appl Biol Chem, Tokyo, Japan; [Umehara, Mikihisa; Hanada, Atsushi; Yamaguchi, Shinjiro] RIKEN, Plant Sci Ctr, Yokohama, Kanagawa, Japan	University of Tokyo; RIKEN	Ito, S (corresponding author), Univ Tokyo, Dept Appl Biol Chem, Tokyo, Japan.	asami@pgr1.ch.a.u-tokyo.ac.jp	Umehara, M/D-2416-2011; Yamaguchi, Shinjiro/F-9684-2010		Program for the Promotion of Basic Research Activities for Innovative Biosciences (PRO-BRAIN); Japan Society for the Promotion of Science	Program for the Promotion of Basic Research Activities for Innovative Biosciences (PRO-BRAIN); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by a Grant to T.A. from the Program for the Promotion of Basic Research Activities for Innovative Biosciences (PRO-BRAIN), and a Research Fellowship to S.I. from the Japan Society for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama K, 2005, NATURE, V435, P824, DOI 10.1038/nature03608; Asami T, 2003, J PLANT GROWTH REGUL, V22, P336, DOI 10.1007/s00344-003-0065-0; Asami T, 2000, PLANT PHYSIOL, V123, P93, DOI 10.1104/pp.123.1.93; Beveridge CA, 2010, CURR OPIN PLANT BIOL, V13, P34, DOI 10.1016/j.pbi.2009.10.003; Cardoso C, 2011, PLANT SCI, V180, P414, DOI 10.1016/j.plantsci.2010.11.007; COOK CE, 1966, SCIENCE, V154, P1189, DOI 10.1126/science.154.3753.1189; Drummond RSM, 2009, PLANT PHYSIOL, V151, P1867, DOI 10.1104/pp.109.146720; Gomez-Roldan V, 2008, NATURE, V455, P189, DOI 10.1038/nature07271; Ito S, 2010, PLANT CELL PHYSIOL, V51, P1143, DOI 10.1093/pcp/pcq077; Jamil M, 2010, ARCH BIOCHEM BIOPHYS, V504, P123, DOI 10.1016/j.abb.2010.08.005; Kapulnik Y, 2011, PLANTA, V233, P209, DOI 10.1007/s00425-010-1310-y; Komatsu T, 2010, PLANT J, V61, P409, DOI 10.1111/j.1365-313X.2009.04077.x; MANGNUS EM, 1992, J AGR FOOD CHEM, V40, P1230, DOI 10.1021/jf00019a031; Min YK, 1999, BIOORG MED CHEM LETT, V9, P425, DOI 10.1016/S0960-894X(99)00008-6; Parker C, 2009, PEST MANAG SCI, V65, P453, DOI 10.1002/ps.1713; Rani K, 2008, PLANT PHYSIOL BIOCH, V46, P617, DOI 10.1016/j.plaphy.2008.04.012; Ruyter-Spira C, 2011, PLANT PHYSIOL, V155, P721, DOI 10.1104/pp.110.166645; Sugimoto Y, 2008, PHYTOCHEMISTRY, V69, P212, DOI 10.1016/j.phytochem.2007.06.011; Umehara M, 2008, NATURE, V455, P195, DOI 10.1038/nature07272; Yin YH, 2002, CELL, V109, P181, DOI 10.1016/S0092-8674(02)00721-3; Zhang AP, 2011, J AGR FOOD CHEM, V59, P4300, DOI 10.1021/jf104828q	21	35	36	3	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2011	6	7							e21723	10.1371/journal.pone.0021723	http://dx.doi.org/10.1371/journal.pone.0021723			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791IA	21760901	Green Published, Green Submitted, gold			2022-12-27	WOS:000292657200019
J	Pinto, OA; Munoz, MA				Pinto, Oscar A.; Munoz, Miguel A.			Quasi-Neutral Theory of Epidemic Outbreaks	PLOS ONE			English	Article							SELF-ORGANIZED CRITICALITY; PHASE-TRANSITIONS; SCALING PROPERTIES; POWER LAWS; PATHOGENICITY; DIVERSITY; SYSTEMS; DISEASE; MODELS	Some epidemics have been empirically observed to exhibit outbreaks of all sizes, i.e., to be scale-free or scale-invariant. Different explanations for this finding have been put forward; among them there is a model for "accidental pathogens" which leads to power-law distributed outbreaks without apparent need of parameter fine tuning. This model has been claimed to be related to self-organized criticality, and its critical properties have been conjectured to be related to directed percolation. Instead, we show that this is a (quasi) neutral model, analogous to those used in Population Genetics and Ecology, with the same critical behavior as the voter-model, i.e. the theory of accidental pathogens is a (quasi)-neutral theory. This analogy allows us to explain all the system phenomenology, including generic scale invariance and the associated scaling exponents, in a parsimonious and simple way.	[Pinto, Oscar A.] Univ Nacl San Luis, CONICET, Inst Fis Aplicada, Dept Fis, San Luis, Argentina; [Pinto, Oscar A.; Munoz, Miguel A.] Univ Granada, Fac Ciencias, Inst Fis Teor & Computac Carlos 1, Dept Electromagnetismo & Fis Mat, Granada, Spain	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Universidad Nacional de San Luis; University of Granada	Pinto, OA (corresponding author), Univ Nacl San Luis, CONICET, Inst Fis Aplicada, Dept Fis, San Luis, Argentina.	mamunoz@onsager.ugr.es	Munoz, Miguel A/J-9627-2012; MUÑOZ, MIGUEL A/M-4099-2015	Munoz, Miguel A/0000-0002-0529-6221; MUÑOZ, MIGUEL A/0000-0003-0152-9080	Spanish MICINN-FEDER [FIS2009-08451]; Junta de Andalucia Proyecto de Excelencia [P09FQM-4682]; Accion Integrada Hispano-Argentina, MICINN [AR2009-0003]	Spanish MICINN-FEDER(Ministry of Science and Innovation, Spain (MICINN)Spanish GovernmentEuropean Commission); Junta de Andalucia Proyecto de Excelencia(Junta de Andalucia); Accion Integrada Hispano-Argentina, MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	The authors acknowledge financial support from the Spanish MICINN-FEDER under project FIS2009-08451, from Junta de Andalucia Proyecto de Excelencia P09FQM-4682, and from the Accion Integrada Hispano-Argentina, MICINN AR2009-0003. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Hammal O, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.230601; Amit DJ., 2005, FIELD THEORY RENORMA, V3; ANDERSON R M, 1991; Azaele S, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.051901; BAK P, 1987, PHYS REV LETT, V59, P381, DOI 10.1103/PhysRevLett.59.381; Bak P., 1996, NATURE WORKS SCI SEL; Bonachela JA, 2007, PHYSICA A, V384, P89, DOI 10.1016/j.physa.2007.04.110; Bonachela JA, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.050102; Bonachela JA, 2009, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2009/09/P09009; Bonachela JA, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.041102; Bramson M, 1996, ANN PROBAB, V24, P1727; Bramson M, 1998, ANN PROBAB, V26, P658; Dickman R, 2000, BRAZ J PHYS, V30, P27, DOI 10.1590/S0103-97332000000100004; DICKMAN R, 1995, PHYS REV E, V52, P3218, DOI 10.1103/PhysRevE.52.3218; DOI M, 1976, J PHYS A-MATH GEN, V9, P1479, DOI 10.1088/0305-4470/9/9/009; DOMANY E, 1984, PHYS REV LETT, V53, P311, DOI 10.1103/PhysRevLett.53.311; Dornic I, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.100601; Dornic I, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.045701; Gardiner C. W., 1985, HDB STOCHASTIC METHO, V3; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; GRASSBERGER P, 1982, Z PHYS B CON MAT, V47, P365, DOI 10.1007/BF01313803; GRINSTEIN G, 1991, J APPL PHYS, V69, P5441, DOI 10.1063/1.348003; GRINSTEIN G, 1994, P 1994 NATO ADV STUD; Guinea F, 2005, BIOPHYS CHEM, V115, P181, DOI 10.1016/j.bpc.2004.12.024; Harnos A., 2006, Applied Ecology and Environmental Research, V4, P151; Harris TE, 1989, THEORY BRANCHING PRO; Henkel M, 2008, THEOR MATH PHYS SER, P1; Hethcote HW, 2000, SIAM REV, V42, P599, DOI 10.1137/S0036144500371907; Hinrichsen H, 2000, ADV PHYS, V49, P815, DOI 10.1080/00018730050198152; Hubbell Stephen P., 2001, V32, pi; JANSSEN HK, 1981, Z PHYS B CON MAT, V42, P151, DOI 10.1007/BF01319549; Jensen H.J., 1998, SELF ORG CRITICALITY; Keeling M, 1999, PHILOS T R SOC B, V354, P769, DOI 10.1098/rstb.1999.0429; Kimura M., 1983, NEUTRAL THEORY MOL E; Leigh EG, 2007, J EVOLUTION BIOL, V20, P2075, DOI 10.1111/j.1420-9101.2007.01410.x; Ligget T. M., 1985, INTERACTING PARTICLE; Maiden MCJ, 2000, INT J MED MICROBIOL, V290, P183; MARRO J, 2005, R NONEQUILIBRIUM PHA; Moran P., 1962, STAT PROCESSES EVOLU; Munoz MA, 1999, PHYS REV E, V59, P6175, DOI 10.1103/PhysRevE.59.6175; Murray JD.., 2003, MATH BIOL, DOI DOI 10.1007/B98869; Newman MEJ, 2005, CONTEMP PHYS, V46, P323, DOI 10.1080/00107510500052444; Odor G, 2004, REV MOD PHYS, V76, P663, DOI 10.1103/RevModPhys.76.663; PELITI L, 1985, J PHYS-PARIS, V46, P1469, DOI 10.1051/jphys:019850046090146900; PHILIPPE P, 2000, NONLINEAR DYNAMICS P, V4, P275; Rhodes CJ, 1996, PHILOS T R SOC B, V351, P1679, DOI 10.1098/rstb.1996.0150; Rhodes CJ, 1997, P ROY SOC B-BIOL SCI, V264, P1639, DOI 10.1098/rspb.1997.0228; Rhodes CJ, 1998, J MOL MED, V76, P111, DOI 10.1007/s001090050198; Rhodes CJ, 1996, NATURE, V381, P600, DOI 10.1038/381600a0; Stollenwerk N, 2005, AIP CONF PROC, V779, P191, DOI 10.1063/1.2008613; Stollenwerk N, 2004, P NATL ACAD SCI USA, V101, P10229, DOI 10.1073/pnas.0400695101; Stollenwerk N, 2003, PHYS LETT A, V317, P87, DOI 10.1016/j.physleta.2003.08.017; Stollenwerk N, 2003, J THEOR BIOL, V222, P347, DOI 10.1016/S0022-5193(03)00041-9; Stollenwerk N, 2005, RECENT ADVANCES IN APPLIED PROBABILITY, P455, DOI 10.1007/0-387-23394-6_19; Trottier H, 2005, J THEOR BIOL, V235, P326, DOI 10.1016/j.jtbi.2005.01.013; Vespignani A, 2000, PHYS REV E, V62, P4564, DOI 10.1103/PhysRevE.62.4564; Vespignani A, 1998, PHYS REV LETT, V81, P5676, DOI 10.1103/PhysRevLett.81.5676; Zillio T, 2008, P NATL ACAD SCI USA, V105, P18714, DOI 10.1073/pnas.0807380105	58	20	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2011	6	7							e21946	10.1371/journal.pone.0021946	http://dx.doi.org/10.1371/journal.pone.0021946			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791IA	21760930	Green Submitted, Green Published, gold			2022-12-27	WOS:000292657200034
J	Suguitan, AL; Cheng, X; Wang, WJ; Wang, SX; Jin, H; Lu, S				Suguitan, Amorsolo L., Jr.; Cheng, Xing; Wang, Weijia; Wang, Shixia; Jin, Hong; Lu, Shan			Influenza H5 Hemagglutinin DNA Primes the Antibody Response Elicited by the Live Attenuated Influenza A/Vietnam/1203/2004 Vaccine in Ferrets	PLOS ONE			English	Article							AVIAN INFLUENZA; A VIRUS; MF59-ADJUVANTED INFLUENZA; IMMUNOGENICITY; PROTECTION; IMMUNITY; BOOST; MICE; H1N1; CHALLENGE	Priming immunization plays a key role in protecting individuals or populations to influenza viruses that are novel to humans. To identify the most promising vaccine priming strategy, we have evaluated different prime-boost regimens using inactivated, DNA and live attenuated vaccines in ferrets. Live attenuated influenza A/Vietnam/1203/2004 (H5N1) candidate vaccine (LAIV, VN04 ca) primed ferrets efficiently while inactivated H5N1 vaccine could not prime the immune response in seronegative ferrets unless an adjuvant was used. However, the H5 HA DNA vaccine alone was as successful as an adjuvanted inactivated VN04 vaccine in priming the immune response to VN04 ca virus. The serum antibody titers of ferrets primed with H5 HA DNA followed by intranasal vaccination of VN04 ca virus were comparable to that induced by two doses of VN04 ca virus. Both LAIV-LAIV and DNA-LAIV vaccine regimens could induce antibody responses that cross-neutralized antigenically distinct H5N1 virus isolates including A/HongKong/213/2003 (HK03) and prevented nasal infection of HK03 vaccine virus. Thus, H5 HA DNA vaccination may offer an alternative option for pandemic preparedness.	[Suguitan, Amorsolo L., Jr.; Cheng, Xing; Wang, Weijia; Jin, Hong] MedImmune, Mountain View, CA USA; [Wang, Shixia; Lu, Shan] Univ Massachusetts, Sch Med, Dept Med, Worcester, MA USA	AstraZeneca; Medimmune; University of Massachusetts System; University of Massachusetts Worcester	Suguitan, AL (corresponding author), MedImmune, Mountain View, CA USA.	jinh@medimmune.com		Lu, Shan/0000-0002-8417-7588	NIH/NIAID [AI078073]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI078073] Funding Source: NIH RePORTER	NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by NIH/NIAID grant AI078073. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Ambrose CS, 2008, PEDIATR INFECT DIS J, V27, P744, DOI 10.1097/INF.0b013e318174e0f8; Ambrose CS, 2010, PEDIATR INFECT DIS J, V29, P806, DOI 10.1097/INF.0b013e3181e2872f; Chen H, 2006, P NATL ACAD SCI USA, V103, P2845, DOI 10.1073/pnas.0511120103; Chen ZY, 2010, J VIROL, V84, P44, DOI 10.1128/JVI.02106-09; CLEMENTS ML, 1986, J CLIN MICROBIOL, V24, P157, DOI 10.1128/JCM.24.1.157-160.1986; Dejpichai R, 2009, EMERG INFECT DIS, V15, P756, DOI 10.3201/eid1505.080316; Epstein SL, 2002, EMERG INFECT DIS, V8, P796; Glezen WP, 1996, EPIDEMIOL REV, V18, P64, DOI 10.1093/oxfordjournals.epirev.a017917; GORSE GJ, 1995, J INFECT DIS, V172, P1, DOI 10.1093/infdis/172.1.1; Greenberg ME, 2009, NEW ENGL J MED, V361, P2405, DOI 10.1056/NEJMoa0907413; Hauge S, 2007, CLIN VACCINE IMMUNOL, V14, P978, DOI 10.1128/CVI.00033-07; Hoffmann E, 2000, P NATL ACAD SCI USA, V97, P6108, DOI 10.1073/pnas.100133697; Huber VC, 2009, VACCINE, V27, P1192, DOI 10.1016/j.vaccine.2008.12.023; Jennings LC, 2008, LANCET INFECT DIS, V8, P650, DOI 10.1016/S1473-3099(08)70232-9; Jin H, 2003, VIROLOGY, V306, P18, DOI 10.1016/S0042-6822(02)00035-1; Johnson NPAS, 2002, B HIST MED, V76, P105, DOI 10.1353/bhm.2002.0022; Kongkasuriyachai D, 2004, VACCINE, V22, P3205, DOI 10.1016/j.vaccine.2003.11.060; Koyama S, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000759; Lalor PA, 2008, J INFECT DIS, V197, P1643, DOI 10.1086/588431; Leroux-Roels I, 2007, LANCET, V370, P580, DOI 10.1016/S0140-6736(07)61297-5; Li YB, 2010, J VIROL, V84, P8389, DOI 10.1128/JVI.00413-10; Li YH, 2010, VACCINE, V28, P5370, DOI 10.1016/j.vaccine.2010.04.067; Lu S, 2008, HUM VACCINES, V4, P449, DOI 10.4161/hv.4.6.6179; MAASSAB HF, 1969, J IMMUNOL, V102, P728; Nicholson KG, 2001, LANCET, V357, P1937, DOI 10.1016/S0140-6736(00)05066-2; Nolan T, 2010, JAMA-J AM MED ASSOC, V303, P37, DOI 10.1001/jama.2009.1911; Octaviani CP, 2010, J VIROL, V84, P10918, DOI 10.1128/JVI.01140-10; POWERS DC, 1989, J CLIN MICROBIOL, V27, P2666, DOI 10.1128/JCM.27.12.2666-2671.1989; Santhia K, 2009, INFLUENZA OTHER RESP, V3, P81, DOI 10.1111/j.1750-2659.2009.00069.x; Stephenson I, 2005, J INFECT DIS, V191, P1210, DOI 10.1086/428948; Stephenson I, 2003, VACCINE, V21, P1687, DOI 10.1016/S0264-410X(02)00632-1; Stephenson I, 2008, NEW ENGL J MED, V359, P1631, DOI 10.1056/NEJMc0805274; Suguitan AL, 2006, PLOS MED, V3, P1541, DOI 10.1371/journal.pmed.0030360; Talaat KR, 2010, J INFECT DIS, V202, P1327, DOI 10.1086/656601; Tanghe A, 2001, INFECT IMMUN, V69, P3041, DOI 10.1128/IAI.69.5.3041-3047.2001; TOMODA T, 1995, VACCINE, V13, P185, DOI 10.1016/0264-410X(95)93134-U; Treanor JJ, 2006, NEW ENGL J MED, V354, P1343, DOI 10.1056/NEJMoa055778; Ulmer JB, 1998, J VIROL, V72, P5648, DOI 10.1128/JVI.72.7.5648-5653.1998; Wang M, 2009, NEW ENGL J MED, V360, P2583, DOI 10.1056/NEJMc0900358; Wang SX, 2008, VACCINE, V26, P2100, DOI 10.1016/j.vaccine.2008.02.033; Wang S, 2008, VACCINE, V26, P3946, DOI 10.1016/j.vaccine.2008.04.025; Wang S, 2008, VACCINE, V26, P3626, DOI 10.1016/j.vaccine.2008.04.073; Wang SX, 2006, J VIROL, V80, P11628, DOI 10.1128/JVI.01065-06; Wang WJ, 2010, J VIROL, V84, P6570, DOI 10.1128/JVI.00221-10; Wei CJ, 2010, SCIENCE, V329, P1060, DOI 10.1126/science.1192517; WHO, 2010, CUM NUMB CONF HUM CA; Xu GF, 2009, VACCINE, V27, P3821, DOI 10.1016/j.vaccine.2009.04.008; Zangwill KM, 2008, J INFECT DIS, V197, P580, DOI 10.1086/526537; Zhu YC, 2010, VACCINE, V28, P5347, DOI 10.1016/j.vaccine.2010.05.017	49	31	33	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2011	6	7							e21942	10.1371/journal.pone.0021942	http://dx.doi.org/10.1371/journal.pone.0021942			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791IA	21760928	gold, Green Published, Green Submitted			2022-12-27	WOS:000292657200032
J	Zhang, YP; Liu, YZ; Guo, Y; Liu, XG; Xu, XH; Guo, YF; Chen, Y; Zhang, F; Pan, F; Zhu, XZ; Deng, HW				Zhang, Yin-Ping; Liu, Yao-Zhong; Guo, Yan; Liu, Xiao-Gang; Xu, Xiang-Hong; Guo, Yan-Fang; Chen, Yuan; Zhang, Feng; Pan, Feng; Zhu, Xue-Zhen; Deng, Hong-Wen			Pathway-Based Association Analyses Identified TRAIL Pathway for Osteoporotic Fractures	PLOS ONE			English	Article							NF-KAPPA-B; APOPTOSIS-INDUCING LIGAND; GENOME-WIDE ASSOCIATION; HUMAN OSTEOCLAST APOPTOSIS; BONE-MINERAL DENSITY; TNF FAMILY; RECEPTOR; DIFFERENTIATION; ACTIVATION; OSTEOPROTEGERIN	Introduction: Hip OF carries the highest morbidity and mortality. Previous studies revealed that individual genes/loci in the Tumor Necrosis Factor (TNF) -Related Apoptosis-Inducing Ligand (TRAIL) pathway were associated with bone metabolism. This study aims to verify the potential association between hip OF and TRAIL pathway. Methods: Using genome-wide genotype data from Affymetrix 500 K SNP arrays, we performed novel pathway-based association analyses for hip OF in 700 elderly Chinese Han subjects (350 with hip OF and 350 healthy matched controls). Results: The TRAIL pathway achieved a significant p value (p = 0.01) for association with hip OF. Among the 38 genes in the TRAIL pathway, seven genes achieved nominally significant association with hip OF (p<0.05); the TNFSF10 (TRAIL) gene obtained the most significant p value (p = 1.7x10(-4)). SNPs (rs719126, rs6533015, rs9594738, rs1805034, rs11160706) from five genes (CFLAR, NFKB1, TNFSF11, TNFRSF11A, TRAF3) of the pathway had minor alleles that appear to be protective to hip OF. SNPs (rs6445063 and rs4259415) from two genes (TNFSF10 and TNFRSF10B) of the pathway had minor alleles (A) that are associated with an increased risk of hip OF, with the ORs (odds ratios) of 16.51 (95%CI:3.83-71.24) and 1.37 (95%CI:1.08-1.74), respectively. Conclusions: Our study supports the potential role of the TRAIL pathway in the pathogenesis of hip OF in Chinese Han population. Further functional study of this pathway will be pursued to determine the mechanism by which it confers risk to hip OF.	[Zhang, Yin-Ping; Zhang, Feng] Xi An Jiao Tong Univ, Coll Med, Minist Educ, Key Lab Environm & Genes Related Dis, Xian 710049, Shaanxi, Peoples R China; [Liu, Yao-Zhong; Deng, Hong-Wen] Tulane Univ, Sch Publ Hlth & Trop Med, Dept Biostat, New Orleans, LA USA; [Guo, Yan; Liu, Xiao-Gang; Xu, Xiang-Hong; Guo, Yan-Fang; Chen, Yuan; Pan, Feng; Deng, Hong-Wen] Xi An Jiao Tong Univ, Sch Life Sci & Technol, Minist Educ, Key Lab Biomed Informat Engn, Xian 710049, Shaanxi, Peoples R China; [Guo, Yan; Liu, Xiao-Gang; Xu, Xiang-Hong; Guo, Yan-Fang; Chen, Yuan; Pan, Feng; Deng, Hong-Wen] Inst Mol Genet, Xian 710049, Shaanxi, Peoples R China; [Zhu, Xue-Zhen; Deng, Hong-Wen] Univ Shanghai Sci & Technol, Shanghai, Peoples R China	Xi'an Jiaotong University; Tulane University; Xi'an Jiaotong University; University of Shanghai for Science & Technology	Zhang, YP (corresponding author), Xi An Jiao Tong Univ, Coll Med, Minist Educ, Key Lab Environm & Genes Related Dis, Xian 710049, Shaanxi, Peoples R China.	cathyzh@mail.xjtu.edu.cn; hdeng2@tulane.edu	Guo, Yan/G-8742-2014; Liu, Yaozhong/ABD-5544-2020	Guo, Yan/0000-0002-7364-2392; Deng, Hong-Wen/0000-0002-0387-8818	National Institutes of Health [R01 AR050496, R21 AG027110, R01 AG026564, P50 AR055081, 5R03TW008221, 5R01AR057049, R21 AA015973]; Guanghua Foundation [GH0203416]; Xi'an Jiaotong University, Shaanxi Province [2010K16-01]; National Natural Science Foundation of China [81000363, 31000554]; Huo Ying Dong Education Foundation; China Scholarship Council; Programs Foundation of Ministry of Education of China [20100201120058]; Shanghai Leading Academic Discipline Project [S30501]; Ministry of Education; University of Shanghai for Science and Technology; FOGARTY INTERNATIONAL CENTER [R03TW008221] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR057049, P50AR055081, R01AR050496] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG027110, R01AG026564] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R21AA015973] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Guanghua Foundation; Xi'an Jiaotong University, Shaanxi Province; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Huo Ying Dong Education Foundation; China Scholarship Council(China Scholarship Council); Programs Foundation of Ministry of Education of China(Ministry of Education, China); Shanghai Leading Academic Discipline Project(Shanghai Leading Academic Discipline Project); Ministry of Education; University of Shanghai for Science and Technology; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	Investigators of this work were partially supported by grants from National Institutes of Health (R01 AR050496, R21 AG027110, R01 AG026564, P50 AR055081, 5R03TW008221, 5R01AR057049, and R21 AA015973). The study was also benefited from grants from Guanghua Foundation (GH0203416), Xi'an Jiaotong University, Shaanxi Province (2010K16-01), National Natural Science Foundation of China (81000363, 31000554), Huo Ying Dong Education Foundation, and China Scholarship Council, Programs Foundation of Ministry of Education of China (20100201120058), Shanghai Leading Academic Discipline Project (S30501), a grant from Ministry of Education to ShangHai University of Science and Technology, and startup fund from University of Shanghai for Science and Technology. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chamoux E, 2008, J CELL PHYSIOL, V216, P536, DOI 10.1002/jcp.21430; Chanock SJ, 2007, NATURE, V447, P655, DOI 10.1038/447655a; Chen Y, 2010, BONE, V46, P129, DOI 10.1016/j.bone.2009.09.025; Colucci S, 2007, APOPTOSIS, V12, P1623, DOI 10.1007/s10495-007-0095-3; COOPER C, 1992, OSTEOPOROSIS INT, V2, P285, DOI 10.1007/BF01623184; Curtis RK, 2005, TRENDS BIOTECHNOL, V23, P429, DOI 10.1016/j.tibtech.2005.05.011; Darnay BG, 1999, J BIOL CHEM, V274, P7724, DOI 10.1074/jbc.274.12.7724; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Di XJ, 2005, BIOINFORMATICS, V21, P1958, DOI 10.1093/bioinformatics/bti275; Emery JG, 1998, J BIOL CHEM, V273, P14363, DOI 10.1074/jbc.273.23.14363; Feng X, 2005, GENE, V350, P1, DOI 10.1016/j.gene.2005.01.014; Grimaud E, 2003, AM J PATHOL, V163, P2021, DOI 10.1016/S0002-9440(10)63560-2; Gullberg B, 1997, OSTEOPOROSIS INT, V7, P407, DOI 10.1007/PL00004148; Hauer J, 2005, P NATL ACAD SCI USA, V102, P2874, DOI 10.1073/pnas.0500187102; HSU PN, 2009, J IMMUNOL, V182, P14; Lacey DL, 1998, CELL, V93, P165, DOI 10.1016/S0092-8674(00)81569-X; Mogi M, 2004, BONE, V35, P507, DOI 10.1016/j.bone.2004.03.003; Pan GH, 1997, SCIENCE, V276, P111, DOI 10.1126/science.276.5309.111; Pitt RM, 1996, J BIOL CHEM, V271, P12687, DOI 10.1074/jbc.271.22.12687; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pritchard JK, 2000, GENETICS, V155, P945; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rabbee N, 2006, BIOINFORMATICS, V22, P7, DOI 10.1093/bioinformatics/bti741; Ross PD, 1998, ENDOCRIN METAB CLIN, V27, P289, DOI 10.1016/S0889-8529(05)70006-2; Sanjay A, 2001, J CELL BIOL, V152, P181, DOI 10.1083/jcb.152.1.181; Sedger LM, 2002, EUR J IMMUNOL, V32, P2246, DOI 10.1002/1521-4141(200208)32:8<2246::AID-IMMU2246>3.0.CO;2-6; Styrkarsdottir U, 2008, NEW ENGL J MED, V358, P2355, DOI 10.1056/NEJMoa0801197; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Thomas DC, 2002, CANCER EPIDEM BIOMAR, V11, P505; Tranah GJ, 2008, CALCIFIED TISSUE INT, V83, P155, DOI 10.1007/s00223-008-9165-y; Tschopp J, 1998, CURR OPIN IMMUNOL, V10, P552, DOI 10.1016/S0952-7915(98)80223-9; Vaira S, 2008, J CLIN INVEST, V118, P2088, DOI 10.1172/JCI33392; Wakeyama H, 2007, J BONE MINER RES, V22, P1631, DOI 10.1359/JBMR.070619; Wiley SR, 1995, IMMUNITY, V3, P673, DOI 10.1016/1074-7613(95)90057-8; Xu JK, 2009, CYTOKINE GROWTH F R, V20, P7, DOI 10.1016/j.cytogfr.2008.11.007; Yao GQ, 2000, ENDOCRINOLOGY, V141, P2914, DOI 10.1210/en.141.8.2914; Yen ML, 2008, MOL IMMUNOL, V45, P2205, DOI 10.1016/j.molimm.2007.12.003; Zauli G, 2004, BLOOD, V104, P2044, DOI 10.1182/blood-2004-03-1196; Zhang LS, 2010, J BONE MINER RES, V25, P1572, DOI 10.1002/jbmr.36	39	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2011	6	7							e21835	10.1371/journal.pone.0021835	http://dx.doi.org/10.1371/journal.pone.0021835			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791IA	21760914	Green Published, gold, Green Submitted			2022-12-27	WOS:000292657200026
J	Bergeron, MJ; Boggavarapu, R; Meury, M; Ucurum, Z; Caron, L; Isenring, P; Hediger, MA; Fotiadis, D				Bergeron, Marc J.; Boggavarapu, Rajendra; Meury, Marcel; Ucurum, Zoehre; Caron, Luc; Isenring, Paul; Hediger, Matthias A.; Fotiadis, Dimitrios			Frog Oocytes to Unveil the Structure and Supramolecular Organization of Human Transport Proteins	PLOS ONE			English	Article							K+-CL-COTRANSPORTERS; XENOPUS-LAEVIS; IDENTIFICATION; EXPRESSION; TERMINUS; SYSTEM	Structural analyses of heterologously expressed mammalian membrane proteins remain a great challenge given that microgram to milligram amounts of correctly folded and highly purified proteins are required. Here, we present a novel method for the expression and affinity purification of recombinant mammalian and in particular human transport proteins in Xenopus laevis frog oocytes. The method was validated for four human and one murine transporter. Negative stain transmission electron microscopy (TEM) and single particle analysis (SPA) of two of these transporters, i.e., the potassium-chloride cotransporter 4 (KCC4) and the aquaporin-1 (AQP1) water channel, revealed the expected quaternary structures within homogeneous preparations, and thus correct protein folding and assembly. This is the first time a cation-chloride cotransporter (SLC12) family member is isolated, and its shape, dimensions, low-resolution structure and oligomeric state determined by TEM, i.e., by a direct method. Finally, we were able to grow 2D crystals of human AQP1. The ability of AQP1 to crystallize was a strong indicator for the structural integrity of the purified recombinant protein. This approach will open the way for the structure determination of many human membrane transporters taking full advantage of the Xenopus laevis oocyte expression system that generally yields robust functional expression.	[Bergeron, Marc J.; Boggavarapu, Rajendra; Meury, Marcel; Ucurum, Zoehre; Hediger, Matthias A.; Fotiadis, Dimitrios] Univ Bern, Inst Biochem & Mol Med, Bern, Switzerland; [Bergeron, Marc J.; Boggavarapu, Rajendra; Meury, Marcel; Ucurum, Zoehre; Hediger, Matthias A.; Fotiadis, Dimitrios] Univ Bern, Swiss Natl Ctr Competence Res NCCR TransCure, Bern, Switzerland; [Bergeron, Marc J.] Univ Laval Robert Giffard, Ctr Rech, Unite Neurobiol Cellulaire, Quebec City, PQ, Canada; [Caron, Luc; Isenring, Paul] Univ Laval, Fac Med, Dept Med, Nephrol Res Grp,CHUQ Hotel Dieu Quebec Inst, Quebec City, PQ G1K 7P4, Canada	University of Bern; University of Bern; Laval University; Laval University	Bergeron, MJ (corresponding author), Univ Bern, Inst Biochem & Mol Med, Bern, Switzerland.	dimitrios.fotiadis@ibmm.unibe.ch		Boggavarapu, Venkata/0000-0001-6312-5722; Hediger, Matthias/0000-0003-1946-027X	Swiss National Foundation for Scientific Research [31003A_125150]; Bern University Research Foundation; National Centre of Competence in Research (NCCR) TransCure; Canadian Institutes of Health Research (CIHR)	Swiss National Foundation for Scientific Research(Swiss National Science Foundation (SNSF)); Bern University Research Foundation; National Centre of Competence in Research (NCCR) TransCure(Swiss National Science Foundation (SNSF)); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This research has been supported by the Swiss National Foundation for Scientific Research (Grant 31003A_125150 to DF), the Bern University Research Foundation and the National Centre of Competence in Research (NCCR) TransCure. MJB was supported by a Canadian Institutes of Health Research (CIHR) fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baur R, 2006, FEBS LETT, V580, P1616, DOI 10.1016/j.febslet.2006.02.002; Bergeron MJ, 2006, J BIOL CHEM, V281, P15959, DOI 10.1074/jbc.M600015200; Bergeron MJ, 2009, J CELL PHYSIOL, V219, P787, DOI 10.1002/jcp.21725; Bergeron MJ, 2003, AM J PHYSIOL-RENAL, V285, pF68, DOI 10.1152/ajprenal.00032.2003; Fotiadis D, 2002, J MOL BIOL, V318, P1381, DOI 10.1016/S0022-2836(02)00143-2; Hogg RC, 2008, J NEUROSCI METH, V169, P65, DOI 10.1016/j.jneumeth.2007.11.028; Lee JK, 2010, CURR OPIN STRUC BIOL, V20, P464, DOI 10.1016/j.sbi.2010.05.004; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; MARKOVICH D, 2007, PROTOCOL EXCHANGE, DOI DOI 10.1038/NPROT.2007.1331; Quick M, 2002, P NATL ACAD SCI USA, V99, P8597, DOI 10.1073/pnas.132266599; Romero MF, 1998, METHOD ENZYMOL, V296, P17; Saxton WO, 1996, J STRUCT BIOL, V116, P230, DOI 10.1006/jsbi.1996.0035; Simard CF, 2007, J BIOL CHEM, V282, P18083, DOI 10.1074/jbc.M607811200; Theis S, 2001, PROTEIN EXPRES PURIF, V22, P436, DOI 10.1006/prep.2001.1455; Wagner CA, 2000, CELL PHYSIOL BIOCHEM, V10, P1, DOI 10.1159/000016341; WALZ T, 1994, EMBO J, V13, P2985, DOI 10.1002/j.1460-2075.1994.tb06597.x; WILEY HS, 1981, J BIOL CHEM, V256, P8626; Yang WB, 2002, J BIOL CHEM, V277, P38350, DOI 10.1074/jbc.M202052200	18	24	25	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2011	6	7							e21901	10.1371/journal.pone.0021901	http://dx.doi.org/10.1371/journal.pone.0021901			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791HI	21760919	Green Published, Green Submitted, gold			2022-12-27	WOS:000292655400025
J	Sheridan, R; Lampe, K; Shanmukhappa, SK; Putnam, P; Keddache, M; Divanovic, S; Bezerra, J; Hoebe, K				Sheridan, Rachel; Lampe, Kristin; Shanmukhappa, Shiva Kumar; Putnam, Patrick; Keddache, Mehdi; Divanovic, Senad; Bezerra, Jorge; Hoebe, Kasper			Lampe1: An ENU-Germline Mutation Causing Spontaneous Hepatosteatosis Identified through Targeted Exon-Enrichment and Next-Generation Sequencing	PLOS ONE			English	Article							ACYL-COA OXIDASE; ACTIVATED RECEPTOR-ALPHA; INFLAMMATORY RESPONSE; GENETIC-ANALYSIS; BETA-OXIDATION; PPAR-ALPHA; CELL-DEATH; MICE; LIVER; OBESITY	Using a small scale ENU mutagenesis approach we identified a recessive germline mutant, designated Lampe1 that exhibited growth retardation and spontaneous hepatosteatosis. Low resolution mapping based on 20 intercrossed Lampe1 mice revealed linkage to a similar to 14 Mb interval on the distal site of chromosome 11 containing a total of 285 genes. Exons and 50 bp flanking sequences within the critical region were enriched with sequence capture microarrays and subsequently analyzed by next-generation sequencing. Using this approach 98.1 percent of the targeted DNA was covered with a depth of 10 or more reads per nucleotide and 3 homozygote mutations were identified. Two mutations represented intronic nucleotide changes whereas one mutation affected a splice donor site in intron 11-12 of Palmitoyl Acetyl-coenzyme A oxygenase-1 (Acox1), causing skipping of exon 12. Phenotyping of Acox1(Lampe1) mutants revealed a progression from hepatosteatosis to steatohepatitis, and ultimately hepatocellular carcinoma. The current approach provides a highly efficient and affordable method to identify causative mutations induced by ENU mutagenesis and animal models relevant to human pathology.	[Sheridan, Rachel] Cincinnati Childrens Hosp Med Ctr, Dept Pathol & Lab Med, Cincinnati, OH USA; [Lampe, Kristin; Divanovic, Senad; Hoebe, Kasper] Cincinnati Childrens Hosp Res Fdn, Dept Mol Immunol, Cincinnati, OH USA; [Shanmukhappa, Shiva Kumar] Harvard Univ, New England Reg Primate Res Ctr, Sch Med, Div Comparat Med & Pathol, Southborough, MA 01772 USA; [Putnam, Patrick; Keddache, Mehdi] Cincinnati Childrens Hosp Res Fdn, Dept Human Genet, Cincinnati, OH USA; [Bezerra, Jorge] Cincinnati Childrens Hosp Res Fdn, Dept Gastroenterol Hepatol & Nutr, Cincinnati, OH USA	Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Research Foundation; Harvard University; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Research Foundation; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Research Foundation	Sheridan, R (corresponding author), Cincinnati Childrens Hosp Med Ctr, Dept Pathol & Lab Med, Cincinnati, OH USA.	kasper.hoebe@cchmc.org		Hoebe, Kasper/0000-0002-3626-8098; Sheridan, Rachel/0000-0002-8318-8920	NIH; NIH/NCI [00290411]; NIH/NIAID [00426912]; PHS (Integrative Morphology Core of the Cincinnati Digestive Disease Research Core Center) [P30 DK078392]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK078392] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); PHS (Integrative Morphology Core of the Cincinnati Digestive Disease Research Core Center)(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was funded by grants from the NIH, including NIH/NCI R21 Grant 00290411, NIH/NIAID RO1 Grant 00426912, and PHS Grant P30 DK078392 (Integrative Morphology Core of the Cincinnati Digestive Disease Research Core Center). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Competing Interests: The authors have declared that no	Barker DL, 2004, GENOME RES, V14, P901, DOI 10.1101/gr.1949704; Barnes MJ, 2010, J IMMUNOL, V184, P3743, DOI 10.4049/jimmunol.0903164; Barnes MJ, 2009, PLOS BIOL, V7, P513, DOI 10.1371/journal.pbio.1000051; Beutler B, 2004, NATURE, V430, P257, DOI 10.1038/nature02761; Beutler B, 2007, NAT IMMUNOL, V8, P659, DOI 10.1038/ni0707-659; Beutler B, 2006, ANNU REV IMMUNOL, V24, P353, DOI 10.1146/annurev.immunol.24.021605.090552; Bianchini F, 2002, LANCET ONCOL, V3, P565, DOI 10.1016/S1470-2045(02)00849-5; Caldwell SH, 2004, GASTROENTEROLOGY, V127, pS97, DOI 10.1053/j.gastro.2004.09.021; Calle EE, 2004, NAT REV CANCER, V4, P579, DOI 10.1038/nrc1408; Concepcion D, 2004, GENETICS, V168, P953, DOI 10.1534/genetics.104.029843; Devchand PR, 1996, NATURE, V384, P39, DOI 10.1038/384039a0; Fan CY, 1996, J BIOL CHEM, V271, P24698, DOI 10.1074/jbc.271.40.24698; Fan CY, 1998, J BIOL CHEM, V273, P15639, DOI 10.1074/jbc.273.25.15639; Fan CY, 1996, ANN NY ACAD SCI, V804, P530, DOI 10.1111/j.1749-6632.1996.tb18643.x; Gordon H, 1936, AM J PATHOL, V12, P545; GORDON H, 1936, AM J PATHOL, V12, P541; HARDWICK JP, 1987, J BIOL CHEM, V262, P801; Hashimoto T, 1999, J BIOL CHEM, V274, P19228, DOI 10.1074/jbc.274.27.19228; Hoebe Kasper, 2009, V517, P239, DOI 10.1007/978-1-59745-541-1_15; Hostetler HA, 2005, J BIOL CHEM, V280, P18667, DOI 10.1074/jbc.M412062200; Janssen E, 2006, IMMUNITY, V24, P787, DOI 10.1016/j.immuni.2006.03.024; Justice MJ, 2000, MAMM GENOME, V11, P484, DOI 10.1007/s003350010094; Kile BT, 2003, NATURE, V425, P81, DOI 10.1038/nature01865; Kim SO, 2003, J BIOL CHEM, V278, P7413, DOI 10.1074/jbc.M209279200; KLIEWER SA, 1992, NATURE, V355, P446, DOI 10.1038/355446a0; Kono H, 2010, J CLIN INVEST, V120, P1939, DOI 10.1172/JCI40124; Kurochkin IV, 2007, EMBO J, V26, P835, DOI 10.1038/sj.emboj.7601525; MIURA S, 1992, J BIOL CHEM, V267, P14405; Obeid M, 2007, NAT MED, V13, P54, DOI 10.1038/nm1523; Park EJ, 2010, CELL, V140, P197, DOI 10.1016/j.cell.2009.12.052; Rao MS, 2004, HEPATOLOGY, V40, P783, DOI 10.1002/hep.20453; REDDY JK, 1986, P NATL ACAD SCI USA, V83, P1747, DOI 10.1073/pnas.83.6.1747; Rock KL, 2010, ANNU REV IMMUNOL, V28, P321, DOI 10.1146/annurev-immunol-030409-101311; WANLESS IR, 1995, HEPATOLOGY, V22, P983, DOI 10.1002/hep.1840220341; Yeldandi AV, 2000, MUTAT RES-FUND MOL M, V448, P159, DOI 10.1016/S0027-5107(99)00234-1	35	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2011	6	7							e21979	10.1371/journal.pone.0021979	http://dx.doi.org/10.1371/journal.pone.0021979			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791HI	21760938	Green Submitted, Green Published, gold			2022-12-27	WOS:000292655400033
J	Gamfeldt, L; Hillebrand, H				Gamfeldt, Lars; Hillebrand, Helmut			Effects of Total Resources, Resource Ratios, and Species Richness on Algal Productivity and Evenness at Both Metacommunity and Local Scales	PLOS ONE			English	Article							PRODUCER DIVERSITY; DRIVE DIVERSITY; VICE-VERSA; BIODIVERSITY; HETEROGENEITY; MARINE; AVAILABILITY; COMPETITION; PHOSPHORUS; LIMITATION	The study of the interrelationship between productivity and biodiversity is a major research field in ecology. Theory predicts that if essential resources are heterogeneously distributed across a metacommunity, single species may dominate productivity in individual metacommunity patches, but a mixture of species will maximize productivity across the whole metacommunity. It also predicts that a balanced supply of resources within local patches should favor species coexistence, whereas resource imbalance would favor the dominance of one species. We performed an experiment with five freshwater algal species to study the effects of total supply of resources, their ratios, and species richness on biovolume production and evenness at the scale of both local patches and metacommunities. Generally, algal biovolume increased, whereas algal resource use efficiency (RUE) and evenness decreased with increasing total supply of resources in mixed communities containing all five species. In contrast to predictions for biovolume production, the species mixtures did not outperform all monocultures at the scale of metacommunities. In other words, we observed no general transgressive overyielding. However, RUE was always higher in mixtures than predicted from monocultures, and analyses indicate that resource partitioning or facilitation in mixtures resulted in higher-than-expected productivity at high resource supply. Contrasting our predictions for the local scale, balanced supply of resources did not generally favor higher local evenness, however lowest evenness was confined to patches with the most imbalanced supply. Thus, our study provides mixed support for recent theoretical advancements to understand biodiversity-productivity relationships.	[Gamfeldt, Lars; Hillebrand, Helmut] Univ Cologne, Inst Bot, D-5000 Cologne, Germany; [Gamfeldt, Lars] Univ Gothenburg, Dept Marine Ecol, Gothenburg, Sweden; [Hillebrand, Helmut] Carl von Ossietzky Univ Oldenburg, Inst Chem & Biol Marine Environm ICBM, D-26111 Oldenburg, Germany	University of Cologne; University of Gothenburg; Carl von Ossietzky Universitat Oldenburg	Gamfeldt, L (corresponding author), Univ Cologne, Inst Bot, Gyrhofstr 15, D-5000 Cologne, Germany.	lars.gamfeldt@marecol.gu.se	Hillebrand, Helmut/I-1717-2014	Hillebrand, Helmut/0000-0001-7449-1613	Swedish Research Council Formas [2006-1173]	Swedish Research Council Formas(Swedish Research CouncilSwedish Research Council Formas)	This work was supported by a postdoc grant (2006-1173) from the Swedish Research Council Formas (www.formas.se) to LG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAMS PA, 1995, ECOLOGY, V76, P2019, DOI 10.2307/1941677; Braakhekke WG, 1999, J VEG SCI, V10, P187, DOI 10.2307/3237140; Bruno JF, 2005, ECOL LETT, V8, P1165, DOI 10.1111/j.1461-0248.2005.00823.x; Bunker D.E., 2009, BIODIVERSITY ECOSYST; Cardinale BJ, 2011, AM J BOT, V98, P572, DOI 10.3732/ajb.1000364; Cardinale BJ, 2009, ECOLOGY, V90, P1227, DOI 10.1890/08-1038.1; Cardinale BJ, 2009, ECOL LETT, V12, P475, DOI 10.1111/j.1461-0248.2009.01317.x; Chase JM, 2010, SCIENCE, V328, P1388, DOI 10.1126/science.1187820; CURRIE DJ, 1991, AM NAT, V137, P27, DOI 10.1086/285144; Elser JJ, 2007, ECOL LETT, V10, P1135, DOI 10.1111/j.1461-0248.2007.01113.x; Gamfeldt L, 2005, ECOL LETT, V8, P696, DOI 10.1111/j.1461-0248.2005.00765.x; Gause G. F., 1934, STRUGGLE EXISTENCE; Griffin JN, 2009, OIKOS, V118, P1335, DOI 10.1111/j.1600-0706.2009.17572.x; Gross K, 2007, AM NAT, V170, P207, DOI 10.1086/518950; Guildford SJ, 2000, LIMNOL OCEANOGR, V45, P1213, DOI 10.4319/lo.2000.45.6.1213; Guillard R.R.L., 1975, CULTURE MARINE INVER, P29, DOI [10.1007/978-1-4615-8714-9_3, DOI 10.1007/978-1-4615-8714-9_3]; Hillebrand H, 1999, J PHYCOL, V35, P403, DOI 10.1046/j.1529-8817.1999.3520403.x; Hillebrand H, 2011, AM NATURALI IN PRESS; Hillebrand H, 2007, P NATL ACAD SCI USA, V104, P10904, DOI 10.1073/pnas.0701918104; Interlandi SJ, 2001, ECOLOGY, V82, P1270, DOI 10.2307/2679988; Kaiser J, 2000, SCIENCE, V289, P1282, DOI 10.1126/science.289.5483.1282; KANE TC, 1976, ECOLOGY, V57, P793, DOI 10.2307/1936192; Kolasa J., 1991, ECOLOGICAL HETEROGEN, V86, P1, DOI DOI 10.1007/978-1-4612-3062-5_1; Langenheder S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010834; Loreau M, 2001, NATURE, V412, P72, DOI 10.1038/35083573; Loreau M, 2001, SCIENCE, V294, P804, DOI 10.1126/science.1064088; Magurran A.E., 1988, ECOLOGICAL DIVERSITY; Matthiessen B, 2010, HYDROBIOLOGIA, V653, P65, DOI 10.1007/s10750-010-0349-x; MCQUAID CD, 1990, OECOLOGIA, V84, P142, DOI 10.1007/BF00665608; Mittelbach GG, 2001, ECOLOGY, V82, P2381, DOI 10.1890/0012-9658(2001)082[2381:WITORB]2.0.CO;2; Naeem S, 2002, ECOLOGY, V83, P2925; Ptacnik R, 2008, P NATL ACAD SCI USA, V105, P5134, DOI 10.1073/pnas.0708328105; Ptacnik R, 2010, ADV ECOL RES, V43, P1, DOI 10.1016/S0065-2504(10)43001-9; Quigg A, 2003, NATURE, V425, P291, DOI 10.1038/nature01953; REDFIELD AC, 1958, AM SCI, V46, P205; Replansky T, 2009, OIKOS, V118, P233, DOI 10.1111/j.1600-0706.2008.16948.x; Rosenzweig Michael L., 1993, P52; Salles JF, 2009, ECOLOGY, V90, P3324, DOI 10.1890/09-0188.1; Schmid B., 2009, BIODIVERSITY ECOSYST; Schnitzer SA, 2011, ECOLOGY, V92, P296, DOI 10.1890/10-0773.1; Sterner R.W., 2002, ECOLOGICAL STOICHIOM; Tilman D., 1982, Monographs in Population Biology, pi; TITMAN D, 1976, SCIENCE, V192, P463, DOI 10.1126/science.192.4238.463; Tiunov AV, 2005, ECOL LETT, V8, P618, DOI 10.1111/j.1461-0248.2005.00757.x; Trenbath B. R., 1974, Advances in Agronomy, V26, P177, DOI 10.1016/S0065-2113(08)60871-8; Tylianakis JM, 2008, PLOS BIOL, V6, P947, DOI 10.1371/journal.pbio.0060122; Venail PA, 2008, NATURE, V452, P210, DOI 10.1038/nature06554; Waide RB, 1999, ANNU REV ECOL SYST, V30, P257, DOI 10.1146/annurev.ecolsys.30.1.257; Weis JJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002825; Zhang QG, 2006, OIKOS, V114, P385, DOI 10.1111/j.2006.0030-1299.14723.x	50	28	28	0	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2011	6	7							e21972	10.1371/journal.pone.0021972	http://dx.doi.org/10.1371/journal.pone.0021972			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791AK	21755016	gold, Green Submitted, Green Published			2022-12-27	WOS:000292632000043
J	Henningsson, F; Ding, ZJ; Dahlin, JS; Linkevicius, M; Carlsson, F; Gronvik, KO; Hallgren, J; Heyman, B				Henningsson, Frida; Ding, Zhoujie; Dahlin, Joakim S.; Linkevicius, Marius; Carlsson, Fredrik; Gronvik, Kjell-Olov; Hallgren, Jenny; Heyman, Birgitta			IgE-Mediated Enhancement of CD4(+) T Cell Responses in Mice Requires Antigen Presentation by CD11c(+) Cells and Not by B Cells	PLOS ONE			English	Article							LOW-AFFINITY RECEPTOR; IN-VIVO; ANTIBODY-RESPONSES; PRESENTING CELLS; DENDRITIC CELLS; MARGINAL ZONE; IMMUNE-COMPLEXES; IMMUNOGLOBULIN-E; CD23; COMPLEMENT	IgE antibodies, administered to mice together with their specific antigen, enhance antibody and CD4(+) T cell responses to this antigen. The effect is dependent on the low affinity receptor for IgE, CD23, and the receptor must be expressed on B cells. In vitro, IgE-antigen complexes are endocytosed via CD23 on B cells, which subsequently present the antigen to CD4(+) T cells. This mechanism has been suggested to explain also IgE-mediated enhancement of immune responses in vivo. We recently found that CD23(+) B cells capture IgE-antigen complexes in peripheral blood and rapidly transport them to B cell follicles in the spleen. This provides an alternative explanation for the requirement for CD23(+) B cells. The aim of the present study was to determine whether B-cell mediated antigen presentation of IgE-antigen complexes explains the enhancing effect of IgE on immune responses in vivo. The ability of spleen cells, taken from mice 1-4 h after immunization with IgE-antigen, to present antigen to specific CD4(+) T cells was analyzed. Antigen presentation was intact when spleens were depleted of CD19(+) cells (i.e., primarily B cells) but was severely impaired after depletion of CD11c(+) cells (i.e., primarily dendritic cells). In agreement with this, the ability of IgE to enhance proliferation of CD4(+) T cells was abolished in CD11c-DTR mice conditionally depleted of CD11c(+) cells. Finally, the lack of IgE-mediated enhancemen of CD4(+) T cell responses in CD23(-/-) mice could be rescued by transfer of MHC-II-compatible as well as by MHC-II-incompatible CD23(+) B cells. These findings argue against the idea that IgE-mediated enhancement of specific CD4(+) T cell responses in vivo is caused by increased antigen presentation by B cells. A model where CD23(+) B cells act as antigen transporting cells, delivering antigen to CD11c(+) cells for presentation to T cells is consistent with available experimental data.	[Henningsson, Frida; Ding, Zhoujie; Dahlin, Joakim S.; Linkevicius, Marius; Gronvik, Kjell-Olov; Hallgren, Jenny; Heyman, Birgitta] Uppsala Univ, BMC, Dept Med Biochem & Microbiol, Uppsala, Sweden; [Carlsson, Fredrik] Uppsala Univ, Dept Immunol Pathol & Genet, Uppsala, Sweden; [Gronvik, Kjell-Olov] Natl Vet Inst, S-75007 Uppsala, Sweden	Uppsala University; Uppsala University; National Veterinary Institute SVA	Henningsson, F (corresponding author), Uppsala Univ, BMC, Dept Med Biochem & Microbiol, Uppsala, Sweden.	birgitta.heyman@imbim.uu.se	Hallgren Martinsson, Jenny/AAZ-5937-2021; Dahlin, Joakim/J-1057-2019; Hallgren Martinsson, Jenny/AAZ-6356-2021	Hallgren Martinsson, Jenny/0000-0002-3685-5364; Dahlin, Joakim/0000-0003-3007-9875; Heyman, Birgitta/0000-0003-0869-0483; Linkevicius, Marius/0000-0001-5760-2721; Ding, Zhoujie/0000-0001-8765-8814	Swedish Research Council; King Gustaf V:s 80 Years Foundation; Ellen, Walter and Lennart Hesselman's Foundation; Hans von Kantzow's Foundation; Ollie and Elof Ericsson's Foundation; Linne Foundation; Ake Wiberg Foundation; Magnus Bergvall Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); King Gustaf V:s 80 Years Foundation; Ellen, Walter and Lennart Hesselman's Foundation; Hans von Kantzow's Foundation; Ollie and Elof Ericsson's Foundation; Linne Foundation; Ake Wiberg Foundation; Magnus Bergvall Foundation	This work was supported by grants from the Swedish Research Council (www.vr.se); King Gustaf V:s 80 Years Foundation (ams.orbelon.com/gv80/); Ellen, Walter and Lennart Hesselman's Foundation; Hans von Kantzow's Foundation; Ollie and Elof Ericsson's Foundation (oestiftelse.se/); Linne Foundation; Ake Wiberg Foundation (www.ake-wiberg.com/); and Magnus Bergvall Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attanavanich K, 2004, J IMMUNOL, V172, P803, DOI 10.4049/jimmunol.172.2.803; Bar-On L, 2010, METHODS MOL BIOL, V595, P429, DOI 10.1007/978-1-60761-421-0_28; Bergtold A, 2005, IMMUNITY, V23, P503, DOI 10.1016/j.immuni.2005.09.013; Boackle SA, 1997, EUR J IMMUNOL, V27, P122, DOI 10.1002/eji.1830270119; Bowman J M, 1988, Transfus Med Rev, V2, P129, DOI 10.1016/S0887-7963(88)70039-5; Carlsson F, 2007, SCAND J IMMUNOL, V66, P261, DOI 10.1111/j.1365-3083.2007.01953.x; Carlsson F, 2009, SCAND J IMMUNOL, V70, P77, DOI 10.1111/j.1365-3083.2009.02274.x; Cherukuri A, 2001, J IMMUNOL, V167, P163, DOI 10.4049/jimmunol.167.1.163; Cinamon G, 2008, NAT IMMUNOL, V9, P54, DOI 10.1038/ni1542; CLARKE C A, 1963, Br Med J, V1, P979; CONSTANT S, 1995, J IMMUNOL, V155, P3734; Constant SL, 1999, J IMMUNOL, V162, P5695; Crawford A, 2006, J IMMUNOL, V176, P3498, DOI 10.4049/jimmunol.176.6.3498; de Stahl TD, 2003, J EXP MED, V197, P1183, DOI 10.1084/jem.20022232; DIERKS SE, 1993, J IMMUNOL, V150, P2372; EYNON EE, 1992, J EXP MED, V175, P131, DOI 10.1084/jem.175.1.131; Ferguson AR, 2004, INT IMMUNOL, V16, P1411, DOI 10.1093/intimm/dxh142; Ford JW, 2009, CELL IMMUNOL, V254, P124, DOI 10.1016/j.cellimm.2008.08.003; FUCHS EJ, 1992, SCIENCE, V258, P1156, DOI 10.1126/science.1439825; FUJIWARA H, 1994, P NATL ACAD SCI USA, V91, P6835, DOI 10.1073/pnas.91.15.6835; Getahun A, 2005, J IMMUNOL, V175, P1473, DOI 10.4049/jimmunol.175.3.1473; Good A., 1980, SELECTED METHODS CEL, P343; Griffith QK, 2011, J IMMUNOL, V186, P1060, DOI 10.4049/jimmunol.1002709; Gustavsson S, 2000, J IMMUNOL, V164, P3990, DOI 10.4049/jimmunol.164.8.3990; GUSTAVSSON S, 1994, J IMMUNOL, V152, P4793; HASKINS K, 1983, J EXP MED, V157, P1149, DOI 10.1084/jem.157.4.1149; HEYMAN B, 1988, J EXP MED, V167, P1999, DOI 10.1084/jem.167.6.1999; HEYMAN B, 1993, EUR J IMMUNOL, V23, P1739, DOI 10.1002/eji.1830230754; Heyman B, 2000, ANNU REV IMMUNOL, V18, P709, DOI 10.1146/annurev.immunol.18.1.709; Hjelm F, 2008, J IMMUNOL, V180, P6604, DOI 10.4049/jimmunol.180.10.6604; HJULSTROM S, 1995, EUR J IMMUNOL, V25, P1469, DOI 10.1002/eji.1830250552; Huang NN, 2005, J IMMUNOL, V175, P7125, DOI 10.4049/jimmunol.175.11.7125; Jenkins MK, 2001, ANNU REV IMMUNOL, V19, P23, DOI 10.1146/annurev.immunol.19.1.23; Jung S, 2002, IMMUNITY, V17, P211, DOI 10.1016/S1074-7613(02)00365-5; Karlsson MCI, 2001, J IMMUNOL, V167, P5558, DOI 10.4049/jimmunol.167.10.5558; Karlsson MCI, 1999, P NATL ACAD SCI USA, V96, P2244, DOI 10.1073/pnas.96.5.2244; KEHRY MR, 1989, P NATL ACAD SCI USA, V86, P7556, DOI 10.1073/pnas.86.19.7556; Lewis G, 2004, IMMUNOGENETICS, V56, P564, DOI 10.1007/s00251-004-0728-4; Lindquist RL, 2004, NAT IMMUNOL, V5, P1243, DOI 10.1038/ni1139; MAEDA K, 1992, J IMMUNOL, V148, P2340; Mathews JA, 2010, J BIOL CHEM, V285, P37531, DOI 10.1074/jbc.M110.141556; McGreal EP, 2005, CURR OPIN IMMUNOL, V17, P18, DOI 10.1016/j.coi.2004.12.001; Milich DR, 1997, P NATL ACAD SCI USA, V94, P14648, DOI 10.1073/pnas.94.26.14648; MURPHY KM, 1990, SCIENCE, V250, P1720, DOI 10.1126/science.2125367; Mwinzi PNM, 2009, J INFECT DIS, V199, P272, DOI 10.1086/595792; Palaniyandi S, 2011, J IMMUNOL, V186, P3484, DOI 10.4049/jimmunol.1002146; Payet ME, 1999, J IMMUNOL, V163, P217; PIRRON U, 1990, EUR J IMMUNOL, V20, P1547, DOI 10.1002/eji.1830200721; RAO M, 1987, J IMMUNOL, V138, P1845; Rechavi O, 2009, FEBS LETT, V583, P1792, DOI 10.1016/j.febslet.2009.03.014; RONCHESE F, 1993, J EXP MED, V177, P679, DOI 10.1084/jem.177.3.679; RUDOLPH AK, 1981, EUR J IMMUNOL, V11, P527, DOI 10.1002/eji.1830110617; SANTAMARIA LF, 1993, HUM IMMUNOL, V37, P23, DOI 10.1016/0198-8859(93)90139-R; THORNTON BP, 1994, J IMMUNOL, V152, P1727; Tu Y, 2005, GASTROENTEROLOGY, V129, P928, DOI 10.1053/j.gastro.2005.06.014; VANDERHEIJDEN FL, 1993, J IMMUNOL, V150, P3643; von Behring E., 1892, Z HYG INFEKTIONSKR, V12, P10; Wernersson S, 1999, J IMMUNOL, V163, P618; Westman S, 1997, SCAND J IMMUNOL, V46, P10, DOI 10.1046/j.1365-3083.1997.d01-89.x; Yang PC, 2000, J CLIN INVEST, V106, P879, DOI 10.1172/JCI9258; Youd ME, 2002, EUR J IMMUNOL, V32, P2328, DOI 10.1002/1521-4141(200208)32:8<2328::AID-IMMU2328>3.0.CO;2-T; Yu LCH, 2003, AM J PHYSIOL-GASTR L, V285, pG223, DOI 10.1152/ajpgi.00445.2002; YU P, 1994, NATURE, V369, P753, DOI 10.1038/369753a0	63	29	30	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2011	6	7							e21760	10.1371/journal.pone.0021760	http://dx.doi.org/10.1371/journal.pone.0021760			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791AK	21765910	Green Submitted, Green Published, gold			2022-12-27	WOS:000292632000024
J	Mutevedzi, PC; Lessells, RJ; Rodger, AJ; Newell, ML				Mutevedzi, Portia C.; Lessells, Richard J.; Rodger, Alison J.; Newell, Marie-Louise			Association of Age with Mortality and Virological and Immunological Response to Antiretroviral Therapy in Rural South African Adults	PLOS ONE			English	Article							RECONSTITUTION INFLAMMATORY SYNDROME; HIV-INFECTION; OLDER-ADULTS; HIGH-RATES; FOLLOW-UP; SCALE-UP; PROGRAM; INCOME; SEROCONVERSION; PREVALENCE	Objective: To assess whether treatment outcomes vary with age for adults receiving antiretroviral therapy (ART) in a large rural HIV treatment cohort. Design: Retrospective cohort analysis using data from a public HIV Treatment & Care Programme. Methods: Adults initiating ART 1(st) August 2004 - 31(st) October 2009 were stratified by age at initiation: young adults (16-24 years) mid-age adults (25-49 years) and older (>= 50 years) adults. Kaplan-Meier survival analysis was used to estimate mortality rates and age and person-time stratified Cox regression to determine factors associated with mortality. Changes in CD4 cell counts were quantified using a piecewise linear model based on follow-up CD4 cell counts measured at six-monthly time points. Results: 8846 adults were included, 808 (9.1%) young adults; 7119 (80.5%) mid-age adults and 919 (10.4%) older adults, with 997 deaths over 14,778 person-years of follow-up. Adjusting for baseline characteristics, older adults had 32% excess mortality (p = 0.004) compared to those aged 25-49 years. Overall mortality rates (MR) per 100 person-years were 6.18 (95% CI 4.90-7.78); 6.55 (95% CI 6.11-7.02) and 8.69 (95% CI 7.34-10.28) for young, mid-age and older adults respectively. In the first year on ART, for older compared to both young and mid-aged adults, MR per 100 person-years were significantly higher; 0-3 months (MR: 27.1 vs 17.17 and 21.36) and 3-12 months (MR: 9.5 vs 4.02 and 6.02) respectively. CD4 count reconstitution was lower, despite better virological response in the older adults. There were no significant differences in MR after 1year of ART. Baseline markers of advanced disease were independently associated with very early mortality (0-3 months) whilst immunological and virological responses were associated with mortality after 12months. Conclusions: Early ART initiation and improving clinical care of older adults are required to reduce high early mortality and enhance immunologic recovery, particularly in the initial phases of ART.	[Mutevedzi, Portia C.; Lessells, Richard J.; Newell, Marie-Louise] Univ KwaZulu Natal, Africa Ctr Hlth & Populat Studies, Somkhele, South Africa; [Mutevedzi, Portia C.; Rodger, Alison J.] UCL, Dept Infect & Populat Hlth, London, England; [Lessells, Richard J.] London Sch Hyg & Trop Med, Fac Infect & Trop Dis, London WC1, England; [Newell, Marie-Louise] UCL, Inst Child Hlth, London, England	University of Kwazulu Natal; University of London; University College London; University of London; London School of Hygiene & Tropical Medicine; University of London; University College London	Mutevedzi, PC (corresponding author), Univ KwaZulu Natal, Africa Ctr Hlth & Populat Studies, Somkhele, South Africa.	pmutevedzi@africacentre.ac.za	Newell, Marie-Louise/AAE-8222-2019	Newell, Marie-Louise/0000-0002-1074-7699; Lessells, Richard/0000-0003-0926-710X	Wellcome Trust [082384/Z/07/Z]; United States Agency for International Development (USAID); President's Emergency Plan (PEPFAR) [674-A-00-08-00001-00]	Wellcome Trust(Wellcome Trust); United States Agency for International Development (USAID)(United States Agency for International Development (USAID)CGIAR); President's Emergency Plan (PEPFAR)(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	The Africa Centre for Health and Population Studies is funded by a core grant from the Wellcome Trust (Grant number 082384/Z/07/Z) [www.wellcome.ac.uk]. The Hlabisa HIV Treatment and Care Programme receives support through the United States Agency for International Development (USAID) and the President's Emergency Plan (PEPFAR) under the terms of Award No. 674-A-00-08-00001-00. The opinions expressed herein are those of the authors and do not necessarily reflect the view of the USAID or the United States Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babiker AG, 2001, J CLIN EPIDEMIOL, V54, pS16, DOI 10.1016/S0895-4356(01)00456-5; Bakanda C, 2011, AIDS, V25, P701, DOI 10.1097/QAD.0b013e3283437ed7; Boulle A, 2008, B WORLD HEALTH ORGAN, V86, P678, DOI 10.2471/BLT.07.045294; Braitstein P, 2006, LANCET, V367, P817, DOI 10.1016/S0140-6736(06)68337-2; Brinkhof MWG, 2008, B WORLD HEALTH ORGAN, V86, P559, DOI 10.2471/BLT.07.044248; Brinkhof MWG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005790; Brinkhof MWG, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000066; Castelnuovo B, 2009, CLIN INFECT DIS, V49, P965, DOI 10.1086/605500; Collaboration of Observational HIV Epidemiological Research Europe (COHERE) Study Group, 2008, AIDS, V22, P1463, DOI 10.1097/QAD.0b013e3282f88d02; *DEP HLTH, 2004, NAT ANT TREATM GUID; Etard JF, 2006, AIDS, V20, P1181, DOI 10.1097/01.aids.0000226959.87471.01; Fairall LR, 2008, ARCH INTERN MED, V168, P86, DOI 10.1001/archinternmed.2007.10; Franey C, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-143; Gebo Kelly A, 2008, Aging health, V4, P615, DOI 10.2217/1745509X.4.6.615; Glynn JR, 2007, AIDS, V21, P625, DOI 10.1097/QAD.0b013e328017f857; Grabar S, 2004, AIDS, V18, P2029, DOI 10.1097/00002030-200410210-00007; Grabar S, 2006, J ANTIMICROB CHEMOTH, V57, P4, DOI 10.1093/jac/dki411; GRAMBSCH PM, 1994, BIOMETRIKA, V81, P515; Greenbaum AH, 2008, AIDS, V22, P2331, DOI 10.1097/QAD.0b013e32831883f9; Houlihan CF, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-23; HOULIHAN CF, 2010, INT J EPIDEMIOL 0212; Lawn SD, 2005, AIDS, V19, P2141, DOI 10.1097/01.aids.0000194802.89540.e1; Lawn SD, 2006, CLIN INFECT DIS, V43, P770, DOI 10.1086/507095; Lawn SD, 2010, CURR OPIN HIV AIDS, V5, P18, DOI 10.1097/COH.0b013e328333850f; Lawn SD, 2009, AIDS, V23, P335, DOI 10.1097/QAD.0b013e328321823f; LESSELLS RJ, 2010, J ACQUIR IM IN PRESS; Levey Andrew S., 2000, Journal of the American Society of Nephrology, V11, p155A; MacPherson P, 2009, T ROY SOC TROP MED H, V103, P588, DOI 10.1016/j.trstmh.2008.10.001; May M, 2009, J INFECT DIS, V200, P1729, DOI 10.1086/648096; Muller M, 2010, LANCET INFECT DIS, V10, P251, DOI 10.1016/S1473-3099(10)70026-8; Mutevedzi PC, 2010, B WORLD HEALTH ORGAN, V88, P593, DOI 10.2471/BLT.09.069419; Negin J, 2010, B WORLD HEALTH ORGAN, V88, P847, DOI 10.2471/BLT.10.076349; Negin J, 2010, JAIDS-J ACQ IMM DEF, V55, P239, DOI 10.1097/QAI.0b013e3181e9b3f2; Nguyen N, 2008, CLIN INTERV AGING, V3, P453; Nogueras M, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-159; Patterson K, 2007, HIV MED, V8, P406, DOI 10.1111/j.1468-1293.2007.00485.x; Sabin CA, 2004, AIDS, V18, P2145, DOI 10.1097/00002030-200411050-00006; Schmid GP, 2009, B WORLD HEALTH ORGAN, V87, P162, DOI 10.2471/BLT.09.064030; Silverberg MJ, 2007, ARCH INTERN MED, V167, P684, DOI 10.1001/archinte.167.7.684; Smith RD, 2010, AIDS, V24, P2109, DOI 10.1097/QAD.0b013e32833c7b9c; Stringer JSA, 2006, JAMA-J AM MED ASSOC, V296, P782, DOI 10.1001/jama.296.7.782; Todd J, 2007, AIDS, V21, pS55, DOI 10.1097/01.aids.0000299411.75269.e8; Toure S, 2008, AIDS, V22, P873, DOI 10.1097/QAD.0b013e3282f768f8; Tuboi SH, 2010, JAIDS-J ACQ IMM DEF, V53, P70, DOI 10.1097/QAI.0b013e3181c22d19; *UNAIDS, 2006, UND LAT EST 2006 REP; *UNAIDS, 2008, REP GLOB HIV AIDS EP; Van der Paal L, 2007, AIDS, V21, pS21, DOI 10.1097/01.aids.0000299407.52399.05; van Deventer HE, 2008, CLIN CHEM, V54, P1197, DOI 10.1373/clinchem.2007.099085; WALLRAUCH C, 2010, S AFR MED J IN PRESS; Welz T, 2007, AIDS, V21, P1467, DOI 10.1097/QAD.0b013e3280ef6af2; Zwahlen M, 2008, SEX TRANSM INFECT, V84, pI31, DOI 10.1136/sti.2008.029793	51	79	81	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2011	6	7							e21795	10.1371/journal.pone.0021795	http://dx.doi.org/10.1371/journal.pone.0021795			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786HC	21747959	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000292293400035
J	Eugster, MR; Loessner, MJ				Eugster, Marcel R.; Loessner, Martin J.			Rapid Analysis of Listeria monocytogenes Cell Wall Teichoic Acid Carbohydrates by ESI-MS/MS	PLOS ONE			English	Article							GRAM-POSITIVE BACTERIA; LIPOTEICHOIC ACID; N-ACETYLGLUCOSAMINE; PEPTIDOGLYCAN; SURFACE; MUREIN; BIOSYNTHESIS; BIOCHEMISTRY; NUCLEOTIDES; PHYSIOLOGY	We report the application of electrospray ionization (ESI) mass spectrometry for compositional characterization of wall teichoic acids (WTA), a major component of Gram-positive bacterial cell walls. Tandem mass spectrometry (ESI-MS/MS) of purified and chemically hydrolyzed monomeric WTA components provided sufficient information to identify WTA monomers and their specific carbohydrate constituents. A lithium matrix was used for ionization of uncharged WTA monomers, and successfully applied to analyze the WTA molecules of four Listeria strains differing in carbohydrate substitution on a conserved polyribitol-phosphate backbone structure. Carbohydrate residues such as N-acetylglucosamine or rhamnose linked to the WTA could directly be identified by ESI-MS/MS, circumventing the need for quantitative analysis by gas chromatography. The presence of a terminal N-acetylglucosamine residue tethered to the ribitol was confirmed using fluorescently labeled wheat-germ agglutinin. In conclusion, the mass spectrometry method described here will greatly facilitate compositional analysis and characterization of teichoic acids and similar macromolecules from diverse bacterial species, and represents a significant advance in the identification of serovar-specific carbohydrates and sugar molecules on bacteria.	[Eugster, Marcel R.; Loessner, Martin J.] ETH, Inst Food Nutr & Hlth, Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Eugster, MR (corresponding author), ETH, Inst Food Nutr & Hlth, Zurich, Switzerland.	martin.loessner@ethz.ch	Loessner, Martin J/B-4316-2012	Loessner, Martin J/0000-0002-8162-2631	ETH Zurich	ETH Zurich(ETH Zurich)	This work was funded by ETH Zurich. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abachin E, 2002, MOL MICROBIOL, V43, P1, DOI 10.1046/j.1365-2958.2002.02723.x; Ames B. N., 1966, METHOD ENZYMOL, P115, DOI DOI 10.1016/0076-6879(66)08014-5; ARAKI Y, 1989, CRIT REV MICROBIOL, V17, P121, DOI 10.3109/10408418909105745; ARMSTRONG JJ, 1958, NATURE, V181, P1692, DOI 10.1038/1811692a0; Baddiley J, 1972, Essays Biochem, V8, P35; CHEN PS, 1956, ANAL CHEM, V28, P1756, DOI 10.1021/ac60119a033; Cheng Y, 2008, APPL ENVIRON MICROB, V74, P1653, DOI 10.1128/AEM.01773-07; Fedtke I, 2007, MOL MICROBIOL, V65, P1078, DOI 10.1111/j.1365-2958.2007.05854.x; FIEDLER F, 1983, SYST APPL MICROBIOL, V4, P444, DOI 10.1016/S0723-2020(83)80002-2; FIEDLER F, 1988, INFECTION, V16, pS92, DOI 10.1007/BF01639729; FIEDLER F, 1984, SYST APPL MICROBIOL, V5, P360, DOI 10.1016/S0723-2020(84)80038-7; FIEDLER F, 1981, ARCH MICROBIOL, V129, P85, DOI 10.1007/BF00417186; FIEDLER F, 1987, B I PASTEUR, V85, P287; FISCHER W, 1988, ADV MICROB PHYSIOL, V29, P233, DOI 10.1016/S0065-2911(08)60349-5; Fischer W, 1994, BACTERIAL CELL WALL, P199; FUJII H, 1985, J BIOCHEM-TOKYO, V97, P883, DOI 10.1093/oxfordjournals.jbchem.a135130; GLASER L, 1964, J BIOL CHEM, V239, P3187; KAMISANGO K, 1983, J BIOCHEM-TOKYO, V93, P1401, DOI 10.1093/oxfordjournals.jbchem.a134275; KAYA S, 1985, EUR J BIOCHEM, V147, P41, DOI 10.1111/j.1432-1033.1985.tb08715.x; KOJIMA N, 1983, J BIOL CHEM, V258, P9043; LIPKIN D, 1969, J ORG CHEM, V34, P1539, DOI 10.1021/jo01258a003; LOESSNER MJ, 1990, APPL ENVIRON MICROB, V56, P1912, DOI 10.1128/AEM.56.6.1912-1918.1990; Loessner MJ, 2002, MOL MICROBIOL, V44, P335, DOI 10.1046/j.1365-2958.2002.02889.x; Naumova IB, 2001, FEMS MICROBIOL REV, V25, P269, DOI 10.1016/S0168-6445(00)00064-4; Navarre WW, 1999, MICROBIOL MOL BIOL R, V63, P174, DOI 10.1128/MMBR.63.1.174-229.1999; Neuhaus FC, 2003, MICROBIOL MOL BIOL R, V67, P686, DOI 10.1128/MMBR.67.4.686-723.2003; PEREGO M, 1995, J BIOL CHEM, V270, P15598, DOI 10.1074/jbc.270.26.15598; Peschel A, 1999, J BIOL CHEM, V274, P8405, DOI 10.1074/jbc.274.13.8405; Seo HS, 2008, J BACTERIOL, V190, P2379, DOI 10.1128/JB.01795-07; Swoboda JG, 2010, CHEMBIOCHEM, V11, P35, DOI 10.1002/cbic.200900557; Tran HL, 1999, APPL ENVIRON MICROB, V65, P4793; UCHIKAWA KI, 1986, J BIOCHEM-TOKYO, V99, P315, DOI 10.1093/oxfordjournals.jbchem.a135486; ULLMANN WW, 1969, J BACTERIOL, V98, P486, DOI 10.1128/JB.98.2.486-493.1969; VALYASEVI R, 1990, APPL ENVIRON MICROB, V56, P1882, DOI 10.1128/AEM.56.6.1882-1889.1990; Weidenmaier C, 2004, NAT MED, V10, P243, DOI 10.1038/nm991; Weidenmaier C, 2008, NAT REV MICROBIOL, V6, P276, DOI 10.1038/nrmicro1861; Wendlinger G, 1996, MICROBIOL-UK, V142, P985, DOI 10.1099/00221287-142-4-985; WRIGHT CS, 1984, J MOL BIOL, V178, P91, DOI 10.1016/0022-2836(84)90232-8; Xia G, 2008, CHEM BIOL, V15, P95, DOI 10.1016/j.chembiol.2008.02.005	39	26	27	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2011	6	6							e21500	10.1371/journal.pone.0021500	http://dx.doi.org/10.1371/journal.pone.0021500			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786GP	21738682	Green Published, gold, Green Submitted			2022-12-27	WOS:000292291800017
J	Lee, PH; Kim, HS; Lee, JE; Choi, Y; Hong, JY; Nam, HS; Sohn, YH; Kim, HO				Lee, Phil Hyu; Kim, Han-Soo; Lee, Ji E.; Choi, Youjeong; Hong, Jin Yong; Nam, Hyo Suk; Sohn, Young H.; Kim, Hyun Ok			Comparison of Endothelial Progenitor Cells in Parkinson's Disease Patients Treated with Levodopa and Levodopa/COMT Inhibitor	PLOS ONE			English	Article							PLASMA HOMOCYSTEINE LEVELS; STROKE; NUMBER	Background: Levodopa treatment in Parkinson's disease (PD) increases in serum homocysteine levels due to its metabolism via catechol O-methyltransferase. Endothelial progenitor cells (EPCs) have the capacity to differentiate into mature endothelial cells and are markers for endothelial functions and cardiovascular risks. Along with traditional vascular risk factors, hyperhomocysteinemia is known to decrease the level of EPCs. In the present study, we hypothesized that that levodopa-induced hyperhomocysteinemia leads to a change in EPC levels. Methodology/Principal Findings: We prospectively enrolled PD patients who had been prescribed either levodopa/carbidopa (PD-L group, n=28) or levodopa/carbidopa/COMT inhibitor (PD-LC group, n=25) for more than 1 year. The number of circulating EPCs was measured by flow cytometry using dual staining of anti-CD34 and anti-KDR antibodies. The EPCs were divided into tertiles based on their distributions and a logistic regression analysis was used to estimate independent predictors of the highest tertile of EPCs. The number of endothelial progenitor cells was significantly decreased in PD-L patients (118+/-99/mL) compared with either PD-LC patients (269+/-258/mL, p=0.007) or controls (206+/-204/mL, p=0.012). The level of homocysteine was significantly increased in PD-L patients (14.9+/-5.3 mu mol/L) compared with either PD-LC patients (11.9+/-3.0 mmol/L, p=0.028) or controls (11.1+/-2.5 mmol/L, p=0.012). The level of homocysteine was negatively correlated with endothelial progenitor cell levels (r=-0.252, p=0.028) and was an independent predictor of the highest tertile of endothelial progenitor cell levels (OR; 0.749 [95% CI: 0.584-0.961]). Conclusions/Significance: These data indicate that a higher consumption of EPC for restoration of endothelial damage may be associated with chronic levodopa treatment in PD patients.	[Lee, Phil Hyu; Lee, Ji E.; Hong, Jin Yong; Nam, Hyo Suk; Sohn, Young H.] Yonsei Univ, Coll Med, Dept Neurol, Seoul, South Korea; [Lee, Phil Hyu; Lee, Ji E.; Hong, Jin Yong; Nam, Hyo Suk; Sohn, Young H.] Yonsei Univ, Coll Med, Brain Res Inst, Seoul, South Korea; [Kim, Han-Soo; Choi, Youjeong; Kim, Hyun Ok] Yonsei Univ, Coll Med, Dept Lab Med, Seoul, South Korea; [Kim, Han-Soo; Choi, Youjeong; Kim, Hyun Ok] Yonsei Univ, Coll Med, Yonsei Cell Therapy Ctr, Seoul, South Korea; [Lee, Phil Hyu] Yonsei Univ, Severance Biomed Sci Inst, Seoul 120749, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University	Lee, PH (corresponding author), Yonsei Univ, Coll Med, Dept Neurol, Seoul, South Korea.	phisland@chol.com; hyunok1019@yuhs.ac		Hong, Jin Yong/0000-0002-2476-3737; NAM, HYO SUK/0000-0002-4415-3995; Kim, Hyun Ok/0000-0002-4964-1963; Lee, Phil Hyu/0000-0001-9931-8462; Sohn, Young H./0000-0001-6533-2610	Ministry for Health, Welfare & Family Affairs, Republic of Korea [A091159]	Ministry for Health, Welfare & Family Affairs, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea)	This study was supported by a grant of the Korea Healthcare technology R&D Project, Ministry for Health, Welfare & Family Affairs, Republic of Korea (A091159). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam MM, 2009, J CEREBR BLOOD F MET, V29, P157, DOI 10.1038/jcbfm.2008.99; Chen JZ, 2004, J MOL CELL CARDIOL, V36, P233, DOI 10.1016/j.yjmcc.2003.10.005; Diaz-Arrastia R, 2000, ARCH NEUROL-CHICAGO, V57, P1422, DOI 10.1001/archneur.57.10.1422; FROSST P, 1995, NAT GENET, V10, P111, DOI 10.1038/ng0595-111; Hill JM, 2003, NEW ENGL J MED, V348, P593, DOI 10.1056/NEJMoa022287; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; Ingram DA, 2005, BLOOD, V106, P1525, DOI 10.1182/blood-2005-04-1509; Jickling G, 2009, STROKE, V40, P3191, DOI 10.1161/STROKEAHA.109.554527; Lamberti P, 2005, MOVEMENT DISORD, V20, P69, DOI 10.1002/mds.20261; Lorenzen J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011477; Muller T, 2004, ARCH NEUROL-CHICAGO, V61, P657, DOI 10.1001/archneur.61.5.657; Nakaso K, 2003, J NEUROL SCI, V207, P19, DOI 10.1016/S0022-510X(02)00353-2; Nanhoe-Mahabier W, 2009, NAT REV NEUROL, V5, P533, DOI 10.1038/nrneurol.2009.136; Postuma RB, 2004, NEUROLOGY, V63, P886, DOI 10.1212/01.WNL.0000137886.74175.5A; Rogers JD, 2003, ARCH NEUROL-CHICAGO, V60, P59, DOI 10.1001/archneur.60.1.59; Rouhl RPW, 2008, STROKE, V39, P2158, DOI 10.1161/STROKEAHA.107.507251; Shin JW, 2005, YONSEI MED J, V46, P260, DOI 10.3349/ymj.2005.46.2.260; Valkovic P, 2005, PARKINSONISM RELAT D, V11, P253, DOI 10.1016/j.parkreldis.2005.01.007; Verma S, 2002, CIRCULATION, V105, P546, DOI 10.1161/hc0502.104540; Werner N, 2005, NEW ENGL J MED, V353, P999, DOI 10.1056/NEJMoa043814; Yoder MC, 2007, BLOOD, V109, P1801, DOI 10.1182/blood-2006-08-043471; Yong SW, 2010, PARKINSONISM RELAT D, V16, P225, DOI 10.1016/j.parkreldis.2009.09.003; Zhu JH, 2006, ARCH MED RES, V37, P484, DOI 10.1016/j.arcmed.2005.09.017	23	4	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2011	6	6							e21536	10.1371/journal.pone.0021536	http://dx.doi.org/10.1371/journal.pone.0021536			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	784FW	21738693	Green Submitted, Green Published, gold			2022-12-27	WOS:000292142800033
J	Siegmund, KD; Marjoram, P; Tavare, S; Shibata, D				Siegmund, Kimberly D.; Marjoram, Paul; Tavare, Simon; Shibata, Darryl			High DNA Methylation Pattern Intratumoral Diversity Implies Weak Selection in Many Human Colorectal Cancers	PLOS ONE			English	Article							BREAST-CANCER; MICROSATELLITE INSTABILITY; PANCREATIC-CANCER; TUMOR EVOLUTION; CELL-LINES; METASTASIS; MUTATIONS; GENOME; PROGRESSION; DYNAMICS	Background: It is possible to infer the past of populations by comparing genomes between individuals. In general, older populations have more genomic diversity than younger populations. The force of selection can also be inferred from population diversity. If selection is strong and frequently eliminates less fit variants, diversity will be limited because new, initially homogeneous populations constantly emerge. Methodology and Results: Here we translate a population genetics approach to human somatic cancer cell populations by measuring genomic diversity within and between small colorectal cancer (CRC) glands. Control tissue culture and xenograft experiments demonstrate that the population diversity of certain passenger DNA methylation patterns is reduced after cloning but subsequently increases with time. When measured in CRC gland populations, passenger methylation diversity from different parts of nine CRCs was relatively high and uniform, consistent with older, stable lineages rather than mixtures of younger homogeneous populations arising from frequent cycles of selection. The diversity of six metastases was also high, suggesting dissemination early after transformation. Diversity was lower in DNA mismatch repair deficient CRC glands, possibly suggesting more selection and the elimination of less fit variants when mutation rates are elevated. Conclusion/Significance: The many hitchhiking passenger variants observed in primary and metastatic CRC cell populations are consistent with relatively old populations, suggesting that clonal evolution leading to selective sweeps may be rare after transformation. Selection in human cancers appears to be a weaker than presumed force after transformation, consistent with the observed rarity of driver mutations in cancer genomes. Phenotypic plasticity rather than the stepwise acquisition of new driver mutations may better account for the many different phenotypes within human tumors.	[Siegmund, Kimberly D.; Marjoram, Paul] Univ So Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA 90033 USA; [Tavare, Simon] Univ So Calif, Dept Biol Sci, Los Angeles, CA 90089 USA; [Tavare, Simon] Univ Cambridge, Dept Oncol, Cambridge, England; [Shibata, Darryl] Univ So Calif, Keck Sch Med, Dept Pathol, Los Angeles, CA 90033 USA	University of Southern California; University of Southern California; University of Cambridge; University of Southern California	Siegmund, KD (corresponding author), Univ So Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA 90033 USA.	dshibata@usc.edu			National Institutes of Health [R33 CA111940, R21 CA149990]; CRUK; NATIONAL CANCER INSTITUTE [R01CA097346, R21CA149990, R33CA111940] Funding Source: NIH RePORTER; Cancer Research UK [19556] Funding Source: researchfish	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CRUK(Cancer Research UK); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Cancer Research UK(Cancer Research UK)	This work was supported by grants from the National Institutes of Health (R33 CA111940 and R21 CA149990). ST is supported in part by a grant from CRUK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernards R, 2002, NATURE, V418, P823, DOI 10.1038/418823a; BHATTACHARYYA NP, 1994, P NATL ACAD SCI USA, V91, P6319, DOI 10.1073/pnas.91.14.6319; Bozic I, 2010, P NATL ACAD SCI USA, V107, P18545, DOI 10.1073/pnas.1010978107; Campbell PJ, 2010, NATURE, V467, P1109, DOI 10.1038/nature09460; CHARLESWORTH B, 1993, GENETICS, V134, P1289; Ding L, 2010, NATURE, V464, P999, DOI 10.1038/nature08989; Drescher KM, 2010, CLIN DEV IMMUNOL, DOI 10.1155/2010/170432; DREWINKO B, 1976, CANCER RES, V36, P467; Dy GK, 2008, CANCER-AM CANCER SOC, V113, P1857, DOI 10.1002/cncr.23651; FELSENSTEIN J, 1974, GENETICS, V78, P737; Hill RP, 2007, JNCI-J NATL CANCER I, V99, P1435, DOI 10.1093/jnci/djm136; Hoeijmakers JHJ, 2009, NEW ENGL J MED, V361, P1475, DOI 10.1056/NEJMra0804615; Hong YJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012002; Husemann Y, 2008, CANCER CELL, V13, P58, DOI 10.1016/j.ccr.2007.12.003; Jones S, 2008, P NATL ACAD SCI USA, V105, P4283, DOI 10.1073/pnas.0712345105; KIMURA M, 1969, GENETICS, V61, P763; Marusyk A, 2010, BBA-REV CANCER, V1805, P105, DOI 10.1016/j.bbcan.2009.11.002; Navin N, 2011, NATURE, V472, P90, DOI 10.1038/nature09807; NORTON L, 1988, CANCER RES, V48, P7067; NOWELL PC, 1976, SCIENCE, V194, P23, DOI 10.1126/science.959840; Pleasance ED, 2010, NATURE, V463, P191, DOI 10.1038/nature08658; Quintana E, 2010, CANCER CELL, V18, P510, DOI 10.1016/j.ccr.2010.10.012; Shibata D, 2006, CELL CYCLE, V5, P610, DOI 10.4161/cc.5.6.2570; Shibata D, 2011, CARCINOGENESIS, V32, P123, DOI 10.1093/carcin/bgq239; Siegmund KD, 2009, P NATL ACAD SCI USA, V106, P4828, DOI 10.1073/pnas.0810276106; Sinicrope FA, 2006, AM J GASTROENTEROL, V101, P2818, DOI 10.1111/j.1572-0241.2006.00845.x; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; UMAR A, 1994, J BIOL CHEM, V269, P14367; Wang TL, 2002, P NATL ACAD SCI USA, V99, P3076, DOI 10.1073/pnas.261714699; Yachida S, 2010, NATURE, V467, P1114, DOI 10.1038/nature09515	30	17	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2011	6	6							e21657	10.1371/journal.pone.0021657	http://dx.doi.org/10.1371/journal.pone.0021657			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	784FW	21738754	Green Submitted, Green Published, gold			2022-12-27	WOS:000292142800054
J	Cui, J; Eldredge, JB; Xu, Y; Puett, D				Cui, Juan; Eldredge, Joanna B.; Xu, Ying; Puett, David			MicroRNA Expression and Regulation in Human Ovarian Carcinoma Cells by Luteinizing Hormone	PLOS ONE			English	Article							CANCER; GENES; GONADOTROPINS; SIGNATURES; PROGNOSIS; IDENTIFICATION; PROFILES; INVASION; GROWTH; SITES	Background: MicroRNAs have been widely-studied with regard to their aberrant expression and high correlation with tumorigenesis and progression in various solid tumors. With the major goal of assessing gonadotropin (luteinizing hormone, LH) contributions to LH receptor (LHR)-positive ovarian cancer cells, we have conducted a genome-wide transcriptomic analysis on human epithelial ovarian cancer cells to identify the microRNA-associated cellular response to LH-mediated activation of LHR. Methods: Human ovarian cancer cells (SKOV3) were chosen as negative control (LHR-) and stably transfected to express functional LHR (LHR+), followed by incubation with LH (0-20 h). At different times of LH-mediated activation of LHR the cancer cells were analyzed by a high-density Ovarian Cancer Disease-Specific-Array (DSA, ALMAC (TM)), which profiled similar to 100,000 transcripts with similar to 400 non-coding microRNAs. Findings: In total, 65 microRNAs were identified to exhibit differential expression in either LHR expressing SKOV3 cells or LH-treated cells, a few of which have been found in the genomic fragile regions that are associated with abnormal deletion or amplification in cancer, such as miR-21, miR-101-1, miR-210 and miR-301a. By incorporating the dramatic expression changes observed in mRNAs, strong microRNA/mRNA regulatory pairs were predicted through statistical analyses coupled with collective computational prediction. The role of each microRNA was then determined through a functional analysis based on the highly-confident microRNA/mRNA pairs. Conclusion: The overall impact on the transcriptome-level expression indicates that LH may regulate apoptosis and cell growth of LHR+ SKOV3 cells, particularly by reducing cancer cell proliferation, with some microRNAs involved in regulatory roles.	[Cui, Juan; Eldredge, Joanna B.; Xu, Ying; Puett, David] Univ Georgia, Dept Biochem & Mol Biol, Athens, GA 30602 USA; [Xu, Ying] Univ Georgia, Inst Bioinformat, Athens, GA 30602 USA; [Xu, Ying] Jilin Univ, Coll Comp Sci & Technol, Changchun 130023, Jilin, Peoples R China	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; Jilin University	Cui, J (corresponding author), Univ Georgia, Dept Biochem & Mol Biol, Athens, GA 30602 USA.	puett@bmb.uga.edu	Puett, J. David/AIE-8612-2022		NIH [DK069711, DK033973, GM075331]; NSF [DEB-0830024, DBI-0542119]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK033973, R01DK069711] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM075331] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by NIH (DK069711, DK033973, GM075331) and by NSF (DEB-0830024, DBI-0542119). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Ambs S, 2008, CANCER RES, V68, P6162, DOI 10.1158/0008-5472.CAN-08-0144; ASCOLI M, 2009, GONADOTROPIN HORMONE; Barlund M, 2000, CANCER RES, V60, P5340; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bignell GR, 2010, NATURE, V463, P893, DOI 10.1038/nature08768; Bloomston M, 2007, JAMA-J AM MED ASSOC, V297, P1901, DOI 10.1001/jama.297.17.1901; Calin GA, 2002, P NATL ACAD SCI USA, V99, P15524, DOI 10.1073/pnas.242606799; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Calin GA, 2005, NEW ENGL J MED, V353, P1793, DOI 10.1056/NEJMoa050995; Choi JH, 2007, ENDOCR REV, V28, P440, DOI 10.1210/er.2006-0036; Croce CM, 2009, NAT REV GENET, V10, P704, DOI 10.1038/nrg2634; CUI J, 2011, BMC CANC IN PRESS; Dai Yang, 2010, Open Access Bioinformatics, V2, P29; Garzon R, 2008, BLOOD, V111, P3183, DOI 10.1182/blood-2007-07-098749; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Huang X, 2009, MOL CELL, V35, P856, DOI 10.1016/j.molcel.2009.09.006; Huhtaniemi I, 2010, MOL CELL ENDOCRINOL, V329, P56, DOI 10.1016/j.mce.2010.04.028; Iorio MV, 2007, CANCER RES, V67, P8699, DOI 10.1158/0008-5472.CAN-07-1936; Jiang QH, 2009, NUCLEIC ACIDS RES, V37, pD98, DOI 10.1093/nar/gkn714; Kramer S, 1998, INT J BIOL MARKER, V13, P165; Kwintkiewicz J, 2009, SEMIN REPROD MED, V27, P43, DOI 10.1055/s-0028-1108009; Leung PCK, 2007, HUM REPROD UPDATE, V13, P143, DOI 10.1093/humupd/dml002; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li J, 2010, GYNECOL ONCOL, V119, P543, DOI 10.1016/j.ygyno.2010.08.034; Li SD, 2010, J CELL MOL MED, V14, P2240, DOI 10.1111/j.1582-4934.2010.01058.x; Marchini S, 2011, LANCET ONCOL, V12, P273, DOI 10.1016/S1470-2045(11)70012-2; Miranda KC, 2006, CELL, V126, P1203, DOI 10.1016/j.cell.2006.07.031; Mosgaard BJ, 1997, FERTIL STERIL, V67, P1005, DOI 10.1016/S0015-0282(97)81431-8; Ness RB, 2002, AM J EPIDEMIOL, V155, P217, DOI 10.1093/aje/155.3.217; Ozols RF, 2004, CANCER CELL, V5, P19, DOI 10.1016/S1535-6108(04)00002-9; Pan Q, 2008, J CELL MOL MED, V12, P227, DOI 10.1111/j.1582-4934.2007.00207.x; Peng HQ, 2000, INT J CANCER, V86, P690, DOI 10.1002/(SICI)1097-0215(20000601)86:5<690::AID-IJC14>3.0.CO;2-K; Rodriguez A, 2004, GENOME RES, V14, P1902, DOI 10.1101/gr.2722704; Rozengurt E, 2007, J CELL PHYSIOL, V213, P589, DOI 10.1002/jcp.21246; Sanner K, 2009, FERTIL STERIL, V91, P1152, DOI 10.1016/j.fertnstert.2008.01.073; Schetter AJ, 2008, JAMA-J AM MED ASSOC, V299, P425, DOI 10.1001/jama.299.4.425; Tingulstad S, 2003, OBSTET GYNECOL, V101, P885, DOI 10.1016/S0029-7844(03)00123-6; Wang YH, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000866; Warrenfeltz SW, 2008, MOL CANCER RES, V6, P1775, DOI 10.1158/1541-7786.MCR-08-0214; Wyman SK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005311; Xiao FF, 2009, NUCLEIC ACIDS RES, V37, pD105, DOI 10.1093/nar/gkn851; Yanaihara N, 2006, CANCER CELL, V9, P189, DOI 10.1016/j.ccr.2006.01.025; Zhang L, 2008, P NATL ACAD SCI USA, V105, P7004, DOI 10.1073/pnas.0801615105	45	22	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2011	6	7							e21730	10.1371/journal.pone.0021730	http://dx.doi.org/10.1371/journal.pone.0021730			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791WM	21765906	gold, Green Published			2022-12-27	WOS:000292699000010
J	Fan, HF; Cox, MM; Li, HW				Fan, Hsiu-Fang; Cox, Michael M.; Li, Hung-Wen			Developing Single-Molecule TPM Experiments for Direct Observation of Successful RecA-Mediated Strand Exchange Reaction	PLOS ONE			English	Article							TETHERED PARTICLE MOTION; RECOMBINATIONAL DNA-REPAIR; ATP HYDROLYSIS; ESCHERICHIA-COLI; DUPLEX DNA; HOMOLOGOUS RECOMBINATION; PROTEIN-BINDING; NUCLEOPROTEIN FILAMENTS; BRANCH MIGRATION; MECHANISM	RecA recombinases play a central role in homologous recombination. Once assembled on single-stranded (ss) DNA, RecA nucleoprotein filaments mediate the pairing of homologous DNA sequences and strand exchange processes. We have designed two experiments based on tethered particle motion (TPM) to investigate the fates of the invading and the outgoing strands during E. coli RecA-mediated pairing and strand exchange at the single-molecule level in the absence of force. TPM experiments measure the tethered bead Brownian motion indicative of the DNA tether length change resulting from RecA binding and dissociation. Experiments with beads labeled on either the invading strand or the outgoing strand showed that DNA pairing and strand exchange occurs successfully in the presence of either ATP or its non-hydrolyzable analog, ATP gamma S. The strand exchange rates and efficiencies are similar under both ATP and ATP gamma S conditions. In addition, the Brownian motion time-courses suggest that the strand exchange process progresses uni-directionally in the 5'-to-3' fashion, using a synapse segment with a wide and continuous size distribution.	[Fan, Hsiu-Fang; Li, Hung-Wen] Natl Taiwan Univ, Dept Chem, Taipei 10764, Taiwan; [Fan, Hsiu-Fang] Natl Yang Ming Univ, Dept Life Sci, Taipei 112, Taiwan; [Fan, Hsiu-Fang] Natl Yang Ming Univ, Inst Genome Sci, Taipei 112, Taiwan; [Cox, Michael M.] Univ Wisconsin, Dept Biochem, Madison, WI 53705 USA	National Taiwan University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; University of Wisconsin System; University of Wisconsin Madison	Fan, HF (corresponding author), Natl Taiwan Univ, Dept Chem, Taipei 10764, Taiwan.	hwli@ntu.edu.tw		LI, HUNG-WEN/0000-0002-5614-3727	National Science Council of Taiwan; United States National Institutes of Health [GM32335]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM032335] Funding Source: NIH RePORTER	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This project is supported by National Science Council of Taiwan to HWL and the United States National Institutes of Health (GM32335) to MMC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson DG, 1999, J BIOL CHEM, V274, P27139, DOI 10.1074/jbc.274.38.27139; Arenson TA, 1999, J MOL BIOL, V288, P391, DOI 10.1006/jmbi.1999.2705; Bazemore LR, 1997, J BIOL CHEM, V272, P14672, DOI 10.1074/jbc.272.23.14672; Bedale WA, 1996, J BIOL CHEM, V271, P5725, DOI 10.1074/jbc.271.10.5725; Bell CE, 2005, MOL MICROBIOL, V58, P358, DOI 10.1111/j.1365-2958.2005.04876.x; BERLINER E, 1995, NATURE, V373, P718, DOI 10.1038/373718a0; Bianco P. R., 1998, FRONT BIOSCI, V3, pD570; Cox JM, 2005, PLOS BIOL, V3, P231, DOI 10.1371/journal.pbio.0030052; Cox MM, 2007, CRIT REV BIOCHEM MOL, V42, P41, DOI 10.1080/10409230701260258; Cox MM, 2003, ANNU REV MICROBIOL, V57, P551, DOI 10.1146/annurev.micro.57.030502.090953; Fan HF, 2009, BIOPHYS J, V96, P1875, DOI [10.1016/j.bpj.2008.11.048, 10.1016/j.bpj.2()08.11.048]; Fulconis R, 2006, EMBO J, V25, P4293, DOI 10.1038/sj.emboj.7601260; Hegner M, 1999, P NATL ACAD SCI USA, V96, P10109, DOI 10.1073/pnas.96.18.10109; JAIN SK, 1994, J BIOL CHEM, V269, P20653; KIM JI, 1992, J BIOL CHEM, V267, P16444; KIM JI, 1992, J BIOL CHEM, V267, P16438; KOWALCZYKOWSKI SC, 1995, P NATL ACAD SCI USA, V92, P3478, DOI 10.1073/pnas.92.8.3478; KOWALCZYKOWSKI SC, 1994, MICROBIOL REV, V58, P401, DOI 10.1128/MMBR.58.3.401-465.1994; LINDSLEY JE, 1989, J MOL BIOL, V205, P695, DOI 10.1016/0022-2836(89)90315-X; Lusetti SL, 2002, ANNU REV BIOCHEM, V71, P71, DOI 10.1146/annurev.biochem.71.083101.133940; McGrew DA, 2003, CRIT REV BIOCHEM MOL, V38, P385, DOI 10.1080/10409230390242489; MENETSKI JP, 1987, J BIOL CHEM, V262, P2093; MENETSKI JP, 1990, P NATL ACAD SCI USA, V87, P21, DOI 10.1073/pnas.87.1.21; MENETSKI JP, 1988, BIOCHEMISTRY-US, V27, P1205, DOI 10.1021/bi00404a021; Nelson PC, 2006, J PHYS CHEM B, V110, P17260, DOI 10.1021/jp0630673; PUGH BF, 1988, J MOL BIOL, V203, P479, DOI 10.1016/0022-2836(88)90014-9; PUGH BF, 1987, J BIOL CHEM, V262, P1326; PUGH BF, 1987, J BIOL CHEM, V262, P1337; REDDY G, 1995, BIOCHEMISTRY-US, V34, P10194, DOI 10.1021/bi00032a013; REGISTER JC, 1987, J BIOL CHEM, V262, P12812; REHRAUER WM, 1993, J BIOL CHEM, V268, P1292; Roca AI, 1997, PROG NUCLEIC ACID RE, V56, P129, DOI 10.1016/S0079-6603(08)61005-3; SCHAFER DA, 1991, NATURE, V352, P444, DOI 10.1038/352444a0; Schlacher K, 2006, CHEM REV, V106, P406, DOI 10.1021/cr0404951; Shan Q, 1996, J BIOL CHEM, V271, P5712, DOI 10.1074/jbc.271.10.5712; SILVER MS, 1982, BIOCHEMISTRY-US, V21, P6066, DOI 10.1021/bi00267a007; ULLSPERGER CJ, 1995, BIOCHEMISTRY-US, V34, P10859, DOI 10.1021/bi00034a019; van der Heijden T, 2008, MOL CELL, V30, P530, DOI 10.1016/j.molcel.2008.03.010; YIN H, 1994, BIOPHYS J, V67, P2468, DOI 10.1016/S0006-3495(94)80735-0	39	24	24	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2011	6	7							e21359	10.1371/journal.pone.0021359	http://dx.doi.org/10.1371/journal.pone.0021359			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791WM	21765895	Green Submitted, Green Published, gold			2022-12-27	WOS:000292699000005
J	Gottlieb, GS; Smith, RA; Badiane, NMD; Ba, S; Hawes, SE; Toure, M; Starling, AK; Traore, F; Sall, F; Cherne, SL; Stern, J; Wong, KG; Lu, P; Kim, M; Raugi, DN; Lam, A; Mullins, JI; Kiviat, NB; Sow, PS				Gottlieb, Geoffrey S.; Smith, Robert A.; Badiane, Ndeye Mery Dia; Ba, Selly; Hawes, Stephen E.; Toure, Macoumba; Starling, Alison K.; Traore, Fatou; Sall, Fatima; Cherne, Stephen L.; Stern, Joshua; Wong, Kim G.; Lu, Paul; Kim, Moon; Raugi, Dana N.; Lam, Airin; Mullins, James I.; Kiviat, Nancy B.; Sow, Papa Salif		UW-Dakar HIV-2 Study Grp	HIV-2 Integrase Variation in Integrase Inhibitor-Naive Adults in Senegal, West Africa	PLOS ONE			English	Article							VITRO PHENOTYPIC SUSCEPTIBILITY; IN-VITRO; RESISTANCE PROFILE; CONTROLLED-TRIALS; DRUG-RESISTANCE; GENITAL-TRACT; RALTEGRAVIR; INFECTION; TRANSMISSION; INDIVIDUALS	Background: Antiretroviral therapy for HIV-2 infection is hampered by intrinsic resistance to many of the drugs used to treat HIV-1. Limited studies suggest that the integrase inhibitors (INIs) raltegravir and elvitegravir have potent activity against HIV-2 in culture and in infected patients. There is a paucity of data on genotypic variation in HIV-2 integrase that might confer intrinsic or transmitted INI resistance. Methods: We PCR amplified and analyzed 122 HIV-2 integrase consensus sequences from 39 HIV-2-infected, INI-naive adults in Senegal, West Africa. We assessed genetic variation and canonical mutations known to confer INI-resistance in HIV-1. Results: No amino acid-altering mutations were detected at sites known to be pivotal for INI resistance in HIV-1 (integrase positions 143, 148 and 155). Polymorphisms at several other HIV-1 INI resistance-associated sites were detected at positions 72, 95, 125, 154, 165, 201, 203, and 263 of the HIV-2 integrase protein. Conclusion: Emerging genotypic and phenotypic data suggest that HIV-2 is susceptible to the new class of HIV integrase inhibitors. We hypothesize that intrinsic HIV-2 integrase variation at "secondary'' HIV-1 INI-resistance sites may affect the genetic barrier to HIV-2 INI resistance. Further studies will be needed to assess INI efficacy as part of combination antiretroviral therapy in HIV-2-infected patients.	[Gottlieb, Geoffrey S.; Raugi, Dana N.; Mullins, James I.; Kiviat, Nancy B.] Univ Washington, Sch Med, Dept Med, Seattle, WA 98195 USA; [Smith, Robert A.; Starling, Alison K.; Cherne, Stephen L.; Stern, Joshua; Kiviat, Nancy B.] Univ Washington, Sch Med, Dept Pathol, Seattle, WA 98195 USA; [Badiane, Ndeye Mery Dia; Ba, Selly; Toure, Macoumba; Traore, Fatou; Sall, Fatima; Sow, Papa Salif] Univ Cheikh Anta Diop Dakar, Ctr Hosp Univ Fann, Clin Malad Infect Ibrahima DIOP Mar, Dakar, Senegal; [Hawes, Stephen E.] Univ Washington, Sch Publ Hlth & Community Med, Dept Epidemiol, Seattle, WA 98195 USA; [Wong, Kim G.; Lu, Paul; Kim, Moon; Lam, Airin; Mullins, James I.] Univ Washington, Sch Med, Dept Microbiol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University Cheikh Anta Diop Dakar; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Gottlieb, GS (corresponding author), Univ Washington, Sch Med, Dept Med, Seattle, WA 98195 USA.	gottlieb@uw.edu		Lu, Paul Matthew/0000-0002-7519-9689; Gottlieb, Geoffrey/0000-0002-5749-481X	National Institutes of Health/National Institute of Allergy and Infectious Diseases [2R01-AI060466]; University of Washington Center for AIDS Research [213]; University of Washington; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI060466] Funding Source: NIH RePORTER	National Institutes of Health/National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); University of Washington Center for AIDS Research; University of Washington(University of Washington); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	These studies were supported by grants to GSG from the National Institutes of Health/National Institute of Allergy and Infectious Diseases (2R01-AI060466), the University of Washington Center 213 for AIDS Research, and the University of Washington Royalty Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong-James D, 2010, ANTIVIR RES, V86, P224, DOI 10.1016/j.antiviral.2010.02.324; Bercoff DP, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-98; Boyer PL, 2006, PLOS PATHOG, V2, P101, DOI 10.1371/journal.ppat0020010; Charpentier C, 2011, ANTIMICROB AGENTS CH, V55, P1293, DOI 10.1128/AAC.00942-10; Charpentier C, 2010, AIDS, V24, P2753, DOI 10.1097/QAD.0b013e32833f9e36; Damond F, 2008, AIDS, V22, P665, DOI 10.1097/QAD.0b013e3282f51203; DECOCK KM, 1993, JAMA-J AM MED ASSOC, V270, P2083, DOI 10.1001/jama.270.17.2083; Desbois D, 2008, ANTIMICROB AGENTS CH, V52, P1545, DOI 10.1128/AAC.01284-07; Garrett N, 2008, AIDS, V22, P1091, DOI 10.1097/QAD.0b013e3282f9b165; Goethals O, 2010, VIROLOGY, V402, P338, DOI 10.1016/j.virol.2010.03.034; Gottlieb GS, 2008, AIDS, V22, P2069, DOI 10.1097/QAD.0b013e32830edd44; Gottlieb GS, 2008, AIDS RES HUM RETROV, V24, P857, DOI 10.1089/aid.2008.0015; Gottlieb GS, 2009, CLIN INFECT DIS, V48, P476, DOI 10.1086/596504; Gottlieb GS, 2006, AIDS, V20, P895, DOI 10.1097/01.aids.0000218554.59531.80; Gottlieb GS, 2002, J INFECT DIS, V185, P905, DOI 10.1086/339295; Hawes SE, 2008, AIDS, V22, P2517, DOI 10.1097/QAD.0b013e328315cdbc; KANKI PJ, 1994, LANCET, V343, P943, DOI 10.1016/S0140-6736(94)90065-5; Kobayashi M, 2011, ANTIMICROB AGENTS CH, V55, P813, DOI 10.1128/AAC.01209-10; MARLINK R, 1994, SCIENCE, V265, P1587, DOI 10.1126/science.7915856; Matheron S, 2003, AIDS, V17, P2593, DOI 10.1097/00002030-200312050-00006; Matheron S, 2008, AIDS, V22, P2073, DOI 10.1097/QAD.0b013e32830edd59; Poveda E, 2004, AIDS RES HUM RETROV, V20, P347, DOI 10.1089/088922204322996590; Roquebert B, 2008, J ANTIMICROB CHEMOTH, V62, P914, DOI 10.1093/jac/dkn335; Roquebert B, 2008, AIDS, V22, P2045, DOI 10.1097/QAD.0b013e32830f4c7d; Salgado M, 2009, J CLIN VIROL, V46, P173, DOI 10.1016/j.jcv.2009.06.020; Shimura K, 2008, J VIROL, V82, P764, DOI 10.1128/JVI.01534-07; SIMON F, 1993, AIDS, V7, P1411, DOI 10.1097/00002030-199311000-00002; Smith RA, 2008, ANTIMICROB AGENTS CH, V52, P329, DOI 10.1128/AAC.01004-07; Smith RA, 2009, J INFECT DIS, V199, P1323, DOI 10.1086/597802; Witvrouw M, 2004, ANTIVIR THER, V9, P57; Xu L, 2008, AIDS RES HUM RETROV, V24, P1003, DOI 10.1089/aid.2007.0303; Xu L, 2009, AIDS RES HUM RETROV, V25, P843, DOI 10.1089/aid.2009.0039	32	20	20	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2011	6	7							e22204	10.1371/journal.pone.0022204	http://dx.doi.org/10.1371/journal.pone.0022204			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791WM	21765953	Green Submitted, Green Published, gold			2022-12-27	WOS:000292699000030
J	Guan, XY; Lee, JJ; Pang, MX; Shi, XL; Stelly, DM; Chen, ZJ				Guan, Xueying; Lee, Jinsuk J.; Pang, Mingxiong; Shi, Xiaoli; Stelly, David M.; Chen, Z. Jeffrey			Activation of Arabidopsis Seed Hair Development by Cotton Fiber-Related Genes	PLOS ONE			English	Article							LASER CAPTURE MICRODISSECTION; TRICHOME CELL FATE; COAT DEVELOPMENT; IN-VITRO; EXPRESSION; ELONGATION; INITIATION; TRIPTYCHON; ENCODES; GROWTH	Each cotton fiber is a single-celled seed trichome or hair, and over 20,000 fibers may develop semi-synchronously on each seed. The molecular basis for seed hair development is unknown but is likely to share many similarities with leaf trichome development in Arabidopsis. Leaf trichome initiation in Arabidopsis thaliana is activated by GLABROUS1 (GL1) that is negatively regulated by TRIPTYCHON (TRY). Using laser capture microdissection and microarray analysis, we found that many putative MYB transcription factor and structural protein genes were differentially expressed in fiber and non-fiber tissues. Gossypium hirsutum MYB2 (GhMYB2), a putative GL1 homolog, and its downstream gene, GhRDL1, were highly expressed during fiber cell initiation. GhRDL1, a fiber-related gene with unknown function, was predominately localized around cell walls in stems, sepals, seed coats, and pollen grains. GFP:GhRDL1 and GhMYB2:YFP were co-localized in the nuclei of ectopic trichomes in siliques. Overexpressing GhRDL1 or GhMYB2 in A. thaliana Columbia-0 (Col-0) activated fiber-like hair production in 4-6% of seeds and had on obvious effects on trichome development in leaves or siliques. Co-overexpressing GhRDL1 and GhMYB2 in A. thaliana Col-0 plants increased hair formation in similar to 8% of seeds. Overexpressing both GhRDL1 and GhMYB2 in A. thaliana Col-0 try mutant plants produced seed hair in similar to 10% of seeds as well as dense trichomes inside and outside siliques, suggesting synergistic effects of GhRDL1 and GhMYB2 with try on development of trichomes inside and outside of siliques and seed hair in A. thaliana. These data suggest that a different combination of factors is required for the full development of trichomes (hairs) in leaves, siliques, and seeds. A. thaliana can be developed as a model a system for discovering additional genes that control seed hair development in general and cotton fiber in particular.	[Guan, Xueying; Lee, Jinsuk J.; Pang, Mingxiong; Shi, Xiaoli; Chen, Z. Jeffrey] Univ Texas Austin, Sect Mol Cell & Dev Biol, Austin, TX 78712 USA; [Guan, Xueying; Lee, Jinsuk J.; Pang, Mingxiong; Shi, Xiaoli; Chen, Z. Jeffrey] Univ Texas Austin, Inst Cellular & Mol Biol, Austin, TX 78712 USA; [Stelly, David M.] Texas A&M Univ, Dept Soil & Crop Sci, College Stn, TX 77843 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; Texas A&M University System; Texas A&M University College Station	Guan, XY (corresponding author), Univ Texas Austin, Sect Mol Cell & Dev Biol, Austin, TX 78712 USA.	zjchen@mail.utexas.edu	Stelly, David/ABC-7400-2020	Stelly, David/0000-0002-3468-4119	National Science Foundation [DBI1025947]; Cotton Incorporated [07-161]; Division Of Integrative Organismal Systems [1025947] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Cotton Incorporated(Cotton R&D Corp); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	The work was supported by the grants from the National Science Foundation Plant Genome Research Program (DBI1025947) and Cotton Incorporated (07-161). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BASRA AS, 1984, INT REV CYTOL, V89, P65, DOI 10.1016/S0074-7696(08)61300-5; Batchelor AK, 2002, PLANTA, V215, P523, DOI 10.1007/s00425-002-0798-1; BEASLEY CA, 1971, BIOSCIENCE, V21, P906, DOI 10.2307/1295669; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Cai SQ, 2006, PLANT J, V48, P628, DOI 10.1111/j.1365-313X.2006.02886.x; Casson S, 2005, PLANT J, V42, P111, DOI 10.1111/j.1365-313X.2005.02355.x; Clark G, 2010, PLANT PHYSIOL, V152, P1073, DOI 10.1104/pp.109.147637; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Dai XB, 2010, PLANT PHYSIOL, V152, P44, DOI 10.1104/pp.109.145813; Esch JJ, 2004, PLANT J, V40, P860, DOI 10.1111/j.1365-313X.2004.02259.x; Guan XY, 2008, PHYSIOL PLANTARUM, V134, P174, DOI 10.1111/j.1399-3054.2008.01115.x; Haughn G, 2005, TRENDS PLANT SCI, V10, P472, DOI 10.1016/j.tplants.2005.08.005; Herwig R, 1999, GENOME RES, V9, P1093, DOI 10.1101/gr.9.11.1093; Hovav R, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040025; Hulskamp M, 2004, NAT REV MOL CELL BIO, V5, P471, DOI 10.1038/nrm1404; HULSKAMP M, 1994, CELL, V76, P555, DOI 10.1016/0092-8674(94)90118-X; Humphries JA, 2005, PLANT MOL BIOL, V57, P67, DOI 10.1007/s11103-004-6768-1; Ishida T, 2008, ANNU REV PLANT BIOL, V59, P365, DOI 10.1146/annurev.arplant.59.032607.092949; Jakoby MJ, 2008, PLANT PHYSIOL, V148, P1583, DOI 10.1104/pp.108.126979; Ji SJ, 2002, BIOCHEM BIOPH RES CO, V296, P1245, DOI 10.1016/S0006-291X(02)02069-7; Kim HJ, 2001, PLANT PHYSIOL, V127, P1361, DOI 10.1104/pp.010724; Kirik V, 2004, DEV BIOL, V268, P506, DOI 10.1016/j.ydbio.2003.12.037; Lee J.K, 2005, PROC 2005 IEEE RUSSI, P1; Lee JJ, 2007, ANN BOT-LONDON, V100, P1391, DOI 10.1093/aob/mcm232; Li CH, 2002, PLANT SCI, V163, P1113, DOI 10.1016/S0168-9452(02)00320-5; Li SF, 2009, PLANT CELL, V21, P72, DOI 10.1105/tpc.108.063503; Loguercio LL, 1999, MOL GEN GENET, V261, P660; Luschnig C, 2002, TRENDS PLANT SCI, V7, P329, DOI 10.1016/S1360-1385(02)02292-6; Machado A, 2009, PLANT J, V59, P52, DOI 10.1111/j.1365-313X.2009.03847.x; Marks MD, 2009, MOL PLANT, V2, P803, DOI 10.1093/mp/ssp037; MEINERT MC, 1977, PLANT PHYSIOL, V59, P1088, DOI 10.1104/pp.59.6.1088; Murai K, 2002, PLANT J, V29, P169, DOI 10.1046/j.0960-7412.2001.01203.x; Payne T, 1999, DEVELOPMENT, V126, P671; Pesch M, 2009, CURR OPIN PLANT BIOL, V12, P587, DOI 10.1016/j.pbi.2009.07.015; Pu L, 2008, GENETICS, V180, P811, DOI 10.1534/genetics.108.093070; RERIE WG, 1994, GENE DEV, V8, P1388, DOI 10.1101/gad.8.12.1388; Ruan YL, 2003, PLANT CELL, V15, P952, DOI 10.1105/tpc.010108; Schellmann S, 2002, EMBO J, V21, P5036, DOI 10.1093/emboj/cdf524; Shi YH, 2006, PLANT CELL, V18, P651, DOI 10.1105/tpc.105.040303; Szymanski DB, 2000, TRENDS PLANT SCI, V5, P214, DOI 10.1016/S1360-1385(00)01597-1; Szymanski DB, 1998, PLANT CELL, V10, P2047, DOI 10.1105/tpc.10.12.2047; Taliercio EW, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-22; Tian L, 2003, GENETICS, V165, P399; Udall JA, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-81; Wang JL, 2006, GENETICS, V172, P507, DOI 10.1534/genetics.105.047894; Wang S, 2004, PLANT CELL, V16, P2323, DOI 10.1105/tpc.104.024844; Western TL, 2004, PLANT PHYSIOL, V134, P296, DOI 10.1104/pp.103.035519; WILCOXON F, 1946, J ECON ENTOMOL, V39, P269, DOI 10.1093/jee/39.2.269; Wu J, 2007, PLANT PHYSIOL, V144, P961, DOI 10.1104/pp.107.097568; Wu Y, 2007, PLANTA, V226, P1475, DOI 10.1007/s00425-007-0580-5; Wu YR, 2006, PLANT CELL PHYSIOL, V47, P107, DOI 10.1093/pcp/pci228; YAMAGUCHISHINOZAKI K, 1993, MOL GEN GENET, V238, P17, DOI 10.1007/BF00279525; Yang SS, 2006, PLANT J, V47, P761, DOI 10.1111/j.1365-313X.2006.02829.x; Zhang F, 2003, DEVELOPMENT, V130, P4859, DOI 10.1242/dev.00681; Zhao M, 2008, DEVELOPMENT, V135, P1991, DOI 10.1242/dev.016873	55	52	58	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2011	6	7							e21301	10.1371/journal.pone.0021301	http://dx.doi.org/10.1371/journal.pone.0021301			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791QY	21779324	Green Published, Green Submitted, gold			2022-12-27	WOS:000292680900004
J	Iglesias, ALH; Kudo, K; Manabe, T; Berdugo, AEC; Baeza, AC; Ramos, LA; Gutierrez, RG; Zavala, MEM; Takasaki, J; Izumi, S; Bautista, E; Padilla, JRP				Higuera Iglesias, Anjarath Lorena; Kudo, Koichiro; Manabe, Toshie; Corcho Berdugo, Alexander Enrique; Corrales Baeza, Ariel; Alfaro Ramos, Leticia; Guevara Gutierrez, Rene; Manjarrez Zavala, Maria Eugenia; Takasaki, Jin; Izumi, Shinyu; Bautista, Edgar; Perez Padilla, Jose Rogelio			Reducing Occurrence and Severity of Pneumonia Due to Pandemic H1N1 2009 by Early Oseltamivir Administration: A Retrospective Study in Mexico	PLOS ONE			English	Article							INFLUENZA-A H1N1; CRITICALLY-ILL PATIENTS; VIRUS-INFECTION; A(H1N1) INFECTION; NEURAMINIDASE	Background: Anti-viral treatment has been used to treat severe or progressive illness due to pandemic H1N1 2009. A main cause of severe illness in pandemic H1N1 2009 is viral pneumonia; however, it is unclear how effective antiviral treatment is against pneumonia when administered >48 hours after symptom onset. Therefore, we aimed to determine how time from symptom onset to antiviral administration affected the effectiveness of antiviral treatment against pneumonia due to pandemic (H1N1) 2009. Methods/Principal Findings: A retrospective medical chart review of 442 patients was conducted in a hospital in Mexico. Subjects had tested positive for pandemic H1N1 2009 virus by real-time reverse-transcriptase-polymerase-chain-reaction and were administered oseltamivir. Median time from symptom onset to oseltamivir administration was 5.0 days (range, 0-43). 442 subjects, 71 (16.1%) had severe pneumonia which required mechanical ventilation, 191 (43.2%) had mild to moderate pneumonia, and 180 (40%) did not have pneumonia. Subjects were divided into four groups based on time to oseltamivir administration: >= 2, 3-7, 8-14, and >14 days. Severity of respiratory features was associated with time to treatment, and multivariate analysis indicated that time to oseltamivir administration was associated with severity of respiratory features. A proportional odds model indicated that 50% probability for occurrence of pneumonia of any severity and that of severe pneumonia in patients who would develop pneumonia reached at approximately 3.4 and 21 days, respectively, after symptom onset. Patients with a shorter time to oseltamivir administration were discharged earlier from the hospital. Conclusions: Earlier initiation of oseltamivir administration after symptom onset significantly reduced occurrence and severity of pneumonia and shortened hospitalization due to pandemic H1N1 2009. Even when administered >48 hours after symptom onset, oseltamivir showed considerable potential for reducing pneumonia. Application of these results would benefit patients affected by future influenza pandemics.	[Higuera Iglesias, Anjarath Lorena; Corcho Berdugo, Alexander Enrique; Corrales Baeza, Ariel; Alfaro Ramos, Leticia; Guevara Gutierrez, Rene; Manjarrez Zavala, Maria Eugenia; Bautista, Edgar; Perez Padilla, Jose Rogelio] Natl Inst Resp Dis, Mexico City, DF, Mexico; [Kudo, Koichiro; Manabe, Toshie; Takasaki, Jin; Izumi, Shinyu] Natl Ctr Global Hlth & Med, Tokyo, Japan	National Center for Global Health & Medicine - Japan	Iglesias, ALH (corresponding author), Natl Inst Resp Dis, Mexico City, DF, Mexico.	kudo@dcc.go.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by the Japan Initiative for Global Research Network on Infectious Diseases from the Ministry of Education, Culture, Sports, Science and Technology of Japan at http://www.crnid.riken.jp/pfrc/indexE.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agresti A., 2010, ANAL ORDINAL CATEGOR, DOI [DOI 10.1002/9780470594001, 10.1002/9780470594001]; [Anonymous], 2010, WHO GUID PHARM MAN P; Bautista E, 2010, NEW ENGL J MED, V362, P1708, DOI 10.1056/NEJMra1000449; Center for Disease Control and Prevention, 2010, UPD INT REC US ANT M; Dominguez-Cherit G, 2009, JAMA-J AM MED ASSOC, V302, P1880, DOI 10.1001/jama.2009.1536; Hayden FG, 1998, J CLIN INVEST, V101, P643, DOI 10.1172/JCI1355; Kumar A, 2009, JAMA-J AM MED ASSOC, V302, P1872, DOI 10.1001/jama.2009.1496; Lee N, 2010, THORAX, V65, P510, DOI 10.1136/thx.2009.130799; Louie JK, 2009, JAMA-J AM MED ASSOC, V302, P1896, DOI 10.1001/jama.2009.1583; Matrosovich MN, 2004, J VIROL, V78, P12665, DOI 10.1128/JVI.78.22.12665-12667.2004; Perez-Padilla R, 2009, NEW ENGL J MED, V361, P680, DOI 10.1056/NEJMoa0904252; *ROCH LAB INC, 2010, TAM PROD INF PRES IN; Safronetz D, 2011, J VIROL, V85, P1214, DOI 10.1128/JVI.01848-10; SALUDE, 2010, SIT ACT EP; Shieh WJ, 2010, AM J PATHOL, V177, P166, DOI 10.2353/ajpath.2010.100115; Slopen M. E., 2010, Morbidity and Mortality Weekly Report, V58, P1436; Su B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008495; To KKW, 2010, CLIN INFECT DIS, V50, P850, DOI 10.1086/650581; Webb SAR, 2009, NEW ENGL J MED, V361, P1925, DOI 10.1056/NEJMoa0908481; WHO (World Health Organization), 2010, PAND H1N1 2009 UPD 9	20	32	32	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2011	6	7							e21838	10.1371/journal.pone.0021838	http://dx.doi.org/10.1371/journal.pone.0021838			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791IA	21760915	gold, Green Submitted, Green Published			2022-12-27	WOS:000292657200027
J	Welsh, MM; Karagas, MR; Kuriger, JK; Houseman, A; Spencer, SK; Perry, AE; Nelson, HH				Welsh, Marleen M.; Karagas, Margaret R.; Kuriger, Jacquelyn K.; Houseman, Andres; Spencer, Steven K.; Perry, Ann E.; Nelson, Heather H.			Genetic Determinants of UV-Susceptibility in Non-Melanoma Skin Cancer	PLOS ONE			English	Article							INTERLEUKIN-10 PROMOTER POLYMORPHISMS; DELAYED-TYPE HYPERSENSITIVITY; SYSTEMIC IMMUNE SUPPRESSION; NECROSIS-FACTOR-ALPHA; CONTACT HYPERSENSITIVITY; EPIDERMODYSPLASIA-VERRUCIFORMIS; REGION POLYMORPHISMS; LANGERHANS CELLS; RECEPTOR-ALPHA; BETA-ESTRADIOL	A milieu of cytokines and signaling molecules are involved in the induction of UV-induced immune suppression and thus the etiology of non-melanoma skin cancer (NMSC). Targeting the UV-induced immunosuppression pathway, and using a large population based study of NMSC, we have investigated the risk associated with functional variants in 10 genes (IL10, IL4, IL4R, TNF, TNFR2, HTR2A, HRH2, IL12B, PTGS2, and HAL). The most prominent single genetic effect was observed for IL10. There was increasing risk for both basal cell carcinoma (BCC) and squamous cell carcinoma (SCC) with increasing number of variant IL10 haplotypes (BCC: p(trend) = 0.0048; SCC: p(trend) = 0.031). Having two IL10 GC haplotypes was associated with increased odds ratios of BCC and SCC (OR(BCC) = 1.5, 95% CI 1.1-1.9; OR(SCC) = 1.4, 95% CI 1.0-1.9), and these associations were largely confined to women (OR(BCC) = 2.2, 95% CI 1.4-3.4; SCC: OR(SCC) = 1.8, 95% CI 1.1-3.0). To examine how combinations of these variants contribute to risk of BCC and SCC, we used multifactor dimensionality reduction (MDR) and classification and regression trees (CART). Results from both of these methods found that in men, a combination of skin type, burns, IL10, IL4R, and possibly TNFR2 were important in both BCC and SCC. In women, skin type, burns, and IL10 were the most critical risk factors in SCC, with risk of BCC involving these same factors plus genetic variants in HTR2A, IL12B and IL4R. These data suggest differential genetic susceptibility to UV-induced immune suppression and skin cancer risk by gender.	[Welsh, Marleen M.] Uniformed Serv Univ Hlth Sci, Dept Prevent Med & Biometr, Bethesda, MD 20814 USA; [Karagas, Margaret R.] Dartmouth Med Sch, Dept Community & Family Med, Lebanon, NH USA; [Karagas, Margaret R.] Dartmouth Med Sch, Norris Cotton Canc Ctr, Lebanon, NH USA; [Kuriger, Jacquelyn K.; Nelson, Heather H.] Univ Minnesota, Mason Canc Ctr, Minneapolis, MN USA; [Nelson, Heather H.] Univ Minnesota, Div Epidemiol & Community Hlth, Minneapolis, MN USA; [Houseman, Andres] Brown Univ, Dept Community Hlth, Providence, RI 02912 USA; [Houseman, Andres] Brown Univ, Ctr Environm Hlth & Technol, Providence, RI 02912 USA; [Spencer, Steven K.] Dartmouth Hitchcock Med Ctr, Dept Med, Lebanon, NH 03766 USA; [Perry, Ann E.] Dartmouth Hitchcock Med Ctr, Dept Pathol, Lebanon, NH 03766 USA	Uniformed Services University of the Health Sciences - USA; Dartmouth College; Dartmouth College; Norris Cotton Cancer Center; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Brown University; Brown University; Dartmouth College; Dartmouth College	Welsh, MM (corresponding author), Uniformed Serv Univ Hlth Sci, Dept Prevent Med & Biometr, Bethesda, MD 20814 USA.	hhnelson@umn.edu		Nelson, Heather/0000-0003-1901-9513; Houseman, Eugene Andres/0000-0003-0703-1830	NIH [CA082354, CA057494]; NATIONAL CANCER INSTITUTE [R01CA057494, R01CA082354] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by NIH grants CA082354 and CA057494. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	*ACS, 2005, CANC FACTS FIG 2005; Alamartine E, 2003, J INVEST DERMATOL, V120, P99, DOI 10.1046/j.1523-1747.2003.12016.x; Allen MH, 1998, BRIT J DERMATOL, V139, P225; Andrews RP, 2001, CLIN IMMUNOL, V100, P298, DOI 10.1006/clim.2001.5082; Balic A, 2006, INT IMMUNOL, V18, P1421, DOI 10.1093/intimm/dxl075; Borchers A, 2000, SEMIN ARTHRITIS RHEU, V29, P385, DOI 10.1053/sarh.2000.7173; Bouma G, 1996, SCAND J IMMUNOL, V43, P456, DOI 10.1046/j.1365-3083.1996.d01-65.x; Braun N, 1996, NEUROSCI LETT, V215, P75, DOI 10.1016/0304-3940(96)12920-7; Breiman L., 1984, CLASSIFICATION REGRE; COOPER KD, 1992, P NATL ACAD SCI USA, V89, P8497, DOI 10.1073/pnas.89.18.8497; de Oliveira WRP, 2003, J AM ACAD DERMATOL, V49, P639, DOI 10.1067/S0190-9622(03)01567-6; English DR, 1998, CANCER EPIDEM BIOMAR, V7, P857; Ide A, 2002, HUM IMMUNOL, V63, P690, DOI 10.1016/S0198-8859(02)00417-2; JESSUP JM, 1978, CELL IMMUNOL, V38, P105, DOI 10.1016/0008-8749(78)90036-9; Karagas M, 2006, CANC EPIDEMIOLOGY PR; Karagas MR, 1999, INT J CANCER, V81, P555, DOI 10.1002/(SICI)1097-0215(19990517)81:4<555::AID-IJC9>3.0.CO;2-R; MAJEWSKI S, 1995, ARCH DERMATOL, V131, P1312, DOI 10.1001/archderm.131.11.1312; MATSUSHIMA GK, 1989, CELL IMMUNOL, V119, P171, DOI 10.1016/0008-8749(89)90233-5; Mitsuyasu H, 1998, NAT GENET, V19, P119, DOI 10.1038/472; Miyazoe S, 2002, AM J GASTROENTEROL, V97, P2086, DOI 10.1111/j.1572-0241.2002.05926.x; Moore JH, 2006, J THEOR BIOL, V241, P252, DOI 10.1016/j.jtbi.2005.11.036; MORISON WL, 1984, IMMUNOLOGY, V52, P299; Morita C, 2001, ARTHRITIS RHEUM-US, V44, P2819, DOI 10.1002/1529-0131(200112)44:12<2819::AID-ART469>3.0.CO;2-2; Myers RL, 2007, BIOL PSYCHIAT, V61, P167, DOI 10.1016/j.biopsych.2005.12.018; Nagano T, 2008, PHOTOCHEM PHOTOBIOL, V84, P63, DOI 10.1111/j.1751-1097.2007.00245.x; Noonan FP, 2003, J INVEST DERMATOL, V121, P1175, DOI 10.1046/j.1523-1747.2003.12560.x; NOONAN FP, 1994, IMMUNOGENETICS, V39, P29, DOI 10.1007/BF00171794; NOONAN FP, 1984, J IMMUNOL, V132, P2408; Origuchi T, 2003, ANN RHEUM DIS, V62, P1117, DOI 10.1136/ard.62.11.1117; Risma KA, 2002, J IMMUNOL, V169, P1604, DOI 10.4049/jimmunol.169.3.1604; ROSENWASSER LJ, 1995, CLIN EXP ALLERGY, V25, P74, DOI 10.1111/j.1365-2222.1995.tb00428.x; Rosso S, 2002, INT J EPIDEMIOL, V31, P439, DOI 10.1093/ije/31.2.439; Saijo S, 1996, PHOTODERMATOL PHOTO, V12, P145, DOI 10.1111/j.1600-0781.1996.tb00191.x; Salem ML, 2000, INT ARCH ALLERGY IMM, V121, P161, DOI 10.1159/000024312; Salem ML, 2000, INT ARCH ALLERGY IMM, V121, P235, DOI 10.1159/000024323; Seegers D, 2002, GENES IMMUN, V3, P419, DOI 10.1038/sj.gene.6363919; Shreedhar V, 1998, J IMMUNOL, V160, P3783; Steinberg D., 1997, CART CLASSIFICATION; SUCHI M, 1995, GENOMICS, V29, P98, DOI 10.1006/geno.1995.1219; Turner DM, 1997, EUR J IMMUNOGENET, V24, P1, DOI 10.1111/j.1365-2370.1997.tb00001.x; ULLRICH SE, 1984, J IMMUNOL, V133, P2786; VERMEER M, 1991, J INVEST DERMATOL, V97, P729, DOI 10.1111/1523-1747.ep12484259; WEGMANN TG, 1993, IMMUNOL TODAY, V14, P353, DOI 10.1016/0167-5699(93)90235-D; WELSH MM, 2008, CARCINOGENESIS; Wilkening S, 2006, BRIT J DERMATOL, V155, P1139, DOI 10.1111/j.1365-2133.2006.07440.x; YOSHIKAWA T, 1990, J INVEST DERMATOL, V95, P530, DOI 10.1111/1523-1747.ep12504877; Zhang XM, 2005, GASTROENTEROLOGY, V129, P565, DOI 10.1053/j.gastro.2005.05.003; [No title captured]	48	34	36	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2011	6	7							e20019	10.1371/journal.pone.0020019	http://dx.doi.org/10.1371/journal.pone.0020019			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791IA	21760883	Green Submitted, Green Published, gold			2022-12-27	WOS:000292657200002
J	Hoile, SP; Lillycrop, KA; Thomas, NA; Hanson, MA; Burdge, GC				Hoile, Samuel P.; Lillycrop, Karen A.; Thomas, Nicola A.; Hanson, Mark A.; Burdge, Graham C.			Dietary Protein Restriction during F-0 Pregnancy in Rats Induces Transgenerational Changes in the Hepatic Transcriptome in Female Offspring	PLOS ONE			English	Article							FOLIC-ACID SUPPLEMENTATION; DUTCH FAMINE; IN-UTERO; GENERATION; DISEASE; GENE; LIFE; METHYLATION; EXPOSURE; GLUCOSE	There is considerable evidence for non-genomic transmission between generations of phenotypes induced by environmental exposures during development, although the mechanism is poorly understood. We investigated whether alterations in expression of the liver transcriptome induced in F1 offspring by feeding F0 dams a protein-restricted (PR) diet during pregnancy were passed with or without further change to two subsequent generations. The number of genes that differed between adult female offspring of F0 protein-restricted (PR) and protein-sufficient (PS) dams was F1 1,684 genes, F2 1,680 and F3 2,062. 63/113 genes that were altered in all three generations showed directionally opposite differences between generations. There was a trend toward increased proportions of up-regulated genes in F3 compared to F1. KEGG analysis showed that only the Adherens Junctions pathway was altered in all three generations. PR offspring showed altered fasting glucose homeostasis and changes in phosphoenolpyruvate carboxykinase promoter methylation and expression in all three generations. These findings show that dietary challenge during F0 pregnancy induced altered gene expression in all three generations, but relatively few genes showed transmission of altered expression between generations. For the majority of altered genes, these changes were not found in all generations, including some genes that were changed in F3 but not F1, or the direction and magnitude of difference between PR and PS differed between generations. Such variation may reflect differences between generations in the signals received by the fetus from the mother as a consequence of changes in the interaction between her phenotype and the environment.	[Hoile, Samuel P.; Thomas, Nicola A.; Hanson, Mark A.; Burdge, Graham C.] Univ Southampton, Acad Unit Human Dev & Hlth, Fac Med, Southampton SO9 5NH, Hants, England; [Lillycrop, Karen A.] Univ Southampton, Fac Nat & Environm Sci, Southampton SO9 5NH, Hants, England	University of Southampton; University of Southampton	Hoile, SP (corresponding author), Univ Southampton, Acad Unit Human Dev & Hlth, Fac Med, Southampton SO9 5NH, Hants, England.	g.c.burdge@southampton.ac.uk	Hanson, Mark/AAE-8236-2019; Burdge, Graham/A-2370-2014	Hanson, Mark/0000-0002-6907-613X; Burdge, Graham/0000-0002-7665-2967; Lillycrop, Karen/0000-0001-7350-5489	BBSRC [BB/F013043/1]; Wessex Medical Research; British Heart Foundation [CH/02/01]; Biotechnology and Biological Sciences Research Council [BB/F013043/1] Funding Source: researchfish	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wessex Medical Research; British Heart Foundation(British Heart Foundation); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by grants from the BBSRC (BB/F013043/1) (www.bbsrc.ac.uk) to GCB, KAL and MAH, and Wessex Medical Research (www.wesmed.org.uk) to GCB. MAH receives salary support from the British Heart Foundation (CH/02/01) (www.bhf.org.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anway MD, 2008, GENOMICS, V91, P30, DOI 10.1016/j.ygeno.2007.10.002; Anway MD, 2005, SCIENCE, V308, P1466, DOI 10.1126/science.1108190; Badyaev AV, 2008, ANN NY ACAD SCI, V1133, P151, DOI 10.1196/annals.1438.009; BEALE EG, 1985, J BIOL CHEM, V260, P748; BENVENISTY N, 1985, BIOCHEMISTRY-US, V24, P5015, DOI 10.1021/bi00340a009; Benyshek DC, 2006, DIABETOLOGIA, V49, P1117, DOI 10.1007/s00125-006-0196-5; Bertram CE, 2001, BRIT MED BULL, V60, P103, DOI 10.1093/bmb/60.1.103; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Burdge GC, 2007, PROSTAG LEUKOTR ESS, V77, P59, DOI 10.1016/j.plefa.2007.06.003; Burdge GC, 2008, BRIT J NUTR, V99, P540, DOI 10.1017/S0007114507815819; Burdge GC, 2007, BRIT J NUTR, V97, P435, DOI 10.1017/S0007114507352392; Burdge GC, 2009, J NUTR, V139, P1054, DOI 10.3945/jn.109.104653; Burns SP, 1997, J CLIN INVEST, V100, P1768, DOI 10.1172/JCI119703; CHANDRA RK, 1975, SCIENCE, V190, P289, DOI 10.1126/science.1179211; Cropley JE, 2006, P NATL ACAD SCI USA, V103, P17308, DOI 10.1073/pnas.0607090103; Drake AJ, 2005, AM J PHYSIOL-REG I, V288, pR34, DOI 10.1152/ajpregu.00106.2004; Gluckman PD, 2005, NESTLE NUTR WORKS SE, V55, P17, DOI 10.1159/000082591; Gluckman PD, 2004, SCIENCE, V305, P1733, DOI 10.1126/science.1095292; Gluckman PD, 2008, NEW ENGL J MED, V359, P61, DOI 10.1056/NEJMra0708473; Gluckman PD, 2007, BIOESSAYS, V29, P145, DOI 10.1002/bies.20522; HERRERA E, 1968, BIOCHIM BIOPHYS ACTA, V170, P244, DOI 10.1016/0304-4165(68)90004-4; Jablonka E, 2009, Q REV BIOL, V84, P131, DOI 10.1086/598822; Koyama I, 2001, ELECTROPHORESIS, V22, P12, DOI 10.1002/1522-2683(200101)22:1<12::AID-ELPS12>3.0.CO;2-6; Lillycrop KA, 2008, BRIT J NUTR, V100, P278, DOI 10.1017/S0007114507894438; Lillycrop KA, 2010, BRIT J NUTR, V103, P1711, DOI 10.1017/S0007114509993795; Martin JF, 2000, J NUTR, V130, P741, DOI 10.1093/jn/130.4.741; MOUSSEAU TA, 1991, ANNU REV ENTOMOL, V36, P511, DOI 10.1146/annurev.en.36.010191.002455; Painter RC, 2008, BJOG-INT J OBSTET GY, V115, P1243, DOI 10.1111/j.1471-0528.2008.01822.x; Pembrey ME, 2006, EUR J HUM GENET, V14, P159, DOI 10.1038/sj.ejhg.5201538; Skinner MK, 2008, REPROD TOXICOL, V25, P2, DOI 10.1016/j.reprotox.2007.09.001; Skinner MK, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003745; Stein AD, 2000, HUM BIOL, V72, P641; Torrens C, 2008, BRIT J NUTR, V100, P760, DOI 10.1017/S0007114508921747; Waterland RA, 2008, INT J OBESITY, V32, P1373, DOI 10.1038/ijo.2008.100; Yang JQ, 2009, J BIOL CHEM, V284, P27031, DOI 10.1074/jbc.R109.040535; Zambrano E, 2005, J PHYSIOL-LONDON, V566, P225, DOI 10.1113/jphysiol.2005.086462; ZAMENHOF S, 1971, SCIENCE, V172, P850, DOI 10.1126/science.172.3985.850	37	53	55	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2011	6	7							e21668	10.1371/journal.pone.0021668	http://dx.doi.org/10.1371/journal.pone.0021668			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791HI	21750721	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000292655400010
J	Khan, SH; Ling, J; Kumar, R				Khan, Shagufta H.; Ling, Jun; Kumar, Raj			TBP Binding-Induced Folding of the Glucocorticoid Receptor AF1 Domain Facilitates Its Interaction with Steroid Receptor Coactivator-1	PLOS ONE			English	Article							PROTEIN-PROTEIN INTERACTIONS; NUCLEAR HORMONE-RECEPTORS; ESTROGEN-RECEPTOR; TRANSCRIPTIONAL ACTIVATION; TRANSACTIVATION DOMAIN; INTRINSIC DISORDER; IN-VITRO; UNSTRUCTURED PROTEINS; SMALL REGION; DNA-BINDING	The precise mechanism by which glucocorticoid receptor (GR) regulates the transcription of its target genes is largely unknown. This is, in part, due to the lack of structural and functional information about GR's N-terminal activation function domain, AF1. Like many steroid hormone receptors (SHRs), the GR AF1 exists in an intrinsically disordered (ID) conformation or an ensemble of conformers that collectively appears to be unstructured. The GR AF1 is known to recruit several coregulatory proteins, including those from the basal transcriptional machinery, e. g., TATA box binding protein (TBP) that forms the basis for the multiprotein transcription initiation complex. However, the precise mechanism of this process is unknown. We have earlier shown that conditional folding of the GR AF1 is the key for its interactions with critical coactivator proteins. We hypothesize that binding of TBP to AF1 results in the structural rearrangement of the ID AF1 domain such that its surfaces become easily accessible for interaction with other coactivators. To test this hypothesis, we determined whether TBP binding-induced structure formation in the GR AF1 facilitates its interaction with steroid receptor coactivator-1 (SRC-1), a critical coactivator that is important for GR-mediated transcriptional activity. Our data show that stoichiometric binding of TBP induces significantly higher helical content at the expense of random coil configuration in the GR AF1. Further, we found that this induced AF1 conformation facilitates its interaction with SRC-1, and subsequent AF1-mediated transcriptional activity. Our results may provide a potential mechanism through which GR and by large other SHRs may regulate the expression of the GR-target genes.	[Khan, Shagufta H.; Ling, Jun; Kumar, Raj] Commonwealth Med Coll, Dept Basic Sci, Scranton, PA USA	Geisinger Commonwealth School of Medicine	Khan, SH (corresponding author), Commonwealth Med Coll, Dept Basic Sci, Scranton, PA USA.	rkumar@tcmedc.org			NIH, NIDDK [RO1 DK058829]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058829] Funding Source: NIH RePORTER	NIH, NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by a grant from NIH, NIDDK RO1 DK058829 (R K.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almlof T, 1998, BIOCHEMISTRY-US, V37, P9586, DOI 10.1021/bi973029x; ARCHER TK, 1995, J STEROID BIOCHEM, V53, P421, DOI 10.1016/0960-0760(95)00088-H; Bain DL, 2000, J BIOL CHEM, V275, P7313, DOI 10.1074/jbc.275.10.7313; Beck IME, 2009, ENDOCR REV, V30, P830, DOI 10.1210/er.2009-0013; Bledsoe RK, 2002, CELL, V110, P93, DOI 10.1016/S0092-8674(02)00817-6; Brzozowski AM, 1997, NATURE, V389, P753, DOI 10.1038/39645; Chen H, 1997, J BIOL CHEM, V272, P25873, DOI 10.1074/jbc.272.41.25873; Combet C, 2000, TRENDS BIOCHEM SCI, V25, P147, DOI 10.1016/S0968-0004(99)01540-6; Copik AJ, 2006, MOL ENDOCRINOL, V20, P1218, DOI 10.1210/me.2005-0257; CRIVICI A, 1995, ANNU REV BIOPH BIOM, V24, P85, DOI 10.1146/annurev.bb.24.060195.000505; DAHLMANWRIGHT K, 1995, P NATL ACAD SCI USA, V92, P1699, DOI 10.1073/pnas.92.5.1699; DAHLMANWRIGHT K, 1994, P NATL ACAD SCI USA, V91, P1619, DOI 10.1073/pnas.91.5.1619; Deroo BJ, 2001, ONCOGENE, V20, P3039, DOI 10.1038/sj.onc.1204328; Dosztanyi Z, 2005, BIOINFORMATICS, V21, P3433, DOI 10.1093/bioinformatics/bti541; Dunker AK, 2008, NAT CHEM BIOL, V4, P229, DOI 10.1038/nchembio0408-229; Dyson HJ, 2002, CURR OPIN STRUC BIOL, V12, P54, DOI 10.1016/S0959-440X(02)00289-0; Ford J, 1997, MOL ENDOCRINOL, V11, P1467, DOI 10.1210/me.11.10.1467; Fujita T, 2003, J BIOL CHEM, V278, P26704, DOI 10.1074/jbc.M301031200; Garza AMS, 2010, MOL CELL BIOL, V30, P220, DOI 10.1128/MCB.00552-09; GIGUERE V, 1986, CELL, V46, P645, DOI 10.1016/0092-8674(86)90339-9; Glass CK, 1997, CURR OPIN CELL BIOL, V9, P222, DOI 10.1016/S0955-0674(97)80066-X; GODOWSKI PJ, 1987, NATURE, V325, P365, DOI 10.1038/325365a0; Hittelman AB, 1999, EMBO J, V18, P5380, DOI 10.1093/emboj/18.19.5380; HOLLENBERG SM, 1987, CELL, V49, P39, DOI 10.1016/0092-8674(87)90753-7; HOLLENBERG SM, 1988, CELL, V55, P899, DOI 10.1016/0092-8674(88)90145-6; Horwitz KB, 1996, MOL ENDOCRINOL, V10, P1167, DOI 10.1210/me.10.10.1167; Iakoucheva LM, 2004, NUCLEIC ACIDS RES, V32, P1037, DOI 10.1093/nar/gkh253; Iakoucheva LM, 2002, J MOL BIOL, V323, P573, DOI 10.1016/S0022-2836(02)00969-5; IniguezLluhi JA, 1997, J BIOL CHEM, V272, P4149, DOI 10.1074/jbc.272.7.4149; Juo ZS, 1996, J MOL BIOL, V261, P239, DOI 10.1006/jmbi.1996.0456; Kriwacki RW, 1996, P NATL ACAD SCI USA, V93, P11504, DOI 10.1073/pnas.93.21.11504; Kumar R, 1999, STEROIDS, V64, P310, DOI 10.1016/S0039-128X(99)00014-8; Kumar R, 2003, MOL ENDOCRINOL, V17, P1, DOI 10.1210/me.2002-0258; Kumar R, 2004, P NATL ACAD SCI USA, V101, P16425, DOI 10.1073/pnas.0407160101; Kumar R, 2001, J BIOL CHEM, V276, P18146, DOI 10.1074/jbc.M100825200; LEES JA, 1989, NUCLEIC ACIDS RES, V17, P5477, DOI 10.1093/nar/17.14.5477; Liu JG, 2006, BIOCHEMISTRY-US, V45, P6873, DOI 10.1021/bi0602718; Loven MA, 2003, MOL ENDOCRINOL, V17, P67, DOI 10.1210/me.2002-0280; Ma H, 1999, MOL CELL BIOL, V19, P6164; McEwan IJ, 1996, BIOCHEMISTRY-US, V35, P9584, DOI 10.1021/bi960793v; McKenna NJ, 1999, ENDOCR REV, V20, P321, DOI 10.1210/er.20.3.321; McNally JG, 2000, SCIENCE, V287, P1262, DOI 10.1126/science.287.5456.1262; MIESFELD R, 1987, SCIENCE, V236, P423, DOI 10.1126/science.3563519; Namba K, 2001, GENES CELLS, V6, P1, DOI 10.1046/j.1365-2443.2001.00384.x; Prilusky J, 2005, BIOINFORMATICS, V21, P3435, DOI 10.1093/bioinformatics/bti537; Qu YX, 2002, BIOPHYS CHEM, V101, P155, DOI 10.1016/S0301-4622(02)00148-5; Reid J, 2002, J BIOL CHEM, V277, P20079, DOI 10.1074/jbc.M201003200; Romero P, 2001, PROTEINS, V42, P38, DOI 10.1002/1097-0134(20010101)42:1<38::AID-PROT50>3.0.CO;2-3; Romero Pedro, 2004, Appl Bioinformatics, V3, P105, DOI 10.2165/00822942-200403020-00005; Shen F, 1996, J BIOL CHEM, V271, P4827; SIGLER PB, 1988, NATURE, V333, P210, DOI 10.1038/333210a0; Stenoien DL, 2001, NAT CELL BIOL, V3, P15, DOI 10.1038/35050515; Tompa P, 2003, BIOESSAYS, V25, P847, DOI 10.1002/bies.10324; Tompa P, 2008, TRENDS BIOCHEM SCI, V33, P2, DOI 10.1016/j.tibs.2007.10.003; Uversky VN, 2000, PROTEINS, V41, P415, DOI 10.1002/1097-0134(20001115)41:3<415::AID-PROT130>3.3.CO;2-Z; Ward JJ, 2004, J MOL BIOL, V337, P635, DOI 10.1016/j.jmb.2004.02.002; Warnmark A, 2001, J BIOL CHEM, V276, P45939, DOI 10.1074/jbc.M107875200; Yamamoto KR, 1998, COLD SPRING HARB SYM, V63, P587, DOI 10.1101/sqb.1998.63.587	58	18	18	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2011	6	7							e21939	10.1371/journal.pone.0021939	http://dx.doi.org/10.1371/journal.pone.0021939			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791HI	21760925	Green Published, gold, Green Submitted			2022-12-27	WOS:000292655400029
J	Smith, MA; Eveleigh, ES; McCann, KS; Merilo, MT; McCarthy, PC; Van Rooyen, KI				Smith, M. Alex; Eveleigh, Eldon S.; McCann, Kevin S.; Merilo, Mark T.; McCarthy, Peter C.; Van Rooyen, Kathleen I.			Barcoding a Quantified Food Web: Crypsis, Concepts, Ecology and Hypotheses	PLOS ONE			English	Article							CHORISTONEURA SPECIES LEPIDOPTERA; PARASITOID FLIES DIPTERA; DNA BARCODES; HYPERPARASITOIDS HYMENOPTERA; BIODIVERSITY ASSESSMENT; SECONDARY STRUCTURE; MOLECULAR METHODS; HOST-SPECIFICITY; IDENTIFICATION; DIVERSITY	The efficient and effective monitoring of individuals and populations is critically dependent on correct species identification. While this point may seem obvious, identifying the majority of the more than 100 natural enemies involved in the spruce budworm (Choristoneura fumiferana - SBW) food web remains a non-trivial endeavor. Insect parasitoids play a major role in the processes governing the population dynamics of SBW throughout eastern North America. However, these species are at the leading edge of the taxonomic impediment and integrating standardized identification capacity into existing field programs would provide clear benefits. We asked to what extent DNA barcoding the SBW food web would alter our understanding of the diversity and connectence of the food web and the frequency of generalists vs. specialists in different forest habitats. We DNA barcoded over 10% of the insects collected from the SBW food web in three New Brunswick forest plots from 1983 to 1993. For 30% of these specimens, we amplified at least one additional nuclear region. When the nodes of the food web were estimated based on barcode divergences (using molecular operational taxonomic units (MOTU) or phylogenetic diversity (PD) - the food web became much more diverse and connectence was reduced. We tested one measure of food web structure (the "bird feeder effect") and found no difference compared to the morphologically based predictions. Many, but not all, of the presumably polyphagous parasitoids now appear to be morphologically-cryptic host-specialists. To our knowledge, this project is the first to barcode a food web in which interactions have already been well-documented and described in space, time and abundance. It is poised to be a system in which field-based methods permit the identification capacity required by forestry scientists. Food web barcoding provided an effective tool for the accurate identification of all species involved in the cascading effects of future budworm outbreaks. Integrating standardized barcodes within food webs may ultimately change the face of community ecology. This will be most poignantly felt in food webs that have not yet been quantified. Here, more accurate and precise connections will be within the grasp of any researcher for the first time.	[Smith, M. Alex; Merilo, Mark T.] Univ Guelph, Biodivers Inst Ontario, Guelph, ON N1G 2W1, Canada; [Smith, M. Alex; McCann, Kevin S.; Merilo, Mark T.] Univ Guelph, Dept Integrat Biol, Guelph, ON N1G 2W1, Canada; [Eveleigh, Eldon S.; McCarthy, Peter C.; Van Rooyen, Kathleen I.] Nat Resources Canada, Canadian Forest Serv, Atlantic Forestry Ctr, Fredericton, NB, Canada; [Eveleigh, Eldon S.] Univ New Brunswick, Populat Ecol Grp, Fredericton, NB, Canada	University of Guelph; University of Guelph; Natural Resources Canada; Canadian Forest Service; University of New Brunswick	Smith, MA (corresponding author), Univ Guelph, Biodivers Inst Ontario, Guelph, ON N1G 2W1, Canada.	salex@uoguelph.ca	Smith, M Alex/B-4468-2013	Smith, M Alex/0000-0002-8650-2575	Canadian Forest Service; Genome Canada through the Ontario Genomics Institute; Genome Canada through Natural Sciences and Engineering Research Council of Canada (NSERC)	Canadian Forest Service(Natural Resources CanadaCanadian Forest Service); Genome Canada through the Ontario Genomics Institute(Genome Canada); Genome Canada through Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	The field study was funded by the Canadian Forest Service to ESE and laboratory reagents were funded by Genome Canada through the Ontario Genomics Institute and through a Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery Grant to MAS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acs Z, 2010, MOL PHYLOGENET EVOL, V55, P210, DOI 10.1016/j.ympev.2009.12.004; Agapow P.-M., 2008, CONSERVE 4; Austerlitz F, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S14-S10; Avise JC, 2009, J BIOGEOGR, V36, P3, DOI 10.1111/j.1365-2699.2008.02032.x; Bennett AMR, 2008, CAN ENTOMOL, V140, P1; Bensasson D, 2001, TRENDS ECOL EVOL, V16, P314, DOI 10.1016/S0169-5347(01)02151-6; Birky CW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010609; Brown JH, 2003, P NATL ACAD SCI USA, V100, P1467, DOI 10.1073/pnas.0630310100; Canada H, 2005, PRINC SPRUC BUDW INT; Canada NR, 2009, STAT CAN FOR ANN REP; Cavender-Bares J, 2009, ECOL LETT, V12, P693, DOI 10.1111/j.1461-0248.2009.01314.x; Clare EL, 2009, MOL ECOL, V18, P2532, DOI 10.1111/j.1365-294X.2009.04184.x; Cohen JE, 2003, P NATL ACAD SCI USA, V100, P1781, DOI 10.1073/pnas.232715699; COHEN JE, 1978, FOOD WEBS NICHE SPAC; Coleman AW, 2009, MOL PHYLOGENET EVOL, V50, P197, DOI 10.1016/j.ympev.2008.10.008; Corse E, 2010, MOL ECOL RESOUR, V10, P96, DOI 10.1111/j.1755-0998.2009.02795.x; Cracraft J., 1989, P28; Crawford AJ, 2010, P NATL ACAD SCI USA, V107, P13777, DOI 10.1073/pnas.0914115107; Crozier RH, 1999, FEMS MICROBIOL ECOL, V28, P325; De Queiroz K, 2007, SYST BIOL, V56, P879, DOI 10.1080/10635150701701083; Dunne JA, 2004, MAR ECOL PROG SER, V273, P291, DOI 10.3354/meps273291; Emmerson MC, 2004, J ANIM ECOL, V73, P399, DOI 10.1111/j.0021-8790.2004.00818.x; Eveleigh ES, 2007, P NATL ACAD SCI USA, V104, P16976, DOI 10.1073/pnas.0704301104; Eveleigh ES, 2003, CAN ENTOMOL, V135, P677; FAITH DP, 1992, BIOL CONSERV, V61, P1, DOI 10.1016/0006-3207(92)91201-3; Fernanez-Triana JL, 2010, CAN ENTOMOL, V142, P1; Floyd R, 2002, MOL ECOL, V11, P839, DOI 10.1046/j.1365-294X.2002.01485.x; Frankham R, 2010, CONSERV GENET, V11, P661, DOI 10.1007/s10592-009-0010-2; Gariepy T, 2008, J APPL ECOL, V45, P708, DOI 10.1111/j.1365-2664.2007.01451.x; Garros C, 2008, MOL ECOL RESOUR, V8, P512, DOI 10.1111/j.1471-8286.2007.02013.x; Godfray H. C. J., 1994, Parasitoids: behavioral and evolutionary ecology.; Greenstone MH, 2006, B ENTOMOL RES, V96, P1, DOI 10.1079/BER2005402; Hardy CM, 2010, MOL ECOL, V19, P197, DOI 10.1111/j.1365-294X.2009.04411.x; Higgs PG, 2000, Q REV BIOPHYS, V33, P199, DOI 10.1017/S0033583500003620; Huber JT, 1996, CAN ENTOMOL, V128, P1167, DOI 10.4039/Ent1281167-6; Ivanova NV, 2006, MOL ECOL NOTES, V6, P998, DOI 10.1111/j.1471-8286.2006.01428.x; Janzen DH, 2009, MOL ECOL RESOUR, V9, P1, DOI 10.1111/j.1755-0998.2009.02628.x; Ji YJ, 2003, MOL ECOL NOTES, V3, P581, DOI 10.1046/j.1471-8286.2003.00519.x; Kaartinen R, 2010, ECOL ENTOMOL, V35, P623, DOI 10.1111/j.1365-2311.2010.01224.x; Koetschan C, 2010, NUCLEIC ACIDS RES, V38, pD275, DOI 10.1093/nar/gkp966; LaSalle J., 1991, Redia, V74, P315; Locke SA, 2010, MOL ECOL, V19, P2813, DOI 10.1111/j.1365-294X.2010.04713.x; MacLean DA, 2001, CAN J FOREST RES, V31, P1742, DOI 10.1139/cjfr-31-10-1742; MARTINEZ ND, 1993, OIKOS, V66, P403, DOI 10.2307/3544934; May RM, 1983, NATURE, V301, P566; Mayr E., 1942, P1; McCann K, 2007, NATURE, V446, P29, DOI 10.1038/446029a; Muller T, 2007, RNA, V13, P1469, DOI 10.1261/rna.617107; O'Hara JE, 2005, ZOOTAXA, P1; O'Meara BC, 2010, SYST BIOL, V59, P59, DOI 10.1093/sysbio/syp077; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Rosenberg NA, 2007, EVOLUTION, V61, P317, DOI 10.1111/j.1558-5646.2007.00023.x; Rougerie R, 2010, MOL ECOLOGY IN PRESS; Royama T., 1992, Analytical population dynamics.; Ruhl MW, 2010, MOL PHYLOGENET EVOL, V54, P664, DOI 10.1016/j.ympev.2009.07.036; SAMWAYS MJ, 1993, BIODIVERS CONSERV, V2, P258, DOI 10.1007/BF00056672; Schultz J, 2009, MOL PHYLOGENET EVOL, V52, P520, DOI 10.1016/j.ympev.2009.01.008; Seibel PN, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-498; Smith MA, 2008, P NATL ACAD SCI USA, V105, P12359, DOI 10.1073/pnas.0805319105; Smith MA, 2007, P NATL ACAD SCI USA, V104, P4967, DOI 10.1073/pnas.0700050104; Smith MA, 2009, FRONT ZOOL, V6, DOI 10.1186/1742-9994-6-31; Smith MA, 2009, MOL ECOL RESOUR, V9, P208, DOI 10.1111/j.1755-0998.2009.02646.x; Smith MA, 2006, P NATL ACAD SCI USA, V103, P3657, DOI 10.1073/pnas.0511318103; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Van Veen FJF, 2003, EUR J ENTOMOL, V100, P449, DOI 10.14411/eje.2003.067; Virgilio M, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-206; WILEY EO, 1978, SYST ZOOL, V27, P17, DOI 10.2307/2412809; Yoon I, 2004, P SOC PHOTO-OPT INS, V5295, P124, DOI 10.1117/12.526956; Zhang AB, 2010, MOL PHYLOGENET EVOL, V54, P1035, DOI 10.1016/j.ympev.2009.09.014; Zhou X, 2009, FRONT ZOOL, V6, DOI 10.1186/1742-9994-6-30	70	69	75	3	77	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2011	6	7							e14424	10.1371/journal.pone.0014424	http://dx.doi.org/10.1371/journal.pone.0014424			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791AK	21754977	Green Published, Green Submitted, gold			2022-12-27	WOS:000292632000001
J	Ping, JH; Keleta, L; Forbes, NE; Dankar, S; Stecho, W; Tyler, S; Zhou, Y; Babiuk, L; Weingartl, H; Halpin, RA; Boyne, A; Bera, J; Hostetler, J; Fedorova, NB; Proudfoot, K; Katzel, DA; Stockwell, TB; Ghedin, E; Spiro, DJ; Brown, EG				Ping, Jihui; Keleta, Liya; Forbes, Nicole E.; Dankar, Samar; Stecho, William; Tyler, Shaun; Zhou, Yan; Babiuk, Lorne; Weingartl, Hana; Halpin, Rebecca A.; Boyne, Alex; Bera, Jayati; Hostetler, Jessicah; Fedorova, Nadia B.; Proudfoot, Katie; Katzel, Dan A.; Stockwell, Tim B.; Ghedin, Elodie; Spiro, David J.; Brown, Earl G.			Genomic and Protein Structural Maps of Adaptive Evolution of Human Influenza A Virus to Increased Virulence in the Mouse	PLOS ONE			English	Article							POLYMERASE SUBUNIT PB2; LOW-PH STABILITY; HOST-RANGE; MATRIX PROTEIN; SIALIDASE ACTIVITY; NS1 PROTEIN; PARALLEL EVOLUTION; MAMMALIAN-CELLS; MOLECULAR-BASIS; MUTATION-RATES	Adaptive evolution is characterized by positive and parallel, or repeated selection of mutations. Mouse adaptation of influenza A virus (IAV) produces virulent mutants that demonstrate positive and parallel evolution of mutations in the hemagglutinin (HA) receptor and non-structural protein 1 (NS1) interferon antagonist genes. We now present a genomic analysis of all 11 genes of 39 mouse adapted IAV variants from 10 replicate adaptation experiments. Mutations were mapped on the primary and structural maps of each protein and specific mutations were validated with respect to virulence, replication, and RNA polymerase activity. Mouse adapted (MA) variants obtained after 12 or 20-21 serial infections acquired on average 5.8 and 7.9 nonsynonymous mutations per genome of 11 genes, respectively. Among a total of 115 nonsynonymous mutations, 51 demonstrated properties of natural selection including 27 parallel mutations. The greatest degree of parallel evolution occurred in the HA receptor and ribonucleocapsid components, polymerase subunits (PB1, PB2, PA) and NP. Mutations occurred in host nuclear trafficking factor binding sites as well as sites of virus-virus protein subunit interaction for NP, NS1, HA and NA proteins. Adaptive regions included cap binding and endonuclease domains in the PB2 and PA polymerase subunits. Four mutations in NS1 resulted in loss of binding to the host cleavage and polyadenylation specificity factor (CPSF30) suggesting that a reduction in inhibition of host gene expression was being selected. The most prevalent mutations in PB2 and NP were shown to increase virulence but differed in their ability to enhance replication and demonstrated epistatic effects. Several positively selected RNA polymerase mutations demonstrated increased virulence associated with >300% enhanced polymerase activity. Adaptive mutations that control host range and virulence were identified by their repeated selection to comprise a defined model for studying IAV evolution to increased virulence in the mouse.	[Ping, Jihui; Keleta, Liya; Forbes, Nicole E.; Dankar, Samar; Stecho, William; Brown, Earl G.] Univ Ottawa, Fac Med, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada; [Ping, Jihui; Keleta, Liya; Forbes, Nicole E.; Dankar, Samar; Stecho, William; Brown, Earl G.] Univ Ottawa, Emerging Pathogens Res Ctr, Ottawa, ON, Canada; [Tyler, Shaun] Publ Hlth Agcy Canada, Natl Microbiol Lab, Canadian Sci Ctr Human & Anim Hlth, Winnipeg, MB, Canada; [Zhou, Yan; Babiuk, Lorne] Univ Saskatchewan, Vaccine & Infect Dis Org, Saskatoon, SK, Canada; [Weingartl, Hana] Canadian Food Inspect Agcy, Natl Ctr Foreign Anim Dis, Winnipeg, MB, Canada; [Halpin, Rebecca A.; Boyne, Alex; Bera, Jayati; Hostetler, Jessicah; Fedorova, Nadia B.; Proudfoot, Katie; Katzel, Dan A.; Stockwell, Tim B.; Ghedin, Elodie; Spiro, David J.] J Craig Venter Inst, Viral Genom Grp, Rockville, MD USA; [Ping, Jihui; Keleta, Liya; Forbes, Nicole E.; Dankar, Samar; Zhou, Yan; Babiuk, Lorne; Weingartl, Hana; Brown, Earl G.] Univ Ottawa, Canadian Inst Hlth Res CIHR, Canadian Influenza Pathogenesis Team, Ottawa, ON, Canada; [Ghedin, Elodie] Univ Pittsburgh, Sch Med, Ctr Vaccine Res, Dept Computat & Syst Biol, Pittsburgh, PA USA	University of Ottawa; University of Ottawa; Canadian Science Centre for Human & Animal Health; Public Health Agency of Canada; University of Saskatchewan; Canadian Food Inspection Agency; J. Craig Venter Institute; University of Ottawa; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Ping, JH (corresponding author), Univ Ottawa, Fac Med, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada.	Earl.Brown@uottawa.ca	Stecho, William/E-1656-2013; Ghedin, Elodie/Y-5654-2019	Stecho, William/0000-0002-2891-9348; Ghedin, Elodie/0000-0002-1515-725X; Forbes, Nicole/0000-0002-2645-695X; Katzel, Daniel/0000-0002-3191-0694; Stockwell, Timothy/0000-0002-3595-4539	National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services [N01-AI-30071, HHSN272200900007C]; CIHR Pandemic Preparedness Team [TPA-90188]; Canadian Institutes of Heath Research (CIHR, Institute of Infection and Immunity) [MOP-74526]; Influenza Genome	National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); CIHR Pandemic Preparedness Team(Canadian Institutes of Health Research (CIHR)); Canadian Institutes of Heath Research (CIHR, Institute of Infection and Immunity)(Canadian Institutes of Health Research (CIHR)); Influenza Genome	This project has been funded in part through the Influenza Genome Sequencing Project with federal funds from the National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services, http://www.niaid.nih.gov/, under contract numbers N01-AI-30071 and HHSN272200900007C; the CIHR Pandemic Preparedness Team grant to the CIHR Canadian Influenza Pathogenesis Team (EGB, LB, YZ, and HW) TPA-90188, and Canadian Institutes of Heath Research (CIHR, Institute of Infection and Immunity, http://www.cihr-irsc.gc.ca/, operating grant MOP-74526 (EGB)). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alizon S, 2009, J EVOLUTION BIOL, V22, P245, DOI 10.1111/j.1420-9101.2008.01658.x; Arendt J, 2008, TRENDS ECOL EVOL, V23, P26, DOI 10.1016/j.tree.2007.09.011; Baranovich T, 2010, J CLIN VIROL, V47, P23, DOI 10.1016/j.jcv.2009.11.003; Barton NH, 2002, NAT REV GENET, V3, P11, DOI 10.1038/nrg700; Basler CF, 2008, ANTIVIR RES, V79, P166, DOI 10.1016/j.antiviral.2008.04.006; Baudin F, 2001, VIROLOGY, V281, P102, DOI 10.1006/viro.2000.0804; Bloom JD, 2010, SCIENCE, V328, P1272, DOI 10.1126/science.1187816; Boivin S, 2010, J BIOL CHEM, V285, P28411, DOI 10.1074/jbc.R110.117531; Boulo S, 2007, VIRUS RES, V124, P12, DOI 10.1016/j.virusres.2006.09.013; Brown E. G., 2008, Current Topics in Virology. Volume 7, P99; Brown EG, 2000, BIOMED PHARMACOTHER, V54, P196, DOI 10.1016/S0753-3322(00)89026-5; BROWN EG, 1990, J VIROL, V64, P4523, DOI 10.1128/JVI.64.9.4523-4533.1990; Brown EG, 1999, VIRUS RES, V61, P63, DOI 10.1016/S0168-1702(99)00027-1; Brown EG, 2001, P NATL ACAD SCI USA, V98, P6883, DOI 10.1073/pnas.111165798; Bull JJ, 1997, GENETICS, V147, P1497; Conenello GM, 2007, PLOS PATHOG, V3, P1414, DOI 10.1371/journal.ppat.0030141; Conenello GM, 2011, J VIROL, V85, P652, DOI 10.1128/JVI.01987-10; Coombs KM, 2010, J VIROL, V84, P10888, DOI 10.1128/JVI.00431-10; CRECELIUS DM, 1984, VIROLOGY, V139, P164, DOI 10.1016/0042-6822(84)90337-4; DANIELS RS, 1987, EMBO J, V6, P1459, DOI 10.1002/j.1460-2075.1987.tb02387.x; Dankar SK, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-13; Das K, 2008, P NATL ACAD SCI USA, V105, P13093, DOI 10.1073/pnas.0805213105; Deyde VM, 2007, J INFECT DIS, V196, P249, DOI 10.1086/518936; Engelhardt OG, 2006, REV MED VIROL, V16, P329, DOI 10.1002/rmv.512; Flick R, 1999, J GEN VIROL, V80, P2565, DOI 10.1099/0022-1317-80-10-2565; Gabriel G, 2007, J VIROL, V81, P9601, DOI 10.1128/JVI.00666-07; Gabriel G, 2005, P NATL ACAD SCI USA, V102, P18590, DOI 10.1073/pnas.0507415102; Gabriel G, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040011; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; GERHARD W, 1981, NATURE, V290, P713, DOI 10.1038/290713a0; Ghedin E, 2005, NATURE, V437, P1162, DOI 10.1038/nature04239; Guilligay D, 2008, NAT STRUCT MOL BIOL, V15, P500, DOI 10.1038/nsmb.1421; Hale BG, 2008, J GEN VIROL, V89, P2359, DOI 10.1099/vir.0.2008/004606-0; Hale BG, 2010, J VIROL, V84, P6909, DOI 10.1128/JVI.00081-10; Handel A, 2006, PLOS COMPUT BIOL, V2, P1262, DOI 10.1371/journal.pcbi.0020137; Hara K, 2006, J VIROL, V80, P7789, DOI 10.1128/JVI.00600-06; Hatta M, 2001, SCIENCE, V293, P1840, DOI 10.1126/science.1062882; Hayward JJ, 2010, J VIROL, V84, P12636, DOI 10.1128/JVI.01350-10; Herfst S, 2010, J VIROL, V84, P3752, DOI 10.1128/JVI.02634-09; Hossain MJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003170; Hu YW, 2005, VIROLOGY, V332, P538, DOI 10.1016/j.virol.2004.11.041; Huarte M, 2001, J VIROL, V75, P8597, DOI 10.1128/JVI.75.18.8597-8604.2001; Ibricevic A, 2006, J VIROL, V80, P7469, DOI 10.1128/JVI.02677-05; Ilyushina NA, 2010, J VIROL, V84, P8607, DOI 10.1128/JVI.00159-10; Itoh Y, 2009, NATURE, V460, P1021, DOI 10.1038/nature08260; Jackson D, 2008, P NATL ACAD SCI USA, V105, P4381, DOI 10.1073/pnas.0800482105; Katz JM, 2000, J VIROL, V74, P10807, DOI 10.1128/JVI.74.22.10807-10810.2000; Keleta L, 2008, J VIROL, V82, P11599, DOI 10.1128/JVI.01393-08; Kochs G., 2007, J VIROL; Kuiken T, 2006, SCIENCE, V312, P394, DOI 10.1126/science.1122818; Kuo RL, 2009, J VIROL, V83, P1611, DOI 10.1128/JVI.01491-08; LAMB RA, 1985, CELL, V40, P627, DOI 10.1016/0092-8674(85)90211-9; Li CJ, 2008, J VIROL, V82, P11880, DOI 10.1128/JVI.01445-08; Li JW, 2009, VIRUS RES, V144, P123, DOI 10.1016/j.virusres.2009.04.008; Li ZJ, 2005, J VIROL, V79, P12058, DOI 10.1128/JVI.79.18.12058-12064.2005; Lipatov AS, 2003, J VIROL, V77, P3816, DOI 10.1128/JVI.77.6.3816-3823.2003; Liu Qinfang, 2009, J Mol Genet Med, V3, P225; Matsuoka Yumiko, 2009, Curr Protoc Microbiol, VChapter 15, DOI [10.1002/9780471729259.mc15g03s13, 10.1002/9780471729259.mc15g02s13]; Mehle A, 2009, P NATL ACAD SCI USA, V106, P21312, DOI 10.1073/pnas.0911915106; Miller J, 2004, BEHAV RES METH INS C, V36, P11, DOI 10.3758/BF03195545; Moreland JL, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-21; Naffakh N, 2008, ANNU REV MICROBIOL, V62, P403, DOI 10.1146/annurev.micro.62.081307.162746; Narasaraju T, 2009, MICROBES INFECT, V11, P2, DOI 10.1016/j.micinf.2008.09.013; NAYAK DP, 1989, ANNU REV MICROBIOL, V43, P465, DOI 10.1146/annurev.mi.43.100189.002341; Nelson M, 2009, PLOS CURR INFLUENZA; Nelson MI, 2006, PLOS PATHOG, V2, P1144, DOI 10.1371/journal.ppat.0020125; Nemeroff ME, 1998, MOL CELL, V1, P991, DOI 10.1016/S1097-2765(00)80099-4; Neumann G, 2006, EMERG INFECT DIS, V12, P881, DOI 10.3201/eid1206.051336; O'Neill RE, 1998, EMBO J, V17, P288, DOI 10.1093/emboj/17.1.288; Obayashi E, 2008, NATURE, V454, P1127, DOI [10.1038/nature07225, 10.5940/jcrsj.50.329]; Orr HA, 2005, NAT REV GENET, V6, P119, DOI 10.1038/nrg1523; Orr HA, 2005, EVOLUTION, V59, P216; Palese P., 2007, FIELDS VIROLOGY, P1647; PARVIN JD, 1986, J VIROL, V59, P377, DOI 10.1128/JVI.59.2.377-383.1986; Pepin KM, 2010, NAT REV MICROBIOL, V8, P802, DOI 10.1038/nrmicro2440; Pielak RM, 2009, P NATL ACAD SCI USA, V106, P7379, DOI 10.1073/pnas.0902548106; Ping JH, 2010, J VIROL, V84, P10606, DOI 10.1128/JVI.01187-10; Quynh ML, 2009, J VIROL, V83, P5278, DOI 10.1128/JVI.00063-09; Ralph P, 2010, GENETICS, V186, P647, DOI 10.1534/genetics.110.119594; Rambaut A, 2008, NATURE, V453, P615, DOI 10.1038/nature06945; Reid AH, 2004, NAT REV MICROBIOL, V2, P909, DOI 10.1038/nrmicro1027; Reid AH, 2004, J VIROL, V78, P12462, DOI 10.1128/JVI.78.22.12462-12470.2004; Reid AH, 2003, AVIAN DIS, V47, P921, DOI 10.1637/0005-2086-47.s3.921; Reid AH, 1999, P NATL ACAD SCI USA, V96, P1651, DOI 10.1073/pnas.96.4.1651; Rigoni M, 2007, VIROLOGY, V364, P28, DOI 10.1016/j.virol.2007.02.031; Rolling T, 2009, J VIROL, V83, P6673, DOI 10.1128/JVI.00212-09; Schnell JR, 2008, NATURE, V451, P591, DOI 10.1038/nature06531; Seo SH, 2002, NAT MED, V8, P950, DOI 10.1038/nm757; Shapira SD, 2009, CELL, V139, P1255, DOI 10.1016/j.cell.2009.12.018; Shinya K, 2007, J GEN VIROL, V88, P547, DOI 10.1099/vir.0.82411-0; Skehel JJ, 2000, ANNU REV BIOCHEM, V69, P531, DOI 10.1146/annurev.biochem.69.1.531; Smee Donald F., 2007, Antiviral Chemistry & Chemotherapy, V18, P317; SMEENK CA, 1994, J VIROL, V68, P530, DOI 10.1128/JVI.68.1.530-534.1994; Smeenk CA, 1996, VIRUS RES, V44, P79, DOI 10.1016/0168-1702(96)01329-9; Song MS, 2009, J VIROL, V83, P12325, DOI 10.1128/JVI.01373-09; STEINHAUER DA, 1991, P NATL ACAD SCI USA, V88, P11525, DOI 10.1073/pnas.88.24.11525; STEVENS J, 2004, SCIENCE; SUAREZ P, 1992, J VIROL, V66, P2491; Suzuki T, 2004, FEBS LETT, V557, P228, DOI 10.1016/S0014-5793(03)01503-5; Takahashi T, 2003, FEBS LETT, V543, P71, DOI 10.1016/S0014-5793(03)00403-4; Takahashi T, 2001, J BIOCHEM-TOKYO, V130, P279, DOI 10.1093/oxfordjournals.jbchem.a002983; Takahashi T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015556; Tarendeau F, 2007, NAT STRUCT MOL BIOL, V14, P229, DOI 10.1038/nsmb1212; Taubenberger JK, 2010, CELL HOST MICROBE, V7, P440, DOI 10.1016/j.chom.2010.05.009; Tumpey TM, 2005, SCIENCE, V310, P77, DOI 10.1126/science.1119392; Twu KY, 2007, J VIROL, V81, P8112, DOI 10.1128/JVI.00006-07; VARGHESE JN, 1983, NATURE, V303, P35, DOI 10.1038/303035a0; Ward AC, 1997, VIRUS GENES, V14, P187, DOI 10.1023/A:1007979709403; Watanabe T, 2010, CELL HOST MICROBE, V7, P427, DOI 10.1016/j.chom.2010.05.008; Webster RG, 2007, AVIAN DIS, V51, P269, DOI 10.1637/7641-050206R.1; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; Wichman HA, 1999, SCIENCE, V285, P422, DOI 10.1126/science.285.5426.422; Wichman HA, 2000, PHILOS T R SOC B, V355, P1677, DOI 10.1098/rstb.2000.0731; WIN C, 1859, ORIGIN SPECIES MEANS; Wood TE, 2005, GENETICA, V123, P157, DOI 10.1007/s10709-003-2738-9; Wu R, 2009, VET MICROBIOL, V138, P85, DOI 10.1016/j.vetmic.2009.03.010; Ye JQ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001145; Ye ZP, 1999, J VIROL, V73, P7467, DOI 10.1128/JVI.73.9.7467-7473.1999; YE ZP, 1989, J VIROL, V63, P3586, DOI 10.1128/JVI.63.9.3586-3594.1989; YE ZP, 1987, J VIROL, V61, P239, DOI 10.1128/JVI.61.2.239-246.1987; YE ZP, 1995, J VIROL, V69, P1964, DOI 10.1128/JVI.69.3.1964-1970.1995; Zhou B, 2011, J VIROL, V85, P357, DOI 10.1128/JVI.01694-10; Zhou B, 2009, J VIROL, V83, P10309, DOI 10.1128/JVI.01109-09	123	66	69	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2011	6	6							e21740	10.1371/journal.pone.0021740	http://dx.doi.org/10.1371/journal.pone.0021740			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786GP	21738783	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000292291800035
J	Eldawlatly, S; Oweiss, KG				Eldawlatly, Seif; Oweiss, Karim G.			Millisecond-Timescale Local Network Coding in the Rat Primary Somatosensory Cortex	PLOS ONE			English	Article							BARREL CORTEX; STIMULUS LOCATION; CELL ASSEMBLIES; INFORMATION; NEURONS; SPARSE; SYNCHRONIZATION; CONNECTIVITY; ORGANIZATION; OSCILLATIONS	Correlation among neocortical neurons is thought to play an indispensable role in mediating sensory processing of external stimuli. The role of temporal precision in this correlation has been hypothesized to enhance information flow along sensory pathways. Its role in mediating the integration of information at the output of these pathways, however, remains poorly understood. Here, we examined spike timing correlation between simultaneously recorded layer V neurons within and across columns of the primary somatosensory cortex of anesthetized rats during unilateral whisker stimulation. We used Bayesian statistics and information theory to quantify the causal influence between the recorded cells with millisecond precision. For each stimulated whisker, we inferred stable, whisker-specific, dynamic Bayesian networks over many repeated trials, with network similarity of 83.3 +/- 6% within whisker, compared to only 50.3 +/- 18% across whiskers. These networks further provided information about whisker identity that was approximately 6 times higher than what was provided by the latency to first spike and 13 times higher than what was provided by the spike count of individual neurons examined separately. Furthermore, prediction of individual neurons' precise firing conditioned on knowledge of putative pre-synaptic cell firing was 3 times higher than predictions conditioned on stimulus onset alone. Taken together, these results suggest the presence of a temporally precise network coding mechanism that integrates information across neighboring columns within layer V about vibrissa position and whisking kinetics to mediate whisker movement by motor areas innervated by layer V.	[Eldawlatly, Seif; Oweiss, Karim G.] Michigan State Univ, Dept Elect & Comp Engn, E Lansing, MI 48824 USA; [Oweiss, Karim G.] Michigan State Univ, Neurosci Program, E Lansing, MI 48824 USA	Michigan State University; Michigan State University	Eldawlatly, S (corresponding author), Michigan State Univ, Dept Elect & Comp Engn, E Lansing, MI 48824 USA.	koweiss@msu.edu	Eldawlatly, Seif/AAF-4857-2020	Eldawlatly, Seif/0000-0003-2873-0569	NINDS [NS054148]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R33NS054148, R21NS054148] Funding Source: NIH RePORTER	NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by NINDS grant number NS054148. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeles M., 1982, LOCAL CORTICAL CIRCU; Alloway KD, 2008, CEREB CORTEX, V18, P979, DOI 10.1093/cercor/bhm138; Arabzadeh E, 2006, J NEUROSCI, V26, P9216, DOI 10.1523/JNEUROSCI.1491-06.2006; Atencio CA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009521; Barth DS, 2003, J NEUROSCI, V23, P2502; Buzsaki G, 2010, NEURON, V68, P362, DOI 10.1016/j.neuron.2010.09.023; Celikel T, 2004, NAT NEUROSCI, V7, P534, DOI 10.1038/nn1222; COOPER GF, 1992, MACH LEARN, V9, P309, DOI 10.1007/BF00994110; de Kock CPJ, 2007, J PHYSIOL-LONDON, V581, P139, DOI 10.1113/jphysiol.2006.124321; Devonshire IM, 2010, EUR J NEUROSCI, V32, P786, DOI 10.1111/j.1460-9568.2010.07322.x; Eldawlatly S, 2010, STATISTICAL SIGNAL PROCESSING FOR NEUROSCIENCE AND NEUROTECHNOLOGY, P129, DOI 10.1016/B978-0-12-375027-3.00005-3; Eldawlatly S, 2010, NEURAL COMPUT, V22, P158, DOI 10.1162/neco.2009.11-08-900; Engel AK, 2001, NAT REV NEUROSCI, V2, P704, DOI 10.1038/35094565; Erchova IA, 2002, EUR J NEUROSCI, V15, P744, DOI 10.1046/j.0953-816x.2002.01898.x; Foffani G, 2004, J NEUROSCI, V24, P7266, DOI 10.1523/JNEUROSCI.2523-04.2004; Foffani G, 2009, J NEUROSCI, V29, P5964, DOI 10.1523/JNEUROSCI.4416-08.2009; Fujisawa S, 2008, NAT NEUROSCI, V11, P823, DOI 10.1038/nn.2134; Gerhard F, 2011, FRONT COMPUT NEUROSC, V5, P1, DOI [10.3389/fncom.2011.00004, 10.3389/fncom.2011.00023]; Ghazanfar AA, 2001, CEREB CORTEX, V11, P183, DOI 10.1093/cercor/11.3.183; Ghazanfar AA, 1997, J NEUROPHYSIOL, V78, P506, DOI 10.1152/jn.1997.78.1.506; Ghazanfar AA, 1999, CEREB CORTEX, V9, P348, DOI 10.1093/cercor/9.4.348; Haider B, 2009, NEURON, V62, P171, DOI 10.1016/j.neuron.2009.04.008; Harris KD, 2005, NAT REV NEUROSCI, V6, P399, DOI 10.1038/nrn1669; Harris KD, 2003, NATURE, V424, P552, DOI 10.1038/nature01834; Hebb Donald O., 1949, ORG BEHAV; Histed MH, 2009, NEURON, V63, P508, DOI 10.1016/j.neuron.2009.07.016; Hooks BM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000572; IZRAELI R, 1995, EXP BRAIN RES, V104, P41; Jadhav SP, 2009, NAT NEUROSCI, V12, P792, DOI 10.1038/nn.2328; Jones MC, 1996, J AM STAT ASSOC, V91, P401, DOI 10.2307/2291420; Josic K, 2009, NEURAL COMPUT, V21, P2774, DOI 10.1162/neco.2009.10-08-879; Kapfer C, 2007, NAT NEUROSCI, V10, P743, DOI 10.1038/nn1909; KIRKPATRICK S, 1983, SCIENCE, V220, P671, DOI 10.1126/science.220.4598.671; Kleinfeld D, 2006, CURR OPIN NEUROBIOL, V16, P435, DOI 10.1016/j.conb.2006.06.009; Kwon KY, 2009, I IEEE EMBS C NEUR E, P615; Lebedev MA, 2000, CEREB CORTEX, V10, P23, DOI 10.1093/cercor/10.1.23; Lindsey BG, 2000, RESP PHYSIOL, V122, P183, DOI 10.1016/S0034-5687(00)00158-4; Luo B, 2003, PATTERN RECOGN, V36, P2213, DOI 10.1016/S0031-3203(03)00084-0; Matyas F, 2010, SCIENCE, V330, P1240, DOI 10.1126/science.1195797; MERCIER BE, 1990, P NATL ACAD SCI USA, V87, P4388, DOI 10.1073/pnas.87.11.4388; Mirabella G, 2001, CEREB CORTEX, V11, P164, DOI 10.1093/cercor/11.2.164; Murphy KP., 2002, THESIS UC BERKELEY; Nettleton JS, 2000, J NEUROPHYSIOL, V83, P3310, DOI 10.1152/jn.2000.83.6.3310; NICOLL A, 1993, NEURAL COMPUT, V5, P665, DOI 10.1162/neco.1993.5.5.665; Niessing J, 2010, NATURE, V465, P47, DOI 10.1038/nature08961; Ohiorhenuan IE, 2010, NATURE, V466, P617, DOI 10.1038/nature09178; Panzeri S, 2001, NEURON, V29, P769, DOI 10.1016/S0896-6273(01)00251-3; PERKEL DH, 1967, BIOPHYS J, V7, P419, DOI 10.1016/S0006-3495(67)86597-4; Petersen CCH, 2007, NEURON, V56, P339, DOI 10.1016/j.neuron.2007.09.017; Petersen RS, 2002, CURR OPIN NEUROBIOL, V12, P441, DOI 10.1016/S0959-4388(02)00338-0; Petersen RS, 2001, NEURON, V32, P503, DOI 10.1016/S0896-6273(01)00481-0; Pillow JW, 2008, NATURE, V454, P995, DOI 10.1038/nature07140; Quiroga RQ, 2009, NAT REV NEUROSCI, V10, P173, DOI 10.1038/nrn2578; Schiff ND, 1999, J NEUROPHYSIOL, V82, P2182, DOI 10.1152/jn.1999.82.5.2182; Schneidman E, 2006, NATURE, V440, P1007, DOI 10.1038/nature04701; Schubert D, 2001, J NEUROSCI, V21, P3580, DOI 10.1523/JNEUROSCI.21-10-03580.2001; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; Shimegi S, 2000, J NEUROSCI, V20, P6241, DOI 10.1523/JNEUROSCI.20-16-06241.2000; SIMONS DJ, 1992, EXP BRAIN RES, V91, P259; Simons SB, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-43; Smith VA, 2006, PLOS COMPUT BIOL, V2, P1436, DOI 10.1371/journal.pcbi.0020161; Temereanca S, 2008, J NEUROSCI, V28, P11153, DOI 10.1523/JNEUROSCI.1586-08.2008; Truccolo W, 2005, J NEUROPHYSIOL, V93, P1074, DOI 10.1152/jn.00697.2004; Truccolo W, 2010, NAT NEUROSCI, V13, P105, DOI 10.1038/nn.2455; Varela F, 2001, NAT REV NEUROSCI, V2, P229, DOI 10.1038/35067550; Vijayan S, 2010, J NEUROPHYSIOL, V103, P2074, DOI 10.1152/jn.00474.2009; Wiest MC, 2005, J NEUROPHYSIOL, V93, P2966, DOI 10.1152/jn.00556.2004; Wilent WB, 2005, J NEUROSCI, V25, P2983, DOI 10.1523/JNEUROSCI.4906-04.2005; Wright N, 2010, J NEUROPHYSIOL, V103, P709, DOI 10.1152/jn.00560.2009; Yu J, 2004, BIOINFORMATICS, V20, P3594, DOI 10.1093/bioinformatics/bth448; Zhang ML, 2004, J NEUROPHYSIOL, V92, P1464, DOI 10.1152/jn.01272.2003	71	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2011	6	6							e21649	10.1371/journal.pone.0021649	http://dx.doi.org/10.1371/journal.pone.0021649			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786FZ	21738751	Green Submitted, Green Published, gold			2022-12-27	WOS:000292290100051
J	Sinkko, H; Lukkari, K; Jama, AS; Sihvonen, LM; Sivonen, K; Leivuori, M; Rantanen, M; Paulin, L; Lyra, C				Sinkko, Hanna; Lukkari, Kaarina; Jama, Abdullahi S.; Sihvonen, Leila M.; Sivonen, Kaarina; Leivuori, Mirja; Rantanen, Matias; Paulin, Lars; Lyra, Christina			Phosphorus Chemistry and Bacterial Community Composition Interact in Brackish Sediments Receiving Agricultural Discharges	PLOS ONE			English	Article							FRAGMENT-LENGTH-POLYMORPHISMS; RIBOSOMAL-RNA SEQUENCES; MARINE-SEDIMENTS; VERTICAL-DISTRIBUTION; MICROBIAL DIVERSITY; CHEMICAL CHARACTER; SULFATE REDUCTION; ORGANIC-MATTER; LAKE-SEDIMENTS; IRON	Background: External nutrient discharges have caused eutrophication in many estuaries and coastal seas such as the Baltic Sea. The sedimented nutrients can affect bacterial communities which, in turn, are widely believed to contribute to release of nutrients such as phosphorus from the sediment. Methods: We investigated relationships between bacterial communities and chemical forms of phosphorus as well as elements involved in its cycling in brackish sediments using up-to-date multivariate statistical methods. Bacterial community composition was determined by terminal restriction fragment length polymorphism and cloning of the 16S rRNA gene. Results and Conclusions: The bacterial community composition differed along gradients of nutrients, especially of different phosphorus forms, from the estuary receiving agricultural phosphorus loading to the open sea. This suggests that the chemical composition of sediment phosphorus, which has been affected by riverine phosphorus loading, influenced on bacterial communities. Chemical and spatial parameters explained 25% and 11% of the variation in bacterial communities. Deltaproteobacteria, presumptively sulphate and sulphur/iron reducing, were strongly associated to chemical parameters, also when spatial autocorrelation was taken into account. Sulphate reducers correlated positively with labile organic phosphorus and total nitrogen in the open sea sediments. Sulphur/iron reducers and sulphate reducers linked to iron reduction correlated positively with aluminium-and iron-bound phosphorus, and total iron in the estuary. The sulphate and sulphur/iron reducing bacteria can thus have an important role both in the mineralization and mobilization of nutrients from sediment. Significance: Novelty in our study is that relationships between bacterial community composition and different phosphorus forms, instead of total phosphorus, were investigated. Total phosphorus does not necessarily bring out interactions between bacteria and phosphorus chemistry since proportions of easily usable mobile (reactive) phosphorus and immobile phosphorus forms in different sediments can vary. Our study suggested possible feedbacks between different forms of phosphorus and bacterial community composition.	[Sinkko, Hanna; Jama, Abdullahi S.; Sihvonen, Leila M.; Sivonen, Kaarina; Lyra, Christina] Univ Helsinki, Dept Food & Environm Sci, Helsinki, Finland; [Lukkari, Kaarina] Ctr Marine Res, Finnish Environm Inst, Helsinki, Finland; [Sihvonen, Leila M.] Natl Inst Hlth & Welf, Helsinki, Finland; [Leivuori, Mirja] Finnish Environm Inst, Reference Lab, Helsinki, Finland; [Rantanen, Matias; Paulin, Lars] Univ Helsinki, Inst Biotechnol, Helsinki, Finland	University of Helsinki; Finnish Environment Institute; Finland National Institute for Health & Welfare; Finnish Environment Institute; University of Helsinki	Sinkko, H (corresponding author), Univ Helsinki, Dept Food & Environm Sci, Helsinki, Finland.	kaarina.sivonen@helsinki.fi		Sivonen, Kaarina/0000-0002-2904-0458; Sinkko, Hanna/0000-0002-4003-0429	Maj and Tor Nessling Foundation; Baltic Sea Research Program (BIREME) [202441]; Centre of Excellence [53305, 118637]; Academy of Finland [214457, 115400]	Maj and Tor Nessling Foundation; Baltic Sea Research Program (BIREME); Centre of Excellence; Academy of Finland(Academy of Finland)	This work was supported by Maj and Tor Nessling Foundation, Baltic Sea Research Program (BIREME, 202441), the Centre of Excellence (53305, 118637), and the grants of the Academy of Finland to K.S. (214457) and C.L. (115400). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdo Z, 2006, ENVIRON MICROBIOL, V8, P929, DOI 10.1111/j.1462-2920.2005.00959.x; AHLGREN J, 2006, ACTA U UPSALIENSIS, V160; Anderson M.J., 2003, DISTLM FORWARD FORTR; Anderson MJ, 1998, AUST J ECOL, V23, P158, DOI 10.1111/j.1442-9993.1998.tb00713.x; Anderson MJ, 2003, ECOLOGY, V84, P511, DOI 10.1890/0012-9658(2003)084[0511:CAOPCA]2.0.CO;2; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Anderson MJ, 2004, DISTLM V 5 FORTRAN C; Benitez-Nelson CR, 2004, LIMNOL OCEANOGR, V49, P1593, DOI 10.4319/lo.2004.49.5.1593; BERNER RA, 1970, AM J SCI, V268, P1, DOI 10.2475/ajs.268.1.1; BORCARD D, 1992, ECOLOGY, V73, P1045, DOI 10.2307/1940179; BOYLE EA, 1977, GEOCHIM COSMOCHIM AC, V41, P1313, DOI 10.1016/0016-7037(77)90075-8; Burdige DJ, 2007, CHEM REV, V107, P467, DOI 10.1021/cr050347q; Byrne ME, 2010, P NATL ACAD SCI USA, V107, P12263, DOI 10.1073/pnas.1001290107; CANFIELD DE, 1993, MAR GEOL, V113, P27, DOI 10.1016/0025-3227(93)90147-N; CARACO NF, 1989, NATURE, V341, P316, DOI 10.1038/341316a0; Carman R, 1998, VIE MILIEU, V48, P229; Cole JR, 2007, NUCLEIC ACIDS RES, V35, pD169, DOI 10.1093/nar/gkl889; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Conley DJ, 2009, ENVIRON SCI TECHNOL, V43, P3412, DOI 10.1021/es802762a; Conley DJ, 1999, HYDROBIOLOGIA, V410, P87, DOI 10.1023/A:1003784504005; DYBERN BI, 1981, BALTIC SEA, P351; Edlund A, 2006, ENVIRON MICROBIOL, V8, P223, DOI 10.1111/j.1462-2920.2005.00887.x; Edlund A, 2008, ENVIRON MICROBIOL, V10, P2051, DOI 10.1111/j.1462-2920.2008.01624.x; Ekholm P, 2007, AGR FOOD SCI, V16, P282, DOI 10.2137/145960607784125401; Elmgren R, 2001, AMBIO, V30, P222, DOI 10.1639/0044-7447(2001)030[0222:UHIOTB]2.0.CO;2; Engebretson JJ, 2003, APPL ENVIRON MICROB, V69, P4823, DOI 10.1128/AEM.69.8.4823-4829.2003; GACHTER R, 1993, HYDROBIOLOGIA, V253, P103, DOI 10.1007/BF00050731; Hartnett HE, 1998, NATURE, V391, P572, DOI 10.1038/35351; *HELCOM, 2010, HELCOM IN HOL ASS BA, V122; HELCOM, 1998, BALT SEA ENV P; HINGSTON FJ, 1972, J SOIL SCI, V23, P177, DOI 10.1111/j.1365-2389.1972.tb01652.x; Holmer M, 2001, FRESHWATER BIOL, V46, P431, DOI 10.1046/j.1365-2427.2001.00687.x; Howarth R, 2008, P NATL ACAD SCI USA, V105, pE103, DOI 10.1073/pnas.0807266106; Hupfer M, 2008, INT REV HYDROBIOL, V93, P415, DOI 10.1002/iroh.200711054; HUTCHENS E, 2006, GEOMICROBIOL J, V19, P343; Hyacinthe C, 2004, MAR CHEM, V91, P227, DOI 10.1016/j.marchem.2004.04.006; INGALL ED, 1993, GEOCHIM COSMOCHIM AC, V57, P303, DOI 10.1016/0016-7037(93)90433-W; JENSEN HS, 1993, HYDROBIOLOGIA, V253, P47, DOI 10.1007/BF00050721; Jordan TE, 2008, LIMNOL OCEANOGR, V53, P172, DOI 10.4319/lo.2008.53.1.0172; JORGENSEN BB, 1982, NATURE, V296, P643, DOI 10.1038/296643a0; Kitts C L, 2001, Curr Issues Intest Microbiol, V2, P17; Kononova SV, 2002, BIOCHEMISTRY-MOSCOW+, V67, P184, DOI 10.1023/A:1014409929875; KROM MD, 1981, GEOCHIM COSMOCHIM AC, V45, P207; KUEVER J, 2005, BERGEYS MANUAL SYS C, P1005; LANE DJ, 1985, P NATL ACAD SCI USA, V82, P6955, DOI 10.1073/pnas.82.20.6955; Legendre P., 2012, NUMERICAL ECOLOGY, V3rd ed.; Liu WT, 1997, APPL ENVIRON MICROB, V63, P4516, DOI 10.1128/AEM.63.11.4516-4522.1997; Lukkari K, 2008, BIOGEOCHEMISTRY, V90, P171, DOI 10.1007/s10533-008-9243-2; Lukkari K, 2009, BIOGEOCHEMISTRY, V96, P25, DOI 10.1007/s10533-009-9343-7; Lukkari K, 2007, LIMNOL OCEANOGR-METH, V5, P433, DOI 10.4319/lom.2007.5.433; Lukkari K, 2007, LIMNOL OCEANOGR-METH, V5, P445, DOI 10.4319/lom.2007.5.445; Lukkari K, 2009, BIOGEOCHEMISTRY, V94, P141, DOI 10.1007/s10533-009-9315-y; Mattila J, 2006, BOREAL ENVIRON RES, V11, P95; McArdle BH, 2001, ECOLOGY, V82, P290, DOI 10.1890/0012-9658(2001)082[0290:FMMTCD]2.0.CO;2; Mort HP, 2010, GEOCHIM COSMOCHIM AC, V74, P1350, DOI 10.1016/j.gca.2009.11.016; Mortimer CH, 1942, J ECOL, V30, P147, DOI 10.2307/2256691; Mortimer CH, 1941, J ECOL, V29, P280, DOI 10.2307/2256395; NAUTCH M, 2006, MAR ECOL-PROG SER, V321, P9; Oksanen J., 2008, VEGAN COMMUNITY ECOL; Paoli A, 2008, FEMS MICROBIOL ECOL, V64, P219, DOI 10.1111/j.1574-6941.2008.00459.x; Park HS, 2008, ANTON LEEUW INT J G, V93, P79, DOI 10.1007/s10482-007-9181-3; R Development Core Team, 2007, R LANG ENV STAT COMP; Rivers AR, 2009, ENVIRON MICROBIOL, V11, P382, DOI 10.1111/j.1462-2920.2008.01778.x; Sahm K, 1999, ENVIRON MICROBIOL, V1, P65, DOI 10.1046/j.1462-2920.1999.00007.x; Sait L, 2003, APPL ENVIRON MICROB, V69, P2100, DOI 10.1128/AEM.69.4.2100-2109.2003; SHOLKOVITZ ER, 1976, GEOCHIM COSMOCHIM AC, V40, P831, DOI 10.1016/0016-7037(76)90035-1; SUZUMURA M, 1995, GEOCHIM COSMOCHIM AC, V59, P1021, DOI 10.1016/0016-7037(95)00006-2; Ternan NG, 1998, WORLD J MICROB BIOT, V14, P635, DOI 10.1023/A:1008848401799; Uusitalo R, 2003, J ENVIRON QUAL, V32, P2007, DOI 10.2134/jeq2003.2007; Uusitalo R, 2000, WATER RES, V34, P2477, DOI 10.1016/S0043-1354(99)00419-4; Valpasvuo-Jaatinen P, 1997, AMBIO, V26, P448; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Welch SA, 2002, GEOMICROBIOL J, V19, P343, DOI 10.1080/01490450290098414; YliHalla M, 1996, AGR FOOD SCI FINLAND, V5, P193, DOI 10.23986/afsci.72735	74	32	34	4	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2011	6	6							e21555	10.1371/journal.pone.0021555	http://dx.doi.org/10.1371/journal.pone.0021555			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786FZ	21747910	Green Published, gold, Green Submitted			2022-12-27	WOS:000292290100038
J	Bode, S; He, AH; Soon, CS; Trampel, R; Turner, R; Haynes, JD				Bode, Stefan; He, Anna Hanxi; Soon, Chun Siong; Trampel, Robert; Turner, Robert; Haynes, John-Dylan			Tracking the Unconscious Generation of Free Decisions Using UItra-High Field fMRI	PLOS ONE			English	Article							ANTERIOR PREFRONTAL CORTEX; MEDIAL FRONTAL-CORTEX; HUMAN BRAIN; CONSCIOUS INTENTION; FRONTOPOLAR CORTEX; VISUAL-CORTEX; MOTOR AREAS; MOVEMENT; COGNITION; EXECUTION	Recently, we demonstrated using functional magnetic resonance imaging (fMRI) that the outcome of free decisions can be decoded from brain activity several seconds before reaching conscious awareness. Activity patterns in anterior frontopolar cortex (BA 10) were temporally the first to carry intention-related information and thus a candidate region for the unconscious generation of free decisions. In the present study, the original paradigm was replicated and multivariate pattern classification was applied to functional images of frontopolar cortex, acquired using ultra-high field fMRI at 7 Tesla. Here, we show that predictive activity patterns recorded before a decision was made became increasingly stable with increasing temporal proximity to the time point of the conscious decision. Furthermore, detailed questionnaires exploring subjects' thoughts before and during the decision confirmed that decisions were made spontaneously and subjects were unaware of the evolution of their decision outcomes. These results give further evidence that FPC stands at the top of the prefrontal executive hierarchy in the unconscious generation of free decisions.	[Bode, Stefan; He, Anna Hanxi; Soon, Chun Siong; Trampel, Robert; Turner, Robert; Haynes, John-Dylan] Max Planck Inst Human Cognit & Brain Sci, Leipzig, Germany; [Bode, Stefan; Haynes, John-Dylan] Univ Magdeburg, Dept Neurol, D-39106 Magdeburg, Germany; [He, Anna Hanxi] Univ Melbourne, Melbourne Med Sch, Melbourne, Vic, Australia; [Soon, Chun Siong; Haynes, John-Dylan] Bernstein Ctr Computat Neurosci Berlin, Berlin, Germany; [Soon, Chun Siong; Haynes, John-Dylan] Charite, D-13353 Berlin, Germany; [Soon, Chun Siong] Duke NUS Grad Med Sch, Singapore, Singapore; [Haynes, John-Dylan] Humboldt Univ, Grad Sch Mind & Brain, Berlin, Germany	Max Planck Society; Otto von Guericke University; University of Melbourne; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; National University of Singapore; Humboldt University of Berlin	Bode, S (corresponding author), Max Planck Inst Human Cognit & Brain Sci, Leipzig, Germany.	sbode@unimelb.edu.au; haynes@bccn-berlin.de	Soon, Chun Siong/O-8409-2017	He, Anna/0000-0002-6924-8798; Soon, Chun Siong/0000-0003-2073-4557; Bode, Stefan/0000-0002-0258-7795	Max Planck Society	Max Planck Society(Max Planck Society)	This work was funded by the Max Planck Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amodio DM, 2006, NAT REV NEUROSCI, V7, P268, DOI 10.1038/nrn1884; Badre D, 2009, NAT REV NEUROSCI, V10, P659, DOI 10.1038/nrn2667; Ball T, 1999, NEUROIMAGE, V10, P682, DOI 10.1006/nimg.1999.0507; Bode S, 2009, NEUROIMAGE, V45, P606, DOI 10.1016/j.neuroimage.2008.11.031; Boorman ED, 2009, NEURON, V62, P733, DOI 10.1016/j.neuron.2009.05.014; BREITMEYER BG, 1985, BEHAV BRAIN SCI, V8, P539, DOI 10.1017/S0140525X00044915; Brodmann K, 1909, VERGLEICHENDE LOKALI; Bunge S. A., 2007, NEUROSCIENCE RULE GU; Bunge Silvia A., 2004, Cognitive Affective & Behavioral Neuroscience, V4, P564; Burgess PW, 2007, TRENDS COGN SCI, V11, P290, DOI 10.1016/j.tics.2007.05.004; Burgess PW, 2001, NEUROPSYCHOLOGIA, V39, P545, DOI 10.1016/S0028-3932(00)00149-4; Christoff K, 2000, PSYCHOBIOLOGY, V28, P168; Christoff K, 2001, NEUROIMAGE, V14, P1136, DOI 10.1006/nimg.2001.0922; Cox DD, 2003, NEUROIMAGE, V19, P261, DOI 10.1016/S1053-8119(03)00049-1; Cunnington R, 2002, NEUROIMAGE, V15, P373, DOI 10.1006/nimg.2001.0976; Custers R, 2010, SCIENCE, V329, P47, DOI 10.1126/science.1188595; DEECKE L, 1987, J NEUROL NEUROSUR PS, V50, P1430, DOI 10.1136/jnnp.50.11.1430; Dehaene S, 2007, NEURON, V56, P384, DOI 10.1016/j.neuron.2007.10.004; Deiber MP, 1999, J NEUROPHYSIOL, V81, P3065, DOI 10.1152/jn.1999.81.6.3065; Duncan J, 2001, NAT REV NEUROSCI, V2, P820, DOI 10.1038/35097575; Haggard P, 2005, TRENDS COGN SCI, V9, P290, DOI 10.1016/j.tics.2005.04.012; Haggard P, 1999, EXP BRAIN RES, V126, P128, DOI 10.1007/s002210050722; Hampton AN, 2007, P NATL ACAD SCI USA, V104, P1377, DOI 10.1073/pnas.0606297104; Haxby JV, 2001, SCIENCE, V293, P2425, DOI 10.1126/science.1063736; Haynes JD, 2005, NAT NEUROSCI, V8, P686, DOI 10.1038/nn1445; Haynes JD, 2007, CURR BIOL, V17, P323, DOI 10.1016/j.cub.2006.11.072; Haynes JD, 2006, NAT REV NEUROSCI, V7, P523, DOI 10.1038/nrn1931; Herron JE, 2004, NEUROIMAGE, V21, P302, DOI 10.1016/j.neuroimage.2003.09.039; Jacobs B, 2001, CEREB CORTEX, V11, P558, DOI 10.1093/cercor/11.6.558; Jenkins IH, 2000, BRAIN, V123, P1216, DOI 10.1093/brain/123.6.1216; Kamitani Y, 2005, NAT NEUROSCI, V8, P679, DOI 10.1038/nn1444; Koechlin E, 2000, P NATL ACAD SCI USA, V97, P7651, DOI 10.1073/pnas.130177397; Koechlin E, 2007, SCIENCE, V318, P594, DOI 10.1126/science.1142995; KORNHUBE.HH, 1965, PFLUG ARCH GES PHYS, V284, P1, DOI 10.1007/BF00412364; Kriegeskorte N, 2006, P NATL ACAD SCI USA, V103, P3863, DOI 10.1073/pnas.0600244103; Kriegeskorte N, 2009, NAT NEUROSCI, V12, P535, DOI 10.1038/nn.2303; Kroger JK, 2002, CEREB CORTEX, V12, P477, DOI 10.1093/cercor/12.5.477; Lau HC, 2007, J COGNITIVE NEUROSCI, V19, P81, DOI 10.1162/jocn.2007.19.1.81; Lau HC, 2004, SCIENCE, V303, P1208, DOI 10.1126/science.1090973; Lepage M, 2000, P NATL ACAD SCI USA, V97, P506, DOI 10.1073/pnas.97.1.506; LIBET B, 1983, BRAIN, V106, P623, DOI 10.1093/brain/106.3.623; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Mouao-Miranda J, 2007, NEUROIMAGE, V36, P88, DOI 10.1016/j.neuroimage.2007.02.020; Muller KR, 2001, IEEE T NEURAL NETWOR, V12, P181, DOI 10.1109/72.914517; Mur M, 2009, SOC COGN AFFECT NEUR, V4, P101, DOI 10.1093/scan/nsn044; Nachev P, 2005, CURR BIOL, V15, P122, DOI 10.1016/j.cub.2005.01.006; Nachev P, 2007, NEUROIMAGE, V36, pT155, DOI 10.1016/j.neuroimage.2007.03.034; Norman KA, 2006, TRENDS COGN SCI, V10, P424, DOI 10.1016/j.tics.2006.07.005; Ongur D, 2003, J COMP NEUROL, V460, P425, DOI 10.1002/cne.10609; Passingham R., 1995, FRONTAL LOBES VOLUNT; Ramnani N, 2004, NAT REV NEUROSCI, V5, P184, DOI 10.1038/nrn1343; Rolls ET, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00033; Sakai K, 2008, ANNU REV NEUROSCI, V31, P219, DOI 10.1146/annurev.neuro.31.060407.125642; Semendeferi K, 2001, AM J PHYS ANTHROPOL, V114, P224, DOI 10.1002/1096-8644(200103)114:3<224::AID-AJPA1022>3.3.CO;2-9; Sigala N, 2008, P NATL ACAD SCI USA, V105, P11969, DOI 10.1073/pnas.0802569105; Smith PL, 2004, TRENDS NEUROSCI, V27, P161, DOI 10.1016/j.tins.2004.01.006; Soon CS, 2008, NAT NEUROSCI, V11, P543, DOI 10.1038/nn.2112; Trevena JA, 2002, CONSCIOUS COGN, V11, P162, DOI 10.1006/ccog.2002.0548; van de Grind W, 2002, CONSCIOUS COGN, V11, P241, DOI 10.1006/ccog.2002.0560; Wegner DM, 2003, TRENDS COGN SCI, V7, P65, DOI 10.1016/S1364-6613(03)00002-0	60	86	88	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2011	6	6							e21612	10.1371/journal.pone.0021612	http://dx.doi.org/10.1371/journal.pone.0021612			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	783OD	21760881	Green Published, gold			2022-12-27	WOS:000292092600062
J	Brzuszkiewicz, E; Weiner, J; Wollherr, A; Thurmer, A; Hupeden, J; Lomholt, HB; Kilian, M; Gottschalk, G; Daniel, R; Mollenkopf, HJ; Meyer, TF; Bruggemann, H				Brzuszkiewicz, Elzbieta; Weiner, January; Wollherr, Antje; Thuermer, Andrea; Huepeden, Jennifer; Lomholt, Hans B.; Kilian, Mogens; Gottschalk, Gerhard; Daniel, Rolf; Mollenkopf, Hans-Joachim; Meyer, Thomas F.; Brueggemann, Holger			Comparative Genomics and Transcriptomics of Propionibacterium acnes	PLOS ONE			English	Article							ESCHERICHIA-COLI; HUMAN KERATINOCYTES; GENE-CLUSTER; P-ACNES; EXPRESSION; PROTEINS; SKIN; IDENTIFICATION; INFECTIONS; ACTIVATION	The anaerobic Gram-positive bacterium Propionibacterium acnes is a human skin commensal that is occasionally associated with inflammatory diseases. Recent work has indicated that evolutionary distinct lineages of P. acnes play etiologic roles in disease while others are associated with maintenance of skin homeostasis. To shed light on the molecular basis for differential strain properties, we carried out genomic and transcriptomic analysis of distinct P. acnes strains. We sequenced the genome of the P. acnes strain 266, a type I-1a strain. Comparative genome analysis of strain 266 and four other P. acnes strains revealed that overall genome plasticity is relatively low; however, a number of island-like genomic regions, encoding a variety of putative virulence-associated and fitness traits differ between phylotypes, as judged from PCR analysis of a collection of P. acnes strains. Comparative transcriptome analysis of strains KPA171202 (type I-2) and 266 during exponential growth revealed inter-strain differences in gene expression of transport systems and metabolic pathways. In addition, transcript levels of genes encoding possible virulence factors such as dermatan-sulphate adhesin, polyunsaturated fatty acid isomerase, iron acquisition protein HtaA and lipase GehA were upregulated in strain 266. We investigated differential gene expression during exponential and stationary growth phases. Genes encoding components of the energy-conserving respiratory chain as well as secreted and virulence-associated factors were transcribed during the exponential phase, while the stationary growth phase was characterized by upregulation of genes involved in stress responses and amino acid metabolism. Our data highlight the genomic basis for strain diversity and identify, for the first time, the actively transcribed part of the genome, underlining the important role growth status plays in the inflammation-inducing activity of P. acnes. We argue that the disease-causing potential of different P. acnes strains is not only determined by the phylotype-specific genome content but also by variable gene expression.	[Brzuszkiewicz, Elzbieta; Wollherr, Antje; Thuermer, Andrea; Huepeden, Jennifer; Gottschalk, Gerhard; Daniel, Rolf] Univ Gottingen, Gottingen Genom Lab, Inst Microbiol & Genet, Gottingen, Germany; [Weiner, January] Max Planck Inst Infect Biol, Dept Immunol, Berlin, Germany; [Lomholt, Hans B.; Kilian, Mogens] Aarhus Univ, Dept Med Microbiol & Immunol, Aarhus, Denmark; [Mollenkopf, Hans-Joachim] Max Planck Inst Infect Biol, Core Facil Microarray, Berlin, Germany; [Meyer, Thomas F.; Brueggemann, Holger] Max Planck Inst Infect Biol, Dept Mol Biol, Berlin, Germany	University of Gottingen; Max Planck Society; Aarhus University; Max Planck Society; Max Planck Society	Brzuszkiewicz, E (corresponding author), Univ Gottingen, Gottingen Genom Lab, Inst Microbiol & Genet, Gottingen, Germany.	brueggemann@mpiib-berlin.mpg.de	Daniel, Rolf/AAQ-5933-2021; Mollenkopf, Hans-Joachim/AAH-2500-2019; Weiner, January/D-9470-2012; Meyer, Thomas F. F/J-2485-2013	Daniel, Rolf/0000-0002-8646-7925; Weiner, January/0000-0003-1438-7819; Meyer, Thomas F. F/0000-0002-6120-8679; Bruggemann, Holger/0000-0001-7433-0190; Mollenkopf, Hans-Joachim/0000-0003-1167-4783; Kilian, Mogens/0000-0002-5861-0472	Max Planck Society	Max Planck Society(Max Planck SocietyFoundation CELLEX)	Funding was provided by the Max Planck Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brown LCW, 2009, P NATL ACAD SCI USA, V106, P2549, DOI [10.1073/pnas.0900008105, 10.1073/pnas.0900008106]; Bruggemann H, 2004, SCIENCE, V305, P671, DOI 10.1126/science.1100330; Carver TJ, 2005, BIOINFORMATICS, V21, P3422, DOI 10.1093/bioinformatics/bti553; Chahal HK, 2009, BIOCHEMISTRY-US, V48, P10644, DOI 10.1021/bi901518y; Churchill GA, 2002, NAT GENET, V32, P490, DOI 10.1038/ng1031; Cogen AL, 2008, BRIT J DERMATOL, V158, P442, DOI 10.1111/j.1365-2133.2008.08437.x; Datta V, 2005, MOL MICROBIOL, V56, P681, DOI 10.1111/j.1365-2958.2005.04583.x; Dessinioti C, 2010, CLIN DERMATOL, V28, P2, DOI 10.1016/j.clindermatol.2009.03.012; Engelhardt K, 2010, APPL ENVIRON MICROB, V76, P7093, DOI 10.1128/AEM.01442-10; Falentin H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011748; Farrar MD, 2007, J BACTERIOL, V189, P4161, DOI 10.1128/JB.00106-07; Farrar MD, 2000, FEMS MICROBIOL LETT, V191, P183, DOI 10.1016/S0378-1097(00)00387-6; Fehri LF, 2011, INT J MED MICROBIOL, V301, P69, DOI 10.1016/j.ijmm.2010.08.014; GAMPER M, 1991, J BACTERIOL, V173, P4742, DOI 10.1128/jb.173.15.4742-4750.1991; Graham GM, 2004, BRIT J DERMATOL, V150, P421, DOI 10.1046/j.1365-2133.2004.05762.x; GRIBBON EM, 1993, J GEN MICROBIOL, V139, P1745, DOI 10.1099/00221287-139-8-1745; Gruening P, 2006, J BACTERIOL, V188, P361, DOI 10.1128/JB.188.2.361-369.2006; Holland C, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-230; Holmberg A, 2009, CLIN MICROBIOL INFEC, V15, P787, DOI 10.1111/j.1469-0691.2009.02747.x; Hu YM, 2006, INFECT IMMUN, V74, P861, DOI 10.1128/IAI.74.2.861-868.2006; Jakab E, 1996, YALE J BIOL MED, V69, P477; Jappe U, 2002, BRIT J DERMATOL, V146, P202, DOI 10.1046/j.1365-2133.2002.04602.x; Jones SA, 2007, INFECT IMMUN, V75, P4891, DOI 10.1128/IAI.00484-07; Jorgensen MG, 2009, J BACTERIOL, V191, P1191, DOI 10.1128/JB.01013-08; Jugeau S, 2005, BRIT J DERMATOL, V153, P1105, DOI 10.1111/j.1365-2133.2005.06933.x; Kim J, 2002, J IMMUNOL, V169, P1535, DOI 10.4049/jimmunol.169.3.1535; Langille MGI, 2009, BIOINFORMATICS, V25, P664, DOI 10.1093/bioinformatics/btp030; Liavonchanka A, 2006, P NATL ACAD SCI USA, V103, P2576, DOI 10.1073/pnas.0510144103; Lodes MJ, 2006, MICROBIOL-SGM, V152, P3667, DOI 10.1099/mic.0.29219-0; Lomholt HB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012277; Maghnouj A, 1998, J BACTERIOL, V180, P6468, DOI 10.1128/JB.180.24.6468-6475.1998; Makarova KS, 2006, BIOINFORMATICS, V22, P2581, DOI 10.1093/bioinformatics/btl418; McDowell A, 2005, J CLIN MICROBIOL, V43, P326, DOI 10.1128/JCM.43.1.326-334.2005; Miskin JE, 1997, MICROBIOL-UK, V143, P1745, DOI 10.1099/00221287-143-5-1745; Mujacic M, 2006, MOL MICROBIOL, V60, P1576, DOI 10.1111/j.1365-2958.2006.05207.x; Nagy I, 2005, J INVEST DERMATOL, V124, P931, DOI 10.1111/j.0022-202X.2005.23705.x; Nagy I, 2006, MICROBES INFECT, V8, P2195, DOI 10.1016/j.micinf.2006.04.001; Nelson KE, 2010, SCIENCE, V328, P994, DOI 10.1126/science.1183605; Overbeek R, 2003, NUCLEIC ACIDS RES, V31, P164, DOI 10.1093/nar/gkg148; Shin DH, 2004, ACTA CRYSTALLOGR D, V60, P903, DOI 10.1107/S0907444904005013; Soderquist B, 2010, ANAEROBE, V16, P304, DOI 10.1016/j.anaerobe.2009.10.009; Staden R, 2003, INTRO BIOINFORMATICS; Tanabe T, 2006, BBA-MOL BASIS DIS, V1762, P794, DOI 10.1016/j.bbadis.2006.07.006; Tech Maike, 2003, In Silico Biology, V3, P441; Valanne S, 2005, MICROBIOL-SGM, V151, P1369, DOI 10.1099/mic.0.27788-0; Wernersson R, 2007, NAT PROTOC, V2, P2677, DOI 10.1038/nprot.2007.370; Wilcox HE, 2007, BRIT J DERMATOL, V156, P460, DOI 10.1111/j.1365-2133.2006.07631.x; Wood H G, 1981, Curr Top Cell Regul, V18, P255; Yu Y, 2009, ACS CHEM BIOL, V4, P855, DOI 10.1021/cb900133x	50	90	94	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2011	6	6							e21581	10.1371/journal.pone.0021581	http://dx.doi.org/10.1371/journal.pone.0021581			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	783OD	21738717	Green Published, gold, Green Submitted			2022-12-27	WOS:000292092600055
J	Tachezy, R; Smahelova, J; Salakova, M; Arbyn, M; Rob, L; Skapa, P; Jirasek, T; Hamsikova, E				Tachezy, Ruth; Smahelova, Jana; Salakova, Martina; Arbyn, Marc; Rob, Lukas; Skapa, Petr; Jirasek, Tomas; Hamsikova, Eva			Human Papillomavirus Genotype Distribution in Czech Women and Men with Diseases Etiologically Linked to HPV	PLOS ONE			English	Article							INVASIVE CERVICAL-CANCER; PARTICLE VACCINE; PCR DETECTION; END-POINTS; INFECTION; LESIONS; PREVALENCE; VULVAR; DNA; WORLDWIDE	Background: The HPV prevalence and genotype distribution are important for the estimation of the impact of HPV-based cervical cancer screening and HPV vaccination on the incidence of diseases etiologically linked to HPVs. The HPV genotype distribution varies across different geographical regions. Therefore, we investigated the type-specific HPV prevalence in Czech women and men with anogenital diseases. Methods: We analyzed 157 squamous cell carcinoma samples, 695 precancerous lesion samples and 64 cervical, vulvar and anal condylomata acuminate samples. HPV detection and typing were performed by PCR with GP5+/6+ primers, reverse line blot assay and sequencing. Results: Thirty different HPV genotypes were detected in our study, HPV 16 being the most prevalent type both in precancerous lesions (45%) and squamous cell carcinomas (59%). In benign lesions, HPV 6 (72%) was the most common type. Altogether, 61% of carcinoma samples and 43% of precancerous lesion samples contained HPV 16 and/or 18. The presence of HPV types related to the vaccinal ones (HPV 31, 45, 33, 52, 58) were detected in 16% of carcinoma samples and 18% of precancerous lesion samples. HPV 16 and/or 18 were present in 76% of cervical cancer samples, 33% of CIN1, 43% CIN2 and 71% of CIN3 samples. HPV types 6 and/or 11 were detected in 84% samples of condylomata acuminate samples. Conclusions: The prevalence of vaccinal and related HPV types in patients with HPV-associated diseases in the Czech Republic is very high. We may assume that the implementation of routine vaccination against HPV would greatly reduce the burden of HPV-associated diseases in the Czech Republic.	[Tachezy, Ruth; Smahelova, Jana; Salakova, Martina; Hamsikova, Eva] Inst Hematol & Blood Transfus, Dept Expt Virol, CR-12820 Prague, Czech Republic; [Arbyn, Marc] Sci Inst Publ Hlth, Canc Epidemiol Unit, Brussels, Belgium; [Rob, Lukas] Charles Univ Prague, Dept Obstet & Gynecol, Fac Med 2, Prague, Czech Republic; [Skapa, Petr] Charles Univ Prague, Dept Pathol & Mol Med, Fac Med 2, Prague, Czech Republic; [Jirasek, Tomas] Charles Univ Prague, Dept Pathol, Fac Med 3, Prague, Czech Republic	Institute of Hematology Prague; Charles University Prague; Charles University Prague; Charles University Prague	Tachezy, R (corresponding author), Inst Hematol & Blood Transfus, Dept Expt Virol, CR-12820 Prague, Czech Republic.	rutach@uhkt.cz	Šmahelová, Jana/N-4284-2017; Tachezy, Ruth/H-3785-2017; Škapa, Petr/W-4830-2018; Rob, Lukas/AFQ-9215-2022; Jirásek, Tomáš/AAH-5957-2020; Salakova, Martina/N-4288-2017	Šmahelová, Jana/0000-0002-9164-4279; Tachezy, Ruth/0000-0001-7689-9727; Škapa, Petr/0000-0002-7722-3718; Rob, Lukas/0000-0003-3770-651X; Salakova, Martina/0000-0003-0827-1211	Ministry of Health of the Czech Republic [NS 10/656-3/2009]; European Commission (DG of SANCO, Luxembourg, Grand-Duchy of Luxembourg); DG Research of the European Commission [242061]; Sanofi-Pasteur MSD (manufacturer of a quadrivalent HPV vaccine)	Ministry of Health of the Czech Republic(Ministry of Health, Czech Republic); European Commission (DG of SANCO, Luxembourg, Grand-Duchy of Luxembourg)(European CommissionEuropean Commission Joint Research Centre); DG Research of the European Commission(European CommissionEuropean Commission Joint Research Centre); Sanofi-Pasteur MSD (manufacturer of a quadrivalent HPV vaccine)	This work was supported by grant NS 10/656-3/2009 from the Ministry of Health of the Czech Republic). M. Arbyn was supported by the European Commission (DG of SANCO, Luxembourg, Grand-Duchy of Luxembourg), through the ECCG project (European Cooperation on development and implementation of Cancer screening and prevention Guidelines, IARC, Lyon, France) and the 7th Framework Programme of DG Research of the European Commission through the PREHDICT project (grant No. 242061, coordinated by the Vrije Universiteit Amsterdam, the Netherlands). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have read the journal's policy and RT, LR, and EH have the following conflicts: membership in the Czech GSK advisory board for the prevention of cervical carcinoma. MA had membership in the Belgian advisory board up to 2008 for Cervarix (bivalent HPV vaccine, produced by GSK) and received travel funding from Sanofi-Pasteur MSD (manufacturer of a quadrivalent HPV vaccine). MS, JS, TJ, and PS have declared that no competing interests exist.	[Anonymous], 2007, IARC MON EV CARC RIS; [Anonymous], 2010, CANC INCIDENCE 2007; Arbyn M, 2007, ANN ONCOL, V18, P1423, DOI 10.1093/annonc/mdm377; Arbyn M, 2010, ANN ONCOL, V21, P448, DOI 10.1093/annonc/mdp471; Arbyn M, 2010, INT J BIOL MARKER, V25, P117, DOI 10.1177/172460081002500301; Bardin A, 2008, EUR J CANCER, V44, P557, DOI 10.1016/j.ejca.2007.12.001; Bernard HU, 2010, VIROLOGY, V401, P70, DOI 10.1016/j.virol.2010.02.002; Brown DR, 2009, J INFECT DIS, V199, P926, DOI 10.1086/597307; Clifford GM, 2003, BRIT J CANCER, V89, P101, DOI 10.1038/sj.bjc.6601024; Clifford GM, 2005, CANCER EPIDEM BIOMAR, V14, P1157, DOI 10.1158/1055-9965.EPI-04-0812; Clifford GM, 2003, BRIT J CANCER, V88, P63, DOI 10.1038/sj.bjc.6600688; de Sanjose S, 2007, LANCET INFECT DIS, V7, P453, DOI 10.1016/S1473-3099(07)70158-5; de Sanjose S, 2010, LANCET ONCOL, V11, P1048, DOI 10.1016/S1470-2045(10)70230-8; De Vuyst H, 2009, INT J CANCER, V124, P1626, DOI 10.1002/ijc.24116; Eklund C, 2010, J CLIN MICROBIOL, V48, P4147, DOI 10.1128/JCM.00918-10; Garland SM, 2009, CANCER EPIDEM BIOMAR, V18, P1777, DOI 10.1158/1055-9965.EPI-09-0067; Gillison Maura L, 2003, J Natl Cancer Inst Monogr, P57; HO GYF, 1995, JNCI-J NATL CANCER I, V87, P1365, DOI 10.1093/jnci/87.18.1365; Hoots BE, 2009, INT J CANCER, V124, P2375, DOI 10.1002/ijc.24215; Jenkins D, 2008, GYNECOL ONCOL, V110, pS18, DOI 10.1016/j.ygyno.2008.06.027; Kornya L, 2002, EUR J OBSTET GYN R B, V100, P231, DOI 10.1016/S0301-2115(01)00474-2; Kowalewska M, 2010, INT J GYNECOL CANCER, V20, P434, DOI 10.1111/IGC.0b013e3181d320f1; Kreimer AR, 2005, CANCER EPIDEM BIOMAR, V14, P467, DOI 10.1158/1055-9965.EPI-04-0551; Kuhmala SMA, 2007, J MED VIROL, V79, P771, DOI 10.1002/jmv.20839; Munoz N, 2004, INT J CANCER, V111, P278, DOI 10.1002/ijc.20244; Munoz N, 2003, NEW ENGL J MED, V348, P518, DOI 10.1056/NEJMoa021641; Munoz N, 2010, JNCI-J NATL CANCER I, V102, P325, DOI 10.1093/jnci/djp534; Paovonen J, 2009, LANCET, V374, P301, DOI 10.1016/S0140-6736(09)61248-4; Parkin DM, 2006, VACCINE S3, V24, pS3/11; Remmerbach TW, 2004, J CLIN VIROL, V30, P302, DOI 10.1016/j.jcv.2003.12.011; Sabol I, 2008, J CLIN MICROBIOL, V46, P1606, DOI 10.1128/JCM.02328-07; SAIKI RK, 1985, SCIENCE, V230, P1350, DOI 10.1126/science.2999980; Shipitsyna E, 2011, CANCER EPIDEMIOL, V35, P160, DOI 10.1016/j.canep.2010.08.010; Skapa P, 2007, AM J SURG PATHOL, V31, P1834, DOI 10.1097/PAS.0b013e3180686d10; Smith JS, 2007, INT J CANCER, V121, P621, DOI 10.1002/ijc.22527; Smith JS, 2009, OBSTET GYNECOL, V113, P917, DOI 10.1097/AOG.0b013e31819bd6e0; Speich N, 2004, J MED MICROBIOL, V53, P125, DOI 10.1099/jmm.0.05447-0; Szostek S, 2008, ACTA BIOCHIM POL, V55, P687; Tachezy R, 2007, APMIS, V115, P195, DOI 10.1111/j.1600-0463.2007.apm_526.x; Tachezy R, 2006, EUR J CLIN MICROBIOL, V25, P492, DOI 10.1007/s10096-006-0172-5; Tachezy R, 1999, J MED VIROL, V58, P378, DOI 10.1002/(SICI)1096-9071(199908)58:4&lt;378::AID-JMV10&gt;3.0.CO;2-P; van den Brule AJC, 2002, J CLIN MICROBIOL, V40, P779, DOI 10.1128/JCM.40.3.779-787.2002; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F; Wentzensen N, 2009, INT J CANCER, V125, P2151, DOI 10.1002/ijc.24528; Wheeler CM, 2009, J INFECT DIS, V199, P936, DOI 10.1086/597309; zur Hausen H, 1975, Bibl Haematol, P569	46	18	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2011	6	7							e21913	10.1371/journal.pone.0021913	http://dx.doi.org/10.1371/journal.pone.0021913			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	792WQ	21765924	Green Published, gold, Green Submitted			2022-12-27	WOS:000292781500021
J	Zhou, Y; Wei, Y; Zhu, J; Wang, QY; Bao, L; Ma, Y; Chen, Y; Feng, DQ; Zhang, AJ; Sun, J; Nallar, SC; Shen, K; Kalvakolanu, DV; Xiao, WH; Ling, B				Zhou, Ying; Wei, Ying; Zhu, Jing; Wang, Qingyuan; Bao, Liang; Ma, Yang; Chen, Yu; Feng, Dingqing; Zhang, Aijin; Sun, Jie; Nallar, Shreeram C.; Shen, Keng; Kalvakolanu, Dhananjaya V.; Xiao, Weihua; Ling, Bin			GRIM-19 Disrupts E6/E6AP Complex to Rescue p53 and Induce Apoptosis in Cervical Cancers	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS TYPE-16; UBIQUITIN-PROTEIN LIGASE; CELL-DEATH; E6-ASSOCIATED PROTEIN; E2 PROTEINS; E6-MEDIATED DEGRADATION; NUCLEAR-LOCALIZATION; E6 ONCOPROTEIN; GENE; E6-AP	Background: Our previous studies showed a down-regulation of GRIM-19 in primary human cervical cancers, and restoration of GRIM-19 induced tumor regression. The induction of tumor suppressor protein p53 ubiquitination and degradation by E6 oncoportein of high risk-HPV through forming a stable complex with E6AP is considered as a critical mechanism for cervical tumor development. The aims of this study were to determine the potential role of GRIM-19 in rescuing p53 protein and inducing cervical cancer cell apoptosis. Methodology/Principal Findings: The protein levels of GRIM-19 and p53 were detected in normal cervical tissues from 45 patients who underwent hysterectomy for reasons other than neoplasias of either the cervix or endometrium, and cervical cancer tissues from 60 patients with non-metastatic squamous epithelial carcinomas. Coimmunoprecipitation and GST pull-down assay were performed to examine the interaction of GRIM-19 with 18E6 and E6AP in vivo and in vitro respectively. The competition of 18E6 with E6AP in binding GRIM-19 by performing competition pull-down assays was designed to examine the disruption of E6/E6AP complex by GRIM-19. The augment of E6AP ubiquitination by GRIM-19 was detected in vivo and in vitro ubiquitination assay. The effects of GRIM-19-dependent p53 accumulation on cell proliferation, cell cycle, apoptosis were explored by MTT, flow cytometry and transmission electron microscopy respectively. The tumor suppression was detected by xenograft mouse model. Conclusion/Significance: The levels of GRIM-19 and p53 were concurrently down regulated in cervical cancers. The restoration of GRIM-19 can induce ubiquitination and degradation of E6AP, and disrupt the E6/E6AP complex through the interaction of N-terminus of GRIM-19 with both E6 and E6AP, which protected p53 from degradation and promoted cell apoptosis. Tumor xenograft studies also revealed the suppression of p53 degradation in presence of GRIM-19. These data suggest that GRIM-19 can block E6/E6AP complex; and synergistically suppress cervical tumor growth with p53.	[Zhou, Ying; Wei, Ying; Zhu, Jing; Wang, Qingyuan; Chen, Yu; Feng, Dingqing; Ling, Bin] Anhui Med Univ, Dept Obstet & Gynecol, Anhui Prov Hosp Affiliated, Hefei, Anhui, Peoples R China; [Bao, Liang; Ma, Yang; Zhang, Aijin; Sun, Jie; Xiao, Weihua] Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Hefei 230026, Anhui, Peoples R China; [Bao, Liang; Ma, Yang; Zhang, Aijin; Sun, Jie; Xiao, Weihua] Univ Sci & Technol China, Sch Life Sci, Hefei 230026, Anhui, Peoples R China; [Nallar, Shreeram C.; Kalvakolanu, Dhananjaya V.] Univ Maryland, Sch Med, Greenebaum Canc Ctr, Dept Microbiol & Immunol, Baltimore, MD 21201 USA; [Shen, Keng] Peking Union Med Coll Hosp, Dept Obstet & Gynecol, Beijing, Peoples R China	Anhui Medical University; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; University System of Maryland; University of Maryland Baltimore; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital	Zhou, Y (corresponding author), Anhui Med Univ, Dept Obstet & Gynecol, Anhui Prov Hosp Affiliated, Hefei, Anhui, Peoples R China.	xiaow@ustc.edu.cn; lingbin.ling@gmail.com	Xiao, Weihua/N-2775-2013	Xiao, Weihua/0000-0001-9102-6326	National Basic Research Program of China (973 Program) [2007CB914503]; National Natural Science Foundation of China [81071683, 81001168 81072127, 91029710]; National Technology Support Programme [2008BAI57B03]; National Institutes of Health [CA105005, CA78282, P30-CA134274]; Anhui Provincial Natural Science Foundation [20090413117, 11040606M178]; Anhui Provincial Higher University Education [KJ2010B375]; NATIONAL CANCER INSTITUTE [R01CA105005, P30CA134274, R01CA078282] Funding Source: NIH RePORTER	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Technology Support Programme; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Anhui Provincial Natural Science Foundation(Natural Science Foundation of Anhui Province); Anhui Provincial Higher University Education; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Basic Research Program of China (973 Program): 2007CB914503 http://www.973.gov.cn, National Natural Science Foundation of China (No. 81071683, 81001168 81072127 and 91029710) http://www.nsfc.gov.cn, "Eleventh Five-Year" National Technology Support Programme (2008BAI57B03) http://kjzc.jhgl.org, National Institutes of Health grants CA105005, CA78282 and P30-CA134274 http://grants.nih.gov. Anhui Provincial Natural Science Foundation project (20090413117, 11040606M178) http://www.ahkjt.gov.cn, and Provincial Natural Science Research Project of Anhui Provincial Higher University Education (KJ2010B375) http://www.ahedu.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alchanati I, 2006, ONCOGENE, V25, P7138, DOI 10.1038/sj.onc.1209708; Angell JE, 2000, J BIOL CHEM, V275, P33416, DOI 10.1074/jbc.M003929200; Baleja JD, 2006, ANTIVIR RES, V72, P49, DOI 10.1016/j.antiviral.2006.03.014; Beaudenon S, 2008, BMC BIOCHEM, V9, DOI 10.1186/1471-2091-9-S1-S4; Blachon S, 2003, BIOCHIMIE, V85, P813, DOI 10.1016/j.biochi.2003.09.008; Castellsague X, 2008, GYNECOL ONCOL, V110, pS4, DOI 10.1016/j.ygyno.2008.07.045; El-Mofty SK, 2007, HEAD NECK PATHOL, V1, P181, DOI 10.1007/s12105-007-0021-6; Fang P, 1999, HUM MOL GENET, V8, P129, DOI 10.1093/hmg/8.1.129; Gewin L, 2004, GENE DEV, V18, P2269, DOI 10.1101/gad.1214704; Hegde RS, 2002, ANNU REV BIOPH BIOM, V31, P343, DOI 10.1146/annurev.biophys.31.100901.142129; Hengstermann A, 2001, P NATL ACAD SCI USA, V98, P1218, DOI 10.1073/pnas.031470698; Hodge DR, 2004, CANCER BIOL THER, V3, P188, DOI 10.4161/cbt.3.2.621; Hou SY, 2002, J BIOL CHEM, V277, P45619, DOI 10.1074/jbc.M206829200; Jiang YH, 1998, NEURON, V21, P799, DOI 10.1016/S0896-6273(00)80596-6; Kelley ML, 2005, J VIROL, V79, P3737, DOI 10.1128/JVI.79.6.3737-3747.2005; Kishino T, 1997, NAT GENET, V15, P70, DOI 10.1038/ng0197-70; Kuballa P, 2007, J BIOL CHEM, V282, P65, DOI 10.1074/jbc.M605117200; Lee D, 2010, CANCER LETT, V292, P125, DOI 10.1016/j.canlet.2009.11.015; Lee TL, 2008, INT J CANCER, V122, P1987, DOI 10.1002/ijc.23324; Lin J, 2002, ONCOGENE, V21, P3082, DOI 10.1038/sj.onc.1205426; Louria-Hayon I, 2009, CELL DEATH DIFFER, V16, P1156, DOI 10.1038/cdd.2009.31; Lufei CC, 2003, EMBO J, V22, P1325, DOI 10.1093/emboj/cdg135; Ma X, 2007, ONCOGENE, V26, P4842, DOI 10.1038/sj.onc.1210287; Marur S, 2010, LANCET ONCOL, V11, P781, DOI 10.1016/S1470-2045(10)70017-6; Masson M, 2003, J GEN VIROL, V84, P2099, DOI 10.1099/vir.0.18961-0; Moody CA, 2010, NAT REV CANCER, V10, P550, DOI 10.1038/nrc2886; Moscicki AB, 2006, VACCINE S3, V24; Mou H Z, 1994, Zhonghua Fu Chan Ke Za Zhi, V29, P162; Murph MM, 2007, MOL CANCER RES, V5, P1201, DOI 10.1158/1541-7786.MCR-06-0338; Narisawa-Saito M, 2007, CANCER SCI, V98, P1505, DOI 10.1111/j.1349-7006.2007.00546.x; Nawaz Z, 1999, P NATL ACAD SCI USA, V96, P1858, DOI 10.1073/pnas.96.5.1858; Nguyen M, 2002, J VIROL, V76, P13039, DOI 10.1128/JVI.76.24.13039-13048.2002; Niu GL, 2005, MOL CELL BIOL, V25, P7432, DOI 10.1128/MCB.25.17.7432-7440.2005; Nuber U, 1998, EUR J BIOCHEM, V254, P643, DOI 10.1046/j.1432-1327.1998.2540643.x; Oda H, 1999, P NATL ACAD SCI USA, V96, P9557, DOI 10.1073/pnas.96.17.9557; Ramamoorthy Sivapriya, 2008, Nucl Recept Signal, V6, pe006, DOI 10.1621/nrs.06006; SCHEFFNER M, 1990, CELL, V63, P1129, DOI 10.1016/0092-8674(90)90409-8; SCHEFFNER M, 1993, CELL, V75, P495, DOI 10.1016/0092-8674(93)90384-3; Scheffner M, 1998, PHARMACOL THERAPEUT, V78, P129, DOI 10.1016/S0163-7258(98)00003-5; Sehr P, 2007, J BIOMOL SCREEN, V12, P560, DOI 10.1177/1087057107301246; Seo T, 2002, J VIROL, V76, P8797, DOI 10.1128/JVI.76.17.8797-8807.2002; Shai A, 2010, CANCER RES, V70, P5064, DOI 10.1158/0008-5472.CAN-09-3307; Song SY, 1999, J VIROL, V73, P5887, DOI 10.1128/JVI.73.7.5887-5893.1999; Sun G, 2008, INT J ONCOL, V32, P1065; Sun P, 2009, ONCOGENE, V28, P1339, DOI 10.1038/onc.2008.480; Sun P, 2010, J BIOL CHEM, V285, P27545, DOI 10.1074/jbc.M110.105767; Syrjanen KJ, 2002, J CLIN PATHOL, V55, P885, DOI 10.1136/jcp.55.12.885; Talis AL, 1998, J BIOL CHEM, V273, P6439, DOI 10.1074/jbc.273.11.6439; Tommasino M, 2003, HUM MUTAT, V21, P307, DOI 10.1002/humu.10178; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F; Wang HB, 2010, J BIOL CHEM, V285, P13201, DOI 10.1074/jbc.M109.058669; Yamamoto Y, 1997, GENOMICS, V41, P263, DOI 10.1006/geno.1997.4617; Yang YC, 2006, BIOCHEM BIOPH RES CO, V343, P428, DOI 10.1016/j.bbrc.2006.02.166; Yeo WM, 2008, J VIROL, V82, P1011, DOI 10.1128/JVI.01156-07; Zaaroor-Regev D, 2010, P NATL ACAD SCI USA, V107, P6788, DOI 10.1073/pnas.1003108107; Zhang HFM, 2005, MOL CELL BIOL, V25, P6247, DOI 10.1128/MCB.25.14.6247-6258.2005; Zhang J, 2003, P NATL ACAD SCI USA, V100, P9342, DOI 10.1073/pnas.1633516100; Zhang L, 2008, CLIN CANCER RES, V14, P559, DOI 10.1158/1078-0432.CCR-07-1176; Zhao CY, 2010, CANCER RES, V70, P3372, DOI 10.1158/0008-5472.CAN-09-2787; Zhou Y, 2009, J INTERF CYTOK RES, V29, P695, DOI 10.1089/jir.2009.0003	60	20	23	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2011	6	7							e22065	10.1371/journal.pone.0022065	http://dx.doi.org/10.1371/journal.pone.0022065			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791WM	21765936	Green Published, gold, Green Submitted			2022-12-27	WOS:000292699000022
J	Abdel-Haleem, AM; El-Zeiry, MI; Mahran, LG; Abou-Aisha, K; Rady, MH; Rohde, J; Mostageer, M; Spahn-Langguth, H				Abdel-Haleem, Alyaa M.; El-Zeiry, Maha I.; Mahran, Laila G.; Abou-Aisha, Khaled; Rady, Mona H.; Rohde, Jan; Mostageer, Marwa; Spahn-Langguth, Hilde			Expression of RFC/SLC19A1 is Associated with Tumor Type in Bladder Cancer Patients	PLOS ONE			English	Article							REDUCED FOLATE CARRIER; ACUTE LYMPHOBLASTIC-LEUKEMIA; GENE-EXPRESSION; ANTIFOLATE RESISTANCE; CELLULAR PHARMACOLOGY; TRANSCRIPTION FACTORS; MEMBRANE-TRANSPORT; METHOTREXATE; CELLS; OSTEOSARCOMA	Urinary bladder cancer (UBC) ranks ninth in worldwide cancer. In Egypt, the pattern of bladder cancer is unique in that both the transitional and squamous cell types prevail. Despite much research on the topic, it is still difficult to predict tumor progression, optimal therapy and clinical outcome. The reduced folate carrier (RFC/SLC19A1) is the major transport system for folates in mammalian cells and tissues. RFC is also the primary means of cellular uptake for antifolate cancer chemotherapeutic drugs, however, membrane transport of antifolates by RFC is considered as limiting to antitumor activity. The purpose of this study was to compare the mRNA expression level of RFC/SLC19A1 in urothelial and non-urothelial variants of bladder carcinomas. Quantification of RFC mRNA in the mucosa of 41 untreated bladder cancer patients was performed using RT-qPCR. RFC mRNA steady-state levels were similar to 9-fold higher (N = 39; P < 0.0001) in bladder tumor specimens relative to normal bladder mRNA. RFC upregulation was strongly correlated with tumor type (urothelial vs. non-urothelial; p < 0.05) where median RFC mRNA expression was significantly (p < 0.05) higher in the urothelial (similar to 14-fold) compared to the non-urothelial (similar to 4-fold) variant. This may account for the variation in response to antifolate-containing regimens used in the treatment of either type. RFC mRNA levels were not associated with tumor grade (I, II and III) or stage (muscle-invasive vs. non-muscle invasive) implying that RFC cannot be used for prognostic purposes in bladder carcinomas and its increased expression is an early event in human bladder tumors pathogenesis. Further, RFC can be considered as a potential marker for predicting response to antifolate chemotherapy in urothelial carcinomas.	[Abdel-Haleem, Alyaa M.; El-Zeiry, Maha I.; Mahran, Laila G.; Abou-Aisha, Khaled; Rady, Mona H.; Rohde, Jan; Mostageer, Marwa; Spahn-Langguth, Hilde] German Univ Cairo, Dept Pharmacol & Toxicol, Cairo, Egypt; [Spahn-Langguth, Hilde] Graz Univ, Inst Pharmaceut Sci, Dept Pharmaceut Chem, Graz, Austria	Egyptian Knowledge Bank (EKB); German University in Cairo; University of Graz	Abdel-Haleem, AM (corresponding author), German Univ Cairo, Dept Pharmacol & Toxicol, Cairo, Egypt.	alyaa.abdelhaleem@guc.edu; egspahnlan@uni-graz.at		Rady, Mona/0000-0002-7561-853X	DAAD; GUC	DAAD(Deutscher Akademischer Austausch Dienst (DAAD)); GUC	This work was funded by the DAAD as well as GUC as MSC project funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Assaraf YG, 2007, CANCER METAST REV, V26, P153, DOI 10.1007/s10555-007-9049-z; Blount BC, 1997, P NATL ACAD SCI USA, V94, P3290, DOI 10.1073/pnas.94.7.3290; BRADELY D, 2010, MVAC NEW IMPROVED 3, P247; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Choi SW, 2000, J NUTR, V130, P129, DOI 10.1093/jn/130.2.129; Eissa S, 2000, CLIN CHIM ACTA, V300, P159, DOI 10.1016/S0009-8981(00)00317-X; Erdemir F, 2007, INT UROL NEPHROL, V39, P803, DOI 10.1007/s11255-006-9151-0; Felix AS, 2008, CANCER CAUSE CONTROL, V19, P421, DOI 10.1007/s10552-007-9104-7; Flatley RM, 2004, CLIN CANCER RES, V10, P5111, DOI 10.1158/1078-0432.CCR-04-0116; Frisch M, 2009, NUCLEIC ACIDS RES, V37, pW135, DOI 10.1093/nar/gkp303; GOLDMAN ID, 1985, PHARMACOL THERAPEUT, V28, P77, DOI 10.1016/0163-7258(85)90083-X; Goldman ID, 2002, SEMIN ONCOL, V29, P3, DOI 10.1053/sonc.2002.37461; GORLICK R, 2000, MIL DRUG TH, P9; GREENE FL, AJCC CANC STAGING AT; Guo W, 1999, CLIN CANCER RES, V5, P621; Haitel A, 2001, J UROLOGY, V165, P1481, DOI 10.1016/S0022-5347(05)66332-X; Matherly LH, 2008, VITAM HORM, V79, P145, DOI 10.1016/S0083-6729(08)00405-6; Matherly LH, 2007, CANCER METAST REV, V26, P111, DOI 10.1007/s10555-007-9046-2; Matherly LH, 2003, VITAM HORM, V66, P403, DOI 10.1016/S0083-6729(03)01012-4; MATHERLY LH, 2008, STRUCTURE FUNCTION R; Memon AA, 2004, BRIT J CANCER, V91, P2034, DOI 10.1038/sj.bjc.6602251; Ohl F, 2006, J UROLOGY, V175, P1915, DOI 10.1016/S0022-5347(05)00919-5; Parkin DM, 2008, SCAND J UROL NEPHROL, V42, P12, DOI 10.1080/03008880802285032; Ploeg M, 2009, WORLD J UROL, V27, P289, DOI 10.1007/s00345-009-0383-3; Reznikoff CA, 2000, UROL ONCOL, V5, P191, DOI 10.1016/S1078-1439(00)00079-X; Rothem L, 2004, MOL PHARMACOL, V66, P1536, DOI 10.1124/mol.104.004135; Rothem L, 2003, J BIOL CHEM, V278, P8935, DOI 10.1074/jbc.M209578200; Schabath MB, 2005, NUTR CANCER, V53, P144, DOI 10.1207/s15327914nc5302_3; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Sirotnak FM, 1999, ANNU REV NUTR, V19, P91, DOI 10.1146/annurev.nutr.19.1.91; Sowers R, 2003, MOL CANCER THER, V2, P535; UEKI O, 1992, CANCER CHEMOTH PHARM, V30, pS72, DOI 10.1007/BF00686947; Whetstine JR, 2001, J BIOL CHEM, V276, P6350, DOI 10.1074/jbc.M008074200; Wu XR, 2005, NAT REV CANCER, V5, P713, DOI 10.1038/nrc1697; Zhang L, 1998, CLIN CANCER RES, V4, P2169	35	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2011	6	7							e21820	10.1371/journal.pone.0021820	http://dx.doi.org/10.1371/journal.pone.0021820			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791IA	21760912	Green Published, gold, Green Submitted			2022-12-27	WOS:000292657200024
J	Kang, HY; Wang, Y; Fedak, G; Cao, WG; Zhang, HQ; Fan, X; Sha, LN; Xu, LL; Zheng, YL; Zhou, YH				Kang, Houyang; Wang, Yi; Fedak, George; Cao, Wenguang; Zhang, Haiqin; Fan, Xing; Sha, Lina; Xu, Lili; Zheng, Youliang; Zhou, Yonghong			Introgression of Chromosome 3Ns from Psathyrostachys huashanica into Wheat Specifying Resistance to Stripe Rust	PLOS ONE			English	Article							F-SP TRITICI; BREAD WHEAT; CYTOGENETIC CHARACTERIZATION; CONFERRING RESISTANCE; DISEASE RESISTANCE; SUBSTITUTION LINES; GENES; TRANSLOCATIONS; LOCATION; MARKERS	Wheat stripe rust is a destructive disease in the cool and humid wheat-growing areas of the world. Finding diverse sources of stripe rust resistance is critical for increasing genetic diversity of resistance for wheat breeding programs. Stripe rust resistance was identified in the alien species Psathyrostachys huashanica, and a wheat- P. huashanica amphiploid line (PHWSA) with stripe rust resistance was reported previously. In this study, a P. huashanica 3Ns monosomic addition line (PW11) with superior resistance to stripe rust was developed, which was derived from the cross between PHW-SA and wheat J-11. We evaluated the alien introgressions PW11-2, PW11-5 and PW11-8 which were derived from line PW11 for reaction to new Pst race CYR32, and used molecular and cytogenetic tools to characterize these lines. The introgressions were remarkably resistant to CYR32, suggesting that the resistance to stripe rust of the introgressions thus was controlled by gene(s) located on P. huashanica chromosome 3Ns. All derived lines were cytologically stable in term of meiotic chromosome behavior. Two 3Ns chromosomes of P. huashanica were detected in the disomic addition line PW11-2. Chromosomes 1B of substitution line PW11-5 had been replaced by a pair of P. huashanica 3Ns chromosomes. In PW11-8, a small terminal segment from P. huashanica chromosome arm 3NsS was translocated to the terminal region of wheat chromosomes 3BL. Thus, this translocated chromosome is designated T3BL-3NsS. These conclusions were further confirmed by SSR analyses. Two 3Ns-specific markers Xgwm181 and Xgwm161 will be useful to rapidly identify and trace the translocated fragments. These introgressions, which had significant characteristics of resistance to stripe rust, could be utilized as novel germplasms for wheat breeding.	[Kang, Houyang; Wang, Yi; Zhang, Haiqin; Fan, Xing; Sha, Lina; Xu, Lili; Zheng, Youliang; Zhou, Yonghong] Sichuan Agr Univ, Triticeae Res Inst, Chengdu, Sichuan, Peoples R China; [Wang, Yi; Fedak, George; Cao, Wenguang] Eastern Cereal & Oilseed Res Ctr, Dept Agr & Agr Food Canada, Ottawa, ON, Canada; [Zheng, Youliang; Zhou, Yonghong] Sichuan Agr Univ, Minist Educ, Key Lab Crop Genet Resources & Improvement, Yaan, Sichuan, Peoples R China	Sichuan Agricultural University; Sichuan Agricultural University	Kang, HY (corresponding author), Sichuan Agr Univ, Triticeae Res Inst, Chengdu, Sichuan, Peoples R China.	zhouyhdavid@126.com	xu, li/GNH-3667-2022; Haiqin, Zhang/ABC-4056-2020	Cao, Guangwen/0000-0002-8094-1278	State Transgenic Project [2008zx08009-001, 2011zx08009-001]; National Natural Science Foundation of China [30870154, 30900087]; Natural Science Foundation for Young Scientists of Sichuan Province, China [2010JQ0046]; Education Bureau and Science and Technology Bureau of Sichuan Province, China	State Transgenic Project; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation for Young Scientists of Sichuan Province, China; Education Bureau and Science and Technology Bureau of Sichuan Province, China	The authors are thankful to the State Transgenic Project (numbers 2008zx08009-001, 2011zx08009-001), the National Natural Science Foundation of China (numbers 30870154, 30900087), the Natural Science Foundation for Young Scientists of Sichuan Province, China (number 2010JQ0046), and the Education Bureau and Science and Technology Bureau of Sichuan Province, China for the financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2000, J NW AGR U; BADEN C, 1991, NORD J BOT, V11, P3, DOI 10.1111/j.1756-1051.1991.tb01790.x; BARIANA HS, 1993, GENOME, V36, P476, DOI 10.1139/g93-065; BAYLISS MW, 1980, INT REV CYTOL 11A, P113; CHEN Q, 1988, CHINESE SCI BULL, V33, P2071; CHEN S, 1991, Acta Genetica Sinica, V18, P508; Cheng P, 2010, THEOR APPL GENET, V121, P195, DOI 10.1007/s00122-010-1302-0; Chhuneja P, 2008, THEOR APPL GENET, V116, P313, DOI 10.1007/s00122-007-0668-0; Doyle JJ, 1987, PHYTOCHEM B, V19, P11, DOI 10.1016/j.bse.2009.07.003; Dubcovsky J, 2007, SCIENCE, V316, P1862, DOI 10.1126/science.1143986; Faris JD, 2008, CHROMOSOME RES, V16, P1097, DOI 10.1007/s10577-008-1261-3; Fedak G, 2000, GENOME, V43, P712, DOI 10.1139/gen-43-4-712; Friebe B, 1996, EUPHYTICA, V91, P59, DOI 10.1007/BF00035277; [傅杰 Fu Jie], 2003, [西北植物学报, Acta Botanica Boreali-Occidentalla Sinica], V23, P1905; GILL BS, 1991, GENOME, V34, P830, DOI 10.1139/g91-128; JIANG JM, 1994, EUPHYTICA, V73, P199, DOI 10.1007/BF00036700; Jing JinXue, 1999, Acta Phytopathologica Sinica, V29, P147; Kang HY, 2009, PLANT BREEDING, V128, P36, DOI 10.1111/j.1439-0523.2008.01542.x; Kang HY, 2008, EUPHYTICA, V162, P441, DOI 10.1007/s10681-007-9608-y; Kang HY, 2010, GENET RESOUR CROP EV, V57, P111, DOI 10.1007/s10722-009-9455-x; Korzun V, 1997, EUPHYTICA, V95, P149, DOI 10.1023/A:1002922706905; Kuo P. C., 1987, FLORA REIPUBLICAE PO, P51; Kuraparthy V, 2007, THEOR APPL GENET, V114, P1379, DOI 10.1007/s00122-007-0524-2; Line RF, 2002, ANNU REV PHYTOPATHOL, V40, P75, DOI 10.1146/annurev.phyto.40.020102.111645; Luan Y, 2010, PLANTA, V232, P501, DOI 10.1007/s00425-010-1187-9; Lukaszewski A. J., 1987, Plant Breeding Reviews, V5, P41; Luo PG, 2008, CAN J PLANT PATHOL, V30, P254, DOI 10.1080/07060661.2008.10540540; Luo PG, 2005, PHYTOPATHOLOGY, V95, P1266, DOI 10.1094/PHYTO-95-1266; Ma H, 1997, EUPHYTICA, V94, P279, DOI 10.1023/A:1002979706378; McIntosh R, 2008, P 11 INT WHEAT GEN S; Molnar-Lang M, 2000, EUPHYTICA, V112, P117, DOI 10.1023/A:1003840200744; Pestsova E, 2000, THEOR APPL GENET, V101, P95, DOI 10.1007/s001220051455; PLOURDE A, 1990, THEOR APPL GENET, V79, P45, DOI 10.1007/BF00223785; Pu ZJ, 2010, PLANT BREEDING, V129, P53, DOI 10.1111/j.1439-0523.2009.01649.x; Qi ZJ, 2010, THEOR APPL GENET, V121, P589, DOI 10.1007/s00122-010-1332-7; READER SM, 1994, TRENDS GENET, V10, P265, DOI 10.1016/0168-9525(90)90007-S; REN Z, 1991, Acta Genetica Sinica, V18, P228; Ren ZL, 1997, SCI CHINA SER C, V40, P323, DOI 10.1007/BF02879094; RILEY R, 1968, GENET RES, V12, P199, DOI 10.1017/S0016672300011800; Roder MS, 1998, GENETICS, V149, P2007; SEARS E R, 1972, P23; SEARS ER, 1993, CROP SCI, V33, P897, DOI 10.2135/cropsci1993.0011183X003300050004x; Somers DJ, 2004, THEOR APPL GENET, V109, P1105, DOI 10.1007/s00122-004-1740-7; Stubbs R, 1988, BREEDING STRATEGIES, V8, P23; Wan AM, 2004, PLANT DIS, V88, P896, DOI 10.1094/PDIS.2004.88.8.896; Wang Xiue, 1998, Journal of Nanjing Agricultural University, V21, P10; Yang ZuoMin, 2003, Acta Agronomica Sinica, V29, P161; Zhao JX, 2010, GENET RESOUR CROP EV, V57, P387, DOI 10.1007/s10722-009-9477-4; Zhao JiXin, 2004, Acta Botanica Boreali-Occidentalia Sinica, V24, P2277; [赵继新 Zhao Jixin], 2004, [西北农林科技大学学报. 自然科学版, Journal of northwest sci-tech university of agriculture and forestry], V32, P105	50	38	50	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2011	6	7							e21802	10.1371/journal.pone.0021802	http://dx.doi.org/10.1371/journal.pone.0021802			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791IA	21760909	Green Published, Green Submitted, gold			2022-12-27	WOS:000292657200023
J	Yu, ZH; Kastenmuller, G; He, Y; Belcredi, P; Moller, G; Prehn, C; Mendes, J; Wahl, S; Roemisch-Margl, W; Ceglarek, U; Polonikov, A; Dahmen, N; Prokisch, H; Xie, L; Li, YX; Wichmann, HE; Peters, A; Kronenberg, F; Suhre, K; Adamski, J; Illig, T; Wang-Sattler, R				Yu, Zhonghao; Kastenmueller, Gabi; He, Ying; Belcredi, Petra; Moeller, Gabriele; Prehn, Cornelia; Mendes, Joaquim; Wahl, Simone; Roemisch-Margl, Werner; Ceglarek, Uta; Polonikov, Alexey; Dahmen, Norbert; Prokisch, Holger; Xie, Lu; Li, Yixue; Wichmann, H. -Erich; Peters, Annette; Kronenberg, Florian; Suhre, Karsten; Adamski, Jerzy; Illig, Thomas; Wang-Sattler, Rui			Differences between Human Plasma and Serum Metabolite Profiles	PLOS ONE			English	Article							CHROMATOGRAPHY; METABOLOMICS; COLLECTION; SAMPLES; ISSUES; ACID	Background: Human plasma and serum are widely used matrices in clinical and biological studies. However, different collecting procedures and the coagulation cascade influence concentrations of both proteins and metabolites in these matrices. The effects on metabolite concentration profiles have not been fully characterized. Methodology/Principal Findings: We analyzed the concentrations of 163 metabolites in plasma and serum samples collected simultaneously from 377 fasting individuals. To ensure data quality, 41 metabolites with low measurement stability were excluded from further analysis. In addition, plasma and corresponding serum samples from 83 individuals were re-measured in the same plates and mean correlation coefficients (r) of all metabolites between the duplicates were 0.83 and 0.80 in plasma and serum, respectively, indicating significantly better stability of plasma compared to serum (p = 0.01). Metabolite profiles from plasma and serum were clearly distinct with 104 metabolites showing significantly higher concentrations in serum. In particular, 9 metabolites showed relative concentration differences larger than 20%. Despite differences in absolute concentration between the two matrices, for most metabolites the overall correlation was high (mean r = 0.81 +/- 0.10), which reflects a proportional change in concentration. Furthermore, when two groups of individuals with different phenotypes were compared with each other using both matrices, more metabolites with significantly different concentrations could be identified in serum than in plasma. For example, when 51 type 2 diabetes (T2D) patients were compared with 326 non-T2D individuals, 15 more significantly different metabolites were found in serum, in addition to the 25 common to both matrices. Conclusions/Significance: Our study shows that reproducibility was good in both plasma and serum, and better in plasma. Furthermore, as long as the same blood preparation procedure is used, either matrix should generate similar results in clinical and biological studies. The higher metabolite concentrations in serum, however, make it possible to provide more sensitive results in biomarker detection.	[Yu, Zhonghao; He, Ying; Wahl, Simone; Illig, Thomas; Wang-Sattler, Rui] Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Res Unit Mol Epidemiol, Neuherberg, Germany; [Kastenmueller, Gabi; Roemisch-Margl, Werner; Suhre, Karsten] Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Inst Bioinformat & Syst Biol, Neuherberg, Germany; [He, Ying; Xie, Lu; Li, Yixue] Shanghai Ctr Bioinformat Technol, Shanghai, Peoples R China; [He, Ying; Li, Yixue] Chinese Acad Sci, Shanghai Inst Biol Sci, Key Lab Syst Biol, Bioinformat Ctr, Shanghai, Peoples R China; [Belcredi, Petra; Peters, Annette] Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Inst Epidemiol 2, Neuherberg, Germany; [Moeller, Gabriele; Prehn, Cornelia; Adamski, Jerzy] Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Genome Anal Ctr, Inst Expt Genet, Neuherberg, Germany; [Mendes, Joaquim] Tech Univ Munich, Dept Chem, Solid State NMR Spect, D-8046 Garching, Germany; [Mendes, Joaquim] Tech Univ Munich, Dept Chem, Ctr Integrated Prot Sci, D-8046 Garching, Germany; [Mendes, Joaquim] Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Inst Biol Struct, Neuherberg, Germany; [Ceglarek, Uta] Univ Hosp Leipzig, Inst Lab Med Clin Chem & Mol Diagnost, Leipzig, Germany; [Polonikov, Alexey] Kursk State Med Univ, Dept Biol Med Genet & Ecol, Kursk, Russia; [Dahmen, Norbert] Johannes Gutenberg Univ Mainz, Dept Psychiat, D-6500 Mainz, Germany; [Prokisch, Holger] Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Inst Human Genet, Neuherberg, Germany; [Wichmann, H. -Erich] Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Inst Epidemiol, Neuherberg, Germany; [Wichmann, H. -Erich] Univ Munich, Inst Med Informat Biometry & Epidemiol, Munich, Germany; [Kronenberg, Florian] Innsbruck Med Univ, Dept Med Genet Mol & Clin Pharmacol, Div Genet Epidemiol, Innsbruck, Austria; [Suhre, Karsten] Univ Munich, Fac Biol, Planegg Martinsried, Germany; [Suhre, Karsten] Educ City Qatar Fdn, Weill Cornell Med Coll Qatar, Dept Physiol & Biophys, Doha, Qatar; [Adamski, Jerzy] Tech Univ Munich, Lehrstuhl Expt Genet, Munich, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Chinese Academy of Sciences; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Leipzig University; Kursk State Medical University; Johannes Gutenberg University of Mainz; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; Medical University of Innsbruck; University of Munich; Qatar Foundation (QF); Weill Cornell Medical College Qatar; Technical University of Munich	Yu, ZH (corresponding author), Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Res Unit Mol Epidemiol, Neuherberg, Germany.	rui.wang-sattler@helmholtz-muenchen.de	Prokisch, Holger/N-8964-2013; Kastenmüller, Gabi/ABF-5987-2020; Ceglarek, Uta/GOE-5561-2022; Peters, Annette/A-6117-2011; Wichmann, Heinz Erich/AAA-5695-2022; Kronenberg, Florian/B-1736-2008; Polonikov, Alexey/R-7537-2016; Suhre, Karsten/AAF-1778-2020; Yu, Zhonghao/F-5459-2011; Wang-Sattler, Rui/B-5354-2014	Peters, Annette/0000-0001-6645-0985; Kronenberg, Florian/0000-0003-2229-1120; Polonikov, Alexey/0000-0001-6280-247X; Suhre, Karsten/0000-0001-9638-3912; Yu, Zhonghao/0000-0001-7144-9356; Wang-Sattler, Rui/0000-0002-8794-8229; Moller, Gabriele/0000-0002-2730-1351; Kastenmuller, Gabi/0000-0002-2368-7322; Adamski, Jerzy/0000-0001-9259-0199; Prokisch, Holger/0000-0003-2379-6286; Prehn, Cornelia/0000-0002-1274-4715	German Federal Ministry of Education and Research (BMBF)	German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	This work was supported by the German Federal Ministry of Education and Research (BMBF) by funding the Project "SysMBo: Systems Biology of Metabotypes" (FKZ: 0315494A). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki J, 2002, J BIOL CHEM, V277, P48737, DOI 10.1074/jbc.M206812200; Bando K, 2010, J BIOSCI BIOENG, V110, P491, DOI 10.1016/j.jbiosc.2010.04.010; Barelli S, 2007, EXPERT REV PROTEOMIC, V4, P363, DOI 10.1586/14789450.4.3.363; Denery JR, 2011, ANAL CHEM, V83, P1040, DOI 10.1021/ac102806p; Dettmer K, 2010, ELECTROPHORESIS, V31, P2365, DOI 10.1002/elps.200900778; Doring A, 2008, NAT GENET, V40, P430, DOI 10.1038/ng.107; Gieger C, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000282; Holle R, 2005, GESUNDHEITSWESEN, V67, pS19, DOI 10.1055/s-2005-858235; Illig T, 2010, NAT GENET, V42, P137, DOI 10.1038/ng.507; Jaffe AS, 2000, CIRCULATION, V102, P1216, DOI 10.1161/01.CIR.102.11.1216; Kaddurah-Daouk R, 2008, ANNU REV PHARMACOL, V48, P653, DOI 10.1146/annurev.pharmtox.48.113006.094715; Kolz M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000504; Kronenberg F, 1998, KIDNEY INT, V54, P1385, DOI 10.1046/j.1523-1755.1998.00086.x; LADENSON JH, 1974, AM J CLIN PATHOL, V62, P545; Liu LS, 2010, ANAL BIOCHEM, V406, P105, DOI 10.1016/j.ab.2010.07.015; Mannello F, 2008, ARTERIOSCL THROM VAS, V28, P611, DOI 10.1161/ATVBAHA.107.159608; Psychogios N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016957; Romisch-Margl W, 2011, METABOLOMICS; Sacks DB, 2002, CLIN CHEM, V48, P436; Schnabel RB, 2010, BLOOD, V115, P5289, DOI 10.1182/blood-2009-05-221382; Suhre K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013953; Teahan O, 2006, ANAL CHEM, V78, P4307, DOI 10.1021/ac051972y; Teerlink T, 2002, ANAL BIOCHEM, V303, P131, DOI 10.1006/abio.2001.5575; Wang-Sattler R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003863; Yatomi Y, 1997, J BIOCHEM, V121, P969; Zhai G, 2010, ANN RHEUM DIS, V69, P1227, DOI 10.1136/ard.2009.120857	26	164	167	3	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2011	6	7							e21230	10.1371/journal.pone.0021230	http://dx.doi.org/10.1371/journal.pone.0021230			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791IA	21760889	Green Published, gold, Green Submitted			2022-12-27	WOS:000292657200008
J	Larrue, A; Rattner, A; Peter, ZA; Olivier, C; Laroche, N; Vico, L; Peyrin, F				Larrue, Aymeric; Rattner, Aline; Peter, Zsolt-Andrei; Olivier, Cecile; Laroche, Norbert; Vico, Laurence; Peyrin, Francoise			Synchrotron Radiation Micro-CT at the Micrometer Scale for the Analysis of the Three-Dimensional Morphology of Microcracks in Human Trabecular Bone	PLOS ONE			English	Article							HUMAN CORTICAL BONE; MICRODAMAGE ACCUMULATION; BIOMECHANICAL PROPERTIES; CANCELLOUS BONE; DAMAGE; FRACTURE; BISPHOSPHONATES; PROPAGATION; TURNOVER; STRENGTH	Bone quality is an important concept to explain bone fragility in addition to bone mass. Among bone quality factors, microdamage which appears in daily life is thought to have a marked impact on bone strength and plays a major role in the repair process. The starting point for all studies designed to further our understanding of how bone microdamage initiate or dissipate energy, or to investigate the impact of age, gender or disease, remains reliable observation and measurement of microdamage. In this study, 3D Synchrotron Radiation (SR) micro-CT at the micrometric scale was coupled to image analysis for the three-dimensional characterization of bone microdamage in human trabecular bone specimens taken from femoral heads. Specimens were imaged by 3D SR micro-CT with a voxel size of 1.4 mm. A new tailored 3D image analysis technique was developed to segment and quantify microcracks. Microcracks from human trabecular bone were observed in different tomographic sections as well as from 3D renderings. New 3D quantitative measurements on the microcrack density and morphology are reported on five specimens. The 3D microcrack density was found between 3.1 and 9.4/mm3 corresponding to a 2D density between 0.55 and 0.76 /mm2. The microcrack length and width measured in 3D on five selected microcrack ranged respectively from 164 mm to 209 mm and 100 mm to 120 mm. This is the first time that various microcracks in unloaded human trabecular bone - from the simplest linear crack to more complex cross-hatch cracks - have been examined and quantified by 3D imaging at this scale. The suspected complex morphology of microcracks is here considerably more evident than in the 2D observations. In conclusion, this technique opens new perspective for the 3D investigation of microcracks and the impact of age, disease or treatment.	[Larrue, Aymeric; Peter, Zsolt-Andrei; Olivier, Cecile; Peyrin, Francoise] Univ Lyon 1, CNRS 5220, INSERM, CREATIS,INSA Lyon,U1044, F-69622 Villeurbanne, France; [Larrue, Aymeric; Olivier, Cecile; Peyrin, Francoise] ESRF, Grenoble, France; [Rattner, Aline; Laroche, Norbert; Vico, Laurence] Univ Lyon, LBTO, INSERM, IFR143,IFRESIS,U890, St Etienne, France; [Peter, Zsolt-Andrei] Univ Paris 10, PST IUT Ville Avray, Dept GTE, Ville Davray, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National des Sciences Appliquees de Lyon - INSA Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; European Synchrotron Radiation Facility (ESRF); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris Nanterre	Larrue, A (corresponding author), Univ Lyon 1, CNRS 5220, INSERM, CREATIS,INSA Lyon,U1044, F-69622 Villeurbanne, France.	peyrin@esrf.fr	Vico, Laurence/O-1927-2018; Peyrin, Francoise/G-2823-2013; Vico, Laurence/ABG-7239-2020	Vico, Laurence/0000-0002-2110-287X; Peyrin, Francoise/0000-0002-1988-3435; Vico, Laurence/0000-0002-2110-287X	Rhones-Alpes Region, France; CNRS/Inserm	Rhones-Alpes Region, France; CNRS/Inserm(Institut National de la Sante et de la Recherche Medicale (Inserm)Centre National de la Recherche Scientifique (CNRS))	This work was funded by the "Cluster de Recherche Handicap Vieillissement Neuroscience" of the Rhones-Alpes Region, France. It was also supported by the GDR STIC-Sante (Groupe de Recherche Science et Technologie de l'Information et de la Communication - Sante) CNRS/Inserm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGUET F, 2005, P 2005 INT C IM PROC, V2, P1158; Allen MR, 2006, BONE, V39, P872, DOI 10.1016/j.bone.2006.04.028; Arlot ME, 2008, J BONE MINER RES, V23, P1613, DOI 10.1359/JBMR.080517; Barth HD, 2010, BONE, V46, P1475, DOI 10.1016/j.bone.2010.02.025; Bonnassie A, 2003, IEEE T SYST MAN CY B, V33, P700, DOI 10.1109/TSMCB.2003.814298; BURR DB, 1990, CLIN ORTHOP RELAT R, P305, DOI 10.1097/00003086-199011000-00047; Chapurlat RD, 2007, J BONE MINER RES, V22, P1502, DOI 10.1359/JBMR.070609; Cloetens P, 1997, J APPL PHYS, V81, P5878, DOI 10.1063/1.364374; Davies CM, 2006, EUR CELLS MATER, V11, P57, DOI 10.22203/eCM.v011a07; Donahue Seth W., 2006, Critical Reviews in Biomedical Engineering, V34, P215, DOI 10.1615/CritRevBiomedEng.v34.i3.20; Fantner GE, 2005, NAT MATER, V4, P612, DOI 10.1038/nmat1428; Fazzalari NL, 1998, BONE, V23, P373, DOI 10.1016/S8756-3282(98)00111-2; Fazzalari NL, 2002, BONE, V31, P697, DOI 10.1016/S8756-3282(02)00906-7; Fratzl P, 2008, NAT MATER, V7, P610, DOI 10.1038/nmat2240; Hazenberg JG, 2007, OSTEOPOROSIS INT, V18, P1, DOI 10.1007/s00198-006-0222-y; HOSHEN J, 1976, PHYS REV B, V14, P3438, DOI 10.1103/PhysRevB.14.3438; Koester KJ, 2008, NAT MATER, V7, P672, DOI 10.1038/nmat2221; Landrigan MD, 2011, BONE, V48, P443, DOI 10.1016/j.bone.2010.10.160; Lee TC, 2003, J ANAT, V203, P161, DOI 10.1046/j.1469-7580.2003.00211.x; Leng HJ, 2008, J MECH BEHAV BIOMED, V1, P68, DOI 10.1016/j.jmbbm.2007.06.002; Lievers WB, 2010, MED ENG PHYS, V32, P921, DOI 10.1016/j.medengphy.2010.06.001; Martin RB, 2007, BONE, V40, P1159, DOI 10.1016/j.bone.2006.11.014; Martin-Badosa E, 2003, COMPUT MED IMAG GRAP, V27, P447, DOI 10.1016/S0895-6111(03)00031-4; Mashiba T, 2001, BONE, V28, P524, DOI 10.1016/S8756-3282(01)00414-8; Mohsin S, 2006, J ANAT, V209, P119, DOI 10.1111/j.1469-7580.2006.00554.x; Moore TLA, 2002, J BIOMECH ENG-T ASME, V124, P63, DOI 10.1115/1.1428745; Mori S, 1997, BONE, V21, P521, DOI 10.1016/S8756-3282(97)00200-7; Nalla RK, 2003, NAT MATER, V2, P164, DOI 10.1038/nmat832; Norman TL, 1997, BONE, V20, P375, DOI 10.1016/S8756-3282(97)00004-5; Nuzzo S, 2002, MED PHYS, V29, P2672, DOI 10.1118/1.1513161; O'Brien FJ, 2000, J ANAT, V197, P413, DOI 10.1046/j.1469-7580.2000.19730413.x; Reilly GC, 2000, J BIOMECH, V33, P337, DOI 10.1016/S0021-9290(99)00167-0; Salome M, 1999, MED PHYS, V26, P2194, DOI 10.1118/1.598736; Schaffler MB, 1995, BONE, V17, P521, DOI 10.1016/8756-3282(95)00370-3; Seeman E, 2006, NEW ENGL J MED, V354, P2250, DOI 10.1056/NEJMra053077; Serra J, 1983, IMAGE ANAL MATH MORP; Taylor D, 1998, J BIOMECH, V31, P1177, DOI 10.1016/S0021-9290(98)00133-X; Taylor D, 2007, NAT MATER, V6, P263, DOI 10.1038/nmat1866; Thurner PJ, 2006, BONE, V39, P289, DOI 10.1016/j.bone.2006.01.147; Tomasi C, 1998, SIXTH INTERNATIONAL CONFERENCE ON COMPUTER VISION, P839, DOI 10.1109/ICCV.1998.710815; Un K, 2006, J BIOMECH, V39, P1955, DOI 10.1016/j.jbiomech.2006.05.012; Vashishth D, 2000, BONE, V26, P375, DOI 10.1016/S8756-3282(00)00236-2; Voide R, 2009, BONE, V45, P164, DOI 10.1016/j.bone.2009.04.248; Wang XA, 2006, J BIOMECH, V39, P781, DOI 10.1016/j.jbiomech.2005.02.007; Wang X, 2008, J BIOMECH, V41, P2654, DOI 10.1016/j.jbiomech.2008.06.011; Wang X, 2007, J BIOMECH, V40, P3397, DOI 10.1016/j.jbiomech.2007.05.009; Yeni YN, 2003, ANN BIOMED ENG, V31, P726, DOI 10.1114/1.1569264; Zarrinkalam K. H., 2005, European Journal of Morphology, V42, P81; ZIOUPOS P, 1994, J MATER SCI, V29, P978, DOI 10.1007/BF00351420	49	50	50	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2011	6	7							e21297	10.1371/journal.pone.0021297	http://dx.doi.org/10.1371/journal.pone.0021297			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791HI	21750707	Green Published, gold, Green Submitted			2022-12-27	WOS:000292655400003
J	Nankabirwa, V; Tylleskar, T; Nankunda, J; Engebretsen, IMS; Sommerfelt, H; Tumwine, JK				Nankabirwa, Victoria; Tylleskar, Thorkild; Nankunda, Jolly; Engebretsen, Ingunn Marie S.; Sommerfelt, Halvor; Tumwine, James K.		PROMISE EBF Res Consortium	Malaria Parasitaemia among Infants and Its Association with Breastfeeding Peer Counselling and Vitamin A Supplementation: A Secondary Analysis of a Cluster Randomized Trial	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM; YOUNG-CHILDREN; MORBIDITY; PRESCHOOL; DISEASES; GUINEA; FAMINE	Background: Malaria is the second highest contributor to the disease burden in Africa and there is a need to identify low cost prevention strategies. The objectives of this study were to estimate the prevalence of malaria parasitaemia among infants and to measure the association between peer counselling for exclusive breastfeeding (EBF), vitamin A supplementation, anthropometric status (weight and length) and malaria parasitaemia. Methods: A cluster randomized intervention trial was conducted between 2006 and 2008 where 12 of 24 clusters, each comprising one or two villages, in Eastern Uganda were allocated to receive peer counselling for EBF. Women in their third trimester of pregnancy (based on the last normal menstrual period) were recruited in all 24 clusters and followed up until their children's first birthday. Blood was drawn from 483 infants between 3 and 12 months of age, to test for malaria parasitaemia. Results: The prevalence of malaria parasitaemia was 11% in the intervention areas and 10% in the control areas. The intervention did not seem to decrease the prevalence of malaria (PR 1.7; 95% CI: 0.9, 3.3). After controlling for potential confounders, infants not supplemented with Vitamin A had a higher prevalence for malaria compared to those who had been supplemented (PR 6.1; 95% CI: 2.1, 17.6). Among children supplemented with vitamin A, every unit increase in length-for-age Z (LAZ) scores was associated with a reduced prevalence in malaria (PR 0.5; 95% CI: 0.4, 0.6). There was no association between LAZ scores and malaria among children that had not been supplemented. Conclusion: Peer counselling for exclusive breastfeeding did not decrease the prevalence of malaria parasitaemia. Children that had not received Vitamin A supplementation had a higher prevalence of malaria compared to children that had been supplemented. registration:	[Nankabirwa, Victoria; Nankunda, Jolly; Tumwine, James K.] Makerere Univ, Dept Paediat & Child Hlth, Sch Med, Coll Hlth Sci, Kampala, Uganda; [Nankabirwa, Victoria; Tylleskar, Thorkild; Nankunda, Jolly; Engebretsen, Ingunn Marie S.; Sommerfelt, Halvor] Univ Bergen, Ctr Int Hlth, Bergen, Norway; [Sommerfelt, Halvor] Norwegian Inst Publ Hlth, Div Infect Dis Control, Oslo, Norway	Makerere University; University of Bergen; Norwegian Institute of Public Health (NIPH)	Nankabirwa, V (corresponding author), Makerere Univ, Dept Paediat & Child Hlth, Sch Med, Coll Hlth Sci, Kampala, Uganda.	nankabirwav@gmail.com	Van de Perre, Philippe/B-9692-2008; Sommerfelt, Halvor/ABD-3552-2020; Tylleskär, Thorkild/S-5529-2017; Engebretsen, Ingunn Marie S/N-5692-2017; Nankunda, Jolly/AAS-4036-2020; Fadnes, Lars T/E-9086-2016	Van de Perre, Philippe/0000-0002-3912-0427; Sommerfelt, Halvor/0000-0002-5670-9786; Tylleskär, Thorkild/0000-0003-4801-4324; Engebretsen, Ingunn Marie S/0000-0001-5852-3611; Fadnes, Lars T/0000-0001-8757-2092; Olsen, Oystein Evjen/0000-0003-0963-4731; Nankabirwa, Victoria/0000-0002-9952-8942	EU [INCO-CT2004-003660]; Research Council of Norway [172226]; NUFU; University of Bergen	EU(European Commission); Research Council of Norway(Research Council of Norway); NUFU; University of Bergen	The study was part of the EU-funded project PROMISE-EBF (contract no INCO-CT2004-003660, web http://www.promiseresearch.net). It was also financially supported by the Research Council of Norway's GlobVac programme grant no 172226 "Focus on Nutrition and Child Health: Intervention Studies in Low-Income Countries, the NUFU grant "Essential Nutrition and Child Health in Uganda'' and the University of Bergen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benn CS, 2009, VACCINE, V27, P2891, DOI 10.1016/j.vaccine.2009.02.080; Benn CS, 2009, INT J EPIDEMIOL, V38, P304, DOI 10.1093/ije/dyn195; BINKA FN, 1995, AM J CLIN NUTR, V61, P853, DOI 10.1093/ajcn/61.4.853; Breman JG, 2004, AM J TROP MED HYG, V71, P1; Caulfield LE, 2004, AM J TROP MED HYG, V71, P55, DOI 10.4269/ajtmh.2004.71.55; Eisele TP, 2007, EMERG INFECT DIS, V13, P1494, DOI 10.3201/eid1310.070567; Friis H, 1997, AM J CLIN NUTR, V66, P665, DOI 10.1093/ajcn/66.3.665; Genton B, 1998, AM J CLIN NUTR, V68, P734, DOI 10.1093/ajcn/68.3.734; GLASZIOU PP, 1993, BMJ-BRIT MED J, V306, P366, DOI 10.1136/bmj.306.6874.366; Guinovart C, 2006, CURR MOL MED, V6, P137, DOI 10.2174/156652406776055131; Ikeh E I, 2008, Niger Postgrad Med J, V15, P65; JACKSON M, 2009, AM PUBL HLTH ASS 137; Jorgensen MJ, 2011, SCAND J INFECT DIS, V43, P296, DOI 10.3109/00365548.2010.535845; Kalanda BF, 2006, EUR J CLIN NUTR, V60, P401, DOI 10.1038/sj.ejcn.1602330; Koyanagi A, 2009, AM J CLIN NUTR, V89, P1375, DOI 10.3945/ajcn.2008.26810; Krogstad DJ, 1996, EPIDEMIOL REV, V18, P77, DOI 10.1093/oxfordjournals.epirev.a017918; Lindblade KA, 1999, T ROY SOC TROP MED H, V93, P480, DOI 10.1016/S0035-9203(99)90344-9; Man WDC, 1998, TROP MED INT HEALTH, V3, P678, DOI 10.1046/j.1365-3156.1998.00283.x; MURRAY MJ, 1978, AM J CLIN NUTR, V31, P57, DOI 10.1093/ajcn/31.1.57; MURRAY MJ, 1976, LANCET, V1, P1283; Odongo-Aginya E, 2005, Afr Health Sci, V5, P238; Oliveira-Menegozzo JM, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005944.pub2; PIWOZ EG, 2001, BREASTFEEDING REPLAC; Serghides L, 2002, LANCET, V359, P1404, DOI 10.1016/S0140-6736(02)08360-5; Shankar AH, 2000, J INFECT DIS, V182, pS37, DOI 10.1086/315906; Shankar AH, 1999, LANCET, V354, P203, DOI 10.1016/S0140-6736(98)08293-2; Sinnis P, 1996, J EXP MED, V184, P945, DOI 10.1084/jem.184.3.945; Tshikuka JG, 1997, TROP MED INT HEALTH, V2, P374; UBOS, 2002, UG POP HOUS CENS; UBOS, 2007, UG DEM HLTH SURV 200; Villamor E, 2003, TROP MED INT HEALTH, V8, P1051, DOI 10.1046/j.1360-2276.2003.01134.x; WHO & UNICEF (World Health Organization & UNICEF), 1993, BREASTF COUNS TRAIN; World Health Organization (WHO), 2009, WHO ANTHROPLUS PERS; Zeba AN, 2008, NUTR J, V7, DOI 10.1186/1475-2891-7-7	34	16	16	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2011	6	7							e21862	10.1371/journal.pone.0021862	http://dx.doi.org/10.1371/journal.pone.0021862			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791HI	21760916	Green Published, gold, Green Submitted			2022-12-27	WOS:000292655400022
J	Radoshitzky, SR; Longobardi, LE; Kuhn, JH; Retterer, C; Dong, L; Clester, JC; Kota, K; Carra, J; Bavari, S				Radoshitzky, Sheli R.; Longobardi, Lindsay E.; Kuhn, Jens H.; Retterer, Cary; Dong, Lian; Clester, Jeremiah C.; Kota, Krishna; Carra, John; Bavari, Sina			Machupo Virus Glycoprotein Determinants for Human Transferrin Receptor 1 Binding and Cell Entry	PLOS ONE			English	Article							HEMORRHAGIC-FEVER ARENAVIRUSES; GP-C; SUBTILASE SKI-1/S1P; SIGNAL PEPTIDE; IDENTIFICATION; CLEAVAGE; JUNIN	Machupo virus (MACV) is a highly pathogenic New World arenavirus that causes hemorrhagic fever in humans. MACV, as well as other pathogenic New World arenaviruses, enter cells after their GP1 attachment glycoprotein binds to their cellular receptor, transferrin receptor 1 (TfR1). TfR1 residues essential for this interaction have been described, and a co-crystal of MACV GP1 bound to TfR1 suggests GP1 residues important for this association. We created MACV GP1 variants and tested their effect on TfR1 binding and virus entry to evaluate the functional significance of some of these and additional residues in human and simian cells. We found residues R111, D123, Y122, and F226 to be essential, D155, and P160 important, and D114, S116, D140, and K169 expendable for the GP1-TfR1 interaction and MACV entry. Several MACV GP1 residues that are critical for the interaction with TfR1 are conserved among other New World arenaviruses, indicating a common basis of receptor interaction. Our findings also open avenues for the rational development of viral entry inhibitors.	[Radoshitzky, Sheli R.; Longobardi, Lindsay E.; Retterer, Cary; Dong, Lian; Clester, Jeremiah C.; Kota, Krishna; Carra, John; Bavari, Sina] USAMRIID, Div Toxicol, Frederick, MD USA; [Kuhn, Jens H.] NIAID, Integrated Res Facil Ft Detrick IRF Frederick, DCR, NIH, Frederick, MD USA	United States Army Medical Research Institute of Infectious Diseases; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Radoshitzky, SR (corresponding author), USAMRIID, Div Toxicol, Frederick, MD USA.	sina.bavari@amedd.army.mil	Radoshitzky, Sheli S/F-2766-2019; Kota, Krishna/GPF-8474-2022; Bavari, Sina/L-3642-2019; Radoshitzky, Sheli/L-8410-2019; Kuhn, Jens H./B-7615-2011	Bavari, Sina/0000-0001-8424-5635; Radoshitzky, Sheli/0000-0001-8976-8056; Kuhn, Jens H./0000-0002-7800-6045	Joint Science and Technology Office Transformational Medical Technologies [TMTI0048_09_RD_T]; Defense Threat Reduction Agency [4.10022_08_RD_B]; NIAID [HHSN272200200016I]	Joint Science and Technology Office Transformational Medical Technologies; Defense Threat Reduction Agency(United States Department of DefenseDefense Threat Reduction Agency); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was partially supported by the Joint Science and Technology Office Transformational Medical Technologies (proposal # TMTI0048_09_RD_T) and Defense Threat Reduction Agency (proposal #4.10022_08_RD_B) to SB. JHK performed this work as an employee of Tunnell Consulting, Inc., a subcontractor to Battelle Memorial Institute under its prime contract with NIAID, Contract No. HHSN272200200016I. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham J, 2010, NAT STRUCT MOL BIOL, V17, P438, DOI 10.1038/nsmb.1772; Abraham J, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000358; Agnihothram SS, 2007, J VIROL, V81, P4331, DOI 10.1128/JVI.02779-06; Aguilar PV, 2009, EMERG INFECT DIS, V15, P1526, DOI 10.3201/eid1509.090017; Beyer WR, 2003, J VIROL, V77, P2866, DOI 10.1128/JVI.77.5.2866-2872.2003; Bowden TA, 2009, J VIROL, V83, P8259, DOI 10.1128/JVI.00761-09; Briese T, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000455; BUCHMEIER MJ, 1987, J VIROL, V61, P982, DOI 10.1128/JVI.61.4.982-985.1987; Buchmeier MJ., 2007, FIELDS VIROLOGY, P1791; Delgado S, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000047; Eichler R, 2003, EMBO REP, V4, P1084, DOI 10.1038/sj.embor.7400002; Eschli B, 2006, J VIROL, V80, P5897, DOI 10.1128/JVI.00008-06; Flanagan ML, 2008, J VIROL, V82, P938, DOI 10.1128/JVI.01397-07; Kunz S, 2003, VIROLOGY, V314, P168, DOI 10.1016/S0042-6822(03)00421-5; Lenz O, 2001, P NATL ACAD SCI USA, V98, P12701, DOI 10.1073/pnas.221447598; Li WH, 2003, NATURE, V426, P450, DOI 10.1038/nature02145; Martin VK, 2010, J VIROL, V84, P1176, DOI 10.1128/JVI.01625-09; *NIAID, 2010, NIAID CAT PRIOR PATH; Oldenburg J, 2007, VIROLOGY, V364, P132, DOI 10.1016/j.virol.2007.03.003; PETERS CJ, 1974, AM J EPIDEMIOL, V99, P425, DOI 10.1093/oxfordjournals.aje.a121631; Radoshitzky SR, 2008, P NATL ACAD SCI USA, V105, P2664, DOI 10.1073/pnas.0709254105; Radoshitzky SR, 2007, NATURE, V446, P92, DOI 10.1038/nature05539; Reignier T, 2006, VIROLOGY, V353, P111, DOI 10.1016/j.virol.2006.05.018; Rojek JM, 2006, VIROLOGY, V349, P476, DOI 10.1016/j.virol.2006.02.033; Salvato MS, 2005, VIRUS TAXONOMY, P725; *US DHHS, 2007, HHS PUBL	26	26	27	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2011	6	7							e21398	10.1371/journal.pone.0021398	http://dx.doi.org/10.1371/journal.pone.0021398			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791HI	21750710	gold, Green Submitted, Green Published			2022-12-27	WOS:000292655400005
J	Brents, LK; Reichard, EE; Zimmerman, SM; Moran, JH; Fantegrossi, WE; Prather, PL				Brents, Lisa K.; Reichard, Emily E.; Zimmerman, Sarah M.; Moran, Jeffery H.; Fantegrossi, William E.; Prather, Paul L.			Phase I Hydroxylated Metabolites of the K2 Synthetic Cannabinoid JWH-018 Retain In Vitro and In Vivo Cannabinoid 1 Receptor Affinity and Activity	PLOS ONE			English	Article							PENTYLENETETRAZOLE-INDUCED SEIZURE; CANNABIMIMETIC INDOLES; CB2; ANTICONVULSANT; ACTIVATION; AGONIST; SPICE; BRAIN; IDENTIFICATION; PHARMACOLOGY	Background: K2 products are synthetic cannabinoid-laced, marijuana-like drugs of abuse, use of which is often associated with clinical symptoms atypical of marijuana use, including hypertension, agitation, hallucinations, psychosis, seizures and panic attacks. JWH-018, a prevalent K2 synthetic cannabinoid, is structurally distinct from Delta(9)-THC, the main psychoactive ingredient in marijuana. Since even subtle structural differences can lead to differential metabolism, formation of novel, biologically active metabolites may be responsible for the distinct effects associated with K2 use. The present study proposes that K2's high adverse effect occurrence is due, at least in part, to distinct JWH-018 metabolite activity at the cannabinoid 1 receptor (CB1R). Methods/Principal Findings: JWH-018, five potential monohydroxylated metabolites (M1-M5), and one carboxy metabolite (M6) were examined in mouse brain homogenates containing CB1Rs, first for CB1R affinity using a competition binding assay employing the cannabinoid receptor radioligand [H-3]CP-55,940, and then for CB1R intrinsic efficacy using an [S-35]GTP gamma S binding assay. JWH-018 and M1-M5 bound CB1Rs with high affinity, exhibiting K-i values that were lower than or equivalent to Delta(9)-THC. These molecules also stimulated G-proteins with equal or greater efficacy relative to Delta(9)-THC, a CB1R partial agonist. Most importantly, JWH-018, M2, M3, and M5 produced full CB1R agonist levels of activation. CB1R-mediated activation was demonstrated by blockade with O-2050, a CB1R-selective neutral antagonist. Similar to Delta 9-THC, JWH-018 and M1 produced a marked depression of locomotor activity and core body temperature in mice that were both blocked by the CB1R-preferring antagonist/inverse agonist AM251. Conclusions/Significance: Unlike metabolites of most drugs, the studied JWH-018 monohydroxylated compounds, but not the carboxy metabolite, retain in vitro and in vivo activity at CB1Rs. These observations, combined with higher CB1R affinity and activity relative to Delta(9)-THC, may contribute to the greater prevalence of adverse effects observed with JWH-018-containing products relative to cannabis.	[Brents, Lisa K.; Reichard, Emily E.; Zimmerman, Sarah M.; Moran, Jeffery H.; Fantegrossi, William E.; Prather, Paul L.] Univ Arkansas Med Sci, Dept Pharmacol & Toxicol, Little Rock, AR 72205 USA; [Moran, Jeffery H.] Arkansas Dept Hlth, Publ Hlth Lab, Little Rock, AR 72205 USA	University of Arkansas System; University of Arkansas Medical Sciences	Brents, LK (corresponding author), Univ Arkansas Med Sci, Dept Pharmacol & Toxicol, Little Rock, AR 72205 USA.	PratherPaulL@uams.edu			Association of Public Health Laboratories; US PHS [RR020146]; UAMS; University of Arkansas for Medical Sciences Center for Clinical and Translational Research; National Center For Research Resources [1UL1RR029884]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR029884, P20RR020146] Funding Source: NIH RePORTER	Association of Public Health Laboratories; US PHS(United States Department of Health & Human ServicesUnited States Public Health Service); UAMS; University of Arkansas for Medical Sciences Center for Clinical and Translational Research; National Center For Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by the Association of Public Health Laboratories Award (JHM), US PHS Grant RR020146 (WEF), UAMS Pilot Study Award (PLP), and a Pilot Research Award from the University of Arkansas for Medical Sciences Center for Clinical and Translational Research, supported by a grant from the National Center For Research Resources, 1UL1RR029884 (JHM, WEF, and PLP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], WORLD DRUG REPORT; Atwood BK, 2010, BRIT J PHARMACOL, V160, P585, DOI 10.1111/j.1476-5381.2009.00582.x; Aung MM, 2000, DRUG ALCOHOL DEPEN, V60, P133, DOI 10.1016/S0376-8716(99)00152-0; Auwarter V, 2009, J MASS SPECTROM, V44, P832, DOI 10.1002/jms.1558; Bahremand A, 2008, EPILEPSY RES, V81, P44, DOI 10.1016/j.eplepsyres.2008.04.010; Bari M, 2011, FRONT BIOSCI-LANDMRK, V16, P498, DOI 10.2741/3701; Bisogno T, 2010, CNS NEUROL DISORD-DR, V9, P564, DOI 10.2174/187152710793361568; Cascio MG, 2006, BRIT J PHARMACOL, V149, P431, DOI 10.1038/sj.bjp.0706888; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Childers SR, 2006, AAPS J, V8, pE112, DOI 10.1208/aapsj080113; Chin CN, 1999, J PHARMACOL EXP THER, V291, P837; Dennis I, 2008, BRIT J PHARMACOL, V154, P1349, DOI 10.1038/bjp.2008.190; Deyama S, 2010, J PHARMACOL SCI, V114, P123, DOI 10.1254/jphs.10139SC; Durant C, 2010, CURR TOP BEHAV NEURO, V2, P303, DOI 10.1007/7854_2009_8; EISSENSTAT MA, 1995, J MED CHEM, V38, P3094, DOI 10.1021/jm00016a013; *EMCDDA EUR, 2008, ADD EUR EMCFDAD; Every-Palmer S, 2010, ADDICTION, V105, P1859, DOI 10.1111/j.1360-0443.2010.03119.x; GALIEGUE S, 1995, EUR J BIOCHEM, V232, P54, DOI 10.1111/j.1432-1033.1995.tb20780.x; Gholizadeh S, 2007, NEUROPHARMACOLOGY, V53, P763, DOI 10.1016/j.neuropharm.2007.08.005; GORZALKA BB, 2010, PROG NEUROPSYCHOPHAR; Halberstadt A.L., 2011, NEUROPHARMACOLOGY; Heinz A, 2010, SCHIZOPHRENIA BULL, V36, P472, DOI 10.1093/schbul/sbq031; HERKENHAM M, 1990, P NATL ACAD SCI USA, V87, P1932, DOI 10.1073/pnas.87.5.1932; Hill AJ, 2010, EPILEPSIA, V51, P1522, DOI 10.1111/j.1528-1167.2010.02523.x; Holtkamp M, 2007, CELL MOL LIFE SCI, V64, P2023, DOI 10.1007/s00018-007-7021-2; HUFFMAN JW, 1994, BIOORG MED CHEM LETT, V4, P563, DOI 10.1016/S0960-894X(01)80155-4; Hurlemann R, 2010, PSYCHOL MED, V40, P1839, DOI 10.1017/S0033291709992376; Javitt DC, 2010, ISR J PSYCHIATR REL, V47, P4; Jones NA, 2010, J PHARMACOL EXP THER, V332, P569, DOI 10.1124/jpet.109.159145; Karst M, 2010, DRUGS, V70, P2409, DOI 10.2165/11585260-000000000-00000; Leonhart M., 2010, FED REGISTER, P71635; LI C, 2011, PHARM THER; Liu JG, 2001, MOL PHARMACOL, V60, P53, DOI 10.1124/mol.60.1.53; Lutz B, 2004, BIOCHEM PHARMACOL, V68, P1691, DOI 10.1016/j.bcp.2004.07.007; Macdonald RL, 2010, J PHYSIOL-LONDON, V588, P1861, DOI 10.1113/jphysiol.2010.186999; Mantegazza M, 2010, LANCET NEUROL, V9, P413, DOI 10.1016/S1474-4422(10)70059-4; Mares P, 2010, EPILEPSIA, V51, P24, DOI 10.1111/j.1528-1167.2010.02604.x; Maurer HH, 2006, THER DRUG MONIT, V28, P447, DOI 10.1097/01.ftd.0000211812.27558.6e; MOLLER I, 2010, DRUG TEST ANAL; MORAN CL, 2011, ANAL CHEM; Muller H, 2010, PHARMACOPSYCHIATRY, V43, P152, DOI 10.1055/s-0029-1243252; Muller H, 2010, SCHIZOPHR RES, V118, P309, DOI 10.1016/j.schres.2009.12.001; Pertwee RG, 2010, PHARMACOL REV, V62, P588, DOI 10.1124/pr.110.003004; Prather PL, 2000, MOL PHARMACOL, V57, P1000; ROSSI F, 2011, BONE; SCHNEIR AB, 2010, J EMERG MED; Shoemaker JL, 2005, J PHARMACOL EXP THER, V314, P868, DOI 10.1124/jpet.105.085282; Showalter VM, 1996, J PHARMACOL EXP THER, V278, P989; SMITH PB, 1994, J PHARMACOL EXP THER, V270, P219; Sobolevsky T, 2010, FORENSIC SCI INT, V200, P141, DOI 10.1016/j.forsciint.2010.04.003; STJAMES J, 2010, DOCTORS CONCERNED PO; Uchiyama N, 2010, FORENSIC SCI INT, V198, P31, DOI 10.1016/j.forsciint.2010.01.004; Uchiyama N, 2009, CHEM PHARM BULL, V57, P439, DOI 10.1248/cpb.57.439; Vardakou I, 2010, TOXICOL LETT, V197, P157, DOI 10.1016/j.toxlet.2010.06.002; Vearrier D, 2010, PEDIATR EMERG CARE, V26, P462, DOI 10.1097/PEC.0b013e3181e4f416; Watkins BA, 2010, J NUTR BIOCHEM, V21, P1141, DOI 10.1016/j.jnutbio.2010.04.011; Wehrman J., 2010, FAKE MARIJUANA SPURS; Wiley JL, 1998, J PHARMACOL EXP THER, V285, P995; Wintermeyer A, 2010, ANAL BIOANAL CHEM, V398, P2141, DOI 10.1007/s00216-010-4171-0; Zhang Q, 2006, ANAL BIOANAL CHEM, V386, P1345, DOI 10.1007/s00216-006-0717-6; Zimmermann US, 2009, DTSCH ARZTEBL INT, V106, P464, DOI 10.3238/arztebl.2009.0464	61	172	173	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2011	6	7							e21917	10.1371/journal.pone.0021917	http://dx.doi.org/10.1371/journal.pone.0021917			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791AK	21755008	gold, Green Submitted, Green Published			2022-12-27	WOS:000292632000035
J	Ishizu, T; Zeki, S				Ishizu, Tomohiro; Zeki, Semir			Toward A Brain-Based Theory of Beauty	PLOS ONE			English	Article							MEDIAL ORBITOFRONTAL CORTEX; FACIAL ATTRACTIVENESS; ROMANTIC LOVE; REWARD VALUE; PREFERENCE; RESPONSES; EMOTION; SYSTEMS	We wanted to learn whether activity in the same area(s) of the brain correlate with the experience of beauty derived from different sources. 21 subjects took part in a brain-scanning experiment using functional magnetic resonance imaging. Prior to the experiment, they viewed pictures of paintings and listened to musical excerpts, both of which they rated on a scale of 1-9, with 9 being the most beautiful. This allowed us to select three sets of stimuli-beautiful, indifferent and ugly-which subjects viewed and heard in the scanner, and rated at the end of each presentation. The results of a conjunction analysis of brain activity showed that, of the several areas that were active with each type of stimulus, only one cortical area, located in the medial orbito-frontal cortex (mOFC), was active during the experience of musical and visual beauty, with the activity produced by the experience of beauty derived from either source overlapping almost completely within it. The strength of activation in this part of the mOFC was proportional to the strength of the declared intensity of the experience of beauty. We conclude that, as far as activity in the brain is concerned, there is a faculty of beauty that is not dependent on the modality through which it is conveyed but which can be activated by at least two sources-musical and visual-and probably by other sources as well. This has led us to formulate a brain-based theory of beauty.	[Ishizu, Tomohiro] UCL, Wellcome Lab Neurobiol, London, England; UCL, Wellcome Dept Imaging Neurosci, London, England	University of London; University College London; University of London; University College London	Ishizu, T (corresponding author), UCL, Wellcome Lab Neurobiol, London, England.	zeki.pa@ucl.ac.uk	Zeki, Semir/AAA-1789-2020; Ishizu, Tomohiro/Q-2155-2019	Ishizu, Tomohiro/0000-0001-7107-657X	Wellcome Trust, London	Wellcome Trust, London(Wellcome Trust)	This work was supported by the Wellcome Trust, London. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aron A, 2005, J NEUROPHYSIOL, V94, P327, DOI 10.1152/jn.00838.2004; Bartels A, 2000, NEUROREPORT, V11, P3829, DOI 10.1097/00001756-200011270-00046; Bechara A, 2000, CEREB CORTEX, V10, P295, DOI 10.1093/cercor/10.3.295; BELL C, 1921, ART LONDON CHATTO WI; Blood AJ, 1999, NAT NEUROSCI, V2, P382, DOI 10.1038/7299; Bray S, 2010, J NEUROPHYSIOL, V103, P2506, DOI 10.1152/jn.01030.2009; Burke E., 1757, PHILOS ENQUIRY ORIGI; Carretie L, 2009, NEUROSCIENCE, V164, P1615, DOI 10.1016/j.neuroscience.2009.09.031; Cela-Conde CJ, 2009, P NATL ACAD SCI USA, V106, P3847, DOI 10.1073/pnas.0900304106; Cloutier J, 2008, J COGNITIVE NEUROSCI, V20, P941, DOI 10.1162/jocn.2008.20062; Di Dio C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001201; FitzGerald THB, 2009, J NEUROSCI, V29, P8388, DOI 10.1523/JNEUROSCI.0717-09.2009; Gordon G., 1997, PHILOS ARTS; GOTSHALK DW, 1935, J PHILOS, V32, P604; Grabenhorst F, 2011, TRENDS COGN SCI, V15, P56, DOI 10.1016/j.tics.2010.12.004; Jacobsen T, 2006, NEUROIMAGE, V29, P276, DOI 10.1016/j.neuroimage.2005.07.010; Kant I., 1952, CRITIQUE JUDGMENT; Kawabata H, 2004, J NEUROPHYSIOL, V91, P1699, DOI 10.1152/jn.00696.2003; Kawabata H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003027; Kim H, 2011, CEREB CORTEX, V21, P769, DOI 10.1093/cercor/bhq145; Kirk U, 2009, NEUROIMAGE, V44, P1125, DOI 10.1016/j.neuroimage.2008.10.009; Kornysheva K, 2010, HUM BRAIN MAPP, V31, P48, DOI 10.1002/hbm.20844; Kranz F, 2006, CURR BIOL, V16, P63, DOI 10.1016/j.cub.2005.10.070; Margulies DS, 2007, NEUROIMAGE, V37, P579, DOI 10.1016/j.neuroimage.2007.05.019; O'Doherty J, 2003, NEUROPSYCHOLOGIA, V41, P147, DOI 10.1016/S0028-3932(02)00145-8; Peters J, 2010, BEHAV BRAIN RES, V213, P135, DOI 10.1016/j.bbr.2010.04.031; Price CJ, 1997, NEUROIMAGE, V5, P261, DOI 10.1006/nimg.1997.0269; Schultz W, 2010, EUR J NEUROSCI, V31, P2124, DOI 10.1111/j.1460-9568.2010.07282.x; Sescousse G, 2010, J NEUROSCI, V30, P13095, DOI 10.1523/JNEUROSCI.3501-10.2010; TSUKIURA T, 2011, SOC COGN AFFECT NEUR; Vartanian O, 2004, NEUROREPORT, V15, P893, DOI 10.1097/00001756-200404090-00032; Winston JS, 2007, NEUROPSYCHOLOGIA, V45, P195, DOI 10.1016/j.neuropsychologia.2006.05.009; Zeki S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015802; Zeki S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002180	34	250	255	6	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2011	6	7							e21852	10.1371/journal.pone.0021852	http://dx.doi.org/10.1371/journal.pone.0021852			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791AK	21755004	Green Published, gold, Green Submitted			2022-12-27	WOS:000292632000031
J	Stany, MP; Vathipadiekal, V; Ozbun, L; Stone, RL; Mok, SC; Xue, H; Kagami, T; Wang, YW; McAlpine, JN; Bowtell, D; Gout, PW; Miller, DM; Gilks, CB; Huntsman, DG; Ellard, SL; Wang, YZ; Vivas-Mejia, P; Lopez-Berestein, G; Sood, AK; Birrer, MJ				Stany, Michael P.; Vathipadiekal, Vinod; Ozbun, Laurent; Stone, Rebecca L.; Mok, Samuel C.; Xue, Hui; Kagami, Takashi; Wang, Yuwei; McAlpine, Jessica N.; Bowtell, David; Gout, Peter W.; Miller, Dianne M.; Gilks, C. Blake; Huntsman, David G.; Ellard, Susan L.; Wang, Yu-Zhuo; Vivas-Mejia, Pablo; Lopez-Berestein, Gabriel; Sood, Anil K.; Birrer, Michael J.			Identification of Novel Therapeutic Targets in Microdissected Clear Cell Ovarian Cancers	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; HYPOXIA-INDUCIBLE FACTOR-1-ALPHA; INTERFERING RNA DELIVERY; IN-VIVO; FACTOR EXPRESSION; GENE-EXPRESSION; ANTITUMOR-ACTIVITY; TYROSINE KINASE; FACTOR RECEPTOR; CARCINOMA	Clear cell ovarian cancer is an epithelial ovarian cancer histotype that is less responsive to chemotherapy and carries poorer prognosis than serous and endometrioid histotypes. Despite this, patients with these tumors are treated in a similar fashion as all other ovarian cancers. Previous genomic analysis has suggested that clear cell cancers represent a unique tumor subtype. Here we generated the first whole genomic expression profiling using epithelial component of clear cell ovarian cancers and normal ovarian surface specimens isolated by laser capture microdissection. All the arrays were analyzed using BRB ArrayTools and PathwayStudio software to identify the signaling pathways. Identified pathways validated using serous, clear cell cancer cell lines and RNAi technology. In vivo validations carried out using an orthotopic mouse model and liposomal encapsulated siRNA. Patient-derived clear cell and serous ovarian tumors were grafted under the renal capsule of NOD-SCID mice to evaluate the therapeutic potential of the identified pathway. We identified major activated pathways in clear cells involving in hypoxic cell growth, angiogenesis, and glucose metabolism not seen in other histotypes. Knockdown of key genes in these pathways sensitized clear cell ovarian cancer cell lines to hypoxia/glucose deprivation. In vivo experiments using patient derived tumors demonstrate that clear cell tumors are exquisitely sensitive to antiangiogenesis therapy (i.e. sunitinib) compared with serous tumors. We generated a histotype specific, gene signature associated with clear cell ovarian cancer which identifies important activated pathways critical for their clinicopathologic characteristics. These results provide a rational basis for a radically different treatment for ovarian clear cell patients.	[Stany, Michael P.] Walter Reed Army Med Ctr, Washington, DC 20307 USA; [Vathipadiekal, Vinod; Birrer, Michael J.] Massachusetts Gen Hosp, Ctr Canc, Boston, MA USA; [Vathipadiekal, Vinod; Birrer, Michael J.] Harvard Univ, Sch Med, Boston, MA USA; [Ozbun, Laurent] NCI, Cell & Canc Biol Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Stone, Rebecca L.; Sood, Anil K.] Univ Texas MD Anderson Canc Ctr, Dept Gynecol Oncol, Houston, TX 77030 USA; [Mok, Samuel C.] Harvard Univ, Brigham & Womens Hosp, Sch Publ Hlth, Boston, MA 02115 USA; [Xue, Hui; Kagami, Takashi; Wang, Yuwei; Gout, Peter W.; Wang, Yu-Zhuo] British Columbia Canc Agcy, Living Tumor Lab, Vancouver, BC V5Z 4E6, Canada; [McAlpine, Jessica N.; Miller, Dianne M.] Univ British Columbia, Dept Obstet & Gynecol, Div Gynecol Oncol, Vancouver, BC V5Z 1M9, Canada; [Bowtell, David] Peter MacCallum Canc Ctr, Melbourne, Vic, Australia; [Gilks, C. Blake; Huntsman, David G.] British Columbia Canc Agcy, Ctr Translat & Appl Genom, Vancouver Gen Hosp, Dept Pathol,Genet Pathol Evaluat Ctr, Vancouver, BC V5Z 4E6, Canada; [Ellard, Susan L.] British Columbia Canc Agcy So Interior, Dept Med Oncol, Kelowna, BC, Canada; [Wang, Yu-Zhuo] Univ British Columbia, Dept Urol Sci, Vancouver, BC V5Z 1M9, Canada; [Wang, Yu-Zhuo] Univ British Columbia, Vancouver Prostate Ctr, Vancouver, BC V5Z 1M9, Canada; [Vivas-Mejia, Pablo; Lopez-Berestein, Gabriel] Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX 77030 USA; [Lopez-Berestein, Gabriel; Sood, Anil K.] Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77030 USA; [Lopez-Berestein, Gabriel; Sood, Anil K.] Univ Texas MD Anderson Canc Ctr, Ctr RNA Interference & Noncoding RNA, Houston, TX 77030 USA	United States Department of Defense; United States Army; Walter Reed National Military Medical Center; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Texas System; UTMD Anderson Cancer Center; Harvard University; Brigham & Women's Hospital; Harvard T.H. Chan School of Public Health; British Columbia Cancer Agency; University of British Columbia; Peter Maccallum Cancer Center; British Columbia Cancer Agency; University of British Columbia; University of British Columbia; University of British Columbia; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Stany, MP (corresponding author), Walter Reed Army Med Ctr, Washington, DC 20307 USA.	mbirrer@partners.org	Bowtell, David/H-1007-2016; Huntsman, David/ABE-6082-2020	Bowtell, David/0000-0001-9089-7525; Ellard, Susan/0000-0001-5757-9787; /0000-0002-8181-6890; Wang, Yuzhuo/0000-0002-9749-8591	National Cancer Institute at the National Institutes of the Health; OvCaRe (an initiative of the Vancouver General Hospital and University of BC Hospital Foundation and the BC Cancer Foundation); BC Cancer Foundation; Pfizer Canada	National Cancer Institute at the National Institutes of the Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); OvCaRe (an initiative of the Vancouver General Hospital and University of BC Hospital Foundation and the BC Cancer Foundation); BC Cancer Foundation; Pfizer Canada(Pfizer)	This work was supported in part by the Intramural Research Program of the National Cancer Institute at the National Institutes of the Health (MJB) and OvCaRe (an initiative of the Vancouver General Hospital and University of BC Hospital Foundation and the BC Cancer Foundation) (YZW), the BC Cancer Foundation and Pfizer Canada (Investigator-initiated project, SLE and YZW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Aponte M, 2008, CANCER RES, V68, P5839, DOI 10.1158/0008-5472.CAN-07-5771; Bonome T, 2005, CANCER RES, V65, P10602, DOI 10.1158/0008-5472.CAN-05-2240; Cappellini Maria Domenica, 2007, Hematology Am Soc Hematol Educ Program, P74; Chen J, 2003, AM J PATHOL, V162, P1283, DOI 10.1016/S0002-9440(10)63924-7; Ciofani M, 2005, NAT IMMUNOL, V6, P881, DOI 10.1038/ni1234; CROZIER MA, 1989, GYNECOL ONCOL, V35, P199, DOI 10.1016/0090-8258(89)90043-7; CRUTCHLEY DJ, 1995, CIRCULATION, V92, P238, DOI 10.1161/01.CIR.92.2.238; Cuadrado MJ, 2006, J THROMB HAEMOST, V4, P2461, DOI 10.1111/j.1538-7836.2006.02193.x; DICKERSIN GR, 1980, CANCER-AM CANCER SOC, V45, P1615, DOI 10.1002/1097-0142(19800401)45:7<1615::AID-CNCR2820450717>3.0.CO;2-E; Donninger H, 2004, ONCOGENE, V23, P8065, DOI 10.1038/sj.onc.1207959; Ebos JML, 2007, P NATL ACAD SCI USA, V104, P17069, DOI 10.1073/pnas.0708148104; Frede S, 2005, CANCER RES, V65, P4690, DOI 10.1158/0008-5472.CAN-04-3877; GENTON CY, 1979, VIRCHOWS ARCH A, V385, P77, DOI 10.1007/BF00433543; Gitlits VM, 2001, J INVEST MED, V49, P138, DOI 10.2310/6650.2001.34040; Gwak GY, 2005, J HEPATOL, V42, P358, DOI 10.1016/j.jhep.2004.11.020; Halder J, 2006, CLIN CANCER RES, V12, P4916, DOI 10.1158/1078-0432.CCR-06-0021; Isaacs JS, 2002, J BIOL CHEM, V277, P29936, DOI 10.1074/jbc.M204733200; Ito N, 2001, CELL SIGNAL, V13, P849, DOI 10.1016/S0898-6568(01)00209-1; JENISON EL, 1989, GYNECOL ONCOL, V32, P65, DOI 10.1016/0090-8258(89)90852-4; Kelly BD, 2003, CIRC RES, V93, P1074, DOI 10.1161/01.RES.0000102937.50486.1B; KENNEDY AW, 1989, GYNECOL ONCOL, V32, P342, DOI 10.1016/0090-8258(89)90637-9; Kilic M, 2007, ONCOGENE, V26, P2027, DOI 10.1038/sj.onc.1210008; Kobel M, 2010, INT J GYNECOL PATHOL, V29, P203, DOI 10.1097/PGP.0b013e3181c042b6; Landen CN, 2007, CANCER RES, V67, P10389, DOI 10.1158/0008-5472.CAN-07-0858; Landen CN, 2005, CANCER RES, V65, P6910, DOI 10.1158/0008-5472.CAN-05-0530; Lee CH, 2005, GYNECOL ONCOL, V96, P48, DOI 10.1016/j.ygyno.2004.09.025; Maeshima K, 2004, ENDOCRINOLOGY, V145, P3739, DOI 10.1210/en.2004-0213; Matsuura Y, 2007, GYNECOL ONCOL, V104, P406, DOI 10.1016/j.ygyno.2006.08.026; Medina P, 2007, THROMB HAEMOSTASIS, V98, P564, DOI 10.1160/TH07-01-0071; Mendel DB, 2003, CLIN CANCER RES, V9, P327; Mok SC, 2009, CANCER CELL, V16, P521, DOI 10.1016/j.ccr.2009.10.018; Nevo O, 2006, AM J PHYSIOL-REG I, V291, pR1085, DOI 10.1152/ajpregu.00794.2005; Nordback I, 1980, Int J Gynaecol Obstet, V18, P85; Pectasides D, 2006, ONCOLOGIST, V11, P1089, DOI 10.1634/theoncologist.11-10-1089; Pollard PJ, 2006, J CLIN ENDOCR METAB, V91, P4593, DOI 10.1210/jc.2006-0920; Poulaki V, 2004, AM J PATHOL, V165, P457, DOI 10.1016/S0002-9440(10)63311-1; Press JZ, 2008, GYNECOL ONCOL, V110, P256, DOI 10.1016/j.ygyno.2008.03.011; Schiller W., 1939, AM J CANCER, V35, P1; Schwartz DR, 2002, CANCER RES, V62, P4722; Semenza GL, 1996, J BIOL CHEM, V271, P32529, DOI 10.1074/jbc.271.51.32529; SILVERBERG SG, 1973, AM J OBSTET GYNECOL, V115, P394, DOI 10.1016/0002-9378(73)90596-6; SPRECHER CA, 1994, P NATL ACAD SCI USA, V91, P3353, DOI 10.1073/pnas.91.8.3353; Sugiyama T, 2000, CANCER, V88, P2584, DOI 10.1002/1097-0142(20000601)88:11<2584::AID-CNCR22>3.0.CO;2-5; Sun L, 2003, J MED CHEM, V46, P1116, DOI 10.1021/jm0204183; Tsao MS, 1997, CLIN CANCER RES, V3, P1807; Walter M, 1995, J AUTOIMMUN, V8, P931, DOI 10.1016/S0896-8411(95)80027-1; Wang ZW, 2006, CANCER RES, V66, P2778, DOI 10.1158/0008-5472.CAN-05-4281; Welsh S, 2004, MOL CANCER THER, V3, P233; Wu MH, 2007, AM J PATHOL, V170, P590, DOI 10.2353/ajpath.2007.060477; Wu R, 2007, CANCER CELL, V11, P321, DOI 10.1016/j.ccr.2007.02.016; Yamaguchi K, 2010, ONCOGENE, V29, P1741, DOI 10.1038/onc.2009.470; Zorn KK, 2003, CLIN CANCER RES, V9, P4811; Zorn KK, 2005, CLIN CANCER RES, V11, P6422, DOI 10.1158/1078-0432.CCR-05-0508	53	60	61	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2011	6	7							e21121	10.1371/journal.pone.0021121	http://dx.doi.org/10.1371/journal.pone.0021121			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791AK	21754983	Green Published, Green Submitted, gold			2022-12-27	WOS:000292632000007
J	Brown, JD; Oligino, E; Rader, DJ; Saghatelian, A; Plutzky, J				Brown, Jonathan D.; Oligino, Eric; Rader, Daniel J.; Saghatelian, Alan; Plutzky, Jorge			VLDL Hydrolysis by Hepatic Lipase Regulates PPAR delta Transcriptional Responses	PLOS ONE			English	Article							PROLIFERATOR-ACTIVATED RECEPTORS; LIPOPROTEIN METABOLISM; ENDOTHELIAL LIPASE; FATTY-ACIDS; ALPHA; MICE; ATHEROSCLEROSIS; EXPRESSION; DEFICIENT; EICOSANOIDS	Background: PPARs (alpha,gamma,delta) are a family of ligand-activated transcription factors that regulate energy balance, including lipid metabolism. Despite these critical functions, the integration between specific pathways of lipid metabolism and distinct PPAR responses remains obscure. Previous work has revealed that lipolytic pathways can activate PPARs. Whether hepatic lipase (HL), an enzyme that regulates VLDL and HDL catabolism, participates in PPAR responses is unknown. Methods/Principal Findings: Using PPAR ligand binding domain transactivation assays, we found that HL interacted with triglyceride-rich VLDL (>HDL >> LDL, IDL) to activate PPAR delta preferentially over PPAR alpha or PPAR gamma, an effect dependent on HL catalytic activity. In cell free ligand displacement assays, VLDL hydrolysis by HL activated PPAR delta in a VLDL-concentration dependent manner. Extended further, VLDL stimulation of HL-expressing HUVECs and FAO hepatoma cells increased mRNA expression of canonical PPAR delta target genes, including adipocyte differentiation related protein (ADRP), angiopoietin like protein 4 and pyruvate dehydrogenase kinase-4. HL/VLDL regulated ADRP through a PPRE in the promoter region of this gene. In vivo, adenoviral-mediated hepatic HL expression in C57BL/6 mice increased hepatic ADRP mRNA levels by 30%. In ob/ob mice, a model with higher triglycerides than C57BL/6 mice, HL overexpression increased ADRP expression by 70%, demonstrating the importance of triglyceride substrate for HL-mediated PPAR delta activation. Global metabolite profiling identified HL/VLDL released fatty acids including oleic acid and palmitoleic acid that were capable of recapitulating PPARd activation and ADRP gene regulation in vitro. Conclusions: These data define a novel pathway involving HL hydrolysis of VLDL that activates PPARd through generation of specific monounsaturated fatty acids. These data also demonstrate how integrating cell biology with metabolomic approaches provides insight into specific lipid mediators and pathways of lipid metabolism that regulate transcription.	[Brown, Jonathan D.; Oligino, Eric; Plutzky, Jorge] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Cardiovasc Med, Boston, MA 02115 USA; [Brown, Jonathan D.] VA Boston Healthcare, W Roxbury, MA USA; [Oligino, Eric] Yale New Haven Med Ctr, Div Cardiol, New Haven, CT 06504 USA; [Rader, Daniel J.] Hosp Univ Penn, Dept Med, Philadelphia, PA 19104 USA; [Saghatelian, Alan] Harvard Univ, Dept Chem, Cambridge, MA 02138 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System; Yale University; University of Pennsylvania; Pennsylvania Medicine; Harvard University	Brown, JD (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Cardiovasc Med, Boston, MA 02115 USA.	jplutzky@rics.bwh.harvard.edu	Plutzky, Jorge/V-3410-2019		National Institutes of Health [NHBLI HL048743, NHLBI HL071745, NHLBI K08HL105678-01]; Sarnoff Cardiovascular Research Foundation; Searle Scholars Award; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071745, P01HL048743, K08HL105678] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sarnoff Cardiovascular Research Foundation; Searle Scholars Award; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This paper was supported by National Institutes of Health grants NHBLI HL048743 and NHLBI HL071745 (JP) and NHLBI K08HL105678-01 (JB), the Sarnoff Cardiovascular Research Foundation (JB, EO), and the Searle Scholars Award (AS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed W, 2006, CIRC RES, V98, P490, DOI 10.1161/01.RES.0000205846.46812.be; ApplebaumBowden D, 1996, J CLIN INVEST, V97, P799, DOI 10.1172/JCI118479; Braschi S, 1998, BBA-LIPID LIPID MET, V1392, P276, DOI 10.1016/S0005-2760(98)00046-0; Brown JD, 2007, CIRCULATION, V115, P518, DOI 10.1161/CIRCULATIONAHA.104.475673; Chakravarthy MV, 2009, CELL, V138, P476, DOI 10.1016/j.cell.2009.05.036; Chawla A, 2003, P NATL ACAD SCI USA, V100, P1268, DOI 10.1073/pnas.0337331100; Chiu HK, 2010, ENDOCRINOLOGY, V151, P993, DOI 10.1210/en.2009-1100; Dugi KA, 2000, ARTERIOSCL THROM VAS, V20, P793, DOI 10.1161/01.ATV.20.3.793; Duncan JG, 2010, CIRCULATION, V121, P426, DOI 10.1161/CIRCULATIONAHA.109.888735; Duong M, 2003, BIOCHEMISTRY-US, V42, P13778, DOI 10.1021/bi034990n; Evans RM, 2004, NAT MED, V10, P355, DOI 10.1038/nm1025; Forman BM, 1997, P NATL ACAD SCI USA, V94, P4312, DOI 10.1073/pnas.94.9.4312; Freeman L, 2007, J LIPID RES, V48, P104, DOI 10.1194/jlr.M600321-JLR200; HEGELE RA, 1991, BIOCHEM BIOPH RES CO, V179, P78, DOI 10.1016/0006-291X(91)91336-B; HOMANICS GE, 1995, J BIOL CHEM, V270, P2974, DOI 10.1074/jbc.270.7.2974; Jansen H, 2002, J LIPID RES, V43, P1352, DOI 10.1194/jlr.R200008-JLR200; Kanda T, 2009, J CLIN INVEST, V119, P110, DOI 10.1172/JCI36233; Kersten S, 1999, J CLIN INVEST, V103, P1489, DOI 10.1172/JCI6223; Kersten S, 2000, NATURE, V405, P421, DOI 10.1038/35013000; Kliewer SA, 1997, P NATL ACAD SCI USA, V94, P4318, DOI 10.1073/pnas.94.9.4318; Lee CH, 2003, SCIENCE, V302, P453, DOI 10.1126/science.1087344; Lee CH, 2006, P NATL ACAD SCI USA, V103, P3444, DOI 10.1073/pnas.0511253103; Li AC, 2000, J CLIN INVEST, V106, P523, DOI 10.1172/JCI10370; Lo JC, 2007, SCIENCE, V316, P285, DOI 10.1126/science.1137221; Marx N, 1999, CIRCULATION, V99, P3125, DOI 10.1161/01.CIR.99.24.3125; Marx N, 2000, J IMMUNOL, V164, P6503, DOI 10.4049/jimmunol.164.12.6503; McCoy MG, 2002, J LIPID RES, V43, P921; Mead JR, 2002, J MOL MED, V80, P753, DOI 10.1007/s00109-002-0384-9; Mineo C, 2003, J BIOL CHEM, V278, P9142, DOI 10.1074/jbc.M211394200; Nong ZX, 2003, J CLIN INVEST, V112, P367, DOI 10.1172/JCI200316484; Qian K, 2007, ATHEROSCLEROSIS, V195, P66, DOI 10.1016/j.atherosclerosis.2006.12.002; Ruby MA, 2010, J LIPID RES, V51, P2275, DOI 10.1194/jlr.M005561; Saghatelian A, 2004, BIOCHEMISTRY-US, V43, P14332, DOI 10.1021/bi0480335; Sanderson LM, 2009, MOL CELL BIOL, V29, P6257, DOI 10.1128/MCB.00370-09; Santamarina-Fojo S, 2004, ARTERIOSCL THROM VAS, V24, P1750, DOI 10.1161/01.ATV.0000140818.00570.2d; Santamarina-Fojo S, 1998, CURR OPIN LIPIDOL, V9, P211, DOI 10.1097/00041433-199806000-00005; Tachibana Keisuke, 2005, Nucl Recept, V3, P3, DOI 10.1186/1478-1336-3-3; Tagore R, 2008, J AM CHEM SOC, V130, P14111, DOI 10.1021/ja806463c; Tan NS, 2002, MOL CELL BIOL, V22, P5114, DOI 10.1128/MCB.22.14.5114-5127.2002; Teran-Garcia M, 2005, DIABETES, V54, P2251, DOI 10.2337/diabetes.54.7.2251; van Haperen R, 2009, BBA-MOL CELL BIOL L, V1791, P1031, DOI 10.1016/j.bbalip.2009.06.001; Wiesner P, 2009, J LIPID RES, V50, P574, DOI 10.1194/jlr.D800028-JLR200; Yang X, 2007, COLD SPRING HARB SYM, V72, P387, DOI 10.1101/sqb.2007.72.058; Ziouzenkova O, 2003, P NATL ACAD SCI USA, V100, P2730, DOI 10.1073/pnas.0538015100	44	12	12	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2011	6	7							e21209	10.1371/journal.pone.0021209	http://dx.doi.org/10.1371/journal.pone.0021209			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	789JO	21750705	Green Submitted, Green Published, gold			2022-12-27	WOS:000292512000010
J	Falord, M; Mader, U; Hiron, A; Debarbouille, M; Msadek, T				Falord, Melanie; Maeder, Ulrike; Hiron, Aurelia; Debarbouille, Michel; Msadek, Tarek			Investigation of the Staphylococcus aureus GraSR Regulon Reveals Novel Links to Virulence, Stress Response and Cell Wall Signal Transduction Pathways	PLOS ONE			English	Article							BACILLUS-SUBTILIS; TRANSCRIPTIONAL REGULATION; ANTIMICROBIAL PEPTIDES; 2-COMPONENT SYSTEM; BIOFILM FORMATION; TEICHOIC-ACID; RESISTANCE; GENE; EXPRESSION; IDENTIFICATION	The GraS/GraR two-component system has been shown to control cationic antimicrobial peptide (CAMP) resistance in the major human pathogen Staphylococcus aureus. We demonstrated that graX, also involved in CAMP resistance and cotranscribed with graRS, encodes a regulatory cofactor of the GraSR signaling pathway, effectively constituting a three-component system. We identified a highly conserved ten base pair palindromic sequence (5' ACAAA TTTGT 3') located upstream from GraR-regulated genes (mprF and the dlt and vraFG operons), which we show to be essential for transcriptional regulation by GraR and induction in response to CAMPs, suggesting it is the likely GraR binding site. Genome-based predictions and transcriptome analysis revealed several novel GraR target genes. We also found that the GraSR TCS is required for growth of S. aureus at high temperatures and resistance to oxidative stress. The GraSR system has previously been shown to play a role in S. aureus pathogenesis and we have uncovered previously unsuspected links with the AgrCA peptide quorum-sensing system controlling virulence gene expression. We also show that the GraSR TCS controls stress reponse and cell wall metabolism signal transduction pathways, sharing an extensive overlap with the WalKR regulon. This is the first report showing a role for the GraSR TCS in high temperature and oxidative stress survival and linking this system to stress response, cell wall and pathogenesis control pathways.	[Falord, Melanie; Hiron, Aurelia; Debarbouille, Michel; Msadek, Tarek] Inst Pasteur, Dept Microbiol, Paris, France; [Falord, Melanie; Hiron, Aurelia; Debarbouille, Michel; Msadek, Tarek] CNRS, URA 2172, Paris, France; [Maeder, Ulrike] Ernst Moritz Arndt Univ Greifswald, Dept Funct Genom, Interfac Inst Genet & Funct Genom, Greifswald, Germany	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); Ernst Moritz Arndt Universitat Greifswald	Falord, M (corresponding author), Inst Pasteur, Dept Microbiol, Paris, France.	tmsadek@pasteur.fr	Hiron, Aurélia/AAC-8048-2020		European Commission [LHSM-CT-2006-019064, LSHG-CT-2006-037469]; Centre National de la Recherche Scientifique [CNRS URA 2172]; Agence Nationale de la Recherche (ANR GrabIron and NaBab); Institut Pasteur [PTR Nu256, PTR Nu336]; Conseil Pasteur-Weizmann	European Commission(European CommissionEuropean Commission Joint Research Centre); Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Agence Nationale de la Recherche (ANR GrabIron and NaBab)(French National Research Agency (ANR)); Institut Pasteur(European Commission); Conseil Pasteur-Weizmann	This work was supported by research funds from the European Commission (StaphDynamics [LHSM-CT-2006-019064] and BaSysBio [LSHG-CT-2006-037469] grants), the Centre National de la Recherche Scientifique (CNRS URA 2172), Agence Nationale de la Recherche (ANR GrabIron and NaBab), and the Institut Pasteur (PTR Nu256 and PTR Nu336). Melanie Falord received a Young Scientist Fellowship from the Conseil Pasteur-Weizmann. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGAISSE H, 1994, MOL MICROBIOL, V13, P97, DOI 10.1111/j.1365-2958.1994.tb00405.x; Archambaud C, 2005, MOL MICROBIOL, V56, P383, DOI 10.1111/j.1365-2958.2005.04551.x; Arnaud M, 2004, APPL ENVIRON MICROB, V70, P6887, DOI 10.1128/AEM.70.11.6887-6891.2004; Belcheva A, 2009, BIOCHEMISTRY-US, V48, P5592, DOI 10.1021/bi900478b; Blanco AG, 2002, STRUCTURE, V10, P701, DOI 10.1016/S0969-2126(02)00761-X; Boles BR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010146; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brunskill EW, 1996, J BACTERIOL, V178, P611, DOI 10.1128/jb.178.3.611-618.1996; Chang S, 2003, NEW ENGL J MED, V348, P1342, DOI 10.1056/NEJMoa025025; Chastanet A, 2001, J BACTERIOL, V183, P7295, DOI 10.1128/JB.183.24.7295-7307.2001; Cheung GYC, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001133; Cui LZ, 2005, ANTIMICROB AGENTS CH, V49, P3404, DOI 10.1128/AAC.49.8.3404-3413.2005; de Been M, 2008, ENVIRON MICROBIOL, V10, P2796, DOI 10.1111/j.1462-2920.2008.01700.x; Dubrac S, 2004, J BACTERIOL, V186, P1175, DOI 10.1128/JB.186.4.1175-1181.2004; Dubrac S, 2007, J BACTERIOL, V189, P8257, DOI 10.1128/JB.00645-07; Dubrac S, 2008, MOL MICROBIOL, V70, P1307, DOI 10.1111/j.1365-2958.2008.06483.x; Even S, 2006, J BACTERIOL, V188, P2184, DOI 10.1128/JB.188.6.2184-2197.2006; Gillaspy A.F., 2006, GRAM POSITIVE PATHOG, P381; Hale JD, 2007, EXPERT REV ANTI-INFE, V5, P951, DOI 10.1586/14787210.5.6.951; Hancock R E, 2001, Lancet Infect Dis, V1, P156, DOI 10.1016/S1473-3099(01)00092-5; Hancock REW, 1999, ANTIMICROB AGENTS CH, V43, P1317, DOI 10.1128/AAC.43.6.1317; Hancock REW, 2006, NAT BIOTECHNOL, V24, P1551, DOI 10.1038/nbt1267; Harris RM, 2001, J BACTERIOL, V183, P5008, DOI 10.1128/JB.183.17.5008-5014.2001; Haugen SP, 2008, NAT REV MICROBIOL, V6, P507, DOI 10.1038/nrmicro1912; Herbert S, 2007, PLOS PATHOG, V3, P981, DOI 10.1371/journal.ppat.0030102; Herbert S, 2010, INFECT IMMUN, V78, P2877, DOI 10.1128/IAI.00088-10; Horsburgh MJ, 2002, MOL MICROBIOL, V44, P1269, DOI 10.1046/j.1365-2958.2002.02944.x; Jenssen H, 2006, CLIN MICROBIOL REV, V19, P491, DOI 10.1128/CMR.00056-05; Joanne P, 2009, BIOCHEMISTRY-US, V48, P9372, DOI 10.1021/bi901222p; Kobayashi K, 2001, J BACTERIOL, V183, P7365, DOI 10.1128/JB.183.24.7365-7370.2001; Koprivnjak T, 2006, J BACTERIOL, V188, P3622, DOI 10.1128/JB.188.10.3622-3630.2006; Kraus D, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-85; KREISWIRTH BN, 1983, NATURE, V305, P709, DOI 10.1038/305709a0; Kuroda M, 2001, LANCET, V357, P1225, DOI 10.1016/S0140-6736(00)04403-2; Kurokawa K, 2007, METHOD ENZYMOL, V422, P233, DOI 10.1016/S0076-6879(06)22011-1; Li M, 2007, MOL MICROBIOL, V66, P1136, DOI 10.1111/j.1365-2958.2007.05986.x; Li M, 2007, P NATL ACAD SCI USA, V104, P9469, DOI 10.1073/pnas.0702159104; Lowy FD, 2003, J CLIN INVEST, V111, P1265, DOI 10.1172/JC1200318535; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; Mandin P, 2005, MOL MICROBIOL, V57, P1367, DOI 10.1111/j.1365-2958.2005.04776.x; MartinezHackert E, 1997, J MOL BIOL, V269, P301, DOI 10.1006/jmbi.1997.1065; Mascher T, 2006, FEMS MICROBIOL LETT, V264, P133, DOI 10.1111/j.1574-6968.2006.00444.x; Meehl M, 2007, ANTIMICROB AGENTS CH, V51, P2679, DOI 10.1128/AAC.00209-07; Michel A, 2006, J BACTERIOL, V188, P5783, DOI 10.1128/JB.00074-06; Miller JH., 1972, EXPT MOL GENETICS; MSADEK T, 1991, J BACTERIOL, V173, P2366, DOI 10.1128/JB.173.7.2366-2377.1991; Msadek T, 1999, TRENDS MICROBIOL, V7, P201, DOI 10.1016/S0966-842X(99)01479-1; Nizet V, 2006, CURR ISSUES MOL BIOL, V8, P11; Nizet V, 2007, J ALLERGY CLIN IMMUN, V120, P13, DOI 10.1016/j.jaci.2007.06.005; Novick RP, 2003, MOL MICROBIOL, V48, P1429, DOI 10.1046/j.1365-2958.2003.03526.x; Ohki R, 2003, MOL MICROBIOL, V49, P1135, DOI 10.1046/j.1365-2958.2003.03653.x; Perichon B, 2009, ANTIMICROB AGENTS CH, V53, P4580, DOI 10.1128/AAC.00346-09; PERKINS JB, 1986, P NATL ACAD SCI USA, V83, P140, DOI 10.1073/pnas.83.1.140; Pietiainen M, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-429; Rasmussen S, 2009, MOL MICROBIOL, V73, P1043, DOI 10.1111/j.1365-2958.2009.06830.x; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Sass P, 2009, INT J MED MICROBIOL, V299, P313, DOI 10.1016/j.ijmm.2008.10.005; Shanks RMQ, 2008, INFECT IMMUN, V76, P2469, DOI 10.1128/IAI.01370-07; Sharma-Kuinkel BK, 2009, J BACTERIOL, V191, P4767, DOI 10.1128/JB.00348-09; SULLIVAN MA, 1984, GENE, V29, P21, DOI 10.1016/0378-1119(84)90161-6; Tabuchi Y, 2010, J IMMUNOL, V185, P2424, DOI 10.4049/jimmunol.1000625; Tamber S, 2010, INFECT IMMUN, V78, P4384, DOI 10.1128/IAI.00401-10; Vergara-Irigaray M, 2008, MICROBIOL-SGM, V154, P865, DOI 10.1099/mic.0.2007/013292-0; Wei HR, 2008, NUCLEIC ACIDS RES, V36, P2926, DOI 10.1093/nar/gkn133; WEINRAUCH Y, 1990, GENE DEV, V4, P860, DOI 10.1101/gad.4.5.860; Wernersson R, 2005, NUCLEIC ACIDS RES, V33, pW611, DOI 10.1093/nar/gki399; Wertheim HFL, 2005, LANCET INFECT DIS, V5, P751, DOI 10.1016/S1473-3099(05)70295-4; Xia GQ, 2010, J BIOL CHEM, V285, P13405, DOI 10.1074/jbc.M109.096172; ZOCK J, 1994, GENE, V151, P37, DOI 10.1016/0378-1119(94)90630-0; ZUBER P, 1983, CELL, V35, P275, DOI 10.1016/0092-8674(83)90230-1	71	112	114	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2011	6	7							e21323	10.1371/journal.pone.0021323	http://dx.doi.org/10.1371/journal.pone.0021323			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786HC	21765893	Green Published, gold, Green Submitted			2022-12-27	WOS:000292293400010
J	Lebre, MC; Vergunst, CE; Choi, IYK; Aarrass, S; Oliveira, ASF; Wyant, T; Horuk, R; Reedquist, KA; Tak, PP				Lebre, Maria C.; Vergunst, Clarissa E.; Choi, Ivy Y. K.; Aarrass, Saida; Oliveira, Ana S. F.; Wyant, Tim; Horuk, Richard; Reedquist, Kris A.; Tak, Paul P.			Why CCR2 and CCR5 Blockade Failed and Why CCR1 Blockade Might Still Be Effective in the Treatment of Rheumatoid Arthritis	PLOS ONE			English	Article							COLLAGEN-INDUCED ARTHRITIS; CHEMOKINE RECEPTOR EXPRESSION; CONTROLLED CLINICAL-TRIAL; PROOF-OF-CONCEPT; SYNOVIAL TISSUE; DOUBLE-BLIND; INFLAMMATORY DISEASE; PERIPHERAL-BLOOD; MACROPHAGES; ANTAGONIST	Background: The aim of this study was to provide more insight into the question as to why blockade of CCR1, CCR2, and CCR5 may have failed in clinical trials in rheumatoid arthritis (RA) patients, using an in vitro monocyte migration system model. Methodology/Principal Findings: Monocytes from healthy donors (HD; n = 8) or from RA patients (for CCR2 and CCR5 antibody n = 8; for CCR1 blockade n = 13) were isolated from peripheral blood and pre-incubated with different concentrations of either anti-CCR1, anti-CCR2, or anti-CCR5 blocking antibodies (or medium or isotype controls). In addition, a small molecule CCR1 antagonist (BX471) was tested. Chemotaxis was induced by CCL2/MCP-1 (CCR2 ligand), CCL5/RANTES (CCR1 and CCR5 ligand), or by a mix of 5 RA synovial fluids (SFs), and cellular responses compared to chemotaxis in the presence of medium alone. Anti-CCR2 antibody treatment blocked CCL2/MCP-1-induced chemotaxis of both HD and RA monocytes compared to isotype control. Similarly, anti-CCR5 antibody treatment blocked CCL5/RANTES-induced chemotaxis of RA monocytes. While neither CCR2 nor CCR5 blocking antibodies were able to inhibit SF-induced monocyte chemotaxis, even when both receptors were blocked simultaneously, both anti-CCR1 antibodies and the CCR1 antagonist were able to inhibit SF-induced monocyte chemotaxis. Conclusions/Significance: The RA synovial compartment contains several ligands for CCR1, CCR2, and CCR5 as well as other chemokines and receptors involved in monocyte recruitment to the site of inflammation. The results suggest that CCR2 and CCR5 are not critical for the migration of monocytes towards the synovial compartment in RA. In contrast, blockade of CCR1 may be effective. Conceivably, CCR1 blockade failed in clinical trials, not because CCR1 is not a good target, but because very high levels of receptor occupancy at all times may be needed to inhibit monocyte migration in vivo.	[Lebre, Maria C.; Vergunst, Clarissa E.; Choi, Ivy Y. K.; Aarrass, Saida; Oliveira, Ana S. F.; Reedquist, Kris A.; Tak, Paul P.] Univ Amsterdam, Acad Med Ctr, Div Clin Immunol & Rheumatol, NL-1105 AZ Amsterdam, Netherlands; [Wyant, Tim] Millennium Pharmaceut Inc, Cambridge, MA USA; [Horuk, Richard] Univ Calif Davis, Dept Pharmacol, Davis, CA 95616 USA	University of Amsterdam; Academic Medical Center Amsterdam; Takeda Pharmaceutical Company Ltd; Millennium Pharmaceuticals; University of California System; University of California Davis	Lebre, MC (corresponding author), Univ Amsterdam, Acad Med Ctr, Div Clin Immunol & Rheumatol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	c.lebre@amc.uva.nl	Oliveira, Ana/L-1850-2014	Oliveira, Ana/0000-0002-2220-5862	Millennium Pharmaceuticals Inc.	Millennium Pharmaceuticals Inc.(Takeda Pharmaceutical Company Ltd)	The study was financed by Millennium Pharmaceuticals Inc. Dr. T. Wyant is an employee of Millennium Pharmaceuticals and contributed with reagents and with the writing of the manuscript. The funders therefore played a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AlMughales J, 1996, CLIN EXP IMMUNOL, V106, P230, DOI 10.1046/j.1365-2249.1996.d01-836.x; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Dairaghi DJ, 2011, CLIN PHARMACOL THER, V89, P726, DOI 10.1038/clpt.2011.33; GERLAG DM, 2010, ARTHRITIS RHEUM; Gladue RP, 2010, CURR TOP MED CHEM, V10, P1268; Grabiec AM, 2010, J IMMUNOL, V184, P2718, DOI 10.4049/jimmunol.0901467; Hamilton JA, 2009, ARTHRITIS RHEUM-US, V60, P1210, DOI 10.1002/art.24505; Haringman JJ, 2006, ARTHRITIS RHEUM, V54, P2387, DOI 10.1002/art.21975; Haringman JJ, 2006, ANN RHEUM DIS, V65, P294, DOI 10.1136/ard.2005.037176; Haringman JJ, 2004, ANN RHEUM DIS, V63, P1186, DOI 10.1136/ard.2004.020529; Haringman JJ, 2004, ARTHRITIS RES THER, V6, P93, DOI 10.1186/ar1172; Haringman JJ, 2003, ANN RHEUM DIS, V62, P715, DOI 10.1136/ard.62.8.715; Hart D, 2008, J IMMUNOL, V181, P8053, DOI 10.4049/jimmunol.181.11.8053; Jiao Z, 2007, SCAND J RHEUMATOL, V36, P428, DOI 10.1080/03009740701482800; Katschke KJ, 2001, ARTHRITIS RHEUM, V44, P1022, DOI 10.1002/1529-0131(200105)44:5<1022::AID-ANR181>3.3.CO;2-E; Kinne RW, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2333; KOCH AE, 1994, J CLIN INVEST, V93, P921, DOI 10.1172/JCI117097; Koch AE, 2005, ARTHRITIS RHEUM, V52, P710, DOI 10.1002/art.20932; Patel DD, 2001, CLIN IMMUNOL, V98, P39, DOI 10.1006/clim.2000.4957; Pease JE, 2009, EXPERT OPIN THER PAT, V19, P199, DOI 10.1517/13543770802641353; Pease JE, 2009, EXPERT OPIN THER PAT, V19, P39, DOI 10.1517/13543770802641346; PlaterZyberk C, 1997, IMMUNOL LETT, V57, P117, DOI 10.1016/S0165-2478(97)00075-8; Proudfoot AEI, 2008, ARTHRITIS RHEUM, V58, P1889, DOI 10.1002/art.23590; Quinones MP, 2005, J MOL MED, V83, P672, DOI 10.1007/s00109-005-0637-5; Sallusto F, 2000, ANNU REV IMMUNOL, V18, P593, DOI 10.1146/annurev.immunol.18.1.593; Schall TJ, 2011, NAT REV IMMUNOL, V11, P355, DOI 10.1038/nri2972; Tak PP, 1997, ARTHRITIS RHEUM, V40, P217, DOI 10.1002/art.1780400206; Thurlings RM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007865; van Kuijk AWR, 2010, ANN RHEUM DIS, V69, P2013, DOI 10.1136/ard.2010.131235; Vergunst CE, 2008, ARTHRITIS RHEUM-US, V58, P1931, DOI 10.1002/art.23591; Vergunst CE, 2009, ARTHRITIS RHEUM-US, V60, P3572, DOI 10.1002/art.24978; Vierboom MPM, 2005, ARTHRITIS RHEUM-US, V52, P627, DOI 10.1002/art.20850; Volin MV, 1998, CLIN IMMUNOL IMMUNOP, V89, P44, DOI 10.1006/clin.1998.4590; Wijbrandts CA, 2007, ARTHRITIS RHEUM, V56, P3869, DOI 10.1002/art.22964	34	68	74	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2011	6	7							e21772	10.1371/journal.pone.0021772	http://dx.doi.org/10.1371/journal.pone.0021772			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786HC	21747955	Green Submitted, gold, Green Published			2022-12-27	WOS:000292293400031
J	Lever, M; George, PM; Atkinson, W; Molyneux, SL; Elmslie, JL; Slow, S; Richards, AM; Chambers, ST				Lever, Michael; George, Peter M.; Atkinson, Wendy; Molyneux, Sarah L.; Elmslie, Jane L.; Slow, Sandy; Richards, A. Mark; Chambers, Stephen T.			Plasma Lipids and Betaine Are Related in an Acute Coronary Syndrome Cohort	PLOS ONE			English	Article							GLYCINE BETAINE; GROWTH-PERFORMANCE; BLOOD-LIPIDS; COMMON FOODS; SUPPLEMENTATION; HOMOCYSTEINE; CHOLINE; HYPERHOMOCYSTEINEMIA; DERIVATIVES; METABOLISM	Background: Low plasma betaine has been associated with unfavorable plasma lipid profiles and cardiovascular risk. In some studies raised plasma betaine after supplementation is associated with elevations in plasma lipids. We aimed to measure the relationships between plasma and urine betaine and plasma lipids, and the effects of lipid-lowering drugs on these. Methodology: Fasting plasma samples were collected from 531 subjects (and urine samples from 415) 4 months after hospitalization for an acute coronary syndrome episode. In this cross-sectional study, plasma betaine and dimethylglycine concentrations and urine excretions were compared with plasma lipid concentrations. Subgroup comparisons were made for gender, with and without diabetes mellitus, and for drug treatment. Principal Findings: Plasma betaine negatively correlated with triglyceride (Spearman's r(s) = -20.22, p < 0.0001) and non-high-density lipoprotein cholesterol (r(s) = -20.27, p < 0.0001). Plasma betaine was a predictor of BMI (p < 0.05) and plasma non-high-density lipoprotein cholesterol and triglyceride (p < 0.001) independently of gender, age and the presence of diabetes. Using data grouped by plasma betaine decile, increasing plasma betaine was linearly related to decreases in BMI (p = 0.008) and plasma non-HDL cholesterol (p = 0.002). In a non-linear relationship betaine was negatively associated with elevated plasma triglycerides (p = 0.004) only for plasma betaine > 45 mu mol/L. Subjects taking statins had higher plasma betaine concentrations (p < 0.001). Subjects treated with a fibrate had lower plasma betaine (p = 0.003) possibly caused by elevated urine betaine loss (p < 0.001). The ratio of coenzyme Q to non-high-density lipoprotein cholesterol was higher in subjects with higher plasma betaine, and in subjects taking a statin. Conclusion: Low plasma betaine concentrations correlated with an unfavourable lipid profile. Betaine deficiency may be common in the study population. Controlled clinical trials of betaine supplementation should be conducted in appropriate populations to determine whether correction affects cardiovascular risk.	[Lever, Michael; George, Peter M.; Atkinson, Wendy; Molyneux, Sarah L.; Elmslie, Jane L.; Slow, Sandy] Canterbury Hlth Labs, Clin Biochem Unit, Christchurch, New Zealand; [Lever, Michael; George, Peter M.; Slow, Sandy; Chambers, Stephen T.] Univ Otago, Christchurch Sch Med & Hlth Sci, Dept Pathol, Christchurch, New Zealand; [Richards, A. Mark] Univ Otago, Christchurch Sch Med & Hlth Sci, Dept Med, Christchurch, New Zealand	Canterbury Health Laboratories; University of Otago; University of Otago	Lever, M (corresponding author), Canterbury Hlth Labs, Clin Biochem Unit, Christchurch, New Zealand.	michael.lever@otago.ac.nz	George, Peter M/A-1315-2013	George, Peter M/0000-0001-9100-3466; Chambers, Stephen/0000-0002-0698-3285; Molyneux, Sarah/0000-0001-6816-5619	National Heart Foundation of New Zealand [1090]; Paykel Trust; Neurological Foundation of New Zealand	National Heart Foundation of New Zealand; Paykel Trust; Neurological Foundation of New Zealand	This study was supported by a grant (1090) from the National Heart Foundation of New Zealand supplemented by grants from the Paykel Trust and the Neurological Foundation of New Zealand. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Danne O, 2010, EXPERT REV MOL DIAGN, V10, P159, DOI 10.1586/ERM.10.2; de Lemos JA, 2001, NEW ENGL J MED, V345, P1014, DOI 10.1056/NEJMoa011053; de Zwart FJ, 2003, FOOD CHEM, V83, P197, DOI 10.1016/S0308-8146(03)00063-3; Eklund M, 2005, NUTR RES REV, V18, P31, DOI 10.1079/NRR200493; Hayes KC, 2003, FOOD CHEM TOXICOL, V41, P1685, DOI 10.1016/S0278-6915(03)00196-0; Hwang YH, 2010, J MUSCLE FOODS, V21, P87, DOI 10.1111/j.1745-4573.2009.00169.x; Kim HJ, 2011, J PROTEOME RES, V10, P722, DOI 10.1021/pr100892r; Kim SH, 2009, ANAL BIOANAL CHEM, V395, P1117, DOI 10.1007/s00216-009-3054-8; Konstantinova SV, 2008, J NUTR, V138, P914, DOI 10.1093/jn/138.5.914; Lever M, 2005, METABOLISM, V54, P1, DOI 10.1016/j.metabol.2004.07.007; Lever M, 2004, CLIN BIOCHEM, V37, P184, DOI 10.1016/j.clinbiochem.2003.11.004; Lever M, 2007, CLIN BIOCHEM, V40, P1225, DOI 10.1016/j.clinbiochem.2007.05.021; Lever M, 2010, CLIN BIOCHEM, V43, P732, DOI 10.1016/j.clinbiochem.2010.03.009; Lever M, 2009, CARDIOVASC DRUG THER, V23, P395, DOI 10.1007/s10557-009-6188-1; Lever M, 2009, CLIN BIOCHEM, V42, P706, DOI 10.1016/j.clinbiochem.2009.02.001; Liao JK, 2005, ANNU REV PHARMACOL, V45, P89, DOI 10.1146/annurev.pharmtox.45.120403.095748; Lv SW, 2009, EUR J NUTR, V48, P205, DOI 10.1007/s00394-009-0003-4; Martins JM, 2010, EUR J LIPID SCI TECH, V112, P295, DOI 10.1002/ejlt.200900066; Molyneux S, 2007, NUTR RES, V27, P307, DOI 10.1016/j.nutres.2007.04.011; Olthof MR, 2005, PLOS MED, V2, P446, DOI 10.1371/journal.pmed.0020135; Price RK, 2010, J NUTR, V140, P2153, DOI 10.3945/jn.110.126961; Ratriyanto A, 2009, ASIAN AUSTRAL J ANIM, V22, P1461, DOI 10.5713/ajas.2009.80659; Schwab U, 2002, AM J CLIN NUTR, V76, P961, DOI 10.1093/ajcn/76.5.961; SCHWAB U, 2010, EUR J CLIN NUTR, P1; Schwahn BC, 2007, ATHEROSCLEROSIS, V195, pE100, DOI 10.1016/j.atherosclerosis.2007.06.030; Slow S, 2009, PHYSIOL RES, V58, P403, DOI 10.33549/physiolres.931569; Sparks JD, 2006, BIOCHEM J, V395, P363, DOI 10.1042/BJ20051966; Storer MK, 2006, J CHROMATOGR A, V1104, P263, DOI 10.1016/j.chroma.2005.11.123; Storer MK, 2006, ANAL CHIM ACTA, V558, P319, DOI 10.1016/j.aca.2005.10.060; Strakova J, 2010, NUTR RES, V30, P492, DOI 10.1016/j.nutres.2010.06.017; Ueland PM, 2011, J INHERIT METAB DIS, V34, P3, DOI 10.1007/s10545-010-9088-4; Wang YZ, 2004, ANIM FEED SCI TECH, V116, P151, DOI 10.1016/j.anifeedsci.2004.05.003; Wang ZN, 2011, NATURE, V472, P57, DOI 10.1038/nature09922; Zeisel SH, 2006, NUTR REV, V64, P77, DOI 10.1111/j.1753-4887.2006.tb00190.x; Zeisel SH, 2003, J NUTR, V133, P1302; Zhan XA, 2006, BRIT POULTRY SCI, V47, P576, DOI 10.1080/00071660600963438; Zhang AQ, 1999, FOOD CHEM TOXICOL, V37, P515, DOI 10.1016/S0278-6915(99)00028-9	37	42	43	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2011	6	7							e21666	10.1371/journal.pone.0021666	http://dx.doi.org/10.1371/journal.pone.0021666			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786HC	21747945	gold, Green Published, Green Submitted			2022-12-27	WOS:000292293400021
J	Li, HD; Liu, WX; Michalak, M				Li, Hao-Dong; Liu, Wen-Xin; Michalak, Marek			Enhanced Clathrin-Dependent Endocytosis in the Absence of Calnexin	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; SYNAPTIC VESICLE ENDOCYTOSIS; MEDIATED ENDOCYTOSIS; CHAPERONE CALNEXIN; CALRETICULIN; MEMBRANE; BINDING; PROTEIN; ERP57; MECHANISMS	Background: Calnexin, together with calreticulin, constitute the calnexin/calreticulin cycle. Calnexin is a type I endoplasmic reticulum integral membrane protein and molecular chaperone responsible for the folding and quality control of newly-synthesized (glyco) proteins. The endoplasmic reticulum luminal domain of calnexin is responsible for lectin-like activity and interaction with nascent polypeptide chains. The role of the C-terminal, cytoplasmic portion of calnexin is not clear. Methodology/Principal Findings: Using yeast two hybrid screen and immunoprecipitation techniques, we showed that the Src homology 3-domain growth factor receptor-bound 2-like (Endophilin) interacting protein 1 (SGIP1), a neuronal specific regulator of endocytosis, forms complexes with the C-terminal cytoplasmic domain of calnexin. The calnexin cytoplasmic C-tail interacts with SGIP1 C-terminal domains containing the adaptor complexes medium subunit (Adap-Comp-Sub) region. Calnexin-deficient cells have enhanced clathrin-dependent endocytosis in neuronal cells and mouse neuronal system. This is reversed by expression of full length calnexin or calnexin C-tail. Conclusions/Significance: We show that the effects of SGIP1 and calnexin C-tail on clathrin-dependent endocytosis are due to modulation of the internalization of the receptor-ligand complexes. Enhanced clathrin-dependent endocytosis in the absence of calnexin may contribute to the neurological phenotype of calnexin-deficient mice.	[Li, Hao-Dong; Liu, Wen-Xin; Michalak, Marek] Univ Alberta, Dept Biochem, Edmonton, AB, Canada	University of Alberta	Li, HD (corresponding author), Univ Alberta, Dept Biochem, Edmonton, AB, Canada.	marek.michalak@ualberta.ca			Canadian Institutes of Health Research [MOP-15291]; Alberta Innovates-Health Solutions; Heart and Stroke Foundation of Canada; AstraZeneca	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Alberta Innovates-Health Solutions; Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); AstraZeneca(AstraZeneca)	This work was supported by a grant from the Canadian Institutes of Health Research (MOP-15291). H-DL was supported by a postdoctoral fellowship from the Alberta Innovates-Health Solutions, Heart and Stroke Foundation of Canada and AstraZeneca. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bedard K, 2005, INT REV CYTOL, V245, P91, DOI 10.1016/S0074-7696(05)45004-4; BERGERON JJM, 1994, TRENDS BIOCHEM SCI, V19, P124, DOI 10.1016/0968-0004(94)90205-4; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chevet E, 1999, EMBO J, V18, P3655, DOI 10.1093/emboj/18.13.3655; Coe H, 2008, CELL STRESS CHAPERON, V13, P497, DOI 10.1007/s12192-008-0049-x; Cousin MA, 2000, J NEUROSCI, V20, P949, DOI 10.1523/JNEUROSCI.20-03-00949.2000; Denzel A, 2002, MOL CELL BIOL, V22, P7398, DOI 10.1128/MCB.22.21.7398-7404.2002; Doherty GJ, 2009, ANNU REV BIOCHEM, V78, P857, DOI 10.1146/annurev.biochem.78.081307.110540; Frickel EM, 2002, P NATL ACAD SCI USA, V99, P1954, DOI 10.1073/pnas.042699099; Gloor SM, 2001, BRAIN RES REV, V36, P258, DOI 10.1016/S0165-0173(01)00102-3; JACKSON AP, 1987, NATURE, V326, P154, DOI 10.1038/326154a0; Kennedy MJ, 2006, ANNU REV NEUROSCI, V29, P325, DOI 10.1146/annurev.neuro.29.051605.112808; Kraus A, 2010, J BIOL CHEM, V285, P18928, DOI 10.1074/jbc.M110.107201; Leach MR, 2002, J BIOL CHEM, V277, P29686, DOI 10.1074/jbc.M202405200; Lee W, 2005, BIOCHEM BIOPH RES CO, V338, P1018, DOI 10.1016/j.bbrc.2005.10.041; LENTER M, 1994, J BIOL CHEM, V269, P12263; Liu Jiang, 2003, Biol Res Nurs, V5, P117, DOI 10.1177/1099800403256860; Lozyk MD, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-54; MacDonald PE, 2005, J CELL SCI, V118, P5911, DOI 10.1242/jcs.02685; MAYCOX PR, 1992, J CELL BIOL, V118, P1379, DOI 10.1083/jcb.118.6.1379; Miaczynska M, 2008, J CELL BIOL, V180, P7, DOI 10.1083/jcb.200711073; Michalak M, 2002, CELL CALCIUM, V32, P269, DOI 10.1016/S0143416002001884; Michalak M, 2009, BIOCHEM J, V417, P651, DOI 10.1042/BJ20081847; Muller-Taubenberger A, 2001, EMBO J, V20, P6772, DOI 10.1093/emboj/20.23.6772; OU WJ, 1992, J BIOL CHEM, V267, P23789; Piddini E, 2003, CURR OPIN CELL BIOL, V15, P474, DOI 10.1016/S0955-0674(03)00072-3; Rappoport JZ, 2008, BIOCHEM J, V412, P415, DOI 10.1042/BJ20080474; Ritter B, 2004, BIOCHEM SOC T, V32, P769, DOI 10.1042/BST0320769; Roderick HL, 2000, J CELL BIOL, V149, P1235, DOI 10.1083/jcb.149.6.1235; Rosenbaum EE, 2006, NEURON, V49, P229, DOI 10.1016/j.neuron.2005.12.011; Royle SJ, 2010, TRAFFIC, V11, P1489, DOI 10.1111/j.1600-0854.2010.01104.x; Russell SJ, 2004, J BIOL CHEM, V279, P18861, DOI 10.1074/jbc.M400575200; Schrag JD, 2001, MOL CELL, V8, P633, DOI 10.1016/S1097-2765(01)00318-5; Silvennoinen L, 2004, J BIOL CHEM, V279, P13607, DOI 10.1074/jbc.M313054200; Smith SM, 2008, TRENDS NEUROSCI, V31, P559, DOI 10.1016/j.tins.2008.08.005; Sorkin A, 2004, CURR OPIN CELL BIOL, V16, P392, DOI 10.1016/j.ceb.2004.06.001; Sudhof TC, 2004, ANNU REV NEUROSCI, V27, P509, DOI 10.1146/annurev.neuro.26.041002.131412; Takizawa T, 2004, J BIOCHEM, V136, P399, DOI 10.1093/jb/mvh133; TJOELKER LW, 1994, BIOCHEMISTRY-US, V33, P3229, DOI 10.1021/bi00177a013; Trevaskis J, 2005, ENDOCRINOLOGY, V146, P3757, DOI 10.1210/en.2005-0282; Uezu A, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M703815200; WADA I, 1991, J BIOL CHEM, V266, P19599; Williams DB, 2006, J CELL SCI, V119, P615, DOI 10.1242/jcs.02856; Wolfe BL, 2007, TRAFFIC, V8, P462, DOI 10.1111/j.1600-0854.2007.00551.x; Zapun A, 1999, STRUCT FOLD DES, V7, pR173, DOI 10.1016/S0969-2126(99)80112-9; Zuppini A, 2002, BIOCHEMISTRY-US, V41, P2850, DOI 10.1021/bi015967+	46	16	18	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2011	6	7							e21678	10.1371/journal.pone.0021678	http://dx.doi.org/10.1371/journal.pone.0021678			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786HC	21747946	Green Published, gold, Green Submitted			2022-12-27	WOS:000292293400022
J	Scharf, ME; Karl, ZJ; Sethi, A; Boucias, DG				Scharf, Michael E.; Karl, Zachary J.; Sethi, Amit; Boucias, Drion G.			Multiple Levels of Synergistic Collaboration in Termite Lignocellulose Digestion	PLOS ONE			English	Article							RETICULITERMES-FLAVIPES; GENE-EXPRESSION; CELLULASE GENE; GUT; GLUCOSIDASE; HYDROLYSIS; PROTOZOA; GENOME; HOST	In addition to evolving eusocial lifestyles, two equally fascinating aspects of termite biology are their mutualistic relationships with gut symbionts and their use of lignocellulose as a primary nutrition source. Termites are also considered excellent model systems for studying the production of bioethanol and renewable bioenergy from 2nd generation (non-food) feedstocks. While the idea that gut symbionts are the sole contributors to termite lignocellulose digestion has remained popular and compelling, in recent years host contributions to the digestion process have become increasingly apparent. However, the degree to which host and symbiont, and host enzymes, collaborate in lignocellulose digestion remain poorly understood. Also, how digestive enzymes specifically collaborate (i.e., in additive or synergistic ways) is largely unknown. In the present study we undertook translational-genomic studies to gain unprecedented insights into digestion by the lower termite Reticulitermes flavipes and its symbiotic gut flora. We used a combination of native gut tissue preparations and recombinant enzymes derived from the host gut transcriptome to identify synergistic collaborations between host and symbiont, and also among enzymes produced exclusively by the host termite. Our findings provide important new evidence of synergistic collaboration among enzymes in the release of fermentable monosaccharides from wood lignocellulose. These monosaccharides (glucose and pentoses) are highly relevant to 2(nd)-generation bioethanol production. We also show that, although significant digestion capabilities occur in host termite tissues, catalytic tradeoffs exist that apparently favor mutualism with symbiotic lignocellulose-digesting microbes. These findings contribute important new insights towards the development of termite-derived biofuel processing biotechnologies and shed new light on selective forces that likely favored symbiosis and, subsequently, group living in primitive termites and their cockroach ancestors.	[Scharf, Michael E.; Karl, Zachary J.; Boucias, Drion G.] Univ Florida, Dept Entomol & Nematol, Gainesville, FL 32611 USA; [Scharf, Michael E.; Boucias, Drion G.] Purdue Univ, Dept Entomol, W Lafayette, IN 47907 USA	State University System of Florida; University of Florida; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Scharf, ME (corresponding author), Purdue Univ, Dept Entomol, W Lafayette, IN 47907 USA.	mscharf@purdue.edu			Consortium for Plant Biotechnology Research Inc.; Department of Energy (DOE) [DE-FG36-02GO12026]; United States Department of Agriculture-National Institute of Food and Agriculture-Agriculture and Food Research Initiative [2009-05245]; Phase I and II DOE-Small Business Innovation Research [DE-FG02-08ER85063, DE-85538 S08-II]	Consortium for Plant Biotechnology Research Inc.; Department of Energy (DOE)(United States Department of Energy (DOE)); United States Department of Agriculture-National Institute of Food and Agriculture-Agriculture and Food Research Initiative(United States Department of Agriculture (USDA)); Phase I and II DOE-Small Business Innovation Research	Funding was provided by The Consortium for Plant Biotechnology Research Inc. (http://www.cpbr.org/) and the Department of Energy (DOE) (http://www.energy.gov/) prime agreement no. DE-FG36-02GO12026 to MES and DGB, the United States Department of Agriculture-National Institute of Food and Agriculture-Agriculture and Food Research Initiative (http://www.nifa.usda.gov/funding/rfas/afri.html) grant no. 2009-05245 to MES and DGB, and Phase I and II DOE-Small Business Innovation Research (http://www.energy.gov/) grant nos. DE-FG02-08ER85063 and DE-85538 S08-II to Chesapeake-PERL Inc. (Savage, MD) and MES. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Support of this research does not constitute an endorsement by the DOE or by The Consortium for Plant Biotechnology Research, Inc. of the views expressed in this publication. Chesapeake-PERL Inc. played a role in recombinant protein production, preparation, and purification but has voluntarily declined co-authorship.	[Anonymous], 1971, INSECT SOC; BREZNAK JA, 1994, ANNU REV ENTOMOL, V39, P453, DOI 10.1146/annurev.en.39.010194.002321; BRUNE A, 1995, APPL ENVIRON MICROB, V61, P2681, DOI 10.1128/AEM.61.7.2681-2687.1995; Burnum KE, 2011, ISME J, V5, P161, DOI 10.1038/ismej.2010.97; Cleveland L. R., 1934, Mem Amer Acad Arts Sci Menasha, V17, P185; CLEVELAND L. R., 1928, BIOL BULL MARINE BIOL LAB, V54, P231, DOI 10.2307/1536855; Cleveland LR, 1923, P NATL ACAD SCI USA, V9, P424, DOI 10.1073/pnas.9.12.424; CLEVELAND LR, 1924, BIOL BULL, V46, P177; Coy MR, 2010, INSECT BIOCHEM MOLEC, V40, P723, DOI 10.1016/j.ibmb.2010.07.004; DESCHATELETS L, 1986, APPL MICROBIOL BIOT, V24, P379, DOI 10.1007/BF00294594; Dittmer NT, 2010, INSECT BIOCHEM MOLEC, V40, P179, DOI 10.1016/j.ibmb.2010.02.006; GUSAKOV AV, 1984, ENZYME MICROB TECH, V6, P275, DOI 10.1016/0141-0229(84)90130-3; Hongoh Y, 2008, SCIENCE, V322, P1108, DOI 10.1126/science.1165578; Hongoh Y, 2008, P NATL ACAD SCI USA, V105, P5555, DOI 10.1073/pnas.0801389105; Hungate RE, 1938, ECOLOGY, V19, P1, DOI 10.2307/1930363; Mathews C.K., 1990, BIOCHEMISTRY-US, V3d; Nalepa Christine A., 1994, P57; Ohkuma M, 2003, APPL MICROBIOL BIOT, V61, P1, DOI 10.1007/s00253-002-1189-z; Ragauskas AJ, 2006, SCIENCE, V311, P484, DOI 10.1126/science.1114736; ROE JH, 1948, J BIOL CHEM, V173, P507; Scharf ME, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r62; Scharf ME, 2010, INSECT BIOCHEM MOLEC, V40, P611, DOI 10.1016/j.ibmb.2010.06.002; Scharf ME, 2008, BIOFUEL BIOPROD BIOR, V2, P540, DOI 10.1002/bbb.107; Simmons BA, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-12-242; Tartar A, 2009, BIOTECHNOL BIOFUELS, V2, DOI 10.1186/1754-6834-2-25; Thorne BL, 2003, ANNU REV ENTOMOL, V48, P283, DOI 10.1146/annurev.ento.48.091801.112611; Warnecke F, 2007, NATURE, V450, P560, DOI 10.1038/nature06269; Watanabe H, 1998, NATURE, V394, P330, DOI 10.1038/28527; Xiao ZZ, 2004, APPL BIOCHEM BIOTECH, V113, P1115, DOI 10.1385/ABAB:115:1-3:1115; Yapi DYA, 2009, J INSECT SCI, V9, DOI 10.1673/031.009.0401; Zhou XG, 2007, GENE, V395, P29, DOI 10.1016/j.gene.2007.01.004; Zhou XG, 2010, ARCH INSECT BIOCHEM, V74, P147, DOI 10.1002/arch.20368; [No title captured], DOI DOI 10.1021/BA-1984-0207.CH002	33	80	91	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2011	6	7							e21709	10.1371/journal.pone.0021709	http://dx.doi.org/10.1371/journal.pone.0021709			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786HC	21747950	Green Submitted, gold, Green Published			2022-12-27	WOS:000292293400026
J	Wang, L; Li, X; Zhang, YQ; Zhang, Y; Zhang, K				Wang, Lin; Li, Xiang; Zhang, Yi-Qing; Zhang, Yan; Zhang, Kan			Evolution of Scaling Emergence in Large-Scale Spatial Epidemic Spreading	PLOS ONE			English	Article							METAPOPULATION DYNAMICS; PANDEMIC INFLUENZA; POWER-LAWS; DISTRIBUTIONS; UNIVERSALITY; NETWORKS; OUTBREAK; A(H1N1); MODELS; FLU	Background: Zipf's law and Heaps' law are two representatives of the scaling concepts, which play a significant role in the study of complexity science. The coexistence of the Zipf's law and the Heaps' law motivates different understandings on the dependence between these two scalings, which has still hardly been clarified. Methodology/Principal Findings: In this article, we observe an evolution process of the scalings: the Zipf's law and the Heaps' law are naturally shaped to coexist at the initial time, while the crossover comes with the emergence of their inconsistency at the larger time before reaching a stable state, where the Heaps' law still exists with the disappearance of strict Zipf's law. Such findings are illustrated with a scenario of large-scale spatial epidemic spreading, and the empirical results of pandemic disease support a universal analysis of the relation between the two laws regardless of the biological details of disease. Employing the United States domestic air transportation and demographic data to construct a metapopulation model for simulating the pandemic spread at the U.S. country level, we uncover that the broad heterogeneity of the infrastructure plays a key role in the evolution of scaling emergence. Conclusions/Significance: The analyses of large-scale spatial epidemic spreading help understand the temporal evolution of scalings, indicating the coexistence of the Zipf's law and the Heaps' law depends on the collective dynamics of epidemic processes, and the heterogeneity of epidemic spread indicates the significance of performing targeted containment strategies at the early time of a pandemic disease.	[Wang, Lin; Li, Xiang; Zhang, Yi-Qing; Zhang, Yan; Zhang, Kan] Fudan Univ, Dept Elect Engn, Adapt Networks & Control Lab, Shanghai 200433, Peoples R China	Fudan University	Wang, L (corresponding author), Fudan Univ, Dept Elect Engn, Adapt Networks & Control Lab, Shanghai 200433, Peoples R China.	lix@fudan.edu.cn	Li, Xiang/AAB-4134-2020; li, xiang/GWM-6319-2022; Wang, Lin/B-4145-2013; Li, Xiang/C-4127-2009	Li, Xiang/0000-0002-6482-2535; Wang, Lin/0000-0002-5371-2138; Zhang, Yiqing/0000-0003-2621-7876	National Key Basic Research and Development Program [2010CB731403]; Natural Science Foundation of China [60874089]; Shanghai Rising-Star Program [09QH1400200]; NECT [NCET-09-0317]	National Key Basic Research and Development Program(National Basic Research Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Rising-Star Program; NECT	We acknowledge support from the National Key Basic Research and Development Program (No. 2010CB731403), the Natural Science Foundation of China (Grant No. 60874089), Shanghai Rising-Star Program (No. 09QH1400200) and the NECT program (No. NCET-09-0317). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON R M, 1991; Serrano MA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005372; Axtell RL, 2001, SCIENCE, V293, P1818, DOI 10.1126/science.1062081; Baek SK, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.046113; Bajardi P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016591; Balcan D, 2011, NAT PHYS, V7, P581, DOI 10.1038/NPHYS1944; Balcan D, 2009, P NATL ACAD SCI USA, V106, P21484, DOI 10.1073/pnas.0906910106; Balcan D, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-45; Barabasi A.-L., 2010, BURSTS HIDDEN PATTER; Barthelemy M, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.178701; Batty M, 2006, NATURE, V444, P592, DOI 10.1038/nature05302; Benz RW, 2008, J CHEM INF MODEL, V48, P1138, DOI 10.1021/ci700353m; Bettencourt LMA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002185; Blasius B, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.218701; Boelle PY, 2009, EUROSURVEILLANCE, V14, P10; Brown J., 2000, SCALING BIOL; *BTS, 2009, US AIR CARR TRAFF CA; *BTS, 2010, SUMM 2009 TRAFF DAT; Cardy J., 1996, SCALING RENORMALIZAT; Castellano C, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.218701; Cattuto C, 2007, P NATL ACAD SCI USA, V104, P1461, DOI 10.1073/pnas.0610487104; Cattuto C, 2009, P NATL ACAD SCI USA, V106, P10511, DOI 10.1073/pnas.0901136106; *CDCP, US SWIN INFL A H1N1; Chan M., 2009, WORLD NOW START 2009; Chen Q, 2009, EPL-EUROPHYS LETT, V88, DOI 10.1209/0295-5075/88/38001; Clauset A, 2009, SIAM REV, V51, P661, DOI 10.1137/070710111; Colizza V, 2006, P NATL ACAD SCI USA, V103, P2015, DOI 10.1073/pnas.0510525103; Colizza V, 2008, J THEOR BIOL, V251, P450, DOI 10.1016/j.jtbi.2007.11.028; Colizza V, 2007, PLOS MED, V4, P95, DOI 10.1371/journal.pmed.0040013; Colizza V, 2007, NAT PHYS, V3, P276, DOI 10.1038/nphys560; Cooper BS, 2006, PLOS MED, V3, P845, DOI 10.1371/journal.pmed.0030212; Cornell SJ, 2008, THEOR POPUL BIOL, V74, P209, DOI 10.1016/j.tpb.2008.07.003; Coronel-Brizio HF, 2005, PHYSICA A, V354, P437, DOI 10.1016/j.physa.2005.03.001; Coronel-Brizio HF, 2005, REV MEX FIS, V51, P27; Decker EH, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000934; Eguiluz VM, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.108701; Epstein JM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000401; Ferrer-i-Cancho R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009411; Fraser C, 2004, P NATL ACAD SCI USA, V101, P6146, DOI 10.1073/pnas.0307506101; Fraser C, 2009, SCIENCE, V324, P1557, DOI 10.1126/science.1176062; Furusawa C, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.088102; Gozzi A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016406; Gross T, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.208701; Hamer W.H., 1906, LANCET, V167, P733, DOI DOI 10.1016/S0140-6736(01)80340-8; Han XP, 2007, PHYS LETT A, V365, P1, DOI 10.1016/j.physleta.2006.12.054; Han XP, 2009, ARXIV09121390; Heaps Harold Stanley, 1978, INFORM RETRIEVAL COM; Hufnagel L, 2004, P NATL ACAD SCI USA, V101, P15124, DOI 10.1073/pnas.0308344101; Iwami S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004915; KANTER I, 1995, PHYS REV LETT, V74, P4559, DOI 10.1103/PhysRevLett.74.4559; Lessler J, 2009, LANCET INFECT DIS, V9, P291, DOI 10.1016/S1473-3099(09)70069-6; Li X, 2006, IEEE T AUTOMAT CONTR, V51, P534, DOI 10.1109/TAC.2005.864203; Li X, 2010, EUR PHYS J B, V75, P319, DOI 10.1140/epjb/e2010-00090-9; Lieberman E, 2007, NATURE, V449, P713, DOI 10.1038/nature06137; Longini IM, 2005, SCIENCE, V309, P1083, DOI 10.1126/science.1115717; Lu L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014139; Maillart T, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.218701; Martinez-Mekler G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004791; Matrajt L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013767; MONTEMURRO MA, 2002, GLOTTOMETRICS, V4, P86; Newman MEJ, 2005, CONTEMP PHYS, V46, P323, DOI 10.1080/00107510500052444; Nishiura H, 2009, EUROSURVEILLANCE, V14; Ogasawara O, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007943; Ovaskainen O, 2006, THEOR POPUL BIOL, V69, P13, DOI 10.1016/j.tpb.2005.05.005; Parshani R, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.258701; Pastor-Satorras R, 2001, PHYS REV LETT, V86, P3200, DOI 10.1103/PhysRevLett.86.3200; Pulliam JRC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000165; Redner S, 1998, EUR PHYS J B, V4, P131, DOI 10.1007/s100510050359; RVACHEV LA, 1985, MATH BIOSCI, V75, P3, DOI 10.1016/0025-5564(85)90064-1; Saichev A., 2009, LECT NOTES EC MATH S, VVolume 632; Scoglio C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011569; Shannon C.E., 1964, MATH THEORY COMMUNIC; SIMON HA, 1955, BIOMETRIKA, V42, P425; Sornette D, 1998, PHYS REV E, V57, P4811, DOI 10.1103/PhysRevE.57.4811; Stanley HE, 1999, REV MOD PHYS, V71, pS358, DOI 10.1103/RevModPhys.71.S358; Stanley HE, 2000, PHYSICA A, V281, P60, DOI 10.1016/S0378-4371(00)00195-3; *US BUR CENS, AM FACTF; *US BUR CENS, 2000, ANN EST POP METR MIC; *US OMB, 2009, OMB B, V1002; Van den Broeck W, 2011, BMC INFECT DIS, V11, DOI [10.1186/1471-2334-11-37, 10.1186/1471-2458-11-575]; Vergu E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009371; World Health Organization (WHO), 2009, SIT UPD PAND H1N1; Yang R, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.066109; Yang Y, 2009, SCIENCE, V326, P729, DOI 10.1126/science.1177373; ZANETTE DH, 2005, J QUANT LINGUIST, V12, P29, DOI DOI 10.1080/09296170500055293; Zhang ZK, 2008, EUR PHYS J B, V66, P557, DOI 10.1140/epjb/e2008-00453-9; Zhou T, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.056109; Zipf G. K., 1949, HUMAN BEHAV PRINCIPL	88	60	61	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2011	6	7							e21197	10.1371/journal.pone.0021197	http://dx.doi.org/10.1371/journal.pone.0021197			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786HC	21747932	Green Published, Green Submitted, gold			2022-12-27	WOS:000292293400007
J	Pinho, AJ; Ferreira, PJSG; Neves, AJR; Bastos, CAC				Pinho, Armando J.; Ferreira, Paulo J. S. G.; Neves, Antonio J. R.; Bastos, Carlos A. C.			On the Representability of Complete Genomes by Multiple Competing Finite-Context (Markov) Models	PLOS ONE			English	Article							DNA-SEQUENCES; COMPRESSION; ALGORITHM; IDENTIFICATION; GENES; TOOL	A finite-context (Markov) model of order k yields the probability distribution of the next symbol in a sequence of symbols, given the recent past up to depth k. Markov modeling has long been applied to DNA sequences, for example to find gene-coding regions. With the first studies came the discovery that DNA sequences are non-stationary: distinct regions require distinct model orders. Since then, Markov and hidden Markov models have been extensively used to describe the gene structure of prokaryotes and eukaryotes. However, to our knowledge, a comprehensive study about the potential of Markov models to describe complete genomes is still lacking. We address this gap in this paper. Our approach relies on (i) multiple competing Markov models of different orders (ii) careful programming techniques that allow orders as large as sixteen (iii) adequate inverted repeat handling (iv) probability estimates suited to the wide range of context depths used. To measure how well a model fits the data at a particular position in the sequence we use the negative logarithm of the probability estimate at that position. The measure yields information profiles of the sequence, which are of independent interest. The average over the entire sequence, which amounts to the average number of bits per base needed to describe the sequence, is used as a global performance measure. Our main conclusion is that, from the probabilistic or information theoretic point of view and according to this performance measure, multiple competing Markov models explain entire genomes almost as well or even better than state-of-the-art DNA compression methods, such as XM, which rely on very different statistical models. This is surprising, because Markov models are local (short-range), contrasting with the statistical models underlying other methods, where the extensive data repetitions in DNA sequences is explored, and therefore have a non-local character.	[Pinho, Armando J.; Ferreira, Paulo J. S. G.; Neves, Antonio J. R.; Bastos, Carlos A. C.] Univ Aveiro, Signal Proc Lab, IEETA DETI, P-3800 Aveiro, Portugal	Universidade de Aveiro	Pinho, AJ (corresponding author), Univ Aveiro, Signal Proc Lab, IEETA DETI, P-3800 Aveiro, Portugal.	ap@ua.pt	Neves, Antonio J. R./AAF-9857-2019; Pinho, Armando J/A-2309-2012	Neves, Antonio J. R./0000-0001-5433-6667; Ferreira, Paulo/0000-0002-5147-0948; Bastos, Carlos/0000-0001-6869-4713; Pinho, Armando/0000-0002-9164-0016	Fundacao para a Ciencia e Tecnologia (FCT) [FCOMP-01-0124-FEDER-007252, PTDC/EIA/72569/2006, FCOMP-01-0124-FEDER-010099, PTDC/EIA-EIA/103099/2008]	Fundacao para a Ciencia e Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission)	This work was supported in part by the grants with the COMPETE reference FCOMP-01-0124-FEDER-007252 (FCT reference PTDC/EIA/72569/2006), and FCOMP-01-0124-FEDER-010099 (FCT reference PTDC/EIA-EIA/103099/2008), Fundacao para a Ciencia e Tecnologia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison L, 1998, Proc Int Conf Intell Syst Mol Biol, V6, P8; ALLISON L, 1990, B MATH BIOL, V52, P431, DOI 10.1016/S0092-8240(05)80219-8; Bayes T., 1997, A M F R S PHILOS T R, V53, P370, DOI DOI 10.1098/RSTL.1763.0053; Behzadi B, 2005, LECT NOTES COMPUT SC, V3537, P190; BORODOVSKII MY, 1986, MOL BIOL+, V20, P833; BORODOVSKII MY, 1986, MOL BIOL+, V20, P826; BORODOVSKY M, 1993, COMPUT CHEM, V17, P123, DOI 10.1016/0097-8485(93)85004-V; Brown M, 1993, Proc Int Conf Intell Syst Mol Biol, V1, P47; Burge CB, 1998, CURR OPIN STRUC BIOL, V8, P346, DOI 10.1016/S0959-440X(98)80069-9; Cao MD, 2007, IEEE DATA COMPR CONF, P43; Chen X, 2001, IEEE ENG MED BIOL, V20, P61, DOI 10.1109/51.940049; Delcher AL, 2007, BIOINFORMATICS, V23, P673, DOI 10.1093/bioinformatics/btm009; Dix TI, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S2-S10; Ferragina P, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-252; Giancarlo R, 2009, BIOINFORMATICS, V25, P1575, DOI 10.1093/bioinformatics/btp117; Grumbach S, 1993, P IEEE DAT COMPR C D, P340; HARDY GF, 1889, COMMUNICATION, P457; Johnson W. E., 1932, MIND, V41, P409, DOI DOI 10.1093/MIND/XLI.164.409; Korodi G, 2005, ACM T INFORM SYST, V23, P3, DOI 10.1145/1055709.1055711; Korodi G, 2007, IEEE DATA COMPR CONF, P33; Laplace PS., 1774, MEMOIRES ACAD ROYALE, V6, P621; Liu ZQ, 2007, SPRINGER SER OPTIM A, V7, P47; Loewenstern D, 1997, IEEE DATA COMPR CONF, P151, DOI 10.1109/DCC.1997.581998; Manzini G, 2004, SOFTWARE PRACT EXPER, V34, P1397, DOI 10.1002/spe.619; MILOSAVLJEVIC A, 1993, COMPUT APPL BIOSCI, V9, P407; Minh DC, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-599; Pinho A. J., 2008, P 16 EUR SIGN PROC C; RHO M, 2010, NUCL ACIDS RES; Richard H, 2003, NUCLEIC ACIDS RES, V31, P3679, DOI 10.1093/nar/gkg613; RISSANEN J, 1978, AUTOMATICA, V14, P465, DOI 10.1016/0005-1098(78)90005-5; RIVALS E, 1996, P DAT COMPR C DCC 96; Robelin D, 2003, NUCLEIC ACIDS RES, V31, P3669, DOI 10.1093/nar/gkg596; SALAMON P, 1992, COMPUT CHEM, V16, P117, DOI 10.1016/0097-8485(92)80038-2; Salzberg SL, 1999, GENOMICS, V59, P24, DOI 10.1006/geno.1999.5854; Sayood K., 2006, INTRO DATA COMPRESSI; Sjolander K, 1996, COMPUT APPL BIOSCI, V12, P327; Stanke M, 2003, BIOINFORMATICS, V19, pII215, DOI 10.1093/bioinformatics/btg1080; Tabus I, 2003, IEEE DATA COMPR CONF, P253; TAVARE S, 1989, B MATH BIOL, V51, P95; Venn J., 1876, LOGIC CHANCE, V2nd ed.; Venn J., 1866, LOGIC CHANCE; Venn J., 1888, LOGIC CHANCE; WHITTAKER ET, 1920, T FACULTY ACTUARIES, V8, P163; Zabell S.L., 1989, ERKENNTNIS, V31, P283, DOI DOI 10.1007/BF01236567; ZABELL SL, 1982, ANN STAT, V10, P1091; Zhu Wenhan, 2010, Nucleic Acids Res, V38, pe132, DOI 10.1093/nar/gkq275; ZIV J, 1977, IEEE T INFORM THEORY, V23, P337, DOI 10.1109/TIT.1977.1055714	49	40	42	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2011	6	6							e21588	10.1371/journal.pone.0021588	http://dx.doi.org/10.1371/journal.pone.0021588			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786GP	21738720	Green Published, Green Submitted, gold			2022-12-27	WOS:000292291800025
J	Buonanno, M; de Toledo, SM; Azzam, EI				Buonanno, Manuela; de Toledo, Sonia M.; Azzam, Edouard I.			Increased Frequency of Spontaneous Neoplastic Transformation in Progeny of Bystander Cells from Cultures Exposed to Densely Ionizing Radiation	PLOS ONE			English	Article							CLUSTERED DNA DAMAGES; IN-VITRO; X-RAYS; POSTCONFLUENCE INHIBITION; ADAPTIVE RESPONSE; HUMAN FIBROBLASTS; ALPHA-PARTICLES; CANCER; EXPRESSION; DEPENDENCE	An increased risk of carcinogenesis caused by exposure to space radiation during prolonged space travel is a limiting factor for human space exploration. Typically, astronauts are exposed to low fluences of ionizing particles that target only a few cells in a tissue at any one time. The propagation of stressful effects from irradiated to neighboring bystander cells and their transmission to progeny cells would be of importance in estimates of the health risks of exposure to space radiation. With relevance to the risk of carcinogenesis, we investigated, in model C3H 10T1/2 mouse embryo fibroblasts (MEFs), modulation of the spontaneous frequency of neoplastic transformation in the progeny of bystander MEFs that had been in co-culture 10 population doublings earlier with MEFs exposed to moderate doses of densely ionizing iron ions (1 GeV/nucleon) or sparsely ionizing protons (1 GeV). An increase (P<0.05) in neoplastic transformation frequency, likely mediated by intercellular communication through gap junctions, was observed in the progeny of bystander cells that had been in co-culture with cells irradiated with iron ions, but not with protons.	[Buonanno, Manuela; de Toledo, Sonia M.; Azzam, Edouard I.] Univ Med & Dent New Jersey, New Jersey Med Sch, Ctr Canc, Dept Radiol, Newark, NJ 07103 USA; [Buonanno, Manuela; Azzam, Edouard I.] Univ Med & Dent New Jersey, Grad Sch Biomed Sci, Newark, NJ 07103 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center	Buonanno, M (corresponding author), Univ Med & Dent New Jersey, New Jersey Med Sch, Ctr Canc, Dept Radiol, Newark, NJ 07103 USA.	azzamei@umdnj.edu	buonanno, manuela/AAM-1588-2020	buonanno, manuela/0000-0002-3455-3602	National Aeronautical Space Radiation Administration (NASA) [NNJ06HD91G]; National Institute of Health [CA049062]; NATIONAL CANCER INSTITUTE [P01CA049062] Funding Source: NIH RePORTER	National Aeronautical Space Radiation Administration (NASA)(National Aeronautics & Space Administration (NASA)); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was funded by Grant NNJ06HD91G from the National Aeronautical Space Radiation Administration (NASA) (www.nasa.gov) and by Grant CA049062 from the National Institute of Health (www.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AUTSAVAPROMPORN N, 2011, J RAD RES IN PRESS; Autsavapromporn N, 2011, RADIAT RES, V175, P347, DOI 10.1667/RR2372.1; Azzam EI, 1996, RADIAT RES, V146, P369, DOI 10.2307/3579298; AZZAM EI, 1994, RADIAT RES, V138, pS28, DOI 10.2307/3578755; Azzam EI, 2003, CANCER RES, V63, P7128; Azzam EI, 2001, P NATL ACAD SCI USA, V98, P473, DOI 10.1073/pnas.011417098; BALCERKUBICZEK EK, 1987, INT J RADIAT BIOL, V51, P219, DOI 10.1080/09553008714550721; BRENNER DJ, 1995, RADIAT RES, V142, P61, DOI 10.2307/3578967; Buonanno M, 2011, RADIAT RES, V175, P405, DOI 10.1667/RR2461.1; CERUTTI PA, 1985, SCIENCE, V227, P375, DOI 10.1126/science.2981433; Chappell LJ, 2010, RADIAT RES, V174, P691, DOI 10.1667/RR2204.1; CHARLTON DE, 1991, INT J RADIAT BIOL, V59, P447, DOI 10.1080/09553009114550401; Committee on the Evaluation of Radiation Shielding for Space Exploration N. R. C, 2008, MAN SPAC RAD RISK NE; Cucinotta FA, 2000, RADIAT RES, V153, P459, DOI 10.1667/0033-7587(2000)153[0459:MFRDOF]2.0.CO;2; Cucinotta FA, 2006, LANCET ONCOL, V7, P431, DOI 10.1016/S1470-2045(06)70695-7; Ding LH, 2005, RADIAT RES, V164, P17, DOI 10.1667/RR3354; Durante M, 2010, NAT REV CLIN ONCOL, V7, P37, DOI 10.1038/nrclinonc.2009.183; Elmore E, 2006, RADIAT RES, V166, P832, DOI 10.1667/RR0682.1; Elmore E, 2009, RADIAT RES, V171, P764, DOI 10.1667/RR1673.1; Georgakilas AG, 2008, MOL BIOSYST, V4, P30, DOI 10.1039/b713178j; Gerashchenko BI, 2005, CYTOM PART A, V66A, P62, DOI 10.1002/cyto.a.20150; GOODHEAD DT, 1988, HEALTH PHYS, V55, P231, DOI 10.1097/00004032-198808000-00015; GRAY LH, 1953, BRIT J RADIOL, V26, P638, DOI 10.1259/0007-1285-26-312-638; Hamada Nobuyuki, 2011, Curr Mol Pharmacol, V4, P79; Hei TK, 2008, J PHARM PHARMACOL, V60, P943, DOI 10.1211/jpp.60.8.0001; Little JB, 2003, ONCOGENE, V22, P6978, DOI 10.1038/sj.onc.1206988; Miller RC, 1999, P NATL ACAD SCI USA, V96, P19, DOI 10.1073/pnas.96.1.19; NCRP, 2006, 153 NCRP; Okada T, 2010, J RADIAT RES, V51, P355, DOI 10.1269/jrr.10016; Preston DL, 2003, RADIAT RES, V160, P381, DOI 10.1667/RR3049; Prise KM, 2009, NAT REV CANCER, V9, P351, DOI 10.1038/nrc2603; PUCK TT, 1956, J EXP MED, V103, P653, DOI 10.1084/jem.103.5.653; RAAPHORST GP, 1986, INT J RADIAT BIOL, V49, P383; Redpath JL, 1998, RADIAT RES, V149, P517, DOI 10.2307/3579792; REZNIKOFF CA, 1973, CANCER RES, V33, P3231; REZNIKOFF CA, 1973, CANCER RES, V33, P3239; RHIM JS, 1993, CRIT REV ONCOGENESIS, V4, P313; RUECKERT RR, 1960, CANCER RES, V20, P944; Sawant SG, 2001, RADIAT RES, V155, P397, DOI 10.1667/0033-7587(2001)155[0397:TBEIRO]2.0.CO;2; SCHILLACI ME, 1989, RADIAT RES, V118, P83, DOI 10.2307/3577424; Shao CL, 2003, FASEB J, V17, P1422, DOI 10.1096/fj.02-1115com; Shore RE, 2009, HEALTH PHYS, V97, P481, DOI 10.1097/HP.0b013e3181ab98d9; Spitz DR, 2004, CANCER METAST REV, V23, P311, DOI 10.1023/B:CANC.0000031769.14728.bc; Sutherland BM, 2001, PHYS MEDICA, V17, P202; Sutherland BM, 2001, RADIAT PROT DOSIM, V97, P33, DOI 10.1093/oxfordjournals.rpd.a006635; TERASIMA T, 1963, SCIENCE, V140, P490, DOI 10.1126/science.140.3566.490; Trosko JE, 2002, CURR DRUG TARGETS, V3, P465, DOI 10.2174/1389450023347371; White RJ, 2001, NATURE, V409, P1115, DOI 10.1038/35059243; Yang HY, 2007, RADIAT RES, V168, P292, DOI 10.1667/RR0864.1	49	36	36	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2011	6	6							e21540	10.1371/journal.pone.0021540	http://dx.doi.org/10.1371/journal.pone.0021540			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	784FW	21738697	Green Published, gold, Green Submitted			2022-12-27	WOS:000292142800035
J	Franciosa, G; Scalfaro, C; Di Bonito, P; Vitale, M; Aureli, P				Franciosa, Giovanna; Scalfaro, Concetta; Di Bonito, Paola; Vitale, Marco; Aureli, Paolo			Identification of Novel Linear Megaplasmids Carrying a beta-Lactamase Gene in Neurotoxigenic Clostridium butyricum Type E Strains	PLOS ONE			English	Article							FIELD GEL-ELECTROPHORESIS; INFANT BOTULISM; COMPLEX GENES; TOXIN; OUTBREAK; SIZE	Since the first isolation of type E botulinum toxin-producing Clostridium butyricum from two infant botulism cases in Italy in 1984, this peculiar microorganism has been implicated in different forms of botulism worldwide. By applying particular pulsed-field gel electrophoresis run conditions, we were able to show for the first time that ten neurotoxigenic C. butyricum type E strains originated from Italy and China have linear megaplasmids in their genomes. At least four different megaplasmid sizes were identified among the ten neurotoxigenic C. butyricum type E strains. Each isolate displayed a single sized megaplasmid that was shown to possess a linear structure by ATP-dependent exonuclease digestion. Some of the neurotoxigenic C. butyricum type E strains possessed additional smaller circular plasmids. In order to investigate the genetic content of the newly identified megaplasmids, selected gene probes were designed and used in Southern hybridization experiments. Our results revealed that the type E botulinum neurotoxin gene was chromosome-located in all neurotoxigenic C. butyricum type E strains. Similar results were obtained with the 16S rRNA, the tetracycline tet(P) and the lincomycin resistance protein lmrB gene probes. A specific mobA gene probe only hybridized to the smaller plasmids of the Italian C. butyricum type E strains. Of note, a beta-lactamase gene probe hybridized to the megaplasmids of eight neurotoxigenic C. butyricum type E strains, of which seven from clinical sources and the remaining one from a food implicated in foodborne botulism, whereas this beta-lactam antibiotic resistance gene was absent form the megaplasmids of the two soil strains examined. The widespread occurrence among C. butyricum type E strains associated to human disease of linear megaplasmids harboring an antibiotic resistance gene strongly suggests that the megaplasmids could have played an important role in the emergence of C. butyricum type E as a human pathogen.	[Franciosa, Giovanna; Scalfaro, Concetta; Vitale, Marco; Aureli, Paolo] Ist Super Sanita, Dept Food Safety & Vet Publ Hlth, I-00161 Rome, Italy; [Di Bonito, Paola] Ist Super Sanita, Dept Infect Parasyt & Immunomediated Dis, I-00161 Rome, Italy	Istituto Superiore di Sanita (ISS); Istituto Superiore di Sanita (ISS)	Franciosa, G (corresponding author), Ist Super Sanita, Dept Food Safety & Vet Publ Hlth, Viale Regina Elena 299, I-00161 Rome, Italy.	giovanna.franciosa@iss.it	Di Bonito, Paola/AAI-3583-2021; Di Bonito, Paola/A-6675-2013; SCALFARO, CONCETTA/C-7041-2015; FRANCIOSA, GIOVANNA/C-7040-2015	Di Bonito, Paola/0000-0002-4737-374X; Di Bonito, Paola/0000-0002-4737-374X; SCALFARO, CONCETTA/0000-0001-8626-7563; FRANCIOSA, GIOVANNA/0000-0003-1520-4826	Istituto Superiore di Sanita, Rome, Italy	Istituto Superiore di Sanita, Rome, Italy	Funding was provided by the Istituto Superiore di Sanita, Rome, Italy (www.iss.it). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe Y, 2008, PEDIATR NEUROL, V38, P55, DOI 10.1016/j.pediatrneurol.2007.08.013; Anniballi F, 2002, J FOOD PROTECT, V65, P1267, DOI 10.4315/0362-028X-65.8.1267; Arnon SS, 2001, JAMA-J AM MED ASSOC, V285, P1059, DOI 10.1001/jama.285.8.1059; AURELI P, 1986, J INFECT DIS, V154, P207, DOI 10.1093/infdis/154.2.207; Bruggemann H, 2005, CURR OPIN MICROBIOL, V8, P601, DOI 10.1016/j.mib.2005.08.006; CASHORE WJ, 1981, J PEDIATR-US, V98, P308, DOI 10.1016/S0022-3476(81)80667-1; Chaudhry R, 1998, EMERG INFECT DIS, V4, P506, DOI 10.3201/eid0403.980347; DYKES JK, 2008, 45 INT RES COORD COM; Fenicia L, 2002, EUR J CLIN MICROBIOL, V21, P736, DOI 10.1007/s10096-002-0816-z; Fenicia L, 1999, CLIN INFECT DIS, V29, P1381, DOI 10.1086/313497; FENICIA L, 2008, CLOSTR BOT EP DIAGN; FRANCIOSA G, 1994, J CLIN MICROBIOL, V32, P1911, DOI 10.1128/JCM.32.8.1911-1917.1994; Franciosa G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004829; HAUSER D, 1992, FEMS MICROBIOL LETT, V99, P251, DOI 10.1111/j.1574-6968.1992.tb05576.x; Herschleb J, 2007, NAT PROTOC, V2, P677, DOI 10.1038/nprot.2007.94; Hill KK, 2007, J BACTERIOL, V189, P818, DOI 10.1128/JB.01180-06; Hill KK, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-66; Hunter SB, 2005, J CLIN MICROBIOL, V43, P1045, DOI 10.1128/JCM.43.3.1045-1050.2005; HUTSON RA, 1993, FEMS MICROBIOL LETT, V108, P103, DOI 10.1016/0378-1097(93)90495-N; Konstantinidis KT, 2004, P NATL ACAD SCI USA, V101, P3160, DOI 10.1073/pnas.0308653100; KRAWIEC S, 1990, MICROBIOL REV, V54, P502, DOI 10.1128/MMBR.54.4.502-539.1990; LEVENE SD, 1987, P NATL ACAD SCI USA, V84, P4054, DOI 10.1073/pnas.84.12.4054; Li Y, 2007, J BACTERIOL, V189, P6128, DOI 10.1128/JB.00447-07; Marshall KM, 2007, BIOCHEM BIOPH RES CO, V361, P49, DOI 10.1016/j.bbrc.2007.06.166; Marshall KM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011087; MCCROSKEY LM, 1986, J CLIN MICROBIOL, V23, P201, DOI 10.1128/JCM.23.1.201-202.1986; Meng X, 1999, J MED MICROBIOL, V48, P133, DOI 10.1099/00222615-48-2-133; Meng XQ, 1997, J CLIN MICROBIOL, V35, P2160, DOI 10.1128/JCM.35.8.2160-2162.1997; Meyer R, 2009, PLASMID, V62, P57, DOI 10.1016/j.plasmid.2009.05.001; Nakanishi S, 2010, ANAEROBE, V16, P253, DOI 10.1016/j.anaerobe.2009.10.002; Obladen M, 2009, NEONATOLOGY, V96, P203, DOI 10.1159/000215590; Pourshaban M, 2002, FEMS MICROBIOL LETT, V214, P119, DOI 10.1016/S0378-1097(02)00849-2; Sayeed S, 2010, INFECT IMMUN, V78, P495, DOI 10.1128/IAI.00838-09; Seki H, 2003, PEDIATR INT, V45, P86, DOI 10.1046/j.1442-200X.2003.01671.x; Smith TJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001271; SUEN JC, 1988, J CLIN MICROBIOL, V26, P2191, DOI 10.1128/JCM.26.10.2191-2192.1988; Umeda K, 2009, J CLIN MICROBIOL, V47, P2720, DOI 10.1128/JCM.00077-09; Van Immerseel F, 2010, J MED MICROBIOL, V59, P141, DOI 10.1099/jmm.0.017541-0; Wang XM, 2000, APPL ENVIRON MICROB, V66, P4992, DOI 10.1128/AEM.66.11.4992-4997.2000; Zhang CH, 2009, CURR MICROBIOL, V59, P656, DOI 10.1007/s00284-009-9491-y; ZHOU Y, 1993, APPL ENVIRON MICROB, V59, P3825, DOI 10.1128/AEM.59.11.3825-3831.1993; ZHOU Y, 1995, INFECT IMMUN, V63, P2987	42	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2011	6	6							e21706	10.1371/journal.pone.0021706	http://dx.doi.org/10.1371/journal.pone.0021706			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	784FW	21738770	Green Published, gold, Green Submitted			2022-12-27	WOS:000292142800061
J	Nelson, CD; Nonnecke, BJ; Reinhardt, TA; Waters, WR; Beitz, DC; Lippolis, JD				Nelson, Corwin D.; Nonnecke, Brian J.; Reinhardt, Timothy A.; Waters, W. Ray; Beitz, Donald C.; Lippolis, John D.			Regulation of Mycobacterium-Specific Mononuclear Cell Responses by 25-Hydroxyvitamin D-3	PLOS ONE			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; VITAMIN-D DEFICIENCY; CD4 T-CELLS; 1,25-DIHYDROXYVITAMIN D-3; MULTIPLE-SCLEROSIS; IN-VITRO; BOVINE TUBERCULOSIS; IMMUNE REGULATION; GENE-EXPRESSION; D-RECEPTOR	The active vitamin D metabolite, 1,25-dihydroxyvitamin D-3 (1,25(OH)(2)D-3), has been shown to be an important regulator of innate and adaptive immune function. In addition, synthesis of 1,25(OH)(2)D-3 from 25-hydroxyvitamin D-3 (25(OH)D-3) by the enzyme 1 alpha-hydroxylase in monocytes upon activation by TLR signaling has been found to regulate innate immune responses of monocytes in an intracrine fashion. In this study we wanted to determine what cells expressed 1 alpha-hydroxylase in stimulated peripheral blood mononuclear cell (PBMC) cultures and if conversion of 25(OH)D-3 to 1,25(OH)(2)D-3 in PBMC cultures regulated antigen-specific immune responses. Initially, we found that stimulation of PBMCs from animals vaccinated with Mycobacterium bovis (M. bovis) BCG with purified protein derivative of M. bovis (M. bovis PPD) induced 1 alpha-hydroxylase gene expression and that treatment with a physiological concentration of 25(OH)D-3 down-regulated IFN-gamma and IL-17F gene expression. Next, we stimulated PBMCs from M. bovis BCG-vaccinated and non-vaccinated cattle with M. bovis PPD and sorted them by FACS according to surface markers for monocytes/macrophages (CD14), B cells (IgM), and T cells (CD3). Sorting the PBMCs revealed that 1 alpha-hydroxylase expression was induced in the monocytes and B cells, but not in the T cells. Furthermore, treatment of stimulated PBMCs with 25(OH) D-3 down-regulated antigen-specific IFN-gamma and IL-17F responses in the T cells, even though 1 alpha-hydroxylase expression was not induced in the T cells. Based on evidence of no T cell 1a-hydroxylase we hypothesize that activated monocytes and B cells synthesize 1,25(OH)(2)D-3 and that 1,25(OH)(2)D-3 down-regulates antigen-specific expression oIFN-gamma and IL-17F in T cells in a paracrine fashion.	[Nelson, Corwin D.; Nonnecke, Brian J.; Reinhardt, Timothy A.; Lippolis, John D.] ARS, Ruminant Dis & Immunol Res Unit, Natl Anim Dis Ctr, USDA, Ames, IA USA; [Waters, W. Ray] ARS, Bacterial Dis Livestock Res Unit, Natl Anim Dis Ctr, USDA, Ames, IA USA; [Nelson, Corwin D.; Beitz, Donald C.] Iowa State Univ, Dept Biochem Biophys & Mol Biol, Ames, IA USA; [Beitz, Donald C.] Iowa State Univ, Dept Anim Sci, Ames, IA USA	United States Department of Agriculture (USDA); United States Department of Agriculture (USDA); Iowa State University; Iowa State University	Nelson, CD (corresponding author), Univ Wisconsin, Dept Biochem, 420 Henry Mall, Madison, WI 53705 USA.	john.lippolis@ars.usda.gov	Reinhardt, Timothy/A-7536-2009	Reinhardt, Timothy/0000-0001-5552-2509; Nelson, Corwin/0000-0003-0195-5610; Lippolis, John/0000-0003-2314-4384	United States Department of Agriculture, Agriculture Research Service [3625-32000-094-00]	United States Department of Agriculture, Agriculture Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This work was supported by United States Department of Agriculture, Agriculture Research Service Internal Funding, Project Number: 3625-32000-094-00. The study design, data collection and analysis, decision to publish, or preparation of the manuscript is determined by the USDA. No current external funding sources for this study.	Adams JS, 2010, J CLIN ENDOCR METAB, V95, P471, DOI 10.1210/jc.2009-1773; Adams JS, 2009, J IMMUNOL, V182, P4289, DOI 10.4049/jimmunol.0803736; Baeke F, 2010, J STEROID BIOCH MOL; Bogdan C, 2011, METHODS MOL BIOL, V677, P375, DOI 10.1007/978-1-60761-869-0_24; Burton JM, 2010, NEUROLOGY, V74, P1852, DOI 10.1212/WNL.0b013e3181e1cec2; Cantorna MT, 2010, P NUTR SOC, V69, P286, DOI 10.1017/S0029665110001722; Cantorna MT, 1996, P NATL ACAD SCI USA, V93, P7861, DOI 10.1073/pnas.93.15.7861; Chang JH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012925; Chen S, 2007, J IMMUNOL, V179, P1634, DOI 10.4049/jimmunol.179.3.1634; Cooper AM, 2009, CURR OPIN IMMUNOL, V21, P378, DOI 10.1016/j.coi.2009.06.004; Curtis MM, 2009, IMMUNOLOGY, V126, P177, DOI 10.1111/j.1365-2567.2008.03017.x; de Almeida DE, 2008, VET IMMUNOL IMMUNOP, V125, P234, DOI 10.1016/j.vetimm.2008.05.019; Dittel BN, 2008, BRAIN BEHAV IMMUN, V22, P421, DOI 10.1016/j.bbi.2007.11.010; Dong C, 2008, IMMUNOL REV, V226, P80, DOI 10.1111/j.1600-065X.2008.00709.x; Endsley JJ, 2009, VET IMMUNOL IMMUNOP, V128, P199, DOI 10.1016/j.vetimm.2008.10.312; Foote MR, 2007, J DAIRY SCI, V90, P5208, DOI 10.3168/jds.2007-0285; Ginde AA, 2009, ARCH INTERN MED, V169, P384, DOI 10.1001/archinternmed.2008.560; Gombart AF, 2005, FASEB J, V19, P1067, DOI 10.1096/fj.04-3284com; Heaney RP, 2008, NUTR REV, V66, pS178, DOI 10.1111/j.1753-4887.2008.00102.x; Hewison M, 2010, MOL CELL ENDOCRINOL, V321, P103, DOI 10.1016/j.mce.2010.02.013; Holick MF, 2008, ADV EXP MED BIOL, V624, P1, DOI 10.1007/978-0-387-77574-6_1; Hollis BW, 2009, NAT REV ENDOCRINOL, V5, P534, DOI 10.1038/nrendo.2009.178; Hollis BW, 2005, J NUTR, V135, P317, DOI 10.1093/jn/135.2.317; Horst RL, 2005, J MAMMARY GLAND BIOL, V10, P141, DOI 10.1007/s10911-005-5397-x; HORST RL, 1994, J DAIRY SCI, V77, P1936, DOI 10.3168/jds.S0022-0302(94)77140-X; Horst RL, 2003, ACTA VET SCAND, P35; Hu XY, 2009, IMMUNITY, V31, P539, DOI 10.1016/j.immuni.2009.09.002; Jeffery LE, 2009, J IMMUNOL, V183, P5458, DOI 10.4049/jimmunol.0803217; KOIZUMI T, 1985, CELL IMMUNOL, V96, P455, DOI 10.1016/0008-8749(85)90377-6; Koszewski NJ, 1996, J STEROID BIOCHEM, V59, P377, DOI 10.1016/S0960-0760(96)00127-6; LEMIRE JM, 1984, J CLIN INVEST, V74, P657, DOI 10.1172/JCI111465; LEMIRE JM, 1991, J CLIN INVEST, V87, P1103, DOI 10.1172/JCI115072; LEMIRE JM, 1995, J STEROID BIOCHEM, V53, P599, DOI 10.1016/0960-0760(95)00106-A; LEMIRE JM, 1985, J IMMUNOL, V134, P3032; Levy JA, 2009, J IMMUNOL, V182, P3945, DOI 10.4049/jimmunol.0990015; Liu PT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005810; Liu PT, 2006, SCIENCE, V311, P1770, DOI 10.1126/science.1123933; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Martineau AR, 2007, AM J RESP CRIT CARE, V176, P208, DOI 10.1164/rccm.200701-007OC; MAYNE CG, 2011, EUROPEAN J IN PRESS; MULLER K, 1992, AUTOIMMUNITY, V14, P37; Munger KL, 2006, JAMA-J AM MED ASSOC, V296, P2832, DOI 10.1001/jama.296.23.2832; Munger KL, 2004, NEUROLOGY, V62, P60, DOI 10.1212/01.WNL.0000101723.79681.38; NASEM (National Academies of Science Engineering and Medicine), 2001, NUTR REQ DAIR CATTL, V7th, DOI 10.17226/9825; Nashold FE, 2001, J NEUROIMMUNOL, V119, P16, DOI 10.1016/S0165-5728(01)00360-5; Nelson CD, 2010, J DAIRY SCI, V93, P1041, DOI 10.3168/jds.2009-2663; Nelson CD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015469; Nnoaham KE, 2008, INT J EPIDEMIOL, V37, P113, DOI 10.1093/ije/dym247; Nonnecke BJ, 2010, J DAIRY SCI, V93, P2684, DOI 10.3168/jds.2009-2892; NONNECKE BJ, 1993, VET IMMUNOL IMMUNOP, V38, P75, DOI 10.1016/0165-2427(93)90114-J; Palmer MT, 2011, J BIOL CHEM, V286, P997, DOI 10.1074/jbc.M110.163790; Peck A, 2010, INFECT IMMUN, V78, P32, DOI 10.1128/IAI.00929-09; Pedersen LB, 2007, J NEUROSCI RES, V85, P2480, DOI 10.1002/jnr.21382; Pike JW, 2007, J STEROID BIOCHEM, V103, P389, DOI 10.1016/j.jsbmb.2006.12.050; PROVVEDINI DM, 1983, SCIENCE, V221, P1181, DOI 10.1126/science.6310748; REICHEL H, 1987, P NATL ACAD SCI USA, V84, P3385, DOI 10.1073/pnas.84.10.3385; REINHARDT TA, 1982, BIOCHEM BIOPH RES CO, V106, P1012, DOI 10.1016/0006-291X(82)91812-5; Rhodes SG, 2003, CLIN DIAGN LAB IMMUN, V10, P1129, DOI 10.1128/CDLI.10.6.1129-1135.2003; Rozen S, 2000, Methods Mol Biol, V132, P365; Sakaki T, 2005, FRONT BIOSCI, V10, P119; Sigmundsdottir H, 2007, NAT IMMUNOL, V8, P285, DOI 10.1038/ni1433; Smolders J, 2010, J STEROID BIOCHEM, V121, P243, DOI 10.1016/j.jsbmb.2010.03.001; Spach KM, 2005, J IMMUNOL, V175, P4119, DOI 10.4049/jimmunol.175.6.4119; Staeva-Vieira TP, 2002, J IMMUNOL, V168, P1181, DOI 10.4049/jimmunol.168.3.1181; Stoffels K, 2007, J STEROID BIOCHEM, V103, P567, DOI 10.1016/j.jsbmb.2006.12.091; Stoffels K, 2006, J BONE MINER RES, V21, P37, DOI 10.1359/JBMR.050908; Tang J, 2009, J IMMUNOL, V182, P4624, DOI 10.4049/jimmunol.0801543; Urashima M, 2010, AM J CLIN NUTR; Van Rhijn I, 2008, MICROBES INFECT, V10, P711, DOI 10.1016/j.micinf.2008.04.005; Veldman CM, 2000, ARCH BIOCHEM BIOPHYS, V374, P334, DOI 10.1006/abbi.1999.1605; Vieth R, 2007, J BONE MINER RES, V22, pV64, DOI 10.1359/JBMR.07S221; Vordermeier HM, 2009, INFECT IMMUN, V77, P3364, DOI 10.1128/IAI.00287-09; Waldron MR, 2003, J DAIRY SCI, V86, P3440, DOI 10.3168/jds.S0022-0302(03)73948-4; Wang TT, 2010, J BIOL CHEM, V285, P2237, DOI 10.1074/jbc.C109.071225; Wang TT, 2004, J IMMUNOL, V173, P2909, DOI 10.4049/jimmunol.173.5.2909; Waters WR, 2001, CLIN DIAGN LAB IMMUN, V8, P1204, DOI 10.1128/CDLI.8.6.1204-1212.2001; Widdison S, 2008, MOL IMMUNOL, V45, P740, DOI 10.1016/j.molimm.2007.06.357; Williams B, 2008, PEDIATR INFECT DIS J, V27, P941, DOI 10.1097/INF.0b013e31817525df	78	35	35	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2011	6	6							e21674	10.1371/journal.pone.0021674	http://dx.doi.org/10.1371/journal.pone.0021674			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	784FW	21738762	Green Published, Green Submitted, gold			2022-12-27	WOS:000292142800058
J	Favier, B; HoWangYin, KY; Wu, J; Caumartin, J; Daouya, M; Horuzsko, A; Carosella, ED; LeMaoult, J				Favier, Benoit; HoWangYin, Kiave-Yune; Wu, Juan; Caumartin, Julien; Daouya, Marina; Horuzsko, Anatolij; Carosella, Edgardo D.; LeMaoult, Joel			Tolerogenic Function of Dimeric Forms of HLA-G Recombinant Proteins: A Comparative Study In Vivo	PLOS ONE			English	Article							ANTIGEN-PRESENTING CELLS; NATURAL-KILLER-CELLS; INHIBITORY RECEPTOR; DENDRITIC CELLS; G EXPRESSION; G MOLECULE; T-CELLS; MYELOMONOCYTIC CELLS; PATHWAY; SURFACE	HLA-G is a natural tolerogenic molecule involved in the best example of tolerance to foreign tissues there is: the maternalfetal tolerance. The further involvement of HLA-G in the tolerance of allogeneic transplants has also been demonstrated and some of its mechanisms of action have been elucidated. For these reasons, therapeutic HLA-G molecules for tolerance induction in transplantation are actively investigated. In the present study, we studied the tolerogenic functions of three different HLA-G recombinant proteins: HLA-G heavy chain fused to beta 2-microglobulin (B2M), HLA-G heavy chain fused to B2M and to the Fc portion of an immunoglobulin, and HLA-G alpha-1 domain either fused to the Fc part of an immunoglobulin or as a synthetic peptide. Our results demonstrate the tolerogenic function of B2M-HLA-G fusion proteins, and especially of B2M-HLA-G5, which were capable of significantly delaying allogeneic skin graft rejection in a murine in vivo transplantation model. The results from our studies suggest that HLA-G recombinant proteins are relevant candidates for tolerance induction in human transplantation.	[Favier, Benoit; HoWangYin, Kiave-Yune; Caumartin, Julien; Daouya, Marina; Carosella, Edgardo D.; LeMaoult, Joel] CEA, I2BM, Serv Rech Hemato Immunol, Paris, France; [Favier, Benoit; HoWangYin, Kiave-Yune; Caumartin, Julien; Daouya, Marina; Carosella, Edgardo D.; LeMaoult, Joel] Hop St Louis, Inst Univ Hematol, Paris, France; [HoWangYin, Kiave-Yune] Univ Paris 07, Biol & Biotechnol PhD Program, Paris, France; [Wu, Juan; Horuzsko, Anatolij] Georgia Hlth Sci Univ, Ctr Mol Chaperone Radiobiol & Canc Virol, Augusta, GA USA	CEA; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; University System of Georgia; Augusta University	Favier, B (corresponding author), CEA, I2BM, Serv Rech Hemato Immunol, Paris, France.	Joel.LeMaoult@cea.fr	FAVIER, Benoit/W-7379-2019; LeMaoult, Joel/E-9583-2011	LeMaoult, Joel/0000-0002-4513-9482	Commissariat a l'Energie Atomique; Agence de la Biomedecine; HLA-G Technologies; National Institute of Health [R56 AI055923]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI055923] Funding Source: NIH RePORTER	Commissariat a l'Energie Atomique(French Atomic Energy Commission); Agence de la Biomedecine; HLA-G Technologies; National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by Commissariat a l'Energie Atomique, by the Agence de la Biomedecine, in part by HLA-G Technologies (to A. H.), and by National Institute of Health grant R56 AI055923 (to A. H.). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The commercial source HLA-G Technologies has partially funded this study by contributing to the expenses of in vivo experiments. They did not take any part in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Aractingi S, 2001, AM J PATHOL, V159, P71, DOI 10.1016/S0002-9440(10)61675-6; Bahri R, 2006, J IMMUNOL, V176, P1331, DOI 10.4049/jimmunol.176.3.1331; Boyson JE, 2002, P NATL ACAD SCI USA, V99, P16180, DOI 10.1073/pnas.212643199; Carosella ED, 2008, BLOOD, V111, P4862, DOI 10.1182/blood-2007-12-127662; Carosella ED, 2008, TRENDS IMMUNOL, V29, P125, DOI 10.1016/j.it.2007.11.005; Caumartin J, 2007, EMBO J, V26, P1423, DOI 10.1038/sj.emboj.7601570; CHEN HX, 2010, HUMAN IMMUNOLO UNPUB; Colonna M, 1998, J IMMUNOL, V160, P3096; Colonna M, 1997, J EXP MED, V186, P1809, DOI 10.1084/jem.186.11.1809; Gonen-Gross T, 2003, J IMMUNOL, V171, P1343, DOI 10.4049/jimmunol.171.3.1343; Gregori S, 2010, BLOOD, V116, P935, DOI 10.1182/blood-2009-07-234872; Greten TF, 2002, J IMMUNOL METHODS, V271, P125, DOI 10.1016/S0022-1759(02)00346-0; Horuzsko A, 2001, INT IMMUNOL, V13, P385, DOI 10.1093/intimm/13.3.385; Huang JH, 2010, J VIROL, V84, P10784, DOI 10.1128/JVI.01292-10; Kren L, 2010, J NEUROIMMUNOL, V220, P131, DOI 10.1016/j.jneuroim.2010.01.014; LeMaoult J, 2004, P NATL ACAD SCI USA, V101, P7064, DOI 10.1073/pnas.0401922101; Liang S, 2008, P NATL ACAD SCI USA, V105, P8357, DOI 10.1073/pnas.0803341105; Liang SY, 2002, EUR J IMMUNOL, V32, P2418, DOI 10.1002/1521-4141(200209)32:9<2418::AID-IMMU2418>3.0.CO;2-L; Lila N, 2000, LANCET, V355, P2138, DOI 10.1016/S0140-6736(00)02386-2; Lila N, 2002, CIRCULATION, V105, P1949, DOI 10.1161/01.CIR.0000015075.89984.46; Lozano JM, 2002, AIDS, V16, P347, DOI 10.1097/00002030-200202150-00005; Mitsdoerffer M, 2005, J NEUROIMMUNOL, V159, P155, DOI 10.1016/j.jneuroim.2004.09.016; Morandi F, 2007, CANCER RES, V67, P6433, DOI 10.1158/0008-5472.CAN-06-4588; Nuckel H, 2005, BLOOD, V105, P1694, DOI 10.1182/blood-2004-08-3335; Pangault C, 2002, HUM IMMUNOL, V63, P83, DOI 10.1016/S0198-8859(01)00373-1; Paul P, 1998, P NATL ACAD SCI USA, V95, P4510, DOI 10.1073/pnas.95.8.4510; Rajagopalan S, 1999, J EXP MED, V189, P1093, DOI 10.1084/jem.189.7.1093; Rebmann V, 2005, HUM IMMUNOL, V66, P853, DOI 10.1016/j.humimm.2005.05.003; Ristich V, 2005, EUR J IMMUNOL, V35, P1133, DOI 10.1002/eji.200425741; Riteau B, 2001, J IMMUNOL, V166, P5018, DOI 10.4049/jimmunol.166.8.5018; Rouas-Freiss N, 2003, AM J TRANSPLANT, V3, P11, DOI 10.1034/j.1600-6143.2003.30103.x; RouasFreiss N, 1997, P NATL ACAD SCI USA, V94, P5249, DOI 10.1073/pnas.94.10.5249; Shiroishi M, 2006, J BIOL CHEM, V281, P10439, DOI 10.1074/jbc.M512305200; Shiroishi M, 2003, P NATL ACAD SCI USA, V100, P8856, DOI 10.1073/pnas.1431057100; Shiroishi M, 2006, P NATL ACAD SCI USA, V103, P16412, DOI 10.1073/pnas.0605228103; Wiendl H, 2000, ANN NEUROL, V48, P679, DOI 10.1002/1531-8249(200010)48:4<679::AID-ANA19>3.3.CO;2-M	36	18	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2011	6	7							e21011	10.1371/journal.pone.0021011	http://dx.doi.org/10.1371/journal.pone.0021011			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	793HP	21779321	Green Published, gold, Green Submitted			2022-12-27	WOS:000292811300006
J	Chen, YY; Enoksson, SL; Johansson, C; Karlsson, MA; Lundeberg, L; Nilsson, G; Scheynius, A; Karlsson, MCI				Chen, Yunying; Enoksson, Sara Lind; Johansson, Catharina; Karlsson, Maria A.; Lundeberg, Lena; Nilsson, Gunnar; Scheynius, Annika; Karlsson, Mikael C. I.			The Expression of BAFF, APRIL and TWEAK Is Altered in Eczema Skin but Not in the Circulation of Atopic and Seborrheic Eczema Patients	PLOS ONE			English	Article							IL-18; CYTOKINE; INDUCTION; CELLS; IGE; DERMATITIS; INTERLEUKIN-18; PATHOGENESIS; DIAGNOSIS; THERAPY	The TNF family cytokines BAFF (B-cell activating factor of the TNF family) and APRIL (a proliferation-inducing ligand) are crucial survival factors for B-cell development and activation. B-cell directed treatments have been shown to improve atopic eczema (AE), suggesting the involvement of these cytokines in the pathogenesis of AE. We therefore analyzed the expression of these TNF cytokines in AE, seborrheic eczema (SE) and healthy controls (HC). The serum/plasma concentration of BAFF, APRIL and a close TNF member TWEAK (TNF-like weak inducer of apoptosis) was measured by ELISA. The expression of these cytokines and their receptors in skin was analyzed by quantitative RT-PCR and immunofluorescence. Unlike other inflammatory diseases including autoimmune diseases and asthma, the circulating levels of BAFF, APRIL and TWEAK were not elevated in AE or SE patients compared with HCs and did not correlate with the disease severity or systemic IgE levels in AE patients. Interestingly, we found that the expression of these cytokines and their receptors was altered in positive atopy patch test reactions in AE patients (APT-AE) and in lesional skin of AE and SE patients. The expression of APRIL was decreased and the expression of BAFF was increased in eczema skin of AE and SE, which could contribute to a reduced negative regulatory input on B-cells. This was found to be more pronounced in APT-AE, the initiating acute stage of AE, which may result in dysregulation of over-activated B-cells. Furthermore, the expression levels of TWEAK and its receptor positively correlated to each other in SE lesions, but inversely correlated in AE lesions. These results shed light on potential pathogenic roles of these TNF factors in AE and SE, and pinpoint a potential of tailored treatments towards these factors in AE and SE.	[Chen, Yunying; Enoksson, Sara Lind; Johansson, Catharina; Scheynius, Annika; Karlsson, Mikael C. I.] Karolinska Inst, Dept Med Solna, Clin Allergy Res Unit, Stockholm, Sweden; [Chen, Yunying; Enoksson, Sara Lind; Johansson, Catharina; Karlsson, Maria A.; Lundeberg, Lena; Nilsson, Gunnar; Scheynius, Annika; Karlsson, Mikael C. I.] Karolinska Univ Hosp Solna, Stockholm, Sweden; [Karlsson, Maria A.; Lundeberg, Lena] Karolinska Inst, Dept Med Solna, Dermatol Unit, Stockholm, Sweden; [Nilsson, Gunnar] Karolinska Inst, Dept Med Solna, Clin Immunol & Allergy Unit, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska Institutet	Chen, YY (corresponding author), Karolinska Inst, Dept Med Solna, Clin Allergy Res Unit, Stockholm, Sweden.	yunying.chen@ki.se		Nilsson, Gunnar/0000-0001-6795-5512	The Centre for Allergy Research, Karolinska Institutet; The Swedish Research Council; The Swedish Medical Society; The Hesselman Foundation; The Swedish International Development Agency; The Swedish Foundation for Strategic Research; Magnus Bergvall's Foundation; Stockholm County Council; The Karolinska Institutet	The Centre for Allergy Research, Karolinska Institutet; The Swedish Research Council(Swedish Research Council); The Swedish Medical Society; The Hesselman Foundation; The Swedish International Development Agency; The Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Magnus Bergvall's Foundation; Stockholm County Council(Stockholm County Council); The Karolinska Institutet(Karolinska Institutet)	This study was supported by grants from The Centre for Allergy Research, Karolinska Institutet, The Swedish Research Council, The Swedish Medical Society, The Hesselman Foundation, The Swedish International Development Agency, The Swedish Foundation for Strategic Research, Magnus Bergvall's Foundation, and through the regional agreement on medical training and clinical research (ALF) between Stockholm County Council and The Karolinska Institutet. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akdis CA, 2006, ALLERGY, V61, P969, DOI 10.1111/j.1398-9995.2006.01153.x; Bieber T, 2008, NEW ENGL J MED, V358, P1483, DOI 10.1056/NEJMra074081; Burkly LC, 2007, CYTOKINE, V40, P1, DOI 10.1016/j.cyto.2007.09.007; Daridon C, 2008, AUTOIMMUN REV, V7, P267, DOI 10.1016/j.autrev.2007.05.002; Daridon C, 2009, CURR OPIN RHEUMATOL, V21, P205, DOI 10.1097/BOR.0b013e32832a0760; Darsow U, 2000, CLIN EXP DERMATOL, V25, P544, DOI 10.1046/j.1365-2230.2000.00695.x; Gaitanis G, 2010, MALASSEZIA AND THE SKIN: SCIENCE AND CLINICAL PRACTICE, P201, DOI 10.1007/978-3-642-03616-3; Harvima IT, 1999, ACTA DERM-VENEREOL, V79, P217; Hoshino T, 2000, EUR J IMMUNOL, V30, P1998, DOI 10.1002/1521-4141(200007)30:7<1998::AID-IMMU1998>3.0.CO;2-U; Jee HM, 2009, CLIN EXP DERMATOL, V53, P795; Jin L, 2004, J INVEST DERMATOL, V122, P1175, DOI 10.1111/j.0022-202X.2004.22419.x; Johansson C, 2002, J INVEST DERMATOL, V118, P1044, DOI 10.1046/j.1523-1747.2002.01758.x; Johansson C, 2009, INT ARCH ALLERGY IMM, V150, P51, DOI 10.1159/000210380; Kanda N, 2007, EUR J IMMUNOL, V37, P338, DOI 10.1002/eji.200636420; Kang JS, 2006, INT ARCH ALLERGY IMM, V141, P181, DOI 10.1159/000094897; Kunz B, 1997, DERMATOLOGY, V195, P10, DOI 10.1159/000245677; Lind SM, 2009, EUR J IMMUNOL, V39, P2293, DOI 10.1002/eji.200839195; Mackay F, 2009, NAT REV IMMUNOL, V9, P491, DOI 10.1038/nri2572; Matsushita T, 2008, EXP DERMATOL, V17, P197, DOI 10.1111/j.1600-0625.2007.00642.x; MITCHELL EB, 1982, LANCET, V1, P127; Nagel A, 2009, J INVEST DERMATOL, V129, P289, DOI 10.1038/jid.2008.192; Naldi L, 2009, NEW ENGL J MED, V360, P387, DOI 10.1056/NEJMcp0806464; Ohta Y, 2001, ARCH DERMATOL RES, V293, P334, DOI 10.1007/s004030100240; OKAMURA H, 1995, NATURE, V378, P88, DOI 10.1038/378088a0; Park MC, 2008, SCAND J RHEUMATOL, V37, P173, DOI 10.1080/03009740801898608; Pastore S, 2006, EUR J DERMATOL, V16, P125; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Seshasayee D, 2003, IMMUNITY, V18, P279, DOI 10.1016/S1074-7613(03)00025-6; Shaker OG, 2009, J DERMATOL SCI, V53, P153, DOI 10.1016/j.jdermsci.2008.08.018; Shibata S, 2010, J INVEST DERMATOL, V130, P1034, DOI 10.1038/jid.2009.349; Simon D, 2008, J ALLERGY CLIN IMMUN, V121, P122, DOI 10.1016/j.jaci.2007.11.016; Sims JE, 2010, NAT REV IMMUNOL, V10, P89, DOI 10.1038/nri2691; Tanaka T, 2001, INT ARCH ALLERGY IMM, V125, P236, DOI 10.1159/000053821; Vilhelmsson M, 2008, MOL IMMUNOL, V46, P294, DOI 10.1016/j.molimm.2008.07.036; Winkles JA, 2008, NAT REV DRUG DISCOV, V7, P411, DOI 10.1038/nrd2488; Wittmann M, 2009, AUTOIMMUN REV, V9, P45, DOI 10.1016/j.autrev.2009.03.003; Wittmann M, 2009, J ALLERGY CLIN IMMUN, V124, P81, DOI 10.1016/j.jaci.2009.04.026; Yanaba K, 2009, J RHEUMATOL, V36, P1657, DOI 10.3899/jrheum.081310; Yoshimoto T, 2000, NAT IMMUNOL, V1, P132, DOI 10.1038/77811; Zargari A, 2003, ALLERGY, V58, P306, DOI 10.1034/j.1398-9995.2003.00082.x; Zimmermann M, 2011, J ALLERGY CLIN IMMUN, V127, P200, DOI 10.1016/j.jaci.2010.11.005	41	18	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2011	6	7							e22202	10.1371/journal.pone.0022202	http://dx.doi.org/10.1371/journal.pone.0022202			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	792WQ	21765951	gold, Green Published, Green Submitted			2022-12-27	WOS:000292781500040
J	Halder, N; Kelso, JK; Milne, GJ				Halder, Nilimesh; Kelso, Joel K.; Milne, George J.			Cost-Effective Strategies for Mitigating a Future Influenza Pandemic with H1N1 2009 Characteristics	PLOS ONE			English	Article							UNITED-STATES; SCHOOL CLOSURE; TRANSMISSION; STRAIN	Background: We performed an analysis of the cost-effectiveness of pandemic intervention strategies using a detailed, individual-based simulation model of a community in Australia together with health outcome data of infected individuals gathered during 2009-2010. The aim was to examine the cost-effectiveness of a range of interventions to determine the most cost-effective strategies suitable for a future pandemic with H1N1 2009 characteristics. Methodology/Principal Findings: Using transmissibility, age-stratified attack rates and health outcomes determined from H1N1 2009 data, we determined that the most cost-effective strategies involved treatment and household prophylaxis using antiviral drugs combined with limited duration school closure, with costs ranging from $632 to $777 per case prevented. When school closure was used as a sole intervention we found the use of limited duration school closure to be significantly more cost-effective compared to continuous school closure, a result with applicability to countries with limited access to antiviral drugs. Other social distancing strategies, such as reduced workplace attendance, were found to be costly due to productivity losses. Conclusion: The mild severity (low hospitalisation and case fatality rates) and low transmissibility of H1N1 2009 meant that health treatment costs were dominated by the higher productivity losses arising from workplace absence due to illness and childcare requirements following school closure. Further analysis for higher transmissibility but with the same, mild severity had no effect on the overall findings.	[Halder, Nilimesh; Kelso, Joel K.; Milne, George J.] Univ Western Australia, Sch Comp Sci & Software Engn, Crawley, WA, Australia	University of Western Australia	Halder, N (corresponding author), Univ Western Australia, Sch Comp Sci & Software Engn, Crawley, WA, Australia.	joel@csse.uwa.edu.au	Kelso, Joel/C-2433-2013; Milne, George/C-6839-2013	Kelso, Joel/0000-0001-9814-6435; Milne, George/0000-0002-9796-0600	National Health and Medical Research Council of Australia	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	The authors acknowledge the funding of the National Health and Medical Research Council of Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Australian Bureau of Statistics, 2004, 2004 AUSTR CENS; Australian Commonwealth Department of Health and Ageing, 2009, AUSTR HLTH MAN PLAN; Baguelin M, 2010, VACCINE, V28, P2370, DOI 10.1016/j.vaccine.2010.01.002; Chowell G, 2008, EPIDEMIOL INFECT, V136, P852, DOI 10.1017/S0950268807009144; Cruz-Pacheco G, 2009, EUROSURVEILLANCE, V14; *ECDC, 2009, ECDC RISK ASS 2009 I; Fraser C, 2009, SCIENCE, V324, P1557, DOI 10.1126/science.1176062; Garber AA, 2008, J ECON PERSPECT, V22, P27, DOI 10.1257/jep.22.4.27; Gold MR, 1996, COST EFFECTIVENESS H; Halder N, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-221; Halder N, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-168; Kelly HA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011341; Kelso JK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013797; Kelso JK, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-117; McBryde E, 2009, EURO SURVEILL, V14; Meltzer MI, 1999, EMERG INFECT DIS, V5, P659, DOI 10.3201/eid0505.990507; Milne G, 2010, J R SOC INTERFACE, V7, P573, DOI 10.1098/rsif.2009.0312; Milne GJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004005; Munayco CV, 2009, EUROSURVEILLANCE, V14, P6; Newall AT, 2010, EMERG INFECT DIS, V16, P224, DOI 10.3201/eid1602.090571; Newall AT, 2008, VACCINE, V26, P6818, DOI 10.1016/j.vaccine.2008.09.086; Nishiura H, 2009, EUROSURVEILLANCE, V14; Perlroth DJ, 2010, CLIN INFECT DIS, V50, P165, DOI 10.1086/649867; *RAT, 2010, US HIST CONS PRIC IN; Sander B, 2009, VALUE HEALTH, V12, P226, DOI 10.1111/j.1524-4733.2008.00437.x; Sypsa V, 2009, EUROSURVEILLANCE, V14; *THOMS, 2006, PHYS DESK REF 2006 R; Tsuchiya A, 2001, EC EVALUATION HLTH C, P22; *UK DEP HLTH, 2007, PAND FLU FRAM RESP I; *US DEP HHS, 2009, PAND INFL PLAN; Webb SAR, 2009, NEW ENGL J MED, V361, P1925, DOI 10.1056/NEJMoa0908481; World Health Organization, 2009, PAND INFL PREP RESP	32	32	33	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2011	6	7							e22087	10.1371/journal.pone.0022087	http://dx.doi.org/10.1371/journal.pone.0022087			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791IA	21760957	Green Published, Green Submitted, gold			2022-12-27	WOS:000292657200046
J	Junker, H; Venz, S; Zimmermann, U; Thiele, A; Scharf, C; Walther, R				Junker, Heike; Venz, Simone; Zimmermann, Uwe; Thiele, Andrea; Scharf, Christian; Walther, Reinhard			Stage-Related Alterations in Renal Cell Carcinoma - Comprehensive Quantitative Analysis by 2D-DIGE and Protein Network Analysis	PLOS ONE			English	Article							COMPARATIVE GENOMIC HYBRIDIZATION; CANDIDATE BIOMARKERS; PROTEOMIC ANALYSIS; PEROXIREDOXIN-III; PROHIBITIN GENE; CANCER-CELLS; EXPRESSION; OVEREXPRESSION; PHOSPHORYLATION; IDENTIFICATION	Renal cell carcinoma accounts for about 3% of adult malignancies and 85% of neoplasms arising from the kidney. To identify potential progression markers for kidney cancer we examined non-neoplastic and neoplastic kidney tissue from three groups of patients, which represent different tumor stages (pT1, pT2, pT3) by a fluorescence two-dimensional difference gel electrophoresis (2D-DIGE) approach combined with MALDI-ToF-MS/MS. Delta2D software package was used for gel image based quantification and statistical analysis. Thereby, a comprehensive Principal Component Analysis (PCA) could be performed and allowed a robust quality control of the experiment as well as a classification of the analyzed samples, which correlated with the predicted stages from the pathological examination. Additionally for selected candidate proteins we detected a correlation to the tumor grading as revealed by immunohistochemistry. On the 2D protein map 176 spots out of 989 were detected as at least 2-fold differentially expressed. These spots were analyzed by MALDI-ToF-MS/MS and 187 different proteins were identified. The functional clustering of the identified proteins revealed ten groups. Within these groups we found 86 enzymes, 63 proteins of unknown function, 14 transporter, 8 peptidases and 7 kinases. From the systems biology approach we could map many of these proteins in major pathways involved in remodelling of cytoskeleton, mitochondrial dysfunctions and changes in lipid metabolism. Due to complexity of the highly interconnected pathway network, further expression and functional validation of these proteins might provide new insights in kidney cancer progression to design novel diagnostic and therapeutic strategies.	[Junker, Heike; Venz, Simone; Walther, Reinhard] Ernst Moritz Arndt Univ Greifswald, Dept Med Biochem & Mol Biol, Greifswald, Germany; [Venz, Simone; Scharf, Christian] Ernst Moritz Arndt Univ Greifswald, Interfacultary Inst Genet & Funct Genom, Greifswald, Germany; [Zimmermann, Uwe] Ernst Moritz Arndt Univ Greifswald, Dept Urol, Greifswald, Germany; [Thiele, Andrea] Ernst Moritz Arndt Univ Greifswald, Dept Pathol, Greifswald, Germany; [Scharf, Christian] Ernst Moritz Arndt Univ Greifswald, Dept Otorhinolaryngol Head & Neck Surg, Greifswald, Germany	Ernst Moritz Arndt Universitat Greifswald; Ernst Moritz Arndt Universitat Greifswald; Ernst Moritz Arndt Universitat Greifswald; Ernst Moritz Arndt Universitat Greifswald; Ernst Moritz Arndt Universitat Greifswald	Junker, H (corresponding author), Ernst Moritz Arndt Univ Greifswald, Dept Med Biochem & Mol Biol, Greifswald, Germany.	rwalther@uni-greifswald.de	Scharf, Christian/A-7931-2011	Scharf, Christian/0000-0001-6806-6450				Alessandro Riccardo, 2005, Clin Colorectal Cancer, V4, P396, DOI 10.3816/CCC.2005.n.012; Ande SR, 2009, BBA-MOL CELL RES, V1793, P1372, DOI 10.1016/j.bbamcr.2009.05.008; Ande SR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004586; Arai K, 2008, CURR CANCER DRUG TAR, V8, P243, DOI 10.2174/156800908784533445; ASAMOTO M, 1994, CANCER LETT, V83, P201, DOI 10.1016/0304-3835(94)90320-4; Baak JPA, 2003, EUR J CANCER, V39, P1199, DOI 10.1016/S0959-8049(03)00265-X; Balabanov S, 2001, EUR J BIOCHEM, V268, P5977, DOI 10.1046/j.0014-2956.2001.02546.x; BJELLQVIST B, 1982, J BIOCHEM BIOPH METH, V6, P317, DOI 10.1016/0165-022X(82)90013-6; Boer JM, 2001, GENOME RES, V11, P1861, DOI 10.1101/gr.184501; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Choi D, 2008, ONCOGENE, V27, P1716, DOI 10.1038/sj.onc.1210806; Choi JH, 2002, ANTICANCER RES, V22, P3331; Chowdhury I, 2007, ENDOCRINOLOGY, V148, P206, DOI 10.1210/en.2006-0187; Craven RA, 2006, PROTEOMICS, V6, P2853, DOI 10.1002/pmic.200500549; Dallmann K, 2004, INT J CANCER, V108, P342, DOI 10.1002/ijc.11459; Eymann C, 2004, PROTEOMICS, V4, P2849, DOI 10.1002/pmic.200400907; FUHRMAN SA, 1982, AM J SURG PATHOL, V6, P655, DOI 10.1097/00000478-198210000-00007; Fusaro G, 2002, ONCOGENE, V21, P4539, DOI 10.1038/sj.onc.1205551; Ghavami S, 2009, EUR J PHARMACOL, V625, P73, DOI 10.1016/j.ejphar.2009.08.044; Gregory-Bass RC, 2008, INT J CANCER, V122, P1923, DOI 10.1002/ijc.23351; Hobbs JAR, 2003, MOL CELL BIOL, V23, P2564, DOI 10.1128/MCB.23.7.2564-2576.2003; Horsch S, 2004, INT J CLIN PHARM TH, V42, P63; Ichikawa M, 2011, MOL CANCER RES, V9, P133, DOI 10.1158/1541-7786.MCR-10-0394; Immenschuh S, 2005, ANTIOXID REDOX SIGN, V7, P768, DOI 10.1089/ars.2005.7.768; Johann DJ, 2010, ANAL CHEM, V82, P1584, DOI 10.1021/ac902204k; Karihtala P, 2003, CLIN CANCER RES, V9, P3418; Kim DS, 2010, J PROTEOME RES, V9, P3710, DOI 10.1021/pr100236r; Kim HK, 2010, J PROTEOME RES, V9, P4123, DOI 10.1021/pr100302b; Kinnula VL, 2002, J PATHOL, V196, P316, DOI 10.1002/path.1042; Koskimaa HM, 2010, CANCER EPIDEM BIOMAR, V19, P2003, DOI 10.1158/1055-9965.EPI-09-0781; Lichtenfels R, 2009, MOL CELL PROTEOMICS, V8, P2827, DOI 10.1074/mcp.M900168-MCP200; Manitz MP, 2003, MOL CELL BIOL, V23, P1034, DOI 10.1128/MCB.23.3.1034-1043.2003; Manjeshwar S, 2003, CANCER RES, V63, P5251; Marouga R, 2005, ANAL BIOANAL CHEM, V382, P669, DOI 10.1007/s00216-005-3126-3; MCCLUNG JK, 1989, BIOCHEM BIOPH RES CO, V164, P1316, DOI 10.1016/0006-291X(89)91813-5; Moch H, 1996, CANCER RES, V56, P27; Nijtmans LGJ, 2002, CELL MOL LIFE SCI, V59, P143, DOI 10.1007/s00018-002-8411-0; OFARRELL PH, 1975, J BIOL CHEM, V250, P4007; Okamura N, 2008, PROTEOMICS, V8, P3194, DOI 10.1002/pmic.200700619; Park JH, 2006, RESPIROLOGY, V11, P269, DOI 10.1111/j.1440-1843.2006.00849.x; Peng XJ, 2006, CANCER RES, V66, P7361, DOI 10.1158/0008-5472.CAN-06-1004; Perroud B, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-64; Rini BI, 2009, LANCET, V373, P1119, DOI 10.1016/S0140-6736(09)60229-4; Sanchez-Quiles V, 2010, PROTEOMICS, V10, P1609, DOI 10.1002/pmic.200900757; Sarto C, 1999, ELECTROPHORESIS, V20, P3458, DOI 10.1002/(SICI)1522-2683(19991101)20:17<3458::AID-ELPS3458>3.3.CO;2-X; Sarto C, 1997, ELECTROPHORESIS, V18, P599, DOI 10.1002/elps.1150180343; Seliger B, 2007, PROTEOMICS, V7, P4601, DOI 10.1002/pmic.200700415; Seliger B, 2009, PROTEOMICS, V9, P1567, DOI 10.1002/pmic.200700288; Seyfried TN, 2008, EPILEPSIA, V49, P114, DOI 10.1111/j.1528-1167.2008.01853.x; Sievers C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012735; Sinz A, 2002, ELECTROPHORESIS, V23, P3445, DOI 10.1002/1522-2683(200210)23:19<3445::AID-ELPS3445>3.0.CO;2-J; Siu KWM, 2009, J PROTEOME RES, V8, P3797, DOI 10.1021/pr800389e; Smallbone K, 2005, J THEOR BIOL, V235, P476, DOI 10.1016/j.jtbi.2005.02.001; Sobin, 2009, UICC TNM CLASSIFICAT; Sonini Y, 2006, APMIS, V114, P329; Stern R, 2002, EXP CELL RES, V276, P24, DOI 10.1006/excr.2002.5508; Sun RC, 2010, BREAST CANCER RES TR, V120, P253, DOI 10.1007/s10549-009-0435-9; Thompson WE, 2003, BIOL REPROD, V69, P254, DOI 10.1095/biolreprod.102.010975; Unwin RD, 2003, PROTEOMICS, V3, P1620, DOI 10.1002/pmic.200300464; Wang S, 1999, ONCOGENE, V18, P3501, DOI 10.1038/sj.onc.1202684; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Wilhelm M, 2002, CANCER RES, V62, P957; Wilkins MR, 1996, BIOTECHNOL GENET ENG, V13, P19, DOI 10.1080/02648725.1996.10647923; Wolf G, 2010, J ENDOCRINOL, V207, P163, DOI 10.1677/JOE-09-0455; Xu RH, 2005, CANCER RES, V65, P613; Zhang B, 2009, CANCER LETT, V286, P154, DOI 10.1016/j.canlet.2009.04.043; Zhao LA, 2010, FEBS J, V277, P4195, DOI 10.1111/j.1742-4658.2010.07808.x; Zimmermann U, 2004, CANCER LETT, V209, P111, DOI 10.1016/j.canlet.2003.12.002	68	34	35	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2011	6	7							e21867	10.1371/journal.pone.0021867	http://dx.doi.org/10.1371/journal.pone.0021867			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791HI	21760917	Green Published, gold, Green Submitted			2022-12-27	WOS:000292655400023
J	Moreno, BG; Peypoch, XM				Gel Moreno, Bernat; Messeguer Peypoch, Xavier			GenExp: An Interactive Web-Based Genomic DAS Client with Client-Side Data Rendering	PLOS ONE			English	Article							DISTRIBUTED ANNOTATION SYSTEM; SEQUENCE; BROWSER; INFORMATION	Background: The Distributed Annotation System (DAS) offers a standard protocol for sharing and integrating annotations on biological sequences. There are more than 1000 DAS sources available and the number is steadily increasing. Clients are an essential part of the DAS system and integrate data from several independent sources in order to create a useful representation to the user. While web-based DAS clients exist, most of them do not have direct interaction capabilities such as dragging and zooming with the mouse. Results: Here we present GenExp, a web based and fully interactive visual DAS client. GenExp is a genome oriented DAS client capable of creating informative representations of genomic data zooming out from base level to complete chromosomes. It proposes a novel approach to genomic data rendering and uses the latest HTML5 web technologies to create the data representation inside the client browser. Thanks to client-side rendering most position changes do not need a network request to the server and so responses to zooming and panning are almost immediate. In GenExp it is possible to explore the genome intuitively moving it with the mouse just like geographical map applications. Additionally, in GenExp it is possible to have more than one data viewer at the same time and to save the current state of the application to revisit it later on. Conclusions: GenExp is a new interactive web-based client for DAS and addresses some of the short-comings of the existing clients. It uses client-side data rendering techniques resulting in easier genome browsing and exploration. GenExp is open source under the GPL license and it is freely available at http://gralggen.lsi.upc.edu/recerca/genexp.	[Gel Moreno, Bernat; Messeguer Peypoch, Xavier] UPC BarcelonaTech, Software Dept, Barcelona, Spain	Universitat Politecnica de Catalunya	Moreno, BG (corresponding author), UPC BarcelonaTech, Software Dept, Barcelona, Spain.	bgel@lsi.upc.edu	Gel Moreno, Bernat/B-8806-2016	Gel Moreno, Bernat/0000-0001-8878-349X	Departament d'Universitats, Recerca i Societat de la Informacio de la Generalitat de Catalunya; Spanish Ministry of Science and Technology [TIN2010-21062-C02-01, TIN 2007-68093-C02-01]	Departament d'Universitats, Recerca i Societat de la Informacio de la Generalitat de Catalunya; Spanish Ministry of Science and Technology(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	BGM was supported by an FI predoctoral grant from Departament d'Universitats, Recerca i Societat de la Informacio de la Generalitat de Catalunya (http://www.gencat.cat/diue/). BGM and XMP are also supported by the projects SweetLogics (TIN2010-21062-C02-01) and LogicTools-2 (TIN 2007-68093-C02-01) funded by the Spanish Ministry of Science and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cases I, 2007, NUCLEIC ACIDS RES, V35, pW16, DOI 10.1093/nar/gkm280; Dowell RD, 2001, BMC BIOINFORMATICS, V2, DOI 10.1186/1471-2105-2-7; Hubbard TJP, 2009, NUCLEIC ACIDS RES, V37, pD690, DOI 10.1093/nar/gkn828; Jenkinson AM, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S8-S3; Jimenez RC, 2008, BIOINFORMATICS, V24, P2119, DOI 10.1093/bioinformatics/btn387; Kuhn RM, 2009, NUCLEIC ACIDS RES, V37, pD755, DOI 10.1093/nar/gkn875; Macias JR, 2007, J STRUCT BIOL, V158, P205, DOI 10.1016/j.jsb.2007.02.004; Messina DN, 2009, BIOINFORMATICS, V25, P1333, DOI 10.1093/bioinformatics/btp153; Moreno BG, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-23; Nicol JW, 2009, BIOINFORMATICS, V25, P2730, DOI 10.1093/bioinformatics/btp472; Prlic A, 2005, BIOINFORMATICS, V21, P40, DOI 10.1093/bioinformatics/bti1106; Prlic A, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-333; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Stein LD, 2002, GENOME RES, V12, P1599, DOI 10.1101/gr.403602; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033	15	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2011	6	7							e21270	10.1371/journal.pone.0021270	http://dx.doi.org/10.1371/journal.pone.0021270			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	789JO	21750706	Green Published, gold			2022-12-27	WOS:000292512000011
J	Li, JY; Wang, NA				Li, Jinyun; Wang, Nian			Genome-Wide Mutagenesis of Xanthomonas axonopodis pv. citri Reveals Novel Genetic Determinants and Regulation Mechanisms of Biofilm Formation	PLOS ONE			English	Article							CELL-CELL COMMUNICATION; C-DI-GMP; ESCHERICHIA-COLI; POLYSACCHARIDE PRODUCTION; STAPHYLOCOCCUS-AUREUS; SUBSP CITRI; HD-GYP; CAMPESTRIS; VIRULENCE; PROTEIN	Xanthomonas axonopodis pv. citri (Xac) causes citrus canker disease, a major threat to citrus production worldwide. Accumulating evidence suggests that the formation of biofilms on citrus leaves plays an important role in the epiphytic survival of this pathogen prior to the development of canker disease. However, the process of Xac biofilm formation is poorly understood. Here, we report a genome-scale study of Xac biofilm formation in which we identified 92 genes, including 33 novel genes involved in biofilm formation and 7 previously characterized genes, colR, fhaB, fliC, galU, gumD, wxacO, and rbfC, known to be important for Xac biofilm formation. In addition, 52 other genes with defined or putative functions in biofilm formation were identified, even though they had not previously reported been to be associated with biofilm formation. The 92 genes were isolated from 292 biofilm-defective mutants following a screen of a transposon insertion library containing 22,000 Xac strain 306 mutants. Further analyses indicated that 16 of the novel genes are involved in the production of extracellular polysaccharide (EPS) and/or lipopolysaccharide (LPS), 7 genes are involved in signaling and regulatory pathways, and 5 genes have unknown roles in biofilm formation. Furthermore, two novel genes, XAC0482, encoding a haloacid dehalogenase-like phosphatase, and XAC0494 (designated as rbfS), encoding a two-component sensor protein, were confirmed to be biofilm-related genes through complementation assays. Our data demonstrate that the formation of mature biofilm requires EPS, LPS, both flagellum-dependent and flagellum-independent cell motility, secreted proteins and extracellular DNA. Additionally, multiple signaling pathways are involved in Xac biofilm formation. This work is the first report on a genome-wide scale of the genetic processes of biofilm formation in plant pathogenic bacteria. The report provides significant new information about the genetic determinants and regulatory mechanism of biofilm formation.	[Li, Jinyun; Wang, Nian] Univ Florida, Ctr Citrus Res & Educ, Dept Microbiol & Cell Sci, Lake Alfred, FL USA	State University System of Florida; University of Florida	Li, JY (corresponding author), Univ Florida, Ctr Citrus Res & Educ, Dept Microbiol & Cell Sci, Lake Alfred, FL USA.	nianwang@crec.ifas.ufl.edu	Wang, Nian/HDM-2087-2022	Wang, Nian/0000-0001-7743-0728	United States Department of Agriculture, Cooperative State Research, Education, and Extension Service [88811]	United States Department of Agriculture, Cooperative State Research, Education, and Extension Service(United States Department of Agriculture (USDA)National Institute of Food and Agriculture)	This work was supported by the United States Department of Agriculture, Cooperative State Research, Education, and Extension Service, Special Citrus Canker Grant Project 88811 (www.csrees.usda.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alegria MC, 2005, J BACTERIOL, V187, P2315, DOI 10.1128/JB.187.7.2315-2325.2005; Andrade MO, 2006, MOL MICROBIOL, V62, P537, DOI 10.1111/j.1365-2958.2006.05386.x; Barrios AFG, 2006, J BACTERIOL, V188, P305, DOI 10.1128/JB.188.1.305-316.2006; Boch J, 2010, ANNU REV PHYTOPATHOL, V48, P419, DOI 10.1146/annurev-phyto-080508-081936; Breton C, 2006, GLYCOBIOLOGY, V16, p29R, DOI 10.1093/glycob/cwj016; Brown BL, 2011, J BIOL CHEM, V286, P2285, DOI 10.1074/jbc.M110.172643; Caspi R, 2010, NUCLEIC ACIDS RES, V38, pD473, DOI 10.1093/nar/gkp875; Cheng DW, 2010, J PLANT PATHOL, V92, P415; Cubero J, 2002, APPL ENVIRON MICROB, V68, P1257, DOI 10.1128/AEM.68.3.1257-1264.2002; da Silva ACR, 2002, NATURE, V417, P459, DOI 10.1038/417459a; Danhorn T, 2007, ANNU REV MICROBIOL, V61, P401, DOI 10.1146/annurev.micro.61.080706.093316; Dow JM, 2003, P NATL ACAD SCI USA, V100, P10995, DOI 10.1073/pnas.1833360100; DUCEY TF, 2002, EPICENTRE FORUM, V9, P6; Dunger G, 2007, ARCH MICROBIOL, V188, P127, DOI 10.1007/s00203-007-0227-8; El Yacoubi B, 2007, APPL ENVIRON MICROB, V73, P1612, DOI 10.1128/AEM.00261-06; Finn RD, 2006, NUCLEIC ACIDS RES, V34, pD247, DOI 10.1093/nar/gkj149; Flemming HC, 2010, NAT REV MICROBIOL, V8, P623, DOI 10.1038/nrmicro2415; GABRIEL D, 2003, J BIOL CHEM, V278, P43728; Gerstmeir R, 2004, J BACTERIOL, V186, P2798, DOI 10.1128/JB.186.9.2798-2809.2004; Gottig N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004358; Gottwald T. R., 2002, Plant Health Progress, P1; Graham JH, 2004, MOL PLANT PATHOL, V5, P1, DOI 10.1046/j.1364-3703.2004.00197.x; Guo YP, 2010, APPL ENVIRON MICROB, V76, P2234, DOI 10.1128/AEM.02897-09; He YW, 2007, MOL MICROBIOL, V64, P281, DOI 10.1111/j.1365-2958.2007.05670.x; He YW, 2009, MOL MICROBIOL, V71, P1464, DOI 10.1111/j.1365-2958.2009.06617.x; He YW, 2006, MOL MICROBIOL, V59, P610, DOI 10.1111/j.1365-2958.2005.04961.x; Hennig S, 2010, J BACTERIOL, V192, P4153, DOI 10.1128/JB.00226-10; Kane SR, 2007, J BACTERIOL, V189, P1931, DOI 10.1128/JB.01259-06; Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896; Karatan E, 2009, MICROBIOL MOL BIOL R, V73, P310, DOI 10.1128/MMBR.00041-08; Kube M, 2008, ENVIRON MICROBIOL, V10, P2211, DOI 10.1111/j.1462-2920.2008.01639.x; Kuznetsova E, 2006, J BIOL CHEM, V281, P36149, DOI 10.1074/jbc.M605449200; Laia ML, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-12; Lau PCY, 2009, J BACTERIOL, V191, P6618, DOI 10.1128/JB.00698-09; Leduc JL, 2009, J BACTERIOL, V191, P7121, DOI 10.1128/JB.00845-09; Li JY, 2011, MOL PLANT PATHOL, V12, P381, DOI 10.1111/j.1364-3703.2010.00681.x; Lu GT, 2009, J BACTERIOL, V191, P3639, DOI 10.1128/JB.00009-09; Mack M, 1997, FEBS LETT, V405, P209, DOI 10.1016/S0014-5793(97)00187-7; Malamud F, 2011, MICROBIOL-SGM, V157, P819, DOI 10.1099/mic.0.044255-0; Marin M, 2010, J BACTERIOL, V192, P1543, DOI 10.1128/JB.01208-09; Mascher T, 2006, MICROBIOL MOL BIOL R, V70, P910, DOI 10.1128/MMBR.00020-06; Moreira LM, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-238; Puttamreddy S, 2010, INFECT IMMUN, V78, P2377, DOI 10.1128/IAI.00156-10; Qian W, 2008, MOL PLANT MICROBE IN, V21, P1128, DOI 10.1094/MPMI-21-8-1128; Quoc PHT, 2007, INFECT IMMUN, V75, P1079, DOI 10.1128/IAI.01143-06; Rice KC, 2007, P NATL ACAD SCI USA, V104, P8113, DOI 10.1073/pnas.0610226104; Rigano LA, 2007, MOL PLANT MICROBE IN, V20, P1222, DOI 10.1094/mpmi-20-10-1222; Romling U, 2005, MOL MICROBIOL, V57, P629, DOI 10.1111/j.1365-2958.2005.04697.x; Rosenshine I, 1996, EMBO J, V15, P2613, DOI 10.1002/j.1460-2075.1996.tb00621.x; Ryan RP, 2010, P NATL ACAD SCI USA, V107, P5989, DOI 10.1073/pnas.0912839107; Rybak M, 2009, MOL PLANT PATHOL, V10, P249, DOI 10.1111/j.1364-3703.2008.00528.x; Salzberg SL, 2008, BMC GENOMICS, DOI 10.1186/1471-2164-9-534; Sambrook J, 2001, MOL CLONING LAB MANU, P633; Schaad Norman W, 2006, Syst Appl Microbiol, V29, P690, DOI 10.1016/j.syapm.2006.08.001; Simm R, 2004, MOL MICROBIOL, V53, P1123, DOI 10.1111/j.1365-2958.2004.04206.x; Sofia HJ, 2001, NUCLEIC ACIDS RES, V29, P1097, DOI 10.1093/nar/29.5.1097; Spychala J, 1996, P NATL ACAD SCI USA, V93, P1232, DOI 10.1073/pnas.93.3.1232; Stojnev T, 2007, CURR MICROBIOL, V55, P99, DOI 10.1007/s00284-006-0516-5; Sukumaran SK, 2002, J BIOL CHEM, V277, P12253, DOI 10.1074/jbc.M110740200; Tao F, 2010, ENVIRON MICROBIOL, V12, P3159, DOI 10.1111/j.1462-2920.2010.02288.x; Tischler AD, 2004, MOL MICROBIOL, V53, P857, DOI 10.1111/j.1365-2958.2004.04155.x; Torres PS, 2007, ENVIRON MICROBIOL, V9, P2101, DOI 10.1111/j.1462-2920.2007.01332.x; VAUTERIN L, 1995, INT J SYST BACTERIOL, V45, P472, DOI 10.1099/00207713-45-3-472; Wang L, 2007, APPL ENVIRON MICROB, V73, P8023, DOI 10.1128/AEM.01414-07; Wexler M, 2000, J BIOL CHEM, V275, P16717, DOI 10.1074/jbc.M000800200; Wu LQ, 2005, APPL ENVIRON MICROB, V71, P1581, DOI 10.1128/AEM.71.3.1581-1590.2005; Yamashita Y, 1998, J BACTERIOL, V180, P5803, DOI 10.1128/JB.180.21.5803-5807.1998; Yan Q, 2011, J BACTERIOL, V193, P1590, DOI 10.1128/JB.01415-10	68	58	60	2	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2011	6	7							e21804	10.1371/journal.pone.0021804	http://dx.doi.org/10.1371/journal.pone.0021804			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	789JO	21750733	gold, Green Published, Green Submitted			2022-12-27	WOS:000292512000025
J	Lin, CC; Li, CI; Chang, CK; Liu, CS; Lin, CH; Meng, NH; Lee, YD; Chen, FN; Li, TC				Lin, Cheng-Chieh; Li, Chia-Ing; Chang, Chiu-Kai; Liu, Chiu-Shong; Lin, Chih-Hsueh; Meng, Nai-Hsin; Lee, Yih-Dar; Chen, Fei-Na; Li, Tsai-Chung			Reduced Health-Related Quality of Life in Elders with Frailty: A Cross-Sectional Study of Community-Dwelling Elders in Taiwan	PLOS ONE			English	Article							OLDER-ADULTS; SHORT-FORM; SURVEY SF-36; VALIDITY; PEOPLE	Purpose: Exploring the domains and degrees of health-related quality of life (HRQOL) that are affected by the frailty of elders will help clinicians understand the impact of frailty. This association has not been investigated in community-dwelling elders. Therefore, we examined the domains and degree of HRQOL of elders with frailty in the community in Taiwan. Methods: A total of 933 subjects aged 65 years and over were recruited in 2009 from a metropolitan city in Taiwan. Using an adoption of the Fried criteria, frailty was defined by five components: shrinking, weakness, poor endurance and energy, slowness, and low physical activity level. HRQOL was assessed by the short form 36 (SF-36). The multiple linear regression model was used to test the independent effects of frailty on HRQOL. Results: After multivariate adjustment, elders without frailty reported significantly better health than did the pre-frail and frail elders on all scales, and the pre-frail elders reported better health than did the frail elders for all scales except the scales of role limitation due to physical and emotional problems and the Mental Component Summary (MCS). The significantly negative differences between frail and robust elders ranged from 3.58 points for the MCS to 22.92 points for the physical functioning scale. The magnitude of the effects of frail components was largest for poor endurance and energy, and next was for slowness. The percentages of the variations of these 10 scales explained by all factors in the models ranged from 11.1% (scale of role limitation due to emotional problems) to 49.1% (scale of bodily pain). Conclusions: Our study demonstrates that the disabilities in physical health inherent in frailty are linked to a reduction in HRQOL. Such an association between clinical measures and a generic measure of the HRQOL may offer clinicians new information to understand frailty and to conceptualize it within the broader context of disability.	[Lin, Cheng-Chieh; Liu, Chiu-Shong; Lin, Chih-Hsueh] China Med Univ & Hosp, Coll Med, Dept Family Med, Taichung, Taiwan; [Lin, Cheng-Chieh; Li, Tsai-Chung] China Med Univ & Hosp, Coll Publ Hlth, Inst Hlth Care Adm, Taichung, Taiwan; [Lin, Cheng-Chieh] Asia Univ, Coll Hlth Sci, Dept Healthcare Adm, Taichung, Taiwan; [Chang, Chiu-Kai; Meng, Nai-Hsin] China Med Univ & Hosp, Dept Phys Med & Rehabil, Taichung, Taiwan; [Lee, Yih-Dar] Natl Cheng Kung Univ, Coll Med, Dept Psychiat, Tainan 70101, Taiwan; [Lee, Yih-Dar] Bristol Myers Squibb Taiwan Ltd, Global Dev & Med Affair, Taipei, Taiwan; [Chen, Fei-Na] China Med Univ & Hosp, Sch Med, Taichung, Taiwan; [Li, Tsai-Chung] China Med Univ & Hosp, Grad Inst Biostat & Chinese Med Sci, Taichung, Taiwan; [Li, Tsai-Chung] China Med Univ & Hosp, Ctr Biostat, Taichung, Taiwan	China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; Asia University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; National Cheng Kung University; Bristol-Myers Squibb; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan	Lin, CC (corresponding author), China Med Univ & Hosp, Coll Med, Dept Family Med, Taichung, Taiwan.	iucs@ms14.hinet.net; feina@mail.cmu.edu.tw; tcli@mail.cmu.edu.tw	Li, Tsai-Chung/P-2052-2015; Lin, Cheng-Chieh/P-2564-2015	Li, Tsai-Chung/0000-0002-3346-7462; Lin, Cheng-Chieh/0000-0002-9625-6216	National Health Research Institutes of Taiwan [NHRI-EX98-9838PI]; China Medical University [CMU98-S-11]; Taiwan Department of Health Clinical Trial and Research Center of Excellence [DOH99-TD-B-111-004]	National Health Research Institutes of Taiwan(National Health Research Institutes - Taiwan); China Medical University(China Medical University); Taiwan Department of Health Clinical Trial and Research Center of Excellence	This study was supported by grants from the National Health Research Institutes of Taiwan (NHRI-EX98-9838PI), China Medical University (CMU98-S-11), and the Taiwan Department of Health Clinical Trial and Research Center of Excellence (DOH99-TD-B-111-004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKKI S, 1991, J AM GERIATR SOC, V39, pA22; Bilotta C, 2010, HEALTH QUAL LIFE OUT, V8, DOI 10.1186/1477-7525-8-56; Buck D, 1999, QUAL LIFE RES, V8, P675, DOI 10.1023/A:1008916326411; BUCK HG, 2010, EUR J CARDIOVASC NUR; Campbell AJ, 1997, AGE AGEING, V26, P315, DOI 10.1093/ageing/26.4.315; Chandler JM, 1996, CLIN GERIATR MED, V12, P761; Cochran W.G., 1967, STAT METHODS; Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146, DOI 10.1093/gerona/56.3.M146; Fried LP, 1998, PRINCIPLES GERIATRIC, V4, P1387; Kanauchi M, 2008, INT J CLIN PRACT, V62, P1447, DOI 10.1111/j.1742-1241.2008.01830.x; Kang Y, 2009, NURS HEALTH SCI, V11, P301, DOI 10.1111/j.1442-2018.2009.00460.x; LYONS RA, 1994, J EPIDEMIOL COMMUN H, V48, P388, DOI 10.1136/jech.48.4.388; Masel MC, 2009, HEALTH QUAL LIFE OUT, V7, DOI 10.1186/1477-7525-7-70; MCHORNEY CA, 1993, MED CARE, V31, P247, DOI 10.1097/00005650-199303000-00006; MCHORNEY CA, 1992, MED CARE, V30, pMS253, DOI 10.1097/00005650-199205001-00025; ORME JG, 1986, J CLIN PSYCHOL, V42, P28, DOI 10.1002/1097-4679(198601)42:1<28::AID-JCLP2270420104>3.0.CO;2-T; Paw MJMCA, 1999, J CLIN EPIDEMIOL, V52, P1015; Puts MTE, 2007, QUAL LIFE RES, V16, P263, DOI 10.1007/s11136-006-9121-0; Rockwood K, 1999, LANCET, V353, P205, DOI 10.1016/S0140-6736(98)04402-X; Rockwood K, 2005, CAN MED ASSOC J, V173, P489, DOI 10.1503/cmaj.050051; Sayer AA, 2006, AGE AGEING, V35, P409, DOI 10.1093/ageing/afl024; Sitoh YY, 2005, INTERN MED J, V35, P131, DOI 10.1111/j.1445-5994.2004.00742.x; SPEECHLEY M, 1991, J AM GERIATR SOC, V39, P46, DOI 10.1111/j.1532-5415.1991.tb05905.x; Walston J, 2006, J AM GERIATR SOC, V54, P991, DOI 10.1111/j.1532-5415.2006.00745.x; Ware J., 1993, SF 36 HLTH SURVEY MA; WARE J, 2001, SF 36 PHYS MENTAL HL, P57; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002	27	88	90	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2011	6	7							e21841	10.1371/journal.pone.0021841	http://dx.doi.org/10.1371/journal.pone.0021841			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	786HC	21747961	Green Published, gold, Green Submitted			2022-12-27	WOS:000292293400037
J	Alves, FD; Boot, E; Schmitz, N; Nederveen, A; Vorstman, J; Lavini, C; Pouwels, P; de Haan, L; Linszen, D; van Amelsvoort, T				Alves, Fabiana da Silva; Boot, Erik; Schmitz, Nicole; Nederveen, Aart; Vorstman, Jacob; Lavini, Christina; Pouwels, Petra; de Haan, Lieuwe; Linszen, Don; van Amelsvoort, Therese			Proton Magnetic Resonance Spectroscopy in 22q11 Deletion Syndrome	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; VELOCARDIOFACIAL SYNDROME; SCHIZOPHRENIC-PATIENTS; PREFRONTAL CORTEX; TEMPORAL-LOBE; GLUTAMATE; HYPERPROLINEMIA; METABOLITES; MYOINOSITOL; EXPRESSION	Objective: People with velo-cardio-facial syndrome or 22q11 deletion syndrome (22q11DS) have behavioral, cognitive and psychiatric problems. Approximately 30% of affected individuals develop schizophrenia-like psychosis. Glutamate dysfunction is thought to play a crucial role in schizophrenia. However, it is unknown if and how the glutamate system is altered in 22q11DS. People with 22q11DS are vulnerable for haploinsufficiency of PRODH, a gene that codes for an enzyme converting proline into glutamate. Therefore, it can be hypothesized that glutamatergic abnormalities may be present in 22q11DS. Method: We employed proton magnetic resonance spectroscopy (H-1-MRS) to quantify glutamate and other neurometabolites in the dorsolateral prefrontal cortex (DLPFC) and hippocampus of 22 adults with 22q11DS (22q11DS SCZ+) and without (22q11DS SCZ-) schizophrenia and 23 age-matched healthy controls. Also, plasma proline levels were determined in the 22q11DS group. Results: We found significantly increased concentrations of glutamate and myo-inositol in the hippocampal region of 22q11DS SCZ+ compared to 22q11DS SCZ-. There were no significant differences in levels of plasma proline between 22q11DS SCZ+ and 22q11DS SCZ-. There was no relationship between plasma proline and cerebral glutamate in 22q11DS. Conclusion: This is the first in vivo H-1-MRS study in 22q11DS. Our results suggest vulnerability of the hippocampus in the psychopathology of 22q11DS SCZ+. Altered hippocampal glutamate and myo-inositol metabolism may partially explain the psychotic symptoms and cognitive impairments seen in this group of patients.	[Alves, Fabiana da Silva; Boot, Erik; Schmitz, Nicole; de Haan, Lieuwe; Linszen, Don; van Amelsvoort, Therese] Univ Amsterdam, Acad Med Ctr, Dept Psychiat, NL-1105 AZ Amsterdam, Netherlands; [Boot, Erik] Ctr People Intellectual Disabil, Zwammerdam, Netherlands; [Nederveen, Aart; Lavini, Christina] Univ Amsterdam, Acad Med Ctr, Dept Radiol, NL-1105 AZ Amsterdam, Netherlands; [Vorstman, Jacob] Univ Med Ctr Utrecht, Dept Psychiat, Rudolf Magnus Inst Neurosci, Utrecht, Netherlands; [Pouwels, Petra] VU Univ Med Ctr Amsterdam, Dept Phys & Med Technol, Amsterdam, Netherlands; [van Amelsvoort, Therese] Arkin Mental Hlth Care, Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Utrecht University; Utrecht University Medical Center; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER	Alves, FD (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Psychiat, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	F.daSilvaAlves@amc.nl	Schmitz, Nicole/F-9471-2011; Boot, Erik/AAV-8592-2021	Schmitz, Nicole/0000-0003-4178-4756; Boot, Erik/0000-0002-0593-1539	Dutch Brain Foundation	Dutch Brain Foundation	The study was funded by the Dutch Brain Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arguello PA, 2006, NEURON, V52, P179, DOI 10.1016/j.neuron.2006.09.023; Bartha R, 1997, ARCH GEN PSYCHIAT, V54, P959; Beacher F, 2005, ARCH GEN PSYCHIAT, V62, P1360, DOI 10.1001/archpsyc.62.12.1360; Bender HU, 2005, AM J HUM GENET, V76, P409, DOI 10.1086/428142; Beneyto M, 2007, NEUROPSYCHOPHARMACOL, V32, P1888, DOI 10.1038/sj.npp.1301312; Bertolino A, 2001, BIOL PSYCHIAT, V49, P39, DOI 10.1016/S0006-3223(00)00997-5; BLOEMEN OJ, 2011, BIOL PSYCHI IN PRESS; Botto LD, 2003, PEDIATRICS, V112, P101, DOI 10.1542/peds.112.1.101; Burbaeva GS, 2003, PROG NEURO-PSYCHOPH, V27, P675, DOI 10.1016/S0278-5846(03)00078-2; CANAVAN AGM, 1986, BRIT J CLIN PSYCHOL, V25, P81, DOI 10.1111/j.2044-8260.1986.tb00675.x; Catani M, 2001, NEUROREPORT, V12, P2315, DOI 10.1097/00001756-200108080-00007; Chang L, 2007, BIOL PSYCHIAT, V62, P1396, DOI 10.1016/j.biopsych.2007.05.025; Cohen SM, 1997, BRAIN RES, V769, P333, DOI 10.1016/S0006-8993(97)00721-X; Cohen SM, 1997, BRAIN RES, V761, P271, DOI 10.1016/S0006-8993(97)00352-1; Coyle JT, 2006, CELL MOL NEUROBIOL, V26, P365, DOI 10.1007/s10571-006-9062-8; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; Delwing D, 2007, LIFE SCI, V81, P1645, DOI 10.1016/j.lfs.2007.09.031; Eliez S, 2001, AM J PSYCHIAT, V158, P447, DOI 10.1176/appi.ajp.158.3.447; Fisher SK, 2002, J NEUROCHEM, V82, P736, DOI 10.1046/j.1471-4159.2002.01041.x; Goff DC, 1999, ARCH GEN PSYCHIAT, V56, P21, DOI 10.1001/archpsyc.56.1.21; Goldman AL, 2009, ARCH GEN PSYCHIAT, V66, P467, DOI 10.1001/archgenpsychiatry.2009.24; Goodman BK, 2000, J INHERIT METAB DIS, V23, P847, DOI 10.1023/A:1026773005303; Gothelf D, 2008, DEV DISABIL RES REV, V14, P59, DOI 10.1002/ddrr.9; Harrison PJ, 2005, MOL PSYCHIATR, V10, P40, DOI 10.1038/sj.mp.4001558; Hoogendoorn MLC, 2008, SCHIZOPHR RES, V98, P84, DOI 10.1016/j.schres.2007.09.025; Irvine RF, 2001, NAT REV MOL CELL BIO, V2, P327, DOI 10.1038/35073015; Jacquet H, 2002, HUM MOL GENET, V11, P2243, DOI 10.1093/hmg/11.19.2243; Kane JA, 2003, J CLIN PSYCHIAT, V64, P5; Kates WR, 2006, J AM ACAD CHILD PSY, V45, P587, DOI 10.1097/01.chi.0000205704.33077.4a; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261, DOI 10.1093/schbul/13.2.261; Kegeles LS, 2000, PSYCHIAT RES-NEUROIM, V98, P163, DOI 10.1016/S0925-4927(00)00044-5; KRYSTAL JH, 1994, ARCH GEN PSYCHIAT, V51, P199, DOI 10.1001/archpsyc.1994.03950030035004; LAHTI AC, 1995, NEUROPSYCHOPHARMACOL, V13, P9, DOI 10.1016/0893-133X(94)00131-I; Lindsay EA, 2001, NAT REV GENET, V2, P858, DOI 10.1038/35098574; Lipska BK, 2004, J PSYCHIATR NEUROSCI, V29, P282; Liu H, 2002, P NATL ACAD SCI USA, V99, P3717, DOI 10.1073/pnas.042700699; LUTKENHOFF ES, 2008, MOL PSYCHIA IN PRESS; Moghaddam B, 2004, PSYCHOPHARMACOLOGY, V174, P39, DOI 10.1007/s00213-004-1792-z; Murphy KC, 1999, ARCH GEN PSYCHIAT, V56, P940, DOI 10.1001/archpsyc.56.10.940; Ohrmann P, 2007, J PSYCHIATR RES, V41, P625, DOI 10.1016/j.jpsychires.2006.07.002; Olbrich HM, 2008, WORLD J BIOL PSYCHIA, V9, P59, DOI 10.1080/15622970701227811; Olney JW, 1999, J PSYCHIAT RES, V33, P523, DOI 10.1016/S0022-3956(99)00029-1; Paterlini M, 2005, NAT NEUROSCI, V8, P1586, DOI 10.1038/nn1562; Perneger TV, 1998, BRIT MED J, V316, P1236, DOI 10.1136/bmj.316.7139.1236; Phang JM, 2001, DISORDERS PROLINE HY, P1821; Pilowsky LS, 2006, MOL PSYCHIATR, V11, P118, DOI 10.1038/sj.mp.4001751; PROVENCHER SW, 1993, MAGNET RESON MED, V30, P672, DOI 10.1002/mrm.1910300604; Raux G, 2007, HUM MOL GENET, V16, P83, DOI 10.1093/hmg/ddl443; Rusch N, 2008, SCHIZOPHR RES, V99, P155, DOI 10.1016/j.schres.2007.05.024; Schousboe A, 2003, NEUROCHEM RES, V28, P347, DOI 10.1023/A:1022397704922; Siger M, 2009, ALZ DIS ASSOC DIS, V23, P57, DOI 10.1097/WAD.0b013e3181875434; Soares DP, 2009, CLIN RADIOL, V64, P12, DOI 10.1016/j.crad.2008.07.002; Stone JM, 2010, BIOL PSYCHIAT, V68, P599, DOI 10.1016/j.biopsych.2010.05.034; Stone JM, 2009, BIOL PSYCHIAT, V66, P533, DOI 10.1016/j.biopsych.2009.05.006; Stone JL, 2008, NATURE, V455, P237, DOI 10.1038/nature07239; Tayoshi S, 2009, SCHIZOPHR RES, V108, P69, DOI 10.1016/j.schres.2008.11.014; Theberge J, 2003, AM J PSYCHIAT, V160, P2231, DOI 10.1176/appi.ajp.160.12.2231; Theberge J, 2002, AM J PSYCHIAT, V159, P1944, DOI 10.1176/appi.ajp.159.11.1944; van Elst LT, 2005, BIOL PSYCHIAT, V58, P724, DOI 10.1016/j.biopsych.2005.04.041; Vorstman JAS, 2009, NEUROPSYCHOPHARMACOL, V34, P739, DOI 10.1038/npp.2008.132; Wechsler D, 1997, WAIS 3 WECHSLER ADUL; Willis A, 2008, AMINO ACIDS, V35, P673, DOI 10.1007/s00726-008-0111-0	62	26	26	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2011	6	6							e21685	10.1371/journal.pone.0021685	http://dx.doi.org/10.1371/journal.pone.0021685			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786GP	21738766	Green Published, gold			2022-12-27	WOS:000292291800031
J	Magrach, A; Larrinaga, AR; Santamaria, L				Magrach, Ainhoa; Larrinaga, Asier R.; Santamaria, Luis			Changes in Patch Features May Exacerbate or Compensate for the Effect of Habitat Loss on Forest Bird Populations	PLOS ONE			English	Article							TEMPERATE RAIN-FORESTS; SEED DISPERSAL; CHILOE ARCHIPELAGO; SPECIES-DIVERSITY; CLIMATE-CHANGE; FRAGMENTATION; MODELS; ISLAND; HUMMINGBIRDS; CONSERVATION	One and a half centuries after Darwin visited Chiloe Island, what he described as "...an island covered by one great forest...'' has lost two-thirds of its forested areas. At this biodiversity hotspot, forest surface is becoming increasingly fragmented due to unregulated logging, clearing for pastures and replacement by exotic tree plantations. Decrease in patch size, increased isolation and "edge effects'' can influence the persistence of forest species in remnant fragments. We assessed how these variables affect local density for six forest birds, chosen to include the most important seed dispersers (four species) and bird pollinators (two species, one of which acts also as seed disperser), plus the most common insectivore (Aphrastura spinicauda). Based on cue-count point surveys (8 points per fragment), we estimated bird densities for each species in 22 forest fragments of varying size, shape, isolation and internal-habitat structure (e.g. tree size and epiphyte cover). Bird densities varied with fragment connectivity (three species) and shape (three species), but none of the species was significantly affected by patch size. Satellite image analyses revealed that, from 1985 to 2008, forested area decreased by 8.8% and the remaining forest fragments became 16% smaller, 58-73% more isolated and 11-50% more regular. During that period, bird density estimates for the northern part of Chiloe (covering an area of 1214.75 km(2)) decreased for one species (elaenia), increased for another two (chucao and hummingbird) and did not vary for three (rayadito, thrust and blackbird). For the first three species, changes in patch features respectively exacerbated, balanced and overcame the effects of forest loss on bird population size (landscape-level abundance). Hence, changes in patch features can modulate the effect of habitat fragmentation on forest birds, suggesting that spatial planning (guided by spatially-explicit models) can be an effective tool to facilitate their conservation.	[Magrach, Ainhoa; Larrinaga, Asier R.; Santamaria, Luis] CSIC UIB, Mediterranean Inst Adv Studies, IMEDEA, Mallorca, Balearic Isl, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Mediterraneo de Estudios Avanzados (IMEDEA); Universitat de les Illes Balears; University of Barcelona	Magrach, A (corresponding author), CSIC UIB, Mediterranean Inst Adv Studies, IMEDEA, Mallorca, Balearic Isl, Spain.	ainhoamagrach@hotmail.com	Santamaria, Luis/C-1438-2012; Magrach, Ainhoa/B-1038-2012; Larrinaga, Asier/B-3826-2013	Santamaria, Luis/0000-0002-5072-2912; Magrach, Ainhoa/0000-0003-2155-7556; Larrinaga, Asier/0000-0001-6813-8784	Banco Bilbao Vizcaya Argentaria (BBVA) Foundation; Basque Country Government; Spanish Research Council (CSIC)	Banco Bilbao Vizcaya Argentaria (BBVA) Foundation(BBVA Foundation); Basque Country Government(Basque Government); Spanish Research Council (CSIC)	Funding by the Banco Bilbao Vizcaya Argentaria (BBVA) Foundation (project DOSEL) and the Basque Country Government (pre-doctoral fellowship for A. M.) are gratefully acknowledged. A. R. L. received funding from the JAEDOC program of the Spanish Research Council (CSIC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amico Guillermo C, 2005, Ecol. austral, V15, P89; ARMESTO JJ, 1989, J BIOGEOGR, V16, P219, DOI 10.2307/2845258; ARMESTO JJ, 1987, J BIOGEOGR, V14, P367, DOI 10.2307/2844944; Armesto JJ, 2009, ECOL STUD-ANAL SYNTH, V207, P367, DOI 10.1007/978-3-540-92706-8_16; Beaumont LJ, 2008, ECOL LETT, V11, P1135, DOI 10.1111/j.1461-0248.2008.01231.x; Bender DJ, 1998, ECOLOGY, V79, P517, DOI 10.2307/176950; Braschler B, 2009, ECOL ENTOMOL, V34, P321, DOI 10.1111/j.1365-2311.2008.01080.x; Buckland S., 2004, ADV DISTANCE SAMPLIN; Buckland S.T., 2001, pi; Bunnell FL, 1999, WILDLIFE MANAGEMENT, pvii; Castellon TD, 2007, ECOL APPL, V17, P2152, DOI 10.1890/06-0945.1; Castellon TD, 2006, ECOL APPL, V16, P2223, DOI 10.1890/1051-0761(2006)016[2223:LHFAPO]2.0.CO;2; Collinge SK, 2002, LANDSCAPE ECOL, V17, P647, DOI 10.1023/A:1021536302195; Cornelius C, 2000, CONSERV BIOL, V14, P534, DOI 10.1046/j.1523-1739.2000.98409.x; CORNELIUS C, 2006, THESIS U MISSOURI ST; Davies KF, 1998, J ANIM ECOL, V67, P460, DOI 10.1046/j.1365-2656.1998.00210.x; Diaz IA, 2005, BIOL CONSERV, V123, P91, DOI 10.1016/j.biocon.2004.10.011; Echeverria C, 2008, ECOL MODEL, V212, P439, DOI 10.1016/j.ecolmodel.2007.10.045; Ewers RM, 2006, BIOL REV, V81, P117, DOI 10.1017/S1464793105006949; Exeler N, 2008, CONSERV GENET, V9, P1233, DOI 10.1007/s10592-007-9450-8; Fahrig L, 2003, ANNU REV ECOL EVOL S, V34, P487, DOI 10.1146/annurev.ecolsys.34.011802.132419; Ferraz G, 2007, SCIENCE, V315, P238, DOI 10.1126/science.1133097; Fischer J, 2007, GLOBAL ECOL BIOGEOGR, V16, P265, DOI 10.1111/j.1466-8238.2007.00287.x; Franklin AB, 2002, STUD AVIAN BIOL-SER, P20; Haila Y, 2002, ECOL APPL, V12, P321, DOI 10.1890/1051-0761(2002)012[0321:ACGOFR]2.0.CO;2; Hanski Ilkka, 2004, P3, DOI 10.1016/B978-012323448-3/50003-9; Jaramillo A., 2003, BIRDS CHILE; JOHNS AD, 1985, BIOL CONSERV, V31, P355, DOI 10.1016/0006-3207(85)90091-6; Kolb A, 2005, J ECOL, V93, P1226, DOI 10.1111/j.1365-2745.2005.01049.x; Lang S, 2003, VLATE EXTENSION ARCG; LARA A, BOSQUES INFORM PAIS, P131; Levey DJ, 2005, SCIENCE, V309, P146, DOI 10.1126/science.1111479; Lindenmayer D, 2006, HABITAT FRAGMENTATIO; Lindenmayer DB, 2002, ECOL MONOGR, V72, P1, DOI 10.1890/0012-9615(2002)072[0001:EOFFOB]2.0.CO;2; LINHART YB, 1987, ECOLOGY, V68, P1696, DOI 10.2307/1939862; Martinez-Meyer E, 2004, GLOBAL ECOL BIOGEOGR, V13, P305, DOI 10.1111/j.1466-822X.2004.00107.x; McGarigal K., 2002, FRAGSTATS SPATIAL PA; Meyer CFJ, 2009, BIOTROPICA, V41, P95, DOI 10.1111/j.1744-7429.2008.00443.x; MITCHELL B, 2007, FRAGSTATSBATCH ARCGI; MURCIA C, 1995, TRENDS ECOL EVOL, V10, P58, DOI 10.1016/S0169-5347(00)88977-6; Olson DM, 1998, CONSERV BIOL, V12, P502, DOI 10.1046/j.1523-1739.1998.012003502.x; Pearson RG, 2003, GLOBAL ECOL BIOGEOGR, V12, P361, DOI 10.1046/j.1466-822X.2003.00042.x; Porter AH, 1999, CONSERV BIOL, V13, P850, DOI 10.1046/j.1523-1739.1999.98308.x; Restrepo C, 1999, ECOLOGY, V80, P668, DOI 10.1890/0012-9658(1999)080[0668:AETGAF]2.0.CO;2; Ricketts TH, 2001, AM NAT, V158, P87, DOI 10.1086/320863; Rozzi R, 1996, REV CHIL HIST NAT, V69, P125; Saunders D.A., 1995, BIRDS SW AUSTR ATLAS; Smith-Ramirez C, 2003, AUSTRAL ECOL, V28, P53, DOI 10.1046/j.1442-9993.2003.01248.x; SMITHRAMIREZ C, 1993, REV CHIL HIST NAT, V66, P65; STILES FG, 1975, ECOLOGY, V56, P285, DOI 10.2307/1934961; STOUFFER PC, 1995, CONSERV BIOL, V9, P1085, DOI 10.1046/j.1523-1739.1995.9051072.x-i1; THIOLLAY JM, 1992, CONSERV BIOL, V6, P47, DOI 10.1046/j.1523-1739.1992.610047.x; THOMAS L., 2006, DISTANCE 5 0 RELEASE; Wilcove D.S., 1986, P237; Willson MF, 2004, CONDOR, V106, P166, DOI 10.1650/7303; WILLSON MF, 1994, CONSERV BIOL, V8, P508, DOI 10.1046/j.1523-1739.1994.08020508.x; Willson MF, 1996, REV CHIL HIST NAT, V69, P343; Wilson TL, 2009, LANDSCAPE ECOL, V24, P351, DOI 10.1007/s10980-008-9309-5; Zanette L, 2001, J AVIAN BIOL, V32, P38, DOI 10.1034/j.1600-048X.2001.320106.x; [No title captured]	60	15	16	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2011	6	6							e21596	10.1371/journal.pone.0021596	http://dx.doi.org/10.1371/journal.pone.0021596			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	784FW	21738723	gold, Green Submitted, Green Published			2022-12-27	WOS:000292142800042
J	Chadwick, W; Mitchell, N; Caroll, J; Zhou, Y; Park, SS; Wang, LY; Becker, KG; Zhang, YQ; Lehrmann, E; Wood, WH; Martin, B; Maudsley, S				Chadwick, Wayne; Mitchell, Nick; Caroll, Jenna; Zhou, Yu; Park, Sung-Soo; Wang, Liyun; Becker, Kevin G.; Zhang, Yongqing; Lehrmann, Elin; Wood, William H., III; Martin, Bronwen; Maudsley, Stuart			Amitriptyline-Mediated Cognitive Enhancement in Aged 3xTg Alzheimer's Disease Mice Is Associated with Neurogenesis and Neurotrophic Activity	PLOS ONE			English	Article							NERVE GROWTH-FACTOR; COMMON MECHANISM; A-BETA; BRAIN; HIPPOCAMPAL; OLIGOMERS; MOUSE; TAU; ANGIOGENESIS; IMPAIRMENT	Approximately 35 million people worldwide suffer from Alzheimer's disease (AD). Existing therapeutics, while moderately effective, are currently unable to stem the widespread rise in AD prevalence. AD is associated with an increase in amyloid beta (A beta) oligomers and hyperphosphorylated tau, along with cognitive impairment and neurodegeneration. Several antidepressants have shown promise in improving cognition and alleviating oxidative stress in AD but have failed as long-term therapeutics. In this study, amitriptyline, an FDA-approved tricyclic antidepressant, was administered orally to aged and cognitively impaired transgenic AD mice (3xTgAD). After amitriptyline treatment, cognitive behavior testing demonstrated that there was a significant improvement in both long-and short-term memory retention. Amitriptyline treatment also caused a significant potentiation of non-toxic A beta monomer with a concomitant decrease in cytotoxic dimer A beta load, compared to vehicle-treated 3xTgAD controls. In addition, amitriptyline administration caused a significant increase in dentate gyrus neurogenesis as well as increases in expression of neurosynaptic marker proteins. Amitriptyline treatment resulted in increases in hippocampal brain-derived neurotrophic factor protein as well as increased tyrosine phosphorylation of its cognate receptor (TrkB). These results indicate that amitriptyline has significant beneficial actions in aged and damaged AD brains and that it shows promise as a tolerable novel therapeutic for the treatment of AD.	[Chadwick, Wayne; Zhou, Yu; Park, Sung-Soo; Wang, Liyun; Maudsley, Stuart] NIA, Receptor Pharmacol Unit, NIH, Baltimore, MD 21224 USA; [Mitchell, Nick] NIA, Neurosci Lab, NIH, Baltimore, MD 21224 USA; [Caroll, Jenna] Univ Penn, Ctr Neurodegenerat Dis Res, Philadelphia, PA 19104 USA; [Becker, Kevin G.; Zhang, Yongqing; Lehrmann, Elin; Wood, William H., III] NIA, Genom Unit, Res Resources Branch, NIH, Baltimore, MD 21224 USA; [Martin, Bronwen] NIA, Metab Unit, NIH, Baltimore, MD 21224 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of Pennsylvania; Pennsylvania Medicine; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Chadwick, W (corresponding author), NIA, Receptor Pharmacol Unit, NIH, Baltimore, MD 21224 USA.	maudsleyst@mail.nih.gov	Maudsley, Stuart/AAV-9929-2021; Zhou, Yu/M-7975-2014; Maudsley, Stuart/Q-4782-2019; Mitchell, Nicholas/A-7066-2018	Maudsley, Stuart/0000-0002-1868-184X; Mitchell, Nicholas/0000-0003-2088-5419; Martin, Bronwen/0000-0002-9185-6925; Lehrmann, Elin/0000-0002-9869-9475; Becker, Kevin/0000-0002-6794-6656	National Institutes of Health; NATIONAL INSTITUTE ON AGING [ZICAG000616, ZIAAG000318, ZIAAG000916, ZIAAG000917, ZIAAG000325, ZIAAG000915, ZIAAG000319] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was carried out in-part by funding from the Intramural Research Program of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Andorfer C, 2003, J NEUROCHEM, V86, P582, DOI 10.1046/j.1471-4159.2003.01879.x; Archer HA, 2007, ALZ DIS ASSOC DIS, V21, P101, DOI 10.1097/WAD.0b013e318065bfc2; Bradford D, 2010, J COMP NEUROL, V518, P3237, DOI 10.1002/cne.22397; Bucciantini M, 2002, NATURE, V416, P507, DOI 10.1038/416507a; Calissano P, 2010, DEV NEUROBIOL, V70, P372, DOI 10.1002/dneu.20759; Carrettiero DC, 2009, J NEUROSCI, V29, P2151, DOI 10.1523/JNEUROSCI.4660-08.2009; CHADWICK W, 2010, INT J ALZHEIMERS DIS, DOI DOI 10.4061/2010/604792; Chadwick W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014352; Chafekar SM, 2008, BBA-MOL BASIS DIS, V1782, P523, DOI 10.1016/j.bbadis.2008.06.003; Chafekar SM, 2007, ANTIOXID REDOX SIGN, V9, P2245, DOI 10.1089/ars.2007.1797; Chen WQ, 2007, ELECTROPHORESIS, V28, P4392, DOI 10.1002/elps.200700336; Chi ZH, 2006, NEUROREPORT, V17, P1807, DOI 10.1097/01.wnr.0000239968.06438.c5; Conway KA, 2000, P NATL ACAD SCI USA, V97, P571, DOI 10.1073/pnas.97.2.571; Eikelenboom P, 2002, GLIA, V40, P232, DOI 10.1002/glia.10146; Fernandez A, 2010, ALZ DIS ASSOC DIS, V24, P182, DOI 10.1097/WAD.0b013e3181c727f7; FREIR DB, 2010, NEUROBIOL AGING 0122; Giuffrida ML, 2009, J NEUROSCI, V29, P10582, DOI 10.1523/JNEUROSCI.1736-09.2009; Golden E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010099; Handschin C, 2006, ENDOCR REV, V27, P728, DOI 10.1210/er.2006-0037; Hellweg R, 2008, PHARMACOPSYCHIATRY, V41, P66, DOI 10.1055/s-2007-1004594; Hongo S, 2006, J CELL BIOCHEM, V98, P185, DOI 10.1002/jcb.20763; Ichikawa-Shindo Y, 2008, J CLIN INVEST, V118, P29, DOI 10.1172/JCI33022; Jang SW, 2009, CHEM BIOL, V16, P644, DOI 10.1016/j.chembiol.2009.05.010; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kee HJ, 2002, J CEREBR BLOOD F MET, V22, P1054, DOI 10.1097/00004647-200209000-00003; Lee JK, 2008, J NEUROSCI, V28, P8517, DOI 10.1523/JNEUROSCI.1806-08.2008; Lue LF, 1999, AM J PATHOL, V155, P853, DOI 10.1016/S0002-9440(10)65184-X; Martin B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004146; Martin B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002750; Martin B, 2009, J BIOL CHEM, V284, P2493, DOI 10.1074/jbc.M804545200; Matheson SF, 2006, DEV NEUROSCI-BASEL, V28, P538, DOI 10.1159/000095116; Michael M, 2010, CURR BIOL, V20, P783, DOI 10.1016/j.cub.2010.03.048; Munderloh C, 2009, J NEUROSCI, V29, P6607, DOI 10.1523/JNEUROSCI.0870-09.2009; Nagy N, 2008, J MOL CELL CARDIOL, V44, P252, DOI 10.1016/j.yjmcc.2007.08.021; Nelson RL, 2007, EXP NEUROL, V205, P166, DOI 10.1016/j.expneurol.2007.01.037; Oddo S, 2003, NEURON, V39, P409, DOI 10.1016/S0896-6273(03)00434-3; Phoenix TN, 2010, GENE DEV, V24, P45, DOI 10.1101/gad.1839510; Reixach N, 2004, P NATL ACAD SCI USA, V101, P2817, DOI 10.1073/pnas.0400062101; Rosario ER, 2006, J NEUROSCI, V26, P13384, DOI 10.1523/JNEUROSCI.2514-06.2006; Rozzini L, 2010, INT PSYCHOGERIATR, V22, P114, DOI 10.1017/S1041610209990184; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Stranahan AM, 2009, CURR MED CHEM, V16, P4668, DOI 10.2174/092986709789878292; Tai YH, 2009, ANESTHESIOLOGY, V110, P1379, DOI 10.1097/ALN.0b013e31819fccd5; Volkert MR, 2000, P NATL ACAD SCI USA, V97, P14530, DOI 10.1073/pnas.260495897; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Wang XN, 2007, NAT NEUROSCI, V10, P177, DOI 10.1038/nn1841; Xu HY, 2003, NEUROPSYCHOPHARMACOL, V28, P53, DOI 10.1038/sj.npp.1300009; Zaltsman Y, 2010, NAT CELL BIOL, V12, P553, DOI 10.1038/ncb2057; Zhang LH, 2008, BRAIN RES BULL, V77, P55, DOI 10.1016/j.brainresbull.2008.03.014; Zhou RH, 2001, GENOMICS, V73, P86, DOI 10.1006/geno.2000.6496	50	73	75	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2011	6	6							e21660	10.1371/journal.pone.0021660	http://dx.doi.org/10.1371/journal.pone.0021660			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	783OD	21738757	Green Published, Green Submitted, gold			2022-12-27	WOS:000292092600069
J	Heni, M; Hennige, AM; Peter, A; Siegel-Axel, D; Ordelheide, AM; Krebs, N; Machicao, F; Fritsche, A; Haring, HU; Staiger, H				Heni, Martin; Hennige, Anita M.; Peter, Andreas; Siegel-Axel, Dorothea; Ordelheide, Anna-Maria; Krebs, Norbert; Machicao, Fausto; Fritsche, Andreas; Haering, Hans-Ulrich; Staiger, Harald			Insulin Promotes Glycogen Storage and Cell Proliferation in Primary Human Astrocytes	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; BRAIN ENERGY-METABOLISM; GLUCOSE-TRANSPORTER; STIMULATION; RAT; EXPRESSION; LACTATE; BARRIER; OBESITY	Introduction: In the human brain, there are at least as many astrocytes as neurons. Astrocytes are known to modulate neuronal function in several ways. Thus, they may also contribute to cerebral insulin actions. Therefore, we examined whether primary human astrocytes are insulin-responsive and whether their metabolic functions are affected by the hormone. Methods: Commercially available Normal Human Astrocytes were grown in the recommended medium. Major players in the insulin signaling pathway were detected by real-time RT-PCR and Western blotting. Phosphorylation events were detected by phospho-specific antibodies. Glucose uptake and glycogen synthesis were assessed using radio-labeled glucose. Glycogen content was assessed by histochemistry. Lactate levels were measured enzymatically. Cell proliferation was assessed by WST-1 assay. Results: We detected expression of key proteins for insulin signaling, such as insulin receptor beta-subunit, insulin receptor substrat-1, Akt/protein kinase B and glycogen synthase kinase 3, in human astrocytes. Akt was phosphorylated and PI-3 kinase activity increased following insulin stimulation in a dose-dependent manner. Neither increased glucose uptake nor lactate secretion after insulin stimulation could be evidenced in this cell type. However, we found increased insulin-dependent glucose incorporation into glycogen. Furthermore, cell numbers increased dose-dependently upon insulin treatment. Discussion: This study demonstrated that human astrocytes are insulin-responsive at the molecular level. We identified glycogen synthesis and cell proliferation as biological responses of insulin signaling in these brain cells. Hence, this cell type may contribute to the effects of insulin in the human brain.	[Heni, Martin; Hennige, Anita M.; Peter, Andreas; Siegel-Axel, Dorothea; Ordelheide, Anna-Maria; Krebs, Norbert; Machicao, Fausto; Fritsche, Andreas; Haering, Hans-Ulrich; Staiger, Harald] Univ Tubingen, Dept Internal Med, Div Endocrinol Diabetol Angiol Nephrol & Clin Che, D-7400 Tubingen, Germany	Eberhard Karls University of Tubingen	Heni, M (corresponding author), Univ Tubingen, Dept Internal Med, Div Endocrinol Diabetol Angiol Nephrol & Clin Che, D-7400 Tubingen, Germany.	hans-ulrich.haering@med.uni-tuebingen.de	Staiger, Harald/N-5871-2014	Heni, Martin/0000-0002-8462-3832; Staiger, Harald/0000-0002-9507-5333	German Diabetes Association (DDG); University of Tubingen [1908-0-0]; German Federal Ministry of Education and Research (BMBF)	German Diabetes Association (DDG); University of Tubingen; German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	This study was supported in part by grants from the German Diabetes Association (DDG) and the University of Tubingen (fortune-program, grant 1908-0-0) to MH and a grant from the German Federal Ministry of Education and Research (BMBF) to the German Center for Diabetes Research (DZD e.V.). The other part was funded by the institutional budget. Funding was obtained for direct costs (DDG, DZD, fortune) and for staff (fortune). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barres BA, 2003, GLIA, V43, P4, DOI 10.1002/glia.10252; Belfiore A, 2009, ENDOCR REV, V30, P586, DOI 10.1210/er.2008-0047; Brockmann K, 2009, BRAIN DEV-JPN, V31, P545, DOI 10.1016/j.braindev.2009.02.008; Brown AM, 2005, J NEUROSCI RES, V79, P74, DOI 10.1002/jnr.20335; Brown AM, 2007, GLIA, V55, P1263, DOI 10.1002/glia.20557; Cidad P, 2001, J NEUROCHEM, V79, P17, DOI 10.1046/j.1471-4159.2001.00523.x; Cloix JF, 2009, CURR MED CHEM, V16, P841, DOI 10.2174/092986709787549316; DRINGEN R, 1992, J NEUROCHEM, V58, P511, DOI 10.1111/j.1471-4159.1992.tb09750.x; Fillenz M, 2005, NEUROCHEM INT, V47, P413, DOI 10.1016/j.neuint.2005.05.011; Guthoff M, 2010, J CLIN ENDOCR METAB, V95, P748, DOI 10.1210/jc.2009-1677; Hallschmid M, 2009, DIABETOLOGIA, V52, P2264, DOI 10.1007/s00125-009-1501-x; Hamai M, 1999, J NEUROCHEM, V73, P400, DOI 10.1046/j.1471-4159.1999.0730400.x; HASELBACHER GK, 1985, P NATL ACAD SCI USA, V82, P2153, DOI 10.1073/pnas.82.7.2153; HAVRANKOVA J, 1978, NATURE, V272, P827, DOI 10.1038/272827a0; Henneberger C, 2010, NATURE, V463, P232, DOI 10.1038/nature08673; Hennige AM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001765; Hilgetag CC, 2009, BRAIN STRUCT FUNCT, V213, P365, DOI 10.1007/s00429-009-0202-z; Kausch C, 2003, HORM METAB RES, V35, P570, DOI 10.1055/s-2003-43501; Kern W, 2006, DIABETOLOGIA, V49, P2790, DOI 10.1007/s00125-006-0409-y; Koehler RC, 2009, TRENDS NEUROSCI, V32, P160, DOI 10.1016/j.tins.2008.11.005; KUM W, 1992, GLIA, V6, P264, DOI 10.1002/glia.440060404; Laron Zvi, 2009, Archives of Physiology and Biochemistry, V115, P112, DOI 10.1080/13813450902949012; Lin XY, 2004, J CLIN INVEST, V114, P908, DOI [10.1172/JCI22217, 10.1172/JCI200422217]; Mangia S, 2009, J NEUROCHEM, V109, P55, DOI 10.1111/j.1471-4159.2009.06003.x; Manolescu AR, 2007, PHYSIOLOGY, V22, P234, DOI 10.1152/physiol.00011.2007; Morton GJ, 2006, NATURE, V443, P289, DOI 10.1038/nature05026; Mussig K, 2010, EXP CLIN ENDOCR DIAB, V118, P356, DOI 10.1055/s-0029-1243603; Oberheim NA, 2009, J NEUROSCI, V29, P3276, DOI 10.1523/JNEUROSCI.4707-08.2009; Pellerin L, 2007, GLIA, V55, P1251, DOI 10.1002/glia.20528; Rajkowska G., 2007, CNS & Neurological Disorders-Drug Targets, V6, P219, DOI 10.2174/187152707780619326; Schwartz MW, 2005, SCIENCE, V307, P375, DOI 10.1126/science.1104344; Simpson IA, 1999, J NEUROCHEM, V72, P238, DOI 10.1046/j.1471-4159.1999.0720238.x; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Sofroniew MV, 2009, TRENDS NEUROSCI, V32, P638, DOI 10.1016/j.tins.2009.08.002; SWANSON RA, 1992, NEUROSCIENCE, V51, P451, DOI 10.1016/0306-4522(92)90329-Z; Tschritter O, 2006, P NATL ACAD SCI USA, V103, P12103, DOI 10.1073/pnas.0604404103; Volterra A, 2005, NAT REV NEUROSCI, V6, P626, DOI 10.1038/nrn1722; Wiesinger H, 1997, GLIA, V21, P22, DOI 10.1002/(SICI)1098-1136(199709)21:1<22::AID-GLIA3>3.0.CO;2-3; Wu XF, 2010, BIOCHEM BIOPH RES CO, V393, P514, DOI 10.1016/j.bbrc.2010.02.038; Zlokovic BV, 2008, NEURON, V57, P178, DOI 10.1016/j.neuron.2008.01.003	40	108	109	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2011	6	6							e21594	10.1371/journal.pone.0021594	http://dx.doi.org/10.1371/journal.pone.0021594			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	783OD	21738722	Green Published, Green Submitted, gold			2022-12-27	WOS:000292092600058
J	Dong, SM; Yu, D; Cui, LK; Qutob, D; Tedman-Jones, J; Kale, SD; Tyler, BM; Wang, YC; Gijzen, M				Dong, Suomeng; Yu, Dan; Cui, Linkai; Qutob, Dinah; Tedman-Jones, Jennifer; Kale, Shiv D.; Tyler, Brett M.; Wang, Yuanchao; Gijzen, Mark			Sequence Variants of the Phytophthora sojae RXLR Effector Avr3a/5 Are Differentially Recognized by Rps3a and Rps5 in Soybean	PLOS ONE			English	Article							AVIRULENCE GENES; DISEASE RESISTANCE; PATHOGEN; EXPRESSION; PROTEIN; AVR4; ARABIDOPSIS; INHERITANCE; ENCODES; LINKAGE	The perception of Phytophthora sojae avirulence (Avr) gene products by corresponding soybean resistance (Rps) gene products causes effector triggered immunity. Past studies have shown that the Avr3a and Avr5 genes of P. sojae are genetically linked, and the Avr3a gene encoding a secreted RXLR effector protein was recently identified. We now provide evidence that Avr3a and Avr5 are allelic. Genetic mapping data from F-2 progeny indicates that Avr3a and Avr5 co-segregate, and haplotype analysis of P. sojae strain collections reveal sequence and transcriptional polymorphisms that are consistent with a single genetic locus encoding Avr3a/5. Transformation of P. sojae and transient expression in soybean were performed to test how Avr3a/5 alleles interact with soybean Rps3a and Rps5. Over-expression of Avr3a/5 in a P. sojae strain that is normally virulent on Rps3a and Rps5 results in avirulence to Rps3a and Rps5; whereas silencing of Avr3a/5 causes gain of virulence in a P. sojae strain that is normally avirulent on Rps3a and Rps5 soybean lines. Transient expression and co-bombardment with a reporter gene confirms that Avr3a/5 triggers cell death in Rps5 soybean leaves in an appropriate allele-specific manner. Sequence analysis of the Avr3a/5 gene identifies crucial residues in the effector domain that distinguish recognition by Rps3a and Rps5.	[Dong, Suomeng; Yu, Dan; Qutob, Dinah; Tedman-Jones, Jennifer; Gijzen, Mark] Agr & Agri Food Canada, London, ON, Canada; [Dong, Suomeng; Yu, Dan; Cui, Linkai; Wang, Yuanchao] Nanjing Agr Univ, Dept Plant Pathol, Nanjing, Peoples R China; [Kale, Shiv D.; Tyler, Brett M.] Virginia Tech, Virginia Bioinformat Inst, Blacksburg, VA USA	Agriculture & Agri Food Canada; Nanjing Agricultural University; Virginia Polytechnic Institute & State University	Dong, SM (corresponding author), Agr & Agri Food Canada, London, ON, Canada.	mark.gijzen@agr.gc.ca	Gijzen, Mark/C-6284-2011; wang, yuanchao/G-9667-2011	Gijzen, Mark/0000-0002-3715-6389; wang, yuanchao/0000-0001-5803-5343	Agriculture and Agri-Food Canada (AAFC) Crop Genomics Initiative; National Natural Science Foundation of China [30900932]; Agriculture and Food Research Initiative of the USDA National Institute for Food and Agriculture [2007-35600-18530, 2007-35319-18100]; US National Science Foundation (NSF) [MCB-0731969, IOS-0924861]; China Scholarship Council; NSF	Agriculture and Agri-Food Canada (AAFC) Crop Genomics Initiative(Agriculture & Agri Food Canada); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Agriculture and Food Research Initiative of the USDA National Institute for Food and Agriculture; US National Science Foundation (NSF)(National Science Foundation (NSF)); China Scholarship Council(China Scholarship Council); NSF(National Science Foundation (NSF))	This work was supported by grants to MG from the Agriculture and Agri-Food Canada (AAFC) Crop Genomics Initiative; to SD from the National Natural Science Foundation of China (30900932); and to BMT from the Agriculture and Food Research Initiative of the USDA National Institute for Food and Agriculture, grant numbers 2007-35600-18530 and 2007-35319-18100, and from the US National Science Foundation (NSF), grant numbers MCB-0731969 and IOS-0924861. SD and DY were supported at AAFC by the China Scholarship Council. SDK was supported by an NSF pre-doctoral fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen RL, 2004, SCIENCE, V306, P1957, DOI 10.1126/science.1104022; Armstrong MR, 2005, P NATL ACAD SCI USA, V102, P7766, DOI 10.1073/pnas.0500113102; Bailey K, 2011, MOL PLANT M IN PRESS; Cui LK, 2010, PLANT DIS, V94, P881, DOI 10.1094/PDIS-94-7-0881; Dodds PN, 2010, NAT REV GENET, V11, P539, DOI 10.1038/nrg2812; Dong SM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005556; Dorrance AE, 2003, PLANT DIS, V87, P139, DOI 10.1094/PDIS.2003.87.2.139; Dou DL, 2008, PLANT CELL, V20, P1930, DOI 10.1105/tpc.107.056093; Dou DL, 2008, PLANT CELL, V20, P1118, DOI 10.1105/tpc.107.057067; Dou DL, 2010, MOL PLANT MICROBE IN, V23, P425, DOI 10.1094/MPMI-23-4-0425; FLOR HH, 1971, ANNU REV PHYTOPATHOL, V9, P275, DOI 10.1146/annurev.py.09.090171.001423; Gijzen M, 1996, CAN J BOT, V74, P800, DOI 10.1139/b96-100; Gijzen M., 2008, OOMYCETE GENETICS GE, P303, DOI [10.1002/9780470475898.ch15, DOI 10.1002/9780470475898.CH15]; Haas BJ, 2009, NATURE, V461, P393, DOI 10.1038/nature08358; Hua CL, 2008, EUKARYOT CELL, V7, P2133, DOI 10.1128/EC.00286-08; Jiang RHY, 2008, P NATL ACAD SCI USA, V105, P4874, DOI 10.1073/pnas.0709303105; JUDELSON HS, 1991, MOL PLANT MICROBE IN, V4, P602, DOI 10.1094/MPMI-4-602; Kaitany RC, 2001, PLANT DIS, V85, P1103, DOI 10.1094/PDIS.2001.85.10.1103; Kale SD, 2010, CELL, V142, P284, DOI 10.1016/j.cell.2010.06.008; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; May KJ, 2002, FUNGAL GENET BIOL, V37, P1, DOI 10.1016/S1087-1845(02)00027-0; Moy P, 2004, MOL PLANT MICROBE IN, V17, P1051, DOI 10.1094/MPMI.2004.17.10.1051; Oh SK, 2009, PLANT CELL, V21, P2928, DOI 10.1105/tpc.109.068247; Qutob D, 2002, PLANT J, V32, P361, DOI 10.1046/j.1365-313X.2002.01439.x; Qutob D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005066; Rehmany AP, 2005, PLANT CELL, V17, P1839, DOI 10.1105/tpc.105.031807; Shan WX, 2004, MOL PLANT MICROBE IN, V17, P394, DOI 10.1094/MPMI.2004.17.4.394; TYLER BM, 1995, MOL PLANT MICROBE IN, V8, P515, DOI 10.1094/MPMI-8-0515; Tyler BM, 2007, MOL PLANT PATHOL, V8, P1, DOI 10.1111/j.1364-3703.2006.00373.x; Tyler BM, 2006, SCIENCE, V313, P1261, DOI 10.1126/science.1128796; van Poppel PMJA, 2008, MOL PLANT MICROBE IN, V21, P1460, DOI 10.1094/MPMI-21-11-1460; Vleeshouwers VGAA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002875; WHISSON SC, 1994, CURR GENET, V27, P77, DOI 10.1007/BF00326582; Whisson SC, 1995, MOL PLANT MICROBE IN, V8, P988, DOI 10.1094/MPMI-8-0988; Whisson SC, 2004, FUNGAL GENET BIOL, V41, P62, DOI 10.1016/j.fgb.2003.08.007; Whisson SC, 2007, NATURE, V450, P115, DOI 10.1038/nature06203	36	46	51	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2011	6	7							e20172	10.1371/journal.pone.0020172	http://dx.doi.org/10.1371/journal.pone.0020172			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	793HP	21779316	Green Published, gold, Green Submitted			2022-12-27	WOS:000292811300002
J	Wu, CL; Guo, XZ; Wang, F; Li, XS; Tian, XC; Li, L; Wu, ZF; Zhang, SQ				Wu, Changli; Guo, Xinzheng; Wang, Fang; Li, Xiaoshuang; Tian, X. Cindy; Li, Li; Wu, Zhenfang; Zhang, Shouquan			Simulated Microgravity Compromises Mouse Oocyte Maturation by Disrupting Meiotic Spindle Organization and Inducing Cytoplasmic Blebbing	PLOS ONE			English	Article							SHEAR MODELED MICROGRAVITY; ACTIVATED PROTEIN-KINASE; GAMMA-TUBULIN COMPLEXES; GENE-EXPRESSION; IN-VITRO; SPACE; CELLS; CYTOSKELETON; SPACEFLIGHT; RATS	In the present study, we discovered that mouse oocyte maturation was inhibited by simulated microgravity via disturbing spindle organization. We cultured mouse oocytes under microgravity condition simulated by NASA's rotary cell culture system, examined the maturation rate and observed the spindle morphology (organization of cytoskeleton) during the mouse oocytes meiotic maturation. While the rate of germinal vesicle breakdown did not differ between 1 g gravity and simulated microgravity, rate of oocyte maturation decreased significantly in simulated microgravity. The rate of maturation was 8.94% in simulated microgravity and was 73.0% in 1 g gravity. The results show that the maturation of mouse oocytes in vitro was inhibited by the simulated microgravity. The spindle morphology observation shows that the microtubules and chromosomes can not form a complete spindle during oocyte meiotic maturation under simulated microgravity. And the disorder of gamma-tubulin may partially result in disorganization of microtubules under simulated microgravity. These observations suggest that the meiotic spindle organization is gravity dependent. Although the spindle organization was disrupted by simulated microgravity, the function and organization of microfilaments were not pronouncedly affected by simulated microgravity. And we found that simulated microgravity induced oocytes cytoplasmic blebbing via an unknown mechanism. Transmission electron microscope detection showed that the components of the blebs were identified with the cytoplasm. Collectively, these results indicated that the simulated microgravity inhibits mouse oocyte maturation via disturbing spindle organization and inducing cytoplasmic blebbing.	[Wu, Changli; Guo, Xinzheng; Wang, Fang; Li, Xiaoshuang; Li, Li; Wu, Zhenfang; Zhang, Shouquan] S China Agr Univ, Coll Anim Sci, Guangdong Prov Key Lab Agroanim Genom & Mol Breed, Guangzhou, Guangdong, Peoples R China; [Tian, X. Cindy] Univ Connecticut, Dept Anim Sci, Ctr Regenerat Biol, Storrs, CT 06269 USA	South China Agricultural University; University of Connecticut	Wu, CL (corresponding author), Guangdong Med Coll, 2 Wenming Donglu, Zhanjiang, Guangdong, Peoples R China.	sqzhang@scau.edu.cn	Guo, Xinzheng/AAF-4285-2019	Wu, Zhenfang/0000-0002-5586-6771	National Basic Research Program of China (973 Program) [2010CB945001, 2011CB944202, 2011CB944203]	National Basic Research Program of China (973 Program)(National Basic Research Program of China)	The work was supported by National Basic Research Program of China (973 Program, 2010CB945001; 2011CB944202; 2011CB944203) to Shouquan Zhang. The funders had no role in study design, date collection and analysis, decision to publish, or preparation of the manuscript.	Barrett SL, 2007, BIOL REPROD, V76, P949, DOI 10.1095/biolreprod.106.057141; Bezanilla M, 2009, CURR BIOL, V19, pR168, DOI 10.1016/j.cub.2008.12.026; Burden HW, 1999, J REPROD FERTIL, V116, P229; Calarco PG, 2005, MICROSC MICROANAL, V11, P146, DOI 10.1017/S1431927605050154; Carabatsos MJ, 2000, MICROSC RES TECHNIQ, V49, P435, DOI 10.1002/(SICI)1097-0029(20000601)49:5<435::AID-JEMT5>3.0.CO;2-H; Chang CC, 2006, REPROD BIOMED ONLINE, V13, P213, DOI 10.1016/S1472-6483(10)60618-9; DEAVER DR, 1992, J ANDROL, V13, P224; Gabrion J, 1996, BRAIN RES, V734, P301, DOI 10.1016/S0006-8993(96)00659-2; Gharbi N, 1996, J Gravit Physiol, V3, P63; Graebe A, 2004, J CLIN PHARMACOL, V44, P837, DOI 10.1177/0091270004267193; Higashibata Akira, 2006, BMC Biochemistry, V7, DOI 10.1186/1471-2091-7-19; Hughes-Fulford M, 2003, ADV SPACE RES-SERIES, V32, P1585, DOI 10.1016/S0273-1177(03)90399-1; HughesFulford M, 1996, EXP CELL RES, V224, P103, DOI 10.1006/excr.1996.0116; Infanger M, 2006, CELL TISSUE RES, V324, P267, DOI 10.1007/s00441-005-0142-8; Ingber D, 1999, FASEB J, V13, pS3; Jennings RT, 2000, OBSTET GYNECOL SURV, V55, P109, DOI 10.1097/00006254-200002000-00025; Kline-Smith SL, 2004, MOL CELL, V15, P317, DOI 10.1016/j.molcel.2004.07.012; Lewis ML, 1998, FASEB J, V12, P1007, DOI 10.1096/fasebj.12.11.1007; Maiato H, 2004, INT REV CYTOL, V241, P53, DOI 10.1016/S0074-7696(04)41002-X; Meloni MA, 2006, PROTOPLASMA, V229, P243, DOI 10.1007/s00709-006-0210-2; Meng XQ, 2004, J REPROD DEVELOP, V50, P97, DOI 10.1262/jrd.50.97; Nichiporuk I A, 1998, J Gravit Physiol, V5, pP101; Nickerson CA, 2003, J MICROBIOL METH, V54, P1, DOI 10.1016/S0167-7012(03)00018-6; Pellegrini M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009064; Purevdorj-Gage B, 2006, APPL ENVIRON MICROB, V72, P4569, DOI 10.1128/AEM.03050-05; Raynaud-Messina B, 2007, CURR OPIN CELL BIOL, V19, P24, DOI 10.1016/j.ceb.2006.12.008; Rosner H, 2006, PROTOPLASMA, V229, P225, DOI 10.1007/s00709-006-0202-2; Ronca A E, 2001, J Gravit Physiol, V8, pP133; Ronca AE, 2003, ADV SPACE B, V9, P217, DOI 10.1016/S1569-2574(03)09009-9; SAPP WJ, 1990, FASEB J, V4, P101, DOI 10.1096/fasebj.4.1.2295370; Schwarz R P, 1992, J Tissue Cult Methods, V14, P51, DOI 10.1007/BF01404744; Strollo F, 2004, J Gravit Physiol, V11, pP187; Sun QY, 2001, BIOL REPROD, V64, P879, DOI 10.1095/biolreprod64.3.879; Tou J, 2002, BIOL REPROD, V67, P1681, DOI 10.1095/biolreprod.102.007252; Vassy J, 2003, ADV SPACE RES-SERIES, V32, P1595, DOI 10.1016/S0273-1177(03)90400-5; Vassy J., 2001, FASEB Journal, V15, P1104; Verlhac MH, 2000, CURR BIOL, V10, P1303, DOI 10.1016/S0960-9822(00)00753-3; Wakayama S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006753; White RJ, 2001, NATURE, V409, P1115, DOI 10.1038/35059243; Xie YF, 2006, BIOL REPROD, V75, P45, DOI 10.1095/biolreprod.105.049791; Zayzafoon M, 2005, IMMUNOL REV, V208, P267, DOI 10.1111/j.0105-2896.2005.00330.x; Zimmerman WC, 2004, MOL BIOL CELL, V15, P3642, DOI 10.1091/mbc.E03-11-0796	42	15	16	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2011	6	7							e22214	10.1371/journal.pone.0022214	http://dx.doi.org/10.1371/journal.pone.0022214			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	792WQ	21765954	Green Published, gold, Green Submitted			2022-12-27	WOS:000292781500041
J	Losdat, S; Richner, H; Blount, JD; Helfenstein, F				Losdat, Sylvain; Richner, Heinz; Blount, Jonathan D.; Helfenstein, Fabrice			Immune Activation Reduces Sperm Quality in the Great Tit	PLOS ONE			English	Article							INDUCED OXIDATIVE STRESS; BROOD SIZE MANIPULATION; VITAMIN-E; PARUS-MAJOR; GALLUS-DOMESTICUS; CAROTENOID AVAILABILITY; FERTILIZING EFFICIENCY; SEXUAL SIGNALS; ZEBRA FINCHES; FREE-RADICALS	Mounting an immune response against pathogens incurs costs to organisms by its effects on important life-history traits, such as reproductive investment and survival. As shown recently, immune activation produces large amounts of reactive species and is suggested to induce oxidative stress. Sperm are highly susceptible to oxidative stress, which can negatively impact sperm function and ultimately male fertilizing efficiency. Here we address the question as to whether mounting an immune response affects sperm quality through the damaging effects of oxidative stress. It has been demonstrated recently in birds that carotenoid-based ornaments can be reliable signals of a male's ability to protect sperm from oxidative damage. In a full-factorial design, we immune-challenged great tit males while simultaneously increasing their vitamin E availability, and assessed the effect on sperm quality and oxidative damage. We conducted this experiment in a natural population and tested the males' response to the experimental treatment in relation to their carotenoid-based breast coloration, a condition-dependent trait. Immune activation induced a steeper decline in sperm swimming velocity, thus highlighting the potential costs of an induced immune response on sperm competitive ability and fertilizing efficiency. We found sperm oxidative damage to be negatively correlated with sperm swimming velocity. However, blood resistance to a free-radical attack (a measure of somatic antioxidant capacity) as well as plasma and sperm levels of oxidative damage (lipid peroxidation) remained unaffected, thus suggesting that the observed effect did not arise through oxidative stress. Towards the end of their breeding cycle, swimming velocity of sperm of more intensely colored males was higher, which has important implications for the evolution of mate choice and multiple mating in females because females may accrue both direct and indirect benefits by mating with males having better quality sperm.	[Losdat, Sylvain; Richner, Heinz; Helfenstein, Fabrice] Univ Bern, Inst Ecol & Evolut, Evolutionary Ecol Lab, Bern, Switzerland; [Blount, Jonathan D.] Univ Exeter, Coll Life & Environm Sci, Ctr Ecol & Conservat, Penryn, England	University of Bern; University of Exeter	Losdat, S (corresponding author), Univ Bern, Inst Ecol & Evolut, Evolutionary Ecol Lab, Bern, Switzerland.	sylvain_losdat@yahoo.fr	Richner, Heinz/B-1659-2008; Blount, Jonathan/K-7695-2012; Helfenstein, Fabrice/I-5634-2013	Richner, Heinz/0000-0001-7390-0526; Blount, Jonathan/0000-0002-0016-0130; Helfenstein, Fabrice/0000-0001-8412-0461	Swiss National Science Foundation [3100A0-122566]; Royal Society	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Royal Society(Royal Society of London)	The study was financially supported by a Swiss National Science Foundation grant (3100A0-122566) to HR. JDB was supported by a Royal Society Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitken RJ, 1999, J REPROD FERTIL, V115, P1; Aitken RJ, 2006, MOL CELL ENDOCRINOL, V250, P66, DOI 10.1016/j.mce.2005.12.026; Alonso-Alvarez C, 2004, ECOL LETT, V7, P363, DOI 10.1111/j.1461-0248.2004.00594.x; Alonso-Alvarez C, 2004, AM NAT, V164, P651, DOI 10.1086/424971; AMIR D, 1973, ANN BIOL ANIM BIOCH, V13, P321, DOI 10.1051/rnd:19730302; Andersson S., 2006, BIRD COLORATION, P76; Armitage SAO, 2003, J EVOLUTION BIOL, V16, P1038, DOI 10.1046/j.1420-9101.2003.00551.x; Barja G, 2004, TRENDS NEUROSCI, V27, P595, DOI 10.1016/j.tins.2004.07.005; Bertrand S, 2006, OECOLOGIA, V147, P576, DOI 10.1007/s00442-005-0317-8; Bertrand S, 2006, J EXP BIOL, V209, P4414, DOI 10.1242/jeb.02540; BHAT G, 1988, ZOOL ANZ, V221, P430; Birkhead TR, 2002, NAT REV GENET, V3, P262, DOI 10.1038/nrg774; Birkhead TR, 1999, P ROY SOC B-BIOL SCI, V266, P1759, DOI 10.1098/rspb.1999.0843; Birkhead TR, 1998, SPERM COMPETITION SE; Biswas A, 2007, THERIOGENOLOGY, V67, P259, DOI 10.1016/j.theriogenology.2006.07.010; Blount JD, 2003, SCIENCE, V300, P125, DOI 10.1126/science.1082142; Blount JD, 2001, ECOL LETT, V4, P393, DOI 10.1046/j.1461-0248.2001.00255.x; Bonneaud C, 2003, AM NAT, V161, P367, DOI 10.1086/346134; Brecchia G, 2010, ANIM REPROD SCI, V118, P310, DOI 10.1016/j.anireprosci.2009.06.016; Breque C, 2003, MOL REPROD DEV, V66, P314, DOI 10.1002/mrd.10347; Brzezinska-Slebodzinska E, 2001, ACTA VET HUNG, V49, P413, DOI 10.1556/AVet.49.2001.4.5; Catoni C, 2008, ANIM BEHAV, V76, P1107, DOI 10.1016/j.anbehav.2008.05.027; Charge R, 2010, J ANIM ECOL, V79, P843, DOI 10.1111/j.1365-2656.2010.01696.x; Costantini D, 2009, COMP BIOCHEM PHYS A, V153, P339, DOI 10.1016/j.cbpa.2009.03.010; CROCKER AH, 2002, METHODS ESTIMATING D; de Ayala RM, 2006, BEHAV ECOL SOCIOBIOL, V60, P619, DOI 10.1007/s00265-006-0206-0; de Reviers M., 1968, 6 INT C AN REPR, V1, P183; DEWSBURY DA, 1982, AM NAT, V119, P601, DOI 10.1086/283938; DIPLOCK AT, 1967, BRIT J NUTR, V21, P103, DOI 10.1079/BJN19670011; Eid Y, 2006, BRIT POULTRY SCI, V47, P350, DOI 10.1080/00071660600753912; ENDLER JA, 1993, ECOL MONOGR, V63, P1, DOI 10.2307/2937121; Endler JA, 2005, BIOL J LINN SOC, V86, P405, DOI 10.1111/j.1095-8312.2005.00540.x; Esterbauer H, 1996, REV PHYSIOL BIOCH P, V127, P31, DOI 10.1007/BFb0048264; Evans SR, 2010, BIOL J LINN SOC, V101, P777, DOI 10.1111/j.1095-8312.2010.01548.x; Fair JM, 2002, ECOTOXICOLOGY, V11, P199, DOI 10.1023/A:1015474832239; Froman D, 2003, BIOL REPROD, V69, P248, DOI 10.1095/biolreprod.102.013482; Froman DP, 2006, BIOL REPROD, V74, P487, DOI 10.1095/biolreprod.105.046755; Froman DP, 2002, P ROY SOC B-BIOL SCI, V269, P607, DOI 10.1098/rspb.2001.1925; GARRATT M, 2010, P R SOC LOND B; Hadfield JD, 2006, J EVOLUTION BIOL, V19, P1104, DOI 10.1111/j.1420-9101.2006.01095.x; Halliwell B., 2007, FREE RADICALS BIOL M; Hart NS, 2000, J COMP PHYSIOL A, V186, P375, DOI 10.1007/s003590050437; Hartley RC, 2004, TRENDS ECOL EVOL, V19, P353, DOI 10.1016/j.tree.2004.04.002; Helfenstein F, 2010, ECOL LETT, V13, P213, DOI 10.1111/j.1461-0248.2009.01419.x; Ilmonen P, 2003, OECOLOGIA, V136, P148, DOI 10.1007/s00442-003-1243-2; Kelber A, 2003, BIOL REV, V78, P81, DOI 10.1017/S1464793102005985; Keskes-Ammar L, 2003, ARCH ANDROLOGY, V49, P83, DOI 10.1080/713828100; Konsman JP, 2002, TRENDS NEUROSCI, V25, P154, DOI 10.1016/S0166-2236(00)02088-9; Locatello L, 2006, J EVOLUTION BIOL, V19, P1595, DOI 10.1111/j.1420-9101.2006.01117.x; Lochmiller RL, 2000, OIKOS, V88, P87, DOI 10.1034/j.1600-0706.2000.880110.x; Lopes S, 1998, FERTIL STERIL, V69, P528, DOI 10.1016/S0015-0282(97)00536-0; LOSDAT S, BEHAV ECOL IN PRESS; Lubjuhn T, 1999, BEHAVIOUR, V136, P1157, DOI 10.1163/156853999501810; Lubjuhn T, 2007, ZOOLOGY, V110, P387, DOI 10.1016/j.zool.2007.07.005; MARCHAND CR, 1977, CR SOC BIOL, V171, P927; Metukuri MR, 2010, INFLAMMATION, V33, P235, DOI 10.1007/s10753-009-9177-4; Moret Y, 2000, SCIENCE, V290, P1166, DOI 10.1126/science.290.5494.1166; Mougeot F, 2009, P ROY SOC B-BIOL SCI, V276, P1093, DOI 10.1098/rspb.2008.1570; Nakagawa S, 2010, BIOL REV, V85, P935, DOI 10.1111/j.1469-185X.2010.00141.x; O'Bryan MK, 2000, ENDOCRINOLOGY, V141, P238, DOI 10.1210/en.141.1.238; Parejo D, 2006, BEHAV ECOL SOCIOBIOL, V60, P184, DOI 10.1007/s00265-005-0155-z; Parker G.A., 1998, SPERM COMPETITION SE, P3, DOI DOI 10.1016/B978-012100543-6/50026-X; PERRINS CM, 1965, J ANIM ECOL, V34, P601, DOI 10.2307/2453; Peters A, 2004, J EVOLUTION BIOL, V17, P1111, DOI 10.1111/j.1420-9101.2004.00743.x; Peters A, 2008, FUNCT ECOL, V22, P831, DOI 10.1111/j.1365-2435.2008.01437.x; Pike TW, 2010, BIOL LETTERS, V6, P191, DOI 10.1098/rsbl.2009.0815; Pitcher TE, 2007, J FISH BIOL, V70, P165, DOI 10.1111/j.1095-8649.2006.01292.x; Pizzari T, 2000, NATURE, V405, P787, DOI 10.1038/35015558; Pizzari T, 2007, P ROY SOC B-BIOL SCI, V274, P853, DOI 10.1098/rspb.2006.0080; Pizzari T, 2009, SPERM BIOLOGY: AN EVOLUTIONARY PERSPECTIVE, P207, DOI 10.1016/B978-0-12-372568-4.00006-9; Pizzari T, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-332; Pizzari Tommaso, 2007, P137; Prendergast BJ, 2004, BIOL REPROD, V70, P813, DOI 10.1095/biolreprod.103.023408; R Core Team, 2018, R LANG ENV STAT COMP; Raberg L, 2000, ECOL LETT, V3, P382, DOI 10.1046/j.1461-0248.2000.00154.x; Reddy MM, 2006, REPROD TOXICOL, V22, P493, DOI 10.1016/j.reprotox.2006.03.003; Saks L, 2003, FUNCT ECOL, V17, P555, DOI 10.1046/j.1365-2435.2003.00765.x; SHELDON BC, 1994, P ROY SOC B-BIOL SCI, V257, P25, DOI 10.1098/rspb.1994.0089; Sies H., 1991, OXIDATIVE STRESS OXI; Snook RR, 2005, TRENDS ECOL EVOL, V20, P46, DOI 10.1016/j.tree.2004.10.011; Sorci G, 2009, PHILOS T R SOC B, V364, P71, DOI 10.1098/rstb.2008.0151; Surai P. F., 2002, NATURAL ANTIOXIDANTS; Swindle EJ, 2007, IMMUNOL REV, V217, P186, DOI 10.1111/j.1600-065X.2007.00513.x; Tremellen K, 2008, HUM REPROD UPDATE, V14, P243, DOI 10.1093/humupd/dmn004; Velando A, 2008, BIOESSAYS, V30, P1212, DOI 10.1002/bies.20838; Vernon GG, 1999, CELL MOTIL CYTOSKEL, V42, P149, DOI 10.1002/(SICI)1097-0169(1999)42:2<149::AID-CM6>3.0.CO;2-0; von Schantz T, 1999, P ROY SOC B-BIOL SCI, V266, P1, DOI 10.1098/rspb.1999.0597; Vorobyev M, 1998, J COMP PHYSIOL A, V183, P621, DOI 10.1007/s003590050286; Wahl RUR, 1998, J CHEM SOC PERK T 2, P2009, DOI 10.1039/a801624k; Whittingham MJ, 2006, J ANIM ECOL, V75, P1182, DOI 10.1111/j.1365-2656.2006.01141.x; Wiersma P, 2004, P ROY SOC B-BIOL SCI, V271, pS360, DOI 10.1098/rsbl.2004.0171; Wilson-Leedy JG, 2007, THERIOGENOLOGY, V67, P661, DOI 10.1016/j.theriogenology.2006.10.003; Wolfson A., 1952, Bird-Banding, V23, P159; Yasui Y, 1997, AM NAT, V149, P573, DOI 10.1086/286006; Zou CG, 2001, LIFE SCI, V69, P75, DOI 10.1016/S0024-3205(01)01112-2	95	38	38	0	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2011	6	7							e22221	10.1371/journal.pone.0022221	http://dx.doi.org/10.1371/journal.pone.0022221			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791WM	21765955	Green Published, gold, Green Submitted			2022-12-27	WOS:000292699000031
J	Nam, SW; Chen, X; Lim, J; Kim, SH; Kim, ST; Cho, YH; Yoon, J; Park, S				Nam, Seong-Won; Chen, Xiaoqiang; Lim, Jeesun; Kim, So Hyun; Kim, Sang-Tae; Cho, You-Hee; Yoon, Juyoung; Park, Sungsu			In Vivo Fluorescence Imaging of Bacteriogenic Cyanide in the Lungs of Live Mice Infected with Cystic Fibrosis Pathogens	PLOS ONE			English	Article							BURKHOLDERIA-CEPACIA COMPLEX; PSEUDOMONAS-AERUGINOSA; SELECTIVE CHEMOSENSOR; HYDROGEN-CYANIDE; RAT MODEL; GROWTH; EPIDEMIOLOGY; ACCUMULATION; DYSFUNCTION; INDUCTION	Background: Pseudomonas aeruginosa (PA) and Burkholderia cepacia complex (Bcc), commonly found in the lungs of cystic fibrosis (CF) patients, often produce cyanide (CN), which inhibits cellular respiration. CN in sputa is a potential biomarker for lung infection by CF pathogens. However, its actual concentration in the infected lungs is unknown. Methods and Findings: This work reports observation of CN in the lungs of mice infected with cyanogenic PA or Bcc strains using a CN fluorescent chemosensor (4',5'-fluorescein dicarboxaldehyde) with a whole animal imaging system. When the CN chemosensor was injected into the lungs of mice intratracheally infected with either PA or B. cepacia strains embedded in agar beads, CN was detected in the millimolar range (1.8 to 4 mM) in the infected lungs. CN concentration in PA-infected lungs rapidly increased within 24 hours but gradually decreased over the following days, while CN concentration in B. cepacia-infected lungs slowly increased, reaching a maximum at 5 days. CN concentrations correlated with the bacterial loads in the lungs. In vivo efficacy of antimicrobial treatments was tested in live mice by monitoring bacteriogenic CN in the lungs. Conclusions: The in vivo imaging method was also found suitable for minimally invasive testing the efficacy of antibiotic compounds as well as for aiding the understanding of bacterial cyanogenesis in CF lungs.	[Nam, Seong-Won; Chen, Xiaoqiang; Lim, Jeesun; Kim, So Hyun; Yoon, Juyoung; Park, Sungsu] Ewha Womans Univ, Dept Chem & Nano Sci, Seoul, South Korea; [Chen, Xiaoqiang; Yoon, Juyoung] Ewha Womans Univ, Dept Bioinspired Sci, Seoul, South Korea; [Kim, Sang-Tae] Ewha Womans Univ, Div Life & Pharmaceut Sci, Seoul, South Korea; [Cho, You-Hee] CHA Univ, Dept Pharm, Gyeonggi, South Korea; [Park, Sungsu] NUS, Mechanobiol Inst MBI, Singapore, Singapore	Ewha Womans University; Ewha Womans University; Ewha Womans University; Pochon Cha University; National University of Singapore	Nam, SW (corresponding author), Ewha Womans Univ, Dept Chem & Nano Sci, Seoul, South Korea.	jyoon@ewha.ac.kr; nanopark@ewha.ac.kr	Park, Sungsu/L-1920-2013; Cho, You-Hee/AAF-8582-2020; Yoon, Juyoung/M-3248-2014; Park, Sungsu/AAF-4792-2020	Park, Sungsu/0000-0003-3062-1302; Cho, You-Hee/0000-0001-7942-5893	Korean Government (MEST) [20100001480, 2010-0018895, R31-2008-000-10010-0, R01-2008-000-20593-0]; Ewha Womans University	Korean Government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government); Ewha Womans University	This work was equally supported by the National Research Foundation of Korea (NRF) grants funded by the Korean Government (MEST) (Science Research Center program 20100001480: National Research Lab program 2010-0018895: World Class University Program R31-2008-000-10010-0: Basic Science Research Program R01-2008-000-20593-0). The first author was supported by Research Program-Grant 2010 of Ewha Womans University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boat TF., 1989, CYSTIC FIBROSIS META, V6th, P2649; BRINT JM, 1995, J BACTERIOL, V177, P7155, DOI 10.1128/jb.177.24.7155-7163.1995; Burdette SC, 2001, J AM CHEM SOC, V123, P7831, DOI 10.1021/ja010059l; CASTRIC P, 1994, CURR MICROBIOL, V29, P19, DOI 10.1007/BF01570186; Chen XQ, 2010, CHEM COMMUN, V46, P8953, DOI 10.1039/c0cc03398g; Chung SY, 2009, CHEM COMMUN, P2866, DOI 10.1039/b901140d; Cody WL, 2009, J BACTERIOL, V191, P2993, DOI 10.1128/JB.01156-08; Demidova TN, 2005, J PHOTOCH PHOTOBIO B, V81, P15, DOI 10.1016/j.jphotobiol.2005.05.007; Domaille DW, 2008, NAT CHEM BIOL, V4, P168, DOI 10.1038/nchembio.69; Doring G, 2000, EUR RESPIR J, V16, P749, DOI 10.1034/j.1399-3003.2000.16d30.x; Drevinek P, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-121; Ekmekci Z, 2008, ORG LETT, V10, P461, DOI 10.1021/ol702823u; Enderby B, 2009, PEDIATR PULM, V44, P142, DOI 10.1002/ppul.20963; FITZSIMMONS SC, 1993, J PEDIATR-US, V122, P1, DOI 10.1016/S0022-3476(05)83478-X; Govan JRW, 1996, MICROBIOL REV, V60, P539, DOI 10.1128/MMBR.60.3.539-574.1996; Heo YJ, 2005, J MICROBIOL BIOTECHN, V15, P1368; HOWLAND MA, 2006, GOLDFRANKS TOXICOLOG, P1731; ISLES A, 1984, J PEDIATR-US, V104, P206, DOI 10.1016/S0022-3476(84)80993-2; IWATA M, 1991, INFECT IMMUN, V59, P1514, DOI 10.1128/IAI.59.4.1514-1520.1991; Kadurugamuwa JL, 2003, INFECT IMMUN, V71, P882, DOI 10.1128/IAI.71.2.882-890.2003; Kukavica-Ibrulj I, 2008, J BACTERIOL, V190, P2804, DOI 10.1128/JB.01572-07; Lee KS, 2008, ORG LETT, V10, P49, DOI 10.1021/ol7025763; Leevy WM, 2006, J AM CHEM SOC, V128, P16476, DOI 10.1021/ja0665592; Leevy W Matthew, 2007, Drug Discov Today Dis Models, V4, P91, DOI 10.1016/j.ddmod.2007.07.001; Li L, 2005, TOXICOL SCI, V86, P116, DOI 10.1093/toxsci/kfi164; Liberati NT, 2006, P NATL ACAD SCI USA, V103, P2833, DOI 10.1073/pnas.0511100103; Lou XD, 2008, CHEM COMMUN, P5848, DOI 10.1039/b812746h; MCCARTHY WF, 2007, COBRA PREPRINT SERIE; Muller M, 2006, FREE RADICAL BIO MED, V41, P1670, DOI 10.1016/j.freeradbiomed.2006.09.004; NIELSON DW, 1981, P NATL ACAD SCI-BIOL, V78, P7119, DOI 10.1073/pnas.78.11.7119; Park S, 2003, SCIENCE, V301, P188, DOI 10.1126/science.1079805; RAHME LG, 1995, SCIENCE, V268, P1899, DOI 10.1126/science.7604262; Rajan S, 2000, AM J RESP CELL MOL, V23, P304, DOI 10.1165/ajrcmb.23.3.4098; Rasmussen TB, 2005, MICROBIOL-SGM, V151, P1325, DOI 10.1099/mic.0.27715-0; Ratjen F, 2003, LANCET, V361, P681, DOI 10.1016/S0140-6736(03)12567-6; Ren JQ, 2008, TALANTA, V75, P760, DOI 10.1016/j.talanta.2007.12.024; Richard JC, 2004, PEDIATR PULM, V37, P286, DOI 10.1002/ppul.20024; Ryall B, 2008, EUR RESPIR J, V32, P740, DOI 10.1183/09031936.00159607; Ryall B, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-108; SCHUBERT J, 1968, J PHARMACOL EXP THER, V162, P352; SMITH ER, 1967, ANN NY ACAD SCI, V141, P386, DOI 10.1111/j.1749-6632.1967.tb34901.x; Soh N, 2006, ANAL BIOANAL CHEM, V386, P532, DOI 10.1007/s00216-006-0366-9; Speert DP, 2002, EMERG INFECT DIS, V8, P181; Teichgraber V, 2008, NAT MED, V14, P382, DOI 10.1038/nm1748; Vock EH, 1998, MUTAT RES-GEN TOX EN, V413, P83, DOI 10.1016/S1383-5718(98)00019-9; Wang WH, 2005, J AM CHEM SOC, V127, P15949, DOI 10.1021/ja054962n; Xu Z, 2010, CHEM SOC REV, V39, P127, DOI 10.1039/b907368j; YAMAMOTO H, 1995, TOXICOL LETT, V80, P29, DOI 10.1016/0378-4274(95)03260-R	48	33	33	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2011	6	7							e21387	10.1371/journal.pone.0021387	http://dx.doi.org/10.1371/journal.pone.0021387			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791HI	21750709	Green Published, Green Submitted, gold			2022-12-27	WOS:000292655400004
J	Fodrie, FJ; Heck, KL				Fodrie, F. Joel; Heck, Kenneth L., Jr.			Response of Coastal Fishes to the Gulf of Mexico Oil Disaster	PLOS ONE			English	Article							PRINCE-WILLIAM-SOUND; HERRING CLUPEA-PALLASI; DEEP-WATER-HORIZON; PINK SALMON; CRUDE-OIL; EXPOSURE; SPILL; CONSEQUENCES; SENSITIVITY; ECOLOGY	The ecosystem-level impacts of the Deepwater Horizon disaster have been largely unpredictable due to the unique setting and magnitude of this spill. We used a five-year (2006-2010) data set within the oil-affected region to explore acute consequences for early-stage survival of fish species inhabiting seagrass nursery habitat. Although many of these species spawned during spring-summer, and produced larvae vulnerable to oil-polluted water, overall and species-by-species catch rates were high in 2010 after the spill (1,989 +/- 220 fishes km-towed(-1) [mu +/- 1SE]) relative to the previous four years (1,080 +/- 43 fishes km-towed(-1)). Also, several exploited species were characterized by notably higher juvenile catch rates during 2010 following large-scale fisheries closures in the northern Gulf, although overall statistical results for the effects of fishery closures on assemblage-wide CPUE data were ambiguous. We conclude that immediate, catastrophic losses of 2010 cohorts were largely avoided, and that no shifts in species composition occurred following the spill. The potential long-term impacts facing fishes as a result of chronic exposure and delayed, indirect effects now require attention.	[Fodrie, F. Joel] Univ N Carolina Chapel Hill, Inst Marine Sci, Morehead City, NC USA; [Fodrie, F. Joel] Univ N Carolina Chapel Hill, Dept Marine Sci, Morehead City, NC USA; [Heck, Kenneth L., Jr.] Univ S Alabama, Dauphin Isl Sea Lab, Dauphin Isl, AL USA; [Heck, Kenneth L., Jr.] Univ S Alabama, Dept Marine Sci, Dauphin Isl, AL USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Dauphin Island Sea Lab; University of South Alabama; University of South Alabama	Fodrie, FJ (corresponding author), Univ N Carolina Chapel Hill, Inst Marine Sci, Morehead City, NC USA.	jfodrie@unc.edu			National Marine Fisheries Service; National Oceanic and Atmospheric Administration Marine Fisheries Initiative; Northern Gulf Institute	National Marine Fisheries Service; National Oceanic and Atmospheric Administration Marine Fisheries Initiative; Northern Gulf Institute	The authors acknowledge support from the National Marine Fisheries Service, National Oceanic and Atmospheric Administration Marine Fisheries Initiative and Northern Gulf Institute. The funders had no role in study design, data collection and analyses, decision to publish, or preparation of the manuscript.	ABLE KW, ECOLOGY ESTUARINE FI; Baum JK, 2004, ECOL LETT, V7, P135, DOI 10.1111/j.1461-0248.2003.00564.x; Beck MW, 2001, BIOSCIENCE, V51, P633, DOI 10.1641/0006-3568(2001)051[0633:TICAMO]2.0.CO;2; Brown ED, 1996, AM FISH S S, V18, P448; Bue BG, 1998, T AM FISH SOC, V127, P35, DOI 10.1577/1548-8659(1998)127<0035:EODTPS>2.0.CO;2; Byron D, 2006, ESTUARIES COASTS, V29, P939, DOI 10.1007/BF02798654; Camilli R, 2010, SCIENCE, V330, P201, DOI 10.1126/science.1195223; Carls MG, 1999, ENVIRON TOXICOL CHEM, V18, P481, DOI 10.1002/etc.5620180317; CLARK KR, 2001, PRIMER V5 USER MANUA; Crone TJ, 2010, SCIENCE, V330, P634, DOI 10.1126/science.1195840; D'Alessandro EK, 2010, MAR ECOL PROG SER, V410, P159, DOI 10.3354/meps08632; Diaz RJ, 2008, SCIENCE, V321, P926, DOI 10.1126/science.1156401; Edgar GJ, 2003, MAR POLLUT BULL, V47, P296, DOI 10.1016/S0025-326X(03)00158-9; Fodrie FJ, 2010, GLOBAL CHANGE BIOL, V16, P48, DOI 10.1111/j.1365-2486.2009.01889.x; Graham WM, 2010, ENVIRON RES LETT, V5, DOI 10.1088/1748-9326/5/4/045301; HANZEN TC, 2010, SCIENCE, V330, P204; Heintz RA, 2000, MAR ECOL PROG SER, V208, P205, DOI 10.3354/meps208205; Hilborn R, 1996, AM FISH S S, V18, P639; Holt GJ, 2000, MAR ECOL PROG SER, V193, P181, DOI 10.3354/meps193181; Kerr R, 2010, SCIENCE, V328, P674, DOI 10.1126/science.328.5979.674; Kocan RM, 1996, CAN J FISH AQUAT SCI, V53, P2366, DOI 10.1139/cjfas-53-10-2366; Levin LA, 2006, INTEGR COMP BIOL, V46, P282, DOI 10.1093/icb/icj024; MILLER BS, EARLY LIFE HIST MARI; Moran MD, 2003, OIKOS, V100, P403, DOI 10.1034/j.1600-0706.2003.12010.x; *NOAA FISH SERV, DEEPW HOR OIL SPILL; Pearson WH, 1999, CAN J FISH AQUAT SCI, V56, P711, DOI 10.1139/cjfas-56-4-711; Peterson CH, 1996, CAN J FISH AQUAT SCI, V53, P2637, DOI 10.1139/cjfas-53-11-2637; Peterson CH, 2003, SCIENCE, V302, P2082, DOI 10.1126/science.1084282; Sagarin R, 2010, FRONT ECOL ENVIRON, V8, P379, DOI 10.1890/090001; TUVIKENE A, 1995, ANN ZOOL FENN, V32, P295; UNDERWOOD AJ, DETECTING ECOLOGICAL, P151; *US DEP INT, 2002069 OCS MMS; Wertheimer AC, 2000, T AM FISH SOC, V129, P989, DOI 10.1577/1548-8659(2000)129&lt;0989:SOAPSF&gt;2.3.CO;2; [No title captured]	34	70	72	1	120	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2011	6	7							e21609	10.1371/journal.pone.0021609	http://dx.doi.org/10.1371/journal.pone.0021609			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791AK	21754992	Green Published, gold, Green Submitted			2022-12-27	WOS:000292632000016
J	Hoggard, SJ; Wilson, PD; Beattie, AJ; Stow, AJ				Hoggard, Stephen J.; Wilson, Peter D.; Beattie, Andrew J.; Stow, Adam J.			Social Complexity and Nesting Habits Are Factors in the Evolution of Antimicrobial Defences in Wasps	PLOS ONE			English	Article							BEES HYMENOPTERA; PHYLOGENY; VESPOIDEA	Microbial diseases are important selective agents in social insects and one major defense mechanism is the secretion of cuticular antimicrobial compounds. We hypothesized that given differences in group size, social complexity, and nest type the secretions of these antimicrobials will be under different selective pressures. To test this we extracted secretions from nine wasp species of varying social complexity and nesting habits and assayed their antimicrobial compounds against cultures of Staphylococcus aureus. These data were then combined with phylogenetic data to provide an evolutionary context. Social species showed significantly higher (18x) antimicrobial activity than solitary species and species with paper nests showed significantly higher (11x) antimicrobial activity than those which excavated burrows. Mud-nest species showed no antimicrobial activity. Solitary, burrow-provisioning wasps diverged at more basal nodes of the phylogenetic trees, while social wasps diverged from the most recent nodes. These data suggest that antimicrobial defences may have evolved in response to ground-dwelling pathogens but the most important variable leading to increased antimicrobial strength was increase in group size and social complexity.	[Hoggard, Stephen J.; Wilson, Peter D.; Beattie, Andrew J.; Stow, Adam J.] Macquarie Univ, Dept Biol Sci, N Ryde, NSW, Australia	Macquarie University	Hoggard, SJ (corresponding author), Macquarie Univ, Dept Biol Sci, N Ryde, NSW, Australia.	stephen.hoggard@mq.edu.au		Wilson, Peter/0000-0001-7375-0791; Stow, Adam/0000-0002-6796-4854	Australian Research Council (ARC) [DP0879229]	Australian Research Council (ARC)(Australian Research Council)	The work was funded by Australian Research Council (ARC) Discovery Grant (#DP0879229). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BROCKMANN HJ, 1980, FLA ENTOMOL, V63, P53, DOI 10.2307/3494656; Brothers DJ, 1999, ZOOL SCR, V28, P233, DOI 10.1046/j.1463-6409.1999.00003.x; COOPER KW, 1957, J EXP ZOOL, V134, P469, DOI 10.1002/jez.1401340305; Dowton M, 1998, MOL PHYLOGENET EVOL, V10, P354, DOI 10.1006/mpev.1998.0533; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; EVANS HE, 1973, T ROY ENT SOC LONDON, V125, P45, DOI 10.1111/j.1365-2311.1973.tb00537.x; Evans HE., 2007, SAND WASPS NATURAL H; Evans JD, 2010, J INVERTEBR PATHOL, V103, pS62, DOI 10.1016/j.jip.2009.06.019; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Hines HM, 2007, P NATL ACAD SCI USA, V104, P3295, DOI 10.1073/pnas.0610140104; Hunt J.H., 2007, EVOLUTION SOCIAL WAS, DOI DOI 10.1093/ACPROF:OSO/9780195307979.001.0001; Inoue M, 2008, J ETHOL, V26, P43, DOI 10.1007/s10164-006-0028-6; KLOOS WE, 1980, ANNU REV MICROBIOL, V34, P559, DOI 10.1146/annurev.mi.34.100180.003015; Pilgrim EM, 2008, ZOOL SCR, V37, P539, DOI 10.1111/j.1463-6409.2008.00340.x; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; R Core Team, 2021, R LANGUAGE ENV STAT; Rambaut A., 2007, TRACER V1 4; Rambaut A, 2010, FIGTREE V131; Smith SM, 2008, J MICROBIOL METH, V72, P103, DOI 10.1016/j.mimet.2007.10.003; Stow A, 2008, BRAIN BEHAV IMMUN, V22, P1009, DOI 10.1016/j.bbi.2008.03.008; Stow A, 2007, BIOL LETTERS, V3, P422, DOI 10.1098/rsbl.2007.0178; Sunnucks P, 1996, MOL BIOL EVOL, V13, P510, DOI 10.1093/oxfordjournals.molbev.a025612; Swofford DL., 2003, PAUP PHYLOGENETIC AN; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Turillazzi S, 2006, J AM SOC MASS SPECTR, V17, P376, DOI 10.1016/j.jasms.2005.11.017; Turnbull C, 2011, BIOL LETTERS, V7, P249, DOI 10.1098/rsbl.2010.0719; Wcislo WT, 1996, ANNU REV ENTOMOL, V41, P257, DOI 10.1146/annurev.en.41.010196.001353	27	21	21	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2011	6	7							e21763	10.1371/journal.pone.0021763	http://dx.doi.org/10.1371/journal.pone.0021763			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791AK	21754998	Green Published, Green Submitted, gold			2022-12-27	WOS:000292632000025
J	Caffrey, DR; Zhao, J; Song, ZL; Schaffer, ME; Haney, SA; Subramanian, RR; Seymour, AB; Hughes, JD				Caffrey, Daniel R.; Zhao, Juan; Song, Zhili; Schaffer, Michael E.; Haney, Steven A.; Subramanian, Romesh R.; Seymour, Albert B.; Hughes, Jason D.			siRNA Off-Target Effects Can Be Reduced at Concentrations That Match Their Individual Potency	PLOS ONE			English	Article							SMALL INTERFERING RNAS; EXPRESSION; DETERMINANTS; MATURATION; MICRORNAS; PROTEINS; BIOLOGY; DESIGN; DICER	Small interfering RNAs (siRNAs) are routinely used to reduce mRNA levels for a specific gene with the goal of studying its function. Several studies have demonstrated that siRNAs are not always specific and can have many off-target effects. The 39 UTRs of off-target mRNAs are often enriched in sequences that are complementary to the seed-region of the siRNA. We demonstrate that siRNA off-targets can be significantly reduced when cells are treated with a dose of siRNA that is relatively low (e. g. 1 nM), but sufficient to effectively silence the intended target. The reduction in off-targets was demonstrated for both modified and unmodified siRNAs that targeted either STAT3 or hexokinase II. Low concentrations reduced silencing of transcripts with complementarity to the seed region of the siRNA. Similarly, off-targets that were not complementary to the siRNA were reduced at lower doses, including up-regulated genes that are involved in immune response. Importantly, the unintended induction of caspase activity following treatment with a siRNA that targeted hexokinase II was also shown to be a concentration-dependent off-target effect. We conclude that off-targets and their related phenotypic effects can be reduced for certain siRNA that potently silence their intended target at low concentrations.	[Caffrey, Daniel R.; Zhao, Juan; Song, Zhili; Schaffer, Michael E.; Haney, Steven A.; Subramanian, Romesh R.; Seymour, Albert B.; Hughes, Jason D.] Pfizer Inc, Cambridge, MA USA; [Schaffer, Michael E.] Centocor R&D Inc, Radnor, PA USA; [Seymour, Albert B.] Shire HGT, Res & Dev, Lexington, MA USA; [Hughes, Jason D.] Merck Res Labs, Boston, MA USA	Pfizer; Johnson & Johnson; Johnson & Johnson USA; Shire Pharmaceuticals Limited; Merck & Company	Caffrey, DR (corresponding author), Univ Massachusetts, Sch Med, Dept Med, Amherst, MA 01003 USA.	Daniel.Caffrey@umassmed.edu		Subramanian, Romesh/0000-0001-5586-9895	Pfizer Inc.	Pfizer Inc.(Pfizer)	This study was funded by Pfizer Inc. through the employment of all the authors, who contributed to all aspects of the study.	Aagaard L, 2007, ADV DRUG DELIVER REV, V59, P75, DOI 10.1016/j.addr.2007.03.005; Anderson Emily, 2008, V442, P45, DOI 10.1007/978-1-59745-191-8_4; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Birchler JA, 2008, SCIENCE, V320, P1023, DOI 10.1126/science.1159018; Birmingham A, 2006, NAT METHODS, V3, P199, DOI 10.1038/NMETH854; Bolognani F, 2010, NUCLEIC ACIDS RES, V38, P117, DOI 10.1093/nar/gkp863; Boutros M, 2008, NAT REV GENET, V9, P554, DOI 10.1038/nrg2364; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179; Doench JG, 2004, GENE DEV, V18, P504, DOI 10.1101/gad.1184404; Doench JG, 2003, GENE DEV, V17, P438, DOI 10.1101/gad.1064703; Eckelman BP, 2006, EMBO REP, V7, P988, DOI 10.1038/sj.embor.7400795; Falcon S, 2007, BIOINFORMATICS, V23, P257, DOI 10.1093/bioinformatics/btl567; Fedorov Y, 2006, RNA, V12, P1188, DOI 10.1261/rna.28106; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Hammell M, 2008, NAT METHODS, V5, P813, DOI 10.1038/NMETH.1247; Hammond SM, 2000, NATURE, V404, P293, DOI 10.1038/35005107; Hutvagner G, 2001, SCIENCE, V293, P834, DOI 10.1126/science.1062961; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jackson AL, 2006, RNA, V12, P1197, DOI 10.1261/rna.30706; Jackson AL, 2006, RNA, V12, P1179, DOI 10.1261/rna.25706; Jackson AL, 2010, NAT REV DRUG DISCOV, V9, P57, DOI 10.1038/nrd3010; Jackson AL, 2003, NAT BIOTECHNOL, V21, P635, DOI 10.1038/nbt831; JACOBSEN A, SIGNATURES RNA BINDI, P1010; Judge AD, 2006, MOL THER, V13, P494, DOI 10.1016/j.ymthe.2005.11.002; Kertesz M, 2007, NAT GENET, V39, P1278, DOI 10.1038/ng2135; Ketting RF, 2001, GENE DEV, V15, P2654, DOI 10.1101/gad.927801; Knight SW, 2001, SCIENCE, V293, P2269, DOI 10.1126/science.1062039; Lee Y, 2002, EMBO J, V21, P4663, DOI 10.1093/emboj/cdf476; Lin XY, 2005, NUCLEIC ACIDS RES, V33, P4527, DOI 10.1093/nar/gki762; MacRae IJ, 2008, P NATL ACAD SCI USA, V105, P512, DOI 10.1073/pnas.0710869105; Mellor HR, 2007, CANCER METAST REV, V26, P553, DOI 10.1007/s10555-007-9080-0; Nielsen CB, 2007, RNA, V13, P1894, DOI 10.1261/rna.768207; Ohi N, 1999, CELL DEATH DIFFER, V6, P314, DOI 10.1038/sj.cdd.4400493; Persengiev SP, 2004, RNA, V10, P12, DOI 10.1261/rna5160904; Robbins M, 2009, OLIGONUCLEOTIDES, V19, P89, DOI 10.1089/oli.2009.0180; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Stabenau A, 2004, GENOME RES, V14, P929, DOI 10.1101/gr.1857204; Tomari Y, 2005, GENE DEV, V19, P517, DOI 10.1101/gad.1284105; Ui-Tei K, 2008, NUCLEIC ACIDS RES, V36, P7100, DOI 10.1093/nar/gkn902; van Dongen S, 2008, NAT METHODS, V5, P1023, DOI 10.1038/nmeth.1267; Zeng Y, 2003, P NATL ACAD SCI USA, V100, P9779, DOI 10.1073/pnas.1630797100	43	58	63	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2011	6	7							e21503	10.1371/journal.pone.0021503	http://dx.doi.org/10.1371/journal.pone.0021503			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	789JO	21750714	Green Submitted, Green Published, gold			2022-12-27	WOS:000292512000015
J	Cyr, DD; Lucas, JE; Thompson, JW; Patel, K; Clark, PJ; Thompson, A; Tillmann, HL; McHutchison, JG; Moseley, MA; McCarthy, JJ				Cyr, Derek D.; Lucas, Joseph E.; Thompson, J. Will; Patel, Keyur; Clark, Paul J.; Thompson, Alexander; Tillmann, Hans L.; McHutchison, John G.; Moseley, M. Arthur; McCarthy, Jeanette J.			Characterization of Serum Proteins Associated with IL28B Genotype among Patients with Chronic Hepatitis C	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; PITUITARY-ADRENAL AXIS; GENETIC-VARIATION; BINDING GLOBULIN; INSULIN; EXPRESSION; CLEARANCE; RIBAVIRIN; CORTISOL; THERAPY	Introduction: Polymorphisms near the IL28B gene (e.g. rs12979860) encoding interferon lambda 3 have recently been associated with both spontaneous clearance and treatment response to pegIFN/RBV in chronic hepatitis C (CHC) patients. The molecular consequences of this genetic variation are unknown. To gain further insight into IL28B function we assessed the association of rs12979860 with expression of protein quantitative traits (pQTL analysis) generated using open-platform proteomics in serum from patients. Methods: 41 patients with genotype 1 chronic hepatitis C infection from the Duke Liver Clinic were genotyped for rs12979860. Proteomic profiles were generated by LC-MS/MS analysis following immunodepletion of serum with MARS14 columns and trypsin-digestion. Next, a latent factor model was used to classify peptides into metaproteins based on co-expression and using only those peptides with protein identifications. Metaproteins were then analyzed for association with IL28B genotype using one-way analysis of variance. Results: There were a total of 4,186 peptides in the data set with positive identifications. These were matched with 253 proteins of which 110 had two or more associated, identified peptides. The IL28B treatment response genotype (rs12979860_CC) was significantly associated with lower serum levels of corticosteroid binding globulin (CBG; p = 9.2x10(-6)), a major transport protein for glucocorticoids and progestins. Moreover, the CBG metaprotein was associated with treatment response (p = 0.0148), but this association was attenuated when both IL28B genotype and CBG were included in the model, suggesting that the CBG association may be independent of treatment response. Conclusions: In this cohort of chronic hepatitis C patients, IL28B polymorphism was associated with serum levels of corticosteroid binding globulin, a major transporter of cortisol, however, CBG does not appear to mediate the association of IL28B with treatment response. Further investigation of this pathway is warranted to determine if it plays a role in other comorbidities of HCV-infection.	[Cyr, Derek D.; Lucas, Joseph E.; Thompson, J. Will; Moseley, M. Arthur; McCarthy, Jeanette J.] Duke Univ, Med Ctr, Inst Genome Sci & Policy, Durham, NC 27708 USA; [Patel, Keyur; Clark, Paul J.; Thompson, Alexander; Tillmann, Hans L.; McHutchison, John G.] Duke Univ, Med Ctr, Duke Clin Res Inst, Durham, NC USA; [Patel, Keyur; Clark, Paul J.; Thompson, Alexander; Tillmann, Hans L.; McHutchison, John G.] Duke Univ, Med Ctr, Div Gastroenterol, Durham, NC 27710 USA; [McCarthy, Jeanette J.] Duke Univ, Med Ctr, Div Community & Family Med, Durham, NC 27710 USA	Duke University; Duke University; Duke University; Duke University	Cyr, DD (corresponding author), Duke Univ, Med Ctr, Inst Genome Sci & Policy, Durham, NC 27708 USA.	jeanette.mccarthy@duke.edu	Clark, Paul J/A-1480-2012	Clark, Paul J/0000-0002-1821-4969	David H Murdock Institute for Business and Culture; NIH [1 UL1 RR024128-01]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024128] Funding Source: NIH RePORTER	David H Murdock Institute for Business and Culture; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This study was funded by a generous grant from the David H Murdock Institute for Business and Culture via the M.U.R.D.O.C.K. Study and NIH CTSA award 1 UL1 RR024128-01 to Duke University (Dr. Robert Califf, Principal Investigator). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Brown RS, 2005, NATURE, V436, P973, DOI 10.1038/nature04083; Charlton MR, 2011, HEPATOLOGY, V53, P317, DOI 10.1002/hep.24074; CRAVE JC, 1995, J CLIN ENDOCR METAB, V80, P1283, DOI 10.1210/jc.80.4.1283; Dhillo WS, 2002, EUR J ENDOCRINOL, V146, P231, DOI 10.1530/eje.0.1460231; Fernandez-Real JM, 2002, J CLIN ENDOCR METAB, V87, P4686, DOI 10.1210/jc.2001-011843; Fernandez-Real JM, 1999, J CLIN ENDOCR METAB, V84, P3192, DOI 10.1210/jc.84.9.3192; Foss EJ, 2007, NAT GENET, V39, P1369, DOI 10.1038/ng.2007.22; Gagliardi L, 2010, MOL CELL ENDOCRINOL, V316, P24, DOI 10.1016/j.mce.2009.07.015; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; Honda M, 2010, GASTROENTEROLOGY, V139, P499, DOI 10.1053/j.gastro.2010.04.049; Hutin Y, 2004, J CLIN PHARMACOL, V44, P20, DOI 10.1177/0091270003258669; Livak KJ, 1999, GENET ANAL-BIOMOL E, V14, P143, DOI 10.1016/S1050-3862(98)00019-9; McCarthy JJ, 2010, GASTROENTEROLOGY, V138, P2307, DOI 10.1053/j.gastro.2010.02.009; Melzer D, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000072; Metz TO, 2008, J PROTEOME RES, V7, P698, DOI 10.1021/pr700606w; Ohno Y, 1998, J CLIN ENDOCR METAB, V83, P3681, DOI 10.1210/jc.83.10.3681; PATEL K, 2011, HEPATOLOGY IN PRESS; Raison CL, 2010, MOL PSYCHIATR, V15, P535, DOI 10.1038/mp.2008.58; Rauch A, 2010, GASTROENTEROLOGY, V138, P1338, DOI 10.1053/j.gastro.2009.12.056; Romero-Gomez M, 2005, GASTROENTEROLOGY, V128, P636, DOI 10.1053/j.gastro.2004.12.049; Sarasin-Filipowicz M, 2008, P NATL ACAD SCI USA, V105, P7034, DOI 10.1073/pnas.0707882105; Suppiah V, 2009, NAT GENET, V41, P1100, DOI 10.1038/ng.447; Tanaka Y, 2009, NAT GENET, V41, P1105, DOI 10.1038/ng.449; Thomas DL, 2009, NATURE, V461, P798, DOI 10.1038/nature08463; Urban TJ, 2010, HEPATOLOGY, V52, P1888, DOI 10.1002/hep.23912; Vincent RP, 2009, ANN CLIN BIOCHEM, V46, P505, DOI 10.1258/acb.2009.009030	26	18	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2011	6	7							e21854	10.1371/journal.pone.0021854	http://dx.doi.org/10.1371/journal.pone.0021854			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	789JO	21750736	Green Published, Green Submitted, gold			2022-12-27	WOS:000292512000028
J	Yu, QJ; Wang, T; Zhou, XX; Wu, JX; Chen, XM; Liu, Y; Wu, DM; Zhai, QW				Yu, Qiujing; Wang, Ting; Zhou, Xuexia; Wu, Jingxia; Chen, Xingmiao; Liu, Yang; Wu, Dongmei; Zhai, Qiwei			Wld(S) Reduces Paraquat-Induced Cytotoxicity via SIRT1 in Non-Neuronal Cells by Attenuating the Depletion of NAD	PLOS ONE			English	Article							WALLERIAN DEGENERATION; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; AXONAL DEGENERATION; DEATH; GENE; MITOCHONDRIAL; DEACETYLASE; STRESS; APOPTOSIS; SURVIVAL	Wld(S) is a fusion protein with NAD synthesis activity, and has been reported to protect axonal and synaptic compartments of neurons from various mechanical, genetic and chemical insults. However, whether Wld(S) can protect non-neuronal cells against toxic chemicals is largely unknown. Here we found that Wld(S) significantly reduced the cytotoxicity of bipyridylium herbicides paraquat and diquat in mouse embryonic fibroblasts, but had no effect on the cytotoxicity induced by chromium (VI), hydrogen peroxide, etoposide, tunicamycin or brefeldin A. Wld(S) also slowed down the death of mice induced by intraperitoneal injection of paraquat. Further studies demonstrated that Wld(S) markedly attenuated mitochondrial injury including disruption of mitochondrial membrane potential, structural damage and decline of ATP induced by paraquat. Disruption of the NAD synthesis activity of Wld(S) by an H112A or F116S point mutation resulted in loss of its protective function against paraquat-induced cell death. Furthermore, WldS delayed the decrease of intracellular NAD levels induced by paraquat. Similarly, treatment with NAD or its precursor nicotinamide mononucleotide attenuated paraquat-induced cytotoxicity and decline of ATP and NAD levels. In addition, we showed that SIRT1 was required for both exogenous NAD and Wld(S)-mediated cellular protection against paraquat. These findings suggest that NAD and SIRT1 mediate the protective function of Wld(S) against the cytotoxicity induced by paraquat, which provides new clues for the mechanisms underlying the protective function of Wld(S) in both neuronal and non-neuronal cells, and implies that attenuation of NAD depletion may be effective to alleviate paraquat poisoning.	[Yu, Qiujing; Wang, Ting; Zhou, Xuexia; Wu, Jingxia; Chen, Xingmiao; Liu, Yang; Wu, Dongmei; Zhai, Qiwei] Chinese Acad Sci, Grad Sch, Shanghai Inst Biol Sci, Inst Nutr Sci,Key Lab Nutr & Metab, Shanghai, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Yu, QJ (corresponding author), Chinese Acad Sci, Grad Sch, Shanghai Inst Biol Sci, Inst Nutr Sci,Key Lab Nutr & Metab, Shanghai, Peoples R China.	qwzhai@sibs.ac.cn	wu, Jingxia/AFR-6587-2022	Zhai, Qiwei/0000-0002-9617-7403	National Natural Science Foundation of China [30825009, 30970619, 31030022, 81021002]; National Basic Research Program of China (973 Program) [2009CB918403, 2007CB914501]; Director Foundation of Institute for Nutritional Sciences [20090101]; Sanofi-Aventis-Shanghai Institutes for Biological Sciences	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 Program)(National Basic Research Program of China); Director Foundation of Institute for Nutritional Sciences; Sanofi-Aventis-Shanghai Institutes for Biological Sciences	This study was supported by grants from National Natural Science Foundation of China (30825009, 30970619, 31030022 and 81021002), National Basic Research Program of China (973 Program, 2009CB918403, 2007CB914501), Director Foundation of Institute for Nutritional Sciences (20090101) and Sanofi-Aventis-Shanghai Institutes for Biological Sciences Scholarship Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adalbert R, 2006, EUR J NEUROSCI, V24, P2163, DOI 10.1111/j.1460-9568.2006.05103.x; Araki T, 2004, SCIENCE, V305, P1010, DOI 10.1126/science.1098014; Avery MA, 2009, J CELL BIOL, V184, P501, DOI 10.1083/jcb.200808042; Barrientos SA, 2011, J NEUROSCI, V31, P966, DOI 10.1523/JNEUROSCI.4065-10.2011; BROWN OR, 1981, SCIENCE, V212, P1510, DOI 10.1126/science.7233236; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Bursch W, 1996, CARCINOGENESIS, V17, P1595, DOI 10.1093/carcin/17.8.1595; Castello PR, 2007, J BIOL CHEM, V282, P14186, DOI 10.1074/jbc.M700827200; Chen LH, 2007, MOL CANCER THER, V6, P2581, DOI 10.1158/1535-7163.MCT-07-0220; Cocheme HM, 2009, METHOD ENZYMOL, V456, P395, DOI 10.1016/S0076-6879(08)04422-4; Cohen HY, 2004, SCIENCE, V305, P390, DOI 10.1126/science.1099196; Coleman MP, 2010, ANNU REV NEUROSCI, V33, P245, DOI 10.1146/annurev-neuro-060909-153248; Conforti L, 2000, P NATL ACAD SCI USA, V97, P11377, DOI 10.1073/pnas.97.21.11377; Conforti L, 2009, J CELL BIOL, V184, P491, DOI 10.1083/jcb.200807175; DECKWERTH TL, 1994, DEV BIOL, V165, P63, DOI 10.1006/dbio.1994.1234; Dinis-Oliveira RJ, 2008, CRIT REV TOXICOL, V38, P13, DOI 10.1080/10408440701669959; Fulco M, 2008, DEV CELL, V14, P661, DOI 10.1016/j.devcel.2008.02.004; Ghazi-Khansari M, 2005, ARCH TOXICOL, V79, P341, DOI 10.1007/s00204-004-0632-6; Gilley J, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000300; Hasmann M, 2003, CANCER RES, V63, P7436; HEITKAMP M, 1981, BIOCHIM BIOPHYS ACTA, V676, P345, DOI 10.1016/0304-4165(81)90169-0; Hilliard MA, 2009, J NEUROCHEM, V108, P23, DOI 10.1111/j.1471-4159.2008.05754.x; Ho YS, 2007, FREE RADICAL BIO MED, V43, P1299, DOI 10.1016/j.freeradbiomed.2007.07.025; Houtkooper RH, 2010, ENDOCR REV, V31, P194, DOI 10.1210/er.2009-0026; Hsu CP, 2009, CIRC RES, V105, P481, DOI 10.1161/CIRCRESAHA.109.203703; Jia HQ, 2007, NEUROSCI LETT, V413, P46, DOI 10.1016/j.neulet.2006.11.067; LUNN ER, 1989, EUR J NEUROSCI, V1, P27, DOI 10.1111/j.1460-9568.1989.tb00771.x; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; Mack TGA, 2001, NAT NEUROSCI, V4, P1199, DOI 10.1038/nn770; McBurney MW, 2003, MOL CELL BIOL, V23, P38, DOI 10.1128/MCB.23.1.38-54.2003; Mi WQ, 2002, J NEUROSCI METH, V113, P215, DOI 10.1016/S0165-0270(01)00501-5; Pillai JB, 2005, J BIOL CHEM, V280, P43121, DOI 10.1074/jbc.M506162200; Press C, 2008, J NEUROSCI, V28, P4861, DOI 10.1523/JNEUROSCI.0525-08.2008; Revollo JR, 2004, J BIOL CHEM, V279, P50754, DOI 10.1074/jbc.M408388200; RIBCHESTER RR, 1995, EUR J NEUROSCI, V7, P1641, DOI 10.1111/j.1460-9568.1995.tb01159.x; RICHARDSON DR, 1995, BLOOD, V86, P4295, DOI 10.1182/blood.V86.11.4295.bloodjournal86114295; UEDA T, 1985, J ELECTRON MICROSC, V34, P85; van der Veer E, 2007, J BIOL CHEM, V282, P10841, DOI 10.1074/jbc.C700018200; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; Wang J, 2005, J CELL BIOL, V170, P349, DOI 10.1083/jcb.200504028; Wang SP, 2008, STROKE, V39, P2587, DOI 10.1161/STROKEAHA.107.509158; Westerheide SD, 2009, SCIENCE, V323, P1063, DOI 10.1126/science.1165946; Wishart TM, 2007, MOL CELL PROTEOMICS, V6, P1318, DOI 10.1074/mcp.M600457-MCP200; Wishart TM, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-148; Wright AK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015108; Yang HY, 2007, CELL, V130, P1095, DOI 10.1016/j.cell.2007.07.035; Yang W, 2008, J TOXICOL ENV HEAL A, V71, P289, DOI 10.1080/15287390701738467; Ying WH, 2006, FRONT BIOSCI-LANDMRK, V11, P3129, DOI 10.2741/2038; Ying WH, 2001, P NATL ACAD SCI USA, V98, P12227, DOI 10.1073/pnas.211202598; Zhang T, 2009, J BIOL CHEM, V284, P20408, DOI 10.1074/jbc.M109.016469	50	11	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2011	6	7							e21770	10.1371/journal.pone.0021770	http://dx.doi.org/10.1371/journal.pone.0021770			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	789JO	21750730	Green Published, Green Submitted, gold			2022-12-27	WOS:000292512000022
J	Zhang, F; Baumer, N; Rode, M; Ji, P; Zhang, T; Berdel, WE; Muller-Tidow, C				Zhang, Feng; Baeumer, Nicole; Rode, Miriam; Ji, Ping; Zhang, Tao; Berdel, Wolfgang E.; Mueller-Tidow, Carsten			The Inhibitor of Growth Protein 5 (ING5) Depends on INCA1 as a Co-Factor for Its Antiproliferative Effects	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; CYCLIN A1-CDK2 COMPLEX; HUMAN HEAD; EXPRESSION; FAMILY; GENE; A1; TRANSCRIPTION; REGULATORS; CANCER	The proteins of the Inhibitor of Growth (ING) family are involved in multiple cellular functions such as cell cycle regulation, apoptosis, and chromatin remodeling. For ING5, its actual role in growth suppression and the necessary partners are not known. In a yeast-two-hybrid approach with human bone marrow derived cDNA, we identified ING5 as well as several other proteins as interaction partners of Inhibitor of cyclin A1 (INCA1) that we previously characterized as a novel interaction partner of cyclin A1/CDK2. ING5 expression in leukemic AML blasts was severely reduced compared to normal bone marrow. In line, ING5 inhibited bone marrow colony formation upon retroviral transduction. However, Inca1(-/-) bone marrow colony formation was not suppressed by ING5. In murine embryonic fibroblast (MEF) cells from Inca1(+/+) and Inca1(-/-) mice, overexpression of ING5 suppressed cell proliferation only in the presence of INCA1, while ING5 had no effect in Inca1(-/-) MEFs. ING5 overexpression induced a delay in S-phase progression, which required INCA1. Finally, ING5 overexpression enhanced Fas-induced apoptosis in Inca1(+/+) MEFs, while Inca1(-/-) MEFs were protected from Fas antibody-induced apoptosis. Taken together, these results indicate that ING5 is a growth suppressor with suppressed expression in AML whose functions depend on its interaction with INCA1.	[Zhang, Feng; Baeumer, Nicole; Rode, Miriam; Ji, Ping; Berdel, Wolfgang E.; Mueller-Tidow, Carsten] Univ Munster, Dept Med Hematol Oncol, Munster, Germany; [Zhang, Feng] Fourth Mil Med Univ, Sch Pharm, Dept Pharmacol, Xian 710032, Peoples R China; [Ji, Ping] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA; [Zhang, Tao] Fourth Mil Med Univ, Tangdu Hosp, Dept Thorac Surg, Xian 710032, Peoples R China	University of Munster; Air Force Military Medical University; University of Texas System; UTMD Anderson Cancer Center; Air Force Military Medical University	Zhang, F (corresponding author), Univ Munster, Dept Med Hematol Oncol, Munster, Germany.	muellerc@ukmuenster.de	Müller-Tidow, Carsten CMT/B-5257-2014; Müller-Tidow, Carsten/O-7207-2018	Müller-Tidow, Carsten/0000-0002-7166-5232	Deutsche DFG [MU1328/6-1]	Deutsche DFG(German Research Foundation (DFG))	This work is supported by grants from the Deutsche DFG (MU1328/6-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAUMER N, 2011, J BIOL CHEM IN PRESS; Campos EI, 2004, CELL MOL LIFE SCI, V61, P2597, DOI 10.1007/s00018-004-4199-4; Cengiz B, 2010, INT J CANCER, V127, P2088, DOI 10.1002/ijc.25224; Diederichs S, 2005, INT J CANCER, V116, P207, DOI 10.1002/ijc.21034; Diederichs S, 2004, J BIOL CHEM, V279, P33727, DOI 10.1074/jbc.M401708200; Doyon Y, 2006, MOL CELL, V21, P51, DOI 10.1016/j.molcel.2005.12.007; Feng XL, 2002, TRENDS CELL BIOL, V12, P532, DOI 10.1016/S0962-8924(02)02391-7; Garkavtsev I, 1996, NAT GENET, V14, P415, DOI 10.1038/ng1296-415; Garkavtsev I, 1998, NATURE, V391, P295, DOI 10.1038/34675; Grallert B, 2008, CELL CYCLE, V7, P2315, DOI 10.4161/cc.6389; Gunduz M, 2002, ONCOGENE, V21, P4462, DOI 10.1038/sj.onc.1205540; HARTWELL LH, 1994, SCIENCE, V266, P1821, DOI 10.1126/science.7997877; Li XH, 2011, J ONCOL, V2011, DOI 10.1155/2011/963614; Li XH, 2010, J CANCER RES CLIN, V136, P1573, DOI 10.1007/s00432-010-0815-x; Liu D, 1998, NAT GENET, V20, P377, DOI 10.1038/3855; Muller C, 1999, J BIOL CHEM, V274, P11220, DOI 10.1074/jbc.274.16.11220; Muller-Tidow C, 2004, MOL CELL BIOL, V24, P8917, DOI 10.1128/MCB.24.20.8917-8928.2004; Nagashima M, 2003, ONCOGENE, V22, P343, DOI 10.1038/sj.onc.1206115; Nagashima M, 2001, P NATL ACAD SCI USA, V98, P9671, DOI 10.1073/pnas.161151798; Nigg EA, 2001, NAT REV MOL CELL BIO, V2, P21, DOI 10.1038/35048096; Ortega S, 2003, NAT GENET, V35, P25, DOI 10.1038/ng1232; Russell M, 2006, EXP CELL RES, V312, P951, DOI 10.1016/j.yexcr.2006.01.020; Shi XB, 2005, J CELL BIOCHEM, V96, P1127, DOI 10.1002/jcb.20625; Shiseki M, 2003, CANCER RES, V63, P2373; Ullah M, 2008, MOL CELL BIOL, V28, P6828, DOI 10.1128/MCB.01297-08; Unoki M, 2009, CANCER SCI, V100, P1173, DOI 10.1111/j.1349-7006.2009.01183.x; Xing YN, 2011, HUM PATHOL, V42, P25, DOI 10.1016/j.humpath.2010.05.024; Yang R, 1999, MOL CELL BIOL, V19, P2400; Yang R, 1997, CANCER RES, V57, P913; Yang R, 1999, BLOOD, V93, P2067; Zheng HC, 2011, HUM PATHOL, V42, P424, DOI 10.1016/j.humpath.2009.12.018	31	22	26	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2011	6	7							e21505	10.1371/journal.pone.0021505	http://dx.doi.org/10.1371/journal.pone.0021505			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	789JO	21750715	Green Published, Green Submitted, gold			2022-12-27	WOS:000292512000016
J	Chen, ZQ; Yi, HL; Li, M; Wang, CF; Zhang, JT; Yang, CW; Zhao, YC; Lu, YH				Chen, Ziqiang; Yi, Honglei; Li, Ming; Wang, Chuanfeng; Zhang, Jingtao; Yang, Changwei; Zhao, Yingchuan; Lu, Yanghu			Associations between Body Mass and the Outcome of Surgery for Scoliosis in Chinese Adults	PLOS ONE			English	Article							ADOLESCENT IDIOPATHIC SCOLIOSIS; ANTERIOR SPINAL OVERGROWTH; FOCUS GROUP DEBATE; GROWTH; OBESITY	Background: In this study we intended to prove that being overweight has an unfavorable impact on the surgical treatment outcome of adult idiopathic scoliosis (AdIS). Methods: This is a retrospective study on the surgical treatment of seventy-one more than 30 years old (58 females and 13 males; mean age 42.9 +/- 12.2) idiopathic scoliotic patients with a minimum follow up of at least 2 years. The patients were divided into an overweight group (BMI >= 23) and a non-overweight group (BMI < 23). Preoperative, postoperative first erect and final follow-up radiographic measures, perioperative data, the Oswestry disability index (ODI), and the visual analog scale (VAS) were reviewed and compared. Findings: In the overweight group, no significant differences in radiographic measures, perioperative data, preoperative comorbidities, or postoperative complications, except for the more frequent concomitance of preoperative thoracic kyphosis 37.9 +/- 7.7 vs. 26.5 +/- 11.8 (P = 0.000) and thoracolumbar kyphosis 14.9 +/- 10.1 overweighted group vs. 6.5 +/- 9.9 non-overweighted group respectively (P = 0.002) were found. A higher morbidity of hypertension 36.8% vs. 9.6% (P = 0.004) was also observed in the overweight group. Postoperative ODI and VAS improved significantly in both groups compared to preoperative values. The postoperative ODI of the overweight group (19.6 +/- 12.4) was significantly higher than that of the non-overweight group (12.4 +/- 7.9) (P = 0.022). Conclusions: Overweight adult idiopathic scoliotic patients had more frequent concomitance of preoperative thoracic kyphosis and thoracolumbar kyphosis and more serious postoperative pain. However, BMI did not affect the outcomes of surgical correction for coronal and sagittal scoliotic deformity and their postoperative complication rates were not significantly affected.	[Chen, Ziqiang; Yi, Honglei; Li, Ming; Wang, Chuanfeng; Zhang, Jingtao; Yang, Changwei; Zhao, Yingchuan; Lu, Yanghu] Second Mil Med Univ, Affiliated Changhai Hosp, Dept Orthopaed Surg, Shanghai, Peoples R China; [Yi, Honglei] Chinese Peoples Liberat Army 89 Hosp, Weifang, Peoples R China	Naval Medical University	Chen, ZQ (corresponding author), Second Mil Med Univ, Affiliated Changhai Hosp, Dept Orthopaed Surg, Shanghai, Peoples R China.	limingch@21cn.com	Zhang, Jing/GWZ-7332-2022					ADJEI OB, 2008, 43 ANN M SCOL RES SO, P120; Aebi M, 2005, EUR SPINE J, V14, P925, DOI 10.1007/s00586-005-1053-9; Cheng JCY, 1999, SPINE, V24, P1218, DOI 10.1097/00007632-199906150-00008; DICKSON RA, 1988, LANCET, V1, P1151; Djurasovic M, 2008, SPINE, V33, P1789, DOI 10.1097/BRS.0b013e31817b8f6f; Fairbank J C, 1980, Physiotherapy, V66, P271; Fang A, 2005, SPINE, V30, P1460, DOI 10.1097/01.brs.0000166532.58227.4f; Guo X, 2005, EUR SPINE J, V14, P862, DOI 10.1007/s00586-005-1002-7; Guo X, 2003, J BONE JOINT SURG BR, V85B, P1026, DOI 10.1302/0301-620X.85B7.14046; Hangai M, 2008, SPINE J, V8, P732, DOI 10.1016/j.spinee.2007.07.392; JENSEN MP, 1994, J CONSULT CLIN PSYCH, V62, P172, DOI 10.1037/0022-006X.62.1.172; Mogul H R, 1999, Heart Dis, V1, P295; Patel JK, 2003, LANCET, V361, P85, DOI 10.1016/S0140-6736(03)12150-2; Patel N, 2007, J NEUROSURG-SPINE, V6, P291, DOI 10.3171/spi.2007.6.4.1; Stokes IAF, 2006, SCOLIOSIS SPINAL DIS, V1, DOI 10.1186/1748-7161-1-16; Upasani VV, 2008, SPINE, V33, P295, DOI 10.1097/BRS.0b013e3181624573; Vedantam R, 1998, SPINE, V23, P211, DOI 10.1097/00007632-199801150-00012; Wang W, 2001, Zhonghua Liu Xing Bing Xue Za Zhi, V22, P129; WEINSTEIN SL, 1983, J BONE JOINT SURG AM, V65, P447, DOI 10.2106/00004623-198365040-00004; WHO, 2004, LANCET, V363, P902; XIONG B, 1994, J ORTHOPAED RES, V12, P113, DOI 10.1002/jor.1100120114	21	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2011	6	7							e21601	10.1371/journal.pone.0021601	http://dx.doi.org/10.1371/journal.pone.0021601			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786HC	21747941	Green Submitted, gold, Green Published			2022-12-27	WOS:000292293400017
J	Cook, AL; Vitale, AM; Ravishankar, S; Matigian, N; Sutherland, GT; Shan, J; Sutharsan, R; Perry, C; Silburn, PA; Mellick, GD; Whitelaw, ML; Wells, CA; Mackay-Sim, A; Wood, SA				Cook, Anthony L.; Vitale, Alejandra M.; Ravishankar, Sugandha; Matigian, Nicholas; Sutherland, Greg T.; Shan, Jiangou; Sutharsan, Ratneswary; Perry, Chris; Silburn, Peter A.; Mellick, George D.; Whitelaw, Murray L.; Wells, Christine A.; Mackay-Sim, Alan; Wood, Stephen A.			NRF2 Activation Restores Disease Related Metabolic Deficiencies in Olfactory Neurosphere-Derived Cells from Patients with Sporadic Parkinson's Disease	PLOS ONE			English	Article							ANTIOXIDANT RESPONSE ELEMENT; MITOCHONDRIAL COMPLEX-I; TRANSCRIPTION FACTOR NRF2; SMALL MAF PROTEINS; OXIDATIVE STRESS; NF-E2-RELATED FACTOR-2; MEDIATED EXPRESSION; ENVIRONMENT INTERACTIONS; INTRAVENOUS GLUTATHIONE; ENDOTHELIAL-CELLS	Background: Without appropriate cellular models the etiology of idiopathic Parkinson's disease remains unknown. We recently reported a novel patient-derived cellular model generated from biopsies of the olfactory mucosa (termed olfactory neurosphere-derived (hONS) cells) which express functional and genetic differences in a disease-specific manner. Transcriptomic analysis of Patient and Control hONS cells identified the NRF2 transcription factor signalling pathway as the most differentially expressed in Parkinson's disease. Results: We tested the robustness of our initial findings by including additional cell lines and confirmed that hONS cells from Patients had 20% reductions in reduced glutathione levels and MTS [3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium, inner salt] metabolism compared to cultures from healthy Control donors. We also confirmed that Patient hONS cells are in a state of oxidative stress due to higher production of H2O2 than Control cultures. siRNA-mediated ablation of NRF2 in Control donor cells decreased both total glutathione content and MTS metabolism to levels detected in cells from Parkinson's Disease patients. Conversely, and more importantly, we showed that activation of the NRF2 pathway in Parkinson's disease hONS cultures restored glutathione levels and MTS metabolism to Control levels. Paradoxically, transcriptomic analysis after NRF2 pathway activation revealed an increased number of differentially expressed mRNAs within the NRF2 pathway in L-SUL treated Patient-derived hONS cells compared to L-SUL treated Controls, even though their metabolism was restored to normal. We also identified differential expression of the PI3K/AKT signalling pathway, but only post-treatment. Conclusions: Our results confirmed NRF2 as a potential therapeutic target for Parkinson's disease and provided the first demonstration that NRF2 function was inducible in Patient-derived cells from donors with uniquely varied genetic backgrounds. However, our results also demonstrated that the response of PD patient-derived cells was not co-ordinated in the same way as in Control cells. This may be an important factor when developing new therapeutics.	[Cook, Anthony L.; Vitale, Alejandra M.; Ravishankar, Sugandha; Matigian, Nicholas; Sutherland, Greg T.; Shan, Jiangou; Sutharsan, Ratneswary; Perry, Chris; Silburn, Peter A.; Mellick, George D.; Wells, Christine A.; Mackay-Sim, Alan; Wood, Stephen A.] Griffith Univ, Eskitis Inst Cell & Mol Therapies, Natl Ctr Adult Stem Cell Res, Brisbane, Qld 4111, Australia; [Perry, Chris] Princess Alexandra Hosp, Dept Otolaryngol Head & Neck Surg, Brisbane, Qld 4102, Australia; [Silburn, Peter A.] Univ Queensland, Sch Med, Brisbane, Qld, Australia; [Whitelaw, Murray L.] Univ Adelaide, Sch Mol & Biomed Sci Biochem, Adelaide, SA, Australia	Griffith University; University of Queensland; University of Adelaide	Cook, AL (corresponding author), Univ Tasmania, Sch Human Life Sci, Hobart, Tas 7001, Australia.	s.wood@griffith.edu.au	Sutherland, Greg/Q-5582-2019; Sutherland, Greg T/C-8674-2015; Sutharsan, Ratneswary R/G-8761-2013; Cook, Anthony/K-9489-2018; Vitale, Alejandra M/F-2326-2011; Matigian, Nicholas/AAF-9390-2020; Mackay-Sim, Alan/C-3431-2008; Mellick, George D./A-7650-2010; Wells, Christine A/A-5071-2010; Sutharsan, Ratneswary/AAB-7410-2020; Matigian, Nicholas A/A-4935-2009; Wood, Stephen A/E-8357-2011	Sutherland, Greg/0000-0003-2493-9736; Sutherland, Greg T/0000-0003-2493-9736; Sutharsan, Ratneswary R/0000-0003-1287-4007; Cook, Anthony/0000-0003-1770-7910; Matigian, Nicholas/0000-0001-7735-9415; Mackay-Sim, Alan/0000-0003-4446-5371; Mellick, George D./0000-0002-7211-4651; Wells, Christine A/0000-0003-3133-3628; Sutharsan, Ratneswary/0000-0003-1287-4007; Matigian, Nicholas A/0000-0001-7735-9415; Wood, Stephen A/0000-0002-2576-7457	Australian Department of Health and Ageing	Australian Department of Health and Ageing(Australian GovernmentDepartment of Health & Ageing)	This work was supported by an Australian Department of Health and Ageing grant to AM-S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleyasin H, 2010, P NATL ACAD SCI USA, V107, P3186, DOI 10.1073/pnas.0914876107; Berridge MV, 2005, BIOTECHNOL ANN REV, V11, P127, DOI 10.1016/S1387-2656(05)11004-7; Blank V, 2008, J MOL BIOL, V376, P913, DOI 10.1016/j.jmb.2007.11.074; Chen PC, 2009, P NATL ACAD SCI USA, V106, P2933, DOI 10.1073/pnas.0813361106; Chinta SJ, 2007, J NEUROSCI, V27, P13997, DOI 10.1523/JNEUROSCI.3885-07.2007; Chu YP, 2010, ANN NY ACAD SCI, V1184, P55, DOI 10.1111/j.1749-6632.2009.05229.x; CLARK J, 2008, ANTIOXID REDOX SIGNA; Cook AL, 2009, J INVEST DERMATOL, V129, P392, DOI 10.1038/jid.2008.211; CORY AH, 1991, CANCER COMMUN, V3, P207, DOI 10.3727/095535491820873191; Cuadrado A, 2009, EXPERT OPIN THER TAR, V13, P319, DOI [10.1517/13543780802716501, 10.1517/13543780802716501 ]; Dawson TM, 2003, SCIENCE, V302, P819, DOI 10.1126/science.1087753; Dhakshinamoorthy S, 2000, J BIOL CHEM, V275, P40134, DOI 10.1074/jbc.M003531200; Dick FD, 2007, OCCUP ENVIRON MED, V64, P673, DOI 10.1136/oem.2006.032078; Duan WS, 2009, IN VITRO CELL DEV-AN, V45, P388, DOI 10.1007/s11626-009-9194-5; Duke DC, 2006, NEUROGENETICS, V7, P139, DOI 10.1007/s10048-006-0033-5; DUNIGAN DD, 1995, BIOTECHNIQUES, V19, P640; Elbaz A, 2008, CURR OPIN NEUROL, V21, P454, DOI 10.1097/WCO.0b013e3283050461; Esteves AR, 2010, J NEUROCHEM, V113, P674, DOI 10.1111/j.1471-4159.2010.06631.x; Feron F, 1998, ARCH OTOLARYNGOL, V124, P861, DOI 10.1001/archotol.124.8.861; HAAS RH, 1995, ANN NEUROL, V37, P714, DOI 10.1002/ana.410370604; Haehner A, 2009, PARKINSONISM RELAT D, V15, P490, DOI 10.1016/j.parkreldis.2008.12.005; Harvey CJ, 2009, FREE RADICAL BIO MED, V46, P443, DOI 10.1016/j.freeradbiomed.2008.10.040; Hauser RA, 2009, MOVEMENT DISORD, V24, P979, DOI 10.1002/mds.22401; He CH, 2001, J BIOL CHEM, V276, P20858, DOI 10.1074/jbc.M101198200; Hindle JV, 2010, AGE AGEING, V39, P156, DOI 10.1093/ageing/afp223; Hwang YP, 2008, FEBS LETT, V582, P2655, DOI 10.1016/j.febslet.2008.06.045; Itoh K, 1999, GENE DEV, V13, P76, DOI 10.1101/gad.13.1.76; Jancova P, 2010, BIOMED PAP, V154, P103, DOI 10.5507/bp.2010.017; Katsuoka F, 2005, MOL CELL BIOL, V25, P8044, DOI 10.1128/MCB.25.18.8044-8051.2005; Katsuoka F, 2005, J BIOL CHEM, V280, P4483, DOI 10.1074/jbc.M411451200; Katsuoka F, 2003, MOL CELL BIOL, V23, P1163, DOI 10.1128/MCB.23.4.1163-1174.2003; Kim YJ, 2007, CANCER RES, V67, P546, DOI 10.1158/0008-5472.CAN-06-2401; Knight TR, 2008, TOXICOL SCI, V106, P329, DOI 10.1093/toxsci/kfn179; Kobayashi M, 2009, MOL CELL BIOL, V29, P493, DOI 10.1128/MCB.01080-08; Kordower JH, 2008, NAT MED, V14, P504, DOI 10.1038/nm1747; Kwak MK, 2003, J BIOL CHEM, V278, P8135, DOI 10.1074/jbc.M211898200; Le Couteur David G, 2002, Rev Environ Health, V17, P51; Lee JM, 2003, J BIOL CHEM, V278, P37948, DOI 10.1074/jbc.M305204200; Lee OH, 2007, J BIOL CHEM, V282, P36412, DOI 10.1074/jbc.M706517200; Leiser SF, 2010, MOL CELL BIOL, V30, P871, DOI 10.1128/MCB.01145-09; Leonard MO, 2006, FASEB J, V20, P2624, DOI 10.1096/fj.06-5097fje; Leung CT, 2007, NAT NEUROSCI, V10, P720, DOI 10.1038/nn1882; Lewis KN, 2010, INTEGR COMP BIOL, V50, P829, DOI 10.1093/icb/icq034; Loignon M, 2009, MOL CANCER THER, V8, P2432, DOI 10.1158/1535-7163.MCT-08-1186; Martin HL, 2009, FASEB J, V23, P3263, DOI 10.1096/fj.08-125443; Matigian N, 2010, DIS MODEL MECH, V3, P785, DOI 10.1242/dmm.005447; Mellick GD, 2006, J NEURAL TRANSM-SUPP, P159; Mellick GD, 2009, PARKINSONISM RELAT D, V15, P105, DOI 10.1016/j.parkreldis.2007.11.016; Menegon A, 1998, LANCET, V352, P1344, DOI 10.1016/S0140-6736(98)03453-9; Nakaso K, 2003, FEBS LETT, V546, P181, DOI 10.1016/S0014-5793(03)00517-9; Nguyen T, 2009, J BIOL CHEM, V284, P13291, DOI 10.1074/jbc.R900010200; PARKER WD, 1989, ANN NEUROL, V26, P719, DOI 10.1002/ana.410260606; Ramos-Gomez M, 2001, P NATL ACAD SCI USA, V98, P3410, DOI 10.1073/pnas.051618798; Ramsey CP, 2007, J NEUROPATH EXP NEUR, V66, P75, DOI 10.1097/nen.0b013e31802d6da9; RIEDERER P, 1989, J NEUROCHEM, V52, P515, DOI 10.1111/j.1471-4159.1989.tb09150.x; Sakamoto K, 2009, MOL BIOL CELL, V20, P1606, DOI 10.1091/mbc.E08-07-0762; Sakurai A, 2005, J CELL PHYSIOL, V203, P529, DOI 10.1002/jcp.20246; Schapira AHV, 2010, EXP NEUROL, V224, P331, DOI 10.1016/j.expneurol.2010.03.028; Sechi G, 1996, PROG NEURO-PSYCHOPH, V20, P1159, DOI 10.1016/S0278-5846(96)00103-0; Segu VBG, 1998, METABOLISM, V47, P824, DOI 10.1016/S0026-0495(98)90120-2; Shavit JA, 1998, GENE DEV, V12, P2164, DOI 10.1101/gad.12.14.2164; SIAN J, 1994, ANN NEUROL, V36, P348, DOI 10.1002/ana.410360305; SOFIC E, 1992, NEUROSCI LETT, V142, P128, DOI 10.1016/0304-3940(92)90355-B; Suh JH, 2004, P NATL ACAD SCI USA, V101, P3381, DOI 10.1073/pnas.0400282101; Terzioglu M, 2008, FEBS J, V275, P1384, DOI 10.1111/j.1742-4658.2008.06302.x; Thimmulappa RK, 2002, CANCER RES, V62, P5196; Thomas B, 2007, HUM MOL GENET, V16, pR183, DOI 10.1093/hmg/ddm159; Venugopal R, 1998, ONCOGENE, V17, P3145, DOI 10.1038/sj.onc.1202237; Venugopal R, 1996, P NATL ACAD SCI USA, V93, P14960, DOI 10.1073/pnas.93.25.14960; von Otter M, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-36; Wang XT, 2007, HUM MOL GENET, V16, P1188, DOI 10.1093/hmg/ddm066; Warabi E, 2007, FREE RADICAL BIO MED, V42, P260, DOI 10.1016/j.freeradbiomed.2006.10.043; Yang HP, 2010, HEPATOLOGY, V51, P1291, DOI 10.1002/hep.23471; Yang YF, 2005, P NATL ACAD SCI USA, V102, P13670, DOI 10.1073/pnas.0504610102; Yates MS, 2006, CANCER RES, V66, P2488, DOI 10.1158/0008-5472.CAN-05-3823; YOSHINO H, 1992, J NEURAL TRANSM-PARK, V4, P27, DOI 10.1007/BF02257619	76	68	74	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2011	6	7							e21907	10.1371/journal.pone.0021907	http://dx.doi.org/10.1371/journal.pone.0021907			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786HC	21747966	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000292293400042
J	Moll, G; Jitschin, R; von Bahr, L; Rasmusson-Duprez, I; Sundberg, B; Lonnies, L; Elgue, G; Nilsson-Ekdahl, K; Mougiakakos, D; Lambris, JD; Ringden, O; Le Blanc, K; Nilsson, B				Moll, Guido; Jitschin, Regina; von Bahr, Lena; Rasmusson-Duprez, Ida; Sundberg, Berit; Lonnies, Lena; Elgue, Graciela; Nilsson-Ekdahl, Kristina; Mougiakakos, Dimitrios; Lambris, John D.; Ringden, Olle; Le Blanc, Katarina; Nilsson, Bo			Mesenchymal Stromal Cells Engage Complement and Complement Receptor Bearing Innate Effector Cells to Modulate Immune Responses	PLOS ONE			English	Article							STEM-CELLS; ISLET TRANSPLANTATION; STEM/PROGENITOR CELLS; APOPTOTIC CELLS; TISSUE-REPAIR; BLOOD; C5A; ACTIVATION; MSCS	Infusion of human third-party mesenchymal stromal cells (MSCs) appears to be a promising therapy for acute graft-versus-host disease (aGvHD). To date, little is known about how MSCs interact with the body's innate immune system after clinical infusion. This study shows, that exposure of MSCs to blood type ABO-matched human blood activates the complement system, which triggers complement-mediated lymphoid and myeloid effector cell activation in blood. We found deposition of complement component C3-derived fragments iC3b and C3dg on MSCs and fluid-phase generation of the chemotactic anaphylatoxins C3a and C5a. MSCs bound low amounts of immunoglobulins and lacked expression of complement regulatory proteins MCP (CD46) and DAF (CD55), but were protected from complement lysis via expression of protectin (CD59). Cell-surface-opsonization and anaphylatoxin-formation triggered complement receptor 3 (CD11b/CD18)-mediated effector cell activation in blood. The complement-activating properties of individual MSCs were furthermore correlated with their potency to inhibit PBMC-proliferation in vitro, and both effector cell activation and the immunosuppressive effect could be blocked either by using complement inhibitor Compstatin or by depletion of CD14/CD11b-high myeloid effector cells from mixed lymphocyte reactions. Our study demonstrates for the first time a major role of the complement system in governing the immunomodulatory activity of MSCs and elucidates how complement activation mediates the interaction with other immune cells.	[Moll, Guido; Jitschin, Regina; von Bahr, Lena; Sundberg, Berit; Lonnies, Lena; Mougiakakos, Dimitrios; Ringden, Olle; Le Blanc, Katarina] Karolinska Inst, Dept Lab Med Clin Immunol & Transfus Med, Stockholm, Sweden; [Moll, Guido; Jitschin, Regina; von Bahr, Lena; Sundberg, Berit; Lonnies, Lena; Mougiakakos, Dimitrios; Ringden, Olle; Le Blanc, Katarina] Karolinska Univ, Huddinge Hosp, Hematol Ctr, Stockholm, Sweden; [Rasmusson-Duprez, Ida; Elgue, Graciela; Nilsson-Ekdahl, Kristina; Nilsson, Bo] Uppsala Univ, Rudbeck Lab, Dept Immunol Genet & Pathol, Uppsala, Sweden; [Lambris, John D.] Univ Penn, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Mougiakakos, Dimitrios] Karolinska Inst, CCK, Dept Pathol & Oncol, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Uppsala University; University of Pennsylvania; Karolinska Institutet	Moll, G (corresponding author), Karolinska Inst, Dept Lab Med Clin Immunol & Transfus Med, Stockholm, Sweden.	guido.moll@ki.se	Lambris, John/Q-5633-2018; Ekdahl, Kristina Nilsson/B-5301-2012; Le Blanc, Katarina/L-4631-2019; Moll, Guido/L-6321-2019; Moll, Guido/Q-1044-2018; Nilsson, Bo/B-3102-2012	Lambris, John/0000-0002-9370-5776; Moll, Guido/0000-0001-6173-5957; Nilsson, Bo/0000-0003-0057-2730	Swedish Cancer Society [08 0502, 07 0529]; Children's Cancer Foundation [08/071, 05/077]; Swedish Research Council [K2005-32P-15457-01A, K2008-64X-05971-28-3, K2007-65X-05647-28-3 950, 2009-4462, 2009-4675]; Tobias Foundation; Cancer Society in Stockholm; Swedish Society of Medicine; Stockholm County Council; Sven and Ebba-Christina Hagbergs Foundation; Karolinska Institutet; Swedish Research Council/Vinnova/Swedish Foundation Strategic Research [6076170]; National Institutes of Health (NIH) [GM-62134, AI-068730]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI068730] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062134] Funding Source: NIH RePORTER	Swedish Cancer Society(Swedish Cancer Society); Children's Cancer Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); Tobias Foundation; Cancer Society in Stockholm; Swedish Society of Medicine; Stockholm County Council(Stockholm County Council); Sven and Ebba-Christina Hagbergs Foundation; Karolinska Institutet(Karolinska Institutet); Swedish Research Council/Vinnova/Swedish Foundation Strategic Research(VinnovaSwedish Research Council); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by grants from the Swedish Cancer Society (08 0502, 07 0529), the Children's Cancer Foundation (08/071, 05/077), the Swedish Research Council (K2005-32P-15457-01A, K2008-64X-05971-28-3), the Tobias Foundation, the Cancer Society in Stockholm, the Swedish Society of Medicine, the Stockholm County Council, the Sven and Ebba-Christina Hagbergs Foundation, and Karolinska Institutet (to K.L.B.); the Swedish Research Council (K2007-65X-05647-28-3 950, 2009-4462, 2009-4675) and Swedish Research Council/Vinnova/Swedish Foundation Strategic Research (6076170) (to B.N.) and partially supported by National Institutes of Health (NIH) grants (GM-62134 and AI-068730 (to J.D.L.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANKRUM J, TRENDS MOL MED, V16, P203; Bennet W, 1999, DIABETES, V48, P1907, DOI 10.2337/diabetes.48.10.1907; Caplan A, 2009, J PATHOL, V217, P318, DOI 10.1002/path.2469; EKDAHL KN, 1992, SCAND J IMMUNOL, V35, P85, DOI 10.1111/j.1365-3083.1992.tb02837.x; Finch AM, 1999, J MED CHEM, V42, P1965, DOI 10.1021/jm9806594; Fox JM, 2007, BRIT J HAEMATOL, V137, P491, DOI 10.1111/j.1365-2141.2007.06610.x; Groh ME, 2005, EXP HEMATOL, V33, P928, DOI 10.1016/j.exphem.2005.05.002; IGNATIUS A, J CELL BIOCH; Janssen BJC, 2005, NATURE, V437, P505, DOI 10.1038/nature04005; Katragadda M, 2006, J MED CHEM, V49, P4616, DOI 10.1021/jm0603419; Le Blanc K, 2007, LEUKEMIA, V21, P1733, DOI 10.1038/sj.leu.2404777; Le Blanc K, 2005, CYTOTHERAPY, V7, P36, DOI 10.1080/14653240510018118; Le Blanc K, 2003, SCAND J IMMUNOL, V57, P11, DOI 10.1046/j.1365-3083.2003.01176.x; LeBlanc K, 2008, LANCET, V371, P1579, DOI 10.1016/S0140-6736(08)60690-X; Markiewski MM, 2008, NAT IMMUNOL, V9, P1225, DOI 10.1038/ni.1655; Markiewski MM, 2007, TRENDS IMMUNOL, V28, P184, DOI 10.1016/j.it.2007.02.006; Mason JC, 1999, BLOOD, V94, P1673, DOI 10.1182/blood.V94.5.1673.417a05_1673_1682; Mollnes TE, 2002, BLOOD, V100, P1869; Nauta AJ, 2003, TRENDS IMMUNOL, V24, P148, DOI 10.1016/S1471-4906(03)00030-9; Nemeth K, 2009, NAT MED, V15, P42, DOI 10.1038/nm.1905; NILSSON B, 1990, BIOCHEM J, V268, P55, DOI 10.1042/bj2680055; Ohtaki H, 2008, P NATL ACAD SCI USA, V105, P14638, DOI 10.1073/pnas.0803670105; Ostrand-Rosenberg S, 2008, NAT BIOTECHNOL, V26, P1348, DOI 10.1038/nbt1208-1348; Pittenger M, 2009, CELL STEM CELL, V5, P8, DOI 10.1016/j.stem.2009.06.013; Prockop DJ, 2007, BLOOD, V109, P3147, DOI 10.1182/blood-2006-03-013433; Rabinovich GA, 2007, ANNU REV IMMUNOL, V25, P267, DOI 10.1146/annurev.immunol.25.022106.141609; Ren GW, 2008, CELL STEM CELL, V2, P141, DOI 10.1016/j.stem.2007.11.014; Ricklin D, 2007, NAT BIOTECHNOL, V25, P1265, DOI 10.1038/nbt1342; Ringden O, 2007, LEUKEMIA, V21, P2271, DOI 10.1038/sj.leu.2404833; Schraufstatter IU, 2009, J IMMUNOL, V182, P3827, DOI 10.4049/jimmunol.0803055; Tjernberg J, 2008, TRANSPLANTATION, V85, P1193, DOI 10.1097/TP.0b013e31816b22f3; UCCELLI A, 2008, NAT REV IMMUNOL; VERMES I, 1995, J IMMUNOL METHODS, V184, P39, DOI 10.1016/0022-1759(95)00072-I	33	97	101	3	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2011	6	7							e21703	10.1371/journal.pone.0021703	http://dx.doi.org/10.1371/journal.pone.0021703			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786HC	21747949	gold, Green Published, Green Submitted			2022-12-27	WOS:000292293400025
J	Cooper, DM; Petchkovsky, DV; Hackett, TL; Knight, DA; Granville, DJ				Cooper, Dawn M.; Petchkovsky, Dmitri V.; Hackett, Tillie L.; Knight, Darryl A.; Granville, David J.			Granzyme K Activates Protease-Activated Receptor-1	PLOS ONE			English	Article							MONOCYTE CHEMOATTRACTANT PROTEIN-1; FIBROBLAST PROLIFERATION; EXTRACELLULAR ACTIVITIES; SIGNALING PATHWAYS; TARGET-CELLS; THROMBIN; INFLAMMATION; RESPONSES; DISEASE; INTERLEUKIN-8	Granzyme K (GrK) is a trypsin-like serine protease that is elevated in patients with sepsis and acute lung inflammation. While GrK was originally believed to function exclusively as a pro-apoptotic protease, recent studies now suggest that GrK may possess other non-cytotoxic functions. In the context of acute lung inflammation, we hypothesized that GrK induces pro-inflammatory cytokine release through the activation of protease-activated receptors. The direct effect of extracellular GrK on PAR activation, intracellular signaling and cytokine was assessed using cultured human lung fibroblasts. Extracellular GrK induced secretion of IL-6, IL-8 and MCP-1 in a dose-and time-dependent manner in lung fibroblasts. Heat-inactivated GrK did not induce cytokine release indicating that protease activity is required. Furthermore, GrK induced activation of both the ERK1/2 and p38 MAP kinase signaling pathways, and significantly increased fibroblast proliferation. Inhibition of ERK1/2 abrogated the GrK-mediated cytokine release. Through the use of PAR-1 and PAR-2 neutralizing antibodies, it was determined that PAR-1 is essential for GrK-induced IL-6, IL-8 and MCP-1 release. In summary, extracellular GrK is capable of activating PAR-1 and inducing fibroblast cytokine secretion and proliferation.	[Cooper, Dawn M.; Petchkovsky, Dmitri V.; Hackett, Tillie L.; Knight, Darryl A.; Granville, David J.] St Pauls Hosp, Inst Heart & Lung Hlth, Vancouver, BC V6Z 1Y6, Canada; [Cooper, Dawn M.; Granville, David J.] Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC V5Z 1M9, Canada; [Petchkovsky, Dmitri V.; Hackett, Tillie L.; Knight, Darryl A.] Univ British Columbia, Dept Anesthesiol Pharmacol & Therapeut, Vancouver, BC V5Z 1M9, Canada	St. Paul's Hospital; University of Saskatchewan; University of British Columbia; University of British Columbia	Cooper, DM (corresponding author), St Pauls Hosp, Inst Heart & Lung Hlth, Vancouver, BC V6Z 1Y6, Canada.	david.granville@hli.ubc.ca		Pechkovsky, Dmitri/0000-0001-8908-3444	British Columbia Lung Association [DJG:20R64011]; Natural Sciences Engineering Research Council (NSERC); Canadian Institutes for Health Research (CIHR) IMPACT; Heart & Stroke Foundation of Canada; CIHR/Candian Lung Association/GSK; IMPACT; Michael Smith Foundation for Health Research (MSFHR)	British Columbia Lung Association; Natural Sciences Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institutes for Health Research (CIHR) IMPACT(Canadian Institutes of Health Research (CIHR)); Heart & Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); CIHR/Candian Lung Association/GSK(Canadian Institutes of Health Research (CIHR)GlaxoSmithKline); IMPACT(European Commission); Michael Smith Foundation for Health Research (MSFHR)(Michael Smith Foundation for Health Research)	This research was funded by a grants from the British Columbia Lung Association (DJG:20R64011). DMC is the recipient of Natural Sciences Engineering Research Council (NSERC), Canadian Institutes for Health Research (CIHR) IMPACT, and Heart & Stroke Foundation of Canada postdoctoral fellowships. TLH is supported by CIHR/Candian Lung Association/GSK, IMPACT, and Michael Smith Foundation for Health Research (MSFHR) postdoctoral fellowships. DAK is a Canada Research Chair in Airway Disease and a MSFHR Career Investigator. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akers IA, 2000, AM J PHYSIOL-LUNG C, V278, pL193, DOI 10.1152/ajplung.2000.278.1.L193; Akira S, 1996, Curr Opin Hematol, V3, P87; AKIRA S, 1992, IMMUNOL REV, V127, P25, DOI 10.1111/j.1600-065X.1992.tb01407.x; Anthony DA, 2010, IMMUNOL REV, V235, P73, DOI 10.1111/j.0105-2896.2010.00907.x; Bade B, 2005, EUR J IMMUNOL, V35, P2940, DOI 10.1002/eji.200526249; Boivin WA, 2009, LAB INVEST, V89, P1195, DOI 10.1038/labinvest.2009.91; Borensztajn K, 2008, AM J PATHOL, V172, P309, DOI 10.2353/ajpath.2008.070347; Bovenschen N, 2009, J BIOL CHEM, V284, P3504, DOI 10.1074/jbc.M806716200; Bratke K, 2008, THORAX, V63, P1006, DOI 10.1136/thx.2007.091215; Brousseau C, 2009, CAN J PHYSIOL PHARM, V87, P694, DOI [10.1139/y09-063, 10.1139/Y09-063]; Chambers RC, 1998, BIOCHEM J, V333, P121, DOI 10.1042/bj3330121; Darrah E, 2010, CELL DEATH DIFFER, V17, P624, DOI 10.1038/cdd.2009.197; Deng XL, 2008, MOL BIOL CELL, V19, P2520, DOI 10.1091/mbc.E07-07-0720; Froelich CJ, 2009, TRENDS IMMUNOL, V30, P117, DOI 10.1016/j.it.2009.01.002; Ge SJ, 2004, J BIOL CHEM, V279, P6688, DOI 10.1074/jbc.M311769200; Georganas C, 2000, J IMMUNOL, V165, P7199, DOI 10.4049/jimmunol.165.12.7199; GharaeeKermani M, 1996, J BIOL CHEM, V271, P17779, DOI 10.1074/jbc.271.30.17779; Granville DJ, 2010, CELL DEATH DIFFER, V17, P565, DOI 10.1038/cdd.2009.218; Guo YM, 2008, MOL IMMUNOL, V45, P2225, DOI 10.1016/j.molimm.2007.11.020; Hendel A, 2010, CELL DEATH DIFFER, V17, P596, DOI 10.1038/cdd.2010.5; HIEBERT PR, 2010, EXP GERONTOL; IRMLER M, 1995, J EXP MED, V181, P1917, DOI 10.1084/jem.181.5.1917; JOECKEL LT, 2011, CELL DEATH DIFFER; Lim YP, 2003, J INFECT DIS, V188, P919, DOI 10.1086/377642; Ludwicka-Bradley A, 2000, AM J RESP CELL MOL, V22, P235, DOI 10.1165/ajrcmb.22.2.3642; Metkar SS, 2008, IMMUNITY, V29, P720, DOI 10.1016/j.immuni.2008.08.014; Moore BB, 2005, AM J PATHOL, V166, P675, DOI 10.1016/S0002-9440(10)62289-4; Moore BB, 2003, AM J PHYSIOL-LUNG C, V284, pL342, DOI 10.1152/ajplung.00168.2002; Nakanishi-Matsui M, 2000, NATURE, V404, P609, DOI 10.1038/35007085; O'Brien PJ, 2000, J BIOL CHEM, V275, P13502, DOI 10.1074/jbc.275.18.13502; Ossovskaya VS, 2004, PHYSIOL REV, V84, P579, DOI 10.1152/physrev.00028.2003; Ostrowska E, 2008, BIOCHEM BIOPH RES CO, V366, P1030, DOI 10.1016/j.bbrc.2007.12.064; Pao LI, 2005, J IMMUNOL, V175, P3235, DOI 10.4049/jimmunol.175.5.3235; Pardo J, 2009, BLOOD, V114, P3968, DOI 10.1182/blood-2009-07-231027; Reed CE, 2004, J ALLERGY CLIN IMMUN, V114, P997, DOI 10.1016/j.jaci.2004.07.060; Rucevic M, 2007, SHOCK, V27, P488, DOI 10.1097/01.shk.0000246905.24895.e5; SHI LF, 1992, J EXP MED, V175, P553, DOI 10.1084/jem.175.2.553; Shi XL, 2004, MOL CANCER RES, V2, P395; Shinoda H, 2009, RESPIRATION, V78, P285, DOI 10.1159/000207617; Shpacovitch V, 2008, J LEUKOCYTE BIOL, V83, P1309, DOI 10.1189/jlb.0108001; Singh K, 2010, PEDIATR RES, V68, P242, DOI 10.1203/00006450-201011001-00474; Sower LE, 1996, CELL IMMUNOL, V171, P159, DOI 10.1006/cimm.1996.0187; Sower LE, 1996, J IMMUNOL, V156, P2585; Steinhoff M, 2005, ENDOCR REV, V26, P1, DOI 10.1210/er.2003-0025; Suga M, 1999, EUR RESPIR J, V14, P376, DOI 10.1034/j.1399-3003.1999.14b23.x; Tak PP, 1999, CLIN EXP IMMUNOL, V116, P366; TAK PP, 1994, ARTHRITIS RHEUM, V37, P1735, DOI 10.1002/art.1780371205; Vernooy JHJ, 2007, AM J RESP CRIT CARE, V175, P464, DOI 10.1164/rccm.200602-169OC; Wang L, 2006, INT J BIOCHEM CELL B, V38, P1571, DOI 10.1016/j.biocel.2006.03.016; Zhao T, 2007, CELL DEATH DIFFER, V14, P489, DOI 10.1038/sj.cdd.4402040; Zhao TB, 2007, J BIOL CHEM, V282, P12104, DOI 10.1074/jbc.M611006200	51	48	49	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2011	6	6							e21484	10.1371/journal.pone.0021484	http://dx.doi.org/10.1371/journal.pone.0021484			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786GP	21760880	Green Published, gold, Green Submitted			2022-12-27	WOS:000292291800016
J	Dredge, BK; Jensen, KB				Dredge, B. Kate; Jensen, Kirk B.			NeuN/Rbfox3 Nuclear and Cytoplasmic Isoforms Differentially Regulate Alternative Splicing and Nonsense-Mediated Decay of Rbfox2	PLOS ONE			English	Article							RNA-BINDING PROTEINS; NEURONAL MARKER NEUN; MESSENGER-RNA; EXPORT SIGNALS; CELF FAMILY; EXPRESSION; TRACT; BRAIN; NOVA; CRM1	Anti-NeuN (Neuronal Nuclei) is a monoclonal antibody used extensively to specifically detect post-mitotic neurons. Anti-NeuN reactivity is predominantly nuclear; by western it detects multiple bands ranging in molecular weight from 45 kDa to > 75 kDa. Expression screening putatively identified R3hdm2 as NeuN; however immunoprecipitation and mass spectrometry of the two major NeuN species at 45-50 kDa identified both as the RNA binding protein Rbfox3 (a member of the Fox family of alternative splicing factors), confirming and extending the identification of the 45 kDa band as Rbfox3 by Kim et al. Mapping of the anti-NeuN reactive epitopes in both R3hdm2 and Rbfox3 reveals a common proline-and glutamine-rich domain that lies at the N-terminus of the Rbfox3 protein. Our data suggests that alternative splicing of the Rbfox3 pre-mRNA itself leads to the production of four protein isoforms that migrate in the 45-50 kDa range, and that one of these splicing choices regulates Rbfox3/NeuN sub-cellular steady-state distribution, through the addition or removal of a short C-terminal extension containing the second half of a bipartite hydrophobic proline-tyrosine nuclear localization signal. Rbfox3 regulates alternative splicing of the Rbfox2 pre-mRNA, producing a message encoding a dominant negative form of the Rbfox2 protein. We show here that nuclear Rbfox3 isoforms can also enhance the inclusion of cryptic exons in the Rbfox2 mRNA, resulting in nonsense-mediated decay of the message, thereby contributing to the negative regulation of Rbfox2 by Rbfox3 through a novel mechanism.	[Dredge, B. Kate; Jensen, Kirk B.] Univ Adelaide, Sch Mol & Biomed Sci, Adelaide, SA, Australia	University of Adelaide	Dredge, BK (corresponding author), Univ Adelaide, Sch Mol & Biomed Sci, Adelaide, SA, Australia.	kate.dredge@adelaide.edu.au	Jensen, Kirk/B-4756-2008; Jensen, Kirk/AAL-5883-2020	Jensen, Kirk/0000-0002-2084-1734; Jensen, Kirk/0000-0002-2084-1734; Dredge, Kate/0000-0002-6103-5165	ARC Special Research Centre for the Molecular Genetics of Development; ARC [DP0559550]; APD on ARC Discovery Project [DP0559550]	ARC Special Research Centre for the Molecular Genetics of Development(Australian Research Council); ARC(Australian Research Council); APD on ARC Discovery Project(Australian Research Council)	This project was funded by the ARC Special Research Centre for the Molecular Genetics of Development and ARC Discovery Project Grant DP0559550 arc.gov.au. BKD was funded in part as an APD on ARC Discovery Project Grant DP0559550. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boutz PL, 2007, GENE DEV, V21, P1636, DOI 10.1101/gad.1558107; BUCKANOVICH RJ, 1993, NEURON, V11, P657, DOI 10.1016/0896-6273(93)90077-5; Chi SW, 2009, NATURE, V460, P479, DOI 10.1038/nature08170; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Damianov A, 2010, RNA, V16, P405, DOI 10.1261/rna.1838210; Fornerod M, 1997, CELL, V90, P1051, DOI 10.1016/S0092-8674(00)80371-2; Fukuda M, 1997, NATURE, V390, P308, DOI 10.1038/36894; Grishin NV, 1998, TRENDS BIOCHEM SCI, V23, P329, DOI 10.1016/S0968-0004(98)01258-4; Hall MP, 2004, MOL BIOL CELL, V15, P774, DOI 10.1091/mbc.E03-09-0692; Henderson BR, 2000, EXP CELL RES, V256, P213, DOI 10.1006/excr.2000.4825; Jensen Kirk B., 2008, V488, P85, DOI 10.1007/978-1-60327-475-3_6; Jin Y, 2003, EMBO J, V22, P905, DOI 10.1093/emboj/cdg089; Kiehl TR, 2001, MAMM GENOME, V12, P595, DOI 10.1007/s00335-001-2056-4; Kim KK, 2009, J BIOL CHEM, V284, P31052, DOI 10.1074/jbc.M109.052969; Kuroyanagi H, 2009, CELL MOL LIFE SCI, V66, P3895, DOI 10.1007/s00018-009-0120-5; Ladd AN, 2004, J BIOL CHEM, V279, P17756, DOI 10.1074/jbc.M310687200; Ladd AN, 2001, MOL CELL BIOL, V21, P1285, DOI 10.1128/MCB.21.4.1285-1296.2001; Lee BJ, 2006, CELL, V126, P543, DOI 10.1016/j.cell.2006.05.049; Lee JA, 2009, GENE DEV, V23, P2284, DOI 10.1101/gad.1837009; Licatalosi DD, 2008, NATURE, V456, P464, DOI 10.1038/nature07488; Lind D, 2005, J NEUROSCI RES, V79, P295, DOI 10.1002/jnr.20354; McKee AE, 2005, BMC DEV BIOL, V5, DOI 10.1186/1471-213X-5-14; MULLEN RJ, 1992, DEVELOPMENT, V116, P201; Nagy E, 1998, TRENDS BIOCHEM SCI, V23, P198, DOI 10.1016/S0968-0004(98)01208-0; Nakahata S, 2005, NUCLEIC ACIDS RES, V33, P2078, DOI 10.1093/nar/gki338; Ni JZ, 2007, GENE DEV, V21, P708, DOI 10.1101/gad.1525507; Noensie EN, 2001, NAT BIOTECHNOL, V19, P434, DOI 10.1038/88099; Okano HJ, 1997, J NEUROSCI, V17, P3024; OssarehNazari B, 1997, SCIENCE, V278, P141, DOI 10.1126/science.278.5335.141; Polydorides AD, 2000, P NATL ACAD SCI USA, V97, P6350, DOI 10.1073/pnas.110128397; Rahman L, 2002, GENOMICS, V80, P245, DOI 10.1006/geno.2002.6826; Rossbach O, 2009, MOL CELL BIOL, V29, P1442, DOI 10.1128/MCB.01689-08; Shibata H, 2000, HUM MOL GENET, V9, P1303, DOI 10.1093/hmg/9.9.1303; Spellman R, 2007, MOL CELL, V27, P420, DOI 10.1016/j.molcel.2007.06.016; Sureau A, 2001, EMBO J, V20, P1785, DOI 10.1093/emboj/20.7.1785; Tang ZZ, 2009, MOL CELL BIOL, V29, P4757, DOI 10.1128/MCB.00608-09; Ule J, 2003, SCIENCE, V302, P1212, DOI 10.1126/science.1090095; Underwood JG, 2005, MOL CELL BIOL, V25, P10005, DOI 10.1128/MCB.25.22.10005-10016.2005; Van Nassauw L, 2005, HISTOCHEM CELL BIOL, V124, P369, DOI 10.1007/s00418-005-0019-7; Weyer A, 2003, J NEUROSCI RES, V73, P400, DOI 10.1002/jnr.10655; Wollerton MC, 2004, MOL CELL, V13, P91, DOI 10.1016/S1097-2765(03)00502-1; Yang YYL, 1998, P NATL ACAD SCI USA, V95, P13254, DOI 10.1073/pnas.95.22.13254; Yeo GW, 2009, NAT STRUCT MOL BIOL, V16, P130, DOI 10.1038/nsmb.1545; Zhang CJ, 2008, NAT PROD RES, V22, P1, DOI 10.1080/14786410701619076; Zhou HL, 2007, MOL CELL BIOL, V27, P830, DOI 10.1128/MCB.01015-06	45	66	73	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2011	6	6							e21585	10.1371/journal.pone.0021585	http://dx.doi.org/10.1371/journal.pone.0021585			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786FZ	21747913	gold, Green Published, Green Submitted			2022-12-27	WOS:000292290100042
J	Wang, YY; Lai, SK; So, C; Schneider, C; Cone, R; Hanes, J				Wang, Ying-Ying; Lai, Samuel K.; So, Conan; Schneider, Craig; Cone, Richard; Hanes, Justin			Mucoadhesive Nanoparticles May Disrupt the Protective Human Mucus Barrier by Altering Its Microstructure	PLOS ONE			English	Article							HUMAN CERVICAL-MUCUS; PARTICLE TRACKING MEASUREMENTS; DIFFUSION; NETWORKS; MUCIN; HYDROGELS; SPUTUM; MUC5B; LAYER; RAT	Mucus secretions typically protect exposed surfaces of the eyes and respiratory, gastrointestinal and female reproductive tracts from foreign entities, including pathogens and environmental ultrafine particles. We hypothesized that excess exposure to some foreign particles, however, may cause disruption of the mucus barrier. Many synthetic nanoparticles are likely to be mucoadhesive due to hydrophobic, electrostatic or hydrogen bonding interactions. We therefore sought to determine whether mucoadhesive particles (MAP) could alter the mucus microstructure, thereby allowing other foreign particles to more easily penetrate mucus. We engineered muco-inert probe particles 1 mm in diameter, whose diffusion in mucus is limited only by steric obstruction from the mucus mesh, and used them to measure possible MAP-induced changes to the microstructure of fresh human cervicovaginal mucus. We found that a 0.24% w/v concentration of 200 nm MAP in mucus induced a similar to 10-fold increase in the average effective diffusivity of the probe particles, and a 2- to 3-fold increase in the fraction capable of penetrating physiologically thick mucus layers. The same concentration of muco-inert particles, and a low concentration (0.0006% w/v) of MAP, had no detectable effect on probe particle penetration rates. Using an obstruction-scaling model, we determined that the higher MAP dose increased the average mesh spacing ("pore'' size) of mucus from 380 nm to 470 nm. The bulk viscoelasticity of mucus was unaffected by MAP exposure, suggesting MAP may not directly impair mucus clearance or its function as a lubricant, both of which depend critically on the bulk rheological properties of mucus. Our findings suggest mucoadhesive nanoparticles can substantially alter the microstructure of mucus, highlighting the potential of mucoadhesive environmental or engineered nanoparticles to disrupt mucus barriers and cause greater exposure to foreign particles, including pathogens and other potentially toxic nanomaterials.	[Wang, Ying-Ying; So, Conan; Hanes, Justin] Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Baltimore, MD 21205 USA; [Lai, Samuel K.; Schneider, Craig; Hanes, Justin] Johns Hopkins Univ, Dept Chem & Biomol Engn, Baltimore, MD USA; [Cone, Richard] Johns Hopkins Univ, Dept Biophys, Baltimore, MD USA; [Hanes, Justin] Johns Hopkins Univ, Sch Med, Wilmer Eye Inst, Dept Ophthalmol, Baltimore, MD 21205 USA; [Hanes, Justin] Johns Hopkins Sch Publ Hlth, Dept Environm Hlth Sci, Baltimore, MD USA; [Hanes, Justin] Johns Hopkins Univ, Inst NanoBioTechnol, Ctr Canc Nanotechnol Excellence, Baltimore, MD USA; [Hanes, Justin] Johns Hopkins Univ, Sch Med, Ctr Nanomed, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins University	Wang, YY (corresponding author), Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Baltimore, MD 21205 USA.	hanes@jhu.edu	wang, yingying/GRS-3058-2022	Lai, Samuel/0000-0003-4721-528X	National Institutes of Health [5U01AI066726, P01HL51811, R21HL089816, R01HD062844]; National Science Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD062844] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL089816, P01HL051811] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI066726] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by the National Institutes of Health (http://www.nih.gov/) grants 5U01AI066726 (R.C.), P01HL51811 (J.H.), R21HL089816 and R01HD062844 (J.H. and R.C.) and by a National Science Foundation (http://www.nsf.gov/) graduate research fellowship (Y.-Y.W.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Heart, Lung, and Blood Institute, the National Institute of Biomedical Imaging and Bioengineering, the National Cancer Institute or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali MS, 2007, LARYNGOSCOPE, V117, P932, DOI 10.1097/MLG.0b013e3180383651; Amsden B, 1999, MACROMOLECULES, V32, P874, DOI 10.1021/ma980922a; Amsden B, 1998, MACROMOLECULES, V31, P8382, DOI 10.1021/ma980765f; Apgar J, 2000, BIOPHYS J, V79, P1095, DOI 10.1016/S0006-3495(00)76363-6; Boskey ER, 2003, SEX TRANSM DIS, V30, P107, DOI 10.1097/00007435-200302000-00002; Ceric F, 2005, J ELECTRON MICROSC, V54, P479, DOI 10.1093/jmicro/dfh106; Donaldson K, 2001, OCCUP ENVIRON MED, V58, P211, DOI 10.1136/oem.58.3.211; EPA, 1997, EXP FACT HDB; Fahy JV, 2010, NEW ENGL J MED, V363, P2233, DOI 10.1056/NEJMra0910061; Gardel ML, 2004, SCIENCE, V304, P1301, DOI 10.1126/science.1095087; Gipson IK, 2001, J CLIN ENDOCR METAB, V86, P594, DOI 10.1210/jc.86.2.594; GREAVES JL, 1993, ADV DRUG DELIVER REV, V11, P349, DOI 10.1016/0169-409X(93)90016-W; Hummer G, 2001, NATURE, V414, P188, DOI 10.1038/35102535; ICRP, 1994, ANN ICRP, V24, P36; Jordan N, 1998, CLIN SCI, V95, P97, DOI 10.1042/CS19980081; Kim WD, 1997, EUR RESPIR J, V10, P1914, DOI 10.1183/09031936.97.10081914; King M, 2006, PAEDIATR RESPIR REV, V7, pS212, DOI 10.1016/j.prrv.2006.04.199; KING MV, 1991, CELL BIOPHYS, V18, P31, DOI 10.1007/BF02990514; Lai SK, 2007, P NATL ACAD SCI USA, V104, P1482, DOI 10.1073/pnas.0608611104; Lai SK, 2010, P NATL ACAD SCI USA, V107, P598, DOI 10.1073/pnas.0911748107; Lai SK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004294; Lai SK, 2009, ADV DRUG DELIVER REV, V61, P158, DOI 10.1016/j.addr.2008.11.002; Lai SK, 2009, ADV DRUG DELIVER REV, V61, P86, DOI 10.1016/j.addr.2008.09.012; Li BK, 2004, COLLOID SURFACE B, V36, P81, DOI 10.1016/j.colsurfb.2004.05.006; MACKINTOSH FC, 1995, PHYS REV LETT, V75, P4425, DOI 10.1103/PhysRevLett.75.4425; Matsuo K, 1997, GUT, V40, P782, DOI 10.1136/gut.40.6.782; MERCER RR, 1994, AM J RESP CELL MOL, V10, P613, DOI 10.1165/ajrcmb.10.6.8003339; MOLLENHAUER HH, 1993, MICROSC RES TECHNIQ, V26, P496, DOI 10.1002/jemt.1070260604; Nel A, 2005, SCIENCE, V308, P804, DOI 10.1126/science.1108752; Nel A, 2006, SCIENCE, V311, P622, DOI 10.1126/science.1114397; ODEBLAD E, 1968, ACTA OBSTET GYN SCAN, VS 47, P57, DOI 10.3109/00016346809156845; Olmsted SS, 2001, BIOPHYS J, V81, P1930, DOI 10.1016/S0006-3495(01)75844-4; *OSHA, OSHA OCC SAF HLTH GU; Palmer A, 1999, BIOPHYS J, V76, P1063, DOI 10.1016/S0006-3495(99)77271-1; Puchelle Edith, 2002, Paediatr Respir Rev, V3, P115, DOI 10.1016/S1526-0550(02)00005-7; Shen H, 2006, BIOPHYS J, V91, P639, DOI 10.1529/biophysj.105.077404; SINGH EJ, 1975, AM J OBSTET GYNECOL, V123, P128, DOI 10.1016/0002-9378(75)90515-3; Suk JS, 2009, BIOMATERIALS, V30, P2591, DOI 10.1016/j.biomaterials.2008.12.076; Valentine MT, 2004, BIOPHYS J, V86, P4004, DOI 10.1529/biophysj.103.037812; Vanhecke D, 2008, METHOD CELL BIOL, V88, P151, DOI 10.1016/S0091-679X(08)00409-3; Verkman AS, 2003, AM J PHYSIOL-CELL PH, V284, pC2, DOI 10.1152/ajpcell.00417.2002; Voynow JA, 2009, CHEST, V135, P505, DOI 10.1378/chest.08-0412; Wang YY, 2008, ANGEW CHEM INT EDIT, V47, P9726, DOI 10.1002/anie.200803526; Wickstrom C, 1998, BIOCHEM J, V334, P685, DOI 10.1042/bj3340685; Yang M, 2011, ANGEW CHEM INT EDIT, V50, P2597, DOI 10.1002/anie.201006849	45	62	64	0	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2011	6	6							e21547	10.1371/journal.pone.0021547	http://dx.doi.org/10.1371/journal.pone.0021547			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786FZ	21738703	Green Submitted, Green Published, gold			2022-12-27	WOS:000292290100035
J	Fimognari, C; Lenzi, M; Ferruzzi, L; Turrini, E; Scartezzini, P; Poli, F; Gotti, R; Guerrini, A; Carulli, G; Ottaviano, V; Cantelli-Forti, G; Hrelia, P				Fimognari, Carmela; Lenzi, Monia; Ferruzzi, Lorenzo; Turrini, Eleonora; Scartezzini, Paolo; Poli, Ferruccio; Gotti, Roberto; Guerrini, Alessandra; Carulli, Giovanni; Ottaviano, Virginia; Cantelli-Forti, Giorgio; Hrelia, Patrizia			Mitochondrial Pathway Mediates the Antileukemic Effects of Hemidesmus Indicus, a Promising Botanical Drug	PLOS ONE			English	Article							CELL-CYCLE; S-PHASE; PERMEABILITY TRANSITION; OVARIAN-CANCER; APOPTOSIS; CALCIUM; THERAPEUTICS; TARGETS; ARREST; DEATH	Background: Although cancers are characterized by the deregulation of multiple signalling pathways, most current anticancer therapies involve the modulation of a single target. Because of the enormous biological diversity of cancer, strategic combination of agents targeted against the most critical of those alterations is needed. Due to their complex nature, plant products interact with numerous targets and influence several biochemical and molecular cascades. The interest in further development of botanical drugs has been increasing steadily and the FDA recently approved the first new botanical prescription drug. The present study is designed to explore the potential antileukemic properties of Hemidesmus indicus with a view to contributing to further development of botanical drugs. Hemidesmus was submitted to an extensive in vitro preclinical evaluation. Methodology/Principal Findings: A variety of cellular assays and flow cytometry, as well as a phytochemical screening, were performed on different leukemic cell lines. We have demonstrated that Hemidesmus modulated many components of intracellular signaling pathways involved in cell viability and proliferation and altered the protein expression, eventually leading to tumor cell death, mediated by a loss of mitochondrial transmembrane potential and increased Bax/Bcl-2 ratio. ADP, adenine nucleotide translocator and mitochondrial permeability transition pore inhibitors did not reverse Hemidesmus-induced mitochondrial depolarization. Hemidesmus induced a significant [Ca(2+)](i) raise through the mobilization of intracellular Ca(2+) stores. Moreover, Hemidesmus significantly enhanced the antitumor activity of three commonly used chemotherapeutic drugs (methotrexate, 6-thioguanine, cytarabine). A clinically relevant observation is that its cytotoxic activity was also recorded in primary cells from acute myeloid leukemic patients. Conclusions/Significance: These results indicate the molecular basis of the antileukemic effects of Hemidesmus and identify the mitochondrial pathways and [Ca(2+)](i) as crucial actors in its anticancer activity. On these bases, we conclude that Hemidesmus can represent a valuable tool in the anticancer pharmacology, and should be considered for further investigations.	[Fimognari, Carmela; Lenzi, Monia; Ferruzzi, Lorenzo; Turrini, Eleonora; Cantelli-Forti, Giorgio; Hrelia, Patrizia] Univ Bologna, Dept Pharmacol, Bologna, Italy; [Scartezzini, Paolo; Poli, Ferruccio] Univ Bologna, Dept Evolutionary & Expt Biol, Bologna, Italy; [Gotti, Roberto] Univ Bologna, Dept Pharmaceut Sci, I-40126 Bologna, Italy; [Guerrini, Alessandra] Univ Ferrara, Dept Biol & Evolut, I-44100 Ferrara, Italy; [Carulli, Giovanni; Ottaviano, Virginia] Univ Pisa, Div Hematol, Dept Oncol Transplants & New Technol Med, Pisa, Italy	University of Bologna; University of Bologna; University of Bologna; University of Ferrara; University of Pisa	Fimognari, C (corresponding author), Univ Bologna, Dept Pharmacol, Bologna, Italy.	carmela.fimognari@unibo.it	Hrelia, Patrizia/AAC-2071-2020; Guerrini, Alessandra/N-1419-2015; Turrini, Eleonora/I-3629-2019; Fimognari, Carmela/J-7678-2019	Guerrini, Alessandra/0000-0002-6553-3938; Turrini, Eleonora/0000-0003-4743-1126; Fimognari, Carmela/0000-0002-2461-8214; gotti, roberto/0000-0003-0622-2248; HRELIA, Patrizia/0000-0002-8415-3711	Ministero dell'Istruzione dell'Universita e della Ricerca [2007SSZMPK]; FIRB Piattaforme/Reti [RBPR05NWWC_002]	Ministero dell'Istruzione dell'Universita e della Ricerca(Ministry of Education, Universities and Research (MIUR)); FIRB Piattaforme/Reti	This work was supported by Ministero dell'Istruzione dell'Universita e della Ricerca (http://sitouniversitario.cineca.it; grant number: 2007SSZMPK) and FIRB Piattaforme/Reti 2006 (http://sitofirb.cineca.it; grant number: RBPR05NWWC_002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JM, 1998, SCIENCE, V281, P1322, DOI 10.1126/science.281.5381.1322; Aggarwal BB, 2009, BIOCHEM PHARMACOL, V78, P1083, DOI 10.1016/j.bcp.2009.05.027; Anand P, 2008, CANCER LETT, V267, P133, DOI 10.1016/j.canlet.2008.03.025; Armstrong JS, 2006, MITOCHONDRION, V6, P225, DOI 10.1016/j.mito.2006.07.006; Austin A., 2008, BR J BIOL SCI, V8, P1, DOI DOI 10.3923/jbs.2008.1.12; Borel F, 2002, J CELL SCI, V115, P2829; Bosanquet AG, 2008, INNOVATIVE LEUKEMIA, P23; BOSANQUET AG, 1994, FORUM TRENDS EXP CLI, V4, P179; Bosanquet Andrew G, 2004, J Exp Ther Oncol, V4, P145; Chen ST, 2008, NAT BIOTECHNOL, V26, P1077, DOI 10.1038/nbt1008-1077; Choi JH, 2008, FOOD CHEM TOXICOL, V46, P3486, DOI 10.1016/j.fct.2008.08.026; Cree IA, 2009, CURR OPIN OBSTET GYN, V21, P39, DOI 10.1097/GCO.0b013e32832210ff; Crompton M, 1999, BIOCHEM J, V341, P233, DOI 10.1042/0264-6021:3410233; Cuello M, 2001, GYNECOL ONCOL, V81, P380, DOI 10.1006/gyno.2001.6194; Das S, 2006, PHYTOTHER RES, V20, P784, DOI 10.1002/ptr.1963; de Kok TM, 2008, EUR J NUTR, V47, P51, DOI 10.1007/s00394-008-2006-y; Deepak D, 1997, PHYTOCHEMISTRY, V44, P145, DOI 10.1016/S0031-9422(96)00393-7; Gartel AL, 2005, CANCER RES, V65, P3980, DOI 10.1158/0008-5472.CAN-04-3995; Geley S, 2001, J CELL BIOL, V153, P137, DOI 10.1083/jcb.153.1.137; *GOV IND MIN HLTH, 1989, AYURV PHARM IND; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Harper JL, 2003, BIOCHEM PHARMACOL, V65, P329, DOI 10.1016/S0006-2952(02)01488-0; Hsin YH, 2006, APOPTOSIS, V11, P2167, DOI 10.1007/s10495-006-0289-0; Ichikawa H, 2007, CURR PHARM DESIGN, V13, P3400, DOI 10.2174/138161207782360492; Jiang N, 2006, WORLD J GASTROENTERO, V12, P4694, DOI 10.3748/wjg.v12.i29.4694; Keith CT, 2005, NAT REV DRUG DISCOV, V4, P71, DOI 10.1038/nrd1609; Khan N, 2007, CARCINOGENESIS, V28, P233, DOI 10.1093/carcin/bgl243; Knudsen KE, 2000, MOL CELL BIOL, V20, P7751, DOI 10.1128/MCB.20.20.7751-7763.2000; KOFF A, 1992, SCIENCE, V257, P1689, DOI 10.1126/science.1388288; Koh DW, 2005, PHARMACOL RES, V52, P5, DOI 10.1016/j.phrs.2005.02.011; Kotnis MS, 2004, NEPHROLOGY, V9, P142, DOI 10.1111/j.1440-1797.2004.00247.x; Lampronti I, 2005, MED CHEM, V1, P327, DOI 10.2174/1573406054368684; Levi F, 2007, ADV DRUG DELIVER REV, V59, P1015, DOI 10.1016/j.addr.2006.11.001; Macho A, 1999, CELL DEATH DIFFER, V6, P155, DOI 10.1038/sj.cdd.4400465; Macho A, 2004, BIOCHEM PHARMACOL, V68, P875, DOI 10.1016/j.bcp.2004.05.016; Meshinchi S, 2009, CLIN CANCER RES, V15, P4263, DOI 10.1158/1078-0432.CCR-08-1123; Moncada S, 2010, BRIT J PHARMACOL, V160, P217, DOI 10.1111/j.1476-5381.2010.00706.x; Nagourney Robert A, 2006, Curr Treat Options Oncol, V7, P103, DOI 10.1007/s11864-006-0045-2; Nicotera P, 1998, CELL CALCIUM, V23, P173, DOI 10.1016/S0143-4160(98)90116-6; NYGREN P, 2008, EXP OPIN MED DIAGN, V2, P1, DOI DOI 10.1517/17530059.2.1.1; Ogryzko VV, 1997, MOL CELL BIOL, V17, P4877, DOI 10.1128/MCB.17.8.4877; Pedeux R, 1998, J INVEST DERMATOL, V111, P472, DOI 10.1046/j.1523-1747.1998.00324.x; Prabakan M, 2000, FITOTERAPIA, V71, P55, DOI 10.1016/S0367-326X(99)00120-3; Previati M, 2007, J CHEM NEUROANAT, V34, P128, DOI 10.1016/j.jchemneu.2007.05.009; Qanungo S, 2005, CARCINOGENESIS, V26, P958, DOI 10.1093/carcin/bgi040; Qureshi S, 1997, Hindustan Antibiot Bull, V39, P56; Radhakrishnan SK, 2004, ONCOGENE, V23, P4173, DOI 10.1038/sj.onc.1207571; Roy SK, 2001, PHARMAZIE, V56, P244; Salvioli S, 1997, FEBS LETT, V411, P77, DOI 10.1016/S0014-5793(97)00669-8; Shapiro GI, 1999, J CLIN INVEST, V104, P1645, DOI 10.1172/JCI9054; Sircar D, 2007, CHROMATOGRAPHIA, V65, P349, DOI 10.1365/s10337-006-0146-x; THASTRUP O, 1990, P NATL ACAD SCI USA, V87, P2466, DOI 10.1073/pnas.87.7.2466; Toogood PL, 2002, CURR OPIN CHEM BIOL, V6, P472, DOI 10.1016/S1367-5931(02)00342-3; Tsang WY, 2007, J CELL BIOL, V178, P621, DOI 10.1083/jcb.200701166; *US DEP HHS, 2004, GUID IND; Williams SN, 2000, CHEM-BIOL INTERACT, V128, P211, DOI 10.1016/S0009-2797(00)00204-0; Zhao L, 2004, CLIN CANCER RES, V10, P7994, DOI 10.1158/1078-0432.CCR-04-1087; Zhou JR, 2003, J NUTR, V133, P516, DOI 10.1093/jn/133.2.516; Zimmermann GR, 2007, DRUG DISCOV TODAY, V12, P34, DOI 10.1016/j.drudis.2006.11.008	59	27	27	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2011	6	6							e21544	10.1371/journal.pone.0021544	http://dx.doi.org/10.1371/journal.pone.0021544			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	784FW	21738701	gold, Green Published, Green Submitted			2022-12-27	WOS:000292142800038
J	Trotta, E				Trotta, Edoardo			The 3-Base Periodicity and Codon Usage of Coding Sequences Are Correlated with Gene Expression at the Level of Transcription Elongation	PLOS ONE			English	Article							GENOME-WIDE ANALYSIS; ESCHERICHIA-COLI; SACCHAROMYCES-CEREVISIAE; PROTEIN EXPRESSION; RESPECTIVE CODONS; READING FRAME; TRANSFER-RNAS; YEAST; TRANSLATION; DNA	Background: Gene transcription is regulated by DNA transcriptional regulatory elements, promoters and enhancers that are located outside the coding regions. Here, we examine the characteristic 3-base periodicity of the coding sequences and analyse its correlation with the genome-wide transcriptional profile of yeast. Principal Findings: The analysis of coding sequences by a new class of indices proposed here identified two different sources of 3-base periodicity: the codon frequency and the codon sequence. In exponentially growing yeast cells, the codon-frequency component of periodicity accounts for 71.9% of the variability of the cellular mRNA by a strong association with the density of elongating mRNA polymerase II complexes. The mRNA abundance explains most of the correlation between the codon-frequency component of periodicity and protein levels. Furthermore, pyrimidine-ending codons of the four-fold degenerate small amino acids alanine, glycine and valine are associated with genes with double the transcription rate of those associated with purine-ending codons. Conclusions: We demonstrate that the 3-base periodicity of coding sequences is higher than expected by the codon usage frequency (CUF) and that its components, associated with codon bias and amino acid composition, are correlated with gene expression, principally at the level of transcription elongation. This indicates a role of codon sequences in maximising the transcription efficiency in exponentially growing yeast cells. Moreover, the results contrast with the common Darwinian explanation that attributes the codon bias to translational selection by an adjustment of synonymous codon frequencies to the most abundant isoaccepting tRNA. Here, we show that selection on codon bias likely acts at both the transcriptional and translational level and that codon usage and the relative abundance of tRNA could drive each other in order to synergistically optimize the efficiency of gene expression.	CNR, Inst Translat Pharmacol, Rome, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Farmacologia Traslazionale (IFT-CNR)	Trotta, E (corresponding author), CNR, Inst Translat Pharmacol, Rome, Italy.	edoardo.trotta@ift.cnr.it	Trotta, Edoardo/AAW-4697-2020	Trotta, Edoardo/0000-0002-1417-9238				ANDERSSON SGE, 1990, MICROBIOL REV, V54, P198, DOI 10.1128/MMBR.54.2.198-210.1990; Arava Y, 2003, P NATL ACAD SCI USA, V100, P3889, DOI 10.1073/pnas.0635171100; Boycheva S, 2003, BIOINFORMATICS, V19, P987, DOI 10.1093/bioinformatics/btg082; BULMER M, 1987, NATURE, V325, P728, DOI 10.1038/325728a0; Cannarrozzi G, 2010, CELL, V141, P355, DOI 10.1016/j.cell.2010.02.036; Dekker J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r116; Dittmar KA, 2006, PLOS GENET, V2, P2107, DOI 10.1371/journal.pgen.0020221; Epshtein V, 2003, SCIENCE, V300, P801, DOI 10.1126/science.1083219; Eskesen ST, 2004, BMC MOL BIOL, V5, DOI 10.1186/1471-2199-5-12; Frenkel FE, 2009, DNA RES, V16, P105, DOI 10.1093/dnares/dsp002; Futcher B, 1999, MOL CELL BIOL, V19, P7357; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Grigull J, 2004, MOL CELL BIOL, V24, P5534, DOI 10.1128/MCB.24.12.5534-5547.2004; GUTIERREZ G, 1994, J THEOR BIOL, V167, P413, DOI 10.1006/jtbi.1994.1080; Hershberg R, 2008, ANNU REV GENET, V42, P287, DOI 10.1146/annurev.genet.42.110807.091442; Holstege FCP, 1998, CELL, V95, P717, DOI 10.1016/S0092-8674(00)81641-4; IKEMURA T, 1982, J MOL BIOL, V158, P573, DOI 10.1016/0022-2836(82)90250-9; IKEMURA T, 1981, J MOL BIOL, V151, P389, DOI 10.1016/0022-2836(81)90003-6; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; IRWIN B, 1995, J BIOL CHEM, V270, P22801, DOI 10.1074/jbc.270.39.22801; Juneau K, 2007, P NATL ACAD SCI USA, V104, P1522, DOI 10.1073/pnas.0610354104; Kertesz M, 2010, NATURE, V467, P103, DOI 10.1038/nature09322; Knuth D, 1997, SEMINUMERICAL ALGORI, V3; Kudla G, 2009, SCIENCE, V324, P255, DOI 10.1126/science.1170160; Kulaeva OI, 2010, P NATL ACAD SCI USA, V107, P11325, DOI 10.1073/pnas.1001148107; Lu P, 2007, NAT BIOTECHNOL, V25, P117, DOI 10.1038/nbt1270; Marin A, 2003, YEAST, V20, P703, DOI 10.1002/yea.992; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Pelechano V, 2010, YEAST, V27, P413, DOI 10.1002/yea.1768; Pelechano V, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000614; Perez-Ortin Jose E., 2007, Briefings in Functional Genomics & Proteomics, V6, P282, DOI 10.1093/bfgp/elm029; Plotkin JB, 2011, NAT REV GENET, V12, P32, DOI 10.1038/nrg2899; Ponty Y, 2006, BIOINFORMATICS, V22, P1534, DOI 10.1093/bioinformatics/btl113; Saeki H, 2009, MOL CELL, V35, P191, DOI 10.1016/j.molcel.2009.06.009; Saunders A, 2006, NAT REV MOL CELL BIO, V7, P557, DOI 10.1038/nrm1981; SHARP PM, 1986, J MOL EVOL, V24, P28, DOI 10.1007/BF02099948; SHARP PM, 1987, NUCLEIC ACIDS RES, V15, P1281, DOI 10.1093/nar/15.3.1281; SHEPHERD JCW, 1981, P NATL ACAD SCI-BIOL, V78, P1596, DOI 10.1073/pnas.78.3.1596; Simic R, 2003, EMBO J, V22, P1846, DOI 10.1093/emboj/cdg179; Stoletzki N, 2007, MOL BIOL EVOL, V24, P374, DOI 10.1093/molbev/msl166; Tiwari S, 1997, COMPUT APPL BIOSCI, V13, P263; TRIFONOV EN, 1980, P NATL ACAD SCI-BIOL, V77, P3816, DOI 10.1073/pnas.77.7.3816; TSONIS AA, 1991, J THEOR BIOL, V151, P323, DOI 10.1016/S0022-5193(05)80381-9; Velculescu VE, 1997, CELL, V88, P243, DOI 10.1016/S0092-8674(00)81845-0; Waldman YY, 2010, NUCLEIC ACIDS RES, V38, P2964, DOI 10.1093/nar/gkq009; Wang YL, 2002, P NATL ACAD SCI USA, V99, P5860, DOI 10.1073/pnas.092538799; Yin CC, 2005, J COMPUT BIOL, V12, P1153, DOI 10.1089/cmb.2005.12.1153; Yin CC, 2007, J THEOR BIOL, V247, P687, DOI 10.1016/j.jtbi.2007.03.038; Zenklusen D, 2008, NAT STRUCT MOL BIOL, V15, P1263, DOI 10.1038/nsmb.1514; Zhao Y, 2006, MOL CELL BIOL, V26, P4853, DOI 10.1128/MCB.02367-05	50	18	19	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2011	6	6							e21590	10.1371/journal.pone.0021590	http://dx.doi.org/10.1371/journal.pone.0021590			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	784FW	21738721	gold, Green Published, Green Submitted			2022-12-27	WOS:000292142800041
J	Thevenet, J; Gobert, RP; van Huijsduijnen, RH; Wiessner, C; Sagot, YJ				Thevenet, Jonathan; Gobert, Rosanna Pescini; van Huijsduijnen, Robertus Hooft; Wiessner, Christoph; Sagot, Yves Jean			Regulation of LRRK2 Expression Points to a Functional Role in Human Monocyte Maturation	PLOS ONE			English	Article							ANTIGEN-PRESENTING CELLS; PARKINSONS-DISEASE; DENDRITIC CELLS; BLOOD; MOUSE; MICE; INFECTION; PROTEIN; ALPHA; ACCUMULATION	Genetic variants of Leucine-Rich Repeat Kinase 2 (LRRK2) are associated with a significantly enhanced risk for Parkinson disease, the second most common human neurodegenerative disorder. Despite major efforts, our understanding of LRRK2 biological function and regulation remains rudimentary. In the present study we analyze LRRK2 mRNA and protein expression in sub-populations of human peripheral blood mononuclear cells (PBMCs). LRRK2 mRNA and protein was found in circulating CD19(+) B cells and in CD14(+) monocytes, whereas CD4(+) and CD8(+) T cells were devoid of LRRK2 mRNA. Within CD14(+) cells the CD14(+) CD16(+) sub-population of monocytes exhibited high levels of LRRK2 protein, in contrast to CD14(+) CD16(-) cells. However both populations expressed LRRK2 mRNA. As CD14(+) CD16(+) cells represent a more mature subset of monocytes, we monitored LRRK2 expression after in vitro treatment with various stress factors known to induce monocyte activation. We found that IFN-gamma in particular robustly increased LRRK2 mRNA and protein levels in monocytes concomitant with a shift of CD14(+) CD16(-) cells towards CD14(+) CD16(+) cells. Interestingly, the recently described LRRK2 inhibitor IN-1 attenuated this shift towards CD14(+) CD16(+) after IFN-gamma stimulation. Based on these findings we speculate that LRRK2 might have a role in monocyte maturation. Our results provide further evidence for the emerging role of LRRK2 in immune cells and regulation at the transcriptional and translational level. Our data might also reflect an involvement of peripheral and brain immune cells in the disease course of PD, in line with increasing awareness of the role of the immune system in PD.	[Thevenet, Jonathan; Wiessner, Christoph; Sagot, Yves Jean] Merck Serono SA, TA NDD Res, Pharmacol Parkinsons Dis, Geneva, Switzerland; [Gobert, Rosanna Pescini; van Huijsduijnen, Robertus Hooft] Merck Serono SA, TA NDD Res, Multiple Sclerosis Drug Discovery, Geneva, Switzerland	Merck KGaA; EMD Serono Inc.; Merck KGaA; EMD Serono Inc.	Thevenet, J (corresponding author), Merck Serono SA, TA NDD Res, Pharmacol Parkinsons Dis, Geneva, Switzerland.	yves.sagot@merckserono.net	van Huijsduijnen, Rob A.M. Hooft/B-3653-2009	van Huijsduijnen, Rob A.M. Hooft/0000-0002-2261-9424; Pescini Gobert, Rosanna/0000-0002-2434-7530	Merck Serono SA	Merck Serono SA	This study was funded by Merck Serono SA. The company had a role in this study due to employment of one or more authors of this study.	ANDREESEN R, 1990, J LEUKOCYTE BIOL, V47, P490, DOI 10.1002/jlb.47.6.490; Andres-Mateos E, 2009, J NEUROSCI, V29, P15846, DOI 10.1523/JNEUROSCI.4357-09.2009; Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Belge KU, 2002, J IMMUNOL, V168, P3536, DOI 10.4049/jimmunol.168.7.3536; Brochard V, 2009, J CLIN INVEST, V119, P182, DOI 10.1172/JCI36470; Brodacki B, 2008, NEUROSCI LETT, V441, P158, DOI 10.1016/j.neulet.2008.06.040; Cookson MR, 2010, NAT REV NEUROSCI, V11, P791, DOI 10.1038/nrn2935; Dawson TM, 2010, NEURON, V66, P646, DOI 10.1016/j.neuron.2010.04.034; Deng XM, 2011, NAT CHEM BIOL, V7, P203, DOI 10.1038/NCHEMBIO.538; Ding XD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005949; Dzamko N, 2010, BIOCHEM J, V430, P405, DOI 10.1042/BJ20100784; Fischer-Smith T, 2001, J NEUROVIROL, V7, P528, DOI 10.1080/135502801753248114; Gardet A, 2010, J IMMUNOL, V185, P5577, DOI 10.4049/jimmunol.1000548; Gerlini G, 2008, J IMMUNOL, V181, P2999, DOI 10.4049/jimmunol.181.5.2999; Gottfried-Blackmore A, 2009, P NATL ACAD SCI USA, V106, P20918, DOI 10.1073/pnas.0911509106; Hamza TH, 2010, NAT GENET, V42, P781, DOI 10.1038/ng.642; Ingersoll MA, 2010, BLOOD, V115, pE10, DOI 10.1182/blood-2009-07-235028; Jorgensen ND, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008463; Ko HS, 2009, P NATL ACAD SCI USA, V106, P2897, DOI 10.1073/pnas.0810123106; Kruger R, 2008, BMC MED, V6, DOI 10.1186/1741-7015-6-33; Kubo M, 2010, J NEUROIMMUNOL, V229, P123, DOI 10.1016/j.jneuroim.2010.07.021; Larsen K, 2009, MOL BIOL REP, V36, P237, DOI 10.1007/s11033-007-9172-5; Lees AJ, 2009, LANCET, V373, P2055, DOI 10.1016/S0140-6736(09)60492-X; Li XT, 2010, J NEUROSCI, V30, P1788, DOI 10.1523/JNEUROSCI.5604-09.2010; Li YP, 2009, NAT NEUROSCI, V12, P826, DOI 10.1038/nn.2349; Maekawa T, 2010, BIOCHEM BIOPH RES CO, V392, P431, DOI 10.1016/j.bbrc.2010.01.041; MCGEER PL, 1988, NEUROLOGY, V38, P1285, DOI 10.1212/WNL.38.8.1285; Melrose HL, 2010, NEUROBIOL DIS, V40, P503, DOI 10.1016/j.nbd.2010.07.010; Meylan E, 2005, TRENDS BIOCHEM SCI, V30, P151, DOI 10.1016/j.tibs.2005.01.003; MOST J, 1992, J IMMUNOL, V148, P1635; MUTEZ E, 2010, NEUROBIOL AGING, DOI DOI 10.1016/J.NEUROBIOLAGING.2009.1010.1016; Nichols RJ, 2009, BIOCHEM J, V424, P47, DOI 10.1042/BJ20091035; Ohta E, 2010, BIOCHEM BIOPH RES CO, V391, P242, DOI 10.1016/j.bbrc.2009.11.043; PASSLICK B, 1989, BLOOD, V74, P2527, DOI 10.1182/blood.V74.7.2527.2527; Randolph GJ, 2002, J EXP MED, V196, P517, DOI 10.1084/jem.20011608; Reale M, 2009, MINI-REV MED CHEM, V9, P1229, DOI 10.2174/138955709789055199; Rivas-Carvalho A, 2004, INT IMMUNOL, V16, P1251, DOI 10.1093/intimm/dxh127; Song IU, 2009, EUR NEUROL, V62, P99, DOI 10.1159/000222780; Stephanou A, 1999, J BIOL CHEM, V274, P1723, DOI 10.1074/jbc.274.3.1723; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Tacke F, 2006, IMMUNOBIOLOGY, V211, P609, DOI 10.1016/j.imbio.2006.05.025; Tamura T, 2002, J INTERF CYTOK RES, V22, P145, DOI 10.1089/107999002753452755; Tan EK, 2008, MOL GENET METAB, V95, P113, DOI 10.1016/j.ymgme.2008.06.004; Thieblemont N, 1995, EUR J IMMUNOL, V25, P3418, DOI 10.1002/eji.1830251232; Tong YR, 2010, P NATL ACAD SCI USA, V107, P9879, DOI 10.1073/pnas.1004676107; Wang LZ, 2008, J NEUROSCI, V28, P3384, DOI 10.1523/JNEUROSCI.0185-08.2008; Ziegler-Heitbrock L, 2007, J LEUKOCYTE BIOL, V81, P584, DOI 10.1189/jlb.0806510; Ziegler-Heitbrock L, 2010, BLOOD, V116, pE74, DOI 10.1182/blood-2010-02-258558	48	123	124	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2011	6	6							e21519	10.1371/journal.pone.0021519	http://dx.doi.org/10.1371/journal.pone.0021519			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	783OD	21738687	Green Published, Green Submitted, gold			2022-12-27	WOS:000292092600048
J	Li, YH; Romeis, J; Wang, P; Peng, YF; Shelton, AM				Li, Yunhe; Romeis, Joerg; Wang, Ping; Peng, Yufa; Shelton, Anthony M.			A Comprehensive Assessment of the Effects of Bt Cotton on Coleomegilla maculata Demonstrates No Detrimental Effects by Cry1Ac and Cry2Ab	PLOS ONE			English	Article							RESISTANT TRANSGENIC PLANTS; BACILLUS-THURINGIENSIS; CORN POLLEN; LEPIDOPTERA; NONTARGET; SURVIVAL; TOXIN; COLEOPTERA; PREDATORS; PROTEINS	The ladybird beetle, Coleomegilla maculata (DeGeer), is a common and abundant predator in many cropping systems. Its larvae and adults are predaceous, feeding on aphids, thrips, lepidopteran larvae and plant tissues, such as pollen. Therefore, this species is exposed to insecticidal proteins expressed in insect-resistant, genetically engineered cotton expressing Cry proteins derived from Bacillus thuringiensis (Bt). A tritrophic bioassay was conduced to evaluate the potential impact of Cry2Ab- and Cry1Ac-expressing cotton on fitness parameters of C. maculata using Bt-susceptible and -resistant larvae of Trichoplusia ni as prey. Coleomegilla maculata survival, development time, adult weight and fecundity were not different when they were fed with resistant T. ni larvae reared on either Bt or control cotton. To ensure that C. maculata were not sensitive to the tested Cry toxins independent from the plant background and to add certainty to the hazard assessment, C. maculata larvae were fed artificial diet incorporated with Cry2Ab, Cry1Ac or both at > 10 times higher concentrations than in cotton tissue. Artificial diet containing E-64 was included as a positive control. No differences were detected in any life-table parameters between Cry protein-containing diet treatments and the control diet. In contrast, larvae of C. maculata fed the E-64 could not develop to the pupal stage and the 7-d larval weight was significantly negatively affected. In both feeding assays, the stability and bioactivity of Cry proteins in the food sources were confirmed by ELISA and sensitive-insect bioassays. Our results show that C. maculata is not affected by Bt cotton and is not sensitive to Cry2Ab and Cry1Ac at concentrations exceeding the levels in Bt cotton, thus demonstrating that Bt cotton will pose a negligible risk to C. maculata. More importantly, this study demonstrates a comprehensive system for assessing the risk of genetically modified plants on non-target organisms.	[Li, Yunhe; Wang, Ping; Shelton, Anthony M.] Cornell Univ, Dept Entomol, NYSAES, Geneva, NY USA; [Li, Yunhe; Peng, Yufa] Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Plant Dis & Insect Pests, Beijing 100193, Peoples R China; [Romeis, Joerg] Agroscope Reckenholz Tanikon Res Stn ART, Zurich, Switzerland	Cornell University; Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS; Swiss Federal Research Station Agroscope; Swiss Federal Research Station for Agroecology & Agriculture	Shelton, AM (corresponding author), Cornell Univ, Dept Entomol, NYSAES, Geneva, NY USA.	ams5@cornell.edu	peng, yu/GXW-2071-2022; li, Yu/HCI-9086-2022; Chen, Yong/B-9051-2008; Romeis, Joerg/J-5360-2013; li, yu/HGL-9518-2022	Chen, Yong/0000-0003-2580-5895; Romeis, Joerg/0000-0003-3652-8360; 	National Key Basic Research and Development (973) Program in China [2007CB109204]; Swiss National Science Foundation [PBBEP3-125563]	National Key Basic Research and Development (973) Program in China(National Basic Research Program of China); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This research was supported by the National Key Basic Research and Development (973) Program (2007CB109204) in China and funded by a postdoctoral grant from the Swiss National Science Foundation (PBBEP3-125563). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Alfageme F, 2011, TRANSGENIC RES, V20, P467, DOI 10.1007/s11248-010-9430-5; BOODLEY JW, 1977, CORNELL U COOPERATIO, V43; BROOKES G, 2010, GM CROPS GLOBAL SOCI; CAB International, 2007, CROP PROT COMP; Chen M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002284; Duan JJ, 2002, ENTOMOL EXP APPL, V104, P271, DOI 10.1023/A:1021258803866; Dutton A, 2003, BIOCONTROL, V48, P611, DOI 10.1023/A:1026313719424; Ferry N, 2007, TRANSGENIC RES, V16, P795, DOI 10.1007/s11248-007-9088-9; Garcia-Alonso Monica, 2006, Environmental Biosafety Research, V5, P57, DOI 10.1051/ebr:2006018; Greenplate JT, 2003, J APPL ENTOMOL, V127, P340, DOI 10.1046/j.1439-0418.2003.00766.x; Groot AT, 2002, PLANT J, V31, P387, DOI 10.1046/j.1365-313X.2002.01366.x; Hogervorst PAM, 2006, J INSECT PHYSIOL, V52, P614, DOI 10.1016/j.jinsphys.2006.02.011; Kain WC, 2004, J ECON ENTOMOL, V97, P2073, DOI 10.1603/0022-0493-97.6.2073; Kennedy George G., 2008, V5, P1; Knox O. G. G., 2008, The Open Agriculture Journal, V2, P105, DOI 10.2174/1874331500802010105; Lawo NC, 2010, J INSECT PHYSIOL, V56, P1702, DOI 10.1016/j.jinsphys.2010.06.012; Li YX, 2006, CROP PROT, V25, P940, DOI 10.1016/j.cropro.2005.12.007; Li YH, 2011, ENVIRON ENTOMOL, V40, P496, DOI 10.1603/EN10248; Li YH, 2010, BIOL CONTROL, V53, P337, DOI 10.1016/j.biocontrol.2009.12.003; LIU CX, 2010, SCIENCE CHINA C, V8, P934; Lundgren JG, 2004, J INSECT PHYSIOL, V50, P567, DOI 10.1016/j.jinsphys.2004.04.003; Lundgren JG, 2002, ENVIRON ENTOMOL, V31, P1213, DOI 10.1603/0046-225X-31.6.1213; Naranjo S., 2009, CAB REV PERSPECTIVES, V4; Naranjo SE, 2011, J AGR FOOD CHEM, V59, P5842, DOI 10.1021/jf102939c; Naranjon Steven E., 2008, V5, P159, DOI 10.1007/978-1-4020-8373-0_6; NAS (National Academy of Sciences), 2002, ENV EFF TRANSG PLANT; Organisation for Economic Co-operation and Development (OECD), 2007, SER HARM REG OV BIOT; Pilcher CD, 1997, ENVIRON ENTOMOL, V26, P446, DOI 10.1093/ee/26.2.446; Raybould A, 2010, TRANSGENIC RES, V20, P599, DOI DOI 10.1007/S11248-010-9442-1; ROGER C, 1999, THESIS MCGILI U MONT; Romeis J, 2006, NAT BIOTECHNOL, V24, P63, DOI 10.1038/nbt1180; Romeis J, 2008, NAT BIOTECHNOL, V26, P203, DOI 10.1038/nbt1381; Romeis J, 2011, TRANSGENIC RES, V20, P1, DOI 10.1007/s11248-010-9446-x; SHELTON AM, 1991, J ENTOMOL SCI, V26, P17, DOI 10.18474/0749-8004-26.1.17; Stewart SD, 2001, J ECON ENTOMOL, V94, P752, DOI 10.1603/0022-0493-94.3.752; USEPA, 2002, 006487 EPA AMENDED	36	76	84	1	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2011	6	7							e22185	10.1371/journal.pone.0022185	http://dx.doi.org/10.1371/journal.pone.0022185			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791WM	22022595	Green Submitted, gold, Green Published			2022-12-27	WOS:000292699000028
J	Zhao, X; Mo, DL; Li, AN; Gong, W; Xiao, SQ; Zhang, Y; Qin, LM; Niu, YN; Guo, YX; Liu, XH; Cong, PQ; He, ZY; Wang, C; Li, JQ; Chen, YS				Zhao, Xiao; Mo, Delin; Li, Anning; Gong, Wen; Xiao, Shuqi; Zhang, Yue; Qin, Limei; Niu, Yuna; Guo, Yunxue; Liu, Xiaohong; Cong, Peiqing; He, Zuyong; Wang, Chong; Li, Jiaqi; Chen, Yaosheng			Comparative Analyses by Sequencing of Transcriptomes during Skeletal Muscle Development between Pig Breeds Differing in Muscle Growth Rate and Fatness	PLOS ONE			English	Article							ACTIVATED RECEPTOR-GAMMA; BINDING-PROTEIN GENE; FIBER TYPE; IN-VITRO; MOLECULAR REGULATION; EXPRESSION PROFILES; INTRAMUSCULAR FAT; WNT/BETA-CATENIN; MYOGENIC CELLS; LANDRACE PIGS	Understanding the dynamics of muscle transcriptome during development and between breeds differing in muscle growth is necessary to uncover the complex mechanism underlying muscle development. Herein, we present the first transcriptome-wide longissimus dorsi muscle development research concerning Lantang (LT, obese) and Landrace (LR, lean) pig breeds during 10 time-points from 35 days-post-coitus (dpc) to 180 days-post-natum (dpn) using Solexa/Illumina's Genome Analyzer. The data demonstrated that myogenesis was almost completed before 77 dpc, but the muscle phenotypes were still changed from 77 dpc to 28 dpn. Comparative analysis of the two breeds suggested that myogenesis started earlier but progressed more slowly in LT than in LR, the stages ranging from 49 dpc to 77 dpc are critical for formation of different muscle phenotypes. 595 differentially expressed myogenesis genes were identified, and their roles in myogenesis were discussed. Furthermore, GSK3B, IKBKB, ACVR1, ITGA and STMN1 might contribute to later myogenesis and more muscle fibers in LR than LT. Some myogenesis inhibitors (ID1, ID2, CABIN1, MSTN, SMAD4, CTNNA1, NOTCH2, GPC3 and HMOX1) were higher expressed in LT than in LR, which might contribute to more slow muscle differentiation in LT than in LR. We also identified several genes which might contribute to intramuscular adipose differentiation. Most important, we further proposed a novel model in which MyoD and MEF2A controls the balance between intramuscular adipogenesis and myogenesis by regulating CEBP family; Myf5 and MEF2C are essential during the whole myogenesis process while MEF2D affects muscle growth and maturation. The MRFs and MEF2 families are also critical for the phenotypic differences between the two pig breeds. Overall, this study contributes to elucidating the mechanism underlying muscle development, which could provide valuable information for pig meat quality improvement. The raw data have been submitted to Gene Expression Omnibus (GEO) under series GSE25406.	[Zhao, Xiao; Mo, Delin; Li, Anning; Gong, Wen; Xiao, Shuqi; Zhang, Yue; Qin, Limei; Niu, Yuna; Guo, Yunxue; Liu, Xiaohong; Cong, Peiqing; He, Zuyong; Chen, Yaosheng] Sun Yat Sen Univ, State Key Lab Biocontrol, Guangzhou 510275, Guangdong, Peoples R China; [Wang, Chong; Li, Jiaqi] S China Agr Univ, Coll Anim Sci, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University; South China Agricultural University	Zhao, X (corresponding author), Sun Yat Sen Univ, State Key Lab Biocontrol, Guangzhou 510275, Guangdong, Peoples R China.	chyaosh@mail.sysu.edu.cn	He, Zuyong/AAU-9430-2021	Wang, Chong/0000-0002-1515-9669; Garrick, Dorian/0000-0001-8640-5372; Chen, Yaosheng/0000-0002-3871-7651; Mo, Delin/0000-0002-8738-4486; Dittmer, Keren/0000-0002-1813-2197; Li, Anning/0000-0001-7695-161X	National Natural Science Foundation of China [U0731003, 31072008]; National High Science and Technology Foundation of China [2006CB102101]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Science and Technology Foundation of China	This research was supported by the Joint Funds of the National Natural Science Foundation of China (U0731003), the National High Science and Technology Foundation of China (2006CB102101) and National Natural Science Foundation of China (31072008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2001, CURRENT GENOMICS; Arimura T, 2009, J AM COLL CARDIOL, V54, P334, DOI 10.1016/j.jacc.2008.12.082; ASHMORE CR, 1973, J ANIM SCI, V36, P1088, DOI 10.2527/jas1973.3661088x; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Aurino S, 2008, Acta Myol, V27, P90; Bakkar N, 2008, J CELL BIOL, V180, P787, DOI 10.1083/jcb.200707179; Balogh A, 1996, EXP CELL RES, V224, P8, DOI 10.1006/excr.1996.0106; Buckingham M, 2001, CURR OPIN GENET DEV, V11, P440, DOI 10.1016/S0959-437X(00)00215-X; Buckingham M, 2003, J ANAT, V202, P59, DOI 10.1046/j.1469-7580.2003.00139.x; Buckingham M, 2006, CURR OPIN GENET DEV, V16, P525, DOI 10.1016/j.gde.2006.08.008; Buckingham M, 2009, CURR OPIN GENET DEV, V19, P444, DOI 10.1016/j.gde.2009.08.001; Cagnazzo M, 2006, J ANIM SCI, V84, P1; Calabria E, 2009, P NATL ACAD SCI USA, V106, P13335, DOI 10.1073/pnas.0812911106; Cerri PS, 2003, MICRON, V34, P365, DOI 10.1016/S0968-4328(03)00098-2; Charge SBP, 2004, PHYSIOL REV, V84, P209, DOI 10.1152/physrev.00019.2003; Chen AE, 2005, NATURE, V433, P317, DOI 10.1038/nature03126; Cowling BS, 2008, J CELL BIOL, V183, P1033, DOI 10.1083/jcb.200804077; Dayton W R, 2008, J Anim Sci, V86, pE217, DOI 10.2527/jas.2007-0456; Draghici S, 2007, GENOME RES, V17, P1537, DOI 10.1101/gr.6202607; Gerbens F, 1998, MAMM GENOME, V9, P1022, DOI 10.1007/s003359900918; Gerbens F, 1999, J ANIM SCI, V77, P846; Gerbens F, 1997, MAMM GENOME, V8, P328, DOI 10.1007/s003359900433; Goudenege S, 2009, MOL THER, V17, P1064, DOI 10.1038/mt.2009.67; Grifone R, 2007, DEV BIOL, V302, P602, DOI 10.1016/j.ydbio.2006.08.059; Guo J, 2011, J ANIM SCI, V89, P185, DOI 10.2527/jas.2010-2983; Hutcheson DA, 2009, GENE DEV, V23, P997, DOI 10.1101/gad.1769009; Kajimura S, 2010, CELL METAB, V11, P257, DOI 10.1016/j.cmet.2010.03.005; Kardon G, 2003, DEV CELL, V5, P937, DOI 10.1016/S1534-5807(03)00360-5; Kim JM, 2010, ANIM GENET, V41, P642, DOI 10.1111/j.1365-2052.2010.02042.x; Kim KS, 2004, MAMM GENOME, V15, P552, DOI 10.1007/s00335-004-2341-0; Kronnie GT, 2002, J MUSCLE RES CELL M, V23, P65; Lee CT, 2004, MOL CELL BIOL, V24, P10835, DOI 10.1128/MCB.24.24.10835-10843.2004; LEFAUCHEUR L, 1986, MEAT SCI, V16, P199, DOI 10.1016/0309-1740(86)90026-4; LI J, 2003, J GENET GENOMICS, V30, P835; Li YH, 2006, FEBS LETT, V580, P5423, DOI 10.1016/j.febslet.2006.09.011; Liu JQ, 2004, J BIOL CHEM, V279, P24493, DOI [10.1074/jbc.M402920200, 10.1074/jbc.M407050200]; Macqueen DJ, 2010, BIOCHEM BIOPH RES CO, V400, P599, DOI 10.1016/j.bbrc.2010.08.110; Mankoo BS, 1999, NATURE, V400, P69, DOI 10.1038/21892; MASCARELLO F, 1992, J ANIM SCI, V70, P1806, DOI 10.2527/1992.7061806x; Miller LD, 2002, CANCER CELL, V2, P353, DOI 10.1016/S1535-6108(02)00181-2; Muir T, 2008, MOL REPROD DEV, V75, P1637, DOI 10.1002/mrd.20902; Murani E, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-109; Newcom DW, 2004, J ANIM SCI, V82, P2264; Ono Y, 2011, CELL DEATH DIFFER, V18, P222, DOI 10.1038/cdd.2010.95; Parker MH, 2003, NAT REV GENET, V4, P497, DOI 10.1038/nrg1109; PAS MFW, 2006, ARCH TIERZ DUMMERSTO, V49, P110; PAS MFW, 2005, ARCH ANIM BREED, V48, P141; Pas MFWT, 2005, J MUSCLE RES CELL M, V26, P157, DOI 10.1007/s10974-005-7004-6; PAS MT, 2004, MUSCLE DEV LIVESTOCK, P201; Picard B, 2002, REPROD NUTR DEV, V42, P415, DOI 10.1051/rnd:2002035; Porrello A, 2000, J CELL BIOL, V151, P1295, DOI 10.1083/jcb.151.6.1295; Rajesh RV, 2010, COMP BIOCHEM PHYS D, V5, P234, DOI 10.1016/j.cbd.2010.06.004; Ramoni MF, 2002, P NATL ACAD SCI USA, V99, P9121, DOI 10.1073/pnas.132656399; Ridgeway AG, 2000, J BIOL CHEM, V275, P32398, DOI 10.1074/jbc.M004349200; Sabourin LA, 2000, CLIN GENET, V57, P16, DOI 10.1034/j.1399-0004.2000.570103.x; Sartorelli V, 2005, CURR OPIN GENET DEV, V15, P528, DOI 10.1016/j.gde.2005.04.015; Sartorelli V, 1997, MOL CELL BIOL, V17, P1010, DOI 10.1128/MCB.17.2.1010; Sato Y, 2010, J BIOL CHEM, V285, P7111, DOI 10.1074/jbc.M109.052977; Schlitt T, 2003, GENOME RES, V13, P2568, DOI 10.1101/gr.1111403; Schook L, 2005, ANIM BIOTECHNOL, V16, P183, DOI 10.1080/10495390500265034; SCHULER F, 1995, J CELL SCI, V108, P3795; Shan TZ, 2009, J CELL BIOCHEM, V107, P984, DOI 10.1002/jcb.22203; Shiseki M, 2003, CANCER RES, V63, P2373; Shore EM, 2006, NAT GENET, V38, P525, DOI 10.1038/ng1783; Spencer JA, 2000, J CELL BIOL, V150, P771, DOI 10.1083/jcb.150.4.771; Stary M, 2005, EXP CELL RES, V310, P331, DOI 10.1016/j.yexcr.2005.07.013; SUZUKI A, 1991, MEAT SCI, V29, P31, DOI 10.1016/0309-1740(91)90021-H; t Hoen PAC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn705; Tang ZL, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r115; te Pas MFW, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-66; Tee JM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005880; Waddell JN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015055; WIGMORE PMC, 1983, J ANAT, V137, P235; Yang H, 2010, ANIM BIOTECHNOL, V21, P64, DOI 10.1080/10495390903385983; Yoon JC, 2000, MOL CELL BIOL, V20, P5343, DOI 10.1128/MCB.20.14.5343-5349.2000; Zhang Suzhen, 2008, Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi, V22, P753; Zhao SH, 2003, J ANIM SCI, V81, P2179; Zhong HH, 2002, MOL CELL, V9, P625, DOI 10.1016/S1097-2765(02)00477-X; Zirn B, 2006, GENE CHROMOSOME CANC, V45, P565, DOI 10.1002/gcc.20319	79	122	132	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2011	6	5							e19774	10.1371/journal.pone.0019774	http://dx.doi.org/10.1371/journal.pone.0019774			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XS	21637832	Green Published, Green Submitted, gold			2022-12-27	WOS:000291052200014
J	Zhao, CJ; Wang, XF; Zhao, YW; Li, ZM; Lin, S; Wei, YQ; Yang, HS				Zhao, Chengjian; Wang, Xiaofei; Zhao, Yuwei; Li, Zhimian; Lin, Shuo; Wei, Yuquan; Yang, Hanshuo			A Novel Xenograft Model in Zebrafish for High-Resolution Investigating Dynamics of Neovascularization in Tumors	PLOS ONE			English	Article							ANTIANGIOGENIC THERAPY; ANGIOGENESIS; GROWTH; RECRUITMENT; CELLS; METASTASIS; EXPRESSION; DISCOVERY; INVASION; CORNEA	Tumor neovascularization is a highly complex process including multiple steps. Understanding this process, especially the initial stage, has been limited by the difficulties of real-time visualizing the neovascularization embedded in tumor tissues in living animal models. In the present study, we have established a xenograft model in zebrafish by implanting mammalian tumor cells into the perivitelline space of 48 hours old Tg(Flk1:EGFP) transgenic zebrafish embryos. With this model, we dynamically visualized the process of tumor neovascularization, with unprecedented high-resolution, including new sprouts from the host vessels and the origination from VEGFR2(+) individual endothelial cells. Moreover, we quantified their contributions during the formation of vascular network in tumor. Real-time observations revealed that angiogenic sprouts in tumors preferred to connect each other to form endothelial loops, and more and more endothelial loops accumulated into the irregular and chaotic vascular network. The over-expression of VEGF165 in tumor cells significantly affected the vascularization in xenografts, not only the number and size of neo-vessels but the abnormalities of tumor vascular architecture. The specific inhibitor of VEGFR2, SU5416, significantly inhibited the vascularization and the growth of melanoma xenografts, but had little affects to normal vessels in zebrafish. Thus, this zebrafish/tumor xenograft model not only provides a unique window to investigate the earliest events of tumoral neoangiogenesis, but is sensitive to be used as an experimental platform to rapidly and visually evaluate functions of angiogenic-related genes. Finally, it also offers an efficient and cost-effective means for the rapid evaluation of anti-angiogenic chemicals.	[Zhao, Chengjian; Wang, Xiaofei; Zhao, Yuwei; Li, Zhimian; Lin, Shuo; Wei, Yuquan; Yang, Hanshuo] Sichuan Univ, W China Med Sch, State Key Lab Biotherapy, W China Hosp, Chengdu 610064, Sichuan, Peoples R China; [Zhao, Chengjian; Wang, Xiaofei; Zhao, Yuwei; Li, Zhimian; Lin, Shuo; Wei, Yuquan; Yang, Hanshuo] Sichuan Univ, W China Med Sch, Ctr Canc, W China Hosp, Chengdu 610064, Sichuan, Peoples R China; [Lin, Shuo] Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA USA	Sichuan University; Sichuan University; University of California System; University of California Los Angeles	Zhao, CJ (corresponding author), Sichuan Univ, W China Med Sch, State Key Lab Biotherapy, W China Hosp, Chengdu 610064, Sichuan, Peoples R China.	yhansh@scu.edu.cn		Dong, Jing/0000-0001-9856-5963; Wei, Yu-quan/0000-0002-6211-3217; chen, daozhen/0000-0003-4791-8065	National Key Basic Research Program of China [2010CB529900]	National Key Basic Research Program of China(National Basic Research Program of China)	This work was supported by the National Key Basic Research Program of China (2010CB529900). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amatruda JF, 2002, CANCER CELL, V1, P229, DOI 10.1016/S1535-6108(02)00052-1; Bergers G, 2003, NAT REV CANCER, V3, P401, DOI 10.1038/nrc1093; Blagosklonny MV, 2004, CANCER CELL, V5, P13, DOI 10.1016/S1535-6108(03)00336-2; Du R, 2008, CANCER CELL, V13, P206, DOI 10.1016/j.ccr.2008.01.034; Dvorak HF, 2003, AM J PATHOL, V162, P1747, DOI 10.1016/S0002-9440(10)64309-X; Erler JT, 2009, CANCER CELL, V15, P35, DOI 10.1016/j.ccr.2008.11.012; Folkman J, 2006, ANNU REV MED, V57, P1, DOI 10.1146/annurev.med.57.121304.131306; Folkman J, 2002, SEMIN ONCOL, V29, P15, DOI 10.1053/sonc.2002.37263; Hasan Jurjees, 2004, Angiogenesis, V7, P1, DOI 10.1023/B:AGEN.0000037338.51851.d1; Heldin CH, 2004, NAT REV CANCER, V4, P806, DOI 10.1038/nrc1456; Jain RK, 2003, NAT MED, V9, P685, DOI 10.1038/nm0603-685; JAIN RK, 1994, SCI AM, V271, P58, DOI 10.1038/scientificamerican0794-58; Jain RK, 2005, SCIENCE, V307, P58, DOI 10.1126/science.1104819; Kalluri R, 2003, NAT REV CANCER, V3, P422, DOI 10.1038/nrc1094; Kenyon BM, 1996, INVEST OPHTH VIS SCI, V37, P1625; KNIGHTON D, 1977, BRIT J CANCER, V35, P347, DOI 10.1038/bjc.1977.49; Lee SLC, 2009, P NATL ACAD SCI USA, V106, P19485, DOI 10.1073/pnas.0909228106; Lieschke GJ, 2007, NAT REV GENET, V8, P353, DOI 10.1038/nrg2091; Lyden D, 2001, NAT MED, V7, P1194, DOI 10.1038/nm1101-1194; McCawley LJ, 2001, CURR OPIN CELL BIOL, V13, P534, DOI 10.1016/S0955-0674(00)00248-9; Nicoli S, 2007, NAT PROTOC, V2, P2918, DOI 10.1038/nprot.2007.412; Nicoli S, 2007, CANCER RES, V67, P2927, DOI 10.1158/0008-5472.CAN-06-4268; Parng C, 2005, CURR OPIN DRUG DISC, V8, P100; Peterson RT, 2004, NAT BIOTECHNOL, V22, P595, DOI 10.1038/nbt963; Phillips G D, 1994, In Vivo, V8, P961; Pichler FB, 2003, NAT BIOTECHNOL, V21, P879, DOI 10.1038/nbt852; Rafii S, 2002, GENE THER, V9, P631, DOI 10.1038/sj.gt.3301723; Stoletov K, 2007, P NATL ACAD SCI USA, V104, P17406, DOI 10.1073/pnas.0703446104; Vajkoczy P, 2002, J CLIN INVEST, V109, P777, DOI 10.1172/JCI200214105; Witek ME, 2005, CLIN CANCER RES, V11, P8549, DOI 10.1158/1078-0432.CCR-05-1624; Zon LI, 2005, NAT REV DRUG DISCOV, V4, P35, DOI 10.1038/nrd1606	31	214	220	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2011	6	7							e21768	10.1371/journal.pone.0021768	http://dx.doi.org/10.1371/journal.pone.0021768			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	792WQ	21765912	Green Published, gold, Green Submitted			2022-12-27	WOS:000292781500014
J	Li, YC; Li, YM; Zhang, H; Chen, Y				Li, Yichen; Li, Yumin; Zhang, Hui; Chen, Yong			MicroRNA-Mediated Positive Feedback Loop and Optimized Bistable Switch in a Cancer Network Involving miR-17-92	PLOS ONE			English	Article							CELL-CYCLE OSCILLATOR; GENE-REGULATION; NOISE; HETEROGENEITY; BIOGENESIS; MOTIFS; MEMORY	MicroRNAs (miRNAs) are small, noncoding RNAs that play an important role in many key biological processes, including development, cell differentiation, the cell cycle and apoptosis, as central post-transcriptional regulators of gene expression. Recent studies have shown that miRNAs can act as oncogenes and tumor suppressors depending on the context. The present work focuses on the physiological significance of miRNAs and their role in regulating the switching behavior. We illustrate an abstract model of the Myc/E2F/miR-17-92 network presented by Aguda et al. (2008), which is composed of coupling between the E2F/Myc positive feedback loops and the E2F/Myc/miR-17-92 negative feedback loop. By systematically analyzing the network in close association with plausible experimental parameters, we show that, in the presence of miRNAs, the system bistability emerges from the system, with a bistable switch and a one-way switch presented by Aguda et al. instead of a single one-way switch. Moreover, the miRNAs can optimize the switching process. The model produces a diverse array of response-signal behaviors in response to various potential regulating scenarios. The model predicts that this transition exists, one from cell death or the cancerous phenotype directly to cell quiescence, due to the existence of miRNAs. It was also found that the network involving miR-17-92 exhibits high noise sensitivity due to a positive feedback loop and also maintains resistance to noise from a negative feedback loop.	[Li, Yichen; Li, Yumin] Lanzhou Univ, Sch Life Sci, Lanzhou 730000, Peoples R China; [Li, Yichen; Li, Yumin; Chen, Yong] Key Lab Digest Syst Tumors, Lanzhou, Peoples R China; [Zhang, Hui; Chen, Yong] Lanzhou Univ, Inst Theoret Phys, Lanzhou 730000, Peoples R China	Lanzhou University; Lanzhou University	Li, YC (corresponding author), Lanzhou Univ, Sch Life Sci, Lanzhou 730000, Peoples R China.	liym@lzu.edu.cn; ychen@lzu.edu.cn	peng, yu/GXW-2071-2022; li, Yu/HCI-9086-2022; Chen, Yong/B-9051-2008; Romeis, Joerg/J-5360-2013; li, yu/HGL-9518-2022	Chen, Yong/0000-0003-2580-5895; Romeis, Joerg/0000-0003-3652-8360; 	National Natural Science Foundation of China [10975063, 30870364]; High Technology Research and Development Program of China (863 program) [2007AA021807]; Key Technology R&D Program of Gansu Province [0708NKCA129]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); High Technology Research and Development Program of China (863 program)(National High Technology Research and Development Program of China); Key Technology R&D Program of Gansu Province	This work was supported by the National Natural Science Foundation of China (Grant No. 10975063, 30870364), the High Technology Research and Development Program of China (863 program, Grant No. 2007AA021807), and The Key Technology R&D Program of Gansu Province (Grant No. 0708NKCA129). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acar M, 2005, NATURE, V435, P228, DOI 10.1038/nature03524; Aguda BD, 2008, P NATL ACAD SCI USA, V105, P19678, DOI 10.1073/pnas.0811166106; Barrio M, 2006, PLOS COMPUT BIOL, V2, P1017, DOI 10.1371/journal.pcbi.0020117; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Becskei A, 2000, NATURE, V405, P590, DOI 10.1038/35014651; Becskei A, 2001, EMBO J, V20, P2528, DOI 10.1093/emboj/20.10.2528; Bhalla US, 2002, SCIENCE, V297, P1018, DOI 10.1126/science.1068873; Bhalla US, 2001, CHAOS, V11, P221, DOI 10.1063/1.1350440; Blake WJ, 2003, NATURE, V422, P633, DOI 10.1038/nature01546; Brandman O, 2005, SCIENCE, V310, P496, DOI 10.1126/science.1113834; Bratsun D, 2005, P NATL ACAD SCI USA, V102, P14593, DOI 10.1073/pnas.0503858102; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Carthew RW, 2006, CURR OPIN GENET DEV, V16, P203, DOI 10.1016/j.gde.2006.02.012; Coller HA, 2007, PLOS GENET, V3, P1319, DOI 10.1371/journal.pgen.0030146; Cui QH, 2007, TRENDS GENET, V23, P372, DOI 10.1016/j.tig.2007.04.003; Dews M, 2006, NAT GENET, V38, P1060, DOI 10.1038/ng1855; Garzon R, 2009, ANNU REV MED, V60, P167, DOI 10.1146/annurev.med.59.053006.104707; Hornung G, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.0040008; Inui M, 2010, NAT REV MOL CELL BIO, V11, P252, DOI 10.1038/nrm2868; KASDIN NJ, 1995, P IEEE, V83, P802, DOI 10.1109/5.381848; KASDIN NJ, 1995, J GUID CONTROL DYNAM, V18, P114, DOI 10.2514/3.56665; Khanin R, 2008, J COMPUT BIOL, V15, P305, DOI 10.1089/cmb.2007.0184; Kim VN, 2005, NAT REV MOL CELL BIO, V6, P376, DOI 10.1038/nrm1644; Lee K, 2000, SCIENCE, V289, P107, DOI 10.1126/science.289.5476.107; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Li MF, 2010, AAPS J, V12, P309, DOI 10.1208/s12248-010-9194-0; Lindner B, 2004, PHYS REP, V392, P321, DOI 10.1016/j.physrep.2003.10.015; Mendell JT, 2008, CELL, V133, P217, DOI 10.1016/j.cell.2008.04.001; Nevozhay D, 2009, P NATL ACAD SCI USA, V106, P5123, DOI 10.1073/pnas.0809901106; Novak B, 2008, NAT REV MOL CELL BIO, V9, P981, DOI 10.1038/nrm2530; O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677; Paulsson J, 2004, NATURE, V427, P415, DOI 10.1038/nature02257; Petrocca F, 2008, CANCER CELL, V13, P272, DOI 10.1016/j.ccr.2008.02.013; Pomerening JR, 2005, CELL, V122, P565, DOI 10.1016/j.cell.2005.06.016; Pomerening JR, 2003, NAT CELL BIOL, V5, P346, DOI 10.1038/ncb954; Ramsey SA, 2006, NAT GENET, V38, P1082, DOI 10.1038/ng1869; Schlicht R, 2008, J MATH BIOL, V57, P613, DOI 10.1007/s00285-008-0178-y; Shearman LP, 2000, SCIENCE, V288, P1013, DOI 10.1126/science.288.5468.1013; Smolen P, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.031902; Tian XJ, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.011926; Tsai TYC, 2008, SCIENCE, V321, P126, DOI 10.1126/science.1156951; Tsang J, 2007, MOL CELL, V26, P753, DOI 10.1016/j.molcel.2007.05.018; Tyson JJ, 2003, CURR OPIN CELL BIOL, V15, P221, DOI 10.1016/S0955-0674(03)00017-6; van der Pol B, 1926, PHILOS MAG, V2, P978; Ventura A, 2008, CELL, V132, P875, DOI 10.1016/j.cell.2008.02.019; Wee KB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004407; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; Wolf DM, 2003, CURR OPIN MICROBIOL, V6, P125, DOI 10.1016/S1369-5274(03)00033-X; Xiao CC, 2008, NAT IMMUNOL, V9, P405, DOI 10.1038/ni1575; Xiong W, 2003, NATURE, V426, P460, DOI 10.1038/nature02089; Yao G, 2008, NAT CELL BIOL, V10, P476, DOI 10.1038/ncb1711; Zhang XP, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.031924; Zhang XP, 2009, P NATL ACAD SCI USA, V106, P12245, DOI 10.1073/pnas.0813088106	53	76	84	1	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2011	6	10							e26302	10.1371/journal.pone.0026302	http://dx.doi.org/10.1371/journal.pone.0026302			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834RQ	22022595	Green Submitted, Green Published, gold			2022-12-27	WOS:000295981600052
J	Li, J; Chen, CS; Chen, CH; He, QH; Li, H; Li, J; Moyzis, RK; Xue, G; Dong, Q				Li, Jin; Chen, Chuansheng; Chen, Chunhui; He, Qinghua; Li, He; Li, Jun; Moyzis, Robert K.; Xue, Gui; Dong, Qi			Neurotensin Receptor 1 Gene (NTSR1) Polymorphism Is Associated with Working Memory	PLOS ONE			English	Article							PREFRONTAL CORTEX; NUCLEUS-ACCUMBENS; CORTICAL DOPAMINE; SCHIZOPHRENIA; LOCALIZATION; EXPRESSION; NEURONS; BRAIN; ENDOPHENOTYPE; STIMULATION	Background: Recent molecular genetics studies showed significant associations between dopamine-related genes (including genes for dopamine receptors, transporters, and degradation) and working memory, but little is known about the role of genes for dopamine modulation, such as those related to neurotensin (NT), in working memory. A recent animal study has suggested that NT antagonist administration impaired working memory in a learning task. The current study examined associations between NT genes and working memory among humans. Methods: Four hundred and sixty healthy undergraduate students were assessed with a 2-back working memory paradigm. 5 SNPs in the NTSR1 gene were genotyped. 5 ANOVA tests were conducted to examine whether and how working memory differed by NTSR1 genotype, with each SNP variant as the independent variable and the average accuracy on the working memory task as the dependent variable. Results: ANOVA results suggested that two SNPs in the NTSR1 gene (rs4334545 and rs6090453) were significantly associated with working memory. These results survived corrections for multiple comparisons. Conclusions: Our results demonstrated that NTSR1 SNP polymorphisms were significantly associated with variance in working memory performance among healthy adults. This result extended previous rodent studies showing that the NT deficiency impairs the working memory function. Future research should replicate our findings and extend to an examination of other dopamine modulators.	[Li, Jin; Chen, Chunhui; He, Qinghua; Li, He; Li, Jun; Xue, Gui; Dong, Qi] Beijing Normal Univ, Natl Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China; [Li, Jin; Chen, Chuansheng] Univ Calif Irvine, Dept Psychol & Social Behav, Irvine, CA USA; [He, Qinghua; Xue, Gui] Univ So Calif, Dept Psychol, Los Angeles, CA 90089 USA; [Moyzis, Robert K.] Univ Calif Irvine, Dept Biol Chem, Irvine, CA 92717 USA	Beijing Normal University; University of California System; University of California Irvine; University of Southern California; University of California System; University of California Irvine	Li, J (corresponding author), Beijing Normal Univ, Natl Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China.	cschen@uci.edu; dongqi@bnu.edu.cn	Xue, Gui/A-1762-2009; He, Qinghua/B-2573-2008	Xue, Gui/0000-0001-7891-8151; He, Qinghua/0000-0001-6396-6273; li, jin/0000-0002-4413-5746; Chen, Chuansheng/0000-0002-8224-1005	Ministry of Education of China [B07008]	Ministry of Education of China(Ministry of Education, China)	This research was supported by the 111 Project from the Ministry of Education of China (B07008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander MJ, 1998, J COMP NEUROL, V402, P475; Ando J, 2001, BEHAV GENET, V31, P615, DOI 10.1023/A:1013353613591; Austin J, 2000, MOL PSYCHIATR, V5, P552, DOI 10.1038/sj.mp.4000761; Azmi N, 2006, BEHAV PHARMACOL, V17, P357, DOI 10.1097/01.fbp.0000224382.63744.20; Baddeley A, 2010, CURR BIOL, V20, pR136, DOI 10.1016/j.cub.2009.12.014; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bertolino A, 2006, J NEUROSCI, V26, P3918, DOI 10.1523/JNEUROSCI.4975-05.2006; Binder EB, 2001, PHARMACOL REV, V53, P453; Binder EB, 2001, J NEUROSCI, V21, P601, DOI 10.1523/JNEUROSCI.21-02-00601.2001; Boudin H, 1996, J COMP NEUROL, V373, P76; Braver TS, 1997, NEUROIMAGE, V5, P49, DOI 10.1006/nimg.1996.0247; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Castner SA, 2000, SCIENCE, V287, P2020, DOI 10.1126/science.287.5460.2020; Fatigati MD, 2000, BRAIN RES, V876, P196, DOI 10.1016/S0006-8993(00)02654-8; Froehlich TE, 2007, BIOL PSYCHIAT, V62, P243, DOI 10.1016/j.biopsych.2006.09.039; Glahn DC, 2003, BIOL PSYCHIAT, V53, P624, DOI 10.1016/S0006-3223(02)01641-4; Hamid EH, 2002, BIOL PSYCHIAT, V51, P795, DOI 10.1016/S0006-3223(01)01325-7; HETIER E, 1988, N-S ARCH PHARMACOL, V337, P13; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Huezo-Diaz P, 2004, SCHIZOPHR RES, V66, P193, DOI 10.1016/S0920-9964(03)00128-2; Jomphe C, 2006, EUR J NEUROSCI, V24, P2789, DOI 10.1111/j.1460-9568.2006.05151.x; Kimberg DY, 2003, NEUROPSYCHOLOGIA, V41, P1020, DOI 10.1016/S0028-3932(02)00317-2; Kondo H, 2004, NEUROIMAGE, V23, P670, DOI 10.1016/j.neuroimage.2004.06.014; Kremen WS, 2007, NEUROPSYCHOLOGY, V21, P569, DOI 10.1037/0894-4105.21.5.569; LAMBERT PD, 1995, ANN NY ACAD SCI, V757, P377, DOI 10.1111/j.1749-6632.1995.tb17496.x; LAURENT P, 1994, MAMM GENOME, V5, P303, DOI 10.1007/BF00389545; Le F, 1997, J BIOL CHEM, V272, P1315, DOI 10.1074/jbc.272.2.1315; Lee YS, 1999, SCHIZOPHR RES, V36, P92; Liang YQ, 2010, NEUROPHARMACOLOGY, V58, P1199, DOI 10.1016/j.neuropharm.2010.02.015; MAI JK, 1987, NEUROSCIENCE, V22, P499, DOI 10.1016/0306-4522(87)90349-6; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; Marchini J, 2010, NAT REV GENET, V11, P499, DOI 10.1038/nrg2796; McNab F, 2009, SCIENCE, V323, P800, DOI 10.1126/science.1166102; Mizumoto Y, 1997, MOL CELL ENDOCRINOL, V135, P129, DOI 10.1016/S0303-7207(97)00195-0; Mizuno T, 2006, J PSYCHOSOM RES, V60, P91, DOI 10.1016/j.jpsychores.2005.06.068; Mondadori CRA, 2007, CEREB CORTEX, V17, P1934, DOI 10.1093/cercor/bhl103; Nackley AG, 2006, SCIENCE, V314, P1930, DOI 10.1126/science.1131262; Ohinata K, 2007, PEPTIDES, V28, P1470, DOI 10.1016/j.peptides.2007.06.002; Petkova-Kirova P, 2008, NEUROCHEM INT, V53, P355, DOI 10.1016/j.neuint.2008.08.010; Prus AJ, 2007, BRAIN RES, V1184, P354, DOI 10.1016/j.brainres.2007.09.092; QUIRION R, 1983, PEPTIDES, V4, P609, DOI 10.1016/0196-9781(83)90005-0; QUIRION R, 1985, BRAIN RES, V327, P385, DOI 10.1016/0006-8993(85)91542-2; ROMPRE PP, 1992, EUR J PHARMACOL, V211, P295, DOI 10.1016/0014-2999(92)90384-G; Saperstein AM, 2006, SCHIZOPHRENIA BULL, V32, P498, DOI 10.1093/schbul/sbj072; SEROOGY KB, 1987, EXP BRAIN RES, V68, P277; SEUTIN V, 1989, NEUROPHARMACOLOGY, V28, P949, DOI 10.1016/0028-3908(89)90194-9; Sharma RP, 1997, AM J PSYCHIAT, V154, P1019; STUDLER JM, 1988, NEUROPEPTIDES, V11, P95, DOI 10.1016/0143-4179(88)90076-5; Tirado-Santiago G, 2006, BEHAV NEUROSCI, V120, P1093, DOI 10.1037/0735-7044.120.5.1093; Vijayraghavan S, 2007, NAT NEUROSCI, V10, P376, DOI 10.1038/nn1846; Wright M, 2001, Twin Res, V4, P48, DOI 10.1375/1369052012146; Xue G, 2004, NEUROIMAGE, V22, P1, DOI 10.1016/j.neuroimage.2004.01.013; Zhang Y, 2007, P NATL ACAD SCI USA, V104, P20552, DOI 10.1073/pnas.0707106104; Zhu B, 2010, MEMORY, V18, P543, DOI 10.1080/09658211.2010.487051	54	27	28	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2011	6	3							e17365	10.1371/journal.pone.0017365	http://dx.doi.org/10.1371/journal.pone.0017365			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	730HX	21738684	Green Published, gold			2022-12-27	WOS:000288025500012
J	Dai, JN; Zong, Y; Zhong, LM; Li, YM; Zhang, W; Bian, LG; Ai, QL; Liu, YD; Sun, J; Lu, D				Dai, Ji-Nan; Zong, Yi; Zhong, Lian-Mei; Li, Yue-Min; Zhang, Wei; Bian, Li-Gong; Ai, Qing-Long; Liu, Yi-Dan; Sun, Jun; Lu, Di			Gastrodin Inhibits Expression of Inducible NO Synthase, Cyclooxygenase-2 and Proinflammatory Cytokines in Cultured LPS-Stimulated Microglia via MAPK Pathways	PLOS ONE			English	Article							NF-KAPPA-B; ACTIVATED PROTEIN-KINASE; ADAPTIVE IMMUNE-RESPONSES; P-HYDROXYBENZYL ALCOHOL; CENTRAL-NERVOUS-SYSTEM; NITRIC-OXIDE; NEURODEGENERATIVE DISEASES; SIGNALING PATHWAYS; CELLS; INFLAMMATION	Background: Microglial activation plays an important role in neurodegenerative diseases by producing several proinflammatory enzymes and proinflammatory cytokines. The phenolic glucoside gastrodin, a main constituent of a Chinese herbal medicine, has been known to display anti-inflammatory properties. The current study investigates the potential mechanisms whereby gastrodin affects the expression of potentially pro-inflammatory proteins by cultured murine microglial BV-2 cells stimulated with lipopolysaccharide (LPS). Methodology/Principal Findings: BV-2 cells were pretreated with gastrodin (30, 40, and 60 mu M) for 1 h and then stimulated with LPS (1 mu g/ml) for another 4 h. The effects on proinflammatory enzymes, inducible nitric oxide synthase (iNOS) and cyclooxygenase-2 (COX-2), and proinflammatory cytokines, tumor necrosis factor-alpha (TNF-alpha), and interleukin-1 beta (IL-1 beta), are analysed by double-immunofluorescence labeling and RT-PCR assay. To reveal the mechanisms of action of gastrodin we investigated the involvement of mitogen-activated protein kinases (MAPKs) cascades and their downstream transcription factors, nuclear factor-kappa B (NF-kappa B) and cyclic AMP-responsive element (CRE)-binding protein (CREB). Gastrodin significantly reduced the LPS-induced protein and mRNA expression levels of iNOS, COX-2, TNF-alpha, IL-1 beta and NF-kappa B. LPS (1 mu g/ml, 30 min)-induced phosphorylation of extracellular signal-regulated kinase 1/2 (ERK1/2), c-Jun N-terminal protein kinase (JNK) and p38 mitogen-activated protein kinase (p38 MAPK) and this was inhibited by pretreatment of BV-2 cells with different concentrations of gastrodin (30, 40, and 60 mu M). In addition, gastrodin blocked LPS-induced phosphorylation of inhibitor kappa B-alpha (I kappa B-alpha) (and hence the activation of NF-kappa B) and of CREB, respectively. Conclusion and Implications: This study indicates that gastrodin significantly attenuate levels of neurotoxic proinflammatory mediators and proinflammatory cytokines by inhibition of the NF-kappa B signaling pathway and phosphorylation of MAPKs in LPS-stimulated microglial cells. Arising from the above, we suggest that gastrodin has a potential as an anti-inflammatory drug candidate in neurodegenerative diseases.	[Dai, Ji-Nan; Zong, Yi; Li, Yue-Min; Bian, Li-Gong; Sun, Jun; Lu, Di] Kunming Med Univ, Dept Anat, Kunming, Yunnan, Peoples R China; [Zhong, Lian-Mei; Zhang, Wei; Ai, Qing-Long] Kunming Med Univ, Affiliated Hosp 1, Dept Neurol, Kunming, Yunnan, Peoples R China; [Liu, Yi-Dan] Kunming Pharmaceut Corp, Kunming, Yunnan, Peoples R China; [Lu, Di] Kunming Med Univ, Rehabil Engn Res Lab, Biomed Engn Res Ctr, Kunming, Yunnan, Peoples R China	Kunming Medical University; Kunming Medical University; Kunming Medical University	Dai, JN (corresponding author), Kunming Med Univ, Dept Anat, Kunming, Yunnan, Peoples R China.	sunjun91@hotmail.com; ludi20040609@126.com		FRANCK, Gregory/0000-0002-4288-9034; Michineau, Stephanie/0000-0001-7752-2956; GERVAIS, Marianne/0000-0002-4431-789X	National Natural Sciences Foundation of China [30860336, 30560170]; Department of Science and Technology of Yunnan Province [2008CC007, 2009CI033]; Department of Science and Technology of Yunnan Province-Kunming Medical University [2008CD016, 2010CD156]	National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); Department of Science and Technology of Yunnan Province; Department of Science and Technology of Yunnan Province-Kunming Medical University	This work was supported in part by grants (30860336 and 30560170) from the National Natural Sciences Foundation of China, the grants (2008CC007 and 2009CI033) from the Department of Science and Technology of Yunnan Province, and the grants (2008CD016 and 2010CD156) from the Joint Special Funds for the Department of Science and Technology of Yunnan Province-Kunming Medical University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Ajmone-Cat MA, 2003, J NEUROCHEM, V84, P413, DOI 10.1046/j.1471-4159.2003.01562.x; Amor S, 2010, IMMUNOLOGY, V129, P154, DOI 10.1111/j.1365-2567.2009.03225.x; Ankeny DP, 2009, NEUROSCIENCE, V158, P1112, DOI 10.1016/j.neuroscience.2008.07.001; Asanuma M, 2004, CURR PHARM DESIGN, V10, P695, DOI 10.2174/1381612043453072; Bal-Price A, 2002, J NEUROCHEM, V80, P73, DOI 10.1046/j.0022-3042.2001.00675.x; BLASI E, 1990, J NEUROIMMUNOL, V27, P229, DOI 10.1016/0165-5728(90)90073-V; Brown GC, 2010, MOL NEUROBIOL, V41, P242, DOI 10.1007/s12035-010-8105-9; Cao Q, 2010, J NEUROSCI RES, V88, P2701, DOI 10.1002/jnr.22429; Chen SR, 2010, BIOL PHARM BULL, V33, P1307, DOI 10.1248/bpb.33.1307; Choi Y, 2009, BRIT J PHARMACOL, V156, P933, DOI 10.1111/j.1476-5381.2009.00022.x; Fontana A, 2010, BRAIN, V133, P1300, DOI 10.1093/brain/awq086; Giovannini MG, 2003, INT J IMMUNOPATH PH, V16, P31; Hanisch UK, 2002, GLIA, V40, P140, DOI 10.1002/glia.10161; Hatziieremia S, 2006, BRIT J PHARMACOL, V149, P188, DOI 10.1038/sj.bjp.0706856; Hsieh MT, 1997, J ETHNOPHARMACOL, V56, P45, DOI 10.1016/S0378-8741(96)01501-2; Klegeris A, 2007, CURR OPIN NEUROL, V20, P351, DOI 10.1097/WCO.0b013e3280adc943; Lee MJ, 2009, J PHARMACOL SCI, V111, P216, DOI 10.1254/jphs.09153SC; Liang X, 2007, J MOL NEUROSCI, V33, P94, DOI 10.1007/s12031-007-0058-8; Lim JY, 2010, EUR J PHARMACOL, V642, P10, DOI 10.1016/j.ejphar.2010.05.047; Lin LC, 2008, J PHARMACEUT BIOMED, V48, P909, DOI 10.1016/j.jpba.2008.07.013; Long-Smith CM, 2009, PROG NEUROBIOL, V89, P277, DOI 10.1016/j.pneurobio.2009.08.001; Lue LF, 2010, MOL NEUROBIOL, V41, P115, DOI 10.1007/s12035-010-8106-8; Martindale JL, 2002, J CELL PHYSIOL, V192, P1, DOI 10.1002/jcp.10119; Matsuda T, 2005, AM J TRANSPLANT, V5, P484, DOI 10.1046/j.1600-6143.2004.00716.x; Miller RL, 2009, NEUROCHEM RES, V34, P55, DOI 10.1007/s11064-008-9656-2; Murphy S, 2000, GLIA, V29, P1, DOI 10.1002/(SICI)1098-1136(20000101)29:1<1::AID-GLIA1>3.0.CO;2-N; Nakajima K, 1998, Hum Cell, V11, P141; Nakajima K, 2001, J BIOCHEM-TOKYO, V130, P169, DOI 10.1093/oxfordjournals.jbchem.a002969; Nam KN, 2008, EUR J PHARMACOL, V589, P53, DOI 10.1016/j.ejphar.2008.03.034; Nam KN, 2010, EUR J PHARMACOL, V648, P110, DOI 10.1016/j.ejphar.2010.09.003; Ojemann LM, 2006, EPILEPSY BEHAV, V8, P376, DOI 10.1016/j.yebeh.2005.12.009; Olson JK, 2004, J IMMUNOL, V173, P3916, DOI 10.4049/jimmunol.173.6.3916; Roy A, 2006, J BIOL CHEM, V281, P14971, DOI 10.1074/jbc.M600236200; SALVEMINI D, 1993, P NATL ACAD SCI USA, V90, P7240, DOI 10.1073/pnas.90.15.7240; Son HY, 2009, J PHARMACOL SCI, V109, P368, DOI 10.1254/jphs.08197FP; Spooren A, 2010, CELL SIGNAL, V22, P871, DOI 10.1016/j.cellsig.2010.01.018; Suzumura A, 2006, ANN NY ACAD SCI, V1088, P219, DOI 10.1196/annals.1366.012; Szczepanik AM, 2003, J ALZHEIMERS DIS, V5, P105, DOI 10.3233/JAD-2003-5205; Tai YF, 2007, BRAIN RES BULL, V72, P148, DOI 10.1016/j.brainresbull.2006.10.029; Tansey MG, 2010, NEUROBIOL DIS, V37, P510, DOI 10.1016/j.nbd.2009.11.004; Vaillancourt F, 2007, J CELL BIOCHEM, V100, P1217, DOI 10.1002/jcb.21110; Vitor CE, 2009, BRIT J PHARMACOL, V157, P1034, DOI 10.1111/j.1476-5381.2009.00271.x; Wang JY, 2003, J NEUROSCI RES, V72, P508, DOI 10.1002/jnr.10597; Wang MJ, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-99; Weiner HL, 2009, ANN NEUROL, V65, P239, DOI 10.1002/ana.21640; Wu CR, 1996, PLANTA MED, V62, P317, DOI 10.1055/s-2006-957892; Xu X, 2007, PLANTA MED, V73, P650, DOI 10.1055/s-2007-981523; Yabe T, 2005, GLIA, V50, P223, DOI 10.1002/glia.20171; Zeng XH, 2006, PLANTA MED, V72, P1359, DOI 10.1055/s-2006-951709	49	185	205	3	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2011	6	7							e21891	10.1371/journal.pone.0021891	http://dx.doi.org/10.1371/journal.pone.0021891			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791WM	22194945	Green Published, Green Submitted, gold			2022-12-27	WOS:000292699000014
J	Liu, CC; Guo, MS; Lin, FHY; Hsiao, KN; Chang, KHW; Chou, AH; Wang, YC; Chen, YC; Yang, CS; Chong, PCS				Liu, Chia-Chyi; Guo, Meng-Shin; Lin, Fion Hsiao-Yu; Hsiao, Kuang-Nan; Chang, Kate Hsuen-Wen; Chou, Ai-Hsiang; Wang, Yu-Chao; Chen, Yu-Ching; Yang, Chung-Shi; Chong, Pele Choi-Sing			Purification and Characterization of Enterovirus 71 Viral Particles Produced from Vero Cells Grown in a Serum-Free Microcarrier Bioreactor System	PLOS ONE			English	Article							LETHAL ENTEROVIRUS-71; PUBLIC-HEALTH; DISEASE VIRUS; PROTECTS MICE; POLIOVIRUS; INFECTION; VACCINE; STRAIN; VP1; IDENTIFICATION	Background: Enterovirus 71 (EV71) infections manifest most commonly as a childhood exanthema known as hand-foot-and-mouth disease (HFMD) and can cause neurological disease during acute infection. Principal Finding: In this study, we describe the production, purification and characterization of EV71 virus produced from Vero cells grown in a five-liter serum-free bioreactor system containing 5 g/L Cytodex 1 microcarrier. The viral titer was >10(6) TCID(50)/mL by 6 days post infection when a MOI of 10(-5) was used at the initial infection. Two EV71 virus fractions were separated and detected when the harvested EV71 virus concentrate was purified by sucrose gradient zonal ultracentrifugation. The EV71 viral particles detected in the 24-28% sucrose fractions had an icosahedral structure 30-31 nm in diameter and had low viral infectivity and RNA content. Three major viral proteins (VP0, VP1 and VP3) were observed by SDS-PAGE. The EV71 viral particles detected in the fractions containing 35-38% sucrose were 33-35 nm in size, had high viral infectivity and RNA content, and were composed of four viral proteins (VP1, VP2, VP3 and VP4), as shown by SDS-PAGE analyses. The two virus fractions were formalin-inactivated and induced high virus neutralizing antibody responses in mouse immunogenicity studies. Both mouse antisera recognized the immunodominant linear neutralization epitope of VP1 (residues 211-225). Conclusion: These results provide important information for cell-based EV71 vaccine development, particularly for the preparation of working standards for viral antigen quantification.	[Liu, Chia-Chyi; Guo, Meng-Shin; Lin, Fion Hsiao-Yu; Hsiao, Kuang-Nan; Chang, Kate Hsuen-Wen; Chou, Ai-Hsiang; Chong, Pele Choi-Sing] Natl Hlth Res Inst, Vaccine Res & Dev Ctr, Zhunan Town, Miaoli County, Taiwan; [Wang, Yu-Chao; Chen, Yu-Ching; Yang, Chung-Shi] Natl Hlth Res Inst, Ctr Nanomed Res, Zhunan Town, Miaoli County, Taiwan; [Chong, Pele Choi-Sing] China Med Univ, Grad Inst Immunol, Taichung, Taiwan	National Health Research Institutes - Taiwan; National Health Research Institutes - Taiwan; China Medical University Taiwan	Liu, CC (corresponding author), Natl Hlth Res Inst, Vaccine Res & Dev Ctr, Zhunan Town, Miaoli County, Taiwan.	pelechong@nhri.org.tw	Liu, Chia-Chyi/A-8215-2012; Chong, Pele/E-3855-2010; Yang, Chung-Shi/E-3999-2010; Loos, Ruth/Q-2862-2016	Liu, Chia-Chyi/0000-0002-6257-0389; Loos, Ruth/0000-0002-8532-5087	Department of Health, the Taiwan CDC; National Science Council; National Health Research Institutes, Taiwan	Department of Health, the Taiwan CDC; National Science Council(Ministry of Science and Technology, Taiwan); National Health Research Institutes, Taiwan(National Health Research Institutes - Taiwan)	This work was supported by the Department of Health, the Taiwan CDC, the National Science Council and the National Health Research Institutes, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arita M, 2007, J VIROL, V81, P9386, DOI 10.1128/JVI.02856-06; Blom N, 1996, PROTEIN SCI, V5, P2203, DOI 10.1002/pro.5560051107; Brown BA, 1995, VIRUS RES, V39, P195, DOI 10.1016/0168-1702(95)00087-9; Chang GH, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-106; Chiu CH, 2006, MICROBES INFECT, V8, P1671, DOI 10.1016/j.micinf.2006.01.021; Chung YC, 2008, VACCINE, V26, P1855, DOI 10.1016/j.vaccine.2008.01.058; Curry S, 1997, J VIROL, V71, P9743, DOI 10.1128/JVI.71.12.9743-9752.1997; FERGUSON M, 1990, J GEN VIROL, V71, P1271, DOI 10.1099/0022-1317-71-6-1271; Guang D, 2007, VIRUS RES, V125, P61, DOI 10.1016/j.virusres.2006.12.005; Guang DM, 2007, MICROBES INFECT, V9, P1299; Ho MT, 1999, NEW ENGL J MED, V341, P929, DOI 10.1056/NEJM199909233411301; Huang SW, 2009, J CLIN MICROBIOL, V47, P3653, DOI 10.1128/JCM.00630-09; HUMMELER K, 1962, VIROLOGY, V16, P84, DOI 10.1016/0042-6822(62)90205-2; Lee MS, 2010, EXPERT REV VACCINES, V9, P149, DOI [10.1586/erv.09.152, 10.1586/ERV.09.152]; Lin KH, 2006, J MED VIROL, V78, P254, DOI 10.1002/jmv.20534; Lin YC, 2002, VACCINE, V20, P2485, DOI 10.1016/S0264-410X(02)00182-2; Liu CC, 2007, VACCINE, V25, P19, DOI 10.1016/j.vaccine.2006.06.083; MAYER MM, 1957, J IMMUNOL, V78, P435; McMinn PC, 2002, FEMS MICROBIOL REV, V26, P91, DOI 10.1111/j.1574-6976.2002.tb00601.x; McMinn PC, 2003, NEUROL J SE ASIA, V8, P57; MINOR PD, 1980, J GEN VIROL, V51, P147, DOI 10.1099/0022-1317-51-1-147; MINOR PD, 1991, J GEN VIROL, V72, P2475, DOI 10.1099/0022-1317-72-10-2475; Nishimura Y, 2009, NAT MED, V15, P794, DOI 10.1038/nm.1961; Ong KC, 2010, J VIROL, V84, P661, DOI 10.1128/JVI.00999-09; PANEZUTTI H, 1993, INFECT IMMUN, V61, P1867, DOI 10.1128/IAI.61.5.1867-1872.1993; Qiu J, 2008, LANCET NEUROL, V7, P868, DOI 10.1016/S1474-4422(08)70207-2; REED L. J., 1938, AMER JOUR HYG, V27, P493; SCHMIDT NJ, 1974, J INFECT DIS, V129, P304, DOI 10.1093/infdis/129.3.304; Sivasamugham LA, 2006, J MED VIROL, V78, P1096, DOI 10.1002/jmv.20668; Tung Wong Siew, 2007, Genet Vaccines Ther, V5, P6, DOI 10.1186/1479-0556-5-6; VONSEEFRIED A, 1984, REV INFECT DIS, V6, pS345; Wu CN, 2001, VACCINE, V20, P895, DOI 10.1016/S0264-410X(01)00385-1; Wu SC, 2004, VACCINE, V22, P3858, DOI 10.1016/j.vaccine.2004.05.037; Xu J, 2010, VACCINE, V28, P3516, DOI 10.1016/j.vaccine.2010.03.003; Yamayoshi S, 2009, NAT MED, V15, P798, DOI 10.1038/nm.1992	35	139	164	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2011	6	5							e20005	10.1371/journal.pone.0020005	http://dx.doi.org/10.1371/journal.pone.0020005			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	763LP	21603631	Green Submitted, Green Published, gold			2022-12-27	WOS:000290558500041
J	Schmeier, S; Schaefer, U; MacPherson, CR; Bajic, VB				Schmeier, Sebastian; Schaefer, Ulf; MacPherson, Cameron R.; Bajic, Vladimir B.			dPORE-miRNA: Polymorphic Regulation of MicroRNA Genes	PLOS ONE			English	Article							TRANSCRIPTION FACTOR-BINDING; DATABASE; CANCER; IDENTIFICATION; DISEASES; UPDATE; ROLES; SITES; SNP	Background: MicroRNAs (miRNAs) are short non-coding RNA molecules that act as post-transcriptional regulators and affect the regulation of protein-coding genes. Mostly transcribed by PolII, miRNA genes are regulated at the transcriptional level similarly to protein-coding genes. In this study we focus on human miRNAs. These miRNAs are involved in a variety of pathways and can affect many diseases. Our interest is on possible deregulation of the transcription initiation of the miRNA encoding genes, which is facilitated by variations in the genomic sequence of transcriptional control regions (promoters). Methodology: Our aim is to provide an online resource to facilitate the investigation of the potential effects of single nucleotide polymorphisms (SNPs) on miRNA gene regulation. We analyzed SNPs overlapped with predicted transcription factor binding sites (TFBSs) in promoters of miRNA genes. We also accounted for the creation of novel TFBSs due to polymorphisms not present in the reference genome. The resulting changes in the original TFBSs and potential creation of new TFBSs were incorporated into the Dragon Database of Polymorphic Regulation of miRNA genes (dPORE-miRNA). Conclusions: The dPORE-miRNA database enables researchers to explore potential effects of SNPs on the regulation of miRNAs. dPORE-miRNA can be interrogated with regards to: a/miRNAs (their targets, or involvement in diseases, or biological pathways), b/SNPs, or c/transcription factors. dPORE-miRNA can be accessed at http://cbrc.kaust.edu.sa/dpore and http://apps.sanbi.ac.za/dpore/. Its use is free for academic and non-profit users.	[Schmeier, Sebastian; Schaefer, Ulf; MacPherson, Cameron R.; Bajic, Vladimir B.] King Abdullah Univ Sci & Technol KAUST, Computat Biosci Res Ctr CBRC, Jeddah, Saudi Arabia	King Abdullah University of Science & Technology	Schmeier, S (corresponding author), King Abdullah Univ Sci & Technol KAUST, Computat Biosci Res Ctr CBRC, Jeddah, Saudi Arabia.	vladimir.bajic@kaust.edu.sa	Schmeier, Sebastian/D-4731-2011; Bajic, Vladimir/D-2810-2009	Schmeier, Sebastian/0000-0002-3947-8226; MacPherson, Cameron/0000-0002-8945-9736; Bajic, Vladimir/0000-0001-5435-4750; Jankovic, Boris/0000-0003-1868-6007				Alexiou P, 2010, NUCLEIC ACIDS RES, V38, pD137, DOI 10.1093/nar/gkp888; Bandiera S, 2010, CLIN GENET, V77, P306, DOI 10.1111/j.1399-0004.2010.01370.x; Bao L, 2007, NUCLEIC ACIDS RES, V35, pD51, DOI 10.1093/nar/gkl797; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bohnsack MT, 2004, RNA, V10, P185, DOI 10.1261/rna.5167604; Borchert GM, 2006, NAT STRUCT MOL BIOL, V13, P1097, DOI 10.1038/nsmb1167; Bracht J, 2004, RNA, V10, P1586, DOI 10.1261/rna.7122604; Brookes AJ, 1999, GENE, V234, P177, DOI 10.1016/S0378-1119(99)00219-X; Cai XZ, 2004, RNA, V10, P1957, DOI 10.1261/rna.7135204; Canella D, 2010, GENOME RES, V20, P710, DOI 10.1101/gr.101337.109; Conde L, 2006, NUCLEIC ACIDS RES, V34, pW621, DOI 10.1093/nar/gkl071; Corcoran DL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005279; Denli AM, 2004, NATURE, V432, P231, DOI 10.1038/nature03049; Du LQ, 2010, CANCER METAST REV, V29, P109, DOI 10.1007/s10555-010-9204-9; Fujita S, 2008, BIOINFORMATICS, V24, P303, DOI 10.1093/bioinformatics/btm589; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Gregory RI, 2004, NATURE, V432, P235, DOI 10.1038/nature03120; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Hariharan M, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-108; Heckmann JM, 2010, GENES IMMUN, V11, P1, DOI 10.1038/gene.2009.61; Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896; Kasowski M, 2010, SCIENCE, V328, P232, DOI 10.1126/science.1183621; Kel AE, 2003, NUCLEIC ACIDS RES, V31, P3576, DOI 10.1093/nar/gkg585; Kim BC, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S1-S2; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lee Y, 2004, EMBO J, V23, P4051, DOI 10.1038/sj.emboj.7600385; Lee Y, 2002, EMBO J, V21, P4663, DOI 10.1093/emboj/cdf476; Li GQ, 2010, BLOOD, V115, P1416, DOI 10.1182/blood-2009-07-234963; Loeffler-Ragg J, 2008, EXPERT OPIN INV DRUG, V17, P1517, DOI 10.1517/13543784.17.10.1517 ; Marson A, 2008, CELL, V134, P521, DOI 10.1016/j.cell.2008.07.020; Matys V, 2006, NUCLEIC ACIDS RES, V34, pD108, DOI 10.1093/nar/gkj143; Milanezi F, 2008, EXPERT REV MOL DIAGN, V8, P417, DOI 10.1586/14737159.8.4.417; O'Connell RM, 2010, NAT REV IMMUNOL, V10, P111, DOI 10.1038/nri2708; Ozsolak F, 2008, GENE DEV, V22, P3172, DOI 10.1101/gad.1706508; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Papadopoulos GL, 2009, NUCLEIC ACIDS RES, V37, pD155, DOI 10.1093/nar/gkn809; Rajewsky N, 2006, NAT GENET, V38, pS8, DOI 10.1038/ng1798; Rhead B, 2010, NUCLEIC ACIDS RES, V38, pD613, DOI 10.1093/nar/gkp939; Rioux JD, 2001, NAT GENET, V29, P223, DOI 10.1038/ng1001-223; Ruepp A, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-1-r6; Sayers EW, 2010, NUCLEIC ACIDS RES, V38, pD5, DOI 10.1093/nar/gkp967; Schmeier S, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-595; Vignal A, 2002, GENET SEL EVOL, V34, P275, DOI [10.1186/1297-9686-34-3-275, 10.1051/gse:2002009]; Wang J, 2010, NUCLEIC ACIDS RES, V38, pD119, DOI 10.1093/nar/gkp803; Yu ZR, 2010, AM J PATHOL, V176, P1058, DOI 10.2353/ajpath.2010.090664; Yue P, 2006, J MOL BIOL, V356, P1263, DOI 10.1016/j.jmb.2005.12.025; Zhou XF, 2007, PLOS COMPUT BIOL, V3, P412, DOI 10.1371/journal.pcbi.0030037	50	27	31	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2011	6	2							e16657	10.1371/journal.pone.0016657	http://dx.doi.org/10.1371/journal.pone.0016657			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717IN	21750739	gold, Green Submitted, Green Published			2022-12-27	WOS:000287037000016
